PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zalenskaya, IA; Joseph, T; Bavarva, J; Yousefieh, N; Jackson, SS; Fashemi, T; Yamamoto, HS; Settlage, R; Fichorova, RN; Doncel, GF				Zalenskaya, Irina A.; Joseph, Theresa; Bavarva, Jasmin; Yousefieh, Nazita; Jackson, Suzanne S.; Fashemi, Titilayo; Yamamoto, Hidemi S.; Settlage, Robert; Fichorova, Raina N.; Doncel, Gustavo F.			Gene Expression Profiling of Human Vaginal Cells In Vitro Discriminates Compounds with Pro-Inflammatory and Mucosa-Altering Properties: Novel Biomarkers for Preclinical Testing of HIV Microbicide Candidates	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; CCR6-EXPRESSING TH17 CELLS; T-CELLS; SEXUAL TRANSMISSION; EPITHELIAL-CELLS; CERVICOVAGINAL INFLAMMATION; NEISSERIA-GONORRHOEAE; TOPICAL MICROBICIDES; BACTERIAL VAGINOSIS; IMMUNE-RESPONSES	Background Inflammation and immune activation of the cervicovaginal mucosa are considered factors that increase susceptibility to HIV infection. Therefore, it is essential to screen candidate anti-HIV microbicides for potential mucosal immunomodulatory/inflammatory effects prior to further clinical development. The goal of this study was to develop an in vitro method for preclinical evaluation of the inflammatory potential of new candidate microbicides using a microarray gene expression profiling strategy. Methods To this end, we compared transcriptomes of human vaginal cells (Vk2/E6E7) treated with well-characterized pro-inflammatory (PIC) and non-inflammatory (NIC) compounds. PICs included compounds with different mechanisms of action. Gene expression was analyzed using Affymetrix U133 Plus 2 arrays. Data processing was performed using GeneSpring 11.5 (Agilent Technologies, Santa Clara, CA). Results Microarraray comparative analysis allowed us to generate a panel of 20 genes that were consistently deregulated by PICs compared to NICs, thus distinguishing between these two groups. Functional analysis mapped 14 of these genes to immune and inflammatory responses. This was confirmed by the fact that PICs induced NF kappa B pathway activation in Vk2 cells. By testing microbicide candidates previously characterized in clinical trials we demonstrated that the selected PIC-associated genes properly identified compounds with mucosa-altering effects. The discriminatory power of these genes was further demonstrated after culturing vaginal cells with vaginal bacteria. Prevotella bivia, prevalent bacteria in the disturbed microbiota of bacterial vaginosis, induced strong upregulation of seven selected PIC-associated genes, while a commensal Lactobacillus gasseri associated to vaginal health did not cause any changes. Conclusions In vitro evaluation of the immunoinflammatory potential of microbicides using the PIC-associated genes defined in this study could help in the initial screening of candidates prior to entering clinical trials. Additional characterization of these genes can provide further insight into the cervicovaginal immunoinflammatory and mucosal-altering processes that facilitate or limit HIV transmission with implications for the design of prevention strategies.	[Zalenskaya, Irina A.; Joseph, Theresa; Yousefieh, Nazita; Jackson, Suzanne S.; Doncel, Gustavo F.] Eastern Virginia Med Sch, Dept Obstet & Gynecol, CONRAD, Norfolk, VA 23501 USA; [Bavarva, Jasmin; Settlage, Robert] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Fashemi, Titilayo; Yamamoto, Hidemi S.; Fichorova, Raina N.] Harvard Univ, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Lab Genital Tract Biol,Med Sch, Boston, MA 02115 USA	Eastern Virginia Medical School; Virginia Polytechnic Institute & State University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Zalenskaya, IA (corresponding author), Eastern Virginia Med Sch, Dept Obstet & Gynecol, CONRAD, Norfolk, VA 23501 USA.	ZalensIA@EVMS.edu; DoncelGF@EVMS.edu			CONRAD funds; USAID [GPO-A-00-08-00005-00]; NIH/NIAID [YI-AI-1756-01]; Bill and Melinda Gates Foundation [41266]	CONRAD funds(United States Agency for International Development (USAID)); USAID(United States Agency for International Development (USAID)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by CONRAD funds from a cooperative agreement with USAID GPO-A-00-08-00005-00 with additional funds from an interagency agreement with NIH/NIAID YI-AI-1756-01 (GFD), and grant 41266 from the Bill and Melinda Gates Foundation(GFD). The views of the authors expressed in this manuscript do not necessarily reflect those of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Leidos Biomedical Research, Inc. provided support in the form of salaries for author JB but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JL, 2012, BEST PRACT RES CLIN; Aleman-Muench GR, 2012, IMMUNOL CELL BIOL, V90, P137, DOI 10.1038/icb.2011.32; Anderson AC, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0312-5; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Baggiolini M, 1997, J EXP MED, V186, P1189, DOI 10.1084/jem.186.8.1189; Ballagh SA, 2002, CONTRACEPTION, V66, P369, DOI 10.1016/S0010-7824(02)00433-X; Ballweber L, 2011, J VIROL, V85, P13443, DOI 10.1128/JVI.05615-11; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; Blauvelt A, 2000, AIDS, V14, P647, DOI 10.1097/00002030-200004140-00003; Borrow P, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-84; Buve A, 2014, AIDS, V28, P2333, DOI 10.1097/QAD.0000000000000432; Catalone BJ, 2004, ANTIMICROB AGENTS CH, V48, P1837, DOI 10.1128/AAC.48.5.1837-1847.2004; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; Coombs RW, 2003, AIDS, V17, P455, DOI 10.1097/00002030-200303070-00001; Cremel M, 2005, J LEUKOCYTE BIOL, V78, P158, DOI 10.1189/jlb.0305147; Cummins JE, 2009, SEX TRANSM DIS, V36, pS84, DOI 10.1097/OLQ.0b013e3181994191; Darnell GA, 2006, J BIOL CHEM, V281, P31348, DOI 10.1074/jbc.M604220200; de Jong MAWP, 2008, J GEN VIROL, V89, P2398, DOI 10.1099/vir.0.2008/003129-0; Doncel GF, 2004, JAIDS-J ACQ IMM DEF, V37, pS174, DOI 10.1097/00126334-200410013-00008; Doncel GF, 2010, ANTIVIR RES, V88, pS10, DOI 10.1016/j.antiviral.2010.09.018; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Drexler SK, 2010, INT J BIOCHEM CELL B, V42, P506, DOI 10.1016/j.biocel.2009.10.009; Dumais N, 1998, J BIOL CHEM, V273, P27306, DOI 10.1074/jbc.273.42.27306; El Hed A, 2010, J INFECT DIS, V201, P843, DOI 10.1086/651021; Fahrbach KM, 2007, J VIROL, V81, P6858, DOI 10.1128/JVI.02472-06; Fazeli A, 2005, HUM REPROD, V20, P1372, DOI 10.1093/humrep/deh775; Feldblum PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001474; Fichorova RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048418; Fichorova RN, 2011, MBIO, V2, DOI 10.1128/mBio.00168-11; Fichorova RN, 1999, BIOL REPROD, V60, P508, DOI 10.1095/biolreprod60.2.508; Fichorova RN, 2004, JAIDS-J ACQ IMM DEF, V37, pS184, DOI 10.1097/00126334-200410013-00010; Fichorova RN, 2004, BIOL REPROD, V71, P761, DOI 10.1095/biolreprod.104.029603; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Fichorova RN, 2001, INFECT IMMUN, V69, P5840, DOI 10.1128/IAI.69.9.5840-5848.2001; Fichorova RN, 2002, J IMMUNOL, V168, P2424, DOI 10.4049/jimmunol.168.5.2424; Fields S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110980; Friend DR, 2013, ANTIVIR RES, V99, P391, DOI 10.1016/j.antiviral.2013.06.021; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gengiah TN, 2012, EXPERT OPIN INV DRUG, V21, P695, DOI 10.1517/13543784.2012.667072; Gray RH, 2012, J INFECT DIS, V205, P351, DOI 10.1093/infdis/jir751; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Harizi H, 2003, J LEUKOCYTE BIOL, V73, P756, DOI 10.1189/jlb.1002483; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Herbst-Kralovetz MM, 2008, AM J REPROD IMMUNOL, V59, P212, DOI 10.1111/j.1600-0897.2007.00566.x; HILL GB, 1993, AM J OBSTET GYNECOL, V169, P450, DOI 10.1016/0002-9378(93)90339-K; Hirata T, 2010, ENDOCRINOLOGY, V151, P5468, DOI 10.1210/en.2010-0398; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Hladik F, 2010, ANTIVIR RES, V88, pS3, DOI 10.1016/j.antiviral.2010.09.011; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hughes JP, 2012, J INFECT DIS, V205, P358, DOI 10.1093/infdis/jir747; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jespers V, 2013, SEX TRANSM DIS, V40, P729, DOI 10.1097/01.olq.0000431070.38601.03; Johnson TJ, 2012, ANTIMICROB AGENTS CH, V56, P6272, DOI 10.1128/AAC.01431-12; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441; Joseph T, 2012, AM J REPROD IMMUNOL, V67, P482, DOI 10.1111/j.1600-0897.2011.01099.x; Kabashima K, 2003, NAT MED, V9, P744, DOI 10.1038/nm872; Kader M, 2009, MUCOSAL IMMUNOL, V2, P439, DOI 10.1038/mi.2009.90; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2012, BEST PRACT RES CL OB, V26, P427, DOI 10.1016/j.bpobgyn.2012.01.010; KELLER AD, 1991, GENE DEV, V5, P868, DOI 10.1101/gad.5.5.868; Khaidakov M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020277; Kim H, 2010, NAT IMMUNOL, V11, P743, DOI 10.1038/ni.1897; Lane BR, 2001, J VIROL, V75, P8195, DOI 10.1128/JVI.75.17.8195-8202.2001; Li DY, 2000, CIRCULATION, V101, P2889, DOI 10.1161/01.CIR.101.25.2889; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McKinnon LR, 2011, J IMMUNOL, V187, P6032, DOI 10.4049/jimmunol.1101836; Medzhitov R, 2000, TRENDS MICROBIOL, V8, P452, DOI 10.1016/S0966-842X(00)01845-X; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Miossec P, 2009, MICROBES INFECT, V11, P625, DOI 10.1016/j.micinf.2009.04.003; Monteiro P, 2011, J IMMUNOL, V186, P4618, DOI 10.4049/jimmunol.1004151; Narimatsu R, 2005, AIDS RES HUM RETROV, V21, P228, DOI 10.1089/aid.2005.21.228; Nasu K, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/976024; NIRUTHISARD S, 1991, SEX TRANSM DIS, V18, P176, DOI 10.1097/00007435-199107000-00010; Nolan GP, 1992, CURR OPIN GENET DEV, V2, P211, DOI 10.1016/S0959-437X(05)80276-X; Obiero J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-289; Onderdonk AB, 2003, J CLIN MICROBIOL, V41, P1073, DOI 10.1128/JCM.41.3.1073-1079.2003; Patton DL, 2007, ANTIMICROB AGENTS CH, V51, P1608, DOI 10.1128/AAC.00984-06; Pavlova SI, 2002, J APPL MICROBIOL, V92, P451, DOI 10.1046/j.1365-2672.2002.01547.x; Pendharkar S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-43; Peterson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001312; Prendergast A, 2010, AIDS, V24, P491, DOI 10.1097/QAD.0b013e3283344895; Pudney J, 2005, BIOL REPROD, V73, P1253, DOI 10.1095/biolreprod.105.043133; Ravel J, 2012, MBIO, V3, DOI 10.1128/mBio.00370-12; REDONDOLOPEZ V, 1990, REV INFECT DIS, V12, P856; Romano JW, 2012, CURR HIV RES, V10, P9, DOI 10.2174/157016212799304625; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Sabroe I, 2008, J PATHOL, V214, P126, DOI 10.1002/path.2264; Schroder WA, 2011, CRIT REV IMMUNOL, V31, P15, DOI 10.1615/CritRevImmunol.v31.i1.20; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Shacklett BL, 2010, CURR OPIN HIV AIDS, V5, P128, DOI 10.1097/COH.0b013e328335c178; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Shipitsyna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060670; Sokal DC, 2013, ANTIVIR THER, V18, P301, DOI 10.3851/IMP2311; Spandorfer SD, 2001, J REPROD MED, V46, P806; Stone AB, 2013, AIDS, V27, P2261, DOI 10.1097/QAD.0b013e32836239b4; Sugaya M, 2004, J IMMUNOL, V172, P2219, DOI 10.4049/jimmunol.172.4.2219; Szameit S, 2008, CLIN CHEM, V54, P525, DOI 10.1373/clinchem.2007.097386; Thurman AR, 2011, AM J REPROD IMMUNOL, V65, P89, DOI 10.1111/j.1600-0897.2010.00902.x; Tureci O, 2003, FASEB J, V17, P836, DOI 10.1096/fj.02-0724com; Turini ME, 2002, ANNU REV MED, V53, P35, DOI 10.1146/annurev.med.53.082901.103952; Van Damme L, 2004, TROP MED INT HEALTH, V9, P1290, DOI 10.1111/j.1365-3156.2004.01338.x; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Verstrepen L, 2010, BIOCHEM PHARMACOL, V80, P2009, DOI 10.1016/j.bcp.2010.06.044; Ward H, 2010, CURR OPIN HIV AIDS, V5, P305, DOI 10.1097/COH.0b013e32833a8844; WARREN JS, 1990, CRIT REV CL LAB SCI, V28, P37, DOI 10.3109/10408369009105897; Weiler AM, 2008, J VIROL, V82, P4154, DOI 10.1128/JVI.01947-07; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Yu L, 2009, AM J REPROD IMMUNOL, V62, P1, DOI 10.1111/j.1600-0897.2009.00712.x; Zalenskaya IA, 2000, BIOCHEM BIOPH RES CO, V279, P213, DOI 10.1006/bbrc.2000.3917; Zalenskaya IA, 2011, AM J REPROD IMMUNOL, V65, P569, DOI 10.1111/j.1600-0897.2010.00964.x; Zhong MH, 2012, ANTIMICROB AGENTS CH, V56, P3121, DOI 10.1128/AAC.05950-11	122	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128557	10.1371/journal.pone.0128557	http://dx.doi.org/10.1371/journal.pone.0128557			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052926	Green Published, gold, Green Submitted			2022-12-27	WOS:000355955300044
J	Balkenius, A; Johansson, AJ; Balkenius, C				Balkenius, Anna; Johansson, Anders J.; Balkenius, Christian			Comparing Analysis Methods in Functional Calcium Imaging of the Insect Brain	PLOS ONE			English	Article							HONEYBEE BRAIN; PARAMETER-ESTIMATION; ANTENNAL LOBE; MUSHROOM BODY; MANDUCA-SEXTA; ROC CURVE; MOTH; REPRESENTATION; PATTERNS; NEURONS	We investigate four different methods for background estimation in calcium imaging of the insect brain and evaluate their performance on six data sets consisting of data recorded from two sites in two species of moths. The calcium fluorescence decay curve outside the potential response is estimated using either a low-pass filter or constant, linear or polynomial regression, and is subsequently used to calculate the magnitude, latency and duration of the response. The magnitude and variance of the responses that are obtained by the different methods are compared, and, by computing the receiver operating characteristics of a classifier based on response magnitude, we evaluate the ability of each method to detect the stimulus type and conclude that a polynomial approximation of the background gives the overall best result.	[Balkenius, Anna] Swedish Univ Agr Sci, Alnarp, Sweden; [Johansson, Anders J.] Lund Univ, Lund, Sweden; [Balkenius, Christian] Lund Univ Cognit Sci, Lund, Sweden	Swedish University of Agricultural Sciences; Lund University; Lund University	Balkenius, A (corresponding author), Swedish Univ Agr Sci, Alnarp, Sweden.	anna.balkenius@slu.se	Balkenius, Christian/V-6456-2019	Balkenius, Christian/0000-0002-1478-6329	Swedish Research Council (VR); Crafoord Foundation	Swedish Research Council (VR)(Swedish Research Council); Crafoord Foundation	This work was funded by grants from the Swedish Research Council (VR: vr.se; FORMAS: formas.se) and the Crafoord Foundation (www.crafoord.se) to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, VECLIB REF; [Anonymous], 2011, VIMAGE PROGR GUID; Balkenius A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032133; Balkenius A, 2009, J EXP BIOL, V212, P535, DOI 10.1242/jeb.021220; Bisch-Knaden S, 2012, J EXP BIOL, V215, P1542, DOI 10.1242/jeb.068064; Bootman MD, 2013, COLD SPRING HARBOR P, V2013, DOI [10.1101/pdb.top066050, DOI 10.1101/PDB.TOP066050]; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Chang C, 1998, APPL MATH COMPUT, V96, P101, DOI 10.1016/S0096-3003(97)10108-4; Chen TW, 2006, BIOPHYS J, V90, P2534, DOI 10.1529/biophysj.105.070854; Duda RO, 1999, PATTERN CLASSIFICATI; Enderlein J, 1997, OPT COMMUN, V134, P371, DOI 10.1016/S0030-4018(96)00384-7; Galizia CG, 1997, J NEUROSCI METH, V76, P61, DOI 10.1016/S0165-0270(97)00080-0; Galizia CG, 1999, NATURWISSENSCHAFTEN, V86, P533, DOI 10.1007/s001140050669; Galizia CG, 2004, ADV INSECT SENSORY N, P349, DOI DOI 10.1201/9781420039429.CH13; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hansson BS, 2003, J COMP PHYSIOL A, V189, P301, DOI 10.1007/s00359-003-0403-5; Holmstrom K, 2002, APPL MATH COMPUT, V126, P31, DOI 10.1016/S0096-3003(00)00138-7; Janz N, 2013, P ROYAL SOC B, V280, P1; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Joucla S, 2013, CELL CALCIUM, V54, P71, DOI 10.1016/j.ceca.2013.04.005; Meijerink J, 2003, J COMP NEUROL, V467, P11, DOI 10.1002/cne.10914; Menzel R, 2005, J EXP BIOL, V208, P4317, DOI 10.1242/jeb.01908; Nahavandipoor V, 2011, CONCURRENT PROGRAMMI; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Saveer AM, 2012, P ROY SOC B-BIOL SCI, V279, P2314, DOI 10.1098/rspb.2011.2710; Soelter J, 2014, NEUROIMAGE, V98, P279, DOI 10.1016/j.neuroimage.2014.04.041; STERNBERG SR, 1983, BIOMEDICAL IMAGE PRO, P22; Stetter M, 2001, NEUROIMAGE, V13, P119, DOI 10.1006/nimg.2000.0679; Trona F, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0267	29	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129614	10.1371/journal.pone.0129614	http://dx.doi.org/10.1371/journal.pone.0129614			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046538	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000355652200164
J	Ghaleb, AM; Bialkowska, AB; Snider, AJ; Gnatenko, DV; Hannun, YA; Yang, VW; Schmidt, VA				Ghaleb, Amr M.; Bialkowska, Agnieszka B.; Snider, Ashley J.; Gnatenko, Dmitri V.; Hannun, Yusuf A.; Yang, Vincent W.; Schmidt, Valentina A.			IQ Motif-Containing GTPase-Activating Protein 2 (IQGAP2) Is a Novel Regulator of Colonic Inflammation in Mice	PLOS ONE			English	Article							NF-KAPPA-B; SIGNAL-TRANSDUCTION PATHWAY; SODIUM-INDUCED COLITIS; TIME QUANTITATIVE PCR; BOWEL-DISEASE; GENE-EXPRESSION; CANCER; TUMORIGENESIS; MACROPHAGES; INVASION	IQ motif-containing GTPase-activating protein 2 (IQGAP2) is a multidomain scaffolding protein that plays a role in cytoskeleton regulation by juxtaposing Rho GTPase and Ca2+/calmodulin signals. While IQGAP2 suppresses tumorigenesis in liver, its role in pathophysiology of the gastrointestinal tract remains unexplored. Here we report that IQGAP2 is required for the inflammatory response in colon. Mice lacking Iqgap2 gene (Iqgap2(-/-) mice) were resistant to chemically-induced colitis. Unlike wild-type controls, Iqgap2(-/-) mice treated with 3% dextran sulfate sodium (DSS) in water for 13 days displayed no injury to colonic epithelium. Mechanistically, resistance to colitis was associated with suppression of colonic NF-kappa B signaling and IL-6 synthesis, along with diminished neutrophil and macrophage production and recruitment in Iqgap2(-/-) mice. Finally, alterations in IQGAP2 expression were found in colons of patients with inflammatory bowel disease (IBD). Our findings indicate that IQGAP2 promotes inflammatory response at two distinct levels; locally, in colonic epithelium through TLR4/NF-kappa B signaling pathway, and systemically, via control of maturation and recruitment of myeloid immune cells. This work identifies a novel mechanism of colonic inflammation mediated by signal transducing scaffolding protein IQGAP2. IQGAP2 domain-specific blocking agents may represent a conceptually novel strategy for therapy of IBD and other inflammation-associated disorders, including cancer.	[Ghaleb, Amr M.; Bialkowska, Agnieszka B.; Snider, Ashley J.; Gnatenko, Dmitri V.; Hannun, Yusuf A.; Yang, Vincent W.; Schmidt, Valentina A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Snider, Ashley J.] Northport Vet Affairs Med Ctr, Northport, NY USA; [Snider, Ashley J.; Hannun, Yusuf A.; Yang, Vincent W.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Gnatenko, Dmitri V.] SUNY Stony Brook, Genom Core Facil, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Schmidt, VA (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.	Valentina.Schmidt@stonybrookmedicine.edu			Research Scholar Grant from the American Cancer Society [RSG-09-033-01-CSM]; National Institutes of Health [DK052230, DK093680]; Sphingolipid Animal Cancer Pathobiology Core grant [P01CA097132]; Department of Medicine and Cancer Center, Stony Brook University; NATIONAL CANCER INSTITUTE [R01CA172517, P01CA097132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093680] Funding Source: NIH RePORTER	Research Scholar Grant from the American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sphingolipid Animal Cancer Pathobiology Core grant; Department of Medicine and Cancer Center, Stony Brook University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Research Scholar Grant RSG-09-033-01-CSM from the American Cancer Society (to VAS), National Institutes of Health grants DK052230 and DK093680 (to VWY); Sphingolipid Animal Cancer Pathobiology Core grant (P01CA097132), and the Institutional Funding from the Department of Medicine and Cancer Center, Stony Brook University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Anakk S, 2013, CELL REP, V5, P1060, DOI 10.1016/j.celrep.2013.10.030; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Buettner R, 2002, CLIN CANCER RES, V8, P945; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Fan BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029824; Gnatenko DV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071826; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Jameson KL, 2013, NAT MED, V19, P626, DOI 10.1038/nm.3165; Jin SH, 2008, INT J CANCER, V122, P1040, DOI 10.1002/ijc.23181; Joseph F., 2012, P 103 ANN M AM ASS C; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mahler M, 1998, AM J PHYSIOL-GASTR L, V274, pG544, DOI 10.1152/ajpgi.1998.274.3.G544; Marrero JA, 2000, AM J PHYSIOL-GASTR L, V278, pG797, DOI 10.1152/ajpgi.2000.278.5.G797; McLean DTF, 2013, BIOCHIMIE, V95, P875, DOI 10.1016/j.biochi.2012.12.004; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Muise AM, 2011, GASTROENTEROLOGY, V141, P633, DOI 10.1053/j.gastro.2011.04.057; Nabeshima K, 2002, CANCER LETT, V176, P101, DOI 10.1016/S0304-3835(01)00742-X; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Ortega-Cava CF, 2003, J IMMUNOL, V170, P3977, DOI 10.4049/jimmunol.170.8.3977; Osman MA, 2013, BBA-REV CANCER, V1836, P166, DOI 10.1016/j.bbcan.2013.04.005; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Qualls JE, 2006, J LEUKOCYTE BIOL, V80, P802, DOI 10.1189/jlb.1205734; Raddatz D, 2005, EUR J GASTROEN HEPAT, V17, P547, DOI 10.1097/00042737-200505000-00012; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Sbroggio M, 2011, CARDIOVASC RES, V91, P456, DOI 10.1093/cvr/cvr103; Schmidt VA, 2003, BLOOD, V101, P3021, DOI 10.1182/blood-2002-09-2807; Schmidt VA, 2008, MOL CELL BIOL, V28, P1489, DOI 10.1128/MCB.01090-07; Schmidt VA, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/958673; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; Tang MC, 2011, CANCER LETT, V308, P162, DOI 10.1016/j.canlet.2011.05.001; Turgeon N, 2014, AM J PHYSIOL-GASTR L, V306, pG594, DOI 10.1152/ajpgi.00393.2013; Uno JK, 2010, GASTROENTEROLOGY, V139, P1642, DOI 10.1053/j.gastro.2010.07.008; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Wu F DF, 2014, GSE59648, Patent No. GSE59648; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xie YZ, 2012, ORG LETT, V14, P3, DOI 10.1021/ol202923u; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073	51	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129314	10.1371/journal.pone.0129314	http://dx.doi.org/10.1371/journal.pone.0129314			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047140	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200149
J	Jian, YT; Yang, Y; Tian, T; Stanford, C; Zhang, XP; Zhao, K				Jian, Yu-Tao; Yang, Yue; Tian, Tian; Stanford, Clark; Zhang, Xin-Ping; Zhao, Ke			Effect of Pore Size and Porosity on the Biomechanical Properties and Cytocompatibility of Porous NiTi Alloys	PLOS ONE			English	Article							TISSUE; FABRICATION; SCAFFOLDS; IMPLANTS; CELLS	Five types of porous Nickel-Titanium (NiTi) alloy samples of different porosities and pore sizes were fabricated. According to compressive and fracture strengths, three groups of porous NiTi alloy samples underwent further cytocompatibility experiments. Porous NiTi alloys exhibited a lower Young's modulus (2.0 GPa similar to 0.8 GPa). Both compressive strength (108.8 MPa similar to 56.2 MPa) and fracture strength (64.6 MPa similar to 41.6 MPa) decreased gradually with increasing mean pore size (MPS). Cells grew and spread well on all porous NiTi alloy samples. Cells attached more strongly on control group and blank group than on all porous NiTi alloy samples (p < 0.05). Cell adhesion on porous NiTi alloys was correlated negatively to MPS (277.2 mu m similar to 566.5 mu m; p < 0.05). More cells proliferated on control group and blank group than on all porous NiTi alloy samples (p < 0.05). Cellular ALP activity on all porous NiTi alloy samples was higher than on control group and blank group (p < 0.05). The porous NiTi alloys with optimized pore size could be a potential orthopedic material.	[Jian, Yu-Tao] Sun Yat Sen Univ, Inst Stomatol Res, Guangdong Prov Key Lab Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Yue; Tian, Tian; Zhao, Ke] Sun Yat Sen Univ, Guanghua Sch Stomatol, Dept Prosthodont, Guangdong Prov Key Lab Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Stanford, Clark] Univ Iowa, Coll Dent, Dows Inst Dent Res, Iowa City, IA 52242 USA; [Zhang, Xin-Ping] S China Univ Technol, Sch Mat Sci & Engn, Dept Metall Mat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; University of Iowa; South China University of Technology	Zhao, K (corresponding author), Sun Yat Sen Univ, Guanghua Sch Stomatol, Dept Prosthodont, Guangdong Prov Key Lab Stomatol, Guangzhou 510275, Guangdong, Peoples R China.	zhaoke@mail.sysu.edu.cn			Natural Science Foundation of China [50871039]; Guangdong Provincial Natural Science Foundation [S2013020012805]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	Funding for this work came from the Natural Science Foundation of China (No. 50871039, http://www.nsfc.gov.cn/) to KZ and the Guangdong Provincial Natural Science Foundation (Key Grant No. S2013020012805, http://www.gdstc.gov.cn/) also to KZ.	Aly MS, 2010, MATER LETT, V64, P935, DOI 10.1016/j.matlet.2010.01.064; Ayers RA, 2007, J BIOMED MATER RES A, V81A, P634, DOI 10.1002/jbm.a.31017; Bayraktar HH, 2004, J BIOMECH, V37, P27, DOI 10.1016/S0021-9290(03)00257-4; CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Frosch K.-H., 2006, EUR J TRAUMA, V32, P149, DOI [10.1007/s00068-006-6041-1, DOI 10.1007/s00068-006-6041-1]; Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931; Gonzalez-Barcenas LA, 2003, AIP CONF PROC, V682, P173, DOI 10.1063/1.1615117; HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309; Jiang B, 2007, SCRIPTA MATER, V56, P169, DOI 10.1016/j.scriptamat.2006.08.070; Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4; Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025; Li DS, 2009, J ALLOY COMPD, V470, pL1, DOI 10.1016/j.jallcom.2008.02.059; Li YH, 2002, J ALLOY COMPD, V345, P271, DOI 10.1016/S0925-8388(02)00412-7; Li YC, 2010, J ALLOY COMPD, V494, P323, DOI 10.1016/j.jallcom.2010.01.026; Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154; Liu XM, 2011, BIOMATERIALS, V32, P330, DOI 10.1016/j.biomaterials.2010.08.102; Parthasarathy J, 2010, J MECH BEHAV BIOMED, V3, P249, DOI 10.1016/j.jmbbm.2009.10.006; Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039; Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002; Sargeant TD, 2008, BIOMATERIALS, V29, P161, DOI 10.1016/j.biomaterials.2007.09.012; St-Pierre JP, 2005, BIOMATERIALS, V26, P7319, DOI 10.1016/j.biomaterials.2005.05.046; Stangl R., 2001, European Cells & Materials, V2, P1; Subramaniam M, 2002, J CELL BIOCHEM, V87, P9, DOI 10.1002/jcb.10259; Wang JF, 2008, J MATER PROCESS TECH, V197, P428, DOI 10.1016/j.jmatprotec.2007.06.065; Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0; Yen ML, 2007, STEM CELLS, V25, P125, DOI 10.1634/stemcells.2006-0295; Zhang YP, 2007, SCRIPTA MATER, V57, P1020, DOI 10.1016/j.scriptamat.2007.07.043	28	19	22	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128138	10.1371/journal.pone.0128138	http://dx.doi.org/10.1371/journal.pone.0128138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047515	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200042
J	Khokhlova, OE; Hung, WC; Wan, TW; Iwao, Y; Takano, T; Higuchi, W; Yachenko, SV; Teplyakova, OV; Kamshilova, VV; Kotlovsky, YV; Nishiyama, A; Reva, IV; Sidorenko, SV; Peryanova, OV; Reva, GV; Teng, LJ; Salmina, AB; Yamamoto, T				Khokhlova, Olga E.; Hung, Wei-Chun; Wan, Tsai-Wen; Iwao, Yasuhisa; Takano, Tomomi; Higuchi, Wataru; Yachenko, Svetlana V.; Teplyakova, Olga V.; Kamshilova, Vera V.; Kotlovsky, Yuri V.; Nishiyama, Akihito; Reva, Ivan V.; Sidorenko, Sergey V.; Peryanova, Olga V.; Reva, Galina V.; Teng, Lee-Jene; Salmina, Alla B.; Yamamoto, Tatsuo			Healthcare- and Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) and Fatal Pneumonia with Pediatric Deaths in Krasnoyarsk, Siberian Russia: Unique MRSA's Multiple Virulence Factors, Genome, and Stepwise Evolution	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; TOXIC-SHOCK-SYNDROME; ANTIMICROBIAL RESISTANCE; GENETIC BACKGROUNDS; NUCLEOTIDE-SEQUENCE; BIOFILM FORMATION; USA300 CLONE; T-CELLS; STRAINS; IDENTIFICATION	Methicillin-resistant Staphylococcus aureus (MRSA) is a common multidrug-resistant (MDR) pathogen. We herein discussed MRSA and its infections in Krasnoyarsk, Siberian Russia between 2007 and 2011. The incidence of MRSA in 3,662 subjects was 22.0% and 2.9% for healthcare-and community-associated MRSA (HA-and CA-MRSA), respectively. The 15-day mortality rates for MRSA hospital-and community-acquired pneumonia (HAP and CAP) were 6.5% and 50%, respectively. MRSA CAP cases included pediatric deaths; of the MRSA pneumonia episodes available, >= 27.3% were associated with bacteremia. Most cases of HA-MRSA examined exhibited ST239/spa3(t037)/SCCmecIII.1.1.2 (designated as ST239(Kras)), while all CA-MRSA cases examined were ST8/spa1(t008)/SCCme-cIV.3.1.1(IVc) (designated as ST8(Kras)). ST239(Kras) and ST8(Kras) strongly expressed cytolytic peptide (phenol-soluble modulin a, PSMa; and delta-hemolysin, Hld) genes, similar to CA-MRSA. ST239(Kras) pneumonia may have been attributed to a unique set of multiple virulence factors (MVFs): toxic shock syndrome toxin-1 (TSST-1), elevated PSMa/Hld expression, alpha-hemolysin, the staphylococcal enterotoxin SEK/SEQ, the immune evasion factor SCIN/SAK, and collagen adhesin. Regarding ST8(Kras), SEA was included in MVFs, some of which were common to ST239(Kras). The ST239(Kras) (strain OC3) genome contained: a completely unique phage, phi Sa7-like (W), with no att repetition; S. aureus pathogenicity island SaPI2R, the first TSST-1 gene-positive (tst(+)) SaPI in the ST239 lineage; and a super copy of IS256 (>= 22 copies/genome). ST239(Kras) carried the Brazilian SCCmecIII.1.1.2 and United Kingdom-type tst. ST239(Kras) and ST8(Kras) were MDR, with the same levofloxacin resistance mutations; small, but transmissible chloramphenicol resistance plasmids spread widely enough to not be ignored. These results suggest that novel MDR and MVF+ HA-and CA-MRSA (ST239(Kras) and ST8(Kras)) emerged in Siberian Russia (Krasnoyarsk) associated with fatal pneumonia, and also with ST239(Kras), a new (Siberian Russian) clade of the ST239 lineage, which was created through stepwise evolution during its potential transmission route of Brazil-Europe-Russia/Krasnoyarsk, thereby selective advantages from unique MVFs and the MDR.	[Khokhlova, Olga E.; Iwao, Yasuhisa; Peryanova, Olga V.; Yamamoto, Tatsuo] Krasnoyarsk State Med Univ, Russia Japan Ctr Microbiol Metagen & Infect Dis, Krasnoyarsk, Russia; [Khokhlova, Olga E.; Peryanova, Olga V.] Krasnoyarsk State Med Univ, Dept Microbiol, Krasnoyarsk, Russia; [Khokhlova, Olga E.; Hung, Wei-Chun; Iwao, Yasuhisa; Takano, Tomomi; Higuchi, Wataru; Nishiyama, Akihito; Reva, Ivan V.; Yamamoto, Tatsuo] Niigata Univ, Grad Sch Med & Dent Sci, Dept Infect Dis Control & Int Med, Div Bacteriol, Niigata, Japan; [Khokhlova, Olga E.; Hung, Wei-Chun; Wan, Tsai-Wen; Iwao, Yasuhisa; Reva, Ivan V.; Yamamoto, Tatsuo] Int Med Educ & Res Ctr, Dept Epidemiol Genom & Evolut, Niigata, Japan; [Wan, Tsai-Wen; Teng, Lee-Jene] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Hung, Wei-Chun] Kaohsiung Med Univ, Dept Microbiol & Immunol, Kaohsiung, Taiwan; [Yachenko, Svetlana V.] Krasnoyarsk Reg Ctr Prevent & Control AIDS & Infe, Krasnoyarsk, Russia; [Teplyakova, Olga V.] City Clin Hosp 7, Krasnoyarsk, Russia; [Teplyakova, Olga V.] Krasnoyarsk State Med Univ, Dept Gen Surg, Krasnoyarsk, Russia; [Kamshilova, Vera V.] Municipal Hosp Emergency Med Care, Krasnoyarsk, Russia; [Kotlovsky, Yuri V.] Krasnoyarsk State Med Univ, Cent Res Lab, Krasnoyarsk, Russia; [Reva, Ivan V.; Reva, Galina V.] Far Eastern Fed Univ, Sch Biomed, Vladivostok, Russia; [Sidorenko, Sergey V.] Res Inst Childrens Infect, St Petersburg, Russia; [Salmina, Alla B.] Krasnoyarsk State Med Univ, Res Inst Mol Med & Pathobiochem, Krasnoyarsk, Russia	Krasnoyarsk State Medical University; Krasnoyarsk State Medical University; Niigata University; National Taiwan University; Kaohsiung Medical University; Krasnoyarsk State Medical University; Krasnoyarsk State Medical University; Far Eastern Federal University; Krasnoyarsk State Medical University	Yamamoto, T (corresponding author), Krasnoyarsk State Med Univ, Russia Japan Ctr Microbiol Metagen & Infect Dis, Krasnoyarsk, Russia.	tatsuoy@imerc.jp	Teplyakova, Olga/AAE-5112-2019; Khokhlova, Olga/J-3119-2017; Teplyakova, Olga V./M-7060-2014; Salmina, Alla B./L-7977-2013; Sidorenko, Sergey/E-5870-2011; Olga, Peryanova/N-7432-2015	Teplyakova, Olga/0000-0003-0005-3316; Khokhlova, Olga/0000-0002-2829-5117; Teplyakova, Olga V./0000-0003-0005-3316; Sidorenko, Sergey/0000-0003-3550-7875; TENG, LEE-JENE/0000-0003-0104-741X; Reva, Galina/0000-0001-6502-4271; Reva, Ivan/0000-0002-3727-393X; Olga, Peryanova/0000-0001-7150-9670	Krasnoyarsk Regional Government (Russia); Japan-Russia Youth Exchange Center (Japan)	Krasnoyarsk Regional Government (Russia); Japan-Russia Youth Exchange Center (Japan)	This study was supported by a fund/grant from the Krasnoyarsk Regional Government (Russia) and Japan-Russia Youth Exchange Center (Japan), and by each institutional sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028189; Alouf JE, 2003, INT J MED MICROBIOL, V292, P429, DOI 10.1078/1438-4221-00232; Arakere G, 2009, FEMS MICROBIOL LETT, V292, P141, DOI 10.1111/j.1574-6968.2008.01482.x; Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Baranovich T, 2007, EUROSURVEILLANCE, V12; Bartels MD, 2008, EUR J CLIN MICROBIOL, V27, P757, DOI 10.1007/s10096-008-0500-z; Becker EC, 2012, J BACTERIOL, V194, P5368, DOI 10.1128/JB.00818-12; Benson MA, 2014, MOL MICROBIOL, V93, P664, DOI 10.1111/mmi.12682; Berg T, 1998, J BACTERIOL, V180, P4350, DOI 10.1128/JB.180.17.4350-4359.1998; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Brusina EB, 2013, ANTIMICROB RESIST S1, V2, pP57; BYRNE ME, 1989, GENE, V81, P361, DOI 10.1016/0378-1119(89)90197-2; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P707; Costa MOC, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00576-13; Chen CJ, 2014, CLIN MICROBIOL INFEC, V20, P605, DOI 10.1111/1469-0691.12705; Chen FJ, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01011-13; Chen L, 2009, J CLIN MICROBIOL, V47, P3692, DOI 10.1128/JCM.00766-09; Cheung AL, 2008, INT J BIOCHEM CELL B, V40, P355, DOI 10.1016/j.biocel.2007.10.032; Cirlan Maria, 2005, Infection Genetics and Evolution, V5, P335, DOI 10.1016/j.meegid.2004.09.005; Clinical and Laboratory Standards Institute, 2012, M100S22 CLIN LAB STA; Committee for the Japanese Respiratory Society Guidelines in Management of Respiratory, 2004, Respirology, V9 Suppl 1, pS16; Conceicao T, 2007, CLIN MICROBIOL INFEC, V13, P971, DOI 10.1111/j.1469-0691.2007.01794.x; Coombs GW, 2013, COMMUN DIS INTELL, V37, pE210; Cue D, 2013, J BACTERIOL, V195, P1515, DOI 10.1128/JB.00012-13; de Bentzmann S, 2004, J INFECT DIS, V190, P1506, DOI 10.1086/424521; de Lencastre Herminia, 1997, Clin Microbiol Infect, V3, P289; de Sousa MA, 2005, J CLIN MICROBIOL, V43, P5150, DOI 10.1128/JCM.43.10.5150-5157.2005; de Sousa MA, 2004, FEMS IMMUNOL MED MIC, V40, P101, DOI 10.1016/S0928-8244(03)00370-5; de Sousa MA, 1998, J CLIN MICROBIOL, V36, P2590, DOI 10.1128/JCM.36.9.2590-2596.1998; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Edgeworth JD, 2007, CLIN INFECT DIS, V44, P493, DOI 10.1086/511034; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Espadinha D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059960; Ferry T, 2005, CLIN INFECT DIS, V41, P771, DOI 10.1086/432798; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Goerke C, 2009, J BACTERIOL, V191, P3462, DOI 10.1128/JB.01804-08; Gupta RK, 2013, J INFECT DIS, V208, P1841, DOI 10.1093/infdis/jit367; Hampele IC, 1997, J MOL BIOL, V268, P21, DOI 10.1006/jmbi.1997.0944; Harinstein L, 2011, J HOSP INFECT, V79, P194, DOI 10.1016/j.jhin.2011.03.017; Haroche J, 2002, ANTIMICROB AGENTS CH, V46, P2337, DOI 10.1128/AAC.46.8.2337-2343.2002; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Harro JM, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00037-12; Havaei SA, 2011, J CLIN MICROBIOL, V49, P3990, DOI 10.1128/JCM.05445-11; HIGUCHI W, 2010, J INFECT CHEMOTHER, V16, P144, DOI DOI 10.1007/s10156-010-0029-9; Holden MTG, 2010, J BACTERIOL, V192, P888, DOI 10.1128/JB.01255-09; Howden BP, 2010, J BACTERIOL, V192, P5848, DOI 10.1128/JB.00951-10; Huang YC, 2011, INT J ANTIMICROB AG, V38, P2, DOI 10.1016/j.ijantimicag.2011.01.011; Hung WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046987; Isobe H, 2012, BIOMED RES-TOKYO, V33, P97, DOI 10.2220/biomedres.33.97; Issa NC, 2001, POSTGRAD MED, V110, P55, DOI 10.3810/pgm.2001.10.1045; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Iwao Y, 2012, J INFECT CHEMOTHER, V18, P228, DOI 10.1007/s10156-012-0379-6; Iwao Y, 2012, JPN J INFECT DIS, V65, P184; Joo HS, 2011, J BIOL CHEM, V286, P8933, DOI 10.1074/jbc.M111.221382; Kadlec K, 2010, ANTIMICROB AGENTS CH, V54, P3475, DOI 10.1128/AAC.00464-10; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kalyan S, 2004, J INFECT DIS, V189, P1892, DOI 10.1086/383478; Kang MS, 2013, J BIOL CHEM, V288, P20520, DOI 10.1074/jbc.M113.454462; KAPPLER J, 1989, SCIENCE, V244, P811, DOI 10.1126/science.2524876; Khan SA, 1997, MICROBIOL MOL BIOL R, V61, P442, DOI 10.1128/.61.4.442-455.1997; Khokhlova O, 2015, J MICROBIOL IMMUNOL, V48, P335, DOI 10.1016/j.jmii.2012.09.004; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Ko KS, 2005, J CLIN MICROBIOL, V43, P421, DOI 10.1128/JCM.43.1.421-426.2005; Kozitskaya S, 2004, INFECT IMMUN, V72, P1210, DOI 10.1128/IAI.72.2.1210-1215.2004; Krakauer T, 1999, IMMUNOL RES, V20, P163, DOI 10.1007/BF02786471; Kriegeskorte A, 2012, NAT MED, V18, P662, DOI 10.1038/nm.2765; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Li HM, 1998, IMMUNOL REV, V163, P177, DOI 10.1111/j.1600-065X.1998.tb01196.x; Li M, 2012, NAT MED, V18, P816, DOI 10.1038/nm.2692; Li Y, 2011, J BACTERIOL, V193, P3411, DOI 10.1128/JB.05135-11; Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI 10.1093/cid/cir034; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Lucas AL, 2013, MICROB PATHOGENESIS, V57, P52, DOI 10.1016/j.micpath.2012.11.008; LYON BR, 1987, MICROBIOL REV, V51, P88, DOI 10.1128/MMBR.51.1.88-134.1987; McDougal LK, 2010, ANTIMICROB AGENTS CH, V54, P3804, DOI 10.1128/AAC.00351-10; Mendes RE, 2012, J CLIN MICROBIOL, V50, P3694, DOI 10.1128/JCM.02024-12; Mirzaii M, 2015, J INFECT PUBLIC HEAL, V8, P202, DOI 10.1016/j.jiph.2014.09.002; Monecke S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097833; MURPHY E, 1984, NATURE, V307, P292, DOI 10.1038/307292a0; Murphy E., 1990, MOL BIOL STAPHYLOCOC, P123; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Nienaber JJC, 2011, J INFECT DIS, V204, P704, DOI 10.1093/infdis/jir389; Nishiyama A, 2012, FEMS IMMUNOL MED MIC, V66, P343, DOI 10.1111/j.1574-695X.2012.01027.x; Noto MJ, 2008, J BACTERIOL, V190, P1276, DOI 10.1128/JB.01128-07; Novick Richard P, 2007, Chem Immunol Allergy, V93, P42, DOI 10.1159/000100857; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Oliveira D., 1998, Clin Microbiol Infect, V4, P373, DOI 10.1111/j.1469-0691.1998.tb00081.x; Oliveira DC, 2001, MICROB DRUG RESIST, V7, P349, DOI 10.1089/10766290152773365; Pragman AA, 2004, J BACTERIOL, V186, P2430, DOI 10.1128/JB.186.8.2430-2438.2004; Robinson DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004; Rolo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034768; Romanov AV, 2011, CLIN MICROBIOL ANTIM, V13, P169; [Романов Андрей Вячеславович Romanov А.V.], 2012, [Клиническая микробиология и антимикробная химиотерапия, Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya], V14, P201; Sawanobori E, 2015, J MICROBIOL IMMUNOL, V48, P565, DOI 10.1016/j.jmii.2014.04.015; SHALITA Z, 1980, PLASMID, V3, P291, DOI 10.1016/0147-619X(80)90042-6; Shi D, 2011, J CLIN MICROBIOL, V49, P1972, DOI 10.1128/JCM.01742-10; Shibuya Yasuhiro, 2008, Journal of Infection and Chemotherapy, V14, P439, DOI 10.1007/s10156-008-0640-1; Shore AC, 2010, ANTIMICROB AGENTS CH, V54, P4978, DOI 10.1128/AAC.01113-10; Simpson AE, 2003, J BACTERIOL, V185, P2143, DOI 10.1128/JB.185.7.2143-2152.2003; Smyth DS, 2009, J BACTERIOL, V191, P5964, DOI 10.1128/JB.00352-09; Stach CS, 2014, IMMUNOL RES, V59, P177, DOI 10.1007/s12026-014-8539-7; Stegger M, 2012, J BACTERIOL, V194, P1625, DOI 10.1128/JB.06653-11; Stratchounski LS, 2005, J CHEMOTHERAPY, V17, P54, DOI 10.1179/joc.2005.17.1.54; Takahashi N, 1998, LANCET, V351, P1614, DOI 10.1016/S0140-6736(97)11125-4; Takano T, 2008, ANTIMICROB AGENTS CH, V52, P837, DOI 10.1128/AAC.01001-07; Takano T, 2013, ANTIMICROB AGENTS CH, V57, P1589, DOI 10.1128/AAC.01147-12; Takano T, 2009, J INFECT CHEMOTHER, V15, P54, DOI 10.1007/s10156-008-0665-5; Takizawa Y, 2005, J CLIN MICROBIOL, V43, P3356, DOI 10.1128/JCM.43.7.3356-3363.2005; Tanaka T, 1995, J INFECT CHEMOTHER, V1, P40; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Thurlow LR, 2012, FEMS IMMUNOL MED MIC, V65, P5, DOI 10.1111/j.1574-695X.2012.00937.x; Uhlemann AC, 2014, INFECT GENET EVOL, V21, P563, DOI 10.1016/j.meegid.2013.04.030; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Vivoni AM, 2006, J CLIN MICROBIOL, V44, P1686, DOI 10.1128/JCM.44.5.1686-1691.2006; Vojtov N, 2002, P NATL ACAD SCI USA, V99, P10102, DOI 10.1073/pnas.152152499; Vorobieva V, 2008, APMIS, V116, P877, DOI 10.1111/j.1600-0463.2008.01092.x; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wang T, 1998, ANTIMICROB AGENTS CH, V42, P236; Wang Z, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-529; WESTH H, 1995, ANTIMICROB AGENTS CH, V39, P369, DOI 10.1128/AAC.39.2.369; Wichelhaus TA, 1999, ANTIMICROB AGENTS CH, V43, P2813, DOI 10.1128/AAC.43.11.2813; Widdowson CA, 2000, ANTIMICROB AGENTS CH, V44, P393, DOI 10.1128/AAC.44.2.393-395.2000; World Health Organization, 2014, ANT RES GLOB REP SUR; Xia GQ, 2014, INFECT GENET EVOL, V21, P593, DOI 10.1016/j.meegid.2013.04.022; Xu SX, 2014, INFECT IMMUN, V82, P3588, DOI 10.1128/IAI.02110-14; Xu SX, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00052; Yamamoto T, 2013, BIOMEDICINE-TAIWAN, V3, P2, DOI 10.1016/j.biomed.2012.12.001; Yamamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029187; Zhang KY, 2008, J INFECT DIS, V197, P195, DOI 10.1086/523763; Zhang X, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00449-14; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	135	34	45	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128017	10.1371/journal.pone.0128017	http://dx.doi.org/10.1371/journal.pone.0128017			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047024	Green Submitted, gold, Green Published			2022-12-27	WOS:000355652200038
J	Mailath-Pokorny, M; Polterauer, S; Worda, K; Springer, S; Bettelheim, D				Mailath-Pokorny, Mariella; Polterauer, Stephan; Worda, Katharina; Springer, Stephanie; Bettelheim, Dieter			Isolated Short Fetal Femur Length in the Second Trimester and the Association with Adverse Perinatal Outcome: Experiences from a Tertiary Referral Center	PLOS ONE			English	Article							GROWTH RESTRICTION; GESTATIONAL-AGE; 2ND-TRIMESTER; PREGNANCY; FETUSES; LONG; BODY	Objective To determine the association between isolated mid-trimester short fetal femur length and adverse perinatal outcome. Methods This is a retrospective cohort study of patients with singleton gestations routinely assessed by second trimester ultrasound examination during 2006-2013. A fetal isolated short femur was defined as a femur length (FL) below the 5th percentile in a fetus with an abdominal circumference greater than the 10th percentile. Cases of aneuploidy, skeletal dysplasia and major anomalies were excluded. Primary outcomes of interest included the risk of small for gestational age neonates, low birth weight and preterm birth (PTB). Secondary outcome parameters were a 5-min Apgar score less than 7 and a neonatal intensive care unit admission. A control group of 200 fetuses with FL >= 5th percentile was used to compare primary and secondary outcome parameters within both groups. Chi-square and Student's t-tests were used where appropriate. Results Out of 608 eligible patients with a short FL, 117 met the inclusion criteria. Isolated short FL was associated with an increased risk for small for gestational age (19.7% versus 8.0%, p = 0.002) neonates, low birth weight (23.9% versus 8.5%, p<0.001), PTB (19.7% versus 6.0%, p<0.001) and neonatal intensive care unit admissions (13.7% versus 3.5%, p = 0.001). The incidence of a 5-min Apgar score less than 7 was similar in both groups. Conclusion Isolated short FL is associated with a subsequent delivery of small for gestational age and Low birth weight neonates as well as an increased risk for PTB. This information should be considered when counseling patients after mid-trimester isolated short FL is diagnosed.	[Mailath-Pokorny, Mariella; Worda, Katharina; Springer, Stephanie; Bettelheim, Dieter] Med Univ Vienna, Dept Obstet & Gynecol, Div Obstet & Fetomaternal Med, Vienna, Austria; [Polterauer, Stephan] Med Univ Vienna, Dept Obstet & Gynecol, Div Gen Gynecol & Gynecol Oncol, Comprehens Canc Ctr,Gynecol Canc Unit, Vienna, Austria; [Polterauer, Stephan] Karl Landsteiner Inst Gen Gynecol & Expt Gynecol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Mailath-Pokorny, M (corresponding author), Med Univ Vienna, Dept Obstet & Gynecol, Div Obstet & Fetomaternal Med, Vienna, Austria.	mariella.mailath-pokorny@meduniwien.ac.at	Polterauer, Stephan/AAG-1331-2021	Polterauer, Stephan/0000-0002-9649-4505				ACOG committee opinion. Committee on Obstetric Practice. American College of Obstetricians and Gynecologists, 1997, INT J GYNAECOL OBSTE, V59, P269; Bromley B, 2002, J ULTRAS MED, V21, P1087, DOI 10.7863/jum.2002.21.10.1087; Goetzinger KR, 2012, J ULTRAS MED, V31, P1935; HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4; KURTZ AB, 1990, RADIOLOGY, V177, P197, DOI 10.1148/radiology.177.1.2399317; Leung TY, 2006, ULTRASOUND OBST GYN, V27, P156, DOI 10.1002/uog.2656; Lindqvist PG, 2005, ULTRASOUND OBST GYN, V25, P258, DOI 10.1002/uog.1806; Mancilla EE, 1998, ENDOCRINOLOGY, V139, P2900, DOI 10.1210/en.139.6.2900; Mathiesen JM, 2014, ULTRASOUND OBST GYN, V44, P160, DOI 10.1002/uog.13286; Nyberg DA, 2008, ULTRASOUND OBST GYN, V31, P489, DOI 10.1002/uog.5358; NYBERG DA, 1993, AM J OBSTET GYNECOL, V168, P534, DOI 10.1016/0002-9378(93)90487-4; Ozlu T, 2013, PRENATAL DIAG, V33, P1063, DOI 10.1002/pd.4197; Papageorghiou AT, 2008, ULTRASOUND OBST GYN, V31, P507, DOI 10.1002/uog.5265; PEETERS LLH, 1979, AM J OBSTET GYNECOL, V135, P637, DOI 10.1016/S0002-9378(16)32989-1; Prefumo F, 2006, HUM REPROD, V21, P3019, DOI 10.1093/humrep/del058; Qin XZ, 2006, ENDOCRINOLOGY, V147, P5653, DOI 10.1210/en.2006-1055; SHELDON RE, 1979, AM J OBSTET GYNECOL, V135, P1071, DOI 10.1016/0002-9378(79)90739-7; Snijders RJM, 2000, ULTRASOUND OBST GYN, V16, P142, DOI 10.1046/j.1469-0705.2000.00198.x; SOGC Clinical Practice Guidelines, 2003, J OBSTET GYNECOL CAN, V25, P601; Todros T, 1996, EARLY HUM DEV, V45, P1, DOI 10.1016/0378-3782(95)01717-8; Todros T, 2004, BJOG-INT J OBSTET GY, V111, P83, DOI 10.1046/j.1471-0528.2003.00015.x; Ventura W, 2012, J CLIN ULTRASOUND, V40, P63, DOI 10.1002/jcu.20889; Vermeer N, 2013, PRENATAL DIAG, V33, P365, DOI 10.1002/pd.4068; Weisz B, 2008, ULTRASOUND OBST GYN, V31, P512, DOI 10.1002/uog.5349; Zalel Y, 2002, PRENATAL DIAG, V22, P553, DOI 10.1002/pd.364	25	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128820	10.1371/journal.pone.0128820	http://dx.doi.org/10.1371/journal.pone.0128820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046665	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200105
J	Okigbo, CC; Speizer, IS				Okigbo, Chinelo C.; Speizer, Ilene S.			Determinants of Sexual Activity and Pregnancy among Unmarried Young Women in Urban Kenya: A Cross-Sectional Study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; UNINTENDED PREGNANCY; DEVELOPING-COUNTRIES; HEALTH; ADOLESCENTS; INITIATION; BEHAVIOR; OUTCOMES; YOUTH; TRANSITIONS	Objectives With age of marriage rising in Kenya, the period between onset of puberty and first marriage has increased, resulting in higher rates of premarital sexual activity and pregnancy. We assessed the determinants of sexual activity and pregnancy among young unmarried women in urban Kenya. Methods Baseline data from five urban areas in Kenya (Nairobi, Mombasa, Kisumu, Machakos, and Kakamega) collected in 2010 by the Measurement, Learning & Evaluation project were used. Women aged 15-24 years, who had never been married, and were not living with a male partner at the time of survey (weighted n=2020) were included. Using weighted, multivariate Cox proportional hazard regression and logistic regression analyses, we assessed factors associated with three outcome measures: time to first sex, time to first pregnancy, and teenage pregnancy. Results One-half of our sample had ever had sex; the mean age at first sex among the sexually-experienced was 17.7 (+/- 2.6) years. About 15% had ever been pregnant; mean age at first pregnancy was 18.3 (+/- 2.2) years. Approximately 11% had a teenage pregnancy. Three-quarters (76%) of those who had ever been pregnant (weighted n=306) reported the pregnancy was unwanted at the time. Having secondary education was associated with a later time to first sex and first pregnancy. In addition, religion, religiosity, and employment status were associated with time to first sex while city of residence, household size, characteristics of household head, family planning knowledge and misconceptions, and early sexual debut were significantly associated with time to first pregnancy. Education, city of residence, household wealth, early sexual debut, and contraceptive use at sexual debut were associated with teenage pregnancy for those 20-24 years. Conclusion Understanding risk and protective factors of youth sexual and reproductive health can inform programs to improve young people's long-term potential by avoiding early and unintended pregnancies.	[Okigbo, Chinelo C.; Speizer, Ilene S.] Univ N Carolina, Dept Maternal & Child Hlth, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27514 USA; [Okigbo, Chinelo C.; Speizer, Ilene S.] Univ N Carolina, Carolina Populat Ctr, Measurement Learning & Evaluat Project, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Okigbo, CC (corresponding author), Univ N Carolina, Dept Maternal & Child Hlth, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27514 USA.	cokigbo@live.unc.edu	Okigbo, Chinelo/AAF-4505-2020; Okigbo, Chinelo C/F-3933-2015	Okigbo, Chinelo/0000-0002-4983-9339; Okigbo, Chinelo C/0000-0002-4983-9339	Bill & Melinda Gates Foundation; Carolina Population Center by the Eunice Kennedy Shriver National Institute of Child Health and Human Development [5 R24 HD050924]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Carolina Population Center by the Eunice Kennedy Shriver National Institute of Child Health and Human Development	This research work was funded by the Bill & Melinda Gates Foundation (www.gatesfoundation.org/) and was supported by grant, 5 R24 HD050924, Carolina Population Center, awarded to the Carolina Population Center at The University of North Carolina at Chapel Hill by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (www.nichd.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, the contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the funders.	Agha S, 2009, ARCH SEX BEHAV, V38, P899, DOI 10.1007/s10508-008-9395-0; Beguy D, 2011, J URBAN HEALTH, V88, P318, DOI 10.1007/s11524-011-9547-8; Beguy D, 2009, J ADOLESCENT HEALTH, V45, P595, DOI 10.1016/j.jadohealth.2009.03.014; Blum RW, 2007, J ADOLESCENT HEALTH, V41, P230, DOI 10.1016/j.jadohealth.2007.04.005; Chandra-Mouli V, 2013, J ADOLESCENT HEALTH, V52, P517, DOI 10.1016/j.jadohealth.2013.03.002; Chiao C, 2009, AIDS CARE, V21, P881, DOI 10.1080/09540120802537856; Curtis SL, 2004, SEX TRANSM INFECT, V80, P22, DOI 10.1136/sti.2004.011650; Dodoo FNA, 2007, SOC SCI MED, V64, P1019, DOI 10.1016/j.socscimed.2006.10.007; Fatusi AO, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-136; Finer LB, 2014, WOMEN HEALTH ISS, V24, pE271, DOI 10.1016/j.whi.2014.02.002; GAGE AJ, 1994, SOC BIOL, V41, P44; Ganchimeg T, 2014, BJOG-INT J OBSTET GY, V121, P40, DOI 10.1111/1471-0528.12630; Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x; Guo W, 2012, INT PERSPECT SEX R H, V38, P196, DOI 10.1363/3819612; Gupta N, 2003, STUD FAMILY PLANN, V34, P19, DOI 10.1111/j.1728-4465.2003.00019.x; Ikamari L, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-69; Jessor R, 1977, PROBLEM BEHAV PSYCHO, VXV, P281; Jessor R., 2001, RISIKOVERHALTENSWEIS, P61, DOI 10.1007/978-3-663-11310-2_3; Kabiru CW, 2009, J ADOLESCENCE, V32, P1023, DOI 10.1016/j.adolescence.2008.08.001; Kenya A, 2014, KEN AIDS IND SURV; Kenya National Bureau of Statistics (KNBS), 2010, 2009 KEN POP HOUS C, V1C; Khan S, 2008, 19 DHS MACR INT INC; Luke N, 2003, STUD FAMILY PLANN, V34, P67, DOI 10.1111/j.1728-4465.2003.00067.x; Luke N, 2012, STUD FAMILY PLANN, V43, P115, DOI 10.1111/j.1728-4465.2012.00309.x; Magadi MA, 2009, J BIOSOC SCI, V41, P409, DOI 10.1017/S0021932008003210; Marston C, 2003, POP STUD-J DEMOG, V57, P77, DOI 10.1080/0032472032000061749; Marston C, 2006, LANCET, V368, P1581, DOI 10.1016/S0140-6736(06)69662-1; Marston M, 2013, INT PERSPECT SEX R H, V39, P22, DOI 10.1363/3902213; MCCARTHY J, 1992, STUD FAMILY PLANN, V23, P23, DOI 10.2307/1966825; Measurement Learning & Evaluation (MLE) Project Tupange KNBS, 2011, BAS HOUS SURV KEN UR; MEEKERS D, 1994, POP STUD-J DEMOG, V48, P47, DOI 10.1080/0032472031000147466; MLE Project, 2013, MEAS LEARN EV PROJ U; Nalugoda F, 2014, JAIDS-J ACQ IMM DEF, V65, P91, DOI 10.1097/QAI.0b013e3182a7f08a; Ndugwa RP, 2011, J URBAN HEALTH, V88, P298, DOI 10.1007/s11524-010-9462-4; Ngom P, 2003, J ADOLESCENT HEALTH, V33, P369, DOI 10.1016/S1054-139X(03)00213-1; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Rutstein SO, 2004, DHS COMP REPORTS, V6; Sanga K, 2014, AUST NZ J OBSTET GYN, V54, P360, DOI 10.1111/ajo.12219; Speizer IS, 2000, INT FAM PLAN PERSPEC, V26, P13, DOI 10.2307/2648285; StataCorp, 2013, STATA STAT SOFTW REL; Were M, 2007, ECON HUM BIOL, V5, P322, DOI 10.1016/j.ehb.2007.03.005	41	23	23	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129286	10.1371/journal.pone.0129286	http://dx.doi.org/10.1371/journal.pone.0129286			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7CR	26047505	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200142
J	Tokuda, H; Kuroyanagi, G; Tsujimoto, M; Enomoto, Y; Matsushima-Nishiwaki, R; Onuma, T; Kojima, A; Doi, T; Tanabe, K; Akamatsu, S; Iida, H; Ogura, S; Otsuka, T; Iwama, T; Tanikawa, T; Ishikawa, K; Kojima, K; Kozawa, O				Tokuda, Haruhiko; Kuroyanagi, Gen; Tsujimoto, Masanori; Enomoto, Yukiko; Matsushima-Nishiwaki, Rie; Onuma, Takashi; Kojima, Akiko; Doi, Tomoaki; Tanabe, Kumiko; Akamatsu, Shigeru; Iida, Hiroki; Ogura, Shinji; Otsuka, Takanobu; Iwama, Toru; Tanikawa, Takahisa; Ishikawa, Kei; Kojima, Kumi; Kozawa, Osamu			Release of Phosphorylated HSP27 (HSPB1) from Platelets Is Accompanied with the Acceleration of Aggregation in Diabetic Patients	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ALPHA-B-CRYSTALLIN; CARDIOVASCULAR-DISEASE; MAP KINASE; CELL-DEATH; COLLAGEN; RECEPTOR; ACTIVATION; HEAT-SHOCK-PROTEIN-27; MECHANISMS	We investigated the relationship between HSP27 phosphorylation and collagen-stimulated activation of platelets in patients with diabetes mellitus (DM). Platelet-rich plasma was prepared from blood of type 2 DM patients. The platelet aggregation was analyzed in size of aggregates by an aggregometer using a laser scattering method. The protein phosphorylation was analyzed by Western blotting. Phosphorylated-HSP27 and PDGF-AB released from platelets were measured by ELISA. The phosphorylated-HSP27 levels at Ser-78 and Ser-82 induced by collagen were directly proportional to the platelet aggregation. Total HSP27 levels in platelets were decreased concomitantly with the phosphorylation. The released HSP27 levels were significantly correlated with the phosphorylated levels of HSP27 in the platelets stimulated by 0.3 mu g/ml collagen. The low dose collagen-stimulated release of HSP27 was detected but relatively small in healthy donors. The released levels of PDGF-AB were in parallel with the levels of released HSP27. Area under the curve (AUC) of small aggregation (9-25 mu m)induced by 0.3 mu g/ml collagen was inversely proportional to the levels of released HSP27. AUC of large aggregation (50-70 mu m) was directly proportional to the levels of released HSP27. Exogenous recombinant phosphorylated-HSP27 hardly affected the aggregation or the released levels of PDGF-AB induced by collagen. These results strongly suggest that HSP27 is released from human platelets accompanied with its phosphorylation induced by collagen, which is correlated with the acceleration of platelet aggregation in type 2 DM patients.	[Tokuda, Haruhiko; Tanikawa, Takahisa; Ishikawa, Kei; Kojima, Kumi] Natl Ctr Geriatr & Gerontol, Dept Clin Lab, Obu, Aichi, Japan; [Tokuda, Haruhiko; Kuroyanagi, Gen; Tsujimoto, Masanori; Matsushima-Nishiwaki, Rie; Onuma, Takashi; Kojima, Akiko; Kozawa, Osamu] Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu, Japan; [Kuroyanagi, Gen; Otsuka, Takanobu] Nagoya City Univ, Grad Sch Med Sci, Dept Orthoped Surg, Nagoya, Aichi, Japan; [Tsujimoto, Masanori; Enomoto, Yukiko; Iwama, Toru] Gifu Univ, Grad Sch Med, Dept Neurosurg, Gifu, Japan; [Onuma, Takashi; Kojima, Akiko; Tanabe, Kumiko; Iida, Hiroki] Gifu Univ, Grad Sch Med, Dept Anesthesiol & Pain Med, Gifu, Japan; [Kojima, Akiko; Akamatsu, Shigeru] Matsunami Gen Hosp, Dept Anesthesiol & Crit Care Med, Gifu, Japan; [Doi, Tomoaki; Ogura, Shinji] Gifu Univ, Grad Sch Med, Dept Emergency & Disaster Med, Gifu, Japan	National Center for Geriatrics & Gerontology; Gifu University; Nagoya City University; Gifu University; Gifu University; Gifu University	Tokuda, H (corresponding author), Natl Ctr Geriatr & Gerontol, Dept Clin Lab, Obu, Aichi, Japan.	tokuda@ncgg.go.jp		Iwama, Toru/0000-0002-9426-284X; Ogura, Shinji/0000-0001-7686-6001	Research Funding for Longevity Sciences from National Center for Geriatrics and Gerontology (NCGG), Japan [25-4]; Ministry of Education, Science, Sports and Culture of Japan [23592249]	Research Funding for Longevity Sciences from National Center for Geriatrics and Gerontology (NCGG), Japan; Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This investigation was supported in part by the Research Funding for Longevity Sciences (25-4) from National Center for Geriatrics and Gerontology (NCGG), Japan, and a Grant-in-Aid for Scientific Research (23592249) from the Ministry of Education, Science, Sports and Culture of Japan.	Acunzo J, 2012, INT J BIOCHEM CELL B, V44, P1622, DOI 10.1016/j.biocel.2012.04.002; Arrigo AP, 2007, ADV EXP MED BIOL, V594, P14; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Hanai Y, 2009, LIFE SCI, V85, P386, DOI 10.1016/j.lfs.2009.07.003; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; INAGUMA Y, 1993, J BIOCHEM-TOKYO, V114, P378, DOI 10.1093/oxfordjournals.jbchem.a124184; Jin CH, 2014, MOL MED, V20, P280, DOI 10.2119/molmed.2014.00058; Kageyama Y, 2013, INT J MOL MED, V32, P813, DOI 10.3892/ijmm.2013.1455; Kardys I, 2008, CLIN CHEM, V54, P139, DOI 10.1373/clinchem.2007.094961; Kato K, 1996, J NEUROCHEM, V66, P946; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDRY J, 1992, J BIOL CHEM, V267, P794; Matsuno H, 2005, J CLIN ENDOCR METAB, V90, P920, DOI 10.1210/jc.2004-0137; Matsuno H, 1998, FEBS LETT, V429, P327, DOI 10.1016/S0014-5793(98)00626-7; Moroi M, 2004, THROMB RES, V114, P221, DOI 10.1016/j.thromres.2004.06.046; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Pockley AG, 2002, CIRCULATION, V105, P1012, DOI 10.1161/hc0802.103729; Rayner K, 2008, CIRC RES, V103, P133, DOI 10.1161/CIRCRESAHA.108.172155; Saklatvala J, 1996, J BIOL CHEM, V271, P6586, DOI 10.1074/jbc.271.12.6586; Salari S, 2013, CELL STRESS CHAPERON, V18, P53, DOI 10.1007/s12192-012-0356-0; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	27	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128977	10.1371/journal.pone.0128977	http://dx.doi.org/10.1371/journal.pone.0128977			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046355	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200113
J	Tor, YS; Yazan, LS; Foo, JB; Wibowo, A; Ismail, N; Cheah, YK; Abdullah, R; Ismail, M; Ismail, IS; Yeap, SK				Tor, Yin Sim; Yazan, Latifah Saiful; Foo, Jhi Biau; Wibowo, Agustono; Ismail, Norsharina; Cheah, Yoke Kqueen; Abdullah, Rasedee; Ismail, Maznah; Ismail, Intan Safinar; Yeap, Swee Keong			Induction of Apoptosis in MCF-7 Cells via Oxidative Stress Generation, Mitochondria-Dependent and Caspase-Independent Pathway by Ethyl Acetate Extract of Dillenia suffruticosa and Its Chemical Profile	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; MEDIATED APOPTOSIS; ALPHA-TOCOPHEROL; REACTIVE OXYGEN; DOWN-REGULATION; CANCER CELLS; DEATH; FLAVONOIDS; ACID; ERK	Dillenia suffruticosa, which is locally known as Simpoh air, has been traditionally used to treat cancerous growth. The ethyl acetate extract of D. suffruticosa (EADs) has been shown to induce apoptosis in MCF-7 breast cancer cells in our previous study. The present study aimed to elucidate the molecular mechanisms involved in EADs-induced apoptosis and to identify the major compounds in the extract. EADs was found to promote oxidative stress in MCF-7 cells that led to cell death because the pre-treatment with antioxidants a-tocopherol and ascorbic acid significantly reduced the cytotoxicity of the extract (P<0.05). DCFH-DA assay revealed that treatment with EADs attenuated the generation of intracellular ROS. Apoptosis induced by EADs was not inhibited by the use of caspase-inhibitor Z-VAD-FMK, suggesting that the cell death is caspase-independent. The use of JC-1 dye reflected that EADs caused disruption in the mitochondrial membrane potential. The related molecular pathways involved in EADs-induced apoptosis were determined by GeXP multiplex system and Western blot analysis. EADs is postulated to induce cell cycle arrest that is p53- and p21-dependent based on the upregulated expression of p53- and p21 (P<0.05). The expression of Bax was upregulated with downregulation of Bcl-2 following treatment with EADs. The elevated Bax/Bcl-2 ratio and the depolarization of mitochondrial membrane potential suggest that EADs-induced apoptosis is mitochondria-dependent. The expression of oxidative stress-related AKT, p-AKT, ERK, and p-ERK was downregulated with upregulation of JNK and p-JNK. The data indicate that induction of oxidative-stress related apoptosis by EADs was mediated by inhibition of AKT and ERK, and activation of JNK. The isolation of compounds in EADs was carried out using column chromatography and elucidated using the nuclear resonance magnetic analysis producing a total of six compounds including 3-epimaslinic acid, kaempferol, kaempferide, protocatechuic acid, gallic acid and beta-sitosterol-3-O-a-D-glucopyranoside. The cytotoxicity of the isolated compounds was determined using MTT assay. Gallic acid was found to be most cytotoxic against MCF-7 cell line compared to others, with IC50 of 36 +/- 1.7 mu g/mL (P<0.05). In summary, EADs generated oxidative stress, induced cell cycle arrest and apoptosis in MCF-7 cells by regulating numerous genes and proteins that are involved in the apoptotic signal transduction pathway. Therefore, EADs has the potential to be developed as an anti-cancer agent against breast cancer.	[Tor, Yin Sim; Yazan, Latifah Saiful; Foo, Jhi Biau; Wibowo, Agustono; Ismail, Norsharina; Ismail, Maznah] Univ Putra Malaysia, Lab Mol Biomed, Inst Biosci, Serdang 43400, Selangor, Malaysia; [Yazan, Latifah Saiful; Cheah, Yoke Kqueen] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Biomed Sci, Serdang 43400, Selangor, Malaysia; [Abdullah, Rasedee] Univ Putra Malaysia, Fac Vet Med, Dept Vet Pathol & Microbiol, Serdang 43400, Selangor, Malaysia; [Ismail, Intan Safinar] Univ Putra Malaysia, Fac Sci, Dept Chem, Serdang 43400, Selangor, Malaysia; [Yeap, Swee Keong] Univ Putra Malaysia, Inst Biosci, Lab Vaccines & Immunotherapeut, Serdang 43400, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Yazan, LS (corresponding author), Univ Putra Malaysia, Lab Mol Biomed, Inst Biosci, Serdang 43400, Selangor, Malaysia.	latifahsy@upm.edu.my	Ismail, Intan Safinar/AAO-5386-2020; Wibowo, Agustono/U-8679-2019; Rasedee, Abdullah/E-9119-2013; Foo, Jhi Biau/J-2844-2019; Yeap, Swee Keong/H-9285-2013; sim, tor yin/M-6258-2017	Ismail, Intan Safinar/0000-0003-3960-0022; Wibowo, Agustono/0000-0001-6588-9507; Rasedee, Abdullah/0000-0001-6625-508X; Yeap, Swee Keong/0000-0002-4736-0674; sim, tor yin/0000-0002-4354-1486; Foo, Jhi Biau/0000-0002-5880-2220; ISMAIL, MAZNAH/0000-0002-2378-0519; Cheah, Yoke Kqueen/0000-0001-9258-3749	Ministry of Higher Education (MOHE), Malaysia [04-04-10-884FR]	Ministry of Higher Education (MOHE), Malaysia	The work was supported by Fundamental Research Grant Scheme (04-04-10-884FR) from Ministry of Higher Education (MOHE), Malaysia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2013, ANTIOXIDANT PRINCIPL; Armania N, 2013, J ETHNOPHARMACOL, V146, P525, DOI 10.1016/j.jep.2013.01.017; Bai L, 2006, J CANC MOL, V2, P141; Balasundram N, 2006, FOOD CHEM, V99, P191, DOI 10.1016/j.foodchem.2005.07.042; Batra P, 2013, 3 BIOTECH, V3, P439, DOI 10.1007/s13205-013-0117-5; Bayoumi SAL, 2010, PHYTOCHEMISTRY, V71, P598, DOI 10.1016/j.phytochem.2009.10.012; Bhatt AN, 2010, INDIAN J MED RES, V132, P129; Blagosklonny MV, 2000, LEUKEMIA, V14, P1502, DOI 10.1038/sj.leu.2401864; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; Burlacu A, 2003, J CELL MOL MED, V7, P249, DOI 10.1111/j.1582-4934.2003.tb00225.x; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Calderon-Montano JM, 2011, MINI-REV MED CHEM, V11, P298, DOI 10.2174/138955711795305335; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; Constantinou C, 2009, CURR CANCER DRUG TAR, V9, P717, DOI 10.2174/156800909789271512; Nguyen DMC, 2013, MICROB PATHOGENESIS, V59-60, P52, DOI 10.1016/j.micpath.2013.04.005; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Eldahshan O. A., 2011, Current Research Journal of Biological Sciences, V3, P52; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Foo JB, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-197; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gomes CA, 2003, J MED CHEM, V46, P5395, DOI 10.1021/jm030956v; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsu JD, 2011, J AGR FOOD CHEM, V59, P1996, DOI 10.1021/jf103656v; Hung H, 2004, J CELL PHYSIOL, V198, P197, DOI 10.1002/jcp.10398; Janicke RU, 2009, BREAST CANCER RES TR, V117, P219, DOI 10.1007/s10549-008-0217-9; Jiang GX, 2013, FOOD CHEM, V136, P563, DOI 10.1016/j.foodchem.2012.08.089; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; KamalEldin A, 1996, LIPIDS, V31, P671, DOI 10.1007/BF02522884; Kang GY, 2009, EUR J PHARMACOL, V611, P17, DOI 10.1016/j.ejphar.2009.03.068; Kasibhatla S, 2003, MOL CANCER THER, V2, P573; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Karamac Magdalena, 2006, Polish Journal of Food and Nutrition Sciences, V15, P55; Lee E, 2008, B KOREAN CHEM SOC, V29, P507; Lee HJ, 2010, J KOREAN SOC APPL BI, V53, P826, DOI 10.3839/jksabc.2010.125; Leist M, 2003, CASPASE INDEPENDENT; Li XC, 2011, FUNCT FOODS HEALTH D, V1, P232; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Luo HT, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-16; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Ma XH, 2009, DRUG DISCOV TODAY, V14, P579, DOI 10.1016/j.drudis.2009.03.012; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mundhe K. S., 2011, Journal of Chemical and Pharmaceutical Research, V3, P764; Nylandsted J, 2000, P NATL ACAD SCI USA, V97, P7871, DOI 10.1073/pnas.97.14.7871; Ohashi T, 2002, FEBS LETT, V511, P21, DOI 10.1016/S0014-5793(01)03262-8; Ostrakhovitch EA, 2005, J CELL BIOCHEM, V95, P1120, DOI 10.1002/jcb.20484; Otake Y, 2002, DRUG METAB DISPOS, V30, P103, DOI 10.1124/dmd.30.2.103; Patra RC, 2001, TOXICOLOGY, V162, P81, DOI 10.1016/S0300-483X(01)00345-6; PETIT PX, 1995, J CELL BIOL, V130, P157, DOI 10.1083/jcb.130.1.157; Petrelli A, 2008, CURR MED CHEM, V15, P422; Piccolo MT., 2012, J CAN RES UPDATES, V1, P189, DOI DOI 10.6000/1929-2279.2012.01.02.5; Ravishankar D, 2013, INT J BIOCHEM CELL B, V45, P2821, DOI 10.1016/j.biocel.2013.10.004; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roy Sanjit K, 2010, J Mol Signal, V5, P10, DOI 10.1186/1750-2187-5-10; Seo S Y T, 1981, JOURNAL OF THE AMERI, V101, P2075; Shim HY, 2007, MOL CELLS, V24, P95; SIES H, 1991, KLIN WOCHENSCHR, V69, P965, DOI 10.1007/BF01645140; SOULE HD, 1990, CANCER RES, V50, P6075; Tanaka T., 2011, Journal of Experimental and Clinical Medicine, V3, P27, DOI 10.1016/j.jecm.2010.12.005; TOR YS, 2014, BMC COMPLEM ALTERN M, V14, DOI DOI 10.1186/1472-6882-; vanAcker SABE, 1996, FREE RADICAL BIO MED, V20, P331, DOI 10.1016/0891-5849(95)02047-0; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wagner H, 2009, PHYTOMEDICINE, V16, P97, DOI 10.1016/j.phymed.2008.12.018; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang K, 2014, J BIOCHEM MOL TOXIC, V28, P387, DOI 10.1002/jbt.21575; Wardman P, 2002, J FLUORESC, V12, P65, DOI 10.1023/A:1015363220266; Wen J, 2002, J BIOL CHEM, V277, P38954, DOI 10.1074/jbc.M203842200; Williamson EM, 2001, PHYTOMEDICINE, V8, P401, DOI 10.1078/0944-7113-00060	78	61	63	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127441	10.1371/journal.pone.0127441	http://dx.doi.org/10.1371/journal.pone.0127441			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047480	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200021
J	Chahar, P; Kaushik, M; Gill, SS; Gakhar, SK; Gopalan, N; Datt, M; Sharma, A; Gill, R				Chahar, Priyanka; Kaushik, Manjeri; Gill, Sarvajeet Singh; Gakhar, Surendra Kumar; Gopalan, Natrajan; Datt, Manish; Sharma, Amit; Gill, Ritu			Genome-Wide Collation of the Plasmodium falciparum WDR Protein Superfamily Reveals Malarial Parasite-Specific Features	PLOS ONE			English	Article							GLOBAL ANALYSIS; REPEAT; PREDICTION; EXPORT; TRANSCRIPTOME; ENVIRONMENT; EXPRESSION; PROTEOMICS; EVOLUTION; SEQUENCE	Despite a significant drop in malaria deaths during the past decade, malaria continues to be one of the biggest health problems around the globe. WD40 repeats (WDRs) containing proteins comprise one of the largest and functionally diverse protein superfamily in eukaryotes, acting as scaffolds for assembling large protein complexes. In the present study, we report an extensive in silico analysis of the WDR gene family in human malaria parasite Plasmodium falciparum. Our genome-wide identification has revealed 80 putative WDR genes in Plasmodium falciparum (PfWDRs). Five distinct domain compositions were discovered in Plasmodium as compared to the human host. Notably, 31 PfWDRs were annotated/re-annotated on the basis of their orthologs in other species. Interestingly, most PfWDRs were larger as compared to their human homologs highlighting the presence of parasite-specific insertions. Fifteen PfWDRs appeared specific to the Plasmodium with no assigned orthologs. Expression profiling of PfWDRs revealed a mixture of linear and nonlinear relationships between transcriptome and proteome, and only nine PfWDRs were found to be stage-specific. Homology modeling identified conservation of major binding sites in PfCAF-1 and PfRACK. Protein-protein interaction network analyses suggested that PfWDRs are highly connected proteins with similar to 1928 potential interactions, supporting their role as hubs in cellular networks. The present study highlights the roles and relevance of the WDR family in Plasmodium falciparum, and identifies unique features that lay a foundation for further experimental dissection of PfWDRs.	[Chahar, Priyanka; Kaushik, Manjeri; Gill, Sarvajeet Singh; Gakhar, Surendra Kumar; Gill, Ritu] Maharshi Dayanand Univ, Ctr Biotechnol, Rohtak, Haryana, India; [Gopalan, Natrajan] DRDO BU Ctr Life Sci, Coimbatore, Tamil Nadu, India; [Datt, Manish; Sharma, Amit] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, New Delhi, India	Maharshi Dayanand University; Defence Research & Development Organisation (DRDO); DRDO BU Center Life Sciences; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Gill, R (corresponding author), Maharshi Dayanand Univ, Ctr Biotechnol, Rohtak, Haryana, India.	ritu_gill@hotmail.com	Gill, Sarvajeet Singh/Q-4021-2017; Gill, Sarvajeet Singh/ABD-6031-2021; Datt, Manish/AAD-6989-2019; Gill, Ritu/GPS-6806-2022	Gill, Sarvajeet Singh/0000-0002-8953-7714; Gill, Sarvajeet Singh/0000-0002-8953-7714; Datt, Manish/0000-0002-9578-4113; Gill, Ritu/0000-0002-6837-0281	UGC; DST, Government of India, India; University Research Fellowship from MD University, Rohtak; OSRF grant from Department of Biotechnology, Government of India, India	UGC(University Grants Commission, India); DST, Government of India, India; University Research Fellowship from MD University, Rohtak; OSRF grant from Department of Biotechnology, Government of India, India	Work on malaria molecular biology in RG's laboratory is supported by UGC and DST, Government of India, India. PC and MK acknowledge the receipt of University Research Fellowship from MD University, Rohtak. AS is supported by OSRF grant from Department of Biotechnology, Government of India, India.	Adisa A, 2001, J CELL SCI, V114, P3377; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bischoff E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-34; Brehelin L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-35; Carrillo DR, 2012, ACTA CRYSTALLOGR F, V68, P867, DOI 10.1107/S1744309112027480; Chen CKM, 2011, TRENDS BIOCHEM SCI, V36, P553, DOI 10.1016/j.tibs.2011.07.004; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Dahan-Pasternak N, 2013, J CELL SCI, V126, P3055, DOI 10.1242/jcs.122119; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eckert C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-268; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Felsenstein J, 2009, PHYLIP PHYLOGENY INF; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Guttery DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002554; Hain AUP, 2013, COMPUT STRUCT BIOTEC, V8, DOI 10.5936/csbj.201308002; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hudson Andrew M., 2008, V48, P6, DOI 10.1007/978-0-387-09595-0_2; Huerta-Cepas J, 2008, NUCLEIC ACIDS RES, V36, pD491, DOI 10.1093/nar/gkm899; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Lasonder E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000195; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lejon S, 2011, J BIOL CHEM, V286, P1196, DOI 10.1074/jbc.M110.195842; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Lindner SE, 2013, MOL CELL PROTEOMICS, V12, P1127, DOI 10.1074/mcp.M112.024505; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mishra AM, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095280, 10.1371/journal.pone.0086852]; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Ochoa A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-90; Oehring SC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r108; Ouyang YD, 2012, BMC GENOMICS, V13, DOI [10.1186/1471-2164-13-100, 10.1186/1471-2164-14-396]; Pease BN, 2013, J PROTEOME RES, V12, P4028, DOI 10.1021/pr400394g; Rorick NK, 2011, AM J MED GENET A, V155A, P1314, DOI 10.1002/ajmg.a.33980; Sartorello R, 2009, BIOCHEM BIOPH RES CO, V389, P586, DOI 10.1016/j.bbrc.2009.09.025; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silvestrini F, 2010, MOL CELL PROTEOMICS, V9, P1437, DOI 10.1074/mcp.M900479-MCP200; Singh GP, 2004, MOL BIOCHEM PARASIT, V137, P307, DOI 10.1016/j.molbiopara.2004.05.016; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104; Thevenin A, 2014, NUCLEIC ACIDS RES, V42, P9854, DOI 10.1093/nar/gku667; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; van Nocker S, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-50; Wheeler TJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-7; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Woodland HR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003778; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Zuegge J, 2001, GENE, V280, P19, DOI 10.1016/S0378-1119(01)00776-4	68	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128507	10.1371/journal.pone.0128507	http://dx.doi.org/10.1371/journal.pone.0128507			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043001	Green Published, gold, Green Submitted			2022-12-27	WOS:000355701600051
J	Cinar, HN; Gopinath, G; Jarvis, K; Murphy, HR				Cinar, Hediye Nese; Gopinath, Gopal; Jarvis, Karen; Murphy, Helen R.			The Complete Mitochondrial Genome of the Foodborne Parasitic Pathogen Cyclospora cayetanensis	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; PLASMODIUM-FALCIPARUM; SEQUENCE; ALIGNMENT	Cyclospora cayetanensis is a human-specific coccidian parasite responsible for several food and water-related outbreaks around the world, including the most recent ones involving over 900 persons in 2013 and 2014 outbreaks in the USA. Multicopy organellar DNA such as mitochondrion genomes have been particularly informative for detection and genetic traceback analysis in other parasites. We sequenced the Cyclospora cayetanensis genomic DNA obtained from stool samples from patients infected with Cyclospora in Nepal using the Illumina MiSeq platform. By bioinformatically filtering out the metagenomic reads of non-coccidian origin sequences and concentrating the reads by targeted alignment, we were able to obtain contigs containing Eimeria-like mitochondrial, apicoplastic and some chromosomal genomic fragments. A mitochondrial genomic sequence was assembled and confirmed by cloning and sequencing targeted PCR products amplified from Cyclospora DNA using primers based on our draft assembly sequence. The results show that the Cyclospora cayetanensis mitochondrion genome is 6274 bp in length, with 33% GC content, and likely exists in concatemeric arrays as in Eimeria mitochondrial genomes. Phylogenetic analysis of the Cyclospora cayetanensis mitochondrial genome places this organism in a tight cluster with Eimeria species. The mitochondrial genome of Cyclospora cayetanensis contains three protein coding genes, cytochrome (cytb), cytochrome C oxidase subunit 1 (cox1), and cytochrome C oxidase subunit 3 (cox3), in addition to 14 large subunit (LSU) and nine small subunit (SSU) fragmented rRNA genes.	[Cinar, Hediye Nese; Gopinath, Gopal; Jarvis, Karen; Murphy, Helen R.] US FDA, Ctr Food Safety & Nutr, Off Appl Res, Div Virulence Assessment, Laurel, MD 20708 USA	US Food & Drug Administration (FDA)	Cinar, HN (corresponding author), US FDA, Ctr Food Safety & Nutr, Off Appl Res, Div Virulence Assessment, Laurel, MD 20708 USA.	hediye.cinar@fda.hhs.gov		Murphy, Helen/0000-0002-5489-0614				Abbott James C., 2007, V395, P57; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Arrowood MJ, 1996, J EUKARYOT MICROBIOL, V43, pS89, DOI 10.1111/j.1550-7408.1996.tb05015.x; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Conway DJ, 2007, CLIN MICROBIOL REV, V20, P188, DOI 10.1128/CMR.00021-06; Conway DJ, 2003, TRENDS GENET, V19, P671, DOI 10.1016/j.tig.2003.10.007; Eberhard ML, 1999, EMERG INFECT DIS, V5, P651, DOI 10.3201/eid0505.990505; Eberhard ML, 2000, J PARASITOL, V86, P577, DOI 10.1645/0022-3395(2000)086[0577:ATEECC]2.0.CO;2; Fast NM, 2002, J EUKARYOT MICROBIOL, V49, P30, DOI 10.1111/j.1550-7408.2002.tb00336.x; Gray MW, 2004, ANNU REV GENET, V38, P477, DOI 10.1146/annurev.genet.37.110801.142526; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Hikosaka K, 2013, MOL BIOCHEM PARASIT, V188, P26, DOI 10.1016/j.molbiopara.2013.02.006; Hikosaka K, 2011, MITOCHONDRION, V11, P273, DOI 10.1016/j.mito.2010.10.003; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lin RQ, 2011, GENE, V480, P28, DOI 10.1016/j.gene.2011.03.004; Lopez FA, 1999, J INFECT DIS, V179, P670, DOI 10.1086/314645; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Ogedengbe ME, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-335; Olivier C, 2001, INT J PARASITOL, V31, P1475, DOI 10.1016/S0020-7519(01)00283-1; Ortega YR, 2010, CLIN MICROBIOL REV, V23, P218, DOI 10.1128/CMR.00026-09; ORTEGA YR, 1994, J PARASITOL, V80, P625, DOI 10.2307/3283201; ORTEGA YR, 1993, NEW ENGL J MED, V328, P1308, DOI 10.1056/NEJM199305063281804; Pieniazek NJ, 1997, EMERG INFECT DIS, V3, P381, DOI 10.3201/eid0303.970319; Preston MD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5052; Relman DA, 1996, J INFECT DIS, V173, P440, DOI 10.1093/infdis/173.2.440; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Sterling CR, 1999, EMERG INFECT DIS, V5, P48, DOI 10.3201/eid0501.990106; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]	29	24	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128645	10.1371/journal.pone.0128645	http://dx.doi.org/10.1371/journal.pone.0128645			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042787	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600057
J	Menninghaus, W; Wagner, V; Hanich, J; Wassiliwizky, E; Kuehnast, M; Jacobsen, T				Menninghaus, Winfried; Wagner, Valentin; Hanich, Julian; Wassiliwizky, Eugen; Kuehnast, Milena; Jacobsen, Thomas			Towards a Psychological Construct of Being Moved	PLOS ONE			English	Article							MIXED EMOTIONAL EXPERIENCE; SOCIAL-CONTEXT; AWE; SAD; APPRAISAL; NOSTALGIA; PLEASURE; MUSIC; PROBABILITY; POIGNANCY	The emotional state of being moved, though frequently referred to in both classical rhetoric and current language use, is far from established as a well-defined psychological construct. In a series of three studies, we investigated eliciting scenarios, emotional ingredients, appraisal patterns, feeling qualities, and the affective signature of being moved and related emotional states. The great majority of the eliciting scenarios can be assigned to significant relationship and critical life events (especially death, birth, marriage, separation, and reunion). Sadness and joy turned out to be the two preeminent emotions involved in episodes of being moved. Both the sad and the joyful variants of being moved showed a coactivation of positive and negative affect and can thus be ranked among the mixed emotions. Moreover, being moved, while featuring only low-to-mid arousal levels, was experienced as an emotional state of high intensity; this applied to responses to fictional artworks no less than to own-life and other real, but media-represented, events. The most distinctive findings regarding cognitive appraisal dimensions were very low ratings for causation of the event by oneself and for having the power to change its outcome, along with very high ratings for appraisals of compatibility with social norms and self-ideals. Putting together the characteristics identified and discussed throughout the three studies, the paper ends with a sketch of a psychological construct of being moved.	[Menninghaus, Winfried; Wagner, Valentin; Wassiliwizky, Eugen] Max Planck Inst Empir Aesthet, Frankfurt, Germany; [Menninghaus, Winfried; Wagner, Valentin; Hanich, Julian; Wassiliwizky, Eugen; Kuehnast, Milena; Jacobsen, Thomas] Free Univ Berlin, Res Cluster Languages Emot, Berlin, Germany; [Jacobsen, Thomas] Univ Fed Armed Forces Hamburg, Helmut Schmidt Univ, Hamburg, Germany	Free University of Berlin; Helmut Schmidt University	Menninghaus, W (corresponding author), Max Planck Inst Empir Aesthet, Frankfurt, Germany.	w.m@aesthetics.mpg.de	Wagner, Valentin/C-9642-2015; Jacobsen, Thomas/B-5796-2011	Wagner, Valentin/0000-0001-9510-351X; Jacobsen, Thomas/0000-0002-1523-3996; Kuehnast, Milena/0000-0003-2962-1006; Wassiliwizky, Eugen/0000-0002-1087-1657; Hanich, Julian/0000-0002-1471-2821	research cluster "Languages of Emotion" [409]; Deutsche Forschungsgemeinschaft [EXC 302]; Max Planck Institute	research cluster "Languages of Emotion"; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Institute(Foundation CELLEX)	The data acquisition was performed with the help of a research grant (409) by the research cluster "Languages of Emotion" (http://www.loe.fuberlin.de/) that is part of Freie Universitat Berlin and is itself sponsored by a research grant (EXC 302) of Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.jsp). The data analysis and the writing of the paper was performed using regular research funds of the Max Planck Institute for Empirical Aesthetics in Frankfurt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JG, 1974, J CONSULT CLIN PSYCH, V42, P663, DOI 10.1037/h0037046; Andrade EB, 2007, J CONSUM RES, V34, P283, DOI 10.1086/519498; [Anonymous], 2008, J MEDIA PSYCHOL-GER, DOI DOI 10.1027/1864-1105.20.3.97; [Anonymous], 2008, PSYCHOL AESTHETICS C, P115, DOI [10.1037/1931-3896.2.2.115, DOI 10.1037/1931-3896.2.2.115]; Apter MJ, 1982, THE EXPERIENCE OF MO; Armstrong T, 2008, REV GEN PSYCHOL, V12, P305, DOI 10.1037/a0012558; Bartsch A, 2008, MEDIA PSYCHOL, V11, P7, DOI 10.1080/15213260701813447; Bartsch A, 2010, COMMUN RES, V37, P167, DOI 10.1177/0093650209356441; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Benedek M, 2011, BIOL PSYCHOL, V86, P320, DOI 10.1016/j.biopsycho.2010.12.012; BenZeev A, 1996, THEOR PSYCHOL, V6, P509, DOI 10.1177/0959354396063009; Bibliographisches Institut, BEWEGEND; Bibliographisches Institut, ERGREIFEND; Bonner E. T., 2011, HUMANIST PSYCHOL, V39, P222, DOI [10.1080/08873267.2011.593372, DOI 10.1080/08873267.2011.593372]; Borg I, 2010, MODERN MULTIDIMENSIO; Brehm J W, 1999, Pers Soc Psychol Rev, V3, P2, DOI 10.1207/s15327957pspr0301_1; Cacioppo JT, 1999, ANNU REV PSYCHOL, V50, P191, DOI 10.1146/annurev.psych.50.1.191; Cacioppo JT, 1999, CURR DIR PSYCHOL SCI, V8, P133, DOI 10.1111/1467-8721.00031; Campos B, 2013, COGNITION EMOTION, V27, P37, DOI 10.1080/02699931.2012.683852; Carrera P, 2007, COGNITION EMOTION, V21, P422, DOI 10.1080/02699930600557904; Cicero De Oratore, 1959, DE ORATORE WITH AN E; Cicero Orator, 1962, CICERO BRUTUS ORATOR; Clore G.L., 1994, NATURE EMOTION FUNDA, P386; Colver MC, 2016, PSYCHOL MUSIC, V44, P413, DOI 10.1177/0305735615572358; Cova F, 2014, PHILOS STUD, V169, P447, DOI 10.1007/s11098-013-0192-9; Dachselt R, 2003, TRADITION UND AKTUAL; Darwin C., 1871, THE DESCENT OF MAN A; Deese J, 1965, THE STRUCTURE OF ASS; Descartes R, 1835, OEUVRES PHILOSOPHIQU; Deutsche Gesellschaft fur Psychologie (DGPs) Berufsverband Deutscher Psychologinnen und Psychologen (BDP), 2004, ETHISCHE RICHTLINIEN; Disgust Menninghaus W., 2003, THEORY AND HISTORY O; EISENBERG N, 1988, PERS SOC PSYCHOL B, V14, P298, DOI 10.1177/0146167288142008; Ersner-Hershfield H, 2008, J PERS SOC PSYCHOL, V94, P158, DOI 10.1037/0022-3514.94.1.158; ERTEL S, 1964, Psychol Forsch, V28, P1, DOI 10.1007/BF00421521; ERTEL S, 1965, Z Exp Angew Psychol, V12, P22; FEHR B, 1984, J EXP PSYCHOL GEN, V113, P464, DOI 10.1037/0096-3445.113.3.464; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; Fontaine JRJ, 2002, COGNITION EMOTION, V16, P61, DOI 10.1080/02699933014000130; Fontius M, 2003, ASTHETISCHE GRUNDBEG, V5, P487; Frijda N. H., 2007, THE LAWS OF EMOTION; Frijda NH, 2005, COGNITION EMOTION, V19, P473, DOI 10.1080/02699930441000346; FRIJDA NH, 1989, J PERS SOC PSYCHOL, V57, P212, DOI 10.1037/0022-3514.57.2.212; FRIJDA NH, 1988, AM PSYCHOL, V43, P349, DOI 10.1037/0003-066X.43.5.349; Frijda NH, 2007, PERSPECT PSYCHOL SCI, V2, P227, DOI 10.1111/j.1745-6916.2007.00042.x; Gerger G, 2014, ACTA PSYCHOL, V151, P174, DOI 10.1016/j.actpsy.2014.06.008; Hanich J, CINEMA STUD IN PRESS; Hanich J, 2014, PSYCHOL AESTHET CREA, V8, P130, DOI 10.1037/a0035690; Hofer M, 2012, J MEDIA PSYCHOL-GER, V24, P43, DOI 10.1027/1864-1105/a000061; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hume D, 1793, ESSAYS AND TREATISES, P235; Huron D, 2011, MUSIC SCI, V15, P146, DOI 10.1177/1029864911401171; INMAN HF, 1989, COMMUN STAT THEORY, V18, P3851, DOI 10.1080/03610928908830127; Jakobs E, 1996, J NONVERBAL BEHAV, V20, P123, DOI 10.1007/BF02253073; Jakobs E, 2001, EMOTION, V1, P51, DOI 10.1037/1528-3542.1.1.51; James W, 1890, THE PRINCIPLES OF PS; Kant I, 1790, KRITIK DER URTHEILSK; Keltner D, 2003, COGNITION EMOTION, V17, P297, DOI 10.1080/02699930302297; Koelsch S, PHYSICS LIFE REV IN; Konecni V. J., 2005, B PSYCHOL ARTS, V5, P27; Konecni VJ, 2007, AM J PSYCHOL, V120, P619, DOI 10.2307/20445428; Konecni VJ, 2011, PHILOS TODAY, V55, P64, DOI 10.5840/philtoday201155162; Kuehnast M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01242; Larsen JT, 2011, J PERS SOC PSYCHOL, V100, P1095, DOI 10.1037/a0021846; Larsen JT, 2004, PSYCHOL SCI, V15, P325, DOI 10.1111/j.0956-7976.2004.00677.x; Larsen R.J., 2008, SCI SUBJECTIVE WELL, P258; Leach CW, 2007, J PERS SOC PSYCHOL, V93, P234, DOI 10.1037/0022-3514.93.2.234; MANTEL N, 1967, CANCER RES, V27, P209; MARX W, 1976, Z EXP ANGEW PSYCHOL, V23, P62; MEHRABIAN A, 1972, J PERS, V40, P525, DOI 10.1111/j.1467-6494.1972.tb00078.x; Menninghaus Winfried, 1991, COMPARATIO, V3, P129; Norris CJ, 2010, BIOL PSYCHOL, V84, P422, DOI 10.1016/j.biopsycho.2010.03.011; Nusbaum EC, 2011, SOC PSYCHOL PERS SCI, V2, P199, DOI 10.1177/1948550610386810; Oceja L, 2009, EUR J PSYCHOL ASSESS, V25, P58, DOI 10.1027/1015-5759.25.1.58; Oliver MB, 2012, HUM COMMUN RES, V38, DOI 10.1111/j.1468-2958.2012.01427.x; Oliver MB, 2010, HUM COMMUN RES, V36, P53, DOI 10.1111/j.1468-2958.2009.01368.x; OLIVER MB, 1993, HUM COMMUN RES, V19, P315, DOI 10.1111/j.1468-2958.1993.tb00304.x; Oliver MB, 2000, J BROADCAST ELECTRON, V44, P282, DOI 10.1207/s15506878jobem4402_8; ORTONY A, 1987, COGNITIVE SCI, V11, P341, DOI 10.1207/s15516709cog1103_4; Osgood C. E., 1957, THE MEASUREMENT OF M; Panksepp J, 2002, BEHAV PROCESS, V60, P133, DOI 10.1016/S0376-6357(02)00080-3; Panksepp J, 1995, MUSIC PERCEPT, V13, P171; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Rafaeli E, 2007, PERS SOC PSYCHOL B, V33, P915, DOI 10.1177/0146167207301009; REISENZEIN R, 1994, J PERS SOC PSYCHOL, V67, P525, DOI 10.1037/0022-3514.67.3.525; Revelle W., 2013, PSYCH PROCEDURES FOR; Routledge C, 2011, J PERS SOC PSYCHOL, V101, P638, DOI 10.1037/a0024292; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; Rudd M, 2012, PSYCHOL SCI, V23, P1130, DOI 10.1177/0956797612438731; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; Saucier G, 2014, J PERS, V82, P1, DOI 10.1111/jopy.12028; SCHALLER M, 1993, BASIC APPL SOC PSYCH, V14, P285, DOI 10.1207/s15324834basp1403_3; Scherer K. R., 2001, MUSIC EMOTION THEORY, DOI DOI 10.1016/j.jsams.2011.06.003; Scherer KR, 2001, MUSIC SCI, V5, P149, DOI 10.1177/10298649020050S106; Scherer KR, 2005, SOC SCI INFORM, V44, P695, DOI 10.1177/0539018405058216; Scherer KR, 2004, SOC SCI INFORM, V43, P499, DOI 10.1177/0539018404047701; Schiller F, 1792, UBER DEN GRUND DES V; Schimmack U, 2001, COGNITION EMOTION, V15, P81, DOI 10.1080/0269993004200123; Schindler I, 2013, COGNITION EMOTION, V27, P85, DOI 10.1080/02699931.2012.698253; Schneider JW, 2007, J AM SOC INF SCI TEC, V58, P1596, DOI 10.1002/asi.20642; Schutter DJLG, 2012, MOTIV EMOTION, V36, P46, DOI 10.1007/s11031-011-9237-6; Shiota MN, 2007, COGNITION EMOTION, V21, P944, DOI 10.1080/02699930600923668; Silvia PJ, 2011, PSYCHOL AESTHET CREA, V5, P208, DOI 10.1037/a0021914; SONNEMANS J, 1995, COGNITION EMOTION, V9, P483, DOI 10.1080/02699939508408977; SPENCER H., 1858, ESSAYS SCI POLITICAL, VI, P359; Stel M, 2008, EUR J SOC PSYCHOL, V38, P965, DOI 10.1002/ejsp.472; Szalay LB, 1978, SUBJECTIVE MEANING A; Tan E.S., 1999, PASSIONATE VIEWS FIL, P48; Tan E. S., 2009, COMPANION EMOTION AF, P74; Tokaji A, 2003, JPN PSYCHOL RES, V45, P235, DOI 10.1111/1468-5884.00226; Valdesolo P, 2014, PSYCHOL SCI, V25, P170, DOI 10.1177/0956797613501884; Van Cappellen P, 2012, PSYCHOL RELIG SPIRIT, V4, P223, DOI 10.1037/a0025986; Vo MLH, 2009, BEHAV RES METHODS, V41, P534, DOI 10.3758/BRM.41.2.534; Wagner V, 2014, PSYCHOL AESTHET CREA, V8, P120, DOI 10.1037/a0036126; Wildschut T, 2006, J PERS SOC PSYCHOL, V91, P975, DOI 10.1037/0022-3514.91.5.975; Wildschut T, 2010, J PERS SOC PSYCHOL, V98, P573, DOI 10.1037/a0017597; Williams P, 2002, J CONSUM RES, V28, P636, DOI 10.1086/338206; Zelle Carsten, 1987, ANGENEHMES GRAUEN LI; Zentner M, 2008, EMOTION, V8, P494, DOI 10.1037/1528-3542.8.4.494; Zhang X, 2010, PSYCHOL AGING, V25, P310, DOI 10.1037/a0019078; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	120	148	149	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128451	10.1371/journal.pone.0128451	http://dx.doi.org/10.1371/journal.pone.0128451			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CJ7TC	26042816	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600049
J	Kauppi, JP; Hahne, J; Muller, KR; Hyvarinen, A				Kauppi, Jukka-Pekka; Hahne, Janne; Mueller, Klaus-Robert; Hyvaerinen, Aapo			Three-Way Analysis of Spectrospatial Electromyography Data: Classification and Interpretation	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; DISCRIMINANT-ANALYSIS; PRINCIPAL-COMPONENTS; EMG; REGULARIZATION; DECOMPOSITION; REDUCTION; SELECTION; FEATURES; EEG	Classifying multivariate electromyography (EMG) data is an important problem in prosthesis control as well as in neurophysiological studies and diagnosis. With modern high-density EMG sensor technology, it is possible to capture the rich spectrospatial structure of the myoelectric activity. We hypothesize that multi-way machine learning methods can efficiently utilize this structure in classification as well as reveal interesting patterns in it. To this end, we investigate the suitability of existing three-way classification methods to EMG-based hand movement classification in spectrospatial domain, as well as extend these methods by sparsification and regularization. We propose to use Fourier-domain independent component analysis as preprocessing to improve classification and interpretability of the results. In high-density EMG experiments on hand movements across 10 subjects, three-way classification yielded higher average performance compared with state-of-the art classification based on temporal features, suggesting that the three-way analysis approach can efficiently utilize detailed spectrospatial information of high-density EMG. Phase and amplitude patterns of features selected by the classifier in finger-movement data were found to be consistent with known physiology. Thus, our approach can accurately resolve hand and finger movements on the basis of detailed spectrospatial information, and at the same time allows for physiological interpretation of the results.	[Kauppi, Jukka-Pekka; Hyvaerinen, Aapo] Univ Helsinki, Dept Comp Sci, HIIT, SF-00510 Helsinki, Finland; [Kauppi, Jukka-Pekka] Aalto Univ, Brain Res Unit, OV Lounasmaa Lab, Espoo, Finland; [Hahne, Janne; Mueller, Klaus-Robert] Berlin Inst Technol, Dept Comp Sci, Machine Learning Grp, Berlin, Germany; [Hahne, Janne] Univ Med Gottingen, Dept Neurorehabil Engn, D-37073 Gottingen, Germany; [Mueller, Klaus-Robert] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Hyvaerinen, Aapo] Adv Telecommun Res Inst Int ATR, Dept Dynam Brain Imaging, Kyoto, Japan	Aalto University; University of Helsinki; Aalto University; Technical University of Berlin; University of Gottingen; Korea University; Advanced Telecommunications Research Institute International	Kauppi, JP (corresponding author), Univ Helsinki, Dept Comp Sci, HIIT, Teollisuuskatu 23, SF-00510 Helsinki, Finland.	jukka-pekka.kauppi@helsinki.fi	Mueller, Klaus-Robert/Y-3547-2019	Mueller, Klaus-Robert/0000-0002-3861-7685; Hyvarinen, Aapo/0000-0002-5806-4432	Academy of Finland, Centre of Excellence in Inverse Problems [213476]; Academy of Finland, Centre of Excellence in Algorithmic Data Analysis [118653]; Academy of Finland, Computational Sciences [135198]; Japanese Ministry of Internal Affairs and Communication, project "Novel and innovative R&D making use of brain structures"; Marie Curie IAPP grant "AMYO" [251555]; Marie Currie IAPP grant "AMYO" [251555]; Brain Korea 21 Plus Program; SGER Grant through the National Research Foundation of Korea - Ministry of Education [2014055911]	Academy of Finland, Centre of Excellence in Inverse Problems; Academy of Finland, Centre of Excellence in Algorithmic Data Analysis(Academy of Finland); Academy of Finland, Computational Sciences; Japanese Ministry of Internal Affairs and Communication, project "Novel and innovative R&D making use of brain structures"; Marie Curie IAPP grant "AMYO"; Marie Currie IAPP grant "AMYO"; Brain Korea 21 Plus Program; SGER Grant through the National Research Foundation of Korea - Ministry of Education	JPK and AH were supported by the Academy of Finland, Centre of Excellence in Inverse Problems (project number 213476), Centre of Excellence in Algorithmic Data Analysis (project number 118653), Computational Sciences (project number 135198), http://www.aka.fi/en-GB/A/Programmes-and-cooperation/Centres-of-Excellence-/. AH was further supported by the Japanese Ministry of Internal Affairs and Communication, project "Novel and innovative R&D making use of brain structures." JH was supported by the Marie Curie IAPP grant "AMYO" (project number 251555), http://cordis.europa.eu/project/rcn/95059_en.html. KRM was supported by the Marie Currie IAPP grant "AMYO" (project number 251555) and the Brain Korea 21 Plus Program as well as the SGER Grant 2014055911 through the National Research Foundation of Korea funded by the Ministry of Education, http://www.nrf.re.kr/nrf_eng_cms/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews A, 2009, IEEE ENG MED BIO, P2987, DOI 10.1109/IEMBS.2009.5332520; Anemuller J, 2003, NEURAL NETWORKS, V16, P1311, DOI 10.1016/j.neunet.2003.08.003; Biessmann Felix, 2011, IEEE Rev Biomed Eng, V4, P26, DOI 10.1109/RBME.2011.2170675; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Blok JH, 2002, REV SCI INSTRUM, V73, P1887, DOI 10.1063/1.1455134; Casarotto S, 2004, CLIN NEUROPHYSIOL, V115, P609, DOI 10.1016/j.clinph.2003.10.018; Castellini C, 2009, BIOL CYBERN, V100, P35, DOI 10.1007/s00422-008-0278-1; Cichocki A., 2009, NONNEGATIVE MATRIX T, DOI DOI 10.1002/9780470747278; Dyrholm M, 2007, J MACH LEARN RES, V8, P1097; Engelhart K, 1999, MED ENG PHYS, V21, P431, DOI 10.1016/S1350-4533(99)00066-1; Farina D, 2013, INTRO NEURAL ENG MOT, V40; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hahne JM, 2012, IEEE T BIO-MED ENG, V59, P1436, DOI 10.1109/TBME.2012.2188799; Hargrove LJ, 2009, IEEE T BIO-MED ENG, V56, P1407, DOI 10.1109/TBME.2008.2008171; Hwang HJ, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056008; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Hyvarinen A, 2010, NEUROIMAGE, V49, P257, DOI 10.1016/j.neuroimage.2009.08.028; Jiang N, 2012, IEEE SIGNAL PROC MAG, V29, P147, DOI 10.1109/MSP.2012.2203480; Jiang N, 2011, IEEE T BIO-MED ENG, V58, P550, DOI 10.1109/TBME.2010.2084999; Kauppi JP, 2013, NEUROIMAGE, V83, P921, DOI 10.1016/j.neuroimage.2013.07.026; Kimura J, 2013, ELECTRODIAGNOSIS DIS, V4th; Lu HP, 2009, IEEE T NEURAL NETWOR, V20, P103, DOI 10.1109/TNN.2008.2004625; Matsubara T, 2013, IEEE T BIO-MED ENG, V60, P2205, DOI 10.1109/TBME.2013.2250502; Morup M, 2008, NEUROIMAGE, V42, P1439, DOI 10.1016/j.neuroimage.2008.05.062; Naik GR, 2014, IEEE ENG MED BIO, P3829, DOI 10.1109/EMBC.2014.6944458; Oskoei MA, 2007, BIOMED SIGNAL PROCES, V2, P275, DOI 10.1016/j.bspc.2007.07.009; Peleg D, 2002, IEEE T NEUR SYS REH, V10, P290, DOI 10.1109/TNSRE.2002.806831; Phinyomark A, 2012, EXPERT SYST APPL, V39, P7420, DOI 10.1016/j.eswa.2012.01.102; Pirsiavash H., 2009, P ADV NEUR INF PROC, P1482; Porro-Munoz D, 2011, SIGNAL PROCESS, V91, P2520, DOI 10.1016/j.sigpro.2011.05.004; Ren XM, 2006, MED BIOL ENG COMPUT, V44, P371, DOI 10.1007/s11517-006-0051-3; Saponas TS, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P515; Schmidt M., 2010, THESIS U BRIT COLUMB; Schmidt M, 2007, LECT NOTES ARTIF INT, V4701, P286; Staudenmann D, 2007, IEEE T BIO-MED ENG, V54, P751, DOI 10.1109/TBME.2006.889202; Tan XY, 2010, LECT NOTES COMPUT SC, V6316, P504, DOI 10.1007/978-3-642-15567-3_37; Tao DC, 2007, IEEE T PATTERN ANAL, V29, P1700, DOI 10.1109/TPAMI.2007.1096; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tomioka R, 2011, J MACH LEARN RES, V12, P1537; Tomioka R, 2010, NEUROIMAGE, V49, P415, DOI 10.1016/j.neuroimage.2009.07.045; van Gerven M, 2009, J NEUROSCI METH, V179, P78, DOI 10.1016/j.jneumeth.2009.01.016; Vigario R, 2000, IEEE T BIO-MED ENG, V47, P589, DOI 10.1109/10.841330; Weiss M, 2012, ELECTRODIAGNOSIS NEU, V24; Werner RA, 2011, MUSCLE NERVE, V44, P597, DOI 10.1002/mus.22208; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008; Ye J., 2004, P ADV NEUR INF PROC, P1569; Yu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100097	48	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127231	10.1371/journal.pone.0127231	http://dx.doi.org/10.1371/journal.pone.0127231			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039100	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700054
J	Kim, SG; Jung, WH; Kim, SN; Jang, JH; Kwon, JS				Kim, Seung-Goo; Jung, Wi Hoon; Kim, Sung Nyun; Jang, Joon Hwan; Kwon, Jun Soo			Alterations of Gray and White Matter Networks in Patients with Obsessive-Compulsive Disorder: A Multimodal Fusion Analysis of Structural MRI and DTI Using mCCA plus jICA	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; SOURCE-BASED MORPHOMETRY; VOXEL-BASED MORPHOMETRY; CANONICAL CORRELATION-ANALYSIS; DIFFUSION TENSOR; CORTICAL THICKNESS; DRUG-NAIVE; CEREBRAL-CORTEX; ABNORMALITIES; SYMPTOM	Many of previous neuroimaging studies on neuronal structures in patients with obsessivecompulsive disorder (OCD) used univariate statistical tests on unimodal imaging measurements. Although the univariate methods revealed important aberrance of local morphometry in OCD patients, the covariance structure of the anatomical alterations remains unclear. Motivated by recent developments of multivariate techniques in the neuroimaging field, we applied a fusion method called "mCCA+jICA" on multimodal structural data of T1-weighted magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) of 30 unmedicated patients with OCD and 34 healthy controls. Amongst six highly correlated multimodal networks (p < 0.0001), we found significant alterations of the interrelated gray and white matter networks over occipital and parietal cortices, frontal interhemispheric connections and cerebella (False Discovery Rate q <= 0.05). In addition, we found white matter networks around basal ganglia that correlated with a subdimension of OC symptoms, namely 'harm/checking' (q <= 0.05). The present study not only agrees with the previous unimodal findings of OCD, but also quantifies the association of the altered networks across imaging modalities.	[Kim, Seung-Goo; Jung, Wi Hoon; Kwon, Jun Soo] Seoul Natl Univ Hosp, SNU MRC, Inst Human Behav Med, Seoul 110744, South Korea; [Kim, Seung-Goo] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Kim, Sung Nyun; Jang, Joon Hwan; Kwon, Jun Soo] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Kwon, Jun Soo] Seoul Natl Univ, Coll Nat Sci, Dept Brain & Cognit Sci, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University Hospital; Max Planck Society; Seoul National University (SNU); Seoul National University (SNU)	Kwon, JS (corresponding author), Seoul Natl Univ Hosp, SNU MRC, Inst Human Behav Med, Seoul 110744, South Korea.	kwonjs@snu.ac.kr	Kim, Seung-Goo/T-5779-2019; Jung, Wi Hoon/J-4033-2019; Kim, Seung-Goo/T-5683-2019	Kim, Seung-Goo/0000-0003-0558-8547; Jung, Wi Hoon/0000-0002-8697-9584	National Research Foundation of Korea grant - Ministry of Education, Science and Technology (MEST) of the Republic of Korea [2012-0005150]	National Research Foundation of Korea grant - Ministry of Education, Science and Technology (MEST) of the Republic of Korea	This work is supported by the National Research Foundation of Korea grant funded by the Ministry of Education, Science and Technology (MEST) of the Republic of Korea (reference number: 2012-0005150; http://english.mest.go.kr/).	Abramowitz JS, 2006, J ANXIETY DISORD, V20, P1016, DOI 10.1016/j.janxdis.2006.03.001; Ahmari SE, 2013, SCIENCE, V340, P1234, DOI 10.1126/science.1234733; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bora E, 2011, J PSYCHIATR NEUROSCI, V36, P42, DOI 10.1503/jpn.100082; Burbaud P, 2013, BRAIN, V136, P304, DOI 10.1093/brain/aws306; Calhoun VD, 2006, HUM BRAIN MAPP, V27, P47, DOI 10.1002/hbm.20166; Cannistraro PA, 2005, BIOL PSYCHIAT, V57, p10S; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Chung MK, 2001, NEUROIMAGE, V14, P595, DOI 10.1006/nimg.2001.0862; Chung MK, 2013, LECT NOTES COMPUT SC, V8149, P300, DOI 10.1007/978-3-642-40811-3_38; Correa NM, 2010, IEEE SIGNAL PROC MAG, V27, P39, DOI 10.1109/MSP.2010.936725; Correa NM, 2008, IEEE J-STSP, V2, P998, DOI 10.1109/JSTSP.2008.2008265; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; de Wit SJ, 2014, AM J PSYCHIAT, V171, P340, DOI 10.1176/appi.ajp.2013.13040574; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Evans AC, 2013, NEUROIMAGE, V80, P489, DOI 10.1016/j.neuroimage.2013.05.054; Frazier JA, 2005, AM J PSYCHIAT, V162, P1256, DOI 10.1176/appi.ajp.162.7.1256; Garibotto V, 2010, NEUROBIOL DIS, V37, P468, DOI 10.1016/j.nbd.2009.11.003; Gelman A, 2003, INT STAT REV, V71, P369; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gilbert AR, 2008, J AFFECT DISORDERS, V109, P117, DOI 10.1016/j.jad.2007.12.223; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Groves AR, 2011, NEUROIMAGE, V54, P2198, DOI 10.1016/j.neuroimage.2010.09.073; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Huyser C, 2013, WORLD J BIOL PSYCHIA, V14, P319, DOI 10.3109/15622975.2012.674215; JARQUE CM, 1987, INT STAT REV, V55, P163, DOI 10.2307/1403192; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kasparek T, 2010, HUM BRAIN MAPP, V31, P300, DOI 10.1002/hbm.20865; Khundrakpam BS, 2013, CEREB CORTEX, V23, P2072, DOI 10.1093/cercor/bhs187; Kim JJ, 2001, BRIT J PSYCHIAT, V179, P330, DOI 10.1192/bjp.179.4.330; Kim SG, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00302; Kim SG, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P42, DOI 10.1109/ISBI.2012.6235479; Kim SG, 2011, I S BIOMED IMAGING, P808, DOI 10.1109/ISBI.2011.5872528; Koch K, 2012, J PSYCHIATR RES, V46, P264, DOI 10.1016/j.jpsychires.2011.10.016; Kwon JS, 2009, EXPERT REV NEUROTHER, V9, P255, DOI 10.1586/14737175.9.2.255; Lerch JP, 2008, NEUROIMAGE, V41, P243, DOI 10.1016/j.neuroimage.2008.02.019; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Li YO, 2012, HUM BRAIN MAPP, V33, P1431, DOI 10.1002/hbm.21292; Li YO, 2009, IEEE T SIGNAL PROCES, V57, P3918, DOI 10.1109/TSP.2009.2021636; Mataix-Cols D, 1999, AM J PSYCHIAT, V156, P1409; Mataix-Cols D, 2006, PSYCHIAT CLIN N AM, V29, P391, DOI 10.1016/j.psc.2006.02.006; Mechelli A, 2005, J NEUROSCI, V25, P8303, DOI 10.1523/JNEUROSCI.0357-05.2005; Menzies L, 2008, AM J PSYCHIAT, V165, P1308, DOI 10.1176/appi.ajp.2008.07101677; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Menzies L, 2007, BRAIN, V130, P3223, DOI 10.1093/brain/awm205; Nakamae T, 2011, J PSYCHIATR RES, V45, P687, DOI 10.1016/j.jpsychires.2010.09.016; Oh JS, 2012, HUM BRAIN MAPP, V33, P2441, DOI 10.1002/hbm.21372; Peng ZW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085663; Pujol J, 2004, ARCH GEN PSYCHIAT, V61, P720, DOI 10.1001/archpsyc.61.7.720; Radua J, 2014, NEUROPSYCHOPHARMACOL, V39, P1547, DOI 10.1038/npp.2014.5; Radua J, 2009, BRIT J PSYCHIAT, V195, P393, DOI 10.1192/bjp.bp.108.055046; Raznahan A, 2011, NEURON, V72, P873, DOI 10.1016/j.neuron.2011.09.028; Riffkin J, 2005, PSYCHIAT RES-NEUROIM, V138, P99, DOI 10.1016/j.pscychresns.2004.11.007; Rosario-Campos MC, 2006, MOL PSYCHIATR, V11, P495, DOI 10.1038/sj.mp.4001798; Rotge JY, 2010, NEUROPSYCHOPHARMACOL, V35, P686, DOI 10.1038/npp.2009.175; Saito Y, 2008, EUR PSYCHIAT, V23, pS353, DOI 10.1016/j.eurpsy.2008.01.1221; SANAVIO E, 1988, BEHAV RES THER, V26, P169, DOI 10.1016/0005-7967(88)90116-7; Saxena S, 1998, BRIT J PSYCHIAT, V173, P26; Saxena S, 2000, PSYCHIAT CLIN N AM, V23, P563, DOI 10.1016/S0193-953X(05)70181-7; Schutter DJLG, 2005, CEREBELLUM, V4, P290, DOI 10.1080/14734220500348584; Silk T, 2013, PSYCHIAT RES-NEUROIM, V213, P154, DOI 10.1016/j.pscychresns.2013.04.003; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Sui J, 2014, NEUROIMAGE, V102, P11, DOI 10.1016/j.neuroimage.2013.09.044; Sui J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00235; Sui J, 2012, J NEUROSCI METH, V204, P68, DOI 10.1016/j.jneumeth.2011.10.031; Sui J, 2011, NEUROIMAGE, V57, P839, DOI 10.1016/j.neuroimage.2011.05.055; Sui J, 2010, NEUROIMAGE, V51, P123, DOI 10.1016/j.neuroimage.2010.01.069; Szeszko PR, 2008, AM J PSYCHIAT, V165, P1299, DOI 10.1176/appi.ajp.2008.08010033; Szeszko PR, 2005, ARCH GEN PSYCHIAT, V62, P782, DOI 10.1001/archpsyc.62.7.782; Tobe RH, 2010, ANN NEUROL, V67, P479, DOI 10.1002/ana.21918; Valente AA, 2005, BIOL PSYCHIAT, V58, P479, DOI 10.1016/j.biopsych.2005.04.021; van den Heuvel OA, 2009, BRAIN, V132, P853, DOI 10.1093/brain/awn267; Venkatasubramanian G, 2012, J PSYCHIATR RES, V46, P1161, DOI 10.1016/j.jpsychires.2012.06.003; Worsley KJ, 2004, NEUROIMAGE, V23, pS189, DOI 10.1016/j.neuroimage.2004.07.026; Xu L, 2009, HUM BRAIN MAPP, V30, P711, DOI 10.1002/hbm.20540; Xu L, 2009, NEUROIMAGE, V44, P777, DOI 10.1016/j.neuroimage.2008.09.051; Yoo SY, 2007, ACTA PSYCHIAT SCAND, V116, P211, DOI 10.1111/j.1600-0447.2007.01046.x; Zarei M, 2011, BIOL PSYCHIAT, V70, P1083, DOI 10.1016/j.biopsych.2011.06.032	90	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127118	10.1371/journal.pone.0127118	http://dx.doi.org/10.1371/journal.pone.0127118			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26038825	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700050
J	Kumar, P; Kumar, R; Manuja, BK; Singha, H; Sharma, A; Virmani, N; Yadav, SC; Manuja, A				Kumar, Parveen; Kumar, Rakesh; Manuja, Balvinder Kumar; Singha, Harisankar; Sharma, Anshu; Virmani, Nitin; Yadav, Suresh Chandra; Manuja, Anju			CpG-ODN Class C Mediated Immunostimulation in Rabbit Model of Trypanosoma evansi Infection	PLOS ONE			English	Article							DEPENDENT PROTECTION; ANTIGENIC VARIATION; BACTERIAL-DNA; OLIGODEOXYNUCLEOTIDES; MOTIFS; OLIGONUCLEOTIDES; INDUCTION; IMMUNITY; DONKEYS; ELISA	CpG oligodeoxynucleotides (CpG-ODN) stimulate immune cells from a wide spectrum of mammalian species. Class C CpG-ODN is relatively stable and has the combined immune effects of both A and B classes of CpG-ODN. Trypanosoma evansi produces the state of immuno-suppression in the infected hosts. The current chemotherapeutic agents against this parasite are limited in number and usually associated with severe side effects. The present work aimed to determine the immunostimulatory effects of CpG-ODN class C in T. evansi infected rabbits. Rabbits inoculated with CpG C and challenged with T. evansi resulted in delayed onset of clinical signs with reduced severity in comparison to that of T. evansi infected rabbits. The treatment also enhanced humoral immune responses. Histopathological findings in liver and spleen revealed enhancement of mononuclear cell infiltration and secondary B cell follicles. These results demonstrate that CpG-ODN class C, has immunostimulatory properties in rabbit model of trypanosomosis. The use of booster doses or sustained delivery of CpG-ODN will further elucidate the prolonged CpG-ODN generated immune responses.	[Kumar, Parveen; Manuja, Balvinder Kumar; Singha, Harisankar; Virmani, Nitin; Yadav, Suresh Chandra; Manuja, Anju] Natl Res Ctr Equines, Hisar 125001, Haryana, India; [Kumar, Parveen; Kumar, Rakesh; Sharma, Anshu] Lala Lajpat Rai Univ Vet & Anim Sci, Hisar 125001, Haryana, India	Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Equines; Lala Lajpat Rai University of Veterinary & Animal Sciences	Manuja, A (corresponding author), Natl Res Ctr Equines, Sirsa Rd, Hisar 125001, Haryana, India.	amanuja@rediffmail.com			Indian Council of Agricultural Research, Ministry of Agriculture, India [IXX00276]	Indian Council of Agricultural Research, Ministry of Agriculture, India	Funding was received from the Indian Council of Agricultural Research, Ministry of Agriculture, India (IXX00276). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaffar AH, 2007, MED J BABYLON, V4, P358; Ballas ZK, 1996, J IMMUNOL, V157, P1840; Baral TN, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/389153; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Becker PD, 2001, VACCINE, V19, P4603, DOI 10.1016/S0264-410X(01)00259-6; Biswas D, 2001, EXP PARASITOL, V99, P148, DOI 10.1006/expr.2001.4664; BORST P, 1994, SCIENCE, V264, P1872, DOI 10.1126/science.7516579; Burtis C. A., 1999, TIETZ TXB CLIN CHEM; Cadioli FA, 2006, ARQ BRAS MED VET ZOO, V58, P749, DOI 10.1590/S0102-09352006000500008; CROSS GAM, 1990, ANNU REV IMMUNOL, V8, P83, DOI 10.1146/annurev.iy.08.040190.000503; DAMAYANTI R, 1994, J COMP PATHOL, V110, P237, DOI 10.1016/S0021-9975(08)80277-0; Dargantes AP, 2005, J COMP PATHOL, V133, P261, DOI 10.1016/j.jcpa.2005.06.001; Davis HL, 1998, J IMMUNOL, V160, P870; Elkins KL, 1999, J IMMUNOL, V162, P2291; Flynn B, 2005, INFECT IMMUN, V73, P4948, DOI 10.1128/IAI.73.8.4948-4954.2005; Frank FM, 2003, VACCINE, V22, P77, DOI 10.1016/S0264-410X(03)00541-3; Gramzinski RA, 2001, INFECT IMMUN, V69, P1643, DOI 10.1128/IAI.69.3.1643-1649.2001; Harris TH, 2007, INFECT IMMUN, V75, P2366, DOI 10.1128/IAI.01649-06; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Jurk M, 2004, IMMUNOBIOLOGY, V209, P141, DOI 10.1016/j.imbio.2004.02.006; Juyal P.D., 2011, TROPMED INT WISSEN P, P1; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Kumar R, 2015, J EQUINE VET SCI, V35, P337, DOI 10.1016/j.jevs.2015.02.004; Kumar R, 2013, VET PARASITOL, V196, P251, DOI 10.1016/j.vetpar.2013.04.018; Manuja A, 2014, NANOMEDICINE-UK, V9, P1625, DOI [10.2217/nnm.13.148, 10.2217/NNM.13.148]; Manuja A, 2014, INT IMMUNOPHARMACOL, V22, P366, DOI 10.1016/j.intimp.2014.07.016; Manuja A, 2013, IMMUNOPHARM IMMUNOT, V35, P535, DOI 10.3109/08923973.2013.828743; MONZON CM, 1990, VET PARASITOL, V36, P295, DOI 10.1016/0304-4017(90)90041-9; NGERANWA JJN, 1993, RES VET SCI, V54, P283, DOI 10.1016/0034-5288(93)90124-X; Rad M, 2006, J APPL ANIM RES, V29, P145, DOI 10.1080/09712119.2006.9706591; SANDS H, 1994, MOL PHARMACOL, V45, P932; Shukoor MI, 2012, J MATER CHEM, V22, P8826, DOI 10.1039/c2jm16903g; Silva RAMS, 1999, VET PARASITOL, V85, P87, DOI 10.1016/S0304-4017(99)00081-3; Singh, 2012, NANOTECH DEV, V2, P4, DOI [10.4081/nd.2012.e4, DOI 10.4081/ND.2012.E4]; SivaJothi S., 2013, Journal of Advanced Veterinary Research, V3, P122; Soodan JS, 1996, INDIAN J ANIM SCI, V66, P443; SUDARTO MW, 1990, J PARASITOL, V76, P162, DOI 10.2307/3283007; Tizard IR, 1998, IMUNOLOGIA VET INTRO, P331; Vollmer J, 2004, EUR J IMMUNOL, V34, P251, DOI 10.1002/eji.200324032; Von Brand T., 1973, BIOCH PARASITES; Weeratna RD, 2000, VACCINE, V18, P1755, DOI 10.1016/S0264-410X(99)00526-5; Weiner GJ, 1997, P NATL ACAD SCI USA, V94, P10833, DOI 10.1073/pnas.94.20.10833; Yadav S C, 2014, J Parasit Dis, V38, P124, DOI 10.1007/s12639-012-0204-2; Yadav SC, 2011, PARASITOL RES, V109, P559, DOI 10.1007/s00436-011-2284-9; Zhao QY, 1999, BIOORG MED CHEM LETT, V9, P3453; Zhao QY, 1997, ANTISENSE NUCLEIC A, V7, P495, DOI 10.1089/oli.1.1997.7.495	49	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127437	10.1371/journal.pone.0127437	http://dx.doi.org/10.1371/journal.pone.0127437			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039713	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700060
J	Luo, ST; Han, LT; Lu, HY; Dou, Z; Tao, Q; Khoshnood, K; Wu, ZY; Xu, J				Luo, Sitong; Han, Litao; Lu, Hongyan; Dou, Zhi; Tao, Qian; Khoshnood, Kaveh; Wu, Zunyou; Xu, Jie			Evaluating the Impact of Test-and-Treat on the HIV Epidemic among MSM in China Using a Mathematical Model	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; PREVENTION; INFECTION; STRATEGY; TRANSMISSION; RATES; MEN; SEX	Background Various studies have modeled the impact of test-and-treat policies on the HIV epidemics worldwide. However, few modeling studies have taken into account China's context. To understand the potential effect of test-and-treat on the HIV epidemic among men who have sex with men (MSM) in China, we developed a mathematical model to evaluate the impact of the strategy. Method Based on the natural history of the CD4 count of people living with HIV and AIDS (PLWHA), we constructed a dynamic compartmental model of HIV transmission among Chinese MSM to project the number of HIV new infections and prevalence over 10 years. We predicted the annual number of HIV new infections and the total number of MSM living with HIV and AIDS (based on Beijing data) between 2010 and 2022 under the following conditions: (1) current practice (testing rate of 50% and ART coverage of 39%); (2) both testing rate and ART coverage increasing to 70% in 2013; (3) both testing rate and ART coverage increasing to 90% in 2013; and (4) both testing rate and ART coverage increasing gradually every year until 90% since 2013. Results Based on our model, if the HIV test-and-treat policy was implemented among Chinese MSM, the total number of HIV new infections over 10 years (2013-2022) would be reduced by 50.6-70.9% compared with the current policy. When ART coverage for PLWHA increased to 58% since 2013, the 'turning point' would occur on the curve of HIV new infections by 2015. A 25% reduction in annual number of HIV new infections by 2015 might be achieved if the testing rate increased from 50% to 70% and treatment coverage for PLWHA increased to 55% since 2013. Conclusion Implementation of the test-and-treat strategy may significantly reduce HIV new infections among MSM in China. Great efforts need to be made to scale up HIV testing rate and ART coverage among Chinese MSM.	[Luo, Sitong; Dou, Zhi; Wu, Zunyou; Xu, Jie] Chinese Ctr Dis Control & Prevent, Div Prevent Intervent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Luo, Sitong] Peking Union Med Coll, Dept Epidemiol & Biostat, Beijing 100021, Peoples R China; [Han, Litao; Tao, Qian] Renmin Univ China, Sch Informat, Beijing, Peoples R China; [Lu, Hongyan] Beijing Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Beijing, Peoples R China; [Khoshnood, Kaveh] Yale Univ, Dept Epidemiol Microbial Dis, New Haven, CT USA	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Renmin University of China; Yale University	Han, LT (corresponding author), Renmin Univ China, Sch Informat, Beijing, Peoples R China.	hanlitao@ruc.edu.cn; xujie@chinaaids.cn	Khoshnood, Kaveh/AAX-1402-2020; Luo, Sitong/GZL-1517-2022	Khoshnood, Kaveh/0000-0003-2795-0447; Luo, Sitong/0000-0002-5612-418X	China National AIDS Program; China national technical support and operational research for HIV/AIDS prevention, treatment and care project [131-11-0001-0501]; National Science and Technology Major Project on Prevention and Treatment of Major Infectious Diseases including AIDS and Viral Hepatitis [2012ZX10001-007]; Fogarty International Center; National Institute on Drug Abuse at the US National Institutes of Health (China ICOHRTA2, NIH Research grant) [U2RTW06918]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062294] Funding Source: NIH RePORTER	China National AIDS Program; China national technical support and operational research for HIV/AIDS prevention, treatment and care project; National Science and Technology Major Project on Prevention and Treatment of Major Infectious Diseases including AIDS and Viral Hepatitis; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute on Drug Abuse at the US National Institutes of Health (China ICOHRTA2, NIH Research grant); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by: (1) the China National AIDS Program (grant number is not available; receiver: ZW), (2) the China national technical support and operational research for HIV/AIDS prevention, treatment and care project (grant number: 131-11-0001-0501; receiver: ZW), (3) the National Science and Technology Major Project on Prevention and Treatment of Major Infectious Diseases including AIDS and Viral Hepatitis (grant number: 2012ZX10001-007; receiver: ZW) and (4) the Fogarty International Center and the National Institute on Drug Abuse at the US National Institutes of Health (China ICOHRTA2, NIH Research grant no: U2RTW06918; receiver: ZW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beijing Municipal Bureau of Statistics, 2013, TABULATION ON THE 20, P168; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Burns DN, 2010, CLIN INFECT DIS, V51, P725, DOI 10.1086/655889; Charlebois ED, 2011, CLIN INFECT DIS, V52, P1046, DOI 10.1093/cid/cir085; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Fauci AS, 1996, ANN INTERN MED, V124, P654, DOI 10.7326/0003-4819-124-7-199604010-00006; Garnett GP, 2009, LANCET, V373, P9, DOI 10.1016/S0140-6736(08)61698-0; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hayes R, 2011, CURR HIV RES, V9, P429, DOI 10.2174/157016211798038515; He SF, 2014, CHIN J AIDS STD, V20, P593; Huang XJ, 2013, JAIDS-J ACQ IMM DEF, V62, P441, DOI 10.1097/QAI.0b013e31827f5c9a; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Liu Z.J., 2011, THESIS; Luo S, 2013, CHIN J AIDS STD, V19, P780; Ministry of Health of the People's Republic of China UNAIDS WHO, 2009, ESTIMATES FOR THE HI, P7; Ministry of Health of the People's Republic of China UNAIDS WHO, 2011, EN 2011, P5, DOI [10.3967/0895-3988.2011.04.004, DOI 10.3967/0895-3988.2011.04.004]; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Office of the State Council Working Committee to Combat AIDS in China UNAIDS Task Force in China, 2007, ESTIMATES FOR THE HI, P8; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Saag MS, 1996, NAT MED, V2, P625, DOI 10.1038/nm0696-625; Smith K, 2011, CURR OPIN HIV AIDS, V6, P315, DOI 10.1097/COH.0b013e32834788e7; Sorensen SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029098; UNAIDS, 2012, WORLD AIDS DAY REPOR, P43; van Sighem A, 2010, AIDS, V24, P1527, DOI 10.1097/QAD.0b013e32833a3946; von Bubnoff Andreas, 2012, IAVI Rep, V16, P18; Wagner B, 2010, LANCET, V376, P953, DOI 10.1016/S0140-6736(10)61442-0; Wagner BG, 2010, AIDS, V24, P775, DOI 10.1097/QAD.0b013e3283366782; Walensky RP, 2010, CLIN INFECT DIS, V51, P392, DOI 10.1086/655130; Wang L, 2009, AIDS, P34; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Yan Y., 2010, THE NEWS CHINA; Zhang Bing, 2002, Computer Integrated Manufacturing Systems, V8, P197; Zhang F, 2012, NATIONAL GUIDELINE F, P17	36	20	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126893	10.1371/journal.pone.0126893	http://dx.doi.org/10.1371/journal.pone.0126893			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039075	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700041
J	Bazmara, H; Soltani, M; Sefidgar, M; Bazargan, M; Naeenian, MM; Rahmim, A				Bazmara, Hossein; Soltani, Madjid; Sefidgar, Mostafa; Bazargan, Majid; Naeenian, Mojtaba Mousavi; Rahmim, Arman			The Vital Role of Blood Flow-Induced Proliferation and Migration in Capillary Network Formation in a Multiscale Model of Angiogenesis	PLOS ONE			English	Article							FLUID SHEAR-STRESS; FOCAL ADHESION KINASE; ENDOTHELIAL-CELLS; SIGNAL-TRANSDUCTION; DRUG-DELIVERY; VESSEL FUSION; TUMOR-GROWTH; MECHANISMS; EXPRESSION; MECHANOTRANSDUCTION	Sprouting angiogenesis and capillary network formation are tissue scale phenomena. There are also sub-scale phenomena involved in angiogenesis including at the cellular and intracellular (molecular) scales. In this work, a multiscale model of angiogenesis spanning intracellular, cellular, and tissue scales is developed in detail. The key events that are considered at the tissue scale are formation of closed flow path (that is called loop in this article) and blood flow initiation in the loop. At the cellular scale, growth, migration, and anastomosis of endothelial cells (ECs) are important. At the intracellular scale, cell phenotype determination as well as alteration due to blood flow is included, having pivotal roles in the model. The main feature of the model is to obtain the physical behavior of a closed loop at the tissue scale, relying on the events at the cellular and intracellular scales, and not by imposing physical behavior upon it. Results show that, when blood flow is considered in the loop, the anastomosed sprouts stabilize and elongate. By contrast, when the loop is modeled without consideration of blood flow, the loop collapses. The results obtained in this work show that proper determination of EC phenotype is the key for its survival.	[Bazmara, Hossein; Soltani, Madjid; Sefidgar, Mostafa; Bazargan, Majid; Naeenian, Mojtaba Mousavi] KNT Univ Technol, Dept Mech Engn, Tehran, Iran; [Soltani, Madjid; Rahmim, Arman] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Div Nucl Med, Baltimore, MD USA	Johns Hopkins University	Soltani, M (corresponding author), KNT Univ Technol, Dept Mech Engn, Tehran, Iran.	msoltani@jhu.edu	Bazmara, Hossein/AAO-8162-2021; Rahmim, Arman/ACS-4963-2022; Sefidgar, Mostafa/AAO-8634-2021; Bazargan, Majid/AAS-3204-2020	Rahmim, Arman/0000-0002-9980-2403; Bazargan, Majid/0000-0001-8747-664X				Anderson ARA, 2012, MODELING TUMOR VASCULATURE: MOLECULAR, CELLULAR, AND TISSUE LEVEL ASPECTS AND IMPLICATIONS, P105, DOI 10.1007/978-1-4614-0052-3_5; Ando J, 2013, CARDIOVASC RES, V99, P260, DOI 10.1093/cvr/cvt084; Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583; [Anonymous], EMBO J; Armer HEJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007716; AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8; Bauer AL, 2007, BIOPHYS J, V92, P3105, DOI 10.1529/biophysj.106.101501; Bauer AL, 2012, MODELING TUMOR VASCULATURE: MOLECULAR, CELLULAR, AND TISSUE LEVEL ASPECTS AND IMPLICATIONS, P79, DOI 10.1007/978-1-4614-0052-3_4; Bauer AL, 2010, J THEOR BIOL, V264, P838, DOI 10.1016/j.jtbi.2010.03.025; Bauer AL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000445; Berk BC, 2008, CIRCULATION, V117, P1082, DOI 10.1161/CIRCULATIONAHA.107.720730; Cai Y, 2011, J THEOR BIOL, V279, P90, DOI 10.1016/j.jtbi.2011.02.017; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Chaplain MAJ, 2012, MODELING TUMOR VASCULATURE: MOLECULAR, CELLULAR, AND TISSUE LEVEL ASPECTS AND IMPLICATIONS, P167, DOI 10.1007/978-1-4614-0052-3_8; Chen KD, 1999, J BIOL CHEM, V274, P18393, DOI 10.1074/jbc.274.26.18393; Chien S, 1998, HYPERTENSION, V31, P162, DOI 10.1161/01.HYP.31.1.162; Chun TH, 1997, HYPERTENSION, V29, P1296, DOI 10.1161/01.HYP.29.6.1296; Clark ER, 1918, AM J ANAT, V23, P37, DOI 10.1002/aja.1000230103; COOKE JP, 1991, J CLIN INVEST, V88, P1663, DOI 10.1172/JCI115481; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Dimmeler S, 1996, FEBS LETT, V399, P71, DOI 10.1016/S0014-5793(96)01289-6; Estrach S, 2011, CIRC RES, V109, P172, DOI 10.1161/CIRCRESAHA.111.240622; Garipcan B, 2011, ADV ENG MATER, V13, pB54, DOI 10.1002/adem.201080076; GERLOWSKI LE, 1986, MICROVASC RES, V31, P288, DOI 10.1016/0026-2862(86)90018-X; GIMBRONE MA, 1974, J NATL CANCER I, V52, P413, DOI 10.1093/jnci/52.2.413; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; Herwig L, 2011, CURR BIOL, V21, P1942, DOI 10.1016/j.cub.2011.10.016; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Hsu PP, 2001, BIOCHEM BIOPH RES CO, V285, P751, DOI 10.1006/bbrc.2001.5221; Ishida T, 1996, CIRC RES, V79, P310, DOI 10.1161/01.RES.79.2.310; Jiang Y, 2005, BIOPHYS J, V89, P3884, DOI 10.1529/biophysj.105.060640; Jin ZG, 2003, CIRC RES, V93, P354, DOI 10.1161/01.RES.0000089257.94002.96; Johnson BD, 2011, VASC MED, V16, P365, DOI 10.1177/1358863X11422109; Kaiser D, 1997, BIOCHEM BIOPH RES CO, V231, P586, DOI 10.1006/bbrc.1997.6146; Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kesmarky G, 2008, CLIN HEMORHEOL MICRO, V39, P243, DOI 10.3233/CH-2008-1088; Lee HJ, 2003, BIOCHEM BIOPH RES CO, V304, P399, DOI 10.1016/S0006-291X(03)00592-8; Lehoux S, 1998, HYPERTENSION, V32, P338, DOI 10.1161/01.HYP.32.2.338; Lenard A, 2013, DEV CELL, V25, P492, DOI 10.1016/j.devcel.2013.05.010; LEVESQUE MJ, 1990, BIOMATERIALS, V11, P702, DOI 10.1016/0142-9612(90)90031-K; Li S, 2005, J CELL BIOCHEM, V96, P1110, DOI 10.1002/jcb.20614; Li S, 2002, P NATL ACAD SCI USA, V99, P3546, DOI 10.1073/pnas.052018099; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030; Mahoney AW, 2012, IEEE ACM T COMPUT BI, V9, P169, DOI 10.1109/TCBB.2010.39; Mahoney AW, 2008, 2008 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P215; Mantzaris NV, 2004, J MATH BIOL, V49, P111, DOI 10.1007/s00285-003-0262-2; Mariggi G, 2012, THESIS U COLL LONDON; Meeson A, 1996, DEVELOPMENT, V122, P3929; Merks RMH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000163; Milde F, 2008, BIOPHYS J, V95, P3146, DOI 10.1529/biophysj.107.124511; Munoz-Chapuli R, 2004, CELL MOL LIFE SCI, V61, P2224, DOI 10.1007/s00018-004-4070-7; MUTHUKKARUPPAN VR, 1982, J NATL CANCER I, V69, P699; Ngai C., 2010, OPEN CIRC VASC J, V3, P85; OKAHARA K, 1995, FEBS LETT, V373, P108, DOI 10.1016/0014-5793(95)01027-C; Osawa M, 2002, J CELL BIOL, V158, P773, DOI 10.1083/jcb.200205049; Owen MR, 2009, J MATH BIOL, V58, P689, DOI 10.1007/s00285-008-0213-z; Pan S, 2009, ANTIOXID REDOX SIGN, V11, P1669, DOI [10.1089/ars.2009.2487, 10.1089/ARS.2009.2487]; PAWELETZ N, 1989, CRIT REV ONCOL HEMAT, V9, P197, DOI 10.1016/S1040-8428(89)80002-2; Perfahl H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014790; Pries AR, 2001, HYPERTENSION, V38, P1476, DOI 10.1161/hy1201.100592; Pries AR, 1996, CARDIOVASC RES, V32, P654, DOI 10.1016/S0008-6363(96)00065-X; PRIES AR, 1992, AM J PHYSIOL, V263, pH1770, DOI 10.1152/ajpheart.1992.263.6.H1770; Quitub AA, 2009, IEEE ENG MED BIOL, V28, P14, DOI 10.1109/MEMB.2009.931791; Resnick N, 2003, PROG BIOPHYS MOL BIO, V81, P177, DOI 10.1016/S0079-6107(02)00052-4; Riaz A, 2013, THESIS UPPSALA U; Sefidgar M, 2015, MICROVASC RES, V99, P43, DOI 10.1016/j.mvr.2015.02.007; Sefidgar M, 2014, J TISSUE SCI ENG S, DOI [10.4172/2157-7552.S4-003, DOI 10.4172/2157-7552.S4-003]; Sefidgar M, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-12; Shamloo A, 2010, LAB CHIP, V10, P3061, DOI 10.1039/c005069e; Shay-Salit A, 2002, P NATL ACAD SCI USA, V99, P9462, DOI 10.1073/pnas.142224299; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; Shyy JY, 2002, CIRC RES, V91, P769, DOI 10.1161/01.RES.0000038487.19924.18; Soltani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067025; Soltani M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020344; Song JW, 2012, INTEGR BIOL-UK, V4, P857, DOI 10.1039/c2ib20061a; Song JW, 2011, P NATL ACAD SCI USA, V108, P15342, DOI 10.1073/pnas.1105316108; Stapor PC., 2011, CARDIOVASC ENG TECHN, V2, P124, DOI [10.1007/S13239-011-0041-Y, DOI 10.1007/S13239-011-0041-Y]; Stephanou A, 2006, MATH COMPUT MODEL, V44, P96, DOI 10.1016/j.mcm.2004.07.021; Stylianopoulos T, 2013, ANN BIOMED ENG, V41, P68, DOI 10.1007/s10439-012-0630-4; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Udan RS, 2013, DEVELOPMENT, V140, P4041, DOI 10.1242/dev.096255; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	85	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128878	10.1371/journal.pone.0128878	http://dx.doi.org/10.1371/journal.pone.0128878			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047145	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200109
J	Chan, CXJ; Joseph, IG; Huang, A; Jackson, DN; Lipke, PN				Chan, Cho X. J.; Joseph, Ivor G.; Huang, Andy; Jackson, Desmond N.; Lipke, Peter N.			Quantitative Analyses of Force-Induced Amyloid Formation in Candida albicans Als5p: Activation by Standard Laboratory Procedures	PLOS ONE			English	Article							THIN AGGREGATIVE FIMBRIAE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; ADHESION NANODOMAINS; PROTEIN-STRUCTURE; FIBRIL FORMATION; SURFACE; CURLI; MOLECULE; FIBERS	Candida albicans adhesins have amyloid-forming sequences. In Als5p, these amyloid sequences cluster cell surface adhesins to create high avidity surface adhesion nanodomains. Such nanodomains form after force is applied to the cell surface by atomic force microscopy or laminar flow. Here we report centrifuging and resuspending S. cerevisiae cells expressing Als5p led to 1.7-fold increase in initial rate of adhesion to ligand coated beads. Furthermore, mechanical stress from vortex-mixing of Als5p cells or C. albicans cells also induced additional formation of amyloid nanodomains and consequent activation of adhesion. Vortex-mixing for 60 seconds increased the initial rate of adhesion 1.6-fold. The effects of vortex-mixing were replicated in heat-killed cells as well. Activation was accompanied by increases in thioflavin T cell surface fluorescence measured by flow cytometry or by confocal microscopy. There was no adhesion activation in cells expressing amyloid-impaired Als5p(V326N) or in cells incubated with inhibitory concentrations of anti-amyloid dyes. Together these results demonstrated the activation of cell surface amyloid nanodomains in yeast expressing Als adhesins, and further delineate the forces that can activate adhesion in vivo. Consequently there is quantitative support for the hypothesis that amyloid forming adhesins act as both force sensors and effectors.	[Chan, Cho X. J.; Joseph, Ivor G.; Huang, Andy; Jackson, Desmond N.; Lipke, Peter N.] CUNY Brooklyn Coll, Dept Biol, New York, NY 11210 USA; [Chan, Cho X. J.; Lipke, Peter N.] CUNY, Grad Ctr, New York, NY USA; [Chan, Cho X. J.] Pace Univ, Haskins Labs, New York, NY 10038 USA; [Chan, Cho X. J.] Pace Univ, Dept Chem & Phys Sci, New York, NY 10038 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; Pace University; Pace University	Lipke, PN (corresponding author), CUNY Brooklyn Coll, Dept Biol, New York, NY 11210 USA.	plipke@brookyn.cuny.edu	Lipke, Peter N./AAW-4914-2020	Lipke, Peter N./0000-0003-1733-0690	National Institute of Health [R01 GM098616]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098616] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Health Grant# R01 GM098616 (http://grants.nih.gov/grants/funding/r01.htm) to PNL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsteens D, 2013, ANAL METHODS-UK, V5, P3657, DOI 10.1039/c3ay40473k; Alsteens D, 2012, ACS NANO, V6, P7703, DOI 10.1021/nn3025699; Alsteens D, 2010, P NATL ACAD SCI USA, V107, P20744, DOI 10.1073/pnas.1013893107; Alsteens D, 2009, ACS NANO, V3, P1677, DOI 10.1021/nn900078p; Austin JW, 1998, FEMS MICROBIOL LETT, V162, P295, DOI 10.1016/S0378-1097(98)00137-2; Bai G, 2012, INT J PHARMACEUT, V423, P264, DOI 10.1016/j.ijpharm.2011.11.044; Beaussart A, 2012, ACS NANO, V6, P10950, DOI 10.1021/nn304505s; BenNasr A, 1996, MOL MICROBIOL, V20, P927; Calamai M, 2005, BIOPHYS J, V89, P4201, DOI 10.1529/biophysj.105.068726; Chan CXJ, 2014, EUKARYOT CELL, V13, P1136, DOI 10.1128/EC.00068-14; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; CHARM SE, 1969, BIBL ANAT, P85; Coleman DA, 2010, MICROBIOL-SGM, V156, P3645, DOI 10.1099/mic.0.043851-0; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dunstan DE, 2009, PROTEIN ENG DES SEL, V22, P741, DOI 10.1093/protein/gzp059; Dutton LC, 2014, MBIO, V5, DOI 10.1128/mBio.00911-14; Fandrich M, 2006, ACTA HISTOCHEM, V108, P215, DOI 10.1016/j.acthis.2006.03.012; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Garcia MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017632; Garcia-Herranz M, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092413, 10.1371/journal.pone.0086067]; Gaur NK, 1997, INFECT IMMUN, V65, P5289, DOI 10.1128/IAI.65.12.5289-5294.1997; Gilchrist KB, 2012, J INFECT DIS, V206, P1473, DOI 10.1093/infdis/jis464; Harper JD, 1997, CHEM BIOL, V4, P951, DOI 10.1016/S1074-5521(97)90303-3; Hill EK, 2006, BIOMACROMOLECULES, V7, P10, DOI 10.1021/bm0505078; HOYER LL, 1995, MOL MICROBIOL, V15, P39, DOI 10.1111/j.1365-2958.1995.tb02219.x; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Ladner-Keay CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098753; Lipke PN, 2012, TRENDS MICROBIOL, V20, P59, DOI 10.1016/j.tim.2011.10.002; MCCUTCHEN SL, 1995, BIOCHEMISTRY-US, V34, P13527, DOI 10.1021/bi00041a032; Merlini G, 2005, CLIN CHIM ACTA, V357, P168, DOI 10.1016/j.cccn.2005.03.022; Morris KL, 2013, ANGEW CHEM INT EDIT, V52, P2279, DOI 10.1002/anie.201207699; Oli MW, 2012, MICROBIOL-SGM, V158, P2903, DOI 10.1099/mic.0.060855-0; OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0; Olsen A, 1998, INFECT IMMUN, V66, P944; Otoo HN, 2008, EUKARYOT CELL, V7, P776, DOI 10.1128/EC.00309-07; Ramsook CB, 2010, EUKARYOT CELL, V9, P393, DOI 10.1128/EC.00068-09; Rauceo JM, 2004, INFECT IMMUN, V72, P4948, DOI 10.1128/IAI.72.9.4948-4955.2004; Romero D, 2011, MOL MICROBIOL, V80, P1155, DOI 10.1111/j.1365-2958.2011.07653.x; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; SJOBRING U, 1994, MOL MICROBIOL, V14, P443, DOI 10.1111/j.1365-2958.1994.tb02179.x; Sunde M, 1998, Q REV BIOPHYS, V31, P1, DOI 10.1017/S0033583598003400; Vidal O, 1998, J BACTERIOL, V180, P2442, DOI 10.1128/JB.180.9.2442-2449.1998	44	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129152	10.1371/journal.pone.0129152	http://dx.doi.org/10.1371/journal.pone.0129152			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047318	Green Published, gold			2022-12-27	WOS:000355652200130
J	Huber, SKR; Camps, MGM; Jacobi, RHJ; Mouthaan, J; van Dijken, H; van Beek, J; Ossendorp, F; de Jonge, J				Huber, S. K. Rosendahl; Camps, M. G. M.; Jacobi, R. H. J.; Mouthaan, J.; van Dijken, H.; van Beek, J.; Ossendorp, F.; de Jonge, J.			Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets	PLOS ONE			English	Article							A VIRUS; PROTECTIVE IMMUNITY; TRANSGENIC MICE; FUSION PEPTIDE; H5N1 VIRUS; INFECTION; HUMANS; IDENTIFICATION; HEMAGGLUTININ; LYMPHOCYTES	Currently licensed influenza vaccines mainly induce antibodies against highly variable epitopes. Due to antigenic drift, protection is subtype or strain-specific and regular vaccine updates are required. In case of antigenic shifts, which have caused several pandemics in the past, completely new vaccines need to be developed. We set out to develop a vaccine that provides protection against a broad range of influenza viruses. Therefore, highly conserved parts of the influenza A virus (IAV) were selected of which we constructed antibody and T cell inducing peptide-based vaccines. The B epitope vaccine consists of the highly conserved HA2 fusion peptide and M2e peptide coupled to a CD4 helper epitope. The T epitope vaccine comprises 25 overlapping synthetic long peptides of 26-34 amino acids, thereby avoiding restriction for a certain MHC haplotype. These peptides are derived from nucleoprotein (NP), polymerase basic protein 1 (PB1) and matrix protein 1 (M1). C57BL/6 mice, BALB/c mice, and ferrets were vaccinated with the B epitopes, 25 SLP or a combination of both. Vaccine-specific antibodies were detected in sera of mice and ferrets and vaccine-specific cellular responses were measured in mice. Following challenge, both mice and ferrets showed a reduction of virus titers in the lungs in response to vaccination. Summarizing, a peptide-based vaccine directed against conserved parts of influenza virus containing B and T cell epitopes shows promising results for further development. Such a vaccine may reduce disease burden and virus transmission during pandemic outbreaks.	[Huber, S. K. Rosendahl; Jacobi, R. H. J.; Mouthaan, J.; van Dijken, H.; van Beek, J.; de Jonge, J.] Ctr Infect Dis Control Cib, Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Camps, M. G. M.; Ossendorp, F.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands	Netherlands National Institute for Public Health & the Environment; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	de Jonge, J (corresponding author), Ctr Infect Dis Control Cib, Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands.	Jorgen.de.Jonge@rivm.nl		de Jonge, Jorgen/0000-0003-3167-2435	European Union Seventh Framework Programme, Identification of Mechanisms Correlating with Susceptibility for Avian Influenza (IMECS) [201169]; Health Program of the European Union, Fast Vaccination (FASTVAC) [2009-1106]	European Union Seventh Framework Programme, Identification of Mechanisms Correlating with Susceptibility for Avian Influenza (IMECS); Health Program of the European Union, Fast Vaccination (FASTVAC)	Funding provided to FO, JvB, JdJ by the European Union Seventh Framework Programme under grant number 201169, Identification of Mechanisms Correlating with Susceptibility for Avian Influenza (IMECS), http://ec.europa.eu/research/health/infectious-diseases/emerging-epidemics/projects/175_en.html. Funding provided to JdJ, HvD, JM by the Health Program of the European Union under grant number 2009-1106, Fast Vaccination (FASTVAC), http://www.fastvac.eu/work-packages/liaison-for-vaccine-deployment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; Alexander J, 2010, HUM IMMUNOL, V71, P468, DOI 10.1016/j.humimm.2010.02.014; [Anonymous], 2013, VACCINES; Assarsson E, 2008, J VIROL, V82, P12241, DOI 10.1128/JVI.01563-08; ATASSI MZ, 1983, P NATL ACAD SCI-BIOL, V80, P840, DOI 10.1073/pnas.80.3.840; Bijker MS, 2008, EUR J IMMUNOL, V38, P1033, DOI 10.1002/eji.200737995; Bijker MS, 2007, J IMMUNOL, V179, P5033, DOI 10.4049/jimmunol.179.8.5033; Bodewes R, 2010, EXPERT REV VACCINES, V9, P59, DOI [10.1586/erv.09.148, 10.1586/ERV.09.148]; Chun S, 2008, VACCINE, V26, P6068, DOI 10.1016/j.vaccine.2008.09.015; Cross KJ, 2009, PROTEIN PEPTIDE LETT, V16, P766, DOI 10.2174/092986609788681715; Du LY, 2010, MICROBES INFECT, V12, P280, DOI 10.1016/j.micinf.2010.01.001; Ebrahimi SM, 2011, VIRUS GENES, V42, P1, DOI 10.1007/s11262-010-0547-7; Fiers W, 2004, VIRUS RES, V103, P173, DOI 10.1016/j.virusres.2004.02.030; FINKELMAN FD, 1988, J IMMUNOL, V140, P1022; Francis JN, 2015, VACCINE, V33, P396, DOI 10.1016/j.vaccine.2014.06.006; Grant E, 2013, IMMUNOL CELL BIOL, V91, P184, DOI 10.1038/icb.2012.78; Hiemstra HS, 1997, P NATL ACAD SCI USA, V94, P10313, DOI 10.1073/pnas.94.19.10313; Hillaire MLB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/939860; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Ichihashi T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024626; Jegaskanda S, 2013, J IMMUNOL, V190, P1837, DOI 10.4049/jimmunol.1201574; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Laidlaw BJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003207; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Matsui M, 2010, BIOCHEM BIOPH RES CO, V391, P1494, DOI 10.1016/j.bbrc.2009.12.100; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Ossendorp F, 1998, J EXP MED, V187, P693, DOI 10.1084/jem.187.5.693; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Pleguezuelos O, 2012, VACCINE, V30, P4655, DOI 10.1016/j.vaccine.2012.04.089; Plotnicky H, 2003, VIROLOGY, V309, P320, DOI 10.1016/S0042-6822(03)00072-2; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Quinones-Parra S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00285; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schuurhuis DH, 2000, J EXP MED, V192, P145, DOI 10.1084/jem.192.1.145; SIGAL LJ, 1995, MOL IMMUNOL, V32, P623, DOI 10.1016/0161-5890(95)00031-9; SNAPPER CM, 1988, J EXP MED, V167, P183, DOI 10.1084/jem.167.1.183; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Stanekova Z, 2011, ACTA VIROL, V55, P61, DOI 10.4149/av_2011_01_61; Stanekova Z, 2012, INFLUENZA OTHER RESP, V6, P389, DOI 10.1111/j.1750-2659.2011.00328.x; Stanekova Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-351; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Stoloff GA, 2007, EUR J IMMUNOL, V37, P2441, DOI 10.1002/eji.200737254; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Suda T, 2011, ANTIVIR RES, V91, P252, DOI 10.1016/j.antiviral.2011.06.008; SUKENO N, 1979, TOHOKU J EXP MED, V128, P241, DOI 10.1620/tjem.128.241; Tan ACL, 2013, IMMUNOL CELL BIOL, V91, P96, DOI 10.1038/icb.2012.54; van den Brand JMA, 2010, J INFECT DIS, V201, P993, DOI 10.1086/651132; Wang MJ, 2007, VACCINE, V25, P2823, DOI 10.1016/j.vaccine.2006.12.038; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wolf AI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028445	54	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127969	10.1371/journal.pone.0127969	http://dx.doi.org/10.1371/journal.pone.0127969			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046664	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200035
J	Kim, JI; Yoon, HS; Yi, G; Kim, HS; Yih, W; Shin, W				Kim, Jong Im; Yoon, Hwan Su; Yi, Gangman; Kim, Hyung Seop; Yih, Wonho; Shin, Woongghi			The Plastid Genome of the Cryptomonad Teleaulax amphioxeia	PLOS ONE			English	Article							CILIATE MESODINIUM-RUBRUM; DINOFLAGELLATE GENUS DINOPHYSIS; POLYMERASE-III HOLOENZYME; RED WATER-BLOOM; COMPLETE SEQUENCE; NUCLEOMORPH GENOME; CRYPTOPHYTE ALGA; PHYLOGENOMIC EVIDENCE; EVOLUTIONARY HISTORY; MITOCHONDRIAL GENOME	Teleaulax amphioxeia is a photosynthetic unicellular cryptophyte alga that is distributed throughout marine habitats worldwide. This alga is an important plastid donor to the dinoflagellate Dinophysis caudata through the ciliate Mesodinium rubrum in the marine food web. To better understand the genomic characteristics of T. amphioxeia, we have sequenced and analyzed its plastid genome. The plastid genome sequence of T. amphioxeia is similar to that of Rhodomonas salina, and they share significant synteny. This sequence exhibits less similarity to that of Guillardia theta, the representative plastid genome of photosynthetic cryptophytes. The gene content and order of the three photosynthetic cryptomonad plastid genomes studied is highly conserved. The plastid genome of T. amphioxeia is composed of 129,772 bp and includes 143 protein-coding genes, 2 rRNA operons and 30 tRNA sequences. The DNA polymerase III gene (dnaX) was most likely acquired via lateral gene transfer (LGT) from a firmicute bacterium, identical to what occurred in R. salina. On the other hand, the psbN gene was independently encoded by the plastid genome without a reverse transcriptase gene as an intron. To clarify the phylogenetic relationships of the algae with red-algal derived plastids, phylogenetic analyses of 32 taxa were performed, including three previously sequenced cryptophyte plastid genomes containing 93 protein-coding genes. The stramenopiles were found to have branched out from the Chromista taxa (cryptophytes, haptophytes, and stramenopiles), while the cryptophytes and haptophytes were consistently grouped into sister relationships with high resolution.	[Kim, Jong Im; Shin, Woongghi] Chungnam Natl Univ, Dept Biol, Taejon, South Korea; [Yoon, Hwan Su] Sungkyunkwan Univ, Dept Biol Sci, Suwon, South Korea; [Yi, Gangman] Gangneung Wonju Natl Univ, Dept Comp Sci, Wonju, South Korea; [Kim, Hyung Seop; Yih, Wonho] Kunsan Natl Univ, Dept Marine Biotechnol, Kunsan, South Korea	Chungnam National University; Sungkyunkwan University (SKKU); Kangnung Wonju National University; Kunsan National University	Yih, W (corresponding author), Kunsan Natl Univ, Dept Marine Biotechnol, Kunsan, South Korea.	ywonho@kunsan.ac.kr; shinw@cnu.ac.kr	Yoon, Hwan Su/A-2974-2013	Yoon, Hwan Su/0000-0001-9507-0105; shin, woongghi/0000-0001-7926-732X	National Research Foundation (NRF) of Korea - Ministry of Science, ICT & Future Planning, Basic Science Research Program (MSIP) [NRF-2013R1A1A3012539]; Ministry of Education [NRF-2013R1A1A2063006]; Mid-career Researcher Program by MSIP [NRF-C1ABA001-2010-0020700]; NRF [MEST: 2014R1A2A2A01003588]; Korean RDA Next-generation BioGreen21 [PJ009525]; Marine Biotechnology Program - Ministry of Oceans and Fisheries, Korea [PJT200620]; Korea Polar Research [PE15020]	National Research Foundation (NRF) of Korea - Ministry of Science, ICT & Future Planning, Basic Science Research Program (MSIP); Ministry of Education; Mid-career Researcher Program by MSIP; NRF; Korean RDA Next-generation BioGreen21; Marine Biotechnology Program - Ministry of Oceans and Fisheries, Korea; Korea Polar Research	This research was supported by the National Research Foundation (NRF) of Korea funded by the Ministry of Science, ICT & Future Planning, Basic Science Research Program (MSIP; NRF-2013R1A1A3012539) to J.I. Kim; the Ministry of Education (NRF-2013R1A1A2063006) to G. Yi; the Mid-career Researcher Program by MSIP (NRF-C1ABA001-2010-0020700) to W. Yih; NRF (MEST: 2014R1A2A2A01003588), Korean RDA Next-generation BioGreen21 (PJ009525), the Marine Biotechnology Program (PJT200620) funded by Ministry of Oceans and Fisheries, Korea, to H.S. Yoon; and the Korea Polar Research (Grant PE15020) to W. Shin.	Archibald JM, 2005, MICROBIAL PHYLOGENY, P238; Archibald JM, 2007, BIOESSAYS, V29, P392, DOI 10.1002/bies.20551; Barlow SB, 2002, HYDROBIOLOGIA, V473, P129, DOI 10.1023/A:1016585818665; Bary B. M., 1950, Transactions and Proceedings of the Royal Society of New Zealand, V78, P86; Baurain D, 2010, MOL BIOL EVOL, V27, P1698, DOI 10.1093/molbev/msq059; BHATTACHARYA D, 1995, J PHYCOL, V31, P489, DOI 10.1111/j.1529-8817.1995.tb02542.x; Bhattacharya D, 2013, MOL BIOL EVOL, V30, P1843, DOI 10.1093/molbev/mst084; Blankenship R. E., 2002, MOLECULAR MECHANISMS; BLINKOVA A, 1993, J BACTERIOL, V175, P6018, DOI 10.1128/JB.175.18.6018-6027.1993; BOOTH BC, 1982, DEEP-SEA RES, V29, P185, DOI 10.1016/0198-0149(82)90108-X; Borza T, 2005, EUKARYOT CELL, V4, P253, DOI 10.1128/EC.4.2.253-261.2005; Burki F, 2012, P ROY SOC B-BIOL SCI, V279, P2246, DOI 10.1098/rspb.2011.2301; Clemens WA, 1935, NATURE, V135, P473, DOI 10.1038/135473b0; Cruz S, 2013, J EXP BOT, V64, P3999, DOI 10.1093/jxb/ert197; Curtis BA, 2012, NATURE, V492, P59, DOI 10.1038/nature11681; DALLMANN HG, 1995, J BIOL CHEM, V270, P29563, DOI 10.1074/jbc.270.49.29563; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; de Vries J, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2519; de Vries J, 2013, GENOME BIOL EVOL, V5, P2540, DOI 10.1093/gbe/evt205; Delwiche CF, 1996, MOL BIOL EVOL, V13, P873, DOI 10.1093/oxfordjournals.molbev.a025647; Donaher N, 2009, GENOME BIOL EVOL, V1, P439, DOI 10.1093/gbe/evp047; Douglas S, 2001, NATURE, V410, P1091, DOI 10.1038/35074092; DOUGLAS SE, 1991, NATURE, V350, P148, DOI 10.1038/350148a0; Douglas SE, 1999, J MOL EVOL, V48, P236, DOI 10.1007/PL00006462; Gilson PR, 1997, CURR OPIN GENET DEV, V7, P800, DOI 10.1016/S0959-437X(97)80043-3; Gustafson DE, 2000, NATURE, V405, P1049, DOI 10.1038/35016570; Hackett JD, 2003, J PHYCOL, V39, P440, DOI 10.1046/j.1529-8817.2003.02100.x; Hackett JD, 2007, MOL BIOL EVOL, V24, P1702, DOI 10.1093/molbev/msm089; Hall N, 2002, NATURE, V419, P527, DOI 10.1038/nature01095; HALLICK RB, 1993, NUCLEIC ACIDS RES, V21, P3537, DOI 10.1093/nar/21.15.3537; Hansen PJ, 2013, HARMFUL ALGAE, V28, P126, DOI 10.1016/j.hal.2013.06.004; Hart TJ, 1943, NATURE, V152, P661, DOI 10.1038/152661b0; Hart TJ, 1934, NATURE, V134, P459, DOI 10.1038/134459b0; Hauth AM, 2005, NUCLEIC ACIDS RES, V33, P4433, DOI 10.1093/nar/gki757; Hewes CD, 1998, J PHYCOL, V34, P945, DOI 10.1046/j.1529-8817.1998.340945.x; HILL DRA, 1991, PHYCOLOGIA, V30, P170, DOI 10.2216/i0031-8884-30-2-170.1; HILL DRA, 1992, ANN BOT FENN, V29, P173; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Janson S, 2003, PHYCOLOGIA, V42, P473, DOI 10.2216/i0031-8884-42-5-473.1; Janson S, 2004, ENVIRON MICROBIOL, V6, P1102, DOI 10.1111/j.1462-2920.2004.00646.x; Johnson MD, 2007, NATURE, V445, P426, DOI 10.1038/nature05496; Johnson MD, 2011, J EUKARYOT MICROBIOL, V58, P185, DOI 10.1111/j.1550-7408.2011.00545.x; Keeling PJ, 2004, AM J BOT, V91, P1481, DOI 10.3732/ajb.91.10.1481; Khan H, 2007, MOL BIOL EVOL, V24, P1832, DOI 10.1093/molbev/msm101; Kim E., 2009, V13, P1, DOI 10.1007/7089_2008_17; Kim E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-215; Kim M, 2014, J EUKARYOT MICROBIOL, V61, P354, DOI 10.1111/jeu.12115; Kim M, 2012, HARMFUL ALGAE, V13, P105, DOI 10.1016/j.hal.2011.10.010; Kowallik KV, 1995, PLANT MOL BIOL REP, V13, P336, DOI 10.1007/BF02669188; Lane CE, 2007, P NATL ACAD SCI USA, V104, P19908, DOI 10.1073/pnas.0707419104; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lindholm T., 1985, Advances in Aquatic Microbiology, V3, P1; LUCAS IAN, 1990, J PHYCOL, V26, P345, DOI 10.1111/j.0022-3646.1990.00345.x; MCFADDEN GI, 1993, ADV BOT RES, V19, P189, DOI 10.1016/S0065-2296(08)60205-0; Moeller HV, 2011, J PHYCOL, V47, P324, DOI 10.1111/j.1529-8817.2010.00954.x; Moore CE, 2012, GENOME BIOL EVOL, V4, P1162, DOI 10.1093/gbe/evs090; Myung G, 2011, HARMFUL ALGAE, V10, P536, DOI 10.1016/j.hal.2011.04.005; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Nishitani G, 2012, APPL ENVIRON MICROB, V78, P813, DOI 10.1128/AEM.06544-11; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; NOVARINO G, 1991, NORD J BOT, V11, P599, DOI 10.1111/j.1756-1051.1991.tb01269.x; Novarino G, 1997, J PLANKTON RES, V19, P1081, DOI 10.1093/plankt/19.8.1081; Ohta N, 2003, DNA RES, V10, P67, DOI 10.1093/dnares/10.2.67; Oudot-Le Secq MP, 2007, MOL GENET GENOMICS, V277, P427, DOI 10.1007/s00438-006-0199-4; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; Palmer JD, 2003, J PHYCOL, V39, P4, DOI 10.1046/j.1529-8817.2003.02185.x; Park MG, 2008, J PHYCOL, V44, P1154, DOI 10.1111/j.1529-8817.2008.00579.x; Park MG, 2006, AQUAT MICROB ECOL, V45, P101, DOI 10.3354/ame045101; Patron NJ, 2007, CURR BIOL, V17, P887, DOI 10.1016/j.cub.2007.03.069; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Puerta MVS, 2005, DNA RES, V12, P151, DOI 10.1093/dnares/12.2.151; Rice DW, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-31; Rogers MB, 2007, MOL BIOL EVOL, V24, P54, DOI 10.1093/molbev/msl129; RYTHER JH, 1967, NATURE, V214, P1318, DOI 10.1038/2141318a0; SCHNEPF E, 1988, BOT ACTA, V101, P196, DOI 10.1111/j.1438-8677.1988.tb00033.x; Seoane S, 2005, HYDROBIOLOGIA, V549, P1, DOI 10.1007/s10750-005-1736-6; Shi CL, 2006, BIOTECHNOL PROGR, V22, P1050, DOI 10.1021/bp060087d; Simpson CL, 2002, PLANT PHYSIOL, V129, P957, DOI 10.1104/pp.010908; SMITH SW, 1994, COMPUT APPL BIOSCI, V10, P671; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stiller JW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6764; Stoebe B, 1999, TRENDS GENET, V15, P344, DOI 10.1016/S0168-9525(99)01815-6; Takishita K, 2002, PROTIST, V153, P293, DOI 10.1078/1434-4610-00106; Tanifuji G, 2011, GENOME BIOL EVOL, V3, P44, DOI 10.1093/gbe/evq082; TAYLOR FJR, 1971, J FISH RES BOARD CAN, V28, P391, DOI 10.1139/f71-052; TAYLOR FJR, 1969, NATURE, V224, P819, DOI 10.1038/224819a0; Wagele H, 2011, MOL BIOL EVOL, V28, P699, DOI 10.1093/molbev/msq239; WANG SG, 1991, P NATL ACAD SCI USA, V88, P10783, DOI 10.1073/pnas.88.23.10783; WHITE AW, 1977, J FISH RES BOARD CAN, V34, P413, DOI 10.1139/f77-066; Wickett NJ, 2008, MOL BIOL EVOL, V25, P393, DOI 10.1093/molbev/msm267; Yih W, 2004, AQUAT MICROB ECOL, V36, P165, DOI 10.3354/ame036165; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P15507, DOI 10.1073/pnas.242379899	93	25	26	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129284	10.1371/journal.pone.0129284	http://dx.doi.org/10.1371/journal.pone.0129284			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047475	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200141
J	Nadeem, S; Masood, S; Mehmood, R; Sadiq, MA				Nadeem, Sohail; Masood, Sadaf; Mehmood, Rashid; Sadiq, Muhammad Adil			Optimal and Numerical Solutions for an MHD Micropolar Nanofluid between Rotating Horizontal Parallel Plates	PLOS ONE			English	Article							STAGNATION POINT FLOW; NON-NEWTONIAN NANOFLUID; HEAT-TRANSFER; FLUID-FLOW; NATURAL-CONVECTION; POROUS CHANNEL; ENCLOSURE; RADIATION; SURFACE	The present analysis deals with flow and heat transfer aspects of a micropolar nanofluid between two horizontal parallel plates in a rotating system. The governing partial differential equations for momentum, energy, micro rotation and nano-particles concentration are presented. Similarity transformations are utilized to convert the system of partial differential equations into system of ordinary differential equations. The reduced equations are solved analytically with the help of optimal homotopy analysis method (OHAM). Analytical solutions for velocity, temperature, micro-rotation and concentration profiles are expressed graphically against various emerging physical parameters. Physical quantities of interest such as skin friction co-efficient, local heat and local mass fluxes are also computed both analytically and numerically through mid-point integration scheme. It is found that both the solutions are in excellent agreement. Local skin friction coefficient is found to be higher for the case of strong concentration i.e. n=0, as compared to the case of weak concentration n=0.50. Influence of strong and weak concentration on Nusselt and Sherwood number appear to be similar in a quantitative sense.	[Nadeem, Sohail; Masood, Sadaf; Mehmood, Rashid] Quaid I Azam Univ, Dept Math, Islamabad 45320, Pakistan; [Sadiq, Muhammad Adil] KFUPM, Dammam Community Coll, Dept Math, Dhahran 31261, Saudi Arabia	Quaid I Azam University; King Fahd University of Petroleum & Minerals	Mehmood, R (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad 45320, Pakistan.	rmqau@hotmail.com	Mehmood, Rashid/GLU-5155-2022; Nadeem, Sohail/AAA-1202-2019; Sadiq, Muhammad A/D-5833-2015; Nadeem, Sohail/I-5248-2013; Nadeem, Sohail/I-5356-2015	Nadeem, Sohail/0000-0002-1052-011X; Nadeem, Sohail/0000-0002-1052-011X; Sadiq, Muhammad/0000-0002-4965-2259	King Fahad university of Petroleum and minerals [IN131017]	King Fahad university of Petroleum and minerals	This project is funded by King Fahad university of Petroleum and minerals (Project Code IN131017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi AR, 2014, POWDER TECHNOL, V258, P125, DOI 10.1016/j.powtec.2014.03.021; Aman F, 2013, B MALAYS MATH SCI SO, V36, P865; [Anonymous], 1995, SIAM CLASS APPL MATH; Ascher UM, 1998, COMPUTER METHODS ORD; Bhargava R, 2003, INT J ENG SCI, V41, P123, DOI 10.1016/S0020-7225(02)00157-X; Bhargava R, 2003, INT J ENG SCI, V41, P2161, DOI 10.1016/S0020-7225(03)00209-X; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Choi S.U.S., 1995, ASME, V66, P99, DOI DOI 10.1115/1.1532008; Ellahi R, 2013, APPL MATH MODEL, V37, P1451, DOI 10.1016/j.apm.2012.04.004; Ellahi R, 2012, INT J NUMER METHOD H, V22, P24, DOI 10.1108/09615531211188775; Eringen A. C., 1964, INT J ENG SCI, V2, P205; ERINGEN AC, 1966, J MATH MECH, V16, P1; Eringen AC., 2001, MICROCONTINUM FIELD; Hatami M, 2014, J MOL LIQ, V195, P230, DOI 10.1016/j.molliq.2014.02.024; Hatami M, 2014, CASE STUD THERM ENG, V2, P14, DOI 10.1016/j.csite.2013.11.001; Hatami M, 2014, J MOL LIQ, V190, P159, DOI 10.1016/j.molliq.2013.11.005; Ishak A, 2008, COMPUT MATH APPL, V56, P3188, DOI 10.1016/j.camwa.2008.09.013; Joneidi AA, 2009, INT COMMUN HEAT MASS, V36, P1082, DOI 10.1016/j.icheatmasstransfer.2009.06.021; Kuznetsov AV, 2010, INT J THERM SCI, V49, P243, DOI 10.1016/j.ijthermalsci.2009.07.015; Liao SJ, 2010, COMMUN NONLINEAR SCI, V15, P2003, DOI 10.1016/j.cnsns.2009.09.002; Liao SJ, 2009, COMMUN NONLINEAR SCI, V14, P983, DOI 10.1016/j.cnsns.2008.04.013; Lukaszewicz G., 1999, MICROPOLAR FLUIDS TH; Mehmood R, 2013, J TAIWAN INST CHEM E, V44, P586, DOI 10.1016/j.jtice.2012.12.027; Mohamed RA, 2009, INT J THERM SCI, V48, P1800, DOI 10.1016/j.ijthermalsci.2009.01.019; Nadeem S, 2014, INT J THERM SCI, V78, P90, DOI 10.1016/j.ijthermalsci.2013.12.001; Narayana PVS, 2013, AIN SHAMS ENG J, V4, P843, DOI 10.1016/j.asej.2013.02.002; Nazar R, 2004, INT J NONLIN MECH, V39, P1227, DOI [10.1016/j.ijnonlinmec.2003.08.007, 10.1016/j.ijnonlinemec.2003.08.007]; Rashidi S, 2015, J MAGN MAGN MATER, V378, P128, DOI 10.1016/j.jmmm.2014.11.020; Rosali H, 2012, INT COMMUN HEAT MASS, V39, P826, DOI 10.1016/j.icheatmasstransfer.2012.04.008; Sheikholeslami M, 2014, INT J NUMER METHOD H, V24, P1906, DOI 10.1108/HFF-07-2013-0225; Sheikholeslami M, 2014, J MOL LIQ, V194, P30, DOI 10.1016/j.molliq.2014.01.005; Sheikholeslami M, 2013, POWDER TECHNOL, V239, P259, DOI 10.1016/j.powtec.2013.02.006; Sheikholeslami M, 2013, POWDER TECHNOL, V235, P873, DOI 10.1016/j.powtec.2012.11.030; Sheikholeslami M, 2012, SCI IRAN, V19, P437, DOI 10.1016/j.scient.2012.03.006; Sheikholeslami M, 2012, INT COMMUN HEAT MASS, V39, P978, DOI 10.1016/j.icheatmasstransfer.2012.05.020; Sheikholeslami M, 2011, MATH PROBL ENG, V2011, DOI 10.1155/2011/258734; Sheikholeslami M, 2015, COMPUT METHOD APPL M, V283, P651, DOI 10.1016/j.cma.2014.09.038; Sheikholeslami M, 2014, J MAGN MAGN MATER, V369, P69, DOI 10.1016/j.jmmm.2014.06.017; Sheikholeslami M, 2012, SAINS MALAYS, V41, P1281; Turkyilmazoglu M, 2014, INT J HEAT MASS TRAN, V72, P388, DOI 10.1016/j.ijheatmasstransfer.2014.01.039; Ziabakhsh Z., 2008, ADV THEOR APPL MECH, V1, P79	41	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0124016	10.1371/journal.pone.0124016	http://dx.doi.org/10.1371/journal.pone.0124016			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046637	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200005
J	Yang, JM; Yang, HJ; Liao, H; Wang, JT; Zeng, JQ				Yang, Jianmei; Yang, Huijie; Liao, Hao; Wang, Jiangtao; Zeng, Jinqun			Energy Spectral Behaviors of Communication Networks of Open-Source Communities	PLOS ONE			English	Article							PARTICIPATION	Large-scale online collaborative production activities in open-source communities must be accompanied by large-scale communication activities. Nowadays, the production activities of open-source communities, especially their communication activities, have been more and more concerned. Take CodePlex C # community for example, this paper constructs the complex network models of 12 periods of communication structures of the community based on real data; then discusses the basic concepts of quantum mapping of complex networks, and points out that the purpose of the mapping is to study the structures of complex networks according to the idea of quantum mechanism in studying the structures of large molecules; finally, according to this idea, analyzes and compares the fractal features of the spectra in different quantum mappings of the networks, and concludes that there are multiple self-similarity and criticality in the communication structures of the community. In addition, this paper discusses the insights and application conditions of different quantum mappings in revealing the characteristics of the structures. The proposed quantum mapping method can also be applied to the structural studies of other large-scale organizations.	[Yang, Jianmei; Wang, Jiangtao; Zeng, Jinqun] S China Univ Technol, Sch Business Adm, Guangzhou 510641, Guangdong, Peoples R China; [Yang, Huijie] Univ Shanghai Sci & Technol, Sch Business, Shanghai, Peoples R China; [Liao, Hao] Shenzhen Univ, Coll Comp Sci & Software Engn, Guangdong Prov Key Lab Popular High Performance C, Shenzhen, Peoples R China; [Liao, Hao] Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland	South China University of Technology; University of Shanghai for Science & Technology; Shenzhen University; University of Fribourg	Yang, JM (corresponding author), S China Univ Technol, Sch Business Adm, Guangzhou 510641, Guangdong, Peoples R China.	fbajyang@scut.edu.cn; jamesliao520@gmail.com			National Natural Science Foundation of China [71273093, U1301252, 61170076]; Guangdong Natural Science Foundation [2014A030313553]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	The work was supported by the National Natural Science Foundation of China (Project No. 71273093). HL acknowledges support by the the National Natural Science Foundation of China (Project No. U1301252, 61170076) and The Guangdong Natural Science Foundation (Project No. 2014A030313553).	Agaev I., DETECTION FINANCIAL; Bak P., 1996, NATURE WORKS SCI SEL; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bianchi AJ, 2012, ORGAN SCI, V23, P341, DOI 10.1287/orsc.1100.0580; Crowston K., 2006, Knowledge Technology & Policy, V18, P65, DOI 10.1007/s12130-006-1004-8; Crowston K, 2012, ACM COMPUT SURV, V44, DOI 10.1145/2089125.2089127; Ermann L, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-31090-8; Fang YL, 2009, J MANAGE INFORM SYST, V25, P9, DOI 10.2753/MIS0742-1222250401; Feng D, 1991, PROGR PHYS, V11, P127; Feng D, 2001, PHYSICS, V3, P271; Kantelhardt JW, 2002, PHYSICA A, V316, P87, DOI 10.1016/S0378-4371(02)01383-3; KANTELHARDT JW, 1995, PHYSICA A, V220, P219, DOI 10.1016/0378-4371(95)00267-B; Ledford H, 2013, NATURE, V499, P16, DOI 10.1038/499016a; Lerner J, 2002, J IND ECON, V50, P197, DOI 10.1111/1467-6451.00174; Liao H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112022; Lopes R, 2009, MED IMAGE ANAL, V13, P634, DOI 10.1016/j.media.2009.05.003; Mandelbrot B, 1997, LARGE DEVIATION THEO; Oishi K, 2014, SCI REPORTS; Porcello D, 2013, SCIENCE, V341, P240, DOI 10.1126/science.1234722; Powell J., 2009, ARXIV09061640V6; Raymond Eric, 1999, CATHEDRAL BAZAAR, DOI DOI 10.1007/S12130-999-1026-0; Roberts JA, 2006, MANAGE SCI, V52, P984, DOI 10.1287/mnsc.1060.0554; Santhanam MS, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.015201; Vanni T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093376; Wagstrom PA, 2005, 1 INT C OP SOURC SYS; Yang HJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066104; Yang HJ, 2006, CHAOS, V16, DOI 10.1063/1.2364178; Yang HJ, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.045101; Zeng Jin-qun, 2013, Industrial Engineering Journal, V16, P110, DOI 10.3969/j.issn.1007-7375.2013.03.018; Zhao FC, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046119; Zhu KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100023	31	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128251	10.1371/journal.pone.0128251	http://dx.doi.org/10.1371/journal.pone.0128251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7CR	26047331	Green Published, gold			2022-12-27	WOS:000355652200050
J	Exley, C; Rotheray, E; Goulson, D				Exley, Christopher; Rotheray, Ellen; Goulson, David			Bumblebee Pupae Contain High Levels of Aluminium	PLOS ONE			English	Article							SPATIAL MEMORY; BEHAVIOR; COPPER; IRON; BEE	The causes of declines in bees and other pollinators remains an on-going debate. While recent attention has focussed upon pesticides, other environmental pollutants have largely been ignored. Aluminium is the most significant environmental contaminant of recent times and we speculated that it could be a factor in pollinator decline. Herein we have measured the content of aluminium in bumblebee pupae taken from naturally foraging colonies in the UK. Individual pupae were acid-digested in a microwave oven and their aluminium content determined using transversely heated graphite furnace atomic absorption spectrometry. Pupae were heavily contaminated with aluminium giving values between 13.4 and 193.4 mu g/g dry wt. and a mean (SD) value of 51.0 (33.0) mu g/g dry wt. for the 72 pupae tested. Mean aluminium content was shown to be a significant negative predictor of average pupal weight in colonies. While no other statistically significant relationships were found relating aluminium to bee or colony health, the actual content of aluminium in pupae are extremely high and demonstrate significant exposure to aluminium. Bees rely heavily on cognitive function and aluminium is a known neurotoxin with links, for example, to Alzheimer's disease in humans. The significant contamination of bumblebee pupae by aluminium raises the intriguing spectre of cognitive dysfunction playing a role in their population decline.	[Exley, Christopher] Keele Univ, Birchall Ctr, Lennard Jones Labs, Stoke On Trent ST5 5BG, Staffs, England; [Rotheray, Ellen; Goulson, David] Univ Sussex, Sch Life Sci, Evolut Behav & Ecol, Brighton BN1 9QG, E Sussex, England	Keele University; University of Sussex	Exley, C (corresponding author), Keele Univ, Birchall Ctr, Lennard Jones Labs, Stoke On Trent ST5 5BG, Staffs, England.	c.exley@keele.ac.uk	Goulson, David/A-2462-2010	Goulson, David/0000-0003-4421-2876; Exley, Christopher/0000-0002-5116-7607	BBSRC [BB/J014753/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J014753/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Becher MA, 2013, J APPL ECOL, V51, P470; Blank S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062009; Bryden J, 2013, ECOL LETT, V16, P1463, DOI 10.1111/ele.12188; Cheeseman JF, 2014, P NATL ACAD SCI USA, V111, P8949, DOI 10.1073/pnas.1408039111; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; Collett M, 2013, CURR BIOL, V23, pR789, DOI 10.1016/j.cub.2013.07.020; Dukas R, 2008, ANNU REV ENTOMOL, V53, P145, DOI 10.1146/annurev.ento.53.103106.093343; Exley C., 2012, CURR INORG CHEM, V2, P3, DOI [DOI 10.2174/1877944111202010003, 10.2174/1877944111202010003]; Exley C, 2014, EXPERT REV NEUROTHER, V14, P589, DOI 10.1586/14737175.2014.915745; Exley C, 2013, ENVIRON SCI-PROC IMP, V15, P1807, DOI 10.1039/c3em00374d; Exley C, 2012, J ALZHEIMERS DIS, V31, P725, DOI 10.3233/JAD-2012-120766; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; House E, 2012, METALLOMICS, V4, P56, DOI 10.1039/c1mt00139f; Kijak E, 2014, INSECT SCI, V21, P189, DOI 10.1111/1744-7917.12017; Maingon R, 2008, T ROY SOC TROP MED H, V102, P1140, DOI 10.1016/j.trstmh.2008.04.012; Meindl GA, 2013, ENVIRON POLLUT, V177, P78, DOI 10.1016/j.envpol.2013.02.017; Menzel R, 2006, J COMP PHYSIOL A, V192, P889, DOI 10.1007/s00359-006-0136-3; Milivojevic T, 2015, CHEMOSPHERE, V120, P547, DOI 10.1016/j.chemosphere.2014.07.054; Morgano MA, 2010, J AGR FOOD CHEM, V58, P6876, DOI 10.1021/jf100433p; Porrini C, 2014, B INSECTOL, V67, P137; Raine NE, 2006, ADV STUD BEHAV, V36, P305, DOI 10.1016/S0065-3454(06)36007-X; van der Steen JJM, 2012, ENVIRON MONIT ASSESS, V184, P4119, DOI 10.1007/s10661-011-2248-7	22	19	19	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0127665	10.1371/journal.pone.0127665	http://dx.doi.org/10.1371/journal.pone.0127665			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042788	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000355701600017
J	Hampel, U; Schroder, A; Mitchell, T; Brown, S; Snikeris, P; Garreis, F; Kunnen, C; Willcox, M; Paulsen, F				Hampel, Ulrike; Schroeder, Antje; Mitchell, Todd; Brown, Simon; Snikeris, Peta; Garreis, Fabian; Kunnen, Carolina; Willcox, Mark; Paulsen, Friedrich			Serum-Induced Keratinization Processes in an Immortalized Human Meibomian Gland Epithelial Cell Line	PLOS ONE			English	Article							HUMAN MEIBUM; INTERNATIONAL WORKSHOP; DYSFUNCTION REPORT; LIPID-COMPOSITION; EPIDERMAL-CELLS; EYELID MARGIN; FATTY-ACIDS; REAL-TIME; SUBCOMMITTEE; DIFFERENTIATION	Purpose The aim of this study was to evaluate a human meibomian gland epithelial cell line (HMGEC) as a model for meibomian gland (patho) physiology in vitro. Methods HMGEC were cultured in the absence or presence of serum. Sudan III lipid staining, ultrastructural analysis and lipidomic analyses were performed. Impedance sensing, desmoplakin 1/2 mRNA and cytokeratin (CK) 1, 5, 6, 14 levels were evaluated. Serum containing medium supplemented with higher serum, glucose, an omega-3 lipid cocktail, eicosapentaenoic acid or sebomed medium were investigated for lipid accumulation and ultrastructural morphology. Results Lipid droplet accumulation in HMGEC was induced by serum containing media after 1 day, but decreased over time. Cultivation in serum induced desmosome and cytokeratin filament formation. Desmoplakin 1/2 gene levels were significantly upregulated after 1d of serum treatment. Furthermore, the normalized impedance increased significantly. Lipidome analysis revealed high levels of phospholipids (over 50%), but very low levels of wax ester and cholesteryl esters (under 1%). Stimulation with eicosapentaenoic acid increased lipid accumulation after one day. Conclusion Serum treatment of HMGEC caused lipid droplet formation to some extent but also induced keratinization. The cells did not produce typical meibum lipids under these growth conditions. HMGEC are well suited to study (hyper) keratinization processes of meibomian gland epithelial cells in vitro.	[Hampel, Ulrike; Schroeder, Antje; Garreis, Fabian; Paulsen, Friedrich] Univ Erlangen Nurnberg, Dept Anat 2, D-91054 Erlangen, Germany; [Mitchell, Todd; Brown, Simon; Snikeris, Peta] Univ Wollongong, Illawara Hlth & Med Res Inst, Wollongong, NSW, Australia; [Mitchell, Todd; Brown, Simon; Snikeris, Peta] Univ Wollongong, Sch Med, Wollongong, NSW, Australia; [Kunnen, Carolina; Willcox, Mark] Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia	University of Erlangen Nuremberg; University of Wollongong; University of Wollongong; University of New South Wales Sydney	Hampel, U (corresponding author), Univ Erlangen Nurnberg, Dept Anat 2, D-91054 Erlangen, Germany.	ulrike.hampel@anatomie2.med.uni-erlangen.de	Snikeris, Peta/L-9082-2017; Mitchell, Todd/G-7044-2012; Brown, Simon/A-3261-2009	Snikeris, Peta/0000-0002-2334-1102; Mitchell, Todd/0000-0002-1372-9963; Paulsen, Friedrich/0000-0002-0527-0953; willcox, mark/0000-0003-3842-7563; Brown, Simon/0000-0003-3997-4614	DFG [HA 6344/2-1, PA 738/9-2]; Ernst Muck-Stiftung; Forschungsforderung "Dysfunktion der Meibomdrusen und Augenoberflache"; Dr. Ernst und Anita Bauer-Stiftung; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg	DFG(German Research Foundation (DFG)); Ernst Muck-Stiftung; Forschungsforderung "Dysfunktion der Meibomdrusen und Augenoberflache"; Dr. Ernst und Anita Bauer-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg	This work was supported by DFG grant HA 6344/2-1 and PA 738/9-2, Ernst Muck-Stiftung, Forschungsforderung "Dysfunktion der Meibomdrusen und Augenoberflache" and Dr. Ernst und Anita Bauer-Stiftung. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouameur JE, 2014, J INVEST DERMATOL, V134, P885, DOI 10.1038/jid.2013.498; Brown SHJ, 2013, INVEST OPHTH VIS SCI, V54, P7417, DOI 10.1167/iovs.13-12916; Butovich IA, 2008, INVEST OPHTH VIS SCI, V49, P3779, DOI 10.1167/iovs.08-1889; Butovich IA, 2008, CURR EYE RES, V33, P405, DOI 10.1080/02713680802018419; Butovich IA, 2007, J LIPID RES, V48, P2220, DOI 10.1194/jlr.M700237-JLR200; Butovich IA, 2014, INVEST OPHTH VIS SCI, V55, P87, DOI 10.1167/iovs.13-13355; Butovich IA, 2010, INVEST OPHTH VIS SCI, V51, P6908, DOI 10.1167/iovs.10-6328; Butovich IA, 2009, J LIPID RES, V50, P2471, DOI 10.1194/jlr.M900252-JLR200; Butovich IA, 2009, J LIPID RES, V50, P501, DOI 10.1194/jlr.M800426-JLR200; Green-Church KB, 2011, INVEST OPHTH VIS SCI, V52, P1979, DOI 10.1167/iovs.10-6997d; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; JESTER JV, 1981, INVEST OPHTH VIS SCI, V20, P537; Kien CL, 2011, OBESITY, V19, P305, DOI 10.1038/oby.2010.135; Knop E, 2011, INVEST OPHTH VIS SCI, V52, P1938, DOI 10.1167/iovs.10-6997c; Lam SM, 2014, J LIPID RES, V55, P1959, DOI 10.1194/jlr.P051185; Lam SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024339; Liu SH, 2007, ARCH OPHTHALMOL-CHIC, V125, P523, DOI 10.1001/archopht.125.4.523; Liu SH, 2013, INVEST OPHTH VIS SCI, V54, P2541, DOI 10.1167/iovs.12-11221; Liu SH, 2010, INVEST OPHTH VIS SCI, V51, P3993, DOI 10.1167/iovs.09-5108; Liu Y, 2014, TOXICOLOGY, V320, P1, DOI 10.1016/j.tox.2014.02.014; Liu Y, 2014, JAMA OPHTHALMOL, V132, P226, DOI 10.1001/jamaophthalmol.2013.6030; Lo CM, 1999, EXP CELL RES, V250, P576, DOI 10.1006/excr.1999.4538; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Nelson JD, 2011, INVEST OPHTH VIS SCI, V52, P1930, DOI 10.1167/iovs.10-6997b; Pappas A, 2009, DERM-ENDOCRINOL, V1, P72, DOI 10.4161/derm.1.2.7811; Parfitt GJ, 2013, AGING-US, V5, P825, DOI 10.18632/aging.100615; Parfitt GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053245; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PONEC M, 1991, ADV LIPID RES, V24, P83; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Schulze U, 2014, INVEST OPHTH VIS SCI, V55, P3037, DOI 10.1167/iovs.13-13423; SIRIGU P, 1992, INVEST OPHTH VIS SCI, V33, P2284; Sullivan DA, 2014, INVEST OPHTH VIS SCI, V55, P3866, DOI 10.1167/iovs.13-13407; Tektas OY, 2012, ANN ANAT, V194, P436, DOI 10.1016/j.aanat.2012.07.004; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; Tran PN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5773; WATT FM, 1982, NATURE, V295, P434, DOI 10.1038/295434a0; Wojtowicz JC, 2009, OCUL SURF, V7, P145, DOI 10.1016/S1542-0124(12)70309-9; Yu H, 2002, IM PROC 2002 P 2002	39	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128096	10.1371/journal.pone.0128096	http://dx.doi.org/10.1371/journal.pone.0128096			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042605	gold, Green Published, Green Submitted			2022-12-27	WOS:000355701600034
J	Lambert, AA; Lam, JO; Paik, JJ; Ugarte-Gil, C; Drummond, MB; Crowell, TA				Lambert, Allison A.; Lam, Jennifer O.; Paik, Julie J.; Ugarte-Gil, Cesar; Drummond, M. Bradley; Crowell, Trevor A.			Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							ACID-SUPPRESSIVE THERAPY; OLDER-ADULTS; HOSPITALIZATION; BLOCKERS; BURDEN; HEALTH	Background Proton-pump inhibitors (PPIs) are among the most frequently prescribed medications. Community-acquired pneumonia (CAP) is a common cause of morbidity, mortality and healthcare spending. Some studies suggest an increased risk of CAP among PPI users. We conducted a systematic review and meta-analysis to determine the association between outpatient PPI therapy and risk of CAP in adults. Methods We conducted systematic searches of MEDLINE, EMBASE, CINAHL, Cochrane Central Register of Controlled Trials, Scopus and Web of Science on February 3, 2014. Case-control studies, case-crossover, cohort studies and randomized controlled trials reporting outpatient PPI exposure and CAP diagnosis for patients >= 18 years old were eligible. Our primary outcome was the association between CAP and PPI therapy. A secondary outcome examined the risk of hospitalization for CAP and subgroup analyses evaluated the association between PPI use and CAP among patients of different age groups, by different PPI doses, and by different durations of PPI therapy. Results Systematic review of 33 studies was performed, of which 26 studies were included in the meta-analysis. These 26 studies included 226,769 cases of CAP among 6,351,656 participants. We observed a pooled risk of CAP with ambulatory PPI therapy of 1.49 (95% CI 1.16, 1.92; I2 99.2%). This risk was increased during the first month of therapy (OR 2.10; 95% CI 1.39, 3.16), regardless of PPI dose or patient age. PPI therapy also increased risk for hospitalization for CAP (OR 1.61; 95% CI: 1.12, 2.31). Discussion Outpatient PPI use is associated with a 1.5-fold increased risk of CAP, with the highest risk within the first 30 days after initiation of therapy. Providers should be aware of this risk when considering PPI use, especially in cases where alternative regimens may be available or the benefits of PPI use are uncertain.	[Lambert, Allison A.; Drummond, M. Bradley] Johns Hopkins Univ, Dept Med, Div Pulm & Crit Care, Baltimore, MD 21218 USA; [Lam, Jennifer O.; Ugarte-Gil, Cesar] Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD USA; [Paik, Julie J.] Johns Hopkins Univ, Dept Med, Div Rheumatol, Baltimore, MD USA; [Ugarte-Gil, Cesar] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander Von Humboldt, Lima, Peru; [Crowell, Trevor A.] Johns Hopkins Univ, Dept Med, Div Infect Dis, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Universidad Peruana Cayetano Heredia; Johns Hopkins University	Lambert, AA (corresponding author), Johns Hopkins Univ, Dept Med, Div Pulm & Crit Care, Baltimore, MD 21218 USA.	alamber5@jhmi.edu	Ugarte-Gil, Cesar/E-6074-2013; Crowell, Trevor A./W-3904-2019	Ugarte-Gil, Cesar/0000-0002-2833-9087; Crowell, Trevor A./0000-0001-5947-265X; Drummond, Michael/0000-0002-6968-4610	NIH [T32 HL007534 31A1, K23 HL103192 04, T32 AI007291 23]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007534, K23HL103192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007291] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	No funding was provided specifically for the conduct of this review. Dr. Lambert is supported by NIH Grant T32 HL007534 31A1, Dr. Drummond by NIH Grant K23 HL103192 04 and Dr. Crowell by NIH Grant T32 AI007291 23. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almirall J, 2008, EUR RESPIR J, V31, P1274, DOI 10.1183/09031936.00095807; Altman KW, 2007, ANN OTO RHINOL LARYN, V116, P229, DOI 10.1177/000348940711600311; Altman KW, 2003, LARYNGOSCOPE, V113, P1927, DOI 10.1097/00005537-200311000-00013; Anglemyer A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000034.pub2; BORRIELLO SP, 1985, J CLIN PATHOL, V38, P946, DOI 10.1136/jcp.38.8.946; Chen CH, 2015, J MICROBIOL IMMUNOL, V48, P390, DOI 10.1016/j.jmii.2013.10.004; Chey WD, 2009, CURR MED RES OPIN, V25, P1869, DOI 10.1185/03007990903035745; DELLIPIANI AW, 1964, CLIN SCI, V26, P359; Dublin S, 2010, PHARMACOEPIDEM DR S, V19, P792, DOI 10.1002/pds.1978; Eom CS, 2011, CAN MED ASSOC J, V183, P310, DOI 10.1503/cmaj.092129; Ernst P, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-113; File TM, 2010, POSTGRAD MED, V122, P130, DOI 10.3810/pgm.2010.03.2130; Filion KB, 2014, GUT, V63, P552, DOI 10.1136/gutjnl-2013-304738; Fohl Alexander L, 2011, World J Gastrointest Pharmacol Ther, V2, P17, DOI 10.4292/wjgpt.v2.i3.17; Fung HB, 2010, AM J GERIATR PHARMAC, V8, P47, DOI 10.1016/j.amjopharm.2010.01.003; Rodriguez LAG, 2009, EPIDEMIOLOGY, V20, P800, DOI 10.1097/EDE.0b013e3181b5f27d; Gau JT, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-45; Giuliano C, 2012, EXPERT REV CLIN PHAR, V5, P337, DOI [10.1586/ECP.12.20, 10.1586/ecp.12.20]; Gulmez SE, 2007, ARCH INTERN MED, V167, P950, DOI 10.1001/archinte.167.9.950; Hanania NA, 2009, NEW ENGL J MED, V360, P1487, DOI 10.1056/NEJMoa0806290; Heidelbaugh JJ, 2010, AM J MANAG CARE, V16, pE228; Heidelbaugh JJ, 2009, AM J GASTROENTEROL, V104, pS27, DOI 10.1038/ajg.2009.49; Hennessy S, 2007, J CLIN EPIDEMIOL, V60, P911, DOI 10.1016/j.jclinepi.2006.11.022; Hermos JA, 2012, CLIN INFECT DIS, V54, P33, DOI 10.1093/cid/cir767; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; IMS Institute for Healthcare Informatics, 2014, MED US SHIFT COSTS H; IMS Institute for Healthcare Informatics, 2012, US MED US REV 2011; Jacobson BC, 2003, AM J GASTROENTEROL, V98, P51, DOI 10.1111/j.1572-0241.2003.07186.x; Jena AB, 2013, J GEN INTERN MED, V28, P223, DOI 10.1007/s11606-012-2211-5; Johnstone J, 2007, ARCH INTERN MED, V167, P1938, DOI 10.1001/archinte.167.18.1938; Juthani-Mehta M, 2013, J AM GERIATR SOC, V61, P1111, DOI 10.1111/jgs.12325; Kahrilas Peter J, 2008, Gastroenterology, V135, P1383, DOI 10.1053/j.gastro.2008.08.045; Koivula I, 1997, AM J MED, V103, P281, DOI 10.1016/S0002-9343(97)00149-6; Laheij RJF, 2004, JAMA-J AM MED ASSOC, V292, P1955, DOI 10.1001/jama.292.16.1955; Laheij RJF, 2003, ALIMENT PHARM THER, V18, P847, DOI 10.1046/j.1365-2036.2003.01744.x; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liu CL, 2012, J HYPERTENS, V30, P2223, DOI 10.1097/HJH.0b013e328357a87a; Long MD, 2013, AM J GASTROENTEROL, V108, P240, DOI 10.1038/ajg.2012.406; Macaskill P, 2001, STAT MED, V20, P641, DOI 10.1002/sim.698; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Meijvis SCA, 2011, EUR RESPIR J, V38, P1165, DOI 10.1183/09031936.00020811; Morris G, 2013, AM J TRANSPLANT, V13, P550; Mullerova H, 2012, RESP MED, V106, P1124, DOI 10.1016/j.rmed.2012.04.008; Myles PR, 2009, PHARMACOEPIDEM DR S, V18, P269, DOI 10.1002/pds.1715; Nielsen AG, 2012, CRIT CARE, V16, DOI 10.1186/cc11418; Pasina L, 2011, EUR J INTERN MED, V22, P205, DOI 10.1016/j.ejim.2010.11.009; Pierson TC, 2002, J VIROL, V76, P4138, DOI 10.1128/JVI.76.8.4138-4144.2002; Ramsay EN, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-82; Restrepo MI, 2010, CURR OPIN INFECT DIS, V23, P145, DOI 10.1097/QCO.0b013e328336eac1; Roughead EE, 2009, MED J AUSTRALIA, V190, P114, DOI 10.5694/j.1326-5377.2009.tb02307.x; Sanduleanu S, 2001, ALIMENT PHARM THER, V15, P379, DOI 10.1046/j.1365-2036.2001.00888.x; Sarkar M, 2008, ANN INTERN MED, V149, P391, DOI 10.7326/0003-4819-149-6-200809160-00005; Scheiman JM, 2011, HEART, V97, P797, DOI 10.1136/hrt.2010.217547; Shrier I, 2007, AM J EPIDEMIOL, V166, P1203, DOI 10.1093/aje/kwm189; StataCorp, 2012, STAT STAT SOFTW REL; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sugano K, 2012, J GASTROENTEROL, V47, P540, DOI 10.1007/s00535-012-0541-z; Sugano K, 2011, J GASTROENTEROL, V46, P724, DOI 10.1007/s00535-011-0397-7; van de Garde EMW, 2006, THORAX, V61, P957, DOI 10.1136/thx.2006.062885; van de Garde EMW, 2006, EUR RESPIR J, V27, P1217, DOI 10.1183/09031936.06.00110005; van de Garde EMW, 2007, J HYPERTENS, V25, P235, DOI 10.1097/HJH.0b013e328010520a; Wells G., 2013, OTTAWA HOSP RES I; Williams C, 2006, ALIMENT PHARM THER, V23, P3, DOI 10.1111/j.1365-2036.2006.02707.x; Yu H, 2012, J AM GERIATR SOC, V60, P2137, DOI 10.1111/j.1532-5415.2012.04208.x; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	68	196	200	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128004	10.1371/journal.pone.0128004	http://dx.doi.org/10.1371/journal.pone.0128004			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042842	Green Submitted, gold, Green Published			2022-12-27	WOS:000355701600029
J	Andrade, BM; Baldanza, MR; Ribeiro, KC; Porto, A; Pecanha, R; Fortes, FSA; Zapata-Sudo, G; Campos-de-Carvalho, AC; Goldenberg, RCS; Werneck-de-Castro, JP				Andrade, Bruno M.; Baldanza, Marcelo R.; Ribeiro, Karla C.; Porto, Anderson; Pecanha, Ramon; Fortes, Fabio S. A.; Zapata-Sudo, Gisele; Campos-de-Carvalho, Antonio C.; Goldenberg, Regina C. S.; Werneck-de-Castro, Joao Pedro			Bone Marrow Mesenchymal Cells Improve Muscle Function in a Skeletal Muscle Re-Injury Model	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; STROMAL CELLS; IN-VITRO; MOLECULAR REGULATION; ANTIFIBROTIC AGENT; REGENERATION; SURAMIN; DIFFERENTIATION; FIBROSIS; TRANSPLANTATION	Skeletal muscle injury is the most common problem in orthopedic and sports medicine, and severe injury leads to fibrosis and muscle dysfunction. Conventional treatment for successive muscle injury is currently controversial, although new therapies, like cell therapy, seem to be promise. We developed a model of successive injuries in rat to evaluate the therapeutic potential of bone marrow mesenchymal cells (BMMC) injected directly into the injured muscle. Functional and histological assays were performed 14 and 28 days after the injury protocol by isometric tension recording and picrosirius/Hematoxilin & Eosin staining, respectively. We also evaluated the presence and the fate of BMMC on treated muscles; and muscle fiber regeneration. BMMC treatment increased maximal skeletal muscle contraction 14 and 28 days after muscle injury compared to non-treated group (4.5 +/- 1.7 vs 2.5 +/- 0.98 N/cm(2), p<0.05 and 8.4 +/- 2.3 vs. 5.7 +/- 1.3 N/cm(2), p<0.05 respectively). Furthermore, BMMC treatment increased muscle fiber cross-sectional area and the presence of mature muscle fiber 28 days after muscle injury. However, there was no difference in collagen deposition between groups. Immunoassays for cytoskeleton markers of skeletal and smooth muscle cells revealed an apparent integration of the BMMC within the muscle. These data suggest that BMMC transplantation accelerates and improves muscle function recovery in our extensive muscle re-injury model.	[Andrade, Bruno M.; Baldanza, Marcelo R.; Porto, Anderson; Pecanha, Ramon; Werneck-de-Castro, Joao Pedro] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Biol Exercicio, BR-21941 Rio De Janeiro, RJ, Brazil; [Andrade, Bruno M.; Baldanza, Marcelo R.; Porto, Anderson; Pecanha, Ramon; Werneck-de-Castro, Joao Pedro] Univ Fed Rio de Janeiro, Escola Educ Fis & Desportos, BR-21941 Rio De Janeiro, RJ, Brazil; [Andrade, Bruno M.; Ribeiro, Karla C.; Fortes, Fabio S. A.; Campos-de-Carvalho, Antonio C.; Goldenberg, Regina C. S.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Ctr Ciencias & Saude, BR-21941 Rio De Janeiro, RJ, Brazil; [Zapata-Sudo, Gisele] Univ Fed Rio de Janeiro, Dept Farmacol Basica & Clin, Ctr Ciencias & Saude, BR-21941 Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Werneck-de-Castro, JP (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Biol Exercicio, BR-21941 Rio De Janeiro, RJ, Brazil.	joaopedrowerneck@yahoo.com.br	Goldenberg, Regina/ABI-2609-2020; Zapata-Sudo, Gisele/AAG-8790-2020; de Carvalho, Antonio Carlos Campos/A-3152-2008	Goldenberg, Regina/0000-0002-0886-9603; de Carvalho, Antonio Carlos Campos/0000-0002-0062-3043; Fortes, Fabiane/0000-0001-6217-3474; Werneck-de-Castro, Joao Pedro/0000-0001-9242-7930	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was supported by research grants from CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Barbero A, 2001, J CELL PHYSIOL, V186, P183, DOI 10.1002/1097-4652(200102)186:2<183::AID-JCP1020>3.3.CO;2-H; Bedair HS, 2008, AM J SPORT MED, V36, P1548, DOI 10.1177/0363546508315470; Bittner RE, 1999, ANAT EMBRYOL, V199, P391, DOI 10.1007/s004290050237; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Carvalho AB, 2008, STEM CELLS, V26, P1307, DOI 10.1634/stemcells.2007-0941; Chan YS, 2005, AM J SPORT MED, V33, P43, DOI 10.1177/0363546504265190; Chan YS, 2003, J APPL PHYSIOL, V95, P771, DOI 10.1152/japplphysiol.00915.2002; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Corbel SY, 2003, NAT MED, V9, P1528, DOI 10.1038/nm959; Croisier JL, 2002, AM J SPORT MED, V30, P199, DOI 10.1177/03635465020300020901; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Dong YJ, 2013, AM J PHYSIOL-ENDOC M, V305, pE367, DOI 10.1152/ajpendo.00644.2012; Fakhfakh R, 2012, CELL TRANSPLANT, V21, P139, DOI 10.3727/096368911X576045; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fidelis-de-Oliveira P, 2012, CELL TRANSPLANT, V21, P1011, DOI 10.3727/096368911X623916; Foster W, 2003, J ORTHOP RES, V21, P798, DOI 10.1016/S0736-0266(03)00059-7; Goncalves MAFV, 2006, HUM MOL GENET, V15, P213, DOI 10.1093/hmg/ddi438; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Huard J, 2002, J BONE JOINT SURG AM, V84A, P822, DOI 10.2106/00004623-200205000-00022; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kobayashi T, 2013, J APPL PHYSIOL, V114, P262, DOI 10.1152/japplphysiol.00140.2011; Lee EM, 2015, CELL TRANSPLANT, V24, P939, DOI 10.3727/096368914X678599; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Li Y, 2002, AM J PATHOL, V161, P895, DOI 10.1016/S0002-9440(10)64250-2; Matziolis G, 2006, TISSUE ENG, V12, P361, DOI 10.1089/ten.2006.12.361; Muguruma Y, 2003, EXP HEMATOL, V31, P1323, DOI 10.1016/j.exphem.2003.09.003; Natsu K, 2004, TISSUE ENG, V10, P1093, DOI 10.1089/1076327041887754; Noonan T J, 1999, J Am Acad Orthop Surg, V7, P262; Nozaki M, 2012, MUSCLE NERVE, V46, P70, DOI 10.1002/mus.23280; Nozaki M, 2008, AM J SPORT MED, V36, P2354, DOI 10.1177/0363546508322886; Olivares EL, 2004, AM J PHYSIOL-HEART C, V287, pH464, DOI 10.1152/ajpheart.01141.2003; Olivares EL, 2007, EUR J HEART FAIL, V9, P558, DOI 10.1016/j.ejheart.2007.02.003; Otto A, 2009, J ANAT, V215, P477, DOI 10.1111/j.1469-7580.2009.01138.x; Palermo AT, 2005, DEV BIOL, V279, P336, DOI 10.1016/j.ydbio.2004.12.024; Park JK, 2012, CELL TRANSPLANT, V21, P2407, DOI 10.3727/096368912X637055; Pecanha R, 2012, J BONE JOINT SURG AM, V94A, P609, DOI 10.2106/JBJS.K.00351; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Quintanilha LF, 2008, CELL TRANSPLANT, V17, P943, DOI 10.3727/096368908786576453; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Salah-Mohellibi N, 2006, STEM CELLS, V24, P2723, DOI 10.1634/stemcells.2006-0170; Sato K, 2003, MUSCLE NERVE, V28, P365, DOI 10.1002/mus.10436; Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565; Terada S, 2013, J BONE JOINT SURG AM, V95A, P980, DOI 10.2106/JBJS.L.00266; Winkler T, 2009, TISSUE ENG PT A, V15, P487, DOI 10.1089/ten.tea.2007.0426; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zemper ED, 2005, MED SPORT SCI, V48, P138, DOI 10.1159/000084287; Zheng LH, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-46; Zhu J, 2007, J BIOL CHEM, V282, P25852, DOI 10.1074/jbc.M704146200	49	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127561	10.1371/journal.pone.0127561	http://dx.doi.org/10.1371/journal.pone.0127561			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039243	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700066
J	Santamaria, ME; Arnaiz, A; Diaz-Mendoza, M; Martinez, M; Diaz, I				Estrella Santamaria, M.; Arnaiz, Ana; Diaz-Mendoza, Mercedes; Martinez, Manuel; Diaz, Isabel			Inhibitory Properties of Cysteine Protease Pro-Peptides from Barley Confer Resistance to Spider Mite Feeding	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; TETRANYCHUS-URTICAE; MANDUCA-SEXTA; GENE FAMILY; PROTEINASE; CYSTATIN; PAPAIN; ENDOPEPTIDASE; MOBILIZATION; SENESCENCE	C1A plant cysteine proteases are synthesized as pre-pro-enzymes that need to be processed to become active by the pro-peptide claves off from its cognate enzyme. These prosequences play multifunctional roles including the capacity to specifically inhibit their own as well as other C1A protease activities from diverse origin. In this study, it is analysed the potential role of C1A pro-regions from barley as regulators of cysteine proteases in target phytophagous arthropods (coleopteran and acari). The in vitro inhibitory action of these prosequences, purified as recombinant proteins, is demonstrated. Moreover, transgenic Arabidopsis plants expressing different fragments of HvPap-1 barley gene containing the propeptide sequence were generated and the acaricide function was confirmed by bioassays conducted with the two-spotted spider mite Tetranychus urticae. Feeding trials resulted in a significant reduction of leaf damage in the transgenic lines expressing the pro-peptide in comparison to non-transformed control and strongly correlated with an increase in mite mortality. Additionally, the analysis of the expression levels of a selection of potential mite targets (proteases and protease inhibitors) revealed a mite strategy to counteract the inhibitory activity produced by the C1A barley pro-prodomain. These findings demonstrate that pro-peptides can control mite pests and could be applied as defence proteins in biotechnological systems.	[Estrella Santamaria, M.; Arnaiz, Ana; Diaz-Mendoza, Mercedes; Martinez, Manuel; Diaz, Isabel] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Madrid 28223, Spain	Universidad Politecnica de Madrid	Diaz, I (corresponding author), Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Autovia M40 Km 38, Madrid 28223, Spain.	i.diaz@upm.es	Martinez, Manuel/I-8743-2014; SANTAMARIA, M ESTRELLA/I-9337-2014; Arnaiz, Ana/L-5178-2014; Diaz-Mendoza, Mercedes/K-2897-2014; Diaz, Isabel/I-8840-2014	Martinez, Manuel/0000-0002-7826-5872; SANTAMARIA, M ESTRELLA/0000-0003-4999-6227; Arnaiz, Ana/0000-0002-3842-498X; Diaz-Mendoza, Mercedes/0000-0002-3545-987X; Diaz, Isabel/0000-0001-9865-902X	Ministerio de Economia y Competitividad of Spain [AGL2011-23650]	Ministerio de Economia y Competitividad of Spain(Spanish Government)	Financial support from the Ministerio de Economia y Competitividad of Spain (project AGL2011-23650) is gratefully acknowledged.	Alvarez-Alfageme F, 2007, TRANSGENIC RES, V16, P1, DOI 10.1007/s11248-006-9022-6; Benchabane M, 2010, BIOCHIMIE, V92, P1657, DOI 10.1016/j.biochi.2010.06.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cambra I, 2012, J EXP BOT, V63, P4615, DOI 10.1093/jxb/ers137; Cambra I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037234; Carrillo L, 2011, PLANT CELL REP, V30, P101, DOI 10.1007/s00299-010-0948-z; Carrion CA, 2013, J EXP BOT, V64, P4967, DOI 10.1093/jxb/ert285; Cazaux M, 2014, JOVE-J VIS EXP, DOI 10.3791/51738; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Demidyuk Ilya V, 2010, Biomol Concepts, V1, P305, DOI 10.1515/bmc.2010.025; Diaz I, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P1852, DOI 10.1016/B978-0-12-382219-2.00417-8; Diaz-Mendoza M, 2014, J EXP BOT, V65, P3825, DOI 10.1093/jxb/eru043; Santamaria ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043011; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Gutierrez-Gonzalez LH, 2006, ARCH BIOCHEM BIOPHYS, V446, P151, DOI 10.1016/j.abb.2005.12.005; Harrison RL, 2010, TOXINS, V2, P935, DOI 10.3390/toxins2050935; Helm M, 2008, AM J BOT, V95, P1049, DOI 10.3732/ajb.2007404; Hierl G, 2014, PLANT MOL BIOL, V84, P605, DOI 10.1007/s11103-013-0157-6; Kim JH, 2003, ARCH INSECT BIOCHEM, V52, P139, DOI 10.1002/arch.10074; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lara P, 2000, TRANSGENIC RES, V9, P169, DOI 10.1023/A:1008905631440; Li YH, 2010, J INSECT PHYSIOL, V56, P157, DOI 10.1016/j.jinsphys.2009.09.011; Lima AM, 2015, PROTEIN PEPTIDE LETT, V22, P104, DOI 10.2174/0929866521666140418101711; Marra BM, 2009, PEPTIDES, V30, P825, DOI 10.1016/j.peptides.2009.01.022; Martinez M, 2012, PHYSIOL PLANTARUM, V145, P85, DOI 10.1111/j.1399-3054.2012.01569.x; Martinez M, 2009, PLANT PHYSIOL, V151, P1531, DOI 10.1104/pp.109.146019; Martinez M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-198; McCafferty HRK, 2008, PLANT SCI, V175, P385, DOI 10.1016/j.plantsci.2008.05.007; McCafferty HRK, 2006, TRANSGENIC RES, V15, P337, DOI 10.1007/s11248-006-0005-4; McLellan H, 2009, NEW PHYTOL, V183, P408, DOI 10.1111/j.1469-8137.2009.02865.x; Migeon A., 2011, SPIDER MITES WEB COM; Novillo C, 1997, ARCH INSECT BIOCHEM, V36, P181, DOI 10.1002/(SICI)1520-6327(1997)36:3<181::AID-ARCH3>3.0.CO;2-X; Okamoto T, 2003, PLANT PHYSIOL, V132, P1892, DOI 10.1104/pp.103.021147; Onate-Sanchez Luis, 2008, BMC Res Notes, V1, P93, DOI 10.1186/1756-0500-1-93; Ortego Felix, 2012, P75; Pandey KC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005694; Parrott DL, 2010, NEW PHYTOL, V187, P313, DOI 10.1111/j.1469-8137.2010.03278.x; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rovenska GZ, 2005, BIOL CONTROL, V33, P293, DOI 10.1016/j.biocontrol.2005.03.017; Santamaria ME, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-307; Schmid M, 2001, P NATL ACAD SCI USA, V98, P5353, DOI 10.1073/pnas.061038298; Shindo T, 2008, MOL PLANT PATHOL, V9, P119, DOI [10.1111/j.1364-3703.2007.00439.x, 10.1111/J.1364-3703.2007.00439.X]; Silva FB, 2007, PEPTIDES, V28, P1292, DOI 10.1016/j.peptides.2007.03.020; Silva Francine B, 2004, Genet Mol Res, V3, P342; TAYLOR MAJ, 1995, PROTEIN ENG, V8, P59, DOI 10.1093/protein/8.1.59; Taylor MAJ, 1997, BIOCHEM BIOPH RES CO, V235, P606, DOI 10.1006/bbrc.1997.6839; Thie NMR, 1997, INSECT BIOCHEM, V20, P313; Van Leeuween T., 2012, P NATL ACAD SCI USA, V105, P598; Vinokurov KS, 2006, COMP BIOCHEM PHYS B, V145, P138, DOI 10.1016/j.cbpb.2006.05.004; Visal S, 1998, FEBS LETT, V434, P401, DOI 10.1016/S0014-5793(98)01018-7; Wang W, 2014, MOLECULES, V19, P2374, DOI 10.3390/molecules19022374; Wiederanders B, 2003, ACTA BIOCHIM POL, V50, P691; Zhang DD, 2014, PLANT CELL, V26, P2939, DOI 10.1105/tpc.114.127282	54	23	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128323	10.1371/journal.pone.0128323	http://dx.doi.org/10.1371/journal.pone.0128323			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039069	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700096
J	Girard, SL; Dion, PA; Bourassa, CV; Geoffroy, S; Lachance-Touchette, P; Barhdadi, A; Langlois, M; Joober, R; Krebs, MO; Dube, MP; Rouleau, GA				Girard, Simon L.; Dion, Patrick A.; Bourassa, Cynthia V.; Geoffroy, Steve; Lachance-Touchette, Pamela; Barhdadi, Amina; Langlois, Mathieu; Joober, Ridha; Krebs, Marie-Odile; Dube, Marie-Pierre; Rouleau, Guy A.			Mutation Burden of Rare Variants in Schizophrenia Candidate Genes	PLOS ONE			English	Article							DE-NOVO MUTATIONS; SEQUENCING DATA; ASSOCIATION; PARADIGM; SHANK3	Background Schizophrenia (SCZ) is a very heterogeneous disease that affects approximately 1% of the general population. Recently, the genetic complexity thought to underlie this condition was further supported by three independent studies that identified an increased number of damaging de novo mutations DNM in different SCZ probands. While these three reports support the implication of DNM in the pathogenesis of SCZ, the absence of overlap in the genes identified suggests that the number of genes involved in SCZ is likely to be very large; a notion that has been supported by the moderate success of Genome-Wide Association Studies (GWAS). Methods To further examine the genetic heterogeneity of this disease, we resequenced 62 genes that were found to have a DNM in SCZ patients, and 40 genes that encode for proteins known to interact with the products of the genes with DNM, in a cohort of 235 SCZ cases and 233 controls. Results We found an enrichment of private nonsense mutations amongst schizophrenia patients. Using a kernel association method, we were able to assess for association for different sets. Although our power of detection was limited, we observed an increased mutation burden in the genes that have DNM.	[Girard, Simon L.] McGill Univ, Montreal, PQ, Canada; [Girard, Simon L.] McGill Univ, Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Girard, Simon L.; Dion, Patrick A.; Bourassa, Cynthia V.; Rouleau, Guy A.] McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada; [Geoffroy, Steve; Barhdadi, Amina; Langlois, Mathieu; Dube, Marie-Pierre] Inst Cardiol Montreal, Ctr Pharmacogenom Beaulieu Saucier, Montreal, PQ, Canada; [Dion, Patrick A.; Lachance-Touchette, Pamela; Dube, Marie-Pierre] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [Dion, Patrick A.] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ H3C 3J7, Canada; [Krebs, Marie-Odile] Univ Paris 05, Fac Med Paris Descartes, Paris, France; [Krebs, Marie-Odile] INSERM, U894, Lab Physiopathol Malad Psychiat, Paris, France; [Krebs, Marie-Odile] Serv Hosp Univ, Ctr Hosp St Anne, F-75014 Paris, France; [Joober, Ridha] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada	McGill University; McGill University; McGill University; Universite de Montreal; Institut de Cardiologie de Montreal; Universite de Montreal; Universite de Montreal; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; McGill University	Girard, SL (corresponding author), McGill Univ, Montreal, PQ, Canada.	simon.l.girard@mcgill.ca	Dubé, Marie-Pierre/B-9364-2008; Krebs, Marie-Odile/O-2104-2017	Dubé, Marie-Pierre/0000-0001-8442-4393; Krebs, Marie-Odile/0000-0002-4715-9890; Girard, Simon/0000-0002-4089-2280; Lachance, Pamela/0000-0002-8774-877X	Canada Research Chair in Genetics of the Nervous System; Jeanne-et-J.-Louis-Levesque Chair for the Genetics of Brain Diseases; Fonds de Recherches Quebec Sante	Canada Research Chair in Genetics of the Nervous System; Jeanne-et-J.-Louis-Levesque Chair for the Genetics of Brain Diseases; Fonds de Recherches Quebec Sante	Guy A. Rouleau received financial support through his positions as Canada Research Chair in Genetics of the Nervous System and Jeanne-et-J.-Louis-Levesque Chair for the Genetics of Brain Diseases. Simon L. Girard received financial support from the Fonds de Recherches Quebec Sante. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019; BALDWIN CT, 1994, HUM MUTAT, V3, P205, DOI 10.1002/humu.1380030306; Eckner R, 1994, GENE DEV, V8; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Kobayashi A, 2003, NUCL ACIDS RES, V31; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Messias EL, 2007, PSYCHIAT CLIN N AM, V30, P323, DOI 10.1016/j.psc.2007.04.007; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Roelfsema JH, 2005, AM J HUM GENET, V76, P572, DOI 10.1086/429130; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902	27	15	15	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128988	10.1371/journal.pone.0128988	http://dx.doi.org/10.1371/journal.pone.0128988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039597	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000355700700134
J	Simon, TW; Budinsky, RA; Rowlands, JC				Simon, Ted W.; Budinsky, Robert A.; Rowlands, J. Craig			A Model for Aryl Hydrocarbon Receptor-Activated Gene Expression Shows Potency and Efficacy Changes and Predicts Squelching Due to Competition for Transcription Co-Activators	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; SIGNAL-TRANSDUCTION PATHWAYS; NONMONOTONIC DOSE-RESPONSES; COREGULATOR BINDING ASSAY; RNA-POLYMERASE-II; NUCLEAR RECEPTORS; RISK-ASSESSMENT; SINGLE-CELL; CROSS-TALK; DEPENDENT TRANSCRIPTION	A stochastic model of nuclear receptor-mediated transcription was developed based on activation of the aryl hydrocarbon receptor (AHR) by 2,3,7,8-tetrachlorodibenzodioxin (TCDD) and subsequent binding the activated AHR to xenobiotic response elements (XREs) on DNA. The model was based on effects observed in cells lines commonly used as in vitro experimental systems. Following ligand binding, the AHR moves into the cell nucleus and forms a heterodimer with the aryl hydrocarbon nuclear translocator (ARNT). In the model, a requirement for binding to DNA is that a generic coregulatory protein is subsequently bound to the AHR-ARNT dimer. Varying the amount of coregulator available within the nucleus altered both the potency and efficacy of TCDD for inducing for transcription of CYP1A1 mRNA, a commonly used marker for activation of the AHR. Lowering the amount of available cofactor slightly increased the EC50 for the transcriptional response without changing the efficacy or maximal response. Further reduction in the amount of cofactor reduced the efficacy and produced non-monotonic dose-response curves (NMDRCs) at higher ligand concentrations. The shapes of these NMDRCs were reminiscent of the phenomenon of squelching. Resource limitations for transcriptional machinery are becoming apparent in eukaryotic cells. Within single cells, nuclear receptor-mediated gene expression appears to be a stochastic process; however, intercellular communication and other aspects of tissue coordination may represent a compensatory process to maintain an organism's ability to respond on a phenotypic level to various stimuli within an inconstant environment.	[Simon, Ted W.] Ted Simon LLC, Winston, GA 30187 USA; [Budinsky, Robert A.; Rowlands, J. Craig] Dow Chem Co USA, Toxicol & Environm Res & Consulting, Midland, MI 48674 USA	Dow Chemical Company	Simon, TW (corresponding author), Ted Simon LLC, Winston, GA 30187 USA.	ted@tedsimon-toxicology.com	Simon, Ted/M-9188-2013; Lin, Zhao/C-8319-2011	Simon, Ted/0000-0001-9405-3020; Lin, Zhao/0000-0002-6131-9723	Dow Chemical Company [PO93437034]	Dow Chemical Company	This work was funded by a grant to TWS from the Dow Chemical Company through PO93437034. Ted Simon LLC & The Dow Chemical Company provided support in the form of salaries for authors TWS, RAB and JCR retrospectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Aarts JMMJG, 2013, CHEM RES TOXICOL, V26, P336, DOI 10.1021/tx300463b; Aitken S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008845; Aoyagi S, 2008, MOL CELL ENDOCRINOL, V280, P1, DOI 10.1016/j.mce.2007.08.016; Bakstad D, 2012, CURR OPIN BIOTECH, V23, P103, DOI 10.1016/j.copbio.2011.11.007; Ball DA, 2013, CELL CYCLE, V12, P3203, DOI 10.4161/cc.26257; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Beischlag TV, 2002, MOL CELL BIOL, V22, P4319, DOI 10.1128/MCB.22.12.4319-4333.2002; Ben-Ari Y, 2010, J CELL SCI, V123, P1761, DOI 10.1242/jcs.062638; Bernshausen T, 2006, ARCH TOXICOL, V80, P206, DOI 10.1007/s00204-005-0025-5; Birnbaum LS, 2012, ENVIRON HEALTH PERSP, V120, pA143, DOI 10.1289/ehp.1205179; Blackford JA, 2012, J BIOL CHEM, V287, P40982, DOI 10.1074/jbc.M112.414805; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bock KW, 2013, BIOL CHEM, V394, P729, DOI 10.1515/hsz-2012-0340; Borgert CJ, 2013, REGUL TOXICOL PHARM, V67, P83, DOI 10.1016/j.yrtph.2013.06.007; Brunnberg S, 2003, P NATL ACAD SCI USA, V100, P6517, DOI 10.1073/pnas.1136688100; Budinsky RA, 2014, CRIT REV TOXICOL, V44, P83, DOI 10.3109/10408444.2013.835787; Charlier Thierry D, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS20, DOI 10.1016/j.psyneuen.2009.05.004; Chen JG, 2006, MOL ENDOCRINOL, V20, P1, DOI 10.1210/me.2005-0192; Chen W, 2011, SEMIN CELL DEV BIOL, V22, P749, DOI 10.1016/j.semcdb.2011.07.026; Conolly RB, 2004, TOXICOL SCI, V77, P151, DOI 10.1093/toxsci/kfh007; Coulon A, 2013, NAT REV GENET, V14, P572, DOI 10.1038/nrg3484; Darzacq X, 2008, MOL CELL, V30, P545, DOI 10.1016/j.molcel.2008.05.009; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; De Vos D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028494; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Dere E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-365; Dere E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-193; Dietrich DD, 2013, ACTA PHYS POL B PR S, V6, P27, DOI 10.5506/APhysPolBSupp.6.27; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Dong D, 2011, NUCLEIC ACIDS RES, V39, P403, DOI 10.1093/nar/gkq844; Edelman LB, 2012, CURR OPIN GENET DEV, V22, P110, DOI 10.1016/j.gde.2012.01.010; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Genot AJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.208102; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; Gorski SA, 2008, MOL CELL, V30, P486, DOI 10.1016/j.molcel.2008.04.021; Gradin K, 1996, MOL CELL BIOL, V16, P5221; Greive SJ, 2011, BIOPHYS J, V101, P1155, DOI 10.1016/j.bpj.2011.07.042; Greive SJ, 2011, BIOPHYS J, V101, P1166, DOI 10.1016/j.bpj.2011.07.043; Grunwald D, 2011, NATURE, V475, P333, DOI 10.1038/nature10318; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4; Hankinson O, 2005, ARCH BIOCHEM BIOPHYS, V433, P379, DOI 10.1016/j.abb.2004.09.031; Hayes JD, 2009, TOXICOL SCI, V111, P199, DOI 10.1093/toxsci/kfp168; Hocine S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000752; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Isella C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-382; Kang J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002094; Karchner SI, 2009, MOL CELL BIOL, V29, P3465, DOI 10.1128/MCB.00206-09; Kimura H, 1999, MOL CELL BIOL, V19, P5383; KO MSH, 1991, J THEOR BIOL, V153, P181, DOI 10.1016/S0022-5193(05)80421-7; Kohn MC, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290113; Kolitz SE, 2012, BIOCHEMISTRY-US, V51, P7433, DOI 10.1021/bi300846p; Lebedeva G, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-138; Li L, 2007, J MOL ENDOCRINOL, V38, P569, DOI 10.1677/JME-07-0003; Ling ZQ, 2010, BIOINFORMATICS, V26, P1431, DOI 10.1093/bioinformatics/btq163; Lipniacki T, 2006, J THEOR BIOL, V238, P348, DOI 10.1016/j.jtbi.2005.05.032; Lo R, 2013, TOXICOL APPL PHARM, V270, P139, DOI 10.1016/j.taap.2013.03.029; Lo R, 2012, TOXICOL SCI, V130, P349, DOI 10.1093/toxsci/kfs253; Lo R, 2011, TOXICOL APPL PHARM, V257, P38, DOI 10.1016/j.taap.2011.08.016; MacPherson L, 2014, INT J MOL SCI, V15, P7939, DOI 10.3390/ijms15057939; MacPherson L, 2013, NUCLEIC ACIDS RES, V41, P1604, DOI 10.1093/nar/gks1337; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Mathworks T., 2015, SIMBIOLOGY DOCUMENTA; Matthews J, 2005, MOL CELL BIOL, V25, P5317, DOI 10.1128/MCB.25.13.5317-5328.2005; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; MEYER ME, 1989, CELL, V57, P433, DOI 10.1016/0092-8674(89)90918-5; Min GS, 2002, J BIOL CHEM, V277, P34626, DOI 10.1074/jbc.M205239200; Murugan R, 2006, BIOPHYS CHEM, V121, P51, DOI 10.1016/j.bpc.2005.12.010; National Research Council NRC, 2014, REV EPA STAT OF THE; Ong KM, 2010, P NATL ACAD SCI USA, V107, P7107, DOI 10.1073/pnas.0911095107; Pandey PK, 2005, MOL CELL BIOL, V25, P10695, DOI 10.1128/MCB.25.24.10695-10710.2005; Patlewicz G, 2013, REGUL TOXICOL PHARM, V65, P259, DOI 10.1016/j.yrtph.2012.12.008; Powis M, 2011, BIOCHEM BIOPH RES CO, V410, P859, DOI 10.1016/j.bbrc.2011.06.079; Puga A, 2009, BIOCHEM PHARMACOL, V77, P713, DOI 10.1016/j.bcp.2008.08.031; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Reddy KL, 2008, METHODS, V45, P242, DOI 10.1016/j.ymeth.2008.06.013; Reif DM, 2010, ENVIRON HEALTH PERSP, V118, P1714, DOI 10.1289/ehp.1002180; Rhomberg LR, 2012, REGUL TOXICOL PHARM, V64, P130, DOI 10.1016/j.yrtph.2012.06.015; Ribeiro AS, 2010, MATH BIOSCI, V223, P1, DOI 10.1016/j.mbs.2009.10.007; Ribeiro AS, 2009, J COMPUT BIOL, V16, P539, DOI 10.1089/cmb.2008.0153; Rondelez Y, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.018102; Rotroff DM, 2013, ENVIRON HEALTH PERSP, V121, P7, DOI 10.1289/ehp.1205065; Rowland MA, 2012, BIOPHYS J, V103, P2389, DOI 10.1016/j.bpj.2012.10.006; Ruegg J, 2008, MOL ENDOCRINOL, V22, P304, DOI 10.1210/me.2007-0128; Sanchez A, 2013, METHODS, V62, P13, DOI 10.1016/j.ymeth.2013.03.026; Sand S, 2006, TOXICOL SCI, V90, P241, DOI 10.1093/toxsci/kfj057; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Selimkhanov J, 2012, CURR OPIN BIOTECH, V23, P34, DOI 10.1016/j.copbio.2011.11.006; Shaik JS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-347; Simon TW, 2014, CRIT REV TOXICOL, V44, P17, DOI 10.3109/10408444.2014.931925; Simons SS, 2008, BIOESSAYS, V30, P744, DOI 10.1002/bies.20792; Simons SS, 2006, CURR TOP MED CHEM, V6, P271, DOI 10.2174/156802606776173465; Simons SS, 2003, TRENDS PHARMACOL SCI, V24, P253, DOI 10.1016/S0165-6147(03)00101-9; Sipes NS, 2013, CHEM RES TOXICOL, V26, P878, DOI 10.1021/tx400021f; Solaimani P, 2013, TOXICOL SCI, V136, P107, DOI 10.1093/toxsci/kft191; Sorg O, 2014, TOXICOL LETT, V230, P225, DOI 10.1016/j.toxlet.2013.10.039; Starsichova A, 2012, CELL SIGNAL, V24, P1665, DOI 10.1016/j.cellsig.2012.04.008; Stein GS, 2010, CRIT REV EUKAR GENE, V20, P149, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.50; Tigges J, 2013, J INVEST DERMATOL, V133, P87, DOI 10.1038/jid.2012.259; Treuter E, 1999, J BIOL CHEM, V274, P6667, DOI 10.1074/jbc.274.10.6667; Ullah M, 2006, IEE P SYST BIOL, V153, P53, DOI 10.1049/ip-syb:20050064; United States Environmental Protection Agency (USEPA), 2013, STAT SCI EV NONM DOS; Vandenberg LN, 2014, VITAM HORM, V94, P129, DOI 10.1016/B978-0-12-800095-3.00005-5; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Vogel CFA, 2014, J BIOL CHEM, V289, P1866, DOI 10.1074/jbc.M113.505578; Volfson D, 2006, NATURE, V439, P861, DOI 10.1038/nature04281; Voliotis M, 2008, BIOPHYS J, V94, P334, DOI 10.1529/biophysj.107.105767; Voss TC, 2014, NAT REV GENET, V15, P69, DOI 10.1038/nrg3623; Wakabayashi N, 2010, ANTIOXID REDOX SIGN, V13, P1649, DOI 10.1089/ars.2010.3216; Wang LP, 2013, ARCH BIOCHEM BIOPHYS, V537, P31, DOI 10.1016/j.abb.2013.06.001; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang S, 2013, ALTEX-ALTERN ANIM EX, V30, P145, DOI 10.14573/altex.2013.2.145; Wincent E, 2012, P NATL ACAD SCI USA, V109, P4479, DOI 10.1073/pnas.1118467109; Wincent E, 2009, J BIOL CHEM, V284, P2690, DOI 10.1074/jbc.M808321200; Xu LJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S23; Yeager RL, 2009, TOXICOL SCI, V111, P238, DOI 10.1093/toxsci/kfp115; Zhang X, 2012, J BIOL CHEM, V287, P30468, DOI 10.1074/jbc.M112.373738; Zhang ZP, 2001, MOL CELL ENDOCRINOL, V172, P223, DOI 10.1016/S0303-7207(00)00372-5	124	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127952	10.1371/journal.pone.0127952	http://dx.doi.org/10.1371/journal.pone.0127952			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039703	gold, Green Published, Green Submitted			2022-12-27	WOS:000355700700081
J	Takahashi, H; Izuma, K; Matsumoto, M; Matsumoto, K; Omori, T				Takahashi, Hideyuki; Izuma, Keise; Matsumoto, Madoka; Matsumoto, Kenji; Omori, Takashi			The Anterior Insula Tracks Behavioral Entropy during an Interpersonal Competitive Game	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; MIXED-STRATEGY GAME; DECISION-MAKING; HUMAN BRAIN; NEURAL BASIS; AUTISM; GENERATION; SIGNALS; RISK; FMRI	In competitive situations, individuals need to adjust their behavioral strategy dynamically in response to their opponent's behavior. In the present study, we investigated the neural basis of how individuals adjust their strategy during a simple, competitive game of matching pennies. We used entropy as a behavioral index of randomness in decision-making, because maximizing randomness is thought to be an optimal strategy in the game, according to game theory. While undergoing functional magnetic resonance imaging (fMRI), subjects played matching pennies with either a human or computer opponent in each block, although in reality they played the game with the same computer algorithm under both conditions. The winning rate of each block was also manipulated. Both the opponent (human or computer), and the winning rate, independently affected subjects' block-wise entropy during the game. The fMRI results revealed that activity in the bilateral anterior insula was positively correlated with subjects' (not opponent's) behavioral entropy during the game, which indicates that during an interpersonal competitive game, the anterior insula tracked how uncertain subjects' behavior was, rather than how uncertain subjects felt their opponent's behavior was. Our results suggest that intuitive or automatic processes based on somatic markers may be a key to optimally adjusting behavioral strategies in competitive situations.	[Takahashi, Hideyuki; Izuma, Keise; Matsumoto, Kenji; Omori, Takashi] Tamagawa Univ, Brain Sci Inst, Machida, Tokyo, Japan; [Takahashi, Hideyuki] Osaka Univ, Grad Sch Engn, Suita, Osaka, Japan; [Izuma, Keise] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Matsumoto, Madoka] Tokyo Univ Hosp, Dept Neuropsychiat, Bunkyo Ku, Tokyo 113, Japan	Osaka University; California Institute of Technology; University of Tokyo	Takahashi, H (corresponding author), Tamagawa Univ, Brain Sci Inst, Machida, Tokyo, Japan.	hideyuki@ams.eng.osaka-u.ac.jp		Matsumoto, Kenji/0000-0003-0883-4280	Ministry of Education, Culture, Sports, Science and Technology, Japan [4101, 24118708, 4103, 21120010, 24120717, 23700321]; Grants-in-Aid for Scientific Research [26560415, 26284001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Founding a creative society via collaboration between humans and robots (No. 4101)" (24118708), Grant-in-Aid for Scientific Research on Innovative Areas " The study on the neural dynamics for understanding communication in terms of complex hetero systems (No. 4103)" (21120010 and 24120717), Grant-in-Aid for Young Scientists (B) No. 23700321, and Tamagawa University Global Center of Excellence grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, ANN NY ACAD SCI, V1239, P100, DOI 10.1111/j.1749-6632.2011.06223.x; Abe H, 2011, NEURON, V70, P731, DOI 10.1016/j.neuron.2011.03.026; Allman JM, 2005, TRENDS COGN SCI, V9, P367, DOI 10.1016/j.tics.2005.06.008; Baek K, 2013, PSYCHIAT RES, V207, P158, DOI 10.1016/j.psychres.2012.09.003; Bar-On R, 2003, BRAIN, V126, P1790, DOI 10.1093/brain/awg177; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Bechara A, 2001, Semin Clin Neuropsychiatry, V6, P205, DOI 10.1053/scnp.2001.22927; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Calder AJ, 2007, EUR J NEUROSCI, V25, P3422, DOI 10.1111/j.1460-9568.2007.05604.x; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Clark L, 2008, BRAIN, V131, P1311, DOI 10.1093/brain/awn066; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Damasio A.R., 2005, DESCARTES ERROR EMOT; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Daniels C, 2003, NEUROSCI LETT, V345, P25, DOI 10.1016/S0304-3940(03)00496-8; Denson TF, 2009, J COGNITIVE NEUROSCI, V21, P734, DOI 10.1162/jocn.2009.21051; Downs A, 2004, J AUTISM DEV DISORD, V34, P625, DOI 10.1007/s10803-004-5284-0; Fukui H, 2006, NEUROIMAGE, V32, P913, DOI 10.1016/j.neuroimage.2006.03.039; Gallagher HL, 2002, NEUROIMAGE, V16, P814, DOI 10.1006/nimg.2002.1117; Goni J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017408; Hill EL, 2004, J CONSCIOUSNESS STUD, V11, P144; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; Izuma K, 2011, P NATL ACAD SCI USA, V108, P17302, DOI 10.1073/pnas.1107038108; Jahanshahi M, 2000, NEUROIMAGE, V12, P713, DOI 10.1006/nimg.2000.0647; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Krach S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002597; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Lieberman MD, 2003, REFLECTIVE REFLEXIVE; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Ohira H, 2013, NEUROSCIENCE, V246, P362, DOI 10.1016/j.neuroscience.2013.04.050; Paulus MP, 2005, NEUROIMAGE, V25, P607, DOI 10.1016/j.neuroimage.2004.12.055; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; RAPOPORT A, 1992, J EXP PSYCHOL GEN, V121, P352, DOI 10.1037/0096-3445.121.3.352; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; Seo H, 2007, CEREB CORTEX, V17, pI110, DOI 10.1093/cercor/bhm064; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Seo H, 2009, J NEUROSCI, V29, P3627, DOI 10.1523/JNEUROSCI.4726-08.2009; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Takahashi H, 2014, CORTEX, V58, P289, DOI 10.1016/j.cortex.2014.03.011; Takahashi H, 2013, JPN PSYCHOL RES, V55, P144, DOI 10.1111/jpr.12007; Uddin LQ, 2009, NEUROSCI BIOBEHAV R, V33, P1198, DOI 10.1016/j.neubiorev.2009.06.002; Vickery TJ, 2011, NEURON, V72, P166, DOI 10.1016/j.neuron.2011.08.011	47	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0123329	10.1371/journal.pone.0123329	http://dx.doi.org/10.1371/journal.pone.0123329			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7ST	26039634	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000355700700003
J	Uthaikhup, S; Prasert, R; Paungmali, A; Boontha, K				Uthaikhup, Sureeporn; Prasert, Romchat; Paungmali, Aatit; Boontha, Kritsana			Altered Pain Sensitivity in Elderly Women with Chronic Neck Pain	PLOS ONE			English	Article							WIDESPREAD SENSORY HYPERSENSITIVITY; AGE-RELATED DIFFERENCES; PRESSURE PAIN; SURAL NERVE; OLDER; PEOPLE	Background Age-related changes occur in both the peripheral and central nervous system, yet little is known about the influence of chronic pain on pain sensitivity in older persons. The aim of this study was to investigate pain sensitivity in elders with chronic neck pain compared to healthy elders. Methods Thirty elderly women with chronic neck pain and 30 controls were recruited. Measures of pain sensitivity included pressure pain thresholds, heat/cold pain thresholds and supra-threshold heat pain responses. The pain measures were assessed over the cervical spine and at a remote site, the tibialis anterior muscle. Results Elders with chronic neck pain had lower pressure pain threshold over the articular pillar of C5-C6 and decreased cold pain thresholds over the cervical spine and tibialis anterior muscle when compared with controls (p < 0.05). There were no between group differences in heat pain thresholds and suprathreshold heat pain responses (p > 0.05). Conclusion The presence of pain hypersensitivity in elderly women with chronic neck pain appears to be dependent on types of painful stimuli. This may reflect changes in the peripheral and central nervous system with age.	[Uthaikhup, Sureeporn; Prasert, Romchat; Paungmali, Aatit; Boontha, Kritsana] Chiang Mai Univ, Fac Associated Med Sci, Dept Phys Therapy, Chiang Mai 50000, Thailand; [Uthaikhup, Sureeporn] Khon Kaen Univ, Back Neck & Other Joint Pain Res Grp, Khon Kaen, Thailand	Chiang Mai University; Khon Kaen University	Uthaikhup, S (corresponding author), Chiang Mai Univ, Fac Associated Med Sci, Dept Phys Therapy, Chiang Mai 50000, Thailand.	sureeporn.uthaikhup@cmu.ac.th	Paungmali, Aatit/GXA-0248-2022		Faculty of Associated Medical Sciences, Chiang Mai University	Faculty of Associated Medical Sciences, Chiang Mai University	This study was funded by the Faculty of Associated Medical Sciences, Chiang Mai University. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ashina S, 2006, CEPHALALGIA, V26, P940, DOI 10.1111/j.1468-2982.2006.01150.x; Bartley EJ, 2013, BRIT J ANAESTH, V111, P52, DOI 10.1093/bja/aet127; Brochet B, 1998, AGE AGEING, V27, P279, DOI 10.1093/ageing/27.3.279; Cavanaugh JA, 2006, J BONE JOINT SURG AM, V88A, P63, DOI 10.2106/JBJS.E.01411; Chien A, 2010, MANUAL THER, V15, P48, DOI 10.1016/j.math.2009.05.012; Curatolo Michele, 2006, Phys Med Rehabil Clin N Am, V17, P287, DOI 10.1016/j.pmr.2005.12.010; Edwards RR, 2003, PAIN, V101, P155, DOI 10.1016/S0304-3959(02)00324-X; Gibson SJ, 2004, CLIN J PAIN, V20, P227, DOI 10.1097/00002508-200407000-00004; Gibson SJ, 2001, CLIN GERIATR MED, V17, P433, DOI 10.1016/S0749-0690(05)70079-3; Graven-Nielsen T, 1998, BRAIN RES, V787, P203, DOI 10.1016/S0006-8993(97)01480-7; Hansson P, 2007, PAIN, V129, P256, DOI 10.1016/j.pain.2007.03.030; Herr KA, 2001, CLIN GERIATR MED, V17, P457, DOI 10.1016/S0749-0690(05)70080-X; JACOBS JM, 1985, BRAIN, V108, P897, DOI 10.1093/brain/108.4.897; Javanshir K, 2010, J MANIP PHYSIOL THER, V33, P493, DOI 10.1016/j.jmpt.2010.08.022; Johnston V, 2008, PAIN, V137, P257, DOI 10.1016/j.pain.2007.08.037; Jorm AF, 2000, PSYCHOL MED, V30, P11, DOI 10.1017/S0033291799001452; KANDA T, 1991, BRAIN, V114, P585, DOI 10.1093/brain/114.1.585; Kotchabhakdi N, 1983, STATE TRAIT ANXIETY; La Touche R, 2010, J PAIN, V11, P256, DOI 10.1016/j.jpain.2009.07.003; Lautenbacher S, 2012, PAIN MED, V13, pS44, DOI 10.1111/j.1526-4637.2012.01326.x; Lee YC, 2011, ARTHRIT CARE RES, V63, P320, DOI 10.1002/acr.20373; Luksanapruksa Panya, 2012, Journal of the Medical Association of Thailand, V95, P681; Prushansk T, 2004, CLIN J PAIN, V20, P341, DOI 10.1097/00002508-200409000-00009; Quiton RL, 2007, ANN NY ACAD SCI, V1097, P175, DOI 10.1196/annals.1379.024; Robinson Michael E, 2010, J Pain Res, V3, P25; Scott D, 2005, CLIN J PAIN, V21, P175, DOI 10.1097/00002508-200503000-00009; Sofaer B, 2005, AGE AGEING, V34, P462, DOI 10.1093/ageing/afi139; Thongtang Orapun, 2002, Journal of the Medical Association of Thailand, V85, P540; Train the Brain forum Committee, 1994, SIRIRAJ HOSP GAZETTE, V46, P1; Uthaikhup S, 2011, SPINE, V36, pE1415, DOI 10.1097/BRS.0b013e31820e68ac; Uthaikhup S, 2009, CLIN J PAIN, V25, P699, DOI 10.1097/AJP.0b013e3181a38f88; Valencia C, 2011, J PAIN, V12, P133, DOI 10.1016/j.jpain.2010.06.002; Wallin M, 2012, CLIN J PAIN, V28, P211, DOI 10.1097/AJP.0b013e318226c3fd	33	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128946	10.1371/journal.pone.0128946	http://dx.doi.org/10.1371/journal.pone.0128946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039149	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700130
J	Yoon, HI; Chung, Y; Chang, JS; Lee, JY; Park, SJ; Koom, WS				Yoon, Hong In; Chung, Yoonsun; Chang, Jee Suk; Lee, Joo Yong; Park, Soo Jung; Koom, Woong Sub			Evaluating Variations of Bladder Volume Using an Ultrasound Scanner in Rectal Cancer Patients during Chemoradiation: Is Protocol-Based Full Bladder Maintenance Using a Bladder Scanner Useful to Maintain the Bladder Volume?	PLOS ONE			English	Article							POSTOPERATIVE CHEMORADIOTHERAPY; PREOPERATIVE RADIOTHERAPY; CONFORMAL RADIOTHERAPY; PROSTATE-CANCER; TRIAL; BOWEL	Purpose The maintenance of full bladder is important to reduce radiation-induced toxicities and maintain the therapeutic consistency in locally advanced rectal cancer patients who underwent radiotherapy (RT). So, the aim of this study was to evaluate the effectiveness of protocol-based full bladder maintenance by assessing bladder volume variation using an ultrasound bladder scanner to maintain bladder volume. Materials and Methods From March 2011 to May 2011, twenty consecutive rectal cancer patients receiving external beam RT participated in this prospective study. Protocol-based full bladder maintenance consisted of education, training and continuous biofeedback by measuring bladder volume. Bladder volume was measured by bladder scan immediately before simulation CT scan and before each treatment three times weekly during the RT period. The relative bladder volume change was calculated. Intra-patient bladder volume variations were quantified using inter-quartile range (IQR) of relative bladder vol ume change in each patient. We compared intra-patient bladder volume variations obtained (n=20) with data from our previous study patients (n=20) performing self-controlled maintenance without protocol. Results Bladder volumes measured by bladder scan highly correlated with those on simulation CT scan (R=0.87, p<0.001). Patients from this study showed lower median IQR of relative bladder volume change compared to patients of self-controlled maintenance from our previous study, although it was not statistically significant (median 32.56% vs. 42.19%, p=0.058). Upon logistic regression, the IQR of relative bladder volume change was significantly related to protocol- based maintenance [relative risk 1.045, 95% confidence intervals (CI) 1.004-1.087, p=0.033]. Protocol-based maintenance included significantly more patients with an IQR of relative bladder volume change less than 37% than self-controlled maintenance (p=0.025). Conclusion Our findings show that bladder volume could be maintained more consistently during RT by protocol-based management using a bladder scan.	[Yoon, Hong In; Chang, Jee Suk; Koom, Woong Sub] Yonsei Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea; [Chung, Yoonsun] Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Lee, Joo Yong] Yonsei Univ, Coll Med, Dept Urol, Seoul, South Korea; [Park, Soo Jung] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Park, Soo Jung] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea; [Koom, Woong Sub] Yonsei Univ, Coll Med, Yonsei Song Dang Inst Canc Res, Seoul, South Korea	Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Park, SJ (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	SJPARK@yuhs.ac; mdgold@yuhs.ac	; Lee, Joo Yong/C-3851-2013	Chang, Jee Suk/0000-0001-7685-3382; Yoon, Hong In/0000-0002-2106-6856; Lee, Joo Yong/0000-0002-3470-1767; Koom, Woong Sub/0000-0002-9435-7750				Ahmad R, 2008, RADIOTHER ONCOL, V89, P172, DOI 10.1016/j.radonc.2008.07.005; [Anonymous], 1985, NEW ENGL J MED, V312, P1465; Chang JS, 2013, RADIAT ONCOL J, V31, P41, DOI 10.3857/roj.2013.31.1.41; Chung Y, 2013, ONKOLOGIE, V36, P241, DOI 10.1159/000350299; Doherty UM, 2006, RADIOTHER ONCOL, V79, P335, DOI 10.1016/j.radonc.2006.05.007; Drzymala M, 2009, BRIT J RADIOL, V82, P321, DOI 10.1259/bjr/57848689; Fiorino C, 2005, RADIOTHER ONCOL, V74, P187, DOI 10.1016/j.radonc.2004.10.002; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; Gray R, 2001, LANCET, V358, P1291; Hynds S, 2011, BRIT J RADIOL, V84, P813, DOI 10.1259/bjr/50048151; Kavanagh BD, 2010, INT J RADIAT ONCOL, V76, pS101, DOI 10.1016/j.ijrobp.2009.05.071; KROOK JE, 1991, NEW ENGL J MED, V324, P709, DOI 10.1056/NEJM199103143241101; Navarro M, 2006, INT J RADIAT ONCOL, V66, P201, DOI 10.1016/j.ijrobp.2006.04.007; Nijkamp J, 2012, RADIOTHER ONCOL, V102, P22, DOI 10.1016/j.radonc.2011.05.076; Roh MS, 2009, J CLIN ONCOL, V27, P5124, DOI 10.1200/JCO.2009.22.0467; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Sauer R, 2012, J CLIN ONCOL, V30, P1926, DOI 10.1200/JCO.2011.40.1836; Sebag-Montefiore D, 2009, LANCET, V373, P811, DOI 10.1016/S0140-6736(09)60484-0; Stam MR, 2006, INT J RADIAT ONCOL, V65, P371, DOI 10.1016/j.ijrobp.2005.12.039	19	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128791	10.1371/journal.pone.0128791	http://dx.doi.org/10.1371/journal.pone.0128791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039198	Green Published, gold			2022-12-27	WOS:000355700700121
J	Wang, C; Li, YF; Gao, SC; Cheng, DX; Zhao, SH; Liu, EQ				Wang, Chuan; Li, Yafeng; Gao, Shoucui; Cheng, Daxin; Zhao, Sihai; Liu, Enqi			Breviscapine Injection Improves the Therapeutic Effect of Western Medicine on Angina Pectoris Patients	PLOS ONE			English	Article							CORONARY-HEART-DISEASE	To evaluate the beneficial and adverse effects of breviscapine injection in combination with Western medicine on the treatment of patients with angina pectoris. The Cochrane Central Register of Controlled Trials, Medline, Science Citation Index, EMBASE, the China National Knowledge Infrastructure, the Wanfang Database, the Chongqing VIP Information Database and the China Biomedical Database were searched to identify randomized clinical trials (RCTs) that evaluated the effects of Western medicine compared to breviscapine injection plus Western medicine on angina pectoris patients. The included studies were analyzed using RevMan 5.1.0 software. The literature search yielded 460 studies, wherein 16 studies matched the selection criteria. The results showed that combined therapy using Breviscapine plus Western medicine was superior to Western medicine alone for improving angina pectoris symptoms (OR = 3.77, 95% Cl: 2.76 similar to 5.15) and also resulted in increased electrocardiogram (ECG) improvement (OR = 2.77, 95% Cl: 2.16 similar to 3.53). The current evidence suggests that Breviscapine plus Western medicine achieved a superior therapeutic effect compared to Western medicine alone.	[Wang, Chuan; Li, Yafeng; Gao, Shoucui; Cheng, Daxin; Zhao, Sihai; Liu, Enqi] Xi An Jiao Tong Univ, Cardiovasc Res Ctr, Res Inst Atherosclerot Dis, Xian, Shaanxi, Peoples R China; [Wang, Chuan] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Pathol, Kofu, Yamanashi, Japan; [Cheng, Daxin] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 3, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; University of Yamanashi; Xi'an Jiaotong University	Zhao, SH (corresponding author), Xi An Jiao Tong Univ, Cardiovasc Res Ctr, Res Inst Atherosclerot Dis, Xian, Shaanxi, Peoples R China.	sihaizhao@mail.xjtu.edu.cn; liuenqi@mail.xjtu.edu.cn	liu, enqi/S-7771-2019; Wang, Chuan/AAK-3148-2020	Zhao, Sihai/0000-0002-5845-6639; Wang, Chuan/0000-0002-8016-0113; Liu, Enqi/0000-0002-2092-3158	National Natural Science Foundation of China [81370379]; Fundamental Research Funds for the Central Universities; Natural Science Foundation of Shaanxi Province [2012KJXX-07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province)	This work was supported in part by the National Natural Science Foundation of China (No. 81370379), the Fundamental Research Funds for the Central Universities and the Natural Science Foundation of Shaanxi Province (2012KJXX-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1979, Circulation, V59, P607; [崔建梅 Cui Jianmei], 2003, [天然产物研究与开发, Natural Product R & D], V15, P255; Deng K, 2009, J ANHUI TRADITIONAL, V29, P14; FLAHERTY JT, 1984, AM J MED, V76, P52, DOI 10.1016/0002-9343(84)91043-X; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hemingway H, 2003, BRIT MED J, V327, P895, DOI 10.1136/bmj.327.7420.895; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hu S, 2011, J NEW MED, V21, P283; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Li HP, 2011, CHINESE J CLIN RES, V24, P944; Liang T, 2010, HENAN TRADITIONAL CH, V30, P998; Lin LL, 2007, J CARDIOVASC PHARM, V50, P327, DOI 10.1097/FJC.0b013e3180cbd0e7; Lu YJ, 2010, CLIN J CHINESE MED, V2, P30; Meng LC, 2010, GUIDING J TRADITIONA, V21, P283; Ministry of Health P, 2004, CHIN HLTH STAT YB; Peng Dayan GY., 2011, J HUBEI COLL TRADIT, V13, P15; PSATY BM, 1990, JAMA-J AM MED ASSOC, V263, P1653, DOI 10.1001/jama.263.12.1653; Ren YP, 2014, CHINESE MED J-PEKING, V127, P2991, DOI 10.3760/cma.j.issn.0366-6999.20140036; Saydah SH, 2006, J ALTERN COMPLEM MED, V12, P805, DOI 10.1089/acm.2006.12.805; Shao ZB, 2009, CLIN J TRADITIONAL C, V21, P119; Shi SH, 2011, QINDAO MED J, V43, P282; Tan ZH, 2009, CHINESE J ETHNOMEDIC, V18, P65; Wang Jin, 2006, ZHEJIANG SPORT SCIEN, V28, P41; Wang M, 2008, AM J CHINESE MED, V36, P1199, DOI 10.1142/S0192415X08006521; Wang M, 2010, ACTA DIABETOL, V47, pS209, DOI 10.1007/s00592-009-0164-x; Yan L, 2010, J CELL BIOCHEM, V109, P1158, DOI 10.1002/jcb.22495; Yu HW, 2001, J INFORM TRADITIONAL, V8, P68; Zhang QM, 2012, TIANJIN J TRADITIONA, V29, P133; Zhang XD, 2011, GUIDE CHINA MED, V19, P280; Zhao J.G., 2010, CHIN J INTEGR MED CA, V8, P396, DOI [10.3969/j.issn.1672-1349.2010.04.008, DOI 10.3969/J.ISSN.1672-1349.2010.04.008]; Zhao SH, 2011, ANTIVIR RES, V89, P156, DOI 10.1016/j.antiviral.2010.12.003; Zhou BX, 2007, MED WORLD, V8, P91	32	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129969	10.1371/journal.pone.0129969	http://dx.doi.org/10.1371/journal.pone.0129969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052709	Green Published, gold, Green Submitted			2022-12-27	WOS:000355955300173
J	Buse, J; Fassbender, S; Entling, MH; Pavlicek, T				Buse, Joern; Fassbender, Samuel; Entling, Martin H.; Pavlicek, Tomas			Microclimatic Divergence in a Mediterranean Canyon Affects Richness, Composition, and Body Size in Saproxylic Beetle Assemblages	PLOS ONE			English	Article							LOWER NAHAL-OREN; EVOLUTION-CANYON; CLIMATE-CHANGE; SPECIES-RICHNESS; MOUNT-CARMEL; INTERSLOPE DIVERGENCE; LATITUDINAL GRADIENTS; FOREST COMPOSITION; INSECT HERBIVORES; MT. CARMEL	Large valleys with opposing slopes may act as a model system with which the effects of strong climatic gradients on biodiversity can be evaluated. The advantage of such comparisons is that the impact of a change of climate can be studied on the same species pool without the need to consider regional differences. The aim of this study was to compare the assemblage of saproxylic beetles on such opposing slopes at Lower Nahal Oren, Mt. Carmel, Israel (also known as "Evolution Canyon") with a 200-800% higher solar radiation on the south-facing (SFS) compared to the north-facing slope (NFS). We tested specific hypotheses of species richness patterns, assemblage structure, and body size resulting from interslope differences in microclimate. Fifteen flight-interception traps per slope were distributed over three elevation levels ranging from 50 to 100 m a.s.l. Richness of saproxylic beetles was on average 34% higher on the SFS compared with the NFS, with no detected influence of elevation levels. Both assemblage structure and average body size were determined by slope aspect, with more small-bodied beetles found on the SFS. Both the increase in species richness and the higher prevalence of small species on the SFS reflect ecological rules present on larger spatial grain (species-energy hypothesis and community body size shift hypothesis), and both can be explained by the metabolic theory of ecology. This is encouraging for the complementary use of micro-and macroclimatic gradients to study impacts of climate warming on biodiversity.	[Buse, Joern; Fassbender, Samuel; Entling, Martin H.] Univ Koblenz Landau, Inst Environm Sci, Ecosyst Anal, Landau, Germany; [Pavlicek, Tomas] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel	University of Koblenz & Landau; University of Haifa	Buse, J (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Ecosyst Anal, Frt Str 7, Landau, Germany.	joernbuse@gmx.de	Buse, Joern/G-6588-2015; Entling, Martin H/C-6953-2008; Pavlicek, Tomas/C-4768-2008	Buse, Joern/0000-0001-8226-1893; 				Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderegg WRL, 2012, CONSERV BIOL, V26, P1082, DOI 10.1111/j.1523-1739.2012.01913.x; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Bassler C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065842; Bassler C, 2010, ECOL INDIC, V10, P341, DOI 10.1016/j.ecolind.2009.06.014; Baselga A, 2008, ECOGRAPHY, V31, P263, DOI 10.1111/j.0906-7590.2008.5335.x; Basset Y, 2001, J APPL ECOL, V38, P1045, DOI 10.1046/j.1365-2664.2001.00660.x; Blackburn Tim M., 1999, Diversity and Distributions, V5, P165, DOI 10.1046/j.1472-4642.1999.00046.x; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Buse J, 2008, CONSERV BIOL, V22, P329, DOI 10.1111/j.1523-1739.2007.00880.x; Buse J, 2013, INSECT CONSERV DIVER, V6, P687, DOI 10.1111/icad.12023; Buse J, 2013, BIODIVERS CONSERV, V22, P1115, DOI 10.1007/s10531-012-0395-y; Chikatunov V, 2000, BIOL J LINN SOC, V69, P139, DOI 10.1006/bijl.1999.0322; Chikatunov V, 1997, J ARID ENVIRON, V37, P367, DOI 10.1006/jare.1997.0278; Chow E. D., 2007, ELLIPSE FUNCTIONS DR; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; Clark JS, 2011, GLOBAL CHANGE BIOL, V17, P1834, DOI 10.1111/j.1365-2486.2010.02380.x; Colwell RK, 2013, DIVERS DISTRIB, V14, P1; Cudmore TJ, 2010, J APPL ECOL, V47, P1036, DOI 10.1111/j.1365-2664.2010.01848.x; CUSHMAN JH, 1993, OECOLOGIA, V95, P30, DOI 10.1007/BF00649503; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Entling MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045875; Entling W, 2010, J BIOGEOGR, V37, P477, DOI 10.1111/j.1365-2699.2009.02216.x; Evans JP, 2009, CLIMATIC CHANGE, V92, P417, DOI 10.1007/s10584-008-9438-5; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Graham JH, 2010, SYMMETRY-BASEL, V2, P466, DOI 10.3390/sym2020466; Grove SJ, 2002, ANNU REV ECOL SYST, V33, P1, DOI 10.1146/annurev.ecolsys.33.010802.150507; HAWKINS BA, 1995, OECOLOGIA, V102, P31, DOI 10.1007/BF00333307; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Horak J, 2014, FOREST ECOL MANAG, V315, P80, DOI 10.1016/j.foreco.2013.12.018; Hyvarinen E, 2006, EUR J ENTOMOL, V103, P397, DOI 10.14411/eje.2006.054; Kaniewski D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102090; Keena MA, 2006, ENVIRON ENTOMOL, V35, P912, DOI 10.1603/0046-225X-35.4.912; Koricheva J, 1998, ANNU REV ENTOMOL, V43, P195, DOI 10.1146/annurev.ento.43.1.195; Krams I, 2012, FOREST ECOL MANAG, V270, P147, DOI 10.1016/j.foreco.2012.01.012; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Melamud V, 2007, ACTA ZOOL ACAD SCI H, V53, P381; MENDEL Z, 1983, PHYTOPARASITICA, V11, P13, DOI 10.1007/BF02980707; Millien V, 2006, ECOL LETT, V9, P853, DOI 10.1111/j.1461-0248.2006.00928.x; Muller J, ECOGRAPHY IN PRESS, V37; Netherer S, 2010, FOREST ECOL MANAG, V259, P831, DOI 10.1016/j.foreco.2009.07.034; Nevo E, 1999, ISR J PLANT SCI, V47, P49, DOI 10.1080/07929978.1999.10676751; Nevo E, 1996, ISR J ZOOL, V42, P395; Nevo E, 2012, P NATL ACAD SCI USA, V109, P2960, DOI 10.1073/pnas.1120633109; Nevo E, 2011, GENOME BIOL EVOL, V3, P1039, DOI 10.1093/gbe/evr052; Newbold T, 2009, J BIOGEOGR, V36, P2085, DOI 10.1111/j.1365-2699.2009.02140.x; Novotny V, 2010, J ANIM ECOL, V79, P1193, DOI 10.1111/j.1365-2656.2010.01728.x; Nuche P, 2014, ECOL INDIC, V40, P68, DOI 10.1016/j.ecolind.2013.12.023; Oksanen J., 2016, R PACKAG; Oliver I, 1996, CONSERV BIOL, V10, P99, DOI 10.1046/j.1523-1739.1996.10010099.x; Palm T, 1959, HOLZ RINDENKAFER SUD; Pavlicek T, 2008, BIOL J LINN SOC, V93, P147; Pavlicek Tomas, 2003, Israel Journal of Earth Sciences, V52, P1, DOI 10.1560/QD0A-9T22-4FGL-FGH6; Pavlicek Tomas, 2008, Ecologia Mediterranea, V34, P25; R-Core-Development-Team, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; Ramirez-Hernandez A, 2014, BIODIVERS CONSERV, V23, P2069, DOI 10.1007/s10531-014-0705-7; Raz S, 2011, BIOL J LINN SOC, V102, P876; Raz S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005214; Reitalu T, 2013, J BIOGEOGR, V40, P1524, DOI 10.1111/jbi.12092; Roberts D.W., 2010, LABDSV ORDINATION MU; Rouault G, 2006, ANN FOREST SCI, V63, P613, DOI 10.1051/forest:2006044; Ruiz-Labourdette D, 2012, J BIOGEOGR, V39, P162, DOI 10.1111/j.1365-2699.2011.02592.x; Schmidl Juergen, 2004, Naturschutz und Landschaftsplanung, V36, P202; Schuldt A, 2009, ECOGRAPHY, V32, P1; Shepherd BL, 2008, J INSECT PHYSIOL, V54, P604, DOI 10.1016/j.jinsphys.2007.12.007; Stokland J.N., 2012, BIODIVERSITY DEAD WO; Sverdrup-Thygeson A, 2009, J INSECT CONSERV, V13, P183, DOI 10.1007/s10841-008-9141-x; Venables WN., 2002, MODERN APPL STAT S 4; Vodka S, 2009, J INSECT CONSERV, V13, P553, DOI 10.1007/s10841-008-9202-1; Volney WJA, 2000, AGR ECOSYST ENVIRON, V82, P283, DOI 10.1016/S0167-8809(00)00232-2; Walczynska A, 2012, B ENTOMOL RES, V102, P644, DOI 10.1017/S0007485312000296; WHITE T C R, 1969, Ecology (Washington D C), V50, P905, DOI 10.2307/1933707; Widerberg MK, 2012, BIODIVERS CONSERV, V21, P3035, DOI 10.1007/s10531-012-0353-8; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109	80	4	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129323	10.1371/journal.pone.0129323	http://dx.doi.org/10.1371/journal.pone.0129323			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047491	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200151
J	Dadheech, N; Srivastava, A; Paranjape, N; Gupta, S; Dave, A; Shah, GM; Bhonde, RR; Gupta, S				Dadheech, Nidheesh; Srivastava, Abhay; Paranjape, Neha; Gupta, Shivika; Dave, Arpita; Shah, Girish M.; Bhonde, Ramesh R.; Gupta, Sarita			Swertisin an Anti-Diabetic Compound Facilitate Islet Neogenesis from Pancreatic Stem/Progenitor Cells via p-38 MAP Kinase-SMAD Pathway: An In-Vitro and In-Vivo Study	PLOS ONE			English	Article							ENICOSTEMMA-LITTORALE BLUME; AQUEOUS EXTRACT; BETA-CELLS; STEM-CELLS; ACTIVIN-A; DIFFERENTIATION; EXPRESSION; INSULIN; IDENTIFICATION; CARCINOMA	Transplanting islets serves best option for restoring lost beta cell mass and function. Small bio-chemical agents do have the potential to generate new islets mass, however lack of understanding about mechanistic action of these small molecules eventually restricts their use in cell-based therapies for diabetes. We recently reported "Swertisin" as a novel islet differentiation inducer, generating new beta cells mass more effectively. Henceforth, in the present study we attempted to investigate the molecular signals that Swertisin generate for promoting differentiation of pancreatic progenitors into islet cells. To begin with, both human pancreatic progenitors (PANC-1 cells) and primary cultured mouse intra-islet progenitor cells (mIPC) were used and tested for Swertisin induced islet neogenesis mechanism, by monitoring immunoblot profile of key transcription factors in time dependent manner. We observed Swertisin follow Activin-A mediated MEPK-TKK pathway involving role of p38 MAPK via activating Neurogenin-3 (Ngn-3) and Smad Proteins cascade. This MAP Kinase intervention in differentiation of cells was confirmed using strong pharmacological inhibitor of p38 MAPK (SB203580), which effectively abrogated this process. We further confirmed this mechanism in-vivo in partial pancreatectomised (PPx) mice model, where we could show Swertisin exerted potential increase in insulin transcript levels with persistent down-regulation of progenitor markers like Nestin, Ngn-3 and Pancreatic Duodenal Homeobox Gene-1 (PDX-1) expression, within three days post PPx. With detailed molecular investigations here in, we first time report the molecular mode of action of Swertisin for islet neogenesis mediated through MAP Kinase (MEPK-TKK) pathway involving Ngn-3 and Smad transcriptional regulation. These findings held importance for developing Swertisin as potent pharmacological drug candidate for effective and endogenous differentiation of islets in cell based therapy for diabetes.	[Dadheech, Nidheesh; Srivastava, Abhay; Dave, Arpita; Gupta, Sarita] Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Biochem, Mol Endocrinol & Stem Cell Res Lab, Vadodara, Gujarat, India; [Paranjape, Neha; Gupta, Shivika] Hislope Coll Biotechnol, Nagpur, Maharashtra, India; [Shah, Girish M.] Univ Laval, CHUQ, CHUL, Skin Canc Res Lab,Ctr Rech, Quebec City, PQ, Canada; [Bhonde, Ramesh R.] Manipal Hosp, Manipal Hosp & Regenerat Med Ctr, Manipal, Karnataka, India	Maharaja Sayajirao University Baroda; Laval University; Manipal Academy of Higher Education (MAHE)	Gupta, S (corresponding author), Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Biochem, Mol Endocrinol & Stem Cell Res Lab, Vadodara, Gujarat, India.	saritagupta9@gmail.com	Dadheech, Nidheesh/E-3142-2017	Dadheech, Nidheesh/0000-0002-7155-0486; Shah, Girish/0000-0002-9291-1164	Department of Biotechnology, Government of India, New Delhi, India [BT/TR-7721/MED/14/1071/2006, BT/PR3564/BRB/10/975/2011]; DBT-MSUB-ILSPARE programme [BT/PR14551/INF/22/122/2010]; Natural Sciences and Engineering Research Council of Canada [155257-2011]; Department of Biotechnology-HRD, MST Government of India, New Delhi, India; Canadian Government; Canadian Commonwealth Scholarship Program; India Studies Faculty Research Fellowship Award from Shastri Indo-Canadian Institute	Department of Biotechnology, Government of India, New Delhi, India(Department of Biotechnology (DBT) India); DBT-MSUB-ILSPARE programme; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Department of Biotechnology-HRD, MST Government of India, New Delhi, India; Canadian Government; Canadian Commonwealth Scholarship Program; India Studies Faculty Research Fellowship Award from Shastri Indo-Canadian Institute	The authors acknowledge the Department of Biotechnology, Government of India, New Delhi, India, for funding the project (grant no. BT/TR-7721/MED/14/1071/2006 and grant no. BT/PR3564/BRB/10/975/2011) and for establishing central instrumental facility for confocal microscopy at Maharaja Sayajirao University, Baroda, India under DBT-MSUB-ILSPARE programme (Grant no. BT/PR14551/INF/22/122/2010). The work carried out at Laval University was supported by the Discovery grant # 155257-2011 to Dr. Girish Shah from the Natural Sciences and Engineering Research Council of Canada. The authors also thank Department of Biotechnology-HRD, MST Government of India, New Delhi, India, for proving financial grant, and the Canadian Government for financially supporting Dr. Nidheesh Dadheech with Canadian Commonwealth Scholarship Program to carry out some part of study under the supervision of Dr. GM Shah, in Laval University, Quebec, Canada. Dr. GM Shah was recipient of the India Studies Faculty Research Fellowship Award from the Shastri Indo-Canadian Institute for his work in India and Canada on this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeyens L, 2006, CELL DEATH DIFFER, V13, P1892, DOI 10.1038/sj.cdd.4401883; Bonal C, 2008, BIOCHEM SOC T, V36, P286, DOI 10.1042/BST0360286; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Brown ML, 2010, TRENDS ENDOCRIN MET, V21, P441, DOI 10.1016/j.tem.2010.02.008; Dalvi MP, 2009, J BIOSCIENCES, V34, P523, DOI 10.1007/s12038-009-0071-x; Demeterco C, 2000, J CLIN ENDOCR METAB, V85, P3892, DOI 10.1210/jc.85.10.3892; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Granger A, 2009, J INTERN MED, V266, P325, DOI 10.1111/j.1365-2796.2009.02156.x; Hardikar AA, 2003, P NATL ACAD SCI USA, V100, P7117, DOI 10.1073/pnas.1232230100; Ilieva A, 1999, J ENDOCRINOL, V161, P357, DOI 10.1677/joe.0.1610357; Kim SK, 2002, CURR OPIN GENET DEV, V12, P540, DOI 10.1016/S0959-437X(02)00338-6; Kojima I, 2006, INT J BIOCHEM CELL B, V38, P923, DOI 10.1016/j.biocel.2005.09.019; Kojima I, 1997, SER S US, P189; Lardon J, 2002, HISTOCHEM CELL BIOL, V117, P535, DOI 10.1007/s00418-002-0412-4; Lee SH, 2011, ISLETS, V3, P188, DOI 10.4161/isl.3.4.16338; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Maroo J, 2003, PHYTOMEDICINE, V10, P196, DOI 10.1078/094471103321659933; Maroo J, 2002, J ETHNOPHARMACOL, V81, P317, DOI 10.1016/S0378-8741(02)00095-8; Misfeldt AA, 2008, DIABETES, V57, P3069, DOI 10.2337/db08-0878; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Nidheesh D, 2013, EVIDENCE BASED COMPL; Ogihara T, 2003, J BIOL CHEM, V278, P21693, DOI 10.1074/jbc.M302684200; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Penny C, 2002, CELL BIOL INT, V26, P1057, DOI 10.1006/cbir.2002.0965; Pittenger GL, 2009, DIABETOLOGIA, V52, P735, DOI 10.1007/s00125-009-1322-y; Sarita Gupta, 2010, International Journal of Integrative Biology, V9, P49; Selander L, 2002, MECH DEVELOP, V113, P189, DOI 10.1016/S0925-4773(02)00023-0; Soria B, 2001, DIABETOLOGIA, V44, P407, DOI 10.1007/s001250051636; Stratta RJ, 1999, ANN SURG, V229, P701, DOI 10.1097/00000658-199905000-00013; Swift GH, 1998, MOL CELL BIOL, V18, P5109, DOI 10.1128/MCB.18.9.5109; Tsuchida K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-15; Umezawa K, 2003, BIOMED PHARMACOTHER, V57, P341, DOI 10.1016/S0753-3322(03)00096-9; Uzan B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004734; Vasu VT, 2005, J ETHNOPHARMACOL, V101, P277, DOI 10.1016/j.jep.2005.05.007; Wu YX, 2010, LAB INVEST, V90, P1373, DOI 10.1038/labinvest.2010.106; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhang YQ, 2005, J CELL MOL MED, V9, P331, DOI 10.1111/j.1582-4934.2005.tb00359.x; Zhang YQ, 2003, DIABETES-METAB RES, V19, P363, DOI 10.1002/dmrr.406; Zhang YQ, 2002, ENDOCRINOLOGY, V143, P3540, DOI 10.1210/en.2002-220089; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	41	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128244	10.1371/journal.pone.0128244	http://dx.doi.org/10.1371/journal.pone.0128244			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047129	gold, Green Published, Green Submitted			2022-12-27	WOS:000355652200049
J	Hargrove, JS; Weyl, OLF; Allen, MS; Deacon, NR				Hargrove, John S.; Weyl, Olaf L. F.; Allen, Micheal S.; Deacon, Neil R.			Using Tournament Angler Data to Rapidly Assess the Invasion Status of Alien Sport Fishes (Micropterus spp.) in Southern Africa	PLOS ONE			English	Article							FRESH-WATER FISH; INTRODUCTIONS; BIODIVERSITY; MANAGEMENT; CONFLICTS; IMPACT; RISK	Fishes are one of the most commonly introduced aquatic taxa worldwide, and invasive fish species pose threats to biodiversity and ecosystem function in recipient waters. Considerable research efforts have focused on predicting the invasibility of different fish taxa; however, accurate records detailing the establishment and spread of invasive fishes are lacking for large numbers of fish around the globe. In response to these data limitations, a low-cost method of cataloging and quantifying the temporal and spatial status of fish invasions was explored. Specifically, angler catch data derived from competitive bass angling tournaments was used to document the distribution of 66 non-native populations of black bass (Micropterus spp.) in southern Africa. Additionally, catch data from standardized tournament events were used to assess the abundance and growth of non-native bass populations in southern Africa relative to their native distribution (southern and eastern United States). Differences in metrics of catch per unit effort (average number of fish retained per angler per day), daily bag weights (the average weight of fish retained per angler), and average fish weight were assessed using catch data from 14,890 angler days of tournament fishing (11,045 days from South Africa and Zimbabwe; 3,845 days from the United States). No significant differences were found between catch rates, average daily bag weight, or the average fish weight between countries, suggesting that bass populations in southern Africa reach comparable sizes and numbers relative to waters in their native distribution. Given the minimal cost associated with data collection (i.e. records are collected by tournament organizers), the standardized nature of the events, and consistent bias (i.e. selection for the biggest fish in a population), the use of angler catch data represents a novel approach to infer the status and distribution of invasive sport fish.	[Hargrove, John S.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA; [Weyl, Olaf L. F.; Deacon, Neil R.] South African Inst Aquat Biodivers, Grahamstown, South Africa; [Weyl, Olaf L. F.] SAIAB, Ctr Invas Biol, Grahamstown, South Africa; [Allen, Micheal S.] Univ Florida, Fisheries & Aquat Sci Program, Gainesville, FL USA	State University System of Florida; University of Florida; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; State University System of Florida; University of Florida	Hargrove, JS (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA.	tractor@ufl.edu; O.Weyl@saiab.ac.za		Hargrove, John/0000-0002-8643-7822; Weyl, Olaf/0000-0002-8935-3296	Institute of Food and Agricultural Sciences, University of Florida; National Research Foundation (N.R.F.); DST/NRF Centre of Excellence in Invasion Biology (CIB)	Institute of Food and Agricultural Sciences, University of Florida(University of Florida); National Research Foundation (N.R.F.); DST/NRF Centre of Excellence in Invasion Biology (CIB)	Financial support for JSH was provided by a graduate assistantship from the Institute of Food and Agricultural Sciences, University of Florida. The National Research Foundation (N.R.F.) and DST/NRF Centre of Excellence in Invasion Biology (CIB) contributed significantly to funding this research.	Beamesderfer Raymond C. P., 1995, North American Journal of Fisheries Management, V15, P688, DOI 10.1577/1548-8675(1995)015<0688:GNMAPR>2.3.CO;2; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Bonar SA, 2009, STANDARD METHODS FOR SAMPLING NORTH AMERICAN FRESHWATER FISHES, P1; Britton JR, 2011, FISH FISH, V12, P256, DOI 10.1111/j.1467-2979.2010.00390.x; Cambray JA, 2003, HYDROBIOLOGIA, V500, P217, DOI 10.1023/A:1024648719995; Carlander KD, 1977, HDB FRESHWATER FISH, V2; Casal CMV, 2006, BIOL INVASIONS, V8, P3, DOI 10.1007/s10530-005-0231-3; Clarkson RW, 2005, FISHERIES, V30, P20, DOI 10.1577/1548-8446(2005)30[20:CBNFAN]2.0.CO;2; DOLMAN W B, 1991, North American Journal of Fisheries Management, V11, P177, DOI 10.1577/1548-8675(1991)011<0177:COBCTR>2.3.CO;2; Driscoll M. Todd, 2012, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V66, P25; Ebbers M.A., 1987, North American Journal of Fisheries Management, V76, P252; Ellender BR, 2014, J FISH BIOL, V85, P1890, DOI 10.1111/jfb.12512; Ellender BR, 2014, AQUAT INVASIONS, V9, P117, DOI 10.3391/ai.2014.9.2.01; Farman R.S., 1982, North American Journal of Fisheries Management, V2, P249, DOI 10.1577/1548-8659(1982)2<249:ELBAUC>2.0.CO;2; GABELHOUSE D W JR, 1986, North American Journal of Fisheries Management, V6, P481, DOI 10.1577/1548-8659(1986)6<481:BAUOAC>2.0.CO;2; Garcia-Berthou E, 2007, J FISH BIOL, V71, P33, DOI 10.1111/j.1095-8649.2007.01668.x; Garcia-Berthou E, 2005, CAN J FISH AQUAT SCI, V62, P453, DOI 10.1139/F05-017; Gozlan RE, 2008, FISH FISH, V9, P106, DOI 10.1111/j.1467-2979.2007.00267.x; Hunt LM, 2011, ECOL APPL, V21, P2555, DOI 10.1890/10-1237.1; Jackson DA, 2002, AM FISH S S, V31, P221; Jackson ZJ, 2008, FISHERIES MANAG ECOL, V15, P107, DOI 10.1111/j.1365-2400.2007.00591.x; Jones JPG, 2011, J APPL ECOL, V48, P9, DOI 10.1111/j.1365-2664.2010.01917.x; Kolar CS, 2002, SCIENCE, V298, P1233, DOI 10.1126/science.1075753; Lundberg JG, 2000, ANN MO BOT GARD, V87, P26, DOI 10.2307/2666207; Maceina Michael J., 1998, North American Journal of Fisheries Management, V18, P998, DOI 10.1577/1548-8675(1998)018<0998:VILBRI>2.0.CO;2; Marchetti MP, 2004, ECOL APPL, V14, P587, DOI 10.1890/02-5301; Matthias BG, 2014, FISHERIES, V39, P261, DOI 10.1080/03632415.2014.903836; McCafferty JR, 2012, WATER SA, V38, P327, DOI 10.4314/wsa.v38i2.18; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Noble RL, 2002, AM FISH S S, V31, P419; Olson D.E., 1989, North American Journal of Fisheries Management, V9, P287, DOI 10.1577/1548-8675(1989)009<0287:SFTSBA>2.3.CO;2; Pita P, 2014, FISHERIES MANAG ECOL, V21, P454, DOI 10.1111/fme.12095; Pope KL, 2010, INLAND FISHERIES MANAGEMENT IN NORTH AMERICA, THIRD EDITION, P325; Post JR, 2008, ECOL APPL, V18, P1038, DOI 10.1890/07-0465.1; Powell KI, 2011, AM J BOT, V98, P539, DOI 10.3732/ajb.1000402; Quinn S., 2009, CENTRARCHID FISHES D, P312; R Core Team, 2021, R LANGUAGE ENV STAT; Ricciardi A, 1998, CAN J FISH AQUAT SCI, V55, P1759, DOI 10.1139/cjfas-55-7-1759; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Robbins W.H., 1974, BLACKBASS AM OVERSEA; Ruesink JL, 2005, CONSERV BIOL, V19, P1883, DOI 10.1111/j.1523-1739.2005.00267.x-i1; Schramm HL, 2007, FISHERIES, V32, P234, DOI 10.1577/1548-8446(2007)32[234:IBAPAW]2.0.CO;2; SCHRAMM HL, 1991, FISHERIES, V16, P4, DOI 10.1577/1548-8446(1991)016<0004:TSOCSF>2.0.CO;2; Scott L. E. P., 2006, Smithiana Monograph, P1; Taylor GC, 2015, FISH RES, V162, P37, DOI 10.1016/j.fishres.2014.09.014; US Department of the Interior US Fish and Wildlife Service and US Department of Commerce US Census Bureau, 2011, NAT SURV FISH HUNT W; van Rensburg BJ, 2011, BIOLOGICAL INVASIONS: ECONOMIC AND ENVIRONMENTAL COSTS OF ALIEN PLANT, ANIMAL, AND MICROBE SPECIES, 2ND EDITION, P325; Welcomme RL, 1988, 294 FAO, P328; Wilde Gene R., 1998, North American Journal of Fisheries Management, V18, P972, DOI 10.1577/1548-8675(1998)018&lt;0972:COTBBF&gt;2.0.CO;2; Williamson M., 1996, BIOL INVASIONS, P15; WILLIS DW, 1986, FISHERIES, V11, P7, DOI 10.1577/1548-8446(1986)011<0007:TKBBTM>2.0.CO;2; Winker H, 2011, MAR FRESHWATER RES, V62, P1270, DOI 10.1071/MF11054	52	26	27	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0130056	10.1371/journal.pone.0130056	http://dx.doi.org/10.1371/journal.pone.0130056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047487	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200171
J	Harrington, JR; Boski, P; Gelfand, MJ				Harrington, Jesse R.; Boski, Pawel; Gelfand, Michele J.			Culture and National Well-Being: Should Societies Emphasize Freedom or Constraint?	PLOS ONE			English	Article							VALUES	Throughout history and within numerous disciplines, there exists a perennial debate about how societies should best be organized. Should they emphasize individual freedom and autonomy or security and constraint? Contrary to proponents who tout the benefits of one over the other, we demonstrate across 32 nations that both freedom and constraint exhibit a curvilinear relationship with many indicators of societal well-being. Relative to moderate nations, very permissive and very constrained nations exhibit worse psychosocial outcomes (lower happiness, greater dysthymia, higher suicide rates), worse health outcomes (lower life expectancy, greater mortality rates from cardiovascular disease and diabetes) and poorer economic and political outcomes (lower gross domestic product per capita, greater risk for political instability). This supports the notion that a balance between freedom and constraint results in the best national outcomes. Accordingly, it is time to shift the debate away from either constraint or freedom and focus on both in moderation.	[Harrington, Jesse R.; Gelfand, Michele J.] Univ Maryland, College Pk, MD 20742 USA; [Boski, Pawel] Univ Social Sci & Humanities, Warsaw, Poland	University System of Maryland; University of Maryland College Park; SWPS University of Social Sciences & Humanities	Harrington, JR (corresponding author), Univ Maryland, College Pk, MD 20742 USA.	jesserh@umd.edu; mgelfand@umd.edu			US Army Research Laboratory; US Army Research Office [W911NF-08-1- 0144]; U.S. Airforce grant [FA955-01-41-0020]; National Science Foundation (NSF) Graduate Research Fellowship [DGE 1322106]; National Science Foundation [SMA-1416651]; Direct For Social, Behav & Economic Scie [1416651] Funding Source: National Science Foundation	US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); US Army Research Office; U.S. Airforce grant; National Science Foundation (NSF) Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was supported in part by the US Army Research Laboratory and the US Army Research Office (http://www.arl.army.mil/www/default.cfm) under Grant W911NF-08-1-0144, U.S. Airforce grant FA955-01-41-0020, a National Science Foundation (NSF) Graduate Research Fellowship under Grant DGE 1322106 (http://www.nsf.gov/), and by the National Science Foundation under Grant Number SMA-1416651. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the Department of Defense or the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ashton MC, 1999, PERS SOC PSYCHOL B, V25, P225, DOI 10.1177/0146167299025002008; Central Intelligence Agency, 2013, GDP PER CAP DAT FIL; Central Intelligence Agency, DISTR FAM INC DAT FI; Central Intelligence Agency, 2013, LIF EXP BIRTH DAT FI; Church AT, 2013, J CROSS CULT PSYCHOL, V44, P507, DOI 10.1177/0022022112466590; Durkheim E., 1951, SUICIDE STUDY SOCIOL, DOI 10.2307/2088294; Etzioni A., 1996, NEW GOLDEN RULE COMM; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Fiske ST, 2003, ONT SYMP P, V9, P233; Fromm Erich, 1941, ESCAPE FREEDOM; Fujihara K, 2012, EXP CLIN ENDOCR DIAB, V120, P560, DOI 10.1055/s-0032-1314873; Gelfand MJ, 2013, J APPL PSYCHOL, V98, P504, DOI 10.1037/a0031908; Gelfand MJ, 2011, SCIENCE, V332, P1100, DOI 10.1126/science.1197754; Hayek F. A., 2011, CONSTITUTION LIBERTY; Hoppe H.H., 2001, DEMOCRACY GOD FAILED; Jussim L, 1995, WHY STUDY STEREOTYPE, P3; Jussim L., 2012, SOCIAL PERCEPTION SO, DOI 10.1093/acprof:oso/9780195366600.003.0074; Jussim L, 1995, ARE TEACHER EXPECTAT, P245; Medrano JD, MAP OF HAPPINESS; Mill J.S., 1869, LIBERTY; Mises Lv, 2012, LIBERALISM; Peng KP, 1997, PSYCHOL METHODS, V2, P329, DOI 10.1037/1082-989X.2.4.329; Pew Research Center, 2011, CONF DEM CAP WAN FOR; Pew Research Center, 2006, RUSS WEAK DEM EMBR; Pew Research Centre, 2012, RUSS BACK PROT POL F; Rawls J., 1971, THEORY JUSTICE; Rothbard M., 2000, EGALITARIANISM REVOL; Shteynberg G, 2009, J CROSS CULT PSYCHOL, V40, P46, DOI 10.1177/0022022108326196; Terracciano A, 2006, SCIENCE, V311, P777; Terracciano A, 2005, SCIENCE, V310, P96, DOI 10.1126/science.1117199; The Economist Intelligence Unit, 2010, SOC UNR DAT FIL; The Hofstede Center, COUNTR COMP CULT TOO; Wan C, 2007, J CROSS CULT PSYCHOL, V38, P213, DOI 10.1177/0022022106297300; Wan C, 2007, J PERS SOC PSYCHOL, V92, P337, DOI 10.1037/0022-3514.92.2.337; World Health Organization, 2002, WORLD REPORT VIOLENC; World Health Organization, 2008, MORT CARD DIS DIAB D; Yamagishi T, 2008, PSYCHOL SCI, V19, P579, DOI 10.1111/j.1467-9280.2008.02126.x; Zou X, 2009, J PERS SOC PSYCHOL, V97, P579, DOI 10.1037/a0016399	39	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127173	10.1371/journal.pone.0127173	http://dx.doi.org/10.1371/journal.pone.0127173			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7CR	26046772	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200016
J	Kamr, AM; Dembek, KA; Reed, SM; Slovis, NM; Zaghawa, AA; Rosol, TJ; Toribio, RE				Kamr, Ahmed M.; Dembek, Katarzyna A.; Reed, Stephen M.; Slovis, Nathan M.; Zaghawa, Ahmed A.; Rosol, Thomas J.; Toribio, Ramiro E.			Vitamin D Metabolites and Their Association with Calcium, Phosphorus, and PTH Concentrations, Severity of Illness, and Mortality in Hospitalized Equine Neonates	PLOS ONE			English	Article							SERUM PARATHYROID-HORMONE; D DEFICIENCY; MAGNESIUM CONCENTRATIONS; D SUPPLEMENTATION; HORSES; FOALS; PREVALENCE; SEPSIS; HYPOCALCEMIA; EXPRESSION	Background Hypocalcemia is a frequent abnormality that has been associated with disease severity and outcome in hospitalized foals. However, the pathogenesis of equine neonatal hypocalcemia is poorly understood. Hypovitaminosis D in critically ill people has been linked to hypocalcemia and mortality; however, information on vitamin D metabolites and their association with clinical findings and outcome in critically ill foals is lacking. The goal of this study was to determine the prevalence of vitamin D deficiency (hypovitaminosis D) and its association with serum calcium, phosphorus, and parathyroid hormone (PTH) concentrations, disease severity, and mortality in hospitalized newborn foals. Methods and Results One hundred newborn foals <= 72 hours old divided into hospitalized (n = 83; 59 septic, 24 sick non-septic [SNS]) and healthy (n = 17) groups were included. Blood samples were collected on admission to measure serum 25-hydroxyvitamin D-3 [25(OH)D-3], 1,25-dihydroxyvitamin D-3 [1,25(OH)(2)D-3], and PTH concentrations. Data were analyzed by nonparametric methods and univariate logistic regression. The prevalence of hypovitaminosis D [defined as 25(OH)D-3 <9.51 ng/mL] was 63% for hospitalized, 64% for septic, and 63% for SNS foals. Serum 25(OH)D-3 and 1,25(OH)(2)D-3 concentrations were significantly lower in septic and SNS compared to healthy foals (P<0.0001; P = 0.037). Septic foals had significantly lower calcium and higher phosphorus and PTH concentrations than healthy and SNS foals (P<0.05). In hospitalized and septic foals, low 1,25(OH)(2)D-3 concentrations were associated with increased PTH but not with calcium or phosphorus concentrations. Septic foals with 25(OH)D-3 <9.51 ng/mL and 1,25(OH)(2)D-3 <7.09 pmol/L were more likely to die (OR=3.62; 95% CI = 1.1-12.40; OR = 5.41; 95% CI = 1.19-24.52, respectively). Conclusions Low 25(OH)D-3 and 1,25(OH)(2)D-3 concentrations are associated with disease severity and mortality in hospitalized foals. Vitamin D deficiency may contribute to a pro-inflammatory state in equine perinatal diseases. Hypocalcemia and hyperphosphatemia together with decreased 1,25(OH)(2)D-3 but increased PTH concentrations in septic foals indicates that PTH resistance may be associated with the development of these abnormalities.	[Kamr, Ahmed M.; Dembek, Katarzyna A.; Rosol, Thomas J.; Toribio, Ramiro E.] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA; [Reed, Stephen M.] Rood & Riddle Equine Hosp, Lexington, KY USA; [Slovis, Nathan M.] Hagyard Equine Med Inst, Lexington, KY USA; [Zaghawa, Ahmed A.] Univ Sadat City, Fac Vet Med, Sadat City, Egypt	University System of Ohio; Ohio State University; Egyptian Knowledge Bank (EKB); University of Sadat City	Toribio, RE (corresponding author), Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA.	toribio.1@osu.edu	Rosol, Thomas/G-9585-2011; Kamr, Ahmed/AAG-2904-2021; Toribio, Ramiro/H-7838-2013	Rosol, Thomas/0000-0003-3737-1190; Kamr, Ahmed/0000-0002-7409-0227; Toribio, Ramiro/0000-0002-9063-540X; zaghawa, ahmed/0000-0002-3263-2948	Ohio State University [520402]; United States Department of Agriculture; Egyptian Cultural and Educational Bureau	Ohio State University(Ohio State University); United States Department of Agriculture(United States Department of Agriculture (USDA)); Egyptian Cultural and Educational Bureau(Egyptian Cultural & Educational Bureau)	Equine Research Funds of The Ohio State University 520402 and The United States Department of Agriculture. Financial support was provided by the Egyptian Cultural and Educational Bureau to A. Kamr. Partial funding for Open Access provided by The Ohio State University Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrein K, 2014, CRIT CARE, V18, DOI 10.1186/cc13790; Amrein K, 2011, CRIT CARE, V15, DOI 10.1186/cc10120; Aygencel G, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/856747; Borella E, 2014, ANN NY ACAD SCI, V1317, P76, DOI 10.1111/nyas.12321; BREWER BD, 1988, EQUINE VET J, V20, P18, DOI 10.1111/j.2042-3306.1988.tb01445.x; Christensen EI, 2012, PHYSIOLOGY, V27, P223, DOI 10.1152/physiol.00022.2012; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; DiBartola SP, 2005, FLUID ELECTROLYTE AC, P195; Edfeldt K, 2010, P NATL ACAD SCI USA, V107, P22593, DOI 10.1073/pnas.1011624108; Garcia-Lopez JM, 2001, AM J VET RES, V62, P7, DOI 10.2460/ajvr.2001.62.7; Han JE, 2014, AM J RESP CRIT CARE, V190, P483, DOI 10.1164/rccm.201408-1443ED; Haroon M, 2012, CLIN RHEUMATOL, V31, P199, DOI 10.1007/s10067-011-1880-5; Hebbar KB, 2014, J CLIN TRANSL ENDOCR, V1, P170, DOI 10.1016/j.jcte.2014.09.002; HOLICK MF, 1990, J NUTR, V120, P1464, DOI 10.1093/jn/120.suppl_11.1464; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hurcombe SDA, 2009, J VET INTERN MED, V23, P335, DOI 10.1111/j.1939-1676.2009.0275.x; Izadpanah M, 2013, IMMUNOTHERAPY-UK, V5, P843, DOI [10.2217/imt.13.84, 10.2217/IMT.13.84]; Jeng L, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-28; Jones G, 2008, AM J CLIN NUTR, V88, p582S, DOI 10.1093/ajcn/88.2.582S; Karefylakis C, 2014, OBES SURG, V24, P343, DOI 10.1007/s11695-013-1104-y; Kuro-o M, 2010, PEDIATR NEPHROL, V25, P583, DOI 10.1007/s00467-009-1260-4; Lang C.-L., 2014, ISRN Endocrinol, V2014, P1, DOI [DOI 10.1155/2014/105456, 10.1155/2014/105456]; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Lee P, 2009, INTENS CARE MED, V35, P2028, DOI 10.1007/s00134-009-1642-x; Lind L, 2000, CRIT CARE MED, V28, P93, DOI 10.1097/00003246-200001000-00015; Madej JP, 2009, POL J VET SCI, V12, P499; Marzolo MP, 2011, BIOL RES, V44, P89, DOI 10.4067/S0716-97602011000100012; McKinney JD, 2011, J AM MED DIR ASSOC, V12, P208, DOI 10.1016/j.jamda.2010.04.004; Meier U, 2006, CLIN CHEM, V52, P1247, DOI 10.1373/clinchem.2005.065680; Nair P, 2013, INTENS CARE MED, V39, P267, DOI 10.1007/s00134-012-2713-y; Nguyen HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064348; Norman AW, 2008, AM J CLIN NUTR, V88, p491S, DOI 10.1093/ajcn/88.2.491S; Olauson H, 2014, SEMIN NEPHROL, V34, P586, DOI 10.1016/j.semnephrol.2014.09.005; Pozza ME, 2014, VET J, V199, P451, DOI 10.1016/j.tvjl.2014.01.002; Rippel C, 2012, INTENS CARE MED, V38, P2055, DOI 10.1007/s00134-012-2718-6; RUDE RK, 1976, CLIN ENDOCRINOL, V5, P209, DOI 10.1111/j.1365-2265.1976.tb01947.x; Salle BL, 2000, AM J CLIN NUTR, V71, p1317S, DOI 10.1093/ajcn/71.5.1317s; Meneses JFSE, 2009, PEDIATR CRIT CARE ME, V10, P234, DOI 10.1097/PCC.0b013e3181937042; Schreiber A, 2012, KIDNEY INT, V82, P53, DOI 10.1038/ki.2012.62; Speeckaert MM, 2014, ADV CLIN CHEM, V63, P1, DOI 10.1016/B978-0-12-800094-6.00001-7; Toribio RE, 2011, VET CLIN N AM-EQUINE, V27, P129, DOI 10.1016/j.cveq.2010.12.010; Toribio RE, 2011, VET CLIN N AM-EQUINE, V27, P35, DOI 10.1016/j.cveq.2010.12.011; Toribio RE, 2005, J VET INTERN MED, V19, P223, DOI 10.1892/0891-6640(2005)19&lt;223:AISPHA&gt;2.0.CO;2; Toribio RE, 2003, J MOL ENDOCRINOL, V31, P609, DOI 10.1677/jme.0.0310609; Toribio RE, 2001, AM J VET RES, V62, P938, DOI 10.2460/ajvr.2001.62.938; Venkatesh B, 2014, CRIT CARE, V18, DOI 10.1186/cc13863; Waldron JL, 2013, J CLIN PATHOL, V66, P620, DOI 10.1136/jclinpath-2012-201301; Watkins RR, 2011, J INFECTION, V63, P321, DOI 10.1016/j.jinf.2011.07.002	48	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127684	10.1371/journal.pone.0127684	http://dx.doi.org/10.1371/journal.pone.0127684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046642	gold, Green Submitted, Green Published			2022-12-27	WOS:000355652200025
J	Majaneva, M; Hyytiainen, K; Varvio, SL; Nagai, S; Blomster, J				Majaneva, Markus; Hyytiainen, Kirsi; Varvio, Sirkka Liisa; Nagai, Satoshi; Blomster, Jaanika			Bioinformatic Amplicon Read Processing Strategies Strongly Affect Eukaryotic Diversity and the Taxonomic Composition of Communities	PLOS ONE			English	Article							RARE BIOSPHERE; SPECIES RICHNESS; SEQUENCES; WRINKLES; SEARCH; FUNGI; UNITS	Amplicon read sequencing has revolutionized the field of microbial diversity studies. The technique has been developed for bacterial assemblages and has undergone rigorous testing with mock communities. However, due to the great complexity of eukaryotes and the numbers of different rDNA copies, analyzing eukaryotic diversity is more demanding than analyzing bacterial or mock communities, so studies are needed that test the methods of analyses on taxonomically diverse natural communities. In this study, we used 20 samples collected from the Baltic Sea ice, slush and under-ice water to investigate three program packages (UPARSE, mothur and QIIME) and 18 different bioinformatic strategies implemented in them. Our aim was to assess the impact of the initial steps of bioinformatic strategies on the results when analyzing natural eukaryotic communities. We found significant differences among the strategies in resulting read length, number of OTUs and estimates of diversity as well as clear differences in the taxonomic composition of communities. The differences arose mainly because of the variable number of chimeric reads that passed the pre-processing steps. Singleton removal and denoising substantially lowered the number of errors. Our study showed that the initial steps of the bioinformatic amplicon read processing strategies require careful consideration before applying them to eukaryotic communities.	[Majaneva, Markus; Hyytiainen, Kirsi; Blomster, Jaanika] Univ Helsinki, Dept Environm Sci, Helsinki, Finland; [Majaneva, Markus; Hyytiainen, Kirsi] Univ Helsinki, Tvarminne Zool Stn, Hango, Finland; [Varvio, Sirkka Liisa] Univ Helsinki, Dept Math & Stat, Helsinki, Finland; [Nagai, Satoshi] Natl Res Inst Fisheries Sci, Res Ctr Aquat Genom, Yokohama, Kanagawa, Japan	University of Helsinki; University of Helsinki; University of Helsinki; Japan Fisheries Research & Education Agency (FRA)	Majaneva, M (corresponding author), Univ Helsinki, Dept Environm Sci, Helsinki, Finland.	markus.majaneva@gmail.com		Blomster, Jaanika/0000-0003-1347-7919; Majaneva, Markus/0000-0003-3884-2548	Walter and Andree de Nottbeck Foundation; University of Helsinki 3-year grant; Onni Talas Foundation	Walter and Andree de Nottbeck Foundation; University of Helsinki 3-year grant; Onni Talas Foundation	This work was supported by Walter and Andree de Nottbeck Foundation (MM), University of Helsinki 3-year grant (JB, MM, KH) and Onni Talas Foundation (KH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RI, 2013, MICROB ECOL, V66, P735, DOI 10.1007/s00248-013-0266-4; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Bachy C, 2013, ISME J, V7, P244, DOI 10.1038/ismej.2012.106; Behnke A, 2011, ENVIRON MICROBIOL, V13, P340, DOI 10.1111/j.1462-2920.2010.02332.x; Behnke A, 2010, FEMS MICROBIOL ECOL, V72, P89, DOI 10.1111/j.1574-6941.2010.00836.x; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Caron DA, 2009, APPL ENVIRON MICROB, V75, P5797, DOI 10.1128/AEM.00298-09; Cermeno P, 2013, MAR ECOL PROG SER, V488, P1, DOI 10.3354/meps10443; Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edgcomb V, 2011, ISME J, V5, P1344, DOI 10.1038/ismej.2011.6; Egge E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074371; Epstein S, 2008, BIODIVERS CONSERV, V17, P261, DOI 10.1007/s10531-007-9250-y; Erlich Y, 2008, NAT METHODS, V5, P679, DOI 10.1038/nmeth.1230; Fenchel T, 1997, OIKOS, V80, P220, DOI 10.2307/3546589; Finlay BJ, 2004, PROTIST, V155, P237, DOI 10.1078/143446104774199619; Finlay BJ, 1999, PROTIST, V150, P419, DOI 10.1016/S1434-4610(99)70042-8; Gaspar JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060458; Gong J, 2013, PROTIST, V164, P369, DOI 10.1016/j.protis.2012.11.006; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lie AAY, 2014, APPL ENVIRON MICROB, V80, P4363, DOI 10.1128/AEM.00057-14; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Lucking R, 2014, J MOL EVOL, V78, P148, DOI 10.1007/s00239-013-9603-y; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Maggs CA, 1996, J PHYCOL, V32, P176, DOI 10.1111/j.0022-3646.1996.00176.x; Maidak BL, 1999, NUCLEIC ACIDS RES, V27, P171, DOI 10.1093/nar/27.1.171; Majaneva M, 2012, POLAR BIOL, V35, P875, DOI 10.1007/s00300-011-1132-9; May A, 2014, BIOINFORMATICS, V30, P1530, DOI 10.1093/bioinformatics/btu085; Mohamed DJ, 2011, ISME J, V5, P379, DOI 10.1038/ismej.2010.137; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Moreira D, 2002, TRENDS MICROBIOL, V10, P31, DOI 10.1016/S0966-842X(01)02257-0; Nebel M, 2011, ENV MICROBIOL REP, V3, P154, DOI 10.1111/j.1758-2229.2010.00200.x; NICKRENT DL, 1991, NUCLEIC ACIDS RES, V19, P227, DOI 10.1093/nar/19.2.227; Nilsson RH, 2010, MOL ECOL RESOUR, V10, P1076, DOI 10.1111/j.1755-0998.2010.02850.x; Nishitani G, 2012, APPL ENVIRON MICROB, V78, P813, DOI 10.1128/AEM.06544-11; Prokopowich CD, 2003, GENOME, V46, P48, DOI 10.1139/G02-103; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Reeder J, 2009, NAT METHODS, V6, P636, DOI 10.1038/nmeth0909-636; Rodriguez-Ramos T, 2014, J PLANKTON RES, V36, P334, DOI 10.1093/plankt/fbt115; Santoferrara LF, 2014, ENVIRON MICROBIOL, V16, P2752, DOI 10.1111/1462-2920.12380; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Stoeck T, 2014, ENVIRON MICROBIOL, V16, P430, DOI 10.1111/1462-2920.12194; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Unterseher M, 2011, MOL ECOL, V20, P275, DOI 10.1111/j.1365-294X.2010.04948.x; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Wuyts J, 2000, NUCLEIC ACIDS RES, V28, P4698, DOI 10.1093/nar/28.23.4698; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006	63	47	49	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0130035	10.1371/journal.pone.0130035	http://dx.doi.org/10.1371/journal.pone.0130035			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047335	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200170
J	Munoz-Luna, R				Munoz-Luna, Rosa			Main Ingredients for Success in L2 Academic Writing: Outlining, Drafting and Proofreading	PLOS ONE			English	Article								Spanish undergraduates of English Studies are required to submit their essays in academic English, a genre which most of them are not acquainted with. This paper aims to explore the extralinguistic side of second language (L2) academic writing, more specifically, the combination of metalinguistic items (e.g. transition and frame markers, among others) with students' writing strategies when composing an academic text in L2 English. The research sample conveys a group of 200 Spanish undergraduates of English Studies; they are in their fourth year, so they are expected to be proficient in English academic writing but their written production quality varies considerably. Results are analysed following a mixed methodology by which metalinguistic items are statistically measured, and then contrasted with semi-structured interview results; SPSS and NVivo provide quantitative and qualitative outcomes, respectively. The analyses reveal that undergraduate students who produce complex sentences and more coherent texts employ a wider range of writing strategies both prior and while writing, being able to (un) consciously structure and design their texts more successfully. These high-scoring students make more proficient use of complex transition markers for coherence and frame markers for textual cohesion; their commonly used (pre-) writing strategies are drafting, outlining, and proofreading.	Univ Malaga, Dept English French & German, E-29071 Malaga, Spain	Universidad de Malaga	Munoz-Luna, R (corresponding author), Univ Malaga, Dept English French & German, E-29071 Malaga, Spain.	rmluna@uma.es			Formacion de Profesorado Universitario; Spanish Ministry of Education	Formacion de Profesorado Universitario(Spanish Government); Spanish Ministry of Education(Spanish Government)	Formacion de Profesorado Universitario, Research Grant, Spanish Ministry of Education. 2008-2012.	Llach MPA, 2009, REV ESP LINGUIST APL, V22, P9; Arkin F, 2010, PROCD SOC BEHV, V2, P3339, DOI 10.1016/j.sbspro.2010.03.513; Arndt V., 2000, ALIVE TO LANGUAGE; Branthwaite A., 1980, PSYCHOL WRITTEN COMM, P98; Cameron D., 2000, CHANG ENGL, V7, P203; Coll C., 2007, CONSTRUCTIVISMO AULA; Corder S. P., 1981, ERROR ANAL INTERLANG; de Larios JR, 2008, J SECOND LANG WRIT, V17, P30, DOI 10.1016/j.jslw.2007.08.005; Dornyei Z, 2007, RES METHODS APPL LIN; Friedlander A., 1990, 2 LANGUAGE WRITING R, P109; Hyland K, 2005, SECOND LANGUAGE WRITING RESEARCH: PERSPECTIVES ON THE PROCESS OF KNOWLEDGE CONSTRUCTION, P177; Hyland K., 2002, TEACHING RES WRITING; Hyland K, 2006, ROUTL APPL LINGU SER, P1; Jordan R. R., 2004, ENGLISH ACAD PURPOSE; Kaufman D., 2004, ANNU REV APPL LINGUI, V24, P303, DOI [10.1017/S0267190504000121, DOI 10.1017/S0267190504000121]; Kennedy J, 2005, STUDY SKILLS MAXIMIS; Kizach J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076326; Lillis T, 2006, WRIT COMMUN, V23, P3, DOI 10.1177/0741088305283754; Lines H, 2010, ANN STAFF STUD RES C; Lotte Rienecker, 2003, TEACHING ACAD WRITIN, P101; Mayer R, 1988, LEARNING STUDY STRAT, P22; Mazandarani O, 2010, ANN STAFF STUD RES C; McCarthy M, 1993, DISCOURSE ANAL LANGU; McKay SL, 2006, ESL APPL LING PROF, P1; Mitchell R., 2004, 2 LANGUAGE LEARNING; Munoz-Luna R, 2013, PROFILE J, V16, P167; Munoz-Luna R, 2014, RESLA, V27; Murphy L, 2008, LANG TEACH RES, V12, P83, DOI 10.1177/1362168807084495; Nacera A, 2010, PROCD SOC BEHV, V2, P4021, DOI 10.1016/j.sbspro.2010.03.634; Nelson N., 1998, READING WRITING CONN, P1; O'Malley JM, 1988, LEARNING STUDY STRAT, P215; Oppenheim A. N., 1992, QUESTIONNAIRE DESIGN; Paltridge B, 2001, RES PERSPECTIVES ENG, P55, DOI DOI 10.1017/CBO9781139524766.007; Peacock M, 2010, IBERICA, P9; Peacock Matthew., 2001, RES PERSPECTIVES ENG, P268; Philips T., 2008, RES TEACHING SPECIAL, P811; Pinker Steven, 2014, CHRON HIGHER EDUC; Rubin D, 1998, READING WRITING CONN, P53; Vongpumivitch V, 2009, ENGL SPECIF PURP, V28, P33, DOI 10.1016/j.esp.2008.08.003; Waters A, 2001, RES PERSPECTIVES ENG, P375	40	1	1	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128309	10.1371/journal.pone.0128309	http://dx.doi.org/10.1371/journal.pone.0128309			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046836	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200057
J	O'Leary-Barrett, M; Pihl, RO; Artiges, E; Banaschewski, T; Bokde, ALW; Buchel, C; Flor, H; Frouin, V; Garavan, H; Heinz, A; Ittermann, B; Mann, K; Paillere-Martinot, ML; Nees, F; Paus, T; Pausova, Z; Poustka, L; Rietschel, M; Robbins, TW; Smolka, MN; Strohle, A; Schumann, G; Conrod, PJ				O'Leary-Barrett, Maeve; Pihl, Robert O.; Artiges, Eric; Banaschewski, Tobias; Bokde, Arun L. W.; Buechel, Christian; Flor, Herta; Frouin, Vincent; Garavan, Hugh; Heinz, Andreas; Ittermann, Bernd; Mann, Karl; Paillere-Martinot, Marie-Laure; Nees, Frauke; Paus, Tomas; Pausova, Zdenka; Poustka, Luise; Rietschel, Marcella; Robbins, Trevor W.; Smolka, Michael N.; Stroehle, Andreas; Schumann, Gunter; Conrod, Patricia J.		IMAGEN Consortium	Personality, Attentional Biases towards Emotional Faces and Symptoms of Mental Disorders in an Adolescent Sample	PLOS ONE			English	Article							RISK PROFILE SCALE; POSTTRAUMATIC-STRESS-DISORDER; SUBSTANCE USE; SELECTIVE ATTENTION; PREDICTIVE-VALIDITY; ANXIETY DISORDERS; CHILDREN; THREAT; DEPRESSION; PSYCHOPATHOLOGY	Objective To investigate the role of personality factors and attentional biases towards emotional faces, in establishing concurrent and prospective risk for mental disorder diagnosis in adolescence. Method Data were obtained as part of the IMAGEN study, conducted across 8 European sites, with a community sample of 2257 adolescents. At 14 years, participants completed an emotional variant of the dot-probe task, as well two personality measures, namely the Substance Use Risk Profile Scale and the revised NEO Personality Inventory. At 14 and 16 years, participants and their parents were interviewed to determine symptoms of mental disorders. Results Personality traits were general and specific risk indicators for mental disorders at 14 years. Increased specificity was obtained when investigating the likelihood of mental disorders over a 2-year period, with the Substance Use Risk Profile Scale showing incremental validity over the NEO Personality Inventory. Attentional biases to emotional faces did not characterise or predict mental disorders examined in the current sample. Discussion Personality traits can indicate concurrent and prospective risk for mental disorders in a community youth sample, and identify at-risk youth beyond the impact of baseline symptoms. This study does not support the hypothesis that attentional biases mediate the relationship between personality and psychopathology in a community sample. Task and sample characteristics that contribute to differing results among studies are discussed.	[O'Leary-Barrett, Maeve; Pihl, Robert O.] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Artiges, Eric; Paillere-Martinot, Marie-Laure] Univ Paris 11, INSERM CEA Unit Imaging & Psychiat 1000, INSERM, Paris, France; [Artiges, Eric; Paillere-Martinot, Marie-Laure] Univ Paris 05, AP HP, Dept Adolescent Psychopathol & Med, Maison de Solenn, Paris, France; [Banaschewski, Tobias; Poustka, Luise] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychiat, Mannheim, Germany; [Bokde, Arun L. W.] Univ Dublin Trinity Coll, Sch Med, Trinity Coll Inst Neurosci & Discipline Psychiat, Dublin 2, Ireland; [Buechel, Christian] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany; [Flor, Herta; Mann, Karl; Nees, Frauke; Rietschel, Marcella] Cent Inst Mental Hlth, Mannheim, Germany; [Flor, Herta; Mann, Karl; Nees, Frauke; Rietschel, Marcella] Heidelberg Univ, Med Fac Mannheim, Heidelberg, Germany; [Frouin, Vincent] Commissariat Energie Atom & Energies Alternat, Neurospin, Paris, France; [Garavan, Hugh] Univ Dublin Trinity Coll, Inst Neurosci, Dublin 2, Ireland; [Garavan, Hugh] Univ Vermont, Dept Psychiat, Burlington, VT USA; [Garavan, Hugh] Univ Vermont, Dept Psychol, Burlington, VT 05405 USA; [Heinz, Andreas; Stroehle, Andreas] Charite, Dept Psychiat & Psychotherapy, Campus Charite Mitte, D-13353 Berlin, Germany; [Ittermann, Bernd] Phys Tech Bundesanstalt, Braunschweig & Berlin, Berlin, Germany; [Paus, Tomas] Univ Toronto, Rotman Res Inst, Toronto, ON, Canada; [Paus, Tomas] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England; [Paus, Tomas] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Pausova, Zdenka] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Robbins, Trevor W.] Univ Cambridge, Dept Expt Psychol, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England; [Smolka, Michael N.] Tech Univ Dresden, Dept Psychiat & Psychotherapy, D-01062 Dresden, Germany; [Smolka, Michael N.] Tech Univ Dresden, Neuroimaging Ctr, D-01062 Dresden, Germany; [Schumann, Gunter] Kings Coll London, Inst Psychiat, MRC Social Genet & Dev Psychiat SGDP, London, England; [Conrod, Patricia J.] Kings Coll London, Inst Psychiat, Dept Psychol Med & Psychiat, London WC2R 2LS, England; [Conrod, Patricia J.] Univ Montreal, Dept Psychiat, CHU Ste Justine Hosp, Montreal, PQ H3C 3J7, Canada	McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Trinity College Dublin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; CEA; Trinity College Dublin; University of Vermont; University of Vermont; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Physikalisch-Technische Bundesanstalt (PTB); University of Toronto; University Toronto Affiliates; Baycrest; University of Nottingham; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Cambridge; Technische Universitat Dresden; Technische Universitat Dresden; University of London; King's College London; University of London; King's College London; Universite de Montreal	Conrod, PJ (corresponding author), Kings Coll London, Inst Psychiat, Dept Psychol Med & Psychiat, London WC2R 2LS, England.	patricia.conrod@kcl.ac.uk	Heinz, Andreas/ABB-7736-2020; Connolly, Colm G./H-5917-2019; Artiges, Eric/AAT-7219-2021; Banaschewski, Tobias/ABE-5985-2020; Artiges, Eric/C-2815-2019; Conrod, Patricia J/P-4187-2018; Robbins, Trevor W/A-7551-2008; Poustka, Luise/D-9299-2017; Clarke, Toni/AAE-7069-2019; Sommer, Wolfgang H./I-4809-2019; Desrivières, Sylvane/ABC-4336-2021; Nees, Frauke/AAZ-2150-2020; Vollstädt-Klein, Sabine/C-6744-2012	Heinz, Andreas/0000-0001-5405-9065; Connolly, Colm G./0000-0002-4051-3682; Artiges, Eric/0000-0003-4461-7646; Banaschewski, Tobias/0000-0003-4595-1144; Artiges, Eric/0000-0003-4461-7646; Clarke, Toni/0000-0002-7745-6351; Sommer, Wolfgang H./0000-0002-5903-6521; Desrivières, Sylvane/0000-0002-9120-7060; Vollstädt-Klein, Sabine/0000-0002-6210-672X; Lourdusamy, Anbarasu/0000-0002-1978-6301; Costafreda Gonzalez, Sergi/0000-0001-6914-086X; Smith, Lorraine/0000-0002-3499-1514; opoku, anita/0000-0001-7243-8157; Heym, Nadja/0000-0003-2414-8854; Flor, Herta/0000-0003-4809-5398; Bokde, Arun/0000-0003-0114-4914; Robbins, Trevor/0000-0003-0642-5977; Lalor, Edmund/0000-0002-2498-6631; Nees, Frauke/0000-0002-7796-8234	IMAGEN study; European Community's Sixth Framework Programme [LSHM-CT-2007-037286]; FP7 projects ADAMS (genomic variations underlying common neuropsychiatric diseases and disease-related cognitive traits in different human populations) [242257]; Innovative Medicine Initiative Project EU-AIMS [115300-2]; UK National Institute for Health Research Biomedical Research Centre Mental Health; Medical Research Council [93558]; German Bundesministerium fur Bildung und Forschung (NGFN Plus) [FKZ: 01GS08152]; Fondation de Recherche Sante-Quebec [20393]; Aides a la Formation-Recherche (AFR) grant from the Fonds National de Recherche (FNR) du Luxembourg; Le Centre de Documentation et d'Information sur l'Enseignement Superieur (CEDIES) Luxembourg; Fondation de Recherche en Sante du Quebec (FRSQ); Canadian Institute of Health Research (CIHR); National Institute for Health, Research Biomedical Research Centre for Mental Health at the South London; Maudsley National Health Service Foundation Trust, at the Institute of Psychiatry, King's College, London; Medical Research Council [G0001354, G1000183B, G0901858, G0001354B, G9817803B] Funding Source: researchfish; MRC [G0901858] Funding Source: UKRI	IMAGEN study; European Community's Sixth Framework Programme(European Commission); FP7 projects ADAMS (genomic variations underlying common neuropsychiatric diseases and disease-related cognitive traits in different human populations); Innovative Medicine Initiative Project EU-AIMS; UK National Institute for Health Research Biomedical Research Centre Mental Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Bundesministerium fur Bildung und Forschung (NGFN Plus)(Federal Ministry of Education & Research (BMBF)); Fondation de Recherche Sante-Quebec; Aides a la Formation-Recherche (AFR) grant from the Fonds National de Recherche (FNR) du Luxembourg(Luxembourg National Research Fund); Le Centre de Documentation et d'Information sur l'Enseignement Superieur (CEDIES) Luxembourg; Fondation de Recherche en Sante du Quebec (FRSQ); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institute for Health, Research Biomedical Research Centre for Mental Health at the South London; Maudsley National Health Service Foundation Trust, at the Institute of Psychiatry, King's College, London; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The IMAGEN study, which receives research funding from the European Community's Sixth Framework Programme (LSHM-CT-2007-037286). Further support was provided by the FP7 projects ADAMS (genomic variations underlying common neuropsychiatric diseases and disease-related cognitive traits in different human populations; 242257), the Innovative Medicine Initiative Project EU-AIMS (115300-2), the UK National Institute for Health Research Biomedical Research Centre Mental Health, the Medical Research Council Programme Grant 'Developmental pathways into adolescent substance abuse' (93558), the German Bundesministerium fur Bildung und Forschung (NGFN Plus; FKZ: 01GS08152), as well as the Fondation de Recherche Sante-Quebec (Chercheur-Boursier Pc 20393). Ms. O'Leary-Barrett is supported by an Aides a la Formation-Recherche (AFR) grant from the Fonds National de Recherche (FNR) du Luxembourg and Le Centre de Documentation et d'Information sur l'Enseignement Superieur (CEDIES) Luxembourg. Dr. Conrod is supported by a Scientist career (2010-2013) award from the Fondation de Recherche en Sante du Quebec (FRSQ), a Canadian Institute of Health Research (CIHR) grant, and funding from the National Institute for Health, Research Biomedical Research Centre for Mental Health at the South London and Maudsley National Health Service Foundation Trust, at the Institute of Psychiatry, King's College, London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beck A.T., 1987, J COGN PSYCHOTHER, V1, P5; Beck AT, 2014, ANNU REV CLIN PSYCHO, V10, P1, DOI 10.1146/annurev-clinpsy-032813-153734; Brodeur DA, 2000, COGNITIVE DEV, V15, P367, DOI 10.1016/S0885-2014(00)00025-3; Calder AJ, 2011, PHILOS T R SOC B, V366, P1684, DOI 10.1098/rstb.2010.0362; Canli T, 2004, J PERS, V72, P1105, DOI 10.1111/j.1467-6494.2004.00292.x; Canli T, 2001, BEHAV NEUROSCI, V115, P33, DOI 10.1037//0735-7044.115.1.33; Caspi A, 1996, ARCH GEN PSYCHIAT, V53, P1033; Castellanos-Ryan N, 2013, ALCOHOL CLIN EXP RES, V37, pE281, DOI 10.1111/j.1530-0277.2012.01931.x; Castellanos-Ryan N, 2011, ALCOHOL CLIN EXP RES, V35, P140, DOI 10.1111/j.1530-0277.2010.01331.x; Clark D.A., 1999, SCI FDN COGNITIVE TH; Connor-Smith JK, 2007, J PERS SOC PSYCHOL, V93, P1080, DOI 10.1037/0022-3514.93.6.1080; Conrod PJ, 2013, JAMA PSYCHIAT, V70, P334, DOI 10.1001/jamapsychiatry.2013.651; Costa P.T., 1992, PSYCHOL ASSESSMENT, V4, P5, DOI [https://doi.org/10.1037/1040-3590.4.1.5, DOI 10.1037/1040-3590.4.1.5, 10.1037/1040-3590.4.1.5]; Cuijpers P, 2010, ARCH GEN PSYCHIAT, V67, P1086, DOI 10.1001/archgenpsychiatry.2010.130; d'Acremont M, 2007, J ABNORM CHILD PSYCH, V35, P313, DOI 10.1007/s10802-006-9092-1; Dalgleish T, 2001, PSYCHOL MED, V31, P541, DOI 10.1017/S0033291701003567; Dalgleish T, 2003, J CLIN CHILD ADOLESC, V32, P10, DOI 10.1207/S15374424JCCP3201_02; De Fruyt F, 2000, ASSESSMENT, V7, P329, DOI 10.1177/107319110000700403; Everaert J, 2014, EMOTION, V14, P331, DOI 10.1037/a0035250; Faunce GJ, 2004, PERS INDIV DIFFER, V36, P1975, DOI 10.1016/j.paid.2003.07.016; Frewen PA, 2008, CLIN PSYCHOL REV, V28, P307, DOI 10.1016/j.cpr.2007.05.006; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; Heim-Dreger U, 2006, EMOTION, V6, P320, DOI 10.1037/1528-3542.6.2.320; KAGAN J, 1991, PSYCHOL SCI, V2, P40, DOI 10.1111/j.1467-9280.1991.tb00094.x; Koster EHW, 2004, BEHAV RES THER, V42, P1183, DOI 10.1016/j.brat.2003.08.001; Kotov R, 2010, PSYCHOL BULL, V136, P768, DOI 10.1037/a0020327; Krank M, 2011, ADDICT BEHAV, V36, P37, DOI 10.1016/j.addbeh.2010.08.010; Krueger RF, 2003, J PERS DISORD, V17, P109, DOI 10.1521/pedi.17.2.109.23986; Kuhn C, 2010, EUR PSYCHIAT, V25, P1475; Lonigan CJ, 2004, J CLIN CHILD ADOLESC, V33, P8, DOI 10.1207/S15374424JCCP3301_2; LUENGO MA, 1994, J PERS SOC PSYCHOL, V66, P542, DOI 10.1037/0022-3514.66.3.542; MacLeod C, 2002, J ABNORM PSYCHOL, V111, P107, DOI 10.1037//0021-843X.111.1.107; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; MAHER BA, 1994, J ABNORM PSYCHOL, V103, P72, DOI 10.1037/0021-843X.103.1.72; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; McCrae RR, 2002, J PERS SOC PSYCHOL, V83, P1456, DOI 10.1037//0022-3514.83.6.1456; Mogg K, 2004, COGNITION EMOTION, V18, P689, DOI 10.1080/02699930341000158; Mohr C, 2014, PSYCHOPATHOLOGY; O'Leary-Barrett M, 2013, J AM ACAD CHILD PSY, V52, P911, DOI 10.1016/j.jaac.2013.05.020; Peckham AD, 2010, DEPRESS ANXIETY, V27, P1135, DOI 10.1002/da.20755; Pine DS, 2005, J AM ACAD CHILD PSY, V44, P664, DOI 10.1097/01.chi.0000162580.92029.f4; Puliafico AC, 2006, CLIN CHILD FAM PSYCH, V9, P162, DOI 10.1007/s10567-006-0009-x; Rutherford EM, 2004, COGNITION EMOTION, V18, P711, DOI 10.1080/02699930341000121; Schultz D, 2004, DEV PSYCHOPATHOL, V16, P371, DOI 10.1017/S0954579404044566; Schumann G, 2010, MOL PSYCHIATR, V15, P1128, DOI 10.1038/mp.2010.4; Stewart SH, 2001, ADDICT BEHAV, V26, P775, DOI 10.1016/S0306-4603(01)00236-2; Taghavi MR, 1999, J ABNORM CHILD PSYCH, V27, P215, DOI 10.1023/A:1021952407074; VASEY MW, 1995, J ABNORM CHILD PSYCH, V23, P267, DOI 10.1007/BF01447092; Waters AM, 2008, BIOL PSYCHOL, V78, P10, DOI 10.1016/j.biopsycho.2007.12.005; Waters AM, 2004, J EXP CHILD PSYCHOL, V89, P320, DOI 10.1016/j.jecp.2004.06.003; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Winstanley CA, 2006, CLIN PSYCHOL REV, V26, P379, DOI 10.1016/j.cpr.2006.01.001; Woicik PA, 2009, ADDICT BEHAV, V34, P1042, DOI 10.1016/j.addbeh.2009.07.001; Yiend J, 2010, COGNITION EMOTION, V24, P3, DOI 10.1080/02699930903205698; Zvielli A, 2014, CLIN PSYCHOL SCI, P1	60	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128271	10.1371/journal.pone.0128271	http://dx.doi.org/10.1371/journal.pone.0128271			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7CR	26046352	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200053
J	Boisvert, I; McMahon, CM; Dowell, RC; Lyxell, B				Boisvert, Isabelle; McMahon, Catherine M.; Dowell, Richard C.; Lyxell, Bjorn			Long-Term Asymmetric Hearing Affects Cochlear Implantation Outcomes Differently in Adults with Pre- and Postlingual Hearing Loss	PLOS ONE			English	Article							DEAFENED ADULTS; ELECTRICAL-STIMULATION; PRELINGUAL DEAFNESS; RESIDUAL HEARING; BIMODAL HEARING; EAR; SPEECH; PERFORMANCE; RECOGNITION; PERCEPTION	In many countries, a single cochlear implant is offered as a treatment for a bilateral hearing loss. In cases where there is asymmetry in the amount of sound deprivation between the ears, there is a dilemma in choosing which ear should be implanted. In many clinics, the choice of ear has been guided by an assumption that the reorganisation of the auditory pathways caused by longer duration of deafness in one ear is associated with poorer implantation outcomes for that ear. This assumption, however, is mainly derived from studies of early childhood deafness. This study compared outcomes following implantation of the better or poorer ear in cases of long-term hearing asymmetries. Audiological records of 146 adults with bilateral hearing loss using a single hearing aid were reviewed. The unaided ear had 15 to 72 years of unaided severe to profound hearing loss before unilateral cochlear implantation. 98 received the implant in their long-term sound-deprived ear. A multiple regression analysis was conducted to assess the relative contribution of potential predictors to speech recognition performance after implantation. Duration of bilateral significant hearing loss and the presence of a prelingual hearing loss explained the majority of variance in speech recognition performance following cochlear implantation. For participants with post-lingual hearing loss, similar outcomes were obtained by implanting either ear. With prelingual hearing loss, poorer outcomes were obtained when implanting the long-term sound-deprived ear, but the duration of the sound deprivation in the implanted ear did not reliably predict outcomes. Contrary to an apparent clinical consensus, duration of sound deprivation in one ear has limited value in predicting speech recognition outcomes of cochlear implantation in that ear. Outcomes of cochlear implantation are more closely related to the period of time for which the brain is deprived of auditory stimulation from both ears.	[Boisvert, Isabelle; McMahon, Catherine M.] Macquarie Univ, Dept Linguist, Sydney, NSW 2109, Australia; [Boisvert, Isabelle; McMahon, Catherine M.; Dowell, Richard C.] HEARing Cooperat Res Ctr, Melbourne, Vic, Australia; [Boisvert, Isabelle] SCIC Cochlear Implant Program, Sydney, NSW, Australia; [Dowell, Richard C.] Univ Melbourne, Dept Audiol & Speech Pathol, Melbourne, Vic, Australia; [Dowell, Richard C.] Royal Victorian Eye & Ear Hosp, Audiol, Melbourne, Vic 3002, Australia; [Lyxell, Bjorn] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Boisvert, Isabelle; Lyxell, Bjorn] Swedish Inst Disabil Res, Linnaeus Ctr HEAD, Linkoping, Sweden	Macquarie University; University of Melbourne; Royal Victorian Eye & Ear Hospital; Linkoping University	Boisvert, I (corresponding author), Macquarie Univ, Dept Linguist, Sydney, NSW 2109, Australia.	Isabelle.boisvert@mq.edu.au	Dowell, Richard/AAX-7046-2020; Boisvert, Isabelle/AAB-8090-2021	Boisvert, Isabelle/0000-0001-7050-3197; McMahon, Catherine/0000-0001-7312-6593	Macquarie University Research Excellence Scheme; HEARing CRC, under Cooperative Research Centres Program - Business Australia; Linnaeus Centre HEAD, The Swedish Institute for Disability Research	Macquarie University Research Excellence Scheme; HEARing CRC, under Cooperative Research Centres Program - Business Australia; Linnaeus Centre HEAD, The Swedish Institute for Disability Research	This work was funded by the Macquarie University Research Excellence Scheme (http://mq.edu.au/) (IB), the HEARing CRC, established and supported under the Cooperative Research Centres Program - Business Australia (http://www.hearingcrc.org) (IB RD CM) and the Linnaeus Centre HEAD, The Swedish Institute for Disability Research (https://www.liu.se/ihv/linnecentrum-head?l=en) (BL, IB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlinger S, 2003, INT J AUDIOL, V42, pS17; Blamey P, 1996, Audiol Neurootol, V1, P293; Blamey P, 2013, AUDIOL NEURO-OTOL, V18, P36, DOI 10.1159/000343189; Boisvert I, 2011, EAR HEARING, V32, P758, DOI 10.1097/AUD.0b013e3182234c45; Caposecco A, 2012, EAR HEARING, V33, P221, DOI 10.1097/AUD.0b013e31822eb16c; Chen JM, 2001, OTOL NEUROTOL, V22, P335, DOI 10.1097/00129492-200105000-00011; Ching Teresa Y C, 2009, Cochlear Implants Int, V10 Suppl 1, P23, DOI 10.1179/cim.2009.10.Supplement-1.23; Ching TYC, 2004, EAR HEARING, V25, P9, DOI 10.1097/01.AUD.0000111261.84611.C8; Clark GM, 2013, JAMA-J AM MED ASSOC, V310, P1225, DOI 10.1001/jama.2013.278142; Connell SS, 2006, CLIN GERIATR MED, V22, P677, DOI 10.1016/j.cger.2006.04.003; Cullington HE, 2011, EAR HEARING, V32, P16, DOI 10.1097/AUD.0b013e3181edfbd2; Dettman S., 2010, OXFORD HDB DEAF STUD, V2, P331; Firszt JB, 2008, J REHABIL RES DEV, V45, P749, DOI 10.1682/JRRD.2007.08.0120; Firszt JB, 2012, EAR HEARING, V33, P521, DOI 10.1097/AUD.0b013e31824b9dfc; Francis HW, 2005, EAR HEARING, V26, p7S, DOI 10.1097/00003446-200508001-00003; Francis HW, 2004, LARYNGOSCOPE, V114, P1747, DOI 10.1097/00005537-200410000-00013; Friedland DR, 2003, OTOL NEUROTOL, V24, P582, DOI 10.1097/00129492-200307000-00009; Giraud AL, 2007, RESTOR NEUROL NEUROS, V25, P381; Gomaa NA, 2003, EAR HEARING, V24, P539, DOI 10.1097/01.AUD.0000100208.26628.2D; Gordon KA, 2013, BRAIN, V136, P1609, DOI 10.1093/brain/awt052; Green Steven H., 2008, V31, P275; Kral A, 2013, BRAIN, V136, P180, DOI 10.1093/brain/aws305; Lazard DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048739; Lyxell B, 1998, SCAND J PSYCHOL, V39, P175, DOI 10.1111/1467-9450.393075; Moore DR, 2009, NAT NEUROSCI, V12, P686, DOI 10.1038/nn.2326; Nayagam BA, 2011, HEARING RES, V278, P2, DOI 10.1016/j.heares.2011.04.003; O'Neil JN, 2010, J COMP NEUROL, V518, P2382, DOI 10.1002/cne.22339; Pedley K., 2005, ADULT COCHLEAR IMPLA; PELIZZONE M, 1991, ACTA OTO-LARYNGOL, V111, P263, DOI 10.3109/00016489109137385; Pelosi S, 2013, OTOL NEUROTOL, V34, P1642, DOI 10.1097/MAO.0b013e3182a0034e; Perreau Ann E, 2007, Am J Audiol, V16, P85; Peterson NR, 2010, RESTOR NEUROL NEUROS, V28, P237, DOI 10.3233/RNN-2010-0535; Potts LG, 2009, J AM ACAD AUDIOL, V20, P353, DOI 10.3766/jaaa.20.6.4; Ryugo DK, 1997, J COMP NEUROL, V385, P230, DOI 10.1002/(SICI)1096-9861(19970825)385:2<230::AID-CNE4>3.0.CO;2-2; Sammeth Carol A., 2011, Seminars in Hearing, V32, P3, DOI 10.1055/s-0031-1271945; Shepherd RK, 2008, HEARING RES, V242, P100, DOI 10.1016/j.heares.2007.12.005; Teoh SW, 2004, LARYNGOSCOPE, V114, P1714, DOI 10.1097/00005537-200410000-00007; Teoh SW, 2004, LARYNGOSCOPE, V114, P1536; Toner J, 2004, EAR HEARING, V25, P310, DOI 10.1097/01.AUD.0000134549.48718.53; Waltzmann SB, 2002, OTOL NEUROTOL, V23, P333, DOI 10.1097/00129492-200205000-00018; Wilson BS, 2008, J REHABIL RES DEV, V45, P695, DOI 10.1682/JRRD.2007.10.0173	41	19	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0129167	10.1371/journal.pone.0129167	http://dx.doi.org/10.1371/journal.pone.0129167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043227	Green Published, gold			2022-12-27	WOS:000355701600092
J	Latif, N; Quillon, A; Sarathchandra, P; McCormack, A; Lozanoski, A; Yacoub, MH; Chester, AH				Latif, Najma; Quillon, Alfred; Sarathchandra, Padmini; McCormack, Ann; Lozanoski, Alec; Yacoub, Magdi H.; Chester, Adrian H.			Modulation of Human Valve Interstitial Cell Phenotype and Function Using a Fibroblast Growth Factor 2 Formulation	PLOS ONE			English	Article							AORTIC-VALVE; MYOFIBROBLAST ACTIVATION; HEART-VALVES; MYOCARDIN; REPAIR; CALCIFICATION; INSULIN	Valve interstitial cells (VICs) are fibroblastic in nature however in culture it is widely accepted that they differentiate into a myofibroblastic phenotype. This study assessed a fibroblast culture media formulation for its ability to maintain the phenotype and function of VICs as in the intact healthy valve. Normal human VICs were cultured separately in standard DMEM and in fibroblast media consisting of FGF2 (10ng/ml), insulin (50ng/ml) and 2% FCS for at least a week. Cell morphology, aspect ratio, size, levels and distribution of protein expression, proliferation, cell cycle, contraction and migration were assessed. Some VICs and some valve endothelial cells expressed FGF2 in valve tissue and this expression was increased in calcified valves. VICs in DMEM exhibited large, spread cells whereas VICs in fibroblast media were smaller, elongated and spindly. Aspect ratio and size were both significantly higher in DMEM (p<0.01). The level of expression of alpha-SMA was significantly reduced in fibroblast media at day 2 after isolation (p<0.01) and the expression of alpha-SMA, SM22 and EDA-fibronectin was significantly reduced in fibroblast media at days 7 and 12 post-isolation (p<0.01). Expression of cytoskeletal proteins, bone marker proteins and extracellular matrix proteins was reduced in fibroblast media. Proliferation of VICs in fibroblast media was significantly reduced at weeks 1 (p<0.05) and 2 (p<0.01). Collagen gel contraction was significantly reduced in fibroblast media (p<0.05). VICs were found to have significantly fewer and smaller focal adhesions in fibroblast media (p<0.01) with significantly fewer supermature focal adhesions in fibroblast media (p<0.001). Ultrastructurally, VICs in fibroblast media resembled native VICs from intact valves. VICs in fibroblast media demonstrated a slower migratory ability after wounding at 72 hours (p<0.01). Treatment of human VICs with this fibroblast media formulation has the ability to maintain and to dedifferentiate the VICs back to a fibroblastic phenotype with phenotypic and functional characteristics ascribed to cells in the intact valve. This methodology is fundamental in the study of normal valve biology, pathology and in the field of tissue engineering.	[Latif, Najma; Sarathchandra, Padmini; McCormack, Ann; Lozanoski, Alec; Yacoub, Magdi H.; Chester, Adrian H.] Univ London Imperial Coll Sci Technol & Med, Harefield Hosp, Heart Sci Ctr, Harefield UB9 6JH, Middx, England; [Latif, Najma; Yacoub, Magdi H.; Chester, Adrian H.] Qatar Fdn, Qatar Cardiovasc Res Ctr, QCRC, Doha, Qatar; [Quillon, Alfred] Univ Lyon, Ecole Normale Super Lyon, Dept Biol, UCB Lyon1, F-69365 Lyon, France	Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Computing Research Institute; Qatar Cardiovascular Research Center; Ecole Normale Superieure de Lyon (ENS de LYON)	Latif, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Harefield Hosp, Heart Sci Ctr, Harefield UB9 6JH, Middx, England.	n.latif@imperial.ac.uk	LATIF, NAJMA/AAT-1973-2021	LATIF, NAJMA/0000-0002-5622-2150	Magdi Yacoub Institute	Magdi Yacoub Institute	Funding provided by Magdi Yacoub Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa E, 2006, CIRCULATION, V113, P1344, DOI 10.1161/CIRCULATIONAHA.105.591768; BAIRATI A, 1981, ANAT EMBRYOL, V161, P329, DOI 10.1007/BF00301830; Balachandran K, 2009, AM J PHYSIOL-HEART C, V296, pH756, DOI 10.1152/ajpheart.00900.2008; Chester Adrian H, 2014, Glob Cardiol Sci Pract, V2014, P52, DOI 10.5339/gcsp.2014.11; Crider BJ, 2011, J INVEST DERMATOL, V131, P2378, DOI 10.1038/jid.2011.219; Cushing MC, 2008, FASEB J, V22, P1769, DOI 10.1096/fj.07-087627; Della Rocca F, 2000, ANN THORAC SURG, V70, P1594, DOI 10.1016/S0003-4975(00)01979-2; FILIP DA, 1986, CIRC RES, V59, P310, DOI 10.1161/01.RES.59.3.310; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Galeone A, 2013, INT J CARDIOL, V169, P296, DOI 10.1016/j.ijcard.2013.09.012; Gotlieb AI, 2002, J THORAC CARDIOV SUR, V124, P591, DOI 10.1067/mtc.2002.123812; Greenberg RS, 2006, FASEB J, V20, P1006, DOI 10.1096/fj.05-4838fje; Guettler S, 2008, MOL CELL BIOL, V28, P732, DOI 10.1128/MCB.01623-07; Han L, 2012, CARDIOVASC PATHOL, V21, P382, DOI 10.1016/j.carpath.2011.12.001; Han L, 2011, AM J PATHOL, V178, P119, DOI 10.1016/j.ajpath.2010.11.038; Hinton RB, 2011, ANNU REV PHYSIOL, V73, P29, DOI 10.1146/annurev-physiol-012110-142145; Hinton RB, 2006, CIRC RES, V98, P1431, DOI 10.1161/01.RES.0000224114.65109.4e; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Iovino S, 2014, DIABETES, V63, P4130, DOI 10.2337/db14-0109; JOHNSON CM, 1987, J MOL CELL CARDIOL, V19, P1185, DOI 10.1016/S0022-2828(87)80529-1; Latif N, 2007, J HEART VALVE DIS, V16, P56; Latif N, 2015, EUR HEART J, V36, P1335, DOI 10.1093/eurheartj/eht547; LESTER W, 1988, LAB INVEST, V59, P710; Liao S, 2009, DEV DYNAM, V238, P249, DOI 10.1002/dvdy.21677; Liu AC, 2007, AM J PATHOL, V171, P1407, DOI 10.2353/ajpath.2007.070251; Mack CP, 2000, CIRC RES, V86, P221, DOI 10.1161/01.RES.86.2.221; MESSIER RH, 1994, J SURG RES, V57, P1, DOI 10.1006/jsre.1994.1102; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5; Okada S, 1998, EMBO J, V17, P2554, DOI 10.1093/emboj/17.9.2554; Poggio P, 2014, ARTERIOSCL THROM VAS, V34, P2086, DOI 10.1161/ATVBAHA.113.303017; Rabkin-Aikawa E, 2004, J HEART VALVE DIS, V13, P841; Rohr S, 2011, J CARDIOVASC PHARM, V57, P389, DOI 10.1097/FJC.0b013e3182137e17; Shimizu A, 2001, J BIOL CHEM, V276, P11031, DOI 10.1074/jbc.M003535200; Siddle K, 2011, J MOL ENDOCRINOL, V47, pR1, DOI 10.1530/JME-11-0022; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Somers P, 2012, GROWTH FACTORS, V30, P37, DOI 10.3109/08977194.2011.634411; Strassburger K, 2012, DEV BIOL, V367, P187, DOI 10.1016/j.ydbio.2012.05.008; Sun W, 2013, GENOMICS, V101, P326, DOI 10.1016/j.ygeno.2013.03.004; Taylor PM, 2000, J HEART VALVE DIS, V9, P150; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Yip CYY, 2009, ARTERIOSCL THROM VAS, V29, P936, DOI 10.1161/ATVBAHA.108.182394; ZACKS S, 1991, ARCH PATHOL LAB MED, V115, P774	43	47	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0127844	10.1371/journal.pone.0127844	http://dx.doi.org/10.1371/journal.pone.0127844			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042674	Green Published, gold, Green Submitted			2022-12-27	WOS:000355701600025
J	Tonnessen, E; Svendsen, IS; Olsen, IC; Guttormsen, A; Haugen, T				Tonnessen, Espen; Svendsen, Ida Siobhan; Olsen, Inge Christoffer; Guttormsen, Atle; Haugen, Thomas			Performance Development in Adolescent Track and Field Athletes According to Age, Sex and Sport Discipline	PLOS ONE			English	Article							SKELETAL MATURITY; GROWTH; MATURATION; INJURIES; MEDICINE; WOMEN; MEN	Introduction Sex-specific differences that arise during puberty have a pronounced effect on the training process. However, the consequences this should have for goal-setting, planning and implementation of training for boys and girls of different ages remains poorly understood. The aim of this study was to quantify performance developments in athletic running and jumping disciplines in the age range 11-18 and identify progression differences as a function of age, discipline and sex. Methods The 100 all-time best Norwegian male and female 60-m, 800-m, long jump and high jump athletes in each age category from 11 to 18 years were analysed using mixed models with random intercept according to athlete. Results Male and female athletes perform almost equally in running and jumping events up to the age of 12. Beyond this age, males outperform females. Relative annual performance development in females gradually decreases throughout the analyzed age period. In males, annual relative performance development accelerates up to the age of 13 (for running events) or 14 (for jumping events) and then gradually declines when approaching 18 years of age. The relative improvement from age 11 to 18 was twice as high in jumping events compared to running events. For all of the analyzed disciplines, overall improvement rates were >50% higher for males than for females. The performance sex difference evolves from < 5% to 10-18% in all the analyzed disciplines from age 11 to 18 yr. Conclusion To the authors' knowledge, this is the first study to present absolute and relative annual performance developments in running and jumping events for competitive athletes from earlyto late adolescence. These results allow coaches and athletes to set realistic goals and prescribe conditioning programs that take into account sex-specific differences in the rate of performance development at different stages of maturation.	[Tonnessen, Espen; Haugen, Thomas] Norwegian Olymp Federat, Oslo, Norway; [Svendsen, Ida Siobhan] Univ Loughborough, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Olsen, Inge Christoffer] Diakonhjemmet, Oslo, Norway; [Guttormsen, Atle] Univ Life Sci, As, Norway	Loughborough University; Diakonhjemmet Hospital; Norwegian University of Life Sciences	Tonnessen, E (corresponding author), Norwegian Olymp Federat, Oslo, Norway.	espen.tonnessen@olympiatoppen.no	Olsen, Inge Christoffer/R-9128-2019; Haugen, Thomas/AAQ-5280-2021; Guttormsen, Atle/GZG-2356-2022; Haugen, Thomas/I-9580-2015	Olsen, Inge Christoffer/0000-0001-6889-5873; Haugen, Thomas/0000-0001-5929-0389				Armstrong N, 1999, J APPL PHYSIOL, V87, P2230, DOI 10.1152/jappl.1999.87.6.2230; Atkinson G, 2012, INT J SPORTS MED, V33, P505, DOI 10.1055/s-0032-1316355; Berthelot G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001552; Beunen G, 1978, PHYSICAL FITNESS ASS, P229; Beunen G, 2008, THE YOUNG ATHLETE; Cheuvront SN, 2005, SPORTS MED, V35, P1017, DOI 10.2165/00007256-200535120-00002; Eisenmann JC, 2003, J SPORT SCI, V21, P551, DOI 10.1080/0264041031000101845; Geithner CA, 2004, MED SCI SPORT EXER, V36, P1616, DOI 10.1249/01.MSS.0000139807.72229.41; Goswami B., 2014, AM J SPORT MED, V2, P34, DOI 10.12691/ajssm-2-5A-8; Hewett TE, 2004, J BONE JOINT SURG AM, V86A, P1601, DOI 10.2106/00004623-200408000-00001; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Krahenbuhl G S, 1985, Exerc Sport Sci Rev, V13, P503; LEES A, 1994, J APPL BIOMECH, V10, P61, DOI 10.1123/jab.10.1.61; Little NG, 1997, AM J HUM BIOL, V9, P163, DOI 10.1002/(SICI)1520-6300(1997)9:2<163::AID-AJHB2>3.0.CO;2-1; LOUCKS AB, 1992, MED SCI SPORT EXER, V24, pS288; Malina R.M., 2004, GROWTH MATURATION PH, V2nd ed., DOI DOI 10.1016/j.jsams.2011.04.003; MALINA RM, 1988, ANNU REV ANTHROPOL, V17, P187, DOI 10.1146/annurev.an.17.100188.001155; Malina RM, 1997, INT J SPORTS MED, V18, pS179, DOI 10.1055/s-2007-972711; MALINA RM, 1986, ANN HUM BIOL, V13, P331, DOI 10.1080/03014468600008511; Malina RM, 2014, RES Q EXERCISE SPORT, V85, P157, DOI 10.1080/02701367.2014.897592; Malina RM, 2010, J HUM KINET, V24, P79, DOI 10.2478/v10078-010-0023-4; Myer GD, 2004, SCAND J MED SCI SPOR, V14, P275, DOI 10.1111/j.1600-0838.2004.00410.x; Nevill AM, 2005, MED SCI SPORT EXER, V37, P1785, DOI 10.1249/01.mss.0000181676.62054.79; Norwegian Athletics Federation, ALL TIM BEST STAT; Schmidt R. A., 2008, MOTOR LEARNING PERFO; Seiler S, 2007, MED SCI SPORT EXER, V39, P534, DOI 10.1249/01.mss.0000247005.17342.2b; Seyfarth A, 1999, J BIOMECH, V32, P1259, DOI 10.1016/S0021-9290(99)00137-2; Siervogel RM, 2003, HORM RES, V60, P36, DOI 10.1159/000071224; TANNER JM, 1976, ANN HUM BIOL, V3, P109, DOI 10.1080/03014467600001231; Thibault V, 2010, J SPORT SCI MED, V9, P214; TURSZ A, 1986, AM J SPORT MED, V14, P294, DOI 10.1177/036354658601400409; Valente-dos-Santos J, 2012, J SPORT SCI MED, V11, P371	32	55	57	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0129014	10.1371/journal.pone.0129014	http://dx.doi.org/10.1371/journal.pone.0129014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043192	Green Published, gold, Green Accepted			2022-12-27	WOS:000355701600082
J	Uehara, Y; Oda, K; Ikeda, Y; Koso, T; Tsuji, S; Yamamoto, S; Asada, K; Sone, K; Kurikawa, R; Makii, C; Hagiwara, O; Tanikawa, M; Maeda, D; Hasegawa, K; Nakagawa, S; Wada-Hiraike, O; Kawana, K; Fukayama, M; Fujiwara, K; Yano, T; Osuga, Y; Fujii, T; Aburatani, H				Uehara, Yuriko; Oda, Katsutoshi; Ikeda, Yuji; Koso, Takahiro; Tsuji, Shingo; Yamamoto, Shogo; Asada, Kayo; Sone, Kenbun; Kurikawa, Reiko; Makii, Chinami; Hagiwara, Otoe; Tanikawa, Michihiro; Maeda, Daichi; Hasegawa, Kosei; Nakagawa, Shunsuke; Wada-Hiraike, Osamu; Kawana, Kei; Fukayama, Masashi; Fujiwara, Keiichi; Yano, Tetsu; Osuga, Yutaka; Fujii, Tomoyuki; Aburatani, Hiroyuki			Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas	PLOS ONE			English	Article							GENE-EXPRESSION; POOR-PROGNOSIS; CANCER; MUTATIONS; PIK3CA; ARID1A; INSTABILITY; ENDOMETRIOSIS; SIGNATURE; REFLECTS	Ovarian clear cell carcinoma (CCC) is generally associated with chemoresistance and poor clinical outcome, even with early diagnosis; whereas high-grade serous carcinomas (SCs) and endometrioid carcinomas (ECs) are commonly chemosensitive at advanced stages. Although an integrated genomic analysis of SC has been performed, conclusive views on copy number and expression profiles for CCC are still limited. In this study, we performed single nucleotide polymorphism analysis with 57 epithelial ovarian cancers (31 CCCs, 14 SCs, and 12 ECs) and microarray expression analysis with 55 cancers (25 CCCs, 16 SCs, and 14 ECs). We then evaluated PIK3CA mutations and ARID1A expression in CCCs. SNP array analysis classified 13% of CCCs into a cluster with high frequency and focal range of copy number alterations (CNAs), significantly lower than for SCs (93%, P < 0.01) and ECs (50%, P = 0.017). The ratio of whole-arm to all CNAs was higher in CCCs (46.9%) than SCs (21.7%; P < 0.0001). SCs with loss of heterozygosity (LOH) of BRCA1 (85%) also had LOH of NF1 and TP53, and LOH of BRCA2 (62%) coexisted with LOH of RB1 and TP53. Microarray analysis classified CCCs into three clusters. One cluster (CCC-2, n = 10) showed more favorable prognosis than the CCC-1 and CCC-3 clusters (P = 0.041). Coexistent alterations of PIK3CA and ARID1A were more common in CCC-1 and CCC-3 (7/11, 64%) than in CCC2 (0/10, 0%; P < 0.01). Being in cluster CCC-2 was an independent favorable prognostic factor in CCC. In conclusion, CCC was characterized by a high ratio of whole-arm CNAs; whereas CNAs in SC were mainly focal, but preferentially caused LOH of well-known tumor suppressor genes. As such, expression profiles might be useful for sub-classification of CCC, and might provide useful information on prognosis.	[Uehara, Yuriko; Koso, Takahiro; Tsuji, Shingo; Yamamoto, Shogo; Asada, Kayo; Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo, Japan; [Uehara, Yuriko; Oda, Katsutoshi; Ikeda, Yuji; Koso, Takahiro; Asada, Kayo; Sone, Kenbun; Kurikawa, Reiko; Makii, Chinami; Hagiwara, Otoe; Tanikawa, Michihiro; Wada-Hiraike, Osamu; Kawana, Kei; Osuga, Yutaka; Fujii, Tomoyuki] Univ Tokyo, Dept Obstet & Gynecol, Tokyo, Japan; [Maeda, Daichi; Fukayama, Masashi] Univ Tokyo, Dept Pathol, Tokyo, Japan; [Hasegawa, Kosei; Fujiwara, Keiichi] Saitama Med Univ, Int Med Ctr, Dept Obstet & Gynecol, Saitama, Japan; [Nakagawa, Shunsuke] Teikyo Univ Int, Dept Obstet & Gynecol, Tokyo, Japan; [Yano, Tetsu] Natl Ctr Global Hlth & Med, Dept Obstet & Gynecol, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Saitama Medical University; National Center for Global Health & Medicine - Japan	Oda, K (corresponding author), Univ Tokyo, Dept Obstet & Gynecol, Tokyo, Japan.	katsutoshi-tky@umin.ac.jp		Wada-Hiraike, Osamu/0000-0002-3458-6711	Ministry of Education, Science, Sports, and Culture [24221011]; Ministry of Education, Culture, Sports, Science and Technology of Japan [26462515, 25861473]; Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) Grant, Ministry of Education, Culture, Sports, Science and Technology of Japan [11114014]	Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) Grant, Ministry of Education, Culture, Sports, Science and Technology of Japan	Grant Support: Ministry of Education, Science, Sports, and Culture Grant Number: Scientific Research (S) 24221011 (to H. Aburatani); the Grant-in-aid for Scientific Research (C), Grant Number 26462515 (to K. Oda), and the Grant-in-aid for Young Scientific Research (B), Grant Number 25861473 (to Y. Uehara) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and a research program grant (to T. Yano) from the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) Grant Number 11114014, Ministry of Education, Culture, Sports, Science and Technology of Japan.	Anglesio MS, 2011, GYNECOL ONCOL, V121, P407, DOI 10.1016/j.ygyno.2011.01.005; Berns EMJJ, 2012, CANCER RES, V72, P2701, DOI 10.1158/0008-5472.CAN-11-3911; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Chan JK, 2008, GYNECOL ONCOL, V109, P370, DOI 10.1016/j.ygyno.2008.02.006; Chapman KB, 2012, FUTURE ONCOL, V8, P1031, DOI [10.2217/FON.12.79, 10.2217/fon.12.79]; Cheon DJ, 2014, CLIN CANCER RES, V20, P711, DOI 10.1158/1078-0432.CCR-13-1256; Fujiwara T, 2012, LUNG CANCER, V75, P119, DOI 10.1016/j.lungcan.2011.05.028; Fukunaga M, 1997, HISTOPATHOLOGY, V30, P249, DOI 10.1046/j.1365-2559.1997.d01-592.x; Gelmon KA, 2011, LANCET ONCOL, V12, P852, DOI 10.1016/S1470-2045(11)70214-5; Guan B, 2011, AM J SURG PATHOL, V35, P625, DOI 10.1097/PAS.0b013e318212782a; Haverty PM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-21; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; Huang RY, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-47; Hutti JE, 2012, CANCER RES, V72, P3260, DOI 10.1158/0008-5472.CAN-11-4141; Ishikawa S, 2005, BIOCHEM BIOPH RES CO, V333, P1309, DOI 10.1016/j.bbrc.2005.06.040; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kashiyama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087220; Kuo KT, 2010, CLIN CANCER RES, V16, P1997, DOI 10.1158/1078-0432.CCR-09-2105; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; Ledermann J, 2012, NEW ENGL J MED, V366, P1382, DOI 10.1056/NEJMoa1105535; Lee YY, 2011, GYNECOL ONCOL, V122, P541, DOI 10.1016/j.ygyno.2011.05.009; Li CG, 2011, ONCOGENE, V30, P4824, DOI 10.1038/onc.2011.190; Maeda D, 2010, INT J MOL SCI, V11, P5121, DOI 10.3390/ijms11125120; Marquez RT, 2005, CLIN CANCER RES, V11, P6116, DOI 10.1158/1078-0432.CCR-04-2509; Morita Y, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-14; Murayama-Hosokawa S, 2010, ONCOGENE, V29, P1897, DOI 10.1038/onc.2009.474; Oda K, 2005, CANCER RES, V65, P10669, DOI 10.1158/0008-5472.CAN-05-2620; Oda K, 2008, CANCER RES, V68, P8127, DOI 10.1158/0008-5472.CAN-08-0755; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rahman MT, 2012, CANCER-AM CANCER SOC, V118, P2846, DOI 10.1002/cncr.26598; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Schwartz DR, 2002, CANCER RES, V62, P4722; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Tan DSP, 2011, CLIN CANCER RES, V17, P1521, DOI 10.1158/1078-0432.CCR-10-1688; Tsuchiya A, 2003, AM J PATHOL, V163, P2503, DOI 10.1016/S0002-9440(10)63605-X; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Walsh CS, 2008, CLIN CANCER RES, V14, P7645, DOI 10.1158/1078-0432.CCR-08-1291; Wang ZGC, 2012, CLIN CANCER RES, V18, P5806, DOI 10.1158/1078-0432.CCR-12-0857; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Yamaguchi K, 2010, ONCOGENE, V29, P1741, DOI 10.1038/onc.2009.470; Yamaguchi K, 2008, CLIN CANCER RES, V14, P32, DOI 10.1158/1078-0432.CCR-07-1614; Yamamoto S, 2008, J PATHOL, V216, P103, DOI 10.1002/path.2386; Yamamoto S, 2012, MODERN PATHOL, V25, P615, DOI 10.1038/modpathol.2011.189; Yang JY, 2013, J CLIN INVEST, V123, P3740, DOI 10.1172/JCI68509; Yang Y, 2015, INT J CANCER, V136, pE39, DOI 10.1002/ijc.29150; Zorn KK, 2005, CLIN CANCER RES, V11, P6422, DOI 10.1158/1078-0432.CCR-05-0508	49	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128066	10.1371/journal.pone.0128066	http://dx.doi.org/10.1371/journal.pone.0128066			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043110	gold, Green Published, Green Submitted			2022-12-27	WOS:000355701600031
J	Irwin, RW; Solinsky, CM; Loya, CM; Salituro, FG; Rodgers, KE; Bauer, G; Rogawski, MA; Brinton, RD				Irwin, Ronald W.; Solinsky, Christine M.; Loya, Carlos M.; Salituro, Francesco G.; Rodgers, Kathleen E.; Bauer, Gerhard; Rogawski, Michael A.; Brinton, Roberta Diaz			Allopregnanolone Preclinical Acute Pharmacokinetic and Pharmacodynamic Studies to Predict Tolerability and Efficacy for Alzheimer's Disease	PLOS ONE			English	Article							NEUROACTIVE STEROID ALLOPREGNANOLONE; NEURAL PROGENITOR CELLS; NEUROSTEROID ALLOPREGNANOLONE; HIPPOCAMPAL NEUROGENESIS; HEALTHY WOMEN; HUMAN BRAIN; RAT-BRAIN; IN-VITRO; STRESS; GABA	To develop allopregnanolone as a therapeutic for Alzheimer's disease, we investigated multiple formulations and routes of administration in translationally relevant animal models of both sexes. Subcutaneous, topical (transdermal and intranasal), intramuscular, and intravenous allopregnanolone were bolus-administered. Pharmacokinetic analyses of intravenous allopregnanolone in rabbit and mouse indicated that peak plasma and brain levels (3-fold brain/plasma ratios) at 5min were sufficient to activate neuroregenerative responses at subsedative doses. Slow-release subcutaneous suspension of allopregnanolone displayed 5-fold brain/plasma ratio at C-max at 30min. At therapeutic doses by either subcutaneous or intravenous routes, allopregnanolone mouse plasma levels ranged between 34-51ng/ml by 30min, comparable to published endogenous human level in the third trimester of pregnancy. Exposure to subcutaneous, topical, intramuscular, and intravenous allopregnanolone, at safe and tolerable doses, increased hippocampal markers of neurogenesis including BrdU and PCNA in young 3xTgAD and aged wildtype mice. Intravenous allopregnanolone transiently and robustly phosphorylated CREB within 5min and increased levels of neuronal differentiation transcription factor NeuroD within 4h. Neurogenic efficacy was achieved with allopregnanolone brain exposure of 300-500hr*ng/g. Formulations were tested to determine the no observable adverse effect level (NOAEL) and maximally tolerated doses (MTD) in male and female rats by sedation behavior time course. Sex differences were apparent, males exhibited >= 40% more sedation time compared to females. Allopregnanolone formulated in sulfobutyl-ether-beta-cyclodextrin at optimized complexation ratio maximized allopregnanolone delivery and neurogenic efficacy. To establish the NOAEL and MTD for Allo-induced sedation using a once-per-week intravenous regenerative treatment regimen: In female rats the NOAEL was 0.5mg/kg and MTD 2mg/kg. The predicted MTD in human female is 0.37mg/kg. In male rats the NOAEL and MTD were less than those determined for female. Outcomes of these PK/PD studies predict a safe and efficacious dose range for initial clinical trials of allopregnanolone for Alzheimer's disease. These findings have translational relevance to multiple neurodegenerative conditions.	[Irwin, Ronald W.; Brinton, Roberta Diaz] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Solinsky, Christine M.] Univ So Calif, Clin & Expt Therapeut Program, Los Angeles, CA USA; [Loya, Carlos M.; Salituro, Francesco G.] Sage Therapeut, Cambridge, MA USA; [Rodgers, Kathleen E.] Univ So Calif, Sch Pharm, Family Dept Clin Pharm & Pharmaceut Econ & Policy, Los Angeles, CA USA; [Bauer, Gerhard] Univ Calif Davis, Sch Med, Dept Internal Med, Sacramento, CA 95817 USA; [Rogawski, Michael A.] Univ Calif Davis, Sch Med, Dept Neurol, Sacramento, CA 95817 USA; [Brinton, Roberta Diaz] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of California System; University of California Davis; University of California System; University of California Davis; University of Southern California	Brinton, RD (corresponding author), Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA.	rbrinton@usc.edu	Irwin, Ronald W./N-8686-2013; Rogawski, Michael A/B-6353-2009	Irwin, Ronald W./0000-0002-6969-6021; Rogawski, Michael A/0000-0002-3296-8193	National Institute on Aging [U01 AG031115, U01 AG047222]; Department of Defense [W81XWH-09-1-0746]; NATIONAL INSTITUTE ON AGING [U01AG047222, U01AG031115] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institute on Aging (http://www.nia.nih.gov/) U01 AG031115 and U01 AG047222 to RDB. Allopregnanolone was supplied through support by the Department of Defense under award number W81XWH-09-1-0746 to MAR. Views and opinions of, and endorsements by the authors do not reflect those of the US Army or the Department of Defense. Sage Therapeutics, Cambridge MA supported the mouse pharmacokinetic LC-MS/MS data acquisition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's Association, 2013, ALZH DIS FACTS FIG; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Bilsland JG, 2006, J NEUROSCI METH, V157, P54, DOI 10.1016/j.jneumeth.2006.03.026; Brinton RD, 2013, NAT REV ENDOCRINOL, V9, P241, DOI 10.1038/nrendo.2013.31; Caruso D, 2010, J NEUROENDOCRINOL, V22, P1137, DOI 10.1111/j.1365-2826.2010.02064.x; Caruso D, 2013, NEUROBIOL AGING, V34, P1080, DOI 10.1016/j.neurobiolaging.2012.10.007; Chen SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024293; ClinicalTrials.gov, 2014, ALL MILD COGN IMP DU; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; D'Ascenzo M, 2006, EUR J NEUROSCI, V23, P935, DOI 10.1111/j.1460-9568.2006.04628.x; Damianisch K, 2001, NEUROPSYCHOPHARMACOL, V25, P576, DOI 10.1016/S0893-133X(01)00242-1; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; FDA Center for Drug Evaluation and Research (CDER), 2005, GUID IND EST MAX SAF; FRIEDEMANN MN, 1992, NEUROBIOL AGING, V13, P325, DOI 10.1016/0197-4580(92)90046-Z; Girdler SS, 2001, BIOL PSYCHIAT, V49, P788, DOI 10.1016/S0006-3223(00)01044-1; Girdler SS, 2012, PSYCHONEUROENDOCRINO, V37, P543, DOI 10.1016/j.psyneuen.2011.08.004; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Grant KA, 2008, J PHARMACOL EXP THER, V326, P354, DOI 10.1124/jpet.108.137315; Griffin LD, 2004, NAT MED, V10, P704, DOI 10.1038/nm1073; Henry S, 2009, BIOSCI TRENDS, V3, P233; Irwin RW, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00203; Irwin RW, 2014, PROG NEUROBIOL, V113, P40, DOI 10.1016/j.pneurobio.2013.08.004; Irwin Ronald W, 2011, Front Endocrinol (Lausanne), V2, P117, DOI 10.3389/fendo.2011.00117; JUPTNER M, 1990, EXP BRAIN RES, V81, P297; Kask K, 2008, PSYCHOPHARMACOLOGY, V199, P161, DOI 10.1007/s00213-008-1150-7; Kask K, 2009, PHARMACOL BIOCHEM BE, V92, P608, DOI 10.1016/j.pbb.2009.02.014; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Lancel M, 1997, J PHARMACOL EXP THER, V282, P1213; Lazarov O, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00043; Lepski G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00155; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Luisi S, 2000, J CLIN ENDOCR METAB, V85, P2429, DOI 10.1210/jc.85.7.2429; Luke DR, 2010, J PHARM SCI-US, V99, P3291, DOI 10.1002/jps.22109; Magnaghi V, 2010, J NEUROCHEM, V112, P980, DOI 10.1111/j.1471-4159.2009.06512.x; Marx CE, 2003, NEUROPSYCHOPHARMACOL, V28, P1, DOI 10.1038/sj.npp.1300015; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; PURDY RH, 1991, P NATL ACAD SCI USA, V88, P4553, DOI 10.1073/pnas.88.10.4553; Ramirez M, 2012, NEUROSCIENCE, V224, P210, DOI 10.1016/j.neuroscience.2012.08.044; Rao MS, 2006, AGING CELL, V5, P545, DOI 10.1111/j.1474-9726.2006.00243.x; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Rogawski MA, 2013, Edible oils to enhance delivery of orally administered steroids patent, Patent No. [WO 2013043985 A1, 2013043985]; Rogawski MA, 2013, EPILEPSIA, V54, P93, DOI 10.1111/epi.12289; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Singh C, 2012, NEUROBIOL AGING, V33, P1493, DOI 10.1016/j.neurobiolaging.2011.06.008; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Steinmetz Karen L., 2009, BMC Pharmacology, V9, pS2, DOI 10.1186/1471-2377-9-S1-S2; Stella VJ, 2008, TOXICOL PATHOL, V36, P30, DOI 10.1177/0192623307310945; Timby E, 2006, PSYCHOPHARMACOLOGY, V186, P414, DOI 10.1007/s00213-005-0148-7; van Broekhoven F, 2007, PSYCHONEUROENDOCRINO, V32, P555, DOI 10.1016/j.psyneuen.2007.03.009; WALLACE JE, 1980, J GERONTOL, V35, P364, DOI 10.1093/geronj/35.3.364; Wang JM, 2005, J NEUROSCI, V25, P4706, DOI 10.1523/JNEUROSCI.4520-04.2005; Wang JM, 2010, P NATL ACAD SCI USA, V107, P6498, DOI 10.1073/pnas.1001422107; Wang JM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S11; Weill-Engerer S, 2002, J CLIN ENDOCR METAB, V87, P5138, DOI 10.1210/jc.2002-020878; Zampieri S, 2009, J CELL MOL MED, V13, P3786, DOI 10.1111/j.1582-4934.2008.00493.x; Zolkowska D, 2013, EPILEPSY CURR S1, V13, P11; Zorumski CF, 2013, NEUROSCI BIOBEHAV R, V37, P109, DOI 10.1016/j.neubiorev.2012.10.005	59	28	30	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128313	10.1371/journal.pone.0128313	http://dx.doi.org/10.1371/journal.pone.0128313			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039057	Green Submitted, gold, Green Published			2022-12-27	WOS:000355700700095
J	Kline, DI; Teneva, L; Hauri, C; Schneider, K; Miard, T; Chai, A; Marker, M; Dunbar, R; Caldeira, K; Lazar, B; Rivlin, T; Mitchell, BG; Dove, S; Hoegh-Guldberg, O				Kline, David I.; Teneva, Lida; Hauri, Claudine; Schneider, Kenneth; Miard, Thomas; Chai, Aaron; Marker, Malcolm; Dunbar, Rob; Caldeira, Ken; Lazar, Boaz; Rivlin, Tanya; Mitchell, Brian Gregory; Dove, Sophie; Hoegh-Guldberg, Ove			Six Month In Situ High-Resolution Carbonate Chemistry and Temperature Study on a Coral Reef Flat Reveals Asynchronous pH and Temperature Anomalies	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CLIMATE-CHANGE; OCEAN ACIDIFICATION; CALCIFICATION; SEAWATER; FUTURE; PHOTOSYNTHESIS; VULNERABILITY; DISSOCIATION; VARIABILITY	Understanding the temporal dynamics of present thermal and pH exposure on coral reefs is crucial for elucidating reef response to future global change. Diel ranges in temperature and carbonate chemistry parameters coupled with seasonal changes in the mean conditions define periods during the year when a reef habitat is exposed to anomalous thermal and/or pH exposure. Anomalous conditions are defined as values that exceed an empirically estimated threshold for each variable. We present a 200-day time series from June through December 2010 of carbonate chemistry and environmental parameters measured on the Heron Island reef flat. These data reveal that aragonite saturation state, pH, and pCO(2) were primarily modulated by biologically-driven changes in dissolved organic carbon (DIC) and total alkalinity (TA), rather than salinity and temperature. The largest diel temperature ranges occurred in austral spring, in October (1.5 - 6.6 degrees C) and lowest diel ranges (0.9 - 3.2 degrees C) were observed in July, at the peak of winter. We observed large diel total pH variability, with a maximum range of 7.7 - 8.5 total pH units, with minimum diel average pH values occurring during spring and maximum during fall. As with many other reefs, the nighttime pH minima on the reef flat were far lower than pH values predicted for the open ocean by 2100. DIC and TA both increased from June (end of Fall) to December (end of Spring). Using this high-resolution dataset, we developed exposure metrics of pH and temperature individually for intensity, duration, and severity of low pH and high temperature events, as well as a combined metric. Periods of anomalous temperature and pH exposure were asynchronous on the Heron Island reef flat, which underlines the importance of understanding the dynamics of co-occurrence of multiple stressors on coastal ecosystems.	[Kline, David I.; Mitchell, Brian Gregory] Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, San Diego, CA 92103 USA; [Kline, David I.; Dove, Sophie; Hoegh-Guldberg, Ove] Univ Queensland, Global Change Inst, Brisbane, Qld, Australia; [Kline, David I.; Miard, Thomas; Chai, Aaron; Dove, Sophie; Hoegh-Guldberg, Ove] Univ Queensland, Sch Biol Sci, Coral Reef Ecosyst Lab, Brisbane, Qld, Australia; [Dove, Sophie; Hoegh-Guldberg, Ove] Univ Queensland, ARC Ctr Excellence Coral Reef Studies, Brisbane, Qld, Australia; [Teneva, Lida; Schneider, Kenneth; Dunbar, Rob] Stanford Univ, Environm Earth Syst Sci, Stanford, CA 94305 USA; [Teneva, Lida] Conservat Int, Betty & Gordon Moore Ctr Sci & Oceans, Honolulu, HI 96825 USA; [Schneider, Kenneth; Caldeira, Ken] Carnegie Inst, Dept Global Ecol, Stanford, CA USA; [Hauri, Claudine] Univ Hawaii, Int Pacific Res Ctr, Honolulu, HI 96822 USA; [Hauri, Claudine] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Inst Marine Sci, Fairbanks, AK USA; [Miard, Thomas] Inst Oceanog Paul Ricard, F-83140 Ile Des Embiez Le Brusc, Six Fours Les P, France; [Marker, Malcolm] Univ Queensland, Fac Engn Architecture & Informat Technol, Brisbane, Qld, Australia; [Lazar, Boaz; Rivlin, Tanya] Hebrew Univ Jerusalem, H Steinitz Marine Biol Lab, Interuniv Inst Marine Sci, Elat, Israel	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Queensland; University of Queensland; University of Queensland; Stanford University; Conservation International; Carnegie Institution for Science; University of Hawaii System; University of Alaska System; University of Alaska Fairbanks; University of Queensland; Hebrew University of Jerusalem	Kline, DI (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, San Diego, CA 92103 USA.	dkline@ucsd.edu	Caldeira, Ken/E-7914-2011; Dove, Sophie/I-7873-2013; Hoegh-Guldberg, Ove/ABA-5420-2020; Hauri, Christoph P/B-6192-2013; /AAL-3738-2021	Caldeira, Ken/0000-0002-4591-643X; Dove, Sophie/0000-0003-1823-8634; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Hauri, Christoph P/0000-0002-8751-0585; Mitchell, B. Greg/0000-0002-8550-4333; Kline, David/0000-0001-5128-9439; Dunbar, Robert/0000-0002-9728-5609; Lazar, Boaz/0000-0002-2304-8993	Australian Research Council (ARC) Linkage Infrastructure Equipment and Facilities grant [LE0989608]; ARC Linkage grant [LP0775303]; ARC Centre of Excellence grant [CE0561435]; Queensland Government Smart State Premier's Fellowship; National Science Foundation grant (NSF) [OCE-0729236, ATM-0941760]; Pacific Blue Foundation	Australian Research Council (ARC) Linkage Infrastructure Equipment and Facilities grant(Australian Research Council); ARC Linkage grant(Australian Research Council); ARC Centre of Excellence grant(Australian Research Council); Queensland Government Smart State Premier's Fellowship; National Science Foundation grant (NSF)(National Science Foundation (NSF)); Pacific Blue Foundation	This research was funded by the Australian Research Council (ARC) Linkage Infrastructure Equipment and Facilities grant #LE0989608 (OHG, DK, SD), ARC Linkage grant #LP0775303 (OHG, SD), ARC Centre of Excellence grant #CE0561435 (OHG, SD), a Queensland Government Smart State Premier's Fellowship to OHG, National Science Foundation grants (NSF OCE-0729236, to RBD; and NSF ATM-0941760 to BGM), and the Pacific Blue Foundation (DK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AJ, 2013, ANNU REV MAR SCI, V5, P321, DOI 10.1146/annurev-marine-121211-172241; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P3655, DOI 10.1111/j.1365-2486.2011.02510.x; Anthony KRN, 2002, LIMNOL OCEANOGR, V47, P1417, DOI 10.4319/lo.2002.47.5.1417; Ban SS, 2014, GLOBAL CHANGE BIOL, V20, P681, DOI 10.1111/gcb.12453; Bates NR, 2010, BIOGEOSCIENCES, V7, P2509, DOI 10.5194/bg-7-2509-2010; BELL PRF, 1992, WATER RES, V26, P553, DOI 10.1016/0043-1354(92)90228-V; Boylan P., 2008, PROC 11 INT CORAL RE, V2, P854; Brown CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065765; Cao L, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035072; Chen D, 1997, DEVEL SEDIM, V54, P867; Crabbe MJC, 2008, COMPUT BIOL CHEM, V32, P311, DOI 10.1016/j.compbiolchem.2008.04.001; de Putron SJ, 2011, CORAL REEFS, V30, P321, DOI 10.1007/s00338-010-0697-z; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; Dickson AG, 2003, MAR CHEM, V80, P185, DOI 10.1016/S0304-4203(02)00133-0; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; Doropoulos C, 2012, ECOL LETT, V15, P338, DOI 10.1111/j.1461-0248.2012.01743.x; Dove SG, 2013, P NATL ACAD SCI USA, V110, P15342, DOI 10.1073/pnas.1302701110; Dufault AM, 2012, P ROY SOC B-BIOL SCI, V279, P2951, DOI 10.1098/rspb.2011.2545; Edenhofer O., 2014, CONTRIBUTION WORKING; Erez J, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P151, DOI 10.1007/978-94-007-0114-4_10; Falter JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053303; Frankignoulle M, 1996, MAR ECOL PROG SER, V145, P123, DOI 10.3354/meps145123; Gattuso JP, 1999, P NATL ACAD SCI USA, V96, P13017, DOI 10.1073/pnas.96.23.13017; Gourlay MR, 1993, HERON ISLAND SPOIL D; Gove JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061974; Gray SEC, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004114; Guadayol O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085213; Hauri C, 2013, BIOGEOSCIENCES, V10, P193, DOI 10.5194/bg-10-193-2013; Hauri C, 2013, GEOPHYS RES LETT, V40; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Hofmann GE, 2010, ANNU REV ECOL EVOL S, V41, P127, DOI 10.1146/annurev.ecolsys.110308.120227; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kennedy EV, 2013, CURR BIOL, V23, P912, DOI 10.1016/j.cub.2013.04.020; Kleypas JA, 2009, OCEANOGRAPHY, V22, P108, DOI 10.5670/oceanog.2009.101; Kline DI, 2012, SCI REP-UK, V2, DOI 10.1038/srep00413; Kline DI, 2014, 200 DAY SITU E UNPUB; Koweek D, 2015, CORAL REEFS, V34, P339, DOI 10.1007/s00338-014-1217-3; Lee K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027207; Liu G, 2008, P 11 INT COR REEF S; Manzello DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041715; Marker M, 2010, OCEANS 2010 IEEE SYD, P1, DOI [10.1038/srep00413, DOI 10.1109/OCEANSSYD.2010.5603603]; McGowan HA, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014218; McLeod E, 2012, COAST MANAGE, V40, P651, DOI 10.1080/08920753.2012.728123; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Middlebrook R, 2008, J EXP BIOL, V211, P1050, DOI 10.1242/jeb.013284; Ohde S, 1999, B MAR SCI, V65, P559; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Palumbi SR, 2014, SCIENCE, V344, P895, DOI 10.1126/science.1251336; Price NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043843; Putnam HM, 2011, J EXP MAR BIOL ECOL, V396, P216, DOI 10.1016/j.jembe.2010.10.026; Ricke KL, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034003; SABINE CL, 1995, GLOBAL BIOGEOCHEM CY, V9, P637, DOI 10.1029/95GB02382; Santos IR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046053; Schneider K, 2006, LIMNOL OCEANOGR, V51, P1284, DOI 10.4319/lo.2006.51.3.1284; Schneider K, 2009, LIMNOL OCEANOGR, V54, P1995, DOI 10.4319/lo.2009.54.6.1995; Schoepf V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075049; Shamberger KEF, 2011, MAR CHEM, V127, P64, DOI 10.1016/j.marchem.2011.08.003; Shaw EC, 2013, GLOBAL CHANGE BIOL, V19, P1632, DOI 10.1111/gcb.12154; Shaw EC, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007655; Silverman J, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001974; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; Teneva L, 2013, LIMNOL OCEANOGR, V58, P1851, DOI 10.4319/lo.2013.58.5.1851; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; vanHeuven S. M. A. C., 2009, ORNLCDIAC105B; Ward S., 2002, P1123	71	44	44	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127648	10.1371/journal.pone.0127648	http://dx.doi.org/10.1371/journal.pone.0127648			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039687	Green Submitted, Green Published, gold			2022-12-27	WOS:000355700700070
J	Skeie, E; Strand, E; Pedersen, ER; Bjorndal, B; Bohov, P; Berge, RK; Svingen, GFT; Seifert, R; Ueland, PM; Midttun, O; Ulvik, A; Hustad, S; Drevon, CA; Gregory, JF; Nygard, O				Skeie, Eli; Strand, Elin; Pedersen, Eva R.; Bjorndal, Bodil; Bohov, Pavol; Berge, Rolf K.; Svingen, Gard F. T.; Seifert, Reinhard; Ueland, Per M.; Midttun, Oivind; Ulvik, Arve; Hustad, Steinar; Drevon, Christian A.; Gregory, Jesse F.; Nygard, Ottar			Circulating B-Vitamins and Smoking Habits Are Associated with Serum Polyunsaturated Fatty Acids in Patients with Suspected Coronary Heart Disease: A Cross-Sectional Study	PLOS ONE			English	Article							RAT-LIVER MICROSOMES; PHOSPHATIDYLETHANOLAMINE-N-METHYLTRANSFERASE; LINOLEIC-ACID; FOLIC-ACID; MICROBIOLOGICAL ASSAY; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; MASS-SPECTROMETRY; ARACHIDONIC-ACID; CIGARETTE-SMOKE	The long-chain polyunsaturated fatty acids are considered to be of major health importance, and recent studies indicate that their endogenous metabolism is influenced by B-vitamin status and smoking habits. We investigated the associations of circulating B-vitamins and smoking habits with serum polyunsaturated fatty acids among 1,366 patients who underwent coronary angiography due to suspected coronary heart disease at Haukeland University Hospital, Norway. Of these, 52% provided information on dietary habits by a food frequency questionnaire. Associations were assessed using partial correlation (Spearman's rho). In the total population, the concentrations of most circulating B-vitamins were positively associated with serum n-3 polyunsaturated fatty acids, but negatively with serum n-6 polyunsaturated fatty acids. However, the associations between B-vitamins and polyunsaturated fatty acids tended to be weaker in smokers. This could not be solely explained by differences in dietary intake. Furthermore, plasma cotinine, a marker of recent nicotine exposure, showed a negative relationship with serum n-3 polyunsaturated fatty acids, but a positive relationship with serum n-6 polyunsaturated fatty acids. In conclusion, circulating B-vitamins are, in contrast to plasma cotinine, generally positively associated with serum n-3 polyunsaturated fatty acids and negatively with serum n-6 polyunsaturated fatty acids in patients with suspected coronary heart disease. Further studies should investigate whether B-vitamin status and smoking habits may modify the clinical effects of polyunsaturated fatty acid intake.	[Skeie, Eli; Berge, Rolf K.; Seifert, Reinhard; Nygard, Ottar] Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway; [Strand, Elin; Pedersen, Eva R.; Bjorndal, Bodil; Bohov, Pavol; Svingen, Gard F. T.; Ueland, Per M.; Hustad, Steinar; Nygard, Ottar] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Midttun, Oivind; Ulvik, Arve] Bevital AS, Bergen, Norway; [Drevon, Christian A.] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Gregory, Jesse F.] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA	University of Bergen; Haukeland University Hospital; University of Bergen; University of Oslo; State University System of Florida; University of Florida	Skeie, E (corresponding author), Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway.	eli.skeie@helse-bergen.no	Bjørndal, Bodil/H-6143-2017; Bjørndal, Bodil/HDN-4287-2022; Ueland, Per M/C-7340-2013	Bjørndal, Bodil/0000-0001-9718-5117; Ueland, Per Magne/0000-0002-1903-0571	Norwegian Foundation for Health and Rehabilitation; Norwegian Heart and Lung Patient Organization; Norwegian Ministry of Health and Care Services; Western Norway Regional Health Authority; Department of Heart Disease, Haukeland University Hospital; Johan Throne Holst Foundation for Nutrition Research; Freia Medical Research Fund, Norway	Norwegian Foundation for Health and Rehabilitation; Norwegian Heart and Lung Patient Organization; Norwegian Ministry of Health and Care Services; Western Norway Regional Health Authority; Department of Heart Disease, Haukeland University Hospital; Johan Throne Holst Foundation for Nutrition Research; Freia Medical Research Fund, Norway	This work was supported by the Norwegian Foundation for Health and Rehabilitation, the Norwegian Heart and Lung Patient Organization, the Norwegian Ministry of Health and Care Services, the Western Norway Regional Health Authority, the Department of Heart Disease, Haukeland University Hospital, Johan Throne Holst Foundation for Nutrition Research and Freia Medical Research Fund, Norway. Bevital AS provided support in the form of salaries for authors OM and AU, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abeywardena MY, 2001, CARDIOVASC RES, V52, P361, DOI 10.1016/S0008-6363(01)00406-0; Agaku IT, 2014, AM J EPIDEMIOL, V180, P749, DOI 10.1093/aje/kwu182; Berstad P, 2007, AM J CLIN NUTR, V85, P1598, DOI 10.1093/ajcn/85.6.1598; Bertrandt J, 2004, BIOFACTORS, V22, P189, DOI 10.1002/biof.5520220139; Bilski P, 2000, PHOTOCHEM PHOTOBIOL, V71, P129, DOI 10.1562/0031-8655(2000)071&lt;0129:SIPVBP&gt;2.0.CO;2; Block Robert C, 2008, Open Biomark J, V1, P1, DOI 10.2174/1875318300801010001; Bokor S, 2010, J LIPID RES, V51, P2325, DOI 10.1194/jlr.M006205; Bordoni A, 1998, PROSTAG LEUKOTR ESS, V58, P417, DOI 10.1016/S0952-3278(98)90163-6; COBURN SP, 1990, ANN NY ACAD SCI, V585, P76, DOI 10.1111/j.1749-6632.1990.tb28043.x; Das Undurti N., 2006, Biotechnology Journal, V1, P420, DOI 10.1002/biot.200600012; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Domei T, 2012, CIRC J, V76, P423, DOI 10.1253/circj.CJ-11-0941; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; Eussen SRBM, 2012, EUR HEART J, V33, P1582, DOI 10.1093/eurheartj/ehr499; Ghezzi S, 2007, LIPIDS, V42, P629, DOI 10.1007/s11745-007-3070-4; GIRAUD DW, 1995, AM J CLIN NUTR, V62, P104, DOI 10.1093/ajcn/62.1.104; Harris WS, 2008, AM J CLIN NUTR, V87, p1997S, DOI 10.1093/ajcn/87.6.1997S; JARVIS MJ, 1987, AM J PUBLIC HEALTH, V77, P1435, DOI 10.2105/AJPH.77.11.1435; Jones P, 1998, AM J CARDIOL, V81, P582, DOI 10.1016/S0002-9149(97)00965-X; Joshi R, 2001, FREE RADICAL BIO MED, V30, P1390, DOI 10.1016/S0891-5849(01)00543-3; KELLEHER BP, 1991, J CLIN PATHOL, V44, P592, DOI 10.1136/jcp.44.7.592; Kelly PJ, 2003, STROKE, V34, pE51, DOI 10.1161/01.STR.0000071109.23410.AB; Krajcovickova-Kudlackova M, 2004, ANN NUTR METAB, V48, P118, DOI 10.1159/000077068; Kume A, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-41; Li D, 2006, LIPIDS, V41, P85, DOI 10.1007/s11745-006-5074-x; Liou YA, 2009, PROSTAG LEUKOTR ESS, V80, P201, DOI 10.1016/j.plefa.2009.02.003; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Manger MS, 2010, AM J CLIN NUTR, V92, P244, DOI 10.3945/ajcn.2010.29175; Marti-Carvajal AJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006612.pub3; Midttun O, 2009, RAPID COMMUN MASS SP, V23, P1371, DOI 10.1002/rcm.4013; Molloy AM, 1997, METHOD ENZYMOL, V281, P43; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359; Rise P, 2009, PROSTAG LEUKOTR ESS, V80, P71, DOI 10.1016/j.plefa.2008.11.005; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Robinson K, 1998, CIRCULATION, V97, P437; Roncaglioni MC, 2013, NEW ENGL J MED, V368, P1800, DOI 10.1056/NEJMoa1205409; Rosenson Robert S, 2003, Expert Rev Cardiovasc Ther, V1, P495, DOI 10.1586/14779072.1.4.495; SHE QB, 1994, BIOSCI BIOTECH BIOCH, V58, P459, DOI 10.1271/bbb.58.459; SHE QB, 1995, BIOSCI BIOTECH BIOCH, V59, P163, DOI 10.1271/bbb.59.163; Stavropoulos-Kalinoglou A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2429; Strand E, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-216; Strand E, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-82; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P215, DOI 10.1016/S0753-3322(02)00193-2; The Nordic Council, 2013, NEW NORD NUTR REC 20, P85; TOYOSAKI T, 1992, J AGR FOOD CHEM, V40, P1727, DOI 10.1021/jf00022a001; Ueland PM, 2007, CLIN CHEM LAB MED, V45, P1737, DOI 10.1515/CCLM.2007.339; Ulvik A, 2010, CLIN CHEM, V56, P755, DOI 10.1373/clinchem.2009.137513; van Wijk N, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-49; Vance DE, 2013, BBA-MOL CELL BIOL L, V1831, P626, DOI 10.1016/j.bbalip.2012.07.017; Verhoef P, 1996, AM J EPIDEMIOL, V143, P845, DOI 10.1093/oxfordjournals.aje.a008828; Watkins SM, 2003, J NUTR, V133, P3386, DOI 10.1093/jn/133.11.3386; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; Zhao M, 2013, AM J PHYSIOL-ENDOC M, V304, pE342, DOI 10.1152/ajpendo.00359.2012; Zhao M, 2012, J NUTR, V142, P1791, DOI 10.3945/jn.112.163246	54	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0129049	10.1371/journal.pone.0129049	http://dx.doi.org/10.1371/journal.pone.0129049			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039046	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700139
J	Tsai, CF; Chu, CJ; Huang, YH; Wang, YP; Liu, PY; Lin, HC; Lee, FY; Lu, CL				Tsai, Chia-Fen; Chu, Chi-Jen; Huang, Yi-Hsiang; Wang, Yen-Po; Liu, Pei-Yi; Lin, Han-Chieh; Lee, Fa-Yauh; Lu, Ching-Liang			Detecting Minimal Hepatic Encephalopathy in an Endemic Country for Hepatitis B: The Role of Psychometrics and Serum IL-6	PLOS ONE			English	Article							CHRONIC LIVER-FAILURE; NECROSIS-FACTOR-ALPHA; PROGNOSTIC-SIGNIFICANCE; CONSENSUS STATEMENT; COGNITIVE DECLINE; WORKING PARTY; CIRRHOSIS; INTERLEUKIN-6; DIAGNOSIS; AMMONIA	Background & Aims It remains unknown what the prevalence of minimal hepatic encephalopathy is in Taiwan, a highly endemic country for chronic viral hepatitis infection. It is also unclear whether abnormal serum cytokine levels can be indicative of the presence of minimal hepatic encephalopathy. We aimed to standardize the tests of psychometric hepatic encephalopathy score and predictive value of proinflammatory cytokines in minimal hepatic encephalopathy in Taiwan. Methods 180 healthy subjects and 94 cirrhotic patients without a history of overt hepatic encephalopathy from a tertiary center were invited to participate in this cross-sectional study. Blood sampling for determination of serum levels of interleukin 6 and 18 and tumor necrosis factor-alpha was performed. Based on the normogram of psychometric hepatic encephalopathy score from healthy volunteers, patients with minimal hepatic encephalopathy were identified from the cirrhotic patients using the criterion of a psychometric hepatic encephalopathy score less than -4. Results In the healthy subjects, age and education were predictors of subtests of psychometric hepatic encephalopathy score. Minimal hepatic encephalopathy was identified in 27 (29%) cirrhotic patients. Serum interleukin 6 level (OR = 6.50, 95% CI = 1.64-25.76, P = 0.008) was predictive of the presence of minimal hepatic encephalopathy after multivariate analysis. Conclusions The psychometric hepatic encephalopathy score can be a useful tool for detecting patients with minimal hepatic encephalopathy in Taiwan and around one third of cirrhotic outpatients fulfill this diagnosis. A high serum interleukin 6 level is predictive of the presence of minimal hepatic encephalopathy.	[Tsai, Chia-Fen; Wang, Yen-Po; Liu, Pei-Yi; Lu, Ching-Liang] Natl Yang Ming Univ, Sch Med, Inst Brain Sci, Taipei 112, Taiwan; [Tsai, Chia-Fen; Chu, Chi-Jen; Huang, Yi-Hsiang; Wang, Yen-Po; Lin, Han-Chieh; Lee, Fa-Yauh; Lu, Ching-Liang] Natl Yang Ming Univ, Sch Med, Dept Med, Taipei 112, Taiwan; [Chu, Chi-Jen; Huang, Yi-Hsiang; Wang, Yen-Po; Lin, Han-Chieh; Lee, Fa-Yauh; Lu, Ching-Liang] Taipei Vet Gen Hosp, Div Gastroenterol, Taipei, Taiwan; [Tsai, Chia-Fen] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Lu, CL (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Brain Sci, Taipei 112, Taiwan.	cllu@vghtpe.gov.tw		Huang, Yi-Hsiang/0000-0001-5241-5425; Wang, Yen-Po/0000-0002-3769-0020	Taipei Veterans General Hospital [V99C1-105, V100C-105, V101C-151, V102B-019, V102C-091]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study was supported by grants from the Taipei Veterans General Hospital (V99C1-105, V100C-105, V101C-151, V102B-019, V102C-091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio P, 2008, J HEPATOL, V49, P346, DOI 10.1016/j.jhep.2008.04.022; Bajaj JS, 2011, ALIMENT PHARM THER, V33, P739, DOI 10.1111/j.1365-2036.2011.04590.x; Bajaj JS, 2007, AM J GASTROENTEROL, V102, P1903, DOI 10.1111/j.1572-0241.2007.01424.x; Bajaj JS, 2013, HEPATOLOGY, V58, P1122, DOI 10.1002/hep.26309; Bismuth M, 2011, EUR J GASTROEN HEPAT, V23, P8, DOI 10.1097/MEG.0b013e3283417567; Campbell MS, 2004, ALIMENT PHARM THER, V20, P249, DOI 10.1111/j.1365-2036.2004.02071.x; Cauli O, 2009, J NEUROSCI RES, V87, P1369, DOI 10.1002/jnr.21947; Cordoba J, 2011, J HEPATOL, V54, P1030, DOI 10.1016/j.jhep.2010.11.015; Daniluk J, 2001, ALCOHOL, V23, P29, DOI 10.1016/S0741-8329(00)00134-8; Dhiman RK, 2010, DIGEST DIS SCI, V55, P2381, DOI 10.1007/s10620-010-1249-7; Dhiman RK, 2010, J GASTROEN HEPATOL, V25, P1029, DOI 10.1111/j.1440-1746.2010.06318.x; Duarte-Rojo A, 2011, DIGEST DIS SCI, V56, P3014, DOI 10.1007/s10620-011-1684-0; Economos A, 2013, NEUROEPIDEMIOLOGY, V40, P253, DOI 10.1159/000343276; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Felipo V, 2013, NAT REV NEUROSCI, V14, P851, DOI 10.1038/nrn3587; Felipo V, 2012, METAB BRAIN DIS, V27, P51, DOI 10.1007/s11011-011-9269-3; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Genesca J, 1999, AM J GASTROENTEROL, V94, P169; Goldbecker A, 2013, GUT, V62, P1497, DOI 10.1136/gutjnl-2012-303262; Hartmann IJC, 2000, AM J GASTROENTEROL, V95, P2029; Hiroyasu Morikawa, 2011, CLIN J GASTROENTEROL, V4, P283; Jain L, 2012, DIGEST LIVER DIS, V44, P1027, DOI 10.1016/j.dld.2012.07.002; Kalaitzakis E, 2013, SCAND J GASTROENTERO, V48, P577, DOI 10.3109/00365521.2013.777468; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Krabbe KS, 2005, BRAIN BEHAV IMMUN, V19, P453, DOI 10.1016/j.bbi.2005.04.010; Li SW, 2013, WORLD J GASTROENTERO, V19, P8745, DOI 10.3748/wjg.v19.i46.8745; Luo M, 2013, CLIN RES HEPATOL GAS, V37, P384, DOI 10.1016/j.clinre.2012.08.007; Montoliu C, 2009, J CLIN GASTROENTEROL, V43, P272, DOI 10.1097/MCG.0b013e31815e7f58; Morgan M, 2010, GASTROENTEROLOGY, V29, P91; Odeh M, 2005, ANN MED, V37, P603, DOI 10.1080/07853890500317414; Odeh M, 2004, LIVER INT, V24, P110, DOI 10.1111/j.1478-3231.2004.0894.x; Ong JP, 2003, AM J MED, V114, P188, DOI 10.1016/S0002-9343(02)01477-8; Roman E, 2011, AM J GASTROENTEROL, V106, P476, DOI 10.1038/ajg.2010.413; Romero-Gomez M, 2007, HEPATOLOGY, V45, P879, DOI 10.1002/hep.21586; Seo YS, 2012, J GASTROEN HEPATOL, V27, P1695, DOI 10.1111/j.1440-1746.2012.07217.x; Singh-Manoux A, 2014, NEUROLOGY, V83, P486, DOI 10.1212/WNL.0000000000000665; Stewart CA, 2011, PRIM CARE COMPANION, V13; Swain MG, 2006, CAN J GASTROENTEROL, V20, P181, DOI 10.1155/2006/624832; Taiwan Ministry of Health and Welfare, 2013, 2012 ANN STAT REP CA; Teunissen CE, 2003, J NEUROIMMUNOL, V134, P142, DOI 10.1016/S0165-5728(02)00398-3; Weissenborn K, 2013, METAB BRAIN DIS, V28, P227, DOI 10.1007/s11011-012-9336-4; Wunsch E, 2013, EUR J GASTROEN HEPAT, V25, P1402, DOI 10.1097/MEG.0b013e328365a447; YAMAMOTO Y, 1994, J INT MED RES, V22, P95, DOI 10.1177/030006059402200205; Zahr NM, 2011, NAT REV NEUROL, V7, P284, DOI 10.1038/nrneurol.2011.42; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128437	10.1371/journal.pone.0128437	http://dx.doi.org/10.1371/journal.pone.0128437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039496	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700101
J	Hartman, ML; Talar, B; Gajos-Michniewicz, A; Czyz, M				Hartman, Mariusz L.; Talar, Beata; Gajos-Michniewicz, Anna; Czyz, Malgorzata			MCL-1, BCL-X-L and MITF Are Diversely Employed in Adaptive Response of Melanoma Cells to Changes in Microenvironment	PLOS ONE			English	Article							CANCER STEM-CELLS; THERAPY RESISTANCE; FAMILY PROTEINS; APOPTOSIS; PARTHENOLIDE; METASTASIS; INHIBITION; EXPRESSION; PLASTICITY; SURVIVAL	Melanoma cells can switch their phenotypes in response to microenvironmental insults. Heterogeneous melanoma populations characterized by long-term growth and a high self-renewal capacity can be obtained in vitro in EGF(+)bFGF(+) medium whilst invasive potential of melanoma cells is increased in serum-containing cultures. In the present study, we have shown that originally these patient-derived melanoma populations exhibit variable expression of pro-survival genes from the BCL-2 family and inhibitors of apoptosis (IAPs), and differ in the baseline MCL-1 transcript stability as well. While being transferred to serum-containing medium, melanoma cells are well protected from death. Immediate adaptive response of melanoma cells selectively involves a temporary MCL-1 increase, both at mRNA and protein levels, and BCL-X-L can complement MCL-1, especially in MITFlow populations. Thus, the extent of MCL-1 and BCL-XL contributions seems to be cell context-dependent. An increase in MCL-1 level results from a transiently enhanced stability of its transcript, but not from altered protein turnover. Inhibition of MCL-1 preceding transfer to serum-containing medium caused the induction of cell death in a subset of melanoma cells, which confirms the involvement of MCL-1 in melanoma cell survival during the rapid alteration of growth conditions. Additionally, immediate response to serum involves the transient increase in MITF expression and inhibition of ERK-1/2 activity. Uncovering the mechanisms of adaptive response to rapid changes in microenvironment may extend our knowledge on melanoma biology, especially at the stage of dissemination.	[Hartman, Mariusz L.; Talar, Beata; Gajos-Michniewicz, Anna; Czyz, Malgorzata] Med Univ Lodz, Dept Mol Biol Canc, Lodz, Poland	Medical University Lodz	Czyz, M (corresponding author), Med Univ Lodz, Dept Mol Biol Canc, Lodz, Poland.	malgorzata.czyz@umed.lodz.pl	/S-9995-2016; Czyz, Malgorzata/AAD-1869-2020	Czyz, Malgorzata/0000-0002-8279-4742; Hartman, Mariusz/0000-0002-2231-3740; Gajos-Michniewicz, Anna/0000-0002-6159-4194	National Science Centre [2013/09/N/NZ1/01025]; Medical University of Lodz [502-03/1-156-01/502-14-138]	National Science Centre(National Science Centre, Poland); Medical University of Lodz	Research in the authors' laboratory is supported by Grant 2013/09/N/NZ1/01025 from the National Science Centre and 502-03/1-156-01/502-14-138 from Medical University of Lodz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KW, 2007, J BIOL CHEM, V282, P6192, DOI 10.1074/jbc.M610643200; Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684; Austin M, 2005, J BIOL CHEM, V280, P33280, DOI 10.1074/jbc.M508187200; Bakhshi J, 2008, APOPTOSIS, V13, P904, DOI 10.1007/s10495-008-0221-x; Balakrishnan K, 2014, NEOPLASIA, V16, P1036, DOI 10.1016/j.neo.2014.10.002; Bell RE, 2011, PIGM CELL MELANOMA R, V24, P1088, DOI 10.1111/j.1755-148X.2011.00931.x; Boisvert-Adamo K, 2009, MOL CANCER RES, V7, P549, DOI 10.1158/1541-7786.MCR-08-0358; Bonfanti P, 2010, NATURE, V466, P978, DOI 10.1038/nature09269; Braun F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023577; Buchheit CL, 2014, NAT REV CANCER, V14, P632, DOI 10.1038/nrc3789; Callejo SA, 2007, EYE, V21, P752, DOI 10.1038/sj.eye.6702322; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Cheli Y, 2011, ONCOGENE, V30, P2307, DOI 10.1038/onc.2010.598; Chen G, 2014, HEMATOL ONCOL CLIN N, V28, P523, DOI 10.1016/j.hoc.2014.03.001; Czyz M, 2010, BRIT J PHARMACOL, V160, P1144, DOI 10.1111/j.1476-5381.2010.00749.x; Czyz M, 2013, CANCER BIOL THER, V14, P135, DOI 10.4161/cbt.22952; Damsky WE, 2014, ONCOGENE, V33, P2413, DOI 10.1038/onc.2013.194; de Souza CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044800; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Dong L, 2011, ONCOGENE, V30, P3716, DOI 10.1038/onc.2011.87; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Fernandez Y, 2000, CELL DEATH DIFFER, V7, P350, DOI 10.1038/sj.cdd.4400662; Fessler E, 2013, CANCER LETT, V341, P97, DOI 10.1016/j.canlet.2012.10.015; Ghislin S, 2012, MELANOMA RES, V22, P184, DOI 10.1097/CMR.0b013e328351e7c4; Giorgini S, 2007, MOL CANCER RES, V5, P761, DOI 10.1158/1541-7786.MCR-07-0088; Hartman ML, 2015, CELL MOL LIFE SCI, V72, P1249, DOI 10.1007/s00018-014-1791-0; Hartman ML, 2015, J INVEST DERMATOL, V135, P352, DOI 10.1038/jid.2014.319; Hartman ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095157; Hartman ML, 2013, CANCER LETT, V331, P24, DOI 10.1016/j.canlet.2013.01.010; Hartman ML, 2012, ANTI-CANCER AGENT ME, V12, P966; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Iqbal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030764; Juin P, 2013, NAT REV CANCER, V13, P455, DOI 10.1038/nrc3538; Kim JW, 2004, CANCER LETT, V213, P203, DOI 10.1016/j.canlet.2004.03.042; Koprowska K, 2013, ANTI-CANCER DRUG, V24, P835, DOI 10.1097/CAD.0b013e3283635a04; Kucharzewska P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116740; Kunjithapatham R, 2014, SCI REP-UK, V4, DOI 10.1038/srep06816; Kvansakul M, 2015, APOPTOSIS, V20, P136, DOI 10.1007/s10495-014-1051-7; Lee M, 2008, APOPTOSIS, V13, P972, DOI 10.1007/s10495-008-0229-2; Lee SB, 2011, ONCOL REP, V25, P1337, DOI 10.3892/or.2011.1210; Liu SY, 2012, APOPTOSIS, V17, P1156, DOI 10.1007/s10495-012-0758-6; Liu YB, 2015, PIGM CELL MELANOMA R, V28, P161, DOI 10.1111/pcmr.12325; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Nifoussi SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047060; O'Connell MP, 2013, CANCER DISCOV, V3, P1378, DOI 10.1158/2159-8290.CD-13-0005; Ossowski L, 2010, PIGM CELL MELANOMA R, V23, P41, DOI 10.1111/j.1755-148X.2009.00647.x; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; Perego M, 2010, J INVEST DERMATOL, V130, P1877, DOI 10.1038/jid.2010.69; Pinner S, 2009, CANCER RES, V69, P7969, DOI 10.1158/0008-5472.CAN-09-0781; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Ramgolam K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018784; Roesch A, 2015, ONCOGENE, V34, P2951, DOI 10.1038/onc.2014.249; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rondeau G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101160; Rooswinkel RW, 2014, BLOOD, V123, P2806, DOI 10.1182/blood-2013-08-519470; Schubert KM, 2001, BIOCHEM J, V356, P473, DOI 10.1042/0264-6021:3560473; Seftor EA, 2006, J CELL MOL MED, V10, P174, DOI 10.1111/j.1582-4934.2006.tb00299.x; Senft D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030821; Serasinghe MN, 2015, ONCOGENE, V34, P857, DOI 10.1038/onc.2014.21; Shakhova O, 2013, CANCER LETT, V338, P74, DOI 10.1016/j.canlet.2012.10.009; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Su ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098823; Sztiller-Sikorska M, 2015, LAB INVEST, V95, P672, DOI 10.1038/labinvest.2015.48; Sztiller-Sikorska M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090783; Sztiller-Sikorska M, 2012, MELANOMA RES, V22, P215, DOI 10.1097/CMR.0b013e3283531317; Taddei ML, 2013, CANCER LETT, V341, P80, DOI 10.1016/j.canlet.2013.01.042; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; Thomas LW, 2010, PLOS ONE, V7; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Vickers ER, 2004, MOL CELL BIOL, V24, P10340, DOI 10.1128/MCB.24.23.10340-10351.2004; Wang CY, 2010, APOPTOSIS, V15, P439, DOI 10.1007/s10495-009-0431-x; Wang D, 2011, MOL CELL BIOL, V31, P3670, DOI 10.1128/MCB.05704-11; Weigel KJ, 2014, MOL CANCER RES, V12, P855, DOI 10.1158/1541-7786.MCR-14-0090; Weiler M, 2006, CELL DEATH DIFFER, V13, P1156, DOI 10.1038/sj.cdd.4401786; Wensveen FM, 2011, APOPTOSIS, V16, P708, DOI 10.1007/s10495-011-0599-8; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Zhou D, 2014, J THEOR BIOL, V357, P35, DOI 10.1016/j.jtbi.2014.04.039	80	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128796	10.1371/journal.pone.0128796	http://dx.doi.org/10.1371/journal.pone.0128796			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035829	Green Submitted, gold, Green Published			2022-12-27	WOS:000355699100049
J	Eng, JLV; Chan, A; Ablio, AP; Wolkon, A; de Leon, GP; Gimnig, J; Morgan, J				Eng, Jodi L. Vanden; Chan, Adeline; Ablio, Ana Paula; Wolkon, Adam; de Leon, Gabriel Ponce; Gimnig, John; Morgan, Juliette			Bed Net Durability Assessments: Exploring a Composite Measure of Net Damage	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; CULEX-QUINQUEFASCIATUS MOSQUITOS; PYRETHROID-RESISTANT MOSQUITOS; EXPERIMENTAL HUT EVALUATION; PHYSICAL CONDITION; ANOPHELES-GAMBIAE; WESTERN KENYA; MALARIA VECTORS; OLYSET(R) NETS; HOUSEHOLD USE	Background The durability of Long Lasting Insecticidal Nets (LLINs) in field conditions is of great importance for malaria prevention and control efforts; however, the physical integrity of the net fabric is not well understood making it challenging to determine overall effectiveness of nets as they age. The 2011 World Health Organization Pesticide Evaluation Scheme (WHOPES) guidelines provide a simple, standardized method using a proportional hole index (PHI) for assessing net damage with the intent to provide national malaria control programs with guidelines to assess the useful life of LLINS and estimate the rate of replacement. Methods We evaluated the utility of the PHI measure using 409 LLINs collected over three years in Nampula Province, Mozambique following a mass distribution campaign in 2008. For each LLIN the diameter and distance from the bottom of the net were recorded for every hole. Holes were classified into four size categories and a PHI was calculated following WHOPES guidelines. We investigate how the size, shape, and location of holes influence the PHI. The areas of the WHOPES defined categories were compared to circular and elliptical areas based on approximate shape and actual measured axes of each hole and the PHI was compared to cumulative damaged surface area of the LLIN. Results The damaged area of small, medium, large, and extra-large holes was overestimated using the WHOPES categories compared to elliptical areas using the actual measured axes. Similar results were found when comparing to circular areas except for extra-large holes which were underestimated. (Wilcoxon signed rank test of differences p < 0.0001 for all sizes). Approximating holes as circular overestimated hole surface area by 1.5 to 2 times or more. There was a significant difference in the mean number of holes < 0.5 cm by brand and there were more holes of all sizes on the bottom of nets than the top. For a range of hypothetical PHI thresholds used to designate a "failed LLIN", roughly 75 to 80% of failed LLINs were detected by considering large and extra-large holes alone, but sensitivity varied by brand. Conclusions Future studies may refine the PHI to better approximate overall damaged surface area. Furthermore, research is needed to identify whether or not appropriate PHI thresholds can be used to deem a net no longer protective. Once a cutoff is selected, simpler methods of determining the effective lifespan of LLINs can help guide replacement strategies for malaria control programs.	[Eng, Jodi L. Vanden; Wolkon, Adam; de Leon, Gabriel Ponce; Morgan, Juliette] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Malaria Branch, Atlanta, GA 30333 USA; [Chan, Adeline; Gimnig, John] Ctr Dis Control & Prevent, Entomol Branch, Div Parasit Dis & Malaria, Atlanta, GA USA; [Ablio, Ana Paula] Minist Saude, Inst Nacl Saude, Maputo, Mozambique; [de Leon, Gabriel Ponce; Morgan, Juliette] Ctr Dis Control & Prevent, US Presidents Malaria Initiat, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Eng, JLV (corresponding author), Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Malaria Branch, Atlanta, GA 30333 USA.	JEV8@cdc.gov		Abilio, Ana Paula/0000-0003-3652-1329	U.S. President's Malaria Initiative through the U.S. Agency for International Development	U.S. President's Malaria Initiative through the U.S. Agency for International Development(United States Agency for International Development (USAID)President's Malaria Initiative (PMI))	This study was funded by the U.S. President's Malaria Initiative through the U.S. Agency for International Development. Two co-authors are affiliated with the President's Malaria Initiative. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allan R, 2012, AM J TROP MED HYG, V87, P407, DOI 10.4269/ajtmh.2012.11-0331; [Anonymous], 2008, GLOB MAL ACT PLAN; [Anonymous], 2005, GUIDELINES LAB FIELD; Ashton RA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-134; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Asidi AN, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-25; Asidi AN, 2004, MED VET ENTOMOL, V18, P134, DOI 10.1111/j.0269-283X.2004.00485.x; Atieli HE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-113; Banek K, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-84; Batisso E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-183; Bhatt RM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-189; CARNEVALE P, 1992, T ROY SOC TROP MED H, V86, P362, DOI 10.1016/0035-9203(92)90219-3; Chandre F, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-65; CURTIS CF, 1992, MEM I OSWALDO CRUZ, V87, P363, DOI 10.1590/S0074-02761992000700063; Curtis CF, 1996, MED VET ENTOMOL, V10, P1, DOI 10.1111/j.1365-2915.1996.tb00075.x; Erlanger TE, 2004, MED VET ENTOMOL, V18, P153, DOI 10.1111/j.0269-283X.2004.00491.x; Gerstl S, 2010, TROP MED INT HEALTH, V15, P480, DOI 10.1111/j.1365-3156.2010.02478.x; Gimnig JE, 2005, TROP MED INT HEALTH, V10, P1022, DOI 10.1111/j.1365-3156.2005.01481.x; Githinji S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-250; Gnanguenon V, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-69; Graves PM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-354; Irish SR, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-17; Kilian A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-299; Kilian A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-49; LINES JD, 1987, MED VET ENTOMOL, V1, P37, DOI 10.1111/j.1365-2915.1987.tb00321.x; Lines JD, 1985, TESTS REPELLENT INSE; Malima RC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-38; Maxwell CA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-44; Maxwell CA, 1999, T ROY SOC TROP MED H, V93, P4, DOI 10.1016/S0035-9203(99)90158-X; Maxwell CA, 2002, TROP MED INT HEALTH, V7, P1003, DOI 10.1046/j.1365-3156.2002.00966.x; Mejia P, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-158; Morgan J, 2014, AM J TROPIC IN PRESS; Mutuku FM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-46; Mwangi TW, 2003, T ROY SOC TROP MED H, V97, P369, DOI 10.1016/S0035-9203(03)90056-3; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Ngondi JM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-92; Ngufor C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-343; Odhiambo MTO, 2013, J TROP MED-US, V2013, DOI 10.1155/2013/563957; Panter-Brick C, 2006, SOC SCI MED, V62, P2810, DOI 10.1016/j.socscimed.2005.10.009; Picado A, 2012, T ROY SOC TROP MED H, V106, P150, DOI 10.1016/j.trstmh.2011.10.014; PORT GR, 1982, B ENTOMOL RES, V72, P483, DOI 10.1017/S0007485300013663; Rehman AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019205; Shirayama Y, 2007, PUBLIC HEALTH, V121, P122, DOI 10.1016/j.puhe.2006.06.016; Skovmand O, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-87; Smith SC, 2007, AM J TROP MED HYG, V77, P243, DOI 10.4269/ajtmh.2007.77.243; Spencer S, 2004, T ROY SOC TROP MED H, V98, P719, DOI 10.1016/j.trstmh.2004.01.012; Tami A, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-19; Tsuang A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-211; Tsuzuki A, 2011, SE ASIAN J TROP MED, V42, P268; Vatandoost H., 2006, Journal of Vector Borne Diseases, V43, P133; WHO, 2012, WHOPES REC REP WHOPE; WHO, 2013, VECT CONTR TECHN EXP, DOI [10.1186/1475-2875-12-213, DOI 10.1186/1475-2875-12-213]; WHO, 2011, GUIDELINES MONITORIN; Wills AB, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-242	54	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128499	10.1371/journal.pone.0128499	http://dx.doi.org/10.1371/journal.pone.0128499			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047494	gold, Green Published			2022-12-27	WOS:000355652200071
J	Nokkari, A; Mouhieddine, TH; Itani, MM; Abou-Kheir, W; Daoud, G; Zhu, R; Meshref, Y; Soueid, J; Al Hariri, M; Mondello, S; Jaffa, AA; Kobeissy, F				Nokkari, Amaly; Mouhieddine, Tarek H.; Itani, Muhieddine M.; Abou-Kheir, Wassim; Daoud, Georges; Zhu, Rui; Meshref, Yehia; Soueid, Jihane; Al Hariri, Moustafa; Mondello, Stefania; Jaffa, Ayad A.; Kobeissy, Firas			Characterization of the Kallikrein-Kinin System Post Chemical Neuronal Injury: An In Vitro Biochemical and Neuroproteomics Assessment	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; BRADYKININ B-2 RECEPTOR; PC12 CELLS; PROTEOMIC ANALYSIS; INDUCED APOPTOSIS; PHOSPHOLIPASE-D; CALCIUM; BIOMARKERS; BIOLOGY; DEATH	Traumatic Brain Injury (TBI) is the result of a mechanical impact on the brain provoking mild, moderate or severe symptoms. It is acknowledged that TBI leads to apoptotic and necrotic cell death; however, the exact mechanism by which brain trauma leads to neural injury is not fully elucidated. Some studies have highlighted the pivotal role of the Kallikrein-Kinin System (KKS) in brain trauma but the results are still controversial and inconclusive. In this study, we investigated both the expression and the role of Bradykinin 1 and 2 receptors (B1R and B2R), in mediating neuronal injury under chemical neurotoxicity paradigm in PC12 cell lines. The neuronal cell line PC12 was treated with the apoptotic drug Staurosporine (STS) to induce cell death. Intracellular calcium release was evaluated by Fluo 4-AM staining and showed that inhibition of the B2R prevented calcium release following STS treatment. Differential analyses utilizing immunofluorescence, Western blot and Real-time Polymerase Chain Reaction revealed an upregulation of both bradykinin receptors occurring at 3h and 12h post-STS treatment, but with a higher induction of B2R compared to B1R. This implies that STS-mediated apoptosis in PC12 cells is mainly conducted through B2R and partly via B1R. Finally, a neuroproteomics approach was conducted to find relevant proteins associated to STS and KKS in PC12 cells. Neuroproteomics results confirmed the presence of an inflammatory response leading to cell death during apoptosis-mediated STS treatment; however, a "survival" capacity was shown following inhibition of B2R coupled with STS treatment. Our data suggest that B2R is a key player in the inflammatory pathway following STS-mediated apoptosis in PC12 cells and its inhibition may represent a potential therapeutic tool in TBI.	[Nokkari, Amaly; Soueid, Jihane; Al Hariri, Moustafa; Kobeissy, Firas] Amer Univ Beirut, Fac Med, Dept Biochem & Mol Genet, Beirut, Lebanon; [Mouhieddine, Tarek H.] Amer Univ Beirut, Fac Med, Med Ctr, Beirut, Lebanon; [Itani, Muhieddine M.] St George Univ London, Fac Med, Nicosia, Cyprus; [Abou-Kheir, Wassim; Daoud, Georges] Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol, Beirut, Lebanon; [Zhu, Rui; Meshref, Yehia] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Mondello, Stefania] Univ Messina, Dept Neurosci, Messina, Italy	American University of Beirut; American University of Beirut; American University of Beirut; Texas Tech University System; Texas Tech University; University of Messina	Nokkari, A (corresponding author), Amer Univ Beirut, Fac Med, Dept Biochem & Mol Genet, Beirut, Lebanon.	amalyn.breizh@gmail.com; wa12@aub.edu.lb; firasko@gmail.com	Itani, Muhieddine/R-3826-2019; Mondello, Stefania/A-1813-2012; Kobeissy, Firas/E-7042-2017; Abou-Kheir, Wassim/AAP-2587-2020	Mondello, Stefania/0000-0002-8587-3614; Kobeissy, Firas/0000-0002-5008-6944; Abou-Kheir, Wassim/0000-0001-9719-9324; Daoud, Georges/0000-0001-8043-3882; Mouhieddine, Tarek/0000-0002-1190-5978; Soueid, Jihane/0000-0002-1973-8705	National Institutes of Health [HL077192, HL087986]; Medical Practice Grant faculty of Medicine; CNRS [10267]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087986, R01HL077192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Practice Grant faculty of Medicine; CNRS(Centre National de la Recherche Scientifique (CNRS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health grants HL077192 and HL087986, Medical Practice Grant faculty of Medicine, CNRS Award Number 10267 (AAJ). Grant recipient: Dr. Ayad Jaffa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert-Weissenberger C, 2013, PROG NEUROBIOL, V101, P65, DOI 10.1016/j.pneurobio.2012.11.004; Bal-Price A, 2006, NITRIC OXIDE-BIOL CH, V14, P238, DOI 10.1016/j.niox.2005.10.002; Ballesteros MA, 2007, INTENS CARE MED, V33, P58, DOI 10.1007/s00134-006-0361-9; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Boutte AM, 2012, ELECTROPHORESIS, V33, P3693, DOI 10.1002/elps.201200196; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Fischer H., 2014, GUIDE US MILITARY CA; Furuno T, 2006, NEUROSCI LETT, V392, P240, DOI 10.1016/j.neulet.2005.09.031; Guevara-Lora I, 2012, NEUROCHEM INT, V61, P72, DOI 10.1016/j.neuint.2012.04.013; Guingab-Cagmat JD, 2012, ELECTROPHORESIS, V33, P3786, DOI 10.1002/elps.201200326; Hanson CJ, 2004, CURR BIOL, V14, pR933, DOI 10.1016/j.cub.2004.10.019; Hellal F, 2003, J NEUROTRAUM, V20, P841, DOI 10.1089/089771503322385773; Hillmeister P, 2012, ACTA PHYSIOL, V206, P215, DOI 10.1111/apha.12007; HORWITZ J, 1991, J NEUROCHEM, V56, P509, DOI 10.1111/j.1471-4159.1991.tb08179.x; HORWITZ J, 1992, J NEUROCHEM, V59, P1474, DOI 10.1111/j.1471-4159.1992.tb08463.x; Jaffa MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044714; Jiang CY, 2014, BIOL TRACE ELEM RES, V158, P249, DOI 10.1007/s12011-014-9918-6; Jiang H, 2014, INT J MOL MED, V33, P1298, DOI 10.3892/ijmm.2014.1684; KLYSZCZNASKO H, 1993, ARCH BIOCHEM BIOPHYS, V306, P383, DOI 10.1006/abbi.1993.1527; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kobeissy FH, 2010, METHODS MOL BIOL, V662, P303, DOI 10.1007/978-1-60761-800-3_15; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kumar S, 2015, LEUKEMIA LYMPHOMA, V56, P1846, DOI 10.3109/10428194.2014.974042; Liu Bo, 2003, V237, P99; Liu J, 2013, BIOL CHEM, V394, P319, DOI 10.1515/hsz-2012-0316; Malekinejad H, 2014, IRAN J PHARM RES, V13, P191; Marks J, 2003, J BIOL CHEM, V278, P34158, DOI 10.1074/jbc.M304543200; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Nakayama T, 2004, BIOCHEM J, V377, P299, DOI 10.1042/BJ20030599; NEUHAUS R, 1991, J NEUROSCI, V11, P3984; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Cunha MP, 2014, ASN NEURO, V6, DOI 10.1177/1759091414554945; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Rizzuto Rosario, 2004, Sci STKE, V2004, pre1, DOI 10.1126/stke.2152004re1; Shen S, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-11; Stutzmann GE, 2005, NEUROSCIENTIST, V11, P110, DOI 10.1177/1073858404270899; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Tang SCW, 2011, CONTRIB NEPHROL, V170, P145, DOI 10.1159/000325650; Tinetti ME, 2008, NEW ENGL J MED, V359, P252, DOI 10.1056/NEJMoa0801748; Trabold R, 2010, J CEREBR BLOOD F MET, V30, P130, DOI 10.1038/jcbfm.2009.196; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	42	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128601	10.1371/journal.pone.0128601	http://dx.doi.org/10.1371/journal.pone.0128601			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047500	Green Published, gold			2022-12-27	WOS:000355652200082
J	Audfray, A; Beldjoudi, M; Breiman, A; Hurbin, A; Boos, I; Unverzagt, C; Bouras, M; Lantuejoul, S; Coll, JL; Varrot, A; Le Pendu, J; Busser, B; Imberty, A				Audfray, Aymeric; Beldjoudi, Mona; Breiman, Adrien; Hurbin, Amandine; Boos, Irene; Unverzagt, Carlo; Bouras, Mourad; Lantuejoul, Sylvie; Coll, Jean-Luc; Varrot, Annabelle; Le Pendu, Jacques; Busser, Benoit; Imberty, Anne			A Recombinant Fungal Lectin for Labeling Truncated Glycans on Human Cancer Cells	PLOS ONE			English	Article							LINKED N-ACETYLGLUCOSAMINE; RHEUMATOID-ARTHRITIS; GLYCOSYLATION; BINDING; VIRUS; GLYCOPROTEIN; RESIDUES; GLYCOME; IGG	Cell surface glycoconjugates present alterations of their structures in chronic diseases and distinct oligosaccharide epitopes have been associated with cancer. Among them, truncated glycans present terminal non-reducing beta-N-acetylglucosamine (GlcNAc) residues that are rare on healthy tissues. Lectins from unconventional sources such as fungi or algi provide novel markers that bind specifically to such epitopes, but their availability may be challenging. A GlcNAc-binding lectin from the fruiting body of the fungus Psathyrella velutina (PVL) has been produced in good yield in bacterial culture. A strong specificity for terminal GlcNAc residues was evidenced by glycan array. Affinity values obtained by microcalorimetry and surface plasmon resonance demonstrated a micromolar affinity for GlcNAc beta-1-3Gal epitopes and for biantennary N-glycans with GlcNAc beta-1-2Man capped branches. Crystal structure of PVL complexed with GlcNAc beta-1-3Gal established the structural basis of the specificity. Labeling of several types of cancer cells and use of inhibitors of glycan metabolism indicated that rPVL binds to terminal GlcNAc but also to sialic acid (Neu5Ac). Analysis of glycosyltransferase expression confirmed the higher amount of GlcNAc present on cancer cells. rPVL binding is specific to cancer tissue and weak or no labeling is observed for healthy ones, except for stomach glands that present unique aGlcNAc-presenting mucins. In lung, breast and colon carcinomas, a clear delineation could be observed between cancer regions and surrounding healthy tissues. PVL is therefore a useful tool for labeling agalacto- glycans in cancer or other diseases.	[Audfray, Aymeric; Varrot, Annabelle; Imberty, Anne] Univ Grenoble Alpes, CNRS, CERMAV, UPR5301, F-38041 Grenoble, France; [Beldjoudi, Mona; Hurbin, Amandine; Lantuejoul, Sylvie; Coll, Jean-Luc; Busser, Benoit] Univ Grenoble Alpes, IAB, F-38000 Grenoble, France; [Beldjoudi, Mona; Hurbin, Amandine; Lantuejoul, Sylvie; Coll, Jean-Luc; Busser, Benoit] INSERM, IAB, U823, F-38000 Grenoble, France; [Beldjoudi, Mona; Bouras, Mourad] Univ El Hadj Lakhdar, Batna 05000, Algeria; [Breiman, Adrien; Le Pendu, Jacques] INSERM, UMR892, F-44007 Nantes, France; [Breiman, Adrien] CNRS, UMR6299, F-44007 Nantes, France; [Breiman, Adrien] Univ Nantes, IRS UN, Nantes, France; [Breiman, Adrien] Nantes Univ Hosp, F-44000 Nantes, France; [Boos, Irene; Unverzagt, Carlo] Univ Bayreuth, Bioorgan Chem, D-95440 Bayreuth, Germany; [Lantuejoul, Sylvie; Busser, Benoit] Grenoble Univ Hosp, F-38000 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Batna; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Nantes Universite; Nantes Universite; CHU de Nantes; University of Bayreuth; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Le Pendu, J (corresponding author), INSERM, UMR892, F-44007 Nantes, France.	jacques.le-pendu@inserm.fr; bbusser@chu-grenoble.fr; imberty@cermav.cnrs.fr	Boos, Irene/K-3382-2015; lantuejoul, sylvie/N-9315-2017; Coll, Jean-Luc/G-2520-2013; Busser, Benoit/N-1841-2013; Breiman, Adrien/K-8772-2015; Lantuejoul, Sylvie/N-4671-2013; Le Pendu, Jacques/F-4760-2013; Imberty, Anne/P-6451-2018; Hurbin, Amandine/M-2693-2013	Boos, Irene/0000-0002-8244-4312; lantuejoul, sylvie/0000-0003-4310-6975; Coll, Jean-Luc/0000-0002-2453-3552; Busser, Benoit/0000-0002-9425-1577; Le Pendu, Jacques/0000-0002-4856-0387; Varrot, Annabelle/0000-0001-6667-8162; Imberty, Anne/0000-0001-6825-9527; Hurbin, Amandine/0000-0003-0535-1945	Agence Natioale de la Recherche [NeoLect-11-BSV5, ANR-11-LABX-003]; European Cooperation in Science and Technology: COST Action [CM1102]	Agence Natioale de la Recherche; European Cooperation in Science and Technology: COST Action(European Cooperation in Science and Technology (COST))	Agence Natioale de la Recherche: grants NeoLect-11-BSV5 and ANR-11-LABX-003 (http://www.agence-nationale-recherche.fr/). European Cooperation in Science and Technology: COST Action CM1102 (http://www.cost.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Audfray A, 2012, J BIOL CHEM, V287, P4335, DOI 10.1074/jbc.M111.314831; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boeggeman E, 2007, BIOCONJUGATE CHEM, V18, P806, DOI 10.1021/bc060341n; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cioci G, 2006, J MOL BIOL, V357, P1575, DOI 10.1016/j.jmb.2006.01.066; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Futakawa S, 2012, NEUROBIOL AGING, V33, P1807, DOI 10.1016/j.neurobiolaging.2011.02.023; Hakomori S, 1996, CANCER RES, V56, P5309; Hanisch FG, 2014, J BIOL CHEM, V289, P27363, DOI 10.1074/jbc.M114.597757; Hsu KL, 2009, CURR OPIN CHEM BIOL, V13, P427, DOI 10.1016/j.cbpa.2009.07.013; HU J, 1994, GLYCOBIOLOGY, V4, P251; Ishihara K, 1996, BIOCHEM J, V318, P409, DOI 10.1042/bj3180409; Jiang S, 2012, BIOCHEM J, V443, P369, DOI 10.1042/BJ20112061; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KOCHIBE N, 1989, J BIOL CHEM, V264, P173; Krokhin O, 2003, MOL CELL PROTEOMICS, V2, P346, DOI 10.1074/mcp.M300048-MCP200; Kyselova Z, 2007, J PROTEOME RES, V6, P1822, DOI 10.1021/pr060664t; Liljeblad M, 2000, GLYCOCONJUGATE J, V17, P323, DOI 10.1023/A:1007169621518; Liu DL, 2014, CANCER RES, V74, P5045, DOI 10.1158/0008-5472.CAN-14-0392; Lonardi Emanuela, 2013, Biology (Basel), V2, P894, DOI 10.3390/biology2030894; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meichenin M, 2000, CANCER RES, V60, P5499; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakamura N, 1998, J HISTOCHEM CYTOCHEM, V46, P793, DOI 10.1177/002215549804600702; Newsom-Davis TE, 2009, CANCER RES, V69, P2018, DOI 10.1158/0008-5472.CAN-08-3589; Oliveira C, 2013, CRIT REV BIOTECHNOL, V33, P66, DOI 10.3109/07388551.2012.670614; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Powlesland AS, 2008, J BIOL CHEM, V283, P593, DOI 10.1074/jbc.M706292200; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Roth M, 2002, ACTA CRYSTALLOGR D, V58, P805, DOI 10.1107/S0907444902003943; Satomaa T, 2009, CANCER RES, V69, P5811, DOI 10.1158/0008-5472.CAN-08-0289; Seko A, 1997, BBA-GEN SUBJECTS, V1335, P23, DOI 10.1016/S0304-4165(96)00118-3; Soga K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083886; Su LJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-140; Svarovsky SA, 2014, ANAL METHODS-UK, V6, P3918, DOI 10.1039/c3ay42243g; TSUCHIYA N, 1993, J IMMUNOL, V151, P1137; Ueda H, 2002, J BIOL CHEM, V277, P24916, DOI 10.1074/jbc.M110727200; Ullmann V, 2012, ANGEW CHEM INT EDIT, V51, P11566, DOI 10.1002/anie.201204272	41	19	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128190	10.1371/journal.pone.0128190	http://dx.doi.org/10.1371/journal.pone.0128190			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042789	Green Submitted, Green Published, gold			2022-12-27	WOS:000355701600037
J	Hsieh, CJ; Wang, PW; Hu, TH				Hsieh, Ching-Jung; Wang, Pei Wen; Hu, Tsung Hui			Association of Adiponectin Gene Polymorphism with Nonalcoholic Fatty Liver Disease in Taiwanese Patients with Type 2 Diabetes	PLOS ONE			English	Article							LEPTIN RECEPTOR GENE; METABOLIC SYNDROME; PLASMA ADIPONECTIN; INSULIN-RESISTANCE; CHINESE PEOPLE; POPULATION; VARIANTS; SUSCEPTIBILITY; PREVALENCE; RISK	Objective Patients with type 2 diabetes and nonalcoholic fatty liver disease (NAFLD) have a higher prevalence of cardiovascular diseases. In this study we investigated the frequency of single nucleotide polymorphisms (SNPs) of several candidate genes associated with NAFLD in Taiwanese patients with type 2 diabetes mellitus (DM) and NAFLD and in those with DM but without fatty liver disease. Methods We enrolled 350 patients with type 2 DM and NAFLD and 209 patients with DM but without NAFLD. Body mass index (BMI), % body fat (% BF), glycated hemoglobin (HbA1c), high molecular weight (HMW) isoform of adiponectin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglyceride (TG) levels were measured. Thirteen SNPs in 5 genes (adiponectin, leptin, peroxisome proliferator-activated receptor alpha, adiponutrin/patatin-like phospholipase domain-containing protein 3 and peroxisome proliferator-activated receptor. co-activator 1 alpha) were measured. Results Only adiponectin rs266729 polymorphism was associated with susceptibility to NAFLD (p = 0.001). Subgroup analysis revealed that the proportion of subjects with homozygous genotype GG was higher in patients with NAFLD (31%) than in controls (11%) and that the proportions of heterozygous CG and homozygous CC were higher in controls (37% and 52%, respectively) than in patients with NAFLD (33% and 36%, respectively). Patients with NAFLD carrying the GG genotype of rs266729 showed significantly lower serum HMW adiponectin levels than patients carrying the GC or CC genotype (3.75 +/- 0.37 vs. 3.99 +/- 0.66 vs. 4.79 +/- 0.58 mu g/ml, p< 0.001). Body fat and serum HMW adiponectin levels were the strongest predictors of developing NAFLD (p < 0.001 and 0.004, respectively). Conclusions In patients with type 2 diabetes gene polymorphism of adiponectin rs266729 is associated with risk of NAFLD. G allele of rs266729 is associated with hypoadiponectinemia. Low serum adiponectin level may precipitate liver steatosis in patients with type 2 diabetes.	[Hsieh, Ching-Jung; Wang, Pei Wen] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Endocrinol & Metab, Kaohsiung, Taiwan; [Hsieh, Ching-Jung; Wang, Pei Wen; Hu, Tsung Hui] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Hu, Tsung Hui] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Hepatogastroenterol, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Hsieh, CJ (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Endocrinol & Metab, 123 Ta Pei Rd, Kaohsiung, Taiwan.	c2607c@ms56.hinet.net			Chang Gung Memorial Hospital - Kaohsiung Medical Center, Chang Gung University College of Medicine, Taiwan [CMRPG8B0451]	Chang Gung Memorial Hospital - Kaohsiung Medical Center, Chang Gung University College of Medicine, Taiwan	CMRPG8B0451 from Chang Gung Memorial Hospital - Kaohsiung Medical Center, Chang Gung University College of Medicine, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Amarapurkar D, 2007, ANN HEPATOL, V6, P161, DOI 10.1016/S1665-2681(19)31922-2; Bonapace S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088371; Bonapace S, 2012, DIABETES CARE, V35, P389, DOI 10.2337/dc11-1820; Bugianesi E, 2005, J CLIN ENDOCR METAB, V90, P3498, DOI 10.1210/jc.2004-2240; Chen CH, 2007, J GASTROEN HEPATOL, V22, P1482, DOI 10.1111/j.1440-1746.2006.04615.x; Chen SH, 2008, J GASTROEN HEPATOL, V23, P1415, DOI 10.1111/j.1440-1746.2008.05523.x; Souza Mônica Rodrigues de Araújo, 2012, Arq. Gastroenterol., V49, P89, DOI 10.1590/S0004-28032012000100015; Gupta AC, 2012, GENE, V496, P63, DOI 10.1016/j.gene.2011.12.023; Hallsworth K, 2013, J HEPATOL, V58, P757, DOI 10.1016/j.jhep.2012.11.015; Hashemi M, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.9527; Hui E, 2013, J DIABETES INVEST, V4, P413, DOI 10.1111/jdi.12093; Hui Y, 2008, LIVER INT, V28, P385, DOI 10.1111/j.1478-3231.2007.01623.x; Leite NC, 2009, LIVER INT, V29, P113, DOI 10.1111/j.1478-3231.2008.01718.x; Li YY, 2012, WORLD J GASTROENTERO, V18, P6546, DOI 10.3748/wjg.v18.i45.6546; Lin YC, 2014, AM J CLIN NUTR, V99, P869, DOI 10.3945/ajcn.113.079749; Lu HY, 2009, J GASTROEN HEPATOL, V24, P228, DOI 10.1111/j.1440-1746.2008.05544.x; Lu JF, 2014, HUM IMMUNOL, V75, P1062, DOI 10.1016/j.humimm.2014.09.004; Meirhaeghe A, 2005, MOL GENET METAB, V86, P293, DOI 10.1016/j.ymgme.2005.05.006; Merat S, 2009, MIDDLE E J DIGESTIVE, V1, P74; Musso G, 2005, HEPATOLOGY, V42, P1175, DOI 10.1002/hep.20896; Musso G, 2008, HEPATOLOGY, V47, P1167, DOI 10.1002/hep.22142; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Ranjith Naresh, 2008, Metabolic Syndrome and Related Disorders, V6, P209, DOI 10.1089/met.2008.0023; Shen F, 2014, WORLD J GASTROENTERO, V20, P4702, DOI 10.3748/wjg.v20.i16.4702; Shen J, 2014, ALIMENT PHARM THER, V39, P532, DOI 10.1111/apt.12609; Suriyaprom K, 2014, ASIA PAC J CLIN NUTR, V23, P167, DOI 10.6133/apjcn.2014.23.1.01; Tandon Rakesh K, 2013, J Assoc Physicians India, V61, P445; Tapper EB, 2015, CLIN GASTROENTEROL H, V13, P27, DOI 10.1016/j.cgh.2014.04.039; Tokushige K, 2009, J GASTROENTEROL, V44, P976, DOI 10.1007/s00535-009-0085-z; Wang PW, 2008, DIABETES RES CLIN PR, V81, P202, DOI 10.1016/j.diabres.2008.04.014; Wang ZL, 2008, J ENDOCRINOL INVEST, V31, P1086, DOI 10.1007/BF03345657; Yoneda M, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-27; Yu So Young, 2007, Nutr Res Pract, V1, P363, DOI 10.4162/nrp.2007.1.4.363; Zain SM, 2013, J GASTROEN HEPATOL, V28, P873, DOI 10.1111/jgh.12104; Zhou YJ, 2012, J DIGEST DIS, V13, P153, DOI 10.1111/j.1751-2980.2011.00571.x; Zhou YJ, 2010, J GASTROEN HEPATOL, V25, P772, DOI 10.1111/j.1440-1746.2009.06144.x	37	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0127521	10.1371/journal.pone.0127521	http://dx.doi.org/10.1371/journal.pone.0127521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042596	gold, Green Submitted, Green Published			2022-12-27	WOS:000355701600014
J	Yohannes, S; Bekele, E				Yohannes, Seile; Bekele, Endashaw			Ethiopian Population Dermatoglyphic Study Reveals Linguistic Stratification of Diversity	PLOS ONE			English	Article								The manifestation of ethnic, blood type, & gender-wise population variations regarding Dermatoglyphic manifestations are of interest to assess intra-group diversity and differentiation. The present study reports on the analysis of qualitaive and quantitative finger Dermatoglyphic traits of 382 individuals cross-sectionally sampled from an administrative region of Ethiopia, consisting of five ethnic cohorts from the Afro-Asiatic & Nilo-Saharan affiliations. These Dermatoglyphic parameters were then applied in the assessment of diversity & differentiation, including Heterozygosity, Fixation, Panmixia, Wahlund's variance, Nei's measure of genetic diversity, and thumb & finger pattern genotypes, which were inturn used in homology inferences as summarized by a Neighbour-Joining tree constructed from Nei's standard genetic distance. Results revealed significant correlation between Dermatoglyphics & population parameters that were further found to be in concordance with the historical accounts of the ethnic groups. Such inductions as the ancient north-eastern presence and subsequent admixure events of the Oromos (PII = 15.01), the high diversity of the Amharas (H = 0.1978, F = 0.6453, and P = 0.4144), and the Nilo-Saharan origin of the Berta group (PII = 10.66) are evidences to this. The study has further tested the possibility of applying Dermatoglyphics in population genetic & anthropologic research, highlighting on the prospect of developing a method to trace back population origins & ancient movement patterns. Additionally, linguistic clustering was deemed significant for the Ethiopian population, coinciding with recent genome wide studies that have ascertained that linguistic clustering as to being more crucial than the geographical patterning in the Ethiopian context. Finally, Dermatoglyphic markers have been proven to be endowed with a strong potential as non-invasive preliminary tools applicable prior to genetic studies to analyze ethnically sub-divided populations and also to reveal the stratification mechanism in play.	[Yohannes, Seile] Jigjiga Univ, Dept Biol, Jijiga, Ethiopia; [Bekele, Endashaw] Univ Addis Ababa, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia; [Bekele, Endashaw] Ctr Human Genet Div, Addis Ababa, Ethiopia	Addis Ababa University	Yohannes, S (corresponding author), Jigjiga Univ, Dept Biol, Jijiga, Ethiopia.	sygenetix@gmail.com		Yohannes, Seile/0000-0001-9984-5166	Addis Ababa University	Addis Ababa University	Funded by Addis Ababa University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharadwaja A, 2004, J INDIAN ACAD FORENS, V26, P6; Cummins H, 1961, FINGERPRINTS PALMS S; Dankmeijer J, 1938, AM J PHYS ANTHROPOL, V23, P377, DOI 10.1002/ajpa.1330230402; DU RP, 2004, POPULATION GENETICS; Furuhata T., 1927, JAPAN MED WORLD, V7, P162; HOLT SB, 1968, GENETICS DERMAL RIDG; Kumar S, 2010, ANTHROPOLOGIST, V10, P11; Medland SE, 2007, ANN HUM BIOL, V34, P504, DOI 10.1080/03014460701431896; Medland SE, 2007, PLOS GENET, V3, P1736, DOI 10.1371/journal.pgen.0030165; Merrell D.J., 1981, ECOLOGICAL GENETICS; MILLER JR, 1973, J INVEST DERMATOL, V60, P435, DOI 10.1111/1523-1747.ep12702906; NAFFAH J, 1977, B NEW YORK ACAD MED, V53, P681; Namouchi I., 2011, INT J MOD ANTHR, V1, P12; Negash AN, 2014, IJCR, V6, P4448; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nei M., 1975, MOL POPULATION GENET; Olejnik S, 1997, J EDUC BEHAV STAT, V22, P389, DOI 10.3102/10769986022004389; Omar AS, 2008, MICROSOFT ENCARTA; Pagani L, 2012, AM J HUM GENET, V91, P83, DOI 10.1016/j.ajhg.2012.05.015; RIFE DC, 1953, AM J HUM GENET, V5, P389; SEAMAN MA, 1991, PSYCHOL BULL, V110, P577, DOI 10.1037/0033-2909.110.3.577; Sharma PR, 2008, INTERNET J BIOL ANTH, V2, DOI [10.5580/2330, DOI 10.5580/2330]; Sivakova D, 2007, ANTHROPOL ANZ, V65, P137, DOI 10.1127/anthranz/65/2007/137; SLATIS HM, 1976, AM J HUM GENET, V28, P280; Supriyo Chakraborty, 2011, Notulae Scientia Biologicae, V3, P15; Ta'a T, 2004, JOS, V11, P1; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomason Sarah G., 2001, LANGUAGE CONTACT INT; Zhang HG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008783	31	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0126897	10.1371/journal.pone.0126897	http://dx.doi.org/10.1371/journal.pone.0126897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7TC	26042929	Green Published, gold, Green Submitted			2022-12-27	WOS:000355701600009
J	Chou, WC; Duann, JR; She, HC; Huang, LY; Jung, TP				Chou, Wen-Chi; Duann, Jeng-Ren; She, Hsiao-Ching; Huang, Li-Yu; Jung, Tzyy-Ping			Explore the Functional Connectivity between Brain Regions during a Chemistry Working Memory Task	PLOS ONE			English	Article							SHORT-TERM-MEMORY; INDEPENDENT COMPONENT ANALYSIS; THETA-OSCILLATIONS; NEURONAL SYNCHRONIZATION; PHASE SYNCHRONIZATION; PREFRONTAL CORTEX; BLIND SEPARATION; VISUAL-CORTEX; EEG COHERENCE; DYNAMICS	Previous studies have rarely examined how temporal dynamic patterns, event-related coherence, and phase-locking are related to each other. This study assessed reaction-time-sorted spectral perturbation and event-related spectral perturbation in order to examine the temporal dynamic patterns in the frontal midline (F), central parietal (CP), and occipital (O) regions during a chemistry working memory task at theta, alpha, and beta frequencies. Furthermore, the functional connectivity between F-CP, CP-O, and F-O were assessed by component event-related coherence (ERCoh) and component phase-locking (PL) at different frequency bands. In addition, this study examined whether the temporal dynamic patterns are consistent with the functional connectivity patterns across different frequencies and time courses. Component ERCoh/PL measured the interactions between different independent components decomposed from the scalp EEG, mixtures of time courses of activities arising from different brain, and artifactual sources. The results indicate that the O and CP regions' temporal dynamic patterns are similar to each other. Furthermore, pronounced component ERCoh/PL patterns were found to exist between the O and CP regions across each stimulus and probe presentation, in both theta and alpha frequencies. The consistent theta component ERCoh/PL between the F and O regions was found at the first stimulus and after probe presentation. These findings demonstrate that temporal dynamic patterns at different regions are in accordance with the functional connectivity patterns. Such coordinated and robust EEG temporal dynamics and component ERCoh/PL patterns suggest that these brain regions' neurons work together both to induce similar event-related spectral perturbation and to synchronize or desynchronize simultaneously in order to swiftly accomplish a particular goal. The possible mechanisms for such distinct component phase-locking and coherence patterns were also further discussed.	[Chou, Wen-Chi; She, Hsiao-Ching; Huang, Li-Yu] Natl Chiao Tung Univ, Inst Educ, Hsinchu, Taiwan; [Duann, Jeng-Ren] China Med Univ, Biomed Engn Res Ctr, Taichung, Taiwan; [Duann, Jeng-Ren] China Med Univ, Grad Inst Clin & Med Sci, Taichung, Taiwan; [Duann, Jeng-Ren; Jung, Tzyy-Ping] Univ Calif San Diego, Inst Neural Computat, Swartz Ctr Computat Neurosci, San Diego, CA 92103 USA	National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Taiwan; University of California System; University of California San Diego	She, HC (corresponding author), Natl Chiao Tung Univ, Inst Educ, Hsinchu, Taiwan.	hcshe@mail.nctu.edu.tw		Jung, Tzyy-Ping/0000-0002-8377-2166	Ministry of Science and Technology, Taiwan [NSC 101-2511-S009-003-MY3];  [MOST 103-2911-I-009-101];  [MOST 103-2221-E-039-007-MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); ; 	This work was supported mainly by the Ministry of Science and Technology, Taiwan, under Grant Number NSC 101-2511-S009-003-MY3 and partially supported by Grand Number MOST 103-2911-I-009-101, MOST 103-2221-E-039-007-MY3.	Anderson KL, 2010, CEREB CORTEX, V20, P1604, DOI 10.1093/cercor/bhp223; Babiloni C, 2004, BEHAV NEUROSCI, V118, P687, DOI 10.1037/0735-7044.118.4.687; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Brookes MJ, 2011, NEUROIMAGE, V55, P1804, DOI 10.1016/j.neuroimage.2010.10.074; CARTER GC, 1987, P IEEE, V75, P236, DOI 10.1109/PROC.1987.13723; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Doesburg SM, 2008, CEREB CORTEX, V18, P386, DOI 10.1093/cercor/bhm073; Duann JR, 2009, J NEUROSCI, V29, P10171, DOI 10.1523/JNEUROSCI.1300-09.2009; Fell J, 2003, EUR J NEUROSCI, V17, P1082, DOI 10.1046/j.1460-9568.2003.02522.x; Fingelkurts AA, 2005, NEUROSCI BIOBEHAV R, V28, P827, DOI 10.1016/j.neubiorev.2004.10.009; Ford JM, 2002, BIOL PSYCHIAT, V51, P485, DOI 10.1016/S0006-3223(01)01335-X; Freunberger R, 2008, NEUROIMAGE, V42, P928, DOI 10.1016/j.neuroimage.2008.05.020; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Fries P, 2002, J NEUROSCI, V22, P3739; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Gazzaniga M. S., 2009, COGNITIVE NEUROSCIEN; Gramann K, 2010, J COGNITIVE NEUROSCI, V22, P2836, DOI 10.1162/jocn.2009.21369; Gross J, 2004, P NATL ACAD SCI USA, V101, P13050, DOI 10.1073/pnas.0404944101; Guevara MA, 1996, INT J PSYCHOPHYSIOL, V23, P145, DOI 10.1016/S0167-8760(96)00038-4; Hanslmayr S, 2009, CEREB CORTEX, V19, P1631, DOI 10.1093/cercor/bhn197; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Jung TP, 2001, P IEEE, V89, P1107, DOI 10.1109/5.939827; Jung TP, 2001, HUM BRAIN MAPP, V14, P166, DOI 10.1002/hbm.1050; Kawasaki M, 2012, NEUROIMAGE, V59, P808, DOI 10.1016/j.neuroimage.2011.07.042; Klimesch W, 2004, COGNITIVE BRAIN RES, V19, P302, DOI 10.1016/j.cogbrainres.2003.11.016; Klimesch W, 2006, CEREB CORTEX, V16, P280, DOI 10.1093/cercor/bhi107; Klimesch W., 2011, FRONT PSYCHOL, V2, P1, DOI [10.3389/fpsyg.2011.00001, DOI 10.3389/FPSYG.2011.00001]; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kropotov, 2009, QUANTITATIVE EEG EVE; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lai K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041784; Lee L, 2003, NEUROIMAGE, V19, P457, DOI 10.1016/S1053-8119(03)00062-4; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Leocani L, 1997, EVOKED POTENTIAL, V104, P199, DOI 10.1016/S0168-5597(96)96051-7; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Makeig S, 1996, ADV NEUR IN, V8, P145; Meltzer JA, 2008, CEREB CORTEX, V18, P1843, DOI 10.1093/cercor/bhm213; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Onton J, 2006, NEUROSCI BIOBEHAV R, V30, P808, DOI 10.1016/j.neubiorev.2006.06.007; Onton Julie, 2009, Front Hum Neurosci, V3, P61, DOI 10.3389/neuro.09.061.2009; Oostenveld R, 2002, HUM BRAIN MAPP, V17, P179, DOI 10.1002/hbm.10061; Postle BR, 2004, COGNITIVE BRAIN RES, V20, P194, DOI 10.1016/j.cogbrainres.2004.02.008; Raghavachari S, 2006, J NEUROPHYSIOL, V95, P1630, DOI 10.1152/jn.00409.2005; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Rappelsberger P., 1994, Brain Topography, V7, P121, DOI 10.1007/BF01186770; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Skinner J. E., 1977, ATTENTION VOLUNTARY, P30; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns Olaf, 2002, Complexity, V8, P56, DOI 10.1002/cplx.10047; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Tallon-Baudry C, 1999, VISUAL NEUROSCI, V16, P449, DOI 10.1017/S0952523899163065; Tallon-Baudry C, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0008.2001; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002	62	12	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0129019	10.1371/journal.pone.0129019	http://dx.doi.org/10.1371/journal.pone.0129019			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039885	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700137
J	Hassanzadeh, H; Groza, T; Nguyen, A; Hunter, J				Hassanzadeh, Hamed; Groza, Tudor; Nguyen, Anthony; Hunter, Jane			A Supervised Approach to Quantifying Sentence Similarity: With Application to Evidence Based Medicine	PLOS ONE			English	Article								Following the Evidence Based Medicine (EBM) practice, practitioners make use of the existing evidence to make therapeutic decisions. This evidence, in the form of scientific statements, is usually found in scholarly publications such as randomised control trials and systematic reviews. However, finding such information in the overwhelming amount of published material is particularly challenging. Approaches have been proposed to automatically extract scientific artefacts in EBM using standardised schemas. Our work takes this stream a step forward and looks into consolidating extracted artefacts-i.e., quantifying their degree of similarity based on the assumption that they carry the same rhetorical role. By semantically connecting key statements in the literature of EBM, practitioners are not only able to find available evidence more easily, but also can track the effects of different treatments/outcomes in a number of related studies. We devise a regression model based on a varied set of features and evaluate it both on a general English corpus (the SICK corpus), as well as on an EBM corpus (the NICTA-PIBOSO corpus). Experimental results show that our approach performs on par with the state of the art on the general English and achieves encouraging results on the biomedical text when compared against human judgement.	[Hassanzadeh, Hamed; Groza, Tudor; Hunter, Jane] Univ Queensland, Sch ITEE, Brisbane, Qld, Australia; [Groza, Tudor] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; [Nguyen, Anthony] CSIRO, Australian E Hlth Res Ctr, Brisbane, Qld, Australia	University of Queensland; Garvan Institute of Medical Research; St Vincents Hospital Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Hassanzadeh, H (corresponding author), Univ Queensland, Sch ITEE, Brisbane, Qld, Australia.	h.hassanzadeh@uq.edu.au	Hassanzadeh, Hamed/K-9151-2016; Nguyen, Anthony/B-5913-2009; Nguyen, Anthony/AFQ-7018-2022; Nguyen, Anthony/X-6421-2019; Hassanzadeh, Hamed/O-2719-2019; Hunter, Jane/E-5213-2013	Hassanzadeh, Hamed/0000-0003-2315-1963; Nguyen, Anthony/0000-0002-6215-6954; Nguyen, Anthony/0000-0002-6215-6954; Hassanzadeh, Hamed/0000-0003-2315-1963; Groza, Tudor/0000-0003-2267-8333; Hunter, Jane/0000-0002-7163-4137	Australian Research Council (ARC) Discovery Early Career Researcher Award (DECRA) [DE120100508]	Australian Research Council (ARC) Discovery Early Career Researcher Award (DECRA)(Australian Research Council)	This research is funded by the Australian Research Council (ARC) Discovery Early Career Researcher Award (DECRA)-DE120100508. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, 8 INT WORKSHOP SEMAN; Boudin Florian, 2010, HUMAN LANGUAGE TECHN, P822; Chapman WW, 2001, J BIOMED INFORM, V34, P301, DOI 10.1006/jbin.2001.1029; Cleary J. G., 1995, Machine Learning. Proceedings of the Twelfth International Conference on Machine Learning, P108; Cohen T, 2009, J BIOMED INFORM, V42, P390, DOI 10.1016/j.jbi.2009.02.002; Esposito F, 1999, APPL STOCH MODEL BUS, V15, P277, DOI 10.1002/(SICI)1526-4025(199910/12)15:4<277::AID-ASMB393>3.0.CO;2-B; Fillmore CJ, 2003, INT J LEXICOGR, V16, P235, DOI 10.1093/ijl/16.3.235; Finlayson M. A., 2014, P 7 GLOB WORDN C TAR; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hassanzadeh H, 2014, J BIOMED INFORM, V49, P159, DOI 10.1016/j.jbi.2014.02.006; Holmes G, 1999, LECT NOTES ARTIF INT, V1747, P1; Jimenez S., 2014, P 8 INT WORKSH SEM E, P732, DOI DOI 10.3115/V1/S14-2131; Jonnalagadda Siddhartha, 2013, International Journal of Computational Biology and Drug Design, V6, P5, DOI 10.1504/IJCBDD.2013.052198; Kim SN, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S2-S5; Klein D, 2003, 41ST ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P423, DOI 10.3115/1075096.1075150; Lai A, 2014, P SYMP PURE MATH, V88, P329, DOI 10.1090/pspum/088/01460; Lesk M., 1986, P 5 ANN INT C SYST D, P24, DOI DOI 10.1145/318723.318728; Liakata M, 2012, BIOINFORMATICS, V28, P991, DOI 10.1093/bioinformatics/bts071; Lin D., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P296; Lund K, 1996, BEHAV RES METH INSTR, V28, P203, DOI 10.3758/BF03204766; Marelli M., 2014, P 9 INT C LANGUAGE R, P216; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Mitchell J., 2008, P ASS COMP LING HUM, P236, DOI DOI 10.1039/9781847558633-00236; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Pedersen T, 2004, J MOL BIOL, P38; Pedersen Ted, 2009, P HUM LANG TECHN 200, P17; Resnik P, 1995, INT JOINT CONF ARTIF, P448; Saric F., 2012, P 1 JOINT C LEX COMP, V2, P441, DOI DOI 10.5555/2387636.2387708; Sarker A, 2013, P 4 INT LOUHI WORKSH; Sitbon L, 2012, INT J SEMANT COMPUT, V6, P329, DOI 10.1142/S1793351X12500055; Turney PD, 2010, J ARTIF INTELL RES, V37, P141, DOI 10.1613/jair.2934; Verbeke M., 2012, P 2012 JOINT C EMP M, P579; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Widdows D., 2008, P 6 INT C LANG RES E; Wilbur WJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-356; Zhao J., 2014, P SEMEVAL, P271, DOI DOI 10.3115/V1/S14-2044	37	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0129392	10.1371/journal.pone.0129392	http://dx.doi.org/10.1371/journal.pone.0129392			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039310	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700143
J	Ricciardi, GRR; Adamo, B; Ieni, A; Licata, L; Cardia, R; Ferraro, G; Franchina, T; Tuccari, G; Adamo, V				Rita Ricciardi, Giuseppina Rosaria; Adamo, Barbara; Ieni, Antonio; Licata, Luana; Cardia, Roberta; Ferraro, Giuseppa; Franchina, Tindara; Tuccari, Giovanni; Adamo, Vincenzo			Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients	PLOS ONE			English	Article							EXPRESSION; CARCINOMA; BASAL; KI67; CHEMOTHERAPY; IDENTIFICATION; PROLIFERATION; PATTERNS; ADHESION; SUBTYPES	Background TNBC is an aggressive subset of breast cancer (BC) without specific target therapy. Methods This observational, retrospective study included 45 cases of TNBC. The aim of this study was to evaluate the expression of the AR, E-cadherin and Ki-67 in relation to histological type, time to relapse and overall survival (OS). Immunohistochemistry (IHC) was carried out on formalin-fixed paraffin-embedded tumor samples obtained from patients defined TNBC. Results The AR was positive (IHC >10%) in 26.6%. E-cadherin (CDH1) expression was considered positive if the score was >= 2. This expression was negative in 53.3% cases. The Ki-67 index was >= 20% in 37.7%. Univariate analyses showed that AR, CDH1 and Ki-67 are significantly associated with OS. Multivariate analysis showed that AR and Ki-67 expression are independent variables associated with OS. The statistical analysis showed that patients with AR negative and Ki-67 positive expression have a significant correlation with poor outcome. Conclusions Our data suggest that the combination of AR and E-cadherin expression as well as Ki-67 status might be useful prognostic markers in TNBC. Hence, these molecular determinants could play an interesting role to classify subgroups of TNBC.	[Rita Ricciardi, Giuseppina Rosaria; Ferraro, Giuseppa; Franchina, Tindara; Adamo, Vincenzo] Univ Messina, Med Oncol Unit AOOR Papardo Piemonte, Messina, Italy; [Rita Ricciardi, Giuseppina Rosaria; Ferraro, Giuseppa; Franchina, Tindara; Adamo, Vincenzo] Univ Messina, Dept Human Pathol, Messina, Italy; [Adamo, Barbara] Oncol Med Hosp Clin, Barcelona, Spain; [Ieni, Antonio; Licata, Luana; Cardia, Roberta; Tuccari, Giovanni] Univ Messina, Sect Anat Pathol, Dept Human Pathol Gaetano Barresi, Messina, Italy	University of Messina; University of Messina; University of Messina	Adamo, V (corresponding author), Univ Messina, Med Oncol Unit AOOR Papardo Piemonte, Messina, Italy.	vadamo@unime.it	Ieni, Antonio/AAC-7265-2019	Ieni, Antonio/0000-0003-2878-3572; Adamo, Barbara/0000-0001-7129-8156; Ricciardi, Giuseppina Rosaria Rita/0000-0002-7282-3597				Adamo B, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2852; Adamo V, 2012, EUR J CANCER, V48, P642, DOI 10.1016/j.ejca.2011.06.028; Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; Bertucci F, 2008, INT J CANCER, V123, P236, DOI 10.1002/ijc.23518; Birrell SN, 1998, J MAMMARY GLAND BIOL, V3, P95, DOI 10.1023/A:1018730519839; BRYAN RM, 1984, CANCER, V54, P2436, DOI 10.1002/1097-0142(19841201)54:11<2436::AID-CNCR2820541121>3.0.CO;2-H; Burstein MD, 2014, CLIN CANC RES; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Carey LA, 2011, ONCOLOGIST, V16, P71, DOI 10.1634/theoncologist.2011-S1-71; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Fornier M, 2012, BREAST J, V18, P41, DOI 10.1111/j.1524-4741.2011.01175.x; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; GERDES J, 1991, AM J PATHOL, V138, P867; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Gonzalez-Angulo AM, 2009, CLIN CANCER RES, V15, P2472, DOI 10.1158/1078-0432.CCR-08-1763; Gucalp A, 2013, CLIN CANCER RES, V19, P5505, DOI 10.1158/1078-0432.CCR-12-3327; Gucalp A, 2010, CANCER J, V16, P62, DOI 10.1097/PPO.0b013e3181ce4ae1; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Harrell JC, 2012, BREAST CANCER RES TR, V132, P523, DOI 10.1007/s10549-011-1619-7; He JH, 2012, MED ONCOL, V29, P406, DOI 10.1007/s12032-011-9832-0; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Irvin WJ, 2008, EUR J CANCER, V44, P2799, DOI 10.1016/j.ejca.2008.09.034; Jones RL, 2009, BREAST CANCER RES TR, V116, P53, DOI 10.1007/s10549-008-0081-7; Kashiwagi S, 2010, BRIT J CANCER, V103, P249, DOI 10.1038/sj.bjc.6605735; Kashiwagi S, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3068; Keam B, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-203; Lehmann BD, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0406-x; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liao DJ, 2002, J STEROID BIOCHEM, V80, P175, DOI 10.1016/S0960-0760(01)00185-6; Lin NU, 2008, CANCER-AM CANCER SOC, V113, P2638, DOI 10.1002/cncr.23930; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Park S, 2010, ANN ONCOL, V21, P488, DOI 10.1093/annonc/mdp510; Pathmanathan N, 2013, J CLIN PATHOL, V66, P512, DOI 10.1136/jclinpath-2012-201085; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; PERSIJN JP, 1975, BRIT MED J, V4, P503, DOI 10.1136/bmj.4.5995.503; Petit T, 2004, EUR J CANCER, V40, P205, DOI 10.1016/S0959-8049(03)00675-0; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Pristauz G, 2010, HISTOPATHOLOGY, V57, P877, DOI 10.1111/j.1365-2559.2010.03724.x; Rakha EA, 2005, HISTOPATHOLOGY, V46, P685, DOI 10.1111/j.1365-2559.2005.02156.x; Rakha E, 2008, CLIN CANCER RES, V14, P618, DOI 10.1158/1078-0432.CCR-07-1943; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Rakha EA, 2009, PATHOLOGY, V41, P40, DOI 10.1080/00313020802563510; Riva C, 2005, VIRCHOWS ARCH, V447, P695, DOI 10.1007/s00428-005-0003-6; Rothberg BEG, 2006, BREAST CANCER RES TR, V100, P139, DOI 10.1007/s10549-006-9248-2; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tang DB, 2012, MED ONCOL, V29, P526, DOI 10.1007/s12032-011-9948-2; Vera-Badillo FE, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt319; Wong YC, 2001, MARC MALPIG SYMP SER, V7, P111; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Yu KD, 2013, CLIN CANCER RES, V19, P2723, DOI 10.1158/1078-0432.CCR-12-2986	54	43	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128368	10.1371/journal.pone.0128368	http://dx.doi.org/10.1371/journal.pone.0128368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039245	gold, Green Published, Green Submitted			2022-12-27	WOS:000355700700099
J	Thanos, PK; Michaelides, M; Subrize, M; Miller, ML; Bellezza, R; Cooney, RN; Leggio, L; Wang, GJ; Rogers, AM; Volkow, ND; Hajnal, A				Thanos, Panayotis K.; Michaelides, Mike; Subrize, Mike; Miller, Mike L.; Bellezza, Robert; Cooney, Robert N.; Leggio, Lorenzo; Wang, Gene-Jack; Rogers, Ann M.; Volkow, Nora D.; Hajnal, Andras			Roux-en-Y Gastric Bypass Alters Brain Activity in Regions that Underlie Reward and Taste Perception	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; VERTICAL BANDED GASTROPLASTY; WEIGHT-LOSS; BARIATRIC SURGERY; SWEET TASTE; NEURAL RESPONSIVITY; ENERGY-EXPENDITURE; NUCLEUS-ACCUMBENS; INCREASES ETHANOL; EATING BEHAVIORS	Background Roux-en-Y gastric bypass (RYGB) surgery is a very effective bariatric procedure to achieve significant and sustained weight loss, yet little is known about the procedure's impact on the brain. This study examined the effects of RYGB on the brain's response to the anticipation of highly palatable versus regular food. Methods High fat diet-induced obese rats underwent RYGB or sham operation and were then tested for conditioned place preference (CPP) for the bacon-paired chamber, relative to the chow-paired chamber. After CPP, animals were placed in either chamber without the food stimulus, and brain-glucose metabolism (BGluM) was measured using positron emission tomography (mu PET). Results Bacon CPP was only observed in RYGB rats that had stable weight loss following surgery. BGluM assessment revealed that RYGB selectively activated regions of the right and midline cerebellum (Lob 8) involved in subjective processes related to reward or expectation. Also, bacon anticipation led to significant activation in the medial parabrachial nuclei (important in gustatory processing) and dorsomedial tegmental area (key to reward, motivation, cognition and addiction) in RYGB rats; and activation in the retrosplenial cortex (default mode network), and the primary visual cortex in control rats. Conclusions RYGB alters brain activity in areas involved in reward expectation and sensory (taste) processing when anticipating a palatable fatty food. Thus, RYGB may lead to changes in brain activity in regions that process reward and taste-related behaviors. Specific cerebellar regions with altered metabolism following RYGB may help identify novel therapeutic targets for treatment of obesity.	[Thanos, Panayotis K.; Subrize, Mike; Bellezza, Robert] SUNY Stony Brook, Dept Psychol, Behav Neuropharmacol & Neuroimaging Lab, Stony Brook, NY 11794 USA; [Michaelides, Mike; Miller, Mike L.] Mt Sinai Med Ctr, Dept Neurosci, New York, NY USA; [Cooney, Robert N.] SUNY Upstate Med Univ, Dept Surg, Syracuse, NY 13210 USA; [Leggio, Lorenzo] NIAAA, Sect Clin Psychoneuroendocrinol & Neuropsychophar, Lab Clin & Translat Studies, NIH, Bethesda, MD USA; [Leggio, Lorenzo] NIDA, Intramural Res Program, NIH, Baltimore, MD USA; [Leggio, Lorenzo] Brown Univ, Ctr Alcohol & Addict Studies, Dept Behav & Social Sci, Providence, RI 02912 USA; [Wang, Gene-Jack; Volkow, Nora D.] NIAAA, Intramural Res Program, NIH, Bethesda, MD USA; [Hajnal, Andras] Penn State Univ, Dept Neural & Behav Sci, Hershey, PA USA; [Rogers, Ann M.; Hajnal, Andras] Penn State Univ, Dept Surg, Hershey, PA USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Icahn School of Medicine at Mount Sinai; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Brown University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Thanos, PK (corresponding author), SUNY Stony Brook, Dept Psychol, Behav Neuropharmacol & Neuroimaging Lab, Stony Brook, NY 11794 USA.	peter.thanos@stonybrook.edu	Leggio, Lorenzo/M-2972-2016; Michaelides, Mike/V-5199-2019; Michaelides, Michael/K-4736-2013; Miller, Michael/B-8077-2014	Michaelides, Michael/0000-0003-0398-4917; Miller, Michael/0000-0002-6350-5706	National Institute of Diabetes and Digestive and Kidney Diseases [DK080899]; National Institute on Alcohol Abuse and Alcoholism [AA 11034]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011034, ZIAAA000218, ZIAAA000550] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	National Institute of Diabetes and Digestive and Kidney Diseases (DK080899) and National Institute on Alcohol Abuse and Alcoholism (AA 11034).	Babbs RK, 2013, PHYSIOL BEHAV, V121, P103, DOI 10.1016/j.physbeh.2013.03.025; Beck NN, 2012, EAT BEHAV, V13, P394, DOI 10.1016/j.eatbeh.2012.06.001; Berman SM, 2013, CEREBELLUM, V12, P59, DOI 10.1007/s12311-012-0360-z; Berthoud H-R, 2011, PHYSL BEHAV IN PRESS; BLACKBURN JR, 1989, BEHAV NEUROSCI, V103, P15, DOI 10.1037/0735-7044.103.1.15; BROWN EK, 1982, J AM DIET ASSOC, V80, P437; Brunault P, 2012, PSYCHOSOMATICS, V53, P363, DOI 10.1016/j.psym.2011.12.008; Bueter M, 2011, INT J OBESITY, V35, pS35, DOI 10.1038/ijo.2011.146; Christou NV, 2006, ANN SURG, V244, P734, DOI 10.1097/01.sla.0000217592.04061.d5; Clark SM, 2013, EAT BEHAV, V14, P216, DOI 10.1016/j.eatbeh.2013.01.002; Clement K, 2005, P NUTR SOC, V64, P133, DOI 10.1079/PNS2005416; Colles SL, 2008, OBESITY, V16, P615, DOI 10.1038/oby.2007.101; Colles SL, 2008, OBESITY, V16, P608, DOI 10.1038/oby.2007.99; Conason A, 2013, JAMA SURG, V148, P145, DOI 10.1001/2013.jamasurg.265; Conceicao E, 2013, EAT WEIGHT DISORD; Corwin RL, 2009, J NUTR, V139, P617, DOI 10.3945/jn.108.097691; Davis JF, 2013, OBES SURG, V23, P920, DOI 10.1007/s11695-013-0884-4; Dunn JP, 2010, BRAIN RES, V1350, P123, DOI 10.1016/j.brainres.2010.03.064; Dutta S, 2006, OBES SURG, V16, P780, DOI 10.1381/096089206777346646; Ertelt TW, 2008, SURG OBES RELAT DIS, V4, P647, DOI 10.1016/j.soard.2008.01.004; Geraedts MCP, 2012, AM J PHYSIOL-ENDOC M, V303, pE464, DOI 10.1152/ajpendo.00163.2012; GOSSOP MR, 1980, BRIT J ADDICT, V75, P305; Hajnal A, 2004, AM J PHYSIOL-REG I, V286, pR31, DOI 10.1152/ajpregu.00282.2003; Hajnal A, 1997, J NEUROCHEM, V68, P667; Hajnal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049121; Hajnal A, 2010, AM J PHYSIOL-GASTR L, V299, pG967, DOI 10.1152/ajpgi.00070.2010; HALMI KA, 1981, INT J OBESITY, V5, P457; Hsu LKG, 1998, PSYCHOSOM MED, V60, P338, DOI 10.1097/00006842-199805000-00021; Hudson JI, 2010, AM J CLIN NUTR, V91, P1568, DOI 10.3945/ajcn.2010.29203; Huijbers W, 2012, NEUROPSYCHOLOGIA, V50, P3764, DOI 10.1016/j.neuropsychologia.2012.08.021; Kalarchian MA, 2002, OBES SURG, V12, P270, DOI 10.1381/096089202762552494; Kaye WH, 2013, BIOL PSYCHIAT, V73, P836, DOI 10.1016/j.biopsych.2013.01.002; KENLER HA, 1990, AM J CLIN NUTR, V52, P87, DOI 10.1093/ajcn/52.1.87; King WC, 2012, JAMA-J AM MED ASSOC, V307, P2516, DOI 10.1001/jama.2012.6147; Kofman MD, 2010, OBESITY, V18, P1938, DOI 10.1038/oby.2010.27; Koros C, 2009, NUTRITION, V25, P85, DOI 10.1016/j.nut.2008.06.033; Lam JM, 2013, HUM BRAIN MAPP, V34, P176, DOI 10.1002/hbm.21431; Lautenbach A, 2013, INT J EAT DISORDER, V46, P280, DOI 10.1002/eat.22081; Le Roux CW, 2011, AMERICAN JOURNAL OF; Lent MR, 2012, EAT BEHAV, V13, P67, DOI 10.1016/j.eatbeh.2011.10.006; Marek RJ, 2014, INT J EATING DISORDE; Mathes CM, 2012, PHYSIOL BEHAV, V107, P476, DOI 10.1016/j.physbeh.2012.02.013; Mathes CM, PHYSL AMP BEHAV; Mercer JG, 1998, ENDOCRINOLOGY, V139, P29, DOI 10.1210/en.139.1.29; Michaelides M, 2010, EUR J NEUROSCI, V32, P668, DOI 10.1111/j.1460-9568.2010.07319.x; Miras AD, 2012, AM J CLIN NUTR, V96, P467, DOI 10.3945/ajcn.112.036921; Mitchell JE, 2012, SURG OBES RELAT DIS, V8, P533, DOI 10.1016/j.soard.2012.07.001; Mitchell JE, 2001, OBES SURG, V11, P464, DOI 10.1381/096089201321209341; Miyazaki K, 1998, NEUROREPORT, V9, P3943, DOI 10.1097/00001756-199812010-00032; Miyazaki K, 2004, NEUROREPORT, V15, P721, DOI 10.1097/00001756-200403220-00030; Mottin CC, 2005, OBES SURG, V15, P788, DOI 10.1381/0960892054222830; Mueller K, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.121; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Ochner CN, 2012, NEUROSCIENCE, V209, P128, DOI 10.1016/j.neuroscience.2012.02.030; Ochner CN, 2012, NEUROSCI RES, V74, P138, DOI 10.1016/j.neures.2012.08.002; Ochner CN, 2011, ANN SURG, V253, P502, DOI 10.1097/SLA.0b013e318203a289; Odom J, 2010, OBES SURG, V20, P349, DOI 10.1007/s11695-009-9895-6; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogura K, 2013, BRAIN DEV-JPN, V35, P427, DOI 10.1016/j.braindev.2012.07.013; Olbers T, 2006, ANN SURG, V244, P715, DOI 10.1097/01.sla.0000218085.25902.f8; Polston JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083741; Ranganath C, 2012, NAT REV NEUROSCI, V13, P713, DOI 10.1038/nrn3338; Reilly S, 1999, BRAIN RES BULL, V48, P239, DOI 10.1016/S0361-9230(98)00173-7; Richardson KA, 2012, J NEUROSCI, V32, P3809, DOI 10.1523/JNEUROSCI.3917-11.2012; Robinson TE, 2009, BIOL PSYCHIAT, V65, P869, DOI 10.1016/j.biopsych.2008.09.006; Schelbert KB, 2009, PRIMARY CARE, V36, P271, DOI 10.1016/j.pop.2009.01.009; Schweighofer N, 2004, BRAIN RES REV, V44, P103, DOI 10.1016/j.brainresrev.2003.10.004; Sewards TV, 2004, BRAIN RES BULL, V62, P271, DOI 10.1016/j.brainresbull.2003.10.004; Seyfried F, 2013, SURG ENDOSC, V27, P4192, DOI 10.1007/s00464-013-3020-6; Shin AC, 2011, INT J OBESITY, V35, P642, DOI 10.1038/ijo.2010.174; Steele KE, 2010, OBES SURG, V20, P369, DOI 10.1007/s11695-009-0015-4; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Stice E, 2009, PHYSIOL BEHAV, V97, P551, DOI 10.1016/j.physbeh.2009.03.020; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Stylopoulos N, 2009, OBESITY, V17, P1839, DOI 10.1038/oby.2009.207; Suzuki J, 2012, OBES SURG, V22, P201, DOI 10.1007/s11695-010-0346-1; Suzuki S, 2005, SURGERY, V138, P283, DOI 10.1016/j.surg.2005.05.013; Tapia-Gonzalez S, 2011, J NEUROENDOCRINOL, V23, P365, DOI 10.1111/j.1365-2826.2011.02113.x; Thanos P, 2012, OBESITY SURGERY; Thanos PK, 2010, J PSYCHOPHARMACOL, V24, P897, DOI 10.1177/0269881109102613; Thanos PK, 2008, SYNAPSE, V62, P637, DOI 10.1002/syn.20531; Thanos PK, 2008, SYNAPSE, V62, P50, DOI 10.1002/syn.20468; Thanos PK, 2013, J NEUROSCI, V33, P6343, DOI 10.1523/JNEUROSCI.4997-12.2013; Thanos PK, 2012, OBES SURG, V22, P1884, DOI 10.1007/s11695-012-0749-2; Thanos PK, 2010, PHYSIOL BEHAV, V101, P713, DOI 10.1016/j.physbeh.2010.08.011; Thoma P, 2008, CEREBELLUM, V7, P433, DOI 10.1007/s12311-008-0046-8; Tichansky DS, 2011, SURG ENDOSC, V25, P1176, DOI 10.1007/s00464-010-1335-0; Tomasi D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006847; TROSTLER N, 1995, OBES SURG, V5, P39, DOI 10.1381/096089295765558141; Volkow ND, 2003, INT J EAT DISORDER, V33, P136, DOI 10.1002/eat.10118; Volkow ND, 2002, SYNAPSE, V44, P175, DOI 10.1002/syn.10075; Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002; Wang GJ, 2011, OBESITY, V19, P1601, DOI 10.1038/oby.2011.27; Wang GJ, 2009, J ADDICT MED, V3, P8, DOI 10.1097/ADM.0b013e31819a86f7; Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wilson-Perez HE, 2013, INT J OBESITY, V37, P288, DOI 10.1038/ijo.2012.18; Xu Y, 2002, J SURG RES, V107, P56, DOI [10.1006/jsre.2002.6508, 10.1016/S0022-4804(02)96508-X]; Zhang X, 2013, NEUROIMAGE, V65, P223, DOI 10.1016/j.neuroimage.2012.08.063; Zheng HY, 2009, AM J PHYSIOL-REG I, V297, pR1273, DOI 10.1152/ajpregu.00343.2009	100	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0125570	10.1371/journal.pone.0125570	http://dx.doi.org/10.1371/journal.pone.0125570			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039080	Green Submitted, Green Published, gold			2022-12-27	WOS:000355700700009
J	Hwang, IC; Jeon, JY; Kim, Y; Kim, HM; Yoon, YE; Lee, SP; Kim, HK; Sohn, DW; Sung, J; Kim, YJ				Hwang, In-Chang; Jeon, Joo-Yeong; Kim, Younhee; Kim, Hyue Mee; Yoon, Yeonyee E.; Lee, Seung-Pyo; Kim, Hyung-Kwan; Sohn, Dae-Won; Sung, Jidong; Kim, Yong-Jin			Association between Aspirin Therapy and Clinical Outcomes in Patients with Non-Obstructive Coronary Artery Disease: A Cohort Study	PLOS ONE			English	Article							COMPUTED TOMOGRAPHIC ANGIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; ALL-CAUSE MORTALITY; PRIMARY PREVENTION; CARDIOVASCULAR EVENTS; PROGNOSTIC VALUE; CT ANGIOGRAPHY; RISK-FACTORS; STROKE; CALCIUM	Background Presence of non-obstructive coronary artery disease (CAD) is associated with increased prescription of cardiovascular preventive medications including aspirin. However, the association between aspirin therapy with all-cause mortality and coronary revascularization in this population has not been investigated. Methods and Findings Among the cohort of individuals who underwent coronary computed tomography angiography (CCTA) from 2007 to 2011, 8372 consecutive patients with non-obstructive CAD (1-49% stenosis) were identified. Patients with statin or aspirin prescription before CCTA, and those with history of revascularization before CCTA were excluded. We analyzed the differences of all-cause mortality and a composite of mortality and late coronary revascularization (>90 days after CCTA) between aspirin users (n=3751; 44.8%) and non-users. During a median of 828 (interquartile range 385-1,342) days of follow-up, 221 (2.6%) mortality cases and 295 (3.5%) cases of composite endpoint were observed. Annualized mortality rates were 0.97% in aspirin users versus 1.28% in non-users, and annualized rates of composite endpoint were 1.56% versus 1.48%, respectively. Aspirin therapy was associated with significantly lower risk of all-cause mortality (adjusted HR 0.649; 95% CI 0.492-0.857; p=0.0023), but not with the composite endpoint (adjusted HR 0.841; 95% CI 0.662-1.069; p=0.1577). Association between aspirin and lower all-cause mortality was limited to patients with age >= 65 years, diabetes, hypertension, decreased renal function, and higher levels of coronary artery calcium score, low-density lipoprotein cholesterol and high-sensitivity C-reactive protein. Conclusions Among the patients with non-obstructive CAD documented by CCTA, aspirin is associated with lower all-cause mortality only in those with higher risk.	[Hwang, In-Chang; Kim, Hyue Mee; Yoon, Yeonyee E.; Lee, Seung-Pyo; Kim, Hyung-Kwan; Sohn, Dae-Won; Kim, Yong-Jin] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Hwang, In-Chang; Kim, Hyue Mee; Lee, Seung-Pyo; Kim, Hyung-Kwan; Sohn, Dae-Won; Kim, Yong-Jin] Seoul Natl Univ Hosp, Ctr Cardiovasc, Seoul 110744, South Korea; [Jeon, Joo-Yeong] Sungkyunkwan Univ, Dept Stat, Seoul, South Korea; [Kim, Younhee] Seoul Natl Univ, Inst Hlth & Environm, Sch Publ Hlth, Seoul 151, South Korea; [Yoon, Yeonyee E.] Seoul Natl Univ, Div Cardiol, Bundang Hosp, Dept Internal Med, Seongnam Si, Gyeonggi Do, South Korea; [Sung, Jidong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Internal Med, Seoul, South Korea; [Kim, Yong-Jin] Sungkyunkwan Univ, Sch Med, Ctr Hlth Promot, Samsung Med Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Seoul National University (SNU); Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, YJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	kimdamas@snu.ac.kr	Hwang, In-Chang/K-8562-2012; sung, jd/O-5936-2014; Kim, Hyung-Kwan/R-8375-2019	Hwang, In-Chang/0000-0003-4966-3924; Kim, Hyung-Kwan/0000-0001-7950-2131	Korean Health Technology Research and Development Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [HI13C1961]	Korean Health Technology Research and Development Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This study was supported by a grant of the Korean Health Technology Research and Development Project (HI13C1961), Ministry for Health, Welfare & Family Affairs, Republic of Korea. URL: http://english.mw.go.kr/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2008, STROKE, V39, P1647, DOI 10.1161/STROKEAHA.107.189063; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bartolucci AA, 2011, AM J CARDIOL, V107, P1796, DOI 10.1016/j.amjcard.2011.02.325; Benavente OR, 2012, NEW ENGL J MED, V367, P817, DOI 10.1056/NEJMoa1204133; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Blaha MJ, 2011, LANCET, V378, P684, DOI 10.1016/S0140-6736(11)60784-8; Cheezum MK, 2013, JACC-CARDIOVASC IMAG, V6, P574, DOI 10.1016/j.jcmg.2012.11.016; Cheng Victor Y, 2011, Circulation, V124, P2423, DOI 10.1161/CIRCULATIONAHA.111.039255; Choi EK, 2008, J AM COLL CARDIOL, V52, P357, DOI 10.1016/j.jacc.2008.02.086; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Germano G, 2012, EUR HEART J, V33, P137; Goldstein LB, 2006, STROKE, V37, P1583, DOI 10.1161/01.STR.0000223048.70103.F1; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Hayden M, 2002, ANN INTERN MED, V136, P161, DOI 10.7326/0003-4819-136-2-200201150-00016; Hennekens CH, 2014, NAT REV CARDIOL, V11, P438, DOI 10.1038/nrcardio.2014.88; Hoffmann U, 2009, J AM COLL CARDIOL, V53, P1642, DOI 10.1016/j.jacc.2009.01.052; Hulten E, 2014, CIRC-CARDIOVASC IMAG, V7, P629, DOI 10.1161/CIRCIMAGING.113.001564; Hulten E, 2014, ATHEROSCLEROSIS, V233, P190, DOI 10.1016/j.atherosclerosis.2013.12.029; Hulten EA, 2011, J AM COLL CARDIOL, V57, P1237, DOI 10.1016/j.jacc.2010.10.011; Hwang IC, 2015, ATHEROSCLEROSIS, V239, P335, DOI 10.1016/j.atherosclerosis.2015.01.036; Ikeda Y, 2014, JAMA-J AM MED ASSOC, V312, P2510, DOI 10.1001/jama.2014.15690; Jespersen L, 2012, EUR HEART J, V33, P734, DOI 10.1093/eurheartj/ehr331; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Kim L, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014008; Kwon S, 2003, HEALTH POLICY PLANN, V18, P84, DOI 10.1093/heapol/18.1.84; Lee CH, 2013, THORAX, V68, P1105, DOI 10.1136/thoraxjnl-2012-203175; Maddox TM, 2014, JAMA-J AM MED ASSOC, V312, P1754, DOI 10.1001/jama.2014.14681; Matthys F, 2014, EUR J PREV CARDIOL, V21, P354, DOI 10.1177/2047487312472077; McEvoy JW, 2011, ARCH INTERN MED, V171, P1260, DOI 10.1001/archinternmed.2011.204; Miedema MD, 2014, CIRC-CARDIOVASC QUAL, V7, P453, DOI 10.1161/CIRCOUTCOMES.113.000690; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Min JK, 2007, J AM COLL CARDIOL, V50, P1161, DOI 10.1016/j.jacc.2007.03.067; Min JK, 2011, J AM COLL CARDIOL, V58, P849, DOI 10.1016/j.jacc.2011.02.074; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Pen A, 2013, EUR HEART J, V34, P1075, DOI 10.1093/eurheartj/ehs473; Seshasai SRK, 2012, ARCH INTERN MED, V172, P209, DOI 10.1001/archinternmed.2011.628; Shaw LJ, 2012, J AM COLL CARDIOL, V60, P2103, DOI 10.1016/j.jacc.2012.05.062; Sutcliffe P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081970; Tonelli M, 2012, LANCET, V380, P807, DOI 10.1016/S0140-6736(12)60572-8; van Kruijsdijk RCM, 2015, HEART, V101, P369, DOI 10.1136/heartjnl-2014-306342; Vandvik O, 2012, CHEST, V141, pE637S, DOI 10.1378/chest.11-2306	45	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0129584	10.1371/journal.pone.0129584	http://dx.doi.org/10.1371/journal.pone.0129584			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035823	Green Published, gold, Green Submitted			2022-12-27	WOS:000355699100073
J	Kakimoto, Y; Kamiguchi, H; Ochiai, E; Satoh, F; Osawa, M				Kakimoto, Yu; Kamiguchi, Hiroshi; Ochiai, Eriko; Satoh, Fumiko; Osawa, Motoki			MicroRNA Stability in Postmortem FFPE Tissues: Quantitative Analysis Using Autoptic Samples from Acute Myocardial Infarction Patients	PLOS ONE			English	Article							CIRCULATING MICRORNAS; FRESH-FROZEN; RNA; EXPRESSION; BIOMARKERS; INTEGRITY; QUALITY; SERUM; PCR; ELECTROPHORESIS	MicroRNAs (miRNAs) are very short (18-24 nucleotides) nucleic acids that are expressed in a number of biological tissues and have been shown to be more resistant to extreme temperatures and pH compared to longer RNA molecules, like mRNAs. As miRNAs contribute to diverse biological process and respond to various kinds of cellular stress, their utility as diagnostic biomarkers and/or therapeutic targets has recently been explored. Here, we have evaluated the usefulness of miRNA quantification during postmortem examination of cardiac tissue from acute myocardial infarction (AMI) patients. Cardiac tissue was collected within one week of the patient's death and either frozen (19 samples) or fixed in formalin for up to three years (36 samples). RNA integrity was evaluated with an electropherogram, and it appears that longer RNAs are fragmented after death in the long-term fixed samples. Quantitative PCR was also performed for seven miRNAs and three other small RNAs in order to determine the appropriate controls for our postmortem analysis. Our data indicate that miR-191 and miR-26b are more suitable than the other types of small RNA molecules as they are stably detected after death and long-term fixation. Further, we also applied our quantitation method, using these endogenous controls, to evaluate the expression of three previously identified miRNA biomarkers, miR-1, miR-208b, and miR-499a, in formalin-fixed tissues from AMI patients. Although miR-1 and miR-208b decreased (1.4-fold) and increased (1.2-fold), respectively, in the AMI samples compared to the controls, the significance of these changes was limited by our sample size. In contrast, the relative level of miR-499a was significantly decreased in the AMI samples (2.1-fold). This study highlights the stability of miRNAs after death and long-term fixation, validating their use as reliable biomarkers for AMI during postmortem examination.	[Kakimoto, Yu; Ochiai, Eriko; Satoh, Fumiko; Osawa, Motoki] Tokai Univ, Sch Med, Dept Forens Med, Isehara, Kanagawa 25911, Japan; [Kamiguchi, Hiroshi] Tokai Univ, Support Ctr Med Res & Educ, Isehara, Kanagawa, Japan	Tokai University; Tokai University	Osawa, M (corresponding author), Tokai Univ, Sch Med, Dept Forens Med, Isehara, Kanagawa 25911, Japan.	osawa@is.icc.u-tokai.ac.jp			Tokai University Educational System General Research Organization [14NS289941]; JSPS KAKENHI Grant [26893278]	Tokai University Educational System General Research Organization; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Research and Study Project of Tokai University Educational System General Research Organization (14NS289941) and JSPS KAKENHI Grant (26893278).	Ai J, 2010, BIOCHEM BIOPH RES CO, V391, P73, DOI 10.1016/j.bbrc.2009.11.005; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Applied Biosystems, 2008, GUIDE TO PERFORMING; Becker C, 2010, METHODS, V50, P237, DOI 10.1016/j.ymeth.2010.01.010; Bostjancic E, 2010, CARDIOLOGY, V115, P163, DOI 10.1159/000268088; Bronze-da-Rocha E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/985408; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Deddens JC, 2013, J CARDIOVASC TRANSL, V6, P884, DOI 10.1007/s12265-013-9493-9; Di Leva G, 2013, CURR OPIN GENET DEV, V23, P3, DOI 10.1016/j.gde.2013.01.004; Guo ZY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05150; Haile S, 2003, RNA, V9, P1491, DOI 10.1261/rna.5940703; Imbeaud S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni054; Kakimoto Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000565; Kakimoto Y, 2013, AM J FOREN MED PATH, V34, P242, DOI 10.1097/PAF.0b013e31828879cd; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kumar V, 2010, ROBBINS AND COTRAN P, P545; Kuwabara Y, 2011, CIRC-CARDIOVASC GENE, V4, P446, DOI 10.1161/CIRCGENETICS.110.958975; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long GW, 2012, INT J BIOL SCI, V8, P811, DOI 10.7150/ijbs.4439; Lv P, 2014, INT J MOL SCI, V15, P5774, DOI 10.3390/ijms15045774; Macabeo-Ong M, 2002, MODERN PATHOL, V15, P979, DOI 10.1097/01.MP.0000026054.62220.FC; Meng W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064393; Micke P, 2006, LAB INVEST, V86, P202, DOI 10.1038/labinvest.3700372; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moret I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082753; Muciaccia B, 2015, INT J LEGAL MED, V129, P11, DOI 10.1007/s00414-014-1066-1; Olivieri F, 2013, INT J CARDIOL, V167, P531, DOI 10.1016/j.ijcard.2012.01.075; Peiro-Chova L, 2013, VIRCHOWS ARCH, V463, P765, DOI 10.1007/s00428-013-1485-2; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Plattner T, 2008, J Forensic Leg Med, V15, P325, DOI 10.1016/j.jflm.2007.12.019; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Satoh M, 2010, J CARD FAIL, V16, P404, DOI 10.1016/j.cardfail.2010.01.002; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Slagter-Jager JG, 2012, J PHARMACEUT BIOMED, V70, P657, DOI 10.1016/j.jpba.2012.04.031; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Turashvili G, 2012, EXP MOL PATHOL, V92, P33, DOI 10.1016/j.yexmp.2011.09.013; Wong L, 2007, PUBLICATION; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Xiao JJ, 2014, INT J CLIN EXP MED, V7, P136; Zhang H, 2013, SCI JUSTICE, V53, P115, DOI 10.1016/j.scijus.2012.11.005	45	34	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129338	10.1371/journal.pone.0129338	http://dx.doi.org/10.1371/journal.pone.0129338			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046358	gold, Green Published, Green Submitted			2022-12-27	WOS:000355652200153
J	Madlala, HP; Van Heerden, FR; Mubagwa, K; Musabayane, CT				Madlala, Hlengiwe Pretty; Van Heerden, Fanie Retief; Mubagwa, Kanigula; Musabayane, Cephas Tagumirwa			Changes in Renal Function and Oxidative Status Associated with the Hypotensive Effects of Oleanolic Acid and Related Synthetic Derivatives in Experimental Animals	PLOS ONE			English	Article							BARK ETHANOLIC EXTRACT; ORUJO OLIVE OIL; NITRIC-OXIDE; URSOLIC ACIDS; BLOOD-GLUCOSE; TRITERPENOIDS; HYPERTENSION; ANTIOXIDANT; STRESS; KIDNEY	Purpose The triterpene oleanolic acid (OA) is known to possess antihypertensive actions. In the present study we to compared the effects of the triterpene on mean arterial blood pressure (MAP) and kidney function following acute administration in normotensive animals with those of its related oleanane synthetic derivatives (brominated oleanolic acid, Br-OA and oleanolic acid methyl ester, Me-OA). We also used experimental models of hypertension to further explore the effects of sub-chronic oral OA treatment and evaluated influences on oxidative status. Methods OA was extracted from dried flower buds of Syzygium aromaticum using a previously validated protocol in our laboratory. Me-OA and Br-OA were synthesized according to a method described. Rats were supplemented with lithium chloride (12 mmol L-1) prior to experimentation in order to raise plasma lithium to allow measurements of lithium clearance and fractional excretion (FELi) as indices of proximal tubular Na+ handling. Anaesthetized animals were continuously infused via the right jugular with 0.077M NaCl. MAP was measured via a cannula inserted in the carotid artery, and urine was collected through a cannula inserted in the bladder. After a 3.5 h equilibration, MAP, urine flow, electrolyte excretion rates were determined for 4 h of 1 h control, 1.5 h treatment and 1.5 h recovery periods. OA, Me-OA and Br-OA were added to the infusate during the treatment period. We evaluated sub-chronic effects on MAP and kidney function in normotensive Wistar rats and in two animal models of hypertension, spontaneously hypertensive rats (SHR) and Dahl salt-sensitive (DSS) rats, during 9-week administration of OA (p.o.). Tissue oxidative status was examined in these animals at the end of the study. Increasing evidence suggests that and renal function disturbances and oxidative stress play major roles in the pathogenesis of hypertension. Results Acute infusion OA and oleanane derivatives displayed qualitatively similar effects in decreasing MAP and increasing urinary Na+ outputs. The drugs increased the FENa and FELi without influencing GFR indicating that at least part of the overall natriuretic effect involved proximal tubular Na+ reabsorption. Sub-chronic OA administration (p.o.) also elicited hypotensive responses in Wistar, DSS and SHR rats. The MAP lowering effect was more marked in hypertensive animals and were positively correlated with increased urinary Na+ excretion. Compared with respective control rats, OA treatment reduced malondialdehyde (MDA, a marker of lipid peroxidation) and increased activities of antioxidant enzymes; superoxide dismutase and glutathione peroxidase in hepatic, cardiac and renal tissues. Conclusions OA and oleanane derivatives have similar effects on MAP, kidney function and oxidative stress. The amelioration of oxidative stress and blood pressure lowering effects by OA are more marked in hypertensive animals and correlated with an increased urinary Na+ output.	[Madlala, Hlengiwe Pretty; Musabayane, Cephas Tagumirwa] Univ KwaZulu Natal, Coll Hlth Sci, Sch Lab Med & Med Sci, Durban, South Africa; [Van Heerden, Fanie Retief] Univ KwaZulu Natal, Coll Sci Engn & Agr, Sch Chem & Phys, Pietermaritzburg, South Africa; [Mubagwa, Kanigula] Katholieke Univ Leuven, Fac Med, Dept Cardiovasc Med, Leuven, Belgium	University of Kwazulu Natal; University of Kwazulu Natal; KU Leuven	Musabayane, CT (corresponding author), Univ KwaZulu Natal, Coll Hlth Sci, Sch Lab Med & Med Sci, Durban, South Africa.	musabayanec@ukzn.ac.za	Van Heerden, Fanie R/A-5685-2008	Van Heerden, Fanie R/0000-0002-5710-7525	NRF; MRC South Africa; University of KwaZulu-Natal, Research Division	NRF; MRC South Africa; University of KwaZulu-Natal, Research Division	The authors are grateful to the NRF and MRC South Africa and the University of KwaZulu-Natal, Research Division for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo M, 2014, ANTIOXID REDOX SIGN, V20, P74, DOI 10.1089/ars.2013.5259; Ayyanar M, 2011, J ETHNOPHARMACOL, V134, P851, DOI 10.1016/j.jep.2011.01.029; Couch RD, 2005, BIOORG MED CHEM LETT, V15, P2215, DOI 10.1016/j.bmcl.2005.03.031; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Dongmo AB, 2011, J ETHNOPHARMACOL, V133, P204, DOI 10.1016/j.jep.2010.09.033; Drenjancevic-Peric I, 2011, KIDNEY BLOOD PRESS R, V34, P1, DOI 10.1159/000320387; Forstermann U, 2010, PFLUG ARCH EUR J PHY, V459, P923, DOI 10.1007/s00424-010-0808-2; Fu LF, 2013, ORG LETT, V15, P1622, DOI 10.1021/ol400399x; Gondwe M, 2008, PHYTOMEDICINE, V15, P699, DOI 10.1016/j.phymed.2008.02.004; Grossman E, 2008, DIABETES CARE, V31, pS185, DOI 10.2337/dc08-s246; Honda T, 2000, J MED CHEM, V43, P4233, DOI 10.1021/jm0002230; Kamadyaapa DR, 2009, CARDIOVASC J AFR, V20, P161; Kasapoglu M, 2001, EXP GERONTOL, V36, P209, DOI 10.1016/S0531-5565(00)00198-4; Khathi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081632; Liu JZ, 2014, CHEM-BIOL INTERACT, V221, P88, DOI 10.1016/j.cbi.2014.07.017; Madlala HP, 2012, RENAL FAILURE, V34, P767, DOI 10.3109/0886022X.2012.678172; MAHATO SB, 1994, PHYTOCHEMISTRY, V37, P1517, DOI 10.1016/S0031-9422(00)89569-2; Majid DSA, 2007, CLIN EXP PHARMACOL P, V34, P946, DOI 10.1111/j.1440-1681.2007.04642.x; Mapanga RF, 2009, RENAL FAILURE, V31, P481, DOI 10.1080/08860220902963558; Mizuno Yoshiko, 2010, Curr Cardiol Rep, V12, P472, DOI 10.1007/s11886-010-0142-5; Mkhwanazi BN, 2014, RENAL FAILURE, V36, P419, DOI 10.3109/0886022X.2013.867799; Musabayane CT, 2007, RENAL FAILURE, V29, P389, DOI 10.1080/08860220701260735; Musabayane CT, 2010, RENAL FAILURE, V32, P832, DOI 10.3109/0886022X.2010.494802; Musabayane CT, 2005, J ETHNOPHARMACOL, V97, P485, DOI 10.1016/j.jep.2004.12.005; Ngubane PS, 2011, RENAL FAILURE, V33, P434, DOI 10.3109/0886022X.2011.568147; Panza JA, 1997, CLIN CARDIOL, V20, P26; Perona JS, 2006, J NUTR BIOCHEM, V17, P429, DOI 10.1016/j.jnutbio.2005.11.007; Rahmani AH, 2014, INT J CLIN EXP MED, V7, P483; Rodriguez-Rodriguez R, 2008, BRIT J PHARMACOL, V155, P535, DOI 10.1038/bjp.2008.289; Rodriguez-Rodriguez R, 2006, J AGR FOOD CHEM, V54, P2096, DOI 10.1021/jf0528512; Rodriguez-Rodriguezl R, 2004, BRIT J NUTR, V92, P635, DOI 10.1079/BJN20041231; Somova LI, 2004, PHYTOMEDICINE, V11, P121, DOI 10.1078/0944-7113-00329; Somova LI, 1999, J S AFR VET ASSOC, V70, P14; Somova LO, 2003, PHYTOMEDICINE, V10, P115, DOI 10.1078/094471103321659807; Sporn MB, 2011, J NAT PROD, V74, P537, DOI 10.1021/np100826q; Thomsen K, 1990, KIDNEY INT, V37, P10; WEINBERGER MH, 1986, HYPERTENSION, V8, P127, DOI 10.1161/01.HYP.8.6_Pt_2.II127; [World Health Organization 2013], 2013, WHODCOWHD20132; Yates MS, 2007, MOL CANCER THER, V6, P154, DOI 10.1158/1535-7163.MCT-06-0516; Zicha J, 2012, PHYSIOL RES, V61, pS35, DOI 10.33549/physiolres.932363	40	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128192	10.1371/journal.pone.0128192	http://dx.doi.org/10.1371/journal.pone.0128192			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046776	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200046
J	Mets, OM; Roothaan, SM; Bronsveld, I; Luijk, B; van de Graaf, EA; Vink, A; de Jong, PA				Mets, Onno M.; Roothaan, Suzan M.; Bronsveld, Inez; Luijk, Bart; van de Graaf, Ed A.; Vink, Aryan; de Jong, Pim A.			Emphysema Is Common in Lungs of Cystic Fibrosis Lung Transplantation Patients: A Histopathological and Computed Tomography Study	PLOS ONE			English	Article							CT; DENSITY; DISEASE; MORPHOMETRY; MICE	Background Lung disease in cystic fibrosis (CF) involves excessive inflammation, repetitive infections and development of bronchiectasis. Recently, literature on emphysema in CF has emerged, which might become an increasingly important disease component due to the increased life expectancy. The purpose of this study was to assess the presence and extent of emphysema in endstage CF lungs. Methods In explanted lungs of 20 CF patients emphysema was semi-quantitatively assessed on histology specimens. Also, emphysema was automatically quantified on pre-transplantation computed tomography (CT) using the percentage of voxels below -950 Houndfield Units and was visually scored on CT. The relation between emphysema extent, pre-transplantation lung function and age was determined. Results All CF patients showed emphysema on histological examination: 3/20 (15%) showed mild, 15/20 (75%) moderate and 2/20 (10%) severe emphysema, defined as 0-20% emphysema, 20-50% emphysema and >50% emphysema in residual lung tissue, respectively. Visually upper lobe bullous emphysema was identified in 13/20 and more diffuse non-bullous emphysema in 18/20. Histology showed a significant correlation to quantified CT emphysema (p = 0.03) and visual emphysema score (p = 0.001). CT and visual emphysema extent were positively correlated with age (p = 0.045 and p = 0.04, respectively). Conclusions In conclusion, this study both pathologically and radiologically confirms that emphysema is common in end-stage CF lungs, and is age related. Emphysema might become an increasingly important disease component in the aging CF population.	[Mets, Onno M.; de Jong, Pim A.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Roothaan, Suzan M.; Vink, Aryan] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Bronsveld, Inez; Luijk, Bart; van de Graaf, Ed A.] Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Mets, OM (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	o.m.mets@umcutrecht.nl	de Jong, Pim A/G-7220-2014	de Jong, Pim A/0000-0003-4840-6854				Bedrossian CW, 1976, LUNG CYSTIC FIBROSIS; Brody AS, 2006, J THORAC IMAG, V21, P14, DOI 10.1097/01.rti.0000203937.82276.ce; de Jong PA, 2004, RADIOLOGY, V231, P434, DOI 10.1148/radiol.2312021393; Gehrig S, 2014, AM J RESP CRIT CARE, V189, P1082, DOI 10.1164/rccm.201311-1932OC; Gevenois PA, 1996, AM J RESP CRIT CARE, V154, P187, DOI 10.1164/ajrccm.154.1.8680679; GEVENOIS PA, 1995, AM J RESP CRIT CARE, V152, P653, DOI 10.1164/ajrccm.152.2.7633722; Gianotti A, 2013, AM J RESP CELL MOL, V49, P445, DOI 10.1165/rcmb.2012-0408OC; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Hartl D, 2012, J CYST FIBROS, V11, P363, DOI 10.1016/j.jcf.2012.07.003; Helbich TH, 1999, RADIOLOGY, V213, P537, DOI 10.1148/radiology.213.2.r99nv04537; Helbich TH, 1999, AM J ROENTGENOL, V173, P81, DOI 10.2214/ajr.173.1.10397104; Loeve M, 2009, THORAX, V64, P876, DOI 10.1136/thx.2008.110908; Mall MA, 2008, AM J RESP CRIT CARE, V177, P730, DOI 10.1164/rccm.200708-1233OC; Mashefski JF, 2008, DAIL HAMMARS PULMONA, VI; MENEELY GR, 1962, AM REV RESPIR DIS, V85, P762; Mets OM, 2012, AM J ROENTGENOL, V199, P336, DOI 10.2214/AJR.11.7808; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MULLER NL, 1988, CHEST, V94, P782, DOI 10.1378/chest.94.4.782; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Salvatore D, 2011, J CYST FIBROS, V10, P71, DOI 10.1016/j.jcf.2010.12.005; SOBONYA RE, 1986, AM REV RESPIR DIS, V134, P290; TOMASHEFSKI JF, 1985, HUM PATHOL, V16, P253, DOI 10.1016/S0046-8177(85)80011-3; TOMASHEFSKI JF, 1986, AM REV RESPIR DIS, V133, P535; Trojanek JB, 2014, AM J RESP CELL MOL, V51, P709, DOI 10.1165/rcmb.2013-0407OC; Wielputz MO, 2011, EUR RESPIR J, V38, P1060, DOI 10.1183/09031936.00149810; Wielputz MO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073142	26	17	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128062	10.1371/journal.pone.0128062	http://dx.doi.org/10.1371/journal.pone.0128062			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047144	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200039
J	Shukla, A; Singh, VK; Bharadwaj, DR; Kumar, R; Rai, A; Rai, AK; Mugasimangalam, R; Parameswaran, S; Singh, M; Naik, PS				Shukla, Anjali; Singh, V. K.; Bharadwaj, D. R.; Kumar, Rajesh; Rai, Ashutosh; Rai, A. K.; Mugasimangalam, Raja; Parameswaran, Sriram; Singh, Major; Naik, P. S.			De Novo Assembly of Bitter Gourd Transcriptomes: Gene Expression and Sequence Variations in Gynoecious and Monoecious Lines	PLOS ONE			English	Article							MELON MOMORDICA-CHARANTIA; RNA-SEQ; ARABIDOPSIS; MARKERS; ETHYLENE; GENOME; MICROSATELLITES; BIOINFORMATICS; IMPROVEMENT; ANNOTATION	Bitter gourd (Momordica charantia L.) is a nutritious vegetable crop of Asian origin, used as a medicinal herb in Indian and Chinese traditional medicine. Molecular breeding in bitter gourd is in its infancy, due to limited molecular resources, particularly on functional markers for traits such as gynoecy. We performed de novo transcriptome sequencing of bitter gourd using Illumina next-generation sequencer, from root, flower buds, stem and leaf samples of gynoecious line (Gy323) and a monoecious line (DRAR1). A total of 65,540 transcripts for Gy323 and 61,490 for DRAR1 were obtained. Comparisons revealed SNP and SSR variations between these lines and, identification of gene classes. Based on available transcripts we identified 80 WRKY transcription factors, several reported in responses to biotic and abiotic stresses; 56 ARF genes which play a pivotal role in auxin-regulated gene expression and development. The data presented will be useful in both functions studies and breeding programs in bitter gourd.	[Shukla, Anjali; Bharadwaj, D. R.; Kumar, Rajesh; Rai, Ashutosh; Singh, Major; Naik, P. S.] Indian Inst Vegetable Res, Div Crop Improvement, Varanasi 221305, Uttar Pradesh, India; [Singh, V. K.] Banaras Hindu Univ, Sch Biotechnol, Ctr Bioinformat, Varanasi 221005, Uttar Pradesh, India; [Rai, A. K.] Banaras Hindu Univ, Ctr Adv Studies, Dept Bot, Varanasi 221005, Uttar Pradesh, India; [Mugasimangalam, Raja; Parameswaran, Sriram] Genotyp Technol P Ltd, Bangalore 560094, Karnataka, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Vegetable Research; Banaras Hindu University (BHU); Banaras Hindu University (BHU)	Singh, M (corresponding author), Indian Inst Vegetable Res, Div Crop Improvement, Post Bag 01, Varanasi 221305, Uttar Pradesh, India.	singhvns@gmail.com	Rai, Ashutosh/P-6120-2018; Niranjan, Vidya/AAF-5553-2019; Niranjan, Vidya/O-6464-2016; Singh, Major/P-9790-2019	Rai, Ashutosh/0000-0001-6136-6696; Niranjan, Vidya/0000-0001-9187-7753; Niranjan, Vidya/0000-0001-9187-7753; Singh, Major/0000-0002-0247-861X	Indian Council of Agricultural Research, New Delhi; Genotypic Technology (P) Ltd.	Indian Council of Agricultural Research, New Delhi(Indian Council of Agricultural Research (ICAR)); Genotypic Technology (P) Ltd.	Genotypic Technology (P) Ltd., provided indirect support in the form letting the authors from Genotypic RM & SP to work on this project, but did not provide any financial support or have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The Indian Council of Agricultural Research, New Delhi provided financial support for basic research facilities, infrastructure etc for Indian Institute of Vegetable Research, Varanasi. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baby Joseph, 2013, Asian Pacific Journal of Tropical Disease, V3, P93, DOI 10.1016/S2222-1808(13)60052-3; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Basch E, 2003, AM J HEALTH-SYST PH, V60, P356, DOI 10.1093/ajhp/60.4.356; Behera T. K., 2004, Journal of New Seeds, V6, P217; Blouin MS, 1996, MOL ECOL, V5, P393, DOI 10.1111/j.1365-294X.1996.tb00329.x; Boualem A, 2008, SCIENCE, V321, P836, DOI 10.1126/science.1159023; Brennan VC, 2012, J MED FOOD, V15, P325, DOI 10.1089/jmf.2011.0158; BYERS RE, 1972, P NATL ACAD SCI USA, V69, P717, DOI 10.1073/pnas.69.3.717; Chan SMH, 2013, J PHARM PHARM SCI, V16, P207, DOI 10.18433/J3T60G; Chikhi R, 2014, BIOINFORMATICS, V30, P31, DOI 10.1093/bioinformatics/btt310; Clarke K, 2013, SCI CHINA LIFE SCI, V56, P156, DOI 10.1007/s11427-013-4444-x; Da Maia LC, 2008, INT J SYSTEMATIC BIO, V4, P363; Dalamu, 2012, INDIAN J HORTIC, V69, P65; de Jong Mark, 2010, BMC Res Notes, V3, P73, DOI 10.1186/1756-0500-3-73; Dey SS, 2006, SCI HORTIC-AMSTERDAM, V109, P21, DOI 10.1016/j.scienta.2006.03.006; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Fang EF, 2011, CURR MOL MED, V11, P417; Filippi CV, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0360-x; Gaikwad AB, 2008, HORTSCIENCE, V43, P127, DOI 10.21273/HORTSCI.43.1.127; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Grover JK, 2004, J ETHNOPHARMACOL, V93, P123, DOI 10.1016/j.jep.2004.03.035; Guo DL, 2012, AM J BOT, V99, pE182, DOI 10.3732/ajb.1100277; Guo XY, 2007, FEBS LETT, V581, P1015, DOI 10.1016/j.febslet.2007.01.088; Gupta PK, 2002, PLANT CELL TISS ORG, V70, P229, DOI 10.1023/A:1016597404454; Gupta S, 2014, SUGAR TECH, V16, P372, DOI 10.1007/s12355-013-0288-8; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Iwamoto Eishin, 2006, Horticultural Research (Japan), V5, P101, DOI 10.2503/hrj.5.101; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Kalloo G., 1988, VEGETABLE BREEDING, V1, P105; Katsaounis TI, 2008, J STAT PLAN INFER, V138, P245, DOI 10.1016/j.jspi.2007.05.008; Khan SA, 2007, WORLD J GASTROENTERO, V13, P1761, DOI 10.3748/wjg.v13.i11.1761; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kudapa H, 2012, MOL PLANT, V5, P1020, DOI 10.1093/mp/ssr111; Kumar Sanjeet, 2004, Journal of New Seeds, V6, P383; Kushwaha H, 2013, MOL BIOTECHNOL, V54, P1, DOI 10.1007/s12033-012-9536-5; Kushwaha H, 2011, MOL BIOL REP, V38, P5037, DOI 10.1007/s11033-010-0650-9; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mammadov J, 2012, INT J PLANT GENOMICS, V2012, DOI [DOI 10.1155/2012/728398, 10.1155/2012/728398]; Matsumura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087138; Mochida K, 2011, PLANT CELL PHYSIOL, V52, P2017, DOI 10.1093/pcp/pcr153; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Nemhauser JL, 2000, DEVELOPMENT, V127, P3877; Ooi CP, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007845.pub2; QUELLER DC, 1993, TRENDS ECOL EVOL, V8, P285, DOI 10.1016/0169-5347(93)90256-O; Ram D., 2002, Cucurbit Genetics Cooperative, P65; Ram D., 2002, Indian Journal of Agricultural Sciences, V72, P348; Ram D, 2006, J HERED, V97, P294, DOI 10.1093/jhered/esj028; Ramirez-Gonzalez RH, 2012, SOURCE CODE BIOL MED, V7, DOI 10.1186/1751-0473-7-6; Rhee SY, 2006, ANNU REV PLANT BIOL, V57, P335, DOI 10.1146/annurev.arplant.56.032604.144103; RUDICH J, 1972, PLANT PHYSIOL, V49, P998, DOI 10.1104/pp.49.6.998; Saeed MK., 2010, PHARMACOLOGYONLINE, V1, P252; Sathishsekar D, 2005, ASIA PAC J CLIN NUTR, V14, P153; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sharma B, 2013, NEW PHYTOL, V197, P949, DOI 10.1111/nph.12078; Singh AK, 2007, J HORTIC SCI BIOTECH, V82, P217, DOI 10.1080/14620316.2007.11512222; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Singh VK, 2011, INT J BIOINFORM RES, V3, P221; Staub Jack E., 2008, V1, P241; Steve OO, 2008, AFR J BIOTECHNOL, V7, P2535; Stokes TL, 2002, GENE DEV, V16, P171, DOI 10.1101/gad.952102; Sundberg E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001628; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Wang SZ, 2010, AM J BOT, V97, pE75, DOI 10.3732/ajb.1000153; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xu P, 2014, PLANT J, V77, P430, DOI 10.1111/tpj.12370; Yang Peizhen, 2010, BMC Plant Biol, V10, P250, DOI 10.1186/1471-2229-10-250; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou WB, 1998, PLANT BREED ABSTR, V68, P1002	77	11	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128331	10.1371/journal.pone.0128331	http://dx.doi.org/10.1371/journal.pone.0128331			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047102	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200059
J	Tang, X; Chen, HQ; Chen, YQ; Chen, W; Garre, V; Song, YD; Ratledge, C				Tang, Xin; Chen, Haiqin; Chen, Yong Q.; Chen, Wei; Garre, Victoriano; Song, Yuanda; Ratledge, Colin			Comparison of Biochemical Activities between High and Low Lipid-Producing Strains of Mucor circinelloides: An Explanation for the High Oleaginicity of Strain WJ11	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; MALIC ENZYME; OLEAGINOUS MICROORGANISMS; ACCUMULATION; OVEREXPRESSION; CULTIVATION; TURNOVER; NADPH	The oleaginous fungus, Mucor circinelloides, is one of few fungi that produce high amounts of gamma-linolenic acid (GLA); however, it usually only produces <25% lipid. Nevertheless, a new strain (WJ11) isolated in this laboratory can produce lipid up to 36% (w/w) cell dry weight (CDW). We have investigated the potential mechanism of high lipid accumulation in Mucor circinelloides WJ11 by comparative biochemical analysis with a low lipid-producing strain, Mucor circinelloides CBS 277.49, which accumulates less than 15% (w/w) lipid. Mucor circinelloides WJ11 produced more cell mass than that of strain CBS 277.49, although with slower glucose consumption. In the lipid accumulation phase, activities of glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase in strain WJ11 were greater than in CBS 277.49 by 46% and 17%, respectively, and therefore may provide more NADPH for fatty acid biosynthesis. The activities of NAD(+): isocitrate dehydrogenase and NADP(+): isocitrate dehydrogenase, however, were 43% and 54%, respectively, lower in WJ11 than in CBS 277.49 and may retard the tricarboxylic acid cycle and thereby provide more substrate for ATP: citrate lyase (ACL) to produce acetyl-CoA. Also, the activities of ACL and fatty acid synthase in the high lipid-producing strain, WJ11, were 25% and 56%, respectively, greater than in strain CBS 277.49. These enzymes may therefore cooperatively regulate the fatty acid biosynthesis in these two strains.	[Tang, Xin; Chen, Haiqin; Chen, Yong Q.; Chen, Wei; Song, Yuanda] Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Chen, Haiqin; Chen, Yong Q.; Chen, Wei] Synergist Innovat Ctr Food Safety & Nutr, Wuxi, Peoples R China; [Garre, Victoriano] Univ Murcia, Fac Biol, Dept Genet & Microbiol, Unidad Asociada IQFR CSIC, Murcia, Spain; [Ratledge, Colin] Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England	Jiangnan University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Murcia; University of Hull	Song, YD (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.	ysong@jiangnan.edu.cn	Chen, Wei/GZK-7348-2022; Garre, Victoriano/H-2533-2015; Chen, Yong Q/AAI-9864-2021	Garre, Victoriano/0000-0001-7605-1726; Chen, Yong Q/0000-0003-4747-4708	National Natural Science Foundation of China [31271812, 81071685, 21276108]; National High Technology Research and Development Program of China [2012AA022105C]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1249]; Program for New Century Excellent Talents [NCET-13-0831]; Strategic Merieux Research Grant	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Program for New Century Excellent Talents(Program for New Century Excellent Talents in University (NCET)); Strategic Merieux Research Grant	This work was supported by the National Natural Science Foundation of China (31271812, 81071685, 21276108), the National High Technology Research and Development Program of China (2012AA022105C), the Program for Changjiang Scholars and Innovative Research Team in University (IRT1249), the Program for New Century Excellent Talents (NCET-13-0831), and the Strategic Merieux Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AP, 2010, METAB ENG, V12, P488, DOI 10.1016/j.ymben.2010.04.002; Alvarez HM, 2002, APPL MICROBIOL BIOT, V60, P367, DOI 10.1007/s00253-002-1135-0; Rodriguez-Frometa RA, 2013, APPL MICROBIOL BIOT, V97, P3063, DOI 10.1007/s00253-012-4432-2; Beopoulos A, 2008, APPL ENVIRON MICROB, V74, P7779, DOI 10.1128/AEM.01412-08; Blazeck J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4131; BOTHAM PA, 1979, J GEN MICROBIOL, V114, P361, DOI 10.1099/00221287-114-2-361; BOULTON CA, 1981, J GEN MICROBIOL, V127, P169; CHANEY AL, 1962, CLIN CHEM, V8, P130; DILEEPAN KN, 1979, LIFE SCI, V24, P89, DOI 10.1016/0024-3205(79)90284-4; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hao GF, 2014, APPL ENVIRON MICROB, V80, P2672, DOI 10.1128/AEM.00140-14; HOLDSWORTH JE, 1988, J GEN MICROBIOL, V134, P339; KENDRICK A, 1992, EUR J BIOCHEM, V209, P667, DOI 10.1111/j.1432-1033.1992.tb17334.x; Krebs H A, 1970, Adv Enzyme Regul, V8, P335, DOI 10.1016/0065-2571(70)90028-2; Laoteng K, 2011, CHEM PAP, V65, P97, DOI 10.2478/s11696-010-0097-4; Li YH, 2007, ENZYME MICROB TECH, V41, P312, DOI 10.1016/j.enzmictec.2007.02.008; Li Z, 2013, APPL MICROBIOL BIOT, V97, P4927, DOI 10.1007/s00253-012-4571-5; Liang MH, 2013, PROG LIPID RES, V52, P395, DOI 10.1016/j.plipres.2013.05.002; Liu ZJ, 2013, BIORESOURCE TECHNOL, V130, P144, DOI 10.1016/j.biortech.2012.12.072; Papanikolaou S, 2004, J APPL MICROBIOL, V97, P867, DOI 10.1111/j.1365-2672.2004.02376.x; Ratledge C, 2002, ADV APPL MICROBIOL, V51, P1, DOI 10.1016/S0065-2164(02)51000-5; Ratledge C., 2005, HDB FUNCTIONAL LIPID, P19, DOI [10.1201/9781420039184.ch2, DOI 10.1201/9781420039184.CH2]; Ratledge C, 2014, BIOTECHNOL LETT, V36, P1557, DOI 10.1007/s10529-014-1532-3; Tamano K, 2013, APPL MICROBIOL BIOT, V97, P269, DOI 10.1007/s00253-012-4193-y; Tang X, 2014, CURR MICROBIOL, V69, P899, DOI 10.1007/s00284-014-0671-z; Vongsangnak W, 2013, GENE, V521, P180, DOI 10.1016/j.gene.2013.03.012; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028319; Wasylenko T.M., 2015, METAB ENG; Wynn JP, 1999, MICROBIOL-UK, V145, P1911, DOI 10.1099/13500872-145-8-1911; Wynn JP, 1997, MICROBIOL-SGM, V143, P253, DOI 10.1099/00221287-143-1-253; Wynn JP, 2001, MICROBIOL-SGM, V147, P2857, DOI 10.1099/00221287-147-10-2857; Xia CJ, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-15; Xiong W, 2010, PLANT PHYSIOL, V154, P1001, DOI 10.1104/pp.110.158956; Zhang HY, 2014, J BIOTECHNOL, V192, P78, DOI 10.1016/j.jbiotec.2014.10.004; Zhang Y, 2007, MICROBIOL-SGM, V153, P2013, DOI 10.1099/mic.0.2006/002683-0; Zhu ZW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2112	36	51	52	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128396	10.1371/journal.pone.0128396	http://dx.doi.org/10.1371/journal.pone.0128396			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046932	Green Published, gold			2022-12-27	WOS:000355652200067
J	Ye, JX; Jiang, L; Wu, CL; Liu, AQ; Mao, SF; Ge, LY				Ye, Jiaxiang; Jiang, Li; Wu, Changliang; Liu, Aiqun; Mao, Sufei; Ge, Lianying			Three ADIPOR1 Polymorphisms and Cancer Risk: A Meta-Analysis of Case-Control Studies	PLOS ONE			English	Article							COLORECTAL-CANCER; BREAST-CANCER; ADIPONECTIN LEVELS; PROSTATE-CANCER; GENES; OBESITY; EXPRESSION; RECEPTORS; VARIANTS; BIAS	Background Studies have come to conflicting conclusions about whether polymorphisms in the adiponectin receptor 1 gene (ADIPOR1) are associated with cancer risk. To help resolve this question, we meta-analyzed case-control studies in the literature. Methods PubMed, EMBASE, Cochrane Library, the Chinese Biological Medical Database and the Chinese National Knowledge Infrastructure Database were systematically searched to identify all case-control studies published through February 2015 examining any ADIPOR1 polymorphisms and risk of any type of cancer. Pooled odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were calculated. Results A total of 13 case-control studies involving 5,750 cases and 6,762 controls were analyzed. Analysis of the entire study population revealed a significant association between rs1342387 (G/A) and overall cancer risk using a homozygousmodel (OR 0.82, 95% CI 0.72 to 0.94), heterozygous model (OR 0.84, 95% CI 0.76 to 0.93), dominant model (OR 0.85, 95% CI 0.75 to 0.97) and allele contrast model (OR 0.88, 95% CI 0.80 to 0.97). However, subgroup analysis showed that this association was significant only for Asians in the case of colorectal cancer. No significant associations were found between rs12733285(C/T) or rs7539542(C/G) and cancer risk, either in analyses of the entire study population or in analyses of subgroups. Conclusions Our meta-analysis suggests that the ADIPOR1 rs1342387(G/A) polymorphism, but not rs12733285(C/T) or rs7539542(C/G), may be associated with cancer risk, especially risk of colorectal cancer in Asians. Large, well-designed studies are needed to verify our findings.	[Ye, Jiaxiang; Liu, Aiqun; Mao, Sufei; Ge, Lianying] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Med Oncol, Inst Canc, Nanning 530021, Guangxi, Peoples R China; [Jiang, Li] Guangxi Med Univ, Grad Sch, Nanning 530021, Guangxi, Peoples R China; [Wu, Changliang] Guangxi Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanning 530021, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Wu, CL (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanning 530021, Guangxi, Peoples R China.	wuchangliang2013@126.com; gelianying1996@126.com			Natural Science Foundation of Guangxi [2012GXNSFDA053021]	Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province)	This study was supported by the Natural Science Foundation of Guangxi (No. 2012GXNSFDA053021, http://www.gxst.gov.cn/zwgk/kjxmgl/xmxdgg/637057.shtml). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An W, 2012, EUR J CANCER PREV, V21, P126, DOI 10.1097/CEJ.0b013e32834c9b55; Beebe-Dimmer JL, 2010, PROSTATE CANCER P D, V13, P362, DOI 10.1038/pcan.2010.27; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bennett DA, 2004, J CLIN EPIDEMIOL, V57, P349, DOI 10.1016/j.jclinepi.2003.09.015; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Cohen S, 2011, ANAL CELL PATHOL, V34, P1, DOI 10.3233/ACP-2011-0007; Dalamaga M, 2009, CANCER CAUSE CONTROL, V20, P625, DOI 10.1007/s10552-008-9273-z; Dhillon PK, 2011, CANCER EPIDEM BIOMAR, V20, P2618, DOI 10.1158/1055-9965.EPI-11-0434; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; He BS, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-94; Heid IM, 2006, DIABETES, V55, P375, DOI 10.2337/diabetes.55.02.06.db05-0747; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kaklamani V, 2011, METABOLISM, V60, P1234, DOI 10.1016/j.metabol.2011.01.005; Kaklamani VG, 2008, JAMA-J AM MED ASSOC, V300, P1523, DOI 10.1001/jama.300.13.1523; Kaklamani VG, 2008, CANCER RES, V68, P3178, DOI 10.1158/0008-5472.CAN-08-0533; Kharroubi I, 2003, BIOCHEM BIOPH RES CO, V312, P1118, DOI 10.1016/j.bbrc.2003.11.042; Kim AY, 2010, MOL ENDOCRINOL, V24, P1441, DOI 10.1210/me.2009-0498; Korner A, 2007, J CLIN ENDOCR METAB, V92, P1041, DOI 10.1210/jc.2006-1858; Liu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027301; Ogunwobi OO, 2008, MOL CELL ENDOCRINOL, V285, P43, DOI 10.1016/j.mce.2008.01.023; Ou YY, 2012, THESIS; Pan ZL, 2005, PLOS MED, V2, P1309, DOI 10.1371/journal.pmed.0020334; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Song MY, 2015, INT J CANCER, V137, P154, DOI 10.1002/ijc.29360; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Teras LR, 2009, CANCER EPIDEM BIOMAR, V18, P2553, DOI 10.1158/1055-9965.EPI-09-0542; Williams CJ, 2008, ENDOCR-RELAT CANCER, V15, P289, DOI 10.1677/ERC-07-0197; Wolk A, 2001, CANCER CAUSE CONTROL, V12, P13, DOI 10.1023/A:1008995217664; Wu MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104630; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Ye JJ, 2014, EUR J CANCER PREV, V23, P158, DOI 10.1097/CEJ.0b013e328364f293; Yi NJ, 2011, ANN HUM GENET, V75, P90, DOI 10.1111/j.1469-1809.2010.00605.x; Yu LX, 2014, ASIAN PAC J CANCER P, V15, P7515, DOI 10.7314/APJCP.2014.15.18.7515; Zhang Ying, 2012, Journal of Jiangsu University - Medicine Edition, V22, P336	35	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127253	10.1371/journal.pone.0127253	http://dx.doi.org/10.1371/journal.pone.0127253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047008	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200018
J	Dmitrieva, NI; Burg, MB				Dmitrieva, Natalia I.; Burg, Maurice B.			Elevated Sodium and Dehydration Stimulate Inflammatory Signaling in Endothelial Cells and Promote Atherosclerosis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PLASMA SODIUM; CARDIOVASCULAR-DISEASE; LEUKOCYTE RECRUITMENT; VASCULAR ENDOTHELIUM; SALT INTAKE; RISK-FACTOR; PREDICTION; STROKE; MICE	Cardiovascular diseases (CVDs) are a leading health problem worldwide. Epidemiologic studies link high salt intake and conditions predisposing to dehydration such as low water intake, diabetes and old age to increased risk of CVD. Previously, we demonstrated that elevation of extracellular sodium, which is a common consequence of these conditions, stimulates production by endothelial cells of clotting initiator, von Willebrand Factor, increases its level in blood and promotes thrombogenesis. In present study, by PCR array, using human umbilical vein endothelial cells (HUVECs), we analyzed the effect of high NaCl on 84 genes related to endothelial cell biology. The analysis showed that the affected genes regulate many aspects of endothelial cell biology including cell adhesion, proliferation, leukocyte and lymphocyte activation, coagulation, angiogenesis and inflammatory response. The genes whose expression increased the most were adhesion molecules VCAM1 and E-selectin and the chemoattractant MCP-1. These are key participants in the leukocyte adhesion and transmigration that play a major role in the inflammation and pathophysiology of CVD, including atherosclerosis. Indeed, high NaCl increased adhesion of mononuclear cells and their transmigration through HUVECs monolayers. In mice, mild water restriction that elevates serum sodium by 5 mmol/l, increased VCAM1, E-selectin and MCP-1 expression in mouse tissues, accelerated atherosclerotic plaque formation in aortic root and caused thickening or walls of coronary arteries. Multivariable linear regression analysis of clinical data from the Atherosclerosis Risk in Communities Study (n = 12779) demonstrated that serum sodium is a significant predictor of 10 Years Risk of coronary heart disease. These findings indicate that elevation of extracellular sodium within the physiological range is accompanied by vascular changes that facilitate development of CVD. The findings bring attention to serum sodium as a risk factor for CVDs and give additional support to recommendations for dietary salt restriction and adequate water intake as preventives of CVD.	[Dmitrieva, Natalia I.; Burg, Maurice B.] NHLBI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Dmitrieva, NI (corresponding author), NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA.	dmitrien@nhlbi.nih.gov	Dmitrieva, Natalia/A-2924-2013; Dmitrieva, Natalia/Q-9175-2019	Dmitrieva, Natalia/0000-0001-8074-6950; Dmitrieva, Natalia/0000-0001-8074-6950	Intramural Program of National Lung Heart and Blood Institute	Intramural Program of National Lung Heart and Blood Institute	The study was supported by the Intramural Program of National Lung Heart and Blood Institute.	Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; [Anonymous], 2005, STANDING COMMITTEE O, P558; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Chambless LE, 2003, J CLIN EPIDEMIOL, V56, P880, DOI 10.1016/S0895-4356(03)00055-6; Chan J, 2002, AM J EPIDEMIOL, V155, P827, DOI 10.1093/aje/155.9.827; Chien S, 2003, PROG BIOPHYS MOL BIO, V83, P131, DOI 10.1016/s0079-6107(03)00053-1; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Cowen LE, 2013, ENDOCRIN METAB CLIN, V42, P349, DOI 10.1016/j.ecl.2013.02.005; Croce K, 2007, CURR OPIN HEMATOL, V14, P55, DOI 10.1097/00062752-200701000-00011; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; DAHL LK, 1958, NEW ENGL J MED, V258, P1205, DOI 10.1056/NEJM195806122582406; Daugherty Alan, 2003, Methods Mol Biol, V209, P293; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dmitrieva NI, 2007, CELL CYCLE, V6, P3108, DOI 10.4161/cc.6.24.5084; Dmitrieva NI, 2014, P NATL ACAD SCI USA, V111, P6485, DOI 10.1073/pnas.1404809111; Folsom AR, 2003, DIABETES CARE, V26, P2777, DOI 10.2337/diacare.26.10.2777; Fox CS, 2010, TRENDS CARDIOVAS MED, V20, P90, DOI 10.1016/j.tcm.2010.08.001; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; He FJ, 2012, ANN MED, V44, pS127, DOI 10.3109/07853890.2012.660495; He FJ, 2005, HYPERTENSION, V45, P98, DOI 10.1161/01.HYP.0000149431.79450.a2; Hickey MJ, 2013, IMMUNOL CELL BIOL, V91, P281, DOI 10.1038/icb.2012.83; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Hui X, 2013, AM J KIDNEY DIS, V62, P691, DOI 10.1053/j.ajkd.2013.04.010; Katz MH, 2003, ANN INTERN MED, V138, P644, DOI 10.7326/0003-4819-138-8-200304150-00012; Katz MH., 2011, MULTIVARIABLE ANAL A; Komiya I, 1997, J HYPERTENS, V15, P65, DOI 10.1097/00004872-199715010-00006; Kovesdy CP, 2012, NEPHROL DIAL TRANSPL, V27, P891, DOI 10.1093/ndt/gfs038; Krychtiuk KA, 2013, HAMOSTASEOLOGIE, V33, P269, DOI 10.5482/HAMO-13-07-0039; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lim Gregory B, 2013, Nat Rev Cardiol, V10, P59, DOI 10.1038/nrcardio.2012.194; Liu LX, 2003, THROMB HAEMOSTASIS, V89, P213; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Maganto-Garcia E, 2012, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1524s96; Maletkovic J, 2013, ENDOCRIN METAB CLIN, V42, P677, DOI 10.1016/j.ecl.2013.07.001; Manz F, 2005, NUTR REV, V63, pS2, DOI [10.1111/j.1753-4887.2005.tb00150.x, 10.1301/nr.2005.jun.S2-S5]; Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333; Muller WA, ANGIOGENESIS IN VITR, P155; Nieswandt B, 2011, J PHYSIOL-LONDON, V589, P4115, DOI 10.1113/jphysiol.2011.212886; North BJ, 2012, CIRC RES, V110, P1097, DOI 10.1161/CIRCRESAHA.111.246876; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Oberleithner H, 2007, P NATL ACAD SCI USA, V104, P16281, DOI 10.1073/pnas.0707791104; Oberleithner H, 2012, ANN MED, V44, pS143, DOI 10.3109/07853890.2011.653397; Oberleithner H, 2011, PFLUG ARCH EUR J PHY, V462, P519, DOI 10.1007/s00424-011-0999-1; Oh SW, 2013, J KOREAN MED SCI, V28, P1034, DOI 10.3346/jkms.2013.28.7.1034; Osada J, 2000, CURR OPIN LIPIDOL, V11, P25, DOI 10.1097/00041433-200002000-00004; Pham NA, 2007, DIAGN PATHOL, V2, DOI 10.1186/1746-1596-2-8; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Ramcharan KS, 2011, THROMB RES, V128, P1, DOI 10.1016/j.thromres.2010.11.019; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Royston P, 2008, MULTIVARIABLE MODEL, P23; SAGNELLA GA, 1989, AM J PHYSIOL, V256, pR1171, DOI 10.1152/ajpregu.1989.256.6.R1171; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schnermann JB, 1998, REGULATION OF EXTRAC, P79; SENAY LC, 1965, J APPL PHYSIOL, V20, P1136, DOI 10.1152/jappl.1965.20.6.1136; Suckling RJ, 2012, KIDNEY INT, V81, P407, DOI 10.1038/ki.2011.369; Titze J, 2003, AM J PHYSIOL-RENAL, V285, pF1108, DOI 10.1152/ajprenal.00200.2003; Titze J, 2014, CAN J CARDIOL, V30, P473, DOI 10.1016/j.cjca.2014.02.006; Wakkee M, 2014, J INVEST DERMATOL, V134, DOI 10.1038/jid.2014.132; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; Wild J, 2014, THROMB HAEMOSTASIS, V112, P183, DOI 10.1160/TH13-11-0908; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Zhang Z, 2014, AM J PHYSIOL-RENAL, V306, pF1534, DOI 10.1152/ajprenal.00585.2013	69	55	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128870	10.1371/journal.pone.0128870	http://dx.doi.org/10.1371/journal.pone.0128870			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042828	gold, Green Published, Green Submitted			2022-12-27	WOS:000355701600069
J	Saxton-Shaw, KD; Ledermann, JP; Kenney, JL; Berl, E; Graham, AC; Russo, JM; Powers, AM; Mutebi, JP				Saxton-Shaw, Kali D.; Ledermann, Jeremy P.; Kenney, Joan L.; Berl, Erica; Graham, Alan C.; Russo, Joel M.; Powers, Ann M.; Mutebi, John-Paul			The First Outbreak of Eastern Equine Encephalitis in Vermont: Outbreak Description and Phylogenetic Relationships of the Virus Isolate	PLOS ONE			English	Article							ENCEPHALOMYELITIS VIRUS; ARBOVIRUS ISOLATIONS; MOSQUITOS DIPTERA; CULICIDAE; STRAINS	The first known outbreak of eastern equine encephalitis (EEE) in Vermont occurred on an emu farm in Rutland County in 2011. The first isolation of EEE virus (EEEV) in Vermont (VT11) was during this outbreak. Phylogenetic analysis revealed that VT11 was most closely related to FL01, a strain from Florida isolated in 2001, which is both geographically and temporally distinct from VT11. EEEV RNA was not detected in any of the 3,905 mosquito specimens tested, and the specific vectors associated with this outbreak are undetermined.	[Saxton-Shaw, Kali D.; Ledermann, Jeremy P.; Kenney, Joan L.; Powers, Ann M.; Mutebi, John-Paul] Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Ft Collins, CO 80521 USA; [Berl, Erica] Vermont Dept Hlth, Burlington, VT 05402 USA; [Graham, Alan C.] Vermont Agcy Agr Food & Markets, Waterbury, VT USA; [Russo, Joel M.] USDA, APHIS VS, Montpelier, VT USA	Centers for Disease Control & Prevention - USA; United States Department of Agriculture (USDA)	Mutebi, JP (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Ft Collins, CO 80521 USA.	grv0@cdc.gov	Kenney, Joan L./AAE-7416-2019	Kenney, Joanie/0000-0002-6761-4272				Andreadis TG, 1998, J MED ENTOMOL, V35, P296, DOI 10.1093/jmedent/35.3.296; Armstrong PM, 2008, AM J TROP MED HYG, V79, P291, DOI 10.4269/ajtmh.2008.79.291; Armstrong PM, 2013, NEW ENGL J MED, V368, P1670, DOI 10.1056/NEJMp1213696; Arrigo NC, 2010, J VIROL, V84, P1014, DOI 10.1128/JVI.01586-09; Berl E, 2013, AM J TROP MED HYG, V88, P103, DOI 10.4269/ajtmh.2012.12-0236; BIGLER WJ, 1976, AM J TROP MED HYG, V25, P884, DOI 10.4269/ajtmh.1976.25.884; Brault AC, 1999, AM J TROP MED HYG, V61, P579, DOI 10.4269/ajtmh.1999.61.579; CHAMBERLAIN RW, 1969, AM J EPIDEMIOL, V89, P82, DOI 10.1093/oxfordjournals.aje.a120918; Chenier S, 2010, CAN VET J, V51, P1011; CRANS WJ, 1986, J AM MOSQUITO CONTR, V2, P68; Darsie RFJ, 2005, IDENTIFICATION GEOGR; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Forthergill LD, 1938, NEW ENGL J MED, V219, P411; Gibney KB, 2011, VECTOR-BORNE ZOONOT, V11, P637, DOI 10.1089/vbz.2010.0189; Giltner LT, 1933, SCIENCE, V78, P587, DOI 10.1126/science.78.2034.587-a; HAYES RO, 1964, AM J TROP MED HYG, V13, P851, DOI 10.4269/ajtmh.1964.13.851; Komar N, 1999, AM J TROP MED HYG, V60, P387, DOI 10.4269/ajtmh.1999.60.387; Miller MA, 2010, CREATING CIPRES SCI; Morris C. D., 1988, The arboviruses: epidemiology and ecology. Volume III., P1; Mutebi JP, 2012, J WILDLIFE DIS, V48, P1109, DOI 10.7589/2012-03-076; Scott T. W., 1989, Advances in Virus Research, V37, P277, DOI 10.1016/S0065-3527(08)60838-6; Silverman MA, 2013, EMERG INFECT DIS, V19, P194, DOI 10.3201/eid1902.120039; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; SUDIA WD, 1968, AM J EPIDEMIOL, V87, P112, DOI 10.1093/oxfordjournals.aje.a120792; Tengelsen LA, 2001, J AM VET MED ASSOC, V218, P1469, DOI 10.2460/javma.2001.218.1469; Turell MJ, 1998, J MED ENTOMOL, V35, P670, DOI 10.1093/jmedent/35.5.670; TURELL MJ, 1994, J MED ENTOMOL, V31, P287, DOI 10.1093/jmedent/31.2.287; USDA, 2009, SUMM E EQ ENC CAS US; Weaver SC, 2005, ARCH VIROL, P33; WEAVER SC, 1994, J VIROL, V68, P158, DOI 10.1128/JVI.68.1.158-169.1994; Webster LT, 1938, SCIENCE, V88, P305, DOI 10.1126/science.88.2283.305; Young DS, 2008, EMERG INFECT DIS, V14, P454, DOI 10.3201/eid1403.070816	32	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128712	10.1371/journal.pone.0128712	http://dx.doi.org/10.1371/journal.pone.0128712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043136	Green Submitted, Green Published, gold			2022-12-27	WOS:000355701600062
J	Ueno, T; Niimi, H; Yoneda, N; Yoneda, S; Mori, M; Tabata, H; Minami, H; Saito, S; Kitajima, I				Ueno, Tomohiro; Niimi, Hideki; Yoneda, Noriko; Yoneda, Satoshi; Mori, Masashi; Tabata, Homare; Minami, Hiroshi; Saito, Shigeru; Kitajima, Isao			Eukaryote-Made Thermostable DNA Polymerase Enables Rapid PCR-Based Detection of Mycoplasma, Ureaplasma and Other Bacteria in the Amniotic Fluid of Preterm Labor Cases	PLOS ONE			English	Article							CHAIN-REACTION; INTRAUTERINE INFECTION; RESPIRATORY-TRACT; UROGENITAL TRACT; UREALYTICUM; NEWBORNS; BIRTH; CONTAMINATION; ELIMINATION; PATHOGENS	Background Intra-amniotic infection has long been recognized as the leading cause of preterm delivery. Microbial culture is the gold standard for the detection of intra-amniotic infection, but several days are required, and many bacterial species in the amniotic fluid are difficult to cultivate. Methods We developed a novel nested-PCR-based assay for detecting Mycoplasma, Ureaplasma, other bacteria and fungi in amniotic fluid samples within three hours of sample collection. To detect prokaryotes, eukaryote-made thermostable DNA polymerase, which is free from bacterial DNA contamination, is used in combination with bacterial universal primers. In contrast, to detect eukaryotes, conventional bacterially-made thermostable DNA polymerase is used in combination with fungal universal primers. To assess the validity of the PCR assay, we compared the PCR and conventional culture results using 300 amniotic fluid samples. Results Based on the detection level (positive and negative), 93.3% (280/300) of Mycoplasma, 94.3% (283/300) of Ureaplasma, 89.3%(268/300) of other bacteria and 99.7% (299/300) of fungi matched the culture results. Meanwhile, concerning the detection of bacteria other than Mycoplasma and Ureaplasma, 228 samples were negative according to the PCR method, 98.2%(224/228) of which were also negative based on the culture method. Employing the devised primer sets, mixed amniotic fluid infections of Mycoplasma, Ureaplasma and/or other bacteria could be clearly distinguished. In addition, we also attempted to compare the relative abundance in 28 amniotic fluid samples with mixed infection, and judged dominance by comparing the Ct values of quantitative real-time PCR. Conclusions We developed a novel PCR assay for the rapid detection of Mycoplasma, Ureaplasma, other bacteria and fungi in amniotic fluid samples. This assay can also be applied to accurately diagnose the absence of bacteria in samples. We believe that this assay will positively contribute to the treatment of intra-amniotic infection and the prevention of preterm delivery.	[Ueno, Tomohiro; Niimi, Hideki; Kitajima, Isao] Toyama Univ Hosp, Clin Lab Ctr, Toyama 9300194, Japan; [Yoneda, Noriko; Yoneda, Satoshi; Saito, Shigeru] Toyama Univ Hosp, Dept Obstet & Gynecol, Toyama 9300194, Japan; [Mori, Masashi] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan; [Tabata, Homare; Minami, Hiroshi] Hokkaido Mitsui Chem Inc, Life Sci Ctr, Kushiro, Hokkaido 0730138, Japan	University of Toyama; University of Toyama; Ishikawa Prefecture University; Mitsui Chemicals	Niimi, H (corresponding author), Toyama Univ Hosp, Clin Lab Ctr, Toyama 9300194, Japan.	hiniimi@med.u-toyama.ac.jp			EXT/JSPS KAKENHI [24590682, 23390386, 24592463, 25861478]; Charitable Trust Laboratory Medicine Research Foundation; Society for Women's Health Science Research of Japan; Japanese Society of Laboratory Medicine Fund for the Promotion of Scientific Research; Urakami Foundation; Life Science Center; Hokkaido Mitsui Chemicals, Inc.; Grants-in-Aid for Scientific Research [26670717] Funding Source: KAKEN	EXT/JSPS KAKENHI; Charitable Trust Laboratory Medicine Research Foundation; Society for Women's Health Science Research of Japan; Japanese Society of Laboratory Medicine Fund for the Promotion of Scientific Research; Urakami Foundation(Urakami Foundation); Life Science Center; Hokkaido Mitsui Chemicals, Inc.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by EXT/JSPS KAKENHI grant numbers 24590682, 23390386, 24592463, 25861478, Charitable Trust Laboratory Medicine Research Foundation, Society for Women's Health Science Research of Japan, Japanese Society of Laboratory Medicine Fund for the Promotion of Scientific Research and the Urakami Foundation. Life Science Center, Hokkaido Mitsui Chemicals, Inc. provided support in the form of salaries for authors Homare Tabata and Hiroshi Minami, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AbeleHorn M, 1996, EUR J CLIN MICROBIOL, V15, P595, DOI 10.1007/BF01709369; BLANCHARD A, 1993, CLIN INFECT DIS, V17, pS148, DOI 10.1093/clinids/17.Supplement_1.S148; CASSELL GH, 1993, CLIN MICROBIOL REV, V6, P69, DOI 10.1128/CMR.6.1.69-87.1993; Colaizy TT, 2007, PEDIATR RES, V61, P578, DOI 10.1203/pdr.0b013e318045be03; Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Dudley DJ, 1997, J REPROD IMMUNOL, V36, P93, DOI 10.1016/S0165-0378(97)00065-X; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hill G B, 1998, Ann Periodontol, V3, P222, DOI 10.1902/annals.1998.3.1.222; HILL GB, 1993, CLIN INFECT DIS, V16, pS423, DOI 10.1093/clinids/16.Supplement_4.S423; HUGHES MS, 1994, J CLIN MICROBIOL, V32, P2007, DOI 10.1128/JCM.32.8.2007-2008.1994; Kirchner L, 2007, EUR J OBSTET GYN R B, V134, P44, DOI 10.1016/j.ejogrb.2006.09.013; Kundsin RB, 1996, OBSTET GYNECOL, V87, P122, DOI 10.1016/0029-7844(95)00376-2; Kuypers MMM, 2007, SCIENCE, V317, P1510, DOI 10.1126/science.1148538; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; MAHER CF, 1994, AUST NZ J OBSTET GYN, V34, P477, DOI 10.1111/j.1479-828X.1994.tb01276.x; MEIER A, 1993, J CLIN MICROBIOL, V31, P646, DOI 10.1128/JCM.31.3.646-652.1993; Niimi H, 2011, J CLIN MICROBIOL, V49, P3316, DOI 10.1128/JCM.00584-11; Nikkari S, 2001, J CLIN MICROBIOL, V39, P1956, DOI 10.1128/JCM.39.5.1956-1959.2001; Palmer H M, 1991, Int J STD AIDS, V2, P261; RAND KH, 1990, MOL CELL PROBE, V4, P445, DOI 10.1016/0890-8508(90)90003-I; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Waites KB, 2005, CLIN MICROBIOL REV, V18, P757, DOI 10.1128/CMR.18.4.757-789.2005; WATTS DH, 1992, OBSTET GYNECOL, V79, P351; Witt A, 2005, AM J OBSTET GYNECOL, V193, P1663, DOI 10.1016/j.ajog.2005.03.067; Yoon BH, 2003, AM J OBSTET GYNECOL, V189, P919, DOI 10.1067/S0002-9378(03)00839-1; Yoon BH, 2000, AM J OBSTET GYNECOL, V183, P1130, DOI 10.1067/mob.2000.109036	28	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0129032	10.1371/journal.pone.0129032	http://dx.doi.org/10.1371/journal.pone.0129032			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042418	gold, Green Published, Green Submitted			2022-12-27	WOS:000355701600083
J	Wang, HL; Fan, SS; Pang, M; Liu, YH; Guo, M; Liang, JB; Zhang, JL; Yu, BF; Guo, R; Xie, J; Zheng, GP				Wang, Hai-long; Fan, Sha-sha; Pang, Min; Liu, Yi-heng; Guo, Min; Liang, Jun-bo; Zhang, Jian-lin; Yu, Bao-feng; Guo, Rui; Xie, Jun; Zheng, Guo-ping			The Ankyrin Repeat Domain 49 (ANKRD49) Augments Autophagy of Serum-Starved GC-1 Cells through the NF-kappa B Pathway	PLOS ONE			English	Article							APOPTOSIS; SPERMATOGENESIS; PROTEIN; GENE; BIOGENESIS; INHIBITOR; DEATH; YEAST; LIFE	The ankyrin repeat domain 49 (ANKRD49) is an evolutionarily conserved protein highly expressed in testes. However, the function of ANKRD49 in spermatogenesis is unknown. In this study, we found that ANKRD49 resides primarily in nucleus of spermatogonia, spermatocytes and round spermatids. ANKRD49 overexpression augments starvation-induced autophagy in male germ GC-1 cells whereas shRNA knockdown of ANKRD49 attenuates the autophagy. Inhibition of NF-kappa B pathway by its inhibitors or p65 siRNA prevents the ANKRD49-dependent autophagy augmentation, demonstrating that ANKRD49 enhances autophagy via NF-kappa B pathway. Our findings suggest that ANKRD49 plays an important role in spermatogenesis via promotion of autophagy-dependent survival.	[Wang, Hai-long; Fan, Sha-sha; Zhang, Jian-lin; Yu, Bao-feng; Guo, Rui; Xie, Jun; Zheng, Guo-ping] Shanxi Med Univ, Dept Biochem & Mol Biol, Taiyuan 030001, Shanxi, Peoples R China; [Pang, Min] Shanxi Med Univ, Affiliated Hosp 1, Dept Resp, Taiyuan 030001, Shanxi, Peoples R China; [Liu, Yi-heng] Shanxi Med Univ, Dept Anestesioloy, Class 041002, Taiyuan 030001, Shanxi, Peoples R China; [Guo, Min] Shanxi Med Univ, Ctr Lab Anim, Taiyuan 030001, Shanxi, Peoples R China; [Liang, Jun-bo] Tsinghua Univ, Peking Union Med Coll, Chinese Acad Med Sci, Inst Basic Med Sci,State Key Lab Med Mol Biol, Beijing 100005, Peoples R China	Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Tsinghua University	Guo, R (corresponding author), Shanxi Med Univ, Dept Biochem & Mol Biol, Taiyuan 030001, Shanxi, Peoples R China.	15834151276@139.com; xiejun1968@126.com; guoping.zheng@sydney.edu.au	Zheng, Guoping/AAF-2332-2019; Liang, Junbo/AFN-3446-2022	zheng, guoping/0000-0002-5551-4522	Scientific Research Foundation for Returned Scholars of Shanxi Province [2011-043, 2010-677]; Biology Postdoctoral Mobile Research Station of Shanxi Medical University	Scientific Research Foundation for Returned Scholars of Shanxi Province; Biology Postdoctoral Mobile Research Station of Shanxi Medical University	This study was supported by the Scientific Research Foundation for Returned Scholars of Shanxi Province (2011-043, 2010-677) and the Biology Postdoctoral Mobile Research Station of Shanxi Medical University.	Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; BREEDEN L, 1987, NATURE, V329, P651, DOI 10.1038/329651a0; Chen L, 2014, J GASTROENTEROL, V49, P864, DOI 10.1007/s00535-013-0848-4; Christensen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080666; Comb WC, 2011, ONCOGENE, V30, P1727, DOI 10.1038/onc.2010.553; Dong WW, 2014, ASIAN J ANDROL, V16, P124, DOI 10.4103/1008-682X.122592; Dorogova NV, 2014, GENESIS, V52, P738, DOI 10.1002/dvg.22789; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Eskelinen EL, 2011, CURR OPIN PHARMACOL, V11, P294, DOI 10.1016/j.coph.2011.03.009; Fu LL, 2013, INT J BIOCHEM CELL B, V45, P921, DOI 10.1016/j.biocel.2013.02.007; Han SP, 2015, ENVIRON TOXICOL, V30, P323, DOI 10.1002/tox.21910; Hayashi K, 2015, CELL SIGNAL, V27, P382, DOI 10.1016/j.cellsig.2014.11.024; Hikim APS, 1997, BIOL REPROD, V57, P1193, DOI 10.1095/biolreprod57.5.1193; Hikim APS, 1999, REV REPROD, V4, P38; Hsu YC, 2009, CLIN CANCER RES, V15, P7309, DOI 10.1158/1078-0432.CCR-09-1572; Hu W, 2014, CANCER LETT, V343, P239, DOI 10.1016/j.canlet.2013.09.035; Huang AC, 2013, INT J ONCOL, V43, P485, DOI 10.3892/ijo.2013.1952; Jiang K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-551; Juarez E, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-152; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaczmarek K, 2011, MOL BIOL CELL, V22, P1766, DOI 10.1091/mbc.E09-12-0993; KIERSZENBAUM AL, 1994, ENDOCR REV, V15, P116, DOI 10.1210/er.15.1.116; Kim KS, 2009, EUR J PHARMACOL, V613, P167, DOI 10.1016/j.ejphar.2009.04.026; Lee KH, 2013, J BIOL CHEM, V288, P32777, DOI 10.1074/jbc.M113.480921; Li CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101526; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Pan H, 2014, AM J PHYSIOL-LUNG C, V306, pL183, DOI 10.1152/ajplung.00147.2013; Rajender S, 2011, MUTAT RES-REV MUTAT, V727, P62, DOI 10.1016/j.mrrev.2011.04.002; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Sui XB, 2015, MOL MED REP, V11, P1214, DOI 10.3892/mmr.2014.2853; Wan HT, 2013, EXPERT OPIN THER TAR, V17, P839, DOI 10.1517/14728222.2013.791679; Wang HL, 2011, CELL MOL LIFE SCI, V68, P2129, DOI 10.1007/s00018-010-0559-4; Wang HN, 2014, CELL RES, V24, P852, DOI 10.1038/cr.2014.70; Wang PY, 2012, CLIN VACCINE IMMUNOL, V19, P1916, DOI 10.1128/CVI.00397-12; Wang Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-25; White-Cooper H, 2010, REPRODUCTION, V139, P11, DOI 10.1530/REP-09-0083; Williams-Bey Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097957; Xu XJ, 2014, NAT IMMUNOL, V15, P1152, DOI 10.1038/ni.3025; Zeng M, 2013, BIOCHEM BIOPH RES CO, V436, P180, DOI 10.1016/j.bbrc.2013.05.070; Zhang MQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041412; Zhang N, 2010, MOL BIOL CELL, V21, P4312, DOI 10.1091/mbc.E10-04-0310; Zhou B, 2013, CELL CYCLE, V12, P1901, DOI 10.4161/cc.24929	43	10	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128551	10.1371/journal.pone.0128551	http://dx.doi.org/10.1371/journal.pone.0128551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043108	Green Published, gold, Green Submitted			2022-12-27	WOS:000355701600052
J	Liu, J; Ying, DW; Rymer, WZ; Zhou, P				Liu, Jie; Ying, Dongwen; Rymer, William Z.; Zhou, Ping			Robust Muscle Activity Onset Detection Using an Unsupervised Electromyogram Learning Framework	PLOS ONE			English	Article							VOICE ACTIVITY DETECTION; SURFACE EMG; ACTIVATION INTERVALS; MYOELECTRIC SIGNAL; MODEL; ALGORITHM; RECOGNITION; CONTRACTION; LIKELIHOOD; GAIT	Accurate muscle activity onset detection is an essential prerequisite for many applications of surface electromyogram (EMG). This study presents an unsupervised EMG learning framework based on a sequential Gaussian mixture model (GMM) to detect muscle activity onsets. The distribution of the logarithmic power of EMG signal was characterized by a two-component GMM in each frequency band, in which the two components respectively correspond to the posterior distribution of EMG burst and non-burst logarithmic powers. The parameter set of the GMM was sequentially estimated based on maximum likelihood, subject to constraints derived from the relationship between EMG burst and non-burst distributions. An optimal threshold for EMG burst/non-burst classification was determined using the GMM at each frequency band, and the final decision was obtained by a voting procedure. The proposed novel framework was applied to simulated and experimental surface EMG signals for muscle activity onset detection. Compared with conventional approaches, it demonstrated robust performance for low and changing signal to noise ratios in a dynamic environment. The framework is applicable for real-time implementation, and does not require the assumption of non EMG burst in the initial stage. Such features facilitate its practical application.	[Liu, Jie; Rymer, William Z.] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Ying, Dongwen] Chinese Acad Sci, Inst Acoust, Beijing, Peoples R China; [Rymer, William Z.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Zhou, Ping] Univ Texas Hlth Sci Ctr Houston, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Zhou, Ping] TIRR Mem Hermann Res Ctr, Houston, TX USA; [Zhou, Ping] Univ Sci & Technol China, Biomed Engn Program, Hefei 230026, Peoples R China	Shirley Ryan AbilityLab; Chinese Academy of Sciences; Institute of Acoustics, CAS; Northwestern University; University of Texas System; University of Texas Health Science Center Houston; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhou, P (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Phys Med & Rehabil, Houston, TX 77030 USA.	dr.ping.zhou@ieee.org			National Institutes of Health [R24HD050821, R01NS080839]; Memorial Hermann Foundation; National Natural Science Foundation of China [61271426, 81271658]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA06030100]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Memorial Hermann Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institutes of Health under Grants R24HD050821 and R01NS080839, the Memorial Hermann Foundation, the National Natural Science Foundation of China under Grants 61271426 and 81271658, and the Strategic Priority Research Program of the Chinese Academy of Sciences under Grant XDA06030100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink JH, 1998, J ORAL REHABIL, V25, P365; BANFIELD JD, 1993, BIOMETRICS, V49, P803, DOI 10.2307/2532201; BEKEY GA, 1977, P IEEE, V65, P674, DOI 10.1109/PROC.1977.10546; BOGEY RA, 1992, ARCH PHYS MED REHAB, V73, P835; Bonato P, 1998, IEEE T BIO-MED ENG, V45, P287, DOI 10.1109/10.661154; Chan ADC, 2006, IEEE T BIO-MED ENG, V53, P676, DOI 10.1109/TBME.2006.870224; Cournapeau D, 2010, IEEE J-STSP, V4, P1071, DOI 10.1109/JSTSP.2010.2080821; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DIFABIO RP, 1987, PHYS THER, V67, P43, DOI 10.1093/ptj/67.1.43; Gauvain JL, 1994, IEEE T SPEECH AUDI P, V2, P291, DOI 10.1109/89.279278; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0013-4694(96)95190-5; Lauer RT, 2009, ANN BIOMED ENG, V37, P1584, DOI 10.1007/s10439-009-9727-9; Lee AS, 2007, J BIOMECH, V40, P3521, DOI 10.1016/j.jbiomech.2007.05.012; Lee KS, 2008, IEEE T BIO-MED ENG, V55, P930, DOI 10.1109/TBME.2008.915658; Li XY, 2007, ANN BIOMED ENG, V35, P1532, DOI 10.1007/s10439-007-9320-z; Liu J, 2014, INT J NEURAL SYST, V24, DOI 10.1142/S0129065714500221; Lu XG, 2008, SPEECH COMMUN, V50, P312, DOI 10.1016/j.specom.2007.10.005; Merlo A, 2003, IEEE T BIO-MED ENG, V50, P316, DOI 10.1109/TBME.2003.808829; Micera S, 1998, MED ENG PHYS, V20, P211, DOI 10.1016/S1350-4533(98)00017-4; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Severini G, 2012, J ELECTROMYOGR KINES, V22, P878, DOI 10.1016/j.jelekin.2012.04.010; SHWEDYK E, 1977, IEEE T BIO-MED ENG, V24, P417, DOI 10.1109/TBME.1977.326175; Solnik S, 2010, EUR J APPL PHYSIOL, V110, P489, DOI 10.1007/s00421-010-1521-8; Staude G., 2001, EURASIP Journal on Applied Signal Processing, V2001, P67, DOI 10.1155/S1110865701000191; Staude GH, 2001, IEEE T BIO-MED ENG, V48, P1292, DOI 10.1109/10.959325; STULEN FB, 1981, IEEE T BIO-MED ENG, V28, P515, DOI 10.1109/TBME.1981.324738; Suh Y, 2012, IEEE SIGNAL PROC LET, V19, P507, DOI 10.1109/LSP.2012.2204978; Vannozzi G, 2010, J ELECTROMYOGR KINES, V20, P767, DOI 10.1016/j.jelekin.2010.02.007; Xu Q, 2013, IEEE T NEUR SYS REH, V21, P65, DOI 10.1109/TNSRE.2012.2226916; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141; Ying DW, 2011, IEEE T AUDIO SPEECH, V19, P2624, DOI 10.1109/TASL.2011.2125953; Zhang X, 2012, J ELECTROMYOGR KINES, V22, P901, DOI 10.1016/j.jelekin.2012.06.005	32	16	18	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127990	10.1371/journal.pone.0127990	http://dx.doi.org/10.1371/journal.pone.0127990			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26038820	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700083
J	Seo, HLS; Machado, LC; Honorato, LA; Da Silva, BF; do Amarante, AFT; Bricarello, PA				Sarti Seo, Hizumi Lua; Pinheiro Machado Filho, Luiz Carlos; Honorato, Luciana Aparecida; Da Silva, Bruna Fernanda; Talamini do Amarante, Alessandro Fernando; Bricarello, Patrizia Ana			The Effect of Gastrointestinal Nematode Infection Level on Grazing Distance from Dung	PLOS ONE			English	Article							CYTOKINE GENE-EXPRESSION; PARASITE CONTROL; TRADE-OFF; RESISTANCE; CATTLE; RESPONSES; SELECTION; BEHAVIOR; SHEEP; STRATEGIES	Avoiding grazing near feces is an efficient strategy to prevent parasitic infection and contamination; therefore, in the evolution of herbivorous species, this behavior may have developed as a mechanism to protect the host against infection by gastrointestinal nematodes. The aim of this study was to assess whether grazing distance from dung is related to the level of parasitic infection in cattle. Based on Fecal Egg Count (FEC) means, 18 castrated male steers, aged 18 months, were divided into three groups: High (FEC >= 315); Medium (FEC = 130-160); and Low (FEC = 40-70). To analyze the response to a new natural infection by gastrointestinal nematodes and to standardize infection levels, all animals received anthelmintic treatment at twenty days prior to field observation. Three observers simultaneously collected data on grazing behavior for 2.5 hours/week for 12 weeks. Observers recorded the distance when grazing occurred at less than one meter from dung. Every two weeks, fecal samples were collected for FEC, as well as serum samples to measure immunoglobulin G (IgG) levels against larvae and adult antigens of the parasitic species Haemonchus placei. All groups grazed farther from the dung on days of greater insolation (r = 0.62; P = 0.03). Animals with high levels of parasitism grazed farther from the dung (P < 0.05) but had lower levels (P < 0.0001) of IgG serum levels compared to those with medium and low levels of infection. FEC values varied over the experiment, remaining below 200 for the low and medium group and reaching 1000 (P < 0.01) for the animals with the highest rates of parasitism. Our results indicate that cattle showing high levels of parasitism are more likely to avoid contaminated areas than animals with lower infection levels, and the immune system seems to be involved in such behavior.	[Sarti Seo, Hizumi Lua; Pinheiro Machado Filho, Luiz Carlos; Honorato, Luciana Aparecida] Univ Fed Santa Catarina, Lab Etol Aplicada Bem Estar Anim, Dept Zootecnia Desenvolvimento Rural, Florianopolis, SC, Brazil; [Da Silva, Bruna Fernanda] Univ Planalto Catarinense, Lages, Brazil; [Talamini do Amarante, Alessandro Fernando] UNESP Univ Estadual Paulista, Inst Biociencias, Dept Parasitol, Botucatu, SP, Brazil; [Bricarello, Patrizia Ana] Univ Fed Santa Catarina, Lab Parasitol Anim, Dept Zootecnia Desenvolvimento Rural, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade do Planalto Catarinense; Universidade Estadual Paulista; Universidade Federal de Santa Catarina (UFSC)	Machado, LC (corresponding author), Univ Fed Santa Catarina, Lab Etol Aplicada Bem Estar Anim, Dept Zootecnia Desenvolvimento Rural, Florianopolis, SC, Brazil.	pinheiro.machado@ufsc.br	Filho, Luiz Carlos Pinheiro Machado/I-4330-2013; do Amarante, Alessandro Francisco Talamini/C-8773-2012; Bricarello, Patrizia Ana/HHN-7158-2022; Amarante, Alessandro/ABF-9373-2020; Silva, Bruna Fernanda da/B-7643-2012	Filho, Luiz Carlos Pinheiro Machado/0000-0002-8182-8365; do Amarante, Alessandro Francisco Talamini/0000-0003-3995-5501; Amarante, Alessandro/0000-0003-3995-5501; Silva, Bruna Fernanda da/0000-0002-3513-8072	CNPq (National Council on Scientific and Technological Development), Project Inter-institutional Network of the Agroecological Dairy Productive Chain, LCPMF [562908/2010-2, Call 22/2010]; CNPq (National Council for Scientific and Technological Development, Brazil)	CNPq (National Council on Scientific and Technological Development), Project Inter-institutional Network of the Agroecological Dairy Productive Chain, LCPMF(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq (National Council for Scientific and Technological Development, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grant number: 562908/2010-2, Call 22/2010, from CNPq (National Council on Scientific and Technological Development, www.cnpq.br), Project Inter-institutional Network of the Agroecological Dairy Productive Chain, LCPMF. LCPMF and AFTA were also provided with financial support from CNPq (National Council for Scientific and Technological Development, Brazil).	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 1989, SAS STAT US GUID, P943; AOYAMA M, 1994, APPL ANIM BEHAV SCI, V40, P253, DOI 10.1016/0168-1591(94)90066-3; Beh KJ, 1996, INT J PARASITOL, V26, P879, DOI 10.1016/S0020-7519(96)80060-9; Brasil, 2014, DIARIO OFICIAL UNIAO, P55; Bricarello PA, 2008, VET PARASITOL, V155, P95, DOI 10.1016/j.vetpar.2008.03.016; Bricarello PA, 2007, VET PARASITOL, V148, P272, DOI 10.1016/j.vetpar.2007.06.013; Broom DB, 2010, COMPORTAMENTO BEM ES, P438; Cardoso CP, 2013, VET PARASITOL, V192, P183, DOI 10.1016/j.vetpar.2012.10.018; Coltman DW, 2001, EVOLUTION, V55, P2116, DOI 10.1111/j.0014-3820.2001.tb01326.x; Condi GK, 2009, VET PARASITOL, V161, P213, DOI 10.1016/j.vetpar.2009.01.031; Cooper J, 2000, APPL ANIM BEHAV SCI, V69, P15, DOI 10.1016/S0168-1591(00)00116-7; Delgado FED, 2009, REV BRAS PARASITOL V, V18, P29, DOI 10.4322/rbpv.01803005; Da Rocha RA, 2008, REV BRAS PARASITOL V, V17, P227, DOI 10.1590/S1984-29612008000400011; Diez-Tascon C, 2005, PHYSIOL GENOMICS, V21, P59, DOI 10.1152/physiolgenomics.00257.2004; DOHI H, 1991, J CHEM ECOL, V17, P1197, DOI 10.1007/BF01402943; Dohi H, 1999, J ANIM SCI, V77, P756; Fleurance G, 2007, APPL ANIM BEHAV SCI, V108, P288, DOI 10.1016/j.applanim.2006.11.019; Fox NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077996; Gasbarre LC, 2001, VET PARASITOL, V98, P51, DOI 10.1016/S0304-4017(01)00423-X; HART BL, 1990, NEUROSCI BIOBEHAV R, V14, P273, DOI 10.1016/S0149-7634(05)80038-7; HAWKINS JA, 1993, VET PARASITOL, V46, P159, DOI 10.1016/0304-4017(93)90056-S; Hutchings MR, 2007, P R SOC B, V274, P1839, DOI 10.1098/rspb.2007.0398; Hutchings MR, 1998, ANIM SCI, V67, P97, DOI 10.1017/S1357729800009838; Hutchings MR, 2003, P NUTR SOC, V62, P361, DOI 10.1079/PNS2003243; Hutchings MR, 2001, ECOLOGY, V82, P1138, DOI 10.1890/0012-9658(2001)082[1138:HPSAFT]2.0.CO;2; Hutchings MR, 2001, ANIM BEHAV, V62, P955, DOI 10.1006/anbe.2001.1837; Kanobana K, 2001, PARASITE IMMUNOL, V23, P641, DOI 10.1046/j.1365-3024.2001.00426.x; KEITH RK, 1953, AUST J ZOOL, V1, P223, DOI 10.1071/ZO9530223; Lehner PN, 1996, HDB ETHOLOGICAL METH, P672; Lisonbee LD, 2009, BEHAV PROCESS, V82, P184, DOI 10.1016/j.beproc.2009.06.009; Mcrae KM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-637; Morris CA, 2005, NEW ZEAL J AGR RES, V48, P1, DOI 10.1080/00288233.2005.9513625; Phillips C, 1992, FARM ANIMALS ENV, P430; Redbo I, 2001, CAN J ANIM SCI, V81, P9, DOI 10.4141/A00-071; ROBERTS FHS, 1950, AUST J AGR RES, V1, P99, DOI 10.1071/AR9500099; Rodrigues DS, 2014, IMPACTO ECONOMICO DA; SKINNER WD, 1980, AM J VET RES, V41, P395; Soutello RGV, 2007, VET PARASITOL, V148, P360, DOI 10.1016/j.vetpar.2007.06.023; Stevens ANP, 2012, NAT ED KNOWL, V3, P1; Sutherland IA, 2011, TRENDS PARASITOL, V27, P176, DOI 10.1016/j.pt.2010.11.008; Szyszka O, 2013, VET PARASITOL, V193, P214, DOI 10.1016/j.vetpar.2012.10.023; Ueno H., 1998, MANUAL DIAGNOSTICO H, P149; van Dijk J, 2010, ANIMAL, V4, P377, DOI 10.1017/S1751731109990991; Zanin M, 2009, REV BRAS AGROECOL, V4, P2695; Zaros LG, 2010, VET PARASITOL, V171, P68, DOI 10.1016/j.vetpar.2010.03.020	46	7	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126340	10.1371/journal.pone.0126340	http://dx.doi.org/10.1371/journal.pone.0126340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039729	Green Submitted, Green Published, gold			2022-12-27	WOS:000355700700027
J	Scyphers, SB; Gouhier, TC; Grabowski, JH; Beck, MW; Mareska, J; Powers, SP				Scyphers, Steven B.; Gouhier, Tarik C.; Grabowski, Jonathan H.; Beck, Michael W.; Mareska, John; Powers, Sean P.			Natural Shorelines Promote the Stability of Fish Communities in an Urbanized Coastal System	PLOS ONE			English	Article							ECOSYSTEMS; IMPACT; MANAGEMENT; ESTUARINE; DIVERSITY; SPILLOVER; HABITATS; BIOMASS; PREY	Habitat loss and fragmentation are leading causes of species extinctions in terrestrial, aquatic and marine systems. Along coastlines, natural habitats support high biodiversity and valuable ecosystem services but are often replaced with engineered structures for coastal protection or erosion control. We coupled high-resolution shoreline condition data with an eleven-year time series of fish community structure to examine how coastal protection structures impact community stability. Our analyses revealed that the most stable fish communities were nearest natural shorelines. Structurally complex engineered shorelines appeared to promote greater stability than simpler alternatives as communities nearest vertical walls, which are among the most prevalent structures, were most dissimilar from natural shorelines and had the lowest stability. We conclude that conserving and restoring natural habitats is essential for promoting ecological stability. However, in scenarios when natural habitats are not viable, engineered landscapes designed to mimic the complexity of natural habitats may provide similar ecological functions.	[Scyphers, Steven B.; Gouhier, Tarik C.; Grabowski, Jonathan H.] Northeastern Univ, Ctr Marine Sci, Dept Marine & Environm Sci, Nahant, MA 01905 USA; [Beck, Michael W.] Nature Conservancy, Global Marine Program, Santa Cruz, CA 95060 USA; [Mareska, John] Alabama Dept Conservat & Nat Resources, Dauphin Isl, AL 36528 USA; [Powers, Sean P.] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA; [Powers, Sean P.] Dauphin Isl Sea Lab, Mobile, AL 36688 USA	Northeastern University; Nature Conservancy; University of South Alabama; Dauphin Island Sea Lab	Scyphers, SB (corresponding author), Northeastern Univ, Ctr Marine Sci, Dept Marine & Environm Sci, Nahant, MA 01905 USA.	s.scyphers@neu.edu	Gouhier, Tarik/C-3611-2009; Beck, Michael W./AAB-2844-2019	Beck, Michael W./0000-0002-5107-9973; Powers, Sean/0000-0002-4770-9944; Gouhier, Tarik/0000-0002-9537-7358; Grabowski, Jonathan/0000-0003-4711-5481	National Science Foundation (NSF) [OCE-1215825, OCE-12-03859]; Pew Fellowship; Lyda Hill Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Pew Fellowship; Lyda Hill Foundation	This study was supported by a National Science Foundation (NSF) SEES Fellowship to SS (OCE-1215825). JG was supported by NSF grant OCE-12-03859. MB was supported by a Pew Fellowship and the Lyda Hill Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton A, 2009, B MAR SCI, V85, P45; Arkema KK, 2013, NATURE CLIM CHANGE; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Barbier EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058715; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Bell SS, 1997, RESTOR ECOL, V5, P318, DOI 10.1046/j.1526-100X.1997.00545.x; Bilkovic DM, 2008, MAR ECOL PROG SER, V358, P27, DOI 10.3354/meps07279; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Botsford LW, 2001, ECOL LETT, V4, P144; Bozek Catherine M., 2005, Wetlands Ecology and Management, V13, P553, DOI 10.1007/s11273-004-5543-z; Briggs CJ, 2004, THEOR POPUL BIOL, V65, P299, DOI 10.1016/j.tpb.2003.11.001; Cebrian J, 2008, AQUAT ECOL, V42, P391, DOI 10.1007/s10452-007-9096-0; Chapman MG, 2009, OECOLOGIA, V161, P625, DOI 10.1007/s00442-009-1393-y; Chapman MG, 2003, MAR ECOL PROG SER, V264, P21, DOI 10.3354/meps264021; Davis JLD, 2002, MAR BIOL, V140, P1249, DOI 10.1007/s00227-002-0779-8; Douglass S.L., 1999, SHORE BEACH, V67, P19; Fodrie FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021609; Goni R, 2008, MAR ECOL PROG SER, V366, P159, DOI 10.3354/meps07532; Gouhier T. C., 2012, **DATA OBJECT**; Gouhier TC, 2010, AM NAT, V175, pE16, DOI 10.1086/649579; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Holling CS, 1996, ECOL APPL, V6, P733, DOI 10.2307/2269475; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 2001, P NATL ACAD SCI USA, V98, P5411, DOI 10.1073/pnas.091092898; Jones S.C., 2009, 0921 GEOL SURV AL; Levin S., 1999, FRAGILE DOMINION; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; May R.M., 1973, STABILITY COMPLEXITY; McClanahan TR, 2000, ECOL APPL, V10, P1792, DOI 10.2307/2641239; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; National Research Council (NRC), 2007, MITIGATING SHORE ERO; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scyphers SB, 2015, CONSERV LETT, V8, P41, DOI 10.1111/conl.12114; Scyphers SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022396; Seitz RD, 2006, MAR ECOL PROG SER, V326, P11, DOI 10.3354/meps326011; Spalding MD, 2014, CONSERV LETT, V7, P293, DOI 10.1111/conl.12074; STONER AW, 1983, FISH B-NOAA, V81, P837; Thayer GW, 1978, HABITAT VALUES SALT, P235; Thibaut LM, 2012, ECOLOGY, V93, P891, DOI 10.1890/11-1753.1; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; TURNER MG, 1989, ANNU REV ECOL SYST, V20, P171, DOI 10.1146/annurev.es.20.110189.001131; Vitousek P., 1997, SCIENCE, V277; WALKER B, 1995, CONSERV BIOL, V9, P747, DOI 10.1046/j.1523-1739.1995.09040747.x	47	19	20	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0118580	10.1371/journal.pone.0118580	http://dx.doi.org/10.1371/journal.pone.0118580			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039407	Green Submitted, Green Published, gold			2022-12-27	WOS:000355700700001
J	Sholtis, KM; Shelton, RM; Hedrick, TL				Sholtis, Katherine M.; Shelton, Ryan M.; Hedrick, Tyson L.			Field Flight Dynamics of Hummingbirds during Territory Encroachment and Defense	PLOS ONE			English	Article							HOVERING PERFORMANCE; AERODYNAMICS; KINEMATICS; ENERGETICS; LIMITS; MASS	Hummingbirds are known to defend food resources such as nectar sources from encroachment by competitors (including conspecifics). These competitive intraspecific interactions provide an opportunity to quantify the biomechanics of hummingbird flight performance during ecologically relevant natural behavior. We recorded the three-dimensional flight trajectories of Ruby-throated Hummingbirds defending, being chased from and freely departing from a feeder. These trajectories allowed us to compare natural flight performance to earlier laboratory measurements of maximum flight speed, aerodynamic force generation and power estimates. During field observation, hummingbirds rarely approached the maximal flight speeds previously reported from wind tunnel tests and never did so during level flight. However, the accelerations and rates of change in kinetic and potential energy we recorded indicate that these hummingbirds likely operated near the maximum of their flight force and metabolic power capabilities during these competitive interactions. Furthermore, although birds departing from the feeder while chased did so faster than freely-departing birds, these speed gains were accomplished by modulating kinetic and potential energy gains (or losses) rather than increasing overall power output, essentially trading altitude for speed during their evasive maneuver. Finally, the trajectories of defending birds were directed toward the position of the encroaching bird rather than the feeder.	[Sholtis, Katherine M.; Shelton, Ryan M.; Hedrick, Tyson L.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill	Hedrick, TL (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC USA.	thedrick@bio.unc.edu	Hedrick, Tyson/GZH-3140-2022	Hedrick, Tyson/0000-0002-6573-9602; James, Katherine/0000-0002-5854-8787	Office of Naval Research MURI [N000141010952]; National Science Foundation [IOS-1253276]; Div Of Civil, Mechanical, & Manufact Inn [1234787] Funding Source: National Science Foundation	Office of Naval Research MURI(MURIOffice of Naval Research); National Science Foundation(National Science Foundation (NSF)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was funded by Office of Naval Research (http://www.onr.navy.mil) MURI N000141010952 to TLH and 8 others and by National Science Foundation (http://www.nsf.gov/) IOS-1253276 to TLH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DL, 2006, AM NAT, V167, P216, DOI 10.1086/498622; Bahlman JW, 2013, J R SOC INTERFACE, P10; Bomphrey RJ, 2005, J EXP BIOL, V208, P1079, DOI 10.1242/jeb.01471; BROWN RHJ, 1948, J EXP BIOL, V25, P322; Byrnes G, 2008, P R SOC B, V275, P1007, DOI 10.1098/rspb.2007.1684; Chai P, 1996, J EXP BIOL, V199, P2285; Chai P, 1999, AM NAT, V153, P398, DOI 10.1086/303179; Chai P, 1997, J EXP BIOL, V200, P921; Chai P, 1996, J EXP BIOL, V199, P2745; CHAI P, 1995, NATURE, V377, P722, DOI 10.1038/377722a0; Clark CJ, 2012, ANIM BEHAV, V84, P269, DOI 10.1016/j.anbehav.2012.04.012; Clark CJ, 2011, J ORNITHOL, V152, P397, DOI 10.1007/s10336-010-0550-8; Clark CJ, 2009, P ROY SOC B-BIOL SCI, V276, P3047, DOI 10.1098/rspb.2009.0508; Hedrick TL, 2007, J EXP BIOL, V210, P1897, DOI 10.1242/jeb.002055; Hedrick TL, 2002, J EXP BIOL, V205, P1389; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; Hubel TY, 2009, EXP FLUIDS, V46, P933, DOI 10.1007/s00348-009-0624-7; Jackson BE, 2009, ALLOMETRY BIRD FLIGH; Morris CR, 2010, J EXP BIOL, V213, P2788, DOI 10.1242/jeb.035717; Poole A., 2005, BIRDS N AM ONLINE; Portugal SJ, 2014, NATURE, V505, P399, DOI 10.1038/nature12939; Ros IG, 2011, P NATL ACAD SCI USA, V108, P19990, DOI 10.1073/pnas.1107519108; Rousseu F, 2014, ECOL EVOL, V4, P776, DOI 10.1002/ece3.972; Shelton RM, 2014, J EXP BIOL, V217, P2717, DOI 10.1242/jeb.101329; Song J, 2014, J R SOC INTERFACE, P11; Spedding GR, 2003, J EXP BIOL, V206, P2313, DOI 10.1242/jeb.00423; STILES FG, 1982, CONDOR, V84, P208, DOI 10.2307/1367674; Stolpe M., 1939, Journal fuer Ornithologie, V87, P136, DOI 10.1007/BF01950821; Theriault DH, 2014, J EXP BIOL, V217, P1843, DOI 10.1242/jeb.100529; Tobalske BW, 2007, J EXP BIOL, V210, P2368, DOI 10.1242/jeb.005686; Tobalske BW, 2003, NATURE, V421, P363, DOI 10.1038/nature01284; TUCKER VA, 1973, J EXP BIOL, V58, P689; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; Warrick DR, 2005, NATURE, V435, P1094, DOI 10.1038/nature03647; WELLS DJ, 1993, J EXP BIOL, V178, P39; WITTER MS, 1994, ANIM BEHAV, V48, P201, DOI 10.1006/anbe.1994.1227	36	24	24	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0125659	10.1371/journal.pone.0125659	http://dx.doi.org/10.1371/journal.pone.0125659			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039101	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700010
J	Thompson, MJ; Rubbi, L; Dawson, DW; Donahue, TR; Pellegrini, M				Thompson, Michael J.; Rubbi, Liudmilla; Dawson, David W.; Donahue, Timothy R.; Pellegrini, Matteo			Pancreatic Cancer Patient Survival Correlates with DNA Methylation of Pancreas Development Genes	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; PROMOTER HYPERMETHYLATION; EPIGENETIC INACTIVATION; DUCTAL ADENOCARCINOMA; DOWN-REGULATION; RASSF10; EXPRESSION; FREQUENT; DIFFERENTIATION; HETEROCHROMATIN	DNA methylation is an epigenetic mark associated with regulation of transcription and genome structure. These markers have been investigated in a variety of cancer settings for their utility in differentiating normal tissue from tumor tissue. Here, we examine the direct correlation between DNA methylation and patient survival. We find that changes in the DNA methylation of key pancreatic developmental genes are strongly associated with patient survival.	[Thompson, Michael J.; Rubbi, Liudmilla; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Dawson, David W.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Donahue, Timothy R.] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90095 USA; [Donahue, Timothy R.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Dawson, David W.; Donahue, Timothy R.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Pellegrini, M (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	matteop@mcdb.ucla.edu		Pellegrini, Matteo/0000-0001-9355-9564; Thompson, Michael/0000-0002-2914-1080	Hirshberg Foundation for Pancreatic Research;  [P01 GM099134]; NATIONAL CANCER INSTITUTE [P01CA163200, P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099134] Funding Source: NIH RePORTER	Hirshberg Foundation for Pancreatic Research; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support for pancreas tissue banking (DWD) was provided by the Hirshberg Foundation for Pancreatic Research. M.J.T. was supported by grant P01 GM099134.	Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Alvarez H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001356; Anglim PP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-62; Arai E, 2012, CARCINOGENESIS, V33, P1487, DOI 10.1093/carcin/bgs177; Bais AJ, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-22; Baronchelli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057462; Benjamini Y, 2010, J R STAT SOC B, V72, P405, DOI 10.1111/j.1467-9868.2010.00746.x; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blackford A, 2009, CLIN CANCER RES, V15, P4674, DOI 10.1158/1078-0432.CCR-09-0227; Cabarcas S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-74; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cheon DJ, 2014, CLIN CANCER RES, V20, P711, DOI 10.1158/1078-0432.CCR-13-1256; Chiang JH, 2014, OMICS, V18, P310, DOI 10.1089/omi.2013.0084; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; COX DR, 1972, J R STAT SOC B, V34, P187; Dansranjavin T, 2012, PROSTATE, V72, P1550, DOI 10.1002/pros.22510; De S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003137; Delpu Y, 2011, CURR GENOMICS, V12, P15, DOI 10.2174/138920211794520132; Donahue TR, 2012, CLIN CANCER RES, V18, P1352, DOI 10.1158/1078-0432.CCR-11-1539; Du CP, 2011, CANCER LETT, V309, P54, DOI 10.1016/j.canlet.2011.05.016; Duhoux FP, 2012, BRIT J HAEMATOL, V156, P76, DOI 10.1111/j.1365-2141.2011.08918.x; Gruber TA, 2012, CANCER CELL, V22, P683, DOI 10.1016/j.ccr.2012.10.007; Guo WL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-774; Hagel C, 2013, J NEURO-ONCOL, V112, P191, DOI 10.1007/s11060-013-1062-1; Helmbold P, 2012, J INVEST DERMATOL, V132, P687, DOI 10.1038/jid.2011.380; Henrich KO, 2011, CANCER RES, V71, P3142, DOI 10.1158/0008-5472.CAN-10-3014; Hesson LB, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-42; Hill VK, 2011, ONCOGENE, V30, P978, DOI 10.1038/onc.2010.471; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jacquemin P, 2003, DEV BIOL, V258, P105, DOI 10.1016/S0012-1606(03)00115-5; Jiang XH, 2008, ONCOL REP, V19, P157; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kajiho H, 2011, J BIOL CHEM, V286, P24364, DOI 10.1074/jbc.M110.172445; Kang CM, 2014, PANCREAS, V43, P183, DOI 10.1097/MPA.0000000000000088; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim Y, 2013, 2013 WORLD HAPTICS CONFERENCE (WHC), P133, DOI 10.1109/WHC.2013.6548397; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; Leal JFM, 2008, ONCOGENE, V27, P1961, DOI 10.1038/sj.onc.1210846; Li ZH, 2014, ONCOL REP, V31, P1661, DOI 10.3892/or.2014.3039; Liu B, 2014, ONCOL REP, V31, P2625, DOI 10.3892/or.2014.3158; Liu MH, 2013, PANCREAS, V42, P1169, DOI 10.1097/MPA.0b013e3182962acb; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lu D, 2014, DISCOV MED, V17, P169; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Miotto E, 2004, CANCER RES, V64, P8156, DOI 10.1158/0008-5472.CAN-04-3000; Moelans CB, 2011, J PATHOL, V225, P222, DOI 10.1002/path.2930; Newhook TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105631; Nones K, 2014, INT J CANCER, V135, P1110, DOI 10.1002/ijc.28765; Okawa ER, 2008, ONCOGENE, V27, P803, DOI 10.1038/sj.onc.1210675; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pesek M, 2011, ANTICANCER RES, V31, P4647; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; Prevot PP, 2012, GUT, V61, P1723, DOI 10.1136/gutjnl-2011-300266; Richter AM, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.18; Salaverria I, 2012, GENE CHROMOSOME CANC, V51, P338, DOI 10.1002/gcc.21919; Schagdarsurengin U, 2009, EPIGENETICS-US, V4, P571, DOI 10.4161/epi.4.8.10056; Schraivogel D, 2011, EMBO J, V30, P4309, DOI 10.1038/emboj.2011.301; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Society AC, 2014, CANC FACTS FIGURES; Steidl U, 2007, J CLIN INVEST, V117, P2611, DOI 10.1172/JCI30525; Stratford JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000307; Sussel L, 1998, DEVELOPMENT, V125, P2213; Suzuki M, 2011, GENOME RES, V21, P1833, DOI 10.1101/gr.116509.110; Tian Y, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-772; Tsukasaki K, 2001, ONCOGENE, V20, P3301, DOI 10.1038/sj.onc.1204421; Underhill-Day N, 2011, EPIGENETICS-US, V6, P284, DOI 10.4161/epi.6.3.14108; Vincent A, 2011, CLIN CANCER RES, V17, P4341, DOI 10.1158/1078-0432.CCR-10-3431; Wang CL, 2012, J CLIN NEUROSCI, V19, P541, DOI 10.1016/j.jocn.2011.04.047; Wang D, 2014, MOL CELL BIOCHEM, V396, P67, DOI 10.1007/s11010-014-2143-y; Wang YF, 2014, BIOMED PHARMACOTHER, V68, P321, DOI 10.1016/j.biopha.2013.12.005; Wei ZR, 2013, BIOCHEM BIOPH RES CO, V432, P632, DOI 10.1016/j.bbrc.2013.02.033; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yang Q, 2014, CLIN BIOCHEM, V47, P111, DOI 10.1016/j.clinbiochem.2013.10.014; Yao DM, 2012, CLIN CHIM ACTA, V413, P787, DOI 10.1016/j.cca.2012.01.013; Ying JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039797; Yu SN, 2010, CANCER RES, V70, P6015, DOI 10.1158/0008-5472.CAN-09-4531; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhao G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073803; Zhu PF, 2014, BIOCHEM BIOPH RES CO, V452, P567, DOI 10.1016/j.bbrc.2014.08.101	82	38	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128814	10.1371/journal.pone.0128814	http://dx.doi.org/10.1371/journal.pone.0128814			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039411	gold, Green Published, Green Submitted			2022-12-27	WOS:000355700700123
J	Schwendicke, F; Karimbux, N; Allareddy, V; Gluud, C				Schwendicke, Falk; Karimbux, Nadeem; Allareddy, Veerasathpurush; Gluud, Christian			Periodontal Treatment for Preventing Adverse Pregnancy Outcomes: A Meta- and Trial Sequential Analysis	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; STRICT PLAQUE CONTROL; PRETERM BIRTH; THERAPY; DISEASE; METAANALYSIS; REDUCE; WOMEN; RISK; BIAS	Objectives Periodontal treatment might reduce adverse pregnancy outcomes. The efficacy of periodontal treatment to prevent preterm birth, low birth weight, and perinatal mortality was evaluated using meta-analysis and trial sequential analysis. Methods An existing systematic review was updated and meta-analyses performed. Risk of bias, heterogeneity, and publication bias were evaluated, and meta-regression performed. Subgroup analysis was used to compare different studies with low and high risk of bias and different populations, i.e., risk groups. Trial sequential analysis was used to assess risk of random errors. Results Thirteen randomized clinical trials evaluating 6283 pregnant women were meta-analyzed. Four and nine trials had low and high risk of bias, respectively. Overall, periodontal treatment had no significant effect on preterm birth (odds ratio [95% confidence interval] 0.79 [0.57-1.10]) or low birth weight (0.69 [0.43-1.13]). Trial sequential analysis demonstrated that futility was not reached for any of the outcomes. For populations with moderate occurrence (<20%) of preterm birth or low birth weight, periodontal treatment was not efficacious for any of the outcomes, and trial sequential analyses indicated that further trials might be futile. For populations with high occurrence (>= 20%) of preterm birth and low birth weight, periodontal treatment seemed to reduce the risk of preterm birth (0.42 [0.24-0.73]) and low birth weight (0.32 [0.15-0.67]), but trial sequential analyses showed that firm evidence was not reached. Periodontal treatment did not significantly affect perinatal mortality, and firm evidence was not reached. Risk of bias, but not publication bias or patients' age modified the effect estimates. Conclusions Providing periodontal treatment to pregnant women could potentially reduce the risks of perinatal outcomes, especially in mothers with high risks. Conclusive evidence could not be reached due to risks of bias, risks of random errors, and unclear effects of confounding. Further randomized clinical trials are required.	[Schwendicke, Falk] Charite, Dept Operat & Prevent Dent, D-13353 Berlin, Germany; [Karimbux, Nadeem] Tufts Univ, Sch Dent Med, Boston, MA 02111 USA; [Allareddy, Veerasathpurush] Univ Iowa, Coll Dent, Dept Orthodont, Iowa City, IA 52242 USA; [Gluud, Christian] Copenhagen Univ Hosp, Copenhagen Trial Unit, Ctr Clin Intervent Res, Rigshosp, Copenhagen, Denmark	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Tufts University; University of Iowa; Rigshospitalet; University of Copenhagen	Schwendicke, F (corresponding author), Charite, Dept Operat & Prevent Dent, D-13353 Berlin, Germany.	falk.schwendicke@charite.de	Gluud, Christian/AAY-1027-2021; Gluud, Christian/HGB-3191-2022	Gluud, Christian/0000-0002-8861-0799; Schwendicke, Falk/0000-0003-1223-1669				Baccaglini L, 2011, J AM DENT ASSOC, V142, P1192, DOI 10.14219/jada.archive.2011.0089; Barbour V, 2008, PLOS MED, V5, P1299, DOI 10.1371/journal.pmed.0050199; Boggess KA, 2010, AM J OBSTET GYNECOL, V202, P101, DOI 10.1016/j.ajog.2009.12.018; Boots AB, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.004; Chambrone L, 2011, J CLIN PERIODONTOL, V38, P902, DOI 10.1111/j.1600-051X.2011.01761.x; Copenhagen Trial Unit, TSA TRIAL SEQ AN; Davidoff F, 2001, NEW ENGL J MED, V345, P825, DOI 10.1056/NEJMed20010093; DeFranco EA, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.015; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; Deshpande SN, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17400; Dudley NJ, 2005, ULTRASOUND OBST GYN, V25, P80, DOI 10.1002/uog.1751; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fogacci MF, 2011, OBSTET GYNECOL, V117, P153, DOI 10.1097/AOG.0b013e3181fdebc0; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Jakobsen J. C., 2013, British Journal of Medicine and Medical Research, V3, P1453; Jakobsen JC, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-120; Jeffcoat M, 2011, BJOG-INT J OBSTET GY, V118, P250, DOI 10.1111/j.1471-0528.2010.02713.x; Jeffcoat MK, 2003, J PERIODONTOL, V74, P1214, DOI 10.1902/jop.2003.74.8.1214; Keus F, 2010, J CLIN EPIDEMIOL, V63, P246, DOI 10.1016/j.jclinepi.2009.08.023; Kim AJ, 2012, J PERIODONTOL, V83, P1508, DOI 10.1902/jop.2012.110636; Lafaurie GI, 2007, J CLIN PERIODONTOL, V34, P873, DOI 10.1111/j.1600-051X.2007.01125.x; Lopez NJ, 2015, PERIODONTOL 2000, V67, P87, DOI 10.1111/prd.12073; Lopez NJ, 2014, CLIN ORAL INVEST, V18, P343, DOI 10.1007/s00784-013-1145-6; Lopez NJ, 2002, J PERIODONTOL, V73, P911, DOI 10.1902/jop.2002.73.8.911; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; Michalowicz BS, 2006, NEW ENGL J MED, V355, P1885, DOI 10.1056/NEJMoa062249; Michalowicz BS, 2013, J PERIODONTOL, V84, pS195, DOI [10.1902/jop.2013.1340014, 10.1111/jcpe.12081]; Newnham JP, 2009, OBSTET GYNECOL, V114, P1239, DOI 10.1097/AOG.0b013e3181c15b40; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Offenbacher S, 1998, Ann Periodontol, V3, P233, DOI 10.1902/annals.1998.3.1.233; Offenbacher S, 2006, J PERIODONTOL, V77, P2011, DOI 10.1902/jop.2006.060047; Offenbacher S, 2009, OBSTET GYNECOL, V114, P551, DOI 10.1097/AOG.0b013e3181b1341f; Pirie M, 2013, J PERIODONTOL, V84, P1391, DOI 10.1902/jop.2012.120572; Polyzos NP, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c7017; Radnai M, 2009, J DENT RES, V88, P280, DOI 10.1177/0022034508330229; Sadatmansouri S, 2006, J Indian Soc Pedod Prev Dent, V24, P23; Shaw DM, 2014, JAMA-J AM MED ASSOC, V312, P697, DOI 10.1001/jama.2014.8035; Oliveira AMSD, 2011, CLIN ORAL INVEST, V15, P609, DOI 10.1007/s00784-010-0424-8; Suvan JE, 2000, PERIODONTOLOGY, V37, P48, DOI [10.1111/j.1600-0757.2004.03794.x, DOI 10.1111/J.1600-0757.2004.03794.X]; Tarannum F, 2007, J PERIODONTOL, V78, P2095, DOI 10.1902/jop.2007.060388; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Thorlund K., 2011, USER MANUAL TRIAL SE, P1, DOI DOI 10.1158/1055-9965.EPI-08-0169; Vergnes J. N., 2007, AM J OBSTET GYNECOL, V196, DOI DOI 10.1016/J.AJ0G.2006.09.028; Weidlich P, 2013, CLIN ORAL INVEST, V17, P37, DOI 10.1007/s00784-012-0679-3; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Wetterslev J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-86; Worthington HV, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004625.pub4	49	30	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0129060	10.1371/journal.pone.0129060	http://dx.doi.org/10.1371/journal.pone.0129060			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035835	Green Published, Green Submitted, gold			2022-12-27	WOS:000355699100066
J	Jiang, P; Loyau, S; Tchitchinadze, M; Ropers, J; Jondeau, G; Jandrot-Perrus, M				Jiang, Peng; Loyau, Stephane; Tchitchinadze, Maria; Ropers, Jacques; Jondeau, Guillaume; Jandrot-Perrus, Martine			Inhibition of Glycoprotein VI Clustering by Collagen as a Mechanism of Inhibiting Collagen-Induced Platelet Responses: The Example of Losartan	PLOS ONE			English	Article							ANGIOTENSIN-II; THROMBUS FORMATION; NITRIC-OXIDE; RECEPTOR; ACTIVATION; BINDING; GPVI; AGGREGATION; ANTAGONIST; ADHESION	Exposure of platelets to collagen triggers the formation of a platelet clot. Pharmacological agents capable of inhibiting platelet activation by collagen are thus of potential therapeutic interest. Thrombus formation is initiated by the interaction of the GPIb-V-IX complex with collagen-bound vWF, while GPVI interaction with collagen triggers platelet activation that is reinforced by ADP and thromboxane A2. Losartan is an angiotensin II (Ang II) type I receptor (AT1R) antagonist proposed to have an antiplatelet activity via the inhibition of both the thromboxane A2 (TXA2) receptor (TP) and the glycoprotein VI (GPVI). Here, we characterized in vitro the effects of losartan at different doses on platelet responses: losartan inhibited platelet aggregation and secretion induced by 1 mu g.mL(-1) and 10 mu g.mL(-1) of collagen with an IC50 of similar to 6 mu M. Losartan inhibited platelet responses induced by the GPVI specific collagen related peptide but not by the alpha 2 beta 1 specific peptide. However, losartan did not inhibit the binding of recombinant GPVI to collagen, which is not in favor of a simple competition. Indeed, the clustering of GPVI observed in flow cytometry and using the Duolink methodology, was inhibited by losartan. The impact of a therapeutic dose of losartan (100 mg/day) on platelet responses was analyzed ex vivo in a double blind study. No statistically significant differences were observed between losartan-treated (n=25) and non-treated (n=30) patients in terms of collagen and U46619-induced platelet activation. These data indicate that in treated patients, losartan does not achieve a measurable antiplatelet effect but provide the proof of concept that inhibiting collagen-induced GPVI clustering is of pharmacological interest to obtain an antithrombotic efficacy.	[Jiang, Peng; Loyau, Stephane; Jondeau, Guillaume; Jandrot-Perrus, Martine] INSERM, UMR S1148, Paris, France; [Jiang, Peng; Jondeau, Guillaume; Jandrot-Perrus, Martine] Univ Paris Diderot, Sorbonne Paris Cite, UMR S1148, Paris, France; [Tchitchinadze, Maria; Jondeau, Guillaume] Hop Bichat Claude Bernard, Serv Cardiol, APHP CNMR Syndrome Marfan & Apparentes, F-75877 Paris, France; [Ropers, Jacques] Univ Versailles St Quentin, UFR Med Paris Ile de France Ouest, Unite Rech Clin, Hop Ambroise Pare, Boulogne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay	Jandrot-Perrus, M (corresponding author), INSERM, UMR S1148, Paris, France.	martine.jandrot-perrus@inserm.fr	Jandrot-Perrus, Martine/GZM-1526-2022	Loyau, stephane/0000-0001-8748-501X; JANDROT-PERRUS, Martine/0000-0002-8450-9247; ROPERS, Jacques/0000-0001-9255-3144; JIANG, Peng/0000-0001-6081-6288	China Scholarship Council	China Scholarship Council(China Scholarship Council)	PJ was supported by the China Scholarship Council.	ARAI M, 1995, BRIT J HAEMATOL, V89, P124, DOI 10.1111/j.1365-2141.1995.tb08900.x; Bigalke B, 2010, SEMIN THROMB HEMOST, V36, P203, DOI 10.1055/s-0030-1251505; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Bultmann A, 2006, THROMB HAEMOSTASIS, V95, P763, DOI 10.1160/TH05-11-0731; Clemetson JM, 1999, J BIOL CHEM, V274, P29019, DOI 10.1074/jbc.274.41.29019; Detaint D, 2010, ARCH CARDIOVASC DIS, V103, P317, DOI 10.1016/j.acvd.2010.04.008; Devi S, 2010, AM J PATHOL, V177, P1131, DOI 10.2353/ajpath.2010.091143; Dumont B, 2006, J MOL BIOL, V361, P877, DOI 10.1016/j.jmb.2006.06.053; Geirsson A, 2012, CIRCULATION, V126, pS189, DOI 10.1161/CIRCULATIONAHA.111.082610; Grothusen C, 2007, ARTERIOSCL THROM VAS, V27, P1184, DOI 10.1161/ATVBAHA.106.138693; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Horii K, 2006, BLOOD, V108, P936, DOI 10.1182/blood-2006-01-010215; Jagroop IA, 2000, J HUM HYPERTENS, V14, P581, DOI 10.1038/sj.jhh.1001102; Jandrot-Perrus M, 2000, BLOOD, V96, P1798, DOI 10.1182/blood.V96.5.1798.h8001798_1798_1807; JandrotPerrus M, 1997, J BIOL CHEM, V272, P27035, DOI 10.1074/jbc.272.43.27035; Jung SM, 2012, J BIOL CHEM, V287, P30000, DOI 10.1074/jbc.M112.359125; Kalinowski L, 2002, HYPERTENSION, V40, P521, DOI 10.1161/01.HYP.0000034745.98129.EC; Kehrel B, 1998, BLOOD, V91, P491; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Lagrue-Lak-Hal AH, 2001, J BIOL CHEM, V276, P15316, DOI 10.1074/jbc.M009117200; Lecut C, 2004, J BIOL CHEM, V279, P52293, DOI 10.1074/jbc.M406342200; Lecut C, 2003, J THROMB HAEMOST, V1, P2653, DOI 10.1111/j.1538-7836.2003.00495.x; Li P, 1998, J CARDIOVASC PHARM, V32, P198, DOI 10.1097/00005344-199808000-00005; LIU ECK, 1992, PROSTAG OTH LIPID M, V44, P89, DOI 10.1016/0090-6980(92)90070-A; Lockyer S, 2006, THROMB RES, V118, P371, DOI 10.1016/j.thromres.2005.08.001; Loyau S, 2012, ARTERIOSCL THROM VAS, V32, P778, DOI 10.1161/ATVBAHA.111.241067; Matys T, 2000, J PHYSIOL PHARMACOL, V51, P705; Miura Y, 2002, J BIOL CHEM, V277, P46197, DOI 10.1074/jbc.M204029200; MOROI M, 1989, J CLIN INVEST, V84, P1440, DOI 10.1172/JCI114318; MUNAFO A, 1992, CLIN PHARMACOL THER, V51, P513, DOI 10.1038/clpt.1992.56; Murad JP, 2012, J CARDIOVASC PHARM T, V17, P308, DOI 10.1177/1074248411425491; Nieswandt B, 2001, BLOOD, V97, P3829, DOI 10.1182/blood.V97.12.3829; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Onley DJ, 2000, J BIOL CHEM, V275, P24560, DOI 10.1074/jbc.M004111200; Ono K, 2010, J MED CHEM, V53, P2087, DOI 10.1021/jm901534d; Pees C, 2013, AM J CARDIOL, V112, P1477, DOI 10.1016/j.amjcard.2013.06.019; Presta P, 2011, EUR J INTERN MED, V22, pE90, DOI 10.1016/j.ejim.2011.08.021; Sakamoto T, 2014, HYPERTENS RES; Senchenkova EY, 2010, HYPERTENSION, V56, P1089, DOI 10.1161/HYPERTENSIONAHA.110.158220; Shimizu A, 2008, HYPERTENS RES, V31, P1711, DOI 10.1291/hypres.31.1711; Sigalov AB, 2008, EXPERT OPIN THER TAR, V12, P677, DOI 10.1517/14728222.12.6.677 ; Suzuki-Inoue K, 2002, J BIOL CHEM, V277, P21561, DOI 10.1074/jbc.M201012200; Tamaki T, 1997, CARDIOVASC DRUG REV, V15, P122, DOI 10.1111/j.1527-3466.1997.tb00327.x; Taylor L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101209; Tole S, 2010, AM J PHYSIOL-CELL PH, V298, pC1469, DOI 10.1152/ajpcell.00380.2009; Touat Z, 2008, ARTERIOSCL THROM VAS, V28, P940, DOI 10.1161/ATVBAHA.107.158576; Zahid M, 2011, ANAL BIOCHEM, V417, P274, DOI 10.1016/j.ab.2011.06.036; Zervou M, 2014, BBA-BIOMEMBRANES, V1838, P1031, DOI 10.1016/j.bbamem.2013.12.012	49	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128744	10.1371/journal.pone.0128744	http://dx.doi.org/10.1371/journal.pone.0128744			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052700	gold, Green Published, Green Submitted			2022-12-27	WOS:000355955300056
J	Chen, C; Hu, KL; Li, H; Yun, AP; Li, BG				Chen, Chong; Hu, Kelin; Li, Hong; Yun, Anping; Li, Baoguo			Three-Dimensional Mapping of Soil Organic Carbon by Combining Kriging Method with Profile Depth Function	PLOS ONE			English	Article							TOTAL NITROGEN; LAND-USE; SPATIAL-DISTRIBUTION; LOESS PLATEAU; MATTER; VARIABILITY; STORAGE; TEXTURE; 3D; GRASSLAND	Understanding spatial variation of soil organic carbon (SOC) in three-dimensional direction is helpful for land use management. Due to the effect of profile depths and soil texture on vertical distribution of SOC, the stationary assumption for SOC cannot be met in the vertical direction. Therefore the three-dimensional (3D) ordinary kriging technique cannot be directly used to map the distribution of SOC at a regional scale. The objectives of this study were to map the 3D distribution of SOC at a regional scale by combining kriging method with the profile depth function of SOC (KPDF), and to explore the effects of soil texture and land use type on vertical distribution of SOC in a fluvial plain. A total of 605 samples were collected from 121 soil profiles (0.0 to 1.0 m, 0.20 m increment) in Quzhou County, China and SOC contents were determined for each soil sample. The KPDF method was used to obtain the 3D map of SOC at the county scale. The results showed that the exponential equation well described the vertical distribution of mean values of the SOC contents. The coefficients of determination, root mean squared error and mean prediction error between the measured and the predicted SOC contents were 0.52, 1.82 and -0.24 g kg(-1) respectively, suggesting that the KPDF method could be used to produce a 3D map of SOC content. The surface SOC contents were high in the mid-west and south regions, and low values lay in the southeast corner. The SOC contents showed significant positive correlations between the five different depths and the correlations of SOC contents were larger in adjacent layers than in non-adjacent layers. Soil texture and land use type had significant effects on the spatial distribution of SOC. The influence of land use type was more important than that of soil texture in the surface soil, and soil texture played a more important role in influencing the SOC levels for 0.2-0.4 m layer.	[Chen, Chong; Hu, Kelin; Yun, Anping; Li, Baoguo] China Agr Univ, Dept Soil & Water Sci, Beijing 100193, Peoples R China; [Li, Hong] Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Haikou 571101, Peoples R China; [Li, Hong] Nova Scotia Agr Coll, Dept Plant & Anim Sci, Truro, NS B2N 5E3, Canada	China Agricultural University; Chinese Academy of Tropical Agricultural Sciences; Dalhousie University	Hu, KL (corresponding author), China Agr Univ, Dept Soil & Water Sci, 2 Yuan Ming Yuan Xi Lu, Beijing 100193, Peoples R China.	hukel@cau.edu.cn	Yun, Anping/AAN-3643-2020	Yun, Anping/0000-0001-5783-0492	National Natural Science Foundation of China [41171184]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (41171184) (study design).	Arthur E, 2014, EUR J SOIL SCI, V65, P218, DOI 10.1111/ejss.12121; Arweiler Nicole Birgit, 2014, BASIC LINEAR GEOSTAT, V18, P2129, DOI [10.1007/s00784-014-1193-6, 10.1007/s00449-014-1169-6]; BURKE IC, 1989, SOIL SCI SOC AM J, V53, P800, DOI 10.2136/sssaj1989.03615995005300030029x; Caspersen JP, 2000, SCIENCE, V290, P1148, DOI 10.1126/science.290.5494.1148; Castrignano A, 2002, SOIL TILL RES, V65, P95, DOI 10.1016/S0167-1987(01)00288-4; Celik I, 2005, SOIL TILL RES, V83, P270, DOI 10.1016/j.still.2004.08.001; Chen C, 2015, ENVIRON EARTH SCI, V73, P4339, DOI 10.1007/s12665-014-3720-9; DEUTSCH CV, 1998, GSLIB GEOSTAT SOFTWA; Dolan MS, 2006, SOIL TILL RES, V89, P221, DOI 10.1016/j.still.2005.07.015; Du ZL, 2010, SOIL SCI SOC AM J, V74, P196, DOI 10.2136/sssaj2009.0048; Fang X, 2012, CATENA, V88, P6, DOI 10.1016/j.catena.2011.07.012; Flores C, 2009, CHEMOSPHERE, V74, P1544, DOI 10.1016/j.chemosphere.2008.10.060; Government of Quzhou County, 2009, AGR YB QUZH COUNT; He Y, 2009, AUST J SOIL RES, V47, P622, DOI 10.1071/SR08218; Hu KL, 2014, GEODERMA, V226, P54, DOI 10.1016/j.geoderma.2014.03.001; Huang B, 2007, GEODERMA, V139, P336, DOI 10.1016/j.geoderma.2007.02.012; Lacoste M, 2014, GEODERMA, V213, P296, DOI 10.1016/j.geoderma.2013.07.002; Li HY, 2013, GEODERMA, V195, P31, DOI 10.1016/j.geoderma.2012.11.005; Li MM, 2013, CATENA, V101, P11, DOI 10.1016/j.catena.2012.09.012; Liu F, 2013, SOIL SCI SOC AM J, V77, P1241, DOI 10.2136/sssaj2012.0317; Liu TL, 2006, SOIL SCI SOC AM J, V70, P1200, DOI 10.2136/sssaj2005.0126; Malone BP, 2009, GEODERMA, V154, P138, DOI 10.1016/j.geoderma.2009.10.007; McGrath D, 2003, APPL GEOCHEM, V18, P1629, DOI 10.1016/S0883-2927(03)00045-3; Meersmans J, 2008, GEODERMA, V143, P1, DOI 10.1016/j.geoderma.2007.08.025; Meersmans J, 2009, GEODERMA, V152, P43, DOI 10.1016/j.geoderma.2009.05.015; Minasny B, 2006, AUST J SOIL RES, V44, P233, DOI 10.1071/SR05136; Mishra U, 2009, SOIL SCI SOC AM J, V73, P614, DOI 10.2136/sssaj2007.0410; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Rawls WJ, 2003, GEODERMA, V116, P61, DOI 10.1016/S0016-7061(03)00094-6; Six J, 2000, SOIL SCI SOC AM J, V64, P681, DOI 10.2136/sssaj2000.642681x; Soil Survey Staff, 2010, KEYS SOIL TAX; Van Meirvenne M, 2003, BIOL FERT SOILS, V37, P147; Veronesi F, 2012, SOIL TILL RES, V124, P111, DOI 10.1016/j.still.2012.05.009; Wang DD, 2010, PEDOSPHERE, V20, P525, DOI 10.1016/S1002-0160(10)60042-2; Wiesmeier M, 2012, GLOBAL CHANGE BIOL, V18, P2233, DOI 10.1111/j.1365-2486.2012.02699.x; Ye M, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006924; Yimer F, 2006, GEODERMA, V135, P335, DOI 10.1016/j.geoderma.2006.01.005; Zhang C, 2013, EUR J SOIL BIOL, V54, P16, DOI 10.1016/j.ejsobi.2012.10.007; Zhang SW, 2012, GEODERMA, V171, P35, DOI 10.1016/j.geoderma.2011.07.012; Zheng L, 2015, SOIL TILL RES, V145, P78, DOI 10.1016/j.still.2014.08.003; Zinn YL, 2005, GEODERMA, V127, P168, DOI 10.1016/j.geoderma.2005.02.010	41	16	17	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129038	10.1371/journal.pone.0129038	http://dx.doi.org/10.1371/journal.pone.0129038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047012	gold, Green Submitted, Green Published			2022-12-27	WOS:000355652200118
J	Lackey, B; Seas, C; Van der Stuyft, P; Otero, L				Lackey, Brian; Seas, Carlos; Van der Stuyft, Patrick; Otero, Larissa			Patient Characteristics Associated with Tuberculosis Treatment Default: A Cohort Study in a High-Incidence Area of Lima, Peru	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; RISK-FACTORS; ADHERENCE; PREDICTORS; STRATEGIES; 5-YEAR	Background Although tuberculosis (TB) is usually curable with antibiotics, poor adherence to medication can lead to increased transmission, drug resistance, and death. Prior research has shown several factors to be associated with poor adherence, but this problem remains a substantial barrier to global TB control. We studied patients in a high-incidence district of Lima, Peru to identify factors associated with premature termination of treatment (treatment default). Methods We conducted a prospective cohort study of adult smear-positive TB patients enrolled between January 2010 and December 2011 with no history of TB disease. Descriptive statistics and multivariable logistic regression analyses were performed to determine risk factors associated with treatment default. Results Of the 1233 patients studied, 127 (10%) defaulted from treatment. Patients who defaulted were more likely to have used illegal drugs (OR = 4.78, 95% CI: 3.05-7.49), have multidrug-resistant TB (OR = 3.04, 95% CI: 1.58-5.85), not have been tested for HIV (OR = 2.30, 95% CI: 1.50-3.54), drink alcohol at least weekly (OR = 2.22, 95% CI: 1.40-3.52), be underweight (OR = 2.08, 95% CI: 1.21-3.56), or not have completed secondary education (OR = 1.55, 95% CI: 1.03-2.33). Conclusions Our study identified several factors associated with defaulting from treatment, suggesting a complex set of causes that might lead to default. Addressing these factors individually would be difficult, but they might help to identify certain high-risk patients for supplemental	[Lackey, Brian] Univ Texas Austin, Sch Publ Hlth Austin, Austin, TX 78712 USA; [Seas, Carlos; Otero, Larissa] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Seas, Carlos] Univ Peruana Cayetano Heredia, Fac Med Alberto Hurtado, Lima, Peru; [Van der Stuyft, Patrick] Inst Trop Med, Dept Publ Hlth, Gen Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; [Van der Stuyft, Patrick] Univ Ghent, Fac Med, Dept Publ Hlth, B-9000 Ghent, Belgium	University of Texas System; University of Texas Austin; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Institute of Tropical Medicine (ITM); Ghent University	Lackey, B (corresponding author), Univ Texas Austin, Sch Publ Hlth Austin, Reg Campus, Austin, TX 78712 USA.	brianwlackey@gmail.com		Otero, Larissa/0000-0002-8348-4340; Seas, Carlos/0000-0001-7067-9141	Belgian Cooperation; Institute of Tropical Medicine in Antwerp, Belgium (FA3); Instituto de Medicina Tropical Alexander von Humboldt in Lima, Peru	Belgian Cooperation; Institute of Tropical Medicine in Antwerp, Belgium (FA3); Instituto de Medicina Tropical Alexander von Humboldt in Lima, Peru	This study was funded by the Belgian Cooperation (www.dg-d.be) through a project of institutional collaboration between the Institute of Tropical Medicine in Antwerp, Belgium (FA3) and the Instituto de Medicina Tropical Alexander von Humboldt in Lima, Peru. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS R H, 1960, Bull World Health Organ, V23, P463; [Anonymous], 1993, MMWR Recomm Rep, V42, P1; [Anonymous], 2011, TUB COUNTR PROF PER; Blackstone K, 2013, AIDS BEHAV, V17, P74, DOI 10.1007/s10461-012-0308-9; Brasil Pedro Emmanuel Alvarenga Americano do, 2008, Cad. Saúde Pública, V24, ps485, DOI 10.1590/S0102-311X2008001600003; Cayla JA, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-121; Chung-Delgado K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027610; Cramm JM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-72; Culqui DR, 2012, ARCH BRONCONEUMOL, V48, P150, DOI 10.1016/j.arbres.2011.12.008; DAWSON JJY, 1966, B WORLD HEALTH ORGAN, V34, P533; Finlay A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-56; FOX W, 1958, Tubercle, V39, P269, DOI 10.1016/S0041-3879(58)80088-4; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; Frieden T, 2004, TOMANS TUBERCULOSIS; Hasker E, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-97; Haynes RB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub3; ISEMAN MD, 1993, NEW ENGL J MED, V328, P576, DOI 10.1056/NEJM199302253280811; KAMAT SR, 1966, B WORLD HEALTH ORGAN, V34, P517; Keshavjee S, 2012, NEW ENGL J MED, V367, P931, DOI 10.1056/NEJMra1205429; Kruk ME, 2008, TROP MED INT HEALTH, V13, P703, DOI 10.1111/j.1365-3156.2008.02042.x; Kurbatova EV, 2012, TUBERCULOSIS, V92, P397, DOI 10.1016/j.tube.2012.06.003; Molfenter TD, 2012, PATIENT PREFER ADHER, V6, P643, DOI 10.2147/PPA.S34711; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Otero L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026276; PablosMendez A, 1997, AM J MED, V102, P164, DOI 10.1016/S0002-9343(96)00402-0; Sanders MJ, 2013, AM J OCCUP THER, V67, P91, DOI 10.5014/ajot.2013.005033; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20, DOI [10.1371/journal.pone.0108591, DOI 10.1371/JOURNAL.PONE.0108591]; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; Tuberculosis Chemotherapy Centre, 1959, Bull World Health Organ, V21, P51; Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1	31	27	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128541	10.1371/journal.pone.0128541	http://dx.doi.org/10.1371/journal.pone.0128541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046766	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200076
J	Li, Y; Chang, WQ; Zhang, M; Li, XB; Jiao, Y; Lou, HX				Li, Ying; Chang, Wenqiang; Zhang, Ming; Li, Xiaobin; Jiao, Yang; Lou, Hongxiang			Diorcinol D Exerts Fungicidal Action against Candida albicans through Cytoplasm Membrane Destruction and ROS Accumulation	PLOS ONE			English	Article							AMPHOTERICIN-B; CELL-DEATH; MITOCHONDRIAL; MECHANISMS; PATHWAY; EPIDEMIOLOGY; ENDOPHYTES; RESISTANCE; GROWTH; LEADS	Candida albicans, which is the most common human fungal pathogen, causes high mortality among immunocompromised patients. Antifungal drug resistance becomes a major challenge for the management of Candida infection. Diorcinol D (DD), a diphenyl ether derivative isolated from an endolichenic fungus, exerted fungicidal action against Candida species. In this study, we investigated the possible mechanism of its antifungal activity. The change of membrane dynamics and permeability suggested that the cell membrane was disrupted by the treatment of DD. This was further supported by the evidences of intracellular glycerol accumulation, alteration of cell ultrastructure, and down-regulation of genes involved in cell membrane synthesis. In addition, the treatment of Candida albicans with DD resulted in the elevation of reactive oxygen species (ROS), which caused the dysfunction of mitochondria. These altogether suggested that DD exerted its antifungal activity through cytoplasmic membrane destruction and ROS accumulation. This finding is helpful to uncover the underlying mechanisms for the diphenyl ether derivatives and provides a potential application in fighting clinical fungal infections.	[Li, Ying; Chang, Wenqiang; Zhang, Ming; Li, Xiaobin; Jiao, Yang; Lou, Hongxiang] Shandong Univ, Minist Educ, Key Lab Chem Biol, Dept Nat Prod Chem, Jinan 250100, Peoples R China	Shandong University	Lou, HX (corresponding author), Shandong Univ, Minist Educ, Key Lab Chem Biol, Dept Nat Prod Chem, 44 West Wenhua Rd, Jinan 250100, Peoples R China.	louhongxiang@sdu.edu.cn			Natural Scientific Foundation of China (NSFC) [81172956, 81273383, 81402804]	Natural Scientific Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Scientific Foundation of China (NSFC Nos, 81172956, 81273383, 81402804), http://www.nsfc.gov.cn/. The funder Hongxiang Lou conceived and designed the experiments for this manuscript.	Ahting U, 1999, J CELL BIOL, V147, P959, DOI 10.1083/jcb.147.5.959; Alonso-Valle H, 2003, EUR J CLIN MICROBIOL, V22, P254, DOI 10.1007/s10096-003-0890-x; Aly AH, 2010, FUNGAL DIVERS, V41, P1, DOI 10.1007/s13225-010-0034-4; BRAND MD, 1994, BBA-BIOENERGETICS, V1187, P132, DOI 10.1016/0005-2728(94)90099-X; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Brix J, 1999, J BIOL CHEM, V274, P16522, DOI 10.1074/jbc.274.23.16522; Chen L, 1982, PROBING MITOCHONDRIA, V123, P141; Choi H, 2012, BBA-BIOMEMBRANES, V1818, P1648, DOI 10.1016/j.bbamem.2012.02.026; Deray G, 2002, J ANTIMICROB CHEMOTH, V49, P37, DOI 10.1093/jac/49.suppl_1.37; Eisenberg T, 2007, APOPTOSIS, V12, P1011, DOI 10.1007/s10495-007-0758-0; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; FRASER VJ, 1992, CLIN INFECT DIS, V15, P414, DOI 10.1093/clind/15.3.414; Gerami-Nejad M, 2001, YEAST, V18, P859, DOI 10.1002/yea.738; Gregori C, 2007, EUKARYOT CELL, V6, P1635, DOI 10.1128/EC.00106-07; Halama P, 2004, BIOCONTROL, V49, P95, DOI 10.1023/B:BICO.0000009378.31023.ba; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Jones E. W., 1982, MOL BIOL YEAST SACCH, P181; Keilin D, 1936, PROC R SOC SER B-BIO, V121, P165, DOI 10.1098/rspb.1936.0056; KINOSITA K, 1981, BIOCHEMISTRY-US, V20, P4270, DOI 10.1021/bi00518a006; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Li L, 2014, ACTA PHARM SINICA; Li Y, 2015, FEMS YEAST RES; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Mishra Nagendra Nath, 2007, Acta Microbiologica et Immunologica Hungarica, V54, P201, DOI 10.1556/AMicr.54.2007.3.1; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nash TH., 1996, LICHEN BIOL; Newman DJ, 2008, J MED CHEM, V51, P2589, DOI 10.1021/jm0704090; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Phillips AJ, 2003, P NATL ACAD SCI USA, V100, P14327, DOI 10.1073/pnas.2332326100; Tan RX, 2001, NAT PROD REP, V18, P448, DOI 10.1039/b100918o; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Wang YY, 2013, CANCER LETT, V329, P207, DOI 10.1016/j.canlet.2012.10.042; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Wu XZ, 2010, BBA-GEN SUBJECTS, V1800, P439, DOI 10.1016/j.bbagen.2010.01.001; Wu XZ, 2009, BBA-GEN SUBJECTS, V1790, P770, DOI 10.1016/j.bbagen.2009.05.002; Wu XZ, 2008, ACTA PHARMACOL SIN, V29, P1478, DOI 10.1111/j.1745-7254.2008.00900.x; Zhang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028953; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	39	45	49	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128693	10.1371/journal.pone.0128693	http://dx.doi.org/10.1371/journal.pone.0128693			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047493	gold, Green Published, Green Submitted			2022-12-27	WOS:000355652200091
J	[Anonymous]				[Anonymous]			Adjustments of the Pesticide Risk Index Used in Environmental Policy in Flanders	PLOS ONE			English	Article							SURFACE WATERS; RESIDUES; LOSSES	Indicators are used to quantify the pressure of pesticides on the environment. Pesticide risk indicators typically require weighting environmental exposure by a no effect concentration. An indicator based on spread equivalents (Sigma Seq) is used in environmental policy in Flanders (Belgium). The pesticide risk for aquatic life is estimated by weighting active ingredient usage by the ratio of their maximum allowable concentration and their soil halflife. Accurate estimates of total pesticide usage in the region are essential in such calculations. Up to 2012, the environmental impact of pesticides was estimated on sales figures provided by the Federal Government. Since 2013, pesticide use is calculated based on results from the Farm Accountancy Data Network (FADN). The estimation of pesticide use was supplemented with data for non-agricultural use based on sales figures of amateur use provided by industry and data obtained from public services. The Seq-indicator was modified to better reflect reality. This method was applied for the period 2009-2012 and showed differences between estimated use and sales figures of pesticides. The estimated use of pesticides based on accountancy data is more accurate compared to sales figures. This approach resulted in a better view on pesticide use and its respective environmental impact in Flanders.							Flemish Environment Agency (VMM)	Flemish Environment Agency (VMM)	This study was financed by the Flemish Environment Agency (VMM). The funder played a role in study design and decision to publish.	Adriaanse PI, 1997, SURFACE WATER MODELS; [Anonymous], OFFICIAL J EUROPEA L; [Anonymous], 2008, COMMISSION REGULATIO, VL250, P1; [Anonymous], 2009, OFFICIAL J EUROPEA L, V309/71, DOI DOI 10.3000/17252555.L_2009.309.ENG; [Anonymous], 2011, OFFICIAL J EUROPEA L, V180, P3; Bedos C, 2002, AGRONOMIE, V22, P21, DOI 10.1051/agro:2001003; Beernaerts S, 2005, INT J ENVIRON AN CH, V85, P41, DOI 10.1080/0306731042000303143; Carter A., 2000, Pesticide Outlook, V11, P149, DOI 10.1039/b006243j; Claeys D, 2005, BEPALING VERBRUIK GE; Claeys S, 2007, MILIEURAPPORT VLAAND; Council Directive 91/414/EE, 1991, OFFICIAL J L, V230; Darvas B, 1998, APPL AGR, P188; De Kraker J, 1994, TEELT SLA HAAR SOORT, V63; De Moel CP, 1993, TEELT VAN BLOEMKOOL; De Smet B, 2005, CROP PROT, V24, P363, DOI 10.1016/j.cropro.2004.09.005; De Smet B, 2002, MIRA200202 U GENT VA; De Wilde T, 2007, PEST MANAG SCI, V63, P111, DOI 10.1002/ps.1323; Dutry C, 2013, GEZINSWEEKBLAD BOND; EC (European Commission), AGR RUR DEV FARM ACC; Fytoweb, 2012, LIJST BELG ERK BESTR; Gray SM, 1996, CROP PROT, V15, P687, DOI 10.1016/S0261-2194(96)00040-3; Huber A, 1998, SCI TOTAL ENVIRON, V223, P177, DOI 10.1016/S0048-9697(98)00314-3; Lenders S., 2013, GEBRUIK ENERGIE GEWA; Lenders S, 2010, MILIEUDRUK VANUIT LA; Lenders S., 2012, BODEMBALANS VLAAMSE; LNE, ACT MIL 2003 2007 PE; Nault BA, 2004, CROP PROT, V23, P147, DOI 10.1016/j.cropro.2003.08.002; Niemeijer D, 2008, ECOL INDIC, V8, P14, DOI 10.1016/j.ecolind.2006.11.012; Niemeijer David, 2008, Environment Development and Sustainability, V10, P89, DOI 10.1007/s10668-006-9040-9; Nuyttens D, 2013, PEST MANAG SCI, V69, P564, DOI 10.1002/ps.3485; Pannecoucque J, 2013, BELGISCHE BESCHRIJVE; Peeters B, 2010, MILIEU EN NATUURRAPP; Pussemier L, 1997, LANDBOUW TOEGEPASTE, V62, P157; Reichenberger S, 2007, SCI TOTAL ENVIRON, V384, P1, DOI 10.1016/j.scitotenv.2007.04.046; Schulz R, 2002, ENVIRON TOXICOL CHEM, V21, P2172, DOI [10.1002/etc.5620211021, 10.1897/1551-5028(2002)021&lt;2172:ACMAFA&gt;2.0.CO;2]; Smeets E., 1999, 25 EUR ENV AG; Snoek NJ, 1987, TEELT AND; Taylor AG, 2001, HORTSCIENCE, V36, P199, DOI 10.21273/HORTSCI.36.2.199; Van den Bossche A, 2002, MIRA200205; Van den Bossche A, 2003, ONDERZOEK NAAR GEBRU; Vanparijs L, 1986, DE TEELT VAN PREI; Vercruysse F, 2002, CROP PROT, V21, P307, DOI 10.1016/S0261-2194(01)00102-8; Volksgezondheid FOD Veiligheid van de Voedselketen en Leefmilie. Directoraat Generaal Dier Plant en voeding: Dienst Pesticiden en Meststoffen, 2009, GIDS AANV ERK PROD A; Vryzas Z, 2009, WATER RES, V43, P1, DOI 10.1016/j.watres.2008.09.021; Vryzas Z, 2011, ECOTOX ENVIRON SAFE, V74, P174, DOI 10.1016/j.ecoenv.2010.04.011; Wustenberghs H, 2012, PEST MANAG SCI, V68, P1130, DOI 10.1002/ps.3332; OFFICIAL J EUROPEA L, V327	47	2	2	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129669	10.1371/journal.pone.0129669	http://dx.doi.org/10.1371/journal.pone.0129669			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046655	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200165
J	Hu, RF; Huang, XS; Huang, JK; Li, YF; Zhang, C; Yin, Y; Chen, ZH; Jin, YH; Cai, JY; Cui, F				Hu, Ruifa; Huang, Xusheng; Huang, Jikun; Li, Yifan; Zhang, Chao; Yin, Yanhong; Chen, Zhaohui; Jin, Yanhong; Cai, Jinyang; Cui, Fang			Long- and Short-Term Health Effects of Pesticide Exposure: A Cohort Study from China	PLOS ONE			English	Article							TOTAL NEUROPATHY SCORE; OCCUPATIONAL-EXPOSURE; FARM-WORKERS; ORGANOPHOSPHATE; APPLICATORS; CANCER; NEUROTOXICITY; SYMPTOMS; COTTON; RISK	Pesticides are extensively used by farmers in China. However, the effects of pesticides on farmers' health have not yet been systematically studied. This study evaluated the effects of pesticides exposure on hematological and neurological indicators over 3 years and 10 days respectively. A cohort of 246 farmers was randomly selected from 3 provinces (Guangdong, Jiangxi, and Hebei) in China. Two rounds of health investigations, including blood tests and neurological examinations, were conducted by medical doctors before and after the crop season in 2012. The data on pesticide use in 2009-2011 were collected retrospectively via face-to-face interviews and the 2012 data were collected from personal records maintained by participants prospectively. Ordinary least square (OLS), Probit, and fixed effect models were used to evaluate the relationship between pesticides exposure frequency and the health indicators. Long-term pesticide exposure was found to be associated with increased abnormality of nerve conductions, especially in sensory nerves. It also affected a wide spectrum of health indicators based on blood tests and decreased the tibial nerve compound muscle action potential amplitudes. Short-term health effects included alterations in complete blood count, hepatic and renal functions, and nerve conduction velocities and amplitudes. However, these effects could not be detected after 3 days following pesticide exposure. Overall, our results demonstrate that pesticide exposure adversely affects blood cells, the liver, and the peripheral nervous system. Future studies are needed to elucidate the specific effects of each pesticide and the mechanisms of these effects.	[Hu, Ruifa; Zhang, Chao; Cai, Jinyang] Beijing Inst Technol, Sch Management & Econ, Beijing 100081, Peoples R China; [Huang, Xusheng; Li, Yifan; Yin, Yanhong; Chen, Zhaohui; Cui, Fang] Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing 100853, Peoples R China; [Huang, Jikun] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Ctr Chinese Agr Policy, Beijing, Peoples R China; [Jin, Yanhong] Rutgers State Univ, Dept Agr Food & Resource Econ, New Brunswick, NJ 08903 USA	Beijing Institute of Technology; Chinese People's Liberation Army General Hospital; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Rutgers State University New Brunswick	Hu, RF (corresponding author), Beijing Inst Technol, Sch Management & Econ, Beijing 100081, Peoples R China.	ruifa@bit.edu.cn; lewish301@sina.com; jkhuang.ccap@igsnrr.ac.cn	Zhang, Chao/ABH-9758-2020	Zhang, Chao/0000-0003-2882-9374	National Natural Sciences Foundation in China [71173014, 71210004]; International Development Research Center [106160-002]	National Natural Sciences Foundation in China(National Natural Science Foundation of China (NSFC)); International Development Research Center	This work was supported by the National Natural Sciences Foundation in China (71173014 and 71210004, http://www.nsfc.gov.cn/, RH) and International Development Research Center (106160-002, http://www.idrc.ca/EN/Pages/default.aspx, RH).	Alavanja MCR, 2004, ANNU REV PUBL HEALTH, V25, P155, DOI 10.1146/annurev.publhealth.25.101802.123020; Albers JW, 2004, MUSCLE NERVE, V29, P677, DOI 10.1002/mus.20007; Cavaletti G, 2007, J PERIPHER NERV SYST, V12, P210, DOI 10.1111/j.1529-8027.2007.00141.x; Cornblath DR, 1999, NEUROLOGY, V53, P1660, DOI 10.1212/WNL.53.8.1660; Eissa FI, 2010, ACTA BIOL HUNG, V61, P33, DOI 10.1556/ABiol.61.2010.1.4; EKSTROM G, 1990, REV ENVIRON CONTAM T, V114, P23; Engel LS, 1998, ARCH ENVIRON HEALTH, V53, P7, DOI 10.1080/00039899809605684; Fareed M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069755; Hayden KM, 2010, NEUROLOGY, V74, P1524, DOI 10.1212/WNL.0b013e3181dd4423; Hossain F, 2004, INT J OCCUP ENV HEAL, V10, P296, DOI 10.1179/oeh.2004.10.3.296; Huang JK, 2002, AUST J AGR RESOUR EC, V46, P367, DOI 10.1079/9780851996189.0393; Jaggi AS, 2012, TOXICOLOGY, V291, P1, DOI 10.1016/j.tox.2011.10.019; Jamal GA, 2002, OCCUP ENVIRON MED, V59, P434, DOI 10.1136/oem.59.7.434; Jayasinghe SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049405; Kamel F, 2005, ENVIRON HEALTH PERSP, V113, P877, DOI 10.1289/ehp.7645; Karami-Mohajeri S, 2011, HUM EXP TOXICOL, V30, P1119, DOI 10.1177/0960327110388959; London L, 1998, SCAND J WORK ENV HEA, V24, P18, DOI 10.5271/sjweh.274; Lotti M, 2002, MUSCLE NERVE, V25, P492, DOI 10.1002/mus.10086; Merhi M, 2007, CANCER CAUSE CONTROL, V18, P1209, DOI 10.1007/s10552-007-9061-1; Mondal S, 2012, TOXICOL IND HEALTH, V28, P422, DOI 10.1177/0748233711413800; Moretto A, 1998, J NEUROL NEUROSUR PS, V64, P463, DOI 10.1136/jnnp.64.4.463; Naylor R. L., 1997, Nature's services: societal dependence on natural ecosystems., P151; Oerke EC, J AGR SCI, V144, P31; Payan-Renteria R, 2012, ARCH ENVIRON OCCUP H, V67, P22, DOI 10.1080/19338244.2011.564230; Peshin Rajinder, 2009, P1, DOI 10.1007/978-1-4020-8992-3_1; PIMENTEL D, 1992, BIOSCIENCE, V42, P354, DOI 10.2307/1311782; Pingali P, 1995, IMPACT PESTICIDES FA; Qiao FB, 2012, CHINA AGR ECON REV, V4, P468, DOI 10.1108/17561371211284821; ROSENSTOCK L, 1991, LANCET, V338, P223, DOI 10.1016/0140-6736(91)90356-T; Starks SE, 2012, ENVIRON HEALTH PERSP, V120, P515, DOI 10.1289/ehp.1103944; Steenland K, 2000, ENVIRON HEALTH PERSP, V108, P293, DOI 10.2307/3454346; STOKES L, 1995, OCCUP ENVIRON MED, V52, P648, DOI 10.1136/oem.52.10.648; Zhang WenJun, 2011, Proceedings of the International Academy of Ecology and Environmental Sciences, V1, P125	33	47	51	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128766	10.1371/journal.pone.0128766	http://dx.doi.org/10.1371/journal.pone.0128766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042669	Green Published, gold			2022-12-27	WOS:000355701600065
J	Liu, CY; Mei, WJ; Tang, J; Yuan, QJ; Huang, L; Lu, MM; Wu, L; Peng, ZZ; Meng, J; Yang, HX; Shen, H; Lv, B; Hu, GY; Tao, LJ				Liu, Chunyan; Mei, Wenjuan; Tang, Juan; Yuan, Qiongjing; Huang, Ling; Lu, Miaomiao; Wu, Lin; Peng, Zhangzhe; Meng, Jie; Yang, Huixiang; Shen, Hong; Lv, Ben; Hu, Gaoyun; Tao, Lijian			Mefunidone Attenuates Tubulointerstitial Fibrosis in a Rat Model of Unilateral Ureteral Obstruction	PLOS ONE			English	Article							INTERSTITIAL FIBROSIS; RENAL-FUNCTION; PIRFENIDONE; CELLS; TRANSCRIPTION; NEPHROPATHY; EXPRESSION; INJURY; INFLAMMATION; ACTIVATION	Background Inflammation has a crucial role in renal interstitial fibrosis, which is the common pathway of chronic kidney diseases. Mefunidone (MFD) is a new compound which could effectively inhibit the proliferation of renal fibroblasts in vitro. However, the overall effect of Mefunidone in renal fibrosis remains unknown. Methods Sprague-Dawley rats were randomly divided intro 6 groups: sham operation, unilateral ureteral obstruction (UUO), UUO/Mefunidone (25, 50, 100mg/kg/day) and UUO/PFD (500mg/kg/day). The rats were sacrificed respectively on days 3, 7, and 14 after the operation. Tubulointerstitial injury index, interstitial collagen deposition, expression of fibronectin (FN), alpha-smooth muscle actin (alpha-SMA), type I and III collagen and the number of CD3+ and CD68+ cells were determined. The expressions of proinflammatory cytokines, p-ERK, p-I kappa B, and p-STAT3 were measured in human renal proximal tubular epithelial cells of HK-2 or macrophages. Results Mefunidone treatment significantly attenuated tubulointerstitial injury, interstitial collagen deposition, expression of FN, alpha-SMA, type I and III collagen in the obstructive kidneys, which correlated with significantly reduced the number of T cells and macrophages in the obstructive kidneys. Mechanistically, Mefunidone significantly inhibited tumor necrosis factor- alpha(TNF-alpha) or lipopolysaccharide (LPS)-induced production of proinflammatory cytokines. This effect is possibly due to the inhibition of phosphorylation of ERK, I kappa B, and STAT3. Conclusion Mefunidone treatment attenuated tubulointerstitial fibrosis in a rat model of UUO, at least in part, through inhibition of inflammation.	[Liu, Chunyan; Mei, Wenjuan; Tang, Juan; Yuan, Qiongjing; Huang, Ling; Lu, Miaomiao; Wu, Lin; Peng, Zhangzhe; Tao, Lijian] Cent S Univ, Xiangya Hosp, Dept Nephrol, Changsha, Hunan, Peoples R China; [Liu, Chunyan] Hunan Univ Chinese Med, Dept Pathol, Changsha, Hunan, Peoples R China; [Meng, Jie] Cent S Univ, Xiangya Hosp, Dept Respirat, Changsha, Hunan, Peoples R China; [Yang, Huixiang] Cent S Univ, Xiangya Hosp, Dept Gastroenterol, Changsha, Hunan, Peoples R China; [Shen, Hong] Cent S Univ, Xiangya Hosp, Inst Med Sci, Changsha, Hunan, Peoples R China; [Lv, Ben] Cent S Univ, Xiangya Hosp 3, Dept Hematol, Changsha, Hunan, Peoples R China; [Hu, Gaoyun] Cent S Univ, Sch Pharmaceut Sci, Dept Med Chem, Changsha, Hunan, Peoples R China; [Tao, Lijian] Cent S Univ, State Key Lab Med Genet China, Changsha, Hunan, Peoples R China	Central South University; Hunan University of Chinese Medicine; Central South University; Central South University; Central South University; Central South University; Central South University; Central South University	Tao, LJ (corresponding author), Cent S Univ, Xiangya Hosp, Dept Nephrol, Changsha, Hunan, Peoples R China.	taolj@csu.edu.cn	Shen, Hong/N-9734-2019; TAO, Li/HIR-4254-2022	Shen, Hong/0000-0002-6456-8231; 	Doctoral Foundation of the Ministry of Education of China [20120162130001]; National Natural Science Foundation of China [81273575, 21172268, 81300610]; major new-drug developing fund of National Science and Technology Foundation of China [2012ZX09103101]	Doctoral Foundation of the Ministry of Education of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); major new-drug developing fund of National Science and Technology Foundation of China	This project was supported by: the Doctoral Foundation of the Ministry of Education of China (grant no. 20120162130001), the National Natural Science Foundation of China (grant no. 81273575), the National Natural Science Foundation of China (grant no. 21172268), the major new-drug developing fund of the National Science and Technology Foundation of China (2012ZX09103101), and the National Natural Science Foundation of China (grant no. 81300610). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, NAT REV DRUG DISCOV, V7, DOI 10.1038/nrd2767; Bascands JL, 2005, KIDNEY INT, V68, P925, DOI 10.1111/j.1523-1755.2005.00486.x; Boyun Wang Y.L.G.H., 2001, PATHOLOGICAL TECHNIQ, P144; Broekema M, 2007, J AM SOC NEPHROL, V18, P165, DOI 10.1681/ASN.2005070730; Chatziantoniou C, 2008, CURR OPIN NEPHROL HY, V17, P76, DOI 10.1097/MNH.0b013e3282f1bb69; de Souza JAC, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/650812; Cho ME, 2007, CLIN J AM SOC NEPHRO, V2, P906, DOI 10.2215/CJN.01050207; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Gasser M, 2002, J AM SOC NEPHROL, V13, P1937, DOI 10.1097/01.ASN.0000019401.12257.C4; Holdsworth SR, 2008, J AM SOC NEPHROL, V19, P2254, DOI 10.1681/ASN.2008010015; Huang L, 2012, INFLAMMATION, V35, P1154, DOI 10.1007/s10753-011-9423-4; Ishidoya S, 1996, KIDNEY INT, V49, P1110, DOI 10.1038/ki.1996.161; John R, 2007, J AM SOC NEPHROL, V18, P2628, DOI 10.1681/ASN.2007030273; Kelly CJ, 1999, SEMIN NEPHROL, V19, P182; Kitamura H, 2008, NEPHROL DIAL TRANSPL, V23, P1521, DOI 10.1093/ndt/gfm842; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Kovarik P, 2001, EMBO J, V20, P91, DOI 10.1093/emboj/20.1.91; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; LeBleu VS, 2008, LAB INVEST, V88, P284, DOI 10.1038/labinvest.3700715; Li BX, 2011, MOL CELL BIOCHEM, V354, P263, DOI 10.1007/s11010-011-0826-1; Lin SL, 2005, J AM SOC NEPHROL, V16, P2702, DOI 10.1681/ASN.2005040435; Luo C-J., 2009, CLIN MED ENG, V16, P15; Matsui F, 2012, J SURG RES, V178, P339, DOI 10.1016/j.jss.2012.06.050; Misseri R, 2004, J UROLOGY, V172, P1595, DOI 10.1097/01.ju.0000138902.57626.70; Ning WB, 2011, INT IMMUNOPHARMACOL, V11, P1327, DOI 10.1016/j.intimp.2011.04.016; Pang MY, 2009, AM J PHYSIOL-RENAL, V297, pF996, DOI 10.1152/ajprenal.00282.2009; Peng ZZ, 2009, NEPHROLOGY, V14, P565, DOI 10.1111/j.1440-1797.2009.01129.x; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Radford MG, 1997, J AM SOC NEPHROL, V8, P199; Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; Sean Eardley K, 2005, KIDNEY INT, V68, P437, DOI 10.1111/j.1523-1755.2005.00422.x; Sharma K, 2011, J AM SOC NEPHROL, V22, P1144, DOI 10.1681/ASN.2010101049; Shimizu T, 1998, KIDNEY INT, V54, P99, DOI 10.1046/j.1523-1755.1998.00962.x; Tang YT, 2008, INT IMMUNOPHARMACOL, V8, P1646, DOI 10.1016/j.intimp.2008.07.014; Vielhauer V, 2004, KIDNEY INT, V66, P2264, DOI 10.1111/j.1523-1755.2004.66038.x; Wada T, 2007, KIDNEY INT, V72, P269, DOI 10.1038/sj.ki.5002325; Wamsley-Davis A, 2004, AM J PHYSIOL-RENAL, V287, pF474, DOI 10.1152/ajprenal.00452.2003; Wang L, 2009, PHARMAZIE, V64, P680, DOI 10.1691/ph.2009.9525; Wang LH, 2011, PHARMACOLOGY, V88, P88, DOI 10.1159/000329419; Xaubet A, 2014, EXPERT OPIN PHARMACO, V15, P275, DOI 10.1517/14656566.2014.867328; Yuan QJ, 2011, PHARMAZIE, V66, P961, DOI 10.1691/ph.2011.1535; Yuan QJ, 2011, AM J NEPHROL, V34, P181, DOI 10.1159/000329080; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang XH, 2003, AM J PHYSIOL-RENAL, V284, pF82, DOI 10.1152/ajprenal.00200.2002	46	23	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0129283	10.1371/journal.pone.0129283	http://dx.doi.org/10.1371/journal.pone.0129283			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042668	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600095
J	Yao, Y; Huang, J; Geng, YJ; Qian, HY; Wang, F; Liu, XH; Shang, MS; Nie, SP; Liu, NA; Du, X; Dong, JZ; Ma, CS				Yao, Yan; Huang, Ji; Geng, Yongjian; Qian, Haiyan; Wang, Fan; Liu, Xiaohui; Shang, Meisheng; Nie, Shaoping; Liu, Nian; Du, Xin; Dong, Jianzeng; Ma, Changsheng			Paracrine Action of Mesenchymal Stem Cells Revealed by Single Cell Gene Profiling in Infarcted Murine Hearts	PLOS ONE			English	Article							BONE-MARROW; MYOCARDIAL-INFARCTION; PROGENITOR CELLS; GROWTH-FACTOR; CARDIAC PROTECTION; IMPROVES SURVIVAL; ISCHEMIC-HEART; DOUBLE-BLIND; IN-VITRO; ACTIVATION	Background Mesenchymal stem cells (MSCs) have been recently demonstrated as a promising stem cell type to rescue damaged myocardium after acute infarction. One of the most important mechanisms underlying their therapeutic effects is the secretion of paracrine factors. However, the expression profile of paracrine factors of MSCs in infarcted hearts, especially at single cell level, is poorly defined. Methods and Results We aimed to depict the transcriptional profile of paracrine factors secreted by MSCs in vivo, with particular interest in the comparison between normal and infarcted hearts. Bone marrow mesenchymal stem cells were isolated and injected into mice hearts immediately after infarction surgery. Bioluminescence imaging (BLI) indicated a proportion of cells still alive even up to 10 days post surgery. Paralleled with survived cells, cardiac function was significantly improved after MSC injection compared to that in PBS-injected mice, indicated by MRI and histology. Despite increased number of vessels in MSC-injected hearts, endothelial cells and cardiomyocytes transdifferentiation were not observed in infarcted hearts 5 days after infarction. Furthermore, laser capture microdissection (LCM) followed by high through-put real time PCR was employed in our study, uncovering that the injected MSCs, compared to local cardiomyocytes, displayed elevated levels of secreted factors. To further investigate the regulation of those factors, we performed single cell analysis to dissect the gene expression profile of MSCs at single cell level in infarcted and normal hearts, respectively. Consistent with the in vivo observation, a similar regulation pattern of those factors was detected in cultured MSCs under hypoxia. Conclusions Our study, for the first time, elucidated gene expression profiles, as well as regulation of paracrine factors, of MSCs at single cell level in vivo, indicating that paracrine factors from MSCs account for the improvement of cardiac function after infarction.	[Yao, Yan; Huang, Ji; Liu, Xiaohui; Shang, Meisheng; Liu, Nian; Du, Xin; Dong, Jianzeng; Ma, Changsheng] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Cardiol, Beijing, Peoples R China; [Geng, Yongjian] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Internal Med, Ctr Cardiovasc Biol & Atherosclerosis, Houston, TX 77030 USA; [Qian, Haiyan] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Ctr Coronary Heart Dis,Dept Cardiol,State Key Lab, Beijing 100730, Peoples R China; [Qian, Haiyan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Fan] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Nie, Shaoping] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Emergency & Crit Care Ctr, Beijing, Peoples R China	Capital Medical University; University of Texas System; University of Texas Health Science Center Houston; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Pennsylvania; Capital Medical University	Yao, Y (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Cardiol, Beijing, Peoples R China.	iceyaya614@163.com	Nie, S/K-1124-2019; Liu, Nian/M-5808-2019	Dong, Jianzeng/0000-0001-7299-7805; WANG, FAN/0000-0001-9806-5037	National Natural Science Foundation of China [81200141, 81070091, 81000130, 81000091]; Beijing Novel Program [2011081, Z131103000413116]; Program of International S&T Cooperation Project of China [2013DFB30310]; "973" National Program on Key Basic Research Project of China [2013CB531105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Novel Program(Beijing Municipal Science & Technology Commission); Program of International S&T Cooperation Project of China; "973" National Program on Key Basic Research Project of China	2 This work was supported by grants from the National Natural Science Foundation of China (No. 81200141, 81070091, 81000130, 81000091), Beijing Novel Program (No. 2011081, Z131103000413116), Program of International S&T Cooperation Project of China (No. 2013DFB30310) and "973" National Program on Key Basic Research Project of China (No. 2013CB531105).	Aicher A, 2003, CIRCULATION, V107, P2134, DOI 10.1161/01.CIR.0000062649.63838.C9; Burchfield JS, 2008, CIRC RES, V103, P203, DOI 10.1161/CIRCRESAHA.108.178475; Cantoni S, 2012, PHARMACOL RES, V65, P275, DOI 10.1016/j.phrs.2011.12.004; Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680; Fang J, 2011, J MOL CELL CARDIOL, V51, P839, DOI 10.1016/j.yjmcc.2011.06.013; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Haynesworth SE, 1996, J CELL PHYSIOL, V166, P585, DOI 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Imanishi Y, 2008, J MOL CELL CARDIOL, V44, P662, DOI 10.1016/j.yjmcc.2007.11.001; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Ohnishi S, 2007, STEM CELLS, V25, P1166, DOI 10.1634/stemcells.2006-0347; Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Rubakhin SS, 2011, NAT METHODS, V8, pS20, DOI [10.1038/NMETH.1549, 10.1038/nmeth.1549]; Schuleri KH, 2009, EUR HEART J, V30, P2722, DOI 10.1093/eurheartj/ehp265; Shabbir A, 2010, AM J PHYSIOL-HEART C, V299, pH1428, DOI 10.1152/ajpheart.00488.2010; Takahashi M, 2006, AM J PHYSIOL-HEART C, V291, pH886, DOI 10.1152/ajpheart.00142.2006; Trachtenberg B, 2011, AM HEART J, V161, P487, DOI 10.1016/j.ahj.2010.11.024; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; van der Spoel TIG, 2011, CARDIOVASC RES, V91, P649, DOI 10.1093/cvr/cvr113; Wang XH, 2009, STEM CELLS, V27, P3021, DOI 10.1002/stem.230; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Williams AR, 2011, CIRC RES, V108, P792, DOI 10.1161/CIRCRESAHA.111.242610; Windmolders S, 2014, J MOL CELL CARDIOL, V66, P177, DOI 10.1016/j.yjmcc.2013.11.016; Xu MF, 2007, J MOL CELL CARDIOL, V42, P441, DOI 10.1016/j.yjmcc.2006.10.009; Yang YJ, 2008, EUR HEART J, V29, P1578, DOI 10.1093/eurheartj/ehn167; Yang YJ, 2009, ARTERIOSCL THROM VAS, V29, P2076, DOI 10.1161/ATVBAHA.109.189662; Zisa D, 2011, AM J PHYSIOL-HEART C, V301, pH2422, DOI 10.1152/ajpheart.00343.2011	35	46	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0129164	10.1371/journal.pone.0129164	http://dx.doi.org/10.1371/journal.pone.0129164			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043119	Green Submitted, gold, Green Published			2022-12-27	WOS:000355701600091
J	Chebat, DR; Maidenbaum, S; Amedi, A				Chebat, Daniel-Robert; Maidenbaum, Shachar; Amedi, Amir			Navigation Using Sensory Substitution in Real and Virtual Mazes	PLOS ONE			English	Article							VISUAL EXPERIENCE; VISION-SUBSTITUTION; PATH-INTEGRATION; BLIND; REPRESENTATION; PERCEPTION; SPACE; REHABILITATION; LOCALIZATION; ENVIRONMENT	Under certain specific conditions people who are blind have a perception of space that is equivalent to that of sighted individuals. However, in most cases their spatial perception is impaired. Is this simply due to their current lack of access to visual information or does the lack of visual information throughout development prevent the proper integration of the neural systems underlying spatial cognition? Sensory Substitution devices (SSDs) can transfer visual information via other senses and provide a unique tool to examine this question. We hypothesize that the use of our SSD (The EyeCane: a device that translates distance information into sounds and vibrations) can enable blind people to attain a similar performance level as the sighted in a spatial navigation task. We gave fifty-six participants training with the EyeCane. They navigated in real life-size mazes using the EyeCane SSD and in virtual renditions of the same mazes using a virtual-EyeCane. The participants were divided into four groups according to visual experience: congenitally blind, low vision & late blind, blindfolded sighted and sighted visual controls. We found that with the EyeCane participants made fewer errors in the maze, had fewer collisions, and completed the maze in less time on the last session compared to the first. By the third session, participants improved to the point where individual trials were no longer significantly different from the initial performance of the sighted visual group in terms of errors, time and collision.	[Chebat, Daniel-Robert; Maidenbaum, Shachar; Amedi, Amir] Hebrew Univ Jerusalem, Fac Med, Inst Med Res Israel Canada, Dept Med Neurobiol, Jerusalem, Israel; [Chebat, Daniel-Robert; Maidenbaum, Shachar; Amedi, Amir] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Res, Jerusalem, Israel; [Chebat, Daniel-Robert] Ariel Univ, Dept Behav Sci, Ariel, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Ariel University	Chebat, DR (corresponding author), Hebrew Univ Jerusalem, Fac Med, Inst Med Res Israel Canada, Dept Med Neurobiol, Jerusalem, Israel.	danielc@ariel.ac.il	Chebat, Daniel-Robert/AAG-5664-2019; Maidenbaum, Shachar/K-4277-2019; Chebat, Daniel-Robert/L-1840-2019	Chebat, Daniel-Robert/0000-0003-1252-9393; Maidenbaum, Shachar/0000-0002-2078-3896; Amedi, Amir/0000-0001-5042-2533	European Research Council grant [310809]; Charitable Gatsby Foundation; James S. McDonnell Foundation Scholar Award [220020284]; Israel Science Foundation [ISF 1684/08]; Edmond and Lily Safra Center for Brain Sciences (ELSC) Vision center grant; Azrieli International Post-Doctoral Fellows Program	European Research Council grant(European Research Council (ERC)); Charitable Gatsby Foundation; James S. McDonnell Foundation Scholar Award; Israel Science Foundation(Israel Science Foundation); Edmond and Lily Safra Center for Brain Sciences (ELSC) Vision center grant; Azrieli International Post-Doctoral Fellows Program	This work was supported by a European Research Council grant (grant number 310809); The Charitable Gatsby Foundation; The James S. McDonnell Foundation Scholar Award (to AA: grant number 220020284); The Israel Science Foundation (grant number ISF 1684/08); The Edmond and Lily Safra Center for Brain Sciences (ELSC) Vision center grant (AA, SM and DRC). The authors also wish to thank the Maratier family for its generosity and support to this research. DRC was funded by the Azrieli International Post-Doctoral Fellows Program. The authors thank the Optical Center Jerusalem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud S, 2014, RESTOR NEUROL NEUROS, V32, P247, DOI 10.3233/RNN-130338; Amedi A, 2007, NAT NEUROSCI, V10, P687, DOI 10.1038/nn1912; BACH P, 1969, NATURE, V221, P963, DOI 10.1038/221963a0; BACHYRITA P, 1970, MED BIOL ILLUS, V20, P6; Buchs G, 2014, OBSTACLE IDENTIFICAT; Cecchetti L, 2015, BRAIN STRUCT FUNCT, DOI [10.1016/j.bbr.2015.01.037, DOI 10.1016/J.BBR.2015.01.037]; Chandler E, 2013, APPL ERGON, V44, P919, DOI 10.1016/j.apergo.2013.03.030; Chebat DR, 2007, NEUROREPORT, V18, P1901, DOI 10.1097/WNR.0b013e3282f2a63; Chebat DR, 2007, NEUROREPORT, V18, P329, DOI 10.1097/WNR.0b013e32802b70f8; Chebat DR, 2011, NEUROREPORT, V22, P342, DOI 10.1097/WNR.0b013e3283462def; Collignon O, 2007, CEREB CORTEX, V17, P457, DOI 10.1093/cercor/bhj162; CONNORS EC, 2014, FRONT HUM NEUROSCI, V8, DOI DOI 10.3389/FNHUM; Gagnon L, 2010, NEUROREPORT, V21, P989, DOI 10.1097/WNR.0b013e32833eaaf9; Gallace A, 2009, PSYCHOL BULL, V135, P380, DOI 10.1037/a0015325; Giudice NA, 2013, EXP BRAIN RES, V224, P141, DOI 10.1007/s00221-012-3295-1; Giudice NA, 2011, J EXP PSYCHOL LEARN, V37, P621, DOI 10.1037/a0022331; Gori M, 2014, BRAIN, V137, P288, DOI 10.1093/brain/awt311; Gori M, 2010, CURR BIOL, V20, P223, DOI 10.1016/j.cub.2009.11.069; Hebb DO, 1946, J GEN PSYCHOL, V34, P59, DOI 10.1080/00221309.1946.10544520; Iachini T, 2010, PERCEPTION, V39, P953, DOI 10.1068/p6457; KING AJ, 1993, EXP BRAIN RES, V94, P444; King AJ, 2009, PHILOS T R SOC B, V364, P331, DOI 10.1098/rstb.2008.0230; KNUDSEN EI, 1985, SCIENCE, V230, P545, DOI 10.1126/science.4048948; Kupers R, 2010, P NATL ACAD SCI USA, V107, P12716, DOI 10.1073/pnas.1006199107; Lacey S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00730; Lahav O, 2006, CYBERPSYCHOL BEHAV, V9, P174, DOI 10.1089/cpb.2006.9.174; Lahav O, 2012, DISABIL REHABIL-ASSI, V7, P420, DOI 10.3109/17483107.2011.635327; Lepore N, 2009, NEUROIMAGE, V46, P949, DOI 10.1016/j.neuroimage.2009.01.071; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; Loomis JM, 2012, ATTEN PERCEPT PSYCHO, V74, P1260, DOI 10.3758/s13414-012-0311-2; LOOMIS JM, 1993, J EXP PSYCHOL GEN, V122, P73, DOI 10.1037/0096-3445.122.1.73; Loomis JM, 2012, MULTISENSORY IMAGERY, DOI [10.1016/j.addbeh.2013.11.023, DOI 10.1016/J.ADDBEH.2013.11.023]; Maidenbaum S, 2014, RESTOR NEUROL NEUROS, V32, P813, DOI 10.3233/RNN-130351; Maidenbaum S, 2014, NEUROSCI BIOBEHAV R, V41, P3, DOI 10.1016/j.neubiorev.2013.11.007; Maidenbaum S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072555; Max M L, 1997, Stud Health Technol Inform, V39, P54; MEIJER PBL, 1992, IEEE T BIO-MED ENG, V39, P112, DOI 10.1109/10.121642; Merabet LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044958; MEUNIER M, 1986, PHYSIOL BEHAV, V37, P909, DOI 10.1016/S0031-9384(86)80011-7; Millar Susanna, 1994, UNDERSTANDING REPRES, DOI 10.1093/acprof:oso/9780198521426.001.0001; Noordzij ML, 2006, COGNITION, V100, P321, DOI 10.1016/j.cognition.2005.05.006; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Pasqualotto A, 2013, BEHAV BRAIN RES, V236, P175, DOI 10.1016/j.bbr.2012.08.042; Pasqualotto A, 2012, NEUROSCI BIOBEHAV R, V36, P1179, DOI 10.1016/j.neubiorev.2012.01.008; PASSINI R, 1990, ENVIRON BEHAV, V22, P91, DOI 10.1177/0013916590221005; Proulx MJ, 2014, NEUROSCI BIOBEHAV R, V41, P1, DOI 10.1016/j.neubiorev.2014.03.004; Ptito M, 2005, BRAIN, V128, P606, DOI 10.1093/brain/awh380; Ptito M, 2008, EXP BRAIN RES, V187, P41, DOI 10.1007/s00221-008-1273-4; RAUSCHECKER JP, 1995, BEHAV BRAIN RES, V66, P7, DOI 10.1016/0166-4328(94)00117-X; Renier L, 2010, DISABIL REHABIL-ASSI, V5, P175, DOI 10.3109/17483100903253936; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sanchez J, 1999, Cyberpsychol Behav, V2, P101, DOI 10.1089/cpb.1999.2.101; Sanchez J, 2010, IEEE T NEUR SYS REH, V18, P210, DOI 10.1109/TNSRE.2009.2032186; SAVILLE DJ, 1990, AM STAT, V44, P174, DOI 10.2307/2684163; Segond H, 2013, PERCEPTION, V42, P508, DOI 10.1068/p6339; Serino A, 2007, PSYCHOL SCI, V18, P642, DOI 10.1111/j.1467-9280.2007.01952.x; Shore DI, 2001, COGN AFFECT BEHAV NE, V1, P83, DOI 10.3758/CABN.1.1.83; Striem-Amit E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033136; Tcheang L, 2011, P NATL ACAD SCI USA, V108, P1152, DOI 10.1073/pnas.1011843108; ThinusBlanc C, 1997, PSYCHOL BULL, V121, P20, DOI 10.1037/0033-2909.121.1.20; Tinti C, 2006, Q J EXP PSYCHOL, V59, P1306, DOI 10.1080/17470210500214275; UNGAR S, 1995, PERCEPTION, V24, P891, DOI 10.1068/p240891; Wolbers T, 2011, CURR BIOL, V21, P984, DOI 10.1016/j.cub.2011.04.038; ZIMMERMANN R R, 1969, Developmental Psychobiology, V2, P40, DOI 10.1002/dev.420020110	64	54	54	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126307	10.1371/journal.pone.0126307	http://dx.doi.org/10.1371/journal.pone.0126307			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039580	Green Submitted, Green Published, gold			2022-12-27	WOS:000355700700025
J	Inafuku, M; Matsuzaki, G; Oku, H				Inafuku, Masashi; Matsuzaki, Goro; Oku, Hirosuke			Intravenous Mycobacterium Bovis Bacillus Calmette-Guerin Ameliorates Nonalcoholic Fatty Liver Disease in Obese, Diabetic ob/ob Mice	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TUMOR-NECROSIS-FACTOR; INSULIN-RESISTANCE; METABOLIC SYNDROME; IMMUNE-RESPONSE; NOD MICE; HELICOBACTER-PYLORI; ADIPOSE-TISSUE; TUBERCULOSIS; PATHOGENESIS	Inflammation and immune response profoundly influence metabolic syndrome and fatty acid metabolism. To analyze influence of systemic inflammatory response to metabolic syndrome, we inoculated an attenuated vaccine strain of Mycobacterium bovis Bacillus Calmette-Guerin (BCG) into leptin-deficient ob/ob mice. BCG administration significantly decreased epididymal white adipose tissue weight, serum insulin levels, and a homeostasis model assessment of insulin resistance. Serum high molecular weight (HMW) adiponectin level and HMW/total adiponectin ratio of the BCG treated mice were significantly higher than those of control mice. Hepatic triglyceride accumulation and macrovesicular steatosis were markedly alleviated, and the enzymatic activities and mRNA levels of lipogenic-related genes in liver were significantly decreased in the BCG injected mice. We also exposed human hepatocellular carcinoma HepG2 cells to high levels of palmitate, which enhanced endoplasmic reticulum stress-related gene expression and impaired insulin-stimulated Akt phosphorylation (Ser473). BCG treatment ameliorated both of these detrimental events. The present study therefore suggested that BCG administration suppressed development of nonalcoholic fatty liver disease, at least partly, by alleviating fatty acid-induced insulin resistance in the liver.	[Inafuku, Masashi; Oku, Hirosuke] Univ Ryukyus, Trop Biosphere Res Ctr, Dept Trop Bioresources, Nishihara, Okinawa 90301, Japan; [Matsuzaki, Goro] Univ Ryukyus, Trop Biosphere Res Ctr, Dept Infect Dis, Nishihara, Okinawa 90301, Japan	University of the Ryukyus; University of the Ryukyus	Inafuku, M (corresponding author), Univ Ryukyus, Trop Biosphere Res Ctr, Dept Trop Bioresources, Nishihara, Okinawa 90301, Japan.	h098648@eve.u-ryukyu.ac.jp	Matsuzaki, Goro/AAX-3110-2020		JSPS KAKENHI [2400755]; Grants-in-Aid for Scientific Research [25293105] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the JSPS KAKENHI, Grant Number 2400755(Identify author, MI), (http://www.jsps.go.jp/english/e-grants). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard CS, 2012, ENDOCRINOLOGY, V153, P2164, DOI 10.1210/en.2011-1881; Agarwal P, 2014, MICROBES INFECT, V16, P571, DOI 10.1016/j.micinf.2014.04.006; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Boden Guenther, 2006, Curr Diab Rep, V6, P177, DOI 10.1007/s11892-006-0031-x; Bugianesi E, 2010, CURR PHARM DESIGN, V16, P1941, DOI 10.2174/138161210791208875; Day CP, 2002, BEST PRACT RES CL GA, V16, P663, DOI 10.1053/bega.2002.0333; Erol A, 2008, MED HYPOTHESES, V71, P222, DOI 10.1016/j.mehy.2008.03.028; Fang DL, 2013, MOL CELL BIOCHEM, V381, P127, DOI 10.1007/s11010-013-1694-7; Faustman DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041756; Fernandez-Real JM, 2006, DIABETES CARE, V29, P1058, DOI 10.2337/dc05-2068; FLETCHER MJ, 1968, CLIN CHIM ACTA, V22, P393, DOI 10.1016/0009-8981(68)90041-7; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; FOLCH J, 1957, J BIOL CHEM, V226, P497; Formiguera X, 2004, BEST PRACT RES CL GA, V18, P1125, DOI [10.1016/S1521-6918(04)00091-5, 10.1016/j.bpg.2004.06.030]; Genoni G, 2014, EUR J PEDIATR, V173, P25, DOI 10.1007/s00431-013-2178-1; Grimble RF, 2002, CURR OPIN CLIN NUTR, V5, P551, DOI 10.1097/00075197-200209000-00015; Gunji T, 2008, AM J GASTROENTEROL, V103, P3005, DOI 10.1111/j.1572-0241.2008.02151.x; HARADA M, 1990, DIABETES RES CLIN PR, V8, P85, DOI 10.1016/0168-8227(90)90017-N; Hirose H, 2010, J ATHEROSCLER THROMB, V17, P1201, DOI 10.5551/jat.6106; Hirota Morihiko, 2006, Journal of Toxicological Sciences, V31, P149, DOI 10.2131/jts.31.149; Ikejima S, 2005, DIABETES, V54, P182, DOI 10.2337/diabetes.54.1.182; Kalupahana NS, 2012, MOL ASPECTS MED, V33, P26, DOI 10.1016/j.mam.2011.10.011; Kim JS, 2011, MICROBES INFECT, V13, P1242, DOI 10.1016/j.micinf.2011.07.002; Kodama S, 2005, CELL MOL LIFE SCI, V62, P1850, DOI 10.1007/s00018-005-5022-6; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Leung CC, 2008, AM J EPIDEMIOL, V167, P1486, DOI 10.1093/aje/kwn075; Leung CC, 2007, ARCH INTERN MED, V167, P1297, DOI 10.1001/archinte.167.12.1297; Liang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115922; Martens GW, 2007, AM J RESP CELL MOL, V37, P518, DOI 10.1165/rcmb.2006-0478OC; Milic S, 2012, DIGEST DIS, V30, P158, DOI 10.1159/000336669; Nabipour I, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-25; Nagao K, 2010, J AGR FOOD CHEM, V58, P9028, DOI 10.1021/jf1020329; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; O'Rourke RW, 2012, METABOLISM, V61, P1152, DOI 10.1016/j.metabol.2012.01.018; Organization WH, 2014, GLOB TUB REP 2014; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park S, 2009, INFECT IMMUN, V77, P3374, DOI 10.1128/IAI.00319-09; Patel PS, 2013, J OBES, V2013, DOI 10.1155/2013/616193; Qin HY, 2004, INT IMMUNOL, V16, P1723, DOI 10.1093/intimm/dxh173; Qin HY, 1997, J AUTOIMMUN, V10, P271, DOI 10.1006/jaut.1997.0136; Rahman Masmudur M, 2006, PLoS Pathog, V2, pe4; Saeed M, 2011, J BIOL CHEM, V286, P37264, DOI 10.1074/jbc.M111.259085; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Sell H, 2007, CURR OPIN LIPIDOL, V18, P258, DOI 10.1097/MOL.0b013e3281338546; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Strandberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007605; Su QZ, 2014, AM J PHYSIOL-ENDOC M, V306, pE1264, DOI 10.1152/ajpendo.00438.2013; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang YM, 2006, BIOSCI BIOTECH BIOCH, V70, P355, DOI 10.1271/bbb.70.355; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Wieland CW, 2005, INT IMMUNOL, V17, P1399, DOI 10.1093/intimm/dxh317; Yamashiro S, 2005, CLIN EXP IMMUNOL, V139, P57, DOI 10.1111/j.1365-2249.2005.02677.x; Zhang Y, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-122	58	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128676	10.1371/journal.pone.0128676	http://dx.doi.org/10.1371/journal.pone.0128676			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039731	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700114
J	Ren, ZJ; Mummalaneni, S; Qian, J; Baumgarten, CM; DeSimone, JA; Lyall, V				Ren, Zuo Jun; Mummalaneni, Shobha; Qian, Jie; Baumgarten, Clive M.; DeSimone, John A.; Lyall, Vijay			Nicotinic Acetylcholine Receptor (nAChR) Dependent Chorda Tympani Taste Nerve Responses to Nicotine, Ethanol and Acetylcholine	PLOS ONE			English	Article							ACTIVATED CL-CURRENT; SWEET; ALCOHOL; BITTER; RAT; CELLS; TRPM5; MECAMYLAMINE; MODULATION; SALTY	Nicotine elicits bitter taste by activating TRPM5-dependent and TRPM5-independent but neuronal nAChR-dependent pathways. The nAChRs represent common targets at which acetylcholine, nicotine and ethanol functionally interact in the central nervous system. Here, we investigated if the nAChRs also represent a common pathway through which the bitter taste of nicotine, ethanol and acetylcholine is transduced. To this end, chorda tympani (CT) taste nerve responses were monitored in rats, wild-type mice and TRPM5 knockout (KO) mice following lingual stimulation with nicotine free base, ethanol, and acetylcholine, in the absence and presence of nAChR agonists and antagonists. The nAChR modulators: meca-mylamine, dihydro-beta-erythroidine, and CP-601932 (a partial agonist of the alpha 3 beta 4* nAChR), inhibited CT responses to nicotine, ethanol, and acetylcholine. CT responses to nicotine and ethanol were also inhibited by topical lingual application of 8-chlorophenylthio (CPT)-cAMP and loading taste cells with [Ca2+](i) by topical lingual application of ionomycin + CaCl2. In contrast, CT responses to nicotine were enhanced when TRC [Ca2+](i) was reduced by topical lingual application of BAPTA-AM. In patch-clamp experiments, only a subset of isolated rat fungiform taste cells exposed to nicotine responded with an increase in meca-mylamine-sensitive inward currents. We conclude that nAChRs expressed in a subset of taste cells serve as common receptors for the detection of the TRPM5-independent bitter taste of nicotine, acetylcholine and ethanol.	[Ren, Zuo Jun; Mummalaneni, Shobha; Qian, Jie; Baumgarten, Clive M.; DeSimone, John A.; Lyall, Vijay] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23219 USA	Virginia Commonwealth University	Lyall, V (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23219 USA.	vlyall@vcu.edu			National Institute on Deafness and other Communication Disorders (NIDCD) [DC-005981, DC-011569]; Jeffress Memorial Trust [J-1031]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011569, R01DC005981] Funding Source: NIH RePORTER	National Institute on Deafness and other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Jeffress Memorial Trust; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by the National Institute on Deafness and other Communication Disorders (NIDCD) grants DC-005981 and DC-011569 and the Jeffress Memorial Trust grant J-1031 to VL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Bancroft A, 2000, NEUROPHARMACOLOGY, V39, P2770, DOI 10.1016/S0028-3908(00)00099-X; BEHE P, 1990, J GEN PHYSIOL, V96, P1061, DOI 10.1085/jgp.96.5.1061; Bito-Onon JJ, 2011, ADDICT BIOL, V16, P440, DOI 10.1111/j.1369-1600.2010.00309.x; Blizard DA, 2007, BEHAV GENET, V37, P146, DOI 10.1007/s10519-006-9121-4; BLOMQVIST O, 1993, EUR J PHARMACOL, V249, P207, DOI 10.1016/0014-2999(93)90434-J; Blomqvist O, 1997, EUR J PHARMACOL, V334, P149, DOI 10.1016/S0014-2999(97)01220-X; BOBO JK, 1992, J PSYCHOACTIVE DRUGS, V24, P123, DOI 10.1080/02791072.1992.10471633; Bryant B, 2010, ACS CHEM NEUROSCI, V1, P246, DOI 10.1021/cn900042c; Carstens E, 1998, J NEUROPHYSIOL, V80, P465, DOI 10.1152/jn.1998.80.2.465; Chatterjee S, 2011, NEUROPSYCHOPHARMACOL, V36, P603, DOI [10.1038/npp.2010.191, 10.1038/npp.2011.268]; Chi H, 2003, ALCOHOL CLIN EXP RES, V27, P780, DOI 10.1097/01.ALC.0000065435.12068.24; Coleman J, 2011, J NEUROPHYSIOL, V106, P2606, DOI 10.1152/jn.00196.2010; Damak S, 2006, CHEM SENSES, V31, P253, DOI 10.1093/chemse/bjj027; DeSimone JA, 2012, J NEUROPHYSIOL, V108, P3221, DOI 10.1152/jn.00129.2012; DeSimone JA, 2012, J NEUROPHYSIOL, V108, P3206, DOI 10.1152/jn.00916.2011; Di Angelantonio S, 2011, J PHYSIOL-LONDON, V589, P2755, DOI 10.1113/jphysiol.2011.207282; DIFRANZA JR, 1990, J STUD ALCOHOL, V51, P130, DOI 10.15288/jsa.1990.51.130; FAULKNER DC, 1980, J PHARM PHARMACOL, V32, P656, DOI 10.1111/j.2042-7158.1980.tb13027.x; FEYERABEND C, 1982, BRIT MED J, V284, P1002, DOI 10.1136/bmj.284.6321.1002; Gees M, 2014, CHEM SENSES, V39, P295, DOI 10.1093/chemse/bjt115; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P1107, DOI 10.1001/archpsyc.61.11.1107; Gu YC, 2008, J EXP BIOL, V211, P3167, DOI 10.1242/jeb.019646; Guo XC, 2007, J NEUROPHYSIOL, V97, P93, DOI 10.1152/jn.01047.2005; Hendrickson Linzy M, 2013, Front Psychiatry, V4, P29, DOI 10.3389/fpsyt.2013.00029; Hendrickson LM, 2010, J NEUROSCI, V30, P10169, DOI 10.1523/JNEUROSCI.2601-10.2010; HUGANIR RL, 1990, NEURON, V5, P555, DOI 10.1016/0896-6273(90)90211-W; Korkosz A, 2003, ALCOHOL, V30, P211, DOI 10.1016/S0741-8329(03)00133-2; Li XC, 2005, BEHAV BRAIN RES, V157, P79, DOI 10.1016/j.bbr.2004.06.010; Lyall V, 2005, J GEN PHYSIOL, V125, P587, DOI 10.1085/jgp.200509264; Lyall V, 2002, J NEUROPHYSIOL, V87, P399, DOI 10.1152/jn.00331.2001; Lyall V, 2007, J NEUROPHYSIOL, V98, P1662, DOI 10.1152/jn.00366.2007; Lyall V, 2009, J NEUROPHYSIOL, V102, P1591, DOI 10.1152/jn.91301.2008; Miller NS, 1998, J ADDICT DIS, V17, P55, DOI 10.1300/J069v17n01_06; Mummalaneni S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098049; NAKAYAMA H, 1993, MOL BRAIN RES, V20, P171, DOI 10.1016/0169-328X(93)90123-7; Nashmi R, 2007, J NEUROSCI, V27, P8202, DOI 10.1523/JNEUROSCI.2199-07.2007; Nuutinen S, 2006, EUR J PHARMACOL, V544, P21, DOI 10.1016/j.ejphar.2006.06.038; Ogura T, 2007, CELL TISSUE RES, V330, P17, DOI 10.1007/s00441-007-0470-y; Oliveira-Maia AJ, 2009, P NATL ACAD SCI USA, V106, P1596, DOI 10.1073/pnas.0810184106; Patra M, 2006, BIOPHYS J, V90, P1121, DOI 10.1529/biophysj.105.062364; Pfaffmann C., 1959, HDB PHYSL NEUROPHYSI, V1, P507; Qian J, 2014, ACHEMS 36 ANN M APR, P76; Ren ZJ, 2005, AM J PHYSIOL-HEART C, V288, pH2628, DOI 10.1152/ajpheart.00992.2004; Ren Z, 2008, CARDIOVASC RES, V77, P73, DOI 10.1093/cvr/cvm031; Ren ZJ, 2013, AM J PHYSIOL-GASTR L, V305, pG106, DOI 10.1152/ajpgi.00053.2013; Rezvani AH, 2010, PSYCHOPHARMACOLOGY, V211, P161, DOI 10.1007/s00213-010-1878-8; ROSE JE, 1989, PHARMACOL BIOCHEM BE, V32, P933, DOI 10.1016/0091-3057(89)90061-0; Schiffman SS, 2000, PHYSIOL BEHAV, V69, P147, DOI 10.1016/S0031-9384(00)00198-0; Scinska A, 2000, DRUG ALCOHOL DEPEN, V60, P199, DOI 10.1016/S0376-8716(99)00149-0; Simons CT, 2006, J NEUROPHYSIOL, V96, P1877, DOI 10.1152/jn.00345.2006; Soderpalm B, 2000, BEHAV BRAIN RES, V113, P85, DOI 10.1016/S0166-4328(00)00203-5; STROUD RM, 1990, BIOCHEMISTRY-US, V29, P11009, DOI 10.1021/bi00502a001; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; Talavera K, 2008, FASEB J, V22, P1343, DOI 10.1096/fj.07-9591com; Talavera K, 2009, NAT NEUROSCI, V12, P1293, DOI 10.1038/nn.2379; Thuerauf N, 2006, NEUROPSYCHOPHARMACOL, V31, P450, DOI 10.1038/sj.npp.1300842; Vinnikova AK, 2004, J NEUROPHYSIOL, V91, P1297, DOI 10.1152/jn.00809.2003; Wang K, 2004, J BIOL CHEM, V279, P8779, DOI 10.1074/jbc.M309652200; Yoon JY, 2014, AM J PHYSIOL-CELL PH, V306, pC726, DOI 10.1152/ajpcell.00354.2013; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	61	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127936	10.1371/journal.pone.0127936	http://dx.doi.org/10.1371/journal.pone.0127936			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039516	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700079
J	Savetsky, IL; Ghanta, S; Gardenier, JC; Torrisi, JS; Nores, GDG; Hespe, GE; Nitti, MD; Kataru, RP; Mehrara, BJ				Savetsky, Ira L.; Ghanta, Swapna; Gardenier, Jason C.; Torrisi, Jeremy S.; Nores, Gabriela D. Garcia; Hespe, Geoffrey E.; Nitti, Matthew D.; Kataru, Raghu P.; Mehrara, Babak J.			Th2 Cytokines Inhibit Lymphangiogenesis	PLOS ONE			English	Article							LYMPHATIC REGENERATION; WOUND REPAIR; VEGF; LYMPHEDEMA; INFLAMMATION; HYPERPLASIA; EXPRESSION; VESSELS	Lymphangiogenesis is the process by which new lymphatic vessels grow in response to pathologic stimuli such as wound healing, inflammation, and tumor metastasis. It is well-recognized that growth factors and cytokines regulate lymphangiogenesis by promoting or inhibiting lymphatic endothelial cell (LEC) proliferation, migration and differentiation. Our group has shown that the expression of T-helper 2 (Th2) cytokines is markedly increased in lymphedema, and that these cytokines inhibit lymphatic function by increasing fibrosis and promoting changes in the extracellular matrix. However, while the evidence supporting a role for T cells and Th2 cytokines as negative regulators of lymphatic function is clear, the direct effects of Th2 cytokines on isolated LECs remains poorly understood. Using in vitro and in vivo studies, we show that physiologic doses of interleukin-4 (IL-4) and interleukin-13 (IL-13) have profound anti-lymphangiogenic effects and potently impair LEC survival, proliferation, migration, and tubule formation. Inhibition of these cytokines with targeted monoclonal antibodies in the cornea suture model specifically increases inflammatory lymphangiogenesis without concomitant changes in angiogenesis. These findings suggest that manipulation of anti-lymphangiogenic pathways may represent a novel and potent means of improving lymphangiogenesis.	[Savetsky, Ira L.; Ghanta, Swapna; Gardenier, Jason C.; Torrisi, Jeremy S.; Nores, Gabriela D. Garcia; Hespe, Geoffrey E.; Nitti, Matthew D.; Kataru, Raghu P.; Mehrara, Babak J.] Mem Sloan Kettering Canc Ctr, Dept Surg, Div Plast & Reconstruct Surg, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Mehrara, BJ (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Div Plast & Reconstruct Surg, 1275 York Ave, New York, NY 10021 USA.	mehrarab@mskcc.org	Kataru, Raghu P/AAB-9990-2022; Kataru, Raghu/K-8896-2019	Kataru, Raghu/0000-0003-1315-7982; Savetsky, Ira/0000-0002-0175-7692; Hespe, Geoffrey/0000-0003-1961-7484	National Institute of Health [R01 HL111130-01, T32 CA009685-21A1]; Plastic Surgery Foundation Pilot Research Grant [274165]; Sharp Foundation Fund philanthropic gift; NATIONAL CANCER INSTITUTE [T32CA009501] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111130] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Plastic Surgery Foundation Pilot Research Grant; Sharp Foundation Fund philanthropic gift; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institute of Health R01 HL111130-01 awarded to BJM; 2013 Plastic Surgery Foundation Pilot Research Grant 274165 awarded to SG; Sharp Foundation Fund philanthropic gift to BJM; National Institute of Health T32 CA009685-21A1 grant to GGN.	Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; Avraham T, 2013, FASEB J, V27, P1114, DOI 10.1096/fj.12-222695; Avraham T, 2010, AM J PATHOL, V177, P3202, DOI 10.2353/ajpath.2010.100594; Bjorndahl MA, 2005, CANCER RES, V65, P9261, DOI 10.1158/0008-5472.CAN-04-2345; Cao RH, 2011, NAT PROTOC, V6, P817, DOI 10.1038/nprot.2011.359; Clavin NW, 2008, AM J PHYSIOL-HEART C, V295, pH2113, DOI 10.1152/ajpheart.00879.2008; Cursiefen C, 2006, CORNEA, V25, P443, DOI 10.1097/01.ico.0000183485.85636.ff; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Goldman J, 2005, CIRC RES, V96, P1193, DOI 10.1161/01.RES.0000168918.27576.78; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Kataru RP, 2011, IMMUNITY, V34, P96, DOI 10.1016/j.immuni.2010.12.016; Kataru RP, 2009, BLOOD, V113, P5650, DOI 10.1182/blood-2008-09-176776; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Oka M, 2008, BLOOD, V111, P4571, DOI 10.1182/blood-2007-10-120337; Rutkowski JM, 2006, MICROVASC RES, V72, P161, DOI 10.1016/j.mvr.2006.05.009; Shao XJ, 2006, J INTERF CYTOK RES, V26, P568, DOI 10.1089/jir.2006.26.568; Shin K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7196; Zampell JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049940; Zampell JC, 2012, AM J PHYSIOL-CELL PH, V302, pC392, DOI 10.1152/ajpcell.00306.2011; Zampell JC, 2011, AM J PHYSIOL-CELL PH, V300, pC1107, DOI 10.1152/ajpcell.00378.2010	23	68	69	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126908	10.1371/journal.pone.0126908	http://dx.doi.org/10.1371/journal.pone.0126908			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039103	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700042
J	Youssef, NH; Farag, IF; Rinke, C; Hallam, SJ; Woyke, T; Elshahed, MS				Youssef, Noha H.; Farag, Ibrahim F.; Rinke, Christian; Hallam, Steven J.; Woyke, Tanja; Elshahed, Mostafa S.			In Silico Analysis of the Metabolic Potential and Niche Specialization of Candidate Phylum "Latescibacteria" (WS3)	PLOS ONE			English	Article							EXTRACELLULAR POLYMERIC SUBSTANCES; CELL-WALL; BACTERIAL COMMUNITIES; GREEN-ALGA; DEGRADATION; DIVERSITY; INSIGHTS; POLYSACCHARIDE; MICROALGAE; SEA	The "Latescibacteria" (formerly WS3), member of the Fibrobacteres-Chlorobi-Bacteroidetes (FCB) superphylum, represents a ubiquitous candidate phylum found in terrestrial, aquatic, and marine ecosystems. Recently, single-cell amplified genomes (SAGs) representing the "Latescibacteria" were obtained from the anoxic monimolimnion layers of Sakinaw Lake (British Columbia, Canada), and anoxic sediments of a coastal lagoon (Etoliko lagoon, Western Greece). Here, we present a detailed in-silico analysis of the four SAGs to gain some insights on their metabolic potential and apparent ecological roles. Metabolic reconstruction suggests an anaerobic fermentative mode of metabolism, as well as the capability to degrade multiple polysaccharides and glycoproteins that represent integral components of green (Charophyta and Chlorophyta) and brown (Phaeophycaea) algae cell walls (pectin, alginate, ulvan, fucan, hydroxyproline-rich glycoproteins), storage molecules (starch and trehalose), and extracellular polymeric substances (EPSs). The analyzed SAGs also encode dedicated transporters for the uptake of produced sugars and amino acids/oligopeptides, as well as an extensive machinery for the catabolism of all transported sugars, including the production of a bacterial microcompartment (BMC) to sequester propionaldehyde, a toxic intermediate produced during fucose and rhamnose metabolism. Finally, genes for the formation of gas vesicles, flagella, type IV pili, and oxidative stress response were found, features that could aid in cellular association with algal detritus. Collectively, these results indicate that the analyzed "Latescibacteria" mediate the turnover of multiple complex organic polymers of algal origin that reach deeper anoxic/microoxic habitats in lakes and lagoons. The implications of such process on our understanding of niche specialization in microbial communities mediating organic carbon turnover in stratified water bodies are discussed.	[Youssef, Noha H.; Farag, Ibrahim F.; Elshahed, Mostafa S.] Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA; [Rinke, Christian; Woyke, Tanja] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Hallam, Steven J.] Univ British Columbia, Grad Program Bioinformat, Vancouver, BC V5Z 1M9, Canada	Oklahoma State University System; Oklahoma State University - Stillwater; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of British Columbia	Youssef, NH (corresponding author), Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA.	Noha@Okstate.edu	Youssef, Noha H./T-5198-2019; Rinke, Christian/ABA-3139-2021; Rinke, Christian/AAE-8100-2019	Youssef, Noha H./0000-0001-9159-3785; Rinke, Christian/0000-0003-4632-1187; Farag, Ibrahim/0000-0002-5732-4108	National Science Foundation Microbial Observatories Program [EF0801858]; Tula Foundation; Natural Sciences and Engineering Research Council (NSERC) of Canada; Canada Foundation for Innovation (CFI); Canadian Institute for Advanced Research (CIFAR); U.S. Department of Energy Joint Genome Institute [DE-AC02-05CH11231]	National Science Foundation Microbial Observatories Program(National Science Foundation (NSF)); Tula Foundation; Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); U.S. Department of Energy Joint Genome Institute(United States Department of Energy (DOE))	This work was supported by the National Science Foundation Microbial Observatories Program (Grant EF0801858); the Tula Foundation, Natural Sciences and Engineering Research Council (NSERC) of Canada, Canada Foundation for Innovation (CFI), and the Canadian Institute for Advanced Research (CIFAR) through grants awarded to SJH. The work conducted by the U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility, is supported under Contract No. DE-AC02-05CH11231.	Abbott DW, 2008, MICROBIOL MOL BIOL R, V72, P301, DOI 10.1128/MMBR.00038-07; [Anonymous], 2010, CARBOHYD RES, DOI DOI 10.1126/SCIENCE.1179555; [Anonymous], 2009, PILER GENOMIC REPEAT; Axen SD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003898; Bakunina I, 2013, MAR DRUGS, V11, P1977, DOI 10.3390/md11061977; Bellinger BJ, 2010, J PHYCOL, V46, P484, DOI 10.1111/j.1529-8817.2010.00829.x; Benjdia A, 2007, J AM CHEM SOC, V129, P3462, DOI 10.1021/ja067175e; Benoit I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-321; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Bresciani M, 2013, EUR J REMOTE SENS, V46, P445, DOI 10.5721/EuJRS20134626; Briggs BR, 2011, APPL ENVIRON MICROB, V77, P6780, DOI 10.1128/AEM.00288-11; Briukhanov A L, 2007, Prikl Biokhim Mikrobiol, V43, P635; Buchan A, 2014, NAT REV MICROBIOL, V12, P686, DOI 10.1038/nrmicro3326; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Campbell JH, 2013, P NATL ACAD SCI USA, V110, P5540, DOI 10.1073/pnas.1303090110; Carbonetto B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099949; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Chiellini F, 2011, ULVAN VERSATILE PLAT; Chisti Y, 2008, TRENDS BIOTECHNOL, V26, P126, DOI 10.1016/j.tibtech.2007.12.002; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Cobucci-Ponzano B, 2010, BIOCHIMIE, V92, P1895, DOI 10.1016/j.biochi.2010.07.016; Collen PN, 2011, J BIOL CHEM, V286, P42063, DOI 10.1074/jbc.M111.271825; Coulthurst SJ, 2013, RES MICROBIOL, V164, P640, DOI 10.1016/j.resmic.2013.03.017; Deschamps P, 2008, TRENDS PLANT SCI, V13, P574, DOI 10.1016/j.tplants.2008.08.009; DIAPOULIS A, 1987, Acta Adriatica, V28, P85; Dierks T, 1998, J BIOL CHEM, V273, P25560, DOI 10.1074/jbc.273.40.25560; Dojka MA, 1998, APPL ENVIRON MICROB, V64, P3869; Domozych DS, 2014, PLANT PHYSIOL, V165, P105, DOI 10.1104/pp.114.236257; Domozych DS, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00082; Domozych DS, 2009, ANN BOT-LONDON, V104, P1045, DOI 10.1093/aob/mcp193; Domozych DS, 2011, ALGAL CELL WALLS ELS; Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002; Eder M, 2010, PROTOPLASMA, V243, P25, DOI 10.1007/s00709-009-0040-0; Estevez JM, 2009, GLYCOBIOLOGY, V19, P212, DOI 10.1093/glycob/cwn101; Farag IF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092139; Ferrari B, 2014, SCI REP-UK, V4, DOI 10.1038/srep03957; FERRO DR, 1990, CARBOHYD RES, V195, P157, DOI 10.1016/0008-6215(90)84164-P; Fuchsman CA, 2011, FEMS MICROBIOL ECOL, V78, P586, DOI 10.1111/j.1574-6941.2011.01189.x; Fujita K, 2011, J BIOL CHEM, V286, P5143, DOI 10.1074/jbc.M110.190512; Gerken HG, 2013, PLANTA, V237, P239, DOI 10.1007/s00425-012-1765-0; Gonzalez ET, 2003, MOL PLANT MICROBE IN, V16, P536, DOI 10.1094/MPMI.2003.16.6.536; Havemann GD, 2003, J BACTERIOL, V185, P5086, DOI 10.1128/JB.185.17.5086-5095.2003; Hernandez-Raquet G, 2006, FEMS MICROBIOL ECOL, V58, P550, DOI 10.1111/j.1574-6941.2006.00187.x; Ikegaya H, 2008, PHYCOL RES, V56, P216, DOI 10.1111/j.1440-1835.2008.00503.x; Ikenaga M, 2010, MICROB ECOL, V59, P284, DOI 10.1007/s00248-009-9572-2; Jiao GL, 2011, MAR DRUGS, V9, P196, DOI 10.3390/md9020196; Kabisch A, 2014, ISME J, V8, P1492, DOI 10.1038/ismej.2014.4; Kamke J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087353; Kamke J, 2013, ISME J, V7, P2287, DOI 10.1038/ismej.2013.111; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kantor RS, 2013, MBIO, V4, DOI 10.1128/mBio.00708-13; Knoch E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00198; Kormas KA, 2008, GEOBIOLOGY, V6, P450, DOI 10.1111/j.1472-4669.2008.00172.x; Kormas KA, 2001, MAR ECOL-P S Z N I, V22, P201, DOI 10.1046/j.1439-0485.2001.01720.x; LAHAYE M, 1994, CARBOHYD RES, V262, P115, DOI 10.1016/0008-6215(94)84008-3; Lee OO, 2012, APPL ENVIRON MICROB, V78, P7173, DOI 10.1128/AEM.01111-12; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; MAHADEVASWAMY M, 1986, AGR WASTES, V18, P93, DOI 10.1016/0141-4607(86)90002-8; Mamedov T, 2011, FEBS OPEN BIO, V1, P15, DOI 10.1016/j.fob.2011.10.003; Mann AJ, 2013, APPL ENVIRON MICROB, V79, P6813, DOI 10.1128/AEM.01937-13; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McLean Jeffrey S, 2013, Proc Natl Acad Sci U S A, V110, pE2390, DOI 10.1073/pnas.1219809110; MEYERS PA, 1993, ORG GEOCHEM, V20, P867, DOI 10.1016/0146-6380(93)90100-P; MEYERS PA, 1994, CHEM GEOL, V114, P289, DOI 10.1016/0009-2541(94)90059-0; Michel G, 2010, NEW PHYTOL, V188, P82, DOI 10.1111/j.1469-8137.2010.03374.x; Mishra A, 2011, CARBOHYD POLYM, V83, P852, DOI 10.1016/j.carbpol.2010.08.067; Ohkuma M, 2007, FEMS MICROBIOL ECOL, V60, P467, DOI 10.1111/j.1574-6941.2007.00311.x; Paerl HW, 2010, ENVIRON SCI TECHNOL, V44, P7756, DOI 10.1021/es102665e; Pereira AD, 2014, BIORESOURCE TECHNOL, V166, P103, DOI 10.1016/j.biortech.2014.05.043; Perry KA, 1990, CHEM LIMNOLOGY 2 MER; Petit E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054337; Pfeifer F, 2012, NAT REV MICROBIOL, V10, P705, DOI 10.1038/nrmicro2834; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; Portillo MC, 2009, EXTREMOPHILES, V13, P321, DOI 10.1007/s00792-008-0219-x; Prajapati SK, 2013, BIORESOURCE TECHNOL, V135, P232, DOI [10.1016/j.biortech.2012.08.069, 10.1016/]; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Redouan E, 2009, CARBOHYD RES, V344, P1670, DOI 10.1016/j.carres.2009.05.031; Reed AJ, 2006, EXTREMOPHILES, V10, P199, DOI 10.1007/s00792-005-0488-6; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Saier MH, 2014, NUCLEIC ACIDS RES, V42, pD251, DOI 10.1093/nar/gkt1097; Sapp M, 2007, MICROB ECOL, V53, P683, DOI 10.1007/s00248-006-9162-5; Schabereiter-Gurtner C, 2004, FEMS MICROBIOL ECOL, V47, P235, DOI 10.1016/S0168-6496(03)00280-0; Sharma KK, 2012, ENERGIES, V5, P1532, DOI 10.3390/en5051532; Sialve B, 2009, BIOTECHNOL ADV, V27, P409, DOI 10.1016/j.biotechadv.2009.03.001; Sutherland DL, 2014, WATER RES, V66, P53, DOI 10.1016/j.watres.2014.08.010; Takami H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030559; Takhar HK, 2013, J BIOL CHEM, V288, P9721, DOI 10.1074/jbc.M113.453506; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Valentini M, 2011, J BACTERIOL, V193, P4307, DOI 10.1128/JB.05074-11; Vergara-Fernandez A, 2008, BIOMASS BIOENERG, V32, P338, DOI 10.1016/j.biombioe.2007.10.005; WALSBY AE, 1994, MICROBIOL REV, V58, P94, DOI 10.1128/MMBR.58.1.94-144.1994; Ward AJ, 2014, ALGAL RES, V5, P204, DOI 10.1016/j.algal.2014.02.001; Wilson MC, 2014, NATURE, V506, P58, DOI 10.1038/nature12959; Winsley TJ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00345; Wrighton KC, 2014, ISME J, V8, P1452, DOI 10.1038/ismej.2013.249; Yakimov MM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03554; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Youssef NH, 2015, ISME J, V9, P447, DOI 10.1038/ismej.2014.141	100	69	69	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127499	10.1371/journal.pone.0127499	http://dx.doi.org/10.1371/journal.pone.0127499			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039074	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700063
J	Tsai, SB; Chien, MF; Xue, YZ; Li, L; Jiang, XD; Chen, Q; Zhou, J; Wang, L				Tsai, Sang-Bing; Chien, Min-Fang; Xue, Youzhi; Li, Lei; Jiang, Xiaodong; Chen, Quan; Zhou, Jie; Wang, Lei			Using the Fuzzy DEMATEL to Determine Environmental Performance: A Case of Printed Circuit Board Industry in Taiwan	PLOS ONE			English	Article							GREEN SUPPLY CHAIN; MANAGEMENT	The method by which high-technology product manufacturers balance profits and environmental performance is of crucial concern for governments and enterprises. To examine the environmental performance of manufacturers, the present study applied Fuzzy-DEMATEL model to examine environmental performance of the PCB industry in Taiwan. Fuzzy theory was employed to examine the environmental performance criteria of manufacturers and analyse fuzzy linguistics. The fuzzy-DEMATEL model was then employed to assess the direction and level of interaction between environmental performance criteria. The core environmental performance criteria which were critical for enhancing environmental performance of the PCB industry in Taiwan were identified and presented. The present study revealed that green design (a1), green material procurement (a2), and energy consumption (b3) constitute crucial reason criteria, the core criteria influencing other criteria, and the driving factors for resolving problems.	[Tsai, Sang-Bing; Chen, Quan] Univ Elect Sci & Technol China, Sch Management, Zhongshan Inst, Zhongshan 528402, Guangdong, Peoples R China; [Tsai, Sang-Bing; Xue, Youzhi] Nankai Univ, China Acad Corp Governance, Tianjin 300071, Peoples R China; [Tsai, Sang-Bing] Nankai Univ, Sch Law, Tianjin 300071, Peoples R China; [Chien, Min-Fang; Xue, Youzhi; Wang, Lei] Nankai Univ, Sch Business, Tianjin 300071, Peoples R China; [Li, Lei] Tianjin Univ, Coll Management & Econ, Tianjin 300072, Peoples R China; [Jiang, Xiaodong] Shanghai Univ Finance & Econ, Sch Int Business Adm, Shanghai 200433, Peoples R China; [Zhou, Jie] Nankai Univ, Coll Tourism & Serv Management, Tianjin 300071, Peoples R China	University of Electronic Science & Technology of China; Nankai University; Nankai University; Nankai University; Tianjin University; Shanghai University of Finance & Economics; Nankai University	Tsai, SB (corresponding author), Univ Elect Sci & Technol China, Sch Management, Zhongshan Inst, Zhongshan 528402, Guangdong, Peoples R China.	sangbing@hotmail.com; dorries.chien@msa.hinet.net; xue1965@nankai.edu.cn; zhoujie_1980@126.com; mralai123@yahoo.com	Tsai, Sang-Bing/C-2978-2014	Tsai, Sang-Bing/0000-0001-6988-5829	Department of Social Sciences of the Ministry of Education of the People's Republic of China [11JJD630002]; National Social Science Fund of China [12CGL033]; National Natural Science Foundation of China [71372092, 71132001]	Department of Social Sciences of the Ministry of Education of the People's Republic of China; National Social Science Fund of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Department of Social Sciences of the Ministry of Education of the People's Republic of China, No. 11JJD630002; National Social Science Fund of China, No. 12CGL033; and National Natural Science Foundation of China, No. 71372092 and No. 71132001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahi P, 2013, J CLEAN PROD, V52, P329, DOI 10.1016/j.jclepro.2013.02.018; Blome C, 2014, INT J PROD RES, V52, P32, DOI 10.1080/00207543.2013.825748; Carter CR, 2009, TRANSPORT RES B-LOG, V36, P219; Chang B, 2011, EXPERT SYST APPL, V38, P1850, DOI 10.1016/j.eswa.2010.07.114; Cheng Y, 2013, P I MECH ENG B-J ENG, V227, P1901, DOI 10.1177/0954405413492966; Chiang SY, 2011, CLEAN TECHNOL ENVIR, V13, P37, DOI 10.1007/s10098-010-0284-6; Chu CH, 2009, COMPUT IND, V60, P485, DOI 10.1016/j.compind.2009.02.003; CONRAD K, 1989, SOUTHERN ECON J, V55, P684, DOI 10.2307/1059582; Despeisse M, 2012, P I MECH ENG B-J ENG, V226, P1648, DOI 10.1177/0954405412449937; Gabus A., 1976, THE DEMATEL OBSERVER; Gabus A., 1973, PERCEPTIONS WORLD PR; Heidrich O, 2013, INT J PROD RES, V51, P5884, DOI 10.1080/00207543.2013.807372; Hetzel MW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096810; Huarng K, 2006, PHYSICA A, V363, P481, DOI 10.1016/j.physa.2005.08.014; Kainuma Y, 2006, INT J PROD ECON, V101, P99, DOI 10.1016/j.ijpe.2005.05.010; Kumar S, 2012, INT J PROD RES, V50, P1278, DOI 10.1080/00207543.2011.571924; Lee YC, 2014, PENSEE, V76, P190; Lee YC, 2011, AFR J BUS MANAGE, V5, P2312; Lee YC, 2014, INT J PROD RES, V52, P2931, DOI 10.1080/00207543.2013.857057; Lee YC, 2010, EXPERT SYST APPL, V37, P1745, DOI 10.1016/j.eswa.2009.07.034; Li CW, 2009, EXPERT SYST APPL, V36, P9891, DOI 10.1016/j.eswa.2009.01.073; Lin SW, 2004, CHEM ENG SCI, V59, P53, DOI 10.1016/j.ces.2003.09.019; Ming-Lang T, 2009, COMPUT IND ENG, V57, P330, DOI 10.1016/j.cie.2008.12.001; Tsai SB, 2015, P I MECH ENG B-J ENG, V229, P1395, DOI 10.1177/0954405414535923; Tsai SB, 2015, P I MECH ENG B-J ENG, V229, P135, DOI 10.1177/0954405414558740; Tsai SB, 2013, S AFR J IND ENG, V24, P112; Tsai SB, 2013, APPL MECH MATER, V437, P1012, DOI 10.4028/www.scientific.net/AMM.437.1012; Tsaur RC, 2011, EXPERT SYST APPL, V38, P9164, DOI 10.1016/j.eswa.2011.01.059; Tseng M.L., 2008, ASIA PACIFIC MANAG R, V13, P583; Tseng ML, 2009, EXPERT SYST APPL, V36, P7738, DOI 10.1016/j.eswa.2008.09.011; Tsireme AI, 2012, CLEAN TECHNOL ENVIR, V14, P953, DOI 10.1007/s10098-012-0461-x; Vimmerstedt LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035082; WINN SF, 1993, R&D MANAGE, V23, P147, DOI 10.1111/j.1467-9310.1993.tb00082.x; Wu HH, 2010, EXPERT SYST APPL, V37, P5219, DOI 10.1016/j.eswa.2009.12.068; Wu WW, 2007, EXPERT SYST APPL, V32, P499, DOI 10.1016/j.eswa.2005.12.005; Wu WW, 2012, APPL SOFT COMPUT, V12, P527, DOI 10.1016/j.asoc.2011.08.008; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zhu QH, 2011, TRANSPORT RES E-LOG, V47, P808, DOI 10.1016/j.tre.2010.09.013	38	111	111	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129153	10.1371/journal.pone.0129153	http://dx.doi.org/10.1371/journal.pone.0129153			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052710	Green Submitted, Green Published, gold			2022-12-27	WOS:000355955300095
J	de Beco, S; Perney, JB; Coscoy, S; Amblard, F				de Beco, Simon; Perney, Jean-Baptiste; Coscoy, Sylvie; Amblard, Francois			Mechanosensitive Adaptation of E-Cadherin Turnover across adherens Junctions	PLOS ONE			English	Article							COLLECTIVE CELL-MIGRATION; ALPHA-CATENIN; ACTIN CYTOSKELETON; 2-PHOTON FRAP; F-ACTIN; VINCULIN; TENSION; ADHESION; BINDING; MECHANOTRANSDUCTION	In the natural and technological world, multi-agent systems strongly depend on how the interactions are ruled between their individual components, and the proper control of timescales and synchronization is a key issue. This certainly applies to living tissues when multicellular assemblies such as epithelial cells achieve complex morphogenetic processes. In epithelia, because cells are known to individually generate actomyosin contractile stress, each individual intercellular adhesive junction line is subjected to the opposed stresses independently generated by its two partner cells. Contact lines should thus move unless their two partner cells mechanically match. The geometric homeostasis of mature epithelia observed at short enough time-scale thus raises the problem to understand how cells, if considered as noisy individual actuators, do adapt across individual intercellular contacts to locally balance their time-average contractile stress. Structural components of adherens junctions, cytoskeleton (F-actin) and homophilic bonds (E-cadherin) are quickly renewed at steady-state. These turnovers, if they depend on forces exerted at contacts, may play a key role in the mechanical adaptation of epithelia. Here we focus on E-cadherin as a force transducer, and we study the local regulation and the mechanosensitivity of its turnover in junctions. We show that E-cadherin turnover rates match remarkably well on either side of mature intercellular contacts, despite the fact that they exhibit large fluctuations in time and variations from one junction to another. Using local mechanical and biochemical perturbations, we find faster turnover rates with increased tension, and asymmetric rates at unbalanced junctions. Together, the observations that E-cadherin turnover, and its local symmetry or asymmetry at each side of the junction, are mechanosensitive, support the hypothesis that E-cadherin turnover could be involved in mechanical homeostasis of epithelia.	[de Beco, Simon; Perney, Jean-Baptiste; Coscoy, Sylvie; Amblard, Francois] Inst Curie, Ctr Rech, Lab Physicochim, Paris, France; [de Beco, Simon; Perney, Jean-Baptiste; Coscoy, Sylvie; Amblard, Francois] CNRS, Unite Mixte Rech 168, Paris, France; [de Beco, Simon; Perney, Jean-Baptiste; Coscoy, Sylvie; Amblard, Francois] Univ Paris 06, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Amblard, F (corresponding author), Inst Curie, Ctr Rech, Lab Physicochim, Paris, France.	francois.amblard@curie.fr		de Beco, Simon/0000-0003-1730-3000; Coscoy, Sylvie/0000-0003-3963-3609	CNRS (Centre National de la Recherche Scientifique); Institut Curie; ANR (Agence Nationale de la Recherche) [ANR-08-pcvi-0012-02]; FRM (Fondation pour la Recherche Medicale) [FDT20090916704]; MENRT; CelTisPhyBio Labex [ANR-10-LBX-0038]	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Institut Curie; ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale); MENRT; CelTisPhyBio Labex	This work was supported by CNRS (Centre National de la Recherche Scientifique) http://www.cnrs.fr/; (Institut Curie) http://www.curie.fr/; ANR (Agence Nationale de la Recherche) http://www.agence-nationale-recherche.fr/: Grant 3Dphotopol ANR-08-pcvi-0012-02; Grants for Simon de Beco: FRM (Fondation pour la Recherche Medicale) http://www.frm.org/, FDT20090916704, and MENRT http://www.education.gouv.fr/; CelTisPhyBio Labex (No ANR-10-LBX-0038).	Benazeraf B, 2013, ANNU REV CELL DEV BI, V29, P1, DOI 10.1146/annurev-cellbio-101011-155703; Quang BAT, 2013, CURR BIOL, V23, P2197, DOI 10.1016/j.cub.2013.09.015; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Coscoy S, 2002, P NATL ACAD SCI USA, V99, P12813, DOI 10.1073/pnas.192084599; de Beco S, 2012, INT REV CEL MOL BIO, V295, P63, DOI 10.1016/B978-0-12-394306-4.00008-3; de Beco S, 2009, P NATL ACAD SCI USA, V106, P7010, DOI 10.1073/pnas.0811253106; Dufour S, 2013, CELL ADHES MIGR, V7, P345, DOI 10.4161/cam.25139; Engl W, 2014, NAT CELL BIOL, V16, P584, DOI 10.1038/ncb2973; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Hong S, 2013, J CELL BIOL, V201, P131, DOI 10.1083/jcb.201211054; Hong S, 2010, P NATL ACAD SCI USA, V107, P3528, DOI 10.1073/pnas.0911027107; Iruela-Arispe ML, 2013, DEVELOPMENT, V140, P2851, DOI 10.1242/dev.070680; Kim TJ, 2015, CURR BIOL, V25, P218, DOI 10.1016/j.cub.2014.11.017; Kourakis MJ, 2014, DEV BIOL, V395, P120, DOI 10.1016/j.ydbio.2014.08.023; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Leckband DE, 2014, ANNU REV CELL DEV BI, V30, P291, DOI 10.1146/annurev-cellbio-100913-013212; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Nanes BA, 2012, J CELL BIOL, V199, P365, DOI 10.1083/jcb.201205029; Reffay M, 2014, NAT CELL BIOL, V16, P217, DOI 10.1038/ncb2917; Schwarz US, 2012, J CELL SCI, V125, P3051, DOI 10.1242/jcs.093716; Smutny M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022458; Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050; Twiss F, 2012, BIOL OPEN, V1, P1128, DOI 10.1242/bio.20122428; Waharte F, 2005, BIOPHYS J, V88, P1467, DOI 10.1529/biophysj.104.049619; Warner SJ, 2009, J CELL BIOL, V187, P119, DOI [10.1083/jcb.200906047, 10.1083/jcb.200901029]; Wu SK, 2013, CELL COMMUN ADHES, V20, P201, DOI 10.3109/15419061.2013.856889; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yao MX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5525; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	33	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128281	10.1371/journal.pone.0128281	http://dx.doi.org/10.1371/journal.pone.0128281			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046627	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200055
J	Esposito, S; Piralla, A; Zampiero, A; Bianchini, S; Di Pietro, G; Scala, A; Pinzani, R; Fossali, E; Baldanti, F; Principi, N				Esposito, Susanna; Piralla, Antonio; Zampiero, Alberto; Bianchini, Sonia; Di Pietro, Giada; Scala, Alessia; Pinzani, Raffaella; Fossali, Emilio; Baldanti, Fausto; Principi, Nicola			Characteristics and Their Clinical Relevance of Respiratory Syncytial Virus Types and Genotypes Circulating in Northern Italy in Five Consecutive Winter Seasons	PLOS ONE			English	Article							GLYCOPROTEIN G GENE; MOLECULAR EPIDEMIOLOGY; GROUP-A; PHYLOGENETIC ANALYSIS; RAPID SPREAD; ON1 GENOTYPE; B GENOTYPE; VARIABILITY; INFECTION; SEVERITY	In order to investigate the genetic diversity and patterns of the co-circulating genotypes of respiratory syncytial virus (RSV) and their possible relationships with the severity of RSV infection, we studied all of the RSV-positive nasopharyngeal samples collected from children during five consecutive winters (2009-2010, 2010-2011, 2011-2012, 2012-2013 and 2013-2014). The RSVs were detected using the respiratory virus panel fast assay and single-tube RT-PCR, their nucleotides were sequenced, and they were tested for positive selection. Of the 165 positive samples, 131 (79.4%) carried RSV-A and 34 (20.6%) RSV-B; both groups co-circulated in all of the study periods, with RSV-A predominating in all the seasons except for winter 2010-2011, which had a predominance of RSV-B. Phylogenetic analysis of the RSV-A sequences identified genotypes NA1 and ON1, the second replacing the first during the last two years of the study period. The RSV-B belonged to genotypes BA9 and BA10. BA9 was detected in all the years of the study whereas BA only desultorily. Comparison of the subjects infected by RSV-A and RSV-B types did not reveal any significant differences, but the children infected by genotype A/NA1 more frequently had lower respiratory tract infections (p<0.0001) and required hospitalisation (p = 0.007) more often than those infected by genotype A/ON1. These findings show that RSV has complex patterns of circulation characterised by the periodical replacement of the predominant genotypes, and indicate that the circulation and pathogenic role of the different RSV strains should be investigated as each may have a different impact on the host. A knowledge of the correlations between types, genotypes and disease severity may also be important in order to be able to include the more virulent strains in future vaccines.	[Esposito, Susanna; Zampiero, Alberto; Bianchini, Sonia; Di Pietro, Giada; Scala, Alessia; Pinzani, Raffaella; Principi, Nicola] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Pediat Highly Intens Care Unit, Milan, Italy; [Piralla, Antonio; Baldanti, Fausto] Fdn IRCCS Policlin San Matteo, Microbiol & Virol Dept, Mol Virol Unit, Pavia, Italy; [Fossali, Emilio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Emergency Unit, Milan, Italy; [Baldanti, Fausto] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Microbiol Sect, I-27100 Pavia, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Fondazione San Matteo; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Pavia	Esposito, S (corresponding author), Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Pediat Highly Intens Care Unit, Milan, Italy.	susanna.esposito@unimi.it	Fossali, Emilio/K-2200-2015; Esposito, Susanna/K-3475-2016; Baldanti, Fausto/J-4924-2018; Piralla, Antonio/K-4756-2018	Fossali, Emilio/0000-0002-3197-062X; Esposito, Susanna/0000-0003-4103-2837; Baldanti, Fausto/0000-0002-3358-8969; Piralla, Antonio/0000-0002-6062-2579	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	The study was supported by a grant of the Italian Ministry of Health (Bando Giovani Ricercatori 2009).	Agoti CN, 2014, EMERG INFECT DIS, V20, P950, DOI 10.3201/eid2006.131438; Arnott A, 2011, J CLIN MICROBIOL, V49, P3504, DOI 10.1128/JCM.01131-11; Auksornkitti V, 2014, ARCH VIROL, V159, P499, DOI 10.1007/s00705-013-1773-9; Baek YH, 2012, ARCH VIROL, V157, P1039, DOI 10.1007/s00705-012-1267-1; Balmaks R, 2014, J MED VIROL, V86, P1971, DOI 10.1002/jmv.23855; Blanc A, 2005, ARCH VIROL, V150, P603, DOI 10.1007/s00705-004-0412-x; Borchers AT, 2013, CLIN REV ALLERG IMMU, V45, P331, DOI 10.1007/s12016-013-8368-9; Botosso VF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000254; Choi EH, 2013, CURR TOP MICROBIOL, V372, P121, DOI 10.1007/978-3-642-38919-1_6; Choudhary ML, 2013, INFECT GENET EVOL, V20, P369, DOI 10.1016/j.meegid.2013.09.025; Cui GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075020; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Esposito S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-271; Fodha I, 2007, J MED VIROL, V79, P1951, DOI 10.1002/jmv.21026; Gilca R, 2006, J INFECT DIS, V193, P54, DOI 10.1086/498526; Hall CB, 2013, CURR TOP MICROBIOL, V372, P39, DOI 10.1007/978-3-642-38919-1_2; Hirano E, 2014, INFECT GENET EVOL, V28, P183, DOI 10.1016/j.meegid.2014.09.030; Hornsleth A, 1998, PEDIATR INFECT DIS J, V17, P1114, DOI 10.1097/00006454-199812000-00003; Imaz MS, 2000, J MED VIROL, V61, P76, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;76::AID-JMV12&gt;3.0.CO;2-P; Kaplan NM, 2008, J MED VIROL, V80, P168, DOI 10.1002/jmv.21067; Katzov-Eckert H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041953; Khor CS, 2013, INFECT GENET EVOL, V14, P357, DOI 10.1016/j.meegid.2012.12.017; Kim YJ, 2014, INFECT GENET EVOL, V26, P103, DOI 10.1016/j.meegid.2014.05.007; MCCONNOCHIE KM, 1990, J PEDIATR-US, V117, P52, DOI 10.1016/S0022-3476(05)82443-6; Panayiotou C, 2014, EPIDEMIOL INFECT, V142, P2406, DOI 10.1017/S0950268814000028; Parveen S, 2006, J CLIN MICROBIOL, V44, P3055, DOI 10.1128/JCM.00187-06; Paulus SC, 2007, CLIN IMMUNOL, V123, P252, DOI 10.1016/j.clim.2007.03.003; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Pierangeli A, 2014, EUROSURVEILLANCE, V19, P11, DOI 10.2807/1560-7917.ES2014.19.26.20843; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Prifert C, 2013, EMERG INFECT DIS, V19, P1029, DOI 10.3201/eid1906.121582; Rebuffo-Scheer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025468; Ren L, 2014, INFECT GENET EVOL, V27, P339, DOI 10.1016/j.meegid.2014.07.030; RUEDA P, 1991, J VIROL, V65, P3374, DOI 10.1128/JVI.65.6.3374-3378.1991; Shobugawa Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09; SULLENDER WM, 1993, J CLIN MICROBIOL, V31, P1224, DOI 10.1128/JCM.31.5.1224-1231.1993; Tabatabai J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109191; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tapia LI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090786; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Tsukagoshi H, 2013, MICROBIOL IMMUNOL, V57, P655, DOI 10.1111/1348-0421.12075; van Elden LJR, 2003, J CLIN MICROBIOL, V41, P4378, DOI 10.1128/JCM.41.9.4378-4381.2003; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; Walsh EE, 1997, J INFECT DIS, V175, P814, DOI 10.1086/513976; Wu WN, 2012, MICROB PATHOGENESIS, V52, P184, DOI 10.1016/j.micpath.2011.12.006	48	78	81	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129369	10.1371/journal.pone.0129369	http://dx.doi.org/10.1371/journal.pone.0129369			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047100	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200159
J	Moreira, ADR; Huf, G; Vieira, MAMD; da Costa, PA; Aguiar, F; Marsico, AG; Fonseca, LD; Ricks, M; Oliveira, MM; Detjen, A; Fujiwara, PI; Squire, SB; Kritski, AL				Rezende Moreira, Adriana da Silva; Huf, Gisele; Monteiro da Silva Vieira, Maria Armanda; da Costa, Paulo Albuquerque; Aguiar, Fabio; Marsico, Anna Grazia; Fonseca, Leila de Souza; Ricks, Monica; Oliveira, Martha Maria; Detjen, Anne; Fujiwara, Paula Isono; Squire, Stephen Bertel; Kritski, Afranio Lineu			Liquid vs Solid Culture Medium to Evaluate Proportion and Time to Change in Management of Suspects of Tuberculosis-A Pragmatic Randomized Trial in Secondary and Tertiary Health Care Units in Brazil	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; MULTICENTER EVALUATION; TB; HOSPITALS; DIAGNOSIS; SYSTEMS; SAMPLES; MALAWI	Background The use of liquid medium (MGIT960) for tuberculosis (TB) diagnosis was recommended by WHO in 2007. However, there has been no evaluation of its effectiveness on clinically important outcomes. Methods and Findings A pragmatic trial was carried out in a tertiary hospital and a secondary health care unit in Rio de Janeiro City, Brazil. Participants were 16 years or older, suspected of having TB. They were excluded if only cerebral spinal fluid or blood specimens were available for analysis. MGIT960 technique was compared with the Lowenstein-Jensen (LJ) method for laboratory diagnosis of active TB. Primary outcome was the proportion of patients who had their initial medical management changed within 2 months after randomisation. Secondary outcomes were: mean time for changing the procedure, patient satisfaction with the overall treatment and adverse events. Data were analysed by intention-to-treat. Between April 2008 and September 2011, 693 patients were enrolled (348 to MGIT, 345 to LJ). Smear and culture results were positive for 10% and 15.7% of participants, respectively. Patients in the MGIT arm had their initial medical management changed more frequently than those in the LJ group (10.1% MGIT vs 3.8% LJ, RR 2.67 95% CI 1.44-.96, p = 0.002, NNT 16, 95% CI 1039). Mean time for changing the initial procedure was greater in LJ group at both sites: 20.0 and 29.6 days in MGIT group and 52.2 and 64.3 in LJ group (MD 33.5, 95% CI 30.6-36.4, p = 0.0001). No other important differences were observed. Conclusions This study suggests that opting for the MGIT960 system for TB diagnosis provides a promising case management model for improving the quality of care and control of TB.	[Rezende Moreira, Adriana da Silva; Huf, Gisele; Monteiro da Silva Vieira, Maria Armanda; da Costa, Paulo Albuquerque; Aguiar, Fabio; Marsico, Anna Grazia; Fonseca, Leila de Souza; Oliveira, Martha Maria; Kritski, Afranio Lineu] Univ Fed Rio de Janeiro, Sch Med, TB Acad Program, Rio De Janeiro, Brazil; [da Costa, Paulo Albuquerque; Ricks, Monica] Policlin Augusto Amaral Peixoto, Guadalupe SMS, Rio De Janeiro, Brazil; [Detjen, Anne; Fujiwara, Paula Isono] Int Union TB & Lung Dis, Paris, France; [Squire, Stephen Bertel] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Universidade Federal do Rio de Janeiro; Liverpool School of Tropical Medicine; University of Liverpool	Kritski, AL (corresponding author), Univ Fed Rio de Janeiro, Sch Med, TB Acad Program, Rio De Janeiro, Brazil.	kritskia@gmail.com	Kritski, Afranio/I-6760-2016	Squire, Stephen/0000-0001-7173-9038; kritski, afranio/0000-0002-5900-6007	Decit/MS-CNPq [559081/2009-0]; Faperj [E: 26/111608/2008]; CNPq	Decit/MS-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Decit/MS-CNPq -Process: 559081/2009-0; Faperj Process: No E: 26/111608/2008. AK and LFS are the recipients of a career award from CNPq (research produtivity) and FAPERJ (Science of our State). The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript. No author received any specific funding for taking part of the research.	[Anonymous], 2010, GUID TB CONTR; Anthony RM, 2009, INT J TUBERC LUNG D, V13, P1051; Brito RC, 2010, INT J TUBERC LUNG D, V14, P24; Chiang CY, 2007, INT J TUBERC LUNG D, V11, P739; Cobelens F, 2012, J INFECT DIS, V205, pS191, DOI 10.1093/infdis/jis188; Cruciani M, 2004, J CLIN MICROBIOL, V42, P2321, DOI 10.1128/JCM.42.5.2321-2325.2004; de Oliveira GP, 2013, BRAZ J INFECT DIS, V17, P218, DOI 10.1016/j.bjid.2013.01.005; Dinnes J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11030; Dowdy DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004057; Fair E, 2007, EXPERT REV ANTI-INFE, V5, P61, DOI 10.1586/14787210.5.1.61; Giampaglia CMS, 2007, INT J TUBERC LUNG D, V11, P986; Harries AD, 2001, INT J TUBERC LUNG D, V5, P1000; Hillemann D, 2006, J CLIN MICROBIOL, V44, P4014, DOI 10.1128/JCM.00829-06; Kritski A, 2013, BRAZ J INFECT DIS, V17, P211, DOI 10.1016/j.bjid.2013.01.004; Kyeyune R, 2010, JAIDS-J ACQ IMM DEF, V55, P446, DOI 10.1097/QAI.0b013e3181eb611a; Mann G, 2010, INT J TUBERC LUNG D, V14, P1518; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; Paulson T, 2013, NATURE, V502, pS2, DOI 10.1038/502S2a; Perdigao J, 2013, J ANTIMICROB CHEMOTH, V68, P27, DOI 10.1093/jac/dks371; Silva DR, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-57; Sorlozano A, 2009, J MICROBIOL BIOTECHN, V19, P1259, DOI 10.4014/jmb.0901.059; Stop TB Partnership and World Health Organization, 2006, GLOB PLAN STOP TB 20; Tyrrell FC, 2012, J CLIN MICROBIOL, V50, P3275, DOI 10.1128/JCM.01225-12; van Kampen SC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-93; van Kampen SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011649; Vorkas C, 2012, MALAWI MED J, V24, P21; Wei X, 2008, BMC PUBLIC HEALTH, V29, P8; WHO, 1998, LAB SERV TUB CONTR 2; *WHO, 2007, US LIQ MED CULT DST; World Health Organization, 2013, SYST SCREEN ACT TUB; Yoon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048599	31	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127588	10.1371/journal.pone.0127588	http://dx.doi.org/10.1371/journal.pone.0127588			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046532	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000355652200024
J	Acharya, MM; Patel, NH; Craver, BM; Tran, KK; Giedzinski, E; Tseng, BP; Parihar, VK; Limoli, CL				Acharya, Munjal M.; Patel, Neal H.; Craver, Brianna M.; Tran, Katherine K.; Giedzinski, Erich; Tseng, Bertrand P.; Parihar, Vipan K.; Limoli, Charles L.			Consequences of Low Dose Ionizing Radiation Exposure on the Hippocampal Microenvironment	PLOS ONE			English	Article							NEURAL PRECURSOR CELLS; COGNITIVE IMPAIRMENTS; BRAIN; CCR2; IRRADIATION; EXPRESSION; CHEMOKINES; PATHOLOGY; INJURY; RAT	The response of the brain to irradiation is complex, involving a multitude of stress inducible pathways that regulate neurotransmission within a dynamic microenvironment. While significant past work has detailed the consequences of CNS radiotherapy following relatively high doses (>= 45 Gy), few studies have been conducted at much lower doses (<= 2 Gy), where the response of the CNS (like many other tissues) may differ substantially from that expected from linear extrapolations of high dose data. Low dose exposure could elicit radio-adaptive modulation of critical CNS processes such as neurogenesis, that provide cellular input into hippocampal circuits known to impact learning and memory. Here we show that mice deficient for chemokine signaling through genetic disruption of the CCR2 receptor exhibit a neuroprotective phenotype. Compared to wild type (WT) animals, CCR2 deficiency spared reductions in hippocampal neural progenitor cell survival and stabilized neurogenesis following exposure to low dose irradiation. While radiation-induced changes in microglia levels were not found in WT or CCR2 deficient animals, the number of Iba1+ cells did differ between each genotype at the higher dosing paradigms, suggesting that blockade of this signaling axis could moderate the neuroinflammatory response. Interestingly, changes in proinflammatory gene expression were limited in WT animals, while irradiation caused significant elevations in these markers that were attenuated significantly after radioadaptive dosing paradigms in CCR2 deficient mice. These data point to the importance of chemokine signaling under low dose paradigms, findings of potential significance to those exposed to ionizing radiation under a variety of occupational and/or medical scenarios.	[Acharya, Munjal M.; Patel, Neal H.; Craver, Brianna M.; Tran, Katherine K.; Giedzinski, Erich; Tseng, Bertrand P.; Parihar, Vipan K.; Limoli, Charles L.] Univ Calif Irvine, Dept Radiat Oncol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Limoli, CL (corresponding author), Univ Calif Irvine, Dept Radiat Oncol, Irvine, CA 92697 USA.	climoli@uci.edu	Parihar, Vipan K/Z-1195-2018; Limoli, Charles/AAW-1748-2020	Parihar, Vipan K/0000-0003-4878-7386; Limoli, Charles/0000-0002-1321-4142; Hoover, Brianna/0000-0002-1844-7922	Office of Science (BER) U.S. Department of Energy [DE-FG02-09ER64798]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER	Office of Science (BER) U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work for supported by the Office of Science (BER) U.S. Department of Energy grant no. DE-FG02-09ER64798 (CLL).	Acharya MM, 2011, CANCER RES, V71, P4834, DOI 10.1158/0008-5472.CAN-11-0027; Allen AR, 2013, RADIAT RES, V180, P78, DOI 10.1667/RR3344.1; Babcock AA, 2003, J NEUROSCI, V23, P7922; Banisadr G, 2002, J NEUROCHEM, V81, P257, DOI 10.1046/j.1471-4159.2002.00809.x; Belarbi K, 2013, CANCER RES, V73, P1201, DOI 10.1158/0008-5472.CAN-12-2989; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; Chen ZG, 2008, HUM MOL GENET, V17, pR84, DOI 10.1093/hmg/ddn104; Chiang CS, 1997, INT J RADIAT BIOL, V72, P45, DOI 10.1080/095530097143527; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Fike JR, 2007, NEUROSURG CLIN N AM, V18, P115, DOI 10.1016/j.nec.2006.10.010; Fike JR, 2009, SEMIN RADIAT ONCOL, V19, P122, DOI 10.1016/j.semradonc.2008.12.003; Greene-Schloesser D, 2013, CLIN CANCER RES, V19, P2294, DOI 10.1158/1078-0432.CCR-11-2903; Liao AC, 2013, RADIAT RES, V180, P1, DOI 10.1667/RR3339.1; Limoli CL, 2004, RADIAT RES, V161, P17, DOI 10.1667/RR3112; Linard C, 2004, INT J RADIAT ONCOL, V58, P427, DOI 10.1016/j.ijrobp.2003.09.039; McBride William H, 2002, Mil Med, V167, P66; Morganti JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093650; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Naert G, 2011, J NEUROSCI, V31, P6208, DOI 10.1523/JNEUROSCI.0299-11.2011; Parihar VK, 2014, TRANSL CANCER RES, V3, P124, DOI 10.3978/j.issn.2218-676X.2013.06.02; Parihar VK, 2015, BRAIN STRUCT FUNCT, V220, P1161, DOI 10.1007/s00429-014-0709-9; Parihar VK, 2013, P NATL ACAD SCI USA, V110, P12822, DOI 10.1073/pnas.1307301110; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Schnegg CI, 2013, FREE RADICAL BIO MED, V61, P1, DOI 10.1016/j.freeradbiomed.2013.03.002; Schnegg CI, 2011, PPAR RES, V2011, DOI 10.1155/2011/373560; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Tseng BP, 2014, ANTIOXID REDOX SIGN, V20, P1410, DOI 10.1089/ars.2012.5134; van der Meer P, 2000, EXP MOL PATHOL, V69, P192, DOI 10.1006/exmp.2000.2336	29	31	37	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128316	10.1371/journal.pone.0128316	http://dx.doi.org/10.1371/journal.pone.0128316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042591	gold, Green Published, Green Submitted			2022-12-27	WOS:000355701600044
J	Balasubramani, PP; Chakravarthy, VS; Ali, M; Ravindran, B; Moustafa, AA				Balasubramani, Pragathi Priyadharsini; Chakravarthy, V. Srinivasa; Ali, Manal; Ravindran, Balaraman; Moustafa, Ahmed A.			Identifying the Basal Ganglia Network Model Markers for Medication-Induced Impulsivity in Parkinson's Disease Patients	PLOS ONE			English	Article							SUBTHALAMIC NUCLEUS; REACTION-TIME; DECISION-MAKING; COMPULSIVE BEHAVIORS; CONTROL DISORDERS; FUNCTIONAL-ANATOMY; DOPAMINE-RECEPTORS; REWARD PREDICTION; SEROTONIN; LESIONS	Impulsivity, i.e. irresistibility in the execution of actions, may be prominent in Parkinson's disease (PD) patients who are treated with dopamine precursors or dopamine receptor agonists. In this study, we combine clinical investigations with computational modeling to explore whether impulsivity in PD patients on medication may arise as a result of abnormalities in risk, reward and punishment learning. In order to empirically assess learning outcomes involving risk, reward and punishment, four subject groups were examined: healthy controls, ON medication PD patients with impulse control disorder (PD-ON ICD) or without ICD (PD-ON non-ICD), and OFF medication PD patients (PD-OFF). A neural network model of the Basal Ganglia (BG) that has the capacity to predict the dysfunction of both the dopaminergic (DA) and the serotonergic (5HT) neuromodulator systems was developed and used to facilitate the interpretation of experimental results. In the model, the BG action selection dynamics were mimicked using a utility function based decision making framework, with DA controlling reward prediction and 5HT controlling punishment and risk predictions. The striatal model included three pools of Medium Spiny Neurons (MSNs), with D1 receptor (R) alone, D2R alone and co-expressing D1R-D2R. Empirical studies showed that reward optimality was increased in PD-ON ICD patients while punishment optimality was increased in PD-OFF patients. Empirical studies also revealed that PD-ON ICD subjects had lower reaction times (RT) compared to that of the PD-ON non-ICD patients. Computational modeling suggested that PD-OFF patients have higher punishment sensitivity, while healthy controls showed comparatively higher risk sensitivity. A significant decrease in sensitivity to punishment and risk was crucial for explaining behavioral changes observed in PD-ON ICD patients. Our results highlight the power of computational modelling for identifying neuronal circuitry implicated in learning, and its impairment in PD. The results presented here not only show that computational modelling can be used as a valuable tool for understanding and interpreting clinical data, but they also show that computational modeling has the potential to become an invaluable tool to predict the onset of behavioral changes during disease progression.	[Balasubramani, Pragathi Priyadharsini; Chakravarthy, V. Srinivasa] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India; [Ali, Manal] Ain Shams Univ, Sch Med, Cairo, Egypt; [Ravindran, Balaraman] Indian Inst Technol, Dept Comp Sci & Engn, Madras 600036, Tamil Nadu, India; [Moustafa, Ahmed A.] Univ Western Sydney, Marcs Inst Brain & Behav, Penrith, NSW 1797, Australia; [Moustafa, Ahmed A.] Univ Western Sydney, Sch Social Sci & Psychol, Penrith, NSW 1797, Australia	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Egyptian Knowledge Bank (EKB); Ain Shams University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Western Sydney University; Western Sydney University	Chakravarthy, VS (corresponding author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	schakra@iitm.ac.in	Moustafa, Ahmed/AAM-2836-2021	Chakravarthy, Srinivasa/0000-0002-2453-1637; Moustafa, Ahmed/0000-0001-5971-273X; Ravindran, Balaraman/0000-0002-5364-7639; balasubramani, pragathi priyadharsini/0000-0003-2836-6429				Ahlskog JE, 2010, NEUROLOGY, V75, P1226, DOI 10.1212/WNL.0b013e3181f5d507; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Albin RL, 1998, J MED GENET, V35, P258, DOI 10.1136/jmg.35.3.258; Alex KD, 2007, PHARMACOL THERAPEUT, V113, P296, DOI 10.1016/j.pharmthera.2006.08.004; Allen AT, 2011, GENETICS, V188, P579, DOI 10.1534/genetics.111.128512; AMALRIC M, 1995, EUR J NEUROSCI, V7, P972, DOI 10.1111/j.1460-9568.1995.tb01085.x; Amemori KI, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00047; [Anonymous], 1928, REV GEN ELECTR, DOI DOI 10.1007/S00221-011-2827-4; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Avanzi M, 2006, MOVEMENT DISORD, V21, P2068, DOI 10.1002/mds.21072; Averbeck BB, 2014, ANNU REV CLIN PSYCHO, V10, P553, DOI 10.1146/annurev-clinpsy-032813-153705; Balasubramani PP, NETWORK MODEL UNPUB; Balasubramani PP, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00047; Ballanger B, 2009, ANN NEUROL, V66, P817, DOI 10.1002/ana.21795; Bar-Gad I, 2001, CURR OPIN NEUROBIOL, V11, P689, DOI 10.1016/S0959-4388(01)00270-7; BAUNEZ C, 1995, J NEUROSCI, V15, P6531; Baunez C, 1997, EUR J NEUROSCI, V9, P2086, DOI 10.1111/j.1460-9568.1997.tb01376.x; Bedard C, 2011, PARKINSONISM RELAT D, V17, P593, DOI 10.1016/j.parkreldis.2011.05.012; BELL DE, 1995, MANAGE SCI, V41, P23, DOI 10.1287/mnsc.41.1.23; Bellebaum C, 2008, BRAIN, V131, P829, DOI 10.1093/brain/awn011; Belujon P, 2007, J NEUROSCI, V27, P9595, DOI 10.1523/JNEUROSCI.2583-07.2007; Bertran-Gonzalez J, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00136; BLOXHAM CA, 1987, J NEUROL NEUROSUR PS, V50, P1178, DOI 10.1136/jnnp.50.9.1178; Bogacz R, 2007, NEURAL COMPUT, V19, P442, DOI 10.1162/neco.2007.19.2.442; Brown G.K., 2005, BECK DEPRESSION INVE; Bugalho P, 2013, BEHAV NEUROL, V27, P547, DOI [10.3233/BEN-129019, 10.1155/2013/826742]; Calabresi P, 2014, NAT NEUROSCI, V17, P1022, DOI 10.1038/nn.3743; Chakravarthy VS, 2010, BIOL CYBERN, V103, P237, DOI 10.1007/s00422-010-0401-y; Chakravarthy VS, 2013, ENCY COMPUTATIONAL N; Chang JY, 2002, EXP BRAIN RES, V142, P67, DOI 10.1007/s00221-001-0918-3; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Cohen JD, 2007, PHILOS T R SOC B, V362, P933, DOI 10.1098/rstb.2007.2098; Cohen MX, 2009, BEHAV BRAIN RES, V199, P141, DOI 10.1016/j.bbr.2008.09.029; COOLS AR, 1984, J NEUROL NEUROSUR PS, V47, P443, DOI 10.1136/jnnp.47.5.443; Cools R, 2008, NEUROPSYCHOPHARMACOL, V33, P2291, DOI 10.1038/sj.npp.1301598; d'Acremont M, 2009, NEUROIMAGE, V47, P1929, DOI 10.1016/j.neuroimage.2009.04.096; Dalley JW, 2008, PHARMACOL BIOCHEM BE, V90, P250, DOI 10.1016/j.pbb.2007.12.021; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Dayan P, 2006, NETWORK-COMP NEURAL, V17, P335, DOI 10.1080/09548980601004024; Delaville C, 2012, NEUROBIOL DIS, V47, P322, DOI 10.1016/j.nbd.2012.05.019; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Djamshidian A, 2011, J NEUROL SCI, V310, P183, DOI 10.1016/j.jns.2011.07.031; Dougherty DM, 2005, BEHAV RES METHODS, V37, P82, DOI 10.3758/BF03206401; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Doya K, 2008, NAT NEUROSCI, V11, P410, DOI 10.1038/nn2077; EberleWang K, 1997, J COMP NEUROL, V384, P233, DOI 10.1002/(SICI)1096-9861(19970728)384:2<233::AID-CNE5>3.0.CO;2-2; Economidou D, 2012, NEUROPSYCHOPHARMACOL, V37, P2057, DOI 10.1038/npp.2012.53; Evans AH, 2006, ANN NEUROL, V59, P852, DOI 10.1002/ana.20822; Evans AH, 2009, MOVEMENT DISORD, V24, P1561, DOI 10.1002/mds.22505; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; FAHN S, 1975, NEUROLOGY, V25, P861, DOI 10.1212/WNL.25.9.861; FAHN S, 1971, J NEUROL SCI, V14, P427, DOI 10.1016/0022-510X(71)90178-X; Florio T, 2001, BEHAV BRAIN RES, V126, P93, DOI 10.1016/S0166-4328(01)00248-0; Foley P, 2004, J NEURAL TRANSM, V111, P1375, DOI 10.1007/s00702-003-0059-x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox SH, 2009, MOVEMENT DISORD, V24, P1255, DOI 10.1002/mds.22473; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frank MJ, 2007, PHILOS T R SOC B, V362, P1641, DOI 10.1098/rstb.2007.2058; Frank MJ, 2009, NAT NEUROSCI, V12, P1062, DOI 10.1038/nn.2342; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Gerfen CR, 1996, HDB CHEM NEUROANATOM, P371, DOI [10.1016/S0924-8196(96)80004-2, DOI 10.1016/S0924-8196(96)80004-2]; Goldberg D.E., 1989, GENETIC ALGORITHMS S; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Gupta A, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00172; HALLIDAY GM, 1990, BRAIN RES, V510, P104, DOI 10.1016/0006-8993(90)90733-R; Hamidovic A, 2008, J CLIN PSYCHOPHARM, V28, P45, DOI 10.1097/jcp.0b013e3181602fab; HARDEN DG, 1995, J NEUROSCI, V15, P6157; Houk JC, 2007, PHILOS T R SOC B, V362, P1573, DOI 10.1098/rstb.2007.2063; Humphries MD, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.026.2009; Jakab RL, 1996, J COMP NEUROL, V369, P137; JIANG LH, 1990, BRAIN RES, V513, P156; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kalenscher T, 2007, CURR BIOL, V17, pR58, DOI 10.1016/j.cub.2006.12.016; Kalva SK, 2012, NEURAL NETWORKS, V32, P65, DOI 10.1016/j.neunet.2012.02.031; Kalva SK, 2012, NEURAL NETWORKS; Sarvestani IK, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00013; KAWAGUCHI Y, 1990, J NEUROSCI, V10, P3421; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Kordower JH, 2013, BRAIN, V136, P2419, DOI 10.1093/brain/awt192; Krishnan R, 2011, NEURAL NETWORKS, V24, P801, DOI 10.1016/j.neunet.2011.06.002; Kuhn AA, 2009, EXP NEUROL, V215, P380, DOI 10.1016/j.expneurol.2008.11.008; Kuhn AA, 2006, BRAIN, V129, P695, DOI 10.1093/brain/awh715; Lang AE, 1989, ASSESSMENT PARKINSON, P285; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Levy R, 2002, J NEUROSCI, V22, P2855, DOI 10.1523/JNEUROSCI.22-07-02855.2002; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Long AB, 2009, SOC COGN AFFECT NEUR, V4, P346, DOI 10.1093/scan/nsp020; Magdoom KN, 2011, NEURAL COMPUT, V23, P477, DOI 10.1162/NECO_a_00073; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Moyer JT, 2007, J NEUROPHYSIOL, V98, P3731, DOI 10.1152/jn.00335.2007; Muralidharan V, 2014, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00190; Nadjar A, 2006, J NEUROSCI, V26, P8653, DOI 10.1523/JNEUROSCI.2582-06.2006; Nakamura K, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00060; Nombela C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085747; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2006, NEURON, V49, P157, DOI 10.1016/j.neuron.2005.11.014; Oades RD, 2002, BEHAV BRAIN RES, V130, P97, DOI 10.1016/S0166-4328(01)00440-5; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; Park C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051530; Perreault ML, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00031; Phillips JM, 1999, EUR J NEUROSCI, V11, P1003, DOI 10.1046/j.1460-9568.1999.00509.x; Piray P, 2014, J NEUROSCI, V34, P7814, DOI 10.1523/JNEUROSCI.4063-13.2014; Plenz D, 1999, NATURE, V400, P677, DOI 10.1038/23281; Ray N, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/594860; Ridderinkhof K.R, 2002, ACTIVATION SUPPRESSI; SCHNEIDER JS, 1987, NEUROLOGY, V37, P951, DOI 10.1212/WNL.37.6.951; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2013, CURR OPIN NEUROBIOL, V23, P229, DOI 10.1016/j.conb.2012.11.012; Schultz W, 2010, EUR J NEUROSCI, V31, P2124, DOI 10.1111/j.1460-9568.2010.07282.x; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; SERVANSCHREIBER D, 1990, SCIENCE, V249, P892, DOI 10.1126/science.2392679; Stauffer WR, 2014, CURR BIOL, V24, P2491, DOI 10.1016/j.cub.2014.08.064; Steeves TDL, 2009, BRAIN, V132, P1376, DOI 10.1093/brain/awp054; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Swann AC, 2013, PSYCHOPHARMACOLOGY, V229, P83, DOI 10.1007/s00213-013-3088-7; Tanaka SC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001333; Tanaka SC, 2006, NEURAL NETWORKS, V19, P1233, DOI 10.1016/j.neunet.2006.05.039; Thurley K, 2008, J NEUROPHYSIOL, V99, P2985, DOI 10.1152/jn.01098.2007; Uttl B, 2002, J CLIN EXP NEUROPSYC, V24, P1123, DOI 10.1076/jcen.24.8.1123.8375; Voon V, 2006, NEUROLOGY, V67, P1254, DOI 10.1212/01.wnl.0000238503.20816.13; Wang R, 1996, NEUROSCIENCE, V74, P199, DOI 10.1016/0306-4522(96)00116-9; Ward RP, 1996, J COMP NEUROL, V370, P405, DOI 10.1002/(SICI)1096-9861(19960701)370:3<405::AID-CNE10>3.0.CO;2-R; Weintraub D, 2006, ARCH NEUROL-CHICAGO, V63, P969, DOI 10.1001/archneur.63.7.969; Williams D, 2005, EUR J NEUROSCI, V21, P249, DOI 10.1111/j.1460-9568.2004.03817.x; Winstanley CA, 2005, NEUROPSYCHOPHARMACOL, V30, P669, DOI 10.1038/sj.npp.1300610; Winstanley CA, 2004, PSYCHOPHARMACOLOGY, V176, P376, DOI 10.1007/s00213-004-1884-9; Wylie SA, 2012, J NEUROLOGY NEUROSUR; Wylie SA, 2010, J COGNITIVE NEUROSCI, V22, P2058, DOI 10.1162/jocn.2009.21326	132	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0127542	10.1371/journal.pone.0127542	http://dx.doi.org/10.1371/journal.pone.0127542			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042675	Green Submitted, gold, Green Published			2022-12-27	WOS:000355701600015
J	Edmonds, R; Burkett, B; Leicht, A; McKean, M				Edmonds, Rohan; Burkett, Brendan; Leicht, Anthony; McKean, Mark			Effect of Chronic Training on Heart Rate Variability, Salivary IgA and Salivary Alpha-Amylase in Elite Swimmers with a Disability	PLOS ONE			English	Article							POINCARE PLOT ANALYSIS; AUTONOMIC ADAPTATIONS; PHYSICAL PERFORMANCE; RESPIRATORY ILLNESS; ADRENERGIC ACTIVITY; EXERCISE SCIENCE; IMMUNOGLOBULIN-A; SOCCER PLAYERS; NERVOUS-SYSTEM; INTENSITY	The purpose of this study was to a) determine the heart rate variability (HRV) and saliva markers of immunity (salivary immunoglobulin A; sIgA) and stress (salivary alpha-amylase; sAA) responses to chronic training in elite swimmers with a disability; and b) identify the relationships between HRV, sIgA, sAA and training volume. Eight members of a high performance Paralympic swimming program were monitored for their weekly resting HRV, sIgA and sAA levels in the 14 weeks leading up to a major international competition. The 14 week training program included aerobic, anaerobic, power and speed, and taper training phases, while also incorporating two swimming step tests and two swimming competitions. Specific time (root mean square of the successive differences; RMSSD) and frequency (high frequency normalized units [HFnu]) domain measures, along with non-linear indices (standard deviation of instantaneous RR variability; SD1 and short term fractal scaling exponent; alpha 1) of HRV were used for all analyses with effects examined using magnitude-based inferences. Relationships between HRV and saliva markers were identified by Spearman rank rho (rho) correlation coefficients. Compared with week 1, SD1 was very likely lower (96/4/0, ES = -2.21), while sAA was very likely elevated (100/0/0, ES = 2.32) at the beginning of week 7 for all athletes. The training program did not alter HRV or saliva whereas competition did. There were also no apparent differences observed for HRV, sIgA and sAA between each of the training phases during the 14 week swimming program. Correlations were observed between sAA and SD1 (rho = -0.212, p<0.05), along with sAA and mean HR (rho = 0.309, p<0.05). These results show that high level national competition influences depresses HRV (SD1) and increases saliva biomarkers of stress (sAA). It appears that a well-managed and periodised swimming program can maintain these indices within normal baseline levels. The study also highlighted the parasympathetic nervous system influence on sAA.	[Edmonds, Rohan; Burkett, Brendan; McKean, Mark] Univ Sunshine Coast, Sch Hlth & Sport Sci, Sippy Downs, Qld 4556, Australia; [Leicht, Anthony] James Cook Univ, Coll Healthcare Sci, Douglas, Qld, Australia	University of the Sunshine Coast; James Cook University	Edmonds, R (corresponding author), Univ Sunshine Coast, Sch Hlth & Sport Sci, Sippy Downs, Qld 4556, Australia.	rohan.edmonds@research.usc.edu.au	Leicht, Anthony/C-7187-2009	Leicht, Anthony/0000-0002-0537-5392; Burkett, Brendan/0000-0002-1974-673X; Edmonds, Rohan/0000-0002-2923-4914				Al Haddad H, 2012, INT J SPORT PHYSIOL, V7, P33, DOI 10.1123/ijspp.7.1.33; Boullosa DA, 2013, INT J SPORT PHYSIOL, V8, P400, DOI 10.1123/ijspp.8.4.400; Boullosa DA, 2012, EUR J APPL PHYSIOL, V112, P2233, DOI 10.1007/s00421-011-2202-y; Buchheit M, 2012, EUR J APPL PHYSIOL, V112, P711, DOI 10.1007/s00421-011-2014-0; Chatterton RT, 1996, CLIN PHYSIOL, V16, P433, DOI 10.1111/j.1475-097X.1996.tb00731.x; Dunbar J, 2011, INVESTIGATING USE PO, P85; Dunbar J AM, 2013, INT J EXERCISE SCI C, V10, P45; Edmonds R., 2014, J SPORT HLT IN PRESS; Edmonds R.C., 2014, J EXERCISE PHYSL ONL, V17, P84; Edmonds RC, 2013, INT J SPORTS MED; Fahlman MM, 2005, MED SCI SPORT EXER, V37, P374, DOI 10.1249/01.MSS.0000155432.67020.88; GILMAN S, 1979, HORM METAB RES, V11, P454, DOI 10.1055/s-0028-1095789; GLEESON M, 1995, CLIN EXP IMMUNOL, V102, P210; Gleeson M, 2000, CLIN J SPORT MED, V10, P206, DOI 10.1097/00042752-200007000-00011; Gleeson M, 2000, INT J SPORTS MED, V21, P302, DOI 10.1055/s-2000-313; Hautala AJ, 2009, NEUROSCI BIOBEHAV R, V33, P107, DOI 10.1016/j.neubiorev.2008.04.009; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Kivlighan KT, 2006, PSYCHONEUROENDOCRINO, V31, P703, DOI 10.1016/j.psyneuen.2006.01.007; Leicht AS, 2003, CAN J APPL PHYSIOL, V28, P446, DOI 10.1139/h03-033; Leicht AS, 2003, CAN J APPL PHYSIOL, V28, P898, DOI 10.1139/h03-064; Ljungberg G, 1997, SCAND J MED SCI SPOR, V7, P214; MCDOWELL SL, 1991, EUR J APPL PHYSIOL O, V63, P108, DOI 10.1007/BF00235178; McLean BD, 2010, INT J SPORT PHYSIOL, V5, P367, DOI 10.1123/ijspp.5.3.367; Mourot L, 2004, CLIN PHYSIOL FUNCT I, V24, P10, DOI 10.1046/j.1475-0961.2003.00523.x; Mourot L, 2004, EUR J APPL PHYSIOL, V91, P79, DOI 10.1007/s00421-003-0917-0; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Nater UM, 2006, PSYCHONEUROENDOCRINO, V31, P49, DOI 10.1016/j.psyneuen.2005.05.010; NEXO E, 1988, SCAND J CLIN LAB INV, V48, P269, DOI 10.3109/00365518809167494; OCONNOR PJ, 1987, MED SCI SPORT EXER, V19, P224; Oliveira RS, 2013, INT J SPORTS MED, V34, P424, DOI 10.1055/s-0032-1323720; Papacosta E, 2011, J SCI MED SPORT, V14, P424, DOI 10.1016/j.jsams.2011.03.004; Pichot V, 2002, MED SCI SPORT EXER, V34, P1660, DOI 10.1097/00005768-200210000-00019; Plews DJ, 2013, INT J SPORT PHYSIOL, V8, P688, DOI 10.1123/ijspp.8.6.688; Plews DJ, 2013, SPORTS MED, V43, P773, DOI 10.1007/s40279-013-0071-8; Plews DJ, 2012, EUR J APPL PHYSIOL, V112, P3729, DOI 10.1007/s00421-012-2354-4; Pyne DB, 2001, MED SCI SPORT EXER, V33, P348, DOI 10.1097/00005768-200103000-00002; Rohleder N, 2009, PSYCHONEUROENDOCRINO, V34, P469, DOI 10.1016/j.psyneuen.2008.12.004; Seiler S, 2007, MED SCI SPORT EXER, V39, P1366, DOI 10.1249/mss.0b013e318060f17d; Stanley J, 2014, EUROPEAN J APPL PHYS; Steerenberg PA, 1997, EUR J ORAL SCI, V105, P305, DOI 10.1111/j.1600-0722.1997.tb00245.x; Strahler J, 2010, PSYCHOPHYSIOLOGY, V47, P587, DOI 10.1111/j.1469-8986.2009.00957.x; Walker D, 2004, ANN ACAD MED SINGAP, V33, P27; Walsh NP, 1999, J SPORT SCI, V17, P129, DOI 10.1080/026404199366226	43	28	29	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0127749	10.1371/journal.pone.0127749	http://dx.doi.org/10.1371/journal.pone.0127749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043224	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000355701600022
J	Feng, DR; Youn, DY; Zhao, XP; Gao, YG; Quinn, WJ; Xiaoli, AM; Sun, Y; Birnbaum, MJ; Pessin, JE; Yang, FJ				Feng, Daorong; Youn, Dou Yeon; Zhao, Xiaoping; Gao, Yanguang; Quinn, William J., III; Xiaoli, Alus M.; Sun, Yan; Birnbaum, Morris J.; Pessin, Jeffrey E.; Yang, Fajun			mTORC1 Down-Regulates Cyclin-Dependent Kinase 8 (CDK8) and Cyclin C (CycC)	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN-1; LIPID-METABOLISM; TRANSCRIPTIONAL ACTIVATION; INSULIN-RESISTANCE; CULTURED-CELLS; COMPLEX 1; LIPOGENESIS; SREBP-1C; GROWTH; EXPRESSION	In non-alcoholic fatty liver disease (NAFLD) and insulin resistance, hepatic de novo lipogenesis is often elevated, but the underlying mechanisms remain poorly understood. Recently, we show that CDK8 functions to suppress de novo lipogenesis. Here, we identify the mammalian target of rapamycin complex 1 (mTORC1) as a critical regulator of CDK8 and its activating partner CycC. Using pharmacologic and genetic approaches, we show that increased mTORC1 activation causes the reduction of the CDK8-CycC complex in vitro and in mouse liver in vivo. In addition, mTORC1 is more active in three mouse models of NAFLD, correlated with the lower abundance of the CDK8-CycC complex. Consistent with the inhibitory role of CDK8 on de novo lipogenesis, nuclear SREBP-1c proteins and lipogenic enzymes are accumulated in NAFLD models. Thus, our results suggest that mTORC1 activation in NAFLD and insulin resistance results in down-regulation of the CDK8-CycC complex and elevation of lipogenic protein expression.	[Feng, Daorong; Youn, Dou Yeon; Zhao, Xiaoping; Gao, Yanguang; Xiaoli, Alus M.; Pessin, Jeffrey E.; Yang, Fajun] Albert Einstein Coll Med, Diabet Res Ctr, Dept Med, Div Endocrinol, New York, NY 10032 USA; [Zhao, Xiaoping] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China; [Gao, Yanguang] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China; [Quinn, William J., III; Birnbaum, Morris J.] Univ Penn, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; [Sun, Yan] Fudan Univ, Zhongshan Hosp, Dept Geriatr, Shanghai 200433, Peoples R China; [Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Mol Pharmacol, New York, NY USA; [Yang, Fajun] Albert Einstein Coll Med, Dept Dev & Mol Biol, New York, NY USA	Yeshiva University; Shanghai Jiao Tong University; Harbin Institute of Technology; University of Pennsylvania; Fudan University; Yeshiva University; Yeshiva University	Yang, FJ (corresponding author), Albert Einstein Coll Med, Diabet Res Ctr, Dept Med, Div Endocrinol, New York, NY 10032 USA.	fajun.yang@einstein.yu.edu	Quinn, William/K-1889-2019	Quinn, William/0000-0002-3642-584X; Birnbaum, Morris/0000-0001-9972-8680	National Institutes of Health [DK093623, AA022968, DK098439, DK020541, DK056886]; American Diabetes Association [7-11-BS-173]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056886, P30DK020541, R01DK093623, P60DK020541, R01DK098439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA022968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded by National Institutes of Health: DK093623 (FY), AA022968 (FY), DK098439 (JEP), DK020541 (JEP), DK056886 (MJB); American Diabetes Association: 7-11-BS-173 (FY). FY, JEP and MJB participated in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Abdulla A, 2014, J BIOL CHEM, V289, P29937, DOI 10.1074/jbc.M114.573659; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Elmlund H, 2006, P NATL ACAD SCI USA, V103, P15788, DOI 10.1073/pnas.0607483103; Ferre P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Filhoulaud G, 2013, TRENDS ENDOCRIN MET, V24, P257, DOI 10.1016/j.tem.2013.01.003; Floreani A, 2007, DIGEST DIS, V25, P138, DOI 10.1159/000099478; Galbraith MD, 2013, CELL, V153, P1327, DOI 10.1016/j.cell.2013.04.048; Hasty AH, 2000, J BIOL CHEM, V275, P31069, DOI 10.1074/jbc.M003335200; HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Lambert JE, 2013, GASTROENTEROLOGY; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; MENAHAN LA, 1983, METABOLISM, V32, P172, DOI 10.1016/0026-0495(83)90225-1; Meyer KD, 2008, EMBO J, V27, P1447, DOI 10.1038/emboj.2008.78; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Quinn WJ, 2012, P NATL ACAD SCI USA, V109, P15974, DOI 10.1073/pnas.1214113109; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tang ZY, 2005, AM J PHYSIOL-ENDOC M, V289, pE288, DOI 10.1152/ajpendo.00494.2004; Urano J, 2005, MOL MICROBIOL, V58, P1074, DOI 10.1111/j.1365-2958.2005.04877.x; Wan M, 2011, CELL METAB, V14, P516, DOI 10.1016/j.cmet.2011.09.001; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yan ZH, 2012, GENE, V506, P289, DOI 10.1016/j.gene.2012.07.009; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Zhao XP, 2012, J CLIN INVEST, V122, P2417, DOI 10.1172/JCI61462; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	49	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0126240	10.1371/journal.pone.0126240	http://dx.doi.org/10.1371/journal.pone.0126240			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042770	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600006
J	Mahdi, Y; Xu, XM; Carlson, BA; Fradejas, N; Gunter, P; Braun, D; Southon, E; Tessarollo, L; Hatfield, DL; Schweizer, U				Mahdi, Yassin; Xu, Xue-Ming; Carlson, Bradley A.; Fradejas, Noelia; Guenter, Paul; Braun, Doreen; Southon, Eileen; Tessarollo, Lino; Hatfield, Dolph L.; Schweizer, Ulrich			Expression of Selenoproteins Is Maintained in Mice Carrying Mutations in SECp43, the tRNA Selenocysteine 1 Associated Protein (Trnau1ap)	PLOS ONE			English	Article							INCORPORATION MACHINERY; SECIS ELEMENTS; LIVER; GENE; UGA; EXTINCTION; DISRUPTION	Selenocysteine tRNA 1 associated protein (Trnau1ap) has been characterized as a tRNA([Ser]Sec)-binding protein of 43 kDa, hence initially named SECp43. Previous studies reported its presence in complexes containing tRNA([Ser]Sec) implying a role of SECp43 as a co-factor in selenoprotein expression. We generated two conditionally mutant mouse models targeting exons 3+4 and exons 7+8 eliminating parts of the first RNA recognition motif or of the tyrosine-rich domain, respectively. Constitutive inactivation of exons 3+4 of SECp43 apparently did not affect the mice or selenoprotein expression in several organs. Constitutive deletion of exons 7+8 was embryonic lethal. We therefore generated hepatocyte-specific Secp43 knockout mice and characterized selenoprotein expression in livers of mutant mice. We found no significant changes in the levels of Se-75-labelled hepatic proteins, selenoprotein levels as determined by Western blot analysis, enzymatic activity or selenoprotein mRNA abundance. The methylation pattern of tRNA([Ser]Sec) remained unchanged. Truncated Secp43(Delta 7,8)mRNA increased in Secp43-mutant livers suggesting auto-regulation of Secp43 mRNA abundance. We found no signs of liver damage in Secp433-mutant mice, but neuron-specific deletion of exons 7+8 impaired motor performance, while not affecting cerebral selenoprotein expression or cerebellar development. These findings suggest that the targeted domains in the SECp43 protein are not essential for selenoprotein biosynthesis in hepatocytes and neurons. Whether the remaining second RNA recognition motif plays a role in selenoprotein biosynthesis and which other cellular process depends on SECp43 remains to be determined.	[Mahdi, Yassin; Fradejas, Noelia; Guenter, Paul; Braun, Doreen; Schweizer, Ulrich] Univ Bonn, Inst Biochem & Mol Biol, Bonn, Germany; [Xu, Xue-Ming; Carlson, Bradley A.; Southon, Eileen; Tessarollo, Lino; Hatfield, Dolph L.] NCI, Mouse Canc Genet Program, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	University of Bonn; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Schweizer, U (corresponding author), Univ Bonn, Inst Biochem & Mol Biol, Bonn, Germany.	uschweiz@uni-bonn.de		Schweizer, Ulrich/0000-0003-1380-4780; Fradejas-Villar, Noelia/0000-0003-3418-0743	Deutsche Forschungsgemeinschaft (DFG) [Schw914/2-1US]; Intramural Research Program National Cancer Institute, DLH; NATIONAL CANCER INSTITUTE [ZICBC011265] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Intramural Research Program National Cancer Institute, DLH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Deutsche Forschungsgemeinschaft (DFG), www.dfg.de Schw914/2-1US; Intramural Research Program National Cancer Institute, DLH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agamy O, 2010, AM J HUM GENET, V87, P538, DOI 10.1016/j.ajhg.2010.09.007; BERRY MJ, 1993, EMBO J, V12, P3315, DOI 10.1002/j.1460-2075.1993.tb06001.x; BOCK A, 1991, TRENDS BIOCHEM SCI, V16, P463, DOI 10.1016/0968-0004(91)90180-4; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; Budiman ME, 2009, MOL CELL, V35, P479, DOI 10.1016/j.molcel.2009.06.026; Chapple CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002968; Chiu-Ugalde J, 2010, BIOCHEM J, V431, P103, DOI 10.1042/BJ20100779; Ding F, 1999, RNA, V5, P1561, DOI 10.1017/S1355838299991598; Fradejas N, 2013, BIOCHEM J, V450, P427, DOI 10.1042/BJ20121713; GELPI C, 1992, P NATL ACAD SCI USA, V89, P9739, DOI 10.1073/pnas.89.20.9739; Gupta N, 2013, J MOL BIOL, V425, P2415, DOI 10.1016/j.jmb.2013.04.016; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; Hoffmann PR, 2007, NUCLEIC ACIDS RES, V35, P3963, DOI 10.1093/nar/gkm355; KELMERS AD, 1971, ANAL BIOCHEM, V44, P486, DOI 10.1016/0003-2697(71)90236-3; Kumaraswamy E, 2003, MOL CELL BIOL, V23, P1477, DOI 10.1128/MCB.23.5.1477-1488.2003; Latreche L, 2009, NUCLEIC ACIDS RES, V37, P5868, DOI 10.1093/nar/gkp635; Lobanov AV, 2010, CRIT REV BIOCHEM MOL, V45, P257, DOI 10.3109/10409231003786094; McKee AE, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-14; Moustafa ME, 2001, MOL CELL BIOL, V21, P3840, DOI 10.1128/MCB.21.11.3840-3852.2001; Otero L, 2014, RNA, V20, P1023, DOI 10.1261/rna.043877.113; Prigge JR, 2012, FREE RADICAL BIO MED, V52, P803, DOI 10.1016/j.freeradbiomed.2011.11.025; Raman AV, 2012, GENES BRAIN BEHAV, V11, P601, DOI 10.1111/j.1601-183X.2012.00794.x; Renko K, 2008, BIOCHEM J, V409, P741, DOI 10.1042/BJ20071172; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Schomburg L, 2009, BBA-GEN SUBJECTS, V1790, P1453, DOI 10.1016/j.bbagen.2009.03.015; Schweizer U, 2004, BIOCHEM J, V378, P21, DOI 10.1042/BJ20031795; Schweizer U, 2005, BIOCHEM J, V386, P221, DOI 10.1042/BJ20041973; Seeher S, 2014, ANTIOXID REDOX SIGN, V21, P835, DOI 10.1089/ars.2013.5358; Seeher S, 2014, BIOCHEM J, V462, P67, DOI 10.1042/BJ20140423; Sengupta A, 2008, BIOCHEM J, V413, P151, DOI 10.1042/BJ20080277; Small-Howard A, 2006, MOL CELL BIOL, V26, P2337, DOI 10.1128/MCB.26.6.2337-2346.2006; Squires JE, 2007, MOL CELL BIOL, V27, P7848, DOI 10.1128/MCB.00793-07; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Stock T, 2009, BBA-GEN SUBJECTS, V1790, P1520, DOI 10.1016/j.bbagen.2009.03.022; Streckfuss F, 2005, BIOCHEM BIOPH RES CO, V337, P739, DOI 10.1016/j.bbrc.2005.09.102; Suvorova ES, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006158; Suzuki T, 2008, J BIOL CHEM, V283, P2021, DOI 10.1074/jbc.M708352200; Wirth EK, 2014, BIOL TRACE ELEM RES, V158, P203, DOI 10.1007/s12011-014-9920-z; Wirth EK, 2010, FASEB J, V24, P844, DOI 10.1096/fj.09-143974; Xu XM, 2005, J BIOL CHEM, V280, P41568, DOI 10.1074/jbc.M506696200; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104	42	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0127349	10.1371/journal.pone.0127349	http://dx.doi.org/10.1371/journal.pone.0127349			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043259	Green Published, gold, Green Submitted			2022-12-27	WOS:000355701600012
J	Olafsdottir, OB; Eliasdottir, TS; Kristjansdottir, JV; Hardarson, SH; Stefansson, E				Olafsdottir, Olof Birna; Eliasdottir, Thorunn Scheving; Kristjansdottir, Jona Valgerdur; Hardarson, Sveinn Hakon; Stefansson, Einar			Retinal Vessel Oxygen Saturation during 100% Oxygen Breathing in Healthy Individuals	PLOS ONE			English	Article							BLOOD-FLOW; HYPEROXIA; OXIMETRY; TENSION; CAT; ARTERIOLAR; OCCLUSION; NORMOXIA; INNER; PIGS	Purpose To detect how systemic hyperoxia affects oxygen saturation in retinal arterioles and venules in healthy individuals. Methods Retinal vessel oxygen saturation was measured in 30 healthy individuals with a spectrophotometric retinal oximeter (Oxymap T1). Oximetry was performed during breathing of room air, 100% oxygen (10 minutes, 6L/min) and then again room air (10 minutes recovery). Results Mean oxygen saturation rises modestly in retinal arterioles during 100% oxygen breathing (94.5% +/- 3.8 vs. 92.0% +/- 3.7% at baseline, p < 0.0001) and dramatically in retinal venules (76.2% +/- 8.0% vs. 51.3% +/- 5.6%, p < 0.0001). The arteriovenous difference decreased during 100% oxygen breathing (18.3% +/- 9.0% vs. 40.7% +/- 5.7%, p < 0.0001). The mean diameter of arterioles decreased during 100% oxygen breathing compared to baseline (9.7 +/- 1.4 pixels vs. 10.3 +/- 1.3 pixels, p < 0.0001) and the same applies to the mean venular diameter (11.4 +/- 1.2 pixels vs. 13.3 +/- 1.5 pixels, p < 0.0001). Conclusions Breathing 100% oxygen increases oxygen saturation in retinal arterioles and more so in venules and constricts them compared to baseline levels. The dramatic increase in oxygen saturation in venules reflects oxygen flow from the choroid and the unusual vascular anatomy and oxygen physiology of the eye.	[Olafsdottir, Olof Birna; Eliasdottir, Thorunn Scheving; Kristjansdottir, Jona Valgerdur; Hardarson, Sveinn Hakon; Stefansson, Einar] Univ Iceland, Dept Ophthalmol, Reykjavik, Iceland; [Olafsdottir, Olof Birna; Eliasdottir, Thorunn Scheving; Kristjansdottir, Jona Valgerdur; Hardarson, Sveinn Hakon; Stefansson, Einar] Natl Univ Hosp Iceland, Landspitali, Dept Ophthalmol, Reykjavik, Iceland	University of Iceland; Landspitali National University Hospital	Stefansson, E (corresponding author), Univ Iceland, Dept Ophthalmol, Reykjavik, Iceland.	einarste@landspitali.is		Eliasdottir, Thorunn/0000-0003-4217-7050; Hardarson, Sveinn Hakon/0000-0001-5865-6756	Icelandic Centre for Research [100429021]; Landspitali-University Hospital Research Fund [A-2013-023]; Icelandic Fund for Prevention of Blindness	Icelandic Centre for Research; Landspitali-University Hospital Research Fund; Icelandic Fund for Prevention of Blindness	This work was supported by the Icelandic Centre for Research (rannis.is, OBO, grant no. 100429021), Landspitali-University Hospital Research Fund (lsh.is, OBO, grant no. A-2013-023) and the Icelandic Fund for Prevention of Blindness (no URL exists, OBO, TSE, JVK, no grant number exists). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beach JM, 1999, J APPL PHYSIOL, V86, P748, DOI 10.1152/jappl.1999.86.2.748; Berne RM, 1998, PHYSIOLOGY; BRAUN RD, 1995, INVEST OPHTH VIS SCI, V36, P523; BRAUN RD, 1995, INVEST OPHTH VIS SCI, V36, P542; EPERON G, 1975, INVEST OPHTH VISUAL, V14, P342; Geirsdottir A, 2012, INVEST OPHTH VIS SCI, V53, P5433, DOI 10.1167/iovs.12-9912; Geiser MH, 2000, CURR EYE RES, V21, P669, DOI 10.1076/0271-3683(200008)21:2;1-V;FT669; Hardarson SH, 2006, INVEST OPHTH VIS SCI, V47, P5011, DOI 10.1167/iovs.06-0039; Harris A, 2003, OPHTHAL SURG LAS IM, V34, P152, DOI 10.3928/1542-8877-20030301-16; Jean-Louis S, 2005, INVEST OPHTH VIS SCI, V46, P1714, DOI 10.1167/iovs.04-1216; Kiss B, 2002, MICROVASC RES, V64, P75, DOI 10.1006/mvre.2002.2402; Lange CAK, 2011, AM J OPHTHALMOL, V152, P406, DOI 10.1016/j.ajo.2011.02.014; LINSENMEIER RA, 1989, INVEST OPHTH VIS SCI, V30, P612; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Olafsdottir OB, 2014, BRIT J OPHTHALMOL, V98, P329, DOI 10.1136/bjophthalmol-2013-303162; PAKOLA SJ, 1993, INVEST OPHTH VIS SCI, V34, P2866; Palkovits S, 2014, INVEST OPHTH VIS SCI, V55, P4707, DOI 10.1167/iovs.14-14593; POURNARAS CJ, 1989, EXP EYE RES, V49, P347, DOI 10.1016/0014-4835(89)90045-6; RANDALL D, 1997, ANIMAL PHYSL; RIVA CE, 1986, J APPL PHYSIOL, V61, P592, DOI 10.1152/jappl.1986.61.2.592; RIVA CE, 1983, INVEST OPHTH VIS SCI, V24, P47; Rose PA, 2007, MICROVASC RES, V73, P35, DOI 10.1016/j.mvr.2006.10.001; Schmidl D, 2011, EXP EYE RES, V93, P141, DOI 10.1016/j.exer.2010.09.002; Stefansson E, 1999, INVEST OPHTH VIS SCI, V40, P2756; Tayyari F, 2009, INVEST OPHTH VIS SCI, V50, P4814, DOI 10.1167/iovs.09-3373; Williamson TH, 2009, GRAEF ARCH CLIN EXP, V247, P1019, DOI 10.1007/s00417-009-1072-z; WOLBARSHT ML, 1987, EXP BIOL, V47, P49	27	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128780	10.1371/journal.pone.0128780	http://dx.doi.org/10.1371/journal.pone.0128780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042732	gold, Green Submitted, Green Published			2022-12-27	WOS:000355701600066
J	Zhou, GM; Cheng, ZJ; Yue, ZZ; Tredoux, C; He, JB; Wang, L				Zhou, Guomei; Cheng, Zhijie; Yue, Zhenzhu; Tredoux, Colin; He, Jibo; Wang, Ling			Own-Race Faces Capture Attention Faster than Other-Race Faces: Evidence from Response Time and the N2pc	PLOS ONE			English	Article							VISUAL-ATTENTION; PERCEPTION; MEMORY; RECOGNITION; BIAS; CATEGORIZATION; COMPONENT; ACCOUNT; GENDER; IDENTIFICATION	Studies have shown that people are better at recognizing human faces from their own-race than from other-races, an effect often termed the Own-Race Advantage. The current study investigates whether there is an Own-Race Advantage in attention and its neural correlates. Participants were asked to search for a human face among animal faces. Experiment 1 showed a classic Own-Race Advantage in response time both for Chinese and Black South African participants. Using event-related potentials (ERPs), Experiment 2 showed a similar Own-Race Advantage in response time for both upright faces and inverted faces. Moreover, the latency of N2pc for own-race faces was earlier than that for other-race faces. These results suggested that own-race faces capture attention more efficiently than other-race faces.	[Zhou, Guomei; Cheng, Zhijie; Yue, Zhenzhu] Sun Yat Sen Univ, Dept Psychol, Guangzhou 510275, Guangdong, Peoples R China; [Tredoux, Colin] Univ Cape Town, Dept Psychol, ZA-7925 Cape Town, Western Cape, South Africa; [He, Jibo] Wichita State Univ, Dept Psychol, Wichita, KS 67208 USA; [Wang, Ling] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Wang, Ling] S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; University of Cape Town; Wichita State University; South China Normal University; South China Normal University	Zhou, GM (corresponding author), Sun Yat Sen Univ, Dept Psychol, Guangzhou 510275, Guangdong, Peoples R China.	zhougm@mail.sysu.edu.cn; yuezhenzhu@gmail.com	Tredoux, Colin G/E-7235-2010; Zhou, Guomei/E-4370-2010; Wang, Ling/A-1749-2017; He, Jibo/U-6757-2017	Tredoux, Colin G/0000-0002-9653-786X; Zhou, Guomei/0000-0001-9377-9663; He, Jibo/0000-0002-5110-581X; Wang, Ling/0000-0002-3935-5795; Yue, Zhenzhu/0000-0003-1965-2132	National Natural Science Foundation of China [31170978, 31100739, 31470978]; Ministry of Education of China [10YJCXLX055]; Major Program of the National Social Science Foundation of China [14ZDB015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Major Program of the National Social Science Foundation of China	This research was supported by the National Natural Science Foundation of China (31170978) to GZ, the National Natural Science Foundation of China (31100739, 31470978) to ZY, the Ministry of Education of China (10YJCXLX055) to ZY, and the Major Program of the National Social Science Foundation of China (14ZDB015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Caharel S, 2011, INT J PSYCHOPHYSIOL, V79, P266, DOI 10.1016/j.ijpsycho.2010.10.018; Chanon VW, 2008, VIS COGN, V16, P325, DOI 10.1080/13506280701459026; Chiroro PM, 2008, PSYCHON B REV, V15, P1089, DOI 10.3758/PBR.15.6.1089; CHRISTIE J, 1995, MEM COGNITION, V23, P547, DOI 10.3758/BF03197256; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; Eimer M, 1996, ELECTROEN CLIN NEURO, V99, P225, DOI 10.1016/0013-4694(96)95711-9; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; Hayward WG, 2013, VIS COGN, V21, P1224, DOI 10.1080/13506285.2013.824530; Herzmann G, 2011, NEUROPSYCHOLOGIA, V49, P3103, DOI 10.1016/j.neuropsychologia.2011.07.019; Hirose Y, 2007, VIS COGN, V15, P647, DOI 10.1080/13506280601069578; Hodsoll J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012509; Hugenberg K, 2013, VIS COGN, V21, P1392, DOI 10.1080/13506285.2013.821429; Hugenberg K, 2010, PSYCHOL REV, V117, P1168, DOI 10.1037/a0020463; Humphreys GW, 2005, VIS COGN, V12, P249, DOI 10.1080/13506280444000148; Ito TA, 2005, COGN AFFECT BEHAV NE, V5, P21, DOI 10.3758/CABN.5.1.21; Ito TA, 2003, J PERS SOC PSYCHOL, V85, P616, DOI 10.1037/0022-3514.85.4.616; Ito TA, 2013, VIS COGN, V21, P1096, DOI 10.1080/13506285.2013.821430; Kubota JT, 2007, J EXP SOC PSYCHOL, V43, P738, DOI 10.1016/j.jesp.2006.10.023; Levin DT, 2000, J EXP PSYCHOL GEN, V129, P559, DOI 10.1037//0096-3445.129.4.559; Lorenzo-Lopez L, 2011, NEUROPSYCHOLOGIA, V49, P858, DOI 10.1016/j.neuropsychologia.2011.01.015; Loven J, 2012, MEMORY, V20, P321, DOI 10.1080/09658211.2012.658064; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P1000, DOI 10.1037/0096-1523.20.5.1000; Luck SJ, 2006, SCHIZOPHR RES, V85, P174, DOI 10.1016/j.schres.2006.03.040; MacLin OH, 2001, PSYCHOL PUBLIC POL L, V7, P98, DOI 10.1037//1076-8971.7.1.98; Malpass RS., 1990, BEHAV SCI RES, V24, P1, DOI DOI 10.1177/106939719002400101; Marcon JL, 2010, VIS COGN, V18, P767, DOI 10.1080/13506280903178622; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Natu V, 2013, VIS COGN, V21, P1081, DOI 10.1080/13506285.2013.811455; Papesh MH, 2010, COGNITION, V116, P283, DOI 10.1016/j.cognition.2010.05.001; Rodriguez Holguin S, 2009, INT J PSYCHOPHYSIOL, V73, P279, DOI 10.1016/j.ijpsycho.2009.04.006; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rousselet GA, 2004, J VISION, V4, P13, DOI 10.1167/4.1.2; Susa KJ, 2010, SOC COGNITION, V28, P523, DOI 10.1521/soco.2010.28.4.523; Tanaka JW, 2013, VIS COGN, V21, P1183, DOI 10.1080/13506285.2013.826315; Tanaka JW, 2009, COGN AFFECT BEHAV NE, V9, P122, DOI 10.3758/CABN.9.1.122; Tanaka JW, 2004, COGNITION, V93, pB1, DOI 10.1016/j.cognition.2003.09.011; Van Bavel JJ, 2012, PERS SOC PSYCHOL B, V38, P1566, DOI 10.1177/0146167212455829; Vizioli L, 2010, J VISION, V10, DOI 10.1167/10.1.15; Wiese H, 2014, CEREB CORTEX, V24, P826, DOI 10.1093/cercor/bhs369; Wiese H, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00898; Wiese H, 2009, BIOL PSYCHOL, V81, P103, DOI 10.1016/j.biopsycho.2009.03.002; Woodman GF, 1999, NATURE, V400, P867, DOI 10.1038/23698; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; Zhou GM, 2014, VIS COGN, V22, P1296, DOI 10.1080/13506285.2014.998324; Zhou GM, 2010, CONSCIOUS COGN, V19, P408, DOI 10.1016/j.concog.2009.12.009	48	15	16	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0127709	10.1371/journal.pone.0127709	http://dx.doi.org/10.1371/journal.pone.0127709			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7TC	26042843	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600019
J	Amado, D; Sanchez-Oliva, D; Gonzalez-Ponce, I; Pulido-Gonzalez, JJ; Sanchez-Miguel, PA				Amado, Diana; Sanchez-Oliva, David; Gonzalez-Ponce, Inmaculada; Jose Pulido-Gonzalez, Juan; Antonio Sanchez-Miguel, Pedro			Incidence of Parental Support and Pressure on Their Children's Motivational Processes towards Sport Practice Regarding Gender	PLOS ONE			English	Article							SELF-DETERMINATION THEORY; MEASURED PHYSICAL-ACTIVITY; BASIC PSYCHOLOGICAL NEEDS; COACH AUTONOMY SUPPORT; YOUNG SOCCER PLAYERS; INTRINSIC MOTIVATION; SOCIAL-INFLUENCE; YOUTH SPORT; PERCEPTIONS; ENGAGEMENT	Grounded in Self-Determination Theory, structural equation modeling (SEM) with the aim of examining how parental support/pressure could influence their children's motivational processes in sport was conducted, as well as the models' differences in operability regarding gender. The sample size was 321 children ranging in age from 10 to 16 years old who were athletes from Extremadura, and 321 parents (included only the father or mother more involved with the sport of his or her child). 175 participants were male and 146 were female from individual (n = 130), and team sports (n=191). A questionnaire was conducted to assess parental perception of support/pressure and another questionnaire was conducted to measure satisfaction of basic psychological needs, type of motivation and enjoyment/boredom showed by their children towards sport practice. Results revealed that parental pressure negatively predicted satisfaction of the basic psychological needs. It also emerged as a strong positive predictor of intrinsic motivation and negative predictor of amotivation. Moreover, intrinsic motivation emerged as positive predictor of enjoyment and a negative predictor of boredom, whereas amotivation positively predicted boredom and negatively predicted enjoyment. Furthermore, results showed there were mean differences by gender: male athletes perceived greater parental pressure. Hence, it is necessary to decrease parental pressure towards their children in sport, with the aim of making them more motivated and enjoy, promoting positive consequences.	[Amado, Diana] Catholic Univ Murcia UCAM, Dept Phys Act & Sport Sci, Murcia, Spain; [Sanchez-Oliva, David] Univ Cadiz UCA, Dept Didact Phys Plast & Mus Educ, Cadiz, Spain; [Gonzalez-Ponce, Inmaculada; Jose Pulido-Gonzalez, Juan; Antonio Sanchez-Miguel, Pedro] Univ Extremadura, Dept Didact Mus Plast & Corporal Express, Caceres, Spain	Universidad Catolica de Murcia; Universidad de Cadiz; Universidad de Extremadura	Amado, D (corresponding author), Catholic Univ Murcia UCAM, Dept Phys Act & Sport Sci, Murcia, Spain.	damado@ucam.edu	Ponce, Inmaculada ingopo González/L-4841-2014; SANCHEZ-OLIVA, DAVID/O-1139-2019; OLIVA, DAVID SANCHEZ/L-1698-2014; Pulido, Juan José/L-1596-2014; Pulido, Juan/AAX-2599-2020	Ponce, Inmaculada ingopo González/0000-0002-7816-7789; SANCHEZ-OLIVA, DAVID/0000-0001-9678-963X; Pulido, Juan José/0000-0003-2416-4141; 	Sports Council in Spain	Sports Council in Spain	This study has been realized thanks to the financing of the Sports Council in Spain, with its funds for conducting research projects at the university.	Adie JW, 2012, PSYCHOL SPORT EXERC, V13, P51, DOI 10.1016/j.psychsport.2011.07.008; Anderson JC, 2003, J APPL DEV PSYCHOL, V24, P241, DOI 10.1016/S0193-3973(03)00046-7; Baena-Extremera A, 2012, REV PSICODIDACT, V17, P377, DOI 10.1387/RevPsicodidact.4037; Balaguer I, 2012, J SPORT SCI, V30, P1619, DOI 10.1080/02640414.2012.731517; Bartholomew KJ, 2011, PERS SOC PSYCHOL B, V37, P1459, DOI 10.1177/0146167211413125; BROWN BA, 1989, SEX ROLES, V20, P397, DOI 10.1007/BF00287999; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Brustad R. J., 2001, HDB SPORT PSYCHOL, P604; Bunke S, 2013, EUR J SPORT SCI, V13, P86, DOI 10.1080/17461391.2011.617390; Byrne B. M., 2001, STRUCTURAL EQUATION; DECI EL, 1987, J PERS SOC PSYCHOL, V53, P1024, DOI 10.1037/0022-3514.53.6.1024; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Deci EL, 1985, INTRINSIC MOTIVATION; Duda JL, 1992, J EDUC PSYCHOL, V84, P1, DOI DOI 10.1037/0022-0663.84.3.290; Durand-Bush N, 2004, STAPS, V64, P15; Dysvik A, 2013, J APPL SOC PSYCHOL, V43, P1050, DOI 10.1111/jasp.12068; Edwardson CL, 2010, PEDIATR EXERC SCI, V22, P105, DOI 10.1123/pes.22.1.105; Fenton SAM, 2014, PSYCHOL SPORT EXERC, V15, P453, DOI 10.1016/j.psychsport.2014.04.005; Fraser-Thomas J, 2008, J APPL SPORT PSYCHOL, V20, P318, DOI 10.1080/10413200802163549; Fuemmeler BF, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-17; Gagne M, 2005, J ORGAN BEHAV, V26, P331, DOI 10.1002/job.322; Garcia-Calvo T, 2011, 13 SPORT PSYCH C MAD; Gillet N, 2010, PSYCHOL SPORT EXERC, V11, P155, DOI 10.1016/j.psychsport.2009.10.004; Heitzler CD, 2006, PREV MED, V42, P254, DOI 10.1016/j.ypmed.2006.01.010; Hu L T., 1995, STRUCTURAL EQUATION, P76, DOI DOI 10.1080/10705519909540118; Jago R., 2011, PREV MED, V52, P44, DOI [10.1016/j.ypmed.2010.11.001, DOI 10.1016/j.ypmed.2010.11.001]; Joesaar H, 2012, PSYCHOL SPORT EXERC, V13, P257, DOI 10.1016/j.psychsport.2011.12.001; Le Bars H, 2009, SCAND J MED SCI SPOR, V19, P274, DOI 10.1111/j.1600-0838.2008.00786.x; Lee M., 1997, EUROPEAN J PHYS ED, V2, P167, DOI [DOI 10.1080/1740898970020204, 10.1080/1740898970020204]; LEFF SS, 1995, J YOUTH ADOLESCENCE, V24, P187, DOI 10.1007/BF01537149; Lewis MA, 2005, PERS SOC PSYCHOL B, V31, P416, DOI 10.1177/0146167204271600; MOORE LL, 1991, J PEDIATR-US, V118, P215, DOI 10.1016/S0022-3476(05)80485-8; Murcia JAM, 2008, REV MEX PSICOL, V25, P295; Muller H, 2004, J EXP PSYCHOL HUMAN, V30, P212, DOI 10.1037/0096-1523.30.1.212; O'Rourke DJ, 2014, J APPL SPORT PSYCHOL, V26, P395, DOI 10.1080/10413200.2014.907838; Philippe FL, 2008, MOTIV EMOTION, V32, P81, DOI 10.1007/s11031-008-9087-z; Ramis Y, 2013, AN PSICOL-SPAIN, V29, P243, DOI 10.6018/analesps.29.1.124011; redricks J. A., 2004, DEV SPORT EXERCISE P, P145; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; S?nchez-Oliva D., 2013, MOTRICIDAD EUROPEAN, V30, P53; Sanchez-Miguel PA, 2014, UNIV PSYCHOL, V13, P15; Sanchez-Miguel PA, 2013, J HUM KINET, V36, P169, DOI 10.2478/hukin-2013-0017; Sanchez-Oliva D, 2012, REV IBEROAM PSICOL E, V7, P227; Skinner E., 2002, HDB SELF DETERMINATI, P297; SKINNER EA, 1993, J EDUC PSYCHOL, V85, P571, DOI 10.1037/0022-0663.85.4.571; Alvarez MS, 2009, SPAN J PSYCHOL, V12, P138, DOI 10.1017/S1138741600001554; Spink KS, 2008, SOC INFLUENCE, V3, P189, DOI 10.1080/15534510802280819; Ullrich-French S, 2006, PSYCHOL SPORT EXERC, V7, P193, DOI 10.1016/j.psychsport.2005.08.006; Vallerand R. J., 2012, HDB SPORT PSYCHOL, V3rd, P59, DOI [DOI 10.1002/9781118270011.CH3, 10.1002/9781118270011.ch3]; Vlachopoulos SP, 2006, MEAS PHYS EDUC EXERC, V10, P179, DOI 10.1207/s15327841mpee1003_4; Weiss M.R., 2002, ADV SPORT PSYCHOL, V2nd ed., P101; Wilson KS, 2007, J SPORT EXERCISE PSY, V29, pS217; Wolfenden LE, 2005, J APPL SPORT PSYCHOL, V17, P108, DOI 10.1080/10413200590932416	53	39	45	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128015	10.1371/journal.pone.0128015	http://dx.doi.org/10.1371/journal.pone.0128015			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7ST	26039062	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700085
J	Blackwell, SB; Nations, CS; McDonald, TL; Thode, AM; Mathias, D; Kim, KH; Greene, CR; Macrander, AM				Blackwell, Susanna B.; Nations, Christopher S.; McDonald, Trent L.; Thode, Aaron M.; Mathias, Delphine; Kim, Katherine H.; Greene, Charles R., Jr.; Macrander, A. Michael			Effects of Airgun Sounds on Bowhead Whale Calling Rates: Evidence for Two Behavioral Thresholds	PLOS ONE			English	Article							BALAENA-MYSTICETUS; MARINE MAMMALS; BEAUFORT SEA; NOISE; FREQUENCY; EXPOSURE; ISLAND; OCEAN; BLUE	In proximity to seismic operations, bowhead whales (Balaenamysticetus) decrease their calling rates. Here, we investigate the transition from normal calling behavior to decreased calling and identify two threshold levels of received sound from airgun pulses at which calling behavior changes. Data were collected in August-October 2007-2010, during the westward autumn migration in the Alaskan Beaufort Sea. Up to 40 directional acoustic recorders (DASARs) were deployed at five sites offshore of the Alaskan North Slope. Using triangulation, whale calls localized within 2 km of each DASAR were identified and tallied every 10 minutes each season, so that the detected call rate could be interpreted as the actual call production rate. Moreover, airgun pulses were identified on each DASAR, analyzed, and a cumulative sound exposure level was computed for each 10-min period each season (CSEL10-min). A Poisson regression model was used to examine the relationship between the received CSEL10-min from airguns and the number of detected bowhead calls. Calling rates increased as soon as airgun pulses were detectable, compared to calling rates in the absence of airgun pulses. After the initial increase, calling rates leveled off at a received CSEL10-min of similar to 94 dB re 1 mu Pa-2-s (the lower threshold). In contrast, once CSEL10-min exceeded similar to 127 dB re 1 mu Pa-2-s (the upper threshold), whale calling rates began decreasing, and when CSEL10-min values were above similar to 160 dB re 1 mu Pa-2-s, the whales were virtually silent.	[Blackwell, Susanna B.; Kim, Katherine H.; Greene, Charles R., Jr.] Greeneridge Sci Inc, Santa Barbara, CA 93117 USA; [Nations, Christopher S.; McDonald, Trent L.] Western EcoSyst Technol Inc, Cheyenne, WY USA; [Thode, Aaron M.; Mathias, Delphine] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Macrander, A. Michael] Shell Explorat & Prod Co, Anchorage, AK USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Royal Dutch Shell	Blackwell, SB (corresponding author), Greeneridge Sci Inc, Santa Barbara, CA 93117 USA.	susanna@greeneridge.com			Greeneridge Sciences, Inc.; Western EcoSystems Technology, Inc.	Greeneridge Sciences, Inc.; Western EcoSystems Technology, Inc.	Greeneridge Sciences, Inc. and Western EcoSystems Technology, Inc. provided support in the form of salaries for authors SB, CN, TM, HK and CG but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andrew R. K., 2002, Acoustics Research Letters Online, V3, P65, DOI 10.1121/1.1461915; Bezrukov SM, 2003, UNSOLVED PROBLEMS NO; Blackwell SB, 2004, J ACOUST SOC AM, V115, P2346, DOI 10.1121/1.1701899; Blackwell SB, 2011, JOINT MONITORING PRO; Blackwell SB, 2010, JOINT MONITORING PRO; Blackwell SB, 2007, ARCTIC, V60, P255; Blackwell SB, 2013, MAR MAMMAL SCI, V29, pE342, DOI 10.1111/mms.12001; BOWLES AE, 1994, J ACOUST SOC AM, V96, P2469, DOI 10.1121/1.410120; Clarke JT, 2011, 2010033 OCS BOEMRE N; Croll DA, 2001, ANIM CONSERV, V4, P13, DOI 10.1017/S1367943001001020; Di Iorio L, 2010, BIOL LETTERS, V6, P51, DOI 10.1098/rsbl.2009.0651; Ellison WT, 2012, CONSERV BIOL, V26, P21, DOI 10.1111/j.1523-1739.2011.01803.x; Fristrup KM, 2003, J ACOUST SOC AM, V113, P3411, DOI 10.1121/1.1573637; Funk D., 2008, MARINE MAMMAL MONITO; George JC, 1999, CAN J ZOOL, V77, P571, DOI 10.1139/cjz-77-4-571; Givens GH, 2013, SCI COMM INT WHAL CO; Greene CR, 2004, J ACOUST SOC AM, V116, P799, DOI 10.1121/1.1765191; Greene CR., 1998, J ACOUST SOC AM, V104, P1826, DOI [10.1121/1.423473, DOI 10.1121/1.423473]; Greene CR., 1999, J ACOUST SOC AM, V106, P2280, DOI 10.1121/1.427798; Guerra M, 2011, J ACOUST SOC AM, V130, P3046, DOI 10.1121/1.3628326; Hannay D, 2009, MARINE MAMMAL MONITO; Koski WR, 1987, RESPONSES BOWHEAD WH; Koski WR, 2009, SCI COMM INT WHAL CO; Lahiri S. N., 2003, RESAMPLING METHODS D, P115; LENTH RV, 1981, TECHNOMETRICS, V23, P149, DOI 10.2307/1268030; LJUNGBLAD DK, 1988, ARCTIC, V41, P183; Madsen P. T., 2002, Aquatic Mammals, V28, P231; Madsen PT, 2005, J ACOUST SOC AM, V117, P3952, DOI 10.1121/1.1921508; McCauley R.D., 2000, APPEA J, V40, P692, DOI DOI 10.1071/AJ99048; McCauley RD, 1998, APPEA J, V38, P692; MCDONALD MA, 1995, J ACOUST SOC AM, V98, P712, DOI 10.1121/1.413565; McDonald MA, 2006, J ACOUST SOC AM, V120, P711, DOI 10.1121/1.2216565; Melcon ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032681; Miller GW, 2005, OFFSHORE OIL AND GAS ENVIRONMENTAL EFFECTS MONITORING: APPROACHES AND TECHNOLOGIES, P511; Miller PJO, 2009, DEEP-SEA RES PT I, V56, P1168, DOI 10.1016/j.dsr.2009.02.008; Miller PJO, 2000, NATURE, V405, P903, DOI 10.1038/35016148; Moore Sue E., 1993, Society for Marine Mammalogy Special Publication, V2, P313; Mosher DC, 2009, CANADA BASIN SEISMIC; Mosher DC, 2010, CANADA BASIN SEISMIC; Nieukirk SL, 2012, J ACOUST SOC AM, V131, P1102, DOI 10.1121/1.3672648; Oldham KB, 2008, ATLAS FUNCTIONS, P75; Parks SE, 2011, BIOL LETTERS, V7, P33, DOI 10.1098/rsbl.2010.0451; Passchier-Vermeer W, 2000, ENVIRON HEALTH PERSP, V108, P123, DOI 10.1289/ehp.00108s1123; Richardson W. John, 1993, Society for Marine Mammalogy Special Publication, V2, P631; RICHARDSON WJ, 1985, BIOL CONSERV, V32, P195; RICHARDSON WJ, 1986, J ACOUST SOC AM, V79, P1117, DOI 10.1121/1.393384; Risch D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029741; Robertson FC, 2013, ENDANGER SPECIES RES, V21, P143, DOI 10.3354/esr00515; Ross D, 2005, IEEE J OCEANIC ENG, V30, P257, DOI 10.1109/JOE.2005.850879; Ross D., 1993, Acoustics Bulletin, V18, P5; Slabbekoorn H, 2010, TRENDS ECOL EVOL, V25, P419, DOI 10.1016/j.tree.2010.04.005; Sousa-Lima RS., 2008, CAN ACOUST, V36, P174, DOI DOI 10.1227/01.NEU.0000255476.06247.F1; Sousa-Lima RS, 2002, J ACOUST SOC AM, V112, P2430, DOI DOI 10.1121/1.4779974; Southall Brandon L., 2007, Aquatic Mammals, V33, pI; Streever B, 2012, INT C HLTH SAF ENV O; Thode A, 2010, J ACOUST SOC AM, V128, pE181, DOI 10.1121/1.3479686; Thode AM, 2012, J ACOUST SOC AM, V131, P3726, DOI 10.1121/1.3699247	57	56	57	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0125720	10.1371/journal.pone.0125720	http://dx.doi.org/10.1371/journal.pone.0125720			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039218	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700011
J	Buas, MF; Onstad, L; Levine, DM; Risch, HA; Chow, WH; Liu, G; Fitzgerald, RC; Bernstein, L; Ye, WM; Bird, NC; Romero, Y; Casson, AG; Corley, DA; Shaheen, NJ; Wu, AH; Gammon, MD; Reid, BJ; Hardie, LJ; Peters, U; Whiteman, DC; Vaughan, TL				Buas, Matthew F.; Onstad, Lynn; Levine, David M.; Risch, Harvey A.; Chow, Wong-Ho; Liu, Geoffrey; Fitzgerald, Rebecca C.; Bernstein, Leslie; Ye, Weimin; Bird, Nigel C.; Romero, Yvonne; Casson, Alan G.; Corley, Douglas A.; Shaheen, Nicholas J.; Wu, Anna H.; Gammon, Marilie D.; Reid, Brian J.; Hardie, Laura J.; Peters, Ulrike; Whiteman, David C.; Vaughan, Thomas L.			MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; BINDING-SITE POLYMORPHISMS; DNA-REPAIR GENES; MICRORNA EXPRESSION; CANCER RISK; FUNCTIONAL POLYMORPHISM; SUSCEPTIBILITY LOCI; CERVICAL-CANCER; BREAST-CANCER; LUNG-CANCER	Incidence of esophageal adenocarcinoma (EA) has increased substantially in recent decades. Multiple risk factors have been identified for EA and its precursor, Barrett's esophagus (BE), such as reflux, European ancestry, male sex, obesity, and tobacco smoking, and several germline genetic variants were recently associated with disease risk. Using data from the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON) genome-wide association study (GWAS) of 2,515 EA cases, 3,295 BE cases, and 3,207 controls, we examined single nucleotide polymorphisms (SNPs) that potentially affect the biogenesis or biological activity of microRNAs (miRNAs), small non-coding RNAs implicated in post-transcriptional gene regulation, and deregulated in many cancers, including EA. Polymorphisms in three classes of genes were examined for association with risk of EA or BE: miRNA biogenesis genes (157 SNPs, 21 genes); miRNA gene loci (234 SNPs, 210 genes); and miRNA-targeted mRNAs (177 SNPs, 158 genes). Nominal associations (P<0.05) of 29 SNPs with EA risk, and 25 SNPs with BE risk, were observed. None remained significant after correction for multiple comparisons (FDR q>0.50), and we did not find evidence for interactions between variants analyzed and two risk factors for EA/BE (smoking and obesity). This analysis provides the most extensive assessment to date of miRNA-related SNPs in relation to risk of EA and BE. While common genetic variants within components of the miRNA biogenesis core pathway appear unlikely to modulate susceptibility to EA or BE, further studies may be warranted to examine potential associations between unassessed variants in miRNA genes and targets with disease risk.	[Buas, Matthew F.; Onstad, Lynn; Reid, Brian J.; Vaughan, Thomas L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Levine, David M.] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA; [Risch, Harvey A.] Yale Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA; [Chow, Wong-Ho] Univ Texas Houston, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Liu, Geoffrey] Ontario Canc Inst, Pharmacogen Epidemiol, Toronto, ON M5G 2M9, Canada; [Liu, Geoffrey] Hutchison MRC Res Ctr, MRC, Canc Cell Unit, Cambridge, England; [Liu, Geoffrey] Univ Cambridge, Cambridge, England; [Fitzgerald, Rebecca C.] Beckman Res Inst, Dept Populat Sci, Duarte, CA USA; [Bernstein, Leslie] City Hope Comprehens Canc Ctr, Duarte, CA USA; [Ye, Weimin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Bird, Nigel C.] Univ Sheffield, Dept Oncol, Sch Med, Sheffield, S Yorkshire, England; [Romero, Yvonne] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Romero, Yvonne] Mayo Clin, Romero Registry, Rochester, MN USA; [Casson, Alan G.] Univ Saskatchewan, Dept Surg, Saskatoon, SK, Canada; [Corley, Douglas A.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Corley, Douglas A.] Kaiser Permanente No Calif, San Francisco Med Ctr, San Francisco, CA USA; [Shaheen, Nicholas J.] Univ N Carolina, Sch Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Wu, Anna H.] Univ So Calif, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA USA; [Gammon, Marilie D.] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Reid, Brian J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Hardie, Laura J.] Univ Leeds, Div Epidemiol, Leeds, W Yorkshire, England; [Peters, Ulrike; Vaughan, Thomas L.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Whiteman, David C.] QIMR Berghofer Med Res Inst, Canc Control, Brisbane, Qld, Australia	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Yale University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Cambridge; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Karolinska Institutet; University of Sheffield; Mayo Clinic; Mayo Clinic; University of Saskatchewan; Kaiser Permanente; Kaiser Permanente; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Southern California; University of North Carolina; University of North Carolina Chapel Hill; Fred Hutchinson Cancer Center; University of Leeds; University of Washington; University of Washington Seattle; QIMR Berghofer Medical Research Institute	Buas, MF (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	mbuas@fhcrc.org; tvaughan@u.washington.edu	Whiteman, David C/P-2728-2014; Liu, Geoffrey/N-4421-2016; Hardie, Laura/AAY-6724-2020	Whiteman, David C/0000-0003-2563-9559; Hardie, Laura/0000-0001-5039-2100; Liu, Geoffrey/0000-0002-2603-7296; Buas, Matthew F/0000-0002-8524-3428; ye, weimin/0000-0002-6859-4648; Fitzgerald, Rebecca/0000-0002-3434-3568	National Institutes of Health [R01CA136725, T32CA009168, K05CA124911]; MRC [MC_UU_12022/2] Funding Source: UKRI; Medical Research Council [MC_UU_12022/2] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [K05CA124911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK100548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health [R01CA136725 to T.L.V. and D.C.W, T32CA009168 to T.L.V, and K05CA124911 to T.L.V.]. Additional funding sources for individual studies included in the BEACON GWAS, and for BEACON investigators, have been acknowledged previously (16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2011, HUM MOL GENET, V20, P5012, DOI 10.1093/hmg/ddr415; [Anonymous], 2014, GASTROENTEROLOGY; Babar M, 2012, AM J GASTROENTEROL, V107, P1331, DOI 10.1038/ajg.2012.134; Bae JS, 2012, DIG LIVER DIS; Bansal A, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2014.17; Bansal A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054240; Buas MF, 2014, CARCINOGENESIS, V35, P2740, DOI 10.1093/carcin/bgu207; Bull LM, 2009, DIS ESOPHAGUS, V22, P571, DOI 10.1111/j.1442-2050.2009.00947.x; Casson AG, 2006, CANCER DETECT PREV, V30, P423, DOI 10.1016/j.cdp.2006.09.005; Chen AX, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002259; Cheung WY, 2012, INT J CANCER; Contreras J, 2012, LEUKEMIA, V26, P404, DOI 10.1038/leu.2011.356; Cummings N, 2012, INT J OBESITY, V36, P201, DOI 10.1038/ijo.2011.67; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; di Martino E, 2007, GENET MED, V9, P341, DOI 10.1097/GIM.0b013e3180654ccd; Doecke J, 2008, INT J CANCER, V123, P174, DOI 10.1002/ijc.23410; Ek WE, 2013, JNCI-J NATL CANCER I, V105, P1711, DOI 10.1093/jnci/djt303; Fassan M, 2011, INT J CANCER, V129, P1661, DOI 10.1002/ijc.25823; Feber A, 2008, J THORAC CARDIOV SUR, V135, P255, DOI 10.1016/j.jtcvs.2007.08.055; Garman KS, 2013, DIGEST DIS SCI, V58, P3178, DOI 10.1007/s10620-013-2806-7; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; Guo H, 2010, FAM CANCER, V9, P599, DOI 10.1007/s10689-010-9370-5; Holmes RS, 2007, SEMIN RADIAT ONCOL, V17, P2, DOI 10.1016/j.semradonc.2006.09.003; Hulsmans M, 2011, FASEB J, V25, P2515, DOI 10.1096/fj.11-181149; Kim JS, 2010, MOL CARCINOGEN, V49, P913, DOI 10.1002/mc.20672; Kristinsson JO, 2009, WORLD J GASTROENTERO, V15, P3493, DOI 10.3748/wjg.15.3493; Lagergren K, 2014, INT J CANCER, V135, P2183, DOI 10.1002/ijc.28869; Landi D, 2008, DNA CELL BIOL, V27, P35, DOI 10.1089/dna.2007.0650; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Lee YH, 2013, GENE, V525, P107, DOI 10.1016/j.gene.2013.04.014; Leidner RS, 2012, GENE CHROMOSOME CANC, V51, P473, DOI 10.1002/gcc.21934; Levine DM, 2013, NAT GENET, V45, P1487, DOI 10.1038/ng.2796; Liang D, 2010, CANCER RES, V70, P9765, DOI 10.1158/0008-5472.CAN-10-0130; Liu CY, 2010, CARCINOGENESIS, V31, P1259, DOI 10.1093/carcin/bgq092; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032230; Liu ZS, 2011, CARCINOGENESIS, V32, P1668, DOI 10.1093/carcin/bgr209; Maru DM, 2009, AM J PATHOL, V174, P1940, DOI 10.2353/ajpath.2009.080718; Mathe EA, 2009, CLIN CANCER RES, V15, P6192, DOI 10.1158/1078-0432.CCR-09-1467; Menke V, 2012, SCAND J GASTROENTERO, V47, P378, DOI 10.3109/00365521.2011.650192; Moons LMG, 2007, AM J GASTROENTEROL, V102, P2373, DOI 10.1111/j.1572-0241.2007.01373.x; Moore AE, 2012, ONCOGENE, V31, P1592, DOI 10.1038/onc.2011.349; Newson R, 2003, STATA J, V3, P109, DOI 10.1177/1536867X0300300202; Nguyen GH, 2010, CLIN CANCER RES, V16, P5824, DOI 10.1158/1078-0432.CCR-10-1110; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Orloff M, 2011, JAMA-J AM MED ASSOC, V306, P410, DOI 10.1001/jama.2011.1029; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Pelletier C, 2010, EXPERT REV MOL DIAGN, V10, P817, DOI [10.1586/erm.10.59, 10.1586/ERM.10.59]; Permuth-Wey J, 2011, CANCER RES, V71, P3896, DOI 10.1158/0008-5472.CAN-10-4167; Reid BJ, 2010, NAT REV CANCER, V10, P87, DOI 10.1038/nrc2773; Reshmi G, 2011, GENOMICS, V98, P189, DOI 10.1016/j.ygeno.2011.06.005; Revilla-Nuin B, 2013, ANN SURG, V257, P886, DOI 10.1097/SLA.0b013e31826ddba6; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Saad R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064463; Sakai NS, 2013, SEMIN CANCER BIOL, V23, P512, DOI 10.1016/j.semcancer.2013.08.005; Streppel MM, 2013, CLIN CANCER RES, V19, P4067, DOI 10.1158/1078-0432.CCR-13-0601; Su Z, 2012, NAT GENET, V44, P1131, DOI 10.1038/ng.2408; Sung H, 2011, BREAST CANCER RES TR, V130, P939, DOI 10.1007/s10549-011-1656-2; Teo MTW, 2012, CARCINOGENESIS, V33, P581, DOI 10.1093/carcin/bgr300; Thomas LF, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr414; Wang HG, 2020, ONCOGENE, V39, P2905, DOI 10.1038/s41388-020-1191-x; Wang K, 2010, BIOMARKERS, V15, P614, DOI 10.3109/1354750X.2010.505299; Wijnhoven BPL, 2010, BRIT J SURG, V97, P853, DOI 10.1002/bjs.7000; Wu XF, 2013, CANCER PREV RES, V6, P196, DOI 10.1158/1940-6207.CAPR-12-0276; Xiong F, 2011, CANCER RES, V71, P5175, DOI 10.1158/0008-5472.CAN-10-4407; Xu Y, 2011, INT J CANCER, V128, P412, DOI 10.1002/ijc.25342; Yang HS, 2009, CLIN CANCER RES, V15, P5744, DOI 10.1158/1078-0432.CCR-09-0385; Yang L, 2012, CARCINOGENESIS, V33, P338, DOI 10.1093/carcin/bgr272; Ye YQ, 2008, CANCER PREV RES, V1, P460, DOI 10.1158/1940-6207.CAPR-08-0135; Yu Q, 2012, WORLD J GASTROENTERO, V18, P383, DOI 10.3748/wjg.v18.i4.383; Zhai RH, 2008, CARCINOGENESIS, V29, P2330, DOI 10.1093/carcin/bgn210; Zhang LN, 2011, P NATL ACAD SCI USA, V108, P13653, DOI 10.1073/pnas.1103360108; Zhang XF, 2010, CARCINOGENESIS, V31, P2118, DOI 10.1093/carcin/bgq177; Zheng H, 2011, INT J ONCOL, V38, P1153, DOI 10.3892/ijo.2011.940; Zhou XY, 2010, GYNECOL ONCOL, V117, P287, DOI 10.1016/j.ygyno.2010.01.020	74	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128617	10.1371/journal.pone.0128617	http://dx.doi.org/10.1371/journal.pone.0128617			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039359	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000355700700110
J	Hessenauer, JM; Vokoun, JC; Suski, CD; Davis, J; Jacobs, R; O'Donnell, E				Hessenauer, Jan-Michael; Vokoun, Jason C.; Suski, Cory D.; Davis, Justin; Jacobs, Robert; O'Donnell, Eileen			Differences in the Metabolic Rates of Exploited and Unexploited Fish Populations: A Signature of Recreational Fisheries Induced Evolution?	PLOS ONE			English	Article							BASS MICROPTERUS-SALMOIDES; LARGEMOUTH BASS; PERSONALITY-TRAITS; ANIMAL PERSONALITY; DISSOLVED-OXYGEN; SMALLMOUTH BASS; TELEOST FISH; LONG-TERM; VULNERABILITY; PRODUCTIVITY	Non-random mortality associated with commercial and recreational fisheries have the potential to cause evolutionary changes in fish populations. Inland recreational fisheries offer unique opportunities for the study of fisheries induced evolution due to the ability to replicate study systems, limited gene flow among populations, and the existence of unexploited reference populations. Experimental research has demonstrated that angling vulnerability is heritable in Largemouth Bass Micropterus salmoides, and is correlated with elevated resting metabolic rates (RMR) and higher fitness. However, whether such differences are present in wild populations is unclear. This study sought to quantify differences in RMR among replicated exploited and unexploited populations of Largemouth Bass. We collected age-0 Largemouth Bass from two Connecticut drinking water reservoirs unexploited by anglers for almost a century, and two exploited lakes, then transported and reared them in the same pond. Field RMR of individuals from each population was quantified using intermittent-flow respirometry. Individuals from unexploited reservoirs had a significantly higher mean RMR (6%) than individuals from exploited populations. These findings are consistent with expectations derived from artificial selection by angling on Largemouth Bass, suggesting that recreational angling may act as an evolutionary force influencing the metabolic rates of fishes in the wild. Reduced RMR as a result of fisheries induced evolution may have ecosystem level effects on energy demand, and be common in exploited recreational populations globally.	[Hessenauer, Jan-Michael; Vokoun, Jason C.] Univ Connecticut, Dept Nat Resources & Environm, Wildlife & Fisheries Conservat Ctr, Storrs, CT 06269 USA; [Suski, Cory D.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL USA; [Davis, Justin; Jacobs, Robert; O'Donnell, Eileen] Connecticut Dept Energy & Environm Protect, Inland Fisheries Div, Marlborough, MA USA	University of Connecticut; University of Illinois System; University of Illinois Urbana-Champaign	Hessenauer, JM (corresponding author), Univ Connecticut, Dept Nat Resources & Environm, Wildlife & Fisheries Conservat Ctr, Storrs, CT 06269 USA.	jan-michael.hessenauer@uconn.edu		Suski, Cory/0000-0001-8280-873X	Inland Fisheries Division of the Connecticut Department of Energy and Environmental Protection, through the Sportfish Restoration Act	Inland Fisheries Division of the Connecticut Department of Energy and Environmental Protection, through the Sportfish Restoration Act	Funding was provided by the Inland Fisheries Division of the Connecticut Department of Energy and Environmental Protection, through the Sportfish Restoration Act.	Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; Alos J, 2014, MAR ECOL PROG SER; Alos J, 2014, ECOL EVOL, V4, P2154, DOI 10.1002/ece3.1075; [Anonymous], 2012, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0048030; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Biro PA, 2008, P NATL ACAD SCI USA, V105, P2919, DOI 10.1073/pnas.0708159105; Biro PA, 2009, TRENDS ECOL EVOL, V24, P66, DOI 10.1016/j.tree.2008.11.001; Blevins ZW, 2013, ECOL INDIC, V24, P224, DOI 10.1016/j.ecolind.2012.06.016; Bourret SL, 2008, J FRESHWATER ECOL, V23, P413, DOI 10.1080/02705060.2008.9664218; Brett J.R., 1979, FISH PHYSIOL, V8, P280; CARPENTER SR, 1987, ECOLOGY, V68, P1863, DOI 10.2307/1939878; Carter AJ, 2012, ANIM BEHAV, V83, P1051, DOI 10.1016/j.anbehav.2012.01.033; CECH JJ, 1979, T AM FISH SOC, V108, P166, DOI 10.1577/1548-8659(1979)108&lt;166:RROLBM&gt;2.0.CO;2; Christie MR, 2012, P NATL ACAD SCI USA, V109, P238, DOI 10.1073/pnas.1111073109; Conover DO, 2005, CAN J FISH AQUAT SCI, V62, P730, DOI 10.1139/F05-069; Cooke SJ, 2004, BIOSCIENCE, V54, P857, DOI 10.1641/0006-3568(2004)054[0857:TRORFI]2.0.CO;2; Cooke SJ, 2006, BIOL CONSERV, V128, P93, DOI 10.1016/j.biocon.2005.09.019; Cooke SJ, 2007, PHYSIOL BIOCHEM ZOOL, V80, P480, DOI 10.1086/520618; CruzNeto AP, 1997, J FISH BIOL, V50, P759, DOI 10.1006/jfbi.1996.0337; Eikeset AM, 2013, P NATL ACAD SCI USA, V110, P12259, DOI 10.1073/pnas.1212593110; Fraser DJ, 2013, CAN J FISH AQUAT SCI, V70, P1417, DOI 10.1139/cjfas-2013-0171; Giesing ER, 2011, P ROY SOC B-BIOL SCI, V278, P1753, DOI 10.1098/rspb.2010.1819; Herrmann JP, 2000, J FISH BIOL, V57, P746, DOI [10.1006/jfbi.2000.1348, 10.1111/j.1095-8649.2000.tb00272.x]; Hessenauer JM, 2014, J FRESHWATER ECOL, V29, P429, DOI 10.1080/02705060.2014.910147; Hessenauer JM, 2012, T AM FISH SOC, V141, P1672, DOI 10.1080/00028487.2012.720632; KIEFFER JD, 1995, T AM FISH SOC, V124, P70, DOI 10.1577/1548-8659(1995)124<0070:EOCARA>2.3.CO;2; Kocovsky PM, 2001, N AM J FISH MANAGE, V21, P178, DOI 10.1577/1548-8675(2001)021<0178:DOTUWP>2.0.CO;2; Kuparinen A, 2007, TRENDS ECOL EVOL, V22, P652, DOI 10.1016/j.tree.2007.08.011; Laugen AT, 2014, FISH FISH, V15, P65, DOI 10.1111/faf.12007; Law R, 2007, MAR ECOL PROG SER, V335, P271, DOI 10.3354/meps335271; Lewin WC, 2006, REV FISH SCI, V14, P305, DOI 10.1080/10641260600886455; MATSUMURA S, 2011, EVOL ECOL, V25, P711, DOI DOI 10.1007/s10682-010-9444-8; MITTELBACH GG, 1995, ECOLOGY, V76, P2347, DOI 10.2307/2265812; Montgomery D.C., 2013, DESIGN ANAL EXPT; Mueller KW, 2005, NORTHWEST SCI, V79, P131; Mueller P, 2001, P NATL ACAD SCI USA, V98, P12550, DOI 10.1073/pnas.221456698; Muoneke Maurice I., 1994, Reviews in Fisheries Science, V2, P123; Nannini MA, 2011, J FISH BIOL, V79, P1017, DOI 10.1111/j.1095-8649.2011.03079.x; Philipp David P., 1997, North American Journal of Fisheries Management, V17, P557, DOI 10.1577/1548-8675(1997)017<0557:TIOCAR>2.3.CO;2; Philipp DP, 2009, T AM FISH SOC, V138, P189, DOI 10.1577/T06-243.1; Pope KL, 2001, ENVIRON BIOL FISH, V61, P329, DOI 10.1023/A:1011096819147; Post J., 2012, FISH MANAGE ECOL; Post JR, 2002, FISHERIES, V27, P6, DOI 10.1577/1548-8446(2002)027&lt;0006:CRF&gt;2.0.CO;2; Redpath TD, 2010, CAN J FISH AQUAT SCI, V67, P1983, DOI 10.1139/F10-120; Shultz AD, 2011, J EXP MAR BIOL ECOL, V402, P19, DOI 10.1016/j.jembe.2011.03.009; STEFFENSEN JF, 1989, FISH PHYSIOL BIOCHEM, V6, P49, DOI 10.1007/BF02995809; Stein JA, 2014, ENVIRON BIOL FISH, P1; Suski CD, 2004, T AM FISH SOC, V133, P1100, DOI 10.1577/T03-079.1; Sutter DAH, 2012, P NATL ACAD SCI USA, V109, P20960, DOI 10.1073/pnas.1212536109; Theriault V, 2008, EVOL APPL, V1, P409, DOI 10.1111/j.1752-4571.2008.00022.x; *US FISH WILDL SER, 2006, NAT SURV FISH HUNT W; Uusi-Heikkila S, 2008, TRENDS ECOL EVOL, V23, P419, DOI 10.1016/j.tree.2008.04.006; Wagner T, 2006, FISHERIES, V31, P180, DOI 10.1577/1548-8446(2006)31[180:AFMDSI]2.0.CO;2; Whitworth W. R., 1996, FRESHWATER FISHES CO; WILSON DS, 1993, J COMP PSYCHOL, V107, P250, DOI 10.1037/0735-7036.107.3.250	55	27	27	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128336	10.1371/journal.pone.0128336	http://dx.doi.org/10.1371/journal.pone.0128336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039091	gold, Green Published			2022-12-27	WOS:000355700700097
J	Kim, NH; Yoshimaru, T; Chen, YA; Matsuo, T; Komatsu, M; Miyoshi, Y; Tanaka, E; Sasa, M; Mizuguchi, K; Katagiri, T				Kim, Nam-Hee; Yoshimaru, Tetsuro; Chen, Yi-An; Matsuo, Taisuke; Komatsu, Masato; Miyoshi, Yasuo; Tanaka, Eiji; Sasa, Mitsunori; Mizuguchi, Kenji; Katagiri, Toyomasa			BIG3 Inhibits the Estrogen-Dependent Nuclear Translocation of PHB2 via Multiple Karyopherin-Alpha Proteins in Breast Cancer Cells	PLOS ONE			English	Article							RECEPTOR ACTIVITY; IMPORTIN-ALPHA; EXPRESSION; PROHIBITIN; TRANSPORT; REPRESSOR; SURVIVAL	We recently reported that brefeldin A-inhibited guanine nucleotide-exchange protein 3 (BIG3) binds Prohibitin 2 (PHB2) in cytoplasm, thereby causing a loss of function of the PHB2 tumor suppressor in the nuclei of breast cancer cells. However, little is known regarding the mechanism by which BIG3 inhibits the nuclear translocation of PHB2 into breast cancer cells. Here, we report that BIG3 blocks the estrogen (E2)-dependent nuclear import of PHB2 via the karyopherin alpha (KPNA) family in breast cancer cells. We found that over-expressed PHB2 interacted with KPNA1, KPNA5, and KPNA6, thereby leading to the E2-dependent translocation of PHB2 into the nuclei of breast cancer cells. More importantly, knockdown of each endogenous KPNA by siRNA caused a significant inhibition of E2-dependent translocation of PHB2 in BIG3-depleted breast cancer cells, thereby enhancing activation of estrogen receptor alpha (ER alpha). These data indicated that BIG3 may block the KPNAs (KPNA1, KPNA5, and KPNA6) binding region(s) of PHB2, thereby leading to inhibition of KPNAs-mediated PHB2 nuclear translocation in the presence of E2 in breast cancer cells. Understanding this regulation of PHB2 nuclear import may provide therapeutic strategies for controlling E2/ER alpha signals in breast cancer cells.	[Kim, Nam-Hee; Yoshimaru, Tetsuro; Matsuo, Taisuke; Komatsu, Masato; Katagiri, Toyomasa] Univ Tokushima, Inst Genome Res, Div Genome Med, Tokushima 770, Japan; [Kim, Nam-Hee; Tanaka, Eiji] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Orthodont & Dentofacial Orthoped, Tokushima 770, Japan; [Chen, Yi-An; Mizuguchi, Kenji] Natl Inst Biomed Innovat, Osaka, Japan; [Miyoshi, Yasuo] Hyogo Coll Med, Div Breast & Endocrine Surg, Dept Surg, Kobe, Hyogo, Japan; [Sasa, Mitsunori] Tokushima Breast Care Clin, Dept Surg, Tokushima, Japan	Tokushima University; Tokushima University; National Institute of Health Sciences - Japan; Hyogo College of Medicine; University of Hyogo	Katagiri, T (corresponding author), Univ Tokushima, Inst Genome Res, Div Genome Med, Tokushima 770, Japan.	tkatagi@genome.tokushima-u.ac.jp	Tanaka, Eiji/E-7105-2015; Mizuguchi, Kenji/GVS-5857-2022; Miyoshi, Yasuo/AAI-6321-2020; Yoshimaru, Tetsuro/AAE-5335-2020	Tanaka, Eiji/0000-0002-2707-1613; Mizuguchi, Kenji/0000-0003-3021-7078; Miyoshi, Yasuo/0000-0001-8535-4008; Yoshimaru, Tetsuro/0000-0001-8582-3011	Project Future of Relay For Life Japan; Tokushima Breast Care Clinic; MEXT KAKENHI Grant [251347212, 25293079, 26461948]; IMSUT Joint Research Project	Project Future of Relay For Life Japan; Tokushima Breast Care Clinic; MEXT KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); IMSUT Joint Research Project	This work was supported by the Project Future of Relay For Life Japan, grant/research support from Tokushima Breast Care Clinic, a Grant-in-Aid for Scientific Research on Innovative Areas (MEXT KAKENHI Grant Number 251347212), Grants-in-Aid for Scientific Research (MEXT KAKENHI Grant Numbers 25293079 and 26461948), an IMSUT Joint Research Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Yi-An, 2014, BMC Res Notes, V7, P435, DOI 10.1186/1756-0500-7-435; Dankof A, 2007, VIRCHOWS ARCH, V451, P877, DOI 10.1007/s00428-007-0513-5; Delage-Mourroux R, 2000, J BIOL CHEM, V275, P35848, DOI 10.1074/jbc.M001327200; Gluz O, 2008, INT J CANCER, V123, P1433, DOI 10.1002/ijc.23628; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; He B, 2008, MOL ENDOCRINOL, V22, P344, DOI 10.1210/me.2007-0400; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63; Kim JW, 2009, CANCER SCI, V100, P1468, DOI 10.1111/j.1349-7006.2009.01209.x; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kurebayashi J, 1996, BRIT J CANCER, V74, P200, DOI 10.1038/bjc.1996.338; Kurtev V, 2004, J BIOL CHEM, V279, P24834, DOI 10.1074/jbc.M312300200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lin JR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-157; Mishra S, 2005, TRENDS MOL MED, V11, P192, DOI 10.1016/j.molmed.2005.02.004; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Mishra S, 2010, FEBS J, V277, P3937, DOI 10.1111/j.1742-4658.2010.07809.x; Montano MM, 1999, P NATL ACAD SCI USA, V96, P6947, DOI 10.1073/pnas.96.12.6947; Mortezavi A, 2011, CLIN CANCER RES, V17, P1111, DOI 10.1158/1078-0432.CCR-10-0081; Park JH, 2006, CANCER RES, V66, P9186, DOI 10.1158/0008-5472.CAN-06-1601; Sakai M, 2010, ANTICANCER RES, V30, P851; Shimo A, 2007, CANCER SCI, V98, P174, DOI 10.1111/j.1349-7006.2006.00381.x; Thuaud F, 2013, CHEM BIOL, V20, P316, DOI 10.1016/j.chembiol.2013.02.006; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Yoneda Y, 2000, GENES CELLS, V5, P777, DOI 10.1046/j.1365-2443.2000.00366.x; Yoshimaru T, 2014, SCI REP-UK, V4, DOI 10.1038/srep07355; Yoshimaru T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3443	28	16	21	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0127707	10.1371/journal.pone.0127707	http://dx.doi.org/10.1371/journal.pone.0127707			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052702	gold, Green Submitted, Green Published			2022-12-27	WOS:000355955300017
J	Larson, S; Farrer, D; Lowry, D; Ebert, DA				Larson, Shawn; Farrer, Debbie; Lowry, Dayv; Ebert, David A.			Preliminary Observations of Population Genetics and Relatedness of the Broadnose Sevengill Shark, Notorynchus cepedianus, in Two Northeast Pacific Estuaries	PLOS ONE			English	Article							GULF-OF-MEXICO; CARCHARHINUS-LIMBATUS; MICROSATELLITE LOCI; COMPUTER-PROGRAM; BLACKTIP SHARK; LEMON SHARK; ATLANTIC; RECONSTRUCTION; POLYANDRY; EVOLUTION	The broadnose sevengill shark, Notorynchus cepedianus, a common coastal species in the eastern North Pacific, was sampled during routine capture and tagging operations conducted from 2005-2012. One hundred and thirty three biopsy samples were taken during these research operations in Willapa Bay, Washington and in San Francisco Bay, California. Genotypic data from seven polymorphic microsatellites (derived from the related sixgill shark, Hexanchus griseus) were used to describe Notorynchus cepedianus genetic diversity, population structure and relatedness. Diversity within Notorynchus cepedianus was found to be low to moderate with an average observed heterozygosity of 0.41, expected heterozygosity of 0.53, and an average of 5.1 alleles per microsatellite locus. There was no evidence of a recent population bottleneck based on genetic data. Analyses of genetic differences between the two sampled estuaries suggest two distinct populations with some genetic mixing of sharks sampled during 2005-2006. Relatedness within sampled populations was high, with percent relatedness among sharks caught in the same area indicating 42.30% first-order relative relationships (full or half siblings). Estuary-specific familial relationships suggest that management of Notorynchus cepedianus on the U.S. West Coast should incorporate stock-specific management goals to conserve this ecologically important predator.	[Larson, Shawn] Seattle Aquarium, Seattle, WA 98101 USA; [Farrer, Debbie; Lowry, Dayv] Washington Dept Fish & Wildlife, Washington, DC USA; [Ebert, David A.] Moss Landing Marine Labs, Pacific Shark Res Ctr, Moss Landing, CA 95039 USA	Washington Department of Fish & Wildlife (WDFW); Moss Landing Marine Laboratories	Larson, S (corresponding author), Seattle Aquarium, Seattle, WA 98101 USA.	s.larson@seattleaquarium.org		Lowry, Dayv/0000-0003-1159-3828	Seattle Aquarium; Foley Frischkorn Wildlife Conservation Fund	Seattle Aquarium; Foley Frischkorn Wildlife Conservation Fund	This research was supported by the Seattle Aquarium and the Foley Frischkorn Wildlife Conservation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen H, 2009, MOL ECOL, V18, P4409, DOI 10.1111/j.1365-294X.2009.04377.x; Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Buston PM, 2009, MOL ECOL, V18, P4707, DOI 10.1111/j.1365-294X.2009.04383.x; Chapman DD, 2004, MOL ECOL, V13, P1965, DOI 10.1111/j.1365-294X.2004.02178.x; Daly-Engel TS, 2010, MAR ECOL PROG SER, V403, P255, DOI 10.3354/meps08417; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Ebert, 2003, SHARKS RAYS CHIMERAS; EBERT DA, 1989, CALIF FISH GAME, V75, P102; EBERT DA, 1991, S AFR J MARINE SCI, V11, P455, DOI 10.2989/025776191784287637; Ebert DA, 2001, CALIFORNIAS LIVING M, P470; ELLEGREN H, 1995, NAT GENET, V11, P360, DOI 10.1038/ng1295-360; Feldheim KA, 2001, MOL ECOL, V10, P295, DOI 10.1046/j.1365-294x.2001.01182.x; Feldheim KA, 2004, EVOLUTION, V58, P2332, DOI 10.1111/j.0014-3820.2004.tb01607.x; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Heist EJ, 1999, COPEIA, P182, DOI 10.2307/1447399; Heist EJ, 2003, MOL ECOL NOTES, V3, P59, DOI 10.1046/j.1471-8286.2003.00348.x; HOENIG J M, 1990, NOAA Technical Report NMFS, P1; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Keeney DB, 2003, MAR BIOL, V143, P1039, DOI 10.1007/s00227-003-1166-9; Keeney DB, 2005, MOL ECOL, V14, P1911, DOI 10.1111/j.1365-294X.2005.02549.x; Larson S, 2011, CONSERV GENET, V12, P679, DOI 10.1007/s10592-010-0174-9; Miller-Sims VC, 2008, MOL ECOL, V17, P5036, DOI 10.1111/j.1365-294X.2008.03986.x; Musick JA, 2000, FISHERIES, V25, P9, DOI 10.1577/1548-8446(2000)025<0009:MOSATR>2.0.CO;2; Olsen KH, 2004, CAN J FISH AQUAT SCI, V61, P328, DOI [10.1139/f04-067, 10.1139/F04-067]; Ovenden JR, 2006, MOL ECOL NOTES, V6, P415, DOI 10.1111/j.1471-8286.2005.01254.x; Ovenden JR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-40; Pardini AT, 2000, MOL ECOL, V9, P1176, DOI 10.1046/j.1365-294x.2000.00954-4.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; PLANES S, 1993, MAR BIOL, V117, P665, DOI 10.1007/BF00349779; Portnoy DS, 2007, MOL ECOL, V16, P187, DOI 10.1111/j.1365-294X.2006.03138.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Schindler DE, 2002, ECOL APPL, V12, P735, DOI 10.2307/3060985; Schmidt JV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004988; Selkoe KA, 2006, ECOLOGY, V87, P3082, DOI 10.1890/0012-9658(2006)87[3082:CSAKAE]2.0.CO;2; Sikkel PC, 2010, J FISH BIOL, V76, P1671, DOI 10.1111/j.1095-8649.2010.02607.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Williams GD, 2012, J FISH BIOL, V80, P1380, DOI 10.1111/j.1095-8649.2011.03179.x; Williams GD, 2011, ENVIRON BIOL FISH, V91, P379, DOI 10.1007/s10641-011-9797-z	46	9	9	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129278	10.1371/journal.pone.0129278	http://dx.doi.org/10.1371/journal.pone.0129278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052706	gold, Green Submitted, Green Published			2022-12-27	WOS:000355955300108
J	Robertoni, FSZ; Olivo, CR; Lourenco, JD; Goncalves, NG; Velosa, APP; Lin, CJ; Flo, CM; Saraiva-Romanholo, BM; Sasaki, SD; Martins, MA; Teodoro, WR; Lopes, FDTQS				Robertoni, Fabola S. Z.; Olivo, Clarice R.; Lourenco, Juliana D.; Goncalves, Natalia G.; Velosa, Ana Paula P.; Lin, Chin J.; Flo, Claudia M.; Saraiva-Romanholo, Beatriz M.; Sasaki, Sergio D.; Martins, Milton A.; Teodoro, Walcy R.; Lopes, Fernanda Degobbi T. Q. S.			Collagenase mRNA Overexpression and Decreased Extracellular Matrix Components Are Early Events in the Pathogenesis of Emphysema	PLOS ONE			English	Article							SMOKE-INDUCED EMPHYSEMA; OBSTRUCTIVE PULMONARY-DISEASE; ELASTASE-INDUCED EMPHYSEMA; ACUTE LUNG INJURY; CONNECTIVE-TISSUE; AEROBIC EXERCISE; III COLLAGEN; MICE; DEGRADATION; METALLOPROTEINASES	To describe the progression of parenchymal remodeling and metalloproteinases gene expression in earlier stages of emphysema, mice received porcine pancreatic elastase (PPE) instillation and Control groups received saline solution. After PPE instillation (1, 3, 6 hours, 3 and 21 days) we measured the mean linear intercept, the volume proportion of types I and III collagen, elastin, fibrillin and the MMP-1, -8, -12 and -13 gene expression. We observed an initial decrease in type I (at the 3rd day) and type III collagen (from the 6th hour until the 3rd day), in posterior time points in which we detected increased gene expression for MMP-8 and -13 in PPE groups. After 21 days, the type III collagen fibers increased and the type I collagen values returned to similar values compared to control groups. The MMP-12 gene expression was increased in earlier times (3 and 6 hours) to which we detected a reduced proportion of elastin (3 days) in PPE groups, reinforcing the already established importance of MMP-12 in the breakdown of ECM. Such findings will be useful to better elucidate the alterations in ECM components and the importance of not only metalloelastase but also collagenases in earlier emphysema stages, providing new clues to novel therapeutic targets.	[Robertoni, Fabola S. Z.; Olivo, Clarice R.; Lourenco, Juliana D.; Velosa, Ana Paula P.; Flo, Claudia M.; Saraiva-Romanholo, Beatriz M.; Martins, Milton A.; Teodoro, Walcy R.; Lopes, Fernanda Degobbi T. Q. S.] Univ Sao Paulo, Sch Med, Dept Med, Sao Paulo, Brazil; [Goncalves, Natalia G.; Lin, Chin J.] Univ Sao Paulo, Sch Med, Dept Phatol, Sao Paulo, Brazil; [Saraiva-Romanholo, Beatriz M.] Univ City Sao Paulo, Sao Paulo, Brazil; [Sasaki, Sergio D.] UFABC, Ctr Nat & Human Sci, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Cidade de Sao Paulo; Universidade Federal do ABC (UFABC)	Lopes, FDTQS (corresponding author), Univ Sao Paulo, Sch Med, Dept Med, Sao Paulo, Brazil.	fernandadtqsl@gmail.com	Pereira Velosa, Ana Paula/AGH-4935-2022; Martins, Milton A/L-7541-2017; Teodoro, Walcy/H-5133-2017; Lourenço, Juliana D./C-5326-2013; Sasaki, Sergio Daishi/AAR-2928-2021; Lin, Chin J/B-7895-2013; Olivo, Clarice Rosa/K-2236-2012; GonÃalves, Natalia/AAE-7276-2022; teodoro, walcy/J-7602-2018; Saraiva-Romanholo, Beatriz Mangueira/I-5482-2013	Teodoro, Walcy/0000-0001-7559-4542; Lourenço, Juliana D./0000-0002-9291-5237; Sasaki, Sergio Daishi/0000-0002-6233-3316; Lin, Chin J/0000-0001-7489-560X; teodoro, walcy/0000-0001-7559-4542; Saraiva-Romanholo, Beatriz Mangueira/0000-0003-0853-9708; Pereira Velosa, Ana Paula/0000-0002-6465-0796; Gomes Goncalves, Natalia/0000-0002-5253-5483; DTQS Lopes, Fernanda/0000-0002-6402-3055	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/08584-6, 2012/02957-8]; Laboratorio de Investigacao Medica [LIM 20]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Laboratorio de Investigacao Medica	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Grant Numbers: 2011/08584-6 and 2012/02957-8); Laboratorio de Investigacao Medica (LIM 20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham T, 2000, J STRUCTURAL BIOL S2, P189; ABRAMS WR, 1988, EXP LUNG RES, V14, P459, DOI 10.3109/01902148809087821; Anciaes AM, 2011, CLINICS, V66, P1797, DOI 10.1590/S1807-59322011001000020; Ashworth JL, 1999, BIOCHEM J, V340, P171, DOI 10.1042/0264-6021:3400171; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Betsuyaku T, 1999, AM J RESP CRIT CARE, V159, P1985, DOI 10.1164/ajrccm.159.6.9809043; Cavarra E, 1996, LAB INVEST, V75, P273; Churg A, 2004, AM J RESP CRIT CARE, V170, P492, DOI 10.1164/rccm.200404-511OC; Churg A, 2012, EUR RESPIR J, V39, P197, DOI 10.1183/09031936.00121611; Churg A, 2007, THORAX, V62, P706, DOI 10.1136/thx.2006.068353; DARMIENTO J, 1992, CELL, V71, P955, DOI 10.1016/0092-8674(92)90391-O; Finlay GA, 1997, AM J RESP CRIT CARE, V156, P240, DOI 10.1164/ajrccm.156.1.9612018; GOLD, 2011, GLOB STRAT DIAGN MAN; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Imai K, 2001, AM J RESP CRIT CARE, V163, P786, DOI 10.1164/ajrccm.163.3.2001073; Ito S, 2005, J APPL PHYSIOL, V98, P503, DOI 10.1152/japplphysiol.00590.2004; Kawakami M, 2008, BIOL PHARM BULL, V31, P1434, DOI 10.1248/bpb.31.1434; Koenders MMJF, 2009, J PATHOL, V218, P446, DOI 10.1002/path.2548; Kononov S, 2001, AM J RESP CRIT CARE, V164, P1920, DOI 10.1164/ajrccm.164.10.2101083; KUHN C, 1976, LAB INVEST, V34, P372; Kurimoto E, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-5; LANG MR, 1994, THORAX, V49, P319, DOI 10.1136/thx.49.4.319; Lee EJ, 2009, CHEST, V135, P344, DOI 10.1378/chest.08-1583; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lourenco JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098216; Lucey EC, 1998, AM J RESP CRIT CARE, V158, P555, DOI 10.1164/ajrccm.158.2.9705021; MARGRAF LR, 1991, AM REV RESPIR DIS, V143, P391; Ramos DS, 2010, MED SCI SPORT EXER, V42, P113, DOI 10.1249/MSS.0b013e3181ad1c72; Goncalves CTR, 2012, CRIT CARE, V16, DOI 10.1186/cc11807; Rubio ML, 2004, CHEST, V125, P1500, DOI 10.1378/chest.125.4.1500; Segura-Valdez L, 2000, CHEST, V117, P684, DOI 10.1378/chest.117.3.684; SHAPIRO SD, 1994, AM J RESP CRIT CARE, V150, pS160, DOI 10.1164/ajrccm/150.6_Pt_2.S160; Shapiro SD, 1999, AM J RESP CELL MOL, V20, P1100, DOI 10.1165/ajrcmb.20.6.f151; Shifren A, 2007, AM J PHYSIOL-LUNG C, V292, pL778, DOI 10.1152/ajplung.00352.2006; Shifren Adrian, 2006, Proc Am Thorac Soc, V3, P428, DOI 10.1513/pats.200601-009AW; Shiomi T, 2003, EXP LUNG RES, V29, P1, DOI 10.1080/01902140303761; Silver FH, 2002, J THEOR BIOL, V216, P243, DOI 10.1006/jtbi.2002.2542; SNIDER GL, 1986, AM REV RESPIR DIS, V133, P149, DOI 10.1164/arrd.1986.133.1.149; SNIDER GL, 1988, AM REV RESPIR DIS, V137, P918, DOI 10.1164/ajrccm/137.4.918; Spiess K, 2007, CONNECT TISSUE RES, V48, P99, DOI 10.1080/03008200601166194; Stockley RA, 2001, NOVART FDN SYMP, V234, P189; STOLK J, 1992, J PATHOL, V167, P349, DOI 10.1002/path.1711670314; STONE PJ, 1995, AM J RESP CRIT CARE, V151, P952; Suki B, 2008, RESP PHYSIOL NEUROBI, V163, P33, DOI 10.1016/j.resp.2008.03.015; Suki B, 2011, COMPR PHYSIOL, V1, P1317, DOI 10.1002/cphy.c100033; Takubo Y, 2002, AM J RESP CRIT CARE, V166, P1596, DOI 10.1164/rccm.2202001; Vieira RD, 2012, MED SCI SPORT EXER, V44, P1227, DOI 10.1249/MSS.0b013e31824b2877; Vlahovic G, 1999, AM J RESP CRIT CARE, V160, P2086, DOI 10.1164/ajrccm.160.6.9706031; WEIBEL ER, 1963, LAB INVEST, V12, P131	49	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129590	10.1371/journal.pone.0129590	http://dx.doi.org/10.1371/journal.pone.0129590			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052708	Green Submitted, Green Published, gold			2022-12-27	WOS:000355955300147
J	Boyd, A; Almeida, JR; Darrah, PA; Sauce, D; Seder, RA; Appay, V; Gorochov, G; Larsen, M				Boyd, Anders; Almeida, Jorge R.; Darrah, Patricia A.; Sauce, Delphine; Seder, Robert A.; Appay, Victor; Gorochov, Guy; Larsen, Martin			Pathogen-Specific T Cell Polyfunctionality Is a Correlate of T Cell Efficacy and Immune Protection	PLOS ONE			English	Article							ANTIGEN-SENSITIVITY; VIRUS	Introduction Understanding the factors that delineate the efficacy of T cell responses towards pathogens is crucial for our ability to develop potent therapies against infectious diseases. Multidimensional evaluation of T cell functionality at the single-cell level enables exhaustive analysis of combinatorial functional properties, hence polyfunctionality. We have recently invented an algorithm that quantifies polyfunctionality, the Polyfunctionality Index (Larsen et al. PLoS One 2012). Here we demonstrate that quantitative assessment of T cell polyfunctionality correlates with T cell efficacy measured as the capacity to kill target cells in vitro and control infection in vivo. Methods We employed the polyfunctionality index on two datasets selected for their unique ability to evaluate the polyfunctional imprint on T cell efficacy. 1) HIV-specific CD8(+) T cells and 2) Leishmania major-specific CD4(+) T cells were analysed for their capacity to secrete multiple effector molecules, kill target cells and control infection. Briefly, employing the Polyfunctionality Index algorithm we determined the parameter estimates resulting in optimal correlation between T cell polyfunctionality and T cell efficacy. Results T cell polyfunctionality is correlated with T cell efficacy measured as 1) target killing (r=0.807, P<0.0001) and 2) lesion size upon challenge with Leishmania major (r=-0.50, P=0.004). Contrary to an approach relying on the Polyfunctionality Index algorithm, quantitative evaluation of T cell polyfunctionality traditionally ignores the gradual contribution of more or less polyfunctional T cells. Indeed, comparing both approaches we show that optimal description of T cell efficacy is obtained when gradually integrating all levels of polyfunctionality in accordance with the Polyfunctionality Index. Conclusions Our study presents a generalizable methodology to objectively evaluate the impact of polyfunctionality on T cell efficacy. We show that T cell polyfunctionality is a superior correlate of T cell efficacy both in vitro and in vivo as compared with response size. Therefore, future immunotherapies should aim to increase T cell polyfunctionality.	[Boyd, Anders] Inst Pierre Louis Epidemiol & Sante Publ, INSERM, UMR S1136, Paris, France; [Almeida, Jorge R.; Sauce, Delphine; Appay, Victor; Gorochov, Guy; Larsen, Martin] Ctr Immunol & Malad Infect CIMI Paris, INSERM, UMR S1135, Paris, France; [Darrah, Patricia A.; Seder, Robert A.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Gorochov, Guy; Larsen, Martin] Grp Hosp Pitie Salpetriere, AP HP, Dept Immunol, F-75634 Paris, France; [Gorochov, Guy; Larsen, Martin] Univ Paris 06, Sorbonne Univ, CR7, CIMI Paris, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Larsen, M (corresponding author), Ctr Immunol & Malad Infect CIMI Paris, INSERM, UMR S1135, Paris, France.	Martin.Larsen@upmc.fr	Boyd, Anders/GLQ-8906-2022; SAUCE, Delphine/ABE-5975-2020; Appay, Victor/M-4830-2017; Appay, Victor/AAM-7701-2021; Gorochov, Guy/P-2911-2017; Larsen, Martin/A-7316-2014	Boyd, Anders/0000-0001-9512-8928; SAUCE, Delphine/0000-0003-4596-7373; Larsen, Martin/0000-0003-1375-4816; Appay, Victor/0000-0001-5434-3963; Gorochov, Guy/0000-0003-2097-9677	INSERM; University Pierre et Marie Curie EMERGENCE" program; Fondation pour l'Aide a la Recherche sur la Sclerose En Plaques; ARTHRITIS Fondation COURTIN; Agence nationale de recherche sur le Sida et les hepatites	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Pierre et Marie Curie EMERGENCE" program; Fondation pour l'Aide a la Recherche sur la Sclerose En Plaques(Fondation pour la Recherche Medicale); ARTHRITIS Fondation COURTIN; Agence nationale de recherche sur le Sida et les hepatites	The study was funded by INSERM, the University Pierre et Marie Curie EMERGENCE" program (www.upmc.fr), "Fondation pour l'Aide a la Recherche sur la Sclerose En Plaques" (www.ARSEP.org) and ARTHRITIS Fondation COURTIN (http://www.fondation-arthritis.org). A.B. was awarded a post-doctoral fellowship with the "Agence nationale de recherche sur le Sida et les hepatites" (www.agence-nationale-recherche.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Graw F, 2014, J VIROL, V88, P10134, DOI 10.1128/JVI.00647-14; Larsen M, 2011, TLS-TIMES LIT SUPPL, P6; Larsen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042403; Lissina A, 2014, AIDS, V28, P477, DOI 10.1097/QAD.0000000000000175; McKinstry KK, 2012, J CLIN INVEST, V122, P2847, DOI 10.1172/JCI63689; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Peters NC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004538; Radaelli A, 2007, VACCINE, V25, P2128, DOI 10.1016/j.vaccine.2006.11.009; Rizzuto GA, 2009, J EXP MED, V206, P849, DOI 10.1084/jem.20081382; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Smolen KK, 2014, J IMMUNOL, V193, P3003, DOI 10.4049/jimmunol.1400895; Swadling L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009185; Szaba FM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004142; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; Yuan JD, 2008, P NATL ACAD SCI USA, V105, P20410, DOI 10.1073/pnas.0810114105	19	49	50	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128714	10.1371/journal.pone.0128714	http://dx.doi.org/10.1371/journal.pone.0128714			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046523	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200094
J	Dai, PS; Luo, HY; Sheng, HW; Zhao, YL; Li, L; Wu, J; Zhao, YQ; Suzuki, KJ				Dai, Peishan; Luo, Hanyuan; Sheng, Hanwei; Zhao, Yali; Li, Ling; Wu, Jing; Zhao, Yuqian; Suzuki, Kenji			A New Approach to Segment Both Main and Peripheral Retinal Vessels Based on Gray-Voting and Gaussian Mixture Model	PLOS ONE			English	Article							BLOOD-VESSELS; MATCHED-FILTER; IMAGES; EXTRACTION; WAVELET	Vessel segmentation in retinal fundus images is a preliminary step to clinical diagnosis for some systemic diseases and some eye diseases. The performances of existing methods for segmenting small vessels which are usually of more importance than the main vessels in a clinical diagnosis are not satisfactory in clinical use. In this paper, we present a method for both main and peripheral vessel segmentation. A local gray-level change enhancement algorithm called gray-voting is used to enhance the small vessels, while a two-dimensional Gabor wavelet is used to extract the main vessels. We fuse the gray-voting results with the 2D-Gabor filter results as pre-processing outcome. A Gaussian mixture model is then used to extract vessel clusters from the pre-processing outcome, while small vessels fragments are obtained using another gray-voting process, which complements the vessel cluster extraction already performed. At the last step, we eliminate the fragments that do not belong to the vessels based on the shape of the fragments. We evaluated the approach with two publicly available DRIVE (Staal et al., 2004) and STARE (Hoover et at., 2000) datasets with manually segmented results. For the STARE dataset, when using the second manually segmented results which include much more small vessels than the first manually segmented results as the "gold standard," this approach achieved an average sensitivity, accuracy and specificity of 65.0%, 92.1% and 97.0%, respectively. The sensitivities of this approach were much higher than those of the other existing methods, with comparable specificities; these results thus demonstrated that this approach was sensitive to detection of small vessels.	[Dai, Peishan; Luo, Hanyuan; Sheng, Hanwei; Zhao, Yali; Li, Ling; Wu, Jing; Zhao, Yuqian] Cent South Univ, Sch Geosci & Infophys, Dept Biomed Engn, Changsha, Hunan, Peoples R China; [Suzuki, Kenji] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA	Central South University; University of Chicago	Dai, PS (corresponding author), Cent South Univ, Sch Geosci & Infophys, Dept Biomed Engn, Changsha, Hunan, Peoples R China.	daipeishan@163.com; kenjisuzuki00@gmail.com	Suzuki, Kenji/A-1284-2007	Suzuki, Kenji/0000-0002-3993-8309	National Natural Science Foundation of China [81171420]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China under Grants 81171420.	Cheung CYL, 2014, ALZHEIMERS DEMENT, V10, P135, DOI 10.1016/j.jalz.2013.06.009; Fathi A, 2013, BIOMED SIGNAL PROCES, V8, P71, DOI 10.1016/j.bspc.2012.05.005; Fraz MM, 2012, COMPUT METH PROG BIO, V108, P600, DOI 10.1016/j.cmpb.2011.08.009; Fraz MM, 2012, IEEE T BIO-MED ENG, V59, P2538, DOI 10.1109/TBME.2012.2205687; Goatman KA, 2011, IEEE T MED IMAGING, V30, P972, DOI 10.1109/TMI.2010.2099236; Hoover A, 2000, IEEE T MED IMAGING, V19, P203, DOI 10.1109/42.845178; Kose C, 2011, EXPERT SYST APPL, V38, P13670, DOI 10.1016/j.eswa.2011.04.141; Li Q, 2012, EXPERT SYST APPL, V39, P7600, DOI 10.1016/j.eswa.2011.12.046; Marin D, 2011, IEEE T MED IMAGING, V30, P146, DOI 10.1109/TMI.2010.2064333; Martinez-Perez ME, 2007, MED IMAGE ANAL, V11, P47, DOI 10.1016/j.media.2006.11.004; Mendonca AM, 2006, IEEE T MED IMAGING, V25, P1200, DOI 10.1109/TMI.2006.879955; Nguyen UTV, 2011, LECT NOTES COMPUT SC, V7009, P117, DOI 10.1007/978-3-642-24319-6_15; Niemeijer M, 2004, PROC SPIE, V5370, P648, DOI 10.1117/12.535349; Ramlugun GS, 2012, EXPERT SYST APPL, V39, P1141, DOI 10.1016/j.eswa.2011.07.115; Ricci E, 2007, IEEE T MED IMAGING, V26, P1357, DOI 10.1109/TMI.2007.898551; Saleh MD, 2011, J DIGIT IMAGING, V24, P564, DOI 10.1007/s10278-010-9302-9; Shahbeig S, 2013, IMAGE PROCESSING IET, V7, DOI [10.1007/s10916-009-9337-y, DOI 10.1007/S10916-009-9337-Y]; Soares JVB, 2006, IEEE T MED IMAGING, V25, P1214, DOI 10.1109/TMI.2006.879967; Staal J, 2004, IEEE T MED IMAGING, V23, P501, DOI 10.1109/TMI.2004.825627; Suzuki K, 2012, QUANT IMAG MED SURG, V2, P163, DOI 10.3978/j.issn.2223-4292.2012.09.02; Xiao ZY, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/401413; Yin Y, 2012, PATTERN RECOGN, V45, P1235, DOI 10.1016/j.patcog.2011.09.019; You XG, 2011, PATTERN RECOGN, V44, P2314, DOI 10.1016/j.patcog.2011.01.007; Zhang B, 2010, COMPUT BIOL MED, V40, P438, DOI 10.1016/j.compbiomed.2010.02.008; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zheng J, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/927285	26	41	43	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127748	10.1371/journal.pone.0127748	http://dx.doi.org/10.1371/journal.pone.0127748			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047128	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200029
J	Delamou, A; Dubourg, D; Beavogui, AH; Delvaux, T; Kolle, JS; Barry, TH; Camara, BS; Edginton, M; Hinderaker, S; De Brouwere, V				Delamou, Alexandre; Dubourg, Dominique; Beavogui, Abdoul Habib; Delvaux, Therese; Kolle, Jacques Seraphin; Barry, Thierno Hamidou; Camara, Bienvenu Salim; Edginton, Mary; Hinderaker, Sven; De Brouwere, Vincent			How Has the Free Obstetric Care Policy Impacted Unmet Obstetric Need in a Rural Health District in Guinea?	PLOS ONE			English	Article							REDUCING FINANCIAL BARRIERS; REGION; ACCESS	Introduction In 2010, the Ministry of Health (MoH) of Guinea introduced a free emergency obstetric care policy in all the public health facilities of the country. This included antenatal checks, normal delivery and Caesarean section. Objective This study aims at assessing the changes in coverage of obstetric care according to the Unmet Obstetric Need concept before (2008) and after (2012) the implementation of the free emergency obstetric care policy in a rural health district in Guinea. Methods We carried out a descriptive cross-sectional study involving the retrospective review of routine programme data during the period April to June 2014. Results No statistical difference was observed in women's sociodemographic characteristics and indications (absolute maternal indications versus non-absolute maternal indications) before and after the implementation of the policy. Compared to referrals from health centers of patients, direct admissions at hospital significantly increased from 49% to 66% between 2008 and 2012 (p = 0.001). In rural areas, this increase concerned all maternal complications regardless of their severity, while in urban areas it mainly affected very severe complications. Compared to 2008, there were significantly more Major Obstetric Interventions for Maternal Absolute Indications in 2012 (p<0.001). Maternal deaths decreased between 2008 and 2012 from 1.5% to 1.1% while neonatal death increased from 12% in 2008 to 15% in 2012. Conclusion The implementation of the free obstetric care policy led to a significant decrease in unmet obstetric need between 2008 and 2012 in the health district of Kissidougou. However, more research is needed to allow comparisons with other health districts in the country and to analyse the trends.	[Delamou, Alexandre; Beavogui, Abdoul Habib; Camara, Bienvenu Salim] Ctr Natl Format & Rech Sante Rurale Maferinyah, Forecariah, Guinea; [Delamou, Alexandre] Univ Libre Bruxelles, Ecole Sante Publ, Brussels, Belgium; [Dubourg, Dominique] Observ Wallon Sante, Namur, Belgium; [Kolle, Jacques Seraphin; Barry, Thierno Hamidou] Hop Prefectoral Kissidougou, Kissidougou, Guinea; [Edginton, Mary] Int Union TB & Lung Dis, Paris, France; [Edginton, Mary] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Hinderaker, Sven] Univ Bergen, Bergen, Norway; [Delamou, Alexandre; Delvaux, Therese; De Brouwere, Vincent] Inst Trop Med, Women & Child Hlth Res Ctr, B-2000 Antwerp, Belgium	Universite Libre de Bruxelles; University of Witwatersrand; University of Bergen; Institute of Tropical Medicine (ITM)	Delamou, A (corresponding author), Ctr Natl Format & Rech Sante Rurale Maferinyah, Forecariah, Guinea.	alexdelamou@yahoo.fr	Camara, Bienvenu/HGA-3369-2022		Union; Department for International Development (DFID); WHO; DGD-ITM Individual PhD Fellowship Program; MSF	Union; Department for International Development (DFID); WHO(World Health Organization); DGD-ITM Individual PhD Fellowship Program; MSF	The programme was funded by The Union, MSF, the Department for International Development (DFID) and WHO. The first author is a doctoral fellow funded by the DGD-ITM Individual PhD Fellowship Program, registered at ULB.	Belaid L, 2015, HEALTH POLICY PLANN, V30, P309, DOI 10.1093/heapol/czu012; Ben Ameur A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-412; Boudreaux C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089784; Brazier E, 2015, HEALTH POLICY PLANN, V30, P885, DOI 10.1093/heapol/czu089; De Brouwere V, 2002, LANCET, V359, P974, DOI 10.1016/S0140-6736(02)07993-X; De Brouwere V, 1998, BESOINS OBSTETRICAUX; Delamou A, 2014, TROP MED INT HEALTH, V19, P65, DOI 10.1111/tmi.12219; Dubourg D, 2003, UNMET OBSTET NEEDS N; Edginton M, 2012, PUBLIC HEALTH ACTION, V2, P21, DOI [10.5588/pha.12.0001, 10.5588/pha.12.0028]; Fistula Care, 2013, PROJ REP OCT 2007 DE; Fournier P, 2009, B WORLD HEALTH ORGAN, V87, P30, DOI 10.2471/BLT.07.047076; Guindo G, 2004, HEALTH POLICY PLANN, V19, pI87, DOI 10.1093/heapol/czh049; Hunger C, 2007, TROP MED INT HEALTH, V12, P1239, DOI 10.1111/j.1365-3156.2007.01909.x; Institut National des Statistiques, 2014, GUIN 2012 DEM HLTH S; Institut National des Statistiques de Guinee, 2013, PAUVR IN GUIN 1994 2; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Kruk ME, 2014, B WORLD HEALTH ORGAN, V92, P246, DOI 10.2471/BLT.13.126417; Lee K, 2009, GLOB INST, P1; Leive A, 2008, B WORLD HEALTH ORGAN, V86, P849, DOI 10.2471/BLT.07.049403; Lohela TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052110; McPake B, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-46; Meessen B, 2011, HEALTH POLICY PLANN, V26, pII16, DOI 10.1093/heapol/czr062; Ministry of Health of Guinea, 2013, ANN STAT SAN NAT 201; Ouedraogo L T, 2003, Sante, V13, P17; Prytherch Helen, 2007, BMC Pregnancy Childbirth, V7, P16, DOI 10.1186/1471-2393-7-16; Richard F, 2007, TROP MED INT HEALTH, V12, P972, DOI 10.1111/j.1365-3156.2007.01877.x; Richard F, 2010, AM J PUBLIC HEALTH, V100, P1845, DOI 10.2105/AJPH.2009.179689; Ridde V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033082; Ridde V, 2011, SANTE PUBLIQUE, V23, P61, DOI 10.3917/spub.111.0061; Ronsmans C, 1999, TROP MED INT HEALTH, V4, P514, DOI 10.1046/j.1365-3156.1999.00429.x; Ronsmans C, 2010, B WORLD HEALTH ORGAN, V88, P289, DOI 10.2471/BLT.09.069385; Saizonou J, 2009, BENIN MED, V42, P42; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; Wilunda C, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-27	35	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129162	10.1371/journal.pone.0129162	http://dx.doi.org/10.1371/journal.pone.0129162			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047472	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200131
J	Natarajan, V; Madhan, B; Tiku, ML				Natarajan, Venkatachalam; Madhan, Balaraman; Tiku, Moti L.			Intra-Articular Injections of Polyphenols Protect Articular Cartilage from Inflammation-Induced Degradation: Suggesting a Potential Role in Cartilage Therapeutics	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; NECROSIS-FACTOR-ALPHA; IN-VITRO EVALUATION; TANNIC-ACID; CROSS-LINKING; ELASTIN STABILIZATION; PLANT POLYPHENOLS; TISSUE; EXPRESSION; CURCUMIN	Arthritic diseases, such as osteoarthritis and rheumatoid arthritis, inflict an enormous health care burden on society. Osteoarthritis, a degenerative joint disease with high prevalence among older people, and rheumatoid arthritis, an autoimmune inflammatory disease, both lead to irreversible structural and functional damage to articular cartilage. The aim of this study was to investigate the effect of polyphenols such as catechin, quercetin, epigallocatechin gallate, and tannic acid, on crosslinking type II collagen and the roles of these agents in managing in vivo articular cartilage degradation. The thermal, enzymatic, and physical stability of bovine articular cartilage explants following polyphenolic treatment were assessed for efficiency. Epigallocatechin gallate and tannic acid-treated explants showed >12 degrees C increase over native cartilage in thermal stability, thereby confirming cartilage crosslinking. Polyphenol-treated cartilage also showed a significant reduction in the percentage of collagen degradation and the release of glycosaminoglycans against collagenase digestion, indicating the increase physical integrity and resistance of polyphenol crosslinked cartilage to enzymatic digestion. To examine the in vivo cartilage protective effects, polyphenols were injected intra-articularly before (prophylactic) and after (therapeutic) the induction of collagen-induced arthritis in rats. The hind paw volume and histomorphological scoring was done for cartilage damage. The intra-articular injection of epigallocatechin gallate and tannic acid did not significantly influence the time of onset or the intensity of joint inflammation. However, histomorphological scoring of the articular cartilage showed a significant reduction in cartilage degradation in prophylactic-and therapeutic-groups, indicating that intra-articular injections of polyphenols bind to articular cartilage and making it resistant to degradation despite ongoing inflammation. These studies establish the value of intra-articular injections of polyphenol in stabilization of cartilage collagen against degradation and indicate the unique beneficial role of injectable polyphenols in protecting the cartilage in arthritic conditions.	[Natarajan, Venkatachalam; Madhan, Balaraman] CSIR, Cent Leather Res Inst, Madras, Tamil Nadu, India; [Tiku, Moti L.] Rutgers State Univ, Robert Wood Johnson Med Sch, New Brunswick, NJ 08903 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Leather Research Institute (CLRI); Rutgers State University New Brunswick; Rutgers State University Medical Center	Madhan, B (corresponding author), CSIR, Cent Leather Res Inst, Madras, Tamil Nadu, India.	bmadhan76@yahoo.co.in	Balaraman, Madhan/B-3136-2009; Venkatachalam, Natarajan/B-7930-2009	Balaraman, Madhan/0000-0002-4198-8452; Venkatachalam, Natarajan/0000-0003-1491-8886	CSIR India under the CSIR-YSA Project of BM [1105]; CSIR	CSIR India under the CSIR-YSA Project of BM; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	BM and VN are grateful to CSIR India for providing financial assistance under the CSIR-YSA Project of BM (CSIR-CLRI Communication No. 1105). Author VN thanks CSIR for providing a Senior Research Fellowship.	Adcocks C, 2002, J NUTR, V132, P341, DOI 10.1093/jn/132.3.341; Ahmed S, 2004, J PHARMACOL EXP THER, V308, P767, DOI 10.1124/jpet.103.059220; Ahmed S, 2009, ARTHRITIS RHEUM-US, V60, P1282, DOI 10.1002/art.24488; Aly Maha Nasr Sayed, 2008, Recent Pat Drug Deliv Formul, V2, P231; Athens AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060719; Avila MY, 2010, J CATARACT REFR SURG, V36, P659, DOI 10.1016/j.jcrs.2009.11.003; Barker MK, 2001, RHEUMATOLOGY, V40, P274, DOI 10.1093/rheumatology/40.3.274; Baxter NJ, 1997, BIOCHEMISTRY-US, V36, P5566, DOI 10.1021/bi9700328; Bhosale AM, 2008, BRIT MED BULL, V87, P77, DOI 10.1093/bmb/ldn025; Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P487; Chang TL, 2013, BIOL CHEM, V394, P561, DOI 10.1515/hsz-2012-0277; Charlton AJ, 2002, J AGR FOOD CHEM, V50, P1593, DOI 10.1021/jf010897z; Chen X, 2003, CLIN CANCER RES, V9, P3115; Cheng DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091571; Chuang TH, 2009, TISSUE ENG PT A, V15, P2837, DOI [10.1089/ten.tea.2008.0394, 10.1089/ten.TEA.2008.0394]; Clutterbuck AL, 2009, ANN NY ACAD SCI, V1171, P428, DOI 10.1111/j.1749-6632.2009.04687.x; Covington AD, 2009, TANNING CHEMISTRY: THE SCIENCE OF LEATHER, P1; Csotye J, 2009, J THERM ANAL CALORIM, V95, P805, DOI 10.1007/s10973-008-9414-3; Fessel G, 2014, ACTA BIOMATER, V10, P1897, DOI 10.1016/j.actbio.2013.12.048; Fox AJS, 2009, SPORTS HEALTH, V1, P461, DOI 10.1177/1941738109350438; Ganesan K, 2008, RHEUMATOL INT, V28, P345, DOI 10.1007/s00296-007-0446-y; Henrotin Y, 2010, OSTEOARTHR CARTILAGE, V18, P141, DOI 10.1016/j.joca.2009.10.002; Hiraishi N, 2013, DENT MATER, V29, P1048, DOI 10.1016/j.dental.2013.07.015; Htay HH, 2013, GREEN TEA POLYPHENOL, P139; Isenburg JC, 2007, CIRCULATION, V115, P1729, DOI 10.1161/CIRCULATIONAHA.106.672873; Isenburg JC, 2006, BIOMATERIALS, V27, P3645, DOI 10.1016/j.biomaterials.2006.02.016; Isenburg JC, 2005, BIOMATERIALS, V26, P1237, DOI 10.1016/j.biomaterials.2004.04.034; Isenburg JC, 2004, BIOMATERIALS, V25, P3293, DOI 10.1016/j.biomaterials.2003.10.001; Jackson JK, 2010, J MATER SCI-MATER M, V21, P1435, DOI 10.1007/s10856-010-4019-3; Jean-Gilles D, 2012, J AGR FOOD CHEM, V60, P5755, DOI 10.1021/jf203456w; Kasyanov V, 2006, BIOMATERIALS, V27, P745, DOI 10.1016/j.biomaterials.2005.06.022; Kona FR, 2014, REC ADV POLYPHEN RES, V4, P209; Larsen C, 2008, J PHARM SCI-US, V97, P4622, DOI 10.1002/jps.21346; Lay E, 2012, J NUTR BIOCHEM, V23, P106, DOI 10.1016/j.jnutbio.2010.11.004; Liu XQ, 2005, J NUTR, V135, P165, DOI 10.1093/jn/135.2.165; Liu Z, 2012, BIOMATERIALS, V33, P7336, DOI 10.1016/j.biomaterials.2012.06.080; Madhan B, 2005, INT J BIOL MACROMOL, V37, P47, DOI 10.1016/j.ijbiomac.2005.08.005; Madhan B, 2002, BIOMATERIALS, V23, P2841, DOI 10.1016/S0142-9612(01)00410-0; Madhan B, 2001, CHEM PHYS LETT, V346, P334, DOI 10.1016/S0009-2614(01)00910-1; Makris EA, 2014, P NATL ACAD SCI USA, V111, pE4832, DOI 10.1073/pnas.1414271111; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Mohan A, 2013, ANTI-CANCER AGENT ME, V13, P281, DOI 10.2174/1871520611313020015; Morinobu A, 2008, ARTHRITIS RHEUM, V58, P2012, DOI 10.1002/art.23594; Mort JS, 2001, ARTHRITIS RES, V3, P337, DOI 10.1186/ar325; Naumov I, 2012, J THERM ANAL CALORIM, V108, P59, DOI 10.1007/s10973-011-1532-7; Ofek G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002795; Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498; Pearson W, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-19; Rasheed Z, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2700; Satyam A, 2014, J TISSUE ENG REGEN M, V8, P233, DOI 10.1002/term.1522; SCHLEBUSCH H, 1972, ANGIOLOGICA, V9, P248; Shen CL, 2012, J NUTR BIOCHEM, V23, P1367, DOI 10.1016/j.jnutbio.2012.04.001; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Sung HW, 1999, BIOMATERIALS, V20, P1759, DOI 10.1016/S0142-9612(99)00069-1; Svelander L, 2009, EUR J PHARMACOL, V613, P155, DOI 10.1016/j.ejphar.2009.03.074; Tang HR, 2003, J AGR FOOD CHEM, V51, P6652, DOI 10.1021/jf034380u; Tedder ME, 2009, TISSUE ENG PT A, V15, P1257, DOI 10.1089/ten.tea.2008.0263; Than P, 2005, J THERM ANAL CALORIM, V82, P213, DOI 10.1007/s10973-005-0868-2; Tiku ML, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2274; Tyyni A, 2000, SCAND J MED SCI SPOR, V10, P249, DOI 10.1034/j.1600-0838.2000.010005249.x; Ulrich-Vinther Michael, 2003, J Am Acad Orthop Surg, V11, P421; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Yang CS, 2013, ANNU REV NUTR, V33, P161, DOI 10.1146/annurev-nutr-071811-150717; Yun HJ, 2008, RHEUMATOL INT, V29, P23, DOI 10.1007/s00296-008-0597-5	65	33	33	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127165	10.1371/journal.pone.0127165	http://dx.doi.org/10.1371/journal.pone.0127165			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046639	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200015
J	Wang, SY; Hu, BL; Si, WY; Jia, L; Zheng, XJ; Zhou, JY				Wang, Sanying; Hu, Boli; Si, Weiying; Jia, Lu; Zheng, Xiaojuan; Zhou, Jiyong			Avibirnavirus VP4 Protein Is a Phosphoprotein and Partially Contributes to the Cleavage of Intermediate Precursor VP4-VP3 Polyprotein	PLOS ONE			English	Article							BURSAL DISEASE VIRUS; N-TERMINAL PHOSPHORYLATION; DEPENDENT RNA-POLYMERASE; HOST-CELLS; CATALYTIC DYAD; DOMAIN; CONTAINS; GENOME; IDENTIFICATION; NUCLEOPROTEIN	Birnavirus-encoded viral protein 4 (VP4) utilizes a Ser/Lys catalytic dyad mechanism to process polyprotein. Here three phosphorylated amino acid residues Ser538, Tyr611 and Thr674 within the VP4 protein of the infectious bursal disease virus (IBDV), a member of the genus Avibirnavirus of the family Birnaviridae, were identified by mass spectrometry. Anti-VP4 monoclonal antibodies finely mapping to phosphorylated (p) Ser538 and the epitope motif (530)PVVDGIL(536) were generated and verified. Proteomic analysis showed that in IBDV-infected cells the VP4 was distributed mainly in the cytoskeletal fraction and existed with different isoelectric points and several phosphorylation modifications. Phosphorylation of VP4 did not influence the aggregation of VP4 molecules. The proteolytic activity analysis verified that the pTyr611 and pThr674 sites within VP4 are involved in the cleavage of viral intermediate precursor VP4-VP3. This study demonstrates that IBDV-encoded VP4 protein is a unique phosphoprotein and that phosphorylation of Tyr611 and Thr674 of VP4 affects its serine-protease activity.	[Wang, Sanying; Si, Weiying; Jia, Lu; Zheng, Xiaojuan; Zhou, Jiyong] Zhejiang Univ, Minist Agr, Key Lab Anim Virol, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Boli; Zhou, Jiyong] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China; [Zheng, Xiaojuan; Zhou, Jiyong] Zhejiang Univ, Affiliated Hosp 1, State Key Lab & Collaborat Innovat, Ctr Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Sanying] Shaoxing Ctr Dis Control & Prevent, Shaoxing, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University; Nanjing Agricultural University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Zheng, XJ (corresponding author), Zhejiang Univ, Minist Agr, Key Lab Anim Virol, Hangzhou 310003, Zhejiang, Peoples R China.	zhengxiaojuan@zju.edu.cn; jyzhou@njau.edu.cn			China Agriculture Research System [CARS-41-K11]; National Natural Science Foundation of China [30870117, 30800825]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from China Agriculture Research System (Grant No. CARS-41-K11) and National Natural Science Foundation of China (Grant No. 30870117 and 30800825). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnitz RA, 2010, J VIROL, V84, P6410, DOI 10.1128/JVI.02273-09; Bhuvanakantham R, 2010, MICROBES INFECT, V12, P615, DOI 10.1016/j.micinf.2010.04.005; Birghan C, 2000, EMBO J, V19, P114, DOI 10.1093/emboj/19.1.114; Brandt M, 2001, J VIROL, V75, P11974, DOI 10.1128/JVI.75.24.11974-11982.2001; Chang GRL, 2012, PROTEIN ENG DES SEL, V25, P789, DOI 10.1093/protein/gzs087; Chen LY, 2013, J VIROL, V87, P3177, DOI 10.1128/JVI.02761-12; Chung IYW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.198812; Da Costa B, 2002, J VIROL, V76, P2393, DOI 10.1128/JVI.76.5.2393-2402.2002; Da Costa B, 2003, J VIROL, V77, P719, DOI 10.1128/JVI.77.1.719-725.2003; Escaffre O, 2013, J VIROL, V87, P2767, DOI 10.1128/JVI.02360-12; Feldman AR, 2006, J MOL BIOL, V358, P1378, DOI 10.1016/j.jmb.2006.02.045; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Granzow H, 1997, J VIROL, V71, P8879, DOI 10.1128/JVI.71.11.8879-8885.1997; Hagiwara K, 2008, PROTEOMICS, V8, P1871, DOI 10.1002/pmic.200701051; Irigoyen N, 2012, J BIOL CHEM, V287, P24473, DOI 10.1074/jbc.M112.356113; Irigoyen N, 2009, J BIOL CHEM, V284, P8064, DOI 10.1074/jbc.M808942200; Jackwood DJ, 2008, VIROLOGY, V377, P110, DOI 10.1016/j.virol.2008.04.018; Kibenge FSB, 1997, ARCH VIROL, V142, P1227, DOI 10.1007/s007050050154; Kolesnikova L, 2012, CELL MICROBIOL, V14, P182, DOI 10.1111/j.1462-5822.2011.01709.x; Lappalainen P, 1998, MOL BIOL CELL, V9, P1951, DOI 10.1091/mbc.9.8.1951; Le Nouen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028064; Lee J, 2006, ACTA CRYSTALLOGR F, V62, P1235, DOI 10.1107/S1744309106046070; Lejal N, 2000, J GEN VIROL, V81, P983, DOI 10.1099/0022-1317-81-4-983; Lemay KL, 2013, J VIROL, V87, P1255, DOI 10.1128/JVI.02154-12; Letzel T, 2007, J VIROL, V81, P12827, DOI 10.1128/JVI.01501-07; Li WG, 2011, PHYS RES INT, V2011, P1, DOI [10.1155/2011/791545, DOI 10.1155/2011/791545]; Li ZH, 2013, J VIROL, V87, P1221, DOI 10.1128/JVI.02421-12; Li ZH, 2012, J VIROL, V86, P1328, DOI 10.1128/JVI.06104-11; Liu MH, 2004, VIROLOGY, V330, P62, DOI 10.1016/j.virol.2004.09.009; Luque D, 2009, J MOL BIOL, V386, P891, DOI 10.1016/j.jmb.2008.11.029; Machesky LM, 2001, TRENDS CELL BIOL, V11, P286, DOI 10.1016/S0962-8924(01)02009-8; Maraver A, 2003, J VIROL, V77, P6438, DOI 10.1128/JVI.77.11.6438-6449.2003; Mostafa HH, 2013, J VIROL, V87, P2109, DOI 10.1128/JVI.02588-12; MULLER H, 1987, VIROLOGY, V159, P174, DOI 10.1016/0042-6822(87)90363-1; OPPLING V, 1991, J GEN VIROL, V72, P2275, DOI 10.1099/0022-1317-72-9-2275; Paunola E, 2002, FEBS LETT, V513, P92, DOI 10.1016/S0014-5793(01)03242-2; Petit S, 2000, J VIROL, V74, P2057, DOI 10.1128/JVI.74.5.2057-2066.2000; Rodriguez-Lecompte JC, 2002, VIROLOGY, V292, P241, DOI 10.1006/viro.2001.1260; Sanchez AB, 1999, VIROLOGY, V262, P190, DOI 10.1006/viro.1999.9910; SCHNITZLER D, 1993, J GEN VIROL, V74, P1563, DOI 10.1099/0022-1317-74-8-1563; Shang SB, 2009, MOL IMMUNOL, V46, P327, DOI 10.1016/j.molimm.2008.10.028; SPIES U, 1989, NUCLEIC ACIDS RES, V17, P7982, DOI 10.1093/nar/17.19.7982; Stradal T, 1998, FEBS LETT, V431, P134, DOI 10.1016/S0014-5793(98)00751-0; Tacken MGJ, 2004, ARCH VIROL, V149, P2245, DOI 10.1007/s00705-004-0365-0; Tacken MGJ, 2002, J VIROL, V76, P11301, DOI 10.1128/JVI.76.22.11301-11311.2002; Wang SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084503; Wang YZ, 2009, MOL IMMUNOL, V46, P1964, DOI 10.1016/j.molimm.2009.03.011; Weeds A, 1993, CURR OPIN CELL BIOL, V5, P63, DOI 10.1016/S0955-0674(05)80009-2; Wu YP, 2012, PROTEOMICS, V12, P1844, DOI 10.1002/pmic.201100479; Wu YP, 2009, ARCH VIROL, V154, P1873, DOI 10.1007/s00705-009-0524-4; Yamaguchi T, 1996, VIROLOGY, V223, P219, DOI 10.1006/viro.1996.0470; Zhang X, 2009, J PROTEOME RES, V8, P5111, DOI 10.1021/pr900488q; Zheng XJ, 2008, MOL CELL PROTEOMICS, V7, P612, DOI 10.1074/mcp.M700396-MCP200; Zhou JY, 2005, PROG BIOCHEM BIOPHYS, V32, P37	54	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128828	10.1371/journal.pone.0128828	http://dx.doi.org/10.1371/journal.pone.0128828			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046798	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200106
J	Csak, T; Bala, S; Lippai, D; Kodys, K; Catalano, D; Iracheta-Vellve, A; Szabo, G				Csak, Timea; Bala, Shashi; Lippai, Dora; Kodys, Karen; Catalano, Donna; Iracheta-Vellve, Arvin; Szabo, Gyongyi			MicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of Steatohepatitis	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; EPITHELIAL-MESENCHYMAL TRANSITION; DIFFERENTIATION-RELATED PROTEIN; HEPATIC STELLATE CELLS; CHOLINE-DEFICIENT; TRIGLYCERIDE SYNTHESIS; ACID; EXPRESSION; DIET; HEPATOCYTES	Background & Aim MicroRNAs (miRs) regulate hepatic steatosis, inflammation and fibrosis. Fibrosis is the consequence of chronic tissue damage and inflammation. We hypothesized that deficiency of miR-155, a master regulator of inflammation, attenuates steatohepatitis and fibrosis. Methods Wild type (WT) and miR-155-deficient (KO) mice were fed methionine-choline-deficient (MCD) or -supplemented (MCS) control diet for 5 weeks. Liver injury, inflammation, steatosis and fibrosis were assessed. Results MCD diet resulted in steatohepatitis and increased miR-155 expression in total liver, hepatocytes and Kupffer cells. Steatosis and expression of genes involved in fatty acid metabolism were attenuated in miR-155 KO mice after MCD feeding. In contrast, miR-155 deficiency failed to attenuate inflammatory cell infiltration, nuclear factor. beta (NF-kappa B) activation and enhanced the expression of the pro-inflammatory cytokines tumor necrosis factor alpha (TNF alpha) and monocyte chemoattractant protein-1 (MCP1) in MCD diet-fed mice. We found a significant attenuation of apoptosis (cleaved caspase-3) and reduction in collagen and a smooth muscle actin (alpha SMA) levels in miR-155 KO mice compared to WTs on MCD diet. In addition, we found attenuation of platelet derived growth factor (PDGF), a profibrotic cytokine; SMAD family member 3 (Smad3), a protein involved in transforming growth factor-alpha (TGF alpha) signal transduction and vimentin, a mesenchymal marker and indirect indicator of epithelial-to-mesenchymal transition (EMT) in miR-155 KO mice. Nuclear binding of CCAAT enhancer binding protein beta (C/EBP beta) a miR-155 target involved in EMT was significantly increased in miR-155 KO compared to WT mice. Conclusions Our novel data demonstrate that miR-155 deficiency can reduce steatosis and fibrosis without decreasing inflammation in steatohepatitis.	[Csak, Timea; Bala, Shashi; Kodys, Karen; Catalano, Donna; Iracheta-Vellve, Arvin; Szabo, Gyongyi] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA; [Lippai, Dora] Semmelweis Univ, Dept Med 2, H-1085 Budapest, Hungary	University of Massachusetts System; University of Massachusetts Worcester; Semmelweis University	Szabo, G (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA.	gyongyi.szabo@umassmed.edu	Iracheta-Vellve, Arvin/K-6140-2014	Iracheta-Vellve, Arvin/0000-0002-6635-3904	National Institute on Alcohol Abuse and Alcoholism [AA020744]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020744] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institute on Alcohol Abuse and Alcoholism-AA020744 to G.S. http://www.niaaa.nih.gov), and National Institute on Alcohol Abuse and Alcoholism had no role in the study design, collection, analysis, or interpretation of data.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Ai D, 2012, J CLIN INVEST, V122, P1262, DOI 10.1172/JCI61919; Bala S, 2012, HEPATOLOGY, V56, p1107A; Bala S, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/498232; Bala S, 2011, J BIOL CHEM, V286, P1436, DOI 10.1074/jbc.M110.145870; Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Chakraborty JB, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/648915; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Cicchini C, 2015, LIVER INT, V35, P302, DOI 10.1111/liv.12577; Connolly MK, 2009, J CLIN INVEST, V119, P3213, DOI 10.1172/JCI37581; Csak T, 2015, LIVER INT, V35, P532, DOI 10.1111/liv.12633; Csak T, 2011, HEPATOLOGY, V54, P133, DOI 10.1002/hep.24341; Csak T, 2011, AM J PHYSIOL-GASTR L, V300, pG433, DOI 10.1152/ajpgi.00163.2009; Dattaroy D, 2015, AM J PHYSIOL-GASTR L, V308, pG298, DOI 10.1152/ajpgi.00346.2014; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dolganiuc A, 2009, ALCOHOL CLIN EXP RES, V33, P1704, DOI 10.1111/j.1530-0277.2009.01007.x; Edvardsson U, 2006, J LIPID RES, V47, P329, DOI 10.1194/jlr.M500203-JLR200; Elpek GO, 2014, WORLD J GASTROENTERO, V20, P7260, DOI 10.3748/wjg.v20.i23.7260; Estep M, 2010, ALIMENT PHARM THER, V32, P487, DOI 10.1111/j.1365-2036.2010.04366.x; Feingold KR, 2008, J LIPID RES, V49, P2179, DOI 10.1194/jlr.M800233-JLR200; FonTacer K, 2011, J LIPIDS; Imajo K, 2013, INT J MOL SCI, V14, P21833, DOI 10.3390/ijms141121833; Johansson J, 2013, ONCOGENE, V32, P5614, DOI 10.1038/onc.2013.322; Kainuma M, 2006, J GASTROENTEROL, V41, P971, DOI 10.1007/s00535-006-1883-1; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Li JX, 2014, J CELL SCI, V127, P3735, DOI 10.1242/jcs.148759; Louafi F, 2010, J BIOL CHEM, V285, P41328, DOI 10.1074/jbc.M110.146852; Magnusson B, 2006, ARTERIOSCL THROM VAS, V26, P1566, DOI 10.1161/01.ATV.0000223345.11820.da; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Miller AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072324; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Nath B, 2011, HEPATOLOGY, V53, P1526, DOI 10.1002/hep.24256; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Paland N, 2014, ATHEROSCLEROSIS, V237, P200, DOI 10.1016/j.atherosclerosis.2014.09.003; Patel DD, 2001, J LIPID RES, V42, P328; Pogribny IP, 2010, LAB INVEST, V90, P1437, DOI 10.1038/labinvest.2010.113; Pradere JP, 2013, HEPATOLOGY, V58, P1461, DOI 10.1002/hep.26429; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Seki E, 2012, J PHYSIOL-LONDON, V590, P447, DOI 10.1113/jphysiol.2011.219691; Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87; Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368; Thumser AE, 2014, CURR OPIN CLIN NUTR, V17, P124, DOI 10.1097/MCO.0000000000000031; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tili E, 2008, NAT CLIN PRACT RHEUM, V4, P534, DOI 10.1038/ncprheum0885; Velayudham A, 2009, HEPATOLOGY, V49, P989, DOI 10.1002/hep.22711; Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100; Witek RP, 2009, HEPATOLOGY, V50, P1421, DOI 10.1002/hep.23167; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; Yang L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00138; Yang LL, 2014, BIOCHEM BIOPH RES CO, V453, P153, DOI 10.1016/j.bbrc.2014.09.077; Zammit VA, 2013, BIOCHEM J, V451, P1, DOI 10.1042/BJ20121689; Zeng L, 2014, INT J CLIN EXP MED, V7, P1624	57	68	70	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0129251	10.1371/journal.pone.0129251	http://dx.doi.org/10.1371/journal.pone.0129251			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042593	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600094
J	Golzan, SM; Morgan, WH; Georgevsky, D; Graham, SL				Golzan, S. Mojtaba; Morgan, William H.; Georgevsky, Dana; Graham, Stuart L.			Correlation of Retinal Nerve Fibre Layer Thickness and Spontaneous Retinal Venous Pulsations in Glaucoma and Normal Controls	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; CEREBROSPINAL-FLUID PRESSURE; BLOOD-FLOW; INTRAOCULAR-PRESSURE; VESSEL DIAMETER; VEIN; EYE; ASSOCIATION; ARTERY	Purpose To study the relationship between amplitude of spontaneous retinal venous pulsatility (SRVP) and retinal nerve fibre layer (RNFL) thickness in glaucomatous eyes, and to determine if this parameter may be a potential marker for glaucoma severity. Method 85 subjects including 50 glaucoma (21 males, 67 +/- 10 yrs) and 35 normals (16 males, 62 +/- 11 yrs) were studied. SRVP amplitude was measured using the Dynamic Vessel Analyser (DVA, Imedos, Germany) at four regions of the retina simultaneously within one disc diameter from the optic disc-temporal-superior (TS), nasal-superior (NS), temporal-inferior (TI) and nasal-inferior (NI)). This was followed by RNFL thickness measurement using spectral domain optical coherence tomography (Spectralis OCT). The correlation between SRVP amplitude and corresponding sectoral RNFL thickness was assessed by means of non-linear regression (i.e. logarithmic). Linear regression was also applied and slopes were compared using analysis of covariance (ANCOVA). Results Greater SRVP amplitude was associated with thicker RNFL. Global SRVP amplitude was significantly lower in glaucoma eyes compared with normals (p < 0.0001). The correlation coefficient of the linear regression between RNFL and SRVP at TS, NS, TI and NI quadrants in the glaucoma group were r = 0.5, 0.5, 0.48, 0.62. Mean SRVP amplitude and RNFL thickness for TS, NS, TI and NI quadrants were 4.3 +/- 1.5, 3.5 +/- 1.3, 4.7 +/- 1.6, 3.1 +/- 1 mu m and 96 +/- 30, 75 +/- 22, 89 +/- 35 and 88 +/- 30 mu m, respectively. The ANCOVA test showed that the slope of linear regression between the four quadrants was not significant (p > 0.05). Since the slopes are not significantly different, it is possible to calculate one slope for all the data. The pooled slope equals 10.8 (i.e. RNFL = 10.8SRVP+41). Conclusion While SRVP was present and measurable in all individuals, the amplitude of SRVP is reduced in glaucoma with increasing RNFL loss. Our findings suggest the degree of SRVP may be an additional marker for glaucoma severity. Further studies are needed to determine the mechanism of reduction in SRVP, and whether changes can predict increased risk of progression.	[Golzan, S. Mojtaba; Georgevsky, Dana; Graham, Stuart L.] Macquarie Univ, Dept Clin Med, Fac Med & Hlth Sci, Sydney, NSW 2109, Australia; [Morgan, William H.] Univ Western Australia, Lions Eye Inst, Perth, WA 6009, Australia	Macquarie University; Lions Eye Institute; University of Western Australia	Golzan, SM (corresponding author), Macquarie Univ, Dept Clin Med, Fac Med & Hlth Sci, Sydney, NSW 2109, Australia.	mojtaba.golzan@mq.edu.au		Graham, Stuart/0000-0001-7519-969X; Golzan, Mojtaba/0000-0002-4479-3917	Australian National Health and Medical Research Council [1020367]; "Rebecca L. Cooper" Medical Foundation; Perpetual-Hillcrest	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); "Rebecca L. Cooper" Medical Foundation; Perpetual-Hillcrest	The authors received funding from the Australian National Health and Medical Research Council (1020367), the "Rebecca L. Cooper" Medical Foundation and "Perpetual-Hillcrest" to conduct this study. The funds provided are solely for assistance with project costs and does not include investigator employment, consultancy, patents, products in development and marketed products. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldoori MI, 1998, ACTA OPHTHALMOL SCAN, V76, P668, DOI 10.1034/j.1600-0420.1998.760606.x; Amerasinghe N, 2008, INVEST OPHTH VIS SCI, V49, P5397, DOI 10.1167/iovs.08-2142; Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berisha F, 2008, AM J OPHTHALMOL, V146, P466, DOI 10.1016/j.ajo.2008.04.034; Budenz DL, 2006, OPHTHALMOLOGY, V113, P2137, DOI 10.1016/j.ophtha.2006.06.022; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Golzan SM, 2011, CURR EYE RES, V36, P53, DOI 10.3109/02713683.2010.530731; Graham SL, 2013, J GLAUCOMA, V22, P98, DOI 10.1097/IJG.0b013e3182254bc0; Harder B, 2007, BRIT J OPHTHALMOL, V91, P401, DOI 10.1136/bjo.2006.103341; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Jonas JB, 2003, INVEST OPHTH VIS SCI, V44, P5189, DOI 10.1167/iovs.03-0174; Kaiser HJ, 1997, AM J OPHTHALMOL, V123, P320, DOI 10.1016/S0002-9394(14)70127-8; Leaney J, 2012, CLIN EXP OPHTHALMOL, V40, P802, DOI 10.1111/j.1442-9071.2012.02807.x; LEVIN BE, 1978, ARCH NEUROL-CHICAGO, V35, P37, DOI 10.1001/archneur.1978.00500250041009; Levine DN, 1998, MICROVASC RES, V56, P154, DOI 10.1006/mvre.1998.2098; Mitchell P, 2005, OPHTHALMOLOGY, V112, P245, DOI 10.1016/j.ophtha.2004.08.015; Morgan WH, 2009, BRIT J OPHTHALMOL, V93, P594, DOI 10.1136/bjo.2008.149963; Morgan WH, 1998, INVEST OPHTH VIS SCI, V39, P1419; Morgan WH, 2004, OPHTHALMOLOGY, V111, P1489, DOI 10.1016/j.ophtha.2003.12.053; Morgan WH, 1997, MICROVASC RES, V53, P211, DOI 10.1006/mvre.1997.2010; Morgan William H, 2013, J Glaucoma, V22 Suppl 5, pS15, DOI 10.1097/IJG.0b013e31829349d7; Morgan WH, 2012, INVEST OPHTH VIS SCI, V53, P4676, DOI 10.1167/iovs.12-9837; PARR JC, 1974, AM J OPHTHALMOL, V77, P472, DOI 10.1016/0002-9394(74)90457-7; Pinto LA, 2013, ACTA OPHTHALMOL, V91, P514, DOI 10.1111/j.1755-3768.2012.02472.x; Plange N, 2006, BRIT J OPHTHALMOL, V90, P1501, DOI 10.1136/bjo.2006.099853; Polak K, 2000, BRIT J OPHTHALMOL, V84, P1285, DOI 10.1136/bjo.84.11.1285; Remky A, 2004, SPEKTRUM AUGENHEILKD, V18, P25; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Siesky B, 2015, J GLAUCOMA, V24, P117, DOI 10.1097/IJG.0b013e31829d9bb0; Sperduto RD, 1998, OPHTHALMOLOGY, V105, P765, DOI 10.1016/S0161-6420(98)95012-6; Wang SA, 2007, CLIN EXP OPHTHALMOL, V35, P800, DOI 10.1111/j.1442-9071.2007.01627.x; Wong SH, 2013, J NEURO-OPHTHALMOL, V33, P17, DOI 10.1097/WNO.0b013e3182622207	32	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128433	10.1371/journal.pone.0128433	http://dx.doi.org/10.1371/journal.pone.0128433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042791	Green Submitted, gold, Green Published			2022-12-27	WOS:000355701600048
J	Manchaiah, V; Ronnberg, J; Andersson, G; Lunner, T				Manchaiah, Vinaya; Ronnberg, Jerker; Andersson, Gerhard; Lunner, Thomas			Stages of Change Profiles among Adults Experiencing Hearing Difficulties Who Have Not Taken Any Action: A Cross-Sectional Study	PLOS ONE			English	Article							ISLAND CHANGE ASSESSMENT; HEALTH BEHAVIOR-CHANGE; PATIENT JOURNEY MODEL; TRANSTHEORETICAL MODEL; HELP-SEEKING; HOSPITAL ANXIETY; DISABILITY; IMPAIRMENT; MOTIVATION; SMOKING	The aim of the current study was to test the hypothesis that adults experiencing hearing difficulties who are aware of their difficulties but have not taken any action would fall under contemplation and preparation stages based on the transtheoretical stages-of-change model. The study employed a cross-sectional design. The study was conducted in United Kingdom and 90 participants completed University of Rhode Island Change Assessment (URICA) scale as well as measures of self-reported hearing disability, self-reported anxiety and depression, self-reported hearing disability acceptance, and provided additional demographic details online. As predicted, the results indicate that a high percentage of participants (over 90%) were in the contemplation and preparation stages. No statistically significant differences were observed among groups of stage with highest URICA scores and factors such as: years since hearing disability, self-reported hearing disability, self-reported anxiety and depression, and self-reported hearing disability acceptance. Cluster analysis identified three stages-of-change clusters, which were named as: decision making (53% of sample), participation (28% of sample), and disinterest (19% of sample). Study results support the stages-of-change model. In addition, implications of the current study and areas for future research are discussed.	[Manchaiah, Vinaya] Lamar Univ, Dept Speech & Hearing Sci, Beaumont, TX 77710 USA; [Manchaiah, Vinaya; Ronnberg, Jerker; Andersson, Gerhard; Lunner, Thomas] Linkoping Univ, Dept Behav Sci & Learning, Swedish Inst Disabil Res, Linnaeus Ctr HEAD, Linkoping, Sweden; [Manchaiah, Vinaya] Audiol India, Mysore, Karnataka, India; [Andersson, Gerhard] Karolinska Inst, Dept Clin Neurosci, Div Psychiat, Stockholm, Sweden; [Lunner, Thomas] Oticon AS, Eriksholm Res Ctr, Snekkersten, Denmark	Texas State University System; Lamar University; Linkoping University; Karolinska Institutet; Oticon	Manchaiah, V (corresponding author), Lamar Univ, Dept Speech & Hearing Sci, Beaumont, TX 77710 USA.	vinaya.manchaiah@lamar.edu	Andersson, Gerhard/J-8529-2012; Manchaiah, Vinaya/I-1824-2014; Ronnberg, Jerker/AAW-5049-2021	Andersson, Gerhard/0000-0003-4753-6745; Manchaiah, Vinaya/0000-0002-1254-8407; 	Swedish Council for Working Life and Social Research [2009-0055]; Swedish Research Council [2007-8654]; Eriksholm Research Centre; Oticon A/S	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Eriksholm Research Centre; Oticon A/S	This study was partly funded by the grants from Swedish Council for Working Life and Social Research 2009-0055 and Swedish Research Council 2007-8654. Eriksholm Research Centre, Oticon A/S, provided support in the form of a salary for author TL, but did not have any additional role in the study design, data collection and analysis, decisions to publish, or preparation of the manuscript. The specific role of the authors are articulated in the 'author contributions' section.	Amodei N, 2004, DRUG ALCOHOL DEPEN, V73, P301, DOI 10.1016/j.drugalcdep.2003.11.005; Babeu LA, 2004, J ACAD REHABIL AUDIO, V37, P47; Buchanan T, 2002, PROF PSYCHOL-RES PR, V33, P148, DOI 10.1037//0735-7028.33.2.148; Davis A, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11420; Davis A.C., 1995, HEARING IN ADULTS; DICLEMENTE CC, 1991, J CONSULT CLIN PSYCH, V59, P295, DOI 10.1037/0022-006X.59.2.295; Dozois DJA, 2004, BEHAV RES THER, V42, P711, DOI 10.1016/S0005-7967(03)00193-1; Erdman S. A., 1994, J ACAD REHAB AUDIOL, V27, P45; Etter JF, 1997, PREV MED, V26, P580, DOI 10.1006/pmed.1997.0179; Ferreira L, 2009, COMMUN STAT-SIMUL C, V38, P1925, DOI 10.1080/03610910903168603; Field CA, 2007, DRUG ALCOHOL DEPEN, V91, P77, DOI 10.1016/j.drugalcdep.2007.05.009; Gatehouse S, 2004, INT J AUDIOL, V43, P85, DOI 10.1080/14992020400050014; Gilliver M, 2011, INT J AUDIOL, V50, P850, DOI 10.3109/14992027.2011.601468; Glasgow RE, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.2.e11; Hannula S, 2011, J AM ACAD AUDIOL, V22, P550, DOI 10.3766/jaaa.22.8.7; Hartley D, 2010, J AM ACAD AUDIOL, V21, P642, DOI 10.3766/jaaa.21.10.4; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; Hickson Louise, 2008, Australian and New Zealand Journal of Audiology, V30, P99; Jenstad L, 2011, AUDIOL RES, V1, P91, DOI 10.4081/audiores.2011.e25; Kaldo Viktor, 2006, Psychol Health Med, V11, P483, DOI 10.1080/13548500600726674; Keefe FJ, 2000, PAIN, V87, P303, DOI 10.1016/S0304-3959(00)00294-3; Kiely KM, 2012, J AGING HEALTH, V24, P439, DOI 10.1177/0898264311425088; Knudsen LV, 2010, TRENDS AMPLIF, V14, P127, DOI 10.1177/1084713810385712; Kochkin S., 2009, HEAR REV, V16, P12; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; Laplante-Levesque A, 2015, EAR HEARING, V36, P92, DOI 10.1097/AUD.0000000000000085; Laplante-Levesque A, 2013, EAR HEARING, V34, P447, DOI 10.1097/AUD.0b013e3182772c49; Manchaiah VKC, 2012, J LARYNGOL OTOL, V126, P475, DOI 10.1017/S0022215111003197; Manchaiah VKC, 2011, CLIN OTOLARYNGOL, V36, P227, DOI 10.1111/j.1749-4486.2011.02320.x; Manchaiah V.K.C., 2012, AUDIOL MED, V10, P21, DOI DOI 10.3109/1651386X.2012.655914; Manchaiah V, 2014, BMC EAR NOSE THROAT, V14, DOI 10.1186/1472-6815-14-3; Manchaiah VKC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004066; Manchaiah VKC, 2013, HEARING BALANC COMMU, V11, P6, DOI 10.3109/21695717.2012.756624; Manchaiah VKC, 2012, AUDIOL RES, V2, P12, DOI [10.4081/audiores.2011.e4, 10.4081/audiores.2012.e4]; Manchaiah VKC, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-25; MCCONNAUGHY EA, 1983, PSYCHOTHER-THEOR RES, V20, P368, DOI 10.1037/h0090198; Meyer C, 2012, INT J AUDIOL, V51, P66, DOI 10.3109/14992027.2011.611178; Milstein D, 2002, J ACAD REH, V35, P43; Nieuwenhuijsen ER, 2006, DISABIL REHABIL, V28, P245, DOI 10.1080/09638280500197743; Noble W, 2008, EAR HEARING, V29, P112; Noh S., 1994, J ACAD REHABILITATIV, VXXVII, P375; Pantalon MV, 2003, PSYCHOL ADDICT BEHAV, V17, P91, DOI 10.1037/0893-164X.17.2.91; Pantalon MV, 2002, PSYCHOL ADDICT BEHAV, V16, P299, DOI 10.1037//0893-164X.16.4.299; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037//0022-006X.51.3.390; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Prochaska JO., 2009, HDB HLTH BEHAV CHANG, P59; Proschaska J., 1984, TRANSTHEORETICAL APP; Ravesloot C, 2011, DISABIL HEALTH J, V4, P19, DOI 10.1016/j.dhjo.2010.05.006; Rawool VW, 2008, NOISE HEALTH, V10, P1, DOI 10.4103/1463-1741.39002; Saunders GH, 2012, AM J AUDIOL, V21, P331, DOI 10.1044/1059-0889(2012/12-0028); Schum D, 2014, AUDIOLOGY ONLINE; Sobel Judith, 2008, Seminars in Hearing, V29, P81, DOI 10.1055/s-2007-1021775; Stephens D., 2011, J ACAD REHAB AUDIOL, V44, P29, DOI [DOI 10.1111/J.1749-4486.2011.02320.X, 10.1111/j.1749-4486.2011.02320.x]; Sutton S, 2001, ADDICTION, V96, P175, DOI 10.1046/j.1360-0443.2001.96117513.x; Thorell E, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-30; Treasure JL, 1999, BEHAV RES THER, V37, P405, DOI 10.1016/S0005-7967(98)00149-1; vandenBrink RHS, 1996, BRIT J AUDIOL, V30, P313, DOI 10.3109/03005369609076779; Velasquez MM, 1999, ADDICT BEHAV, V24, P481, DOI 10.1016/S0306-4603(98)00103-8; Velicer W, 1998, HOMEOSTASIS HLTH DIS, V38, P216; Westin V, 2008, BEHAV RES THER, V46, P1259, DOI 10.1016/j.brat.2008.08.008; Whitehead LC, 2007, SOC SCI MED, V65, P782, DOI 10.1016/j.socscimed.2007.03.005; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	63	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0129107	10.1371/journal.pone.0129107	http://dx.doi.org/10.1371/journal.pone.0129107			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7TC	26042790	Green Published, gold, Green Submitted			2022-12-27	WOS:000355701600087
J	Ao, D; Wang, HJ; Wang, LF; Song, JY; Yang, HX; Wang, Y				Ao, Deng; Wang, Hai-jun; Wang, Li-fang; Song, Jie-yun; Yang, Hui-xia; Wang, Yan			The rs2237892 Polymorphism in KCNQ1 Influences Gestational Diabetes Mellitus and Glucose Levels: A Case-Control Study and Meta-Analysis	PLOS ONE			English	Article							CHINESE WOMEN; KOREAN POPULATION; ASSOCIATION; RISK; VARIANTS; PREGNANCY; SUSCEPTIBILITY; HYPERGLYCEMIA; LOAD	Objective Recent genetic studies have shown that potassium voltage-gated channel, KQT-like subfamily, member1 (KCNQ1) gene is related to gestational diabetes mellitus (GDM). However, studies for the rs2237892 polymorphism in KCNQ1 and GDM remain conflicting in Asians. Furthermore, associations of this polymorphism with glucose levels during oral glucose tolerance test (OGTT) have not been described in Chinese pregnant women. The present study aimed to provide evidence for the associations of rs2237892 in KCNQ1 with GDM and glucose levels, and to systematically evaluate the effect of rs2237892 on GDM in Asians. Methods A case-control study on 562 women with GDM and 453 controls was conducted in Beijing, China. The association of rs2237892 with risk of GDM was analyzed using logistic regression. The associations with quantitative glucose levels were assessed using linear regression models. A meta-analysis including the present case-control study and four previously published reports in Asians was conducted. Results The rs2237892 polymorphism in KCNQ1 was associated with GDM (OR (95% CI) = 1.99 (1.26-3.15)). Additionally, the polymorphism was associated with levels of 1h and 2h glucose during OGTT. The pre-pregnancy BMI, age and genotypes of KCNQ1 polymorphism were independent risk factors of GDM. Subsequently, we performed a meta-analysis in Asians. In total, C-allele carriers of rs2237892 polymorphism had a 50% higher risk for GDM (OR (95% CI) = 1.50(1.15-1.78)). Conclusion The study demonstrated for the first time that the KCNQ1 rs2237892 polymorphism was associated with GDM and glucose levels in Chinese women. The study provides systematic evidence for the association between this polymorphism and GDM in Asians.	[Ao, Deng; Wang, Hai-jun; Wang, Li-fang; Song, Jie-yun; Wang, Yan] Peking Univ, Sch Publ Hlth, Dept Child Adolescent & Womens Hlth, Beijing 100871, Peoples R China; [Ao, Deng; Wang, Hai-jun; Wang, Li-fang; Song, Jie-yun; Wang, Yan] Minist Hlth, Key Lab Reprod Hlth, Beijing, Peoples R China; [Yang, Hui-xia] Peking Univ, Dept Obstet & Gynecol, Hosp 1, Beijing 100871, Peoples R China	Peking University; Peking University	Yang, HX (corresponding author), Peking Univ, Dept Obstet & Gynecol, Hosp 1, Beijing 100871, Peoples R China.	yanghuixia@bjmu.edu.cn; wangyan@bjmu.edu.cn	Wang, Haijun/AAD-1302-2021	Wang, Haijun/0000-0003-0849-2903; YANG, HUIXIA/0000-0001-9913-2721; Yang, Huixia/0000-0001-8954-2102	Specialized Research Fund for the Doctoral Program of Higher Education [20120001110014]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by a grant from the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20120001110014). YW received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chon SJ, 2013, YONSEI MED J, V54, P352, DOI 10.3349/ymj.2013.54.2.352; Dai YE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113748; Ferrara A, 2004, OBSTET GYNECOL, V103, P526, DOI 10.1097/01.AOG.0000113623.18286.20; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; He LW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111981; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holmkvist J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005872; Jonsson A, 2009, DIABETES, V58, P2409, DOI 10.2337/db09-0246; Kim C, 2014, DIABETES METAB J, V38, P1, DOI 10.4093/dmj.2014.38.1.1; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Kubo A, 2014, DIABETES CARE, V37, P2996, DOI 10.2337/dc14-1438; Kwak SH, 2012, DIABETES, V61, P531, DOI 10.2337/db11-1034; Kwak SH, 2010, HORM RES PAEDIAT, V74, P333, DOI 10.1159/000313918; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Liu Z, 2014, CHINESE MED J-PEKING, V127, P1255, DOI 10.3760/cma.j.issn.0366-6999.20132772; Luo X, 2014, ASIAN PAC J CANCER P, V15, P9241, DOI 10.7314/APJCP.2014.15.21.9241; Mao HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045882; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Mussig K, 2009, DIABETES, V58, P1715, DOI 10.2337/db08-1589; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Qi QB, 2009, HUM MOL GENET, V18, P3508, DOI 10.1093/hmg/ddp294; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Retnakaran R, 2008, DIABETES CARE, V31, P2026, DOI 10.2337/dc08-0972; Shin D, 2015, J MATERN-FETAL NEO M, V28, P1679, DOI 10.3109/14767058.2014.964675; Shin HD, 2010, J CLIN ENDOCR METAB, V95, P445, DOI 10.1210/jc.2009-1393; Sun QM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048578; Ullrich S, 2005, PFLUG ARCH EUR J PHY, V451, P428, DOI 10.1007/s00424-005-1479-2; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; van Poppel MNM, 2014, MED SPORT SCI, V60, P104, DOI 10.1159/000357340; Wendland EM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-23; Xi Bo, 2012, PLoS One, V7, pe45731, DOI 10.1371/journal.pone.0045731; Yang H, 2009, DIABETIC MED, V26, P1099, DOI 10.1111/j.1464-5491.2009.02845.x; Yang HX, 2012, CHINESE MED J-PEKING, V125, P1212, DOI 10.3760/cma.j.issn.0366-6999.2012.07.004; Yu W, 2012, DIABETOLOGIA, V55, P2655, DOI 10.1007/s00125-012-2636-8; Zhai YS WT, 2014, ZHONG GUO YOU SHENG, V22, P13; Zhang CL, 2006, DIABETES CARE, V29, P2223, DOI 10.2337/dc06-0266; Zhang F, 2011, DIABETIC MED, V28, P652, DOI 10.1111/j.1464-5491.2010.03205.x; Zhou Q, 2009, DIABETOLOGIA, V52, P2466, DOI 10.1007/s00125-009-1500-y; Zhu WW, 2013, DIABETES CARE, V36, P2038, DOI 10.2337/dc12-2465	39	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128901	10.1371/journal.pone.0128901	http://dx.doi.org/10.1371/journal.pone.0128901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039078	gold, Green Published, Green Submitted			2022-12-27	WOS:000355700700129
J	Arnfinnsdottir, NB; Ottesen, V; Lale, R; Sletmoen, M				Arnfinnsdottir, Nina Bjork; Ottesen, Vegar; Lale, Rahmi; Sletmoen, Marit			The Design of Simple Bacterial Microarrays: Development towards Immobilizing Single Living Bacteria on Predefined Micro-Sized Spots on Patterned Surfaces	PLOS ONE			English	Article							SOFT LITHOGRAPHY; PSEUDOMONAS-PUTIDA; GENE-EXPRESSION; CELLS; ARRAYS; IDENTIFICATION; ATTACHMENT	In this paper we demonstrate a procedure for preparing bacterial arrays that is fast, easy, and applicable in a standard molecular biology laboratory. Microcontact printing is used to deposit chemicals promoting bacterial adherence in predefined positions on glass surfaces coated with polymers known for their resistance to bacterial adhesion. Highly ordered arrays of immobilized bacteria were obtained using microcontact printed islands of polydopamine (PD) on glass surfaces coated with the antiadhesive polymer polyethylene glycol (PEG). On such PEG-coated glass surfaces, bacteria were attached to 97 to 100% of the PD islands, 21 to 62% of which were occupied by a single bacterium. A viability test revealed that 99% of the bacteria were alive following immobilization onto patterned surfaces. Time series imaging of bacteria on such arrays revealed that the attached bacteria both divided and expressed green fluorescent protein, both of which indicates that this method of patterning of bacteria is a suitable method for single-cell analysis.	[Arnfinnsdottir, Nina Bjork; Ottesen, Vegar; Sletmoen, Marit] Norwegian Univ Sci & Technol, Dept Phys, Biophys & Med Technol, NO-7491 Trondheim, Norway; [Lale, Rahmi] Norwegian Univ Sci & Technol, Dept Biotechnol, NO-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Sletmoen, M (corresponding author), Norwegian Univ Sci & Technol, Dept Phys, Biophys & Med Technol, NO-7491 Trondheim, Norway.	marit.sletmoen@ntnu.no	Sletmoen, Marit/H-8896-2016; Ottesen, Vegar/AAD-3383-2021	Ottesen, Vegar/0000-0003-1810-2710; Lale, Rahmi/0000-0001-5460-3163	Research Council of Norway [197411/V30]	Research Council of Norway(Research Council of Norway)	The Research Council of Norway is acknowledged for the support to the Norwegian Micro- and Nano-Fabrication Facility, NorFab (197411/V30).	Balzer S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-26; Barrett DA, 2001, ANAL CHEM, V73, P5232, DOI 10.1021/ac010368u; Beckwith KM, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/4/045009; Caro A, 2009, J PHYS CHEM B, V113, P2101, DOI 10.1021/jp805284s; Cerf A, 2008, COLLOID SURFACE B, V65, P285, DOI 10.1016/j.colsurfb.2008.04.016; Cerf A, 2009, LANGMUIR, V25, P5731, DOI 10.1021/la9004642; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Colville K, 2010, LANGMUIR, V26, P2639, DOI 10.1021/la902826n; de Souza N, 2012, NAT METHODS, V9, P35, DOI 10.1038/nmeth.1819; Hochbaum AI, 2010, NANO LETT, V10, P3717, DOI 10.1021/nl102290k; Howell SW, 2003, LANGMUIR, V19, P436, DOI 10.1021/la026365+; Kim J, 2012, J AM CHEM SOC, V134, P16500, DOI 10.1021/ja3073808; Kim JH, 2009, MICROFLUID NANOFLUID, V7, P829, DOI 10.1007/s10404-009-0441-6; Kingshott P, 2003, LANGMUIR, V19, P6912, DOI 10.1021/la034032m; Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2; KUMAR A, 1994, LANGMUIR, V10, P1498, DOI 10.1021/la00017a030; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; Lidstrom ME, 2010, NAT CHEM BIOL, V6, P705, DOI [10.1038/nchembio.436, 10.1038/NCHEMBIO.436]; Lieder S, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0207-7; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Mossoba MM, 2005, VIB SPECTROSC, V38, P229, DOI 10.1016/j.vibspec.2005.04.006; Oh YJ, 2008, ULTRAMICROSCOPY, V108, P1124, DOI 10.1016/j.ultramic.2008.04.055; Peterbauer T, 2006, LAB CHIP, V6, P857, DOI 10.1039/b601803c; Ramos-Gonzalez MI, 2005, J BACTERIOL, V187, P4033, DOI 10.1128/JB.187.12.4033-4041.2005; Rozhok S, 2005, SMALL, V1, P445, DOI 10.1002/smll.200400072; Rozhok S, 2006, LANGMUIR, V22, P11251, DOI 10.1021/la0609726; Sun K, 2012, LANGMUIR, V28, P2131, DOI 10.1021/la2041967; van Oijen AM, 2008, NAT CHEM BIOL, V4, P440, DOI 10.1038/nchembio0808-440; van Oijen AM, 2011, CURR OPIN BIOTECH, V22, P75, DOI 10.1016/j.copbio.2010.10.002; Weibel DB, 2005, LANGMUIR, V21, P6436, DOI 10.1021/la047173c; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Wong I, 2012, RSC ADV, V2, P7673, DOI 10.1039/c2ra20938a; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Xu LP, 2007, NANO LETT, V7, P2068, DOI 10.1021/nl070983z; Ye Q, 2011, CHEM SOC REV, V40, P4244, DOI 10.1039/c1cs15026j	35	12	12	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128162	10.1371/journal.pone.0128162	http://dx.doi.org/10.1371/journal.pone.0128162			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039378	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700089
J	Caze, B; Merle, D; Schneider, S				Caze, Bruno; Merle, Didier; Schneider, Simon			UV Light Reveals the Diversity of Jurassic Shell Colour Patterns: Examples from the Cordebugle Lagerstatte (Calvados, France)	PLOS ONE			English	Article							TURBO GASTROPODA; AQUITAINE BASIN; MIDDLE MIOCENE; PART; COSSMANN; REVISION; NORMANDY; TERTIARY; POLAND; FAUNA	Viewed under UV light the diverse and exceptionally well-preserved molluscs from the Late Jurassic Cordebugle Konservat Lagerstatte (Calvados, Normandy, France) reveal fluorescent fossil shell colour patterns predating the oldest previously known instance of such patterns by 100 Myr. Evidently, residual colour patterns are observable in Mesozoic molluscs by application of this non-destructive method, provided the shells are not decalcified or recrystallized. Among 46 species which are assigned to twelve gastropod families and eight bivalve families, no less than 25 species yielded positive results. Out of nine colour pattern morphologies that have been distinguished six occur in gastropods and three in bivalves. The presence of these variant morphologies clearly indicates a significant pre-Cenozoic diversification of colour patterns, especially in gastropods. In addition, the occurrence of two distinct types of fluorescence highlights a major difference in the chemical composition of the pigments involved in colour pattern formation in gastropods. This discovery enables us to discriminate members of higher clades, i.e. the Vetigastropoda emitting red fluorescence from the Caenogastropoda and Heterobranchia emitting whitish-beige to yellow fluorescence. Consequently, fluorescent colour patterns may help to allocate part of the numerous enigmatic Mesozoic gastropod taxa to their correct systematic position.	[Caze, Bruno; Merle, Didier] Univ Paris 06, Sorbonne Univ, CNRS, Dept Hist Terre,CR2P MNHN, Paris, France; [Schneider, Simon] Univ Cambridge, CASP, Cambridge, England	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Cambridge	Merle, D (corresponding author), Univ Paris 06, Sorbonne Univ, CNRS, Dept Hist Terre,CR2P MNHN, Paris, France.	dmerle@mnhn.fr		Schneider, Simon/0000-0001-6493-357X				ALLISON EC, 1955, J PALEONTOL, V29, P400; Bigot A, 1938, B SOC GEOL FR, V7, P425; Bigot A, 1893, MEMOIRES SOC LINNEEN, V17, P295; Bigot A, 1950, B SOC LINN NORM, V9, P57; Bonnot Alain, 2009, Revue de Paleobiologie, V28, P371; BRILL KG, 1952, SCIENCE, V116, P517; BUFFETAUT E, 1985, CR ACAD SCI II, V300, P929; Buffetaut E, 2001, CR ACAD SCI II A, V333, P405, DOI 10.1016/S1251-8050(00)71401-7; Buvignier A, 1843, MEMOIRES SOC PHILOMA, V2, P225; Buvignier A., 1852, STAT GEOLOGIQUE MINE; Caze B., 2012, COQUILLAGES LEOCENE, V3, P15; Caze B, 2011, ACTA PALAEONTOL POL, V56, P329, DOI 10.4202/app.2009.0084; Caze B, 2011, CR PALEVOL, V10, P171, DOI 10.1016/j.crpv.2010.10.005; Caze B, 2010, GEODIVERSITAS, V32, P417, DOI 10.5252/g2010n3a4; Chavan A., 1946, Bull Mus Hist nat Paris (2), V18, P345; Chavan A, 1945, ASTARTIDAE CYPRINIDA, V86, P41; Chavan A, 1969, TREATISE INVERTEBR N, V2, pN562; Chavan A, 1954, CAHIERS GEOLOGIQUES, V23, P206; Chavan Andre, 1952, MEMOIRES SUISSES PAL, V69, P1; Cluzaud Alain, 2006, Bulletin de la Societe Linneenne de Bordeaux, V34, P15; Cluzaud Alain, 2006, Bulletin de la Societe Linneenne de Bordeaux, V34, P103; COMFORT A, 1949, BIOCHEM J, V45, P199, DOI 10.1042/bj0450199; COMFORT A, 1949, BIOCHEM J, V44, P111, DOI 10.1042/bj0440111; Cossmann M., 1913, MEMOIRES SOC GEOLOGI, V46, P1; Cox LR, 1969, TREATISE INVERTEBR N, V1, P3; Delpey G, 1938, B SOC GEOL FR, V7, P419; Dockery D.T. III, 1980, Mississippi Geology, V1, P3; Dockery DT III, 1977, MISSISSIPPI GEOLOGIC, V120, P6; Dockery III DT, 2011, GEOLOGY MISSISSIPPI; DORBIGNY A., 1850, PRODROME PALEONTOLOG, V1; Eudes-Deslongchamps JA, 1843, MEMOIRES SOC LINNEEN, V7, P215; Fischer H., 1909, J CONCHYLIOL, V56, P256; Fischer J.-C., 1997, REVISION CRITIQUE PA, V2; Francis A.O., 2000, THESIS U BIRMINGHAM; Gorka M, 2008, ACTA GEOL POL, V58, P105; Grundel J, 2006, ACTA GEOL POL, V56, P121; Grundel J, 2008, NEUES JAHRB GEOL P-A, V250, P177, DOI 10.1127/0077-7749/2008/0250-0177; Hardy E, 2014, HARDYS INTERNET GUID; Hedegaard C, 2006, J MOLLUS STUD, V72, P157, DOI 10.1093/mollus/eyi062; Hudleston WH, 1887, P GEOL ASS, V10, P166; Juignet P., 1976, B INF GEOL BASSIN PA, V13, P22; Kaim A, 2013, B GEOSCI, V88, P505, DOI 10.3140/bull.geosci.1395; KOBLUK D R, 1989, Palaios, V4, P63, DOI 10.2307/3514734; KRIZ J, 1974, J PALEONTOL, V48, P41; KRUEGER KK, 1974, CURATOR, V17, P36; Lamarck J., 1801, SYSTEME ANIMAUX SANS; Landau Bernard M., 2013, Cainozoic Research, V11-1, P3; Loriol de P, 1874, MEMOIRES SOC PHYS HI, V23, P38; Loriol de P, 1875, MEMOIRES SOC PHYS HI, V24, P1; MAPES RH, 1988, J PALEONTOL, V62, P439, DOI 10.1017/S0022336000059217; MEINHARDT H, 1998, ALGORITHMIC BEAUTY S; Merle D., 2008, STRATOTYPE LUT 10, P182; Merle Didier, 2003, Annales de Paleontologie, V89, P191, DOI 10.1016/S0753-3969(03)00024-7; MIETHE A., 1928, PALAEONTOL ZEITSCHR, V9, P343; Neuffer O., 1972, Notizblatt Hess Landesamt Bodenforsch Wiesbaden, V100, P41; Neuffer O., 1971, ABHANDLUNGEN HESSISC, V60, P121; Newton R. Bullen, 1907, Proceedings of the Malacological Society of London, V7; Olsson A.A, 1967, SOME TERTIARY MOLLUS; Orbignyd' A., 1851, PALEONTOLOGIE FRANCA; Pictet FJ, 1862, MAT PALEONTOLOGIE SU, V3, P1; Rioult M., 1980, MEM BUR RECH GEOL MI, V103, P209; Romer F. A., 1836, VERSTEINERUNGEN NORD; Schmidt M, 1905, ABHANDLUNGEN PREUSSI, V41, P1; Schneider Simon, 2007, Beringeria, V37, P143; Smith William, 1817, STRATIGRAPHICAL SYST; Sowerby J, 1818, TREATISE INVERTEBR N, V3, P17; Swann C.T., 1985, Mississippi Geology, V5, P1; Szabo Janos, 2004, Fragmenta Palaeontologica Hungarica, V22, P9; Tichy G., 1980, VERHANDLUNG GEOLOGIS, V2, P175; Vokes H. E., 1968, Tulane Studies in Geology, V6, P71; Zittel (von) KA, 1861, J CONCHYLIOL, V9, P192	71	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126745	10.1371/journal.pone.0126745	http://dx.doi.org/10.1371/journal.pone.0126745			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039592	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700035
J	Chang, XY; Chen, BM; Liu, G; Zhou, T; Jia, XR; Peng, SL				Chang, Xiao-Yu; Chen, Bao-Ming; Liu, Gang; Zhou, Ting; Jia, Xiao-Rong; Peng, Shao-Lin			Effects of Climate Change on Plant Population Growth Rate and Community Composition Change	PLOS ONE			English	Article							TROPICAL FORESTS; GLOBAL CHANGE; WATER AVAILABILITY; CARBON DYNAMICS; SOUTHERN CHINA; CHANGE IMPACTS; RANGE SHIFTS; TREE GROWTH; SUCCESSION; RESPONSES	The impacts of climate change on forest community composition are still not well known. Although directional trends in climate change and community composition change were reported in recent years, further quantitative analyses are urgently needed. Previous studies focused on measuring population growth rates in a single time period, neglecting the development of the populations. Here we aimed to compose a method for calculating the community composition change, and to testify the impacts of climate change on community composition change within a relatively short period (several decades) based on long-term monitoring data from two plots-Dinghushan Biosphere Reserve, China (DBR) and Barro Colorado Island, Panama (BCI)-that are located in tropical and subtropical regions. We proposed a relatively more concise index, Sln lambda, which refers to an overall population growth rate based on the dominant species in a community. The results indicated that the population growth rate of a majority of populations has decreased over the past few decades. This decrease was mainly caused by population development. The increasing temperature had a positive effect on population growth rates and community change rates. Our results promote understanding and explaining variations in population growth rates and community composition rates, and are helpful to predict population dynamics and population responses to climate change.	[Chang, Xiao-Yu; Chen, Bao-Ming; Liu, Gang; Zhou, Ting; Jia, Xiao-Rong; Peng, Shao-Lin] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510006, Guangdong, Peoples R China	Sun Yat Sen University	Chen, BM (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510006, Guangdong, Peoples R China.	chbaoming@163.com; lsspsl@mail.sysu.edu.cn	Chen, Bao-Ming/H-9024-2016	Chen, Bao-Ming/0000-0003-1891-8752; Liu, Gang/0000-0002-5633-4216	National Natural Science Foundation of China [31030015, 31070481]; Scientific Research Fund of Hongda Zhang; Sun Yat-sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Hongda Zhang; Sun Yat-sen University	This study was supported by the National Natural Science Foundation of China (31030015, 31070481) and the Scientific Research Fund of Hongda Zhang, Sun Yat-sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderson KJ, 2007, AM NAT, V169, P780, DOI 10.1086/516653; [Anonymous], 2012, ECOLOGY; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Buckley YM, 2010, ECOL LETT, V13, P1182, DOI 10.1111/j.1461-0248.2010.01506.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Clark DA, 2003, P NATL ACAD SCI USA, V100, P5852, DOI 10.1073/pnas.0935903100; Clark JS, 2014, GLOBAL CHANGE BIOL, V20, P1136, DOI 10.1111/gcb.12420; Comita LS, 2009, ECOLOGY, V90, P2755, DOI 10.1890/08-1482.1; Condit R, 1996, J VEG SCI, V7, P405, DOI 10.2307/3236284; Condit R, 1996, J TROP ECOL, V12, P231, DOI 10.1017/S0266467400009433; Conlisk E, 2013, GLOBAL CHANGE BIOL, V19, P858, DOI 10.1111/gcb.12090; Dahlgren JP, 2011, OIKOS, V120, P1183, DOI 10.1111/j.1600-0706.2010.19063.x; Dalgleish HJ, 2011, ECOLOGY, V92, P75, DOI 10.1890/10-0780.1; Deng JM, 2012, P NATL ACAD SCI USA, V109, P8600, DOI 10.1073/pnas.1205663109; Fang JY, 2012, ECOGRAPHY, V35, P1059, DOI 10.1111/j.1600-0587.2013.00161.x; Feeley KJ, 2007, ECOL LETT, V10, P461, DOI 10.1111/j.1461-0248.2007.01033.x; Feeley KJ, 2011, ECOLOGY, V92, P871, DOI 10.1890/10-0724.1; Foster BL, 2000, PLANT ECOL, V146, P1, DOI 10.1023/A:1009895103017; HUANG ZL, 2000, CHINESE J ECOL, V19, P24; HUSTON M, 1987, AM NAT, V130, P168, DOI 10.1086/284704; Iverson LR, 2001, ECOSYSTEMS, V4, P186, DOI 10.1007/s10021-001-0003-6; JASSBY AD, 1974, AM NAT, V108, P688, DOI 10.1086/282944; Kerr RA, 2007, SCIENCE, V316, P188, DOI 10.1126/science.316.5822.188; Kimball S, 2010, GLOBAL CHANGE BIOL, V16, P1555, DOI 10.1111/j.1365-2486.2009.02106.x; Korner C, 2009, ANNU REV ECOL EVOL S, V40, P61, DOI 10.1146/annurev.ecolsys.110308.120217; Krushelnycky PD, 2013, GLOBAL CHANGE BIOL, V19, P911, DOI 10.1111/gcb.12111; Laurance WF, 2004, NATURE, V428, P171, DOI 10.1038/nature02383; Lenihan JM, 2003, ECOL APPL, V13, P1667, DOI 10.1890/025295; Lenoir J, 2010, J VEG SCI, V21, P949, DOI 10.1111/j.1654-1103.2010.01201.x; Lewis SL, 2004, PHILOS T R SOC B, V359, P437, DOI 10.1098/rstb.2003.1432; Lloyd AH, 2011, GLOBAL CHANGE BIOL, V17, P1935, DOI 10.1111/j.1365-2486.2010.02360.x; Loudermilk EL, 2013, GLOBAL CHANGE BIOL, V19, P3502, DOI 10.1111/gcb.12310; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; Morin X, 2008, J ECOL, V96, P784, DOI 10.1111/j.1365-2745.2008.01369.x; Morris WF, 2008, ECOLOGY, V89, P19, DOI 10.1890/07-0774.1; Munson SM, 2012, GLOBAL CHANGE BIOL, V18, P1083, DOI 10.1111/j.1365-2486.2011.02598.x; Nicole F, 2011, J ECOL, V99, P1211, DOI 10.1111/j.1365-2745.2011.01852.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Peng SL, 2010, ECOL MODEL, V221, P1317, DOI 10.1016/j.ecolmodel.2010.01.016; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Prieto P, 2009, ECOGRAPHY, V32, P623, DOI 10.1111/j.1600-0587.2009.05738.x; Purves D, 2008, SCIENCE, V320, P1452, DOI 10.1126/science.1155359; Ruger N, 2011, OIKOS, V120, P1047, DOI 10.1111/j.1600-0706.2010.19021.x; Shen Y, 2013, J TROP ECOL, V29, P131, DOI 10.1017/S0266467413000059; SHUGART HH, 1973, SCIENCE, V180, P1379, DOI 10.1126/science.180.4093.1379; Shuman JK, 2011, GLOBAL CHANGE BIOL, V17, P2370, DOI 10.1111/j.1365-2486.2011.02417.x; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Thuiller W, 2006, DIVERS DISTRIB, V12, P49, DOI 10.1111/j.1366-9516.2006.00216.x; Tuljapurkar S.D., 1990, POPULATION DYNAMICS; Vanderwel MC, 2014, ECOGRAPHY, V37, P10, DOI 10.1111/j.1600-0587.2013.00345.x; Vittoz P, 2009, GLOBAL CHANGE BIOL, V15, P209, DOI 10.1111/j.1365-2486.2008.01707.x; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WANG B, 1987, ACTA ECOLOGICA SINIC, V7, P214; Wu ZT, 2011, GLOBAL CHANGE BIOL, V17, P927, DOI 10.1111/j.1365-2486.2010.02302.x; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P2936, DOI 10.1111/j.1365-2486.2011.02423.x; Zhou GY, 2011, GLOBAL CHANGE BIOL, V17, P3736, DOI 10.1111/j.1365-2486.2011.02499.x; Zuidema Pieter A, 2013, Trends Plant Sci, V18, P413, DOI 10.1016/j.tplants.2013.05.006	62	7	7	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126228	10.1371/journal.pone.0126228	http://dx.doi.org/10.1371/journal.pone.0126228			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039073	gold, Green Submitted, Green Published			2022-12-27	WOS:000355700700019
J	Huang, SW; Wang, SF; Cowo, AE; Chen, M; Lin, YT; Hung, CP; Chen, YH; Yang, JY; Tang, HJ; Chen, YMA				Huang, Szu-Wei; Wang, Sheng-Fan; Cowo, Angel E.; Chen, Marcelo; Lin, Yu-Ting; Hung, Chun-Po; Chen, Yi-Hsien; Yang, Jyh-Yuan; Tang, Hung-Jen; Chen, Yi-Ming Arthur			Molecular Epidemiology of HIV-1 Infection among Men who Have Sex with Men in Taiwan in 2012	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; UNPROTECTED ANAL INTERCOURSE; INJECTION-DRUG USERS; SUBSTANCE USE; BISEXUAL MEN; RISK-FACTORS; YOUNG GAY; SUBTYPE-B; TRANSMISSION; PATTERNS	The number of men who have sex with men (MSM) infected with HIV-1 in Taiwan has increased rapidly in the past few years. The goal of this study was to conduct a molecular epidemiological study of HIV-1 infection among MSM in Taiwan to identify risk factors for intervention. Voluntary counseling program and anonymous testing were provided to patrons at 1 gay bar, 7 night clubs and 3 gay saunas in Taipei and New Taipei Cities in 2012. HIV-1 subtypes were determined using gag subtype-specific PCR and phylogenetic analysis by env sequences. Recent HIV-1 infection was determined using LAg-Avidity EIA. In-depth interviews and questionnaires were used to identify risk factors. The prevalence and incidence of HIV-1 among MSM in Taiwan were 4.38%(53/1,208) and 3.29 per 100 person-years, respectively. Of 49 cases genotyped, 48 (97.9%) were infected with subtype B and 1 with CRF01_AE (2%). Phylogenetic analysis of 46 HIV-1 strains showed that 25 (54.4%) subtype B strains formed 9 clusters with each other or with other local strains. The CRF01_ AE case clustered with a reference strain from a Thai blood donor with bootstrap value of 99. Multivariate logistic regression analysis showed that risk factors associated with HIV-1 infection included use of oil-based solution as lubricant (vs. saliva or waterbased lubricants, OR=4.23; p < 0.001); exclusively receptive role (vs. insertive role, OR=9.69; p < 0.001); versatile role (vs. insertive role, OR=6.45; p=0.003); oral sex (vs. insertive role, OR=11.93; p=0.044); times of sexual contact per week (2-3 vs. zero per week, OR=3.41; p=0.021); illegal drug use (OR=4.12; p < 0.001); and history of sexually transmitted diseases (OR=3.65; p=0.002). In conclusion, there was no new HIV-1 subtype or circulating recombinant in Taiwan in 2012. Misuse of oil-based solution as lubricant is a new risk factor identified among MSM in Taiwan. The Taiwan's Centers for Disease Control has created a video (www.youtube. com/watch?v= BinExvvOTMM&feature = iv& src_vid=BW81-PfmY3E&annotation_ id = annotation_2436493705) to correct such misconception in its AIDS prevention campaign.	[Huang, Szu-Wei; Chen, Yi-Ming Arthur] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 11221, Taiwan; [Huang, Szu-Wei; Wang, Sheng-Fan; Lin, Yu-Ting; Chen, Yi-Hsien; Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung 80708, Taiwan; [Wang, Sheng-Fan] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung 80708, Taiwan; [Cowo, Angel E.] Natl Yang Ming Univ, Int Hlth Program, Taipei 11221, Taiwan; [Chen, Marcelo] Mackay Mem Hosp, Dept Urol, Taipei 10449, Taiwan; [Chen, Marcelo] Mackay Jr Coll Med Nursing & Management, Dept Cosmet Applicat & Management, Taipei 25245, Taiwan; [Chen, Marcelo] Mackay Med Coll, Sch Med, New Taipei City 25245, Taiwan; [Hung, Chun-Po] Taiwan Soc Prevent Med, Living Hope Org, Rainbow Queer Hlth & Culture Ctr, Taipei 10084, Taiwan; [Yang, Jyh-Yuan] Ctr Dis Control, Taipei 10050, Taiwan; [Tang, Hung-Jen] Chi Mei Med Ctr, Dept Med, Tainan 71067, Taiwan; [Tang, Hung-Jen] Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan 71710, Taiwan; [Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Coll Med, Inst Med Res, Dept Microbiol & Immunol, Kaohsiung 80708, Taiwan; [Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Coll Med, Inst Clin Med, Kaohsiung 80708, Taiwan	National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Mackay Medical College; Centers For Disease Control - Taiwan; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Kaohsiung Medical University; Kaohsiung Medical University	Chen, YMA (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 11221, Taiwan.	arthur@kmu.edu.tw	Huang, Szu-Wei/AAT-1998-2020; Wang, Sheng-Fan/ABA-7842-2020; HUANG, SZU-WEI/AAT-5153-2021	Huang, Szu-Wei/0000-0002-3813-7737; Wang, Sheng-Fan/0000-0002-8142-4707; Wang, Sheng-Fan/0000-0002-4183-3872	Centers for Disease Control of Taiwan [DOH101-DC-1001]; Kaohsiung Medical University Aim for the Top Universities Grant [KMU-TP103E01]; Kaohsiung Medical University Research Foundation [103CM-KMU-02]; Chi-Mei Medical Center	Centers for Disease Control of Taiwan; Kaohsiung Medical University Aim for the Top Universities Grant; Kaohsiung Medical University Research Foundation; Chi-Mei Medical Center	This research was supported by the Centers for Disease Control of Taiwan [grant number DOH101-DC-1001] and partially by Kaohsiung Medical University Aim for the Top Universities Grant [grant number KMU-TP103E01] and Chi-Mei Medical Center and Kaohsiung Medical University Research Foundation [grant number 103CM-KMU-02].	Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Beyrer C, 2012, LANCET, V380, P424, DOI 10.1016/S0140-6736(12)61022-8; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Blashill AJ, 2013, ANN BEHAV MED, V46, P149, DOI [10.1007/s12160-013-9527-1, 10.1007/s12160-013-9489-3]; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Chen YJ, 2012, JAIDS-J ACQ IMM DEF, V59, P438, DOI 10.1097/QAI.0b013e3182454ea3; Chen YJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-334; Chen YJ, 2010, JAIDS-J ACQ IMM DEF, V53, P425, DOI 10.1097/QAI.0b013e3181ccba1a; Chen YMA, 2007, LANCET, V369, P623, DOI 10.1016/S0140-6736(07)60291-8; Chen YM, 2001, J ACQUIR IMMUNE DEFI, V26; Chen YMA, 1998, J ACQ IMMUN DEF SYND, V18, P299, DOI 10.1097/00042560-199807010-00016; Chen YMA, 2006, EMERG INFECT DIS, V12, P703, DOI 10.3201/eid1204.050762; Chesson HW, 2000, J ACQ IMMUN DEF SYND, V24, P48; Crosby GM, 1998, DRUG ALCOHOL DEPEN, V52, P177, DOI 10.1016/S0376-8716(98)00093-3; Drumright LN, 2006, JAIDS-J ACQ IMM DEF, V43, P344, DOI 10.1097/01.qai.0000230530.02212.86; Drumright LN, 2009, AIDS BEHAV, V13, P328, DOI 10.1007/s10461-007-9330-8; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; Ellis RJ, 2003, J INFECT DIS, V188, P1820, DOI 10.1086/379894; Felsenstein J, 2005, PHILOS T R SOC B, V360, P1427, DOI 10.1098/rstb.2005.1669; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Green SM, 2011, ANN EMERG MED, V57, P449, DOI 10.1016/j.annemergmed.2010.11.030; Greene SL, 2008, EMERG MED AUSTRALAS, V20, P391, DOI 10.1111/j.1742-6723.2008.01114.x; Greenwood GL, 2001, DRUG ALCOHOL DEPEN, V61, P105, DOI 10.1016/S0376-8716(00)00129-0; Hall TA, 1999, NUCL ACIDS S SERIES, P95; Hauser A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098038; He Q, 2011, SE ASIAN J TROP MED, V42, P616; Hidaka Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-239; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Huang SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114441; Huang YF, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001625; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Joint United Nations Programme on HIV/ AIDS, 2012, GLOB REP UNAIDS REP; Kelly BC, 2005, SUBST USE MISUSE, V40, P1443, DOI 10.1081/JA-200066812; Kittinunvorakoon C. PW, 17 INT AIDS C; Ko NY, 2011, AIDS BEHAV, V15, P292, DOI 10.1007/s10461-010-9748-2; Lan YC, 2008, J MED VIROL, V80, P183, DOI 10.1002/jmv.21065; Lee SJ, 2003, J ADDICT DIS, V22, P47, DOI 10.1300/J069v22n04_05; Leri F, 2003, ADDICTION, V98, P7, DOI 10.1046/j.1360-0443.2003.00236.x; Lin YT, 2007, J INFECT DIS, V195, P1283, DOI 10.1086/513437; Longosz AF, 2014, AIDS RES HUM RETROV, V30, P339, DOI [10.1089/aid.2013.0169, 10.1089/AID.2013.0169]; Lyu SY, 2012, LANCET, V379, pE28, DOI 10.1016/S0140-6736(11)60786-1; MARTIN DJ, 1992, PUBLIC HEALTH REP, V107, P468; Maxwell JC, 2005, SUBST USE MISUSE, V40, P1203, DOI 10.1081/JA-200066736; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Patterson TL, 2005, J URBAN HEALTH, V82, pI120, DOI 10.1093/jurban/jti031; Piaseczna MA, 2001, J ACQ IMMUN DEF SYND, V28, P187, DOI 10.1097/00042560-200110010-00012; Read TRH, 2007, SEX HEALTH, V4, P35, DOI 10.1071/SH06043; Reback CJ, 2003, AIDS CARE, V15, P775, DOI 10.1080/09540120310001618621; Romanelli Frank, 2003, Top HIV Med, V11, P25; Rusch M, 2004, SEX TRANSM DIS, V31, P492, DOI 10.1097/01.olq.0000135991.21755.18; Rutvisuttinunt W, 2012, AIDS RES HUM RETROV, V28, P1703, DOI [10.1089/aid.2011.0339, 10.1089/AID.2011.0339]; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van Griensven F, 2013, AIDS, V27, P825, DOI 10.1097/QAD.0b013e32835c546e; van Griensven F, 2009, CURR OPIN HIV AIDS, V4, P300, DOI 10.1097/COH.0b013e32832c3bb3; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001; Weber AE, 2001, J ACQ IMMUN DEF SYND, V28, P81, DOI 10.1097/00042560-200109010-00012; Wei M, 2004, J CLIN MICROBIOL, V42, P4261, DOI 10.1128/JCM.42.9.4261-4267.2004; Wilson PA, 2008, SEX TRANSM INFECT, V84, P506, DOI 10.1136/sti.2008.031583; Xu HL, 2013, ASIAN J ANDROL, V15, P545, DOI 10.1038/aja.2013.51; Ye JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054238; Zhang XX, 2007, AIDS, V21, pS53, DOI 10.1097/01.aids.0000304697.39637.4c; Zhao B, 2011, AIDS RES HUM RETROV, V27, P1047, DOI [10.1089/aid.2010.0119, 10.1089/AID.2010.0119]; Zhong F, 2011, AIDS BEHAV, V15, P1058, DOI 10.1007/s10461-009-9619-x	64	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128266	10.1371/journal.pone.0128266	http://dx.doi.org/10.1371/journal.pone.0128266			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039757	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700093
J	Martins, AF; Bessant, M; Manukyan, L; Milinkovitch, MC				Martins, Antonio F.; Bessant, Michel; Manukyan, Liana; Milinkovitch, Michel C.			(ROBBIE)-O-2-3D, a Fast Robotic High-Resolution System for Quantitative Phenotyping of Surface Geometry and Colour-Texture	PLOS ONE			English	Article							BARRIER	While recent imaging techniques provide insights into biological processes from the molecular to the cellular scale, phenotypes at larger scales remain poorly amenable to quantitative analyses. For example, investigations of the biophysical mechanisms generating skin morphological complexity and diversity would greatly benefit from 3D geometry and colour-texture reconstructions. Here, we report on (ROBBIE)-O-2-3D, an integrated system that combines a robotic arm, a high-resolution digital colour camera, an illumination basket of high-intensity light-emitting diodes and state-of-the-art 3D-reconstruction approaches. We demonstrate that (ROBBIE)-O-2 generates accurate 3D models of biological objects between 1 and 100 cm, makes multiview photometric stereo scanning possible in practical processing times, and enables the capture of colour-texture and geometric resolutions better than 15 mu m without the use of magnifying lenses. (ROBBIE)-O-2 has the potential to greatly improve quantitative analyses of phenotypes in addition to providing multiple new applications in, e.g., biomedical science.	[Martins, Antonio F.; Bessant, Michel; Manukyan, Liana; Milinkovitch, Michel C.] Univ Geneva, LANE, Dept Genet & Evolut, Geneva, Switzerland; [Martins, Antonio F.; Manukyan, Liana; Milinkovitch, Michel C.] SIB Swiss Inst Bioinformat, Geneva, Switzerland	University of Geneva; Swiss Institute of Bioinformatics	Milinkovitch, MC (corresponding author), Univ Geneva, LANE, Dept Genet & Evolut, Geneva, Switzerland.	Michel.Milinkovitch@unige.ch		Martins, Antonio Filipe/0000-0002-5561-1226; Milinkovitch, Michel/0000-0002-2553-0724	CADMOS program at the University of Geneva; Swiss National Science Foundation (FNSNF) [31003A_125060, Sinergia CRSII3_132430]; SystemsX.ch initiative (project EpiPhysX)	CADMOS program at the University of Geneva; Swiss National Science Foundation (FNSNF)(Swiss National Science Foundation (SNSF)); SystemsX.ch initiative (project EpiPhysX)	This work was supported by the CADMOS program at the University of Geneva (http://www.unige.ch; Switzerland), the Swiss National Science Foundation (FNSNF, http://www.snf.ch/en; grants 31003A_125060 and Sinergia CRSII3_132430), and the SystemsX.ch initiative (project EpiPhysX; http://www.systemsx.ch/projects/research-technology-and-development-projects/epiphysx).	Chen T, 2006, P IEEE C COMP VIS PA, P1825, DOI [10.1109/CVPR.2006.182, DOI 10.1109/CVPR.2006.182]; Cignoni P, 2008, COMPUTING, P129, DOI DOI 10.2312/LOCALCHAPTEREVENTS/ITALCHAP/ITALIANCHAPCONF2008/129-136; Crete F., 2007, P SPIE, V6492; Favaro P, 2012, IEEE INT C COMP VIS; Furukawa Y, 2010, IEEE T PATTERN ANAL, V32, P1362, DOI 10.1109/TPAMI.2009.161; Furukawa Y, 2009, INT J COMPUT VISION, V84, P257, DOI 10.1007/s11263-009-0232-2; Guidi G, 2011, P SOC PHOTO-OPT INS, V7864, P1; Guidi G, 2010, SENSORS-BASEL, V10, P7192, DOI 10.3390/s100807192; Harris AR, 2012, P NATL ACAD SCI USA, V109, P16449, DOI 10.1073/pnas.1213301109; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Johnson JT, 2006, PLOS GENET, V2, P471, DOI 10.1371/journal.pgen.0020061; Kazhdan M., 2006, P 4 EUROGRAPHICS S G, P61; Kazhdan M, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2487228.2487237; LAURENTINI A, 1994, IEEE T PATTERN ANAL, V16, P150, DOI 10.1109/34.273735; Lin Z, 2009, UILUENG092215 UIUC; Liu YB, 2009, PROC CVPR IEEE, P2121, DOI [10.1109/CVPR.2009.5206712, 10.1109/CVPRW.2009.5206712]; Loveland AB, 2012, NAT METHODS, V9, P987, DOI [10.1038/nmeth.2174, 10.1038/NMETH.2174]; Malzbender T, 2006, P EUR S REND; Milinkovitch MC, 2013, SCIENCE, V339, P78, DOI 10.1126/science.1226265; Nehab D, 2005, ACM T GRAPHIC, V24, P536, DOI 10.1145/1073204.1073226; Nguyen CV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094346; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Salvi J, 2004, PATTERN RECOGN, V37, P827, DOI 10.1016/j.patcog.2003.10.002; Seitz S.M., 2006, P IEEE COMPUTER SOC, P519; Snavely N, 2008, INT J COMPUT VISION, V80, P189, DOI 10.1007/s11263-007-0107-3; Snavely N, 2006, ACM T GRAPHIC, V25, P835, DOI 10.1145/1141911.1141964; Soroldoni D, 2014, SCIENCE, V345, P222, DOI 10.1126/science.1253089; Strecha C., 2008, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/CVPR.2008.4587706; Toler-Franklin C, 2007, NPAR 2007: 5TH INTERNATIONAL SYMPOSIUM ON NON-PHOTOREALISTIC ANIMATION AND RENDERING, PROCEEDINGS, P111; Vu H., 2009, IEEE C COMP VIS PATT; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; Weinmann M., 2011, 2011 International Conference on 3D Imaging, Modeling, Processing, Visualization and Transmission (3DIMPVT), P397, DOI 10.1109/3DIMPVT.2011.57; Woodham R. J., 1989, SHAPE SHADING, P513; Wu L, 2011, LECT NOTES COMPUT SC, V6494, P703, DOI 10.1007/978-3-642-19318-7_55; Young MT, 2010, ZOOL J LINN SOC-LOND, V158, P801, DOI 10.1111/j.1096-3642.2009.00571.x	36	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126740	10.1371/journal.pone.0126740	http://dx.doi.org/10.1371/journal.pone.0126740			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039509	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700034
J	Beltra, A; Addison, P; Avalos, JA; Crochard, D; Garcia-Mari, F; Guerrieri, E; Giliomee, JH; Malausa, T; Navarro-Campos, C; Palero, F; Soto, A				Beltra, Aleixandre; Addison, Pia; Avalos, Juan Antonio; Crochard, Didier; Garcia-Mari, Ferran; Guerrieri, Emilio; Giliomee, Jan H.; Malausa, Thibaut; Navarro-Campos, Cristina; Palero, Ferran; Soto, Antonia			Guiding Classical Biological Control of an Invasive Mealybug Using Integrative Taxonomy	PLOS ONE			English	Article							PARACOCCUS-MARGINATUS HEMIPTERA; GYRANUSOIDEA-TEBYGI NOYES; MOLECULAR-IDENTIFICATION; SCALE INSECTS; MORPHOLOGICAL CHARACTERIZATION; BIOTYPE B; PSEUDOCOCCIDAE; HYMENOPTERA; PARASITOIDS; HOMOPTERA	Delottococcus aberiae De Lotto (Hemiptera: Pseudococcidae) is a mealybug of Southern African origin that has recently been introduced into Eastern Spain. It causes severe distortions on young citrus fruits and represents a growing threat to Mediterranean citrus production. So far, biological control has proven unsatisfactory due to the absence of efficient natural enemies in Spain. Hence, the management of this pest currently relies only on chemical control. The introduction of natural enemies of Delottococcus aberiae from the native area of the pest represents a sustainable and economically viable alternative to reduce the risks linked to pesticide applications. Since biological control of mealybugs has been traditionally challenged by taxonomic misidentification, an intensive survey of Delottococcus spp. and their associated parasitoids in South Africa was required as a first step towards a classical biological control programme. Combining morphological and molecular characterization (integrative taxonomy) a total of nine mealybug species were identified in this study, including three species of Delottococcus. Different populations of Delottococcus aberiae were found on wild olive trees, in citrus orchards and on plants of Chrysanthemoides monilifera, showing intra-specific divergences according to their host plants. Interestingly, the invasive mealybug populations from Spanish orchards clustered together with the population on citrus from Limpopo Province (South Africa), sharing COI haplotypes. This result pointed to an optimum location to collect natural enemies against the invasive mealybug. A total of 14 parasitoid species were recovered from Delottococcus spp. and identified to genus and species level, by integrating morphological and molecular data. A parasitoid belonging to the genus Anagyrus, collected from Delottococcus aberiae in citrus orchards in Limpopo, is proposed here as a good biological control agent to be introduced into Spain.	[Beltra, Aleixandre; Avalos, Juan Antonio; Garcia-Mari, Ferran; Navarro-Campos, Cristina; Soto, Antonia] Univ Politecn Valencia, Inst Agroforestal Mediterrani, E-46022 Valencia, Spain; [Addison, Pia] Univ Stellenbosch, Dept Conservat Ecol & Entomol, ZA-7600 Stellenbosch, South Africa; [Crochard, Didier; Malausa, Thibaut; Palero, Ferran] Univ Nice Sophia Antipolis, CNRS, UMR 1355 7254, INRA,Inst Sophia Agrobiotech, F-06900 Sophia Antipolis, France; [Guerrieri, Emilio] CNR, Ist Protez Sostenibile Piante, Portici, Italy; [Giliomee, Jan H.] Univ Stellenbosch, Dept Bot & Zool, Ctr Invas Biol, ZA-7600 Stellenbosch, South Africa	Universitat Politecnica de Valencia; Stellenbosch University; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR); Stellenbosch University	Soto, A (corresponding author), Univ Politecn Valencia, Inst Agroforestal Mediterrani, E-46022 Valencia, Spain.	asoto@eaf.upv.es	Malausa, Thibaut/X-1614-2018; Guerrieri, Emilio/ABB-7498-2020; Addison, Pia/G-9372-2012; Palero, Feran/L-7186-2019; Palero, Ferran/A-7830-2012	Malausa, Thibaut/0000-0003-1681-7958; Addison, Pia/0000-0002-8227-339X; Palero, Feran/0000-0002-0343-8329; Palero, Ferran/0000-0002-0343-8329	European Union Seventh Framework Programme FP7-IRSES "IPRABIO" [269196]; European Union Seventh Framework Programme FP7-IAPP "COLBICS" [324475]; European Union Seventh Framework Programme FP7-IRSES "BIOMODICS" [612566]	European Union Seventh Framework Programme FP7-IRSES "IPRABIO"; European Union Seventh Framework Programme FP7-IAPP "COLBICS"; European Union Seventh Framework Programme FP7-IRSES "BIOMODICS"	This work was supported by the European Union Seventh Framework Programme FP7-IRSES #269196 "IPRABIO" and FP7-IAPP #324475 "COLBICS" and FP7-IRSES #612566 "BIOMODICS". The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRICOLA U, 1989, B ENTOMOL RES, V79, P671, DOI 10.1017/S0007485300018824; Amarasekare KG, 2009, BIOL CONTROL, V51, P91, DOI 10.1016/j.biocontrol.2009.07.005; Anga Jean-Marc, 1999, Bulletin of the Natural History Museum Entomology Series, V68, P93; [Anonymous], 1999, HDB BIOL CONTROL; Jacas JA, 2010, INTEGR MANAG PLANT P, V5, P61, DOI 10.1007/978-90-481-8606-8_3; Bartlett BR., 1978, INTRO PARASITES PRED, P137; Baumann L, 2002, APPL ENVIRON MICROB, V68, P3198, DOI 10.1128/AEM.68.7.3198-3205.2002; Beltra A, 2012, B ENTOMOL RES, V102, P165, DOI 10.1017/S0007485311000514; Beltra A, 2013, LEVANTE AGRICOLA, V419, P348; Blumberg D, 1997, BIOL CONTROL, V8, P225, DOI 10.1006/bcon.1997.0502; BRAIN C. K., 1915, Trans. R. Soc. South Africa, V5, P65; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Charles JG, 2011, BIOCONTROL, V56, P155, DOI 10.1007/s10526-010-9322-x; Correa MCG, 2012, B ENTOMOL RES, V102, P524, DOI 10.1017/S0007485312000053; COX JM, 1986, B ENTOMOL RES, V76, P481, DOI 10.1017/S0007485300014966; DANKS HV, 1988, ANNU REV ENTOMOL, V33, P271, DOI 10.1146/annurev.en.33.010188.001415; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; de Lotto G., 1977, Journal of the Entomological Society of Southern Africa, V40, P13; DE LOTTO G., 1964, Bull. Brit. Mus (nat. Hist.) Ent., V14, P343; De Lotto G., 1961, Bulletin of the British Museum (Natural History) Entomology, V10, P211; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Foldi Imre, 1997, Memoires du Museum National d'Histoire Naturelle, V173, P203; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Garcia-Mari F, 2012, PLAGAS CITRICOS GEST; Goolsby JA, 1998, BIOL CONTROL, V12, P127, DOI 10.1006/bcon.1998.0624; GROSS P, 1993, ANNU REV ENTOMOL, V38, P251, DOI 10.1146/annurev.en.38.010193.001343; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hardy NB, 2008, SYST ENTOMOL, V33, P51, DOI 10.1111/j.1365-3113.2007.00408.x; HATTINGH V, 1998, CITRUS PESTS REPUBLI, P112; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heraty J, 2004, SYST ENTOMOL, V29, P544, DOI 10.1111/j.0307-6970.2004.00267.x; Hufbauer RA, 2005, BIOL CONTROL, V35, P227, DOI 10.1016/j.biocontrol.2005.04.004; Japoshvili G., 2010, Entomologia Hellenica, V19, P132; Kairo M. T. K., 2000, Integrated Pest Management Reviews, V5, P241, DOI 10.1023/A:1012997619132; KERRICH G. J., 1967, Bulletin of the British Museum (Natural History), B. Entomology, V20, P143; Kirk AA, 2000, B ENTOMOL RES, V90, P317, DOI 10.1017/S0007485300000444; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; McKenzie H.L., 1967, MEALYBUGS CALIFORNIA; Miller DR, 2011, AFR ENTOMOL, V19, P614, DOI 10.4001/003.019.0306; Miller DR, 2002, P ENTOMOL SOC WASH, V104, P825; Moore D., 1988, Biocontrol News and Information, V9, P209; Muniappan R, 2006, FLA ENTOMOL, V89, P212, DOI 10.1653/0015-4040(2006)89[212:CBCOTP]2.0.CO;2; NEUENSCHWANDER P, 1994, BIOCONTROL SCI TECHN, V4, P61, DOI 10.1080/09583159409355313; Neuenschwander P, 2001, BIOL CONTROL, V21, P214, DOI 10.1006/bcon.2001.0937; NOYES JS, 1982, J NAT HIST, V16, P315, DOI 10.1080/00222938200770261; Noyes JS, 1994, ORIENTAL MEALYBUG PA; da Silva VCP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103480, 10.1371/journal.pone.0093049, 10.1371/journal.pone.0105072, 10.1371/journal.pone.0087588, 10.1371/journal.pone.0103267, 10.1371/journal.pone.0091910, 10.1371/journal.pone.0107196, 10.1371/journal.pone.0110033, 10.1371/journal.pone.0096514, 10.1371/journal.pone.0087348, 10.1371/journal.pone.0103535, 10.1371/journal.pone.0095536, 10.1371/journal.pone.0099366, 10.1371/journal.pone.0113637, 10.1371/journal.pone.0095422]; Park DS, 2011, B ENTOMOL RES, V101, P429, DOI 10.1017/S0007485310000714; Park DS, 2010, J ECON ENTOMOL, V103, P25, DOI 10.1603/EC09144; Pellizzari Giuseppina, 2010, BioRisk, V4, P475; Pieterse W, 2010, AFR ENTOMOL, V18, P23, DOI 10.4001/003.018.0104; Prinsloo G.L., 1998, African Plant Protection, V4, P81; Prinsloo G.L., 2001, Journal of Hymenoptera Research, V10, P145; PRINSLOO GL, 1988, J NAT HIST, V22, P1465, DOI 10.1080/00222938800770891; Prinsloo GL, 2003, AFR ENTOMOL, V11, P77; PRINSLOO GL, 1983, J ENTOMOL SOC S AFR, V46, P103; Prinsloo GL, 1983, ENTOMOL MEM DEP AGR, V60, P1; Prinsloo GL, 1976, J ENTOMOL SOC S AFR, V39, P190; Rosen D., 1973, Entomophaga, V18, P215, DOI 10.1007/BF02371468; Rugman-Jones PF, 2011, BIOCONTROL, V56, P265, DOI 10.1007/s10526-010-9328-4; Rung A, 2008, ANN ENTOMOL SOC AM, V101, P525, DOI 10.1603/0013-8746(2008)101[525:MIOTCR]2.0.CO;2; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Sequeira AS, 2000, P ROY SOC B-BIOL SCI, V267, P2359, DOI 10.1098/rspb.2000.1292; Sethusa MT, 2014, AFR ENTOMOL, V22, P257, DOI 10.4001/003.022.0218; Sforza R, 2013, P 4 INT S BIOL CONTR, P46; Stiling Peter, 1993, American Entomologist, V39, P31; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Triapitsyn SV, 2007, BIOL CONTROL, V41, P14, DOI 10.1016/j.biocontrol.2006.12.013; Trjapitzin V.A., 1989, Opredeliteli po Faune SSSR, V158, P1; Wakgari WM, 2005, AFR ENTOMOL, V13, P281; Williams D. J., 1992, Mealybugs of Central and South America.; Zhang YZ, 2011, BIOL CONTROL, V58, P182, DOI 10.1016/j.biocontrol.2011.05.006	75	25	26	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128685	10.1371/journal.pone.0128685	http://dx.doi.org/10.1371/journal.pone.0128685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047349	Green Published, gold			2022-12-27	WOS:000355652200090
J	Fogelgren, B; Polgar, N; Lui, VH; Lee, AJ; Tamashiro, KKA; Napoli, JA; Walton, CB; Zuo, XF; Lipschutz, JH				Fogelgren, Ben; Polgar, Noemi; Lui, Vanessa H.; Lee, Amanda J.; Tamashiro, Kadee-Kalia A.; Napoli, Josephine Andrea; Walton, Chad B.; Zuo, Xiaofeng; Lipschutz, Joshua H.			Urothelial Defects from Targeted Inactivation of Exocyst Sec10 in Mice Cause Ureteropelvic Junction Obstructions	PLOS ONE			English	Article							CADHERIN GENE PROMOTER; CHRONIC-RENAL-FAILURE; PRIMARY CILIOGENESIS; DEVELOPING KIDNEY; PLASMA-MEMBRANE; CELL BIOLOGY; PROTEIN SEC8; MOUSE; EXOCYTOSIS; EXPRESSION	Most cases of congenital obstructive nephropathy are the result of ureteropelvic junction obstructions, and despite their high prevalence, we have a poor understanding of their etiology and scarcity of genetic models. The eight-protein exocyst complex regulates polarized exocytosis of intracellular vesicles in a large variety of cell types. Here we report generation of a conditional knockout mouse for Sec10, a central component of the exocyst, which is the first conditional allele for any exocyst gene. Inactivation of Sec10 in ureteric bud-derived cells using Ksp1.3-Cre mice resulted in severe bilateral hydronephrosis and complete anuria in newborns, with death occurring 6-14 hours after birth. Sec10(FL/FL); Ksp-Cre embryos developed ureteropelvic junction obstructions between E17.5 and E18.5 as a result of degeneration of the urothelium and subsequent overgrowth by surrounding mesenchymal cells. The urothelial cell layer that lines the urinary tract must maintain a hydrophobic luminal barrier again urine while remaining highly stretchable. This barrier is largely established by production of uroplakin proteins that are transported to the apical surface to establish large plaques. By E16.5, Sec10(FL/FL); Ksp-Cre ureter and pelvic urothelium showed decreased uroplakin-3 protein at the luminal surface, and complete absence of uroplakin-3 by E17.5. Affected urothelium at the UPJ showed irregular barriers that exposed the smooth muscle layer to urine, suggesting this may trigger the surrounding mesenchymal cells to overgrow the lumen. Findings from this novel mouse model show Sec10 is critical for the development of the urothelium in ureters, and provides experimental evidence that failure of this urothelial barrier may contribute to human congenital urinary tract obstructions.	[Fogelgren, Ben; Polgar, Noemi; Lui, Vanessa H.; Lee, Amanda J.; Tamashiro, Kadee-Kalia A.; Napoli, Josephine Andrea] Univ Hawaii Manoa, John A Burns Sch Med, Dept Anat Biochem & Physiol, Honolulu, HI 96822 USA; [Walton, Chad B.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Med, Honolulu, HI 96822 USA; [Zuo, Xiaofeng; Lipschutz, Joshua H.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Lipschutz, Joshua H.] Ralph H Johnson Vet Affairs Med Ctr, Dept Med, Charleston, SC USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Fogelgren, B (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Anat Biochem & Physiol, Honolulu, HI 96822 USA.	fogelgre@hawaii.edu		Polgar, Noemi/0000-0002-8400-162X	National Institutes of Health [K01DK087852, R03DK100738, P20GM103457-06A1-8293, R01DK069909, R21DK070980]; United States Department of Veteran's Affairs [I01 BX000820]; Satellite Healthcare Norman S. Coplon Extramural Research Grant; Hawaii Community Foundation [12ADVC-51347]; University of Alabama at Birmingham Hepato/Renal Fibrocystic Diseases Core Center [5P30DK074038]; March of Dimes: Basil O'Connor Starter Scholar Research Award [5-FY14-56]; University of Hawaii at Manoa Research Centers in Minority Institute, BRIDGES program [5G12MD007601]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK070980, R03DK100738, P60DK079626, P30DK074038, R01DK069909, K01DK087852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103457, P30GM103341] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007601] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veteran's Affairs(US Department of Veterans Affairs); Satellite Healthcare Norman S. Coplon Extramural Research Grant; Hawaii Community Foundation; University of Alabama at Birmingham Hepato/Renal Fibrocystic Diseases Core Center; March of Dimes: Basil O'Connor Starter Scholar Research Award(March of Dimes); University of Hawaii at Manoa Research Centers in Minority Institute, BRIDGES program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by 1) National Institutes of Health: Grant # K01DK087852 to BF; http://www.nih.gov/. 2) National Institutes of Health: Grant # R03DK100738 to BF; http://www.nih.gov/. 3) National Institutes of Health: Grant # P20GM103457-06A1-8293 to BF; http://www.nih.gov/. 4) National Institutes of Health: Grant # R01DK069909 to JL; http://www.nih.gov/. 5) National Institutes of Health: Grant # R21DK070980 to JL; http://www.nih.gov/. 6) United States Department of Veteran's Affairs: Merit Award # I01 BX000820 to JL; http://www.research.va.gov/funding/. 7) Satellite Healthcare Norman S. Coplon Extramural Research Grant to JL; http://www.satellitehealth.com/about_satellite/philanthropy/coplon_grants/. 8) Hawaii Community Foundation: Grant # 12ADVC-51347 to BF; http://www.hawaiicommunityfoundation.org/. 9) University of Alabama at Birmingham Hepato/Renal Fibrocystic Diseases Core Center: Pilot Award # 5P30DK074038 to BF; http://www.uab.edu/medicine/hrfdcc/. 10) March of Dimes: Basil O'Connor Starter Scholar Research Award #5-FY14-56 to BF; http://www.marchofdimes.org/. 11) University of Hawaii at Manoa Research Centers in Minority Institute, BRIDGES program: Pilot Award # 5G12MD007601 to BF; http://rcmi-bridges.jabsom.hawaii.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airik R, 2007, KIDNEY INT, V72, P1459, DOI 10.1038/sj.ki.5002589; Aoki Y, 2004, GENES CELLS, V9, P1287, DOI 10.1111/j.1365-2443.2004.00805.x; Bakris G, 2008, AM J KIDNEY DIS, V51, pS1, DOI 10.1053/j.ajkd.2008.01.015; Bartoli FA, 1996, UROL RES, V24, P9, DOI 10.1007/BF00296726; Bascands JL, 2005, KIDNEY INT, V68, P925, DOI 10.1111/j.1523-1755.2005.00486.x; Benfield MR, 2003, PEDIATR TRANSPLANT, V7, P321, DOI 10.1034/j.1399-3046.2003.00029.x; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; Cain JE, 2011, J CLIN INVEST, V121, P1199, DOI 10.1172/JCI45523; Chang CP, 2004, J CLIN INVEST, V113, P1051, DOI 10.1172/JCI200420049; Chen XW, 2011, NAT CELL BIOL, V13, P580, DOI 10.1038/ncb2226; Chevalier RL, 2010, PEDIATR NEPHROL, V25, P687, DOI 10.1007/s00467-009-1316-5; Dressler GR, 2009, DEVELOPMENT, V136, P3863, DOI 10.1242/dev.034876; Erman A, 2006, TISSUE CELL, V38, P293, DOI 10.1016/j.tice.2006.07.001; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fogelgren B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001361; Fogelgren B, 2009, AM J PHYSIOL-RENAL, V296, pF1166, DOI 10.1152/ajprenal.90550.2008; Friedel Roland H., 2007, Briefings in Functional Genomics & Proteomics, V6, P180, DOI 10.1093/bfgp/elm022; Friedrich GA, 1997, DEV BIOL, V192, P364, DOI 10.1006/dbio.1997.8727; Gandhi D, 2013, DEV CELL, V26, P469, DOI 10.1016/j.devcel.2013.07.017; Guichard A, 2013, CELL HOST MICROBE, V14, P294, DOI 10.1016/j.chom.2013.08.001; Guichard A, 2010, NATURE, V467, P854, DOI 10.1038/nature09446; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Haraguchi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042245; Heider MR, 2012, EXORCISING EXOCYST C; Hu CCA, 2005, MOL BIOL CELL, V16, P3937, DOI 10.1091/mbc.E05-02-0136; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Igarashi P, 2003, NEPHRON EXP NEPHROL, V94, pE1, DOI 10.1159/000070812; Igarashi P, 1999, AM J PHYSIOL-RENAL, V277, pF599, DOI 10.1152/ajprenal.1999.277.4.F599; Ingraham SE, 2011, PEDIATR NEPHROL, V26, P1453, DOI 10.1007/s00467-011-1799-8; Ingraham SE, 2010, PEDIATR RES, V68, P500, DOI 10.1203/PDR.0b013e3181f82f15; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Khandelwal P, 2008, P NATL ACAD SCI USA, V105, P15773, DOI 10.1073/pnas.0805636105; Khandelwal P, 2013, MOL BIOL CELL, V24, P1007, DOI 10.1091/mbc.E12-08-0568; Khandelwal P, 2009, AM J PHYSIOL-RENAL, V297, pF1477, DOI 10.1152/ajprenal.00327.2009; Klein J, 2011, INT J EXP PATHOL, V92, P168, DOI 10.1111/j.1365-2613.2010.00727.x; Kong XT, 2004, J CELL BIOL, V167, P1195, DOI 10.1083/jcb.200406025; Letinic K, 2009, P NATL ACAD SCI USA, V106, P11342, DOI 10.1073/pnas.0904244106; Li L, 2009, AM J PHYSIOL-RENAL, V297, pF1526, DOI 10.1152/ajprenal.00318.2009; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Lipschutz JH, 2000, MOL BIOL CELL, V11, P4259, DOI 10.1091/mbc.11.12.4259; Liu JL, 2009, MOL BIOL CELL, V20, P3763, DOI 10.1091/mbc.E08-09-0967; Lloyd KCK, 2011, ANN NY ACAD SCI, V1245, P24, DOI 10.1111/j.1749-6632.2011.06311.x; Lu HZ, 2013, DEV CELL, V27, P560, DOI 10.1016/j.devcel.2013.10.020; Lyons PD, 2009, BIOSCIENCE REP, V29, P229, DOI 10.1042/BSR20080162; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mathai JC, 2014, BIOPHYS J, V107, P1273, DOI 10.1016/j.bpj.2014.07.047; Mesrobian HGO, 2012, PEDIATR CLIN N AM, V59, P839, DOI 10.1016/j.pcl.2012.05.008; Nichols CD, 2010, CURR BIOL, V20, P1316, DOI 10.1016/j.cub.2010.05.065; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Park KM, 2010, AM J PHYSIOL-RENAL, V298, pF818, DOI 10.1152/ajprenal.00596.2009; Ren JQ, 2012, DEV CELL, V22, P967, DOI 10.1016/j.devcel.2012.03.005; Roth D, 1998, MOL BIOL CELL, V9, P1725, DOI 10.1091/mbc.9.7.1725; Roth JA, 2001, CURR OPIN PEDIATR, V13, P138, DOI 10.1097/00008480-200104000-00009; Roth KS, 2002, CLIN PEDIATR, V41, P309, DOI 10.1177/000992280204100503; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016443.50138.CD; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; Singh S, 2007, J AM SOC NEPHROL, V18, P461, DOI 10.1681/ASN.2006040405; Thapa N, 2012, DEV CELL, V22, P116, DOI 10.1016/j.devcel.2011.10.030; Tripathi P, 2012, J AM SOC NEPHROL, V23, P618, DOI 10.1681/ASN.2011060566; Vega IE, 2001, J NEUROSCI, V21, P3839, DOI 10.1523/JNEUROSCI.21-11-03839.2001; Whyte DA, 1999, AM J PHYSIOL-RENAL, V277, pF587, DOI 10.1152/ajprenal.1999.277.4.F587; Woodward M, 2002, BJU INT, V89, P149, DOI 10.1046/j.1464-4096.2001.woodward.2578.x; Woolf AS, 2013, J AM SOC NEPHROL, V24, P19, DOI 10.1681/ASN.2012020127; Woolf AS, 2001, ADV RENAL REPLACE TH, V8, P157, DOI 10.1053/jarr.2001.26348; Wu H, 2008, TRENDS CELL BIOL, V18, P397, DOI 10.1016/j.tcb.2008.06.007; Yamany T, 2014, CURR OPIN ORGAN TRAN, V19, P323, DOI 10.1097/MOT.0000000000000084; Yu J, 2002, DEVELOPMENT, V129, P5301; Zuo XF, 2011, J BIOL CHEM, V286, P22469, DOI 10.1074/jbc.M111.238469; Zuo XF, 2009, MOL BIOL CELL, V20, P2522, DOI 10.1091/mbc.E08-07-0772	73	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129346	10.1371/journal.pone.0129346	http://dx.doi.org/10.1371/journal.pone.0129346			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046524	gold, Green Submitted, Green Published			2022-12-27	WOS:000355652200154
J	Quashie, PK; Han, YS; Hassounah, S; Mesplede, T; Wainberg, MA				Quashie, Peter K.; Han, Ying-Shan; Hassounah, Said; Mesplede, Thibault; Wainberg, Mark A.			Structural Studies of the HIV-1 Integrase Protein: Compound Screening and Characterization of a DNA-Binding Inhibitor	PLOS ONE			English	Article							STRAND TRANSFER; I-TASSER; STRUCTURE PREDICTION; BIOCHEMICAL-ANALYSIS; HOMOLOGY DETECTION; CRYSTAL-STRUCTURE; TERMINAL DOMAINS; CATALYTIC DOMAIN; NUCLEAR IMPORT; VIRAL-DNA	Understanding the HIV integrase protein and mechanisms of resistance to HIV integrase inhibitors is complicated by the lack of a full length HIV integrase crystal structure. Moreover, a lentiviral integrase structure with co-crystallised DNA has not been described. For these reasons, we have developed a structural method that utilizes free software to create quaternary HIV integrase homology models, based partially on available full-length prototype foamy virus integrase structures as well as several structures of truncated HIV integrase. We have tested the utility of these models in screening of small anti-integrase compounds using randomly selected molecules from the ZINC database as well as a well characterized IN: DNA binding inhibitor, FZ41, and a putative IN: DNA binding inhibitor, HDS1. Docking studies showed that the ZINC compounds that had the best binding energies bound at the IN: IN dimer interface and that the FZ41 and HDS1 compounds docked at approximately the same location in integrase, i.e. behind the DNA binding domain, although there is some overlap with the IN: IN dimer interface to which the ZINC compounds bind. Thus, we have revealed two possible locations in integrase that could potentially be targeted by allosteric integrase inhibitors, that are distinct from the binding sites of other allosteric molecules such as LEDGF inhibitors. Virological and biochemical studies confirmed that HDS1 and FZ41 share a similar activity profile and that both can inhibit each of integrase and reverse transcriptase activities. The inhibitory mechanism of HDS1 for HIV integrase seems to be at the DNA binding step and not at either of the strand transfer or 3' processing steps of the integrase reaction. Furthermore, HDS1 does not directly interact with DNA. The modeling and docking methodology described here will be useful for future screening of integrase inhibitors as well as for the generation of models for the study of integrase drug resistance.	[Quashie, Peter K.; Han, Ying-Shan; Hassounah, Said; Mesplede, Thibault; Wainberg, Mark A.] McGill Univ, Jewish Gen Hosp, AIDS Ctr, Lady Davis Med Res, Montreal, PQ H3T 1E2, Canada; [Quashie, Peter K.; Hassounah, Said; Wainberg, Mark A.] McGill Univ, Fac Med, Div Expt Med, Montreal, PQ H3T 1E2, Canada; [Wainberg, Mark A.] McGill Univ, Fac Med, Dept Microbiol & Immunol, Montreal, PQ H3T 1E2, Canada	McGill University; McGill University; McGill University	Wainberg, MA (corresponding author), McGill Univ, Jewish Gen Hosp, AIDS Ctr, Lady Davis Med Res, Montreal, PQ H3T 1E2, Canada.	mark.wainberg@mcgill.ca	Mesplède, Thibault/E-8550-2014	Mesplède, Thibault/0000-0003-0515-9128; Quashie, Peter/0000-0003-4114-5460; Hassounah, Said/0000-0002-9712-1313	Canadian Institutes of Health Research (CIHR) [CCM104886]; Reseau SIDA of the Fonds de Recherche du Quebec; CAHR/CIHR; Bristol Myers Squibb/Canadian HIV Trials Network (BMS/CTN); Fonds de la Recherche du Quebec en Sante (FRQS)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Reseau SIDA of the Fonds de Recherche du Quebec; CAHR/CIHR; Bristol Myers Squibb/Canadian HIV Trials Network (BMS/CTN); Fonds de la Recherche du Quebec en Sante (FRQS)	This work was supported by research grants from the Canadian Institutes of Health Research (CIHR grant number CCM104886) and the Reseau SIDA of the Fonds de Recherche du Quebec. P.K.Q. was the recipient of a doctoral scholarship from CAHR/CIHR. T.M. was a recipient of a Postdoctoral Fellowship from Bristol Myers Squibb/Canadian HIV Trials Network (BMS/CTN). S.A.H. is the recipient of a doctoral studentship from the Fonds de la Recherche du Quebec en Sante (FRQS).	[Anonymous], PYMOL MOL GRAPHICS S; Baldi P, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P39; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blanco JL, 2011, J INFECT DIS, V203, P1204, DOI 10.1093/infdis/jir025; Bonnenfant S, 2004, J VIROL, V78, P5728, DOI 10.1128/JVI.78.11.5728-5736.2004; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Buenavista MT, 2012, BIOINFORMATICS, V28, P1851, DOI 10.1093/bioinformatics/bts292; Ceccherini-Silberstein F, 2009, AIDS REV, V11, P17; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Dallakyan S, 2015, METHODS MOL BIOL, V1263, P243, DOI 10.1007/978-1-4939-2269-7_19; De Luca L, 2011, CHEMMEDCHEM, V6, P1184, DOI 10.1002/cmdc.201100071; Desimmie BA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-57; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Dicker IB, 2008, J BIOL CHEM, V283, P23599, DOI 10.1074/jbc.M804213200; DUNBRACK RL, 1994, NAT STRUCT BIOL, V1, P334, DOI 10.1038/nsb0594-334; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Engelman A, 1997, J VIROL, V71, P3507, DOI 10.1128/JVI.71.5.3507-3514.1997; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; FDA, FDA APPR IS RALT; Goethals O, 2008, J VIROL, V82, P10366, DOI 10.1128/JVI.00470-08; Grobler JA, 2002, P NATL ACAD SCI USA, V99, P6661, DOI 10.1073/pnas.092056199; Han YS, 2013, ANTIVIR RES, V98, P441, DOI 10.1016/j.antiviral.2013.04.001; Han YS, 2012, J VIROL METHODS, V184, P34, DOI 10.1016/j.jviromet.2012.05.003; Hare S, 2012, EMBO J, V31, P3020, DOI 10.1038/emboj.2012.118; Hare S, 2011, MOL PHARMACOL, V80, P565, DOI 10.1124/mol.111.073189; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Johnson BC, 2013, J MOL BIOL, V425, P2133, DOI 10.1016/j.jmb.2013.03.027; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kessl JJ, 2011, NUCLEIC ACIDS RES, V39, P9009, DOI 10.1093/nar/gkr581; Kessl JJ, 2009, VIRUSES-BASEL, V1, P713, DOI 10.3390/v1030713; KOLTUN WL, 1965, BIOPOLYMERS, V3, P665, DOI 10.1002/bip.360030606; Kramer VG, 2012, ANTIMICROB AGENTS CH, V56, P4154, DOI 10.1128/AAC.00409-12; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Levin A, 2010, NUCLEUS-PHILA, V1, P422, DOI 10.4161/nucl.1.5.12903; Li XA, 2011, VIROLOGY, V411, P194, DOI 10.1016/j.virol.2010.12.008; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Melo F, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P187; Mesplede T, 2014, J ANTIMICROB CHEMOTH, V69, P2733, DOI 10.1093/jac/dku199; Mesplede T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-22; Mesplede T, 2012, CURR OPIN HIV AIDS, V7, P401, DOI 10.1097/COH.0b013e328356db89; Mousnier A, 2004, MOL PHARMACOL, V66, P783, DOI 10.1124/mol.104.001735; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Prlic A, 2010, BIOINFORMATICS, V26, P2983, DOI 10.1093/bioinformatics/btq572; Quashie PK, 2015, J VIROL, V89, P3163, DOI 10.1128/JVI.03353-14; Quashie PK, 2013, ANTIMICROB AGENTS CH, V57, P6223, DOI 10.1128/AAC.01835-13; Quashie PK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-34; Quashie PK, 2012, J VIROL, V86, P2696, DOI 10.1128/JVI.06591-11; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rhodes David I., 2011, Antiviral Chemistry & Chemotherapy, V21, P155, DOI 10.3851/IMP1716; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schrijvers R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002558; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Serrao E, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-25; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sun R, 2011, BIOORG MED CHEM LETT, V21, P961, DOI 10.1016/j.bmcl.2010.12.055; Sussman JL, 1998, ACTA CRYSTALLOGR D, V54, P1078, DOI 10.1107/S0907444998009378; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Wainberg MA, 2012, CURR OPIN VIROL, V2, P656, DOI 10.1016/j.coviro.2012.08.007; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Wang Q, 2008, NAT PROTOC, V3, P1832, DOI 10.1038/nprot.2008.184; Xu HT, 2011, J VIROL, V85, P11300, DOI 10.1128/JVI.05584-11; Yan Hua, 2005, Antiviral Chemistry & Chemotherapy, V16, P363; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	74	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128310	10.1371/journal.pone.0128310	http://dx.doi.org/10.1371/journal.pone.0128310			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046987	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200058
J	Zhong, Y; Cheng, CZ; Jiang, NH; Jiang, B; Zhang, YY; Hu, BML; Zeng, JW; Yan, HX; Yi, GJ; Zhong, GY				Zhong, Yun; Cheng, Chun-Zhen; Jiang, Nong-Hui; Jiang, Bo; Zhang, Yong-Yan; Hu, Bowu Min-Lun; Zeng, Ji-Wu; Yan, Hua-Xue; Yi, Gan-Jun; Zhong, Guang-Yan			Comparative Transcriptome and iTRAQ Proteome Analyses of Citrus Root Responses to Candidatus Liberibacter asiaticus Infection	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; SWEET ORANGE; DISEASE RESISTANCE; GREENING DISEASE; GENE-EXPRESSION; SINENSIS; DEFENSE; ACYLTRANSFERASE; OVEREXPRESSION; DEFICIENCY	Root samples of 'Sanhu' red tangerine trees infected with and without Candidatus Liberibacter asiaticus (CLas) were collected at 50 days post inoculation and subjected to RNA-sequencing and isobaric tags for relative and absolute quantification (iTRAQ) to profile the differentially expressed genes (DEGs) and proteins (DEPs), respectively. Quantitative real-time PCR was subsequently used to confirm the expression of 16 selected DEGs. Results showed that a total of 3956 genes and 78 proteins were differentially regulated by HLB-infection. Among the most highly up-regulated DEPs were sperm specific protein 411, copper ion binding protein, germin-like proteins, subtilisin-like proteins and serine carboxypeptidase-like 40 proteins whose transcript levels were concomitantly up-regulated as shown by RNA-seq data. Comparison between our results and those of the previously reported showed that known HLB-modulated biological pathways including cell-wall modification, protease-involved protein degradation, carbohydrate metabolism, hormone synthesis and signaling, transcription activities, and stress responses were similarly regulated by HLB infection but different or root-specific changes did exist. The root unique changes included the down-regulation in genes of ubiquitin-dependent protein degradation pathway, secondary metabolism, cytochrome P450s, UDP-glucosyl transferases and pentatricopeptide repeat containing proteins. Notably, nutrient absorption was impaired by HLB-infection as the expression of the genes involved in Fe, Zn, N and P adsorption and transportation were significantly changed. HLB-infection induced some cellular defense responses but simultaneously reduced the biosynthesis of the three major classes of secondary metabolites, many of which are known to have anti-pathogen activities. Genes involved in callose deposition were up-regulated whereas those involved in callose degradation were also upregulated, indicating that the sieve tube elements in roots were hanging on the balance of life and death at this stage. In addition, signs of carbohydrate starvation were already eminent in roots at this stage. Other interesting genes and pathways that were changed by HLB-infection were also discussed based on our findings.	[Zhong, Yun; Cheng, Chun-Zhen; Jiang, Nong-Hui; Jiang, Bo; Zhang, Yong-Yan; Hu, Bowu Min-Lun; Zeng, Ji-Wu; Yan, Hua-Xue; Zhong, Guang-Yan] Guangdong Acad Agr Sci, Inst Fruit Tree Res, Guangzhou 510640, Guangdong, Peoples R China; [Zhong, Yun; Cheng, Chun-Zhen; Jiang, Nong-Hui; Jiang, Bo; Zhang, Yong-Yan; Hu, Bowu Min-Lun; Zeng, Ji-Wu; Yan, Hua-Xue; Yi, Gan-Jun; Zhong, Guang-Yan] Minist Agr, Key Lab South Subtrop Fruit Biol & Genet Resource, Guangzhou 510640, Guangdong, Peoples R China; [Zhong, Yun; Cheng, Chun-Zhen; Jiang, Nong-Hui; Jiang, Bo; Zhang, Yong-Yan; Hu, Bowu Min-Lun; Zeng, Ji-Wu; Yan, Hua-Xue; Yi, Gan-Jun; Zhong, Guang-Yan] Key Lab Trop & Subtrop Fruit Tree Res, Guangzhou 510640, Guangdong, Peoples R China	Guangdong Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Zhong, GY (corresponding author), Guangdong Acad Agr Sci, Inst Fruit Tree Res, Guangzhou 510640, Guangdong, Peoples R China.	gy_zhong@163.com	Zhong, Yun/HCH-6868-2022; Cheng, Chunzhen/HGA-1240-2022	Cheng, Chunzhen/0000-0003-1978-0097; Wu, Bo/0000-0003-2027-8651	International Science & Technology Cooperation Program of China [2012DFA30610]; Guangdong provincial Science and technology Programs [S2013010015149, 2012B050700006, 2013B090700007]	International Science & Technology Cooperation Program of China; Guangdong provincial Science and technology Programs	This work was supported by the International Science & Technology Cooperation Program of China (2012DFA30610, G-YZ received the funding), by the Guangdong provincial Science and technology Programs (S2013010015149, YZ received the funding; 2012B050700006, YZ received the funding; 2013B090700007, G-YZ received the funding).	Achor D. S., 2010, Plant Pathology Journal (Faisalabad), V9, P56; Albrecht U, 2008, PLANT SCI, V175, P291, DOI 10.1016/j.plantsci.2008.05.001; Albrecht U, 2012, PLANT SCI, V185, P118, DOI 10.1016/j.plantsci.2011.09.008; Albrecht U, 2009, HORTSCIENCE, V44, P1967, DOI 10.21273/HORTSCI.44.7.1967; Aritua V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073742; Avrova AO, 1999, MOL PLANT MICROBE IN, V12, P1114, DOI 10.1094/MPMI.1999.12.12.1114; Barratt DHP, 2011, PLANT PHYSIOL, V155, P328, DOI 10.1104/pp.110.166330; Batool A, 2007, HORTIC SCI, V34, P159, DOI 10.17221/1897-HORTSCI; Beffa R, 1996, GENE, V179, P97, DOI 10.1016/S0378-1119(96)00421-0; Beneteau J, 2010, PLANT PHYSIOL, V153, P1345, DOI 10.1104/pp.110.153882; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bove JM, 2006, J PLANT PATHOL, V88, P7; Castro AJ, 2003, THEOR APPL GENET, V107, P922, DOI 10.1007/s00122-003-1329-6; Chen SX, 2006, PROTEOMICS, V6, P5504, DOI 10.1002/pmic.200600143; [程春振 Cheng Chunzhen], 2013, [园艺学报, Acta Horticulturae Sinica], V40, P1656; Cheng CZ, 2015, J INTEGR AGR, DOI [10.1016/S2095-3119(14)60937-00, DOI 10.1016/S2095-3119(14)60937-00]; Citovsky V, 2009, SEMIN CELL DEV BIOL, V20, P1048, DOI 10.1016/j.semcdb.2009.05.012; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Coletta HD, 2005, PLANT DIS, V89, P848, DOI 10.1094/PD-89-0848; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Connolly EL, 2003, PLANT PHYSIOL, V133, P1102, DOI 10.1104/pp.103.025122; Cushing DA, 2005, PLANTA, V221, P424, DOI 10.1007/s00425-004-1452-x; Etxeberria E, 2009, PHYSIOL MOL PLANT P, V74, P76, DOI 10.1016/j.pmpp.2009.09.004; Fan J, 2012, MOL PLANT MICROBE IN, V25, P1396, DOI 10.1094/MPMI-06-12-0150-R; Fan J, 2011, PHYSIOL PLANTARUM, V143, P235, DOI 10.1111/j.1399-3054.2011.01502.x; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hocquellet A, 1999, MOL CELL PROBE, V13, P373, DOI 10.1006/mcpr.1999.0263; Huang CY, 2000, PLANT PHYSIOL, V124, P415, DOI 10.1104/pp.124.1.415; Johnson EG, 2014, PLANT PATHOL, V63, P290, DOI 10.1111/ppa.12109; Kim JS, 2009, PHYTOPATHOLOGY, V99, P50, DOI 10.1094/PHYTO-99-1-0050; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kogenaru S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-629; Laluk K, 2011, PLANT PHYSIOL, V156, P2053, DOI 10.1104/pp.111.177501; Langlois-Meurinne M, 2005, PLANT PHYSIOL, V139, P1890, DOI 10.1104/pp.105.067223; Lepikson-Neto J, 2013, BIORESOURCES, V8, P1747; Li AX, 2000, P NATL ACAD SCI USA, V97, P6902, DOI 10.1073/pnas.110154197; Liao HL, 2012, J EXP BOT, V63, P3307, DOI 10.1093/jxb/ers070; Liu J, 2000, PLANT BREEDING, V119, P21, DOI 10.1046/j.1439-0523.2000.00431.x; Liu YQ, 2001, PLANT PHYSIOL, V127, P1788, DOI 10.1104/pp.010593; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Mafra V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-247; Martinelli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074256; Martinelli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038039; Maruthasalam S, 2007, PLANT CELL REP, V26, P791, DOI 10.1007/s00299-006-0292-5; Masaoka Y, 2011, JARQ-JPN AGR RES Q, V45, P269, DOI 10.6090/jarq.45.269; Mugford ST, 2009, PLANT CELL, V21, P2473, DOI 10.1105/tpc.109.065870; Mukhtar MS, 2009, CELL, V137, P804, DOI 10.1016/j.cell.2009.05.010; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Persans MW, 2001, PLANT PHYSIOL, V125, P1126, DOI 10.1104/pp.125.2.1126; Ramirez V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003445; Razi MFUD, 2011, PAK J AGR SCI, V48, P299; READ SM, 1983, PLANTA, V158, P119, DOI 10.1007/BF00397704; Roman MP, 2004, PLANT DIS, V88, P453, DOI 10.1094/PDIS.2004.88.5.453; Song JT, 2004, PLANT J, V40, P200, DOI 10.1111/j.1365-313X.2004.02200.x; Tatineni S, 2008, PHYTOPATHOLOGY, V98, P592, DOI 10.1094/PHYTO-98-5-0592; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; von Saint Paul V, 2011, PLANT CELL, V23, P4124, DOI 10.1105/tpc.111.088443; Wang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061722; Will T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00336; Xia YJ, 2004, EMBO J, V23, P980, DOI 10.1038/sj.emboj.7600086; Yan HX, 2015, PEST MANAG SCI, V71, P893, DOI 10.1002/ps.3915; Yang QS, 2012, MOL CELL PROTEOMICS, V11, P1853, DOI 10.1074/mcp.M112.022079; Yu QB, 2009, PLANT J, V59, P1011, DOI 10.1111/j.1365-313X.2009.03930.x; Zeng LR, 2006, CELL RES, V16, P413, DOI 10.1038/sj.cr.7310053; Zhang CL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-11; Zhao HW, 2013, MOL PLANT, V6, P301, DOI 10.1093/mp/sst002; Zhong GY, 2000, ANAL BIOCHEM, V282, P129, DOI 10.1006/abio.2000.4581; Zsigmond L, 2008, PLANT PHYSIOL, V146, P1721, DOI 10.1104/pp.107.111260; Zwenger S., 2008, Biotechnology and Molecular Biology Reviews, V3, P001	73	56	66	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0126973	10.1371/journal.pone.0126973	http://dx.doi.org/10.1371/journal.pone.0126973			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046530	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200014
J	Meng, XL; Liu, P; Jia, FL; Li, J; Gao, BQ				Meng, Xian-liang; Liu, Ping; Jia, Fu-long; Li, Jian; Gao, Bao-quan			De novo Transcriptome Analysis of Portunus trituberculatus Ovary and Testis by RNA-Seq: Identification of Genes Involved in Gonadal Development	PLOS ONE			English	Article							RED SWAMP CRAYFISH; CRUSTACEAN HYPERGLYCEMIC HORMONES; METHYL FARNESOATE; IN-VIVO; PROCAMBARUS-CLARKII; REPRODUCTIVE-CYCLE; PROSTAGLANDIN E(2); SIGNALING PATHWAY; STEROID-HORMONES; CRAB	The swimming crab Portunus trituberculatus is a commercially important crab species in East Asia countries. Gonadal development is a physiological process of great significance to the reproduction as well as commercial seed production for Portunus trituberculatus. However, little is currently known about the molecular mechanisms governing the developmental processes of gonads in this species. To open avenues of molecular research on Portunus trituberculatus gonadal development, Illumina paired-end sequencing technology was employed to develop deep-coverage transcriptome sequencing data for its gonads. Illumina sequencing generated 58,429,148 and 70,474,978 high-quality reads from the ovary and testis cDNA library, respectively. All these reads were assembled into 54,960 unigenes with an average sequence length of 879 bp, of which 12,340 unigenes (22.45% of the total) matched sequences in GenBank non-redundant database. Based on our transcriptome analysis as well as published literature, a number of candidate genes potentially involved in the regulation of gonadal development of Portunus trituberculatus were identified, such as FAOMeT, mPR gamma, PGMRC1, PGDS, PGER4, 3 beta-HSD and 17 beta-HSDs. Differential expression analysis generated 5,919 differentially expressed genes between ovary and testis, among which many genes related to gametogenesis and several genes previously reported to be critical in differentiation and development of gonads were found, including Foxl2, Wnt4, Fst, Fem-1 and Sox9. Furthermore, 28,534 SSRs and 111,646 high-quality SNPs were identified in this transcriptome dataset. This work represents the first transcriptome analysis of Portunus trituberculatus gonads using the next generation sequencing technology and provides a valuable dataset for understanding molecular mechanisms controlling development of gonads and facilitating future investigation of reproductive biology in this species. The molecular markers obtained in this study will provide a fundamental basis for population genetics and functional genomics in Portunus trituberculatus and other closely related species.	[Meng, Xian-liang; Liu, Ping; Jia, Fu-long; Li, Jian; Gao, Bao-quan] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Qingdao, Shandong, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS	Meng, XL (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Qingdao, Shandong, Peoples R China.	xlmeng@ysfri.ac.cn; liuping@ysfri.ac.cn	MENG, XIANLIANG/F-9114-2015	MENG, XIANLIANG/0000-0002-2580-6786	National High Technology R&D Program of China [2012AA10A409]; Natural Science Foundation of China [41306178]; Special Scientific Research Funds for Central Nonprofit Institutes, Yellow Sea Fisheries Research Institutes [20603022013027]	National High Technology R&D Program of China(National High Technology Research and Development Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Scientific Research Funds for Central Nonprofit Institutes, Yellow Sea Fisheries Research Institutes	This work was supported by the National High Technology R&D Program of China (2012AA10A409), the grants from the Natural Science Foundation of China (41306178), and the Special Scientific Research Funds for Central Nonprofit Institutes, Yellow Sea Fisheries Research Institutes (20603022013027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MA, 2008, GEN COMP ENDOCR, V157, P75, DOI 10.1016/j.ygcen.2008.03.018; Beltz B.S., 1988, Invertebrate Endocrinology, V2, P235; BORST DW, 1987, INSECT BIOCHEM, V17, P1123, DOI 10.1016/0020-1790(87)90133-8; Borst DW, 2001, AM ZOOL, V41, P430, DOI 10.1668/0003-1569(2001)041[0430:ROTCMO]2.0.CO;2; Boyer A, 2010, TRENDS ENDOCRIN MET, V21, P25, DOI 10.1016/j.tem.2009.08.005; Cardoso AM, 1997, J AM SOC MASS SPECTR, V8, P365, DOI 10.1016/S1044-0305(96)00282-6; CHANG ES, 1993, ANNU REV ENTOMOL, V38, P161, DOI 10.1146/annurev.en.38.010193.001113; Chung JS, 2008, FEBS J, V275, P693, DOI 10.1111/j.1742-4658.2007.06231.x; Chung JS, 2015, GEN COMP ENDOCR, V214, P177, DOI 10.1016/j.ygcen.2014.08.017; Chung JS, 2010, GEN COMP ENDOCR, V166, P447, DOI 10.1016/j.ygcen.2009.12.011; Coccia E, 2010, BIOL BULL-US, V218, P36, DOI 10.1086/BBLv218n1p36; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Cui ZX, 2010, FISH SHELLFISH IMMUN, V28, P56, DOI 10.1016/j.fsi.2009.09.018; Dai A, 1986, MARINE CRABS IN CHIN; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; DONIACH T, 1984, DEV BIOL, V106, P223, DOI 10.1016/0012-1606(84)90077-0; Duffy DM, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-131; Fingerman M, 1997, INVERTEBR REPROD DEV, V31, P47, DOI 10.1080/07924259.1997.9672562; Fomitcheva J, 1998, J BIOL CHEM, V273, P22664, DOI 10.1074/jbc.273.35.22664; Gao J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-585; Gong XY, 2009, BIOL REPROD, V81, P730, DOI 10.1095/biolreprod.108.070086; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hannas BR, 2010, MOL CELL ENDOCRINOL, V315, P208, DOI 10.1016/j.mce.2009.07.013; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053915; He L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033735, 10.1371/journal.pone.0045607]; HOLLAND DL, 1985, PROSTAGLANDINS, V29, P1021, DOI 10.1016/0090-6980(85)90225-4; Hopkins P.M., 2009, ECDYSONE STRUCTURES, P73, DOI DOI 10.1007/978-1-4020-9112-4_3; Jiang HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105122; Jin SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076840; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kalavathy Y, 1999, NATURWISSENSCHAFTEN, V86, P394, DOI 10.1007/s001140050639; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KING LE, 1995, INSECT BIOCHEM MOLEC, V25, P495, DOI 10.1016/0965-1748(94)00089-H; Kishori B, 2012, GLOBAL J BIOTECH BIO, V7, P110, DOI [10.5829/idosi.gjbb.2012.7.4.65126, DOI 10.5829/IDOSI.GJBB.2012.7.4.65126]; Knight PG, 2001, REPRODUCTION, V121, P503, DOI 10.1530/reprod/121.4.503; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; KOSKELA RW, 1992, COMP BIOCHEM PHYS A, V101, P295, DOI 10.1016/0300-9629(92)90535-X; KULKARNI GK, 1992, BIOL BULL, V182, P341, DOI 10.2307/1542254; Kunstner A, 2010, MOL ECOL, V19, P266, DOI 10.1111/j.1365-294X.2009.04487.x; LAFONT R, 1991, INSECT BIOCHEM, V21, P697, DOI 10.1016/0020-1790(91)90112-R; Laufer H., 1990, Advances in Invertebrate Reproduction, V5, P217; LAUFER H, 1987, SCIENCE, V235, P202, DOI 10.1126/science.235.4785.202; Lee SO, 2011, COMP BIOCHEM PHYS B, V159, P148, DOI 10.1016/j.cbpb.2011.03.004; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Liu F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-58; Liu K, 2006, DEV BIOL, V299, P1, DOI 10.1016/j.ydbio.2006.07.038; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Medesani DA, 2015, INVERTEBR REPROD DEV, V59, P104, DOI 10.1080/07924259.2015.1019014; Meng XL, 2014, AQUACULTURE, V434, P11, DOI 10.1016/j.aquaculture.2014.07.021; Mindnich R, 2005, J MOL ENDOCRINOL, V35, P305, DOI 10.1677/jme.1.01853; Miyakawa H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2868; Mohd-Shamsudin MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060839; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NAGABHUSHANAM R, 1981, AQUACULTURE, V23, P19, DOI 10.1016/0044-8486(81)90004-1; Nagaraju GPC, 2006, FISHERIES SCI, V72, P410, DOI 10.1111/j.1444-2906.2006.01164.x; Nagaraju GPC, 2007, AQUACULTURE, V272, P39, DOI 10.1016/j.aquaculture.2007.05.014; Nagaraju GPC, 2011, J EXP BIOL, V214, P3, DOI 10.1242/jeb.047183; Oda S, 2005, CHEMOSPHERE, V61, P1168, DOI 10.1016/j.chemosphere.2005.02.075; Olmstead AW, 2002, J EXP ZOOL, V293, P736, DOI 10.1002/jez.10162; QUINITIO ET, 1994, COMP BIOCHEM PHYS C, V109, P21, DOI 10.1016/0742-8413(94)00044-B; Ray LB, 2009, SCI SIGNAL, V2, pec231, DOI [10.1126/scisignal.278ec231, DOI 10.1126/SCISIGNAL.278EC231]; Reddy PR, 2006, AQUACULTURE, V254, P768, DOI 10.1016/j.aquaculture.2005.11.023; Rodriguez EM, 2002, J EXP ZOOL, V292, P82, DOI 10.1002/jez.1144; Rozen S, 2000, Methods Mol Biol, V132, P365; Sagi A, 1995, GEN COMP ENDOCR, V100, P308, DOI 10.1006/gcen.1995.1161; Sainath SB, 2011, AQUACULTURE, V313, P144, DOI 10.1016/j.aquaculture.2011.01.010; SAROJINI R, 1993, COMP BIOCHEM PHYS C, V106, P321, DOI 10.1016/0742-8413(93)90140-G; SAROJINI R, 1995, J EXP ZOOL, V271, P395, DOI 10.1002/jez.1402710509; SPAZIANI EP, 1993, J COMP PHYSIOL B, V163, P541, DOI 10.1007/BF00302112; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Styrishave B, 2008, J MAR BIOL ASSOC UK, V88, P575, DOI [10.1017/S0025315408000878, 10.1017/S0025315408000879]; Subramoniam T, 2011, FISHERIES SCI, V77, P1, DOI 10.1007/s12562-010-0301-z; Subramoniam T, 2000, COMP BIOCHEM PHYS C, V125, P135, DOI 10.1016/S0742-8413(99)00098-5; Sumiya E, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0060-2; Swetha CH, 2014, J EXP ZOOL PART A, V321, P531, DOI 10.1002/jez.1884; SWETHA CH, 2011, J MARINE SCI RES D S, V3, DOI DOI 10.4172/2155-9910.S3-001; Teaniniuraitemoana V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-491; Tevosian SG, 2008, DEV DYNAM, V237, P3672, DOI 10.1002/dvdy.21784; Thomas P, 2008, FRONT NEUROENDOCRIN, V29, P292, DOI 10.1016/j.yfrne.2008.01.001; Tomic D, 2004, MOL ENDOCRINOL, V18, P2224, DOI 10.1210/me.2003-0414; Toyota K, 2015, J INSECT PHYSIOL, V80, P22, DOI 10.1016/j.jinsphys.2015.02.002; Twombly V, 1996, DEVELOPMENT, V122, P1555; Uawisetwathana U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024427; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; VANBEEK E, 1988, COMP BIOCHEM PHYS A, V89, P595, DOI 10.1016/0300-9629(88)90839-0; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wimuttisuk W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076934; [吴旭干 WU Xugan], 2007, [海洋学报, Acta Oceanologica Sinica], V29, P120; Xu JJ, 2010, J INSECT PHYSIOL, V56, P1471, DOI 10.1016/j.jinsphys.2010.04.004; Yano I, 2000, RE ADV MAR BIOTECHNO, V4, P161; Ye Hai-hui, 2002, Zoological Research, V23, P141; Zapata V, 2003, AQUACULTURE, V224, P339, DOI 10.1016/S0044-8486(03)00226-6; ZHAO HF, 1991, J BIOL CHEM, V266, P583	98	57	59	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128659	10.1371/journal.pone.0128659	http://dx.doi.org/10.1371/journal.pone.0128659			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042806	Green Published, gold, Green Submitted			2022-12-27	WOS:000355701600058
J	Colston, TJ; Noonan, BP; Jackson, CR				Colston, Timothy J.; Noonan, Brice P.; Jackson, Colin R.			Phylogenetic Analysis of Bacterial Communities in Different Regions of the Gastrointestinal Tract of Agkistrodon piscivorus, the Cottonmouth Snake	PLOS ONE			English	Article							MICROBIAL COMMUNITY; GUT MICROBIOTA; HEAD SHAPE; DIVERSITY	Vertebrates are metagenomic organisms in that they are composed not only of their own genes but also those of their associated microbial cells. The majority of these associated microorganisms are found in the gastrointestinal tract (GIT) and presumably assist in processes such as energy and nutrient acquisition. Few studies have investigated the associated gut bacterial communities of non-mammalian vertebrates, and most rely on captive animals and/or fecal samples only. Here we investigate the gut bacterial community composition of a squamate reptile, the cottonmouth snake, Agkistrodon piscivorus through pyrosequencing of the bacterial 16S rRNA gene. We characterize the bacterial communities present in the small intestine, large intestine and cloaca. Many bacterial lineages present have been reported by other vertebrate gut community studies, but we also recovered unexpected bacteria that may be unique to squamate gut communities. Bacterial communities were not phylogenetically clustered according to GIT region, but there were statistically significant differences in community composition between regions. Additionally we demonstrate the utility of using cloacal swabs as a method for sampling snake gut bacterial communities.	[Colston, Timothy J.; Noonan, Brice P.; Jackson, Colin R.] Univ Mississippi, Dept Biol, University, MS 38677 USA	University of Mississippi	Colston, TJ (corresponding author), Univ Mississippi, Dept Biol, University, MS 38677 USA.	tim@maddreptiles.com			University of Mississippi Graduate College; Theodore Roosevelt Memorial Fund from the American Museum of Natural History	University of Mississippi Graduate College; Theodore Roosevelt Memorial Fund from the American Museum of Natural History	The fieldwork was supported in part by grants to TJC by the University of Mississippi Graduate College (gradschool.olemiss.edu) and the Theodore Roosevelt Memorial Fund from the American Museum of Natural History (amnh.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Clements KD, 2014, MOL ECOL, V23, P1891, DOI 10.1111/mec.12699; Costello EK, 2010, ISME J, V4, P1375, DOI 10.1038/ismej.2010.71; DeVault TL, 2002, HERPETOLOGICA, V58, P429, DOI 10.1655/0018-0831(2002)058[0429:SBSAEO]2.0.CO;2; Dill-McFarland KA, 2014, MOL ECOL, V23, P4658, DOI 10.1111/mec.12884; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Ford NB, 1997, BIOL VIPERS, V1987, P167; Guiher TJ, 2008, MOL PHYLOGENET EVOL, V48, P543, DOI 10.1016/j.ympev.2008.04.008; Hill Jacques G. III, 2008, Herpetological Review, V39, P433; Hird SM, 2014, PEERJ, V2, DOI 10.7717/peerj.321; Hong PY, 2011, ISME J, V5, P1461, DOI 10.1038/ismej.2011.33; Jackson CR, 2001, ECOLOGY, V82, P555, DOI 10.2307/2679879; Jackson CR, 2001, ENVIRON MICROBIOL, V3, P532, DOI 10.1046/j.1462-2920.2001.00221.x; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lomonte B, 2014, J PROTEOMICS, V96, P103, DOI 10.1016/j.jprot.2013.10.036; McDonald R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048018; Rambaut A, 2007, TREEANNOTATOR V 1 5; Roth ED, 2005, J HERPETOL, V39, P308, DOI 10.1670/134-04N; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sullam KE, 2012, MOL ECOL, V21, P3363, DOI 10.1111/j.1365-294X.2012.05552.x; Vincent SE, 2004, J ZOOL, V264, P53, DOI 10.1017/S0952836904005503; Vincent SE, 2004, BIOL J LINN SOC, V81, P151, DOI 10.1111/j.1095-8312.2004.00282.x; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418	26	45	49	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128793	10.1371/journal.pone.0128793	http://dx.doi.org/10.1371/journal.pone.0128793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039313	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700122
J	Jurgens, LJ; Rogers-Bennett, L; Raimondi, PT; Schiebelhut, LM; Dawson, MN; Grosberg, RK; Gaylord, B				Jurgens, Laura J.; Rogers-Bennett, Laura; Raimondi, Peter T.; Schiebelhut, Lauren M.; Dawson, Michael N.; Grosberg, Richard K.; Gaylord, Brian			Patterns of Mass Mortality among Rocky Shore Invertebrates across 100 km of Northeastern Pacific Coastline	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; PURPLE SEA-URCHIN; DIADEMA-ANTILLARUM; STRONGYLOCENTROTUS-PURPURATUS; LEPTASTERIAS-HEXACTIS; MARINE INVERTEBRATE; WASTING DISEASE; BLACK ABALONE; HYPOXIC EVENT; CALIFORNIA	Mass mortalities in natural populations, particularly those that leave few survivors over large spatial areas, may cause long-term ecological perturbations. Yet mass mortalities may remain undocumented or poorly described due to challenges in responding rapidly to unforeseen events, scarcity of baseline data, and difficulties in quantifying rare or patchily distributed species, especially in remote or marine systems. Better chronicling the geographic pattern and intensity of mass mortalities is especially critical in the face of global changes predicted to alter regional disturbance regimes. Here, we couple replicated post-mortality surveys with preceding long-term surveys and historical data to describe a rapid and severe mass mortality of rocky shore invertebrates along the north-central California coast of the northeastern Pacific Ocean. In late August 2011, formerly abundant intertidal populations of the purple sea urchin (Strongylocentrotus purpuratus, a well-known ecosystem engineer), and the predatory six-armed sea star (Leptasterias sp.) were functionally extirpated from similar to 100 km of coastline. Other invertebrates, including the gumboot chiton (Cryptochiton stelleri) the ochre sea star (Pisaster ochraceus), and subtidal populations of purple sea urchins also exhibited elevated mortality. The pattern and extent of mortality suggest the potential for long-term population, community, and ecosystem consequences, recovery from which may depend on the different dispersal abilities of the affected species.	[Jurgens, Laura J.; Gaylord, Brian] Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA; [Jurgens, Laura J.; Gaylord, Brian] Univ Calif Davis, Dept Ecol & Evolut, Bodega Bay, CA USA; [Rogers-Bennett, Laura] Univ Calif Davis, Calif Dept Fish & Wildlife, Bodega Marine Lab, Bodega Bay, CA USA; [Rogers-Bennett, Laura] Univ Calif Davis, Wildlife Hlth Ctr, Bodega Marine Lab, Bodega Bay, CA USA; [Raimondi, Peter T.] Univ Calif Santa Cruz, Dept Ecol & Evolut, Santa Cruz, CA 95064 USA; [Schiebelhut, Lauren M.; Dawson, Michael N.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Grosberg, Richard K.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Santa Cruz; University of California System; University of California Merced; University of California System; University of California Davis	Jurgens, LJ (corresponding author), Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA.	ljurgens@ucdavis.edu		Dawson, Michael/0000-0001-7927-8395; Jurgens, Laura/0000-0003-3565-455X	United States National Science Foundation (NSF) [OCE-1243958, OCE-1243970, OCE-1356966]; Monitoring Enterprise; California Ocean Sciences Trust; Partnership for Interdisciplinary Studies of Coastal Oceans (PISCO); David and Lucile Packard Foundation; California Department of Fish and Wildlife invertebrate management project; Directorate For Geosciences [1357077] Funding Source: National Science Foundation; Division Of Ocean Sciences [1243958, 1356966] Funding Source: National Science Foundation	United States National Science Foundation (NSF)(National Science Foundation (NSF)); Monitoring Enterprise; California Ocean Sciences Trust; Partnership for Interdisciplinary Studies of Coastal Oceans (PISCO); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); California Department of Fish and Wildlife invertebrate management project; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was supported by United States National Science Foundation (NSF) grants OCE-1243958, OCE-1243970, and OCE-1356966 (http://www.nsf.gov/geo/oce/programs/biores.jsp). The North Central Coast Marine Protected Area intertidal baseline monitoring surveys were supported by the Monitoring Enterprise, the California Ocean Sciences Trust (http://calost.org/), and the Partnership for Interdisciplinary Studies of Coastal Oceans (PISCO) with support from The David and Lucile Packard Foundation (http://www.packard.org/). Subtidal surveys were supported by the California Department of Fish and Wildlife invertebrate management project (http://www.dfg.ca.gov/marine/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altstatt JM, 1996, MAR ECOL PROG SER, V142, P185, DOI 10.3354/meps142185; Anthony KRN, 2007, MAR BIOL, V151, P1623, DOI 10.1007/s00227-006-0573-0; Benitez-Villalobos F, 2009, CORAL REEFS, V28, P1017, DOI 10.1007/s00338-009-0541-5; Betti F, 2012, MAR ECOL-EVOL PERSP, V33, P49, DOI [10.1111/j.1439-0485.2012.00525.x, 10.1111/j.1439-0485.2011.00456.x]; CAMERON RA, 1980, MAR ECOL PROG SER, V2, P243, DOI 10.3354/meps002243; CARLTON JT, 1991, BIOL BULL, V180, P72, DOI 10.2307/1542430; Cebrian E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020211; Cerrano C, 2006, ITAL J ZOOL, V73, P355, DOI 10.1080/11250000600911675; Cerrano C, 2009, ECOL STUD-ANAL SYNTH, V206, P295, DOI 10.1007/978-3-540-92704-4_21; Clark H. L., 1913, ECHINODERMS LOWER CA; Cottam Clarence, 1944, JOUR WILDLIFE MANAGEMENT, V8, P36, DOI 10.2307/3796194; Dawson MN, 2014, ECOL MONOGR, V84, P435, DOI 10.1890/13-0871.1; Dawson MN, 2014, FRONT BIOGEOGR, V6, P11; Dayton P.K., 1990, Elsevier Oceanography Series, V52, P433; De Wit P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4652; DENNY MW, 1989, AM NAT, V134, P859, DOI 10.1086/285018; Diaz RJ, 2001, J ENVIRON QUAL, V30, P275, DOI 10.2134/jeq2001.302275x; DUGGINS DO, 1981, LIMNOL OCEANOGR, V26, P391, DOI 10.4319/lo.1981.26.2.0391; DUNGAN ML, 1982, SCIENCE, V216, P989, DOI 10.1126/science.216.4549.989; Dupont JM, 2010, MAR ECOL PROG SER, V415, P189, DOI 10.3354/meps08739; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; EBELING AW, 1985, MAR BIOL, V84, P287, DOI 10.1007/BF00392498; EBERT TA, 1988, LIMNOL OCEANOGR, V33, P286, DOI 10.4319/lo.1988.33.2.0286; Ebert TA, 2010, MAR ECOL PROG SER, V406, P105, DOI 10.3354/meps08547; Eernisse DJ, 2010, ZOOTAXA, P22, DOI 10.11646/zootaxa.2329.1.2; Fewkes J. W., 1890, AM NAT, V24, P1; Fey SB, 2015, P NATL ACAD SCI USA, V112, P1083, DOI 10.1073/pnas.1414894112; Flowers JM, 2001, MAR BIOL, V139, P475, DOI 10.1007/s002270100595; Foltz DW, 2008, MAR BIOL, V154, P593, DOI 10.1007/s00227-008-0952-9; Foltz DW, 1997, EVOLUTION, V51, P283, DOI 10.1111/j.1558-5646.1997.tb02410.x; Forsterra G, 2014, B MAR SCI, V90, P895, DOI 10.5343/bms.2013.1064; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Gaylord B, 1999, J EXP MAR BIOL ECOL, V239, P85, DOI 10.1016/S0022-0981(99)00031-3; Gaylord B, 2000, LIMNOL OCEANOGR, V45, P174, DOI 10.4319/lo.2000.45.1.0174; Gaylord B, 2013, P NATL ACAD SCI USA, V110, P6901, DOI 10.1073/pnas.1220680110; Girard D, 2012, MAR ECOL-EVOL PERSP, V33, P377, DOI 10.1111/j.1439-0485.2011.00491.x; Gobler CJ, 2012, HARMFUL ALGAE, V14, P36, DOI 10.1016/j.hal.2011.10.013; GONOR J J, 1972, Journal of Experimental Marine Biology and Ecology, V10, P89; Gotshall DW, 1971, 734 CAL DEP FISH GAM; Gravem SA, 2015, THESIS U CALIFORNIA; Grupe B.M., 2006, THESIS U OREGON EUGE; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Hallegraeff GM, 2010, J PHYCOL, V46, P220, DOI 10.1111/j.1529-8817.2010.00815.x; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Harger BW, 1983, EFFECTS WASTE DISPOS, P70; Harley CDG, 2008, MAR ECOL PROG SER, V371, P37, DOI 10.3354/meps07711; HARROLD C, 1985, ECOLOGY, V66, P1160, DOI 10.2307/1939168; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hendler Gordon, 2013, Bulletin Southern California Academy of Sciences, V112, P19; Hernandez-Miranda E, 2012, REV BIOL MAR OCEANOG, V47, P475, DOI 10.4067/S0718-19572012000300010; Hernandez-Miranda E, 2012, MAR ENVIRON RES, V79, P16, DOI 10.1016/j.marenvres.2012.04.004; Hewson I, 2014, P NATL ACAD SCI USA, V111, P17278, DOI 10.1073/pnas.1416625111; Howard MDA, 2009, APPL ENVIRON MICROB, V75, P54, DOI 10.1128/AEM.00818-08; Huete-Stauffer C, 2011, MAR ECOL-EVOL PERSP, V32, P107, DOI 10.1111/j.1439-0485.2011.00429.x; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; HUYER A, 1983, PROG OCEANOGR, V12, P259, DOI 10.1016/0079-6611(83)90010-1; JONES GM, 1985, J PARASITOL, V71, P559, DOI 10.2307/3281424; Kalvass P, 1989, 913 CAL DEP FISH GAM, P91; KARLSON RH, 1990, OECOLOGIA, V82, P40, DOI 10.1007/BF00318531; Kemp DW, 2011, GLOBAL CHANGE BIOL, V17, P3468, DOI 10.1111/j.1365-2486.2011.02487.x; Knowlton N, 2004, PROG OCEANOGR, V60, P387, DOI 10.1016/j.pocean.2004.02.011; Kudela RM, 2010, PROG OCEANOGR, V85, P122, DOI 10.1016/j.pocean.2010.02.008; Landsberg JH, 2002, REV FISH SCI, V10, P113, DOI 10.1080/20026491051695; LARGIER JL, 1993, J GEOPHYS RES-OCEANS, V98, P18147, DOI 10.1029/93JC01074; Leighton D. L., 1971, Beih Nova Hedwigia, VNo. 32, P421; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; LESSIOS HA, 1995, P ROY SOC B-BIOL SCI, V259, P331, DOI 10.1098/rspb.1995.0049; Lester SE, 2007, ECOLOGY, V88, P2229, DOI 10.1890/06-1784.1; LEVITAN DR, 1991, BIOL BULL-US, V181, P261, DOI 10.2307/1542097; Lewitus AJ, 2012, HARMFUL ALGAE, V19, P133, DOI 10.1016/j.hal.2012.06.009; Lord JP, 2011, J MOLLUS STUD, V77, P182, DOI 10.1093/mollus/eyr004; Mah CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035644; Mangel M, 2005, PHILOS T R SOC B, V360, P95, DOI 10.1098/rstb.2004.1571; MEAD KS, 1995, BIOL BULL-US, V188, P46, DOI 10.2307/1542066; MENGE BA, 1975, MAR BIOL, V31, P87, DOI 10.1007/BF00390651; MENGE BA, 1994, ECOL MONOGR, V64, P249, DOI 10.2307/2937163; MENGE JL, 1974, ECOL MONOGR, V44, P189, DOI 10.2307/1942311; Micheli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040832; MILLER RJ, 1983, MAR BIOL, V73, P263, DOI 10.1007/BF00392252; PAINE RT, 1969, LIMNOL OCEANOGR, V14, P710, DOI 10.4319/lo.1969.14.5.0710; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PAINE RT, 1974, OECOLOGIA, V15, P93, DOI 10.1007/BF00345739; Paine RT, 2002, SCIENCE, V296, P736, DOI 10.1126/science.1069811; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; PEARSE JS, 1986, J EXP ZOOL, V237, P107, DOI 10.1002/jez.1402370115; PEARSE JS, 1979, MAR BIOL, V51, P83, DOI 10.1007/BF00389034; PENNINGTON JT, 1985, BIOL BULL-US, V169, P417, DOI 10.2307/1541492; PHILLIPS DW, 1981, MAR BIOL, V64, P95, DOI 10.1007/BF00394085; Raimondi PT, 2002, MAR ECOL PROG SER, V242, P143, DOI 10.3354/meps242143; Rasmussen E., 1977, Marine Science (Dekker), V4, P1; Rhodes L, 2006, HARMFUL ALGAE, V5, P148, DOI 10.1016/j.hal.2005.06.008; Ricketts E.F., 1985, PACIFIC TIDES, VFifth; Riginos C, 2011, ECOGRAPHY, V34, P566, DOI 10.1111/j.1600-0587.2010.06511.x; ROBERTSON A, 1991, J MAR BIOL ASSOC UK, V71, P569, DOI 10.1017/S0025315400053157; Rogers-Bennett L, 2013, DEV AQUAC FISH SCI, V38, P413, DOI 10.1016/B978-0-12-396491-5.00027-7; Rogers-Bennett Laura, 2012, Harmful Algae News, V46, P10; SCHEIBLING R, 1986, OECOLOGIA, V68, P186, DOI 10.1007/BF00384786; Scheibling RE, 2010, MAR ECOL PROG SER, V408, P109, DOI 10.3354/meps08579; Schimmelmann A, 1991, GLOBAL BIOGEOCHEM CY, V5, P173, DOI 10.1029/91GB00382; SHORT FT, 1986, MAR ECOL PROG SER, V29, P89, DOI 10.3354/meps029089; Stabili L, 2012, MICROB ECOL, V64, P802, DOI 10.1007/s00248-012-0068-0; Stokesbury KDE, 2007, MAR ECOL PROG SER, V349, P151, DOI 10.3354/meps07113; Stokstad E, 2014, SCIENCE, V344, P464, DOI 10.1126/science.344.6183.464; STRATHMANN R, 1978, J EXP MAR BIOL ECOL, V34, P23, DOI 10.1016/0022-0981(78)90054-0; Suchanek T. H., 1979, THESIS U WASHINGTON; Tegner M.J., 1987, Advances in Ecological Research, V17, P243, DOI 10.1016/S0065-2504(08)60247-0; TEGNER MJ, 1991, MAR ECOL PROG SER, V77, P49, DOI 10.3354/meps077049; THOMAS LA, 1985, BIOL BULL, V169, P675, DOI 10.2307/1541309; Uthicke S, 2009, ECOL MONOGR, V79, P3, DOI 10.1890/07-2136.1; WOODLEY JD, 1981, SCIENCE, V214, P749, DOI 10.1126/science.214.4522.749	112	39	39	1	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126280	10.1371/journal.pone.0126280	http://dx.doi.org/10.1371/journal.pone.0126280			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039349	Green Submitted, Green Published, gold			2022-12-27	WOS:000355700700023
J	Lindner, MD; Nakamura, RK				Lindner, Mark D.; Nakamura, Richard K.			Examining the Predictive Validity of NIH Peer Review Scores	PLOS ONE			English	Review							CITATION BIAS; GENETIC ASSOCIATIONS; STATISTICAL-ANALYSIS; PERCENTILE RANKING; PUBLICATION BIAS; INCREASING VALUE; SALARIES; REPLICATION; PROMOTION; QUALITY	The predictive validity of peer review at the National Institutes of Health (NIH) has not yet been demonstrated empirically. It might be assumed that the most efficient and expedient test of the predictive validity of NIH peer review would be an examination of the correlation between percentile scores from peer review and bibliometric indices of the publications produced from funded projects. The present study used a large dataset to examine the rationale for such a study, to determine if it would satisfy the requirements for a test of predictive validity. The results show significant restriction of range in the applications selected for funding. Furthermore, those few applications that are funded with slightly worse peer review scores are not selected at random or representative of other applications in the same range. The funding institutes also negotiate with applicants to address issues identified during peer review. Therefore, the peer review scores assigned to the submitted applications, especially for those few funded applications with slightly worse peer review scores, do not reflect the changed and improved projects that are eventually funded. In addition, citation metrics by themselves are not valid or appropriate measures of scientific impact. The use of bibliometric indices on their own to measure scientific impact would likely increase the inefficiencies and problems with replicability already largely attributed to the current over-emphasis on bibliometric indices. Therefore, retrospective analyses of the correlation between percentile scores from peer review and bibliometric indices of the publications resulting from funded grant applications are not valid tests of the predictive validity of peer review at the NIH.	[Lindner, Mark D.; Nakamura, Richard K.] NIH, Ctr Sci Review, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Lindner, MD (corresponding author), NIH, Ctr Sci Review, 6701 Rockledge Dr, Bethesda, MD 20892 USA.	Mark.Lindner@nih.gov		Lindner, Mark/0000-0002-8646-2980; Nakamura, Richard/0000-0002-7846-6017				Abbott A, 2010, NATURE, V465, P860, DOI 10.1038/465860a; Adler NJ, 2009, ACAD MANAG LEARN EDU, V8, P72, DOI 10.5465/AMLE.2009.37012181; Anderson MS, 2007, SCI ENG ETHICS, V13, P387, DOI 10.1007/s11948-007-9047-0; Arias E., 2013, NATIONAL VITAL STATI, V62; Bakker M, 2012, PERSPECT PSYCHOL SCI, V7, P543, DOI 10.1177/1745691612459060; Balogun JA, 2007, PERCEPT MOTOR SKILL, V104, P1107, DOI 10.2466/PMS.104.4.1107-1115; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Berg JM, 2014, 6 2 2014 PRODUCTIVIT; BORNSTEIN RF, 1990, J SOC BEHAV PERS, V5, P71; BROOKS TA, 1985, J AM SOC INFORM SCI, V36, P223, DOI 10.1002/asi.4630360402; Browman Howard I, 2008, ETHICS SCI ENV POLIT, V8, P1; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chapman S, 2009, AUST NZ J PSYCHIAT, V43, P277, DOI 10.1080/00048670802653372; Chapman SJ, 2014, BMJ-BRIT MED J, P349; Chatterjee SK, 2014, NAT BIOTECHNOL, V32, P52, DOI 10.1038/nbt.2785; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Collins Harry, 1992, CHANGING ORDER REPLI; COUNSELL CE, 1994, BMJ-BRIT MED J, V309, P1677, DOI 10.1136/bmj.309.6970.1677; Danthi N, 2014, CIRC RES, V114, P600, DOI 10.1161/CIRCRESAHA.114.302656; Demicheli V, 2007, COCHRANE DATABASE SY; DIAMOND AM, 1986, J HUM RESOUR, V21, P200; DICKERSIN K, 1993, ANN NY ACAD SCI, V703, P135, DOI 10.1111/j.1749-6632.1993.tb26343.x; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; Dirnagl U, 2006, J CEREBR BLOOD F MET, V26, P1465, DOI 10.1038/sj.jcbfm.9600298; Ehrlich E, 2011, EC ENGINE NIH RES EM; Fairweather JS, 2005, J HIGH EDUC, V76, P401, DOI 10.1353/jhe.2005.0027; Fanelli D., 2010, PLOS ONE, V5; Fanelli D, 2012, SCIENTOMETRICS, V90, P891, DOI 10.1007/s11192-011-0494-7; Franzoni C, 2011, SCIENCE, V333, P702, DOI 10.1126/science.1197286; Gallo SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106474; GARFIELD E, 1979, SCIENTOMETRICS, V1, P359, DOI 10.1007/BF02019306; GILBERT GN, 1977, SOC STUD SCI, V7, P113; GOTZSCHE PC, 1987, BRIT MED J, V295, P654, DOI 10.1136/bmj.295.6599.654; Graber M, 2008, GER ECON REV, V9, P457, DOI 10.1111/j.1468-0475.2008.00449.x; Greenberg SA, 2009, BMJ-BRIT MED J, V339, P210; HAMERMESH DS, 1982, SOUTHERN ECON J, V49, P472, DOI 10.2307/1058497; Hartwig F., 1979, EXPLORATORY DATA ANA; Hoaglin D.C., 1983, UNDERSTANDING ROBUST; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Ioannidis JPA, 2005, LANCET, V365, P454, DOI 10.1016/S0140-6736(05)17878-7; Jannot AS, 2013, J CLIN EPIDEMIOL, V66, P296, DOI 10.1016/j.jclinepi.2012.09.015; Johnson VE, 2008, P NATL ACAD SCI USA, V105, P11076, DOI 10.1073/pnas.0804538105; Kaltman JR, 2014, CIRC RES, V115, P617, DOI 10.1161/CIRCRESAHA.115.304766; Kaplan D, 2007, FASEB J, V21, P305, DOI 10.1096/fj.07-0204ufm; KATZ DA, 1973, AM ECON REV, V63, P469; Kerr N L, 1998, Pers Soc Psychol Rev, V2, P196, DOI 10.1207/s15327957pspr0203_4; Kirschner M, 2013, SCIENCE, V340, P1265, DOI 10.1126/science.1240456; Kjaergard LL, 2002, J CLIN EPIDEMIOL, V55, P407, DOI 10.1016/S0895-4356(01)00513-3; Lawrence P.A., 2008, ETHICS SCI ENV POLIT, V8, P9, DOI [10.3354/esep00079, DOI 10.3354/ESEP00079]; Lawrence PA, 2003, NATURE, V422, P259, DOI 10.1038/422259a; Lindner MD, 2007, PHARMACOL THERAPEUT, V115, P148, DOI 10.1016/j.pharmthera.2007.05.002; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Macdonald S, 2007, J INF SCI, V33, P702, DOI 10.1177/0165551507077419; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; Mahoney M., 2004, SCI SUBJECT PSYCHOL; Mahoney M.J., 1977, COGNITIVE THER RES, V6, P229, DOI [10.1007/BF01186796, DOI 10.1007/BF01186796]; Mahoney M.J., 1977, COGNITIVE THER RES, V1, P161, DOI [10.1007/BF01173636, DOI 10.1007/BF01173636]; Mahoney MJ, 2004, SCI SUBJECT PSYCHOL, P187; Makomva K, 2008, YOUR OWN BACKYARD NI; Mandel Richard, 1996, HALF CENTURY PEER RE; Manton KG, 2006, P NATL ACAD SCI USA, V103, P18374, DOI 10.1073/pnas.0608483103; Martinson BC, 2005, NATURE, V435, P737, DOI 10.1038/435737a; McMillan GS, 2000, RES POLICY, V29, P1, DOI 10.1016/s0048-7333(99)00030-x; Mitroff Ian I., 1974, SUBJECTIVE SIDE SCI; Moore WJ, 1998, J LABOR ECON, V16, P352, DOI 10.1086/209892; Moore WJ, 2001, ECON INQ, V39, P663, DOI 10.1093/ei/39.4.663; Munafo MR, 2009, MOL PSYCHIATR, V14, P119, DOI 10.1038/mp.2008.77; Narin F, 1997, RES POLICY, V26, P317, DOI 10.1016/S0048-7333(97)00013-9; National Academy of Sciences, 2007, NAT AC ENG I MED RIS; Nicholson JM, 2012, NATURE, V492, P34, DOI 10.1038/492034a; Nunnally J., 1978, PSYCHOMETRIC THEORY; O'Keefe S, 2013, SOC SCI J, V50, P45, DOI 10.1016/j.soscij.2012.09.008; Pilcher ES, 2009, J DENT EDUC, V73, P375; Pocock SJ, 1997, CONTROL CLIN TRIALS, V18, P530, DOI 10.1016/S0197-2456(97)00008-1; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Reinstein A, 2011, ISS ACCOUNT EDUC, V26, P99, DOI 10.2308/iace.2011.26.1.99; Renkewitz F, 2011, JUDGM DECIS MAK, V6, P870; Robinson KA, 2011, ANN INTERN MED, V154, P50, DOI 10.7326/0003-4819-154-1-201101040-00007; SALTHOUSE TA, 1978, J HIGH EDUC, V49, P176; Scheiner SM, 2013, FRONT ECOL ENVIRON, V11, P406, DOI 10.1890/13.WB.017; Schrag M, 2011, PROG NEUROBIOL, V94, P296, DOI 10.1016/j.pneurobio.2011.05.001; Seipel MMO, 2003, J SOC WORK EDUC, V39, P79, DOI 10.1080/10437797.2003.10779120; Shao JF, 2011, LEARN PUBL, V24, P95, DOI 10.1087/20110203; SHELDON PJ, 1990, ANN TOURISM RES, V17, P556, DOI 10.1016/0160-7383(90)90027-O; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Stevens AJ, 2011, NEW ENGL J MED, V364, P535, DOI 10.1056/NEJMsa1008268; Steward O, 2012, EXP NEUROL, V233, P597, DOI 10.1016/j.expneurol.2011.06.017; Street D. L., 1994, J ACCOUNTING ED, V12, P121, DOI [10.1016/0748-5751(94)90012-4, DOI 10.1016/0748-5751(94)90012-4]; Su JW, 2008, CRIT CARE MED, V36, P1059, DOI 10.1097/CCM.0B013E318164403B; Tatsioni A, 2010, FASEB J, V24, P1335, DOI 10.1096/fj.09-148239; Thorndike Robert L., 1949, PERSONNEL SELECTION; Trikalinos TA, 2004, EUR J HUM GENET, V12, P762, DOI 10.1038/sj.ejhg.5201227; Tripp S, 2011, EC IMPACT HUMAN GENN; van Dalen HP, 2012, J AM SOC INF SCI TEC, V63, P1282, DOI 10.1002/asi.22636; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; Vineis P, 2009, JNCI-J NATL CANCER I, V101, P24, DOI 10.1093/jnci/djn437; Youn TIK, 2009, J HIGH EDUC, V80, P204, DOI 10.1080/00221546.2009.11772139; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201; Zinner DE, 2001, HEALTH AFFAIR, V20, P202, DOI 10.1377/hlthaff.20.5.202	108	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126938	10.1371/journal.pone.0126938	http://dx.doi.org/10.1371/journal.pone.0126938			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7ST	26039440	Green Published, gold			2022-12-27	WOS:000355700700045
J	Pujol-Autonell, I; Serracant-Prat, A; Cano-Sarabia, M; Ampudia, RM; Rodriguez-Fernandez, S; Sanchez, A; Izquierdo, C; Stratmann, T; Puig-Domingo, M; Maspoch, D; Verdaguer, J; Vives-Pi, M				Pujol-Autonell, Irma; Serracant-Prat, Arnau; Cano-Sarabia, Mary; Ampudia, Rosa M.; Rodriguez-Fernandez, Silvia; Sanchez, Alex; Izquierdo, Cristina; Stratmann, Thomas; Puig-Domingo, Manuel; Maspoch, Daniel; Verdaguer, Joan; Vives-Pi, Marta			Use of Autoantigen-Loaded Phosphatidylserine-Liposomes to Arrest Autoimmunity in Type 1 Diabetes	PLOS ONE			English	Article							APOPTOTIC CELLS; DENDRITIC CELLS; IN-VIVO; PROSTAGLANDIN-E; NOD MICE; ANTIGEN; BETA; TOLERANCE; INFLAMMATION; ACTIVATION	Introduction The development of new therapies to induce self-tolerance has been an important medical health challenge in type 1 diabetes. An ideal immunotherapy should inhibit the autoimmune attack, avoid systemic side effects and allow a-cell regeneration. Based on the immunomodulatory effects of apoptosis, we hypothesized that apoptotic mimicry can help to restore tolerance lost in autoimmune diabetes. Objective To generate a synthetic antigen-specific immunotherapy based on apoptosis features to specifically reestablish tolerance to a-cells in type 1 diabetes. Methods A central event on the surface of apoptotic cells is the exposure of phosphatidylserine, which provides the main signal for efferocytosis. Therefore, phosphatidylserine-liposomes loaded with insulin peptides were generated to simulate apoptotic cells recognition by antigen presenting cells. The effect of antigen-specific phosphatidylserine-liposomes in the reestablishment of peripheral tolerance was assessed in NOD mice, the spontaneous model of autoimmune diabetes. MHC class II-peptide tetramers were used to analyze the T cell specific response after treatment with phosphatidylserine-liposomes loaded with peptides. Results We have shown that phosphatidylserine-liposomes loaded with insulin peptides induce tolerogenic dendritic cells and impair autoreactive T cell proliferation. When administered to NOD mice, liposome signal was detected in the pancreas and draining lymph nodes. This immunotherapy arrests the autoimmune aggression, reduces the severity of insulitis and prevents type 1 diabetes by apoptotic mimicry. MHC class II tetramer analysis showed that peptide-loaded phosphatidylserine-liposomes expand antigen-specific CD4+ T cells in vivo. The administration of phosphatidylserine-free liposomes emphasizes the importance of phosphatidylserine in the modulation of antigen-specific CD4+ T cell expansion. Conclusions We conclude that this innovative immunotherapy based on the use of liposomes constitutes a promising strategy for autoimmune diseases.	[Pujol-Autonell, Irma; Serracant-Prat, Arnau; Ampudia, Rosa M.; Rodriguez-Fernandez, Silvia; Vives-Pi, Marta] Autonomous Univ Barcelona, Dept Immunol, Germans Trias & Pujol Res Inst, Badalona, Spain; [Cano-Sarabia, Mary; Maspoch, Daniel] Catalan Inst Nanosci & Nanotechnol, Bellaterra, Spain; [Sanchez, Alex] Univ Barcelona, Fac Biol, Dept Stat, Barcelona, Spain; [Izquierdo, Cristina; Stratmann, Thomas] Univ Barcelona, Fac Biol, Dept Physiol & Immunol, Barcelona, Spain; [Puig-Domingo, Manuel] Hosp Badalona Germans Trias & Pujol, Endocrinol & Nutr Serv, Badalona, Spain; [Maspoch, Daniel] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Verdaguer, Joan] Univ Lleida, Immunol Unit, Dept Expt Med, Lleida, Spain; [Verdaguer, Joan] IRBLleida, Lleida, Spain	Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Catalan Institute of Nanoscience & Nanotechnology (ICN2); University of Barcelona; University of Barcelona; Hospital Germans Trias i Pujol; ICREA; Universitat de Lleida	Vives-Pi, M (corresponding author), Autonomous Univ Barcelona, Dept Immunol, Germans Trias & Pujol Res Inst, Badalona, Spain.	mvives@igtp.cat	Maspoch, Daniel/AAF-3727-2022; Maspoch, Daniel/AFI-3557-2022; Autonell, Joan Verdaguer/A-2059-2010; Maspoch, Daniel/O-9266-2015; Puig-Domingo, Manel/S-2169-2019; Sánchez-Pla, Alex/H-8310-2015; Vives-Pi, Marta/AAM-8158-2020; Cano-Sarabia, Mary/A-1648-2015	Autonell, Joan Verdaguer/0000-0003-1768-9310; Maspoch, Daniel/0000-0003-1325-9161; Puig-Domingo, Manel/0000-0002-6744-7195; Sánchez-Pla, Alex/0000-0002-8673-7737; Vives-Pi, Marta/0000-0003-3735-0779; Stratmann, Thomas/0000-0001-6196-1487; Cano-Sarabia, Mary/0000-0003-4254-8157; Rodriguez-Fernandez, Silvia/0000-0001-8429-4293	Spanish Government [FIS PI12/00195]; AGAUR, Generalitat de Catalunya; Health Dept. of the Catalan Government, Generalitat de Catalunya; ICREA Funding Source: Custom	Spanish Government(Spanish GovernmentEuropean Commission); AGAUR, Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Health Dept. of the Catalan Government, Generalitat de Catalunya(Generalitat de Catalunya); ICREA(ICREA)	This work was supported by a grant from Spanish Government (FIS PI12/00195). IPA was supported by AGAUR, Generalitat de Catalunya. MVP and RA are supported by the Health Dept. of the Catalan Government, Generalitat de Catalunya. Special thanks to Ms. M.A. Cardus and her family for their generous donation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba A, 2004, J IMMUNOL, V173, P6667, DOI 10.4049/jimmunol.173.11.6667; ALLEN TM, 1993, BIOCHIM BIOPHYS ACTA, V1150, P9, DOI 10.1016/0005-2736(93)90115-G; Arif S, 2011, DIABETES, V60, P2112, DOI 10.2337/db10-1643; Biermann M, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/6/065007; Blacher NE, 2005, PLOS BIOL, V3, P1070, DOI 10.1371/journal.pbio.0030185; BUITING AMJ, 1993, IMMUNOBIOLOGY, V188, P13, DOI 10.1016/S0171-2985(11)80483-3; Carrero JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059701; Chen X, 2004, J IMMUNOL, V173, P2985, DOI 10.4049/jimmunol.173.5.2985; Clemente-Casares X, 2014, IMMUNOL LETT, V158, P167, DOI 10.1016/j.imlet.2013.12.018; Corper AL, 2000, SCIENCE, V288, P505, DOI 10.1126/science.288.5465.505; Creusot RJ, 2009, BLOOD, V113, P6638, DOI 10.1182/blood-2009-02-204321; Daniel D, 1996, P NATL ACAD SCI USA, V93, P956, DOI 10.1073/pnas.93.2.956; Diana J, 2013, NAT MED, V19, P65, DOI 10.1038/nm.3042; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Endruschat J, 2000, INT J PHARM, V196, P151, DOI 10.1016/S0378-5173(99)00410-X; Fadok VA, 2001, J CLIN INVEST, V108, P957, DOI 10.1172/JCI14122; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fenske DB, 2008, EXPERT OPIN DRUG DEL, V5, P25, DOI 10.1517/17425247.5.1.25; Foged C, 2004, VACCINE, V22, P1903, DOI 10.1016/j.vaccine.2003.11.008; Hall BM, 2011, CURR OPIN IMMUNOL, V23, P641, DOI 10.1016/j.coi.2011.07.012; HANCOCK WW, 1995, AM J PATHOL, V147, P1193; Harel-Adar T, 2011, P NATL ACAD SCI USA, V108, P1827, DOI 10.1073/pnas.1015623108; HASKINS K, 1988, DIABETES, V37, P1444, DOI 10.2337/diabetes.37.10.1444; Hillaireau H, 2009, CELL MOL LIFE SCI, V66, P2873, DOI 10.1007/s00018-009-0053-z; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; LATIF N, 1984, J BIOSCIENCES, V6, P491, DOI 10.1007/BF02703901; Lutsiak MEC, 2002, J PHARM PHARM SCI, V5, P288; Marin-Gallen S, 2010, CLIN EXP IMMUNOL, V160, P207, DOI 10.1111/j.1365-2249.2009.04082.x; Martin DSD, 2009, NEUROIMMUNOMODULAT, V16, P400, DOI 10.1159/000228915; Mitragotri S, 2011, ARCH PHARM RES, V34, P1887, DOI 10.1007/s12272-011-1109-9; MUELLER C, 1987, THYMUS, V9, P3; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; O'Brien BA, 2006, J AUTOIMMUN, V26, P104, DOI 10.1016/j.jaut.2005.11.006; Panus JF, 2000, J EXP MED, V192, P1301, DOI 10.1084/jem.192.9.1301; Presa M, 2013, EUR J IMMUNOL, V43, P2969, DOI 10.1002/eji.201343633; Pugliese A, 2004, IMMUNOLOGY, V111, P138, DOI 10.1111/j.0019-2805.2003.01804.x; Pujol-Autonell I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063296; Ramos GC, 2007, BRIT J PHARMACOL, V151, P844, DOI 10.1038/sj.bjp.0707302; Roep BO, 2004, NAT REV IMMUNOL, V4, P989, DOI 10.1038/nri1502; Shi DM, 2007, ARCH DERMATOL RES, V299, P327, DOI 10.1007/s00403-007-0770-9; Smith DM, 2013, NAT REV IMMUNOL, V13, P592, DOI 10.1038/nri3488; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Stratmann T, 2000, J IMMUNOL, V165, P3214, DOI 10.4049/jimmunol.165.6.3214; Stratmann T, 2003, J CLIN INVEST, V112, P902, DOI 10.1172/JCI200318337; Thebault-Baumont K, 2003, J CLIN INVEST, V111, P851, DOI 10.1172/JCI200316584; Tsai S, 2011, CELL MOL LIFE SCI, V68, P3781, DOI 10.1007/s00018-011-0738-y; Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015; Ulrich AS, 2002, BIOSCIENCE REP, V22, P129, DOI 10.1023/A:1020178304031; Verginis P, 2005, J IMMUNOL, V174, P7433, DOI 10.4049/jimmunol.174.11.7433; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Wu Z, 2010, J IMMUNOL, V184, P3191, DOI 10.4049/jimmunol.0803609; Yoshida K, 2002, INT IMMUNOL, V14, P1439, DOI 10.1093/intimm/dxf106; Zhang J, 2006, J NEUROIMMUNOL, V172, P112, DOI 10.1016/j.jneuroim.2005.11.008; ZHANG ZJ, 1991, P NATL ACAD SCI USA, V88, P10252, DOI 10.1073/pnas.88.22.10252	56	53	53	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127057	10.1371/journal.pone.0127057	http://dx.doi.org/10.1371/journal.pone.0127057			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039878	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700049
J	Tejera-Alhambra, M; Casrouge, A; de Andres, C; Seyfferth, A; Ramos-Medina, R; Alonso, B; Vega, J; Fernandez-Paredes, L; Albert, ML; Sanchez-Ramon, S				Tejera-Alhambra, Marta; Casrouge, Armanda; de Andres, Clara; Seyfferth, Ansgar; Ramos-Medina, Rocio; Alonso, Barbara; Vega, Janet; Fernandez-Paredes, Lidia; Albert, Matthew L.; Sanchez-Ramon, Silvia			Plasma Biomarkers Discriminate Clinical Forms of Multiple Sclerosis	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; CHEMOKINE RECEPTOR EXPRESSION; APPEARING WHITE-MATTER; FACTOR-SCATTER FACTOR; CEREBROSPINAL-FLUID; T-CELLS; C-MET; BETA-CHEMOKINES; UP-REGULATION	Multiple sclerosis, the most common cause of neurological disability in young population after trauma, represents a significant public health burden. Current challenges associated with management of multiple sclerosis (MS) patients stem from the lack of biomarkers that might enable stratification of the different clinical forms of MS and thus prompt treatment for those patients with progressive MS, for whom there is currently no therapy available. In the present work we analyzed a set of thirty different plasma cytokines, chemokines and growth factors present in circulation of 129 MS patients with different clinical forms (relapsing remitting, secondary progressive and primary progressive MS) and 53 healthy controls, across two independent cohorts. The set of plasma analytes was quantified with Luminex xMAP technology and their predictive power regarding clinical outcome was evaluated both individually using ROC curves and in combination using logistic regression analysis. Our results from two independent cohorts of MS patients demonstrate that the divergent clinical and histology-based MS forms are associated with distinct profiles of circulating plasma protein biomarkers, with distinct signatures being composed of chemokines and growth/angiogenic factors. With this work, we propose that an evaluation of a set of 4 circulating biomarkers (HGF, Eotaxin/CCL11, EGF and MIP-1 beta/CCL4) in MS patients might serve as an effective tool in the diagnosis and more personalized therapeutic targeting of MS patients.	[Tejera-Alhambra, Marta; Ramos-Medina, Rocio; Alonso, Barbara; Sanchez-Ramon, Silvia] Hosp Gen Univ Gregorio Maranon, Dept Immunol, Madrid, Spain; [Casrouge, Armanda; Albert, Matthew L.] Inst Pasteur, Dept Immunol, Ctr Human Immunol, F-75724 Paris, France; [Casrouge, Armanda; Albert, Matthew L.] Inst Pasteur, Dept Immunol, INSERM U818, F-75724 Paris, France; [de Andres, Clara] Hosp Gen Univ Gregorio Maranon, Dept Neurol, Madrid, Spain; [Seyfferth, Ansgar] STAT UP Stat Consulting & Serv, Madrid, Spain; [Vega, Janet] Ctr Alicia Koplowitz Multiple Sclerosis Community, Madrid, Spain; [Fernandez-Paredes, Lidia] Hosp Clin San Carlos, Dept Clin Immunol, Madrid, Spain	General University Gregorio Maranon Hospital; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; General University Gregorio Maranon Hospital; Hospital Clinico San Carlos	Sanchez-Ramon, S (corresponding author), Hosp Clin San Carlos, Dept Clin Immunol, Madrid, Spain.	ssramon@salud.madrid.org	Albert, Matthew L/C-9782-2009; Sanchez-Ramon, Silvia/AAZ-7670-2020; Sanchez-Ramon, Silvia/I-8242-2019	Sanchez-Ramon, Silvia/0000-0001-9585-6167; Sanchez-Ramon, Silvia/0000-0001-9585-6167; Fernandez Paredes, Lidia/0000-0002-6302-6908; CASROUGE, Armanda/0000-0002-7356-0901; Ramos-Medina, Rocio/0000-0001-6059-4152; Sanchez, Silvia/0000-0002-6405-1443	Fundacion Mapfre; Fundacion Salud; Fondo de Investigacion Sanitaria (FIS) [12/2759]; European Research Council Starting Award; EFIS grant	Fundacion Mapfre; Fundacion Salud; Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); European Research Council Starting Award; EFIS grant	This study was funded by Fundacion Mapfre (http://www.fundacionmapfre.org), Fundacion Salud 2000 (http://www.fundacionsalud2000.com), Fondo de Investigacion Sanitaria (FIS#12/2759), and the European Research Council Starting Award (http://erc.europa.eu). Marta Tejera-Alhambra received an EFIS grant in 2011 for her stay at Institut Pasteur in Paris. Ansgar Seyfferth is an independent statistical consultant for STAT-UP Statistical Consulting & Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achim CL, 1997, DEV BRAIN RES, V102, P299, DOI 10.1016/S0165-3806(97)00108-9; ADAMS DH, 1994, P NATL ACAD SCI USA, V91, P7144, DOI 10.1073/pnas.91.15.7144; Adzemovic MZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039794; Amano H, 2004, J IMMUNOL, V172, P398, DOI 10.4049/jimmunol.172.1.398; Baek JH, 2012, J IMMUNOL, V189, P1699, DOI 10.4049/jimmunol.1200729; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Balashov KE, 1997, P NATL ACAD SCI USA, V94, P599, DOI 10.1073/pnas.94.2.599; Balashov KE, 1999, P NATL ACAD SCI USA, V96, P6873, DOI 10.1073/pnas.96.12.6873; Banisor I, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-7; Bartosik-Psujek H, 2005, J NEURAL TRANSM, V112, P797, DOI 10.1007/s00702-004-0225-9; Bartosik-Psujek H, 2004, EUR NEUROL, V52, P237, DOI 10.1159/000082164; Bartosik-Psujek H, 2005, EUR J NEUROL, V12, P49, DOI 10.1111/j.1468-1331.2004.00951.x; Bettelli Estelle, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P389; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Bugeja MJ, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-64; Butt AM, 2005, EXP NEUROL, V192, P125, DOI 10.1016/j.expneurol.2004.11.007; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmody RJ, 2002, J NEUROIMMUNOL, V133, P95, DOI 10.1016/S0165-5728(02)00366-1; Cepok S, 2009, ARCH NEUROL-CHICAGO, V66, P1216, DOI 10.1001/archneurol.2009.138; Clemente D, 2011, J NEUROSCI, V31, P14899, DOI 10.1523/JNEUROSCI.1158-11.2011; Comini-Frota ER, 2011, CNS DRUGS, V25, P971, DOI 10.2165/11595060-000000000-00000; Compston A, 1997, J ANAT, V190, P161, DOI 10.1046/j.1469-7580.1997.19020161.x; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Croll SD, 2004, EXP NEUROL, V187, P388, DOI 10.1016/j.expneurol.2004.02.010; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; Fassbender K, 1998, NEUROLOGY, V51, P753, DOI 10.1212/WNL.51.3.753; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; Barco DG, 2011, RESTOR NEUROL NEUROS, V29, P243, DOI 10.3233/RNN-2011-0595; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Glabinski AR, 2003, SCAND J IMMUNOL, V58, P81, DOI 10.1046/j.1365-3083.2003.01285.x; Goddard DR, 2001, MOL CELL NEUROSCI, V18, P557, DOI 10.1006/mcne.2001.1025; Godessart N, 2001, CURR OPIN IMMUNOL, V13, P670, DOI 10.1016/S0952-7915(01)00277-1; GODISKA R, 1995, J NEUROIMMUNOL, V58, P167, DOI 10.1016/0165-5728(95)00008-P; Gonzalez-Perez O, 2009, STEM CELLS, V27, P2032, DOI 10.1002/stem.119; Graumann U, 2003, BRAIN PATHOL, V13, P554, DOI 10.1111/j.1750-3639.2003.tb00485.x; HIEHLE JF, 1994, MAGNET RESON MED, V32, P285, DOI 10.1002/mrm.1910320303; HONDA S, 1995, MOL BRAIN RES, V32, P197, DOI 10.1016/0169-328X(95)00075-4; HULKOWER K, 1993, J IMMUNOL, V150, P2525; Iacobaeus E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019138; Iarlori C, 2002, J NEUROIMMUNOL, V123, P170, DOI 10.1016/S0165-5728(01)00487-8; Ibrahim SM, 2001, BRAIN, V124, P1927, DOI 10.1093/brain/124.10.1927; Jeong SR, 2012, EXP NEUROL, V233, P312, DOI 10.1016/j.expneurol.2011.10.021; JUNG W, 1994, J CELL BIOL, V126, P485, DOI 10.1083/jcb.126.2.485; Kern MA, 2001, CYTOKINE, V14, P170, DOI 10.1006/cyto.2001.0875; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Kurz SM, 2002, EUR J IMMUNOL, V32, P1832, DOI 10.1002/1521-4141(200207)32:7<1832::AID-IMMU1832>3.0.CO;2-2; Lalive PH, 2005, EUR J IMMUNOL, V35, P727, DOI 10.1002/eji.200425430; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Magy L, 2003, EXP NEUROL, V184, P912, DOI 10.1016/j.expneurol.2003.08.019; Malmestrom C, 2006, J NEUROIMMUNOL, V175, P176, DOI 10.1016/j.jneuroim.2006.03.004; Misu T, 2001, J NEUROIMMUNOL, V114, P207, DOI 10.1016/S0165-5728(00)00456-2; Muller AM, 2012, J NEUROIMMUNOL, V251, P80, DOI 10.1016/j.jneuroim.2012.06.008; Narikawa K, 2004, J NEUROIMMUNOL, V149, P182, DOI 10.1016/j.jneuroim.2003.12.010; NORONHA A, 1993, J NEUROIMMUNOL, V46, P145, DOI 10.1016/0165-5728(93)90244-S; Ockinger J, 2010, GENES IMMUN, V11, P142, DOI 10.1038/gene.2009.82; OWENS T, 1995, NEUROL CLIN, V13, P51, DOI 10.1016/S0733-8619(18)30061-6; PARK M, 1986, CELL, V45, P895, DOI 10.1016/0092-8674(86)90564-7; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Proescholdt MA, 2002, J NEUROPATH EXP NEUR, V61, P914, DOI 10.1093/jnen/61.10.914; Rajan AJ, 2000, J IMMUNOL, V164, P2120, DOI 10.4049/jimmunol.164.4.2120; Ransohoff RM, 2002, J INFECT DIS, V186, pS152, DOI 10.1086/344266; RIECKMANN P, 1994, NEUROLOGY, V44, P1523, DOI 10.1212/WNL.44.8.1523; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Rottlaender A, 2011, IMMUNOLOGY, V133, P370, DOI 10.1111/j.1365-2567.2011.03450.x; Sarchielli P, 2008, NEUROSCI LETT, V435, P223, DOI 10.1016/j.neulet.2008.02.040; Scalabrino G, 2010, BRAIN RES, V1333, P64, DOI 10.1016/j.brainres.2010.03.073; Scarpini E, 2002, J NEUROL SCI, V195, P41, DOI 10.1016/S0022-510X(01)00680-3; Sellebjerg F, 2009, EUR J NEUROL, V16, P1291, DOI 10.1111/j.1468-1331.2009.02716.x; Simpson JE, 1998, J NEUROIMMUNOL, V84, P238, DOI 10.1016/S0165-5728(97)00208-7; Sindern E, 2001, ACTA NEUROL SCAND, V104, P88, DOI 10.1034/j.1600-0404.2001.104002088.x; Skuljec J, 2011, CELL IMMUNOL, V270, P164, DOI 10.1016/j.cellimm.2011.05.001; Sorensen TL, 1999, J CLIN INVEST, V103, P807, DOI 10.1172/JCI5150; Sorensen TL, 2001, EUR J NEUROL, V8, P665, DOI 10.1046/j.1468-1331.2001.00327.x; Spuler S, 1996, J NEUROIMMUNOL, V66, P57; Su JJ, 2006, J NEUROL SCI, V243, P21, DOI 10.1016/j.jns.2005.11.006; Szczucinski A, 2007, ACTA NEUROL SCAND, V115, P137, DOI 10.1111/j.1600-0404.2006.00749.x; Tsuboi Y, 2002, ACTA NEUROL SCAND, V106, P99, DOI 10.1034/j.1600-0404.2002.01125.x; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Ubogu EE, 2006, TRENDS PHARMACOL SCI, V27, P48, DOI 10.1016/j.tips.2005.11.002; van Boxel-Dezaire AHH, 2001, J NEUROIMMUNOL, V120, P152, DOI 10.1016/S0165-5728(01)00398-8; vanderVoort R, 1997, J EXP MED, V185, P2121, DOI 10.1084/jem.185.12.2121; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Zang YCQ, 2000, BRAIN, V123, P1874, DOI 10.1093/brain/123.9.1874; Zhang YW, 2006, STEM CELLS DEV, V15, P943, DOI 10.1089/scd.2006.15.943	85	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128952	10.1371/journal.pone.0128952	http://dx.doi.org/10.1371/journal.pone.0128952			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039252	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700131
J	Wang, L; Yang, MJ; Arias, A; Song, L; Li, FQ; Tian, F; Qin, MH; Yukht, A; Williamson, IK; Shah, PK; Sharifi, BG				Wang, Lai; Yang, Mingjie; Arias, Ana; Song, Lei; Li, Fuqiang; Tian, Fang; Qin, Minghui; Yukht, Ada; Williamson, Ian K.; Shah, Prediman K.; Sharifi, Behrooz G.			Splenocytes Seed Bone Marrow of Myeloablated Mice: Implication for Atherosclerosis	PLOS ONE			English	Article							E-DEFICIENT MICE; MACROPHAGE HETEROGENEITY; MYOCARDIAL-INFARCTION; EXTRAMEDULLARY HEMATOPOIESIS; ACCELERATES ATHEROSCLEROSIS; ALTERNATIVE ACTIVATION; SPLEEN DEVELOPMENT; TRANSPLANTATION; CELLS; GENE	Extramedullary hematopoiesis has been shown to contribute to the pathogenesis of a variety of diseases including cardiovascular diseases. In this process, the spleen is seeded with mobilized bone marrow cells that augment its hematopoietic ability. It is unclear whether these immigrant cells that are produced/reprogrammed in spleen are similar or different from those found in the bone marrow. To begin to understand this, we investigated the relative potency of adult splenocytes per se to repopulate bone marrow of lethally-irradiated mice and its functional consequences in atherosclerosis. The splenocytes were harvested from GFP donor mice and transplanted into myeloablated wild type recipient mice without the inclusion of any bone marrow helper cells. We found that adult splenocytes repopulated bone marrow of myeloablated mice and the transplanted cells differentiated into a full repertoire of myeloid cell lineages. The level of monocytes/macrophages in the bone marrow of recipient mice was dependent on the cell origin, i.e., the donor splenocytes gave rise to significantly more monocytes/macrophages than the donor bone marrow cells. This occurred despite a significantly lower number of hematopoietic stem cells being present in the donor splenocytes when compared with donor bone marrow cells. Atherosclerosis studies revealed that donor splenocytes displayed a similar level of atherogenic and atheroprotective activities to those of donor bone marrow cells. Cell culture studies showed that the phenotype of macrophages derived from spleen is different from those of bone marrow. Together, these results demonstrate that splenocytes can seed bone marrow of myeloablated mice and modulate atherosclerosis. In addition, our study shows the potential of splenocytes for therapeutic interventions in inflammatory disease.	[Wang, Lai; Yang, Mingjie; Arias, Ana; Song, Lei; Li, Fuqiang; Tian, Fang; Qin, Minghui; Yukht, Ada; Williamson, Ian K.; Shah, Prediman K.; Sharifi, Behrooz G.] Cedars Sinai Heart Inst, Div Cardiol, Oppenheimer Atherosclerosis Res Ctr, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Sharifi, BG (corresponding author), Cedars Sinai Heart Inst, Div Cardiol, Oppenheimer Atherosclerosis Res Ctr, Los Angeles, CA 90048 USA.	Sharifi@cshs.org			Heart Foundation; Eisner Foundation; Spielberg Foundation; Corday Foundation; Skirball Foundation; NHLBI grant [R01 HL104068]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104068] Funding Source: NIH RePORTER	Heart Foundation; Eisner Foundation; Spielberg Foundation; Corday Foundation; Skirball Foundation; NHLBI grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors gratefully acknowledge the support of the Heart Foundation, the Eisner Foundation, the Spielberg Foundation, Corday Foundation, and the Skirball Foundation. The evolution of this approach was initially supported by a program project grant from NHLBI grant R01 HL104068.	ASAI K, 1988, ANGIOLOGY, V39, P497, DOI 10.1177/000331978803900602; BOISVERT WA, 1995, J CLIN INVEST, V96, P1118, DOI 10.1172/JCI118098; Bronte V, 2013, IMMUNITY, V39, P806, DOI 10.1016/j.immuni.2013.10.010; DEAR TN, 1995, DEVELOPMENT, V121, P2909; Dieguez-Acuna F, 2007, LEUKEMIA, V21, P2192, DOI 10.1038/sj.leu.2404927; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; ENGLEN MD, 1995, J IMMUNOL METHODS, V184, P281, DOI 10.1016/0022-1759(95)00136-X; Faustman DL, 2010, INT J BIOCHEM CELL B, V42, P1576, DOI 10.1016/j.biocel.2010.06.012; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2007, J CLIN INVEST, V117, P89, DOI 10.1172/JCI30992; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; GOULMY E, 1976, LANCET, V2, P1206; Greenfield A, 1996, NAT GENET, V14, P474, DOI 10.1038/ng1296-474; Hansson GK, 2001, ARTERIOSCL THROM VAS, V21, P1876, DOI 10.1161/hq1201.100220; Herijgers N, 1997, ARTERIOSCL THROM VAS, V17, P1995, DOI 10.1161/01.ATV.17.10.1995; Johns JL, 2012, VET PATHOL, V49, P508, DOI 10.1177/0300985811432344; JONASSON L, 1986, ARTERIOSCLEROSIS, V6, P131, DOI 10.1161/01.ATV.6.2.131; Kabelitz D, 2008, TRENDS IMMUNOL, V29, P68, DOI 10.1016/j.it.2007.11.001; Kanzler B, 2001, DEV BIOL, V234, P231, DOI 10.1006/dbio.2001.0239; Kim CH, 2010, J BLOOD MED, V1, P13, DOI 10.2147/JBM.S7224; Kodama S, 2005, CELL MOL LIFE SCI, V62, P1850, DOI 10.1007/s00018-005-5022-6; Kodama S, 2005, TRENDS MOL MED, V11, P271, DOI 10.1016/j.molmed.2005.04.004; Kodama Shohta, 2005, Sci Aging Knowledge Environ, V2005, ppe2, DOI 10.1126/sageke.2005.3.pe2; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Li FQ, 2012, J IMMUNOL METHODS, V386, P101, DOI 10.1016/j.jim.2012.08.014; LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332; Liu GW, 2006, J CELL PHYSIOL, V209, P341, DOI 10.1002/jcp.20732; Lonyai A, 2008, HORM METAB RES, V40, P137, DOI 10.1055/s-2007-1022560; Lonyai A, 2008, IMMUNOL CELL BIOL, V86, P301, DOI 10.1038/icb.2008.6; Macias MP, 2001, J CLIN INVEST, V107, P949, DOI 10.1172/JCI11232; Malliaras K, 2014, EMBO MOL MED, V6, P760, DOI 10.1002/emmm.201303626; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Prieur X, 2010, BBA-MOL CELL BIOL L, V1801, P327, DOI 10.1016/j.bbalip.2009.09.017; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Robbins CS, 2012, CIRCULATION, V125, P364, DOI 10.1161/CIRCULATIONAHA.111.061986; Robertson SA, 2008, J PEDIATR SURG, V43, P274, DOI 10.1016/j.jpedsurg.2007.10.013; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sharifi BG, 2006, ARTERIOSCL THROM VAS, V26, P1273, DOI 10.1161/01.ATV.0000222017.05085.8e; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Song L, 2010, J VASC SURG; Tran SD, 2007, ANN RHEUM DIS, V66, P812, DOI 10.1136/ard.2006.064030; Tyznik AJ, 2007, J IMMUNOL, V179, P4988, DOI 10.4049/jimmunol.179.8.4988; VanEck M, 1997, ARTERIOSCL THROM VAS, V17, P3117, DOI 10.1161/01.ATV.17.11.3117; Wang CQ, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-6; Wang L, 2012, CARDIOVASCULAR PATHO; Wang L, 2007, CIRCULATION, V116, P34; Wang L, 2006, J AM COLL CARDIOL, V48, P1459, DOI 10.1016/j.jacc.2006.07.040; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631	51	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0125961	10.1371/journal.pone.0125961	http://dx.doi.org/10.1371/journal.pone.0125961			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26038819	gold, Green Published			2022-12-27	WOS:000355700700017
J	Zhao, J; Liu, J; Xiao, JX; Du, J; Que, CL; Shi, X; Liang, W; Sun, WP; Zhang, W; Lv, H; Yuan, Y; Wang, ZX				Zhao, Juan; Liu, Jing; Xiao, Jiangxi; Du, Jing; Que, Chengli; Shi, Xin; Liang, Wei; Sun, Weiping; Zhang, Wei; Lv, He; Yuan, Yun; Wang, Zhaoxia			Clinical and Muscle Imaging Findings in 14 Mainland Chinese Patients with Oculopharyngodistal Myopathy	PLOS ONE			English	Article							MYOTONIC-DYSTROPHY TYPE-1; MUSCULAR-DYSTROPHY; DISTAL MYOPATHY; RIMMED VACUOLES; DISTINCT; FEATURES; DIAGNOSIS; ENTITY; FAMILY; ONSET	Oculopharyngodistal myopathy (OPDM) is an extremely rare, adult-onset hereditary muscular disease characterized by progressive external ocular, pharyngeal, and distal muscle weakness and myopathological rimmed vacuole changes. The causative gene is currently unknown; therefore, diagnosis of OPDM is based on clinical and histopathological features and genetic exclusion of similar conditions. Moreover, variable manifestations of this disorder are reported in terms of muscle involvement and severity. We present the clinical profile and magnetic resonance imaging (MRI) changes of lower limb muscles in 14 mainland Chinese patients with OPDM, emphasizing the role of muscle MRI in disease identification and differential diagnosis. The patients came from 10 unrelated families and presented with progressive external ocular, laryngopharyngeal, facial, distal limb muscle weakness that had been present since early adulthood. Serum creatine kinase was mildly to moderately elevated. Electromyography revealed myogenic changes with inconsistent myotonic discharge. The respiratory function test revealed subclinical respiratory muscle involvement. Myopathological findings showed rimmed vacuoles with varying degrees of muscular dystrophic changes. All known genes responsible for distal and myofibrillar myopathies, vacuolar myopathies, and muscular dystrophies were excluded by PCR or targeted next-generation sequencing. Muscle MRI revealed that the distal lower legs had more severe fatty replacement than the thigh muscles. Serious involvement of the soleus and long head of the biceps femoris was observed in all patients, whereas the popliteus, gracilis and short head of biceps femoris were almost completely spared, even in advanced stages. Not only does our study widen the spectrum of OPDM in China, but it also demonstrates that OPDM has a specific pattern of muscle involvement that may provide valuable information for its differential diagnosis and show further evidence supporting the conclusion that OPDM is a unique disease phenotype.	[Zhao, Juan; Liu, Jing; Shi, Xin; Liang, Wei; Sun, Weiping; Zhang, Wei; Lv, He; Yuan, Yun; Wang, Zhaoxia] Peking Univ, Hosp 1, Dept Neurol, Beijing 100871, Peoples R China; [Xiao, Jiangxi; Du, Jing] Peking Univ, Hosp 1, Dept Radiol, Beijing 100871, Peoples R China; [Que, Chengli] Peking Univ, Hosp 1, Dept Pneumol, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Yuan, Y (corresponding author), Peking Univ, Hosp 1, Dept Neurol, Beijing 100871, Peoples R China.	yuanyun2002@sohu.com; drwangzx@163.com			Ministry of Science and Technology of China [2011ZX09307-001-07]; National Natural Science Foundation of China [81341040]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by the Ministry of Science and Technology of China (No. 2011ZX09307-001-07) to YY and the National Natural Science Foundation of China (No. 81341040) to ZW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMATO AA, 1995, MUSCLE NERVE, V18, P842, DOI 10.1002/mus.880180807; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Cote C, 2011, CAN J NEUROL SCI, V38, P112, DOI 10.1017/S0317167100011148; Durmus H, 2011, NEUROLOGY, V76, P227, DOI 10.1212/WNL.0b013e318207b043; Fischer D, 2008, NEUROLOGY, V71, P758, DOI 10.1212/01.wnl.0000324927.28817.9b; Fischmann A, 2011, J NEUROL, V258, P1333, DOI 10.1007/s00415-011-5937-9; JASPAR HHJ, 1977, CLIN NEUROL NEUROSUR, V80, P272; Jungbluth H, 2004, NEUROMUSCULAR DISORD, V14, P785, DOI 10.1016/j.nmd.2004.08.006; Kornblum C, 2006, J NEUROL, V253, P753, DOI 10.1007/s00415-006-0111-5; Kraya T, 2013, J NEURAL TRANSM, V120, pS3, DOI 10.1007/s00702-013-1058-1; Lu H, 2008, NEUROPATHOLOGY, V28, P599, DOI 10.1111/j.1440-1789.2008.00924.x; [鲁向辉 Lu Xianghui], 2012, [中华神经科杂志, Chinese Journal of Neurology], V45, P557; Mercuri E, 2002, NEUROPEDIATRICS, V33, P10, DOI 10.1055/s-2002-23593; Mercuri E, 2010, DEV MED CHILD NEUROL, V52, P693, DOI 10.1111/j.1469-8749.2010.03726.x; Mercuri E, 2010, ANN NEUROL, V67, P201, DOI 10.1002/ana.21846; Mignarri A, 2012, NEUROMUSCULAR DISORD, V22, P759, DOI 10.1016/j.nmd.2012.03.010; Minami N, 2001, NEUROMUSCULAR DISORD, V11, P699, DOI 10.1016/S0960-8966(01)00227-9; Nakashima Dainari, 2003, Rinsho Shinkeigaku, V43, P560; Nalini A, 2010, NEUROL INDIA, V58, P235, DOI 10.4103/0028-3886.63804; Shan JL, 2014, NEUROMOL MED, V16, P782, DOI 10.1007/s12017-014-8327-5; Tasca G, 2012, J NEUROL, V259, P1358, DOI 10.1007/s00415-011-6357-6; Udd B, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-013-0434-4; Uyama E, 1998, NEUROMUSCULAR DISORD, V8, P119, DOI 10.1016/S0960-8966(98)00002-9; van der Sluijs BM, 2004, J NEUROL NEUROSUR PS, V75, P1499, DOI 10.1136/jnnp.2003.025072	25	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128629	10.1371/journal.pone.0128629	http://dx.doi.org/10.1371/journal.pone.0128629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039504	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700111
J	Bratanov, D; Balandin, T; Round, E; Shevchenko, V; Gushchin, I; Polovinkin, V; Borshchevskiy, V; Gordeliy, V				Bratanov, Dmitry; Balandin, Taras; Round, Ekaterina; Shevchenko, Vitaly; Gushchin, Ivan; Polovinkin, Vitaly; Borshchevskiy, Valentin; Gordeliy, Valentin			An Approach to Heterologous Expression of Membrane Proteins. The Case of Bacteriorhodopsin	PLOS ONE			English	Article							SENSORY RHODOPSIN-II; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PHARAONIS PHOBORHODOPSIN; FUNCTIONAL EXPRESSION; GENE-EXPRESSION; PROTON PUMP; BACTERIOOPSIN; DETERMINANTS; PURIFICATION	Heterologous overexpression of functional membrane proteins is a major bottleneck of structural biology. Bacteriorhodopsin from Halobium salinarum (bR) is a striking example of the difficulties in membrane protein overexpression. We suggest a general approach with a finite number of steps which allows one to localize the underlying problem of poor expression of a membrane protein using bR as an example. Our approach is based on constructing chimeric proteins comprising parts of a protein of interest and complementary parts of a homologous protein demonstrating advantageous expression. This complementary protein approach allowed us to increase bR expression by two orders of magnitude through the introduction of two silent mutations into bR coding DNA. For the first time the high quality crystals of bR expressed in E. Coli were obtained using the produced protein. The crystals obtained with in meso nanovolume crystallization diffracted to 1.67 angstrom.	[Bratanov, Dmitry; Balandin, Taras; Round, Ekaterina; Shevchenko, Vitaly; Gushchin, Ivan; Polovinkin, Vitaly; Borshchevskiy, Valentin; Gordeliy, Valentin] Res Ctr Julich, ICS Struct Biochem 6, Inst Complex Syst, Julich, Germany; [Bratanov, Dmitry] Univ Aachen RWTH, Inst Crystallog, Aachen, Germany; [Round, Ekaterina; Gushchin, Ivan; Polovinkin, Vitaly; Gordeliy, Valentin] Univ Grenoble Alpes, IBS, Grenoble, France; [Round, Ekaterina; Gushchin, Ivan; Polovinkin, Vitaly; Gordeliy, Valentin] CNRS, IBS, Grenoble, France; [Round, Ekaterina; Gushchin, Ivan; Polovinkin, Vitaly; Gordeliy, Valentin] CEA, IBS, Grenoble, France; [Shevchenko, Vitaly; Gushchin, Ivan; Polovinkin, Vitaly; Borshchevskiy, Valentin; Gordeliy, Valentin] Moscow Inst Phys & Technol, Res Educ Ctr Bionanophys, Dolgoprudnyi, Russia	Helmholtz Association; Research Center Julich; RWTH Aachen University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Moscow Institute of Physics & Technology	Gordeliy, V (corresponding author), Res Ctr Julich, ICS Struct Biochem 6, Inst Complex Syst, Julich, Germany.	valentin.gordeliy@ibs.fr	Bratanov, Dmitry/J-6865-2015; Borshchevskiy, Valentin I./F-2287-2014; Shevchenko, Vitaly/F-2956-2014; Polovinkin, Vitaly/G-6627-2017; Gushchin, Ivan/K-9197-2015; Gordeliy, Valentin I/J-3636-2013; Gushchin, Ivan/AAO-8829-2020	Borshchevskiy, Valentin I./0000-0003-4398-9712; Polovinkin, Vitaly/0000-0002-3630-5565; Gushchin, Ivan/0000-0002-5348-6070; Gordeliy, Valentin I/0000-0001-5782-5896; Gushchin, Ivan/0000-0002-5348-6070	program "Chaires d'excellence" of ANR France, CEA(IBS) - HGF(FZJ) STC 5.1 specific agreement; MC grant (Marie Curie, project SBMPs) [FP7-PEOPLE-2007-1-1-ITN]; EC FP7 grant [HEALTH-201924]; BMBF (PhoNa - Photonic Nanomaterials); 5 top 100-program of the Ministry for science and education of Russia; RFBR [13-04-91320]; ONEXIM, Russia; FRISBI [ANR-10-INSB-05-02]; GRAL within Grenoble Partnership for Structural Biology (PSB) [ANR-10-LABX-49-01]	program "Chaires d'excellence" of ANR France, CEA(IBS) - HGF(FZJ) STC 5.1 specific agreement(French National Research Agency (ANR)); MC grant (Marie Curie, project SBMPs); EC FP7 grant; BMBF (PhoNa - Photonic Nanomaterials)(Federal Ministry of Education & Research (BMBF)); 5 top 100-program of the Ministry for science and education of Russia; RFBR(Russian Foundation for Basic Research (RFBR)); ONEXIM, Russia; FRISBI; GRAL within Grenoble Partnership for Structural Biology (PSB)	The work was supported by the program "Chaires d'excellence" edition 2008 of ANR France, CEA(IBS) - HGF(FZJ) STC 5.1 specific agreement; the MC grant (Marie Curie, FP7-PEOPLE-2007-1-1-ITN, project SBMPs); and an EC FP7 grant for the EDICTconsortium (HEALTH-201924). Part of this work was supported by BMBF (PhoNa - Photonic Nanomaterials). The work was partially supported by the 5 top 100-program of the Ministry for science and education of Russia and by RFBR, research project No. 13-04-91320. The authors greatly acknowledge support of this work by ONEXIM, Russia. The work used the platforms of the Grenoble Instruct centre (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X; Birge RR, 1999, J PHYS CHEM B, V103, P10746, DOI 10.1021/jp991883n; Bogdanov M, 2010, P NATL ACAD SCI USA, V107, P15057, DOI 10.1073/pnas.1006286107; Booth PJ, 2010, P NATL ACAD SCI USA, V107, P3947, DOI 10.1073/pnas.0914478107; Booth PJ, 1997, BIOCHEMISTRY-US, V36, P197, DOI 10.1021/bi962200m; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BROUILLETTE CG, 1989, PROTEINS, V5, P38, DOI 10.1002/prot.340050106; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cartailler JP, 2003, ANNU REV BIOPH BIOM, V32, P285, DOI 10.1146/annurev.biophys.32.110601.142516; Chen GQ, 1996, PROTEIN SCI, V5, P456; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Curran AR, 1999, BIOCHEMISTRY-US, V38, P9328, DOI 10.1021/bi982322+; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Essen LO, 1998, P NATL ACAD SCI USA, V95, P11673, DOI 10.1073/pnas.95.20.11673; FERRANDO E, 1993, GENE, V125, P41, DOI 10.1016/0378-1119(93)90743-M; Francis Dana M, 2010, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0524s61; Fu HY, 2010, J BACTERIOL, V192, P5866, DOI 10.1128/JB.00642-10; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; Gushchin I, 2013, P NATL ACAD SCI USA, V110, P12631, DOI 10.1073/pnas.1221629110; Hampp N, 2000, CHEM REV, V100, P1755, DOI 10.1021/cr980072x; Hohenfeld IP, 1999, FEBS LETT, V442, P198, DOI 10.1016/S0014-5793(98)01659-7; Hsu MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056363; HUANG KS, 1982, J BIOL CHEM, V257, P8596; Hunt JF, 1997, BIOCHEMISTRY-US, V36, P15177, DOI 10.1021/bi970147b; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamo N, 2006, BIOCHEM BIOPH RES CO, V341, P285, DOI 10.1016/j.bbrc.2005.12.181; KARNIK S, 1990, P NATL ACAD SCI USA, V87, P8955, DOI 10.1073/pnas.87.22.8955; KARNIK SS, 1987, J BIOL CHEM, V262, P9255; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; KAYUSHIN LP, 1974, FEBS LETT, V39, P39, DOI 10.1016/0014-5793(74)80011-6; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; LORBER B, 1990, FEBS LETT, V261, P14, DOI 10.1016/0014-5793(90)80625-S; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MIERCKE LJW, 1989, J BIOL CHEM, V264, P7531; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nekrasova OV, 2010, J BIOTECHNOL, V147, P145, DOI 10.1016/j.jbiotec.2010.03.019; OESTERHELT D, 1973, P NATL ACAD SCI USA, V70, P2853, DOI 10.1073/pnas.70.10.2853; Petrovskaya LE, 2010, FEBS LETT, V584, P4193, DOI 10.1016/j.febslet.2010.09.005; POMPEJUS M, 1993, EUR J BIOCHEM, V211, P27, DOI 10.1111/j.1432-1033.1993.tb19866.x; Raine A, 2003, BIOCHIMIE, V85, P659, DOI 10.1016/S0300-9084(03)00130-5; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Royant A, 2001, P NATL ACAD SCI USA, V98, P10131, DOI 10.1073/pnas.181203898; Samuelson J, 2011, PRODUCTION OF MEMBRANE PROTEINS: STRATEGIES FOR EXPRESSION AND ISOLATION, P13; SHAND RF, 1991, BIOCHEMISTRY-US, V30, P3082, DOI 10.1021/bi00226a015; Shevchenko V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112873; Shimono K, 2003, J BIOL CHEM, V278, P23882, DOI 10.1074/jbc.M301200200; Shimono K, 1997, FEBS LETT, V420, P54, DOI 10.1016/S0014-5793(97)01487-7; Steffen P, 2006, BIOINFORMATICS, V22, P500, DOI 10.1093/bioinformatics/btk010; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Szpirer CY, 2005, BIOTECHNIQUES, V38, P775, DOI 10.2144/05385RR02; Tusnady GE, 2004, BIOINFORMATICS, V20, P2964, DOI 10.1093/bioinformatics/bth340; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; vanKlompenburg W, 1997, EMBO J, V16, P4261, DOI 10.1093/emboj/16.14.4261; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; White SH, 2009, NATURE, V459, P344, DOI [10.1038/nature08142, 10.1038/nature]	58	18	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128390	10.1371/journal.pone.0128390	http://dx.doi.org/10.1371/journal.pone.0128390			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046789	Green Published, gold			2022-12-27	WOS:000355652200066
J	Cai, L; Cai, MH; Wang, MY; Xu, YF; Chen, WZ; Qin, SY; Wan, CL; He, L				Cai, Lei; Cai, Mei-Hong; Wang, Mei-Yan; Xu, Yi-Feng; Chen, Wen-Zhong; Qin, Shen-Ying; Wan, Chun-Ling; He, Lin			Meta-Analysis-Based Preliminary Exploration of the Connection between ATDILI and Schizophrenia by GSTM1/T1 Gene Polymorphisms	PLOS ONE			English	Article							DRUG-INDUCED HEPATOTOXICITY; GLUTATHIONE S-TRANSFERASES; POLYMERASE-CHAIN-REACTION; COPY NUMBER VARIATION; INDUCED LIVER-INJURY; ANTITUBERCULOSIS DRUGS; TISSUE DISTRIBUTION; METAANALYSIS; SUSCEPTIBILITY; GSTT1	Anti-tuberculosis drugs have some adverse effects such as anti-tuberculosis drug-induced liver injury (ATDILI) and mental disorders. The involvement of glutathione S-transferase (GST) genes in pathogenesis of ATDILI or schizophrenia (SCZ) has been reported. Therefore, GST genes may exemplify molecular connectors between ATDILI and SCZ. However, association studies of GSTM1/T1 polymorphisms with these two diseases have yielded conflicting results. After searching case-control association studies in PubMed, ISI Web of Science, EMBASE, Chinese National Knowledge Infrastructure (CNKI), and Chinese BioMedical Literature Database, we performed meta-analyses across a total of 20 published association studies on 3146 subjects for the association of GSTM1 and ATDILI, 2587 for the GSTT1-ATDILI association, 2283 for GSTM1-SCZ and 1116 for GSTT1-SCZ to test the associations of GSTM1/T1 polymorphisms with ATDILI and SCZ. The GSTM1 present genotype was significantly associated with decreased risks of ATDILI (risk ratio(RR): 0.81, 95% confidence interval (CI): 0.75-0.88, P < 0.0001) and SCZ (RR: 0.88, 95% CI: 0.80-0.96, P = 0.004) according to the fixed-effect model, while the GSTT1 present genotype was significantly associated only with a high risk of SCZ (RR: 1.17, 95% CI: 1.04-1.32, P = 0.01) according to both the random- and fixed-effect models, but not with ATDILI (P = 0.82) according to the fixed-effect model. Moreover, these significant results were supported with moderate evidence according to the Venice criteria. These results indicate that GSTM1 represents a genetic connection between ATDILI and SCZ, and suggest that ATDILI and SCZ may be co-occurring for the subjects with GSTM1 null genotype.	[Cai, Lei; Xu, Yi-Feng; Qin, Shen-Ying; Wan, Chun-Ling; He, Lin] Shanghai Jiao Tong Univ, Minist Educ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China; [Cai, Lei; Xu, Yi-Feng; Chen, Wen-Zhong; Qin, Shen-Ying; Wan, Chun-Ling; He, Lin] Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Shanghai 200240, Peoples R China; [Cai, Mei-Hong] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200020, Peoples R China; [Wang, Mei-Yan] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tongji University	Cai, L (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China.	cailei2010@126.com; helinhelin3@gmail.com	Xu, Yifeng/AAA-2064-2021; Cai, Lei/H-3972-2017	Xu, Yifeng/0000-0002-0403-1141; Cai, Lei/0000-0002-5726-2971	973 Program [2012CB910102, 2010CB529600]; Chinese National Science Foundation [31101015, 81271486, 31100252, 81421061]; scientific research foundation for the returned overseas, the Chinese Ministry of Education [12Z102050009]	973 Program(National Basic Research Program of China); Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); scientific research foundation for the returned overseas, the Chinese Ministry of Education	This work was supported by the 973 Program (grant numbers 2012CB910102, 2010CB529600), the Chinese National Science Foundation (No. 31101015, 81271486, 31100252 and 81421061) and the scientific research foundation for the returned overseas, the Chinese Ministry of Education (No. 12Z102050009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Baez S, 1997, BIOCHEM J, V324, P25, DOI 10.1042/bj3240025; BOYER TD, 1989, HEPATOLOGY, V9, P486, DOI 10.1002/hep.1840090324; Cai L, 2013, HUM GENET, V132, P265, DOI 10.1007/s00439-012-1244-5; Cai Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047769; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Das Roy P, 2008, PHARMACOGENOMICS, V9, P311, DOI 10.2217/14622416.9.3.311; Teixeira RLD, 2011, MEM I OSWALDO CRUZ, V106, P716, DOI 10.1590/S0074-02762011000600011; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Doherty AM, 2013, GEN HOSP PSYCHIAT, V35, P398, DOI 10.1016/j.genhosppsych.2013.03.018; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gravina P, 2011, PSYCHIAT RES, V187, P454, DOI 10.1016/j.psychres.2010.10.008; Harada S, 2001, BIOCHEM BIOPH RES CO, V281, P267, DOI 10.1006/bbrc.2001.4347; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang RS, 2009, HUM MOL GENET, V18, P366, DOI 10.1093/hmg/ddn345; Huang YS, 2007, EXPERT OPIN DRUG MET, V3, P1, DOI 10.1517/17425255.3.1.1; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Juronen E, 1996, BIOCHEM MOL BIOL INT, V39, P21; Kerb R, 1999, PHARMACOGENETICS, V9, P89; Kim SH, 2010, TUBERCULOSIS, V90, P39, DOI 10.1016/j.tube.2009.12.001; Landi S, 2000, MUTAT RES-REV MUTAT, V463, P247, DOI 10.1016/S1383-5742(00)00050-8; Li C, 2013, EUR J CLIN MICROBIOL, V32, P859, DOI 10.1007/s10096-013-1831-y; Nathwani RA, 2006, CLIN LIVER DIS, V10, pvii; Nathwani Rahul A, 2006, Clin Liver Dis, V10, P207, DOI 10.1016/j.cld.2006.05.009; PEARSON WR, 1993, AM J HUM GENET, V53, P220; Petitti D, 1994, METAANALYSIS DECISIO; Rowe JD, 1997, BIOCHEM J, V325, P481, DOI 10.1042/bj3250481; Roy B, 2001, J GASTROEN HEPATOL, V16, P1033, DOI 10.1046/j.1440-1746.2001.02585.x; Saadat M, 2007, PSYCHIAT RES, V153, P87, DOI 10.1016/j.psychres.2006.03.024; Smythies J, 1999, EUR J PHARMACOL, V370, P1, DOI 10.1016/S0014-2999(99)00048-5; Sodhi C P, 1996, J Biochem Toxicol, V11, P139, DOI 10.1002/(SICI)1522-7146(1996)11:3<139::AID-JBT6>3.0.CO;2-L; Sprenger R, 2000, PHARMACOGENETICS, V10, P557, DOI 10.1097/00008571-200008000-00009; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Sutton AJAK, 2000, METHODS METAANALYSIS; Tang N, 2013, INT J TUBERC LUNG D, V17, P17, DOI 10.5588/ijtld.12.0447; THOMPSON NP, 1995, EUR RESPIR J, V8, P1384, DOI 10.1183/09031936.95.08081384; Valentini A., 2008, ROLE GLUTATHIONE STR; Watanabe Y, 2010, SCHIZOPHR RES, V124, P236, DOI 10.1016/j.schres.2010.08.001; Webb G, 1996, GENOMICS, V33, P121, DOI 10.1006/geno.1996.0167; World Health Organization (WHO), 2020, GLOB TUB REP; Yao JK, 2001, CNS DRUGS, V15, P287, DOI 10.2165/00023210-200115040-00004; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC; Yew WW, 2006, RESPIROLOGY, V11, P699, DOI 10.1111/j.1440-1843.2006.00941.x	45	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128643	10.1371/journal.pone.0128643	http://dx.doi.org/10.1371/journal.pone.0128643			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046920	Green Submitted, gold, Green Published			2022-12-27	WOS:000355652200087
J	Calinger, K; Calhoon, E; Chang, HC; Whitacre, J; Wenzel, J; Comita, L; Queenborough, S				Calinger, Kellen; Calhoon, Elisabeth; Chang, Hsiao-chi; Whitacre, James; Wenzel, John; Comita, Liza; Queenborough, Simon			Historic Mining and Agriculture as Indicators of Occurrence and Abundance of Widespread Invasive Plant Species	PLOS ONE			English	Article							LAND-USE HISTORY; FOREST; MINE; ROADS; LANDSCAPE; PATTERNS; NITROGEN; CARBON; SHRUB; FIELD	Anthropogenic disturbances often change ecological communities and provide opportunities for non-native species invasion. Understanding the impacts of disturbances on species invasion is therefore crucial for invasive species management. We used generalized linear mixed effects models to explore the influence of land-use history and distance to roads on the occurrence and abundance of two invasive plant species (Rosa multiflora and Berberis thunbergii) in a 900-ha deciduous forest in the eastern U.S.A., the Powdermill Nature Reserve. Although much of the reserve has been continuously forested since at least 1939, aerial photos revealed a variety of land-uses since then including agriculture, mining, logging, and development. By 2008, both Rosa multiflora and Berberis thunbergii were widespread throughout the reserve (occurring in 24% and 13% of 4417 10-m diameter regularly-placed vegetation plots, respectively) with occurrence and abundance of each varying significantly with land-use history. Rosa multiflora was more likely to occur in historically farmed, mined, logged or developed plots than in plots that remained forested, (log odds of 1.8 to 3.0); Berberis thunbergii was more likely to occur in plots with agricultural, mining, or logging history than in plots without disturbance (log odds of 1.4 to 2.1). Mining, logging, and agriculture increased the probability that Rosa multiflora had >10% cover while only past agriculture was related to cover of Berberis thunbergii. Proximity to roads was positively correlated with the occurrence of Rosa multiflora (a 0.26 increase in the log odds for every 1-m closer) but not Berberis thunbergii, and roads had no impact on the abundance of either species. Our results indicated that a wide variety of disturbances may aid the introduction of invasive species into new habitats, while high-impact disturbances such as agriculture and mining increase the likelihood of high abundance post-introduction.	[Calinger, Kellen; Calhoon, Elisabeth; Chang, Hsiao-chi; Comita, Liza; Queenborough, Simon] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA; [Whitacre, James; Wenzel, John] Carnegie Museum Nat Hist, Powdermill Nat Reserve, Rector, PA 15677 USA; [Comita, Liza] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Whitacre, James] Univ Illinois, Univ Lib, Urbana, IL 61801 USA	University System of Ohio; Ohio State University; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Illinois System; University of Illinois Urbana-Champaign	Calinger, K (corresponding author), Ohio State Univ, Dept Evolut Ecol & Organismal Biol, 318 W 12th Ave, Columbus, OH 43210 USA.	kcalinger@gmail.com		Whitacre, James/0000-0003-3464-9337	Heinz Endowment	Heinz Endowment	The vegetation survey was made possible through a grant from the Heinz Endowment, http://www.heinz.org/.	Amrine J, 2002, BIOL CONTROL INVASIV, P265; Anderson JR, 1976, GEOL SURV PROF PAP; Bates D, 2013, NO LME4 LINEAR MIXED; Bravo M, 2011, MULTIFLORA ROSE; Brown CD, 2009, BIOL CONSERV, V142, P1647, DOI 10.1016/j.biocon.2009.02.035; Burgess CH, 1948, FARM Q, V3, P50; Cassidy TM, 2004, BIOL INVASIONS, V6, P113, DOI 10.1023/B:BINV.0000010128.44332.0f; Compton JE, 2000, ECOLOGY, V81, P2314, DOI 10.1890/0012-9658(2000)081[2314:LTIOAO]2.0.CO;2; Corbett EA, 1996, RESTOR ECOL, V4, P346, DOI 10.1111/j.1526-100X.1996.tb00187.x; DeGasperis BG, 2007, ECOLOGY, V88, P3115, DOI 10.1890/06-2014.1; Drummond MA, 2010, BIOSCIENCE, V60, P286, DOI 10.1525/bio.2010.60.4.7; E.S.R.I, 2012, ARCGIS; Ehrenfeld JG, 1997, J TORREY BOT SOC, V124, P210, DOI 10.2307/2996586; Ekka NJ, 2011, TROP ECOL, V52, P337; Evans DM, 2013, ECOL ENG, V51, P16, DOI 10.1016/j.ecoleng.2012.12.065; Flory SL, 2006, PLANT ECOL, V184, P131, DOI 10.1007/s11258-005-9057-4; Gray AN, 2005, ENVIRON MONIT ASSESS, V100, P109, DOI 10.1007/s10661-005-7060-9; Klimstra WD, 1956, T ILL STATE ACAD SCI, V58, P66; Kuhman TR, 2011, CAN J FOREST RES, V41, P920, DOI [10.1139/X11-026, 10.1139/x11-026]; Kuhman TR, 2010, LANDSCAPE ECOL, V25, P1433, DOI 10.1007/s10980-010-9500-3; Lee TD, 2012, FOREST ECOL MANAG, V265, P201, DOI 10.1016/j.foreco.2011.10.035; Lemke D, 2013, INT J MIN RECLAM ENV, V27, P275, DOI 10.1080/17480930.2012.699215; Lundgren MR, 2004, NORTHEAST NAT, V11, P313, DOI 10.1656/1092-6194(2004)011[0313:IOLUAS]2.0.CO;2; McDonald RI, 2008, J TORREY BOT SOC, V135, P260, DOI 10.3159/08-RA-012.1; McDonald RI, 2008, FOREST ECOL MANAG, V255, P4021, DOI 10.1016/j.foreco.2008.03.054; Meiners SJ, 2002, ECOGRAPHY, V25, P215, DOI 10.1034/j.1600-0587.2002.250209.x; Mosher ES, 2009, BIOL INVASIONS, V11, P2317, DOI 10.1007/s10530-008-9418-8; Norland MR, 1993, SOIL FACTORS AFFECTI, P9345; Parendes LA, 2000, CONSERV BIOL, V14, P64, DOI 10.1046/j.1523-1739.2000.99089.x; Parker JD, 2010, BIOL INVASIONS, V12, P1557, DOI 10.1007/s10530-009-9568-3; Pauchard A, 2004, CONSERV BIOL, V18, P238, DOI 10.1111/j.1523-1739.2004.00300.x; R Core Team, 2018, R LANG ENV STAT COMP; Silander J. A., 1999, Biological Invasions, V1, P189, DOI 10.1023/A:1010024202294; Silva LCR, 2013, ECOL APPL, V23, P1345, DOI 10.1890/12-1957.1; STEFFEY J, 1985, AM HORTIC, V64, P4; SYLVIA DM, 1990, AGR ECOSYST ENVIRON, V31, P253, DOI 10.1016/0167-8809(90)90224-2; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; USDA Forest Service Forest Health Staff, 2006, MULT ROS; Von Holle B, 2007, BIOL CONSERV, V136, P33, DOI 10.1016/j.biocon.2006.10.044; Zipper CE, 2011, J ENVIRON QUAL, V40, P1567, DOI 10.2134/jeq2011.0040	40	14	14	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128161	10.1371/journal.pone.0128161	http://dx.doi.org/10.1371/journal.pone.0128161			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046534	gold, Green Published			2022-12-27	WOS:000355652200044
J	D'Agata, F; Cicerale, A; Mingolla, A; Caroppo, P; Orsi, L; Mortara, P; Troni, W; Pinessi, L				D'Agata, Federico; Cicerale, Alessandro; Mingolla, Arianna; Caroppo, Paola; Orsi, Laura; Mortara, Paolo; Troni, Walter; Pinessi, Lorenzo			Double-Cone Coil TMS Stimulation of the Medial Cortex Inhibits Central Pain Habituation	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; ANTERIOR CINGULATE CORTEX; DEEP BRAIN-STIMULATION; FRONTAL-CORTEX; PLACEBO ANALGESIA; EVOKED-POTENTIALS; PERCEPTION; MODULATION; HUMANS; CONNECTIVITY	Objective The aim of this study was to investigate whether Transcranial Magnetic Stimulation (TMS) applied over the medial line of the scalp affects the subjective perception of continuous pain induced by means of electric stimulation. In addition, we wanted to identify the point of stimulation where this effect was maximum. Methods Superficial electrical stimulation was used to induce continuous pain on the dominant hand. At the beginning of the experiment we reached a pain rating of 5 on an 11-point numeric rating scale (NRS; 0 = no pain and 10 = maximum tolerable pain) for each subject by setting individually the current intensity. The TMS (five pulses at increasing intensities) was applied on 5 equidistant points (one per session) over the medial line of the scalp in 13 healthy volunteers using a double-cone coil to stimulate underlying parts of the brain cortex. In every experimental session the painful stimulation lasted 45 minutes, during which pain and distress intensities NRS were recorded continuously. We calculated the effect of adaptation and the immediate effect of the TMS stimulation for all locations. Additionally, an ALE (Activation Likelihood Estimation) meta-analysis was performed to compare our results with the neuroimaging literature on subjective pain rating. Results TMS stimulation temporarily decreased the pain ratings, and pain adaptation was suppressed when applying the TMS over the FCz site on the scalp. No effect was found for distress ratings. Conclusions The present data suggest that the medial cortex in proximity of the cingulated gyrus has a causal role in adaptation mechanisms and in processing ongoing pain and subjective sensation of pain intensity.	[D'Agata, Federico; Cicerale, Alessandro; Mingolla, Arianna] Univ Turin, LabNI, Turin, Italy; [D'Agata, Federico; Cicerale, Alessandro; Mortara, Paolo; Troni, Walter; Pinessi, Lorenzo] Univ Turin, Neurosci Dept, Turin, Italy; [Caroppo, Paola] Hop La Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, ICM, Paris, France; [Orsi, Laura; Mortara, Paolo; Pinessi, Lorenzo] AOU Citta Salute & Sci Presidio Molinette, Neurosci Dept, Turin, Italy	University of Turin; University of Turin; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette	Cicerale, A (corresponding author), Univ Turin, LabNI, Turin, Italy.	alessandro.cicerale@unito.it	Caroppo, Paola/J-5044-2018; D'Agata, Federico/ABG-8839-2021	Caroppo, Paola/0000-0003-4274-9004; D'Agata, Federico/0000-0001-9432-0248				Amanzio M, 2013, HUM BRAIN MAPP, V34, P738, DOI 10.1002/hbm.21471; Bingel U, 2007, PAIN, V131, P21, DOI 10.1016/j.pain.2006.12.005; Bingel U, 2006, PAIN, V120, P8, DOI 10.1016/j.pain.2005.08.027; Bittar RG, 2005, J CLIN NEUROSCI, V12, P515, DOI 10.1016/j.jocn.2004.10.005; Buhle JT, 2012, PSYCHOL SCI, V23, P246, DOI 10.1177/0956797611427919; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; de Tommaso M, 2005, CLIN NEUROPHYSIOL, V116, P1254, DOI 10.1016/j.clinph.2005.02.018; Deng ZD, 2013, BRAIN STIMUL, V6, P1, DOI 10.1016/j.brs.2012.02.005; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Ferreira-Valente MA, 2011, PAIN, V152, P2399, DOI 10.1016/j.pain.2011.07.005; Fields HL, 2005, TXB PAIN, P125; FINNER H, 1993, J AM STAT ASSOC, V88, P920, DOI 10.2307/2290782; Frot M, 2008, J NEUROSCI, V28, P944, DOI 10.1523/JNEUROSCI.2934-07.2008; Garcia-Larrea L, 2003, NEUROPHYSIOL CLIN, V33, P279, DOI 10.1016/j.neucli.2003.10.008; Gersner R, 2011, J NEUROSCI, V31, P7521, DOI 10.1523/JNEUROSCI.6751-10.2011; Greffrath W, 2007, PAIN, V132, P301, DOI 10.1016/j.pain.2007.04.026; Hayward G, 2007, EUR J NEUROSCI, V25, P2224, DOI 10.1111/j.1460-9568.2007.05430.x; Kanda M, 2003, CLIN NEUROPHYSIOL, V114, P860, DOI 10.1016/S1388-2457(03)00034-8; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Laird AR, 2005, NEUROINFORMATICS, V3, P65, DOI 10.1385/NI:3:1:065; LEBLANC J, 1966, CAN J PHYSIOL PHARM, V44, P287, DOI 10.1139/y66-033; Lenz FA, 1998, J NEUROPHYSIOL, V79, P2231, DOI 10.1152/jn.1998.79.4.2231; Lozano AM, 2012, J NEUROSURG, V116, P315, DOI 10.3171/2011.10.JNS102122; Machii K, 1999, CLIN NEUROPHYSIOL, V110, P1315, DOI 10.1016/S1388-2457(99)00065-6; Melzack R, 1999, PAIN, pS121, DOI 10.1016/S0304-3959(99)00145-1; Mobascher A, 2010, INT J PSYCHOPHYSIOL, V75, P16, DOI 10.1016/j.ijpsycho.2009.10.008; Mylius V, 2006, CLIN NEUROPHYSIOL, V117, P1814, DOI 10.1016/j.clinph.2006.04.013; Mylius V, 2012, PAIN, V153, P1350, DOI 10.1016/j.pain.2012.04.009; Nuwer M R, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P11; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Rennefeld C, 2010, PAIN, V148, P503, DOI 10.1016/j.pain.2009.12.014; Roth Y, 2002, J CLIN NEUROPHYSIOL, V19, P361, DOI 10.1097/00004691-200208000-00008; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Valeriani M, 2000, CLIN NEUROPHYSIOL, V111, P1103, DOI 10.1016/S1388-2457(00)00273-X; Valeriani M, 2003, PAIN, V105, P57, DOI 10.1016/S0304-3959(03)00137-4; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; Vogt B. A., 2009, CINGULATE NEUROBIOLO; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wang G, 2014, PAIN, V155, P755, DOI 10.1016/j.pain.2014.01.005; Wood BM, 2010, J PAIN, V11, P1259, DOI 10.1016/j.jpain.2010.02.025; Yoo WK, 2006, NEUROREPORT, V17, P141, DOI 10.1097/01.wnr.0000198438.37012.d6	42	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128765	10.1371/journal.pone.0128765	http://dx.doi.org/10.1371/journal.pone.0128765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046985	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200098
J	Hu, DM; Hu, SY; Wan, W; Xu, M; Du, RK; Zhao, W; Gao, XL; Liu, J; Liu, HY; Hong, J				Hu, Dongmei; Hu, Siyi; Wan, Wen; Xu, Man; Du, Ruikai; Zhao, Wei; Gao, Xiaolian; Liu, Jing; Liu, Haiyan; Hong, Jiong			Effective Optimization of Antibody Affinity by Phage Display Integrated with High-Throughput DNA Synthesis and Sequencing Technologies	PLOS ONE			English	Article							MATURATION; LIBRARIES; CONSTRUCTION; MUTAGENESIS; ANTIGEN; DIVERSITY; REGIONS; PROTEIN; A21	Phage display technology has been widely used for antibody affinity maturation for decades. The limited library sequence diversity together with excessive redundancy and labour-consuming procedure for candidate identification are two major obstacles to widespread adoption of this technology. We hereby describe a novel library generation and screening approach to address the problems. The approach started with the targeted diversification of multiple complementarity determining regions (CDRs) of a humanized anti-ErbB2 antibody, HuA21, with a small perturbation mutagenesis strategy. A combination of three degenerate codons, NWG, NWC, and NSG, were chosen for amino acid saturation mutagenesis without introducing cysteine and stop residues. In total, 7,749 degenerate oligonucleotides were synthesized on two microchips and released to construct five single-chain antibody fragment (scFv) gene libraries with 4 x 106 DNA sequences. Deep sequencing of the unselected and selected phage libraries using the Illumina platform allowed for an in-depth evaluation of the enrichment landscapes in CDR sequences and amino acid substitutions. Potent candidates were identified according to their high frequencies using NGS analysis, by-passing the need for the primary screening of target-binding clones. Furthermore, a subsequent library by recombination of the 10 most abundant variants from four CDRs was constructed and screened, and a mutant with 158-fold increased affinity (K-d = 25.5 pM) was obtained. These results suggest the potential application of the developed methodology for optimizing the binding properties of other antibodies and biomolecules.	[Hu, Dongmei; Hu, Siyi; Wan, Wen; Xu, Man; Du, Ruikai; Zhao, Wei; Gao, Xiaolian; Liu, Jing; Liu, Haiyan; Hong, Jiong] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Gao, Xiaolian] Univ Houston, Dept Biol & Biochem, Houston, TX USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Houston System; University of Houston	Liu, HY (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China.	hjiong@ustc.edu.cn; hyliu@ustc.edu.cn	Liu, Haiyan/O-9637-2014; HONG, Jiong/N-1996-2013	HONG, Jiong/0000-0002-4592-7083; Liu, Haiyan/0000-0002-5926-820X	Ministry of Science and Technology of Major Projects; National Natural Science Foundation of China; National High Technology Research and Development Program; National Basic Research Program of China	Ministry of Science and Technology of Major Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China)	This work received funding from these sources: Ministry of Science and Technology of Major Projects [http://www.nmp.gov.cn] (JL). National Natural Science Foundation of China [http://www.nsfc.gov.cn] (JH). National High Technology Research and Development Program [http://www.863.gov.cn] (HYL, JH). National Basic Research Program of China [http://program.most.gov.cn] (JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borovkov AY, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq677; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Chang L, 2010, J COMPUT AID MOL DES, V24, P37, DOI 10.1007/s10822-009-9312-1; Cheng LS, 2003, CELL RES, V13, P35, DOI 10.1038/sj.cr.7290149; Chowdhury PS, 1999, NAT BIOTECHNOL, V17, P568, DOI 10.1038/9872; Cleary MA, 2004, NAT METHODS, V1, P241, DOI 10.1038/nmeth724; Derda R, 2011, MOLECULES, V16, P1776, DOI 10.3390/molecules16021776; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Ge X, 2010, BIOTECHNOL BIOENG, V106, P347, DOI 10.1002/bit.22712; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; Gonzalez-Munoz A, 2012, MABS-AUSTIN, V4, P664, DOI 10.4161/mabs.21728; Hu SY, 2008, PROTEINS, V70, P938, DOI 10.1002/prot.21551; Irving RA, 1996, IMMUNOTECHNOLOGY, V2, P127, DOI 10.1016/1380-2933(96)00044-9; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Kunik V, 2012, NUCLEIC ACIDS RES, V40, pW521, DOI 10.1093/nar/gks480; Laffly E, 2008, J MOL BIOL, V378, P1094, DOI 10.1016/j.jmb.2008.03.045; Larman HB, 2012, P NATL ACAD SCI USA, V109, P18523, DOI 10.1073/pnas.1215549109; Larman HB, 2011, NAT BIOTECHNOL, V29, P535, DOI 10.1038/nbt.1856; Low NM, 1996, J MOL BIOL, V260, P359, DOI 10.1006/jmbi.1996.0406; Martineau Pierre, 2002, Methods Mol Biol, V178, P287; Rajpal A, 2005, P NATL ACAD SCI USA, V102, P8466, DOI 10.1073/pnas.0503543102; Ravn U, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq789; Ravn U, 2013, METHODS, V60, P99, DOI 10.1016/j.ymeth.2013.03.001; Schier R, 1996, J MOL BIOL, V255, P28, DOI 10.1006/jmbi.1996.0004; Tian JD, 2004, NATURE, V432, P1050, DOI 10.1038/nature03151; Wan W, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku405; Wark KL, 2006, ADV DRUG DELIVER REV, V58, P657, DOI 10.1016/j.addr.2006.01.025; Whitehead TA, 2012, NAT BIOTECHNOL, V30, P543, DOI 10.1038/nbt.2214; Wu HR, 1998, P NATL ACAD SCI USA, V95, P6037, DOI 10.1073/pnas.95.11.6037; Xu M, 2015, J BIOTECHNOL, V194, P27, DOI 10.1016/j.jbiotec.2014.11.007; YANG WP, 1995, J MOL BIOL, V254, P392, DOI 10.1006/jmbi.1995.0626; Zhou HH, 2011, J BIOL CHEM, V286, P31676, DOI 10.1074/jbc.M111.235184; Zhou XC, 2004, NUCLEIC ACIDS RES, V32, P5409, DOI 10.1093/nar/gkh879	34	47	50	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129125	10.1371/journal.pone.0129125	http://dx.doi.org/10.1371/journal.pone.0129125			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046845	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200127
J	Kassab, MA; Mudassir, M; Singh, A; Muthuraman, N; Bhagat, M; Palanichamy, JK; Ramalingam, P; Chosdol, K; Sinha, S; Chattopadhyay, P				Kassab, Muzaffer Ahmad; Mudassir, Madeeha; Singh, Anand; Muthuraman, N.; Bhagat, Mohita; Palanichamy, Jayanth Kumar; Ramalingam, Pradeep; Chosdol, Kunzang; Sinha, Subrata; Chattopadhyay, Parthaprasad			Gene Silencing and Activation of Human Papillomavirus 18 Is Modulated by Sense Promoter Associated RNA in Bidirectionally Transcribed Long Control Region	PLOS ONE			English	Article							TERM SUPPRESSION; CANCER-CELLS; TIME PCR; E6; INTERFERENCE; EXPRESSION	Background Recently various studies have demonstrated the role of promoter associated non-coding RNAs (pRNA) in dsRNA induced transcriptional gene silencing and activation. However the exact mechanistic details of these processes with respect to the orientation of pRNAs are poorly defined. Methodology/Principal Findings We have identified novel sense and antisense long control region (LCR) associated RNAs (pRNAs) in HPV18 positive cervical cancer cell lines HeLa, C-4 I and C-4 II. Using dsRNAs against these pRNAs, we were able to achieve upregulation or downregulation of the sense and antisense pRNAs and the downstream E6 and E7 oncogenes. We present evidence that knockdown of the sense pRNA is associated with reduction in E6 and E7 oncogenes and an upregulation of antisense pRNA. Conversely upregulation of sense pRNA is accompanied by an induction of the oncogenes and a concomitant reduction in antisense pRNA. Moreover, the exact role of sense and antisense pRNAs in dsRNA mediated gene modulation was confirmed by their selective degradation using antisense phosphorothioate oligodeoxynucleotides (ODN). Degradation of sense pRNA with antisense ODN led to loss of dsRNA induced silencing and activation, suggesting that dsRNA mediated gene modulation requires sense pRNA. Both processes were accompanied with congruent changes in the methylation pattern of activating and repressive histones. Conclusion/Significance Thus this data identifies and demonstrates the role of previously unknown important regulatory transcripts in HPV18 gene expression which can prove valuable targets in cervical cancer therapeutics. This mode of gene regulation by bidirectional transcription could be operational in other promoters as well and serve as a mechanism of regulating gene expression.	[Kassab, Muzaffer Ahmad; Mudassir, Madeeha; Bhagat, Mohita; Palanichamy, Jayanth Kumar; Chosdol, Kunzang; Chattopadhyay, Parthaprasad] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India; [Singh, Anand] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Muthuraman, N.] Inst Liver & Biliary Sci, Dept Biochem, New Delhi, Vasant Kunj, India; [Ramalingam, Pradeep] Weill Cornell Med Coll, New York, NY USA; [Sinha, Subrata] Natl Brain Res Ctr, Gurgaon, Haryana, India	All India Institute of Medical Sciences (AIIMS) New Delhi; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Institute of Liver & Biliary Sciences (ILBS); Cornell University; Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Chattopadhyay, P (corresponding author), All India Inst Med Sci, Dept Biochem, New Delhi 110029, India.	parthoaiims@hotmail.com	Kassab, Muzaffer Ahmad/AAH-7977-2019; Ramalingam, Pradeep/AAO-3210-2020; Palanichamy, Jayanth Kumar/B-5715-2009	Ramalingam, Pradeep/0000-0002-5943-9670; Palanichamy, Jayanth Kumar/0000-0002-3903-7252; chosdol, kunzang/0000-0002-7065-3395	Department of Biotechnology (DBT), Govt. of India [BT/01/COE/05/13, BT/PR13733/AGR/36/667/2010]; ICMR JRF	Department of Biotechnology (DBT), Govt. of India(Department of Biotechnology (DBT) India); ICMR JRF	This work was supported by a grant from the Department of Biotechnology (DBT), Govt. of India, Sanction No. BT/01/COE/05/13, BT/PR13733/AGR/36/667/2010 to Parthaprasad Chattopadhyay and ICMR JRF to Muzaffer Ahmad Kassab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2001, CURR CANCER DRUG TAR, V1, P197, DOI 10.2174/1568009013334160; Alvarez-Salas LM, 1998, P NATL ACAD SCI USA, V95, P1189, DOI 10.1073/pnas.95.3.1189; AUERSPERG N, 1962, J NATL CANCER I, V28, P605; Bernard HU, 2002, ANTIVIR THER, V7, P219; Butz K, 2003, ONCOGENE, V22, P5938, DOI 10.1038/sj.onc.1206894; Chang JTC, 2010, CANCER GENE THER, V17, P827, DOI 10.1038/cgt.2010.38; CHEN JJ, 1995, SCIENCE, V269, P529, DOI 10.1126/science.7624774; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Graffmann N, 2006, ANAL BIOCHEM, V354, P308, DOI 10.1016/j.ab.2006.03.039; Hall AHS, 2003, J VIROL, V77, P6066, DOI 10.1128/JVI.77.10.6066-6069.2003; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; Hawkins PG, 2009, NUCLEIC ACIDS RES, V37, P2984, DOI 10.1093/nar/gkp127; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Koivusalo R, 2006, CANCER RES, V66, P11817, DOI 10.1158/0008-5472.CAN-06-2185; LAIMINS LA, 1993, INFECT AGENT DIS, V2, P74; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Palanichamy JK, 2010, MOL CANCER THER, V9, P2114, DOI 10.1158/1535-7163.MCT-09-0977; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schwartz JC, 2008, NAT STRUCT MOL BIOL, V15, P842, DOI 10.1038/nsmb.1444; Singh A, 2014, J ANTIMICROB CHEMOTH, V69, P404, DOI 10.1093/jac/dkt348; Suzuki K, 2008, J BIOL CHEM, V283, P23353, DOI 10.1074/jbc.M709651200; Tang S, 2006, ONCOGENE, V25, P2094, DOI 10.1038/sj.onc.1209244; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Zelkowitz R, 2009, SCIENCE, V323, P580, DOI 10.1126/science.323.5914.580; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	31	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128416	10.1371/journal.pone.0128416	http://dx.doi.org/10.1371/journal.pone.0128416			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047143	gold, Green Published, Green Submitted			2022-12-27	WOS:000355652200069
J	Xavier, AL; Guedes, TB; Napoli, MF				Xavier, Ariane Lima; Guedes, Thais Barreto; Napoli, Marcelo Felgueiras			Biogeography of Anurans from the Poorly Known and Threatened Coastal Sandplains of Eastern Brazil	PLOS ONE			English	Article							BIOTIC ELEMENT ANALYSIS; DISTRIBUTION PATTERNS; ATLANTIC FOREST; CONSERVATION; VICARIANCE; AREAS; BIODIVERSITY; DIVERSITY; COMMUNITY; ENDEMISM	The east coast of Brazil comprises an extensive area inserted in the Tropical Atlantic Domain and is represented by sandy plains of beach ridges commonly known as Restingas. The coastal environments are unique and house a rich amphibian fauna, the geographical distribution patterns of which are incipient. Biogeographical studies can explain the current distributional patterns and provide the identification of natural biogeographical units. These areas are important in elucidating the evolutionary history of the taxa and the areas where they occur. The aim of this study was to seek natural biogeographical units in the Brazilian sandy plains of beach ridges by means of distribution data of amphibians and to test the main predictions of the vicariance model to explain the patterns found. We revised and georeferenced data on the geographical distribution of 63 anuran species. We performed a search for latitudinal distribution patterns along the sandy coastal plains of Brazil using the non-metric multidimensional scaling method (NMDS) and the biotic element analysis to identify natural biogeographical units. The results showed a monotonic variation in anuran species composition along the latitudinal gradient with a break in the clinal pattern from 23 degrees S to 25 degrees S latitude (states of Rio de Janeiro to Sao Paulo). The major predictions of the vicariance model were corroborated by the detection of four biotic elements with significantly clustered distribution and by the presence of congeneric species distributed in distinct biotic elements. The results support the hypothesis that vicariance could be one of the factors responsible for the distribution patterns of the anuran communities along the sandy coastal plains of eastern Brazil. The results of the clusters are also congruent with the predictions of paleoclimatic models made for the Last Glacial Maximum of the Pleistocene, such as the presence of historical forest refugia and biogeographical patterns already detected for amphibians in the Atlantic Rainforest.	[Xavier, Ariane Lima; Napoli, Marcelo Felgueiras] Univ Fed Bahia, Programa Posgrad Ecol & Biomonitoramento, Inst Biol, Salvador, BA, Brazil; [Xavier, Ariane Lima] Inst Fed Educ Ciencia & Tecnol Baiano, Valenca, BA, Brazil; [Guedes, Thais Barreto] Univ Fed Sao Paulo, Programa Posgrad Ecol & Evolucao, Sao Paulo, Brazil; [Guedes, Thais Barreto] Univ Sao Paulo, Museu Zool, Sao Paulo, SP, Brazil; [Napoli, Marcelo Felgueiras] Univ Fed Bahia, Inst Biol, Dept Zool, Museu Zool, Salvador, BA, Brazil; [Napoli, Marcelo Felgueiras] Univ Fed Rio de Janeiro, Museu Nacl, Dept Vertebrados, Rio De Janeiro, RJ, Brazil	Universidade Federal da Bahia; Instituto Federal Baiano (IFBAIANO); Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Federal da Bahia; Universidade Federal do Rio de Janeiro	Napoli, MF (corresponding author), Univ Fed Bahia, Programa Posgrad Ecol & Biomonitoramento, Inst Biol, Salvador, BA, Brazil.	napoli@ufba.br	Napoli, Marcelo/G-3720-2012; Guedes, Thaís B./U-9342-2017	Napoli, Marcelo/0000-0003-3843-0543; Guedes, Thaís B./0000-0003-3318-7193	Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) [21/2008]; Fundacao O Boticario de Protecao a Natureza [0844-20092]	Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Fundacao O Boticario de Protecao a Natureza	This study was supported by the Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB, grant 21/2008 to MFN; http://www.fapesb.ba.gov.br/) for financial support to the project "Adequacao da Pos-Graduacao em Diversidade Animal ao uso de metodos e ferramentas de analise espacial;" the Fundacao O Boticario de Protecao a Natureza (grant 0844-20092 to MFN; http://www.fundacaogrupoboticario.org.br) for financial support to the project "Areas prioritarias para a conservacao de anfibios anuros nas restingas do litoral brasileiro."	Ab'Saber A.N, 1977, GEOMORFOLOGIA, V52, P1, DOI DOI 10.3897/ZOOKEYS.150.2109; AbSaber AN, 1977, PALEOCLIMAS, V3, P1; ABSABER Aziz, 2003, DOMINIOS NATUREZA BR; Almeida E. A. B., 2010, BIOGEOGRAFIA AM PADR, P52; Amorim DS, 1996, NEOTROPICAL BIOGEOGR, P183; Bastazini CV, 2007, HERPETOLOGICA, V63, P459, DOI 10.1655/0018-0831(2007)63[459:WEVBEC]2.0.CO;2; Bates JM, 1998, J BIOGEOGR, V25, P783, DOI 10.1046/j.1365-2699.1998.2540783.x; Becker FG, 2006, BIODIVERSIDADE REGIO, P10; Brown J. H., 1998, BIOGEOGRAPHY; Caldas Francis Luiz Santos, 2011, Check List, V7, P55; Camardelli M, 2012, HERPETOLOGICA, V68, P31, DOI 10.1655/HERPETOLOGICA-D-10-00033.1; Caramaschi U, 2004, AMPHIBIA-REPTILIA, V25, P1, DOI 10.1163/156853804322992788; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carnaval AC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1461; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Carvalho SB, 2011, DIVERS DISTRIB, V17, P408, DOI 10.1111/j.1472-4642.2011.00752.x; Casagranda MD, 2012, CLADISTICS, V28, P645, DOI 10.1111/j.1096-0031.2012.00410.x; Casazza G, 2009, J BIOGEOGR, V36, P2056, DOI 10.1111/j.1365-2699.2009.02156.x; Chen YH, 2013, CURR ZOOL, V59, P449, DOI 10.1093/czoolo/59.4.449; Condamine FL, 2013, CLADISTICS, V29, P88, DOI 10.1111/j.1096-0031.2012.00412.x; Costa LP, 2000, BIOTROPICA, V32, P872; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; CROIZAT L, 1974, SYST ZOOL, V23, P265, DOI 10.2307/2412139; da Silva JMC, 2004, GLOBAL ECOL BIOGEOGR, V13, P85, DOI 10.1111/j.1466-882X.2004.00077.x; Dabes L, 2012, HERPETOLOGICA, V68, P443, DOI 10.1655/HERPETOLOGICA-D-10-00058; de Sa RO, 2014, S AM J HERPETOL, V9, pS1, DOI 10.2994/SAJH-D-13-00022.1; Duellman WE, 1999, PATTERNS DISTRIBUTIO; Ficetola GF, 2013, J BIOGEOGR, V40, P1202, DOI [10.1111/jbi.12060, 10.1111/jbi.12206]; FRANCO A. C, 1984, RESTINGAS ORIGEM EST, P413; Frost D.R., 2021, AMPHIBIAN SPECIES WO; Garcia P, 2004, IUCN RED LIST THREAT; Garcia P.C.A., 2007, CIENCIA AMBIENTE, V35, P65; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Guedes TB, 2014, J BIOGEOGR, V41, P919, DOI 10.1111/jbi.12272; Hausdorf B, 2004, J BIOGEOGR, V31, P1751, DOI 10.1111/j.1365-2699.2004.01090.x; Hausdorf B, 2003, SYST BIOL, V52, P717, DOI 10.1080/10635150390235584; Hausdorf B, 2002, SYST BIOL, V51, P648, DOI 10.1080/10635150290102320; Hennig C, 2006, SYST BIOL, V55, P170, DOI 10.1080/10635150500481523; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Humphries C.J., 1999, CLADISTIC BIOGEOGRAP; IBGE-Instituto Brasileiro de Geografia e Estatistica & USGS-United States Geological Survey, 1992, MAP VEG BRAS VECT DI; Langone J.A., 1987, Comunicaciones Zoologicas del Museo de Historia Natural de Montevideo, V11, P1; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; Maciel Daniel Bastos, 2010, Zootaxa, V2640, P53; McCune B, 2002, ANAL ECOLOGICAL COMM; McLennan DA, 2002, J BIOGEOGR, V29, P1055, DOI 10.1046/j.1365-2699.2002.00733.x; Morrone J.J., 2009, EVOLUTIONARY BIOGEOG; MORRONE JJ, 1994, SYST BIOL, V43, P438, DOI 10.2307/2413679; Morrone JJ, 2014, J BIOGEOGR, V41, P842, DOI 10.1111/jbi.12251; Muller P, 1973, BIOGEOGRAPHICA; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Napoli Marcelo Felgueiras, 1999, Alytes (Paris), V16, P165; Nelson G., 1981, SYSTEMATICS BIOGEORA; Nogueira C, 2011, J BIOGEOGR, V38, P1907, DOI 10.1111/j.1365-2699.2011.02538.x; Nunes I, 2011, HERPETOLOGICA, V67, P80, DOI 10.1655/HERPETOLOGICA-D-10-00026.1; Pellegrino KCM, 2005, BIOL J LINN SOC, V85, P13, DOI 10.1111/j.1095-8312.2005.00472.x; Pereira de Andrade Sheila, 2012, Check List, V8, P149; PLATNICK NI, 1978, SYST ZOOL, V27, P1, DOI 10.2307/2412808; Prance G.T., 1982, BIOL DIVERSIFICATION, P137; R-Core-Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Rocha CFD., 2007, Braz. J. Biol., V67, P263, DOI 10.1590/S1519-69842007000200011; ROSEN DE, 1978, SYST ZOOL, V27, P159, DOI 10.2307/2412970; Sigrist Mário Sérgio, 2008, Biota Neotrop., V8, P0, DOI 10.1590/S1676-06032008000400002; Silva J. M. C., 2005, MATA ATLANTICA BIODI, P43; Silva MB, 2008, THESIS U SAO PAULO S; Sondersom TR, 1988, P WORKSH NEOTR DISTR, P121; Souza CRG, 2008, RESTINGA CONCEITOS E; Stevaux Maria Nazaré, 2002, Rev. Bras. Zool., V19, P235, DOI 10.1590/S0101-81752002000500018; Szumik CA, 2002, SYST BIOL, V51, P806, DOI 10.1080/10635150290102483; Vasconcelos TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104130; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Wronski T, 2008, J BIOGEOGR, V35, P1759, DOI 10.1111/j.1365-2699.2008.01933.x; Zina Juliana, 2010, Check List, V6, P230	74	10	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128268	10.1371/journal.pone.0128268	http://dx.doi.org/10.1371/journal.pone.0128268			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047484	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200051
J	Draganidis, D; Chatzinikolaou, A; Avloniti, A; Barbero-Alvarez, JC; Mohr, M; Malliou, P; Gourgoulis, V; Deli, CK; Douroudos, II; Margonis, K; Gioftsidou, A; Fouris, AD; Jamurtas, AZ; Koutedakis, Y; Fatouros, IG				Draganidis, Dimitrios; Chatzinikolaou, Athanasios; Avloniti, Alexandra; Barbero-Alvarez, Jose C.; Mohr, Magni; Malliou, Paraskevi; Gourgoulis, Vassilios; Deli, Chariklia K.; Douroudos, Ioannis I.; Margonis, Konstantinos; Gioftsidou, Asimenia; Fouris, Andreas D.; Jamurtas, Athanasios Z.; Koutedakis, Yiannis; Fatouros, Ioannis G.			Recovery Kinetics of Knee Flexor and Extensor Strength after a Football Match	PLOS ONE			English	Article							PROFESSIONAL SOCCER PLAYERS; HAMSTRING/QUADRICEPS FORCE CAPACITY; MEDICAL-RESEARCH PROGRAM; MUSCLE DAMAGE; PHYSIOLOGICAL-RESPONSE; HAMSTRING INJURY; PHYSICAL PERFORMANCE; ISOKINETIC STRENGTH; PRESEASON STRENGTH; OXIDATIVE STRESS	We examined the temporal changes of isokinetic strength performance of knee flexor (KF) and extensor (KE) strength after a footballmatch. Players were randomly assigned to a control (N = 14, participated only in measurements and practices) or an experimental group (N = 20, participated also in a football match). Participants trained daily during the two days after the match. Match and training overload was monitored with GPS devices. Venous blood was sampled and muscle damage was assessed pre-match, post-match and at 12h, 36h and 60h post-match. Isometric strength as well as eccentric and concentric peak torque of knee flexors and extensors in both limbs (dominant and non-dominant) were measured on an isokinetic dynamometer at baseline and at 12h, 36h and 60h after the match. Functional (KFecc/KEcon) and conventional (KFcon/KEcon) ratios were then calculated. Only eccentric peak torque of knee flexors declined at 60h after the match in the control group. In the experimental group: a) isometric strength of knee extensors and knee flexors declined (P<0.05) at 12h (both limbs) and 36h (dominant limb only), b) eccentric and concentric peak torque of knee extensors and flexors declined (P<0.05) in both limbs for 36h at 60 degrees/s and for 60h at 180 degrees/s with eccentric peak torque of knee flexors demonstrating a greater (P<0.05) reduction than concentric peak torque, c) strength deterioration was greater (P<0.05) at 180 degrees/s and in dominant limb, d) the functional ratio was more sensitive tomatch-induced fatigue demonstrating a more prolonged decline. Discriminant and regression analysis revealed that strength deterioration and recovery may be related to the amount of eccentric actions performed during the match and athletes' football-specific conditioning. Our data suggest that recovery kinetics of knee flexor and extensor strength after a football match demonstrate strength, limb and velocity specificity and may depend on match physical overload and players' physical conditioning level.	[Draganidis, Dimitrios; Chatzinikolaou, Athanasios; Avloniti, Alexandra; Malliou, Paraskevi; Gourgoulis, Vassilios; Douroudos, Ioannis I.; Margonis, Konstantinos; Gioftsidou, Asimenia; Fatouros, Ioannis G.] Democritus Univ Thrace, Sch Phys Educ & Sports Sci, Komotini, Greece; [Barbero-Alvarez, Jose C.] Univ Granada, Melilla, Spain; [Mohr, Magni] Univ Faroe Islands, Fac Nat & Hlth Sci, Torshavn, Faroe Islands, Denmark; [Mohr, Magni] Univ Gothenburg, Dept Food & Nutr, Ctr Hlth & Human Performance, Gothenburg, Sweden; [Deli, Chariklia K.; Fouris, Andreas D.; Jamurtas, Athanasios Z.; Koutedakis, Yiannis; Fatouros, Ioannis G.] Univ Thessaly, Sch Phys Educ & Sports Sci, Trikala, Greece; [Fouris, Andreas D.; Jamurtas, Athanasios Z.; Koutedakis, Yiannis] Ctr Res & Technol, Inst Human Performance & Rehabil, Thessaly CERETETH, Trikala, Greece; [Koutedakis, Yiannis] Wolverhampton Univ, Sch Sports Performing Arts & Leisure, Wolverhampton WV1 1DJ, W Midlands, England	Democritus University of Thrace; University of Granada; University of the Faroe Islands; University of Gothenburg; University of Thessaly; University of Wolverhampton	Fatouros, IG (corresponding author), Democritus Univ Thrace, Sch Phys Educ & Sports Sci, Komotini, Greece.	ifatouro@phyed.duth.gr	GIOFTSIDOU, ASIMENIA/AAK-9858-2021; Gourgoulis, Vassilios/AAK-8611-2021; KOURETAS, DEMETRIOS/ABE-8519-2020; Jamurtas, Athanasios/Y-4568-2019; Chatzinikolaou, Athanasios/AAL-4463-2021; Deli, Chariklia K./ABD-2677-2021; Avloniti, Alexandra/AAL-4715-2021; Barbero-Alvarez, José Carlos/AAN-1205-2021; Barbero-Alvarez, Jose Carlos/ABD-1205-2021	Gourgoulis, Vassilios/0000-0001-6857-2564; KOURETAS, DEMETRIOS/0000-0002-7469-6640; Deli, Chariklia K./0000-0002-5762-8419; Barbero-Alvarez, Jose Carlos/0000-0002-4055-6332; Jamurtas, Thanasis/0000-0001-5115-9490; Koutedakis, Yiannis/0000-0002-7065-9447	Bodosakis Foundation, Athens, Greece Departmental funding	Bodosakis Foundation, Athens, Greece Departmental funding	Donation received by Bodosakis Foundation, Athens, Greece Departmental funding to IGF.	Aagaard P, 1998, AM J SPORT MED, V26, P231, DOI 10.1177/03635465980260021201; Akenhead R, 2013, J SCI MED SPORT, V16, P556, DOI 10.1016/j.jsams.2012.12.005; Ascensao A, 2008, CLIN BIOCHEM, V41, P841, DOI 10.1016/j.clinbiochem.2008.04.008; Ascensao A, 2011, J SPORT SCI, V29, P217, DOI 10.1080/02640414.2010.526132; Askling C, 2003, SCAND J MED SCI SPOR, V13, P244, DOI 10.1034/j.1600-0838.2003.00312.x; Baldari C, 2009, EUR J APPL PHYSIOL, V107, P105, DOI 10.1007/s00421-009-1107-5; Bangsbo J, 2008, SPORTS MED, V38, P37, DOI 10.2165/00007256-200838010-00004; Bangsbo J, 2006, J SPORT SCI, V24, P665, DOI 10.1080/02640410500482529; Barbero-Alvarez JC, 2010, J SCI MED SPORT, V13, P232, DOI 10.1016/j.jsams.2009.02.005; Bendiksen M, 2012, MED SCI SPORT EXER, V44, P1595, DOI 10.1249/MSS.0b013e31824cc23b; Bennell K, 1998, BRIT J SPORT MED, V32, P309, DOI 10.1136/bjsm.32.4.309; Chatzinikolaou A, 2014, J STRENGTH COND RES, V28, P1981, DOI 10.1519/JSC.0000000000000330; Chatzinikolaou A, 2014, J SPORT SCI, V32, P870, DOI 10.1080/02640414.2013.865251; CLARKSON PM, 1988, J APPL PHYSIOL, V65, P1, DOI 10.1152/jappl.1988.65.1.1; Croisier JL, 2008, AM J SPORT MED, V36, P1469, DOI 10.1177/0363546508316764; Camarda SRD, 2012, J SCI MED SPORT, V15, P355, DOI 10.1016/j.jsams.2011.11.257; Delextrat A, 2013, SCAND J MED SCI SPOR, V23, P478, DOI 10.1111/j.1600-0838.2011.01415.x; Delextrat A, 2010, INT J SPORTS MED, V31, P192, DOI 10.1055/s-0029-1243642; Ekstrand J, 2011, AM J SPORT MED, V39, P1226, DOI 10.1177/0363546510395879; Fatouros IG, 2010, J STRENGTH COND RES, V24, P3278, DOI 10.1519/JSC.0b013e3181b60444; Fousekis K, 2010, J SPORT SCI MED, V9, P364; Greco CC, 2013, CLIN PHYSIOL FUNCT I, V33, P18, DOI 10.1111/j.1475-097X.2012.01160.x; Greig M, 2008, AM J SPORT MED, V36, P1403, DOI 10.1177/0363546508314413; Hair J. F., 1992, MULTIVARIATE DATA AN; Hawkins RD, 2001, BRIT J SPORT MED, V35, P43, DOI 10.1136/bjsm.35.1.43; Ispirlidis I, 2008, CLIN J SPORT MED, V18, P423, DOI 10.1097/JSM.0b013e3181818e0b; Johnston RJ, 2014, J STRENGTH COND RES, V28, P1649, DOI 10.1519/JSC.0000000000000323; Kellis E, 2007, J SPORT SCI MED, V6, P154; KNAPIK JJ, 1991, AM J SPORT MED, V19, P76, DOI 10.1177/036354659101900113; Krustrup P, 2006, MED SCI SPORT EXER, V38, P1666, DOI 10.1249/01.mss.0000227538.20799.08; Krustrup P, 2011, EUR J APPL PHYSIOL, V111, P2987, DOI 10.1007/s00421-011-1919-y; Kurosaka M, 2012, ACTA PHYSIOL, V205, P159, DOI 10.1111/j.1748-1716.2011.02381.x; Lavender AP, 2008, J SCI MED SPORT, V11, P291, DOI 10.1016/j.jsams.2007.03.005; Magalhaes J, 2004, J SPORT MED PHYS FIT, V44, P119; Malm C, 2004, ACTA PHYSIOL SCAND, V180, P143, DOI 10.1046/j.0001-6772.2003.01232.x; Marshall PWM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102753; McCall A, 2015, BRIT J SPORT MED, V49, P583, DOI 10.1136/bjsports-2014-094104; Michailidis Y, 2013, AM J CLIN NUTR, V98, P233, DOI 10.3945/ajcn.112.049163; Mohr M, 2005, J SPORT SCI, V23, P593, DOI 10.1080/02640410400021286; Mougios V, 2007, BRIT J SPORT MED, V41, P674, DOI 10.1136/bjsm.2006.034041; Nedelec M, 2014, J STRENGTH COND RES, V28, P1517, DOI 10.1519/JSC.0000000000000293; Rahnama N, 2003, J SPORT SCI, V21, P933, DOI 10.1080/0264041031000140428; Rampinini E, 2011, MED SCI SPORT EXER, V43, P2161, DOI 10.1249/MSS.0b013e31821e9c5c; Randers MB, 2010, SCAND J MED SCI SPOR, V20, P14, DOI 10.1111/j.1600-0838.2010.01069.x; Randers MB, 2010, J SPORT SCI, V28, P171, DOI 10.1080/02640410903428525; Scott BR, 2013, INT J SPORT PHYSIOL, V8, P195, DOI 10.1123/ijspp.8.2.195; Silva JR, 2013, EUR J APPL PHYSIOL, V113, P2193, DOI 10.1007/s00421-013-2633-8; Small K, 2008, J SCI MED SPORT, V29, P1; Takarada Y, 2003, BRIT J SPORT MED, V37, P416, DOI 10.1136/bjsm.37.5.416; Varley MC, 2013, INT J SPORTS MED, V34, P34, DOI 10.1055/s-0032-1316315; Warren GL, 1999, SPORTS MED, V27, P43, DOI 10.2165/00007256-199927010-00004; Woods C, 2004, BRIT J SPORT MED, V38, P36, DOI 10.1136/bjsm.2002.002352; Young WB, 2012, J STRENGTH COND RES, V26, P492, DOI 10.1519/JSC.0b013e318225a1c4; Zebis MK, 2011, J STRENGTH COND RES, V25, P1989, DOI 10.1519/JSC.0b013e3181e501a6	54	25	25	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128072	10.1371/journal.pone.0128072	http://dx.doi.org/10.1371/journal.pone.0128072			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043222	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600032
J	Ling, ZG; Wu, YB; Ming, MY; Cai, SQ; Chen, YQ				Ling, Zhou-Gui; Wu, Yan-bin; Ming, Mo-yu; Cai, Shuang-qi; Chen, Yi-Qiang			The Effect of Pleural Abrasion on the Treatment of Primary Spontaneous Pneumothorax: A Systematic Review of Randomized Controlled Trials	PLOS ONE			English	Article							STAPLE LINE COVERAGE; THORACOSCOPIC SURGERY; MECHANICAL PLEURODESIS; SURGICAL-MANAGEMENT; AUTOLOGOUS BLOOD; TUBE DRAINAGE; TALC POUDRAGE; BULLECTOMY; THORACOTOMY; METAANALYSIS	Background Pleural abrasion has been widely used to control the recurrence of primary spontaneous pneumothorax (PSP). However, controversy still exists regarding the advantages and disadvantages of pleural abrasion compared with other interventions in preventing the recurrence of PSP. Methods The PubMed, Embase, and Cochrane Central Register of Controlled Trials databases were searched up to December 15, 2014 to identify randomized controlled trials (RCTs) that compared the effects of pleural abrasion with those of other interventions in the treatment of PSP. The study outcomes included the PSP recurrence rate and the occurrence rate of adverse effects. Results Mechanical pleural abrasion and apical pleurectomy after thoracoscopic stapled bullectomy exhibited similarly persistent postoperative air leak occurrence rates (p = 0.978) and 1-year PSP recurrence rates (p = 0.821), whereas pleural abrasion led to reduced residual chest pain and discomfort (p = 0.001) and a smaller rate of hemothorax (p = 0.036) than did apical pleurectomy. However, the addition of minocycline pleurodesis to pleural abrasion did not reduce the pneumothorax recurrence rate compared with apical pleurectomy (3.8% for both procedures) but was associated with fewer complications. There was no statistical difference in the pneumothorax recurrence rate between mechanical pleural abrasion and chemical pleurodesis with minocycline on either an intention-to-treat basis (4 of 42 versus 0 of 42, p = 0.12; Fisher exact test) or after exclusions (2 of 40 versus 0 of 42, p = 0.24; Fisher exact test). Pleural abrasion plus minocycline pleurodesis also did not reduce the pneumothorax recurrence rate compared with pleural abrasion alone (p = 0.055). Moreover, pleural abrasion plus minocycline pleurodesis was associated with more intense acute chest pain. The postoperative overall recurrence rate in patients who underwent staple line coverage with absorbable cellulose mesh and fibrin glue was similar to that with mechanical abrasion after thoracoscopic bullectomy (13.8% vs. 14.2%, respectively; p = 0.555), but staple line coverage resulted in less postoperative residual pain than mechanical abrasion (0.4% vs. 3.2%; p<0.0001). Pleural abrasion after thoracoscopic wedge resection did not decrease the recurrence of pneumothorax compared with wedge resection alone (p = 0.791), but the intraoperative bleeding and postoperative pleural drainage rates were higher when pleural abrasion was performed. Conclusions In addition to resulting in the same pneumothorax recurrence rate, thoracoscopic pleural abrasion with or without minocycline pleurodesis is safer than apical pleurectomy in the treatment of PSP. However, minocycline pleurodesis with or without pleural abrasion is not any more effective than pleural abrasion alone. Moreover, additional mechanical abrasion is not safer than additional staple line coverage with absorbable cellulose mesh and fibrin glue after thoracoscopic bullectomy because of increased postoperative pain. Additionally, pleural abrasion after thoracoscopic wedge resection should not be recommended for routine application due to the greater incidence of adverse effects than wedge resection alone. However, further large-scale, well-designed RCTs are needed to confirm the best procedure.	[Ling, Zhou-Gui; Wu, Yan-bin; Cai, Shuang-qi; Chen, Yi-Qiang] Guangxi Med Univ, Affiliated Hosp 1, Inst Resp Dis, Nanning, Guangxi, Peoples R China; [Ming, Mo-yu] Guangxi Med Univ, Affiliated Hosp 4, Dept Resp Dis, Liuzhou, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University	Chen, YQ (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Inst Resp Dis, Nanning, Guangxi, Peoples R China.	chenyq228@163.com			National Natural Science Foundation of China [81360018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by research grant 81360018 from National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aelony Y, 2003, CHEST, V123, P1318, DOI 10.1378/chest.123.4.1318; Alayouty HD, 2011, INTERACT CARDIOV TH, V13, P475, DOI 10.1510/icvts.2011.270280; Ayed AK, 2009, KUWAIT MED J, V41, P108; Ayed AK, 2000, MED PRIN PRACT, V9, P113, DOI 10.1159/000026127; Ayed AK, 2006, EUR RESPIR J, V27, P477, DOI 10.1183/09031936.06.00091505; Ayed AK, 2000, CHEST, V118, P235, DOI 10.1378/chest.118.1.235; BERGER R, 1994, CHEST, V106, P992, DOI 10.1378/chest.106.4.992; Bertrand PC, 1996, ANN THORAC SURG, V61, P1641, DOI 10.1016/0003-4975(96)00190-7; Bille A, 2012, GEN THORAC CARDIOVAS, V60, P321, DOI 10.1007/s11748-012-0080-9; Cao GQ, 2012, ANN THORAC SURG, V93, P1652, DOI 10.1016/j.athoracsur.2012.01.093; Cardillo G, 2006, J THORAC CARDIOV SUR, V131, P322, DOI 10.1016/j.jtcvs.2005.10.025; Chang YC, 2006, SURG ENDOSC, V20, P757, DOI 10.1007/s00464-005-0275-6; Chen JS, 2012, ANN SURG, V255, P440, DOI 10.1097/SLA.0b013e31824723f4; Chen JS, 2006, AM J RESP CRIT CARE, V173, P548, DOI 10.1164/rccm.200509-1414OC; Cho S, 2009, SURG ENDOSC, V23, P986, DOI 10.1007/s00464-008-0083-x; Dikensoy O, 2005, CURR OPIN PULM MED, V11, P340, DOI 10.1097/01.mcp.0000166587.24127.91; Freixinet JL, 2004, ANN THORAC SURG, V78, P417, DOI 10.1016/j.athoracsur.2003.11.038; Grundy S, 2012, RESPIRATION, V83, P185, DOI 10.1159/000335993; Gu WJ, 2012, CHEST, V142, P859, DOI 10.1378/chest.12-0679; Henry M, 2003, THORAX, V58, pII39, DOI 10.1136/thorax.58.suppl_2.ii39; Huh Up, 2012, Korean J Thorac Cardiovasc Surg, V45, P316, DOI 10.5090/kjtcs.2012.45.5.316; Jiang L, 2014, ANN THORAC SURG, V97, P1008, DOI 10.1016/j.athoracsur.2013.10.031; Lang-Lazdunski L, 2003, ANN THORAC SURG, V75, P960, DOI 10.1016/S0003-4975(02)04544-7; LANGE P, 1988, THORAX, V43, P559, DOI 10.1136/thx.43.7.559; Lee S, 2013, ANN THORAC SURG, V95, P1919, DOI 10.1016/j.athoracsur.2013.03.011; Lee S, 2014, ANN THORAC SURG, V98, P2005, DOI 10.1016/j.athoracsur.2014.06.047; [李志军 LI Zhijun], 2006, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V32, P711; Margolis M, 2003, ANN THORAC SURG, V76, P1661, DOI 10.1016/S0003-4975(02)04816-6; Massard G, 1998, ANN THORAC SURG, V66, P592, DOI 10.1016/S0003-4975(98)00621-3; Min XJ, 2014, ANN THORAC SURG, V98, P1790, DOI 10.1016/j.athoracsur.2014.06.034; Mohamed EE, 2013, EGYPT J CHEST DIS TU, V62, P105, DOI 10.1016/j.ejcdt.2013.01.004; Muramatsu T, 2007, SURG TODAY, V37, P745, DOI 10.1007/s00595-007-3512-x; NKERE UU, 1994, THORAC CARDIOV SURG, V42, P45, DOI 10.1055/s-2007-1016454; Noppen M, 2002, AM J RESP CRIT CARE, V165, P1240, DOI 10.1164/rccm.200111-078OC; Park JS, 2012, SURG LAPARO ENDO PER, V22, P62, DOI 10.1097/SLE.0b013e31823cc61e; Peter JV, 2008, BMJ-BRIT MED J, V336, P1006, DOI 10.1136/bmj.39537.939039.BE; Rera O, 2008, EUR RESPIR J, V31, P837, DOI 10.1183/09031936.00140806; ROBINSON CLN, 1987, CAN J SURG, V30, P428; Rodriguez-Panadero F, 2012, RESPIRATION, V83, P91, DOI 10.1159/000335419; Sakamoto K, 2004, SURG ENDOSC, V18, P478, DOI 10.1007/s00464-003-8918-y; SEREMETIS MG, 1970, CHEST, V57, P65, DOI 10.1378/chest.57.1.65; Suarez P M Rodriguez, 2013, Monaldi Arch Chest Dis, V79, P81; WALLER DA, 1994, ANN THORAC SURG, V58, P372, DOI 10.1016/0003-4975(94)92210-1; WEEDEN D, 1983, THORAX, V38, P737, DOI 10.1136/thx.38.10.737; WIED U, 1983, J THORAC CARDIOV SUR, V86, P591; Xia H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087060; YOUMANS CR, 1970, AM J SURG, V120, P644, DOI 10.1016/S0002-9610(70)80185-4	47	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0127857	10.1371/journal.pone.0127857	http://dx.doi.org/10.1371/journal.pone.0127857			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042737	Green Published, gold, Green Submitted			2022-12-27	WOS:000355701600026
J	Park, SB; Kim, B; Bae, H; Lee, H; Lee, S; Choi, EH; Kim, SJ				Park, Sung-Bin; Kim, Byungtak; Bae, Hansol; Lee, Hyunkyung; Lee, Seungyeon; Choi, Eun H.; Kim, Sun Jung			Differential Epigenetic Effects of Atmospheric Cold Plasma on MCF-7 and MDA-MB-231 Breast Cancer Cells	PLOS ONE			English	Article							DNA METHYLATION; OXIDATIVE STRESS; OVARIAN-CANCER; APOPTOSIS; THERAPY; GENES; CARCINOGENESIS; METASTASIS; EXPRESSION; PROMOTER	Cold atmospheric plasma (plasma) has emerged as a novel tool for a cancer treatment option, having been successfully applied to a few types of cancer cells, as well as tissues. However, to date, no studies have been performed to examine the effect of plasma on epigenetic alterations, including CpG methylation. In this study, the effects of plasma on DNA methylation changes in breast cancer cells were examined by treating cultured MCF-7 and MDA-MB-231 cells, representing estrogen-positive and estrogen-negative cancer cells, respectively, with plasma. A pyrosequencing analysis of Alu indicated that a specific CpG site was induced to be hypomethylated from 23.4 to 20.3% (p < 0.05) by plasma treatment in the estrogen-negative MDA-MB-231 cells only. A genome-wide methylation analysis identified "cellular movement, connective tissue development and function, tissue development" and "cell-to-cell signaling and interaction, cell death and survival, cellular development" as the top networks. Of the two cell types, the MDA-MB-231 cells underwent a higher rate of apoptosis and a decreased proliferation rate upon plasma treatment. Taken together, these results indicate that plasma induces epigenetic and cellular changes in a cell type-specific manner, suggesting that a careful screening of target cells and tissues is necessary for the potential application of plasma as a cancer treatment option.	[Park, Sung-Bin; Kim, Byungtak; Bae, Hansol; Lee, Hyunkyung; Lee, Seungyeon; Kim, Sun Jung] Dongguk Univ Seoul, Dept Life Sci, Goyang, South Korea; [Choi, Eun H.] Kwangwoon Univ, Plasma Biosci Res Ctr, Seoul, South Korea	Dongguk University; Kwangwoon University	Kim, SJ (corresponding author), Dongguk Univ Seoul, Dept Life Sci, Goyang, South Korea.	sunjungk@dongguk.edu	Choi, Eun Ha/AFN-9488-2022; kim, sun jung/T-1013-2019	Choi, Eun Ha/0000-0001-5385-1878; 	National Research Foundation of Korea [NRF-2012R1A1A2040830, NRF-2010-0027963]	National Research Foundation of Korea(National Research Foundation of Korea)	Funding was provided by National Research Foundation of Korea (www.nrf.re.kr) grants NRF-2012R1A1A2040830 and NRF-2010-0027963. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpay M, 2015, BREAST CANCER RES TR, V151, P75, DOI 10.1007/s10549-015-3368-5; Arndt S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079325; Arndt S, 2013, EXP DERMATOL, V22, P284, DOI 10.1111/exd.12127; Aypar U, 2011, MUTAT RES-FUND MOL M, V707, P24, DOI 10.1016/j.mrfmmm.2010.12.003; Bekeschus S, 2014, FREE RADICAL RES, V48, P542, DOI 10.3109/10715762.2014.892937; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Chang JW, 2014, ARCH BIOCHEM BIOPHYS, V545, P133, DOI 10.1016/j.abb.2014.01.022; Cui Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002990; Deferme L, 2015, TOXICOL IN VITRO, V29, P845, DOI 10.1016/j.tiv.2015.03.007; Faryna M, 2012, FASEB J, V26, P4937, DOI 10.1096/fj.12-209502; Geiger TR, 2007, CANCER RES, V67, P6221, DOI 10.1158/0008-5472.CAN-07-0121; Goetz W, 2011, RADIAT RES, V175, P575, DOI 10.1667/RR2390.1; Guerrero-Preston R, 2014, INT J MOL MED, V34, P941, DOI 10.3892/ijmm.2014.1849; Hu JM, 2014, EPIGENETICS-US, V9, P1366, DOI 10.4161/15592294.2014.969625; Huoh YS, 2014, BIOCHEMISTRY-US, V53, P4946, DOI 10.1021/bi5005156; Ishaq M, 2014, INT J CANCER, V134, P1517, DOI 10.1002/ijc.28323; Jha P, 2014, NEURO-ONCOLOGY, V16, P1607, DOI 10.1093/neuonc/nou113; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Kile ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013730; Kim JY, 2010, SMALL, V6, P1474, DOI 10.1002/smll.201000480; KOCHANEK S, 1993, EMBO J, V12, P1141, DOI 10.1002/j.1460-2075.1993.tb05755.x; Koritzer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064498; Lahtz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044858; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee HS, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005260; Liebmann J, 2011, NITRIC OXIDE-BIOL CH, V24, P8, DOI 10.1016/j.niox.2010.09.005; Ma YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091947; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Partecke LI, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-473; Pawlowski KM, 2013, VET RES COMMUN, V37, P123, DOI 10.1007/s11259-013-9554-1; Pickeral OK, 2000, GENOME RES, V10, P411, DOI 10.1101/gr.10.4.411; Saka M, 2010, J NEUROSURG, V113, P270, DOI 10.3171/2009.9.JNS09708; Thiyagarajan M, 2014, BIOTECHNOL BIOENG, V111, P565, DOI 10.1002/bit.25114; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214; Utsumi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081576; Wang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073741; Woloszynska-Read A, 2008, CLIN CANCER RES, V14, P3283, DOI 10.1158/1078-0432.CCR-07-5279; Wu QH, 2015, CURR DRUG TARGETS, V16, P13, DOI 10.2174/1389450116666150113121054; Yan PS, 2003, CANCER RES, V63, P6178; Ye S, 2014, MUTAT RES-GEN TOX EN, V773, P34, DOI 10.1016/j.mrgentox.2014.08.004; Zhou F, 2014, CLIN CHEM LAB MED, V52, P735, DOI 10.1515/cclm-2013-0736	42	49	51	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0129931	10.1371/journal.pone.0129931	http://dx.doi.org/10.1371/journal.pone.0129931			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042423	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600103
J	Wang, CW; Perez, MJ; Helmke, BP; Viola, F; Lawrence, MB				Wang, Caroline W.; Perez, Matthew J.; Helmke, Brian P.; Viola, Francesco; Lawrence, Michael B.			Integration of Acoustic Radiation Force and Optical Imaging for Blood Plasma Clot Stiffness Measurement	PLOS ONE			English	Article							VISCOELASTIC PROPERTIES; IN-VIVO; MECHANICAL-PROPERTIES; ELASTIC PROPERTIES; CONTRACTILE-FORCE; TISSUE FACTOR; COAGULATION; STRAIN; THROMBOELASTOGRAPHY; MICRORHEOLOGY	Despite the life-preserving function blood clotting serves in the body, inadequate or excessive blood clot stiffness has been associated with life-threatening diseases such as stroke, hemorrhage, and heart attack. The relationship between blood clot stiffness and vascular diseases underscores the importance of quantifying the magnitude and kinetics of blood's transformation from a fluid to a viscoelastic solid. To measure blood plasma clot stiffness, we have developed a method that uses ultrasound acoustic radiation force (ARF) to induce micron-scaled displacements (1-500 mu m) on microbeads suspended in blood plasma. The displacements were detected by optical microscopy and took place within a micro-liter sized clot region formed within a larger volume (2 mL sample) to minimize container surface effects. Modulation of the ultrasound generated acoustic radiation force allowed stiffness measurements to be made in blood plasma from before its gel point to the stage where it was a fully developed viscoelastic solid. A 0.5 wt % agarose hydrogel was 9.8-fold stiffer than the plasma (platelet-rich) clot at 1 h post-kaolin stimulus. The acoustic radiation force microbead method was sensitive to the presence of platelets and strength of coagulation stimulus. Platelet depletion reduced clot stiffness 6.9 fold relative to platelet rich plasma. The sensitivity of acoustic radiation force based stiffness assessment may allow for studying platelet regulation of both incipient and mature clot mechanical properties.	[Wang, Caroline W.; Perez, Matthew J.; Helmke, Brian P.; Lawrence, Michael B.] Univ Virginia Hlth Syst, Dept Biomed Engn, Sch Engn & Appl Sci, Charlottesville, VA 22903 USA; [Wang, Caroline W.; Perez, Matthew J.; Helmke, Brian P.; Lawrence, Michael B.] Univ Virginia Hlth Syst, Sch Med, Charlottesville, VA USA; [Viola, Francesco] HemoSonics LLC, Charlottesville, VA USA	University of Virginia; University of Virginia	Lawrence, MB (corresponding author), Univ Virginia Hlth Syst, Dept Biomed Engn, Sch Engn & Appl Sci, Charlottesville, VA 22903 USA.	mbl2a@virginia.edu			National Institutes of Health [1R01EB005433, 4R44DK085844, 5T32GM080186]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R44DK085844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge grant support from the National Institutes of Health (1R01EB005433 (MBL), 4R44DK085844 (FV), and 5T32GM080186 (JB)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2004, J RHEOL, V48, P1195, DOI 10.1122/1.1795193; Averett LE, 2009, BIOPHYS J, V97, P2820, DOI [10.1016/j.bpj.2009.0X.042, 10.1016/j.bpj.2009.08.042]; Averett RD, 2012, BIOPHYS J, V103, P1537, DOI 10.1016/j.bpj.2012.08.038; Barrangou LM, 2006, FOOD HYDROCOLLOID, V20, P184, DOI 10.1016/j.foodhyd.2005.02.019; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bouchard RR, 2009, J ACOUST SOC AM, V126, P2733, DOI 10.1121/1.3238235; Burghardt WR, 1995, BIORHEOLOGY, V32, P621, DOI 10.1016/0006-355X(95)00041-7; Cakmak O, 2013, METHODS, V63, P225, DOI 10.1016/j.ymeth.2013.07.009; Calor MM, 2006, ULTRASOUND MED BIOL, V32, P1055, DOI 10.1016/j.ultrasmedbio.2006.04.002; Carr ME, 2003, CELL BIOCHEM BIOPHYS, V38, P55, DOI 10.1385/CBB:38:1:55; Chaudhuri O, 2009, NAT METHODS, V6, P383, DOI [10.1038/NMETH.1320, 10.1038/nmeth.1320]; Cheezum MK, 2001, BIOPHYS J, V81, P2378, DOI 10.1016/S0006-3495(01)75884-5; Chitlur M, 2008, BRIT J HAEMATOL, V142, P250, DOI 10.1111/j.1365-2141.2008.07063.x; Cicuta P, 2007, SOFT MATTER, V3, P1449, DOI 10.1039/b706004c; Collet JP, 2006, ARTERIOSCL THROM VAS, V26, P2567, DOI 10.1161/01.ATV.0000241589.52950.4c; Collet JP, 2005, P NATL ACAD SCI USA, V102, P9133, DOI 10.1073/pnas.0504120102; Culjat MO, 2010, ULTRASOUND MED BIOL, V36, P861, DOI 10.1016/j.ultrasmedbio.2010.02.012; Dayton PA, 2002, J ACOUST SOC AM, V112, P2183, DOI 10.1121/1.1509428; Deen, 1998, ANAL TRANSPORT PHENO; DELGROSS.VA, 1972, J ACOUST SOC AM, V52, P1442, DOI 10.1121/1.1913258; Elliott A, 2015, INT J STROKE, V10, P194, DOI 10.1111/j.1747-4949.2012.00919.x; Essell J H, 1993, J Cardiothorac Vasc Anesth, V7, P410, DOI 10.1016/1053-0770(93)90161-D; Evans PA, 2008, MED ENG PHYS, V30, P671, DOI 10.1016/j.medengphy.2007.08.005; Evans P. A., 2006, RHEOLOGY REV, P255; Fatemi M, 2003, P IEEE, V91, P1503, DOI 10.1109/JPROC.2003.817865; Fernandez E, 2008, J POLYM SCI POL PHYS, V46, P322, DOI 10.1002/polb.21370; Fine I, 2012, LASER PHYS, V22, P469, DOI 10.1134/S1054660X12020090; Gennisson JL, 2006, ULTRASOUND MED BIOL, V32, P1529, DOI 10.1016/j.ultrasmedbio.2006.06.008; Greenleaf JF, 2003, ANNU REV BIOMED ENG, V5, P57, DOI 10.1146/annurev.bioeng.5.040202.121623; Guthold M, 2007, CELL BIOCH BIOPHYS; Hamhaber U, 2003, MAGNET RESON MED, V49, P71, DOI 10.1002/mrm.10343; Hathcock JJ, 2006, ARTERIOSCL THROM VAS, V26, P1729, DOI 10.1161/01.ATV.0000229658.76797.30; Hooke R, 1678, LECT POTENTIA RESTIT; Huang CC, 2011, ULTRASOUND MED BIOL, V37, P1722, DOI 10.1016/j.ultrasmedbio.2011.06.026; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Ilinskii YA, 2005, J ACOUST SOC AM, V117, P2338, DOI 10.1121/1.1863672; JEN CJ, 1982, CELL MOTIL CYTOSKEL, V2, P445, DOI 10.1002/cm.970020504; JENSEN JA, 1992, IEEE T ULTRASON FERR, V39, P262, DOI 10.1109/58.139123; Jerjes-Sanchez C, 2005, EUR HEART J, V26, P3, DOI 10.1093/eurheartj/ehi041; Kashuk JL, 2009, SURGERY, V146, P764, DOI 10.1016/j.surg.2009.06.054; Katori N, 2005, ANESTH ANALG, V100, P1781, DOI 10.1213/01.ANE.0000149902.73689.64; Khurana S, 1997, J LAB CLIN MED, V130, P401, DOI 10.1016/S0022-2143(97)90040-8; Kopechek JA, 2011, J ACOUST SOC AM, V130, P3472, DOI 10.1121/1.3626124; Lam WA, 2011, NAT MATER, V10, P61, DOI 10.1038/NMAT2903; Lang T, 2004, J THROMB HAEMOST, V2, P147, DOI 10.1111/j.1538-7836.2004.00555.x; Leighton TG, 2007, PROG BIOPHYS MOL BIO, V93, P3, DOI 10.1016/j.pbiomolbio.2006.07.026; Liang XM, 2010, LAB CHIP, V10, P991, DOI 10.1039/b918719g; Liu W, 2010, J THROMB HAEMOST, V8, P1030, DOI 10.1111/j.1538-7836.2010.03745.x; Long JA, 2005, ASAIO J, V51, P563, DOI 10.1097/01.mat.0000180353.12963.f2; Mauldin FW, 2010, CLIN CHIM ACTA, V411, P638, DOI 10.1016/j.cca.2010.01.018; Negron LA, 2002, IEEE T ULTRASON FERR, V49, P1543, DOI 10.1109/TUFFC.2002.1049736; Nielsen VG, 2000, ANESTH ANALG, V91, P35, DOI 10.1097/00000539-200007000-00007; Nightingale K, 2003, ULTRASOUND MED BIOL, V29, P1715, DOI 10.1016/j.ultrasmedbio.2003.08.008; Nightingale K, 2002, ULTRASON, P1821; Nightingale K, 2002, ULTRASOUND MED BIOL, V28, P227, DOI 10.1016/S0301-5629(01)00499-9; Palmeri ML, 2008, ULTRASOUND MED BIOL, V34, P546, DOI 10.1016/j.ultrasmedbio.2007.10.009; Park J.B., 2007, BIOMATERIALS; PARKER KJ, 1990, ULTRASOUND MED BIOL, V16, P241, DOI 10.1016/0301-5629(90)90003-U; Riha P, 1999, CLIN HEMORHEOL MICRO, V21, P45; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; Schmitt C, 2013, IEEE T MED IMAGING, V32, P565, DOI 10.1109/TMI.2012.2231093; Schmitt C, 2011, J BIOMECH, V44, P622, DOI 10.1016/j.jbiomech.2010.11.015; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott DJA, 2011, ARTERIOSCL THROM VAS, V31, P3004, DOI 10.1161/ATVBAHA.111.236786; Shah JV, 1997, RHEOL ACTA, V36, P262, DOI 10.1007/BF00366667; Shinton NK, 2010, DESK REFERENCE HEMAT; TORR GR, 1984, AM J PHYS, V52, P402, DOI 10.1119/1.13625; Tran R, 2013, J CELL MOL MED, V17, P579, DOI 10.1111/jcmm.12041; Tripathi MM, 2014, BIOMED OPT EXPRESS, V5, P817, DOI 10.1364/BOE.5.000817; Viola F, 2004, ANN BIOMED ENG, V32, P696, DOI 10.1023/B:ABME.0000030235.72255.df; Viola F, 2003, IEEE T ULTRASON FERR, V50, P736, DOI 10.1109/TUFFC.2003.1209564; Viola F, 2010, CLIN CHIM ACTA, V411, P106, DOI 10.1016/j.cca.2009.10.017; Weihs D, 2006, BIOPHYS J, V91, P4296, DOI 10.1529/biophysj.106.081109; Weisel JW, 2010, J THROMB HAEMOST, V8, P1027, DOI 10.1111/j.1538-7836.2010.03808.x; Weisel JW, 2008, SCIENCE, V320, P456, DOI 10.1126/science.1154210; Xu WC, 2012, J MICROELECTROMECH S, V21, P302, DOI 10.1109/JMEMS.2011.2179011	76	5	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128799	10.1371/journal.pone.0128799	http://dx.doi.org/10.1371/journal.pone.0128799			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042775	Green Published, gold, Green Submitted			2022-12-27	WOS:000355701600067
J	Yuan, ML; Zhang, QL; Guo, ZL; Wang, J; Shen, YY				Yuan, Ming-Long; Zhang, Qi-Lin; Guo, Zhong-Long; Wang, Juan; Shen, Yu-Ying			The Complete Mitochondrial Genome of Corizus tetraspilus (Hemiptera: Rhopalidae) and Phylogenetic Analysis of Pentatomomorpha	PLOS ONE			English	Article							GENE REARRANGEMENTS; NUCLEAR 18S; RNA GENES; HETEROPTERA; INSECTA; BUG; SEQUENCES; EVOLUTION; MODEL; CHARACTERS	Insect mitochondrial genome (mitogenome) are the most extensively used genetic information for molecular evolution, phylogenetics and population genetics. Pentatomomorpha (>14,000 species) is the second largest infraorder of Heteroptera and of great economic importance. To better understand the diversity and phylogeny within Pentatomomorpha, we sequenced and annotated the complete mitogenome of Corizus tetraspilus (Hemiptera: Rhopalidae), an important pest of alfalfa in China. We analyzed the main features of the C. tetraspilus mitogenome, and provided a comparative analysis with four other Coreoidea species. Our results reveal that gene content, gene arrangement, nucleotide composition, codon usage, rRNA structures and sequences of mitochondrial transcription termination factor are conserved in Coreoidea. Comparative analysis shows that different protein-coding genes have been subject to different evolutionary rates correlated with the G+C content. All the transfer RNA genes found in Coreoidea have the typical clover leaf secondary structure, except for trnS1 (AGN) which lacks the dihydrouridine (DHU) arm and possesses a unusual anticodon stem (9 bp vs. the normal 5 bp). The control regions (CRs) among Coreoidea are highly variable in size, of which the CR of C. tetraspilus is the smallest (440 bp), making the C. tetraspilus mitogenome the smallest (14,989 bp) within all completely sequenced Coreoidea mitogenomes. No conserved motifs are found in the CRs of Coreoidea. In addition, the A+T content (60.68%) of the CR of C. tetraspilus is much lower than that of the entire mitogenome (74.88%), and is lowest among Coreoidea. Phylogenetic analyses based on mitogenomic data support the monophyly of each superfamily within Pentatomomorpha, and recognize a phylogenetic relationship of (Aradoidea + (Pentatomoidea + (Lygaeoidea + (Pyrrhocoroidea + Coreoidea)))).	[Yuan, Ming-Long; Zhang, Qi-Lin; Guo, Zhong-Long; Wang, Juan; Shen, Yu-Ying] Lanzhou Univ, State Key Lab Grassland Agroecosyst, Coll Pastoral Agr Sci & Technol, Lanzhou 730000, Gansu, Peoples R China	Lanzhou University	Yuan, ML (corresponding author), Lanzhou Univ, State Key Lab Grassland Agroecosyst, Coll Pastoral Agr Sci & Technol, Lanzhou 730000, Gansu, Peoples R China.	yuanml@lzu.edu.cn	Yuan, Ming-Long/Q-6798-2019	Yuan, Ming-Long/0000-0002-4078-8723; Zhang, Qi-Lin/0000-0002-7055-897X	Keygrant Project of Chinese Ministry of Education [313028]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13019]; Fundamental Research Funds for the Central Universities [lzujbky-2012-91]	Keygrant Project of Chinese Ministry of Education(Ministry of Education, China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The research was funded by the Keygrant Project of Chinese Ministry of Education (313028), the Program for Changjiang Scholars and Innovative Research Team in University (IRT13019), and the Fundamental Research Funds for the Central Universities (lzujbky-2012-91). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boore JL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-182; Boore JL, 2006, TRENDS ECOL EVOL, V21, P439, DOI 10.1016/j.tree.2006.05.009; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 2001, MOL BIOL EVOL, V18, P1413, DOI 10.1093/oxfordjournals.molbev.a003925; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Cameron SL, 2012, MOL PHYLOGENET EVOL, V65, P163, DOI 10.1016/j.ympev.2012.05.034; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-15; Cook CE, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-105; Dai Yuting, 2012, Entomotaxonomia, V34, P613; Dowton M, 2002, INVERTEBR SYST, V16, P345, DOI 10.1071/IS02003; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Henry TJ, 1997, ANN ENTOMOL SOC AM, V90, P275, DOI 10.1093/aesa/90.3.275; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hua Ji-Meng, 2009, Acta Zootaxonomica Sinica, V34, P1; Hua JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-610; Jung S, 2011, MOL ECOL RESOUR, V11, P266, DOI 10.1111/j.1755-0998.2010.02945.x; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kocher A, 2014, GENE, V552, P184, DOI 10.1016/j.gene.2014.09.033; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lavrov DV, 2000, P NATL ACAD SCI USA, V97, P13738, DOI 10.1073/pnas.250402997; Lavrov DV, 2002, MOL BIOL EVOL, V19, P163, DOI 10.1093/oxfordjournals.molbev.a004068; Leavitt JR, 2013, MOL PHYLOGENET EVOL, V67, P494, DOI 10.1016/j.ympev.2013.02.019; Lee W, 2009, MOL CELLS, V28, P155, DOI 10.1007/s10059-009-0125-9; Li HM, 2005, MOL PHYLOGENET EVOL, V37, P313, DOI 10.1016/j.ympev.2005.07.013; Li H, 2016, MITOCHONDRIAL DNA A, V27, P14, DOI 10.3109/19401736.2013.867437; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045925; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029419; Li H, 2012, INT J BIOL SCI, V8, P93, DOI 10.7150/ijbs.8.93; Li T, 2016, MITOCHONDRIAL DNA A, V27, P618, DOI 10.3109/19401736.2014.908372; Li T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055381; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu L, 2012, ZOOTAXA, P29; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mao M, 2014, GENOME BIOL EVOL, V6, P1862, DOI 10.1093/gbe/evu145; Masta SE, 2004, MOL BIOL EVOL, V21, P893, DOI 10.1093/molbev/msh096; Masta SE, 2010, GENE, V449, P9, DOI 10.1016/j.gene.2009.09.009; Miller M.A., 2010, P GAT COMP ENV WORKS; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Page RDM, 2000, NUCLEIC ACIDS RES, V28, P3839, DOI 10.1093/nar/28.20.3839; Park DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018749; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Raupach MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106940; Roberti M, 2003, NUCLEIC ACIDS RES, V31, P1597, DOI 10.1093/nar/gkg272; Shi AM, 2012, ZOOTAXA, P23, DOI 10.11646/zootaxa.3238.1.2; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Song N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048778; Song W, 2013, ZOOTAXA, V3620, P260, DOI 10.11646/zootaxa.3620.2.4; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tian XX, 2011, ZOOTAXA, P57, DOI 10.11646/zootaxa.2888.1.5; Wang IJ, 2010, MOL ECOL, V19, P2605, DOI 10.1111/j.1365-294X.2010.04715.x; Wang P, 2014, INSECT SCI, V21, P159, DOI 10.1111/1744-7917.12029; Wang Y, 2016, MITOCHONDRIAL DNA A, V27, P222, DOI 10.3109/19401736.2014.880898; Wang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101375; WANG YP, 2013, PLOS COMPUT BIOL, V9, DOI DOI 10.1371/JOURNAL.PONE.0077511; Wei SJ, 2014, MOL PHYLOGENET EVOL, V77, P1, DOI 10.1016/j.ympev.2014.03.023; Weirauch C, 2011, ANNU REV ENTOMOL, V56, P487, DOI 10.1146/annurev-ento-120709-144833; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xie Q, 2005, MOL PHYLOGENET EVOL, V34, P448, DOI 10.1016/j.ympev.2004.10.015; Yuan ML, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-597; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7; Zhang QL, 2016, MITOCHONDRIAL DNA A, V27, P734, DOI 10.3109/19401736.2014.913164; Zhang QL, 2013, MITOCHONDR DNA, V24, P469, DOI 10.3109/19401736.2013.766182; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	72	38	44	5	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0129003	10.1371/journal.pone.0129003	http://dx.doi.org/10.1371/journal.pone.0129003			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042898	gold, Green Published, Green Submitted			2022-12-27	WOS:000355701600080
J	O'Donnell, AJ; Cook, ER; Palmer, JG; Turney, CSM; Page, GFM; Grierson, PF				O'Donnell, Alison J.; Cook, Edward R.; Palmer, Jonathan G.; Turney, Chris S. M.; Page, Gerald F. M.; Grierson, Pauline F.			Tree Rings Show Recent High Summer-Autumn Precipitation in Northwest Australia Is Unprecedented within the Last Two Centuries	PLOS ONE			English	Article							SOUTHERN ANNULAR MODE; TROPICAL CYCLONE ACTIVITY; CLIMATE-CHANGE; RAINFALL VARIABILITY; WESTERN-AUSTRALIA; WINTER RAINFALL; TRENDS; TIME; MILLENNIUM; EVOLUTION	An understanding of past hydroclimatic variability is critical to resolving the significance of recent recorded trends in Australian precipitation and informing climate models. Our aim was to reconstruct past hydroclimatic variability in semi-arid northwest Australia to provide a longer context within which to examine a recent period of unusually high summer-autumn precipitation. We developed a 210-year ring-width chronology from Callitris columellaris, which was highly correlated with summer-autumn (Dec-May) precipitation (r = 0.81; 1910-2011; p < 0.0001) and autumn (Mar-May) self-calibrating Palmer drought severity index (scPDSI, r = 0.73; 1910-2011; p < 0.0001) across semi-arid northwest Australia. A linear regression model was used to reconstruct precipitation and explained 66% of the variance in observed summer-autumn precipitation. Our reconstruction reveals inter-annual to multi-decadal scale variation in hydroclimate of the region during the last 210 years, typically showing periods of below average precipitation extending from one to three decades and periods of above average precipitation, which were often less than a decade. Our results demonstrate that the last two decades (1995-2012) have been unusually wet (average summerautumn precipitation of 310 mm) compared to the previous two centuries (average summer-autumn precipitation of 229 mm), coinciding with both an anomalously high frequency and intensity of tropical cyclones in northwest Australia and the dominance of the positive phase of the Southern Annular Mode.	[O'Donnell, Alison J.; Page, Gerald F. M.; Grierson, Pauline F.] Univ Western Australia, Sch Plant Biol, Ecosyst Res Grp, Crawley, WA, Australia; [Cook, Edward R.] Columbia Univ, Lamont Doherty Geol Observ, Palisades, NY 10964 USA; [Palmer, Jonathan G.; Turney, Chris S. M.] Univ New S Wales, Climate Change Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	University of Western Australia; Columbia University; University of New South Wales Sydney	O'Donnell, AJ (corresponding author), Univ Western Australia, Sch Plant Biol, Ecosyst Res Grp, Crawley, WA, Australia.	alison.odonnell@uwa.edu.au	Turney, Chris S M/P-8701-2018; O'Donnell, Alison/H-8389-2012; Grierson, Pauline F/A-9240-2008; Page, Gerald F M/I-1743-2013; Palmer, Jonathan G/J-7834-2012	Turney, Chris S M/0000-0001-6733-0993; O'Donnell, Alison/0000-0001-7597-7965; Grierson, Pauline F/0000-0003-2135-0272; Page, Gerald F M/0000-0003-3531-7123; Palmer, Jonathan G/0000-0002-6665-4483	Australian Research Council; Rio Tinto [LP120100310]	Australian Research Council(Australian Research Council); Rio Tinto	This research was funded jointly by the Australian Research Council (http://www.arc.gov.au/) and Rio Tinto under Linkage Project LP120100310. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram NJ, 2014, NAT CLIM CHANGE, V4, P564, DOI [10.1038/nclimate2235, 10.1038/NCLIMATE2235]; Alexander LV, 2009, INT J CLIMATOL, V29, P417, DOI 10.1002/joc.1730; [Anonymous], 2015, CLIM DYNAM, DOI DOI 10.1007/S0; Australian Bureau of Meteorology, 2015, AUSTR CLIM INFL; Baker PJ, 2008, AUST J BOT, V56, P311, DOI 10.1071/BT08040; Brodribb TJ, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt052; Buckley BM, 2007, CLIM DYNAM, V29, P63, DOI 10.1007/s00382-007-0225-1; Cai WJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028037; Cai WJ, 2014, J CLIMATE, V27, P3145, DOI 10.1175/JCLI-D-13-00322.1; Charles S., 2013, INTERIM REPORT HYDRO; Christie DA, 2011, CLIM DYNAM, V36, P1505, DOI 10.1007/s00382-009-0723-4; Clayton-Greene KA., 1981, AUTECOLOGY CALLITRIS; Cook E.R., 2013, METHODS DENDROCHRONO; Cook ER, 1997, HOLOCENE, V7, P361, DOI 10.1177/095968369700700314; Cullen LE, 2009, CLIM DYNAM, V33, P433, DOI 10.1007/s00382-008-0457-8; D'Arrigo R, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034393; Denniston RF, 2013, QUATERNARY SCI REV, V78, P155, DOI 10.1016/j.quascirev.2013.08.004; Dogramaci S, 2012, J HYDROL, V475, P281, DOI 10.1016/j.jhydrol.2012.10.004; Doi T, 2015, J GEOPHYS RES-OCEANS, V120, P1388, DOI 10.1002/2014JC010562; Emanuel KA, 2013, P NATL ACAD SCI USA, V110, P12219, DOI 10.1073/pnas.1301293110; Feng M, 2015, GEOPHYS RES LETT, V42, P104, DOI 10.1002/2014GL062509; Fierro AO, 2013, J CLIMATE, V26, P2222, DOI 10.1175/JCLI-D-12-00129.1; Fogt RL, 2009, J CLIMATE, V22, P5346, DOI 10.1175/2009JCLI2786.1; Friedman J.H., 1984, 5 STANF U LAB COMP S; Fritts H. C., 1976, TREE RINGS CLIMATE; Goebbert KH, 2010, J CLIMATE, V23, P4538, DOI 10.1175/2010JCLI3362.1; Grissino-Mayer, 2001, TREE-RING RES, V57, P205, DOI DOI 10.1016/J.DENDRO.2010.12.002; Haig J, 2014, NATURE, V505, P667, DOI 10.1038/nature12882; Hassim MEE, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001804; Heinrich I, 2009, CLIM DYNAM, V33, P63, DOI 10.1007/s00382-009-0544-5; Hendon HH, 2007, J CLIMATE, V20, P2452, DOI 10.1175/JCLI4134.1; Hendon HH, 2014, J CLIMATE, V27, P3446, DOI 10.1175/JCLI-D-13-00550.1; Holmgren M, 2006, FRONT ECOL ENVIRON, V4, P87, DOI 10.1890/1540-9295(2006)004[0087:ECESAA]2.0.CO;2; Jones JM, 2009, J CLIMATE, V22, P5319, DOI 10.1175/2009JCLI2785.1; Kaplan A, 1998, J GEOPHYS RES-OCEANS, V103, P18567, DOI 10.1029/97JC01734; Kataoka T, 2014, CLIM DYNAM, V43, P1463, DOI 10.1007/s00382-013-1961-z; Kuhnert H, 2000, INT J EARTH SCI, V88, P725, DOI 10.1007/s005310050300; Kuleshov Y, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032983; Lavender SL, 2013, CLIM DYNAM, V40, P317, DOI 10.1007/s00382-012-1566-y; Letnic M, 2006, BIODIVERS CONSERV, V15, P3847, DOI 10.1007/s10531-005-0601-2; Liu KS, 2012, INT J CLIMATOL, V32, P190, DOI 10.1002/joc.2259; Lough JM, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001377; Lough JM, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002050; Marshall GJ, 2003, J CLIMATE, V16, P4134, DOI 10.1175/1520-0442(2003)016<4134:TITSAM>2.0.CO;2; Marvel K, 2013, P NATL ACAD SCI USA, V110, P19301, DOI 10.1073/pnas.1314382110; McGrath GS, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050263; Melvin TM, 2008, DENDROCHRONOLOGIA, V26, P71, DOI 10.1016/j.dendro.2007.12.001; Melvin Thomas M., 2007, Dendrochronologia, V25, P65, DOI 10.1016/j.dendro.2007.01.004; Neukom R, 2012, HOLOCENE, V22, P501, DOI 10.1177/0959683611427335; Nicholls N, 1998, METEOROL ATMOS PHYS, V65, P197, DOI 10.1007/BF01030788; Nicholls N., 1997, WEATHER, V52, P66, DOI DOI 10.1002/J.1477-8696.1997.TB06274.X; O'Donnell AJ, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00189.1; O'Donnell AJ, 2010, DENDROCHRONOLOGIA, V28, P37, DOI 10.1016/j.dendro.2009.01.002; R Core Team, 2014, R LANG ENV STAT COMP, DOI [10.1016/j.jneumeth.2014.06.019, DOI 10.1016/J.JNEUMETH.2014.06.019]; Raut BA, 2014, J CLIMATE, V27, P5801, DOI 10.1175/JCLI-D-13-00773.1; Risbey JS, 2009, MON WEATHER REV, V137, P3233, DOI 10.1175/2009MWR2861.1; Rotstayn LD, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007712; Rouillard A, 2015, HYDROL EART IN PRESS; Shi G, 2008, J CLIMATE, V21, P2938, DOI 10.1175/2007JCLI1908.1; Stokes M.A., 1968, INTRO TREE RING DATI; Taschetto AS, 2009, INT J CLIMATOL, V29, P791, DOI 10.1002/joc.1736; Thompson DWJ, 2011, NAT GEOSCI, V4, P741, DOI [10.1038/ngeo1296, 10.1038/NGEO1296]; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; van der Schrier G, 2013, J GEOPHYS RES-ATMOS, V118, P4025, DOI 10.1002/jgrd.50355; Villalba R, 2012, NAT GEOSCI, V5, P793, DOI [10.1038/NGEO1613, 10.1038/ngeo1613]; Visbeck M, 2009, J CLIMATE, V22, P940, DOI 10.1175/2008JCLI2260.1; Wardle R, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020157; Watterson I, 2007, CLIM CHANG AUSTR TEC, P49; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/; Zinke J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4607	71	37	37	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128533	10.1371/journal.pone.0128533	http://dx.doi.org/10.1371/journal.pone.0128533			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039148	Green Published, gold			2022-12-27	WOS:000355700700108
J	Ma, JQ; Huang, L; Ma, CL; Jin, JQ; Li, CF; Wang, RK; Zheng, HK; Yao, MZ; Chen, L				Ma, Jian-Qiang; Huang, Long; Ma, Chun-Lei; Jin, Ji-Qiang; Li, Chun-Fang; Wang, Rong-Kai; Zheng, Hong-Kun; Yao, Ming-Zhe; Chen, Liang			Large-Scale SNP Discovery and Genotyping for Constructing a High-Density Genetic Map of Tea Plant Using Specific-Locus Amplified Fragment Sequencing (SLAF-seq)	PLOS ONE			English	Article							QTL ANALYSIS; LINKAGE MAP; GENOME	Genetic maps are important tools in plant genomics and breeding. The present study reports the large-scale discovery of single nucleotide polymorphisms (SNPs) for genetic map construction in tea plant. We developed a total of 6,042 valid SNP markers using specific-locus amplified fragment sequencing (SLAF-seq), and subsequently mapped them into the previous framework map. The final map contained 6,448 molecular markers, distributing on fifteen linkage groups corresponding to the number of tea plant chromosomes. The total map length was 3,965 cM, with an average inter-locus distance of 1.0 cM. This map is the first SNP-based reference map of tea plant, as well as the most saturated one developed to date. The SNP markers and map resources generated in this study provide a wealth of genetic information that can serve as a foundation for downstream genetic analyses, such as the fine mapping of quantitative trait loci (QTL), map-based cloning, marker-assisted selection, and anchoring of scaffolds to facilitate the process of whole genome sequencing projects for tea plant.	[Ma, Jian-Qiang; Ma, Chun-Lei; Jin, Ji-Qiang; Li, Chun-Fang; Yao, Ming-Zhe; Chen, Liang] Chinese Acad Agr Sci, Tea Res Inst, Natl Ctr Tea Improvement, Hangzhou, Zhejiang, Peoples R China; [Ma, Jian-Qiang; Ma, Chun-Lei; Jin, Ji-Qiang; Li, Chun-Fang; Yao, Ming-Zhe; Chen, Liang] Minist Agr, Key Lab Tea Biol & Resources Utilizat, Hangzhou, Zhejiang, Peoples R China; [Huang, Long; Wang, Rong-Kai; Zheng, Hong-Kun] Biomarker Technol Co Ltd, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Yao, MZ (corresponding author), Chinese Acad Agr Sci, Tea Res Inst, Natl Ctr Tea Improvement, Hangzhou, Zhejiang, Peoples R China.	yaomz@tricaas.com; liangchen@tricaas.com	Chen, Liang/R-4438-2019; MINGZHE, YAO/AAH-7748-2021	Chen, Liang/0000-0002-7507-3947; 	Ministry of Agriculture of China through Earmarked Fund for China Agriculture Research System [CARS-023]; Science and Technology Major Project for New Crop Varieties Breeding of Zhejiang Province [2012C12905-6]; National Natural Science Foundation of China [31170624, 31400581, 31100504]	Ministry of Agriculture of China through Earmarked Fund for China Agriculture Research System; Science and Technology Major Project for New Crop Varieties Breeding of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Agriculture of China through the Earmarked Fund for China Agriculture Research System (CARS-023) received by LC, by the Science and Technology Major Project for New Crop Varieties Breeding of Zhejiang Province (2012C12905-6) received by LC, and by the National Natural Science Foundation of China (Nos. 31170624 received by MZY, 31400581 received by CFL, and 31100504 received by CLM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Chagne D, 2002, ANN FOREST SCI, V59, P627, DOI 10.1051/forest:2002048; Chen SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065122; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Ferreira A, 2006, GENET MOL BIOL, V29, P187, DOI 10.1590/S1415-47572006000100033; Ganal MW, 2009, CURR OPIN PLANT BIOL, V12, P211, DOI 10.1016/j.pbi.2008.12.009; Hackett CA, 2000, HEREDITY, V85, P346, DOI 10.1046/j.1365-2540.2000.00769.x; Hayat K, 2015, CRIT REV FOOD SCI, V55, P939, DOI 10.1080/10408398.2012.678949; Hu CY, 2013, EUPHYTICA, V191, P141, DOI 10.1007/s10681-013-0908-0; Huang FuPing, 2006, Journal of Tea Science, V26, P171; Huang JianAn, 2005, Journal of Tea Science, V25, P7; Huang SX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3640; International Tea Committee, 2013, ANN B STAT 2013, P48; Kamunya SM, 2010, TREE GENET GENOMES, V6, P915, DOI 10.1007/s11295-010-0301-2; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khan N, 2013, CURR PHARM DESIGN, V19, P6141, DOI 10.2174/1381612811319340008; Kumar S., 2012, INT J COMP APP IRAFI, V5, P1; Li B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1086; Li H, 2010, HEREDITY, V105, P257, DOI 10.1038/hdy.2010.56; Li XH, 2011, THEOR APPL GENET, V123, P667, DOI 10.1007/s00122-011-1617-5; Liu DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098855; Ma JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093131; Ota S, 1999, BREED RES, V1, P16; Qi ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104871; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Talukder ZI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098628; Tan LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081611; Tanaka J., 2006, CHAGYO KENKYU HOKOKU, V101, P1, DOI DOI 10.5979/CHA.2006.1; Taniguchi F, 2014, TREE GENET GENOMES, V10, P1555, DOI 10.1007/s11295-014-0779-0; Taniguchi F, 2012, BREEDING SCI, V62, P263, DOI 10.1270/jsbbs.62.263; Truong HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037565; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172; van Poecke RMP, 2013, PLANT BIOTECHNOL J, V11, P809, DOI 10.1111/pbi.12072; Wei QZ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1158; Xu P, 2014, NAT GENET, V46, P1212, DOI 10.1038/ng.3098; Xu XW, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00768; Zhang YX, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-141	39	44	56	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128798	10.1371/journal.pone.0128798	http://dx.doi.org/10.1371/journal.pone.0128798			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035838	gold, Green Submitted, Green Published			2022-12-27	WOS:000355699100050
J	Spinelli, KJ; Osterberg, VR; Meshul, CK; Soumyanath, A; Unni, VK				Spinelli, Kateri J.; Osterberg, Valerie R.; Meshul, Charles K.; Soumyanath, Amala; Unni, Vivek K.			Curcumin Treatment Improves Motor Behavior in alpha-Synuclein Transgenic Mice	PLOS ONE			English	Article							PARKINSONS-DISEASE; IN-VIVO; GAIT; AGGREGATION; VARIABILITY; PLAQUES; BIOAVAILABILITY; SUPPRESSES; AUTOPHAGY; PATHWAY	The curry spice curcumin plays a protective role in mouse models of neurodegenerative diseases, and can also directly modulate aggregation of alpha-synuclein protein in vitro, yet no studies have described the interaction of curcumin and alpha-synuclein in genetic synucleinopathy mouse models. Here we examined the effect of chronic and acute curcumin treatment in the Syn-GFP mouse line, which overexpresses wild-type human alpha-synuclein protein. We discovered that curcumin diet intervention significantly improved gait impairments and resulted in an increase in phosphorylated forms of alpha-synuclein at cortical presynaptic terminals. Acute curcumin treatment also caused an increase in phosphorylated alpha-synuclein in terminals, but had no direct effect on alpha-synuclein aggregation, as measured by in vivo multi-photon imaging and Proteinase-K digestion. Using LC-MS/MS, we detected similar to 5 ng/mL and similar to 12 ng/mL free curcumin in the plasma of chronic or acutely treated mice, with a glucuronidation rate of 94% and 97%, respectively. Despite the low plasma levels and extensive metabolism of curcumin, these results show that dietary curcumin intervention correlates with significant behavioral and molecular changes in a genetic synucleinopathy mouse model that mimics human disease.	[Spinelli, Kateri J.; Osterberg, Valerie R.; Unni, Vivek K.] Oregon Hlth & Sci Univ, Jungers Ctr Neurosci Res, Portland, OR 97201 USA; [Spinelli, Kateri J.; Osterberg, Valerie R.; Soumyanath, Amala; Unni, Vivek K.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Meshul, Charles K.] Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Res Serv, Portland, OR 97201 USA; [Meshul, Charles K.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Unni, Vivek K.] Oregon Hlth & Sci Univ, Parkinson Ctr Oregon, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Oregon Health & Science University; Oregon Health & Science University	Spinelli, KJ (corresponding author), Oregon Hlth & Sci Univ, Jungers Ctr Neurosci Res, Portland, OR 97201 USA.	spinelli@ohsu.edu		Spinelli, Kateri/0000-0002-6290-0886	National Institutes of Health-National Center for Complementary & Alternative Medicine grant [AT002688]; National Institutes of Health-National Institute of Neurological Disorders and Stroke grant [NS069625]; Merit Review Program grant from United States (U.S.) Department of Veterans Affairs Biomedical Laboratory Research and Development [1BX 001643]; National Institutes of Health-National Institute of Neurological Disorders and Stroke Shared Resource Grant [P30 NS061800]; National Center for Complementary & Integrative Health [T32AT002688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800, K08NS069625] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001643, I01BX000552] Funding Source: NIH RePORTER	National Institutes of Health-National Center for Complementary & Alternative Medicine grant; National Institutes of Health-National Institute of Neurological Disorders and Stroke grant; Merit Review Program grant from United States (U.S.) Department of Veterans Affairs Biomedical Laboratory Research and Development; National Institutes of Health-National Institute of Neurological Disorders and Stroke Shared Resource Grant; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	The work was supported by the following: National Institutes of Health-National Center for Complementary & Alternative Medicine grant AT002688 to KJS (http://nccam.nih.gov/); National Institutes of Health-National Institute of Neurological Disorders and Stroke grant NS069625 to VKU (http://www.ninds.nih.gov/); Merit Review Program grant #1BX 001643 to CKM from the United States (U.S.) Department of Veterans Affairs Biomedical Laboratory Research and Development (http://www.research.va.gov/services/shared_docs/merit_review.cfm); and National Institutes of Health-National Institute of Neurological Disorders and Stroke P30 NS061800 Shared Resource Grant (http://www.ninds.nih.gov/). The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.	Ahmad B, 2012, J BIOL CHEM, V287, P9193, DOI 10.1074/jbc.M111.325548; Ali RE, 2006, ANN NY ACAD SCI, V1067, P394, DOI 10.1196/annals.1354.056; Amende Ivo, 2005, J Neuroeng Rehabil, V2, P20, DOI 10.1186/1743-0003-2-20; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455; BLIN O, 1990, J NEUROL SCI, V98, P91, DOI 10.1016/0022-510X(90)90184-O; Cole GM, 2007, ADV EXP MED BIOL, V595, P197; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Emmer KL, 2011, J BIOL CHEM, V286, P35104, DOI 10.1074/jbc.M111.247965; Fan X, 2013, CURR PHARM DESIGN, V19, P2011; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Hampton TG, 2010, J MOTOR BEHAV, V42, P1, DOI 10.1080/00222890903272025; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Liu ZH, 2011, PHARMACOL RES, V63, P439, DOI 10.1016/j.phrs.2011.01.004; Ma QL, 2013, J BIOL CHEM, V288, P4056, DOI 10.1074/jbc.M112.393751; Maries E, 2003, NAT REV NEUROSCI, V4, P727, DOI 10.1038/nrn1199; Mohorko N, 2010, J NEUROPATH EXP NEUR, V69, P405, DOI 10.1097/NEN.0b013e3181d709eb; Mutsuga M, 2012, J VET MED SCI, V74, P51, DOI 10.1292/jvms.11-0307; Nubling GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098906; Oueslati A, 2013, P NATL ACAD SCI USA, V110, pE3945, DOI 10.1073/pnas.1309991110; Pan J, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-16; Pan MH, 1999, DRUG METAB DISPOS, V27, P486; Pandey N, 2008, ACTA NEUROPATHOL, V115, P479, DOI 10.1007/s00401-007-0332-4; Rockenstein E, 2005, J NEUROSCI RES, V80, P247, DOI 10.1002/jnr.20446; Roemmich RT, 2012, GAIT POSTURE, V36, P340, DOI 10.1016/j.gaitpost.2012.01.018; Spinelli KJ, 2014, J NEUROSCI, V34, P2037, DOI 10.1523/JNEUROSCI.2581-13.2014; Wang C, 2014, EUR J PHARMACOL, V740, P312, DOI 10.1016/j.ejphar.2014.06.051; Wang MS, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-57; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yang KY, 2007, J CHROMATOGR B, V853, P183, DOI 10.1016/j.jchromb.2007.03.010	36	34	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128510	10.1371/journal.pone.0128510	http://dx.doi.org/10.1371/journal.pone.0128510			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035833	Green Published, gold, Green Submitted			2022-12-27	WOS:000355699100034
J	Bogner, B; Boye, SL; Min, SH; Peterson, JJ; Ruan, Q; Zhang, ZH; Reitsamer, HA; Hauswirth, WW; Boye, SE				Bogner, Barbara; Boye, Sanford L.; Min, Seok Hong; Peterson, James J.; Ruan, Qing; Zhang, Zhonghong; Reitsamer, Herbert A.; Hauswirth, William W.; Boye, Shannon E.			Capsid Mutated Adeno-Associated Virus Delivered to the Anterior Chamber Results in Efficient Transduction of Trabecular Meshwork in Mouse and Rat	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; GLUCOCORTICOID-INDUCIBLE MMP1; LEBER CONGENITAL AMAUROSIS; GENE-THERAPY; TISSUE TRANSGLUTAMINASE; INTRAOCULAR-PRESSURE; EXTRACELLULAR-MATRIX; GLAUCOMATOUS EYES; OUTFLOW FACILITY; RPE65 MUTATIONS	Background Adeno associated virus (AAV) is well known for its ability to deliver transgenes to retina and to mediate improvements in animal models and patients with inherited retinal disease. Although the field is less advanced, there is growing interest in AAV's ability to target cells of the anterior segment. The purpose of our study was to fully articulate a reliable and reproducible method for injecting the anterior chamber (AC) of mice and rats and to investigate the transduction profiles of AAV2- and AAV8-based capsid mutants containing self-complementary (sc) genomes in the anterior segment of the eye. Methodology/Principle Findings AC injections were performed in C57BL/6 mice and Sprague Dawley rats. The cornea was punctured anterior of the iridocorneal angle. To seal the puncture site and to prevent reflux an air bubble was created in the AC. scAAVs expressing GFP were injected and transduction was evaluated by immunohistochemistry. Both parent serotype and capsid modifications affected expression. scAAV2-based vectors mediated efficient GFP-signal in the corneal endothelium, ciliary non-pigmented epithelium (NPE), iris and chamber angle including trabecular meshwork, with scAAV2(Y444F) and scAAV2(triple) being the most efficient. Conclusions/Significance This is the first study to semi quantitatively evaluate transduction of anterior segment tissues following injection of capsid-mutated AAV vectors. scAAV2-based vectors transduced corneal endothelium, ciliary NPE, iris and trabecular meshwork more effectively than scAAV8-based vectors. Mutagenesis of surface-exposed tyrosine residues greatly enhanced transduction efficiency of scAAV2 in these tissues. The number of Y-F mutations was not directly proportional to transduction efficiency, however, suggesting that proteosomal avoidance alone may not be sufficient. These results are applicable to the development of targeted, gene-based strategies to investigate pathological processes of the anterior segment and may be applied toward the development of gene-based therapies for glaucoma and acquired or inherited corneal anomalies.	[Bogner, Barbara; Zhang, Zhonghong; Reitsamer, Herbert A.] SALK Paracelsus Med Univ, Dept Ophthalmol & Optometry, Salzburg, Austria; [Boye, Sanford L.; Min, Seok Hong; Peterson, James J.; Ruan, Qing; Hauswirth, William W.; Boye, Shannon E.] Univ Florida, Dept Ophthalmol, Gainesville, FL 32611 USA	Paracelsus Private Medical University; State University System of Florida; University of Florida	Boye, SE (corresponding author), Univ Florida, Dept Ophthalmol, Gainesville, FL 32611 USA.	Shannon.Boye@eye.ufl.edu		hauswirth, william/0000-0002-3244-4947; Boye, Shannon/0000-0002-7312-3197	Austrian Academy of Sciences [Doc-fFORTE-22966]; PMU-FFF [S-12/02/006-BOG]; Lotte Schwarz Endowment for Experimental Ophthalmology and Glaucoma Research; Research to Prevent Blindness; Fuchs Endowment; Institutional Grant of University Eye Clinic Salzburg [RO1 EY024280, P30-EY021721]; NATIONAL EYE INSTITUTE [P30EY021721, R01EY024280] Funding Source: NIH RePORTER	Austrian Academy of Sciences; PMU-FFF; Lotte Schwarz Endowment for Experimental Ophthalmology and Glaucoma Research; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Fuchs Endowment; Institutional Grant of University Eye Clinic Salzburg; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by: Doc-fFORTE-22966 (Austrian Academy of Sciences), PMU-FFF S-12/02/006-BOG, Lotte Schwarz Endowment for Experimental Ophthalmology and Glaucoma Research, Fuchs Endowment, Institutional Grant of the University Eye Clinic Salzburg, RO1 EY024280 (SEB), P30-EY021721 (WWH), and Research to Prevent Blindness.	Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; Ashtari M, 2011, J CLIN INVEST, V121, P2160, DOI 10.1172/JCI57377; Aslanidi GV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059142; Aslanidi GV, 2012, VACCINE, V30, P3908, DOI 10.1016/j.vaccine.2012.03.079; Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Auricchio A, 2001, HUM MOL GENET, V10, P3075, DOI 10.1093/hmg/10.26.3075; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Balaggan KS, 2012, GENE THER, V19, P145, DOI 10.1038/gt.2011.153; Barraza RA, 2010, MOL THER, V18, P491, DOI 10.1038/mt.2009.278; Bennett J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002865; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Borras T, 2006, J GENE MED, V8, P589, DOI 10.1002/jgm.886; Borras T, 2012, INVEST OPHTH VIS SCI, V53, P2506, DOI 10.1167/iovs.12-9483o; Bowles DE, 2012, MOL THER, V20, P443, DOI 10.1038/mt.2011.237; Boye SL, 2013, HUM GENE THER, V24, P189, DOI 10.1089/hum.2012.193; Boye SL, 2011, INVEST OPHTH VIS SCI, V52, P7098, DOI 10.1167/iovs.11-7867; Boye SE, 2013, MOL THER, V21, P509, DOI 10.1038/mt.2012.280; Buie LK, 2013, INVEST OPHTH VIS SCI, V54, P5441, DOI 10.1167/iovs.13-11651; Buie LK, 2010, INVEST OPHTH VIS SCI, V51, P236, DOI 10.1167/iovs.09-3847; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; DiMattia M, 2005, ACTA CRYSTALLOGR F, V61, P917, DOI 10.1107/S1744309105028514; DiMattia MA, 2012, J VIROL, V86, P6947, DOI 10.1128/JVI.07232-11; Fleenor DL, 2006, INVEST OPHTH VIS SCI, V47, P226, DOI 10.1167/iovs.05-1060; Flugel-Koch C, 2004, EXP EYE RES, V79, P649, DOI 10.1016/j.exer.2004.07.005; Gabriel N, 2013, HUM GENE THER METHOD, V24, P80, DOI 10.1089/hgtb.2012.194; Gerometta R, 2010, INVEST OPHTH VIS SCI, V51, P3042, DOI 10.1167/iovs.09-4920; Gottanka J, 2004, INVEST OPHTH VIS SCI, V45, P153, DOI 10.1167/iovs.03-0796; Haire SE, 2006, INVEST OPHTH VIS SCI, V47, P3745, DOI 10.1167/iovs.06-0086; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Hippert C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035318; Hiscott P, 2006, PROG RETIN EYE RES, V25, P1, DOI 10.1016/j.preteyeres.2005.05.001; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Junglas B, 2012, AM J PATHOL, V180, P2386, DOI 10.1016/j.ajpath.2012.02.030; Junglas B, 2009, EXP EYE RES, V88, P1065, DOI 10.1016/j.exer.2009.01.008; Kampik D, 2012, EXP EYE RES, V95, P54, DOI 10.1016/j.exer.2011.07.001; Kay CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062097; Klimczak RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007467; Klintworth Gordon K, 2009, Orphanet J Rare Dis, V4, P7, DOI 10.1186/1750-1172-4-7; Koilkonda RD, 2009, MOL VIS, V15; Kuchtey J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001306; Kumar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072447; Lebherz C, 2008, J GENE MED, V10, P375, DOI 10.1002/jgm.1126; Lee ES, 2014, CURR EYE RES, V39, P859, DOI 10.3109/02713683.2014.884593; Li G, 2013, EXP EYE RES, V109, P8, DOI 10.1016/j.exer.2013.01.005; Lipinski DM, 2014, HUM GENE THER, V25, P50, DOI 10.1089/hum.2013.009; Liu J, 2008, MOL VIS, V14, P2087; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Markusic DM, 2010, MOL THER, V18, P2048, DOI 10.1038/mt.2010.172; McCarty DM, 2008, MOL THER, V16, P1648, DOI 10.1038/mt.2008.171; Medina-Ortiz WE, 2013, INVEST OPHTH VIS SCI, V54, P6779, DOI 10.1167/iovs.13-12298; Mohan RR, 2013, OCUL SURF, V11, P150, DOI 10.1016/j.jtos.2012.10.004; Mohan RR, 2012, PROG RETIN EYE RES, V31, P43, DOI 10.1016/j.preteyeres.2011.09.001; Mohan RR, 2011, INVEST OPHTH VIS SCI, V52, P4833, DOI 10.1167/iovs.11-7357; Mohan RR, 2010, MOL VIS, V16, P2494; Nam HJ, 2007, J VIROL, V81, P12260, DOI 10.1128/JVI.01304-07; Opie SR, 2003, J VIROL, V77, P6995, DOI 10.1128/JVI.77.12.6995-7006.2003; Padron E, 2005, J VIROL, V79, P5047, DOI 10.1128/JVI.79.8.5047-5058.2005; Pang JJ, 2011, MOL THER, V19, P234, DOI 10.1038/mt.2010.273; Parker DGA, 2007, GENE THER, V14, P760, DOI 10.1038/sj.gt.3302921; Peterson JJ, 2003, EXP EYE RES, V76, P553, DOI 10.1016/S0014-4835(03)00032-0; Petrs-Silva H, 2011, MOL THER, V19, P293, DOI 10.1038/mt.2010.234; Petrs-Silva H, 2009, MOL THER, V17, P463, DOI 10.1038/mt.2008.269; Prendes MA, 2013, BRIT J OPHTHALMOL, V97, P680, DOI 10.1136/bjophthalmol-2011-301132; Puppo A, 2014, GENE THER, V21, P855, DOI 10.1038/gt.2014.57; Qi XP, 2007, INVEST OPHTH VIS SCI, V48, P1, DOI 10.1167/iovs.06-0789; Rasmussen Carol A, 2014, J Glaucoma, V23, pS15, DOI 10.1097/IJG.0000000000000106; REMTULLA S, 1985, VISION RES, V25, P21, DOI 10.1016/0042-6989(85)90076-8; Sacca SC, 2015, J CELL PHYSIOL, V230, P510, DOI 10.1002/jcp.24826; SCHITTNY JC, 1988, J CELL BIOL, V107, P1599, DOI 10.1083/jcb.107.4.1599; Seo SJ, 2012, EXP EYE RES, V101, P60, DOI 10.1016/j.exer.2012.05.013; Sharma A, 2010, EXP EYE RES, V91, P440, DOI 10.1016/j.exer.2010.06.020; Shepard AR, 2010, INVEST OPHTH VIS SCI, V51, P2067, DOI 10.1167/iovs.09-4567; Spiga MG, 2010, INVEST OPHTH VIS SCI, V51, P3029, DOI 10.1167/iovs.09-4918; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Tamm ER, 2009, EXP EYE RES, V88, P648, DOI 10.1016/j.exer.2009.02.007; Tektas OY, 2009, EXP EYE RES, V88, P769, DOI 10.1016/j.exer.2008.11.025; Tovar-Vidales T, 2008, INVEST OPHTH VIS SCI, V49, P622, DOI 10.1167/iovs.07-0835; TRIPATHI RC, 1994, EXP EYE RES, V59, P723, DOI 10.1006/exer.1994.1158; Vandenberghe LH, 2006, NAT MED, V12, P967, DOI 10.1038/nm1445; Vemuganti GK, 2011, DEV OPHTHALMOL, V48, P24, DOI 10.1159/000324261; Vittitow JL, 2002, MOL VIS, V8, P32; Wang WH, 2008, J CLIN INVEST, V118, P1056, DOI 10.1172/JCI33871; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Weitz AC, 2013, J NEUROPHYSIOL, V109, P1979, DOI 10.1152/jn.00852.2012; Welge-Lussen U, 2000, INVEST OPHTH VIS SCI, V41, P2229; Williams KA, 2012, CURR OPIN OPHTHALMOL, V23, P276, DOI 10.1097/ICU.0b013e3283541eb6; Wordinger RJ, 2007, INVEST OPHTH VIS SCI, V48, P1191, DOI 10.1167/iovs.06-0296; Xiang Y, 2014, INT J OPHTHALMOL-CHI, V7, P924, DOI 10.3980/j.issn.2222-3959.2014.06.02; Xiao W, 2002, J VIROL, V76, P11505, DOI 10.1128/JVI.76.22.11505-11517.2002; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899; Xue W, 2006, INVEST OPHTH VIS SCI, V47, P997, DOI 10.1167/iovs.05-1106; Zhang Z, 2014, INVEST OPHTH VIS SCI, V55, P935, DOI 10.1167/iovs.13-12890; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	96	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128759	10.1371/journal.pone.0128759	http://dx.doi.org/10.1371/journal.pone.0128759			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052939	Green Published, Green Submitted, gold			2022-12-27	WOS:000355955300057
J	Chen, YY; Wang, JP; Jiang, YY; Li, H; Hu, YH; Lee, KO; Li, GW				Chen, Yan Yan; Wang, Jin Ping; Jiang, Ya Yun; Li, Hui; Hu, Ying Hua; Lee, Kok Onn; Li, Guang Wei			Fasting Plasma Insulin at 5 Years of Age Predicted Subsequent Weight Increase in Early Childhood over a 5-Year Period-The Da Qing Children Cohort Study	PLOS ONE			English	Article							BODY-MASS INDEX; METABOLIC-SYNDROME; RESISTANCE; OBESITY; RISK; HYPERINSULINEMIA; GAIN; SENSITIVITY; OVERWEIGHT; ADIPOSITY	Background The association between hyperinsulinemia and obesity is well known. However, it is uncertain especially in childhood obesity, if initial fasting hyperinsulinemia predicts obesity, or obesity leads to hyperinsulinemia through insulin resistance. Objective To investigate the predictive effect of fasting plasma insulin on subsequent weight change after a 5-year interval in childhood. Methods 424 Children from Da Qing city, China, were recruited at 5 years of age and followed up for 5 years. Blood pressure, anthropometric measurements, fasting plasma insulin, glucose and triglycerides were measured at baseline and 5 years later. Results Fasting plasma insulin at 5 years of age was significantly correlated with change of weight from 5 to 10 years (Delta Weight). Children in the lowest insulin quartile had Delta Weight of 13.08 +/- 0.73 kg compare to 18.39 +/- 0.86 in the highest insulin quartile (P<0.0001) in boys, and similarly 12.03 +/- 0.71 vs 15.80 +/- 0.60 kg (P<0.0001) in girls. Multivariate analysis showed that the predictive effect of insulin at 5 years of age on subsequent weight gain over 5 years remained statistically significant even after the adjustment for age, sex, birth weight, TV-viewing time and weight (or body mass index) at baseline. By contrast, the initial weight at 5 years of age did not predict subsequent changes in insulin level 5 years later. Children who had both higher fasting insulin and weight at 5 years of age showed much higher levels of systolic blood pressures, fasting plasma glucose, the homeostasis model assessment for insulin resistance (HOMA-IR) and triglycerides at 10 years of age. Conclusions Fasting plasma insulin at 5 years of age predicts weight gain and cardiovascular risk factors 5 year later in Chinese children of early childhood, but the absolute weight at 5 years of age did not predict subsequent change in fasting insulin.	[Chen, Yan Yan; Li, Guang Wei] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Endocrinol & Cardiovasc Dis Ctr, Fuwai Hosp, Beijing 100730, Peoples R China; [Chen, Yan Yan; Li, Guang Wei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Jin Ping; Jiang, Ya Yun; Li, Hui; Hu, Ying Hua] Da Qing First Hosp, Cardiol, Da Qing, Peoples R China; [Lee, Kok Onn] Natl Univ Singapore, Dept Med, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Li, Guang Wei] China Japan Friendship Hosp, Endocrinol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National University of Singapore; China-Japan Friendship Hospital	Chen, YY (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Endocrinol & Cardiovasc Dis Ctr, Fuwai Hosp, Beijing 100730, Peoples R China.	doc.yan@medmail.com.cn	Lee, Kok-Onn/E-9874-2011	Lee, Kok-Onn/0000-0002-3040-1185; Chen, Yanyan/0000-0002-4697-149X	Scientific Research Foundation of Ministry of Health of China [98-1-080]	Scientific Research Foundation of Ministry of Health of China	This work was supported by Grant 98-1-080 from the Scientific Research Foundation of Ministry of Health of China.	Adam TC, 2009, DIABETES CARE, V32, P2114, DOI 10.2337/dc09-0833; Anthony K, 2006, DIABETES, V55, P2986, DOI 10.2337/db06-0376; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Chen YY, 2011, PEDIATR RES, V70, P307, DOI 10.1203/PDR.0b013e318225f8a9; Folsom AR, 1996, AM J EPIDEMIOL, V144, P235, DOI 10.1093/oxfordjournals.aje.a008918; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Han JC, 2008, J PEDIATR-US, V152, P612, DOI 10.1016/j.jpeds.2007.12.036; Ji CY, 2009, INT J CARDIOL, V132, P1, DOI 10.1016/j.ijcard.2008.07.003; Johnson MS, 2001, J CLIN ENDOCR METAB, V86, P3182, DOI 10.1210/jc.86.7.3182; Labayen I, 2011, INT J OBESITY, V35, P1284, DOI 10.1038/ijo.2011.98; Li Hui, 2009, Zhonghua Er Ke Za Zhi, V47, P493; Ludwig DS, 2007, NEW ENGL J MED, V357, P2325, DOI 10.1056/NEJMp0706538; Maffeis C, 2002, J CLIN ENDOCR METAB, V87, P71, DOI 10.1210/jc.87.1.71; Maffeis C, 2008, J CLIN ENDOCR METAB, V93, P2122, DOI 10.1210/jc.2007-2089; Matteis C, 2010, NUTR METAB CARDIOVAS, V20, P266, DOI 10.1016/j.numecd.2009.04.005; Mattsson N, 2008, ANN MED, V40, P542, DOI 10.1080/07853890802307709; Morrison JA, 2008, AM J CLIN NUTR, V88, P778, DOI 10.1093/ajcn/88.3.778; Morrison JA, 2009, METABOLISM, V58, P290, DOI 10.1016/j.metabol.2008.09.027; NEEL JV, 1962, AM J HUM GENET, V14, P353; Odeleye OE, 1997, DIABETES, V46, P1341, DOI 10.2337/diabetes.46.8.1341; Powell LM, 2007, ARCH PEDIAT ADOL MED, V161, P553, DOI 10.1001/archpedi.161.6.553; Shaikh MG, 2008, EUR J ENDOCRINOL, V159, P791, DOI 10.1530/EJE-08-0533; Wedick NM, 2009, OBESITY, V17, P1609, DOI 10.1038/oby.2008.666; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62; Zong XN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046942	25	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127389	10.1371/journal.pone.0127389	http://dx.doi.org/10.1371/journal.pone.0127389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047327	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200020
J	Flemming, A; Huang, QQ; Jin, JP; Jumaa, H; Herzog, S				Flemming, Alexandra; Huang, Qi-Quan; Jin, Jian-Ping; Jumaa, Hassan; Herzog, Sebastian			A Conditional Knockout Mouse Model Reveals That Calponin-3 Is Dispensable for Early B Cell Development	PLOS ONE			English	Article							PRE-BCR; ACIDIC CALPONIN; SMOOTH-MUSCLE; RAT-BRAIN; ACTIN CYTOSKELETON; NONMUSCLE CELLS; LIGHT-CHAIN; H2-CALPONIN; EXPRESSION; RECEPTOR	Calponins form an evolutionary highly conserved family of actin filament-associated proteins expressed in both smooth muscle and non-muscle cells. Whereas calponin-1 and calponin- 2 have already been studied to some extent, little is known about the role of calponin3 under physiological conditions due to the lack of an appropriate animal model. Here, we have used an unbiased screen to identify novel proteins implicated in signal transduction downstream of the precursor B cell receptor (pre-BCR) in B cells. We find that calponin-3 is expressed throughout early B cell development, localizes to the plasma membrane and is phosphorylated in a Syk-dependent manner, suggesting a putative role in pre-BCR signaling. To investigate this in vivo, we generated a floxed calponin-3-GFP knock-in mouse model that enables tracking of cells expressing calponin-3 from its endogenous promoter and allows its tissue-specific deletion. Using the knock-in allele as a reporter, we show that calponin-3 expression is initiated in early B cells and increases with their maturation, peaking in the periphery. Surprisingly, conditional deletion of the Cnn3 revealed no gross defects in B cell development despite this regulated expression pattern and the in vitro evidence, raising the question whether other components may compensate for its loss in lymphocytes. Together, our work identifies calponin-3 as a putative novel mediator downstream of the pre-BCR. Beyond B cells, the mouse model we generated will help to increase our understanding of calponin-3 in muscle and non-muscle cells under physiological conditions.	[Flemming, Alexandra; Jumaa, Hassan; Herzog, Sebastian] Max Planck Inst Immunobiol & Epigenet, Dept Mol Immunol, Freiburg, Germany; [Flemming, Alexandra; Jumaa, Hassan; Herzog, Sebastian] Univ Freiburg, Fac Biol, Biol 3, D-79106 Freiburg, Germany; [Huang, Qi-Quan] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Jin, Jian-Ping] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Jumaa, Hassan; Herzog, Sebastian] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Herzog, Sebastian] Med Univ Innsbruck, Div Dev Immunol, A-6020 Innsbruck, Austria	Max Planck Society; University of Freiburg; Northwestern University; Feinberg School of Medicine; Wayne State University; University of Freiburg; Medical University of Innsbruck	Jumaa, H (corresponding author), Univ Clin Ulm, Inst Immunol, Ulm, Germany.	hassan.jumaa@uni-ulm.de; sebastian.herzog@i-med.ac.at	Jin, Jian-Ping/AAD-1149-2020	Jin, JP/0000-0001-9932-1063; Herzog, Sebastian/0000-0001-7167-3489	Deutsche Forschungsgemeinschaft (Centre for Biological Signalling Studies, BIOSS) [EXC294]; Deutsche Forschungsgemeinschaft through Transregio Grant [TRR130]	Deutsche Forschungsgemeinschaft (Centre for Biological Signalling Studies, BIOSS); Deutsche Forschungsgemeinschaft through Transregio Grant	This work was funded by the Deutsche Forschungsgemeinschaft Grant EXC294 (the Centre for Biological Signalling Studies, BIOSS) and through Transregio Grant TRR130 to HJ.	Agassandian C, 2000, BRAIN RES, V887, P444, DOI 10.1016/S0006-8993(00)03030-4; Appel S, 2010, MOL BIOL CELL, V21, P1409, DOI 10.1091/mbc.E09-06-0451; APPLEGATE D, 1994, J BIOL CHEM, V269, P10683; Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; Baba Y, 2001, P NATL ACAD SCI USA, V98, P2582, DOI 10.1073/pnas.051626198; Conley ME, 2000, IMMUNOL REV, V178, P75, DOI 10.1034/j.1600-065X.2000.17809.x; Daimon E, 2013, ARCH DERMATOL RES, V305, P571, DOI 10.1007/s00403-013-1343-8; Ferhat L, 1996, EUR J NEUROSCI, V8, P1501, DOI 10.1111/j.1460-9568.1996.tb01612.x; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; FUJII T, 1995, J BIOCHEM-TOKYO, V117, P999, DOI 10.1093/oxfordjournals.jbchem.a124833; Fukui Y, 1997, J DERMATOL SCI, V14, P29, DOI 10.1016/S0923-1811(96)00545-2; Geier JK, 2006, SEMIN IMMUNOL, V18, P31, DOI 10.1016/j.smim.2005.11.001; GIMONA M, 1992, EUR J BIOCHEM, V205, P1067, DOI 10.1111/j.1432-1033.1992.tb16875.x; Haag J, 2007, EXP CELL RES, V313, P3386, DOI 10.1016/j.yexcr.2007.08.003; Harwood NE, 2010, ANNU REV IMMUNOL, V28, P185, DOI 10.1146/annurev-immunol-030409-101216; Herzog S, 2008, NAT IMMUNOL, V9, P623, DOI 10.1038/ni.1616; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hossain MM, 2006, BIOCHEMISTRY-US, V45, P15670, DOI 10.1021/bi061718f; Huang QQ, 2008, J BIOL CHEM, V283, P25887, DOI 10.1074/jbc.M801163200; Jiang WR, 2014, J BIOL CHEM, V289, P1617, DOI 10.1074/jbc.M113.498147; Leinweber BD, 1999, BIOCHEM J, V344, P117, DOI 10.1042/0264-6021:3440117; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Matthew JD, 2000, J PHYSIOL-LONDON, V529, P811, DOI 10.1111/j.1469-7793.2000.00811.x; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; Plantier M, 1999, EUR J NEUROSCI, V11, P2801, DOI 10.1046/j.1460-9568.1999.00702.x; Rami G, 2006, HIPPOCAMPUS, V16, P183, DOI 10.1002/hipo.20145; Rickert RC, 2013, NAT REV IMMUNOL, V13, P578, DOI 10.1038/nri3487; Rodriguez R, 2001, J BIOL CHEM, V276, P47982, DOI 10.1074/jbc.M107577200; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6; Rozenblum GT, 2008, INT J BIOCHEM CELL B, V40, P1990, DOI 10.1016/j.biocel.2007.07.010; Shibukawa Y, 2013, EXP CELL RES, V319, P633, DOI 10.1016/j.yexcr.2012.12.022; Shibukawa Y, 2010, MOL BIOL CELL, V21, P3973, DOI 10.1091/mbc.E10-03-0261; So L, 2012, BIOCHEM J, V442, P465, DOI 10.1042/BJ20112092; Su YW, 2003, J EXP MED, V198, P1699, DOI 10.1084/jem.20031428; Takahashi K, 2000, BIOCHEM BIOPH RES CO, V279, P150, DOI 10.1006/bbrc.2000.3909; Tang J, 2006, J BIOL CHEM, V281, P6664, DOI 10.1074/jbc.M506991200; TRABELSITERZIDIS H, 1995, BIOCHEM J, V306, P211, DOI 10.1042/bj3060211; Ulmer B, 2013, CELL REP, V3, P615, DOI 10.1016/j.celrep.2013.02.015; Winder SJ, 1998, ACTA PHYSIOL SCAND, V164, P415, DOI 10.1111/j.1365-201X.1998.tb10697.x; Wu KC, 2008, CELL BIOCHEM BIOPHYS, V52, P139, DOI 10.1007/s12013-008-9031-6; Yamamoto M, 2006, BLOOD, V108, P2703, DOI 10.1182/blood-2006-05-024968; Yasuda T, 2008, IMMUNITY, V28, P499, DOI 10.1016/j.immuni.2008.02.015; Yoshikawa H, 1998, GENES CELLS, V3, P685, DOI 10.1046/j.1365-2443.1998.00214.x	44	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128385	10.1371/journal.pone.0128385	http://dx.doi.org/10.1371/journal.pone.0128385			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046660	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200065
J	Monaghan, K; McNaughten, J; McGahon, MK; Kelly, C; Kyle, D; Yong, PH; McGeown, JG; Curtis, TM				Monaghan, Kevin; McNaughten, Jennifer; McGahon, Mary K.; Kelly, Catriona; Kyle, Daniel; Yong, Phaik Har; McGeown, J. Graham; Curtis, Tim M.			Hyperglycemia and Diabetes Downregulate the Functional Expression of TRPV4 Channels in Retinal Microvascular Endothelium	PLOS ONE			English	Article							HEAT-EVOKED ACTIVATION; RECEPTOR POTENTIAL V4; CA2+ ENTRY; RETINOPATHY; FLOW; AUTOREGULATION; DILATION; LESIONS; ARTERIOLES; MELLITUS	Retinal endothelial cell dysfunction is believed to play a key role in the etiology and pathogenesis of diabetic retinopathy. Numerous studies have shown that TRPV4 channels are critically involved in maintaining normal endothelial cell function. In the current paper, we demonstrate that TRPV4 is functionally expressed in the endothelium of the retinal microcirculation and that both channel expression and activity is downregulated by hyperglycaemia. Quantitative PCR and immunostaining demonstrated molecular expression of TRPV4 in cultured bovine retinal microvascular endothelial cells (RMECs). Functional TRPV4 activity was assessed in cultured RMECs from endothelial Ca2+-responses recorded using fura-2 microfluorimetry and electrophysiological recordings of membrane currents. The TRPV4 agonist 4 alpha-phorbol 12,13-didecanoate (4-alpha PDD) increased [Ca2+](i) in RMECs and this response was largely abolished using siRNA targeted against TRPV4. These Ca2+-signals were completely inhibited by removal of extracellular Ca2+, confirming their dependence on influx of extracellular Ca2+. The 4-alpha PDD Ca2+-response recorded in the presence of cyclopiazonic acid (CPA), which depletes the intracellular stores preventing any signal amplification through store release, was used as a measure of Ca2+-influx across the cell membrane. This response was blocked by HC067047, a TRPV4 antagonist. Under voltage clamp conditions, the TRPV4 agonist GSK1016790A stimulated a membrane current, which was again inhibited by HC067047. Following incubation with 25mM D-glucose TRPV4 expression was reduced in comparison with RMECs cultured under control conditions, as were 4 alpha PDD-induced Ca2+-responses in the presence of CPA and ion currents evoked by GSK1016790A. Molecular expression of TRPV4 in the retinal vascular endothelium of 3 months' streptozotocin-induced diabetic rats was also reduced in comparison with that in age-matched controls. We conclude that hyperglycaemia and diabetes reduce the molecular and functional expression of TRPV4 channels in retinal microvascular endothelial cells. These changes may contribute to diabetes induced endothelial dysfunction and retinopathy.	[Monaghan, Kevin; McNaughten, Jennifer; McGahon, Mary K.; Kelly, Catriona; Kyle, Daniel; Yong, Phaik Har; McGeown, J. Graham; Curtis, Tim M.] Queens Univ Belfast, Ctr Med Expt, Belfast BT7 1NN, Antrim, North Ireland	Queens University Belfast	Curtis, TM (corresponding author), Queens Univ Belfast, Ctr Med Expt, Belfast BT7 1NN, Antrim, North Ireland.	t.curtis@qub.ac.uk	Curtis, Tim/AEU-9750-2022	Curtis, Tim/0000-0003-1543-2781; Yong, Phaik Har/0000-0002-5888-9856	European Foundation for the Study of Diabetes; Department of Education and Learning Northern Ireland; Biotechnology and Biological Sciences Research Council (UK) [BB/I026359/1]; BBSRC [BB/I026359/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I026359/1] Funding Source: researchfish	European Foundation for the Study of Diabetes; Department of Education and Learning Northern Ireland; Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by The European Foundation for the Study of Diabetes (TC), the Department of Education and Learning Northern Ireland (TC and GM), and the Biotechnology and Biological Sciences Research Council (UK) (Grant Ref: BB/I026359/1; TC and GM). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LP, 2001, AM J OPHTHALMOL, V132, P760, DOI 10.1016/S0002-9394(01)01124-2; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Bagher P, 2012, P NATL ACAD SCI USA, V109, P18174, DOI 10.1073/pnas.1211946109; Banumathi E, 2011, INVEST OPHTH VIS SCI, V52, P3103, DOI 10.1167/iovs.10-6574; Berrout J, 2012, J BIOL CHEM, V287, P8782, DOI 10.1074/jbc.M111.308411; Blum M, 2008, OPHTHALMOLOGICA, V222, P373, DOI 10.1159/000151278; Brayden JE, 2008, CLIN EXP PHARMACOL P, V35, P1116, DOI 10.1111/j.1440-1681.2007.04855.x; Bubolz AH, 2012, AM J PHYSIOL-HEART C, V302, pH634, DOI 10.1152/ajpheart.00717.2011; Chakravarthy U, 2013, LANCET, V382, P1258, DOI 10.1016/S0140-6736(13)61501-9; Cioffi DL, 2009, ANTIOXID REDOX SIGN, V11, P765, DOI 10.1089/ARS.2008.2221; Curtis TM, 2009, EYE, V23, P1496, DOI 10.1038/eye.2009.108; Curtis TM, 2003, DIABETOLOGIA, V46, P1252, DOI 10.1007/s00125-003-1178-5; Dunn KM, 2013, P NATL ACAD SCI USA, V110, P6157, DOI 10.1073/pnas.1216514110; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Earley S, 2009, AM J PHYSIOL-HEART C, V297, pH1096, DOI 10.1152/ajpheart.00241.2009; ERNEST JT, 1983, INVEST OPHTH VIS SCI, V24, P985; Gao F, 2010, J HYPERTENS, V28, P102, DOI 10.1097/HJH.0b013e328332b865; Gardiner TA, 2007, MICROCIRCULATION, V14, P25, DOI 10.1080/10739680601072123; Guler AD, 2002, J NEUROSCI, V22, P6408; Hamanaka K, 2007, AM J PHYSIOL-LUNG C, V293, pL923, DOI 10.1152/ajplung.00221.2007; Hartmannsgruber V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000827; Hatano N, 2013, LIFE SCI, V92, P317, DOI 10.1016/j.lfs.2013.01.002; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; Kern TS, 2010, MOL VIS, V16, P1629; Kohler R, 2006, ARTERIOSCL THROM VAS, V26, P1495, DOI 10.1161/01.ATV.0000225698.36212.6a; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Loot AE, 2008, CARDIOVASC RES, V80, P445, DOI 10.1093/cvr/cvn207; Ma X, 2013, HYPERTENSION, V62, P134, DOI 10.1161/HYPERTENSIONAHA.113.01500; Ma X, 2011, CELL CALCIUM, V50, P502, DOI 10.1016/j.ceca.2011.08.006; Mandecka A, 2007, DIABETES CARE, V30, P3048, DOI 10.2337/dc07-0927; McGahon MK, 2007, CIRC RES, V100, P703, DOI 10.1161/01.RES.0000260182.36481.c9; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Ng LC, 2009, J PHYSIOL-LONDON, V587, P2429, DOI 10.1113/jphysiol.2009.172254; Nguyen TT, 2009, DIABETES CARE, V32, P2075, DOI 10.2337/dc09-0075; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; PATEL V, 1994, CLIN SCI, V86, P689, DOI 10.1042/cs0860689; Pla AF, 2012, ONCOGENE, V31, P200, DOI 10.1038/onc.2011.231; Pournaras CJ, 2008, PROG RETIN EYE RES, V27, P284, DOI 10.1016/j.preteyeres.2008.02.002; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Robinson R, 2012, DIS MODEL MECH, V5, P444, DOI 10.1242/dmm.009597; Roy S, 2010, BIOGERONTOLOGY, V11, P447, DOI 10.1007/s10522-010-9263-x; SHARMA NK, 1985, AM J OPHTHALMOL, V100, P51, DOI 10.1016/S0002-9394(14)74982-7; SINCLAIR SH, 1982, OPHTHALMOLOGY, V89, P748, DOI 10.1016/s0161-6420(82)34720-x; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Willette RN, 2008, J PHARMACOL EXP THER, V326, P443, DOI 10.1124/jpet.107.134551; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Wu SW, 2009, AM J PHYSIOL-LUNG C, V297, pL650, DOI 10.1152/ajplung.00015.2009; Zhang DX, 2009, HYPERTENSION, V53, P532, DOI 10.1161/HYPERTENSIONAHA.108.127100; Zhang LQ, 2013, BRIT J PHARMACOL, V170, P661, DOI 10.1111/bph.12315	55	53	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128359	10.1371/journal.pone.0128359	http://dx.doi.org/10.1371/journal.pone.0128359			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047504	Green Submitted, gold, Green Published			2022-12-27	WOS:000355652200062
J	Sasaki, JI; Hashimoto, M; Yamaguchi, S; Itoh, Y; Yoshimoto, I; Matsumoto, T; Imazato, S				Sasaki, Jun-Ichi; Hashimoto, Masanori; Yamaguchi, Satoshi; Itoh, Yoshihiro; Yoshimoto, Itsumi; Matsumoto, Takuya; Imazato, Satoshi			Fabrication of Biomimetic Bone Tissue Using Mesenchymal Stem Cell-Derived Three-Dimensional Constructs Incorporating Endothelial Cells	PLOS ONE			English	Article							IN-VITRO; REGENERATIVE MEDICINE; ANGIOGENIC FACTORS; VASCULARIZATION; DIFFERENTIATION; OSTEOGENESIS; COCULTURES	The development of technologies to promote vascularization of engineered tissue would drive major developments in tissue engineering and regenerative medicine. Recently, we succeeded in fabricating three-dimensional (3D) cell constructs composed of mesenchymal stem cells (MSCs). However, the majority of cells within the constructs underwent necrosis due to a lack of nutrients and oxygen. We hypothesized that incorporation of vascular endothelial cells would improve the cell survival rate and aid in the fabrication of biomimetic bone tissues in vitro. The purpose of this study was to assess the impact of endothelial cells combined with the MSC constructs (MSC/HUVEC constructs) during short-and long-term culture. When human umbilical vein endothelial cells (HUVECs) were incorporated into the cell constructs, cell viability and growth factor production were increased after 7 days. Furthermore, HUVECs were observed to proliferate and self-organize into reticulate porous structures by interacting with the MSCs. After long-term culture, MSC/HUVEC constructs formed abundant mineralized matrices compared with those composed of MSCs alone. Transmission electron microscopy and qualitative analysis revealed that the mineralized matrices comprised porous cancellous bone-like tissues. These results demonstrate that highly biomimetic bone tissue can be fabricated in vitro by 3D MSC constructs incorporated with HUVECs.	[Sasaki, Jun-Ichi; Hashimoto, Masanori; Yamaguchi, Satoshi; Itoh, Yoshihiro; Yoshimoto, Itsumi; Imazato, Satoshi] Osaka Univ, Grad Sch Dent, Dept Biomat Sci, Osaka, Japan; [Itoh, Yoshihiro] Osaka Univ, Grad Sch Dent, Dept Restorat Dent & Endodontol, Osaka, Japan; [Matsumoto, Takuya] Okayama Univ, Dept Biomat, Okayama, Japan	Osaka University; Osaka University; Okayama University	Sasaki, JI (corresponding author), Osaka Univ, Grad Sch Dent, Dept Biomat Sci, Osaka, Japan.	jun1-s@dent.osaka-u.ac.jp	Yamaguchi, Satoshi/R-1812-2018	Yamaguchi, Satoshi/0000-0002-4661-8821; Imazato, Satoshi/0000-0003-3655-4809	Japan Society for the Promotion of Science [26462969, 24659846]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This project was funded by Grants-in-Aid for Scientific Research (Grant nos. 26462969 and 24659846) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/index.html). The funding source did not play a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082085; Bajaj P, 2014, ANNU REV BIOMED ENG, V16, P247, DOI 10.1146/annurev-bioeng-071813-105155; Bidarra SJ, 2011, STEM CELL RES, V7, P186, DOI 10.1016/j.scr.2011.05.006; Bitar KN, 2013, CURR OPIN BIOTECH, V24, P909, DOI 10.1016/j.copbio.2013.03.021; Boas SEM, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1049; Boskey A, 2007, BIOMATERIALS, V28, P2465, DOI 10.1016/j.biomaterials.2006.11.043; Chan CY, 2013, LAB CHIP, V13, P4697, DOI 10.1039/c3lc90115g; Chim SM, 2013, CYTOKINE GROWTH F R, V24, P297, DOI 10.1016/j.cytogfr.2013.03.008; de Almeida Danilo C, 2013, Clin Biochem Rev, V34, P131; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Lantada AD, 2013, EXPERT REV MED DEVIC, V10, P629, DOI 10.1586/17434440.2013.827506; Drasdo D, 2003, MATH COMPUT MODEL, V37, P1163, DOI 10.1016/S0895-7177(03)00128-6; Garg T, 2014, EXPERT OPIN DRUG DEL, V11, P767, DOI 10.1517/17425247.2014.891014; Gershovich JG, 2013, TISSUE ENG PT A, V19, P2565, DOI [10.1089/ten.tea.2013.0256, 10.1089/ten.TEA.2013.0256]; Haraguchi Y, 2012, NAT PROTOC, V7, P850, DOI 10.1038/nprot.2012.027; Hasan A, 2014, BIOMATERIALS, V35, P7308, DOI 10.1016/j.biomaterials.2014.04.091; Hashimoto M, 2014, J BIOMED MATER RES A, V102, P1838, DOI 10.1002/jbm.a.34854; Kim J, 2013, BIOMATERIALS, V34, P7257, DOI 10.1016/j.biomaterials.2013.06.029; Koob S, 2011, TISSUE ENG PT A, V17, P311, DOI [10.1089/ten.tea.2010.0338, 10.1089/ten.TEA.2010.0338]; Lee JH, 2013, ARTIF ORGANS, V37, P637, DOI 10.1111/aor.12027; LEITH JT, 1995, CELL PROLIFERAT, V28, P415, DOI 10.1111/j.1365-2184.1995.tb00082.x; Ma JL, 2014, J BIOMED MATER RES A, V102, P1026, DOI 10.1002/jbm.a.34775; MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664; Malinen MM, 2014, BIOMATERIALS, V35, P5110, DOI 10.1016/j.biomaterials.2014.03.020; Mason SL, 2011, REGEN MED, V6, P767, DOI [10.2217/rme.11.94, 10.2217/RME.11.94]; Michelini E, 2010, ANAL BIOANAL CHEM, V398, P227, DOI 10.1007/s00216-010-3933-z; Murphy CM, 2013, EUR CELLS MATER, V26, P120, DOI 10.22203/eCM.v026a09; Nishiguchi A, 2014, BIOMATERIALS, V35, P4739, DOI 10.1016/j.biomaterials.2014.01.079; Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004; Orabi H, 2013, SCI WORLD J, DOI 10.1155/2013/154564; Portalska KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046842; Rao RR, 2013, CYTOTHERAPY, V15, P1309, DOI 10.1016/j.jcyt.2013.06.005; Ribatti D, 2013, EXPERT OPIN INV DRUG, V22, P1157, DOI 10.1517/13543784.2013.813933; Ruano-Ravina A, 2006, OSTEOARTHR CARTILAGE, V14, P47, DOI 10.1016/j.joca.2005.07.017; Salgado AJ, 2013, INT REV NEUROBIOL, V108, P1, DOI 10.1016/B978-0-12-410499-0.00001-0; Sasaki JI, 2010, TISSUE ENG PT A, V16, P2497, DOI [10.1089/ten.tea.2009.0523, 10.1089/ten.TEA.2009.0523]; Sasaki JI, 2012, INTEGR BIOL-UK, V4, P1207, DOI 10.1039/c2ib20027a; Sekine H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2406; Sekiya S, 2013, REGEN MED, V8, P371, DOI [10.2217/RME.13.16, 10.2217/rme.13.16]; Steiner D, 2012, J ORTHOP RES, V30, P1682, DOI 10.1002/jor.22130; Swat MH, 2012, METHOD CELL BIOL, V110, P325, DOI 10.1016/B978-0-12-388403-9.00013-8; Theveneau E, 2012, CURR OPIN CELL BIOL, V24, P677, DOI 10.1016/j.ceb.2012.08.002; Twiss F, 2013, CELL MOL LIFE SCI, V70, P4101, DOI 10.1007/s00018-013-1329-x; Xue Y, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-34; Ye K, 2013, REGEN MED, V8, P333, DOI [10.2217/RME.13.28, 10.2217/rme.13.28]; Yildirimer L, 2014, BIOTECHNOL ADV, V32, P984, DOI 10.1016/j.biotechadv.2014.04.014; Zeitlin BD, 2012, LAB INVEST, V92, P988, DOI 10.1038/labinvest.2012.77; Zhou JA, 2011, ACTA BIOMATER, V7, P3999, DOI 10.1016/j.actbio.2011.06.040	48	23	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129266	10.1371/journal.pone.0129266	http://dx.doi.org/10.1371/journal.pone.0129266			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047122	gold, Green Published, Green Submitted			2022-12-27	WOS:000355652200139
J	Yang, BY; Zhang, MM; Li, LL; Pu, F; You, WW; Ke, CH				Yang, Bingye; Zhang, Mingming; Li, Lingling; Pu, Fei; You, Weiwei; Ke, Caihuan			Molecular Analysis of Atypical Family 18 Chitinase from Fujian Oyster Crassostrea angulata and Its Physiological Role in the Digestive System	PLOS ONE			English	Article							CRYSTALLINE STYLE; PROTEINS; EXPRESSION; IDENTIFICATION; PREDICTION; RECEPTOR; DISTINCT; CG-CLP1; RHYTHMS; MUSSEL	Chitinolytic enzymes have an important physiological significance in immune and digestive systems in plants and animals, but chitinase has not been identified as having a role in the digestive system in molluscan. In our study, a novel chitinase homologue, named Ca-Chit, has been cloned and characterized as the oyster Crassostrea angulate. The 3998bp fulllength cDNA of Ca-Chit consisted of 23bp 5-UTR, 3288 ORF and 688bp 3-UTR. The deduced amino acids sequence shares homologue with the chitinase of family 18. The molecular weight of the protein was predicted to be 119.389 kDa, with a pI of 6.74. The Ca-Chit protein was a modular enzyme composed of a glycosyl hydrolase family 18 domain, threonine- rich region profile and a putative membrane anchor domain. Gene expression profiles monitored by quantitative RT-PCR in different adult tissues showed that the mRNA of CaChit expressed markedly higher visceral mass than any other tissues. The results of the whole mount in-situ hybridization displayed that Ca-Chit starts to express the visceral mass of D-veliger larvae and then the digestive gland forms a crystalline structure during larval development. Furthermore, the adult oysters challenged by starvation indicated that the CaChit expression would be regulated by feed. All the observations made suggest that Ca-Chit plays an important role in the digestive system of the oyster, Crassostrea angulate.	[Yang, Bingye] Xiamen Med Coll, Xiamen 361008, Peoples R China; [Yang, Bingye; Pu, Fei; Ke, Caihuan] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361005, Peoples R China; [Yang, Bingye; Pu, Fei; You, Weiwei; Ke, Caihuan] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen 361005, Peoples R China; [Zhang, Mingming; Li, Lingling] Xiamen Univ, Coll Life Sci, Xiamen 361005, Peoples R China	Xiamen Medical College; Xiamen University; Xiamen University; Xiamen University	Ke, CH (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361005, Peoples R China.	chke@xmu.edu.cn			NSFC [41176113]; National Basic Research Program of China [2010CB126403]; Special Fund for Marine Scientific Research in the Public Interest [201305016]; Earmarked Fund for Modern Agro-industry Technology Research System [CARS-48]	NSFC(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Special Fund for Marine Scientific Research in the Public Interest; Earmarked Fund for Modern Agro-industry Technology Research System	This study was funded by NSFC (41176113), The National Basic Research Program of China (No. 2010CB126403), the Special Fund for Marine Scientific Research in the Public Interest (201305016) and the Earmarked Fund for Modern Agro-industry Technology Research System (CARS-48).	Aliakrinskaia I O, 2001, Izv Akad Nauk Ser Biol, P613; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arakane Y, 2003, INSECT BIOCHEM MOLEC, V33, P631, DOI 10.1016/S0965-1748(03)00049-3; Aronson NN, 1997, J CHEM INF COMP SCI, V37, P999, DOI 10.1021/ci970236v; Badariotti F, 2007, FEBS J, V274, P3646, DOI 10.1111/j.1742-4658.2007.05898.x; Badariotti F, 2007, DEV COMP IMMUNOL, V31, P559, DOI 10.1016/j.dci.2006.09.002; Badariotti F, 2006, J BIOL CHEM, V281, P29583, DOI 10.1074/jbc.M605687200; BIRKBECK TH, 1984, COMP BIOCHEM PHYS B, V77, P861, DOI 10.1016/0305-0491(84)90325-0; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Chuang GY, 2012, BIOINFORMATICS, V28, P2249, DOI 10.1093/bioinformatics/bts426; Daimon T, 2003, INSECT BIOCHEM MOLEC, V33, P749, DOI 10.1016/S0965-1748(03)00084-5; Dorit R.L., 1991, ZOOLOGY, P925; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Galtsoff P.S., 1964, FISHERY B FISH WILDL, V64, P1, DOI DOI 10.1111/J.1439-0388.2007.00702.X; Gonzalez M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-213; Gooday GW, 1990, BIODEGRADATION, V1, P177, DOI 10.1007/BF00058835; GRISLEY MS, 1990, COMP BIOCHEM PHYS B, V95, P311, DOI 10.1016/0305-0491(90)90081-4; Hinman VF, 2000, DEV GENES EVOL, V210, P129, DOI 10.1007/s004270050019; JENNER CE, 1956, BIOL BULL, V111, P304; KRISTENSEN J H, 1972, Ophelia, V10, P91; LANGTON RW, 1977, MAR BIOL, V41, P53, DOI 10.1007/BF00390581; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUNDBLAD G, 1976, ACTA CHEM SCAND B, V30, P889, DOI 10.3891/acta.chem.scand.30b-0889; MORTON B, 1971, Biological Journal of the Linnean Society, V3, P329, DOI 10.1111/j.1095-8312.1971.tb00526.x; MORTON JE, 1956, J MAR BIOL ASSOC UK, V35, P563, DOI 10.1017/S0025315400010420; NAKAI K, 1988, J BIOCHEM-TOKYO, V104, P693, DOI 10.1093/oxfordjournals.jbchem.a122535; Nichols S. Jerrine, 1993, P315; Qin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043653; Renkema GH, 1997, EUR J BIOCHEM, V244, P279, DOI 10.1111/j.1432-1033.1997.00279.x; Richard F, 2007, CRASSOSTREA VIRGINIC; ROBERTSON JR, 1979, NAUTILUS, V93, P38; SMUCKER RA, 1984, COMP BIOCHEM PHYS A, V77, P239, DOI 10.1016/0300-9629(84)90054-9; Suzuki M, 2002, J HISTOCHEM CYTOCHEM, V50, P1081, DOI 10.1177/002215540205000810; WATANABE T, 1993, J BIOL CHEM, V268, P18567; Yang BY, 2013, COMP BIOCHEM PHYS B, V164, P168, DOI 10.1016/j.cbpb.2012.12.006; Yang BY, 2012, AQUACULTURE, V366, P54, DOI 10.1016/j.aquaculture.2012.08.040; Yonge C. M., 1932, Scientific Reports Great Barrier Reef Expedition, V1, P259	37	6	6	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129261	10.1371/journal.pone.0129261	http://dx.doi.org/10.1371/journal.pone.0129261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046992	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200138
J	Zhang, HF; Gao, N; Liu, TT; Fang, Y; Qi, B; Wen, Q; Zhou, J; Jia, LJ; Qiao, HL				Zhang, Haifeng; Gao, Na; Liu, Tingting; Fang, Yan; Qi, Bing; Wen, Qiang; Zhou, Jun; Jia, Linjing; Qiao, Hailing			Effect of Cytochrome b5 Content on the Activity of Polymorphic CYP1A2, 2B6, and 2E1 in Human Liver Microsomes	PLOS ONE			English	Article							DRUG-METABOLISM; B(5) REDUCTASE; P450 REDUCTASE; ROLES; OXIDATION; 3A4; PURIFICATION; CYP2E1	Human cytochrome b5 (Cyt b5) plays important roles in cytochrome P450 (CYP)-mediated drug metabolism. However, the expression level of Cyt b5 in normal human liver remains largely unknown. The effect of Cyt b5 on overall CYP activity in human liver microsomes (HLM) has rarely been reported and the relationship between Cyt b5 and the activity of polymorphic CYP has not been systematically investigated. In this study, we found that the median value of Cyt b5 protein was 270.01 pmol/ mg from 123 HLM samples, and 12- and 19fold individual variation was observed in Cyt b5 mRNA and protein levels, respectively. Gender and smoking clearly influenced Cyt b5 content. In addition, we found that Cyt b5 protein levels significantly correlated with the overall activity of CYP1A2, 2B6, and 2E1 in HLM. However, when the CYP activities were sorted by single nucleotide polymorphisms (SNP), the effect of Cyt b5 protein on the kinetic parameters varied greatly. There were significant correlations between Cyt b5 content and Vmax and CLint of CYP1A2 wild-types (3860GG, 2159GG, and 5347CC) as well as homozygous mutants (163AA and 3113GG). In contrast to V-max and C-Lint, the K-m of CYP2B6 516GG and 785AA genotypes was inversely associated with Cyt b5 content. Correlations between Cyt b5 content and V-max and CLint of CYP2E1 -1293GG, -1293GC, 7632TT, 7632TA, -333TT, and -352AA genotypes were also observed. In conclusion, Cyt b5 expression levels varied considerably in the Chinese cohort from this study. Cyt b5 had significant impact on the overall activity of CYP1A2, 2B6, and 2E1 in HLM and the effects of Cyt b5 protein on polymorphic CYP1A2, 2B6, and 2E1 activity were SNP-dependent. These findings suggest that Cyt b5 plays an important role in CYP-mediated activities in HLM and may possibly be a contributing factor for the individual variation observed in CYP enzyme activities.	[Zhang, Haifeng; Gao, Na; Liu, Tingting; Fang, Yan; Qi, Bing; Wen, Qiang; Zhou, Jun; Jia, Linjing; Qiao, Hailing] Zhengzhou Univ, Inst Clin Pharmacol, Zhengzhou 450052, Peoples R China	Zhengzhou University	Qiao, HL (corresponding author), Zhengzhou Univ, Inst Clin Pharmacol, Zhengzhou 450052, Peoples R China.	qiaohl@zzu.edu.cn		qi, bing/0000-0001-8025-493X	National Natural Science Foundation of China [81473279]; Science and Technology Innovative Scholar Program of Henan Province [134200510019]; Scientific and Technical Innovation Team of Zhengzhou City [131PCXTD604]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovative Scholar Program of Henan Province; Scientific and Technical Innovation Team of Zhengzhou City	This work was partly supported by the National Natural Science Foundation of China (No. 81473279), Science and Technology Innovative Scholar Program of Henan Province (No. 134200510019) and Scientific and Technical Innovation Team of Zhengzhou City (No. 131PCXTD604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backes WL, 2003, PHARMACOL THERAPEUT, V98, P221, DOI 10.1016/S0163-7258(03)00031-7; Djordjevic N, 2010, EUR J CLIN PHARMACOL, V66, P697, DOI 10.1007/s00228-010-0823-4; Finn RD, 2008, J BIOL CHEM, V283, P31385, DOI 10.1074/jbc.M803496200; Gan L, 2009, DRUG METAB DISPOS, V37, P90, DOI 10.1124/dmd.108.023424; GIORDANO SJ, 1991, BIOCHEM BIOPH RES CO, V178, P38, DOI 10.1016/0006-291X(91)91776-9; Henderson CJ, 2014, DRUG METAB DISPOS, V42, P70, DOI 10.1124/dmd.113.055277; HILDEBRANDT A, 1971, ARCH BIOCHEM BIOPHYS, V143, P66, DOI 10.1016/0003-9861(71)90186-X; Im SC, 2011, ARCH BIOCHEM BIOPHYS, V507, P144, DOI 10.1016/j.abb.2010.10.023; Jerabek P, 2014, BIOCHEMISTRY-US, V53, P6695, DOI 10.1021/bi500814t; Kandel SE, 2014, CHEM RES TOXICOL, V27, P1474, DOI 10.1021/tx500203s; Kaspera R, 2011, BIOCHEM PHARMACOL, V82, P681, DOI 10.1016/j.bcp.2011.06.027; Kurian JR, 2004, J PHARMACOL EXP THER, V311, P1171, DOI 10.1124/jpet.104.072389; Laki Szilvia, 2013, Acta Pharm Hung, V83, P107; Martiny VY, 2013, J MOL BIOL, V425, P3978, DOI 10.1016/j.jmb.2013.07.010; Meyer UA, 2004, NAT REV GENET, V5, P669, DOI 10.1038/nrg1428; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; OZOLS J, 1989, BIOCHIM BIOPHYS ACTA, V997, P121, DOI 10.1016/0167-4838(89)90143-X; Palma BB, 2013, PHARMACOGENET GENOM, V23, P41, DOI 10.1097/FPC.0b013e32835c2ddf; PATTEN CJ, 1986, ARCH BIOCHEM BIOPHYS, V251, P629, DOI 10.1016/0003-9861(86)90373-5; Peng HM, 2014, J BIOL CHEM, V289, P33838, DOI 10.1074/jbc.M114.608919; Peng HM, 2013, BIOCHEMISTRY-US, V52, P210, DOI 10.1021/bi301384n; Sacco JC, 2010, PHARMACOGENET GENOM, V20, P26, DOI 10.1097/FPC.0b013e3283343296; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; Shimada T, 2005, ARCH BIOCHEM BIOPHYS, V435, P207, DOI 10.1016/j.abb.2004.12.008; SHIMADA T, 1986, J BIOL CHEM, V261, P909; SNYDER R, 1993, TOXICOL APPL PHARM, V122, P172, DOI 10.1006/taap.1993.1185; Soyama Akiko, 2005, Drug Metab Pharmacokinet, V20, P24, DOI 10.2133/dmpk.20.24; Storbeck KH, 2013, MOL CELL ENDOCRINOL, V371, P87, DOI 10.1016/j.mce.2012.11.020; Takahashi K, 2014, PHARM RES-DORDR, V31, P780, DOI 10.1007/s11095-013-1200-7; Trafalis DT, 2010, EXPERT OPIN DRUG MET, V6, P307, DOI 10.1517/17425250903540238; VERGERES G, 1995, BIOCHIMIE, V77, P604, DOI 10.1016/0300-9084(96)88176-4; Xie HJ, 2003, PHARMACOGENOMICS J, V3, P53, DOI 10.1038/sj.tpj.6500157; Yamazaki H, 1997, ARCH BIOCHEM BIOPHYS, V342, P329, DOI 10.1006/abbi.1997.0125; Yamazaki H, 1996, ARCH BIOCHEM BIOPHYS, V325, P174, DOI 10.1006/abbi.1996.0022; Yamazaki H, 1996, BIOCHEM PHARMACOL, V52, P301, DOI 10.1016/0006-2952(96)00208-0; Yamazaki H, 1996, J BIOL CHEM, V271, P27438, DOI 10.1074/jbc.271.44.27438; Yamazaki H, 2002, PROTEIN EXPRES PURIF, V24, P329, DOI 10.1006/prep.2001.1578; Zanger UM, 2008, ANAL BIOANAL CHEM, V392, P1093, DOI 10.1007/s00216-008-2291-6; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zhao CS, 2012, BIOCHEMISTRY-US, V51, P9488, DOI 10.1021/bi301069r	40	32	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128547	10.1371/journal.pone.0128547	http://dx.doi.org/10.1371/journal.pone.0128547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046844	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200077
J	Haakenstad, A; Johnson, E; Graves, C; Olivier, J; Duff, J; Dieleman, JL				Haakenstad, Annie; Johnson, Elizabeth; Graves, Casey; Olivier, Jill; Duff, Jean; Dieleman, Joseph L.			Estimating the Development Assistance for Health Provided to Faith-Based Organizations, 1990-2013	PLOS ONE			English	Article								Background Faith-based organizations (FBOs) have been active in the health sector for decades. Recently, the role of FBOs in global health has been of increased interest. However, little is known about the magnitude and trends in development assistance for health (DAH) channeled through these organizations. Material and Methods Data were collected from the 21 most recent editions of the Report of Voluntary Agencies. These reports provide information on the revenue and expenditure of organizations. Project-level data were also collected and reviewed from the Bill & Melinda Gates Foundation and the Global Fund to Fight AIDS, Tuberculosis and Malaria. More than 1,900 non-governmental organizations received funds from at least one of these three organizations. Background information on these organizations was examined by two independent reviewers to identify the amount of funding channeled through FBOs. Results In 2013, total spending by the FBOs identified in the VolAg amounted to US$1.53 billion. In 1990, FB0s spent 34.1% of total DAH provided by private voluntary organizations reported in the VolAg. In 2013, FBOs expended 31.0%. Funds provided by the Global Fund to FBOs have grown since 2002, amounting to $80.9 million in 2011, or 16.7% of the Global Fund's contributions to NGOs. In 2011, the Gates Foundation's contributions to FBOs amounted to $7.1 million, or 1.1% of the total provided to NGOs. Conclusion Development assistance partners exhibit a range of preferences with respect to the amount of funds provided to FBOs. Overall, estimates show that FBOS have maintained a substantial and consistent share over time, in line with overall spending in global health on NGOs. These estimates provide the foundation for further research on the spending trends and effectiveness of FBOs in global health.	[Haakenstad, Annie; Johnson, Elizabeth; Graves, Casey; Dieleman, Joseph L.] Inst Hlth Metr & Evaluat, Seattle, WA 98104 USA; [Olivier, Jill] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Duff, Jean] Joint Learning Initiat Faith & Local Communities, Washington, DC USA	Institute for Health Metrics & Evaluation; University of Cape Town	Haakenstad, A (corresponding author), Inst Hlth Metr & Evaluat, Seattle, WA 98104 USA.	ahaak@uw.edu	Olivier, Jill/M-9735-2015	Olivier, Jill/0000-0001-9155-6896	Bill & Melinda Gates Foundation [48046]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The work was conducted with the generous support of the Bill & Melinda Gates Foundation (gatesfoundation.org) through core funding for the Institute for Health Metrics and Evaluation (Grant No. 48046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Africa Christian Health Associations Platform, 2001, 5 BIENN AFR CHRIST H; Brooks BP, 2012, FINANCING GLOBAL HLT; Christian Health Association of Ghana, 2006, ANN REP JUN 2005 MAY; Dieleman JL, 2014, HEALTH AFFAIR, V33, P878, DOI 10.1377/hlthaff.2013.1432; Duff J, 2013, TOTAL REVENUE US GOV; Global Health and Africa, GLOB HLTH AFR ASS FA; Haddad B, 2008, POTENTIALS PERILS PA; Kagawa RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048457; Olivier J, 2014, LANCET IN PRESS; Olivier J, 2012, DEV PRACT, V22, P819, DOI 10.1080/09614524.2012.685870; Olivier J, 2014, REV FAITH INT AFF, V12, P53, DOI 10.1080/15570274.2013.876736; Olivier Jill, 2012, ROLE FAITH INSPIRED, V3, P25; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; The Global Fund to Fight AIDS TB and Malaria, 2014, CRIT PARTN LIF COLL; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2008, REP INV FAITH BAS OR	15	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128389	10.1371/journal.pone.0128389	http://dx.doi.org/10.1371/journal.pone.0128389			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042731	gold, Green Submitted, Green Published			2022-12-27	WOS:000355701600046
J	Millar, SR; Perry, IJ; Van den Broeck, J; Phillips, CM				Millar, Sean R.; Perry, Ivan J.; Van den Broeck, Jan; Phillips, Catherine M.			Optimal Central Obesity Measurement Site for Assessing Cardiometabolic and Type 2 Diabetes Risk in Middle-Aged Adults	PLOS ONE			English	Article							BODY-MASS INDEX; TO-HEIGHT RATIO; AMERICAN-HEART-ASSOCIATION; WAIST CIRCUMFERENCE; CARDIOVASCULAR RISK; METABOLIC SYNDROME; ANTHROPOMETRIC INDICATORS; CONSENSUS STATEMENT; INSULIN-RESISTANCE; FAT DISTRIBUTION	Objectives Despite recommendations that central obesity assessment should be employed as a marker of cardiometabolic health, no consensus exists regarding measurement protocol. This study examined a range of anthropometric variables and their relationships with cardiometabolic features and type 2 diabetes in order to ascertain whether measurement site influences discriminatory accuracy. In particular, we compared waist circumference (WC) measured at two sites: (1) immediately below the lowest rib (WC rib) and (2) between the lowest rib and iliac crest (WC midway), which has been recommended by the World Health Organisation and International Diabetes Federation. Materials and Methods This was a cross-sectional study involving a random sample of 2,002 men and women aged 46-73 years. Metabolic profiles and WC, hip circumference, pelvic width and body mass index (BMI) were determined. Correlation, logistic regression and area under the receiver operating characteristic curve analyses were used to evaluate obesity measurement relationships with metabolic risk phenotypes and type 2 diabetes. Results WC rib measures displayed the strongest associations with non-optimal lipid and lipoprotein levels, high blood pressure, insulin resistance, impaired fasting glucose, a clustering of metabolic risk features and type 2 diabetes, in both genders. Rib-derived indices improved discrimination of type 2 diabetes by 3-7% compared to BMI and 2-6% compared toWC midway (in men) and 5-7% compared to BMI and 4-6% compared to WC midway (in women). A prediction model including BMI and central obesity displayed a significantly higher area under the curve for WC rib (0.78, P=0.003), Rib/height ratio (0.80, P<0.001), Rib/pelvis ratio (0.79, P<0.001), but not for WC midway (0.75, P=0.127), when compared to one with BMI alone (0.74). Conclusions WC rib is easier to assess and our data suggest that it is a better method for determining obesity-related cardiometabolic risk than WC midway. The clinical utility of rib-derived indices, or alternative WC measurements, deserves further investigation.	[Millar, Sean R.; Perry, Ivan J.; Phillips, Catherine M.] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, HRB Ctr Hlth & Diet Res, Cork, Ireland; [Van den Broeck, Jan] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway	Health Research Board - Ireland; University College Cork; University of Bergen	Millar, SR (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, HRB Ctr Hlth & Diet Res, Cork, Ireland.	s.millar@ucc.ie		Perry, Ivan/0000-0002-4965-9792	Irish Health Research Board [HRC/2007/13]	Irish Health Research Board	This work was supported by a research grant from the Irish Health Research Board (reference HRC/2007/13). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Arsenault BJ, 2011, CLIN LIPIDOL, V6, P639, DOI 10.2217/CLP.11.51; Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Ashwell M, 2009, OBESITY FACTS, V2, P97, DOI 10.1159/000203363; Bosy-Westphal A, 2010, J NUTR, V140, P954, DOI 10.3945/jn.109.118737; Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Connor JMO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080504; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; Curtis JP, 2005, ARCH INTERN MED, V165, P55, DOI 10.1001/archinte.165.1.55; Esmaillzadeh A, 2004, INT J OBESITY, V28, P1325, DOI 10.1038/sj.ijo.0802757; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Gomez-Ambrosi J, 2012, INT J OBESITY, V36, P286, DOI 10.1038/ijo.2011.100; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Huxley R, 2010, EUR J CLIN NUTR, V64, P16, DOI 10.1038/ejcn.2009.68; Initiative NOE, 2002, PRACT GUID ID EV TRE; Janes H, 2009, STATA J, V9, P17, DOI 10.1177/1536867X0900900102; Janiszewski PM, 2007, DIABETES CARE, V30, P3105, DOI 10.2337/dc07-0945; Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004; Kearney PM, 2013, INT J EPIDEMIOL, V42, P1253, DOI 10.1093/ije/dys131; Klein S, 2007, OBESITY, V15, P1061, DOI 10.1038/oby.2007.632; Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172; Ma WY, 2013, DIABETES CARE, V36, P1660, DOI 10.2337/dc12-1452; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Millar SR, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.S11-004; Ness-Abramof R, 2008, NUTR CLIN PRACT, V23, P397, DOI 10.1177/0884533608321700; Ntuk U, 2014, DIABETES CARE; Okorodudu DO, 2010, INT J OBESITY, V34, P791, DOI 10.1038/ijo.2010.5; Okosun IS, 2012, HDB ANTHROPOMETRY, P2091; Peat J, 2008, BMJ BOOKS; Phillips C.M., 2013, PLOS ONE; Phillips CM, 2013, J CLIN ENDOCR METAB, V98, pE1610, DOI 10.1210/jc.2013-2038; Phillips CM, 2013, OBESITY, V21, pE154, DOI 10.1002/oby.20263; Qiao Q, 2010, EUR J CLIN NUTR, V64, P30, DOI 10.1038/ejcn.2009.93; Ross R, 2008, OBES REV, V9, P312, DOI 10.1111/j.1467-789X.2007.00411.x; Schneider HJ, 2007, J CLIN ENDOCR METAB, V92, P589, DOI 10.1210/jc.2006-0254; Standardization WECoB Organization WH, 1995, PHYS STAT US INT ANT; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Wang J, 2003, AM J CLIN NUTR, V77, P379, DOI 10.1093/ajcn/77.2.379; Welborn TA, 2003, MED J AUSTRALIA, V179, P580, DOI 10.5694/j.1326-5377.2003.tb05704.x; WHO, 2000, OB PREV MAN GLOB EP; WHO, 2008, WAIST CIRCUMFERENCE	47	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0129088	10.1371/journal.pone.0129088	http://dx.doi.org/10.1371/journal.pone.0129088			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042771	gold, Green Published			2022-12-27	WOS:000355701600086
J	Tsukada, T; Simamura, E; Shimada, H; Arai, T; Higashi, N; Akai, T; Iizuka, H; Hatta, T				Tsukada, Tsuyoshi; Simamura, Eriko; Shimada, Hiroki; Arai, Takuma; Higashi, Nobuaki; Akai, Takuya; Iizuka, Hideaki; Hatta, Toshihisa			The Suppression of Maternal-Fetal Leukemia Inhibitory Factor Signal Relay Pathway by Maternal Immune Activation Impairs Brain Development in Mice	PLOS ONE			English	Article							GENE-EXPRESSION; NEURAL STEM; INFLUENZA INFECTION; PRENATAL EXPOSURE; CHILDHOOD; PROLIFERATION; SCHIZOPHRENIA; INFLAMMATION; HIPPOCAMPUS; STEREOLOGY	Recent studies in rodents suggest that maternal immune activation (MIA) by viral infection is associated with schizophrenia and autism in offspring. Although maternal IL-6 is though t to be a possible mediator relating MIA induced these neuropsychiatric disorders, the mechanism remains to be elucidated. Previously, we reported that the maternal leukemia inhibitory factor (LIF)-placental ACTH-fetal LIF signaling relay pathway (maternal-fetal LIF signal relay) promotes neurogenesis of fetal cerebrum in rats. Here we report that the maternalfetal LIF signal relay in mice is suppressed by injection of polyriboinosinic-polyribocytidylic acid into dams, which induces MIA at 12.5 days post-coitum. Maternal IL-6 levels and gene expression of placental suppressor of cytokine signaling 3 (Socs3) increased according to the severity of MIA and gene expression of placental Socs3 correlated with maternal IL-6 levels. Furthermore, we show that MIA causes reduction of LIF level in the fetal cerebrospinal fluid, resulting in the decreased neurogenesis in the cerebrum. These findings suggest that maternal IL-6 interferes the maternal-fetal LIF signal relay by inducing SOCS3 in the placenta and leads to decreased neurogenesis.	[Tsukada, Tsuyoshi; Akai, Takuya; Iizuka, Hideaki] Kanazawa Med Univ, Dept Neurosurg, Uchinada, Ishikawa 9200293, Japan; [Simamura, Eriko; Shimada, Hiroki; Arai, Takuma; Higashi, Nobuaki; Hatta, Toshihisa] Kanazawa Med Univ, Dept Anat, Uchinada, Ishikawa 9200293, Japan	Kanazawa Medical University; Kanazawa Medical University	Hatta, T (corresponding author), Kanazawa Med Univ, Dept Anat, Uchinada, Ishikawa 9200293, Japan.	thatta@kanazawa-med.ac.jp		Tsukada, Tsuyoshi/0000-0003-4404-0103	Japan Society for the Promotion of Science [25293241, 24659512, 23112006, 22390216, 23591606, 24590245]; Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan; grants for promoting research from Kanazawa Medical University [C2009-3, C2010-2, S2008-10, S1201022]; Research for Promoting Technological Seeds [07-035]; grant for project research from the High-Technology Research Centre of Kanazawa Medical University [H2010-14]; Grants-in-Aid for Scientific Research [25293241] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); grants for promoting research from Kanazawa Medical University; Research for Promoting Technological Seeds(Japan Science & Technology Agency (JST)); grant for project research from the High-Technology Research Centre of Kanazawa Medical University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (25293241[TH], 24659512[TH], 23112006[TH], 22390216[TH], 23591606[ES], 24590245[HS]), by the Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan and by grants for promoting research from Kanazawa Medical University (C2009-3[TH], C2010-2[TH], S2008-10 [ES], and S1201022[TH]), by Research for Promoting Technological Seeds (07-035[TH]), and by a grant for project research from the High-Technology Research Centre of Kanazawa Medical University (H2010-14 [TH]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Auernhammer CJ, 1998, MOL ENDOCRINOL, V12, P954, DOI 10.1210/me.12.7.954; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; BARKER DJP, 1993, BRIT MED J, V307, P1524, DOI 10.1136/bmj.307.6918.1524; BARKER DJP, 1986, LANCET, V1, P1077; Brown AS, 2006, SCHIZOPHRENIA BULL, V32, P200, DOI 10.1093/schbul/sbj052; Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774; Brown AS, 2001, BIOL PSYCHIAT, V49, P473, DOI 10.1016/S0006-3223(01)01068-X; Cui K, 2009, SCHIZOPHR RES, V113, P288, DOI 10.1016/j.schres.2009.05.003; Dahlgren J, 2001, AM J PHYSIOL-ENDOC M, V281, pE326, DOI 10.1152/ajpendo.2001.281.2.E326; De Miranda J, 2010, MBIO, V1, DOI 10.1128/mBio.00176-10; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Gallagher D, 2013, CELL STEM CELL, V13, P564, DOI 10.1016/j.stem.2013.10.002; Gilmore JH, 2005, J NEUROIMMUNOL, V159, P106, DOI 10.1016/j.jneuroim.2004.10.008; Godfrey KM, 2002, PLACENTA, V23, pS20, DOI 10.1053/plac.2002.0773; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hatta T, 2002, J NEUROSCI, V22, P5516; Hatta T, 2006, NEUROREPORT, V17, P1863, DOI 10.1097/WNR.0b013e3280113962; Hornig M, 1999, P NATL ACAD SCI USA, V96, P12102, DOI 10.1073/pnas.96.21.12102; Hsiao EY, 2011, BRAIN BEHAV IMMUN, V25, P604, DOI 10.1016/j.bbi.2010.12.017; Kishimoto T, 1995, ANN NY ACAD SCI, V766, P224, DOI 10.1111/j.1749-6632.1995.tb26670.x; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Li QL, 1999, MOL CELL ENDOCRINOL, V158, P143, DOI 10.1016/S0303-7207(99)00168-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006; Myatt L, 2006, J PHYSIOL-LONDON, V572, P25, DOI 10.1113/jphysiol.2006.104968; Nelson Karin B., 2000, Current Opinion in Neurology, V13, P133, DOI 10.1097/00019052-200004000-00004; Okahisa Y, 2010, PROG NEURO-PSYCHOPH, V34, P172, DOI 10.1016/j.pnpbp.2009.10.020; Oskvig DB, 2012, BRAIN BEHAV IMMUN, V26, P623, DOI 10.1016/j.bbi.2012.01.015; Rantakallio P, 1997, INT J EPIDEMIOL, V26, P837, DOI 10.1093/ije/26.4.837; Samuelsson AM, 2006, AM J PHYSIOL-REG I, V290, pR1345, DOI 10.1152/ajpregu.00268.2005; Samuelsson AM, 2004, ENDOCRINOLOGY, V145, P4897, DOI 10.1210/en.2004-0742; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shi LM, 2005, INT J DEV NEUROSCI, V23, P299, DOI 10.1016/j.ijdevneu.2004.05.005; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Simamura E, 2011, CONGENIT ANOM, V51, P47, DOI 10.1111/j.1741-4520.2011.00316.x; Simamura E, 2010, ENDOCRINOLOGY, V151, P1853, DOI 10.1210/en.2009-0985; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Stolp HB, 2011, BRAIN, V134, P3236, DOI 10.1093/brain/awr237; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143	44	25	25	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0129011	10.1371/journal.pone.0129011	http://dx.doi.org/10.1371/journal.pone.0129011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043040	Green Published, gold, Green Submitted			2022-12-27	WOS:000355701600081
J	Henry, JD; Moses, E; Castellini, J; Scott, J				Henry, Julie D.; Moses, Ernestina; Castellini, Julieta; Scott, James			Mental Health Problems in Adolescence and the Interpretation of Unambiguous Threat	PLOS ONE			English	Article							PERCEPTION ABNORMALITIES; ANXIETY; BIAS; INFORMATION; AVOIDANCE; ATTENTION; SYMPTOMS; CHILDREN	Aberrant threat perception has been linked to paranoia, anxiety and other mental health problems, and is widely considered to be a core, transdiagnostic feature of psychopathology. However, to date there has been only limited investigation of whether mental health problems are associated with a biased interpretation of stimuli that have explicit (as opposed to ambiguous) connotations of threat. In the present study, 41 adolescents diagnosed with a mental illness and 45 demographically matched controls were asked to provide danger ratings of stimuli normatively rated as being either low or high in potential threat. All participants were also asked to complete background measures of cognitive function, mental health and wellbeing. The results indicated that the two groups did not differ in their capacity to discriminate between low and high threat stimuli, nor did they differ in the absolute level of threat that they attributed to these stimuli. However, for the control group, the overall level of threat perceived in facial stimuli was correlated with two important indices of mental health (depression and anxiety). No associations emerged in the clinical group. These data are discussed in relation to their potential implications for the role of aberrant threat perception in transdiagnostic models of mental health.	[Henry, Julie D.; Moses, Ernestina; Castellini, Julieta] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia; [Scott, James] Univ Queensland, Sch Med, Clin Res Ctr, St Lucia, Qld, Australia; [Scott, James] Royal Brisbane & Womens Hosp, Australia Metro North Mental Hlth, Herston, Qld, Australia	University of Queensland; University of Queensland; Royal Brisbane & Women's Hospital	Henry, JD (corresponding author), Univ Queensland, Sch Psychol, St Lucia, Qld, Australia.	julie.henry@uq.edu.au	Scott, James G/D-5900-2012	Scott, James G/0000-0002-0744-0688; Henry, Julie/0000-0002-2081-3717	Australian Research Council under Discovery Project Grant [DP1093234]	Australian Research Council under Discovery Project Grant(Australian Research Council)	This work was supported by the Australian Research Council under Discovery Project Grant number DP1093234. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Amir N, 1998, J ABNORM PSYCHOL, V107, P285, DOI 10.1037/0021-843X.107.2.285; Amir N, 2012, J CONSULT CLIN PSYCH, V80, P497, DOI 10.1037/a0026928; Anderson K, 2007, ENCY SOCIAL PSYCHOL, P446; Barlow DH, 2004, BEHAV THER, V35, P205, DOI 10.1016/S0005-7894(04)80036-4; Beck AT, 1985, ANXIETY DISORDERS PH; Bradley BP, 2000, COGNITION EMOTION, V14, P789, DOI 10.1080/02699930050156636; Bradley BP, 1998, COGNITION EMOTION, V12, P737, DOI 10.1080/026999398379411; Britton JC, 2013, AM J PSYCHIAT, V170, P1195, DOI 10.1176/appi.ajp.2013.12050651; Cohen J.E., 1988, STAT POWER ANAL BEHA; Creswell C, 2014, J ABNORM CHILD PSYCH, V42, P453, DOI 10.1007/s10802-013-9795-z; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DODGE KA, 1995, J ABNORM PSYCHOL, V104, P632, DOI 10.1037/0021-843X.104.4.632; Doty TJ, 2013, EMOTION, V13, P183, DOI 10.1037/a0031373; Eysenck M.W., 2015, ANXIETY COGNITIVE PE, DOI 10.4324/9780203775677; EYSENCK MW, 1987, PSYCHOL RES-PSYCH FO, V49, P189, DOI 10.1007/BF00308686; Freeman D, 2000, Q J EXP PSYCHOL-A, V53, P549, DOI 10.1080/713755896; Green MJ, 2004, NEUROSCI BIOBEHAV R, V28, P333, DOI 10.1016/j.neubiorev.2004.03.006; Henry JD, 2010, J INT NEUROPSYCH SOC, V16, P805, DOI 10.1017/S1355617710000640; Henry JD, 2009, J GERONTOL B-PSYCHOL, V64, P603, DOI 10.1093/geronb/gbp064; Hirsch CR, 2012, BEHAV RES THER, V50, P636, DOI 10.1016/j.brat.2012.06.007; Lau JYF, 2013, BEHAV RES THER, V51, P614, DOI 10.1016/j.brat.2013.07.001; MATHEWS A, 1989, J ABNORM PSYCHOL, V98, P31, DOI 10.1037/0021-843X.98.1.31; MATHEWS A, 1990, BEHAV RES THER, V28, P455, DOI 10.1016/0005-7967(90)90132-3; McManus F, 1996, J NERV MENT DIS, V184, P547, DOI 10.1097/00005053-199609000-00006; Muris P, 2000, J BEHAV THER EXP PSY, V31, P123, DOI 10.1016/S0005-7916(00)00016-1; Muris P, 2005, INFANT CHILD DEV, V14, P273, DOI 10.1002/icd.392; Muris P, 2003, J ANXIETY DISORD, V17, P271, DOI 10.1016/S0887-6185(02)00199-8; Pine DS, 2005, AM J PSYCHIAT, V162, P291, DOI 10.1176/appi.ajp.162.2.291; Reynolds C.R., 1985, REVISED CHILDRENS MA; Reynolds W., 2002, REYNOLDS ADOLESCENT; Ruffman T, 2006, J GERONTOL B-PSYCHOL, V61, pP187, DOI 10.1093/geronb/61.4.P187; Salemink E, 2012, BEHAV RES THER, V50, P40, DOI 10.1016/j.brat.2011.10.006; Van Damme S, 2009, J BEHAV THER EXP PSY, V40, P344, DOI 10.1016/j.jbtep.2009.01.004; Vassilopoulos SP, 2005, BEHAV COGN PSYCHOTH, V33, P13, DOI 10.1017/S1352465804001730; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Woud ML, 2014, J ANXIETY DISORD, V28, P83, DOI 10.1016/j.janxdis.2013.11.008	38	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127167	10.1371/journal.pone.0127167	http://dx.doi.org/10.1371/journal.pone.0127167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7ST	26039081	gold, Green Published, Green Submitted			2022-12-27	WOS:000355700700053
J	Prehn, K; Korczykowski, M; Rao, HY; Fang, Z; Detre, JA; Robertson, DC				Prehn, Kristin; Korczykowski, Marc; Rao, Hengyi; Fang, Zhuo; Detre, John A.; Robertson, Diana C.			Neural Correlates of Post-Conventional Moral Reasoning: A Voxel-Based Morphometry Study	PLOS ONE			English	Article							PREFRONTAL CORTEX; BRAIN STRUCTURE; INDIVIDUAL-DIFFERENCES; SELF-ESTEEM; JUDGMENT; GENDER; DAMAGE; AGE; SENSITIVITY; PLASTICITY	Going back to Kohlberg, moral development research affirms that people progress through different stages of moral reasoning as cognitive abilities mature. Individuals at a lower level of moral reasoning judge moral issues mainly based on self-interest (personal interests schema) or based on adherence to laws and rules (maintaining norms schema), whereas individuals at the post-conventional level judge moral issues based on deeper principles and shared ideals. However, the extent to which moral development is reflected in structural brain architecture remains unknown. To investigate this question, we used voxel-based morphometry and examined the brain structure in a sample of 67 Master of Business Administration (MBA) students. Subjects completed the Defining Issues Test (DIT-2) which measures moral development in terms of cognitive schema preference. Results demonstrate that subjects at the post-conventional level of moral reasoning were characterized by increased gray matter volume in the ventromedial prefrontal cortex and subgenual anterior cingulate cortex, compared with subjects at a lower level of moral reasoning. Our findings support an important role for both cognitive and emotional processes in moral reasoning and provide first evidence for individual differences in brain structure according to the stages of moral reasoning first proposed by Kohlberg decades ago.	[Prehn, Kristin] Free Univ Berlin, Cluster Excellence Languages Emot, Berlin, Germany; [Prehn, Kristin] Charite, Dept Neurol, D-13353 Berlin, Germany; [Prehn, Kristin] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Korczykowski, Marc; Rao, Hengyi; Fang, Zhuo; Detre, John A.] Univ Penn, Dept Neurol, Ctr Funct Neuroimaging, Philadelphia, PA 19104 USA; [Korczykowski, Marc; Robertson, Diana C.] Univ Penn, Wharton Sch, Dept Legal Studies & Business Eth, Philadelphia, PA 19104 USA; [Rao, Hengyi; Fang, Zhuo] Sun Yat Sen Univ, Dept Psychol, Guangzhou 510275, Guangdong, Peoples R China	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Sun Yat Sen University	Prehn, K (corresponding author), Free Univ Berlin, Cluster Excellence Languages Emot, Berlin, Germany.	kristin.prehn@charite.de; hengyi@mail.med.upenn.edu	Rao, Hengyi/AAQ-4919-2020; Rao, Hengyi/A-7064-2009; Rao, Hengyi/K-5152-2019	Rao, Hengyi/0000-0003-2735-2500; Rao, Hengyi/0000-0003-2735-2500; Prehn, Kristin/0000-0002-0656-5323	NIH [R03 DA 027098, R01 HL102119, R21 DA032022, P30 NS045839]; Center for Functional Neuroimaging; Zicklin Center for Business Ethics Research; Mack Institute at the Wharton School; Chinese NSF [31070984, 31400872]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA027098, R21DA032022] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Functional Neuroimaging; Zicklin Center for Business Ethics Research; Mack Institute at the Wharton School; Chinese NSF(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported in part by NIH grants R03 DA 027098, R01 HL102119, R21 DA032022, P30 NS045839, a pilot grant from the Center for Functional Neuroimaging, the Zicklin Center for Business Ethics Research, the Mack Institute at the Wharton School, and the Chinese NSF grants 31070984 and 31400872. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barnes J, 2010, NEUROIMAGE, V53, P1244, DOI 10.1016/j.neuroimage.2010.06.025; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chubb NH, 1997, ADOLESCENCE, V32, P113; Ciaramelli E, 2007, SOC COGN AFFECT NEUR, V2, P84, DOI 10.1093/scan/nsm001; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; Decety J, 2012, CEREB CORTEX, V22, P209, DOI 10.1093/cercor/bhr111; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Harasty J, 1997, ARCH NEUROL-CHICAGO, V54, P171, DOI 10.1001/archneur.1997.00550140045011; Hayasaka S, 2004, NEUROIMAGE, V23, P54, DOI 10.1016/j.neuroimage.2004.04.035; Hebb Donald O., 1949, ORG BEHAV; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; King JA, 2006, NEUROIMAGE, V30, P1069, DOI 10.1016/j.neuroimage.2005.10.011; Kling KC, 1999, PSYCHOL BULL, V125, P470, DOI 10.1037/0033-2909.125.4.470; Kluetsch RC, 2012, ARCH GEN PSYCHIAT, V69, P993, DOI 10.1001/archgenpsychiatry.2012.476; Koelsch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077196; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Kohlberg L., 1969, HDB SOCIALIZATION TH, P347, DOI DOI 10.12691/EDUCATION-3-9-16; Lachman ME, 1998, J PERS SOC PSYCHOL, V74, P763, DOI 10.1037/0022-3514.74.3.763; Lewis GJ, 2012, J COGNITIVE NEUROSCI, V24, P1657, DOI 10.1162/jocn_a_00239; Lind G., 2008, CONT PHILOS PSYCHOL, P185; Lind G., 1980, DIAGNOSTICA, V26, P312; Lu F, 2014, PLOS ONE, V9; LUMPKIN JR, 1985, PSYCHOL REP, V57, P655, DOI 10.2466/pr0.1985.57.2.655; Mendez MF, 2009, CNS SPECTRUMS, V14, P608, DOI 10.1017/S1092852900023853; Moll J, 2003, NEUROREPORT, V14, P299, DOI 10.1097/01.wnr.0000057866.05120.28; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Nenadic I, 2010, BRIT J PSYCHIAT, V196, P412, DOI 10.1192/bjp.bp.109.070441; Prehn K, 2008, SOC COGN AFFECT NEUR, V3, P33, DOI 10.1093/scan/nsm037; Prehn K, 2014, LIBR ETHICS APPL PHI, V32, P137, DOI 10.1007/978-3-319-01369-5_8; Quigley NR, 2013, ACAD MANAG LEARN EDU, V12, P579, DOI 10.5465/amle.2011.0524; Rest J, 1999, EDUC PSYCHOL REV, V11, P291, DOI 10.1023/A:1022053215271; Rest J., 1974, MANUAL DEFINING ISSU; REST JR, 1985, DEV PSYCHOL, V21, P709, DOI 10.1037/0012-1649.21.4.709; Robertson D, 2007, NEUROPSYCHOLOGIA, V45, P1985, DOI 10.1016/j.neuropsychologia.2007.01.014; Rosenberg M, 1989, SOC ADOLESCENT SELF; Schwarzer R., 1995, MEASURES HLTH PSYCHO, V12, P329, DOI [DOI 10.1037/T00393-000, 10.1037/t00393-000]; Silver M, 2011, NEUROIMAGE, V54, P992, DOI 10.1016/j.neuroimage.2010.08.049; Takahashi R, 2011, HUM BRAIN MAPP, V32, P1050, DOI 10.1002/hbm.21088; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Witte AV, 2010, NEUROIMAGE, V49, P1205, DOI 10.1016/j.neuroimage.2009.09.046; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; Young L, 2010, NEURON, V65, P845, DOI 10.1016/j.neuron.2010.03.003; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	54	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0122914	10.1371/journal.pone.0122914	http://dx.doi.org/10.1371/journal.pone.0122914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7ST	26039547	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700002
J	Rasanen, E; Pulkkinen, O; Virtanen, T; Zollner, M; Hennig, H				Rasanen, Esa; Pulkkinen, Otto; Virtanen, Tuomas; Zollner, Manfred; Hennig, Holger			Fluctuations of Hi-Hat Timing and Dynamics in a Virtuoso Drum Track of a Popular Music Recording	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; TIME-SERIES; SENSORIMOTOR SYNCHRONIZATION; RATE-VARIABILITY; 1/F NOISE; GROOVE; PERFORMANCE; HEARTBEAT; RHYTHMS; ORGANIZATION	Long-range correlated temporal fluctuations in the beats of musical rhythms are an inevitable consequence of human action. According to recent studies, such fluctuations also lead to a favored listening experience. The scaling laws of amplitude variations in rhythms, however, are widely unknown. Here we use highly sensitive onset detection and time series analysis to study the amplitude and temporal fluctuations of Jeff Porcaro's one-handed hi-hat pattern in "I Keep Forgettin'''-one of the most renowned 16th note patterns in modern drumming. We show that fluctuations of hi-hat amplitudes and interbeat intervals (times between hits) have clear long-range correlations and short-range anticorrelations separated by a characteristic time scale. In addition, we detect subtle features in Porcaro's drumming such as small drifts in the 16th note pulse and non-trivial periodic two-bar patterns in both hi-hat amplitudes and intervals. Through this investigation we introduce a step towards statistical studies of the 20th and 21st century music recordings in the framework of complex systems. Our analysis has direct applications to the development of drum machines and to drumming pedagogy.	[Rasanen, Esa; Pulkkinen, Otto] Tampere Univ Technol, Dept Phys, FI-33101 Tampere, Finland; [Rasanen, Esa; Hennig, Holger] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Virtanen, Tuomas] Tampere Univ Technol, Dept Signal Proc, FI-33101 Tampere, Finland; [Zollner, Manfred] Regensburg Univ Appl Sci, Electroacoust Lab, D-93025 Regensburg, Germany; [Hennig, Holger] Max Planck Inst Dynam & Self Org MPI DS Gottingen, D-37077 Gottingen, Germany	Tampere University; Harvard University; Tampere University; University of Regensburg; Max Planck Society	Rasanen, E (corresponding author), Tampere Univ Technol, Dept Phys, FI-33101 Tampere, Finland.	esa.rasanen@tut.fi	Räsänen, Esa/D-3014-2009	Räsänen, Esa/0000-0001-8736-4496; Pulkkinen, Otto/0000-0001-5739-6278	Academy of Finland [258708]	Academy of Finland(Academy of Finland)	Tuomas Virtanen has been funded by the Academy of Finland, grant number 258708.	[Anonymous], J PORC THROWB THURSD; [Anonymous], 2012, MATLAB VERS 7 14 0; Bello JP, 2005, IEEE T SPEECH AUDI P, V13, P1035, DOI 10.1109/TSA.2005.851998; Bigerelle M, 2000, CHAOS SOLITON FRACT, V11, P2179, DOI 10.1016/S0960-0779(99)00137-X; Davies M, 2013, MUSIC PERCEPT, V30, P497, DOI 10.1525/MP.2013.30.5.497; Fruhauf J, 2013, MUSIC SCI, V17, P246, DOI 10.1177/1029864913486793; GILDEN DL, 1995, SCIENCE, V267, P1837, DOI 10.1126/science.7892611; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Hennig H, 2014, P NATL ACAD SCI USA, V111, P12974, DOI 10.1073/pnas.1324142111; Hennig H, 2012, PHYS TODAY, V65, P64, DOI 10.1063/PT.3.1650; Hennig H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026457; Ivanov PC, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041920; Jennings HD, 2004, PHYSICA A, V336, P585, DOI 10.1016/j.physa.2003.12.049; Jensen KK., 1999, THESIS U COPENHAGEN; Kamen PW, 1996, CLIN SCI, V91, P201, DOI 10.1042/cs0910201; Kantelhardt JW, 2001, PHYSICA A, V295, P441, DOI 10.1016/S0378-4371(01)00144-3; KOBAYASHI M, 1982, IEEE T BIO-MED ENG, V29, P456, DOI 10.1109/TBME.1982.324972; Kotimaki V, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022913; Madison G, 2006, MUSIC PERCEPT, V24, P201, DOI 10.1525/mp.2006.24.2.201; Madison G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00894; Madison G, 2011, J EXP PSYCHOL HUMAN, V37, P1578, DOI 10.1037/a0024323; Mandel Y, 2012, CIRCULATION, V125, P883, DOI 10.1161/CIRCULATIONAHA.111.045146; Matsoukas C, 2000, J GEOPHYS RES-ATMOS, V105, P29165, DOI 10.1029/2000JD900419; McDonald M, 1982, IF THATS WHAT IT TAK; Peng C., 1999, NONLINEAR DYNAMICS S; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PENG CK, 1993, PHYS REV LETT, V70, P1343, DOI 10.1103/PhysRevLett.70.1343; Pilgram B, 1998, PHYSICA D, V114, P108, DOI 10.1016/S0167-2789(97)00188-7; Porcaro J., 2012, INSTRUCTIONAL DVD DR; Rankin SK, 2009, MUSIC PERCEPT, V26, P401, DOI 10.1525/MP.2009.26.5.401; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Ro W, 2009, CHAOS SOLITON FRACT, V42, P2305, DOI 10.1016/j.chaos.2009.03.129; Ruiz MH, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01030; Sioros G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01036; Torre K, 2009, HUM MOVEMENT SCI, V28, P297, DOI 10.1016/j.humov.2009.01.001; Van Orden GC, 2003, J EXP PSYCHOL GEN, V132, P331, DOI 10.1037/0096-3445.132.3.331; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; WING AM, 1973, PERCEPT PSYCHOPHYS, V14, P5, DOI 10.3758/BF03198607; Witek MAG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094446	42	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127902	10.1371/journal.pone.0127902	http://dx.doi.org/10.1371/journal.pone.0127902			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039256	Green Submitted, gold, Green Published			2022-12-27	WOS:000355700700077
J	Rice, CJ; Ramachandran, VK; Shearer, N; Thompson, A				Rice, Christopher J.; Ramachandran, Vinoy K.; Shearer, Neil; Thompson, Arthur			Transcriptional and Post-Transcriptional Modulation of SPI1 and SPI2 Expression by ppGpp, RpoS and DksA in Salmonella enterica sv Typhimurium	PLOS ONE			English	Article							STATIONARY-PHASE INDUCTION; BACTERIAL SIGNAL MOLECULE; SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; PATHOGENICITY ISLAND; STRINGENT RESPONSE; SHIGELLA-FLEXNERI; SECRETION SYSTEM; GENE-EXPRESSION	The expression of genes within Salmonella Pathogenicity Islands 1 and 2 (SPI1, SPI2) is required to facilitate invasion and intracellular replication respectively of S. Typhimurium in host cell lines. Control of their expression is complex and occurs via a variety of factors operating at transcriptional and post-transcriptional levels in response to the environmental stimuli found within the host. Several of the factors that modulate SPI1 and SPI2 expression are involved in the redistribution or modification of RNA polymerase (RNAP) specificity. These factors include the bacterial alarmone, ppGpp, the alternative sigma factor, RpoS, and the RNAP accessory protein, DksA. In this report we show not only how these three factors modulate SPI1 and SPI2 expression but also how they contribute to the 'phased' expression of SPI1 and SPI2 during progress through late-log and stationary phase in aerobic rich broth culture conditions. In addition, we demonstrate that the expression of at least one SPI1-encoded protein, SipC is subject to DksA-dependent post-transcriptional control.	[Rice, Christopher J.; Shearer, Neil; Thompson, Arthur] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Ramachandran, Vinoy K.] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Oxford	Thompson, A (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.	arthur.thompson@ifr.ac.uk			Biotechnology and Biological Sciences Research Council (BBSRC) [44404-000-A]; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: researchfish; BBSRC [BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by Biotechnology and Biological Sciences Research Council (BBSRC; http://www.bbsrc.ac.uk) Grant (44404-000-A), awarded to AT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg A, 2009, J BACTERIOL, V191, P3226, DOI 10.1128/JB.01410-08; Akbar S, 2003, MOL MICROBIOL, V47, P715, DOI 10.1046/j.1365-2958.2003.03322.x; Bailey MJA, 1996, MOL MICROBIOL, V22, P729, DOI 10.1046/j.1365-2958.1996.d01-1726.x; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Bittner M, 2004, MICROB PATHOGENESIS, V36, P19, DOI 10.1016/j.micpath.2003.08.003; Buck MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r97; Costanzo A, 2008, MOL MICROBIOL, V67, P619, DOI 10.1111/j.1365-2958.2007.06072.x; Dalebroux ZD, 2012, NAT REV MICROBIOL, V10, P203, DOI 10.1038/nrmicro2720; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Dong T, 2010, INFECT IMMUN, V78, P887, DOI 10.1128/IAI.00882-09; Ellermeier CD, 2005, MOL MICROBIOL, V57, P691, DOI 10.1111/j.1365-2958.2005.04737.x; Erickson DL, 2004, INFECT IMMUN, V72, P5638, DOI 10.1128/IAI.72.10.5638-5645.2004; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; Fabrega A, 2013, CLIN MICROBIOL REV, V26, P308, DOI 10.1128/CMR.00066-12; FANG FC, 1992, P NATL ACAD SCI USA, V89, P11978, DOI 10.1073/pnas.89.24.11978; GENTRY DR, 1993, J BACTERIOL, V175, P7982, DOI 10.1128/JB.175.24.7982-7989.1993; Giddens SR, 2000, APPL ENVIRON MICROB, V66, P1711, DOI 10.1128/AEM.66.4.1711-1714.2000; Golubeva YA, 2012, GENETICS, V190, P79, DOI 10.1534/genetics.111.132779; Gourse RL, 2006, J BACTERIOL, V188, P4589, DOI 10.1128/JB.00499-06; Gummesson B, 2013, J BIOL CHEM, V288, P21055, DOI 10.1074/jbc.M113.479998; Hammer BK, 2002, MOL MICROBIOL, V44, P107, DOI 10.1046/j.1365-2958.2002.02884.x; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Haralalka S, 2003, J BACTERIOL, V185, P4672, DOI 10.1128/JB.185.16.4672-4682.2003; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; Henard CA, 2014, MOL MICROBIOL, V91, P790, DOI 10.1111/mmi.12498; Henard CA, 2012, INFECT IMMUN, V80, P1373, DOI 10.1128/IAI.06316-11; Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902; Jude F, 2003, J BACTERIOL, V185, P3558, DOI 10.1128/JB.185.12.3558-3566.2003; KANG PJ, 1990, J BACTERIOL, V172, P2055, DOI 10.1128/jb.172.4.2055-2064.1990; Klinkenberg LG, 2010, J INFECT DIS, V202, P1397, DOI 10.1086/656524; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Martinez LC, 2011, MOL MICROBIOL, V80, P1637, DOI 10.1111/j.1365-2958.2011.07674.x; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mizusaki H, 2008, J BACTERIOL, V190, P4624, DOI 10.1128/JB.01957-07; Moest TP, 2013, CURR OPIN MICROBIOL, V16, P38, DOI 10.1016/j.mib.2012.11.006; Mogull SA, 2001, INFECT IMMUN, V69, P5742, DOI 10.1128/IAI.69.9.5742-5751.2001; Muller AJ, 2012, CELL HOST MICROBE, V11, P19, DOI 10.1016/j.chom.2011.11.013; Nagy G, 2006, INFECT IMMUN, V74, P5914, DOI 10.1128/IAI.00619-06; Nakanishi N, 2006, MOL MICROBIOL, V61, P194, DOI 10.1111/j.1365-2958.2006.05217.x; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Nielsen AT, 2006, PLOS PATHOG, V2, P933, DOI 10.1371/journal.ppat.0020109; Nystrom T, 2004, MOL MICROBIOL, V54, P855, DOI 10.1111/j.1365-2958.2004.04342.x; Paul BJ, 2005, P NATL ACAD SCI USA, V102, P7823, DOI 10.1073/pnas.0501170102; Paul BJ, 2004, ANNU REV GENET, V38, P749, DOI 10.1146/annurev.genet.38.072902.091347; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Pfeiffer V, 2007, MOL MICROBIOL, V66, P1174, DOI 10.1111/j.1365-2958.2007.05991.x; Pizarro-Cerda J, 2004, MOL MICROBIOL, V52, P1827, DOI 10.1111/j.1365-2958.2004.04122.x; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Ramachandran VK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092690; Ramachandran VK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-25; Robbe-Saule V, 2003, APPL ENVIRON MICROB, V69, P4352, DOI 10.1128/AEM.69.8.4352-4358.2003; Sharma AK, 2006, MOL MICROBIOL, V62, P469, DOI 10.1111/j.1365-2958.2006.05376.x; SKERRA A, 1994, GENE, V151, P131, DOI 10.1016/0378-1119(94)90643-2; Solis R, 2006, FEMS MICROBIOL LETT, V259, P106, DOI 10.1111/j.1574-6968.2006.00254.x; Song M, 2010, J MICROBIOL, V48, P89, DOI 10.1007/s12275-009-0179-6; Song MY, 2004, J BIOL CHEM, V279, P34183, DOI 10.1074/jbc.M313491200; Taylor CA, 2002, J BACTERIOL, V184, P621, DOI 10.1128/JB.184.3.621-628.2002; Thompson A, 2006, J BIOL CHEM, V281, P30112, DOI 10.1074/jbc.M605616200; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Walthers D, 2007, MOL MICROBIOL, V65, P477, DOI 10.1111/j.1365-2958.2007.05800.x; Webb C, 1999, MOL MICROBIOL, V34, P112, DOI 10.1046/j.1365-2958.1999.01581.x; Yildiz FH, 1998, J BACTERIOL, V180, P773, DOI 10.1128/JB.180.4.773-784.1998; Yun H, 2008, J BACTERIOL, V190, P4512, DOI 10.1128/JB.00105-08; Zusman T, 2002, J BACTERIOL, V184, P67, DOI 10.1128/JB.184.1.67-75.2002	66	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127523	10.1371/journal.pone.0127523	http://dx.doi.org/10.1371/journal.pone.0127523			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039089	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700064
J	Moreira, LAA; de Oliveira, DGR; de Sousa, MBC; Pessoa, DMA				Antonio Moreira, Lais Alves; Rodrigues de Oliveira, Danilo Gustavo; Cordeiro de Sousa, Maria Bernardete; Almeida Pessoa, Daniel Marques			Parturition Signaling by Visual Cues in Female Marmosets (Callithrix jacchus)	PLOS ONE			English	Article							COMMON MARMOSETS; COLOR-VISION; PRIMATE; EVOLUTION; PREGNANCY; SUPPRESSION; MONKEYS; FRUIT; SKIN	New World monkeys have polymorphic color vision, in which all males and some females are dichromats, while most females are trichromats. There is little consensus about which selective pressures fashioned primate color vision, although detection of food, mates and predators has been hypothesized. Behavioral evidence shows that males from different species of Neotropical primates seem to perceive the timing of female conception and gestation, although, no signals fulfilling this function have been identified. Therefore, we used visual models to test the hypothesis that female marmosets show chromatic and/or achromatic cues that may indicate the time of parturition for male and female conspecifics. By recording the reflectance spectra of female marmosets' (Callithrix jacchus) sexual skin, and running chromatic and achromatic discrimination models, we found that both variables fluctuate during the weeks that precede and succeed parturition, forming "U" and inverted "U" patterns for chromatic and achromatic contrast, respectively. We suggest that variation in skin chroma and luminance might be used by female helpers and dominant females to identify the timing of birth, while achromatic variations may be used as clues by potential fathers to identify pregnancy stage in females and prepare for paternal burdens as well as to detect oestrus in the early post-partum period.	[Antonio Moreira, Lais Alves; Almeida Pessoa, Daniel Marques] Univ Fed Rio Grande do Norte, Dept Physiol, Lab Sensory Ecol, BR-59072970 Natal, RN, Brazil; [Antonio Moreira, Lais Alves; Cordeiro de Sousa, Maria Bernardete] Univ Fed Rio Grande do Norte, Dept Physiol, Lab Behav Endocrinol, BR-59072970 Natal, RN, Brazil; [Antonio Moreira, Lais Alves; Cordeiro de Sousa, Maria Bernardete; Almeida Pessoa, Daniel Marques] Univ Fed Rio Grande do Norte, Dept Physiol, Lab Adv Study Primates, BR-59072970 Natal, RN, Brazil; [Rodrigues de Oliveira, Danilo Gustavo] Univ Brasilia, Dept Physiol Sci, Lab Neurosci & Behav, Brasilia, DF, Brazil; [Cordeiro de Sousa, Maria Bernardete] Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade de Brasilia; Universidade Federal do Rio Grande do Norte	Pessoa, DMA (corresponding author), Univ Fed Rio Grande do Norte, Dept Physiol, Lab Sensory Ecol, BR-59072970 Natal, RN, Brazil.	pessoadma@cb.ufrn.br	Pessoa, Daniel Marques Almeida/G-4302-2011	Pessoa, Daniel Marques Almeida/0000-0002-2516-6766; Alves Antonio Moreira, Lais/0000-0001-8182-4551	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [478222/2006-8, 25674/2009, 302592/2009-1, 800074/2010-6, 306018/2013-6]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	LAAM received a M.Sc. scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). DMAP and MBCS were financed by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Proc. No.: 478222/2006-8 (DMAP), 25674/2009 (DMAP), 302592/2009-1 (MBCS), 800074/2010-6 (MBCS) and 306018/2013-6 (MBCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT DH, 1984, AM J PRIMATOL, V6, P169, DOI 10.1002/ajp.1350060305; Pessoa DMA, 2014, AM J PRIMATOL, V76, P721, DOI 10.1002/ajp.22264; Antonio Moreira Lais Alves, 2013, Oecologia Australis, V17, P303; Baker AJ, 1996, AM J PRIMATOL, V38, P47, DOI 10.1002/(SICI)1098-2345(1996)38:1<47::AID-AJP5>3.0.CO;2-T; Barreto CE, 1996, THESIS FEDERAL U RIO; BARRETT J, 1990, J REPROD FERTIL, V90, P411; Barton RA, 1998, P ROY SOC B-BIOL SCI, V265, P1933, DOI 10.1098/rspb.1998.0523; Bradley BJ, 2008, EVOL ANTHROPOL, V17, P97, DOI 10.1002/evan.20164; Buchanan-Smith HM, 2005, AM J PRIMATOL, V67, P393, DOI 10.1002/ajp.20194; Caine NG, 2000, P ROY SOC B-BIOL SCI, V267, P439, DOI 10.1098/rspb.2000.1019; Castro DC, 2005, BRAZ J MED BIOL RES, V38, P65, DOI 10.1590/S0100-879X2005000100011; Changizi MA, 2006, BIOL LETT-UK, V2, P217, DOI 10.1098/rsbl.2006.0440; Clough D, 2009, INT J PRIMATOL, V30, P859, DOI 10.1007/s10764-009-9379-5; DIXSON AF, 1987, PHYSIOL BEHAV, V41, P577, DOI 10.1016/0031-9384(87)90314-3; Dominy NJ, 2001, NATURE, V410, P363, DOI 10.1038/35066567; dusenbery d. b, 1992, SENSORY ECOLOGY ORGA; Fedigan LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084872; French JA, 2007, COOPERATIVE BREEDING, P34; GARBER PA, 1994, AM J PRIMATOL, V34, P199, DOI 10.1002/ajp.1350340210; Gerald MS, 2010, NATURWISSENSCHAFTEN, V97, P89, DOI 10.1007/s00114-009-0619-5; Gerald MS, 2009, BEHAV PROCESS, V80, P7, DOI 10.1016/j.beproc.2008.08.001; Higham JP, 2013, BEHAV ECOL SOCIOBIOL, V67, P1381, DOI 10.1007/s00265-013-1590-x; Higham JP, 2011, P ROY SOC B-BIOL SCI, V278, P3452, DOI 10.1098/rspb.2011.0052; Higham JP, 2010, BEHAV ECOL, V21, P739, DOI 10.1093/beheco/arq047; Jacobs GH, 2007, INT J PRIMATOL, V28, P729, DOI 10.1007/s10764-007-9168-y; Jacobs GH, 2010, OPHTHAL PHYSL OPT, V30, P422, DOI 10.1111/j.1475-1313.2010.00719.x; KOENIG A, 1995, AM J PRIMATOL, V35, P311, DOI 10.1002/ajp.1350350407; Maia R, 2013, METHODS ECOL EVOL, V4, P906, DOI 10.1111/2041-210X.12069; Maryanski Alexandra, 1997, NONVERBAL COMMUNICAT, P191; Melin AD, 2014, INT J PRIMATOL, V35, P258, DOI 10.1007/s10764-013-9730-8; MOLLON JD, 1984, PROC R SOC SER B-BIO, V222, P373, DOI 10.1098/rspb.1984.0071; Mota MTD, 2006, HORM BEHAV, V49, P293, DOI 10.1016/j.yhbeh.2005.07.012; Osorio D, 2004, AM NAT, V164, P696, DOI 10.1086/425332; Perini ES, 2009, J EXP ZOOL PART A, V311A, P289, DOI 10.1002/jez.531; PHILLIPS IR, 1975, J REPROD FERTIL, V43, P103; Russell WMS, 2005, ANIM WELFARE, V14, P279; Rylands Anthony B., 2009, P23, DOI 10.1007/978-0-387-78705-3_2; Saltzman W, 1997, AM J PRIMATOL, V41, P1, DOI 10.1002/(SICI)1098-2345(1997)41:1<1::AID-AJP1>3.0.CO;2-0; Saltzman W, 2009, P ROY SOC B-BIOL SCI, V276, P389, DOI 10.1098/rspb.2008.1374; Semple S, 2013, AM J PRIMATOL, V75, P613, DOI 10.1002/ajp.22139; Setchell JM, 2009, INT J PRIMATOL, V30, P825, DOI 10.1007/s10764-009-9371-0; Smith AC, 2005, INT J PRIMATOL, V26, P337, DOI 10.1007/s10764-005-2928-7; Sousa MBC, 2005, AM J PRIMATOL, V67, P37, DOI 10.1002/ajp.20168; Sousa MBC, 1997, PRIMATOLOGIA BRASIL, P155; SPERLING HC, 1971, SCIENCE, V172, P180, DOI 10.1126/science.172.3979.180; Stevens M, 2009, INT J PRIMATOL, V30, P893, DOI 10.1007/s10764-009-9356-z; Sumner P, 2000, J EXP BIOL, V203, P1963; Sumner P, 2003, AM J PRIMATOL, V59, P67, DOI 10.1002/ajp.10066; Tardif SD, 2003, COMPARATIVE MED, V53, P364; Waitt C, 2003, P ROY SOC B-BIOL SCI, V270, pS144, DOI 10.1098/rsbl.2003.0065; Yamamoto ME, 2009, DEV PRIMATOL-PROG PR, P119, DOI 10.1007/978-1-4419-0293-1_6; Ziegler TE, 2005, HORM BEHAV, V47, P56, DOI 10.1016/j.yhbeh.2004.08.009; Ziegler TE, 2006, BIOL LETT-UK, V2, P181, DOI 10.1098/rsbl.2005.0426	53	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129319	10.1371/journal.pone.0129319	http://dx.doi.org/10.1371/journal.pone.0129319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047350	gold, Green Published, Green Submitted			2022-12-27	WOS:000355652200150
J	Kaehler, N; Adhikar, B; Raut, S; Marahatta, SB; Chapman, RS				Kaehler, Nils; Adhikar, Bipin; Raut, Shristi; Marahatta, Sujan Babu; Chapman, Robert Sedgwick			Perceived Stigma towards Leprosy among Community Members Living Close to Nonsomboon Leprosy Colony in Thailand	PLOS ONE			English	Article							AFFECTED PERSONS; SOCIAL STIGMA; DIMENSIONS; PROVINCE; QUALITY; HEALTH	Background Interpretation of Leprosy as a sickness differs among society. The set of beliefs, knowledge and perceptions towards a disease play a vital role in the construction of stigma towards a disease. The main purpose of this study was to explore the extent and correlates of the perceived stigma towards leprosy in the community living close to the leprosy colony in Non Somboon region of Khon Kaen Province of Thailand. Methods A cross-sectional study was conducted among 257 leprosy unaffected community participants, above the age of 18 who were living close to the Leprosy colony in Non Somboon region of Thailand. Each participant was asked a questionnaire containing characteristics of the participants in terms of socio-demographic background and knowledge regarding the disease. In addition perceived stigma towards leprosy was measured using EMIC (Explanatory Model Interview Catalogue) questionnaire. Results Among EMIC items, shame or embarrassment in the community due to leprosy was felt by 54.5%, dislike to buy food from leprosy affected persons were 49.8% and difficulty to find work for leprosy affected persons were perceived by 47.1%. Higher total EMIC score was found in participants age 61 years or older (p = 0.021), staying longer in the community (p = 0.005), attending fewer years of education (p = 0.024) and who were unemployed (p = 0.08). Similarly, perceptions about leprosy such as difficult to treat (p = 0.015), severe disease (p = 0.004) and punishment by God (p = 0.011) were significantly associated with higher perceived stigma. Conclusions Perceived stigma towards leprosy was found highest among participants with age 61 years or older, longer duration of stay in community close to the leprosy colony, lower duration of education and participants who were unemployed had higher perceived stigma. Similarly, participants with perceptions of leprosy such as difficult to treat, severe disease and punishment by God had higher perceived stigma towards leprosy. There is an urgent need of stigma reduction strategies focused on education and awareness concerning leprosy.	[Kaehler, Nils] Sandefjord Helsepark, Sandefjord, Norway; [Adhikar, Bipin] Nepal Community Hlth & Dev Ctr, Kahmandu, Nepal; [Raut, Shristi] Lumbini Med Coll, Dept Microbiol, Palpa, Nepal; [Marahatta, Sujan Babu] Manmohan Mem Med Coll, Dept Community Med, Kathmandu, Nepal; [Chapman, Robert Sedgwick] Chulalongkorn Univ, Coll Publ Hlth Sci, Bangkok, Thailand	Chulalongkorn University	Adhikar, B (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand.	biopion@gmail.com	Adhikari, Bipin/X-3110-2019	Adhikari, Bipin/0000-0001-8981-3910				Adhikari B, 2013, J Nepal Health Res Counc, V11, P264; Adhikari B, 2013, J MANMOHAN MEMORIAL, V1, P3; Adhikari B, 2013, J HEALTH RES, V27, P295; Adhikari B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002940; Arole S, 2002, LEPROSY REV, V73, P186; Bainson KA, 1998, LEPROSY REV, V69, P341; Calcraft J.H., 2006, ASIA PACIFIC DIABILI, V17, P73; Chen SM, 2005, LEPROSY REV, V76, P335; de Stigter DH, 2000, LEPROSY REV, V71, P492; Ebenso B., 2007, ASIAN PAC DISAB REHA, V18, P98; Heijnders ML, 2004, INT J LEPROSY, V72, P437, DOI 10.1489/1544-581X(2004)72&lt;437:TDOSIL&gt;2.0.CO;2; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000230; Kaehler N, 2013, J HEALTH RES, V27, P359; Kampirapap K, 2005, LEPROSY REV, V76, P325; Kushwah S S, 1981, Lepr India, V53, P221; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Myint T, 1992, Indian J Lepr, V64, P313; Nagaraja V, 2011, STIGMA LEPROSY PATIE, V10; Navon L, 1998, SOC HIST MED, V11, P89, DOI 10.1093/shm/11.1.89; Paoli RD, 2004, BOOK REPORT STIGMA N, P1; Peters RMH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003274; Pieri FM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003324; Predaswat P, 1992, THESIS U CALIFORNIA; Primkaew W, 2005, DIS PREVENTION CONTR, V2005; Rafferty J, 2005, LEPROSY REV, V76, P119; Rao PSS, 2009, INDIAN J LEPR, V80, P167; Rensen C, 2011, DISABIL REHABIL, V33, P711, DOI 10.3109/09638288.2010.506942; Rinaldi A, 2005, PLOS MED, V2, P1222, DOI 10.1371/journal.pmed.0020341; Sermrittirong S, 2014, LEPROSY REV, V85, P36; Nardi SMT, 2011, LEPROSY REV, V82, P55; Try L., 2006, ASIA PAC DISABIL REH, V17, P55; Tsutsumi A, 2007, SOC SCI MED, V64, P2443, DOI 10.1016/j.socscimed.2007.02.014; VALENCIA LB, 1989, INT J LEPROSY, V57, P847; van Brakel WH, 2003, INT J LEPROSY, V71, P190, DOI 10.1489/1544-581X(2003)71&lt;190:MLSPRO&gt;2.0.CO;2; van Brakel WH, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.18394; WEISS MG, 1992, BRIT J PSYCHIAT, V160, P819, DOI 10.1192/bjp.160.6.819; Weiss MG, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000237	37	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129086	10.1371/journal.pone.0129086	http://dx.doi.org/10.1371/journal.pone.0129086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7CR	26047512	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200122
J	Kersemans, V; Kannan, P; Beech, JS; Bates, R; Irving, B; Gilchrist, S; Allen, PD; Thompson, J; Kinchesh, P; Casteleyn, C; Schnabel, J; Partridge, M; Muschel, RJ; Smart, SC				Kersemans, Veerle; Kannan, Pavitra; Beech, John S.; Bates, Russell; Irving, Benjamin; Gilchrist, Stuart; Allen, Philip D.; Thompson, James; Kinchesh, Paul; Casteleyn, Christophe; Schnabel, Julia; Partridge, Mike; Muschel, Ruth J.; Smart, Sean C.			Improving In Vivo High-Resolution CT Imaging of the Tumour Vasculature in Xenograft Mouse Models through Reduction of Motion and Bone-Streak Artefacts	PLOS ONE			English	Article							VOLUME COMPUTED-TOMOGRAPHY; MICRO-CT; MAMMARY CARCINOMAS; ANGIOGENESIS; VISUALIZATION; ENHANCEMENT; MULTISCALE	Introduction Preclinical in vivo CT is commonly used to visualise vessels at a macroscopic scale. However, it is prone to many artefacts which can degrade the quality of CT images significantly. Although some artefacts can be partially corrected for during image processing, they are best avoided during acquisition. Here, a novel imaging cradle and tumour holder was designed to maximise CT resolution. This approach was used to improve preclinical in vivo imaging of the tumour vasculature. Procedures A custom built cradle containing a tumour holder was developed and fix-mounted to the CT system gantry to avoid artefacts arising from scanner vibrations and out-of-field sample positioning. The tumour holder separated the tumour from bones along the axis of rotation of the CT scanner to avoid bone-streaking. It also kept the tumour stationary and insensitive to respiratory motion. System performance was evaluated in terms of tumour immobilisation and reduction of motion and bone artefacts. Pre- and post-contrast CT followed by sequential DCE-MRI of the tumour vasculature in xenograft transplanted mice was performed to confirm vessel patency and demonstrate the multimodal capacity of the new cradle. Vessel characteristics such as diameter, and branching were quantified. Results Image artefacts originating from bones and out-of-field sample positioning were avoided whilst those resulting from motions were reduced significantly, thereby maximising the resolution that can be achieved with CT imaging in vivo. Tumour vessels >= 77 mu m could be resolved and blood flow to the tumour remained functional. The diameter of each tumour vessel was determined and plotted as histograms and vessel branching maps were created. Multimodal imaging using this cradle assembly was preserved and demonstrated. Conclusions The presented imaging workflow minimised image artefacts arising from scanner induced vibrations, respiratory motion and radiopaque structures and enabled in vivo CT imaging and quantitative analysis of the tumour vasculature at higher resolution than was possible before. Moreover, it can be applied in a multimodal setting, therefore combining anatomical and dynamic information.	[Kersemans, Veerle; Kannan, Pavitra; Beech, John S.; Gilchrist, Stuart; Allen, Philip D.; Thompson, James; Kinchesh, Paul; Partridge, Mike; Muschel, Ruth J.; Smart, Sean C.] Univ Oxford, Canc Res UK, Oxford, England; [Kersemans, Veerle; Kannan, Pavitra; Beech, John S.; Gilchrist, Stuart; Allen, Philip D.; Thompson, James; Kinchesh, Paul; Partridge, Mike; Muschel, Ruth J.; Smart, Sean C.] Univ Oxford, MRC, Dept Oncol, Oxford Inst Radiat Oncol, Oxford, England; [Bates, Russell; Irving, Benjamin; Schnabel, Julia] Univ Oxford, Dept Engn Sci, Inst Biomed Engn, Oxford OX1 3PJ, England; [Casteleyn, Christophe] Univ Antwerp, Fac Pharmaceut Biomed & Vet Sci, Dept Vet Sci, Lab Appl Vet Morphol, Antwerp, Belgium	Cancer Research UK; University of Oxford; University of Oxford; University of Oxford; University of Antwerp	Kersemans, V (corresponding author), Univ Oxford, Canc Res UK, Oxford, England.	Veerle.Kersemans@oncology.ox.ac.uk	Irving, Benjamin/AAP-3317-2020; Kannan, Pavitra/I-2796-2019; Schnabel, Julia/ACE-6863-2022; Kersemans, Veerle/AAG-3005-2020	Irving, Benjamin/0000-0003-3879-2050; Kannan, Pavitra/0000-0002-9170-6062; Kersemans, Veerle/0000-0002-4669-236X; Allen, Danny/0000-0002-6200-0925; Schnabel, Julia Anne/0000-0001-6107-3009	Medical Research Council (MRC); Cancer Research United Kingdom (CRUK) [C5255/A12678, C2522/A10339]; Cancer Research UK [20407, 16049, 16466] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/M000133/1, 1363937] Funding Source: researchfish; EPSRC [EP/M000133/1] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research United Kingdom (CRUK)(Cancer Research UK); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors received funding for this study from both the Medical Research Council (MRC; http://www.mrc.ac.uk/) and Cancer Research United Kingdom (CRUK; www.cancerresearchuk.org/) (VK, PK, JSB, BI, SG, PDA, JT, PK, JS, MP, RJM, SCS); CRUK grant numbers: C5255/A12678 and C2522/A10339.	Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065; Boas EF, 2012, IMAGING MED, V4, P229, DOI DOI 10.2217/IIM.12.13; Cebulla J, 2014, ANGIOGENESIS, V17, P695, DOI 10.1007/s10456-014-9429-2; Choyke PL, 2003, J MAGN RESON IMAGING, V17, P509, DOI 10.1002/jmri.10304; Ehling J, 2014, GUT, V63, P1960, DOI 10.1136/gutjnl-2013-306294; Ehling J, 2014, AM J PATHOL, V184, P431, DOI 10.1016/j.ajpath.2013.10.014; Ehling J, 2013, THROMB HAEMOSTASIS, V109, P375, DOI 10.1160/TH12-10-0721; Eisa F, 2012, EUR RADIOL, V22, P900, DOI 10.1007/s00330-011-2318-9; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Jannasch K, 2009, INT J CANCER, V125, P62, DOI 10.1002/ijc.24332; Kersemans V, 2011, J NUCL MED, V52, P1827, DOI 10.2967/jnumed.111.089151; Kiessling F, 2004, NAT MED, V10, P1133, DOI 10.1038/nm1101; Kindlmann Gordon L, 2005, Mol Imaging, V4, P417; Lim E, 2011, JOVE-J VIS EXP, DOI 10.3791/2775; Missbach-Guentner J, 2008, NEOPLASIA, V10, P663, DOI 10.1593/neo.08270; Missbach-Guentner J, 2011, INT J DEV BIOL, V55, P535, DOI 10.1387/ijdb.103229jm; Mondy WL, 2013, MICROSC MICROANAL, V19, P1416, DOI 10.1017/S1431927613013421; Nebuloni L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086562; Nebuloni L, 2013, ACAD RADIOL, V20, P1247, DOI 10.1016/j.acra.2013.06.003; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seong JM, 2013, J KOREAN MED SCI, V28, P1703, DOI 10.3346/jkms.2013.28.12.1703; Toy R, 2013, ACS NANO, V7, P3118, DOI 10.1021/nn3053439; Trachet B, 2009, COMPUT METHOD BIOMEC, V12, P491, DOI 10.1080/10255840802695445; Vandeghinste B, 2011, MOL IMAGING BIOL, V13, P78, DOI 10.1007/s11307-010-0335-8; Willekens I, 2010, CONTRAST MEDIA MOL I, V5, P201, DOI 10.1002/cmmi.394; Zhu WL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086583	27	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128537	10.1371/journal.pone.0128537	http://dx.doi.org/10.1371/journal.pone.0128537			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046526	Green Published, gold			2022-12-27	WOS:000355652200074
J	Kurland, IJ; Broin, PO; Golden, A; Su, G; Meng, F; Liu, LB; Mohney, R; Kulkarni, S; Guha, C				Kurland, Irwin Jack; Broin, Pilib O.; Golden, Aaron; Su, Gang; Meng, Fan; Liu, Laibin; Mohney, Robert; Kulkarni, Shilpa; Guha, Chandan			Integrative Metabolic Signatures for Hepatic Radiation Injury	PLOS ONE			English	Article							INDUCED LIVER-DISEASE; INDOXYL SULFATE; BIOMARKERS; TOXICITY; IDENTIFICATION; RADIOTHERAPY; THERAPY; DAMAGE; CELLS; CYCLE	Background Radiation-induced liver disease (RILD) is a dose-limiting factor in curative radiation therapy (RT) for liver cancers, making early detection of radiation-associated liver injury absolutely essential for medical intervention. A metabolomic approach was used to determine metabolic signatures that could serve as biomarkers for early detection of RILD in mice. Methods Anesthetized C57BL/6 mice received 0, 10 or 50 Gy Whole Liver Irradiation (WLI) and were contrasted to mice, which received 10 Gy whole body irradiation (WBI). Liver and plasma samples were collected at 24 hours after irradiation. The samples were processed using Gas Chromatography/Mass Spectrometry and Liquid Chromatography/Mass Spectrometry. Results Twenty four hours after WLI, 407 metabolites were detected in liver samples while 347 metabolites were detected in plasma. Plasma metabolites associated with 50 Gy WLI included several amino acids, purine and pyrimidine metabolites, microbial metabolites, and most prominently bradykinin and 3-indoxyl-sulfate. Liver metabolites associated with 50 Gy WLI included pentose phosphate, purine, and pyrimidine metabolites in liver. Plasma biomarkers in common between WLI and WBI were enriched in microbial metabolites such as 3 indoxyl sulfate, indole-3-lactic acid, phenyllactic acid, pipecolic acid, hippuric acid, and markers of DNA damage such as 2-deoxyuridine. Metabolites associated with tryptophan and indoles may reflect radiation-induced gut microbiome effects. Predominant liver biomarkers in common between WBI and WLI were amino acids, sugars, TCA metabolites (fumarate), fatty acids (lineolate, n-hexadecanoic acid) and DNA damage markers (uridine). Conclusions We identified a set of metabolomic markers that may prove useful as plasma biomarkers of RILD and WBI. Pathway analysis also suggested that the unique metabolic changes observed after liver irradiation was an integrative response of the intestine, liver and kidney.	[Kurland, Irwin Jack] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Diabet Ctr,Stable Isotope & Metabol Core Facil, Bronx, NY 10467 USA; [Broin, Pilib O.; Golden, Aaron] Albert Einstein Coll Med, Dept Genet, Div Computat Genet, Bronx, NY 10467 USA; [Su, Gang; Meng, Fan] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Liu, Laibin; Kulkarni, Shilpa; Guha, Chandan] Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA; [Mohney, Robert] Metabolon, Durham, NC USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Michigan System; University of Michigan; Yeshiva University; Albert Einstein College of Medicine; Metabolon	Guha, C (corresponding author), Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA.	cguhamd@gmail.com		O Broin, Pilib/0000-0002-6702-8564	NIH [R01 DK064670, R33 CA121051, U19 AI091175]; Einstein DRTC [P60DK020541]; Einstein CMCR [1U19AI091175]; Metabolon; NATIONAL CANCER INSTITUTE [R33CA121051] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI091175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541, R01DK064670, P30DK041296] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Einstein DRTC; Einstein CMCR; Metabolon; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research was supported by NIH grants, R01 DK064670, R33 CA121051 and U19 AI091175 to CG. IJK was supported by P60DK020541 (Einstein DRTC) and 1U19AI091175 (Einstein CMCR). OB, AG, LL and CG were supported by 1U19AI091175 (Einstein CMCR). Additionally, Metabolon provided support in the form of salaries for author [RPM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caruso JC, 1997, EDUC PSYCHOL MEAS, V57, P637, DOI 10.1177/0013164497057004009; Cheng JCH, 2004, INT J RADIAT ONCOL, V60, P1502, DOI 10.1016/j.ijrobp.2004.05.048; Coy SL, 2011, INT J RADIAT BIOL, V87, P802, DOI 10.3109/09553002.2011.556177; Dawson LA, 2005, SEMIN RADIAT ONCOL, V15, P279, DOI 10.1016/j.semradonc.2005.04.005; Deguchi T, 2002, KIDNEY INT, V61, P1760, DOI 10.1046/j.1523-1755.2002.00318.x; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; FAJARDO LF, 1980, ARCH PATHOL LAB MED, V104, P584; Gallazzini M, 2009, PHYSIOLOGY, V24, P245, DOI 10.1152/physiol.00009.2009; GERACI JP, 1994, RADIAT RES, V140, P249, DOI 10.2307/3578909; Guha C, 2002, HEPATOLOGY, V36, P354, DOI 10.1053/jhep.2002.34516; Guha C, 2001, INT J RADIAT ONCOL, V49, P451, DOI 10.1016/S0360-3016(00)01495-4; Guha C, 1999, CANCER RES, V59, P5871; Guha C, 2011, SEMIN RADIAT ONCOL, V21, P256, DOI 10.1016/j.semradonc.2011.05.003; HELD KD, 1993, RADIAT RES, V134, P383, DOI 10.2307/3578201; Holmes E, 2011, TRENDS MICROBIOL, V19, P349, DOI 10.1016/j.tim.2011.05.006; Huang KC, 2003, KIDNEY INT, V64, P704, DOI 10.1046/j.1523-1755.2003.00118.x; INGOLD JA, 1965, AMER J ROENTGENOL RA, V93, P200; Johnson CH, 2012, RADIAT RES, V178, P328, DOI 10.1667/RR2950.1; Johnson CH, 2011, RADIAT RES, V175, P473, DOI 10.1667/RR2437.1; Kennedy AS, 2009, INT J RADIAT ONCOL, V74, P1494, DOI 10.1016/j.ijrobp.2008.10.005; Kohonen T, 2002, NEURAL NETWORKS, V15, P945, DOI 10.1016/S0893-6080(02)00069-2; Kurland IJ, 2013, ANN NY ACAD SCI, V1287, P1, DOI 10.1111/nyas.12116; LAWRENCE TS, 1995, INT J RADIAT ONCOL, V31, P1237, DOI 10.1016/0360-3016(94)00418-K; LAWRENCE TS, 1992, INT J RADIAT ONCOL, V23, P781, DOI 10.1016/0360-3016(92)90651-W; Lee MT, 2009, J CLIN ONCOL, V27, P1585, DOI 10.1200/JCO.2008.20.0600; Li ZY, 2005, J BIOL CHEM, V280, P37798, DOI 10.1074/jbc.M508575200; Liang SX, 2005, CANCER-AM CANCER SOC, V103, P2181, DOI 10.1002/cncr.21012; Liu MC, 2008, J AM SOC NEPHROL, V19, P1360, DOI 10.1681/ASN.2007080901; Manna SK, 2013, J PROTEOME RES, V12, P2269, DOI 10.1021/pr400161k; Manna SK, 2011, J PROTEOME RES, V10, P4120, DOI 10.1021/pr200310s; McGinn CJ, 1998, J CLIN ONCOL, V16, P2246, DOI 10.1200/JCO.1998.16.6.2246; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Patterson AD, 2010, MASS SPECTROM REV, V29, P503, DOI 10.1002/mas.20272; REED GB, 1966, AM J PATHOL, V48, P597; Sempoux C, 1997, HEPATOLOGY, V26, P128; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Takayama F, 2003, AM J KIDNEY DIS, V41, pS142, DOI 10.1053/ajkd.2003.50104; Takemura K, 1998, NEPHRON, V78, P82, DOI 10.1159/000044886; Tuttle S, 2000, RADIAT RES, V153, P781, DOI 10.1667/0033-7587(2000)153[0781:GPDATO]2.0.CO;2; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Yannam GR, 2014, INT J RADIAT ONCOL, V88, P404, DOI 10.1016/j.ijrobp.2013.10.037	43	35	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0124795	10.1371/journal.pone.0124795	http://dx.doi.org/10.1371/journal.pone.0124795			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046990	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200008
J	Oh, MG; Han, MA; Park, J; Ryu, SY; Choi, SW				Oh, Myueng Guen; Han, Mi Ah; Park, Jong; Ryu, So Yeon; Choi, Seong-Woo			The Prevalence of Vitamin D Deficiency among Cancer Survivors in a Nationwide Survey of the Korean Population	PLOS ONE			English	Article							D INSUFFICIENCY; 25-HYDROXYVITAMIN D; CARDIOVASCULAR-DISEASE; SUNLIGHT EXPOSURE; BREAST; HEALTH; RISK; PROGNOSIS	Background Recent studies have shown that inadequate vitamin D levels are associated with a poor cancer prognosis, but data regarding actual vitamin D levels in cancer survivors are limited. This study investigated the vitamin D levels and prevalence of vitamin D deficiency among Korean cancer survivors compared with non-cancer controls, and identified the factors associated with vitamin D deficiency. Methods Using the Korea National Health and Nutrition Examination Survey (KNHANES), 915 cancer survivors and 29,694 controls without a history of cancer were selected. Serum 25(OH) D levels were measured; vitamin D deficiency was defined as 25(OH) D levels less than 20 ng/mL. Chi-square tests and multiple logistic regression analyses were used to evaluate the prevalence of vitamin D deficiency and associated factors. Results Vitamin D deficiency was observed in 62.7% of cancer survivors and 67.1% of controls. Among cancer survivors, vitamin D deficiency was most prevalent among 19-44 year olds (76.2%) and among managers, professionals, and related workers (79.3%). Multiple logistic regression analysis revealed that younger cancer survivors and those who work indoors were predisposed to vitamin D deficiency. Conclusion Vitamin D deficiency was prevalent among both cancer survivors and controls in Korea. The regular evaluation and management of vitamin D levels is needed for both bone health and general health in cancer survivors.	[Oh, Myueng Guen] Jeongup Asan Hosp, Dept Internal Med, Jeongup, South Korea; [Han, Mi Ah; Park, Jong; Ryu, So Yeon; Choi, Seong-Woo] Chosun Univ, Coll Med, Dept Prevent Med, Gwangju, South Korea	Chosun University	Han, MA (corresponding author), Jeongup Asan Hosp, Dept Internal Med, Jeongup, South Korea.	mahan@chosun.ac.kr						Anderson LN, 2011, AM J EPIDEMIOL, V174, P293, DOI 10.1093/aje/kwr091; Bachhel Rachna, 2015, Int J Appl Basic Med Res, V5, P7, DOI 10.4103/2229-516X.149220; Beloyartseva Maria, 2012, Arch Osteoporos, V7, P187, DOI 10.1007/s11657-012-0096-x; Blackmore KM, 2008, AM J EPIDEMIOL, V168, P915, DOI 10.1093/aje/kwn198; Choi HS, 2013, ENDOCRINOL METAB, V28, P12, DOI 10.3803/EnM.2013.28.1.12; Choi HS, 2011, J CLIN ENDOCR METAB, V96, P643, DOI 10.1210/jc.2010-2133; Choudhary A, 2013, PEDIATR BLOOD CANCER, V60, P1237, DOI 10.1002/pbc.24403; Christodoulou S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/396541; Chung JY, 2013, NUTR RES PRACT, V7, P495, DOI 10.4162/nrp.2013.7.6.495; El Hayek J, 2010, J NUTR, V140, P1839, DOI 10.3945/jn.110.124644; Finkelmeier F, 2014, ALIMENT PHARM THER, V39, P1204, DOI 10.1111/apt.12731; Forrest KYZ, 2011, NUTR RES, V31, P48, DOI 10.1016/j.nutres.2010.12.001; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Goodwin PJ, 2009, J CLIN ONCOL, V27, P3757, DOI 10.1200/JCO.2008.20.0725; Grant WB, 2012, DERM-ENDOCRINOL, V4, P203, DOI 10.4161/derm.20965; Guise TA, 2006, ONCOLOGIST, V11, P1121, DOI 10.1634/theoncologist.11-10-1121; Gupta D, 2011, EXP THER MED, V2, P181, DOI 10.3892/etm.2011.205; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Jang H, 2013, WOMEN HEALTH, V53, P504, DOI 10.1080/03630242.2013.806386; Jeong H, 2014, ANN OCCUP ENVIRON ME, V26, DOI 10.1186/s40557-014-0028-x; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Neuhouser ML, 2008, AM J CLIN NUTR, V88, P133, DOI 10.1093/ajcn/88.1.133; Park S, 2012, NUTR RES PRACT, V6, P162, DOI 10.4162/nrp.2012.6.2.162; Pludowski P, 2013, AUTOIMMUN REV, V12, P976, DOI 10.1016/j.autrev.2013.02.004; Prentice A, 2008, NUTR REV, V66, pS153, DOI 10.1111/j.1753-4887.2008.00100.x; Rose AAN, 2013, BREAST CANCER RES TR, V141, P331, DOI 10.1007/s10549-013-2713-9; Sinha A, 2011, PEDIATR BLOOD CANCER, V57, P594, DOI 10.1002/pbc.22963; Tang JY, 2012, J AM ACAD DERMATOL, V67, DOI [10.1016/j.jaad.2012.05.044, 10.1016/j.jaad.2012.07.022]; Tretli S, 2012, CANCER CAUSE CONTROL, V23, P363, DOI 10.1007/s10552-011-9885-6; Trukova KP, 2012, NUTR CLIN PRACT, V27, P122, DOI 10.1177/0884533611431461; Wesa KM, 2015, NUTR CANCER, V67, P424, DOI 10.1080/01635581.2015.998838	32	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129901	10.1371/journal.pone.0129901	http://dx.doi.org/10.1371/journal.pone.0129901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047013	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200168
J	Tilleman, L; Abbruzzetti, S; Ciaccio, C; De Sanctis, G; Nardini, M; Pesce, A; Desmet, F; Moens, L; Van Doorslaer, S; Bruno, S; Bolognesi, M; Ascenzi, P; Coletta, M; Viappiani, C; Dewilde, S				Tilleman, Lesley; Abbruzzetti, Stefania; Ciaccio, Chiara; De Sanctis, Giampiero; Nardini, Marco; Pesce, Alessandra; Desmet, Filip; Moens, Luc; Van Doorslaer, Sabine; Bruno, Stefano; Bolognesi, Martino; Ascenzi, Paolo; Coletta, Massimo; Viappiani, Cristiano; Dewilde, Sylvia			Structural Bases for the Regulation of CO Binding in the Archaeal Protoglobin from Methanosarcina acetivorans	PLOS ONE			English	Article							LIGAND-BINDING; MYOGLOBIN; MIGRATION; METHANE; LIFE	Studies of CO ligand binding revealed that two protein states with different ligand affinities exist in the protoglobin from Methanosarcina acetivorans (in MaPgb*, residue Cys(E20)101 was mutated to Ser). The switch between the two states occurs upon the ligation of MaPgb*. In this work, site-directed mutagenesis was used to explore the role of selected amino acids in ligand sensing and stabilization and in affecting the equilibrium between the "more reactive" and "less reactive" conformational states of MaPgb*. A combination of experimental data obtained from electronic and resonance Raman absorption spectra, CO ligand-binding kinetics, and X-ray crystallography was employed. Three amino acids were assigned a critical role: Trp(60)B9, Tyr(61)B10, and Phe(93)E11. Trp(60)B9 and Tyr(61) B10 are involved in ligand stabilization in the distal heme pocket; the strength of their interaction was reflected by the spectra of the CO-ligated MaPgb* and by the CO dissociation rate constants. In contrast, Phe(93)E11 is a key player in sensing the heme-bound ligand and promotes the rotation of the Trp(60)B9 side chain, thus favoring ligand stabilization. Although the structural bases of the fast CO binding rate constant of MaPgb* are still unclear, Trp(60)B9, Tyr(61)B10, and Phe(93)E11 play a role in regulating heme/ligand affinity.	[Tilleman, Lesley; Moens, Luc; Dewilde, Sylvia] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium; [Abbruzzetti, Stefania; Viappiani, Cristiano] Univ Parma, Dept Phys & Earth Sci, I-43100 Parma, Italy; [Ciaccio, Chiara; Coletta, Massimo] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Rome, Italy; [Ciaccio, Chiara; Coletta, Massimo] Interuniv Consortium Res Chem Met Biol Syst, Bari, Italy; [Nardini, Marco; Bolognesi, Martino] Univ Milan, Dept Biosci, Milan, Italy; [Pesce, Alessandra] Univ Genoa, Dept Phys, Genoa, Italy; [Ascenzi, Paolo] Univ Roma Tre, Interdept Lab Electron Microscopy, Rome, Italy; [Desmet, Filip; Van Doorslaer, Sabine] Univ Antwerp, Dept Phys, B-2020 Antwerp, Belgium; [Bruno, Stefano] Univ Parma, Dept Pharm, Parma, Italy	University of Antwerp; University of Parma; University of Rome Tor Vergata; University of Milan; University of Genoa; Roma Tre University; University of Antwerp; University of Parma	Viappiani, C (corresponding author), Univ Parma, Dept Phys & Earth Sci, I-43100 Parma, Italy.	cristiano.viappiani@fis.unipr.it; sylvia.dewilde@ua.ac.be	abbruzzetti, stefania/AAE-5518-2020; Bolognesi, Martino/B-7924-2017; abbruzzetti, stefania/M-8640-2015; Coletta, Massimiliano/GSN-5927-2022; Nardini, Marco/B-7842-2017; Coletta, Massimo/N-9049-2015; Bruno, Stefano/A-4582-2011; Van Doorslaer, Sabine/E-5050-2017; Viappiani, Cristiano/AAC-7579-2019	abbruzzetti, stefania/0000-0001-7685-8554; Bolognesi, Martino/0000-0002-9253-5170; abbruzzetti, stefania/0000-0001-7685-8554; Nardini, Marco/0000-0002-3718-2165; Bruno, Stefano/0000-0002-7890-2472; Van Doorslaer, Sabine/0000-0002-1685-9202; Viappiani, Cristiano/0000-0001-7470-4770; COLETTA, Massimiliano/0000-0002-5489-9467	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (Azioni Integrate Italia Spagna) [2008BFJ34R, IT10L1M59M]; Ministero degli Affari Esteri, Direzione generale per la promozione del sistema Paese (Progetti di Grande Rilevanza, Italia-Argentina); University of Antwerp; Fund for Scientific Research, Flanders, Belgium [G.0247.09]; Ministry for University and Research of Italy (University Roma Tre, Roma, Italy); University of Milano	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (Azioni Integrate Italia Spagna); Ministero degli Affari Esteri, Direzione generale per la promozione del sistema Paese (Progetti di Grande Rilevanza, Italia-Argentina); University of Antwerp; Fund for Scientific Research, Flanders, Belgium(FWO); Ministry for University and Research of Italy (University Roma Tre, Roma, Italy); University of Milano	The authors acknowledge the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN 2008, 2008BFJ34R, and Azioni Integrate Italia Spagna 2009, IT10L1M59M), and Ministero degli Affari Esteri, Direzione generale per la promozione del sistema Paese (Progetti di Grande Rilevanza, Italia-Argentina 2011-2013), the University of Antwerp and the Fund for Scientific Research, Flanders, Belgium (Grant No G.0247.09) for financial support. This work was partially supported by grants from the Ministry for University and Research of Italy (University Roma Tre, Roma, Italy, "CLAR 2012") and by institutional funds from University of Milano (FIRST-2007 and PUR-2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzetti S, 2006, PHOTOCH PHOTOBIO SCI, V5, P1109, DOI 10.1039/b610236k; Abbruzzetti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033614; Cerda J, 1999, BIOSPECTROSCOPY, V5, P289; Ciaccio C, 2013, BBA-PROTEINS PROTEOM, V1834, P1813, DOI 10.1016/j.bbapap.2013.02.026; Das TK, 2000, BIOCHEMISTRY-US, V39, P837, DOI 10.1021/bi9922087; Das TK, 1999, J BIOL CHEM, V274, P4207, DOI 10.1074/jbc.274.7.4207; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Ferry JG, 2006, MOL BIOL EVOL, V23, P1286, DOI 10.1093/molbev/msk014; Forti F, 2011, J PHYS CHEM B, V115, P13771, DOI 10.1021/jp208562b; Freitas TAK, 2004, P NATL ACAD SCI USA, V101, P6675, DOI 10.1073/pnas.0308657101; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGM, 2003, MOSFLM USER GUIDE MO; Lessner DJ, 2006, P NATL ACAD SCI USA, V103, P17921, DOI 10.1073/pnas.0608833103; Lou BS, 2000, BIOCHEMISTRY-US, V39, P12424, DOI 10.1021/bi001257c; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nardini M, 2008, EMBO REP, V9, P157, DOI 10.1038/sj.embor.7401153; Pesce A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066144; Rother M, 2004, P NATL ACAD SCI USA, V101, P16929, DOI 10.1073/pnas.0407486101; Sottini S, 2005, J PHYS CHEM B, V109, P19523, DOI 10.1021/jp0540981; Sottini S, 2005, J PHYS CHEM B, V109, P11411, DOI 10.1021/jp0514224; SOWERS KR, 1984, APPL ENVIRON MICROB, V47, P971, DOI 10.1128/AEM.47.5.971-978.1984; Spiro TG, 2005, J INORG BIOCHEM, V99, P34, DOI 10.1016/j.jinorgbio.2004.09.026; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Van Doorslaer S, 2012, INORG CHEM, V51, P8834, DOI 10.1021/ic3007074	28	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0125959	10.1371/journal.pone.0125959	http://dx.doi.org/10.1371/journal.pone.0125959			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047471	Green Published, gold			2022-12-27	WOS:000355652200011
J	Wideman, JG; Moore, BP				Wideman, Jeremy G.; Moore, Blake P.			The Evolutionary History of MAPL (Mitochondria-Associated Protein Ligase) and Other Eukaryotic BAM/GIDE Domain Proteins	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; SALMON SALMO-SALAR; MAXIMUM-LIKELIHOOD; MIXED MODELS; MULAN; MITOPHAGY; REPLACEMENT; PEROXISOMES; BIOGENESIS; ACTIVATOR	MAPL (mitochondria-associated protein ligase, also called MULAN/GIDE/MUL1) is a multifunctional mitochondrial outer membrane protein found in human cells that contains a unique BAM (beside a membrane) domain and a C-terminal RING-finger domain. MAPL has been implicated in several processes that occur in animal cells such as NF-kB activation, innate immunity and antiviral signaling, suppression of PINK1/parkin defects, mitophagy in skeletal muscle, and caspase-dependent apoptosis. Previous studies demonstrated that the BAM domain is present in diverse organisms in which most of these processes do not occur, including plants, archaea, and bacteria. Thus the conserved function of MAPL and its BAM domain remains an open question. In order to gain insight into its conserved function, we investigated the evolutionary origins of MAPL by searching for homologues in predicted proteomes of diverse eukaryotes. We show that MAPL proteins with a conserved BAM-RING architecture are present in most animals, protists closely related to animals, a single species of fungus, and several multicellular plants and related green algae. Phylogenetic analysis demonstrated that eukaryotic MAPL proteins originate from a common ancestor and not from independent horizontal gene transfers from bacteria. We also determined that two independent duplications of MAPL occurred, one at the base of multicellular plants and another at the base of vertebrates. Although no other eukaryote genome examined contained a verifiable MAPL orthologue, BAM domain-containing proteins were identified in the protists Bigelowiella natans and Ectocarpus siliculosis. Phylogenetic analyses demonstrated that these proteins are more closely related to prokaryotic BAM proteins and therefore likely arose from independent horizontal gene transfers from bacteria. We conclude that MAPL proteins with BAM-RING architectures have been present in the holozoan and viridiplantae lineages since their very beginnings. Our work paves the way for future studies into MAPL function in alternative model organisms like Capsaspora owczarzaki and Chlamydomonas reinhardtii that will help to answer the question of MAPL's ancestral function in ways that cannot be answered by studying animal cells alone.	[Wideman, Jeremy G.; Moore, Blake P.] Univ Alberta, Augustana Fac, Dept Sci, Camrose, AB T4V 2R3, Canada; [Wideman, Jeremy G.] Univ Alberta, Fac Med & Dent, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta	Wideman, JG (corresponding author), Univ Alberta, Augustana Fac, Dept Sci, Camrose, AB T4V 2R3, Canada.	jeremy.grant.wideman@gmail.com		Wideman, Jeremy/0000-0002-4426-9533				Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambivero CT, 2014, CELL SIGNAL, V26, P2921, DOI 10.1016/j.cellsig.2014.09.004; Andrade-Navarro MA, 2009, CURR OPIN CELL BIOL, V21, P560, DOI 10.1016/j.ceb.2009.04.005; Bae SH, 2012, CELL RES, V22, P873, DOI 10.1038/cr.2012.38; Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066; Braschi E, 2009, EMBO REP, V10, P748, DOI 10.1038/embor.2009.86; Cilenti L, 2014, BBA-MOL CELL RES, V1843, P1295, DOI 10.1016/j.bbamcr.2014.03.027; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Gray MW, 2014, COLD SPRING HARB PER, V6; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huynen MA, 2013, BBA-BIOENERGETICS, V1827, P224, DOI 10.1016/j.bbabio.2012.08.001; Jenkins K, 2013, IMMUNOL CELL BIOL, V91, P321, DOI 10.1038/icb.2013.7; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lokireddy S, 2012, CELL METAB, V16, P613, DOI 10.1016/j.cmet.2012.10.005; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Mohanty A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00268; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Soubannier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052830; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sugiura A., 2014, EMBO J; Tacchi L, 2012, DEV COMP IMMUNOL, V38, P545, DOI 10.1016/j.dci.2012.08.004; Tacchi L, 2011, MOL IMMUNOL, V49, P558, DOI 10.1016/j.molimm.2011.10.005; Yun JN, 2014, ELIFE, V3, DOI 10.7554/eLife.01958; Zemirli N, 2014, FEBS J, V281, P3095, DOI 10.1111/febs.12846; Zhang BC, 2008, CELL RES, V18, P900, DOI 10.1038/cr.2008.75	29	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128795	10.1371/journal.pone.0128795	http://dx.doi.org/10.1371/journal.pone.0128795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047467	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200101
J	Zamparo, P; Zorzi, E; Marcantoni, S; Cesari, P				Zamparo, Paola; Zorzi, Elena; Marcantoni, Sara; Cesari, Paola			Is Beauty in the Eyes of the Beholder? Aesthetic Quality versus Technical Skill in Movement Evaluation of Tai Chi	PLOS ONE			English	Article							ACTION ANTICIPATION; BASKETBALL PLAYERS; VISUAL-PERCEPTION; BIOLOGICAL MOTION; DANCE PERCEPTION; RESONANCE; ACCURACY; SOCCER; SPEED	The aim of this study was to compare experts to naive practitioners in rating the beauty and the technical quality of a Tai Chi sequence observed in video-clips (of high and middle level performances). Our hypothesis are: i) movement evaluation will correlate with the level of skill expressed in the kinematics of the observed action but ii) only experts will be able to unravel the technical component from the aesthetic component of the observed action. The judgments delivered indicate that both expert and non-expert observers are able to discern a good from a mediocre performance; however, as expected, only experts discriminate the technical from the aesthetic component of the action evaluated and do this independently of the level of skill shown by the model (high or middle level performances). Furthermore, the judgments delivered were strongly related to the kinematic variables measured in the observed model, indicating that observers rely on specific movement kinematics (e.g. movement amplitude, jerk and duration) for action evaluation. These results provide evidence of the complementary functional role of visual and motor action representation in movement evaluation and underline the role of expertise in judging the aesthetic quality of movements.	[Zamparo, Paola; Zorzi, Elena; Marcantoni, Sara; Cesari, Paola] Univ Verona, Dept Neurol & Movement Sci, I-37100 Verona, Italy	University of Verona	Zamparo, P (corresponding author), Univ Verona, Dept Neurol & Movement Sci, I-37100 Verona, Italy.	paola.zamparo@univr.it	Zamparo, Paola/AAF-7700-2020	Zamparo, Paola/0000-0002-6919-6721; Cesari, Paola/0000-0002-1705-6065				Abreu AM, 2012, EUR J NEUROSCI, V35, P1646, DOI 10.1111/j.1460-9568.2012.08104.x; Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; ALLARD F, 1980, Journal of Sport Psychology, V2, P14; Almasbakk B., 2000, ENERGETICS HUMAN ACT, P228; Basmajian JV, 1977, MUSCLES MOVEMENTS BA; Bertucco M, 2010, NEUROSCIENCE, V171, P205, DOI 10.1016/j.neuroscience.2010.08.023; Best D., 1974, BRIT J AESTHET, V14, P197, DOI DOI 10.1093/BJAESTHETICS/14.3.197; Blasing B, 2012, ACTA PSYCHOL, V139, P300, DOI 10.1016/j.actpsy.2011.12.005; Brown WM, 2005, NATURE, V438, P1148, DOI 10.1038/nature04344; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Chase W., 1973, VISUAL INFORM PROCES, P215, DOI [10.1016/b978-0-12-170150-5.50011-1, DOI 10.1016/B978-0-12-170150-5.50011-1, 10.1016/B978-0-12-170150-5.50011-1]; Cross ES, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00102; Didierjean A, 2005, VIS COGN, V12, P265, DOI 10.1080/13506280444000021A; Duarte M, 2007, EXP BRAIN RES, V180, P457, DOI 10.1007/s00221-007-0871-x; ENOKA RM, 1994, NEUROMECHANICAL BASI; Grafton ST, 2009, ANN NY ACAD SCI, V1156, P97, DOI 10.1111/j.1749-6632.2009.04425.x; Humphrey D R, 1983, Adv Neurol, V39, P347; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Knoblich G, 2001, PSYCHOL SCI, V12, P467, DOI 10.1111/1467-9280.00387; Makris S, 2015, SOC COGN AFFECT NEUR, V10, P342, DOI 10.1093/scan/nsu052; McPherson SL, 1999, RES Q EXERCISE SPORT, V70, P369, DOI 10.1080/02701367.1999.10608057; Naeve N, 2011, BIOL LETT, V7, P221, DOI [10.1098/rsbl.2010.0619, DOI 10.1098/RSBL.2010.0619]; Newell K.M, 1993, VARIABILITY MOTOR CO; Opacic T, 2009, J EXP PSYCHOL LEARN, V35, P1570, DOI 10.1037/a0017244; Orgs G, 2013, CONSCIOUS COGN, V22, P603, DOI 10.1016/j.concog.2013.03.010; Penrose JMT, 1995, J HUM MOVEMENT STUD, V29, P199; Reber R, 2004, PERS SOC PSYCHOL REV, V8, P364, DOI 10.1207/s15327957pspr0804_3; SCULLY DM, 1986, HUM MOVEMENT SCI, V5, P185, DOI 10.1016/0167-9457(86)90024-2; Tomeo E, 2013, CEREB CORTEX, V23, P2765, DOI 10.1093/cercor/bhs279; Torrents C, 2013, PERCEPTION, V42, P447, DOI 10.1068/p7117; WEWERS ME, 1990, RES NURS HEALTH, V13, P227, DOI 10.1002/nur.4770130405	31	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128357	10.1371/journal.pone.0128357	http://dx.doi.org/10.1371/journal.pone.0128357			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7CR	26047473	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200061
J	Cope, AB; Powers, KA; Kuruc, JD; Leone, PA; Anderson, JA; Ping, LH; Kincer, LP; Swanstrom, R; Mobley, VL; Foust, E; Gay, CL; Eron, JJ; Cohen, MS; Miller, WC				Cope, Anna B.; Powers, Kimberly A.; Kuruc, Joann D.; Leone, Peter A.; Anderson, Jeffrey A.; Ping, Li-Hua; Kincer, Laura P.; Swanstrom, Ronald; Mobley, Victoria L.; Foust, Evelyn; Gay, Cynthia L.; Eron, Joseph J.; Cohen, Myron S.; Miller, William C.			Ongoing HIV Transmission and the HIV Care Continuum in North Carolina	PLOS ONE			English	Article							SEXUAL TRANSMISSION; VIRAL LOAD; BLACK-MEN; VIRUS; INFECTION; PREVENTION; MULTIPLE; UNAWARE; AWARE	Objective HIV transmission is influenced by status awareness and receipt of care and treatment. We analyzed these attributes of named partners of persons with acute HIV infection (index AHI cases) to characterize the transmission landscape in North Carolina (NC). Design Secondary analysis of programmatic data. Methods We used data from the NC Screening and Tracing of Active Transmission Program (2002-2013) to determine HIV status (uninfected, AHI, or chronic HIV infection [CHI]), diagnosis status (new or previously-diagnosed), and care and treatment status (not in care, in care and not on treatment, in care and on treatment) of index AHI cases' named partners. We developed an algorithm identifying the most likely transmission source among known HIV-infected partners to estimate the proportion of transmissions arising from contact with persons at different HIV continuum stages. We conducted a complementary analysis among a subset of index AHI cases and partners with phylogenetically-linked viruses. Results Overall, 358 index AHI cases named 932 partners, of which 218 were found to be HIV-infected (162 (74.3%) previously-diagnosed, 11 (5.0%) new AHI, 45 (20.6%) new CHI). Most transmission events appeared attributable to previously-diagnosed partners (77.4%, 95% confidence interval 69.4-85.3%). Among these previously-diagnosed partners, 23.2% (14.0-32.3%) were reported as in care and on treatment near the index AHI case diagnosis date. In the subset study of 33 phylogenetically-linked cases and partners, 60.6% of partners were previously diagnosed (43.9-77.3%). Conclusions A substantial proportion of HIV transmission in this setting appears attributable to contact with previously-diagnosed partners, reinforcing the need for improved engagement in care after diagnosis.	[Cope, Anna B.; Powers, Kimberly A.; Cohen, Myron S.; Miller, William C.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Kuruc, Joann D.; Leone, Peter A.; Anderson, Jeffrey A.; Gay, Cynthia L.; Eron, Joseph J.; Cohen, Myron S.; Miller, William C.] Univ N Carolina, Sch Med, Dept Med, Div Infect Dis, Chapel Hill, NC USA; [Anderson, Jeffrey A.] Bristol Myers Squibb Co, Lawrenceville, NJ USA; [Ping, Li-Hua; Kincer, Laura P.; Swanstrom, Ronald] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Swanstrom, Ronald] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Swanstrom, Ronald; Eron, Joseph J.; Cohen, Myron S.] Univ N Carolina, UNC Ctr AIDS Res, Sch Med, Chapel Hill, NC USA; [Mobley, Victoria L.; Foust, Evelyn] North Carolina Dept Hlth & Human Serv, Div Publ Hlth, Raleigh, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Bristol-Myers Squibb; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Cope, AB (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA.	acbarry@unc.edu	Laboratory Core, HIV STD/AGD-7085-2022; Miller, William C/H-4800-2014; Gay, Cynthia/AAG-2927-2019	Miller, William C/0000-0002-1934-7827; Gay, Cynthia/0000-0002-3620-3059	National Institutes of Health [KL2-TR001109, R03-MH100987, 1UL1TR00111, UO1-AI067854, R37-AI44667]; Bristol-Myers Squibb;  [P30 AI50410]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001109, UL1TR001111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067854, R37AI044667, P30AI050410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH100987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol-Myers Squibb(Bristol-Myers Squibb); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding for this study was provided by the National Institutes of Health [www.grants.nih.gov] (grant numbers KL2-TR001109 [KP], R03-MH100987 [KP], 1UL1TR00111, UO1-AI067854, R37-AI44667 [RS]) and an administrative supplement to the University of North Carolina Center for AIDS Research [www.unccfar.org] (P30 AI50410 [KP]). Bristol-Myers Squibb provided support in the form of salaries for JE and CG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Anderson JA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001053; [Anonymous], 2013, MMWR-MORBID MORTAL W, V62, P489; Carbon Disclosure Project, 2013, DROP; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Crepaz N, 2009, AIDS, V23, P1617, DOI 10.1097/QAD.0b013e32832effae; Dennis AM, 2012, AIDS, V26, P1813, DOI 10.1097/QAD.0b013e3283573244; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edmonson PF, 1992, NUCL ACIDS RES, V20; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gulick RM, 2004, NEW ENGL J MED, V350, P1850, DOI 10.1056/NEJMoa031772; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hall HI, 2012, AIDS, V26, P893, DOI 10.1097/QAD.0b013e328351f73f; Hurt CB, 2012, JAIDS-J ACQ IMM DEF, V61, P515, DOI 10.1097/QAI.0b013e31827076a4; Kalichman SC, 2008, SEX TRANSM DIS, V35, P55, DOI 10.1097/OLQ.0b013e318141fe9b; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kuruc J, 2009, 18 INT AIDS C CAP TO; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Mattson CL, 2014, AIDS, V28, P1203, DOI 10.1097/QAD.0000000000000273; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Miller WC, 2009, AIDS, V23, P835, DOI 10.1097/QAD.0b013e328326f55e; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Muessig KE, 2014, CURR HIV AIDS REP; North Carolina Department of Health and Human Services Communicable Disease Branch, 2012, EP PROF HIV STD PREV; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Patel P, 2006, JAIDS-J ACQ IMM DEF, V42, P75, DOI 10.1097/01.qai.0000218363.21088.ad; Peters PJ, 2014, MMWR-MORBID MORTAL W, V63, P90; Pilcher CD, 2001, JAMA-J AM MED ASSOC, V286, P1713, DOI 10.1001/jama.286.14.1713; Pilcher CD, 2005, NEW ENGL J MED, V352, P1873, DOI 10.1056/NEJMoa042291; Pilcher CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080629; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rodger A BT, 2014, TOP ANTIVIR MED, V22, P24; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; SIMMONDS P, 1990, J VIROL, V64, P5840, DOI 10.1128/JVI.64.12.5840-5850.1990; Skarbinski J, 2015, JAMA INTERN MED; Stringer JSA, 2005, AIDS, V19, P1309, DOI 10.1097/01.aids.0000180102.88511.7d; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Volz EM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001568; William H., SAGE HDB QUANTITATIV; Zetola NM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-17	44	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0127950	10.1371/journal.pone.0127950	http://dx.doi.org/10.1371/journal.pone.0127950			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042804	gold, Green Published, Green Submitted			2022-12-27	WOS:000355701600028
J	Sieber, T; Hare, E; Hofmann, H; Trepel, M				Sieber, Timo; Hare, Eric; Hofmann, Heike; Trepel, Martin			Biomathematical Description of Synthetic Peptide Libraries	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS; PHAGE DISPLAY; SATURATION MUTAGENESIS; SEQUENCE DIVERSITY; PROTEIN; CONSTRUCTION; VECTORS; COMPLEXITY	Libraries of randomised peptides displayed on phages or viral particles are essential tools in a wide spectrum of applications. However, there is only limited understanding of a library's fundamental dynamics and the influences of encoding schemes and sizes on their quality. Numeric properties of libraries, such as the expected number of different peptides and the library's coverage, have long been in use as measures of a library's quality. Here, we present a graphical framework of these measures together with a library's relative efficiency to help to describe libraries in enough detail for researchers to plan new experiments in a more informed manner. In particular, these values allow us to answer-in a probabilistic fashion-the question of whether a specific library does indeed contain one of the "best" possible peptides. The framework is implemented in a web-interface based on two packages, discreteRV and peptider, to the statistical software environment R. We further provide a user-friendly web-interface called PeLiCa (Peptide Library Calculator, http://www.pelica.org), allowing scientists to plan and analyse their peptide libraries.	[Sieber, Timo] Univ Med Ctr Hamburg Eppendorf, Dept Hematol & Oncol, Hamburg, Germany; [Hare, Eric; Hofmann, Heike] Iowa State Univ, Dept Stat, Ames, IA 50011 USA; [Trepel, Martin] Augsburg Med Ctr, Interdisciplinary Canc Ctr, Dept Hematol & Oncol, Augsburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Iowa State University	Hofmann, H (corresponding author), Iowa State Univ, Dept Stat, Ames, IA 50011 USA.	hofmann@iastate.edu		Hofmann, Heike/0000-0001-6216-5183	Deutsche Krebshilfe [110902]; Margarethe Clemens Foundation	Deutsche Krebshilfe(Deutsche Krebshilfe); Margarethe Clemens Foundation	This work was supported by Deutsche Krebshilfe (http://www.krebshilfe.de/metanavigation/english.html, grant 110902 to MT). MT was also supported by the Margarethe Clemens Foundation (http://themargaretclemonsfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashraf M, 2013, BIOCHEM SOC T, V41, P1189, DOI 10.1042/BST20130123; Binder M, 2011, CANCER-AM CANCER SOC, V117, P1891, DOI 10.1002/cncr.25755; Bosley AD, 2005, BIOMOL ENG, V22, P57, DOI 10.1016/j.bioeng.2004.11.002; Bougioukou DJ, 2009, ADV SYNTH CATAL, V351, P3287, DOI 10.1002/adsc.200900644; Buja A, 2013, DISCRETERV DEFINITIO; Bupp K, 2003, HUM GENE THER, V14, P1557, DOI 10.1089/104303403322495061; DEGRAAF ME, 1993, GENE, V128, P13, DOI 10.1016/0378-1119(93)90147-U; Denault M, 2007, METH MOL B, V352, P127; Deshayes K, 2002, CHEM BIOL, V9, P495, DOI 10.1016/S1074-5521(02)00129-1; Firth AE, 2008, NUCLEIC ACIDS RES, V36, pW281, DOI 10.1093/nar/gkn226; Fukunaga K, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/295719; Gaytan P, 2013, ACS SYNTH BIOL, V2, P453, DOI 10.1021/sb3001326; Girod A, 1999, NAT MED, V5, P1052, DOI 10.1038/12491; Hare E, 2015, R JOURNAL; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hoebenreich S, 2014, ACS SYNTH BIOL; Hofmann H, 2013, PEPTIDER EVALUATION; Hughes MD, 2003, J MOL BIOL, V331, P973, DOI 10.1016/S0022-2836(03)00833-7; Kille S, 2013, ACS SYNTH BIOL, V2, P83, DOI 10.1021/sb300037w; Kong Y, 2009, J THEOR BIOL, V259, P641, DOI 10.1016/j.jtbi.2009.04.008; Kreppel F, 2005, MOL THER, V12, P107, DOI 10.1016/j.ymthe.2005.03.006; Krumpe LR, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-65; Lindner T, 2011, MOLECULES, V16, P1625, DOI 10.3390/molecules16021625; Maersch S, 2010, VIROLOGY, V397, P167, DOI 10.1016/j.virol.2009.10.021; Makowski L, 2003, BIOINFORMATICS, V19, P483, DOI 10.1093/bioinformatics/btg013; MCCONNELL SJ, 1994, GENE, V151, P115, DOI 10.1016/0378-1119(94)90640-8; Michelfelder S, 2007, EXP HEMATOL, V35, P1766, DOI 10.1016/j.exphem.2007.07.018; Michelfelder S, 2009, ADV GENET, V67, P29, DOI 10.1016/S0065-2660(09)67002-4; Michelfelder S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005122; Muller OJ, 2003, NAT BIOTECHNOL, V21, P1040, DOI 10.1038/nbt856; Naumer M, 2012, HUM GENE THER, V23, P492, DOI 10.1089/hum.2011.139; Neuner P, 1998, NUCLEIC ACIDS RES, V26, P1223, DOI 10.1093/nar/26.5.1223; Nishimoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045550; Noren KA, 2001, METHODS, V23, P169, DOI 10.1006/meth.2000.1118; Nov Y, 2014, METHODS MOL BIOL, V1179, P261, DOI 10.1007/978-1-4939-1053-3_18; Nov Y, 2012, APPL ENVIRON MICROB, V78, P258, DOI 10.1128/AEM.06265-11; ONO A, 1995, NUCLEIC ACIDS RES, V23, P4677, DOI 10.1093/nar/23.22.4677; Patrick WM, 2005, BIOMOL ENG, V22, P105, DOI 10.1016/j.bioeng.2005.06.001; Patrick WM, 2003, PROTEIN ENG, V16, P451, DOI 10.1093/protein/gzg057; Perabo L, 2006, J VIROL, V80, P7265, DOI 10.1128/JVI.00076-06; R. Core Team, 2015, R A LANGUAGE AND ENV; Reetz MT, 2008, CHEMBIOCHEM, V9, P1797, DOI 10.1002/cbic.200800298; Rodi DJ, 1999, J MOL BIOL, V285, P197, DOI 10.1006/jmbi.1998.2303; Rodi DJ, 2002, J MOL BIOL, V322, P1039, DOI 10.1016/S0022-2836(02)00844-6; Sanchis J, 2008, APPL MICROBIOL BIOT, V81, P387, DOI 10.1007/s00253-008-1678-9; Scholle MD, 2005, COMB CHEM HIGH T SCR, V8, P545, DOI 10.2174/1386207054867337; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; Tang LX, 2012, BIOTECHNIQUES, V52, P149, DOI 10.2144/000113820; Varadi K, 2012, GENE THER, V19, P800, DOI 10.1038/gt.2011.143; Volles MJ, 2005, NUCLEIC ACIDS RES, V33, P3667, DOI 10.1093/nar/gki669; Waterkamp DA, 2006, J GENE MED, V8, P1307, DOI 10.1002/jgm.967; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899	52	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0129200	10.1371/journal.pone.0129200	http://dx.doi.org/10.1371/journal.pone.0129200			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042419	Green Published, gold, Green Submitted			2022-12-27	WOS:000355701600093
J	Bonnefond, M; Jensen, O				Bonnefond, Mathilde; Jensen, Ole			Gamma Activity Coupled to Alpha Phase as a Mechanism for Top-Down Controlled Gating	PLOS ONE			English	Article							VISUAL-SPATIAL ATTENTION; VISUOSPATIAL ATTENTION; NEURONAL OSCILLATIONS; THETA-OSCILLATIONS; MODULATION; INHIBITION; CORTEX; POWER; SUPPRESSION; INCREASES	Coupling between neural oscillations in different frequency bands has been proposed to coordinate neural processing. In particular, gamma power coupled to alpha phase is proposed to reflect gating of information in the visual system but the existence of such a mechanism remains untested. Here, we recorded ongoing brain activity using magnetoencephalography in subjects who performed a modified Sternberg working memory task in which distractors were presented in the retention interval. During the anticipatory pre-distractor period, we show that the phase of alpha oscillations was coupled with the power of high (80-120Hz) gamma band activity, i.e. gamma power consistently was lower at the trough than at the peak of the alpha cycle (9-12Hz). We further show that high alpha power was associated with weaker gamma power at the trough of the alpha cycle. This result is in line with alpha activity in sensory region implementing a mechanism of pulsed inhibition silencing neuronal firing every similar to 100 ms.	[Bonnefond, Mathilde; Jensen, Ole] Radboud Univ Nijmegen, Donders Inst Brain, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Bonnefond, M (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain, NL-6525 ED Nijmegen, Netherlands.	mathilde.bonnefond@donders.ru.nl; ole.jensen@donders.ru.nl	Bonnefond, Mathilde/J-7572-2012; Jensenq, Ole/D-2120-2010	Jensenq, Ole/0000-0001-8193-8348	Netherlands Organization for Scientific Research (NWO) VICI grant [453-09-002]; Netherlands Initiative Brain and Cognition, Organization for Scientific Research [056-14-011]; Fyssen funding scheme	Netherlands Organization for Scientific Research (NWO) VICI grant(Netherlands Organization for Scientific Research (NWO)); Netherlands Initiative Brain and Cognition, Organization for Scientific Research; Fyssen funding scheme	The authors gratefully acknowledge The Netherlands Organization for Scientific Research (NWO) VICI grant number 453-09-002, "The healthy brain'' funded by the Netherlands Initiative Brain and Cognition, a part of the Organization for Scientific Research under grant number 056-14-011 and the Fyssen funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; Berman JI, 2015, BRAIN CONNECT, V5, P80, DOI 10.1089/brain.2014.0242; Bertrand O, 2000, INT J PSYCHOPHYSIOL, V38, P211, DOI 10.1016/S0167-8760(00)00166-5; Bonnefond Mathilde, 2013, Commun Integr Biol, V6, pe22702, DOI 10.4161/cib.22702; Bonnefond M, 2012, CURR BIOL, V22, P1969, DOI 10.1016/j.cub.2012.08.029; Buschman TJ, 2012, NEURON, V76, P838, DOI 10.1016/j.neuron.2012.09.029; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Capilla A, 2014, CEREB CORTEX, V24, P550, DOI 10.1093/cercor/bhs343; Capotosto P, 2009, J NEUROSCI, V29, P5863, DOI 10.1523/JNEUROSCI.0539-09.2009; Dugue L, 2011, J NEUROSCI, V31, P11889, DOI 10.1523/JNEUROSCI.1161-11.2011; Engel AK, 2012, NEURON, V76, P673, DOI 10.1016/j.neuron.2012.11.003; Foxe JJ, 1998, NEUROREPORT, V9, P3929, DOI 10.1097/00001756-199812010-00030; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Haegens S, 2011, P NATL ACAD SCI USA, V108, P19377, DOI 10.1073/pnas.1117190108; Jensen O, 2015, TRENDS NEUROSCI, V38, P192, DOI 10.1016/j.tins.2015.02.006; Jensen O, 2014, TRENDS NEUROSCI, V37, P357, DOI 10.1016/j.tins.2014.04.001; Jensen O, 2013, TRENDS COGN SCI, V17, P10, DOI 10.1016/j.tics.2012.11.002; Jensen O, 2012, TRENDS COGN SCI, V16, P200, DOI 10.1016/j.tics.2012.03.002; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Khan S, 2013, P NATL ACAD SCI USA, V110, P3107, DOI 10.1073/pnas.1214533110; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Laufs H, 2006, NEUROIMAGE, V31, P1408, DOI 10.1016/j.neuroimage.2006.02.002; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Marshall TR, 2015, J NEUROSCI, V35, P1638, DOI 10.1523/JNEUROSCI.3116-14.2015; Mathewson KE, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00099; Mathewson KE, 2009, J NEUROSCI, V29, P2725, DOI 10.1523/JNEUROSCI.3963-08.2009; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Osipova D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003990; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Romei V, 2008, CEREB CORTEX, V18, P2010, DOI 10.1093/cercor/bhm229; Roux F, 2013, J NEUROSCI, V33, P17827, DOI 10.1523/JNEUROSCI.5778-12.2013; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Sauseng P, 2005, EUR J NEUROSCI, V22, P2917, DOI 10.1111/j.1460-9568.2005.04482.x; Scheeringa R, 2008, INT J PSYCHOPHYSIOL, V67, P242, DOI 10.1016/j.ijpsycho.2007.05.017; Scheeringa R, 2011, J NEUROSCI, V31, P3813, DOI 10.1523/JNEUROSCI.4697-10.2011; Snyder AC, 2010, J NEUROSCI, V30, P4024, DOI 10.1523/JNEUROSCI.5684-09.2010; Spaak E, 2012, CURR BIOL, V22, P2313, DOI 10.1016/j.cub.2012.10.020; Staudigl T, 2013, CURR BIOL, V23, P1101, DOI 10.1016/j.cub.2013.04.074; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; Uhlhaas PJ, 2011, PROG BIOPHYS MOL BIO, V105, P14, DOI 10.1016/j.pbiomolbio.2010.10.004; VanRullen R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00060; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Voytek B, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00191; Welberg L, 2013, NAT REV NEUROSCI, V14, P1, DOI 10.1038/nrn3417; Worden MS, 2000, J NEUROSCI, V20; Zanto TP, 2011, NAT NEUROSCI, V14, P656, DOI 10.1038/nn.2773; Zanto TP, 2010, NEUROIMAGE, V53, P736, DOI 10.1016/j.neuroimage.2010.06.012	50	62	63	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128667	10.1371/journal.pone.0128667	http://dx.doi.org/10.1371/journal.pone.0128667			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039691	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700113
J	Cheng, OM; Li, R; Zhao, L; Yu, LJ; Yang, B; Wang, J; Chen, BB; Yang, JQ				Cheng, Oumei; Li, Rong; Zhao, Lei; Yu, Lijuan; Yang, Bin; Wang, Jia; Chen, Beibei; Yang, Junqing			Short-Term Sleep Deprivation Stimulates Hippocampal Neurogenesis in Rats Following Global Cerebral Ischemia/Reperfusion	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; NEUROTROPHIC FACTOR; FOREBRAIN ISCHEMIA; ADULT HIPPOCAMPUS; DENTATE GYRUS; MEMORY; BDNF; RESTRICTION; MECHANISMS; EXPRESSION	Background Sleep deprivation (SD) plays a complex role in central nervous system (CNS) diseases. Recent studies indicate that short-term SD can affect the extent of ischemic damage. The aim of this study was to investigate whether short-term SD could stimulate hippocampal neurogenesis in a rat model of global cerebral ischemia/reperfusion (GCIR). Methods One hundred Sprague-Dawley rats were randomly divided into Sham, GCIR and short-term SD groups based on different durations of SD; the short-term SD group was randomly divided into three subgroups: the GCIR+6hSD*3d-treated, GCIR+12hSD-treated and GCIR +12hSD*3d-treated groups. The GCIR rat model was induced via the bilateral occlusion of the common carotid arteries and hemorrhagic hypotension. The rats were sleep-deprived starting at 48 h following GCIR. A Morris water maze test was used to assess learning and memory ability; cell proliferation and differentiation were analyzed via 5-bromodeoxyuridine (BrdU) and neuron-specific enolase (NSE), respectively, at 14 and 28 d; the expression of hippocampal BDNF was measured after 7 d. Results The different durations of short-term SD designed in our experiment exhibited improvement in cognitive function as well as increased hippocampal BDNF expression. Additionally, the short-term SD groups also showed an increased number of BrdU-and BrdU/NSE-positive cells compared with the GCIR group. Of the three short-term SD groups, the GCIR +12hSD*3d-treated group experienced the most substantial beneficial effects. Conclusions Short-term SD, especially the GCIR+ 12hSD*3d-treated method, stimulates neurogenesis in the hippocampal dentate gyrus (DG) of rats that undergo GCIR, and BDNF may be an underlying mechanism in this process.	[Cheng, Oumei; Li, Rong; Chen, Beibei] Chongqing Med Univ, Dept Neurol, Affiliated Hosp 1, Chongqing 400016, Peoples R China; [Zhao, Lei; Yu, Lijuan; Yang, Bin; Wang, Jia; Yang, Junqing] Chongqing Med Univ, Dept Pharmacol, Key Lab Biochem & Mol Pharmacol, Chongqing 400016, Peoples R China	Chongqing Medical University; Chongqing Medical University	Yang, JQ (corresponding author), Chongqing Med Univ, Dept Pharmacol, Key Lab Biochem & Mol Pharmacol, Chongqing 400016, Peoples R China.	1139627371@qq.com			National Natural Science Foundation of China [81100981, 81471334]; National Key Clinical Specialties Construction Program of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Clinical Specialties Construction Program of China	This research was supported by the National Natural Science Foundation of China (No. 81100981, 81471334) and the National Key Clinical Specialties Construction Program of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANO M, 1993, JPN J PHARMACOL, V63, P469, DOI 10.1254/jjp.63.469; Bachmann V, 2012, SLEEP, V35, P335, DOI 10.5665/sleep.1690; Chen J, 1998, J NEUROSCI, V18, P4914; Cheng OM, 2012, BRAIN RES, V1470, P111, DOI 10.1016/j.brainres.2012.06.026; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Faraguna U, 2008, J NEUROSCI, V28, P4088, DOI 10.1523/JNEUROSCI.5510-07.2008; Fujihara H, 2003, J MOL NEUROSCI, V21, P223, DOI 10.1385/JMN:21:3:223; Gao B, 2010, SLEEP, V33, P879, DOI 10.1093/sleep/33.7.879; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; Hairston IS, 2005, J NEUROPHYSIOL, V94, P4224, DOI 10.1152/jn.00218.2005; Hairston IS, 2004, J NEUROPHYSIOL, V91, P1586, DOI 10.1152/jn.00894.2003; Harukuni I, 2006, NEUROL CLIN, V24, P1, DOI 10.1016/j.ncl.2005.10.004; Hsu JC, 2003, BRAIN RES, V984, P170, DOI 10.1016/S0006-8993(03)03128-7; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Junek A, 2010, NEUROSCIENCE, V170, P1140, DOI 10.1016/j.neuroscience.2010.08.018; Kawai T, 2004, J CEREBR BLOOD F MET, V24, P548, DOI 10.1097/00004647-200405000-00009; Kee NJ, 2001, EXP BRAIN RES, V136, P313, DOI 10.1007/s002210000591; Kuang G, 2012, PPAR RES, V2012, DOI [10.1155/2012/209794, DOI 10.1155/2012/209794]; Kushikata T, 1999, AM J PHYSIOL-REG I, V276, pR1334, DOI 10.1152/ajpregu.1999.276.5.R1334; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Liu JL, 1998, J NEUROSCI, V18, P7768; LONGSTRETH WT, 1993, ANN EMERG MED, V22, P64, DOI 10.1016/S0196-0644(05)80252-5; Martinez-Vargas M, 2012, NEUROSCI LETT, V529, P118, DOI 10.1016/j.neulet.2012.09.037; Medeiros R, 1998, BRAZ J MED BIOL RES, V31, P675, DOI 10.1590/S0100-879X1998000500012; Mirescu C, 2006, P NATL ACAD SCI USA, V103, P19170, DOI 10.1073/pnas.0608644103; Moldovan M, 2010, EXP NEUROL, V222, P135, DOI 10.1016/j.expneurol.2009.12.023; Murray Patrick S, 2011, Int J Pept, V2011, P654085, DOI 10.1155/2011/654085; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Peskine A, 2010, BRAIN INJURY, V24, P755, DOI 10.3109/02699051003709581; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Quintard H, 2014, NEUROSCIENCE, V277, P72, DOI 10.1016/j.neuroscience.2014.06.047; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385, DOI 10.1111/j.1600-0404.1984.tb07822.x; Taliaz D, 2010, MOL PSYCHIATR, V15, P80, DOI 10.1038/mp.2009.67; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Weil ZM, 2009, EXP NEUROL, V218, P129, DOI 10.1016/j.expneurol.2009.04.018; Yagita Y, 2001, STROKE, V32, P1890, DOI 10.1161/01.STR.32.8.1890; Zhou YL, 2013, J MOL HISTOL, V44, P291, DOI 10.1007/s10735-012-9466-3; Zucconi GG, 2006, BRAIN RES BULL, V69, P375, DOI 10.1016/j.brainresbull.2006.01.009; Zunzunegui C, 2011, SLEEP, V34, P1261, DOI 10.5665/SLEEP.1252	42	23	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0125877	10.1371/journal.pone.0125877	http://dx.doi.org/10.1371/journal.pone.0125877			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039740	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700016
J	Kadoya, R; Matsumoto, K; Ooi, T; Taguchi, S				Kadoya, Ryosuke; Matsumoto, Ken'ichiro; Ooi, Toshihiko; Taguchi, Seiichi			MtgA Deletion-Triggered Cell Enlargement of Escherichia coli for Enhanced Intracellular Polyester Accumulation	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEINS; LACTATE-POLYMERIZING ENZYME; ACETOACETYL-COA REDUCTASE; POLYHYDROXYALKANOATE SYNTHASE; MICROBIAL-PRODUCTION; MONOMER COMPOSITION; PSEUDOMONAS-PUTIDA; PHA SYNTHASE; GENE DOSAGE; BIOSYNTHESIS	Bacterial polyester polyhydroxyalkanoates (PHAs) have been produced in engineered Escherichia coli, which turned into an efficient and versatile platform by applying metabolic and enzyme engineering approaches. The present study aimed at drawing out the latent potential of this organism using genome-wide mutagenesis. To meet this goal, a transposon-based mutagenesis was carried out on E. coli, which was transformed to produce poly (lactate-co-3-hydroxybutyrate) from glucose. A high-throughput screening of polymer-accumulating cells on Nile red-containing plates isolated one mutant that produced 1.8-fold higher quantity of polymer without severe disadvantages in the cell growth and monomer composition of the polymer. The transposon was inserted into the locus within the gene encoding MtgA that takes part, as a non-lethal component, in the formation of the peptidoglycan backbone. Accordingly, the mtgA-deleted strain E. coli JW3175, which was a derivate of superior PHA-producing strain BW25113, was examined for polymer production, and exhibited an enhanced accumulation of the polymer (7.0 g/l) compared to the control (5.2 g/l). Interestingly, an enlargement in cell width associated with polymer accumulation was observed in this strain, resulting in a 1.6-fold greater polymer accumulation per cell compared to the control. This result suggests that the increase in volumetric capacity for accumulating intracellular material contributed to the enhanced polymer production. The mtgA deletion should be combined with conventional engineering approaches, and thus, is a promising strategy for improved production of intracellularly accumulated biopolymers.	[Kadoya, Ryosuke; Matsumoto, Ken'ichiro; Ooi, Toshihiko; Taguchi, Seiichi] Hokkaido Univ, Div Biotechnol & Macromol Chem, Grad Sch Engn, Sapporo, Hokkaido, Japan; [Kadoya, Ryosuke; Taguchi, Seiichi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Hokkaido University; Japan Science & Technology Agency (JST)	Taguchi, S (corresponding author), Hokkaido Univ, Div Biotechnol & Macromol Chem, Grad Sch Engn, Sapporo, Hokkaido, Japan.	staguchi@eng.hokudai.ac.jp	Kadoya, Ryosuke/M-3587-2017; Matsumoto, Ken'ichiro/AAH-3273-2019; タグチ, セイイチ/ABC-7203-2021	Matsumoto, Ken'ichiro/0000-0002-5361-8352; 	Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency (JST)	Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This research was supported by a Core Research for Evolutional Science and Technology (CREST) program "Creation of essential technologies to utilize carbon dioxide as a resource through the enhancement of plant productivity and the exploitation of plant produces" (http://www.jst.go.jp/kisoken/crest/index.html) from the Japan Science and Technology Agency (JST) (http://www.jst.go.jp) (RK and ST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Chee J.Y., 2010, CURR RES TECHNOL ED, V2, P1395; Chung AL, 2013, METAB ENG, V17, P23, DOI 10.1016/j.ymben.2013.02.001; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Derouaux A, 2008, J BACTERIOL, V190, P1831, DOI 10.1128/JB.01377-07; DiBerardino M, 1996, FEBS LETT, V392, P184, DOI 10.1016/0014-5793(96)00809-5; Dmitriev B, 2005, TRENDS MICROBIOL, V13, P569, DOI 10.1016/j.tim.2005.10.001; ELSDEN SR, 1956, J BACTERIOL, V72, P681, DOI 10.1002/path.1700720235; Eraso JM, 2011, CURR BIOL, V21, pR628, DOI 10.1016/j.cub.2011.06.056; Gao X, 2011, CURR OPIN BIOTECH, V22, P768, DOI 10.1016/j.copbio.2011.06.005; Gumel AM, 2013, J POLYM ENVIRON, V21, P580, DOI 10.1007/s10924-012-0527-1; HARA H, 1984, FEBS LETT, V168, P155, DOI 10.1016/0014-5793(84)80226-4; Jiang HY, 2011, BIOPHYS J, V101, P327, DOI 10.1016/j.bpj.2011.06.005; Jo SJ, 2007, J BIOSCI BIOENG, V104, P457, DOI 10.1263/jbb.104.457; Kadoya R, 2014, J BIOSCI BIOENG; Kadoya R, 2011, J BACTERIOL, V193, P1504, DOI 10.1128/JB.01067-10; Kichise T, 2002, APPL ENVIRON MICROB, V68, P2411, DOI 10.1128/AEM.68.5.2411-2419.2002; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Le Meur S, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0131-2; Lee TH, 1998, BIOTECHNOL PROGR, V14, P959, DOI 10.1021/bp980085w; Maehara A, 1998, BIOTECHNOL BIOENG, V60, P61, DOI 10.1002/(SICI)1097-0290(19981005)60:1<61::AID-BIT7>3.3.CO;2-Y; Matsumoto K, 2013, APPL ENVIRON MICROB, V79, P6134, DOI 10.1128/AEM.01768-13; Matsumoto K, 2013, BIOMACROMOLECULES, V14, P1913, DOI 10.1021/bm400278j; Matsumoto K, 2013, APPL MICROBIOL BIOT, V97, P205, DOI 10.1007/s00253-012-4104-2; Matsumoto K, 2011, J BIOTECHNOL, V156, P214, DOI 10.1016/j.jbiotec.2011.07.040; Matsusaki H, 1998, J BACTERIOL, V180, P6459, DOI 10.1128/JB.180.24.6459-6467.1998; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c; Nduko JM, 2014, APPL MICROBIOL BIOT, V98, P2453, DOI 10.1007/s00253-013-5401-0; Nduko JM, 2013, METAB ENG, V15, P159, DOI 10.1016/j.ymben.2012.11.007; PEOPLES OP, 1989, J BIOL CHEM, V264, P15293; Popham DL, 2003, CURR OPIN MICROBIOL, V6, P594, DOI 10.1016/j.mib.2003.10.002; Ren Q, 2005, ANTON LEEUW INT J G, V87, P91, DOI 10.1007/s10482-004-1360-x; Sambrook J., 2001, MOL CLONING LAB MANU; Schiffer G, 1999, J BIOL CHEM, V274, P32031, DOI 10.1074/jbc.274.45.32031; Shozui F, 2010, BIOSCI BIOTECH BIOCH, V74, P1710, DOI 10.1271/bbb.100224; SOM T, 1982, MOL GEN GENET, V187, P375, DOI 10.1007/BF00332615; Spiekermann P, 1999, ARCH MICROBIOL, V171, P73, DOI 10.1007/s002030050681; Taguchi S, 2004, MACROMOL BIOSCI, V4, P145, DOI 10.1002/mabi.200300111; Taguchi S, 2008, P NATL ACAD SCI USA, V105, P17323, DOI 10.1073/pnas.0805653105; Takase K, 2003, J BIOCHEM, V133, P139, DOI 10.1093/jb/mvg015; Tanadchangsaeng N, 2010, BIOMACROMOLECULES, V11, P1615, DOI 10.1021/bm100267k; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Wang Y, 2014, METAB ENG, V25, P183, DOI 10.1016/j.ymben.2014.07.010; Washio K, 2010, BIOSCI BIOTECH BIOCH, V74, P992, DOI 10.1271/bbb.90860; Yamada M, 2010, BIOMACROMOLECULES, V11, P815, DOI 10.1021/bm901437z; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhao K, 2010, NUCLEIC ACIDS RES, V38, P1273, DOI 10.1093/nar/gkp1123; Zinn M, 2011, BIOTECHNOL J, V6, P1240, DOI 10.1002/biot.201100219	50	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0125163	10.1371/journal.pone.0125163	http://dx.doi.org/10.1371/journal.pone.0125163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039058	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700007
J	Ocheretina, O; Shen, LS; Escuyer, VE; Mabou, MM; Royal-Mardi, G; Collins, SE; Pape, JW; Fitzgerald, DW				Ocheretina, Oksana; Shen, Lishuang; Escuyer, Vincent E.; Mabou, Marie-Marcelle; Royal-Mardi, Gertrude; Collins, Sean E.; Pape, Jean W.; Fitzgerald, Daniel W.			Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P-Insights into a Mechanism of Resistance Escalation	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RIFAMPICIN-RESISTANCE; DISCRIMINATORY POWER; COMPLEX STRAINS; DRUG-RESISTANCE; TRANSMISSION; ETHAMBUTOL; SUSCEPTIBILITY; EPIDEMIOLOGY; EVOLUTION	The World Health Organization recommends diagnosing Multidrug-Resistant Tuberculosis (MDR-TB) in high burden countries by detection of mutations in Rifampin (RIF) Resistance Determining Region of Mycobacterium tuberculosis rpoB gene with rapid molecular tests GeneXpert MTB/RIF and Hain MTBDRplus. Such mutations are found in >95% of Mycobacterium tuberculosis strains resistant to RIF by conventional culture-based drug susceptibility testing (DST). However routine diagnostic screening with molecular tests uncovered specific "low level" rpoB mutations conferring resistance to RIF below the critical concentration of 1 mu g/ml in some phenotypically susceptible strains. Cases with discrepant phenotypic (susceptible) and genotypic (resistant) results for resistance to RIF account for at least 10% of resistant diagnoses by molecular tests and urgently require new guidelines to inform therapeutic decision making. Eight strains with a " low level" rpoB mutation L511P were isolated by GHESKIO laboratory between 2008 and 2012 from 6 HIV-negative and 2 HIV-positive patients during routine molecular testing. Five isolates with a single L511P mutation and two isolates with double mutation L511P&M515T had MICs for RIF between 0.125 and 0.5 mu g/ml and tested susceptible in culture-based DST. The eighth isolate carried a double mutation L511P&D516C and was phenotypically resistant to RIF. All eight strains shared the same spoligotype SIT 53 commonly found in Haiti but classic epidemiological investigation failed to uncover direct contacts between the patients. Whole Genome Sequencing (WGS) revealed that L511P cluster isolates resulted from a clonal expansion of an ancestral strain resistant to Isoniazid and to a very low level of RIF. Under the selective pressure of RIF-based therapy the strain acquired mutation in the M306 codon of embB followed by secondary mutations in rpoB and escalation of resistance level. This scenario highlights the importance of subcritical resistance to RIF for both clinical management of patients and public health and provides support for introducing rpoB mutations as proxy for MICs into laboratory diagnosis of RIF resistance. This study illustrates that WGS is a promising multipurpose genotyping tool for high-burden settings as it provides both "gold standard" sequencing results for prediction of drug susceptibility and a high-resolution data for epidemiological investigation in a single assay.	[Ocheretina, Oksana; Collins, Sean E.; Pape, Jean W.; Fitzgerald, Daniel W.] Weill Cornell Med Coll, Ctr Global Hlth, Dept Med, Div Infect Dis, New York, NY 10065 USA; [Ocheretina, Oksana; Mabou, Marie-Marcelle; Royal-Mardi, Gertrude; Pape, Jean W.] Las Ctr GHESKIO, Port Au Prince, Haiti; [Shen, Lishuang] Cornell Univ, Biomed Sci VTBMC, Ithaca, NY USA; [Escuyer, Vincent E.] New York State Dept Hlth, Wadsworth Ctr, Lab Mycobacteriol, Albany, NY USA	Cornell University; Cornell University; State University of New York (SUNY) System; Wadsworth Center	Ocheretina, O (corresponding author), Weill Cornell Med Coll, Ctr Global Hlth, Dept Med, Div Infect Dis, New York, NY 10065 USA.	oko2001@med.cornell.edu	Shen, Lishuang/B-3040-2013	Shen, Lishuang/0000-0002-0436-0199	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [AI098627-02]; Fogarty International Center, Office of the Director, National Institutes of Health [TW000018-25]; National Heart, Blood, and Lung Institute; National Institute of Mental Health; National Institutes of Health [U19AI111143]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI098627, UM1AI069421, U19AI111143] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center, Office of the Director, National Institutes of Health; National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by: 1. Grant K24: AI098627-02 from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; 2. Grant AITRP: TW000018-25 from the Fogarty International Center, Office of the Director, National Institutes of Health, the National Heart, Blood, and Lung Institute, and the National Institute of Mental Health; 3. Grant TBRU: U19AI111143 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JR, 2014, J INFECT DIS, V210, P597, DOI 10.1093/infdis/jiu138; Andrews JR, 2013, AM J EPIDEMIOL, V177, P556, DOI 10.1093/aje/kws331; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Bergval I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029108; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; Chen L, 2010, J ANTIMICROB CHEMOTH, V65, P1299, DOI 10.1093/jac/dkq102; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; International Organization for Migration, 2013, DISPLACEMENT TRACKIN; Ioerger TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007778; Jamieson FB, 2014, J CLIN MICROBIOL, V52, P2157, DOI 10.1128/JCM.00691-14; Kato-Maeda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058235; Koser CU, 2013, NEW ENGL J MED, V369, P290, DOI 10.1056/NEJMc1215305; Kremer K, 2005, J CLIN MICROBIOL, V43, P5628, DOI 10.1128/JCM.43.11.5628-5638.2005; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Mariam DH, 2004, ANTIMICROB AGENTS CH, V48, P1289, DOI 10.1128/AAC.48.4.1289-1294.2004; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; National Committee on Clinical Laboratory Standards, 2003, NCCLS DOCUMENT M24 A; Ocheretina O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090569; Ocheretina O, 2013, J CLIN MICROBIOL, V51, P2232, DOI 10.1128/JCM.00268-13; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Safi H, 2008, ANTIMICROB AGENTS CH, V52, P2027, DOI 10.1128/AAC.01486-07; Safi H, 2013, NAT GENET, V45, P1190, DOI 10.1038/ng.2743; Srivastava S, 2010, J INFECT DIS, V201, P1225, DOI 10.1086/651377; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Traore H, 2000, INT J TUBERC LUNG D, V4, P481; van Belkum A, 2001, CLIN MICROBIOL REV, V14, P547, DOI 10.1128/CMR.14.3.547-560.2001; van der Spuy GD, 2009, INT J TUBERC LUNG D, V13, P419; Van Deun A, 2009, J CLIN MICROBIOL, V47, P3501, DOI 10.1128/JCM.01209-09; Van Deun A, 2013, J CLIN MICROBIOL, V51, P2633, DOI 10.1128/JCM.00553-13; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Williamson DA, 2012, INT J TUBERC LUNG D, V16, P216, DOI 10.5588/ijtld.11.0178; World Health Organization, 2014, DOCUMENT WHO HTM TB; World Health Organization, 1994, DOCUMENT WHO TB 94 1; World Health Organization, 2008, DOCUMENT WHO HTM TB; World Health Organization, 2003, DOCUMENT WHO CDS TB; World Health Organization & Stop TB Initiative, 2009, DOCUMENT WHO HTM TB; Yip CW, 2006, INT J TUBERC LUNG D, V10, P625; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735	48	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0129207	10.1371/journal.pone.0129207	http://dx.doi.org/10.1371/journal.pone.0129207			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039194	Green Submitted, gold, Green Published			2022-12-27	WOS:000355700700142
J	Oeder, S; Kanashova, T; Sippula, O; Sapcariu, SC; Streibel, T; Arteaga-Salas, JM; Passig, J; Dilger, M; Paur, HR; Schlager, C; Mulhopt, S; Diabate, S; Weiss, C; Stengel, B; Rabe, R; Harndorf, H; Torvela, T; Jokiniemi, JK; Hirvonen, MR; Schmidt-Weber, C; Traidl-Hoffmann, C; Berube, KA; Wlodarczyk, AJ; Prytherch, Z; Michalke, B; Krebs, T; Prevot, ASH; Kelbg, M; Tiggesbaumker, J; Karg, E; Jakobi, G; Scholtes, S; Schnelle-Kreis, J; Lintelmann, J; Matuschek, G; Sklorz, M; Klingbeil, S; Orasche, J; Richthammer, P; Muller, L; Elsasser, M; Reda, A; Groger, T; Weggler, B; Schwemer, T; Czech, H; Ruger, CP; Abbaszade, G; Radischat, C; Hiller, K; Buters, JTM; Dittmar, G; Zimmermann, R				Oeder, Sebastian; Kanashova, Tamara; Sippula, Olli; Sapcariu, Sean C.; Streibel, Thorsten; Arteaga-Salas, Jose Manuel; Passig, Johannes; Dilger, Marco; Paur, Hanns-Rudolf; Schlager, Christoph; Mulhopt, Sonja; Diabate, Silvia; Weiss, Carsten; Stengel, Benjamin; Rabe, Rom; Harndorf, Horst; Torvela, Tiina; Jokiniemi, Jorma K.; Hirvonen, Maija-Riitta; Schmidt-Weber, Carsten; Traidl-Hoffmann, Claudia; Berube, Kelly A.; Wlodarczyk, Anna J.; Prytherch, Zoe; Michalke, Bernhard; Krebs, Tobias; Prevot, Andre S. H.; Kelbg, Michael; Tiggesbaumker, Josef; Karg, Erwin; Jakobi, Gert; Scholtes, Sorana; Schnelle-Kreis, Jurgen; Lintelmann, Jutta; Matuschek, Georg; Sklorz, Martin; Klingbeil, Sophie; Orasche, Jurgen; Richthammer, Patrick; Muller, Laarnie; Elsasser, Michael; Reda, Ahmed; Groger, Thomas; Weggler, Benedikt; Schwemer, Theo; Czech, Hendryk; Ruger, Christopher P.; Abbaszade, Gulcin; Radischat, Christian; Hiller, Karsten; Buters, Jeroen T. M.; Dittmar, Gunnar; Zimmermann, Ralf			Particulate Matter from Both Heavy Fuel Oil and Diesel Fuel Shipping Emissions Show Strong Biological Effects on Human Lung Cells at Realistic and Comparable In Vitro Exposure Conditions	PLOS ONE			English	Article							AIR-LIQUID INTERFACE; EPITHELIAL-CELLS; ULTRAFINE PARTICLES; SIZE DISTRIBUTIONS; CELLULAR-RESPONSE; LIFE EXPECTANCY; POLLUTION; IMPACT; TRANSFORMATION; NANOPARTICLES	Background Ship engine emissions are important with regard to lung and cardiovascular diseases especially in coastal regions worldwide. Known cellular responses to combustion particles include oxidative stress and inflammatory signalling. Objectives To provide a molecular link between the chemical and physical characteristics of ship emission particles and the cellular responses they elicit and to identify potentially harmful fractions in shipping emission aerosols. Methods Through an air-liquid interface exposure system, we exposed human lung cells under realistic in vitro conditions to exhaust fumes from a ship engine running on either common heavy fuel oil (HFO) or cleaner-burning diesel fuel (DF). Advanced chemical analyses of the exhaust aerosols were combined with transcriptional, proteomic and metabolomic profiling including isotope labelling methods to characterise the lung cell responses. Results The HFO emissions contained high concentrations of toxic compounds such as metals and polycyclic aromatic hydrocarbon, and were higher in particle mass. These compounds were lower in DF emissions, which in turn had higher concentrations of elemental carbon ("soot"). Common cellular reactions included cellular stress responses and endocytosis. Reactions to HFO emissions were dominated by oxidative stress and inflammatory responses, whereas DF emissions induced generally a broader biological response than HFO emissions and affected essential cellular pathways such as energy metabolism, protein synthesis, and chromatin modification. Conclusions Despite a lower content of known toxic compounds, combustion particles from the clean shipping fuel DF influenced several essential pathways of lung cell metabolism more strongly than particles from the unrefined fuel HFO. This might be attributable to a higher soot content in DF. Thus the role of diesel soot, which is a known carcinogen in acute air pollution-induced health effects should be further investigated. For the use of HFO and DF we recommend a reduction of carbonaceous soot in the ship emissions by implementation of filtration devices.	[Oeder, Sebastian; Kanashova, Tamara; Sippula, Olli; Sapcariu, Sean C.; Streibel, Thorsten; Arteaga-Salas, Jose Manuel; Passig, Johannes; Dilger, Marco; Paur, Hanns-Rudolf; Schlager, Christoph; Mulhopt, Sonja; Diabate, Silvia; Weiss, Carsten; Stengel, Benjamin; Rabe, Rom; Harndorf, Horst; Jokiniemi, Jorma K.; Hirvonen, Maija-Riitta; Berube, Kelly A.; Wlodarczyk, Anna J.; Prytherch, Zoe; Krebs, Tobias; Kelbg, Michael; Tiggesbaumker, Josef; Scholtes, Sorana; Richthammer, Patrick; Weggler, Benedikt; Radischat, Christian; Hiller, Karsten; Buters, Jeroen T. M.; Dittmar, Gunnar; Zimmermann, Ralf] HICE, Helmholtz Virtual Inst Complex Mol Syst Environm, Berlin, Germany; [Oeder, Sebastian; Schmidt-Weber, Carsten; Buters, Jeroen T. M.] Univ Munich, Ctr Allergy & Environm ZAUM, Helmholtz Zentrum Munchen & Tech, German Ctr Lung Res DZL, Munich, Germany; [Oeder, Sebastian; Traidl-Hoffmann, Claudia; Buters, Jeroen T. M.] CK CARE, Chirstine Kuhne Ctr Allergy Resp & Educ, Davos, Switzerland; [Kanashova, Tamara; Dittmar, Gunnar] Max Delbruck Ctr Mol Med, Mass Spectrometry Core Unit, Berlin, Germany; [Sippula, Olli; Torvela, Tiina; Jokiniemi, Jorma K.; Hirvonen, Maija-Riitta] Univ Eastern Finland, Dept Environm Sci, FI-70211 Kuopio, Finland; [Sapcariu, Sean C.; Hiller, Karsten] Univ Luxembourg, Luxembourg Ctr Syst Biomed, L-4362 Luxembourg, Luxembourg; [Streibel, Thorsten; Passig, Johannes; Sklorz, Martin; Klingbeil, Sophie; Schwemer, Theo; Czech, Hendryk; Ruger, Christopher P.; Radischat, Christian; Zimmermann, Ralf] Univ Rostock, Joint Mass Spectrometry Ctr, Chair Analyt Chem, Inst Chem, D-18055 Rostock, Germany; [Streibel, Thorsten; Karg, Erwin; Jakobi, Gert; Scholtes, Sorana; Schnelle-Kreis, Jurgen; Lintelmann, Jutta; Matuschek, Georg; Orasche, Jurgen; Richthammer, Patrick; Muller, Laarnie; Elsasser, Michael; Reda, Ahmed; Groger, Thomas; Weggler, Benedikt; Abbaszade, Gulcin; Zimmermann, Ralf] Joint Mass Spectrometry Ctr, CMA Comprehens Mol Analyt, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Dilger, Marco; Paur, Hanns-Rudolf; Schlager, Christoph; Mulhopt, Sonja] Karlsruhe Inst Technol, Inst Tech Chem, D-76021 Karlsruhe, Germany; [Dilger, Marco; Diabate, Silvia; Weiss, Carsten] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany; [Stengel, Benjamin; Rabe, Rom; Harndorf, Horst] Univ Rostock, Chair Piston Machines & Internal Combust Engines, D-18055 Rostock, Germany; [Jokiniemi, Jorma K.] VTT Tech Res Ctr Finland, FI-02044 Espoo, Finland; [Hirvonen, Maija-Riitta] Natl Inst Hlth & Welf, Dept Environm Hlth, Kuopio, Finland; [Traidl-Hoffmann, Claudia] Tech Univ, UNIKA T, Inst Environm Med, Munich, Germany; [Berube, Kelly A.; Wlodarczyk, Anna J.; Prytherch, Zoe] Cardiff Univ, Sch Biosci, Lung & Particle Res Grp, Cardiff CF10 3AX, S Glam, Wales; [Michalke, Bernhard] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Res Unit Analyt BioGeoChem, Neuherberg, Germany; [Krebs, Tobias] Vitrocell GmbH, Waldkirch, Germany; [Prevot, Andre S. H.] Paul Scherrer Inst, Lab Atmospher Chem, Villigen, Switzerland; [Kelbg, Michael; Tiggesbaumker, Josef] Univ Rostock, Inst Phys, D-18055 Rostock, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Eastern Finland; University of Luxembourg; University of Rostock; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; University of Rostock; VTT Technical Research Center Finland; Finland National Institute for Health & Welfare; Technical University of Munich; Cardiff University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Rostock	Zimmermann, R (corresponding author), HICE, Helmholtz Virtual Inst Complex Mol Syst Environm, Berlin, Germany.	ralf.zimmermann@helmholtz-muenchen.de	Prevot, Andre S. H./C-6677-2008; Matuschek, Georg/M-9824-2014; Schnelle-Kreis, Jürgen/M-9845-2014; BUTERS, JEROEN/AAF-6949-2020; Paur, Hanns-Rudolf/H-1340-2013; Schmidt-Weber, Carsten B./AAU-1621-2021; Dittmar, Gunnar/B-6383-2016; Weiss, Carsten/I-1811-2013; Dittmar, Gunnar/C-6333-2019; BeruBe, Kelly A/A-7162-2010; Kelbg, Michael/AAR-6522-2020; Rüger, Christopher P./AAJ-5548-2020; Buters, Jeroen T/G-5070-2011; Weggler, Benedikt A./AAM-2813-2020	Prevot, Andre S. H./0000-0002-9243-8194; Matuschek, Georg/0000-0003-1090-8699; Schnelle-Kreis, Jürgen/0000-0003-4846-2303; Paur, Hanns-Rudolf/0000-0001-5133-9459; Schmidt-Weber, Carsten B./0000-0002-3203-8084; Dittmar, Gunnar/0000-0003-3647-8623; Weiss, Carsten/0000-0002-5380-3208; Dittmar, Gunnar/0000-0003-3647-8623; BeruBe, Kelly A/0000-0002-7471-7229; Kelbg, Michael/0000-0001-8512-8895; Rüger, Christopher P./0000-0001-9634-9239; Weggler, Benedikt A./0000-0002-5673-0024; Sippula, Olli/0000-0002-6981-2694; Orasche, Jurgen/0000-0002-1037-7544; Mulhopt, Sonja/0000-0003-3951-0131; Hiller, Karsten/0000-0001-9322-5820; Traidl-Hoffmann, Claudia/0000-0001-5085-5179; Passig, Johannes/0000-0002-3876-1716; Buters, Jeroen/0000-0003-3581-5472; Jokiniemi, Jorma/0000-0002-1201-6144; Dilger, Marco/0000-0002-9038-3863; Prytherch, Zoe/0000-0003-0690-0184; Tiggesbaumker, Josef/0000-0002-2027-3001	Impulse and Networking Funds (INF) of the Helmholtz Association (HGF), Berlin, Germany; Helmholtz Zentrum Munchen; University of Rostock; CK-CARE Teilbereich A; Fonds National de la Recherche (FNR); Academy of Finland [258315, 259946]; Saastamoinen foundation; University of Eastern Finland for project "sustainable bioenergy, climate change and health"; German Science Foundation (DFG) [ZI 764/5-1, ZI 764/3-1, INST 264/56-1, INST264/77-1]; SNSF; DFG; Vitrocell GmbH	Impulse and Networking Funds (INF) of the Helmholtz Association (HGF), Berlin, Germany; Helmholtz Zentrum Munchen(Helmholtz Association); University of Rostock; CK-CARE Teilbereich A; Fonds National de la Recherche (FNR)(Luxembourg National Research Fund); Academy of Finland(Academy of Finland); Saastamoinen foundation; University of Eastern Finland for project "sustainable bioenergy, climate change and health"; German Science Foundation (DFG)(German Research Foundation (DFG)); SNSF(Swiss National Science Foundation (SNSF)); DFG(German Research Foundation (DFG)); Vitrocell GmbH	HICE partners received funding from the Impulse and Networking Funds (INF) of the Helmholtz Association (HGF), Berlin, Germany. The support of HICE by the Helmholtz Zentrum Munchen and University of Rostock is gratefully acknowledged. Sebastian Oeder also received funding from CK-CARE Teilbereich A. Sean Sapcariu and Karsten Hiller acknowledge financial support from the Fonds National de la Recherche (FNR), specifically the ATTRACT program Metabolomics Junior Group. Funding from the Academy of Finland (Grant No: 258315 & 259946), Saastamoinen foundation and the strategic funding of the University of Eastern Finland for project "sustainable bioenergy, climate change and health" is acknowledged. Funding from the German Science Foundation (DFG ZI 764/5-1, ZI 764/3-1, INST 264/56-1 and 264/77-1) helped to achieve the presented results. We also thank SNSF and DFG for funding for the DACH project WOOSHI. Vitrocell GmbH provided support in the form of a salary for author T. Krebs, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Adam TW, 2011, ANAL CHEM, V83, P67, DOI 10.1021/ac101859u; Ault AP, 2009, ENVIRON SCI TECHNOL, V43, P3500, DOI 10.1021/es8018918; Baber O, 2011, INHAL TOXICOL, V23, P532, DOI 10.3109/08958378.2011.592869; Barsan M, 2007, NIOHS POCKET GUIDE C; Benbrahim-Tallaa L, 2012, LANCET ONCOL, V13, P663, DOI 10.1016/S1470-2045(12)70280-2; Blatcher DJ, 2013, MAR POLLUT BULL, V74, P10, DOI 10.1016/j.marpolbul.2013.07.010; Chen YY, 2013, P NATL ACAD SCI USA, V110, P12936, DOI 10.1073/pnas.1300018110; Comouth A, 2013, J AEROSOL SCI, V63, P103, DOI 10.1016/j.jaerosci.2013.04.009; Cooney DJ, 2011, TOXICOL IN VITRO, V25, P1953, DOI 10.1016/j.tiv.2011.06.019; Cooper DA, 2003, ATMOS ENVIRON, V37, P3817, DOI 10.1016/S1352-2310(03)00446-1; Corbett JJ, 2007, ENVIRON SCI TECHNOL, V41, P8512, DOI 10.1021/es071686z; Dalsoren SB, 2009, ATMOS CHEM PHYS, V9, P2171, DOI 10.5194/acp-9-2171-2009; Diabate S, 2008, ATLA-ALTERN LAB ANIM, V36, P285, DOI 10.1177/026119290803600306; EPA, 2014, DIES BOATS SHIPS; Eyring V, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005619; Eyring V, 2010, ATMOS ENVIRON, V44, P4735, DOI 10.1016/j.atmosenv.2009.04.059; Ferron GA, 2013, J AEROSOL MED PULM D, V26, P101, DOI 10.1089/jamp.2011.0965; Ghio AJ, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-25; Herzog F, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-11; Holder AL, 2008, TOXICOL SCI, V103, P108, DOI 10.1093/toxsci/kfn014; Karg E, 2014, HYGROSCOPIC PARTICLE; Karthikeyan S, 2013, TOXICOL SCI, V135, P437, DOI 10.1093/toxsci/kft162; Khan MY, 2012, ENVIRON SCI TECHNOL, V46, P5049, DOI 10.1021/es2043646; Kooter IM, 2013, TOXICOL IN VITRO, V27, P2342, DOI 10.1016/j.tiv.2013.10.007; Lack DA, 2011, ENVIRON SCI TECHNOL, V45, P9052, DOI 10.1021/es2013424; Lloyd AC, 2001, J AIR WASTE MANAGE, V51, P809, DOI 10.1080/10473289.2001.10464315; Matthias V, 2010, ENVIRON POLLUT, V158, P2241, DOI 10.1016/j.envpol.2010.02.013; Mueller D, 2011, J OCCUP MED TOXICOL,, V6, DOI 10.1186/1745-6673-6-31; Mueller L, 2015, ANAL BIOANAL CHEM, V407, P5911, DOI 10.1007/s00216-015-8549-x; Oeder S, 2012, AM J RESP CELL MOL, V47, P575, DOI 10.1165/rcmb.2012-0139OC; Oostingh GJ, 2013, TOXICOL IN VITRO, V27, P1746, DOI 10.1016/j.tiv.2013.04.016; Pagels J, 2009, AEROSOL SCI TECH, V43, P629, DOI 10.1080/02786820902810685; Palsson-McDermott EM, 2013, BIOESSAYS, V35, P965, DOI 10.1002/bies.201300084; Park K, 2003, ENVIRON SCI TECHNOL, V37, P577, DOI 10.1021/es025960v; Patel MM, 2013, ENVIRON RES, V121, P71, DOI 10.1016/j.envres.2012.10.012; Paur HR, 2011, J AEROSOL SCI, V42, P668, DOI 10.1016/j.jaerosci.2011.06.005; Persoz C, 2012, TOXICOL LETT, V211, P159, DOI 10.1016/j.toxlet.2012.03.799; Pope CA, 2013, P NATL ACAD SCI USA, V110, P12861, DOI 10.1073/pnas.1310925110; Poplawski K, 2011, ATMOS ENVIRON, V45, P824, DOI 10.1016/j.atmosenv.2010.11.029; REDDEL RR, 1988, CANCER RES, V48, P1904; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwarze PE, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/685142; Steinritz D, 2013, CHEM-BIOL INTERACT, V206, P479, DOI 10.1016/j.cbi.2013.05.001; Tsukue N, 2010, TOXICOL IN VITRO, V24, P363, DOI 10.1016/j.tiv.2009.11.004; Vignati E, 1999, SCI TOTAL ENVIRON, V235, P37, DOI 10.1016/S0048-9697(99)00188-6; Wehner B, 2002, ATMOS ENVIRON, V36, P2215, DOI 10.1016/S1352-2310(02)00174-7; Winebrake JJ, 2009, ENVIRON SCI TECHNOL, V43, P4776, DOI 10.1021/es803224q; Winnes H, 2009, J AIR WASTE MANAGE, V59, P1391, DOI 10.3155/1047-3289.59.12.1391; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050	49	90	92	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126536	10.1371/journal.pone.0126536	http://dx.doi.org/10.1371/journal.pone.0126536			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039251	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000355700700032
J	Plotnikoff, RC; Costigan, SA; Short, C; Grunseit, A; James, E; Johnson, N; Bauman, A; D'Este, C; van der Ploeg, HP; Rhodes, RE				Plotnikoff, Ronald C.; Costigan, Sarah A.; Short, Camille; Grunseit, Anne; James, Erica; Johnson, Natalie; Bauman, Adrian; D'Este, Catherine; van der Ploeg, Hidde P.; Rhodes, Ryan E.			Factors Associated with Higher Sitting Time in General, Chronic Disease, and Psychologically-Distressed, Adult Populations: Findings from the 45 & Up Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; SELF-REPORTED WEIGHT; ALL-CAUSE MORTALITY; SEDENTARY BEHAVIOR; US ADULTS; NEIGHBORHOOD WALKABILITY; HEALTH OUTCOMES; VIEWING TIME; RISK; OBESITY	This study examined factors associated with higher sitting time in general, chronic disease, and psychologically-distressed, adult populations (aged >= 45 years). A series of logistic regression models examined potential socio-demographic and health factors associated with higher sitting (>= 6hrs/day) in adults from the 45 and Up Study (n = 227,187), including four separate subsamples for analysis comprising those who had ever had heart disease (n = 26,599), cancer (n = 36,381), diabetes (n = 19,550) or psychological distress (n = 48,334). Odds of higher sitting were significantly (p<.01) associated with a number of factors across these groups, with an effect size of ORs >= 1.5 observed for the high-income >=$70,000AUD, employed full-time and severe physical limitations demographics. Identification of key factors associated with higher sitting time in this population-based sample will assist development of broad-based, public health and targeted strategies to reduce sitting-time. In particular, those categorized as being high-income earners, full-time workers, as well as those with severe physical limitations need to be of priority, as higher sitting appears to be substantial across these groups.	[Plotnikoff, Ronald C.; Costigan, Sarah A.; James, Erica] Univ Newcastle, Prior Res Ctr Phys Act & Nutr, Newcastle, NSW 2300, Australia; [Short, Camille] Cent Queensland Univ, Inst Hlth & Social Sci Res, Ctr Phys Act Studies, Rockhampton, Qld 4702, Australia; [Grunseit, Anne; Bauman, Adrian; van der Ploeg, Hidde P.] Univ Sydney, Sch Publ Hlth, Prevent Res Collaborat, Sydney, NSW 2006, Australia; [James, Erica; Johnson, Natalie] Univ Newcastle, Fac Hlth & Med, Sch Med & Publ Hlth, Discipline Hlth Behav Sci, Newcastle, NSW 2300, Australia; [D'Este, Catherine] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Res Sch Populat Hlth, ANU Coll Med, Canberra, ACT, Australia; [van der Ploeg, Hidde P.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Rhodes, Ryan E.] Univ Victoria, Sch Exercise Sci, Behav Med Lab, Victoria, BC, Canada	University of Newcastle; Central Queensland University; University of Sydney; University of Newcastle; Australian National University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Victoria	Plotnikoff, RC (corresponding author), Univ Newcastle, Prior Res Ctr Phys Act & Nutr, Newcastle, NSW 2300, Australia.	Ron.Plotnikoff@newcastle.edu.au	van der Ploeg, Hidde/ABD-6402-2021; Rhodes, Ryan/ABB-4896-2020; Grunseit, Anne/AAF-2675-2020; van der Ploeg, Hidde P/B-2599-2013	Rhodes, Ryan/0000-0003-0940-9040; van der Ploeg, Hidde P/0000-0002-3719-5249; James, Erica/0000-0002-0880-3604; Short, Camille/0000-0002-4177-4251; Johnson, Natalie/0000-0001-6676-5266; Grunseit, Anne/0000-0003-1250-3265	National Health & Medical Research Council (NH&MRC) Senior Research Fellowship	National Health & Medical Research Council (NH&MRC) Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	RCP is supported by a National Health & Medical Research Council (NH&MRC) Senior Research Fellowship. This research was completed using data collected through the 45 and Up Study (www.saxinstitute.org.au). The 45 and Up Study is managed by the Sax Institute in collaboration with major partner Cancer Council NSW; and partners: the National Heart Foundation of Australia (NSW Division); NSW Ministry of Health; beyondblue; Ageing, Disability and Home Care, Department of Family and Community Services; the Australian Red Cross Blood Service; and UnitingCare Ageing.	Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x; [Anonymous], 2007, CIRCULATION, DOI DOI 10.1161/CIRCULATIONAHA.107.185649; Arredondo EM, 2012, J HEALTH PSYCHOL, V17, P742, DOI 10.1177/1359105311424468; Australian Bureau of Statistics, 2013, THESIS U NORTHAMPTON; Australian Institute of Health and Welfare, 2004, REM HLTH GUID REM CL; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Bauman A, 2011, AM J PREV MED, V41, P228, DOI 10.1016/j.amepre.2011.05.003; Bellis MA, 2009, MEASURE WE UNDERESTI; Bennie JA, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-107; Berry B, 2007, SOCIOL PERSPECT, V50, P177, DOI 10.1525/sop.2007.50.2.177; Bowman SA, 2006, PREV CHRONIC DIS, V3; Brown WJ, 2003, INT J OBESITY, V27, P1340, DOI 10.1038/sj.ijo.0802426; Brown WJ, 2004, J SCI MED SPORT, V7, P205, DOI 10.1016/S1440-2440(04)80010-0; Bureau of Labor Statistics, 2013, AM TIM US SURV WASH; Chau JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080000; Chau JY, 2012, PREV MED, V54, P195, DOI 10.1016/j.ypmed.2011.12.020; Chen HN, 2010, COMMUN STAT-SIMUL C, V39, P860, DOI 10.1080/03610911003650383; Clark BK, 2014, PREV MED, V64, P1, DOI 10.1016/j.ypmed.2014.03.017; Clark BK, 2010, J PHYS ACT HEALTH, V7, P595, DOI 10.1123/jpah.7.5.595; Clark BK, 2011, MED SCI SPORT EXER, V43, P822, DOI 10.1249/MSS.0b013e3182019510; Coakley EH, 1998, INT J OBESITY, V22, P89, DOI 10.1038/sj.ijo.0800549; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Crawford DA, 1999, INT J OBESITY, V23, P437, DOI 10.1038/sj.ijo.0800845; de Heer HD, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-896; Department of Health, 2014, PHYS ACT SED BEH GUI; Ekelund U, 2008, AM J CLIN NUTR, V88, P612, DOI 10.1093/ajcn/88.3.612; Fox KR, 2007, OBES REV, V8, P115, DOI 10.1111/j.1467-789X.2007.00329.x; Gao X, 2007, DIABETES CARE, V30, P694, DOI 10.2337/dc06-1835; George ES, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-20; George ES, 2012, J AGING PHYS ACTIV, V20, P300, DOI 10.1123/japa.20.3.300; Health Outcomes Assessment Unit-Epidemiology and Analytical Services Health Information Centre, 2001, COLL HLTH WELLB SURV; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Healy GN, 2011, AM J PREV MED, V41, P216, DOI 10.1016/j.amepre.2011.05.005; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Jans MP, 2007, AM J PREV MED, V33, P450, DOI 10.1016/j.amepre.2007.07.033; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; King AC, 2010, AM J PREV MED, V38, P17, DOI 10.1016/j.amepre.2009.08.032; Kronenberg F, 2000, ATHEROSCLEROSIS, V153, P433, DOI 10.1016/S0021-9150(00)00426-3; Magee CA, 2009, PREV MED, V49, P461, DOI 10.1016/j.ypmed.2009.10.006; McCreary DR, 1999, J APPL SOC PSYCHOL, V29, P2342, DOI 10.1111/j.1559-1816.1999.tb00114.x; Must A, 2005, INT J OBESITY, V29, pS84, DOI 10.1038/sj.ijo.0803064; Organization WH, 2009, GLOB HLTH RISKS MORT; Owen N, 2009, BRIT J SPORT MED, V43, P81, DOI 10.1136/bjsm.2008.055269; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Parsons TJ, 2009, EUR J CLIN NUTR, V63, P978, DOI 10.1038/ejcn.2009.6; Pedisic Z, 2014, OBESITY, V22, P2126, DOI 10.1002/oby.20817; Petersen CB, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-13; Proper KI, 2011, AM J PREV MED, V40, P174, DOI 10.1016/j.amepre.2010.10.015; Rhodes RE, 2007, ANN BEHAV MED, V33, P302, DOI 10.1007/BF02879912; Rhodes RE, 2012, AM J PREV MED, V42, pE3, DOI 10.1016/j.amepre.2011.10.020; Rhodes RE, 2009, LEISURE SCI, V31, P124, DOI 10.1080/01490400802685948; Richmond TK, 2010, OBESITY, V18, P1015, DOI 10.1038/oby.2009.391; Salmon J, 2000, INT J OBESITY, V24, P600, DOI 10.1038/sj.ijo.0801203; Shields M, 2 STAT CAN; Shields M, 2008, 2 STAT CAN; Sloan RA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-885; Staiano AE, 2014, BRIT J SPORT MED, V48, P213, DOI 10.1136/bjsports-2012-091896; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Stommel M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-421; Sugiyama T, 2007, AM J PREV MED, V33, P444, DOI 10.1016/j.amepre.2007.07.035; Swartz AM, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-69; Teychenne M, 2011, INT J BEHAV MED, V17, P246, DOI 10.1007/s12529-010-9075-z; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Tigbe WW, 2011, PREV MED, V53, P48, DOI 10.1016/j.ypmed.2011.04.018; Timperio A, 2000, INT J OBESITY, V24, P81, DOI 10.1038/sj.ijo.0801089; Timperio A, 2003, J SCI MED SPORT, V6, P477, DOI 10.1016/S1440-2440(03)80273-6; Touvier M, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-14; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; Van Dyck D, 2012, SOC SCI MED, V74, P1375, DOI 10.1016/j.socscimed.2012.01.018; Van Dyck D, 2010, AM J PREV MED, V39, P25, DOI 10.1016/j.amepre.2010.03.004; Villanueva EV, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-11; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wolin KY, 2008, J PHYS ACT HEALTH, V5, P229, DOI 10.1123/jpah.5.2.229; Zhang M, 2004, CANCER CAUSE CONTROL, V15, P83, DOI 10.1023/B:CACO.0000016633.47025.2a	75	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127689	10.1371/journal.pone.0127689	http://dx.doi.org/10.1371/journal.pone.0127689			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7ST	26039739	Green Published, gold			2022-12-27	WOS:000355700700071
J	Xu, XL; Wang, JW; Zhu, SM; Yang, M; Fang, Y; Zhao, A; Song, Q; Mao, WM				Xu, Xiaoling; Wang, Jiwen; Zhu, Shuang-Mei; Yang, Ming; Fang, Yun; Zhao, An; Song, Qian; Mao, Weimin			Impact of Alcohol Dehydrogenase Gene 4 Polymorphisms on Esophageal Squamous Cell Carcinoma Risk in a Chinese Population	PLOS ONE			English	Article							UPPER AERODIGESTIVE TRACT; DNA-DAMAGE; CANCER; JAPANESE; SUSCEPTIBILITY; ASSOCIATION; VARIANTS; PATTERNS; DRINKING; ADH1B	Background Esophageal squamous cell carcinoma (ESCC) is very common in China and is also one of the most common cancers worldwide. The purpose of this study was to examine the associations between genetic variants of various cancer-related genes and the risk of ESCC. Methods In this study, we first examined the association between 18 potentially disruptive genetic variants of 17 genes, including alcohol dehydrogenase 4 (ADH4) and checkpoint kinase 2 (CHEK2), and ESCC risk in a Hangzhou population of 617 patients matched with 534 controls. Among the 18 single nucleotide polymorphisms (SNPs), two were validated in a Jinan population of 540 patients matched with 550 controls. Results Sixteen SNPs in 15 genes, including CHEK2, did not have significantly different allele frequency distributions between ESCC patients and control subjects. A significantly increased risk of developing ESCC was revealed in subjects with the AA genotype of rs3805322 (ADH4) compared with those with the AG or GG genotype by unconditional univariate logistic regression analysis. Using a dominant model, the CC genotype of rs4822983 (CHEK2) had a marginally significant protective effect compared to the CT and TT genotypes. The association of ESCC risk with these two SNPs (rs3805322 and rs4822983) was further validated in a Jinan case-control set. Individuals with the ADH4 rs3805322 AA or AG genotype had ORs of 1.10 (95% CI = 0.81-1.49, P < 0.001) or 1.86 (95% CI = 1.33-2.59, P = 0.559), respectively, for developing ESCC compared with individuals with the GG genotype. CHEK2 rs4822983 CC carriers showed a marginally significantly decreased ESCC risk compared with those carrying the CT and TT genotypes in the validation set (95% CI = 0.61-1.01, P = 0.064). However, no evidence of interaction existed between the two SNPs and smoking or drinking in the Jinan case-control set. Conclusions In conclusion, this current study provides substantial evidence that genetic polymorphisms of rs3805322 in the ADH4 gene may be associated with an increased risk of developing ESCC in two Chinese Han populations. Future studies to address the biological function of this polymorphism in the development of ESCC are warranted.	[Xu, Xiaoling; Wang, Jiwen; Zhao, An; Mao, Weimin] Canc Res Inst, Hangzhou, Zhejiang, Peoples R China; [Wang, Jiwen; Zhao, An; Mao, Weimin] Zhejiang Canc Hosp, Dept Thorac Surg, Hangzhou, Zhejiang, Peoples R China; [Xu, Xiaoling; Zhao, An; Mao, Weimin] Key Lab Diag & Treatment Technol Thorac Oncol, Hangzhou, Zhejiang, Peoples R China; [Zhu, Shuang-Mei] Wenzhou Med Univ, Affiliated Hosp 6, Lishui Peoples Hosp, Dept Radiochemotherapy Oncol, Wenzhou, Zhejiang, Peoples R China; [Yang, Ming] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing 100029, Peoples R China; [Xu, Xiaoling; Fang, Yun] Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China; [Song, Qian] Zhejiang Canc Hosp, Dept Clin Lab, Hangzhou, Zhejiang, Peoples R China	Zhejiang Cancer Hospital; Wenzhou Medical University; Beijing University of Chemical Technology; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital	Mao, WM (corresponding author), Canc Res Inst, Hangzhou, Zhejiang, Peoples R China.	maowm1418@163.com	Yang, Ming/G-4705-2012; ZHAO, AN/O-1547-2014	Yang, Ming/0000-0002-7722-7487; ZHAO, An/0000-0002-2716-9733	Province of Important Technology and Science [2011C13039-1]	Province of Important Technology and Science	This work was supported by the Province of Important Technology and Science (No. 2011C13039-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown LM, 2001, AM J EPIDEMIOL, V153, P114, DOI 10.1093/aje/153.2.114; Chen HY, 2009, CANCER RES, V69, P3451, DOI 10.1158/0008-5472.CAN-08-4231; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Goh XY, 2011, GUT, V60, P1317, DOI 10.1136/gut.2010.234179; Hao BT, 2004, CANCER RES, V64, P4378, DOI 10.1158/0008-5472.CAN-04-0372; Hashibe M, 2006, CANCER EPIDEM BIOMAR, V15, P696, DOI 10.1158/1055-9965.EPI-05-0710; Huang JX, 2009, WORLD J GASTROENTERO, V15, P4316, DOI 10.3748/wjg.15.4316; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Lee SP, 2006, ALCOHOL, V39, P13, DOI 10.1016/j.alcohol.2006.06.012; Matsuo K, 2007, HUM MUTAT, V28, P506, DOI 10.1002/humu.20477; Osier MV, 2002, AM J HUM GENET, V71, P84, DOI 10.1086/341290; Oze I, 2009, CANCER EPIDEM BIOMAR, V18, P3097, DOI 10.1158/1055-9965.EPI-09-0499; Pickens A, 2003, ANN THORAC SURG, V76, pS1367, DOI 10.1016/S0003-4975(03)01202-5; Saeki N, 2014, INT J MOL SCI, V15, P7958, DOI 10.3390/ijms15057958; Sarbia M, 2007, BRIT J CANCER, V97, P1404, DOI 10.1038/sj.bjc.6604037; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; SHIELDS PG, 1991, JAMA-J AM MED ASSOC, V266, P681, DOI 10.1001/jama.266.5.681; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Stoner GD, 2001, CARCINOGENESIS, V22, P1737, DOI 10.1093/carcin/22.11.1737; Sugiura K, 2007, ONCOL REP, V17, P557; Wang H, 1998, INT J ONCOL, V12, P325; Wang JF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0104882, 10.1371/journal.pone.0094096]; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411; Wu M, 2013, INT J CANCER, V132, P1868, DOI 10.1002/ijc.27803; Yang Chun-Xia, 2005, Asian Pac J Cancer Prev, V6, P256; Yang GY, 1997, INT J CANCER, V72, P746, DOI 10.1002/(SICI)1097-0215(19970904)72:5<746::AID-IJC7>3.3.CO;2-F; Yang ST, 2002, NAT CELL BIOL, V4, P865, DOI 10.1038/ncb869; Yokoyama A, 2002, CARCINOGENESIS, V23, P1851, DOI 10.1093/carcin/23.11.1851	29	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127304	10.1371/journal.pone.0127304	http://dx.doi.org/10.1371/journal.pone.0127304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039424	Green Submitted, gold, Green Published			2022-12-27	WOS:000355700700057
J	Ferrocino, I; Di Cagno, R; De Angelis, M; Turroni, S; Vannini, L; Bancalari, E; Rantsiou, K; Cardinali, G; Neviani, E; Cocolin, L				Ferrocino, Ilario; Di Cagno, Raffaella; De Angelis, Maria; Turroni, Silvia; Vannini, Lucia; Bancalari, Elena; Rantsiou, Kalliopi; Cardinali, Gianluigi; Neviani, Erasmo; Cocolin, Luca			Fecal Microbiota in Healthy Subjects Following Omnivore, Vegetarian and Vegan Diets: Culturable Populations and rRNA DGGE Profiling	PLOS ONE			English	Article							GUT MICROBIOTA; PCR-DGGE; CONSUMPTION; DIVERSITY; IMPACT; CHILDREN	In this study, the fecal microbiota of 153 healthy volunteers, recruited from four different locations in Italy, has been studied by coupling viable counts, on different microbiological media, with ribosomal RNA Denaturing Gradient Gel Electrophoresis (rRNA-DGGE). The volunteers followed three different diets, namely omnivore, ovo-lacto-vegetarian and vegan. The results obtained from culture-dependent and -independent methods have underlined a high level of similarity of the viable fecal microbiota for the three investigated diets. The rRNA DGGE profiles were very complex and comprised a total number of bands that varied from 67 to 64 for the V3 and V9 regions of the 16S rRNA gene, respectively. Only a few bands were specific in/of all three diets, and the presence of common taxa associated with the dietary habits was found. As far as the viable counts are concerned, the high similarity of the fecal microbiota was once again confirmed, with only a few of the investigated groups showing significant differences. Interestingly, the samples grouped differently, according to the recruitment site, thus highlighting a higher impact of the food consumed by the volunteers in the specific geographical locations than that of the type of diet. Lastly, it should be mentioned that the fecal microbiota DGGE profiles obtained from the DNA were clearly separated from those produced using RNA, thus underlining a difference between the total and viable populations in the fecal samples.	[Ferrocino, Ilario; Rantsiou, Kalliopi; Cocolin, Luca] Univ Turin, Dept Agr Forest & Food Sci, I-10095 Grugliasco, Italy; [Di Cagno, Raffaella; De Angelis, Maria] Univ Bari Aldo Moro, Dept Soil Plant & Food Sci, I-70126 Bari, Italy; [Turroni, Silvia] Alma Mater Studiorum Univ Bologna, Dept Pharm & Biotechnol, I-40126 Bologna, Italy; [Vannini, Lucia] Dept Agr & Food Sci, I-40127 Bologna, Italy; [Bancalari, Elena; Neviani, Erasmo] Univ Parma, Dept Food Sci, I-43124 Parma, Italy; [Cardinali, Gianluigi] Univ Perugia, Dept Pharmaceutr Sci, I-06123 Perugia, Italy	University of Turin; Universita degli Studi di Bari Aldo Moro; University of Bologna; University of Parma; University of Perugia	Cocolin, L (corresponding author), Univ Turin, Dept Agr Forest & Food Sci, Largo P Braccini 2, I-10095 Grugliasco, Italy.	lucasimone.cocolin@unito.it	Turroni, Silvia/J-7195-2016; Cocolin, Luca/H-5091-2012; Ferrocino, Ilario/K-7234-2016; De Angelis, Maria/AAA-9909-2019	Turroni, Silvia/0000-0003-2345-9482; Cocolin, Luca/0000-0003-4799-7074; Bancalari, Elena/0000-0002-5975-2923; Di Cagno, Raffaella/0000-0002-9431-4427; FERROCINO, ILARIO/0000-0002-1657-0054; De Angelis, Maria/0000-0002-2010-884X; Vannini, Lucia/0000-0002-9417-8410	Italian Ministry of University and Research (MIUR)	Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This study was supported by the Italian Ministry of University and Research (MIUR) PRIN 2010-2011 program (http://www.diet4microgut.it).	Agans R, 2011, FEMS MICROBIOL ECOL, V77, P404, DOI 10.1111/j.1574-6941.2011.01120.x; Bertrand X, 2007, J APPL MICROBIOL, V102, P1052, DOI 10.1111/j.1365-2672.2006.03148.x; Bianchi F, 2014, FOOD RES INT, V64, P43, DOI 10.1016/j.foodres.2014.05.072; Cecchini DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072766; Ceuppens S, 2014, COMPR REV FOOD SCI F, V13, P551, DOI 10.1111/1541-4337.12072; Chiba M, 2010, WORLD J GASTROENTERO, V16, P2484, DOI 10.3748/wjg.v16.i20.2484; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ferris MJ, 1996, APPL ENVIRON MICROB, V62, P340, DOI 10.1128/AEM.62.2.340-346.1996; Foerster J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109606; Francavilla R, 2012, PEDIAT ALLERG IMM-UK, V23, P420, DOI 10.1111/j.1399-3038.2012.01286.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hayashi H, 2002, MICROBIOL IMMUNOL, V46, P819, DOI 10.1111/j.1348-0421.2002.tb02769.x; Hobbs ME, 2014, BIOCHEMISTRY-US, V53, P4661, DOI 10.1021/bi500656m; Jaquet M, 2009, INT J FOOD MICROBIOL, V130, P117, DOI 10.1016/j.ijfoodmicro.2009.01.011; Kim MS, 2013, ENV MICROBIOL REP, V5, P765, DOI 10.1111/1758-2229.12079; Le Huerou-Luron I, 2010, NUTR RES REV, V23, P23, DOI 10.1017/S0954422410000065; Mai V, 2009, NUTR J, P84; Matijasic BB, 2014, EUR J NUTR, V53, P1051, DOI 10.1007/s00394-013-0607-6; Maukonen J, 2006, FEMS MICROBIOL ECOL, V58, P517, DOI 10.1111/j.1574-6941.2006.00179.x; McEvoy CT, 2012, PUBLIC HEALTH NUTR, V15, P2287, DOI 10.1017/S1368980012000936; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Putignani L, 2013, FRONTIERS MEDIA SA, DOI [10.3389/fcimb.2012.00144, DOI 10.3389/FCIMB.2012.00144]; Ruengsomwong S, 2014, J MICROBIOL BIOTECHN, V24, P1026, DOI 10.4014/jmb.1310.10043; Scott KP, 2013, PHARMACOL RES, V69, P52, DOI 10.1016/j.phrs.2012.10.020; Soare A, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-39; Tannock GW, 2004, APPL ENVIRON MICROB, V70, P2129, DOI 10.1128/AEM.70.4.2129-2136.2004; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Tyakht AV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3469; Vauterin L., 1992, EUROPEAN MICROBIOLOG, V1, P37; Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x; Wu GD, 2013, CLIN GASTROENTEROL H, V11, P774, DOI 10.1016/j.cgh.2013.03.038; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu GD, 2014, GUT, P1, DOI [10.1136/gutjnl-2014-307480, DOI 10.1136/GUTJNL-2014-307480]; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zimmer J, 2012, EUR J CLIN NUTR, V66, P53, DOI 10.1038/ejcn.2011.141	40	52	53	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128669	10.1371/journal.pone.0128669	http://dx.doi.org/10.1371/journal.pone.0128669			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035837	Green Published, gold, Green Submitted			2022-12-27	WOS:000355699100042
J	McCamy, MB; Otero-Millan, J; Leigh, RJ; King, SA; Schneider, RM; Macknik, SL; Martinez-Conde, S				McCamy, Michael B.; Otero-Millan, Jorge; Leigh, R. John; King, Susan A.; Schneider, Rosalyn M.; Macknik, Stephen L.; Martinez-Conde, Susana			Simultaneous Recordings of Human Microsaccades and Drifts with a Contemporary Video Eye Tracker and the Search Coil Technique	PLOS ONE			English	Article							SACCADIC INTRUSIONS; MOVEMENTS; FIXATION; OCULOGRAPHY; ATTENTION; MOTION; DYNAMICS; VISION; SYSTEM; PUPIL	Human eyes move continuously, even during visual fixation. These "fixational eye movements" (FEMs) include microsaccades, intersaccadic drift and oculomotor tremor. Research in human FEMs has grown considerably in the last decade, facilitated by the manufacture of noninvasive, high-resolution/speed video-oculography eye trackers. Due to the small magnitude of FEMs, obtaining reliable data can be challenging, however, and depends critically on the sensitivity and precision of the eye tracking system. Yet, no study has conducted an in-depth comparison of human FEM recordings obtained with the search coil (considered the gold standard for measuring microsaccades and drift) and with contemporary, state-of-the art video trackers. Here we measured human microsaccades and drift simultaneously with the search coil and a popular state-of-the-art video tracker. We found that 95% of microsaccades detected with the search coil were also detected with the video tracker, and 95% of microsaccades detected with video tracking were also detected with the search coil, indicating substantial agreement between the two systems. Peak/mean velocities and main sequence slopes of microsaccades detected with video tracking were significantly higher than those of the same microsaccades detected with the search coil, however. Ocular drift was significantly correlated between the two systems, but drift speeds were higher with video tracking than with the search coil. Overall, our combined results suggest that contemporary video tracking now approaches the search coil for measuring FEMs.	[McCamy, Michael B.; Otero-Millan, Jorge; Macknik, Stephen L.; Martinez-Conde, Susana] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Otero-Millan, Jorge] Univ Vigo, Dept Signal Theory & Commun, Vigo 36310, Spain; [Otero-Millan, Jorge] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Leigh, R. John; King, Susan A.; Schneider, Rosalyn M.] Case Western Reserve Univ, Vet Affairs Med Ctr, Cleveland, OH 44106 USA; [Macknik, Stephen L.; Martinez-Conde, Susana] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA	Barrow Neurological Institute; Universidade de Vigo; Johns Hopkins University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	McCamy, MB (corresponding author), Barrow Neurol Inst, Phoenix, AZ 85013 USA.	mike.mccamy@gmail.com; smart@neuralcorrelate.com	Otero-Millan, Jorge/A-4193-2014; Macknik, Stephen L./H-7704-2019	Otero-Millan, Jorge/0000-0002-9789-8392; Macknik, Stephen L./0000-0002-3143-9230	Research to Prevent Blindness Inc.; National Science Foundation [0852636, 1153786]; Empire Innovation Program; Department of Veterans Affairs and National Institutes of Health [R01 EY06717]; Barrow Neurological Foundation; NATIONAL EYE INSTITUTE [R01EY006717] Funding Source: NIH RePORTER	Research to Prevent Blindness Inc.(Research to Prevent Blindness (RPB)); National Science Foundation(National Science Foundation (NSF)); Empire Innovation Program; Department of Veterans Affairs and National Institutes of Health(US Department of Veterans Affairs); Barrow Neurological Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by a challenge grant from Research to Prevent Blindness Inc. to the Department of Ophthalmology at SUNY Downstate, the Barrow Neurological Foundation (Awards to SMC and SLM), the National Science Foundation (Awards 0852636 and 1153786 to SMC), the Empire Innovation Program (Awards to SMC and SLM), and the Department of Veterans Affairs and National Institutes of Health (Grant R01 EY06717 to RJL).	ALBANO JE, 1995, VISION RES, V35, P3439, DOI 10.1016/0042-6989(95)00079-T; [Anonymous], 2008, EYEL MAN 1 4 0; Boraston Z, 2007, J PHYSIOL-LONDON, V581, P893, DOI 10.1113/jphysiol.2007.133587; Carpenter R.H.S., 1977, MOVEMENTS EYES; Cherici C, 2012, J VISION, V12, DOI 10.1167/12.6.31; COLLEWIJN H, 1975, VISION RES, V15, P447, DOI 10.1016/0042-6989(75)90098-X; Collewijn H, 2008, J VISION, V8, DOI 10.1167/8.14.20; Di Stasi LL, 2013, EUR J NEUROSCI, V38, P2389, DOI 10.1111/ejn.12248; Di Stasi LL, 2012, TRANSPORT RES C-EMER, V21, P122, DOI 10.1016/j.trc.2011.07.002; DISCENNA AO, 1995, J NEUROSCI METH, V58, P89, DOI 10.1016/0165-0270(94)00162-A; Drewes J., 2012, P S EYE TRACKING RES, P209, DOI [DOI 10.1145/2168556.2168596, 10.1145/2168556.2168596]; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engbert R, 2006, P NATL ACAD SCI USA, V103, P7192, DOI 10.1073/pnas.0509557103; Engbert R, 2006, PROG BRAIN RES, V154, P177, DOI 10.1016/S0079-6123(06)54009-9; Fahey MC, 2008, BRAIN, V131, P1035, DOI 10.1093/brain/awm323; Fender DH, 1956, THE FUNCTION OF EYE; Frens MA, 2002, J NEUROPHYSIOL, V88, P692, DOI 10.1152/jn.00457.2001; Gold JM, 2007, SCHIZOPHR RES, V94, P148, DOI 10.1016/j.schres.2007.04.023; Haslwanter T., 2010, HDB CLIN NEUROPHYSIO, VVol. 9, P61; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Hopp J, 2004, PROG NEUROBIOL, V72, P27, DOI 10.1016/j.pneurobio.2003.12.002; Houben MMJ, 2006, INVEST OPHTH VIS SCI, V47, P179, DOI 10.1167/iovs.05-0234; Imai T, 2005, AURIS NASUS LARYNX, V32, P3, DOI 10.1016/j.anl.2004.11.009; Inhoff AW, 1997, CURR DIR PSYCHOL SCI, V6, P153, DOI 10.1111/1467-8721.ep10772929; KAPOULA ZA, 1986, EXP BRAIN RES, V61, P386; Kimmel DL, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00049; Kirkby JA, 2013, BEHAV RES METHODS, V45, P664, DOI 10.3758/s13428-012-0301-2; KRAUSKOPF J, 1960, J OPT SOC AM, V50, P572, DOI 10.1364/JOSA.50.000572; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; Land MF, 2009, VISUAL NEUROSCI, V26, P51, DOI 10.1017/S0952523808080899; Laubrock J, 2005, VISION RES, V45, P721, DOI 10.1016/j.visres.2004.09.029; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Martinez-Conde S, 2006, NEURON, V49, P297, DOI 10.1016/j.neuron.2005.11.033; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Martinez-Conde S, 2006, PROG BRAIN RES, V154, P151; Martinez-Conde S, 2013, NAT REV NEUROSCI, V14, P83, DOI 10.1038/nrn3405; Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006; McCamy MB, 2014, J NEUROSCI, V34, P2956, DOI 10.1523/JNEUROSCI.4448-13.2014; McCamy MB, 2014, NEW VISUAL NEUROSCIENCES, P849; McCamy MB, 2013, PEERJ, V1, DOI 10.7717/peerj.9; McCamy MB, 2013, PEERJ, V1, DOI 10.7717/peerj.14; Mergenthaler K, 2010, EXP BRAIN RES, V203, P753, DOI 10.1007/s00221-010-2272-9; Moller F, 2002, GRAEF ARCH CLIN EXP, V240, P765, DOI 10.1007/s00417-002-0519-2; Nystrom M, 2013, VISION RES, V92, P59, DOI 10.1016/j.visres.2013.09.009; OPTICAN LM, 1980, J NEUROPHYSIOL, V44, P1058, DOI 10.1152/jn.1980.44.6.1058; Otero-Millan J, 2011, J NEUROSCI, V31, P4379, DOI 10.1523/JNEUROSCI.2600-10.2011; Pinnock RA, 2010, J NEUROL, V257, P533, DOI 10.1007/s00415-009-5356-3; RATLIFF F, 1950, J EXP PSYCHOL, V40, P687, DOI 10.1037/h0057754; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Rolfs M, 2006, EXP BRAIN RES, V169, P369, DOI 10.1007/s00221-005-0148-1; Rolfs M, 2009, VISION RES, V49, P2415, DOI 10.1016/j.visres.2009.08.010; Schmitt Kai-Uwe, 2007, J Clin Monit Comput, V21, P49, DOI 10.1007/s10877-006-9057-5; Serra A, 2008, NEUROLOGY, V70, P810, DOI 10.1212/01.wnl.0000286952.01476.eb; Smeets JBJ, 2003, J NEUROPHYSIOL, V90, P12, DOI 10.1152/jn.01075.2002; SNOW R, 1985, INVEST OPHTH VIS SCI, V26, P924; STEINMAN RM, 1973, SCIENCE, V181, P810, DOI 10.1126/science.181.4102.810; Tatler BW, 2011, J VISION, V11, DOI 10.1167/11.5.5; Traisk F, 2005, GRAEF ARCH CLIN EXP, V243, P791, DOI 10.1007/s00417-005-1148-3; Troncoso XG, 2008, P NATL ACAD SCI USA, V105, P16033, DOI 10.1073/pnas.0709389105; TSOTSOS JK, 1995, ARTIF INTELL, V78, P507, DOI 10.1016/0004-3702(95)00025-9; Underwood G, 2009, VIS COGN, V17, P812, DOI 10.1080/13506280902771278; van der Geest JN, 2002, J NEUROSCI METH, V114, P185, DOI 10.1016/S0165-0270(01)00527-1; Wyatt HJ, 2010, VISION RES, V50, P1982, DOI 10.1016/j.visres.2010.07.008; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	65	36	36	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128428	10.1371/journal.pone.0128428	http://dx.doi.org/10.1371/journal.pone.0128428			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035820	Green Published, gold, Green Submitted			2022-12-27	WOS:000355699100033
J	Jafarian, A; Taghikani, M; Abroun, S; Allahverdi, A; Lamei, M; Lakpour, N; Soleimani, M				Jafarian, Arefeh; Taghikani, Mohammad; Abroun, Saeid; Allahverdi, Amir; Lamei, Maryam; Lakpour, Niknam; Soleimani, Masoud			The Generation of Insulin Producing Cells from Human Mesenchymal Stem Cells by MiR-375 and Anti-MiR-9	PLOS ONE			English	Article							CHONDROGENIC DIFFERENTIATION; BONE-MARROW; MICRORNA; EXPRESSION; TRANSPLANTATION; IDENTIFICATION; PROLIFERATION; BIOGENESIS; MECHANISMS; PLAYERS	Background MicroRNAs (miRNAs) are a group of endogenous small non-coding RNAs that regulate gene expression at the post-transcriptional level. A number of studies have led to the notion that some miRNAs have key roles in control of pancreatic islet development and insulin secretion. Based on some studies on miRNAs pattern, the researchers in this paper investigated the pancreatic differentiation of human bone marrow mesenchymal stem cells (hBM-MSCs) by up-regulation of miR-375 and down-regulation of miR-9 by lentiviruses containing miR-375 and anti-miR-9. Methodology After 21 days of induction, islet-like clusters containing insulin producing cells (IPCs) were confirmed by dithizone (DTZ) staining. The IPCs and beta cell specific related genes and proteins were detected using qRT-PCR and immunofluorescence on days 7, 14 and 21 of differentiation. Glucose challenge test was performed at different concentrations of glucose so extracellular and intracellular insulin and C-peptide were assayed using ELISA kit. Although derived IPCs by miR-375 alone were capable to express insulin and other endocrine specific transcription factors, the cells lacked the machinery to respond to glucose. Conclusion It was found that over-expression of miR-375 led to a reduction in levels of Mtpn protein in derived IPCs, while treatment with anti-miR-9 following miR-375 over-expression had synergistic effects on MSCs differentiation and insulin secretion in a glucose-regulated manner. The researchers reported that silencing of miR-9 increased OC-2 protein in IPCs that may contribute to the observed glucose-regulated insulin secretion. Although the roles of miR-375 and miR-9 are well known in pancreatic development and insulin secretion, the use of these miRNAs in transdifferentiation was never demonstrated. These findings highlight miRNAs functions in stem cells differentiation and suggest that they could be used as therapeutic tools for gene-based therapy in diabetes mellitus.	[Jafarian, Arefeh; Taghikani, Mohammad] Tarbiat Modares Univ, Dept Clin Biochem, Fac Med Sci, Tehran, Iran; [Abroun, Saeid; Allahverdi, Amir; Lamei, Maryam; Soleimani, Masoud] Tarbiat Modares Univ, Dept Hematol, Fac Med Sci, Tehran, Iran; [Lakpour, Niknam] Avicenna Res Inst, Nanobiotechnol Res Ctr, ACECR, Tehran, Iran	Tarbiat Modares University; Tarbiat Modares University; Academic Center for Education, Culture & Research (ACECR)	Soleimani, M (corresponding author), Tarbiat Modares Univ, Dept Hematol, Fac Med Sci, Tehran, Iran.	soleim_m@modares.ac.ir	ABROUN, SAEID/GPF-5006-2022	Jafarian, Arefeh/0000-0003-0576-087X	INSF: Iranian National Science Foundation [90006892]	INSF: Iranian National Science Foundation(Iran National Science Foundation (INSF))	The authors would like to thank the INSF: Iranian National Science Foundation for supporting of this project under contract No: 90006892.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bobis S, 2006, FOLIA HISTOCHEM CYTO, V44, P215; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen LB, 2004, WORLD J GASTROENTERO, V10, P3016; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Kantharidis P, 2011, DIABETES, V60, P1832, DOI 10.2337/db11-0082; Kato T, 2006, CELL METAB, V4, P143, DOI 10.1016/j.cmet.2006.06.009; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Krampera M, 2006, BONE, V39, P678, DOI 10.1016/j.bone.2006.04.020; Li M, 2005, DEV CELL, V9, P415, DOI 10.1016/j.devcel.2005.08.002; Li Y, 2010, INT J CLIN EXP PATHO, V3, P254; Li YH, 2007, J CELL PHYSIOL, V211, P36, DOI 10.1002/jcp.20897; Lovis P, 2008, DIABETES, V57, P2728, DOI 10.2337/db07-1252; Marappagounder D, 2013, CELL MOL BIOL LETT, V18, P75, DOI 10.2478/s11658-012-0040-5; Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Pandey AK, 2009, CELL PHYSIOL BIOCHEM, V23, P221, DOI 10.1159/000218169; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Plaisance V, 2006, J BIOL CHEM, V281, P26932, DOI 10.1074/jbc.M601225200; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; Shantikumar S, 2012, CARDIOVASC RES, V93, P583, DOI 10.1093/cvr/cvr300; Shim JH, 2007, DIABETOLOGIA, V50, P1228, DOI 10.1007/s00125-007-0634-z; Shiroi A, 2002, STEM CELLS, V20, P284, DOI 10.1634/stemcells.20-4-284; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Tan Z, 2007, AM J HUM GENET, V81, P829, DOI 10.1086/521200; Tang XQ, 2008, BBA-GENE REGUL MECH, V1779, P697, DOI 10.1016/j.bbagrm.2008.06.010; Zhang BH, 2008, J CELL MOL MED, V12, P3, DOI 10.1111/j.1582-4934.2007.00196.x; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	45	48	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128650	10.1371/journal.pone.0128650	http://dx.doi.org/10.1371/journal.pone.0128650			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047014	gold, Green Published, Green Submitted			2022-12-27	WOS:000355652200088
J	Pereira-Neves, A; Gonzaga, L; Menna-Barreto, RFS; Benchimol, M				Pereira-Neves, Antonio; Gonzaga, Luiz; Menna-Barreto, Rubem F. S.; Benchimol, Marlene			Characterisation of 20S Proteasome in Tritrichomonas foetus and Its Role during the Cell Cycle and Transformation into Endoflagellar Form	PLOS ONE			English	Article							TRICHOMONAS-VAGINALIS; GENE FAMILY; INTRACELLULAR-LOCALIZATION; ENTAMOEBA-HISTOLYTICA; S PROTEASOME; INHIBITORS; SUBUNIT; GROWTH; IDENTIFICATION; EXPRESSION	Proteasomes are intracellular complexes that control selective protein degradation in organisms ranging from Archaea to higher eukaryotes. These structures have multiple proteolytic activities that are required for cell differentiation, replication and maintaining cellular homeostasis. Here, we document the presence of the 20S proteasome in the protist parasite Tritrichomonas foetus. Complementary techniques, such as a combination of whole genome sequencing technologies, bioinformatics algorithms, cell fractionation and biochemistry and microscopy approaches were used to characterise the 20S proteasome of T. foetus. The 14 homologues of the typical eukaryotic proteasome subunits were identified in the T. foetus genome. Alignment analyses showed that the main regulatory and catalytic domains of the proteasome were conserved in the predicted amino acid sequences from T. foetus-proteasome subunits. Immunofluorescence assays using an anti-proteasome antibody revealed a labelling distributed throughout the cytosol as punctate cytoplasmic structures and in the perinuclear region. Electron microscopy of a T. foetus-proteasome-enriched fraction confirmed the presence of particles that resembled the typical eukaryotic 20S proteasome. Fluorogenic assays using specific peptidyl substrates detected presence of the three typical peptidase activities of eukaryotic proteasomes in T. foetus. As expected, these peptidase activities were inhibited by lactacystin, a well-known specific proteasome inhibitor, and were not affected by inhibitors of serine or cysteine proteases. During the transformation of T. foetus to endoflagellar form (EFF), also known as pseudocyst, we observed correlations between the EFF formation rates, increases in the proteasome activities and reduced levels of ubiquitin-protein conjugates. The growth, cell cycle and EFF transformation of T. foetus were inhibited after treatment with lactacystin in a dose-dependent manner. Lactacystin treatment also resulted in an accumulation of ubiquitinated proteins and caused increase in the amount of endoplasmic reticulum membranes in the parasite. Taken together, our results suggest that the ubiquitin-proteasome pathway is required for cell cycle and EFF transformation in T. foetus.	[Pereira-Neves, Antonio] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Posgrad Ciencias Morfol, Rio De Janeiro, RJ, Brazil; [Pereira-Neves, Antonio; Benchimol, Marlene] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, RJ, Brazil; [Pereira-Neves, Antonio] Fiocruz MS, Ctr Pesquisa Aggeu Magalhaes, Dept Microbiol, Lab Microbiol & Biol Celular, Recife, PE, Brazil; [Gonzaga, Luiz] MCT, LNCC, Petropolis, RJ, Brazil; [Menna-Barreto, Rubem F. S.] Fiocruz MS, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil; [Benchimol, Marlene] UNIGRANRIO, Univ Grande Rio, Duque De Caxias, RJ, Brazil; [Benchimol, Marlene] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Laboratorio Nacional de Computacao Cientifica (LNCC); Fundacao Oswaldo Cruz; Universidade do Grande Rio; Universidade Federal do Rio de Janeiro	Benchimol, M (corresponding author), Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, RJ, Brazil.	marlenebenchimol@gmail.com	Pereira-Neves, Antonio/B-8989-2015; Menna-Barreto, Rubem/O-7325-2019; Almeida, Luiz GP/G-5829-2012	Menna-Barreto, Rubem/0000-0002-1352-0641; Almeida, Luiz GP/0000-0002-7124-2715; Pereira-Neves, Antonio/0000-0001-6629-568X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Programa de Nucleos de Excelencia (PRONEX); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Associacao Universitaria Santa Ursula (AUSU)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa de Nucleos de Excelencia (PRONEX)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Associacao Universitaria Santa Ursula (AUSU)	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Programa de Nucleos de Excelencia (PRONEX), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Associacao Universitaria Santa Ursula (AUSU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramova EB, 2004, BIOL BULL+, V31, P115, DOI 10.1023/B:BIBU.0000022464.37305.b4; Agrawal S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003426; Angeloni F, 2011, MOL ECOL RESOUR, V11, P662, DOI 10.1111/j.1755-0998.2011.02990.x; Balasubramanian S, 2012, J BIOL CHEM, V287, P36179, DOI 10.1074/jbc.M112.359281; Bartholomeu DC, 2001, MOL GENET GENOMICS, V265, P986, DOI 10.1007/s004380100493; Belote JM, 2009, HEREDITY, V103, P23, DOI 10.1038/hdy.2009.23; Benchimol M, 2004, MICROSC MICROANAL, V10, P528, DOI 10.1017/S1431927604040905; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bouzat JL, 2000, J MOL EVOL, V51, P532, DOI 10.1007/s002390010117; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Cardoso J, 2008, PARASITOL RES, V103, P941, DOI 10.1007/s00436-008-1081-6; Cardoso J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021027; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; CHEN P, 1995, EMBO J, V14, P2620, DOI 10.1002/j.1460-2075.1995.tb07260.x; Chung DWD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043477; Dahan J, 2001, J EXP BOT, V52, P1947, DOI 10.1093/jexbot/52.362.1947; de Diego JL, 2001, BIOCHEMISTRY-US, V40, P1053, DOI 10.1021/bi001659k; De Jesus JB, 2007, PROTEOMICS, V7, P1961, DOI 10.1002/pmic.200600797; DIAMOND LS, 1957, J PARASITOL, V43, P488, DOI 10.2307/3274682; Emmerlich V, 1999, MOL BIOCHEM PARASIT, V100, P131, DOI 10.1016/S0166-6851(99)00022-5; Fabre B, 2013, MOL CELL PROTEOMICS, V12, P687, DOI 10.1074/mcp.M112.023317; Fang CH, 2000, CLIN SCI, V99, P181, DOI 10.1042/CS20000032; Fang YK, 2014, J MICROBIOL IMMUNOL; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Fornai F, 2003, J NEUROSCI, V23, P8955; Fu HY, 1998, GENETICS, V149, P677; Gantt SM, 1998, ANTIMICROB AGENTS CH, V42, P2731, DOI 10.1128/AAC.42.10.2731; Gille C, 2003, J MOL BIOL, V326, P1437, DOI 10.1016/S0022-2836(02)01470-5; Glenn RJ, 2004, INT J ANTIMICROB AG, V24, P286, DOI 10.1016/j.ijantimicag.2004.02.023; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Gonzalez J, 1996, J EXP MED, V184, P1909, DOI 10.1084/jem.184.5.1909; Gonzalez J, 1999, EUR J BIOCHEM, V264, P897, DOI 10.1046/j.1432-1327.1999.00682.x; Groll M, 2004, BBA-MOL CELL RES, V1695, P33, DOI 10.1016/j.bbamcr.2004.09.025; Heinemeyer W, 1997, J BIOL CHEM, V272, P25200, DOI 10.1074/jbc.272.40.25200; Hua SB, 1996, MOL BIOCHEM PARASIT, V78, P33, DOI 10.1016/S0166-6851(96)02599-6; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Kreidenweiss A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-187; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lamarre SG, 2009, J EXP BIOL, V212, P1294, DOI 10.1242/jeb.028290; Lilburn TG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S5-S9; Torres-Machorro AL, 2009, CURR GENET, V55, P199, DOI 10.1007/s00294-009-0237-y; Lin WC, 2009, GENOMICS, V93, P487, DOI 10.1016/j.ygeno.2009.01.004; Makioka A, 2002, PARASITOL RES, V88, P454, DOI 10.1007/s00436-002-0601-z; Malik SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002879; Manning K, 2010, TOP COMPANION ANIM M, V25, P145, DOI 10.1053/j.tcam.2010.08.001; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Munoz C, 2012, INT J PARASITOL, V42, P715, DOI 10.1016/j.ijpara.2012.03.012; Nederlof PM, 1995, P NATL ACAD SCI USA, V92, P12060, DOI 10.1073/pnas.92.26.12060; Nino CA, 2013, MICROBIOLOGYOPEN, V2, P525, DOI 10.1002/mbo3.88; Noel CJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-99; Paugam A, 2003, TRENDS PARASITOL, V19, P55, DOI 10.1016/S1471-4922(02)00064-8; Paugam A, 2001, PARASITE, V8, P267, DOI 10.1051/parasite/2001084267; Pereira-Neves A, 2012, PROTIST, V163, P529, DOI 10.1016/j.protis.2011.11.005; Pereira-Neves A, 2011, VET PARASITOL, V175, P1, DOI 10.1016/j.vetpar.2010.10.007; Pereira-Neves A, 2009, PROTIST, V160, P536, DOI 10.1016/j.protis.2009.05.001; Perepechaeva ML, 2006, B EXP BIOL MED+, V142, P182, DOI 10.1007/s10517-006-0322-x; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Robertson CD, 1999, MOL BIOCHEM PARASIT, V103, P49, DOI 10.1016/S0166-6851(99)00110-3; Sanchez R, 2002, EXP PARASITOL, V102, P187, DOI 10.1016/S0014-4894(03)00055-9; Selman C, 2002, FREE RADICAL BIO MED, V33, P259, DOI 10.1016/S0891-5849(02)00874-2; Shaw MK, 2000, PARASITOLOGY, V121, P35, DOI 10.1017/S0031182099006071; Silva-Jardim I, 2004, ACTA TROP, V91, P121, DOI 10.1016/j.actatropica.2004.03.007; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Steverding D, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-29; TAMURA T, 1995, CURR BIOL, V5, P766, DOI 10.1016/S0960-9822(95)00153-9; Tanaka K, 2012, BIOL CHEM, V393, P217, DOI 10.1515/hsz-2011-0285; To WY, 1997, FEBS LETT, V404, P253, DOI 10.1016/S0014-5793(97)00116-6; Wang CC, 2003, J BIOL CHEM, V278, P15800, DOI 10.1074/jbc.M300195200; Wenger Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-204; Wojcik C, 2003, INT J BIOCHEM CELL B, V35, P579, DOI 10.1016/S1357-2725(02)00380-1; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Yao CQ, 2013, J MED MICROBIOL, V62, P1, DOI 10.1099/jmm.0.047365-0; Zubacova Z, 2008, MOL BIOCHEM PARASIT, V161, P49, DOI 10.1016/j.molbiopara.2008.06.004	74	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129165	10.1371/journal.pone.0129165	http://dx.doi.org/10.1371/journal.pone.0129165			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047503	gold, Green Submitted, Green Published			2022-12-27	WOS:000355652200132
J	Wang, G; Yu, Y; Tu, YB; Tong, J; Liu, YG; Zhang, C; Chang, YF; Wang, SJ; Jiang, CG; Zhou, EM; Cai, XH				Wang, Gang; Yu, Ying; Tu, Yabin; Tong, Jie; Liu, Yonggang; Zhang, Chong; Chang, Yafei; Wang, Shujie; Jiang, Chenggang; Zhou, En-Min; Cai, Xuehui			Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus Infection Induced Apoptosis and Autophagy in Thymi of Infected Piglets	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; MOLECULAR DISSECTION; REPLICATION; CHINA; NIDOVIRALES; THERAPIES; EMERGENCE; CYTOKINES; PROTEIN; ROLES	Previously, we demonstrated that the highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) HuN4 strain causes obvious thymic atrophy and thymocytes apoptosis in infected piglets after birth, which is more severe than that induced by classical PRRSV. In this study, we investigated apoptosis and autophagy in the thymus of piglets infected with the HP-PRRSV HuN4 strain, and found that both apoptosis and autophagy occurred in the thymus of piglets infected with HP-PRRSV. In addition to a few virus-infected cells, CD14(+) cells, the main autophagic cells in the thymus were thymic epithelial cells. These findings demonstrated that HP-PRRSV induces apoptosis in bystander cells, and induces autophagy in both infected and bystander cells in the thymus of infected piglets. Herein, we first present new data on the thymic lesions induced by HP-PRRSV, and show that apoptosis and autophagy are key mechanisms involved in cell survival and determinants of the severity of thymic atrophy in infected piglets. Finally, future studies of the mechanism underlying immune responses are proposed based on our current understanding of PRRSV-host interactions.	[Wang, Gang; Yu, Ying; Tu, Yabin; Tong, Jie; Liu, Yonggang; Zhang, Chong; Chang, Yafei; Wang, Shujie; Jiang, Chenggang; Cai, Xuehui] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China; [Yu, Ying; Zhou, En-Min] Northwest A&F Univ, Coll Vet Med, Dept Vet Prevent Med, Yangling 712100, Shaanxi, Peoples R China; [Zhang, Chong] Jilin Agr Univ, Changchun 130118, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Northwest A&F University - China; Jilin Agricultural University	Zhou, EM (corresponding author), Northwest A&F Univ, Coll Vet Med, Dept Vet Prevent Med, Yangling 712100, Shaanxi, Peoples R China.	zhouem@nwsuaf.edu.cn; cai139@hvri.ac.cn			National Science Foundation for Young Scholars of China [31201885]; State Key Laboratory of Veterinary Biotechnology, China [SKLVBF201301, SKLVBF201410]; National High Technology Research and Development Program of China [2011AA10A213]	National Science Foundation for Young Scholars of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Veterinary Biotechnology, China; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by grants from the National Science Foundation for Young Scholars of China [grant number 31201885], the State Key Laboratory of Veterinary Biotechnology, China [grant numbers SKLVBF201301, SKLVBF201410] and the National High Technology Research and Development Program of China [grant number 2011AA10A213].	Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Cavanagh D, 1997, ARCH VIROL, V142, P629; Chang HC, 2008, VET MICROBIOL, V129, P281, DOI 10.1016/j.vetmic.2007.12.002; Chen QG, 2012, VIRUS RES, V163, P650, DOI 10.1016/j.virusres.2011.11.008; COLLINS M, 1995, AM J RESP CRIT CARE, V152, pS20, DOI 10.1164/ajrccm/152.4_Pt_2.S20; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Fernandez A, 2002, VIRUS RES, V83, P103, DOI 10.1016/S0168-1702(01)00426-9; Guo BQ, 2013, VIROLOGY, V435, P372, DOI 10.1016/j.virol.2012.09.013; Han Z, 2013, TRANSBOUND EMERG DIS; He YL, 2012, VET MICROBIOL, V160, P455, DOI 10.1016/j.vetmic.2012.05.040; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Labarque G, 2003, VET RES, V34, P249, DOI 10.1051/vetres:2003001; Li YF, 2007, VET J, V174, P577, DOI 10.1016/j.tvjl.2007.07.032; Li YM, 2014, VIRUS RES, V189, P29, DOI 10.1016/j.virusres.2014.04.011; Liu QH, 2012, VIROLOGY, V429, P136, DOI 10.1016/j.virol.2012.03.022; Liu YG, 2010, CLIN VACCINE IMMUNOL, V17, P1439, DOI 10.1128/CVI.00517-09; Lockshin RA, 2001, NAT REV MOL CELL BIO, V2, P545, DOI 10.1038/35080097; Longo L, 2008, MOL CANCER THER, V7, P2476, DOI 10.1158/1535-7163.MCT-08-0361; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Miller LC, 2004, ARCH VIROL, V149, P2453, DOI 10.1007/s00705-004-0377-9; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Oleksiewicz MB, 1999, VET MICROBIOL, V66, P15, DOI 10.1016/S0378-1135(98)00309-5; Patel D, 2009, ANTIVIR THER, V14, P899, DOI 10.3851/IMP1409; Pearse G, 2006, TOXICOL PATHOL, V34, P504, DOI 10.1080/01926230600865549; Reed JC, 2002, NAT REV DRUG DISCOV, V1, P111, DOI 10.1038/nrd726; Reed JC, 2005, BLOOD, V106, P408, DOI 10.1182/blood-2004-07-2761; Rossman JS, 2009, CELL HOST MICROBE, V6, P299, DOI 10.1016/j.chom.2009.09.009; Sedger LM, 2002, J IMMUNOL, V169, P6193, DOI 10.4049/jimmunol.169.11.6193; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sun MX, 2012, AUTOPHAGY, V8, P1434, DOI 10.4161/auto.21159; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Tong GZ, 2007, EMERG INFECT DIS, V13, P1434, DOI 10.3201/eid1309.070399; Wang G, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-2; Wang G, 2011, VET IMMUNOL IMMUNOP, V142, P170, DOI 10.1016/j.vetimm.2011.05.004; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Xu GW, 2007, CELL RES, V17, P759, DOI 10.1038/cr.2007.52; Xu Y, 2006, J BIOL CHEM, V281, P19179, DOI 10.1074/jbc.M513377200; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853	42	31	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128292	10.1371/journal.pone.0128292	http://dx.doi.org/10.1371/journal.pone.0128292			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046751	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200056
J	Yao, XH; Tang, P; Li, ZZ; Li, DW; Liu, YF; Huang, HW				Yao, Xiaohong; Tang, Ping; Li, Zuozhou; Li, Dawei; Liu, Yifei; Huang, Hongwen			The First Complete Chloroplast Genome Sequences in Actinidiaceae: Genome Structure and Comparative Analysis	PLOS ONE			English	Article							TRANSFER-RNA GENES; COMPLETE NUCLEOTIDE-SEQUENCE; INDEPENDENT TRANSFERS; KIWIFRUIT ACTINIDIA; PLASTID GENOMES; DNA; ORGANIZATION; EVOLUTION; MULTIPLE; GENETICS	Actinidia chinensis is an important economic plant belonging to the basal lineage of the asterids. Availability of a complete Actinidia chloroplast genome sequence is crucial to understanding phylogenetic relationships among major lineages of angiosperms and facilitates kiwifruit genetic improvement. We report here the complete nucleotide sequences of the chloroplast genomes for Actinidia chinensis and A. chinensisvar deliciosa obtained through de novo assembly of Illumina paired-end reads produced by total DNA sequencing. The total genome size ranges from 155,446 to 157,557 bp, with an inverted repeat (IR) of 24,013 to 24,391 bp, a large single copy region (LSC) of 87,984 to 88,337 bp and a small single copy region (SSC) of 20,332 to 20,336 bp. The genome encodes 113 different genes, including 79 unique protein-coding genes, 30 tRNA genes and 4 ribosomal RNA genes, with 16 duplicated in the inverted repeats, and a tRNA gene (trnfM-CAU) duplicated once in the LSC region. Comparisons of IR boundaries among four asterid species showed that IR/LSC borders were extended into the 5'portion of the psbAgene and IR contraction occurred in Actinidia. The clap gene has been lost from the chloroplast genome in Actinidia, and may have been transferred to the nucleus during chloroplast evolution. Twenty-seven polymorphic simple sequence repeat (SSR) loci were identified in the Actinidia chloroplast genome. Maximum parsimony analyses of a 72-gene, 16 taxa angiosperm dataset strongly support the placement of Actinidiaceae in Ericales within the basal asterids.	[Yao, Xiaohong; Tang, Ping; Li, Zuozhou; Li, Dawei; Huang, Hongwen] Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan Bot Garden, Wuhan 430074, Hubei, Peoples R China; [Liu, Yifei; Huang, Hongwen] Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou 510650, Guangdong, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS	Huang, HW (corresponding author), Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan Bot Garden, Wuhan 430074, Hubei, Peoples R China.	huanghw@scbg.ac.cn		LI, Dawei/0000-0002-5138-4492	Natural Scientific Foundation of China [31370251]; Fund of Science and Technology Service, Chinese Academy of Sciences [KFJ-EW-STS-076]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Fund of Science and Technology Service, Chinese Academy of Sciences	This work was partly supported by the Natural Scientific Foundation of China (31370251) and Fund of Science and Technology Service, Chinese Academy of Sciences (KFJ-EW-STS-076).	Belrose Inc., 2013, WORLD KIW REV; Bremer B, 2002, MOL PHYLOGENET EVOL, V24, P274, DOI 10.1016/S1055-7903(02)00240-3; Chat J, 2004, AM J BOT, V91, P736, DOI 10.3732/ajb.91.5.736; Cusack BP, 2007, TRENDS GENET, V23, P270, DOI 10.1016/j.tig.2007.03.010; Daniell H, 2002, TRENDS PLANT SCI, V7, P84, DOI 10.1016/S1360-1385(01)02193-8; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fajardo D, 2013, TREE GENET GENOMES, V9, P489, DOI 10.1007/s11295-012-0573-9; Ferguson A. R., 2007, Horticultural Reviews, V33, P1, DOI 10.1002/9780470168011.ch1; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; GANTT JS, 1991, EMBO J, V10, P3073, DOI 10.1002/j.1460-2075.1991.tb07859.x; Haberle RC, 2008, J MOL EVOL, V66, P350, DOI 10.1007/s00239-008-9086-4; Huang HW, 2013, ACTINIDIA TAXONOMY R; HUDSON KR, 1988, CURR GENET, V13, P339, DOI 10.1007/BF00424429; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jansen RK, 2011, MOL BIOL EVOL, V28, P835, DOI 10.1093/molbev/msq261; Khakhlova O, 2006, PLANT J, V46, P85, DOI 10.1111/j.1365-313X.2006.02673.x; Kleine T, 2009, ANNU REV PLANT BIOL, V60, P115, DOI 10.1146/annurev.arplant.043008.092119; Ku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062548; Kurtz S., 2001, NUCLEIC ACIDS RES, V29, P4366; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lee HL, 2007, MOL BIOL EVOL, V24, P1161, DOI 10.1093/molbev/msm036; Li JQ, 2002, SYST BOT, V27, P408; Li JQ, 2007, FLORA CHINA, V12, P334, DOI DOI 10.3233/BME-141227; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Magee AM, 2010, GENOME RES, V20, P1700, DOI 10.1101/gr.111955.110; Maliga P, 2004, ANNU REV PLANT BIOL, V55, P289, DOI 10.1146/annurev.arplant.55.031903.141633; Millen RS, 2001, PLANT CELL, V13, P645, DOI 10.1105/tpc.13.3.645; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; POWELL W, 1995, P NATL ACAD SCI USA, V92, P7759, DOI 10.1073/pnas.92.17.7759; Raubeson L. A., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P45, DOI 10.1079/9780851999043.0045; Scortichini M, 2012, MOL PLANT PATHOL, V13, P631, DOI 10.1111/j.1364-3703.2012.00788.x; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Stegemann S, 2003, P NATL ACAD SCI USA, V100, P8828, DOI 10.1073/pnas.1430924100; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; TSUDZUKI J, 1994, CURR GENET, V26, P153, DOI 10.1007/BF00313804; Ueda M, 2007, GENE, V402, P51, DOI 10.1016/j.gene.2007.07.019; Vasil IK, 1991, CELL CULTURE SOMAT A, V7a, P5, DOI DOI 10.1016/B978-0-12-715007-9.50009-8; Wakasugi T, 1997, P NATL ACAD SCI USA, V94, P5967, DOI 10.1073/pnas.94.11.5967; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073053; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	45	102	107	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129347	10.1371/journal.pone.0129347	http://dx.doi.org/10.1371/journal.pone.0129347			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046631	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200155
J	Heine, A; Held, SAE; Daecke, SN; Riethausen, K; Kotthoff, P; Flores, C; Kurts, C; Brossart, P				Heine, Annkristin; Held, Stefanie Andrea Erika; Daecke, Solveig Nora; Riethausen, Kati; Kotthoff, Philipp; Flores, Chrystel; Kurts, Christian; Brossart, Peter			The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IMMUNITY; CYCLOPHOSPHAMIDE; CARCINOMA; RESPONSES; MELANOMA; SURVIVAL	Inhibitors of VEGF receptor (VEGFR) signaling such as sorafenib and sunitinib that are currently used in the treatment of malignant diseases have been shown to affect immunological responses by inhibition of the function of antigen presenting cells and T lymphocytes. The VEGFR-inhibitor axitinib has recently been approved for second line therapy of metastatic renal cell carcinoma. While there is some evidence that axitinib might interfere with the activation of T cells, not much is known about the effects of axitinib on dendritic cell (DC) phenotype and function. We here show that the addition of axitinib during the final Toll-like receptor-4-induced maturation step of monocyte-derived human DCs results in a reduced DC activation characterized by impaired expression of activation markers and co-stimulatory molecules such as CD80, CD83 and CD86. We further found a decreased secretion of interleukin-12 which was accompanied by reduced nuclear expression of the transcription factor cRel. In addition, we found a dose-dependent reduced activation of p38 and STAT3 in axitinib-exposed DCs, whereas the expression was not affected. The dysfunction of axitinib-exposed DCs was further underlined by their impaired induction of allogeneic T cell proliferation in a mixed lymphocyte reaction assay and inhibition of DC migration. Our results demonstrate that axitinib significantly affects DC differentiation and function primarily via the inhibition of the nuclear factor kappa B signaling pathway leading to impaired T cell activation. This will be of importance for the design of future vaccination protocols and therapeutic approaches aiming at combining different treatment strategies, eg such as programmed death-1 inhibitors with axitinib.	[Heine, Annkristin; Held, Stefanie Andrea Erika; Daecke, Solveig Nora; Riethausen, Kati; Kotthoff, Philipp; Brossart, Peter] Univ Hosp Bonn, Dept Oncol Hematol & Rheumatol, Bonn, Germany; [Flores, Chrystel; Kurts, Christian] Univ Bonn, Inst Expt Immunol, Bonn, Germany	University of Bonn; University of Bonn	Heine, A (corresponding author), Univ Hosp Bonn, Dept Oncol Hematol & Rheumatol, Bonn, Germany.	annkristin.heine@ukb.uni-bonn.de			BONFOR Forschungsforderung;  [SFB704]	BONFOR Forschungsforderung; 	This work was supported by a scholarship from the BONFOR Forschungsforderung and the SFB704. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bose A, 2012, MELANOMA RES, V22, P236, DOI 10.1097/CMR.0b013e3283538293; Chan VWF, 1999, BLOOD, V93, P3610, DOI 10.1182/blood.V93.11.3610.411a48_3610_3616; Doloff JC, 2012, CANCER RES, V72, P1103, DOI 10.1158/0008-5472.CAN-11-3380; Grunebach F, 2008, CANCER IMMUNOL IMMUN, V57, P1483, DOI 10.1007/s00262-008-0486-5; Grumont R, 2001, J EXP MED, V194, P1021, DOI 10.1084/jem.194.8.1021; Heine A, 2013, BLOOD, V122, P1192, DOI 10.1182/blood-2013-03-484642; Heine A, 2009, IMMUNOTHERAPY-UK, V1, P97, DOI 10.2217/1750743X.1.1.97; Held SAE, 2013, CANCER IMMUNOL IMMUN, V62, P715, DOI 10.1007/s00262-012-1373-7; Hipp MM, 2008, BLOOD, V111, P5610, DOI 10.1182/blood-2007-02-075945; Johnson B, 2009, CURR MOL MED, V9, P702, DOI 10.2174/156652409788970634; Kock G, 2011, BLOOD, V117, P3569, DOI 10.1182/blood-2010-08-302224; Kurts C, 2010, NAT REV IMMUNOL, V10, P403, DOI 10.1038/nri2780; Ohm JE, 2001, IMMUNOL RES, V23, P263, DOI 10.1385/IR:23:2-3:263; Ouaaz F, 2002, IMMUNITY, V16, P257, DOI 10.1016/S1074-7613(02)00272-8; Rittig SM, 2011, MOL THER, V19, P990, DOI 10.1038/mt.2010.289; Santoni M, 2014, INT J CANCER, V134, P2772, DOI 10.1002/ijc.28503; Stehle F, 2013, J BIOL CHEM, V288, P16334, DOI 10.1074/jbc.M112.437962; Walter S, 2012, NAT MED, V18, P1254, DOI 10.1038/nm.2883; Zhang XH, 2014, ANTI-CANCER DRUG, V25, P204, DOI 10.1097/CAD.0000000000000033	20	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128897	10.1371/journal.pone.0128897	http://dx.doi.org/10.1371/journal.pone.0128897			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042424	gold, Green Published, Green Submitted			2022-12-27	WOS:000355701600073
J	Erculj, F; Strumbelj, E				Erculj, Frane; Strumbelj, Erik			Basketball Shot Types and Shot Success in Different Levels of Competitive Basketball	PLOS ONE			English	Article							GAME-RELATED STATISTICS; PLAYERS	The purpose of our research was to investigate the relative frequencies of different types of basketball shots (above head, hook shot, layup, dunk, tip-in), some details about their technical execution (one-legged, two-legged, drive, cut, ...), and shot success in different levels of basketball competitions. We analysed video footage and categorized 5024 basketball shots from 40 basketball games and 5 different levels of competitive basketball (National Basketball Association (NBA), Euroleague, Slovenian 1st Division, and two Youth basketball competitions). Statistical analysis with hierarchical multinomial logistic regression models reveals that there are substantial differences between competitions. However, most differences decrease or disappear entirely after we adjust for differences in situations that arise in different competitions (shot location, player type, and attacks in transition). Differences after adjustment are mostly between the Senior and Youth competitions: more shots executed jumping or standing on one leg, more uncategorised shot types, and more dribbling or cutting to the basket in the Youth competitions, which can all be attributed to lesser technical and physical ability of developing basketball players. The two discernible differences within the Senior competitions are that, in the NBA, dunks are more frequent and hook shots are less frequent compared to European basketball, which can be attributed to better athleticism of NBA players. The effect situational variables have on shot types and shot success are found to be very similar for all competitions.	[Erculj, Frane] Univ Ljubljana, Fac Sport, Ljubljana 1000, Slovenia; [Strumbelj, Erik] Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana 1000, Slovenia	University of Ljubljana; University of Ljubljana	Strumbelj, E (corresponding author), Univ Ljubljana, Fac Comp & Informat Sci, Vecna Pot 113, Ljubljana 1000, Slovenia.	erik.strumbelj@fri.uni-lj.si						Bocskocsky A, 2014, HEAT CHECK NEW EVIDE; Csapo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114184; Csataljay G, 2012, J HUM SPORT EXERC, V7, P356, DOI 10.4100/jhse.2012.72.02; Csataljay Gabor, 2009, INT J PERFORM ANAL S, V9, P60, DOI DOI 10.1080/24748668.2009.11868464; Deman B., 2002, ACTA KINESIOLOGIAE U, V7, P71; Dezman B, 2001, COLLEGIUM ANTROPOL, V25, P141; Erculj F, 2009, KINESIOLOGY, V41, P203; Garcia-Rubio J, 2013, J HUM KINET, V36, P161, DOI 10.2478/hukin-2013-0016; Gelman A, 2014, STAT COMPUT, V24, P997, DOI 10.1007/s11222-013-9416-2; Gelman A, 2012, J RES EDUC EFF, V5, P189, DOI 10.1080/19345747.2011.618213; Hay JG, 1993, BIOMECHANICS SPORTS, V4th; Lorenzo A, 2010, J SPORT SCI MED, V9, P664; Miller S, 1996, J SPORT SCI, V14, P243, DOI 10.1080/02640419608727708; Miller S, 1994, J SPORTS SCI, V12, P181; Ortega E, 2006, INT J APPL SPORTS SC, V18, P1; Sampaio J, 2006, EUR J SPORT SCI, V6, P173, DOI 10.1080/17461390600676200; Stan Development Team, 2014, STAN C LIB PROB SAMP; Trninic S, 2002, COLLEGIUM ANTROPOL, V26, P521; Willer R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049807; Wissel H., 1994, BASKETBALL STEPS SUC	20	51	53	7	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128885	10.1371/journal.pone.0128885	http://dx.doi.org/10.1371/journal.pone.0128885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26038836	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700127
J	Lopez-Rosenfeld, M; Calero, CI; Slezak, DF; Garbulsky, G; Bergman, M; Trevisan, M; Sigman, M				Lopez-Rosenfeld, Matias; Calero, Cecilia I.; Fernandez Slezak, Diego; Garbulsky, Gerry; Bergman, Mariano; Trevisan, Marcos; Sigman, Mariano			Neglect in Human Communication: Quantifying the Cost of Cell-Phone Interruptions in Face to Face Dialogs	PLOS ONE			English	Article							HUMAN MOBILITY; PATTERNS; PREDICTABILITY; NETWORK	There is a prevailing belief that interruptions using cellular phones during face to face interactions may affect severely how people relate and perceive each other. We set out to determine this cost quantitatively through an experiment performed in dyads, in a large audience in a TEDx event. One of the two participants (the speaker) narrates a story vividly. The listener is asked to deliberately ignore the speaker during part of the story (for instance, attending to their cell-phone). The speaker is not aware of this treatment. We show that total amount of attention is the major factor driving subjective beliefs about the story and the conversational partner. The effects are mostly independent on how attention is distributed in time. All social parameters of human communication are affected by attention time with a sole exception: the perceived emotion of the story. Interruptions during day-to-day communication between peers are extremely frequent. Our data should provide a note of caution, by indicating that they have a major effect on the perception people have about what they say (whether it is interesting or not ... ) and about the virtues of the people around them.	[Lopez-Rosenfeld, Matias; Fernandez Slezak, Diego] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Computac, Lab Inteligencia Artificial Aplicada, RA-1428 Buenos Aires, DF, Argentina; [Lopez-Rosenfeld, Matias; Calero, Cecilia I.; Bergman, Mariano; Sigman, Mariano] Univ Torcuato Di Tella, Lab Neurociencia, Buenos Aires, DF, Argentina; [Garbulsky, Gerry] El Mundo de las Ideas, Buenos Aires, DF, Argentina; [Trevisan, Marcos] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, RA-1428 Buenos Aires, DF, Argentina	Universidad Torcuato Di Tella; University of Buenos Aires	Sigman, M (corresponding author), Univ Torcuato Di Tella, Lab Neurociencia, Av Figueroa Alcorta 7350,C1428BCW, Buenos Aires, DF, Argentina.	msigman@utdt.edu	Trevisan, Marcos/Y-7158-2019; Slezak, Diego Fernandez/AAD-9543-2019		University of Buenos Aires; CONICET (Argentina); ANPCyT (Argentina); James McDonnell Foundation 21st Century Science Initiative in Understanding Human Cognition; Microsoft Faculty Fellowship	University of Buenos Aires(University of Buenos Aires); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT (Argentina)(ANPCyT); James McDonnell Foundation 21st Century Science Initiative in Understanding Human Cognition; Microsoft Faculty Fellowship(Microsoft)	This research was supported by University of Buenos Aires, CONICET (Argentina) and ANPCyT (Argentina). MS is sponsored by James McDonnell Foundation 21st Century Science Initiative in Understanding Human Cognition. DFS is sponsored by Microsoft Faculty Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Candia J, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/22/224015; Csibra G, 2009, TRENDS COGN SCI, V13, P148, DOI 10.1016/j.tics.2009.01.005; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Festinger L., 1962, THEORY COGNITIVE DIS, V2; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Hyman IE, 2010, APPL COGNITIVE PSYCH, V24, P597, DOI 10.1002/acp.1638; Jiang ZQ, 2013, P NATL ACAD SCI USA, V110, P1600, DOI 10.1073/pnas.1220433110; KAHNEMAN D, 1993, PSYCHOL SCI, V4, P401, DOI 10.1111/j.1467-9280.1993.tb00589.x; Karsai M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040612; Kovanen L, 2013, P NATL ACAD SCI USA, V110, P18070, DOI 10.1073/pnas.1307941110; Kumpula JM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228701; Li MX, 2014, SCI REP-UK, V4, DOI 10.1038/srep05132; Lu X, 2012, P NATL ACAD SCI USA, V109, P11576, DOI 10.1073/pnas.1203882109; McCartt Anne T, 2006, Traffic Inj Prev, V7, P89, DOI 10.1080/15389580600651103; Morreale S. P., 2007, HUMAN COMMUNICATION, P159; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Onnela JP, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/179; Perry B, 2002, BRAIN MIND, V3, P79, DOI DOI 10.1023/A:1016557824657; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Strayer DL, 2003, J EXP PSYCHOL-APPL, V9, P23, DOI 10.1037/1076-898X.9.1.23; Wikipedia, LIST COUNTR NUMB MOB; Wu Y, 2010, P NATL ACAD SCI USA, V107, P18803, DOI 10.1073/pnas.1013140107; Zizzo DJ, 2010, EXP ECON, V13, P75, DOI 10.1007/s10683-009-9230-z	24	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0125772	10.1371/journal.pone.0125772	http://dx.doi.org/10.1371/journal.pone.0125772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7ST	26039326	Green Submitted, gold, Green Published			2022-12-27	WOS:000355700700012
J	Matthews, TD; Schmieder, R; Silva, GGZ; Busch, J; Cassman, N; Dutilh, BE; Green, D; Matlock, B; Heffernan, B; Olsen, GJ; Hanna, LF; Schifferli, DM; Maloy, S; Dinsdale, EA; Edwards, RA				Matthews, T. David; Schmieder, Robert; Silva, Genivaldo G. Z.; Busch, Julia; Cassman, Noriko; Dutilh, Bas E.; Green, Dawn; Matlock, Brian; Heffernan, Brian; Olsen, Gary J.; Hanna, Leigh Farris; Schifferli, Dieter M.; Maloy, Stanley; Dinsdale, Elizabeth A.; Edwards, Robert A.			Genomic Comparison of the Closely-Related Salmonella enterica Serovars Enteritidis, Dublin and Gallinarum	PLOS ONE			English	Article							ETHANOLAMINE UTILIZATION; BACTERIOPHAGE THERAPY; REPRODUCTIVE-TRACT; ELECTRON-ACCEPTOR; REDUCE SALMONELLA; PROVIDES INSIGHTS; ANAEROBIC GROWTH; GENE PREDICTION; TYPHIMURIUM; HOST	The Salmonella enterica serovars Enteritidis, Dublin, and Gallinarum are closely related but differ in virulence and host range. To identify the genetic elements responsible for these differences and to better understand how these serovars are evolving, we sequenced the genomes of Enteritidis strain LK5 and Dublin strain SARB12 and compared these genomes to the publicly available Enteritidis P125109, Dublin CT 02021853 and Dublin SD3246 genome sequences. We also compared the publicly available Gallinarum genome sequences from biotype Gallinarum 287/91 and Pullorum RKS5078. Using bioinformatic approaches, we identified single nucleotide polymorphisms, insertions, deletions, and differences in prophage and pseudogene content between strains belonging to the same serovar. Through our analysis we also identified several prophage cargo genes and pseudogenes that affect virulence and may contribute to a host-specific, systemic lifestyle. These results strongly argue that the Enteritidis, Dublin and Gallinarum serovars of Salmonella enterica evolve by acquiring new genes through horizontal gene transfer, followed by the formation of pseudogenes. The loss of genes necessary for a gastrointestinal lifestyle ultimately leads to a systemic lifestyle and niche exclusion in the host-specific serovars.	[Matthews, T. David; Busch, Julia; Cassman, Noriko; Maloy, Stanley; Dinsdale, Elizabeth A.; Edwards, Robert A.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Schmieder, Robert; Edwards, Robert A.] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA; [Silva, Genivaldo G. Z.] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA; [Dutilh, Bas E.] Univ Utrecht, Theoret Biol & Bioinformat, Utrecht, Netherlands; [Dutilh, Bas E.] Radboud Univ Nijmegen, Ctr Mol & Biomol Informat, Radboud Inst Mol Life Sci, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Edwards, Robert A.] Univ Fed Rio de Janeiro, Dept Marine Biol, Inst Biol, Rio De Janeiro, Brazil; [Green, Dawn; Matlock, Brian; Heffernan, Brian; Olsen, Gary J.] Univ Illinois, Dept Microbiol, Urbana, IL USA; [Hanna, Leigh Farris] Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN USA; [Schifferli, Dieter M.] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Edwards, Robert A.] Argonne Natl Lab, Argonne, IL 60349 USA	California State University System; San Diego State University; California State University System; San Diego State University; California State University System; San Diego State University; Utrecht University; Radboud University Nijmegen; Universidade Federal do Rio de Janeiro; University of Illinois System; University of Illinois Urbana-Champaign; University of Tennessee System; University of Tennessee Health Science Center; University of Pennsylvania; United States Department of Energy (DOE); Argonne National Laboratory	Edwards, RA (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	redwards@mail.sdsu.edu	Maloy, Stanley/AAA-7095-2019; Dutilh, Bas E./B-9719-2011; Schifferli, Dieter/H-2002-2011; Edwards, Robert/Q-1691-2019	Maloy, Stanley/0000-0001-9900-4367; Dutilh, Bas E./0000-0003-2329-7890; Edwards, Robert/0000-0001-8383-8949; /0000-0003-1655-0931; dinsdale, elizabeth/0000-0002-2177-203X	Illinois Council for Food and Agriculture Research; National Science Foundation [DEB-1046413, CNS-1305112, MCB-1330800]; NSF [DUE-1323809, DUE-1330800]; Div Of Molecular and Cellular Bioscience [1330800] Funding Source: National Science Foundation	Illinois Council for Food and Agriculture Research; National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The initial sequencing was supported by the Illinois Council for Food and Agriculture Research (http://www.ilcfar.org/). Edwards is supported by National Science Foundation grants DEB-1046413, CNS-1305112, and MCB-1330800. Dinsdale was supported by NSF grant DUE-1323809 and DUE-1330800. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AILION M, 1993, J BACTERIOL, V175, P7200, DOI 10.1128/JB.175.22.7200-7208.1993; Akhter S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks406; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-272; Ansong C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-433; Ansong Charles, 2008, Briefings in Functional Genomics & Proteomics, V7, P50, DOI 10.1093/bfgp/eln010; Atterbury RJ, 2007, APPL ENVIRON MICROB, V73, P4543, DOI 10.1128/AEM.00049-07; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bakke P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006291; Baranova N, 2002, J BACTERIOL, V184, P4168, DOI 10.1128/JB.184.15.4168-4176.2002; Baumler AJ, 2000, SCIENCE, V287, P50, DOI 10.1126/science.287.5450.50; Betancor Laura, 2012, Open Microbiol J, V6, P5, DOI 10.2174/1874285801206010005; Betancor L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-237; BOYD EF, 1993, J GEN MICROBIOL, V139, P1125, DOI 10.1099/00221287-139-6-1125; Callaway T.R., 2008, J ANIM SCI, V86, P163, DOI [DOI 10.2527/JAS.2007-0457, 10.2527/jas.2007-0457]; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Desai PT, 2013, MBIO, V4, DOI 10.1128/mBio.00579-12; FANG FC, 1991, MEDICINE, V70, P198, DOI 10.1097/00005792-199105000-00004; Figueroa-Bossi N, 2001, MOL MICROBIOL, V39, P260, DOI 10.1046/j.1365-2958.2001.02234.x; Fricke WF, 2011, J BACTERIOL, V193, P3556, DOI 10.1128/JB.00297-11; Giraud A, 2001, CURR OPIN MICROBIOL, V4, P582, DOI 10.1016/S1369-5274(00)00254-X; Goudeau DM, 2013, APPL ENVIRON MICROB, V79, P250, DOI 10.1128/AEM.02290-12; Guibourdenche M, 2010, RES MICROBIOL, V161, P26, DOI 10.1016/j.resmic.2009.10.002; Hanna LF, 2012, APPL ENVIRON MICROB, V78, P1785, DOI 10.1128/AEM.07241-11; Harvey PC, 2011, INFECT IMMUN, V79, P4105, DOI 10.1128/IAI.01390-10; Helm RA, 2001, APPL ENVIRON MICROB, V67, P3295, DOI 10.1128/AEM.67.7.3295-3298.2001; Higgins JP, 2005, POULTRY SCI, V84, P1141, DOI 10.1093/ps/84.7.1141; Holt JG, 1994, BERGEYS MANUAL OF DE; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Holt KE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-36; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; JETER RM, 1990, J GEN MICROBIOL, V136, P887, DOI 10.1099/00221287-136-5-887; JETER RM, 1984, J BACTERIOL, V159, P206, DOI 10.1128/JB.159.1.206-213.1984; KELLER LH, 1995, INFECT IMMUN, V63, P2443, DOI 10.1128/IAI.63.7.2443-2449.1995; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; Kuo CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001050; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lerat E, 2004, GENOME RES, V14, P2273, DOI 10.1101/gr.2925604; Lim TH, 2011, AVIAN DIS, V55, P435, DOI 10.1637/9599-111210-Reg.1; Liu GR, 2002, J BACTERIOL, V184, P2626, DOI 10.1128/JB.184.10.2626-2633.2002; Liu SL, 1998, FEMS MICROBIOL LETT, V164, P275, DOI 10.1016/S0378-1097(98)00225-0; LLAGOSTERA M, 1986, J GEN MICROBIOL, V132, P1035; Maloy S, 2000, METHODS, V20, P73, DOI 10.1006/meth.1999.0907; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matthews TD, 2011, MBIO, V2, DOI 10.1128/mBio.00060-11; Matthews TD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013503; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; McCrindle SL, 2005, ADV MICROB PHYSIOL, V50, P147, DOI 10.1016/S0065-2911(05)50004-3; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mmolawa PT, 2003, J BACTERIOL, V185, P6481, DOI 10.1128/JB.185.21.6481-6485.2003; Mmolawa PT, 2003, J BACTERIOL, V185, P3473, DOI 10.1128/JB.185.11.3473-3475.2003; MOLLER V, 1954, ACTA PATHOL MIC SC, V34, P115; Nielsen P, 2005, BIOINFORMATICS, V21, P4322, DOI 10.1093/bioinformatics/bti701; Nuccio SP, 2014, MBIO, V5, DOI 10.1128/mBio.00929-14; Parker CT, 2002, ENVIRON MICROBIOL, V4, P538, DOI 10.1046/j.1462-2920.2002.00333.x; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Pati A, 2010, NAT METHODS, V7, P455, DOI [10.1038/nmeth.1457, 10.1038/NMETH.1457]; Pomeroy BS, DISEASES OF POULTRY; Popoff MY, BERGEYS MANUAL OF SY, P764; Poptsova MS, 2010, MICROBIOL-SGM, V156, P1909, DOI 10.1099/mic.0.033811-0; Porwollik S, 2005, J BACTERIOL, V187, P6545, DOI 10.1128/JB.187.18.6545-6555.2005; Porwollik S, 2004, J BACTERIOL, V186, P5883, DOI 10.1128/JB.186.17.5883-5898.2004; Porwollik S, 2003, MICROBES INFECT, V5, P977, DOI 10.1016/S1286-4579(03)00186-2; Price-Carter M, 2001, J BACTERIOL, V183, P2463, DOI 10.1128/JB.183.8.2463-2475.2001; Rabsch W, 2000, EMERG INFECT DIS, V6, P443, DOI 10.3201/eid0605.000501; REEVES P, 1993, TRENDS GENET, V9, P17, DOI 10.1016/0168-9525(93)90067-R; Retamal P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009394; Richardson EJ, 2011, J BACTERIOL, V193, P3162, DOI 10.1128/JB.00394-11; ROOF DM, 1988, J BACTERIOL, V170, P3855, DOI 10.1128/jb.170.9.3855-3863.1988; ROTH JR, 1993, J BACTERIOL, V175, P3303, DOI 10.1128/jb.175.11.3303-3316.1993; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SELANDER RK, 1992, J BACTERIOL, V174, P3587, DOI 10.1128/JB.174.11.3587-3592.1992; Silva GGZ, 2013, SOURCE CODE BIOL MED, V8, DOI 10.1186/1751-0473-8-23; Snoeyenbos GH, DISEASES OF POULTRY; Spano S, 2012, SCIENCE, V338, P960, DOI 10.1126/science.1229224; Srikumar S, 2011, APPL ENVIRON MICROB, V77, P281, DOI 10.1128/AEM.01403-10; Sundin GW, 2007, FEMS MICROBIOL LETT, V277, P11, DOI 10.1111/j.1574-6968.2007.00901.x; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Trombert AN, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-312; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Walter D, 1997, J BACTERIOL, V179, P1013, DOI 10.1128/jb.179.4.1013-1022.1997; Winter SE, 2011, GUT MICROBES, V2, P58, DOI 10.4161/gmic.2.1.14911; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415	86	28	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126883	10.1371/journal.pone.0126883	http://dx.doi.org/10.1371/journal.pone.0126883			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039056	Green Submitted, Green Published, gold			2022-12-27	WOS:000355700700040
J	Miyabayashi, K; Tokunaga, K; Otake, H; Baba, T; Shima, Y; Morohashi, K				Miyabayashi, Kanako; Tokunaga, Kaori; Otake, Hiroyuki; Baba, Takashi; Shima, Yuichi; Morohashi, Ken-ichirou			Heterogeneity of Ovarian Theca and Interstitial Gland Cells in Mice	PLOS ONE			English	Article							VENTROMEDIAL HYPOTHALAMIC NUCLEUS; FETAL LEYDIG-CELLS; STEROIDOGENIC FACTOR-1; GENE-TRANSCRIPTION; AD4BP/SF-1 GENE; ADRENAL-CORTEX; MOUSE TESTIS; EXPRESSION; DIFFERENTIATION; RECEPTOR	It has been established that two developmentally and functionally distinct cell types emerge within the mammalian testis and adrenal gland throughout life. Fetal and adult types of steroidogenic cells (i.e., testicular Leydig cells and adrenocortical cells) develop in the prenatal and postnatal period, respectively. Although the ovary synthesizes steroids postnatally, the presence of fetal-type steroidogenic cells has not been described. We had previously established transgenic mouse lines in which fetal Leydig cells were labeled with an EGFP reporter gene by the FLE (fetal Leydig enhancer) of the Ad4BP/SF-1 (Nr5a1) gene. In the present study, we examined the reporter gene expression in females and found that the reporter gene is turned on in postnatal ovaries. A comparison of the expressions of the EGFP and marker genes revealed that EGFP is expressed in not all but rather a proportion of steroidogenic theca and in interstitial gland cells in the ovary. This finding was further supported by experiments using BAC transgenic mice in which reporter gene expression recapitulated endogenous Ad4BP/SF-1 gene expression. In conclusion, our observations from this study strongly suggest that ovarian theca and interstitial gland cells in mice consist of at least two cell types.	[Miyabayashi, Kanako; Tokunaga, Kaori; Otake, Hiroyuki; Baba, Takashi; Shima, Yuichi; Morohashi, Ken-ichirou] Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka, Fukuoka 812, Japan	Kyushu University	Morohashi, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka, Fukuoka 812, Japan.	moro@cell.med.kyushu-u.ac.jp	Baba, Takashi/ABI-2727-2020	Shima, Yuichi/0000-0002-0281-8602	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI [22132002]	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants 22132002 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI (http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4634; Chaffin CL, 2013, EXP BIOL MED, V238, P539, DOI 10.1177/1535370213489437; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Douglas GC, 2004, ENDOCRINOLOGY, V145, P4703, DOI 10.1210/en.2004-0443; Futchiyah, 2006, BIOCHEM BIOPH RES CO, V341, P1036, DOI 10.1016/j.bbrc.2006.01.058; Griswold SL, 2009, SEX DEV, V3, P1, DOI 10.1159/000200077; Hinshelwood MM, 2003, MOL CELL ENDOCRINOL, V207, P39, DOI 10.1016/S0303-7207(03)00257-0; Hoivik EA, 2010, MOL CELL ENDOCRINOL, V315, P27, DOI 10.1016/j.mce.2009.07.003; HONDA S, 1993, J BIOL CHEM, V268, P7494; IKEDA Y, 1993, MOL ENDOCRINOL, V7, P852, DOI 10.1210/me.7.7.852; JUNEAU C, 1993, BIOL REPROD, V48, P226, DOI 10.1095/biolreprod48.2.226; Karpova T, 2005, MOL ENDOCRINOL, V19, P2549, DOI 10.1210/me.2004-0386; Keegan CE, 2002, TRENDS ENDOCRIN MET, V13, P200, DOI 10.1016/S1043-2760(02)00602-1; KERR JB, 1988, DEVELOPMENT, V103, P535; KUOPIO T, 1989, DEVELOPMENT, V107, P213; Lalli E, 2013, MOL CELL ENDOCRINOL, V371, P154, DOI 10.1016/j.mce.2012.11.005; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; McDowell EN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047359; Miyabayashi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068050; MOROHASHI K, 1994, MOL ENDOCRINOL, V8, P643, DOI 10.1210/me.8.5.643; Morohashi K, 2013, SEX DEV, V7, P61, DOI 10.1159/000342272; MOROHASHI K, 1992, J BIOL CHEM, V267, P17913; Morohashi K, 1999, BLOOD, V93, P1586; Nakamura S, 2009, DEV DYNAM, V238, P2652, DOI 10.1002/dvdy.22068; O'Shaughnessy PJ, 2000, ENDOCRINOLOGY, V141, P2631, DOI 10.1210/en.141.7.2631; O'Shaughnessy PJ, 2002, BIOL REPROD, V66, P966, DOI 10.1095/biolreprod66.4.966; RUSSO J, 1971, AM J ANAT, V130, P461, DOI 10.1002/aja.1001300407; SADOVSKY Y, 1995, P NATL ACAD SCI USA, V92, P10939, DOI 10.1073/pnas.92.24.10939; Schimmer BP, 2010, MOL ENDOCRINOL, V24, P1322, DOI 10.1210/me.2009-0519; Shima Y, 2005, MOL ENDOCRINOL, V19, P2812, DOI 10.1210/me.2004-0431; Shima Y, 2008, MOL ENDOCRINOL, V22, P1633, DOI 10.1210/me.2007-0444; Shima Y, 2013, MOL ENDOCRINOL, V27, P63, DOI 10.1210/me.2012-1256; Shima Y, 2012, ENDOCRINOLOGY, V153, P417, DOI 10.1210/en.2011-1407; SHINODA K, 1995, DEV DYNAM, V204, P22, DOI 10.1002/aja.1002040104; Stocco C, 2008, STEROIDS, V73, P473, DOI 10.1016/j.steroids.2008.01.017; TANAKA S, 1995, EXP ANIM TOKYO, V44, P285, DOI 10.1538/expanim.44.285; Zubair M, 2008, MOL CELL BIOL, V28, P7030, DOI 10.1128/MCB.00900-08; Zubair M, 2006, MOL CELL BIOL, V26, P4111, DOI 10.1128/MCB.00222-06	40	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128352	10.1371/journal.pone.0128352	http://dx.doi.org/10.1371/journal.pone.0128352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039146	Green Submitted, Green Published, gold			2022-12-27	WOS:000355700700098
J	Waumans, MC; Nicodeme, T; Bersini, H				Waumans, Michael C.; Nicodeme, Thibaut; Bersini, Hugues			Topology Analysis of Social Networks Extracted from Literature	PLOS ONE			English	Article								In a world where complex networks are an increasingly important part of science, it is interesting to question how the new reading of social realities they provide applies to our cultural background and in particular, popular culture. Are authors of successful novels able to reproduce social networks faithful to the ones found in reality? Is there any common trend connecting an author's oeuvre, or a genre of fiction? Such an analysis could provide new insight on how we, as a culture, perceive human interactions and consume media. The purpose of the work presented in this paper is to define the signature of a novel's story based on the topological analysis of its social network of characters. For this purpose, an automated tool was built that analyses the dialogs in novels, identifies characters and computes their relationships in a time-dependent manner in order to assess the network's evolution over the course of the story.	[Waumans, Michael C.; Nicodeme, Thibaut; Bersini, Hugues] ULB, Ecole Polytech Bruxelles CoDE IRIDIA, Brussels, Belgium	Universite Libre de Bruxelles	Waumans, MC (corresponding author), ULB, Ecole Polytech Bruxelles CoDE IRIDIA, Brussels, Belgium.	mwaumans@ulb.ac.be						Argamon S, 2007, J AM SOC INF SCI TEC, V58, P802, DOI 10.1002/asi.20553; Baccianella S., 2010, SENTIWORDNET 3 0 ENH; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bird Steven, 2004, P ACL INT POST DEM S, P214; Broder A, 2000, COMPUT NETW, V33, P309, DOI 10.1016/S1389-1286(00)00083-9; Clare C., 2012, CITY OF LOST SOULS; Clare C, 2008, CITY OF ASHES; Clare C., 2009, CITY OF GLASS; Clare C., 2011, CITY FALLEN ANGELS; Clare C, 2007, CITY OF BONES; Clare Cassandra, 2014, CITY HEAVENLY FIRE; Fellbaum Christiane, 1998, WORDNET ELECT DATABA; Francis W.N., 1964, STANDARD CORPUS PRES; Hobb R., 2000, SHIP OF DESTINY; Hobb R., 1998, SHIP OF MAGIC; Hobb R, 1999, THE MAD SHIP; Hobb Robin, 2009, THE DRAGON KEEPER; Hobb Robin, 2012, CITY OF DRAGONS; Hobb Robin, 2013, BLOOD OF DRAGONS; Hobb Robin, 2010, DRAGON HAVEN; Hugo V., 2008, MISERABLES; James Hibberd, 2011, ENTERTAINMENT WEEKLY; Jordan R., 1993, THE FIRES OF HEAVEN; Jordan R., 2004, NEW SPRING; Jordan R., 1992, THE SHADOW RISING; Jordan R., 1998, THE PATH OF DAGGERS; Jordan R., 2000, WINTERS HEART; Jordan R, 1994, LORD OF CHAOS; Jordan R, 1990, THE GREAT HUNT; Jordan R, 2010, TOWERS OF MIDNIGHT; Jordan R, 2013, A MEMORY OF LIGHT; Jordan R, 1996, A CROWN OF SWORDS; Jordan R., 1991, THE DRAGIN REBORN; Jordan R., 2003, CROSSROADS TWILIGHT; Jordan R., 2005, KNIFE OF DREAMS; Jordan R., 1990, THE EYE OF THE WORLD; Jordan R, 2009, THE GATHERING STORM; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Martin G. R. R., 1996, GAME THRONES; Martin George R. R., 2011, A CLASH OF KINGS; Martin George R. R., 2005, A FEAST FOR CROWS; Martin GRR, 1999, A STORM OF SWORDS; Meyer Marissa, 2013, SCARLET; Meyer Marissa, 2014, CRESS; Meyer Marissa, 2012, CINDER; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Mislove A, 2007, P 7 ACM SIGCOMM C IN; Mosteller F, 1963, AM STAT ASS J; Muchnik L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01783; Pullman P., 1996, THE SUBTLE KNIFE; Pullman P., 1999, THE AMBER SPYGLASS; Pullman Philip, 1995, NO LIGHTS; Rowling, 2010, HARRY POTTER HALF BL; Rowling J. K., 2003, HARRY POTTER ORDER P; Rowling J. K., 1998, HARRY POTTER CHAMBER; Rowling J.K., 1997, HARRY POTTER PHILOSO, Vfirst; Rowling JK, 2007, HARRY POTTER DEATHLY; Rowling JK, 2000, HARRY POTTER GOBLET; van Halteren H., 2005, J QUANT LINGUIST, V12, P65, DOI [10.1080/09296170500055350, DOI 10.1080/09296170500055350]; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	63	18	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126470	10.1371/journal.pone.0126470	http://dx.doi.org/10.1371/journal.pone.0126470			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039072	gold, Green Published, Green Submitted			2022-12-27	WOS:000355700700030
J	Gong, GC; Fan, WZ; Li, DZ; Tian, X; Chen, SJ; Fu, YC; Xu, WC; Wei, CJ				Gong, Gen-cheng; Fan, Wen-zhu; Li, Di-zheng; Tian, Xiong; Chen, Shao-jun; Fu, Yu-cai; Xu, Wen-can; Wei, Chi-ju			Increased Specific Labeling of INS-1 Pancreatic Beta-Cell by Using RIP-Driven Cre Mutants with Reduced Activity	PLOS ONE			English	Article							INSULIN-PRODUCING CELLS; PROMOTER INTERFERENCE; TRANSGENE EXPRESSION; EFFECTOR NUCLEASES; RECOMBINASE; GENE; BRAIN; VECTORS; MICE; PROGENITORS	Ectopically expressed Cre recombinase in extrapancreatic tissues in RIP-Cre mice has been well documented. The objective of this study was to find a simple solution that allows for improved beta-cell specific targeting. To this end, the RIP-Cre and reporter CMV-loxP-DsRed-loxP-EGFP expression cassettes were configurated into a one-plasmid and two-plasmid systems, which labeled approximately 80% insulin-positive INS-1 cells after 48 h transfection. However, off-target labeling was robustly found in more than 15% insulin-negative Ad293 cells. When an IRES element was inserted in front of Cre to reduce the translation efficiency, the ratio of recombination between INS-1 and Ad293 cells increased 3-4-fold. Further, a series of Cre mutants were generated by site-directed mutagenesis. When one of the mutants, Cre(H289P) in both configurations, was used in the experiment, the percentage of recombination dropped to background levels in a number of insulin-negative cell lines, but decreased only slightly in INS-1 cells. Consistently, DNA substrate digestion assay showed that the enzymatic activity of Cre(H289P) was reduced by 30-fold as compared to that of wild-type. In this study, we reported the generation of constructs containing RIP and Cre mutants, which enabled enhanced beta-cell specific labeling in vitro. These tools could be invaluable for beta-cell targeting and to the study of islet development.	[Gong, Gen-cheng; Fan, Wen-zhu; Li, Di-zheng; Tian, Xiong; Chen, Shao-jun; Wei, Chi-ju] Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China; [Fu, Yu-cai] Shantou Univ, Coll Med, Lab Cell Senescence, Shantou 515041, Guangdong, Peoples R China; [Xu, Wen-can] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Endocrinol, Shantou 515041, Guangdong, Peoples R China	Shantou University; Shantou University; Shantou University	Wei, CJ (corresponding author), Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China.	chijuwei@stu.edu.cn			Li Ka Shing Foundation; Natural Science Foundation of China [30971665, 81172894, 81370925]; Education Department of Guangdong [cxzd1123]	Li Ka Shing Foundation; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Department of Guangdong	This research was supported by the Li Ka Shing Foundation, the Natural Science Foundation of China (http://www.nsfc.gov.cn/) (Grant Nos. 30971665, 81172894, 81370925), and the Education Department of Guangdong (http://www.gdhed.edu.cn/) (Grant No. cxzd1123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fukazawa T, 2006, EXP CELL RES, V312, P3404, DOI 10.1016/j.yexcr.2006.07.015; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gannon M, 2000, GENESIS, V26, P143, DOI 10.1002/(SICI)1526-968X(200002)26:2<143::AID-GENE13>3.0.CO;2-L; Gibb B, 2010, NUCLEIC ACIDS RES, V38, P5817, DOI 10.1093/nar/gkq384; Ginn SL, 2003, HUM GENE THER, V14, P1127, DOI 10.1089/104303403322167975; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Guilinger JP, 2014, NAT METHODS, V11, P429, DOI 10.1038/nmeth.2845; Gustafsson E, 2001, J CELL SCI, V114, P671; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Hasegawa Y, 2014, EXP ANIM TOKYO, V63, P183, DOI 10.1538/expanim.63.183; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hsieh J, 2012, GENE DEV, V26, P1010, DOI 10.1101/gad.187336.112; Johnson JD, 2014, ISLETS, V6, DOI 10.4161/19382014.2014.944439; Juillerat A, 2014, NUCLEIC ACIDS RES, V42, P5390, DOI 10.1093/nar/gku155; Kaczmarczyk SJ, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e56; Kojima H, 2004, P NATL ACAD SCI USA, V101, P2458, DOI 10.1073/pnas.0308690100; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kyriaki G, 2003, CELL MOL NEUROBIOL, V23, P1, DOI 10.1023/A:1022598900246; Lamotte L, 2004, TRANSGENIC RES, V13, P463, DOI 10.1007/s11248-004-9587-x; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Liu YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013533; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Lu S, 2012, NEUROBIOL DIS, V45, P219, DOI 10.1016/j.nbd.2011.08.006; Machida M, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/959737; Magnuson MA, 2013, CELL METAB, V18, P9, DOI 10.1016/j.cmet.2013.06.011; Martin M, 2007, ENDOCR DEV, V12, P24, DOI 10.1159/000109602; Mathijs Iris, 2012, Methods Mol Biol, V933, P317, DOI 10.1007/978-1-62703-068-7_21; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Nunes-Duby SE, 1998, NUCLEIC ACIDS RES, V26, P391, DOI 10.1093/nar/26.2.391; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Pomplun D, 2007, HORM METAB RES, V39, P336, DOI 10.1055/s-2007-976538; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Salpeter SJ, 2006, METHOD ENZYMOL, V419, P322, DOI 10.1016/S0076-6879(06)19013-8; Semprini S, 2007, NUCLEIC ACIDS RES, V35, P1402, DOI 10.1093/nar/gkl1108; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Song JH, 2010, GENESIS, V48, P628, DOI 10.1002/dvg.20672; Tang MM, 2011, MOL THER, V19, P60, DOI 10.1038/mt.2010.187; Uchida N, 2013, HUM GENE THER METHOD, V24, P117, DOI 10.1089/hgtb.2012.152; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036	48	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129092	10.1371/journal.pone.0129092	http://dx.doi.org/10.1371/journal.pone.0129092			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046525	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200124
J	Gurecka, R; Koborova, I; Sebek, J; Sebekova, K				Gurecka, Radana; Koborova, Ivana; Sebek, Jozef; Sebekova, Katarina			Presence of Cardiometabolic Risk Factors Is Not Associated with Microalbuminuria in 14-to-20-Years Old Slovak Adolescents: A Cross-Sectional, Population Study	PLOS ONE			English	Article							URINARY ALBUMIN EXCRETION; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR RISK; ORTHOSTATIC PROTEINURIA; ESSENTIAL-HYPERTENSION; DIABETES-MELLITUS; SCHOOL-CHILDREN; ACCURATE METHOD; OBESITY; OVERWEIGHT	Introduction In adults, microalbuminuria indicates generalized endothelial dysfunction, and is an independent risk factor for cardiovascular and all cause mortality. Slovak adults present one of the highest cardiovascular mortality rates in Europe. Thus Slovak adolescents are on a high-risk to develop cardiovascular afflictions early, and screening for microalbuminuria might be useful in early assessment of their cardiovascular risk. We aimed to study the prevalence of microalbuminuria in Slovak adolescents, and the association of urinary albumin-to-creatinine ratio (ACR) to cardiovascular risk factors. Subjects and methods Anthropometric data, blood pressure, blood count, glucose homeostasis, lipid profile, renal function, inflammatory status, concentrations of homocysteine and uric acid were determined and associated with ACR in 2 666 adolescents (49.4% boys, 51.6% girls) aged 14-to-20 years. Microalbuminuria was classified as ACR 2.5-25.0 mg/mmol in boys and 3.5-35.0 mg/mmol in girls. Results Prevalence of microalbuminuria in both genders reached 3.3%, and did not differ significantly between lean and centrally obese subjects. Girls presented higher ACR than boys (normoalbuminuric: 0.6 +/- 0.5 mg/mmol vs. 0.5 +/- 0.4 mg/mmol, p>0.001; microalbuminuric: 9.3 +/- 7.3 mg/mmol vs. 5.0 +/- 3.8 mg/mmol; p>0.001). Microalbuminuric adolescents and those presenting normoalbuminuria within the upper ACR quartile were slimmer than their normoalbuminuric counterparts or adolescents with normoalbuminuria within the lower quartile, respectively. No association between microalbuminuria and cardiovascular risk markers was revealed. Conclusion Results obtained in this study do not support our assumption that ACR associates with cardiometabolic risk factors in apparently healthy adolescents. Follow-up studies until adulthood are needed to estimate the potential cardiometabolic risk of apparently healthy microalbuminuric adolescents.	[Gurecka, Radana; Koborova, Ivana; Sebekova, Katarina] Comenius Univ, Fac Med, Inst Mol BioMed, Bratislava, Slovakia; [Sebek, Jozef] Slovak Acad Sci, Inst Technol, Bratislava, Slovakia	Comenius University Bratislava; Slovak Academy of Sciences	Gurecka, R (corresponding author), Comenius Univ, Fac Med, Inst Mol BioMed, Bratislava, Slovakia.	radana.kollarova@gmail.com	Gurecka, Radana/AAX-6744-2021; Sebekova, Katarina/H-4906-2016; Sebekova, Katarina/GSD-7056-2022; Stefanadis, Christodoulos/ABH-2232-2020	Sebekova, Katarina/0000-0002-9641-9265; Sebekova, Katarina/0000-0002-9641-9265; Stefanadis, Christodoulos/0000-0001-5974-6454	Bratislava Self-governing Region; Regional Public Health Authority of the Slovak Republic in Bratislava; VEGA [1/0637/13]; APVV [0447-12]	Bratislava Self-governing Region; Regional Public Health Authority of the Slovak Republic in Bratislava; VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)European Commission); APVV(Slovak Research and Development Agency)	This study was supported by the Bratislava Self-governing Region and the Regional Public Health Authority of the Slovak Republic in Bratislava, these funders participated in the design of "Respect for Health" study and data collection; and partially from VEGA No. 1/0637/13 and APVV No. 0447-12 grants (to KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2011, CURR OPIN ENDOCRINOL, V18, P23, DOI 10.1097/MED.0b013e3283424b37; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; BANGSTAD HJ, 1993, ACTA PAEDIATR, V82, P857, DOI 10.1111/j.1651-2227.1993.tb17628.x; Barzilay JI, 2004, AM J KIDNEY DIS, V44, P25, DOI 10.1053/j.ajkd.2004.03.022; Bigazzi R, 1998, J HYPERTENS, V16, P1325, DOI 10.1097/00004872-199816090-00014; Brandle E, 1996, EUR J CLIN NUTR, V50, P734; Brandt JR, 2010, PEDIATR NEPHROL, V25, P1131, DOI 10.1007/s00467-010-1451-z; DAVIES AG, 1984, ARCH DIS CHILD, V59, P625, DOI 10.1136/adc.59.7.625; Deckert T, 1989, STENO HYPOTHESES DIA, V32, P219; Dobiasova M, 2001, CLIN BIOCHEM, V34, P583, DOI 10.1016/S0009-9120(01)00263-6; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Hanevold CD, 2008, HYPERTENSION, V51, P334, DOI 10.1161/HYPERTENSIONAHA.107.098095; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hillege HL, 2001, J INTERN MED, V249, P519, DOI 10.1046/j.1365-2796.2001.00833.x; Hirschler V, 2010, PEDIATR DIABETES, V11, P322, DOI 10.1111/j.1399-5448.2009.00599.x; Hoogeveen EK, 1998, KIDNEY INT, V54, P203, DOI 10.1038/sj.ki.4495353; Johnson DW, 2012, MED J AUSTRALIA, V197, P224, DOI 10.5694/mja11.11468; Jones CA, 2002, AM J KIDNEY DIS, V39, P445, DOI 10.1053/ajkd.2002.31388; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kelsey MM, 2014, GERONTOLOGY, V60, P222, DOI 10.1159/000356023; Kollarova R, 2013, CES SLOV PEDIAT, V68, P211; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Kwak BO, 2011, YONSEI MED J, V52, P476, DOI 10.3349/ymj.2011.52.3.476; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mazaraki A, 2011, EUR J CLIN NUTR, V65, P219, DOI 10.1038/ejcn.2010.244; Mazzoni MBM, 2011, NEPHROL DIAL TRANSPL, V26, P562, DOI 10.1093/ndt/gfq444; Mueller PW, 1999, RENAL FAILURE, V21, P293, DOI 10.3109/08860229909085091; Nguyen S, 2008, PEDIATRICS, V121, P37, DOI 10.1542/peds.2007-3594; NHANES, 2002, TECHNICAL REPORT; Nichols M., 2012, EUROPEAN CARDIOVASCU; Rademacher E, 2008, CLIN J AM SOC NEPHRO, V3, P998, DOI 10.2215/CJN.04631007; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; ROBINSON RR, 1980, KIDNEY INT, V18, P395, DOI 10.1038/ki.1980.151; Rutkowski B, 2013, NEPHROL DIAL TRANSPL, V28, P204, DOI 10.1093/ndt/gft328; Rutkowski P, 2006, J RENAL NUTR, V16, P216, DOI 10.1053/j.jrn.2006.04.017; SANCHEZBAYLE M, 1995, PEDIATR NEPHROL, V9, P428, DOI 10.1007/BF00866717; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Schmieder RE, 2007, CLIN RES CARDIOL, V96, P247, DOI 10.1007/s00392-007-0510-3; Schwartz G, 2007, PEDIATR NEPHROL, V22, P1457; Sebekova K, 2012, Vnitr Lek, V58, P544; Singh A, 2011, PEDIATR NEPHROL, V26, P1957, DOI 10.1007/s00467-011-1777-1; Tsioufis C, 2005, AM J CARDIOL, V96, P946, DOI 10.1016/j.amjcard.2005.05.052; Tsioufis C, 2009, HELL J CARDIOL, V50, P476; World Health Organization, 2013, EUR HLTH REP 2012 CH; YOSHIOKA T, 1986, KIDNEY INT, V30, P538, DOI 10.1038/ki.1986.219	45	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129311	10.1371/journal.pone.0129311	http://dx.doi.org/10.1371/journal.pone.0129311			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046923	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200147
J	McCaughey, EJ; Berry, HR; McLean, AN; Allan, DB; Gollee, H				McCaughey, Euan J.; Berry, Helen R.; McLean, Alan N.; Allan, David B.; Gollee, Henrik			Abdominal Functional Electrical Stimulation to Assist Ventilator Weaning in Acute Tetraplegia: A Cohort Study	PLOS ONE			English	Article							SPINAL-CORD-INJURY; MECHANICAL VENTILATION; PULMONARY-FUNCTION; NERVE-STIMULATION; ENHANCE COUGH; MUSCLES; PREDICTORS; MORTALITY; CAPACITY; HEALTH	Background Severe impairment of the major respiratory muscles resulting from tetraplegia reduces respiratory function, causing many people with tetraplegia to require mechanical ventilation during the acute stage of injury. Abdominal Functional Electrical Stimulation (AFES) can improve respiratory function in non-ventilated patients with sub-acute and chronic tetraplegia. The aim of this study was to investigate the clinical feasibility of using an AFES training program to improve respiratory function and assist ventilator weaning in acute tetraplegia. Methods AFES was applied for between 20 and 40 minutes per day, five times per week on four alternate weeks, with 10 acute ventilator dependent tetraplegic participants. Each participant was matched retrospectively with a ventilator dependent tetraplegic control, based on injury level, age and sex. Tidal Volume (V-T) and Vital Capacity (V-C) were measured weekly, with weaning progress compared to the controls. Results Compliance to training sessions was 96.7%. Stimulated V-T was significantly greater than unstimulated V-T. V-T and V-C increased throughout the study, with mean V-C increasing significantly (V-T: 6.2 mL/kg to 7.8 mL/kg V-C: 12.6 mL/kg to 18.7 mL/kg). Intervention participants weaned from mechanical ventilation on average 11 (sd: +/- 23) days faster than their matched controls. Conclusion The results of this study indicate that AFES is a clinically feasible technique for acute ventilator dependent tetraplegic patients and that this intervention may improve respiratory function and enable faster weaning from mechanical ventilation.	[McCaughey, Euan J.; Gollee, Henrik] Univ Glasgow, Ctr Rehabil Engn, Sch Engn, Glasgow, Lanark, Scotland; [McCaughey, Euan J.; Berry, Helen R.] Univ Strathclyde, Ctr Excellence Rehabil Res, Biomed Engn, Glasgow, Lanark, Scotland; [McCaughey, Euan J.] Macquarie Univ, Ctr Hlth Syst & Safety Res, Australia Inst Hlth Innovat, N Ryde, NSW, Australia; [McLean, Alan N.; Allan, David B.] So Gen Hosp, Queen Elizabeth Natl Spinal Injuries Unit, Glasgow G51 4TF, Lanark, Scotland; [McCaughey, Euan J.; Berry, Helen R.; McLean, Alan N.; Allan, David B.; Gollee, Henrik] Scottish Ctr Innovat Spinal Cord Injury, Glasgow, Lanark, Scotland	University of Glasgow; University of Strathclyde; Macquarie University; University of Glasgow	McCaughey, EJ (corresponding author), Univ Glasgow, Ctr Rehabil Engn, Sch Engn, Glasgow, Lanark, Scotland.	euan.mccaughey@mq.edu.au	Gollee, Henrik/E-9247-2010; Berry, Helen/B-4716-2013	Gollee, Henrik/0000-0002-4286-9113; McCaughey, Euan James/0000-0001-6596-110X; Berry, Helen Russell/0000-0001-9008-9253	Engineering and Physical Sciences Research Council scholarship [EP/50418X/1]; Leverhulme Trust research fellowship; Scottish Government Health Directorates	Engineering and Physical Sciences Research Council scholarship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Leverhulme Trust research fellowship(Leverhulme Trust); Scottish Government Health Directorates	This study was supported by an Engineering and Physical Sciences Research Council scholarship, www.epsrc.ac.uk, grant EP/50418X/1 (EJM), a Leverhulme Trust research fellowship, www.leverhulme.ac.uk (HG), and the Scottish Government Health Directorates, www.sehd.scot.nhs.uk (EJM and HRB).	Atito-Narh E, 2008, BR J INTENSIVE CARE, P95; Charlifue S, 2011, ARCH PHYS MED REHAB, V92, P457, DOI 10.1016/j.apmr.2010.07.237; Cheng PT, 2006, J REHABIL MED, V38, P32, DOI 10.1080/16501970510043387; Chhabra SK, 1998, J ASTHMA, V35, P361, DOI 10.3109/02770909809075669; Chiodo AE, 2008, J SPINAL CORD MED, V31, P72, DOI 10.1080/10790268.2008.11753984; Claxton AR, 1998, CAN J ANAESTH, V45, P144, DOI 10.1007/BF03013253; Dasta JF, 2005, CRIT CARE MED, V33, P1266, DOI 10.1097/01.CCM.0000164543.14619.00; DITUNNO JF, 1994, NEW ENGL J MED, V330, P550, DOI 10.1056/NEJM199402243300808; Ditunno JF, 2004, SPINAL CORD, V42, P383, DOI 10.1038/sj.sc.3101603; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Gay PC, 2013, CHEST, V143, P1203, DOI 10.1378/chest.13-0219; Harper NJN, 2001, BRIT J ANAESTH, V87, P625, DOI 10.1093/bja/87.4.625; JACKSON AB, 1994, ARCH PHYS MED REHAB, V75, P270, DOI 10.1016/0003-9993(94)90027-2; Kottink AI, 2008, PHYS THER, V88, P437, DOI 10.2522/ptj.20070035; Krause JS, 2004, ARCH PHYS MED REHAB, V85, P1764, DOI 10.1016/j.apmr.2004.06.062; Lee BB, 2008, J SPINAL CORD MED, V31, P78, DOI 10.1080/10790268.2008.11753985; Liaw MY, 2000, ARCH PHYS MED REHAB, V81, P752, DOI 10.1016/S0003-9993(00)90106-0; McBain RA, 2013, NEUROREHAB NEURAL RE, V27, P834, DOI 10.1177/1545968313496324; McCaughey EJ, 2014, EUR J APPL PHYSIOL, V114, P2483, DOI 10.1007/s00421-014-2966-y; McCaughey EJ, 2014, MED ENG PHYS, V36, P1057, DOI 10.1016/j.medengphy.2014.04.005; McLachlan AJ, 2013, J SPINAL CORD MED, V36, P97, DOI 10.1179/2045772312Y.0000000031; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Oo T, 1999, SPINAL CORD, V37, P117, DOI 10.1038/sj.sc.3100775; Peterson WP, 1999, SPINAL CORD, V37, P284, DOI 10.1038/sj.sc.3100818; Queen Elizabeth National Spinal Injuries Unit, 2013, EL NAT SPIN INJ UN A; Routsi C, 2010, CRIT CARE, V14, DOI 10.1186/cc8987; SHADE SK, 1985, PHYS THER, V65, P206, DOI 10.1093/ptj/65.2.206; Sheffler LR, 2007, MUSCLE NERVE, V35, P562, DOI 10.1002/mus.20758; Sorli J, 1996, IEEE Trans Rehabil Eng, V4, P1, DOI 10.1109/86.486051; Stanic U, 2000, IEEE T REHABIL ENG, V8, P30, DOI 10.1109/86.830946; Taylor PN, 1999, ARCH PHYS MED REHAB, V80, P1577, DOI 10.1016/S0003-9993(99)90333-7; Tobin MJ, 2001, NEW ENGL J MED, V344, P1986, DOI 10.1056/NEJM200106283442606	32	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128589	10.1371/journal.pone.0128589	http://dx.doi.org/10.1371/journal.pone.0128589			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047468	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200081
J	Tut, TG; Lim, SHS; Dissanayake, IU; Descallar, J; Chua, W; Ng, W; de Souza, P; Shin, JS; Lee, CS				Tut, T. G.; Lim, S. H. S.; Dissanayake, I. U.; Descallar, J.; Chua, W.; Ng, W.; de Souza, P.; Shin, J-S.; Lee, C. S.			Upregulated Polo-Like Kinase 1 Expression Correlates with Inferior Survival Outcomes in Rectal Cancer	PLOS ONE			English	Article							COLON-CANCER; COLORECTAL-CANCER; PROGNOSTIC-FACTOR; MAMMALIAN-CELLS; PLK1; CHEMORADIOTHERAPY; CHECKPOINT; CARCINOMA; APOPTOSIS; TARGET	Background Human polo-like kinase 1 (PLK1) expression has been associated with inferior outcomes in colorectal cancer. Our aims were to analyse PLK1 in rectal cancer, and its association with clinicopathological variables, overall survival as well as tumour regression to neoadjuvant treatment. Methods PLK1 expression was quantified with immunohistochemistry in the centre and periphery (invasive front) of rectal cancers, as well as in the involved regional lymph nodes from 286 patients. Scores were based on staining intensity and percentage of positive cells, multiplied to give weighted scores from 1-12, dichotomised into low (0-5) or high (6-12). Results PLK1 scores in the tumour periphery were significantly different to adjacent normal mucosa. Survival analysis revealed that low PLK1 score in the tumour periphery had a hazard ratio of death of 0.59 in multivariate analysis. Other predictors of survival included age, tumour depth, metastatic status, vascular and perineural invasion and adjuvant chemotherapy. There was no statistically significant correlation between PLK1 score and histological tumour regression in the neoadjuvant cohort. Conclusion Low PLK1 score was an independent predictor of superior overall survival, adjusting for multiple clinicopathological variables including treatment.	[Tut, T. G.; Dissanayake, I. U.; de Souza, P.; Shin, J-S.; Lee, C. S.] Univ Western Sydney, Sch Med, Liverpool, NSW 2170, Australia; [Tut, T. G.; Lim, S. H. S.; Descallar, J.; Chua, W.; Ng, W.; de Souza, P.; Shin, J-S.; Lee, C. S.] Ingham Inst Appl Med Res, Liverpool, NSW 2170, Australia; [Lim, S. H. S.; Descallar, J.; de Souza, P.; Lee, C. S.] Univ New S Wales, Kensington, NSW 2052, Australia; [Lim, S. H. S.; Chua, W.; Ng, W.; de Souza, P.] Liverpool Hosp, Dept Med Oncol, Liverpool, NSW 2170, Australia; [Dissanayake, I. U.; Shin, J-S.; Lee, C. S.] Liverpool Hosp, Dept Anat Pathol, Liverpool, NSW 2170, Australia; [Lee, C. S.] Univ Sydney, Bosch Inst, Camperdown, NSW 2006, Australia	Western Sydney University; Ingham Institute for Applied Medical Research; University of New South Wales Sydney; Liverpool Hospital; Liverpool Hospital; University of Sydney	Lim, SHS (corresponding author), Ingham Inst Appl Med Res, Liverpool, NSW 2170, Australia.	stephanie.lim@sswahs.nsw.gov.au	de Souza, Paul/P-5069-2019	Lee, C. Soon/0000-0003-1058-5826; Ng, Weng/0000-0003-2354-1857; Tut, Thein Ga/0000-0002-1608-9092; Lim, Stephanie Hui-Su/0000-0001-5940-7137				Francescangeli F, 2012, STEM CELLS, V30, P1819, DOI 10.1002/stem.1163; Han DP, 2012, MED SCI MONITOR, V18, pBR237, DOI 10.12659/MSM.882900; Ito Y, 2004, BRIT J CANCER, V90, P414, DOI 10.1038/sj.bjc.6601540; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Lund-Andersen C, 2014, RADIOTHER ONCOLOGY; Qin B, 2013, J BIOL CHEM, V288, P16139, DOI 10.1074/jbc.M113.456780; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Rodel F, 2010, AM J PATHOL, V177, P918, DOI 10.2353/ajpath.2010.100040; Ryan R, 2005, HISTOPATHOLOGY, V47, P141, DOI 10.1111/j.1365-2559.2005.02176.x; Sargent DJ, 2005, J CLIN ONCOL, V23, P8664, DOI 10.1200/JCO.2005.01.6071; Sauer R, 2012, J CLIN ONCOL, V30, P1926, DOI 10.1200/JCO.2011.40.1836; Smith MR, 1997, BIOCHEM BIOPH RES CO, V234, P397, DOI 10.1006/bbrc.1997.6633; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Spaekuch B, 2008, NEOPLASIA, V10, P223, DOI 10.1593/neo.07916; Spankuch-Schmitt B, 2002, JNCI-J NATL CANCER I, V94, P1863, DOI 10.1093/jnci/94.24.1863; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Takahashi T, 2003, CANCER SCI, V94, P148, DOI 10.1111/j.1349-7006.2003.tb01411.x; Takai N, 2005, ONCOGENE, V24, P287, DOI 10.1038/sj.onc.1208272; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; van Vugt MATM, 2001, J BIOL CHEM, V276, P41656, DOI 10.1074/jbc.M101831200; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Weichert W, 2004, BRIT J CANCER, V90, P815, DOI 10.1038/sj.bjc.6601610; Weichert W, 2005, WORLD J GASTROENTERO, V11, P5644, DOI 10.3748/wjg.v11.i36.5644	24	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129313	10.1371/journal.pone.0129313	http://dx.doi.org/10.1371/journal.pone.0129313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047016	Green Submitted, gold, Green Published			2022-12-27	WOS:000355652200148
J	Vasilyeva, A; Sanches, IS; Florindo, C; Dmitriev, A				Vasilyeva, Anastasia; Sanches, Ilda Santos; Florindo, Carlos; Dmitriev, Alexander			Natural Mutations in Streptococcus agalactiae Resulting in Abrogation of beta Antigen Production	PLOS ONE			English	Article							GROUP-B-STREPTOCOCCUS; SEPARATE BINDING-SITES; C-PROTEIN; GENOME SEQUENCE; BAC GENE; VIRULENCE; IDENTIFICATION; SYSTEM; STRAINS; DETERMINANTS	Streptococcus agalactiae genome encodes 21 two-component systems (TCS) and a variety of regulatory proteins in order to control gene expression. One of the TCS, BgrRS, comprising the BgrR DNA-binding regulatory protein and BgrS sensor histidine kinase, was discovered within a putative virulence island. BgrRS influences cell metabolism and positively control the expression of bac gene, coding for beta antigen at transcriptional level. Inactivation of bgrR abrogated bac gene expression and increased virulence properties of Streptococcus agalactiae In this study, a total of 140 strains were screened for the presence of bac gene, and the TCS bgrR and bgrS genes. A total of 53 strains carried the bac, bgrR and bgrS genes. Most of them (48 strains) expressed beta antigen, while five strains did not express beta antigen. Three strains, in which bac gene sequence was intact, while bgrR and/or bgrS genes had mutations, and expression of beta antigen was absent, were complemented with a constructed plasmid pBgrRS(P) encoding functionally active bgrR and bgrS gene alleles. This procedure restored expression of beta antigen indicating the crucial regulatory role of TCS BgrRS The complemented strain A49V/BgrRS demonstrated attenuated virulence in intraperitoneal mice model of Streptococcus agalactiae infection compared to parental strain A49V. In conclusion we showed that disruption of beta antigen expression is associated with: i) insertion of ISSa4 upstream the bac gene just after the ribosomal binding site; ii) point mutation G342A resulting a stop codon TGA within the bac gene and a truncated form of beta antigen; iii) single deletion (G) in position 439 of the bgrR gene resulting in a frameshift and the loss of DNA-binding domain of the BgrR protein, and iv) single base substitutions in bgrR and bgrS genes causing single amino acid substitutions in BgrR (Arg187Lys) and BgrS (Arg252Gln). The fact that BgrRS negatively controls virulent properties of Streptococcus agalactiae gives a novel clue for understanding of Streptococcus agalactiae adaptation to the human.	[Vasilyeva, Anastasia; Dmitriev, Alexander] Russian Acad Med Sci, Inst Expt Med, Dept Mol Microbiol, St Petersburg P-22, Russia; [Sanches, Ilda Santos] Univ Nova Lisboa, Fac Ciencias & Tecnol, Ctr Recursos Microbiol CREM, Dept Life Sci, Caparica, Portugal; [Sanches, Ilda Santos] Univ Nova Lisboa, Fac Ciencias & Tecnol, Res Unit Appl Mol Biosci UCIBIO, REQUIMTE, Caparica, Portugal; [Florindo, Carlos] Natl Inst Hlth, Dept Infect Dis, Lisbon, Portugal; [Dmitriev, Alexander] St Petersburg State Univ, Dept Fundamental Problems Med & Med Technol, St Petersburg 199034, Russia	Institute of Experimental Medicine; Russian Academy of Medical Sciences; Universidade Nova de Lisboa; Universidade Nova de Lisboa; Saint Petersburg State University	Sanches, IS (corresponding author), Univ Nova Lisboa, Fac Ciencias & Tecnol, Ctr Recursos Microbiol CREM, Dept Life Sci, Caparica, Portugal.	isanches@fct.unl.pt	Santos Sanches, Ilda/C-5693-2011	Santos Sanches, Ilda/0000-0002-0079-2672	Russian Federal Agency of Scientific Organization; RFBR [12-04-31431, 13-04-01864a]; NANO_GUARD; Fullerene-based systems for oxidative inactivation of airborne microbial pathogens FP7-MC-IRSES [269138]; Fundacao para a Ciencia e a Tecnologia/Ministerio da Educacao e Ciencia (FCT/MEC), Portugal [PTDC/SAU-MII/105114/2008, Pest-OE/BIA/UI0457/2011-CREM]; Fundacao para a Cincia e Tecnologia, Portugal [SFRH/BD/48231/2008]	Russian Federal Agency of Scientific Organization; RFBR(Russian Foundation for Basic Research (RFBR)); NANO_GUARD; Fullerene-based systems for oxidative inactivation of airborne microbial pathogens FP7-MC-IRSES; Fundacao para a Ciencia e a Tecnologia/Ministerio da Educacao e Ciencia (FCT/MEC), Portugal; Fundacao para a Cincia e Tecnologia, Portugal	This work was supported by i) the Russian Federal Agency of Scientific Organization; ii) RFBR projects. N<SUP>o</SUP> 12-04-31431 and. N<SUP>o</SUP> 13-04-01864a; iii) NANO_GUARD. Fullerene-based systems for oxidative inactivation of airborne microbial pathogens. Project No: 269138. FP7-MC-IRSES; iv) projects PTDC/SAU-MII/105114/2008 and Pest-OE/BIA/UI0457/2011-CREM, both funded by Fundacao para a Ciencia e a Tecnologia/Ministerio da Educacao e Ciencia (FCT/MEC), Portugal. CF is supported by research grant ref SFRH/BD/48231/2008 from Fundacao para a Cincia e Tecnologia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Areschoug T, 2002, J BIOL CHEM, V277, P12642, DOI 10.1074/jbc.M112072200; Berardi A, 2014, J CHEMOTHER, V19, P24; BRADY LJ, 1989, INFECT IMMUN, V57, P1573, DOI 10.1128/IAI.57.5.1573-1581.1989; Dmitriev A, 2006, FOLIA MICROBIOL, V51, P229, DOI 10.1007/BF02932127; Dmitriev A, 2004, J BACTERIOL, V186, P1106, DOI 10.1128/JB.186.4.1106-1109.2004; Dmitriev A, 2002, FEMS MICROBIOL LETT, V208, P93, DOI 10.1111/j.1574-6968.2002.tb11066.x; Dmitriev A, 1998, FEMS MICROBIOL LETT, V167, P33, DOI 10.1111/j.1574-6968.1998.tb13204.x; [ДМИТРИЕВ А.В. Dmitriev A.V.], 2009, [Медицинский академический журнал, Meditsinskii akademicheskii zhurnal], V9, P50; Dutra VG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-323; Eskandarian N, 2015, EUR J CLIN MICROBIOL, V34, P579, DOI 10.1007/s10096-014-2265-x; Faralla C, 2014, MBIO, V5, DOI 10.1128/mBio.00870-14; Flechard M, 2013, FEMS MICROBIOL LETT, V340, P65, DOI 10.1111/1574-6968.12076; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Grabovskaya K. B., 2007, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P44; Granlund M, 1998, J INFECT DIS, V177, P967, DOI 10.1086/515233; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Jiang SM, 2008, J BACTERIOL, V190, P1956, DOI 10.1128/JB.01677-07; Jiang SM, 2005, J BACTERIOL, V187, P1105, DOI 10.1128/JB.187.3.1105-1113.2005; Kong FR, 2006, J MED MICROBIOL, V55, P829, DOI 10.1099/jmm.0.46307-0; Kong FR, 2002, J CLIN MICROBIOL, V40, P620, DOI 10.1128/JCM.40.2.620-626.2002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Larsen JW, 2008, AM J OBSTET GYNECOL, V198, P440, DOI 10.1016/j.ajog.2007.11.030; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Lupo A, 2014, INT J MED MICROBIOL, V304, P717, DOI 10.1016/j.ijmm.2014.05.003; Maniatis T., 1982, MOL CLONING; Nagano N, 2006, MICROBIOL-SGM, V152, P771, DOI 10.1099/mic.0.28535-0; Nitschke H, 2014, J CLIN MICROBIOL, V52, P3933, DOI 10.1128/JCM.02411-14; Nordstrom T, 2011, J BIOL CHEM, V286, P33981, DOI 10.1074/jbc.M111.251728; Poyart C, 2001, J BACTERIOL, V183, P6324, DOI 10.1128/JB.183.21.6324-6334.2001; Rajagopal L, 2009, FUTURE MICROBIOL, V4, P201, DOI 10.2217/17460913.4.2.201; Rozhdestvenskaya AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010212; Sadowy E, 2010, J ANTIMICROB CHEMOTH, V65, P1907, DOI 10.1093/jac/dkq230; Santi I, 2009, J BACTERIOL, V191, P5387, DOI 10.1128/JB.00370-09; Sendi P, 2008, INFECTION, V36, P100, DOI 10.1007/s15010-007-7251-0; Spellerberg B, 2002, INFECT IMMUN, V70, P2434, DOI 10.1128/IAI.70.5.2434-2440.2002; Spellerberg B, 2000, GENE, V241, P51, DOI 10.1016/S0378-1119(99)00469-2; Tamura GS, 2000, J INFECT DIS, V181, P364, DOI 10.1086/315205; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Towbin H, 1992, Biotechnology, V24, P145; Yang HI, 2007, INFECT IMMUN, V75, P3455, DOI 10.1128/IAI.00332-07; Yang Q, 2011, MICROBES INFECT, V13, P757, DOI 10.1016/j.micinf.2011.03.001; Zutkis AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114784	44	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128426	10.1371/journal.pone.0128426	http://dx.doi.org/10.1371/journal.pone.0128426			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047354	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200070
J	Xu, DH; Liu, DX; Wang, BQ; Chen, C; Chen, ZY; Li, D; Yang, YJ; Chen, HL; Kong, MG				Xu, Dehui; Liu, Dingxing; Wang, Biqing; Chen, Chen; Chen, Zeyu; Li, Dong; Yang, Yanjie; Chen, Hailan; Kong, Michael G.			In Situ OH Generation from O-2(-) and H2O2 Plays a Critical Role in Plasma-Induced Cell Death	PLOS ONE			English	Article							HABER-WEISS REACTION; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; IRON TRANSPORTER; TRANSFERRIN; FERRITIN; DMT1; FERROPORTIN; SUPEROXIDE; MECHANISMS	Reactive oxygen and nitrogen species produced by cold atmospheric plasma (CAP) are considered to be the most important species for biomedical applications, including cancer treatment. However, it is not known which species exert the greatest biological effects, and the nature of their interactions with tumor cells remains ill-defined. These questions were addressed in the present study by exposing human mesenchymal stromal and LP-1 cells to reactive oxygen and nitrogen species produced by CAP and evaluating cell viability. Superoxide anion (O-2(-)) and hydrogen peroxide (H2O2) were the two major species present in plasma, but their respective concentrations were not sufficient to cause cell death when used in isolation; however, in the presence of iron, both species enhanced the cell death-inducing effects of plasma. We propose that iron containing proteins in cells catalyze O-2(-) and H2O2 into the highly reactive OH radical that can induce cell death. The results demonstrate how reactive species are transferred to liquid and converted into the OH radical to mediate cytotoxicity and provide mechanistic insight into the molecular mechanisms underlying tumor cell death by plasma treatment.	[Xu, Dehui; Liu, Dingxing; Wang, Biqing; Chen, Chen; Chen, Zeyu; Li, Dong; Yang, Yanjie; Kong, Michael G.] Xi An Jiao Tong Univ, Ctr Plasma Biomed, State Key Lab Elect Insulat & Power Equipment, Xian 710049, Peoples R China; [Chen, Hailan; Kong, Michael G.] Old Dominion Univ, Frank Reidy Ctr Bioelect, Norfolk, VA USA; [Kong, Michael G.] Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA USA	Xi'an Jiaotong University; Old Dominion University; Old Dominion University	Xu, DH (corresponding author), Xi An Jiao Tong Univ, Ctr Plasma Biomed, State Key Lab Elect Insulat & Power Equipment, Xian 710049, Peoples R China.	dehuixu@hotmail.com; mkong@odu.edu	Kong, Michael Gangyu/AAC-9728-2020; Xu, Dehui/K-3811-2016	Chen, Hai-Lan/0000-0002-5766-0531; Kong, Michael/0000-0001-8142-4726	National Natural Science Foundation of China [51307135, 51221005, 51307134]; Fundamental Research Funds for Central Universities [08143069, EIPE 14123]; Scientific Research Foundation for Returned from Overseas Chinese Scholars, State Education Ministry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); Scientific Research Foundation for Returned from Overseas Chinese Scholars, State Education Ministry	This research was supported by the National Natural Science Foundation of China (nos. 51307135, 51221005, and 51307134), the Fundamental Research Funds for Central Universities (nos. 08143069 and EIPE 14123), and the Scientific Research Foundation for Returned from Overseas Chinese Scholars, State Education Ministry.	Ahn HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086173; Al-Qenaei A, 2014, FREE RADICAL BIO MED, V68, P87, DOI 10.1016/j.freeradbiomed.2013.12.006; Andrews NC, 1999, INT J BIOCHEM CELL B, V31, P991, DOI 10.1016/S1357-2725(99)00065-5; Bekeschus S, 2014, FREE RADICAL RES, V48, P542, DOI 10.3109/10715762.2014.892937; Blanksby SJ, 2007, ANGEW CHEM INT EDIT, V46, P4948, DOI 10.1002/anie.200700219; Bleeke T, 2004, CIRC RES, V94, P37, DOI 10.1161/01.RES.0000109412.80157.7D; BRIELAND JK, 1991, ARCH BIOCHEM BIOPHYS, V284, P78, DOI 10.1016/0003-9861(91)90266-L; Brun P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033245; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Chen C, 2014, PLASMA CHEM PLASMA P, V34, P403, DOI 10.1007/s11090-014-9545-1; Chen SX, 1999, EUR J BIOCHEM, V260, P726, DOI 10.1046/j.1432-1327.1999.00199.x; Fenton HJH, 1894, J CHEM SOC, V65; Franco R, 2007, J BIOL CHEM, V282, P30452, DOI 10.1074/jbc.M703091200; Garrick MD, 2003, BIOMETALS, V16, P41, DOI 10.1023/A:1020702213099; Graves DB, 2014, PLASMA PROCESS POLYM, V11, P1120, DOI 10.1002/ppap.201400068; Graves DB, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/26/263001; Hippeli S, 1997, Z NATURFORSCH C, V52, P555; Kanazawa S, MEASUREMENT OH RADIC; Kehrer JP, 2000, TOXICOLOGY, V149, P43, DOI 10.1016/S0300-483X(00)00231-6; Keidar M, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4801516; Kong MG, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115012; Koppenol WH, 2002, REDOX REP, V7, P59, DOI 10.1179/135100002125000208; Li YX, 2013, NEURAL REGEN RES, V8, P6, DOI 10.3969/j.issn.1673-5374.2013.01.001; Lortz S, 2014, J MOL ENDOCRINOL, V52, P301, DOI 10.1530/JME-13-0261; Luck AN, 2013, BIOCHEMISTRY-US, V52, P8333, DOI 10.1021/bi401190m; Nicolescu AC, 2006, NITRIC OXIDE-BIOL CH, V15, P163, DOI 10.1016/j.niox.2006.01.010; PEDEN DB, 1993, AM REV RESPIR DIS, V148, P455, DOI 10.1164/ajrccm/148.2.455; Plewa JM, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/4/043027; Prousek J, 2007, PURE APPL CHEM, V79, P2325, DOI 10.1351/pac200779122325; Shpyleva SI, 2011, BREAST CANCER RES TR, V126, P63, DOI 10.1007/s10549-010-0849-4; Suzuki YA, 2005, CELL MOL LIFE SCI, V62, P2560, DOI 10.1007/s00018-005-5371-1; Tani A, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4729889; Tian W, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/16/165201; Tresp H, 2014, PLASMAMED, DOI [10.1615/ PlasmaMed. 2014009711 doi: Doi 10.1021/ Ja00242a038, DOI 10.1615/PLASMAMED.2014009711]; Wang Q, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-59; Wende K, 2014, CELL BIOL INT, V38, P412, DOI 10.1002/cbin.10200; Wu XN, 2014, EUR J CANCER PREV, V23, P122, DOI 10.1097/CEJ.0b013e3283627f14; Xu D, 2012, LEUKEMIA, V26, P1402, DOI 10.1038/leu.2011.332; Yi YH, 2013, ANGEW CHEM INT EDIT, V52, P8446, DOI 10.1002/anie.201304134; Yusupov M, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/2/025205	40	116	121	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128205	10.1371/journal.pone.0128205	http://dx.doi.org/10.1371/journal.pone.0128205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046915	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200047
J	Babich, V; Di Sole, F				Babich, Victor; Di Sole, Francesca			The Na+/H+ Exchanger-3 (NHE3) Activity Requires Ezrin Binding to Phosphoinositide and Its Phosphorylation	PLOS ONE			English	Article							CALCINEURIN HOMOLOGOUS PROTEIN; F-ACTIN BINDING; RHO-ASSOCIATED KINASE; ERM PROTEINS; PROXIMAL TUBULE; S100 PROTEINS; PH REGULATION; MEMBRANE; MOESIN; DOMAIN	Na+/H+ exchanger-3 (NHE3) plays an essential role in maintaining sodium and fluid homeostasis in the intestine and kidney epithelium. Thus, NHE3 is highly regulated and its function depends on binding to multiple regulatory proteins. Ezrin complexed with NHE3 affects its activity via not well-defined mechanisms. This study investigates mechanisms by which ezrin regulates NHE3 activity in epithelial Opossum Kidney cells. Ezrin is activated sequentially by phosphatidylinositol-4,5-bisphosphate (PIP2) binding and phosphorylation of threonine 567. Expression of ezrin lacking PIP2 binding sites inhibited NHE3 activity (-40%) indicating that ezrin binding to PIP2 is required for preserving NHE3 activity. Expression of a phosphomimetic ezrin mutated at the PIP2 binding region was sufficient not only to reverse NHE3 activity to control levels but also to increase its activity (+80%) similar to that of the expression of ezrin carrying the phosphomimetic mutation alone. Calcineurin Homologous Protein-1 (CHP1) is part, with ezrin, of the NHE3 regulatory complex. CHP1-mediated activation of NHE3 activity was blocked by expression of an ezrin variant that could not be phosphorylated but not by an ezrin variant unable to bind PIP2. Thus, for NHE3 activity under baseline conditions not only ezrin phosphorylation, but also ezrin spatial-temporal targeting on the plasma membrane via PIP2 binding is required; however, phosphorylation of ezrin appears to overcome the control of NHE3 transport. CHP1 action on NHE3 activity is not contingent on ezrin binding to PIP2 but rather on ezrin phosphorylation. These findings are important in understanding the interrelation and dynamics of a CHP1-ezrin-NHE3 regulatory complex.	[Babich, Victor; Di Sole, Francesca] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Babich, Victor; Di Sole, Francesca] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Di Sole, Francesca] Des Moines Univ, Dept Physiol & Pharmacol, Des Moines, IA USA	University System of Maryland; University of Maryland Baltimore; University of Texas System; University of Texas Southwestern Medical Center Dallas	Di Sole, F (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.	disole@dmu.edu			National Institutes of Health [R01DK041612, P30DK079328]; Simmons Family Foundation; Charles and Jane Pak Center of Mineral Metabolism; Carl W. Gottschalk Research Scholar Award from American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041612, P30DK079328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simmons Family Foundation; Charles and Jane Pak Center of Mineral Metabolism; Carl W. Gottschalk Research Scholar Award from American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Contract grant sponsor: National Institutes of Health; Contract grant number: R01DK041612 and P30DK079328. Furthermore, the Simmons Family Foundation and the Charles and Jane Pak Center of Mineral Metabolism. Dr. Di Sole was supported by a Carl W. Gottschalk Research Scholar Award from the American Society of Nephrology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Alexander RT, 2005, P NATL ACAD SCI USA, V102, P12253, DOI 10.1073/pnas.0409197102; ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; AMEMIYA M, 1995, KIDNEY INT, V48, P1206, DOI 10.1038/ki.1995.404; Austermann J, 2008, J BIOL CHEM, V283, P29331, DOI 10.1074/jbc.M806145200; Babich V, 2013, FASEB J, V27, P4646, DOI 10.1096/fj.12-225466; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Baumgartner M, 2004, AM J PHYSIOL-CELL PH, V287, pC844, DOI 10.1152/ajpcell.00094.2004; BIEMESDERFER D, 1993, AM J PHYSIOL, V265, pF736, DOI 10.1152/ajprenal.1993.265.5.F736; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Cha B, 2008, CLIN EXP PHARMACOL P, V35, P863, DOI 10.1111/j.1440-1681.2008.04931.x; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; Di Sole F, 2004, J BIOL CHEM, V279, P2962, DOI 10.1074/jbc.M306838200; Di Sole F, 2008, J CELL PHYSIOL, V216, P221, DOI 10.1002/jcp.21399; Di Sole F, 2012, AM J PHYSIOL-RENAL, V303, pF165, DOI 10.1152/ajprenal.00628.2011; Di Sole F, 2009, J AM SOC NEPHROL, V20, P1776, DOI 10.1681/ASN.2008121255; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Hayashi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055623; Heiska L, 1998, J BIOL CHEM, V273, P21893, DOI 10.1074/jbc.273.34.21893; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Hishiya A, 1999, J BIOL CHEM, V274, P26705, DOI 10.1074/jbc.274.38.26705; Huang LQ, 1998, BIOCHEM BIOPH RES CO, V248, P548, DOI 10.1006/bbrc.1998.9009; Kawasaki H, 1998, BIOMETALS, V11, P277, DOI 10.1023/A:1009282307967; Koltzscher M, 2003, MOL BIOL CELL, V14, P2372, DOI 10.1091/mbc.E02-09-0553; Kuwahara H, 2003, J BIOCHEM, V134, P245, DOI 10.1093/jb/mvg137; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Lin X, 1996, P NATL ACAD SCI USA, V93, P12631, DOI 10.1073/pnas.93.22.12631; Lin X, 1999, J BIOL CHEM, V274, P36125, DOI 10.1074/jbc.274.51.36125; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Meima ME, 2007, CURR OPIN NEPHROL HY, V16, P365, DOI 10.1097/MNH.0b013e3281bd888d; MOE OW, 1991, J CLIN INVEST, V88, P1703, DOI 10.1172/JCI115487; Mohan S, 2010, J BIOL CHEM, V285, P34566, DOI 10.1074/jbc.M110.165712; Nakamura F, 1999, MOL BIOL CELL, V10, P2669, DOI 10.1091/mbc.10.8.2669; Niggli V, 2001, TRENDS BIOCHEM SCI, V26, P604, DOI 10.1016/S0968-0004(01)01927-2; NIGGLI V, 1995, FEBS LETT, V376, P172, DOI 10.1016/0014-5793(95)01270-1; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Pang TX, 2004, BIOCHEMISTRY-US, V43, P3628, DOI 10.1021/bi0360004; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594; PREISIG PA, 1988, AM J PHYSIOL, V255, pF461, DOI 10.1152/ajprenal.1988.255.3.F461; PREISIG PA, 1987, J CLIN INVEST, V80, P970, DOI 10.1172/JCI113190; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Rescher U, 2008, PFLUG ARCH EUR J PHY, V455, P575, DOI 10.1007/s00424-007-0313-4; Rohacs T, 2009, CELL CALCIUM, V45, P554, DOI 10.1016/j.ceca.2009.03.011; Shewan A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004796; Singh V, 2014, J BIOL CHEM, V289, P5449, DOI 10.1074/jbc.M113.521336; Szaszi K, 2000, CELL PHYSIOL BIOCHEM, V10, P265, DOI 10.1159/000016358; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Weinman EJ, 2000, BIOCHEMISTRY-US, V39, P6123, DOI 10.1021/bi000064m; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004; Zhao HR, 2004, P NATL ACAD SCI USA, V101, P9485, DOI 10.1073/pnas.0308400101	62	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0129306	10.1371/journal.pone.0129306	http://dx.doi.org/10.1371/journal.pone.0129306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042733	gold, Green Published, Green Submitted			2022-12-27	WOS:000355701600096
J	Cesar, ASM; Regitano, LCA; Koltes, JE; Fritz-Waters, ER; Lanna, DPD; Gasparin, G; Mourao, GB; Oliveira, PSN; Reecy, JM; Coutinho, LL				Cesar, Aline S. M.; Regitano, Luciana C. A.; Koltes, James E.; Fritz-Waters, Eric R.; Lanna, Dante P. D.; Gasparin, Gustavo; Mourao, Gerson B.; Oliveira, Priscila S. N.; Reecy, James M.; Coutinho, Luiz L.			Putative Regulatory Factors Associated with Intramuscular Fat Content	PLOS ONE			English	Article							GENE-EXPRESSION; LONGISSIMUS MUSCLE; TRANSCRIPTIONAL REGULATION; SKELETAL-MUSCLE; RETINOIC ACID; PPAR-GAMMA; PHENOTYPES; TISSUE; METABOLISM; MECHANISMS	Intramuscular fat (IMF) content is related to insulin resistance, which is an important prediction factor for disorders, such as cardiovascular disease, obesity and type 2 diabetes in human. At the same time, it is an economically important trait, which influences the sensorial and nutritional value of meat. The deposition of IMF is influenced by many factors such as sex, age, nutrition, and genetics. In this study Nellore steers (Bos taurus indicus subspecies) were used to better understand the molecular mechanisms involved in IMF content. This was accomplished by identifying differentially expressed genes (DEG), biological pathways and putative regulatory factors. Animals included in this study had extreme genomic estimated breeding value (GEBV) for IMF. RNA-seq analysis, gene set enrichment analysis (GSEA) and co-expression network methods, such as partial correlation coefficient with information theory (PCIT), regulatory impact factor (RIF) and phenotypic impact factor (PIF) were utilized to better understand intramuscular adipogenesis. A total of 16,101 genes were analyzed in both groups (high (H) and low (L) GEBV) and 77 DEG (FDR 10%) were identified between the two groups. Pathway Studio software identified 13 significantly over-represented pathways, functional classes and small molecule signaling pathways within the DEG list. PCIT analyses identified genes with a difference in the number of gene-gene correlations between H and L group and detected putative regulatory factors involved in IMF content. Candidate genes identified by PCIT include: ANKRD26, HOXC5 and PPAPDC2. RIF and PIF analyses identified several candidate genes: GLI2 and IGF2 (RIF1), MPC1 and UBL5 (RIF2) and a host of small RNAs, including miR-1281 (PIF). These findings contribute to a better understanding of the molecular mechanisms that underlie fat content and energy balance in muscle and provide important information for the production of healthier beef for human consumption.	[Cesar, Aline S. M.; Lanna, Dante P. D.; Gasparin, Gustavo; Mourao, Gerson B.; Coutinho, Luiz L.] Univ Sao Paulo, Dept Anim Sci, BR-13418900 Piracicaba, SP, Brazil; [Regitano, Luciana C. A.] EMBRAPA, Southeast Cattle Res Ctr, BR-13560970 Sao Carlos, SP, Brazil; [Koltes, James E.; Fritz-Waters, Eric R.; Reecy, James M.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Oliveira, Priscila S. N.] Univ Fed Sao Carlos, Dept Genet & Evolut, BR-13565905 Sao Carlos, SP, Brazil	Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Iowa State University; Universidade Federal de Sao Carlos	Coutinho, LL (corresponding author), Univ Sao Paulo, Dept Anim Sci, BR-13418900 Piracicaba, SP, Brazil.	llcoutinho@usp.br	Mourão, Gerson/AID-5711-2022; Coutinho, Luiz L/C-8455-2012; Cesar, Aline Silva Mello/E-6887-2014; Mourão, Gerson B/D-2064-2012; Lanna, Dante P D/J-5475-2014; de Almeida Regitano, Luciana Correia/C-7002-2012; Coutinho, Luiz/P-5233-2019	Mourão, Gerson/0000-0002-0990-4108; Coutinho, Luiz L/0000-0002-7266-8881; Cesar, Aline Silva Mello/0000-0001-9921-214X; Mourão, Gerson B/0000-0002-0990-4108; Lanna, Dante P D/0000-0002-7082-8853; de Almeida Regitano, Luciana Correia/0000-0001-9242-8351; Coutinho, Luiz/0000-0002-7266-8881; Reecy, James/0000-0003-4602-0990	Brazilian Agricultural Research Corporation (EMBRAPA) [01/2005, Macroprograma 1]; State of Sao Paulo (FAPESP) [2011/00005-7, 2012/02383-1, 2012/23638-8]; CNPq	Brazilian Agricultural Research Corporation (EMBRAPA); State of Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Brazilian Agricultural Research Corporation (EMBRAPA) - https://www.embrapa.br - process number: (Macroprograma 1, 01/2005). Foundation for Research Support of the State of Sao Paulo (FAPESP) - https://www.fapesp.br - processes number: 2011/00005-7, 2012/02383-1 and 2012/23638-8. LCAR, GBM and LLC were granted CNPq fellowships. The funders had no role in study design,	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; AOCS, 2004, AM OIL CHEM SOC; ARCIONI L, 1992, EMBO J, V11, P265, DOI 10.1002/j.1460-2075.1992.tb05049.x; Aslan O, 2012, MOL BIOL REP, V39, P4101, DOI 10.1007/s11033-011-1192-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bionaz M, 2013, PPAR RES, V2013, DOI 10.1155/2013/684159; Bozaoglu K, 2006, HUM BIOL, V78, P147, DOI 10.1353/hub.2006.0033; Bradshaw AD, 2003, P NATL ACAD SCI USA, V100, P6045, DOI 10.1073/pnas.1030790100; Byun HR, 2011, NEUROBIOL DIS, V44, P125, DOI 10.1016/j.nbd.2011.06.012; Cepica S, 2012, ANIM GENET, V43, P333, DOI 10.1111/j.1365-2052.2011.02252.x; Cesar ASM, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-39; Colca JR, 2013, CLIN PHARMACOL THER, V93, P352, DOI 10.1038/clpt.2013.10; Cowherd RM, 1997, BIOCHEM BIOPH RES CO, V237, P470, DOI 10.1006/bbrc.1997.7160; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; De Jager N, 2013, J ANIM SCI, V91, P1112, DOI 10.2527/jas.2012-5409; Dinh TTN, 2010, J ANIM SCI, V88, P756, DOI 10.2527/jas.2009-1951; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Gilmour AR, 2009, ASREML USER GUIDE RE; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hausman GJ, 2009, J ANIM SCI, V87, P1218, DOI 10.2527/jas.2008-1427; Hocquette JF, 2014, MEAT SCI, V97, P316, DOI 10.1016/j.meatsci.2013.07.031; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hudson NJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000382; Huff PW, 2004, CAN J ANIM SCI, V84, P49, DOI 10.4141/A02-058; Jin W, 2012, J ANIM SCI, V90, P171, DOI 10.2527/jas.2011-4229; Jowett JB, 2004, DIABETES, V53, P2467, DOI 10.2337/diabetes.53.9.2467; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; Kim JH, 2014, CELL DEATH DIFFER, V21, P594, DOI 10.1038/cdd.2013.181; Koesterke L, 2013, PROCEEDINGS OF THE C, P1; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066267; Lee SH, 2007, J BIOCHEM MOL BIOL, V40, P757; Lehnert SA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213x-7-95; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Mandrup S, 2012, NUCLEUS-PHILA, V3, P12, DOI 10.4161/nucl.18928; McCarthy FM, 2011, NUCLEIC ACIDS RES, V39, pD497, DOI 10.1093/nar/gkq1115; Michal JJ, 2006, ANIM GENET, V37, P400, DOI 10.1111/j.1365-2052.2006.01464.x; MILLIGAN G, 1995, TRENDS BIOCHEM SCI, V20, P181, DOI 10.1016/S0968-0004(00)89004-0; Nakajima I, 2002, BIOL CELL, V94, P197, DOI 10.1016/S0248-4900(02)01189-9; Nguyen LL, 2006, J BIOCHEM MOL BIOL, V39, P457; Nicoloff G, 2006, J INVEST MED, V54, P461, DOI 10.2310/6650.2006.06009; Nie J, 2009, J CELL COMMUN SIGNAL, V3, P247, DOI 10.1007/s12079-009-0064-4; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; O'Quinn TG, 2012, J ANIM SCI, V90, P626, DOI 10.2527/jas.2011-4282; Raciti GA, 2011, DIABETOLOGIA, V54, P2911, DOI 10.1007/s00125-011-2263-9; Ramayo-Caldas Y, 2014, J ANIM SCI, V92, P2832, DOI 10.2527/jas.2013-7484; Ramayo-Caldas Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-547; Resh Marilyn D, 2006, Sci STKE, V2006, pre14, DOI 10.1126/stke.3592006re14; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Reverter A, 2010, BIOINFORMATICS, V26, P896, DOI 10.1093/bioinformatics/btq051; Ribes V, 2009, DEVELOPMENT, V136, P665, DOI 10.1242/dev.016204; Romao JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-137; Rule DC, 1997, J ANIM SCI, V75, P1525; Sahab ZJ, 2010, J CANCER, V1, P14; Salter A. M., 2013, Animal Frontiers, V3, P20, DOI 10.2527/af.2013-0004; Sosnicki AA, 2010, MEAT SCI, V86, P129, DOI 10.1016/j.meatsci.2010.04.034; Steger DJ, 2011, EMBO J, V30, P1418, DOI 10.1038/emboj.2011.80; Stoecklin E, 1999, J STEROID BIOCHEM, V69, P195, DOI 10.1016/S0960-0760(99)00052-7; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Wang YH, 2009, J ANIM SCI, V87, P119, DOI 10.2527/jas.2008-1082; Wang YH, 2005, MAMM GENOME, V16, P201, DOI 10.1007/s00335-004-2419-8	67	58	60	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128350	10.1371/journal.pone.0128350	http://dx.doi.org/10.1371/journal.pone.0128350			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042666	gold, Green Published, Green Submitted			2022-12-27	WOS:000355701600045
J	Hilbert-Wolf, HL; Roberts, EM				Hilbert-Wolf, Hannah Louise; Roberts, Eric M.			Giant Seismites and Megablock Uplift in the East African Rift: Evidence for Late Pleistocene Large Magnitude Earthquakes	PLOS ONE			English	Article							SOFT-SEDIMENT DEFORMATION; RUKWA RIFT; EMPIRICAL RELATIONSHIPS; LACUSTRINE SEDIMENTS; TRIGGER MECHANISMS; ACTIVE FAULTS; BASIN; LIQUEFACTION; TANZANIA; DISTANCE	In lieu of comprehensive instrumental seismic monitoring, short historical records, and limited fault trench investigations for many seismically active areas, the sedimentary record provides important archives of seismicity in the form of preserved horizons of soft-sediment deformation features, termed seismites. Here we report on extensive seismites in the Late Quaternary-Recent (<= similar to 28,000 years BP) alluvial and lacustrine strata of the Rukwa Rift Basin, a segment of the Western Branch of the East African Rift System. We document examples of the most highly deformed sediments in shallow, subsurface strata close to the regional capital of Mbeya, Tanzania. This includes a remarkable, clastic 'megablock complex' that preserves remobilized sediment below vertically displaced blocks of intact strata (megablocks), some in excess of 20 m-wide. Documentation of these seismites expands the database of seismogenic sedimentary structures, and attests to large magnitude, Late Pleistocene-Recent earthquakes along the Western Branch of the East African Rift System. Understanding how seismicity deforms near-surface sediments is critical for predicting and preparing for modern seismic hazards, especially along the East African Rift and other tectonically active, developing regions.	[Hilbert-Wolf, Hannah Louise; Roberts, Eric M.] James Cook Univ, Dept Earth & Oceans, Townsville, Qld 4811, Australia	James Cook University	Hilbert-Wolf, HL (corresponding author), James Cook Univ, Dept Earth & Oceans, Townsville, Qld 4811, Australia.	hannah.hilbertwolf@my.jcu.edu.au	Hilbert-Wolf, Hannah/J-5893-2014	Hilbert-Wolf, Hannah/0000-0002-4419-2337	James Cook University; US National Science Foundation [NSF-BCS-127164, NSF-EAR-1349825]	James Cook University; US National Science Foundation(National Science Foundation (NSF))	Financial support for this study was provided by James Cook University (http://www.jcu.edu.au) and the US National Science Foundation (NSF-BCS-127164, NSF-EAR-1349825). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JRL, 1986, SEDIMENT GEOL, V46, P67, DOI 10.1016/0037-0738(86)90006-0; Alsop GI, 2013, TECTONOPHYSICS, V605, P48, DOI 10.1016/j.tecto.2013.04.004; Ambraseys N. N., 1991, Natural Hazards, V4, P389, DOI 10.1007/BF00126646; AMBRASEYS NN, 1991, TERRA NOVA, V3, P202, DOI 10.1111/j.1365-3121.1991.tb00873.x; AMBRASEYS NN, 1988, EARTHQ ENG STRUCT D, V17, P1, DOI 10.1002/eqe.4290170101; [Anonymous], 2007, SAND INJECTITES IMPL; [Anonymous], 1969, GEOL ROMANA; Atkinson G.M., 1984, EARTHQ SPECTRA, V1, P107, DOI DOI 10.1193/1.1585259; Audemard F.A., 1991, B INT ASS ENG GEOLOG, V44, P5, DOI DOI 10.1007/BF02602705; Backeberg NR, 2009, S AFR J GEOL, V112, P187, DOI 10.2113/gssajg.112.2.187; Camelbeeck T, 1996, GEOPHYS J INT, V124, P612, DOI 10.1111/j.1365-246X.1996.tb07040.x; Cartwright J, 2010, BASIN RES, V22, P502, DOI 10.1111/j.1365-2117.2009.00455.x; Cohen AS, 2013, PALAEOGEOGR PALAEOCL, V392, P79, DOI 10.1016/j.palaeo.2013.09.007; Delvaux D, 2012, J STRUCT GEOL, V37, P161, DOI 10.1016/j.jsg.2012.01.008; Delvaux D, 1998, J AFR EARTH SCI, V26, P397, DOI 10.1016/S0899-5362(98)00023-2; Delvaux D., 1993, RAPPORT ANN 1991 199, P87; Delvaux D, 2011, 23 C AFR GEOL JOH S, V112; FIELD ME, 1982, GEOLOGY, V10, P542, DOI 10.1130/0091-7613(1982)10<542:ESFOAS>2.0.CO;2; Galli P, 2000, TECTONOPHYSICS, V324, P169, DOI 10.1016/S0040-1951(00)00118-9; Haub C., 2012, WORLD POPULATION DAT; HEMPTON MR, 1983, TECTONOPHYSICS, V98, pT7, DOI 10.1016/0040-1951(83)90294-9; Hilbert-Wolf HL, 2009, BASIN RES, V21, P856, DOI 10.1111/j.1365-2117.2009.00398.x; Hurst A, 2011, EARTH-SCI REV, V106, P215, DOI 10.1016/j.earscirev.2011.02.004; Huuse M, 2007, AAPG MEMOIR, V87, P21, DOI DOI 10.1306/1209847M873253; International Seismological Centre, 2012, INT SEISM CTR ON LIN; Jones AP, 2000, SEDIMENTOLOGY, V47, P1211, DOI 10.1046/j.1365-3091.2000.00355.x; Kervyn F, 2006, J AFR EARTH SCI, V44, P151, DOI 10.1016/j.jafrearsci.2005.10.008; Loope DB, 2013, GEOLOGY, V41, P1131, DOI 10.1130/G34619.1; Loseth H, 2012, GEOLOGY, V40, P467, DOI 10.1130/G33117.1; LOWE DR, 1975, SEDIMENTOLOGY, V22, P157, DOI 10.1111/j.1365-3091.1975.tb00290.x; Milga NR, 1994, THESIS DUKE U; Molina JM, 1998, TERRA NOVA, V10, P145; Montenat C, 2007, SEDIMENT GEOL, V196, P5, DOI 10.1016/j.sedgeo.2006.08.004; Moretti M, 2007, SEDIMENT GEOL, V196, P31, DOI 10.1016/j.sedgeo.2006.05.012; Morley CK, 2000, J GEOL SOC LONDON, V157, P983, DOI 10.1144/jgs.157.5.983; NICHOLS RJ, 1994, SEDIMENTOLOGY, V41, P233, DOI 10.1111/j.1365-3091.1994.tb01403.x; Obermeier S.F., 1993, 1536 US GEOL SURV; Obermeier SF, 1996, ENG GEOL, V44, P1, DOI 10.1016/S0013-7952(96)00040-3; Obermeier SF, 2009, INT GEOPHYS SER, V95, P497, DOI 10.1016/S0074-6142(09)95007-0; Owen G, 2011, SEDIMENT GEOL, V235, P141, DOI 10.1016/j.sedgeo.2010.10.003; Papathanassiou G, 2005, J GEODYN, V40, P257, DOI 10.1016/j.jog.2005.07.007; Quigley MC, 2013, GEOLOGY, V41, P419, DOI 10.1130/G33944.1; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Roberts EM, 2012, NAT GEOSCI, V5, P289, DOI [10.1038/ngeo1432, 10.1038/NGEO1432]; Roberts EM, 2010, J AFR EARTH SCI, V57, P179, DOI 10.1016/j.jafrearsci.2009.09.002; Rodriguez-Pascua MA, 2000, SEDIMENT GEOL, V135, P117, DOI 10.1016/S0037-0738(00)00067-1; SCOTT A.S.J., 2009, J SEDIMENT RES, V79, P1, DOI [10.2110/JSR.2009.004, DOI 10.2110/JSR.2009.004]; Sherry TJ, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004157; SIMS JD, 1975, TECTONOPHYSICS, V29, P141, DOI 10.1016/0040-1951(75)90139-0; Skobelev SF, 2004, TECTONOPHYSICS, V380, P131, DOI 10.1016/j.tecto.2003.10.016; Stirling M, 2002, B SEISMOL SOC AM, V92, P812, DOI 10.1785/0120000221; Tsuchida H., 1971, P 3 JOINT M USJAPAN, V14, P91; U. S. Geological Survey, ANSS GLOB EARTHQ CAT; Vigorito M, 2008, J GEOL SOC LONDON, V165, P609, DOI 10.1144/0016-76492007-096; Vigorito M, 2010, J GEOL SOC LONDON, V167, P889, DOI 10.1144/0016-76492010-004; Vittori E, 1997, J GEODYN, V24, P139, DOI 10.1016/S0264-3707(96)00038-5; WELLS DL, 1994, B SEISMOL SOC AM, V84, P974	57	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0129051	10.1371/journal.pone.0129051	http://dx.doi.org/10.1371/journal.pone.0129051			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042601	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000355701600084
J	von Loetzen, CS; Jacob, T; Hartl-Spiegelhauer, O; Vogel, L; Schiller, D; Sporlein-Guttler, C; Schobert, R; Vieths, S; Hartl, MJ; Rosch, P				von Loetzen, Christian Seutter; Jacob, Thessa; Hartl-Spiegelhauer, Olivia; Vogel, Lothar; Schiller, Dirk; Spoerlein-Guettler, Cornelia; Schobert, Rainer; Vieths, Stefan; Hartl, Maximilian Johannes; Roesch, Paul			Ligand Recognition of the Major Birch Pollen Allergen Bet v 1 is Isoform Dependent	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEINS; BIOLOGICAL FUNCTION; IMMUNOGLOBULIN-E; POTENTIAL USE; TREE POLLEN; BET-V-1; BINDING; IGE; QUERCETIN; PURIFICATION	Each spring millions of patients suffer from allergies when birch pollen is released into the air. In most cases, the major pollen allergen Bet v 1 is the elicitor of the allergy symptoms. Bet v 1 comes in a variety of isoforms that share virtually identical conformations, but their relative concentrations are plant-specific. Glycosylated flavonoids, such as quercetin-3-O-sophoroside, are the physiological ligands of Bet v 1, and here we found that three isoforms differing in their allergenic potential also show an individual, highly specific binding behaviour for the different ligands. This specificity is driven by the sugar moieties of the ligands rather than the flavonols. While the influence of the ligands on the allergenicity of the Bet v 1 isoforms may be limited, the isoform and ligand mixtures add up to a complex and thus individual fingerprint of the pollen. We suggest that this mixture is not only acting as an effective chemical sunscreen for pollen DNA, but may also play an important role in recognition processes during pollination.	[von Loetzen, Christian Seutter; Jacob, Thessa; Hartl-Spiegelhauer, Olivia; Hartl, Maximilian Johannes; Roesch, Paul] Univ Bayreuth, Dept Biopolymers, Bayreuth, Bavaria, Germany; [Spoerlein-Guettler, Cornelia; Schobert, Rainer] Univ Bayreuth, Chair Organ Chem, Bayreuth, Bavaria, Germany; [Vogel, Lothar; Schiller, Dirk; Vieths, Stefan] Paul Ehrlich Inst, Div Allergol, Langen, Hesse, Germany	University of Bayreuth; University of Bayreuth; Paul Ehrlich Institute	von Loetzen, CS (corresponding author), Univ Bayreuth, Dept Biopolymers, Bayreuth, Bavaria, Germany.	Christian.Seutter@uni-bayreuth.de						Agarwal P, 2014, MOL BIOL REP, V41, P599, DOI 10.1007/s11033-013-2897-4; Arquint O, 1999, J ALLERGY CLIN IMMUN, V104, P1239, DOI 10.1016/S0091-6749(99)70019-9; Arraez-Roman D, 2007, ANAL BIOANAL CHEM, V389, P1909, DOI 10.1007/s00216-007-1611-6; Asam C, 2014, CLIN EXP ALLERGY; Atkinson RG, 1996, NEW ZEAL J CROP HORT, V24, P103, DOI 10.1080/01140671.1996.9513941; Ballmer-Weber BK, 2005, CLIN EXP ALLERGY, V35, P970, DOI 10.1111/j.1365-2222.2005.02294.x; Bohm B. A., 1998, INTRO FLAVONOIDS; Bollen MA, 2007, MOL NUTR FOOD RES, V51, P1527, DOI 10.1002/mnfr.200700119; BREITENEDER H, 1995, EUR J BIOCHEM, V233, P484, DOI 10.1111/j.1432-1033.1995.484_2.x; BREITENEDER H, 1993, EUR J BIOCHEM, V212, P355, DOI 10.1111/j.1432-1033.1993.tb17669.x; BREITENEDER H, 1989, EMBO J, V8, P1935, DOI 10.1002/j.1460-2075.1989.tb03597.x; Bublin M, 2014, J ALLERGY CLIN IMMUN; Bufe A, 1998, INT ARCH ALLERGY IMM, V117, P215, DOI 10.1159/000024013; Buitink J, 1998, PLANT PHYSIOL, V118, P531, DOI 10.1104/pp.118.2.531; Buters JTM, 2010, ALLERGY, V65, P850, DOI 10.1111/j.1398-9995.2009.02286.x; Buters JTM, 2008, INT ARCH ALLERGY IMM, V145, P122, DOI 10.1159/000108137; Casanal A, 2013, J BIOL CHEM, V288, P35322, DOI 10.1074/jbc.M113.501528; CESKA O, 1984, PHYTOCHEMISTRY, V23, P1822, DOI 10.1016/S0031-9422(00)83510-4; Chirumbolo Salvatore, 2010, Inflammation & Allergy Drug Targets, V9, P263; Cvetkovic D, 2011, J SERB CHEM SOC, V76, P973, DOI 10.2298/JSC101123089C; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DREBORG S, 1988, ANN ALLERGY, V61, P41; ELRIDI MS, 1952, ARCH BIOCHEM BIOPHYS, V39, P317, DOI 10.1016/0003-9861(52)90342-1; Erler A, 2011, PROTEOMICS, V11, P1486, DOI 10.1002/pmic.201000624; Faber C, 1996, J BIOL CHEM, V271, P19243, DOI 10.1074/jbc.271.32.19243; Fernandes H, 2013, FEBS J, V280, P1169, DOI 10.1111/febs.12114; Ferreira F, 1998, FASEB J, V12, P231, DOI 10.1096/fasebj.12.2.231; Ferreira F, 1996, J EXP MED, V183, P599, DOI 10.1084/jem.183.2.599; FERREIRA FD, 1993, J BIOL CHEM, V268, P19574; Firon N, 2012, ANN BOT-LONDON, V109, P1201, DOI 10.1093/aob/mcs070; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Gell PGH, 1968, CLIN ASPECTS IMMUNOL, VSecond, P580; Geroldinger-Simic M, 2011, J ALLERGY CLIN IMMUN, V127, P616, DOI 10.1016/j.jaci.2010.10.027; Gobl C, 2014, PROG NUCL MAG RES SP, V80, P26, DOI 10.1016/j.pnmrs.2014.05.003; Golebski K, 2013, ALLERGY, V68, P152, DOI 10.1111/all.12080; GROTE M, 1993, J HISTOCHEM CYTOCHEM, V41, P745, DOI 10.1177/41.5.8468456; HESLOPHARRISON J, 1975, ANNU REV PLANT PHYS, V26, P403, DOI 10.1146/annurev.pp.26.060175.002155; Hiscock SJ, 2008, NEW PHYTOL, V179, P286, DOI 10.1111/j.1469-8137.2008.02457.x; Hoffmann-Sommergruber K, 2000, INT ARCH ALLERGY IMM, V122, P115, DOI 10.1159/000024367; Hoffmann-Sommergruber K, 2000, INT ARCH ALLERGY IMM, V122, P155, DOI 10.1159/000024392; HoffmannSommergruber K, 1997, GENE, V197, P91, DOI 10.1016/S0378-1119(97)00246-1; Holgersson J, 2005, IMMUNOL CELL BIOL, V83, P694, DOI 10.1111/j.1440-1711.2005.01373.x; Holm J, 2001, J CHROMATOGR B, V756, P307, DOI 10.1016/S0378-4347(01)00089-5; Hostetler GL, 2013, FOOD CHEM, V141, P1406, DOI 10.1016/j.foodchem.2013.04.051; IPSEN H, 1983, J ALLERGY CLIN IMMUN, V72, P150, DOI 10.1016/0091-6749(83)90523-7; JAROLIM E, 1989, ALLERGY, V44, P385, DOI 10.1111/j.1398-9995.1989.tb04169.x; JIA S-S, 1986, Yaoxue Xuebao, V21, P441; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Karioti A, 2008, FLORA, V203, P602, DOI 10.1016/j.flora.2007.09.009; Karlsson AL, 2004, ALLERGY, V59, P1277, DOI 10.1111/j.1398-9995.2004.00585.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koistinen KM, 2005, PHYTOCHEMISTRY, V66, P2524, DOI 10.1016/j.phytochem.2005.09.007; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lavola A, 2013, PHYSIOL PLANTARUM, V149, P499, DOI 10.1111/ppl.12051; Lebel S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-184; Leja M, 2013, PLANT FOOD HUM NUTR, V68, P163, DOI 10.1007/s11130-013-0351-3; Lemieux RU, 1999, ACCOUNTS CHEM RES, V32, P631, DOI 10.1021/ar990027r; Liu JJ, 2006, PHYSIOL MOL PLANT P, V68, P3, DOI 10.1016/j.pmpp.2006.06.004; Markovic-Housley Z, 2003, J MOL BIOL, V325, P123, DOI 10.1016/S0022-2836(02)01197-X; MEURER B, 1988, PHYTOCHEMISTRY, V27, P823, DOI 10.1016/0031-9422(88)84100-1; Mittag D, 2004, J ALLERGY CLIN IMMUN, V114, P1410, DOI 10.1016/j.jaci.2004.09.014; MO YY, 1992, P NATL ACAD SCI USA, V89, P7213, DOI 10.1073/pnas.89.15.7213; Mogensen JE, 2002, J BIOL CHEM, V277, P23684, DOI 10.1074/jbc.M202065200; Mogensen JE, 2007, BIOCHEMISTRY-US, V46, P3356, DOI 10.1021/bi062058h; Morales LO, 2011, PHYSIOL PLANTARUM, V143, P261, DOI 10.1111/j.1399-3054.2011.01511.x; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Munoz C, 2010, MOL PLANT, V3, P113, DOI 10.1093/mp/ssp087; Pacini E., 1994, CONTROL SELF IMCOMPA, P289; Puhringer H, 2000, PLANT SCI, V152, P35, DOI 10.1016/S0168-9452(99)00222-8; Radauer C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-286; Reuter A, 2005, PROTEOMICS, V5, P282, DOI 10.1002/pmic.200400874; Riecken S, 2008, BIOL CHEM, V389, P415, DOI 10.1515/BC.2008.038; Roth-Walter F, 2014, J BIOL CHEM; Schenk MF, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-168; Schenk MF, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-24; Scheurer S, 1997, MOL IMMUNOL, V34, P619, DOI 10.1016/S0161-5890(97)00072-2; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schweimer K, 1999, APPL MAGN RESON, V17, P449, DOI 10.1007/BF03162177; Seutter von Loetzen C, 2014, BIOCHEM J, V457, P379, DOI 10.1042/BJ20130413; Smith GJ, 2000, J PHOTOCH PHOTOBIO A, V136, P87, DOI 10.1016/S1010-6030(00)00320-8; SOSA F, 1965, CR HEBD ACAD SCI, V261, P4544; Srinivas K, 2010, J FOOD ENG, V100, P208, DOI 10.1016/j.jfoodeng.2010.04.001; STEVENS FA, 1951, J ALLERGY, V22, P165, DOI 10.1016/0021-8707(51)90056-1; STRACK D, 1984, PHYTOCHEMISTRY, V23, P2970, DOI 10.1016/0031-9422(84)83059-9; Swaminathan CP, 1998, J AM CHEM SOC, V120, P5153, DOI 10.1021/ja9733696; SWOBODA I, 1995, J BIOL CHEM, V270, P2607, DOI 10.1074/jbc.270.6.2607; SWOBODA I, 1995, PLANT CELL ENVIRON, V18, P865, DOI 10.1111/j.1365-3040.1995.tb00595.x; Tao WW, 2011, PHYTOCHEM ANALYSIS, V22, P455, DOI 10.1002/pca.1302; TOONE EJ, 1994, CURR OPIN STRUC BIOL, V4, P719, DOI 10.1016/S0959-440X(94)90170-8; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; VANEKKREBITZ M, 1995, BIOCHEM BIOPH RES CO, V214, P538, DOI 10.1006/bbrc.1995.2320; Vogel L, 2005, ALLERGY, V60, P1021, DOI 10.1111/j.1398-9995.2005.00803.x; Vrtala S, 2001, FASEB J, V15, P2045, DOI 10.1096/fj.00-0767fje; Yamamoto M, 1997, PLANT CELL PHYSIOL, V38, P1080, DOI 10.1093/oxfordjournals.pcp.a029275; Ziadi S, 2001, PHYSIOL MOL PLANT P, V59, P33, DOI 10.1006/pmpp.2001.0343	96	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128677	10.1371/journal.pone.0128677	http://dx.doi.org/10.1371/journal.pone.0128677			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042900	Green Published, gold, Green Submitted			2022-12-27	WOS:000355701600060
J	Williams, JS; Ng, N; Peltzer, K; Yawson, A; Biritwum, R; Maximova, T; Wu, F; Arokiasamy, P; Kowal, P; Chatterji, S				Williams, Jennifer Stewart; Ng, Nawi; Peltzer, Karl; Yawson, Alfred; Biritwum, Richard; Maximova, Tamara; Wu, Fan; Arokiasamy, Perianayagam; Kowal, Paul; Chatterji, Somnath			Risk Factors and Disability Associated with Low Back Pain in Older Adults in Low- and Middle-Income Countries. Results from the WHO Study on Global AGEing and Adult Health (SAGE)	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; PREVALENCE; EPIDEMIOLOGY; POPULATION; WORLD; BURDEN; IMPACT; COHORT; AGE; ORGANIZATION	Background Back pain is a common disabling chronic condition that burdens individuals, families and societies. Epidemiological evidence, mainly from high-income countries, shows positive association between back pain prevalence and older age. There is an urgent need for accurate epidemiological data on back pain in adult populations in low- and middle-income countries (LMICs) where populations are ageing rapidly. The objectives of this study are to: measure the prevalence of back pain; identify risk factors and determinants associated with back pain, and describe association between back pain and disability in adults aged 50 years and older, in six LMICs from different regions of the world. The findings provide insights into country-level differences in self-reported back pain and disability in a group of socially, culturally, economically and geographically diverse LMICs. Methods Standardized national survey data collected from adults (50 years and older) participating in the World Health Organization (WHO) Study on global AGEing and adult health (SAGE) were analysed. The weighted sample (n = 30, 146) comprised respondents in China, Ghana, India, Mexico, South Africa and the Russian Federation. Multivariable regressions describe factors associated with back pain prevalence and intensity, and back pain as a determinant of disability. Results Prevalence was highest in the Russian Federation (56%) and lowest in China (22%). In the pooled multi-country analyses, female sex, lower education, lower wealth and multiple chronic morbidities were significant in association with past-month back pain (p<0.01). About 8% of respondents reported that they experienced intense back pain in the previous month. Conclusions Evidence on back pain and its impact on disability is needed in developing countries so that governments can invest in cost-effective education and rehabilitation to reduce the growing social and economic burden imposed by this disabling condition.	[Williams, Jennifer Stewart; Ng, Nawi] Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, Umea, Sweden; [Williams, Jennifer Stewart; Kowal, Paul] Univ Newcastle, Fac Hlth, Res Ctr Gender Hlth & Ageing, Newcastle, NSW 2300, Australia; [Peltzer, Karl] Human Sci Res Council, Pretoria, South Africa; [Peltzer, Karl] Univ Free State, Dept Psychol, Bloemfontein, South Africa; [Peltzer, Karl] Mahidol Univ, ASEAN Inst Hlth Dev, Nakhon Pathom, Thailand; [Yawson, Alfred; Biritwum, Richard] Univ Ghana, Dept Community Hlth, Accra, Ghana; [Maximova, Tamara] Natl Res Inst Publ Hlth, FSBI, RAMS, Moscow, Russia; [Wu, Fan] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Arokiasamy, Perianayagam] Int Inst Populat Sci, Bombay, Maharashtra, India; [Kowal, Paul; Chatterji, Somnath] World Hlth Org Study Global AGEing & Adult Hlth, Geneva, Switzerland; [Chatterji, Somnath] WHO, Measurement & Anal Unit, Surveys, CH-1211 Geneva, Switzerland	Umea University; University of Newcastle; Human Sciences Research Council-South Africa; University of the Free State; Mahidol University; University of Ghana; N.A. Semashko National Research Institute of Public Health; Russian Academy of Medical Sciences; Shanghai Center for Disease Control & Prevention; International Institute for Population Sciences; World Health Organization; World Health Organization	Williams, JS (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, Umea, Sweden.	Jennifer.stewart.williams@epiph.umu.se	CHATTERJI, Somnath/ABE-6832-2020; Peltzer, Karl/Q-7334-2019; YAWSON, ALFRED/R-8013-2019; Perianayagam, Arokiasamy/AAT-4147-2020; Peltzer, Karl/D-1518-2019; Ng, Nawi/F-8373-2011	Peltzer, Karl/0000-0002-5980-0876; YAWSON, ALFRED/0000-0003-0159-5686; Perianayagam, Arokiasamy/0000-0001-8698-217X; Peltzer, Karl/0000-0002-5980-0876; Ng, Nawi/0000-0003-0556-1483; Kowal, Paul/0000-0002-6314-8753; YAWSON, ALFRED E/0000-0001-6960-5751	FORTE grant for the Umea Centre for Global Health Research [20061512]; Swedish Research Council's "Linnestod" grant for the Ageing and Living Conditions Programme at Umea University, Sweden [2006-21576-35119-66]	FORTE grant for the Umea Centre for Global Health Research; Swedish Research Council's "Linnestod" grant for the Ageing and Living Conditions Programme at Umea University, Sweden	In this work, Jennifer Stewart Williams and Nawi Ng were supported by the FORTE grant for the Umea Centre for Global Health Research (No. 20061512). Nawi Ng was also supported by the Swedish Research Council's "Linnestod" grant (No 2006-21576-35119-66) for the Ageing and Living Conditions Programme at Umea University, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, BMC MUSCULOSKEL DIS, V8, P14; Bartley EJ, 2013, BRIT J ANAESTH, V111, P52, DOI 10.1093/bja/aet127; Borrell-Carrio F, 2004, ANN FAM MED, V2, P576, DOI 10.1370/afm.245; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Brooks P, 2005, RHEUMATOLOGY, V44, P831, DOI 10.1093/rheumatology/keh648; Brooks PM, 2006, CLIN RHEUMATOL, V25, P778, DOI 10.1007/s10067-006-0240-3; Carr JL, 2005, CHRONIC ILLN, V1, P121, DOI 10.1179/174239505X44826; Cecchi F, 2006, SPINE, V31, P1149, DOI 10.1097/01.brs.0000216606.24142.e1; Cho NH, 2012, SPINE, V37, P2001, DOI 10.1097/BRS.0b013e31825d1fa8; Connelly LB, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P963; Dagan SS, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-12; Dillon C, 2004, SPINE, V29, P892, DOI 10.1097/00007632-200404150-00014; Dionne CE, 2006, AGE AGEING, V35, P229, DOI 10.1093/ageing/afj055; Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94; Donald IP, 2004, RHEUMATOLOGY, V43, P1256, DOI 10.1093/rheumatology/keh298; Fejer R, 2012, CHIROPRACTIC MANUAL, V20, P52; Ferguson B, 2003, HLTH SYSTEMS PERFORM; Gilgil E, 2005, SPINE, V30, P1093, DOI 10.1097/01.brs.0000161007.46849.4c; Goldberg MS, 2000, SPINE, V25, P995, DOI 10.1097/00007632-200004150-00016; Guo HR, 2004, J OCCUP HEALTH, V46, P26, DOI 10.1539/joh.46.26; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; Han TS, 1997, INT J OBESITY, V21, P600, DOI 10.1038/sj.ijo.0800448; He W, 2012, SHADES GRAY CROSS CO; Heistaro S, 1998, AM J EPIDEMIOL, V148, P671, DOI 10.1093/aje/148.7.671; Hirve S, 2013, GLOBAL HLTH ACTION; Howe LD, 2012, INT J EPIDEMIOL, DOI [10.1093/ije/dys037:16, DOI 10.1093/IJE/DYS037:16]; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Hoy D, 2014, ANN RHEUM DIS; Hoy D, 2010, BEST PRACT RES CL RH, V24, P155, DOI 10.1016/j.berh.2009.11.002; Huxley R, 2010, EUR J CLIN NUTR, V64, P16, DOI 10.1038/ejcn.2009.68; Jacobs JM, 2006, SPINE, V31, pE203, DOI 10.1097/01.brs.0000206367.57918.3c; Jin K, 2004, J SAFETY RES, V35, P23, DOI 10.1016/j.jsr.2003.11.002; Karunanayake AL, 2013, INT J RHEUM DIS, V16, P203, DOI 10.1111/1756-185X.12060; Kim GS, 2014, PHYSIOTHERAPY RES IN; Knauer SR, 2010, J AGING HEALTH, V22, P1213, DOI 10.1177/0898264310374111; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Latza U, 2004, SPINE, V29, P1561, DOI 10.1097/01.BRS.0000131435.56714.15; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Manek NJ, 2005, CURR OPIN RHEUMATOL, V17, P134; Maximova TM, 2007, 1 EUR C ADV GER, V20, P273; Moore JE, 2010, PHYS MED REH CLIN N, V21, P801, DOI 10.1016/j.pmr.2010.06.005; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Muraki S, 2011, SPINE, V36, P1312, DOI 10.1097/BRS.0b013e3181fa60d1; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Naidoo N, 2012, DROP; Peltonen M, 2003, PAIN, V104, P549, DOI 10.1016/S0304-3959(03)00091-5; Plouvier S, 1999, SCAND J WORK ENV HEA, V35, P429; Raspe H, 2004, SPINE, V29, P1017, DOI 10.1097/00007632-200405010-00013; Rudy TE, 2007, PAIN, V131, P293, DOI 10.1016/j.pain.2007.01.012; Salomon JA, 2004, BMJ-BRIT MED J, V328, P258, DOI 10.1136/bmj.37963.691632.44; Scheele J, 2012, EUR J PHYS REHAB MED, V48, P379; Shiri R, 2010, AM J EPIDEMIOL, V171, P135, DOI 10.1093/aje/kwp356; Sousa RM, 2010, INT J METH PSYCH RES, V19, P1, DOI 10.1002/mpr.299; Stranjalis G, 2004, SPINE, V29, P1355, DOI 10.1097/01.BRS.0000127181.59012.1C; Tsang A, 2008, J PAIN, V9, P883, DOI 10.1016/j.jpain.2008.05.005; Utsun TB, 2010, MEASURING HLTH DISAB; Utsun TB, 2003, DISABILITY REHABILIT, V25, P656; Volinn E, 1997, SPINE, V22, P1747, DOI 10.1097/00007632-199708010-00013; WADDELL G, 1987, SPINE, V12, P632, DOI 10.1097/00007632-198709000-00002; Weiner DK, 2003, PAIN MED, V4, P311, DOI 10.1111/j.1526-4637.2003.03042.x; Weiner SS, 2010, BEST PRACT RES CL RH, V24, P267, DOI 10.1016/j.berh.2009.12.001; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; World Health Organization, 2008, WAIST CIRCUMFERENCE; World Health Organization, 2003, BURD MUSC COND START; World Health Organization, GLOB PHYS ACT QUEST; World Health Organization, 2004, GLOB STRAT DIET PHYS	67	84	88	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0127880	10.1371/journal.pone.0127880	http://dx.doi.org/10.1371/journal.pone.0127880			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7TC	26042785	Green Published, gold, Green Submitted			2022-12-27	WOS:000355701600027
J	Jang, SJ; Sato, M; Sato, K; Jitsuyama, Y; Fujino, K; Mori, H; Takahashi, R; Benitez, ER; Liu, BH; Yamada, T; Abe, J				Jang, Seong-Jin; Sato, Masako; Sato, Kei; Jitsuyama, Yutaka; Fujino, Kaien; Mori, Haruhide; Takahashi, Ryoji; Benitez, Eduardo R.; Liu, Baohui; Yamada, Tetsuya; Abe, Jun			A Single-Nucleotide Polymorphism in an Endo-1,4-beta-Glucanase Gene Controls Seed Coat Permeability in Soybean	PLOS ONE			English	Article							GLYCINE-MAX; HARD SEEDEDNESS; SEQUENCE; WILD; GERMINATION; EXPRESSION; RESISTANCE; PHOMOPSIS; INFECTION; DORMANCY	Physical dormancy, a structural feature of the seed coat known as hard seededness, is an important characteristic for adaptation of plants against unstable and unpredictable environments. To dissect the molecular basis of qHS1, a quantitative trait locus for hard seededness in soybean (Glycine max (L) Merr.), we developed a near-isogenic line (NIL) of a permeable (soft-seeded) cultivar, Tachinagaha, containing a hard-seed allele from wild soybean (G. soja) introduced by successive backcrossings. The hard-seed allele made the seed coat of Tachinagaha more rigid by increasing the amount of beta-1,4-glucans in the outer layer of palisade cells of the seed coat on the dorsal side of seeds, known to be a point of entrance of water. Fine-mapping and subsequent expression and sequencing analyses revealed that qHS1 encodes an endo-1,4-beta-glucanase. A single-nucleotide polymorphism (SNP) introduced an amino acid substitution in a substrate-binding cleft of the enzyme, possibly reducing or eliminating its affinity for substrates in permeable cultivars. Introduction of the genomic region of qHS1 from the impermeable (hard-seeded) NIL into the permeable cultivar Kariyutaka resulted in accumulation of beta-1,4-glucan in the outer layer of palisade cells and production of hard seeds. The SNP allele found in the NIL was further associated with the occurrence of hard seeds in soybean cultivars of various origins. The findings of this and previous studies may indicate that qHS1 is involved in the accumulation of beta-1,4-glucan derivatives such as xyloglucan and/or beta-(1,3)(1,4)-glucan that reinforce the impermeability of seed coats in soybean.	[Jang, Seong-Jin; Sato, Masako; Sato, Kei; Jitsuyama, Yutaka; Fujino, Kaien; Mori, Haruhide; Yamada, Tetsuya; Abe, Jun] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan; [Takahashi, Ryoji; Benitez, Eduardo R.] Natl Inst Crop Sci, Tsukuba, Ibaraki 3058518, Japan; [Liu, Baohui] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Harbin 150040, Peoples R China	Hokkaido University; National Agriculture & Food Research Organization - Japan; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS	Abe, J (corresponding author), Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan.	jabe@res.agr.hokudai.ac.jp	Mori, Haruhide/AAV-6374-2021	Mori, Haruhide/0000-0001-7346-9131; Yamada, Tetsuya/0000-0001-6671-4995	Ministry of Agriculture, Forestry and Fisheries [DD-2060]; Grants-in-Aid for Scientific Research [26660081, 26257409] Funding Source: KAKEN	Ministry of Agriculture, Forestry and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Genomics for Agricultural Innovation Grants DD-2060 of the Ministry of Agriculture, Forestry and Fisheries.	Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; BROICH SL, 1981, EUPHYTICA, V30, P55, DOI 10.1007/BF00033659; BROICH SL, 1980, EUPHYTICA, V29, P23, DOI 10.1007/BF00037246; Chachalis D, 2000, SEED SCI TECHNOL, V28, P321; Cober ER, 1997, CROP SCI, V37, P1151, DOI 10.2135/cropsci1997.0011183X003700040020x; Dalling JW, 2011, J ECOL, V99, P89, DOI 10.1111/j.1365-2745.2010.01739.x; Dwiyanti MS, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-152; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; HARRIS WM, 1987, BOT GAZ, V148, P324, DOI 10.1086/337660; HARTWIG EE, 1987, CROP SCI, V27, P506, DOI 10.2135/cropsci1987.0011183X002700030015x; HEATHERLY LG, 1995, CROP SCI, V35, P205, DOI 10.2135/cropsci1995.0011183X003500010038x; HEATHERLY LG, 1995, FIELD CROP RES, V40, P57, DOI 10.1016/0378-4290(94)00075-N; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HILL HJ, 1986, CROP SCI, V26, P807, DOI 10.2135/cropsci1986.0011183X002600040038x; HOU FF, 1991, EUPHYTICA, V57, P169, DOI 10.1007/BF00023075; Hymowitz T., 2004, SOYBEANS IMPROVEMENT, P97; KEIM P, 1990, THEOR APPL GENET, V79, P465, DOI 10.1007/BF00226154; Koizumi M, 2008, ANN BOT-LONDON, V102, P343, DOI 10.1093/aob/mcn095; KULIK MM, 1991, CROP SCI, V31, P108, DOI 10.2135/cropsci1991.0011183X003100010027x; KUO WHJ, 1989, SEED SCI TECHNOL, V17, P131; Kuroda Y, 2013, ECOL EVOL, V3, P2150, DOI 10.1002/ece3.606; Libertini E, 2004, J MOL EVOL, V58, P506, DOI 10.1007/s00239-003-2571-x; Liu B, 2007, ANN BOT-LONDON, V100, P1027, DOI 10.1093/aob/mcm149; Ma FS, 2004, ANN BOT-LONDON, V94, P213, DOI 10.1093/aob/mch133; Master ER, 2004, BIOCHEMISTRY-US, V43, P10080, DOI 10.1021/bi049453x; Meyer CJ, 2007, J EXP BOT, V58, P717, DOI 10.1093/jxb/erl244; MOHAMEDYASSEEN Y, 1994, BOT REV, V60, P426, DOI 10.1007/BF02857926; Molhoj M, 2002, PLANT CELL PHYSIOL, V43, P1399, DOI 10.1093/pcp/pcf163; Moore S. H., 2000, Genetic improvement of seed quality. Proceedings of a Symposium sponsored by Divisions C-4, C-1, and C-8 of the Crop Science Society of America, Anaheim, California, USA, 29 October 1997., P59; Mullin WJ, 2000, FOOD RES INT, V33, P883, DOI 10.1016/S0963-9969(00)00118-6; Mullin WJ, 2001, J AGR FOOD CHEM, V49, P5331, DOI 10.1021/jf010303s; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; NOODEN LD, 1985, PLANT PHYSIOL, V79, P543, DOI 10.1104/pp.79.2.543; Paulsen TR, 2013, NEW PHYTOL, V198, P496, DOI 10.1111/nph.12191; POTTS HC, 1978, CROP SCI, V18, P221, DOI 10.2135/cropsci1978.0011183X001800020006x; Qutob D, 2008, BOTANY, V86, P219, DOI 10.1139/B08-002; RAGUS LN, 1987, SEED SCI TECHNOL, V15, P285; Ranathunge K, 2010, PLANTA, V231, P1171, DOI 10.1007/s00425-010-1118-9; ROY KW, 1994, CAN J PLANT PATHOL, V16, P122, DOI 10.1080/07060669409500769; SAIO K, 1976, CEREAL FOOD WORLD, V21, P168; Sakamoto SI, 2004, BREEDING SCI, V54, P133, DOI 10.1270/jsbbs.54.133; Sato H, 2007, PLANT BIOTECHNOL-NAR, V24, P533, DOI 10.5511/plantbiotechnology.24.533; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shao SQ, 2007, J EXP BOT, V58, P1071, DOI 10.1093/jxb/erl268; SHENMILLER J, 1995, AM J BOT, V82, P1367, DOI 10.2307/2445863; Song QJ, 2004, THEOR APPL GENET, V109, P122, DOI 10.1007/s00122-004-1602-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tinius C., 1989, Soybean Genetics Newsletter, V16, P196; TULLY RE, 1981, CROP SCI, V21, P312, DOI 10.2135/cropsci1981.0011183X002100020026x; Urbanowicz BR, 2007, PLANT PHYSIOL, V144, P1693, DOI 10.1104/pp.107.102574; VIEIRA RD, 1992, CROP SCI, V32, P471, DOI 10.2135/cropsci1992.0011183X003200020037x; Watanabe S, 2004, BREEDING SCI, V54, P399, DOI 10.1270/jsbbs.54.399; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; YAKLICH RW, 1987, CROP SCI, V27, P331, DOI 10.2135/cropsci1987.0011183X002700020042x; Yoshida K, 2006, PLANT CELL PHYSIOL, V47, P1541, DOI 10.1093/pcp/pcl020; Zhang B, 2008, CROP SCI, V48, P1341, DOI 10.2135/cropsci2007.10.0544; Zhou S, 2010, J AGR FOOD CHEM, V58, P10972, DOI 10.1021/jf102694k	57	22	27	5	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128527	10.1371/journal.pone.0128527	http://dx.doi.org/10.1371/journal.pone.0128527			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039079	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700107
J	Meir, A; Rubinsky, B				Meir, Arie; Rubinsky, Boris			Electrical Impedance Tomography of Electrolysis	PLOS ONE			English	Article							ELECTROCHEMICAL TREATMENT; TUMOR TREATMENT; CURRENT THERAPY; TISSUE; ELECTROPORATION; MAMMARY; METASTASES; ABLATION; MONITOR; CANCER	The primary goal of this study is to explore the hypothesis that changes in pH during electrolysis can be detected with Electrical Impedance Tomography (EIT). The study has relevance to real time control of minimally invasive surgery with electrolytic ablation. To investigate the hypothesis, we compare EIT reconstructed images to optical images acquired using pH-sensitive dyes embedded in a physiological saline agar gel phantom treated with electrolysis. We further demonstrate the biological relevance of our work using a bacterial E.Coli model, grown on the phantom. The results demonstrate the ability of EIT to image pH changes in a physiological saline phantom and show that these changes correlate with cell death in the E. coli model. The results are promising, and invite further experimental explorations.	[Meir, Arie] Univ Calif Berkeley, Biophys Grad Program, Berkeley, CA 94720 USA; [Rubinsky, Boris] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Meir, A (corresponding author), Univ Calif Berkeley, Biophys Grad Program, Berkeley, CA 94720 USA.	arie.coach@gmail.com						Adler A, 2011, PHYSIOL MEAS, V32, DOI 10.1088/0967-3334/32/7/S01; Amory R, 1886, TREATISE ELECTROLYSI; BARBER DC, 1984, J PHYS E SCI INSTRUM, V17, P723, DOI 10.1088/0022-3735/17/9/002; Pupo AEB, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-85; Boone K, 1997, J MED ENG TECHNOL, V21, P201, DOI 10.3109/03091909709070013; Borsic A, 2010, IEEE T MED IMAGING, V29, P44, DOI 10.1109/TMI.2009.2022540; Brown B. H., 2003, Journal of Medical Engineering & Technology, V27, P97, DOI 10.1080/0309190021000059687; Ciria HMC, 2013, CHINESE J CANCER RES, V25, P223, DOI 10.3978/j.issn.1000-9604.2013.03.03; Cherepenin V, 2001, PHYSIOL MEAS, V22, P9, DOI 10.1088/0967-3334/22/1/302; Chu KF, 2014, NAT REV CANCER, V14, P199, DOI 10.1038/nrc3672; Czymek R, 2011, SAUDI J GASTROENTERO, V17, P335, DOI 10.4103/1319-3767.84491; Davalos R, 2004, J BIOMECH ENG-T ASME, V126, P305, DOI 10.1115/1.1695577; Davalos RV, 2004, IEEE T BIO-MED ENG, V51, P761, DOI 10.1109/TBME.2004.824148; Davalos RV, 2002, IEEE T BIO-MED ENG, V49, P400, DOI 10.1109/10.991168; Edd JF, 2006, 2005 27 ANN INT C IE; Farooq A, 2014, PHYSIOL MEAS, V35, P1125, DOI 10.1088/0967-3334/35/6/1125; Finch JG, 2002, CLIN SCI, V102, P389, DOI 10.1042/cs1020389; Gehl J, 2002, BBA-GEN SUBJECTS, V1569, P51, DOI 10.1016/S0304-4165(01)00233-1; Granot Y, 2009, PHYS MED BIOL, V54, P4927, DOI 10.1088/0031-9155/54/16/006; GRIFFIN DT, 1995, BRIT J CANCER, V72, P31, DOI 10.1038/bjc.1995.272; GRIFFIN DT, 1994, BRIT J CANCER, V69, P875, DOI 10.1038/bjc.1994.169; HANSEN PC, 1992, SIAM REV, V34, P561, DOI 10.1137/1034115; Ivic MLA, 2003, J ELECTROANAL CHEM, V549, P129, DOI 10.1016/S0022-0728(03)00251-1; Laufer S, 2010, PHYSIOL MEAS, V31, P995, DOI 10.1088/0967-3334/31/7/009; Maglietti F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080167; Marty M, 2006, EJC SUPPL, V4, P3, DOI 10.1016/j.ejcsup.2006.08.002; Meir A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08095; MIKLAVCIC D, 1993, BIOELECTROCH BIOENER, V30, P209, DOI 10.1016/0302-4598(93)80080-E; MIKLAVCIC D, 1994, BIOELECTROCH BIOENER, V35, P93, DOI 10.1016/0302-4598(94)87017-9; Nilsson E, 1999, J ELECTROANAL CHEM, V460, P88, DOI 10.1016/S0022-0728(98)00352-0; Nilsson E, 1998, BIOELECTROCH BIOENER, V47, P11, DOI 10.1016/S0302-4598(98)00157-3; Nilsson E, 2000, BIOELECTROCHEMISTRY, V51, P1, DOI 10.1016/S0302-4598(99)00073-2; NORDENSTROM B, 1978, IRCS (International Research Communications System) Medical Science Library Compendium, V6, P537; Nordenstrom B, 1983, BIIOL CLOSED ELECT C; NORDENSTROM BEW, 1989, AM J CLIN ONCOL-CANC, V12, P530, DOI 10.1097/00000421-198912000-00015; Olaiz N, 2010, ELECTROCHEM COMMUN, V12, P94, DOI 10.1016/j.elecom.2009.10.044; Phillips M, TECHNOLOGY, P1; Phillips M, 2014, TECHNOLOGY CANC RES; Jimenez RP, 2011, BIOELECTROMAGNETICS, V32, P120, DOI 10.1002/bem.20611; Tamai M, 2013, J DERMATOL, V40, P1020, DOI 10.1111/1346-8138.12327; Turjanski P, 2009, ELECTROCHIM ACTA, V54, P6199, DOI 10.1016/j.electacta.2009.05.062; Turjanski P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017303; Van Lerberghe W, 2008, WORLD HLTH REPORT 20; Vauhkonen M, 2001, PHYSIOL MEAS, V22, P107, DOI 10.1088/0967-3334/22/1/314; Vogel CR, 1996, SIAM J SCI COMPUT, V17, P227, DOI 10.1137/0917016; von Euler H, 1999, ELECTRO MAGNETOBIOL, V18, P93, DOI 10.3109/15368379909012903; von Euler H, 2001, BIOELECTROCHEMISTRY, V54, P117, DOI 10.1016/S1567-5394(01)00118-9; Yoon DS, 2007, J BREAST CANCER, V10, P162, DOI 10.4048/jbc.2007.10.2.162; Yorkey T J, 1987, Clin Phys Physiol Meas, V8 Suppl A, P55, DOI 10.1088/0143-0815/8/4A/007	49	4	4	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126332	10.1371/journal.pone.0126332	http://dx.doi.org/10.1371/journal.pone.0126332			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039686	Green Published, gold			2022-12-27	WOS:000355700700026
J	Munkler, P; Rothkirch, M; Dalati, Y; Schmack, K; Sterzer, P				Muenkler, Paula; Rothkirch, Marcus; Dalati, Yasmin; Schmack, Katharina; Sterzer, Philipp			Biased Recognition of Facial Affect in Patients with Major Depressive Disorder Reflects Clinical State	PLOS ONE			English	Article							HIGH-RISK; EXPRESSIONS; PERCEPTION; EMOTIONS; MOOD; IDENTIFICATION; JUDGMENT; STIMULI; HAPPY	Cognitive theories of depression posit that perception is negatively biased in depressive disorder. Previous studies have provided empirical evidence for this notion, but left open the question whether the negative perceptual bias reflects a stable trait or the current depressive state. Here we investigated the stability of negatively biased perception over time. Emotion perception was examined in patients with major depressive disorder (MDD) and healthy control participants in two experiments. In the first experiment subjective biases in the recognition of facial emotional expressions were assessed. Participants were presented with faces that were morphed between sad and neutral and happy expressions and had to decide whether the face was sad or happy. The second experiment assessed automatic emotion processing by measuring the potency of emotional faces to gain access to awareness using interocular suppression. A follow-up investigation using the same tests was performed three months later. In the emotion recognition task, patients with major depression showed a shift in the criterion for the differentiation between sad and happy faces: In comparison to healthy controls, patients with MDD required a greater intensity of the happy expression to recognize a face as happy. After three months, this negative perceptual bias was reduced in comparison to the control group. The reduction in negative perceptual bias correlated with the reduction of depressive symptoms. In contrast to previous work, we found no evidence for preferential access to awareness of sad vs. happy faces. Taken together, our results indicate that MDD-related perceptual biases in emotion recognition reflect the current clinical state rather than a stable depressive trait.	[Muenkler, Paula; Rothkirch, Marcus; Dalati, Yasmin; Schmack, Katharina; Sterzer, Philipp] Charite, Campus Charite Mitte, Dept Psychiat & Psychotherapy, Visual Percept Lab, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rothkirch, M (corresponding author), Charite, Campus Charite Mitte, Dept Psychiat & Psychotherapy, Visual Percept Lab, D-13353 Berlin, Germany.	marcus.rothkirch@charite.de	Rothkirch, Marcus/J-8660-2016; Schmack, Katharina/AAX-5667-2020; Schmack, Katharina/J-7314-2016	Rothkirch, Marcus/0000-0001-7545-3432; Schmack, Katharina/0000-0002-3773-0440	Deutsche Forschungsgemeinschaft [STE 1430/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	1. Deutsche Forschungsgemeinschaft (http://dfg.de), STE 1430/2-1. 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson E, 2011, SCIENCE, V332, P1446, DOI 10.1126/science.1201574; Bates D., 2014, ARXIV PREPR ARXIV140; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beck AT, 1979, COGNITIVE THERAPY AN; Bouhuys AL, 1999, J NERV MENT DIS, V187, P595, DOI 10.1097/00005053-199910000-00002; Bouhuys AL, 1997, J AFFECT DISORDERS, V43, P213, DOI 10.1016/S0165-0327(97)01432-8; Ceccarini F, 2013, VIS COGN, V21, P498, DOI 10.1080/13506285.2013.807901; Cohen J, 1992, CURRENT DIRECTIONS P, V1, P98, DOI DOI 10.1111/1467-8721.EP10768783; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Dannlowski U, 2007, PSYCHIAT RES-NEUROIM, V154, P13, DOI 10.1016/j.pscychresns.2006.05.005; ETCOFF NL, 1992, COGNITION, V44, P227, DOI 10.1016/0010-0277(92)90002-Y; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; First MB, 2012, CLINICIAN VERSION AD; Gold JM, 2013, J VISION, V13, DOI 10.1167/13.5.23; Gollan JK, 2008, PSYCHIAT RES, V159, P18, DOI 10.1016/j.psychres.2007.06.011; Gollan JK, 2010, J ABNORM PSYCHOL, V119, P804, DOI 10.1037/a0020234; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P386, DOI 10.1037/0021-843x.113.3.386; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; GUR RC, 1992, PSYCHIAT RES, V42, P241, DOI 10.1016/0165-1781(92)90116-K; Hale WW, 1998, PSYCHIAT RES, V80, P265, DOI 10.1016/S0165-1781(98)00070-5; Hale WW, 1998, J AFFECT DISORDERS, V47, P63, DOI 10.1016/S0165-0327(97)00112-2; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hills PJ, 2011, CONSCIOUS COGN, V20, P1502, DOI 10.1016/j.concog.2011.07.002; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Joormann J, 2010, J CHILD PSYCHOL PSYC, V51, P575, DOI 10.1111/j.1469-7610.2009.02175.x; Lee TMC, 2008, PSYCHIAT RES, V159, P37, DOI 10.1016/j.psychres.2007.04.022; LeMoult J, 2009, J ABNORM PSYCHOL, V118, P828, DOI 10.1037/a0016944; Leppanen JM, 2004, PSYCHIAT RES, V128, P123, DOI 10.1016/j.psychres.2004.05.020; Leppanen JM, 2006, CURR OPIN PSYCHIATR, V19, P34, DOI 10.1097/01.yco.0000191500.46411.00; Levkovitz Y, 2003, J AFFECT DISORDERS, V75, P19, DOI 10.1016/S0165-0327(02)00024-1; LEWINSOHN PM, 1981, J ABNORM PSYCHOL, V90, P213, DOI 10.1037//0021-843X.110.2.203; Liu WH, 2012, PSYCHIAT RES, V197, P217, DOI 10.1016/j.psychres.2011.09.021; Lopez-Duran NL, 2013, J CHILD PSYCHOL PSYC, V54, P565, DOI 10.1111/jcpp.12005; Mikhailova ES, 1996, BIOL PSYCHIAT, V40, P697, DOI 10.1016/0006-3223(96)00032-7; Moriya J, 2013, PSYCHOL RES-PSYCH FO, V77, P698, DOI 10.1007/s00426-012-0463-7; Moscatelli A, 2012, J VISION, V12, DOI 10.1167/12.11.26; Naudin M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086832; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pollak SD, 2002, P NATL ACAD SCI USA, V99, P9072, DOI 10.1073/pnas.142165999; RUBINOW DR, 1992, BIOL PSYCHIAT, V31, P947, DOI 10.1016/0006-3223(92)90120-O; Sato W, 2004, COGNITION EMOTION, V18, P701, DOI 10.1080/02699930341000176; Schmidt KH., 1992, WORTSCHATZTEST; Sterzer P, 2011, PSYCHOL MED, V41, P1615, DOI 10.1017/S0033291710002540; Sterzer P, 2008, J VISION, V8, DOI 10.1167/8.15.10; Sterzer P, 2009, NEUROIMAGE, V46, P803, DOI 10.1016/j.neuroimage.2009.02.046; Surguladze SA, 2004, NEUROPSYCHOLOGY, V18, P212, DOI 10.1037/0894-4105.18.2.212; Suslow T, 2001, PERCEPT MOTOR SKILL, V92, P857, DOI 10.2466/PMS.92.3.857-868; Tukey J.W., EXPLORATORY DATA ANA; Venn HR, 2006, INT J NEUROPSYCHOPH, V9, P229, DOI 10.1017/S1461145705006012; Victor TA, 2013, INT J NEUROPSYCHOPH, V16, P2195, DOI 10.1017/S146114571300062X; Yang E, 2007, EMOTION, V7, P882, DOI 10.1037/1528-3542.7.4.882; Yang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021881	53	32	32	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0129863	10.1371/journal.pone.0129863	http://dx.doi.org/10.1371/journal.pone.0129863			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7ST	26039710	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700147
J	Upchurch, P; Mannion, PD; Taylor, MP				Upchurch, Paul; Mannion, Philip D.; Taylor, Michael P.			The Anatomy and Phylogenetic Relationships of ''Pelorosaurus" becklesii ( Neosauropoda, Macronaria) from the Early Cretaceous of England	PLOS ONE			English	Article							SAUROPOD DINOSAUR; EARLY EVOLUTION; TURIASAURUS-RIODEVENSIS; APPENDICULAR SKELETON; TITANOSAUR DINOSAURIA; FOSSIL RECORD; SP-NOV; OSTEOLOGY; SAURISCHIA; PATAGONIA	The sauropod dinosaur ''Pelorosaurus" becklesii was named in 1852 on the basis of an associated left humerus, ulna, radius and skin impression from the Early Cretaceous (Berriasian- Valanginian) Hastings Beds Group, near Hastings, East Sussex, southeast England, United Kingdom. The taxonomy and nomenclature of this specimen have a complex history, but most recent workers have agreed that "P." becklesii represents a distinct somphospondylan (or at least a titanosauriform) and is potentially the earliest titanosaur body fossil from Europe or even globally. The Hastings specimen is distinct from the approximately contemporaneous Pelorosaurus conybeari from Tilgate Forest, West Sussex. "P." becklesii can be diagnosed on the basis of five autapomorphies, such as: a prominent anteriorly directed process projecting from the anteromedial corner of the distal humerus; the proximal end of the radius is widest anteroposteriorly along its lateral margin; and the unique combination of a robust ulna and slender radius. The new generic name Haestasaurus is therefore erected for "P." becklesii. Three revised and six new fore limb characters (e.g. the presence/absence of condyle-like projections on the posterodistal margin of the radius) are discussed and added to three cladistic data sets for Sauropoda. Phylogenetic analysis confirms that Haestasaurus becklesii is a macronarian, but different data sets place this species either as a non-titanosauriform macronarian, or within a derived clade of titanosaurs that includes Malawisaurus and Saltasauridae. This uncertainty is probably caused by several factors, including the incompleteness of the Haestasaurus holotype and rampant homoplasy in fore limb characters. Haestasaurus most probably represents a basal macronarian that independently acquired the robust ulna, enlarged olecranon, and other states that have previously been regarded as synapomorphies of clades within Titanosauria. There is growing evidence that basal macronarian taxa survived into the Early Cretaceous of Europe and North America.	[Upchurch, Paul] UCL, Dept Earth Sci, London, England; [Mannion, Philip D.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London, England; [Taylor, Michael P.] Univ Bristol, Sch Earth Sci, Bristol, Avon, England	University of London; University College London; Imperial College London; University of Bristol	Upchurch, P (corresponding author), UCL, Dept Earth Sci, London, England.	p.upchurch@ucl.ac.uk	Upchurch, Paul/C-1654-2008	Taylor, Mike/0000-0002-1003-5675; Mannion, Philip/0000-0002-9361-6941	Willi Hennig Society; Imperial College Junior Research Fellowship	Willi Hennig Society; Imperial College Junior Research Fellowship	We wish to thank all those who provided access to sauropod material in their care, especially during data collection visits in 2012 and 2013: Trish Sloan, David Elliott and Stephen Poropat (AAOD); Alejandro Kramarz (MACN); Jose Carballido and Diego Pol (MEPF), Alejandro Otero (MLP); Paul Barrett and Sandra Chapman (NHMUK); Kristen Spring, Jay Nair and Scott Hocknull (QM), Jaime Powell (PVL), Ruben Martinez and Marcelo Luna (UNPSJB). The photographs of Haestasaurus were taken by Phil Hurst, NHM Image Resources. We are grateful to the Willi Hennig Society for its role in supporting and distributing the phylogenetic analysis package TNT vs. 1.1. PDM is supported by an Imperial College Junior Research Fellowship. No permits were required for the described study, which complied with all relevant regulations.	Alifanov VR, 2003, J VERTEBR PALEONTOL, V23, P358, DOI 10.1671/0272-4634(2003)023[0358:FVGESN]2.0.CO;2; Allain R, 2008, GEODIVERSITAS, V30, P345; [Anonymous], 1891, CATALOGUE BECK UNPUB; Bandyopadhyay S, 2010, PALAEONTOLOGY, V53, P533, DOI 10.1111/j.1475-4983.2010.00933.x; Barrett PM, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P125; Bedell MW, 2005, LIFE O PAST, P302; Blows William T., 1998, Bulletin of the New Mexico Museum of Natural History and Science, V14, P29; BLOWS WT, 1995, PALAEONTOLOGY, V38, P187; BONAPARTE J F, 1986, Annales de Paleontologie, V72, P325; Bonaparte JF., 1980, MEMOIRES SOC GEOLOGI, V139, P19; Bonaparte JF, 2006, CRETACEOUS RES, V27, P364, DOI 10.1016/j.cretres.2005.07.004; Borsuk-Biatynicka M., 1977, Palaeontologia Polonica, V37, P5; Britt B. B., 1997, Journal of Vertebrate Paleontology, V17, p34A; Britt BB, 2009, PALAEOGEOGR PALAEOCL, V280, P1, DOI 10.1016/j.palaeo.2009.06.004; Broom R., 1904, Geological Magazine, V(v), P445; Buffetaut E, 2006, NATURWISSENSCHAFTEN, V93, P440, DOI 10.1007/s00114-006-0124-z; Calvo Jorge O., 1995, Gaia, V11, P13; Canudo J.I., 2001, Publicaciones del Seminario de Paleontologia de Zaragoza, V5, P263; Canudo JI, 2008, J VERTEBR PALEONTOL, V28, P712, DOI 10.1671/0272-4634(2008)28[712:ANSTSG]2.0.CO;2; Carballido JL, 2014, J SYST PALAEONTOL, V12, P335, DOI 10.1080/14772019.2013.764935; Carballido JL, 2011, ZOOL J LINN SOC-LOND, V163, P605, DOI 10.1111/j.1096-3642.2011.00723.x; Carballido JL, 2011, J VERTEBR PALEONTOL, V31, P93, DOI 10.1080/02724634.2011.539651; Carpenter K, 2005, LIFE O PAST, P78; Casanovas Maria Lourdes, 2001, Paleontologia i Evolucio, V32-33, P99; Chure D, 2010, NATURWISSENSCHAFTEN, V97, P379, DOI 10.1007/s00114-010-0650-6; COOPER M R, 1984, Palaeontologia Africana, V25, P203; Cope ED, 1877, PALEONTOLOGICAL B, V25, P5; Czerkas S. A., 1997, ENCY DINOSAURS, P669; Czerkas Stephen, 1994, Gaia, V10, P173; D'Emic MD, HISTBIOL IN PRESS; D'Emic MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069375; D'Emic MD, 2013, J SYST PALAEONTOL, V11, P707, DOI 10.1080/14772019.2012.667446; D'Emic MD, 2012, ZOOL J LINN SOC-LOND, V166, P624, DOI 10.1111/j.1096-3642.2012.00853.x; D'Emic MD, 2009, J VERTEBR PALEONTOL, V29, P165, DOI 10.1671/039.029.0131; Dalla Vecchia Fabio Marco, 1998, Geologia Croatica, V51, P105; Dalla Vecchia FM, 2005, LIFE O PAST, P395; Day JJ, 2002, SCIENCE, V296, P1659, DOI 10.1126/science.1070167; Day JJ, 2004, PALAEONTOLOGY, V47, P319, DOI 10.1111/j.0031-0239.2004.00366.x; Dong Zhiming, 1990, Vertebrata Palasiatica, V28, P43; Dong Zhiming, 1997, P19; Foster JR, 2011, J VERTEBR PALEONTOL, V31, P717, DOI 10.1080/02724634.2011.557419; Gallina PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097128; Gervais P., 1852, ZOOLOGIE PALEONTOLOG; Gilmore C. W., 1936, Memoirs of the Carnegie Museum, V11, P175; Gilmore CW., 1946, US DEP INTERGEOL SUR, V210-C, P29, DOI DOI 10.3133/PP210C; Gimenez Olga del Valle, 2007, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V9, P119; Goloboff PA, 2003, CLADISTICS, V19, P324, DOI 10.1016/S0748-3007(03)00060-4; Goloboff P, 2008, CLADISTICS, V24, P91; Goloboff PA, 2008, CLADISTICS, V24, P758, DOI 10.1111/j.1096-0031.2008.00209.x; Goloboff PA, 2006, CLADISTICS, V22, P589, DOI 10.1111/j.1096-0031.2006.00122.x; Gomani EM, 2005, PALAEONTOL ELECTRON, V8; Harris JD, 2007, GEOBIOS-LYON, V40, P501, DOI 10.1016/j.geobios.2006.02.002; Harris JD, 2006, J SYST PALAEONTOL, V4, P185, DOI 10.1017/S1477201906001805; He X, 1988, MIDDLE JURASSIC DINO, V4; Hocknull SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006190; Hooley R. W., 1917, Geological Magazine London Dec 6, V4; Huene Baron F. v., 1927, Eclogae Geologicae Helvetiae, V20, P444; Hulke JW, 1874, Q J GEOL SOC LOND, V30, P16, DOI [DOI 10.1144/GSL.JGS.1874.030.01-04.17, 10.1144/GSL.JGS.1874.030.01-04.17]; Hulke JW, 1872, Q J GEOL SOC LOND, V28, P36; Janensch WJ., 1961, PALAEONTOGRAPHICA S, P177; Knoll F, 2009, ANN PALEONTOL, V95, P165, DOI 10.1016/j.annpal.2009.06.001; Lang E, 2010, HIST BIOL, V22, P142, DOI 10.1080/08912960903515570; Lapparent A. F. de, 1960, Memoires de la Societe Geologique de France Paleontologie, V88A, P1; Le Loeuff J, 2010, GEOL MAG, V147, P750, DOI 10.1017/S0016756810000178; Lu Junchang, 2009, [Journal of the paleontological Society of Korea, 고생물학회지], V25, P43; Carballido JL, 2012, HIST BIOL, V24, P631, DOI 10.1080/08912963.2012.672416; Lydekker R., 1893, Quarterly Journal of the Geological Society, Vxlix, P276; Lydekker R., 1890, Q J GEOL SOC LOND, V46, P182, DOI [10.1144/GSL.JGS.1890.046.01-04.13, DOI 10.1144/GSL.JGS.1890.046.01-04.13]; Lydekker R., 1888, Q J GEOL SOC LOND, V44, P46, DOI DOI 10.1144/GSL.JGS.1888.044.01-04.08; Maddison W.P., MESQUITE MODULAR SYS; Mannion PD, 2013, ZOOL J LINN SOC-LOND, V168, P98, DOI 10.1111/zoj.12029; Mannion PD, 2012, J SYST PALAEONTOL, V10, P521, DOI 10.1080/14772019.2011.595432; Mannion PD, 2012, J VERTEBR PALEONTOL, V32, P614, DOI 10.1080/02724634.2012.660898; Mannion PD, 2011, ZOOL J LINN SOC-LOND, V163, P155, DOI 10.1111/j.1096-3642.2011.00699.x; Mannion PD, 2011, BIOL REV, V86, P157, DOI 10.1111/j.1469-185X.2010.00139.x; Mannion PD, 2010, PALEOBIOLOGY, V36, P283, DOI 10.1666/09008.1; Mannion PD, 2010, PALAEONTOLOGY, V53, P277, DOI 10.1111/j.1475-4983.2009.00919.x; Mantell GA., 1850, PHIL T R SOC, V140, P379, DOI DOI 10.1098/RSTL.1850.0017; Mantell GA., 1852, NOTICES P M MEMBERS, V1, P141; Marsh O., 1883, AM J SCI, V26, P81; Marsh O.C., 1878, AM J SCI ARTS, V15, P241; Marsh OC., 1878, AM J SCI, V16, P411, DOI [DOI 10.2475/AJS.S3-16.95.411, 10.2475/ajs.s3-16.95.411]; Marsh OC., 1884, AM J SCI SERIES, V3, P160; Marsh OC., 1889, AM J SCI SER 3, V37, P323; Marsh OC., 1877, AM J SCI, V3, P514, DOI DOI 10.2475/AJS.S3-14.84.514; Martinez RD, 2004, J VERTEBR PALEONTOL, V24, P107, DOI 10.1671/9.1; Mateus O, 2014, J VERTEBR PALEONTOL, V34, P618, DOI 10.1080/02724634.2013.822875; Mateus O, 2011, AN ACAD BRAS CIENC, V83, P221, DOI 10.1590/S0001-37652011000100012; Mateus O, 2009, J VERTEBR PALEONTOL, V29, p144A; McIntosh J.S., 1990, P345; McIntosh JS, 2005, LIFE O PAST, P38; Melville AG, 1849, PHILOS T ROY SOC LON, V139, P285; Mills A. D., 2003, DICT BRIT PLACE NAME; Mo JY, 2010, ACTA GEOL SIN-ENGL, V84, P1328, DOI 10.1111/j.1755-6724.2010.00331.x; Moussaye de la G, 1885, B SOC FRANCE, V44, P51; Mudroch A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014642; Naish Darren, 2001, Palaeontological Association Field Guides to Fossils, V10, P185; Naish D, 2007, J GEOL SOC LONDON, V164, P493, DOI 10.1144/0016-76492006-032; Nicholson HA, 1889, MANUAL PALAEONTOLOGY, V2; Osborn H. F., 1921, Memoirs from the American Museum of Natural History New York NS, V3, P247; Ostrom J.H., 1966, MARSHS DINOSAURS; Otero A, 2010, ACTA PALAEONTOL POL, V55, P399, DOI 10.4202/app.2009.0099; Ouyang H., 2002, 1 MAMENCHISAURID SKE, P111; Owen R., 1841, P GEOLOGICAL SOC LON, V3, P457; Owen R., 1842, REPORTS BRIT ASS ADV, V11, P60; Owen R., 1884, HIST BRIT FOSSIL REP; Owen R., 1859, PALAEONTOGRAPHICAL S, V11, P20; Owen R., 1876, PALAEONTOGRAPHICAL S, V30, P1, DOI [10.1080/02693445.1876.12113270, DOI 10.1080/02693445.1876.12113270]; PHILLIPS J., 1871, GEOLOGY OXFORD VALLE; Poropat SF, 2015, GONDWANA RES, V27, P995, DOI 10.1016/j.gr.2014.03.014; Poropat SF, 2015, PAP PALAEONTOL, V1, P59, DOI 10.1002/spp2.1004; Powell J.E., 1992, DINOSAURIOS ENTORNO, P165; Rauhut OWM, 2009, PALAEOGEOGR PALAEOCL, V271, P259, DOI 10.1016/j.palaeo.2008.10.019; Rauhut OWM, 2005, NATURE, V435, P670, DOI 10.1038/nature03623; Rawson P.F., 2006, GEOLOGY ENGLAND WALE, P365; Remes K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006924; Rich THV, 1977, NATL GEOGR SOC RES R, V18, P643; Riga BJG, 2003, AMEGHINIANA, V40, P155; Rogers KC, 2001, NATURE, V412, P530, DOI 10.1038/35087566; Rogers KC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P50; Rogers KC, 2009, J VERTEBR PALEONTOL, V29, P1046, DOI 10.1671/039.029.0432; Romer A, 1956, OSTEOLOGY REPTILES; Rose Peter J., 2007, Palaeontologia Electronica, V10, P1; Royo-Torres R., 2009, I ESTUD TUROLENSES F, V6, P1; Royo-Torres R, 2014, ZOOL J LINN SOC-LOND, V171, P623, DOI 10.1111/zoj.12144; Royo-Torres R, 2012, J SYST PALAEONTOL, V10, P553, DOI 10.1080/14772019.2011.598577; Royo-Torres R, 2006, SCIENCE, V314, P1925, DOI 10.1126/science.1132885; Salgado L, HIST BIOL IN PRESS, DOI DOI 10.1080/08912960701679495; Salgado Leonardo, 1997, Ameghiniana, V34, P3; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sauvage HE, 1874, MEMOIRES SOC GEOLOGI, V2, P1; SEELEY H. G., 1869, INDEX FOSSIL REMAINS; Seeley HG., 1870, ANN MAG NAT HIST SER, V5, P279, DOI [10.1080/00222937008696155, DOI 10.1080/00222937008696155]; Sereno PC, 1999, SCIENCE, V286, P1342, DOI 10.1126/science.286.5443.1342; Steel R, 1970, HDB PALAOHERPETOLOGI, V13, P1; Swinton W. E., 1936, Proceedings of the Geologists' Association London, V47, P204; Swinton WE, 1934, DINOSAURS SHORT HIST; Taylor MP, 2007, PALAEONTOLOGY, V50, P1547, DOI 10.1111/j.1475-4983.2007.00728.x; Taylor MP, 2010, GEOL SOC SPEC PUBL, V343, P361, DOI 10.1144/SP343.22; Taylor MP, 2009, J VERTEBR PALEONTOL, V29, P787, DOI 10.1671/039.029.0309; Tidwell Virginia, 1999, Oryctos, V2, P21; Tidwell Virginia A., 2002, Journal of Vertebrate Paleontology, V22, p114A; Upchurch P, 1999, J VERTEBR PALEONTOL, V19, P106, DOI 10.1080/02724634.1999.10011127; Upchurch P, 2003, J VERTEBR PALEONTOL, V23, P208, DOI 10.1671/0272-4634(2003)23[208:TAATOC]2.0.CO;2; Upchurch P, 2011, GEOL SOC SPEC PUBL, V358, P209, DOI 10.1144/SP358.14; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; UPCHURCH P, 1995, PHILOS T R SOC B, V349, P365, DOI 10.1098/rstb.1995.0125; Upchurch P, 2012, ACT 5 JORN INT PAL D, P135; Upchurch P., 2004, NATL SCI MUS MONOGR, V26, P1; Upchurch P, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P104; Upchurch Paul, 2011, Palaeontological Association Field Guides to Fossils, V14, P476; Upchurch Paul, 2009, Bulletin of Zoological Nomenclature, V66, P51; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; von Huene F, 1932, FOSSIL REPTILE ORDER; Whitlock JA, 2011, ZOOL J LINN SOC-LOND, V161, P872, DOI 10.1111/j.1096-3642.2010.00665.x; Wiens JJ, 2001, SYST BIOL, V50, P689, DOI 10.1080/106351501753328811; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Wilson JA, 1999, PALEOBIOLOGY, V25, P252, DOI 10.1017/S0094837300026543; Wilson JA, 2003, J SYST PALAEONTOL, V1, P125, DOI 10.1017/S1477201903001044; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Wilson JA, 2009, J SYST PALAEONTOL, V7, P199, DOI 10.1017/S1477201908002691; Young MT, 2012, NATURWISSENSCHAFTEN, V99, P637, DOI 10.1007/s00114-012-0944-y; Zhang YH., 1988, MIDDLE JURASSIC DINO	163	48	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0125819	10.1371/journal.pone.0125819	http://dx.doi.org/10.1371/journal.pone.0125819			51	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039587	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700014
J	England, CG; Huang, JS; James, KT; Zhang, GD; Gobin, AM; Frieboes, HB				England, Christopher G.; Huang, Justin S.; James, Kurtis T.; Zhang, Guandong; Gobin, Andre M.; Frieboes, Hermann B.			Detection of Phosphatidylcholine-Coated Gold Nanoparticles in Orthotopic Pancreatic Adenocarcinoma using Hyperspectral Imaging	PLOS ONE			English	Article							PHOTOTHERMAL ABLATION; INTERSTITIAL PRESSURE; ELECTRON-MICROSCOPY; PARTICLE-SIZE; CANCER-CELLS; LUNG-CANCER; DELIVERY; TUMORS; PENETRATION; TRANSPORT	Nanoparticle uptake and distribution to solid tumors are limited by reticuloendothelial system systemic filtering and transport limitations induced by irregular intra-tumoral vascularization. Although vascular enhanced permeability and retention can aid targeting, high interstitial fluid pressure and dense extracellular matrix may hinder local penetration. Extravascular diffusivity depends upon nanoparticle size, surface modifications, and tissue vascularization. Gold nanoparticles functionalized with biologically-compatible layers may achieve improved uptake and distribution while enabling cytotoxicity through synergistic combination of chemotherapy and thermal ablation. Evaluation of nanoparticle uptake in vivo remains difficult, as detection methods are limited. We employ hyperspectral imaging of histology sections to analyze uptake and distribution of phosphatidylcholine-coated citrate gold nanoparticles (CGN) and silica-gold nanoshells (SGN) after tail-vein injection in mice bearing orthotopic pancreatic adenocarcinoma. For CGN, the liver and tumor showed 26.5 +/- 8.2 and 23.3 +/- 4.1 particles/100 mu m(2) within 10 mu m from the nearest source and few nanoparticles beyond 50 mu m, respectively. The spleen had 35.5 +/- 9.3 particles/100 mu m(2) within 10 mu m with penetration also limited to 50 mu m. For SGN, the liver showed 31.1 +/- 4.1 particles/100 mu m(2) within 10 mu m of the nearest source with penetration hindered beyond 30 mu m. The spleen and tumor showed uptake of 22.1 +/- 6.2 and 15.8 +/- 6.1 particles/100 mu m(2) within 10 mu m, respectively, with penetration similarly hindered. CGH average concentration (nanoparticles/mu m(2)) was 1.09 +/- 0.14 in the liver, 0.74 +/- 0.12 in the spleen, and 0.43 +/- 0.07 in the tumor. SGN average concentration (nanoparticles/mu m(2)) was 0.43 +/- 0.07 in the liver, 0.30 +/- 0.06 in the spleen, and 0.20 +/- 0.04 in the tumor. Hyperspectral imaging of histology sections enables analysis of phosphatidylcholine-coated gold-based nanoparticles in pancreatic tumors with the goal to improve nanotherapeutic efficacy.	[England, Christopher G.; Frieboes, Hermann B.] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [England, Christopher G.; Frieboes, Hermann B.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Huang, Justin S.] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [James, Kurtis T.; Zhang, Guandong; Gobin, Andre M.; Frieboes, Hermann B.] Univ Louisville, Dept Bioengn, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Frieboes, HB (corresponding author), Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA.	hbfrie01@louisville.edu			IPIBS fellowship at the University of Louisville (CGE); NIH (National Institutes of Health (US) [CA139050]; Department of Pharmacology and Toxicology; Department of Bioengineering; James Graham Brown Cancer Center at the University of Louisville; NATIONAL CANCER INSTITUTE [R00CA139050, K99CA139050] Funding Source: NIH RePORTER	IPIBS fellowship at the University of Louisville (CGE); NIH (National Institutes of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pharmacology and Toxicology; Department of Bioengineering; James Graham Brown Cancer Center at the University of Louisville; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge Dr. Lacey R. McNally (Dept. of Medicine) for helping to design and guide the in vivo experiments. We acknowledge the IPIBS fellowship at the University of Louisville (CGE), NIH (National Institutes of Health (US)) grant CA139050 (McNally via JSH), and the support from the Department of Pharmacology and Toxicology, the Department of Bioengineering and the James Graham Brown Cancer Center at the University of Louisville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAXTER LT, 1989, MICROVASC RES, V37, P77, DOI 10.1016/0026-2862(89)90074-5; BAXTER LT, 1990, MICROVASC RES, V40, P246, DOI 10.1016/0026-2862(90)90023-K; Bootz A, 2004, EUR J PHARM BIOPHARM, V57, P369, DOI 10.1016/S0939-6411(03)00193-0; Cai WB, 2008, NANOTECHNOL SCI APPL, V1, P17, DOI 10.2147/NSA.S3788; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Costa PM, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.30; Darwiche K, 2013, INT J NANOMED, V8, P4533, DOI 10.2147/IJN.S54418; De Jong WH, 2008, BIOMATERIALS, V29, P1912, DOI 10.1016/j.biomaterials.2007.12.037; England CG, 2015, EUR J PHARM BIOPHARM, V92, P120, DOI 10.1016/j.ejpb.2015.02.017; England Christopher G, 2013, Int J Nanomedicine, V8, P3603, DOI 10.2147/IJN.S51668; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; Frieboes HB, 2006, CANCER RES, V66, P1597, DOI 10.1158/0008-5472.CAN-05-3166; Frieboes HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056876; Gobin AM, 2007, NANO LETT, V7, P1929, DOI 10.1021/nl070610y; Goodman TT, 2007, INT J NANOMED, V2, P265; Grosges T, 2011, BIOMED OPT EXPRESS, V2, P1584, DOI 10.1364/BOE.2.001584; Guo CS, 2013, NANOSCALE, V5, P6469, DOI 10.1039/c3nr01025b; Guo Y, 2013, INT J NANOMED, V8, P3437, DOI 10.2147/IJN.S47585; Heindryckx F, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-219; Huang KY, 2012, ACS NANO, V6, P4483, DOI 10.1021/nn301282m; Huo SD, 2013, CANCER RES, V73, P319, DOI 10.1158/0008-5472.CAN-12-2071; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Jeon SO, 2012, J MICROENCAPSUL, V29, P234, DOI 10.3109/02652048.2011.646327; Kempen PJ, 2013, MICROSC MICROANAL, V19, P1290, DOI 10.1017/S143192761300192X; Kitamura N, 2001, CLIN EXP METASTAS, V18, P561, DOI 10.1023/A:1011900818419; Li SD, 2009, BBA-BIOMEMBRANES, V1788, P2259, DOI 10.1016/j.bbamem.2009.06.022; Li YB, 2010, NANOMEDICINE-UK, V5, P1161, DOI 10.2217/NNM.10.85; Luo J, 2013, PLOS ONE, V8; MAYROVITZ HN, 1992, MICROVASC RES, V43, P46, DOI 10.1016/0026-2862(92)90005-A; McNally LR, 2010, CLIN EXP METASTAS, V27, P591, DOI 10.1007/s10585-010-9349-5; Patra CR, 2008, CANCER RES, V68, P1970, DOI 10.1158/0008-5472.CAN-07-6102; Pisal DS, 2010, THROMB HAEMOSTASIS, V104, P1073, DOI 10.1160/TH10-06-0422; Preston TC, 2009, ACS NANO, V3, P3696, DOI 10.1021/nn900883d; Raghunand N, 2003, BRIT J RADIOL, V76, pS11, DOI 10.1259/bjr/12913493; Sadauskas Evaldas, 2007, Part Fibre Toxicol, V4, P10, DOI 10.1186/1743-8977-4-10; Schellekens H, 2013, PHARM RES-DORDR, V30, P1729, DOI 10.1007/s11095-013-1067-7; Society AC, 2013, CANC FACTS FIG 2013; Stober W, 1968, J COLLOID INTERFACE, V21; Straubinger R M, 1993, J Natl Cancer Inst Monogr, P69; Takahashi H, 2006, LANGMUIR, V22, P2, DOI 10.1021/la0520029; Taruttis A, 2010, OPT EXPRESS, V18, P19592, DOI 10.1364/OE.18.019592; van de Ven AL, 2013, NEW J PHYS, V15, DOI [10.1088/1367-2630/15/10/105021, DOI 10.1088/1367-2630/15/10/105021]; van de Ven AL, 2012, AIP ADV, V2, DOI 10.1063/1.3699060; VOGEL W, 1995, LANGMUIR, V11, P401, DOI 10.1021/la00002a005; Wang H, 2011, BIOMATERIALS, V32, P2979, DOI 10.1016/j.biomaterials.2011.01.001; Wang J, 2011, NANOMEDICINE-UK, V6, P1605, DOI [10.2217/nnm.11.141, 10.2217/NNM.11.141]; Wang K, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-23; Weinkauf Heidi, 2009, Biotechnology Journal, V4, P871, DOI 10.1002/biot.200800358; Wu M, 2014, J THEOR BIOL, V355, P194, DOI 10.1016/j.jtbi.2014.04.012; Wu M, 2013, J THEOR BIOL, V320, P131, DOI 10.1016/j.jtbi.2012.11.031; Zarogoulidis P, 2013, FUTURE ONCOL, V9, P1171, DOI [10.2217/fon.13.67, 10.2217/FON.13.67]; Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400; Zhang XM, 2011, INT J NANOMED, V6, P437, DOI 10.2147/IJN.S15997; Zhang ZH, 2010, SMALL, V6, P430, DOI 10.1002/smll.200901515; Zheng JW, 2011, METHODS MOL BIOL, V697, P93, DOI 10.1007/978-1-60327-198-1_9	55	27	27	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129172	10.1371/journal.pone.0129172	http://dx.doi.org/10.1371/journal.pone.0129172			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046360	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200133
J	Marmolejo-Leyva, R; Perez-Angon, MA; Russell, JM				Marmolejo-Leyva, Rafael; Angel Perez-Angon, Miguel; Russell, Jane M.			Mobility and International Collaboration: Case of the Mexican Scientific Diaspora	PLOS ONE			English	Article							INDIAN SCIENTISTS; RESEARCH OUTPUT; BRAIN-DRAIN; DETERMINANTS; COUNTRY; CHINA	We use a data set of Mexican researchers working abroad that are included in the Mexican National System of Researchers (SNI). Our diaspora sample includes 479 researchers, most of them holding postdoctoral positions in mainly seven countries: USA, Great Britain, Germany, France, Spain, Canada and Brazil. Their research output and impact is explored in order to determine their patterns of production, mobility and scientific collaboration as compared with previous studies of the SNI researchers in the periods 1991-2001 and 2003-2009. Our findings confirm that mobility has a strong impact on their international scientific collaboration. We found no substantial influence among the researchers that got their PhD degrees abroad from those trained in Mexican universities. There are significant differences among the areas of knowledge studied: biological sciences, physics and engineering have better production and impact rates than mathematics, geosciences, medicine, agrosciences, chemistry, social sciences and humanities. We found a slight gender difference in research production but Mexican female scientists are underrepresented in our diaspora sample. These findings would have policy implications for the recently established program that will open new academic positions for young Mexican scientists.	[Marmolejo-Leyva, Rafael] Cinvestav IPN, PhD Program Sci Technol & Soc, Mexico City 07360, DF, Mexico; [Angel Perez-Angon, Miguel] Cinvestav IPN, Dept Phys, Mexico City 07360, DF, Mexico; [Russell, Jane M.] Univ Nacl Autonoma Mexico, Bibliotecol & Informat Res Inst, Mexico City 04510, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Nacional Autonoma de Mexico	Perez-Angon, MA (corresponding author), Cinvestav IPN, Dept Phys, Mexico City 07360, DF, Mexico.	mperez@fis.cinvestav.mx	perez, miguel/GXF-5077-2022; Perez Angon, Miguel Angel/L-4313-2017	Perez Angon, Miguel Angel/0000-0003-3029-6861	Conacyt [220066]	Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Conacyt grant 220066.	Adams J, 2012, NATURE, V490, P335, DOI 10.1038/490335a; Arellanes A, 2014, COMMUNICATION; Basu A, 2014, COLLNET J SCIENTOMET, V8, P169, DOI 10.1080/09737766.2014.916860; Basu A, 2013, SCIENTOMETRICS, V94, P1007, DOI 10.1007/s11192-012-0800-z; Cho A, 2004, SCIENCE, V304, P1286, DOI 10.1126/science.304.5675.1286; de Arenas JL, 2001, RES EVALUAT, V10, P115, DOI 10.3152/147154401781777079; Didou S, 2008, REV EDUC SUPER, V37, P5; Didou S, 2011, MOVILIDADES ESTUDIAN; Dutrenit G, 2014, P TALL IND CIENC TEC, P165; Luna-Morales ME, 2012, INTERCIENCIA, V37, P736; Gibson J, 2012, ECON J, V122, P339, DOI 10.1111/j.1468-0297.2012.02498.x; Gonzalez-Brambila C, 2007, RES POLICY, V36, P1035, DOI 10.1016/j.respol.2007.03.005; Jonkers K, 2008, SCIENTOMETRICS, V77, P309, DOI 10.1007/s11192-007-1971-x; Mahanti S, 1998, SCI COMMUNITIES BRAI; Moed H, 2014, SCIENTOMETRICS, V101, P1987, DOI 10.1007/s11192-014-1307-6; Niu XS, 2014, TECHNOL FORECAST SOC, V85, P58, DOI 10.1016/j.techfore.2013.10.014; Russell J. M., 2008, P 4 INT C WEB INF SC; Russell JM, 2014, RES COLLABORATIONS E, P43; Sandstrom U, 2009, RES EVALUAT, V18, P135, DOI 10.3152/095820209X441790; Saxenian A., 2006, NEW ARGONAUTS REGION; Sun W, 2013, IZA J MIGR, V2, DOI 10.1186/2193-9039-2-5; Tejada G, 2012, MIGRATION DEV, V10, P59; Tejada G, 2010, SCI DIASPORAS DEV PA; Tejada G, 2013, SE EUR BLACK SEA STU, V13, P157, DOI 10.1080/14683857.2013.789674; Tyfield D, 2009, SCI PUBL POLICY, V36, P723, DOI 10.3152/030234209X475254; Vidal JP, 1998, J POPUL ECON, V11, P589, DOI 10.1007/s001480050086; Woolley R., 2008, COMP TECHNOL TRANSF, V6, P159, DOI [10.1353/ctt.0.0014, DOI 10.1353/CTT.0.0014]	27	34	35	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0126720	10.1371/journal.pone.0126720	http://dx.doi.org/10.1371/journal.pone.0126720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7CR	26047501	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200012
J	Newell-Fugate, AE; Taibl, JN; Alloosh, M; Sturek, M; Bahr, JM; Nowak, RA; Krisher, RL				Newell-Fugate, Annie E.; Taibl, Jessica N.; Alloosh, Mouhamad; Sturek, Michael; Bahr, Janice M.; Nowak, Romana A.; Krisher, Rebecca L.			Effects of Obesity and Metabolic Syndrome on Steroidogenesis and Folliculogenesis in the Female Ossabaw Mini-Pig	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; POLYCYSTIC-OVARY-SYNDROME; TYPE-2 DIABETES-MELLITUS; CORONARY-ARTERY-DISEASE; INSULIN-RESISTANCE; MINIATURE SWINE; ADIPOSE-TISSUE; OVERWEIGHT/OBESE WOMEN; DIFFERENT PROPENSITIES; ANDROGEN PRODUCTION	The discrete effects of obesity on infertility in females remain undefined to date. To investigate obesity-induced ovarian dysfunction, we characterized metabolic parameters, steroidogenesis, and folliculogenesis in obese and lean female Ossabaw mini-pigs. Nineteen nulliparous, sexually mature female Ossabaw pigs were fed a high fat/cholesterol/fructose diet (n=10) or a control diet (n=9) for eight months. After a three-month diet-induction period, pigs remained on their respective diets and had ovarian ultrasound and blood collection conducted during a five-month study period after which ovaries were collected for histology, cell culture, and gene transcript level analysis. Blood was assayed for steroid and protein hormones. Obese pigs developed abdominal obesity and metabolic syndrome, including hyperglycemia, hypertension, insulin resistance and dyslipidemia. Obese pigs had elongated estrous cycles and hyperandrogenemia with decreased LH, increased FSH and luteal phase progesterone, and increased numbers of medium, ovulatory, and cystic follicles. Theca cells of obese, compared to control, pigs displayed androstenedione hypersecretion in response to in vitro treatment with LH, and up-regulated 3-beta-hydroxysteroid dehydrogenase 1 and 17-beta-hydroxysteroid dehydrogenase 4 transcript levels in response to in vitro treatment with LH or LH + insulin. Granulosa cells of obese pigs had increased 3-beta-hydroxysteroid dehydrogenase 1 transcript levels. In summary, obese Ossabaw pigs have increased transcript levels and function of ovarian enzymes in the delta 4 steroidogenic pathway. Alterations in LH, FSH, and progesterone, coupled with theca cell dysfunction, contribute to the hyperandrogenemia and disrupted folliculogenesis patterns observed in obese pigs. The obese Ossabaw mini-pig is a useful animal model in which to study the effects of obesity and metabolic syndrome on ovarian function and steroidogenesis. Ultimately, this animal model may be useful toward the development of therapies to improve fertility in obese and/or hyperandrogenemic females or in which to examine the effects of obesity on the maternal-fetal environment and offspring health.	[Newell-Fugate, Annie E.; Taibl, Jessica N.; Bahr, Janice M.; Nowak, Romana A.; Krisher, Rebecca L.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Alloosh, Mouhamad; Sturek, Michael] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	University of Illinois System; University of Illinois Urbana-Champaign; Indiana University System; Indiana University Bloomington	Newell-Fugate, AE (corresponding author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA.	anewell-fugate@cvm.tamu.edu	Newell-Fugate, Anne/AAD-5499-2019; Sturek, Michael/CAH-2948-2022	Newell-Fugate, Anne/0000-0002-1878-5892; 	National Institutes of Health [R21 HD060105, K01 OD011177]; Texas A&M University Online Access to Knowledge (OAK) Fund; University Libraries; Office of the Vice President for Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD060105] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR031274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK097512] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD011177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas A&M University Online Access to Knowledge (OAK) Fund; University Libraries; Office of the Vice President for Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the National Institutes of Health R21 HD060105 and K01 OD011177 (www.nih.gov). The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GUIDE CARE USE LAB A; BAHR JM, 1983, BIOL REPROD, V29, P326, DOI 10.1095/biolreprod29.2.326; Bellinger DA, 2006, ILAR J, V47, P243, DOI 10.1093/ilar.47.3.243; Blouin K, 2003, J CLIN ENDOCR METAB, V88, P5944, DOI 10.1210/jc.2003-030535; Blouin K, 2009, MOL CELL ENDOCRINOL, V301, P97, DOI 10.1016/j.mce.2008.10.035; Boots C, 2011, SEMIN REPROD MED, V29, P507, DOI 10.1055/s-0031-1293204; CARA JF, 1994, HORM RES, V42, P49, DOI 10.1159/000184145; Castillo-Martinez L, 2003, NUTRITION, V19, P317, DOI 10.1016/S0899-9007(02)00998-X; Chavarro JE, 2007, OBSTET GYNECOL, V110, P1050, DOI 10.1097/01.AOG.0000287293.25465.e1; CONLEY AJ, 1994, BIOL REPROD, V51, P655, DOI 10.1095/biolreprod51.4.655; Dechaud H, 2006, EUR J OBSTET GYN R B, V127, P88, DOI 10.1016/j.ejogrb.2005.12.009; Diamanti-Kandarakis E, 2001, Obes Rev, V2, P231, DOI 10.1046/j.1467-789X.2001.00041.x; Douchi T, 2002, ACTA OBSTET GYN SCAN, V81, P147, DOI 10.1034/j.1600-0412.2002.810210.x; DUBEY AK, 1985, BIOL REPROD, V33, P423, DOI 10.1095/biolreprod33.2.423; Dyson MC, 2006, COMPARATIVE MED, V56, P35; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Edwards JM, 2010, CARDIOVASC RES, V85, P631, DOI 10.1093/cvr/cvp308; Eisner JR, 2002, FERTIL STERIL, V77, P167, DOI 10.1016/S0015-0282(01)02947-8; Esinler I, 2008, REPROD BIOMED ONLINE, V17, P583, DOI 10.1016/S1472-6483(10)60249-0; ETHERTON TD, 1980, GROWTH, V44, P182; ETHERTON TD, 1980, LIPIDS, V15, P823, DOI 10.1007/BF02534372; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Jungheim ES, 2010, AM J OBSTET GYNECOL, V203, P525, DOI 10.1016/j.ajog.2010.06.043; Knox R, 2009, Soc Reprod Fertil Suppl, V66, P199; Knox RV, 2005, DOMEST ANIM ENDOCRIN, V29, P385, DOI 10.1016/j.domaniend.2005.02.025; Kreutz RP, 2011, DIABET METAB SYND OB, V4, P99, DOI 10.2147/DMSO.S17105; Lado-Abeal J, 1998, J CLIN ENDOCR METAB, V83, P3083, DOI 10.1210/jc.83.9.3083; Lee L, 2009, HEPATOLOGY, V50, P56, DOI 10.1002/hep.22904; Lindheim SR, 2000, FERTIL STERIL, V73, P493, DOI 10.1016/S0015-0282(99)00578-6; Lloyd PG, 2006, FASEB J, V20, pA299; MCNATTY KP, 1979, J CLIN ENDOCR METAB, V49, P851, DOI 10.1210/jcem-49-6-851; Moran L, 2011, AUST NZ J OBSTET GYN, V51, P455, DOI 10.1111/j.1479-828X.2011.01343.x; Neeb ZP, 2010, COMPARATIVE MED, V60, P300; Newell-Fugate AE, 2014, COMPARATIVE MED, V64, P44; Norman RJ, 2004, HUM REPROD UPDATE, V10, P267, DOI 10.1093/humupd/dmh018; Otis CR, 2003, COMPARATIVE MED, V53, P53; PANEPINTO LM, 1983, LAB ANIM SCI, V33, P95; Rainey WE, 2002, TRENDS ENDOCRIN MET, V13, P234, DOI 10.1016/S1043-2760(02)00609-4; Rondanelli M, 2014, ARCH GYNECOL OBSTET, V290, P1079, DOI 10.1007/s00404-014-3433-z; Rosenfield RL, 2010, BRAIN RES, V1364, P186, DOI 10.1016/j.brainres.2010.08.088; San Millan JL, 2004, J CLIN ENDOCR METAB, V89, P2640, DOI 10.1210/jc.2003-031252; SELBY C, 1990, ANN CLIN BIOCHEM, V27, P532, DOI 10.1177/000456329002700603; Silva JRV, 2009, THERIOGENOLOGY, V71, P1193, DOI 10.1016/j.theriogenology.2008.12.015; Sivalingam VN, 2014, HUM REPROD UPDATE, V20, P853, DOI 10.1093/humupd/dmu037; Spandorfer SD, 2004, J REPROD MED, V49, P973; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Srivastava RK, 2011, MOL CELL ENDOCRINOL, V337, P24, DOI 10.1016/j.mce.2011.01.017; Sturek M, 2007, SWINE LAB SURG ANEST, P397; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; van Swieten ECAM, 2005, GYNECOL OBSTET INVES, V59, P220, DOI 10.1159/000084347; Varga O, 2010, OBES REV, V11, P792, DOI 10.1111/j.1467-789X.2009.00667.x; Welsh Michael J, 2009, Trans Am Clin Climatol Assoc, V120, P149; WIESAK T, 1990, J REPROD FERTIL, V89, P633, DOI 10.1530/jrf.0.0890633; Young JM, 2010, REPRODUCTION, V140, P489, DOI 10.1530/REP-10-0094; Zhang D, 2010, GYNECOL ENDOCRINOL, V26, P325, DOI 10.3109/09513591003632100; Ziecik AJ, 2001, SEMIN REPROD MED, V19, P19, DOI 10.1055/s-2001-13907	56	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128749	10.1371/journal.pone.0128749	http://dx.doi.org/10.1371/journal.pone.0128749			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046837	gold, Green Published			2022-12-27	WOS:000355652200097
J	Ran, Y; Ladd, GZ; Ceballos-Diaz, C; Jung, JI; Greenbaum, D; Felsenstein, KM; Golde, TE				Ran, Yong; Ladd, Gabriela Z.; Ceballos-Diaz, Carolina; Jung, Joo In; Greenbaum, Doron; Felsenstein, Kevin M.; Golde, Todd E.			Differential Inhibition of Signal Peptide Peptidase Family Members by Established gamma-Secretase Inhibitors	PLOS ONE			English	Article							VIRUS CORE PROTEIN; AMYLOID PRECURSOR PROTEIN; INTRAMEMBRANE PROTEOLYSIS; B-CELL; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE DOMAIN; TRANSFERRIN RECEPTOR; PRESENILIN HOMOLOGS; ASPARTIC PROTEASE; INVARIANT CHAIN	The signal peptide peptidases (SPPs) are biomedically important proteases implicated as therapeutic targets for hepatitis C (human SPP, (hSPP)), plasmodium (Plasmodium SPP (pSPP)), and B-cell immunomodulation and neoplasia (signal peptide peptidase like 2a, (SPPL2a)). To date, no drug-like, selective inhibitors have been reported. We use a recombinant substrate based on the amino-terminus of BRI2 fused to amyloid beta 1-25 (A beta(1-25)) (FBA) to develop facile, cost-effective SPP/SPPL protease assays. Co-transfection of expression plasmids expressing the FBA substrate with SPP/SPPLs were conducted to evaluate cleavage, which was monitored by ELISA, Western Blot and immunoprecipitation/MALDI-TOF Mass spectrometry (IP/MS). No cleavage is detected in the absence of SPP/SPPL overexpression. Multiple gamma-secretase inhibitors (GSIs) and (Z-LL)(2) ketone differentially inhibited SPP/SPPL activity; for example, IC50 of LY-411,575 varied from 51 +/- 79 nM (on SPPL2a) to 5499 +/- 122 nM (on SPPL2b), while Compound E showed inhibition only on hSPP with IC50 of 1465 +/- 93 nM. Data generated were predictive of effects observed for endogenous SPPL2a cleavage of CD74 in a murine B-Cell line. Thus, it is possible to differentially inhibit SPP family members. These SPP/SPPL cleavage assays will expedite the search for selective inhibitors. The data also reinforce similarities between SPP family member cleavage and cleavage catalyzed by gamma-secretase.	[Ran, Yong; Ceballos-Diaz, Carolina; Jung, Joo In; Felsenstein, Kevin M.; Golde, Todd E.] Univ Florida, Coll Med, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Ladd, Gabriela Z.] Univ Florida, Coll Pharm, Gainesville, FL 32610 USA; [Greenbaum, Doron] Pennsylvania Drug Discovery Inst, Philadelphia, PA USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Ran, Y (corresponding author), Univ Florida, Coll Med, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA.	yran@ufl.edu; tgolde@ufl.edu			National Institutes of Healt [AG20206]; National Cancer Institute [CA166009]; NATIONAL CANCER INSTITUTE [P01CA166009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG020206] Funding Source: NIH RePORTER	National Institutes of Healt(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (http://www.nih.gov/) grants to TEG (AG20206) and National Cancer Institute CA166009 (http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beisner DR, 2013, J EXP MED, V210, P23, DOI 10.1084/jem.20121072; Bergmann H, 2013, J EXP MED, V210, P31, DOI 10.1084/jem.20121076; Casso DJ, 2005, GENETICS, V170, P139, DOI 10.1534/genetics.104.039933; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Dev KK, 2006, EUR J PHARMACOL, V540, P10, DOI 10.1016/j.ejphar.2006.04.011; El Hage F, 2008, P NATL ACAD SCI USA, V105, P10119, DOI 10.1073/pnas.0802753105; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Fluhrer R, 2012, J BIOL CHEM, V287, P5156, DOI 10.1074/jbc.M111.328104; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Golde TE, 2013, BBA-BIOMEMBRANES, V1828, P2898, DOI 10.1016/j.bbamem.2013.06.005; Golde Todd E, 2003, Sci STKE, V2003, pRE4, DOI 10.1126/stke.2003.172.re4; Golde TE, 2009, SEMIN CELL DEV BIOL, V20, P225, DOI 10.1016/j.semcdb.2009.02.003; Grigorenko AP, 2004, P NATL ACAD SCI USA, V101, P14955, DOI 10.1073/pnas.0406462101; Grigorenko AP, 2002, BIOCHEMISTRY-MOSCOW+, V67, P826, DOI 10.1023/A:1016365227942; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Harbut MB, 2012, P NATL ACAD SCI USA, V109, P21486, DOI 10.1073/pnas.1216016110; Heimann M, 2006, J VIROL, V80, P1915, DOI 10.1128/JVI.80.4.1915-1921.2006; Hussy P, 1996, VIROLOGY, V224, P93, DOI 10.1006/viro.1996.0510; Jonas MC, 2010, J CELL SCI, V123, P3378, DOI 10.1242/jcs.068841; Kaup M, 2002, J BIOL CHEM, V277, P38494, DOI 10.1074/jbc.M203461200; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Li XR, 2009, BIOCHEM BIOPH RES CO, V380, P454, DOI 10.1016/j.bbrc.2009.01.083; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Marapana DS, 2012, TRAFFIC, V13, P1457, DOI 10.1111/j.1600-0854.2012.01402.x; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Meyer EL, 2003, J BIOL CHEM, V278, P23786, DOI 10.1074/jbc.M301360200; Mitani Y, 2012, J NEUROSCI, V32, P2037, DOI 10.1523/JNEUROSCI.4264-11.2012; Nakahara S, 2006, FASEB J, V20, P2451, DOI 10.1096/fj.05-5066com; Nyborg AC, 2004, J BIOL CHEM, V279, P43148, DOI 10.1074/jbc.M405879200; Nyborg AC, 2004, J BIOL CHEM, V279, P15153, DOI 10.1074/jbc.M309305200; Nyborg AC, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-16; Nyborg AC, 2006, FASEB J, V20, P1671, DOI 10.1096/fj.06-5762com; Okamoto K, 2004, J VIROL, V78, P6370, DOI 10.1128/JVI.78.12.6370-6380.2004; Parvanova I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005078; Pehar M, 2012, J BIOL CHEM, V287, P29921, DOI 10.1074/jbc.M112.363911; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Ran Y, 2014, J BIOL CHEM, V289, P3276, DOI 10.1074/jbc.M113.512921; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Robakis T, 2008, J BIOL CHEM, V283, P36369, DOI 10.1074/jbc.M807527200; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Schneppenheim J, 2014, MOL CELL BIOL, V34, P1398, DOI 10.1128/MCB.00038-14; Schneppenheim J, 2013, J EXP MED, V210, P41, DOI 10.1084/jem.20121069; SHIH YJ, 1990, J BIOL CHEM, V265, P19077; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Targett-Adams P, 2008, J BIOL CHEM, V283, P16850, DOI 10.1074/jbc.M802273200; Voss M, 2013, BBA-BIOMEMBRANES, V1828, P2828, DOI 10.1016/j.bbamem.2013.03.033; Voss M, 2012, J BIOL CHEM, V287, P43401, DOI 10.1074/jbc.M112.371369; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wolfe MS, 1998, J MED CHEM, V41, P6, DOI 10.1021/jm970621b; Zahn C, 2013, FEBS J, V280, P1653, DOI 10.1111/febs.12176	62	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128619	10.1371/journal.pone.0128619	http://dx.doi.org/10.1371/journal.pone.0128619			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046535	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200084
J	Geng, YY; Wang, XJ; Yang, L; Sun, HL; Wang, YQ; Zhao, Y; She, RP; Wang, MX; Wang, DX; Tang, J				Geng, Yunyun; Wang, Xiaojian; Yang, Luo; Sun, Haili; Wang, Yongqiang; Zhao, Yue; She, Ruiping; Wang, Mei-Xiang; Wang, De-Xian; Tang, Jun			Antitumor Activity of a 5-Hydroxy-1H-Pyrrol-2-(5H)-One-Based Synthetic Small Molecule In Vitro and In Vivo	PLOS ONE			English	Article							CELL-CYCLE ARREST; EPOLACTAENE DERIVATIVES; P53; PHOSPHORYLATION; INHIBITION; ACTIVATION; RESISTANCE; APOPTOSIS; ATM	Alternative chemo-reagents are in great demand because chemotherapy resistance is one of the major challenges in current cancer treatment. 5-hydoxy-1H-pyrrol-2-(5H)-one is an important N-heterocyclic scaffold that is present in natural products and medicinal chemistry. However, its antitumor activity has not been systematically explored. In this study, we screened a panel of 5-hydoxy-1H-pyrrol-2-(5H)-one derivatives and identified compound 1d as possessing strong anti-proliferative activity in multiple cancer cell lines. Cell cycle analysis revealed that 1d can induce S-phase cell cycle arrest and that HCT116 was sensitive to 1d-induced apoptosis. Further analysis indicated that 1d preferentially induced DNA damage and p53 activation in HCT116 cells and that 1d-induced apoptosis is partly dependent on p53. Furthermore, we showed that 1d significantly suppressed tumor growth in xenograft tumor models in vivo. Taken together, our results suggest that 5-hydoxy-1H-pyrrol-2-(5H)-one derivatives bear potential antitumor activity and that 1d is an effective agent for cancer treatment.	[Geng, Yunyun; Wang, Xiaojian; Sun, Haili; Wang, Yongqiang; Zhao, Yue; She, Ruiping; Tang, Jun] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Geng, Yunyun; Wang, Xiaojian; Sun, Haili; Wang, Yongqiang; Zhao, Yue; She, Ruiping; Tang, Jun] China Agr Univ, Coll Vet Med, Beijing 100193, Peoples R China; [Yang, Luo; Wang, De-Xian] Chinese Acad Sci, Beijing Natl Lab Mol Sci, Inst Chem, CAS Key Lab Mol Recognit & Funct, Beijing 100190, Peoples R China; [Wang, Mei-Xiang] Tsinghua Univ, Dept Chem, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Minist Educ, Beijing 100084, Peoples R China	China Agricultural University; China Agricultural University; Chinese Academy of Sciences; Institute of Chemistry, CAS; Tsinghua University	Wang, DX (corresponding author), Chinese Acad Sci, Beijing Natl Lab Mol Sci, Inst Chem, CAS Key Lab Mol Recognit & Funct, Beijing 100190, Peoples R China.	dxwang@iccas.ac.cn; jtang@cau.edu.cn	耿, 云云/GSJ-0054-2022		Chinese Universities Scientific Fund [2013RC013]; research funds from the State Key Laboratory of Agrobiotechnology of China [2013SKLAB06-7]	Chinese Universities Scientific Fund; research funds from the State Key Laboratory of Agrobiotechnology of China	This work was supported by Chinese Universities Scientific Fund (2013RC013); and the research funds from the State Key Laboratory of Agrobiotechnology of China (2013SKLAB06-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi S, 1996, CANCER RES, V56, P3087; Ashimori N, 2009, MOL CANCER THER, V8, P893, DOI 10.1158/1535-7163.MCT-08-1078; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Cheng Q, 2010, CELL CYCLE, V9, P472, DOI 10.4161/cc.9.3.10556; DOUGLAS SA, 1995, HYPERTENSION, V25, P818, DOI 10.1161/01.HYP.25.4.818; Epping MT, 2011, NAT CELL BIOL, V13, P102, DOI 10.1038/ncb2142; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ghavami S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016523; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Hamstra DA, 2006, CANCER RES, V66, P7482, DOI 10.1158/0008-5472.CAN-06-1405; Kakeya H, 1997, J MED CHEM, V40, P391, DOI 10.1021/jm960719a; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kuramochi K, 2006, BIOORGAN MED CHEM, V14, P2151, DOI 10.1016/j.bmc.2005.10.057; Li LJ, 2012, DNA REPAIR, V11, P112, DOI 10.1016/j.dnarep.2011.10.010; Liang XJ, 2010, METHODS MOL BIOL, V596, P467, DOI 10.1007/978-1-60761-416-6_21; Lucas DM, 2010, CURR DRUG TARGETS, V11, P812; Nagumo Y, 2004, BIOORG MED CHEM LETT, V14, P4425, DOI 10.1016/j.bmcl.2004.06.054; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shieh SY, 2000, GENE DEV, V14, P289; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; Tong WG, 2007, ANTI-CANCER DRUG, V18, P535, DOI 10.1097/01.cad.0000231477.22901.8a; Yang L, 2010, ORG LETT, V12, P3918, DOI 10.1021/ol101607z	25	8	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128928	10.1371/journal.pone.0128928	http://dx.doi.org/10.1371/journal.pone.0128928			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042776	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600077
J	Janssen, SJ; Bredenoord, AL; Dhert, W; de Kleuver, M; Oner, FC; Verlaan, JJ				Janssen, Stein J.; Bredenoord, Annelien L.; Dhert, Wouter; de Kleuver, Marinus; Oner, F. Cumhur; Verlaan, Jorrit-Jan			Potential Conflicts of Interest of Editorial Board Members from Five Leading Spine Journals	PLOS ONE			English	Article							MEDICAL JOURNALS; INDUSTRY; DISCLOSURES; AUTHORS; ISSUES; IMPACT	Conflicts of interest arising from ties between pharmaceutical industry and physicians are common and may bias research. The extent to which these ties exist among editorial board members of medical journals is not known. This study aims to determine the prevalence and financial magnitude of potential conflicts of interest among editorial board members of five leading spine journals. The editorial boards of: The Spine Journal; Spine; European Spine Journal; Journal of Neurosurgery: Spine; and Journal of Spinal Disorders & Techniques were extracted on January 2013 from the journals' websites. Disclosure statements were retrieved from the 2013 disclosure index of the North American Spine Society; the program of the 20th International Meeting on Advanced Spine Techniques; the program of the 48th Annual Meeting of the Scoliosis Research Society; the program of the AOSpine global spine congress; the presentations of the 2013 Annual Eurospine meeting; and the disclosure index of the American Academy of Orthopaedic Surgeons. Names of the editorial board members were compared with the individuals who completed a disclosure for one of these indexes. Disclosures were extracted when full names matched. Two hundred and ten (29%) of the 716 identified editorial board members reported a potential conflict of interest and 154 (22%) reported nothing to disclose. The remaining 352 (49%) editorial board members had no disclosure statement listed for one of the indexes. Eighty-nine (42%) of the 210 editorial board members with a potential conflict of interest reported a financial relationship of more than $10,000 during the prior year. This finding confirms that potential conflicts of interest exist in editorial boards which might influence the peer review process and can result in bias. Academia and medical journals in particular should be aware of this and strive to improve transparency of the review process. We emphasize recommendations that contribute to achieving this goal.	[Janssen, Stein J.; Dhert, Wouter; Oner, F. Cumhur; Verlaan, Jorrit-Jan] Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands; [Bredenoord, Annelien L.] Univ Med Ctr, Julius Ctr, Dept Med Humanities, Utrecht, Netherlands; [de Kleuver, Marinus] Vrije Univ Amsterdam, Med Ctr, Dept Orthopaed, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam	Verlaan, JJ (corresponding author), Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands.	j.j.verlaan@umcutrecht.nl	de Kleuver, Marinus/A-1203-2016	de Kleuver, Marinus/0000-0002-3506-1212; Dhert, Wouter/0000-0001-9150-6143	DePuy Synthes spine	DePuy Synthes spine	SJJ, JJV, FCO, ALB and WD reported no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work. MK reports personal fees from DePuy Synthes spine, outside the submitted work; and is a Deputy editor of the journal "Spine Deformity" and reviewer for European Spine Journal, Acta Orthopedica, Journal of Bone and Joint, and Scoliosis. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	AAOS American Academy of Orthopaedic Surgeons, AAOS ORTH DISCL PROG; Ama Manual of Style, 2009, AMA MAN STYL GUID AU; Annals of internal Medicine, 2014, ANN INTERNAL MED; [Anonymous], 2015, SPINE J; [Anonymous], 2013, J NEUROSURGERY SPINE; [Anonymous], 2013, SPINE; [Anonymous], 2012, WHITE PAPER PUBLICAT; [Anonymous], 2013, SPINE J; [Anonymous], 2013, J SPINAL DISORDERS T, DOI 10.1097/BRS.0b013e3181b1c99f; [Anonymous], 2014, PLOS MED COMPETING I; [Anonymous], 2013, EUROPEAN SPINE J; Armstrong D, 2007, WALL STREET J; Bartels RHMA, 2012, EUR SPINE J, V21, P1229, DOI 10.1007/s00586-011-2086-x; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bosch X, 2013, EUR J CLIN INVEST, V43, P660, DOI 10.1111/eci.12090; Buerba RA, 2013, SPINE J, V13, P1780, DOI 10.1016/j.spinee.2013.05.032; Carragee EJ, 2011, SPINE J, V11, P695, DOI 10.1016/j.spinee.2011.08.418; Carragee EJ, 2011, SPINE J, V11, P463, DOI 10.1016/j.spinee.2011.06.001; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; Dyer O, 2004, BRIT MED J, V328, P244, DOI 10.1136/bmj.328.7434.244-b; Emanuel E, 2008, OXFORD TXB CLIN RES; EvaluateMedTech, 2013, TOP 10 CO TOT WORLD; Fauber J, 2012, MILWAUKEE J SENTINEL; Fauber J, 2009, MILWAUKEE J SENTINEL; Garfin SR, 2008, EUR SPINE J, V17, P785, DOI 10.1007/s00586-007-0542-4; Global Spine Congress, 2013, FIN PROGR AOSPINE GL; Haivas I, 2004, CAN MED ASSOC J, V171, P475, DOI 10.1503/cmaj.1031982; ICMJE International Committee of Medical Journal Editors, 2014, REC COND REP ED PUBL; IMAST International Meeting on Advanced Spine Techniques, 2013, FIN PROGR SCOL RES S, DOI 10.1186/s13018-015-0154-3; JACC Journal of the American College of Cardiology, 2014, J AM COLL CARDIOLOGY; Jackson JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022475; Jegede Kolawole, 2011, J Bone Joint Surg Am, V93, pe75, DOI 10.2106/JBJS.J.01411; Khan Safdar N, 2008, Am J Orthop (Belle Mead NJ), V37, pE205; Lipworth WL, 2011, SOC SCI MED, V72, P1056, DOI 10.1016/j.socscimed.2011.02.002; Mayor S, 2006, BRIT MED J, V332, P135, DOI 10.1136/bmj.332.7534.135-a; Meier B., 2013, NY TIMES; Meier B., 2011, NY TIMES; NASS North American Spine Society, 2013, ANN NASS DISCL IND; Neuman J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5621; Park IU, 2014, NATURE, V506, P93, DOI 10.1038/nature12786; Reuters Thomson, 2012, J CITATION REPORTS; Shah RV, 2005, SPINE, V30, P1099, DOI 10.1097/01.brs.0000161004.15308.b4; Smith E, 2012, J MED ETHICS, V38, P679, DOI 10.1136/medethics-2012-100524; SRS Scoliosis Research Society, 2013, FIN PROGR SCOL RES S; Standaert CJ, 2009, ARCH PHYS MED REHAB, V90, P1647, DOI 10.1016/j.apmr.2009.04.025; Steering Committee on Science and Creationism: National Academy of Sciences, 1999, SCI CRETA VIEW NAT A; Steinbrook R, 2012, J LAW MED ETHICS, V40, P488, DOI 10.1111/j.1748-720X.2012.00681.x; The Spine Society of Europe: EuroSpine, 2013, EUROSPINE EUR 2013 L; WAME world association of medical editors, 2015, REC PUBL ETH POL MED; Wong VSS, 2012, J CLIN EPIDEMIOL, V65, P247, DOI 10.1016/j.jclinepi.2011.08.003	50	25	26	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0127362	10.1371/journal.pone.0127362	http://dx.doi.org/10.1371/journal.pone.0127362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042410	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600013
J	Pauwels, J; Coopman, F; Cools, A; Michiels, J; Fremaut, D; De Smet, S; Janssens, GPJ				Pauwels, Jana; Coopman, Frank; Cools, An; Michiels, Joris; Fremaut, Dirk; De Smet, Stefaan; Janssens, Geert P. J.			Selection for Growth Performance in Broiler Chickens Associates with Less Diet Flexibility	PLOS ONE			English	Article							ACID-INSOLUBLE ASH; NUTRIENT DIGESTIBILITY; GASTROINTESTINAL-TRACT; METABOLIZABLE ENERGY; POULTRY PRODUCTION; LARGE-INTESTINE; FEED; FIBER; POLYSACCHARIDES; INGREDIENTS	Global competition for high standard feed-food resources between man and livestock, such as industrial broilers, is a concerning problem. In addition, the low productivity of scavenger chickens in developing countries leaves much to be desired. Changing the ingredients, and therefore, the nutrient composition of feed intake by commercial fed as well as scavenger chickens seems like an obvious solution. In this study, the ability of four broiler chicken breeds to perform on a commercial versus a scavenger diet was tested. The four broiler breeds differed genetically in growth potential. A significant (P < 0.01) negative effect of the scavenger diet on the bodyweight of the fast growing breeds was found and this effect decreased with decreasing growth rate in the other breeds. These differences in bodyweight gain could not be explained by differences in nutrient digestibility but were caused by the lack of ability of the fast growing breeds to increase their feed intake sufficiently.	[Pauwels, Jana; Cools, An; Janssens, Geert P. J.] Univ Ghent, Fac Vet Med, Anim Nutr Lab, Merelbeke, Belgium; [Coopman, Frank; Michiels, Joris; Fremaut, Dirk] Univ Ghent, Dept Appl Biosci, B-9000 Ghent, Belgium; [De Smet, Stefaan] Univ Ghent, Dept Anim Prod, Lab Anim Nutr & Anim Prod Qual, Melle, Belgium	Ghent University; Ghent University; Ghent University	Janssens, GPJ (corresponding author), Univ Ghent, Fac Vet Med, Anim Nutr Lab, Merelbeke, Belgium.	geert.janssens@ugent.be	Coopman, Frank/ABB-8083-2021; Janssens, Geert/C-2264-2008; DeSmet, Stefaan/N-7576-2017	DeSmet, Stefaan/0000-0003-1422-805X	VLADOC phd scholarship - Vlaamse Interuniversitaire Raad - Universitaire OntwikkelingsSamenwerking (VLIR UOS) [2012-04]	VLADOC phd scholarship - Vlaamse Interuniversitaire Raad - Universitaire OntwikkelingsSamenwerking (VLIR UOS)	The experiment was funded by the VLADOC phd scholarship of JP, provided by the Vlaamse Interuniversitaire Raad - Universitaire OntwikkelingsSamenwerking (VLIR UOS). Grant number: 2012-04 http://www.vliruos.be/en/scholarships/. Cobb Europe Ltd provided the chicks and Versele-Laga provided the ingredients for the experimental feeds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON JL, 1984, CAN J FISH AQUAT SCI, V41, P1384, DOI 10.1139/f84-170; Awuni J, 2002, PARAMETERS FAM POULT; Badubi SS, 2006, LIVESTOCK RES RURAL, P18; Barona E, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/024002; Batal AB, 2002, POULTRY SCI, V81, P400, DOI 10.1093/ps/81.3.400; Brunner E, 2002, NONPARAMETRIC ANAL L; CHOCT M, 1992, BRIT POULTRY SCI, V33, P821, DOI 10.1080/00071669208417524; Deeb N, 2002, J HERED, V93, P107, DOI 10.1093/jhered/93.2.107; Delgado C, 2001, OUTLOOK AGR, V30, P27, DOI 10.5367/000000001101293427; Dessie T, 2001, TROP ANIM HEALTH PRO, V33, P521, DOI 10.1023/A:1012740832558; Erb K, 2012, IMPACT IND GRAIN FED, P1; Farrell DJ, 2005, WORLD POULTRY SCI J, V61, P298, DOI 10.1079/WPS200456; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Francesch M, 2004, WORLD POULTRY SCI J, V60, P64, DOI [10.1079/WPS20040006, 10.1079/WPS20035]; GRASHORN MA, 2006, 12 EUR POULT C VER I; Harms RH, 2000, J APPL POULTRY RES, V9, P535, DOI 10.1093/japr/9.4.535; HAVENSTEIN GB, 1994, POULTRY SCI, V73, P1785, DOI 10.3382/ps.0731785; Higgins J.J., 2004, INTRO MODERN NONPARA; Jackson S, 1996, EVOLUTION, V50, P1638, DOI [10.2307/2410900, 10.1111/j.1558-5646.1996.tb03936.x]; Jorgensen H, 1996, BRIT J NUTR, V75, P379, DOI 10.1079/BJN19960141; Kabacoff RI., 2011, R ACTION DATA ANAL G, V1; Kalmar ID, 2007, J ANIM PHYSIOL AN N, V91, P210, DOI 10.1111/j.1439-0396.2007.00694.x; KNUDSEN KEB, 1993, BRIT J NUTR, V70, P537, DOI 10.1079/BJN19930147; Kras RV, 2013, BRAZ J POULTRY SCI, V15, P83, DOI 10.1590/S1516-635X2013000200003; Langhout DJ, 1996, POULTRY SCI, V75, P1236, DOI 10.3382/ps.0751236; Leeson S, 1996, POULTRY SCI, V75, P522, DOI 10.3382/ps.0750522; Leeson S, 1996, POULTRY SCI, V75, P529, DOI 10.3382/ps.0750529; Mekonnen H, 2010, TROP ANIM HEALTH PRO, V42, P123, DOI 10.1007/s11250-009-9395-7; Min Y. N., 2011, International Journal of Poultry Science, V10, P782; Momoh O. M., 2010, Agriculture and Biology Journal of North America, V1, P912, DOI 10.5251/abjna.2010.1.5.912.915; Moran ET, 2006, J APPL POULTRY RES, V15, P154, DOI 10.1093/japr/15.1.154; Mwalusanya NA, 2002, TROP ANIM HEALTH PRO, V34, P405, DOI 10.1023/A:1020048327158; Neumann C, 2002, NUTR RES, V22, P193, DOI 10.1016/S0271-5317(01)00374-8; NITSAN Z, 1991, BRIT POULTRY SCI, V32, P515, DOI 10.1080/00071669108417376; OBST BS, 1992, AUK, V109, P451; OLOMU JM, 1980, POULTRY SCI, V59, P828, DOI 10.3382/ps.0590828; PROUDMAN JA, 1970, POULTRY SCI, V49, P961, DOI 10.3382/ps.0490961; Ravindran V., 2011, POULTRY FEED AVAILAB; Sales J, 2003, POULTRY SCI, V82, P1457, DOI 10.1093/ps/82.9.1457; Sales J, 2007, WORLDS POULT SCI J, V59, P314; Scott TA, 1998, POULTRY SCI, V77, P674, DOI 10.1093/ps/77.5.674; SELL JL, 1991, POULTRY SCI, V70, P1200, DOI 10.3382/ps.0701200; Sonaiya EB, 2007, WORLD POULTRY SCI J, V63, P132, DOI 10.1017/S0043933907001353; TERPSTRA K, 1974, Zeitschrift fuer Tierphysiologie Tierernaehrung und Futtermittelkunde, V32, P306; UNI Z, 1995, POULTRY SCI, V74, P1622, DOI 10.3382/ps.0741622; Van der Hoeven-Hangoor E, 2013, POULTRY SCI, V92, P2713, DOI [10.3382/ps.2013-03017, DOI 10.3382/PS.2013-03017]; VANKEULEN J, 1977, J ANIM SCI, V44, P282; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Wilkinson JM, 2011, ANIMAL, V5, P1014, DOI 10.1017/S175173111100005X; Wiseman J., 1987, FEEDING NONRUMINANT, P9; Yegani M, 2013, POULTRY SCI, V92, P1208, DOI 10.3382/ps.2012-02390	51	6	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0127819	10.1371/journal.pone.0127819	http://dx.doi.org/10.1371/journal.pone.0127819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042600	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600024
J	Hua, X; Yuan, XY; Li, ZJ; Coursey, TG; Pflugfelder, SC; Li, DQ				Hua, Xia; Yuan, Xiaoyong; Li, Zhijie; Coursey, Terry G.; Pflugfelder, Stephen C.; Li, De-Quan			A Novel Innate Response of Human Corneal Epithelium to Heat-killed Candida albicans by Producing Peptidoglycan Recognition Proteins	PLOS ONE			English	Article							L-ALANINE AMIDASE; EXPERIMENTAL FUNGAL KERATITIS; LECTIN-LIKE RECEPTORS; TOLL-LIKE RECEPTORS; NF-KAPPA-B; OCULAR SURFACE; SIGNALING PATHWAYS; IMMUNE-SYSTEM; DECTIN-1; CELLS	Fungal infections of the cornea can be sight-threatening and have a worse prognosis than other types of microbial corneal infections. Peptidoglycan recognition proteins (PGLYRP), which are expressed on the ocular surface, play an important role in the immune response against bacterial corneal infections by activating toll-like receptors (TLRs) or increasing phagocytosis. However, the role of PGLYRPs in innate immune response to fungal pathogens has not been investigated. In this study, we observed a significant induction of three PGLYRPs 2-4 in primary human corneal epithelial cells (HCECs) exposed to live or heat-killed Candida albicans (HKCA). The C-type lectin receptor dectin-1 plays a critical role in controlling Candida albicans infections by promoting phagocytic activity and cytokine production in macrophages and dendritic cells. Here, we demonstrate that dectin-1 is expressed by normal human corneal tissue and primary HCECs. HKCA exposure increased expression of dectin-1 on HCECs at mRNA and protein levels. Interestingly, dectin-1 neutralizing antibody, I kappa B-alpha inhibitor BAY11-7082, and NF-kappa B activation inhibitor quinazoline blocked NF-kappa B p65 nuclear translocation, as well as the induction of the PGLYRPs by HKCA in HCECs. Furthermore, rhPGLYRP-2 was found to suppress colony-forming units of Candida albicans in vitro. In conclusion, these findings demonstrate that dectin-1 is expressed by human corneal epithelial cells, and dectin-1/NF-kappa B signaling pathway plays an important role in regulating Candida albicans/HKCA-induced PGLYRP secretion by HCECs.	[Hua, Xia; Yuan, Xiaoyong] Tianjin Med Univ, Clin Coll Ophthalmol, Tianjin Eye Hosp, Tianjin Key Lab Ophthalmol & Visual Sci, Tianjin, Peoples R China; [Hua, Xia; Yuan, Xiaoyong; Coursey, Terry G.; Pflugfelder, Stephen C.; Li, De-Quan] Baylor Coll Med, Cullen Eye Inst, Dept Ophthalmol, Ocular Surface Ctr, Houston, TX 77030 USA; [Li, Zhijie] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Tianjin Medical University; Baylor College of Medicine; Baylor College of Medicine	Yuan, XY (corresponding author), Tianjin Med Univ, Clin Coll Ophthalmol, Tianjin Eye Hosp, Tianjin Key Lab Ophthalmol & Visual Sci, Tianjin, Peoples R China.	yuanxiaoyong2009@gmail.com; dequanl@bcm.edu	Yuan, Xiaoyong/GZA-6197-2022		National Institutes of Health NEI [EY023598, EY011915]; National Natural Science Foundations of China [81170829, 81400375]; Tianjin Research Program of Application Foundation and Advanced Technology [12JCYBJC15400]; Key Specialty from Bureau of Health, Tianjin; Research to Prevent Blindness; Oshman Foundation; William Stamps Farish Fund; NATIONAL EYE INSTITUTE [R01EY011915, R01EY023598] Funding Source: NIH RePORTER	National Institutes of Health NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Tianjin Research Program of Application Foundation and Advanced Technology; Key Specialty from Bureau of Health, Tianjin; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Oshman Foundation; William Stamps Farish Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health NEI Grants EY023598 (DQL) and EY011915 (SCP), National Natural Science Foundations of China (81170829, 81400375), Tianjin Research Program of Application Foundation and Advanced Technology (12JCYBJC15400), Supporting Project for Key Specialty from Bureau of Health, Tianjin, an unrestricted grant from Research to Prevent Blindness, the Oshman Foundation and the William Stamps Farish Fund.	Alexopoulou L, 2005, CELL MOL LIFE SCI, V62, P1349, DOI 10.1007/s00018-005-5039-x; Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Bian F, 2010, STEM CELLS, V28, P2172, DOI 10.1002/stem.539; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; De Paiva CS, 2006, STEM CELLS, V24, P368, DOI 10.1634/stemcells.2005-0148; Drummond RA, 2011, CURR OPIN MICROBIOL, V14, P392, DOI 10.1016/j.mib.2011.07.001; Dziarski R, 2003, BLOOD, V102, P689, DOI 10.1182/blood-2002-12-3853; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Dziarski R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-232; Gelius E, 2003, BIOCHEM BIOPH RES CO, V306, P988, DOI 10.1016/S0006-291X(03)01096-9; Guan RJ, 2007, TRENDS MICROBIOL, V15, P127, DOI 10.1016/j.tim.2007.01.006; Guo H, 2008, IMMUNOL CELL BIOL, V86, P271, DOI 10.1038/sj.icb.7100158; Hontelez S, 2012, CELL MICROBIOL, V14, P467, DOI 10.1111/j.1462-5822.2012.01748.x; Hua X, 2014, OPHTHALMIC RES, V51, P179, DOI 10.1159/000357977; Huysamen C, 2009, FEMS MICROBIOL LETT, V290, P121, DOI 10.1111/j.1574-6968.2008.01418.x; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kashyap DR, 2011, NAT MED, V17, P676, DOI 10.1038/nm.2357; Kim HS, 2004, EXP EYE RES, V79, P41, DOI 10.1016/j.exer.2004.02.015; Kingeter LM, 2012, CELL MOL IMMUNOL, V9, P105, DOI 10.1038/cmi.2011.58; Li DQ, 2010, INVEST OPHTH VIS SCI, V51, P5623, DOI 10.1167/iovs.09-4992; LI DQ, 1995, J CELL PHYSIOL, V163, P61, DOI 10.1002/jcp.1041630108; Li DQ, 2006, EXP EYE RES, V82, P588, DOI 10.1016/j.exer.2005.08.019; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Lu XF, 2006, J BIOL CHEM, V281, P5895, DOI 10.1074/jbc.M511631200; Luo LH, 2004, INVEST OPHTH VIS SCI, V45, P4293, DOI 10.1167/iovs.03-1145; Ma P, 2010, EXP EYE RES, V90, P130, DOI 10.1016/j.exer.2009.09.021; Meyer T, 2007, BRIT J DERMATOL, V157, P1, DOI 10.1111/j.1365-2133.2007.08264.x; Moyes DL, 2010, CELL HOST MICROBE, V8, P225, DOI 10.1016/j.chom.2010.08.002; Muller CA, 2005, CELL MOL LIFE SCI, V62, P1297, DOI 10.1007/s00018-005-5034-2; Osanai A, 2011, INFECT IMMUN, V79, P858, DOI 10.1128/IAI.00466-10; Park SY, 2013, J IMMUNOL, V190, P3480, DOI 10.4049/jimmunol.1202675; Plato A, 2013, INT REV IMMUNOL, V32, P134, DOI 10.3109/08830185.2013.777065; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; Saha S, 2010, CELL HOST MICROBE, V8, P147, DOI 10.1016/j.chom.2010.07.005; Sun WK, 2012, EUR J CLIN MICROBIOL, V31, P2755, DOI 10.1007/s10096-012-1624-8; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Thomas PA, 2003, EYE, V17, P852, DOI 10.1038/sj.eye.6700557; Thomas PA, 2007, CURR OPIN INFECT DIS, V20, P129, DOI 10.1097/QCO.0b013e328017f878; Tydell CC, 2006, J IMMUNOL, V176, P1154, DOI 10.4049/jimmunol.176.2.1154; Uehara A, 2005, CELL MICROBIOL, V7, P675, DOI 10.1111/j.1462-5822.2004.00500.x; Ueta M, 2010, EYE CONTACT LENS, V36, P269, DOI 10.1097/ICL.0b013e3181ee8971; Wang ZM, 2003, J BIOL CHEM, V278, P49044, DOI 10.1074/jbc.M307758200; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Yoon KC, 2007, INVEST OPHTH VIS SCI, V48, P2561, DOI 10.1167/iovs.07-0002; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854; Yuan XY, 2010, CURR EYE RES, V35, P872, DOI 10.3109/02713683.2010.495812; Yuan XY, 2010, CORNEA, V29, P674, DOI 10.1097/ICO.0b013e3181c29744; Yuan XY, 2010, INVEST OPHTH VIS SCI, V51, P2094, DOI 10.1167/iovs.09-4330; Yuan XY, 2010, EXP EYE RES, V90, P413, DOI 10.1016/j.exer.2009.12.001; Yuan XY, 2009, INVEST OPHTH VIS SCI, V50, P737, DOI 10.1167/iovs.08-2390; Yuan XY, 2008, MOL VIS, V14, P1792; Zhang LL, 2011, INT J BIOCHEM CELL B, V43, P1383, DOI 10.1016/j.biocel.2011.06.003; Zhang YO, 2005, BBA-PROTEINS PROTEOM, V1752, P34, DOI 10.1016/j.bbapap.2005.07.001; Zhu WD, 2012, P NATL ACAD SCI USA, V109, P14194, DOI 10.1073/pnas.1117676109; Zipfel PF, 2011, INT J MED MICROBIOL, V301, P423, DOI 10.1016/j.ijmm.2011.04.010	60	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128039	10.1371/journal.pone.0128039	http://dx.doi.org/10.1371/journal.pone.0128039			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039076	Green Submitted, Green Published, gold			2022-12-27	WOS:000355700700086
J	Kanaoka, R; Kushiyama, A; Seno, Y; Nakatsu, Y; Matsunaga, Y; Fukushima, T; Tsuchiya, Y; Sakoda, H; Fujishiro, M; Yamamotoya, T; Kamata, H; Matsubara, A; Asano, T				Kanaoka, Ryuhei; Kushiyama, Akifumi; Seno, Yasuyuki; Nakatsu, Yusuke; Matsunaga, Yasuka; Fukushima, Toshiaki; Tsuchiya, Yoshihiro; Sakoda, Hideyuki; Fujishiro, Midori; Yamamotoya, Takeshi; Kamata, Hideaki; Matsubara, Akio; Asano, Tomoichiro			Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; PROLYL ISOMERASE PIN1; ANDROGEN RECEPTOR; TUMOR-SUPPRESSOR; GROWTH-FACTOR; TRANSCRIPTIONAL ACTIVITY; BETA-CATENIN; EXPRESSION; OVEREXPRESSION; PROTEIN	Background Prostate cancer initially develops in an androgen-dependent manner but, during its progression, transitions to being androgen-independent in the advanced stage. Pin1, one of the peptidyl-prolyl cis/trans isomerases, is reportedly overexpressed in prostate cancers and is considered to contribute to accelerated cell growth, which may be one of the major factors contributing to their androgen-independent growth. Thus, we investigated how Pin1 modulates the gene expressions in both androgen-dependent and androgen-independent prostate cancer cell lines using microarray analysis. In addition, the effects of Juglone, a commercially available Pin1 inhibitor were also examined. Methods Two prostate cancer cell-lines, LNCaP (androgen-dependent) and DU145 (androgen-independent), were treated with Pin1 siRNA and its effects on gene expressions were analyzed by microarray. Individual gene regulations induced by Pin1 siRNA or the Pin1 inhibitor Juglone were examined using RT-PCR. In addition, the effects of Juglone on the growth of LNCaP and DU145 transplanted into mice were investigated. Results Microarray analysis revealed that transcriptional factors regulated by Pin1 differed markedly between LNCaP and DU145 cells, the only exception being that Nrf was regulated in the same way by Pin1 siRNA in both cell lines. Despite this marked difference in gene regulations, Pin1 siRNA and Juglone exert a strong inhibitory effect on both the LNCaP and the DU145 cell line, suppressing in vitro cell proliferation as well as tumor enlargement when transplanted into mice. Conclusions Despite Pin1-regulated gene expressions differing between these two prostate cancer cell-lines, LNCaP (androgen-dependent) and DU145 (androgen-independent), Pin1 inhibition suppresses proliferation of both cell-lines. These findings suggest the potential effectiveness of Pin1 inhibitors as therapeutic agents for prostate cancers, regardless of their androgen sensitivity.	[Kanaoka, Ryuhei; Seno, Yasuyuki; Nakatsu, Yusuke; Matsunaga, Yasuka; Fukushima, Toshiaki; Tsuchiya, Yoshihiro; Kamata, Hideaki; Asano, Tomoichiro] Hiroshima Univ, Grad Sch Biomed Sci, Dept Med Chem, Div Mol Med Sci,Minami Ku, Hiroshima, Hiroshima, Japan; [Kushiyama, Akifumi] Asahi Life Fdn, Inst Adult Dis, Div Diabet & Metab, Chiyoda Ku, Tokyo, Japan; [Sakoda, Hideyuki; Fujishiro, Midori; Yamamotoya, Takeshi] Univ Tokyo, Grad Sch Med, Dept Internal Med, Bunkyo Ku, Tokyo, Japan; [Matsubara, Akio] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Urol, Hiroshima, Hiroshima, Japan	Hiroshima University; Asahi Life Foundation; University of Tokyo; Hiroshima University	Asano, T (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Med Chem, Div Mol Med Sci,Minami Ku, 1-2-3 Kasumi, Hiroshima, Hiroshima, Japan.	tasano@hiroshima-u.ac.jp	Kushiyama, Akifumi/A-6386-2011; Kamata, Hideaki/N-3907-2017; Kushiyama, Akifumi/W-5988-2019; 祐介, 中津/AAP-8396-2020	Kushiyama, Akifumi/0000-0003-1385-7487; Kushiyama, Akifumi/0000-0003-1385-7487; Nakatsu, Yusuke/0000-0003-3279-1276	Japan Society for the Promotion of Science [26293219, 23117523]; Grants-in-Aid for Scientific Research [25461372] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (26293219, 23117523; T.A.) from the Japan Society for the Promotion of Science.	Allioli N, 2011, PROSTATE, V71, P1239, DOI 10.1002/pros.21340; Atchison FW, 2003, BIOL REPROD, V69, P1989, DOI 10.1095/biolreprod.103.020859; Attar RM, 2009, CLIN CANCER RES, V15, P3251, DOI 10.1158/1078-0432.CCR-08-1171; Ayala G, 2003, CANCER RES, V63, P6244; Bajgelman MC, 2006, PROSTATE, V66, P1455, DOI 10.1002/pros.20462; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Carstens RP, 1997, ONCOGENE, V15, P3059, DOI 10.1038/sj.onc.1201498; Chetram MA, 2011, MOL CANCER RES, V9, P90, DOI 10.1158/1541-7786.MCR-10-0235; Chlenski A, 2001, PROSTATE, V47, P66; Coppola D, 2008, CLIN GENITOURIN CANC, V6, P117, DOI 10.3816/CGC.2008.n.018; Ding T, 2008, J LIPID RES, V49, P376, DOI 10.1194/jlr.M700401-JLR200; Fan G, 2009, CANCER RES, V69, P4589, DOI 10.1158/0008-5472.CAN-08-4117; Farrell AS, 2013, MOL CELL BIOL, V33, P2930, DOI 10.1128/MCB.01455-12; Fila C, 2008, J BIOL CHEM, V283, P21714, DOI 10.1074/jbc.M710264200; Gao LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063563; Green SM, 2012, MOL CELL ENDOCRINOL, V360, P3, DOI 10.1016/j.mce.2011.09.046; Gresham J, 1998, INT J CANCER, V77, P923, DOI 10.1002/(SICI)1097-0215(19980911)77:6<923::AID-IJC21>3.0.CO;2-0; He J, 2007, LUNG CANCER, V56, P51, DOI 10.1016/j.lungcan.2006.11.024; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; HUGGINS C, 1963, JAMA-J AM MED ASSOC, V186, P481, DOI 10.1001/jama.1963.63710050009008; Hwang YC, 2013, BBA-MOL CELL RES, V1833, P3035, DOI 10.1016/j.bbamcr.2013.08.010; Ji YB, 2011, EXP TOXICOL PATHOL, V63, P69, DOI 10.1016/j.etp.2009.09.010; Joseph James D, 2003, Prog Cell Cycle Res, V5, P477; Kan SF, 2007, J CELL BIOCHEM, V101, P44, DOI 10.1002/jcb.21036; Katoh Y, 2009, INT J MOL MED, V23, P307, DOI 10.3892/ijmm_00000132; Khanal P, 2010, MOL CANCER THER, V9, P606, DOI 10.1158/1535-7163.MCT-09-0560; Kumamoto S, 2012, OBES RES CLIN PRACT, V6, pE288, DOI 10.1016/j.orcp.2012.05.005; La Montagna R, 2012, CELL CYCLE, V11, P3415, DOI 10.4161/cc.21730; Lee KH, 2014, BBA-MOL CELL RES, V1843, P2055, DOI 10.1016/j.bbamcr.2014.06.001; Lu KP, 2004, TRENDS BIOCHEM SCI, V29, P200, DOI 10.1016/j.tibs.2004.02.002; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Lu X, 2014, ONCOGENE, V33, P2918, DOI 10.1038/onc.2013.246; MAHLER C, 1992, CANCER, V70, P329, DOI 10.1002/1097-0142(19920701)70:1+<329::AID-CNCR2820701322>3.0.CO;2-Z; Margel D, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000311; Mitchell S, 2000, BJU INT, V85, P932, DOI 10.1046/j.1464-410x.2000.00606.x; Nakatsu Y, 2012, J BIOL CHEM, V287, P44526, DOI 10.1074/jbc.M112.397133; Nakatsu Y, 2011, J BIOL CHEM, V286, P20812, DOI 10.1074/jbc.M110.206904; Nakatsu Y, 2010, J BIOL CHEM, V285, P33018, DOI 10.1074/jbc.M110.137836; Namgoong GM, 2010, J BIOL CHEM, V285, P23829, DOI 10.1074/jbc.M109.092874; Oltean S, 2006, P NATL ACAD SCI USA, V103, P14116, DOI 10.1073/pnas.0603090103; Pampalakis G, 2007, BBA-REV CANCER, V1776, P22, DOI 10.1016/j.bbcan.2007.06.001; Patki M, 2013, J BIOL CHEM, V288, P11047, DOI 10.1074/jbc.M112.438473; Ryo A, 2003, J CELL SCI, V116, P773, DOI 10.1242/jcs.00276; Ryo A, 2005, CLIN CANCER RES, V11, P7523, DOI 10.1158/1078-0432.CCR-05-0457; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Stoyanova T, 2012, GENE DEV, V26, P2271, DOI 10.1101/gad.196451.112; Takeuchi I, 2012, PROSTATE, V72, P1124, DOI 10.1002/pros.22460; Uchida T, 2003, CHEM BIOL, V10, P15, DOI 10.1016/S1074-5521(02)00310-1; Ueberham U, 2014, NEUROPATH APPL NEURO, V40, P815, DOI 10.1111/nan.12163; Vainio P, 2011, AM J PATHOL, V178, P525, DOI 10.1016/j.ajpath.2010.10.002; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; Wang HY, 2013, MOL CELL BIOL, V33, P4889, DOI 10.1128/MCB.00475-13; Wang XDJ, 2006, BIOPOLYMERS, V84, P125, DOI 10.1002/bip.20240; Wanker EE, 2002, DEV CELL, V2, P126, DOI 10.1016/S1534-5807(02)00121-1; Wu ZB, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/131494; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Xu HL, 2012, FOOD CHEM TOXICOL, V50, P590, DOI 10.1016/j.fct.2012.01.002; Xu HL, 2013, BIOORG MED CHEM LETT, V23, P3631, DOI 10.1016/j.bmcl.2013.04.007	58	18	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127467	10.1371/journal.pone.0127467	http://dx.doi.org/10.1371/journal.pone.0127467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039047	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700062
J	Ming, J; Wang, YQ; Du, ZC; Zhang, T; Guo, WQ; Xiao, CD; Xu, XB; Ding, MH; Zhang, DQ; Yang, W				Ming, Jing; Wang, Yaqiang; Du, Zhencai; Zhang, Tong; Guo, Wanqin; Xiao, Cunde; Xu, Xiaobin; Ding, Minghu; Zhang, Dongqi; Yang, Wen			Widespread Albedo Decreasing and Induced Melting of Himalayan Snow and Ice in the Early 21st Century	PLOS ONE			English	Article							SURFACE-ENERGY BALANCE; MASS-BALANCE; GLACIERS; ACCURACY; COVER; BASIN; INDIA	Background The widely distributed glaciers in the greater Himalayan region have generally experienced rapid shrinkage since the 1850s. As invaluable sources of water and because of their scarcity, these glaciers are extremely important. Beginning in the twenty-first century, new methods have been applied to measure the mass budget of these glaciers. Investigations have shown that the albedo is an important parameter that affects the melting of Himalayan glaciers. Methodology/Principal Findings The surface albedo based on the Moderate Resolution Imaging Spectroradiometer (MODIS) data over the Hindu Kush, Karakoram and Himalaya (HKH) glaciers is surveyed in this study for the period 2000-2011. The general albedo trend shows that the glaciers have been darkening since 2000. The most rapid decrease in the surface albedo has occurred in the glacial area above 6000 m, which implies that melting will likely extend to snow accumulation areas. The mass-loss equivalent (MLE) of the HKH glacial area caused by surface shortwave radiation absorption is estimated to be 10.4 Gt yr(-1), which may contribute to 1.2% of the global sea level rise on annual average (2003-2009). Conclusions/Significance This work probably presents a first scene depicting the albedo variations over the whole HKH glacial area during the period 2000-2011. Most rapidly decreasing in albedo has been detected in the highest area, which deserves to be especially concerned.	[Ming, Jing] China Meteorol Adm, Natl Climate Ctr, Beijing, Peoples R China; [Ming, Jing; Guo, Wanqin; Xiao, Cunde; Ding, Minghu; Zhang, Dongqi] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, State Key Lab Cryospher Sci, Lanzhou, Peoples R China; [Wang, Yaqiang; Xiao, Cunde; Xu, Xiaobin; Ding, Minghu; Zhang, Dongqi] Chinese Acad Meteorol Sci, Beijing, Peoples R China; [Du, Zhencai] Chinese Acad Sci, Inst Atmospher Phys, Beijing, Peoples R China; [Zhang, Tong] Univ S Carolina, Interdisciplinary Math Inst, Columbia, SC 29208 USA; [Yang, Wen] Chinese Res Inst Environm Sci, Beijing, Peoples R China; [Ming, Jing; Ding, Minghu; Yang, Wen] Snow Ice Aerosol Analyzing Lab, Beijing, Peoples R China	China Meteorological Administration; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Meteorological Sciences (CAMS); Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Chinese Research Academy of Environmental Sciences	Ming, J (corresponding author), China Meteorol Adm, Natl Climate Ctr, Beijing, Peoples R China.	petermingjing@hotmail.com	Guo, Wanqin/E-7553-2015; Wang, Yaqiang/P-5400-2018; Ming, Jing/C-2975-2008; Xu, Xiaobin/B-3844-2012	Guo, Wanqin/0000-0002-3211-9300; Wang, Yaqiang/0000-0002-4829-0276; Ming, Jing/0000-0001-5527-3768; Xu, Xiaobin/0000-0003-4321-9267	Chinese Academy of Sciences [KJZD-EW-G03-03]; National Natural Science Foundation of China [41425003, 41275167]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is financially supported by the Chinese Academy of Sciences (KJZD-EW-G03-03), and the National Natural Science Foundation of China (Grant 41425003 and 41275167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, MODIS SNOW PRODUCTS; Arendt A., 2012, RANDOLPH GLACIER INV; Azam MF, 2014, CRYOSPHERE, V8, P2195, DOI 10.5194/tc-8-2195-2014; Bolch T, 2012, SCIENCE, V336, P310, DOI 10.1126/science.1215828; Box JE, 2012, CRYOSPHERE, V6, P821, DOI 10.5194/tc-6-821-2012; Brun F, 2015, CRYOSPHERE, V9, P341, DOI 10.5194/tc-9-341-2015; Datt P, 2008, J EARTH SYST SCI, V117, P567, DOI 10.1007/s12040-008-0053-7; Dumont M, 2012, CRYOSPHERE, V6, P1527, DOI 10.5194/tc-6-1527-2012; Gardelle J, 2012, NAT GEOSCI, V5, P322, DOI [10.1038/ngeo1450, 10.1038/NGEO1450]; Gardner AS, 2013, SCIENCE, V340, P852, DOI 10.1126/science.1234532; Gautam R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037641; Gautam R, 2013, GEOPHYS RES LETT, V40, P988, DOI 10.1002/grl.50226; Gurung D, 2011, SNOW COVER MAPPING A; Hoffman MJ, 2008, ANTARCTICA J GEOPHYS, V113; [华维 Hua Wei], 2010, [山地学报, Journal of Mountain Science], V28, P21; Huang XD, 2011, INT J REMOTE SENS, V32, P133, DOI 10.1080/01431160903439924; Immerzeel WW, 2010, SCIENCE, V328, P1382, DOI 10.1126/science.1183188; Jacob T, 2012, NATURE, V482, P514, DOI 10.1038/nature10847; Jain SK, 2008, INT J REMOTE SENS, V29, P3091, DOI 10.1080/01431160701468992; Kaab A, 2012, NATURE, V488, P495, DOI 10.1038/nature11324; Kato S, 2013, J CLIMATE, V26, P2719, DOI 10.1175/JCLI-D-12-00436.1; Ming J, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014021; Nair VS, 2013, TELLUS B, V65, DOI 10.3402/tellusb.v65i0.19738; Nie Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083973; Painter TH, 2013, P NATL ACAD SCI USA, V110, P15216, DOI 10.1073/pnas.1302570110; Palazzi E, 2013, J GEOPHYS RES-ATMOS, V118, P85, DOI 10.1029/2012JD018697; Panday PK, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/024007; Rodriguez E., 2005, ASSESSMENT SRTM TOPO; Shrestha UB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036741; Stroeve JC, 2006, REMOTE SENS ENVIRON, V105, P155, DOI 10.1016/j.rse.2006.06.009; Tekeli AE, 2006, HYDROL PROCESS, V20, P705, DOI 10.1002/hyp.6114; Vincent C, 2013, CRYOSPHERE, V7, P569, DOI 10.5194/tc-7-569-2013; Wagnon P, 2012, EGU GEN ASSEMBLY C A, V14, P5328; Wang J, 2014, HYDROL PROCESS, V28, P3454, DOI 10.1002/hyp.9883; Wang YQ, 2014, METEOROL APPL, V21, P360, DOI 10.1002/met.1345; WGMS (World Glacier Monitoring Service), 2012, FLUCT GLAC 2005 2010, V10; Wolfe RE, 2002, REMOTE SENS ENVIRON, V83, P31, DOI 10.1016/S0034-4257(02)00085-8; Yang W, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015183; Yang X, 2008, ARID METEOROLOGY, V26, P16; Yasunari TJ, 2010, ATMOS CHEM PHYS, V10, P6603, DOI 10.5194/acp-10-6603-2010	40	44	45	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126235	10.1371/journal.pone.0126235	http://dx.doi.org/10.1371/journal.pone.0126235			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039088	gold, Green Submitted, Green Published			2022-12-27	WOS:000355700700020
J	Wang, S; Dong, RJ; Liu, DX; Wang, Y; Liu, B; Zhang, L; Xu, L				Wang, Shuo; Dong, Ruijuan; Liu, Dongxin; Wang, Yuan; Liu, Bo; Zhang, Luo; Xu, Li			The Role of Temporal Envelope and Fine Structure in Mandarin Lexical Tone Perception in Auditory Neuropathy Spectrum Disorder	PLOS ONE			English	Article							COCHLEAR HEARING-LOSS; SPEECH-PERCEPTION; STRUCTURE INFORMATION; FREQUENCY-SELECTIVITY; PITCH DISCRIMINATION; GAP DETECTION; INDIVIDUALS; CHILDREN; ABILITY; IMPLANTATION	Temporal information in a signal can be partitioned into temporal envelope (E) and fine structure (FS). Fine structure is important for lexical tone perception for normal-hearing (NH) listeners, and listeners with sensorineural hearing loss (SNHL) have an impaired ability to use FS in lexical tone perception due to the reduced frequency resolution. The present study was aimed to assess which of the acoustic aspects (E or FS) played a more important role in lexical tone perception in subjects with auditory neuropathy spectrum disorder (ANSD) and to determine whether it was the deficit in temporal resolution or frequency resolution that might lead to more detrimental effects on FS processing in pitch perception. Fifty-eight native Mandarin Chinese-speaking subjects (27 with ANSD, 16 with SNHL, and 15 with NH) were assessed for (1) their ability to recognize lexical tones using acoustic E or FS cues with the "auditory chimera" technique, (2) temporal resolution as measured with temporal gap detection (TGD) threshold, and (3) frequency resolution as measured with the Q(10dB) values of the psychophysical tuning curves. Overall, 26.5%, 60.2%, and 92.1% of lexical tone responses were consistent with FS cues for tone perception for listeners with ANSD, SNHL, and NH, respectively. The mean TGD threshold was significantly higher for listeners with ANSD (11.9 ms) than for SNHL (4.0 ms; p < 0.001) and NH (3.9 ms; p < 0.001) listeners, with no significant difference between SNHL and NH listeners. In contrast, the mean Q10dB for listeners with SNHL (1.8 +/- 0.4) was significantly lower than that for ANSD (3.5 +/- 1.0; p < 0.001) and NH (3.4 +/- 0.9; p < 0.001) listeners, with no significant difference between ANSD and NH listeners. These results suggest that reduced temporal resolution, as opposed to reduced frequency selectivity, in ANSD subjects leads to greater degradation of FS processing for pitch perception.	[Wang, Shuo; Dong, Ruijuan; Liu, Dongxin; Wang, Yuan; Liu, Bo; Zhang, Luo] Capital Med Univ, Beijing Inst Otolaryngol, Beijing Tongren Hosp, Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Xu, Li] Ohio Univ, Sch Rehabil & Commun Sci, Athens, OH 45701 USA	Capital Medical University; University System of Ohio; Ohio University	Zhang, L (corresponding author), Capital Med Univ, Beijing Inst Otolaryngol, Beijing Tongren Hosp, Otolaryngol Head & Neck Surg, Beijing, Peoples R China.	dr.luozhang@gmail.com; xul@ohio.edu	Xu, Li/C-5908-2008	Xu, Li/0000-0002-0988-7934; Zhang, Luo/0000-0002-0910-9884	National Natural Science Foundation of China [81200754]; Beijing Nova Program [Z121107002512033]; Beijing Natural Science Foundation [7122034]; Capital Health Research and Development of Special from Beijing Municipal Health Bureau [2011-1017-04]; Basic-Clinical Cooperative Research Foundation of Capital Medical University [12JL46]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Capital Health Research and Development of Special from Beijing Municipal Health Bureau; Basic-Clinical Cooperative Research Foundation of Capital Medical University	This work was funded in part by grants from the National Natural Science Foundation of China (81200754), the 2012 Beijing Nova Program (Z121107002512033), Beijing Natural Science Foundation (7122034), the Capital Health Research and Development of Special from the Beijing Municipal Health Bureau (2011-1017-04), and the Basic-Clinical Cooperative Research Foundation of Capital Medical University (12JL46). The authors declare no competing financial interests in the present study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apoux F, 2013, ADV EXP MED BIOL, V787, P119, DOI 10.1007/978-1-4614-1590-9_14; Berlin CI, 2003, MENT RETARD DEV D R, V9, P225, DOI 10.1002/mrdd.10084; Bernstein JGW, 2006, J ACOUST SOC AM, V120, P3929, DOI 10.1121/1.2372452; GLASBERG BR, 1992, HEARING RES, V64, P81, DOI 10.1016/0378-5955(92)90170-R; GLASBERG BR, 1987, J ACOUST SOC AM, V81, P1546, DOI 10.1121/1.394507; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; HARRISON RV, 1979, ARCH OTO-RHINO-LARYN, V224, P71, DOI 10.1007/BF00455226; Heinz MG, 2010, NEUROPHYSIOLOGICAL BASES OF AUDITORY PERCEPTION, P621, DOI 10.1007/978-1-4419-5686-6_56; Heinz MG, 2009, JARO-J ASSOC RES OTO, V10, P407, DOI 10.1007/s10162-009-0169-8; Henry KS, 2012, NAT NEUROSCI, V15, P1362, DOI 10.1038/nn.3216; Hopkins K, 2008, J ACOUST SOC AM, V123, P1140, DOI 10.1121/1.2824018; Hopkins K, 2007, J ACOUST SOC AM, V122, P1055, DOI 10.1121/1.2749457; Hopkins K, 2010, J ACOUST SOC AM, V127, P1595, DOI 10.1121/1.3293003; Hopkins K, 2009, J ACOUST SOC AM, V125, P442, DOI 10.1121/1.3037233; Humphriss R, 2013, INT J AUDIOL, V52, P442, DOI 10.3109/14992027.2013.786190; Kale S, 2010, JARO-J ASSOC RES OTO, V11, P657, DOI 10.1007/s10162-010-0223-6; Kong YY, 2006, J ACOUST SOC AM, V120, P2830, DOI 10.1121/1.2346009; Kumar UA, 2006, INT J AUDIOL, V45, P360, DOI 10.1080/14992020600624893; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; LIN MC, 1988, ZHONGGUO YUWEN, V3, P182; Lorenzi C, 2006, P NATL ACAD SCI USA, V103, P18866, DOI 10.1073/pnas.0607364103; Lorenzi C, 2009, J ACOUST SOC AM, V125, P27, DOI 10.1121/1.2939125; Mason JC, 2003, LARYNGOSCOPE, V113, P45, DOI 10.1097/00005537-200301000-00009; Miller RL, 1997, J ACOUST SOC AM, V101, P3602, DOI 10.1121/1.418321; MOORE BCJ, 1992, J ACOUST SOC AM, V91, P2881, DOI 10.1121/1.402925; Moore BCJ, 1996, J ACOUST SOC AM, V100, P481, DOI 10.1121/1.415861; MOORE BCJ, 1988, J ACOUST SOC AM, V83, P1093, DOI 10.1121/1.396054; Moore BCJ, 2008, JARO-J ASSOC RES OTO, V9, P399, DOI 10.1007/s10162-008-0143-x; Moore BCJ, 2006, HEARING RES, V222, P16, DOI 10.1016/j.heares.2006.08.007; Narne VK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055995; Narne VK, 2009, INT J AUDIOL, V48, P700, DOI 10.1080/14992020902931574; Narne VK, 2009, EAR HEARING, V30, P136, DOI 10.1097/AUD.0b013e3181926545; Nelson PB, 1997, J SPEECH LANG HEAR R, V40, P1387, DOI 10.1044/jslhr.4006.1387; Nikolopoulos TP, 2014, INT J PEDIATR OTORHI, V78, P171, DOI 10.1016/j.ijporl.2013.12.021; Peterson Ann, 2003, J Am Acad Audiol, V14, P188; Rance G, 2004, EAR HEARING, V25, P34, DOI 10.1097/01.AUD.0000111259.59690.B8; Rance G, 2008, OTOL NEUROTOL, V29, P179, DOI 10.1097/mao.0b013e31815e92fd; Sek A, 2011, INT J AUDIOL, V50, P237, DOI 10.3109/14992027.2010.550636; Smith ZM, 2002, NATURE, V416, P87, DOI 10.1038/416087a; Starr A, 1996, BRAIN, V119, P741, DOI 10.1093/brain/119.3.741; Strelcyk O, 2009, J ACOUST SOC AM, V125, P3328, DOI 10.1121/1.3097469; TURNER CW, 1995, J ACOUST SOC AM, V97, P2568, DOI 10.1121/1.411911; Turner CW, 1999, J SPEECH LANG HEAR R, V42, P773, DOI 10.1044/jslhr.4204.773; Vinay, 2007, INT J AUDIOL, V46, P39, DOI 10.1080/14992020601077992; Wang S, 2011, JARO-J ASSOC RES OTO, V12, P783, DOI 10.1007/s10162-011-0285-0; Xu L, 2003, J ACOUST SOC AM, V114, P3024, DOI 10.1121/1.1623786; Xu L, 2002, J ACOUST SOC AM, V112, P247, DOI 10.1121/1.1487843; Zeng FG, 2006, J SPEECH LANG HEAR R, V49, P367, DOI 10.1044/1092-4388(2006/029); Zeng FG, 2005, J NEUROPHYSIOL, V93, P3050, DOI 10.1152/jn.00985.2004; Zeng FG, 1999, NEUROREPORT, V10, P3429, DOI 10.1097/00001756-199911080-00031; Zhong ZW, 2014, HEARING RES, V309, P55, DOI 10.1016/j.heares.2013.11.006	51	7	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129710	10.1371/journal.pone.0129710	http://dx.doi.org/10.1371/journal.pone.0129710			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052707	Green Published, gold, Green Submitted			2022-12-27	WOS:000355955300160
J	Kwiatkowski, F; Arbre, M; Bidet, Y; Laquet, C; Uhrhammer, N; Bignon, YJ				Kwiatkowski, Fabrice; Arbre, Marie; Bidet, Yannick; Laquet, Claire; Uhrhammer, Nancy; Bignon, Yves-Jean			BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk	PLOS ONE			English	Article							BREAST-CANCER; CARRIER PROBABILITIES; FEMALE FERTILITY; EARLY-ONSET; POPULATION; SUSCEPTIBILITY; PREGNANCY; DISEASE; GENES; AGE	Background Deleterious mutations in the BRCA genes are responsible for a small, but significant, proportion of breast and ovarian cancers (5 - 10 %). Proof of de novo mutations in hereditary breast/ovarian cancer (HBOC) families is rare, in contrast to founder mutations, thousands of years old, that may be carried by as much as 1% of a population. Thus, if mutations favoring cancer survive selection pressure through time, they must provide advantages that compensate for the loss of life expectancy. Method This hypothesis was tested within 2,150 HBOC families encompassing 96,325 individuals. Parameters included counts of breast/ovarian cancer, age at diagnosis, male breast cancer and other cancer locations. As expected, well-known clinical parameters discriminated between BRCA-mutated families and others: young age at breast cancer, ovarian cancer, pancreatic cancer and male breast cancer. The major fertility differences concerned men in BRCA-mutated families: they had lower first and mean age at paternity, and fewer remained childless. For women in BRCA families, the miscarriage rate was lower. In a logistic regression including clinical factors, the different miscarriage rate and men's mean age at paternity remained significant. Results Fertility advantages were confirmed in a subgroup of 746 BRCA mutation carriers and 483 non-carriers from BRCA mutated families. In particular, female carriers were less often nulliparous (9.1 % of carriers versus 16.0 %, p = 0.003) and had more children (1.8 +/- 1.4 SD versus 1.5 +/- 1.3, p = 0.002) as well as male carriers (1.7 +/- 1.3 versus 1.4 +/- 1.3, p = 0.024). Conclusion Although BRCA mutations shorten the reproductive period due to cancer mortality, they compensate by improving fertility both in male and female carriers.	[Kwiatkowski, Fabrice; Arbre, Marie; Laquet, Claire; Uhrhammer, Nancy; Bignon, Yves-Jean] Ctr Jean Perrin, Oncol Mol Lab, F-63011 Clermont Ferrand, France; [Kwiatkowski, Fabrice] Univ Clermont Ferrand, Math Lab, CNRS, UMR 6620, F-63171 Aubiere, France; [Bidet, Yannick; Bignon, Yves-Jean] Univ Auvergne, Univ Clermont Auvergne, F-63000 Clermont Ferrand, France	UNICANCER; Centre Jean Perrin; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA)	Kwiatkowski, F (corresponding author), Ctr Jean Perrin, Oncol Mol Lab, F-63011 Clermont Ferrand, France.	Fabrice.Kwiatkowski@CJP.fr	Bidet, Yannick/O-5753-2019; , bignon/Y-3243-2019	Bidet, Yannick/0000-0002-9624-8195; 	Centre Jean Perrin	Centre Jean Perrin	This study received no external funding. This research was totally financed by Centre Jean Perrin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas S, 2012, BREAST CANCER RES TR, V133, P347, DOI 10.1007/s10549-012-1958-z; Bonaiti B, 2011, B CANCER, V98, P779, DOI 10.1684/bdc.2011.1397; Buss L, 2006, ACTA OBSTET GYN SCAN, V85, P467, DOI 10.1080/00016340500494887; Caputo S, 2012, NUCLEIC ACIDS RES, V40, pD992, DOI 10.1093/nar/gkr1160; Diez O, 2010, BREAST CANCER RES TR, V121, P221, DOI 10.1007/s10549-009-0494-y; Eisinger F, 2004, B CANCER, V91, P219; Fischer C, 2013, J MED GENET, V50, P360, DOI 10.1136/jmedgenet-2012-101415; Friedman E, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1387; Harboe TL, 2009, FAM CANCER, V8, P413, DOI 10.1007/s10689-009-9257-5; Hinkula M, 2002, INT J CANCER, V98, P912, DOI 10.1002/ijc.10267; Im KM, 2011, HUM GENET, V130, P685, DOI 10.1007/s00439-011-1003-z; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kwiatkowski F, 2000, B CANCER, V87, P715; Laraqui A, 2013, INT J MED SCI, V10, P60, DOI 10.7150/ijms.5014; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; LAYDE PM, 1989, J CLIN EPIDEMIOL, V42, P963, DOI 10.1016/0895-4356(89)90161-3; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Moslehi R, 2010, AM J HUM BIOL, V22, P201, DOI 10.1002/ajhb.20978; Oktay K, 2010, J CLIN ONCOL, V28, P240, DOI 10.1200/JCO.2009.24.2057; Pal T, 2010, FERTIL STERIL, V93, P1805, DOI 10.1016/j.fertnstert.2008.12.052; Parmigiani G, 1998, AM J HUM GENET, V62, P145, DOI 10.1086/301670; Plon SE, 2005, CANCER J, V11, P255, DOI 10.1097/00130404-200507000-00002; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Russo J, 2000, J Natl Cancer Inst Monogr, P17; Smith KR, 2012, P ROY SOC B-BIOL SCI, V279, P1389, DOI 10.1098/rspb.2011.1697; Tyrer J, 2004, STAT MED, V23, P1111, DOI 10.1002/sim.1668; van der Luijt RB, 2001, J MED GENET, V38, P102, DOI 10.1136/jmg.38.2.102; Zinaman MJ, 1996, FERTIL STERIL, V65, P503, DOI 10.1016/S0015-0282(16)58144-8	28	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127363	10.1371/journal.pone.0127363	http://dx.doi.org/10.1371/journal.pone.0127363			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047126	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200019
J	Warsi, J; Hosseinzadeh, Z; Elvira, B; Pelzl, L; Shumilina, E; Zhang, DE; Lang, KS; Lang, PA; Lang, F				Warsi, Jamshed; Hosseinzadeh, Zohreh; Elvira, Bernat; Pelzl, Lisann; Shumilina, Ekaterina; Zhang, Dong-Er; Lang, Karl S.; Lang, Philipp A.; Lang, Florian			USP18 Sensitivity of Peptide Transporters PEPT1 and PEPT2	PLOS ONE			English	Article							NF-KAPPA-B; UP-REGULATION; UBP43 USP18; OLIGOPEPTIDE TRANSPORTER; DOWN-REGULATION; KINASE; GROWTH; CELLS; ISG15; DRUG	USP18 (Ubiquitin-like specific protease 18) is an enzyme cleaving ubiquitin from target proteins. USP18 plays a pivotal role in antiviral and antibacterial immune responses. On the other hand, ubiquitination participates in the regulation of several ion channels and transporters. USP18 sensitivity of transporters has, however, never been reported. The present study thus explored, whether USP18 modifies the activity of the peptide transporters PEPT1 and PEPT2, and whether the peptide transporters are sensitive to the ubiquitin ligase Nedd4-2. To this end, cRNA encoding PEPT1 or PEPT2 was injected into Xenopus laevis oocytes without or with additional injection of cRNA encoding USP18. Electrogenic peptide (glycine-glycine) transport was determined by dual electrode voltage clamp. As a result, in Xenopus laevis oocytes injected with cRNA encoding PEPT1 or PEPT2, but not in oocytes injected with water or with USP18 alone, application of the dipeptide gly-gly (2 mM) was followed by the appearance of an inward current (Igly-gly). Coexpression of USP18 significantly increased Igly-gly in both PEPT1 and PEPT2 expressing oocytes. Kinetic analysis revealed that coexpression of USP18 increased maximal Igly-gly. Conversely, overexpression of the ubiquitin ligase Nedd4-2 decreased Igly-gly. Coexpression of USP30 similarly increased Igly-gly in PEPT1 expressing oocytes. In conclusion, USP18 sensitive cellular functions include activity of the peptide transporters PEPT1 and PEPT2.	[Warsi, Jamshed; Hosseinzadeh, Zohreh; Elvira, Bernat; Pelzl, Lisann; Shumilina, Ekaterina; Lang, Florian] Univ Tubingen, Dept Physiol 1, Tubingen, Germany; [Zhang, Dong-Er] Univ Calif San Diego, Moores UCSD Canc Ctr, Dept Pathol, La Jolla, CA 92093 USA; [Zhang, Dong-Er] Univ Calif San Diego, Moores UCSD Canc Ctr, Div Biol Sci, La Jolla, CA 92093 USA; [Lang, Karl S.] Univ Duisburg Essen, Fac Med, Inst Immunol, Essen, Germany; [Lang, Philipp A.] Univ Duesseldorf, Dept Mol Med 2, Dusseldorf, Germany	Eberhard Karls University of Tubingen; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Duisburg Essen	Lang, F (corresponding author), Univ Tubingen, Dept Physiol 1, Tubingen, Germany.	florian.lang@uni-tuebingen.de	Hosseinzadeh, Zohreh/X-8548-2019; Lang, Karl S/R-2505-2016; Elvira, Bernat/A-2404-2017	Hosseinzadeh, Zohreh/0000-0003-3407-7754; Lang, Karl/0000-0001-9783-7605; Elvira, Bernat/0000-0003-0434-2238	Deutsche Forschungsgemeinschaft [GRK 1302, SFB 773 B4/A1, La 315/13-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft (URL: http://www.dfg.de/): GRK 1302, SFB 773 B4/A1, La 315/13-3. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Ali T, 2009, GENE, V439, P35, DOI 10.1016/j.gene.2009.02.021; Almilaji A, 2014, KIDNEY BLOOD PRESS R, V39, P516, DOI 10.1159/000368462; Alteheld B, 2005, J NUTR, V135, P19, DOI 10.1093/jn/135.1.19; Ayyadurai S, 2013, LAB INVEST, V93, P888, DOI 10.1038/labinvest.2013.77; Baines Deborah, 2013, Curr Mol Pharmacol, V6, P50; Boehmer C, 2008, CELL PHYSIOL BIOCHEM, V22, P705, DOI 10.1159/000185554; Bongiorno D, 2011, CHANNELS, V5, P79, DOI 10.4161/chan.5.1.13967; Brandsch M, 2009, EXPERT OPIN DRUG MET, V5, P887, DOI 10.1517/17425250903042292; Burkart C, 2013, EMBO MOL MED, V5, P1035, DOI 10.1002/emmm.201201864; Burkart C, 2012, J BIOL CHEM, V287, P4883, DOI 10.1074/jbc.M111.255570; Cunningham CN, 2015, NAT CELL BIOL, V17, P160, DOI 10.1038/ncb3097; Dauphinee SM, 2014, GENES IMMUN, V15, P282, DOI 10.1038/gene.2014.17; Duex JE, 2011, J BIOL CHEM, V286, P25377, DOI 10.1074/jbc.M111.222760; Duex JE, 2009, MOL BIOL CELL, V20, P1833, DOI 10.1091/mbc.E08-08-0880; Eaton Douglas C, 2010, Proc Am Thorac Soc, V7, P54, DOI 10.1513/pats.200909-096JS; Elvira B, 2014, KIDNEY BLOOD PRESS R, V39, P353, DOI 10.1159/000355812; Fezai M, 2014, KIDNEY BLOOD PRESS R, V39, P546, DOI 10.1159/000368465; Francois-Newton V, 2012, BIOCHEM J, V446, P509, DOI 10.1042/BJ20120541; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Gonzalez DE, 1998, CANCER RES, V58, P519; Hong BX, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-132; Honke N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003650; Hosseinzadeh Z, 2013, CELL PHYSIOL BIOCHEM, V31, P673, DOI 10.1159/000350086; Ingersoll SA, 2012, AM J PHYSIOL-GASTR L, V302, pG484, DOI 10.1152/ajpgi.00477.2011; Inoue M, 2005, CANCER LETT, V230, P72, DOI 10.1016/j.canlet.2004.12.023; Kamal MA, 2008, DRUG METAB PHARMACOK, V23, P236, DOI 10.2133/dmpk.23.236; Kim JH, 2008, J IMMUNOL, V181, P6467, DOI 10.4049/jimmunol.181.9.6467; Kim YH, 2014, J KOREAN MED SCI, V29, P351, DOI 10.3346/jkms.2014.29.3.351; Laedermann Cedric J, 2014, Handb Exp Pharmacol, V221, P231, DOI 10.1007/978-3-642-41588-3_11; Lang F, 2012, CELL CALCIUM, V52, P347, DOI 10.1016/j.ceca.2012.05.005; Liu XK, 2013, J EXP MED, V210, P1575, DOI 10.1084/jem.20122327; Makki MS, 2013, EXP CELL RES, V319, P612, DOI 10.1016/j.yexcr.2012.12.021; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malhotra S, 2013, EUR J NEUROL, V20, P1390, DOI 10.1111/ene.12193; Manini I, 2013, CANCER BIOL THER, V14, P1158, DOI 10.4161/cbt.26525; Meredith D, 2009, PHILOS T R SOC B, V364, P203, DOI 10.1098/rstb.2008.0139; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Mitsuoka K, 2010, EUR J PHARM SCI, V40, P202, DOI 10.1016/j.ejps.2010.03.010; Munoz C, 2014, CELL PHYSIOL BIOCHEM, V33, P491, DOI 10.1159/000358629; Murray EJ, 2011, ANTIMICROB AGENTS CH, V55, P4311, DOI 10.1128/AAC.00644-11; Nakamura Tsutomu, 2008, Current Drug Delivery, V5, P153, DOI 10.2174/156720108784911749; Newstead S, 2011, BIOCHEM SOC T, V39, P1353, DOI 10.1042/BST0391353; Pakladok T, 2013, CELL PHYSIOL BIOCHEM, V31, P785, DOI 10.1159/000350096; Pieri M, 2010, AM J PHYSIOL-GASTR L, V299, pG136, DOI 10.1152/ajpgi.00014.2010; Potu H, 2010, CANCER RES, V70, P655, DOI 10.1158/0008-5472.CAN-09-1942; Rexhepaj R, 2010, CELL PHYSIOL BIOCHEM, V26, P641, DOI 10.1159/000322331; Rexhepaj R, 2010, CELL PHYSIOL BIOCHEM, V25, P715, DOI 10.1159/000315091; Richer E, 2011, GENES IMMUN, V12, P531, DOI 10.1038/gene.2011.38; Ritchie KJ, 2004, NAT MED, V10, P1374, DOI 10.1038/nm1133; Rotin D, 2011, PFLUG ARCH EUR J PHY, V461, P1, DOI 10.1007/s00424-010-0893-2; Rubio-Aliaga I, 2008, XENOBIOTICA, V38, P1022, DOI [10.1080/00498250701875254, 10.1080/00498250701875254 ]; Santin I, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.158; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Schwer H, 2000, GENOMICS, V65, P44, DOI 10.1006/geno.2000.6148; Snyder PM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.279pe41; Soundararajan R, 2012, CRIT REV BIOCHEM MOL, V47, P349, DOI 10.3109/10409238.2012.678285; Stokes A, 2006, CELL SIGNAL, V18, P1584, DOI 10.1016/j.cellsig.2005.12.009; Strutz-Seebohm N, 2013, CELL PHYSIOL BIOCHEM, V31, P968, DOI 10.1159/000350115; Sun DL, 2013, MOL PHARMACEUT, V10, P1409, DOI 10.1021/mp300700p; Tai W, 2012, MOL PHARM; Terada T, 2012, CURR TOP MEMBR, V70, P257, DOI 10.1016/B978-0-12-394316-3.00008-9; Tsume Y, 2008, MOL PHARMACEUT, V5, P717, DOI 10.1021/mp800008c; Warsi J, 2014, KIDNEY BLOOD PRESS R, V39, P591, DOI 10.1159/000368469; Warsi J, 2014, KIDNEY BLOOD PRESS R, V39, P378, DOI 10.1159/000355816; Warsi J, 2014, KIDNEY BLOOD PRESS R, V39, P388, DOI 10.1159/000368451; Xu DQ, 2012, VIRUS RES, V169, P264, DOI 10.1016/j.virusres.2012.07.002; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Yang XD, 2002, PHARMACEUT RES, V19, P825, DOI 10.1023/A:1016132200104; Yarandi SS, 2011, NUTRITION, V27, P269, DOI 10.1016/j.nut.2010.07.004	69	6	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129365	10.1371/journal.pone.0129365	http://dx.doi.org/10.1371/journal.pone.0129365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046984	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200158
J	Mitchell, AL; Wolff, AB; MacArthur, K; Weaver, JU; Vaidya, B; Bensing, S; Erichsen, MM; Darlay, R; Husebye, ES; Cordell, HJ; Pearce, SHS				Mitchell, Anna L.; Wolff, Anette Boe; MacArthur, Katie; Weaver, Jolanta U.; Vaidya, Bijay; Bensing, Sophie; Erichsen, Martina M.; Darlay, Rebecca; Husebye, Eystein S.; Cordell, Heather J.; Pearce, Simon H. S.		Swedish Addison Registry Study Grp	Linkage Analysis in Autoimmune Addison's Disease: NFATC1 as a Potential Novel Susceptibility Locus	PLOS ONE			English	Article							GRAVES-DISEASE; GENE; POLYMORPHISM; ASSOCIATION; ALLELE; RISK; PTPN22	Background Autoimmune Addison's disease (AAD) is a rare, highly heritable autoimmune endocrinopathy. It is possible that there may be some highly penetrant variants which confer disease susceptibility that have yet to be discovered. Methods DNA samples from 23 multiplex AAD pedigrees from the UK and Norway (50 cases, 67 controls) were genotyped on the Affymetrix SNP 6.0 array. Linkage analysis was performed using Merlin. EMMAX was used to carry out a genome-wide association analysis comparing the familial AAD cases to 2706 UK WTCCC controls. To explore some of the linkage findings further, a replication study was performed by genotyping 64 SNPs in two of the four linked regions (chromosomes 7 and 18), on the Sequenom iPlex platform in three European AAD case-control cohorts (1097 cases, 1117 controls). The data were analysed using a meta-analysis approach. Results In a parametric analysis, applying a rare dominant model, loci on chromosomes 7, 9 and 18 had LOD scores >2.8. In a non-parametric analysis, a locus corresponding to the HLA region on chromosome 6, known to be associated with AAD, had a LOD score >3.0. In the genome-wide association analysis, a SNP cluster on chromosome 2 and a pair of SNPs on chromosome 6 were associated with AAD (P < 5x10(-7)). A meta-analysis of the replication study data demonstrated that three chromosome 18 SNPs were associated with AAD, including a non-synonymous variant in the NFATC1 gene. Conclusion This linkage study has implicated a number of novel chromosomal regions in the pathogenesis of AAD in multiplex AAD families and adds further support to the role of HLA in AAD. The genome-wide association analysis has also identified a region of interest on chromosome 2. A replication study has demonstrated that the NFATC1 gene is worthy of future investigation, however each of the regions identified require further, systematic analysis.	[Mitchell, Anna L.; MacArthur, Katie; Darlay, Rebecca; Cordell, Heather J.; Pearce, Simon H. S.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wolff, Anette Boe; Husebye, Eystein S.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Weaver, Jolanta U.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Vaidya, Bijay] Royal Devon & Exeter NHS Fdn Trust, Exeter, Devon, England; [Swedish Addison Registry Study Grp] Karolinska Inst, Stockholm, Sweden; [Erichsen, Martina M.; Husebye, Eystein S.] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway	Newcastle University - UK; University of Bergen; Newcastle University - UK; University of Exeter; Karolinska Institutet; University of Bergen; Haukeland University Hospital	Mitchell, AL (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	annamitchell@doctors.org.uk	Wolff, Anette/AAN-5981-2020; Pearce, Simon/AAB-3692-2019; Vaidya, Bijay/AAF-1947-2020	Pearce, Simon/0000-0001-8384-8063; Mitchell, Anna L/0000-0002-9946-183X; Cordell, Heather/0000-0002-1879-5572; Wolff, Anette Susanne Boe/0000-0002-8485-2248; Vaidya, Bijay/0000-0002-2223-0494	Medical Research Council UK [G0900390]; European Union Framework 7 grant [201167]; Swedish Society for Medical Research; Swedish Society of Medicine; NovoNordisk Foundation; Karolinska Institutet; Ake Wiberg Foundation; Medical Research Council [G0900390, G0701632, MR/J002526/1, G0900001] Funding Source: researchfish; National Institute for Health Research [ACF-2007-01-004, CL-2014-01-001] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0011005] Funding Source: researchfish; MRC [G0900001, MR/J002526/1, G0900390, G0701632] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union Framework 7 grant; Swedish Society for Medical Research; Swedish Society of Medicine; NovoNordisk Foundation(Novo Nordisk Foundation); Karolinska Institutet(Karolinska Institutet); Ake Wiberg Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by grants from the Medical Research Council UK to Dr A L Mitchell (G0900390) and a European Union Framework 7 grant (201167) to the Euradrenal Consortium. The Swedish contribution was funded by the Swedish Society for Medical Research, the Swedish Society of Medicine, the NovoNordisk Foundation, Karolinska Institutet, and the Ake Wiberg Foundation. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; [Anonymous], 2011, REV MAN REVMAN COMP; Blomhoff A, 2004, J CLIN ENDOCR METAB, V89, P3474, DOI 10.1210/jc.2003-031854; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cohen PTW, 2002, J CELL SCI, V115, P241; Cook JR, 2006, BIOCHEM BIOPH RES CO, V342, P472, DOI 10.1016/j.bbrc.2006.01.167; Edelbrock MA, 2013, MUTAT RES-FUND MOL M, V743, P53, DOI 10.1016/j.mrfmmm.2012.12.008; Gambelunghe G, 1999, J CLIN ENDOCR METAB, V84, P3701, DOI 10.1210/jc.84.10.3701; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Ghaderi M, 2006, J CLIN ENDOCR METAB, V91, P4107, DOI 10.1210/jc.2006-0855; Gombos Z, 2007, EUR J ENDOCRINOL, V157, P757, DOI 10.1530/EJE-07-0290; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Horsley V, 2002, J CELL BIOL, V156, P771, DOI 10.1083/jcb.200111073; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kemp EH, 1998, CLIN ENDOCRINOL, V49, P609; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lopez ER, 2004, EUR J ENDOCRINOL, V151, P193, DOI 10.1530/eje.0.1510193; Lovas K, 2002, CLIN ENDOCRINOL, V56, P787, DOI 10.1046/j.1365-2265.2002.t01-1-01552.x; MACLAREN NK, 1986, J CLIN ENDOCR METAB, V62, P455, DOI 10.1210/jcem-62-3-455; Magitta NF, 2009, GENES IMMUN, V10, P120, DOI 10.1038/gene.2008.85; Maritzen T, 2010, TRAFFIC, V11, P8, DOI 10.1111/j.1600-0854.2009.00971.x; Mitchell AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088991; Mitchell AL, 2012, NAT REV ENDOCRINOL, V8, P306, DOI [10.1038/nrendo.2012.74, 10.1038/nrendo.2012.200, 10.1038/nrendo.2012.56, 10.1038/nrendo.2012.127, 10.1038/nrendo.2012.186, 10.1038/nrendo.2011.245]; Mitchell AL, 2009, J CLIN ENDOCR METAB, V94, P5139, DOI 10.1210/jc.2009-1404; Myhre AG, 2002, J CLIN ENDOCR METAB, V87, P618, DOI 10.1210/jc.87.2.618; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Park YS, 2002, TISSUE ANTIGENS, V60, P155, DOI 10.1034/j.1399-0039.2002.600206.x; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Roycroft M, 2009, CLIN ENDOCRINOL, V70, P358, DOI 10.1111/j.1365-2265.2008.03380.x; Skinningsrud B, 2008, J CLIN ENDOCR METAB, V93, P3310, DOI 10.1210/jc.2008-0821; Skinningsrud B, 2008, EUR J HUM GENET, V16, P977, DOI 10.1038/ejhg.2008.33; Tateossian Hilda, 2009, Pathogenetics, V2, P5, DOI 10.1186/1755-8417-2-5; Velaga MR, 2004, J CLIN ENDOCR METAB, V89, P5862, DOI 10.1210/jc.2004-1108; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204	35	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0123550	10.1371/journal.pone.0123550	http://dx.doi.org/10.1371/journal.pone.0123550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042420	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600003
J	Zhang, Y; Mate, G; Muller, P; Hillebrandt, S; Krufczik, M; Bach, M; Kaufmann, R; Hausmann, M; Heermann, DW				Zhang, Yang; Mate, Gabriell; Mueller, Patrick; Hillebrandt, Sabina; Krufczik, Matthias; Bach, Margund; Kaufmann, Rainer; Hausmann, Michael; Heermann, Dieter W.			Radiation Induced Chromatin Conformation Changes Analysed by Fluorescent Localization Microscopy, Statistical Physics, and Graph Theory	PLOS ONE			English	Article							COMPLEX CELL RESPONSES; DOUBLE-STRAND BREAKS; CHROMOSOME TERRITORIES; NUCLEAR ARCHITECTURE; NANOSCOPY TECHNIQUES; GENE-EXPRESSION; 3D STRUCTURE; DNA; GENOME; RESOLUTION	It has been well established that the architecture of chromatin in cell nuclei is not random but functionally correlated. Chromatin damage caused by ionizing radiation raises complex repair machineries. This is accompanied by local chromatin rearrangements and structural changes which may for instance improve the accessibility of damaged sites for repair protein complexes. Using stably transfected HeLa cells expressing either green fluorescent protein (GFP) labelled histone H2B or yellow fluorescent protein (YFP) labelled histone H2A, we investigated the positioning of individual histone proteins in cell nuclei by means of high resolution localization microscopy (Spectral Position Determination Microscopy = SPDM). The cells were exposed to ionizing radiation of different doses and aliquots were fixed after different repair times for SPDM imaging. In addition to the repair dependent histone protein pattern, the positioning of antibodies specific for heterochromatin and euchromatin was separately recorded by SPDM. The present paper aims to provide a quantitative description of structural changes of chromatin after irradiation and during repair. It introduces a novel approach to analyse SPDM images by means of statistical physics and graph theory. The method is based on the calculation of the radial distribution functions as well as edge length distributions for graphs defined by a triangulation of the marker positions. The obtained results show that through the cell nucleus the different chromatin re-arrangements as detected by the fluorescent nucleosomal pattern average themselves. In contrast heterochromatic regions alone indicate a relaxation after radiation exposure and re-condensation during repair whereas euchromatin seemed to be unaffected or behave contrarily. SPDM in combination with the analysis techniques applied allows the systematic elucidation of chromatin re-arrangements after irradiation and during repair, if selected sub-regions of nuclei are investigated.	[Zhang, Yang; Mate, Gabriell; Heermann, Dieter W.] Heidelberg Univ, Inst Theoret Phys, D-69120 Heidelberg, Germany; [Mueller, Patrick; Hillebrandt, Sabina; Krufczik, Matthias; Bach, Margund; Kaufmann, Rainer; Hausmann, Michael] Heidelberg Univ, Kirchhoff Inst Phys, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Mate, G (corresponding author), Heidelberg Univ, Inst Theoret Phys, Philosophenweg 19, D-69120 Heidelberg, Germany.	g.mate@tphys.uni-heidelberg.de	Kaufmann, Rainer/U-6406-2019	Kaufmann, Rainer/0000-0002-4165-0195; Hillebrandt, Sabina/0000-0002-2628-385X	German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety [FKZ: SR/StSch/INT 3610S30015]; German Science Foundation (DFG) through Research Training Group "Spatio/Temporal Probabilistic Graphical Models and Applications in Image Analysis" [GRK 1653]; German National Academic Foundation (Studienstiftung des Deutschen Volkes); Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences; Institute for Theoretical Physics of the Heidelberg University	German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety; German Science Foundation (DFG) through Research Training Group "Spatio/Temporal Probabilistic Graphical Models and Applications in Image Analysis"(German Research Foundation (DFG)); German National Academic Foundation (Studienstiftung des Deutschen Volkes); Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences; Institute for Theoretical Physics of the Heidelberg University	MH, PM, SH, MB and RK were funded by the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (FKZ: SR/StSch/INT 3610S30015) (http://www.bmub.bund.de/). GM was funded by the German Science Foundation (DFG) (http://www.dfg.de/en/) through the Research Training Group "Spatio/Temporal Probabilistic Graphical Models and Applications in Image Analysis", grant GRK 1653 (http://graphmod.iwr.uni-heidelberg.de/). YZ was funded by the German National Academic Foundation (Studienstiftung des Deutschen Volkes) (http://www.studienstiftung.de/). GM and YZ were also supported by the Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences (http://www.mathcomp.uni-heidelberg.de/) and the Institute for Theoretical Physics of the Heidelberg University (www.thphys.uni-heidelberg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbe E, 1873, ARCH MIKROSKOPISCHE, V9, P411; Albiez H, 2006, CHROMOSOME RES, V14, P707, DOI 10.1007/s10577-006-1086-x; AURENHAMMER F, 1991, COMPUT SURV, V23, P345, DOI 10.1145/116873.116880; ayleigh, 1896, SCIENCE, V42, P167, DOI [10.1080/14786449608620902, DOI 10.1080/14786449608620902]; Baddeley D, 2010, MICROSC MICROANAL, V16, P64, DOI 10.1017/S143192760999122X; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016591; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bohn M, 2010, BIOPHYS J, V99, P1358, DOI 10.1016/j.bpj.2010.05.043; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; Craig JM, 2005, BIOESSAYS, V27, P17, DOI 10.1002/bies.20145; Cremer C, 2013, EUR PHYS J H, V38, P281, DOI 10.1140/epjh/e2012-20060-1; Cremer C, 2011, BIOTECHNOL J, V6, P1037, DOI 10.1002/biot.201100031; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; Delaunay B, 1934, B ACAD SCI URSS, V6, P793; Deschout H, 2014, NAT METHODS, V11, P253, DOI 10.1038/nmeth.2843; Dimitri P, 2005, BIOESSAYS, V27, P29, DOI 10.1002/bies.20158; Dimitri P, 2009, CHROMOSOMA, V118, P419, DOI 10.1007/s00412-009-0211-y; Du Toit A, 2012, NAT REV MOL CELL BIO, V13, DOI 10.1038/nrm3450; Eissenberg JC, 2014, ELS, DOI [10.1002/9780470015902.a0001164.pub3, DOI 10.1002/9780470015902.A0001164.PUB3]; Esa A, 2000, J MICROSC-OXFORD, V199, P96, DOI 10.1046/j.1365-2818.2000.00707.x; Falk M, 2007, BBA-MOL CELL RES, V1773, P1534, DOI 10.1016/j.bbamcr.2007.07.002; Falk M, 2014, CRIT REV EUKAR GENE, V24, P225, DOI 10.1615/CritRevEukaryotGeneExpr.v24.i3.40; Falk M, 2014, CRIT REV EUKAR GENE, V24, P205, DOI 10.1615/CritRevEukaryotGeneExpr.2014010313; Falk M, 2014, APPL RADIAT ISOTOPES, V83, P177, DOI 10.1016/j.apradiso.2013.01.029; Falk M, 2010, MUTAT RES-REV MUTAT, V704, P88, DOI 10.1016/j.mrrev.2010.01.013; Falk M, 2008, BBA-MOL CELL RES, V1783, P2398, DOI 10.1016/j.bbamcr.2008.07.010; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; Foster HA, 2005, CHROMOSOMA, V114, P212, DOI 10.1007/s00412-005-0016-6; Girst S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02511; Grunzke R, 2014, EUROMICRO WORKSHOP P, P317, DOI 10.1109/PDP.2014.119; Hausmann M, 2013, IFMBE P, V38, P93; Heilemann M, 2002, ANAL CHEM, V74, P3511, DOI 10.1021/ac025576g; Hendrix J, 2008, BIOPHYS J, V94, P4103, DOI 10.1529/biophysj.107.123596; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Jakob B, 2009, RADIAT RES, V171, P405, DOI 10.1667/RR1520.1; Jakob B, 2009, P NATL ACAD SCI USA, V106, P3172, DOI 10.1073/pnas.0810987106; Jakob B, 2011, NUCLEIC ACIDS RES, V39, P6489, DOI 10.1093/nar/gkr230; Jerabek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037525; Jezkova L, 2014, APPL RADIAT ISOTOPES, V83, P128, DOI 10.1016/j.apradiso.2013.01.022; Kaufmann R, 2011, J MICROSC-OXFORD, V242, P46, DOI 10.1111/j.1365-2818.2010.03436.x; Kaufmann R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031128; Kaufmann R, 2009, PROC SPIE, V7185, DOI 10.1117/12.809109; Knoch TA, 2002, APPROACHING THE THRE; Kozubek S, 2002, CHROMOSOMA, V111, P321, DOI 10.1007/s00412-002-0210-8; Kupper K, 2007, CHROMOSOMA, V116, P285, DOI 10.1007/s00412-007-0098-4; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lemmer P, 2008, APPL PHYS B-LASERS O, V93, P1, DOI 10.1007/s00340-008-3152-x; Lemmer P, 2009, J MICROSC-OXFORD, V235, P163, DOI 10.1111/j.1365-2818.2009.03196.x; Lukasova E, 2002, CHROMOSOME RES, V10, P535, DOI 10.1023/A:1020958517788; Monajembashi S, 2005, BIOPHYS J, V88, P2309, DOI 10.1529/biophysj.104.048728; Muller P, 2014, HISTOCHEM CELL BIOL, V142, P61, DOI 10.1007/s00418-014-1185-2; Muller P, 2012, CURRENT MICROSCOPY C, V1, P3; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Parada LA, 2002, CURR BIOL, V12, P1692, DOI 10.1016/S0960-9822(02)01166-1; Postberg J, 2010, ESSAYS BIOCHEM, V48, P1, DOI [10.1042/BSE0480001, 10.1042/bse0480001]; Rouquette J, 2010, INT REV CEL MOL BIO, V282, P1, DOI 10.1016/S1937-6448(10)82001-5; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Schwarz-Finsterle J, 2013, MUTAT RES-GEN TOX EN, V756, P56, DOI 10.1016/j.mrgentox.2013.05.004; Scott DW, 1992, MULTIVARIATE DENSITZ; Sinnecker D, 2005, BIOCHEMISTRY-US, V44, P7085, DOI 10.1021/bi047881x; Skalnikova M, 2000, CHROMOSOME RES, V8, P487; Toth KF, 2004, J CELL SCI, V117, P4277, DOI 10.1242/jcs.01293; Vespignani A, 2012, NAT PHYS, V8, P32, DOI 10.1038/nphys2160; Vinayagam A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001699; Weidemann T, 2003, J MOL BIOL, V334, P229, DOI 10.1016/j.jmb.2003.08.063; West DB, 2000, INTRODUCTION TO GRAP; Wiech T, 2009, EUR BIOPHYS J BIOPHY, V38, P793, DOI 10.1007/s00249-009-0474-5; Zhang Y, 2014, CHROMOSOMA, V123, P103, DOI 10.1007/s00412-013-0432-y	74	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128555	10.1371/journal.pone.0128555	http://dx.doi.org/10.1371/journal.pone.0128555			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042422	gold, Green Published, Green Submitted			2022-12-27	WOS:000355701600053
J	Cohen, JH; Berge, J; Moline, MA; Sorensen, AJ; Last, K; Falk-Petersen, S; Renaud, PE; Leu, ES; Grenvald, J; Cottier, F; Cronin, H; Menze, S; Norgren, P; Varpe, O; Daase, M; Darnis, G; Johnsen, G				Cohen, Jonathan H.; Berge, Jorgen; Moline, Mark A.; Sorensen, Asgeir J.; Last, Kim; Falk-Petersen, Stig; Renaud, Paul E.; Leu, Eva S.; Grenvald, Julie; Cottier, Finlo; Cronin, Heather; Menze, Sebastian; Norgren, Petter; Varpe, Oystein; Daase, Malin; Darnis, Gerald; Johnsen, Geir			Is Ambient Light during the High Arctic Polar Night Sufficient to Act as a Visual Cue for Zooplankton?	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; MARGINAL ICE-ZONE; PLANKTONIC BIOLUMINESCENCE; ABSORPTION; PHYSIOLOGY; PATTERNS	The light regime is an ecologically important factor in pelagic habitats, influencing a range of biological processes. However, the availability and importance of light to these processes in high Arctic zooplankton communities during periods of 'complete' darkness (polar night) are poorly studied. Here we characterized the ambient light regime throughout the diel cycle during the high Arctic polar night, and ask whether visual systems of Arctic zooplankton can detect the low levels of irradiance available at this time. To this end, light measurements with a purpose-built irradiance sensor and coupled all-sky digital photographs were used to characterize diel skylight irradiance patterns over 24 hours at 79 degrees N in January 2014 and 2015. Subsequent skylight spectral irradiance and in-water optical property measurements were used to model the underwater light field as a function of depth, which was then weighted by the electrophysiologically determined visual spectral sensitivity of a dominant high Arctic zooplankter, Thysanoessa inermis. Irradiance in air ranged between 1-1.5 x 10(-5) mu mol photons m(-2) s(-1) (400-700 nm) in clear weather conditions at noon and with the moon below the horizon, hence values reflect only solar illumination. Radiative transfer modelling generated underwater light fields with peak transmission at blue-green wavelengths, with a 465 nm transmission maximum in shallow water shifting to 485 nm with depth. To the eye of a zooplankter, light from the surface to 75 m exhibits a maximum at 485 nm, with longer wavelengths (>600 nm) being of little visual significance. Our data are the first quantitative characterisation, including absolute intensities, spectral composition and photoperiod of biologically relevant solar ambient light in the high Arctic during the polar night, and indicate that some species of Arctic zooplankton are able to detect and utilize ambient light down to 20-30m depth during the Arctic polar night.	[Berge, Jorgen; Renaud, Paul E.; Grenvald, Julie; Cronin, Heather; Menze, Sebastian; Varpe, Oystein; Johnsen, Geir] Univ Ctr Svalbard, N-9171 Longyearbyen, Norway; [Berge, Jorgen; Falk-Petersen, Stig; Grenvald, Julie; Daase, Malin] UiT Arctic Univ Norway, Fac Biosci Fisheries & Econ, N-9037 Tromso, Norway; [Cohen, Jonathan H.; Moline, Mark A.; Cronin, Heather] Univ Delaware, Sch Marine Sci & Policy, Lewes, DE 19958 USA; [Sorensen, Asgeir J.; Norgren, Petter; Johnsen, Geir] Norwegian Univ Sci & Technol, Dept Biol, Appl Underwater Robot Lab, N-7491 Trondheim, Norway; [Sorensen, Asgeir J.; Norgren, Petter; Johnsen, Geir] Norwegian Univ Sci & Technol, Dept Marine Technol, N-7491 Trondheim, Norway; [Last, Kim; Cottier, Finlo] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban PA37 1QA, Argyll, Scotland; [Falk-Petersen, Stig; Renaud, Paul E.; Leu, Eva S.; Varpe, Oystein; Darnis, Gerald] Akvaplan Niva AS, Fram Ctr, N-9296 Tromso, Norway	University Centre Svalbard (UNIS); UiT The Arctic University of Tromso; University of Delaware; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); UHI Millennium Institute; Akvaplan-niva	Berge, J (corresponding author), Univ Ctr Svalbard, N-9171 Longyearbyen, Norway.	Jorgen.berge@uit.no	Varpe, Øystein/B-9693-2008; Cottier, Finlo/K-6277-2012; Renaud, Paul E/C-7191-2008; Cohen, Jonathan/GPX-2435-2022; Berge, Jorgen/E-7544-2015	Varpe, Øystein/0000-0002-5895-6983; Daase, Malin/0000-0001-8413-3924; Berge, Jorgen/0000-0003-0900-5679; Cottier, Finlo/0000-0002-3068-1754; Leu, Eva/0000-0002-5328-3396	University Centre in Svalbard through the course "Underwater robotics and polar night biology" [AB334]; University Centre in Svalbard through Norwegian Research Council [223254, 226417, 214271, 195160, 240721]	University Centre in Svalbard through the course "Underwater robotics and polar night biology"; University Centre in Svalbard through Norwegian Research Council	The work was funded by the University Centre in Svalbard through the course AB334 "Underwater robotics and polar night biology" and through the Norwegian Research Council through grants numbers 223254, 226417, 214271, 195160 and 240721. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batnes AS, 2015, POLAR BIOL, V38, P51, DOI 10.1007/s00300-013-1415-4; Berge J, 2012, MAR BIOL, V159, P231, DOI 10.1007/s00227-011-1798-0; Berge J, PROG OCEANO IN PRESS; Berge J, 2014, J PLANKTON RES, V36, P1279, DOI 10.1093/plankt/fbu059; Berge J, 2009, BIOL LETTERS, V5, P69, DOI 10.1098/rsbl.2008.0484; BOLLENS SM, 1989, LIMNOL OCEANOGR, V34, P1072, DOI 10.4319/lo.1989.34.6.1072; Brierley AS, 2009, CURR BIOL, V19, pR602, DOI 10.1016/j.cub.2009.05.046; BUSKEY EJ, 1992, MAR BIOL, V113, P689, DOI 10.1007/BF00349712; Clark GF, 2013, GLOBAL CHANGE BIOL, V19, P3749, DOI 10.1111/gcb.12337; Cohen JH, 2005, MAR BIOL, V147, P399, DOI 10.1007/s00227-005-1570-4; Cohen JH, 2006, BIOL BULL-US, V211, P140, DOI 10.2307/4134588; Cohen JH, 2010, J EXP BIOL, V213, P3843, DOI 10.1242/jeb.048686; Cohen JH, 2009, OCEANOGR MAR BIOL, V47, P77; Dale T, 2000, ICES J MAR SCI, V57, P1800, DOI 10.1006/jmsc.2000.0961; Frank TM, 2003, INTEGR COMP BIOL, V43, P559, DOI 10.1093/icb/43.4.559; Frank TM, 1999, J COMP PHYSIOL A, V185, P255, DOI 10.1007/s003590050385; FRETWELL S D, 1972, P217; Frey KE, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049421; Gaten E, 2008, J GENET, V87, P473, DOI 10.1007/s12041-008-0070-y; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Hancke K, 2014, J MARINE SYST, V130, P219, DOI 10.1016/j.jmarsys.2012.06.006; Hop H, 2002, POLAR RES, V21, P167, DOI 10.1111/j.1751-8369.2002.tb00073.x; Johnsen G., 2009, ECOSYSTEM BARENTS SE, V9, P139; Johnsen G, 2014, POLAR BIOL, V37, P707, DOI 10.1007/s00300-014-1471-4; Johnsen S, 2006, J EXP BIOL, V209, P789, DOI 10.1242/jeb.02053; Jonsson M, 2014, J COMP PHYSIOL A, V200, P949, DOI 10.1007/s00359-014-0941-z; Kraft A, 2013, MAR BIOL, V160, P241, DOI 10.1007/s00227-012-2065-8; LAPOTA D, 1992, MAR BIOL, V112, P665, DOI 10.1007/BF00346185; Leu E, 2011, PROG OCEANOGR, V90, P18, DOI 10.1016/j.pocean.2011.02.004; Li LH, 2014, DEEP-SEA RES PT I, V87, P53, DOI 10.1016/j.dsr.2014.02.005; Marshall N. Justin, 2003, P343, DOI 10.1007/978-0-387-22628-6_18; Moline MA, 2008, ANN NY ACAD SCI, V1134, P267, DOI 10.1196/annals.1439.010; Myslinski T, 2005, MAR BIOL, V147, P619, DOI 10.1007/s00227-005-1606-9; OHMAN MD, 1990, ECOL MONOGR, V60, P257, DOI 10.2307/1943058; Pegau WS, 1997, APPL OPTICS, V36, P6035, DOI 10.1364/AO.36.006035; Perovich DK, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2007GL031138, 10.1029/2007GL031480]; Pope RM, 1997, APPL OPTICS, V36, P8710, DOI 10.1364/AO.36.008710; Sakshaug E, 2009, ECOSYSTEM BARENTS SE; Twardowski MS, 1999, J ATMOS OCEAN TECH, V16, P691, DOI 10.1175/1520-0426(1999)016<0691:MQOTAB>2.0.CO;2; Valle KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114211; Varpe O, 2007, OIKOS, V116, P1331, DOI 10.1111/j.2007.0030-1299.15893.x; VINYARD GL, 1976, J FISH RES BOARD CAN, V33, P2845, DOI 10.1139/f76-342; Volent Z, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2822611; Wallace MI, 2010, LIMNOL OCEANOGR, V55, P831, DOI 10.4319/lo.2009.55.2.0831; Wassmann P, 2011, OCEANOGRAPHY, V24, P220, DOI 10.5670/oceanog.2011.74; Wassmann P, 2011, GLOBAL CHANGE BIOL, V17, P1235, DOI 10.1111/j.1365-2486.2010.02311.x; Webster CN, 2015, POLAR BIOL, V38, P75, DOI 10.1007/s00300-013-1422-5; Zaneveld J. R. V., 1994, OCEAN OPTICS 12, P44, DOI DOI 10.1117/12.190095	49	57	60	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126247	10.1371/journal.pone.0126247	http://dx.doi.org/10.1371/journal.pone.0126247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039111	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700021
J	Seneviratna, A; Lim, GH; Devi, A; Carvalho, LP; Chua, T; Koh, TH; Tan, HC; Foo, D; Tong, KL; Ong, HY; Richards, AM; Yew, CK; Chan, MY				Seneviratna, Aruni; Lim, Gek Hsiang; Devi, Anju; Carvalho, Leonardo P.; Chua, Terrance; Koh, Tian-Hai; Tan, Huay-Cheem; Foo, David; Tong, Khim-Leng; Ong, Hean-Yee; Richards, A. Mark; Yew, Chow Khuan; Chan, Mark Y.			Circadian Dependence of Infarct Size and Acute Heart Failure in ST Elevation Myocardial Infarction	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; LEFT-VENTRICULAR FUNCTION; PRIMARY ANGIOPLASTY; TIME; ONSET; DISEASE; CARDIOMYOCYTE; REPERFUSION; MORTALITY; CLOCK	Objectives There are conflicting data on the relationship between the time of symptom onset during the 24-hour cycle (circadian dependence) and infarct size in ST-elevation myocardial infarction (STEMI). Moreover, the impact of this circadian pattern of infarct size on clinical outcomes is unknown. We sought to study the circadian dependence of infarct size and its impact on clinical outcomes in STEMI. Methods We studied 6,710 consecutive patients hospitalized for STEMI from 2006 to 2009 in a tropical climate with non-varying day-night cycles. We categorized the time of symptom onset into four 6-hour intervals: midnight-6:00 A.M., 6:00 A.M.-noon, noon-6:00 P.M. and 6:00 P.M.-midnight. We used peak creatine kinase as a surrogate marker of infarct size. Results Midnight-6:00 A.M patients had the highest prevalence of diabetes mellitus (P = 0.03), more commonly presented with anterior MI (P = 0.03) and received percutaneous coronary intervention less frequently, as compared with other time intervals (P = 0.03). Adjusted mean peak creatine kinase was highest among midnight-6:00 A.M. patients and lowest among 6:00 A.M.-noon patients (2,590.8 +/- 2,839.1 IU/L and 2,336.3 +/- 2,386.6 IU/L, respectively, P = 0.04). Midnight-6:00 A.M patients were at greatest risk of acute heart failure (P<0.001), 30-day mortality (P = 0.03) and 1-year mortality (P = 0.03), while the converse was observed in 6:00 A.M.-noon patients. After adjusting for diabetes, infarct location and performance of percutaneous coronary intervention, circadian variations in acute heart failure incidence remained strongly significant (P = 0.001). Conclusion We observed a circadian peak and nadir in infarct size during STEMI onset from midnight-6: 00 A.M and 6:00 A.M.-noon respectively. The peak and nadir incidence of acute heart failure paralleled this circadian pattern. Differences in diabetes prevalence, infarct location and mechanical reperfusion may account partly for the observed circadian pattern of infarct size and acute heart failure.	[Seneviratna, Aruni; Tan, Huay-Cheem; Richards, A. Mark; Chan, Mark Y.] Natl Univ Singapore Hosp, Natl Univ Heart Ctr, Dept Cardiac, Singapore, Singapore; [Lim, Gek Hsiang; Devi, Anju; Yew, Chow Khuan] Hlth Promot Board, Natl Registry Dis Off R&SP, Singapore, Singapore; [Carvalho, Leonardo P.; Richards, A. Mark; Chan, Mark Y.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117548, Singapore; [Carvalho, Leonardo P.] Hosp Israelita Albert Einstein, Sao Paulo, Brazil; [Chua, Terrance; Koh, Tian-Hai] Natl Heart Ctr, Dept Cardiol, Singapore, Singapore; [Foo, David] Tan Tock Seng Hosp, Dept Cardiol, Singapore, Singapore; [Tong, Khim-Leng] Changi Gen Hosp, Dept Cardiol, Singapore, Singapore; [Ong, Hean-Yee] Khoo Teck Puat Hosp, Dept Cardiol, Singapore, Singapore	National University of Singapore; National University of Singapore; Hospital Israelita Albert Einstein; National Heart Centre Singapore; Tan Tock Seng Hospital; Changi General Hospital	Chan, MY (corresponding author), Natl Univ Singapore Hosp, Natl Univ Heart Ctr, Dept Cardiac, Singapore, Singapore.	mark_chan@nuhs.edu.sg	Carvalho, Leonardo/AAA-2445-2020; Chan, Yan Yee Mark/ABE-1929-2021	Chan, Yan Yee Mark/0000-0003-0389-7450; Seneviratna, Aruni/0000-0001-5010-1422	Ministry of Health (MOH), Singapore; National Medical Research Council (NMRC), Singapore [NMRC/CSA 2010/028, NMRC/TCR11dec007]	Ministry of Health (MOH), Singapore(Ministry of Health-Singapore); National Medical Research Council (NMRC), Singapore(National Medical Research Council, Singapore)	This study was accomplished with funding support from the Ministry of Health (MOH), Singapore. MYC is supported by a clinician scientist award (NMRC/CSA 2010/028) and AS receives support from a tier 1 Translational Clinical Research grant (NMRC/TCR11dec007), both from the National Medical Research Council (NMRC), Singapore. The funders had no role in study design and analysis, decision to publish, or preparation of the manuscript.	Ammirati E, 2013, CIRC RES, V112, pE110, DOI 10.1161/CIRCRESAHA.112.300778; Angeja BG, 2002, CIRCULATION, V105, P282, DOI 10.1161/hc0302.103588; Bae Myung Hwan, 2010, Korean Circ J, V40, P616, DOI 10.4070/kcj.2010.40.12.616; Boor Cd, 1986, B ASIC SPLINE BASICS, P34; Celik M, 2011, MED SCI MONITOR, V17, pCR210, DOI 10.12659/MSM.881717; Centers for Disease Control and Prevention, INT CLASS DIS 9 REV; Chia S, 2008, JACC-CARDIOVASC INTE, V1, P415, DOI 10.1016/j.jcin.2008.04.010; Cohen MC, 1997, AM J CARDIOL, V79, P1512, DOI 10.1016/S0002-9149(97)00181-1; De Luca G, 2013, INT J CARDIOL, V167, P1508, DOI 10.1016/j.ijcard.2012.04.078; Dominguez-Rodriguez A, 2007, INT J CARDIOL, V119, P227, DOI 10.1016/j.ijcard.2006.07.110; Durgan DJ, 2010, CIRC RES, V106, P546, DOI 10.1161/CIRCRESAHA.109.209346; Durgan DJ, 2005, AM J PHYSIOL-HEART C, V289, pH1530, DOI 10.1152/ajpheart.00406.2005; Fournier S, 2012, AM HEART J, V163, P208, DOI 10.1016/j.ahj.2011.11.006; Fujino T, 2001, ATHEROSCLEROSIS, V155, P171, DOI 10.1016/S0021-9150(00)00531-1; HUGHES K, 1990, J EPIDEMIOL COMMUN H, V44, P24, DOI 10.1136/jech.44.1.24; Khan M S, 2003, J Pak Med Assoc, V53, P84; Magid DJ, 2005, JAMA-J AM MED ASSOC, V294, P803, DOI 10.1001/jama.294.7.803; Mahmoud KD, 2011, JACC-CARDIOVASC INTE, V4, P183, DOI 10.1016/j.jcin.2010.09.025; Maier B, 2010, CLIN RES CARDIOL, V99, P565, DOI 10.1007/s00392-010-0158-2; Marso SP, 2007, AM J CARDIOL, V100, P206, DOI 10.1016/j.amjcard.2007.02.080; Mehta RH, 2009, JACC-CARDIOVASC INTE, V2, P56, DOI 10.1016/j.jcin.2008.10.006; MILLARCRAIG MW, 1978, LANCET, V1, P795; MORES N, 1994, J HYPERTENS, V12, P939; Mukamal KJ, 2000, AM HEART J, V140, P438, DOI 10.1067/mhj.2000.108830; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; MULLER JE, 1989, CIRCULATION, V79, P733, DOI 10.1161/01.CIR.79.4.733; Office NRoD, 2013, TRENDS AC MYOC INF A; PANZA JA, 1991, NEW ENGL J MED, V325, P986, DOI 10.1056/NEJM199110033251402; Park HE, 2010, CIRC J, V74, P970, DOI 10.1253/circj.CJ-09-0344; PETRALITO A, 1982, CHRONOBIOLOGIA, V9, P195; Portaluppi F, 2007, ADV DRUG DELIVER REV, V59, P940, DOI 10.1016/j.addr.2006.10.011; Pride YB, 2010, AM J CARDIOL, V106, P635, DOI 10.1016/j.amjcard.2010.04.012; Rea MS, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/749460; Reiter R, 2012, CIRC RES, V110, P105, DOI 10.1161/CIRCRESAHA.111.254284; Singapore Department of Statistics DoS Ministry of Trade & Industry Republic of Singapore, POP TRENDS 2009 2009; Suarez-Barrientos A, 2011, HEART, V97, P970, DOI 10.1136/hrt.2010.212621; VALKAMA JO, 1992, INT J CARDIOL, V34, P173, DOI 10.1016/0167-5273(92)90153-T; Vinik AI, 2003, DIABETES CARE, V26, P1553, DOI 10.2337/diacare.26.5.1553; WILLICH SN, 1989, CIRCULATION, V80, P853, DOI 10.1161/01.CIR.80.4.853	39	31	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128526	10.1371/journal.pone.0128526	http://dx.doi.org/10.1371/journal.pone.0128526			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039059	Green Submitted, Green Published, gold			2022-12-27	WOS:000355700700106
J	Shi, WL; Tang, HL; Zhai, SD				Shi, Wei-Long; Tang, Hui-Lin; Zhai, Suo-Di			Effects of the CYP3A4*1B Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Adult Renal Transplant Recipients: A Meta-Analysis	PLOS ONE			English	Article							ACUTE REJECTION RATES; CYTOCHROME-P450 3A; CALCINEURIN INHIBITORS; DOSE REQUIREMENTS; CYP3A5; LIVER; PHARMACOGENETICS; CYCLOSPORINE; DISPOSITION; METABOLISM	Background and Objective The association between the CYP3A4*1B single nucleotide polymorphism (SNP) and tacrolimus pharmacokinetics in different studies is controversial. Therefore, a meta-analysis was employed to evaluate the correlation between the CYP3A4*1B genetic polymorphism and tacrolimus pharmacokinetics at different post-transplantation times in adult renal transplant recipients. Methods Studies evaluating the CYP3A4*1B genetic polymorphism and tacrolimus pharmacokinetics were retrieved through a systematical search of Embase, PubMed, the Cochrane Library, ClinicalTrials.gov and three Chinese literature databases (up to Sept. 2014). The pharmacokinetic parameters (weight-adjusted tacrolimus daily dose and tacrolimus trough concentration/weight-adjusted tacrolimus daily dose ratio) were extracted, and the meta-analysis was performed using Stata 12.1. Results Seven studies (involving 1182 adult renal transplant recipients) were included in this meta-analysis. For the weight-adjusted tacrolimus daily dose, in all included renal transplant recipients (European & Indian populations), CYP3A4*1/*1 recipients required a significantly lower weight-adjusted tacrolimus daily dose than did CYP3A4* 1B carriers at 7 days (WMD -0.048; 95% CI -0.083 similar to -0.014), 6 months (WMD -0.058; 95% CI -0.081 similar to -0.036) and 12 months (WMD -0.061; 95% CI -0.096 similar to -0.027) post-transplantation. In light of the heterogeneity, the analysis was repeated after removing the only study in an Indian population, and CYP3A4*1/*1 European recipients (mostly Caucasian) required a lower weight-adjusted tacrolimus daily dose within the first year post-transplantation. The tacrolimus trough concentration/weight-adjusted tacrolimus daily dose ratio (C-0/Dose ratio) was significantly higher in CYP3A4*1/*1 recipients than in CYP3A4*1B carriers at 6 months (WMD 52.588; 95% CI 22.387 similar to 82.789) and 12 months (WMD 62.219; 95% CI 14.218 similar to 110.221) post-transplantation. When the only study in an Indian population was removed to examine European recipients (mostly Caucasian), the significant difference persisted at 1 month, 6 months and 12 months post-transplantation. Conclusion Based on our meta-analysis, the CYP3A4*1B genetic polymorphism affects tacrolimus dose requirements and tacrolimus trough concentration/weight-adjusted tacrolimus daily dose ratio within the first year post-transplantation in adult renal transplant recipients, especially in European recipients (mostly Caucasian).	[Shi, Wei-Long; Tang, Hui-Lin; Zhai, Suo-Di] Peking Univ, Hosp 3, Dept Pharm, Beijing 100871, Peoples R China	Peking University	Zhai, SD (corresponding author), Peking Univ, Hosp 3, Dept Pharm, Beijing 100871, Peoples R China.	zhaisuodi@163.com	Tang, Huilin/M-1668-2017	Tang, Huilin/0000-0002-5814-6657				Benet LZ, 2004, INT J PHARM, V277, P3, DOI 10.1016/j.ijpharm.2002.12.002; Chitnis SD, 2013, XENOBIOTICA, V43, P641, DOI 10.3109/00498254.2012.752118; Eckardt KU, 2009, AM J TRANSPLANT, V9, pS1, DOI 10.1111/j.1600-6143.2009.02834.x; Ferraris JR, 2011, PEDIATR TRANSPLANT, V15, P525, DOI 10.1111/j.1399-3046.2011.01513.x; Gervasini G, 2012, TRANSPL INT, V25, P471, DOI 10.1111/j.1432-2277.2012.01446.x; Hashi S, 2014, TRANSPL P, V46, P758, DOI 10.1016/j.transproceed.2013.11.060; Hesselink DA, 2003, CLIN PHARMACOL THER, V74, P245, DOI 10.1016/S0009-9236(03)00168-1; Hesselink DA, 2014, CLIN PHARMACOKINET, V53, P123, DOI 10.1007/s40262-013-0120-3; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Hronova K, 2014, EXPERT REV CLIN PHAR, V7, P821, DOI 10.1586/17512433.2014.966811; Kahan BD, 2002, CLIN THER, V24, P330, DOI 10.1016/S0149-2918(02)85038-X; Kershner RP, 1996, TRANSPLANTATION, V62, P920, DOI 10.1097/00007890-199610150-00009; Kurzawski M, 2014, PHARMACOGENOMICS, V15, P179, DOI 10.2217/pgs.13.199; Kuypers DRJ, 2007, CLIN PHARMACOL THER, V82, P711, DOI 10.1038/sj.clpt.6100216; Lampen A, 1995, DRUG METAB DISPOS, V23, P1315; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; Liu YY, 2013, GENE, V531, P476, DOI 10.1016/j.gene.2013.09.024; Meier-Kriesche HU, 2006, AM J TRANSPLANT, V6, P1111, DOI 10.1111/j.1600-6143.2006.01270.x; Robles-Piedras Ana Luisa, 2009, Proc West Pharmacol Soc, V52, P33; Rojas L, 2015, PHARMACOGENOMICS J, V15, P38, DOI 10.1038/tpj.2014.38; Rojas L, 2014, PHARMACOGENOMICS J; SHIRAGA T, 1994, BIOCHEM PHARMACOL, V47, P727, DOI 10.1016/0006-2952(94)90136-8; Singh R, 2009, N-S ARCH PHARMACOL, V380, P169, DOI 10.1007/s00210-009-0415-y; Staatz CE, 2004, CLIN PHARMACOKINET, V43, P623, DOI 10.2165/00003088-200443100-00001; Tang HL, 2011, PHARMACOGENET GENOM, V21, P713, DOI 10.1097/FPC.0b013e32834a48ca; Tavira B, 2013, PHARMACOGENET GENOM, V23, P445, DOI 10.1097/FPC.0b013e3283636856; Tavira B, 2011, CLIN CHEM LAB MED, V49, P825, DOI 10.1515/CCLM.2011.143; Terrazzino S, 2013, PHARMACOGENOMICS, V14, P1255, DOI 10.2217/pgs.13.116; Terrazzino S, 2012, PHARMACOGENET GENOM, V22, P642, DOI 10.1097/FPC.0b013e3283557c74; Tuteja S, 2001, TRANSPLANTATION, V71, P1303, DOI 10.1097/00007890-200105150-00021; Wu CY, 2003, DRUG METAB DISPOS, V31, P1292, DOI 10.1124/dmd.31.11.1292; Zhang YC, 2001, CLIN PHARMACOKINET, V40, P159, DOI 10.2165/00003088-200140030-00002; Zhou XD, 2013, THROMB RES, V132, P531, DOI 10.1016/j.thromres.2013.09.005	34	29	31	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127995	10.1371/journal.pone.0127995	http://dx.doi.org/10.1371/journal.pone.0127995			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039043	Green Submitted, gold, Green Published			2022-12-27	WOS:000355700700084
J	Tillmann, AT; Strijbis, K; Cameron, G; Radmaneshfar, E; Thiel, M; Munro, CA; MacCallum, DM; Distel, B; Gow, NAR; Brown, AJP				Tillmann, Anna T.; Strijbis, Karin; Cameron, Gary; Radmaneshfar, Elahe; Thiel, Marco; Munro, Carol A.; MacCallum, Donna M.; Distel, Ben; Gow, Neil A. R.; Brown, Alistair J. P.			Contribution of Fdh3 and Glr1 to Glutathione Redox State, Stress Adaptation and Virulence in Candida albicans	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; YEAST SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; NITRIC-OXIDE; TRANSCRIPTIONAL RESPONSE; NITROSATIVE STRESS; GENE-EXPRESSION; S-NITROSOTHIOLS; IN-VIVO; SUPEROXIDE-DISMUTASE	The major fungal pathogen of humans, Candida albicans, is exposed to reactive nitrogen and oxygen species following phagocytosis by host immune cells. In response to these toxins, this fungus activates potent anti-stress responses that include scavenging of reactive nitrosative and oxidative species via the glutathione system. Here we examine the differential roles of two glutathione recycling enzymes in redox homeostasis, stress adaptation and virulence in C. albicans: glutathione reductase (Glr1) and the S-nitrosoglutathione reductase (GSNOR), Fdh3. We show that the NADPH-dependent Glr1 recycles GSSG to GSH, is induced in response to oxidative stress and is required for resistance to macrophage killing. GLR1 deletion increases the sensitivity of C. albicans cells to H2O2, but not to formaldehyde or NO. In contrast, Fdh3 detoxifies GSNO to GSSG and NH3, and FDH3 inactivation delays NO adaptation and increases NO sensitivity. C. albicans fdh3 Delta cells are also sensitive to formaldehyde, suggesting that Fdh3 also contributes to formaldehyde detoxification. FDH3 is induced in response to nitrosative, oxidative and formaldehyde stress, and fdh3 Delta cells are more sensitive to killing by macrophages. Both Glr1 and Fdh3 contribute to virulence in the Galleria mellonella and mouse models of systemic infection. We conclude that Glr1 and Fdh3 play differential roles during the adaptation of C. albicans cells to oxidative, nitrosative and formaldehyde stress, and hence during the colonisation of the host. Our findings emphasise the importance of the glutathione system and the maintenance of intracellular redox homeostasis in this major pathogen.	[Tillmann, Anna T.; Munro, Carol A.; MacCallum, Donna M.; Gow, Neil A. R.; Brown, Alistair J. P.] Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen Fungal Grp, Aberdeen, Scotland; [Strijbis, Karin; Distel, Ben] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Cameron, Gary] Univ Aberdeen, Mass Spectrometry Sect, Div Appl Med, Aberdeen, Scotland; [Radmaneshfar, Elahe; Thiel, Marco] Univ Aberdeen, SUPA, Inst Complex Syst & Math Biol, Aberdeen, Scotland	University of Aberdeen; University of Amsterdam; Academic Medical Center Amsterdam; University of Aberdeen; University of Aberdeen	Brown, AJP (corresponding author), Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen Fungal Grp, Aberdeen, Scotland.	al.brown@abdn.ac.uk	MacCallum, Donna M./D-7897-2011; GOW, Neil/AAS-5323-2021	MacCallum, Donna M./0000-0003-4833-0378; GOW, Neil/0000-0002-2776-5850; Strijbis, Karin/0000-0001-9167-7137; Brown, Alistair JP/0000-0003-1406-4251	CRISP project (Combinatorial Responses In Stress Pathways) - UK Biotechnology and Biological Research Council [BB/F00513X/1]; Wellcome Trust [080088, 088858, 097377]; European Research Council (STRIFE Advanced Grant) [ERC-2009-AdG-249793]; European Commission [PITN-GA-2008-214004FINSysB, FP7-ITN-2008-237936-Ariadne]; Academic Medical Center, University of Amsterdam; National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) [NC/K000306/1, NC/K50046X/1]; BBSRC [BB/F00513X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F00513X/1] Funding Source: researchfish	CRISP project (Combinatorial Responses In Stress Pathways) - UK Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council (STRIFE Advanced Grant); European Commission(European CommissionEuropean Commission Joint Research Centre); Academic Medical Center, University of Amsterdam; National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the CRISP project (Combinatorial Responses In Stress Pathways), which was funded by the UK Biotechnology and Biological Research Council (www.bbsrc.ac.uk): A.J.P.B., N.A.R.G., A.T.T. (Research Grant; BB/F00513X/1). A.J.P.B., N.A.R.G. and C.A.M. were also supported by the Wellcome Trust (www.wellcome.ac.uk), (Grants: 080088; 088858; 097377). A.J.P.B. was also supported by the European Research Council (http://erc.europa.eu/), (STRIFE Advanced Grant; ERC-2009-AdG-249793). A.J.P.B., N.A.R.G. and C.A.M. were also supported by the European Commission (http://ec.europa.eu/research/fp7), (Grants: PITN-GA-2008-214004FINSysB; FP7-ITN-2008-237936-Ariadne). K.S. received support from the Academic Medical Center, University of Amsterdam (https://www.amc.nl/web/Research/ResearchAMC/Research-Institute.htm). D. M.M. was also supported by the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs: www.nc3rs.org.uk), (Research Grants: NC/K000306/1; NC/K50046X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Monge R, 1999, J BACTERIOL, V181, P3058, DOI 10.1128/JB.181.10.3058-3068.1999; Baek YU, 2004, FEBS LETT, V556, P47, DOI 10.1016/S0014-5793(03)01363-2; Bambach A, 2009, EUKARYOT CELL, V8, P1706, DOI 10.1128/EC.00066-09; Bechtold E, 2010, ACS CHEM BIOL, V5, P405, DOI 10.1021/cb900302u; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Bergin D, 2005, INFECT IMMUN, V73, P4161, DOI 10.1128/IAI.73.7.4161-4170.2005; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Brown AJP, 2009, CURR OPIN MICROBIOL, V12, P384, DOI 10.1016/j.mib.2009.06.007; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; Cabral Vitor, 2012, Methods Mol Biol, V845, P227, DOI 10.1007/978-1-61779-539-8_15; Carlos IZ, 2004, MICROBES INFECT, V6, P207, DOI 10.1016/j.micinf.2003.10.012; Chauvel M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045912; Chaves GM, 2007, GENET MOL RES, V6, P1051; Cheetham J, 2011, J BIOL CHEM, V286, P42002, DOI 10.1074/jbc.M111.265231; Dantas AD, 2010, MOL CELL BIOL, V30, P4550, DOI 10.1128/MCB.00313-10; Dennison PMJ, 2005, FUNGAL GENET BIOL, V42, P737, DOI 10.1016/j.fgb.2005.05.006; Drakulic T, 2005, FEMS YEAST RES, V5, P1215, DOI 10.1016/j.femsyr.2005.06.001; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Enjalbert B, 2003, MOL BIOL CELL, V14, P1460, DOI 10.1091/mbc.E02-08-0546; Enjalbert B, 2007, INFECT IMMUN, V75, P2143, DOI 10.1128/IAI.01680-06; Feechan A, 2005, P NATL ACAD SCI USA, V102, P8054, DOI 10.1073/pnas.0501456102; Flohe L, 2013, BBA-GEN SUBJECTS, V1830, P3139, DOI 10.1016/j.bbagen.2012.10.020; FONZI WA, 1993, GENETICS, V134, P717; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Grant CM, 1997, MOL BIOL CELL, V8, P1699, DOI 10.1091/mbc.8.9.1699; Grant CM, 1999, MOL CELL BIOL, V19, P2650; Grant CM, 1996, CURR GENET, V29, P511, DOI 10.1007/BF02426954; Grant CM, 1996, MOL MICROBIOL, V21, P171, DOI 10.1046/j.1365-2958.1996.6351340.x; Gross NT, 1999, MED MYCOL, V37, P151, DOI 10.1046/j.1365-280X.1999.00209.x; Hall RA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003276; Hauser NC, 1998, YEAST, V14, P1209, DOI 10.1002/(SICI)1097-0061(19980930)14:13<1209::AID-YEA311>3.0.CO;2-N; Hayes A, 2002, METHODS, V26, P281, DOI 10.1016/S1046-2023(02)00032-4; HIDALGO HA, 1992, INFECT IMMUN, V60, P1; Hromatka BS, 2005, MOL BIOL CELL, V16, P4814, DOI 10.1091/mbc.E05-05-0435; Hwang CS, 2002, MICROBIOL-SGM, V148, P3705, DOI 10.1099/00221287-148-11-3705; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Imbeaud S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni054; Inglis DO, 2012, NUCLEIC ACIDS RES, V40, pD667, DOI 10.1093/nar/gkr945; Jain C, 2013, VIRULENCE, V4, P67, DOI 10.4161/viru.22700; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Johnson MA, 2001, J BIOL CHEM, V276, P39872, DOI 10.1074/jbc.M102781200; Jourd'heuil D, 1999, ARCH BIOCHEM BIOPHYS, V361, P323, DOI 10.1006/abbi.1998.1010; Kaloriti D, 2014, MBIO, V5, DOI 10.1128/mBio.01334-14; Kaloriti D, 2012, MED MYCOL, V50, P699, DOI 10.3109/13693786.2012.672770; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Kwolek-Mirek M, 2012, CELL BIOL TOXICOL, V28, P1, DOI 10.1007/s10565-011-9200-z; Kwolek-Mirek M, 2011, YEAST, V28, P595, DOI 10.1002/yea.1889; Li DD, 2013, BIOL PHARM BULL, V36, P1482, DOI 10.1248/bpb.b13-00270; Lima B, 2009, P NATL ACAD SCI USA, V106, P6297, DOI 10.1073/pnas.0901043106; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; MacCallum DM, 2005, MYCOSES, V48, P151, DOI 10.1111/j.1439-0507.2005.01121.x; MacCallum DM, 2010, ANTIMICROB AGENTS CH, V54, P1476, DOI 10.1128/AAC.01645-09; Martchenko M, 2004, MOL BIOL CELL, V15, P456, DOI 10.1091/mbc.E03-03-0179; McKenzie CGJ, 2010, INFECT IMMUN, V78, P1650, DOI 10.1128/IAI.00001-10; McMahon Timothy J, 2006, Proc Am Thorac Soc, V3, P153, DOI 10.1513/pats.200507-066BG; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Missall TA, 2004, EUKARYOT CELL, V3, P835, DOI 10.1128/EC.3.4.835-846.2004; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Mitchell DA, 2007, P NATL ACAD SCI USA, V104, P11609, DOI 10.1073/pnas.0704898104; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Murad AMA, 2001, EMBO J, V20, P4742, DOI 10.1093/emboj/20.17.4742; Negredo A, 1997, MICROBIOL-UK, V143, P297, DOI 10.1099/00221287-143-2-297; Nusse O, 2011, THESCIENTIFICWORLDJO, V11, P2364, DOI 10.1100/2011/741046; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Penninckx MJ, 2002, FEMS YEAST RES, V2, P295, DOI 10.1111/j.1567-1364.2002.tb00098.x; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; Ramon AM, 2003, EUKARYOT CELL, V2, P718, DOI 10.1128/EC.2.4.718-728.2003; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Renwick J, 2007, DEV COMP IMMUNOL, V31, P347, DOI 10.1016/j.dci.2006.06.007; Roos D, 2003, MICROBES INFECT, V5, P1307, DOI 10.1016/j.micinf.2003.09.009; Salamitou S, 2000, MICROBIOL-UK, V146, P2825, DOI 10.1099/00221287-146-11-2825; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Smith DA, 2004, MOL BIOL CELL, V15, P4179, DOI 10.1091/mbc.E04-03-0181; Staab CA, 2008, CELL MOL LIFE SCI, V65, P3950, DOI 10.1007/s00018-008-8592-2; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Steghens JP, 2003, J CHROMATOGR B, V798, P343, DOI 10.1016/j.jchromb.2003.10.007; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Strijbis K., 2009, COMPARTMENTALIZATION; Tan SX, 2010, J BIOL CHEM, V285, P6118, DOI 10.1074/jbc.M109.062844; Thorsen M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-105; Tillmann A, 2011, BIOCHEM SOC T, V39, P219, DOI 10.1042/BST0390219; Toledano MB, 2007, FEBS LETT, V581, P3598, DOI 10.1016/j.febslet.2007.07.002; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Ullmann BD, 2004, EUKARYOT CELL, V3, P715, DOI 10.1128/EC.3.3.715-723.2004; Weichsel A, 2010, PROTEIN SCI, V19, P1801, DOI 10.1002/pro.455; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Winterbourn CC, 2014, BBA-GEN SUBJECTS, V1840, P730, DOI 10.1016/j.bbagen.2013.05.004; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Wysong DR, 1998, INFECT IMMUN, V66, P1953, DOI 10.1128/IAI.66.5.1953-1961.1998; Yadav AK, 2011, MICROBIOL-SGM, V157, P484, DOI 10.1099/mic.0.045054-0; Zai A, 1999, J CLIN INVEST, V103, P393, DOI 10.1172/JCI4890; Zhang Z, 2004, P NATL ACAD SCI USA, V101, P9491, DOI 10.1073/pnas.0402961101; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	102	27	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126940	10.1371/journal.pone.0126940	http://dx.doi.org/10.1371/journal.pone.0126940			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039593	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700046
J	Chen, JL; Zhou, X; Zeng, M; Wu, XC				Chen, Jieling; Zhou, Xiao; Zeng, Min; Wu, Xinchun			Post-Traumatic Stress Symptoms and Post-Traumatic Growth: Evidence from a Longitudinal Study following an Earthquake Disaster	PLOS ONE			English	Article							ADOLESCENTS; CHILDREN; CANCER	Objective The current longitudinal study aims to examine the bidirectional relationship between post-traumatic stress symptoms (PTSS) and post-traumatic growth (PTG). Method One hundred twenty-two adults in the most severely affected area were investigated by self-report questionnaires at 12 months and 18 months after the Wenchuan Earthquake occurred in China. Results The autoregressive cross-lagged structure equation analysis revealed that PTG at 12 months post-earthquake could negatively predict PTSS at 18 months post-earthquake above and beyond PTSS stability, whereas PTSS at 12 months post-earthquake could not significantly predict subsequent PTG. Moreover, PTG at 12 months post-earthquake could predict fewer subsequent intrusions, numbing and hyper-arousal symptoms but not avoidance symptoms. Conclusion Growth can play a role in reducing long-term post-traumatic stress symptoms, and the implication of a positive perspective in post-trauma circumstance is discussed.	[Chen, Jieling; Zhou, Xiao; Zeng, Min; Wu, Xinchun] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China	Beijing Normal University	Wu, XC (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China.	xcwu@bnu.edu.cn			"Key Projects of Humanities and Social Sciences Key Research Base, Ministry of Education, China" [11JD190006]	"Key Projects of Humanities and Social Sciences Key Research Base, Ministry of Education, China"	The study was supported by "Key Projects of Humanities and Social Sciences Key Research Base, Ministry of Education, China". The grant number is No. 11JD190006 (http://www.sinoss.net/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anderson T.W., 1960, MATH METHODS SOCIAL, P205; Asmundson GJG, 2004, J TRAUMA STRESS, V17, P467, DOI 10.1007/s10960-004-5795-7; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bluvstein I, 2013, J CLIN PSYCHOL MED S, V20, P164, DOI 10.1007/s10880-012-9318-z; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Calhoun L., 1999, FACILITATING POSTTRA; Calhoun L.G., 2006, HDB POSTTRAUMATIC GR; Calhoun PS, 2012, DEPRESS ANXIETY, V29, P1032, DOI 10.1002/da.22012; Copeland WE, 2007, ARCH GEN PSYCHIAT, V64, P577, DOI 10.1001/archpsyc.64.5.577; Cordova MJ, 2001, HEALTH PSYCHOL, V20, P176, DOI 10.1037//0278-6133.20.3.176; Davis CG, 1998, J PERS SOC PSYCHOL, V75, P561, DOI 10.1037/0022-3514.75.2.561; Dekel S, 2012, PSYCHOL TRAUMA-US, V4, P94, DOI 10.1037/a0021865; Erbes C., 2005, TRAUMATOLOGY, V11, P285, DOI DOI 10.1177/153476560501100407; Frazier P, 2001, J CONSULT CLIN PSYCH, V69, P1048, DOI 10.1037//0022-006X.69.6.1048; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; [黄国平 HUANG GuoPing], 2006, [中国心理卫生杂志, Chinese Mental Health Journal], V20, P28; Joseph S., 2008, TRAUMA RECOVERY GROW, P3, DOI [https://doi.org/10.1002/9781118269718.ch1, DOI 10.1002/9781118269718.CH1, DOI 10.1002/9781118269718]; King DW, 1998, PSYCHOL ASSESSMENT, V10, P90, DOI 10.1037/1040-3590.10.2.90; McElheran M, 2012, COUNS PSYCHOL Q, V25, P73, DOI 10.1080/09515070.2012.665225; McMillen JC, 1997, J CONSULT CLIN PSYCH, V65, P733, DOI 10.1037/0022-006X.65.5.733; McWilliams LA, 2005, J ANXIETY DISORD, V19, P626, DOI 10.1016/j.janxdis.2004.06.003; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Muthen BO, 2012, MPLUS VERSION 7 0; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Phelps LF, 2008, REHABIL PSYCHOL, V53, P28, DOI 10.1037/0090-5550.53.1.28; Sahin NH, 2007, J TRAUMA STRESS, V20, P335, DOI 10.1002/jts.20217; Salsman JM, 2009, PSYCHO-ONCOLOGY, V18, P30, DOI 10.1002/pon.1367; Shigemoto Y, 2013, PSYCHOL TRAUMA-US, V5, P128, DOI 10.1037/a0026647; Taylor SE, 1996, J PERS, V64, P873, DOI 10.1111/j.1467-6494.1996.tb00947.x; Tedeschi R.G., 1995, TRAUMA TRANSFORMATIO, DOI [10.4135/9781483326931, DOI 10.4135/9781483326931]; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Weiss Daniel S., 1997, P399; Zhou X.-Y., 2014, ADV SCI TECHNOLOGY L, V46, P1; Zoellner T, 2006, CLIN PSYCHOL REV, V26, P626, DOI 10.1016/j.cpr.2006.01.008	38	32	34	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127241	10.1371/journal.pone.0127241	http://dx.doi.org/10.1371/journal.pone.0127241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7CR	26046912	gold, Green Published			2022-12-27	WOS:000355652200017
J	Jiang, N; Leithold, LHE; Post, J; Ziehm, T; Mauler, J; Gremer, L; Cremer, M; Schartmann, E; Shah, NJ; Kutzsche, J; Langen, KJ; Breitkreutz, J; Willbold, D; Willuweit, A				Jiang, Nan; Leithold, Leonie H. E.; Post, Julia; Ziehm, Tamar; Mauler, Joerg; Gremer, Lothar; Cremer, Markus; Schartmann, Elena; Shah, N. Jon; Kutzsche, Janine; Langen, Karl-Josef; Breitkreutz, Joerg; Willbold, Dieter; Willuweit, Antje			Preclinical Pharmacokinetic Studies of the Tritium Labelled D-Enantiomeric Peptide D3 Developed for the Treatment of Alzheimer's Disease	PLOS ONE			English	Article							IMAGE PHAGE DISPLAY; DOUBLE TRANSGENIC MICE; PROTEIN; MIRROR; INFLAMMATION; DELIVERY; MODELS; BRAIN; BLOOD; BODY	Targeting toxic amyloid beta (A beta) oligomers is currently a very attractive drug development strategy for treatment of Alzheimer's disease. Using mirror-image phage display against A beta 1-42, we have previously identified the fully D-enantiomeric peptide D3, which is able to eliminate A beta oligomers and has proven therapeutic potential in transgenic Alzheimer's disease animal models. However, there is little information on the pharmacokinetic behaviour of D-enantiomeric peptides in general. Therefore, we conducted experiments with the tritium labelled D-peptide D3 (H-3-D3) in mice with different administration routes to study its distribution in liver, kidney, brain, plasma and gastrointestinal tract, as well as its bioavailability by i.p. and p.o. administration. In addition, we investigated the metabolic stability in liver microsomes, mouse plasma, brain, liver and kidney homogenates, and estimated the plasma protein binding. Based on its high stability and long biological half-life, our pharmacokinetic results support the therapeutic potential of D-peptides in general, with D3 being a new promising drug candidate for Alzheimer's disease treatment.	[Jiang, Nan; Leithold, Leonie H. E.; Post, Julia; Ziehm, Tamar; Gremer, Lothar; Schartmann, Elena; Kutzsche, Janine; Willbold, Dieter] Forschungszentrum Julich, Inst Complex Syst ICS 6, Struct Biochem, D-52425 Julich, Germany; [Mauler, Joerg; Shah, N. Jon; Langen, Karl-Josef; Willuweit, Antje] Forschungszentrum Julich, Inst Neurosci & Med INM 4, Med Imaging Phys, D-52425 Julich, Germany; [Gremer, Lothar] Forschungszentrum Julich, Inst Neurosci & Med INM 1, Struct & Funct Org Brain, D-52425 Julich, Germany; [Langen, Karl-Josef] Rhein Westfal TH Aachen, Univ Klinikum, Dept Nucl Med, D-52062 Aachen, Germany; [Breitkreutz, Joerg] Univ Dusseldorf, Inst Pharmaceut & Biopharmaceut, Dusseldorf, Germany; [Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; RWTH Aachen University; RWTH Aachen University Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Willbold, D (corresponding author), Forschungszentrum Julich, Inst Complex Syst ICS 6, Struct Biochem, D-52425 Julich, Germany.	D.Willbold@fz-juelich.de; A.Willuweit@fz-juelich.de	Kutzsche, Janine/G-6287-2013; Langen, Karl-Josef/H-4396-2013; Gremer, Lothar/H-9128-2013; Shah, N. Jon/H-5849-2013; Breitkreutz, Joerg/B-9581-2017; Willbold, Dieter/A-6280-2013	Kutzsche, Janine/0000-0003-0271-7390; Langen, Karl-Josef/0000-0003-1101-5075; Gremer, Lothar/0000-0001-7065-5027; Shah, N. Jon/0000-0002-8151-6169; Breitkreutz, Joerg/0000-0002-3982-9823; Willbold, Dieter/0000-0002-0065-7366; Schartmann, Anna Elena/0000-0001-6791-4761; Willuweit, Antje/0000-0002-6725-0755; Ziehm, Tamar/0000-0003-0957-2518	Portfolio Technology and Medicine; Helmholtz-Validierungsfonds of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft; "Portfolio Drug Design" of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft	Portfolio Technology and Medicine; Helmholtz-Validierungsfonds of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft; "Portfolio Drug Design" of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft	DW was supported by grants from the "Portfolio Technology and Medicine" and the Helmholtz-Validierungsfonds of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft; KJL and DW were supported by the "Portfolio Drug Design" of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft (http://www.helmholtz.de/ueber_uns/impuls_und_vernetzungsfonds; no grant numbers available). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berchtold NC, 1998, NEUROBIOL AGING, V19, P173, DOI 10.1016/S0197-4580(98)00052-9; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Chapman ME, 2010, AM J PHYSIOL-RENAL, V299, pF280, DOI 10.1152/ajprenal.00113.2010; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Fletcher L.C.B., 2013, GMS HLTH TECHNOL ASS, V9, DOI [10.3205/HTA000107, DOI 10.3205/HTA000107]; Funke SA, 2010, ACS CHEM NEUROSCI, V1, P639, DOI 10.1021/cn100057j; Kayed R, 2013, J ALZHEIMERS DIS, V33, pS67, DOI 10.3233/JAD-2012-129001; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Lalatsa A, 2012, MOL PHARMACEUT, V9, P1764, DOI 10.1021/mp300068j; Liu M, 2010, P NATL ACAD SCI USA, V107, P14321, DOI 10.1073/pnas.1008930107; Mason JM, 2010, FUTURE MED CHEM, V2, P1813, DOI [10.4155/fmc.10.259, 10.4155/FMC.10.259]; Mikulca JA, 2014, J CLIN PHARM THER, V39, P25, DOI 10.1111/jcpt.12112; MILTON RCD, 1992, SCIENCE, V256, P1445, DOI 10.1126/science.1604320; Nygaard HB, 2013, CLIN THER, V35, P1480, DOI 10.1016/j.clinthera.2013.09.009; Pollaro L, 2010, MEDCHEMCOMM, V1, P319, DOI 10.1039/c0md00111b; Reichel A, 2006, CURR DRUG METAB, V7, P183, DOI 10.2174/138920006775541525; Schenk D, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006387; Schumacher TNM, 1996, SCIENCE, V271, P1854, DOI 10.1126/science.271.5257.1854; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Stockley JH, 2008, CELL MOL LIFE SCI, V65, P3265, DOI 10.1007/s00018-008-8271-3; Sun N, 2012, MINI-REV MED CHEM, V12, P388, DOI 10.2174/138955712800493942; Takagi H, 2010, PEPTIDES, V31, P1421, DOI 10.1016/j.peptides.2010.04.032; Tamaoka Akira, 2013, Rinsho Byori, V61, P1060; TD B, 1993, GENEREVIEWS R; van Groen T, 2013, J ALZHEIMERS DIS, V34, P609, DOI 10.3233/JAD-121792; van Groen T, 2012, ADV PROTEIN CHEM STR, V88, P133, DOI 10.1016/B978-0-12-398314-5.00005-2; van Groen T, 2008, CHEMMEDCHEM, V3, P1848, DOI 10.1002/cmdc.200800273; van Groen T, 2009, CHEMMEDCHEM, V4, P276, DOI 10.1002/cmdc.200800289; Wiesehan K, 2003, CHEMBIOCHEM, V4, P811, DOI 10.1002/cbic.200300570; Wong TW, 2010, J DRUG TARGET, V18, P79, DOI 10.3109/10611860903302815; ZAWADZKE LE, 1992, J AM CHEM SOC, V114, P4002, DOI 10.1021/ja00036a073	31	26	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128553	10.1371/journal.pone.0128553	http://dx.doi.org/10.1371/journal.pone.0128553			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046986	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200078
J	Koudenburg, N; Postmes, T; Gordijn, EH; Broekman, AVM				Koudenburg, Namkje; Postmes, Tom; Gordijn, Ernestine H.; Broekman, Aafke van Mourik			Uniform and Complementary Social Interaction: Distinct Pathways to Solidarity	PLOS ONE			English	Article							GROUP ENTITATIVITY; PERSONALITY CHARACTERISTICS; INTERPERSONAL COORDINATION; MINORITY INFLUENCE; SHARED IDENTITY; DECISION-MAKING; GROUP NORMS; SELF; SYNCHRONY; SIMILARITY	We examine how different forms of co-action give rise to feelings of solidarity. We propose that (a) coordinated action elicits a sense of solidarity, and (b) the process through which such solidarity emerges differs for different forms of co-action. We suggest that whether solidarity within groups emerges from uniform action (e.g. synchronizing, as when people speak in unison) or from more complementary forms of action (e.g. alternating, when speaking in turns) has important consequences for the emergent position of individuals within the group. Uniform action relies on commonality, leaving little scope for individuality. In complementary action each individual makes a distinctive contribution to the group, thereby increasing a sense of personal value to the group, which should contribute to the emergence of solidarity. The predictions receive support from five studies, in which we study groups in laboratory and field settings. Results show that both complementary and uniform co-action increase a sense of solidarity compared to control conditions. However, in the complementary action condition, but not in the uniform action (or synchrony) condition, the effect on feelings of solidarity is mediated by a sense of personal value to the group.	[Koudenburg, Namkje; Postmes, Tom; Gordijn, Ernestine H.; Broekman, Aafke van Mourik] Univ Groningen, Groningen, Netherlands	University of Groningen	Koudenburg, N (corresponding author), Univ Groningen, Groningen, Netherlands.	N.Koudenburg@rug.nl	Koudenburg, Namkje/AAS-9602-2021; Postmes, Tom/A-9004-2010; Gordijn, Ernestine/E-7955-2014	Postmes, Tom/0000-0002-8029-7398; Koudenburg, Namkje/0000-0003-0725-9683; Gordijn, Ernestine/0000-0002-8350-7135				Alter AL, 2009, PERS SOC PSYCHOL REV, V13, P219, DOI 10.1177/1088868309341564; [Anonymous], 1983, IMAGINED COMMUNITIES; BACK KW, 1988, PUBLIC OPIN QUART, V52, P278, DOI 10.1086/269107; Bellah R.N., 2006, R BELLAH READER; Bernieri F.J., 1991, FUNDAMENTALS NONVERB, P401, DOI DOI 10.1017/CBO9781107415324.004; Bettencourt BA, 2001, J PERS SOC PSYCHOL, V81, P1131, DOI 10.1037/0022-3514.81.6.1131; Bliese P.D., 2000, MULTILEVEL THEORY RE, P349; BREWER MB, 1991, PERS SOC PSYCHOL B, V17, P475, DOI 10.1177/0146167291175001; BYRNE D, 1969, J EXP RES PERS, V3, P179; BYRNE D, 1967, J PERS SOC PSYCHOL, V5, P82, DOI 10.1037/h0021198; CAMPBELL DT, 1958, BEHAV SCI, V3, P14, DOI 10.1002/bs.3830030103; Cappella J. N., 1996, DYNAMIC PATTERNS COM, P353; Clark H.H., 1996, USING LANGUAGE; Corneille O., 2004, PSYCHOL GROUP PERCEP; Coxe S, 2009, J PERS ASSESS, V91, P121, DOI 10.1080/00223890802634175; Dasgupta N, 1999, J PERS SOC PSYCHOL, V77, P991, DOI 10.1037/0022-3514.77.5.991; Durkheim E, 1954, ELEMENTARY FORMS REL; Durkheim E., 1984, DIVISION LABOR SOC; FESTINGER L, 1951, J ABNORM SOC PSYCH, V46, P92, DOI 10.1037/h0054899; Fischer R, 2013, HUM NATURE-INT BIOS, V24, P115, DOI 10.1007/s12110-013-9167-y; Gaertner L, 1998, EUR J SOC PSYCHOL, V28, P963, DOI 10.1002/(SICI)1099-0992(1998110)28:6<963::AID-EJSP905>3.0.CO;2-S; Gaertner L, 2006, J PERS SOC PSYCHOL, V90, P426, DOI 10.1037/0022-3514.90.3.426; Gambi C, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00275; GUILFORD JP, 1956, PSYCHOL BULL, V53, P267, DOI 10.1037/h0040755; Hayes A. F., 2012, PROCESS VERSATILE CO; HOFFMAN LR, 1961, J ABNORM SOC PSYCH, V62, P401, DOI 10.1037/h0044025; HOGG MA, 1987, BRIT J SOC PSYCHOL, V26, P325, DOI 10.1111/j.2044-8309.1987.tb00795.x; Hornsey MJ, 2006, J EXP SOC PSYCHOL, V42, P57, DOI 10.1016/j.jesp.2005.01.006; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; Jans L, 2012, J EXP SOC PSYCHOL, V48, P1145, DOI 10.1016/j.jesp.2012.04.013; Jans L, 2011, PERS SOC PSYCHOL B, V37, P1130, DOI 10.1177/0146167211407342; Karau SJ, 1993, J PERS SOC PSYCHOL, V65; Koudenburg N, 2014, BRIT J SOC PSYCHOL, V53, P350, DOI 10.1111/bjso.12027; Koudenburg N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078363; Koudenburg N, 2011, J EXP SOC PSYCHOL, V47, P512, DOI 10.1016/j.jesp.2010.12.006; LAFRANCE M, 1982, POSTURE MIRRORING RA; Lakens D, 2010, J EXP SOC PSYCHOL, V46, P701, DOI 10.1016/j.jesp.2010.03.015; Leach CW, 2008, J PERS SOC PSYCHOL, V95, P144, DOI 10.1037/0022-3514.95.1.144; LeBreton JM, 2008, ORGAN RES METHODS, V11, P815, DOI 10.1177/1094428106296642; Lickel B, 2000, J PERS SOC PSYCHOL, V78, P223, DOI 10.1037/0022-3514.78.2.223; Mannix Elizabeth, 2005, Psychol Sci Public Interest, V6, P31, DOI 10.1111/j.1529-1006.2005.00022.x; Marques J.M., 1994, EUR REV SOC PSYCHOL, V5, P37, DOI [10.1080/14792779543000011, DOI 10.1080/14792779543000011]; Marsh KL, 2009, TOP COGN SCI, V1, P320, DOI 10.1111/j.1756-8765.2009.01022.x; MCGARTY C, 1995, BRIT J SOC PSYCHOL, V34, P237, DOI 10.1111/j.2044-8309.1995.tb01061.x; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Miles LK, 2010, J EXP SOC PSYCHOL, V46, P457, DOI 10.1016/j.jesp.2009.12.006; MOSCOVICI S, 1976, EUR J SOC PSYCHOL, V6, P149, DOI 10.1002/ejsp.2420060202; Muller V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024893; NEMETH CJ, 1986, PSYCHOL REV, V93, P23, DOI 10.1037/0033-295X.93.1.23; Nemeth CJ, 1987, J APPLIED SOCIAL PSY, V17, P786; Paladino MP, 2010, PSYCHOL SCI, V21, P1202, DOI 10.1177/0956797610379234; Paulus PB, 2011, J CREATIVE BEHAV, V45, P38, DOI 10.1002/j.2162-6057.2011.tb01083.x; Postmes T, 2005, J PERS SOC PSYCHOL, V89, P747, DOI 10.1037/0022-3514.89.5.747; Postmes T, 2001, J PERS SOC PSYCHOL, V80, P918, DOI 10.1037//0022-3514.80.6.918; Postmes T., 2005, EUROPEAN REV SOCIAL, V16, P1, DOI [10.1080/10463280440000062, DOI 10.1080/10463280440000062]; Preacher KJ, 2011, PSYCHOL METHODS, V16, P93, DOI 10.1037/a0022658; Preacher KJ, 2010, PSYCHOL METHODS, V15, P209, DOI 10.1037/a0020141; PRENTICE DA, 1994, PERS SOC PSYCHOL B, V20, P484, DOI 10.1177/0146167294205005; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Rietzschel EF, 2007, J EXP SOC PSYCHOL, V43, P933, DOI 10.1016/j.jesp.2006.10.014; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; STASSER G, 1988, J EXP SOC PSYCHOL, V24, P393, DOI 10.1016/0022-1031(88)90028-5; STASSER G, 1989, J PERS SOC PSYCHOL, V57, P67, DOI 10.1037/0022-3514.57.1.67; Stasser G., 1995, J EXPT SOCIAL PSYCHO, V31, P31, DOI DOI 10.1006/JESP.1995.1012; Stryker Sheldon, 1987, IDENTITY THEORY DEV; Swaab R, 2007, PERS SOC PSYCHOL B, V33, P187, DOI 10.1177/0146167206294788; Turner J. C., 1985, ADV GROUP PROCESSES, V2, P77; Turner J.C., 1987, REDISCOVERING SOCIAL; Turner John C., 1982, SOCIAL IDENTITY INTE, P15, DOI DOI 10.1016/J.VACCINE.2011.08.002; Valdesolo P, 2011, EMOTION, V11, P262, DOI 10.1037/a0021302; van Beest I, 2006, J PERS SOC PSYCHOL, V91, P918, DOI 10.1037/0022-3514.91.5.918; Vignoles VL, 2000, PERS SOC PSYCHOL REV, V4, P337, DOI 10.1207/S15327957PSPR0404_4; Wilson M, 2005, PSYCHON B REV, V12, P957, DOI 10.3758/BF03206432; Wiltermuth SS, 2012, J EXP SOC PSYCHOL, V48, P453, DOI 10.1016/j.jesp.2011.10.007	74	23	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129061	10.1371/journal.pone.0129061	http://dx.doi.org/10.1371/journal.pone.0129061			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7CR	26047131	gold, Green Submitted, Green Published			2022-12-27	WOS:000355652200119
J	Ligeti, B; Penzvalto, Z; Vera, R; Gyorffy, B; Pongor, S				Ligeti, Balazs; Penzvalto, Zsofia; Vera, Roberto; Gyorffy, Balazs; Pongor, Sandor			A Network-Based Target Overlap Score for Characterizing Drug Combinations: High Correlation with Cancer Clinical Trial Results	PLOS ONE			English	Article							BREAST-CANCER; ADJUVANT CHEMOTHERAPY; ROC ANALYSIS; FOLLOW-UP; PRIORITIZATION; THERAPEUTICS; TRASTUZUMAB; EVALUATE; SEARCH; PLUS	Drug combinations are highly efficient in systemic treatment of complex multigene diseases such as cancer, diabetes, arthritis and hypertension. Most currently used combinations were found in empirical ways, which limits the speed of discovery for new and more effective combinations. Therefore, there is a substantial need for efficient and fast computational methods. Here, we present a principle that is based on the assumption that perturbations generated by multiple pharmaceutical agents propagate through an interaction network and can cause unexpected amplification at targets not immediately affected by the original drugs. In order to capture this phenomenon, we introduce a novel Target Overlap Score (TOS) that is defined for two pharmaceutical agents as the number of jointly perturbed targets divided by the number of all targets potentially affected by the two agents. We show that this measure is correlated with the known effects of beneficial and deleterious drug combinations taken from the DCDB, TTD and Drugs. com databases. We demonstrate the utility of TOS by correlating the score to the outcome of recent clinical trials evaluating trastuzumab, an effective anticancer agent utilized in combination with anthracycline-and taxane- based systemic chemotherapy in HER2-receptor (erb-b2 receptor tyrosine kinase 2) positive breast cancer.	[Ligeti, Balazs; Vera, Roberto; Pongor, Sandor] Pazmany Peter Catholic Univ, Fac Informat Technol, Budapest, Hungary; [Penzvalto, Zsofia; Gyorffy, Balazs] MTA TTK Lendulet Canc Biomarker Res Grp, Budapest, Hungary; [Vera, Roberto; Pongor, Sandor] Int Ctr Genet Engn & Biotechnol, Prot Struct & Bioinformat Grp, I-34012 Trieste, Italy; [Gyorffy, Balazs] Semmelweis Univ, Dept Pediat 2, H-1085 Budapest, Hungary; [Gyorffy, Balazs] MTA SE Pediat & Nephrol Res Grp, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; International Center for Genetic Engineering & Biotechnology (ICGEB); Semmelweis University; Semmelweis University	Gyorffy, B (corresponding author), MTA TTK Lendulet Canc Biomarker Res Grp, Budapest, Hungary.	zsalab2@yahoo.com; pongor@icgeb.org	Gyorffy, Balazs/AAA-9135-2021	Gyorffy, Balazs/0000-0002-5772-3766; Vera Alvarez, Roberto/0000-0002-4108-5982	Hungarian Scientific Research Fund OTKA [K108655]	Hungarian Scientific Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	LB and RV are graduate students at the Multidisciplinary Doctoral School of Sciences and Technology of Faculty of Information Technology, and Bionics, Pazmany Peter Catholic University, Budapest, Hungary. BG was supported by grant K108655 from the Hungarian Scientific Research Fund OTKA.	Agoston V, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051909; [Anonymous], 2008, WALKING INTERACTOME; [Anonymous], 2005, P 11 ACM SIGKDD INT; [Anonymous], 2011, NUCL ACIDS RES DATAB; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Busa-Fekete R, 2008, J BIOCHEM BIOPH METH, V70, P1210, DOI 10.1016/j.jbbm.2007.06.003; Calzolari D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000249; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; Cokol M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.71; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; Dawood S, 2010, J CLIN ONCOL, V28, P92, DOI 10.1200/JCO.2008.19.9844; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gottlieb A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.26; GRECO WR, 1995, PHARMACOL REV, V47, P331; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hosmer DW, 2013, WILEY SERIES PROBABI; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Jin GX, 2011, BIOINFORMATICS, V27, pI310, DOI 10.1093/bioinformatics/btr202; Katzung BGMSBTAJ, 2012, BASIC CLINICAL PHARM; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kuhn M, 2012, NUCLEIC ACIDS RES, V40, pD876, DOI 10.1093/nar/gkr1011; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Li S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S10; Ligeti B, 2013, BIOM CIRC SYST C BIO; Liu YB, 2010, BIOINFORMATICS, V26, P587, DOI 10.1093/bioinformatics/btp697; Loewe S, 1926, N-S ARCH EX PATH PH, V114, P313; Nitsch D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-460; O'Boyle NM, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-24; Perez EA, 2011, J CLIN ONCOL, V29, P3366, DOI 10.1200/JCO.2011.35.0868; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Resnik P, 1995, INT JOINT CONF ARTIF, P448; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Sonego P, 2008, BRIEF BIOINFORM, V9, P198, DOI 10.1093/bib/bbm064; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Vera R, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat051; Wong PK, 2008, P NATL ACAD SCI USA, V105, P5105, DOI 10.1073/pnas.0800823105; Wu ZK, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S7; Xiong JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013937; Xu KJ, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S1-S5; Yang K, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.60; Young SS, 1993, RESAMPLING BASED MUL; Zhao XM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002323; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	50	6	9	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129267	10.1371/journal.pone.0129267	http://dx.doi.org/10.1371/journal.pone.0129267			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047322	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000355652200140
J	Najjar, A; Amro, Y; Kitaneh, I; Abu-Sharar, S; Sawalha, M; Jamous, A; Qiq, M; Makharzeh, E; Laban, BS; Amro, W; Amro, A				Najjar, Anas; Amro, Yazan; Kitaneh, Islam; Abu-Sharar, Salam; Sawalha, Maryam; Jamous, Abrar; Qiq, Muhannad; Makharzeh, Enas; Laban, Bayan Subb; Amro, Wafa; Amro, Ahmad			Knowledge and Adherence to Medications among Palestinian Geriatrics Living with Chronic Diseases in the West Bank and East Jerusalem	PLOS ONE			English	Article							PITTSBURGH EPIDEMIOLOGY; SOCIOECONOMIC-STATUS; PATIENT ADHERENCE; ELDERLY-PATIENTS; OLDER; NONADHERENCE; ASSOCIATION; THERAPY; ADULTS; RECOMMENDATIONS	Background Adequate patient knowledge about medications is essential for appropriate drug taking behavior and patient adherence. This study aims to assess and quantify the level of knowledge and adherence to medications among Palestinian geriatrics living with chronic diseases and to investigate possible associated socio-demographic characteristics. Methods and Findings We conducted a cross-sectional study during June 2013 and January 2014 among Palestinian geriatrics >= 60 years old living with chronic disease in the West Bank and East Jerusalem. A stratified random sample was selected and a questionnaire-assisted interview was applied for data collection. T-test was applied for bivariate analyzing and one-way ANOVA test was applied for multivariate analyses. Results A total of 1192 Palestinian geriatrics were studied. The average age was 70.3 (SD=8.58) years and ranged from 60-110 years. The sample comprised 659 (55.3%) females and 533 (44.7%) males. The global knowledge and global adherence scores were (67.57%) and (89.29%), respectively. Adequate levels of knowledge were 71.4%, and of adherence 75%, which were recorded for 705 (59.1%) and 1088 (91.3%) participants, respectively. Significant higher levels of global knowledge and global adherence were recorded for males, and for participants who hold a Bachelor's degree, those who live on their own, and did physical activity for more than 40 hours/week (p-value <0.05). Furthermore, workers, participants with a higher monthly income, and non-smokers have a higher knowledge level with (p-value <0.05). We found positive correlation between participants' global adherence and global knowledge (r=0.487 and p-value <0.001). Negative correlation was found between participants' global knowledge and adherence with age (r=-0.236, p-value < 0.001 and r=-0.211 and p-value <0.001, respectively. Negative correlation between global knowledge and the number of drugs taken (r=-0.130, p-value <0.001) was predicted. Conclusion We concluded that patients with a higher level of knowledge are more adherent to their medications and that better understanding of socio-demographic factors has a clear influence on the level of knowledge and adherence to medications and thus contributes to the development of guidelines for treatment and may consequently lead to favourable clinical outcomes and savings of health care costs.	[Najjar, Anas; Kitaneh, Islam; Abu-Sharar, Salam; Sawalha, Maryam; Jamous, Abrar; Qiq, Muhannad; Makharzeh, Enas; Laban, Bayan Subb; Amro, Wafa; Amro, Ahmad] Al Quds Univ, Fac Pharm, Jerusalem, Israel; [Amro, Yazan] Al Quds Univ, Fac Med, Jerusalem, Israel		Amro, A (corresponding author), Al Quds Univ, Fac Pharm, Jerusalem, Israel.	aamro@pharm.alquds.edu	Amro, Ahmad/AAB-1778-2019	Amro, Ahmad/0000-0003-4123-2679				Alkatheri AM, 2013, ANN THORAC MED, V8, P105, DOI 10.4103/1817-1737.109823; ASCIONE FJ, 1986, MED CARE, V24, P1018, DOI 10.1097/00005650-198611000-00006; Barat I, 2001, BRIT J CLIN PHARMACO, V51, P615, DOI 10.1046/j.0306-5251.2001.01401.x; Burge S, 2005, FAM MED, V37, P712; CHUTKA DS, 1995, MAYO CLIN PROC, V70, P685, DOI 10.4065/70.7.685; Cline CMJ, 1999, EUR J HEART FAIL, V1, P145, DOI 10.1016/S1388-9842(99)00014-8; Colom F, 2005, BIPOLAR DISORD, V7, P24, DOI 10.1111/j.1399-5618.2005.00248.x; Cramer JA, 2008, INT J CLIN PRACT, V62, P76, DOI 10.1111/j.1742-1241.2007.01630.x; DiMatteo MR, 2002, MED CARE, V40, P794, DOI 10.1097/01.MLR.0000024612.61915.2D; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; Dunbar-Jacob J, 2001, J CLIN EPIDEMIOL, V54, pS57, DOI 10.1016/S0895-4356(01)00457-7; Gadkari AS, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-98; GERMAN PS, 1982, J AM GERIATR SOC, V30, P568, DOI 10.1111/j.1532-5415.1982.tb05663.x; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Hajjar Emily R, 2003, Am J Geriatr Pharmacother, V1, P82; Halpern MT, 2006, HYPERTENSION, V47, P1039, DOI 10.1161/01.HYP.0000222373.59104.3d; Hayes BD, 2009, J AM GERIATR SOC, V57, P653, DOI 10.1111/j.1532-5415.2008.02166.x; Hope CJ, 2004, AM J HEALTH-SYST PH, V61, P2043, DOI 10.1093/ajhp/61.19.2043; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Huther J, 2013, PATIENT PREFER ADHER, V7, P237, DOI 10.2147/PPA.S38373; Kalichman SC, 1999, J NATL MED ASSOC, V91, P439; Langkamp DL, 2001, AM J PERINAT, V18, P345, DOI 10.1055/s-2001-17860; Olivares JM, 2013, PATIENT PREFER ADHER, V7, P121, DOI [10.2147/PPA.S37534, 10.2147/PPA.537534]; Marks JR, 2010, PATIENT EDUC COUNS, V78, P372, DOI 10.1016/j.pec.2009.06.017; McDonald HP, 2002, JAMA-J AM MED ASSOC, V288, P2868, DOI 10.1001/jama.288.22.2868; Modig S, 2009, EUR J CLIN PHARMACOL, V65, P151, DOI 10.1007/s00228-008-0581-8; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Okuyan B, 2013, PHARMACOEPIDEM DR S, V22, P209, DOI 10.1002/pds.3275; Ownby RL, 2006, GERIATRICS, V61, P30; Piette JD, 2005, ARCH INTERN MED, V165, P1749, DOI 10.1001/archinte.165.15.1749; Ponnusankar S, 2004, PATIENT EDUC COUNS, V54, P55, DOI 10.1016/s0738-3991(03)00193-9; Secrest AM, 2011, ANN EPIDEMIOL, V21, P374, DOI 10.1016/j.annepidem.2011.02.007; Secrest AM, 2011, ANN EPIDEMIOL, V21, P367, DOI 10.1016/j.annepidem.2011.02.011; Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af; Val Jimenez A, 1992, Aten Primaria, V10, P767; van Eijken M, 2003, DRUG AGING, V20, P229, DOI 10.2165/00002512-200320030-00006; Wasti SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035547; Wroth TH, 2006, J AM BOARD FAM MED, V19, P478, DOI 10.3122/jabfm.19.5.478; Yaya I, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1308	39	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129240	10.1371/journal.pone.0129240	http://dx.doi.org/10.1371/journal.pone.0129240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7CR	26046771	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200136
J	Allione, A; Marcon, F; Fiorito, G; Guarrera, S; Siniscalchi, E; Zijno, A; Crebelli, R; Matullo, G				Allione, Alessandra; Marcon, Francesca; Fiorito, Giovanni; Guarrera, Simonetta; Siniscalchi, Ester; Zijno, Andrea; Crebelli, Riccardo; Matullo, Giuseppe			Novel Epigenetic Changes Unveiled by Monozygotic Twins Discordant for Smoking Habits	PLOS ONE			English	Article							DIFFERENTIAL DNA METHYLATION; VITAMIN-D STATUS; CANCER; WEBGESTALT; BIOMARKER; PATTERNS; DISEASE; PLASMA; MYOSIN	Exposure to cigarette smoking affects the epigenome and could increase the risk of developing diseases such as cancer and cardiovascular disorders. Changes in DNA methylation associated with smoking may help to identify molecular pathways that contribute to disease etiology. Previous studies are not completely concordant in the identification of differentially methylated regions in the DNA of smokers. We performed an epigenome-wide DNA methylation study in a group of monozygotic (MZ) twins discordant for smoking habits to determine the effect of smoking on DNA methylation. As MZ twins are considered genetically identical, this model allowed us to identify smoking-related DNA methylation changes independent from genetic components. We investigated the whole blood genome-wide DNA methylation profiles in 20 MZ twin pairs discordant for smoking habits by using the Illumina Human-Methylation450 BeadChip. We identified 22 CpG sites that were differentially methylated between smoker and non-smoker MZ twins by intra-pair analysis. We confirmed eight loci already described by other groups, located in AHRR, F2RL3, MYOG1 genes, at 2q37.1 and 6p21.33 regions, and also identified several new loci. Moreover, pathway analysis showed an enrichment of genes involved in GTPase regulatory activity. Our study confirmed the evidence of smoking-related DNA methylation changes, emphasizing that well-designed MZ twin models can aid the discovery of novel DNA methylation signals, even in a limited sample population.	[Allione, Alessandra; Fiorito, Giovanni; Guarrera, Simonetta; Matullo, Giuseppe] HuGeF, Human Genet Fdn, Turin, Italy; [Allione, Alessandra; Fiorito, Giovanni; Guarrera, Simonetta; Matullo, Giuseppe] Univ Turin, Dept Med Sci, Turin, Italy; [Marcon, Francesca; Siniscalchi, Ester; Zijno, Andrea; Crebelli, Riccardo] Ist Super Sanita, Dept Environm & Primary Prevent, I-00161 Rome, Italy	University of Turin; Istituto Superiore di Sanita (ISS)	Matullo, G (corresponding author), HuGeF, Human Genet Fdn, Turin, Italy.	giuseppe.matullo@unito.it	Guarrera, Simonetta/AAB-8482-2022; Matullo, Giuseppe/K-6383-2016; Crebelli, Riccardo/ABA-3880-2021; marcon, francesca/K-3825-2016	Matullo, Giuseppe/0000-0003-0674-7757; marcon, francesca/0000-0002-0431-8310; Allione, Alessandra/0000-0001-9599-309X; Zijno, Andrea/0000-0002-3736-6984; Fiorito, Giovanni/0000-0002-7651-5452; Siniscalchi, Ester/0000-0001-5168-819X	Compagnia di San Paolo; Human Genetics Foundation; Istituto Superiore di Sanita; Fondazione Umberto Veronesi	Compagnia di San Paolo(Compagnia di San Paolo); Human Genetics Foundation; Istituto Superiore di Sanita; Fondazione Umberto Veronesi(Fondazione Umberto Veronesi)	This study was supported by Compagnia di San Paolo, (www.compagniadisanpaolo.it) (G.M.); Human Genetics Foundation, (www.hugef-torino.org) (G.M.); Istituto Superiore di Sanita, (www.iss.it) (R. C.); Fondazione Umberto Veronesi, (www.fondazioneveronesi.it) (G.M., A.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoli C, 2011, CLIN CHEM LAB MED, V49, P137, DOI 10.1515/CCLM.2011.009; Belinsky SA, 2005, CLIN CANCER RES, V11, P6505, DOI 10.1158/1078-0432.CCR-05-0625; Bell JT, 2011, TRENDS GENET, V27, P116, DOI 10.1016/j.tig.2010.12.005; Besingi W, 2014, HUM MOL GENET, V23, P2290, DOI 10.1093/hmg/ddt621; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Brot C, 1999, EUR J CLIN NUTR, V53, P920, DOI 10.1038/sj.ejcn.1600870; Charlesworth JC, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-29; Davis S., 2013, METHYLUMI HANDLE ILL; Dogan MV, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-151; Elliott HR, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-4; Gandini S, 2011, INT J CANCER, V128, P1414, DOI 10.1002/ijc.25439; Gervin K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002454; Harlid S, 2014, ENVIRON HEALTH PERSP, V122, P673, DOI 10.1289/ehp.1307480; Hattori N, 2014, BIOCHEM BIOPH RES CO, V455, P3, DOI 10.1016/j.bbrc.2014.08.140; Heyn H, 2013, CARCINOGENESIS, V34, P102, DOI 10.1093/carcin/bgs321; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Kozekov ID, 2003, J AM CHEM SOC, V125, P50, DOI 10.1021/ja020778f; Lange NE, 2012, AM J RESP CRIT CARE, V186, P616, DOI 10.1164/rccm.201110-1868OC; Maravillas-Montero JL, 2014, EUR J IMMUNOL, V44, P877, DOI 10.1002/eji.201343873; Marcon F, 2013, MUTAGENESIS, V28, P135, DOI 10.1093/mutage/ges062; Matullo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061253; Monick MM, 2012, AM J MED GENET B, V159B, P141, DOI 10.1002/ajmg.b.32021; Olety B, 2010, FEBS LETT, V584, P493, DOI 10.1016/j.febslet.2009.11.096; Philibert RA, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-19; Rakyan VK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002300; Shenker NS, 2013, HUM MOL GENET, V22, P843, DOI 10.1093/hmg/dds488; Takata K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3338; Tan Q, 2013, ONCOTARGETS THER, V6, P1471, DOI 10.2147/OTT.S51041; Wan ES, 2012, HUM MOL GENET, V21, P3073, DOI 10.1093/hmg/dds135; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Ward-Caviness C, 2013, HUM GENET, V132, P1371, DOI 10.1007/s00439-013-1339-7; Wong CCY, 2014, MOL PSYCHIATR, V19, P495, DOI 10.1038/mp.2013.41; Wong CCY, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12226; Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang Y, 2014, INT J EPIDEMIOL, V43, P1215, DOI 10.1093/ije/dyu006; Zhang Y, 2014, ENVIRON HEALTH PERSP, V122, P131, DOI 10.1289/ehp.1306937; Zheng XE, 2013, J STEROID BIOCHEM, V136, P280, DOI 10.1016/j.jsbmb.2012.09.018	38	36	37	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128265	10.1371/journal.pone.0128265	http://dx.doi.org/10.1371/journal.pone.0128265			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043106	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600041
J	Bian, CR; Lu, DB; Su, J; Zhou, X; Zhuge, HX; Lamberton, PHL				Bian, Chao-Rong; Lu, Da-Bing; Su, Jing; Zhou, Xia; Zhuge, Hong-Xiang; Lamberton, Poppy H. L.			Serological Prevalence of Schistosoma japonicum in Mobile Populations in Previously Endemic but Now Non-Endemic Regions of China: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							DIPSTICK DYE IMMUNOASSAY; HILLY REGIONS; TRANSMISSION; SURVEILLANCE; ELIMINATION; IMMUNODIAGNOSIS; HAEMATOBIUM; INFECTIONS; STRATEGIES; MARSHLAND	Background Schistosomiasis japonica has been resurging in certain areas of China where its transmission was previously well controlled or interrupted. Several factors may be contributing to this, including mobile populations, which if infected, may spread the disease. A wide range of estimates have been published for S. japonicum infections in mobile populations, and a synthesis of these data will elucidate the relative risk presented from these groups. Methods A literature search for publications up to Oct 31, 2014 on S. japonicum infection in mobile populations in previously endemic but now non-endemic regions was conducted using four bibliographic databases: China National Knowledge Infrastructure, WanFang, VIP Chinese Journal Databases, and PubMed. A meta-analysis was conducted by pooling one arm binary data with MetaAnalyst Beta 3.13. The protocol is available on PROSPERO (No. CRD42013005967). Results A total of 41 studies in Chinese met the inclusion criteria, covering seven provinces of China. The time of post-interruption surveillance ranged from the first year to the 31st year. After employing a random-effects model, from 1992 to 2013 the pooled seroprevalence ranged from 0.9% (95% CI: 0.5-1.6%) in 2003 to 2.3% (95% CI: 1.5-3.4) in 1995; from the first year after the disease had been interrupted to the 31st year, the pooled seroprevalence ranged from 0.6% (95% CI: 0.2-2.1%) in the 27th year to 4.0% (95% CI: 1.3-11.3%) in the second year. The pooled seroprevalence in mobile populations each year was significantly lower than among the residents of endemic regions, whilst four papers reported a lower level of infection in the mobile populations than in the local residents out of only 13 papers which included this data. Conclusions The re-emergence of S. japonicum in areas which had previously interrupted transmission might be due to other factors, although risk from re-introduction from mobile populations could not be excluded.	[Bian, Chao-Rong; Lu, Da-Bing; Su, Jing] Soochow Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Suzhou 215123, Peoples R China; [Zhou, Xia; Zhuge, Hong-Xiang] Soochow Univ, Sch Biol & Basic Med Sci, Dept Parasitol, Suzhou 215123, Peoples R China; [Lamberton, Poppy H. L.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England	Soochow University - China; Soochow University - China; Imperial College London	Lu, DB (corresponding author), Soochow Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Suzhou 215123, Peoples R China.	Ludabing@suda.edu.cn	Lamberton, Poppy/AAR-3591-2020	Lamberton, Poppy/0000-0003-1048-6318	National Sciences Foundation of China [81273141]	National Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Sciences Foundation of China (No. 81273141, to DBL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001009; [Anonymous], 2005, J TROPICAL DIS PARAS; [Anonymous], 2005, DIS SURVEILLANCE; [Anonymous], 2005, DIS SURVEILLANCE; [Anonymous], 1994, MODERN PREVENTIVE ME; [Anonymous], 2005, DIS SURVEILLANCE; [Anonymous], 2005, J TROPICAL DIS PARAS; [Anonymous], 1994, MODERN PREVENTIVE ME; [Anonymous], 2005, DIS SURVEILLANCE; [Anonymous], 1996, J TROP MED; Bergquist R, 2010, ADV PARASIT, V72, P109, DOI 10.1016/S0065-308X(10)72005-4; Chen LiQun, 2008, Disease Surveillance, V23, P322; Dang Hui, 2005, Chinese Journal of Schistosomiasis Control, V17, P383; Fang YM, 2009, CHIN J SCHISTO CONTR, V121, P553; Gao YF, 2003, J TROP MED, V3, P84; Gao YuFan, 2007, Journal of Tropical Medicine (Guangzhou), V7, P927; Gower CM, 2013, ACTA TROP, V128, P261, DOI 10.1016/j.actatropica.2012.09.014; Hao Y, 2007, CHIN J SCHISTO CONTR, V19, P401; Hao Y, 2010, CHIN J SCHISTO CONTR, V22, P521; Hao Y, 2008, CHIN J SCHISTO CONTR, V20, P401; Hao Y, 2009, CHIN J SCHISTOSOMIAS, V21, P451; Hao Yang, 2006, Chinese Journal of Schistosomiasis Control, V18, P321; Hao Yang, 2005, Chinese Journal of Schistosomiasis Control, V17, P401; He F, 2006, SH J PREV MED, V18, P399; He TC, 2002, SH J PREV MED, V14, P144; Hu CY, 2014, ZHEJIANG PREV MED, V26, P280; Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410; Ji P., 2000, CHINESE PRIMARY HLTH, V14, P32; Jin YanJun, 2010, Journal of Tropical Medicine (Guangzhou), V10, P999; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; King CH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002431; King CH, 2009, NEW ENGL J MED, V360, P106, DOI 10.1056/NEJMp0808041; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Lei Zheng-long, 2011, Zhongguo Xuexichongbing Fangzhi Zazhi, V23, P599; Leshem E, 2009, EMERG INFECT DIS, V15, P1823, DOI 10.3201/eid1511.090611; Li CS, 2006, J TROP MED, V12, P348; Li JH, 2002, PRACTICAL PREVENTION, V10, P145; Li JL, 2007, ZHEJIANG PREV MED, V19, P35; Li Li, 2013, Acta Parasitologica et Medica Entomologica Sinica, V20, P59; Li SZ, 2009, CHINESE MED J-PEKING, V122, P1009, DOI 10.3760/cma.j.issn.0366-6999.2009.09.002; Li Y H, 1989, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V7, P263; Li YF, 1996, SH J PREV MED, V8, P252; Liang S, 2006, B WORLD HEALTH ORGAN, V84, P139, DOI 10.2471/BLT.05.025031; Lin DD, 2008, PARASITOL INT, V57, P281, DOI 10.1016/j.parint.2008.04.005; Lin LJ, 2010, CHIN J CLIN INFECT D, V3, P371; Lin LJ, 2010, CHIN J CLIN INFECT D, V3, P340; Lin Rui, 2009, Chinese Journal of Schistosomiasis Control, V21, P528; Lou J, 2001, ZHEJIANG PREV MED, V13, P17; Lu DB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001960; Lu DB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000781; Lu DB, 2010, PARASITOLOGY, V137, P99, DOI 10.1017/S003118200999103X; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Pan HD, 2002, ACTA TROP, V82, P301, DOI 10.1016/S0001-706X(02)00023-2; Patsopoulos NA, 2009, INT J EPIDEMIOL, V38, P1740, DOI 10.1093/ije/dyn235; Qiu XF, 2010, SH J PREV MED, V22, P215; Rollinson D, 2013, ACTA TROP, V128, P423, DOI 10.1016/j.actatropica.2012.04.013; Rudge JW, 2013, P NATL ACAD SCI USA, V110, P11457, DOI 10.1073/pnas.1221509110; Sleigh A, 1998, B WORLD HEALTH ORGAN, V76, P361; Song HaiHong, 2011, China Tropical Medicine, V11, P1344; Song HongTao, 2003, Chinese Journal of Schistosomiasis Control, V15, P102; Spear RC, 2011, INT J PARASITOL, V41, P1243, DOI 10.1016/j.ijpara.2011.08.002; Su JH, 2014, JIANGSU J PREV MED, V25, P68; Utzinger J, 2005, ACTA TROP, V96, P69, DOI 10.1016/j.actatropica.2005.08.004; Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80; Wang JinRong, 2013, Disease Surveillance, V28, P567; Wang LD, 2009, NEW ENGL J MED, V360, P121, DOI 10.1056/NEJMoa0800135; Wang W, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-249; Wang W, 2012, ASIAN PAC J TROP MED, V5, P15, DOI 10.1016/S1995-7645(11)60238-1; Wen LY, 2005, ACTA TROP, V96, P142, DOI 10.1016/j.actatropica.2005.07.025; Wu GL, 2002, ACTA TROP, V82, P193, DOI 10.1016/S0001-706X(02)00010-4; Wu WL, 2005, ACTA TROP, V96, P282, DOI 10.1016/j.actatropica.2005.07.022; Wu XH, 2005, ACTA TROP, V96, P276, DOI 10.1016/j.actatropica.2005.07.021; Wu YingZe, 1996, Chinese Journal of Parasitology & Parasitic Diseases, V14, P160; Xiao DongLou, 2004, Chinese Journal of Schistosomiasis Control, V16, P401; Xie JR, 2010, CHIN J SCHISTO CONTR, V22, P514; Xu CH, 2013, DIS SURVEILLANCE, V28, P389; [徐菊英 XU Ju-ying], 2009, [中国媒介生物学及控制杂志, Chinese Journal of Vector Biology and Control], V20, P351; Xu LR, 2009, PREV MED, V10, P44; Xu QH, 2012, CHIN J PHM, V28, P634; Xue CL, 1997, PREV MED LIT INF, V3, P116; Yan CL, 2012, STRAIT J PREV MED, V18, P52; Yang J, 2007, J TROPICAL DIS PARAS, V5, P240; Yang J, 2008, J TROPICAL DIS PARAS, P223; Yu Qing, 2007, Chinese Journal of Schistosomiasis Control, V19, P46; Yu RF, 2009, J TROPICAL DIS PARAS, V7, P229; Yuan GP, 2002, OCCUP HLTH, V18, P58; Zhen J, 1999, CHIN J SCHISTO CONTR, V11, P125; Zheng H, 2011, CHIN J SCHISTO CONTR, V24, P621; Zhou AF, 1998, ZHEJIANG PREV MED, V7, P391; Zhou ShuaiFeng, 2009, Journal of Tropical Medicine (Guangzhou), V9, P335; Zhou WE, 2009, OCCUP HLTH, V25, P1628; Zhou XH, 2008, CHIN TROP MED, V8, P624; Zhou XN, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001408; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005; Zhou XN, 2007, CHIN J PARASIT DIS C, V25, P180; Zhou YJ, 2011, OCCUP HLTH, V27, P1011; Zhu PeiHua, 2012, Disease Surveillance, V27, P650; Zhu YC, 2005, ACTA TROP, V96, P130, DOI 10.1016/j.actatropica.2005.07.007; Zhu YC, 2005, ACTA TROP, V96, P137, DOI 10.1016/j.actatropica.2005.07.008; Zhu YC, 2002, J IMMUNOL METHODS, V266, P1, DOI 10.1016/S0022-1759(02)00086-8	101	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128896	10.1371/journal.pone.0128896	http://dx.doi.org/10.1371/journal.pone.0128896			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043190	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000355701600072
J	Kuo, FC; Su, SW; Wu, CF; Huang, MC; Shiea, J; Chen, BH; Chen, YL; Wu, MT				Kuo, Fu-Chen; Su, Sheng-Wen; Wu, Chia-Fang; Huang, Meng-Chuan; Shiea, Jentaie; Chen, Bai-Hsiu; Chen, Yi-Ling; Wu, Ming-Tsang			Relationship of Urinary Phthalate Metabolites with Serum Thyroid Hormones in Pregnant Women and Their Newborns: A Prospective Birth Cohort in Taiwan	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; DI(2-ETHYLHEXYL)PHTHALATE DEHP; BISPHENOL-A; EXPOSURE; HEALTH; ASSOCIATIONS; ADOLESCENTS; SYSTEM	Background The purpose of this study was to examine the relationship of phthalates exposure with thyroid function in pregnant women and their newborns. Methods One hundred and forty-eight Taiwanese maternal and infant pairs were recruited from E-Da hospital in southern Taiwan between 2009 and 2010 for analysis. One-spot urine samples and blood samples in the third trimester of pregnant women and their cord blood samples at delivery were collected. Nine phthalate metabolites in urine were determined by triple quadrupole liquid chromatography tandem mass spectrometry, whereas serum from pregnant women and their cord blood were used to measure thyroid profiles (thyroid-stimulating hormone [TSH], thyroxine, free thyroxine, and triiodothyronine) by radioimmunoassay. Results Median levels of urinary mono-n-butyl phthalate, mono-ethyl phthalate, and mono-(2-ethyl-5-oxohexyl) phthalate (mu g/g creatinine) were the three highest phthalate metabolites, which were 37.81, 34.51, and 21.73, respectively. Using Bonferroni correction at a significance of < 0.006, we found that urinary mono-benzyl phthalate (MBzP) levels were significantly and negatively associated with serum TSH in cord blood (beta = -2.644, p = 0.003). Conclusions Maternal urinary MBzP, of which the parental compound is butylbenzyl phthalate, may affect TSH activity in newborns. The alteration of thyroid homeostasis by certain phthalates in the early life, a critical period for neurodevelopment, is an urgent concern.	[Kuo, Fu-Chen; Su, Sheng-Wen; Wu, Chia-Fang; Wu, Ming-Tsang] Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan; [Kuo, Fu-Chen] E Da Hosp, Dept Gynecol & Obstet, Kaohsiung, Taiwan; [Kuo, Fu-Chen] I Shou Univ, Coll Med, Sch Med, Kaohsiung, Taiwan; [Huang, Meng-Chuan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Nutr, Kaohsiung, Taiwan; [Shiea, Jentaie] Natl Sun Yat Sen Univ, Dept Chem, Kaohsiung 80424, Taiwan; [Chen, Bai-Hsiu] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan; [Chen, Yi-Ling] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Nucl Med, Kaohsiung, Taiwan; [Wu, Ming-Tsang] Kaohsiung Municipal Hsiaokang Hosp, Ctr Environm & Occupat Med, Kaohsiung, Taiwan; [Wu, Ming-Tsang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan	Kaohsiung Medical University; E-Da Hospital; I Shou University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Wu, MT (corresponding author), Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan.	960021@ms.kmuh.org.tw	Chen, Yi/HIR-2608-2022; Wu, Ming-Tsang/G-5637-2012	Wu, Ming-Tsang/0000-0001-7307-7816; Chen, Bai Hsiun/0000-0001-9496-553X	Taiwan National Health Research Institutes [NHRI-EX102-10209PI]; National Science Council (NSC) [101-2314-B-037-037-MY3]; Kaohsiung Medical University Hospital [KMUH102-2R58]; E-Da Hospital [EDAHP102040]	Taiwan National Health Research Institutes; National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Hospital; E-Da Hospital	This study was supported by grants from the Taiwan National Health Research Institutes (NHRI-EX102-10209PI), the National Science Council (NSC 101-2314-B-037-037-MY3), and Kaohsiung Medical University Hospital (KMUH102-2R58) for Dr. Ming-Tsang Wu, and E-Da Hospital (EDAHP102040) for Dr. Fu-Chen Kuo. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749; Adibi JJ, 2009, AM J EPIDEMIOL, V169, P1015, DOI 10.1093/aje/kwp001; Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235; Anderson WAC, 2001, FOOD ADDIT CONTAM A, V18, P1068, DOI 10.1080/02652030110050113; Andra SS, 2012, J ENVIRON SCI HEAL C, V30, P107, DOI 10.1080/10590501.2012.681487; Berman T, 2009, ENVIRON INT, V35, P353, DOI 10.1016/j.envint.2008.08.010; Boas M, 2012, MOL CELL ENDOCRINOL, V355, P240, DOI 10.1016/j.mce.2011.09.005; Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331; Breous E, 2005, MOL CELL ENDOCRINOL, V244, P75, DOI 10.1016/j.mce.2005.06.009; Chen ML, 2008, ENVIRON INT, V34, P79, DOI 10.1016/j.envint.2007.07.004; Cho SC, 2010, ENVIRON HEALTH PERSP, V118, P1027, DOI 10.1289/ehp.0901376; Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470; Ghisari M, 2009, TOXICOL LETT, V189, P67, DOI 10.1016/j.toxlet.2009.05.004; Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205; Ishihara A, 2003, MOL CELL ENDOCRINOL, V199, P105, DOI 10.1016/S0303-7207(02)00302-7; Jugan ML, 2010, BIOCHEM PHARMACOL, V79, P939, DOI 10.1016/j.bcp.2009.11.006; Jurewicz J, 2011, INT J OCCUP MED ENV, V24, P115, DOI 10.2478/s13382-011-0022-2; Kavlock R, 2006, REPROD TOXICOL, V22, P291, DOI 10.1016/j.reprotox.2006.04.007; Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4; Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3; Koch HM, 2007, J CHROMATOGR B, V847, P114, DOI 10.1016/j.jchromb.2006.09.044; Lin LC, 2011, CHEMOSPHERE, V83, P1192, DOI 10.1016/j.chemosphere.2010.12.079; Lorber M, 2010, J EXPO SCI ENV EPID, V20, P38, DOI 10.1038/jes.2008.74; Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1396, DOI 10.1289/ehp.1103582; Pak VM, 2011, AAOHN J, V59, P228, DOI 10.3928/08910162-20110426-01; Rais-Bahrami K, 2004, ENVIRON HEALTH PERSP, V112, P1339, DOI 10.1289/ehp.6901; Shen OX, 2009, TOXICOL LETT, V191, P9, DOI 10.1016/j.toxlet.2009.07.019; Shimada N, 2004, J ENDOCRINOL, V183, P627, DOI 10.1677/joe.1.05893; Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038; Sugiyama S, 2005, TOXICOL SCI, V88, P367, DOI 10.1093/toxsci/kfi330; Suzuki Yayoi, 2009, Environmental Health and Preventive Medicine, V14, P180, DOI 10.1007/s12199-009-0078-9; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wittassek M, 2009, INT J HYG ENVIR HEAL, V212, P492, DOI 10.1016/j.ijheh.2009.04.001; Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007; Wu CF, 2013, ENVIRON SCI TECHNOL, V47, P13754, DOI 10.1021/es403141u; Wu MT, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055005, 10.1371/journal.pone.0055044]; Wu MT, 2012, ENVIRON INT, V44, P75, DOI 10.1016/j.envint.2012.01.014; Yan X, 2009, HUM ECOL RISK ASSESS, V15, P565, DOI 10.1080/10807030902892554; Ye XB, 2008, ENVIRON RES, V108, P260, DOI 10.1016/j.envres.2008.07.014; Zeman FA, 2013, INT J HYG ENVIR HEAL, V216, P271, DOI 10.1016/j.ijheh.2012.12.005	42	54	54	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0123884	10.1371/journal.pone.0123884	http://dx.doi.org/10.1371/journal.pone.0123884			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042594	gold, Green Submitted, Green Published			2022-12-27	WOS:000355701600004
J	Li, NW; Yang, LY; Wang, HJ; Yi, T; Jia, XB; Chen, C; Xu, P				Li, Ningwei; Yang, Lingyun; Wang, Hongjing; Yi, Tao; Jia, Xibiao; Chen, Cen; Xu, Pan			MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILES; ANTICANCER DRUGS; UP-REGULATION; INVOLVEMENT	Chemoresistance remains a major obstacle to effective treatment in patients with ovarian cancer, and recently increasing evidences suggest that miRNAs are involved in drug-resistance. In this study, we investigated the role of miRNAs in regulating cisplatin resistance in ovarian cancer cell line and analyzed their possible mechanisms. We profiled miRNAs differentially expressed in cisplatin-resistant human ovarian cancer cell line A2780/DDP compared with parental A2780 cells using microarray. Four abnormally expressed miRNAs were selected (miR-146a,-130a, -374a and miR-182) for further studies. Their expression were verified by qRT-PCR. MiRNA mimics or inhibitor were transfected into A2780 and A2780/DDP cells and then drug sensitivity was analyzed by MTS array. RT-PCR and Western blot were carried out to examine the alteration of MDR1, PTEN gene expression. A total of 32 miRNAs were found to be differentially expressed in A2780/DDP cells. Among them, miR-146a was down-regulated and miR-130a,-374a,-182 were upregulated in A2780/DDP cells, which was verified by RT-PCR. MiR-130a and miR-374a mimics decreased the sensitivity of A2780 cells to cisplatin, reversely, their inhibitors could resensitize A2780/DDP cells. Furthermore, overexpression of miR-130a could increase the MDR1 mRNA and P-gp levels in A2780 and A2780/DDP cells, whereas knockdown of miR-130a could inhibit MDR1 gene expression and upregulate the PTEN protein expression. In a conclusion, the deregulation of miR-374a and miR-130a may be involved in the development and regulation of cisplatin resistance in ovarian cancer cells. This role of miR-130a may be achieved by regulating the MDR1 and PTEN gene expression.	[Li, Ningwei; Yang, Lingyun; Wang, Hongjing; Yi, Tao; Jia, Xibiao; Chen, Cen; Xu, Pan] Sichuan Univ, West China Univ Hosp 2, Dept Gynecol & Obstet, Chengdu 610041, Sichuan, Peoples R China	Sichuan University	Wang, HJ (corresponding author), Sichuan Univ, West China Univ Hosp 2, Dept Gynecol & Obstet, Chengdu 610041, Sichuan, Peoples R China.	whjscdx@163.com			local Foundation from Science and Technology Department of Sichuan Province [2012SZ0022]; Program for Changjiang Scholars and the Innovative Research Team in University [IRT0935]	local Foundation from Science and Technology Department of Sichuan Province; Program for Changjiang Scholars and the Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This study was supported by two funds. One is the local Foundation (No. 2012SZ0022) from Science and Technology Department of Sichuan Province (http://www.scst.gov.cn/info/), whose funder is WHJ participating in the study design and decision to publish in this study. The other one is the Program for Changjiang Scholars and the Innovative Research Team in University (NO. IRT0935, http://www.moe.gov.cn/), whose funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglicheau D, 2010, TRANSPLANTATION, V90, P105, DOI 10.1097/TP.0b013e3181e913c2; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Buscaglia Lindsey E Becker, 2011, Chin J Cancer, V30, P371; Cai JC, 2013, J CLIN INVEST, V123, P566, DOI 10.1172/JCI65871; Carracedo A, 2011, CANCER RES, V71, P629, DOI 10.1158/0008-5472.CAN-10-2488; Chiang CH, 2013, BBA-GEN SUBJECTS, V1830, P3067, DOI 10.1016/j.bbagen.2013.01.009; Cui Xiu-ying, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P1813; Du LQ, 2009, MOL CANCER RES, V7, P1234, DOI 10.1158/1541-7786.MCR-08-0507; Foster T, 2009, GYNECOL ONCOL, V115, P290, DOI 10.1016/j.ygyno.2009.07.026; Fraser M, 2008, INT J CANCER, V122, P534, DOI 10.1002/ijc.23086; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Gottesman MM, 2006, FEBS LETT, V580, P998, DOI 10.1016/j.febslet.2005.12.060; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; hun-Zhi Z, 2010, BMC CANCER, V10, P367, DOI [10.1186/1471-2407-10-367, DOI 10.1186/1471-2407-10-367]; Kirschner K, 2010, ANTICANCER RES, V30, P3223; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; Li ZM, 2010, GYNECOL ONCOL, V119, P125, DOI 10.1016/j.ygyno.2010.06.004; Mao C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036653; Materon EM, 2014, BIOSENS BIOELECTRON, V58, P232, DOI 10.1016/j.bios.2014.02.070; Moitra K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045268; Naishadham D, 2013, CANC STAT; Namlos HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048086; Pan YZ, 2009, MOL PHARMACOL, V75, P1374, DOI 10.1124/mol.108.054163; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Takiuchi D, 2013, PANCREATOLOGY, V13, P517, DOI 10.1016/j.pan.2013.06.007; Valeri N, 2010, P NATL ACAD SCI USA, V107, P21098, DOI 10.1073/pnas.1015541107; Wang YX, 2010, J DIGEST DIS, V11, P50, DOI 10.1111/j.1751-2980.2009.00413.x; Xiang Y, 2014, ONCOGENE, V33, P378, DOI 10.1038/onc.2012.575; Xiong X, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.28; Xu N, 2012, BIOCHEM BIOPH RES CO, V425, P468, DOI 10.1016/j.bbrc.2012.07.127; Yang LY, 2012, ONCOL REP, V28, P592, DOI 10.3892/or.2012.1823	32	82	82	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128886	10.1371/journal.pone.0128886	http://dx.doi.org/10.1371/journal.pone.0128886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043084	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600071
J	Reid, CAY; Roberts, LD; Roberts, CM; Piek, JP				Reid, Carly A. Y.; Roberts, Lynne D.; Roberts, Clare M.; Piek, Jan P.			Towards a Model of Contemporary Parenting: The Parenting Behaviours and Dimensions Questionnaire	PLOS ONE			English	Article							PSYCHOLOGICAL CONTROL; OPPOSITIONAL DEFIANT; CORPORAL PUNISHMENT; SELF-DETERMINATION; CHILD; DISCIPLINE; SOCIALIZATION; PATTERNS; MOTHER; FAMILY	The assessment of parenting has been problematic due to theoretical disagreement, concerns over generalisability, and problems with the psychometric properties of current parenting measures. The aim of this study was to develop a comprehensive, psychometrically sound self-report parenting measure for use with parents of preadolescent children, and to use this empirical scale development process to identify the core dimensions of contemporary parenting behaviour. Following item generation and parent review, 846 parents completed an online survey comprising 116 parenting items. Exploratory and confirmatory factor analyses supported a six factor parenting model, comprising Emotional Warmth, Punitive Discipline, Anxious Intrusiveness, Autonomy Support, Permissive Discipline and Democratic Discipline. This measure will allow for the comprehensive and consistent assessment of parenting in future research and practice.	[Reid, Carly A. Y.; Roberts, Lynne D.; Roberts, Clare M.; Piek, Jan P.] Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA 6845, Australia	Curtin University	Piek, JP (corresponding author), Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA 6845, Australia.	j.piek@curtin.edu.au	Roberts, Lynne/B-6647-2013	Roberts, Lynne/0000-0003-0085-9213	Curtin University	Curtin University	This study was supported by funds provided by Curtin University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth MDS, 1971, THE ORIGINS OF HUMAN; Allen PJ, 2010, INT J TECHNOETHICS, V1, P35, DOI 10.4018/jte.2010070104; Arnold D.S., 1993, PSYCHOL ASSESSMENT, V9, P137, DOI [10.1037/1040-3590.5.2.137, DOI 10.1037/1040-3590.5.2.137]; Arrindell WA, 1998, PERS INDIV DIFFER, V24, P341, DOI 10.1016/S0191-8869(97)00187-6; Assor A, 2004, J PERS, V72, P47, DOI 10.1111/j.0022-3506.2004.00256.x; Aunola K, 2005, CHILD DEV, V76, P1144, DOI 10.1111/j.1467-8624.2005.00840.x-i1; Aunola K, 2004, DEV PSYCHOL, V40, P965, DOI 10.1037/0012-1649.40.6.965; Australian Bureau of Statistics, 2011, PUBLICATION; BALDWIN AL, 1946, J PERS, V15, P143, DOI 10.1111/j.1467-6494.1946.tb01058.x; Baldwin AL, 1948, CHILD DEV, V19, P127; BANDURA A, 1965, J PERS SOC PSYCHOL, V1, P589, DOI 10.1037/h0022070; Barber B.K., 2002, INTRUSIVE PARENTING, P15, DOI [https://doi.org/10.1037/10422-002, DOI 10.1037/10422-002]; Barber BK, 1996, CHILD DEV, V67, P3296, DOI 10.2307/1131780; Barber BK, 1996, J MARRIAGE FAM, V58, P433, DOI 10.2307/353507; Barber BK, 2012, J ADOLESCENCE, V35, P273, DOI 10.1016/j.adolescence.2011.10.010; BAUMRIND D, 1967, CHILD DEV, V38, P291, DOI 10.1111/j.1467-8624.1967.tb04348.x; BAUMRIND D, 1966, CHILD DEV, V37, P887, DOI 10.1111/j.1467-8624.1966.tb05416.x; BAUMRIND D, 1971, DEV PSYCHOL, V4, P1, DOI 10.1037/h0030372; Baumrind D, 1997, AGGRESS VIOLENT BEH, V2, P321, DOI 10.1016/S1359-1789(97)00018-9; Baumrind D, 1996, FAM RELAT, V45, P405, DOI 10.2307/585170; BAUMRIND D, 1967, GENET PSYCHOL MONOGR, V75, P43; BAUMRIND D, 1978, YOUTH SOC, V9, P239, DOI 10.1177/0044118X7800900302; Baumrind D., 1991, J EARLY ADOLESC, V11, P56, DOI [DOI 10.1177/0272431691111004, 10.1177/0272431691111004]; BECKER WC, 1964, REV CHILD DEV RES, V1, P169; Bornstein MH., 2010, ASSESSMENT PARENTING, P349, DOI [10.1002/9780470660683.ch31, DOI 10.1002/9780470660683.CH31]; Bornstein MH, 2006, ACCULTURATION AND PA, pxi; Boyle MH, 2004, CHILD DEV, V75, P1457, DOI 10.1111/j.1467-8624.2004.00751.x; Bronfenbrenner U., 1979, THE ECOLOGY OF HUMAN; Bronfenbrenner U., 1983, HDB CHILD PSYCHOL, VVol. 1; Capron, 2004, J INDIV PSYCHOL, V60, P76; Carlson L, 1992, J CONSUM PSYCHOL, V1, P31, DOI [10.1016/s1057-7408(08)80044-7, DOI 10.1016/S1057-7408(08)80044-7]; Caron A, 2006, J CLIN CHILD ADOLESC, V35, P34, DOI 10.1207/s15374424jccp3501_4; Cassano P, 2002, J PSYCHOSOM RES, V53, P849, DOI 10.1016/S0022-3999(02)00304-5; Chorpita BF, 1998, PSYCHOL BULL, V124, P3, DOI 10.1037/0033-2909.124.1.3; Costello AB, 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [DOI 10.7275/JYJ1-4868, DOI 10.1316/S0782-051X03024046-9]; Cunningham CE, 2002, J ABNORM CHILD PSYCH, V30, P555, DOI 10.1023/A:1020855429085; DECI EL, 1987, J PERS SOC PSYCHOL, V53, P1024, DOI 10.1037/0022-3514.53.6.1024; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Deci EL, 1985, INTRINSIC MOTIVATION; DeVellis R. F., 2003, SCALE DEVELOPMENT TH; Dishion T J, 1998, Clin Child Fam Psychol Rev, V1, P61, DOI 10.1023/A:1021800432380; Domitrovich CE, 2001, MERRILL PALMER QUART, V47, P235, DOI 10.1353/mpq.2001.0010; Dretzke Janine, 2009, Child Adolesc Psychiatry Ment Health, V3, P7, DOI 10.1186/1753-2000-3-7; Durant LE, 2000, ARCH SEX BEHAV, V29, P309, DOI 10.1023/A:1001930202526; DWECK CS, 1986, AM PSYCHOL, V41, P1040, DOI 10.1037/0003-066X.41.10.1040; FURMAN W, 1995, CLOSE RELATIONSHIPS, P95; George D., 2003, SPSS FOR WINDOWS STE; Gershoff ET, 2002, PSYCHOL BULL, V128, P539, DOI 10.1037//0033-2909.128.4.539; Goritz AS, 2006, INT J INTERNET SCI, V1, P58; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Grolnick W. S., 2003, THE PSYCHOLOGY OF PA; Grolnick WS, 2009, CHILD DEV PERSPECT, V3, P165, DOI 10.1111/j.1750-8606.2009.00099.x; GRUSEC JE, 1994, DEV PSYCHOL, V30, P4, DOI 10.1037/0012-1649.30.1.4; Hauser S, 1991, FAMILIES AND THEIR A; HAUSER ST, 1984, CHILD DEV, V55, P195, DOI 10.2307/1129845; Hayton JC, 2004, ORGAN RES METHODS, V7, P191, DOI 10.1177/1094428104263675; Hoeve M, 2008, J ABNORM CHILD PSYCH, V36, P223, DOI 10.1007/s10802-007-9172-x; HOFFMAN ML, 1994, DEV PSYCHOL, V30, P26, DOI 10.1037/0012-1649.30.1.26; HOFFMAN ML, 1970, HUM DEV, V13, P90, DOI 10.1159/000270884; HOFFMAN ML, 1963, CHILD DEV, V34, P295; HOFFMAN ML, 1975, DEV PSYCHOL, V11, P228, DOI 10.1037/h0076463; Hoffman ML, 1982, NEW DIR CHILD ADOLES, V1982, P83, DOI [DOI 10.1002/CD.23219821605, 10.1002/cd.23219821605]; Hoghughi M., 2004, HDB PARENTING THEORY; Holden GW, 2010, CHILD DEV PERSPECT, V4, P197, DOI 10.1111/j.1750-8606.2010.00148.x; Holden GW, 1999, PSYCHOL BULL, V125, P223, DOI 10.1037/0033-2909.125.2.223; Johnston C, 2002, J ABNORM CHILD PSYCH, V30, P77, DOI 10.1023/A:1014235200174; Karreman A, 2006, INFANT CHILD DEV, V15, P561, DOI 10.1002/icd.478; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Kline RB, 2005, PRINCIPLES PRACTICE, V2; Krueger RA., 2000, FOCUS GROUPS A PRACT; Kuppens S, 2009, EUR J PSYCHOL ASSESS, V25, P133, DOI 10.1027/1015-5759.25.3.133; Landry SH, 2002, DEV NEUROPSYCHOL, V21, P15, DOI 10.1207/S15326942DN2101_2; Landry SH, 2006, DEV PSYCHOL, V42, P627, DOI 10.1037/0012-1649.42.4.627; LEWIS CC, 1981, PSYCHOL BULL, V90, P547, DOI 10.1037/0033-2909.90.3.547; Locke LM, 2002, CLIN PSYCHOL REV, V22, P895, DOI 10.1016/S0272-7358(02)00133-2; Loeber R, 2000, J AM ACAD CHILD PSY, V39, P1468, DOI 10.1097/00004583-200012000-00007; Loewenthal K. M., 2001, AN INTRODUCTION TO P; Long N, 2004, HANDBOOK OF PARENTIN, P380; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; Mahoney A, 2000, J CLIN CHILD PSYCHOL, V29, P266, DOI 10.1207/S15374424jccp2902_12; MALLINCKRODT B, 1992, J COUNS PSYCHOL, V39, P453, DOI 10.1037/0022-0167.39.4.453; McLeod BD, 2011, HANDBOOK OF CHILD AND ADOLESCENT ANXIETY DISORDERS, P213, DOI 10.1007/978-1-4419-7784-7_15; Morris AS, 2002, J MARRIAGE FAM, V64, P461, DOI 10.1111/j.1741-3737.2002.00461.x; Mulvaney MK, 2006, PARENT-SCI PRACT, V6, P297, DOI 10.1207/s15327922par0604_2; O'Connor TG, 2002, J CHILD PSYCHOL PSYC, V43, P555, DOI 10.1111/1469-7610.00046; Patterson GR, 1976, LIVING WITH CHILDREN; Pettit GS, 1997, CHILD DEV, V68, P908, DOI 10.1111/j.1467-8624.1997.tb01970.x; Rapee R. M., 2001, DEV PSYCHOPATHOL, P481, DOI [DOI 10.1093/MED:PSYCH/9780195123630.003.0021, DOI 10.1093/MED:PSYCH/9780195123630.001.0001]; Reitman D, 2002, J PSYCHOPATHOL BEHAV, V24, P119, DOI 10.1023/A:1015344909518; Rhodes SD, 2003, J EPIDEMIOL COMMUN H, V57, P68, DOI 10.1136/jech.57.1.68; Richardson S, 2005, NO TIME LOSE WELLBEI, P1; ROBERTS GC, 1984, CHILD DEV, V55, P586; ROBINSON CC, 1995, PSYCHOL REP, V77, P819, DOI 10.2466/pr0.1995.77.3.819; Rohner, 1980, CHILD ABUSE NEGLECT, V4, P189, DOI [10.1016/0145-2134(80)90007-1, DOI 10.1016/0145-2134(80)90007-1]; Rohner R. P., 1986, THE WARMTH DIMENSION; Roksa J, 2011, SOCIOL EDUC, V84, P299, DOI 10.1177/0038040711417013; SCHAEFER ES, 1959, J ABNORM SOC PSYCH, V59, P226, DOI 10.1037/h0041114; Seligman M. E. P., 1975, HELPLESSNESS ON DEPR; Shelton KK, 1996, J CLIN CHILD PSYCHOL, V25, P317, DOI 10.1207/s15374424jccp2503_8; Silk JS, 2003, J RES ADOLESCENCE, V13, P113, DOI 10.1111/1532-7795.1301004; Skinner B. F., 1953, SCI HUMAN BEHAV; Skinner E, 2005, PARENT-SCI PRACT, V5, P175, DOI 10.1207/s15327922par0502_3; Soenens B, 2010, DEV REV, V30, P74, DOI 10.1016/j.dr.2009.11.001; Soenens B, 2010, J PERS, V78, P217, DOI 10.1111/j.1467-6494.2009.00614.x; Spokas M, 2009, COGNITIVE THER RES, V33, P543, DOI 10.1007/s10608-008-9227-5; Stolz HE, 2005, J MARRIAGE FAM, V67, P1076, DOI 10.1111/j.1741-3737.2005.00195.x; Stormshak EA, 2000, J CLIN CHILD PSYCHOL, V29, P17, DOI 10.1207/S15374424jccp2901_3; Sturge-Apple ML, 2003, PARENT-SCI PRACT, V3, P327, DOI 10.1207/s15327922par0304_3; Tabachnick B. G., 2001, USING MULTIVARIATE S; Tashakkori A, 2007, J MIX METHOD RES, V1, P207, DOI 10.1177/1558689807302814; Thomasgard M, 1999, CLIN PEDIATR, V38, P347, DOI 10.1177/000992289903800605; THOMASGARD M, 1993, CHILD PSYCHIAT HUM D, V24, P67, DOI 10.1007/BF02367260; Verhoeven M, 2007, PARENT-SCI PRACT, V7, P367, DOI 10.1080/15295190701665672; Vygotsky L., 1962, THOUGHT LANGUAGE; Walling BR., 2007, J CHILD FAM STUD, V16, P642, DOI [10.1007/s10826-006-9113-2, DOI 10.1007/S10826-006-9113-2]; Wentzel K.R., 1991, J EARLY ADOLESC, V11, P321, DOI [10.1177/0272431691113002, DOI 10.1177/0272431691113002]; Wilkinson S., 2008, QUALITATIVE PSYCHOL, P186; Winnicott DW, 1964, THE CHILD THE FAMILY; Wood JJ, 2006, CHILD PSYCHIAT HUM D, V37, P73, DOI 10.1007/s10578-006-0021-x; Zhou Q, 2002, CHILD DEV, V73, P893, DOI 10.1111/1467-8624.00446; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	125	6	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0114179	10.1371/journal.pone.0114179	http://dx.doi.org/10.1371/journal.pone.0114179			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7TC	26043107	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600001
J	Aria, C; Caron, JB				Aria, Cedric; Caron, Jean-Bernard			Cephalic and Limb Anatomy of a New Isoxyid from the Burgess Shale and the Role of "Stem Bivalved Arthropods" in the Disparity of the Frontalmost Appendage	PLOS ONE			English	Article							SIRIUS PASSET LAGERSTATTE; CAMBRIAN CHENGJIANG FAUNA; MORPHOLOGICAL DISPARITY; DIGESTIVE-SYSTEM; EVOLUTION; ORIGIN; HEAD; DIVERSIFICATION; ANOMALOCARIS; AFFINITIES	We herein describe Surusicaris elegans gen. et sp. nov. (in Isoxyidae, amended), a middle (Series 3, Stage 5) Cambrian bivalved arthropod from the new Burgess Shale deposit of Marble Canyon (Kootenay National Park, British Columbia). Surusicaris exhibits 12 simple, partly undivided biramous trunk limbs with long tripartite caeca, which may illustrate a plesiomorphic "fused" condition of exopod and endopod. We construe also that the head is made of five somites (=four segments), including two eyes, one pair of anomalocaridid-like frontalmost appendages, and three pairs of poorly sclerotized uniramous limbs. This fossil may therefore be a candidate for illustrating the origin of the plesiomorphic head condition in euarthropods, and questions the significance of the "two-segmented head" in, e.g., fuxianhuiids. The frontalmost appendage in isoxyids is intriguingly disparate, bearing similarities with both dinocaridids and euarthropods. In order to evaluate the relative importance of bivalved arthropods, such as Surusicaris, in the hypothetical structuro-functional transition between the dinocaridid frontal appendage and the pre-oral-arguably deutocerebral-appendage of euarthropods, we chose a phenetic approach and computed morphospace occupancy for the frontalmost appendages of 36 stem and crown taxa. Results show different levels of evolutionary decoupling between frontalmost appendage disparity and body plans. Variance is greatest in dinocaridids and "stem bivalved" arthropods, but these groups do not occupy the morphospace homogeneously. Rather, the diversity of frontalmost appendages in "stem bivalved" arthropods, distinct in its absence of clear clustering, is found to link the morphologies of "short great appendages," chelicerae and antennules. This find fits the hypothesis of an increase in disparity of the deutocerebral appendage prior to its diversification in euarthropods, and possibly corresponds to its original time of development. The analysis of this pattern, however, is sensitive to the-still unclear-extent of polyphyly of the " stem bivalved" taxa.	[Aria, Cedric; Caron, Jean-Bernard] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada; [Aria, Cedric; Caron, Jean-Bernard] Royal Ontario Museum, Dept Nat Hist Palaeobiol, Toronto, ON M5S 2C6, Canada; [Caron, Jean-Bernard] Univ Toronto, Dept Earth Sci, Toronto, ON M5S 3B1, Canada	University of Toronto; Royal Ontario Museum; University of Toronto	Aria, C (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, 25 Willcocks St, Toronto, ON M5S 3B2, Canada.	cedric.aria@outlook.com	Aria, Cédric/J-4449-2019	Aria, Cédric/0000-0002-0567-1730; Caron, Jean-Bernard/0000-0002-1670-5502	Royal Ontario Museum (JBC); Uppsala University; Swedish Research Council (MS); Pomona College (RRG); Natural Sciences and Engineering Research Council [341944, 311727]; U.S. National Science Foundation [EAR-1046233]; University of Toronto (Dept. of Ecology and Evolution); J-BC's Natural Sciences and Engineering Research Council [341944]	Royal Ontario Museum (JBC); Uppsala University; Swedish Research Council (MS)(Swedish Research Council); Pomona College (RRG); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); U.S. National Science Foundation(National Science Foundation (NSF)); University of Toronto (Dept. of Ecology and Evolution); J-BC's Natural Sciences and Engineering Research Council	Financial support for the 2012 expedition comes from the Royal Ontario Museum (JBC), Uppsala University and the Swedish Research Council (MS), Pomona College (RRG), Natural Sciences and Engineering Research Council Discovery Grants (to JBC #341944 and to GM #311727), and from the U.S. National Science Foundation (to RRG #EAR-1046233). This research was undertaken as part of a PhD thesis (CA) in the Department of Ecology and Evolutionary Biology at the University of Toronto. CA's research is supported by fellowships from the University of Toronto (Dept. of Ecology and Evolution) and J-BC's Natural Sciences and Engineering Research Council Discovery Grant (#341944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOCK AC, 1979, SOC FORCES, V57, P1381, DOI 10.2307/2577276; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 1994, ACTA PALAEONTOL POL; Bengtson Stefan, 2002, Paleontological Society Papers, V8, P289; Bergstrom J, 2005, CRUSTACEAN ISS, V16, P73, DOI 10.1201/9781420037548.ch4; BERGSTROM J, 1992, ACTA ZOOL-STOCKHOLM, V73, P287, DOI 10.1111/j.1463-6395.1992.tb01093.x; Boxshall G.A., 1992, P347; Briggs D.E.G., 1976, GEOL SURV CAN BULL, V264, P1; BRIGGS DEG, 1992, SCIENCE, V256, P1670, DOI 10.1126/science.256.5064.1670; BRIGGS DEG, 1989, SCIENCE, V246, P241, DOI 10.1126/science.246.4927.241; BRIGGS DEG, 1978, PHILOS T ROY SOC B, V281, P439, DOI 10.1098/rstb.1978.0005; Brusatte SL, 2014, CURR BIOL, V24, P2386, DOI 10.1016/j.cub.2014.08.034; Budd GE, 1998, PALAEONTOLOGY, V41, P1201; Budd GE, 2006, BIOL REV, V81, P609, DOI 10.1017/S1464793106007135; Budd GE, 2012, LETHAIA, V45, P83, DOI 10.1111/j.1502-3931.2011.00264.x; Budd GE, 2009, NATURE, V457, P812, DOI 10.1038/nature07890; BUTTERFIELD NJ, 1990, PALEOBIOLOGY, V16, P272, DOI 10.1017/S0094837300009994; Butterfield NJ, 2002, PALEOBIOLOGY, V28, P155, DOI 10.1666/0094-8373(2002)028<0155:LGATIO>2.0.CO;2; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Caron JB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4210; CHATTERTON BDE, 1994, J PALEONTOL, V68, P294, DOI 10.1017/S0022336000022897; Chen JY, 2004, LETHAIA, V37, P3, DOI 10.1080/00241160410004764; Cong PY, 2014, NATURE, V513, P538, DOI 10.1038/nature13486; Cotton TJ, 2004, T ROY SOC EDIN-EARTH, V94, P169, DOI 10.1017/S0263593300000596; Cramer H., 1946, MATH METHODS STAT; Daley AC, 2014, J PALEONTOL, V88, P68, DOI 10.1666/13-067; Daley AC, 2013, J SYST PALAEONTOL, V11, P743, DOI 10.1080/14772019.2012.732723; Daley AC, 2013, PALAEONTOLOGY, V56, P971, DOI 10.1111/pala.12029; Daley AC, 2012, NATURWISSENSCHAFTEN, V99, P501, DOI 10.1007/s00114-012-0910-8; Daley AC, 2010, PALAEONTOLOGY, V53, P721, DOI 10.1111/j.1475-4983.2010.00955.x; Daley AC, 2010, J PALEONTOL, V84, P352, DOI 10.1666/09-136R1.1; Daley AC, 2009, SCIENCE, V323, P1597, DOI 10.1126/science.1169514; DUMONT HJ, 2002, INTRO CLASS BRANCHIO; Edgecombe GD, 2014, PALAEONTOLOGY, V57, P457, DOI 10.1111/pala.12105; Eriksson BJ, 2010, DEV GENES EVOL, V220, P117, DOI 10.1007/s00427-010-0329-1; Erwin DH, 2007, PALAEONTOLOGY, V50, P57, DOI 10.1111/j.1475-4983.2006.00614.x; Felgenhauer B.E., 1992, P225; Foelix R., 2011, BIOL SPIDERS, V3; FOOTE M, 1991, PALAEONTOLOGY, V34, P461; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; FOOTE M, 1992, SCIENCE, V258, P1816, DOI 10.1126/science.258.5089.1816; FOOTE M, 1994, PALEOBIOLOGY, V20, P320, DOI 10.1017/S009483730001280X; Foote Mike, 1995, Contributions from the Museum of Paleontology University of Michigan, V29, P135; Fu DJ, 2011, ACTA PALAEONTOL POL, V56, P843, DOI 10.4202/app.2010.0090; Gaines RR, 2008, GEOLOGY, V36, P755, DOI 10.1130/G24961A.1; Garcia-Bellido DC, 2009, ACTA PALAEONTOL POL, V54, P699, DOI 10.4202/app.2009.0024; Gould S. J., 1989, WONDERFUL LIFE BURGE; GOULD SJ, 1991, PALEOBIOLOGY, V17, P411, DOI 10.1017/S0094837300010745; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Haug JT, 2012, PALAEONTOLOGY, V55, P369, DOI 10.1111/j.1475-4983.2011.01124.x; Hegna TA, 2013, ARTHROPOD SYST PHYLO, V71, P71; Henriksen K. L., 1928, Videnskabelige Meddelelser Naturh Foren Kjob Bd, V86, P1; Hjelle J.T., 1990, P9; Hou XG, 1999, J PALEONTOL, V73, P102; HOU XG, 1995, GFF, V117, P163, DOI 10.1080/11035899509546213; Hou Xianguang, 1997, Fossils and Strata, V45, P1; Hughes M, 2013, P NATL ACAD SCI USA, V110, P13875, DOI 10.1073/pnas.1302642110; HUGHES NC, 1991, GEOLOGY, V19, P913, DOI 10.1130/0091-7613(1991)019<0913:MPAGFI>2.3.CO;2; Jell PA, 1978, ALCHERINGA, V2, P251, DOI 10.1080/03115517808527783; Kotrc B., 2013, EVOLUTION SILICA BIO; Lamsdell JC, 2013, NATURWISSENSCHAFTEN, V100, P811, DOI 10.1007/s00114-013-1081-y; LEE MSY, 1992, SCIENCE, V258, P1816, DOI 10.1126/science.258.5089.1816-a; Legg D, 2013, J PALEONTOL, V87, P493, DOI 10.1666/12-112.1; Legg DA, 2013, LETHAIA, V46, P540, DOI 10.1111/let.12032; Legg DA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3485; Legg DA, 2012, P ROY SOC B-BIOL SCI, V279, P4699, DOI 10.1098/rspb.2012.1958; Liu JN, 2011, NATURE, V470, P526, DOI 10.1038/nature09704; Ma XY, 2014, J SYST PALAEONTOL, V12, P445, DOI 10.1080/14772019.2013.770418; Ma XY, 2012, NATURE, V490, P258, DOI 10.1038/nature11495; Maas A, 2005, HYDROBIOLOGIA, V538, P139, DOI 10.1007/s10750-004-4944-6; Maas A, 2001, ZOOL ANZ, V240, P451, DOI 10.1078/0044-5231-00053; Marshall CR, 2006, ANNU REV EARTH PL SC, V34, P355, DOI 10.1146/annurev.earth.33.031504.103001; Meyer D, 2011, VCD VISUALIZING CATE; Mittmann B, 2003, DEV GENES EVOL, V213, P9, DOI 10.1007/s00427-002-0285-5; Morris SC, 2014, NATURE, V512, P419, DOI 10.1038/nature13414; Morris SC, 2012, BIOL REV, V87, P480, DOI 10.1111/j.1469-185X.2012.00220.x; Nedin C, 1999, GEOLOGY, V27, P987, DOI 10.1130/0091-7613(1999)027<0987:APONAM>2.3.CO;2; OPIK A. A., 1961, PALAEONTOLOGY, V3, P410; Orr PJ, 2008, PALAIOS, V23, P298, DOI 10.2110/palo.2007.p07-015r; Orr PJ, 1998, SCIENCE, V281, P1173, DOI 10.1126/science.281.5380.1173; Ou Q, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2272; Page A, 2008, GEOLOGY, V36, P855, DOI 10.1130/G24991A.1; Peterson KJ, 2009, BIOESSAYS, V31, P736, DOI 10.1002/bies.200900033; Pushie MJ, 2014, PALAIOS, V29, P512, DOI 10.2110/palo.2014.073; RIDLEY M, 1993, PALEOBIOLOGY, V19, P519, DOI 10.1017/S0094837300014123; Ruta M, 2006, P ROY SOC B-BIOL SCI, V273, P2107, DOI 10.1098/rspb.2006.3577; SANDERS HL, 1955, P NATL ACAD SCI USA, V41, P61, DOI 10.1073/pnas.41.1.61; SAUNDERS WB, 1984, PALEOBIOLOGY, V10, P195, DOI 10.1017/S0094837300008162; Scholtz G, 2005, CRUSTACEAN ISS, V16, P139, DOI 10.1201/9781420037548.ch6; Scholtz G, 2006, DEV GENES EVOL, V216, P395, DOI 10.1007/s00427-006-0085-4; Shu DG, 1995, ALCHERINGA, V19, P333, DOI 10.1080/03115519508619512; Shu DG, 1999, LETHAIA, V32, P279; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Smith MR, 2014, NATURE, V514, P363, DOI 10.1038/nature13576; Stein M, 2013, ZOOL ANZ, V253, P164, DOI 10.1016/j.jcz.2013.05.001; Stein M, 2012, J SYST PALAEONTOL, V10, P361, DOI 10.1080/14772019.2011.566634; Stein M, 2010, LETHAIA, V43, P258, DOI 10.1111/j.1502-3931.2009.00189.x; Stein M, 2010, ZOOL J LINN SOC-LOND, V158, P477, DOI 10.1111/j.1096-3642.2009.00562.x; StOrmer L., 1944, SKR NORSKE VIDENS MN, V5, P1; Tanaka G, 2013, NATURE, V502, P364, DOI 10.1038/nature12520; VALENTINE JW, 1995, PALAIOS, V10, P190, DOI 10.2307/3515182; Valentine JW, 1996, DEV BIOL, V173, P373, DOI 10.1006/dbio.1996.0033; Valentine JW, 2002, ANNU REV EARTH PL SC, V30, P285, DOI 10.1146/annurev.earth.30.082901.092917; VALENTINE JW, 1980, PALEOBIOLOGY, V6, P444, DOI 10.1017/S0094837300003614; Vannier J, 2002, LETHAIA, V35, P107, DOI 10.1080/002411602320183971; Vannier J, 2009, P ROY SOC B-BIOL SCI, V276, P2567, DOI 10.1098/rspb.2009.0361; Vannier J, 2000, LETHAIA, V33, P295; Vannier J, 2006, ACTA PALAEONTOL POL, V51, P201; Vannier J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4641; Vinther J, 2014, NATURE, V507, P496, DOI 10.1038/nature13010; Wagner PJ, 1997, PALEOBIOLOGY, V23, P115, DOI 10.1017/S0094837300016675; WAGNER PJ, 1995, PALEOBIOLOGY, V21, P248, DOI 10.1017/S0094837300013294; Walossek D., 1998, Systematics Association Special Volume Series, V55, P139; Walossek D., 1993, FOSSILS STRATA; Waloszek D, 2005, ARTHROPOD STRUCT DEV, V34, P189, DOI 10.1016/j.asd.2005.01.005; Waloszek D, 2007, PALAEOGEOGR PALAEOCL, V254, P273, DOI 10.1016/j.palaeo.2007.03.027; Wang YY, 2013, CHINESE SCI BULL, V58, P3937, DOI 10.1007/s11434-013-5908-x; Webster M, 2007, SCIENCE, V317, P499, DOI 10.1126/science.1142964; Whiteaves J. F., 1892, CANADIAN RECORD SCI, V5, P205; WHITTINGTON HB, 1975, PHILOS T R SOC B, V271, P1, DOI 10.1098/rstb.1975.0033; WILLS MA, 1994, PALEOBIOLOGY, V20, P93, DOI 10.1017/S009483730001263X; Wills MA, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P33; Yang J, 2013, NATURE, V494, P468, DOI 10.1038/nature11874	124	48	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0124979	10.1371/journal.pone.0124979	http://dx.doi.org/10.1371/journal.pone.0124979			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26038846	Green Submitted, gold, Green Published			2022-12-27	WOS:000355700700006
J	Kim, W; Conery, AL; Rajamuthiah, R; Fuchs, BB; Ausubel, FM; Mylonakis, E				Kim, Wooseong; Conery, Annie L.; Rajamuthiah, Rajmohan; Fuchs, Beth Burgwyn; Ausubel, Frederick M.; Mylonakis, Eleftherios			Identification of an Antimicrobial Agent Effective against Methicillin-Resistant Staphylococcus aureus Persisters Using a Fluorescence-Based Screening Strategy	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; PSEUDOMONAS-AERUGINOSA; COLONIZATION; MRSA; ANTIBIOTICS; INFECTION; BIOFILMS; KINASE; METAANALYSIS; DAPTOMYCIN	Persisters are a subpopulation of normal bacterial cells that show tolerance to conventional antibiotics. Persister cells are responsible for recalcitrant chronic infections and new antibiotics effective against persisters would be a major development in the treatment of these infections. Using the reporter dye SYTOX Green that only stains cells with permeabilized membranes, we developed a fluorescence-based screening assay in a 384-well format for identifying compounds that can kill methicillin-resistant Staphylococcus aureus (MRSA) persisters. The assay proved robust and suitable for high throughput screening (Z -factor: >0.7). In screening a library of hits from a previous screen, which identified compounds that had the ability to block killing of the nematode Caenorhabditis by MRSA, we discovered that the low molecular weight compound NH125, a bacterial histidine kinase inhibitor, kills MRSA persisters by causing cell membrane permeabilization, and that 5 mu g/mL of the compound can kill all cells to the limit of detection in a 10(8) CFU/mL culture of MRSA persisters within 3h. Furthermore, NH125 disrupts 50% of established MRSA biofilms at 20 mu g/mL and completely eradicates biofilms at 160 mu g/mL. Our results suggest that the SYTOX Green screening assay is suitable for large-scale projects to identify small molecules effective against MRSA persisters and should be easily adaptable to a broad range of pathogens that form persisters. Since NH125 has strong bactericidal properties against MRSA persisters and high selectivity to bacteria, we believe NH125 is a good anti-MRSA candidate drug that should be further evaluated.	[Kim, Wooseong; Rajamuthiah, Rajmohan; Fuchs, Beth Burgwyn; Mylonakis, Eleftherios] Brown Univ, Alpert Med Sch, Rhode Isl Hosp, Div Infect Dis, Providence, RI 02912 USA; [Conery, Annie L.; Rajamuthiah, Rajmohan; Fuchs, Beth Burgwyn; Ausubel, Frederick M.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Mylonakis, E (corresponding author), Brown Univ, Alpert Med Sch, Rhode Isl Hosp, Div Infect Dis, Providence, RI 02912 USA.	emylonakis@lifespan.org	Kim, Wooseong/AAQ-3221-2020; Kim, Wooseong/A-9256-2017	Kim, Wooseong/0000-0002-4597-8374; Kim, Wooseong/0000-0002-4597-8374	National Institutes of Health grant [P01 AI083214, U54 AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083214, U54AI057159] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grant P01 AI083214 to EM and FMA and grant U54 AI057159 to NERCE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Arora S, 2004, MOL PHARMACOL, V66, P460; Arora S, 2003, CANCER RES, V63, P6894; Bauer J, 2013, ANTIMICROB AGENTS CH, V57, P2726, DOI 10.1128/AAC.00181-13; Belle R, 2011, DEV BIOL, V350, P476, DOI 10.1016/j.ydbio.2010.12.015; Bigger JW, 1944, LANCET, V2, P497; Borysowski J, 2006, EXP BIOL MED, V231, P366, DOI 10.1177/153537020623100402; Boyd WA, 2010, TOXICOL APPL PHARM, V245, P153, DOI 10.1016/j.taap.2010.02.014; Boyd WA, 2010, NEUROTOXICOL TERATOL, V32, P68, DOI 10.1016/j.ntt.2008.12.004; Brumfitt W, 2002, J ANTIMICROB CHEMOTH, V50, P731, DOI 10.1093/jac/dkf190; Cassat JE, 2013, METHODS MOL BIOL, V185, P195, DOI 10.1007/978-1-62703-664-1_12; Climo MW, 1998, ANTIMICROB AGENTS CH, V42, P1355, DOI 10.1128/AAC.42.6.1355; Clinical and Laboratory Standards Institute, 2012, M7A9 CLIN LAB STAND, V11th; Cole RD, 2004, TOXICOL APPL PHARM, V194, P248, DOI 10.1016/j.taap.2003.09.013; Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Costerton JW, 2001, TRENDS MICROBIOL, V9, P50, DOI 10.1016/S0966-842X(00)01918-1; Daugelavicius R, 2000, ANTIMICROB AGENTS CH, V44, P2969, DOI 10.1128/AAC.44.11.2969-2978.2000; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Devkota AK, 2012, BIOCHEMISTRY-US, V51, P2100, DOI 10.1021/bi201787p; Dolla NK, 2014, AUST J CHEM, V67, P1471, DOI 10.1071/CH14426; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Francis S, 2013, MEDCHEMCOMM, V4, P269, DOI 10.1039/c2md20308a; Francius G, 2008, J BACTERIOL, V190, P7904, DOI 10.1128/JB.01116-08; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; Goss CH, 2011, J CYST FIBROS, V10, P298, DOI 10.1016/j.jcf.2011.06.002; Gutierrez D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107307; Helaine S, 2014, TRENDS MICROBIOL, V22, P417, DOI 10.1016/j.tim.2014.03.008; Hobbs JK, 2008, J ANTIMICROB CHEMOTH, V62, P1003, DOI 10.1093/jac/dkn321; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Hu YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011818; Hurdle JG, 2011, NAT REV MICROBIOL, V9, P62, DOI 10.1038/nrmicro2474; Jayamani E, 2015, ANTIMICROB AGENTS CH, V59, P1733, DOI 10.1128/AAC.04198-14; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Kirienko NV, 2013, CELL HOST MICROBE, V13, P406, DOI 10.1016/j.chom.2013.03.003; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Koh JJ, 2013, BBA-BIOMEMBRANES, V1828, P834, DOI 10.1016/j.bbamem.2012.09.004; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; LaFleur MD, 2010, ANTIMICROB AGENTS CH, V54, P39, DOI 10.1128/AAC.00860-09; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Liu DH, 2004, ANGEW CHEM INT EDIT, V43, P1158, DOI 10.1002/anie.200352791; Liu JC, 2014, EMBO MOL MED, V6, P1542, DOI 10.15252/emmm.201404402; Liu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081345; Lu J, 2014, PEERJ, V2, DOI 10.7717/peerj.326; Lu XF, 2006, J BIOL CHEM, V281, P5895, DOI 10.1074/jbc.M511631200; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09; Rajamuthiah R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089189; Rose AJ, 2009, J PHYSIOL-LONDON, V587, P1547, DOI 10.1113/jphysiol.2008.167528; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; Schmidt NW, 2014, ACS NANO, V8, P8786, DOI 10.1021/nn502201a; Silverman JA, 2003, ANTIMICROB AGENTS CH, V47, P2538, DOI 10.1128/AAC.47.8.2538-2544.2003; Sochova I, 2006, ENVIRON INT, V32, P374, DOI 10.1016/j.envint.2005.08.031; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; Szweda P, 2012, APPL MICROBIOL BIOT, V96, P1157, DOI 10.1007/s00253-012-4484-3; TABER HW, 1987, MICROBIOL REV, V51, P439, DOI 10.1128/MMBR.51.4.439-457.1987; Van Bambeke F, 2008, TRENDS PHARMACOL SCI, V29, P124, DOI 10.1016/j.tips.2007.12.004; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; WILLIAMS PL, 1988, TOXICOL IND HEALTH, V4, P469, DOI 10.1177/074823378800400406; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Yamamoto K, 2000, BIOSCI BIOTECH BIOCH, V64, P919, DOI 10.1271/bbb.64.919; Yamamoto K, 2001, BIOSCI BIOTECH BIOCH, V65, P2306, DOI 10.1271/bbb.65.2306; Zacharioudakis IM, 2014, J AM SOC NEPHROL, V25, P2131, DOI 10.1681/ASN.2013091028; Zendo T, 2010, APPL MICROBIOL BIOT, V88, P1, DOI 10.1007/s00253-010-2764-3; Zervou FN, 2014, CLIN INFECT DIS, V59, P1302, DOI 10.1093/cid/ciu559; Zervou FN, 2014, PEDIATRICS, V133, pE1015, DOI 10.1542/peds.2013-3413; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Ziakas PD, 2014, AM J TRANSPLANT, V14, P1887, DOI 10.1111/ajt.12784; Ziakas PD, 2014, CRIT CARE MED, V42, P433, DOI 10.1097/CCM.0b013e3182a66bb8; Zou HX, 2013, J MED CHEM, V56, P2359, DOI 10.1021/jm301683j	74	41	43	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127640	10.1371/journal.pone.0127640	http://dx.doi.org/10.1371/journal.pone.0127640			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039584	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700069
J	Melenka, GW; Carey, JP				Melenka, Garrett W.; Carey, Jason P.			Evaluation of Fiber Reinforced Cement Using Digital Image Correlation	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; HIGH-TEMPERATURE; COMPOSITES	The effect of short fiber reinforcements on the mechanical properties of cement has been examined using a splitting tensile - digital image correlation (DIC) measurement method. Three short fiber reinforcement materials have been used in this study: fiberglass, nylon, and polypropylene. The method outlined provides a simple experimental setup that can be used to evaluate the ultimate tensile strength of brittle materials as well as measure the full field strain across the surface of the splitting tensile test cylindrical specimen. Since the DIC measurement technique is a contact free measurement this method can be used to assess sample failure.	[Melenka, Garrett W.; Carey, Jason P.] Univ Alberta, Edmonton, AB, Canada	University of Alberta	Carey, JP (corresponding author), Univ Alberta, Edmonton, AB, Canada.	jason.carey@ualberta.ca		Carey, Jason/0000-0003-4406-0171; Melenka, Garrett/0000-0002-3885-6926	NSERC [EGP 459245]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Support was provided by NSERC EGP 459245 [http://www.nserc-crsng.gc.ca/index_eng.asp].	Andreev G.E., 1991, MINING SCI TECHNOLOG, V13, P445, DOI [DOI 10.1016/0167-9031(91)91006-4, 10.1016/0167-9031(91)91006-4]; Andreev GE., 1991, MIN SCI TECHNOL, V13, P457, DOI [10.1016/0167-9031(91)91035-G, DOI 10.1016/0167-9031(91)91035-G]; Brandt AM, 2008, COMPOS STRUCT, V86, P3, DOI 10.1016/j.compstruct.2008.03.006; CASTROMONTERO A, 1995, ACI MATER J, V92, P268; Cavdar A, 2014, COMPOS PART B-ENG, V58, P463, DOI 10.1016/j.compositesb.2013.11.013; Cavdar A, 2013, COMPOS PART B-ENG, V45, P78, DOI 10.1016/j.compositesb.2012.09.033; Cavdar A, 2012, COMPOS PART B-ENG, V43, P2452, DOI 10.1016/j.compositesb.2011.10.005; Felekoglu B, 2009, CEMENT CONCRETE RES, V39, P1023, DOI 10.1016/j.cemconres.2009.07.007; Hondros G., 1959, AUST J APPL SCI, V10, P243; LaVision GmbH, 2006, PROD MAN DAVIS 7 2 S; Leung CK, 2013, COMPOS STRUCT, V100, P135, DOI 10.1016/j.compstruct.2012.12.038; Leung CKY, 1996, J ENG MECH-ASCE, V122, P10, DOI 10.1061/(ASCE)0733-9399(1996)122:1(10); Li VC, 1996, CEMENT CONCRETE COMP, V18, P239, DOI 10.1016/0958-9465(95)00029-1; Li VC, 1996, CEMENT CONCRETE COMP, V18, P223, DOI 10.1016/0958-9465(95)00028-3; Liu C, 2010, EXP MECH, V50, P1025, DOI [10.1007/s11340-009-9281-2, 10.1007/S11340-009-9281-2]; Melenka GW, 2013, AM J ORTHOD DENTOFAC, V143, P645, DOI 10.1016/j.ajodo.2012.12.010; MELLOR M, 1971, ENG GEOL, V5, P173, DOI 10.1016/0013-7952(71)90001-9; Muskhelishvili NI, 1953, SOME BASIC PROBLEMS; NAAMAN AE, 1974, J ENG MECH DIV-ASCE, V100, P397; Naaman AE, 1990, ELASTIC MODULUS SIFC; Pan B, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/6/062001; Sutton MA, 2009, IMAGE CORRELATION FOR SHAPE, MOTION AND DEFORMATION MEASUREMENTS: BASIC CONCEPTS, THEORY AND APPLICATIONS, P1, DOI [10.1007/978-0-387-78747-3, 10.1007/978-0-387-78747-3_5]; Ye JH, 2009, INT J ROCK MECH MIN, V46, P568, DOI 10.1016/j.ijrmms.2008.08.004; Zhu DJ, 2012, CEMENT CONCRETE COMP, V34, P147, DOI 10.1016/j.cemconcomp.2011.09.011	24	11	11	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128644	10.1371/journal.pone.0128644	http://dx.doi.org/10.1371/journal.pone.0128644			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039590	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700112
J	Morris, A; Wang, B; Waern, I; Venkatasamy, R; Page, C; Schmidt, EP; Wernersson, S; Li, JP; Spina, D				Morris, Abigail; Wang, Bo; Waern, Ida; Venkatasamy, Radhakrishnan; Page, Clive; Schmidt, Eric P.; Wernersson, Sara; Li, Jin-Ping; Spina, Domenico			The Role of Heparanase in Pulmonary Cell Recruitment in Response to an Allergic but Not Non-Allergic Stimulus	PLOS ONE			English	Article							ENDOTHELIAL GLYCOCALYX; MURINE MODEL; IN-VIVO; EXPRESSION; SULFATE; ADHESION; INFLAMMATION; ANGIOGENESIS; PLATELETS; GROWTH	Heparanase is an endo-a-glucuronidase that specifically cleaves heparan sulfate proteoglycans in the extracellular matrix. Expression of this enzyme is increased in several pathological conditions including inflammation. We have investigated the role of heparanase in pulmonary inflammation in the context of allergic and non-allergic pulmonary cell recruitment using heparanase knockout (Hpa(-/-)) mice as a model. Following local delivery of LPS or zymosan, no significant difference was found in the recruitment of neutrophils to the lung between Hpa(-/-) and wild type (WT) control. Similarly neutrophil recruitment was not inhibited in WT mice treated with a heparanase inhibitor. However, in allergic inflammatory models, Hpa(-/-) mice displayed a significantly reduced eosinophil (but not neutrophil) recruitment to the airways and this was also associated with a reduction in allergen-induced bronchial hyperresponsiveness, indicating that heparanase expression is associated with allergic reactions. This was further demonstrated by pharmacological treatment with a heparanase inhibitor in the WT allergic mice. Examination of lung specimens from patients with different severity of chronic obstructive pulmonary disease (COPD) found increased heparanase expression. Thus, it is established that heparanase contributes to allergen-induced eosinophil recruitment to the lung and could provide a novel therapeutic target for the development of anti-inflammatory drugs for the treatment of asthma and other allergic diseases.	[Morris, Abigail; Venkatasamy, Radhakrishnan; Page, Clive; Spina, Domenico] Kings Coll London, Inst Pharmaceut Sci, Sackler Inst Pulm Pharmacol, London WC2R 2LS, England; [Wang, Bo; Li, Jin-Ping] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Waern, Ida; Wernersson, Sara] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Schmidt, Eric P.] Univ Colorado, Sch Med, Program Translat Lung Res, Aurora, CO USA	University of London; King's College London; Uppsala University; Swedish University of Agricultural Sciences; University of Colorado System; University of Colorado Anschutz Medical Campus	Spina, D (corresponding author), Kings Coll London, Inst Pharmaceut Sci, Sackler Inst Pulm Pharmacol, London WC2R 2LS, England.	domenico.spina@kcl.ac.uk	Wernersson, Sara/D-4580-2011; Wernersson, Sara/N-8830-2019	Wernersson, Sara/0000-0003-3067-7875; Wernersson, Sara/0000-0003-3067-7875; Spina, Domenico/0000-0002-6815-1564; Page, Clive Peter/0000-0002-9358-3799; Schmidt, Eric/0000-0002-7360-0504	Capacity Building Award in Integrative Mammalian Biology fund; British Biotechnology and Science Research Council; British Pharmacology Society; Higher Education Funding Council for England; Medical Research Council; Scottish Funding Council [BB/E527098/1]; Swedish Research Council [K2012-67X-21128-04-4), K2012-57X-22048-01-6]; Swedish Heart and Lung Foundation; Konsul Th C Bergh Foundation; NIH/NHLBI [K08 HL105538]; BBSRC [BB/E527098/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E527098/1] Funding Source: researchfish	Capacity Building Award in Integrative Mammalian Biology fund; British Biotechnology and Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Pharmacology Society; Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Funding Council; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Konsul Th C Bergh Foundation; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	These studies were supported by a Capacity Building Award in Integrative Mammalian Biology fund to DS by the British Biotechnology and Science Research Council, British Pharmacology Society, Higher Education Funding Council for England, Medical Research Council and Scottish Funding Council (BB/E527098/1); Swedish Research Council (K2012-67X-21128-04-4); Swedish Heart and Lung Foundation (to J.P. Li); Swedish Research Council (K2012-57X-22048-01-6) and Konsul Th C Bergh Foundation (to SW) and NIH/NHLBI (K08 HL105538) (to EPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; Benhamron S, 2006, J IMMUNOL, V176, P6417, DOI 10.4049/jimmunol.176.11.6417; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Chan SCH, 2009, AM J RESP CELL MOL, V41, P620, DOI 10.1165/rcmb.2008-0185OC; Cohen-Mazor M, 2008, AM J PHYSIOL-HEART C, V294, pH651, DOI 10.1152/ajpheart.00952.2007; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dredge K, 2010, INVEST NEW DRUG, V28, P276, DOI 10.1007/s10637-009-9245-5; Edovitsky E, 2006, BLOOD, V107, P3609, DOI 10.1182/blood-2005-08-3301; Ewart SL, 2000, AM J RESP CELL MOL, V23, P537, DOI 10.1165/ajrcmb.23.4.4199; Forsberg E, 2001, J CLIN INVEST, V108, P175, DOI 10.1172/JCI13561; Gandhi NS, 2012, GLYCOBIOLOGY, V22, P35, DOI 10.1093/glycob/cwr095; Garsen M, 2014, NEPHROL DIAL TRANSPL, V29, P49, DOI 10.1093/ndt/gft410; GILAT D, 1995, J EXP MED, V181, P1929, DOI 10.1084/jem.181.5.1929; Goldschmidt O, 2003, FASEB J, V17, P1015, DOI 10.1096/fj.02-0773com; Goldshmidt O, 2002, P NATL ACAD SCI USA, V99, P10031, DOI 10.1073/pnas.152070599; Hammond E, 2010, ANAL BIOCHEM, V396, P112, DOI 10.1016/j.ab.2009.09.007; HOOGEWERF AJ, 1995, J BIOL CHEM, V270, P3268, DOI 10.1074/jbc.270.7.3268; Karoli T, 2005, J MED CHEM, V48, P8229, DOI 10.1021/jm050618p; Khasraw M, 2010, ANN ONCOL, V21, P1302, DOI 10.1093/annonc/mdp524; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; Lever R, 2014, AM J PHYSIOL-CELL PH, V306, pC1184, DOI 10.1152/ajpcell.00269.2013; Li RW, 2008, ARTHRITIS RHEUM, V58, P1590, DOI 10.1002/art.23489; LIDER O, 1989, J CLIN INVEST, V83, P752, DOI 10.1172/JCI113953; LIDER O, 1990, EUR J IMMUNOL, V20, P493, DOI 10.1002/eji.1830200306; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Ludwig RJ, 2004, J INVEST DERMATOL, V122, P830, DOI 10.1111/j.0022-202X.2004.22318.x; Lygizos MI, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.153; Maeda T, 2006, ONCOGENE, V25, P1408, DOI 10.1038/sj.onc.1209168; Pitchford SC, 2005, BLOOD, V105, P2074, DOI 10.1182/blood-2004-06-2282; Pitchford SC, 2004, BLOOD, V103, P639, DOI 10.1182/blood-2003-05-1707; Pitchford SC, 2008, AM J RESP CRIT CARE, V177, P604, DOI 10.1164/rccm.200702-214OC; Poon IKH, 2014, EUR J IMMUNOL, V44, P1016, DOI 10.1002/eji.201343645; Riffo-Vasquez Y, 2007, CLIN EXP ALLERGY, V37, P459, DOI 10.1111/j.1365-2222.2007.02670.x; Schmidt EP, 2014, J BIOL CHEM, V289, P8194, DOI 10.1074/jbc.M113.539452; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; Sotnikov I, 2004, J IMMUNOL, V172, P5185, DOI 10.4049/jimmunol.172.9.5185; Stoler-Barak L, 2015, FASEB J         0129; Vaday GG, 2000, J LEUKOCYTE BIOL, V67, P149, DOI 10.1002/jlb.67.2.149; VLODAVSKY I, 1992, INVAS METAST, V12, P112; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Vlodavsky I, 2012, CANCER MICROENVIRON, V5, P115, DOI 10.1007/s12307-011-0082-7; Waern I, 2010, MOL IMMUNOL, V47, P1467, DOI 10.1016/j.molimm.2010.02.004; Waern I, 2009, J IMMUNOL, V183, P6369, DOI 10.4049/jimmunol.0900180; Waterman M, 2007, MODERN PATHOL, V20, P8, DOI 10.1038/modpathol.3800710; Xu J, 2005, J IMMUNOL, V174, P5758, DOI 10.4049/jimmunol.174.9.5758; YAHALOM J, 1988, LEUKEMIA RES, V12, P711, DOI 10.1016/0145-2126(88)90003-3; Yoshida T, 2010, NAT MED, V16, P767, DOI 10.1038/nm.2157; Zcharia E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005181; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zhou ZJ, 2004, CANCER RES, V64, P4699, DOI 10.1158/0008-5472.CAN-04-0810	50	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127032	10.1371/journal.pone.0127032	http://dx.doi.org/10.1371/journal.pone.0127032			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039697	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000355700700047
J	Parsons, JA; Bond, VA; Nixon, SA				Parsons, Janet A.; Bond, Virginia A.; Nixon, Stephanie A.			'Are We Not Human?' Stories of Stigma, Disability and HIV from Lusaka, Zambia and Their Implications for Access to Health Services	PLOS ONE			English	Article							PEOPLE; HIV/AIDS; ART	Background The advent of anti-retroviral therapy (ART) in Southern Africa holds the promise of shifting the experience of HIV toward that of a manageable chronic condition. However, this potential can only be realized when persons living with HIV are able to access services without barriers, which can include stigma. Our qualitative study explored experiences of persons living with disabilities (PWD) in Lusaka, Zambia who became HIV-positive (PWD/HIV+). Methods and Findings We conducted interviews with 32 participants (21 PWD/HIV+ and 11 key informants working in the fields of HIV and/or disability). Inductive thematic analysis of interview transcripts was informed by narrative theory. Participants' accounts highlighted the central role of stigma experienced by PWD/HIV+, with stigmatizing attitudes closely linked to prevailing societal assumptions that PWD are asexual. Seeking diagnostic and treatment services for HIV was perceived as evidence of PWD being sexually active. Participants recounted that for PWD/HIV+, stigma was enacted in a variety of settings, including the queue for health services, their interactions with healthcare providers, and within their communities. Stigmatizing accounts told about PWD/HIV+ were described as having important consequences. Not only did participants recount stories of internalized stigma (with its damaging effects on self-perception), but also that negative experiences resulted in some PWD preferring to "die quietly at home" rather than being subjected to the stigmatizing gaze of others when attempting to access life-preserving ART. Participants recounted how experiences of stigma also affected their willingness to continue ART, their willingness to disclose their HIV status to others, as well as their social relations. However, participants also offered counter-stories, actively resisting stigmatizing accounts and portraying themselves as resilient and resourceful social actors. Conclusions The study highlights a significant barrier to healthcare experienced by PWD/HIV+, with important implications for the future design and equitable delivery of HIV services in Zambia. Stigma importantly affects the abilities of PWD/HIV+ to manage their health conditions.	[Parsons, Janet A.] St Michaels Hosp, Appl Hlth Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Parsons, Janet A.; Nixon, Stephanie A.] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada; [Parsons, Janet A.; Nixon, Stephanie A.] Univ Toronto, Int Ctr Disabil & Rehabil, Toronto, ON, Canada; [Bond, Virginia A.] Univ Zambia, ZAMBART, Sch Med, Lusaka, Zambia; [Bond, Virginia A.] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Fac Publ Hlth & Policy, London WC1, England	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Zambia; University of London; London School of Hygiene & Tropical Medicine	Parsons, JA (corresponding author), St Michaels Hosp, Appl Hlth Res Ctr, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.	parsonsj@smh.ca			Canadian Institutes of Health Research; University of Toronto's Centre for Urban Health Initiatives; University of Toronto Dean's Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Toronto's Centre for Urban Health Initiatives; University of Toronto Dean's Fund(University of Toronto)	This study was funded by the Canadian Institutes of Health Research, the University of Toronto's Centre for Urban Health Initiatives, and the University of Toronto Dean's Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, DIS HIV POL BRIEF; Atkinson P, 2006, NARRAT INQ, V16, P164, DOI 10.1075/ni.16.1.21atk; Bamberg M., 2012, VARIETIES NARRATIVE, P99, DOI DOI 10.4135/9781506335117.n6; Bamberg Michael., 2004, CONSIDERING COUNTER, P351, DOI [DOI 10.1075/SIN.4.43BAM, 10.1075/sin.4.43bam]; Becker HS., 1963, OUTSIDERS STUDIES SO; Berube M., 1996, LIFE WE KNOW IT FATH; Bond V, 2006, J COMMUNITY APPL SOC, V16, P452, DOI 10.1002/casp.893; Bond VA, 2010, AIDS CARE, V22, P6, DOI 10.1080/09540121003720994; Boydell KM, 2000, QUAL HEALTH RES, V10, P26, DOI 10.1177/104973200129118228; Brockmeier J., 2012, OXFORD HDB CULTURE P, P439, DOI DOI 10.1093/OXFORDHB/9780195396430.013.0021; Butler-Kismer L, 2010, QUALITATIVE INQUIRY; Campbell C, 2006, J COMMUNITY APPL SOC, V16, P411, DOI 10.1002/casp.901; Collins T, 2009, STARZ REPORT MOBILIS; Deacon H, 2006, J COMMUNITY APPL SOC, V16, P418, DOI 10.1002/casp.900; Eakin JM, 2003, J EVAL CLIN PRACT, V9, P187, DOI 10.1046/j.1365-2753.2003.00392.x; Frank, 2002, INT J QUAL METH, V1, P109, DOI [10.1177/160940690200100102, DOI 10.1177/160940690200100102]; Frank A., 2016, VARIETIES NARRATIVE, P33, DOI DOI 10.4135/9781506335117.N3; Frank A. W., 2010, LETT STORIES BREATHE; Frank ArthurW, 2004, RENEWAL GENEROSITY; Frank AW., 2013, WOUNDED STORYTELLER; Garro L.C., 2000, NARRATIVE CULTURAL C, P1; Gibson BE, 2014, HEALTH-LONDON, V18, P95, DOI 10.1177/1363459313476967; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Goffman Erving, 1959, MISE SCENE VIE QUOTI; Groce N.E., 2004, GLOBAL SURVEY HIV AI; Groce NE, 2013, SOC SCI MED, V77, P31, DOI 10.1016/j.socscimed.2012.10.024; Hanass-Hancock J, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-28; Hanass-Hancock J, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-34; Howarth C, 2006, J COMMUNITY APPL SOC, V16, P442, DOI 10.1002/casp.898; Jackson Suzanne F, 2008, Prog Community Health Partnersh, V2, P161, DOI 10.1353/cpr.0.0010; Jha CK, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-16; Kuzel AJ., 1999, DOING QUALITATIVE RE, V2, P33, DOI DOI 10.1111/J.1365-2929.2006; Kvale S., 1996, INTERVIEWS; Levinas Emmanuel., 1999, ALTERITY TRANSCENDEN; Link BG, 2006, LANCET, V367, P528, DOI 10.1016/S0140-6736(06)68184-1; Loeb ME, 2008, ALTER, V2, P32, DOI 10.1016/j.alter.2007.06.001; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Momeyer RW, 2002, J MED PHILOS, V27, P403, DOI 10.1076/jmep.27.4.403.8611; Nelson HildeL., 2001, DAMAGED IDENTITIES N; Nixon SA, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18806; Njelesani J, AFRICAN J AIDS RES; Nyblade L, 2003, DISENTANGLING HIV AI; Nyblade L, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-15; Pamphilon B, 1999, QUAL INQ, V5, P393, DOI DOI 10.1177/107780049900500306; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Parsons J, 2013, EVAL PROGRAM PLANN, V36, P165, DOI 10.1016/j.evalprogplan.2012.03.003; Parsons JA, 2008, SOC SCI MED, V67, P1826, DOI 10.1016/j.socscimed.2008.09.011; Poteat T, 2013, SOC SCI MED, V84, P22, DOI 10.1016/j.socscimed.2013.02.019; Reissman CatherineKohler., 1993, NARRATIVE ANAL; Republic of Zambia NAC, 2012, ZAMB COUNTR REP MON; Ricoeur P, 1994, ONESELF ANOTHER; Rohleder P, 2009, DISABIL REHABIL, V31, P51, DOI 10.1080/09638280802280585; Samuels FA, 2011, AIDS CARE, V23, P748, DOI 10.1080/09540121.2010.532535; Sartorius N, 2004, EVERY FAMILY LAND, P373; Scambler G., 2004, SOC THEOR HEALTH, V2, P29, DOI [10.1057/palgrave.sth.8700012, DOI 10.1057/PALGRAVE.STH.8700012]; Scambler G, 2009, SOCIOL HEALTH ILL, V31, P441, DOI 10.1111/j.1467-9566.2009.01161.x; Seeley J, 2010, AIDS CARE, V22, P44, DOI 10.1080/09540121003605054; Shuman A, 2012, VARIETIES NARRATIVE, P125, DOI DOI 10.4135/9781506335117.N7; Smith B, 2008, QUAL RES, V8, P5, DOI 10.1177/1468794107085221; Toumayian AP, 2004, ENCOUNTERING OTHER A; United Nations (UN) General Assembly, 2007, CONV RIGHTS PERS DIS; Weiss MG, 2006, LANCET, V367, P536, DOI 10.1016/S0140-6736(06)68189-0; Weiss MG, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000237; Whitehead E., 2001, STIGMA SOCIAL EXCLUS; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Wickenden A, 2013, AFRICAN J DISABILITY, V2, P8; Yoshida K, 2014, DISABILITY REHABILIT, P1	67	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127392	10.1371/journal.pone.0127392	http://dx.doi.org/10.1371/journal.pone.0127392			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7ST	26039666	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000355700700059
J	Sanders, S; Doust, J; Glasziou, P				Sanders, Sharon; Doust, Jenny; Glasziou, Paul			A Systematic Review of Studies Comparing Diagnostic Clinical Prediction Rules with Clinical Judgment	PLOS ONE			English	Review							SUSPECTED PULMONARY-EMBOLISM; DEEP-VEIN THROMBOSIS; STRUCTURED DATA-COLLECTION; PRETEST PROBABILITY; D-DIMER; ACUTE APPENDICITIS; DECISION RULES; OUT CRITERIA; WELLS SCORE; PERFORMANCE	Background Diagnostic clinical prediction rules (CPRs) are developed to improve diagnosis or decrease diagnostic testing. Whether, and in what situations diagnostic CPRs improve upon clinical judgment is unclear. Methods and Findings We searched MEDLINE, Embase and CINAHL, with supplementary citation and reference checking for studies comparing CPRs and clinical judgment against a current objective reference standard. We report 1) the proportion of study participants classified as not having disease who hence may avoid further testing and or treatment and 2) the proportion, among those classified as not having disease, who do (missed diagnoses) by both approaches. 31 studies of 13 medical conditions were included, with 46 comparisons between CPRs and clinical judgment. In 2 comparisons (4%), CPRs reduced the proportion of missed diagnoses, but this was offset by classifying a larger proportion of study participants as having disease (more false positives). In 36 comparisons (78%) the proportion of diagnoses missed by CPRs and clinical judgment was similar, and in 9 of these, the CPRs classified a larger proportion of participants as not having disease (fewer false positives). In 8 comparisons (17%) the proportion of diagnoses missed by the CPRs was greater. This was offset by classifying a smaller proportion of participants as having the disease (fewer false positives) in 2 comparisons. There were no comparisons where the CPR missed a smaller proportion of diagnoses than clinical judgment and classified more participants as not having the disease. The design of the included studies allows evaluation of CPRs when their results are applied independently of clinical judgment. The performance of CPRs, when implemented by clinicians as a support to their judgment may be different. Conclusions In the limited studies to date, CPRs are rarely superior to clinical judgment and there is generally a trade-off between the proportion classified as not having disease and the proportion of missed diagnoses. Differences between the two methods of judgment are likely the result of different diagnostic thresholds for positivity. Which is the preferred judgment method for a particular clinical condition depends on the relative benefits and harms of true positive and false positive diagnoses.	[Sanders, Sharon; Doust, Jenny; Glasziou, Paul] Bond Univ, Ctr Res Evidence Based Practice, Gold Coast 4226, Australia	Bond University	Sanders, S (corresponding author), Bond Univ, Ctr Res Evidence Based Practice, Gold Coast 4226, Australia.	ssanders@bond.edu.au	Doust, Jenny/AGI-8773-2022; Glasziou, Paul/A-7832-2008	Doust, Jenny/0000-0002-4024-9308; Glasziou, Paul/0000-0001-7564-073X; Sanders, Sharon/0000-0001-7966-9708	Australian Postgraduate Award scholarship; National Health and Medical Research Council Program Grant; Screening and diagnostic Test Evaluation Program	Australian Postgraduate Award scholarship; National Health and Medical Research Council Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Screening and diagnostic Test Evaluation Program	SS received funding from an Australian Postgraduate Award scholarship and the Screening and diagnostic Test Evaluation Program which is supported by a National Health and Medical Research Council Program Grant (https://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEgisdottir S, 2006, COUNS PSYCHOL, V34, P341, DOI 10.1177/0011000005285875; Al Omar Mohammed Z, 2002, Emerg Radiol, V9, P88; Attia MW, 2001, ARCH PEDIAT ADOL MED, V155, P687, DOI 10.1001/archpedi.155.6.687; Auleley GR, 1997, JAMA-J AM MED ASSOC, V277, P1935; Bigaroni A, 2000, THROMB HAEMOSTASIS, V83, P788, DOI 10.1055/s-0037-1613912; Blattler Werner, 2004, Eur J Intern Med, V15, P305, DOI 10.1016/j.ejim.2004.06.001; Bojang KA, 2000, TROP MED INT HEALTH, V5, P231, DOI 10.1046/j.1365-3156.2000.00538.x; Broekhuizen BDL, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X601398; Carrier M, 2006, THROMB RES, V117, P469, DOI 10.1016/j.thromres.2005.04.005; CEBUL RD, 1986, JAMA-J AM MED ASSOC, V256, P3353, DOI 10.1001/jama.256.24.3353; Chagnon I, 2002, AM J MED, V113, P269, DOI 10.1016/S0002-9343(02)01212-3; Collins GS, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-40; Cornuz J, 2002, AM J MED, V112, P198, DOI 10.1016/S0002-9343(01)01110-X; Crowe L, 2010, ARCH DIS CHILD, V95, P1017, DOI 10.1136/adc.2009.174854; El-Solh AA, 1999, CHEST, V116, P968, DOI 10.1378/chest.116.4.968; EMERMAN CL, 1991, ANN EMERG MED, V20, P1215, DOI 10.1016/S0196-0644(05)81474-X; FENYO G, 1987, ACTA CHIR SCAND, V153, P545; Geersing GJ, 2010, BRIT J GEN PRACT, V60, P742, DOI 10.3399/bjgp10X532387; Gigerenzer G., 1999, SIMPLE HEURISTICS MA, P3; Glas AS, 2002, CAN MED ASSOC J, V166, P727; Kabrhel C, 2005, ACAD EMERG MED, V12, P915, DOI 10.1197/j.aem.2005.05.030; Kabrhel C, 2005, CHEST, V127, P1627, DOI 10.1378/chest.127.5.1627; Kabrhel C, 2009, ACAD EMERG MED, V16, P325, DOI 10.1111/j.1553-2712.2009.00368.x; Kline JA, 2008, J THROMB HAEMOST, V6, P772, DOI 10.1111/j.1538-7836.2008.02944.x; Korner H, 1998, BRIT J SURG, V85, P341; Leeflang MMG, 2013, CAN MED ASSOC J, V185, pE537, DOI 10.1503/cmaj.121286; LEIBOVICI L, 1991, ARCH INTERN MED, V151, P1801; Liu JLY, 2006, HEALTH TECHNOL ASSES, V10, P1; Meltzer AC, 2013, ANN EMERG MED, V62, P126, DOI 10.1016/j.annemergmed.2013.01.021; Miron MJ, 2000, J INTERN MED, V247, P249, DOI 10.1046/j.1365-2796.2000.00605.x; Mitchell AM, 2006, ANN EMERG MED, V47, P438, DOI 10.1016/j.annemergmed.2005.10.013; Moons KGM, 2012, CLIN CHEM, V58, P1408, DOI 10.1373/clinchem.2012.182550; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Penaloza A, 2013, ANN EMERG MED, V62, P117, DOI 10.1016/j.annemergmed.2012.11.002; Penaloza A, 2012, THROMB RES, V129, pE189, DOI 10.1016/j.thromres.2012.02.016; Rosenberg Paul, 2002, CJEM, V4, P178; Runyon MS, 2005, ACAD EMERG MED, V12, P587, DOI 10.1197/j.aem.2005.02.010; Sanson BJ, 2000, THROMB HAEMOSTASIS, V83, P199; Singh-Ranger G, 1999, Accid Emerg Nurs, V7, P201, DOI 10.1016/S0965-2302(99)80051-4; Stein J, 2005, ANN EMERG MED, V46, P412, DOI 10.1016/j.annemergmed.2005.05.020; Steyerberg E., 2009, CLIN PREDICTION MODE; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; Vaillancourt C, 2009, ANN EMERG MED, V54, P663, DOI 10.1016/j.annemergmed.2009.03.008; Wang B, 2013, BLOOD COAGUL FIBRIN, V24, P76, DOI 10.1097/MBC.0b013e32835aba49; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	47	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128233	10.1371/journal.pone.0128233	http://dx.doi.org/10.1371/journal.pone.0128233			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039538	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700090
J	El-Ahmir, SHM; Lim, SL; Lamont, BB; He, TH				El-ahmir, Sh-hoob Mohamed; Lim, Sim Lin; Lamont, Byron B.; He, Tianhua			Seed Size, Fecundity and Postfire Regeneration Strategy Are Interdependent in Hakea	PLOS ONE			English	Article							SHRUB BANKSIA-ATTENUATA; LARICINA C GARDNER; SPECIES COEXISTENCE; WESTERN-AUSTRALIA; MASS VARIATION; PROTEACEAE; FIRE; DISPERSAL; PATTERNS; PLANTS	Seed size is a key functional trait that affects plant fitness at the seedling stage and may vary greatly with species fruit size, growth form and fecundity. Using structural equation modelling (SEM) and correlated trait evolution analysis, we investigated the interaction network between seed size and fecundity, postfire regeneration strategy, fruit size, plant height and serotiny (on-plant seed storage) among 82 species of the woody shrub genus, Hakea, with a wide spectrum of seed sizes (2-500 mg). Seed size is negatively correlated with fecundity, while fire-killed species (nonsprouters) produce more seeds than resprouters though they are of similar size. Seed size is unrelated to plant height and level of serotiny while it scales allometrically with fruit size. A strong phylogenetic signal in seed size revealed phylogenetic constraints on seed size variation in Hakea. Our analyses suggest a causal relationship between seed size, fecundity and postfire regeneration strategy in Hakea. These results demonstrate that fruit size, fecundity and evolutionary history have had most control over seed size variation among Hakea species.	[El-ahmir, Sh-hoob Mohamed; Lim, Sim Lin; Lamont, Byron B.; He, Tianhua] Curtin Univ, Dept Environm & Agr, Perth, WA 6845, Australia	Curtin University	El-Ahmir, SHM (corresponding author), Curtin Univ, Dept Environm & Agr, Perth, WA 6845, Australia.	s.el-ahmir@postgrad.curtin.edu.au	Elahmie, Shhoob/AAG-2499-2020; He, Tianhua/Y-5372-2019	He, Tianhua/0000-0002-0924-3637; Lamont, Byron/0000-0001-9279-7149	Australian Research Council [DP120103389]; Libyan Government Scholarship; Curtin Research Fellowship	Australian Research Council(Australian Research Council); Libyan Government Scholarship; Curtin Research Fellowship	This paper is part of Sh-hoob M. El-ahmir's PhD study. This research was supported by the Australian Research Council (DP120103389) to TH and BL, a Libyan Government Scholarship to SME and a Curtin Research Fellowship to TH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, TROPICAL FOREST DIVE; Barker WR, 1999, FLORA AUSTR B, V17, P1; BELL DT, 1993, BOT REV, V59, P24, DOI 10.1007/BF02856612; CARPENTER FL, 1979, AM NAT, V113, P871, DOI 10.1086/283442; Clarke PJ, 2013, NEW PHYTOL, V197, P19, DOI 10.1111/nph.12001; Dickinson HG, 2009, BIOL REV, V84, P589, DOI 10.1111/j.1469-185X.2009.00088.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dubois J, 2012, ANN BOT-LONDON, V110, P1245, DOI 10.1093/aob/mcs203; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enright NJ, 2007, ECOLOGY, V88, P2292, DOI 10.1890/06-1343.1; ENRIGHT NJ, 1992, ACTA OECOL, V13, P727; Esther A, 2011, THEOR ECOL-NETH, V4, P495, DOI 10.1007/s12080-010-0092-y; Geritz SAH, 1999, THEOR POPUL BIOL, V55, P324, DOI 10.1006/tpbi.1998.1409; Gomez JM, 2004, EVOLUTION, V58, P71, DOI 10.1111/j.0014-3820.2004.tb01574.x; GREENE DF, 1994, ECOLOGY, V75, P642, DOI 10.2307/1941722; Groom PK, 2011, PLANT ECOL, V212, P2003, DOI 10.1007/s11258-011-9935-x; Groom PK, 2010, PLANT SOIL, V334, P61, DOI 10.1007/s11104-009-0135-6; Groom Philip K., 1996, P239; Groom PK, 1997, AUST J ECOL, V22, P352, DOI 10.1111/j.1442-9993.1997.tb00682.x; Groom PK, 1996, AUST J BOT, V44, P527, DOI 10.1071/BT9960527; HAMMOND DS, 1995, ECOLOGY, V76, P2544, DOI 10.2307/2265827; Hanley ME, 2009, ANN BOT-LONDON, V103, P1347, DOI 10.1093/aob/mcp081; Hanley ME, 2001, OECOLOGIA, V126, P409, DOI 10.1007/s004420000538; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; HARPER J. L., 1970, Annual review of ecology and systematics., V1, P327, DOI 10.1146/annurev.es.01.110170.001551; He TH, 2004, MOL ECOL, V13, P1099, DOI 10.1111/j.1365-294X.2004.02120.x; He TH, 2011, NEW PHYTOL, V191, P184, DOI 10.1111/j.1469-8137.2011.03663.x; He TH, 2009, ECOGRAPHY, V32, P571, DOI 10.1111/j.1600-0587.2008.05689.x; Hox J.J., 1999, FAMILY SCI REV, V11, P354, DOI DOI 10.1080/10705510903008345; Jakobsson A, 2000, OIKOS, V88, P494, DOI 10.1034/j.1600-0706.2000.880304.x; Kang H, 1999, PLANT SYST EVOL, V219, P151, DOI 10.1007/BF00985576; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; KHAN AM, 1976, AUST J BOT, V24, P783, DOI 10.1071/BT9760783; LAMONT B, 1985, AUST J BOT, V33, P139, DOI 10.1071/BT9850139; Lamont B. B., 2013, American Journal of Plant Sciences, V4, P30; Lamont BB, 2003, EVOL ECOL, V17, P277, DOI 10.1023/A:1025535223021; LAMONT BB, 1991, BOT GAZ, V152, P114, DOI 10.1086/337870; LAMONT BB, 1994, J APPL ECOL, V31, P137, DOI 10.2307/2404606; LAMONT BB, 1988, J ECOL, V76, P1069, DOI 10.2307/2260634; Lamont Byron B., 2000, Plant Species Biology, V15, P157, DOI 10.1046/j.1442-1984.2000.00036.x; Lamont Byron B., 1999, Diversity and Distributions, V5, P15, DOI 10.1046/j.1472-4642.1999.00032.x; LEISHMAN MR, 1995, J ECOL, V83, P517, DOI 10.2307/2261604; Mast AR, 2012, AM J BOT, V99, P472, DOI 10.3732/ajb.1100420; Merwin L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050974; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; Mooers AO, 1999, SYST BIOL, V48, P623, DOI 10.1080/106351599260193; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Pluess AR, 2005, OECOLOGIA, V144, P55, DOI 10.1007/s00442-005-0047-y; PRIMACK RB, 1987, ANNU REV ECOL SYST, V18, P409, DOI 10.1146/annurev.ecolsys.18.1.409; Rambaut A., 2014, TRACER V1 6; Rautio P, 2005, OIKOS, V111, P179, DOI 10.1111/j.0030-1299.2005.14045.x; Richards MB, 1996, OECOLOGIA, V107, P53, DOI 10.1007/BF00582234; Sauquet H, 2009, P NATL ACAD SCI USA, V106, P221, DOI 10.1073/pnas.0805607106; STOCK WD, 1989, FUNCT ECOL, V3, P453, DOI 10.2307/2389619; STOCK WD, 1991, NEW PHYTOL, V117, P109, DOI 10.1111/j.1469-8137.1991.tb00950.x; Susko DJ, 2000, AM J BOT, V87, P56, DOI 10.2307/2656685; Turnbull LA, 1999, J ECOL, V87, P899, DOI 10.1046/j.1365-2745.1999.00405.x; Vaughton G, 1998, J ECOL, V86, P563, DOI 10.1046/j.1365-2745.1998.00279.x; WESTOBY M, 1992, TRENDS ECOL EVOL, V7, P368, DOI 10.1016/0169-5347(92)90006-W; WESTOBY M, 1990, ECOLOGY, V71, P1307, DOI 10.2307/1938268; Young J. A., 2006, HAKEAS W AUSTR FIELD	62	10	10	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0129027	10.1371/journal.pone.0129027	http://dx.doi.org/10.1371/journal.pone.0129027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035821	Green Published, gold, Green Submitted			2022-12-27	WOS:000355699100065
J	Hill, JA; Lee, SY; Njambi, L; Corson, TW; Dimaras, H				Hill, Jessica A.; Lee, Su Yeon; Njambi, Lucy; Corson, Timothy W.; Dimaras, Helen			Cancer Genetics Education in a Low- to Middle-Income Country: Evaluation of an Interactive Workshop for Clinicians in Kenya	PLOS ONE			English	Article							PERSONALIZED MEDICINE; RETINOBLASTOMA; CARE; KNOWLEDGE; ATTITUDES	Background Clinical genetic testing is becoming an integral part of medical care for inherited disorders. While genetic testing and counseling are readily available in high-income countries, in low- and middle-income countries like Kenya genetic testing is limited and genetic counseling is virtually non-existent. Genetic testing is likely to become widespread in Kenya within the next decade, yet there has not been a concomitant increase in genetic counseling resources. To address this gap, we designed an interactive workshop for clinicians in Kenya focused on the genetics of the childhood eye cancer retinoblastoma. The objectives were to increase retinoblastoma genetics knowledge, build genetic counseling skills and increase confidence in those skills. Methods The workshop was conducted at the 2013 Kenyan National Retinoblastoma Strategy meeting. It included a retinoblastoma genetics presentation, small group discussion of case studies and genetic counseling role-play. Knowledge was assessed by standardized test, and genetic counseling skills and confidence by questionnaire. Results Knowledge increased significantly post-workshop, driven by increased knowledge of retinoblastoma causative genetics. One-year post-workshop, participant knowledge had returned to baseline, indicating that knowledge retention requires more frequent reinforcement. Participants reported feeling more confident discussing genetics with patients, and had integrated more genetic counseling into patient interactions. Conclusion A comprehensive retinoblastoma genetics workshop can increase the knowledge and skills necessary for effective retinoblastoma genetic counseling.	[Hill, Jessica A.; Dimaras, Helen] Hosp Sick Children, Dept Ophthalmol & Vis Sci, Toronto, ON M5G 1X8, Canada; [Lee, Su Yeon] Univ Toronto, Lab Med & Pathobiol Program, Toronto, ON, Canada; [Dimaras, Helen] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada; [Njambi, Lucy] Univ Nairobi, Dept Ophthalmol, Nairobi, Kenya; [Dimaras, Helen] Univ Nairobi, Dept Human Pathol, Nairobi, Kenya; [Corson, Timothy W.] Indiana Univ Sch Med, Dept Ophthalmol, Indianapolis, IN 46202 USA; [Corson, Timothy W.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Corson, Timothy W.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Nairobi; University of Nairobi; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Dimaras, H (corresponding author), Hosp Sick Children, Dept Ophthalmol & Vis Sci, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	helen.dimaras@utoronto.ca	Corson, Timothy W./B-6851-2009	Corson, Timothy W./0000-0002-1402-7875; Dimaras, Helen/0000-0003-1164-2001; Lee, Su Yeon/0000-0002-7306-7447	Canadian Gene Cure Foundation; Centre for International Experience, University of Toronto, through the Association of Universities and Colleges in Canada; National Institutes of Health National Center for Advancing Translational Sciences [KL2TR001106]; Research to Prevent Blindness, Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001106] Funding Source: NIH RePORTER	Canadian Gene Cure Foundation; Centre for International Experience, University of Toronto, through the Association of Universities and Colleges in Canada; National Institutes of Health National Center for Advancing Translational Sciences; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	JAH was supported by a Canadian Gene Cure Foundation grant to HD, http://genecure.ca/en/. SYL was supported by the Centre for International Experience, University of Toronto, through the Association of Universities and Colleges in Canada. TWC was supported by the National Institutes of Health National Center for Advancing Translational Sciences KL2TR001106 and by an unrestricted grant from Research to Prevent Blindness, Inc. http://www.ncats.nih.gov/; http://www.rpbusa.org/rpb/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biesecker BB, 1999, NAT GENET, V22, P133, DOI 10.1038/9641; Blacker J, 2005, POP STUD-J DEMOG, V59, P355, DOI 10.1080/00324720500281672; Blazer KR, 2011, GENET MED, V13, P832, DOI 10.1097/GIM.0b013e31821882b7; Carroll JC, 2009, CAN FAM PHYSICIAN, V55, pE92; Chantada GL, 2009, PEDIATR BLOOD CANCER, V53, P338, DOI 10.1002/pbc.21970; Dimaras H, 2008, OPHTHALMOLOGY ROUNDS, V6; Dimaras H, 2008, HUM MOL GENET, V17, P1363, DOI 10.1093/hmg/ddn024; Dimaras H, 2012, LANCET, V379, P1436, DOI 10.1016/S0140-6736(11)61137-9; Fashoyin-Aje L, 2013, ANN ONCOL, V24, P48, DOI 10.1093/annonc/mdt264; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Frueh FW, 2004, PHARMACOGENOMICS, V5, P571, DOI 10.1517/14622416.5.5.571; Gichigo EN, 2014, RETINOBLASTOMA IN KE; Ginsburg GS, 2009, TRANSL RES, V154, P277, DOI 10.1016/j.trsl.2009.09.005; He LQ, 2014, PUBLIC HEALTH GENOM, V17, P221, DOI 10.1159/000363645; Health MO, 2014, RETINOBLASTOMA BEST; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Muthoni A, 2010, HEALTH CARE WOMEN IN, V31, P801, DOI 10.1080/07399331003628453; Nyamori Joseph M, 2014, Middle East Afr J Ophthalmol, V21, P321, DOI 10.4103/0974-9233.142270; Nyamori JM, 2012, BRIT J OPHTHALMOL, V96, P141, DOI 10.1136/bjophthalmol-2011-300739; Rushlow DE, 2013, LANCET ONCOL, V14, P327, DOI 10.1016/S1470-2045(13)70045-7; UNICEF, 2012, KENYA STATISTICS; Weil J, 2002, EMBO REP, V3, P590, DOI 10.1093/embo-reports/kvf144; WHO, 2006, MEDICAL GENETICS SER; Yu CL, 2009, JNCI-J NATL CANCER I, V101, P581, DOI 10.1093/jnci/djp046	24	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0129852	10.1371/journal.pone.0129852	http://dx.doi.org/10.1371/journal.pone.0129852			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035834	Green Published, gold, Green Submitted			2022-12-27	WOS:000355699100074
J	Gong, Y; Cao, KW; Xu, JS; Li, JX; Hong, K; Cheng, XS; Su, H				Gong, Yi; Cao, Kai-wu; Xu, Jin-song; Li, Ju-xiang; Hong, Kui; Cheng, Xiao-shu; Su, Hai			Valuation of Normal Range of Ankle Systolic Blood Pressure in Subjects with Normal Arm Systolic Blood Pressure	PLOS ONE			English	Article							BRACHIAL INDEX; ASSOCIATION; MORTALITY; EXERCISE	Subject This study aimed to establish a normal range for ankle systolic blood pressure (SBP). Methods A total of 948 subjects who had normal brachial SBP (90-139 mmHg) at investigation were enrolled. Supine BP of four limbs was simultaneously measured using four automatic BP measurement devices. The ankle-arm difference (An-a) on SBP of both sides was calculated. Two methods were used for establishing normal range of ankle SBP: the 99% method was decided on the 99% reference range of actual ankle BP, and the An-a method was the sum of An-a and the low or up limits of normal arm SBP (90-139 mmHg). Results Whether in the right or left side, the ankle SBP was significantly higher than the arm SBP (right: 137.1 +/- 16.9 vs 119.7 +/- 11.4 mmHg, P<0.05). Based on the 99% method, the normal range of ankle SBP was 94 +/- 181 mmHg for the total population, 84 +/- 166 mmHg for the young (18-44 y), 107 +/- 176 mmHg for the middle-aged(45-59 y) and 113 +/- 179 mmHg for the elderly (>= 60y) group. As the An-a on SBP was 13mmHg in the young group and 20mmHg in both middle-aged and elderly groups, the normal range of ankle SBP on the An-a method was 103-153 mmHg for young and 110-160 mmHg for middle-elderly subjects. Conclusion A primary reference for normal ankle SBP was suggested as 100-165 mmHg in the young and 110-170 mmHg in the middle-elderly subjects.	[Gong, Yi; Cao, Kai-wu; Xu, Jin-song; Li, Ju-xiang; Hong, Kui; Cheng, Xiao-shu; Su, Hai] Nanchang Univ, Affiliated Hosp 2, Dept Cardiol, Nanchang, Jiangxi, Peoples R China	Nanchang University	Su, H (corresponding author), Nanchang Univ, Affiliated Hosp 2, Dept Cardiol, Nanchang, Jiangxi, Peoples R China.	suyihappy@sohu.com			National High Technology Research and Development Program of China (863 Program) [2012AA02A516]; Ministry of Chinese Education Innovation Team Development Plan [IRT1141]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Ministry of Chinese Education Innovation Team Development Plan	This work was supported by a grant from the National High Technology Research and Development Program of China (863 Program, No. 2012AA02A516) and the Ministry of Chinese Education Innovation Team Development Plan (IRT1141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboyans V, 2010, ATHEROSCLEROSIS, V211, P266, DOI 10.1016/j.atherosclerosis.2010.01.013; Bland JM, 1986, LANCET; Chen SC, 2012, CLIN J AM SOC NEPHRO, V7, P1646, DOI 10.2215/CJN.04570512; Drake MJP, 2013, ANAESTHESIA, V68, P461, DOI 10.1111/anae.12194; ENGVALL J, 1989, CLIN PHYSIOL, V9, P517, DOI 10.1111/j.1475-097X.1989.tb01005.x; Gemignani T, 2012, AM J HYPERTENS, V25, P1083, DOI 10.1038/ajh.2012.101; Hafner F, 2012, ANN THORAC SURG, V93, P1299, DOI 10.1016/j.athoracsur.2011.09.017; Hietanen H, 2010, J HUM HYPERTENS, V24, P577, DOI 10.1038/jhh.2009.102; Hietanen HJ, 2010, STROKE RES TREAT, V2010, DOI 10.4061/2010/729391; Jahangiri B, 2009, CAN J CARDIOL, V25, P111, DOI 10.1016/S0828-282X(09)70487-8; Jimenez M, 2014, ATHEROSCLEROSIS, V233, P72, DOI 10.1016/j.atherosclerosis.2013.12.021; Jones WS, 2014, AM HEART J, V167, P499, DOI 10.1016/j.ahj.2013.12.016; Moore C, 2008, ANAESTHESIA, V63, P1327, DOI 10.1111/j.1365-2044.2008.05633.x; O'Brien E, 2010, BLOOD PRESS MONIT, V15, P23, DOI 10.1097/MBP.0b013e3283360e98; Tarumi T, 2011, J HUM HYPERTENS, V25, P539, DOI 10.1038/jhh.2010.100	15	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0122248	10.1371/journal.pone.0122248	http://dx.doi.org/10.1371/journal.pone.0122248			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052703	Green Submitted, Green Published, gold			2022-12-27	WOS:000355955300004
J	Brown, PA; Akbari, A; Molnar, AO; Taran, S; Bissonnette, J; Sood, M; Hiremath, S				Brown, Pierre Antoine; Akbari, Ayub; Molnar, Amber O.; Taran, Shaurya; Bissonnette, Janice; Sood, Manish; Hiremath, Swapnil			Factors Associated with Unplanned Dialysis Starts in Patients followed by Nephrologists: A Retropective Cohort Study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; CHRONIC KIDNEY-DISEASE; SUBOPTIMAL INITIATION; REPLACEMENT THERAPY; CARE; SURVIVAL; MORTALITY; MODALITY; ACCESS	The number of patients starting dialysis is increasing world wide. Unplanned dialysis starts (patients urgently starting dialysis in hospital) is associated with increased costs and high morbidity and mortality. Risk factors for starting dialysis urgently in hospital have not been well studied. The primary objective of this study was to identify risk factors for unplanned dialysis starts in patients followed in a multidisciplinary chronic kidney disease (CKD) clinic. We performed a retrospective cohort study of 649 advanced CKD patients followed in a multidisciplinary CKD clinic at a tertiary care hospital from January 01, 2010 to April 30, 2013. Patients were classified as unplanned start (in hospital) or elective start. Multivariable logistic regression was used to identify variables associated with unplanned dialysis initiation. 184 patients (28.4%) initiated dialysis, of which 76 patients (41.3%) initiated dialysis in an unplanned fashion and 108 (58.7%) starting electively. Unplanned start patients were more likely to have diabetes (68.4% versus 51.9%; p = 0.04), CAD (42.1% versus 24.1%; p = 0.02), congestive heart failure (36.8% versus 17.6%; p = 0.01), and were less likely to receive modality education (64.5% vs 89.8%; p < 0.01) or be assessed by a surgeon for access creation (40.8% vesrus78.7% p < 0.01). On multivariable analysis, higher body mass index (OR 1.07, 95% CI 1.02, 1.13), and a history of congestive heart failure (OR 2.41, 95% CI 1.09, 5.41) were independently associated with an unplanned start. Unplanned dialysis initiation is common among advanced CKD patients, even if they are followed in a multidisciplinary chronic kidney disease clinic. Timely education and access creation in patients at risk may lead to lower costs and less morbidity and mortality.	[Brown, Pierre Antoine; Akbari, Ayub; Molnar, Amber O.; Bissonnette, Janice; Sood, Manish; Hiremath, Swapnil] Univ Ottawa, Div Nephrol, Dept Med, Ottawa, ON, Canada; [Brown, Pierre Antoine; Akbari, Ayub; Molnar, Amber O.; Bissonnette, Janice; Sood, Manish; Hiremath, Swapnil] Ottawa Hosp, Res Inst, Kidney Res Ctr, Ottawa, ON, Canada; [Akbari, Ayub; Molnar, Amber O.; Bissonnette, Janice; Sood, Manish; Hiremath, Swapnil] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Taran, Shaurya] Univ Ottawa, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Akbari, A (corresponding author), Univ Ottawa, Div Nephrol, Dept Med, Ottawa, ON, Canada.	aakbari@ottawahospital.on.ca	Sood, Manish M/H-3134-2019; Molnar, Amber/K-6093-2019; Hiremath, Swapnil/H-3492-2019; Taran, Shaurya/ABF-1571-2020; Brown, Pierre Antoine/L-2175-2019	Sood, Manish M/0000-0002-9146-2344; Hiremath, Swapnil/0000-0003-0010-3416; Brown, Pierre Antoine/0000-0002-0283-4530	Ottawa Hospital	Ottawa Hospital	An internal grant from The Ottawa Hospital was utilized for funding.	Avron J, 2002, ARCH INTERN MED, V162, P2002; Buck J, 2007, NEPHROL DIAL TRANSPL, V22, P3240, DOI 10.1093/ndt/gfm387; Cornelis T, 2013, HEMODIAL INT, V17, P639, DOI 10.1111/hdi.12042; Goransson LG, 2001, J INTERN MED, V250, P154, DOI 10.1046/j.1365-2796.2001.00869.x; Graham J, 2008, NEPHROL DIAL TRANSPL, V23, P3585, DOI 10.1093/ndt/gfn317; Hemmelgarn BR, 2007, J AM SOC NEPHROL, V18, P993, DOI 10.1681/ASN.2006080860; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hiremath S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028453; Hughes SA, 2013, NEPHROL DIAL TRANSPL, V28, P392, DOI 10.1093/ndt/gfs431; Lee H, 2002, AM J KIDNEY DIS, V40, P611, DOI 10.1053/ajkd.2002.34924; Lorenzo V, 2004, AM J KIDNEY DIS, V43, P999, DOI 10.1053/j.ajkd.2004.02.012; Mendelssohn DC, 2011, NEPHROL DIAL TRANSPL, V26, P2959, DOI 10.1093/ndt/gfq843; Mendelssohn DC, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-22; O'Hare AM, 2012, AM J KIDNEY DIS, V59, P513, DOI 10.1053/j.ajkd.2011.11.044; Perl J, 2011, J AM SOC NEPHROL, V22, P1113, DOI 10.1681/ASN.2010111155; Roderick P, 2002, NEPHROL DIAL TRANSPL, V17, P1252, DOI 10.1093/ndt/17.7.1252; Roubicek C, 2000, AM J KIDNEY DIS, V36, P35, DOI 10.1053/ajkd.2000.8241; Singhal R, 2014, KIDNEY INT, V86, P399, DOI 10.1038/ki.2014.16; Sud M, 2015, J AM SOC NEPHROL, V26, P715, DOI 10.1681/ASN.2014030253; Tennankore KK, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-72; Udayaraj UP, 2011, NEPHROL DIAL TRANSPL, V26, P3646, DOI 10.1093/ndt/gfr164; Winkelmayer WC, 2001, AM J KIDNEY DIS, V38, P1178, DOI 10.1053/ajkd.2001.29207; Zelmer JL, 2007, KIDNEY INT, V72, P1122, DOI 10.1038/sj.ki.5002459	23	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0130080	10.1371/journal.pone.0130080	http://dx.doi.org/10.1371/journal.pone.0130080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047510	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200172
J	Carbonelli, M; La Morgia, C; Savini, G; Cascavilla, ML; Borrelli, E; Chicani, F; Ramos, CD; Salomao, SR; Parisi, V; Sebag, J; Bandello, F; Sadun, AA; Carelli, V; Barboni, P				Carbonelli, Michele; La Morgia, Chiara; Savini, Giacomo; Cascavilla, Maria Lucia; Borrelli, Enrico; Chicani, Filipe; Ramos, Carolina do V. F.; Salomao, Solange R.; Parisi, Vincenzo; Sebag, Jerry; Bandello, Francesco; Sadun, Alfredo A.; Carelli, Valerio; Barboni, Piero			Macular Microcysts in Mitochondrial Optic Neuropathies: Prevalence and Retinal Layer Thickness Measurements	PLOS ONE			English	Article							NERVE-FIBER LAYER; INNER NUCLEAR LAYER; COHERENCE-TOMOGRAPHY; MULTIPLE-SCLEROSIS; ATROPHY; EDEMA; AGE; DEGENERATION; OPA1	Purpose To investigate the thickness of the retinal layers and to assess the prevalence of macular microcysts (MM) in the inner nuclear layer (INL) of patients with mitochondrial optic neuropathies (MON). Methods All patients with molecularly confirmed MON, i.e. Leber's Hereditary Optic Neuropathy (LHON) and Dominant Optic Atrophy (DOA), referred between 2010 and 2012 were enrolled. Eight patients with MM were compared with two control groups: MON patients without MM matched by age, peripapillary retinal nerve fiber layer (RNFL) thickness, and visual acuity, as well as age-matched controls. Retinal segmentation was performed using specific Optical coherence tomography (OCT) software (Carl Zeiss Meditec). Macular segmentation thickness values of the three groups were compared by one-way analysis of variance with Bonferroni post hoc corrections. Results MM were identified in 5/90 (5.6%) patients with LHON and 3/58 (5.2%) with DOA. The INL was thicker in patients with MON compared to controls regardless of the presence of MM [133.1 +/- 7 mu m vs 122.3 +/- 9 mu m in MM patients (p<0.01) and 128.5 +/- 8 mu m vs. 122.3 +/- 9 mu m in no-MM patients (p<0.05)], however the outer nuclear layer (ONL) was thicker in patients with MM (101.4 +/- 1m mu) compared to patients without MM [77.5v8m mu (p<0.001)] and controls 78.4 +/- 7m mu (p<0.001)]. ONL thickness did not significantly differ between patients without MM and controls. Conclusion The prevalence of MM in MON is low (5-6%), but associated with ONL thickening. We speculate that in MON patients with MM, vitreo-retinal traction contributes to the thickening of ONL as well as to the production of cystic spaces.	[Carbonelli, Michele; La Morgia, Chiara; Carelli, Valerio] Bellaria Hosp, IRCCS, Ist Sci Neurol Bologna, Bologna, Italy; [La Morgia, Chiara; Carelli, Valerio] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Neurol Unit, Bologna, Italy; [Savini, Giacomo; Parisi, Vincenzo] IRCCS, GB Bietti Fdn, Rome, Italy; [Cascavilla, Maria Lucia; Borrelli, Enrico; Bandello, Francesco; Barboni, Piero] Ist Sci San Raffaele, I-20132 Milan, Italy; [Chicani, Filipe; Ramos, Carolina do V. F.; Salomao, Solange R.] Univ Fed Sao Paulo, UNIFESP, Dept Ophthalmol, Sao Paulo, Brazil; [Sebag, Jerry; Sadun, Alfredo A.] Univ Calif Los Angeles, Doheny Eye Inst, Los Angeles, CA USA; [Sebag, Jerry] VMR Inst Vitreous Macula Retina, Huntington Beach, CA USA; [Barboni, Piero] Studio Oculist Azeglio, Bologna, Italy	AUSL di Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Universidade Federal de Sao Paulo (UNIFESP); Doheny Eye Institute; University of California System; University of California Los Angeles	Carbonelli, M (corresponding author), Bellaria Hosp, IRCCS, Ist Sci Neurol Bologna, Bologna, Italy.	m.carbonelli@studiodazeglio.it; p.barboni@studiodazeglio.it	Savini, Giacomo/J-9196-2018; bandello, francesco/AAH-2405-2019; Barboni, Piero/AAA-9936-2020; La Morgia, Chiara/H-6765-2012; Salomao, Solange R/G-9500-2012; Borrelli, Enrico/AAR-3693-2020; Parisi, Vincenzo/J-6137-2018; Sebag, J./AAF-3602-2020; Salomao, Solange/AAB-3234-2021	Savini, Giacomo/0000-0003-0075-3582; bandello, francesco/0000-0003-3238-9682; Barboni, Piero/0000-0002-0118-4177; Salomao, Solange R/0000-0002-3436-5599; Borrelli, Enrico/0000-0003-2815-5031; Salomao, Solange/0000-0002-3436-5599; CARELLI, VALERIO/0000-0003-4923-6404; Sebag, J/0000-0001-8648-5747; LA MORGIA, Chiara/0000-0002-4639-8929; Cascavilla, Maria Lucia/0000-0002-6344-5512	Italian Ministry of Health; Fondazione Roma; Telethon Italy [GGP06233]	Italian Ministry of Health(Ministry of Health, Italy); Fondazione Roma(Fondazione RomaEuropean Commission); Telethon Italy(Fondazione Telethon)	This work was supported by the Italian Ministry of Health (to VC, GS and VP) and Fondazione Roma (to GS and VP) and Telethon Italy, grant #GGP06233 (to VC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegg M, 2014, OPHTHALMOLOGY, V121, P142, DOI 10.1016/j.ophtha.2013.08.045; Abegg M, 2012, BRAIN, V135, DOI 10.1093/brain/aws215; Achilli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042242; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; APPIAH AP, 1988, AM J OPHTHALMOL, V106, P533, DOI 10.1016/0002-9394(88)90581-8; Balk LJ, 2012, BRAIN, V135, DOI 10.1093/brain/aws216; Barboni P, 2005, OPHTHALMOLOGY, V112, P120, DOI 10.1016/j.ophtha.2004.06.034; Barboni P, 2013, BRAIN, V136, DOI 10.1093/brain/awt014; Barboni P, 2011, OPHTHALMOLOGY, V118, P2076, DOI 10.1016/j.ophtha.2011.02.027; Caporali L, 2013, BBA-MOL BASIS DIS, V1832, P445, DOI 10.1016/j.bbadis.2012.12.002; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Chen KN, 2014, J BIOMED MATER RES A, V102, P2001, DOI 10.1002/jbm.a.34858; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Gelfand JM, 2013, JAMA NEUROL, V70, P629, DOI 10.1001/jamaneurol.2013.1832; Gelfand JM, 2012, BRAIN, V135, P1786, DOI 10.1093/brain/aws098; Gocho K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/676803; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Gupta P, 2011, BRIT J OPHTHALMOL, V95, P376, DOI 10.1136/bjo.2009.175109; Johnson MW, 2010, AM J OPHTHALMOL, V149, P371, DOI 10.1016/j.ajo.2009.11.022; Kaufhold F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071145; Kaushik M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078341; Knight OJ, 2012, ARCH OPHTHALMOL-CHIC, V130, P312, DOI 10.1001/archopthalmol.2011.1576; Maresca A, 2014, CURR MOL MED; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; Pau D, 2011, EYE, V25, P832, DOI 10.1038/eye.2011.81; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Ronnback C, 2014, OPHTHALMOLOGY, V121, pE30, DOI 10.1016/j.ophtha.2013.12.040; Saidha S, 2012, LANCET NEUROL, V11, P1021, DOI 10.1016/S1474-4422(12)70275-2; Saidha S, 2012, LANCET NEUROL, V11, P963, DOI 10.1016/S1474-4422(12)70213-2; Savini G, 2005, OPHTHALMOLOGY, V112, P127, DOI 10.1016/j.ophtha.2004.09.033; Schneider E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066151; Sebag J, 2009, Trans Am Ophthalmol Soc, V107, P35; SEBAG J, 1991, ARCH OPHTHALMOL-CHIC, V109, P966, DOI 10.1001/archopht.1991.01080070078039; Sebag J, 2012, VITREOUS VITREORETIN; Sebag J., 2002, CLIN OPHTHALMOLOGY, V5; Sebag J, 1989, VITREOUS STRUCTURE F; Strouthidis NG, 2009, INVEST OPHTH VIS SCI, V50, P4709, DOI 10.1167/iovs.09-3586; Sung KR, 2009, OPHTHALMOLOGY, V116, P1119, DOI 10.1016/j.ophtha.2009.01.004; Wang MY, 2009, RETINA-J RET VIT DIS, V29, P644, DOI 10.1097/IAE.0b013e31819e0d92; Wolff B, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/395189; Wolff B, 2013, RETINA-J RET VIT DIS, V33, P2133, DOI 10.1097/IAE.0b013e31828e68d0; Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002	42	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127906	10.1371/journal.pone.0127906	http://dx.doi.org/10.1371/journal.pone.0127906			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047507	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200032
J	Durrans, A; Gao, D; Gupta, R; Fischer, KR; Choi, H; El Rayes, T; Ryu, S; Nasar, A; Spinelli, CF; Andrews, W; Elemento, O; Nolan, D; Stiles, B; Rafii, S; Narula, N; Davuluri, R; Altorki, NK; Mittal, V				Durrans, Anna; Gao, Dingcheng; Gupta, Ravi; Fischer, Kari R.; Choi, Hyejin; El Rayes, Tina; Ryu, Seongho; Nasar, Abu; Spinelli, Cathy F.; Andrews, Weston; Elemento, Olivier; Nolan, Daniel; Stiles, Brendon; Rafii, Shahin; Narula, Navneet; Davuluri, Ramana; Altorki, Nasser K.; Mittal, Vivek			Identification of Reprogrammed Myeloid Cell Transcriptomes in NSCLC	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; LUNG-CANCER; TUMOR MICROENVIRONMENT; ISOFORM EXPRESSION; PROGENITOR CELLS; ANGIOGENESIS; RESISTANCE; THROMBOSPONDIN-1; OSTEOPONTIN; FIBROBLASTS	Lung cancer is the leading cause of cancer related mortality worldwide, with non-small cell lung cancer (NSCLC) as the most prevalent form. Despite advances in treatment options including minimally invasive surgery, CT-guided radiation, novel chemotherapeutic regimens, and targeted therapeutics, prognosis remains dismal. Therefore, further molecular analysis of NSCLC is necessary to identify novel molecular targets that impact prognosis and the design of new-targeted therapies. In recent years, tumor "activated/reprogrammed" stromal cells that promote carcinogenesis have emerged as potential therapeutic targets. However, the contribution of stromal cells to NSCLC is poorly understood. Here, we show increased numbers of bone marrow (BM)-derived hematopoietic cells in the tumor parenchyma of NSCLC patients compared with matched adjacent non-neoplastic lung tissue. By sorting specific cellular fractions from lung cancer patients, we compared the transcriptomes of intratumoral myeloid compartments within the tumor bed with their counterparts within adjacent non-neoplastic tissue from NSCLC patients. The RNA sequencing of specific myeloid compartments (immature monocytic myeloid cells and polymorphonuclear neutrophils) identified differentially regulated genes and mRNA isoforms, which were inconspicuous in whole tumor analysis. Genes encoding secreted factors, including osteopontin (OPN), chemokine (C-C motif) ligand 7 (CCL7) and thrombospondin 1 (TSP1) were identified, which enhanced tumorigenic properties of lung cancer cells indicative of their potential as targets for therapy. This study demonstrates that analysis of homogeneous stromal populations isolated directly from fresh clinical specimens can detect important stromal genes of therapeutic value.	[Durrans, Anna; Gao, Dingcheng; Fischer, Kari R.; Choi, Hyejin; El Rayes, Tina; Ryu, Seongho; Nasar, Abu; Spinelli, Cathy F.; Andrews, Weston; Stiles, Brendon; Altorki, Nasser K.; Mittal, Vivek] Cornell Univ, Weill Cornell Med Coll, Dept Cardiothorac Surg, New York, NY 10065 USA; [Durrans, Anna; Gao, Dingcheng; Fischer, Kari R.; Choi, Hyejin; El Rayes, Tina; Ryu, Seongho; Mittal, Vivek] Cornell Univ, Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA; [Durrans, Anna; Gao, Dingcheng; Fischer, Kari R.; Choi, Hyejin; El Rayes, Tina; Ryu, Seongho; Stiles, Brendon; Altorki, Nasser K.; Mittal, Vivek] Cornell Univ, Weill Cornell Med Coll, Neuberger Berman Lung Canc Ctr, New York, NY 10065 USA; [Gupta, Ravi; Davuluri, Ramana] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA; [Fischer, Kari R.; Choi, Hyejin; El Rayes, Tina] Cornell Univ, Weill Cornell Med Coll, Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA; [Nolan, Daniel; Rafii, Shahin] Cornell Univ, Weill Cornell Med Coll, HHMI, Dept Med Genet, New York, NY 10065 USA; [Elemento, Olivier] Cornell Univ, Weill Cornell Med Coll, Inst Computat Biomed, Dept Physiol & Biophys, New York, NY 10065 USA; [Narula, Navneet] Cornell Univ, Weill Cornell Med Coll, Dept Pathol, New York, NY 10065 USA	Cornell University; Cornell University; Cornell University; The Wistar Institute; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Howard Hughes Medical Institute; Cornell University; Cornell University	Altorki, NK (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Cardiothorac Surg, 1300 York Ave, New York, NY 10065 USA.	nkaltork@med.cornell.edu; vim2010@med.cornell.edu	Gao, Dingcheng/P-5889-2019; El Rayes, Tina/R-8202-2017; Choi, Hyejin/ABC-5099-2020; Choi, Hyejin/ABC-4915-2020; Gupta, Ravi/K-5977-2019	El Rayes, Tina/0000-0002-9935-388X; Choi, Hyejin/0000-0002-4884-2747; Choi, Hyejin/0000-0002-4884-2747; Gupta, Ravi/0000-0001-5242-9528; Andrews, Weston/0000-0003-3709-6838	Neuberger Berman Foundation Lung Cancer Center; Weill Cornell Cancer Center Pilot grant; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER	Neuberger Berman Foundation Lung Cancer Center; Weill Cornell Cancer Center Pilot grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funds from The Neuberger Berman Foundation Lung Cancer Center and Weill Cornell Cancer Center Pilot grant.	Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BAENZIGE.NL, 1971, P NATL ACAD SCI USA, V68, P240, DOI 10.1073/pnas.68.1.240; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Coffelt SB, 2010, AM J PATHOL, V176, P1564, DOI 10.2353/ajpath.2010.090786; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dai JX, 2010, CANCER IMMUNOL IMMUN, V59, P355, DOI 10.1007/s00262-009-0754-z; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Devy L, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/191670; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Firlej V, 2011, CANCER RES, V71, P7649, DOI 10.1158/0008-5472.CAN-11-0833; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Gao DC, 2012, CANCER RES, V72, P1384, DOI 10.1158/0008-5472.CAN-11-2905; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Goparaju CMV, 2010, J THORAC ONCOL, V5, P1516, DOI 10.1097/JTO.0b013e3181eba6bd; Haber DA, 2005, COLD SH Q B, V70, P419, DOI 10.1101/sqb.2005.70.043; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; Hattori K, 2001, J EXP MED, V193, P1005, DOI 10.1084/jem.193.9.1005; Haviv F, 2005, J MED CHEM, V48, P2838, DOI 10.1021/jm0401560; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Ito M, 2012, CHEST; JAFFE EA, 1985, BLOOD, V65, P79; JAFFE EA, 1983, P NATL ACAD SCI-BIOL, V80, P998, DOI 10.1073/pnas.80.4.998; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Jung DW, 2010, INT J CANCER, V127, P332, DOI 10.1002/ijc.25060; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kerber M, 2008, CANCER RES, V68, P7342, DOI 10.1158/0008-5472.CAN-07-6241; Kim H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-305; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x; Lo Iacono M, 2011, J THORAC ONCOL, V6, P473, DOI 10.1097/JTO.0b013e31820b86b0; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; MCPHERSON J, 1981, J BIOL CHEM, V256, P1330; Michalec L, 2002, J IMMUNOL, V168, P846, DOI 10.4049/jimmunol.168.2.846; Nakasone ES, 2012, CANCER CELL, V21, P488, DOI 10.1016/j.ccr.2012.02.017; Navab R, 2011, P NATL ACAD SCI USA, V108, P7160, DOI 10.1073/pnas.1014506108; Oliver TG, 2010, GENE DEV, V24, P837, DOI 10.1101/gad.1897010; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pal S, 2011, GENOME RES, V21, P1260, DOI 10.1101/gr.120535.111; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; RAUGI GJ, 1982, J CELL BIOL, V95, P351, DOI 10.1083/jcb.95.1.351; Rittling SR, 2004, BRIT J CANCER, V90, P1877, DOI 10.1038/sj.bjc.6601839; Ruffell B, 2012, P NATL ACAD SCI USA, V109, P2796, DOI 10.1073/pnas.1104303108; Schmid MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/201026; Shojaei F, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-26; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; TARABOLETTI G, 1987, J CELL BIOL, V105, P2409, DOI 10.1083/jcb.105.5.2409; Tomita M, 2011, ANTICANCER RES, V31, P2995; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang W, 2009, CLIN CANCER RES, V15, P6630, DOI 10.1158/1078-0432.CCR-09-1001; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Yuan A, 2001, J CLIN ONCOL, V19, P432, DOI 10.1200/JCO.2001.19.2.432; Zeng QH, 2005, CANCER CELL, V8, P13, DOI 10.1016/j.ccr.2005.06.004; Zhang J, 2010, PROG MOL BIOL TRANSL, V95, P31, DOI 10.1016/B978-0-12-385071-3.00003-4; Zochbauer-Muller S, 2002, ANNU REV PHYSIOL, V64, P681, DOI 10.1146/annurev.physiol.64.081501.155828	66	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129123	10.1371/journal.pone.0129123	http://dx.doi.org/10.1371/journal.pone.0129123			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046767	gold, Green Published, Green Submitted			2022-12-27	WOS:000355652200126
J	Alonzo, DA; Magarvey, NA; Schmeing, TM				Alonzo, Diego A.; Magarvey, Nathan A.; Schmeing, T. Martin			Characterization of Cereulide Synthetase, a Toxin-Producing Macromolecular Machine	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; IN-VITRO RECONSTITUTION; CARRIER PROTEIN DOMAINS; MBTH-LIKE PROTEINS; BACILLUS-CEREUS; EMETIC TOXIN; ASSEMBLY-LINE; ANTIBIOTIC VALINOMYCIN; BIOSYNTHETIC MACHINERY; CRYSTAL-STRUCTURE	Cereulide synthetase is a two-protein nonribosomal peptide synthetase system that produces a potent emetic toxin in virulent strains of Bacillus cereus. The toxin cereulide is a depsipeptide, as it consists of alternating aminoacyl and hydroxyacyl residues. The hydroxyacyl residues are derived from keto acid substrates, which cereulide synthetase selects and stereospecifically reduces with imbedded ketoreductase domains before incorporating them into the growing depsipeptide chain. We present an in vitro biochemical characterization of cereulide synthetase. We investigate the kinetics and side chain specificity of alpha-keto acid selection, evaluate the requirement of an MbtH-like protein for adenylation domain activity, assay the effectiveness of vinylsulfonamide inhibitors on ester-adding modules, perform NADPH turnover experiments and evaluate in vitro depsipeptide biosynthesis. This work also provides biochemical insight into depsipeptide-synthesizing nonribosomal peptide synthetases responsible for other bioactive molecules such as valinomycin, antimycin and kutzneride.	[Alonzo, Diego A.; Schmeing, T. Martin] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Magarvey, Nathan A.] McMaster Univ, MG DeGroote Inst Infect Dis Res, Dept Chem & Chem Biol, Hamilton, ON L8N 3Z5, Canada; [Schmeing, T. Martin] McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada	McGill University; McMaster University; McGill University	Schmeing, TM (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada.	martin.schmeing@mcgill.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant [418420-12]; CIHR Operating Grant [MOP 106708]; Human Frontiers Science Program Organization Career Development Award; Tier 2 Canada Research Chair (CRC) in Macromolecular Machines; CRC in Natural Products and Chemical Biology; Fonds de la recherche du Quebec - nature et technologies; Consejo Nacional de Ciencia y Tecnologia (CONACYT); Secretaria de Relaciones Exteriores; CIHR Chemical Biology Scholarship; GRASP	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR Operating Grant(Canadian Institutes of Health Research (CIHR)); Human Frontiers Science Program Organization Career Development Award; Tier 2 Canada Research Chair (CRC) in Macromolecular Machines; CRC in Natural Products and Chemical Biology; Fonds de la recherche du Quebec - nature et technologies; Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Secretaria de Relaciones Exteriores; CIHR Chemical Biology Scholarship(Canadian Institutes of Health Research (CIHR)); GRASP	This research was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant 418420-12 awarded to TMS and CIHR Operating Grant MOP 106708 to NAM, a Human Frontiers Science Program Organization Career Development Award to TMS, a Tier 2 Canada Research Chair (CRC) in Macromolecular Machines held by TMS and a CRC in Natural Products and Chemical Biology to NAM. Additional support came from studentships to DAA from the Fonds de la recherche du Quebec - nature et technologies, from Consejo Nacional de Ciencia y Tecnologia (CONACYT), from Secretaria de Relaciones Exteriores, CIHR Chemical Biology Scholarship, and GRASP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATA N, 1995, FEMS MICROBIOL LETT, V129, P17, DOI 10.1016/0378-1097(95)00119-P; AGATA N, 1994, FEMS MICROBIOL LETT, V121, P31, DOI 10.1016/0378-1097(94)90141-4; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Boll B, 2011, J BIOL CHEM, V286, P36281, DOI 10.1074/jbc.M111.288092; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; Chalut C, 2006, P NATL ACAD SCI USA, V103, P8511, DOI 10.1073/pnas.0511129103; COLE FX, 1970, BIOCHEMISTRY-US, V9, P480, DOI 10.1021/bi00805a005; Condurso HL, 2012, NAT PROD REP, V29, P1099, DOI 10.1039/c2np20023f; Dierick K, 2005, J CLIN MICROBIOL, V43, P4277, DOI 10.1128/JCM.43.8.4277-4279.2005; Drake EJ, 2007, J BIOL CHEM, V282, P20425, DOI 10.1074/jbc.M611833200; DUGAN RE, 1971, J BIOL CHEM, V246, P637; Ehling-Schulz M, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-20; Ekman JV, 2012, MICROBIOL-SGM, V158, P1106, DOI 10.1099/mic.0.053520-0; Felnagle EA, 2010, BIOCHEMISTRY-US, V49, P8815, DOI 10.1021/bi1012854; Fujimori DG, 2007, P NATL ACAD SCI USA, V104, P16498, DOI 10.1073/pnas.0708242104; Gaitatzis N, 2001, P NATL ACAD SCI USA, V98, P11136, DOI 10.1073/pnas.201167098; Hoyer KM, 2007, CHEM BIOL, V14, P13, DOI 10.1016/j.chembiol.2006.10.011; Jaitzig J, 2014, ACS SYNTH BIOL, V3, P432, DOI 10.1021/sb400082j; Keating TA, 2000, BIOCHEMISTRY-US, V39, P15522, DOI 10.1021/bi0016523; Kjaerulff L, 2013, MAR DRUGS, V11, P5051, DOI 10.3390/md11125051; Kotiranta A, 2000, MICROBES INFECT, V2, P189, DOI 10.1016/S1286-4579(00)00269-0; Li J, 2014, APPL MICROBIOL BIOT, V98, P591, DOI 10.1007/s00253-013-5309-8; Li X, 2013, BIOORG MED CHEM LETT, V23, P5123, DOI 10.1016/j.bmcl.2013.07.031; Liu Y, 2011, CHEM BIOL, V18, P1482, DOI 10.1016/j.chembiol.2011.09.018; Maass S, 2011, ANAL CHEM, V83, P2677, DOI 10.1021/ac1031836; Magarvey NA, 2006, J AM CHEM SOC, V128, P10698, DOI 10.1021/ja0640187; Makarasen A, 2009, SYNTHESIS-STUTTGART, P2184, DOI 10.1055/s-0029-1216837; Marahiel MA, 2009, J PEPT SCI, V15, P799, DOI 10.1002/psc.1183; McQuade TJ, 2009, ANAL BIOCHEM, V386, P244, DOI 10.1016/j.ab.2008.12.014; Mikkola R, 1999, EUR J BIOCHEM, V263, P112, DOI 10.1046/j.1432-1327.1999.00476.x; Miller DA, 2002, CHEM BIOL, V9, P333, DOI 10.1016/S1074-5521(02)00115-1; Mitchell CA, 2012, BIOCHEMISTRY-US, V51, P3252, DOI 10.1021/bi300112e; Pitchayawasin S, 2004, INT J MASS SPECTROM, V235, P123, DOI 10.1016/j.ijms.2004.04.007; Qiao CH, 2007, J AM CHEM SOC, V129, P6350, DOI 10.1021/ja069201e; Rajkovic A, 2008, LETT APPL MICROBIOL, V46, P536, DOI 10.1111/j.1472-765X.2008.02350.x; Sandy M, 2012, ACS CHEM BIOL, V7, P1956, DOI 10.1021/cb300416w; Sattely ES, 2008, NAT PROD REP, V25, P757, DOI 10.1039/b801747f; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Stawikowski Maciej, 2007, V386, P321, DOI 10.1007/978-1-59745-430-8_13; Strieker M, 2010, CURR OPIN STRUC BIOL, V20, P234, DOI 10.1016/j.sbi.2010.01.009; Sundlov JA, 2012, CHEM BIOL, V19, P188, DOI 10.1016/j.chembiol.2011.11.013; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Vanner SA, 2013, MOL BIOSYST, V9, P2712, DOI 10.1039/c3mb70219g; Walsh CT, 2001, CURR OPIN CHEM BIOL, V5, P525, DOI 10.1016/S1367-5931(00)00235-0; Wang M, 2009, BIOORG MED CHEM LETT, V19, P1413, DOI 10.1016/j.bmcl.2009.01.040; Weckwerth W, 2000, J BIOL CHEM, V275, P17909, DOI 10.1074/jbc.M001084200; Wilson DJ, 2013, BIOCHEMISTRY-US, V52, P926, DOI 10.1021/bi301330q; Wilson DJ, 2010, ANAL BIOCHEM, V404, P56, DOI 10.1016/j.ab.2010.04.033; Xu YQ, 2009, FUNGAL GENET BIOL, V46, P353, DOI 10.1016/j.fgb.2009.03.001	51	19	22	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128569	10.1371/journal.pone.0128569	http://dx.doi.org/10.1371/journal.pone.0128569			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042597	Green Submitted, Green Published, gold			2022-12-27	WOS:000355701600054
J	Carreira, MAMQ; Nogueira, AB; Pena, FM; Kiuchi, MG; Rodrigues, RC; Rodrigues, RR; Matos, JPS; Lugon, JR				Carreira, Maria Angela M. Q.; Nogueira, Andre B.; Pena, Felipe M.; Kiuchi, Marcio G.; Rodrigues, Ronaldo C.; Rodrigues, Rodrigo R.; Matos, Jorge P. S.; Lugon, Jocemir R.			Detection of Autonomic Dysfunction in Hemodialysis Patients Using the Exercise Treadmill Test: The Role of the Chronotropic Index, Heart Rate Recovery, and R-R Variability	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RATE RESPONSE; INCOMPETENCE; CONSEQUENCES; PREDICTOR; DETERMINANTS; ACTIVATION; MORTALITY; STATEMENT; FAILURE	Autonomic dysfunction is highly prevalent in hemodialysis patients and has been implicated in their increased risk of cardiovascular mortality. Objective To evaluate the ability of different parameters of exercise treadmill test to detect autonomic dysfunction in hemodialysis patients. Methods Cross-sectional study involving hemodialysis patients and a control group. Clinical examination, blood sampling, echocardiogram, 24-hour Holter, and exercise treadmill test were performed. A ramp treadmill protocol symptom-limited with active recovery was employed. Results Forty-one hemodialysis patients and 41 controls concluded the study. There was significant difference between hemodialysis patients and controls in autonomic function parameters in 24h-Holter and exercise treadmill test. Probability of having autonomic dysfunction in hemodialysis patients compared to controls was 29.7 at the exercise treadmill test and 13.0 in the 24-hour Holter. Chronotropic index, heart rate recovery at the 1st min, and SDNN at exercise were used to develop an autonomic dysfunction score to grade autonomic dysfunction, in which, 83% of hemodialysis patients reached a scoring >= 2 in contrast to 20% of controls. Hemodialysis was independently associated with either altered chronotropic index or autonomic dysfunction scoring >= 2 in every tested model (OR=50.1, P=0.003; and OR=270.9, P=0.002, respectively, model 5). Conclusion The exercise treadmill test was feasible and useful to diagnose of the autonomic dysfunction in hemodialysis patients. Chronotropic index and autonomic dysfunction scoring >= 2 were the most effective parameters to differentiate between hemodialysis patients and controls suggesting that these variables portrays the best ability to detect autonomic dysfunction in this setting.	[Carreira, Maria Angela M. Q.; Nogueira, Andre B.; Pena, Felipe M.; Rodrigues, Ronaldo C.; Rodrigues, Rodrigo R.] Univ Fed Fluminense, Dept Med, Div Cardiol, Sch Med, Rio De Janeiro, Brazil; [Kiuchi, Marcio G.; Rodrigues, Rodrigo R.; Matos, Jorge P. S.; Lugon, Jocemir R.] Univ Fed Fluminense, Sch Med, Div Nephrol, Dept Med, Rio De Janeiro, Brazil	Universidade Federal Fluminense; Universidade Federal Fluminense	Carreira, MAMQ (corresponding author), Univ Fed Fluminense, Dept Med, Div Cardiol, Sch Med, Rio De Janeiro, Brazil.	macarreira@globo.com	Lugon, Jocemir/G-4187-2019	Lugon, Jocemir/0000-0001-6791-3910	Fundacao de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Fundacao de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This research was all supported by Fundacao de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ) in doctoral program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, INT J CARDIOL, DOI DOI 10.1016/j.ijcard.2007.10.033; Bonanni A, 2011, INT J ENV RES PUB HE, V8, P1631, DOI 10.3390/ijerph8051631; Brotman DJ, 2010, J AM SOC NEPHROL, V21, P1560, DOI 10.1681/ASN.2009111112; Brubaker PH, 2011, CIRCULATION, V123, P1010, DOI 10.1161/CIRCULATIONAHA.110.940577; Chan CT, 2010, CLIN J AM SOC NEPHRO, V5, P1821, DOI 10.2215/CJN.03080410; Elhendy A, 2003, J AM COLL CARDIOL, V42, P823, DOI 10.1016/S0735-1097(03)00832-5; Foster MC, 2013, AM HEART J, V166, P150, DOI 10.1016/j.ahj.2013.03.016; Fotbolcu H, 2011, AM J NEPHROL, V33, P491, DOI 10.1159/000327829; Fukuta H, 2003, NEPHROL DIAL TRANSPL, V18, P318, DOI 10.1093/ndt/18.2.318; Gayda M, 2012, CAN J CARDIOL, V28, P201, DOI 10.1016/j.cjca.2011.12.004; Herzog CA, 2008, SEMIN DIALYSIS, V21, P300, DOI 10.1111/j.1525-139X.2008.00455.x; Huang PH, 2006, HEART, V92, P609, DOI 10.1136/hrt.2005.064147; Ie EHY, 2006, NEPHROL DIAL TRANSPL, V21, P1474, DOI 10.1093/ndt/gfl167; Ikizler TA, 2013, KIDNEY INT, V84, P1096, DOI 10.1038/ki.2013.147; Jae SY, 2009, MOL MED, V15, P291, DOI 10.2119/molmed.2009.00057; Jakubovic BD, 2013, CAN J CARDIOL, V29, P384, DOI 10.1016/j.cjca.2012.07.013; Jofre R, 2006, J AM SOC NEPHROL, V17, pS274, DOI 10.1681/ASN.2006080926; Joles JA, 2004, HYPERTENSION, V43, P699, DOI 10.1161/01.HYP.0000121881.77212.b1; Kesoi I, 2010, NEPHROL DIAL TRANSPL, V25, P509, DOI 10.1093/ndt/gfp504; Khan MN, 2005, AM J CARDIOL, V96, P1328, DOI 10.1016/j.amjcard.2005.06.082; Lentine KL, 2012, J AM COLL CARDIOL, V60, P434, DOI 10.1016/j.jacc.2012.05.008; Lugon Jocemir R, 2003, Hemodial Int, V7, P198, DOI 10.1046/j.1492-7535.2003.00038.x; Maddox TM, 2008, AM HEART J, V156, P736, DOI 10.1016/j.ahj.2008.05.025; Messias LR, 2012, ARQ BRAS CARDIOL, V98, P398, DOI 10.1590/S0066-782X2012005000027; Messias LR, 2011, ARQ BRAS CARDIOL, V96, P370, DOI 10.1590/S0066-782X2011005000044; Messias LR, 2010, REV BRAS CARDIOL, V23, P244; Myers J, 2007, EUR J CARDIOV PREV R, V14, P215, DOI 10.1097/HJR.0b013e328088cb92; NOBREGA ACL, 1993, MED SCI SPORT EXER, V25, P37; Painter P, 2009, ADV CHRONIC KIDNEY D, V16, P437, DOI 10.1053/j.ackd.2009.09.002; Ranpuria R, 2008, NEPHROL DIAL TRANSPL, V23, P444, DOI 10.1093/ndt/gfm634; Routledge HC, 2006, HEART, V92, P577, DOI 10.1136/hrt.2005.079400; Rubinger D, 2004, NEPHROL DIAL TRANSPL, V19, P2053, DOI 10.1093/ndt/gfh306; Savonen KP, 2008, AM J CARDIOL, V101, P992, DOI 10.1016/j.amjcard.2007.11.045; Sesso Ricardo de Castro Cintra, 2012, J Bras Nefrol, V34, P272; Sharain K, 2013, CLIN APPL THROMB-HEM, V19, P303, DOI 10.1177/1076029612454935; Shetler K, 2001, J AM COLL CARDIOL, V38, P1980, DOI 10.1016/S0735-1097(01)01652-7; Meneghelo RS, 2010, Arq. Bras. Cardiol., V95, P1, DOI 10.1590/S0066-782X2010000800001; Stenvinkel P, 2000, NEPHROL DIAL TRANSPL, V15, P953, DOI 10.1093/ndt/15.7.953; United States Renal Data System, 2012, USRDS 2012 ANNUAL DA, P247; Vivekananthan DP, 2003, J AM COLL CARDIOL, V42, P831, DOI 10.1016/S0735-1097(03)00833-7	40	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128123	10.1371/journal.pone.0128123	http://dx.doi.org/10.1371/journal.pone.0128123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042678	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600035
J	Lin, JG; Hsieh, CL; Lin, YW				Lin, Jaung-Geng; Hsieh, Ching-Liang; Lin, Yi-Wen			Analgesic Effect of Electroacupuncture in a Mouse Fibromyalgia Model: Roles of TRPV1, TRPV4, and pERK	PLOS ONE			English	Article							MEDIATE MECHANICAL HYPERALGESIA; RECEPTOR POTENTIAL VANILLOID-4; CAPSAICIN-RECEPTOR; MUSCLE PAIN; NEUROPATHIC PAIN; ION CHANNELS; ACTIVATION; EXPRESSION; NEURONS; KINASE	Fibromyalgia (FM) is among the most common chronic pain syndromes encountered in clinical practice, but there is limited understanding of FM pathogenesis. We examined the contribution of transient receptor potential vanilloid 1 (TRPV1) and TRPV4 channels to chronic pain in the repeated acid injection mouse model of FM and the potential therapeutic efficacy of electroacupuncture. Electroacupuncture (EA) at the bilateral Zusanli (ST36) acupoint reduced the long-lasting mechanical hyperalgesia induced by repeated acid saline (pH 4) injection in mouse hindpaw. Isolated L5 dorsal root ganglion (DRG) neurons from FM model mice (FM group) were hyperexcitable, an effect reversed by EA pretreatment (FM + EA group). The increase in mechanical hyperalgesia was also accompanied by upregulation of TRPV1 expression and phosphoactivation of extracellular signal regulated kinase (pERK) in the DRG, whereas DRG expression levels of TRPV4, p-p38, and p-JNK were unaltered. Blockade of TRPV1, which was achieved using TRPV1 knockout mice or via antagonist injection, and pERK suppressed development of FM-like pain. Both TRPV1 and TRPV4 protein expression levels were increased in the spinal cord (SC) of model mice, and EA at the ST36 acupoint decreased overexpression. This study strongly suggests that DRG TRPV1 overexpression and pERK signaling, as well as SC TRPV1 and TRPV4 overexpression, mediate hyperalgesia in a mouse FM pain model. The therapeutic efficacy of EA may result from the reversal of these changes in pain transmission pathways.	[Lin, Jaung-Geng] China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung 40402, Taiwan; [Hsieh, Ching-Liang] China Med Univ, Grad Inst Integrat Med, Coll Chinese Med, Taichung 40402, Taiwan; [Hsieh, Ching-Liang] China Med Univ Hosp, Dept Chinese Med, Taichung 40402, Taiwan; [Hsieh, Ching-Liang; Lin, Yi-Wen] China Med Univ, Res Ctr Chinese Med & Acupuncture, Taichung 40402, Taiwan; [Lin, Yi-Wen] China Med Univ, Grad Inst Acupuncture Sci, Coll Chinese Med, Taichung 40402, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan	Lin, YW (corresponding author), China Med Univ, Res Ctr Chinese Med & Acupuncture, Taichung 40402, Taiwan.	yiwenlin@mail.cmu.edu.tw	Lin, Yi-Wen/O-3541-2015	Lin, Yi-Wen/0000-0001-7204-8837	CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan [NSC 101-2320-B-039-014-MY3, CMU103-TC-01]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW103-TDU-B-212-113002, DOH102-TD-B-111-004]	CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This study was supported by CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan, NSC 101-2320-B-039-014-MY3, CMU103-TC-01, and in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002 and DOH102-TD-B-111-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham TS, 2011, J CHEM NEUROANAT, V41, P129, DOI 10.1016/j.jchemneu.2011.01.001; Alessandri-Haber N, 2005, PAIN, V118, P70, DOI 10.1016/j.pain.2005.07.016; Alessandri-Haber N, 2004, J NEUROSCI, V24, P4444, DOI 10.1523/JNEUROSCI.0242-04.2004; Alessandri-Haber N, 2008, J NEUROSCI, V28, P1046, DOI 10.1523/JNEUROSCI.4497-07.2008; Alessandri-Haber N, 2009, J NEUROSCI, V29, P6217, DOI 10.1523/JNEUROSCI.0893-09.2009; Brierley SM, 2008, GASTROENTEROLOGY, V134, P2059, DOI 10.1053/j.gastro.2008.01.074; Carlton SM, 2009, BRAIN RES, V1248, P86, DOI 10.1016/j.brainres.2008.10.066; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Ceppa E, 2010, AM J PHYSIOL-GASTR L, V299, pG556, DOI 10.1152/ajpgi.00433.2009; Chen WH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/636848; Chen WH, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-82; Chen WN, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-30; Chen WK, 2010, J NEUROSCI, V30, P10360, DOI 10.1523/JNEUROSCI.1041-10.2010; Chen Y, 2011, NEUROSCIENCE, V193, P440, DOI 10.1016/j.neuroscience.2011.06.085; Cheng SJ, 2011, J NEUROSCI, V31, P2258, DOI 10.1523/JNEUROSCI.5564-10.2011; Christoph T, 2008, MOL CELL NEUROSCI, V37, P579, DOI 10.1016/j.mcn.2007.12.006; Chu KL, 2011, BRAIN RES, V1369, P158, DOI 10.1016/j.brainres.2010.10.101; Ding XL, 2010, BEHAV BRAIN RES, V208, P194, DOI 10.1016/j.bbr.2009.11.034; Eid S R, 2009, Handb Exp Pharmacol, P261, DOI 10.1007/978-3-540-79090-7_8; Facer P, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-11; Fernandes ES, 2011, DISTINCT ROLE TRANSI; Fujii Y, 2008, PAIN, V140, P292, DOI 10.1016/j.pain.2008.08.013; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; Goldman N, 2010, NAT NEUROSCI, V13, P883, DOI 10.1038/nn.2562; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; Han JS, 2003, TRENDS NEUROSCI, V26, P17, DOI 10.1016/S0166-2236(02)00006-1; Hurt JK, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-28; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Kondo T, 2013, NEUROREPORT, V24, P68, DOI 10.1097/WNR.0b013e32835c7df2; Lin CCJ, 2012, P NATL ACAD SCI USA, V109, pE76, DOI 10.1073/pnas.1108903108; Lin JG, 2002, PAIN, V99, P509, DOI 10.1016/S0304-3959(02)00261-0; Lund JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011131; Manjavachi MN, 2010, PAIN, V151, P345, DOI 10.1016/j.pain.2010.07.018; Mense S, 2008, DTSCH ARZTEBL INT, V105, P214, DOI 10.3238/artzebl.2008.0214; Mezey E, 2000, P NATL ACAD SCI USA, V97, P3655, DOI 10.1073/pnas.060496197; Monteith TS, 2011, CURR TREAT OPTION NE, V13, P1, DOI 10.1007/s11940-010-0105-6; Nielsen AN, 2004, EUR J PHARMACOL, V487, P93, DOI 10.1016/j.ejphar.2004.01.017; Ro JY, 2009, PAIN, V144, P270, DOI 10.1016/j.pain.2009.04.021; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Sluka KA, 2001, MUSCLE NERVE, V24, P37, DOI 10.1002/1097-4598(200101)24:1<37::AID-MUS4>3.0.CO;2-8; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; von Banchet GS, 2013, MOL CELL NEUROSCI, V52, P152, DOI 10.1016/j.mcn.2012.11.006; Wei XM, 2011, CEPHALALGIA, V31, P1595, DOI 10.1177/0333102411427600; Yu L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-61; Zhang ZD, 2012, ANESTH ANALG, V114, P879, DOI 10.1213/ANE.0b013e318246536d; Zhuang ZY, 2006, J NEUROSCI, V26, P3551, DOI 10.1523/JNEUROSCI.5290-05.2006	48	18	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128037	10.1371/journal.pone.0128037	http://dx.doi.org/10.1371/journal.pone.0128037			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043006	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600030
J	Zhang, WF; Chen, DW; Xu, YH; Yang, RL; Zhao, ZY				Zhang, Weifang; Chen, Dingwan; Xu, Yanhua; Yang, Rulai; Zhao, Zhengyan			Mortality Rate for Children under 5 Years of Age in Zhejiang Province, China from 1997 to 2012	PLOS ONE			English	Article							VITAL-STATISTICS; DEATHS	Objectives This is a population based descriptive study that examined the trends in childhood mortality among under five children and the major causes under five mortality in Zhejiang Province, China. Methods A population-based survey was conducted through a province-level surveillance network. The mortality rate and leading causes of death for children under 5 years of age were analyzed. The trend in the mortality rate for children under five and cause-specific mortality rates were analyzed by chi-square with SPSS 13.0 software. Results In Zhejiang Province, during 1997-2012, mortality rates in neonates, postneonatal infants, and children under 5 years were reduced by 64.2% (from 7.85 to 2.81 per 1000 livebirths), 66.7% (from 12.73 to 4.24 per 1000 livebirths), and 63% (from 15.76 to 5.85 per 1000 livebirths), respectively. The mortality rates in children under 5 years of age decreased by 59.5% (from 11.09 to 4.49 per 1000 livebirths) and 65.8% (from 19.30 to 6.61 per 1000 livebirths) in urban and rural areas, respectively. Prematurity/low birth weight and congenital heart disease were in the top five causes of death in children under 5 years of age during 1997-2012. Conclusions Zhejiang province has achieved great progress in the reduction of mortality rates in children under five-years-old during the past two decades. The future tasks on reduction of mortality rate still rely on how to improve the management of premature birth/low birth weight, reduce birth defects and prevent accidental deaths in Zhejiang Province.	[Zhang, Weifang; Xu, Yanhua; Yang, Rulai; Zhao, Zhengyan] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Adm, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Dingwan] Zhejiang Med Coll, Dept Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Zhao, ZY (corresponding author), Zhejiang Univ, Sch Med, Childrens Hosp, Dept Adm, Hangzhou 310003, Zhejiang, Peoples R China.	chzwf@zju.edu.cn		Zhang, Weifang/0000-0002-0769-3749				[Anonymous], 2008, LANCET, V371, P1247, DOI [10.1016/S0140-6736(08)60559-0, DOI 10.1016/S0140-6736(08)60559-0]; Feng HZ, 2012, MATERN CHILD HLTH J, V27, P2; Feng Jiang, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P558; Kochanek KD, 2012, PEDIATRICS, V129, P338, DOI 10.1542/peds.2011-3435; Lewando-Hundt G, 1999, SOC SCI MED, V48, P833, DOI 10.1016/S0277-9536(98)00404-3; Li J, 2007, ZHONGGUO GONG GONG W, V23, P103; Li RH, 2006, GUOJI YI YAO WEI SHE, V12, P147; Liang J, 2007, CHIN J EPIDEMIOL, V28; Liu H, 2007, ZHONGGUO CHU JI WEI, V21, P45; Lu M, 2009, ZHONGGUO SHENG YU JI, V20, P102; Martin JA, 2008, PEDIATRICS, V121, P788, DOI 10.1542/peds.2007-3753; Ministry of Health of the People's Republic of China,, 2009, CHIN ANN HLTH STAT R, V19, P1612; Morris SS, 2003, INT J EPIDEMIOL, V32, P1041, DOI 10.1093/ije/dyg241; National Standard of P.R. China, 2008, 2122008 GBT, P1; Rothwell CJ, 2004, PREV CHRONIC DIS, V1; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; United Nations, 2009, MILL DEV GOALS REP 2; United Nations Children's Fund (UNICEF), 2014, STATE WORLDS CHILDRE; Wang YP, 2011, PUBLIC HEALTH, V125, P301, DOI 10.1016/j.puhe.2011.01.003; Wei ZH, 2009, ZHONGGUO WEI SHENG T, V26, P396; World Health Organization, 2005, WORLD HLTH REP 2005; Yan Shujuan, 2014, Zhonghua Yu Fang Yi Xue Za Zhi, V48, P484; Zhang WF, 2014, MED SCI MONITOR, V20, P1162, DOI 10.12659/MSM.890368; Zhu FT., 1985, PRACTICAL PEDIAT	24	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0127770	10.1371/journal.pone.0127770	http://dx.doi.org/10.1371/journal.pone.0127770			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042426	Green Published, gold, Green Submitted			2022-12-27	WOS:000355701600023
J	Ambrosioni, J; Sued, O; Nicolas, D; Parera, M; Lopez-Dieguez, M; Romero, A; Aguero, F; Marcos, MA; Manzardo, C; Zamora, L; Gomez-Carrillo, M; Gatell, JM; Pumarola, T; Miro, JM				Ambrosioni, Juan; Sued, Omar; Nicolas, David; Parera, Marta; Lopez-Dieguez, Maria; Romero, Anabel; Agueero, Fernando; Angeles Marcos, Maria; Manzardo, Christian; Zamora, Laura; Gomez-Carrillo, Manuel; Maria Gatell, Jose; Pumarola, Tomas; Maria Miro, Jose			Trends in Transmission of Drug Resistance and Prevalence of Non-B Subtypes in Patients with Acute or Recent HIV-1 Infection in Barcelona in the Last 16 Years (1997-2012)	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; GENOTYPIC RESISTANCE; MUTATIONS; SPAIN; EPIDEMIOLOGY; INDIVIDUALS; COHORT; SEROCONVERTERS; SURVEILLANCE; PERSISTENCE	Objectives To evaluate the prevalence of transmitted drug resistance (TDR) and non-B subtypes in patients with acute/recent HIV-1 infection in Barcelona during the period 1997-2012. Methods Patients from the "Hospital Clinic Primary HIV-1 Infection Cohort" with a genotyping test performed within 180 days of infection were included. The 2009 WHO List of Mutations for Surveillance of Transmitted HIV-1 Drug Resistance was used for estimating the prevalence of TDR and phylogenetic analysis for subtype determination. Results 189 patients with acute/recent HIV-1 infection were analyzed in 4 time periods (1997-2000, n=28; 2001-4, n=42; 2005-8, n=55 and 2009-12, n=64). The proportion of patients with acute/recent HIV-1 infection with respect to the total of newly HIV-diagnosed patients in our center increased over the time and was 2.18%, 3.82%, 4.15% and 4.55% for the 4 periods, respectively (p=0.005). The global prevalence of TDR was 9%, or 17.9%, 9.5%, 3.6% and 9.4% by study period (p=0.2). The increase in the last period was driven by protease-inhibitor and nucleoside-reverse-transcriptase-inhibitor resistance mutations while non-nucleoside- reverse-transcriptase inhibitor TDR and TDR of more than one family decreased. The overall prevalence of non-B subtypes was 11.1%, or 0%, 4.8%, 9.1% and 20.3 by study period (p=0.01). B/F recombinants, B/G recombinants and subtype F emerged in the last period. We also noticed an increase in the number of immigrant patients (p=0.052). The proportion of men-who-have-sex-with-men (MSM) among patients with acute/recent HIV-1 infection increased over the time (p=0.04). Conclusions The overall prevalence of TDR in patients with acute/recent HIV-1 infection in Barcelona was 9%, and it has stayed relatively stable in recent years. Non-B subtypes and immigrants proportions progressively increased.	[Ambrosioni, Juan; Nicolas, David; Parera, Marta; Lopez-Dieguez, Maria; Agueero, Fernando; Angeles Marcos, Maria; Manzardo, Christian; Zamora, Laura; Maria Gatell, Jose; Pumarola, Tomas; Maria Miro, Jose] Univ Barcelona, Hosp Clin Inst Invest Biomed August Pi Sunyer IDI, Barcelona, Spain; [Sued, Omar] Huesped Fdn, Buenos Aires, DF, Argentina; [Romero, Anabel] Agcy Hlth Qual & Assessment Catalonia AQuAS, Barcelona, Spain; [Angeles Marcos, Maria] Hosp Clin Barcelona, Dept Microbiol, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Gomez-Carrillo, Manuel] Inst Biomed Res Retroviruses & AIDS, Buenos Aires, DF, Argentina	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona	Miro, JM (corresponding author), Univ Barcelona, Hosp Clin Inst Invest Biomed August Pi Sunyer IDI, Barcelona, Spain.	jmmiro@ub.edu	Pumarola, Tomàs/AAB-5532-2019; Suñe, Tomàs Pumarola/F-7583-2017; Sued, Omar/H-3325-2019	Pumarola, Tomàs/0000-0002-5171-7461; Suñe, Tomàs Pumarola/0000-0002-5171-7461; Sued, Omar/0000-0001-5818-770X; Nicolas, David/0000-0002-1968-5287; marcos, maria angeles/0000-0001-8250-3311	"Red Tematica Cooperativa de Grupos de Investigacion en Sida (RIS)" of the Fondo de Investigacion Sanitaria (FIS) [ISCIII-RETIC RD06/006]; Instituto de Salud Carlos III, Madrid, Spain; Instituto de Salud Carlos III; "Ministerio de Economia and Competitividad", Madrid (Spain)	"Red Tematica Cooperativa de Grupos de Investigacion en Sida (RIS)" of the Fondo de Investigacion Sanitaria (FIS); Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); "Ministerio de Economia and Competitividad", Madrid (Spain)(Spanish Government)	This work was partially supported by a grant from the "Red Tematica Cooperativa de Grupos de Investigacion en Sida (RIS)" of the Fondo de Investigacion Sanitaria (FIS) (ISCIII-RETIC RD06/006), Instituto de Salud Carlos III, Madrid, Spain. Anabel Romero is part of the "Ciber de Epidemiologia y Salud Publica (CIBERESP)" and the Doctoral Program in Public Health at the Department of Pediatrics, Obstetrics, and Gynecology, Preventive Medicine and Public Health, Universitat Autonoma de Barcelona (UAB), Bellaterra, Spain. Dr. David Nicolas developed this work in the framework of a postresidency Scholarship Ajuts a la recerca 'Josep Fonts 2014', Hospital Clinic, Barcelona, Spain. Dr. Juan Ambrosioni developed this work in the framework of a 'Juan de la Cierva 2012' post-doctoral program, Ministerio de Competitividad, Spain. This work was also the basis for Dr. Ambrosioni's thesis, Master of AIDS, University of Barcelona, Spain. Dr. M. Lopez-Dieguez and Dr. Fernando Aguero held a Rio Hortega Research Grant from the "Instituto de Salud Carlos III" and the "Ministerio de Economia and Competitividad", Madrid (Spain) whilst this work was being developed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosioni J, 2014, EXPERT REV ANTI-INFE, V12, P793, DOI 10.1586/14787210.2014.913981; Ambrosioni J, 2014, EXPERT REV ANTI-INFE, V12, P523, DOI 10.1586/14787210.2014.906900; Ambrosioni J, 2012, AIDS, V26, P2079, DOI 10.1097/QAD.0b013e32835805b6; Ambrosioni J, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-28; Barbour JD, 2004, AIDS, V18, P1683, DOI 10.1097/01.aids.0000131391.91468.ff; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Booth CL, 2007, J ANTIMICROB CHEMOTH, V59, P1047, DOI 10.1093/jac/dkm082; Castor D, 2012, JAIDS-J ACQ IMM DEF, V61, P1, DOI 10.1097/QAI.0b013e31825a289b; Chaix ML, 2013, CLIN INFECT DIS, V56, P880, DOI 10.1093/cid/cis999; Ciccozzi M, 2012, NEW MICROBIOL, V35, P377; de Mendoza C, 2005, CLIN INFECT DIS, V41, P1350, DOI 10.1086/496982; de Mendoza C, 2005, CLIN INFECT DIS, V41, P227, DOI 10.1086/431203; de Mendoza C, 2009, 7 EUR HIVDRUGRESISTA; Descamps D, 2005, JAIDS-J ACQ IMM DEF, V38, P545, DOI 10.1097/01.qai.0000155201.51232.2e; Descamps D, 2013, J ANTIMICROB CHEMOTH, V68, P2626, DOI 10.1093/jac/dkt238; Girardi E, 2003, SCAND J INFECT DIS, V35, P17, DOI 10.1080/03008870310009597; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Hecht FM, 2006, J INFECT DIS, V194, P725, DOI 10.1086/506616; Holguin A, 2008, CURR HIV RES, V6, P327, DOI 10.2174/157016208785132455; Jorgensen LB, 2003, SCAND J INFECT DIS, V35, P800, DOI 10.1080/00365540310016916; KIM D, 2010, 17 C RETR OPP INF SA; Knyphausen FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095956; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lospitao E, 2005, HIV MED, V6, P313, DOI 10.1111/j.1468-1293.2005.00313.x; Metzner KJ, 2013, J INFECT DIS, V208, P1102, DOI 10.1093/infdis/jit310; Monge S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090710; Palacios R, 2008, ENFERM INFEC MICR CL, V26, P141, DOI 10.1157/13116750; Pao D, 2004, JAIDS-J ACQ IMM DEF, V37, P1570, DOI 10.1097/00126334-200412150-00006; Perez-Alvarez L, 2003, ANTIVIR THER, V8, P355; Pernas B, 2014, AIDS, V28, P1837, DOI 10.1097/QAD.0000000000000326; Smith D, 2007, CLIN INFECT DIS, V44, P456, DOI 10.1086/510748; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Violin M, 2004, JAIDS-J ACQ IMM DEF, V36, P761, DOI 10.1097/00126334-200406010-00017; Weinstock HS, 2004, J INFECT DIS, V189, P2174, DOI 10.1086/420789; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; Yebra G, 2010, ANTIVIR RES, V85, P409, DOI 10.1016/j.antiviral.2009.11.010; Yebra G, 2012, J CLIN MICROBIOL, V50, P407, DOI 10.1128/JCM.05798-11; Yebra G, 2010, MED CLIN-BARCELONA, V135, P561, DOI 10.1016/j.medcli.2009.09.029	42	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0125837	10.1371/journal.pone.0125837	http://dx.doi.org/10.1371/journal.pone.0125837			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039689	gold, Green Published, Green Submitted			2022-12-27	WOS:000355700700015
J	Csefalvay, E; Lapkouski, M; Guzanova, A; Csefalvay, L; Baikova, T; Shevelev, I; Bialevich, V; Shamayeva, K; Janscak, P; Smatanova, IK; Panjikar, S; Carey, J; Weiserova, M; Ettrich, R				Csefalvay, Eva; Lapkouski, Mikalai; Guzanova, Alena; Csefalvay, Ladislav; Baikova, Tatsiana; Shevelev, Igor; Bialevich, Vitali; Shamayeva, Katsiaryna; Janscak, Pavel; Smatanova, Ivana Kuta; Panjikar, Santosh; Carey, Jannette; Weiserova, Marie; Ettrich, Ruediger			Functional Coupling of Duplex Translocation to DNA Cleavage in a Type I Restriction Enzyme	PLOS ONE			English	Article							ESCHERICHIA-COLI; ENDONUCLEASE ECOR124I; HSDR SUBUNIT; RECBCD ENZYME; PROTEIN; GENES; HELICASE; SEQUENCE; FAMILY; DOMAIN	Type I restriction-modification enzymes are multifunctional heteromeric complexes with DNA cleavage and ATP-dependent DNA translocation activities located on motor subunit HsdR. Functional coupling of DNA cleavage and translocation is a hallmark of the Type I restriction systems that is consistent with their proposed role in horizontal gene transfer. DNA cleavage occurs at nonspecific sites distant from the cognate recognition sequence, apparently triggered by stalled translocation. The X-ray crystal structure of the complete HsdR subunit from E. coli plasmid R124 suggested that the triggering mechanism involves interdomain contacts mediated by ATP. In the present work, in vivo and in vitro activity assays and crystal structures of three mutants of EcoR124I HsdR designed to probe this mechanism are reported. The results indicate that interdomain engagement via ATP is indeed responsible for signal transmission between the endonuclease and helicase domains of the motor subunit. A previously identified sequence motif that is shared by the RecB nucleases and some Type I endonucleases is implicated in signaling.	[Csefalvay, Eva; Lapkouski, Mikalai; Csefalvay, Ladislav; Baikova, Tatsiana; Bialevich, Vitali; Shamayeva, Katsiaryna; Smatanova, Ivana Kuta; Carey, Jannette; Ettrich, Ruediger] Acad Sci Czech Republ, Ctr Nanobiol & Struct Biol, Inst Microbiol, CZ-37333 Nove Hrady, Czech Republic; [Csefalvay, Eva; Lapkouski, Mikalai; Csefalvay, Ladislav; Baikova, Tatsiana; Bialevich, Vitali; Shamayeva, Katsiaryna; Smatanova, Ivana Kuta; Carey, Jannette; Ettrich, Ruediger] Acad Sci Czech Republ, Global Change Res Ctr, CZ-37333 Nove Hrady, Czech Republic; [Guzanova, Alena; Weiserova, Marie] Acad Sci Czech Republ, Inst Microbiol, CR-14220 Prague 4, Czech Republic; [Baikova, Tatsiana; Bialevich, Vitali; Shamayeva, Katsiaryna; Smatanova, Ivana Kuta; Ettrich, Ruediger] Univ South Bohemia Ceske Budejovice, Fac Sci, CZ-37333 Nove Hrady, Czech Republic; [Shevelev, Igor; Janscak, Pavel] Acad Sci Czech Republ, Inst Mol Genet, CR-14220 Prague 4, Czech Republic; [Janscak, Pavel] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Panjikar, Santosh] Australian Synchrotron, Clayton, Vic 3168, Australia; [Panjikar, Santosh] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Carey, Jannette] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; University of Zurich; Monash University; Princeton University	Ettrich, R (corresponding author), Acad Sci Czech Republ, Ctr Nanobiol & Struct Biol, Inst Microbiol, Zamek 136, CZ-37333 Nove Hrady, Czech Republic.	ettrich@nh.cas.cz	Cséfalvay, Eva/G-9768-2014; Ettrich, Rudi H/C-1463-2011; Shamayeva, Katsiaryna/K-3112-2017; Janscak, Pavel/Q-3795-2018; Cséfalvay, Ladislav/AAB-4641-2019; Weiserova, Marie/H-7991-2014; Panjikar, Santosh/D-2709-2012; Cséfalvay, Ladislav/G-9761-2014; Smatanova, Ivana Kuta/H-6516-2014; Bialevich, Vitali/K-1961-2017	Cséfalvay, Eva/0000-0002-9297-2784; Ettrich, Rudi H/0000-0001-8624-7706; Shamayeva, Katsiaryna/0000-0002-4224-3145; Janscak, Pavel/0000-0002-1748-7789; Panjikar, Santosh/0000-0001-7429-3879; Cséfalvay, Ladislav/0000-0002-5589-6989; Smatanova, Ivana Kuta/0000-0002-1337-9481; Bialevich, Vitali/0000-0002-1033-8158	Czech Science Foundation [P207/12/2323, P305-10-0281]; Institutional research concept [RVO61388971]; joint Czech - US National Science Foundation-International Research Cooperation [INT03-09049]; Swiss National Science Foundation [3100A0-116008]	Czech Science Foundation(Grant Agency of the Czech Republic); Institutional research concept; joint Czech - US National Science Foundation-International Research Cooperation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We gratefully acknowledge support from the Czech Science Foundation (P207/12/2323 to RE and MW, P305-10-0281 to PJ), http://www.gacr.cz/; Institutional research concept RVO61388971 to MW, http://www.isvav.cz, joint Czech - US National Science Foundation-International Research Cooperation (INT03-09049) to JC, www.nsf.gov, and Swiss National Science Foundation (3100A0-116008 to PJ), www.snf.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2000, NUCLEIC ACIDS RES, V28, P3417, DOI 10.1093/nar/28.18.3417; ARBER W, 1962, J MOL BIOL, V5, P18, DOI 10.1016/S0022-2836(62)80058-8; BARCUS VA, 1995, GENETICS, V140, P1187; BICKLE TA, 1993, MICROBIOL REV, V57, P434, DOI 10.1128/MMBR.57.2.434-450.1993; Bickle TA, 1993, NUCLEASES, P89; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bujnicki JM, 2001, J MOL MICROB BIOTECH, V3, P69; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; Chang HSW, 2001, J BIOL CHEM, V276, P46004, DOI 10.1074/jbc.M108627200; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Davies GP, 1999, J MOL BIOL, V290, P565, DOI 10.1006/jmbi.1999.2908; Dreier J, 1996, J MOL BIOL, V264, P722, DOI 10.1006/jmbi.1996.0672; Dryden DTF, 1997, BIOCHEMISTRY-US, V36, P1065, DOI 10.1021/bi9619435; ENDLICH B, 1985, J BIOL CHEM, V260, P5729; Firman K, 2000, EMBO J, V19, P2094, DOI 10.1093/emboj/19.9.2094; GLOVER SW, 1969, GENET RES, V13, P227, DOI 10.1017/S0016672300002901; GORBALENYA AE, 1991, FEBS LETT, V291, P277, DOI 10.1016/0014-5793(91)81301-N; Handa N, 2012, P NATL ACAD SCI USA, V109, P8901, DOI 10.1073/pnas.1206076109; Hubacek J, 1998, FOLIA MICROBIOL, V43, P353, DOI 10.1007/BF02818573; Ishikawa K, 2009, NUCLEIC ACIDS RES, V37, P3531, DOI 10.1093/nar/gkp214; JACOB F, 1954, ANN I PASTEUR PARIS, V87, P653; Janscak P, 1998, NUCLEIC ACIDS RES, V26, P4439, DOI 10.1093/nar/26.19.4439; Janscak P, 1999, NUCLEIC ACIDS RES, V27, P2638, DOI 10.1093/nar/27.13.2638; Janscak P, 1999, EMBO J, V18, P2638, DOI 10.1093/emboj/18.9.2638; Janscak P, 2000, J MOL BIOL, V295, P1089, DOI 10.1006/jmbi.1999.3414; Janscak P, 1996, J MOL BIOL, V257, P977, DOI 10.1006/jmbi.1996.0217; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kennaway CK, 2012, GENE DEV, V26, P92, DOI 10.1101/gad.179085.111; Lapkouski M, 2007, ACTA CRYSTALLOGR F, V63, P582, DOI 10.1107/S174430910702622X; Lapkouski M, 2009, NAT STRUCT MOL BIOL, V16, P94, DOI 10.1038/nsmb.1523; Leslie AGW, 1992, JOINT CCP4 ESFEACMB, V26; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P20, DOI 10.1093/nar/gkt847; Marini V, 2012, DNA REPAIR, V11, P789, DOI 10.1016/j.dnarep.2012.05.007; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McClelland SE, 2004, NUCL ACID M, V14, P111; MURRAY NE, 1993, MOL MICROBIOL, V9, P133, DOI 10.1111/j.1365-2958.1993.tb01675.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Obarska-Kosinska A, 2008, J MOL BIOL, V376, P438, DOI 10.1016/j.jmb.2007.11.024; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; PATEL J, 1992, GENE, V112, P21, DOI 10.1016/0378-1119(92)90298-4; RANDERATH K, 1964, J CHROMATOGR, V16, P111, DOI 10.1016/S0021-9673(01)82445-6; Redaschi N., 1996, ESCHERICHIA COLI SAL, P773; Roberts GA, 2011, NUCLEIC ACIDS RES, V39, P7667, DOI 10.1093/nar/gkr480; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Seidel R, 2008, EMBO J, V27, P1388, DOI 10.1038/emboj.2008.69; Sinha D, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2334-1; Sisakova E, 2008, NUCLEIC ACIDS RES, V36, P3939, DOI 10.1093/nar/gkn333; Sisakova E, 2008, J MOL BIOL, V384, P1273, DOI 10.1016/j.jmb.2008.10.017; Stanley LK, 2006, NUCLEIC ACIDS RES, V34, P4387, DOI 10.1093/nar/gkl569; STUDIER FW, 1988, P NATL ACAD SCI USA, V85, P4677, DOI 10.1073/pnas.85.13.4677; Szczelkun MD, 1997, J MOL BIOL, V271, P112, DOI 10.1006/jmbi.1997.1172; Szczelkun MD, 1996, EMBO J, V15, P6335, DOI 10.1002/j.1460-2075.1996.tb01023.x; TAYLOR I, 1992, NUCLEIC ACIDS RES, V20, P179, DOI 10.1093/nar/20.2.179; Titheradge AJB, 1996, MOL MICROBIOL, V22, P437, DOI 10.1046/j.1365-2958.1996.00126.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Noort J, 2004, NUCLEIC ACIDS RES, V32, P6540, DOI 10.1093/nar/gkh999; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yu M, 1998, P NATL ACAD SCI USA, V95, P981, DOI 10.1073/pnas.95.3.981; YUAN R, 1980, CELL, V20, P237, DOI 10.1016/0092-8674(80)90251-2	61	5	5	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128700	10.1371/journal.pone.0128700	http://dx.doi.org/10.1371/journal.pone.0128700			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039067	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000355700700118
J	Hu, H; O'Connor, JK; Zhou, ZH				Hu, Han; O'Connor, Jingmai K.; Zhou, Zhonghe			A New Species of Pengornithidae (Aves: Enantiornithes) from the Lower Cretaceous of China Suggests a Specialized Scansorial Habitat Previously Unknown in Early Birds	PLOS ONE			English	Article							JEHOL BIOTA; EVOLUTION; DIVERSITY; HISTOLOGY; ANATOMY; FOSSILS; HEBEI	We describe a new enantiornithine bird, Parapengornis eurycaudatus gen. et sp. nov. from the Lower Cretaceous Jiufotang Formation of Liaoning, China. Although morphologically similar to previously described pengornithids Pengornis houi, Pengornis IVPP V18632, and Eopengornis martini, morphological differences indicate it represents a new taxon of the Pengornithidae. Based on new information from this specimen we reassign IVPP V18632 to Parapengornis sp. The well preserved pygostyle of the new specimen elucidates the morphology of this element for the clade, which is unique in pengornithids among Mesozoic birds. Similarities with modern scansores such as woodpeckers may indicate a specialized vertical climbing and clinging behavior that has not previously been inferred for early birds. The new specimen preserves a pair of fully pennaceous rachis-dominated feathers like those in the holotype of Eopengornis martini; together with the unique morphology of the pygostyle, this discovery lends evidence to early hypotheses that rachis-dominated feathers may have had a functional significance. This discovery adds to the diversity of ecological niches occupied by enantiornithines and if correct reveals are remarkable amount of locomotive differentiation among Enantiornithes.	[Hu, Han; O'Connor, Jingmai K.; Zhou, Zhonghe] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing, Peoples R China; [Hu, Han] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Hu, H (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing, Peoples R China.	huhan_ivpp@163.com		Hu, Han/0000-0001-5926-7306	Chinese Academy of Sciences; National Basic Research Program of China (973 Program) [2012CB821906]; National Natural Science Foundation of China [41172020]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Chinese Academy of Sciences and the National Basic Research Program of China (973 Program, 2012CB821906), the National Natural Science Foundation of China (41172020) and the Chinese Academy of Sciences to ZZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; Benton MJ, 2008, P GEOLOGIST ASSOC, V119, P209, DOI 10.1016/S0016-7878(08)80302-1; Bock WJ, 1959, AM MUS NOVIT, V1931; Burt W. H, 1930, ADAPTIVE MODIFICATIO; Chiappe LM, 1999, B AM MUS NAT HIST, P3; Chiappe Luis M., 1995, Courier Forschungsinstitut Senckenberg, V181, P55; Chiappe Luis M., 2002, P240; Chinsamy A, 1995, PALEOBIOLOGY, V21, P561, DOI 10.1017/S0094837300013543; Chinsamy A, 2001, NATURE, V412, P402, DOI 10.1038/35086650; Chinsamy A., 2005, MICROSTRUCTURE DINOS; Chuong CM, 2003, J EXP ZOOL PART B, V298B, P42, DOI 10.1002/jez.b.00025; Connor JKO, 2009, J VERTEBR PALEONTOL, V29, P188; Felice RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089737; Goloboff P, 2008, CLADISTICS, V24, P91; He HY, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019790; Hopson JA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P211; Hou LH, 2004, NATURWISSENSCHAFTEN, V91, P22, DOI 10.1007/s00114-003-0489-1; Hou Lian-Hai, 1999, Vertebrata Palasiatica, V37, P88; Hu DY, 2012, J VERTEBR PALEONTOL, V32, P639, DOI 10.1080/02724634.2012.652321; Hu DY, 2011, J VERTEBR PALEONTOL, V31, P154, DOI 10.1080/02724634.2011.546305; Hu Han, 2014, Vertebrata Palasiatica, V52, P77; Li L, 2006, ACTA GEOL SIN-ENGL, V80, P38, DOI 10.1111/j.1755-6724.2006.tb00792.x; Linnaeus C, 1758, SYSTEMS NATURAE; Liu Di, 2012, Vertebrata Palasiatica, V50, P39; Manegold A, 2013, J ZOOL SYST EVOL RES, V51, P72, DOI 10.1111/jzs.12000; Martin L.D., 1976, Smithsonian Contributions to Paleobiology, VNo. 27, P35; Morschhauser EM, 2009, J VERTEBR PALEONTOL, V29, P545, DOI 10.1671/039.029.0210; O'Connor, 2009, SYSTEMATIC REV ENANT; O'Connor Jingmai K., 2014, Vertebrata Palasiatica, V52, P112; O'Connor JK, 2013, J VERTEBR PALEONTOL, V33, P1, DOI 10.1080/02724634.2012.719176; O'Connor JK, 2013, J SYST PALAEONTOL, V11, P889, DOI 10.1080/14772019.2012.690455; O'Connor JK, 2011, J SYST PALAEONTOL, V9, P135, DOI 10.1080/14772019.2010.526639; O'Connor JK, 2011, J SYST PALAEONTOL, V9, P51, DOI 10.1080/14772019.2010.512614; O'Connor JMK, 2011, ACTA PALAEONTOL POL, V56, P463, DOI 10.4202/app.2010.0047; Pan YH, 2013, CRETACEOUS RES, V44, P30, DOI 10.1016/j.cretres.2013.03.007; SCHARNKE HANS, 1930, JOUR ORNITH [BERLIN], V78, P308, DOI 10.1007/BF01953326; STOLPE M., 1932, JOUR ORNITHOLOGIE, V80, P161, DOI 10.1007/BF01908701; WALKER CA, 1981, NATURE, V292, P51, DOI 10.1038/292051a0; Wang XL, 2014, BIOL J LINN SOC, V113, P805, DOI 10.1111/bij.12313; Zeffer A, 2003, BIOL J LINN SOC, V79, P461, DOI 10.1046/j.1095-8312.2003.00200.x; Zhang FC, 2001, CHINESE SCI BULL, V46, P945, DOI 10.1007/BF02900473; Zhang FC, 2004, CAN J EARTH SCI, V41, P1097, DOI 10.1139/E04-055; Zhang FC, 2008, SCI CHINA SER D, V51, P625, DOI 10.1007/s11430-008-0050-3; Zhang YH, 2006, RARE METALS, V25, P25, DOI 10.1016/S1001-0521(07)60039-4; Zheng XT, 2007, ACTA GEOL SIN-ENGL, V81, P703; Zhou ZH, 2005, CAN J EARTH SCI, V42, P1331, DOI 10.1139/E05-038; Zhou ZH, 2008, J ANAT, V212, P565, DOI 10.1111/j.1469-7580.2008.00880.x; Zhou Zhonghe, 1995, Vertebrata Palasiatica, V33, P99	48	30	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126791	10.1371/journal.pone.0126791	http://dx.doi.org/10.1371/journal.pone.0126791			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039693	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700036
J	Stacy, SL; Brink, LL; Larkin, JC; Sadovsky, Y; Goldstein, BD; Pitt, BR; Talbott, EO				Stacy, Shaina L.; Brink, Luann L.; Larkin, Jacob C.; Sadovsky, Yoel; Goldstein, Bernard D.; Pitt, Bruce R.; Talbott, Evelyn O.			Perinatal Outcomes and Unconventional Natural Gas Operations in Southwest Pennsylvania	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; AIR-POLLUTION; MATERNAL EXPOSURE; UNITED-STATES; WASTE-WATER; RISK; CHALLENGES; PREGNANCY; HEALTH	Unconventional gas drilling (UGD) has enabled extraordinarily rapid growth in the extraction of natural gas. Despite frequently expressed public concern, human health studies have not kept pace. We investigated the association of proximity to UGD in the Marcellus Shale formation and perinatal outcomes in a retrospective cohort study of 15,451 live births in Southwest Pennsylvania from 2007-2010. Mothers were categorized into exposure quartiles based on inverse distance weighted (IDW) well count; least exposed mothers (first quartile) had an IDW well count less than 0.87 wells per mile, while the most exposed (fourth quartile) had 6.00 wells or greater per mile. Multivariate linear (birth weight) or logistical (small for gestational age (SGA) and prematurity) regression analyses, accounting for differences in maternal and child risk factors, were performed. There was no significant association of proximity and density of UGD with prematurity. Comparison of the most to least exposed, however, revealed lower birth weight (3323 +/- 558 vs 3344 +/- 544 g) and a higher incidence of SGA (6.5 vs 4.8%, respectively; odds ratio: 1.34; 95% confidence interval: 1.10-1.63). While the clinical significance of the differences in birth weight among the exposure groups is unclear, the present findings further emphasize the need for larger studies, in regio-specific fashion, with more precise characterization of exposure over an extended period of time to evaluate the potential public health significance of UGD.	[Stacy, Shaina L.; Goldstein, Bernard D.; Pitt, Bruce R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA; [Brink, Luann L.; Talbott, Evelyn O.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Larkin, Jacob C.; Sadovsky, Yoel] Univ Pittsburgh, Magee Womens Res Inst, Sch Med, Pittsburgh, PA USA; [Goldstein, Bernard D.; Pitt, Bruce R.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Sch Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pitt, BR (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA.	brucep@pitt.edu	Larkin, Jacob/AAF-9192-2020	Sadovsky, Yoel/0000-0003-2969-6737; Stacy, Shaina/0000-0003-3107-9869; Talbott, Evelyn/0000-0002-5198-7939	Heinz Endowments; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	Heinz Endowments; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by the Heinz Endowments (website:http://www.heinz.org/) (BRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adgate JL, 2014, ENVIRON SCI TECHNOL, V48, P8307, DOI 10.1021/es404621d; Adriaanse HP, 1996, PATIENT EDUC COUNS, V28, P25, DOI 10.1016/0738-3991(95)00798-9; Allen DT, 2013, P NATL ACAD SCI USA, V110, P18023, DOI 10.1073/pnas.1318658110; [Anonymous], 2014, ENV IMP SHAL GAS EXT; Aronson RA, 1993, WIS MED J, V92, P613; Backes CH, 2013, TOXICOL LETT, V216, P47, DOI 10.1016/j.toxlet.2012.11.007; Bibby KJ, 2013, ENVIRON SCI TECHNOL, V47, P13220, DOI 10.1021/es404960z; Brauer M, 2008, ENVIRON HEALTH PERSP, V116, P680, DOI 10.1289/ehp.10952; Centers for Disease Control and Prevention, 2005, QUICKSTATS PERC SMAL; Centers for Disease Control and Prevention, 2011, NAT VIT STAT REP 201; Currie J, 2014, AM EC ASS ANN M; Dadvand P, 2013, ENVIRON HEALTH PERSP, V121, P367, DOI 10.1289/ehp.1205575; de Bernabe JV, 2004, EUR J OBSTET GYN R B, V116, P3, DOI 10.1016/j.ejogrb.2004.03.007; Department of Energy, 2009, MOD SHAL GAS DEV US; DiGiuseppe David L, 2002, Matern Child Health J, V6, P169, DOI 10.1023/A:1019726112597; Entrekin S, 2011, FRONT ECOL ENVIRON, V9, P503, DOI 10.1890/110053; Esswein EJ, NIOSH FIELD EFFORT A; Ferrar KJ, 2013, ENVIRON SCI TECHNOL, V47, P3472, DOI 10.1021/es301411q; Forand SP, 2012, ENVIRON HEALTH PERSP, V120, P616, DOI 10.1289/ehp.1103884; Ghosh JKC, 2012, AM J EPIDEMIOL, V175, P1262, DOI 10.1093/aje/kwr469; Goldstein BD, 2014, TOXICOL SCI, V139, P271, DOI 10.1093/toxsci/kfu061; Hill EL, 2013, UNCONVENTIONAL NATUR; Kannan S, 2006, ENVIRON HEALTH PERSP, V114, P1636, DOI 10.1289/ehp.9081; Landrigan PJ, 2004, ENVIRON HEALTH PERSP, V112, P257, DOI 10.1289/ehp.6115; Li X, 2010, HUM REPROD, V25, P1044, DOI 10.1093/humrep/deq004; Lupo PJ, 2011, ENVIRON HEALTH PERSP, V119, P397, DOI 10.1289/ehp.1002212; McKenzie LM, 2014, ENVIRON HEALTH PERSP, V122, P412, DOI 10.1289/ehp.1306722; McKenzie LM, 2012, SCI TOTAL ENVIRON, V424, P79, DOI 10.1016/j.scitotenv.2012.02.018; New York State Department of Health, 2014, PUBL HLTH REV HIGH V; Olsen IE, 2010, PEDIATRICS, V125, pE214, DOI 10.1542/peds.2009-0913; Osborn SG, 2011, P NATL ACAD SCI USA, V108, P8172, DOI 10.1073/pnas.1100682108; Pennsylvania Department of Environmental Protection, OIL GAS REP; Pennsylvania Department of Health, EP QUER MAPP SYST; Pennsylvania Department of Health, BIRTH STAT STAT COUN; Quansah R, 2009, INT ARCH OCC ENV HEA, V82, P529, DOI 10.1007/s00420-008-0349-6; Sapkota A, 2012, AIR QUAL ATMOS HLTH, V5, P369, DOI 10.1007/s11869-010-0106-3; Sever LE, 1995, INTRO ENV EPIDEMIOLO, P81; Shirai S, 2010, J ENVIRON SCI HEAL A, V45, P1468, DOI 10.1080/10934529.2010.500942; Small MJ, 2014, ENVIRON SCI TECHNOL, V48, P8289, DOI 10.1021/es502111u; States S, 2013, J AM WATER WORKS ASS, V105, pE432, DOI 10.5942/jawwa.2013.105.0107; Stieb DM, 2012, ENVIRON RES, V117, P100, DOI 10.1016/j.envres.2012.05.007; United States Census Bureau, MAP 2010 POP DENS CO; Vidic RD, 2013, SCIENCE, V340, DOI 10.1126/science.1235009; Wilson JM, 2012, ENVIRON PRAC, V14, P288, DOI 10.1017/S1466046612000427; Xu XH, 2011, INT ARCH OCC ENV HEA, V84, P251, DOI 10.1007/s00420-010-0545-z; Zahran S, 2012, ENVIRON RES, V112, P139, DOI 10.1016/j.envres.2011.11.008	46	105	106	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126425	10.1371/journal.pone.0126425	http://dx.doi.org/10.1371/journal.pone.0126425			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039051	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000355700700029
J	Tedder, A; Carleial, S; Golebiewska, M; Kappel, C; Shimizu, KK; Stift, M				Tedder, Andrew; Carleial, Samuel; Golebiewska, Martyna; Kappel, Christian; Shimizu, Kentaro K.; Stift, Marc			Evolution of the Selfing Syndrome in Arabis alpina (Brassicaceae)	PLOS ONE			English	Article							MATING-SYSTEM VARIATION; POLLEN-OVULE RATIOS; FLOWER SIZE; INBREEDING DEPRESSION; RECENT SPECIATION; SELECTION; INCOMPATIBILITY; COMPATIBILITY; POPULATIONS; DIVERGENCE	Introduction The transition from cross-fertilisation (outcrossing) to self-fertilisation (selfing) frequently coincides with changes towards a floral morphology that optimises self-pollination, the selfing syndrome. Population genetic studies have reported the existence of both outcrossing and selfing populations in Arabis alpina (Brassicaceae), which is an emerging model species for studying the molecular basis of perenniality and local adaptation. It is unknown whether its selfing populations have evolved a selfing syndrome. Methods Using macro-photography, microscopy and automated cell counting, we compared floral syndromes (size, herkogamy, pollen and ovule numbers) between three outcrossing populations from the Apuan Alps and three selfing populations from the Western and Central Alps (Maritime Alps and Dolomites). In addition, we genotyped the plants for 12 microsatellite loci to confirm previous measures of diversity and inbreeding coefficients based on allozymes, and performed Bayesian clustering. Results and Discussion Plants from the three selfing populations had markedly smaller flowers, less herkogamy and lower pollen production than plants from the three outcrossing populations, whereas pistil length and ovule number have remained constant. Compared to allozymes, microsatellite variation was higher, but revealed similar patterns of low diversity and high Fis in selfing populations. Bayesian clustering revealed two clusters. The first cluster contained the three outcrossing populations from the Apuan Alps, the second contained the three selfing populations from the Maritime Alps and Dolomites. Conclusion We conclude that in comparison to three outcrossing populations, three populations with high selfing rates are characterised by a flower morphology that is closer to the selfing syndrome. The presence of outcrossing and selfing floral syndromes within a single species will facilitate unravelling the genetic basis of the selfing syndrome, and addressing which selective forces drive its evolution.	[Tedder, Andrew; Golebiewska, Martyna; Shimizu, Kentaro K.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Carleial, Samuel; Stift, Marc] Univ Konstanz, Dept Biol, Ecol, Constance, Germany; [Kappel, Christian] Univ Potsdam, Inst Biochemie & Biol, Potsdam, Germany	University of Zurich; University of Konstanz; University of Potsdam	Shimizu, KK (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	kentaro.shimizu@ieu.uzh.ch; marcstift@gmail.com	Tedder, Andrew/H-6678-2019; Stift, Marc/H-4371-2019	Tedder, Andrew/0000-0002-7378-4673; Stift, Marc/0000-0001-7801-9498; Kappel, Christian/0000-0002-1450-1864; Shimizu, Kentaro K./0000-0002-6483-1781	University of Konstanz (Excellence Initiative Independent Research Startup Grant); Swiss National Science Foundation [CRSI33_127155, Sinergia AVE 31003A_140917]; University of Zurich (University Research Priority Program Evolution in Action); Human Frontiers Science Program	University of Konstanz (Excellence Initiative Independent Research Startup Grant); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich (University Research Priority Program Evolution in Action); Human Frontiers Science Program(Human Frontier Science Program)	This work was supported by the University of Konstanz (Excellence Initiative Independent Research Startup Grant to MS, http://www.exzellenz.uni-konstanz.de/en/); the Swiss National Science Foundation (grant numbers CRSI33_127155 and Sinergia AVE 31003A_140917, http://www.snf.ch/en/Pages/default.aspx); the University of Zurich (University Research Priority Program Evolution in Action, http://www.uzh.ch/research/priorityprograms/university_en.html); and the Human Frontiers Science Program (Young Investigator Award to KKS, http://www.hfsp.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani MC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003130; Alvarez N, 2009, ECOL LETT, V12, P632, DOI 10.1111/j.1461-0248.2009.01312.x; Amasino R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-228; Ansell SW, 2008, MOL ECOL, V17, P2245, DOI 10.1111/j.1365-294X.2008.03739.x; Ansell SW, 2011, ANN BOT-LONDON, V108, P241, DOI 10.1093/aob/mcr134; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Barrett SCH, 2002, NAT REV GENET, V3, P274, DOI 10.1038/nrg776; BELAOUSSOFF S, 1995, EVOLUTION, V49, P545, DOI 10.2307/2410278; Bergonzi S, 2013, SCIENCE, V340, P1094, DOI 10.1126/science.1234116; Bernacchi D, 1997, GENETICS, V147, P861; BREESE E. L., 1959, ANN BOT [LONDON], V23, P331; Brunet J, 1998, FUNCT ECOL, V12, P596, DOI 10.1046/j.1365-2435.1998.00231.x; Buehler D, 2012, ANN BOT-LONDON, V109, P1359, DOI 10.1093/aob/mcs066; Busch JW, 2005, AM J BOT, V92, P1503, DOI 10.3732/ajb.92.9.1503; Busch JW, 2005, HEREDITY, V94, P159, DOI 10.1038/sj.hdy.6800584; Button L, 2012, INT J PLANT SCI, V173, P251, DOI 10.1086/663972; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Conner JK, 1996, OECOLOGIA, V105, P509, DOI 10.1007/BF00330014; CRUDEN RW, 1977, EVOLUTION, V31, P32, DOI 10.1111/j.1558-5646.1977.tb00979.x; Darwin C, 1877, EFFECTS CROSS SELF F; Doubleday LAD, 2013, AM J BOT, V100, P2280, DOI 10.3732/ajb.1300159; Duncan TM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00301; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fisher RA, 1941, ANN EUGENIC, V11, P53, DOI 10.1111/j.1469-1809.1941.tb02272.x; Fishman L, 2004, EVOLUTION, V58, P296, DOI 10.1111/j.0014-3820.2004.tb01646.x; Fishman L, 2002, EVOLUTION, V56, P2138, DOI 10.1111/j.0014-3820.2002.tb00139.x; Foxe JP, 2009, P NATL ACAD SCI USA, V106, P5241, DOI 10.1073/pnas.0807679106; Georgiady MS, 2002, GENETICS, V161, P333; Goldberg EE, 2010, SCIENCE, V330, P493, DOI 10.1126/science.1194513; Goodwillie C, 2006, EVOLUTION, V60, P491; Guo YL, 2009, P NATL ACAD SCI USA, V106, P5246, DOI 10.1073/pnas.0808012106; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; HOLTSFORD TP, 1992, EVOLUTION, V46, P216, DOI 10.1111/j.1558-5646.1992.tb01996.x; Igic B, 2006, P NATL ACAD SCI USA, V103, P1359, DOI 10.1073/pnas.0506283103; Igic B, 2004, NEW PHYTOL, V161, P97, DOI 10.1046/j.1469-8137.2003.00952.x; IOERGER TR, 1990, P NATL ACAD SCI USA, V87, P9732, DOI 10.1073/pnas.87.24.9732; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Karron JD, 1997, HEREDITY, V79, P365, DOI 10.1038/hdy.1997.169; Koch MA, 2006, MOL ECOL, V15, P825, DOI 10.1111/j.1365-294X.2005.02848.x; Lin JZ, 1997, GENETICS, V146, P1115; LLOYD DG, 1992, INT J PLANT SCI, V153, P370, DOI 10.1086/297041; LLOYD DG, 1987, AM NAT, V129, P800, DOI 10.1086/284676; Lobreaux S, 2014, MOL ECOL RESOUR, V14, P411, DOI 10.1111/1755-0998.12189; Manel S, 2010, MOL ECOL, V19, P3824, DOI 10.1111/j.1365-294X.2010.04716.x; Medrano M, 2005, ANN BOT-LONDON, V95, P1105, DOI 10.1093/aob/mci129; Medrano M, 2012, PLANT BIOLOGY, V14, P801, DOI 10.1111/j.1438-8677.2012.00569.x; Michalski SG, 2009, NEW PHYTOL, V183, P470, DOI 10.1111/j.1469-8137.2009.02861.x; Motten AF, 2000, AM J BOT, V87, P339, DOI 10.2307/2656629; ORNDUFF R, 1969, Taxon, V18, P121, DOI 10.2307/1218671; Pannell JR, 1998, EVOLUTION, V52, P657, DOI [10.2307/2411261, 10.1111/j.1558-5646.1998.tb03691.x]; Parachnowitsch AL, 2010, NEW PHYTOL, V188, P393, DOI 10.1111/j.1469-8137.2010.03410.x; Penet L, 2009, PLANT BIOLOGY, V11, P38, DOI 10.1111/j.1438-8677.2008.00141.x; Poncet BN, 2010, MOL ECOL, V19, P2896, DOI 10.1111/j.1365-294X.2010.04696.x; PRESTON RE, 1986, AM J BOT, V73, P1732, DOI 10.2307/2444239; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2021, R LANGUAGE ENV STAT; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Richards A. J., 1986, PLANT BREEDING SYSTE; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Shimizu KK, 2011, ANN BOT-LONDON, V108, P777, DOI 10.1093/aob/mcr180; Sicard A, 2011, PLANT CELL, V23, P3156, DOI 10.1105/tpc.111.088237; Sicard A, 2011, ANN BOT-LONDON, V107, P1433, DOI 10.1093/aob/mcr023; Snell Rebecca, 2005, BMC Ecology, V5, P2, DOI 10.1186/1472-6785-5-2; Stebbins G, 1950, VARIATION EVOLUTION, DOI [10.7312/steb94536, DOI 10.7312/STEB94536]; Tedder A, 2011, ANN BOT-LONDON, V108, P699, DOI 10.1093/aob/mcr157; Teixido AL, 2011, ACTA OECOL, V37, P418, DOI 10.1016/j.actao.2011.05.007; Tomimatsu H, 2006, AM J BOT, V93, P134, DOI 10.3732/ajb.93.1.134; Vekemans X, 2014, J EVOLUTION BIOL, V27, P1372, DOI 10.1111/jeb.12372; Wang RH, 2009, NATURE, V459, P423, DOI 10.1038/nature07988; Wright SI, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0133; Zuur A, 2009, MIXED EFFECTS MODELS	73	31	31	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126618	10.1371/journal.pone.0126618	http://dx.doi.org/10.1371/journal.pone.0126618			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039362	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000355700700033
J	Yoshimura, Y; Shiino, A; Muraki, K; Fukami, T; Yamada, S; Satow, T; Fukuda, M; Saiki, M; Hojo, M; Miyamoto, S; Onishi, N; Saya, H; Inubushi, T; Nozaki, K; Tanigaki, K				Yoshimura, Yayoi; Shiino, Akihiko; Muraki, Kazue; Fukami, Tadateru; Yamada, Shigeki; Satow, Takeshi; Fukuda, Miyuki; Saiki, Masaaki; Hojo, Masato; Miyamoto, Susumu; Onishi, Nobuyuki; Saya, Hideyuki; Inubushi, Toshiro; Nozaki, Kazuhiko; Tanigaki, Kenji			Arsenic Trioxide Sensitizes Glioblastoma to a Myc Inhibitor	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; GROWTH-FACTOR RECEPTOR; EGFR GENE AMPLIFICATION; STEM-CELLS; C-MYC; MALIGNANT GLIOMA; INITIATING CELLS; DOWN-REGULATION; CANCER-CELLS; DIFFERENTIATION	Glioblastoma multiforme (GBM) is associated with high mortality due to infiltrative growth and recurrence. Median survival of the patients is less than 15 months, increasing requirements for new therapies. We found that both arsenic trioxide and 10058F4, an inhibitor of Myc, induced differentiation of cancer stem-like cells (CSC) of GBM and that arsenic trioxide drastically enhanced the anti-proliferative effect of 10058F4 but not apoptotic effects. EGFR-driven genetically engineered GBM mouse model showed that this cooperative effect is higher in EGFRvIII-expressing INK4a/Arf(-/-) neural stem cells (NSCs) than in control wild type NSCs. In addition, treatment of GBM CSC xenografts with arsenic trioxide and 10058F4 resulted in significant decrease in tumor growth and increased differentiation with concomitant decrease of proneural and mesenchymal GBM CSCs in vivo. Our study was the first to evaluate arsenic trioxide and 10058F4 interaction in GBM CSC differentiation and to assess new opportunities for arsenic trioxide and 10058F4 combination as a promising approach for future differentiation therapy of GBM.	[Yoshimura, Yayoi; Muraki, Kazue; Tanigaki, Kenji] Shiga Med Ctr, Res Inst, Otsu, Shiga 5248524, Japan; [Yamada, Shigeki; Satow, Takeshi; Fukuda, Miyuki; Saiki, Masaaki; Hojo, Masato] Shiga Med Ctr, Dept Neurosurg, Otsu, Shiga 5248524, Japan; [Shiino, Akihiko; Inubushi, Toshiro] Shiga Univ Med Sci, Biomed MR Sci Ctr, Otsu, Shiga 5202192, Japan; [Yoshimura, Yayoi; Shiino, Akihiko; Fukami, Tadateru; Nozaki, Kazuhiko] Shiga Univ Med Sci, Dept Neurosurg, Otsu, Shiga 5202192, Japan; [Miyamoto, Susumu] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068507, Japan; [Onishi, Nobuyuki; Saya, Hideyuki] Keio Univ, Sch Med, Div Gene Regulat, Tokyo 1608582, Japan	Shiga University of Medical Science; Shiga University of Medical Science; Kyoto University; Keio University	Nozaki, K (corresponding author), Shiga Univ Med Sci, Dept Neurosurg, Otsu, Shiga 5202192, Japan.	noz@belle.shiga-med.ac.jp; tanigaki@res.med.shiga-pref.jp	Yamada, Shigeki/H-6914-2019; Saya, Hideyuki/J-4325-2013	Yamada, Shigeki/0000-0001-7158-5569; Saya, Hideyuki/0000-0001-6610-1902	Sagawa Foundation; Yasuda Medical Foundation	Sagawa Foundation; Yasuda Medical Foundation	This work was supported by Sagawa Foundation (K.T.) and Yasuda Medical Foundation (K.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babic I, 2013, CELL METAB, V17, P1000, DOI 10.1016/j.cmet.2013.04.013; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Buschbeck M, 2007, ONCOGENE, V26, P3415, DOI 10.1038/sj.onc.1210128; Carracedo A, 2012, J CLIN INVEST, V122, P3088, DOI 10.1172/JCI62129; Chen G, 2014, CANCER RES, V74, P4536, DOI 10.1158/0008-5472.CAN-13-3703; Chen GQ, 1996, BLOOD, V88, P1052; Cvrljevic AN, 2011, J CELL SCI, V124, P2938, DOI 10.1242/jcs.083295; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; EKSTRAND AJ, 1994, ONCOGENE, V9, P2313; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fan YJ, 2010, J BIOL CHEM, V285, P7324, DOI 10.1074/jbc.M109.035584; Fang XG, 2014, STEM CELLS, V32, P2033, DOI 10.1002/stem.1730; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Guo JX, 2009, CANCER CHEMOTH PHARM, V63, P615, DOI 10.1007/s00280-008-0774-y; Guo LL, 2014, MOL CELL, V55, P15, DOI 10.1016/j.molcel.2014.04.030; Haga N, 2005, CANCER SCI, V96, P825, DOI 10.1111/j.1349-7006.2005.00114.x; Hayashi Y, 1997, BRAIN PATHOL, V7, P871, DOI 10.1111/j.1750-3639.1997.tb00890.x; Iwanami A, 2013, P NATL ACAD SCI USA, V110, P4339, DOI 10.1073/pnas.1217602110; Jijiwa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024217; Kanzawa T, 2003, CANCER RES, V63, P2103; Kroemer G, 1999, JNCI-J NATL CANCER I, V91, P743, DOI 10.1093/jnci/91.9.743; Labuhn M, 2001, ONCOGENE, V20, P1103, DOI 10.1038/sj.onc.1204197; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Maeda H, 2001, CANCER RES, V61, P5432; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; Miller WH, 2002, CANCER RES, V62, P3893; Morrish F, 2010, J BIOL CHEM, V285, P36267, DOI 10.1074/jbc.M110.141606; Ning SC, 2004, INT J RADIAT ONCOL, V60, P197, DOI 10.1016/j.ijrobp.2004.02.013; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Pattappa G, 2013, TISSUE ENG PART C-ME, V19, DOI [10.1089/ten.tec.2011.0734, 10.1089/ten.TEC.2011.0734]; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Schreck KC, 2010, CLIN CANCER RES, V16, P6060, DOI 10.1158/1078-0432.CCR-10-1624; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Takezaki T, 2011, CANCER SCI, V102, P1306, DOI 10.1111/j.1349-7006.2011.01943.x; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weisberg SP, 2014, CELL REP, V6, P528, DOI 10.1016/j.celrep.2014.01.007; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; WONG AJ, 1987, P NATL ACAD SCI USA, V84, P6899, DOI 10.1073/pnas.84.19.6899; Wu JN, 2013, TOXICOL LETT, V220, P61, DOI 10.1016/j.toxlet.2013.03.019; Zhen YB, 2010, CANCER LETT, V292, P64, DOI 10.1016/j.canlet.2009.11.005; Zirath H, 2013, P NATL ACAD SCI USA, V110, P10258, DOI 10.1073/pnas.1222404110	51	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128288	10.1371/journal.pone.0128288	http://dx.doi.org/10.1371/journal.pone.0128288			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26038891	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700094
J	Caruso, V; Le Greves, M; Fard, SS; Haitina, T; Olszewski, PK; Alsio, J; Schioth, HB; Fredriksson, R				Caruso, Vanni; Le Greves, Madeleine; Fard, Shahrzad Shirazi; Haitina, Tatjana; Olszewski, Pawel K.; Alsio, Johan; Schioth, Helgi B.; Fredriksson, Robert			The Orphan G Protein-Coupled Receptor Gene GPR178 Is Evolutionary Conserved and Altered in Response to Acute Changes in Food Intake	PLOS ONE			English	Article							HIPPOCAMPUS; FAMILIES; MAJORITY; NUCLEUS; HISTORY; SATIETY	G protein-coupled receptors (GPCRs) are a class of integral membrane proteins mediating physiological functions fundamental for survival, including energy homeostasis. A few years ago, an amino acid sequence of a novel GPCR gene was identified and named GPR178. In this study, we provide new insights regarding the biological significance of Gpr178 protein, investigating its evolutionary history and tissue distribution as well as examining the relationship between its expression level and feeding status. Our phylogenetic analysis indicated that GPR178 is highly conserved among all animal species investigated, and that GPR178 is not a member of a protein family. Real-time PCR and in situ hybridization revealed wide expression of Gpr178 mRNA in both the brain and periphery, with high expression density in the hypothalamus and brainstem, areas involved in the regulation of food intake. Hence, changes in receptor expression were assessed following several feeding paradigms including starvation and overfeeding. Short-term starvation (12-48h) or food restriction resulted in upregulation of Gpr178 mRNA expression in the brainstem, hypothalamus and prefrontal cortex. Conversely, short-term (48h) exposure to sucrose or Intralipid solutions downregulated Gpr178 mRNA in the brainstem; long-term exposure (10 days) to a palatable high-fat and high-sugar diet resulted in a downregulation of Gpr178 in the amygdala but not in the hypothalamus. Our results indicate that hypothalamic Gpr178 gene expression is altered during acute exposure to starvation or acute exposure to palatable food. Changes in gene expression following palatable diet consumption suggest a possible involvement of Gpr178 in the complex mechanisms of feeding reward.	[Caruso, Vanni; Le Greves, Madeleine; Fard, Shahrzad Shirazi; Haitina, Tatjana; Olszewski, Pawel K.; Alsio, Johan; Schioth, Helgi B.; Fredriksson, Robert] Uppsala Univ, Unit Funct Pharmacol, Dept Neurosci, Uppsala, Sweden; [Olszewski, Pawel K.] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand	Uppsala University; University of Waikato	Fredriksson, R (corresponding author), Uppsala Univ, Unit Funct Pharmacol, Dept Neurosci, Uppsala, Sweden.	robert.fredriksson@neuro.uu.se	Schioth, Helgi/AAQ-7239-2020; Fredriksson, Robert/AAH-3921-2019; Alsio, Johan/ABB-3210-2021	Fredriksson, Robert/0000-0002-2810-3226; Haitina, Tatjana/0000-0002-8754-5534; Caruso, Vanni/0000-0002-0523-6149; Olszewski, Pawel/0000-0002-2846-0485	Swedish Research Council; Ahlens Foundation; Swedish Brain Research Foundation; Novo Nordisk Foundation; Engkvist Foundation; Magnus Bergvall Foundation; Novo Nordisk Fonden [NNF15OC0016184, NNF13OC0005723, NNF12OC1016287] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ahlens Foundation; Swedish Brain Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Engkvist Foundation; Magnus Bergvall Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by the Swedish Research Council (http://www.vr.se), Ahlens Foundation (http://www.ahlen-stiftelsen.se/), the Swedish Brain Research Foundation (http://www.hjarnfonden.se/), the Novo Nordisk Foundation (http://www.novonordiskfonden.dk/), Engkvist Foundation (http://www.engkviststiftelserna.se/) and Magnus Bergvall Foundation (http://www.magnbergvallsstiftelse.nu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2002, J NEUROSCI, V22, P10958; Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Brauner-Osborne H, 2007, CURR DRUG TARGETS, V8, P169, DOI 10.2174/138945007779315614; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Carlini VP, 2004, BIOCHEM BIOPH RES CO, V313, P635, DOI 10.1016/j.bbrc.2003.11.150; Civelli O, 2013, ANNU REV PHARMACOL, V53, P127, DOI 10.1146/annurev-pharmtox-010611-134548; Davidson TL, 2009, HIPPOCAMPUS, V19, P235, DOI 10.1002/hipo.20499; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gloriam DE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-338; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Krasnoperov VG, 1997, NEURON, V18, P925, DOI 10.1016/S0896-6273(00)80332-3; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lagerstrom MC, 2007, J NEUROCHEM, V100, P1129, DOI 10.1111/j.1471-4159.2006.04281.x; Lagerstrom MC, 2006, PLOS COMPUT BIOL, V2, P493, DOI 10.1371/journal.pcbi.0020054; Land BB, 2014, NAT NEUROSCI, V17, P248, DOI 10.1038/nn.3625; Mietlicki-Baase EG, 2013, AM J PHYSIOL-ENDOC M, V305, pE1367, DOI 10.1152/ajpendo.00413.2013; Nordstrom KJV, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-9; Paxinos G, 2007, PAXINOS AND FRANKLIN; Pecina S, 2003, J NEUROSCI, V23, P9395; Qian ZHANG, 2011, [Frontiers in Biology, 生物学前沿], V6, P82; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Satoh N, 1997, ENDOCRINOLOGY, V138, P947, DOI 10.1210/en.138.3.947; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; STELLAR E, 1994, PSYCHOL REV, V101, P301, DOI 10.1037//0033-295X.101.2.301; Sundberg BE, 2008, J MOL NEUROSCI, V35, P179, DOI 10.1007/s12031-008-9046-x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yeo GSH, 2012, NAT NEUROSCI, V15, P1343, DOI 10.1038/nn.3211	30	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0122061	10.1371/journal.pone.0122061	http://dx.doi.org/10.1371/journal.pone.0122061			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047506	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200002
J	Cornet, E; Debliquis, A; Rimelen, V; Civic, N; Docquier, M; Troussard, X; Drenou, B; Matthes, T				Cornet, Edouard; Debliquis, Agathe; Rimelen, Valerie; Civic, Natacha; Docquier, Mylene; Troussard, Xavier; Drenou, Bernard; Matthes, Thomas			Developing Molecular Signatures for Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							INDUCED CYTIDINE DEAMINASE; GENE-EXPRESSION; ZAP-70 EXPRESSION; MUTATION STATUS; GENOMIC ABERRATIONS; LIPOPROTEIN-LIPASE; B-CELLS; IMMUNOGLOBULIN; SURVIVAL; DIAGNOSIS	Chronic lymphocytic leukemia (CLL) is a clonal malignancy of mature B cells that displays a great clinical heterogeneity, with many patients having an indolent disease that will not require intervention for many years, while others present an aggressive and symptomatic leukemia requiring immediate treatment. Although there is no cure for CLL, the disease is treatable and current standard chemotherapy regimens have been shown to prolong survival. Recent advances in our understanding of the biology of CLL have led to the identification of numerous cellular and molecular markers with potential diagnostic, prognostic and therapeutic significance. We have used the recently developed digital multiplexed gene-expression technique (DMGE) to analyze a cohort of 30 CLL patients for the presence of specific genes with known diagnostic and prognostic potential. Starting from a set of 290 genes we were able to develop a molecular signature, based on the analysis of 13 genes, which allows distinguishing CLL from normal peripheral blood and from normal B cells, and a second signature based on 24 genes, which distinguishes mutated from unmutated cases (LymphCLL Mut). A third classifier (LymphCLL Diag), based on a 44-gene signature, distinguished CLL cases from a series of other B-cell chronic lymphoproliferative disorders (n = 51). While the methodology presented here has the potential to provide a "ready to use" classification tool in routine diagnostics and clinical trials, application to larger sample numbers are still needed and should provide further insights about its robustness and utility in clinical practice.	[Cornet, Edouard; Troussard, Xavier] CHU Caen, Hematol Lab, F-14000 Caen, France; [Cornet, Edouard; Troussard, Xavier] Univ Caen, Sch Med, F-14000 Caen, France; [Debliquis, Agathe; Rimelen, Valerie; Drenou, Bernard] Hop Mulhouse, Dept Hematol, F-68051 Mulhouse, France; [Civic, Natacha; Docquier, Mylene] Univ Med Ctr, Genom Platform iGE3, CH-1211 Geneva, Switzerland; [Matthes, Thomas] Univ Hosp Geneva, Hematol Serv, CH-1211 Geneva, Switzerland; [Matthes, Thomas] Univ Hosp Geneva, Clin Pathol Serv, CH-1211 Geneva, Switzerland	CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Caen Normandie; Universite de Franche-Comte; University of Geneva; University of Geneva; University of Geneva	Matthes, T (corresponding author), Univ Hosp Geneva, Hematol Serv, CH-1211 Geneva, Switzerland.	thomas.matthes@hcuge.ch	Cornet, Edouard/M-5625-2019; Cornet, Edouard/A-9757-2010	Cornet, Edouard/0000-0003-1667-3421; Cornet, Edouard/0000-0003-1667-3421	Swiss National Science foundation [320030_132926]; Fondation Dr Dubois-Ferriere/DinuLipatti; Roche	Swiss National Science foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Dr Dubois-Ferriere/DinuLipatti; Roche(Roche Holding)	This work was supported by the Swiss National Science foundation (http://www.snf.ch; No 320030_132926) (to Thomas Matthes), by the "Fondation Dr Dubois-Ferriere/DinuLipatti" (to Thomas Matthes), as well as by a grant from Roche (http://www.roche.com) (to Thomas Matthes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albesiano E, 2003, BLOOD, V102, P3333, DOI 10.1182/blood-2003-05-1585; Beaume M, 2011, J MICROBIOL METH, V84, P327, DOI 10.1016/j.mimet.2010.12.025; Chiorazzi N, 2012, HEMATOL-AM SOC HEMAT, P76, DOI 10.1182/asheducation-2012.1.76; Cinzia Bologna RB, 2012, J IMMUNOLOGY; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Cro L, 2009, HEMATOL ONCOL, V27, P140, DOI 10.1002/hon.888; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Duzkale H, 2011, BLOOD, V117, P4076, DOI 10.1182/blood-2010-09-304881; Eisele L, 2009, EUR J HAEMATOL, V83, P320, DOI 10.1111/j.1600-0609.2009.01287.x; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Fernandez P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049010; Ferreira PG, 2014, GENOME RES, V24, P212, DOI 10.1101/gr.152132.112; Frezzato F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039902; Gattei V, 2008, BLOOD, V111, P865, DOI 10.1182/blood-2007-05-092486; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Ghia P, 2007, LEUKEMIA, V21, P1, DOI 10.1038/sj.leu.2404457; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Hanoun M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034347; Haslinger C, 2004, J CLIN ONCOL, V22, P3937, DOI 10.1200/JCO.2004.12.133; Heintel D, 2005, LEUKEMIA, V19, P1216, DOI 10.1038/sj.leu.2403748; Jelinek DF, 2003, MOL CANCER RES, V1, P346; Kienle D, 2010, HAEMATOL-HEMATOL J, V95, P102, DOI 10.3324/haematol.2009.010298; Letestu R, 2006, CYTOM PART B-CLIN CY, V70B, P309, DOI 10.1002/cyto.b.20132; Li FJ, 2008, BLOOD, V112, P179, DOI 10.1182/blood-2008-01-131359; Maloum K, 2009, ANN HEMATOL, V88, P1215, DOI 10.1007/s00277-009-0742-6; Masque-Soler N, 2013, BLOOD, V122, P1985, DOI 10.1182/blood-2013-06-508937; MATUTES E, 1994, LEUKEMIA, V8, P1640; McCarthy H, 2003, BLOOD, V101, P4903, DOI 10.1182/blood-2002-09-2906; Oppezzo P, 2005, BLOOD, V106, P650, DOI 10.1182/blood-2004-08-3344; Patricia Weiss EAP, 2012, CANNABINOID RECEPTOR; Porpaczy E, 2013, LEUKEMIA RES, V37, P631, DOI 10.1016/j.leukres.2013.02.008; Rassenti LZ, 2008, BLOOD, V112, P1923, DOI 10.1182/blood-2007-05-092882; Schweighofer CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028277; Scott DW, 2014, BLOOD, V123, P1214, DOI 10.1182/blood-2013-11-536433; Stilgenbauer S, 2014, BLOOD, V123, P3247, DOI 10.1182/blood-2014-01-546150; Sulda ML, 2010, CANCER BIOL THER, V10, P180, DOI 10.4161/cbt.10.2.12168; Sutton LA, 2015, HAEMATOLOGICA, V100, P370, DOI 10.3324/haematol.2014.109777; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; van't Veer MB, 2006, HAEMATOLOGICA, V91, P56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306; Wiggers TGH, 2014, CYTOM PART B-CLIN CY, V86, P280, DOI 10.1002/cyto.b.21132	44	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128990	10.1371/journal.pone.0128990	http://dx.doi.org/10.1371/journal.pone.0128990			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046539	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200114
J	Frouz, J; Kindlmann, P				Frouz, Jan; Kindlmann, Pavel			Source-Sink Colonization as a Possible Strategy of Insects Living in Temporary Habitats	PLOS ONE			English	Article							BUTTERFLY METAPOPULATION; EVOLUTIONARY STABILITY; OVIPOSITION BEHAVIOR; POPULATION; DYNAMICS; DIPTERA; MODEL; CHIRONOMIDAE; PREFERENCE; DISPERSAL	Continuous colonization and re-colonization is critical for survival of insect species living in temporary habitats. When insect populations in temporary habitats are depleted, some species may escape extinction by surviving in permanent, but less suitable habitats, in which long-term population survival can be maintained only by immigration from other populations. Such situation has been repeatedly described in nature, but conditions when and how this occurs and how important this phenomenon is for insect metapopulation survival are still poorly known, mainly because it is difficult to study experimentally. Therefore, we used a simulation model to investigate, how environmental stochasticity, growth rate and the incidence of dispersal affect the positive effect of permanent but poor ("sink") habitats on the likelihood of metapopulation persistence in a network of high quality but temporary ("source") habitats. This model revealed that permanent habitats substantially increase the probability of metapopulation persistence of insect species with poor dispersal ability if the availability of temporary habitats is spatio-temporally synchronized. Addition of permanent habitats to a system sometimes enabled metapopulation persistence even in cases in which the metapopulation would otherwise go extinct, especially for species with high growth rates. For insect species with low growth rates the probability of a metapopulation persistence strongly depended on the proportions of "source" to "source" and "sink" to "source" dispersal rates.	[Frouz, Jan; Kindlmann, Pavel] Charles Univ Prague, Inst Environm Studies, Prague, Czech Republic; [Frouz, Jan] Acad Sci Czech Republic, Inst Soil Biol, CR-37005 Ceske Budejovice, Czech Republic; [Kindlmann, Pavel] Acad Sci Czech Republic, Global Change Res Ctr, Dept Biodivers Res, Brno, Czech Republic	Charles University Prague; Czech Academy of Sciences; Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences	Kindlmann, P (corresponding author), Charles Univ Prague, Inst Environm Studies, Prague, Czech Republic.	pavel.kindlmann@centrum.cz	Kindlmann, Pavel/H-7718-2014; Frouz, Jan/G-2220-2014; Frouz, Jan/P-4388-2016	Frouz, Jan/0000-0002-0908-8606; Kindlmann, Pavel/0000-0003-4772-1182	Grant Agency of the Czech Republic [14-36098G, 526/98/P156]; Ministry of Education [CZ.1.05/1.1.00/02.0073]; Deutscher Akademischer Austauschdienst	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education; Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD))	PK was funded by the Grant Agency of the Czech Republic (www.gacr.cz) grant No. 14-36098G. JF was funded by the Grant Agency of the Czech Republic (www.gacr.cz) grant No. 526/98/P156, by Ministry of Education (www.msmt.cz) grant No. CZ.1.05/1.1.00/02.0073 and by Deutscher Akademischer Austauschdienst (www.daad.de) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigoni F, 2003, ADV APPL PROBAB, V35, P691, DOI 10.1239/aap/1059486824; Bansaye V, 2013, THEOR POPUL BIOL, V88, P31, DOI 10.1016/j.tpb.2013.06.003; Boughton DA, 1999, ECOLOGY, V80, P2727; DELETTRE YR, 1986, REV ECOL BIOL SOL, V23, P29; Donker SA, 2012, WILDLIFE RES, V39, P163, DOI 10.1071/WR11167; Frank K, 1998, LANDSCAPE ECOL, V13, P363, DOI 10.1023/A:1008054906030; Frouz J, 1997, RES POPUL ECOL, V39, P207, DOI 10.1007/BF02765267; Frouz J, 2001, OIKOS, V93, P50, DOI 10.1034/j.1600-0706.2001.930105.x; Griebeler EM, 2000, J INSECT CONSERV, V4, P225, DOI 10.1023/A:1011343609779; HANSKI I, 1989, TRENDS ECOL EVOL, V4, P113, DOI 10.1016/0169-5347(89)90061-X; HANSKI I, 1997, METAPOPULATION BIOL; Hanski I, 1989, METAPOPULATION DYNAM, P17; Harrison Susan, 1997, P27, DOI 10.1016/B978-012323445-2/50004-3; Holt RD, 1997, EVOL ECOL, V11, P723, DOI 10.1023/A:1018438403047; Joshi A, 1997, J BIOSCIENCES, V22, P325, DOI 10.1007/BF02703235; Krkosek M, 2010, THEOR ECOL-NETH, V3, P25, DOI 10.1007/s12080-009-0051-7; MAPPES J, 1993, OECOLOGIA, V93, P38, DOI 10.1007/BF00321188; MCLACHLAN AJ, 1988, ECOL ENTOMOL, V13, P185, DOI 10.1111/j.1365-2311.1988.tb00346.x; McVinish R, 2013, ECOL MODEL, V249, P84, DOI 10.1016/j.ecolmodel.2012.07.001; MINKENBERG OPJM, 1992, OIKOS, V65, P134, DOI 10.2307/3544896; MORRIS DW, 1991, AM NAT, V137, P907, DOI 10.1086/285200; Mustapha F, 1998, AUST J ZOOL, V46, P291; Nylin S, 2000, J INSECT BEHAV, V13, P469, DOI 10.1023/A:1007839200323; Petersen MJ, 2013, ECOL ENTOMOL, V38, P585, DOI 10.1111/een.12058; Pulliam RH, 1991, AM NAT             S, V137, P50; Pulliam RH, 1988, AM NAT, V132, P652, DOI DOI 10.1086/284880; Reigada C, 2012, OIKOS, V121, P1665, DOI 10.1111/j.1600-0706.2011.20259.x; Strasser CA, 2010, THEOR ECOL, V5, P167; Thomas CD, 1996, AM NAT, V148, P957, DOI 10.1086/285966; VALLADARES G, 1991, J ANIM ECOL, V60, P227, DOI 10.2307/5456; Vandermeer J, 2010, LANDSCAPE ECOL, V25, P509, DOI 10.1007/s10980-010-9449-2; Veenstra KH, 1998, PHYSIOL ENTOMOL, V23, P62, DOI 10.1046/j.1365-3032.1998.2310062.x; Zimmerman M, 1998, J INSECT BEHAV, V11, P371, DOI 10.1023/A:1020902714225	33	11	11	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127743	10.1371/journal.pone.0127743	http://dx.doi.org/10.1371/journal.pone.0127743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047010	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200028
J	Han, HS; Iakovenko, L; Wilson, AC				Han, Hesong; Iakovenko, Liudmyla; Wilson, Adam C.			Loss of Homogentisate 1,2-Dioxygenase Activity in Bacillus anthracis Results in Accumulation of Protective Pigment	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; MELANIN PIGMENT; SUBTILIS; DEGRADATION; SPORULATION; STATE; MUTAGENESIS; RESISTANCE; TYROSINE; STRAINS	Melanin production is important to the pathogenicity and survival of some bacterial pathogens. In Bacillus anthracis, loss of hmgA, encoding homogentisate 1,2-dioxygenase, results in accumulation of a melanin-like pigment called pyomelanin. Pyomelanin is produced in the mutant as a byproduct of disrupted catabolism of L-tyrosine and L-phenylalanine. Accumulation of pyomelanin protects B. anthracis cells from UV damage but not from oxidative damage. Neither loss of hmgA nor accumulation of pyomelanin alter virulence gene expression, sporulation or germination. This is the first investigation of homogentisate 1,2-dioxygenase activity in the Gram-positive bacteria, and these results provide insight into a conserved aspect of bacterial physiology.	[Han, Hesong; Iakovenko, Liudmyla; Wilson, Adam C.] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA	University System of Georgia; Georgia State University	Wilson, AC (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA.	acwilson@gsu.edu						Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI 10.1128/jb.186.15.5062-5077.2004; Bongiorni C, 2007, J BACTERIOL, V189, P2637, DOI 10.1128/JB.01798-06; Chiang C, 2011, J BACTERIOL, V193, P52, DOI 10.1128/JB.01656-09; COON SL, 1994, APPL ENVIRON MICROB, V60, P3006, DOI 10.1128/AEM.60.8.3006-3010.1994; CRAWFORD RL, 1976, CAN J MICROBIOL, V22, P276, DOI 10.1139/m76-037; Cybulski RJ, 2009, INFECT IMMUN, V77, P274, DOI 10.1128/IAI.00515-08; Geng JF, 2013, P NATL ACAD SCI USA, V110, P9639, DOI 10.1073/pnas.1301544110; Hammerstrom TG, 2011, MOL MICROBIOL, V82, P634, DOI 10.1111/j.1365-2958.2011.07843.x; Han HS, 2013, J BACTERIOL, V195, P5242, DOI 10.1128/JB.00917-13; Hullo MF, 2001, J BACTERIOL, V183, P5426, DOI 10.1128/JB.183.18.5426-5430.2001; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Koehler TM, 2009, MOL ASPECTS MED, V30, P386, DOI 10.1016/j.mam.2009.07.004; KOEHLER TM, 1994, J BACTERIOL, V176, P586, DOI 10.1128/jb.176.3.586-595.1994; Lai EM, 2003, J BACTERIOL, V185, P1443, DOI 10.1128/JB.185.4.1443-1454.2003; Miller JH., 1972, EXPT MOL GENETICS; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Riesenman PJ, 2000, APPL ENVIRON MICROB, V66, P620, DOI 10.1128/AEM.66.2.620-626.2000; RISTROPH JD, 1983, INFECT IMMUN, V39, P483, DOI 10.1128/IAI.39.1.483-486.1983; Rodriguez-Rojas A, 2009, MICROBIOL-SGM, V155, P1050, DOI 10.1099/mic.0.024745-0; Saile E, 2002, J BACTERIOL, V184, P370, DOI 10.1128/JB.184.2.370-380.2002; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez-Amat A, 1998, COMP BIOCHEM PHYS B, V119, P557, DOI 10.1016/S0305-0491(98)00028-5; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; Schmaler-Ripcke J, 2009, APPL ENVIRON MICROB, V75, P493, DOI 10.1128/AEM.02077-08; Tsvetanova B, 2007, MOL MICROBIOL, V63, P644, DOI 10.1111/j.1365-2958.2006.05543.x; Valeru SP, 2009, INFECT IMMUN, V77, P935, DOI 10.1128/IAI.00929-08; van Schaik W, 2009, INFECT IMMUN, V77, P4437, DOI 10.1128/IAI.00716-09; Wang Z, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00379; Wilson AC, 2008, J BACTERIOL, V190, P5522, DOI 10.1128/JB.00312-08; Wilson AC, 2007, J MICROBIOL METH, V71, P332, DOI 10.1016/j.mimet.2007.09.006; Wilson AC, 2011, METHODS MOL BIOL, V765, P359, DOI 10.1007/978-1-61779-197-0_21; Wilson AC, 2009, MOL MICROBIOL, V72, P109, DOI 10.1111/j.1365-2958.2009.06627.x; Zughaier SM, 1999, INFECT IMMUN, V67, P908, DOI 10.1128/IAI.67.2.908-913.1999	34	13	13	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128967	10.1371/journal.pone.0128967	http://dx.doi.org/10.1371/journal.pone.0128967			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047497	gold, Green Published, Green Submitted			2022-12-27	WOS:000355652200111
J	Hsin, YC; Zhuang, LZ; Yeh, KW; Chang, CW; Horng, JT; Huang, JL				Hsin, Yi-Chen; Zhuang, Lai-Zhen; Yeh, Kuo-Wei; Chang, Cheng-Wei; Horng, Jorng-Tzong; Huang, Jing-Long			Risk of Tuberculosis in Children with Juvenile Idiopathic Arthritis: A Nationwide Population-Based Study in Taiwan	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; THERAPY; SAFETY; ETANERCEPT; REGISTER; EFFICACY	Objective We aimed to determine the risk of tuberculosis in children with juvenile idiopathic arthritis (JIA) in Taiwan. Methods We used the Taiwan National Health Insurance Research Database (NHIRD) to conduct a nested case-control study. We identified a JIA cohort and matched each JIA child with non-JIA children for comparison. Methotrexate (MTX), tumor necrosis factor (TNF) inhibitor administration, and new tuberculosis cases were determined during our study period. To compare tuberculosis (TB) risk among our study groups, Cox proportional regression models were used to determine adjusted hazard ratios (aHRs). Results We identified 1495 children with JIA and 11592 non-JIA children. Majority (68.7%) children with JIA had not received MTX or TNF inhibitors; 23.9% used MTX without TNF inhibitors, and 7.4% received TNF inhibitors, irrespective of MTX administration. In total, 43 children developed tuberculosis. The overall tuberculosis infection rate for children with JIA was two times higher than that for non-JIA children. Compared with non-JIA children, children with JIA who used MTX without TNF inhibitors revealed a significantly increased of tuberculosis infection rate (aHR = 4.67; 95% CI: 1.65-13.17; P = 0.004). Children with JIA who either received TNF inhibitors or never used MTX and TNF inhibitors revealed a tuberculosis infection rate comparable to that of non-JIA children. Conclusions Analysis of nationwide data of Taiwan suggested that children with JIA were at higher risk of tuberculosis compared with those without JIA.	[Hsin, Yi-Chen; Yeh, Kuo-Wei; Huang, Jing-Long] Chang Gung Mem Hosp, Div Pediat, Dept Pediat Allergy Immunol & Rheumatol, Taoyuan, Taiwan; [Zhuang, Lai-Zhen; Horng, Jorng-Tzong] Natl Cent Univ, Dept Comp Sci & Informat Engn, Chungli 32054, Taiwan; [Chang, Cheng-Wei] Hsing Wu Univ, Dept Informat Management, New Taipei City, Taiwan; [Horng, Jorng-Tzong] Asia Univ, Dept Biomed Informat, Taichung, Taiwan	Chang Gung Memorial Hospital; National Central University; Asia University Taiwan	Horng, JT (corresponding author), Natl Cent Univ, Dept Comp Sci & Informat Engn, Chungli 32054, Taiwan.	long@adm.cgmh.org.tw; horng@db.csie.ncu.edu.tw	Yeh, Kuo-Wei/V-3725-2019	Huang, Jing-Long/0000-0001-9280-920X; Huang, Jing-Long/0000-0002-3530-7753				Amine B, 2009, RHEUMATOL INT, V29, P275, DOI 10.1007/s00296-008-0672-y; Arkema EV, 2015, ANN RHEUM DIS, V74, P1212, DOI 10.1136/annrheumdis-2013-204960; Askling J, 2005, ARTHRITIS RHEUM-US, V52, P1986, DOI 10.1002/art.21137; Baronnet L, 2011, JOINT BONE SPINE, V78, P279, DOI 10.1016/j.jbspin.2010.12.004; Beukelman T, 2013, ARTHRITIS RHEUM-US, V65, P1384, DOI 10.1002/art.37866; Brassard P, 2009, ARTHRIT RHEUM-ARTHR, V61, P300, DOI 10.1002/art.24476; Centers for Disease Control R.O.C. (Taiwan), 2012, TAIW TUB CONTR REP 2; Chan PC, 2007, EMERG INFECT DIS, V13, P1361, DOI 10.3201/eid1309.061020; Coulson EJ, 2013, RHEUMATOLOGY, V52, P1163, DOI 10.1093/rheumatology/ket106; Dixon WG, 2010, ANN RHEUM DIS, V69, P522, DOI 10.1136/ard.2009.118935; Foster HE, 2003, ARTHRITIS RHEUM-US, V48, P767, DOI 10.1002/art.10863; Giannini EH, 2009, ARTHRITIS RHEUM, V60, P2794, DOI 10.1002/art.24777; Huang JL, 2004, CLIN EXP RHEUMATOL, V22, P776; Kuo HC, 2011, J MICROBIOL IMMUNOL, V44, P52, DOI 10.1016/j.jmii.2011.01.010; Lovell DJ, 2008, ARTHRITIS RHEUM-US, V58, P1496, DOI 10.1002/art.23427; Malviya A, 2012, ARTHRITIS RHEUM-US, V64, P3016, DOI 10.1002/art.34499; Prince FHM, 2009, ANN RHEUM DIS, V68, P635, DOI 10.1136/ard.2007.087411; Ruperto N, 2010, ANN RHEUM DIS, V69, P718, DOI 10.1136/ard.2009.100354; Shen CC, 2013, SEMIN ARTHRITIS RHEU, V42, P590, DOI 10.1016/j.semarthrit.2012.10.002; Tubach F, 2009, ARTHRITIS RHEUM-US, V60, P1884, DOI 10.1002/art.24632; Tynjala P, 2006, ANN RHEUM DIS, V65, P1044, DOI 10.1136/ard.2005.047225; Winthrop KL, 2013, ANN RHEUM DIS, V72, P37, DOI 10.1136/annrheumdis-2011-200690; Winthrop KL, 2013, NAT REV RHEUMATOL, V9, P524, DOI 10.1038/nrrheum.2013.82; World Health Organization, GLOB TUB REP 2013; Xie X, 2014, J MICROBIOL IMMUNOL, V47, P268, DOI 10.1016/j.jmii.2013.03.005	25	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128768	10.1371/journal.pone.0128768	http://dx.doi.org/10.1371/journal.pone.0128768			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047099	gold, Green Submitted, Green Published			2022-12-27	WOS:000355652200099
J	Nickzad, A; Lepine, F; Deziel, E				Nickzad, Arvin; Lepine, Francois; Deziel, Eric			Quorum Sensing Controls Swarming Motility of Burkholderia glumae through Regulation of Rhamnolipids	PLOS ONE			English	Article							LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY; PSEUDOMONAS-AERUGINOSA; SYSTEM; BIOSYNTHESIS; PSEUDOMALLEI; EXPRESSION; VIRULENCE; BACTERIA	Burkholderia glumae is a plant pathogenic bacterium that uses an acyl-homoserine lactone-mediated quorum sensing system to regulate protein secretion, oxalate production and major virulence determinants such as toxoflavin and flagella. B. glumae also releases surface-active rhamnolipids. In Pseudomonas aeruginosa and Burkholderia thailandensis, rhamnolipids, along with flagella, are required for the social behavior called swarming motility. In the present study, we demonstrate that quorum sensing positively regulates the production of rhamnolipids in B. glumae and that rhamnolipids are necessary for swarming motility also in this species. We show that a rhlA-mutant, which is unable to produce rhamnolipids, loses its ability to swarm, and that this can be complemented by providing exogenous rhamnolipids. Impaired rhamnolipid production in a quorum sensing-deficient B. glumae mutant is the main factor responsible for its defective swarming motility behaviour.	[Nickzad, Arvin; Lepine, Francois; Deziel, Eric] INRS Inst Armand Frappier, Laval, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS)	Deziel, E (corresponding author), INRS Inst Armand Frappier, Laval, PQ, Canada.	eric.deziel@iaf.inrs.ca	Déziel, Eric/A-7678-2008	Déziel, Eric/0000-0002-4609-0115; Nickzad, Arvin/0000-0002-0705-9377	Natural Sciences and Engineering Research Council of Canada (NSERC) [312478]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Investigations on rhamnolipids in the ED laboratory are funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant No. 312478. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mawgoud AM, 2014, METHODS MOL BIOL, V1149, P359, DOI 10.1007/978-1-4939-0473-0_30; Abdel-Mawgoud AM, 2011, MICROBIOL MONOGR, V20, P13, DOI 10.1007/978-3-642-14490-5_2; Becher A, 2000, BIOTECHNIQUES, V29, P948, DOI 10.2144/00295bm04; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Choi KH, 2008, APPL ENVIRON MICROB, V74, P1064, DOI 10.1128/AEM.02430-07; Chun H, 2009, J BACTERIOL, V191, P4152, DOI 10.1128/JB.00227-09; Costa SGVAO, 2011, LETT APPL MICROBIOL, V53, P620, DOI 10.1111/j.1472-765X.2011.03154.x; Daniels R, 2004, FEMS MICROBIOL REV, V28, P261, DOI 10.1016/j.femsre.2003.09.004; Deziel E, 1999, BBA-MOL CELL BIOL L, V1440, P244, DOI 10.1016/S1388-1981(99)00129-8; Dubeau D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-263; Dusane DH, 2010, BIOTECHNOL GENET ENG, V27, P159, DOI 10.1080/02648725.2010.10648149; Goo E, 2012, P NATL ACAD SCI USA, V109, P19775, DOI 10.1073/pnas.1218092109; Goo E, 2010, J PROTEOME RES, V9, P3184, DOI 10.1021/pr100045n; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; Haussler S, 2003, INFECT IMMUN, V71, P2970, DOI 10.1128/IAI.71.5.2970-2975.2003; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Huber B, 2001, MICROBIOL-SGM, V147, P2517, DOI 10.1099/00221287-147-9-2517; Jang MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084831; Jeong Y, 2003, PLANT DIS, V87, P890, DOI 10.1094/PDIS.2003.87.8.890; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kim J, 2004, MOL MICROBIOL, V54, P921, DOI 10.1111/j.1365-2958.2004.04338.x; Kim J, 2007, MOL MICROBIOL, V64, P165, DOI 10.1111/j.1365-2958.2007.05646.x; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Partridge JD, 2013, J BACTERIOL, V195, P909, DOI 10.1128/JB.02063-12; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Tans-Kersten J, 2001, J BACTERIOL, V183, P3597, DOI 10.1128/JB.183.12.3597-3605.2001; Tremblay J, 2007, ENVIRON MICROBIOL, V9, P2622, DOI 10.1111/j.1462-2920.2007.01396.x; Tremblay J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-587; Tremblay J, 2008, J BASIC MICROB, V48, P509, DOI 10.1002/jobm.200800030; Xavier JB, 2011, MOL MICROBIOL, V79, P166, DOI 10.1111/j.1365-2958.2010.07436.x; Zulianello L, 2006, INFECT IMMUN, V74, P3134, DOI 10.1128/IAI.01772-05	31	40	45	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128509	10.1371/journal.pone.0128509	http://dx.doi.org/10.1371/journal.pone.0128509			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047513	Green Published, gold			2022-12-27	WOS:000355652200072
J	Oxlade, O; Huang, CC; Murray, M				Oxlade, Olivia; Huang, Chuan-Chin; Murray, Megan			Estimating the Impact of Reducing Under-Nutrition on the Tuberculosis Epidemic in the Central Eastern States of India: A Dynamic Modeling Study	PLOS ONE			English	Article							RISK; PRACTITIONERS; MALNUTRITION; PROGRESS; ENGLAND; WEIGHT; HEALTH; WALES	Background Tuberculosis (TB) and under-nutrition are widespread in many low and middle-income countries. Momentum to prioritize under-nutrition has been growing at an international level, as demonstrated by the "Scaling Up Nutrition" movement. Low body mass index is an important risk factor for developing TB disease. The objective of this study was to project future trends in TB related outcomes under different scenarios for reducing under-nutrition in the adult population in the Central Eastern states of India. Methods A compartmental TB transmission model stratified by body mass index was parameterized using national and regional data from India. We compared TB related mortality and incidence under several scenarios that represented a range of policies and programs designed to reduce the prevalence of under-nutrition, based on the experience and observed trends in similar countries. Results The modeled nutrition intervention scenarios brought about reductions in TB incidence and TB related mortality in the Central Eastern Indian states ranging from 43% to 71% and 40% to 68% respectively, relative to the scenario of no nutritional intervention. Modest reductions in under-nutrition averted 4.8 (95% UR 0.5, 17.1) million TB cases and 1.6 (95% UR 0.5, 5.2) million TB related deaths over a period of 20 years of intervention, relative to the scenario of no nutritional intervention. Complete elimination of under-nutrition in the Central Eastern states averted 9.4 (95% UR 1.5, 30.6) million TB cases and 3.2 (95% UR 0.7-, 10.1) million TB related deaths, relative to the scenario of no nutritional intervention. Conclusion Our study suggests that intervening on under-nutrition could have a substantial impact on TB incidence and mortality in areas with high prevalence of under-nutrition, even if only small gains in under-nutrition can be achieved. Focusing on under-nutrition may be an effective way to reduce both rates of TB and other diseases associated with under-nutrition.	[Oxlade, Olivia; Huang, Chuan-Chin; Murray, Megan] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Murray, Megan] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Murray, Megan] Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Murray, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	mmurray@hsph.harvard.edu			Canadian Institute of Health Research [FRN 106987]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	OO received a post doctoral fellowship from the Canadian Institute of Health Research (FRN 106987). MM and CCH had no specific funding for this project.	[Anonymous], 2013, MILL DEV GOALS REP 2; Arora VK, 2003, INT J TUBERC LUNG D, V7, P1131; Bowden S, 2014, EUR REV ECON HIST, V18, P57, DOI 10.1093/ereh/het018; Cegielski JP, 2012, AM J EPIDEMIOL, V176, P409, DOI 10.1093/aje/kws007; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Department of International Development/UKAID, 2011, SCAL NUTR UKS POS PA; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Dye C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021161; Food and Agriculture Organization of the United Nations, 2013, STAT FOOD INS WORLD, DOI [10.3945/an.112.003343, DOI 10.3945/AN.112.003343]; Gillespie S, 2013, LANCET, V382, P552, DOI 10.1016/S0140-6736(13)60842-9; Goverment of India, 2011, IND CENS; Indian Nutrition Profile Survey, 1995, IND NUTR PROF SURV; International Food Policy Research Institute, 2013, GLOB HUNG IND 2013; Lin HH, 2008, LANCET, V372, P1473, DOI 10.1016/S0140-6736(08)61345-8; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308; LONNROTH K, 2010, TUBERCULOSIS ROLE RI, P219; MCKEOWN T, 1962, POP STUD-J DEMOG, V16, P94, DOI 10.2307/2173119; Mehler PS, 2010, J NUTR METABOLISM 20, V2010; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; National AIDS Control Organization, IND HIV DAT; Odone A, 2014, LANCET DIABETES ENDO, V2, P754, DOI 10.1016/S2213-8587(14)70164-0; Oxlade O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047533; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; Sachan D, 2013, LANCET, V382, P194, DOI 10.1016/S0140-6736(13)61586-X; SALISBURY JJ, 1995, INT J EAT DISORDER, V17, P337, DOI 10.1002/1098-108X(199505)17:4&lt;337::AID-EAT2260170405&gt;3.0.CO;2-Q; Satyanarayana S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024160; Scaling Up Nutrition, 2013, STAT SUN MOVEMENT PR; Singh A, 2014, ECON DEV CULT CHANGE, V62, P275, DOI 10.1086/674097; SPRINGETT V H, 1971, Tubercle, V52, P73, DOI 10.1016/0041-3879(71)90015-8; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; Styblo K, 1984, SELECTED PAPERS, V24; Subramanyam MA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000424; SUTHERLAND I, 1976, Bulletin of the International Union Against Tuberculosis, V51, P171; Svedberg P, 2008, WHY MALNUTRITION SHI; THOMPSON AM, 1991, IEEE T PATTERN ANAL, V13, P326, DOI 10.1109/34.88568; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD POP PROSP 2012; Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7; Uplekar M, 1998, INT J TUBERC LUNG D, V2, P324; Vollmer S, 2014, LANCET GLOB HEALTH, V2, pE225, DOI 10.1016/S2214-109X(14)70025-7; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; Vynnycky E, 1997, INT J TUBERC LUNG D, V1, P389; Walpole SC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-439; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	47	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128187	10.1371/journal.pone.0128187	http://dx.doi.org/10.1371/journal.pone.0128187			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046649	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200045
J	Schubert, M; Ruedin, P; Civardi, C; Richter, M; Hach, A; Christen, H				Schubert, Mark; Ruedin, Pascal; Civardi, Chiara; Richter, Michael; Hach, Andre; Christen, Herbert			Laccase-Catalyzed Surface Modification of Thermo-Mechanical Pulp (TMP) for the Production of Wood Fiber Insulation Boards Using Industrial Process Water	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; OXIDATION; LIGNIN; MEDIATORS; IMPROVES	Low-density wood fiber insulation boards are traditionally manufactured in a wet process using a closed water circuit (process water). The water of these industrial processes contains natural phenolic extractives, aside from small amounts of admixtures (e.g., binders and paraffin). The suitability of two fungal laccases and one bacterial laccase was determined by biochemical characterization considering stability and substrate spectra. In a series of laboratory scale experiments, the selected commercial laccase from Myceliophtora thermophila was used to catalyze the surface modification of thermo-mechanical pulp (TMP) using process water. The laccase catalyzed the covalent binding of the phenolic compounds of the process water onto the wood fiber surface and led to change of the surface chemistry directly via crosslinking of lignin moieties. Although a complete substitution of the binder was not accomplished by laccase, the combined use of laccase and latex significantly improved the mechanical strength properties of wood fiber boards. The enzymatically-treated TMP showed better interactions with the synthetic binder, as shown by FTIR-analysis. Moreover, the enzyme is extensively stable in the process water and the approach requires no fresh water as well as no cost-intensive mediator. By applying a second-order polynomial model in combination with the genetic algorithm (GA), the required amount of laccase and synthetic latex could be optimized enabling the reduction of the binder by 40%.	[Schubert, Mark; Civardi, Chiara; Hach, Andre] Empa, Swiss Fed Labs Mat Sci & Technol, Lab Appl Wood Mat, St Gallen, Switzerland; [Richter, Michael] Empa, Swiss Fed Labs Mat Sci & Technol, Lab Biointerfaces, St Gallen, Switzerland; [Civardi, Chiara] ETH, Inst Bldg Mat, Zurich, Switzerland; [Ruedin, Pascal; Christen, Herbert] Pavatex SA, Cham, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Swiss Federal Institutes of Technology Domain; ETH Zurich	Schubert, M (corresponding author), Empa, Swiss Fed Labs Mat Sci & Technol, Lab Appl Wood Mat, St Gallen, Switzerland.	mark.schubert@empa.ch		Schubert, Mark/0000-0002-6900-0370	Swiss CTI (innovation promotion agency) Research project Integration of the enzyme laccase in the production of wood fiber insulation boards [11476.2 PFIW-IW]; Pavatex SA	Swiss CTI (innovation promotion agency) Research project Integration of the enzyme laccase in the production of wood fiber insulation boards; Pavatex SA	The present study emerged from the Swiss CTI (innovation promotion agency): https://www.kti.admin.ch/kti/en/home.html, Research project 11476.2 PFIW-IW Integration of the enzyme laccase in the production of wood fiber insulation boards, Recipient: Mark Schubert. Pavatex SA provided support in the form of salaries for authors PR and HC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	[Anonymous], 2012, 13171 EN; BOURBONNAIS R, 1990, FEBS LETT, V267, P99, DOI 10.1016/0014-5793(90)80298-W; Calcaterra A, 2008, J MOL CATAL B-ENZYM, V51, P118, DOI 10.1016/j.molcatb.2007.11.023; Camarero S, 2005, APPL ENVIRON MICROB, V71, P1775, DOI 10.1128/AEM.71.4.1775-1784.2005; Canas AI, 2010, BIOTECHNOL ADV, V28, P694, DOI 10.1016/j.biotechadv.2010.05.002; Chen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025647; d'Acunzo F, 2003, EUR J BIOCHEM, V270, P3634, DOI 10.1046/j.1432-1033.2003.03752.x; Euring M, 2011, BIOTECHNOL J, V6, P1253, DOI 10.1002/biot.201100119; Fackler K, 2008, HOLZFORSCHUNG, V62, P223, DOI 10.1515/HF.2008.045; Felby C, 2004, IND CROP PROD, V20, P181, DOI 10.1016/j.indcrop.2004.04.020; Felby C, 2002, ENZYME MICROB TECH, V31, P736, DOI 10.1016/S0141-0229(02)00111-4; FELBY C, 1998, ACS SYM SER, V687, P88; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Hassingboe J, 1998, 7 INT C BIOT PULP PA; Hollmann F, 2012, POLYMERS-BASEL, V4, P759, DOI 10.3390/polym4010759; Jeyamkondan S, 2001, INT J FOOD MICROBIOL, V64, P343, DOI 10.1016/S0168-1605(00)00483-9; Kharazipour A, 1997, J ADHES SCI TECHNOL, V11, P419, DOI 10.1163/156856197X00796; Kudanga T, 2011, ENZYME MICROB TECH, V48, P195, DOI 10.1016/j.enzmictec.2010.11.007; Kues U., 2007, WOOD PRODUCTION WOOD, P433; Kulys J, 2005, BIOTECHNOL BIOENG, V92, P124, DOI 10.1002/bit.20610; Orsa F, 1997, WOOD SCI TECHNOL, V31, P279, DOI 10.1007/s002260050035; Oscar TR, 2005, J FOOD SCI, V70, pM129, DOI 10.1111/j.1365-2621.2005.tb07103.x; Pardo I., 2015, CELL MOL LIFE SCI, P1, DOI [10.1007/s00018-014-1710-4, DOI 10.1007/S00018-014-1710-4]; Patel SKS, 2014, J MICROBIOL BIOTECHN, V24, P639, DOI 10.4014/jmb.1401.01025; Reiss R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065633; Reiss R, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-9; Schroeder Marc, 2007, Biotechnology Journal, V2, P334, DOI 10.1002/biot.200600209; Schubert M, 2012, J BIOTECHNOL, V161, P429, DOI 10.1016/j.jbiotec.2012.08.003; Schubert M, 2010, APPL MICROBIOL BIOT, V85, P703, DOI 10.1007/s00253-009-2185-3; SJOSTROM J, 1990, J ANAL APPL PYROL, V17, P305, DOI 10.1016/0165-2370(90)85019-J; Unbehaun H, 2000, ACTA BIOTECHNOL, V20, P305, DOI 10.1002/abio.370200311; Widsten P, 2008, ENZYME MICROB TECH, V42, P293, DOI 10.1016/j.enzmictec.2007.12.003; Xu F, 1996, BIOCHEMISTRY-US, V35, P7608, DOI 10.1021/bi952971a; Zhou GW, 2009, BIORESOURCE TECHNOL, V100, P505, DOI 10.1016/j.biortech.2008.06.010	34	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128623	10.1371/journal.pone.0128623	http://dx.doi.org/10.1371/journal.pone.0128623			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046652	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200085
J	Stetzner, ZW; Li, DF; Feng, WC; Liu, MY; Liu, GH; Wiley, J; Lei, BF				Stetzner, Zachary W.; Li, Dengfeng; Feng, Wenchao; Liu, Mengyao; Liu, Guanghui; Wiley, James; Lei, Benfang			Serotype M3 and M28 Group A Streptococci Have Distinct Capacities to Evade Neutrophil and TNF-alpha Responses and to Invade Soft Tissues	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEM; HYALURONIC-ACID CAPSULE; GENOME SEQUENCE; MOLECULAR CHARACTERIZATION; ENHANCED VIRULENCE; GENE-EXPRESSION; M-PROTEIN; IN-VIVO; STRAIN; DISEASE	The M3 Serotype of Group A Streptococcus (GAS) is one of the three most frequent serotypes associated with severe invasive GAS infections, such as necrotizing fasciitis, in the United States and other industrialized countries. The basis for this association and hypervirulence of invasive serotype M3 GAS is not fully understood. In this study, the sequenced serotype M3 strain, MGAS315, and serotype M28 strain, MGAS6180, were characterized in parallel to determine whether contemporary M3 GAS has a higher capacity to invade soft tissues than M28 GAS. In subcutaneous infection, MGAS315 invaded almost the whole skin, inhibited neutrophil recruitment and TNF-alpha production, and was lethal in subcutaneous infection of mice, whereas MGAS6180 did not invade skin, induced robust neutrophil infiltration and TNF-alpha production, and failed to kill mice. In contrast to MGAS6180, MGAS315 had covS G1370T mutation. Either replacement of the covS(1370T) gene with wild-type covS in MGAS315 chromosome or in trans expression of wild-type covS in MGAS315 reduced expression of CovRS-controlled virulence genes hasA, spyCEP, and sse by >10 fold. MGAS315 covS(wt) lost the capacity to extensively invade skin and to inhibit neutrophil recruitment and had attenuated virulence, indicating that the covS G1370T mutation critically contribute to the hypervirulence of MGAS315. Under the background of functional CovRS, MGAS315 covS(wt) still caused greater lesions than MGAS6180, and, consistently under the background of covS deletion, MGAS6180 Delta covS caused smaller lesions than MGAS315 Delta covS. Thus, contemporary invasive M3 GAS has a higher capacity to evade neutrophil and TNF-alpha responses and to invade soft tissue than M28 GAS and that this skin-invading capacity of M3 GAS is maximized by natural CovRS mutations. These findings enhance our understanding of the basis for the frequent association of M3 GAS with necrotizing fasciitis.	[Stetzner, Zachary W.; Li, Dengfeng; Feng, Wenchao; Liu, Mengyao; Liu, Guanghui; Wiley, James; Lei, Benfang] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59718 USA	Montana State University System; Montana State University Bozeman	Lei, BF (corresponding author), Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59718 USA.	blei@montana.edu		Lei, Benfang Lei/0000-0001-8133-6021	National Institutes of Health [AI095704, AI097703, GM110732]; USDA Animal Formula Fund; Montana State Agricultural Experimental Station; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095704, R21AI097703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA Animal Formula Fund; Montana State Agricultural Experimental Station; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants AI095704, AI097703, and GM110732 from the National Institutes of Health, USDA Animal Formula Fund, and the Montana State Agricultural Experimental Station.	Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Beres SB, 2010, P NATL ACAD SCI USA, V107, P4371, DOI 10.1073/pnas.0911295107; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carroll RK, 2011, J CLIN INVEST, V121, P1956, DOI 10.1172/JCI45169; Chatellier S, 2000, INFECT IMMUN, V68, P3523, DOI 10.1128/IAI.68.6.3523-3534.2000; CLEARY PP, 1992, LANCET, V339, P518, DOI 10.1016/0140-6736(92)90339-5; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Cole JN, 2010, MBIO, V1, DOI 10.1128/mBio.00191-10; Davies HD, 1996, NEW ENGL J MED, V335, P547, DOI 10.1056/NEJM199608223350803; Edwards RJ, 2005, J INFECT DIS, V192, P783, DOI 10.1086/432485; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Flores AR, 2014, J INFECT DIS, V209, P1520, DOI 10.1093/infdis/jit674; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Heath A, 1999, INFECT IMMUN, V67, P5298, DOI 10.1128/IAI.67.10.5298-5305.1999; Hidalgo-Grass C, 2006, EMBO J, V25, P4628, DOI 10.1038/sj.emboj.7601327; Horstmann N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002311; Ikebe T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000832; Kansal RG, 2010, J INFECT DIS, V201, P855, DOI 10.1086/651019; Kappeler KV, 2009, INFECT IMMUN, V77, P5411, DOI 10.1128/IAI.00373-09; KAPUR V, 1994, MICROB PATHOGENESIS, V16, P443, DOI 10.1006/mpat.1994.1044; KATZ AR, 1992, CLIN INFECT DIS, V14, P298, DOI 10.1093/clinids/14.1.298; Kaul R, 1997, AM J MED, V103, P18, DOI 10.1016/S0002-9343(97)00160-5; Kazmi SU, 2001, INFECT IMMUN, V69, P4988, DOI 10.1128/IAI.69.8.4988-4995.2001; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Li JQ, 2014, INFECT IMMUN, V82, P1579, DOI 10.1128/IAI.01458-13; Li JQ, 2013, INFECT IMMUN, V81, P974, DOI 10.1128/IAI.01218-12; Li ZY, 2003, J INFECT DIS, V188, P1587, DOI 10.1086/379050; Liu GH, 2013, INFECT IMMUN, V81, P3128, DOI 10.1128/IAI.00398-13; Liu MY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002624; Liu MY, 2006, MICROBIOL-SGM, V152, P967, DOI 10.1099/mic.0.28706-0; Ma YS, 2006, J BACTERIOL, V188, P7626, DOI 10.1128/JB.01059-06; Maamary PG, 2012, FASEB J, V26, P4675, DOI 10.1096/fj.12-212142; MARTIN DR, 1993, J INFECT DIS, V167, P1112, DOI 10.1093/infdis/167.5.1112; Mishalian I, 2011, J IMMUNOL, V187, P6022, DOI 10.4049/jimmunol.1101385; Miyoshi-Akiyama T, 2006, J INFECT DIS, V193, P1677, DOI 10.1086/504263; MUSSER JM, 1993, J INFECT DIS, V167, P337, DOI 10.1093/infdis/167.2.337; MUSSER JM, 1995, INFECT IMMUN, V63, P994, DOI 10.1128/IAI.63.3.994-1003.1995; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; Nasser W, 2014, P NATL ACAD SCI USA, V111, pE1768, DOI 10.1073/pnas.1403138111; National Research Council (US) Committee, 2011, GUIDE CARE USE LAB A, DOI [DOI 10.17226/12910, 10.17226/12910]; O'Loughlin RE, 2007, CLIN INFECT DIS, V45, P853, DOI 10.1086/521264; Olsen RJ, 2012, J INFECT DIS, V205, P1719, DOI 10.1093/infdis/jir825; SEPPALA H, 1994, J INFECT DIS, V169, P519, DOI 10.1093/infdis/169.3.519; Sharkawy A, 2002, CLIN INFECT DIS, V34, P454, DOI 10.1086/338466; Shea PR, 2011, P NATL ACAD SCI USA, V108, P5039, DOI 10.1073/pnas.1016282108; Sitkiewicz I, 2006, P NATL ACAD SCI USA, V103, P16009, DOI 10.1073/pnas.0607669103; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Trevino J, 2009, INFECT IMMUN, V77, P3141, DOI 10.1128/IAI.01560-08; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Zhou Y, 2013, VIRULENCE, V4, P698, DOI 10.4161/viru.26413; Zhu H, 2009, INFECT IMMUN, V77, P5225, DOI 10.1128/IAI.00636-09	55	15	15	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129417	10.1371/journal.pone.0129417	http://dx.doi.org/10.1371/journal.pone.0129417			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047469	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200161
J	Terayama, H; Yamazaki, H; Kanazawa, T; Suyama, K; Tanaka, O; Sawada, M; Ito, M; Ito, K; Akamatsu, T; Masuda, R; Suzuki, T; Sakabe, K				Terayama, Hayato; Yamazaki, Hajime; Kanazawa, Teruhisa; Suyama, Kaori; Tanaka, Osamu; Sawada, Makoto; Ito, Miho; Ito, Kenji; Akamatsu, Tadashi; Masuda, Ritsuko; Suzuki, Toshiyasu; Sakabe, Kou			Multi-Acupuncture Point Injections and Their Anatomical Study in Relation to Neck and Shoulder Pain Syndrome (So-Called Katakori) in Japan	PLOS ONE			English	Article							MYOFASCIAL TRIGGER POINTS; SKELETAL-MUSCLE; DOUBLE-BLIND; MANAGEMENT; STIMULATION; THRESHOLDS; HEADACHE; DAMAGE	Katakori is a symptom name that is unique to Japan, and refers to myofascial pain syndrome-like clinical signs in the shoulder girdle. Various methods of pain relief for katakori have been reported, but in the present study, we examined the clinical effects of multi-acupuncture point injections (MAPI) in the acupuncture points with which we empirically achieved an effect, as well as the anatomical sites affected by liquid medicine. The subjects were idiopathic katakori patients (n = 9), and three cadavers for anatomical investigation. BL-10, GB-21, LI-16, SI-14, and BL-38 as the WHO notation were selected as the acupuncture point. Injections of 1 mL of 1% w/v mepivacaine were introduced at the same time into each of these points in the patients. Assessment items were the Pain Relief Score and the therapeutic effect period. Dissections were centered at the puncture sites of cadavers. India ink was similarly injected into each point, and each site that was darkly-stained with India ink was evaluated. Katakori pain in the present study was significantly reduced by MAPI. Regardless of the presence or absence of trigger points, pain was significantly reduced in these cases. Dark staining with India ink at each of the points in the anatomical analysis was as follows: BL-10: over the rectus capitis posterior minor muscle and rectus capitis posterior major muscle fascia; GB-21: over the supraspinatus muscle fascia; LI-16: over the supraspinatus muscle fascia; SI-14: over the rhomboid muscle fascia; and BL-38: over the rhomboid muscle fascia. The anatomical study suggested that the drug effect was exerted on the muscles above and below the muscle fascia, as well as the peripheral nerves because the points of action in acupuncture were darkly-stained in the spaces between the muscle and the muscle fascia.	[Terayama, Hayato; Kanazawa, Teruhisa; Suyama, Kaori; Tanaka, Osamu; Sakabe, Kou] Tokai Univ, Sch Med, Dept Anat, Isehara, Kanagawa 25911, Japan; [Yamazaki, Hajime; Sawada, Makoto; Ito, Miho; Ito, Kenji; Masuda, Ritsuko; Suzuki, Toshiyasu] Tokai Univ, Sch Med, Dept Anesthesiol, Isehara, Kanagawa 25911, Japan; [Akamatsu, Tadashi] Tokai Univ, Sch Med, Dept Plast & Cosmet Surg, Isehara, Kanagawa 25911, Japan	Tokai University; Tokai University; Tokai University	Yamazaki, H (corresponding author), Tokai Univ, Sch Med, Dept Anesthesiol, Isehara, Kanagawa 25911, Japan.	y-hajime@is.icc.u-tokai.ac.jp	Tanaka, Osamu/AAS-9252-2020		Ministry of Education, Culture, Sports, Science and Technology, Japan [C: 25340050, C: 26460809]; Grants-in-Aid for Scientific Research [26460809] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (C: 25340050, C: 26460809) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Alvarez DJ, 2002, AM FAM PHYSICIAN, V65, P653; [Anonymous], 2007, COMPR SURV LIV COND; Ashina M, 2000, BRAIN, V123, P1830, DOI 10.1093/brain/123.9.1830; Ashina M, 1999, BRAIN, V122, P1629, DOI 10.1093/brain/122.9.1629; Ashina M, 2003, CEPHALALGIA, V23, P109, DOI 10.1046/j.1468-2982.2003.00520.x; BIRCH S, 1998, CLIN J PAIN, V106, P14; Chen SM, 2000, J MUSCULOSKELET PAIN, V8, P83, DOI 10.1300/J094v08n03_07; Cummings TM, 2001, ARCH PHYS MED REHAB, V82, P986, DOI 10.1053/apmr.2001.24023; Dommerholt J, 2010, BONICAS MANAGEMENT P, P450; Dommerholt J, 2006, J MAN MANIP THER, V14, P203, DOI 10.1179/106698106790819991; Dundar U, 2007, CLIN RHEUMATOL, V26, P930, DOI 10.1007/s10067-006-0438-4; Esenyel M, 2000, AM J PHYS MED REHAB, V79, P48, DOI 10.1097/00002060-200001000-00011; Ezzo J, 2000, PAIN, V86, P217, DOI 10.1016/S0304-3959(99)00304-8; Febbraio MA, 2005, EXERC SPORT SCI REV, V33, P114, DOI 10.1097/00003677-200507000-00003; FINE PG, 1988, PAIN, V32, P15, DOI 10.1016/0304-3959(88)90018-8; FOX EJ, 1976, PAIN, V2, P141, DOI 10.1016/0304-3959(76)90109-3; Gerwin Robert D, 2004, Curr Pain Headache Rep, V8, P468, DOI 10.1007/s11916-004-0069-x; Gissel H, 2000, EUR J APPL PHYSIOL, V83, P175, DOI 10.1007/s004210000276; Graboski CL, 2005, PAIN, V118, P170, DOI 10.1016/j.pain.2005.08.012; Han SC, 1997, REGION ANESTH, V22, P89, DOI 10.1016/S1098-7339(06)80062-3; Heine H, 1988, ACAD TRADITIONAL CHI, V8, P207; Itoh Kazunori, 2004, Acupunct Med, V22, P2; Iwama H, 2000, ANESTH ANALG, V91, P408, DOI 10.1097/00000539-200008000-00033; JENSEN R, 1993, PAIN, V52, P193, DOI 10.1016/0304-3959(93)90131-8; Kendall NAS, 1999, BEST PRACT RES CL RH, V13, P545, DOI 10.1053/berh.1999.0044; Kiralp M. Zeki, 2006, Pain Clinic, V18, P63, DOI 10.1163/156856906775249794; Kumazawa T, 1996, NEUROBIOLOGY NOCICEP, P325; Kuniya H, 2013, J NEUROSURG-SPINE, V19, P76, DOI 10.3171/2013.4.SPINE12683; LEXELL J, 1993, CELL TISSUE RES, V273, P357, DOI 10.1007/BF00312838; Maekawa K, 2002, J PAIN, V3, P251, DOI 10.1054/jpai.2002.125923; MCCLAFLIN RR, 1994, POSTGRAD MED, V96, P56, DOI 10.1080/00325481.1994.11945883; MELZACK R, 1975, PAIN, V1, P357, DOI 10.1016/0304-3959(75)90073-1; MELZACK R, 1977, PAIN, V3, P3, DOI 10.1016/0304-3959(77)90032-X; Okuno H, 2008, J JAPAN SOC ACUPUNCT, V59, P30; Otten E, 1988, Exerc Sport Sci Rev, V16, P89; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; Sakai F, 1997, CEPHALALGIA, V17, P15, DOI 10.1046/j.1468-2982.1997.1701015.x; Schmidt-Hansen PT, 2007, PAIN, V129, P113, DOI 10.1016/j.pain.2006.09.037; SCHOENEN J, 1987, NEUROLOGY, V37, P1834, DOI 10.1212/WNL.37.12.1834; Shoji S, 2011, ONCOL LETT, V2, P675, DOI 10.3892/ol.2011.314; Simons D.G., 1999, MYOFASCIAL PAIN DYSF, V1; SIMONS DG, 1981, PAIN, V10, P106, DOI 10.1016/0304-3959(81)90053-1; Simons DG., 2002, J BODYW MOV THER, V6, P81, DOI DOI 10.1054/JBMT.2002.0271; SOLA A E, 1955, Northwest Med, V54, P980; SOLA AE, 1956, NEUROLOGY, V6, P91, DOI 10.1212/WNL.6.2.91; Sola AE, 2001, BONICAS MANAGEMENT P, P530; Stecco C, 2007, Morphologie, V91, P38, DOI 10.1016/j.morpho.2007.05.002; Takakuwa T, 2007, CLIN ORTHOPAEDIC SUR, V42, P403; Terayama H, 2008, SURG RADIOL ANAT, V30, P657, DOI 10.1007/s00276-008-0378-6; Terayama H, 2013, ANAT SCI INT, V88, P171, DOI 10.1007/s12565-013-0172-3; Tesarz J, 2011, NEUROSCIENCE, V194, P302, DOI 10.1016/j.neuroscience.2011.07.066; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Tough EA, 2009, EUR J PAIN, V13, P3, DOI 10.1016/j.ejpain.2008.02.006; Treaster D, 2006, J ELECTROMYOGR KINES, V16, P115, DOI 10.1016/j.jelekin.2005.06.016; Tsiang T, 1991, PROPOSED STANDARD IN; Wall PD, 1994, TXB PAIN, P79; WHO, 2008, WHO STAND AC POINT L, P64	58	2	3	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129006	10.1371/journal.pone.0129006	http://dx.doi.org/10.1371/journal.pone.0129006			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046784	Green Submitted, gold, Green Published			2022-12-27	WOS:000355652200116
J	Pedersen, M; Phillips, A; Plotkin, GD				Pedersen, Michael; Phillips, Andrew; Plotkin, Gordon D.			A High-Level Language for Rule-Based Modelling	PLOS ONE			English	Article							PROCESS ALGEBRA; CONFORMATIONAL SPREAD	Rule-based languages such as Kappa excel in their support for handling the combinatorial complexities prevalent in many biological systems, including signalling pathways. But Kappa provides little structure for organising rules, and large models can therefore be hard to read and maintain. This paper introduces a high-level, modular extension of Kappa called LBS-kappa. We demonstrate the constructs of the language through examples and three case studies: a chemotaxis switch ring, a MAPK cascade, and an insulin signalling pathway. We then provide a formal definition of LBS-kappa through an abstract syntax and a translation to plain Kappa. The translation is implemented in a compiler tool which is available as a web application. We finally demonstrate how to increase the expressivity of LBS-kappa through embedded scripts in a general-purpose programming language, a technique which we view as generally applicable to other domain specific languages.	[Pedersen, Michael] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Pedersen, Michael; Phillips, Andrew] Microsoft Res, Biol Computat Grp, Cambridge, England; [Plotkin, Gordon D.] Univ Edinburgh, Sch Informat, Lab Fdn Comp Sci, Edinburgh, Midlothian, Scotland	University of Cambridge; Microsoft; University of Edinburgh	Pedersen, M (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge, England.	michael.d.pedersen@gmail.com			Microsoft Research through European PhD Scholarship programme; Centre for Systems Biology at Edinburgh, Centre for Integrative Systems Biology - BBSRC; EPSRC [BB/D019621/1, EP/H027955/1]; ERC Advanced Grant "Rule-Based Modelling" [320823]; BBSRC [BB/D019621/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D019621/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H027955/1] Funding Source: researchfish	Microsoft Research through European PhD Scholarship programme(Microsoft); Centre for Systems Biology at Edinburgh, Centre for Integrative Systems Biology - BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ERC Advanced Grant "Rule-Based Modelling"; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The first author is grateful for the support from EPSRC through its Postdoctoral Fellowship programme, reference EP/H027955/1, and from Microsoft Research through its European PhD Scholarship programme. The third author is grateful for support from The Centre for Systems Biology at Edinburgh, a Centre for Integrative Systems Biology funded by BBSRC and EPSRC, reference BB/D019621/1, and then from the ERC Advanced Grant "Rule-Based Modelling," reference 320823. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai F, 2010, SCIENCE, V327, P685, DOI 10.1126/science.1182105; Calder M, 2006, LECT NOTES COMPUT SC, V4230, P1; Chabrier-Rivier N, 2004, LECT NOTES BIOINFORM, V3082, P172, DOI DOI 10.1007/978-3-540-25974-9_14; Ciocchetta F, 2008, ELECTRON NOTES THEOR, V194, P103, DOI 10.1016/j.entcs.2007.12.008; Danos V, 2007, LECT NOTES COMPUT SC, V4703, P17; Danos V, 2009, ELECTRON NOTES THEOR, V229, P3, DOI 10.1016/j.entcs.2009.07.070; Danos V, 2010, IEEE S LOG, P362, DOI 10.1109/LICS.2010.44; Danos V, 2009, LECT NOTES COMPUT SC, V5750, P116; Dematte Lorenzo, 2008, Performance Evaluation Review, V35, P32, DOI 10.1145/1364644.1364653; Duke TAJ, 2001, J MOL BIOL, V308, P541, DOI 10.1006/jmbi.2001.4610; Faeder J R, 2005, P 2005 ACM S APPL CO, P133; Guerriero ML, 2007, LECT NOTES COMPUT SC, V4695, P136; Jensen K, 1992, MONOGRAPHS THEORETIC, P1; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; Kwiatkowski M, 2008, LECT N BIOINFORMAT, V5307, P103, DOI 10.1007/978-3-540-88562-7_11; Lakin MR, 2012, THEOR COMPUT SCI, V431, P181, DOI 10.1016/j.tcs.2011.12.057; Lopez CF, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.1; Mallavarapu A, 2008, J R SOC INTERFACE; Oury N., 2011, P 9 INT C COMP METH, P171, DOI DOI 10.1145/2037509.2037534); Pedersen M, 2013, LBS COMMAND LINE TOO; Pedersen M, 2014, BIOSIMULATORS WEB UI; Pedersen M, 2010, THESIS U EDINBURGH; Pedersen M, 2010, LECT N BIOINFORMAT, V5945, P77; Pedersen M, 2008, LECT N BIOINFORMAT, V5307, P288, DOI 10.1007/978-3-540-88562-7_21; Phillips A, 2006, LECT NOTES COMPUT SC, V4230, P123; Plotkin Gordon D., 2013, In Search of Elegance in the Theory and Practice of Computation. Essays Dedicated to Peter Buneman: LNCS 8000, P445, DOI 10.1007/978-3-642-41660-6_24; Priami C, 2005, LECT NOTES COMPUT SC, V3082, P20; Priami C, 1995, COMPUT J, V38, P578, DOI 10.1093/comjnl/38.7.578; Sedaghat AR, 2002, AM J PHYSIOL-ENDOC M, V283, pE1084, DOI 10.1152/ajpendo.00571.2001; Smith LP, 2009, BIOINFORMATICS, V25, P2452, DOI 10.1093/bioinformatics/btp401	30	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0114296	10.1371/journal.pone.0114296	http://dx.doi.org/10.1371/journal.pone.0114296			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043208	Green Submitted, Green Published, gold			2022-12-27	WOS:000355701600002
J	Zhu, GF; Yang, FX; Shi, SS; Li, DM; Wang, Z; Liu, HL; Huang, D; Wang, CY				Zhu, Genfa; Yang, Fengxi; Shi, Shanshan; Li, Dongmei; Wang, Zhen; Liu, Hailin; Huang, Dan; Wang, Caiyun			Transcriptome Characterization of Cymbidium sinense'Dharma' Using 454 Pyrosequencing and Its Application in the Identification of Genes Associated with Leaf Color Variation	PLOS ONE			English	Article							CHLOROPHYLL BIOSYNTHESIS; PHALAENOPSIS-EQUESTRIS; HIGHER-PLANTS; ORCHID; BREAKDOWN; FLOWERS	The highly variable leaf color of Cymbidium sinense significantly improves its horticultural and economic value, and makes it highly desirable in the flower markets in China and Southeast Asia. However, little is understood about the molecular mechanism underlying leaf-color variations. In this study, we found the content of photosynthetic pigments, especially chlorophyll degradation metabolite in the leaf-color mutants is distinguished significantly from that in the wild type of Cymbidium sinense'Dharma'. To further determine the candidate genes controlling leaf-color variations, we first sequenced the global transcriptome using 454 pyrosequencing. More than 0.7 million expressed sequence tags (ESTs) with an average read length of 445.9 bp were generated and assembled into 103,295 isotigs representing 68,460 genes. Of these isotigs, 43,433 were significantly aligned to known proteins in the public database, of which 29,299 could be categorized into 42 functional groups in the gene ontology system, 10,079 classified into 23 functional classifications in the clusters of orthologous groups system, and 23,092 assigned to 139 clusters of specific metabolic pathways in the Kyoto Encyclopedia of Genes and Genomes. Among these annotations, 95 isotigs were designated as involved in chlorophyll metabolism. On this basis, we identified 16 key enzyme-encoding genes in the chlorophyll metabolism pathway, the full length cDNAs and expressions of which were further confirmed. Expression pattern indicated that the key enzyme-encoding genes for chlorophyll degradation were more highly expressed in the leaf color mutants, as was consistent with their lower chlorophyll contents. This study is the first to supply an informative 454 EST dataset for Cymbidium sinense'Dharma' and to identify original leaf color-associated genes, which provide important resources to facilitate gene discovery for molecular breeding, marketable trait discovery, and investigating various biological process in this species.	[Zhu, Genfa; Yang, Fengxi; Li, Dongmei; Wang, Zhen; Liu, Hailin; Huang, Dan] Guangdong Acad Agr Sci, Environm Hort Res Inst, Guangdong Key Lab Ornamental Plant Germplasm Inno, Guangzhou 510640, Guangdong, Peoples R China; [Zhu, Genfa; Shi, Shanshan; Wang, Caiyun] Huazhong Agr Univ, Coll Hort & Forestry Sci, Wuhan 430070, Hubei, Peoples R China	Guangdong Academy of Agricultural Sciences; Huazhong Agricultural University	Zhu, GF (corresponding author), Guangdong Acad Agr Sci, Environm Hort Res Inst, Guangdong Key Lab Ornamental Plant Germplasm Inno, Guangzhou 510640, Guangdong, Peoples R China.	genfazhu@163.com			Strategic Emerging Industries of Guangdong Province [2012A020800003]; National Natural Science Foundation of China [31471915]; Agriculture common key technology research [2011A020102007]	Strategic Emerging Industries of Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agriculture common key technology research	This research was supported by grants from the Strategic Emerging Industries of Guangdong Province (2012A020800003), the National Natural Science Foundation of China (31471915), and Agriculture common key technology research (2011A020102007).	Aceto S, 2011, CURR GENOMICS, V12, P342, DOI 10.2174/138920211796429754; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Paolo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102155; Eckhardt U, 2004, PLANT MOL BIOL, V56, P1, DOI 10.1007/s11103-004-2331-3; Fukai S, 2002, HORTSCIENCE, V37, P1088, DOI 10.21273/HORTSCI.37.7.1088; Hortensteiner S, 2011, BBA-BIOENERGETICS, V1807, P977, DOI 10.1016/j.bbabio.2010.12.007; Hsiao YY, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-14; Hsu CC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-3; Huang JiaPing, 1998, Journal of Beijing Forestry University, V20, P38; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Leitch IJ, 2009, ANN BOT-LONDON, V104, P469, DOI 10.1093/aob/mcp003; Li XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085480; Li YH, 2004, J JPN SOC HORTIC SCI, V73, P386, DOI 10.2503/jjshs.73.386; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; LIU ZJ, 2006, CHINESE CYMBIDIUM PL; LORENZEN CARL J., 1966, DEEP SEA RES, V13, P223, DOI 10.1016/0011-7471(66)91102-8; Reinbothe Steffen, 1996, Plant Physiology (Rockville), V111, P1; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shi DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080107; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; Su CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080462; Tan J, 2005, BIOTECHNOL LETT, V27, P1517, DOI 10.1007/s10529-005-1468-8; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Teh SL, 2011, MOL BIOL REP, V38, P3903, DOI 10.1007/s11033-010-0506-3; Tsai WC, 2006, PLANT SCI, V170, P426, DOI 10.1016/j.plantsci.2005.08.029; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Xu YF, 2006, PLANT J, V46, P54, DOI 10.1111/j.1365-313X.2006.02669.x; Yukawa T, 2002, BOT J LINN SOC, V138, P383, DOI 10.1046/j.1095-8339.2002.00038.x; Zhang JX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-279; Zhang X, 2010, NO HORTICULTURE, V19, P206; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082	34	27	39	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128592	10.1371/journal.pone.0128592	http://dx.doi.org/10.1371/journal.pone.0128592			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042676	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600055
J	An, Y; Wang, YT; Ma, YT; Wulasihan, M; Huang, Y; Adi, D; Yang, YN; Ma, X; Li, XM; Xie, X; Huang, D; Liu, F; Chen, BD				An, Yong; Wang, Yong-Tao; Ma, Yi-Tong; Wulasihan, Muhuyati; Huang, Ying; Adi, Dilare; Yang, Yi-Ning; Ma, Xiang; Li, Xiao-Mei; Xie, Xiang; Huang, Ding; Liu, Fen; Chen, Bang-Dang			IL-10 Genetic Polymorphisms Were Associated with Valvular Calcification in Han, Uygur and Kazak Populations in Xinjiang, China	PLOS ONE			English	Article							AORTIC-VALVE SCLEROSIS; INFLAMMATION; STENOSIS; PREVALENCE; MORBIDITY; MORTALITY; CALCIUM	Objective Valvular calcification occurs via ongoing endothelial injury associated with inflammation. IL-10 is an anti-inflammatory cytokine and 75% of the variation in IL-10 production is genetically determined. However, the relationship between genetic polymorphisms of IL-10 and valvular calcification has not been studied. The objective of this study was to investigate the association between valvular calcification and IL-10 genetic polymorphisms in the Han, Uygur and Kazak populations in China. Patients and Methods All of the participants were selected from subjects participating in the Cardiovascular Risk Survey (CRS) study. The single nucleotide polymorphisms (SNPs) rs1800871 and rs1800872 of the IL-10 gene were genotyped using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Three independent case-control studies involving the Han population, the Uygur population and the Kazak population were used in the analysis. Results For the Han and Kazak populations, rs1800871 was found to be associated with valvular calcification in the recessive model, and the difference remained statistically significant following multivariate adjustment (p<0.001, p=0.031, respectively). For the Han, Uygur and Kazak populations, rs1800872 was found to be associated with valvular calcification in the dominant model, and the difference remained statistically significant following multivariate adjustment (p<0.001, p=0.009, and p=0.023, respectively) Conclusion Both rs1800871 and rs1800872 of the IL-10 gene are associated with valvular calcification in the Han and Kazak populations in China. Rs1800872 is also associated with valvular calcification in the Uygur population.	[An, Yong; Wang, Yong-Tao; Ma, Yi-Tong; Wulasihan, Muhuyati; Huang, Ying; Adi, Dilare; Yang, Yi-Ning; Ma, Xiang; Li, Xiao-Mei; Xie, Xiang; Huang, Ding; Chen, Bang-Dang] Xinjiang Med Univ, Dept Cardiol, Affiliated Hosp 1, Urumqi 830054, Peoples R China; [An, Yong; Wang, Yong-Tao; Ma, Yi-Tong; Huang, Ying; Adi, Dilare; Yang, Yi-Ning; Ma, Xiang; Li, Xiao-Mei; Xie, Xiang; Liu, Fen; Chen, Bang-Dang] Xinjiang Key Lab Cardiovasc Dis Res, Urumqi 830054, Peoples R China	Xinjiang Medical University	Ma, YT (corresponding author), Xinjiang Med Univ, Dept Cardiol, Affiliated Hosp 1, Urumqi 830054, Peoples R China.	myt_xj@sina.com; muhuyati@163.com	xie, xiang/AAG-2128-2021		special funded project, Key Laboratory of Xinjiang Uygur Autonomous Region [2014KL011]	special funded project, Key Laboratory of Xinjiang Uygur Autonomous Region	This work was supported financially by the special funded project, Key Laboratory of Xinjiang Uygur Autonomous Region (2014KL011).	Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; Al-Aly Ziyad, 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P1; Bella JN, 2007, HYPERTENSION, V49, P453, DOI 10.1161/01.HYP.0000256957.10242.75; Bhatt H, 2014, ANGIOLOGY, V46, P3086; Bienvenu J, 1995, J CARDIOVASC PHARM, V25, pS80, DOI 10.1097/00005344-199500252-00017; Carabello BA, 2009, LANCET, V373, P956, DOI 10.1016/S0140-6736(09)60211-7; Coffey S, 2014, J AM COLL CARDIOL, V63, P2852, DOI 10.1016/j.jacc.2014.04.018; COHEN SBA, 1995, ARTHRITIS RHEUM, V38, P946, DOI 10.1002/art.1780380710; Cosmi JE, 2002, ARCH INTERN MED, V162, P2345, DOI 10.1001/archinte.162.20.2345; Cote N, 2013, INFLAMMATION, V36, P573, DOI 10.1007/s10753-012-9579-6; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; Feng M, 2003, CHIN J GERONTOL, V7, P401; Fox CS, 2003, CIRCULATION, V107, P1492, DOI 10.1161/01.CIR.0000058168.26163.BC; Furukawa KI, 2014, J PHARMACOL SCI, V124, P129, DOI 10.1254/jphs.13R05CR; Gaudreault N, 2011, AM J CARDIOL, V108, P1305, DOI 10.1016/j.amjcard.2011.06.050; Hajeer AH, 1998, SCAND J RHEUMATOL, V27, P142; Kutikhin AG, 2014, MOL BIOL REP, V41, P5645, DOI 10.1007/s11033-014-3434-9; MALEFYT RD, 1991, J EXP MED, V174, P1209; Milin AC, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001111; Moe SM, 2004, CIRC RES, V95, P560, DOI 10.1161/01.RES.0000141775.67189.98; Mohler ER, 2001, CIRCULATION, V103, P1522, DOI 10.1161/01.cir.103.11.1522; MOSMANN TR, 1994, ADV IMMUNOL, V56, P1, DOI 10.1016/S0065-2776(08)60449-6; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Novina CD, 1996, TRENDS GENET, V12, P351, DOI 10.1016/0168-9525(96)10034-2; Ortlepp JR, 2004, EUR HEART J, V25, P514, DOI 10.1016/j.ehj.2003.09.006; Otto CM, 1999, NEW ENGL J MED, V341, P142, DOI 10.1056/NEJM199907153410302; Rusanescu G, 2008, CURR CARDIOL REV, V4, P148, DOI 10.2174/157340308785160552; SAVAGE DD, 1983, AM J CARDIOL, V51, P1375, DOI 10.1016/0002-9149(83)90315-6; Thaden JJ, 2014, PROG CARDIOVASC DIS, V56, P565, DOI 10.1016/j.pcad.2014.02.006; Thanassoulis G, 2013, NEW ENGL J MED, V368, P503, DOI 10.1056/NEJMoa1109034; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; Westendorp RGJ, 1997, LANCET, V349, P170, DOI 10.1016/S0140-6736(96)06413-6; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015181; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013997; Yu ZQ, 2011, J PHARMACOL EXP THER, V337, P16, DOI 10.1124/jpet.110.177915	35	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128965	10.1371/journal.pone.0128965	http://dx.doi.org/10.1371/journal.pone.0128965			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039365	gold, Green Published, Green Submitted			2022-12-27	WOS:000355700700132
J	Bianchin, A; Bell, A; Chubb, AJ; Doolan, N; Leneghan, D; Stavropoulos, I; Shields, DC; Mooney, C				Bianchin, Alessandra; Bell, Angus; Chubb, Anthony J.; Doolan, Nathalie; Leneghan, Darren; Stavropoulos, Ilias; Shields, Denis C.; Mooney, Catherine			Design and Evaluation of Antimalarial Peptides Derived from Prediction of Short Linear Motifs in Proteins Related to Erythrocyte Invasion	PLOS ONE			English	Article							RED-BLOOD-CELLS; PLASMODIUM-FALCIPARUM; MALARIA PARASITES; APICOMPLEXAN PARASITES; LACTATE-DEHYDROGENASE; RECEPTOR; BINDING; PEPDUCIN; SEQUENCE; TARGET	The purpose of this study was to investigate the blood stage of the malaria causing parasite, Plasmodium falciparum, to predict potential protein interactions between the parasite merozoite and the host erythrocyte and design peptides that could interrupt these predicted interactions. We screened the P. falciparum and human proteomes for computationally predicted short linear motifs (SLiMs) in cytoplasmic portions of transmembrane proteins that could play roles in the invasion of the erythrocyte by the merozoite, an essential step in malarial pathogenesis. We tested thirteen peptides predicted to contain SLiMs, twelve of them palmitoylated to enhance membrane targeting, and found three that blocked parasite growth in culture by inhibiting the initiation of new infections in erythrocytes. Scrambled peptides for two of the most promising peptides suggested that their activity may be reflective of amino acid properties, in particular, positive charge. However, one peptide showed effects which were stronger than those of scrambled peptides. This was derived from human red blood cell glycophorin-B. We concluded that proteome-wide computational screening of the intracellular regions of both host and pathogen adhesion proteins provides potential lead peptides for the development of anti-malarial compounds.	[Bianchin, Alessandra; Chubb, Anthony J.; Stavropoulos, Ilias; Shields, Denis C.; Mooney, Catherine] Univ Coll Dublin, Conway Inst Biomol & Biomed Sci, Dublin 2, Ireland; [Bianchin, Alessandra; Chubb, Anthony J.; Stavropoulos, Ilias; Shields, Denis C.; Mooney, Catherine] Univ Coll Dublin, Complex & Adapt Syst Lab, Dublin 2, Ireland; [Bianchin, Alessandra; Chubb, Anthony J.; Doolan, Nathalie; Stavropoulos, Ilias; Shields, Denis C.; Mooney, Catherine] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Bianchin, Alessandra; Bell, Angus; Leneghan, Darren] Univ Dublin Trinity Coll, Moyne Inst Prevent Med, Sch Genet & Microbiol, Dept Microbiol, Dublin 2, Ireland	University College Dublin; University College Dublin; University College Dublin; Trinity College Dublin	Mooney, C (corresponding author), Univ Coll Dublin, Conway Inst Biomol & Biomed Sci, Dublin 2, Ireland.	catherine.mooney@ucd.ie		Bell, Angus/0000-0002-0578-8656; Chubb, Anthony/0000-0003-1875-7100; Shields, Denis/0000-0003-4015-2474; Mooney, Catherine/0000-0002-7696-1364; Leneghan, Darren/0000-0002-9944-5258	Science Foundation Ireland [08/IN. 1/B1864, 10/RFP/GEN2749]; Irish Research Council (UCD Bioinformatics and System Biology PhD programme)	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council (UCD Bioinformatics and System Biology PhD programme)(Irish Research Council for Science, Engineering and Technology)	This work was supported by Science Foundation Ireland http://www.sfi.ie/ (grant numbers 08/IN. 1/B1864, 10/RFP/GEN2749) to DCS and CM and Irish Research Council http://www.research.ie/ (UCD Bioinformatics and System Biology PhD programme) to A. Bianchin and AJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Baum J, 2005, PLOS PATHOG, V1, P299, DOI 10.1371/journal.ppat.0010037; Bell A, 2011, CURR PHARM DESIGN, V17, P2719, DOI 10.2174/138161211797416057; Bernsel A, 2008, P NATL ACAD SCI USA, V105, P7177, DOI 10.1073/pnas.0711151105; Besteiro S, 2011, CELL MICROBIOL, V13, P797, DOI 10.1111/j.1462-5822.2011.01597.x; Covic L, 2002, NAT MED, V8, P1161, DOI 10.1038/nm760; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Cowman AF, 2012, J CELL BIOL, V198, P961, DOI 10.1083/jcb.201206112; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Cunningham E, 2008, ANTIMICROB AGENTS CH, V52, P3221, DOI 10.1128/AAC.01327-07; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Duffy FJ, 2011, J CHEM INF MODEL, V51, P829, DOI 10.1021/ci100431r; Edwards RJ, 2007, NAT CHEM BIOL, V3, P108, DOI 10.1038/nchembio854; Fennell BJ, 2006, MOL BIOCHEM PARASIT, V145, P226, DOI 10.1016/j.molbiopara.2005.08.020; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100; Harris KS, 2005, INFECT IMMUN, V73, P6981, DOI 10.1128/IAI.73.10.6981-6989.2005; Harvey KL, 2012, INT J PARASITOL, V42, P567, DOI 10.1016/j.ijpara.2012.02.011; Hester J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002569; Janz JM, 2011, J AM CHEM SOC, V133, P15878, DOI 10.1021/ja206661w; Johannessen L, 2011, CHEMBIOCHEM, V12, P914, DOI 10.1002/cbic.201000563; KUDO S, 1989, P NATL ACAD SCI USA, V86, P4619, DOI 10.1073/pnas.86.12.4619; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; MAKLER MT, 1993, AM J TROP MED HYG, V48, P205, DOI 10.4269/ajtmh.1993.48.205; MAKLER MT, 1993, AM J TROP MED HYG, V48, P739, DOI 10.4269/ajtmh.1993.48.739; Mitchell GH, 2004, INFECT IMMUN, V72, P154, DOI 10.1128/IAI.72.1.154-158.2004; Mooney C, 2012, J MOL BIOL, V415, P193, DOI 10.1016/j.jmb.2011.10.025; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; O'Callaghan K, 2012, J BIOL CHEM, V287, P12787, DOI 10.1074/jbc.R112.355461; Parthasarathi L, 2006, J CHEM INF MODEL, V46, P2183, DOI 10.1021/ci0600760; Shields DC, 2014, ACCESSSCIENCE, P914; Srinivasan P, 2011, P NATL ACAD SCI USA, V108, P13275, DOI 10.1073/pnas.1110303108; Staalsoe T, 1999, CYTOMETRY, V35, P329, DOI 10.1002/(SICI)1097-0320(19990401)35:4&lt;329::AID-CYTO5&gt;3.0.CO;2-Y; Stavropoulos Ilias, 2014, Bioarchitecture, V4, P103, DOI 10.4161/bioa.32143; Stavropoulos I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044389; Stephens G, 1998, J BIOL CHEM, V273, P20317, DOI 10.1074/jbc.273.32.20317; Tarazona-Santos E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016123; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107; TROTTEIN F, 1995, EUR J BIOCHEM, V227, P214, DOI 10.1111/j.1432-1033.1995.tb20379.x	41	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127383	10.1371/journal.pone.0127383	http://dx.doi.org/10.1371/journal.pone.0127383			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039561	gold, Green Published, Green Submitted			2022-12-27	WOS:000355700700058
J	Accrombessi, M; Ouedraogo, S; Agbota, GC; Gonzalez, R; Massougbodji, A; Menendez, C; Cot, M				Accrombessi, Manfred; Ouedraogo, Smaila; Agbota, Gino Cedric; Gonzalez, Raquel; Massougbodji, Achille; Menendez, Clara; Cot, Michel			Malaria in Pregnancy Is a Predictor of Infant Haemoglobin Concentrations during the First Year of Life in Benin, West Africa	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; PLACENTAL MALARIA; YOUNG-CHILDREN; RISK-FACTORS; ANEMIA; SUSCEPTIBILITY; WOMEN	Background Anaemia is an increasingly recognized health problem in Africa, particularly in infants and pregnant women. Although malaria is known to be the main risk factor of anaemia in both groups, the consequences of maternal factors, particularly malaria in pregnancy (MiP), on infant haemoglobin (Hb) concentrations during the first months of life are still unclear. Methods We followed-up a cohort of 1005 Beninese pregnant women from the beginning of pregnancy until delivery. A subsample composed of the first 400 offspring of these women were selected at birth and followed until the first year of life. Placental histology and blood smear at 1st clinical antenatal visit (ANC), 2nd ANC and delivery were used to assess malaria during pregnancy. Infant Hb concentrations were measured at birth, 6, 9 and 12 months of age. A mixed multi-level model was used to assess the association between MiP and infant Hb variations during the first 12 months of life. Results Placental malaria (difference mean [dm] = -2.8 g/L, 95% CI [-5.3, -0.3], P = 0.03) and maternal peripheral parasitaemia at delivery (dm = -4.6 g/L, 95% CI [-7.9, -1.3], P = 0.007) were the main maternal factors significantly associated with infant Hb concentrations during the first year of life. Poor maternal nutritional status and malaria infection during infancy were also significantly associated with a decrease in infant Hb. Conclusion Antimalarial control and nutritional interventions before and during pregnancy should be reinforced to reduce specifically the incidence of infant anaemia, particularly in SubSaharan countries.	[Accrombessi, Manfred; Agbota, Gino Cedric; Cot, Michel] IRD, Mere & Enfant Face Infect Trop UMR216, Paris, France; [Accrombessi, Manfred; Agbota, Gino Cedric; Cot, Michel] Univ Paris 05, PRES Paris Sorbonne Cite, Paris, France; [Accrombessi, Manfred; Agbota, Gino Cedric; Massougbodji, Achille] Univ Abomey Calavi, Fac Med Cotonou, Cotonou, Benin; [Ouedraogo, Smaila] Univ Ouagadougou, Unite Format & Rech Sci Sante, Ouagadougou, Burkina Faso; [Gonzalez, Raquel; Menendez, Clara] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Gonzalez, Raquel; Menendez, Clara] Manhica Hlth Res Ctr CISM, Manhica, Mozambique	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Abomey Calavi; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica	Accrombessi, M (corresponding author), IRD, Mere & Enfant Face Infect Trop UMR216, Paris, France.	accrombessimanfred@yahoo.fr	Menéndez, Clara/Q-3446-2016; Accrombessi, Manfred/W-1546-2017; Cot, Michel/E-7633-2011; Gonzalez, Raquel/J-3604-2017	Menéndez, Clara/0000-0002-2641-6907; Accrombessi, Manfred/0000-0001-9550-9413; Cot, Michel/0000-0003-3014-4294; Gonzalez, Raquel/0000-0001-5487-801X	Malaria in Pregnancy consortium; Bill and Melinda Gates Foundation; EDCTP [EDCTP-IP.07.31080.002]; Institut de Recherche pour le Developpement grant	Malaria in Pregnancy consortium; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); EDCTP; Institut de Recherche pour le Developpement grant	This study was supported by the Malaria in Pregnancy consortium, which is funded through a grant from the Bill and Melinda Gates Foundation to the Liverpool School of Tropical Medicine. The MiPPAD study was supported by the EDCTP (EDCTP-IP.07.31080.002). Manfred Accrombessi was supported by an Institut de Recherche pour le Developpement grant while writing this paper.	[Anonymous], 2001, IRON DEFICIENCY ANAE; Huynh BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035342; Briand V, 2008, J INFECT DIS, V198, P594, DOI 10.1086/590114; Broen K, 2007, MOL BIOCHEM PARASIT, V151, P1, DOI 10.1016/j.molbiopara.2006.10.001; BULMER JN, 1993, HISTOPATHOLOGY, V22, P211, DOI 10.1111/j.1365-2559.1993.tb00110.x; Cornet M, 1998, AM J TROP MED HYG, V58, P606, DOI 10.4269/ajtmh.1998.58.606; Cot M, 2003, AM J EPIDEMIOL, V157, P203, DOI 10.1093/aje/kwf192; Cottrell G, 2005, AM J TROP MED HYG, V73, P1112, DOI 10.4269/ajtmh.2005.73.1112; DALLMAN PR, 1980, AM J CLIN NUTR, V33, P86, DOI 10.1093/ajcn/33.1.86; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Desai MR, 2005, AM J TROP MED HYG, V72, P47, DOI 10.4269/ajtmh.2005.72.47; Diouf I, 2007, J REPROD IMMUNOL, V74, P152, DOI 10.1016/j.jri.2006.10.001; Gambling L, 2011, AM J CLIN NUTR, V94, p1903S, DOI 10.3945/ajcn.110.000885; Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733; Ismaili J, 2003, CLIN EXP IMMUNOL, V133, P414, DOI 10.1046/j.1365-2249.2003.02243.x; Jonker FAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042670; Kabyemela ER, 2008, J INFECT DIS, V198, P163, DOI 10.1086/589512; Kruger H S, 2005, Curationis, V28, P40; le Cessie S, 2002, ARCH DIS CHILD-FETAL, V86, P182, DOI 10.1136/fn.86.3.F182; Le Port A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027516; Lokeshwar M. R., 2003, Indian Journal of Pediatrics, V70, P893, DOI 10.1007/BF02730596; Magalhaes RJS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000438; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Morse K, 2009, BEST PRACT RES CL OB, V23, P809, DOI 10.1016/j.bpobgyn.2009.09.004; National Institute of Statistic and Economic Analysis (INSAE), 2006, NUTR STAT PREV AN BE, P204; Ouedraogo S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-348; Planche T, 2001, AM J TROP MED HYG, V65, P599, DOI 10.4269/ajtmh.2001.65.599; Rachas A, 2012, CLIN INFECT DIS, V55, P672, DOI 10.1093/cid/cis490; REDD SC, 1994, AM J TROP MED HYG, V51, P170, DOI 10.4269/ajtmh.1994.51.170; Righetti AA, 2012, AM J TROP MED HYG, V87, P425, DOI 10.4269/ajtmh.2012.11-0788; Rogerson SJ, 2003, J CLIN MICROBIOL, V41, P1370, DOI 10.1128/JCM.41.4.1370-1374.2003; Sangare L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087743; Steketee RW, 2003, J NUTR, V133, p1661S, DOI 10.1093/jn/133.5.1661S; Swysen C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-223; Tine Roger C K, 2012, BMC Res Notes, V5, P565, DOI 10.1186/1756-0500-5-565; Uneke Chigozie J, 2007, Yale J Biol Med, V80, P95; United Nations Administrative Committee on Coordination, 2000, WHO TECHN REP SER; *WHO, 1972, WHO TECHN REP SER, V503; World Health Organization, 1995, PHYS STAT US INT ANT; YAMADA M, 1989, AM J TROP MED HYG, V41, P161, DOI 10.4269/ajtmh.1989.41.161	41	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129510	10.1371/journal.pone.0129510	http://dx.doi.org/10.1371/journal.pone.0129510			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052704	gold, Green Published, Green Submitted			2022-12-27	WOS:000355955300134
J	Adlowitz, DG; Barnard, J; Biear, JN; Cistrone, C; Owen, T; Wang, WS; Palanichamy, A; Ezealah, E; Campbell, D; Wei, CW; Looney, RJ; Sanz, I; Anolik, JH				Adlowitz, Diana G.; Barnard, Jennifer; Biear, Jamie N.; Cistrone, Christopher; Owen, Teresa; Wang, Wensheng; Palanichamy, Arumugam; Ezealah, Ezinma; Campbell, Debbie; Wei, Chungwen; Looney, R. John; Sanz, Inaki; Anolik, Jennifer H.			Expansion of Activated Peripheral Blood Memory B Cells in Rheumatoid Arthritis, Impact of B Cell Depletion Therapy, and Biomarkers of Response	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RITUXIMAB THERAPY; BONE-MARROW; SUBSETS; IDENTIFICATION; EXPRESSION; DISEASE; PREDICT; TISSUE	Although B cell depletion therapy (BCDT) is effective in a subset of rheumatoid arthritis (RA) patients, both mechanisms and biomarkers of response are poorly defined. Here we characterized abnormalities in B cell populations in RA and the impact of BCDT in order to elucidate B cell roles in the disease and response biomarkers. In active RA patients both CD27 + IgD-switched memory (SM) and CD27-IgD-double negative memory (DN) peripheral blood B cells contained significantly higher fractions of CD95+ and CD21-activated cells compared to healthy controls. After BCD the predominant B cell populations were memory, and residual memory B cells displayed a high fraction of CD21- and CD95+ compared to pre-depletion indicating some resistance of these activated populations to anti-CD20. The residual memory populations also expressed more Ki-67 compared to pre-treatment, suggesting homeostatic proliferation in the B cell depleted state. Biomarkers of clinical response included lower CD95+ activated memory B cells at depletion time points and a higher ratio of transitional B cells to memory at reconstitution. B cell function in terms of cytokine secretion was dependent on B cell subset and changed with BCD. Thus, SM B cells produced pro-inflammatory (TNF) over regulatory (IL10) cytokines as compared to naive/transitional. Notably, B cell TNF production decreased after BCDT and reconstitution compared to untreated RA. Our results support the hypothesis that the clinical and immunological outcome of BCDT depends on the relative balance of protective and pathogenic B cell subsets established after B cell depletion and repopulation.	[Adlowitz, Diana G.; Barnard, Jennifer; Biear, Jamie N.; Cistrone, Christopher; Owen, Teresa; Wang, Wensheng; Palanichamy, Arumugam; Ezealah, Ezinma; Campbell, Debbie; Looney, R. John; Anolik, Jennifer H.] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Wei, Chungwen; Sanz, Inaki] Emory Univ, Dept Med, Atlanta, GA 30332 USA	University of Rochester; Emory University	Anolik, JH (corresponding author), Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA.	Jennifer_anolik@urmc.rochester.edu	Cistrone, Christopher/AAG-9968-2020	Anolik, Jennifer/0000-0002-1450-1549	Autoimmunity Center of Excellence [R01 AI077674, P01 AI078907, U19 AI56390]; University of Rochester; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056390, U19AI110483, P01AI078907, R01AI077674, R37AI049660] Funding Source: NIH RePORTER	Autoimmunity Center of Excellence; University of Rochester; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants R01 AI077674 (JA), P01 AI078907 (IS, JA, RJL), and U19 AI56390 Autoimmunity Center of Excellence (IS, RJL, JA) and internal funds from the University of Rochester (JA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Anolik JH, 2007, ARTHRITIS RHEUM, V56, P3044, DOI 10.1002/art.22810; Anolik JH, 2004, ARTHRITIS RHEUM-US, V50, P3580, DOI 10.1002/art.20592; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Bohnhorst JO, 2001, J IMMUNOL, V167, P3610, DOI 10.4049/jimmunol.167.7.3610; Bouaziz JD, 2010, EUR J IMMUNOL, V40, P2686, DOI 10.1002/eji.201040673; Chatzidionysiou K, 2011, ANN RHEUM DIS, V70, P1575, DOI 10.1136/ard.2010.148759; Cuss AK, 2006, J IMMUNOL, V176, P1506, DOI 10.4049/jimmunol.176.3.1506; Daridon C, 2007, AUTOIMMUN REV, V6, P427, DOI 10.1016/j.autrev.2007.01.010; Dass S, 2008, ARTHRITIS RHEUM-US, V58, P2993, DOI 10.1002/art.23902; Duddy M, 2007, J IMMUNOL, V178, P6092, DOI 10.4049/jimmunol.178.10.6092; Edwards JCW, 2001, RHEUMATOLOGY, V40, P205, DOI 10.1093/rheumatology/40.2.205; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Evans JG, 2007, J IMMUNOL, V178, P7868, DOI 10.4049/jimmunol.178.12.7868; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; Fu YX, 1998, J EXP MED, V187, P1009, DOI 10.1084/jem.187.7.1009; Hu CY, 2007, J CLIN INVEST, V117, P3857, DOI 10.1172/JCI32405; Illges H, 2000, CLIN EXP IMMUNOL, V122, P270, DOI 10.1046/j.1365-2249.2000.01379.x; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Kavanaugh A, 2008, ANN RHEUM DIS, V67, P402, DOI 10.1136/ard.2007.074229; Lal P, 2011, ARTHRITIS RHEUM-US, V63, P3681, DOI 10.1002/art.30596; Langkjaer A, 2012, CLIN IMMUNOL, V145, P1, DOI 10.1016/j.clim.2012.07.004; Leandro MJ, 2006, ARTHRITIS RHEUM-US, V54, P613, DOI 10.1002/art.21617; Linton PJ, 2000, J IMMUNOL, V165, P5558, DOI 10.4049/jimmunol.165.10.5558; Machold KP, 2007, RHEUMATOLOGY, V46, P342, DOI 10.1093/rheumatology/kel237; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moulin V, 2000, J EXP MED, V192, P475, DOI 10.1084/jem.192.4.475; Nakou M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2798; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Owczarczyk K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002432; Palanichamy A, 2009, J IMMUNOL, V182, P5982, DOI 10.4049/jimmunol.0801859; PASCUAL V, 1994, J EXP MED, V180, P329, DOI 10.1084/jem.180.1.329; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Rehnberg M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2789; Roll P, 2008, ARTHRITIS RHEUM-US, V58, P1566, DOI 10.1002/art.23473; Sellam J, 2011, ARTHRITIS RHEUM-US, V63, P3692, DOI 10.1002/art.30599; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; Skok J, 1999, J IMMUNOL, V163, P4284; SMELAND EB, 1989, J EXP MED, V170, P1463, DOI 10.1084/jem.170.4.1463; Souto-Carneiro MM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2718; SUNG SSJ, 1988, J EXP MED, V168, P1539, DOI 10.1084/jem.168.5.1539; Takemura S, 2001, J IMMUNOL, V167, P4710, DOI 10.4049/jimmunol.167.8.4710; Thurlings RM, 2008, ANN RHEUM DIS, V67, P917, DOI 10.1136/ard.2007.080960; Turesson C, 1999, RHEUMATOLOGY, V38, P668, DOI 10.1093/rheumatology/38.7.668; Vital EM, 2015, ANN RHEUM DIS, V74, P1195, DOI 10.1136/annrheumdis-2013-204544; Vital EM, 2011, ARTHRITIS RHEUM-US, V63, P3038, DOI 10.1002/art.30466; Wei CW, 2011, CYTOM PART A, V79A, P894, DOI 10.1002/cyto.a.21112; Weyand CM, 2003, ANN NY ACAD SCI, V987, P140, DOI 10.1111/j.1749-6632.2003.tb06042.x; Wirths S, 2005, EUR J IMMUNOL, V35, P3433, DOI 10.1002/eji.200535364; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017	54	87	89	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128269	10.1371/journal.pone.0128269	http://dx.doi.org/10.1371/journal.pone.0128269			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047509	gold, Green Published, Green Submitted			2022-12-27	WOS:000355652200052
J	Higuchi, Y; Kojima, M; Ishii, G; Aoyagi, K; Sasaki, H; Ochiai, A				Higuchi, Youichi; Kojima, Motohiro; Ishii, Genichiro; Aoyagi, Kazuhiko; Sasaki, Hiroki; Ochiai, Atsushi			Gastrointestinal Fibroblasts Have Specialized, Diverse Transcriptional Phenotypes: A Comprehensive Gene Expression Analysis of Human Fibroblasts	PLOS ONE			English	Article							HUMAN PERITONEAL FIBROBLASTS; SMOOTH-MUSCLE-CELLS; LIVER FIBROSIS; STROMAL CELLS; STEM-CELLS; CANCER; CYTOKINES; TISSUE; BETA; MYOFIBROBLASTS	Background Fibroblasts are the principal stromal cells that exist in whole organs and play vital roles in many biological processes. Although the functional diversity of fibroblasts has been estimated, a comprehensive analysis of fibroblasts from the whole body has not been performed and their transcriptional diversity has not been sufficiently explored. The aim of this study was to elucidate the transcriptional diversity of human fibroblasts within the whole body. Methods Global gene expression analysis was performed on 63 human primary fibroblasts from 13 organs. Of these, 32 fibroblasts from gastrointestinal organs (gastrointestinal fibroblasts: GIFs) were obtained from a pair of 2 anatomical sites: the submucosal layer (submucosal fibroblasts: SMFs) and the subperitoneal layer (subperitoneal fibroblasts: SPFs). Using hierarchical clustering analysis, we elucidated identifiable subgroups of fibroblasts and analyzed the transcriptional character of each subgroup. Results In unsupervised clustering, 2 major clusters that separate GIFs and non-GIFs were observed. Organ-and anatomical site-dependent clusters within GIFs were also observed. The signature genes that discriminated GIFs from non-GIFs, SMFs from SPFs, and the fibroblasts of one organ from another organ consisted of genes associated with transcriptional regulation, signaling ligands, and extracellular matrix remodeling. Conclusions GIFs are characteristic fibroblasts with specific gene expressions from transcriptional regulation, signaling ligands, and extracellular matrix remodeling related genes. In addition, the anatomical site- and organ-dependent diversity of GIFs was also discovered. These features of GIFs contribute to their specific physiological function and homeostatic maintenance, and create a functional diversity of the gastrointestinal tract.	[Higuchi, Youichi; Ochiai, Atsushi] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Canc Biol Lab, Kashiwa, Chiba, Japan; [Kojima, Motohiro; Ishii, Genichiro; Ochiai, Atsushi] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Div Pathol, Kashiwa, Chiba, Japan; [Aoyagi, Kazuhiko; Sasaki, Hiroki] Natl Canc Ctr, Res Inst, Div Genet, Chuo Ku, Tokyo 104, Japan	University of Tokyo; National Cancer Center - Japan; National Cancer Center - Japan	Ochiai, A (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Canc Biol Lab, Kashiwa, Chiba, Japan.	aochiai@east.ncc.go.jp			Health and Labour Sciences Research Grants (Ministry of Health, Labour and Welfare) [26270601]; 3rd-term Comprehensive 10-year Strategy for Cancer Control (Ministry of Health, Labour and Welfare) [23-A-3]	Health and Labour Sciences Research Grants (Ministry of Health, Labour and Welfare); 3rd-term Comprehensive 10-year Strategy for Cancer Control (Ministry of Health, Labour and Welfare)	This work was supported by: Health and Labour Sciences Research Grants grant number 26270601 (Ministry of Health, Labour and Welfare, [http://www.mhlw.go.jp/: MK]) and a grant of a 3rd-term Comprehensive 10-year Strategy for Cancer Control grant number 23-A-3 (Ministry of Health, Labour and Welfare, [http://www.mhlw.go.jp/: AO]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa M, 2012, PANCREAS, V41, P512, DOI 10.1097/MPA.0b013e31823ca3e0; Balabanova S, 2014, CARCINOGENESIS, V35, P1798, DOI 10.1093/carcin/bgu086; BALLARDINI G, 1988, VIRCHOWS ARCH B, V56, P45, DOI 10.1007/BF02890000; Bauer M, 2010, ONCOGENE, V29, P1732, DOI 10.1038/onc.2009.463; Beswick EJ, 2014, J IMMUNOL, V193, P2218, DOI 10.4049/jimmunol.1203441; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chen WW, 2011, P NATL ACAD SCI USA, V108, P9589, DOI 10.1073/pnas.1017945108; Chiquet M, 2009, BBA-MOL CELL RES, V1793, P911, DOI 10.1016/j.bbamcr.2009.01.012; Darryl C, 2006, HISTOLOGY PATHOLOGIS, V3rd, P547; Elkabets M, 2011, J CLIN INVEST, V121, P784, DOI 10.1172/JCI43757; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Garcia-Arraras JE, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-61; Gimenez-Bastida JA, 2009, J AGR FOOD CHEM, V57, P9305, DOI 10.1021/jf901983g; Gottschling S, 2013, LUNG CANCER, V80, P19, DOI 10.1016/j.lungcan.2012.12.015; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hoshino A, 2008, BIOCHEM BIOPH RES CO, V368, P305, DOI 10.1016/j.bbrc.2008.01.090; Janson DG, 2012, J INVEST DERMATOL, V132, P2565, DOI 10.1038/jid.2012.192; Kabiri Z, 2014, DEVELOPMENT, V141, P2206, DOI 10.1242/dev.104976; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kawazoe Y, 2002, DEV GROWTH DIFFER, V44, P77; KAYE GI, 1968, GASTROENTEROLOGY, V54, P852; Kim BM, 2005, DEV CELL, V8, P611, DOI 10.1016/j.devcel.2005.01.015; Kojima M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088018; Kurashima Y, 2014, IMMUNITY, V40, P530, DOI 10.1016/j.immuni.2014.01.014; Mclin VA, 2009, GASTROENTEROLOGY, V136, P2074, DOI 10.1053/j.gastro.2009.03.001; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Nair DG, 2014, J CELL MOL MED, V18, P444, DOI 10.1111/jcmm.12193; Pabst O, 1999, DEVELOPMENT, V126, P2215; Peng RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059348; Pispa J, 2003, DEV BIOL, V262, P195, DOI 10.1016/S0012-1606(03)00325-7; Powell DW, 2011, ANNU REV PHYSIOL, V73, P213, DOI 10.1146/annurev.physiol.70.113006.100646; Rinn JL, 2008, J INVEST DERMATOL, V128, P776, DOI 10.1038/sj.jid.5700986; Rinn JL, 2008, GENE DEV, V22, P303, DOI 10.1101/gad.1610508; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Takashima S, 2013, DEV GENES EVOL, V223, P85, DOI 10.1007/s00427-012-0422-8; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; Witowski J, 2001, AM J PATHOL, V158, P1441, DOI 10.1016/S0002-9440(10)64095-3; Witowski J, 2006, PERITON DIALYSIS INT, V26, P292; Witowski J, 2009, LAB INVEST, V89, P414, DOI 10.1038/labinvest.2009.1; Yamaguchi Y, 1999, J INVEST DERMATOL, V112, P483, DOI 10.1046/j.1523-1747.1999.00544.x	43	28	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129241	10.1371/journal.pone.0129241	http://dx.doi.org/10.1371/journal.pone.0129241			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046848	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200137
J	Mancini, E; Spinaci, MI; Gordicho, V; Caputo, B; Pombi, M; Vicente, JL; Dinis, J; Rodrigues, A; Petrarca, V; Weetman, D; Pinto, J; della Torre, A				Mancini, Emiliano; Spinaci, Maria Ida; Gordicho, Vasco; Caputo, Beniamino; Pombi, Marco; Vicente, Jose Luis; Dinis, Joao; Rodrigues, Amabelia; Petrarca, Vincenzo; Weetman, David; Pinto, Joao; della Torre, Alessandra			Adaptive Potential of Hybridization among Malaria Vectors: Introgression at the Immune Locus TEP1 between Anopheles coluzzii and A. gambiae in 'Far-West' Africa	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; MOLECULAR-FORMS; S FORMS; INCIPIENT SPECIATION; GENOMIC DIVERGENCE; RESISTANCE; S.S.; DIFFERENTIATION; SOFTWARE; ISLANDS	"Far-West" Africa is known to be a secondary contact zone between the two majormalaria vectors Anopheles coluzzii and A. gambiae. We investigated gene-flow and potentially adaptive introgression between these species along a west-to-east transect in Guinea Bissau, the putative core of this hybrid zone. To evaluate the extent and direction of gene flow, we geno-typed site 702 in Intron-1 of the para Voltage-Gated Sodium Channel gene, a species-diagnostic nucleotide position throughout most of A. coluzzii and A. gambiae sympatric range. We also analyzed polymorphismin the thioester-binding domain (TED) of the innate immunity-linked thioester-containing protein 1 (TEP1) to investigate whether elevated hybridization might facilitate the exchange of variants linked to adaptive immunity and Plasmodium refractoriness. Our results confirm asymmetric introgression of genetic material from A. coluzzii to A. gambiae and disruption of linkage between the centromeric "genomic islands" of inter-specific divergence. We report that A. gambiae from the Guinean hybrid zone possesses an introgressed TEP1 resistant allelic class, found exclusively in A. coluzzii elsewhere and apparently swept to fixation in West Africa (i.e. Mali and Burkina Faso). However, no detectable fixation of this allele was found in Guinea Bissau, which may suggest that ecological pressures driving segregation between the two species in larval habitats in this region may be different from those experienced in northern and more arid parts of the species' range. Finally, our results also suggest a genetic subdivision between coastal and inland A. gambiae Guinean populations and provide clues on the importance of ecological factors in intra-specific differentiation processes.	[Mancini, Emiliano; Spinaci, Maria Ida; Caputo, Beniamino; Pombi, Marco; della Torre, Alessandra] Univ Roma La Sapienza, Dipartimento Sanita Pubbl & Malattie Infett, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Gordicho, Vasco; Vicente, Jose Luis; Pinto, Joao] Univ Nova Lisboa, Inst Higiene & Med Trop, UEI Parasitol Med, P-1200 Lisbon, Portugal; [Gordicho, Vasco; Vicente, Jose Luis; Pinto, Joao] Univ Nova Lisboa, Inst Higiene & Med Trop, Ctr Malaria & Outras Doencas Trop, P-1200 Lisbon, Portugal; [Dinis, Joao; Rodrigues, Amabelia] Inst Nacl Saude Publ, Bissau, Guinea Bissau; [Petrarca, Vincenzo] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol C Darwin, I-00185 Rome, Italy; [Weetman, David] Univ Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England	Fondazione Cenci Bolognetti; Sapienza University Rome; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Sapienza University Rome; Liverpool School of Tropical Medicine; University of Liverpool	Mancini, E (corresponding author), Univ Rome Tre, Dipartimento Sci, I-00146 Rome, Italy.	emiliano.mancini@uniroma3.it	Caputo, Beniamino/I-2880-2015; Pombi, Marco/AAD-6525-2022; J., Pinto/H-6177-2019; Pinto, Joao/C-2208-2012; Weetman, David/M-1261-2014	Caputo, Beniamino/0000-0002-5650-8773; Pombi, Marco/0000-0002-4382-9922; J., Pinto/0000-0001-8572-7708; Pinto, Joao/0000-0001-8572-7708; Weetman, David/0000-0002-5820-1388; MANCINI, Emiliano/0000-0002-7988-4544	European Union's INFRAVEC project (under FP7 program) [228421]; FCT Portugal/FEDER (through program COMPETE) [PTDC/BIA-EVF/120407/2010]; Sapienza' Universita di Roma; MIUR-FIRB "Futuro in Ricerca" grant [RBFR106NTE]	European Union's INFRAVEC project (under FP7 program); FCT Portugal/FEDER (through program COMPETE); Sapienza' Universita di Roma; MIUR-FIRB "Futuro in Ricerca" grant(Ministry of Education, Universities and Research (MIUR))	This work was supported by the European Union's INFRAVEC project (Grant agreement no. 228421, under FP7 program) to AdT and JP; FCT Portugal/FEDER (through program COMPETE) cofunds (PTDC/BIA-EVF/120407/2010); AWARD 2013 grant by 'Sapienza' Universita di Roma to AdT, MIUR-FIRB "Futuro in Ricerca 2010" grant to BC (Grant No RBFR106NTE).	Abbott R, 2005, J EVOLUTION BIOL, V26, P229; [Anonymous], 1987, PUBLICATIONS S AFRIC; [Anonymous], 1968, PUBLICATIONS S AFRIC; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Blandin SA, 2009, SCIENCE, V326, P147, DOI 10.1126/science.1175241; Caputo B, 2014, MOL ECOL, V23, P4574, DOI 10.1111/mec.12866; Caputo B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016415; Cassone BJ, 2014, MOL ECOL, V23, P2242, DOI 10.1111/mec.12733; Clarkson CS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5248; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Diabate A, 2009, P ROY SOC B-BIOL SCI, V276, P4215, DOI 10.1098/rspb.2009.1167; Etang J, 2009, MOL ECOL, V18, P3076, DOI 10.1111/j.1365-294X.2009.04256.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gentile G, 2004, INSECT MOL BIOL, V13, P371, DOI 10.1111/j.0962-1075.2004.00494.x; Gimonneau G, 2012, MED VET ENTOMOL, V26, P9, DOI 10.1111/j.1365-2915.2011.00957.x; Hedrick PW, 2013, MOL ECOL, V22, P4606, DOI 10.1111/mec.12415; Hervy JP, 1998, DIDACTIQUES; Kamdem C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031843; Kangah PAD, 2010, RAINFALL AGR CENTRAL; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Le BV, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002958; Lee Y, 2014, MOL ECOL RESOUR, V14, P297, DOI 10.1111/1755-0998.12181; Lee Y, 2013, P NATL ACAD SCI USA, V110, P19854, DOI 10.1073/pnas.1316851110; Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liebmann B, 2012, J CLIMATE, V25, P4304, DOI 10.1175/JCLI-D-11-00157.1; Marsden CD, 2011, MOL ECOL, V20, P4983, DOI 10.1111/j.1365-294X.2011.05339.x; Neafsey DE, 2010, SCIENCE, V330, P514, DOI 10.1126/science.1193036; Nwakanma DC, 2013, GENETICS, V193, P1221, DOI 10.1534/genetics.112.148718; Obbard DJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-274; Oliveira E, 2008, J MED ENTOMOL, V45, P1057, DOI 10.1603/0022-2585(2008)45[1057:HLOHBM]2.0.CO;2; Pennetier C, 2010, CURR BIOL, V20, P131, DOI 10.1016/j.cub.2009.11.040; PETRARCA V, 1983, Parassitologia (Rome), V25, P29; Pinto J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001243; Reidenbach KR, 2012, GENOME BIOL EVOL, V4, P1202, DOI 10.1093/gbe/evs095; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Santolamazza F, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0522-1; Santolamazza F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-215; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-163; Staden R, 2000, Methods Mol Biol, V132, P115; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Weetman D, 2012, MOL BIOL EVOL, V29, P279, DOI 10.1093/molbev/msr199; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White BJ, 2011, P NATL ACAD SCI USA, V108, P244, DOI 10.1073/pnas.1013648108; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x; Wilkins EE, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-125	50	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127804	10.1371/journal.pone.0127804	http://dx.doi.org/10.1371/journal.pone.0127804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047479	gold, Green Published, Green Accepted			2022-12-27	WOS:000355652200031
J	Moccia, M; Liu, QS; Guida, T; Federico, G; Brescia, A; Zhao, Z; Choi, HG; Deng, XM; Tan, L; Wang, JH; Billaud, M; Gray, NS; Carlomagno, F; Santoro, M				Moccia, Marialuisa; Liu, Qingsong; Guida, Teresa; Federico, Giorgia; Brescia, Annalisa; Zhao, Zheng; Choi, Hwan Geun; Deng, Xianming; Tan, Li; Wang, Jinhua; Billaud, Marc; Gray, Nathanael S.; Carlomagno, Francesca; Santoro, Massimo			Identification of Novel Small Molecule Inhibitors of Oncogenic RET Kinase	PLOS ONE			English	Article							MEDULLARY-THYROID CANCER; CARCINOMA CELL-LINE; LUNG-CANCER; PONATINIB AP24534; POTENT INHIBITOR; GENE FUSION; BCR-ABL; MUTATIONS; RESISTANCE; ADENOCARCINOMA	Oncogenic mutation of the RET receptor tyrosine kinase is observed in several human malignancies. Here, we describe three novel type II RET tyrosine kinase inhibitors (TKI), ALW-II- 41-27, XMD15-44 and HG-6-63-01, that inhibit the cellular activity of oncogenic RET mutants at two digit nanomolar concentration. These three compounds shared a 3-trifluoro-methyl-4-methylpiperazinephenyl pharmacophore that stabilizes the 'DFG-out' inactive conformation of RET activation loop. They blocked RET-mediated signaling and proliferation with an IC50 in the nM range in fibroblasts transformed by the RET/C634R and RET/M918T oncogenes. They also inhibited autophosphorylation of several additional oncogenic RET-derived point mutants and chimeric oncogenes. At a concentration of 10 nM, ALW-II- 41-27, XMD15-44 and HG-6-63-01 inhibited RET kinase and signaling in human thyroid cancer cell lines carrying oncogenic RET alleles; they also inhibited proliferation of cancer, but not non-tumoral Nthy-ori-3-1, thyroid cells, with an IC50 in the nM range. The three compounds were capable of inhibiting the 'gatekeeper' V804M mutant which confers substantial resistance to established RET inhibitors. In conclusion, we have identified a type II TKI scaffold, shared by ALW-II-41-27, XMD15-44 and HG-6-63-01, that may be used as novel lead for the development of novel agents for the treatment of cancers harboring oncogenic activation of RET.	[Moccia, Marialuisa; Guida, Teresa; Federico, Giorgia; Brescia, Annalisa; Carlomagno, Francesca; Santoro, Massimo] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Moccia, Marialuisa; Guida, Teresa; Federico, Giorgia; Brescia, Annalisa; Carlomagno, Francesca; Santoro, Massimo] CNR, Ist Endocrinol & Oncol Sperimentale, I-80125 Naples, Italy; [Liu, Qingsong; Choi, Hwan Geun; Deng, Xianming; Tan, Li; Wang, Jinhua; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Liu, Qingsong; Choi, Hwan Geun; Deng, Xianming; Tan, Li; Wang, Jinhua; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Zhao, Zheng] Chinese Acad Sci, High Field Magnet Lab, Hefei, Anhui, Peoples R China; [Billaud, Marc] CRI INSERM UJF U823, Inst Albert Bonniot, La Tronche, France	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Santoro, M (corresponding author), Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy.	masantor@unina.it	刘, 青松/AEM-1932-2022; Liu, Qingsong/AFS-0714-2022	刘, 青松/0000-0002-7829-2547; Liu, Qingsong/0000-0002-7829-2547; Federico, Giorgia/0000-0001-9420-6699; Tan, Li/0000-0002-1199-9046; Deng, Xianming/0000-0002-9354-5864	Italian Association for Cancer Research (AIRC); FIRB Merit grant of MIUR; NIH grant [R01 CA172592]; NATIONAL CANCER INSTITUTE [R01CA172592] Funding Source: NIH RePORTER	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); FIRB Merit grant of MIUR(Ministry of Education, Universities and Research (MIUR)); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support was provided by the Italian Association for Cancer Research (AIRC) and FIRB Merit grant of MIUR to MS, and NIH grant R01 CA172592 to NSG.	Arnato KR, 2014, J CLIN INVEST, V124, P2037, DOI 10.1172/JCI72522; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ballerini P, 2012, LEUKEMIA, V26, P2384, DOI 10.1038/leu.2012.109; Bossi D, 2014, MOL ONCOL, V8, P221, DOI 10.1016/j.molonc.2013.11.004; CARLOMAGNO F, 1995, BIOCHEM BIOPH RES CO, V207, P1022, DOI 10.1006/bbrc.1995.1287; Carlomagno F, 2002, CANCER RES, V62, P7284; Carlomagno F, 2004, ONCOGENE, V23, P6056, DOI 10.1038/sj.onc.1207810; Carlomagno F, 2009, ENDOCR-RELAT CANCER, V16, P233, DOI 10.1677/ERC-08-0213; Choi Y, 2009, BIOORG MED CHEM LETT, V19, P4467, DOI 10.1016/j.bmcl.2009.05.029; De Falco V, 2013, J CLIN ENDOCR METAB, V98, pE811, DOI 10.1210/jc.2012-2672; de Groot JWB, 2006, ENDOCR REV, V27, P535, DOI 10.1210/er.2006-0017; Deng XM, 2010, BIOORG MED CHEM LETT, V20, P4196, DOI 10.1016/j.bmcl.2010.05.043; Elisei R, 2013, J CLIN ONCOL, V31, P3639, DOI 10.1200/JCO.2012.48.4659; Gild ML, 2011, NAT REV ENDOCRINOL, V7, P617, DOI 10.1038/nrendo.2011.141; ISHIZAKA Y, 1990, BIOCHEM BIOPH RES CO, V168, P402, DOI 10.1016/0006-291X(90)92335-W; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KITAYAMA H, 1995, BLOOD, V85, P790, DOI 10.1182/blood.V85.3.790.bloodjournal853790; Knowles PP, 2006, J BIOL CHEM, V281, P33577, DOI 10.1074/jbc.M605604200; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Li F, 2012, CELL RES, V22, P928, DOI 10.1038/cr.2012.27; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Mologni L, 2013, MOL CELL ENDOCRINOL, V377, P1, DOI 10.1016/j.mce.2013.06.025; Mulligan LM, 2014, NAT REV CANCER, V14, P173, DOI 10.1038/nrc3680; O'Hare T, 2006, CURR OPIN GENET DEV, V16, P92, DOI 10.1016/j.gde.2005.11.002; Okram B, 2006, CHEM BIOL, V13, P779, DOI 10.1016/j.chembiol.2006.05.015; Pasini A, 1997, ONCOGENE, V15, P393, DOI 10.1038/sj.onc.1201199; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Santoro M, 2006, NAT CLIN PRACT ENDOC, V2, P42, DOI 10.1038/ncpendmet0073; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Vitagliano D, 2011, ENDOCR-RELAT CANCER, V18, P1, DOI 10.1677/ERC-09-0292; Wells SA, 2012, J CLIN ONCOL, V30, P134, DOI 10.1200/JCO.2011.35.5040; Wells SA, 2009, CLIN CANCER RES, V15, P7119, DOI 10.1158/1078-0432.CCR-08-2742; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhou TJ, 2011, CHEM BIOL DRUG DES, V77, P1, DOI 10.1111/j.1747-0285.2010.01054.x	36	17	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128364	10.1371/journal.pone.0128364	http://dx.doi.org/10.1371/journal.pone.0128364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046350	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200063
J	Yehia, L; Boulos, F; Jabbour, M; Mahfoud, Z; Fakhruddin, N; El-Sabban, M				Yehia, Lamis; Boulos, Fouad; Jabbour, Mark; Mahfoud, Ziyad; Fakhruddin, Najla; El-Sabban, Marwan			Expression of HIF-1 alpha and Markers of Angiogenesis Are Not Significantly Different in Triple Negative Breast Cancer Compared to Other Breast Cancer Molecular Subtypes: Implications for Future Therapy	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; INVASIVE DUCTAL CARCINOMAS; BASAL-LIKE SUBTYPE; ESTROGEN-RECEPTOR; FACTOR 1-ALPHA; TUMOR HYPOXIA; GROWTH; PHENOTYPE; PROGNOSIS; FEATURES	Introduction Triple negative breast cancer lacks estrogen, progesterone and epidermal growth factor receptors rendering it refractory to available targetedtherapies. TNBC is associated with central fibrosis and necrosis, both indicators of tumor hypoxia. Hypoxia inducible factor 1 alpha is up-regulated under hypoxia and its expression is associated with induction of angiogenesis resulting in proliferation, aggressive tumor phenotype and metastasis. In this study we evaluate the potential use of HIF-1 alpha as aTNBC-specific marker. Methods 62 TNBC, 64 HER2(+), and 64 hormone-receptors positive breast cancer cases were evaluated for central fibrosis and necrosis, HIF-1 alpha, HIF-1 beta, VEGFR3, CD31 expression and microvessel density. RNA extraction from paraffin-embedded samples, followed by quantitative real-time polymerase chain reaction (qRT-PCR) evaluation of HIF-1 alpha and VEGF transcripts was performed on 54 cases (18 from each subtype). Results HIF-1 alpha protein was expressed in 35.5% TNBC, 45.3% HER2(+) and 25.0% ER+/PR+ (p = 0.055; chi(2) test). PCRanalysis of subgroup of breast cancers, 84.2% expressed HIF-1 alpha protein and its transcripts, while only 66.7% expressed VEGF transcripts simultaneously with the HIF-1 alpha protein and its transcripts. Central fibrosis and necrosis was highest in TNBC (p = 0.015; chi(2) test), while MVD was comparable among all groups (p = 0.928; chi(2) test). VEGFR3 was highest in TNBC expressing HIF-1 alpha. HIF-1 beta protein was expressed in 32.0% of HIF-1 alpha(+), and in (44.3%) of HIF-1 alpha(-) breast cancer cases (p = 0.033; chi(2) test). Moreover, HIF-1 alpha expression in cases with central fibrosis and necrosis was highest in the HER2(+) followed by the TNBC (p = 0.156; chi(2)test). Conclusions A proportion of TNBC express HIF-1 alpha but not in a significantly different manner from other breast cancer subtypes. The potential of anti-HIF-1 alpha targeted therapy is therefore not a candidate for exclusive use in TNBC, but should be considered in all breast cancers, especially in the setting of clinically aggressive or refractory disease.	[Yehia, Lamis; El-Sabban, Marwan] Amer Univ Beirut, Dept Anat Cell Biol & Physiol Sci, Beirut, Lebanon; [Boulos, Fouad; Jabbour, Mark; Fakhruddin, Najla] Amer Univ Beirut, Med Ctr, Dept Pathol & Lab Med, Beirut, Lebanon; [Mahfoud, Ziyad] Weill Cornell Med Coll, Dept Publ Hlth, Doha, Qatar; [Fakhruddin, Najla] Hammoud Hosp Univ, Med Ctr, Dept Pathol, Sidon, Lebanon; [Yehia, Lamis] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44195 USA	American University of Beirut; American University of Beirut; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Case Western Reserve University	Fakhruddin, N (corresponding author), Amer Univ Beirut, Med Ctr, Dept Pathol & Lab Med, Beirut, Lebanon.	nf21@aub.edu.lb; me00@aub.edu.lb	Boulos, Fouad/AAL-9299-2021; Yehia, Lamis/AAI-4996-2020	Yehia, Lamis/0000-0002-6389-3059; Mahfoud, Ziyad/0000-0003-4098-6401	Lebanese National Council for Scientific Research (LNCSR) [114160/522240]	Lebanese National Council for Scientific Research (LNCSR)	This study has been supported by the Lebanese National Council for Scientific Research (LNCSR) grant #114160/522240. "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Bos R, 2001, JNCI-J NATL CANCER I, V93, P309, DOI 10.1093/jnci/93.4.309; Bos R, 2005, HISTOPATHOLOGY, V46, P31, DOI 10.1111/j.1365-2559.2005.02045.x; Brizel DM, 1996, CANCER RES, V56, P941; Brown NS, 2001, BREAST CANCER RES, V3, P323, DOI 10.1186/bcr315; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Carvalho FM, 2010, CLINICS, V65, P1033, DOI 10.1590/S1807-59322010001000019; Chappuis PO, 2000, SEMIN SURG ONCOL, V18, P287, DOI 10.1002/(SICI)1098-2388(200006)18:4<287::AID-SSU3>3.3.CO;2-X; Cho J, 2006, J STEROID BIOCHEM, V100, P18, DOI 10.1016/j.jsbmb.2006.03.002; Choi J, 2013, PATHOBIOLOGY, V80, P41, DOI 10.1159/000339513; De Francesco EM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3458; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; dos Santos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045228; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fulford LG, 2006, HISTOPATHOLOGY, V49, P22, DOI 10.1111/j.1365-2559.2006.02453.x; Giatromanolaki A, 2004, CLIN CANCER RES, V10, P7972, DOI 10.1158/1078-0432.CCR-04-1068; Haffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Harris LN, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1622; Hockel M, 1996, CANCER RES, V56, P4509; Hockel M, 1998, INT J CANCER, V79, P365; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ishihara A, 2009, BREAST CANCER-TOKYO, V16, P179, DOI 10.1007/s12282-009-0108-x; Konecny GE, 2004, CLIN CANCER RES, V10, P1706, DOI 10.1158/1078-0432.CCR-0951-3; Kronblad A, 2005, ONCOGENE, V24, P6835, DOI 10.1038/sj.onc.1208830; Kurebayashi J, 2001, JPN J CANCER RES, V92, P1093, DOI 10.1111/j.1349-7006.2001.tb01064.x; Lakhani SR, 2005, CLIN CANCER RES, V11, P5175, DOI 10.1158/1078-0432.CCR-04-2424; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Mimeault M, 2013, J CELL MOL MED, V17, P30, DOI 10.1111/jcmm.12004; Morris GJ, 2007, CANCER-AM CANCER SOC, V110, P876, DOI 10.1002/cncr.22836; Mouawad R, 2009, EUR J CANCER, V45, P1407, DOI 10.1016/j.ejca.2008.12.015; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Onitilo AA, 2009, CLIN MED RES, V7, P4, DOI 10.3121/cmr.2009.825; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Semenza GL, 2000, CANCER METAST REV, V19, P59, DOI 10.1023/A:1026544214667; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Stoner M, 2002, MOL ENDOCRINOL, V16, P2231, DOI 10.1210/me.2001-0347; Tan EY, 2009, BRIT J CANCER, V100, P405, DOI 10.1038/sj.bjc.6604844; Tischkowitz M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-134; TOIKKANEN S, 1992, J CLIN ONCOL, V10, P1044, DOI 10.1200/JCO.1992.10.7.1044; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Tsuda H, 1999, HUM PATHOL, V30, P1134, DOI 10.1016/S0046-8177(99)90028-X; Tsuda H, 2000, AM J SURG PATHOL, V24, P197, DOI 10.1097/00000478-200002000-00005; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Uzzan B, 2004, CANCER RES, V64, P2941, DOI 10.1158/0008-5472.CAN-03-1957; van der Groep P, 2008, BREAST CANCER RES TR, V111, P475, DOI 10.1007/s10549-007-9817-z; Whelan KA, 2013, J BIOL CHEM, V288, P15865, DOI 10.1074/jbc.M112.426999; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108; Xia Y, 2012, EUR J MED CHEM, V49, P24, DOI 10.1016/j.ejmech.2012.01.033; Yamamoto Y, 2008, BREAST CANCER RES TR, V110, P465, DOI 10.1007/s10549-007-9742-1; Yan M, 2009, BRIT J CANCER, V101, P1168, DOI 10.1038/sj.bjc.6605287	57	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129356	10.1371/journal.pone.0129356	http://dx.doi.org/10.1371/journal.pone.0129356			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046764	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200156
J	Zannin, E; Pellegrino, R; Di Toro, A; Antonelli, A; Dellaca, RL; Bernardi, L				Zannin, Emanuela; Pellegrino, Riccardo; Di Toro, Alessandro; Antonelli, Andrea; Dellaca, Raffaele L.; Bernardi, Luciano			Parasympathetic Stimuli on Bronchial and Cardiovascular Systems in Humans	PLOS ONE			English	Article							AIRWAY SMOOTH-MUSCLE; ARTERIAL BAROREFLEX SENSITIVITY; EXPIRATORY FLOW LIMITATION; HEART-RATE-VARIABILITY; REFLEX REGULATION; BLOOD-PRESSURE; OXYGEN; COPD; PATHWAYS; EXERCISE	Background It is not known whether parasympathetic outflow simultaneously acts on bronchial tone and cardiovascular system waxing and waning both systems in parallel, or, alternatively, whether the regulation is more dependent on local factors and therefore independent on each system. The aim of this study was to evaluate the simultaneous effect of different kinds of stimulations, all associated with parasympathetic activation, on bronchomotor tone and cardiovascular autonomic regulation. Methods Respiratory system resistance (Rrs, forced oscillation technique) and cardio-vascular activity (heart rate, oxygen saturation, tissue oxygenation index, blood pressure) were assessed in 13 volunteers at baseline and during a series of parasympathetic stimuli: O-2 inhalation, stimulation of the carotid sinus baroreceptors by neck suction, slow breathing, and inhalation of methacholine. Results Pure cholinergic stimuli, like O-2 inhalation and baroreceptors stimulation, caused an increase in Rrs and a reduction in heart rate and blood pressure. Slow breathing led to bradycardia and hypotension, without significant changes in Rrs. However slow breathing was associated with deep inhalations, and Rrs evaluated at the baseline lung volumes was significantly increased, suggesting that the large tidal volumes reversed the airways narrowing effect of parasympathetic activation. Finally inhaled methacholine caused marked airway narrowing, while the cardiovascular variables were unaffected, presumably because of the sympathetic activity triggered in response to hypoxemia. Conclusions All parasympathetic stimuli affected bronchial tone and moderately affected also the cardiovascular system. However the response differed depending on the nature of the stimulus. Slow breathing was associated with large tidal volumes that reversed the airways narrowing effect of parasympathetic activation.	[Zannin, Emanuela; Dellaca, Raffaele L.] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, I-20133 Milan, Italy; [Pellegrino, Riccardo; Antonelli, Andrea] ASO S Croce & Carle, Allergol & Fisiopatol Resp, Cuneo, Italy; [Di Toro, Alessandro] Univ Pavia, Dipartimento Med Interna, I-27100 Pavia, Italy; [Di Toro, Alessandro] IRCCS, Policlin S Matteo, Pavia, Italy; [Bernardi, Luciano] Folkhalsan Res Ctr, Folkhalsan Inst Genet, Biomed Helsinki, Helsinki, Finland	Polytechnic University of Milan; University of Pavia; IRCCS Fondazione San Matteo; University of Pavia; Folkhalsan Research Center; University of Helsinki	Zannin, E (corresponding author), Politecn Milan, Dipartimento Elettron Informaz & Bioingn, I-20133 Milan, Italy.	emanuela.zannin@gmail.com	Pellegrino, Riccardo/AAA-1667-2022; Dellaca', Raffaele/AAF-7078-2019; Di Toro, Alessandro/AAC-3139-2021	Dellaca', Raffaele/0000-0002-3672-4591; Di Toro, Alessandro/0000-0001-7625-1103	Signe and Ane Gyllenberg Foundation (Helsinki, Finland)	Signe and Ane Gyllenberg Foundation (Helsinki, Finland)	LB is recipient of a grant from the Signe and Ane Gyllenberg Foundation (Helsinki, Finland).	Bartels MN, 2000, CHEST, V118, P691, DOI 10.1378/chest.118.3.691; Belmonte Kristen E, 2005, Proc Am Thorac Soc, V2, P297, DOI 10.1513/pats.200504-043SR; BENICHOU M, 1990, J APPL PHYSIOL, V68, P1634, DOI 10.1152/jappl.1990.68.4.1634; Bernardi L, 1998, LANCET, V351, P1308, DOI 10.1016/S0140-6736(97)10341-5; Bernardi L, 2011, DIABETOLOGIA, V54, P2164, DOI 10.1007/s00125-011-2195-4; Bernardi L, 2002, CIRCULATION, V105, P143, DOI 10.1161/hc0202.103311; BERNARDI L, 1995, CIRCULATION, V92, P2895, DOI 10.1161/01.CIR.92.10.2895; Bernardi L, 1998, CIRCULATION, V97, P1368, DOI 10.1161/01.CIR.97.14.1368; Bernardi L, 2001, J HYPERTENS, V19, P2221, DOI 10.1097/00004872-200112000-00016; Bernardi L, 2010, CLIN AUTON RES, V20, P353, DOI 10.1007/s10286-010-0079-1; BERTINIERI G, 1985, J HYPERTENS, V3, pS79; Brown CM, 2002, CLIN SCI, V102, P623, DOI 10.1042/CS20010242; Budzinska K, 2008, J PHYSIOL PHARMACOL, V59, P163; Canning BJ, 2001, RESP PHYSIOL, V125, P113, DOI 10.1016/S0034-5687(00)00208-5; Canning BJ, 2006, J APPL PHYSIOL, V101, P971, DOI 10.1152/japplphysiol.00313.2006; Coleridge H.M., 1986, HDB PHYSL, P395, DOI [10.1002/cphy.cp030212, DOI 10.1002/CPHY.CP030212]; COLERIDGE HM, 1989, PHARMACOL THERAPEUT, V42, P1, DOI 10.1016/0163-7258(89)90021-1; Dean JB, 2004, J APPL PHYSIOL, V96, P784, DOI 10.1152/japplphysiol.00892.2003; Dellaca RL, 2009, EUR RESPIR J, V33, P1329, DOI 10.1183/09031936.00139608; Dellaca RL, 2004, EUR RESPIR J, V23, P232, DOI 10.1183/09031936.04.00046804; Furlan R, 2003, CIRCULATION, V108, P717, DOI 10.1161/01.CIR.0000084540.91605.0C; Gobbi A, 2009, INTERNATIONAL CONFERENCE ON EHEALTH, TELEMEDICINE, AND SOCIAL MEDICINE: ETELEMED 2009, PROCEEDINGS, P117, DOI 10.1109/eTELEMED.2009.18; Hautala AJ, 2009, NEUROSCI BIOBEHAV R, V33, P107, DOI 10.1016/j.neubiorev.2008.04.009; HUGHES JMB, 1972, J APPL PHYSIOL, V32, P25, DOI 10.1152/jappl.1972.32.1.25; Iellamo F, 2000, CIRCULATION, V102, P2588; Joseph CN, 2005, HYPERTENSION, V46, P714, DOI 10.1161/01.HYP.0000179581.68566.7d; Kaczka DW, ANN BIOMED ENG, V23, P135; Kaczka DW, ANN BIOMED ENG, V27, P340; KARLSSON JA, 1988, J APPL PHYSIOL, V65, P1007, DOI 10.1152/jappl.1988.65.3.1007; Keyl C, 2002, ANESTH ANALG, V95, P1629, DOI 10.1097/00000539-200212000-00029; Krishna BH, 2014, J CLIN DIAGN RES, V8, P14, DOI [10.7860/JCDR/20147784.3983, 10.7860/JCDR/2014/7844.3983]; Lund VE, 1999, ACTA PHYSIOL SCAND, V167, P29; Marczak M, 2004, J PHYSIOL PHARMACOL, V55, P127; MOLFINO NA, 1993, AM REV RESPIR DIS, V148, P1238, DOI 10.1164/ajrccm/148.5.1238; Muralikrishnan Krishnan, 2012, J Ayurveda Integr Med, V3, P91, DOI 10.4103/0975-9476.96528; NAVAJAS D, 1999, EUR RESP MON, V12, P112; Pellegrino R, 1998, EUR RESPIR J, V12, P1219, DOI 10.1183/0903.1936.98.12051219; Peslin R., 1986, HDB PHYSL 3, VIII, P145, DOI [10.1002/cphy.cp030311, DOI 10.1002/CPHY.CP030311]; Piepoli M, 1997, CIRCULATION, V95, P1813; Proskocil Becky J, 2005, Proc Am Thorac Soc, V2, P305, DOI 10.1513/pats.200504-038SR; Raupach T, 2008, EUR RESPIR J, V32, P387, DOI 10.1183/09031936.00109607; Ruan T, 2003, J APPL PHYSIOL, V94, P1987, DOI 10.1152/japplphysiol.01047.2002; Sjoberg F, 2013, J INTERN MED, V274, P505, DOI 10.1111/joim.12139; Smith HJ, 2005, EUROPEAN RESP MONOGR, V31, P72, DOI [DOI 10.1183/1025448X.00031005, 10.1183/1025448x.00031005]; STEIN JF, 1975, RESP PHYSIOL, V25, P363, DOI 10.1016/0034-5687(75)90010-9; Waring WS, 2003, J CARDIOVASC PHARM, V42, P245, DOI 10.1097/00005344-200308000-00014; Weaver LK, 2009, J APPL PHYSIOL, V107, P336, DOI 10.1152/japplphysiol.91012.2008; Xing T, 2014, PROG BRAIN RES, V209, P131, DOI 10.1016/B978-0-444-63274-6.00007-2	48	12	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127697	10.1371/journal.pone.0127697	http://dx.doi.org/10.1371/journal.pone.0127697			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046774	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200026
J	Boehme, S; Ritter, V; Tefikow, S; Stangier, U; Strauss, B; Miltner, WHR; Straube, T				Boehme, Stephanie; Ritter, Viktoria; Tefikow, Susan; Stangier, Ulrich; Strauss, Bernhard; Miltner, Wolfgang H. R.; Straube, Thomas			Neural Correlates of Emotional Interference in Social Anxiety Disorder	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; THREAT-RELATED STIMULI; STROOP INTERFERENCE; AMYGDALA RESPONSE; PROCESSING BIAS; SINGLE-SUBJECT; BRAIN; SELF; ACTIVATION; PHOBIA	Disorder-relevant but task-unrelated stimuli impair cognitive performance in social anxiety disorder (SAD); however, time course and neural correlates of emotional interference are unknown. The present study investigated time course and neural basis of emotional interference in SAD using event-related functional magnetic resonance imaging (fMRI). Patients with SAD and healthy controls performed an emotional stroop task which allowed examining interference effects on the current and the succeeding trial. Reaction time data showed an emotional interference effect in the current trial, but not the succeeding trial, specifically in SAD. FMRI data showed greater activation in the left amygdala, bilateral insula, medial prefrontal cortex (mPFC), dorsal anterior cingulate cortex (ACC), and left opercular part of the inferior frontal gyrus during emotional interference of the current trial in SAD patients. Furthermore, we found a positive correlation between patients' interference scores and activation in the mPFC, dorsal ACC and left angular/supramarginal gyrus. Taken together, results indicate a network of brain regions comprising amygdala, insula, mPFC, ACC, and areas strongly involved in language processing during the processing of task-unrelated threat in SAD. However, specifically the activation in mPFC, dorsal ACC, and left angular/supramarginal gyrus is associated with the strength of the interference effect, suggesting a cognitive network model of attentional bias in SAD. This probably comprises exceeded allocation of attentional resources to disorder-related information of the presented stimuli and increased self-referential and semantic processing of threat words in SAD.	[Boehme, Stephanie] Univ Hosp Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Lab Psychophysiol & Funct Imaging, D-97080 Wurzburg, Germany; [Boehme, Stephanie; Miltner, Wolfgang H. R.] Univ Jena, Dept Biol & Clin Psychol, D-07743 Jena, Germany; [Ritter, Viktoria; Stangier, Ulrich] Goethe Univ Frankfurt, Dept Clin Psychol & Psychotherapy, D-60486 Frankfurt, Germany; [Tefikow, Susan; Strauss, Bernhard] Univ Jena, Jena Univ Hosp, Inst Psychosocial Med & Psychotherapy, D-07740 Jena, Germany; [Straube, Thomas] Univ Munster, Inst Med Psychol & Syst Neurosci, D-48149 Munster, Germany	University of Wurzburg; Friedrich Schiller University of Jena; Goethe University Frankfurt; Friedrich Schiller University of Jena; University of Munster	Boehme, S (corresponding author), Univ Hosp Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Lab Psychophysiol & Funct Imaging, Fuechsleinstr 15, D-97080 Wurzburg, Germany.	Boehme_S@klinik.uni-wuerzburg.de; thomas.straube@uni-muenster.de			Deutsche Forschungsgemeinschaft [STR 987/3-2, SFB/TRR 58: C06, SFB/TRR 58: C07]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.js; Project No. STR 987/3-2; SFB/TRR 58: C06, C07).	Alexander N, 2012, BIOL PSYCHIAT, V72, P49, DOI 10.1016/j.biopsych.2012.01.030; Amir N, 2002, J ANXIETY DISORD, V16, P1, DOI 10.1016/S0887-6185(01)00084-6; Amir N, 1996, BEHAV RES THER, V34, P945, DOI 10.1016/S0005-7967(96)00054-X; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Andersson Gerhard, 2006, Cognitive Behaviour Therapy, V35, P55, DOI 10.1080/16506070500372469; Bar-Haim Y, 2010, J CHILD PSYCHOL PSYC, V51, P859, DOI 10.1111/j.1469-7610.2010.02251.x; Beck A. T., 1985, ANXIETY DISORDERS AN; Becker ES, 2001, J ANXIETY DISORD, V15, P147, DOI 10.1016/S0887-6185(01)00055-X; Benjamini Y, 1995, CONTROLLING THE FALS; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Blair KS, 2007, NEUROIMAGE, V35, P430, DOI 10.1016/j.neuroimage.2006.11.048; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Campbell DW, 2007, BIOL PSYCHIAT, V62, P455, DOI 10.1016/j.biopsych.2006.09.017; Chechko N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005537; Clark D. M., 1995, SOCIALPHOBIA DIAGNOS, P69, DOI DOI 10.1017/S1352465808004487; Clark DM, 2002, BIOL PSYCHIAT, V51, P92, DOI 10.1016/S0006-3223(01)01296-3; Cooney RE, 2006, PSYCHIAT RES-NEUROIM, V148, P55, DOI 10.1016/j.pscychresns.2006.05.003; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Davis KD, 2005, J NEUROSCI, V25, P8402, DOI 10.1523/JNEUROSCI.2315-05.2005; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Etkin A, 2010, AM J PSYCHIAT, V167, P545, DOI 10.1176/appi.ajp.2009.09070931; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Freitas-Ferrari MC, 2010, PROG NEURO-PSYCHOPH, V34, P565, DOI 10.1016/j.pnpbp.2010.02.028; Frings C, 2010, Q J EXP PSYCHOL, V63, P42, DOI 10.1080/17470210903156594; Fydrich T., 1997, STRUKTURIERTES KLINI; Gerlach AL, 2006, BRIT J CLIN PSYCHOL, V45, P279, DOI 10.1348/014466505X49862; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Haas BW, 2006, COGN AFFECT BEHAV NE, V6, P152, DOI 10.3758/CABN.6.2.152; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hautzinger M, 1995, TESTHANDBUCH DER DEU; Heinrichs N, 2001, CLIN PSYCHOL REV, V21, P751, DOI 10.1016/S0272-7358(00)00067-2; Hirsch CR, 2006, BEHAV THER, V37, P223, DOI 10.1016/j.beth.2006.02.001; Hirsch CR, 2004, CLIN PSYCHOL REV, V24, P799, DOI 10.1016/j.cpr.2004.07.005; HOPE DA, 1990, COGNITIVE THER RES, V14, P177, DOI 10.1007/BF01176208; Hsu DT, 2012, J NEUROSCI, V32, P3253, DOI 10.1523/JNEUROSCI.5533-11.2012; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Kindt M, 2003, BEHAV CHANGE, V20, P143, DOI 10.1375/bech.20.3.143.24832; Kuchinke L, 2005, NEUROIMAGE, V28, P1022, DOI 10.1016/j.neuroimage.2005.06.050; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lipka J, 2011, BIOL PSYCHIAT, V70, P472, DOI 10.1016/j.biopsych.2011.04.005; Lundh LG, 1996, PERS INDIV DIFFER, V20, P725, DOI 10.1016/0191-8869(96)00008-6; Maddock RJ, 2003, HUM BRAIN MAPP, V18, P30, DOI 10.1002/hbm.10075; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; MATTIA JI, 1993, BEHAV RES THER, V31, P305, DOI 10.1016/0005-7967(93)90029-T; McKenna FP, 2004, J EXP PSYCHOL LEARN, V30, P382, DOI 10.1037/0278-7393.30.2.382; MCNEIL DW, 1995, J ANXIETY DISORD, V9, P47, DOI 10.1016/0887-6185(94)00027-8; Mechias ML, 2010, NEUROIMAGE, V49, P1760, DOI 10.1016/j.neuroimage.2009.09.040; Mitchell DGV, 2007, NEUROIMAGE, V34, P1299, DOI 10.1016/j.neuroimage.2006.10.012; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Mohanty A, 2007, PSYCHOPHYSIOLOGY, V44, P343, DOI 10.1111/j.1469-8986.2007.00515.x; Mulert C, 2005, INT J PSYCHOPHYSIOL, V56, P65, DOI 10.1016/j.ijpsycho.2004.10.002; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Ohman A, 2005, PSYCHONEUROENDOCRINO, V30, P953, DOI 10.1016/j.psyneuen.2005.03.019; OHMAN A, 1993, J ABNORM PSYCHOL, V102, P121; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Phaf RH, 2007, J BEHAV THER EXP PSY, V38, P184, DOI 10.1016/j.jbtep.2006.10.008; Phan KL, 2006, BIOL PSYCHIAT, V59, P424, DOI 10.1016/j.biopsych.2005.08.012; Rauch SL, 1997, BIOL PSYCHIAT, V42, P446, DOI 10.1016/S0006-3223(97)00145-5; Ray RD, 2012, NEUROSCI BIOBEHAV R, V36, P479, DOI 10.1016/j.neubiorev.2011.08.005; Schmidt S, 2010, BIOL PSYCHOL, V84, P304, DOI 10.1016/j.biopsycho.2010.03.005; Schulz C, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00282; Seghier ML, 2013, BRAIN LANG, V126, P133, DOI 10.1016/j.bandl.2013.04.003; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; Spokas ME, 2004, PSYCHIATRY, V6, P204; Stangier U., 2005, INT SKALEN F R PSYCH, P299; Steele JD, 2004, NEUROIMAGE, V21, P868, DOI 10.1016/j.neuroimage.2003.09.066; Straube T, 2004, NEUROSCI LETT, V372, P204, DOI 10.1016/j.neulet.2004.09.050; Straube T, 2004, BIOL PSYCHIAT, V56, P921, DOI 10.1016/j.biopsych.2004.09.024; Straube T, 2011, NEUROIMAGE, V54, P2534, DOI 10.1016/j.neuroimage.2010.10.010; Talairach J, 1988, CO PLANAR STEREOTAXI; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vassilopoulos SP, 2005, BEHAV COGN PSYCHOTH, V33, P13, DOI 10.1017/S1352465804001730; Waters AJ, 2005, BEHAV RES THER, V43, P715, DOI 10.1016/j.brat.2004.06.003; Weissman DH, 2005, CEREB CORTEX, V15, P229, DOI 10.1093/cercor/bhh125; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Wittchen HU, 1997, SKID; Wyble B, 2008, COGNITION EMOTION, V22, P1019, DOI 10.1080/02699930701597627; Yoon KL, 2007, PSYCHIAT RES-NEUROIM, V154, P93, DOI 10.1016/j.pscychresns.2006.05.004	94	22	24	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128608	10.1371/journal.pone.0128608	http://dx.doi.org/10.1371/journal.pone.0128608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042738	Green Published, gold, Green Submitted			2022-12-27	WOS:000355701600056
J	Kang, YY; Tierney, M; Ong, E; Zhang, LD; Piermarocchi, C; Sacco, A; Paternostro, G				Kang, Yunyi; Tierney, Matthew; Ong, Edison; Zhang, Linda; Piermarocchi, Carlo; Sacco, Alessandra; Paternostro, Giovanni			Combinations of Kinase Inhibitors Protecting Myoblasts against Hypoxia	PLOS ONE			English	Article							SKELETAL-MUSCLE; INDUCED APOPTOSIS; SELF-RENEWAL; DEATH; TRANSPLANTATION; ACTIVATION; MODEL; DIFFERENTIATION; ENGRAFTMENT; EXPRESSION	Cell-based therapies to treat skeletal muscle disease are limited by the poor survival of donor myoblasts, due in part to acute hypoxic stress. After confirming that the microenvironment of transplanted myoblasts is hypoxic, we screened a kinase inhibitor library in vitro and identified five kinase inhibitors that protected myoblasts from cell death or growth arrest in hypoxic conditions. A systematic, combinatorial study of these compounds further improved myoblast viability, showing both synergistic and additive effects. Pathway and target analysis revealed CDK5, CDK2, CDC2, WEE1, and GSK3 beta as the main target kinases. In particular, CDK5 was the center of the target kinase network. Using our recently developed statistical method based on elastic net regression we computationally validated the key role of CDK5 in cell protection against hypoxia. This method provided a list of potential kinase targets with a quantitative measure of their optimal amount of relative inhibition. A modified version of the method was also able to predict the effect of combinations using single-drug response data. This work is the first step towards a broadly applicable system-level strategy for the pharmacology of hypoxic damage.	[Kang, Yunyi; Tierney, Matthew; Zhang, Linda; Sacco, Alessandra; Paternostro, Giovanni] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Ong, Edison] Salgomed Inc, Del Mar, CA USA; [Piermarocchi, Carlo] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA	Sanford Burnham Prebys Medical Discovery Institute; Michigan State University	Paternostro, G (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.	giovanni@sanfordburnham.org	Piermarocchi, Carlo/AAH-2162-2019	Piermarocchi, Carlo/0000-0003-2762-8562; Ong, Edison/0000-0002-5159-414X	NIH [P30 AR061303, 1F31 AR065923, P01 HL098053, R41 CA174059]; Salgomed Inc.; NATIONAL CANCER INSTITUTE [R41CA174059] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR061303, F31AR065923] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Salgomed Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH P30 AR061303 to A.S., NIH 1F31 AR065923 to M.T. and NIH P01 HL098053 and NIH R41 CA174059 to G.P. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Salgomed Inc. provided support in the form of salaries for author E.O., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adachi S, 2001, CIRC RES, V88, P408, DOI 10.1161/01.res.88.4.408; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Augustin M, 2010, J SURG RES, V161, P62, DOI 10.1016/j.jss.2008.12.023; Azarnoush K, 2005, J THORAC CARDIOV SUR, V130, P173, DOI 10.1016/j.jtcvs.2004.11.044; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Bonavita F, 2003, FEBS LETT, V536, P85, DOI 10.1016/S0014-5793(03)00029-2; Bouchentouf M, 2008, GENE THER, V15, P404, DOI 10.1038/sj.gt.3303059; Briggs D, 2013, FEBS J, V280, P4281, DOI 10.1111/febs.12273; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Cowper-Smith CD, 2008, NEUROSCIENCE, V155, P864, DOI 10.1016/j.neuroscience.2008.05.051; Dudley Andrew C, 2004, Cell Commun Signal, V2, P8, DOI 10.1186/1478-811X-2-8; Fan Y, 1996, MUSCLE NERVE, V19, P853, DOI 10.1002/(SICI)1097-4598(199607)19:7<853::AID-MUS7>3.0.CO;2-8; Gheysens O, 2011, MOL IMAGING BIOL, V13, P1124, DOI 10.1007/s11307-011-0471-9; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Guerette B, 1997, J IMMUNOL, V159, P2522; Gussoni E, 1997, NAT MED, V3, P970, DOI 10.1038/nm0997-970; Hong KS, 2011, EXP MOL MED, V43, P653, DOI 10.3858/emm.2011.43.12.074; HUARD J, 1994, HUM GENE THER, V5, P949, DOI 10.1089/hum.1994.5.8-949; Kang YY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4672; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Li W, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/326346; Loberg RD, 2002, J BIOL CHEM, V277, P41667, DOI 10.1074/jbc.M206405200; Loewe S., 1928, ERGEBN PHYSL, V27, P47, DOI [10.1007/BF02322290, DOI 10.1007/BF02322290]; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Merly F, 1998, TRANSPLANTATION, V65, P793, DOI 10.1097/00007890-199803270-00005; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; Pear WS, 2005, CANCER CELL, V8, P435, DOI 10.1016/j.ccr.2005.11.016; Pires IM, 2010, CELL CYCLE, V9, P2502, DOI 10.4161/cc.9.13.12059; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rashidian J, 2005, P NATL ACAD SCI USA, V102, P14080, DOI 10.1073/pnas.0500099102; Sacco A, 2005, J CELL BIOL, V171, P483, DOI 10.1083/jcb.200506123; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Simonatto M, 2007, J CELL PHYSIOL, V213, P642, DOI 10.1002/jcp.21275; Sorensen CS, 2012, NUCLEIC ACIDS RES, V40, P477, DOI 10.1093/nar/gkr697; Tabebordbar M, 2013, ANNU REV PATHOL-MECH, V8, P441, DOI 10.1146/annurev-pathol-011811-132450; Tierney MT, 2014, NAT MED, V20, P1182, DOI 10.1038/nm.3656; Tran TP, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-74; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; Yang CY, 2008, BIOINFORMATICS, V24, pI14, DOI 10.1093/bioinformatics/btn297; Zhou D, 2013, ANNU REV GENOM HUM G, V14, P25, DOI 10.1146/annurev-genom-091212-153439	55	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0126718	10.1371/journal.pone.0126718	http://dx.doi.org/10.1371/journal.pone.0126718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042811	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600007
J	Ohshima, D; Ichikawa, K				Ohshima, Daisuke; Ichikawa, Kazuhisa			Regulation of NF-kappa B Oscillation by Nuclear Transport: Mechanisms Determining the Persistency and Frequency of Oscillation	PLOS ONE			English	Article							MESSENGER-RNA EXPORT; GENE-EXPRESSION; NEGATIVE FEEDBACK; SIGNALING PATHWAY; TEMPORAL CONTROL; SENSITIVITY-ANALYSIS; SYSTEMS BIOLOGY; ALPHA; DYNAMICS; TNF	The activated transcription factor NF-kappa B shuttles between the cytoplasm and the nucleus resulting in the oscillation of nuclear NF-kappa B (NF-kappa B-n). The oscillation pattern of NF-kappa B-n is implicated in the regulation of gene expression profiles. Using computational models, we previously reported that spatial parameters, such as the diffusion coefficient, nuclear to cytoplasmic volume ratio, transport through the nuclear envelope, and the loci of translation of I kappa B protein, modified the oscillation pattern of NF-kappa Bn. In a subsequent report, we elucidated the importance of the "reset" of NF-kappa B-n (returning of NF-kappa B to the original level) and of a "reservoir" of I kappa B in the cytoplasm. When the diffusion coefficient of I kappa B was large, I kappa B stored at a distant location from the nucleus diffused back to the nucleus and "reset" NF-kappa B-n. Herein, we report mechanisms that regulate the persistency and frequency of NF-kappa Bn oscillation by nuclear transport. Among the four parameters of nuclear transport tested in our spatio-temporal computational model, the export of I kappa B mRNA from the nucleus regulated the persistency of oscillation. The import of I kappa B to the nucleus regulated the frequency of oscillation. The remaining two parameters, import and export of NF-kappa B to and from the nucleus, had virtually no effect on the persistency or frequency. Our analyses revealed that lesser export of I kappa B mRNA allowed NF-kappa Bn to transcript greater amounts of I kappa B mRNA, which was retained in the nucleus, and was subsequently exported to the cytoplasm, where large amounts of I kappa B were synthesized to "reset" NF-kappa B-n and drove the persistent oscillation. On the other hand, import of greater amounts of I kappa B led to an increase in the influx and the efflux of NF-kappa B to and from the nucleus, resulting in an increase in the oscillation frequency. Our study revealed the importance of nuclear transport in regulating the oscillation pattern of NF-kappa B-n.	[Ohshima, Daisuke; Ichikawa, Kazuhisa] Univ Tokyo, Inst Med Sci, Div Math Oncol, Minato Ku, Tokyo, Japan	University of Tokyo	Ichikawa, K (corresponding author), Univ Tokyo, Inst Med Sci, Div Math Oncol, Minato Ku, Tokyo, Japan.	kichi@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mehdi AB, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002712; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Bakkar N, 2010, PHYSIOL REV, V90, P495, DOI 10.1152/physrev.00040.2009; Bjork P, 2014, SEMIN CELL DEV BIOL, V32, P47, DOI 10.1016/j.semcdb.2014.04.027; Cheong R, 2006, J BIOL CHEM, V281, P2945, DOI 10.1074/jbc.M510085200; Cho KH, 2003, GENOME RES, V13, P2413, DOI 10.1101/gr.1195703; Cho KH, 2003, SIMUL-T SOC MOD SIM, V79, P726, DOI 10.1177/0037549703040943; Cucurull-Sanchez L, 2012, DRUG DISCOV TODAY, V17, P665, DOI 10.1016/j.drudis.2012.01.015; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Ichikawa K, 2005, NEUROINFORMATICS, V3, P49, DOI 10.1385/NI:3:1:049; Ichikawa K, 2001, BIOINFORMATICS, V17, P483, DOI 10.1093/bioinformatics/17.5.483; Joo J, 2007, ANN NY ACAD SCI, V1115, P221, DOI 10.1196/annals.1407.014; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Kim D, 2009, FASEB J, V23, P2796, DOI 10.1096/fj.09-130369; Kim SY, 2010, BIOCHEM BIOPH RES CO, V391, P28, DOI 10.1016/j.bbrc.2009.10.154; Lu M, 2014, CELL, V157, P1130, DOI 10.1016/j.cell.2014.05.006; Natalizio BJ, 2013, TRENDS CELL BIOL, V23, P365, DOI 10.1016/j.tcb.2013.03.006; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nikolov S, 2009, IET SYST BIOL, V3, P59, DOI 10.1049/iet-syb.2008.0105; Ohshima D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109895; Ohshima D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046911; Park SG, 2006, FEBS LETT, V580, P822, DOI 10.1016/j.febslet.2006.01.004; Sachdev S, 2000, MOL CELL BIOL, V20, P1571, DOI 10.1128/MCB.20.5.1571-1582.2000; Shiha VFS, 2009, P NATL ACAD SCI USA, V106, P9619, DOI 10.1073/pnas.0812367106; Sung MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007163; Takahashi N, 2008, BIOCHEM BIOPH RES CO, V374, P424, DOI 10.1016/j.bbrc.2008.06.128; Takeda A, 2010, J BIOL CHEM, V285, P16248, DOI 10.1074/jbc.M109.048785; Terry AJ, 2011, J THEOR BIOL, V290, P7, DOI 10.1016/j.jtbi.2011.08.036; Wang YJ, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-23; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Xylourgidis N, 2006, J CELL SCI, V119, P4409, DOI 10.1242/jcs.03201; Yamazaki K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000387; Zhou A, 2003, ONCOGENE, V22, P2054, DOI 10.1038/sj.onc.1206262	34	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0127633	10.1371/journal.pone.0127633	http://dx.doi.org/10.1371/journal.pone.0127633			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042739	gold, Green Submitted, Green Published			2022-12-27	WOS:000355701600016
J	Padhukasahasram, B; Reddy, CK; Li, Y; Lanfear, DE				Padhukasahasram, Badri; Reddy, Chandan K.; Li, Yan; Lanfear, David E.			Joint Impact of Clinical and Behavioral Variables on the Risk of Unplanned Readmission and Death after a Heart Failure Hospitalization	PLOS ONE			English	Article							PROPORTIONAL HAZARDS MODEL; ADAPTIVE LASSO; SELECTION; REHOSPITALIZATION; REGULARIZATION; REGRESSION	Most current methods for modeling rehospitalization events in heart failure patients make use of only clinical and medications data that is available in the electronic health records. However, information about patient-reported functional limitations, behavioral variables and socio-economic background of patients may also play an important role in predicting the risk of readmission in heart failure patients. We developed methods for predicting the risk of rehospitalization in heart failure patients using models that integrate clinical characteristics with patient-reported functional limitations, behavioral and socio-economic characteristics. Our goal was to estimate the predictive accuracy of the joint model and compare it with models that make use of clinical data alone or behavioral and socio-economic characteristics alone, using real patient data. We collected data about the occurrence of hospital readmissions from a cohort of 789 heart failure patients for whom a range of clinical and behavioral characteristics data is also available. We applied the Cox model, four different variants of the Cox proportional hazards framework as well as an alternative non-parametric approach and determined the predictive accuracy for different categories of variables. The concordance index obtained from the joint prediction model including all types of variables was significantly higher than the accuracy obtained from using only clinical factors or using only behavioral, socioeconomic background and functional limitations in patients as predictors. Collecting information on behavior, patient-reported estimates of physical limitations and frailty and socio-economic data has significant value in the predicting the risk of readmissions with regards to heart failure events and can lead to substantially more accurate events prediction models.	[Padhukasahasram, Badri; Lanfear, David E.] Henry Ford Hlth Syst, Ctr Hlth Policy & Hlth Serv Res, Detroit, MI USA; [Reddy, Chandan K.; Li, Yan] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Wayne State University	Padhukasahasram, B (corresponding author), Henry Ford Hlth Syst, Ctr Hlth Policy & Hlth Serv Res, Detroit, MI USA.	bpadhuk1@hfhs.org		Reddy, Chandan/0000-0003-2839-3662	R01 grant [HL103871]; National Cancer Institute of National Institutes of Health [R21CA175974]; US National Science Foundation [IIS-1231742, IIS-1242304]; Div Of Information & Intelligent Systems [1231742, 1242304] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [R21CA175974] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103871] Funding Source: NIH RePORTER	R01 grant; National Cancer Institute of National Institutes of Health; US National Science Foundation(National Science Foundation (NSF)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by R01 grant HL103871 to Dr. David E. Lanfear. This work was also supported in part by the National Cancer Institute of the National Institutes of Health under Award Number R21CA175974 and the US National Science Foundation grants IIS-1231742 and IIS-1242304 to Dr. Chandan K. Reddy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALEN O, 1978, ANN STAT, V6, P701, DOI 10.1214/aos/1176344247; Binder H, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-14; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; COX DR, 1972, J R STAT SOC B, V34, P187; Desai AS, 2012, CIRCULATION, V126, P501, DOI 10.1161/CIRCULATIONAHA.112.125435; Dunlay SM, 2010, EUR J HEART FAIL, V12, P367, DOI 10.1093/eurjhf/hfq019; Fan JQ, 2002, ANN STAT, V30, P74; Fonarow GC, 1997, J AM COLL CARDIOL, V30, P725, DOI 10.1016/S0735-1097(97)00208-8; Gheorghiade M, 2013, J AM COLL CARDIOL, V61, P391, DOI 10.1016/j.jacc.2012.09.038; Gonen M, 2005, BIOMETRIKA, V92, P965, DOI 10.1093/biomet/92.4.965; Hans C, 2009, BIOMETRIKA, V96, P835, DOI 10.1093/biomet/asp047; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Kim SM, 2013, JNP-J NURSE PRACT, V9, P224, DOI 10.1016/j.nurpra.2013.01.006; KORNOWSKI R, 1995, AM HEART J, V129, P762, DOI 10.1016/0002-8703(95)90327-5; McCullough PA, 2002, J AM COLL CARDIOL, V39, P60, DOI 10.1016/S0735-1097(01)01700-4; Metra M, 2010, CIRCULATION, V122, P1782, DOI 10.1161/CIRCULATIONAHA.110.982207; NELSON W, 1972, TECHNOMETRICS, V14, P945, DOI 10.2307/1267144; Patnaik D., 2011, P 17 ACM SIGKDD INT; Reddy Chandan K, 2015, HEALTHCARE DATA ANAL; Ross JS, 2008, ARCH INTERN MED, V168, P1371, DOI 10.1001/archinte.168.13.1371; Simon N, 2011, J STAT SOFTW, V39, P1; Sun J, 2012, ACM SIGKDD EXPLORATI, V14, P16, DOI DOI 10.1145/2408736.2408740; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; VERWEIJ PJM, 1994, STAT MED, V13, P2427, DOI 10.1002/sim.4780132307; Vinzamuri B, 2013, IEEE DATA MINING, P757, DOI 10.1109/ICDM.2013.89; West JA, 1997, AM J CARDIOL, V79, P58, DOI 10.1016/S0002-9149(96)00676-5; Ye Jieping, 2012, SIGKDD Explor, V14, P4; Zhang HH, 2007, BIOMETRIKA, V94, P691, DOI 10.1093/biomet/asm037; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	33	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0129553	10.1371/journal.pone.0129553	http://dx.doi.org/10.1371/journal.pone.0129553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042868	Green Submitted, Green Published, gold			2022-12-27	WOS:000355701600099
J	Ribeiro, FO; Gomez-Benito, MJ; Folgado, J; Fernandes, PR; Garcia-Aznar, J				Ribeiro, Frederico O.; Jose Gomez-Benito, Maria; Folgado, Joao; Fernandes, Paulo R.; Manuel Garcia-Aznar, Jose			In silico Mechano-Chemical Model of Bone Healing for the Regeneration of Critical Defects: The Effect of BMP-2	PLOS ONE			English	Article							RECOMBINANT HUMAN BONE; MORPHOGENETIC PROTEIN-2; TISSUE DIFFERENTIATION; COMPUTATIONAL SIMULATION; CHEMOTACTIC MIGRATION; FRACTURE REPAIR; GAP SIZE; SCAFFOLD; DELIVERY; MATRIX	The healing of bone defects is a challenge for both tissue engineering and modern orthopaedics. This problem has been addressed through the study of scaffold constructs combined with mechanoregulatory theories, disregarding the influence of chemical factors and their respective delivery devices. Of the chemical factors involved in the bone healing process, bone morphogenetic protein-2 (BMP-2) has been identified as one of the most powerful osteoinductive proteins. The aim of this work is to develop and validate a mechanochemical regulatory model to study the effect of BMP-2 on the healing of large bone defects in silico. We first collected a range of quantitative experimental data from the literature concerning the effects of BMP-2 on cellular activity, specifically proliferation, migration, differentiation, maturation and extracellular matrix production. These data were then used to define a model governed by mechano-chemical stimuli to simulate the healing of large bone defects under the following conditions: natural healing, an empty hydrogel implanted in the defect and a hydrogel soaked with BMP-2 implanted in the defect. For the latter condition, successful defect healing was predicted, in agreement with previous in vivo experiments. Further in vivo comparisons showed the potential of the model, which accurately predicted bone tissue formation during healing, bone tissue distribution across the defect and the quantity of bone inside the defect. The proposed mechano-chemical model also estimated the effect of BMP-2 on cells and the evolution of healing in large bone defects. This novel in silico tool provides valuable insight for bone tissue regeneration strategies.	[Ribeiro, Frederico O.; Folgado, Joao; Fernandes, Paulo R.] Univ Lisbon, IDMEC, Inst Super Tecn, P-1699 Lisbon, Portugal; [Jose Gomez-Benito, Maria; Manuel Garcia-Aznar, Jose] Univ Zaragoza, Multiscale Mech & Biol Engn M2BE, Aragon Inst Engn Res I3A, Zaragoza, Spain	Universidade de Lisboa; Instituto Superior Tecnico; University of Zaragoza	Fernandes, PR (corresponding author), Univ Lisbon, IDMEC, Inst Super Tecn, P-1699 Lisbon, Portugal.	prfernan@dem.ist.utl.pt	Garcia-Aznar, Jose Manuel/F-8256-2010; Gomez-Benito, Maria Jose/A-5368-2010; Folgado, João/L-4613-2013; Fernandes, Paulo R/L-4961-2013	Garcia-Aznar, Jose Manuel/0000-0002-9864-7683; Gomez-Benito, Maria Jose/0000-0002-1878-8997; Folgado, João/0000-0003-1160-7302; Fernandes, Paulo R/0000-0001-8458-096X	Fundacao para a Ciencia e Tecnologia through the IDMEC (Institute of Mechanical Engineering), under LAETA (Associated Laboratory for Energy, Transports and Aeronautics) [UID/EMS/50022/2013, SFRH/BD/80458/2011]; Spanish Ministry of Economy and Competitiveness [DPI2012-32888]; European Union through the European Regional Development Fund; European Research Council (ERC) [ERC-2012-StG306751]	Fundacao para a Ciencia e Tecnologia through the IDMEC (Institute of Mechanical Engineering), under LAETA (Associated Laboratory for Energy, Transports and Aeronautics); Spanish Ministry of Economy and Competitiveness(Spanish Government); European Union through the European Regional Development Fund(European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission)	This work was funded by the Fundacao para a Ciencia e Tecnologia through the IDMEC (Institute of Mechanical Engineering), under LAETA (Associated Laboratory for Energy, Transports and Aeronautics), project UID/EMS/50022/2013 and through the PhD grant SFRH/BD/80458/2011, the Spanish Ministry of Economy and Competitiveness (Grant DPI2012-32888, project partially funded by the European Union through the European Regional Development Fund), and the European Research Council (ERC) through project ERC-2012-StG306751. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2006, BIOMATERIALS, V27, P3964, DOI 10.1016/j.biomaterials.2006.02.039; Ahearne M, 2008, TOPICS IN TISSUE ENG, V4, pChap12; Albro MB, 2010, JOURNAL OF BIOMECHAN, V129, P503; Ament C, 2000, J BIOMECH, V33, P961, DOI 10.1016/S0021-9290(00)00049-X; ANDERSEN T, 2012, SPR CARB CH, V37, P227, DOI DOI 10.1039/9781849732765-00227; Arrington ED, 1996, CLIN ORTHOP RELAT R, V9, P329; Badugu A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00991; Bailon-Plaza A, 2003, J BIOMECH, V36, P1069, DOI 10.1016/S0021-9290(03)00117-9; Bailon-Plaza A, 2001, J THEOR BIOL, V212, P191, DOI 10.1006/jtbi.2001.2372; Birnbaum DT, 2003, J BIOMAT SCI-POLYM E, V14, P87, DOI 10.1163/15685620360511155; Boerckel JD, 2011, BIOMATERIALS, V32, P5241, DOI 10.1016/j.biomaterials.2011.03.063; Bramono DS, 2012, BONE, V50, P954, DOI 10.1016/j.bone.2011.12.013; BRANNONPEPPAS L, 1991, J CONTROL RELEASE, V16, P319, DOI 10.1016/0168-3659(91)90009-3; Byrne DP, 2007, BIOMATERIALS, V28, P5544, DOI 10.1016/j.biomaterials.2007.09.003; Carlier A, 2012, PLOS COMPUTATIONAL B; Carlier A, 2015, J THEOR BIOL, V365, P247, DOI 10.1016/j.jtbi.2014.10.012; Carlisle Elliot, 2005, Spine J, V5, p240S, DOI 10.1016/j.spinee.2005.02.014; Caron MMJ, 2013, OSTEOARTHR CARTILAGE, V21, P604, DOI 10.1016/j.joca.2013.01.009; Carter DR, 1998, CLIN ORTHOP RELAT R, pS41; Checa S, 2010, J BIOMECH, V43, P961, DOI 10.1016/j.jbiomech.2009.10.044; Chen D, 1997, CALCIFIED TISSUE INT, V60, P283, DOI 10.1007/s002239900230; Cheung G, 2004, MED ENG PHYS, V26, P93, DOI 10.1016/j.medengphy.2003.10.006; Claes LE, 1999, J BIOMECH, V32, P255, DOI 10.1016/S0021-9290(98)00153-5; De Biase P, 2005, INJURY, V36, P43, DOI 10.1016/j.injury.2005.07.034; Draget KI, 2005, ALGINATES FROM ALGAE; Dragoo JL, 2003, J ORTHOP RES, V21, P622, DOI 10.1016/S0736-0266(02)00238-3; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309; Forster REJ, 2010, J MATER SCI-MATER M, V21, P2243, DOI 10.1007/s10856-010-4080-y; Garcia-Aznar JM, 2007, J BIOMECH, V40, P1467, DOI 10.1016/j.jbiomech.2006.06.013; Gardner TN, 2004, MED ENG PHYS, V26, P493, DOI 10.1016/j.medengphy.2004.03.009; Geris L, 2010, BIOMECH MODEL MECHAN, V9, P713, DOI 10.1007/s10237-010-0208-8; Geris L, 2010, PLOS COMPUTATIONAL B, V6, P9; GIORI NJ, 1995, J ARTHROPLASTY, V10, P514, DOI 10.1016/S0883-5403(05)80154-8; Glass GE, 2011, P NATL ACAD SCI USA, V108, P1585, DOI 10.1073/pnas.1018501108; Gomez-Benito MJ, 2005, J THEOR BIOL, V235, P105, DOI 10.1016/j.jtbi.2004.12.023; Holme HK, 2001, CARBOHYD POLYM, V46, P287, DOI 10.1016/S0144-8617(00)00332-5; Huang ZN, 2007, TISSUE ENG, V13, P2311, DOI 10.1089/ten.2006.0423; Huang Z, 2010, CYTOKINE, V51, P305, DOI 10.1016/j.cyto.2010.06.002; Isaksson H, 2008, J THEOR BIOL, V255, P26, DOI 10.1016/j.jtbi.2008.07.037; Isaksson H, 2009, J BIOMECH, V42, P555, DOI 10.1016/j.jbiomech.2009.01.001; Jacobs C.M.J., 1994, THESIS; Kelly DJ, 2006, TISSUE ENG, V12, P2509, DOI 10.1089/ten.2006.12.2509; Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]; Kim HKW, 2013, BONE, V54, P141, DOI 10.1016/j.bone.2013.01.031; Kloen P, 2003, BONE, V33, P362, DOI 10.1016/S8756-3282(03)00191-1; Knippenberg M, 2006, BIOCHEM BIOPH RES CO, V342, P902, DOI 10.1016/j.bbrc.2006.02.052; Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074; Lacroix D, 2002, J BIOMECH, V35, P1163, DOI 10.1016/S0021-9290(02)00086-6; Lacroix D, 2001, THESIS; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Li RH, 2001, TRENDS BIOTECHNOL, V19, P255, DOI 10.1016/S0167-7799(01)01665-1; Lind M, 1996, BONE, V18, P53, DOI 10.1016/8756-3282(95)00423-8; Liu JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076651; Lu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050378; LUYTEN FP, 1989, J BIOL CHEM, V264, P13377; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; Marsell R, 2010, J ORTHOP TRAUMA, V24, pS4, DOI 10.1097/BOT.0b013e3181ca3fab; McKay B, 2002, SPINE, V27, pS66, DOI 10.1097/00007632-200208151-00014; McKinley T, 2003, PRINCIPLES OF FRACTU; Mi M, 2013, GENE, V512, P211, DOI 10.1016/j.gene.2012.09.130; Miljkovic ND, 2008, OSTEOARTHR CARTILAGE, V16, P1121, DOI 10.1016/j.joca.2008.03.003; Moore SR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003604; Moore SR, 2014, PLOS COMPUTATIONAL B; Nyman JS, 2009, J BIOMECH, V42, P891, DOI 10.1016/j.jbiomech.2009.01.016; O'Neill KR, 2012, BONE, V50, P1357, DOI 10.1016/j.bone.2012.03.008; Oest ME, 2007, J ORTHOP RES, V25, P941, DOI 10.1002/jor.20372; Onishi T, 1998, BONE, V22, P605, DOI 10.1016/S8756-3282(98)00056-8; Park Yong, 2008, Cancer Res Treat, V40, P127, DOI 10.4143/crt.2008.40.3.127; PAUWELS F, 1960, Z Anat Entwicklungsgesch, V121, P478, DOI 10.1007/BF00523401; Peppas NA, 1996, J CONTROL RELEASE, V40, P245, DOI 10.1016/0168-3659(95)00191-3; Plavsic MB, 2013, MATERIALS AND MANUFA, V24, P1190; Polak SJ, 2011, ACTA BIOMATER, V7, P1760, DOI 10.1016/j.actbio.2010.12.030; Pothuaud L, 2005, BIOMATERIALS, V26, P6788, DOI 10.1016/j.biomaterials.2005.04.002; Prendergast PJ, 1997, J BIOMECH, V30, P539, DOI 10.1016/S0021-9290(96)00140-6; Rai B, 2007, J BIOMED MATER RES A, V81A, P888, DOI 10.1002/jbm.a.31142; REDDI AH, 1993, J BONE MINER RES, V8, pS499; Roohani-Esfahani SI, 2012, ACTA BIOMATER, V8, P4162, DOI 10.1016/j.actbio.2012.07.036; Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008; Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0; Rumi MN, 2005, J ORTHOP RES, V23, P34, DOI 10.1016/j.orthres.2004.05.003; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Sanz-Herrera JA, 2008, BIOMECH MODEL MECHAN, V7, P355, DOI 10.1007/s10237-007-0089-7; Sapir Y, 2011, BIOMATERIALS, V32, P1838, DOI 10.1016/j.biomaterials.2010.11.008; Sasso RC, 2005, J SPINAL DISORD TECH, V18, pS77, DOI 10.1097/01.bsd.0000112045.36255.83; Schwarz C, 2013, TISSUE ENG PT A, V19, P247, DOI [10.1089/ten.tea.2012.0265, 10.1089/ten.TEA.2012.0265]; Sebald HJ, 2012, ACTA BIOMATER, V8, P3816, DOI 10.1016/j.actbio.2012.06.036; Seeherman H, 2002, SPINE, V27, pS16, DOI 10.1097/00007632-200208151-00005; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P139, DOI 10.1016/S0169-409X(01)00112-0; Sun JC, 2013, MATERIALS, V6, P1285, DOI 10.3390/ma6041285; Topman G, 2013, MICRON, V51, P9, DOI 10.1016/j.micron.2013.06.002; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Umulis D, 2009, DEVELOPMENT, V136, P3715, DOI 10.1242/dev.031534; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Vardar E, 2010, THESIS; Vetter A, 2011, J BIOMECH, V44, P517, DOI 10.1016/j.jbiomech.2010.09.009; Wang CJ, 2009, NITRIC OXIDE-BIOL CH, V20, P298, DOI 10.1016/j.niox.2009.02.006; Wang Q, 2011, BONE, V48, P524, DOI 10.1016/j.bone.2010.10.178; Wang Ye-kai, 2011, Zhongguo Gu Shang, V24, P399; Wehner T, 2010, J BIOMECH, V43, P2473, DOI 10.1016/j.jbiomech.2010.05.028; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212; Wozney JM, 2002, SPINE, V27, pS2, DOI 10.1097/00007632-200208151-00002; Wraighte PJ, 2006, SURGERY OXFORD, V24, P198; Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.tea.2010.0555, 10.1089/ten.TEA.2010.0555]; Zheng LW, 2006, BRIT J ORAL MAX SURG, V44, P487, DOI 10.1016/j.bjoms.2005.09.005	108	39	40	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0127722	10.1371/journal.pone.0127722	http://dx.doi.org/10.1371/journal.pone.0127722			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043112	Green Published, gold, Green Submitted			2022-12-27	WOS:000355701600021
J	Shingate, P; Warwicker, J; Sowdhamini, R				Shingate, Prashant; Warwicker, Jim; Sowdhamini, Ramanathan			Energetic Calculations to Decipher pH-Dependent Oligomerization and Domain Swapping of Proteins	PLOS ONE			English	Article							HIV-INACTIVATING PROTEIN; HUMAN CYSTATIN-C; CYANOVIRIN-N; DIMER; SUBSTITUTION; STABILITY; CHAIN; SETS	Domain swapping mechanism is a specialised mode of oligomerization of proteins in which part of a protein is exchanged in a non-covalent manner between constituent subunits. This mechanism is highly affected by several physiological conditions. Here, we present a detailed analysis of the effect of pH on different regions of the domain swapped oligomer by considering examples which are known to be sensitive to pH in transiting from monomeric to domain-swapped dimeric form. The energetic calculations were performed using a specialized method which considers changes in pH and subsequent changes in the interactions between subunits. This analysis provides definitive hints about the pH-dependence switch from monomer to domain-swapped oligomer and the steps that may be involved in the swapping mechanism.	[Shingate, Prashant; Sowdhamini, Ramanathan] Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India; [Warwicker, Jim] Univ Manchester, Fac Life Sci, Manchester M1 7DN, Lancs, England	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Manchester	Sowdhamini, R (corresponding author), Natl Ctr Biol Sci, GKVK Campus,Bellary Rd, Bangalore 560065, Karnataka, India.	mini@ncbs.res.in	Shingate, Prashant/ABC-1411-2020	Warwicker, Jim/0000-0002-1302-0815	UK-India Education and Research Initiative [SA070015]; UKIERI; Department of Biotechnology fellowship	UK-India Education and Research Initiative; UKIERI(UK Research & Innovation (UKRI)); Department of Biotechnology fellowship	This work was supported by the UK-India Education and Research Initiative (Grant # SA070015). The authors would like to thank UKIERI for financial support for PS's visit to JW's laboratory to carry out this work. PS is supported by a Department of Biotechnology fellowship.	ABRAHAMSON M, 1992, HUM GENET, V89, P377; ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; Barrientos LG, 2002, STRUCTURE, V10, P673, DOI 10.1016/S0969-2126(02)00758-X; Barrientos LG, 2002, BIOCHEM BIOPH RES CO, V298, P598, DOI 10.1016/S0006-291X(02)02489-0; Bennett MJ, 2004, STRUCTURE, V12, P1339, DOI 10.1016/j.str.2004.07.004; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Bergdoll M, 1997, STRUCTURE, V5, P391, DOI 10.1016/S0969-2126(97)00196-2; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bewley CA, 1998, NAT STRUCT BIOL, V5, P571, DOI 10.1038/828; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; Byeon IJL, 2003, J MOL BIOL, V333, P141, DOI 10.1016/S0022-2836(03)00928-8; Chan P, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-69; Francis JW, 2000, J NEUROCHEM, V74, P2528, DOI 10.1046/j.1471-4159.2000.0742528.x; Greaves RB, 2009, BIOCHEM BIOPH RES CO, V380, P581, DOI 10.1016/j.bbrc.2009.01.145; Janowski R, 2004, J MOL BIOL, V341, P151, DOI 10.1016/j.jmb.2004.06.013; Jask M, 2001, REVIEW, V48, P807; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu YS, 2002, PROTEIN SCI, V11, P371, DOI 10.1110/ps.36602; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; O'Neill JW, 2001, ACTA CRYSTALLOGR D, V57, P480, DOI 10.1107/S0907444901000373; Orlikowska M, 2011, J STRUCT BIOL, V173, P406, DOI 10.1016/j.jsb.2010.11.009; Pesenti ME, 2009, J MOL BIOL, V390, P981, DOI 10.1016/j.jmb.2009.05.067; Qin ZL, 2009, J VIROL, V83, P4670, DOI 10.1128/JVI.02646-08; Shameer K, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar042; Shingate P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039305; Sukhwal A, 2013, MOL BIOSYST, V9, P1652, DOI 10.1039/c3mb25484d; Swapna LS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00334; Swapna LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036688; Szymanska A, 2009, ACTA BIOCHIM POL, V56, P455; Warwicker J, 1999, PROTEIN SCI, V8, P418; Warwicker J, 2004, PROTEIN SCI, V13, P2793, DOI 10.1110/ps.04785604; Watson HR, 2013, BIOCHEM J, V456, P297, DOI 10.1042/BJ20130100; Yang F, 1999, J MOL BIOL, V288, P403, DOI 10.1006/jmbi.1999.2693; Zegers I, 1999, P NATL ACAD SCI USA, V96, P818, DOI 10.1073/pnas.96.3.818	35	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0127716	10.1371/journal.pone.0127716	http://dx.doi.org/10.1371/journal.pone.0127716			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043007	gold, Green Published, Green Submitted			2022-12-27	WOS:000355701600020
J	Widjaja, D; Montalto, A; Vlemincx, E; Marinazzo, D; Van Huffel, S; Faes, L				Widjaja, Devy; Montalto, Alessandro; Vlemincx, Elke; Marinazzo, Daniele; Van Huffel, Sabine; Faes, Luca			Cardiorespiratory Information Dynamics during Mental Arithmetic and Sustained Attention	PLOS ONE			English	Article							RESPIRATORY SINUS ARRHYTHMIA; HEART-RATE-VARIABILITY; PSYCHOLOGICAL STRESS; BLOOD-PRESSURE; WORK STRESS; ANXIETY; REACTIVITY; ENTROPY	An analysis of cardiorespiratory dynamics during mental arithmetic, which induces stress, and sustained attention was conducted using information theory. The information storage and internal information of heart rate variability (HRV) were determined respectively as the self-entropy of the tachogram, and the self-entropy of the tachogram conditioned to the knowledge of respiration. The information transfer and cross information from respiration to HRV were assessed as the transfer and cross-entropy, both measures of cardiorespiratory coupling. These information-theoretic measures identified significant nonlinearities in the cardiorespiratory time series. Additionally, it was shown that, although mental stress is related to a reduction in vagal activity, no difference in cardiorespiratory coupling was found when several mental states (rest, mental stress, sustained attention) are compared. However, the self-entropy of HRV conditioned to respiration was very informative to study the predictability of RR interval series during mental tasks, and showed higher predictability during mental arithmetic compared to sustained attention or rest.	[Widjaja, Devy; Van Huffel, Sabine] Katholieke Univ Leuven, Dept Elect Engn ESAT STADIUS, Leuven, Belgium; [Widjaja, Devy; Van Huffel, Sabine] iMinds, Med Informat Technol Dept, Leuven, Belgium; [Montalto, Alessandro; Marinazzo, Daniele] Univ Ghent, Dept Data Anal, B-9000 Ghent, Belgium; [Vlemincx, Elke] Katholieke Univ Leuven, Hlth Psychol, Fac Psychol & Educ Sci, Leuven, Belgium; [Faes, Luca] Univ Trento, Dept Ind Engn, IRCS FBK, Trento, Trento, Italy; [Faes, Luca] Univ Trento, Dept Ind Engn, BIOtech, Trento, Trento, Italy	KU Leuven; IMEC; Ghent University; KU Leuven; Fondazione Bruno Kessler; University of Trento; University of Trento	Van Huffel, S (corresponding author), Katholieke Univ Leuven, Dept Elect Engn ESAT STADIUS, Leuven, Belgium.	sabine.vanhuffel@esat.kuleuven.be	Marinazzo, Daniele/H-4793-2019; Faes, Luca/E-5156-2012	Marinazzo, Daniele/0000-0002-9803-0122; Faes, Luca/0000-0002-3271-5348	Research Council KU Leuven [CoE PFV/10/002 (OPTEC)]; Fonds Wetenschappelijk Onderzoek [G.0427.10N, G.0108.11, G.0869.12N, G.0A5513N]; Agenschap voor Innovatie door Wetenschap en Technologie [TBM 080658-MRI, TBM 110697-NeoGuard]; iMinds Medical Information Technologies SBO, ICON: NXT_Sleep; Flanders Care: Demonstratieproject Tele-Rehab III; Federaal Wetenschapsbeleid (DYSCO) [IUAP P7/19/]; Belgian Foreign Affairs-Development Cooperation: VLIR UOS programs; European Union: the European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC Advanced Grant: BIOTENSORS [339804]; European Commission within INTERREG IVB North-West Europe (NWE) programme [RECAP 209G]; European Commission Marie Curie International Training Network: TRANSACT [316679]; European Commission: ERASMUS EQR [539642-LLP-1-2013]; Zonta International: Amelia Earhart Fellowship; Agenschap voor Innovatie door Wetenschap en Technologie: PhD grant [101345]	Research Council KU Leuven(KU Leuven); Fonds Wetenschappelijk Onderzoek(FWO); Agenschap voor Innovatie door Wetenschap en Technologie; iMinds Medical Information Technologies SBO, ICON: NXT_Sleep; Flanders Care: Demonstratieproject Tele-Rehab III; Federaal Wetenschapsbeleid (DYSCO); Belgian Foreign Affairs-Development Cooperation: VLIR UOS programs; European Union: the European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC Advanced Grant: BIOTENSORS; European Commission within INTERREG IVB North-West Europe (NWE) programme; European Commission Marie Curie International Training Network: TRANSACT; European Commission: ERASMUS EQR; Zonta International: Amelia Earhart Fellowship; Agenschap voor Innovatie door Wetenschap en Technologie: PhD grant	SVH received the following grants: Research Council KU Leuven (admin. kuleuven.be/raden/en/research-council): CoE PFV/10/002 (OPTEC) (PhD/Postdoc grants); Fonds Wetenschappelijk Onderzoek (www.fwo.be): G.0427.10N (Integrated EEG-fMRI), G.0108.11 Compressed Sensing) G.0869.12N (Tumor imaging) G.0A5513N (Deep brain stimulation) (PhD/Postdoc grants); Agenschap voor Innovatie door Wetenschap en Technologie (www.iwt.be): TBM 080658-MRI (EEG-fMRI), TBM 110697-NeoGuard (PhD/Postdoc grants); iMinds (www.iminds.be) Medical Information Technologies SBO 2015, ICON: NXT_Sleep; Flanders Care (www.flanderscare.be): Demonstratieproject Tele-Rehab III (2012-2014); Federaal Wetenschapsbeleid (www.belspo.be): IUAP P7/19/ (DYSCO, "Dynamical systems, control and optimization," 2012-2017); and Belgian Foreign Affairs-Development Cooperation (www.vliruos.be): VLIR UOS programs. The research leading to these results has received funding from European Union (erc.europa.eu): the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Advanced Grant: BIOTENSORS (no 339804). This paper reflects only the authors' views and the Union is not liable for any use that may be made of the contained information. This work was also supported by European Commission (www.nweurope.eu): RECAP 209G within INTERREG IVB North-West Europe (NWE) programme; European Commission Marie Curie International Training Network (ec.europa.eu/research/mariecurieactions): TRANSACT 2012 (no 316679); and European Commission (eacea.ec.europa.eu): ERASMUS EQR: Community service engineer (no 539642-LLP-1-2013). DW received the following grants: Agenschap voor Innovatie door Wetenschap en Technologie (www.iwt.be): PhD grant (101345) and Zonta International (zonta.org): Amelia Earhart Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychological Association Practice Organization, 2010, PSYCH HLTH WORKPL PR; Bernardi L, 2000, J AM COLL CARDIOL, V35, P1462, DOI 10.1016/S0735-1097(00)00595-7; BERNTSON GG, 1993, PSYCHOPHYSIOLOGY, V30, P183, DOI 10.1111/j.1469-8986.1993.tb01731.x; Camm AJ, 1996, EUR HEART J, V17, P354; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Denver JW, 2007, BIOL PSYCHOL, V74, P286, DOI 10.1016/j.biopsycho.2005.09.005; Dimsdale JE, 2008, J AM COLL CARDIOL, V51, P1237, DOI 10.1016/j.jacc.2007.12.024; Eckberg DL, 2003, J PHYSIOL-LONDON, V548, P339, DOI 10.1113/jphysiol.2002.037192; European Agency for Safety and Health at Work, 2014, CALC COSTS WORK REL; Faes L, 2013, COMPUT CARDIOL CONF, V40, P113; Faes L, 2015, ENTROPY-SWITZ, V17, P277, DOI 10.3390/e17010277; Faes L, 2014, IEEE T BIO-MED ENG, V61, P2556, DOI 10.1109/TBME.2014.2323131; Faes L, 2012, COMPUT BIOL MED, V42, P290, DOI 10.1016/j.compbiomed.2011.02.007; Faes L, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00080; Friedman BH, 1998, BIOL PSYCHOL, V47, P243, DOI 10.1016/S0301-0511(97)00027-6; Grossman P, 2007, BIOL PSYCHOL, V74, P263, DOI 10.1016/j.biopsycho.2005.11.014; Hjortskov N, 2004, EUR J APPL PHYSIOL, V92, P84, DOI 10.1007/s00421-004-1055-z; KATONA PG, 1975, J APPL PHYSIOL, V39, P801, DOI 10.1152/jappl.1975.39.5.801; Kelsey RM, 2000, PSYCHOPHYSIOLOGY, V37, P748, DOI 10.1111/1469-8986.3760748; Kivimaki M, 2002, BRIT MED J, V325, P857, DOI 10.1136/bmj.325.7369.857; Kugiumtzis D, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062918; Lee J, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-19; Lizier JT, 2012, INFORM SCIENCES, V208, P39, DOI 10.1016/j.ins.2012.04.016; Magagnin V, 2011, PHYSIOL MEAS, V32, P1775, DOI 10.1088/0967-3334/32/11/S05; Masaoka Y, 1997, INT J PSYCHOPHYSIOL, V27, P153, DOI 10.1016/S0167-8760(97)00052-4; Montalto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109462; Pattyn N, 2010, PHYSIOL BEHAV, V101, P218, DOI 10.1016/j.physbeh.2010.04.037; Ritz T, 2006, PSYCHOSOM MED, V68, P617, DOI 10.1097/01.psy.0000228010.96408.ed; Ritz T, 2009, BIOL PSYCHOL, V80, P158, DOI 10.1016/j.biopsycho.2008.08.003; Rosch P.J., 2001, HLTH STRESS, V3, P1; SAUL JP, 1989, AM J PHYSIOL, V256, pH153, DOI 10.1152/ajpheart.1989.256.1.H153; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; SLOAN RP, 1994, BIOL PSYCHOL, V37, P89, DOI 10.1016/0301-0511(94)90024-8; SUESS WM, 1980, PSYCHOPHYSIOLOGY, V17, P535, DOI 10.1111/j.1469-8986.1980.tb02293.x; Taelman J, 2011, EUR J APPL PHYSIOL, V111, P1497, DOI 10.1007/s00421-010-1776-0; Tarvainen MP, 2002, IEEE T BIO-MED ENG, V49, P172, DOI 10.1109/10.979357; Visnovcova Z, 2014, PHYSIOL MEAS, V35, P1319, DOI 10.1088/0967-3334/35/7/1319; Vlemincx E, 2011, PSYCHOPHYSIOLOGY, V48, P117, DOI 10.1111/j.1469-8986.2010.01043.x; Voss A, 2009, PHILOS T R SOC A, V367, P277, DOI 10.1098/rsta.2008.0232; Vrijkotte TGM, 2000, HYPERTENSION, V35, P880, DOI 10.1161/01.HYP.35.4.880; Widjaja D, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/451857; Widjaja D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101713; Willemsen G, 2000, BIOL PSYCHOL, V52, P127, DOI 10.1016/S0301-0511(99)00028-9; Zhang JB, 2010, RESP PHYSIOL NEUROBI, V170, P91, DOI 10.1016/j.resp.2009.11.003	44	24	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0129112	10.1371/journal.pone.0129112	http://dx.doi.org/10.1371/journal.pone.0129112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042824	Green Submitted, Green Published, gold			2022-12-27	WOS:000355701600088
J	Bender, AM; Kawachi, I; Jorgensen, T; Pisinger, C				Bender, Anne Mette; Kawachi, Ichiro; Jorgensen, Torben; Pisinger, Charlotta			Neighborhood Deprivation Is Strongly Associated with Participation in a Population-Based Health Check	PLOS ONE			English	Article							INCOME INEQUALITY; MORTALITY; AREA; BREAST; LEVEL	Background We sought to examine whether neighborhood deprivation is associated with participation in a large population-based health check. Such analyses will help answer the question whether health checks, which are designed to meet the needs of residents in deprived neighborhoods, may increase participation and prove to be more effective in preventing disease. In Europe, no study has previously looked at the association between neighborhood deprivation and participation in a population-based health check. Methods The study population comprised 12,768 persons invited for a health check including screening for ischemic heart disease and lifestyle counseling. The study population was randomly drawn from a population of 179,097 persons living in 73 neighborhoods in Denmark. Data on neighborhood deprivation (percentage with basic education, with low income and not in work) and individual socioeconomic position were retrieved from national administrative registers. Multilevel regression analyses with log links and binary distributions were conducted to obtain relative risks, intraclass correlation coefficients and proportional change in variance. Results Large differences between neighborhoods existed in both deprivation levels and neighborhood health check participation rate (mean 53%; range 35-84%). In multilevel analyses adjusted for age and sex, higher levels of all three indicators of neighborhood deprivation and a deprivation score were associated with lower participation in a dose-response fashion. Persons living in the most deprived neighborhoods had up to 37% decreased probability of participating compared to those living in the least deprived neighborhoods. Inclusion of individual socioeconomic position in the model attenuated the neighborhood deprivation coefficients, but all except for income deprivation remained statistically significant. Conclusion Neighborhood deprivation was associated with participation in a population-based health check in a dose-response manner, in which increasing neighborhood deprivation was associated with decreasing participation. This suggests the need to develop preventive health checks tailored to deprived neighborhoods.	[Bender, Anne Mette; Jorgensen, Torben; Pisinger, Charlotta] Res Ctr Prevent & Hlth, Glostrup, Denmark; [Bender, Anne Mette; Kawachi, Ichiro] Harvard Univ, Dept Social & Behav Sci, Sch Publ Health, Boston, MA 02115 USA; [Jorgensen, Torben; Pisinger, Charlotta] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Jorgensen, Torben] Aalborg Univ, Fac Med, Aalborg, Denmark	Harvard University; University of Copenhagen; Aalborg University	Bender, AM (corresponding author), Res Ctr Prevent & Hlth, Glostrup, Denmark.	anne.mette.bender@regionh.dk	Jørgensen, Torben/Z-1335-2018	Jorgensen, Torben/0000-0001-9453-2830; /0000-0002-0182-7718; Pisinger, Charlotta/0000-0002-7970-3168	Danish Health Foundation [2010 B 131]	Danish Health Foundation	This work was supported by the Danish Health Foundation (grant number 2010 B 131). http://www.helsefonden.dk/pages.asp?id=63. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuzu A, 2009, EUR J CARDIOV PREV R, V16, P169, DOI 10.1097/HJR.0b013e328325d64d; Artac M, 2013, FAM PRACT, V30, P426, DOI 10.1093/fampra/cmt002; Bender AM, 2014, EUR J PREV CARDIOL, V21, P899, DOI 10.1177/2047487312472076; Dryden R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-723; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Gerdtham UG, 2004, J HUM RESOUR, V39, P228, DOI 10.2307/3559011; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Henriksson G, 2010, SOC SCI MED, V71, P1141, DOI 10.1016/j.socscimed.2010.05.044; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kawachi I., 2003, NEIGHBORHOODS HLTH, DOI [10.1093/acprof:oso/9780195138382.001.0001, DOI 10.1093/ACPROF:OSO/9780195138382.001.0001]; Kawachi I, 2006, INT J EPIDEMIOL, V35, P989, DOI 10.1093/ije/dyl117; Macintyre S., 2003, NEIGHBORHOODS HLTH, V20, P42; Meijer M, 2013, J EPIDEMIOL COMMUN H, V67, P6, DOI 10.1136/jech-2011-200192; Meijer M, 2012, SOC SCI MED, V74, P1204, DOI 10.1016/j.socscimed.2011.11.034; Naess O, 2008, J EPIDEMIOL COMMUN H, V62, P29, DOI 10.1136/jech.2006.048090; Ohlsson H, 2011, SOC SCI MED, V73, P1145, DOI 10.1016/j.socscimed.2011.08.005; Osler M, 2003, J EPIDEMIOL COMMUN H, V57, P266, DOI 10.1136/jech.57.4.266; Osler M, 2002, BRIT MED J, V324, P13, DOI 10.1136/bmj.324.7328.13; Osler M, 2011, INT J EPIDEMIOL, V40, P602, DOI 10.1093/ije/dyq041; Pruitt SL, 2009, CANCER EPIDEM BIOMAR, V18, P2579, DOI 10.1158/1055-9965.EPI-09-0135; Ross CE, 2000, SOC SCI MED, V51, P265, DOI 10.1016/S0277-9536(99)00451-7; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956; Yang HK, 2013, J KOREAN MED SCI, V28, P348, DOI 10.3346/jkms.2013.28.3.348	24	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0129819	10.1371/journal.pone.0129819	http://dx.doi.org/10.1371/journal.pone.0129819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7ST	26039635	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700146
J	Delicat-Loembet, L; Rougeron, V; Ollomo, B; Arnathau, C; Roche, B; Elguero, E; Moukodoum, ND; Okougha, AP; Ondo, BM; Boundenga, L; Houze, S; Galan, M; Nkoghe, D; Leroy, EM; Durand, P; Paupy, C; Renaud, F; Prugnolle, F				Delicat-Loembet, Lucresse; Rougeron, Virginie; Ollomo, Benjamin; Arnathau, Celine; Roche, Benjamin; Elguero, Eric; Moukodoum, Nancy Diamella; Okougha, Alain-Prince; Ondo, Bertrand Mve; Boundenga, Larson; Houze, Sandrine; Galan, Maxime; Nkoghe, Dieudonne; Leroy, Eric M.; Durand, Patrick; Paupy, Christophe; Renaud, Franois; Prugnolle, Franck			No Evidence for Ape Plasmodium Infections in Humans in Gabon	PLOS ONE			English	Article							HUMAN MALARIA PARASITE; AFRICAN GREAT APES; FALCIPARUM; VIVAX; EVOLUTION; ZOONOSES; ORIGIN; HOSTS	African great apes are naturally infected by a multitude of Plasmodium species most of them recently discovered, among which several are closely related to human malaria agents. However, it is still unknown whether these animals can serve as source of infections for humans living in their vicinity. To evaluate this possibility, we analysed the nature of Plasmodium infections from a bank of 4281 human blood samples collected in 210 villages of Gabon, Central Africa. Among them, 2255 were detected positive to Plasmodium using molecular methods (Plasmodium Cytochrome b amplification). A high throughput sequencing technology (454 GS-FLX Titanium technology, Roche) was then used to identify the Plasmodium species present within each positive sample. Overall, we identified with confidence only three species infecting humans in Gabon: P. falciparum, P. malariae and P. ovale. None of the species known to infect non-human primates in Central Africa was found. Our study shows that ape Plasmodium parasites of the subgenus Laverania do not constitute a frequent source of infection for humans. It also suggests that some strong host genetic barriers must exist to prevent the cross species transmission of ape Plasmodium in a context of ever increasing contacts between humans and wildlife.	[Delicat-Loembet, Lucresse; Rougeron, Virginie; Ollomo, Benjamin; Moukodoum, Nancy Diamella; Okougha, Alain-Prince; Ondo, Bertrand Mve; Boundenga, Larson; Nkoghe, Dieudonne; Leroy, Eric M.; Prugnolle, Franck] Ctr Int Rech Med Franceville, Franceville, Gabon; [Rougeron, Virginie; Arnathau, Celine; Elguero, Eric; Leroy, Eric M.; Durand, Patrick; Paupy, Christophe; Renaud, Franois; Prugnolle, Franck] MIVEGEC UMR CNRS IRD 5290, F-34394 Montpellier 5, France; [Arnathau, Celine; Durand, Patrick; Renaud, Franois] CHRU Montpellier, F-34295 Montpellier, France; [Roche, Benjamin] Inst Rech Dev, Unite Modelisat Math & Informat Syst Complexes UM, F-93140 Bondy, France; [Galan, Maxime] INRA, CBGP UMR1062, F-34980 Montferrier Sur Lez, France; [Houze, Sandrine] Hop Bichat Claude Bernard, Lab Parasitol Mycol, F-75018 Paris, France; [Houze, Sandrine] Univ Paris 05, Unite Mixte Rech IRD 216, F-75006 Paris, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CHU de Montpellier; UDICE-French Research Universities; Sorbonne Universite; Cadi Ayyad University of Marrakech; Hanoi University of Science & Technology; Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar; University of Yaounde I; INRAE; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Delicat-Loembet, L (corresponding author), Ctr Int Rech Med Franceville, BP 769, Franceville, Gabon.	delicatlurce@gmail.com; rougeron.virginie@gmail.com; franck.prugnolle@ird.fr	larson, Boundenga/AAK-5003-2020; Galan, Maxime/AAB-9511-2019; Paupy, Christophe/I-4847-2017; LEROY, Eric M/I-4347-2016; Rougeron, Virginie/AAH-7447-2020; sandrine, houze/M-3260-2017	larson, Boundenga/0000-0001-9551-3017; Galan, Maxime/0000-0001-6981-5732; Paupy, Christophe/0000-0002-7122-2079; LEROY, Eric M/0000-0003-0022-0890; Roche, Benjamin/0000-0001-7975-4232; Prugnolle, Franck/0000-0001-8519-1253; Rougeron, Virginie/0000-0001-5873-5681; Moukodoum, Nancy/0000-0003-0121-6068; sandrine, houze/0000-0001-9016-3847	Centre National de la Recherche Scientifique (CNRS, France); Institut de Recherche pour le Developpement (IRD, France); Centre International de Recherches Medicales de Franceville (CIRMF, Gabon); Jeunes Chercheuses et Jeunes Chercheurs Sciences de la Vie, de la Sante et des Ecosysytemes (JCJC SVSE) of the Agence Nationale de la Recherche (ANR, France); ANR JCJC SEST ORIGIN	Centre National de la Recherche Scientifique (CNRS, France)(Centre National de la Recherche Scientifique (CNRS)); Institut de Recherche pour le Developpement (IRD, France); Centre International de Recherches Medicales de Franceville (CIRMF, Gabon); Jeunes Chercheuses et Jeunes Chercheurs Sciences de la Vie, de la Sante et des Ecosysytemes (JCJC SVSE) of the Agence Nationale de la Recherche (ANR, France)(French National Research Agency (ANR)); ANR JCJC SEST ORIGIN(French National Research Agency (ANR))	This work was jointly supported by Centre National de la Recherche Scientifique (CNRS, France), Institut de Recherche pour le Developpement (IRD, France) and Centre International de Recherches Medicales de Franceville (CIRMF, Gabon) as well as the Jeunes Chercheuses et Jeunes Chercheurs Sciences de la Vie, de la Sante et des Ecosysytemes (JCJC SVSE 2012) of the Agence Nationale de la Recherche (ANR, France). Funding was also provided by the ANR JCJC SEST 2012 ORIGIN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becquart P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009126; Carlsen T, 2012, FUNGAL ECOL, V5, P747, DOI 10.1016/j.funeco.2012.06.003; COATNEY GR, 1971, AM J TROP MED HYG, V20, P795, DOI 10.4269/ajtmh.1971.20.795; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Culleton R, 2009, J INFECT DIS, V200, P1465, DOI 10.1086/644510; Despommier D., 2006, PARASITOLOGY, V134, p[537, 137], DOI [10.1017/S0031182006242033, DOI 10.1017/S0031182006242033]; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Galan M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-296; Gonzalez JP, 2013, CURR TOP MICROBIOL, V365, P337, DOI 10.1007/82_2012_304; Hayakawa T, 2008, MOL BIOL EVOL, V25, P2233, DOI 10.1093/molbev/msn171; Hayakawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007412; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Liu WM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4346; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Martin MJ, 2005, P NATL ACAD SCI USA, V102, P12819, DOI 10.1073/pnas.0503819102; Menard D, 2010, P NATL ACAD SCI USA, V107, P5967, DOI 10.1073/pnas.0912496107; Mendes C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001192; Mercereau-Puijalon O, 2010, TRANSFUS CLIN BIOL, V17, P176, DOI 10.1016/j.tracli.2010.06.005; Nkoghe D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-33; Ollomo B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000446; Otto TD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5754; Paupy C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057294; Prugnolle F, 2013, P NATL ACAD SCI USA, V110, P8123, DOI 10.1073/pnas.1306004110; Prugnolle F, 2011, P NATL ACAD SCI USA, V108, P11948, DOI 10.1073/pnas.1109368108; Prugnolle F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001283; Prugnolle F, 2010, P NATL ACAD SCI USA, V107, P1458, DOI 10.1073/pnas.0914440107; Rayner JC, 2011, TRENDS PARASITOL, V27, P222, DOI 10.1016/j.pt.2011.01.006; Sundararaman SA, 2013, P NATL ACAD SCI USA, V110, P7020, DOI 10.1073/pnas.1305201110; Wolfe ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/eid1112.040789; Wright GJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003943	31	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126933	10.1371/journal.pone.0126933	http://dx.doi.org/10.1371/journal.pone.0126933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039338	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700044
J	Miao, FH; Guo, ZG; Xue, R; Wang, XZ; Shen, YY				Miao, Fuhong; Guo, Zhenggang; Xue, Ran; Wang, Xianzhi; Shen, Yuying			Effects of Grazing and Precipitation on Herbage Biomass, Herbage Nutritive Value, and Yak Performance in an Alpine Meadow on the Qinghai-Tibetan Plateau	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; CARBON ASSIMILATION; STOCKING RATE; MANAGEMENT; GRASSLAND; TERM; DYNAMICS; RAINFALL; STEPPE; DEGRADATION	The Qinghai-Tibetan Plateau is a very large land unit and an important terrestrial ecosystem within the Eurasian continent. Because of the harsh climate associated with the high altitude, alpine meadows on the plateau are susceptible to degradation from overgrazing. For this region, and for other alpine meadow pastures internationally, there is a need to define the sustainable stocking rate, to develop sound policy pertaining to future land use. Here we report biomass and liveweight gain per animal and per ha for pastures grazed by yaks at high, medium, or low stocking rates over 4 growing seasons from 2010 to 2013. Measures of herbage nutritive value are reported. The influence of inter-year variation in precipitation on standing herbage biomass was also evaluated. Higher precipitation increased standing herbage biomass and herbage nutritive value, indicating that vegetation suffered summer water deficit even in this environment. The sustainable stocking rate in this environment was determined to be approximately 1 yak ha(-1) (grown from 80 kg to 120 kg liveweight in 90 d). At this stocking rate, yak weight gain per ha was 88% of that achieved at higher stocking rates typically used by farmers, but with little or no evidence of land degradation.	[Miao, Fuhong; Guo, Zhenggang; Xue, Ran; Wang, Xianzhi; Shen, Yuying] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730020, Peoples R China	Lanzhou University	Shen, YY (corresponding author), Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730020, Peoples R China.	yy.shen@lzu.edu.cn		chen, yu ying/0000-0003-3442-0890	Program for Changjiang Scholars and Innovative Research Team in University [IRT13019]; Special Fund for Agro-scientific Research in the Public Interest [200903060, 201203006]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Special Fund for Agro-scientific Research in the Public Interest	Program for Changjiang Scholars and Innovative Research Team in University (IRT13019) "Special Fund for Agro-scientific Research in the Public Interest" (200903060) and (201203006).	Allen E, 2013, AGRON J, V105, P679, DOI 10.2134/agronj2012.0300; Angell DL, 2001, J ARID ENVIRON, V49, P507, DOI 10.1006/jare.2001.0811; [Anonymous], 1999, HARVESTED FORAGES; Bailey DW, 2011, RANGELAND ECOL MANAG, V64, P1, DOI 10.2111/REM-D-09-00184.1; Bosing BM, 2014, LIVEST SCI, V165, P157, DOI 10.1016/j.livsci.2014.03.026; Coblentz WK, 2000, CROP SCI, V40, P1375, DOI 10.2135/cropsci2000.4051375x; COE MJ, 1976, OECOLOGIA, V22, P341, DOI 10.1007/BF00345312; Cui XF, 2009, CLIMATIC CHANGE, V94, P47, DOI 10.1007/s10584-009-9556-8; Cummings DC, 2007, RANGELAND ECOL MANAG, V60, P253, DOI 10.2111/1551-5028(2007)60[253:IAGSOI]2.0.CO;2; Davidson G., 2008, IHDP UPDATE, V2, P59; Debouba M, 2006, J PLANT PHYSIOL, V163, P1247, DOI 10.1016/j.jplph.2005.09.012; Du MY, 2004, GLOBAL PLANET CHANGE, V41, P241, DOI 10.1016/j.gloplacha.2004.01.010; Fanselow N, 2011, PLANT SOIL, V340, P279, DOI 10.1007/s11104-010-0694-6; FAO ISSS ISRIC, 2006, 103 FAO ISSS ISRIC; Fischer AM, 2008, POPUL DEV REV, V34, P631, DOI 10.1111/j.1728-4457.2008.00244.x; Fynn RWS, 2000, J APPL ECOL, V37, P491, DOI 10.1046/j.1365-2664.2000.00513.x; Gao Q, 2002, J SOIL WATER CONSERV, V57, P46; Georges F, 2009, PLANT CELL ENVIRON, V32, P1664, DOI 10.1111/j.1365-3040.2009.02027.x; Goldstein M. C., 2002, HUMAN BIOL PASTORAL, P131; Harris RB, 2010, J ARID ENVIRON, V74, P1, DOI 10.1016/j.jaridenv.2009.06.014; Heisler-White JL, 2008, OECOLOGIA, V158, P129, DOI 10.1007/s00442-008-1116-9; Hockin NL, 2012, PLANT PHYSIOL, V158, P299, DOI 10.1104/pp.111.184333; Huxman TE, 2004, NATURE, V429, P651, DOI 10.1038/nature02561; Jiang YY, 2012, ASIAN AUSTRAL J ANIM, V25, P207, DOI 10.5713/ajas.2011.11261; Kemp DR, 2007, J AGR SCI-CAMBRIDGE, V145, P543, DOI 10.1017/S0021859607007253; Klein JA, 2004, ECOL LETT, V7, P1170, DOI 10.1111/j.1461-0248.2004.00677.x; Klein JA, 2007, ECOL APPL, V17, P541, DOI 10.1890/05-0685; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Legay N, 2012, EGU GEN ASS C, P7413; Maughan B, 2014, ANIM SCI J, V92, P2013; McCarthy B, 2013, GRASS FORAGE SCI, V68, P364, DOI 10.1111/j.1365-2494.2012.00904.x; Mekuria W, 2007, J ARID ENVIRON, V69, P270, DOI 10.1016/j.jaridenv.2006.10.009; Miao FuHong, 2013, Revitalising Grasslands to Sustain our Communities: Proceedings, 22nd International Grassland Congress, 15-19 September, 2013, Sydney, Australia, P1074; Milchunas DG, 1998, OIKOS, V83, P65, DOI 10.2307/3546547; MILCHUNAS DG, 1995, OECOLOGIA, V101, P366, DOI 10.1007/BF00328824; Ministry of Science and Technology of the People's Republic of China, GUIDE CARE USE LAB A; Mysterud A, 2006, WILDLIFE BIOL, V12, P129, DOI 10.2981/0909-6396(2006)12[129:TCOOAI]2.0.CO;2; Ni J, 2004, PLANT ECOL, V174, P217, DOI 10.1023/B:VEGE.0000049097.85960.10; Olofsson J, 2006, J ECOL, V94, P431, DOI 10.1111/j.1365-2745.2006.01100.x; Ren JZ, 2008, RANGELAND J, V30, P199, DOI 10.1071/RJ08002; Sasaki T, 2012, GRASS FORAGE SCI, V67, P446, DOI 10.1111/j.1365-2494.2012.00862.x; Schonbach P, 2011, PLANT SOIL, V340, P103, DOI 10.1007/s11104-010-0366-6; SCHULZE ED, 1994, ANNU REV ECOL SYST, V25, P629, DOI 10.1146/annurev.es.25.110194.003213; Scurlock JMO, 2002, GLOBAL CHANGE BIOL, V8, P736, DOI 10.1046/j.1365-2486.2002.00512.x; Silliman BR, 2001, ECOLOGY, V82, P2830, DOI 10.1890/0012-9658(2001)082[2830:TDCOSA]2.0.CO;2; Speed JDM, 2013, J ECOL, V101, DOI 10.1111/1365-2745.12133; Steel RGD, 1980, PRINCIPLES PROCEDURE; STOBBS TH, 1973, AUST J AGR RES, V24, P821, DOI 10.1071/AR9730821; Stromberg MR, 1996, ECOL APPL, V6, P1189, DOI 10.2307/2269601; Tessema ZK, 2011, J ARID ENVIRON, V75, P662, DOI 10.1016/j.jaridenv.2011.02.004; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Wang XH, 2004, AMBIO, V33, P169; Ward GN, 2013, ANIM PROD SCI, V53, P226, DOI 10.1071/AN12107; Wessels KJ, 2007, J ARID ENVIRON, V68, P271, DOI 10.1016/j.jaridenv.2006.05.015; William H, 2006, OFFICIAL METHODS ANA; Wood KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056287	57	43	58	6	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127275	10.1371/journal.pone.0127275	http://dx.doi.org/10.1371/journal.pone.0127275			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039322	gold, Green Submitted, Green Published			2022-12-27	WOS:000355700700056
J	Mutabazi-Mwesigire, D; Katamba, A; Martin, F; Seeley, J; Wu, AW				Mutabazi-Mwesigire, Doris; Katamba, Achilles; Martin, Faith; Seeley, Janet; Wu, Albert W.			Factors That Affect Quality of Life among People Living with HIV Attending an Urban Clinic in Uganda: A Cohort Study	PLOS ONE			English	Article							RECEIVING ANTIRETROVIRAL THERAPY; MEDICAL OUTCOMES; CAGE QUESTIONNAIRE; INFECTED PATIENTS; HEALTH; RELIABILITY; VALIDITY; DEPRESSION; PATIENT; HAART	Introduction With the availability of antiretroviral therapy (ART) and primary general care for people living with HIV (PLHIV) in resource limited settings, PLHIV are living longer, and HIV has been transformed into a chronic illness. People are diagnosed and started on treatment when they are relatively well. Although ART results in clinical improvement, the ultimate goal of treatment is full physical functioning and general well-being, with a focus on quality of life rather than clinical outcomes. However, there has been little research on the relationship of specific factors to quality of life in PLHIV. The objective of this study was to investigate factors associated with quality of life among PLHIV in Uganda receiving basic care and those on ART. Methods We enrolled 1274 patients attending an HIV outpatient clinic into a prospective cohort study. Of these, 640 received ART. All were followed up at 3 and 6 months. Health related quality of life was assessed with the MOS-HIV Health Survey and the Global Person Generated Index (GPGI). Multivariate linear regression and logistic regression with generalized estimating equations were used to examine the relationship of social behavioral and disease factors with Physical Health Summary (PHS) score, Mental Health Summary (MHS) score, and GPGI. Results Among PLHIV receiving basic care, PHS was associated with: sex (p=0.045) - females had lower PHS; age in years at enrollment (p=0.0001) - older patients had lower PHS; and depression (p<0.001) - depressed patients had lower PHS. MHS was only associated with opportunistic infection (p=0.01) - presence of an opportunistic infection was associated with lower MHS. For the GPG the associated variables were age (p=0.03) - older patients had lower GPGI; education (p=0.01) - higher education associated with higher GPGI; and depression - patients with depression had a lower GPGI (p<0.001). Among patients on ART, PHS was associated with: study visit (p=0.01), with increase in time there was better PHS, and this also improved with increase in education level (p=0.002). Patients with WHO disease stage 3&4 had a lower PHS compared to patients at stage 1&2 (p=0.006), and depressed patients had lower PHS (p<0.001). MHS improved from baseline to six month study visit (p<0.001), and females had lower MHS compared to males (p=0.01). GPGI was associated with higher income (p=0.04), alcohol use was associated with lower GPGI (p=0.004), and depressed patients had a lower GPGI (p<0.001). Conclusion Quality of life improved over time for PLHIV on ART. Regardless of treatment status, PLHIV with depression or low education level and female gender were at risk of having a poor quality of life. Clinicians and policy makers should be aware of these findings, and address them to improve quality of life for PLHIV.	[Mutabazi-Mwesigire, Doris; Katamba, Achilles] Makerere Univ, Dept Med, Coll Hlth Sci, Kampala, Uganda; [Martin, Faith] Univ Bath, Dept Psychol, Bath BA2 7AY, Avon, England; [Seeley, Janet] MRC, AIDS Res Unit, Uganda Virus Res Inst, Entebbe, Uganda; [Wu, Albert W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Makerere University; University of Bath; Uganda Virus Research Institute; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Mutabazi-Mwesigire, D (corresponding author), Makerere Univ, Dept Med, Coll Hlth Sci, Kampala, Uganda.	dmutabazi@semliki.co.ug	Wu, Albert/AAJ-4780-2021	Martin, Faith/0000-0002-0141-1210; Seeley, Janet/0000-0002-0583-5272	Training Health Researchers into Vocational Excellence (THRiVE) in East Africa - Wellcome Trust [087540]; Office of Global AIDS Coordinator [5R24TW008886]; MRC [MC_U950097150] Funding Source: UKRI; FOGARTY INTERNATIONAL CENTER [R24TW008886] Funding Source: NIH RePORTER; Medical Research Council [MC_U950097150] Funding Source: researchfish	Training Health Researchers into Vocational Excellence (THRiVE) in East Africa - Wellcome Trust; Office of Global AIDS Coordinator; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by Training Health Researchers into Vocational Excellence (THRiVE) in East Africa, grant number 087540, funded by Wellcome Trust. This work was made possible by Medical Education for Equitable Services to All Ugandans, a Medical Education Partnership Initiative, grant number 5R24TW008886, from the Office of Global AIDS Coordinator and the U. S. Department of Health and Human Services, Health Resources and Services Administration, and National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the government.	[Anonymous], 2013, ANN HLTH SECT PERF R; [Anonymous], 2017, 2013 UNAIDS REP GLOB; Tran BX, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-27; Bajunirwe F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-430; Bajunirwe F, 2009, AIDS CARE, V21, P271, DOI 10.1080/09540120802241863; BERNADT MW, 1982, LANCET, V1, P325; Figuero LSB, 2011, HIV MED, V12, P22, DOI 10.1111/j.1468-1293.2010.00844.x; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Camfield L, 2007, QUAL LIFE RES, V16, P1039, DOI 10.1007/s11136-007-9182-8; Campos LN, 2010, AIDS BEHAV, V14, P289, DOI 10.1007/s10461-008-9435-8; Campsmith Michael L, 2003, Health Qual Life Outcomes, V1, P12, DOI 10.1186/1477-7525-1-12; Cederfjall C, 2001, AIDS PATIENT CARE ST, V15, P31, DOI 10.1089/108729101460083; Clayson DJ, 2006, PHARMACOECONOMICS, V24, P751, DOI 10.2165/00019053-200624080-00003; Cummins RA, 1998, SOC INDIC RES, V43, P307, DOI 10.1023/A:1006831107052; De Castro N, 2009, CLIN INFECT DIS, V49, P1259, DOI 10.1086/605674; Degroote S, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-40; Deribew A, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-105; Detmar SB, 2002, JAMA-J AM MED ASSOC, V288, P3027, DOI 10.1001/jama.288.23.3027; Epino HM, 2012, AIDS CARE, V24, P1576, DOI 10.1080/09540121.2012.661840; Evans DL, 2002, AM J PSYCHIAT, V159, P1752, DOI 10.1176/appi.ajp.159.10.1752; Ewing JA, 1998, BRIT MED J, V316, P1827, DOI 10.1136/bmj.316.7147.1827; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hays RD, 2000, AM J MED, V108, P714, DOI 10.1016/S0002-9343(00)00387-9; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jaquet A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18867; Jelsma J, 2005, AIDS CARE, V17, P579, DOI 10.1080/09540120412331319714; Jia HG, 2005, AIDS PATIENT CARE ST, V19, P395, DOI 10.1089/apc.2005.19.395; Kaharuza FM, 2006, AIDS BEHAV, V10, pS105, DOI 10.1007/s10461-006-9142-2; KITCHENS JM, 1994, JAMA-J AM MED ASSOC, V272, P1782, DOI 10.1001/jama.272.22.1782; Korthuis PT, 2008, AIDS PATIENT CARE ST, V22, P859, DOI 10.1089/apc.2008.0005; Liu CL, 2006, QUAL LIFE RES, V15, P941, DOI 10.1007/s11136-005-5913-x; Liu CL, 2006, JAIDS-J ACQ IMM DEF, V42, P470, DOI 10.1097/01.qai.0000225730.79610.61; Logie C, 2009, AIDS CARE, V21, P742, DOI 10.1080/09540120802511877; Lorenz KA, 2006, QUAL LIFE RES, V15, P951, DOI 10.1007/s11136-005-6010-x; Mannheimer SB, 2005, AIDS CARE, V17, P10, DOI 10.1080/09540120412331305098; Marcellin F, 2010, AIDS, V24, pS17, DOI 10.1097/01.aids.0000366079.83568.a2; Martin F, 2009, HDB DIS BURDENS QUAL; Martin F, 2010, APPL RES QUAL LIFE, V5, P219, DOI 10.1007/s11482-010-9106-6; Mast TC, 2004, AIDS CARE, V16, P81, DOI 10.1080/09540120310001633994; McDowell I., 1996, MEASURING HLTH GUIDE; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Ministry of Health and ORC Macro, 2006, UG HIV AIDS SER SURV; Ministry Of Health Uganda AIDS Indicator Survey (UAIS). Ministry of Health, 2011, UG AIDS IND SURV UAI; Murri R, 2003, AIDS CARE, V15, P581, DOI 10.1080/0954012031000134818; Mutabazi-Mwesigire D, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-343; Nakasujja N, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-44; Nirmal B., 2008, Indian Journal of Sexually Transmitted Diseases, V29, P15; O'Brien CP, 2008, JAMA-J AM MED ASSOC, V300, P2054, DOI 10.1001/jama.2008.570; Olley BO, 2008, S AFR MED J, V93, P928; Patel R, 2009, AIDS CARE, V21, P1517, DOI 10.1080/09540120902923055; Penzak SR, 2000, AM J HEALTH-SYST PH, V57, P376, DOI 10.1093/ajhp/57.4.376; Perez IR, 2005, QUAL LIFE RES, V14, P1301, DOI 10.1007/s11136-004-4715-x; Pitt J, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-5; Poupard M, 2007, HIV MED, V8, P92, DOI 10.1111/j.1468-1293.2007.00435.x; Preau M, 2007, DRUG ALCOHOL DEPEN, V86, P175, DOI 10.1016/j.drugalcdep.2006.06.012; Preau M, 2007, AIDS, V21, pS19, DOI 10.1097/01.aids.0000255081.24105.d7; Protopopescu C, 2007, QUAL LIFE RES, V16, P577, DOI 10.1007/s11136-006-9151-7; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Revicki DA, 1998, MED CARE, V36, P126, DOI 10.1097/00005650-199802000-00003; RUTA DA, 1994, MED CARE, V32, P1109, DOI 10.1097/00005650-199411000-00004; Smith MY, 1996, QUAL LIFE RES, V5, P47, DOI 10.1007/BF00435968; Stangl AL, 2007, AIDS CARE, V19, P626, DOI 10.1080/09540120701203915; Stangl AL, 2012, QUAL LIFE RES, V21, P1655, DOI 10.1007/s11136-011-0075-5; TARLOV AR, 1989, JAMA-J AM MED ASSOC, V262, P925, DOI 10.1001/jama.262.7.925; Tate D, 2003, AIDS PATIENT CARE ST, V17, P115, DOI 10.1089/108729103763807936; UNAIDS, 2012, HIV AIDS EST; WHOQOL, 1997, MEAS QUAL LIF; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; World Health Organisation, 2010, RAP ADV ANT THER HIV; Wu AW, 1997, QUAL LIFE RES, V6, P481, DOI 10.1023/A:1018451930750; WU AW, 1991, MED CARE, V29, P786, DOI 10.1097/00005650-199108000-00011; Wu AW, 2000, AIDS, V14, P1449, DOI 10.1097/00002030-200007070-00019	74	41	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126810	10.1371/journal.pone.0126810	http://dx.doi.org/10.1371/journal.pone.0126810			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7ST	26039733	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000355700700037
J	Hofberger, JA; Ramirez, AM; van den Bergh, E; Zhu, XG; Bouwmeester, HJ; Schuurink, RC; Schranz, ME				Hofberger, Johannes A.; Ramirez, Aldana M.; van den Bergh, Erik; Zhu, Xinguang; Bouwmeester, Harro J.; Schuurink, Robert C.; Schranz, M. Eric			Large-Scale Evolutionary Analysis of Genes and Supergene Clusters from Terpenoid Modular Pathways Provides Insights into Metabolic Diversification in Flowering Plants	PLOS ONE			English	Article							ISOPENTENYL DIPHOSPHATE ISOMERASES; ARABIDOPSIS-THALIANA; GENOME DUPLICATIONS; WHOLE-GENOME; PROTEIN FAMILIES; DRAFT GENOME; 5-PHOSPHATE SYNTHASE; SECONDARY METABOLISM; MOLECULAR-BIOLOGY; NATURAL VARIATION	An important component of plant evolution is the plethora of pathways producing more than 200,000 biochemically diverse specialized metabolites with pharmacological, nutritional and ecological significance. To unravel dynamics underlying metabolic diversification, it is critical to determine lineage-specific gene family expansion in a phylogenomics framework. However, robust functional annotation is often only available for core enzymes catalyzing committed reaction steps within few model systems. In a genome informatics approach, we extracted information from early-draft gene-space assemblies and non-redundant transcriptomes to identify protein families involved in isoprenoid biosynthesis. Isoprenoids comprise terpenoids with various roles in plant-environment interaction, such as pollinator attraction or pathogen defense. Combining lines of evidence provided by synteny, sequence homology and Hidden-Markov-Modelling, we screened 17 genomes including 12 major crops and found evidence for 1,904 proteins associated with terpenoid biosynthesis. Our terpenoid genes set contains evidence for 840 core terpene-synthases and 338 triterpene-specific synthases. We further identified 190 prenyltransferases, 39 isopentenyl-diphosphate isomerases as well as 278 and 219 proteins involved in mevalonate and methylerithrol pathways, respectively. Assessing the impact of gene and genome duplication to lineage-specific terpenoid pathway expansion, we illustrated key events underlying terpenoid metabolic diversification within 250 million years of flowering plant radiation. By quantifying Angiosperm-wide versatility and phylogenetic relationships of pleiotropic gene families in terpenoid modular pathways, our analysis offers significant insight into evolutionary dynamics underlying diversification of plant secondary metabolism. Furthermore, our data provide a blueprint for future efforts to identify and more rapidly clone terpenoid biosynthetic genes from any plant species.	[Hofberger, Johannes A.; van den Bergh, Erik; Bouwmeester, Harro J.; Schranz, M. Eric] Wageningen Univ & Res Ctr, NL-6708 PB Wageningen, Netherlands; [Hofberger, Johannes A.; Zhu, Xinguang] Chinese Acad Sci, Max Planck Partner Inst Computat Biol, Shanghai 200031, Peoples R China; [Ramirez, Aldana M.; Schuurink, Robert C.] Univ Amsterdam, Swammerdam Inst Life Sci, NL-1098 XH Amsterdam, Netherlands	Wageningen University & Research; Chinese Academy of Sciences; Max Planck Society; University of Amsterdam	Schranz, ME (corresponding author), Wageningen Univ & Res Ctr, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands.	eric.schranz@wur.nl	Schranz, Michael/D-7155-2017; Bouwmeester, Harro J/C-1414-2008; Schranz, M. Eric/AAB-7601-2022	Schranz, Michael/0000-0001-6777-6565; Schranz, M. Eric/0000-0001-6777-6565; Bouwmeester, Harro/0000-0003-0907-2732; van den Bergh, Erik/0000-0001-9865-574X	Netherlands Organization for Scientific Research (NWO) Ecogenomics grant	Netherlands Organization for Scientific Research (NWO) Ecogenomics grant(Netherlands Organization for Scientific Research (NWO))	This work was funded by a Netherlands Organization for Scientific Research (NWO) Ecogenomics grant (M.E.S.).	Abel S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-72; Adams KL, 2007, J HERED, V98, P136, DOI 10.1093/jhered/esl061; Akhtar TA, 2013, PLANT J, V73, P640, DOI 10.1111/tpj.12063; Albert VA, 2013, SCIENCE, V342, P1467, DOI 10.1126/science.1241089; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Aubourg S, 2002, MOL GENET GENOMICS, V267, P730, DOI 10.1007/s00438-002-0709-y; Avraham S, 2008, NUCLEIC ACIDS RES, V36, pD449, DOI 10.1093/nar/gkm908; Barker MS, 2009, GENOME BIOL EVOL, V1, P391, DOI 10.1093/gbe/evp040; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bekaert M, 2011, PLANT CELL, V23, P1719, DOI 10.1105/tpc.110.081281; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Benveniste Pierre, 2002, Arabidopsis Book, V1, pe0004, DOI 10.1199/tab.0004; Berthelot K, 2012, BIOCHIMIE, V94, P1621, DOI 10.1016/j.biochi.2012.03.021; Bohlmann J, 2000, ARCH BIOCHEM BIOPHYS, V375, P261, DOI 10.1006/abbi.1999.1669; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Bombarely A, 2012, MOL PLANT MICROBE IN, V25, P1523, DOI 10.1094/MPMI-06-12-0148-TA; Boutanaev AM, 2015, P NATL ACAD SCI USA, V112, pE81, DOI 10.1073/pnas.1419547112; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Bruskiewich R, 2002, COMPAR FUNCT GENOM, V3, P137, DOI 10.1002/cfg.154; Campos N, 2001, BIOCHEM J, V353, P59, DOI 10.1042/bj3530059; Carretero-Paulet L, 2013, GENE, V524, P40, DOI 10.1016/j.gene.2012.10.071; Carretero-Paulet L, 2012, MOL BIOL EVOL, V29, P3541, DOI 10.1093/molbev/mss162; Chen F, 2004, PLANT PHYSIOL, V135, P1956, DOI 10.1104/pp.104.044388; Chen F, 2003, PLANT CELL, V15, P481, DOI 10.1105/tpc.007989; Chen R, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-78; Cheng AX, 2007, J INTEGR PLANT BIOL, V49, P179, DOI 10.1111/j.1744-7909.2007.00395.x; Cheng SF, 2013, PLANT CELL, V25, P2813, DOI 10.1105/tpc.113.113480; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dai XB, 2010, PLANT PHYSIOL, V152, P44, DOI 10.1104/pp.109.145813; Dalquen DA, 2013, GENOME BIOL EVOL, V5, P1800, DOI 10.1093/gbe/evt132; Dessimoz C, 2012, BIOINFORMATICS, V28, P900, DOI 10.1093/bioinformatics/bts050; Dornelas MC, 2007, GENET MOL BIOL, V30, P832, DOI 10.1590/S1415-47572007000500011; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dvorakova L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-412; Edger PP, 2009, CHROMOSOME RES, V17, P699, DOI 10.1007/s10577-009-9055-9; Estevez JM, 2000, PLANT PHYSIOL, V124, P95, DOI 10.1104/pp.124.1.95; Falara V, 2011, PLANT PHYSIOL, V157, P770, DOI 10.1104/pp.111.179648; Faldt J, 2003, PLANTA, V216, P745, DOI 10.1007/s00425-002-0924-0; Fang L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00261; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Freeling M, 2006, GENOME RES, V16, P805, DOI 10.1101/gr.3681406; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Glenn WS, 2013, CURR OPIN BIOTECH, V24, P354, DOI 10.1016/j.copbio.2012.08.003; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Guimil S, 2007, J EXP BOT, V58, P3829, DOI 10.1093/jxb/erm253; Haas BJ, 2004, BIOINFORMATICS, V20, P3643, DOI 10.1093/bioinformatics/bth397; Han K-H, 2001, ISOPENTENYL DIPHOSPH; Hartmann T, 2007, PHYTOCHEMISTRY, V68, P2831, DOI 10.1016/j.phytochem.2007.09.017; Haudry A, 2013, NAT GENET, V45, P891, DOI 10.1038/ng.2684; Hauser MT, 2014, FRONT PLANT SCI, V5, DOI [10.3389/fpls.2014.00320, 10.3389/fpsyg.2014.00401]; Herde M, 2008, PLANT CELL, V20, P1152, DOI 10.1105/tpc.106.049478; Heyndrickx KS, 2012, PLANT PHYSIOL, V159, P884, DOI 10.1104/pp.112.196725; Hofberger JA, 2015, GENOME BIOL EVOL, V7, P720, DOI 10.1093/gbe/evv020; Hofberger JA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-966; Hofberger JA, 2013, GENOME BIOL EVOL, V5, P2155, DOI 10.1093/gbe/evt162; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Huang MS, 2010, PLANT PHYSIOL, V153, P1293, DOI 10.1104/pp.110.154864; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jalswal P, 2005, COMP FUNCT GENOM, V6, P388, DOI 10.1002/cfg.496; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Johnston JB, 2007, MECH INVESTIGATIONS; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Joron M, 2006, PLOS BIOL, V4, P1831, DOI 10.1371/journal.pbio.0040303; Kamolsukyunyong W, 2013, RICE, V6, DOI 10.1186/1939-8433-6-18; Kang JH, 2014, PLANT PHYSIOL, V164, P80, DOI 10.1104/pp.113.230466; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; Kolesnikova MD, 2007, ORG LETT, V9, P5223, DOI 10.1021/ol702399g; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Kulheim C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-452; Lange BM, 2013, PLANT BIOTECHNOL J, V11, P2, DOI 10.1111/j.1467-7652.2012.00737.x; Laszczyk MN, 2009, PLANTA MED, V75, P1549, DOI 10.1055/s-0029-1186102; Lawler IR, 1998, OECOLOGIA, V116, P160, DOI 10.1007/s004420050575; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; Lipka V, 2005, CURR OPIN PLANT BIOL, V8, P625, DOI 10.1016/j.pbi.2005.09.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodeiro S, 2007, J AM CHEM SOC, V129, P11213, DOI 10.1021/ja073133u; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Lyons E, 2008, PLANT J, V53, P661, DOI 10.1111/j.1365-313X.2007.03326.x; Mandel MA, 1996, PLANT J, V9, P649, DOI 10.1046/j.1365-313X.1996.9050649.x; Marks MD, 2009, MOL PLANT, V2, P803, DOI 10.1093/mp/ssp037; Martin DM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-226; Matsuba Y, 2013, PLANT CELL, V25, P2022, DOI 10.1105/tpc.113.111013; Maynard Smith J., 1989, EVOLUTIONARY GENETIC; Mendes MD, 2014, J PLANT PHYSL; Miller M. A., 2010, CIPRES PORTALS; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Moses T, 2013, NEW PHYTOL, V200, P27, DOI 10.1111/nph.12325; Muhlhausen S, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-202; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; Naur P, 2003, PLANT PHYSIOL, V133, P63, DOI 10.1104/pp.102.019240; Nieuwenhuizen NJ, 2013, PLANT PHYSIOL, V161, P787, DOI 10.1104/pp.112.208249; Ohno S., 1970, P1; Okada K, 2008, PLANT CELL PHYSIOL, V49, P604, DOI 10.1093/pcp/pcn032; Oldfield E, 2012, ANGEW CHEM INT EDIT, V51, P1124, DOI 10.1002/anie.201103110; Paetzold H, 2010, MOL PLANT, V3, P904, DOI 10.1093/mp/ssq032; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pattanaik S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00259; Phillips MA, 2008, PLANT CELL, V20, P677, DOI 10.1105/tpc.107.053926; Phillips MA, 2008, TRENDS PLANT SCI, V13, P619, DOI 10.1016/j.tplants.2008.09.003; Qiu YC, 2014, GENOME BIOL EVOL, V6, P1830, DOI 10.1093/gbe/evu144; Rambaut A., 2009, FIGTREE VERSION 1 3; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roulin A, 2013, PLANT J, V73, P143, DOI 10.1111/tpj.12026; Sallaud C, 2012, PLANT J, V72, P1, DOI 10.1111/j.1365-313X.2012.05068.x; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schranz ME, 2012, CURR OPIN PLANT BIOL, V15, P147, DOI 10.1016/j.pbi.2012.03.011; Schranz ME, 2006, PLANT CELL, V18, P1152, DOI 10.1105/tpc.106.041111; Shack S, 1999, ONCOGENE, V18, P6021, DOI 10.1038/sj.onc.1203002; Shibuya M, 2007, J AM CHEM SOC, V129, P1450, DOI 10.1021/ja066873w; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soltis PS, 2013, ANGIOSPERM PHYLOGENY; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tang HB, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00172; Tang HB, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-102; Tholl D, 2005, PLANT J, V42, P757, DOI 10.1111/j.1365-313X.2005.02417.x; Tholl Dorothea, 2011, Arabidopsis Book, V9, pe0143, DOI 10.1199/tab.0143; Thomas BC, 2006, GENOME RES, V16, P934, DOI 10.1101/gr.4708406; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tissier A, 2012, PLANT J, V70, P51, DOI 10.1111/j.1365-313X.2012.04913.x; Trontin C, 2011, CURR OPIN PLANT BIOL, V14, P225, DOI 10.1016/j.pbi.2011.03.024; van Bakel H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r102; van den Bergh E, 2014, CURR PLANT BIOL, V1, P2, DOI 10.1016/j.cpb.2014.08.001; Vekemans D, 2012, MOL BIOL EVOL, V29, P3793, DOI 10.1093/molbev/mss183; Vranova E, 2013, ANNU REV PLANT BIOL, V64, P665, DOI 10.1146/annurev-arplant-050312-120116; Wagner GJ, 2004, ANN BOT-LONDON, V93, P3, DOI 10.1093/aob/mch011; Wall DP, 2003, BIOINFORMATICS, V19, P1710, DOI 10.1093/bioinformatics/btg213; Wang X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003255; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wolfe K, 2000, NAT GENET, V25, P3, DOI 10.1038/75560; Woodhouse MR, 2011, PLANT CELL, V23, P4241, DOI 10.1105/tpc.111.093567; Xiang T, 2006, ORG LETT, V8, P2835, DOI 10.1021/ol060973p; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yamaguchi S, 1998, PLANT PHYSIOL, V116, P1271, DOI 10.1104/pp.116.4.1271; Yeats C, 2006, NUCLEIC ACIDS RES, V34, pD281, DOI 10.1093/nar/gkj057; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhao YJ, 2014, APPL MICROBIOL BIOT, V98, P2371, DOI 10.1007/s00253-013-5496-3	149	12	12	7	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128808	10.1371/journal.pone.0128808	http://dx.doi.org/10.1371/journal.pone.0128808			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046541	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200104
J	Perga, S; Albo, AG; Lis, K; Minari, N; Falvo, S; Marnetto, F; Caldano, M; Reviglione, R; Berchialla, P; Capobianco, MA; Malentacchi, M; Corpillo, D; Bertolotto, A				Perga, Simona; Albo, Alessandra Giuliano; Lis, Katarzyna; Minari, Nicoletta; Falvo, Sara; Marnetto, Fabiana; Caldano, Marzia; Reviglione, Raffaella; Berchialla, Paola; Capobianco, Marco A.; Malentacchi, Maria; Corpillo, Davide; Bertolotto, Antonio			Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis	PLOS ONE			English	Article							IDENTIFICATION; ASSOCIATION; PHENOTYPE; PROTOCOL; SERUM	Background Multiple sclerosis (MS) is a multifactorial autoimmune disease of the central nervous system with a heterogeneous and unpredictable course. To date there are no prognostic biomarkers even if they would be extremely useful for early patient intervention with personalized therapies. In this context, the analysis of inter-individual differences in cerebrospinal fluid (CSF) proteome may lead to the discovery of biological markers that are able to distinguish the various clinical forms at diagnosis. Methods To this aim, a two dimensional electrophoresis (2-DE) study was carried out on individual CSF samples from 24 untreated women who underwent lumbar puncture (LP) for suspected MS. The patients were clinically monitored for 5 years and then classified according to the degree of disease aggressiveness and the disease-modifying therapies prescribed during follow up. Results The hierarchical cluster analysis of 2-DE dataset revealed three protein spots which were identified by means of mass spectrometry as Apolipoprotein E (ApoE) and two isoforms of vitamin D binding protein (DBP). These three protein spots enabled us to subdivide the patients into subgroups correlated with clinical classification (MS aggressive forms identification: 80%). In particular, we observed an opposite trend of values for the two protein spots corresponding to different DBP isoforms suggesting a role of a post-translational modification rather than the total protein content in patient categorization. Conclusions These findings proved to be very interesting and innovative and may be developed as new candidate prognostic biomarkers of MS aggressiveness, if confirmed.	[Perga, Simona; Marnetto, Fabiana; Caldano, Marzia; Capobianco, Marco A.; Malentacchi, Maria; Bertolotto, Antonio] San Luigi Univ Hosp, Neurol Unit 2, Orbassano, Italy; [Perga, Simona; Marnetto, Fabiana; Caldano, Marzia; Capobianco, Marco A.; Malentacchi, Maria; Bertolotto, Antonio] San Luigi Univ Hosp, Reg Referral Multiple Sclerosis Ctr CReSM, Orbassano, Italy; [Albo, Alessandra Giuliano; Falvo, Sara; Reviglione, Raffaella; Corpillo, Davide] Bioind Pk Silvano Fumero SpA, ABLE Biosci, Colleretto Giacosa, Italy; [Albo, Alessandra Giuliano; Lis, Katarzyna; Minari, Nicoletta; Falvo, Sara; Reviglione, Raffaella; Corpillo, Davide] Bioind Pk Silvano Fumero SpA, LIMA, Colleretto Giacosa, Italy; [Perga, Simona; Marnetto, Fabiana; Caldano, Marzia; Bertolotto, Antonio] San Luigi Univ Hosp, Neurosci Inst Cavalieri Ottolenghi, Orbassano, Italy; [Berchialla, Paola] Univ Turin, Dept Clin & Biol Sci, Turin, Italy	University of Turin	Perga, S (corresponding author), San Luigi Univ Hosp, Neurol Unit 2, Orbassano, Italy.	simona.perga@unito.it	Capobianco, Marco/AAC-2215-2022; Berchialla, Paola/A-3208-2009; Bertolotto, Antonio/K-8346-2015	Capobianco, Marco/0000-0003-2501-2932; Berchialla, Paola/0000-0001-5835-5638; Bertolotto, Antonio/0000-0002-7052-1907	Fondazione Italiana Sclerosi Multipla (FISM) [2007/R/1]; ABLE Biosciences; LIMA	Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); ABLE Biosciences; LIMA	This work was supported by the Fondazione Italiana Sclerosi Multipla (FISM - Grant number 2007/R/1). The sponsor had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation of the manuscript. ABLE Biosciences and LIMA provided support in the form of salaries for authors AGA, KL, NM, SF, RR, and DC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agrawal GK, 2005, PROTEOMICS, V5, P4684, DOI 10.1002/pmic.200500021; Axelsson M, 2013, J NEUROIMMUNOL, V264, P100, DOI 10.1016/j.jneuroim.2013.09.003; Bertolotto A, 2015, CEPHALALGIA; Chiasserini D, 2014, J PROTEOMICS, V106, P191, DOI 10.1016/j.jprot.2014.04.028; Chun RF, 2014, J STEROID BIOCHEM, V144, P132, DOI 10.1016/j.jsbmb.2013.09.012; Chun RF, 2012, CELL BIOCHEM FUNCT, V30, P445, DOI 10.1002/cbf.2835; Comabella M, 2014, LANCET NEUROL, V13, P113, DOI 10.1016/S1474-4422(13)70233-3; Craft GE, 2013, METHODS, V61, P186, DOI 10.1016/j.ymeth.2013.04.008; Disanto G, 2011, J NEUROL, V258, P353, DOI 10.1007/s00415-010-5797-8; Eriksson B, 2008, Patent No. [US2008171394, 2008171394]; Gibson DS, 2012, J PROTEOMICS, V75, P5479, DOI 10.1016/j.jprot.2012.06.024; Giovannoni G, 2014, HAND CLINIC, V122, P681, DOI 10.1016/B978-0-444-52001-2.00029-7; Huhmer AF, 2006, DIS MARKERS, V22, P3; Kroksveen AC, 2012, ACTA NEUROL SCAND, V126, P90, DOI 10.1111/ane.12029; Kroksveen AC, 2011, J PROTEOMICS, V74, P371, DOI 10.1016/j.jprot.2010.11.010; Kulakowska A, 2009, EUROPEAN J NEUROLOGY, V15, P584; Kulakowska A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-107; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lanzillo R, 2012, ACTA NEUROL SCAND, V126, P306, DOI 10.1111/j.1600-0404.2011.01622.x; Lauridsen AL, 2005, CALCIFIED TISSUE INT, V77, P15, DOI 10.1007/s00223-004-0227-5; Lauridsen AL, 2001, CLIN CHEM, V47, P753; Lehmensiek V, 2007, MULT SCLER, V13, P840, DOI 10.1177/1352458507076406; Liguori M, 2014, PLOS ONE, V6, P9; Mila S, 2009, BIOMARK MED, V3, P117, DOI 10.2217/BMM.09.4; Moy KA, 2014, AM J CLIN NUTR, V99, P1424, DOI 10.3945/ajcn.113.080309; Ottervald J, 2010, J PROTEOMICS, V73, P1117, DOI 10.1016/j.jprot.2010.01.004; Pacini S, 2012, ANTICANCER RES, V32, P45; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Qin ZY, 2009, CELL MOL NEUROBIOL, V29, P203, DOI 10.1007/s10571-008-9312-z; Ravnsborg T, 2010, BBA-PROTEINS PROTEOM, V1804, P909, DOI 10.1016/j.bbapap.2009.12.022; Rehder DS, 2009, PROTEIN SCI, V18, P2036, DOI 10.1002/pro.214; Robotti A, 2010, ELECTROPHORESIS, V31, P2882, DOI 10.1002/elps.201000171; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Singer B, 2011, INT J CLIN PRACT, V65, P887, DOI 10.1111/j.1742-1241.2011.02721.x; Smolders J, 2014, MULT SCLER J, V20, P433, DOI 10.1177/1352458513500552; Stoop MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012442; Tamam Y, 2011, EUR REV MED PHARMACO, V15, P1122; Teunissen CE, 2011, MULT SCLER J, V17, P838, DOI 10.1177/1352458511399614; Teunissen CE, 2009, NEUROLOGY, V73, P1914, DOI 10.1212/WNL.0b013e3181c47cc2; Teunissen C, 2013, MULT SCLER J, V19, P1802, DOI 10.1177/1352458513488232; Tumani H, 2009, NEUROSCI LETT, V452, P214, DOI 10.1016/j.neulet.2009.01.057; Yang MC, 2013, MOL NEUROBIOL, V47, P946, DOI 10.1007/s12035-012-8387-1	42	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129291	10.1371/journal.pone.0129291	http://dx.doi.org/10.1371/journal.pone.0129291			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046356	gold, Green Submitted, Green Published			2022-12-27	WOS:000355652200143
J	Wu, JH; Wang, W; Liu, Y; Sun, J; Ye, Y; Li, BY; Liu, XN; Liu, HX; Sun, ZQ; Li, M; Cui, J; Sun, DJ; Yang, YM; Gao, YH				Wu, Junhua; Wang, Wei; Liu, Yang; Sun, Jing; Ye, Yan; Li, Bingyun; Liu, Xiaona; Liu, Hongxu; Sun, Zhenqi; Li, Mang; Cui, Jing; Sun, Dianjun; Yang, Yanmei; Gao, Yanhui			Modifying Role of GSTP1 Polymorphism on the Association between Tea Fluoride Exposure and the Brick-Tea Type Fluorosis	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BONE-MINERAL DENSITY; DENTAL FLUOROSIS; GENE POLYMORPHISMS; ENDEMIC FLUOROSIS; CONSUMPTION; ALUMINUM; QUALITY	Background Brick tea type fluorosis is a public health concern in the north-west area of China. The association between SNPs of genes influencing bone mass and fluorosis has attracted attention, but the association of SNPs with the risk of brick-tea type of fluorosis has not been reported. Objective To investigate the modifying roles of GSTP1 rs1695 polymorphisms on this association. Methods A cross-sectional study was conducted. Brick-tea water was tested by the standard of GB1996-2005 (China). Urinary fluoride was tested by the standard of WS/T 89-2006 (China). Skeletal fluorosis was diagnosed by X-ray, the part we scheduled was forearm, shank, and pelvic, then diagnosed the skeletal fluorosis by the standard of WS/192-2008 (China). Gene polymorphism was tested by Sequenom MassARRAY system. Result The prevalence rate in different ethnical participants was different: Tibetan individuals had the highest prevalence rate of skeletal fluorosis. There were significant differences in genotype frequencies of GSTP1 Rs1695 among different ethnical participants (p < 0.001): Tibetan, Mongolian and Han subjects with homozygous wild type (GSTP1-AA) genotype were numerically higher than Kazakh and Russian subjects (p < 0.001). Compared to Tibetan participants who carried homozygous A allele of GSTP1 Rs1695, Tibetan participants who carried G allele had a significantly decreased risk of skeletal fluorosis (OR = 0.558 [95% CI, 0.326-0.955]). For Kazakh participants, a decreased risk of skeletal fluorosis among carriers of the G allele was limited to non high-loaded fluoride status (OR = 0. 166 [95% CI, 0.03-0.780] vs. OR = 1.478 [95% CI, 0.866-2.552] in participants with high-loaded fluoride status). Neither SNP-IF nor SNP-age for GSTP1 Rs1695 was observed. Conclusion The prevalence rate of the brick tea type fluorosis might have ethnic difference. For Tibetan individuals, who had the highest prevalence rate, G allele of GSTP1 Rs1695 might be a protective factor for brick tea type skeletal fluorosis	[Yang, Yanmei] Harbin Med Univ, Chinese Ctr Dis Control & Prevent, Key Lab Etiol & Epidemiol Educ Bur Heilongjiang P, Ctr Endem Dis Control, Harbin 150081, Heilongjiang Pr, Peoples R China; Minist Hlth 23618504, Harbin 150081, Heilongjiang Pr, Peoples R China	Chinese Center for Disease Control & Prevention; Harbin Medical University	Yang, YM (corresponding author), Harbin Med Univ, Chinese Ctr Dis Control & Prevent, Key Lab Etiol & Epidemiol Educ Bur Heilongjiang P, Ctr Endem Dis Control, Harbin 150081, Heilongjiang Pr, Peoples R China.	yangym0916@163.com; gaoyh411@163.com			National Natural Science Foundation of China [81172605, 30800956]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81172605 and 30800956).	AliOsman F, 1997, J BIOL CHEM, V272, P10004; Ba Y, 2011, BIOL TRACE ELEM RES, V143, P87, DOI 10.1007/s12011-010-8848-1; Ba Y, 2009, ECOTOX ENVIRON SAFE, V72, P2158, DOI 10.1016/j.ecoenv.2009.08.014; Cao J, 1997, FOOD CHEM TOXICOL, V35, P827, DOI 10.1016/S0278-6915(97)00049-5; Cao J, 1996, ENVIRON HEALTH PERSP, V104, P1340, DOI 10.2307/3432972; Cao J, 2003, FOOD CHEM TOXICOL, V41, P535, DOI 10.1016/S0278-6915(02)00285-5; Chandrajith R, 2007, ENVIRON GEOCHEM HLTH, V29, P429, DOI 10.1007/s10653-007-9087-z; Chen YL, 2010, BMC MED GENET, V11, DOI [10.1186/1471-2350-11-46, 10.1186/1471-2350-11-17]; Choubisa S L, 2001, Indian J Environ Health, V43, P177; Choubisa S. L., 2007, Journal of Communicable Diseases, V39, P171; Emekli-Alturfan E, 2009, FOOD CHEM TOXICOL, V47, P1495, DOI 10.1016/j.fct.2009.03.036; Everett ET, 2011, EUR J ORAL SCI, V119, P8, DOI 10.1111/j.1600-0722.2011.00868.x; Everett ET, 2009, CELLS TISSUES ORGANS, V189, P212, DOI 10.1159/000151383; Everett ET, 2002, J DENT RES, V81, P794, DOI 10.1177/0810794; Gavriliuk LA, 2007, KLINICHESKAIA LAB DI, V22, P35; Gong YQ, 1996, AM J HUM GENET, V59, P146; GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F; GRYNPAS M D, 1990, Journal of Bone and Mineral Research, V5, pS169; Gupta P, 2012, J INT SOC PREV COMMU, V2, P64, DOI 10.4103/2231-0762.109371; Huang H, 2008, COMMUNITY DENT ORAL, V36, P517, DOI 10.1111/j.1600-0528.2007.00424.x; Huang QY, 2006, HUM HERED, V61, P237, DOI 10.1159/000095216; Jha SK, 2011, REV ENVIRON CONTAM T, V211, P121, DOI 10.1007/978-1-4419-8011-3_4; Jin C, 2003, ECOTOX ENVIRON SAFE, V56, P222, DOI 10.1016/S0147-6513(03)00065-4; KRISHNAMACHARI KAVR, 1986, PROG FOOD NUTR SCI, V10, P279; Kumar JV, 1998, AM J PUBLIC HEALTH, V88, P1866, DOI 10.2105/AJPH.88.12.1866; Lung SCC, 2008, J EXPO SCI ENV EPID, V18, P158, DOI 10.1038/sj.jes.7500574; MABELYA L, 1994, COMMUNITY DENT ORAL, V22, P415, DOI 10.1111/j.1600-0528.1994.tb00789.x; Malde M K, 2003, Int J Paediatr Dent, V13, P27, DOI 10.1046/j.1365-263X.2003.00422.x; Mandinic Z, 2009, FOOD CHEM TOXICOL, V47, P1080, DOI 10.1016/j.fct.2009.01.038; Peacock M, 2005, J CLIN ENDOCR METAB, V90, P3060, DOI 10.1210/jc.2004-2143; Shu WS, 2003, CHEMOSPHERE, V52, P1475, DOI 10.1016/S0045-6535(03)00485-5; SOGAARD CH, 1994, BONE, V15, P393, DOI 10.1016/8756-3282(94)90815-X; Varol E, 2013, TOXICOL IND HEALTH, V29, P175, DOI 10.1177/0748233711428641; Vieira APGF, 2005, CALCIFIED TISSUE INT, V76, P17, DOI 10.1007/s00223-004-0075-3; Wang Q, 2014, ENVIRON GEOCHEM HLTH, V36, P107, DOI 10.1007/s10653-013-9522-2; Watson MA, 1998, CARCINOGENESIS, V19, P275, DOI 10.1093/carcin/19.2.275; Wen SB, 2012, BIOL TRACE ELEM RES, V147, P84, DOI 10.1007/s12011-011-9313-5; Wong MH, 2003, TOXICOL LETT, V137, P111, DOI 10.1016/S0378-4274(02)00385-5; Yang G, 2005, CANCER-AM CANCER SOC, V103, P52, DOI 10.1002/cncr.20729; Yang LS, 2003, ENVIRON GEOCHEM HLTH, V25, P281, DOI 10.1023/A:1024543819240; Yi J, 2008, J FLUORINE CHEM, V129, P76, DOI 10.1016/j.jfluchem.2007.11.001; Yoder KM, 1998, COMMUNITY DENT ORAL, V26, P382, DOI 10.1111/j.1600-0528.1998.tb01976.x; Zhang T, 2013, BIOL TRACE ELEM RES, V152, P379, DOI 10.1007/s12011-013-9632-9; ZIMNIAK P, 1994, EUR J BIOCHEM, V224, P893, DOI 10.1111/j.1432-1033.1994.00893.x	44	15	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128280	10.1371/journal.pone.0128280	http://dx.doi.org/10.1371/journal.pone.0128280			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046522	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200054
J	Basso, B; Hyndman, DW; Kendall, AD; Grace, PR; Robertson, GP				Basso, Bruno; Hyndman, David W.; Kendall, Anthony D.; Grace, Peter R.; Robertson, G. Philip			Can Impacts of Climate Change and Agricultural Adaptation Strategies Be Accurately Quantified if Crop Models Are Annually Re-Initialized?	PLOS ONE			English	Article							SITE-SPECIFIC TILLAGE; SIMULATION ANALYSIS; FOOD SECURITY; MAIZE; ROTATION; YIELD; NITRATE; UNCERTAINTY; VARIABILITY; EFFICIENCY	Estimates of climate change impacts on global food production are generally based on statistical or process-based models. Process-based models can provide robust predictions of agricultural yield responses to changing climate and management. However, applications of these models often suffer from bias due to the common practice of re-initializing soil conditions to the same state for each year of the forecast period. If simulations neglect to include year-to-year changes in initial soil conditions and water content related to agronomic management, adaptation and mitigation strategies designed to maintain stable yields under climate change cannot be properly evaluated. We apply a process-based crop system model that avoids re-initialization bias to demonstrate the importance of simulating both year-to-year and cumulative changes in pre-season soil carbon, nutrient, and water availability. Results are contrasted with simulations using annual re-initialization, and differences are striking. We then demonstrate the potential for the most likely adaptation strategy to offset climate change impacts on yields using continuous simulations through the end of the 21st century. Simulations that annually re-initialize pre-season soil carbon and water contents introduce an inappropriate yield bias that obscures the potential for agricultural management to ameliorate the deleterious effects of rising temperatures and greater rainfall variability.	[Basso, Bruno; Hyndman, David W.; Kendall, Anthony D.] Michigan State Univ, Dept Geol Sci, E Lansing, MI 48824 USA; [Basso, Bruno; Robertson, G. Philip] Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Grace, Peter R.] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Robertson, G. Philip] Queensland Univ Technol, Inst Future Environm, Brisbane, Qld 4001, Australia	Michigan State University; Michigan State University; Michigan State University; Queensland University of Technology (QUT)	Basso, B (corresponding author), Michigan State Univ, Dept Geol Sci, E Lansing, MI 48824 USA.	basso@msu.edu	Robertson, G Philip/H-3885-2011; Basso, Bruno/AAF-1271-2019; Hyndman, David/G-1576-2010	Robertson, G Philip/0000-0001-9771-9895; Basso, Bruno/0000-0003-2090-4616; Grace, Peter/0000-0003-4136-4129; Hyndman, David/0000-0001-9464-8403	U.S. National Science Foundation [EAR-0911642]; CSCAP-USDA-NIFA [2011-68002-30190]; USDA NIFA Water Cap Award [2014-09400]; Direct For Biological Sciences [1027253] Funding Source: National Science Foundation; Directorate For Geosciences [1039180] Funding Source: National Science Foundation; Division Of Earth Sciences [1039247] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); CSCAP-USDA-NIFA; USDA NIFA Water Cap Award; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was funded by the U.S. National Science Foundation under grant EAR-0911642; CSCAP-USDA-NIFA Award 2011-68002-30190; USDA NIFA Water Cap Award 2014-09400. Any opinions, findings, and conclusions or recommendations expressed in this publication are those of the authors and do not necessarily reflect the views of the NSF or USDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RM, 1990, NATURE, V345, P219, DOI 10.1038/345219a0; Asseng S, 2015, NAT CLIM CHANGE, V5, P143, DOI [10.1038/nclimate2470, 10.1038/NCLIMATE2470]; Asseng S, 2013, NAT CLIM CHANGE, V3, P827, DOI [10.1038/nclimate1916, 10.1038/NCLIMATE1916]; Basso B, 2005, AGR ECOSYST ENVIRON, V108, P329, DOI 10.1016/j.agee.2005.01.011; Basso B, 2009, J AGRON CROP SCI, V195, P301, DOI 10.1111/j.1439-037X.2008.00351.x; Basso B, 2014, ECOLOGY AGR LANDSCAP, P252; Basso B, 2011, SOIL SCI SOC AM J; Basso B, 2007, EUR J AGRON, V26, P82, DOI 10.1016/j.eja.2006.08.008; Basso B, 2012, VADOSE ZONE J, V11, DOI 10.2136/vzj2011.0173; Basso B, 2011, EUR J AGRON, V35, P83, DOI 10.1016/j.eja.2011.04.002; Basso B, 2010, EUR J AGRON, V33, P132, DOI 10.1016/j.eja.2010.04.004; Bassu S, 2014, GLOBAL CHANGE BIOL, V20, P2301, DOI 10.1111/gcb.12520; Bertocco M, 2008, BIORESOURCE TECHNOL, V99, P6957, DOI 10.1016/j.biortech.2008.01.027; Challinor A, 2011, NAT CLIM CHANGE, V1, P103, DOI 10.1038/nclimate1098; Chen J, 2011, J HYDROL, V401, P190, DOI 10.1016/j.jhydrol.2011.02.020; Dzotsi KA, 2013, ECOL MODEL, V260, P62, DOI 10.1016/j.ecolmodel.2013.03.017; Ek M., 2011, GEWEX NEWS, V21, P6; Elliott J, 2014, P NATL ACAD SCI USA, V111, P3239, DOI 10.1073/pnas.1222474110; Ewert F, 2012, NAT CLIM CHANGE, V2, P153, DOI 10.1038/nclimate1426; Giola P, 2012, EUR J AGRON, V38, P43, DOI 10.1016/j.eja.2011.12.001; Hansen J, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080954, 10.1371/journal.pone.0081648]; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Long SP, 2006, SCIENCE, V312, P1918, DOI 10.1126/science.1114722; Masui T, 2011, CLIMATIC CHANGE, V109, P59, DOI 10.1007/s10584-011-0150-5; Ritchie JT, 2008, EUR J AGRON, V28, P273, DOI 10.1016/j.eja.2007.08.003; Rosenzweig C, 2013, AGR FOREST METEOROL, V170, P166, DOI 10.1016/j.agrformet.2012.09.011; ROSENZWEIG C, 1994, NATURE, V367, P133, DOI 10.1038/367133a0; Rotter RP, 2011, NAT CLIM CHANGE, V1, P175; Senthilkumar S, 2009, SCI SOC AM J, V73; Soussana JF, 2012, GLOBAL CHANGE BIOL, V18, P3269, DOI 10.1111/j.1365-2486.2012.02746.x; Suleiman AA, 2001, T ASAE, V44, P235, DOI 10.13031/2013.4683; Syswerda SP, 2012, AGR ECOSYST ENVIRON, V149, P10, DOI 10.1016/j.agee.2011.12.007; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tubiello FN, 2000, EUR J AGRON, V13, P179, DOI 10.1016/S1161-0301(00)00073-3; USDA National Agricultural Statistics Service, 2012, CENS AGR; Vermeulen S, 2012, CURR OPIN ENV SUST, V4, P128, DOI 10.1016/j.cosust.2011.12.004; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; White JW, 2011, FIELD CROP RES, V124, P357, DOI 10.1016/j.fcr.2011.07.001	38	39	39	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0127333	10.1371/journal.pone.0127333	http://dx.doi.org/10.1371/journal.pone.0127333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043188	Green Published, gold, Green Submitted			2022-12-27	WOS:000355701600011
J	Castiglioni, A; Corna, G; Rigamonti, E; Basso, V; Vezzoli, M; Monno, A; Almada, AE; Mondino, A; Wagers, AJ; Manfredi, AA; Rovere-Querini, P				Castiglioni, Alessandra; Corna, Gianfranca; Rigamonti, Elena; Basso, Veronica; Vezzoli, Michela; Monno, Antonella; Almada, Albert E.; Mondino, Anna; Wagers, Amy J.; Manfredi, Angelo A.; Rovere-Querini, Patrizia			FOXP3(+) T Cells Recruited to Sites of Sterile Skeletal Muscle Injury Regulate the Fate of Satellite Cells and Guide Effective Tissue Regeneration	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; GROWTH-FACTOR-I; MUSCULAR-DYSTROPHY; INFLAMMATION; DIFFERENTIATION; RECEPTOR; CD4(+); INTERLEUKIN-2; MACROPHAGES; PROGENITORS	Muscle injury induces a classical inflammatory response in which cells of the innate immune system rapidly invade the tissue. Macrophages are prominently involved in this response and required for proper healing, as they are known to be important for clearing cellular debris and supporting satellite cell differentiation. Here, we sought to assess the role of the adaptive immune system in muscle regeneration after acute damage. We show that T lymphocytes are transiently recruited into the muscle after damage and appear to exert a promyogenic effect on muscle repair. We observed a decrease in the cross-sectional area of regenerating myofibers after injury in Rag2(-/-) gamma-chain(-/-) mice, as compared to WT controls, suggesting that T cell recruitment promotes muscle regeneration. Skeletal muscle infiltrating T lymphocytes were enriched in CD4(+)CD25(+)FOXP3(+) cells. Direct exposure of muscle satellite cells to in vitro induced Treg cells effectively enhanced their expansion, and concurrently inhibited their myogenic differentiation. In vivo, the recruitment of Tregs to acutely injured muscle was limited to the time period of satellite expansion, with possibly important implications for situations in which inflammatory conditions persist, such as muscular dystrophies and inflammatory myopathies. We conclude that the adaptive immune system, in particular T regulatory cells, is critically involved in effective skeletal muscle regeneration. Thus, in addition to their well-established role as regulators of the immune/inflammatory response, T regulatory cells also regulate the activity of skeletal muscle precursor cells, and are instrumental for the proper regeneration of this tissue.	[Castiglioni, Alessandra; Corna, Gianfranca; Rigamonti, Elena; Vezzoli, Michela; Monno, Antonella; Manfredi, Angelo A.; Rovere-Querini, Patrizia] Ist Sci San Raffaele, Div Regenerat Med Stem Cells & Gene Therapy, I-20132 Milan, Italy; [Castiglioni, Alessandra; Corna, Gianfranca; Rigamonti, Elena; Basso, Veronica; Vezzoli, Michela; Monno, Antonella; Mondino, Anna; Manfredi, Angelo A.; Rovere-Querini, Patrizia] Univ Vita Salute San Raffaele, Milan, Italy; [Castiglioni, Alessandra; Almada, Albert E.; Wagers, Amy J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Castiglioni, Alessandra; Almada, Albert E.; Wagers, Amy J.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Castiglioni, Alessandra; Almada, Albert E.; Wagers, Amy J.] Howard Hughes Med Inst, Cambridge, MA USA; [Castiglioni, Alessandra; Almada, Albert E.; Wagers, Amy J.] Harvard Stem Cell Inst, Cambridge, MA USA; [Castiglioni, Alessandra; Almada, Albert E.; Wagers, Amy J.] Harvard Univ, Sch Med, Paul F Glenn Lab Biol Mech Aging, Boston, MA USA; [Basso, Veronica; Mondino, Anna] Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Harvard University; Harvard University; Joslin Diabetes Center, Inc.; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard Medical School; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Castiglioni, A (corresponding author), Ist Sci San Raffaele, Div Regenerat Med Stem Cells & Gene Therapy, I-20132 Milan, Italy.	acastiglioni@fas.harvard.edu	Manfredi, Angelo A./C-7018-2014; Vezzoli, Michela/AAN-7355-2020; Mondino, Anna/K-9434-2016; Basso, Veronica/AAC-8131-2019; Rovere-Querini, Patrizia/J-2340-2012	Manfredi, Angelo A./0000-0001-8370-6970; Mondino, Anna/0000-0003-0833-6927; basso, veronica/0000-0003-1880-8406; CASTIGLIONI, ALESSANDRO/0000-0001-6107-1564; Castiglioni, Alessandra/0000-0002-1761-9761	Italian Ministry of Health; Association Francaise contre les Myopathies [15440]; AIRC - Associazione Italiana per la Ricerca sul Cancro; Ministero dell'Istruzione, dell'Universita' e della Ricerca; Burroughs Wellcome Fund; NIH [1R01 AG033053, 5U01 HL100402, P30 DK036836]; National Institutes of Health (NIH); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033053] Funding Source: NIH RePORTER	Italian Ministry of Health(Ministry of Health, Italy); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); AIRC - Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione, dell'Universita' e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Italian Ministry of Health (Fondo per gli Investimenti della Ricerca di Base-IDEAS to P.R.-Q. and Ricerca Finalizzata to A.A.M. and P.R.-Q.) the Association Francaise contre les Myopathies (Grant 15440 to P.R.-Q.) the AIRC - Associazione Italiana per la Ricerca sul Cancro (to A.A.M.) and Ministero dell'Istruzione, dell'Universita' e della Ricerca (to A.A.M.). A.E. A., Ph.D., holds a Postdoctoral Enrichment Program Award from the Burroughs Wellcome Fund. NIH 1R01 AG033053 and 5U01 HL100402 supported A.J.W., and NIH P30 DK036836 supported the Joslin Diabetes Center Flow Cytometry Core. A.J.W. is an Early Career Scientist of the Howard Hughes Medical Institute. Research described here was supported in part by funding from the National Institutes of Health (NIH). Content is solely the responsibility of the authors and does not necessarily reflect the official views of the NIH or other funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shanti N, 2014, CELL PHYSIOL BIOCHEM, V33, P117, DOI 10.1159/000356655; Andersson A, 1997, EUR J IMMUNOL, V27, P1762, DOI 10.1002/eji.1830270725; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Chaudhry A, 2013, J CLIN INVEST, V123, P939, DOI 10.1172/JCI57175; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; GUSSONI E, 1994, J IMMUNOL, V153, P4798; Jewett A, 2013, J CANCER, V4, P12, DOI 10.7150/jca.5519; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kharraz Y, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/491497; Kumar P, 2013, MUCOSAL IMMUNOL, V6, P69, DOI 10.1038/mi.2012.49; Lu HY, 2011, FASEB J, V25, P358, DOI 10.1096/fj.10-171579; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Reinke S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004754; Rigamonti E, 2013, J IMMUNOL, V190, P1767, DOI 10.4049/jimmunol.1202903; Saclier M, 2013, FEBS J, V280, P4118, DOI 10.1111/febs.12166; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Schmidt-Bleek K, 2014, J TISSUE ENG REGEN M, V8, P120, DOI 10.1002/term.1505; Sciorati C, 2015, ARTHRITIS RHEUMATOL, V67, P809, DOI 10.1002/art.38985; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Spencer MJ, 2001, CLIN IMMUNOL, V98, P235, DOI 10.1006/clim.2000.4966; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Tidball JG, 2005, CURR OPIN RHEUMATOL, V17, P707, DOI 10.1097/01.bor.0000179948.65895.1a; Tumanov AV, 2009, GASTROENTEROLOGY, V136, P694, DOI 10.1053/j.gastro.2008.09.015; Vezzoli M, 2011, ANTIOXID REDOX SIGN, V15, P2161, DOI 10.1089/ars.2010.3341; Vezzoli M, 2010, ANN NY ACAD SCI, V1209, P83, DOI 10.1111/j.1749-6632.2010.05748.x; Villalta SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009925; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110; Wiendl H, 2005, TRENDS IMMUNOL, V26, P373, DOI 10.1016/j.it.2005.05.003; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x	47	98	102	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128094	10.1371/journal.pone.0128094	http://dx.doi.org/10.1371/journal.pone.0128094			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039259	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700088
J	Holder, RC; Kirse, DJ; Evans, AK; Whigham, AS; Peters, TR; Poehling, KA; Swords, WE; Reid, SD				Holder, Robert C.; Kirse, Daniel J.; Evans, Adele K.; Whigham, Amy S.; Peters, Timothy R.; Poehling, Katherine A.; Swords, William E.; Reid, Sean D.			Otopathogens Detected in Middle Ear Fluid Obtained during Tympanostomy Tube Insertion: Contrasting Purulent and Non-Purulent Effusions	PLOS ONE			English	Article							ACUTE OTITIS-MEDIA; STREPTOCOCCUS-PNEUMONIAE; ALLOIOCOCCUS-OTITIDIS; CONJUGATE VACCINE; CHILDREN; BACTERIOLOGY; COHORT; EPIDEMIOLOGY; FREQUENCY; BURDEN	Otitis media is a prominent disease among children. Previous literature indicates that otitis media is a polymicrobial disease, with Haemophilus influenzae, Streptococcus pneumoniae, Alloiococcus otitidis and Moraxella catarrhalis being the most commonly associated bacterial pathogens. Recent literature suggests that introduction of pneumococcal conjugate vaccines has had an effect on the etiology of otitis media. Using a multiplex PCR procedure, we sought to investigate the presence of the aforementioned bacterial pathogens in middle ear fluid collected from children undergoing routine tympanostomy tube placement at Wake Forest Baptist Medical Center during the period between January 2011 and March 2014. In purulent effusions, one or more bacterial organisms were detected in similar to 90% of samples. Most often the presence of H. influenzae alone was detected in purulent effusions (32%; 10 of 31). In non-purulent effusions, the most prevalent organism detected was A. otitidis (26%; 63 of 245). Half of the non-purulent effusions had none of these otopathogens detected. In purulent and non-purulent effusions, the overall presence of S. pneumoniae was lower (19%; 6 of 31, and 4%; 9 of 245, respectively) than that of the other pathogens being identified. The ratio of the percentage of each otopathogen identified in purulent vs. non-purulent effusions was >1 for the classic otopathogens but not for A. otitidis.	[Holder, Robert C.; Swords, William E.; Reid, Sean D.] Wake Forest Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27157 USA; [Kirse, Daniel J.; Evans, Adele K.; Whigham, Amy S.] Wake Forest Sch Med, Dept Otolaryngol Head & Neck Surg, Winston Salem, NC USA; [Peters, Timothy R.; Poehling, Katherine A.] Wake Forest Sch Med, Dept Pediat, Winston Salem, NC USA; [Poehling, Katherine A.] Wake Forest Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC USA; [Reid, Sean D.] Ross Univ, Sch Med, Dept Microbiol & Immunol, Roseau, Dominica	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University	Holder, RC (corresponding author), Wake Forest Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27157 USA.	roholder@wakehealth.edu	Whigham, Amy/AAT-7183-2020	Whigham, Amy/0000-0001-7648-1988	National Institutes of Health [R01 DC10051, T32 AI007401]; American Heart Association [11GRNT7980017]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was supported by R01 DC10051 from the National Institutes of Health to WES, T32 AI007401 from the National Institutes of Health to Dr. Griffith D. Parks (PI), and 11GRNT7980017 from American Heart Association to SDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2014, LARYNGOSCOPE, V124, P301, DOI 10.1002/lary.24190; Alsarraf R, 1999, ARCH OTOLARYNGOL, V125, P12, DOI 10.1001/archotol.125.1.12; Block SL, 2004, PEDIATR INFECT DIS J, V23, P829, DOI 10.1097/01.inf.0000136868.91756.80; Bluestone CD, 2007, MICROBIOLOGY OTITIS, P101; Bondy J, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e72; BOSLEY GS, 1995, J CLIN MICROBIOL, V33, P2876, DOI 10.1128/JCM.33.11.2876-2880.1995; Casey JR, 2010, PEDIATR INFECT DIS J, V29, P304, DOI 10.1097/INF.0b013e3181c1bc48; Casey JR, 2004, PEDIATR INFECT DIS J, V23, P824, DOI 10.1097/01.inf.0000136871.51792.19; Casselbrant M.L, 2003, EVIDENCE BASED OTITI, V2nd, P147; DELBECCARO MA, 1992, J PEDIATR-US, V120, P81, DOI 10.1016/S0022-3476(05)80605-5; Finkelstein JA, 2001, PEDIATRICS, V108, pU113; Grijalva CG, 2009, JAMA-J AM MED ASSOC, V302, P758, DOI 10.1001/jama.2009.1163; Harimaya A, 2006, J CLIN MICROBIOL, V44, P946, DOI 10.1128/JCM.44.3.946-949.2006; Hendolin PH, 1997, J CLIN MICROBIOL, V35, P2854, DOI 10.1128/JCM.35.11.2854-2858.1997; Holder RC, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-87; Khoramrooz SS, 2012, AURIS NASUS LARYNX, V39, P369, DOI 10.1016/j.anl.2011.07.002; Kilpi T, 2001, PEDIATR INFECT DIS J, V20, P654, DOI 10.1097/00006454-200107000-00004; Kim SJ, 2013, ACTA OTO-LARYNGOL, V133, P1133, DOI 10.3109/00016489.2013.816442; Klein JO, 2000, VACCINE, V19, pS2, DOI 10.1016/S0264-410X(00)00271-1; LONG SS, 1983, INFECT IMMUN, V41, P987, DOI 10.1128/IAI.41.3.987-991.1983; McCaig LF, 2002, JAMA-J AM MED ASSOC, V287, P3096, DOI 10.1001/jama.287.23.3096; McEllistrem MC, 2005, CLIN INFECT DIS, V40, P1738, DOI 10.1086/429908; McEllistrem MC, 2003, J INFECT DIS, V188, P1679, DOI 10.1086/379665; Pichichero ME, 2013, PEDIATR CLIN N AM, V60, P391, DOI 10.1016/j.pcl.2012.12.007; Rovers MM, 2008, VACCINE, V26, pG2, DOI 10.1016/j.vaccine.2008.11.005; Schappert S M, 1992, Adv Data, P1; Schwartz SR, 2003, EVIDENCE BASED OTITI, P333; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Vergison A, 2010, LANCET INFECT DIS, V10, P195, DOI 10.1016/S1473-3099(10)70012-8; Vijayasekaran S, 2012, LARYNGOSCOPE, V122, pS61, DOI 10.1002/lary.23817; Zhao AS, 2014, INT J PEDIATR OTORHI, V78, P499, DOI 10.1016/j.ijporl.2013.12.028	31	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128606	10.1371/journal.pone.0128606	http://dx.doi.org/10.1371/journal.pone.0128606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039250	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700109
J	North, AC; Hodgson, DJ; Price, SJ; Griffiths, AGF				North, Alexandra C.; Hodgson, David J.; Price, Stephen J.; Griffiths, Amber G. F.			Anthropogenic and Ecological Drivers of Amphibian Disease (Ranavirosis)	PLOS ONE			English	Article							FROG RANA-TEMPORARIA; GOLDFISH CARASSIUS-AURATUS; AMBYSTOMA-TIGRINUM; UNITED-KINGDOM; BATRACHOCHYTRIUM-DENDROBATIDIS; INFECTIOUS-DISEASES; TIGER SALAMANDER; LIFE-HISTORY; POPULATIONS; SUSCEPTIBILITY	Ranaviruses are causing mass amphibian die-offs in North America, Europe and Asia, and have been implicated in the decline of common frog (Rana temporaria) populations in the UK. Despite this, we have very little understanding of the environmental drivers of disease occurrence and prevalence. Using a long term (1992-2000) dataset of public reports of amphibian mortalities, we assess a set of potential predictors of the occurrence and prevalence of Ranavirus-consistent common frog mortality events in Britain. We reveal the influence of biotic and abiotic drivers of this disease, with many of these abiotic characteristics being anthropogenic. Whilst controlling for the geographic distribution of mortality events, disease prevalence increases with increasing frog population density, presence of fish and wild newts, increasing pond depth and the use of garden chemicals. The presence of an alternative host reduces prevalence, potentially indicating a dilution effect. Ranavirosis occurrence is associated with the presence of toads, an urban setting and the use of fish care products, providing insight into the causes of emergence of disease. Links between occurrence, prevalence, pond characteristics and garden management practices provides useful management implications for reducing the impacts of Ranavirus in the wild.	[North, Alexandra C.; Griffiths, Amber G. F.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England; [Hodgson, David J.] Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England; [Price, Stephen J.] UCL Genet Inst, London, England	University of Exeter; University of Exeter; University of London; University College London	North, AC (corresponding author), Univ Exeter, Environm & Sustainabil Inst, Penryn Campus, Penryn, Cornwall, England.	acn202@exeter.ac.uk; A.Griffiths3@exeter.ac.uk	Price, Stephen J./Q-1535-2019	Price, Stephen J./0000-0001-6983-6250; Griffiths, Amber/0000-0002-7455-6795; North, Alexandra/0000-0002-2942-3467	Marie Curie; University of Exeter	Marie Curie(European Commission); University of Exeter	This work received support from Marie Curie (http://ec.europa.eu/research/mariecurieactions/) and the University of Exeter (http://www.exeter.ac.uk/).	Albert A, 2007, ENVIRON TOXICOL CHEM, V26, P1179, DOI 10.1897/05-622R.1; ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; [Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; ARNOLD HR, 1995, ATLAS AMPHIBIANS REP; Arntzen JW, 2014, MESOTRITON ALPESTRIS; Balseiro A, 2010, VET J, V186, P256, DOI 10.1016/j.tvjl.2009.07.038; Barton K., MUMIN MULTIMODEL INF; Bayley AE, 2013, DIS AQUAT ORGAN, V103, P171, DOI 10.3354/dao02574; Beebee TJC, 2014, J HERPETOL, V48, P2, DOI 10.1670/12-263; BEGON M, 1994, J THEOR BIOL, V169, P275, DOI 10.1006/jtbi.1994.1148; Bradley CA, 2008, ECOL APPL, V18, P1083, DOI 10.1890/07-0822.1; Brand M, 2013, 2013 INT S RAN TENN; Brearley G, 2013, BIOL REV, V88, P427, DOI 10.1111/brv.12009; Brenes RM, 2013, THESIS U TENNESSEE K; Brenes R, 2014, J AQUAT ANIM HEALTH, V26, P118, DOI 10.1080/08997659.2014.886637; Brenes R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092476; Brunner JL, 2007, DIS AQUAT ORGAN, V77, P87, DOI 10.3354/dao01845; Buckley J, 2004, ANIM CONSERV, V7, P221, DOI 10.1017/S1367943004001428; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chinchar VG, 2002, ARCH VIROL, V147, P447, DOI 10.1007/s007050200000; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; Crane M, 2006, PEST MANAG SCI, V62, P5, DOI 10.1002/ps.1134; Cunningham AA, 2007, EPIDEMIOL INFECT, V135, P1200, DOI 10.1017/S0950268806007679; Cunningham AA, 2007, EPIDEMIOL INFECT, V135, P1213, DOI 10.1017/S0950268807007935; Cunningham AA, 2001, THESIS U LONDON; Cunningham AA, 2003, J PARASITOL, V89, P78; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Davies ZG, 2009, BIOL CONSERV, V142, P761, DOI 10.1016/j.biocon.2008.12.016; Duffus ALJ, 2008, J WILDLIFE DIS, V44, P109, DOI 10.7589/0090-3558-44.1.109; Duffus A. L. J., 2013, Herpetological Review, V44, P260; Duffus ALJ, 2009, THESIS QUEEN MARY U; Duffus Amanda L. J., 2014, Herpetological Review, V45, P608; Duffus ALJ, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00074.1; Earl JE, 2014, ECOHEALTH, V11, P581, DOI 10.1007/s10393-014-0950-y; Echaubard P, 2014, EVOL APPL, V7, P723, DOI 10.1111/eva.12169; Echaubard P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013723; Farnsworth ML, 2005, ECOL APPL, V15, P119, DOI 10.1890/04-0194; Forson DD, 2006, ECOL APPL, V16, P2325, DOI 10.1890/1051-0761(2006)016[2325:AIRSIT]2.0.CO;2; FREEMARK K, 1995, AGR ECOSYST ENVIRON, V52, P67, DOI 10.1016/0167-8809(94)00534-L; Gahl MK, 2010, CAN J ZOOL, V88, P108, DOI 10.1139/Z09-124; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Geng Y, 2011, J COMP PATHOL, V145, P95, DOI 10.1016/j.jcpa.2010.11.012; Gray MJ, 2007, DIS AQUAT ORGAN, V77, P97, DOI 10.3354/dao01837; Gray MJ, 2009, DIS AQUAT ORGAN, V87, P243, DOI 10.3354/dao02138; Green DE, 2002, ANN NY ACAD SCI, V969, P323, DOI 10.1111/j.1749-6632.2002.tb04400.x; Greer AL, 2008, J ANIM ECOL, V77, P364, DOI 10.1111/j.1365-2656.2007.01330.x; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Haislip NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022307; Harp EM, 2006, J WILDLIFE DIS, V42, P307, DOI 10.7589/0090-3558-42.2.307; HEDRICK RP, 1995, VET RES, V26, P423; Hitchings SP, 1997, HEREDITY, V79, P117, DOI 10.1038/hdy.1997.134; Holt RD, 2003, ECOL LETT, V6, P837, DOI 10.1046/j.1461-0248.2003.00501.x; Hoverman JT, 2012, ECOHEALTH, V9, P36, DOI 10.1007/s10393-011-0731-9; Hoverman JT, 2011, ECOHEALTH, V8, P301, DOI 10.1007/s10393-011-0717-7; Hoverman JT, 2010, DIS AQUAT ORGAN, V89, P97, DOI 10.3354/dao02200; Hyatt AD, 2000, ARCH VIROL, V145, P301, DOI 10.1007/s007050050025; Jancovich JK, 2005, MOL ECOL, V14, P213, DOI 10.1111/j.1365-294X.2004.02387.x; Jensen BB, 2011, B EUR ASSOC FISH PAT, V31, P112; Johnson PTJ, 2010, J EXP BIOL, V213, P961, DOI 10.1242/jeb.037721; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kerby JL, 2011, ECOHEALTH, V8, P46, DOI 10.1007/s10393-011-0682-1; Kerby JL, 2009, ECOHEALTH, V6, P91, DOI 10.1007/s10393-009-0234-0; Kleinkauf A, 1999, MAMMAL REV, V29, P201, DOI 10.1046/j.1365-2907.1999.00046.x; Kolby JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090750; Kovar R, 2009, AMPHIBIA-REPTILIA, V30, P367, DOI 10.1163/156853809788795236; Kozlowski Jan, 2011, Folia Malacologica, V19, P267, DOI 10.2478/v10125-011-0017-4; Leu T, 2009, AMPHIBIA-REPTILIA, V30, P290, DOI 10.1163/156853809788201153; Mao JH, 1999, VIRUS RES, V63, P45, DOI 10.1016/S0168-1702(99)00057-X; Miller D, 2011, VIRUSES-BASEL, V3, P2351, DOI 10.3390/v3112351; Monello RJ, 2001, J HERPETOL, V35, P350, DOI 10.2307/1566132; Narayan EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073564; Nazir J, 2012, DIS AQUAT ORGAN, V98, P177, DOI 10.3354/dao02443; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; PASANEN S, 1994, ANN ZOOL FENN, V31, P275; Pearman PB, 2005, ECOL LETT, V8, P401, DOI 10.1111/j.1461-0248.2005.00735.x; Piedrahita RH, 1988, AQUACULTURE, V68, P249; Price SJ, 2013, THESIS QUEEN MARY U; Price SJ, 2014, CURR BIOL, V24, P2586, DOI 10.1016/j.cub.2014.09.028; R Development Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Rachowicz LJ, 2005, CONSERV BIOL, V19, P1441, DOI 10.1111/j.1523-1739.2005.00255.x; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Riley SPD, 2005, CONSERV BIOL, V19, P1894, DOI 10.1111/j.1523-1739.2005.00295.x; Rojas S, 2005, DIS AQUAT ORGAN, V63, P95, DOI 10.3354/dao063095; Ryder JJ, 2007, OIKOS, V116, P2017, DOI 10.1111/j.2007.0030-1299.15863.x; Said A, 2004, ENVIRON MANAGE, V34, P406, DOI 10.1007/s00267-004-0210-y; Schloegel LM, 2009, BIOL CONSERV, V142, P1420, DOI 10.1016/j.biocon.2009.02.007; Searle CL, 2011, P NATL ACAD SCI USA, V108, P16322, DOI 10.1073/pnas.1108490108; Seiter SA, 2011, EVOL ECOL RES, V13, P283; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Skinner JA, 1997, J ENVIRON MANAGE, V50, P111, DOI 10.1006/jema.1996.0103; Smith MA, 2005, ECOGRAPHY, V28, P110; St-Amour V, 2008, EMERG INFECT DIS, V14, P1175, DOI 10.3201/eid1407.070602; Stolyar OB, 2008, ARCH ENVIRON CON TOX, V54, P107, DOI 10.1007/s00244-007-9012-6; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tattersall GJ, 2008, BIOL REV, V83, P119, DOI 10.1111/j.1469-185X.2008.00035.x; Teacher AGF, 2010, ANIM CONSERV, V13, P514, DOI 10.1111/j.1469-1795.2010.00373.x; Teacher AGF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004616; WAUCHOPE RD, 1978, J ENVIRON QUAL, V7, P459, DOI 10.2134/jeq1978.00472425000700040001x; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zeisset I, 2010, HEREDITY, V104, P423, DOI 10.1038/hdy.2009.157	100	35	35	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127037	10.1371/journal.pone.0127037	http://dx.doi.org/10.1371/journal.pone.0127037			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039741	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700048
J	Pei, Q; Zhang, DD; Li, GD; Lee, HF				Pei, Qing; Zhang, David D.; Li, Guodong; Lee, Harry F.			Climate Change and the Macroeconomic Structure in Pre-Industrial Europe: New Evidence from Wavelet Analysis	PLOS ONE			English	Article							GRAIN MARKETS; POPULATION; INTERVENTION; TEMPERATURES; TRANSFORM; ECONOMICS; DYNAMICS; HISTORY; SIGNALS; ENGLAND	The relationship between climate change and the macroeconomy in pre-industrial Europe has attracted considerable attention in recent years. This study follows the combined paradigms of evolutionary economics and ecological economics, in which wavelet analysis (spectrum analysis and coherence analysis) is applied as the first attempt to examine the relationship between climate change and the macroeconomic structure in pre-industrial Europe in the frequency domain. Aside from confirming previous results, this study aims to further substantiate the association between climate change and macroeconomy by presenting new evidence obtained from the wavelet analysis. Our spectrum analysis shows a consistent and continuous frequency band of 60-80 years in the temperature, grain yield ratio, grain price, consumer price index, and real wage throughout the study period. Besides, coherence analysis shows that the macroeconomic structure is shaped more by climate change than population change. In addition, temperature is proven as a key climatic factor that influences the macroeconomic structure. The analysis reveals a unique frequency band of about 20 years (15-35 years) in the temperature in AD1600-1700, which could have contributed to the widespread economic crisis in pre-industrial Europe. Our findings may have indications in re-examining the Malthusian theory.	[Pei, Qing; Zhang, David D.; Lee, Harry F.] Univ Hong Kong, Dept Geog, Hong Kong, Hong Kong, Peoples R China; [Pei, Qing; Zhang, David D.; Lee, Harry F.] Univ Hong Kong, Int Ctr China Dev Study, Hong Kong, Hong Kong, Peoples R China; [Pei, Qing; Li, Guodong] Univ Hong Kong, Dept Stat & Actuarial Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Pei, Q (corresponding author), Univ Hong Kong, Dept Geog, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	peiqing618@gmail.com	Li, Guodong/A-2741-2010; Lee, Harry F./M-9979-2019	Li, Guodong/0000-0003-3137-8471; Lee, Harry F./0000-0001-5415-7845	Doris Zimmern HKU-Cambridge Hughes Hall Fellowships [2014-15]; Swiss National Fund [IZK0Z2_160400/1]; Small Project Fund of the University of Hong Kong [201409176047]; Hui Oi-Chow Trust Fund [201205172003, 201302172003]; Seed Funding Programme for Basic Research of the University of Hong Kong [201109159014]; Research Grants Council of The Government of the Hong Kong Special Administrative Region of the People's Republic of China [HKU702613P, HKU758712H, HKU745113H]; Post-doctoral Fellowship Fund from the University of Hong Kong	Doris Zimmern HKU-Cambridge Hughes Hall Fellowships; Swiss National Fund(Swiss National Science Foundation (SNSF)); Small Project Fund of the University of Hong Kong; Hui Oi-Chow Trust Fund; Seed Funding Programme for Basic Research of the University of Hong Kong(University of Hong Kong); Research Grants Council of The Government of the Hong Kong Special Administrative Region of the People's Republic of China(Hong Kong Research Grants Council); Post-doctoral Fellowship Fund from the University of Hong Kong	This work was supported by Doris Zimmern HKU-Cambridge Hughes Hall Fellowships 2014-15, Swiss National Fund for International Short Visit (grant number IZK0Z2_160400/1), Small Project Fund of the University of Hong Kong (project code 201409176047), Hui Oi-Chow Trust Fund (201205172003 and 201302172003), Seed Funding Programme for Basic Research of the University of Hong Kong (201109159014), Research Grants Council of The Government of the Hong Kong Special Administrative Region of the People's Republic of China (HKU702613P, HKU758712H and HKU745113H) and Post-doctoral Fellowship Fund from the University of Hong Kong.	Aceleanu, 2010, THEORETICAL APPL EC, V2, P123; Allen R.C., 2005, LIVING STANDARDS NEW; Allen RC, 2001, EXPLOR ECON HIST, V38, P411, DOI 10.1006/exeh.2001.0775; [Anonymous], 2020, INFECT DIS POVERTY, DOI DOI 10.1186/s40249-020-00640-3; APPLEBY AB, 1973, ECON HIST REV, V26, P403; APPLEBY AB, 1979, J ECON HIST, V39, P865, DOI 10.1017/S002205070009865X; Aston T., 1996, CRISIS EUROPE 1560 1, DOI [10.1073/pnas.1104268108, DOI 10.1073/PNAS.1104268108]; BRANDON PF, 1972, ECON HIST REV, V25, P403; BRENNER R, 1976, PAST PRESENT, P30; Buntgen U, 2011, SCIENCE, V331, P578, DOI 10.1126/science.1197175; Butlin R.A., 1993, HIST GEOGRAPHY GATES; Carsten FL, 1985, WAS THERE EC DECLINE; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; Chilosi D, 2013, EXPLOR ECON HIST, V50, P46, DOI 10.1016/j.eeh.2012.09.002; Clark G, 2007, PRINC ECON HIST W WO; Clark G, 2007, ECON HIST REV, V60, P97, DOI 10.1111/j.1468-0289.2006.00358.x; Corning PA, 1995, J SOC EVOL SYST, V18, P421, DOI 10.1016/1061-7361(95)90027-6; Costanza R., 2015, INTRO ECOLOGICAL EC; DANDO WA, 1980, GEOGRAPHY FAMINE; Davies Norman, 2001, HEART EUROPE POLANDS; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; Ewert UC, 2007, HIST SOC RES, V32, P122; Fagan B., 2000, LITTLE ICE AGE CLIMA, DOI [10.1073/pnas.1201083109, DOI 10.1073/PNAS.1201083109]; Fischer D.H., 1996, GREAT WAVE PRICE REV; Foster G, 1996, ASTRON J, V112, P1709, DOI 10.1086/118137; Foster J, 2004, APPL EVOLUTIONARY EC; Fulbrook Mary., 2004, CONCISE HIST GERMANY; Fussell GE, 1966, FARMING TECHNIQUE PR; GALLOWAY PR, 1986, POPUL DEV REV, V12, P1, DOI 10.2307/1973349; Golyandina N, 2014, COMPUT STAT DATA AN, V71, P934, DOI 10.1016/j.csda.2013.04.009; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Haldrup N, 2013, HANDB RES METH APPL, P61; Hobsbawm Eric, 1954, PAST PRESENT, V5, P33, DOI DOI 10.1093/PAST/5.1.33; Hodgson G., 1996, EC EVOLUTION BRINGIN, DOI DOI 10.3998/MPUB.14010; Hsiang SM, 2014, CLIMATIC CHANGE, V123, P39, DOI 10.1007/s10584-013-0868-3; Hubbard R.G., 2009, ECONOMICS; Kirchhefer AJ, 2001, HOLOCENE, V11, P41, DOI 10.1191/095968301670181592; Klaassen G.A., 1991, ECOL ECON, V4, P93; Kondrashov D, 2006, NONLINEAR PROC GEOPH, V13, P151, DOI 10.5194/npg-13-151-2006; Ludecke HJ, 2013, CLIM PAST, V9, P447, DOI 10.5194/cp-9-447-2013; Macdonald KI, 1998, COMP STUD SOC HIST, V40, P287; Maland D., 1983, EUROPE 17 CENTURY; Mann ME, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017814; McConnell CR, 2002, EC PRINCIPLES PROBLE; McEvedy C., 1978, ATLAS WORLD POPULATI; METCALFE JS, 1994, ECON J, V104, P931, DOI 10.2307/2234988; Mi XC, 2005, PLANT ECOL, V179, P1, DOI 10.1007/s11258-004-5089-4; MILLER DW, 1990, J SOC HIST, V24, P213, DOI 10.1353/jsh/24.1.213; Mulder P, 2001, GROWTH CHANGE, V32, P110, DOI 10.1111/0017-4815.00152; MURTON BRIAN, 2000, CAMBRIDGE WORLD HIST, V2, P1411; Osborn TJ, 2006, SCIENCE, V311, P841, DOI 10.1126/science.1120514; Otazu X, 2004, MON NOT R ASTRON SOC, V351, P215, DOI 10.1111/j.1365-2966.2004.07774.x; Ozmucur S., 2007, NEW COMP EC HIST ESS, P59; Parker Geoffrey, 2013, GLOBAL CRISIS WAR CL; Pei Q, 2013, CLIM RES, V56, P169, DOI 10.3354/cr01145; Pei Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088155; Pennington D.H., 1989, EUROPE 17 CENTURY; Persson KG, 1996, ECON HIST REV, V49, P692; Pindyck R.S., 2013, ECONOMETRIC MODELS E; Raihan S.Md., 2005, WAVELET NEW TOOL BUS; RAMSEY P, 1960, ECON HIST REV, V12, P456; Serrano EP, 1996, IEEE T SIGNAL PROCES, V44, P1270, DOI 10.1109/78.502340; Shyu HC, 2002, MULTIDIM SYST SIGN P, V13, P101, DOI 10.1023/A:1013847512432; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Turchin P, 2003, HIST DYNAMICS; van Bath B. H. Slicher, 1966, AGRARIAN CONDITIONS, P24; van Bath BHS, 1963, AAG BIJDRAGEN, P810; Van den Bergh J.C.J.M., 2007, EVOLUTIONARY EC ENV; Vries J.d., 1976, J UROLOGY, DOI [https://doi.org/10.1017/CBO9781107049772, DOI 10.1097/JU.0000000000002232]; Zhang DD, 2007, P NATL ACAD SCI USA, V104, P19214, DOI 10.1073/pnas.0703073104; Zhang DD, 2011, P NATL ACAD SCI USA, V108, P17296, DOI 10.1073/pnas.1104268108; Zhang DD, 2011, GLOBAL ECOL BIOGEOGR, V20, P520, DOI 10.1111/j.1466-8238.2010.00625.x	72	13	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126480	10.1371/journal.pone.0126480	http://dx.doi.org/10.1371/journal.pone.0126480			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7ST	26039087	gold, Green Published, Green Submitted			2022-12-27	WOS:000355700700031
J	Tropf, FC; Stulp, G; Barban, N; Visscher, PM; Yang, J; Snieder, H; Mills, MC				Tropf, Felix C.; Stulp, Gert; Barban, Nicola; Visscher, Peter M.; Yang, Jian; Snieder, Harold; Mills, Melinda C.			Human Fertility, Molecular Genetics, and Natural Selection in Modern Societies	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON SNPS EXPLAIN; 1ST BIRTH; LARGE PROPORTION; AGE; LOCI; HERITABILITY; TWIN; BEHAVIOR; DETERMINANTS	Research on genetic influences on human fertility outcomes such as number of children ever born (NEB) or the age at first childbirth (AFB) has been solely based on twin and family-designs that suffer from problematic assumptions and practical limitations. The current study exploits recent advances in the field of molecular genetics by applying the genomic-relationship-matrix based restricted maximum likelihood (GREML) methods to quantify for the first time the extent to which common genetic variants influence the NEB and the AFB of women. Using data from the UK and the Netherlands (N = 6,758), results show significant additive genetic effects on both traits explaining 10% (SE = 5) of the variance in the NEB and 15% (SE = 4) in the AFB. We further find a significant negative genetic correlation between AFB and NEB in the pooled sample of -0.62 (SE = 0.27, p-value = 0.02). This finding implies that individuals with genetic predispositions for an earlier AFB had a reproductive advantage and that natural selection operated not only in historical, but also in contemporary populations. The observed postponement in the AFB across the past century in Europe contrasts with these findings, suggesting an evolutionary override by environmental effects and underscoring that evolutionary predictions in modern human societies are not straight forward. It emphasizes the necessity for an integrative research design from the fields of genetics and social sciences in order to understand and predict fertility outcomes. Finally, our results suggest that we may be able to find genetic variants associated with human fertility when conducting GWAS-meta analyses with sufficient sample size.	[Tropf, Felix C.] Univ Groningen, ICS, Dept Sociol, Groningen, Netherlands; [Stulp, Gert] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England; [Barban, Nicola; Mills, Melinda C.] Univ Oxford, Dept Sociol, Nuffield Coll, Oxford, England; [Visscher, Peter M.; Yang, Jian] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Visscher, Peter M.; Yang, Jian] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; University of Queensland; University of Queensland; University of Groningen	Tropf, FC (corresponding author), Univ Groningen, ICS, Dept Sociol, Groningen, Netherlands.	f.tropf@rug.nl	Barban, Nicola/H-3816-2019; Visscher, Peter/ABB-6151-2020; Yang, Jian/A-5852-2010	Barban, Nicola/0000-0002-4362-4652; Visscher, Peter/0000-0002-2143-8760; Yang, Jian/0000-0003-2001-2474; Stulp, Gert/0000-0003-0173-5554	NWO (Dutch National Science Organization) (VIDI) [452-10-012]; European Research Council via an ERC Consolidator Grant SOCIOGENOME [615603]; sciencestarter.de; Wellcome Trust; European Community's Seventh Framework Programme (FP7); National Institute for Health Research (NIHR); King's College London	NWO (Dutch National Science Organization) (VIDI)(Netherlands Organization for Scientific Research (NWO)); European Research Council via an ERC Consolidator Grant SOCIOGENOME; sciencestarter.de; Wellcome Trust(Wellcome TrustEuropean Commission); European Community's Seventh Framework Programme (FP7)(European Commission); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); King's College London	The research leading to these results received funding from NWO (Dutch National Science Organization) (VIDI grant 452-10-012 to M. Mills) and the European Research Council via an ERC Consolidator Grant SOCIOGENOME (615603 awarded to M. Mills, see www.sociogenome.com). Felix C. Tropf additionally received funding from sciencestarter.de for the research visit to the University of Queensland. The TwinsUK study was funded by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013). The study also received support from the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. SNP Genotyping was performed by The Wellcome Trust Sanger Institute and National Eye Institute via NIH/CIDR.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Balbo N, 2013, EUR J POPUL, V29, P1, DOI 10.1007/s10680-012-9277-y; Benjamin DJ, 2012, P NATL ACAD SCI USA, V109, P8026, DOI 10.1073/pnas.1120666109; Bongaarts J, 2000, POPUL DEV REV, V26, P560, DOI 10.1111/j.1728-4457.2000.00560.x; Byars SG, 2010, P NATL ACAD SCI USA, V107, P1787, DOI 10.1073/pnas.0906199106; Chabris CF, 2012, PSYCHOL SCI, V23, P1314, DOI 10.1177/0956797611435528; Conley D, 2009, BIODEMOGR SOC BIOL, V55, P238, DOI 10.1080/19485560903415807; Devlin B, 1997, NATURE, V388, P468, DOI 10.1038/41319; Goodman A, 2012, P ROY SOC B-BIOL SCI, V279, P4342, DOI 10.1098/rspb.2012.1415; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; HETTEMA JM, 1995, BEHAV GENET, V25, P327, DOI 10.1007/BF02197281; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoekstra C, 2008, HUM REPROD UPDATE, V14, P37, DOI 10.1093/humupd/dmm036; Holst K, 2012, COMPUT STAT, P1; Horwitz AV, 2003, J HEALTH SOC BEHAV, V44, P111, DOI 10.2307/1519802; Joffe M, 2010, HUM REPROD, V25, P295, DOI 10.1093/humrep/dep390; Kirk KM, 2001, EVOLUTION, V55, P423; Kohler HP, 2006, INT J ANDROL, V29, P46, DOI 10.1111/j.1365-2605.2005.00606.x; Kohler HP, 2003, OFFSPRING, P46; Kohler HP, 2002, SOC BIOL, V49, P218; Kohler HP, 1999, POPUL DEV REV, V25, P253, DOI 10.1111/j.1728-4457.1999.00253.x; Komlos J, 2007, ANN HUM BIOL, V34, P206, DOI 10.1080/03014460601116803; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Leridon H, 2008, POP STUD-J DEMOG, V62, P15, DOI 10.1080/00324720701804207; Liu YZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000420; Lynch M, 1998, GENETICS AND ANALYSI; Melinda Mills, 2011, INTRODUCING SURVIVAL; MILLER WB, 1994, J APPL SOC PSYCHOL, V24, P218, DOI 10.1111/j.1559-1816.1994.tb00580.x; Mills M, 2011, HUM REPROD UPDATE, V17, P848, DOI 10.1093/humupd/dmr026; Milot E, 2011, P NATL ACAD SCI USA, V108, P17040, DOI 10.1073/pnas.1104210108; Moayyeri A, 2013, INT J EPIDEMIOL, V42, P76, DOI 10.1093/ije/dyr207; Montgomery GW, 2014, MOL HUM REPROD, V20, P1, DOI 10.1093/molehr/gat058; Morrissey MB, 2010, J EVOLUTION BIOL, V23, P2277, DOI 10.1111/j.1420-9101.2010.02084.x; Murphy M, 1999, SOC BIOL, V46, P122; Neiss M, 2002, J BIOSOC SCI, V34, P259, DOI 10.1017/S0021932002002596; Nisen J, 2013, DEMOGRAPHY, V50, P1399, DOI 10.1007/s13524-012-0186-9; Painter JN, 2011, NAT GENET, V43, P51, DOI 10.1038/ng.731; Perry JRB, 2009, NAT GENET, V41, P648, DOI 10.1038/ng.386; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Rietveld CA, 2013, P NATL ACAD SCI USA, V110, P9692, DOI 10.1073/pnas.1222171110; Rijken A, 2009, POP STUD-J DEMOG, V63, P71, DOI 10.1080/00324720802621575; Rodgers JL, 2001, DEMOGRAPHY, V38, P29, DOI 10.2307/3088286; Rodgers JL, 2008, AM J SOCIOL, V114, pS202, DOI 10.1086/592205; Snieder H, 2010, ENCYCLOPEDIA OF LIFE; Snijders T.A.B., 2011, MULTILEVEL ANALYSIS; Sobotka T, 2004, POPUL DEV REV, V30, P195, DOI 10.1111/j.1728-4457.2004.010_1.x; Stearns SC, 2010, NAT REV GENET, V11, P611, DOI 10.1038/nrg2831; Steckel RH, 1995, J ECON LIT, V33, P1903; Steenhof L, 2008, POP STUD-J DEMOG, V62, P69, DOI 10.1080/00324720701788616; Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051; Stolk L, 2009, NAT GENET, V41, P645, DOI 10.1038/ng.387; Stulp G, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0211; Stulp G, 2012, AM J HUM BIOL, V24, P486, DOI 10.1002/ajhb.22252; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; van den Oord EJCG, 2002, BEHAV GENET, V32, P1, DOI 10.1023/A:1014474711118; VANDEKAA DJ, 1987, POPUL BULL, V42, P1; Verduijn M, 2010, NEPHROL DIAL TRANSPL, V25, P1394, DOI 10.1093/ndt/gfq098; Vinkhuyzen AAE, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.27; Vinkhuyzen AAE, 2013, ANNU REV GENET, V47, P75, DOI 10.1146/annurev-genet-111212-133258; Visscher PM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004269; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Visscher PM, 2010, TWIN RES HUM GENET, V13, P517, DOI 10.1375/twin.13.6.517; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520; Zietsch BP, 2014, P NATL ACAD SCI USA, V111, P1032, DOI 10.1073/pnas.1310058111	69	54	54	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126821	10.1371/journal.pone.0126821	http://dx.doi.org/10.1371/journal.pone.0126821			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7ST	26039877	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000355700700038
J	Leroy, P; Tham, A; Wong, H; Tenney, R; Chen, C; Stiner, R; Balmes, JR; Paquet, AC; Arjomandi, M				Leroy, Pascale; Tham, Andrea; Wong, Hofer; Tenney, Rachel; Chen, Chun; Stiner, Rachel; Balmes, John R.; Paquet, Agnes C.; Arjomandi, Mehrdad			Inflammatory and Repair Pathways Induced in Human Bronchoalveolar Lavage Cells with Ozone Inhalation	PLOS ONE			English	Article							AIRWAY INFLAMMATION; EPITHELIAL INJURY; CROSS-LINKING; IN-VITRO; OSTEOPONTIN; LUNG; EXPOSURE; EXPRESSION; SECRETION; INCREASES	Background Inhalation of ambient levels of ozone causes airway inflammation and epithelial injury. Methods To examine the responses of airway cells to ozone-induced oxidative injury, 19 subjects (7 with asthma) were exposed to clean air (0ppb), medium (100ppb), and high (200ppb) ambient levels of ozone for 4h on three separate occasions in a climate-controlled chamber followed by bronchoscopy with bronchoalveolar lavage (BAL) 24h later. BAL cell mRNA expression was examined using Affymetrix GeneChip Microarray. The role of a differentially expressed gene (DEG) in epithelial injury was evaluated in an in vitro model of injury [16HBE14o-cell line scratch assay]. Results Ozone exposure caused a dose-dependent up-regulation of several biologic pathways involved in inflammation and repair including chemokine and cytokine secretion, activity, and receptor binding; metalloproteinase and endopeptidase activity; adhesion, locomotion, and migration; and cell growth and tumorigenesis regulation. Asthmatic subjects had 1.7- to 3.8-fold higher expression of many DEGs suggestive of increased proinflammatory and matrix degradation and remodeling signals. The most highly up-regulated gene was osteopontin, the protein level of which in BAL fluid increased in a dose-dependent manner after ozone exposure. Asthmatic subjects had a disproportionate increase in non-polymerized osteopontin with increasing exposure to ozone. Treatment with polymeric, but not monomeric, osteopontin enhanced the migration of epithelial cells and wound closure in an alpha 9 beta 1 integrin-dependent manner. Conclusions Expression profiling of BAL cells after ozone exposure reveals potential regulatory genes and pathways activated by oxidative stress. One DEG, osteopontin, promotes epithelial wound healing in an in vitro model of injury.	[Leroy, Pascale; Tham, Andrea; Tenney, Rachel; Stiner, Rachel; Arjomandi, Mehrdad] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Wong, Hofer; Balmes, John R.; Arjomandi, Mehrdad] Univ Calif San Francisco, Div Occupat & Environm Med, Human Exposure Lab, San Francisco, CA 94143 USA; [Wong, Hofer; Balmes, John R.; Arjomandi, Mehrdad] Univ Calif San Francisco, Div Pulm Crit Care Allergy & Immunol & Sleep Med, San Francisco, CA 94143 USA; [Chen, Chun] Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA 94143 USA; [Balmes, John R.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Paquet, Agnes C.] CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Arjomandi, M (corresponding author), San Francisco VA Med Ctr, San Francisco, CA 94121 USA.	mehrdad.arjomandi@ucsf.edu	Balmes, John/L-6281-2019; Arjomandi, Mehrdad/ABB-4327-2021	Arjomandi, Mehrdad/0000-0002-0116-9217	National Institute of Health/NHLBI [K23 HL083099]; Stromedix, Inc.; Five Prime Therapeutics, Inc.; National Institute of Health/NCRR/OD UCSF-CTSI [KL2 RR024130, UL1 RR024131]; California Air Resources Board (CARB) [04-322]; Northern California Institute for Research and Education; University of California San Francisco Cardiovascular Research Institute Faculty Development Funds; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131, KL2RR024130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL083099] Funding Source: NIH RePORTER	National Institute of Health/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Stromedix, Inc.; Five Prime Therapeutics, Inc.; National Institute of Health/NCRR/OD UCSF-CTSI; California Air Resources Board (CARB); Northern California Institute for Research and Education; University of California San Francisco Cardiovascular Research Institute Faculty Development Funds; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by: 1) National Institute of Health/NHLBI K23 HL083099 (Arjomandi); 2) Stromedix, Inc. unrestricted research gift (Arjomandi); 3) Five Prime Therapeutics, Inc. investigator-initiated grant (Arjomandi); 4) National Institute of Health/NCRR/OD UCSF-CTSI Grant Number KL2 RR024130 and UL1 RR024131; 5) California Air Resources Board (CARB Contract # 04-322; Balmes); 6) Northern California Institute for Research and Education (Arjomandi); and 7) University of California San Francisco Cardiovascular Research Institute Faculty Development Funds (Arjomandi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjomandi M, 2005, AM J RESP CRIT CARE, V172, P427, DOI 10.1164/rccm.200502-272OC; Arjomandi M, 2005, CHEST, V128, P416, DOI 10.1378/chest.128.1.416; Arjomandi M, 2005, P AM THORACIC SOC, P50; Arjomandi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025678; Balmes J R, 1997, Res Rep Health Eff Inst, P1; BENINATI S, 1994, J BIOCHEM-TOKYO, V115, P675, DOI 10.1093/oxfordjournals.jbchem.a124395; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berman JS, 2004, AM J PHYSIOL-LUNG C, V286, pL1311, DOI 10.1152/ajplung.00394.2003; CASTLEMAN WL, 1980, AM J PATHOL, V98, P811; Chen C, 2006, MUTAGENESIS, V21, P131, DOI 10.1093/mutage/gel007; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; Chen C, 2007, ENVIRON HEALTH PERSP, V115, P1732, DOI 10.1289/ehp.10294; Christian DL, 1998, AM J RESP CRIT CARE, V158, P532, DOI 10.1164/ajrccm.158.2.9709023; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Damera G, 2009, AM J PHYSIOL-LUNG C, V296, pL674, DOI 10.1152/ajplung.90585.2008; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Devlin RB, 1996, TOXICOL APPL PHARM, V138, P176, DOI 10.1006/taap.1996.0111; DEVLIN RB, 1991, AM J RESP CELL MOL, V4, P72, DOI 10.1165/ajrcmb/4.1.72; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Frampton Mark W, 2004, Res Rep Health Eff Inst, P1; Frampton MW, 1997, RES REP HLTH EFF I, V78, P81; Gabehart K, 2014, TOXICOL SCI, V138, P175, DOI 10.1093/toxsci/kft276; GINA, 2012, GLOB IN ASTHM GLOB S; Gohil K, 2003, BIOCHEM BIOPH RES CO, V305, P719, DOI 10.1016/S0006-291X(03)00815-5; Hernandez M, 2012, J ALLERGY CLIN IMMUN, V129, P259, DOI 10.1016/j.jaci.2011.11.007; Hiraiwa K, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/619523; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; HYDE DM, 1992, AM J RESP CELL MOL, V6, P481, DOI 10.1165/ajrcmb/6.5.481; Kaartinen MT, 1999, J BIOL CHEM, V274, P1729, DOI 10.1074/jbc.274.3.1729; KANNER RE, 1994, AM J RESP CRIT CARE, V150, P956, DOI 10.1164/ajrccm.150.4.7921469; Kim CS, 2011, AM J RESP CRIT CARE, V183, P1215, DOI 10.1164/rccm.201011-1813OC; KOREN HS, 1989, AM REV RESPIR DIS, V139, P407, DOI 10.1164/ajrccm/139.2.407; Lee Mei-Ling Ting, 2002, J Biopharm Stat, V12, P1, DOI 10.1081/BIP-120005737; LEIKAUF GD, 1995, ENVIRON HEALTH PERSP, V103, P91, DOI 10.2307/3432455; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liard R, 2000, EUR RESPIR J, V16, P615, DOI 10.1034/j.1399-3003.2000.16d08.x; Liaw L, 1998, J CLIN INVEST, V101, P1468; McKee MD, 2011, CELLS TISSUES ORGANS, V194, P313, DOI 10.1159/000324244; Mills NL, 2005, CIRCULATION, V112, P3930, DOI 10.1161/CIRCULATIONAHA.105.588962; Mudway IS, 2004, AM J RESP CRIT CARE, V169, P1089, DOI 10.1164/rccm.200309-1325PP; Myers DL, 2003, ARTERIOSCL THROM VAS, V23, P1021, DOI 10.1161/01.ATV.0000073312.34450.16; Nadadur SS, 2005, ENVIRON HEALTH PERSP, V113, P1717, DOI 10.1289/ehp.7413; Nishimichi N, 2011, J BIOL CHEM, V286, P11170, DOI 10.1074/jbc.M110.189258; Nishimichi N, 2009, J BIOL CHEM, V284, P14769, DOI 10.1074/jbc.M901515200; O'Regan A, 2003, CYTOKINE GROWTH F R, V14, P479, DOI 10.1016/S1359-6101(03)00055-8; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pepe MS, 2003, BIOMETRICS, V59, P133, DOI 10.1111/1541-0420.00016; PINO MV, 1992, TOXICOL APPL PHARM, V112, P64, DOI 10.1016/0041-008X(92)90280-6; SHASBY DM, 1982, J APPL PHYSIOL, V52, P1237, DOI 10.1152/jappl.1982.52.5.1237; STEPHENS RJ, 1974, AM J PATHOL, V74, P31; Tavakoli S, 2001, AM J PHYSIOL-LUNG C, V280, pL127, DOI 10.1152/ajplung.2001.280.1.L127; Two-Group Comparisons with Permutation Analysis for Differential Expression (PADE), 2005, 2 GROUP COMP PERMUTA; Vasu VT, 2010, INHAL TOXICOL, V22, P1, DOI 10.3109/08958370902838145; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Woodruff PG, 2005, AM J RESP CRIT CARE, V172, P1383, DOI 10.1164/rccm.200505-686OC	58	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0127283	10.1371/journal.pone.0127283	http://dx.doi.org/10.1371/journal.pone.0127283			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035830	Green Submitted, Green Published, gold			2022-12-27	WOS:000355699100010
J	Islam, R; Jackson, C; Eidet, JR; Messelt, EB; Corraya, RM; Lyberg, T; Griffith, M; Dartt, DA; Utheim, TP				Islam, Rakibul; Jackson, Catherine; Eidet, Jon R.; Messelt, Edward B.; Corraya, Rima Maria; Lyberg, Torstein; Griffith, May; Dartt, Darlene A.; Utheim, Tor P.			Effect of Storage Temperature on Structure and Function of Cultured Human Oral Keratinocytes	PLOS ONE			English	Article							LIMBAL EPITHELIAL-CELLS; CORNEAL EPITHELIUM; STEM-CELLS; ORGAN-CULTURE; TRANSPLANTATION; EXPRESSION; APOPTOSIS; THERAPY; RECONSTRUCTION; PROLIFERATION	Purpose/Aims To assess the effect of storage temperature on the viability, phenotype, metabolism, and morphology of cultured human oral keratinocytes (HOK). Materials and Methods Cultured HOK cells were stored in HEPES- and sodium bicarbonate-buffered Minimum Essential Medium (MEM) at nine temperatures in approximately 4 degrees C increments from 4 degrees C to 37 degrees C for seven days. Cells were characterized for viability by calcein fluorescence, phenotype retention by immunocytochemistry, metabolic parameters (pH, glucose, lactate, and O-2) within the storage medium by blood gas analysis, and morphology by scanning electron microscopy and light microscopy. Results Relative to the cultured, but non-stored control cells, a high percentage of viable cells were retained only in the 12 degrees C and 16 degrees C storage groups (85%+/- 13% and 68%+/- 10%, respectively). Expression of ABCG2, Bmi1, C/EBP delta, PCNA, cytokeratin 18, and caspase-3 were preserved after storage in the 5 groups between 4 degrees C and 20 degrees C, compared to the non-stored control. Glucose, pH and pO(2) in the storage medium declined, whereas lactate increased with increasing storage temperature. Morphology was best preserved following storage of the three groups between 12 degrees C, 16 degrees C, and 20 degrees C. Conclusion We conclude that storage temperatures of 12 degrees C and 16 degrees C were optimal for maintenance of cell viability, phenotype, and morphology of cultured HOK. The storage method described in the present study may be applicable for other cell types and tissues; thus its significance may extend beyond HOK and the field of ophthalmology.	[Islam, Rakibul; Messelt, Edward B.; Utheim, Tor P.] Univ Oslo, Fac Dent, Dept Oral Biol, Oslo, Norway; [Islam, Rakibul; Jackson, Catherine; Eidet, Jon R.; Corraya, Rima Maria; Lyberg, Torstein; Utheim, Tor P.] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Griffith, May] Linkoping Univ, Dept Clin & Expt Med, Integrat Regenerat Med Ctr, Linkoping, Sweden; [Islam, Rakibul; Corraya, Rima Maria; Dartt, Darlene A.; Utheim, Tor P.] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst,Massachusetts Eye & Ear, Boston, MA USA	University of Oslo; University of Oslo; Linkoping University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Islam, R (corresponding author), Univ Oslo, Fac Dent, Dept Oral Biol, Oslo, Norway.	rakibul.lubikar@gmail.com		Jackson, Catherine/0000-0001-9683-2343; Islam, Rakibul/0000-0002-7174-9225; Griffith, May/0000-0003-1222-6720	Department of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway [5142001]; NATIONAL EYE INSTITUTE [R01EY019470] Funding Source: NIH RePORTER	Department of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Grant number 5142001, Department of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway (RI).	Ahmad S, 2010, J CELL PHYSIOL, V225, P15, DOI 10.1002/jcp.22251; Armitage WJ, 2009, DEV OPHTHALMOL, V43, P63, DOI 10.1159/000223839; Barbaro V, 2007, J CELL BIOL, V177, P1037, DOI 10.1083/jcb.200703003; BATES RC, 1994, J CELL BIOL, V125, P403, DOI 10.1083/jcb.125.2.403; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Daniels JT, 2006, REGEN MED, V1, P715, DOI 10.2217/17460751.1.5.715; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; Di Girolamo N, 2009, TRANSPLANTATION, V87, P1571, DOI 10.1097/TP.0b013e3181a4bbf2; Dua HS, 2005, BRIT J OPHTHALMOL, V89, P529, DOI 10.1136/bjo.2004.049742; Eidet JR, 2012, EXP EYE RES, V94, P109, DOI 10.1016/j.exer.2011.11.015; Eidet JR, 2014, CURR EYE RES, DOI 10.3109/02713683.2014.909497; Garzon I, 2009, J PERIODONTAL RES, V44, P588, DOI 10.1111/j.1600-0765.2008.01159.x; HALL PA, 1990, J PATHOL, V162, P285, DOI 10.1002/path.1711620403; HJORTDAL JO, 1989, ACTA OPHTHALMOL, V67, P295; Jackson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105808; Laidler K J, 1979, Methods Enzymol, V63, P234; Lee EJ, 2005, CRYOBIOLOGY, V50, P103, DOI 10.1016/j.cryobiol.2004.12.001; LINDEN MD, 1992, AM J CLIN PATHOL, V97, pS4; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; Metcalfe A, 1997, BIOESSAYS, V19, P711, DOI 10.1002/bies.950190812; Nakamura T, 2004, BRIT J OPHTHALMOL, V88, P1280, DOI 10.1136/bjo.2003.038497; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; O'Callaghan AR, 2011, STEM CELLS, V29, P1923, DOI 10.1002/stem.756; Pasovic L, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/216359; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; POOLE CA, 1993, J CELL SCI, V106, P685; Raeder S, 2007, INVEST OPHTH VIS SCI, V48, P5484, DOI 10.1167/iovs.07-0494; Raeder S, 2007, ACTA OPHTHALMOL SCAN, V85, P377, DOI 10.1111/j.1600-0420.2006.00873.x; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; REIM M, 1988, GRAEF ARCH CLIN EXP, V226, P353, DOI 10.1007/BF02172966; Rieder CL, 2002, CELL CYCLE, V1, P169, DOI 10.4161/cc.1.3.119; Slikker W, 2001, FREE RADICAL BIO MED, V31, P405, DOI 10.1016/S0891-5849(01)00593-7; Utheim TP, 2009, BRIT J OPHTHALMOL, V93, P980, DOI 10.1136/bjo.2008.149591; Utheim TP, 2007, BRIT J OPHTHALMOL, V91, P797, DOI 10.1136/bjo.2006.103218; Utheim Tor Paaske, 2013, Methods Mol Biol, V1014, P3, DOI 10.1007/978-1-62703-432-6_1	35	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128306	10.1371/journal.pone.0128306	http://dx.doi.org/10.1371/journal.pone.0128306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052937	Green Published, gold, Green Submitted			2022-12-27	WOS:000355955300031
J	Hiroshima, Y; Zhang, Y; Zhao, M; Zhang, N; Murakami, T; Maawy, A; Mii, S; Uehara, F; Yamamoto, M; Miwa, S; Yano, S; Momiyama, M; Mori, R; Matsuyama, R; Chishima, T; Tanaka, K; Ichikawa, Y; Bouvet, M; Endo, I; Hoffman, RM				Hiroshima, Yukihiko; Zhang, Yong; Zhao, Ming; Zhang, Nan; Murakami, Takashi; Maawy, Ali; Mii, Sumiyuki; Uehara, Fuminari; Yamamoto, Mako; Miwa, Shinji; Yano, Shuya; Momiyama, Masashi; Mori, Ryutaro; Matsuyama, Ryusei; Chishima, Takashi; Tanaka, Kuniya; Ichikawa, Yasushi; Bouvet, Michael; Endo, Itaru; Hoffman, Robert M.			Tumor-Targeting Salmonella typhimurium A1-R in Combination with Trastuzumab Eradicates HER-2-Positive Cervical Cancer Cells in Patient-Derived Mouse Models	PLOS ONE			English	Article							HUMAN PANCREATIC-CANCER; NUDE-MICE; LUNG METASTASIS; UTERINE CERVIX; BREAST-CANCER; CARCINOMA; EFFICACY; CHEMOTHERAPY; THERAPY; SPECIMENS	We have previously developed mouse models of HER-2-positive cervical cancer. Tumors in nude mice had histological structures similar to the original tumor and were stained by anti-HER-2 antibody in the same pattern as the patient's cancer. We have also previously developed tumor-targeting Salmonella typhimurium A1-R and have demonstrated its efficacy against patient-derived tumor mouse models, both alone and in combination. In the current study, we determined the efficacy of S. typhimurium A1-R in combination with trastuzumab on a patient-cancer nude-mouse model of HER-2 positive cervical cancer. Mice were randomized to 5 groups and treated as follows: (1) no treatment; (2) carboplatinum (30 mg/kg, ip, weekly, 5 weeks); (3) trastuzumab (20 mg/kg, ip, weekly, 5 weeks); (4) S. typhimurium A1-R (5 x 10(7) CFU/body, ip, weekly, 5 weeks); (5) S. typhimurium A1-R (5 x 10(7) CFU/body, ip, weekly, 5 weeks) + trastuzumab (20 mg/kg, ip, weekly, 5 weeks). All regimens had significant efficacy compared to the untreated mice. The relative tumor volume of S. typhimurium A1-R + trastuzumab-treated mice was smaller compared to trastuzumab alone (p = 0.007) and S. typhimurium A1-R alone (p = 0.039). No significant body weight loss was found compared to the no treatment group except for carboplatinum-treated mice (p = 0.021). Upon histological examination, viable tumor cells were not detected, and replaced by stromal cells in the tumors treated with S. typhimurium A1-R + trastuzumab. The results of the present study suggest that S. typhimurium A1-R and trastuzumab in combination are highly effective against HER-2-expressing cervical cancer.	[Hiroshima, Yukihiko; Zhang, Yong; Zhao, Ming; Zhang, Nan; Mii, Sumiyuki; Uehara, Fuminari; Yamamoto, Mako; Miwa, Shinji; Yano, Shuya; Hoffman, Robert M.] AntiCanc Inc, San Diego, CA 92111 USA; [Hiroshima, Yukihiko; Maawy, Ali; Mii, Sumiyuki; Uehara, Fuminari; Yamamoto, Mako; Miwa, Shinji; Yano, Shuya; Bouvet, Michael; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Hiroshima, Yukihiko; Murakami, Takashi; Momiyama, Masashi; Mori, Ryutaro; Matsuyama, Ryusei; Chishima, Takashi; Tanaka, Kuniya; Ichikawa, Yasushi; Endo, Itaru] Yokohama City Univ, Dept Surg Gastroenterol, Grad Sch Med, Yokohama, Kanagawa 232, Japan	AntiCancer, Inc.; University of California System; University of California San Diego; Yokohama City University	Hoffman, RM (corresponding author), AntiCanc Inc, San Diego, CA 92111 USA.	all@anticancer.com	Miwa, Shinji/AAI-9309-2020; Yano, Shuya/AAL-8028-2020	Miwa, Shinji/0000-0002-5962-8287; UEHARA, FUMINARI/0000-0001-6567-2113; Murakami, Takashi/0000-0002-9429-5705	National Cancer Institute [CA CA132971, CA142669]; JSPS KAKENHI [26830081, 26462070, 24592009]; NATIONAL CANCER INSTITUTE [R01CA142669, R01CA132971] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by National Cancer Institute grant numbers CA CA132971 and CA142669 and JSPS KAKENHI grant numbers 26830081 to YH, 26462070 to IE and 24592009 to KT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Costa MJ, 1995, AM J CLIN PATHOL, V104, P634; EVANS DB, 1992, ARCH SURG-CHICAGO, V127, P1335; Fu X, 1993, ANTICANCER RES, V25, P283; FU XY, 1993, ANTICANCER RES, V13, P901; FU XY, 1992, P NATL ACAD SCI USA, V89, P5645, DOI 10.1073/pnas.89.12.5645; FU XY, 1991, P NATL ACAD SCI USA, V88, P9345, DOI 10.1073/pnas.88.20.9345; FURUKAWA T, 1993, INT J CANCER, V53, P608, DOI 10.1002/ijc.2910530414; Gamez RG, 2009, DIAGN CYTOPATHOL, V37, P381, DOI 10.1002/dc.21027; Gros SJ, 2010, MOL CANCER THER, V9, P2037, DOI 10.1158/1535-7163.MCT-10-0209; Hashimoto K, 2011, EUR J OBSTET GYN R B, V159, P394, DOI 10.1016/j.ejogrb.2011.07.001; Hayashi K, 2009, J CELL BIOCHEM, V106, P992, DOI 10.1002/jcb.22078; Hayashi K, 2009, CELL CYCLE, V8, P870, DOI 10.4161/cc.8.6.7891; Hiroshima Y, PLOS ONE IN PRESS; Hiroshima Y, 2014, J CELL BIOCHEM, V115, P1254, DOI 10.1002/jcb.24769; Hiroshima Y, 2013, CELL CYCLE, V12, P2774, DOI 10.4161/cc.25872; KIHANA T, 1994, CANCER, V73, P148, DOI 10.1002/1097-0142(19940101)73:1<148::AID-CNCR2820730125>3.0.CO;2-C; Kimura H, 2010, CELL PROLIFERAT, V43, P41, DOI 10.1111/j.1365-2184.2009.00652.x; Matsumoto Y, 2014, J CELL BIOCHEM, V115, P1996, DOI 10.1002/jcb.24871; Miwa S, 2014, ONCOTARGET, V5, P12849, DOI 10.18632/oncotarget.2561; Momiyama M, 2012, CELL CYCLE, V11, P628, DOI 10.4161/cc.11.3.19116; Nagakura C, 2009, ANTICANCER RES, V29, P1873; Sabatier R, 2012, CASE REP ONCOL, V5, P464, DOI 10.1159/000342255; Wang CW, 2009, AM J CLIN PATHOL, V131, P715, DOI 10.1309/AJCPTPBC6V5KUITM; WANG XO, 1992, INT J CANCER, V51, P992; Yam C, 2010, J SURG RES, V164, P248, DOI 10.1016/j.jss.2009.02.023; Yan M, 2014, CANCER TREAT REV, V40, P770, DOI 10.1016/j.ctrv.2014.02.008; Yano S, 2014, CELL CYCLE, V13, P3958, DOI 10.4161/15384101.2014.964115; Zhang Y, 2012, ANTICANCER RES, V32, P2501; Zhao M, 2005, P NATL ACAD SCI USA, V102, P755, DOI 10.1073/pnas.0408422102; Zhao M, 2007, P NATL ACAD SCI USA, V104, P10170, DOI 10.1073/pnas.0703867104; Zhao M, 2006, CANCER RES, V66, P7647, DOI 10.1158/0008-5472.CAN-06-0716; Zhao M, 2012, CELL CYCLE, V11, P187, DOI 10.4161/cc.11.1.18667	32	44	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0120358	10.1371/journal.pone.0120358	http://dx.doi.org/10.1371/journal.pone.0120358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047477	gold, Green Published, Green Submitted			2022-12-27	WOS:000355652200001
J	Perera, OP; Shelby, KS; Popham, HJR; Gould, F; Adang, MJ; Jurat-Fuentes, JL				Perera, Omaththage P.; Shelby, Kent S.; Popham, Holly J. R.; Gould, Fred; Adang, Michael J.; Jurat-Fuentes, Juan Luis			Generation of a Transcriptome in a Model Lepidopteran Pest, Heliothis virescens, Using Multiple Sequencing Strategies for Profiling Midgut Gene Expression	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS CRY1A; ALKALINE-PHOSPHATASE CDNA; AMINOPEPTIDASE-N; BINDING-PROTEINS; COTTON BOLLWORM; DESERT LOCUST; INNATE IMMUNE; RNA-SEQ; INSECT; RESISTANCE	Heliothine pests such as the tobacco budworm, Heliothis virescens (F.), pose a significant threat to production of a variety of crops and ornamental plants and are models for developmental and physiological studies. The efforts to develop new control measures for H. virescens, as well as its use as a relevant biological model, are hampered by a lack of molecular resources. The present work demonstrates the utility of next-generation sequencing technologies for rapid molecular resource generation from this species for which lacks a sequenced genome. In order to amass a de novo transcriptome for this moth, transcript sequences generated from Illumina, Roche 454, and Sanger sequencing platforms were merged into a single de novo transcriptome assembly. This pooling strategy allowed a thorough sampling of transcripts produced under diverse environmental conditions, developmental stages, tissues, and infections with entomopathogens used for biological control, to provide the most complete transcriptome to date for this species. Over 138 million reads from the three platforms were assembled into the final set of 63,648 contigs. Of these, 29,978 had significant BLAST scores indicating orthologous relationships to transcripts of other insect species, with the top-hit species being the monarch butterfly (Danaus plexippus) and silkworm (Bombyx mori). Among identified H. virescens orthologs were immune effectors, signal transduction pathways, olfactory receptors, hormone biosynthetic pathways, peptide hormones and their receptors, digestive enzymes, and insecticide resistancgenomics and for new biological experimentation needed to develop efficient control efforts for this and related Noctuid pest moths.e enzymes. As an example, we demonstrate the utility of this transcriptomic resource to study gene expression profiling of larval midguts and detect transcripts of putative Bacillus thuringiensis (Bt) Cry toxin receptors. The substantial molecular resources described in this study will facilitate development of H. virescens as a relevant biological model for functional	[Perera, Omaththage P.] ARS, Southern Insect Management Res Unit, USDA, Stoneville, MS 38776 USA; [Shelby, Kent S.; Popham, Holly J. R.] ARS, USDA, Biol Control Insects Res Lab, Columbia, MO 65203 USA; [Gould, Fred] N Carolina State Univ, Dept Entomol, Raleigh, NC 27607 USA; [Adang, Michael J.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Jurat-Fuentes, Juan Luis] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37996 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; University of North Carolina; North Carolina State University; University System of Georgia; University of Georgia; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Perera, OP (corresponding author), ARS, Southern Insect Management Res Unit, USDA, Stoneville, MS 38776 USA.	OP.Perera@ars.usda.gov	; Shelby, Kent/E-1605-2011	Jurat-Fuentes, Juan Luis/0000-0002-8945-1814; Shelby, Kent/0000-0001-9859-3497	U. S. Department of Agriculture under National Research Initiative Award [2004-35607-19935]; U. S. Department of Agriculture under Biotechnology Risk Assessment Grant [2008-03046]	U. S. Department of Agriculture under National Research Initiative Award; U. S. Department of Agriculture under Biotechnology Risk Assessment Grant	This work was partially supported by the U. S. Department of Agriculture under National Research Initiative Award No. 2004-35607-19935 to M.J.A. and J.L.J.-F., and Biotechnology Risk Assessment Grant Award No. 2008-03046 to J.L.J.-F. and O.P.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adang MJ, 2014, ADV INSECT PHYSIOL, V47, P39, DOI 10.1016/B978-0-12-800197-4.00002-6; Albernaz KC, 2012, B ENTOMOL RES, V102, P333, DOI 10.1017/S0007485311000678; Aronstein K., 2011, RNA PROCESSING, P157, DOI [10.5772/19768, DOI 10.5772/19768]; Atsumi S, 2012, P NATL ACAD SCI USA, V109, pE1591, DOI 10.1073/pnas.1120698109; Bachman PM, 2013, TRANSGENIC RES, V22, P1207, DOI 10.1007/s11248-013-9716-5; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; Banks DJ, 2003, INSECT BIOCHEM MOLEC, V33, P499, DOI 10.1016/S0965-1748(03)00022-5; Banks DJ, 2001, INSECT BIOCHEM MOLEC, V31, P909, DOI 10.1016/S0965-1748(01)00038-8; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Baxter SW, 2011, GENETICS, V189, P675, DOI 10.1534/genetics.111.130971; Bel Y, 2009, INSECT BIOCHEM MOLEC, V39, P218, DOI 10.1016/j.ibmb.2008.11.005; Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Breitenbach JE, 2013, ARCH VIROL, V158, P1517, DOI 10.1007/s00705-013-1640-8; Breitenbach JE, 2011, VIRUSES-BASEL, V3, P2047, DOI 10.3390/v3112047; Brito LO, 2001, COMP BIOCHEM PHYS B, V128, P365, DOI 10.1016/S1096-4959(00)00325-0; Cabrera AR, 2011, J INSECT PHYSIOL, V57, P52, DOI 10.1016/j.jinsphys.2010.09.006; Celorio-Mancera MD, 2012, ENTOMOL EXP APPL, V144, P123, DOI 10.1111/j.1570-7458.2012.01249.x; Celorio-Mancera MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026676; Chan QWT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-387; Cho S, 2008, SYST ENTOMOL, V33, P581, DOI 10.1111/j.1365-3113.2008.00427.x; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Clem RJ, 2010, INSECT VIROLOGY, P389; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Crava CM, 2013, INSECT BIOCHEM MOLEC, V43, P924, DOI 10.1016/j.ibmb.2013.07.009; Denolf P, 1997, EUR J BIOCHEM, V248, P748, DOI 10.1111/j.1432-1033.1997.t01-1-00748.x; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Fabrick JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097900; Falabella P, 2012, INSECT BIOCHEM MOLEC, V42, P203, DOI 10.1016/j.ibmb.2011.11.011; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; GILL SS, 1995, J BIOL CHEM, V270, P27277, DOI 10.1074/jbc.270.45.27277; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Govind G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008735; Groot AT, 2013, MOL ECOL, V22, P1065, DOI 10.1111/mec.12171; Groot AT, 2011, MOL ECOL, V20, P2676, DOI 10.1111/j.1365-294X.2011.05129.x; Groot AT, 2009, INSECT BIOCHEM MOLEC, V39, P568, DOI 10.1016/j.ibmb.2009.05.002; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Hahn DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-234; Heckel DG, 1998, PHILOS T ROY SOC B, V353, P1713, DOI 10.1098/rstb.1998.0323; Honeybee Genome Sequencing Consortium, 2007, NATURE, V443, P931; Hoover K, 2000, J INSECT PHYSIOL, V46, P999, DOI 10.1016/S0022-1910(99)00211-5; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hunter W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001160; Itoh M, 1999, INSECT BIOCHEM MOLEC, V29, P121, DOI 10.1016/S0965-1748(98)00115-5; ITOH M, 1991, BIOCHIM BIOPHYS ACTA, V1129, P135, DOI 10.1016/0167-4781(91)90229-F; Jiang H, 2010, INVERTEBRATE IMMUNIT, P163; JOHNSTON KA, 1995, INSECT BIOCHEM MOLEC, V25, P375, DOI 10.1016/0965-1748(94)00077-U; Jurat-Fuentes JL, 2004, BIOCHEMISTRY-US, V43, P14299, DOI 10.1021/bi048500i; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; Jurat-Fuentes JL, 2007, J INVERTEBR PATHOL, V95, P187, DOI 10.1016/j.jip.2007.01.008; Jurat-Fuentes JL, 2006, J INVERTEBR PATHOL, V92, P166, DOI 10.1016/j.jip.2006.01.010; Jurat-Fuentes JL, 2006, BIOCHEMISTRY-US, V45, P9688, DOI 10.1021/bi0606703; Jurat-Fuentes JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017606; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Kirkpatrick BA, 1998, J INVERTEBR PATHOL, V72, P63, DOI 10.1006/jipa.1997.4752; KLOCKE JA, 1982, J INSECT PHYSIOL, V28, P911, DOI 10.1016/0022-1910(82)90106-8; Krishnamoorthy M, 2007, INSECT BIOCHEM MOLEC, V37, P189, DOI 10.1016/j.ibmb.2006.10.004; KRUEGER CM, 1993, FLA ENTOMOL, V76, P382, DOI 10.2307/3495738; Loeb MJ, 2001, ARCH INSECT BIOCHEM, V47, P181, DOI 10.1002/arch.1050; Luo K, 1997, INSECT BIOCHEM MOLEC, V27, P735, DOI 10.1016/S0965-1748(97)00052-0; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Margam VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021388; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mittapalli O, 2010, PLOS ONE; Montella IR, 2012, MEM I OSWALDO CRUZ, V107, P437, DOI 10.1590/S0074-02762012000400001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mukherjee K, 2010, APPL ENVIRON MICROB, V76, P310, DOI 10.1128/AEM.01301-09; Ning CM, 2010, J INSECT PHYSIOL, V56, P666, DOI 10.1016/j.jinsphys.2010.02.003; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Oltean DI, 1999, APPL ENVIRON MICROB, V65, P4760; Park Y, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-46; Parthasarathy R, 2007, MECH DEVELOP, V124, P23, DOI 10.1016/j.mod.2006.09.002; Perera OP, 2009, INSECT BIOCHEM MOLEC, V39, P294, DOI 10.1016/j.ibmb.2009.01.006; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Popham HJR, 2010, J INSECT PHYSIOL, V56, P1237, DOI 10.1016/j.jinsphys.2010.03.024; Rotenberg D, 2010, INSECT MOL BIOL, V19, P537, DOI 10.1111/j.1365-2583.2010.01012.x; Schwartz D, 2009, BMC GENOMICS, V10, P663; Shelby KS, 2008, ARCH INSECT BIOCHEM, V69, P127, DOI 10.1002/arch.20274; Shelby Kent S., 2012, Insects, V3, P743, DOI 10.3390/insects3030743; Shelby KS, 2009, J INVERTEBR PATHOL, V101, P86, DOI 10.1016/j.jip.2009.05.002; Shelby KS, 1999, J INSECT PHYSIOL, V45, P507, DOI 10.1016/S0022-1910(98)00144-9; Shelby KS, 2000, J INVERTEBR PATHOL, V75, P218, DOI 10.1006/jipa.2000.4925; Tanaka S, 2013, FEBS J, V280, P1782, DOI 10.1111/febs.12200; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; Ulvila J, 2010, SCAND J IMMUNOL, V71, P146, DOI 10.1111/j.1365-3083.2009.02362.x; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vodovar N, 2012, ADV INSECT PHYSIOL, V42, P1, DOI 10.1016/B978-0-12-387680-5.00001-X; Vogel H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-308; Vogel H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-29; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018644; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wynant N, 2014, INSECT MOL BIOL, V23, P320, DOI 10.1111/imb.12083; Wynant N, 2014, J INSECT PHYSIOL, V64, P7, DOI 10.1016/j.jinsphys.2014.02.010; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Xie RY, 2005, J BIOL CHEM, V280, P8416, DOI 10.1074/jbc.M408403200; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Xue XY, 2012, ADV INSECT PHYSIOL, V42, P73, DOI 10.1016/B978-0-12-387680-5.00003-3; Yang GS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-2; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zhu HS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001345	105	12	12	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128563	10.1371/journal.pone.0128563	http://dx.doi.org/10.1371/journal.pone.0128563			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047101	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200079
J	Wen, XX; Wang, FQ; Xu, C; Wu, ZX; Zhang, Y; Feng, YF; Yan, YB; Lei, W				Wen, Xin-Xin; Wang, Fa-Qi; Xu, Chao; Wu, Zi-Xiang; Zhang, Yang; Feng, Ya-Fei; Yan, Ya-Bo; Lei, Wei			Time Related Changes of Mineral and Collagen and Their Roles in Cortical Bone Mechanics of Ovariectomized Rabbits	PLOS ONE			English	Article							FTIR MICROSPECTROSCOPIC ANALYSIS; ILIAC CREST BIOPSIES; SPECTROSCOPIC CHARACTERIZATION; NANOMECHANICAL PROPERTIES; CRYSTAL SIZE; CROSS-LINKS; OSTEOPOROSIS; QUALITY; WOMEN; MICROSTRUCTURE	As cortical bone has a hierarchical structure, the macroscopic bone strength may be affected by the alterations of mineral crystal and collagen, which are main components of cortical bone. Limited studies focused on the time related alterations of these two components in osteoporosis, and their contributions to bone mechanics at tissue level and whole-bone level. Therefore, the purpose of this study was to elucidate the time related changes of mineral and collagen in cortical bone of ovariectomized (OVX) rabbits, and to relate these changes to cortical bone nanomechanics and macromechanics. 40 Rabbits (7-month-old) were randomly allocated into two groups (OVX and sham). OVX group received bilateral ovariectomy operation. Sham group received sham-OVX operation. Cortical bone quality of five rabbits in each group were assessed by DXA, mu CT, nanoindentation, Fourier transform infrared (FTIR) spectroscopy and biomechanical tests (3-point bending of femoral midshaft) at pre-OVX, 4, 6, and 8 weeks after OVX. As time increased from pre-OVX to 8 weeks, the mineral to matrix ratio decreased with time, while both collagen crosslink ratio and crystallinity increased with time in OVX group. Elastic modulus and hardness measured by nanoindentation, whole-bone strength measured by biomechanical tests all decreased in OVX group with time. Bone material properties measured by FTIR correlated well with nano or whole-bone level mechanics. However, bone mineral density (BMD), structure, tissue-level and whole-bone mechanical properties did not change with age in sham group. Our study demonstrated that OVX could affect the tissue-level mechanics and bone strength of cortical bone. And this influence was attributed to the time related alterations of mineral and collagen properties, which may help us to design earlier interventions and more effective treatment strategies on osteoporosis.	[Wen, Xin-Xin; Wang, Fa-Qi; Xu, Chao; Wu, Zi-Xiang; Zhang, Yang; Feng, Ya-Fei; Yan, Ya-Bo; Lei, Wei] Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian 710032, Peoples R China	Air Force Military Medical University	Yan, YB (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian 710032, Peoples R China.	yanyabo@gmail.com; leiwei@fmmu.edu.cn		Xu, Chao/0000-0001-9693-0218; Lei, Wei/0000-0002-7346-6915	National Nature Science Foundation of China [81301292]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (No. 81301292) to YBY (http://www.nsfc.gov.cn/).	Augat P, 2006, AGE AGEING, V35, P27, DOI 10.1093/ageing/afl081; BAUD CA, 1976, CALC TISS RES, V21, P452; Bi XH, 2011, J BIOMECH, V44, P297, DOI 10.1016/j.jbiomech.2010.10.009; Boskey A, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1922927; Boskey AL, 2005, OSTEOPOROSIS INT, V16, P2031, DOI 10.1007/s00198-005-1992-3; BOSKEY AL, 1990, ORTHOP CLIN N AM, V21, P19; Boskey AL, 2005, VIB SPECTROSC, V38, P107, DOI 10.1016/j.vibspec.2005.02.015; Bourne GH, 1972, BIOCH PHYSL BONE; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Bozzini C, 2012, ENDOCRINE, V42, P411, DOI 10.1007/s12020-012-9616-0; Brennan O, 2012, CALCIFIED TISSUE INT, V91, P440, DOI 10.1007/s00223-012-9657-7; Castaneda S, 2008, J BONE MINER METAB, V26, P53, DOI 10.1007/s00774-007-0797-1; Chang YT, 2011, J MECH BEHAV BIOMED, V4, P1412, DOI 10.1016/j.jmbbm.2011.05.011; Chen HF, 2014, ADVANCED CERAMICS FOR DENTISTRY, P5, DOI 10.1016/B978-0-12-394619-5.00002-X; Cohen S, 1999, ARTHRITIS RHEUM, V42, P2309, DOI 10.1002/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K; Cowin S, 2001, BONE MECH HDB, V2nd, DOI DOI 10.1201/B14263; Currey JD, 1996, J BIOMECH, V29, P257, DOI 10.1016/0021-9290(95)00048-8; DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022; Donnelly E, 2010, J BIOMED MATER RES A, V92A, P1048, DOI 10.1002/jbm.a.32442; Eckstein F, 2004, BONE, V35, P364, DOI 10.1016/j.bone.2004.04.008; Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g; Gadaleta SJ, 1996, CALCIFIED TISSUE INT, V58, P9, DOI 10.1007/s002239900004; Genant HK, 1996, J BONE MINER RES, V11, P707; Gourion-Arsiquaud S, 2009, J BONE MINER RES, V24, P1565, DOI [10.1359/JBMR.090414, 10.1359/jbmr.090414]; Hamed E, 2010, ACTA MECH, V213, P131, DOI 10.1007/s00707-010-0326-5; Hengsberger S, 2002, BONE, V30, P178, DOI 10.1016/S8756-3282(01)00624-X; Huang RY, 2003, BONE, V33, P514, DOI 10.1016/S8756-3282(03)00233-3; Isaksson H, 2010, BONE, V47, P1030, DOI 10.1016/j.bone.2010.08.015; KENT GN, 1983, J BONE JOINT SURG BR, V65, P189, DOI 10.1302/0301-620X.65B2.6826629; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; Li GW, 2012, EUR RADIOL, V22, P923, DOI 10.1007/s00330-011-2325-x; Li ZY, 2007, BIOMATERIALS, V28, P1452, DOI 10.1016/j.biomaterials.2006.11.001; Liu XL, 2012, MED ENG PHYS, V34, P2, DOI 10.1016/j.medengphy.2011.06.010; Malluche Hartmut H, 2013, J Bone Joint Surg Am, V95, pe1391, DOI 10.2106/JBJS.L.01281; Misof BM, 2012, J BONE MINER RES, V27, P2551, DOI 10.1002/jbmr.1699; Nazarian A, 2009, OSTEOPOROSIS INT, V20, P123, DOI 10.1007/s00198-008-0632-0; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Paschalis EP, 2011, CLIN ORTHOP RELAT R, V469, P2170, DOI 10.1007/s11999-010-1751-4; Paschalis EP, 2003, J BONE MINER RES, V18, P769, DOI 10.1359/jbmr.2003.18.4.769; Paschalis EP, 2001, J BONE MINER RES, V16, P1821, DOI 10.1359/jbmr.2001.16.10.1821; Paschalis EP, 2004, J BONE MINER RES, V19, P2000, DOI 10.1359/JBMR.040820; Paschalis EP, 1997, CALCIFIED TISSUE INT, V61, P487, DOI 10.1007/s002239900372; Paschalis EP, 1996, CALCIFIED TISSUE INT, V59, P480, DOI 10.1007/BF00369214; Pienkowski D, 1997, J BONE MINER RES, V12, P1936, DOI 10.1359/jbmr.1997.12.11.1936; PLESHKO N, 1991, BIOPHYS J, V60, P786, DOI 10.1016/S0006-3495(91)82113-0; Rho JY, 1999, J MATER SCI-MATER M, V10, P485, DOI 10.1023/A:1008901109705; Saito M, 2010, OSTEOPOROSIS INT, V21, P655, DOI 10.1007/s00198-009-0980-4; Sparke AJ, 2002, BRIT POULTRY SCI, V43, P127, DOI 10.1080/00071660120109962; Taeyong Lee, 2011, The Journal of Korean Society of Osteoporosis, V9, P222; Tamaki H, 1998, BONE, V23, P147, DOI 10.1016/S8756-3282(98)00075-1; Tommasini SM, 2012, BONE, V50, P596, DOI 10.1016/j.bone.2011.12.012; Vaughan TJ, 2012, J MECH BEHAV BIOMED, V12, P50, DOI 10.1016/j.jmbbm.2012.03.003; Yerramshetty JS, 2008, BONE, V42, P476, DOI 10.1016/j.bone.2007.12.001	54	15	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127973	10.1371/journal.pone.0127973	http://dx.doi.org/10.1371/journal.pone.0127973			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046792	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200036
J	Xu, SP; Jiayong, ZP; Li, B; Zhu, H; Chang, H; Shi, W; Gao, ZX; Ning, XJ; Wang, JH				Xu, Shaopeng; Jiayong, Zepei; Li, Bin; Zhu, Hong; Chang, Hong; Shi, Wei; Gao, Zhengxuan; Ning, Xianjia; Wang, Jinghua			Prevalence and Clustering of Cardiovascular Disease Risk Factors among Tibetan Adults in China: A Population-Based Study	PLOS ONE			English	Article							SOCIOECONOMIC POSITION; METABOLIC SYNDROME; BLOOD-PRESSURE; HYPERTENSION; AWARENESS; MEN; ASSOCIATIONS; MORTALITY; HERDSMEN; OBESITY	Objectives The prevalence of cardiovascular disease risk factors has increased worldwide. However, the prevalence and clustering of cardiovascular disease risk factors among Tibetans is currently unknown. We aimed to explore the prevalence and clustering of cardiovascular disease risk factors among Tibetan adults in China. Methods In 2011, 1659 Tibetan adults (aged >= 18 years) from Changdu, China were recruited to this cross-section study. The questionnaire, physical examinations and laboratory testing were completed and the prevalence of cardiovascular disease risk factors, including hypertension, diabetes, overweight/obesity, dyslipidemia, and current smoking, were counted. The association between the clustering of cardiovascular disease risk factors and demographic characteristics, and geographic altitude were assessed. Results The age-standardized prevalence of hypertension, diabetes, overweight or obesity, dyslipidemia, and current smoking were 62.4%, 6.4%, 34.3%, 42.7%, and 6.1%, respectively, and these risk factors were associated with age, gender, education level, yearly family income, altitude, occupation, and butter tea consumption (P < 0.05). Overall, the age-adjusted prevalence of clustering of >= 1, >= 2, and >= 3 cardiovascular disease risk factors were 79.4%, 47.1%, and 20.9%, respectively. There appeared higher clustering of >= 2 and >= 3 cardiovascular disease risk factors among Tibetans with higher education level and family income yearly, and those living at an altitude < 3500 m and in a township. Conclusions The prevalence of cardiovascular disease risk factors, especially hypertension, was high in Tibetans. Moreover, there was an increased clustering of cardiovascular disease risk factors among those with higher socioeconomic status, lamas and those living at an altitude <3500 m. These findings suggest that without the immediate implementation of an efficient policy to control these risk factors, cardiovascular disease will eventually become a major disease burden among Tibetans.	[Xu, Shaopeng] Tianjin Med Univ, Gen Hosp, Dept Cardiol, Tianjin, Peoples R China; [Jiayong, Zepei; Li, Bin; Chang, Hong; Gao, Zhengxuan] Changdu Reg Peoples Hosp, Dept Internal Med, Tibet, Peoples R China; [Zhu, Hong] Tianjin Med Univ, Dept Epidemiol, Tianjin, Peoples R China; [Shi, Wei] Changdu Reg Peoples Hosp, Clin Lab, Chengdu, Tibet, Peoples R China; [Ning, Xianjia; Wang, Jinghua] Tianjin Med Univ, Gen Hosp, Lab Epidemiol, Tianjin Neurol Inst, Tianjin, Peoples R China; [Ning, Xianjia; Wang, Jinghua] Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Ning, XJ (corresponding author), Tianjin Med Univ, Gen Hosp, Lab Epidemiol, Tianjin Neurol Inst, Tianjin, Peoples R China.	xjn0906@gmail.com; jhw8799@yahoo.com			government of Changdu, Tibet; Tianjin Medical University General Hospital	government of Changdu, Tibet; Tianjin Medical University General Hospital	This study was funded by the government of Changdu, Tibet and Tianjin Medical University General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad OB, 2001, GPE DISCUSSION PAPER, V31, P1; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Chinese Diabetes Society, 2011, CHINA GUIDELINE FOR; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Disease control Ministry of Health of the People's Republic of China, 2006, THE GUIDELINES OF CH; Erem C, 2008, ENDOCRINE, V34, P36, DOI 10.1007/s12020-008-9100-z; Gu DF, 2005, CIRCULATION, V112, P658, DOI 10.1161/CIRCULATIONAHA.104.515072; He J, 2004, CIRCULATION, V110, P405, DOI 10.1161/01.CIR.0000136583.52681.0D; He L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-34; Huang JP, 2011, KIDNEY BLOOD PRESS R, V34, P69, DOI 10.1159/000323164; Insaf TZ, 2014, J EPIDEMIOL COMMUN H, V68, P318, DOI 10.1136/jech-2013-202585; Kavanagh A, 2010, SOC SCI MED, V71, P1150, DOI 10.1016/j.socscimed.2010.05.038; Li H, 2010, J HYPERTENS, V28, P432, DOI 10.1097/HJH.0b013e328334b39e; Liu Longjian, 2004, Clin Exp Pharmacol Physiol, V31 Suppl 2, pS8, DOI 10.1111/j.1440-1681.2004.04105.x; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Murray CJL, 1996, THE GLOBAL BURDEN OF; Penaloza D, 2007, CIRCULATION, V115, P1132, DOI 10.1161/CIRCULATIONAHA.106.624544; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Ploubidis GB, 2013, INT J PUBLIC HEALTH, V58, P133, DOI 10.1007/s00038-012-0389-2; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; Safraj S, 2012, ASIA-PAC J PUBLIC HE, V24, P480, DOI 10.1177/1010539510387822; Sherpa LY, 2013, HIGH ALT MED BIOL, V14, P37, DOI 10.1089/ham.2012.1051; Sims M, 2011, ANN EPIDEMIOL, V21, P892, DOI 10.1016/j.annepidem.2011.05.006; Strand A, 2007, J AM SOC HYPERTENS, V1, P400, DOI 10.1016/j.jash.2007.07.002; The Ministry of Health of the People's Republic of China, 2011, CHINA HEALTH STATIST; Thomas GN, 2007, CLIN ENDOCRINOL, V66, P666, DOI 10.1111/j.1365-2265.2007.02798.x; Tripathy V, 2007, ANN HUM BIOL, V34, P470, DOI 10.1080/03014460701412284; Wang J, 2014, J HUM HYPERTENS, V28, P25, DOI 10.1038/jhh.2013.44; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; World Health Organization, 2003, WORLD HEALTH REPORT; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yu ZJ, 2000, B WORLD HEALTH ORGAN, V78, P1296; Yusuf HR, 1998, PREV MED, V27, P1, DOI 10.1006/pmed.1997.0268; Zhang L, 2011, INT J CARDIOL, V151, P46, DOI 10.1016/j.ijcard.2010.04.056; Zhao XS, 2012, AM J HYPERTENS, V25, P583, DOI 10.1038/ajh.2012.9; Zheng X, 2012, CLIN EXP HYPERTENS, V34, P328, DOI 10.3109/10641963.2011.649930	38	46	47	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129966	10.1371/journal.pone.0129966	http://dx.doi.org/10.1371/journal.pone.0129966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047133	gold, Green Submitted, Green Published			2022-12-27	WOS:000355652200169
J	Yan, XQ; Zeng, RC; Ma, ZS; Chen, CZ; Chen, ED; Zhang, XH; Cao, FL				Yan, Xingqiang; Zeng, Ruichao; Ma, Zhaosheng; Chen, Chengze; Chen, Endong; Zhang, Xiaohua; Cao, Feilin			The Utility of Sentinel Lymph Node Biopsy in Papillary Thyroid Carcinoma with Occult Lymph Nodes	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC THYROIDITIS; RISK-FACTORS; METASTASIS; MICROCARCINOMA; DISSECTION; RECURRENCE; CANCER; SURVIVAL; PATTERN	Background The sentinel lymph node (SLN) is defined as the first draining node from the primary lesion, and it has proven to be a good indicator of the metastatic status of regional lymph nodes in solid tumors. The aim of this study was to evaluate the clinical application of SLN biopsy (SLNB) in papillary thyroid carcinoma (PTC) with occult lymph nodes. Methods From April 2006 to October 2012, 212 consecutive PTC patients were treated with SLNB using carbon nanoparticle suspension (CNS). Then, the stained nodes defined as SLN were collected, and prophylactic central compartment neck dissection (CCND) followed by total thyroidectomy or subtotal thyroidectomy were performed. All the samples were sent for pathological examination. Results There were 78 (36.8%) SLN metastasis (SLNM)-positive cases and 134 (63.2%) SLNM-negative cases. The sensitivity, specificity, positive and negative predictive values, and false-positive and false-negative rates of SLNB were 78.8%, 100%, 100%, 84.3%, 0%, and 21.2%, respectively. The PTC patients with SLNM were more likely to be male (48.2% vs. 32.7%, p = 0.039) and exhibited multifocality (52.6% vs. 33.3%, p = 0.025) and extrathyroidal extension (56.7% vs. 33.5%, p = 0.015). A greater incidence of non-SLN metastases in the central compartment was found in patients with SLNM (41/78, 52.6%) than in those without SLNM (21/134, 15.7%; p < 0.05). However, the SLNM-negative PTC patients with non-SLN metastases were more likely to be male (37.9% vs. 9.5%, p < 0.05). Conclusions The application of SLNB using CNS is technically feasible, safe, and useful, especially for male patients with co-existing multifocality and extrathyroidal extension. However, the sensitivity of SLNB must be improved and its false-negative rate reduced before it can be a routine procedure and replace prophylactic CCND. More attention should be paid to PTC patients (especially males) without SLNM for signs of non-SLN metastases.	[Yan, Xingqiang; Ma, Zhaosheng; Cao, Feilin] Wenzhou Med Univ, Taizhou Hosp, Dept Surg Oncol, Linhai, Zhejiang, Peoples R China; [Yan, Xingqiang; Zeng, Ruichao; Chen, Chengze; Chen, Endong; Zhang, Xiaohua] Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg Oncol, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Cao, FL (corresponding author), Wenzhou Med Univ, Taizhou Hosp, Dept Surg Oncol, Linhai, Zhejiang, Peoples R China.	zhangxiaohua577@163.com; cao_feilin@yahoo.com		Ruichao, Zeng/0000-0002-6990-0520				Ahn D, 2011, ACTA ONCOL, V50, P1228, DOI 10.3109/0284186X.2011.602109; Antonaci A, 2006, Clin Ter, V157, P225; Balasubramanian SP, 2011, BRIT J SURG, V98, P334, DOI 10.1002/bjs.7425; Catarci M, 1998, ANN SURG ONCOL, V5, P580, DOI 10.1007/BF02303825; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Cunningham DK, 2010, ANN SURG ONCOL, V17, P2970, DOI 10.1245/s10434-010-1141-x; Dzodic R, 2006, WORLD J SURG, V30, P841, DOI 10.1007/s00268-005-0298-0; Gulben K, 2008, LANGENBECK ARCH SURG, V393, P25, DOI 10.1007/s00423-007-0213-2; Hao RT, 2012, EJSO-EUR J SURG ONC, V38, P718, DOI 10.1016/j.ejso.2012.02.001; Hay ID, 1993, SURGERY, V114, P1057; Henry JF, 1998, LANGENBECK ARCH SURG, V383, P167, DOI 10.1007/s004230050111; Ito Y, 2007, WORLD J SURG, V31, P2085, DOI 10.1007/s00268-007-9224-y; Kebebew E, 2001, WORLD J SURG, V25, P632, DOI 10.1007/s002680020165; Kim EY, 2009, CLIN ENDOCRINOL, V71, P581, DOI 10.1111/j.1365-2265.2009.03537.x; Kim SS, 2011, HEAD NECK-J SCI SPEC, V33, P1272, DOI 10.1002/hed.21594; Koo BS, 2009, ANN SURG, V249, P840, DOI 10.1097/SLA.0b013e3181a40919; KRAG DN, 1993, SURG ONCOL, V2, P335, DOI 10.1016/0960-7404(93)90064-6; Liu Chien-Liang, 2003, J Chin Med Assoc, V66, P406; Loh KC, 1999, J CLIN ENDOCR METAB, V84, P458, DOI 10.1210/jc.84.2.458; Lundgren CI, 2006, CANCER, V106, P524, DOI 10.1002/cncr.21653; Mazzaferri E L, 2000, Endocr Pract, V6, P469; Mazzaferri EL, 2009, THYROID, V19, P683, DOI 10.1089/thy.2009.1578; Patron V, 2012, ANN OTO RHINOL LARYN, V121, P283, DOI 10.1177/000348941212100501; Pelizzo MR, 2006, BIOMED PHARMACOTHER, V60, P405, DOI 10.1016/j.biopha.2006.08.001; Podnos YD, 2005, AM SURGEON, V71, P731; Raijmakers PGHM, 2008, WORLD J SURG, V32, P1961, DOI 10.1007/s00268-008-9657-y; Roh JL, 2008, ANN SURG ONCOL, V15, P2482, DOI 10.1245/s10434-008-0044-6; Schwartz GF, 2002, CANCER, V94, P2542, DOI 10.1002/cncr.10539; Shaha A R, 2000, Cancer Control, V7, P240; So YK, 2010, SURGERY, V148, P526, DOI 10.1016/j.surg.2010.01.003; VANDERVEEN H, 1994, BRIT J SURG, V81, P1769, DOI 10.1002/bjs.1800811220; Wada N, 2003, ANN SURG, V237, P399, DOI 10.1097/00000658-200303000-00015; Yang Y, 2014, CLINICAL ENDOCRINOLO; Zaydfudim V, 2008, SURGERY, V144, P1070, DOI 10.1016/j.surg.2008.08.034; Zhang L, 2012, J CLIN ENDOCR METAB, V97, P1250, DOI 10.1210/jc.2011-1546	35	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129304	10.1371/journal.pone.0129304	http://dx.doi.org/10.1371/journal.pone.0129304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046782	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200146
J	Cui, B; Cui, LY; Liu, MS; Li, XG; Ma, JF; Fang, J; Ding, QY				Cui, Bo; Cui, Liying; Liu, Mingsheng; Li, Xiaoguang; Ma, Junfang; Fang, Jia; Ding, Qingyun			Neuropsychological Investigation in Chinese Patients with Progressive Muscular Atrophy	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DISEASE; COGNITIVE IMPAIRMENT; RATING-SCALE; CRITERIA; ALS; DYSFUNCTION; DIAGNOSIS; DEGENERATION; CONSENSUS	Background Progressive muscular atrophy (PMA) is a rare type of degenerative motor neuron disease (MND) of which the onset happens in adult period. Despite its well-defined clinical characteristics, its neuropsychological profile has remained poorly understood, considering the consensus of cognitive and behavioral impairment reached in amyotrophic lateral sclerosis (ALS). Methods We conducted a cross-sectional evaluation of Chinese PMA patients with a series of comprehensive batteries emphasizing the executive and attention function, and covering other domains of memory, language, visuospatial function, calculation and behavior as well. Their performances were compared with those of age-and education-matched ALS and healthy controls (HC). Results 21 patients newly diagnosed with PMA were consecutively enrolled into our ALS and other MND registry platform, accounting for 14.7% of all the incident MND cases registered during the same period. 20 patients who completed the neuropsychological batteries were included into analysis. Compared with HC, PMA performed significantly worse in maintenance function of attention, while they exhibited quantitative similarity to ALS in all behavioral inventories and neuropsychological tests except the time for Stroop interference effect. Conclusion PMA could display mild cognitive dysfunction in the same frontal-mediated territory of ALS but in a lesser degree, whereas they did not differ from ALS behaviorally.	[Cui, Bo; Cui, Liying; Liu, Mingsheng; Li, Xiaoguang; Ma, Junfang; Fang, Jia; Ding, Qingyun] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurol, Beijing 100730, Peoples R China; [Cui, Liying] Chinese Acad Med Sci, Ctr Neurosci, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College	Cui, LY (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurol, Beijing 100730, Peoples R China.	pumchcuily@sina.com			Sino-Germany Science Research Foundation [GZ876]	Sino-Germany Science Research Foundation	This work was supported by Sino-Germany Science Research Foundation (GZ876, http://www.sinogermanscience.org.cn) to BC LC ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams S, 1996, BRAIN, V119, P2105, DOI 10.1093/brain/119.6.2105; Armon C, 2000, MUSCLE NERVE, V23, P874, DOI 10.1002/(SICI)1097-4598(200006)23:6<874::AID-MUS5>3.0.CO;2-U; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; BUTTERS N, 1987, J CLIN EXP NEUROPSYC, V9, P479, DOI 10.1080/01688638708410764; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Cui F, 2014, ACTA NEUROL SCAND, V130, P111, DOI 10.1111/ane.12240; Gao S, 2006, APHASIA, P439; Gong Y.X., 1989, MANUAL MODIFIED WECH, P19; Gong Y.X., 1982, MANUAL MODIFIED WECH, P45; Guo Q.H., 2005, CHINESE J NEUROMEDIC, V4, P701, DOI DOI 10.3760/CMA.J.ISSN.1671-8925.2005.07-17; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; HILLEL AD, 1989, NEUROEPIDEMIOLOGY, V8, P142, DOI 10.1159/000110176; Ince PG, 2003, NEUROLOGY, V60, P1252, DOI 10.1212/01.WNL.0000058901.75728.4E; Liu MS, 2014, ACTA NEUROL SCAND, V129, P163, DOI 10.1111/ane.12157; Lomen-Hoerth C, 2011, J MOL NEUROSCI, V45, P656, DOI 10.1007/s12031-011-9636-x; Moberg PJ, 2001, AM J GERIAT PSYCHIAT, V9, P35, DOI 10.1176/appi.ajgp.9.1.35; Montuschi A, 2015, J NEUROL NEUROSUR PS, V86, P168, DOI 10.1136/jnnp-2013-307223; Murphy J, 2014, AMYOTROPH LATERAL SC, V10, P1; Murphy JM, 2007, ARCH NEUROL-CHICAGO, V64, P530, DOI 10.1001/archneur.64.4.530; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Oh SI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087163; Phukan J, 2007, LANCET NEUROL, V6, P994, DOI 10.1016/S1474-4422(07)70265-X; Phukan J, 2012, J NEUROL NEUROSUR PS, V83, P102, DOI 10.1136/jnnp-2011-300188; Piquard A, 2006, AMYOTROPH LATERAL SC, V7, P150, DOI 10.1080/17482960600680371; Quinn C, 2012, NEUROLOGY, V79, P583, DOI 10.1212/WNL.0b013e3182635720; Raaphorst J, 2014, NEUROLOGY, V83, P818, DOI 10.1212/WNL.0000000000000745; Raaphorst J, 2011, J NEUROL NEUROSUR PS, V82, P170, DOI 10.1136/jnnp.2009.204446; Ringholz GM, 2005, NEUROLOGY, V65, P586, DOI 10.1212/01.wnl.0000172911.39167.b6; Sheridan LK, 2006, ARCH CLIN NEUROPSYCH, V21, P23, DOI 10.1016/j.acn.2005.07.003; [史丽丽 SHI Li-Li], 2009, [中国心理卫生杂志, Chinese Mental Health Journal], V23, P701; Strong MJ, 2009, AMYOTROPH LATERAL SC, V10, P131, DOI 10.1080/17482960802654364; The cooperation group for the construction of The Clinical Memory Test, 1986, ACTA PSYCHOL SINICA, V1, P100; VENDRELL P, 1995, NEUROPSYCHOLOGIA, V33, P341, DOI 10.1016/0028-3932(94)00116-7; Visser J, 2007, ARCH NEUROL-CHICAGO, V64, P522, DOI 10.1001/archneur.64.4.522; Wicks P, 2006, NEUROLOGY, V67, P1718, DOI 10.1212/01.wnl.0000242726.36625.f3; Zhang ZX, 1993, CHIN J NEUROL, V32, P149; 孟超, 2004, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V30, P452	39	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128883	10.1371/journal.pone.0128883	http://dx.doi.org/10.1371/journal.pone.0128883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042930	Green Submitted, gold, Green Published			2022-12-27	WOS:000355701600070
J	Etienne, A; Genard, M; Bugaud, C				Etienne, Audrey; Genard, Michel; Bugaud, Christophe			A Process-Based Model of TCA Cycle Functioning to Analyze Citrate Accumulation in Pre- and Post-Harvest Fruits	PLOS ONE			English	Article							ORGANIC-ACID METABOLISM; PEACH FRUIT; SUGAR ACCUMULATION; CARBON METABOLISM; GRAPE BERRIES; BANANA FRUIT; GROWTH; CULTIVARS; MALATE; RESPIRATION	Citrate is one of the most important organic acids in many fruits and its concentration plays a critical role in organoleptic properties. The regulation of citrate accumulation throughout fruit development, and the origins of the phenotypic variability of the citrate concentration within fruit species remain to be clarified. In the present study, we developed a process-based model of citrate accumulation based on a simplified representation of the TCA cycle to predict citrate concentration in fruit pulp during the pre- and post-harvest stages. Banana fruit was taken as a reference because it has the particularity of having post-harvest ripening, during which citrate concentration undergoes substantial changes. The model was calibrated and validated on the two stages, using data sets from three contrasting cultivars in terms of citrate accumulation, and incorporated different fruit load, potassium supply, and harvest dates. The model predicted the pre and post-harvest dynamics of citrate concentration with fairly good accuracy for the three cultivars. The model suggested major differences in TCA cycle functioning among cultivars during post-harvest ripening of banana, and pointed to a potential role for NAD-malic enzyme and mitochondrial malate carriers in the genotypic variability of citrate concentration. The sensitivity of citrate accumulation to growth parameters and temperature differed among cultivars during post-harvest ripening. Finally, the model can be used as a conceptual basis to study citrate accumulation in fleshy fruits and may be a powerful tool to improve our understanding of fruit acidity.	[Etienne, Audrey] Ctr Cooperat Int Rech Agron Dev CIRAD, UMR QUALISUD, Lamentin, France; [Genard, Michel] INRA, UR Plantes & Syst Cultures Hort 1115, Avignon, France; [Bugaud, Christophe] CIRAD, UMR QUALISUD, Montpellier, France	CIRAD; INRAE; CIRAD; Universite de Montpellier	Bugaud, C (corresponding author), CIRAD, UMR QUALISUD, Montpellier, France.	christophe.bugaud@cirad.fr			Structural European Fund	Structural European Fund	Financial support for this study was provided by Structural European Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, BIOCH FRUIT RIPENING; Araujo WL, 2012, PLANT CELL ENVIRON, V35, P1, DOI 10.1111/j.1365-3040.2011.02332.x; BEAUDRY RM, 1989, PLANT PHYSIOL, V91, P1436, DOI 10.1104/pp.91.4.1436; Borsani J, 2009, J EXP BOT, V60, P1823, DOI 10.1093/jxb/erp055; Bugaud C, 2006, SCI HORTIC-AMSTERDAM, V108, P167, DOI 10.1016/j.scienta.2006.01.024; Bugaud C, 2013, POSTHARVEST BIOL TEC, V84, P1, DOI 10.1016/j.postharvbio.2013.03.020; Bugaud C, 2009, FRUITS, V64, P63, DOI 10.1051/fruits/2009001; Cannell MGR, 2000, ANN BOT-LONDON, V85, P45, DOI 10.1006/anbo.1999.0996; Castelan FP, 2012, CROP PROT, V35, P127, DOI 10.1016/j.cropro.2011.08.002; Cercos M, 2006, PLANT MOL BIOL, V62, P513, DOI 10.1007/s11103-006-9037-7; Chen FX, 2009, FOOD CHEM, V114, P657, DOI 10.1016/j.foodchem.2008.10.003; Dai ZW, 2009, FUNCT PLANT BIOL, V36, P527, DOI 10.1071/FP08284; DEJONG TM, 1989, J AM SOC HORTIC SCI, V114, P800; Esti M, 2002, FOOD CHEM, V76, P399, DOI 10.1016/S0308-8146(01)00231-X; Etienne A, 2014, SCI HORTIC-AMSTERDAM, V169, P99, DOI 10.1016/j.scienta.2014.02.013; Etienne A, 2013, J EXP BOT, V64, P1451, DOI 10.1093/jxb/ert035; Etienne A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0310-7; Etienne A, 2013, SCI HORTIC-AMSTERDAM, V162, P125, DOI 10.1016/j.scienta.2013.08.011; Fox J., 2002, APPENDIX R S PLUS CO; Genard M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00085; GERHARDT R, 1984, PLANT PHYSIOL, V75, P542, DOI 10.1104/pp.75.3.542; Gomez L, 2007, J SCI FOOD AGR, V87, P1893, DOI 10.1002/jsfa.2924; GOUDRIAAN J, 1990, ANN BOT-LONDON, V66, P695, DOI 10.1093/oxfordjournals.aob.a088084; GOUT E, 1993, J BIOL CHEM, V268, P3986; Haferkamp I, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00002; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; Harker FR, 2002, POSTHARVEST BIOL TEC, V24, P241, DOI 10.1016/S0925-5214(01)00157-0; Iannetta PPM, 2004, PHYSIOL PLANTARUM, V121, P15, DOI 10.1111/j.0031-9317.2004.00302.x; JEFFERY D, 1984, PLANT PHYSIOL, V74, P32, DOI 10.1104/pp.74.1.32; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Katz E, 2007, PLANTA, V226, P989, DOI 10.1007/s00425-007-0545-8; Katz E, 2011, J EXP BOT, V62, P5367, DOI 10.1093/jxb/err197; Kobayashi K, 2000, AGRON J, V92, P345, DOI 10.1007/s100870050043; KUBICEK CP, 1978, EUR J APPL MICROBIOL, V5, P263, DOI 10.1007/BF00504714; LAKSO AN, 1975, PLANT PHYSIOL, V56, P370, DOI 10.1104/pp.56.3.370; Laloi M, 1999, CELL MOL LIFE SCI, V56, P918, DOI 10.1007/s000180050484; Lechaudel M, 2005, TREE PHYSIOL, V25, P583, DOI 10.1093/treephys/25.5.583; Liu SG, 2004, POSTHARVEST BIOL TEC, V33, P27, DOI 10.1016/j.postharvbio.2004.01.006; Lobit P, 2003, J EXP BOT, V54, P2489, DOI 10.1093/jxb/erg264; Martre P, 2011, NEW PHYTOL, V191, P601, DOI 10.1111/j.1469-8137.2011.03747.x; Moing A, 1998, ACTA HORTIC, P425, DOI 10.17660/ActaHortic.1998.465.53; Monod H, 2006, UNCERTAINTY SENSITIV; Penning de Vries F.W.T., 1982, SIMULATION PLANT GRO, P114, DOI 10.1002/bimj.4710260310; Penning de Vries FWT, 1989, SIMULATION ECOPHYSIO; Regalado A, 2013, PLANTA, V237, P693, DOI 10.1007/s00425-012-1786-8; Sadka A, 2001, AUST J PLANT PHYSIOL, V28, P383, DOI 10.1071/PP00136; Saradhuldhat P, 2007, SCI HORTIC-AMSTERDAM, V112, P297, DOI 10.1016/j.scienta.2006.12.031; Schallau K, 2010, PLANT PHYSIOL, V152, P1763, DOI 10.1104/pp.109.149237; Schauer N, 2006, NAT BIOTECHNOL, V24, P447, DOI 10.1038/nbt1192; SMITH FA, 1979, ANNU REV PLANT PHYS, V30, P289, DOI 10.1146/annurev.pp.30.060179.001445; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; Sweetlove LJ, 2014, TRENDS PLANT SCI, V19, P222, DOI 10.1016/j.tplants.2013.09.005; Thornley JHM., 1990, PLANT CROP MODELLING; Tieman D, 2012, CURR BIOL, V22, P1035, DOI 10.1016/j.cub.2012.04.016; Turner DW., 1995, BANANAS PLANTAINS, P206, DOI [10.1007/978-94-011-0737-2_9, DOI 10.1007/978-94-011-0737-2_9]; VERTREGT N, 1987, J THEOR BIOL, V128, P109, DOI 10.1016/S0022-5193(87)80034-6; WALKER AJ, 1977, ANN BOT-LONDON, V41, P977, DOI 10.1093/oxfordjournals.aob.a085395; Wu BH, 2007, J EXP BOT, V58, P2583, DOI 10.1093/jxb/erm126; Wu BH, 2012, J AGR SCI-CAMBRIDGE, V150, P53, DOI 10.1017/S0021859611000438; Wullschleger SD, 1997, ANN BOT-LONDON, V80, P289, DOI 10.1006/anbo.1997.0434; Zambrano-Bigiarini M, 2013, PACKAGE HYDROPSO	61	8	8	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0126777	10.1371/journal.pone.0126777	http://dx.doi.org/10.1371/journal.pone.0126777			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042830	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600008
J	Jansone, B; Kadish, I; van Groen, T; Beitnere, U; Moore, DR; Plotniece, A; Pajuste, K; Klusa, V				Jansone, Baiba; Kadish, Inga; van Groen, Thomas; Beitnere, Ulrika; Moore, Doyle Ray; Plotniece, Aiva; Pajuste, Karlis; Klusa, Vija			A Novel 1,4-Dihydropyridine Derivative Improves Spatial Learning and Memory and Modifies Brain Protein Expression in Wild Type and Transgenic APP(SweDI) Mice	PLOS ONE			English	Article							CALCIUM-CHANNEL BLOCKING; ALZHEIMERS-DISEASE; AMYLOID-BETA; MODEL; DELIVERY; BLOCKERS; BEHAVIOR; HOMER1C; RISK; GABA	Ca2+ blockers, particularly those capable of crossing the blood-brain barrier (BBB), have been suggested as a possible treatment or disease modifying agents for neurodegenerative disorders, e.g., Alzheimer's disease. The present study investigated the effects of a novel 4-(N-dodecyl) pyridinium group-containing 1,4-dihydropyridine derivative (AP-12) on cognition and synaptic protein expression in the brain. Treatment of AP-12 was investigated in wild type C57BL/6J mice and transgenic Alzheimer's disease model mice (Tg APP(SweDI)) using behavioral tests and immunohistochemistry, as well as mass spectrometry to assess the blood-brain barrier (BBB) penetration. The data demonstrated the ability of AP-12 to cross the BBB, improve spatial learning and memory in both mice strains, induce anxiolytic action in transgenic mice, and increase expression of hippocampal and cortical proteins (GAD67, Homer-1) related to synaptic plasticity. The compound AP-12 can be seen as a prototype molecule for use in the design of novel drugs useful to halt progression of clinical symptoms (more specifically, anxiety and decline in memory) of neurodegenerative diseases, particularly Alzheimer's disease.	[Jansone, Baiba; Beitnere, Ulrika; Klusa, Vija] Univ Latvia, Fac Med, Dept Pharmacol, Riga, Latvia; [Kadish, Inga; van Groen, Thomas] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Moore, Doyle Ray] Univ Alabama Birmingham, Dept Pharmacol Toxicol, Birmingham, AL USA; [Plotniece, Aiva; Pajuste, Karlis] Latvian Inst Organ Synth, Riga, Latvia	University of Latvia; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Latvian Institute of Organic Synthesis	Jansone, B (corresponding author), Univ Latvia, Fac Med, Dept Pharmacol, Riga, Latvia.	baiba.jansone@lu.lv	Plotniece, Aiva/L-1026-2019	Plotniece, Aiva/0000-0003-2187-5693; Pajuste, Karlis/0000-0001-8558-601X; Jansone, Baiba/0000-0002-4062-3363	National Institutes of Health (NIH) [P30 NS47466, P30 AR50948, P30 DK079337]; EU Structural Funds [ESF 2009/0217/1DP/1.1.1.2.0/09/APIA/VIAA/031]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047466] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU Structural Funds; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study is supported by grants from the National Institutes of Health (NIH): P30 NS47466, P30 AR50948, P30 DK079337 (http://grants.nih.gov/grants/guide/index.html) and EU Structural Funds: ESF Nr. 2009/0217/1DP/1.1.1.2.0/09/APIA/VIAA/031 (http://ec.europa.eu/research/infrastructures/index_en.cfm?pg=structural_funds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anekonda TS, 2011, BBA-MOL BASIS DIS, V1812, P1584, DOI 10.1016/j.bbadis.2011.08.013; Aouam K, 2003, THERAPIE, V58, P333, DOI 10.2515/therapie:2003051; Becker C, 2008, NEUROLOGY, V70, P1438, DOI 10.1212/01.wnl.0000303818.38960.44; Belevich GD G.Y., 1986, BIOLOGICHESKIYE MEMB, V3, P386; Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001; Braak H, 1998, J NEURAL TRANSM-SUPP, P127; Buffington SA, 2014, ANNU REV NEUROSCI, V37, P17, DOI 10.1146/annurev-neuro-071013-014100; Burgess N, 2001, PHILOS T R SOC B, V356, P1493, DOI 10.1098/rstb.2001.0948; Davis J, 2004, J BIOL CHEM, V279, P20296, DOI 10.1074/jbc.M312946200; Drever BD, 2011, BEHAV BRAIN RES, V221, P505, DOI 10.1016/j.bbr.2010.11.037; Gerstein H, 2013, NEUROBIOL AGING, V34, P1963, DOI 10.1016/j.neurobiolaging.2013.02.006; Goodison WV, 2012, J ALZHEIMERS DIS, V30, pS269, DOI 10.3233/JAD-2012-111664; Horning SM, 2014, INT J GERIATR PSYCH, V29, P77, DOI 10.1002/gps.3972; Hyvonen Z, 2000, BBA-BIOMEMBRANES, V1509, P451, DOI 10.1016/S0005-2736(00)00327-8; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; Kadish I, 2002, J NEUROSCI, V22, P4095, DOI 10.1523/JNEUROSCI.22-10-04095.2002; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Klegeris A, 2002, EUR J PHARMACOL, V441, P203, DOI 10.1016/S0014-2999(02)01262-1; Klimaviciusa L, 2007, CELL BIOCHEM FUNCT, V25, P15, DOI 10.1002/cbf.1340; Klusa V., 1995, Drugs of the Future, V20, P135; KOELLE GB, 1949, P SOC EXP BIOL MED, V70, P617; Lecourtier L, 2011, HIPPOCAMPUS, V21, P1277, DOI 10.1002/hipo.20837; Limon A, 2012, P NATL ACAD SCI USA, V109, P10071, DOI 10.1073/pnas.1204606109; Lipscombe D, 2013, TRENDS NEUROSCI, V36, P598, DOI 10.1016/j.tins.2013.06.008; Makkar SR, 2010, NEUROPSYCHOPHARMACOL, V35, P1625, DOI 10.1038/npp.2010.53; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; Menard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028666; O'Riordan K, 2014, HIPPOCAMPUS, V24, P1, DOI 10.1002/hipo.22222; PALOMINO E, 1989, J MED CHEM, V32, P622, DOI 10.1021/jm00123a020; Paris D, 2011, MOL MED, V17, P149, DOI 10.2119/molmed.2010.00180; Pinal CS, 1998, PERSPECT DEV NEUROBI, V5, P109; Prokai L, 2000, MED RES REV, V20, P367, DOI 10.1002/1098-1128(200009)20:5<367::AID-MED3>3.0.CO;2-P; Pupure J, 2008, BASIC CLIN PHARMACOL, V103, P401, DOI 10.1111/j.1742-7843.2008.00221.x; Ritz B, 2010, ANN NEUROL, V67, P600, DOI 10.1002/ana.21937; Rosenberg PB, 2013, AM J GERIAT PSYCHIAT, V21, P685, DOI 10.1016/j.jagp.2013.01.006; Rucins M, 2014, CR CHIM, V17, P69, DOI 10.1016/j.crci.2013.07.003; Rumaks J, 2012, MED LITH, V48, P525; Samadi P, 2013, GENES BRAIN BEHAV, V12, P108, DOI 10.1111/j.1601-183X.2012.00858.x; SHEK E, 1976, J MED CHEM, V19, P113, DOI 10.1021/jm00223a019; Simon KC, 2010, MOVEMENT DISORD, V25, P1818, DOI 10.1002/mds.23191; Sinnegger-Brauns MJ, 2009, MOL PHARMACOL, V75, P407, DOI 10.1124/mol.108.049981; Sonkusare S, 2005, LIFE SCI, V77, P1, DOI 10.1016/j.lfs.2004.10.036; Triggle DJ, 2003, CELL MOL NEUROBIOL, V23, P293, DOI 10.1023/A:1023632419813; Tuttolomondo A, 2009, CURR TOP MED CHEM, V9, P1317, DOI 10.2174/156802609789869646; van Groen T, 1999, BRAIN RES REV, V30, P1, DOI 10.1016/S0165-0173(99)00006-5; van Groen T, 2006, NEUROBIOL DIS, V23, P653, DOI 10.1016/j.nbd.2006.05.010; Wallace J, 2014, CELL CALCIUM, V55, P175, DOI 10.1016/j.ceca.2014.02.005; WHISHAW IQ, 1995, PHYSIOL BEHAV, V58, P687, DOI 10.1016/0031-9384(95)00110-5; ZUPAN G, 1993, ARCH INT PHARMACOD T, V325, P61	49	13	14	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0127686	10.1371/journal.pone.0127686	http://dx.doi.org/10.1371/journal.pone.0127686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042808	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600018
J	Li, WB; Zhi, WX; Zou, SM; Qiu, T; Ling, Y; Shan, L; Shi, SS; Ying, JM				Li, Wenbin; Zhi, Wenxue; Zou, Shuangmei; Qiu, Tian; Ling, Yun; Shan, Ling; Shi, Susheng; Ying, Jianming			Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations	PLOS ONE			English	Article							MICROSATELLITE-INSTABILITY STATUS; III COLON-CANCER; ADJUVANT CHEMOTHERAPY; MOLECULAR-FEATURES; RAS MUTATIONS; BRAF; STAGE; SURVIVAL; THERAPY; TRIAL	In sporadic colorectal cancer (CRC), the BRAF(V600E) mutation is associated with deficient mismatch repair (MMR) status and inversely associated with to KRAS mutations. In contrast to deficient MMR (dMMR) CRC, data on the presence of KRAS oncogenic mutations in proficient MMR (pMMR) CRC and their relationship with tumor progression are scarce. We therefore examined the MMR status in combination with KRAS mutations in 913 Chinese patients and correlated the findings obtained with clinical and pathological features. The MMR status was determined based on detection of MLH1, MSH2, MSH6 and PMS2 expression. KRAS mutation and dMMR status were detected in 36.9% and 7.5% of cases, respectively. Four subtypes were determined by MMR and KRAS mutation status: KRAS (+)/pMMR (34.0%), KRAS (+)/dMMR (2.9%), KRAS (-)/pMMR (58.5%) and KRAS (-)/dMMR (4.6%). A higher percentage of pMMR tumors with KRAS mutation were most likely to be female (49.0%), proximal located (45.5%), a mucinous histology (38.4%), and to have increased lymph node metastasis (60.3%), compared with pMMR tumors without BRAF(V600E) and KRAS mutations (36.0%, 29.3%, 29.4% and 50.7%, respectively; all P < 0.01). To the contrary, compared with those with KRAS(-)/dMMR tumors, patients with KRAS(+)/dMMR tumors demonstrated no statistically significant differences in gender, tumor location, pT depth of invasion, lymph node metastasis, pTNM stage, and histologic grade. This study revealed that specific epidemiologic and clinicopathologic characteristics are associated with MMR status stratified by KRAS mutation. Knowledge of MMR and KRAS mutation status may enhance molecular pathologic staging of CRC patients and metastatic progression in CRC can be estimated based on the combination of these biomarkers.	[Shi, Susheng] Chinese Acad Med Sci, Canc Hosp, Dept Pathol, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Shi, SS (corresponding author), Chinese Acad Med Sci, Canc Hosp, Dept Pathol, Beijing 100730, Peoples R China.	shishusheng@sina.com; jmying@hotmail.com	Zou, Shuangmei/GLR-9384-2022		Youth Backbone Program of Cancer Hospital, CAMS, Beijing, China; Natural Basic Research Program of China [2014CB542002]; National Natural Science Foundation of China [81401984]	Youth Backbone Program of Cancer Hospital, CAMS, Beijing, China; Natural Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from Youth Backbone Program (to Jianming Ying) of Cancer Hospital, CAMS, Beijing, China, the Natural Basic Research Program of China (973 program 2014CB542002), and the National Natural Science Foundation of China (81401984). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mulla F, 2001, J PATHOL, V195, P549, DOI 10.1002/path.995; Asaka S, 2009, CARCINOGENESIS, V30, P494, DOI 10.1093/carcin/bgp017; Campbell PT, 2010, JNCI-J NATL CANCER I, V102, P391, DOI 10.1093/jnci/djq011; Campbell PM, 2004, SEMIN CANCER BIOL, V14, P105, DOI 10.1016/j.semcancer.2003.09.015; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; French AJ, 2008, CLIN CANCER RES, V14, P3408, DOI 10.1158/1078-0432.CCR-07-1489; Garre P, 2014, FAM CANCER, V13, P109, DOI 10.1007/s10689-013-9683-2; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jass JR, 1998, GUT, V42, P673, DOI 10.1136/gut.42.5.673; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Moosmann N, 2007, EXPERT OPIN BIOL TH, V7, P243, DOI 10.1517/14712598.7.2.243; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nagasaka T, 2008, GASTROENTEROLOGY, V134, P1950, DOI 10.1053/j.gastro.2008.02.094; Nash GM, 2010, ANN SURG ONCOL, V17, P416, DOI 10.1245/s10434-009-0713-0; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Oliveira C, 2007, ONCOGENE, V26, P158, DOI 10.1038/sj.onc.1209758; Oliveira C, 2004, HUM MOL GENET, V13, P2303, DOI 10.1093/hmg/ddh238; Perkins G, 2014, PHARMACOGENOMICS, V15, P1043, DOI 10.2217/pgs.14.66; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Rosty C, 2013, MODERN PATHOL, V26, P825, DOI 10.1038/modpathol.2012.240; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Salovaara R, 2000, J CLIN ONCOL, V18, P2193, DOI 10.1200/JCO.2000.18.11.2193; Samowitz WS, 2000, CANCER EPIDEM BIOMAR, V9, P1193; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Sinicrope F, 2010, CANCER-AM CANCER SOC, V116, P1691, DOI 10.1002/cncr.24913; Sinicrope FA, 2015, GASTROENTEROLOGY, V148, P88, DOI 10.1053/j.gastro.2014.09.041; Sinicrope FA, 2013, J CLIN ONCOL, V31, P3664, DOI 10.1200/JCO.2013.48.9591; Sinicrope FA, 2012, CLIN CANCER RES, V18, P1506, DOI 10.1158/1078-0432.CCR-11-1469; Sinicrope FA, 2011, JNCI-J NATL CANCER I, V103, P863, DOI 10.1093/jnci/djr153; Umar A, 2004, NAT REV CANCER, V4, P153, DOI 10.1038/nrc1278; Wang L, 2003, CANCER RES, V63, P5209; Whitehall VLJ, 2002, CANCER RES, V62, P6011; Yoon HH, 2014, CLIN CANCER RES, V20, P3033, DOI 10.1158/1078-0432.CCR-13-3140; Zhao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049683; Zlobec I, 2010, INT J CANCER, V127, P2569, DOI 10.1002/ijc.25265	43	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128202	10.1371/journal.pone.0128202	http://dx.doi.org/10.1371/journal.pone.0128202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042813	Green Submitted, Green Published, gold			2022-12-27	WOS:000355701600038
J	Garcia-Mendiguren, O; Montalban, IA; Stewart, D; Moncalean, P; Klimaszewska, K; Rutledge, RG				Garcia-Mendiguren, O.; Montalban, I. A.; Stewart, D.; Moncalean, P.; Klimaszewska, K.; Rutledge, R. G.			Gene Expression Profiling of Shoot-Derived Calli from Adult Radiata Pine and Zygotic Embryo-Derived Embryonal Masses	PLOS ONE			English	Article							REAL-TIME PCR; SOMATIC EMBRYOGENESIS; IN-VITRO; TRANSCRIPTION FACTORS; PICEA-ABIES; TREES; PROPAGATION; INITIATION; PHYLOGENY; CONIFERS	Background Although somatic embryogenesis has an unprecedented potential for large-scale clonal propagation of conifers, the ability to efficiently induce the embryonal cultures required for somatic embryo production has long been a challenge. Furthermore, because early stage zygotic embryos remain the only responsive explants for pines, it is not possible to clone individual trees from vegetative explants at a commercial scale. This is of particular interest for adult trees because many elite characteristics only become apparent following sexual maturation. Findings Shoot explants collected from adult radiata pine trees were cultured on four induction media differing in plant growth regulator composition, either directly after collection or from in vitro-generated axillary shoots. Six callus lines were selected for microscopic examination, which failed to reveal any embryonal masses (EM). qPCR expression profiling of five of these lines indicated that explant type influenced the absolute level of gene expression, but not the type of genes that were expressed. The analysis, which also included three EM lines induced from immature zygotic embryos, encompassed five categories of genes reflective of metabolic, mitotic and meristematic activity, along with putative markers of embryogenicity. Culture medium was found to have no significant impact on gene expression, although differences specific to the explant's origin were apparent. Expression of transcriptional factors associated with vegetative meristems further suggested that all of the callus lines possessed a substantive vegetative character. Most notable, however, was that they all also expressed a putative embryogenic marker (LEC1). Conclusions While limited in scope, these results illustrate the utility of expression profiling for characterizing tissues in culture. For example, although the biological significance of LEC1 expression is unclear, it does present the possibility that these callus lines possess some level of embryogenic character. Additionally, expression of vegetative meristem markers is consistent with their vegetative origin, as are differences in expression patterns as compared with EM.	[Garcia-Mendiguren, O.; Montalban, I. A.; Moncalean, P.] Neiker Tecnalia, Vitoria, Spain; [Stewart, D.; Klimaszewska, K.; Rutledge, R. G.] Laurentian Forestry Ctr, Nat Resources Canada, Canadian Forest Serv, Quebec City, PQ, Canada	Natural Resources Canada; Canadian Forest Service	Moncalean, P (corresponding author), Neiker Tecnalia, Campus Agroalimentario Arkaute, Vitoria, Spain.	pmoncalean@neiker.net; Bob.Rutledge@NRCan.gc.ca		Moncalean, Paloma/0000-0003-0143-4647	Departamento de Desarrollo Economico y Competitividad-Gobierno, Vasco-Spain [SOMAPIN-61.0369.0]	Departamento de Desarrollo Economico y Competitividad-Gobierno, Vasco-Spain	OG-M and IAM and PM received funding from the Departamento de Desarrollo Economico y Competitividad-Gobierno, Vasco-Spain (SOMAPIN-61.0369.0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken-Christie J., 1988, Genetic manipulation of woody plants., P413; Montalban IA, 2013, PHYSIOL PLANTARUM, V148, P214, DOI 10.1111/j.1399-3054.2012.01709.x; Bonga J. M., 2008, Advances in plant biotechnology, P475; Bonga JM, 2010, PLANT CELL TISS ORG, V100, P241, DOI 10.1007/s11240-009-9647-2; Braybrook SA, 2008, TRENDS PLANT SCI, V13, P624, DOI 10.1016/j.tplants.2008.09.008; Breuninger H, 2008, DEV CELL, V14, P867, DOI 10.1016/j.devcel.2008.03.008; De Diego N, 2008, CAN J FOREST RES, V38, P2607, DOI 10.1139/X08-102; De Diego N, 2010, S AFR J BOT, V76, P158, DOI 10.1016/j.sajb.2009.09.007; Diaz-Sala C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00310; Ewald D, 1996, PLANT CELL TISS ORG, V44, P249, DOI 10.1007/BF00048531; Feher A, 2015, BBA-GENE REGUL MECH, V1849, P385, DOI 10.1016/j.bbagrm.2014.07.005; Fenning TM, 2008, NAT BIOTECHNOL, V26, P615, DOI 10.1038/nbt0608-615; Guillet-Claude C, 2004, MOL BIOL EVOL, V21, P2232, DOI 10.1093/molbev/msh235; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; Hargreaves CL, 2009, CAN J FOREST RES, V39, P1566, DOI 10.1139/X09-082; Hay A, 2010, DEVELOPMENT, V137, P3153, DOI 10.1242/dev.030049; Hedman H, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-89; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ikeuchi M, 2013, PLANT CELL, V25, P3159, DOI 10.1105/tpc.113.116053; Ji JB, 2010, PLANT PHYSIOL, V152, P1346, DOI 10.1104/pp.109.149641; Klimaszeswka K, 2007, TREE FOR SCI BIOTEC, V1, P11; Klimaszewska K, 2011, PLANTA, V233, P635, DOI 10.1007/s00425-010-1325-4; Klimaszewska K, 2010, PLANT CELL REP, V29, P723, DOI 10.1007/s00299-010-0859-z; Larsson E, 2012, PLANT CELL REP, V31, P1053, DOI 10.1007/s00299-011-1224-6; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Montalban IA, 2012, ACTA PHYSIOL PLANT, V34, P451, DOI 10.1007/s11738-011-0841-6; Nardmann J, 2007, MOL BIOL EVOL, V24, P2474, DOI 10.1093/molbev/msm182; Nehra NS, 2005, IN VITRO CELL DEV-PL, V41, P701, DOI 10.1079/IVP2005691; Palovaara J, 2008, PLANT MOL BIOL, V66, P533, DOI 10.1007/s11103-008-9289-5; Park SY, 2010, TREE PHYSIOL, V30, P1469, DOI 10.1093/treephys/tpq081; Park YS, 2002, ANN FOR SCI, V59, P651, DOI 10.1051/forest:2002051; QUOIRIN M, 1977, Acta Horticulturae (Wageningen), V78, P437; Radoeva T, 2014, TRENDS PLANT SCI, V19, P709, DOI 10.1016/j.tplants.2014.06.009; Raud JN, 1992, PLANT CELL REP, V11, P563, DOI [10.1007/BF00233093, DOI 10.1007/BF00233093]; Rutledge RG, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-116; Rutledge RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017636; Rutledge RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009731; Rutledge RG, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-96; Rutledge RG, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-47; Siefers N, 2009, PLANT PHYSIOL, V149, P625, DOI 10.1104/pp.108.130591; Suzuki M, 2008, CURR OPIN PLANT BIOL, V11, P548, DOI 10.1016/j.pbi.2008.06.015; Uddenberg D, 2011, PLANTA, V234, P527, DOI 10.1007/s00425-011-1418-8; Vandesompele Jo, 2009, P47; Vasavada N., 2014, ONE WAY ANOVA ANAL V; Vermeulen J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp721; Von Aderkas P, 2000, TREE PHYSIOL, V20, P921; Walter Christian, 2005, V77, P11	48	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128679	10.1371/journal.pone.0128679	http://dx.doi.org/10.1371/journal.pone.0128679			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039876	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700115
J	Boudreau-Beland, J; Duverger, JE; Petitjean, E; Maguy, A; Ledoux, J; Comtois, P				Boudreau-Beland, Jonathan; Duverger, James Elber; Petitjean, Estelle; Maguy, Ange; Ledoux, Jonathan; Comtois, Philippe			Spatiotemporal Stability of Neonatal Rat Cardiomyocyte Monolayers Spontaneous Activity Is Dependent on the Culture Substrate	PLOS ONE			English	Article							CELL-DERIVED CARDIOMYOCYTES; STIFFNESS AFFECTS; SINOATRIAL NODE; HEART-RATE; FUNCTIONAL MATURATION; VENTRICULAR MYOCYTES; PACEMAKER ACTIVITY; GENE-EXPRESSION; CARDIAC TISSUE; IONIC MODEL	In native conditions, cardiac cells must continuously comply with diverse stimuli necessitating a perpetual adaptation. Polydimethylsiloxane (PDMS) is commonly used in cell culture to study cellular response to changes in the mechanical environment. The aim of this study was to evaluate the impact of using PDMS substrates on the properties of spontaneous activity of cardiomyocyte monolayer cultures. We compared PDMS to the gold standard normally used in culture: a glass substrate. Although mean frequency of spontaneous activity remained unaltered, incidence of reentrant activity was significantly higher in samples cultured on glass compared to PDMS substrates. Higher spatial and temporal instability of the spontaneous rate activation was found when cardiomyocytes were cultured on PDMS, and correlated with decreased connexin-43 and increased CaV3.1 and HCN2 mRNA levels. Compared to cultures on glass, cultures on PDMS were associated with the strongest response to isoproterenol and acetylcholine. These results reveal the importance of carefully selecting the culture substrate for studies involving mechanical stimulation, especially for tissue engineering or pharmacological high-throughput screening of cardiac tissue analog.	[Boudreau-Beland, Jonathan; Duverger, James Elber; Petitjean, Estelle; Maguy, Ange; Ledoux, Jonathan; Comtois, Philippe] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Boudreau-Beland, Jonathan; Ledoux, Jonathan; Comtois, Philippe] Univ Montreal, Dept Mol & Integrat Physiol, Montreal, PQ H3T 1J4, Canada; [Duverger, James Elber; Comtois, Philippe] Univ Montreal, Inst Biomed Engn, Montreal, PQ H3T 1J4, Canada; [Ledoux, Jonathan] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Comtois, P (corresponding author), Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada.	philippe.comtois@umontreal.ca	Maguy, Ange/ABG-9298-2021; Ledoux, Jonathan/D-2945-2012	Ledoux, Jonathan/0000-0001-8540-7763; Maguy, Ange/0000-0003-0170-7430	Montreal Heart Institute foundation; Natural Sciences and Engineering Research Council of Canada [RGPIN 201404233]; Fonds de recherche du Quebec - Sante; NIA Heart & Stroke Foundation of Canada	Montreal Heart Institute foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); NIA Heart & Stroke Foundation of Canada	This research was financially supported by the Montreal Heart Institute foundation, no grant number, [https://www.icm-mhi.org/fr/fondation], (P. C.), the Natural Sciences and Engineering Research Council of Canada, grant number: RGPIN 201404233, [http://www.nserc-crsng.gc.ca/index_eng.asp] (P. C.), the Fonds de recherche du Quebec - Sante, Junior 1, no grant number, [http://www.frqs.gouv.qc.ca/en/] (P. C. and J. L.) and the NIA Heart & Stroke Foundation of Canada, no grant number, [http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.2796497/k.BF8B/Home.htm] (J. L., New Investigator Award). The authors would like to gratefully acknowledge the Reseau TheCell [http://www.reseauthecell.qc.ca] (J. B., J.E.D.) for his support during the realisation of this study.	Aguilar M, 2014, BIOPHYS J, V107, P2444, DOI 10.1016/j.bpj.2014.10.014; Annabi N, 2013, LAB CHIP, V13, P3569, DOI 10.1039/c3lc50252j; Arshi A, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/2/025003; Arutunyan A, 2001, AM J PHYSIOL-HEART C, V280, pH1905, DOI 10.1152/ajpheart.2001.280.4.H1905; Averin A. S., 2010, Biofizika, V55, P910; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bhana B, 2010, BIOTECHNOL BIOENG, V105, P1148, DOI 10.1002/bit.22647; Boerboom RA, 2008, ANN BIOMED ENG, V36, P244, DOI 10.1007/s10439-007-9413-8; Brown DA, 2005, J BIOMED MATER RES A, V74A, P419, DOI 10.1002/jbm.a.30344; Brown XQ, 2005, BIOMATERIALS, V26, P3123, DOI 10.1016/j.biomaterials.2004.08.009; Bub G, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.028105; Bub G, 1998, P NATL ACAD SCI USA, V95, P10283, DOI 10.1073/pnas.95.17.10283; Bub G, 2003, J CARDIOVASC ELECTR, V14, pS229, DOI 10.1046/j.1540.8167.90315.x; Bursac N, 2006, CARDIOVASC RES, V69, P381, DOI 10.1016/j.cardiores.2005.09.014; Bursac N, 2004, P NATL ACAD SCI USA, V101, P15530, DOI 10.1073/pnas.0400984101; Bursac N, 2002, CIRC RES, V91, pE45, DOI 10.1161/01.RES.0000047530.88338.EB; Comtois P, 1999, PHYS REV E, V60, P4619, DOI 10.1103/PhysRevE.60.4619; Comtois P, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051927; Cooper PJ, 2005, ANN NY ACAD SCI, V1047, P324, DOI 10.1196/annals.1341.029; De Jong AM, 2013, J CELL MOL MED, V17, P743, DOI 10.1111/jcmm.12064; Dick E, 2010, BIOCHEM SOC T, V38, P1037, DOI 10.1042/BST0381037; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Duverger JE, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/11/113046; El Khoury N, 2013, CIRCULATION, V127, P2009, DOI 10.1161/CIRCULATIONAHA.113.001689; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Entcheva E, 2000, J CARDIOVASC ELECTR, V11, P665, DOI 10.1111/j.1540-8167.2000.tb00029.x; Evans ND, 2009, EUR CELLS MATER, V18, P1; Feng ZG, 2005, IEEE ENG MED BIOL, V24, P73; Fleischmann BK, 2004, J CLIN INVEST, V114, P994, DOI 10.1172/JCI200415925; Galie PA, 2013, CARDIOVASC PATHOL, V22, P219, DOI 10.1016/j.carpath.2012.10.003; Grevesse T, 2013, LAB CHIP, V13, P777, DOI 10.1039/c2lc41168g; Guo WN, 1996, AM J PHYSIOL-CELL PH, V271, pC93, DOI 10.1152/ajpcell.1996.271.1.C93; Hazeltine LB, 2014, ACTA BIOMATER, V10, P604, DOI 10.1016/j.actbio.2013.10.033; Hazeltine Laurie B, 2012, Int J Cell Biol, V2012, P508294, DOI 10.1155/2012/508294; Horning M, 2012, BIOPHYS J, V102, P379, DOI 10.1016/j.bpj.2011.12.018; Hua R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047652; Jacot JG, 2008, BIOPHYS J, V95, P3479, DOI 10.1529/biophysj.107.124545; Kanakov OI, 2007, CHAOS, V17, DOI 10.1063/1.2437581; Kim TJ, 2014, BIOMATERIALS, V35, P8348, DOI 10.1016/j.biomaterials.2014.06.018; Kreutzer J, 2014, MED ENG PHYS, V36, P496, DOI 10.1016/j.medengphy.2013.09.008; Kryukov AK, 2008, CHAOS, V18, DOI 10.1063/1.2956985; Kuijpers NHL, 2007, AM J PHYSIOL-HEART C, V292, pH2832, DOI 10.1152/ajpheart.00923.2006; Kurata Y, 2005, BIOPHYS J, V89, P2865, DOI 10.1529/biophysj.105.060830; Kurata Y, 2010, AM J PHYSIOL-HEART C, V298, pH1748, DOI 10.1152/ajpheart.00729.2009; Ladoux B, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/11/116601; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Larsen JK, 2002, J MOL CELL CARDIOL, V34, P519, DOI 10.1006/jmcc.2001.1534; Li D, 2011, REGEN MED, V6, P229, DOI 10.2217/RME.11.2; Lu TY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3307; Macfelda K, 2007, ARTIF ORGANS, V31, P4, DOI 10.1111/j.1525-1594.2007.00334.x; Maji D, 2012, SURF INTERFACE ANAL, V44, P62, DOI 10.1002/sia.3770; Maltsev Victor A, 2007, Heart Lung Circ, V16, P335, DOI 10.1016/j.hlc.2007.07.005; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; Mesirca P, 2013, J GEN PHYSIOL, V142, P113, DOI 10.1085/jgp.201310996; Miragoli M, 2006, CIRC RES, V98, P801, DOI 10.1161/01.RES.0000214537.44195.a3; Miragoli M, 2007, CIRC RES, V101, P755, DOI 10.1161/CIRCRESAHA.107.160549; Moorthy BS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002295; Morris Gwilym M, 2009, Ther Adv Cardiovasc Dis, V3, P479, DOI 10.1177/1753944709345792; Navarrete EG, 2013, CIRCULATION, V128, pS3, DOI 10.1161/CIRCULATIONAHA.112.000570; Nunes SS, 2013, NAT METHODS, V10, P781, DOI [10.1038/NMETH.2524, 10.1038/nmeth.2524]; ORITA H, 1993, JPN CIRC J, V57, P912, DOI 10.1253/jcj.57.912; Palchesko RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051499; Pillekamp F, 2012, STEM CELLS DEV, V21, P2111, DOI 10.1089/scd.2011.0312; Pimentel RC, 2002, CIRC RES, V90, P671, DOI 10.1161/01.RES.0000014823.75393.4D; Poelzing S, 2004, AM J PHYSIOL-HEART C, V287, pH1762, DOI 10.1152/ajpheart.00346.2004; Ponard JGC, 2007, BIOPHYS J, V92, P3734, DOI 10.1529/biophysj.106.091892; Qu JH, 2001, CIRC RES, V89, pE8, DOI 10.1161/hh1301.094395; Rocchetti M, 2000, J CARDIOVASC ELECTR, V11, P522, DOI 10.1111/j.1540-8167.2000.tb00005.x; ROZANSKI GJ, 1985, AM J PHYSIOL, V249, pH594, DOI 10.1152/ajpheart.1985.249.3.H594; Sachs F, 2011, CARDIAC MECHANOELECT; SADOSHIMA J, 1992, P NATL ACAD SCI USA, V89, P9905, DOI 10.1073/pnas.89.20.9905; SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W; Salameh A, 2012, PFLUG ARCH EUR J PHY, V464, P535, DOI 10.1007/s00424-012-1161-4; Saygili E, 2007, AM J PHYSIOL-HEART C, V292, pH2898, DOI 10.1152/ajpheart.00546.2006; Shapira-Schweitzer K, 2007, ACTA BIOMATER, V3, P33, DOI 10.1016/j.actbio.2006.09.003; Sirenko S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003391; Vunjak-Noyakovic G, 2011, ANNU REV BIOMED ENG, V13, P245, DOI 10.1146/annurev-bioeng-071910-124701; Wang JA, 2009, AM J PHYSIOL-CELL PH, V297, pC823, DOI 10.1152/ajpcell.00505.2008; Wendel JS, 2014, TISSUE ENG PT A, V20, P1325, DOI [10.1089/ten.TEA.2013.0312, 10.1089/ten.tea.2013.0312]; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Yang CH, 2013, ACS APPL MATER INTER, V5, P10418, DOI 10.1021/am403966x; Yang Zhenjiang, 2005, J Mol Cell Cardiol, V38, P299, DOI 10.1016/j.yjmcc.2004.11.015; Yaniv Y, 2013, BIOPHYS J, V105, P1551, DOI 10.1016/j.bpj.2013.08.024; Yaniv Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037582; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zhang DH, 2013, BIOMATERIALS, V34, P5813, DOI 10.1016/j.biomaterials.2013.04.026; Zhuang JP, 2000, CIRC RES, V87, P316, DOI 10.1161/01.RES.87.4.316; Zlochiver S, 2008, BIOPHYS J, V95, P4469, DOI 10.1529/biophysj.108.136473	89	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0127977	10.1371/journal.pone.0127977	http://dx.doi.org/10.1371/journal.pone.0127977			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035822	gold, Green Published, Green Submitted			2022-12-27	WOS:000355699100025
J	Yusof, FH; Ung, NM; Wong, JHD; Jong, WL; Ath, V; Phua, VCE; Heng, SP; Ng, KH				Yusof, Fasihah Hanum; Ung, Ngie Min; Wong, Jeannie Hsiu Ding; Jong, Wei Loong; Ath, Vannyat; Phua, Vincent Chee Ee; Heng, Siew Ping; Ng, Kwan Hoong			On the Use of Optically Stimulated Luminescent Dosimeter for Surface Dose Measurement during Radiotherapy	PLOS ONE			English	Article							BREAST-CANCER; CHEST-WALL; CONTRALATERAL BREAST; 2ND PRIMARY; SKIN; PHOTON; HEAD; FILM; OSL; ASSOCIATION	This study was carried out to investigate the suitability of using the optically stimulated luminescence dosimeter (OSLD) in measuring surface dose during radiotherapy. The water equivalent depth (WED) of the OSLD was first determined by comparing the surface dose measured using the OSLD with the percentage depth dose at the buildup region measured using a Markus ionization chamber. Surface doses were measured on a solid water phantom using the OSLD and compared against the Markus ionization chamber and Gafchromic EBT3 film measurements. The effect of incident beam angles on surface dose was also studied. The OSLD was subsequently used to measure surface dose during tangential breast radiotherapy treatments in a phantom study and in the clinical measurement of 10 patients. Surface dose to the treated breast or chest wall, and on the contralateral breast were measured. The WED of the OSLD was found to be at 0.4 mm. For surface dose measurement on a solid water phantom, the Markus ionization chamber measured 15.95% for 6 MV photon beam and 12.64% for 10 MV photon beam followed by EBT3 film (23.79% and 17.14%) and OSLD (37.77% and 25.38%). Surface dose increased with the increase of the incident beam angle. For phantom and patient breast surface dose measurement, the response of the OSLD was higher than EBT3 film. The in-vivo measurements were also compared with the treatment planning system predicted dose. The OSLD measured higher dose values compared to dose at the surface (Hp(0.0)) by a factor of 2.37 for 6 MV and 2.01 for 10 MV photon beams, respectively. The measurement of absorbed dose at the skin depth of 0.4 mm by the OSLD can still be a useful tool to assess radiation effects on the skin dermis layer. This knowledge can be used to prevent and manage potential acute skin reaction and late skin toxicity from radiotherapy treatments.	[Yusof, Fasihah Hanum; Wong, Jeannie Hsiu Ding; Jong, Wei Loong; Ath, Vannyat; Ng, Kwan Hoong] Univ Malaya, Fac Med, Dept Biomed Imaging, Kuala Lumpur, Malaysia; [Ung, Ngie Min; Phua, Vincent Chee Ee] Univ Malaya, Fac Med, Clin Oncol Unit, Kuala Lumpur, Malaysia; [Wong, Jeannie Hsiu Ding; Ng, Kwan Hoong] Univ Malaya, Fac Med, Res Imaging Ctr, Kuala Lumpur, Malaysia; [Heng, Siew Ping] Pantai Hosp Kuala Lumpur, Inst Canc, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Ung, NM (corresponding author), Univ Malaya, Fac Med, Clin Oncol Unit, Kuala Lumpur, Malaysia.	nm_ung@um.edu.my	Ng, Kwan Hoong/D-2231-2009; WONG, JEANNIE HSIU DING/B-8705-2010; Jong, Wei Loong/L-2300-2015; UNG, NGIE MIN/B-9986-2010	WONG, JEANNIE HSIU DING/0000-0001-8080-1294; Jong, Wei Loong/0000-0002-2735-0938; Ung, Ngie Min/0000-0001-5700-3809	University of Malaya Research Grant [RG507-13HTM]; University of Malaya (UM)/Ministy Of High Education (MOHE) High Impact Research Grant [UM.C/625/1/HIR/MOHE/MED/38]	University of Malaya Research Grant; University of Malaya (UM)/Ministy Of High Education (MOHE) High Impact Research Grant	NMU is funded by the University of Malaya Research Grant (RG507-13HTM). JHDW is funded by the University of Malaya (UM)/Ministy Of High Education (MOHE) High Impact Research Grant (UM.C/625/1/HIR/MOHE/MED/38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanyali SD, 2013, ORGANS RISK RAD TOLE, P117; Alzoubi AS, 2010, AUSTRALAS PHYS ENG S, V33, P137, DOI 10.1007/s13246-010-0011-y; ARCHAMBEAU JO, 1995, INT J RADIAT ONCOL, V31, P1171, DOI 10.1016/0360-3016(94)00423-I; Balter S, 2010, RADIOLOGY, V254, P326, DOI 10.1148/radiol.2542082312; Bilge H, 2009, PHYS MEDICA, V25, P101, DOI 10.1016/j.ejmp.2008.05.001; Brenner DJ, 2010, JNCI-J NATL CANCER I, V102, P444, DOI 10.1093/jnci/djq058; Chandra B., 1982, Radiation Protection Dosimetry, V3, P161; Chang-Claude J, 2005, CLIN CANCER RES, V11, P4802, DOI 10.1158/1078-0432.CCR-04-2657; Chen FQ, 2010, AUSTRALAS PHYS ENG S, V33, P23, DOI 10.1007/s13246-010-0004-x; Cheung T, 2005, PHYS MED BIOL, V50, pN281, DOI 10.1088/0031-9155/50/20/N04; Chougule A, 2007, J CANC RES THERAPEUT, V3; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Corradini N, 2013, MED PHYS, V40, P221; Devic S, 2006, MED PHYS, V33, P1116, DOI 10.1118/1.2179169; DRISCOLL CMH, 1986, RADIAT PROT DOSIM, V17, P367; Dunn L, 2013, RADIAT MEAS, V51-52, P31, DOI 10.1016/j.radmeas.2013.01.012; Fraass B, 1998, MED PHYS, V25, P1773, DOI 10.1118/1.598373; Fry R, 1992, BIOL BASIS DOSE LIMI; GERBI BJ, 1990, MED PHYS, V17, P17, DOI 10.1118/1.596522; HAMERS HP, 1991, RADIOTHER ONCOL, V22, P280, DOI 10.1016/0167-8140(91)90163-B; Hsu SH, 2008, PHYS MED BIOL, V53, P2593, DOI 10.1088/0031-9155/53/10/010; Jones D., 1994, MED PHYS, V21, P833, DOI DOI 10.1118/1.597396; Jong WL, 2014, J APPL CLIN MED PHYS, V15, P120, DOI 10.1120/jacmp.v15i5.4869; Jursinic PA, 2007, MED PHYS, V34, P4594, DOI 10.1118/1.2804555; Jursinic PA, 2011, MED PHYS, V38, P5432, DOI 10.1118/1.3633939; Jursinic PA, 2010, MED PHYS, V37, P132, DOI 10.1118/1.3267489; Kerns JR, 2011, MED PHYS, V38, P3955, DOI 10.1118/1.3596533; Kry SF, 2012, J APPL CLIN MED PHYS, V13, DOI [10.1120/jacmp.v13i3.3942, DOI 10.1120/JACMP.V13I3.3942]; KUTCHER GJ, 1994, MED PHYS, V21, P581, DOI 10.1118/1.597316; Kwan IS, 2008, RADIAT MEAS, V43, P929, DOI 10.1016/j.radmeas.2007.12.052; Laurent A, 2007, VACCINE, V25, P6423, DOI 10.1016/j.vaccine.2007.05.046; Nakano M, 2012, J APPL CLIN MED PHYS, V13, P83, DOI 10.1120/jacmp.v13i3.3727; Perks CA, 2008, RPA 12 12 INT C INT; Qi ZY, 2009, MED PHYS, V36, P59, DOI 10.1118/1.3030951; Quach KY, 2000, MED PHYS, V27, P1676, DOI 10.1118/1.599035; RAWLINSON JA, 1992, MED PHYS, V19, P641, DOI 10.1118/1.596896; Scalchi P, 1998, INT J RADIAT ONCOL, V40, P987, DOI 10.1016/S0360-3016(97)00894-8; Schembri V, 2007, MED PHYS, V34, P2113, DOI 10.1118/1.2737160; Sim G, 2013, J APPL CLIN MED PHYS, V14; Stovall M, 2008, INT J RADIAT ONCOL, V72, P1021, DOI 10.1016/j.ijrobp.2008.02.040; VANVLOTEN WA, 1987, CANCER, V59, P411, DOI 10.1002/1097-0142(19870201)59:3<411::AID-CNCR2820590310>3.0.CO;2-Z; Wahba A. G., 2009, MED J CAIRO U, V77; Yadav BS, 2008, RADIOTHER ONCOL, V86, P171, DOI 10.1016/j.radonc.2007.10.002; Yukihara EG, 2008, MED PHYS, V35, P260, DOI 10.1118/1.2816106	44	27	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128544	10.1371/journal.pone.0128544	http://dx.doi.org/10.1371/journal.pone.0128544			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052690	gold, Green Published, Green Submitted			2022-12-27	WOS:000355955300043
J	Belian, E; Noseda, M; Paiva, MSA; Leja, T; Sampson, R; Schneider, MD				Belian, Elisa; Noseda, Michela; Paiva, Marta S. Abreu; Leja, Thomas; Sampson, Robert; Schneider, Michael D.			Forward Programming of Cardiac Stem Cells by Homogeneous Transduction with MYOCD plus TBX5	PLOS ONE			English	Article							SIDE POPULATION CELLS; SERUM RESPONSE FACTOR; GENE-EXPRESSION; TRANSCRIPTION FACTORS; PROGENITOR CELLS; FIBROBLASTS; HEART; CARDIOMYOCYTES; ACTIVATION; MYOCARDIN	Adult cardiac stem cells (CSCs) express many endogenous cardiogenic transcription factors including members of the Gata, Hand, Mef2, and T-box family. Unlike its DNA-binding targets, Myocardin (Myocd)-a co-activator not only for serum response factor, but also for Gata4 and Tbx5-is not expressed in CSCs. We hypothesised that its absence was a limiting factor for reprogramming. Here, we sought to investigate the susceptibility of adult mouse Sca1(+) side population CSCs to reprogramming by supplementing the triad of GATA4, MEF2C, and TBX5 (GMT), and more specifically by testing the effect of the missing co-activator, Myocd. Exogenous factors were expressed via doxycycline-inducible lentiviral vectors in various combinations. High throughput quantitative RT-PCR was used to test expression of 29 cardiac lineage markers two weeks post-induction. GMT induced more than half the analysed cardiac transcripts. However, no protein was detected for the induced sarcomeric genes Actc1, Myh6, and Myl2. Adding MYOCD to GMT affected only slightly the breadth and level of gene induction, but, importantly, triggered expression of all three proteins examined (alpha-cardiac actin, atrial natriuretic peptide, sarcomeric myosin heavy chains). MYOCD + TBX was the most effective pairwise combination in this system. In clonal derivatives homogenously expressing MYOCD + TBX at high levels, 93% of cardiac transcripts were up-regulated and all five proteins tested were visualized. In summary: (1) GMT induced cardiac genes in CSCs, but not cardiac proteins under the conditions used. (2) Complementing GMT with MYOCD induced cardiac protein expression, indicating a more complete cardiac differentiation program. (3) Homogeneous transduction with MYOCD + TBX5 facilitated the identification of differentiating cells and the validation of this combinatorial reprogramming strategy. Together, these results highlight the pivotal importance of MYOCD in driving CSCs toward a cardiac muscle fate.	[Belian, Elisa; Noseda, Michela; Paiva, Marta S. Abreu; Leja, Thomas; Sampson, Robert; Schneider, Michael D.] Univ London Imperial Coll Sci Technol & Med, British Heart Fdn Ctr Res Excellence, Natl Heart & Lung Inst, London W14 0NN, England	Imperial College London	Schneider, MD (corresponding author), Univ London Imperial Coll Sci Technol & Med, British Heart Fdn Ctr Res Excellence, Natl Heart & Lung Inst, London W14 0NN, England.	m.d.schneider@imperial.ac.uk	Paiva, Marta/V-7397-2017	Paiva, Marta/0000-0003-2933-9895; Sampson, Robert/0000-0003-1983-9589; Noseda, Michela/0000-0002-9553-5029	British Heart Foundation [CH/08/002, RE/08/002, RG/08/007, SI/11/2/28875]; European Commission [223372]; European Research Council [233158]; Medical Research Council-British Heart Foundation Cardiovascular Stem Cell Research Strategic Development Grant [G0901467]; National Heart and Lung Institute Foundation; MRC [G0901467] Funding Source: UKRI; British Heart Foundation [RG/08/007/25296, RG/15/1/31165] Funding Source: researchfish; Medical Research Council [G0901467] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); Medical Research Council-British Heart Foundation Cardiovascular Stem Cell Research Strategic Development Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Heart and Lung Institute Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the British Heart Foundation (CH/08/002, RE/08/002, RG/08/007, SI/11/2/28875), https://www.bhf.org.uk; European Commission (CardioCell, 223372), http://ec.europa.eu/research/fp7/index_en.cfm; European Research Council (233158), http://erc.europa.eu; and a Medical Research Council-British Heart Foundation Cardiovascular Stem Cell Research Strategic Development Grant (G0901467), http://www.mrc.ac.uk to MDS; and by the National Heart and Lung Institute Foundation, http://www.nhlif.info, to EB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis RC, 2013, J MOL CELL CARDIOL, V60, P97, DOI 10.1016/j.yjmcc.2013.04.004; Akkina RK, 1996, J VIROL, V70, P2581, DOI 10.1128/JVI.70.4.2581-2585.1996; Bailey B, 2012, CIRC RES, V111, P750, DOI 10.1161/CIRCRESAHA.112.274662; Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com; Belaguli NS, 2000, MOL CELL BIOL, V20, P7550, DOI 10.1128/MCB.20.20.7550-7558.2000; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bernstein H.S., 2013, PLOS CURR, V15, P5; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Chang CP, 2012, ANNU REV PHYSIOL, V74, P41, DOI 10.1146/annurev-physiol-020911-153242; Chen JX, 2012, CIRC RES, V111, P50, DOI 10.1161/CIRCRESAHA.112.270264; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; Chong JJH, 2011, CELL STEM CELL, V9, P527, DOI 10.1016/j.stem.2011.10.002; Christoforou N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063577; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Creemers EE, 2006, MOL CELL, V23, P83, DOI 10.1016/j.molcel.2006.05.026; Dai YS, 2002, J BIOL CHEM, V277, P24390, DOI 10.1074/jbc.M202490200; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Debril MB, 2004, J BIOL CHEM, V279, P16677, DOI 10.1074/jbc.M312288200; Epting CL, 2008, EXP CELL RES, V314, P1125, DOI 10.1016/j.yexcr.2007.11.010; Furtado MB, 2014, CIRC RES, V114, P1422, DOI 10.1161/CIRCRESAHA.114.302530; Georges R, 2008, MOL CELL BIOL, V28, P4052, DOI 10.1128/MCB.02100-07; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; GREPIN C, 1994, MOL CELL BIOL, V14, P3115, DOI 10.1128/MCB.14.5.3115; GURDON JB, 1993, CELL, V75, P831, DOI 10.1016/0092-8674(93)90526-V; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Hsueh YC, 2014, EMBO MOL MED, V6, P496, DOI 10.1002/emmm.201303687; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Inagawa K, 2013, J CARDIOVASC TRANSL, V6, P37, DOI 10.1007/s12265-012-9412-5; Koyanagi M, 2005, CIRC RES, V96, P1039, DOI 10.1161/01.RES.0000168650.23479.0c; Ladewig J, 2013, NAT REV MOL CELL BIO, V14, P225, DOI 10.1038/nrm3543; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Limana F, 2007, CIRC RES, V101, P1255, DOI 10.1161/CIRCRESAHA.107.150755; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Ma Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056554; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; Mercola M, 2011, GENE DEV, V25, P299, DOI 10.1101/gad.2018411; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Miller SA, 2008, GENE DEV, V22, P2980, DOI 10.1101/gad.1689708; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P4947, DOI 10.1128/MCB.14.7.4947; Mori AD, 2006, DEV BIOL, V297, P566, DOI 10.1016/j.ydbio.2006.05.023; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Nam YJ, 2013, P NATL ACAD SCI USA, V110, P5588, DOI 10.1073/pnas.1301019110; Noseda M, NAT COMMUN IN PRESS; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Oyama T, 2007, J CELL BIOL, V176, P329, DOI 10.1083/jcb.200603014; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Pluta K, 2005, J GENE MED, V7, P803, DOI 10.1002/jgm.712; Protze S, 2012, J MOL CELL CARDIOL, V53, P323, DOI 10.1016/j.yjmcc.2012.04.010; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Reiser J, 1996, P NATL ACAD SCI USA, V93, P15266, DOI 10.1073/pnas.93.26.15266; Rosenblatt-Velin N, 2012, FASEB J, V26, P229, DOI 10.1096/fj.11-189605; Rosenthal N, 2010, HEART DEVELOPMENT AN; Salmon Patrick, 2007, Curr Protoc Hum Genet, VChapter 12, DOI 10.1002/0471142905.hg1210s54; Seidler NW, 2013, GAPDH BIOLOGICAL PRO; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Small EM, 2005, DEVELOPMENT, V132, P987, DOI 10.1242/dev.01684; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890; Toko H, 2014, J BIOL CHEM, V289, P5348, DOI 10.1074/jbc.M113.526442; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; van Tuyn J, 2005, CARDIOVASC RES, V67, P245, DOI 10.1016/j.cardiores.2005.04.013; Vong L, 2006, DEV DYNAM, V235, P1809, DOI 10.1002/dvdy.20828; Wada R, 2013, P NATL ACAD SCI USA, V110, P12667, DOI 10.1073/pnas.1304053110; Wang CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024242; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang L, 2015, CIRC RES, V116, P237, DOI 10.1161/CIRCRESAHA.116.305547; WEISS RA, 1977, VIROLOGY, V76, P808, DOI 10.1016/0042-6822(77)90261-6; ZAVADA J, 1972, NATURE-NEW BIOL, V240, P122, DOI 10.1038/newbio240122a0; Zhou L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048028; Zhou YG, 2011, CIRC RES, V109, P1067, DOI 10.1161/CIRCRESAHA.111.243709; ZHU H, 1991, MOL CELL BIOL, V11, P2273, DOI 10.1128/MCB.11.4.2273	81	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0125384	10.1371/journal.pone.0125384	http://dx.doi.org/10.1371/journal.pone.0125384			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047103	gold, Green Published, Green Submitted			2022-12-27	WOS:000355652200009
J	Han, DP; Wang, SX; Hu, YX; Zhang, YY; Dong, XG; Yang, Z; Wang, JK; Li, JY; Deng, XM				Han, Deping; Wang, Shuxiang; Hu, Yanxin; Zhang, Yuanyuan; Dong, Xianggui; Yang, Zu; Wang, Jiankui; Li, Junying; Deng, Xuemei			Hyperpigmentation Results in Aberrant Immune Development in Silky Fowl (Gallus gallus domesticus Brisson)	PLOS ONE			English	Article							PROHORMONE CONVERTASE 2; WHITE LEGHORN; LUNG INJURY; MELANOCYTES; MELANOBLASTS; PIGMENTATION; INFECTION; MIGRATION; MELANIN; CELLS	The Silky Fowl (SF) is known for its special phenotypes and atypical distribution of melanocytes among internal organs. Although the genes associated with melanocyte migration have been investigated substantially, there is little information on the postnatal distribution of melanocytes in inner organs and the effect of hyperpigmentation on the development of SF. Here, we analyzed melanocyte distribution in 26 tissues or organs on postnatal day 1 and weeks 2, 3, 4, 6, 10, and 23. Except for the liver, pancreas, pituitary gland, and adrenal gland, melanocytes were distributed throughout the body, primarily around blood vessels. Interaction between melanocytes and the tissue cells was observed, and melanin was transported by filopodia delivery through engulfed and internalized membrane-encapsulated melanosomes. SFs less than 10 weeks old have lower indices of spleen, thymus, and bursa of Fabricius than White Leghorns (WLs). The expression levels of interferon-gamma and interlukin-4 genes in the spleen, and serum antibody levels against H5N1 and infectious bursal disease virus were lower in SF than in WL. We also found immune organ developmental difference between Black-boned and non-Black-boned chickens from SFs and WLs hybrid F2 population. However, degeneration of the thymus and bursa of Fabricius occurred later in SF than in WL after sexual maturity. Analysis of apoptotic cells and apoptosis-associated Bax and Bcl-2 proteins indicated that apoptosis is involved in degeneration of the thymus and bursa of Fabricius. Therefore, these results suggest that hyperpigmentation in SF may have a close relationship with immune development in SF, which can provide an important animal model to investigate the roles of melanocyte.	[Han, Deping; Wang, Shuxiang; Zhang, Yuanyuan; Dong, Xianggui; Yang, Zu; Wang, Jiankui; Li, Junying; Deng, Xuemei] China Agr Univ, Minist Agr, Natl Engn Lab Anim Breeding, Beijing 100193, Peoples R China; [Han, Deping; Wang, Shuxiang; Zhang, Yuanyuan; Dong, Xianggui; Yang, Zu; Wang, Jiankui; Li, Junying; Deng, Xuemei] China Agr Univ, Minist Agr, Key Lab Anim Genet Breeding & Reprod, Beijing 100193, Peoples R China; [Hu, Yanxin] China Agr Univ, Coll Vet Med, Beijing 100193, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Deng, XM (corresponding author), China Agr Univ, Minist Agr, Natl Engn Lab Anim Breeding, Beijing 100193, Peoples R China.	deng@cau.edu.cn	zhang, yuanyuan/GYA-4428-2022		National Nature Science Foundation [31472082, U1136605]; National Scientific Supporting Projects of China [2013AA102501]; Program for New Century Excellent Talents of the Ministry of Education of China [NCET-09-0730]	National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); National Scientific Supporting Projects of China; Program for New Century Excellent Talents of the Ministry of Education of China(Program for New Century Excellent Talents in University (NCET))	This work was supported in part by grants from the National Nature Science Foundation (31472082 and U1136605), the National Scientific Supporting Projects of China (2013AA102501), and the Program for New Century Excellent Talents of the Ministry of Education of China (NCET-09-0730). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladowicz E, 2013, FUTURE ONCOL, V9, P713, DOI [10.2217/fon.13.9, 10.2217/FON.13.9]; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; De Freitas PF, 2003, ANAT REC PART A, V273A, P705, DOI 10.1002/ar.a.10078; Dellinger RW, 2014, J PHOTOCH PHOTOBIO B, V138, P317, DOI 10.1016/j.jphotobiol.2014.06.006; Dorshorst B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002412; Dorshorst B, 2010, J HERED, V101, P339, DOI 10.1093/jhered/esp120; Faraco CD, 2001, DEV DYNAM, V220, P212, DOI 10.1002/1097-0177(20010301)220:3<212::AID-DVDY1105>3.0.CO;2-9; Golbar HM, 2014, J COMP PATHOL, V151, P63, DOI 10.1016/j.jcpa.2014.03.002; Han DP, 2014, VET MICROBIOL, V169, P135, DOI 10.1016/j.vetmic.2013.12.022; Hiramoto K, 2013, CLIN EXP DERMATOL, V38, P71, DOI 10.1111/j.1365-2230.2012.04439.x; Hiramoto K, 2014, PHOTODERMATOL PHOTO, V30, P302, DOI 10.1111/phpp.12131; Hu YX, 2012, J VIROL, V86, P3347, DOI 10.1128/JVI.06053-11; Jin XT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113257; Kawakami Akinori, 2011, J Invest Dermatol, V131, pE2, DOI 10.1038/skinbio.2011.2; Kumar V, 2010, MOL IMMUNOL, V48, P14, DOI 10.1016/j.molimm.2010.07.009; Levesque M, 2013, DIS MODEL MECH, V6, P508, DOI 10.1242/dmm.010371; Li YL, 2014, FRONT AGRIC SCI ENG, V1, P299, DOI 10.15302/J-FASE-2014040; Li YL, 2011, MOL BIOL REP, V38, P1433, DOI 10.1007/s11033-010-0248-2; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Liu H, 2006, HEILONGJIANG ANIMAL, V9, P104; Liu WY, 2013, J SCI FOOD AGR, V93, P2782, DOI 10.1002/jsfa.6099; Ma HJ, 2014, J DERMATOL SCI, V76, P222, DOI 10.1016/j.jdermsci.2014.09.005; Murillo-Cuesta S, 2010, PIGM CELL MELANOMA R, V23, P72, DOI 10.1111/j.1755-148X.2009.00646.x; Muroya S, 2000, J VET MED SCI, V62, P391, DOI 10.1292/jvms.62.391; Nishimura S, 2006, BRIT POULTRY SCI, V47, P426, DOI 10.1080/00071660600825082; Ortolani-Machado CF, 2009, TISSUE CELL, V41, P239, DOI 10.1016/j.tice.2008.11.005; Ortolani-Machado C, 2008, ANAT REC, V291, P55, DOI 10.1002/ar.20623; Plonka PM, 2009, EXP DERMATOL, V18, P799, DOI 10.1111/j.1600-0625.2009.00912.x; Reedy MV, 1998, DEV DYNAM, V213, P476, DOI 10.1002/(SICI)1097-0177(199812)213:4<476::AID-AJA12>3.0.CO;2-R; Rui J, 1979, JOURNAL OF FUDAN UNI, V3, P100; RuizMaldonado R, 1997, SEMIN CUTAN MED SURG, V16, P36, DOI 10.1016/S1085-5629(97)80034-X; Shinomiya A, 2012, GENETICS, V190, P627, DOI 10.1534/genetics.111.136705; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Sun Q, 2008, AVIAN PATHOL, V37, P579, DOI 10.1080/03079450802499092; Sun SF, 2008, POULTRY SCI, V87, P1725, DOI 10.3382/ps.2007-00202; Suzuki I, 1996, ENDOCRINOLOGY, V137, P1627, DOI 10.1210/en.137.5.1627; Toyosaki T, 2007, BRIT POULTRY SCI, V48, P449, DOI 10.1080/00071660701466109; Tu YG, 2009, PIGM CELL MELANOMA R, V22, P134, DOI 10.1111/j.1755-148X.2008.00529.x; Wang DC, 2008, VET IMMUNOL IMMUNOP, V124, P19, DOI 10.1016/j.vetimm.2008.01.005; Wong Christina Yin Bin, 2013, N Am J Med Sci, V5, P499, DOI 10.4103/1947-2714.118918; Xie H, 2011, BIOMATERIALS, V32, P495, DOI 10.1016/j.biomaterials.2010.09.024; Yajima I, 2008, PIGM CELL MELANOMA R, V21, P471, DOI 10.1111/j.1755-148X.2008.00483.x; Zhang WJ, 2012, P NATL ACAD SCI USA, V109, P10388, DOI 10.1073/pnas.1205210109	46	15	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0125686	10.1371/journal.pone.0125686	http://dx.doi.org/10.1371/journal.pone.0125686			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047316	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200010
J	Pinho, AV; Bensellam, M; Wauters, E; Rees, M; Giry-Laterriere, M; Mawson, A; Ly, LQ; Biankin, AV; Wu, JM; Laybutt, DR; Rooman, I				Pinho, Andreia V.; Bensellam, Mohammed; Wauters, Elke; Rees, Maxine; Giry-Laterriere, Marc; Mawson, Amanda; Ly, Le Quan; Biankin, Andrew V.; Wu, Jianmin; Laybutt, D. Ross; Rooman, Ilse			Pancreas-Specific Sirt1-Deficiency in Mice Compromises Beta-Cell Function without Development of Hyperglycemia	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; STIMULATED INSULIN-SECRETION; SIRT1; MOUSE; DIFFERENTIATION; HOMEOSTASIS; CANCER; DAMAGE	Aims/Hypothesis Sirtuin 1 (Sirt1) has been reported to be a critical positive regulator of glucose-stimulated insulin secretion in pancreatic beta-cells. The effects on islet cells and blood glucose levels when Sirt1 is deleted specifically in the pancreas are still unclear. Methods This study examined islet glucose responsiveness, blood glucose levels, pancreatic islet histology and gene expression in Pdx1(Cre); Sirt1(ex4F/F) mice that have loss of function and loss of expression of Sirt1 specifically in the pancreas. Results We found that in the Pdx1(Cre); Sirt1(ex4F/F) mice, the relative insulin positive area and the islet size distribution were unchanged. However, beta-cells were functionally impaired, presenting with lower glucose-stimulated insulin secretion. This defect was not due to a reduced expression of insulin but was associated with a decreased expression of the glucose transporter Slc2a2/Glut2 and of the Glucagon like peptide-1 receptor (Glp1r) as well as a marked down regulation of endoplasmic reticulum (ER) chaperones that participate in the Unfolded Protein Response (UPR) pathway. Counter intuitively, the Sirt1-deficient mice did not develop hyperglycemia. Pancreatic polypeptide (PP) cells were the only other islet cells affected, with reduced numbers in the Sirt1-deficient pancreas. Conclusions/Interpretation This study provides new mechanistic insights showing that beta-cell function in Sirt1-deficient pancreas is affected due to altered glucose sensing and deregulation of the UPR pathway. Interestingly, we uncovered a context in which impaired beta-cell function is not accompanied by increased glycemia. This points to a unique compensatory mechanism. Given the reduction in PP, investigation of its role in the control of blood glucose is warranted.	[Pinho, Andreia V.; Rees, Maxine; Giry-Laterriere, Marc; Mawson, Amanda; Ly, Le Quan; Biankin, Andrew V.; Wu, Jianmin; Rooman, Ilse] Kinghorn Canc Ctr, Garvan Inst Med Res, Canc Div, Darlinghurst, NSW, Australia; [Pinho, Andreia V.; Bensellam, Mohammed; Giry-Laterriere, Marc; Wu, Jianmin; Laybutt, D. Ross; Rooman, Ilse] UNSW Australia, Fac Med, St Vincents Clin Sch, Randwick, NSW, Australia; [Bensellam, Mohammed; Laybutt, D. Ross] St Vincents Hosp, Garvan Inst Med Res, Diabet & Metab Div, Darlinghurst, NSW 2010, Australia; [Wauters, Elke; Rooman, Ilse] Vrije Univ Brussel, Diabet Res Ctr, Brussels, Belgium; [Biankin, Andrew V.] Univ Glasgow, Wolfson Wohl Canc Res Ctr, Glasgow, Lanark, Scotland	Garvan Institute of Medical Research; University of New South Wales Sydney; Garvan Institute of Medical Research; St Vincents Hospital Sydney; Vrije Universiteit Brussel; University of Glasgow	Rooman, I (corresponding author), Kinghorn Canc Ctr, Garvan Inst Med Res, Canc Div, Darlinghurst, NSW, Australia.	i.rooman@garvan.org.au	Bensellam, Mohammed/AAI-4760-2020	Biankin, Andrew/0000-0002-0362-5597; Pinho, Andreia V./0000-0003-0647-4015; Bensellam, Mohammed/0000-0002-1641-1694; Rooman, Ilse/0000-0001-7264-2246; Ly, Le Quan/0000-0003-1189-6175	Australian Research Council; National Health and Medical Research Council of Australia; Cancer Research UK [17263] Funding Source: researchfish	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Research UK(Cancer Research UK)	AVP and IR are fellows from Cancer Institute NSW (13ECF104 and 10FRL203). DRL is a recipient of a Future Fellowship from the Australian Research Council and a grant from the National Health and Medical Research Council of Australia. EW is a research fellow of the Fund for Scientific Research Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Boutant M, 2014, MOL METAB, V3, P5, DOI 10.1016/j.molmet.2013.10.006; Chan JY, 2013, DIABETES, V62, P1557, DOI 10.2337/db12-0701; Herranz D, 2010, NAT REV CANCER, V10, P819, DOI 10.1038/nrc2962; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hubbard BP, 2014, TRENDS PHARM SCI; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Laybutt DR, 2007, DIABETOLOGIA, V50, P2117, DOI 10.1007/s00125-007-0749-2; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2011, P NATL ACAD SCI USA, V108, P8885, DOI 10.1073/pnas.1105564108; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Luu L, 2013, DIABETOLOGIA, V56, P2010, DOI 10.1007/s00125-013-2946-5; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Ramsey KM, 2008, AGING CELL, V7, P78, DOI 10.1111/j.1474-9726.2007.00355.x; Thorens B, 2015, DIABETOLOGIA, V58, P221, DOI 10.1007/s00125-014-3451-1; Vetere A, 2014, NAT REV DRUG DISCOV, V13, P278, DOI 10.1038/nrd4231; Wang FM, 2011, BIOCHEM J, V433, P245, DOI 10.1042/BJ20101293; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wang RH, 2013, INT J BIOL SCI, V9, P934, DOI 10.7150/ijbs.7529; Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243; Wauters E, 2013, CANCER RES, V73, P2357, DOI 10.1158/0008-5472.CAN-12-3359; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yulyaningsih E, 2014, CELL METAB, V19, P58, DOI 10.1016/j.cmet.2013.11.019	25	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128012	10.1371/journal.pone.0128012	http://dx.doi.org/10.1371/journal.pone.0128012			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046931	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200037
J	Yang, L; Tang, CH; Xu, B; Wang, WX; Li, JJ; Li, XY; Qin, HF; Gao, HJ; He, K; Song, ST; Liu, XQ				Yang, Lin; Tang, Chuanhao; Xu, Bin; Wang, Weixia; Li, Jianjie; Li, Xiaoyan; Qin, Haifeng; Gao, Hongjun; He, Kun; Song, Santai; Liu, Xiaoqing			Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV Non-Small-Cell Lung Cancer	PLOS ONE			English	Article							EGFR MUTATIONS; OPEN-LABEL; PHASE-III; MASS-SPECTROMETRY; BREAST-CANCER; PLASMA DNA; GEFITINIB; CHEMOTHERAPY; BIOMARKER; ERLOTINIB	Objectives Epidermal growth factor receptor (EGFR) gene mutations in tumors predict tumor response to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small-cell lung cancer (NSCLC). However, obtaining tumor tissue for mutation analysis is challenging. Here, we aimed to detect serum peptides/proteins associated with EGFR gene mutation status, and test whether a classification algorithm based on serum proteomic profiling could be developed to analyze EGFR gene mutation status to aid therapeutic decision-making. Patients and Methods Serum collected from 223 stage IIIB or IV NSCLC patients with known EGFR gene mutation status in their tumors prior to therapy was analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) and ClinProTools software. Differences in serum peptides/proteins between patients with EGFR gene TKI-sensitive mutations and wild-type EGFR genes were detected in a training group of 100 patients; based on this analysis, a serum proteomic classification algorithm was developed to classify EGFR gene mutation status and tested in an independent validation group of 123 patients. The correlation between EGFR gene mutation status, as identified with the serum proteomic classifier and response to EGFR-TKIs was analyzed. Results Nine peptide/protein peaks were significantly different between NSCLC patients with EGFR gene TKI-sensitive mutations and wild-type EGFR genes in the training group. A genetic algorithm model consisting of five peptides/proteins (m/z 4092.4, 4585.05, 1365.1, 4643.49 and 4438.43) was developed from the training group to separate patients with EGFR gene TKI-sensitive mutations and wild-type EGFR genes. The classifier exhibited a sensitivity of 84.6% and a specificity of 77.5% in the validation group. In the 81 patients from the validation group treated with EGFR-TKIs, 28 (59.6%) of 47 patients whose matched samples were labeled as "mutant" by the classifier and 3 (8.8%) of 34 patients whose matched samples were labeled as "wild" achieved an objective response (p<0.0001). Patients whose matched samples were labeled as "mutant" by the classifier had a significantly longer progression-free survival (PFS) than patients whose matched samples were labeled as "wild" (p=0.001). Conclusion Peptides/proteins related to EGFR gene mutation status were found in the serum. Classification of EGFR gene mutation status using the serum proteomic classifier established in the present study in patients with stage IIIB or IV NSCLC is feasible and may predict tumor response to EGFR-TKIs.	[Yang, Lin; Tang, Chuanhao; Wang, Weixia; Li, Jianjie; Li, Xiaoyan; Qin, Haifeng; Gao, Hongjun; Liu, Xiaoqing] PLA, Hosp 307, Dept Pulm Oncol, Beijing, Peoples R China; [Xu, Bin; He, Kun] Natl Ctr Biomed Anal, Beijing, Peoples R China; [Song, Santai] PLA, Hosp 307, Ctr Canc, Beijing, Peoples R China		Liu, XQ (corresponding author), PLA, Hosp 307, Dept Pulm Oncol, Beijing, Peoples R China.	liuxq@medmail.com.cn			Ministry of Science and Technology of the People's Republic of China (Chinese National Instrumentation Program) [2011YQI70067]	Ministry of Science and Technology of the People's Republic of China (Chinese National Instrumentation Program)	This work was supported by a grant from the Ministry of Science and Technology of the People's Republic of China (Chinese National Instrumentation Program, No. 2011YQI70067; URL of funder's website: www.most.gov.cn; XQL received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annecke K, 2008, ADV CLIN CHEM, V45, P31, DOI 10.1016/S0065-2423(07)00002-9; Bai H, 2009, J CLIN ONCOL, V27, P2653, DOI 10.1200/JCO.2008.17.3930; Brevet M, 2011, LUNG CANCER, V73, P96, DOI 10.1016/j.lungcan.2010.10.014; Ciuleanu T, 2012, LANCET ONCOL, V13, P300, DOI 10.1016/S1470-2045(11)70385-0; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Gregorc V, 2014, LANCET ONCOL, V15, P713, DOI 10.1016/S1470-2045(14)70162-7; Guo JA, 2010, J CANCER RES CLIN, V136, P1341, DOI 10.1007/s00432-010-0785-z; He AL, 2012, INT J HEMATOL, V95, P668, DOI 10.1007/s12185-012-1080-3; He C, 2009, INT J CANCER, V125, P2393, DOI 10.1002/ijc.24653; Hojilla CV, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1980; Hong WX, 2013, TOXICOL APPL PHARM, V273, P121, DOI 10.1016/j.taap.2013.08.014; Kawaguchi T, 2014, J CLIN ONCOL, V32, P1902, DOI 10.1200/JCO.2013.52.4694; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Kimura H, 2007, BRIT J CANCER, V97, P778, DOI 10.1038/sj.bjc.6603949; Kimura H, 2006, J THORAC ONCOL, V1, P260, DOI 10.1016/S1556-0864(15)31577-X; Liu J, 2012, J NEUROIMMUNOL, V250, P71, DOI [10.1016/j.jneuroim.2012.04.021, DOI 10.1016/J.JNEUROIM.2012.04.021]; Liu X, 2009, NEUROSCI LETT, V463, P6, DOI 10.1016/j.neulet.2009.07.056; Liu XQ, 2013, J CLIN PATHOL, V66, P1065, DOI 10.1136/jclinpath-2013-201728; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Milan E, 2012, J PROTEOMICS, V76, P91, DOI 10.1016/j.jprot.2012.06.022; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Perez V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087731; Rauser S, 2010, J PROTEOME RES, V9, P1854, DOI 10.1021/pr901008d; Shi YK, 2013, LANCET ONCOL, V14, P953, DOI 10.1016/S1470-2045(13)70355-3; Shin S, 2007, J AM COLL SURGEONS, V204, P1065, DOI 10.1016/j.jamcollsurg.2007.01.036; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Taguchi F, 2007, J NATL CANCER I, V99, P838, DOI 10.1093/jnci/djk195; Tang W, 2011, FRONT BIOSCI-LANDMRK, V16, P2671; Wang L, 2014, EUR J OBSTET GYN R B, V177, P23, DOI 10.1016/j.ejogrb.2014.03.011; Wu X, 2013, ONCOTARGETS THER, V6, P1481, DOI 10.2147/OTT.S51887; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Yanagisawa K, 2003, LANCET, V362, P433, DOI 10.1016/S0140-6736(03)14068-8; Yang J, 2012, J CLIN LAB ANAL, V26, P148, DOI 10.1002/jcla.21502; Yung TKF, 2009, CLIN CANCER RES, V15, P2076, DOI 10.1158/1078-0432.CCR-08-2622; Zhang YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107161	38	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128970	10.1371/journal.pone.0128970	http://dx.doi.org/10.1371/journal.pone.0128970			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047516	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200112
J	Zheng, JC; Yang, ZY; Madgwick, PJ; Carmo-Silva, E; Parry, MAJ; Hu, YG				Zheng, Jiacheng; Yang, Zhiyuan; Madgwick, Pippa J.; Carmo-Silva, Elizabete; Parry, Martin A. J.; Hu, Yin-Gang			TaER Expression Is Associated with Transpiration Efficiency Traits and Yield in Bread Wheat	PLOS ONE			English	Article							WATER-USE EFFICIENCY; RECEPTOR-LIKE KINASE; DRAFT GENOME; ARABIDOPSIS; FAMILY; GROWTH; PROTEIN	ERECTA encodes a receptor-like kinase and is proposed as a candidate for determining transpiration efficiency of plants. Two genes homologous to ERECTA in Arabidopsis were identified on chromosomes 6 (TaER2) and 7 (TaER1) of bread wheat (Triticum aestivum L.), with copies of each gene on the A, B and D genomes of wheat. Similar expression patterns were observed for TaER1 and TaER2 with relatively higher expression of TaER1 in flag leaves of wheat at heading (Z55) and grain-filling (Z73) stages. Significant variations were found in the expression levels of both TaER1 and TaER2 in the flag leaves at both growth stages among 48 diverse bread wheat varieties. Based on the expression of TaER1 and TaER2, the 48 wheat varieties could be classified into three groups having high (5 varieties), medium (27 varieties) and low (16 varieties) levels of TaER expression. Significant differences were also observed between the three groups varying for TaER expression for several transpiration efficiency (TE)-related traits, including stomatal density (SD), transpiration rate, photosynthetic rate (A), instant water use efficiency (WUEi) and carbon isotope discrimination (CID), and yield traits of biomass production plant(-1) (BYPP) and grain yield plant(-1) (GYPP). Correlation analysis revealed that the expression of TaER1 and TaER2 at the two growth stages was significantly and negatively associated with SD (P<0.01), transpiration rate (P<0.05) and CID (P<0.01), while significantly and positively correlated with flag leaf area (FLA, P<0.01), A (P<0.05), WUEi (P<0.05), BYPP (P<0.01) and GYPP (P<0.01), with stronger correlations for TaER1 than TaER2 and at grain-filling stage than at heading stage. These combined results suggested that TaER involved in development of transpiration efficiency -related traits and yield in bread wheat, implying a function for TaER in regulating leaf development of bread wheat and contributing to expression of these traits. Moreover, the results indicate that TaER could be exploitable for manipulating important agronomical traits in wheat improvement.	[Zheng, Jiacheng; Yang, Zhiyuan; Hu, Yin-Gang] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Zheng, Jiacheng; Yang, Zhiyuan; Hu, Yin-Gang] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; [Madgwick, Pippa J.; Carmo-Silva, Elizabete; Parry, Martin A. J.] Rothamsted Res, Dept Plant Biol & Crop Sci, Harpenden, Herts, England; [Hu, Yin-Gang] Inst Water Saving Agr Arid Reg China, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Parry, MAJ (corresponding author), Rothamsted Res, Dept Plant Biol & Crop Sci, Harpenden, Herts, England.	martin.parry@rothamsted.ac.uk; huyingang@126.com	Carmo-Silva, Elizabete/G-7437-2012	Carmo-Silva, Elizabete/0000-0001-6059-9359; Parry, Martin/0000-0002-4477-672X	sub-project of the 863 Program of the Ministry of Science and Technology [2013AA102902]; China 111 Projectct, P. R. China [B12007]; Joint PhD scholarship of the Chinese Scholarship Council; BBSRC 20:20 Wheat Institute Strategic Programme (BBSRC) [BB/J/00426X/1]; Biotechnology and Biological Sciences Research Council [BB/I017372/1, BBS/E/C/00004952, BB/N004485/1, BBS/E/C/00005202] Funding Source: researchfish; BBSRC [BBS/E/C/00004952, BB/I017372/1, BBS/E/C/00005202, BB/N004485/1] Funding Source: UKRI	sub-project of the 863 Program of the Ministry of Science and Technology; China 111 Projectct, P. R. China; Joint PhD scholarship of the Chinese Scholarship Council; BBSRC 20:20 Wheat Institute Strategic Programme (BBSRC); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the sub-project of the 863 Program (2013AA102902) of the Ministry of Science and Technology, and the China 111 Project (B12007), P. R. China. Jia-Cheng Zheng was supported by a Joint PhD scholarship of the Chinese Scholarship Council. Pippa Madgwick, Elizabete Carmo-Silva and Martin Parry acknowledge financial support from the BBSRC 20:20 Wheat Institute Strategic Programme (BBSRC BB/J/00426X/1).	Bemis SM, 2013, J EXP BOT, V64, P5323, DOI 10.1093/jxb/ert270; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062285; Chen XJ, 2012, FIELD CROP RES, V137, P195, DOI 10.1016/j.fcr.2012.09.008; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; Huang LZ, 2013, AUST J CROP SCI, V3, pS381; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; Olsen MT, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-77; Pillitteri LJ, 2012, ANNU REV PLANT BIOL, V63, P591, DOI 10.1146/annurev-arplant-042811-105451; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Roussel M, 2009, J EXP BOT, V60, P2419, DOI 10.1093/jxb/erp100; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028; Shpak ED, 2003, PLANT CELL, V15, P1095, DOI 10.1105/tpc.010413; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; van Zanten M, 2009, TRENDS PLANT SCI, V14, P214, DOI 10.1016/j.tplants.2009.01.010; Villagarcia H, 2012, J EXP BOT, V63, P6493, DOI 10.1093/jxb/ers305; Xing HT, 2011, PLANTA, V234, P229, DOI 10.1007/s00425-011-1389-9; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x	21	16	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128415	10.1371/journal.pone.0128415	http://dx.doi.org/10.1371/journal.pone.0128415			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047019	Green Submitted, gold, Green Published			2022-12-27	WOS:000355652200068
J	Gao, ET; Chen, BY; Yang, JL; Shi, F; Zhu, WF; Xiang, DH; Chen, HY; Zhang, MZ; Chen, XJ				Gao, Enting; Chen, Binyao; Yang, Jianling; Shi, Fei; Zhu, Weifang; Xiang, Dehui; Chen, Haoyu; Zhang, Mingzhi; Chen, Xinjian			Comparison of Retinal Thickness Measurements between the Topcon Algorithm and a Graph-Based Algorithm in Normal and Glaucoma Eyes	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; DIABETIC MACULAR EDEMA; TIME-DOMAIN; DAMAGE; SEGMENTATION; HEAD; DISC; OCT	Purpose To assess the correlation and agreement between the Topcon built-in algorithm and our graph-based algorithm in measuring the total and regional macular thickness for normal and glaucoma subjects. Methods A total of 228 normal eyes and 93 glaucomatous eyes were enrolled in our study. All patients underwent comprehensive ophthalmic examination and Topcon 3D-OCT 2000 scan. One eye was randomly selected for each subject. The thickness of each layer and the total and regional macular thickness on an Early Treatment of Diabetic Retinopathy Study (ETDRS) chart were measured using the Topcon algorithm and our three-dimensional graph-based algorithm. Correlation and agreement analyses between these two algorithms were performed. Results Our graph search algorithm exhibited a strong correlation with Topcon algorithm. The macular GCC thickness values for normal and glaucoma subjects ranged from 0.86 to 0.91 and from 0.78 to 0.90, and the regional macular thickness values ranged from 0.79 to 0.96 and 0.70 to 0.95, respectively. Small differences were observed between the Topcon algorithm and our graph-based algorithm. The span of 95% limits of agreement of macular GCC thickness was less than 28 mu m in both normal and glaucoma subjects, respectively. These limits of total and regional macular thickness were 15.5 mu m and 23.1 mu m for normal subjects and 29.1 mu m and 46.4 mu m for glaucoma subjects, respectively. Conclusion Our graph-based algorithm exhibited a high degree of agreement with the Topcon algorithm with respect to thickness measurements in normal and glaucoma subjects. Moreover, our graph-based algorithm can segment the retina into more layers than the Topcon algorithm does.	[Gao, Enting; Shi, Fei; Zhu, Weifang; Xiang, Dehui; Chen, Xinjian] Soochow Univ, Sch Elect & Informat Engn, Suzhou, Peoples R China; [Gao, Enting] Suzhou Univ Sci & Technol, Sch Elect & Informat Engn, Suzhou, Peoples R China; [Chen, Binyao; Yang, Jianling; Chen, Haoyu; Zhang, Mingzhi] Shantou Univ, Joint Shantou Int Eye Ctr, Shantou, Peoples R China; [Chen, Binyao; Yang, Jianling; Chen, Haoyu; Zhang, Mingzhi] Chinese Univ Hong Kong, Shantou, Peoples R China	Soochow University - China; Suzhou University of Science & Technology; Shantou University	Chen, XJ (corresponding author), Soochow Univ, Sch Elect & Informat Engn, Suzhou, Peoples R China.	xjchen@suda.edu.cn	Xiang, Dehui/B-1938-2016; Chu, Kai On/E-2325-2016; Chen, Haoyu/A-7432-2013	Xiang, Dehui/0000-0001-7873-9778; Chen, Haoyu/0000-0003-0676-4610; Chen, Xinjian/0000-0002-0871-293X	National Basic Research Program of China [2014 CB748600]; National Nature Science Foundation of China [30901646, 81170853]	National Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by National Basic Research Program of China (973 Program, http://www.most.gov.cn/index.htm) under Grant 2014 CB748600 (XC). The funder had a role in study design and data collection and analysis. This work was also supported in part by National Nature Science Foundation of China (30901646 and 81170853) (http://www.nsfc.gov.cn/), XC. This funder had a role in decision to publish and preparation of the manuscript.	Abramoff MD, 2007, INVEST OPHTH VIS SCI, V48, P1665, DOI 10.1167/iovs.06-1081; Chen XJ, 2013, INVEST OPHTH VIS SCI, V54, P6846, DOI 10.1167/iovs.13-12062; Chen XJ, 2012, INVEST OPHTH VIS SCI, V53, P8042, DOI 10.1167/iovs.12-10083; Chen XJ, 2012, IEEE T MED IMAGING, V31, P1521, DOI 10.1109/TMI.2012.2191302; Garvin MK, 2009, IEEE T MED IMAGING, V28, P1436, DOI 10.1109/TMI.2009.2016958; Grover S, 2010, INVEST OPHTH VIS SCI, V51, P2644, DOI 10.1167/iovs.09-4774; Hood DC, 2007, INVEST OPHTH VIS SCI, V48, P3662, DOI 10.1167/iovs.06-1401; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Kanadani FN, 2006, BRIT J OPHTHALMOL, V90, P1393, DOI 10.1136/bjo.2006.099069; Knight OJ, 2009, OPHTHALMOLOGY, V116, P1271, DOI 10.1016/j.ophtha.2008.12.032; Kotera Y, 2011, INVEST OPHTH VIS SCI, V52, P1412, DOI 10.1167/iovs.10-5572; Lee KM, 2009, THESIS, V247; Leite MT, 2011, OPHTHALMOLOGY, V118, P1334, DOI 10.1016/j.ophtha.2010.11.029; Leung CKS, 2008, INVEST OPHTH VIS SCI, V49, P4893, DOI 10.1167/iovs.07-1326; Leung CKS, 2011, OPHTHALMOLOGY, V118, P1558, DOI 10.1016/j.ophtha.2011.01.026; Leung CKS, 2005, OPHTHALMOLOGY, V112, P391, DOI 10.1016/j.ophtha.2004.10.020; Mwanza JC, 2012, OPHTHALMOLOGY, V119, P1151, DOI 10.1016/j.ophtha.2011.12.014; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; QUIGLEY HA, 1982, ARCH OPHTHALMOL-CHIC, V100, P135, DOI 10.1001/archopht.1982.01030030137016; Sánchez-Dalmau B., 2010, Arch Soc Esp Oftalmol, V85, P165, DOI 10.1016/S0365-6691(10)55002-0; Seibold LK, 2010, AM J OPHTHALMOL, V150, P807, DOI 10.1016/j.ajo.2010.06.024; Shi F, 2014, AUTOMATED 3D RETINAL; Srinivasan VJ, 2008, INVEST OPHTH VIS SCI, V49, P5103, DOI 10.1167/iovs.08-2127; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Trick GL, 2006, J NEURO-OPHTHALMOL, V26, P284, DOI 10.1097/01.wno.0000249327.65227.67; Wolf-Schnurrbusch UEK, 2009, INVEST OPHTH VIS SCI, V50, P3432, DOI 10.1167/iovs.08-2970; Wollstein G, 2005, AM J OPHTHALMOL, V139, P39, DOI 10.1016/j.ajo.2004.08.036	28	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128925	10.1371/journal.pone.0128925	http://dx.doi.org/10.1371/journal.pone.0128925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042671	Green Published, gold, Green Submitted			2022-12-27	WOS:000355701600075
J	Salvadori, MR; Ando, RA; Nascimento, CAO; Correa, B				Salvadori, Marcia Regina; Ando, Romulo Augusto; Oller Nascimento, Claudio Augusto; Correa, Benedito			Extra and Intracellular Synthesis of Nickel Oxide Nanoparticles Mediated by Dead Fungal Biomass	PLOS ONE			English	Article							HEAVY-METAL REMOVAL; AQUEOUS-SOLUTION; BIOLOGICAL SYNTHESIS; ASPERGILLUS-NIGER; WASTE-WATER; THIN-FILMS; BIOSORPTION; NI(II); IONS; BIOREMEDIATION	The use of dead biomass of the fungus Hypocrea lixii as a biological system is a new, effective and environmentally friendly bioprocess for the production and uptake of nickel oxide nanoparticles (NPs), which has become a promising field in nanobiotechnology. Dead biomass of the fungus was successfully used to convert nickel ions into nickel oxide NPs in aqueous solution. These NPs accumulated intracellularly and extracellularly on the cell wall surface through biosorption. The average size, morphology and location of the NPs were characterized by transmission electron microscopy, high-resolution transmission electron microscopy, scanning electron microscopy, and energy dispersive X-ray spectroscopy. The NPs were mainly spherical and extra and intracellular NPs had an average size of 3.8 nm and 1.25 nm, respectively. X-ray photoelectron spectroscopy analysis confirmed the formation of nickel oxide NPs. Infrared spectroscopy detected the presence of functional amide groups, which are probable involved in particle binding to the biomass. The production of the NPs by dead biomass was analyzed by determining physicochemical parameters and equilibrium concentrations. The present study opens new perspectives for the biosynthesis of nanomaterials, which could become a potential biosorbent for the removal of toxic metals from polluted sites.	[Salvadori, Marcia Regina; Correa, Benedito] Univ Sao Paulo, Inst Ciencias Biomed 2, Dept Microbiol, Sao Paulo, Brazil; [Ando, Romulo Augusto] Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, Sao Paulo, Brazil; [Oller Nascimento, Claudio Augusto] Univ Sao Paulo, Politecn, Dept Engn Quim, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Salvadori, MR (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed 2, Dept Microbiol, Sao Paulo, Brazil.	mrsal@usp.br	Ando, Romulo Augusto/C-9665-2012; Nascimento, Claudio A.O./G-8565-2014	Ando, Romulo Augusto/0000-0002-3872-8094; Nascimento, Claudio A.O./0000-0001-6110-0249; Correa, Benedito/0000-0003-4314-0751; Salvadori, Marcia Regina/0000-0001-6771-5447	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funding was provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Iqbal, 2006, Indian J Exp Biol, V44, P73; [Anonymous], 2006, J ENVIRON SCI; Arland P, 2006, BIORESOURCE TECHNOL, V97, P1018, DOI 10.1016/j.biortech.2005.04.046; Baldrian P, 2002, MYCOLOGIA, V94, P428, DOI 10.2307/3761777; Bansal V, 2006, J AM CHEM SOC, V128, P14059, DOI 10.1021/ja062113+; Basavaraja S, 2008, MATER RES BULL, V43, P1164, DOI 10.1016/j.materresbull.2007.06.020; Bi H, 2004, J MAGN MAGN MATER, V277, P363, DOI 10.1016/j.jmmm.2003.11.017; Biju V, 2003, SPECTROCHIM ACTA A, V59, P121, DOI 10.1016/S1386-1425(02)00120-8; Bishnoi NR, 2005, J SCI IND RES INDIA, V64, P93; Delgado A, 1998, WATER ENVIRON RES, V70, P370, DOI 10.2175/106143098X125019; Dias MA, 2002, LETT APPL MICROBIOL, V34, P46, DOI 10.1046/j.1472-765x.2002.01040.x; DOOLEY KM, 1994, J CATAL, V145, P402, DOI 10.1006/jcat.1994.1050; Du LW, 2011, J NANOPART RES, V13, P921, DOI 10.1007/s11051-010-0165-2; Fukui T, 2000, J POWER SOURCES, V86, P340, DOI 10.1016/S0378-7753(99)00416-4; FURSTENAU RP, 1985, SURF SCI, V150, P55, DOI 10.1016/0039-6028(85)90211-0; Gavrilescu M, 2004, ENG LIFE SCI, V4, P219, DOI 10.1002/elsc.200420026; Gericke M, 2006, HYDROMETALLURGY, V83, P132, DOI 10.1016/j.hydromet.2006.03.019; GLEITER H, 1989, PROG MATER SCI, V33, P223, DOI 10.1016/0921-5093(89)90083-X; Hanif MA, 2007, J HAZARD MATER, V139, P345, DOI 10.1016/j.jhazmat.2006.06.040; HOLAN ZR, 1994, BIOTECHNOL BIOENG, V43, P1001, DOI 10.1002/bit.260431102; Hotovy I, 1999, SENSOR ACTUAT B-CHEM, V57, P147, DOI 10.1016/S0925-4005(99)00077-5; Iftikhar AR, 2009, J HAZARD MATER, V161, P941, DOI 10.1016/j.jhazmat.2008.04.040; Javaid A, 2010, PAK J BOT, V42, P2105; JOHO M, 1995, J IND MICROBIOL, V14, P164, DOI 10.1007/BF01569899; Kapoor A, 1995, BIORESOURCE TECHNOL, V53, P195, DOI 10.1016/0960-8524(95)00072-1; Kumar BN, 2011, SEP SCI TECHNOL, V46, P997, DOI 10.1080/01496395.2010.537727; Lee IS, 2006, J AM CHEM SOC, V128, P10658, DOI 10.1021/ja063177n; Liu YG, 2006, T NONFERR METAL SOC, V16, P681, DOI 10.1016/S1003-6326(06)60121-0; Mali A., 2014, INT J CIV STRUCT ENV, V4, P11; Malik A, 2004, ENVIRON INT, V30, P261, DOI 10.1016/j.envint.2003.08.001; Malkoc E, 2006, J HAZARD MATER, V137, P899, DOI 10.1016/j.jhazmat.2006.03.004; Narayanan KB, 2010, ADV COLLOID INTERFAC, V156, P1, DOI 10.1016/j.cis.2010.02.001; Navazi Zahra Ranjbar, 2010, Iranian Journal of Biotechnology, V8, P56; Ozer A, 2003, J HAZARD MATER, V100, P219, DOI 10.1016/S0304-3894(03)00109-2; Ozturk A, 2004, COLLOID SURFACE B, V34, P105, DOI 10.1016/j.colsurfb.2003.11.008; Porqueras I, 2001, THIN SOLID FILMS, V398, P41, DOI 10.1016/S0040-6090(01)01301-3; Purvis OW, 1996, LICHENOLOGIST, V28, P571; Quintelas C, 2009, CHEM ENG J, V149, P319, DOI 10.1016/j.cej.2008.11.025; Salvadori MR, 2014, J ENVIRON SCI HEAL A, V49, P1286, DOI 10.1080/10934529.2014.910067; Salvadori MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087968; Salvadori MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080519; Salvadori MR, 2014, SCI REP-UK, V4, DOI 10.1038/srep06404; Sangeetha N, 2013, J NANOBIOTECHNOL, V39, P1; SESSOLI R, 1993, NATURE, V365, P141, DOI 10.1038/365141a0; Sheng PX, 2004, J COLLOID INTERF SCI, V275, P131, DOI 10.1016/j.jcis.2004.01.036; Shoaib A, 2012, INT J AGRIC BIOL, V14, P831; Song PX, 2008, PHYS CHEM CHEM PHYS, V10, P5057, DOI 10.1039/b800672e; Srivastava S, 2006, CURR MICROBIOL, V53, P232, DOI 10.1007/s00284-006-0103-9; Thakkar KN, 2010, NANOMED-NANOTECHNOL, V6, P257, DOI 10.1016/j.nano.2009.07.002; TREENSEARS ME, 1984, BIOTECHNOL BIOENG, V26, P1323, DOI 10.1002/bit.260261109; Varshney R., 2012, NANO BIOMED ENG, V4, P99, DOI [10.5101/nbe.v4i2.p99-106, DOI 10.5101/NBE.V4I2.P99-106]; Veglio F, 1997, HYDROMETALLURGY, V44, P301, DOI 10.1016/S0304-386X(96)00059-X; Volesky B, 2003, HYDROMETALLURGY, V71, P179, DOI 10.1016/S0304-386X(03)00155-5; Volesky B, 2001, HYDROMETALLURGY, V59, P203, DOI 10.1016/S0304-386X(00)00160-2; Wang GZ, 1997, ACTA PHYS-CHIM SIN, V13, P445, DOI 10.3866/PKU.WHXB19970511; Yan GY, 2003, WATER RES, V37, P4486, DOI 10.1016/S0043-1354(03)00409-3; Yan GY, 2001, BIORESOURCE TECHNOL, V78, P243, DOI 10.1016/S0960-8524(01)00020-7; Zhang L, 1998, WATER RES, V32, P1437, DOI 10.1016/S0043-1354(97)00348-5; Zhang YX, 2011, INT J NANOMED, V6, P2899, DOI 10.2147/IJN.S24785	59	35	36	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0129799	10.1371/journal.pone.0129799	http://dx.doi.org/10.1371/journal.pone.0129799			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043111	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600101
J	Tardy, O; Masse, A; Pelletier, F; Fortin, D				Tardy, Olivia; Masse, Ariane; Pelletier, Fanie; Fortin, Daniel			Resampling Method for Applying Density-Dependent Habitat Selection Theory to Wildlife Surveys	PLOS ONE			English	Article							RACCOON RABIES; POPULATION-DENSITY; ECOLOGICAL TRAPS; STRIPED SKUNKS; PROCYON-LOTOR; VACCINATION; SURVEILLANCE; LANDSCAPES; MANAGEMENT; ABUNDANCE	Isodar theory can be used to evaluate fitness consequences of density-dependent habitat selection by animals. A typical habitat isodar is a regression curve plotting competitor densities in two adjacent habitats when individual fitness is equal. Despite the increasing use of habitat isodars, their application remains largely limited to areas composed of pairs of adjacent habitats that are defined a priori. We developed a resampling method that uses data from wildlife surveys to build isodars in heterogeneous landscapes without having to predefine habitat types. The method consists in randomly placing blocks over the survey area and dividing those blocks in two adjacent sub-blocks of the same size. Animal abundance is then estimated within the two sub-blocks. This process is done 100 times. Different functional forms of isodars can be investigated by relating animal abundance and differences in habitat features between sub-blocks. We applied this method to abundance data of raccoons and striped skunks, two of the main hosts of rabies virus in North America. Habitat selection by raccoons and striped skunks depended on both conspecific abundance and the difference in landscape composition and structure between sub-blocks. When conspecific abundance was low, raccoons and striped skunks favored areas with relatively high proportions of forests and anthropogenic features, respectively. Under high conspecific abundance, however, both species preferred areas with rather large corn-forest edge densities and corn field proportions. Based on random sampling techniques, we provide a robust method that is applicable to a broad range of species, including medium-to large-sized mammals with high mobility. The method is sufficiently flexible to incorporate multiple environmental covariates that can reflect key requirements of the focal species. We thus illustrate how isodar theory can be used with wildlife surveys to assess density-dependent habitat selection over large geographic extents.	[Tardy, Olivia; Fortin, Daniel] Univ Laval, Ctr Etud Foret, Quebec City, PQ, Canada; [Tardy, Olivia; Fortin, Daniel] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Masse, Ariane] Minist Forets, Direct Biodivers & Malad Faune, Direct Gen Expertise Faune & Ses Habitats, Quebec City, PQ, Canada; [Pelletier, Fanie] Univ Sherbrooke, Dept Biol, Canada Res Chair Evolutionary Demog & Conservat, Sherbrooke, PQ J1K 2R1, Canada	Laval University; Laval University; University of Sherbrooke	Tardy, O (corresponding author), Univ Laval, Ctr Etud Foret, Quebec City, PQ, Canada.	olivia.tardy.1@ulaval.ca	Fortin, Daniel/ABG-3554-2020	Tardy, Olivia/0000-0002-0242-8137	Ministere des Ressources Naturelles et de la Faune du Quebec; Fonds de recherche du Quebec - Nature et technologies; Dany Garant; Julien Mainguy	Ministere des Ressources Naturelles et de la Faune du Quebec; Fonds de recherche du Quebec - Nature et technologies; Dany Garant; Julien Mainguy	This work was financed by the Ministere des Ressources Naturelles et de la Faune du Quebec and by a team research grant from the Fonds de recherche du Quebec - Nature et technologies to DF, FP, Dany Garant, and Julien Mainguy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsky Z, 1997, OIKOS, V78, P81, DOI 10.2307/3545803; Ale SB, 2011, OIKOS, V120, P1191, DOI 10.1111/j.1600-0706.2010.18933.x; Anderson DR, 2001, WILDLIFE SOC B, V29, P1294; Beasley JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113206; Beasley JC, 2012, J WILDLIFE MANAGE, V76, P1290, DOI 10.1002/jwmg.379; Beyer H. L, 2012, GEOSPATIAL MODELLING; Blanton JD, 2012, JAVMA-J AM VET MED A, V241, P712, DOI 10.2460/javma.241.6.712; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Boyer JP, 2011, J WILDLIFE DIS, V47, P593, DOI 10.7589/0090-3558-47.3.593; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Dennis B, 2010, ECOLOGY, V91, P610, DOI 10.1890/08-1095.1; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Fernandez-Juricic E, 2001, IBIS, V143, P278, DOI 10.1111/j.1474-919X.2001.tb04484.x; FRETWELL S D, 1972, P217; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Greenwood RJ, 1997, J WILDLIFE DIS, V33, P226, DOI 10.7589/0090-3558-33.2.226; Haugen TO, 2006, P ROY SOC B-BIOL SCI, V273, P2917, DOI 10.1098/rspb.2006.3659; Henner CM, 2004, J WILDLIFE MANAGE, V68, P179, DOI 10.2193/0022-541X(2004)068[0179:AMAORD]2.0.CO;2; Hodson J, 2010, OECOLOGIA, V164, P73, DOI 10.1007/s00442-010-1691-4; Houle M, 2011, CAN J ZOOL, V89, P1107, DOI [10.1139/Z11-085, 10.1139/z11-085]; Knight TW, 1996, ECOLOGY, V77, P1756, DOI 10.2307/2265781; Krasnov BR, 2003, OECOLOGIA, V134, P365, DOI 10.1007/s00442-002-1122-2; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Lariviere S, 1998, J APPL ECOL, V35, P207, DOI 10.1046/j.1365-2664.1998.00301.x; Lariviere S, 2000, CAN J ZOOL, V78, P366, DOI 10.1139/cjz-78-3-366; Manly BFJ, 1997, RANDOMIZATION BOOTST; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; Merkle JA, 2014, WILDLIFE SOC B, V38, P196, DOI 10.1002/wsb.382; Morris DW, 2012, EVOL ECOL RES, V14, P689; Morris DW, 2012, OIKOS, V121, P975, DOI 10.1111/j.1600-0706.2011.20492.x; Morris DW, 2011, P ROY SOC B-BIOL SCI, V278, P2401, DOI 10.1098/rspb.2011.0604; Morris DW, 2009, EVOL ECOL RES, V11, P209; MORRIS DW, 1992, EVOL ECOL, V6, P412, DOI 10.1007/BF02270701; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; Morris DW, 2003, WILDLIFE RES, V30, P303, DOI 10.1071/WR02028; Morris DW, 2002, EVOL ECOL RES, V4, P787; MORRIS DW, 1988, EVOL ECOL, V2, P253, DOI 10.1007/BF02214286; MORRIS DW, 1994, EVOL ECOL, V8, P387, DOI 10.1007/BF01238190; MORRIS DW, 1987, ECOL MONOGR, V57, P269, DOI 10.2307/2937087; MORRIS DW, 1990, OIKOS, V59, P303, DOI 10.2307/3545140; Moses MM, 2013, EVOL ECOL RES, V15, P809; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Olfert ED, 1993, GUIDE CARE USE EXPT; Pedlar JH, 1997, J WILDLIFE MANAGE, V61, P102, DOI 10.2307/3802419; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Development Core Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Ramey PC, 2008, J WILDLIFE DIS, V44, P553, DOI 10.7589/0090-3558-44.3.553; Ramp D, 2002, OIKOS, V98, P393, DOI 10.1034/j.1600-0706.2002.980304.x; Rees EE, 2011, J WILDLIFE MANAGE, V75, P1406, DOI 10.1002/jwmg.178; Robert K, 2012, J WILDLIFE DIS, V48, P122, DOI 10.7589/0090-3558-48.1.122; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; Robertson BA, 2013, TRENDS ECOL EVOL, V28, P552, DOI 10.1016/j.tree.2013.04.004; RODRIGUEZ MA, 1995, EVOL ECOL, V9, P169, DOI 10.1007/BF01237755; ROGERS DJ, 1991, NATURE, V351, P739, DOI 10.1038/351739a0; Rosatte R, 2007, J WILDLIFE DIS, V43, P242, DOI 10.7589/0090-3558-43.2.242; Rosatte R, 2006, J WILDLIFE DIS, V42, P589, DOI 10.7589/0090-3558-42.3.589; ROSENZWEIG ML, 1981, ECOLOGY, V62, P327, DOI 10.2307/1936707; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Shenbrot G, 2000, EVOL ECOL RES, V2, P257; Shochat E, 2005, OIKOS, V111, P159, DOI 10.1111/j.0030-1299.2005.13907.x; Talbot B, 2013, ECOSCIENCE, V20, P345, DOI 10.2980/20-4-3633; Tardy O, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00197.1; The Math Works, 2011, MATLAB LANG TECHN CO; Tyler JA, 1997, OIKOS, V79, P376, DOI 10.2307/3546022; van Beest FM, 2014, J ANIM ECOL, V83, P147, DOI 10.1111/1365-2656.12115	65	1	1	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128238	10.1371/journal.pone.0128238	http://dx.doi.org/10.1371/journal.pone.0128238			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042998	gold, Green Published, Green Submitted			2022-12-27	WOS:000355701600040
J	Ahmed, M; Saleem, MR; Zia, S; Qamar, S				Ahmed, Munshoor; Saleem, M. Rehan; Zia, Saqib; Qamar, Shamsul			Central Upwind Scheme for a Compressible Two-Phase Flow Model	PLOS ONE			English	Article								In this article, a compressible two-phase reduced five-equation flow model is numerically investigated. The model is non-conservative and the governing equations consist of two equations describing the conservation of mass, one for overall momentum and one for total energy. The fifth equation is the energy equation for one of the two phases and it includes source term on the right-hand side which represents the energy exchange between two fluids in the form of mechanical and thermodynamical work. For the numerical approximation of the model a high resolution central upwind scheme is implemented. This is a non-oscillatory upwind biased finite volume scheme which does not require a Riemann solver at each time step. Few numerical case studies of two-phase flows are presented. For validation and comparison, the same model is also solved by using kinetic flux-vector splitting (KFVS) and staggered central schemes. It was found that central upwind scheme produces comparable results to the KFVS scheme.	[Ahmed, Munshoor; Saleem, M. Rehan; Zia, Saqib; Qamar, Shamsul] COMSATS Inst Informat Technol, Dept Math, Islamabad, Pakistan	COMSATS University Islamabad (CUI)	Zia, S (corresponding author), COMSATS Inst Informat Technol, Dept Math, Islamabad, Pakistan.	saqibzia81@hotmail.com						Abgrall R, 2003, J COMPUT PHYS, V186, P361, DOI 10.1016/S0021-9991(03)00011-1; Ansari MR, 2013, INT J HEAT FLUID FL, V42, P209, DOI 10.1016/j.ijheatfluidflow.2013.02.003; BAER MR, 1986, INT J MULTIPHAS FLOW, V12, P861, DOI 10.1016/0301-9322(86)90033-9; Coralic V, 2014, J COMPUT PHYS, V274, P95, DOI 10.1016/j.jcp.2014.06.003; de Frahan MTH, 2015, J COMPUT PHYS, V280, P489, DOI 10.1016/j.jcp.2014.09.030; HAAS JF, 1987, J FLUID MECH, V181, P41, DOI 10.1017/S0022112087002003; Kapila AK, 2001, PHYS FLUIDS, V13, P3002, DOI 10.1063/1.1398042; Kreeft JJ, 2010, J COMPUT PHYS, V229, P6220, DOI 10.1016/j.jcp.2010.04.025; Kurganov A, 2000, J COMPUT PHYS, V160, P241, DOI 10.1006/jcph.2000.6459; MANDAL JC, 1994, COMPUT FLUIDS, V23, P447, DOI 10.1016/0045-7930(94)90050-7; Marquina A, 2003, J COMPUT PHYS, V185, P120, DOI 10.1016/S0021-9991(02)00050-5; MENIKOFF R, 1989, REV MOD PHYS, V61, P75, DOI 10.1103/RevModPhys.61.75; Murrone A, 2005, J COMPUT PHYS, V202, P664, DOI 10.1016/j.jcp.2004.07.019; NESSYAHU H, 1990, J COMPUT PHYS, V87, P408, DOI 10.1016/0021-9991(90)90260-8; Qamar S, 2009, J COMPUT PHYS, V228, P9059, DOI 10.1016/j.jcp.2009.09.010; Quirk JJ, 1996, J FLUID MECH, V318, P129, DOI 10.1017/S0022112096007069; Saurel R, 1999, J COMPUT PHYS, V150, P425, DOI 10.1006/jcph.1999.6187; Toro E.F., 2009, RIEMANN SOLVERS NUME, P456; van Leer B., 1982, 8230 ICASE; Wackers J, 2004, MASE0414 CWI; Wood A. B, 1930, TXB SOUND; Zia S, 2014, COMPUT MATH APPL, V67, P1271, DOI 10.1016/j.camwa.2014.01.015	23	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126273	10.1371/journal.pone.0126273	http://dx.doi.org/10.1371/journal.pone.0126273			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039242	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700022
J	Lapchak, PA; Boitano, PD; Butte, PV; Fisher, DJ; Holscher, T; Ley, EJ; Nuno, M; Voie, AH; Rajput, PS				Lapchak, Paul A.; Boitano, Paul D.; Butte, Pramod V.; Fisher, David J.; Hoelscher, Thilo; Ley, Eric J.; Nuno, Miriam; Voie, Arne H.; Rajput, Padmesh S.			Transcranial Near-Infrared Laser Transmission (NILT) Profiles (800 nm): Systematic Comparison in Four Common Research Species	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; TERM NEUROLOGICAL DEFICITS; ACUTE ISCHEMIC-STROKE; LIGHT THERAPY; NEUROTHERA EFFECTIVENESS; EMBOLIC STROKES; RAT-BRAIN; IRRADIATION; SAFETY; RABBITS	Background and Purpose Transcranial near-infrared laser therapy (TLT) is a promising and novel method to promote neuroprotection and clinical improvement in both acute and chronic neurodegenerative diseases such as acute ischemic stroke (AIS), traumatic brain injury (TBI), and Alzheimer's disease (AD) patients based upon efficacy in translational animal models. However, there is limited information in the peer-reviewed literature pertaining to transcranial near-infrared laser transmission (NILT) profiles in various species. Thus, in the present study we systematically evaluated NILT characteristics through the skull of 4 different species: mouse, rat, rabbit and human. Results Using dehydrated skulls from 3 animal species, using a wavelength of 800nm and a surface power density of 700 mW/cm(2), NILT decreased from 40.10% (mouse) to 21.24% (rat) to 11.36% (rabbit) as skull thickness measured at bregma increased from 0.44 mm in mouse to 0.83 mm in rat and then 2.11 mm in rabbit. NILT also significantly increased (p<0.05) when animal skulls were hydrated (i.e. compared to dehydrated); but there was no measurable change in thickness due to hydration. In human calvaria, where mean thickness ranged from 7.19 mm at bregma to 5.91 mm in the parietal skull, only 4.18% and 4.24% of applied near-infrared light was transmitted through the skull. There was a slight (9.2-13.4%), but insignificant effect of hydration state on NILT transmission of human skulls, but there was a significant positive correlation between NILT and thickness at bregma and parietal skull, in both hydrated and dehydrated states. Conclusion This is the first systematic study to demonstrate differential NILT through the skulls of 4 different species; with an inverse relationship between NILT and skull thickness. With animal skulls, transmission profiles are dependent upon the hydration state of the skull, with significantly greater penetration through hydrated skulls compared to dehydrated skulls. Using human skulls, we demonstrate a significant correlation between thickness and penetration, but there was no correlation with skull density. The results suggest that TLT should be optimized in animals using novel approaches incorporating human skull characteristics, because of significant variance of NILT profiles directly related to skull thickness.	[Lapchak, Paul A.; Boitano, Paul D.] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA; [Lapchak, Paul A.; Butte, Pramod V.; Nuno, Miriam; Rajput, Padmesh S.] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Fisher, David J.; Hoelscher, Thilo; Voie, Arne H.] BURL Concepts Inc, San Diego, CA USA; [Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Lapchak, PA (corresponding author), Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA.	Paul.Lapchak@cshs.org	Lapchak, Paul/P-1845-2019	Lapchak, Paul/0000-0003-4413-7554	U01 Translational research grant [NS060685]; R01 research grant [HL091043]; BURL Concepts Inc.	U01 Translational research grant; R01 research grant; BURL Concepts Inc.	Dr. Lapchak serves as Editor-in-Chief of the Journal of Neurology & Neurophysiology and Associate Editor of Translational Stroke Research. The scientific content of this work was not directly supported by NIH or any other funding source external to Cedars-Sinai Medical Center. PAL was supported in part by a U01 Translational research grant NS060685. Dr. Hoelscher is employed by Burl Concepts Inc. TH was supported by an R01 research grant HL091043. This study utilized a K-Laser USA LLC model K-1200 device, but K-Laser USA LLC did not have an editorial influence on the study design or scientific content of this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The scientific content of this work was not directly supported by NIH or any other funding source external to Cedars-Sinai Medical Center. PAL was supported in part by a U01 Translational research grant NS060685. TH was supported by an R01 research grant HL091043. This study utilized a K-Laser USA LLC model K-1200 device, but K-Laser USA LLC did not have an editorial influence on the study design or scientific content of this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors David J. Fisher, Thilo Hoelscher and Arne H. Voie are employed by BURL Concepts Inc. BURL Concepts Inc. provided support in the form of salaries for authors DJF, TH and AHV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ando T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026212; Byrnes KR, 2005, LASER SURG MED, V36, P171, DOI 10.1002/lsm.20143; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; De Taboada L, 2011, J ALZHEIMERS DIS, V23, P521, DOI 10.3233/JAD-2010-100894; Desmet KD, 2006, PHOTOMED LASER SURG, V24, P121, DOI 10.1089/pho.2006.24.121; DeTaboada L, 2006, LASER SURG MED, V38, P70, DOI 10.1002/lsm.20256; Farfara D, 2015, J MOL NEUROSCI, V55, P430, DOI 10.1007/s12031-014-0354-z; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fitzgerald M, 2013, REV NEUROSCIENCE, V24, P205, DOI 10.1515/revneuro-2012-0086; Hacke W, 2014, STROKE, V45, P3187, DOI 10.1161/STROKEAHA.114.005795; Haeussinger FB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026377; Huang YY, 2012, J BIOPHOTONICS, V5, P827, DOI 10.1002/jbio.201200077; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Ilic S, 2006, PHOTOMED LASER SURG, V24, P458, DOI 10.1089/pho.2006.24.458; Kasner SE, 2013, STROKE, V44, P2025, DOI 10.1161/STROKEAHA.113.000870; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lapchak PA, 2007, NEUROSCIENCE, V148, P907, DOI 10.1016/j.neuroscience.2007.07.002; Lapchak PA, 2004, STROKE, V35, P1985, DOI 10.1161/01.STR.0000131808.69640.b7; Lapchak PA, 2008, STROKE, V39, P3073, DOI 10.1161/STROKEAHA.108.516393; Lapchak PA, 2013, TRANSL STROKE RES, V4, P279, DOI 10.1007/s12975-012-0209-2; Lapchak PA, 2012, EXPERT REV MED DEVIC, V9, P71, DOI 10.1586/ERD.11.64; Lapchak PA, 2010, ANN MED, V42, P576, DOI 10.3109/07853890.2010.532811; Lapchak PA, 2010, BRAIN RES, V1306, P100, DOI 10.1016/j.brainres.2009.10.022; Lychagov VV, 2006, PROC SPIE, V6085, DOI 10.1117/12.650116; Mochizuki-Oda N, 2002, NEUROSCI LETT, V323, P207, DOI 10.1016/S0304-3940(02)00159-3; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P443, DOI 10.1089/pho.2011.9908; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Oron A, 2012, J NEUROTRAUM, V29, P401, DOI 10.1089/neu.2011.2062; Oron U, 2001, CIRCULATION, V103, P296; Schellinger PD, 2012, NERVENARZT, V83, P966, DOI 10.1007/s00115-012-3567-9; Trimmer PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-26; Voie A, 2014, COMPUT MED IMAG GRAP, V38, P675, DOI 10.1016/j.compmedimag.2014.06.022; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Xuan WJ, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.108003; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547	38	34	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127580	10.1371/journal.pone.0127580	http://dx.doi.org/10.1371/journal.pone.0127580			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039354	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700067
J	Leidinger, P; Keller, A; Milchram, L; Harz, C; Hart, M; Werth, A; Lenhof, HP; Weinhausel, A; Keck, B; Wullich, B; Ludwig, N; Meese, E				Leidinger, Petra; Keller, Andreas; Milchram, Lisa; Harz, Christian; Hart, Martin; Werth, Angelika; Lenhof, Hans-Peter; Weinhaeusel, Andreas; Keck, Bastian; Wullich, Bernd; Ludwig, Nicole; Meese, Eckart			Combination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients with Benign Prostatic Hyperplasia	PLOS ONE			English	Article							ANTIGEN; BIOMARKERS; MORTALITY; TARGETS; MARCKS; TUMOR; SERUM	Although an increased level of the prostate-specific antigen can be an indication for prostate cancer, other reasons often lead to a high rate of false positive results. Therefore, an additional serological screening of autoantibodies in patients' sera could improve the detection of prostate cancer. We performed protein macroarray screening with sera from 49 prostate cancer patients, 70 patients with benign prostatic hyperplasia and 28 healthy controls and compared the autoimmune response in those groups. We were able to distinguish prostate cancer patients from normal controls with an accuracy of 83.2%, patients with benign prostatic hyperplasia from normal controls with an accuracy of 86.0% and prostate cancer patients from patients with benign prostatic hyperplasia with an accuracy of 70.3%. Combining seroreactivity pattern with a PSA level of higher than 4.0 ng/ml this classification could be improved to an accuracy of 84.1%. For selected proteins we were able to confirm the differential expression by using luminex on 84 samples. We provide a minimally invasive serological method to reduce false positive results in detection of prostate cancer and according to PSA screening to distinguish men with prostate cancer from men with benign prostatic hyperplasia.	[Leidinger, Petra; Harz, Christian; Hart, Martin; Ludwig, Nicole; Meese, Eckart] Univ Saarland, Sch Med, Dept Human Genet, D-66421 Homburg, Germany; [Keller, Andreas] Univ Saarland, Chair Clin Bioinformat, D-66123 Saarbrucken, Germany; [Lenhof, Hans-Peter] Univ Saarland, Ctr Bioinformat, D-66123 Saarbrucken, Germany; [Milchram, Lisa; Weinhaeusel, Andreas] Austrian Inst Technol GmbH, Hlth & Environm Dept, A-1220 Vienna, Austria; [Keck, Bastian; Wullich, Bernd] Univ Erlangen Nurnberg, Univ Clin Urol, D-91054 Erlangen, Germany	Saarland University; Saarland University; Saarland University; Austrian Institute of Technology (AIT); University of Erlangen Nuremberg	Hart, M (corresponding author), Univ Saarland, Sch Med, Dept Human Genet, Bldg 60, D-66421 Homburg, Germany.	martin.hart@uks.eu	Weinhaeusel, Andreas/A-7644-2018; Keller, Andreas/ABB-6412-2021; Meese, Eckart Ulrich/ABD-1983-2021	Keller, Andreas/0000-0002-5361-0895; Weinhaeusel, Andreas/0000-0002-9318-1204				ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; CATALONA WJ, 1991, NEW ENGL J MED, V324, P1156, DOI 10.1056/NEJM199104253241702; Chapman CJ, 2008, THORAX, V63, P228, DOI 10.1136/thx.2007.083592; CHRISTENSSON A, 1990, EUR J BIOCHEM, V194, P755, DOI 10.1111/j.1432-1033.1990.tb19466.x; Christensson A, 1993, J UROL; Cohen Lorenzo, 2003, Cancer Epidemiology Biomarkers & Prevention, V12, P610; Comtesse N, 2005, P NATL ACAD SCI USA, V102, P9601, DOI 10.1073/pnas.0500404102; Erkanli A, 2006, CANCER RES, V66, P1792, DOI 10.1158/0008-5472.CAN-05-0669; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Finlayson A, 2009, BRITISH PARTY POLITICS AND IDEOLOGY AFTER NEW LABOUR, P11; Gao YY, 2009, MOL CANCER THER, V8, P3276, DOI 10.1158/1535-7163.MCT-09-0478; Humphrey PA, 2004, MODERN PATHOL, V17, P292, DOI 10.1038/modpathol.3800054; Jurchott K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001231; Leidinger P, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-18; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Linton HJ, 2003, CLIN CHEM, V49, P253, DOI 10.1373/49.2.253; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; Lu-Yao GL, 2009, JAMA-J AM MED ASSOC, V302, P1202, DOI 10.1001/jama.2009.1348; Madu CO, 2010, J CANCER, V1, P150; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Partin AW, 1998, PROSTATE CANCER P D, V1, P197, DOI 10.1038/sj.pcan.4500232; Piura E, 2008, J ONCOL, V2010, DOI [10.1155/2010/264926, DOI 10.1155/2010/264926]; Poletaev A, 2003, AUTOIMMUN REV, V2, P264, DOI 10.1016/S1568-9972(03)00033-8; Ramsden JJ, 2000, INT J BIOCHEM CELL B, V32, P475, DOI 10.1016/S1357-2725(99)00152-1; Rosario DJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7894; Schmid HP, 2003, RECENT RESULTS CANC, V163, P226; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Sirovich BE, 2003, JAMA-J AM MED ASSOC, V289, P1414, DOI 10.1001/jama.289.11.1414; SMITH DS, 1995, UROLOGY, V45, P70, DOI 10.1016/S0090-4295(95)96812-1; Tabares-Seisdedos R, 2009, MOL PSYCHIATR, V14, P563, DOI 10.1038/mp.2009.2; Tosoian J, 2010, THESCIENTIFICWORLDJO, V10, P1919, DOI 10.1100/tsw.2010.182; Wang H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-91; Wang XJ, 2005, NEW ENGL J MED, V353, P1224, DOI 10.1056/NEJMoa051931; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066; Yang JY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-388	35	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128235	10.1371/journal.pone.0128235	http://dx.doi.org/10.1371/journal.pone.0128235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039628	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700091
J	Shepertycky, M; Li, QG				Shepertycky, Michael; Li, Qingguo			Generating Electricity during Walking with a Lower Limb-Driven Energy Harvester: Targeting a Minimum User Effort	PLOS ONE			English	Article							CENTER-OF-MASS; METABOLIC COST; DETERMINANTS; ENERGETICS; FREQUENCY	Background Much research in the field of energy harvesting has sought to develop devices capable of generating electricity during daily activities with minimum user effort. No previous study has considered the metabolic cost of carrying the harvester when determining the energetic effects it has on the user. When considering device carrying costs, no energy harvester to date has demonstrated the ability to generate a substantial amount of electricity (> 5W) while maintaining a user effort at the same level or lower than conventional power generation methods (e.g. hand crank generator). Methodology/Principal Findings We developed a lower limb-driven energy harvester that is able to generate approximately 9W of electricity. To quantify the performance of the harvester, we introduced a new performance measure, total cost of harvesting (TCOH), which evaluates a harvester's overall efficiency in generating electricity including the device carrying cost. The new harvester captured the motion from both lower limbs and operated in the generative braking mode to assist the knee flexor muscles in slowing the lower limbs. From a testing on 10 participants under different walking conditions, the harvester achieved an average TCOH of 6.1, which is comparable to the estimated TCOH for a conventional power generation method of 6.2. When generating 5.2W of electricity, the TCOH of the lower limb-driven energy harvester (4.0) is lower than that of conventional power generation methods. Conclusions/Significance These results demonstrated that the lower limb-driven energy harvester is an energetically effective option for generating electricity during daily activities.	[Shepertycky, Michael; Li, Qingguo] Queens Univ, Dept Mech & Mat Engn, Biomechatron & Robot Lab, Kingston, ON, Canada	Queens University - Canada	Li, QG (corresponding author), Queens Univ, Dept Mech & Mat Engn, Biomechatron & Robot Lab, Kingston, ON, Canada.	ql3@queensu.ca		Shepertycky, Michael/0000-0002-3516-6532	Natural Science and Engineering Research Council Discovery grant [388774]	Natural Science and Engineering Research Council Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was supported by a Natural Science and Engineering Research Council Discovery grant (388774).	Bertram JEA, 2001, J THEOR BIOL, V209, P445, DOI 10.1006/jtbi.2001.2279; BROCKWAY JM, 1987, HUM NUTR-CLIN NUTR, V41C, P463; Browning RC, 2007, MED SCI SPORT EXER, V39, P515, DOI 10.1249/mss.0b013e31802b3562; CAVAGNA GA, 1986, J PHYSIOL-LONDON, V373, P235, DOI 10.1113/jphysiol.1986.sp016044; Donelan JM, 2008, SCIENCE, V319, P807, DOI 10.1126/science.1149860; Donelan JM, 2001, P ROY SOC B-BIOL SCI, V268, P1985, DOI 10.1098/rspb.2001.1761; Donelan JM, 2002, J EXP BIOL, V205, P3717; Gard SA, 2004, HUM MOVEMENT SCI, V22, P597, DOI 10.1016/j.humov.2003.11.002; Gottschall JS, 2003, J APPL PHYSIOL, V94, P1766, DOI 10.1152/japplphysiol.00670.2002; Griffin TM, 2003, J APPL PHYSIOL, V95, P172, DOI 10.1152/japplphysiol.00944.2002; Huang HJ, 2012, J NEUROSCI, V32, P2182, DOI 10.1523/JNEUROSCI.4003-11.2012; Huang TWP, 2014, J EXP BIOL, V217, P605, DOI 10.1242/jeb.091587; Li QG, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-22; Margaria R, 1968, Int Z Angew Physiol, V25, P339; Ortega JD, 2005, J APPL PHYSIOL, V99, P2099, DOI 10.1152/japplphysiol.00103.2005; Paradiso JA, 2005, IEEE PERVAS COMPUT, V4, P18, DOI 10.1109/MPRV.2005.9; Rome LC, 2005, SCIENCE, V309, P1725, DOI 10.1126/science.1111063; Romero E, 2009, PHYSIOL MEAS, V30, pR35, DOI 10.1088/0967-3334/30/9/R01; Sawicki GS, 2008, J EXP BIOL, V211, P1402, DOI 10.1242/jeb.009241; SOULE RG, 1969, J APPL PHYSIOL, V27, P687, DOI 10.1152/jappl.1969.27.5.687; Vaughan C.L., 1992, DYNAMICS HUMAN GAIT	21	41	42	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127635	10.1371/journal.pone.0127635	http://dx.doi.org/10.1371/journal.pone.0127635			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039493	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700068
J	Yang, SH; Kao, TI; Chiang, BL; Chen, HY; Chen, KH; Chen, JL				Yang, Sien-Hung; Kao, Ting-I; Chiang, Bor-Luen; Chen, Hsing-Yu; Chen, Kuang-Hua; Chen, Jiun-Liang			Immune-Modulatory Effects of Bu-Zhong-Yi-Qi-Tang in Ovalbumin-Induced Murine Model of Allergic Asthma	PLOS ONE			English	Article							HOCHU-EKKI-TO; ATTENUATES AIRWAY INFLAMMATION; TRADITIONAL CHINESE MEDICINE; IGE PRODUCTION; HYPERRESPONSIVENESS; HYPERREACTIVITY; EOSINOPHILS; MEPOLIZUMAB; MECHANISMS; PATHOLOGY	Background Bu-zhong-yi-qi-tang (BZYQT), an herbal formula of traditional Chinese medicine, has been an effective regimen of allergic diseases for nearly 800 years. Our previous report has demonstrated its anti-inflammatory effects in patients with perennial allergic rhinitis, and the aim of this study is to investigate the anti-asthmatic effect of BZYQT. Methods Female BALB/cByJNarl mice were sensitized with normal saline (control group) or OVA. Mice sensitized by OVA were fed with distilled water (OVA group), oral 0.5 g/Kg (low-dose group) or 1 g/Kg (high-dose group) of BZYQT solution once daily on days 36-40 besides their routine diet. Airway hyper-responsiveness (AHR), eosinophil infiltration, levels of cytokines and total immunoglobulin E (IgE) in broncho-alveolar lavage fluid (BALF) were determined. The lungs and tracheas were removed, and histopathologic examination was subsequently performed. Results AHR was significantly reduced in both low-and high-dose BZYQT groups compared with the OVA group after inhalation of the highest dose of methacholine (50 mg/ml). The levels of eotaxin, Th2-related cytokines (IL-4, IL-5, IL-13), IgE, and eosinophil infiltration in BALF were significantly decreased in both BZYQT groups compared with the OVA group. Histopathologic examination revealed that eosinophil infiltration of the lung and trachea tissues was remarkably attenuated in both BZYQT groups. Conclusions Oral administration of BZYQT solution may exert anti-asthmatic effect by relieving AHR in OVA-sensitized mice, which is compatible with our clinical experience. Although detailed mechanism is to be determined, we surmise that it may be correlated with the immune-modulatory effects of inhibiting Th2 responses on the basis of our limited results.	[Yang, Sien-Hung; Kao, Ting-I; Chen, Hsing-Yu; Chen, Jiun-Liang] Chang Gung Mem Hosp, Dept Tradit Chinese Med, Div Chinese Internal Med, Taoyuan, Taiwan; [Yang, Sien-Hung; Chen, Jiun-Liang] Chang Gung Univ, Sch Chinese Med, Taoyuan, Taiwan; [Kao, Ting-I] Chang Gung Univ, Grad Inst Biomed Sci, Div Nat Prod, Taoyuan, Taiwan; [Chiang, Bor-Luen] Natl Taiwan Univ, Grad Inst Immunol, Taipei 10764, Taiwan; [Chiang, Bor-Luen] Natl Taiwan Univ, Dept Pediat, Taipei 10764, Taiwan; [Chen, Hsing-Yu] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Chen, Kuang-Hua] Chang Gung Mem Hosp, Dept Pathol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; National Taiwan University; National Taiwan University; Chang Gung University; Chang Gung Memorial Hospital	Yang, SH (corresponding author), Chang Gung Mem Hosp, Dept Tradit Chinese Med, Div Chinese Internal Med, Taoyuan, Taiwan.	dryang@cgmh.org.tw		CHIANG, BOR-LUEN/0000-0002-6705-0286	New Century Health Care Promotion Foundation	New Century Health Care Promotion Foundation	This study was supported by a grant from the New Century Health Care Promotion Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZZAWI M, 1990, AM REV RESPIR DIS, V142, P1407, DOI 10.1164/ajrccm/142.6_Pt_1.1407; Barrios RJ, 2006, ARCH PATHOL LAB MED, V130, P447; Beal DR, 2013, AM J PHYSIOL-LUNG C, V305, pL866, DOI 10.1152/ajplung.00120.2013; Berend N, 2008, RESPIROLOGY, V13, P624, DOI 10.1111/j.1440-1843.2008.01330.x; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; BRUSSELLE GG, 1994, CLIN EXP ALLERGY, V24, P73, DOI 10.1111/j.1365-2222.1994.tb00920.x; Chang HC, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-174; Cho JY, 2004, J CLIN INVEST, V113, P551, DOI 10.1172/JCI200419133; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Dai Han-yuan, 2011, Zhong Yao Cai, V34, P250; Deckers J, 2013, TRENDS IMMUNOL, V34, P540, DOI 10.1016/j.it.2013.08.004; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Georas SN, 2005, EUR RESPIR J, V26, P1119, DOI 10.1183/09031936.05.00006005; GLEICH GJ, 1979, J IMMUNOL, V123, P2925; Gluck J, 2012, INFLAMM RES, V61, P547, DOI 10.1007/s00011-012-0443-9; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Huang WC, 2008, AM J CHINESE MED, V36, P579, DOI 10.1142/S0192415X08005990; Ishimitsu R, 2001, INT IMMUNOPHARMACOL, V1, P857, DOI 10.1016/S1567-5769(01)00022-4; Kaneko M, 1997, IMMUNOPHARMACOLOGY, V36, P79, DOI 10.1016/S0162-3109(96)00162-2; Kao ST, 2000, IMMUNOPHARM IMMUNOT, V22, P711, DOI 10.3109/08923970009016434; Kao ST, 2001, LIFE SCI, V69, P1485, DOI 10.1016/S0024-3205(01)01226-7; Kariyawasam HH, 2007, CURR OPIN IMMUNOL, V19, P681, DOI 10.1016/j.coi.2007.07.021; KAY AB, 1991, J ALLERGY CLIN IMMUN, V87, P893, DOI 10.1016/0091-6749(91)90408-G; Kobayashi H, 2003, DRUG EXP CLIN RES, V29, P81; Kudo M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00263; Lee MY, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-257; Liou CJ, 2010, FOOD CHEM TOXICOL, V48, P2592, DOI 10.1016/j.fct.2010.06.020; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Nakada T, 2002, INT IMMUNOPHARMACOL, V2, P901, DOI 10.1016/S1567-5769(02)00027-9; Park SJ, 2007, FOOD CHEM TOXICOL, V45, P1459, DOI 10.1016/j.fct.2007.02.013; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; SANTING RE, 1994, J ALLERGY CLIN IMMUN, V93, P1021, DOI 10.1016/S0091-6749(94)70051-6; Scichilone N, 2005, EUR RESPIR J, V25, P364, DOI 10.1183/09031936.05.00080204; Shin IS, 2013, INT IMMUNOPHARMACOL, V17, P867, DOI 10.1016/j.intimp.2013.09.017; Suzuki T, 1999, BIOL PHARM BULL, V22, P1180, DOI 10.1248/bpb.22.1180; Sy LB, 2006, INT IMMUNOPHARMACOL, V6, P1053, DOI 10.1016/j.intimp.2006.01.015; Tanaka H, 2000, CLIN EXP ALLERGY, V30, P874; Venkayya R, 2002, AM J RESP CELL MOL, V26, P202, DOI 10.1165/ajrcmb.26.2.4600; Wu CJ, 2006, CLIN EXP IMMUNOL, V145, P116, DOI 10.1111/j.1365-2249.2006.03099.x; Yang SH, 2008, J ETHNOPHARMACOL, V115, P104, DOI 10.1016/j.jep.2007.09.011	41	22	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0127636	10.1371/journal.pone.0127636	http://dx.doi.org/10.1371/journal.pone.0127636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035827	Green Published, Green Submitted, gold			2022-12-27	WOS:000355699100017
J	Riou, ME; Rioux, F; Lamothe, G; Doucet, E				Riou, Marie-Eve; Rioux, Francois; Lamothe, Gilles; Doucet, Eric			Validation and Reliability of a Classification Method to Measure the Time Spent Performing Different Activities	PLOS ONE			English	Article							DAILY ENERGY-EXPENDITURE; PHYSICAL-ACTIVITY; ACCELEROMETRY; SENSORS; MOTION	The aim of this study was to validate the performance and reliability of results obtained from a classification model that measures time spent performing activities in confined (CE) and unrestricted (UE) environments. In CE, participants wore a pair of biaxial and/or triaxial accelerometers while performing pre-determined training activities classified as variants of lying down, dynamic standing, sitting, walking and running on two separate days. A classification model trained with activities performed in a specific order during the first day was developed to validate the activities performed in a random order on the second day (CE) and over 24 hours on a separate day (UE). The performance of the classification model was validated against triaxial accelerometers using six (x, y and step counts for arm and thigh) or eight (same as six features plus z axis) features. The reliability of the classification model was tested in both environments using six features. Results revealed an overall accuracy of 94% in CE and 90% in UE. The sensitivity in CE and UE was 94% and 95% for lying down, 88% and 80% for dynamic standing, 97% and 89% for sitting, 96% and 78% for walking and 90% and 64% for running, respectively. No significant differences were noted between performances obtained with six or eight features. Results were highly reproducible in both environments. The results obtained from the classification model were accurate and reproducible, and highlight the potential use of this approach in research to quantify the time spent performing different activities.	[Riou, Marie-Eve; Doucet, Eric] Univ Ottawa, Fac Hlth Sci, Sch Human Kinet, BMRU, Ottawa, ON, Canada; [Rioux, Francois] Frisoft Inc, Gatineau, PQ, Canada; [Lamothe, Gilles] Univ Ottawa, Fac Sci, Dept Math & Stat, Ottawa, ON, Canada	University of Ottawa; University of Ottawa	Doucet, E (corresponding author), Univ Ottawa, Fac Hlth Sci, Sch Human Kinet, BMRU, Ottawa, ON, Canada.	eric.doucet@uottawa.ca			Frisoft Inc.	Frisoft Inc.	The authors received no specific funding for this work. Frisoft Inc. provided support in the form of a salary for author FR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abeel T, 2009, J MACH LEARN RES, V10, P931; Banerjee M, 1999, CAN J STAT, V27, P3, DOI 10.2307/3315487; Bao L, 2004, LECT NOTES COMPUT SC, V3001, P1, DOI 10.1007/978-3-540-24646-6_1; Bonomi AG, 2012, INT J OBESITY, V36, P167, DOI 10.1038/ijo.2011.99; Bonomi AG, 2009, J APPL PHYSIOL, V107, P655, DOI 10.1152/japplphysiol.00150.2009; Bonomi AG, 2009, MED SCI SPORT EXER, V41, P1770, DOI 10.1249/MSS.0b013e3181a24536; Busser HJ, 1997, MED ENG PHYS, V19, P440, DOI 10.1016/S1350-4533(97)00007-6; Duncan MJ, 2009, J SCI MED SPORT, V12, P549, DOI 10.1016/j.jsams.2008.10.010; Dunstan DW, 2012, DIABETES RES CLIN PR, V97, P368, DOI 10.1016/j.diabres.2012.05.020; Ermes M, 2008, IEEE T INF TECHNOL B, V12, P20, DOI 10.1109/TITB.2007.899496; Fahrenberg J, 1997, PSYCHOPHYSIOLOGY, V34, P607, DOI 10.1111/j.1469-8986.1997.tb01747.x; Foerster F, 1999, COMPUT HUM BEHAV, V15, P571, DOI 10.1016/S0747-5632(99)00037-0; Karantonis DM, 2006, IEEE T INF TECHNOL B, V10, P156, DOI 10.1109/TITB.2005.856864; Long X, 2009, IEEE ENG MED BIO, P6107, DOI 10.1109/IEMBS.2009.5334925; Lyons GM, 2005, MED ENG PHYS, V27, P497, DOI 10.1016/j.medengphy.2004.11.006; Mathie MJ, 2004, MED BIOL ENG COMPUT, V42, P679, DOI 10.1007/BF02347551; Parkka J, 2006, IEEE T INF TECHNOL B, V10, P119, DOI 10.1109/TITB.2005.856863; Preece SJ, 2009, PHYSIOL MEAS, V30, pR1, DOI 10.1088/0967-3334/30/4/R01; St-Onge M, 2007, AM J CLIN NUTR, V85, P742, DOI 10.1093/ajcn/85.3.742; Uiterwaal M, 1998, J MED ENG TECHNOL, V22, P168, DOI 10.3109/03091909809032535; van den Berg-Emons HJG, 2000, SCAND J REHABIL MED, V32, P187; Van Laerhoven K, 2000, P 4 INT S WEAR COMP, P77, DOI DOI 10.1109/ISWC.2000.888468; Veltink P H, 1996, IEEE Trans Rehabil Eng, V4, P375, DOI 10.1109/86.547939; Yang CC, 2010, SENSORS-BASEL, V10, P7772, DOI 10.3390/s100807772; Zhang K, 2003, OBES RES, V11, P33, DOI 10.1038/oby.2003.7	25	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128299	10.1371/journal.pone.0128299	http://dx.doi.org/10.1371/journal.pone.0128299			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052699	Green Submitted, gold, Green Published			2022-12-27	WOS:000355955300030
J	Bosamia, TC; Mishra, GP; Thankappan, R; Dobaria, JR				Bosamia, Tejas C.; Mishra, Gyan P.; Thankappan, Radhakrishnan; Dobaria, Jentilal R.			Novel and Stress Relevant EST Derived SSR Markers Developed and Validated in Peanut	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; DENSITY GENETIC-MAP; ARACHIS-HYPOGAEA L.; CULTIVATED PEANUT; MICROSATELLITE MARKERS; LINKAGE MAP; IN-SILICO; RUST RESISTANCE; IDENTIFICATION; DISCOVERY	With the aim to increase the number of functional markers in resource poor crop like cultivated peanut (Arachis hypogaea), large numbers of available expressed sequence tags (ESTs) in the public databases, were employed for the development of novel EST derived simple sequence repeat (SSR) markers. From 16424 unigenes, 2784 (16.95%) SSRs containing unigenes having 3373 SSR motifs were identified. Of these, 2027 (72.81%) sequences were annotated and 4124 gene ontology terms were assigned. Among different SSR motif-classes, tri-nucleotide repeats (33.86%) were the most abundant followed by dinucleotide repeats (27.51%) while AG/CT (20.7%) and AAG/CTT (13.25%) were the most abundant repeat-motifs. A total of 2456 EST-SSR novel primer pairs were designed, of which 366 unigenes having relevance to various stresses and other functions, were PCR validated using a set of 11 diverse peanut genotypes. Of these, 340 (92.62%) primer pairs yielded clear and scorable PCR products and 39 (10.66%) primer pairs exhibited polymorphisms. Overall, the number of alleles per marker ranged from 1-12 with an average of 3.77 and the PIC ranged from 0.028 to 0.375 with an average of 0.325. The identified EST-SSRs not only enriched the existing molecular markers kitty, but would also facilitate the targeted research in marker-trait association for various stresses, inter-specific studies and genetic diversity analysis in peanut.	[Bosamia, Tejas C.; Mishra, Gyan P.; Thankappan, Radhakrishnan; Dobaria, Jentilal R.] ICAR Res Complex, Directorate Groundnut Res, Crop Improvement Div, Junagadh 362001, Gujarat, India; [Bosamia, Tejas C.] Junagadh Agr Univ, Dept Biotechnol, Coll Agr, Junagadh 362001, Gujarat, India	Indian Council of Agricultural Research (ICAR); ICAR - Directorate of Groundnut Research	Thankappan, R (corresponding author), ICAR Res Complex, Directorate Groundnut Res, Crop Improvement Div, Junagadh 362001, Gujarat, India.	radhakrishnan.nrcg@gmail.com	Mishra, Gyan P./E-5980-2010; bosamia, tejas/P-2264-2019	Mishra, Gyan P./0000-0002-7023-2638; bosamia, tejas/0000-0002-2079-2397				Agarwal G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052443; Akash MW, 2012, PLANT BREEDING, V131, P522, DOI 10.1111/j.1439-0523.2012.01969.x; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Asp T, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-36; Bao JS, 2002, THEOR APPL GENET, V105, P898, DOI 10.1007/s00122-002-1049-3; Benbouza Halima, 2006, Biotechnologie Agronomie Societe et Environnement, V10, P77; Bhauso Tengale Dipak, 2014, ScientificWorldJournal, V2014, P125967, DOI 10.1155/2014/125967; Blair MW, 2012, MOL ECOL RESOUR, V12, P661, DOI 10.1111/j.1755-0998.2012.03136.x; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Brautigam A, 2011, J EXP BOT, V62, P3093, DOI 10.1093/jxb/err029; Chen XP, 2013, PLANT BIOTECHNOL J, V11, P115, DOI 10.1111/pbi.12018; Cheung F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-272; Childs KL, 2007, NUCLEIC ACIDS RES, V35, pD846, DOI 10.1093/nar/gkl785; Chopra R, 2015, MOL GENET GENOMICS, V290, P1169, DOI 10.1007/s00438-014-0976-4; Chopra R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115055; Cuc LM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-55; Dodia SM, 2014, J PURE APPL MICROBIO, V8, P4623; Doyle J. J., 1987, PHYTOCHEM B, P11; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; FAO, 2019, FOOD AGR ORG UN; Ferguson ME, 2004, THEOR APPL GENET, V108, P1064, DOI 10.1007/s00122-003-1535-2; Gajjar K. N., 2014, Australian Journal of Crop Science, V8, P927; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gautami B, 2012, MOL BREEDING, V30, P757, DOI 10.1007/s11032-011-9660-0; Gautami B., 2009, International Journal of Integrative Biology, V7, P100; Gimenes MA, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-9; Guimaraes PM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-387; Guo Baozhu, 2009, Int J Plant Genomics, V2009, P715605, DOI 10.1155/2009/715605; HALWARD TM, 1991, GENOME, V34, P1013, DOI 10.1139/g91-156; He GH, 2005, EUPHYTICA, V142, P131, DOI 10.1007/s10681-005-1043-3; He Guohao, 2003, BMC Plant Biology, V3, P3, DOI 10.1186/1471-2229-3-3; Hopkins MS, 1999, CROP SCI, V39, P1243, DOI 10.2135/cropsci1999.0011183X003900040047x; Jayashree B., 2006, In Silico Biology, V6, P607; Kalia RK, 2011, EUPHYTICA, V177, P309, DOI 10.1007/s10681-010-0286-9; Kaur S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-104; Khedikar YP, 2010, THEOR APPL GENET, V121, P971, DOI 10.1007/s00122-010-1366-x; Koilkonda P, 2012, MOL BREEDING, V30, P125, DOI 10.1007/s11032-011-9604-8; Krapovickas A., 1994, Bonplandia, V8, P1; Kumari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067742; Kumpatla SP, 2005, GENOME, V48, P985, DOI 10.1139/G05-060; Leal-Bertioli SCM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-112; Li XY, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-58; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Macedo Selma E, 2012, BMC Res Notes, V5, P86, DOI 10.1186/1756-0500-5-86; Martinez Beltran J., 2005, International salinity forum - managing saline soils and water: science, technology and social issues. Oral Presentation Abstracts, Riverside Convention Center, Riverside, California, USA, 25-28 April 2005, P311; Metzgar D, 2000, GENOME RES, V10, P72; Moretzsohn MC, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-40; Moretzsohn MC, 2005, THEOR APPL GENET, V111, P1060, DOI 10.1007/s00122-005-0028-x; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Nagy ED, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-469; Nagy ED, 2010, MOL BREEDING, V26, P357, DOI 10.1007/s11032-010-9430-4; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Pandey MK, 2012, BIOTECHNOL ADV, V30, P639, DOI 10.1016/j.biotechadv.2011.11.001; Pandey MK, 2012, PLANT BREEDING, V131, P139, DOI 10.1111/j.1439-0523.2011.01911.x; Peng Z, 2015, PLANT ANIMAL GENOME, VXXIII, pP0740; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Proite K, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-7; Qiu LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-278; Rathnakumar A.L., 2013, PEANUT CROP PROFILE, V118; Rathnakumar AL, 2013, ANN M GROUNDN RES AL, P1; Ren XP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088091; Saha MC, 2004, THEOR APPL GENET, V109, P783, DOI 10.1007/s00122-004-1681-1; Sarkar T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110507; Sarvamangala C, 2011, FIELD CROP RES, V122, P49, DOI 10.1016/j.fcr.2011.02.010; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Singh D, 2015, J ENVIRON BIOL, V36, P441; SONG G, 2010, ELECTRON J BIOTECHN, V13, P3, DOI DOI 10.2225/VOL13-ISSUE3-FULLTEXT-10; Sujay V, 2012, MOL BREEDING, V30, P773, DOI 10.1007/s11032-011-9661-z; Sukruth M, 2015, EUPHYTICA, V204, P343, DOI 10.1007/s10681-014-1339-2; Tang JF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-374; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Temsch EM, 2000, GENOME, V43, P449, DOI 10.1139/gen-43-3-449; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Thirumalaisamy P. P., 2014, Journal of Mycology and Plant Pathology, V44, P459; Varshney RK, 2014, THEOR APPL GENET, V127, P445, DOI 10.1007/s00122-013-2230-6; Varshney Rajeev K., 2007, P207, DOI 10.1007/978-1-4020-6297-1_10; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Vijay N, 2013, MOL ECOL, V22, P620, DOI 10.1111/mec.12014; Wang CT, 2007, ELECTRON J BIOTECHN, V10, P473, DOI 10.2225/vol10-issue3-fulltext-10; Wang H, 2012, BMC PLANT BIOL, V12, DOI [10.1186/1471-2229-12-10, 10.1186/1471-2229-12-194]; Wang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092029; Wu N, 2013, THEOR APPL GENET, V126, P1145, DOI 10.1007/s00122-013-2042-8; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Young ND, 1996, GENOME MAPPING PLANT, P211; Yuan M, 2010, ELECTRON J BIOTECHN, V13, DOI 10.2225/vol13-issue6-fulltext-6; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zhao Y., 2012, BMC RES NOTES, V5, P362, DOI DOI 10.1186/1756-0500-5-362	91	33	35	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129127	10.1371/journal.pone.0129127	http://dx.doi.org/10.1371/journal.pone.0129127			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046991	Green Submitted, gold, Green Published			2022-12-27	WOS:000355652200128
J	Chen, CW; Wu, MS; Huang, YJ; Lin, PW; Shih, CJ; Lin, FP; Chang, CY				Chen, Chien-Wen; Wu, Ming-Shan; Huang, Yi-Jen; Lin, Pei-Wen; Shih, Chueh-Ju; Lin, Fu-Pang; Chang, Chi-Yao			Iridovirus CARD Protein Inhibits Apoptosis through Intrinsic and Extrinsic Pathways	PLOS ONE			English	Article							RANAVIRUS FAMILY IRIDOVIRIDAE; EPINEPHELUS-AWOARA TEMMINCK; CELL-DEATH; GROUPER IRIDOVIRUS; SWISS-MODEL; INTERLEUKIN-1-BETA GENERATION; COMPLETE GENOME; INFECTED CELLS; SEQUENCE; DOMAIN	Grouper iridovirus (GIV) belongs to the genus Ranavirus of the family Iridoviridae; the genomes of such viruses contain an anti-apoptotic caspase recruitment domain (CARD) gene. The GIV-CARD gene encodes a protein of 91 amino acids with a molecular mass of 10,505 Daltons, and shows high similarity to other viral CARD genes and human ICEBERG. In this study, we used Northern blot to demonstrate that GIV-CARD transcription begins at 4 h post-infection; furthermore, we report that its transcription is completely inhibited by cycloheximide but not by aphidicolin, indicating that GIV-CARD is an early gene. GIV-CARD-EGFP and GIV-CARD-FLAG recombinant proteins were observed to translocate from the cytoplasm into the nucleus, but no obvious nuclear localization sequence was observed within GIV-CARD. RNA interference-mediated knockdown of GIV-CARD in GK cells infected with GIV inhibited expression of GIV-CARD and five other viral genes during the early stages of infection, and also reduced GIV infection ability. Immunostaining was performed to show that apoptosis was effectively inhibited in cells expressing GIV-CARD. HeLa cells irradiated with UV or treated with anti-Fas antibody will undergo apoptosis through the intrinsic and extrinsic pathways, respectively. However, over-expression of recombinant GIV-CARD protein in HeLa cells inhibited apoptosis induced by mitochondrial and death receptor signaling. Finally, we report that expression of GIV-CARD in HeLa cells significantly reduced the activities of caspase-8 and -9 following apoptosis triggered by anti-Fas antibody. Taken together, these results demonstrate that GIV-CARD inhibits apoptosis through both intrinsic and extrinsic pathways.	[Chen, Chien-Wen; Wu, Ming-Shan; Huang, Yi-Jen; Lin, Pei-Wen; Shih, Chueh-Ju; Chang, Chi-Yao] Acad Sinica, Mol Genet Lab, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Chen, Chien-Wen; Shih, Chueh-Ju; Chang, Chi-Yao] Natl Taiwan Univ, Inst Fisheries Sci, Taipei 10764, Taiwan; [Lin, Pei-Wen; Lin, Fu-Pang; Chang, Chi-Yao] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Taiwan Ocean University	Chang, CY (corresponding author), Acad Sinica, Mol Genet Lab, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	cychang@gate.sinica.edu.tw		Lin, Pei-Wen/0000-0002-9744-9546	National Science Council (Ministry of Science and Technology), Taiwan [NSC99-2311-B-001-005-MY3]	National Science Council (Ministry of Science and Technology), Taiwan	This study was supported by Grant no. NSC99-2311-B-001-005-MY3 from the National Science Council (Ministry of Science and Technology), Taiwan. (http://www.most.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benchoua A, 2002, J BIOL CHEM, V277, P34217, DOI 10.1074/jbc.M203941200; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bouchier-Hayes L, 2002, EMBO REP, V3, P616, DOI 10.1093/embo-reports/kvf139; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chang MX, 2010, DEV COMP IMMUNOL, V34, P1, DOI 10.1016/j.dci.2009.08.002; Chen LY, 2003, MOL CELL BIOL, V23, P7108, DOI 10.1128/MCB.23.20.7108-7121.2003; D'Costa SM, 2001, ARCH VIROL, V146, P2165, DOI 10.1007/s007050170027; Druilhe A, 2001, CELL DEATH DIFFER, V8, P649, DOI 10.1038/sj.cdd.4400881; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; He JG, 2002, VIROLOGY, V292, P185, DOI 10.1006/viro.2001.1245; Hengartner MO, 1996, CURR OPIN GENET DEV, V6, P34, DOI 10.1016/S0959-437X(96)90007-6; Henry H, 2002, ONCOGENE, V21, P748, DOI 10.1038/sj.onc.1205125; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; Huang YH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-224; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Jancovich JK, 2010, J VIROL, V84, P2636, DOI 10.1128/JVI.01991-09; Jancovich JK, 2003, VIROLOGY, V316, P90, DOI 10.1016/j.virol.2003.08.001; Kantari C, 2011, BBA-MOL CELL RES, V1813, P558, DOI 10.1016/j.bbamcr.2011.01.026; Lai YS, 2000, J FISH DIS, V23, P379, DOI 10.1046/j.1365-2761.2000.00247.x; Lamkanfi M, 2004, J BIOL CHEM, V279, P51729, DOI 10.1074/jbc.M407891200; Lin PW, 2008, APOPTOSIS, V13, P165, DOI 10.1007/s10495-007-0152-y; Marshall WL, 1999, J VIROL, V73, P5181, DOI 10.1128/JVI.73.6.5181-5185.1999; Matthews GM, 2012, ADV CANCER RES, V116, P165, DOI 10.1016/B978-0-12-394387-3.00005-7; Murali S, 2002, J FISH DIS, V25, P91, DOI 10.1046/j.1365-2761.2002.00343.x; Postigo A, 2006, CELL DEATH DIFFER, V13, P1651, DOI 10.1038/sj.cdd.4401853; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Ross L, 1997, VIROLOGY, V232, P105, DOI 10.1006/viro.1997.8557; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Sachdev S, 1998, MOL CELL BIOL, V18, P2524, DOI 10.1128/MCB.18.5.2524; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shisler JL, 2001, VIROLOGY, V282, P14, DOI 10.1006/viro.2001.0834; Tan WGH, 2004, VIROLOGY, V323, P70, DOI 10.1016/j.virol.2004.02.019; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Thome M, 2001, J CELL BIOL, V152, P1115, DOI 10.1083/jcb.152.5.1115; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Tsai CT, 2005, J VIROL, V79, P2010, DOI 10.1128/JVI.79.4.2010-2023.2005; Wallach D, 1997, TRENDS BIOCHEM SCI, V22, P107, DOI 10.1016/S0968-0004(97)01015-3; Wang X, 2006, BIOCHIM BIOPHYS ACTA, P1762; Yamazaki T, 2014, CLIN EXP VACCINE RES, V3, P5, DOI 10.7774/cevr.2014.3.1.5; Yao YL, 2003, J BIOL CHEM, V278, P42560, DOI 10.1074/jbc.M302955200	46	11	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129071	10.1371/journal.pone.0129071	http://dx.doi.org/10.1371/journal.pone.0129071			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047333	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200120
J	Chen, L; Yang, J; Zheng, MY; Kong, XY; Huang, T; Cai, YD				Chen, Lei; Yang, Jing; Zheng, Mingyue; Kong, Xiangyin; Huang, Tao; Cai, Yu-Dong			The Use of Chemical-Chemical Interaction and Chemical Structure to Identify New Candidate Chemicals Related to Lung Cancer	PLOS ONE			English	Article							TRANS-RETINOIC ACID; INDUCED MALIGNANT-TRANSFORMATION; MITOXANTRONE PLUS PREDNISONE; RESISTANT PROSTATE-CANCER; INDUCED GROWTH-INHIBITION; DNA-DAMAGE; PHASE-III; SOMATIC MUTATIONS; OXIDATIVE STRESS; PIK3CA MUTATION	Lung cancer causes over one million deaths every year worldwide. However, prevention and treatment methods for this serious disease are limited. The identification of new chemicals related to lung cancer may aid in disease prevention and the design of more effective treatments. This study employed a weighted network, constructed using chemical-chemical interaction information, to identify new chemicals related to two types of lung cancer: non-small lung cancer and small-cell lung cancer. Then, a randomization test as well as chemical-chemical interaction and chemical structure information were utilized to make further selections. A final analysis of these new chemicals in the context of the current literature indicates that several chemicals are strongly linked to lung cancer.	[Chen, Lei; Cai, Yu-Dong] Shanghai Univ, Coll Life Sci, Shanghai 200444, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai 201306, Peoples R China; [Yang, Jing; Kong, Xiangyin; Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200031, Peoples R China; [Zheng, Mingyue] Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China	Shanghai University; Shanghai Maritime University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200031, Peoples R China.	tohuangtao@126.com; cai_yud@126.com	Zheng, Mingyue/Z-3582-2019; Zheng, Mingyue/B-4860-2010; Zheng, Mingyue/AAJ-8027-2020; Zheng, Mingyue/HHZ-4062-2022; Chen, Lei/A-2275-2011	Zheng, Mingyue/0000-0002-3323-3092; Zheng, Mingyue/0000-0002-3323-3092; Zheng, Mingyue/0000-0002-3323-3092; Chen, Lei/0000-0003-3068-1583; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510101, 2011CB510102]; National Natural Science Foundation of China [61202021, 31371335, 61373028, 61303099]; Innovation Program of Shanghai Municipal Education Commission [12YZ120, 12ZZ087]; "The First-class Discipline of Universities in Shanghai" of the Shanghai Educational Development Foundation [12CG55]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); "The First-class Discipline of Universities in Shanghai" of the Shanghai Educational Development Foundation	This work was supported by National Basic Research Program of China (2011CB510101, 2011CB510102), the National Natural Science Foundation of China (61202021, 31371335, 61373028, 61303099), the Innovation Program of Shanghai Municipal Education Commission (12YZ120, 12ZZ087), and a grant from "The First-class Discipline of Universities in Shanghai" of the Shanghai Educational Development Foundation (12CG55). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanzar WE, 2002, JNCI-J NATL CANCER I, V94, P1888, DOI 10.1093/jnci/94.24.1888; Aisner DL, 2012, AM J CLIN PATHOL, V138, P332, DOI 10.1309/AJCPFR12WJKCEEZZ; Arcangeli A, 2009, CURR MED CHEM, V16, P66, DOI 10.2174/092986709787002835; Arrieta O, 2006, CANCER-AM CANCER SOC, V107, P1852, DOI 10.1002/cncr.22198; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Bains OS, 2013, J PHARMACOL EXP THER, V347, P375, DOI 10.1124/jpet.113.206805; Basu HS, 2009, CANCER RES, V69, P7689, DOI 10.1158/0008-5472.CAN-08-2472; Ben-Chetrit E, 1998, SEMIN ARTHRITIS RHEU, V28, P48, DOI 10.1016/S0049-0172(98)80028-0; Berthold DR, 2008, J CLIN ONCOL, V26, P242, DOI 10.1200/JCO.2007.12.4008; Blanco JG, 2008, CANCER-AM CANCER SOC, V112, P2789, DOI 10.1002/cncr.23534; Bredfeldt TG, 2006, TOXICOL APPL PHARM, V216, P69, DOI 10.1016/j.taap.2006.04.011; Brouwers L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022187; Buttitta F, 2006, INT J CANCER, V119, P2586, DOI 10.1002/ijc.22143; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Chanvorachote P, 2013, AM J PHYSIOL-CELL PH, V304, pC263, DOI 10.1152/ajpcell.00225.2012; Chen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107767; Chen L, 2014, MOL BIOSYST, V10, P868, DOI 10.1039/c3mb70490d; Chen L, 2013, CURR BIOINFORM, V8, P200, DOI 10.2174/1574893611308020008; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035254; Craven J. B. M., 2005, MARKOV NETWORKS DETE; Cui X, 2004, TOXICOL PATHOL, V32, P64, DOI 10.1080/01926230490261348; Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994; De Greve J, 2012, LUNG CANCER, V76, P123, DOI 10.1016/j.lungcan.2012.01.008; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dunkel M, 2008, NUCLEIC ACIDS RES, V36, pW55, DOI 10.1093/nar/gkn307; Eckardt JR, 2007, J CLIN ONCOL, V25, P2086, DOI 10.1200/JCO.2006.08.3998; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Filaire E, 2013, LUNG CANCER, V82, P383, DOI 10.1016/j.lungcan.2013.09.009; From the American Cancer Society, 2007, CA-CANCER J CLIN, V57, P29; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Gilbert-Diamond D, 2013, ENV HLTH PERSPECT, V121, P154; GOLDFINGER SE, 1972, NEW ENGL J MED, V287, P1302; Gomez SE, 2005, BIOL TRACE ELEM RES, V108, P115, DOI 10.1385/BTER:108:1-3:115; Gormen T. H., 1990, INTRO ALGORITHMS; Graus F, 2002, NEUROLOGY, V59, P764, DOI 10.1212/WNL.59.5.764; GUPTA RS, 1986, J CELL PHYSIOL, V127, P197, DOI 10.1002/jcp.1041270202; Hauptman PJ, 1999, CIRCULATION, V99, P1265, DOI 10.1161/01.CIR.99.9.1265; Heinmoller P, 2003, CLIN CANCER RES, V9, P5238; Henriques BJ, 2010, CURR MED CHEM, V17, P3842; Hodkinson PS, 2007, INT J RADIAT BIOL, V83, P733, DOI 10.1080/09553000701570204; HOLTTA E, 1977, BIOCHEMISTRY-US, V16, P91, DOI 10.1021/bi00620a015; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang YT, 2004, BIOCHEM PHARMACOL, V67, P727, DOI 10.1016/j.bcp.2003.10.013; Hwang JM, 2006, ARCH TOXICOL, V80, P62, DOI 10.1007/s00204-005-0014-8; Jiang HY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-81; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; Kaira Kyoichi, 2014, J Med Case Rep, V8, P119, DOI 10.1186/1752-1947-8-119; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Katiyar SK, 2009, MOL CARCINOGEN, V48, P24, DOI 10.1002/mc.20453; Kawano O, 2006, LUNG CANCER, V54, P209, DOI 10.1016/j.lungcan.2006.07.006; Kheir MM, 2010, FOOD CHEM TOXICOL, V48, P1105, DOI 10.1016/j.fct.2010.01.033; Kojima C, 2009, JNCI-J NATL CANCER I, V101, P1670, DOI 10.1093/jnci/djp414; Kryston TB, 2011, MUTAT RES-FUND MOL M, V711, P193, DOI 10.1016/j.mrfmmm.2010.12.016; Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795; Kuhn M, 2014, NUCLEIC ACIDS RES, V42, pD401, DOI 10.1093/nar/gkt1207; Lakhman SS, 2005, DRUG METAB DISPOS, V33, P254, DOI 10.1124/dmd.104.002006; Li BQ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/267375; Li GW, 2011, J CELL PHYSIOL, V226, P3225, DOI 10.1002/jcp.22683; Li JY, 2003, BIOINFORMATICS, V19, pII93, DOI 10.1093/bioinformatics/btg1066; Lin JG, 1999, AM J CHINESE MED, V27, P265, DOI 10.1142/S0192415X99000306; Lin ZY, 2013, LIFE SCI, V93, P323, DOI 10.1016/j.lfs.2013.07.002; Luo Y, 2008, ACTA PHARMACOL SIN, V29, P628, DOI 10.1111/j.1745-7254.2008.00786.x; Maeno T, 2002, AM J RESP CELL MOL, V26, P246, DOI 10.1165/ajrcmb.26.2.4509; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; MISAKI T, 1982, CHEM PHARM BULL, V30, P354; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mu D, 2003, CANCER CELL, V3, P297, DOI 10.1016/S1535-6108(03)00054-0; Nesnow S, 2002, CHEM RES TOXICOL, V15, P1627, DOI 10.1021/tx025598y; Ni Y, 2012, HUM MOL GENET, V21, P300, DOI 10.1093/hmg/ddr459; Ninsontia C, 2014, ANTICANCER RES, V34, P5495; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; O'Brien MER, 2006, J CLIN ONCOL, V24, P5441, DOI 10.1200/JCO.2006.06.5821; OGATA A, 1994, BLOOD, V84, P3040; Okudela K, 2007, PATHOL INT, V57, P664, DOI 10.1111/j.1440-1827.2007.02155.x; OLHABERRY JV, 1983, S AFR MED J, V64, P894; Osoba D, 1999, J CLIN ONCOL, V17, P1654, DOI 10.1200/JCO.1999.17.6.1654; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Paone A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.482; Pi JB, 2008, FREE RADICAL BIO MED, V45, P651, DOI 10.1016/j.freeradbiomed.2008.05.020; Pirker R, 2012, LANCET ONCOL, V13, P33, DOI 10.1016/S1470-2045(11)70318-7; Pospisil P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105/7/354; Prasad AS, 2009, NUTR CANCER, V61, P879, DOI 10.1080/01635580903285122; Prasad AS, 1998, J AM COLL NUTR, V17, P409, DOI 10.1080/07315724.1998.10718787; Prasad AS, 2000, J INFECT DIS, V182, pS62, DOI 10.1086/315916; Qi HW, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-22; Refaat A, 2013, ONCOL LETT, V6, P840, DOI 10.3892/ol.2013.1434; Ruanghirun T, 2014, ANTICANCER RES, V34, P2231; Saeh JC, 2005, J CHEM INF MODEL, V45, P1122, DOI 10.1021/ci049732r; Saito A, 2007, ENDOCRINOLOGY, V148, P1412, DOI 10.1210/en.2006-0900; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sawyer DB, 2010, PROG CARDIOVASC DIS, V53, P105, DOI 10.1016/j.pcad.2010.06.007; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; SIDELL N, 1991, J IMMUNOL, V146, P3809; Simunek T, 2009, PHARMACOL REP, V61, P154; Singal R, 2015, CLIN GENITOURIN CANC, V13, P22, DOI 10.1016/j.clgc.2014.07.008; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Stueckle TA, 2012, TOXICOL APPL PHARM, V261, P204, DOI 10.1016/j.taap.2012.04.003; Styblo M, 2000, ARCH TOXICOL, V74, P289, DOI 10.1007/s002040000134; Sun Y, 2012, TOXICOL SCI, V125, P20, DOI 10.1093/toxsci/kfr282; Svensson A, 2005, ANTICANCER RES, V25, P207; Tabata C, 2006, AM J PHYSIOL-LUNG C, V290, pL597, DOI 10.1152/ajplung.00282.2005; Tabata C, 2009, EUR RESPIR J, V34, P1159, DOI 10.1183/09031936.00195708; Tannock IF, 1996, J CLIN ONCOL, V14, P1756, DOI 10.1200/JCO.1996.14.6.1756; Tokar EJ, 2012, ARCH TOXICOL, V86, P975, DOI 10.1007/s00204-012-0820-8; Tokar EJ, 2010, CRIT REV TOXICOL, V40, P912, DOI 10.3109/10408444.2010.506641; Tokar EJ, 2010, ENVIRON HEALTH PERSP, V118, P108, DOI 10.1289/ehp.0901059; Toma S, 1999, ANN ONCOL, V10, P95; Treat J, 1996, CANCER INVEST, V14, P415, DOI 10.3109/07357909609018898; Verheye-Dua F. A., 1996, Strahlentherapie und Onkologie, V172, P156; Waalkes MP, 2007, TOXICOL APPL PHARM, V222, P271, DOI 10.1016/j.taap.2006.12.034; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; Wang Y, 2012, INT J BIOCHEM CELL B, V44, P1813, DOI 10.1016/j.biocel.2012.06.028; Wang YL, 2005, CANCER CHEMOTH PHARM, V56, P83, DOI 10.1007/s00280-004-0936-5; Wei D, 2013, INT J MOL SCI, V14, P7273, DOI 10.3390/ijms14047273; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Williams YN, 2006, ONCOGENE, V25, P1446, DOI 10.1038/sj.onc.1209192; Wise Sandra S., 2008, Reviews on Environmental Health, V23, P39; Wnek SM, 2010, TOXICOL SCI, V116, P44, DOI 10.1093/toxsci/kfq106; Wu SN, 1998, LIFE SCI, V62, P2283, DOI 10.1016/S0024-3205(98)00209-4; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; Zhang WM, 2008, LIFE SCI, V82, P764, DOI 10.1016/j.lfs.2008.01.008; Zhao CQ, 1997, P NATL ACAD SCI USA, V94, P10907, DOI 10.1073/pnas.94.20.10907	125	10	11	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128696	10.1371/journal.pone.0128696	http://dx.doi.org/10.1371/journal.pone.0128696			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047514	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200092
J	Collemare, J; Beenen, HG; Crous, PW; de Wit, PJGM; van der Burgt, A				Collemare, Jerome; Beenen, Henriek G.; Crous, Pedro W.; de Wit, Pierre J. G. M.; van der Burgt, Ate			Novel Introner-Like Elements in fungi Are Involved in Parallel Gains of Spliceosomal Introns	PLOS ONE			English	Article							EVOLUTION; GENE; CONSERVATION; POSITIONS; SEQUENCE	Spliceosomal introns are key components of the eukaryotic gene structure. Although they contributed to the emergence of eukaryotes, their origin remains elusive. In fungi, they might originate from the multiplication of invasive introns named Introner-Like Elements (ILEs). However, so far ILEs have been observed in six fungal species only, including Fulvia fulva and Dothistroma septosporum (Dothideomycetes), arguing against ILE insertion as a general mechanism for intron gain. Here, we identified novel ILEs in eight additional fungal species that are phylogenetically related to F. fulva and D. septosporum using PCR amplification with primers derived from previously identified ILEs. The ILE content appeared unique to each species, suggesting independent multiplication events. Interestingly, we identified four genes each containing two gained ILEs. By analysing intron positions in orthologues of these four genes in Ascomycota, we found that three ILEs had inserted within a 15 bp window that contains regular spliceosomal introns in other fungal species. These three positions are not the result of intron sliding because ILEs are newly gained introns. Furthermore, the alternative hypothesis of an inferred ancestral gain followed by independent losses contradicts the observed degeneration of ILEs. These observations clearly indicate three parallel intron gains in four genes that were randomly identified. Our findings suggest that parallel intron gain is a phenomenon that has been highly underestimated in ILE-containing fungi, and likely in the whole fungal kingdom.	[Collemare, Jerome; Beenen, Henriek G.; de Wit, Pierre J. G. M.; van der Burgt, Ate] Wageningen Univ, Lab Phytopathol, NL-6700 AP Wageningen, Netherlands; [Beenen, Henriek G.; van der Burgt, Ate] CBS KNAW Fungal Biodivers Ctr, Evolutionary Phytopathol, Utrecht, Netherlands	Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW)	Collemare, J (corresponding author), IRHS INRA, UMR1345, Beaucouze, France.	j.collemare@gmail.com	Crous, Pedro W/H-1489-2012	Crous, Pedro W/0000-0001-9085-8825; Collemare, Jerome/0000-0001-8152-6642				Ahmadinejad N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-57; Carmel L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-192; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cheewangkoon R, 2008, PERSOONIA, V21, P77, DOI 10.3767/003158508X370857; Collemare Jerome, 2013, Commun Integr Biol, V6, pe23147, DOI 10.4161/cib.23147; Csuros M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002150; Da Lage JL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-40; Da Lage JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019673; de Wit PJGM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003088; Denoeud F, 2010, SCIENCE, V330, P1381, DOI 10.1126/science.1194167; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Flakowski J, 2006, J MOL EVOL, V63, P30, DOI 10.1007/s00239-005-0061-z; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-22; Krauss V, 2005, MOL BIOL EVOL, V22, P74, DOI 10.1093/molbev/msh255; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Li WL, 2014, GENOME BIOL EVOL, V6, P2218, DOI 10.1093/gbe/evu174; Li WL, 2009, SCIENCE, V326, P1260, DOI 10.1126/science.1179302; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Nguyen HD, 2005, PLOS COMPUT BIOL, V1, P631, DOI 10.1371/journal.pcbi.0010079; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Nielsen CB, 2004, PLOS BIOL, V2, P2234, DOI 10.1371/journal.pbio.0020422; Oda T, 2011, MOL BIOL REP, V38, P2285, DOI 10.1007/s11033-010-0360-3; Qiu WG, 2004, MOL BIOL EVOL, V21, P1252, DOI 10.1093/molbev/msh120; Rogozin IB, 2000, TRENDS GENET, V16, P430, DOI 10.1016/S0168-9525(00)02096-5; Roy SW, 2007, MOL BIOL EVOL, V24, P1447, DOI 10.1093/molbev/msm048; Roy SW, 2009, TRENDS GENET, V25, P67, DOI 10.1016/j.tig.2008.11.004; Roy SW, 2005, P NATL ACAD SCI USA, V102, P5773, DOI 10.1073/pnas.0500383102; Sambrook J., 2001, MOL CLONING LAB MANU; Stoltzfus A, 1997, P NATL ACAD SCI USA, V94, P10739, DOI 10.1073/pnas.94.20.10739; Sun Y, 2015, GENOME RES, V25, P100, DOI 10.1101/gr.175653.114; Sverdlov AV, 2005, NUCLEIC ACIDS RES, V33, P1741, DOI 10.1093/nar/gki316; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarrio R, 2003, P NATL ACAD SCI USA, V100, P6580, DOI 10.1073/pnas.0731952100; Torriani SFF, 2011, CURR BIOL, V21, P2017, DOI 10.1016/j.cub.2011.10.041; van der Burgt A, 2012, CURR BIOL, V22, P1260, DOI 10.1016/j.cub.2012.05.011; Verhelst B, 2013, GENOME BIOL EVOL, V5, P2393, DOI 10.1093/gbe/evt189; Wang H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004843; Warf MB, 2010, TRENDS BIOCHEM SCI, V35, P169, DOI 10.1016/j.tibs.2009.10.004; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Yoshihama M, 2006, PLOS GENET, V2, P237, DOI 10.1371/journal.pgen.0020025	41	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129302	10.1371/journal.pone.0129302	http://dx.doi.org/10.1371/journal.pone.0129302			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046656	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200145
J	Kim, JW; Kim, BG; Kim, SH; Kim, W; Lee, KL; Byeon, SJ; Choi, E; Chang, MS				Kim, Ji Won; Kim, Byeong Gwan; Kim, Su Hwan; Kim, Won; Lee, Kook Lae; Byeon, Sun-Ju; Choi, Euno; Chang, Mee Soo			Histomorphological and Immunophenotypic Features of Pill-Induced Esophagitis	PLOS ONE			English	Article							EOSINOPHILIC ESOPHAGITIS; ACTIVATION; LEPTIN; INJURY; DAMAGE	The aim of this study was to investigate histomorphological and immunophenotypic features in pill-induced esophagitis. We comparatively evaluated the histomorphological, immunophenotypic features of pill-induced esophagitis vs. reflux esophagitis, as well as clinical information and endoscopic findings. Fifty-two tissue pieces from 22 cases of pill-induced esophagitis, 46 pieces from 20 reflux esophagitis, and 16 pieces from 14 control samples were subjected to immunohistochemistry for inflammatory infiltrates (CD3 for T lymphocyte, CD20 for B lymphocyte, CD56 for NK cell, CD68 for macrophage, CD117 for mast cell) and eosinophil chemotaxis-associated proteins (Erk, leptin, leptin receptor, pSTAT3, phospho-mTOR). As a result, Histomorphology showed that a diffuse pattern of dilated intercellular spaces was more frequently observed in pill-induced esophagitis, while reactive atypia and subepithelial papillary elongation were more often found in reflux esophagitis (P < 0.05, respectively). Interestingly, intraepithelial eosinophilic microabscess, intraepithelial pustule and diffuse pattern of dilated intercellular spaces were observed in 14% (3 cases), 9% (2 cases) and 32% (7 cases) of pill-induced esophagitis, respectively, but in no cases of reflux esophagitis. Regarding intraepithelial inflammatory infiltrates in pill-induced esophagitis, T lymphocytes were the most common cells, followed by eosinophil; 11 and 7 in one x400 power field, respectively. Intraepithelial pSTAT3-positive pattern was more frequently observed in pill-induced esophagitis than in reflux esophagitis, at 45% (10 cases) versus 10% (2 cases), respectively (P < 0.05). Considering the distal esophageal lesion only, intraepithelial pustule, diffuse dilated intercellular spaces and stromal macrophages were more frequently found in distal pill-induced esophagitis, whereas reactive atypia and intraepithelial mast cells in reflux esophagitis (P < 0.05, respectively). In conclusion, diffuse dilated intercellular spaces, intraepithelial eosinophil microabscess, pustule, T lymphocytes, eosinophils, and pSTAT3 positivity can be added to histopathological features of pill-induced esophagitis, other than non-specific ulcer. Besides, distal pill-induced esophagitis may be histopathologically differentiated from reflux esophagitis.	[Kim, Ji Won; Kim, Byeong Gwan; Kim, Su Hwan; Kim, Won; Lee, Kook Lae] Seoul Natl Univ, Coll Med, Dept Internal Med, Boramae Hosp, Seoul 151, South Korea; [Byeon, Sun-Ju; Choi, Euno; Chang, Mee Soo] Seoul Natl Univ, Coll Med, Dept Pathol, Boramae Hosp, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Chang, MS (corresponding author), Seoul Natl Univ, Coll Med, Dept Pathol, Boramae Hosp, Seoul 151, South Korea.	meesoch@snu.ac.kr	Kim, Won/H-6940-2019; KIM, SUHWAN/GSE-0120-2022	Kim, Won/0000-0002-2926-1007; Byeon, Sun-ju/0000-0002-9599-4970				Abid S, 2005, ENDOSCOPY, V37, P740, DOI 10.1055/s-2005-870129; Arora A S, 2000, Curr Gastroenterol Rep, V2, P224, DOI 10.1007/s11894-000-0065-1; Boehme SA, 1999, J IMMUNOL, V163, P1611; Boyce HW, 1998, GASTROINTEST ENDOSC, V47, P547, DOI 10.1016/S0016-5107(98)70264-0; Cao Q, 2014, EUR ARCH OTORHINOLAR; Carborg B, 1978, LAKARTIDNINGEN, V75, P4609; De Petris G, 2014, INT J SURG PATHOL, V22, P202, DOI 10.1177/1066896913502230; deGroen PC, 1996, NEW ENGL J MED, V335, P1016, DOI 10.1056/NEJM199610033351403; El-Zein O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083360; EVANS KT, 1976, LANCET, V2, P1237; Geagea A, 2008, CURR OPIN GASTROEN, V24, P496, DOI 10.1097/MOG.0b013e328304de94; Higuchi D, 2003, J GASTROINTEST SURG, V7, P836, DOI 10.1016/S1091-255X(03)00138-0; Huang Jennifer J, 2010, Allergy Asthma Clin Immunol, V6, P25, DOI 10.1186/1710-1492-6-25; Jaspersen D, 2000, DRUG SAFETY, V22, P237, DOI 10.2165/00002018-200022030-00007; Kampen GT, 2000, BLOOD, V95, P1911, DOI 10.1182/blood.V95.6.1911; Kato H, 2011, INT ARCH ALLERGY IMM, V155, P335, DOI 10.1159/000321195; Kato M, 2012, INT ARCH ALLERGY IMM, V158, P11, DOI 10.1159/000337752; Kikendall JW, 1999, J CLIN GASTROENTEROL, V28, P298, DOI 10.1097/00004836-199906000-00004; KIKENDALL JW, 1983, DIGEST DIS SCI, V28, P174, DOI 10.1007/BF01315148; Kim SH, 2014, WORLD J GASTROENTERO, V20, P10994, DOI 10.3748/wjg.v20.i31.10994; Lee KN, 2014, BIOCHEM BIOPH RES CO, V446, P822, DOI 10.1016/j.bbrc.2014.02.072; Leong RWL, 2006, EXPERT OPIN DRUG SAF, V5, P585, DOI 10.1517/14740338.5.4.585; MCCALLUM RW, 1987, AM J GASTROENTEROL, V82, P758; Mueller S, 2006, J CLIN PATHOL, V59, P1175, DOI 10.1136/jcp.2005.031922; Mueller S, 2008, HISTOPATHOLOGY, V53, P676, DOI 10.1111/j.1365-2559.2008.03187.x; Mulder DJ, 2009, GUT, V58, P166, DOI 10.1136/gut.2008.157628; PEMBERTON J, 1970, BRIT HEART J, V32, P267; Procaccini C, 2012, J IMMUNOL, V189, P2941, DOI 10.4049/jimmunol.1200935; Rodrigo S, 2008, AM J GASTROENTEROL, V103, P435, DOI 10.1111/j.1572-0241.2007.01594.x; Rothenberg ME, 2001, IMMUNOL REV, V179, P139, DOI 10.1034/j.1600-065X.2001.790114.x; Saxena NK, 2007, CANCER RES, V67, P2497, DOI 10.1158/0008-5472.CAN-06-3075; Seminerio J, 2014, GASTROINTEST ENDOSC, V79, P140, DOI 10.1016/j.gie.2013.08.027	32	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128110	10.1371/journal.pone.0128110	http://dx.doi.org/10.1371/journal.pone.0128110			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047496	gold, Green Published			2022-12-27	WOS:000355652200041
J	Kong, XY; Kase, ET; Herskedal, A; Schjalm, C; Damme, M; Nesset, CK; Thoresen, GH; Rustan, AC; Eskild, W				Kong, Xiang Yi; Kase, Eili Tranheim; Herskedal, Anette; Schjalm, Camilla; Damme, Markus; Nesset, Cecilie Kasi; Thoresen, G. Hege; Rustan, Arild C.; Eskild, Winnie			Lack of the Lysosomal Membrane Protein, GLMP, in Mice Results in Metabolic Dysregulation in Liver	PLOS ONE			English	Article							HEPATIC STEATOSIS; GLUCOSE-UPTAKE; KUPFFER CELLS; FATTY LIVER; TRANSCRIPTION FACTOR; PPAR-GAMMA; RECEPTOR; ACCUMULATION; EXPRESSION; DISEASE	Ablation of glycosylated lysosomal membrane protein (GLMP, formerly known as NCU-G1) has been shown to cause chronic liver injury which progresses into liver fibrosis in mice. Both lysosomal dysfunction and chronic liver injury can cause metabolic dysregulation. Glmp(gt/gt) mice (formerly known as Ncu-g1(gt/gt)mice) were studied between 3 weeks and 9 months of age. Body weight gain and feed efficiency of Glmpgt/gt mice were comparable to wild type siblings, only at the age of 9 months the Glmp(gt/gt) siblings had significantly reduced body weight. Reduced size of epididymal fat pads was accompanied by hepatosplenomegaly in Glmp(gt/gt) mice. Blood analysis revealed reduced levels of blood glucose, circulating triacylglycerol and non-esterified fatty acids in Glmp(gt/gt) mice. Increased flux of glucose, increased de novo lipogenesis and lipid accumulation were detected in Glmp(gt/gt) primary hepatocytes, as well as elevated triacylglycerol levels in Glmp(gt/gt) liver homogenates, compared to hepatocytes and liver from wild type mice. Gene expression analysis showed an increased expression of genes involved in fatty acid uptake and lipogenesis in Glmp(gt/gt) liver compared to wild type. Our findings are in agreement with the metabolic alterations observed in other mouse models lacking lysosomal proteins, and with alterations characteristic for advanced chronic liver injury.	[Kong, Xiang Yi; Herskedal, Anette; Schjalm, Camilla; Nesset, Cecilie Kasi; Eskild, Winnie] Univ Oslo, Dept Biosci, Oslo, Norway; [Kase, Eili Tranheim; Thoresen, G. Hege; Rustan, Arild C.] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway; [Damme, Markus] Univ Kiel, Inst Biochem, Kiel, Germany; [Thoresen, G. Hege] Univ Oslo, Inst Clin Med, Fac Med, Dept Pharmacol, Oslo, Norway; [Thoresen, G. Hege] Oslo Univ Hosp, Oslo, Norway	University of Oslo; University of Oslo; University of Kiel; University of Oslo; University of Oslo	Eskild, W (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.	winnie.eskild@ibv.uio.no		Kong, Xiang Yi/0000-0003-3244-344X				Alroy Joseph, 2014, J. inborn errors metab. screen., V2, pe130001, DOI 10.1177/2326409813517663; Ballabio A, 2009, BBA-MOL CELL RES, V1793, P684, DOI 10.1016/j.bbamcr.2008.12.001; Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; BERG T, 1973, BIOCHIM BIOPHYS ACTA, V321, P585, DOI 10.1016/0005-2744(73)90201-5; Boustany RMN, 2013, NAT REV NEUROL, V9, P583, DOI 10.1038/nrneurol.2013.163; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buque X, 2010, J LIPID RES, V51, P500, DOI 10.1194/jlr.M001966; Caron S, 2011, ARTERIOSCL THROM VAS, V31, P513, DOI 10.1161/ATVBAHA.110.220723; Cox TM, 2012, J PATHOL, V226, P241, DOI 10.1002/path.3021; Dateki M, 2011, J RECEPT SIG TRANSD, V31, P85, DOI 10.3109/10799893.2010.538405; Degrace P, 2006, J LIPID RES, V47, P2647, DOI 10.1194/jlr.M600140-JLR200; Dongiovanni P, 2011, J HEPATOL, V55, P920, DOI 10.1016/j.jhep.2011.05.008; Endo M, 2007, EXP BIOL MED, V232, P614; Feldstein AE, 2010, SEMIN LIVER DIS, V30, P391, DOI 10.1055/s-0030-1267539; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fredenrich A, 1997, J LIPID RES, V38, P1421; Garcia-Monzon C, 2014, EUR J CLIN INVEST, V44, P65, DOI 10.1111/eci.12192; Hansen B, 2002, MOL CELL BIOCHEM, V240, P1, DOI 10.1023/A:1020660303855; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Imano E, 1999, J HEPATOL, V31, P469, DOI 10.1016/S0168-8278(99)80039-7; Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070; JOHANSSON U, 1994, J HEPATOL, V20, P760, DOI 10.1016/S0168-8278(05)80147-3; Katzenellenbogen M, 2006, CANCER RES, V66, P4001, DOI 10.1158/0008-5472.CAN-05-2937; Kong XY, 2014, DIS MODEL MECH, V7, P351, DOI 10.1242/dmm.014050; KRAHENBUHL S, 1992, SCAND J GASTROENTERO, V27, P90, DOI 10.3109/00365529209096012; KRUSZYNSKA YT, 1993, J CLIN INVEST, V91, P1057, DOI 10.1172/JCI116263; LEATHERDALE BA, 1980, CLIN SCI, V59, P191, DOI 10.1042/cs0590191; Ma KL, 2008, HEPATOLOGY, V48, P770, DOI 10.1002/hep.22423; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Moore MC, 2012, ADV NUTR, V3, P286, DOI 10.3945/an.112.002089; Musso G, 2010, OBES REV, V11, P430, DOI 10.1111/j.1467-789X.2009.00657.x; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Nelson JE, 2011, HEPATOLOGY, V53, P448, DOI 10.1002/hep.24038; Nishikawa T, 2014, J HEPATOL, V60, P1203, DOI 10.1016/j.jhep.2014.02.014; Parkinson-Lawrence EJ, 2010, PHYSIOLOGY, V25, P102, DOI 10.1152/physiol.00041.2009; Pavlic M, 2008, ARTERIOSCL THROM VAS, V28, P1660, DOI 10.1161/ATVBAHA.108.169383; Pinzani M, 2011, BEST PRACT RES CL GA, V25, P281, DOI 10.1016/j.bpg.2011.02.009; Platt FM, 2012, J CELL BIOL, V199, P723, DOI 10.1083/jcb.201208152; Popov Y, 2005, J HEPATOL, V43, P1045, DOI 10.1016/j.jhep.2005.06.025; Riganti C, 2012, FREE RADICAL BIO MED, V53, P421, DOI 10.1016/j.freeradbiomed.2012.05.006; Ruan H, 2002, DIABETES, V51, P3176, DOI 10.2337/diabetes.51.11.3176; Sahini N, 2014, PROG LIPID RES, V54, P86, DOI 10.1016/j.plipres.2014.02.002; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schieweck O, 2009, BIOCHEM J, V422, P83, DOI 10.1042/BJ20090567; SCHONFELD G, 1979, METABOLISM, V28, P1001, DOI 10.1016/0026-0495(79)90004-0; Schroder BA, 2010, PROTEOMICS, V10, P4053, DOI 10.1002/pmic.201000196; Schultz ML, 2011, TRENDS NEUROSCI, V34, P401, DOI 10.1016/j.tins.2011.05.006; Settembre C, 2014, TRENDS CELL BIOL, V24, P743, DOI 10.1016/j.tcb.2014.06.006; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Shiri-Sverdlov R, 2006, J HEPATOL, V44, P732, DOI 10.1016/j.jhep.2005.10.033; SHMUELI E, 1993, HEPATOLOGY, V18, P86, DOI 10.1016/0270-9139(93)90511-K; Steffensen KR, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-106; Stienstra R, 2010, HEPATOLOGY, V51, P511, DOI 10.1002/hep.23337; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Wang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103071; Wang YX, 2010, CELL RES, V20, P124, DOI 10.1038/cr.2010.13; Wensaas AJ, 2007, J LIPID RES, V48, P961, DOI 10.1194/jlr.D600047-JLR200; Woloszynek JC, 2007, J BIOL CHEM, V282, P35765, DOI 10.1074/jbc.M705124200; Woloszynek JC, 2009, J BIOL CHEM, V284, P29684, DOI 10.1074/jbc.M109.020818; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	64	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129402	10.1371/journal.pone.0129402	http://dx.doi.org/10.1371/journal.pone.0129402			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047317	Green Published, gold			2022-12-27	WOS:000355652200160
J	Llanos, P; Contreras-Ferrat, A; Barrientos, G; Valencia, M; Mears, D; Hidalgo, C				Llanos, Paola; Contreras-Ferrat, Ariel; Barrientos, Genaro; Valencia, Marco; Mears, David; Hidalgo, Cecilia			Glucose-Dependent Insulin Secretion in Pancreatic beta-Cell Islets from Male Rats Requires Ca2+ Release via ROS-Stimulated Ryanodine Receptors	PLOS ONE			English	Article							CHRONIC OXIDATIVE STRESS; CYCLIC ADP-RIBOSE; ENDOPLASMIC-RETICULUM; INTRACELLULAR CA2+; CALCIUM-RELEASE; INOSITOL 1,4,5-TRISPHOSPHATE; GLUTATHIONE-PEROXIDASE; ACTIVATION; MOBILIZATION; LINE	Glucose-stimulated insulin secretion (GSIS) from pancreatic beta-cells requires an increase in intracellular free Ca2+ concentration ([Ca2+]). Glucose uptake into beta-cells promotes Ca2+ influx and reactive oxygen species (ROS) generation. In other cell types, Ca2+ and ROS jointly induce Ca2+ releasemediated by ryanodine receptor (RyR) channels. Therefore, we explored here if RyR-mediated Ca2+ release contributes to GSIS in beta-cell islets isolated from male rats. Stimulatory glucose increased islet insulin secretion, and promoted ROS generation in islets and dissociated beta-cells. Conventional PCR assays and immunostaining confirmed that a cells express RyR2, the cardiac RyR isoform. Extended incubation of beta-cell islets with inhibitory ryanodine suppressed GSIS; so did the antioxidant N-acetyl cysteine (NAC), which also decreased insulin secretion induced by glucose plus caffeine. Inhibitory ryanodine or NAC did not affect insulin secretion induced by glucose plus carbachol, which engages inositol 1,4,5-trisphosphate receptors. Incubation of islets with H2O2 in basal glucose increased insulin secretion 2-fold. Inhibitory ryanodine significantly decreased H2O2-stimulated insulin secretion and prevented the 4.5-fold increase of cytoplasmic [Ca2+] produced by incubation of dissociated beta-cells with H2O2. Addition of stimulatory glucose or H2O2 (in basal glucose) to beta-cells disaggregated from islets increased RyR2 S-glutathionylation to similar levels, measured by a proximity ligation assay; in contrast, NAC significantly reduced the RyR2 S-glutathionylation increase produced by stimulatory glucose. We propose that RyR2-mediated Ca2+ release, induced by the concomitant increases in [Ca2+] and ROS produced by stimulatory glucose, is an essential step in GSIS.	[Llanos, Paola; Contreras-Ferrat, Ariel] Univ Chile, Fac Odontol, Inst Res Dent Sci, Santiago, Chile; [Llanos, Paola; Contreras-Ferrat, Ariel; Valencia, Marco; Mears, David; Hidalgo, Cecilia] Univ Chile, Fac Med, Ctr Mol Studies Cell, Santiago, Chile; [Barrientos, Genaro; Hidalgo, Cecilia] Univ Chile, Fac Med, Physiol & Biophys Program, Santiago, Chile; [Mears, David] Univ Chile, Fac Med, Inst Biomed Sci, Human Genet Program, Santiago, Chile; [Hidalgo, Cecilia] Univ Chile, Fac Med, Biomed Neurosci Inst, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile	Llanos, P (corresponding author), Univ Chile, Fac Odontol, Inst Res Dent Sci, Santiago, Chile.	pllanos@med.uchile.cl; chidalgo@med.uchile.cl	HIDALGO, Cecilia/H-7107-2013	Llanos, Paola/0000-0003-1383-7961	Fondo de Investigacion Avanzada en Areas Prioritarias FONDAP-CEMC [15010006]; CONICYT-Chile; FONDECYT [3110105, 1050571, 11130267]; USUHS intramural grant program	Fondo de Investigacion Avanzada en Areas Prioritarias FONDAP-CEMC(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); CONICYT-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); USUHS intramural grant program	Specific funding for this work was provided by Fondo de Investigacion Avanzada en Areas Prioritarias FONDAP-CEMC Grant 15010006, CONICYT-Chile (http://spl.conicyt.cl/auth/) to CH; FONDECYT 3110105, CONICYT-Chile (http://spl.conicyt.cl/auth/) to PL; FONDECYT 1050571, CONICYT-Chile (http://spl.conicyt.cl/auth/) and USUHS intramural grant program (www.usuhs.mil) to DM; and FONDECYT 11130267, CONICYT-Chile (http://spl.conicyt.cl/auth/) to AC-F.	Adasme T, 2015, BIOCHEM BIOPH RES CO, V458, P57, DOI 10.1016/j.bbrc.2015.01.065; Adasme T, 2011, P NATL ACAD SCI USA, V108, P3029, DOI 10.1073/pnas.1013580108; Beauvois MC, 2004, J PHYSIOL-LONDON, V559, P141, DOI 10.1113/jphysiol.2004.067454; Bindokas VP, 2003, J BIOL CHEM, V278, P9796, DOI 10.1074/jbc.M206913200; BLONDEL O, 1994, P NATL ACAD SCI USA, V91, P7777, DOI 10.1073/pnas.91.16.7777; Bruton JD, 2002, FASEB J, V16, P301, DOI 10.1096/fj.02-0481fje; Bull R, 2007, AM J PHYSIOL-CELL PH, V293, pC162, DOI 10.1152/ajpcell.00518.2006; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Choi KJ, 2011, KOREAN J PHYSIOL PHA, V15, P53, DOI 10.4196/kjpp.2011.15.1.53; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Gamberucci A, 1999, FEBS LETT, V446, P309, DOI 10.1016/S0014-5793(99)00220-3; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; GRANKVIST K, 1981, BIOCHEM J, V199, P393, DOI 10.1042/bj1990393; Graves TK, 2003, ENDOCRINOLOGY, V144, P3565, DOI 10.1210/en.2002-0104; Gustafsson AJ, 2004, FASEB J, V18, P301, DOI 10.1096/fj.04-2621fje; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hidalgo C, 2008, ANTIOXID REDOX SIGN, V10, P1275, DOI 10.1089/ars.2007.1886; Holz GG, 1999, J BIOL CHEM, V274, P14147, DOI 10.1074/jbc.274.20.14147; ISLAM MS, 1992, FEBS LETT, V296, P287, DOI 10.1016/0014-5793(92)80306-2; Islam MS, 2002, DIABETES, V51, P1299, DOI 10.2337/diabetes.51.5.1299; ISLAM MS, 1993, SCIENCE, V262, P584, DOI 10.1126/science.8211188; Islam MS, 1998, P NATL ACAD SCI USA, V95, P6145, DOI 10.1073/pnas.95.11.6145; Janjic D, 1999, BIOCHEM PHARMACOL, V57, P639, DOI 10.1016/S0006-2952(98)00346-3; Johnson JD, 2004, FASEB J, V18, P878, DOI 10.1096/fj.03-1280fje; Johnson JD, 2004, J BIOL CHEM, V279, P24794, DOI 10.1074/jbc.M401216200; Kang GX, 2001, J PHYSIOL-LONDON, V536, P375, DOI 10.1111/j.1469-7793.2001.0375c.xd; Kemmerling U, 2007, CELL CALCIUM, V41, P491, DOI 10.1016/j.ceca.2006.10.001; Kohler M, 1998, FEBS LETT, V441, P97, DOI 10.1016/S0014-5793(98)01539-7; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Krippeit-Drews P, 1999, J PHYSIOL-LONDON, V514, P471, DOI 10.1111/j.1469-7793.1999.471ae.x; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Maechler P, 1999, J BIOL CHEM, V274, P27905, DOI 10.1074/jbc.274.39.27905; MALAISSE WJ, 1967, J CLIN INVEST, V46, P1724, DOI 10.1172/JCI105663; Marengo JJ, 1998, BIOPHYS J, V74, P1263, DOI 10.1016/S0006-3495(98)77840-3; Mears D, 1999, CELL CALCIUM, V25, P59, DOI 10.1054/ceca.1998.0007; Mears D, 2004, J MEMBRANE BIOL, V200, P57, DOI 10.1007/s00232-004-0692-9; Mitchell KJ, 2003, J BIOL CHEM, V278, P11057, DOI 10.1074/jbc.M210257200; Mitchell KJ, 2001, J CELL BIOL, V155, P41, DOI 10.1083/jcb.200103145; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nakagaki I, 2000, PFLUG ARCH EUR J PHY, V440, P828, DOI 10.1007/s004240000372; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Paula-Lima AC, ANTIOXIDANTS REDOX S, V14, P1209; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; ROJAS E, 1994, ENDOCRINOLOGY, V134, P1771, DOI 10.1210/en.134.4.1771; Sakai K, 2003, BIOCHEM BIOPH RES CO, V300, P216, DOI 10.1016/S0006-291X(02)02832-2; Santulli G, 2015, J CLIN INVEST, V125, P1968, DOI 10.1172/JCI79273; Shigeto M, 2007, J PHARMACOL EXP THER, V322, P1, DOI 10.1124/jpet.107.120592; Takasawa S, 1998, J BIOL CHEM, V273, P2497, DOI 10.1074/jbc.273.5.2497; Takasawa S, 2010, BIOCHEM BIOPH RES CO, V397, P140, DOI 10.1016/j.bbrc.2010.05.051; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P12363, DOI 10.1073/pnas.192445199; Tang JP, 2000, LIFE SCI, V68, P475, DOI 10.1016/S0024-3205(00)00944-9; Tengholm A, 2001, J PHYSIOL-LONDON, V530, P533, DOI 10.1111/j.1469-7793.2001.0533k.x; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; Tsubouchi H, 2005, BIOCHEM BIOPH RES CO, V326, P60, DOI 10.1016/j.bbrc.2004.10.201; WILLMOTT NJ, 1995, FEBS LETT, V371, P99, DOI 10.1016/0014-5793(95)00848-4; WOLFF SP, 1987, BIOCHEM J, V245, P243, DOI 10.1042/bj2450243; WOLLHEIM CB, 1986, J BIOL CHEM, V261, P8314; Woolcott OO, 2006, CELL CALCIUM, V39, P529, DOI 10.1016/j.ceca.2006.02.003; Zheng J, 2012, BIOCHEM BIOPH RES CO, V423, P207, DOI 10.1016/j.bbrc.2012.04.114	67	45	47	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129238	10.1371/journal.pone.0129238	http://dx.doi.org/10.1371/journal.pone.0129238			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046640	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200135
J	Prabudiansyah, I; Kusters, I; Driessen, AJM				Prabudiansyah, Irfan; Kusters, Ilja; Driessen, Arnold J. M.			In Vitro Interaction of the Housekeeping SecA1 with the Accessory SecA2 Protein of Mycobacterium tuberculosis	PLOS ONE			English	Article							ESCHERICHIA-COLI; DIMERIC SECA; ATPASE SECA; PREPROTEIN TRANSLOCATION; CRYSTAL-STRUCTURE; OLIGOMERIC STATE; CATALYTIC CYCLE; SIGNAL-PEPTIDE; BINDING; SECRETION	The majority of proteins that are secreted across the bacterial cytoplasmic membrane leave the cell via the Sec pathway, which in its minimal form consists of the dimeric ATP-driven motor protein SecA that associates with the protein-conducting membrane pore SecYEG. Some Gram-positive bacteria contain two homologues of SecA, termed SecA1 and SecA2. SecA1 is the essential housekeeping protein, whereas SecA2 is not essential but is involved in the translocation of a subset of proteins, including various virulence factors. Some SecA2 containing bacteria also harbor a homologous SecY2 protein that may form a separate translocase. Interestingly, mycobacteria contain only one SecY protein and thus both SecA1 and SecA2 are required to interact with SecYEG, either individually or together as a heterodimer. In order to address whether SecA1 and SecA2 cooperate during secretion of SecA2 dependent proteins, we examined the oligomeric state of SecA1 and SecA2 of Mycobacterium tuberculosis and their interactions with SecA2 and the cognate SecA1, respectively. We conclude that both SecA1 and SecA2 individually form homodimers in solution but when both proteins are present simultaneously, they form dissociable heterodimers.	[Driessen, Arnold J. M.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Mol Microbiol, NL-9727 AG Groningen, Netherlands; Univ Groningen, Zernike Inst Adv Mat, NL-9727 AG Groningen, Netherlands	University of Groningen; University of Groningen	Driessen, AJM (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Mol Microbiol, Nijenborgh 7, NL-9727 AG Groningen, Netherlands.	a.j.m.driessen@rug.nl	Institute, Zernike/W-7033-2019; Driessen, Arnold J.M./D-1876-2012; Kusters, Ilja/J-3492-2019	Kusters, Ilja/0000-0003-3739-8764; Driessen, Arnold J.M./0000-0001-9258-9104; Prabudiansyah, Irfan/0000-0001-7133-6933	Earth and Life Sciences (ALW); Netherlands Organization for scientific Research (NWO); Bernoulli Grant of the University of Groningen	Earth and Life Sciences (ALW); Netherlands Organization for scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Bernoulli Grant of the University of Groningen	This work was supported by Earth and Life Sciences (ALW), which is supported by the Netherlands Organization for scientific Research (NWO). IP was funded through a Bernoulli Grant of the University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKITA M, 1991, BIOCHEM BIOPH RES CO, V174, P211, DOI 10.1016/0006-291X(91)90507-4; Bacia K, 2007, NAT PROTOC, V2, P2842, DOI 10.1038/nprot.2007.410; Bechtluft P, 2010, MOL BIOSYST, V6, P620, DOI 10.1039/b915435c; Benach J, 2003, J BIOL CHEM, V278, P3628, DOI 10.1074/jbc.M205992200; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Bensing BA, 2014, BBA-MOL CELL RES, V1843, P1674, DOI 10.1016/j.bbamcr.2013.10.019; Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x; Braunstein M, 2001, J BACTERIOL, V183, P6979, DOI 10.1128/JB.183.24.6979-6990.2001; BREUKINK E, 1995, J BIOL CHEM, V270, P7902, DOI 10.1074/jbc.270.14.7902; Bu ZM, 2003, J MOL BIOL, V332, P23, DOI 10.1016/S0022-2836(03)00840-4; Caspers M, 2008, ARCH MICROBIOL, V189, P605, DOI 10.1007/s00203-008-0351-0; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; D'Lima NG, 2014, J BIOL CHEM, V289, P2307, DOI 10.1074/jbc.M113.533323; Das S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182931; de Keyzer J, 2005, J BIOL CHEM, V280, P35255, DOI 10.1074/jbc.M506157200; Ding HY, 2003, BIOCHEMISTRY-US, V42, P8729, DOI 10.1021/bi0342057; DRIESSEN AJM, 1993, BIOCHEMISTRY-US, V32, P13190, DOI 10.1021/bi00211a030; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Fagan RP, 2011, J BIOL CHEM, V286, P27483, DOI 10.1074/jbc.M111.263889; Fekkes P, 1998, MOL MICROBIOL, V29, P1179, DOI 10.1046/j.1365-2958.1998.00997.x; Feltcher ME, 2012, NAT REV MICROBIOL, V10, P779, DOI 10.1038/nrmicro2874; Gouridis G, 2013, MOL CELL, V52, P655, DOI 10.1016/j.molcel.2013.10.036; Halbedel S, 2014, MOL CELL PROTEOMICS, V13, P3063, DOI 10.1074/mcp.M114.041327; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hou JM, 2008, J BACTERIOL, V190, P4880, DOI 10.1128/JB.00412-08; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Jilaveanu LB, 2005, P NATL ACAD SCI USA, V102, P7511, DOI 10.1073/pnas.0502774102; Kusters I, 2011, CELL MOL LIFE SCI, V68, P2053, DOI 10.1007/s00018-011-0681-y; Kusters I, 2011, STRUCTURE, V19, P430, DOI 10.1016/j.str.2010.12.016; Lenz LL, 2003, P NATL ACAD SCI USA, V100, P12432, DOI 10.1073/pnas.2133653100; Ligon LS, 2013, J BACTERIOL, V195, P4456, DOI 10.1128/JB.00630-13; Musial-Siwek M, 2005, BIOCHEMISTRY-US, V44, P13987, DOI 10.1021/bi050882k; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; Or E, 2005, J BIOL CHEM, V280, P9097, DOI 10.1074/jbc.M413947200; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; Papanikolau Y, 2007, J MOL BIOL, V366, P1545, DOI 10.1016/j.jmb.2006.12.049; Rigel NW, 2008, MOL MICROBIOL, V69, P291, DOI 10.1111/j.1365-2958.2008.06294.x; Rigel NW, 2009, J BIOL CHEM, V284, P9927, DOI 10.1074/jbc.M900325200; Sardis MF, 2010, MOL MICROBIOL, V76, P1070, DOI 10.1111/j.1365-2958.2010.07176.x; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Sharma V, 2003, P NATL ACAD SCI USA, V100, P2243, DOI 10.1073/pnas.0538077100; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Sullivan JT, 2012, INFECT IMMUN, V80, P996, DOI 10.1128/IAI.05987-11; van der Does C, 2003, METHOD ENZYMOL, V372, P86; van der Wolk JPW, 1997, EMBO J, V16, P7297, DOI 10.1093/emboj/16.24.7297; van der Woude AD, 2014, CELL MICROBIOL, V16, P280, DOI 10.1111/cmi.12221; Vassylyev DG, 2006, J MOL BIOL, V364, P248, DOI 10.1016/j.jmb.2006.09.061; Veldhuis G, 2006, PROTEIN SCI, V15, P1977, DOI 10.1110/ps.062113906; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Woodbury RL, 2002, PROTEIN SCI, V11, P875, DOI 10.1110/ps.4090102; Wowor AJ, 2011, J MOL BIOL, V408, P87, DOI 10.1016/j.jmb.2011.02.006; Zhou MX, 2011, J BACTERIOL, V193, P6560, DOI 10.1128/JB.05668-11; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335; Zimmer J, 2006, J MOL BIOL, V364, P259, DOI 10.1016/j.jmb.2006.08.044	59	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128788	10.1371/journal.pone.0128788	http://dx.doi.org/10.1371/journal.pone.0128788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047312	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200100
J	Tunon, J; Higueras, J; Tarin, N; Cristobal, C; Lorenzo, O; Blanco-Colio, L; Martin-Ventura, JL; Huelmos, A; Alonso, J; Acena, A; Pello, A; Carda, R; Asensio, D; Mahillo-Fernandez, I; Bescos, LL; Egido, J; Farre, J				Tunon, Jose; Higueras, Javier; Tarin, Nieves; Cristobal, Carmen; Lorenzo, Oscar; Blanco-Colio, Luis; Luis Martin-Ventura, Jose; Huelmos, Ana; Alonso, Joaquin; Acena, Alvaro; Pello, Ana; Carda, Rocio; Asensio, Dolores; Mahillo-Fernandez, Ignacio; Lopez Bescos, Lorenzo; Egido, Jesus; Farre, Jeronimo			N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; ENDOTHELIAL GROWTH-FACTOR; LUNG-CANCER; CARDIAC HORMONES; INTERLEUKIN-6 LEVELS; PREDICT MORTALITY; HODGKIN LYMPHOMA; PROGNOSTIC VALUE; CELL LYMPHOMA; ATRIAL	Objective Several papers have reported elevated plasma levels of natriuretic peptides in patients with a previous diagnosis of cancer. We have explored whether N-terminal pro-brain natriuretic peptide (NT-proBNP) plasma levels predict a future diagnosis of cancer in patients with coronary artery disease (CAD). Methods We studied 699 patients with CAD free of cancer. At baseline, NT-proBNP, galectin-3, monocyte chemoattractant protein-1, soluble tumor necrosis factor-like weak inducer of apoptosis, high-sensitivity C-reactive protein, and high-sensitivity cardiac troponin I plasma levels were assessed. The primary outcome was new cancer diagnosis. The secondary outcome was cancer diagnosis, heart failure requiring hospitalization, or death. Results After 2.15 +/- 0.98 years of follow-up, 24 patients developed cancer. They were older (68.5 [61.5, 75.8] vs 60.0 [52.0, 72.0] years; p=0.011), had higher NT-proBNP (302.0 [134.8, 919.8] vs 165.5 [87.4, 407.5] pg/ml; p=0.040) and high-sensitivity C-reactive protein (3.27 [1.33, 5.94] vs 1.92 [0.83, 4.00] mg/L; p=0.030), and lower triglyceride (92.5 [70.5, 132.8] vs 112.0 [82.0, 157.0] mg/dl; p=0.044) plasma levels than those without cancer. NT-proBNP (Hazard Ratio [HR]=1.030; 95% Confidence Interval [CI]=1.008-1.053; p=0.007) and triglyceride levels (HR=0.987; 95% CI= 0.975-0.998; p=0.024) were independent predictors of a new cancer diagnosis (multivariate Cox regression analysis). When patients in whom the suspicion of cancer appeared in the first one-hundred days after blood extraction were excluded, NT-proBNP was the only predictor of cancer (HR=1.061; 95% CI= 1.034-1.088; p<0.001). NT-proBNP was an independent predictor of cancer, heart failure, or death (HR=1.038; 95% CI= 1.023-1.052; p<0.001) along with age, and use of insulin and acenocumarol. Conclusions NT-proBNP is an independent predictor of malignancies in patients with CAD. New studies in large populations are needed to confirm these findings.	[Tunon, Jose] IIS Fdn Jimenez Diaz, Dept Cardiol, Madrid, Spain; [Tunon, Jose; Lorenzo, Oscar; Luis Martin-Ventura, Jose; Egido, Jesus; Farre, Jeronimo] Univ Autonoma Madrid, Madrid, Spain; [Tunon, Jose; Lorenzo, Oscar; Blanco-Colio, Luis; Luis Martin-Ventura, Jose; Egido, Jesus] IIS Fdn Jimenez Diaz, Lab Vasc Pathol, Madrid, Spain; [Higueras, Javier] Hosp Clin Univ San Carlos, Dept Cardiol, Madrid, Spain; [Tarin, Nieves] Hosp Univ Mostoles, Dept Cardiol, Madrid, Spain; [Cristobal, Carmen; Alonso, Joaquin] Hosp Fuenlabrada, Dept Cardiol, Madrid, Spain; [Cristobal, Carmen; Alonso, Joaquin; Lopez Bescos, Lorenzo] Rey Juan Carlos Univ, Madrid, Spain; [Huelmos, Ana] Hosp Univ Fdn Alcorcon, Dept Cardiol, Madrid, Spain; [Asensio, Dolores] IIS Fdn Jimenez Diaz, Dept Biochem, Madrid, Spain; [Mahillo-Fernandez, Ignacio] IIS Fdn Jimenez Diaz, Dept Prevent Med, Madrid, Spain; [Egido, Jesus] CIBERDEM, Madrid, Spain	Fundacion Jimenez Diaz; Autonomous University of Madrid; Fundacion Jimenez Diaz; Hospital Universitario Fuenlabrada; Universidad Rey Juan Carlos; Alcorcon Foundation University Hospital; Fundacion Jimenez Diaz; Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Tunon, J (corresponding author), IIS Fdn Jimenez Diaz, Dept Cardiol, Madrid, Spain.	jtunon@secardiologia.es	Tunon, Jose/ABA-8847-2020; Acena, Alvaro/AAG-4539-2021; Tuñón, José L/R-3037-2016; Tarin-Vicente, Nieves/O-6345-2015; Blanco-Colio, Luis M./Z-2390-2019; MARTIN-VENTURA, JOSE LUIS/Z-2386-2019; Lorenzo, Oscar/L-2526-2013; Tarín-Vicente, Nieves/O-2300-2019; Mahillo-Fernandez, Ignacio/T-2042-2018	Tuñón, José L/0000-0003-2220-180X; Tarin-Vicente, Nieves/0000-0002-7335-418X; Lorenzo, Oscar/0000-0001-5515-6078; Tarín-Vicente, Nieves/0000-0002-7335-418X; Alonso, Joaquin J/0000-0003-4360-5897; Mahillo-Fernandez, Ignacio/0000-0003-0558-6541; Blanco-Colio, Luis Miguel/0000-0002-1560-6609; MARTIN-VENTURA, JOSE LUIS/0000-0003-2090-8641; Tunon, Jose/0000-0002-1373-0999; Higueras, Javier/0000-0002-3842-5990	Fondo de Investigaciones Sanitarias [PI05/0451, PI05/1497, PI05/2475, PI05/1043, PS09/01405, PI10/00072, PI10/0234, PI14/1567]; Spanish Society of Cardiology and Spanish Heart Foundation; Spanish Society of Arteriosclerosis; RECAVA [RD06/0014/0035]; Fundacion Lilly; Instituto de Salud Carlos III FEDER (FJD biobank) [RD09/0076/00101]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Spanish Society of Cardiology and Spanish Heart Foundation; Spanish Society of Arteriosclerosis; RECAVA; Fundacion Lilly; Instituto de Salud Carlos III FEDER (FJD biobank)	This work was supported by grants from Fondo de Investigaciones Sanitarias (PI05/0451, PI05/1497, PI05/2475, PI05/1043, PS09/01405, PI10/00072, and PI10/0234, PI14/1567, Programa de Estabilizacion to LBC); Spanish Society of Cardiology and Spanish Heart Foundation; Spanish Society of Arteriosclerosis; RECAVA (RD06/0014/0035, www.recava.com); Fundacion Lilly; and Instituto de Salud Carlos III FEDER (FJD biobank: RD09/0076/00101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aujollet N, 2010, CLIN LUNG CANCER, V11, P341, DOI 10.3816/CLC.2010.n.043; Barents M, 2008, J AM MED DIR ASSOC, V9, P580, DOI 10.1016/j.jamda.2008.05.002; Biggar RJ, 2008, CLIN CANCER RES, V14, P6974, DOI 10.1158/1078-0432.CCR-08-1026; Blanco-Colio LM, 2007, ARTERIOSCL THROM VAS, V27, P916, DOI 10.1161/01.ATV.0000258972.10109.ff; Burjonroppa SC, 2007, AM J CLIN ONCOL-CANC, V30, P287, DOI 10.1097/01.coc.0000256101.04404.b0; Daniels LB, 2008, J AM COLL CARDIOL, V52, P450, DOI 10.1016/j.jacc.2008.04.033; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Eggers KM, 2013, AM J CARDIOL, V111, P131, DOI 10.1016/j.amjcard.2012.08.058; Gimeno E, 2011, LEUKEMIA RES, V35, P715, DOI 10.1016/j.leukres.2011.01.018; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Knudsen CW, 2005, J AM COLL CARDIOL, V46, P838, DOI 10.1016/j.jacc.2005.05.057; Kritz H, 1996, J CLIN ONCOL, V14, P3043, DOI 10.1200/JCO.1996.14.11.3043; Kuwahara K, 2010, ENDOCR J, V57, P555, DOI 10.1507/endocrj.K10E-150; Lok DJA, 2010, CLIN RES CARDIOL, V99, P323, DOI 10.1007/s00392-010-0125-y; Manimala NJ, 2013, EUR J CLIN INVEST, V43, P1156, DOI 10.1111/eci.12153; Nguyen JP, 2012, EUR J CLIN INVEST, V42, P1061, DOI 10.1111/j.1365-2362.2012.02695.x; Niitsu N, 2002, EUR J HAEMATOL, V68, P91, DOI 10.1034/j.1600-0609.2002.01609.x; Ohsaki Y, 1999, ONCOLOGY-BASEL, V56, P155, DOI 10.1159/000011957; Omland T, 2013, J AM COLL CARDIOL, V61, P1240, DOI 10.1016/j.jacc.2012.12.026; Papazisis KT, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-489; Pedersen LM, 2005, BRIT J HAEMATOL, V128, P813, DOI 10.1111/j.1365-2141.2005.05393.x; Popat Jesal, 2013, Congest Heart Fail, V19, P143, DOI 10.1111/chf.12018; Sandri MT, 2005, CLIN CHEM, V51, P1405, DOI 10.1373/clinchem.2005.050153; SEYMOUR JF, 1995, J CLIN ONCOL, V13, P575, DOI 10.1200/JCO.1995.13.3.575; Skinnider BF, 2002, BLOOD, V99, P618, DOI 10.1182/blood.V99.2.618; Soualmia H, 2009, CLIN LAB, V55, P120; Subramanian V, 2014, EUR J PHARMACOL, V740, P388, DOI 10.1016/j.ejphar.2014.07.024; TORNBERG SA, 1989, JNCI-J NATL CANCER I, V81, P1917, DOI 10.1093/jnci/81.24.1917; Totsune K, 1996, EUR J ENDOCRINOL, V135, P352, DOI 10.1530/eje.0.1350352; Tunon J, 2014, AM J CARDIOL, V113, P434, DOI 10.1016/j.amjcard.2013.10.012; Vaes B, 2009, J AM GERIATR SOC, V57, P823, DOI 10.1111/j.1532-5415.2009.02218.x; Vesely BA, 2005, EUR J CLIN INVEST, V35, P388, DOI 10.1111/j.1365-2362.2005.01501.x; Willett W C, 2000, Oncologist, V5, P393, DOI 10.1634/theoncologist.5-5-393; Wu FY, 2003, CANCER RES, V63, P8318; Zhang J, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-174; Zhang J, 2013, ONCOL LETT, V6, P407, DOI 10.3892/ol.2013.1425	39	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0126741	10.1371/journal.pone.0126741	http://dx.doi.org/10.1371/journal.pone.0126741			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046344	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200013
J	Watanabe, K; Yabe, M; Kasahara, K; Kokubo, T				Watanabe, Kiyoshi; Yabe, Makoto; Kasahara, Koji; Kokubo, Tetsuro			A Random Screen Using a Novel Reporter Assay System Reveals a Set of Sequences That Are Preferred as the TATA or TATA-Like Elements in the CYC1 Promoter of Saccharomyces cerevisiae	PLOS ONE			English	Article							RNA-POLYMERASE-II; CORE-PROMOTER; BINDING PROTEIN; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; REGULATORY ELEMENTS; INHIBITORY DOMAIN; SITE SELECTION; DNA-SEQUENCES; RPS5 PROMOTER	In Saccharomyces cerevisiae, the core promoters of class II genes contain either TATA or TATA-like elements to direct accurate transcriptional initiation. Genome-wide analyses show that the consensus sequence of the TATA element is TATAWAWR (8 bp), whereas TATA-like elements carry one or two mismatches to this consensus. The fact that several functionally distinct TATA sequences have been identified indicates that these elements may function, at least to some extent, in a gene-specific manner. The purpose of the present study was to identify functional TATA sequences enriched in one particular core promoter and compare them with the TATA or TATA-like elements that serve as the pre-initiation complex (PIC) assembly sites on the yeast genome. For this purpose, we conducted a randomized screen of the TATA element in the CYC1 promoter by using a novel reporter assay system and identified several hundreds of unique sequences that were tentatively classified into nine groups. The results indicated that the 7 bp TATA element (i.e., TATAWAD) and several sets of TATA-like sequences are preferred specifically by this promoter. Furthermore, we find that the most frequently isolated TATA-like sequence, i.e., TATTTAAA, is actually utilized as a functional core promoter element for the endogenous genes, e.g., ADE5,7 and ADE6. Collectively, these results indicate that the sequence requirements for the functional TATA or TATA-like elements in one particular core promoter are not as stringent. However, the variation of these sequences differs significantly from that of the PIC assembly sites on the genome, presumably depending on promoter structures and reflecting the gene-specific function of these sequences.	[Watanabe, Kiyoshi; Yabe, Makoto; Kasahara, Koji; Kokubo, Tetsuro] Yokohama City Univ, Grad Sch Med Life Sci, Mol & Cellular Biol Lab, Yokohama, Kanagawa 232, Japan	Yokohama City University	Kokubo, T (corresponding author), Yokohama City Univ, Grad Sch Med Life Sci, Mol & Cellular Biol Lab, Yokohama, Kanagawa 232, Japan.	kokubo@tsurumi.yokohama-cu.ac.jp			Japan Society for the Promotion of Science [23370077]; Ministry of Education, Culture, Sports, Science and Technology of Japan [25118520]; CREST program of the Japan Science and Technology Corporation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST program of the Japan Science and Technology Corporation	This study was supported by grants from the Japan Society for the Promotion of Science (grant number 23370077 to TK), the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant number 25118520 to TK), and the CREST program of the Japan Science and Technology Corporation to TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth WB, 2012, YEAST, V29, P505, DOI 10.1002/yea.2931; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Bjornsdottir G, 2008, NUCLEIC ACIDS RES, V36, P2906, DOI 10.1093/nar/gkn130; Bovee TFH, 2004, GENE, V325, P187, DOI 10.1016/j.gene.2003.10.015; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; CHEN JJ, 1994, P NATL ACAD SCI USA, V91, P11909, DOI 10.1073/pnas.91.25.11909; Cheng JX, 2002, CURR BIOL, V12, P1828, DOI 10.1016/S0960-9822(02)01257-5; de Almeida RA, 2008, YEAST, V25, P71, DOI 10.1002/yea.1570; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; HAHN S, 1989, P NATL ACAD SCI USA, V86, P5718, DOI 10.1073/pnas.86.15.5718; HAHN S, 1985, P NATL ACAD SCI USA, V82, P8562, DOI 10.1073/pnas.82.24.8562; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; HARBURY PAB, 1989, MOL CELL BIOL, V9, P5298, DOI 10.1128/MCB.9.12.5298; Hothorn M, 2009, SCIENCE, V324, P513, DOI 10.1126/science.1168120; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Juven-Gershon T, 2008, GENE DEV, V22, P2823, DOI 10.1101/gad.1698108; Kadonaga JT, 2012, WIRES DEV BIOL, V1, P40, DOI 10.1002/wdev.21; Kadonaga JT, 2002, EXP MOL MED, V34, P259, DOI 10.1038/emm.2002.36; Kainth P, 2009, METHODS, V48, P258, DOI 10.1016/j.ymeth.2009.02.015; Kasahara K, 2008, NUCLEIC ACIDS RES, V36, P1343, DOI 10.1093/nar/gkm1068; Kedmi A, 2014, GENE DEV, V28, P2163, DOI 10.1101/gad.245670.114; Ki S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl135; Ki S, 2007, BIOTECHNIQUES, V42, P209, DOI 10.2144/000112319; Kitazono AA, 2002, YEAST, V19, P141, DOI 10.1002/yea.806; Kobayashi A, 2007, NUCLEIC ACIDS RES, V35, P4882, DOI 10.1093/nar/gkm519; Koehler RN, 2007, EUKARYOT CELL, V6, P1474, DOI 10.1128/EC.00068-07; Kokubo T, 1998, MOL CELL BIOL, V18, P1003, DOI 10.1128/MCB.18.2.1003; Kuraev I.S. VVM, 2004, BIOCH INORGANIC POLY, P15; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Lee SK, 2010, GENETICS, V184, P659, DOI 10.1534/genetics.109.113464; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; LI WZ, 1991, MOL CELL BIOL, V11, P666, DOI 10.1128/MCB.11.2.666; Li XY, 2002, CURR BIOL, V12, P1240, DOI 10.1016/S0960-9822(02)00932-6; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lorenz B. SHC., 1999, PROGR MOL SUBCELLULA, P217; LUE NF, 1987, P NATL ACAD SCI USA, V84, P8839, DOI 10.1073/pnas.84.24.8839; Lundblack V., 1998, CURRENT PROTOCOLS MO, V2; Martens C, 2001, MOL MICROBIOL, V40, P1009, DOI 10.1046/j.1365-2958.2001.02445.x; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Mencia M, 2002, MOL CELL, V9, P823, DOI 10.1016/S1097-2765(02)00490-2; Mogno I, 2013, GENOME RES, V23, P1908, DOI 10.1101/gr.157891.113; Moqtaderi Z, 1996, NATURE, V383, P188, DOI 10.1038/383188a0; Muller F, 2014, BBA-GENE REGUL MECH, V1839, P118, DOI 10.1016/j.bbagrm.2013.11.003; Muller F, 2007, J BIOL CHEM; Ohler U, 2010, DEVELOPMENT, V137, P15, DOI 10.1242/dev.035493; Park D, 2014, NUCLEIC ACIDS RES, V42, P3736, DOI 10.1093/nar/gkt1366; Parry TJ, 2010, GENE DEV, V24, P2013, DOI 10.1101/gad.1951110; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Seizl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027595; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; SIMON MC, 1988, CELL, V52, P723, DOI 10.1016/0092-8674(88)90410-2; SINGER VL, 1990, GENE DEV, V4, P636, DOI 10.1101/gad.4.4.636; Smale ST, 2003, ANN REV BIOCH; STRUHL K, 1989, ANNU REV BIOCHEM, V58, P1051, DOI 10.1146/annurev.bi.58.070189.005155; Sugihara F, 2011, NUCLEIC ACIDS RES, V39, P59, DOI 10.1093/nar/gkq741; Takahata S, 2004, MOL CELL BIOL, V24, P3089, DOI 10.1128/MCB.24.8.3089-3099.2004; Takahata S, 2003, J BIOL CHEM, V278, P45888, DOI 10.1074/jbc.M306886200; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Tsukihashi Y, 2001, J BIOL CHEM, V276, P25715, DOI 10.1074/jbc.M102416200; Tsukihashi Y, 2000, MOL CELL BIOL, V20, P2385, DOI 10.1128/MCB.20.7.2385-2399.2000; Wang YL, 2014, GENE DEV, V28, P1550, DOI 10.1101/gad.245662.114; WEFALD FC, 1990, NATURE, V344, P260, DOI 10.1038/344260a0; WOBBE CR, 1990, MOL CELL BIOL, V10, P3859, DOI 10.1128/MCB.10.8.3859; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029; Zabidi MA, 2015, NATURE, V518, P556, DOI 10.1038/nature13994; Zeevi D, 2011, GENOME RES, V21, P2114, DOI 10.1101/gr.119669.110; Zehavi Y, 2014, J BIOL CHEM, V289, P11993, DOI 10.1074/jbc.M114.550251	75	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129357	10.1371/journal.pone.0129357	http://dx.doi.org/10.1371/journal.pone.0129357			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046838	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200157
J	Chen, TA; Liao, CC; Cheng, YC; Chen, YP; Hsu, YF; Liang, CM; Liang, SM				Chen, Tai-An; Liao, Chiao-Chun; Cheng, Yung-Chih; Chen, Yen-Po; Hsu, Yi-Fan; Liang, Chi-Ming; Liang, Shu-Mei			Stimulation of Proliferation and Migration of Mouse Macrophages by Type B CpG-ODNs Is F-Spondin and IL-1Ra Dependent	PLOS ONE			English	Article							GENE-EXPRESSION; DNA; PROTEIN; CELLS; PHOSPHORYLATION; INHIBITION; ACTIVATION; APOPTOSIS; PROMOTES	Macrophage proliferation and migration are important for many facets of immune response. Here we showed that stimulation of macrophages with type B CpG oligodeoxynucleotides (CpG-B ODNs) such as CpG-ODN 1668 increased the production of anti-inflammatory cytokine interleukin 1 receptor antagonist (IL-1Ra) in a TLR9- and MyD88-dependent manner. The CpG-B ODNs-induced IL-1Ra increased macrophage migration and promoted macrophage proliferation by down-regulating the expression of a cell cycle negative regulator, p27 to increase cell population in the S phase. The induction of IL-1Ra by CpG-B ODNs was F-spondin dependent. Knockdown of F-spondin and IL-1Ra decreased CpG-B ODNs-induced macrophage migration whereas overexpression of IL-1Ra increased migration of those cells. These findings demonstrated novel roles for F-spondin and IL-1Ra in CpG-B ODNs-mediated cell proliferation and migration of macrophages.	[Chen, Tai-An; Cheng, Yung-Chih; Chen, Yen-Po; Hsu, Yi-Fan; Liang, Shu-Mei] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Liao, Chiao-Chun; Liang, Chi-Ming; Liang, Shu-Mei] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan	Liang, SM (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan.	smyang@gate.sinica.edu.tw	Liao, Chiao-Chun/AAX-2241-2020; Chen, Yen Po/GLQ-6423-2022	Liao, Chiao-Chun/0000-0002-8775-8329; Chen, Yen Po/0000-0003-0621-6219; Liang, Shu-Mei/0000-0001-8926-4747	Academia Sinica, Program Project on Genomics and Proteomics [AS-94F-006]	Academia Sinica, Program Project on Genomics and Proteomics	This project was funded by Academia Sinica, Program Project on Genomics and Proteomics (grant AS-94F-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2005, CLIN DIAGN LAB IMMUN, V12, P606, DOI 10.1128/CDLI.12.5.606-621.2005; Berry E, ROLE CAENORHABDITIS; Burstyn-Cohen T, 1998, J NEUROSCI, V18, P8875; Burstyn-Cohen T, 1999, NEURON, V23, P233, DOI 10.1016/S0896-6273(00)80776-X; Cheng YC, 2012, MOL NEUROBIOL, V45, P536, DOI 10.1007/s12035-012-8275-8; Cheng YC, 2009, J NEUROCHEM, V110, P947, DOI 10.1111/j.1471-4159.2009.06186.x; Crabtree TD, 2001, INFECT IMMUN, V69, P2123, DOI 10.1128/IAI.69.4.2123-2129.2001; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Dewberry RM, 2008, FEBS LETT, V582, P886, DOI 10.1016/j.febslet.2008.02.021; Dewberry RM, 2003, CIRC RES, V92, P1285, DOI 10.1161/01.RES.0000078172.52740.9B; Dragoi AM, 2005, EMBO J, V24, P779, DOI 10.1038/sj.emboj.7600539; Hallegua DS, 2002, ANN RHEUM DIS, V61, P960, DOI 10.1136/ard.61.11.960; Hartmann G, 2003, EUR J IMMUNOL, V33, P1633, DOI 10.1002/eji.200323813; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; KLAR A, 1992, CELL, V69, P95, DOI 10.1016/0092-8674(92)90121-R; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Lenert P, 2003, DNA CELL BIOL, V22, P621, DOI 10.1089/104454903770238094; Liao CC, 2013, AUTOPHAGY, V9, P5, DOI 10.4161/auto.22379; Nagarajan G, 2007, VET RES, V38, P795, DOI 10.1051/vetres:2007032; Oka H, 2011, J PERIODONTOL, V82, P1776, DOI 10.1902/jop.2011.110111; Park Y, 2002, J IMMUNOL, V168, P5, DOI 10.4049/jimmunol.168.1.5; Pera T, 2014, J PHARMACOL EXP THER, V349, P229, DOI 10.1124/jpet.113.210138; Rhee JW, 2007, MOL IMMUNOL, V44, P1393, DOI 10.1016/j.molimm.2006.05.003; Sanjuan MA, 2006, J CELL BIOL, V172, P1057, DOI 10.1083/jcb.200508058; Sgroi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025442; Shirota H, 2012, ONCOIMMUNOLOGY, V1, P780, DOI 10.4161/onci.19731; Sohn WJ, 2006, MOL IMMUNOL, V43, P1163, DOI 10.1016/j.molimm.2005.07.020; Takeshita F, 2004, SEMIN IMMUNOL, V16, P17, DOI 10.1016/j.smim.2003.10.009; Utaisincharoen P, 2002, CLIN EXP IMMUNOL, V128, P467, DOI 10.1046/j.1365-2249.2002.01866.x; Verthelyi D, 2003, TRENDS IMMUNOL, V24, P519, DOI 10.1016/S1471-4906(03)00243-6; Vollmer J, 2009, ADV DRUG DELIVER REV, V61, P195, DOI 10.1016/j.addr.2008.12.008; Yasuda H, 2008, AM J PHYSIOL-RENAL, V294, pF1050, DOI 10.1152/ajprenal.00461.2007; Yi AK, 1998, J IMMUNOL, V160, P5898; Zisman S, 2007, J CELL BIOL, V178, P1237, DOI 10.1083/jcb.200702184	34	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128926	10.1371/journal.pone.0128926	http://dx.doi.org/10.1371/journal.pone.0128926			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042735	Green Submitted, gold, Green Published			2022-12-27	WOS:000355701600076
J	Egge, N; Muthusubramanian, A; Cornwall, GA				Egge, Nathan; Muthusubramanian, Archana; Cornwall, Gail A.			Amyloid Properties of the Mouse Egg Zona Pellucida	PLOS ONE			English	Article							FUNCTIONAL AMYLOIDS; VITELLINE ENVELOPE; DOMAIN; PROTEIN; BINDING; SEQUENCE; FIBRILS; MICE; COAT; ZP3	The zona pellucida (ZP) surrounding the oocyte is an extracellular fibrillar matrix that plays critical roles during fertilization including species-specific gamete recognition and protection from polyspermy. The mouse ZP is composed of three proteins, ZP1, ZP2, and ZP3, all of which have a ZP polymerization domain that directs protein fibril formation and assembly into the three-dimensional ZP matrix. Egg coats surrounding oocytes in nonmammalian vertebrates and in invertebrates are also fibrillar matrices and are composed of ZP domain-containing proteins suggesting the basic structure and function of the ZP/egg coat is highly conserved. However, sequence similarity between ZP domains is low across species and thus the mechanism for the conservation of ZP/egg coat structure and its function is not known. Using approaches classically used to identify amyloid including conformation-dependent antibodies and dyes, X-ray diffraction, and negative stain electron microscopy, our studies suggest the mouse ZP is a functional amyloid. Amyloids are cross-beta sheet fibrillar structures that, while typically associated with neurodegenerative and prion diseases in mammals, can also carry out functional roles in normal cells without resulting pathology. An analysis of the ZP domain from mouse ZP3 and ZP3 homologs from five additional taxa using the algorithm AmylPred 2 to identify amyloidogenic sites, revealed in all taxa a remarkable conservation of regions that were predicted to form amyloid. This included a conserved amyloidogenic region that localized to a stretch of hydrophobic amino acids previously shown in mouse ZP3 to be essential for fibril assembly. Similarly, a domain in the yeast protein alpha-agglutinin/Sag 1p, that possesses ZP domain-like features and which is essential for mating, also had sites that were predicted to be amyloidogenic including a hydrophobic stretch that appeared analogous to the critical site in mouse ZP3. Together, these studies suggest that amyloidogenesis may be a conserved mechanism for ZP structure and function across billions of years of evolution.	[Egge, Nathan; Muthusubramanian, Archana; Cornwall, Gail A.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Cornwall, GA (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA.	gail.cornwall@ttuhsc.edu			NIH [RO1HD056182, R21HD078715]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056182, R21HD078715] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIH grants RO1HD056182 and R21HD078715 (to GAC). The content of this report is solely our responsibility and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard JE, 2006, P NATL ACAD SCI USA, V103, P17302, DOI 10.1073/pnas.0603125103; Aagaard JE, 2010, MOL BIOL EVOL, V27, P193, DOI 10.1093/molbev/msp221; Aricescu AR, 2007, CURR OPIN CELL BIOL, V19, P543, DOI 10.1016/j.ceb.2007.09.010; Avella MA, 2014, J CELL BIOL, V205, P801, DOI 10.1083/jcb.201404025; Bacarizo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113224; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; BLEIL JD, 1980, P NATL ACAD SCI-BIOL, V77, P1029, DOI 10.1073/pnas.77.2.1029; Boja ES, 2003, J BIOL CHEM, V278, P34189, DOI 10.1074/jbc.M304026200; Callebaut I, 2007, BIOINFORMATICS, V23, P1871, DOI 10.1093/bioinformatics/btm265; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; deNobel H, 1996, MOL BIOL CELL, V7, P143, DOI 10.1091/mbc.7.1.143; Dranginis AM, 2007, MICROBIOL MOL BIOL R, V71, P282, DOI 10.1128/MMBR.00037-06; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Galindo BE, 2002, GENE, V288, P111, DOI 10.1016/S0378-1119(02)00459-6; GREVE JM, 1985, J MOL BIOL, V181, P253, DOI 10.1016/0022-2836(85)90089-0; Guyonnet B, 2014, MOL CELL BIOL, V34, P2624, DOI 10.1128/MCB.00073-14; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Han L, 2010, CELL, V143, P404, DOI 10.1016/j.cell.2010.09.041; Iconomidou VA, 2000, FEBS LETT, V479, P141, DOI 10.1016/S0014-5793(00)01888-3; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Jovine L, 2004, P NATL ACAD SCI USA, V101, P5922, DOI 10.1073/pnas.0401600101; Kayed R, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-57; Kurotaki Y, 2007, SCIENCE, V316, P719, DOI 10.1126/science.1138591; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Litscher ES, 2008, J CELL PHYSIOL, V214, P153, DOI 10.1002/jcp.21174; Liu CY, 1996, P NATL ACAD SCI USA, V93, P5431, DOI 10.1073/pnas.93.11.5431; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; Llorca O, 2007, J MOL BIOL, V365, P694, DOI 10.1016/j.jmb.2006.10.015; Loksztejn A, 2009, BIOCHEMISTRY-US, V48, P4846, DOI 10.1021/bi900394b; Louros NN, 2014, BIOPOLYMERS, V102, P427, DOI 10.1002/bip.22563; Louros NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073258; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Monne M, 2008, NATURE, V456, P653, DOI 10.1038/nature07599; Monne M, 2011, BIOL REPROD, V85, P661, DOI 10.1095/biolreprod.111.092098; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Plaza S, 2010, TRENDS CELL BIOL, V20, P524, DOI 10.1016/j.tcb.2010.06.002; Podrabsky JE, 2001, AM J PHYSIOL-REG I, V280, pR123, DOI 10.1152/ajpregu.2001.280.1.R123; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; Rankin T, 1996, DEVELOPMENT, V122, P2903; Rankin TL, 2001, DEVELOPMENT, V128, P1119; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Swanson WJ, 2011, MOL BIOL EVOL, V28, P1963, DOI 10.1093/molbev/msr026; Tian J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S45; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175; Tsubamoto H, 1999, BIOL REPROD, V61, P1649, DOI 10.1095/biolreprod61.6.1649; Whelly S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036394; WOJCIECHOWICZ D, 1993, MOL CELL BIOL, V13, P2554, DOI 10.1128/MCB.13.4.2554; YANAGIMACHI R, 1984, GAMETE RES, V9, P1, DOI 10.1002/mrd.1120090102; Zhao M, 2003, MOL CELL BIOL, V23, P8982, DOI 10.1128/MCB.23.24.8982-8991.2003	58	27	29	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0129907	10.1371/journal.pone.0129907	http://dx.doi.org/10.1371/journal.pone.0129907			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043223	gold, Green Published, Green Submitted			2022-12-27	WOS:000355701600102
J	Hu, B; Liu, XY; Yin, SF; Fan, HM; Feng, FM; Yuan, JX				Hu, Bo; Liu, Xiaoyu; Yin, Sufeng; Fan, Hongmin; Feng, Fumin; Yuan, Juxiang			Effects of Psychological Stress on Hypertension in Middle-Aged Chinese: A Cross-Sectional Study	PLOS ONE			English	Article							AMBULATORY BLOOD-PRESSURE; JOINT NATIONAL COMMITTEE; JOB STRAIN; PARAVENTRICULAR NUCLEUS; 7TH REPORT; CORTICOTROPIN; GENDER; RESPONSES; MEN; EXPRESSION	We examined the effect and relative contributions of different types of stress on the risk of hypertension. Using cluster sampling, 5,976 community-dwelling individuals aged 40-60 were selected. Hypertension was defined according to the Seventh Report of the Joint National Committee, and general psychological stress was defined as experiencing stress at work or home. Information on known risk factors of hypertension (e.g., physical activity levels, food intake, smoking behavior) was collected from participants. Logistic regression analysis was used to determine the associations between psychological stress and hypertension, calculating population-attributable risks and 95% confidence intervals (CIs). General stress was significantly related to hypertension (odds ratio [OR] = 1.247, 95% CI [1.076, 1.446]). Additionally, after adjustment for all other risk factors, women showed a greater risk of hypertension if they had either stress at work or at home: OR = 1.285, 95% CI (1.027, 1.609) and OR = 1.231, 95% CI (1.001, 1.514), respectively. However, this increased risk for hypertension by stress was not found in men. General stress contributed approximately 9.1% (95% CI [3.1, 15.0]) to the risk for hypertension. Thus, psychological stress was associated with an increased risk for hypertension, although this increased risk was not consistent across gender.	[Hu, Bo; Yin, Sufeng; Fan, Hongmin; Feng, Fumin; Yuan, Juxiang] Hebei United Univ, Sch Publ Hlth, Tangshan, Hebei Province, Peoples R China; [Hu, Bo; Yin, Sufeng; Fan, Hongmin; Feng, Fumin; Yuan, Juxiang] Hebei United Univ, Hebei Prov Key Lab Occupat Hlth & Safety Coal Ind, Tangshan, Hebei Province, Peoples R China; [Liu, Xiaoyu] Hebei United Univ, Kailuan Gen Hosp, Dept Resp Med, Tangshan, Hebei Province, Peoples R China	North China University of Science & Technology; North China University of Science & Technology; North China University of Science & Technology	Hu, B (corresponding author), Hebei United Univ, Sch Publ Hlth, Tangshan, Hebei Province, Peoples R China.	lxy_hb007@126.com		Feng, Fumin/0000-0001-6506-2235				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; AGUILERA G, 1995, J CLIN INVEST, V96, P1512, DOI 10.1172/JCI118189; ALLAIN CC, 1974, CLIN CHEM, V20, P470; ALLEN MT, 1993, PSYCHOSOM MED, V55, P505, DOI 10.1097/00006842-199311000-00006; BENICHOU J, 1990, BIOMETRICS, V46, P991, DOI 10.2307/2532443; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Choo V, 2002, LANCET, V360, P235, DOI 10.1016/S0140-6736(02)09512-0; Duncko R, 2001, PSYCHONEUROENDOCRINO, V26, P77, DOI 10.1016/S0306-4530(00)00040-8; Fauvel JP, 2003, HYPERTENSION, V42, P1112, DOI 10.1161/01.HYP.0000102862.93418.EE; Greiner BA, 2004, SOC SCI MED, V59, P1081, DOI 10.1016/j.socscimed.2003.12.006; Groeschel M, 2011, AM J PHYSIOL-RENAL, V300, pF1, DOI 10.1152/ajprenal.00208.2010; Guimont C, 2006, AM J PUBLIC HEALTH, V96, P1436, DOI 10.2105/AJPH.2004.057679; HENRY JP, 1988, SOC SCI MED, V26, P293, DOI 10.1016/0277-9536(88)90393-0; HERMAN JP, 1982, LIFE SCI, V30, P2207, DOI 10.1016/0024-3205(82)90295-8; IPAQ-International Physical Activity Questionnaire, GUID DAT PROC AN INT; Iwasaki-Sekino A, 2009, PSYCHONEUROENDOCRINO, V34, P226, DOI 10.1016/j.psyneuen.2008.09.003; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Levenstein S, 2001, ARCH INTERN MED, V161, P1341, DOI 10.1001/archinte.161.10.1341; Linzer M, 1996, AM J MED, V101, P526, DOI 10.1016/S0002-9343(96)00275-6; Ohlin B, 2007, J HYPERTENS, V25, P525; Patten S B, 2000, Chronic Dis Can, V21, P68; Patten S B, 1997, Chronic Dis Can, V18, P109; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Sparrenberger F, 2009, J HUM HYPERTENS, V23, P12, DOI 10.1038/jhh.2008.74; Steptoe A, 2004, J HYPERTENS, V22, P915, DOI 10.1097/00004872-200405000-00012; Steptoe A, 2000, ANN MED, V32, P371, DOI 10.3109/07853890008995940; Sterrenburg L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028128; Sterrenburg L, 2012, J NEUROSCI RES, V90, P179, DOI 10.1002/jnr.22737; STONEY CM, 1988, PSYCHOPHYSIOLOGY, V25, P645, DOI 10.1111/j.1469-8986.1988.tb01902.x; Tidey JW, 1996, BRAIN RES, V721, P140, DOI 10.1016/0006-8993(96)00159-X; Tobe SW, 2007, AM J HYPERTENS, V20, P148, DOI 10.1016/j.amjhyper.2006.07.011; Trainor BC, 2011, HORM BEHAV, V60, P457, DOI 10.1016/j.yhbeh.2011.08.013; Viau V, 2005, ENDOCRINOLOGY, V146, P137, DOI 10.1210/en.2004-0846; WHO, 2008 2013 ACT PLAN G	35	27	27	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0129163	10.1371/journal.pone.0129163	http://dx.doi.org/10.1371/journal.pone.0129163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043027	Green Submitted, gold, Green Published			2022-12-27	WOS:000355701600090
J	Lin, WC; Wen, CC; Chen, YH; Hsiao, PW; Liao, JW; Peng, CI; Yang, NS				Lin, Wen-Ching; Wen, Chih-Chun; Chen, Yung-Hsiang; Hsiao, Pei-Wen; Liao, Jiunn-Wang; Peng, Ching-I; Yang, Ning-Sun			Integrative Approach to Analyze Biodiversity and Anti-Inflammatory Bioactivity of Wedelia Medicinal Plants	PLOS ONE			English	Article							ACID PHENETHYL ESTER; NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; SODIUM-INDUCED COLITIS; CAFFEIC ACID; NUCLEAR-FACTOR; SUBTRIBE ECLIPTINAE; CELL-ACTIVATION; PHENOLIC-ACIDS; MESSENGER-RNA	For the development of "medical foods" and/or botanical drugs as defined USA FDA, clear and systemic characterizations of the taxonomy, index phytochemical components, and the functional or medicinal bioactivities of the reputed or candidate medicinal plant are needed. In this study, we used an integrative approach, including macroscopic and microscopic examination, marker gene analysis, and chemical fingerprinting, to authenticate and validate various species/varieties of Wedelia, a reputed medicinal plant that grows naturally and commonly used in Asian countries. The anti-inflammatory bioactivities of Wedelia extracts were then evaluated in a DSS-induced murine colitis model. Different species/varieties of Wedelia exhibited distinguishable morphology and histological structures. Analysis of the ribosomal DNA internal transcribed spacer (ITS) region revealed significant differences among these plants. Chemical profiling of test Wedelia species demonstrated candidate index compounds and distinguishable secondary metabolites, such as caffeic acid derivatives, which may serve as phytochemical markers or index for quality control and identification of specific Wedelia species. In assessing their effect on treating DSS induced-murine colitis, we observed that only the phytoextract from W. chinensis species exhibited significant anti-inflammatory bioactivity on DSS-induced murine colitis among the various Wedelia species commonly found in Taiwan. Our results provide a translational research approach that may serve as a useful reference platform for biotechnological applications of traditional phytomedicines. Our findings indicate that specific Wedelia species warrant further investigation for potential treatment of human inflammatory bowel disease.	[Lin, Wen-Ching; Wen, Chih-Chun; Chen, Yung-Hsiang; Hsiao, Pei-Wen; Yang, Ning-Sun] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Lin, Wen-Ching] Natl Taiwan Univ, Inst Plant Biol, Taipei 10764, Taiwan; [Liao, Jiunn-Wang] Natl Chung Hsing Univ, Grad Inst Vet Pathol, Taichung 40227, Taiwan; [Peng, Ching-I] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Chung Hsing University; Academia Sinica - Taiwan	Yang, NS (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan.	nsyang@gate.sinica.edu.tw	; Hsiao, Pei-Wen/V-5653-2018	Liao, Jiunn-Wang/0000-0001-7374-1203; Hsiao, Pei-Wen/0000-0002-3589-6754	National Science Council grant [NSC-103-2325-B-001-003]; Academia Sinica, Taiwan [AS-103-TP2-B04]	National Science Council grant; Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This study was supported by a National Science Council grant (NSC-103-2325-B-001-003) and by a grant from the Academia Sinica, Taiwan (AS-103-TP2-B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif MMM, 2005, BRIT J PHARMACOL, V146, P1139, DOI 10.1038/sj.bjp.0706421; Baer BR, 2006, DRUG METAB REV, V38, P451, DOI 10.1080/03602530600688503; Berrin Y, 2006, EUR J INTERN MED, V17, P130, DOI 10.1016/j.ejim.2005.09.022; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Brown M, 2009, ANALYST, V134, P1322, DOI 10.1039/b901179j; Chen WL, 2007, J NAT PROD, V70, P567, DOI 10.1021/np060515p; CHENICLET C, 1985, ISRAEL J BOT, V34, P219; Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003; COOPER HS, 1993, LAB INVEST, V69, P238; Cullen G, 2010, SCAND J GASTROENTERO, V45, P1076, DOI 10.3109/00365521.2010.490595; Cury G, 2009, AUST J BOT, V57, P229, DOI 10.1071/BT08139; CVIKROVA M, 1993, J PLANT PHYSIOL, V142, P1, DOI 10.1016/S0176-1617(11)80098-2; Da Cunha FM, 2004, FREE RADICAL RES, V38, P1241, DOI 10.1080/10715760400016139; Dan M, 2008, PHYTOCHEMISTRY, V69, P2237, DOI 10.1016/j.phytochem.2008.04.015; Danese S, 2010, ONCOGENE, V29, P3313, DOI 10.1038/onc.2010.109; DECAISNE J, 1834, NOUVELLES ANN MUSEUM, V3, P333; Deguchi Y, 2007, DIGEST DIS SCI, V52, P2993, DOI 10.1007/s10620-006-9138-9; Dell B., 1979, ADV BOT RES, V6, P277, DOI DOI 10.1016/S0065-2296(08)60332-8; Ding XX, 2003, ANNU REV PHARMACOL, V43, P149, DOI 10.1146/annurev.pharmtox.43.100901.140251; Ek RO, 2008, DIGEST DIS SCI, V53, P1609, DOI 10.1007/s10620-007-0056-2; Fahn A, 2000, ADV BOT RES, V31, P37, DOI 10.1016/S0065-2296(00)31006-0; Fitzpatrick LR, 2001, J PHARMACOL EXP THER, V299, P915; Ford AC, 2011, AM J GASTROENTEROL, V106, P617, DOI 10.1038/ajg.2011.71; Fosberg FR, 1980, SYSTEMATIC STUDIES M, Viii; Gu XS, 2006, J BIOL CHEM, V281, P17882, DOI 10.1074/jbc.M601302200; Guy PA, 2008, J CHROMATOGR B, V871, P253, DOI 10.1016/j.jchromb.2008.04.034; Harrison HF, 2003, J AGR FOOD CHEM, V51, P2943, DOI 10.1021/jf0211229; Huang YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064152; Jiang GL, 2010, J PHARMACOL EXP THER, V335, P546, DOI 10.1124/jpet.110.173252; Jiang GL, 2007, J PHARMACOL EXP THER, V320, P22, DOI 10.1124/jpet.106.111146; (Jiangsu) Jio MM, 1977, ZHONGYAO DA CIDIAN; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Ke F, 2012, SAUDI J GASTROENTERO, V18, P3, DOI 10.4103/1319-3767.91726; Kovacik J, 2009, ECOTOXICOLOGY, V18, P544, DOI 10.1007/s10646-009-0312-7; Krakauer T, 2002, IMMUNOPHARM IMMUNOT, V24, P113, DOI 10.1081/IPH-120003407; Kumar RM, 2011, INT J PHARM RES DEV, V2, P53; Kwon KH, 2005, BIOCHEM PHARMACOL, V69, P395, DOI 10.1016/j.bcp.2004.10.015; Li SL, 2010, J PHARMACEUT BIOMED, V51, P812, DOI 10.1016/j.jpba.2009.10.002; Li X, 2007, CHEM BIODIVERS, V4, P823, DOI 10.1002/cbdv.200790070; Lin WY, 2008, PLANTA MED, V74, P464, DOI 10.1055/s-2008-1034325; Marquez N, 2004, J PHARMACOL EXP THER, V308, P993, DOI 10.1124/jpet.103.060673; McLean RC, 1941, PLANT SCI FORMULAE R, Vvii; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Moody GA, 1998, PUBLIC HEALTH, V112, P269, DOI 10.1016/S0033-3506(98)00245-5; Panero JL, 1999, AM J BOT, V86, P413, DOI 10.2307/2656762; Peng CI, 1998, FLORA TAIWAN, Vv; Rahimi R, 2009, DIGEST DIS SCI, V54, P471, DOI 10.1007/s10620-008-0368-x; Rawsthorne P, 1999, AM J GASTROENTEROL, V94, P1298, DOI 10.1016/S0002-9270(99)00136-7; Reed KL, 2005, DIGEST DIS SCI, V50, P2366, DOI 10.1007/s10620-005-3066-y; Rivero RM, 2003, J SCI FOOD AGR, V83, P1315, DOI 10.1002/jsfa.1541; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; Russo A, 2002, FITOTERAPIA, V73, pS21, DOI 10.1016/S0367-326X(02)00187-9; Shan JH, 2009, INT IMMUNOPHARMACOL, V9, P1042, DOI 10.1016/j.intimp.2009.04.011; Shteingart S, 2009, GUT, V58, P790, DOI 10.1136/gut.2008.153981; Shyur LF, 2008, CURR OPIN CHEM BIOL, V12, P66, DOI 10.1016/j.cbpa.2008.01.032; Staniforth V, 2012, J NUTR BIOCHEM, V23, P443, DOI 10.1016/j.jnutbio.2011.01.009; SUMMERS CB, 1994, INSECT BIOCHEM MOLEC, V24, P943, DOI 10.1016/0965-1748(94)90023-X; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Techen N, 2004, CURR MED CHEM, V11, P1391, DOI 10.2174/0929867043365206; That QT, 2007, J ORG CHEM, V72, P7102, DOI 10.1021/jo070771m; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toyoda T, 2009, INT J CANCER, V125, P1786, DOI 10.1002/ijc.24586; Vasquez-Robinet C, 2008, J EXP BOT, V59, P2109, DOI 10.1093/jxb/ern073; Wagner WL, 2001, BRITTONIA, V53, P539, DOI 10.1007/BF02809655; Wang YF, 2010, J DIGEST DIS, V11, P76, DOI 10.1111/j.1751-2980.2010.00421.x; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Xie PS, 2010, J PHARMACEUT BIOMED, V52, P452, DOI 10.1016/j.jpba.2010.01.025; Xue D, 2009, MICROSC RES TECHNIQ, V72, P744, DOI 10.1002/jemt.20726; Ye Z, 2009, EXP BIOL MED, V234, P605, DOI 10.3181/0901-RM-1; Zhao WC, 2010, YAKUGAKU ZASSHI, V130, P1239, DOI 10.1248/yakushi.130.1239; Zhong XK, 2009, CURR MED CHEM, V16, P3064, DOI 10.2174/092986709788803051	71	6	6	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0129067	10.1371/journal.pone.0129067	http://dx.doi.org/10.1371/journal.pone.0129067			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042672	Green Submitted, Green Published, gold			2022-12-27	WOS:000355701600085
J	Nobles, T; Zhang, YX				Nobles, Trey; Zhang, Yixin			Survival, Growth and Condition of Freshwater Mussels: Effects of Municipal Wastewater Effluent	PLOS ONE			English	Article							TREATMENT-PLANT; ELLIPTIO-COMPLANATA; VILLOSA-IRIS; LIFE STAGES; TOXICITY; CONTAMINANTS; UNIONIDAE; EXPOSURE; RIVER; COMMUNITIES	Freshwater mussels (Family Unionidae) are among the most imperiled group of organisms in the world, with nearly 65% of North American species considered endangered. Anthropogenic disturbances, including altered flow regimes, habitat alteration, and pollution, are the major driver of this group's decline. We investigated the effects of tertiary treated municipal wastewater effluent on survivorship, growth, and condition of freshwater mussels in experimental cages in a small Central Texas stream. We tested the effluent effects by measuring basic physical parameters of native three ridge mussels (Amblema plicata) and of non-native Asian clams (Corbicula fluminea), before and after 72-day exposure at four sites above and below a municipal wastewater treatment plant outfall. Survivorship and growth of the non-native Asian clams and growth and condition indices of the native three ridge mussels were significantly higher at the reference site above the outfall than in downstream sites. We attribute this reduction in fitness below the outfall to elevated nutrient and heavy metal concentrations, and the potential presence of other untested-for compounds commonly found in municipal effluent. These results, along with an absence of native mussels below the discharge, indicate a significant negative impact of wastewater effluent on both native and non-native mussels in the stream.	[Nobles, Trey] Texas State Univ, Dept Biol, San Marcos, TX USA; [Zhang, Yixin] Xian Jiaotong Liverpool Univ, Dept Environm Sci, Suzhou, Peoples R China	Texas State University System; Texas State University San Marcos; Xi'an Jiaotong-Liverpool University	Zhang, YX (corresponding author), Xian Jiaotong Liverpool Univ, Dept Environm Sci, Suzhou, Peoples R China.	yixin.zhang@xjtlu.edu.cn	Zhang, Yixin/AAG-3575-2021; Zhang, Yixin/D-1706-2012	Zhang, Yixin/0000-0003-1546-4150	City of Austin [NA120000106]	City of Austin	The City of Austin provided funding (#NA120000106) to support this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaishi FM, 2007, AQUAT TOXICOL, V82, P1, DOI 10.1016/j.aquatox.2007.01.008; American Society for Testing and Materials (ASTM), 2001, ANN BOOK ASTM STAND; Anderson KB, 1976, BIOL NOTES, V98; APHA, 2004, STANDARD METHODS EXA; Augspurger T, 2003, ENVIRON TOXICOL CHEM, V22, P2569, DOI 10.1897/02-339; BAYNE BL, 1979, NATURE, V280, P14, DOI 10.1038/280014a0; Blaise C, 2003, FRESEN ENVIRON BULL, V12, P865; Bringolf RB, 2010, ENVIRON TOXICOL CHEM, V29, P1311, DOI 10.1002/etc.157; Chambers P. A., 1997, Water Quality Research Journal of Canada, V32, P659; Ciccotelli M, 1998, CHEMOSPHERE, V37, P2823, DOI 10.1016/S0045-6535(98)00324-5; Cope WG, 2008, J N AM BENTHOL SOC, V27, P451, DOI 10.1899/07-094.1; CROSBY M P, 1990, Journal of Shellfish Research, V9, P233; DIETZ TH, 1990, J EXP BIOL, V150, P395; Farcy E, 2011, ENVIRON RES, V111, P1096, DOI 10.1016/j.envres.2011.07.009; Gagne F, 2001, COMP BIOCHEM PHYS C, V128, P213, DOI 10.1016/S1532-0456(00)00189-7; Gangloff MM, 2009, HYDROBIOLOGIA, V636, P191, DOI 10.1007/s10750-009-9948-9; Gillis PL, 2014, ENVIRON TOXICOL CHEM, V33, P134, DOI 10.1002/etc.2401; Gillis PL, 2012, SCI TOTAL ENVIRON, V431, P348, DOI 10.1016/j.scitotenv.2012.05.061; Goldberg E. D, 1975, MAR POLLUT B, V6, P111, DOI [10.1016/0025-326X(75)90271-4, DOI 10.1016/0025-326X(75)90271-4]; GOUDREAU SE, 1993, HYDROBIOLOGIA, V252, P211, DOI 10.1007/BF00005471; Haag WR, 2014, HYDROBIOLOGIA, V735, P45, DOI 10.1007/s10750-013-1524-7; Halling-Sorensen B, 1998, CHEMOSPHERE, V36, P357, DOI 10.1016/S0045-6535(97)00354-8; HORNE FR, 1979, NAUTILUS, V93, P119; Howells R. G., 1996, FRESHWATER MUSSELS T; IMLAY M J, 1973, Malacologia, V12, P97; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Mummert AK, 2003, ENVIRON TOXICOL CHEM, V22, P2545, DOI 10.1897/02-341; NAIMO TJ, 1995, ECOTOXICOLOGY, V4, P341, DOI 10.1007/BF00118870; Northington RM, 2006, FRESHWATER BIOL, V51, P1959, DOI 10.1111/j.1365-2427.2006.01626.x; Postel S., 1997, Nature's services: societal dependence on natural ecosystems., P195; Quinn B, 2004, AQUAT TOXICOL, V66, P279, DOI 10.1016/j.aquatox.2003.10.007; Roditi HA, 2000, NATURE, V407, P78, DOI 10.1038/35024069; SALOMONS W, 1987, HYDROBIOLOGIA, V149, P13, DOI 10.1007/BF00048643; Sarakinos HC, 2000, ENVIRON TOXICOL CHEM, V19, P63, DOI 10.1002/etc.5620190107; Slye JL, 2011, ENVIRON TOXICOL CHEM, V30, P1127, DOI 10.1002/etc.483; Smolders R, 2003, HUM ECOL RISK ASSESS, V9, P741, DOI 10.1080/713609965; Smolders R, 2005, WATER ENCY, DOI [10.1002/047147844X.wq16, DOI 10.1002/047147844X.WQ16]; Spooner DE, 2006, FRESHWATER BIOL, V51, P1016, DOI 10.1111/j.1365-2427.2006.01547.x; Strayer DL, 2014, HYDROBIOLOGIA, V735, P277, DOI 10.1007/s10750-013-1461-5; Tchobanoglous G., 2003, WASTEWATER ENG TREAT, V4th; Valenti TW, 2006, ENVIRON TOXICOL CHEM, V25, P2512, DOI 10.1897/05-527R1.1; Wassenaar LI, 2010, CAN J FISH AQUAT SCI, V67, P1232, DOI 10.1139/F10-057; Welch KJ, 1984, FRESHWATER INVERTEBR, P139; Widdows J., 1992, Developments in Aquaculture and Fisheries Science, V25, P383; WILLIAMS JD, 1993, FISHERIES, V18, P6, DOI 10.1577/1548-8446(1993)018<0006:CSOFMO>2.0.CO;2; YEAGER MM, 1994, J N AM BENTHOL SOC, V13, P217, DOI 10.2307/1467240	46	22	23	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128488	10.1371/journal.pone.0128488	http://dx.doi.org/10.1371/journal.pone.0128488			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042840	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600050
J	Frederickson, JA; Schaefer, SN; Doucette-Frederickson, JA				Frederickson, Joseph A.; Schaefer, Scott N.; Doucette-Frederickson, Janessa A.			A Gigantic Shark from the Lower Cretaceous Duck Creek Formation of Texas	PLOS ONE			English	Article							LAMNIFORM SHARK; CRETOXYRHINA-MANTELLI; NIOBRARA CHALK; CHONDRICHTHYES; SKELETAL; SPECIMEN; ANATOMY	Three large lamniform shark vertebrae are described from the Lower Cretaceous of Texas. We interpret these fossils as belonging to a single individual with a calculated total body length of 6.3 m. This large individual compares favorably to another shark specimen from the roughly contemporaneous Kiowa Shale of Kansas. Neither specimen was recovered with associated teeth, making confident identification of the species impossible. However, both formations share a similar shark fauna, with Leptostyrax macrorhiza being the largest of the common lamniform sharks. Regardless of its actual identification, this new specimen provides further evidence that large-bodied lamniform sharks had evolved prior to the Late Cretaceous.	[Frederickson, Joseph A.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA; [Schaefer, Scott N.] Univ Wisconsin, Dept Geosci, Milwaukee, WI 53201 USA; [Doucette-Frederickson, Janessa A.] Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Wisconsin System; University of Wisconsin Milwaukee; University of Oklahoma System; University of Oklahoma - Norman	Frederickson, JA (corresponding author), Univ Oklahoma, Dept Biol, Norman, OK 73019 USA.	Joseph.A.Frederickson-1@ou.edu			Open Access Fund from the University of Oklahoma Libraries	Open Access Fund from the University of Oklahoma Libraries	This paper received funding from the Open Access Fund from the University of Oklahoma Libraries. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker Martin A., 2008, Northeastern Geology and Environmental Sciences, V30, P118; Berg L.S., 1958, SYSTEM REZENTEN FOSS; Bonaparte C.L., 1838, NOUVELLES ANN SCI NA, V2, P195; Bullard F.M., 1931, U TEXAS B, V3126, P1; CAPPETTA H., 1987, HDB PALAEOICHTHYOL B, V3B; COBBAN WA, 1952, GEOL SOC AM BULL, V63, P1011, DOI 10.1130/0016-7606(1952)63[1011:COTCFO]2.0.CO;2; Dickerson Ashley A., 2013, Transactions of the Kansas Academy of Science, V115, P125; Everhart M.J., 2004, PalArch Series Vertebrate Palaeontology, V1, P1; Everhart M.J., 2005, PALARCH, V2, P14; Everhart Michael J., 2005, Transactions of the Kansas Academy of Science, V108, P15, DOI 10.1660/0022-8443(2005)108[0015:ANNSDN]2.0.CO;2; Everhart Michael J., 2009, Transactions of the Kansas Academy of Science, V112, P201, DOI 10.1660/062.112.0408; Gottfried MD, 1996, GREAT WHITE SHARKS, P55, DOI 10.1016/B978-012415031-7/50008-2; Gottfried MD, 2001, J VERTEBR PALEONTOL, V21, P730, DOI 10.1671/0272-4634(2001)021[0730:AASOCA]2.0.CO;2; Hansen BB, 2013, B GEOL SOC DENMARK, V61, P37; Huxley TH., 1880, P R SOC LOND, V43, P649, DOI DOI 10.1111/J.1469-7998.1869.TB07343.X; Kear BP, 2003, CRETACEOUS RES, V24, P277, DOI 10.1016/S0195-6671(03)00046-6; Kriwet J, 2008, ZOOL J LINN SOC-LOND, V154, P278, DOI 10.1111/j.1096-3642.2008.00410.x; Longman HA, 1924, MEMOIRS QUEENSLAND M, V10, P1; Perkins B.F., 1955, FONDREN SCI SERIES, V5, P1; Puceat E, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000823; RANDALL JE, 1973, SCIENCE, V181, P169, DOI 10.1126/science.181.4095.169; Scott R. W., 2002, US GULF COAST CRETAC, P277; Scott RW, 1970, U KANSAS PALEONTOLOG, V52, P5; Shimada K, 2004, J PALEONTOL, V78, P205, DOI 10.1666/0022-3360(2004)078<0205:SPTFTU>2.0.CO;2; Shimada K, 1997, J VERTEBR PALEONTOL, V17, P642, DOI 10.1080/02724634.1997.10011014; Shimada K, 1997, J PALEONTOL, V71, P522, DOI 10.1017/S0022336000039536; Shimada K, 2008, J VERTEBR PALEONTOL, V28, P21, DOI 10.1671/0272-4634(2008)28[21:OPALHS]2.0.CO;2; Shimada Kenshu, 2006, Bulletin of the New Mexico Museum of Natural History and Science, V35, P185; Shimada K, 2007, J VERTEBR PALEONTOL, V27, P584, DOI 10.1671/0272-4634(2007)27[584:SADAOL]2.0.CO;2; Shimada Kenshu, 2004, Mosasaur, V7, P35; Siverson M, 2005, ACTA PALAEONTOL POL, V50, P301; Siverson M, 1999, T ROY SOC EDIN-EARTH, V90, P49, DOI 10.1017/S0263593300002509; Siverson M, 2013, ACTA PALAEO IN PRESS; St John OP, 1887, NOTES GEOLOGY SW KAN, P132; Underwood CJ, 2006, PALEOBIOLOGY, V32, P215, DOI 10.1666/04069.1; Welton B.J., 1993, COLLECTORS GUIDE FOS; Winton W. M., 1919, Bull Texas Univ Austin Texas, VNo. 1931, P1	37	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127162	10.1371/journal.pone.0127162	http://dx.doi.org/10.1371/journal.pone.0127162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039066	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700052
J	Ghamrawi, S; Gastebois, A; Zykwinska, A; Vandeputte, P; Marot, A; Mabilleau, G; Cuenot, S; Bouchara, JP				Ghamrawi, Sarah; Gastebois, Amandine; Zykwinska, Agata; Vandeputte, Patrick; Marot, Agnes; Mabilleau, Guillaume; Cuenot, Stephane; Bouchara, Jean-Philippe			A Multifaceted Study of Scedosporium boydii Cell Wall Changes during Germination and Identification of GPI-Anchored Proteins	PLOS ONE			English	Article							HUMAN FUNGAL PATHOGEN; ASPERGILLUS-FUMIGATUS; PSEUDALLESCHERIA-BOYDII; SACCHAROMYCES-CEREVISIAE; PROTEOMIC ANALYSIS; PLASMA-MEMBRANE; CYSTIC-FIBROSIS; APIOSPERMUM INFECTION; CHEMICAL-COMPOSITION; FORCE MICROSCOPY	Scedosporium boydii is a pathogenic filamentous fungus that causes a wide range of human infections, notably respiratory infections in patients with cystic fibrosis. The development of new therapeutic strategies targeting Scedosporium boydii necessitates a better understanding of the physiology of this fungus and the identification of new molecular targets. In this work, we studied the conidium-to-germ tube transition using a variety of techniques including scanning and transmission electron microscopy, atomic force microscopy, two-phase partitioning, micro-electrophoresis and cationized ferritin labeling, chemical force spectroscopy, lectin labeling, and nanoLC-MS/MS for cell wall GPI-anchored protein analysis. We demonstrated that the cell wall undergoes structural changes with germination accompanied with a lower hydrophobicity, electrostatic charge and binding capacity to cationized ferritin. Changes during germination also included a higher accessibility of some cell wall polysaccharides to lectins and less CH3/CH3 interactions (hydrophobic adhesion forces mainly due to glycoproteins). We also extracted and identified 20 GPI-anchored proteins from the cell wall of S. boydii, among which one was detected only in the conidial wall extract and 12 only in the mycelial wall extract. The identified sequences belonged to protein families involved in virulence in other fungi like Gelp/Gasp, Crhp, Bglp/Bgtp families and a superoxide dismutase. These results highlighted the cell wall remodeling during germination in S. boydii with the identification of a substantial number of cell wall GPI-anchored conidial or hyphal specific proteins, which provides a basis to investigate the role of these molecules in the host-pathogen interaction and fungal virulence.	[Ghamrawi, Sarah; Gastebois, Amandine; Vandeputte, Patrick; Marot, Agnes; Bouchara, Jean-Philippe] Univ Angers, LUNAM Univ, Grp Etud Interact Hote Pathogene, EA 3142, Angers, France; [Zykwinska, Agata; Cuenot, Stephane] Univ Nantes, LUNAM Univ, Inst Mat Jean Rouxel, Nantes, France; [Vandeputte, Patrick; Bouchara, Jean-Philippe] CHU Angers, Lab Parasitol Mycol, Angers, France; [Mabilleau, Guillaume] LUNAM Univ, Serv Commun Imageries & Analyses Microscop, Angers, France	Universite d'Angers; Nantes Universite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Ghamrawi, S (corresponding author), Univ Angers, LUNAM Univ, Grp Etud Interact Hote Pathogene, EA 3142, Angers, France.	sarah.ghamrawi@gmail.com	, Protim/C-4687-2012; Mabilleau, Guillaume/M-8261-2018	Mabilleau, Guillaume/0000-0003-1445-329X; Vandeputte, Patrick/0000-0002-9425-9253; Cuenot, Stephane/0000-0003-1883-3847	Region Pays de la Loire, Myco-AFM research program	Region Pays de la Loire, Myco-AFM research program(Region Pays de la Loire)	This work was supported by Region Pays de la Loire as part of the Myco-AFM research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Alastruey-Izquierdo A, 2007, ANTIMICROB AGENTS CH, V51, P748, DOI 10.1128/AAC.01177-06; Amin R, 2010, CHEST, V137, P171, DOI 10.1378/chest.09-1103; BARBOSA IP, 1993, EXP MYCOL, V17, P274, DOI 10.1006/emyc.1993.1026; BARRAN LR, 1975, BIOCHIM BIOPHYS ACTA, V392, P148, DOI 10.1016/0304-4165(75)90175-0; Beguin H, 1994, AEROBIOLOGIA, V10, P157, DOI DOI 10.1007/BF02459231; Bittencourt VCB, 2006, J BIOL CHEM, V281, P22614, DOI 10.1074/jbc.M511417200; BLOCH R, 1974, BIOCHEM BIOPH RES CO, V58, P13, DOI 10.1016/0006-291X(74)90884-5; Bouchara J P, 1999, Contrib Microbiol, V2, P167; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Cabib E, 2008, J BIOL CHEM, V283, P29859, DOI 10.1074/jbc.M804274200; Cabib E, 2007, MOL MICROBIOL, V63, P921, DOI 10.1111/j.1365-2958.2006.05565.x; Cabib E, 2009, EUKARYOT CELL, V8, P1626, DOI 10.1128/EC.00228-09; Castillo L, 2008, PROTEOMICS, V8, P3871, DOI 10.1002/pmic.200800110; Chotirmall SH, 2010, CHEST, V138, P1186, DOI 10.1378/chest.09-2996; Cimon B, 2000, EUR J CLIN MICROBIOL, V19, P53, DOI 10.1007/s100960050011; Cortez KJ, 2008, CLIN MICROBIOL REV, V21, P157, DOI 10.1128/CMR.00039-07; da Silva BA, 2012, J PROTEOME RES, V11, P172, DOI 10.1021/pr200875x; Dague E, 2008, BIOPHYS J, V94, P656, DOI 10.1529/biophysj.107.116491; Dague E, 2007, NANO LETT, V7, P3026, DOI 10.1021/nl071476k; Damveld RA, 2005, FUNGAL GENET BIOL, V42, P873, DOI 10.1016/j.fgb.2005.06.006; de Groot PWJ, 2007, YEAST, V24, P267, DOI 10.1002/yea.1443; de Groot PWJ, 2012, FUNGAL GENET BIOL, V49, P173, DOI 10.1016/j.fgb.2011.12.009; de Groot PWJ, 2009, FUNGAL GENET BIOL, V46, pS72, DOI 10.1016/j.fgb.2008.07.022; de Groot PWJ, 2004, EUKARYOT CELL, V3, P955, DOI 10.1128/EC.3.4.955-965.2004; DeZwaan TM, 1999, PLANT CELL, V11, P2013, DOI 10.1105/tpc.11.10.2013; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Fillaux J, 2012, SCAND J INFECT DIS, V44, P842, DOI 10.3109/00365548.2012.695454; Fontaine T, 2009, CARBOHYD RES, V344, P1960, DOI 10.1016/j.carres.2009.07.012; Free SJ, 2013, ADV GENET, V81, P33, DOI 10.1016/B978-0-12-407677-8.00002-6; Frieman MB, 2004, MICROBIOL-SGM, V150, P3105, DOI 10.1099/mic.0.27420-0; Frohner IE, 2009, MOL MICROBIOL, V71, P240, DOI 10.1111/j.1365-2958.2008.06528.x; Gaderer R, 2014, APPL MICROBIOL BIOT, V98, P4795, DOI 10.1007/s00253-014-5690-y; Gastebois A, 2010, EUKARYOT CELL, V9, P1294, DOI 10.1128/EC.00107-10; Gastebois A, 2010, J BIOL CHEM, V285, P2386, DOI 10.1074/jbc.M109.077545; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Ghamrawi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100290; Gilgado F, 2005, J CLIN MICROBIOL, V43, P4930, DOI 10.1128/JCM.43.10.4930-4942.2005; Gilgado F, 2008, J CLIN MICROBIOL, V46, P766, DOI 10.1128/JCM.01122-07; Gilgado F, 2010, MED MYCOL, V48, P122, DOI 10.3109/13693780902939695; Gleason JE, 2014, P NATL ACAD SCI USA, V111, P5866, DOI 10.1073/pnas.1400137111; Guarro J, 2006, MED MYCOL, V44, P295, DOI 10.1080/13693780600752507; Hamada K, 1999, J BACTERIOL, V181, P3886, DOI 10.1128/JB.181.13.3886-3889.1999; Harun A, 2010, MED MYCOL, V48, pS70, DOI 10.3109/13693786.2010.515254; Heilmann CJ, 2011, MICROBIOL-SGM, V157, P2297, DOI 10.1099/mic.0.049395-0; Hosseini-Moghaddam SM, 2010, SEMIN RESP CRIT CARE, V31, P222, DOI 10.1055/s-0030-1249118; Jabado N, 1998, CLIN INFECT DIS, V27, P1437, DOI 10.1086/515015; Kaltseis J, 2009, MED MYCOL, V47, P398, DOI 10.1080/13693780802585317; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; Kuznets G, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004407; Lackner M, 2014, FUNGAL DIVERSITY; Lackner M, 2012, ANTIMICROB AGENTS CH, V56, P2635, DOI 10.1128/AAC.05910-11; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Latge JP, 2014, CURR OPIN MICROBIOL, V20, P111, DOI 10.1016/j.mib.2014.05.009; Lima OC, 2007, MICROBES INFECT, V9, P558, DOI 10.1016/j.micinf.2007.01.027; Lopes LCL, 2011, MYCOSES, V54, P28, DOI 10.1111/j.1439-0507.2011.02105.x; LOTAN R, 1975, J BIOL CHEM, V250, P8518; Middleton PG, 2013, CURR OPIN PULM MED, V19, P670, DOI 10.1097/MCP.0b013e328365ab74; Mouyna I, 2005, MOL MICROBIOL, V56, P1675, DOI 10.1111/j.1365-2958.2005.04654.x; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; Mouyna I, 1998, MICROBIOL-SGM, V144, P3171, DOI 10.1099/00221287-144-11-3171; Mouyna I, 2000, BIOCHEM J, V347, P741, DOI 10.1042/0264-6021:3470741; Mouyna I, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00081; Muller FMC, 2010, EXPERT REV ANTI-INFE, V8, P957, DOI [10.1586/eri.10.72, 10.1586/ERI.10.72]; Nombela C, 2006, TRENDS MICROBIOL, V14, P15, DOI 10.1016/j.tim.2005.11.009; Ouyang HM, 2013, EUKARYOT CELL, V12, P889, DOI 10.1128/EC.00351-12; Perez A, 2006, FEMS YEAST RES, V6, P1074, DOI 10.1111/j.1567-1364.2006.00131.x; Pihet M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-177; Pihet M, 2009, MED MYCOL, V47, P387, DOI 10.1080/13693780802609604; Pinto MR, 2002, GLYCOBIOLOGY, V12, P251, DOI 10.1093/glycob/12.4.251; Pittet M, 2007, BBA-MOL CELL BIOL L, V1771, P405, DOI 10.1016/j.bbalip.2006.05.015; Rollin-Pinheiro R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098149; Rougeron A, 2015, ENVIRON MICROBIOL, V17, P1039, DOI 10.1111/1462-2920.12472; Sbrana F, 2007, EUR BIOPHYS J BIOPHY, V36, P727, DOI 10.1007/s00249-007-0159-x; Schoffelmeer EAM, 1999, FUNGAL GENET BIOL, V27, P275, DOI 10.1006/fgbi.1999.1153; Sedlacek L, 2015, J CYST FIBROS, V14, P237, DOI 10.1016/j.jcf.2014.12.014; Sundaram C, 2014, INDIAN J PATHOL MICR, V57, P217, DOI 10.4103/0377-4929.134666; Symoens F, 2006, J HEART LUNG TRANSPL, V25, P603, DOI 10.1016/j.healun.2005.12.011; Tronchin G, 1997, INFECT IMMUN, V65, P9, DOI 10.1128/IAI.65.1.9-15.1997; TRONCHIN G, 1995, CAN J MICROBIOL, V41, P714, DOI 10.1139/m95-098; Vaknin Y, 2014, FUNGAL GENET BIOL, V63, P55, DOI 10.1016/j.fgb.2013.12.005; Vandeputte P, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00988-14; Wasylnka JA, 2001, MICROBIOL-UK, V147, P869, DOI 10.1099/00221287-147-4-869; Wasylnka JA, 2000, INFECT IMMUN, V68, P3377, DOI 10.1128/IAI.68.6.3377-3384.2000; Yildiz BK, 2014, INT OPHTHALMOL, V34, P305, DOI 10.1007/s10792-013-9777-8; Yin QY, 2005, J BIOL CHEM, V280, P20894, DOI 10.1074/jbc.M500334200; Zhang L, 2013, APPL ENVIRON MICROB, V79, P5519, DOI 10.1128/AEM.00824-13	87	15	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128680	10.1371/journal.pone.0128680	http://dx.doi.org/10.1371/journal.pone.0128680			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26038837	gold, Green Submitted, Green Published			2022-12-27	WOS:000355700700116
J	Mannelli, LD; Pacini, A; Corti, F; Boccella, S; Luongo, L; Esposito, E; Cuzzocrea, S; Maione, S; Calignano, A; Ghelardini, C				Mannelli, Lorenzo Di Cesare; Pacini, Alessandra; Corti, Francesca; Boccella, Serena; Luongo, Livio; Esposito, Emanuela; Cuzzocrea, Salvatore; Maione, Sabatino; Calignano, Antonio; Ghelardini, Carla			Antineuropathic Profile of N-Palmitoylethanolamine in a Rat Model of Oxaliplatin-Induced Neurotoxicity	PLOS ONE			English	Article							INDUCED PERIPHERAL NEUROPATHY; ACID AMIDE HYDROLASE; 1ST-LINE TREATMENT; NERVOUS-SYSTEM; DIFFERENT SCHEDULES; ADJUVANT TREATMENT; OXIDATIVE STRESS; CHRONIC PAIN; CHEMOTHERAPY; CISPLATIN	Neurotoxicity is a main side effect of the anticancer drug oxaliplatin. The development of a neuropathic syndrome impairs quality of life and potentially results in chemotherapy dose reductions and/or early discontinuation. In the complex pattern of molecular and morphological alterations induced by oxaliplatin in the nervous system, an important activation of glia has been preclinically evidenced. N-Palmitoylethanolamine (PEA) modulates glial cells and exerts antinociceptive effects in several animal models. In order to improve the therapeutic chances for chemotherapy-dependent neuropathy management, the role of PEA was investigated in a rat model of oxaliplatin-induced neuropathy (2.4 mg kg(-1) daily, intraperitoneally). On day 21, a single administration of PEA (30 mg kg(-1) i.p.) was able to reduce oxaliplatin-dependent pain induced by mechanical and thermal stimuli. The repeated treatment with PEA (30 mg kg(-1) daily i.p. for 21 days, from the first oxaliplatin injection) prevented lowering of pain threshold as well as increased pain on suprathreshold stimulation. Ex vivohistological and molecular analysis of dorsal root ganglia, peripheral nerves and spinal cord highlighted neuroprotective effects and glia-activation prevention induced by PEA repeated administration. The protective effect of PEA resulted in the normalization of the electrophysiological activity of the spinal nociceptive neurons. Finally, PEA did not alter the oxaliplatin-induced mortality of the human colon cancer cell line HT-29. The efficacy of PEA in neuropathic pain control and in preventing nervous tissue alteration candidates this endogenous compound as disease modifying agent. These characteristics, joined to the safety profile, suggest the usefulness of PEA in chemotherapy-induced neuropathy.	[Mannelli, Lorenzo Di Cesare; Corti, Francesca; Ghelardini, Carla] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Neurofarba, Pharmacol & Toxicol Sect, Florence, Italy; [Pacini, Alessandra] Univ Florence, DMSC, Anat & Histol Sect, Florence, Italy; [Boccella, Serena; Luongo, Livio; Maione, Sabatino] Univ Naples 2, Dept Expt Med, Div Pharmacol, Naples, Italy; [Esposito, Emanuela; Cuzzocrea, Salvatore] Univ Messina, Dept Biol & Environm Sci, Messina, Italy; [Calignano, Antonio] Univ Naples Federico II, Dept Pharm, Naples, Italy	University of Florence; University of Florence; Universita della Campania Vanvitelli; University of Messina; University of Naples Federico II	Mannelli, LD (corresponding author), Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Neurofarba, Pharmacol & Toxicol Sect, Florence, Italy.	lorenzo.mannelli@unifi.it	Calignano, Antonio/K-2542-2018; Luongo, Livio/GXV-1993-2022; Di Cesare Mannelli, Lorenzo/A-1641-2015	Luongo, Livio/0000-0002-1949-2039; GHELARDINI, CARLA/0000-0001-9856-8144; Cuzzocrea, Salvatore/0000-0001-6131-3690; CALIGNANO, Antonio/0000-0002-1742-3179; Esposito, Emanuela/0000-0002-2663-6387; Di Cesare Mannelli, Lorenzo/0000-0001-8374-4432; Maione, Sabatino/0000-0003-3850-6704	Italian Ministry of Instruction, University and Research (MIUR); University of Florence; Programma Operativo Nazionale [PON01_02512]	Italian Ministry of Instruction, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); University of Florence; Programma Operativo Nazionale	This research was funded by the Italian Ministry of Instruction, University and Research (MIUR), by the University of Florence and by Programma Operativo Nazionale (PON01_02512).	Albers JW, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005228.pub3; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Argyriou AA, 2012, CRIT REV ONCOL HEMAT, V82, P51, DOI 10.1016/j.critrevonc.2011.04.012; Bakitas MA, 2007, NURS RES, V56, P323, DOI 10.1097/01.NNR.0000289503.22414.79; Beijers AJM, 2014, SUPPORT CARE CANCER, V22, P1999, DOI 10.1007/s00520-014-2242-z; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Carlton SM, 2009, PAIN, V147, P265, DOI 10.1016/j.pain.2009.09.030; Cavaletti G, 2002, EUR J CANCER, V38, P1832, DOI 10.1016/S0959-8049(02)00229-0; Cavaletti G, 2001, EUR J CANCER, V37, P2457, DOI 10.1016/S0959-8049(01)00300-8; COGGESHALL RE, 1990, J NEUROSCI METH, V35, P187, DOI 10.1016/0165-0270(90)90123-W; D'Agostino G, 2012, NEUROPSYCHOPHARMACOL, V37, P1784, DOI 10.1038/npp.2012.25; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; de Oliveira DC, 2014, CYTOKINE, V69, P218, DOI 10.1016/j.cyto.2014.06.004; De Petrocellis L, 2002, FUND CLIN PHARMACOL, V16, P297, DOI 10.1046/j.1472-8206.2002.00094.x; Di Cesare Mannelli L, 2014, BIOMED RES INT; Di Marzo V, 2001, BIOCHEM J, V358, P249, DOI 10.1042/0264-6021:3580249; Dodd MJ, 2010, EUR J ONCOL NURS, V14, P101, DOI 10.1016/j.ejon.2009.09.005; Ducreux M, 2011, INT J CANCER, V128, P682, DOI 10.1002/ijc.25369; Esposito E, 2011, BRAIN BEHAV IMMUN, V25, P1099, DOI 10.1016/j.bbi.2011.02.006; Franklin A, 2003, J NEUROSCI, V23, P7767; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; Fu S, 2006, INT J GYNECOL CANCER, V16, P1717, DOI 10.1111/j.1525-1438.2006.00654.x; Gatti A, 2012, PAIN MED, V13, P1121, DOI 10.1111/j.1526-4637.2012.01432.x; Grothey A, 2003, SEMIN ONCOL, V30, P5, DOI 10.1016/S0093-7754(03)00399-3; Guindon J, 2013, PHARMACOL RES, V67, P94, DOI 10.1016/j.phrs.2012.10.013; Guo LH, 2007, CELL MOL LIFE SCI, V64, P1128, DOI 10.1007/s00018-007-6494-3; Hamtiaux L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-92; Hershman DL, 2014, J CLIN ONCOL, V32, P1941, DOI 10.1200/JCO.2013.54.0914; Hesselink J.M.K, 2012, OPEN PAIN J, V5, P2, DOI [DOI 10.2174/1876386301205010012, 10.2174/1876386301205010012]; Hesselink JMK, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/151028; Hesselink JMK, 2013, INT MED CASE REP J, V6, P49, DOI 10.2147/IMCRJ.S51572; Hesselink Jan M Keppel, 2012, J Pain Res, V5, P437, DOI 10.2147/JPR.S32143; Hochster HS, 2014, ANN ONCOL, V25, P1172, DOI 10.1093/annonc/mdu107; Holmes J, 1998, TOXICOL SCI, V46, P342, DOI 10.1093/toxsci/46.2.342; Jacobs S, 2010, CANCER CHEMOTH PHARM, V65, P817, DOI 10.1007/s00280-009-1085-7; Jacobs SS, 2005, CLIN CANCER RES, V11, P1669, DOI 10.1158/1078-0432.CCR-04-1807; KAHLICH R, 1979, J HYG EPID MICROB IM, V23, P11; Kaley TJ, 2009, BRIT J HAEMATOL, V145, P3, DOI 10.1111/j.1365-2141.2008.07558.x; Kannarkat G, 2007, CURR OPIN NEUROL, V20, P719; Khasabova IA, 2012, J NEUROSCI, V32, P7091, DOI 10.1523/JNEUROSCI.0403-12.2012; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; Lambert DM, 2001, EPILEPSIA, V42, P321, DOI 10.1046/j.1528-1157.2001.41499.x; LEIGHTON GE, 1988, BRIT J PHARMACOL, V93, P553, DOI 10.1111/j.1476-5381.1988.tb10310.x; LoVerme J, 2006, J PHARMACOL EXP THER, V319, P1051, DOI 10.1124/jpet.106.111385; Luongo L, 2013, CNS NEUROL DISORD-DR, V12, P45, DOI 10.2174/1871527311312010009; Ma WY, 2012, EXPERT OPIN THER TAR, V16, P527, DOI 10.1517/14728222.2012.680955; Mackie K, 2006, AAPS J, V8, pE298, DOI 10.1007/BF02854900; Mannelli LD, 2013, FREE RADICAL BIO MED, V61, P143, DOI 10.1016/j.freeradbiomed.2013.03.019; Mannelli LD, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/328797; Mannelli LD, 2014, EXP NEUROL, V261, P22, DOI 10.1016/j.expneurol.2014.06.016; Mannelli LD, 2013, J PAIN, V14, P1585, DOI 10.1016/j.jpain.2013.08.002; Mannelli LD, 2012, J PAIN, V13, P276, DOI 10.1016/j.jpain.2011.11.009; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Martin M, 2001, Clin Breast Cancer, V2, P190, DOI 10.3816/CBC.2001.n.022; Mazzari S, 1996, EUR J PHARMACOL, V300, P227, DOI 10.1016/0014-2999(96)00015-5; McGaraughty S, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-14; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; MULLER LJ, 1990, CANCER RES, V50, P2437; Nau R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00138; Obata K, 2003, PAIN, V101, P65, DOI 10.1016/S0304-3959(02)00296-8; Pachman DR, 2011, CLIN PHARMACOL THER, V90, P377, DOI 10.1038/clpt.2011.115; Paxinos G., 2004, J CHEM INF MODEL, V5th; Peters CM, 2007, EXP NEUROL, V203, P42, DOI 10.1016/j.expneurol.2006.07.022; Petrioli R, 2008, CANCER CHEMOTH PHARM, V61, P105, DOI 10.1007/s00280-007-0454-3; Raso GM, 2011, J NEUROENDOCRINOL, V23, P591, DOI 10.1111/j.1365-2826.2011.02152.x; Raso GM, 2013, PHARMACOL RES, V76, P67, DOI 10.1016/j.phrs.2013.07.007; Renn CL, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-29; Sakurai M, 2009, PAIN, V147, P165, DOI 10.1016/j.pain.2009.09.003; Sasso O, 2012, PAIN, V153, P33, DOI 10.1016/j.pain.2011.08.010; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Shimozuma K, 2012, SUPPORT CARE CANCER, V20, P3355, DOI 10.1007/s00520-012-1492-x; Simone Donald A., 2008, Shengli Xuebao, V60, P635; Skaper SD, 2013, MOL NEUROBIOL, V48, P340, DOI 10.1007/s12035-013-8487-6; Smart D, 2002, BRIT J PHARMACOL, V136, P452, DOI 10.1038/sj.bjp.0704732; Smith EML, 2013, JAMA-J AM MED ASSOC, V309, P1359, DOI 10.1001/jama.2013.2813; Smith EML, 2011, J PAIN SYMPTOM MANAG, V42, P822, DOI 10.1016/j.jpainsymman.2011.03.017; Souglakos J, 2002, J CLIN ONCOL, V20, P2651, DOI 10.1200/JCO.2002.08.015; Stubblefield MD, 2009, J NATL COMPR CANC NE, V7, pS1, DOI 10.6004/jnccn.2009.0078; Sung CS, 2012, GLIA, V60, P2004, DOI 10.1002/glia.22415; Telleria-Diaz A, 2010, PAIN, V148, P26, DOI 10.1016/j.pain.2009.08.013; Tofthagen C, 2010, J PALLIAT MED, V13, P1389, DOI 10.1089/jpm.2010.0124; TOMIWA K, 1986, ACTA NEUROPATHOL, V69, P295, DOI 10.1007/BF00688308; Truini A, 2011, CNS NEUROL DISORD-DR, V10, P916, DOI 10.2174/187152711799219307; Vasquez E, 2001, J NEUROSCI, V21, P9001, DOI 10.1523/JNEUROSCI.21-22-09001.2001; Wilson RH, 2002, J CLIN ONCOL, V20, P1767, DOI 10.1200/JCO.2002.07.056; Wolf S, 2008, EUR J CANCER, V44, P1507, DOI 10.1016/j.ejca.2008.04.018; Zanardelli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102758	87	66	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128080	10.1371/journal.pone.0128080	http://dx.doi.org/10.1371/journal.pone.0128080			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039098	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700087
J	Mutso, M; Nikonov, A; Pihlak, A; Zusinaite, E; Viru, L; Selyutina, A; Reintamm, T; Kelve, M; Saarma, M; Karelson, M; Merits, A				Mutso, Margit; Nikonov, Andrei; Pihlak, Arno; Zusinaite, Eva; Viru, Liane; Selyutina, Anastasia; Reintamm, Tonu; Kelve, Merike; Saarma, Mart; Karelson, Mati; Merits, Andres			RNA Interference-Guided Targeting of Hepatitis C Virus Replication with Antisense Locked Nucleic Acid-Based Oligonucleotides Containing 8-oxo-dG Modifications	PLOS ONE			English	Article							GENE-EXPRESSION; SECONDARY STRUCTURE; ORAL DELIVERY; H CLEAVAGE; INHIBITION; DNA; POTENT; IDENTIFICATION; TRANSLATION; ANALOG	The inhibitory potency of an antisense oligonucleotide depends critically on its design and the accessibility of its target site. Here, we used an RNA interference-guided approach to select antisense oligonucleotide target sites in the coding region of the highly structured hepatitis C virus (HCV) RNA genome. We modified the conventional design of an antisense oligonucleotide containing locked nucleic acid (LNA) residues at its termini (LNA/DNA gapmer) by inserting 8-oxo-2'-deoxyguanosine (8-oxo-dG) residues into the central DNA region. Obtained compounds, designed with the aim to analyze the effects of 8-oxo-dG modifications on the antisense oligonucleotides, displayed a unique set of properties. Compared to conventional LNA/DNA gapmers, the melting temperatures of the duplexes formed by modified LNA/DNA gapmers and DNA or RNA targets were reduced by approximately 1.6-3.3 degrees C per modification. Comparative transfection studies showed that small interfering RNA was the most potent HCV RNA replication inhibitor (effective concentration 50 (EC50) : 0.13 nM), whereas isosequential standard and modified LNA/DNA gapmers were approximately 50-fold less efficient (EC50 : 5.5 and 7.1 nM, respectively). However, the presence of 8-oxo-dG residues led to a more complete suppression of HCV replication in transfected cells. These modifications did not affect the efficiency of RNase H cleavage of antisense oligonucleotide: RNA duplexes but did alter specificity, triggering the appearance of multiple cleavage products. Moreover, the incorporation of 8-oxo-dG residues increased the stability of antisense oligonucleotides of different configurations in human serum.	[Mutso, Margit; Nikonov, Andrei; Zusinaite, Eva; Viru, Liane; Selyutina, Anastasia; Merits, Andres] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia; [Mutso, Margit; Nikonov, Andrei; Pihlak, Arno; Zusinaite, Eva; Viru, Liane; Reintamm, Tonu; Kelve, Merike; Karelson, Mati] GeneCode Ltd, Tallinn, Estonia; [Reintamm, Tonu; Kelve, Merike] Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia; [Saarma, Mart] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Karelson, Mati] Univ Tartu, Inst Chem, EE-50090 Tartu, Estonia	University of Tartu; Tallinn University of Technology; University of Helsinki; University of Tartu	Merits, A (corresponding author), Univ Tartu, Inst Technol, Ulikooli 18, EE-50090 Tartu, Estonia.	andres.merits@ut.ee	Merits, Andres/H-3125-2015; Nikonov, Andrei/G-3421-2015	Merits, Andres/0000-0001-8193-0071; Nikonov, Andrei/0000-0003-2121-8984	Estonian Enterprise grant "OLIGO-MOD" European Regional Development Fund through Centre of Excellence in Chemical Biology European Regional Development Fund project "HCV-TECH" Estonian Ministry of Education and Research [3.2.0701.11-0016, SF0140031As09, SF0180087s08]; GeneCode, Ltd.	Estonian Enterprise grant "OLIGO-MOD" European Regional Development Fund through Centre of Excellence in Chemical Biology European Regional Development Fund project "HCV-TECH" Estonian Ministry of Education and Research; GeneCode, Ltd.	Estonian Enterprise grant "OLIGO-MOD" (MKarelson) European Regional Development Fund through the Centre of Excellence in Chemical Biology (AM) European Regional Development Fund project 3.2.0701.11-0016 "HCV-TECH" (AM) Estonian Ministry of Education and Research grants SF0140031As09 (MKarelson) and SF0180087s08 (AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors AP, TR, MM, AN, LV, EZ, M. Kelve and M. Karelson were employed by GeneCode, Ltd at some period of time when the work results of which have been included into this manuscript was in progress. GeneCode, Ltd. provided support in the form of salaries for authors AP, TR, MM, AN, LV, EZ and M. Kelve, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALT M, 1995, HEPATOLOGY, V22, P707; [Anonymous], 2001, ARKIVOC; Brown-Driver V, 1999, ANTISENSE NUCLEIC A, V9, P145, DOI 10.1089/oli.1.1999.9.145; Burdick AD, 2014, NUCLEIC ACIDS RES, V42, P4882, DOI 10.1093/nar/gku142; Caldarelli SA, 2005, BIOORGAN MED CHEM, V13, P5700, DOI 10.1016/j.bmc.2005.06.008; Damha MJ, 1998, J AM CHEM SOC, V120, P12976, DOI 10.1021/ja982325+; Das PK, 2014, J BIOL CHEM, V289, P5635, DOI 10.1074/jbc.M113.503433; Deleavey GF, 2012, CHEM BIOL, V19, P937, DOI 10.1016/j.chembiol.2012.07.011; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; FIERS W, 1976, NATURE, V260, P500, DOI 10.1038/260500a0; Flanagan WM, 1999, P NATL ACAD SCI USA, V96, P3513, DOI 10.1073/pnas.96.7.3513; Frese M, 2003, J GEN VIROL, V84, P1253, DOI 10.1099/vir.0.18997-0; FURDON PJ, 1989, NUCLEIC ACIDS RES, V17, P9193, DOI 10.1093/nar/17.22.9193; Ganguly M, 2012, BIOCHEMISTRY-US, V51, P2018, DOI 10.1021/bi3000269; Grunweller A, 2007, BIODRUGS, V21, P235; Grunweller A, 2003, NUCLEIC ACIDS RES, V31, P3185, DOI 10.1093/nar/gkg409; Hair P, 2013, DRUGS, V73, P487, DOI 10.1007/s40265-013-0042-2; Hamm ML, 2010, J ORG CHEM, V75, P5661, DOI 10.1021/jo1010763; Hanecak R, 1996, J VIROL, V70, P5203, DOI 10.1128/JVI.70.8.5203-5212.1996; HANVEY JC, 1992, SCIENCE, V258, P1481, DOI 10.1126/science.1279811; HAUSEN P, 1970, EUR J BIOCHEM, V14, P278, DOI 10.1111/j.1432-1033.1970.tb00287.x; Heidenreich O, 1997, NUCLEIC ACIDS RES, V25, P776, DOI 10.1093/nar/25.4.776; Herdewijn P, 2000, ANTISENSE NUCLEIC A, V10, P297, DOI 10.1089/108729000421475; Hildebrandt-Eriksen ES, 2012, NUCLEIC ACID THER, V22, P152, DOI 10.1089/nat.2011.0332; Jang YH, 2002, CHEM RES TOXICOL, V15, P1023, DOI 10.1021/tx010146r; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jin Q, 2013, BIOCHEMISTRY-US, V52, P7870, DOI 10.1021/bi4009825; Kapadia SB, 2003, P NATL ACAD SCI USA, V100, P2014, DOI 10.1073/pnas.252783999; Karelson M, 2002, ARK, V2, P51; Kling J, 2010, NAT BIOTECHNOL, V28, P295, DOI 10.1038/nbt0410-295; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Kurreck J, 2002, NUCLEIC ACIDS RES, V30, P1911, DOI 10.1093/nar/30.9.1911; Kurreck J, 2003, EUR J BIOCHEM, V270, P1628, DOI 10.1046/j.1432-1033.2003.03555.x; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Laxton C, 2011, ANTIMICROB AGENTS CH, V55, P3105, DOI 10.1128/AAC.00222-11; Lima WF, 1997, J BIOL CHEM, V272, P626; Lok CN, 2002, BIOCHEMISTRY-US, V41, P3457, DOI 10.1021/bi0115075; Lopp A, 2012, BIOCHIMIE, V94, P1635, DOI 10.1016/j.biochi.2012.04.002; McCaffrey AP, 2003, HEPATOLOGY, V38, P503, DOI 10.1053/jhep.2003.50330; Min KL, 2002, BIOORG MED CHEM LETT, V12, P2651, DOI 10.1016/S0960-894X(02)00439-0; MIZUTANI T, 1995, BIOCHEM BIOPH RES CO, V212, P906, DOI 10.1006/bbrc.1995.2055; MONIA BP, 1993, J BIOL CHEM, V268, P14514; Murray S, 2012, NUCLEIC ACIDS RES, V40, P6135, DOI 10.1093/nar/gks273; Nikonov A, 2008, J BIOL CHEM, V283, P24089, DOI 10.1074/jbc.M803422200; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Nulf CJ, 2004, NUCLEIC ACIDS RES, V32, P3792, DOI 10.1093/nar/gkh706; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Ottosen S, 2015, ANTIMICROB AGENTS CH, V59, P599, DOI 10.1128/AAC.04220-14; Pang PS, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr773; Rait VK, 1999, ANTISENSE NUCLEIC A, V9, P53, DOI 10.1089/oli.1.1999.9.53; Renneberg D, 2002, NUCLEIC ACIDS RES, V30, P2751, DOI 10.1093/nar/gkf412; Romero-Lopez C, 2012, NUCLEIC ACIDS RES, V40, P11697, DOI 10.1093/nar/gks927; Sabatino D, 2007, J AM CHEM SOC, V129, P8259, DOI 10.1021/ja071336c; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Simmonds P, 2004, RNA, V10, P1337, DOI 10.1261/rna.7640104; Singh SK, 2011, NUCLEIC ACIDS RES, V39, P6789, DOI 10.1093/nar/gkr275; STEIN H, 1969, SCIENCE, V166, P393, DOI 10.1126/science.166.3903.393; Suen W, 1999, P NATL ACAD SCI USA, V96, P4500, DOI 10.1073/pnas.96.8.4500; Summerton J, 1999, BBA-GENE STRUCT EXPR, V1489, P141, DOI 10.1016/S0167-4781(99)00150-5; Tillman LG, 2008, J PHARM SCI-US, V97, P225, DOI 10.1002/jps.21084; Tong X, 2006, ANTIVIR RES, V70, P28, DOI 10.1016/j.antiviral.2005.12.003; Toulme JJ, 2001, NAT BIOTECHNOL, V19, P17, DOI 10.1038/83451; Tuplin A, 2012, NUCLEIC ACIDS RES, V40, P6908, DOI 10.1093/nar/gks370; Ueno Y, 1997, NUCLEIC ACIDS RES, V25, P3777, DOI 10.1093/nar/25.19.3777; van der Ree MH, 2014, ANTIVIR RES, V111, P53, DOI 10.1016/j.antiviral.2014.08.015; Van Meerten D, 2001, RNA, V7, P483, DOI 10.1017/S1355838201001984; van Putten M, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.62; Verbeure B, 2001, NUCLEIC ACIDS RES, V29, P4941, DOI 10.1093/nar/29.24.4941; Wahlestedt C, 2000, P NATL ACAD SCI USA, V97, P5633, DOI 10.1073/pnas.97.10.5633; WAKITA T, 1994, J BIOL CHEM, V269, P14205; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Wilson JA, 2005, J VIROL, V79, P7050, DOI 10.1128/JVI.79.11.7050-7058.2005; Wilson JA, 2003, P NATL ACAD SCI USA, V100, P2783, DOI 10.1073/pnas.252758799; Wu HJ, 1999, J BIOL CHEM, V274, P28270, DOI 10.1074/jbc.274.40.28270; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; You Y, 2011, BIOPOLYMERS, V95, P472, DOI 10.1002/bip.21615; Zamaratski E, 2001, J BIOCHEM BIOPH METH, V48, P189, DOI 10.1016/S0165-022X(01)00149-X; Zhou J, 2011, GENE THER, V18, P1134, DOI 10.1038/gt.2011.149	79	7	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128686	10.1371/journal.pone.0128686	http://dx.doi.org/10.1371/journal.pone.0128686			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039055	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700117
J	Tolley, K; Hutchinson, M; You, XJ; Wang, P; Sperling, B; Taneja, A; Siddiqui, MK; Kinter, E				Tolley, Keith; Hutchinson, Michael; You, Xiaojun; Wang, Ping; Sperling, Bjoern; Taneja, Ankush; Siddiqui, Mohammed Kashif; Kinter, Elizabeth			A Network Meta-Analysis of Efficacy and Evaluation of Safety of Subcutaneous Pegylated Interferon Beta-1a versus Other Injectable Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis	PLOS ONE			English	Article							DISEASE-MODIFYING THERAPIES; GLATIRAMER ACETATE; DOUBLE-BLIND; MULTICENTER; ADHERENCE; DISABILITY; TRIALS; FREQUENCY; PHASE-3; REBIF	Subcutaneous pegylated interferon beta-1a (peginterferon beta-1a [PEG-IFN]) 125 mu g every two or four weeks has been studied in relapsing-remitting multiple sclerosis (RRMS) patients in the pivotal Phase 3 ADVANCE trial. In the absence of direct comparative evidence, a network meta-analysis (NMA) was conducted to provide an indirect assessment of the relative efficacy, safety, and tolerability of PEG-IFN versus other injectable RRMS therapies. Systematic searches were conducted in MEDLINE, Embase, and the Cochrane Library, and conference proceedings from relevant annual symposia were hand-searched. Included studies were randomized controlled trials evaluating >= 1 first-line treatments including interferon beta-1a 30, 44, and 22 mu g, interferon beta-1b, and glatiramer acetate in patients with RRMS. Studies were included based on a pre-specified protocol and extracted by a team of independent reviewers and information scientists, utilizing criteria from NICE and IQWiG. In line with ADVANCE findings, NMA results support that PEG-IFN every 2 weeks significantly reduced annualized relapse rate, and 3- and 6-month confirmed disability progression (CDP) versus placebo. There was numerical trend favoring PEG-IFN every 2 weeks versus other IFNs assessed for annualized relapse rate, and versus all other injectables for 3- and 6-month CDP (6-month CDP was significantly reduced versus IFN beta-1a 30 mu g). The safety and tolerability profile of PEG-IFN beta-1a 125 mu g every 2 weeks was consistent with that of other evaluated treatments. Study limitations for the NMA include variant definitions of relapse and other systematic differences across trials, assumptions that populations were sufficiently similar, and inability to perform NMA of adverse events. With similar efficacy compared to other RRMS treatments in terms of annualized relapse rate and 3- and 6-month CDP, a promising safety profile, and up to 93% reduction in number of injections (which may improve adherence), PEG-IFN every 2 weeks offers a valuable alternative treatment option for patients with RRMS.	[Tolley, Keith] Tolley Hlth Econ Ltd, Buxton, Derby, England; [Hutchinson, Michael] St Vincents Univ Hosp, Dublin 4, Ireland; [You, Xiaojun; Wang, Ping; Sperling, Bjoern; Taneja, Ankush; Kinter, Elizabeth] Biogen Idec Inc, Cambridge, MA USA; [Siddiqui, Mohammed Kashif] HERON Commercializat, Chandigarh, India	University College Dublin; Saint Vincent's University Hospital; Biogen	Tolley, K (corresponding author), Tolley Hlth Econ Ltd, Buxton, Derby, England.	keith@tolleyhealtheconomics.com	hutchinson, michael/H-3508-2019	hutchinson, michael/0000-0002-8675-1723	Biogen Idec Inc. (Cambridge, MA, USA)	Biogen Idec Inc. (Cambridge, MA, USA)(Biogen)	This study was sponsored by Biogen Idec Inc. (Cambridge, MA, USA). XY, PW, BS, and EK are employees of Biogen Idec Inc., and were involved in conception and design of the work, data acquisition, analysis and interpretation, critical revision of the manuscript for important intellectual content, and final approval of the version to be published. MKS and AT are employees of HERON, a company that received funding from Biogen Idec to conduct this study. KT receives consulting fees from Biogen Idec Inc. KT is employed by Tolley Health Economics Ltd., Buxton, UK, a commercial company. KT has no other relevant declarations relating to employment, consultancy, patents, products in development or marketed products. MH receives speaker bureau fees from Bayer Schering, Biogen Idec Inc., Merck Serono, and Novartis. There were no restrictions on sharing of data and/or materials. These interests did not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	[Anonymous], 2009, REB INT BET 1A PACK; [Anonymous], 2008, BETASERON INT BET 1B; [Anonymous], 2008, AV INT BET 1A PACK I; [Anonymous], 2009, EXT SC INJ INT BET 1; Biogen Idec Inc, 2014, AV US PRESCR INF; Bolanos-Jimenez R, 2010, J NEUROSCI BEHAV HLT, V3, P44; BORNSTEIN MB, 1987, NEW ENGL J MED, V317, P408, DOI 10.1056/NEJM198708133170703; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Cadavid D, 2009, NEUROLOGY, V72, P1976, DOI 10.1212/01.wnl.0000345970.73354.17; Calabrese M, 2012, MULT SCLER J, V18, P418, DOI 10.1177/1352458510394702; Calabresi PA, 2014, MULT SCLER J, V20, P42; Calabresi PA, 2014, LANCET NEUROL, V13, P657, DOI 10.1016/S1474-4422(14)70068-7; Comi G, 2001, ANN NEUROL, V49, P290, DOI 10.1002/ana.64; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Del Santo F, 2012, EUR J CLIN PHARMACOL, V68, P441, DOI 10.1007/s00228-011-1141-1; Devonshire V, 2011, EUR J NEUROL, V18, P69, DOI 10.1111/j.1468-1331.2010.03110.x; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dias S, 2011, 2 NICE DSU; DUQUETTE P, 1995, NEUROLOGY, V45, P1277; Durelli L, 2002, LANCET, V359, P1453, DOI 10.1016/S0140-6736(02)08430-1; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Etemadifar M, 2006, ACTA NEUROL SCAND, V113, P283, DOI 10.1111/j.1600-0404.2006.00585.x; European Medicines Agency, 2009, EXT EPAR PROD INF; European Medicines Agency (EMA), 2009, BET EPAR PROD INF; European Medicines Agency (EMA), 2009, REB EPAR PROD INF; European Medicines Agency (EMA), 2009, AV EPAR PROD INF; Filippini G, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008933.pub2; Fleurence RL, 2007, PHARMACOECONOMICS, V25, P3, DOI 10.2165/00019053-200725010-00002; Fox RJ, 2012, NEW ENGL J MED, V367, P1087, DOI 10.1056/NEJMoa1206328; Gasperini C, 2012, DRUG DES DEV THER, V6, P175, DOI 10.2147/DDDT.S8927; Hadjigeorgiou GM, 2013, J CLIN PHARM THER, V38, P433, DOI 10.1111/jcpt.12090; Halpern R, 2011, PATIENT PREFER ADHER, V5, P73, DOI 10.2147/PPA.S15702; IQWiG, 2011, I QUAL WIRTSCH GES G; Iskedjian M, 2002, CLIN THER, V24, P302, DOI 10.1016/S0149-2918(02)85026-3; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jansen JP, 2008, VALUE HEALTH, V11, P956, DOI 10.1111/j.1524-4733.2008.00347.x; Jansen JP, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-61; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Kieseier BC, 2014, MULT SCLER; Kieseier BC, 2014, EXPERT REV NEUROTHER, V14, P105, DOI 10.1586/14737175.2014.869478; Liu C, 2000, J NEUROL NEUROSUR PS, V68, P450, DOI 10.1136/jnnp.68.4.450; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lublin Fred D., 2003, Neurology, V61, P1528; Lublin FD, 2013, ANN NEUROL, V73, P327, DOI 10.1002/ana.23863; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; McGraw CA, 2013, NEUROTHERAPEUTICS, V10, P2, DOI 10.1007/s13311-012-0163-4; Menzin J, 2013, J MANAGE CARE PHARM, V19, pS24, DOI 10.18553/jmcp.2013.19.s1.S24; Mikol DD, 2008, LANCET NEUROL, V7, P903, DOI 10.1016/S1474-4422(08)70200-X; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Multiple Sclerosis International Federation, 2013, ATL MS DAT; National Institute for Health and Care Excellence, 2009, SPEC MAN SPONS SUBM; National Multiple Sclerosis Society, 2014, TREAT MS; National Multiple Sclerosis Society, 2008, DIS MAN CONS STAT; Newsome SD, CONS MULT SCLER CTR; Newsome SD, 2014, INT J MS CARE, V5; O'Connor P, 2009, LANCET NEUROL, V8, P889, DOI 10.1016/S1474-4422(09)70226-1; Peyrot M, 2010, DIABETES CARE, V33, P240, DOI 10.2337/dc09-1348; Roskell NS, 2012, CURR MED RES OPIN, V28, P767, DOI 10.1185/03007995.2012.681637; Salanti G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099682; Schwid SR, 2007, CLIN THER, V29, P2031, DOI 10.1016/j.clinthera.2007.09.025; Singh JA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008794.pub2; Steinberg SC, 2010, CLIN DRUG INVEST, V30, P89, DOI 10.2165/11533330-000000000-00000; Teva Neuroscience, 2014, COP US PRESCR INF; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Vollmer TL, 2014, J NEUROL, V261, P773, DOI 10.1007/s00415-014-7264-4; Woods BS, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-54; Zintzaras E, 2012, CLIN THER, V34, P857, DOI 10.1016/j.clinthera.2012.02.018	68	36	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127960	10.1371/journal.pone.0127960	http://dx.doi.org/10.1371/journal.pone.0127960			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039748	Green Submitted, Green Published, gold			2022-12-27	WOS:000355700700082
J	Azar, KMJ; Chung, S; Wang, EJ; Zhao, BN; Linde, RB; Lederer, J; Palaniappan, LP				Azar, Kristen M. J.; Chung, Sukyung; Wang, Elsie J.; Zhao, Beinan; Linde, Randolph B.; Lederer, Janet; Palaniappan, Latha P.			Impact of Education on Weight in Newly Diagnosed Type 2 Diabetes: Every Little Bit Helps	PLOS ONE			English	Article							LIFE-STYLE INTERVENTION; SELF-MANAGEMENT; INDIVIDUALS; ASSOCIATION; SUPPORT	Aims Highly structured, intensive behavioral lifestyle interventions have been shown to be efficacious in research settings for type 2 diabetes management and weight loss. We sought to evaluate the benefit of participation in more limited counseling and/or education among individuals with newly diagnosed type 2 diabetes in more modest real-world clinical settings. Methods Electronic Health Records of newly diagnosed type 2 diabetes patients age 35-74 from a large ambulatory group practice were analyzed (n = 1,314). We examined participation in clinic-based lifestyle counseling/education and subsequent weight loss. Results Of the total cohort, 599 (45.6%) patients received counseling/education with (26.2%) and without (19.4%) medication, 298(22.7%) patients received a prescription for medication alone, and 417(31.7%) patients were only monitored. On average, those who participated in counseling/education attended 2.5 sessions (approximately 2-3 hours). The average weight loss of patients who received counseling/education alone during the follow-up period (up to three years post-exposure to participation) was 6.3 lbs. (3.3% of body weight), and, if received with medication prescription, 8.1lbs. (4.0% of body weight) (all at P<0.001). The weight loss associated with medication was only 3.5 lbs. (P<0.001). No significant weight change was observed in the monitoring only group. Conclusions While efforts to improve both the short-term and long-term effectiveness of behavioral lifestyle interventions in real-world settings are ongoing, it is important for clinicians to continue to utilize less intensive, existing resources. Even relatively small "doses" of health education may help in promoting weight loss and may potentially reduce cardiometabolic risk.	[Azar, Kristen M. J.; Chung, Sukyung; Zhao, Beinan] Palo Alto Med Fdn Res Inst, Palo Alto, CA 94301 USA; [Linde, Randolph B.; Lederer, Janet] Palo Alto Med Fdn, Palo Alto, CA USA; [Wang, Elsie J.; Palaniappan, Latha P.] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA	Palo Alto Medical Foundation Research Institute; Palo Alto Medical Foundation Research Institute; Stanford University	Azar, KMJ (corresponding author), Palo Alto Med Fdn Res Inst, Palo Alto, CA 94301 USA.	azark@pamfri.org		Palaniappan, Latha/0000-0002-1245-665X	National Institute of Diabetes and Digestive and Kidney Diseases [R01DK081371-01]; Agency for Healthcare Research Quality [K01 HS019815]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K01HS019815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081371] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Agency for Healthcare Research Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by funds from National Institute of Diabetes and Digestive and Kidney Diseases (R01DK081371-01) http://www.niddk.nih.gov/Pages/default.aspx and the Agency for Healthcare Research & Quality (K01 HS019815) http://www.ahrq.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, DIABETES CARE, V28, pS4; [Anonymous], 2010, Diabetes Care, V33 Suppl 1, pS4, DOI 10.2337/dc10-S004; [Anonymous], 2009, NCHS DATA BRIEF; Aucott L, 2005, HYPERTENSION, V45, P1035, DOI 10.1161/01.HYP.0000165680.59733.d4; BLACKBURN G, 1995, OBES RES, V3, pS211, DOI 10.1002/j.1550-8528.1995.tb00466.x; Bray GA, 1999, DIABETES CARE, V22, P623; Bureau U.S.C, 2000, PROF GEN DEM CHAR 20; Cauch-Dudek K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-85; Chung S., 2014, PRIMARY CAR IN PRESS; Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2; Delahanty LM, 2008, J AM DIET ASSOC, V108, pS66, DOI 10.1016/j.jada.2008.01.026; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x; Espeland M, 2007, DIABETES CARE, V30, P1374; Forjuoh SN, 2011, PATIENT EDUC COUNS, V85, P133, DOI 10.1016/j.pec.2010.08.004; Gorin A, 2005, J CONSULT CLIN PSYCH, V73, P341, DOI 10.1037/0022-006X.73.2.341; Graziani C, 1999, Fam Med, V31, P358; Gregg EW, 2012, JAMA-J AM MED ASSOC, V308, P2489, DOI 10.1001/jama.2012.67929; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Norris SL, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004096.pub2, 10.1002/14651858.CD004095.pub2, 10.1002/14651858.CD005270]; Palaniappan LP, 2011, J AM BOARD FAM MED, V24, P326, DOI 10.3122/jabfm.2011.03.100220; Paul-Ebhohimhen V, 2009, OBESITY FACTS, V2, P17, DOI 10.1159/000186144; Poobalan A, 2004, Obes Rev, V5, P43, DOI 10.1111/j.1467-789X.2004.00127.x; Rao G, 2013, JAMA INTERN MED, V173, P111, DOI 10.1001/jamainternmed.2013.1232; Steinsbekk A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-213; Thomas SL, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-34; Unick JL, 2013, AM J MED, V126, P236, DOI 10.1016/j.amjmed.2012.10.010; Verheijden MW, 2005, EUR J CLIN NUTR, V59, pS179, DOI 10.1038/sj.ejcn.1602194; Wadden TA, 2006, OBESITY, V14, P737; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334	33	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129348	10.1371/journal.pone.0129348	http://dx.doi.org/10.1371/journal.pone.0129348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052698	gold, Green Submitted, Green Published			2022-12-27	WOS:000355955300121
J	Badawi, M; Greve, P; Cordaux, R				Badawi, Myriam; Greve, Pierre; Cordaux, Richard			Feminization of the Isopod Cylisticus convexus after Transinfection of the wVulC Wolbachia Strain of Armadillidium vulgare	PLOS ONE			English	Article							FEMINIZING WOLBACHIA; DROSOPHILA-SIMULANS; CYTOPLASMIC INCOMPATIBILITY; MOLECULAR-IDENTIFICATION; REPRODUCTIVE PARASITES; TERRESTRIAL CRUSTACEAN; SEX-DETERMINATION; HOST; INFECTION; ENDOSYMBIONTS	Reproductive parasites such as Wolbachia are able to manipulate the reproduction of their hosts by inducing parthenogenesis, male-killing, cytoplasmic incompatibility or feminization of genetic males. Despite extensive studies, no underlying molecular mechanism has been described to date. The goal of this study was to establish a system with a single Wolbachia strain that feminizes two different isopod species to enable comparative analyses aimed at elucidating the genetic basis of feminization. It was previously suggested that Wolbachia wVulC, which naturally induces feminization in Armadillidium vulgare, induces the development of female secondary sexual characters in transinfected Cylisticus convexus adult males. However, this does not demonstrate that wVulC induces feminization in Cylisticus convexus since feminization is the conversion of genetic males into functional females that occurs during development. Nevertheless, it suggests that Cylisticus convexus may represent a feminization model suitable for further development. Knowledge about Cylisticus convexus sexual differentiation is also essential for comparative analyses, as feminization is thought to take place just before or during sexual differentiation. Consequently, we first described gonad morphological differentiation of Cylisticus convexus and compared it with that of Armadillidium vulgare. Then, wVulC was injected into male and female Cylisticus convexus adult individuals. The feminizing effect was demonstrated by the combined appearance of female secondary sexual characters in transinfected adult males, as well as the presence of intersexes and female biases in progenies in which wVulC was vertically transmitted from transinfected mothers. The establishment of a new model of feminization of a Wolbachia strain in a heterologous host constitutes a useful tool towards the understanding of the molecular mechanism of feminization.	[Badawi, Myriam; Greve, Pierre; Cordaux, Richard] Univ Poitiers, UMR CNRS Ecol & Biol Interact 7267, Equipe Ecol Evolut Symbiose, F-86073 Poitiers 9, France	Universite de Poitiers	Cordaux, R (corresponding author), Univ Poitiers, UMR CNRS Ecol & Biol Interact 7267, Equipe Ecol Evolut Symbiose, Bat B8,5 Rue Albert Turpin,TSA 51106, F-86073 Poitiers 9, France.	richard.cordaux@univ-poitiers.fr	badawi, Myriam/ABH-4097-2020	badawi, Myriam/0000-0001-5918-106X	European Research Council Starting (FP7, EndoSexDet) [260729]; Centre National de la Recherche Scientifique (CNRS); French Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche	European Research Council Starting (FP7, EndoSexDet); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche	This research was funded by a European Research Council Starting Grant (FP7/2007-2013, grant 260729 EndoSexDet) to RC and intramural funds from the Centre National de la Recherche Scientifique (CNRS) and the French Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badawi M, 2014, GENOME BIOL EVOL, V6, P2654, DOI 10.1093/gbe/evu207; Baldo L, 2007, CURR MICROBIOL, V55, P367, DOI 10.1007/s00284-007-9009-4; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402; Bouchon D, 2008, INSECT SYMBIOSIS, P273; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; Breeuwer JAJ, 1996, EXP APPL ACAROL, V20, P421, DOI 10.1007/BF00053306; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Bull J, 1983, EVOLUTION SEX DETERM, P192; CHARNIAUXCOTTON H, 1992, REPROD BIOL INVERTEB, V5, P281; COMBES C, 1995, COLLECTION ECOLOGIE, V26; Cordaux R, 2004, HEREDITY, V93, P78, DOI 10.1038/sj.hdy.6800482; Cordaux R, 2012, ZOOKEYS, P123, DOI 10.3897/zookeys.176.2284; Cordaux R, 2011, TRENDS GENET, V27, P332, DOI 10.1016/j.tig.2011.05.002; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; Duron O, 2008, MOL ECOL, V17, P1427, DOI 10.1111/j.1365-294X.2008.03689.x; Duron O, 2012, P ROY SOC B-BIOL SCI, V279, P4473, DOI 10.1098/rspb.2012.1368; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Giorgini M, 2009, HEREDITY, V102, P365, DOI 10.1038/hdy.2008.135; Hagimori T, 2006, CURR MICROBIOL, V52, P97, DOI 10.1007/s00284-005-0092-0; Huigens ME, 2004, P ROY SOC B-BIOL SCI, V271, P509, DOI 10.1098/rspb.2003.2640; Hurst GDD, 1999, P ROY SOC B-BIOL SCI, V266, P735, DOI 10.1098/rspb.1999.0698; JUCHAULT P, 1974, Annales d'Embryologie et de Morphogenese, V7, P265; Juchault P, 1966, CONTRIBUTION ETUDE D; Kageyama D, 2002, HEREDITY, V88, P444, DOI 10.1038/sj.hdy.6800077; Kageyama D, 2008, MICROB ECOL, V56, P733, DOI 10.1007/s00248-008-9392-9; Kang L, 2003, HEREDITY, V90, P71, DOI 10.1038/sj.hdy.6800180; Katakura Y., 1984, S ZOOL SOC LONDON, V53, P127; Le Clec'h W, 2014, J INVERTEBR PATHOL, V116, P18, DOI 10.1016/j.jip.2013.12.003; Le Clec'h W, 2013, ENVIRON MICROBIOL, V15, P2922, DOI 10.1111/1462-2920.12172; Le Clec'h W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002844; LEGRAND J J, 1978, Archives de l'Institut Pasteur de Tunis, V55, P507; LEGRAND JJ, 1986, B ZOOL, V53, P161; LEGRAND JJ, 1963, CR HEBD ACAD SCI, V256, P1606; LePage D, 2013, TRENDS PARASITOL, V29, P385, DOI 10.1016/j.pt.2013.06.003; Marcade I, 1999, HEREDITY, V83, P71, DOI 10.1038/sj.hdy.6885380; MARTIN G, 1973, CR ACAD SCI D NAT, V276, P2313; McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08; Michel-Salzat A, 2001, HEREDITY, V87, P428, DOI 10.1046/j.1365-2540.2001.00920.x; Moret Y, 2001, HEREDITY, V86, P325, DOI 10.1046/j.1365-2540.2001.00831.x; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; Riegler M, 2004, APPL ENVIRON MICROB, V70, P273, DOI 10.1128/AEM.70.1.273-279.2004; Rigaud T, 1997, INFLUENTIAL PASSENGERS, P81; Rigaud T, 1997, BIOESSAYS, V19, P409, DOI 10.1002/bies.950190508; RIGAUD T, 1991, ENDOCYTOBIOSIS CELL, V7, P259; Rigaud T, 1998, CAN J ZOOL, V76, P493, DOI 10.1139/cjz-76-3-493; Rigaud T, 2001, J INVERTEBR PATHOL, V77, P251, DOI 10.1006/jipa.2001.5026; Rigaud T, 1999, HEREDITY, V83, P469, DOI 10.1038/sj.hdy.6885990; ROUSSET F, 1992, P ROY SOC B-BIOL SCI, V247, P163, DOI 10.1098/rspb.1992.0023; Sicard M, 2014, ENVIRON MICROBIOL, V16, P3583, DOI 10.1111/1462-2920.12573; STOUTHAMER R, 1990, P NATL ACAD SCI USA, V87, P2424, DOI 10.1073/pnas.87.7.2424; Suzuki Sachiko, 1995, Crustacean Research, V24, P93; Tabata J, 2011, MICROB ECOL, V61, P254, DOI 10.1007/s00248-010-9799-y; Van Meer MMM, 1999, HEREDITY, V82, P163, DOI 10.1038/sj.hdy.6884610; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Xi ZY, 2006, P R SOC B, V273, P1317, DOI 10.1098/rspb.2005.3405; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	58	3	3	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128660	10.1371/journal.pone.0128660	http://dx.doi.org/10.1371/journal.pone.0128660			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047139	Green Submitted, gold, Green Published			2022-12-27	WOS:000355652200089
J	Jindal, HM; Le, CF; Yusof, MYM; Velayuthan, RD; Lee, VS; Zain, SM; Isa, DM; Sekaran, SD				Jindal, Hassan Mahmood; Le, Cheng Foh; Yusof, Mohd Yasim Mohd; Velayuthan, Rukumani Devi; Lee, Vannajan Sanghiran; Zain, Sharifuddin Md; Isa, Diyana Mohd; Sekaran, Shamala Devi			Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae	PLOS ONE			English	Article							SWISS-MODEL REPOSITORY; ANTIBACTERIAL ACTIVITY; VIRULENCE FACTORS; HYBRID PEPTIDES; IN-VITRO; DESIGN; TRYPTOPHAN; MECHANISMS; BACTERIA; STAPHYLOCOCCUS	Antimicrobial peptides (AMPs) represent promising alternatives to conventional antibiotics in order to defeat multidrug-resistant bacteria such as Streptococcus pneumoniae. In this study, thirteen antimicrobial peptides were designed based on two natural peptides indolicidin and ranalexin. Our results revealed that four hybrid peptides RN7-IN10, RN7-IN9, RN7-IN8, and RN7-IN6 possess potent antibacterial activity against 30 pneumococcal clinical isolates (MIC 7.81-15.62 mu g/ml). These four hybrid peptides also showed broad spectrum antibacterial activity (7.81 mu g/ml) against S. aureus, methicillin resistant S. aureus (MRSA), and E. coli. Furthermore, the time killing assay results showed that the hybrid peptides were able to eliminate S. pneumoniae within less than one hour which is faster than the standard drugs erythromycin and ceftriaxone. The cytotoxic effects of peptides were tested against human erythrocytes, WRL-68 normal liver cell line, and NL-20 normal lung cell line. The results revealed that none of the thirteen peptides have cytotoxic or hemolytic effects at their MIC values. The in silico molecular docking study was carried out to investigate the binding properties of peptides with three pneumococcal virulent targets by Autodock Vina. RN7IN6 showed a strong affinity to target proteins; autolysin, pneumolysin, and pneumococcal surface protein A (PspA) based on rigid docking studies. Our results suggest that the hybrid peptides could be suitable candidates for antibacterial drug development.	[Jindal, Hassan Mahmood; Yusof, Mohd Yasim Mohd; Velayuthan, Rukumani Devi; Sekaran, Shamala Devi] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia; [Le, Cheng Foh] Fac Sci, Sch Pharm, Semenyih 43500, Selangor, Malaysia; [Lee, Vannajan Sanghiran; Zain, Sharifuddin Md; Isa, Diyana Mohd] Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya	Sekaran, SD (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia.	shamalamy@yahoo.com	Devi, Shamala Devi/B-9735-2010; Jindal, Hassan/AAD-3807-2022; Sekaran, Shamala Devi/B-8482-2008; Lee, Vannajan Sanghiran/AAX-5564-2020	Devi, Shamala Devi/0000-0002-0478-0425; Sekaran, Shamala Devi/0000-0002-0478-0425; Jindal, Hassan/0000-0002-0788-3753; Le, Cheng Foh/0000-0002-2295-6690	University of Malaya High Impact Research grant [UM.C/HIR/MOHE/MED/40, H-848 20001-E000079]; University of Malaya Research Grant (UMRG Project) [RP020C-14AFR, RP001C-13ICT]	University of Malaya High Impact Research grant; University of Malaya Research Grant (UMRG Project)	This study was supported by University of Malaya High Impact Research grant (reference number: UM.C/HIR/MOHE/MED/40, account number: H-848 20001-E000079) and University of Malaya Research Grant (UMRG Project no. RP020C-14AFR and RP001C-13ICT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljunid S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-248; ALONSODEVELASCO E, 1995, MICROBIOL REV, V59, P591, DOI 10.1128/MMBR.59.4.591-603.1995; [Anonymous], 2009, DISC STUD VERS 2 5 5; Badosa E, 2007, PEPTIDES, V28, P2276, DOI 10.1016/j.peptides.2007.09.010; Beisswenger C, 2005, CURR PROTEIN PEPT SC, V6, P255, DOI 10.2174/1389203054065428; Bravo LC, 2009, VACCINE, V27, P7282, DOI 10.1016/j.vaccine.2009.04.046; Brogden NK, 2011, INT J ANTIMICROB AG, V38, P217, DOI 10.1016/j.ijantimicag.2011.05.004; Cao J, 2007, VACCINE, V25, P4996, DOI 10.1016/j.vaccine.2007.04.069; Chaibou Y, 2014, MED MALADIES INFECT, V44, P117, DOI 10.1016/j.medmal.2014.01.014; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; CLARK DP, 1994, J BIOL CHEM, V269, P10849; Clinical and Laboratory Standards Institute, 2012, METHODS DILUTION ANT, V9th; Deslouches B, 2005, ANTIMICROB AGENTS CH, V49, P316, DOI 10.1128/AAC.49.1.316-322.2005; Duval E, 2009, PEPTIDES, V30, P1608, DOI 10.1016/j.peptides.2009.06.022; Falla TJ, 1997, ANTIMICROB AGENTS CH, V41, P771, DOI 10.1128/AAC.41.4.771; Fehri LF, 2007, ANTIMICROB AGENTS CH, V51, P468, DOI 10.1128/AAC.01030-06; Giacometti A, 1999, J ANTIMICROB CHEMOTH, V44, P641, DOI 10.1093/jac/44.5.641; Hara S, 2008, BIOCHEM BIOPH RES CO, V374, P709, DOI 10.1016/j.bbrc.2008.07.093; Hirst RA, 2004, CLIN EXP IMMUNOL, V138, P195, DOI 10.1111/j.1365-2249.2004.02611.x; Hirst RA, 2008, J INFECT DIS, V197, P744, DOI 10.1086/527322; Jabes D, 2011, ANTIMICROB AGENTS CH, V55, P1671, DOI 10.1128/AAC.01288-10; Jauneikaite E, 2012, VACCINE, V30, P3503, DOI 10.1016/j.vaccine.2012.03.066; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kaur H, 2007, PROTEIN PEPTIDE LETT, V14, P626; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li LR, 2013, APPL MICROBIOL BIOT, V97, P1711, DOI 10.1007/s00253-012-4352-1; Lin MC, 2013, PEPTIDES, V44, P139, DOI 10.1016/j.peptides.2013.04.004; Lin TY, 2010, VACCINE, V28, P7589, DOI 10.1016/j.vaccine.2010.07.053; Liu ZG, 2007, ANTIMICROB AGENTS CH, V51, P597, DOI 10.1128/AAC.00828-06; Lohner K, 1997, BIOCHEMISTRY-US, V36, P1525, DOI 10.1021/bi961300p; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Matsuzaki K, 2009, BBA-BIOMEMBRANES, V1788, P1687, DOI 10.1016/j.bbamem.2008.09.013; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; MOMANY FA, 1992, J COMPUT CHEM, V13, P888, DOI 10.1002/jcc.540130714; Moschioni M, 2012, VACCINE, V30, P1349, DOI 10.1016/j.vaccine.2011.12.080; Nusslein K, 2006, MICROBIOL-SGM, V152, P1913, DOI 10.1099/mic.0.28812-0; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Rekdal O, 2012, J BIOL CHEM, V287, P233, DOI 10.1074/jbc.M111.279281; Ren B, 2012, CLIN VACCINE IMMUNOL, V19, P1574, DOI 10.1128/CVI.00393-12; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sanchez-Vasquez L, 2013, BBA-GEN SUBJECTS, V1830, P3427, DOI 10.1016/j.bbagen.2013.01.028; Saugar JM, 2006, ANTIMICROB AGENTS CH, V50, P1251, DOI 10.1128/AAC.50.4.1251-1256.2006; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SELSTED ME, 1992, J BIOL CHEM, V267, P4292; Serrano GN, 2009, ANTIMICROB AGENTS CH, V53, P2215, DOI 10.1128/AAC.01100-08; SIPPL MJ, 1993, J COMPUT AID MOL DES, V7, P473, DOI 10.1007/BF02337562; Staples M, 2014, DIAGN MICR INFEC DIS, V78, P307, DOI 10.1016/j.diagmicrobio.2013.11.017; Sun H, 2008, J BIOL CHEM, V283, P22233, DOI 10.1074/jbc.M802074200; Tachi T, 2002, BIOCHEMISTRY-US, V41, P10723, DOI 10.1021/bi0256983; Tian ZG, 2009, APPL MICROBIOL BIOT, V82, P1097, DOI 10.1007/s00253-008-1839-x; Torcato IM, 2013, BBA-BIOMEMBRANES, V1828, P944, DOI 10.1016/j.bbamem.2012.12.002; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Urban E, 2007, INT J ANTIMICROB AG, V29, P317, DOI 10.1016/j.ijantimicag.2006.09.007; Vaara M, 2009, CURR OPIN PHARMACOL, V9, P571, DOI 10.1016/j.coph.2009.08.002; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang KR, 2013, PEPTIDES, V39, P80, DOI 10.1016/j.peptides.2012.11.002; Wilkins MR, 1999, METH MOL B, V112, P531; Xi D, 2013, PROCESS BIOCHEM, V48, P453, DOI 10.1016/j.procbio.2013.01.008; Yang ST, 2006, INT J ANTIMICROB AG, V27, P325, DOI 10.1016/j.ijantimicag.2005.11.014; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zhu WL, 2006, BIOCHEMISTRY-US, V45, P13007, DOI 10.1021/bi060487+	65	55	58	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128532	10.1371/journal.pone.0128532	http://dx.doi.org/10.1371/journal.pone.0128532			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046345	Green Submitted, gold, Green Published			2022-12-27	WOS:000355652200073
J	Krause, BJ; Carrasco-Wong, I; Dominguez, A; Arnaiz, P; Farias, M; Barja, S; Mardones, F; Casanello, P				Krause, Bernardo J.; Carrasco-Wong, Ivo; Dominguez, Angelica; Arnaiz, Pilar; Farias, Marcelo; Barja, Salesa; Mardones, Francisco; Casanello, Paola			Micro-RNAs Let7e and 126 in Plasma as Markers of Metabolic Dysfunction in 10 to 12 Years Old Children	PLOS ONE			English	Article							CIRCULATING MICRORNAS; PERIPHERAL-BLOOD; MESSENGER-RNAS; BIOMARKERS; EXPRESSION; MIRNA; HYPERTENSION; INFLAMMATION; PROGRESSION; SIGNATURES	Background Growing evidence shows that metabolic syndrome (MetS) is already starting in childhood however there is no consensus regarding how to diagnose this condition in pediatric population. Studies in adults show that altered levels of specific micro-RNAs are related with components of the MetS. Objective We determined the plasma levels of four MetS-associated micro-RNAs (miR-126, miR-132, mir-145 and Let-7e) in 10 to 12 years old children with or without MetS traits. Design Pediatric subjects were selected from a cohort of 3325 school-age children, and clustered by the absence (control, n = 30), or the presence of 1 (n = 50), 2 (n = 41) or 3 (n = 35) MetS traits according to Cook's criteria. Micro-RNAs were isolated from plasma, and levels of miR-126, miR-132, miR-145 and Let-7e were determined by Taqman qPCR. Results Regression analysis of the different MetS traits regarding the different miRNAs analyzed showed that Let-7e presented a negative association with HDL-C levels, but a positive correlation with the number of MetS traits. Levels of miR-126 presented a positive correlation with waist circumference, waist to hip ratio, BMI, and plasma triglycerides and VLDL-C. Levels of miR-132 showed a positive correlation with waist to hip ratio. Plasma levels of Let-7e were increased (similar to 3.4 fold) in subjects with 3 MetS traits, and showed significant AUC (0.681; 95%CI = [0.58, 0.78]; p < 0.001) in the ROC analysis which were improved when miR-126 was included in the analysis (AUC 0.729; p < 0.001). In silico analysis of the interaction of proteins derived from mRNAs targeted by Let-7e and miR-126 showed an important effect of both Let-7e and miR-126 regulating the insulin signaling pathway. Conclusions These results suggest that changes in the plasma levels of Let-7e and miR-126 could represent early markers of metabolic dysfunction in children with MetS traits.	[Krause, Bernardo J.; Carrasco-Wong, Ivo; Farias, Marcelo; Casanello, Paola] Pontificia Univ Catolica Chile, Sch Med, Div Obstet & Gynecol, Santiago, Chile; [Dominguez, Angelica; Mardones, Francisco] Pontificia Univ Catolica Chile, Fac Med, Dept Publ Hlth, Santiago, Chile; [Arnaiz, Pilar; Barja, Salesa; Casanello, Paola] Pontificia Univ Catolica Chile, Fac Med, Div Pediat, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Casanello, P (corresponding author), Pontificia Univ Catolica Chile, Sch Med, Div Obstet & Gynecol, Alameda 340, Santiago, Chile.	pcasane@uc.cl	Casanello, Paola/X-7443-2019; Barja, Salesa/AGU-0677-2022; Dominguez, Angelica/HCI-9469-2022; Carrasco-Wong, Ivo/S-5521-2019; Mardones, Francisco/I-1691-2016; Farias, Marcelo/R-6063-2019; Krause, Bernardo J/F-4977-2013	Casanello, Paola/0000-0002-2355-1476; Barja, Salesa/0000-0001-8583-188X; Dominguez, Angelica/0000-0001-7477-7574; Carrasco-Wong, Ivo/0000-0003-1020-734X; Mardones, Francisco/0000-0002-0905-9493; Farias, Marcelo/0000-0003-0473-2295; Krause, Bernardo J/0000-0002-3563-6143	Direccion Investigacion de la Escuela de Medicina, Pontificia Universidad Catolica de Chile [PI 07-12]; Vicerrectoria de Investigacion Pontificia Universidad Catolica de Chile [VRI 1898]; Fondo Nacional de Desarrollo Cientifico y Tegnologico, FONDECYT Chile [1090594, 1120928, 1130801]	Direccion Investigacion de la Escuela de Medicina, Pontificia Universidad Catolica de Chile; Vicerrectoria de Investigacion Pontificia Universidad Catolica de Chile; Fondo Nacional de Desarrollo Cientifico y Tegnologico, FONDECYT Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Direccion de Investigacion de la Escuela de Medicina, Pontificia Universidad Catolica de Chile, PI 07-12 (http://medicina.uc.cl/concursos/inv-cfp). Vicerrectoria de Investigacion Pontificia Universidad Catolica de Chile, VRI 1898 (http://investigacion.uc.cl/Fondos-concursables/fondos-concursables.html). Fondo Nacional de Desarrollo Cientifico y Tegnologico, FONDECYT Chile 1090594, 1120928, 1130801 (http://www.conicyt.cl/fondecyt/).	Bruce KD, 2010, J NUTR, V140, P648, DOI 10.3945/jn.109.111179; Carolan E, 2014, J CLIN ENDOCR METAB, V99, pE474, DOI 10.1210/jc.2013-3529; Chen PY, 2012, CELL REP, V2, P1684, DOI 10.1016/j.celrep.2012.10.021; Chu CY, 2007, J CELL PHYSIOL, V213, P412, DOI 10.1002/jcp.21230; de Boer HC, 2013, EUR HEART J, V34, P3451, DOI 10.1093/eurheartj/eht007; DeBoer MD, 2013, NUTRITION, V29, P379, DOI 10.1016/j.nut.2012.07.003; Dickinson BA, 2013, EUR J HEART FAIL, V15, P650, DOI 10.1093/eurjhf/hft018; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; Gao W, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-55; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; Heneghan HM, 2011, J CLIN ENDOCR METAB, V96, pE846, DOI 10.1210/jc.2010-2701; Hulsmans M, 2013, CARDIOVASC RES, V100, P7, DOI 10.1093/cvr/cvt161; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Karolina DS, 2012, J CLIN ENDOCR METAB, V97, pE2271, DOI 10.1210/jc.2012-1996; Li SQ, 2011, CIRCULATION, V124, P175, DOI 10.1161/CIRCULATIONAHA.110.012237; Liao XY, 2013, J CELL SCI, V126, P3848, DOI 10.1242/jcs.123570; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Marcovecchio ML, 2013, CURR DIABETES REP, V13, P56, DOI 10.1007/s11892-012-0331-2; Mardones F, 2013, CHILE NUTRICION HOSP; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Meder B, 2011, BASIC RES CARDIOL, V106, P13, DOI 10.1007/s00395-010-0123-2; Mozumdar A, 2011, DIABETES CARE, V34, P216, DOI 10.2337/dc10-0879; Muller G, 2012, DIABET METAB SYND OB, V5, P247, DOI 10.2147/DMSO.S32923; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Nazari-Jahantigh M, 2012, THROMB HAEMOSTASIS, V107, P611, DOI 10.1160/TH11-12-0826; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Olivieri Fabiola, 2013, Frontiers in Genetics, V4, P121, DOI 10.3389/fgene.2013.00121; Perez LM, 2013, DIABETES, V62, P2368, DOI 10.2337/db12-1220; Polikepahad S, 2010, J BIOL CHEM, V285, P30139, DOI 10.1074/jbc.M110.145698; Prats-Puig A, 2013, J CLIN ENDOCR METAB, V98, pE1655, DOI 10.1210/jc.2013-1496; Ramasamy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121401; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Takwi AAL, 2012, EMBO MOL MED, V4, P896, DOI 10.1002/emmm.201101045; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Empel VPM, 2012, CURR HYPERTENS REP, V14, P498, DOI 10.1007/s11906-012-0310-7; Vanagas Giedrius, 2004, Interact Cardiovasc Thorac Surg, V3, P319, DOI 10.1016/j.icvts.2004.01.008; Wei YY, 2013, AM J PHYSIOL-HEART C, V304, pH1050, DOI 10.1152/ajpheart.00267.2012; Weiss R, 2013, ANN NY ACAD SCI, V1281, P123, DOI 10.1111/nyas.12030; Willeit P, 2013, CIRC RES, V112, P595, DOI 10.1161/CIRCRESAHA.111.300539; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	48	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128140	10.1371/journal.pone.0128140	http://dx.doi.org/10.1371/journal.pone.0128140			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046362	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200043
J	Le Gallic, C; Phalente, Y; Manens, L; Dublineau, I; Benderitter, M; Gueguen, Y; Lehoux, S; Ebrahimian, TG				Le Gallic, Clelia; Phalente, Yohann; Manens, Line; Dublineau, Isabelle; Benderitter, Marc; Gueguen, Yann; Lehoux, Stephanie; Ebrahimian, Teni G.			Chronic Internal Exposure to Low Dose Cs-137 Induces Positive Impact on the Stability of Atherosclerotic Plaques by Reducing Inflammation in ApoE(-/-) Mice	PLOS ONE			English	Article							IONIZING-RADIATION; MATRIX METALLOPROTEINASES; ACTIVATED MACROPHAGES; CHRONIC INGESTION; GENE-EXPRESSION; X-IRRADIATION; MAYAK PA; LESIONS; CELLS; RADIOTHERAPY	After Chernobyl and Fukushima Dai Chi, two major nuclear accidents, large amounts of radionuclides were released in the environment, mostly caesium 137 (Cs-137). Populations living in contaminated territories are chronically exposed to radionuclides by ingestion of contaminated food. However, questions still remain regarding the effects of low dose ionizing radiation exposure on the development and progression of cardiovascular diseases. We therefore investigated the effects of a chronic internal exposure to Cs-137 on atherosclerosis in predisposed ApoE(-/-) mice. Mice were exposed daily to 0, 4, 20 or 100 kBq/l Cs-137 in drinking water, corresponding to range of concentrations found in contaminated territories, for 6 or 9 months. We evaluated plaque size and phenotype, inflammatory profile, and oxidative stress status in different experimental groups. Results did not show any differences in atherosclerosis progression between mice exposed to Cs-137 and unexposed controls. However, Cs-137 exposed mice developed more stable plaques with decreased macrophage content, associated with reduced aortic expression of pro-inflammatory factors (CRP, TNF alpha, MCP-1, IFN gamma) and adhesion molecules (ICAM-1, VCAM-1 and E-selectin). Lesions of mice exposed to Cs-137 were also characterized by enhanced collagen and smooth muscle cell content, concurrent with reduced matrix metalloproteinase MMP8 and MMP13 expression. These results suggest that low dose chronic exposure of 137Cs in ApoE(-/-) mice enhances atherosclerotic lesion stability by inhibiting pro-inflammatory cytokine and MMP production, resulting in collagen-rich plaques with greater smooth muscle cell and less macrophage content.	[Le Gallic, Clelia; Phalente, Yohann; Manens, Line; Dublineau, Isabelle; Benderitter, Marc; Gueguen, Yann; Ebrahimian, Teni G.] IRSN, Inst Radioprotect & Surete Nucl, Lab RadioToxicol Expt, F-92262 Fontenay Aux Roses, France; [Lehoux, Stephanie] McGill Univ, Lady Davis Inst, Montreal, PQ, Canada	Lady Davis Institute; McGill University	Ebrahimian, TG (corresponding author), IRSN, Inst Radioprotect & Surete Nucl, Lab RadioToxicol Expt, F-92262 Fontenay Aux Roses, France.	teni.ebrahimian@irsn.fr		GUEGUEN, Yann/0000-0002-6234-2888	Electricite de France (EDF)	Electricite de France (EDF)(Electricite de France (EDF))	This work was supported by grants from Electricite de France (EDF) but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa Masanori, 2004, Semin Vasc Med, V4, P357, DOI 10.1055/s-2004-869592; AMENTO EP, 1991, ARTERIOSCLER THROMB, V11, P1223, DOI 10.1161/01.ATV.11.5.1223; ANGELINI A, 1985, INT J CARDIOL, V9, P371, DOI 10.1016/0167-5273(85)90034-8; [Anonymous], 2006, CHERN FOR GROUP ENV; Arenas M, 2012, STRAHLENTHER ONKOL, V188, P975, DOI 10.1007/s00066-012-0170-8; Azizova TV, 2010, RADIAT RES, V174, P851, DOI 10.1667/RR1928.1; Azizova TV, 2010, RADIAT RES, V174, P155, DOI 10.1667/RR1789.1; Bandazhevskaya GS, 2004, SWISS MED WKLY, V134, P725; Bandazhevsky YI, 2003, SWISS MED WKLY, V133, P488; Bashar K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110389; Bertho JM, 2012, RADIOPROTECTION, V47, P219, DOI 10.1051/radiopro/2011161; Bertho JM, 2011, J RADIOL PROT, V31, P25, DOI 10.1088/0952-4746/31/1/001; Bertho JM, 2010, RADIAT ENVIRON BIOPH, V49, P239, DOI 10.1007/s00411-010-0267-3; Bilora F, 2006, TUMORI, V92, P295, DOI 10.1177/030089160609200406; BURLEIGH MC, 1992, ATHEROSCLEROSIS, V96, P71, DOI 10.1016/0021-9150(92)90039-J; Calabrese EJ, 2011, MUTAT RES-GEN TOX EN, V726, P91, DOI 10.1016/j.mrgentox.2011.04.006; Cervelli T, 2014, ATHEROSCLEROSIS, V235, P510, DOI 10.1016/j.atherosclerosis.2014.05.932; Cozlea D L, 2013, Curr Health Sci J, V39, P225; Cwikel J G, 1997, Public Health Rev, V25, P317; Dam K, 1998, DEV BRAIN RES, V108, P39, DOI 10.1016/S0165-3806(98)00028-5; Daugherty Alan, 2003, Methods Mol Biol, V209, P293; Dublineau I, 2007, J TOXICOL ENV HEAL A, V70, P810, DOI 10.1080/15287390701209113; DUNSMORE LD, 1986, J AM COLL CARDIOL, V8, P239, DOI 10.1016/S0735-1097(86)80120-6; Falk E, 2007, ARTERIOSCL THROM VAS, V27, P248, DOI 10.1161/01.ATV.0000249644.86759.81; Frey B, 2009, AUTOIMMUNITY, V42, P346, DOI 10.1080/08916930902831738; Gabriels K, 2014, RADIOTHER ONCOL, V110, P455, DOI 10.1016/j.radonc.2014.01.006; GALIS ZS, 1994, CIRC RES, V75, P181, DOI 10.1161/01.RES.75.1.181; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Gaugler MH, 2010, M S-MED SCI, V26, P740, DOI 10.1051/medsci/2010268-9740; Gorenne I, 2006, CARDIOVASC RES, V72, P9, DOI 10.1016/j.cardiores.2006.06.004; Gueguen Y, 2008, CARDIOVASC TOXICOL, V8, P33, DOI 10.1007/s12012-008-9013-3; Gujral DM, 2014, RADIOTHER ONCOL, V110, P31, DOI 10.1016/j.radonc.2013.08.009; Handl J, 2003, HEALTH PHYS, V84, P502, DOI 10.1097/00004032-200304000-00010; Hildebrandt G, 2003, INT J RADIAT BIOL, V79, P993, DOI 10.1080/09553000310001636639; Hildebrandt G, 1998, INT J RADIAT BIOL, V74, P367, DOI 10.1080/095530098141500; Hoshi M, 2000, HEALTH PHYS, V79, P182, DOI 10.1097/00004032-200008000-00011; Hoving S, 2008, INT J RADIAT ONCOL, V71, P848, DOI 10.1016/j.ijrobp.2008.02.031; Joven J, 2007, ATHEROSCLEROSIS, V195, pE85, DOI 10.1016/j.atherosclerosis.2007.06.012; Kataoka T, 2013, J RADIAT RES, V54, P587, DOI 10.1093/jrr/rrs141; Kaul Alexander, 2008, Annals of the ICRP, V38, P1; Kern PM, 2000, RADIOTHER ONCOL, V54, P273, DOI 10.1016/S0167-8140(00)00141-9; Khartchenko V. P., 2001, Meditsina Truda i Promyshlennaya Ekologiya, P29; Klug F, 2013, CANCER CELL, V24, P589, DOI 10.1016/j.ccr.2013.09.014; Kovaleva L I, 1992, Gig Tr Prof Zabol, P15; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2000, J INTERN MED, V247, P349, DOI 10.1046/j.1365-2796.2000.00654.x; Little MP, 2008, RADIAT RES, V169, P99, DOI 10.1667/RR1070.1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodermann B, 2012, INT J RADIAT BIOL, V88, P727, DOI 10.3109/09553002.2012.689464; MCREYNOLDS RA, 1976, AM J MED, V60, P39, DOI 10.1016/0002-9343(76)90531-3; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; Mitchel REJ, 2011, RADIAT RES, V175, P665, DOI 10.1667/RR2176.1; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Okishio Y, 2000, EUR J PHARMACOL, V388, P97, DOI 10.1016/S0014-2999(99)00856-0; Pakala Rajbabu, 2003, Cardiovasc Radiat Med, V4, P146, DOI 10.1016/S1522-1865(03)00182-3; Park BS, 2013, RADIAT RES, V179, P570, DOI 10.1667/RR3082.1; Puhakainen M, 2003, RADIAT PROT DOSIM, V103, P255, DOI 10.1093/oxfordjournals.rpd.a006141; Randolph GJ, 2013, NAT MED, V19, P1094, DOI 10.1038/nm.3316; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Schaue D, 2002, INT J RADIAT BIOL, V78, P567, DOI 10.1080/09553000210126457; Schiller NK, 2004, J LIPID RES, V45, P1398, DOI 10.1194/jlr.M400036-JLR200; Shao ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092574; Stewart FA, 2006, AM J PATHOL, V168, P649, DOI 10.2353/ajpath.2006.050409; Thalhammer C, 2015, VASA, V44, P23, DOI 10.1024/0301-1526/a000403; Trott K.-R., 1995, Strahlentherapie und Onkologie, V171, P534; Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; von Pannewitz G, 1970, Radiologe, V10, P51; Vykhovanets EV, 2000, RADIAT RES, V153, P760, DOI 10.1667/0033-7587(2000)153[0760:AOBLSI]2.0.CO;2; Weissberg PL, 1996, LANCET, V347, P305, DOI 10.1016/S0140-6736(96)90472-9; Wethal T, 2014, RADIOTHER ONCOL, V110, P448, DOI 10.1016/j.radonc.2013.10.029; Whitman SC, 2000, AM J PATHOL, V157, P1819, DOI 10.1016/S0002-9440(10)64820-1; Wong FL, 1999, RADIAT RES, V151, P736, DOI 10.2307/3580213; Wunderlich R, 2015, CLIN EXP IMMUNOL, V179, P50, DOI 10.1111/cei.12344; Yentrapalli R, 2013, PROTEOMICS, V13, P1096, DOI 10.1002/pmic.201200463; Yu T, 2011, RADIAT RES, V175, P766, DOI 10.1667/RR2482.1; Zhang C, 2011, RADIAT RES, V175, P307, DOI 10.1667/RR1950.1	78	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128539	10.1371/journal.pone.0128539	http://dx.doi.org/10.1371/journal.pone.0128539			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046630	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200075
J	Shastri, MD; Stewart, N; Horne, J; Zaidi, STR; Sohal, SS; Peterson, GM; Korner, H; Gueven, N; Patel, RP				Shastri, Madhur D.; Stewart, Niall; Horne, James; Zaidi, Syed Tabish R.; Sohal, Sukhwinder Singh; Peterson, Gregory M.; Korner, Heinrich; Gueven, Nuri; Patel, Rahul P.			Non-Anticoagulant Fractions of Enoxaparin Suppress Inflammatory Cytokine Release from Peripheral Blood Mononuclear Cells of Allergic Asthmatic Individuals	PLOS ONE			English	Article							LOW-MOLECULAR-WEIGHT; FIBROBLAST-GROWTH-FACTOR; AIRWAY SMOOTH-MUSCLE; STRUCTURAL DETERMINANTS; HEPARAN-SULFATE; T-CELLS; ACTIVATION; BRONCHOCONSTRICTION; GLYCOSAMINOGLYCANS; 6-O-SULFATION	Background Enoxaparin, a low-molecular-weight heparin, is known to possess anti-inflammatory properties. However, its clinical exploitation as an anti-inflammatory agent is hampered by its anticoagulant effect and the associated risk of bleeding. Objective The aim of the current study was to examine the ability of non-anticoagulant fractions of enoxaparin to inhibit the release of key inflammatory cytokines in primed peripheral blood mononuclear cells derived from allergic mild asthmatics. Methods Peripheral blood mononuclear cells from allergic asthmatics were activated with phytohaemag glutinin (PHA), concanavalin-A (ConA) or phorbol 12-myristate 13-acetate (PMA) in the presence or absence of enoxaparin fractions before cytokine levels were quantified using specific cytokine bead arrays. Together with nuclear magnetic resonance analysis, time-dependent and target-specific effects of enoxaparin fractions were used to elucidate structural determinants for their anti-inflammatory effect and gain mechanistic insights into their anti-inflammatory activity. Results Two non-anticoagulant fractions of enoxaparin were identified that significantly inhibited T-cell activation. A disaccharide fraction of enoxaparin inhibited the release of IL-4, IL-5, IL-13 and TNF-alpha by more than 57% while a tetrasaccharide fraction was found to inhibit the release of tested cytokines by more than 68%. Our data suggest that the observed response is likely to be due to an interaction of 6-O-sulfated tetrasaccharide with cellular receptor(s). Conclusion and Clinical Relevance The two identified anti-inflammatory fractions lacked anticoagulant activity and are therefore not associated with risk of bleeding. The findings highlight the potential therapeutic use of enoxaparin-derived fractions, in particular tetrasaccharide, in patients with chronic inflammatory disorders.	[Shastri, Madhur D.; Stewart, Niall; Zaidi, Syed Tabish R.; Peterson, Gregory M.; Gueven, Nuri; Patel, Rahul P.] Univ Tasmania, Fac Hlth, Sch Med, Pharm, Hobart, Tas, Australia; [Horne, James] Univ Tasmania, Cent Sci Lab, Hobart, Tas, Australia; [Korner, Heinrich] Univ Tasmania, Fac Hlth, Menzies Inst Med Res, Hobart, Tas, Australia; [Sohal, Sukhwinder Singh; Peterson, Gregory M.] Univ Tasmania, Sch Med, Fac Hlth, Breathe Well Ctr Res Excellence Chron Resp Dis &, Hobart, Tas, Australia	University of Tasmania; University of Tasmania; University of Tasmania; Menzies Institute for Medical Research; University of Tasmania	Patel, RP (corresponding author), Univ Tasmania, Fac Hlth, Sch Med, Pharm, Hobart, Tas, Australia.	Rahul.Patel@utas.edu.au	Korner, Heinrich/D-9970-2014; Zaidi, Syed Tabish R./J-7336-2014	Korner, Heinrich/0000-0003-4610-2814; Patel, Rahul/0000-0001-9344-1013; Peterson, Gregory/0000-0002-6764-3882; Sohal, Sukhwinder Singh/0000-0001-9627-6498; Shastri, Madhur/0000-0002-1012-2779; Zaidi, Syed Tabish R./0000-0002-2031-1055; Horne, James/0000-0002-1935-2378; Guven, Nuri/0000-0003-3782-767X	Royal Hobart Hospital Research Foundation, Australia [H22074]; University of Tasmania, Australia [105557]	Royal Hobart Hospital Research Foundation, Australia; University of Tasmania, Australia	This work was supported by the Starter Grant from Royal Hobart Hospital Research Foundation, Australia (Grant Number- H22074) awarded to NS, RP and MS (http://www.rhhresearchfoundation. org/index.php/site/research/), Research Enhancement Grant Schemes from University of Tasmania, Australia (Grant Number- 105557) awarded to RP and NG (http://www.utas.edu.au/research-admin/funding/funding-options/internal-funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 1999, AM J RESP CRIT CARE, V160, P576, DOI 10.1164/ajrccm.160.2.9812076; AHMED T, 1993, NEW ENGL J MED, V329, P90, DOI 10.1056/NEJM199307083290204; Baram D, 1997, CLIN EXP IMMUNOL, V110, P485, DOI 10.1046/j.1365-2249.1997.4541471.x; Barblu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032874; Barnes PJ, 1998, J ALLERGY CLIN IMMUN, V102, P531, DOI 10.1016/S0091-6749(98)70268-4; Bloemen K, 2007, IMMUNOL LETT, V113, P6, DOI 10.1016/j.imlet.2007.07.010; Bluestone JA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007542; Bousquet J, 2008, EXPERT OPIN BIOL TH, V8, P1921, DOI [10.1517/14712590802496928, 10.1517/14712590802496928 ]; Boxall C, 2006, EUR RESPIR J, V27, P208, DOI 10.1183/09031936.06.00130004; CASTELLOT JJ, 1984, J CELL PHYSIOL, V120, P315, DOI 10.1002/jcp.1041200309; Chwae YJ, 2002, J IMMUNOL, V169, P3726, DOI 10.4049/jimmunol.169.7.3726; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; den Dekker E, 2008, J IMMUNOL, V180, P3680, DOI 10.4049/jimmunol.180.6.3680; DIAMOND MS, 1995, J CELL BIOL, V130, P1473, DOI 10.1083/jcb.130.6.1473; Faustino L, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/721817; FRIBERG D, 1994, CLIN DIAGN LAB IMMUN, V1, P261, DOI 10.1128/CDLI.1.3.261-268.1994; Fryer A, 1997, J PHARMACOL EXP THER, V282, P208; HAAHTELA T, 1994, NEW ENGL J MED, V331, P700, DOI 10.1056/NEJM199409153311103; Hochart H, 2006, BRIT J HAEMATOL, V133, P62, DOI 10.1111/j.1365-2141.2006.05959.x; Iraji Fariba, 2013, Adv Biomed Res, V2, P76, DOI 10.4103/2277-9175.115798; Kanabar V, 2008, BRIT J PHARMACOL, V154, P833, DOI 10.1038/bjp.2008.109; Kanabar V, 2005, BRIT J PHARMACOL, V146, P370, DOI 10.1038/sj.bjp.0706333; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kilpatrick D, 1995, LECTINS BIOMEDICAL P, P131; Koller M, 2001, INFLAMMATION, V25, P331, DOI 10.1023/A:1012883916991; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; Ludwig Ralf J, 2009, Curr Drug Discov Technol, V6, P281; LUKACS NW, 1995, J IMMUNOL, V154, P5411; Luo YD, 2003, J PHARM SCI-US, V92, P2117, DOI 10.1002/jps.10472; Ma Q, 2007, CURR PHARM DESIGN, V13, P1607, DOI 10.2174/138161207780765918; MILNER SM, 1977, NATURE, V268, P441, DOI 10.1038/268441a0; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Patel RP, 2009, J PHARM SCI-US, V98, P1700, DOI 10.1002/jps.21556; Pelaia G, 2012, NAT REV DRUG DISCOV, V11, P958, DOI 10.1038/nrd3792; Perrin PJ, 1997, IMMUNOLOGY, V90, P534, DOI 10.1046/j.1365-2567.04.00215.x; Peters SP, 2006, RESP MED, V100, P1139, DOI 10.1016/j.rmed.2006.03.031; Roy S, 2011, GLYCOBIOLOGY, V21, P1194, DOI 10.1093/glycob/cwr053; Ruiz-Calero V, 2001, ANALYST, V126, P169, DOI 10.1039/b007300h; Salas A, 2000, GUT, V47, P88, DOI 10.1136/gut.47.1.88; Sharek PJ, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.1.e8; Shastri MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118798; Shastri MD, 2014, EXPERT OPIN INV DRUG, V23, P357, DOI 10.1517/13543784.2014.866092; Shastri MD, 2013, ANAL BIOANAL CHEM, V405, P6043, DOI 10.1007/s00216-013-6996-9; Sheng GJ, 2013, J AM CHEM SOC, V135, P10898, DOI 10.1021/ja4027727; Shifren A., 2012, J ALLERGY CAIRO, V2012; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Torkvist L, 1999, ALIMENT PHARM THERAP, V13, P1323; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; Tyrrell DJ, 1999, ADV PHARMACOL, V46, P151, DOI 10.1016/S1054-3589(08)60471-8; VALENTINE MA, 1985, EUR J IMMUNOL, V15, P851, DOI 10.1002/eji.1830150821; Viegas A, 2011, J CHEM EDUC, V88, P990, DOI 10.1021/ed101169t; Vrij AA, 2001, SCAND J GASTROENTERO, V36, P41, DOI 10.1080/003655201753265091; Wang LC, 2002, J CLIN INVEST, V110, P127, DOI 10.1172/JCI200214996; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; WISKOCIL R, 1985, J IMMUNOL, V134, P1599; WRIGHT TC, 1989, J BIOL CHEM, V264, P1534; Yang B, 2011, ANAL BIOANAL CHEM, V399, P541, DOI 10.1007/s00216-010-4117-6; Young E, 2008, THROMB RES, V122, P743, DOI 10.1016/j.thromres.2006.10.026; Zhang SY, 2012, J BIOL CHEM, V287, P5542, DOI 10.1074/jbc.M111.314716	59	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128803	10.1371/journal.pone.0128803	http://dx.doi.org/10.1371/journal.pone.0128803			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046354	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200103
J	Singh, R; Hassan, MI; Islam, A; Ahmad, F				Singh, Ritu; Hassan, Md. Imtaiyaz; Islam, Asimul; Ahmad, Faizan			Cooperative Unfolding of Residual Structure in Heat Denatured Proteins by Urea and Guanidinium Chloride	PLOS ONE			English	Article							FREE-ENERGY CHANGES; LINEAR EXTRAPOLATION METHOD; ALPHA-LACTALBUMIN; RIBONUCLEASE-A; SECONDARY STRUCTURE; STABILITY; STATES; LYSOZYME; CONFORMATION; EQUILIBRIUM	The denatured states of proteins have always attracted our attention due to the fact that the denatured state is the only experimentally achievable state of a protein, which can be taken as initial reference state for considering the in vitro folding and defining the native protein stability. It is known that heat and guanidinium chloride (GdmCl) give structurally different states of RNase-A, lysozyme, alpha-chymotrypsinogen A and alpha-lactalbumin. On the contrary, differential scanning calorimetric (DSC) and isothermal titration calorimetric measurements, reported in the literature, led to the conclusion that heat denatured and GdmCl denatured states are thermodynamically and structurally identical. In order to resolve this controversy, we have measured changes in the far-UV CD (circular dichroism) of these heat-denatured proteins on the addition of different concentrations of GdmCl. The observed sigmoidal curve of each protein was analyzed for Gibbs free energy change in the absence of the denaturant (Delta G(X-->D)(0)) associated with the process heat denatured (X) state <-> GdmCl denatured (D) state. To confirm that this thermodynamic property represents the property of the protein alone and is not a manifestation of salvation effect, we measured urea-induced denaturation curves of these heat denatured proteins under the same experimental condition in which GdmCl-induced denaturation was carried out. In this paper we report that (a) heat denatured proteins contain secondary structure, and GdmCl (or urea) induces a cooperative transition between X and D states, (b) for each protein at a given pH and temperature, thermodynamic cycle connects quantities, Delta G(N-->X)(0) (native (N) state <-> X state), Delta G(X-->D)(0) and Delta G(N-->D)(0) (N state <-> D state), and (c) there is not a good enthalpy difference between X and D states, which is the reason for the absence of endothermic peak in DSC scan for the transition, X state <-> D state.	[Singh, Ritu; Hassan, Md. Imtaiyaz; Islam, Asimul; Ahmad, Faizan] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India	Jamia Millia Islamia	Ahmad, F (corresponding author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.	fahmad@jmi.ac.in	Ahmad, Faizan/AGH-4493-2022; Hassan, Mohammad/GZA-7507-2022; Hassan, Imtaiyaz/ABF-6485-2020; Hassan, Md Imtaiyaz/G-7072-2017; Islam, Asimul/V-4526-2019	Ahmad, Faizan/0000-0001-7021-7502; Hassan, Mohammad/0000-0002-1712-0004; Hassan, Imtaiyaz/0000-0002-3663-4940; Hassan, Md Imtaiyaz/0000-0002-3663-4940; Islam, Asimul/0000-0001-9060-7970	Council of Scientific and Industrial Research, India [37(1237)/05/EMR-II]; Department of Science and Technology, India [SR/SO/BB-80/2004]	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, India(Department of Science & Technology (India))	This work was supported by the Council of Scientific and Industrial Research, India (Grant No. 37(1237)/05/EMR-II) and the Department of Science and Technology, India (Grant No. SR/SO/BB-80/2004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD F, 1991, INDIAN J BIOCHEM BIO, V28, P168; AHMAD F, 1982, J BIOL CHEM, V257, P2935; AHMAD F, 1983, J BIOL CHEM, V258, P7960; AHMAD F, 1992, BIOCHEM J, V287, P481, DOI 10.1042/bj2870481; ANANTHANARAYANAN VS, 1977, BIOCHIM BIOPHYS ACTA, V492, P194, DOI 10.1016/0005-2795(77)90226-4; AUNE KC, 1967, J BIOL CHEM, V242, P4486; Basharov MA, 2012, INDIAN J BIOCHEM BIO, V49, P7; BIGELOW C C, 1960, C R Trav Lab Carlsberg, V31, P305; Bigelow CC, 1964, J MOL BIOL, V8, P696, DOI 10.1016/S0022-2836(64)80118-2; BISMUTO E, 1983, BIOCHEMISTRY-US, V22, P4165, DOI 10.1021/bi00287a001; Chalikian TV, 1997, J MOL BIOL, V274, P237, DOI 10.1006/jmbi.1997.1394; Chiti F, 1998, BIOCHEMISTRY-US, V37, P1447, DOI 10.1021/bi971692f; CONTAXIS CC, 1981, BIOCHEMISTRY-US, V20, P1618, DOI 10.1021/bi00509a032; FABIAN H, 1995, BIOCHEMISTRY-US, V34, P13651, DOI 10.1021/bi00041a046; FABIAN H, 1993, J MOL BIOL, V232, P967, DOI 10.1006/jmbi.1993.1442; FRANKS F, 1995, ADV PROTEIN CHEM, V46, P105, DOI 10.1016/S0065-3233(08)60333-2; Gast K, 1997, FEBS LETT, V403, P245, DOI 10.1016/S0014-5793(97)00058-6; Gupta R, 1996, BIOCHEMISTRY-US, V35, P11925, DOI 10.1021/bi961079g; HALTIA T, 1994, BIOCHEMISTRY-US, V33, P9731, DOI 10.1021/bi00198a044; HAMAGUCHI K, 1963, J BIOCHEM-TOKYO, V54, P111; KUGIMIYA M, 1973, CAN J BIOCHEM CELL B, V51, P581, DOI 10.1139/o73-072; LABHARDT AM, 1982, J MOL BIOL, V157, P331, DOI 10.1016/0022-2836(82)90238-8; McCarney ER, 2005, CRIT REV BIOCHEM MOL, V40, P181, DOI 10.1080/10409230591008143; Nolting B, 1997, BIOCHEMISTRY-US, V36, P9899, DOI 10.1021/bi962879u; Pace C N, 1986, Methods Enzymol, V131, P266; PACE C N, 1975, Critical Reviews in Biochemistry, V3, P1, DOI 10.3109/10409237509102551; Pace CN, 2000, PROTEINS, P1; Pace CN, 1995, METHOD ENZYMOL, V259, P538; PFEIL W, 1976, BIOPHYS CHEM, V4, P33, DOI 10.1016/0301-4622(76)80004-X; Pfeil W., 1998, PROTEIN STABILITY FO; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; PRIVALOV PL, 1989, J MOL BIOL, V205, P737, DOI 10.1016/0022-2836(89)90318-5; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; ROBERTSON AD, 1991, BIOCHEMISTRY-US, V30, P9907, DOI 10.1021/bi00105a014; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SARFARE PS, 1967, CAN J BIOCHEM CELL B, V45, P651, DOI 10.1139/o67-076; SCHELLMAN JA, 1978, BIOPOLYMERS, V17, P1305, DOI 10.1002/bip.1978.360170515; Sedlak E, 2001, BIOCHEMISTRY-US, V40, P9579, DOI 10.1021/bi010274e; SHARMA RN, 1974, J MOL BIOL, V88, P247, DOI 10.1016/0022-2836(74)90308-8; Singh R, 2008, BIOPHYS CHEM, V133, P81, DOI 10.1016/j.bpc.2007.12.006; SUGAI S, 1973, BIOCHIM BIOPHYS ACTA, V328, P35, DOI 10.1016/0005-2795(73)90327-9; TAMURA Y, 1995, BIOCHEMISTRY-US, V34, P1878, DOI 10.1021/bi00006a008; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7; Wilson G, 1996, BIOCHEMISTRY-US, V35, P12518, DOI 10.1021/bi961314v; Yadav S, 2000, ANAL BIOCHEM, V283, P207, DOI 10.1006/abio.2000.4641; YANG JT, 1986, METHOD ENZYMOL, V130, P208	47	23	22	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128740	10.1371/journal.pone.0128740	http://dx.doi.org/10.1371/journal.pone.0128740			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046628	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200095
J	Talmi, D; Caplan, JB; Richards, B; Moscovitch, M				Talmi, Deborah; Caplan, Jeremy B.; Richards, Brian; Moscovitch, Morris			Long-Term Recency in Anterograde Amnesia	PLOS ONE			English	Article							BILATERAL HIPPOCAMPAL-LESIONS; FREE-RECALL; RECOGNITION MEMORY; RETROACTIVE INTERFERENCE; STORAGE MECHANISMS; TEMPORAL-LOBE; RETRIEVAL; RETENTION; REHEARSAL; EXPLICIT	Amnesia is usually described as an impairment of a long-term memory (LTM) despite an intact short-term memory (STM). The intact recency effect in amnesia had supported this view. Although dual-store models of memory have been challenged by single-store models based on interference theory, this had relatively little influence on our understanding and treatment of amnesia, perhaps because the debate has centred on experiments in the neurologically intact population. Here we tested a key prediction of single-store models for free recall in amnesia: that people with amnesia will exhibit a memory advantage for the most recent items even when all items are stored in and retrieved from LTM, an effect called long-term recency. People with amnesia and matched controls studied, and then free-recalled, word lists with a distractor task following each word, including the last (continual distractor task, CDFR). This condition was compared to an Immediate Free Recall (IFR, no distractors) and a Delayed Free Recall (DFR, end-of-list distractor only) condition. People with amnesia demonstrated the full long-term recency pattern: the recency effect was attenuated in DFR and returned in CDFR. The advantage of recency over midlist items in CDFR was comparable to that of controls, confirming a key prediction of single-store models. Memory deficits appeared only after the first word recalled in each list, suggesting the impairment in amnesia may emerge only as the participant's recall sequence develops, perhaps due to increased susceptibility to output interference. Our findings suggest that interference mechanisms are preserved in amnesia despite the overall impairment to LTM, and challenge strict dual-store models of memory and their dominance in explaining amnesia. We discuss the implication of our findings for rehabilitation.	[Talmi, Deborah; Moscovitch, Morris] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Talmi, Deborah] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Caplan, Jeremy B.; Moscovitch, Morris] Baycrest, Rotman Res Inst, Toronto, ON, Canada; [Caplan, Jeremy B.] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [Caplan, Jeremy B.] Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada; [Richards, Brian] Baycrest Ctr Geriatr Care, Dept Psychol, Toronto, ON, Canada	University of Toronto; University of Manchester; University of Toronto; University Toronto Affiliates; Baycrest; University of Alberta; University of Alberta; University of Toronto; University Toronto Affiliates; Baycrest	Talmi, D (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada.	deborah.talmi@manchester.ac.uk			Canadian Institute of Health Research grant [MOP 49566]	Canadian Institute of Health Research grant(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institute of Health Research grant MOP 49566 to MM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson RC, 1968, ADV RES THEOR, DOI [10.1080/0361073X.2012.672131, DOI 10.1080/0361073X.2012.672131]; Baddeley A. D., 1977, ATTENTION PERFORM, V6, P647; BADDELEY AD, 1970, J VERB LEARN VERB BE, V9, P176, DOI 10.1016/S0022-5371(70)80048-2; Banich M.N., 2011, COGNITIVE NEUROSCIEN; BJORK RA, 1974, COGNITIVE PSYCHOL, V6, P173, DOI 10.1016/0010-0285(74)90009-7; BROOKS DN, 1976, NEUROPSYCHOLOGIA, V14, P111, DOI 10.1016/0028-3932(76)90012-9; BROWN GG, 1980, NEUROPSYCHOLOGIA, V18, P185, DOI 10.1016/0028-3932(80)90064-0; Brown GDA, 2007, PSYCHOL REV, V114, P539, DOI 10.1037/0033-295X.114.3.539; Brown GDA, 2007, PSYCHON B REV, V14, P256, DOI 10.3758/BF03194061; CAPITANI E, 1992, CORTEX, V28, P315, DOI 10.1016/S0010-9452(13)80143-8; Carlesimo GA, 1996, NEUROPSYCHOLOGIA, V34, P177, DOI 10.1016/0028-3932(95)00100-X; Cowan N, 2004, BRAIN, V127, P825, DOI 10.1093/brain/awh107; Crowder R.G., 1976, PRINCIPLES LEARNING; CROWDER RG, 1982, ACTA PSYCHOL, V50, P291, DOI 10.1016/0001-6918(82)90044-0; CROWDER RG, 1993, MEM COGNITION, V21, P142, DOI 10.3758/BF03202725; Davelaar EJ, 2005, PSYCHOL REV, V112, P3, DOI 10.1037/0033-295X.112.1.3; Della SS, 2005, MEMORY, V13, P435; Dewar M, 2012, BRAIN COGNITION, V78, P189, DOI 10.1016/j.bandc.2011.12.005; Dewar M, 2010, NEUROPSYCHOLOGY, V24, P357, DOI 10.1037/a0018207; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; GLANZER M, 1966, J VERB LEARN VERB BE, V5, P351, DOI 10.1016/S0022-5371(66)80044-0; GREENE RL, 1986, PSYCHOL BULL, V99, P221, DOI 10.1037/0033-2909.99.2.221; HOGAN RM, 1975, MEM COGNITION, V3, P197, DOI 10.3758/BF03212898; Howard MW, 1999, J EXP PSYCHOL LEARN, V25, P923, DOI 10.1037/0278-7393.25.4.923; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Kahana MJ, 2008, PSYCHOL REV, V115, P1119, DOI 10.1037/a0013724; Kolb B, 2010, INTRO BRAIN BEHAV; Kucera H., 1967, COMPUTATIONAL ANAL P; Laming D, 1999, INT J PSYCHOL, V34, P419, DOI 10.1080/002075999399774; Mayes A, 2007, TRENDS COGN SCI, V11, P126, DOI 10.1016/j.tics.2006.12.003; MAYES AR, 1987, NEUROPSYCHOLOGIA, V25, P211, DOI 10.1016/0028-3932(87)90132-1; McCabe DP, 2011, MEM COGNITION, V39, P389, DOI 10.3758/s13421-010-0040-5; Moscovitch M, 1982, AGING COGNITIVE PROC, P355; MOSCOVITCH M, 1982, HUMAN MEMORY AMNESIA, P337; MURDOCK BB, 1962, J EXP PSYCHOL, V64, P482, DOI 10.1037/h0045106; Polyn SM, 2009, PSYCHOL REV, V116, P129, DOI 10.1037/a0014420; POSTMAN L, 1965, Q J EXP PSYCHOL, V17, P132, DOI 10.1080/17470216508416422; Ranganath C, 2005, TRENDS COGN SCI, V9, P374, DOI 10.1016/j.tics.2005.06.009; Rosenbaum RS, 2005, NEUROPSYCHOLOGIA, V43, P989, DOI 10.1016/j.neuropsychologia.2004.10.007; Ryan L, 2001, MEM COGNITION, V29, P678, DOI 10.3758/BF03200470; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sederberg PB, 2008, PSYCHOL REV, V115, P893, DOI 10.1037/a0013396; Skotko BG, 2004, NEUROPSYCHOLOGY, V18, P756, DOI 10.1037/0894-4105.18.4.756; STRAUSS E, 1991, COMPENDIUM NEUROPSYC; Talmi D, 2006, MEMORY, V14, P424, DOI 10.1080/09658210500426623; Usher M, 2008, PSYCHOL REV, V115, P1108, DOI 10.1037/a0013725; WARRINGTON EK, 1968, NATURE, V217, P972, DOI 10.1038/217972a0; WAUGH NC, 1965, PSYCHOL REV, V72, P89, DOI 10.1037/h0021797; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594; Winocur G, 1996, BRAIN COGNITION, V30, P44, DOI 10.1006/brcg.1996.0004; Yonelinas AP, 2002, PSYCHON B REV, V9, P575, DOI 10.3758/BF03196315	52	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0124084	10.1371/journal.pone.0124084	http://dx.doi.org/10.1371/journal.pone.0124084			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046770	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200006
J	Vuillaume, B; Valette, V; Lepais, O; Grandjean, F; Breuil, M				Vuillaume, Barbara; Valette, Victorien; Lepais, Olivier; Grandjean, Frederic; Breuil, Michel			Genetic Evidence of Hybridization between the Endangered Native Species Iguana delicatissima and the Invasive Iguana iguana (Reptilia, Iguanidae) in the Lesser Antilles: Management Implications	PLOS ONE			English	Article							POPULATION-STRUCTURE; HYBRIDS; PHYLOGEOGRAPHY; MITOCHONDRIAL; CONSERVATION; INFERENCE; SQUAMATA; INSIGHTS	The worldwide increase of hybridization in different groups is thought to have become more important with the loss of isolating barriers and the introduction of invasive species. This phenomenon could result in the extinction of endemic species. This study aims at investigating the hybridization dynamics between the endemic and threatened Lesser Antillean iguana (Iguana delicatissima) and the invasive common green iguana (Iguana iguana) in the Lesser Antilles, as well as assessing the impact of interspecific hybridization on the decline of I. delicatissima. 59 I. delicatissima (5 localities), 47 I. iguana (12 localities) and 27 hybrids (5 localities), who were all identified based on morphological characters, have been genotyped at 15 microsatellites markers. We also sequenced hybrids using ND4 mitochondrial loci to further investigate mitochondrial introgression. The genetic clustering of species and hybrid genetic assignment were performed using a comparative approach, through the implementation of a Discriminant Analysis of Principal Component (DAPC) based on statistics, as well as genetic clustering approaches based on the genetic models of several populations (Structure, NewHybrids and HIest), in order to get full characterization of hybridization patterns and introgression dynamics across the islands. The iguanas identified as hybrids in the wild, thanks to morphological analysis, were all genetically F1, F2, or back-crosses. A high proportion of individuals were also the result of a longer-term admixture. The absence of reproductive barriers between species leads to hybridization when species are in contact. Yet morphological and behavioral differences between species could explain why males I. iguana may dominate I. delicatissima, thus resulting in short-term species displacement and extinction by hybridization and recurrent introgression from I. iguana toward I. delicatissima. As a consequence, I. delicatissima gets eliminated through introgression, as observed in recent population history over several islands. These results have profound implications for species management of the endangered I. delicatissima and practical conservation recommendations are being discussed in the light of these findings.	[Vuillaume, Barbara; Breuil, Michel] Natl Museum Nat Hist, Lab Reptiles & Amphibiens, F-75231 Paris 05, France; [Vuillaume, Barbara] Lab Genindexe, F-17000 La Rochelle, France; [Valette, Victorien; Grandjean, Frederic] Univ Poitiers, UMR CNRS 7267, Lab Ecol & Biol Interact, Equipe Ecol,Evolut,Symbiose, F-86022 Poitiers, France; [Lepais, Olivier] INRA, UMR 1224, Ecol Comportementale & Biol Populat Poissons, St Pee Sur Nivelle, France; [Lepais, Olivier] Univ Pau & Pays Adour, UMR 1224, Ecol Comportementale & Biol Populat Poissons, Anglet, France	Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; INRAE; Universite de Pau et des Pays de l'Adour; Universite de Pau et des Pays de l'Adour	Grandjean, F (corresponding author), Univ Poitiers, UMR CNRS 7267, Lab Ecol & Biol Interact, Equipe Ecol,Evolut,Symbiose, 6 Rue Michel Brunet, F-86022 Poitiers, France.	frederic.grandjean@univ-poitiers.fr	Lepais, Olivier/D-1849-2009; VUILLAUME, Barbara/AAV-1277-2021	Lepais, Olivier/0000-0002-6102-9478; VUILLAUME, Barbara/0000-0002-5099-6542; grandjean, frederic/0000-0002-8494-0985	Directions regionales de l'Environnement et du Logement de Martinique et de Guadeloupe; Natural Reserve of Saint-Barthelemy; Laboratoire Genindexe	Directions regionales de l'Environnement et du Logement de Martinique et de Guadeloupe; Natural Reserve of Saint-Barthelemy; Laboratoire Genindexe	Financial support of the project was provided by the Directions regionales de l'Environnement et du Logement de Martinique et de Guadeloupe and by the Natural Reserve of Saint-Barthelemy. Laboratoire Genindexe provided support in the form of salaries for author BV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Anderson EC, 2002, GENETICS, V160, P1217; Arnold M.L., 2006, EVOLUTION GENETIC EX, P271; Belkhir K., 2004, 5171 CNRS UMR; Lorvelec Olivier, 2008, Bulletin de la Societe Herpetologique de France, V128, P49; Breuil M, 2011, TROPICAL SAINT BARTH, P37; Breuil M, 2003, CONTRIBUTIONS HERPET, V20, P255; Breuil M., 2000, W INDIAN IGUANA SPEC, V3, P13; Breuil M, 2011, IGUANA IGUANA VERTEB, P82; Breuil M., 2002, PATRIMOINES NATURELS, V54; Breuil M., 2010, COURRIER NATURE, V251, P36; Breuil M, 1994, COURRIER NATURE, V143, P16; Breuil M, 2010, IUCN 2010 IUCN RED L; Breuil M, 2001, IGUANA SPECIALIST GR, V4, P9; Breuil M., 2007, IGUANA SPECIAL GROUP, V10, P15; Breuil Michel, 2013, Bulletin de la Societe Herpetologique de France, V147, P309; Breuil M, 2011, CONSERVATION OF CARIBBEAN ISLAND HERPETOFAUNAS, VOL 2: REGIONAL ACCOUNTS OF THE WEST INDIES, P311; Breuil M, 2009, APPL HERPETOL, V6, P123, DOI 10.1163/157075408X386114; Breuil Michel, 2008, Bulletin de la Societe Herpetologique de France, P41; Day M.L., 2000, W INDIAN IGUANAS STA, P62; Day ML, 1996, CONTRIBUTIONS W INDI, V12, P136; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falcon W, 2013, PAC SCI, V67, P157, DOI 10.2984/67.2.2; Falush D, 2003, GENETICS, V164, P1567; Fitzpatrick BM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-131; Grouard S, 2010, IGUANAS WHAT DINNER; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Gutsche Alexander, 2004, Salamandra, V40, P201; Gutsche Alexander, 2008, Zoosystematics and Evolution, V84, P245, DOI 10.1002/zoos.200800009; Henderson RW, 2005, IGUANA, V12, P108; Henderson RW, 2012, BULL FLA MUS NAT HIS, V51, P148; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Krauss U., 2013, ACT C BIOD INS FLOR, P196; KRYSKO K. L., 2007, IGUANA, V14, P143; LAZELL J D JR, 1973, Bulletin of the Museum of Comparative Zoology, V145, P1; Lopez-Torres AL, 2012, BIOL INVASIONS, V14, P35, DOI 10.1007/s10530-011-0057-0; Lorvelec O, 1999, IGUANA PETITES ANTIL; Lorvelec Olivier, 2007, Applied Herpetology, V4, P131, DOI 10.1163/157075407780681356; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Malone Catherine L., 2004, P45; Malone CL, 2000, MOL PHYLOGENET EVOL, V17, P269, DOI 10.1006/mpev.2000.0836; McCleery, 1999, ESARBICA J, V115, P4, DOI 10.1080/00369220108733271; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parham JF, 2013, MOL PHYLOGENET EVOL, V67, P176, DOI 10.1016/j.ympev.2013.01.004; Pasachnik SA, 2012, REPTILES AMPHIBIANS, V19, P132, DOI [10.17161/randa.v19i2.13895, DOI 10.17161/RANDA.V19I2.13895]; Pasachnik Stesha A., 2006, Catalogue of American Amphibians and Reptiles, V811, P1; Powell R, 2005, IGUANA, V12, P63; Powell Robert, 2006, Applied Herpetology, V3, P293, DOI 10.1163/157075406778905090; Pritchard JK, 2000, GENETICS, V155, P945; R-Core-Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Rassmann K, 1997, J ZOOL, V242, P729, DOI 10.1111/j.1469-7998.1997.tb05822.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Sites JW, 1996, MOL BIOL EVOL, V13, P1087, DOI 10.1093/oxfordjournals.molbev.a025671; Smith PF, 2003, MOL ECOL, V12, P2497, DOI 10.1046/j.1365-294X.2003.01905.x; Stephen CL, 2013, J BIOGEOGR, V40, P50, DOI 10.1111/j.1365-2699.2012.02780.x; Valette V, 2013, CONSERV GENET RESOUR, V5, P173, DOI 10.1007/s12686-012-9761-z	59	37	40	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127575	10.1371/journal.pone.0127575	http://dx.doi.org/10.1371/journal.pone.0127575			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046351	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200023
J	Willecke, F; Yuan, CJ; Oka, K; Chan, L; Hu, YY; Barnhart, S; Bornfeldt, KE; Goldberg, IJ; Fisher, EA				Willecke, Florian; Yuan, Chujun; Oka, Kazuhiro; Chan, Lawrence; Hu, Yunying; Barnhart, Shelley; Bornfeldt, Karin E.; Goldberg, Ira J.; Fisher, Edward A.			Effects of High Fat Feeding and Diabetes on Regression of Atherosclerosis Induced by Low-Density Lipoprotein Receptor Gene Therapy in LDL Receptor-Deficient Mice	PLOS ONE			English	Article							DEPENDENT ADENOVIRAL VECTORS; APOLIPOPROTEIN-A-I; INSULIN-RESISTANCE; CHOLESTEROL; EXPRESSION; PROMOTES; MACROPHAGES; LESIONS; MOUSE; PROGRESSION	We tested whether a high fat diet (HFD) containing the inflammatory dietary fatty acid palmitate or insulin deficient diabetes altered the remodeling of atherosclerotic plaques in LDL receptor knockout (Ldlr(-/-)) mice. Cholesterol reduction was achieved by using a helperdependent adenovirus (HDAd) carrying the gene for the low-density lipoprotein receptor (Ldlr; HDAd-LDLR). After injection of the HDAd-LDLR, mice consuming either HFD, which led to insulin resistance but not hyperglycemia, or low fat diet (LFD), showed regression compared to baseline. However there was no difference between the two groups in terms of atherosclerotic lesion size, or CD68+ cell and lipid content. Because of the lack of effects of these two diets, we then tested whether viral-mediated cholesterol reduction would lead to defective regression in mice with greater hyperglycemia. In both normoglycemic and streptozotocin (STZ)-treated hyperglycemic mice, HDAd-LDLR significantly reduced plasma cholesterol levels, decreased atherosclerotic lesion size, reduced macrophage area and lipid content, and increased collagen content of plaque in the aortic sinus. However, reductions in anti-inflammatory and ER stress-related genes were less pronounced in STZ-diabetic mice compared to non-diabetic mice. In conclusion, HDAd-mediated Ldlr gene therapy is an effective and simple method to induce atherosclerosis regression in Ldlr(-/-) mice in different metabolic states.	[Willecke, Florian; Hu, Yunying; Goldberg, Ira J.] NYU, Langone Med Ctr, Div Endocrinol Diabet & Metab, New York, NY 10016 USA; [Yuan, Chujun; Fisher, Edward A.] NYU, Langone Med Ctr, Div Cardiol, New York, NY 10016 USA; [Oka, Kazuhiro; Chan, Lawrence] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Barnhart, Shelley; Bornfeldt, Karin E.] Univ Washington, Dept Med, Div Metab Endocrinol & Nutr Diabet & Obes, Ctr Excellence, Seattle, WA 98109 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Baylor College of Medicine; University of Washington; University of Washington Seattle	Goldberg, IJ (corresponding author), NYU, Langone Med Ctr, Div Endocrinol Diabet & Metab, New York, NY 10016 USA.	Ira.Goldberg@nyumc.org; Edward.Fisher@nyumc.org	Fisher, Edward/ABE-7469-2020; Bornfeldt, Karin/AAI-2241-2019	Bornfeldt, Karin/0000-0001-9208-6523; Fisher, Edward/0000-0001-9802-143X	Deutsche Forschungsgemeinschaft [Wi 4064/1-1]; National Institutes of Health [R01HL51586/DK105527, P30DK079638, R01HL062887, P01HL092969, R01HL097365, R01HL045095, HL087945, DK095684, HL117226]; American Heart Association [14GRNT20410033]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117226, P01HL092969, R01HL051586, U01HL087945, R01HL045095, R01HL097365, R01HL062887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047, P30DK079638, R01DK095684] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by the following: FW: Wi 4064/1-1; Deutsche Forschungsgemeinschaft; www.dfg.de. LC: National Institutes of Health; www.nih.gov, R01HL51586/DK105527, P30DK079638. KEB: National Institutes of Health; www.nih.gov, R01HL062887, P01HL092969, R01HL097365. American Heart Association; http://www.heart.org/HEARTORG/#, #14GRNT20410033. IJG: National Institutes of Health; www.nih.gov, R01HL045095. EAF: National Institutes of Health; www.nih.gov, HL087945, DK095684, HL117226. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Brosius F., 2003, LOW DOSE STREPTOZOTO; Calkin AC, 2010, ARTERIOSCL THROM VAS, V30, P1513, DOI 10.1161/ATVBAHA.109.191197; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Chereshnev I, 2003, J SURG RES, V111, P171, DOI 10.1016/S0022-4804(03)00039-8; Deonarine K, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-11; Feig JE, 2013, METHODS MOL BIOL, V1027, P123, DOI 10.1007/978-1-60327-369-5_5; Feig JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028534; Feig JE, 2011, P NATL ACAD SCI USA, V108, P7166, DOI 10.1073/pnas.1016086108; Feig JE, 2011, CIRCULATION, V123, P989, DOI 10.1161/CIRCULATIONAHA.110.984146; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Forouhi NG, 2014, LANCET DIABETES ENDO, V2, P810, DOI 10.1016/S2213-8587(14)70146-9; Gaudreault N, 2013, AM J PATHOL, V183, P1981, DOI 10.1016/j.ajpath.2013.08.019; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Goldberg IJ, 2008, DIABETES, V57, P1674, DOI 10.2337/db08-0083; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Harris JD, 2002, GENE THER, V9, P21, DOI 10.1038/sj.gt.3301615; Hsueh W, 2007, CIRC RES, V100, P1415, DOI 10.1161/01.RES.0000266449.37396.1f; Johansson F, 2008, P NATL ACAD SCI USA, V105, P2082, DOI 10.1073/pnas.0709958105; Kanter JE, 2012, P NATL ACAD SCI USA, V109, pE715, DOI 10.1073/pnas.1111600109; Kawashiri M, 2001, J LIPID RES, V42, P943; Kennedy A, 2009, J NUTR, V139, P1, DOI 10.3945/jn.108.098269; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Kim IH, 2001, P NATL ACAD SCI USA, V98, P13282, DOI 10.1073/pnas.241506298; Li Rongying, 2011, J Genet Syndr Gene Ther, V2, P106; Lieu HD, 2003, CIRCULATION, V107, P1315, DOI 10.1161/01.CIR.0000054781.50889.0C; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Moore RE, 2003, ARTERIOSCL THROM VAS, V23, P1914, DOI 10.1161/01.ATV.0000092328.66882.F5; Morral N, 1999, P NATL ACAD SCI USA, V96, P12816, DOI 10.1073/pnas.96.22.12816; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Nicholls SJ, 2011, NEW ENGL J MED, V365, P2078, DOI 10.1056/NEJMoa1110874; Nomura S, 2004, GENE THER, V11, P1540, DOI 10.1038/sj.gt.3302310; Nozue T, 2012, CIRC J, V76, P2188, DOI 10.1253/circj.CJ-11-1303; Oka K, 2005, METH MOLEC MED, V108, P329; Oka Kazuhiro, 2004, Curr Atheroscler Rep, V6, P203, DOI 10.1007/s11883-004-0033-6; Parathath S, 2011, DIABETES, V60, P1759, DOI 10.2337/db10-0778; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Potteaux S, 2011, J CLIN INVEST, V121, P2025, DOI 10.1172/JCI43802; Reis ED, 2001, J VASC SURG, V34, P541, DOI 10.1067/mva.2001.115963; Renard CB, 2004, J CLIN INVEST, V114, P659, DOI 10.1172/JCI200417867; Reynoso R, 2003, MOL CELL BIOCHEM, V246, P155, DOI 10.1023/A:1023423005187; Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002; SPADY DK, 1993, ANNU REV NUTR, V13, P355, DOI [10.1146/annurev.nutr.13.1.355, 10.1146/annurev.nu.13.070193.002035]; Tangirala RK, 1999, CIRCULATION, V100, P1816, DOI 10.1161/01.CIR.100.17.1816; Teupser D, 2003, ARTERIOSCL THROM VAS, V23, P1907, DOI 10.1161/01.ATV.0000090126.34881.B1; Tholstrup T, 2011, AM J CLIN NUTR, V94, P1426, DOI 10.3945/ajcn.111.018846; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; Van Craeyveld E, 2011, J MOL MED, V89, P555, DOI 10.1007/s00109-011-0722-x; Vikramadithyan RK, 2005, J CLIN INVEST, V115, P2434, DOI 10.1172/JCI24819; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Wright JJ, 2009, CARDIOVASC RES, V82, P351, DOI 10.1093/cvr/cvp017	51	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128996	10.1371/journal.pone.0128996	http://dx.doi.org/10.1371/journal.pone.0128996			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046657	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200115
J	Zhang, J; Chong, CCN; Chen, GG; Lai, PBS				Zhang, Jian; Chong, Charing C. N.; Chen, George G.; Lai, Paul B. S.			A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; MICRORNA EXPRESSION; CANCER; PATHWAY; THERAPEUTICS; PROGRESSION; METASTASIS; PROGNOSIS; APOPTOSIS; PROFILES	Hepatocellular carcinoma (HCC) is the fifth common cancer. The differential expression of microRNAs (miRNAs) has been associated with the prognosis of various cancers. However, limited information is available regarding genome-wide miRNA expression profiles in HCC to generate a tumor-specific miRNA signature of prognostic values. In this study, the miRNA profiles in 327 HCC patients, including 327 tumor and 43 adjacent non-tumor tissues, from The Cancer Genome Atlas (TCGA) Liver hepatocellular carcinoma (LIHC) were analyzed. The associations of the differentially expressed miRNAs with patient survival and other clinical characteristics were examined with t-test and Cox proportional regression model. Finally, a tumor-specific miRNA signature was generated and examined with Kaplan-Meier survival, univariate\multivariate Cox regression analyses and KEGG pathway analysis. Results showed that a total of 207 miRNAs were found differentially expressed between tumor and adjacent non-tumor HCC tissues. 78 of them were also discriminatively expressed with gender, race, tumor grade and AJCC tumor stage. Seven miRNAs were significantly associated with survival (P value <0.001). Among the seven significant miRNAs, six (hsa-mir-326, hsa-mir-3677, hsa-mir-511-1, hsa-mir-511-2, hsa-mir-9-1, and hsa-mir-9-2) were negatively associated with overall survival (OS), while the remaining one (hsa-mir-30d) was positively correlated. A tumor-specific 7-miRNAs signature was generated and validated as an independent prognostic predictor. Collectively, we have identified and validated an independent prognostic model based on the expression of seven miRNAs, which can be used to assess patients' survival. Additional work is needed to translate our model into clinical practice.	[Zhang, Jian; Chong, Charing C. N.; Chen, George G.; Lai, Paul B. S.] Chinese Univ Hong Kong, Dept Surg, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Chen, GG (corresponding author), Chinese Univ Hong Kong, Dept Surg, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China.	gchen@cuhk.edu.hk; paullai@surgery.cuhk.edu.hk	zhang, jian/E-7203-2010; Lai, Paul BS/K-8556-2015; ZHANG, Jian/ABB-7267-2020; Chen, George Gong/I-2757-2016; Chong, Charing CN/M-3455-2018	zhang, jian/0000-0001-8870-515X; Lai, Paul BS/0000-0002-9469-6728; ZHANG, Jian/0000-0001-8870-515X; Chong, Charing CN/0000-0002-8425-8767	SRFDP and RGC ERG Joint Research [M-CUHK406/13]; CUHK direct grant [4054160]	SRFDP and RGC ERG Joint Research; CUHK direct grant(Chinese University of Hong Kong)	This study was supported by SRFDP and RGC ERG Joint Research (No: M-CUHK406/13) and CUHK direct grant (4054160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2009, SURGERY, V27, P30, DOI DOI 10.1016/J.MPSUR.2008.12.005; Anwar SL, 2013, INT J CANCER, V133, P660, DOI 10.1002/ijc.28068; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Barbano R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108950; Barry CT, 2012, AM J TRANSPLANT, V12, P428, DOI 10.1111/j.1600-6143.2011.03788.x; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Cao G, 2015, TUMOR BIOL, V36, P4453, DOI 10.1007/s13277-015-3085-z; Fleming NH, 2015, CANCER-AM CANCER SOC, V121, P51, DOI 10.1002/cncr.28981; Ge YZ, 2015, J CANCER RES CLIN, V141, P1291, DOI 10.1007/s00432-015-1927-0; Gu YY, 2015, ONCOTARGET, V6, P2397, DOI 10.18632/oncotarget.2963; Hong CC, 2014, CANCER RES, V74, P6280, DOI 10.1158/0008-5472.CAN-14-0524; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; LaCroix B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-292; Lee H, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-174; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Li J, 2010, BMC EVOL BIOL, V10, DOI [10.1186/1471-2148-10-68, 10.1186/1471-2407-10-354]; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Omura Noriyuki, 2008, Proceedings of the American Association for Cancer Research Annual Meeting, V49, P7; Onnis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012960; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Peters I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091440; Stewart BW, WORLD CANC REPORT 20; Trankenschuh W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013688; Vaira V, 2015, LIVER INT, V35, P1077, DOI 10.1111/liv.12636; Villanueva A, 2010, CLIN CANCER RES, V16, P4688, DOI 10.1158/1078-0432.CCR-09-1811; Wang S, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0373-y; Wang Y, 2014, GENE, V533, P389, DOI 10.1016/j.gene.2013.09.038; Wong QWL, 2010, CLIN CANCER RES, V16, P867, DOI 10.1158/1078-0432.CCR-09-1840; Wu CL, 2013, CELL SIGNAL, V25, P1212, DOI 10.1016/j.cellsig.2013.01.028; Yan W, 2014, ONCOTARGET, V5, P12908, DOI 10.18632/oncotarget.2679; Yang NN, 2015, ADV DRUG DELIVER REV, V81, P62, DOI 10.1016/j.addr.2014.10.029; Yang XJ, 2013, BIOCHEM BIOPH RES CO, V431, P617, DOI 10.1016/j.bbrc.2012.12.083; Yao J, 2010, HEPATOLOGY, V51, P846, DOI 10.1002/hep.23443; Yu HS, 2014, ONCOL LETT, V7, P799, DOI 10.3892/ol.2013.1754; Zhang G, 2010, CURR GENOMICS, V11, P311, DOI 10.2174/138920210791616671; Zhang JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054111; Zhang PY, 2014, J PATHOL, V232, P308, DOI 10.1002/path.4294; Zhao YD, 2008, CANCER INFORM, V6, P9; Zhuang LP, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/731781	39	60	60	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128628	10.1371/journal.pone.0128628	http://dx.doi.org/10.1371/journal.pone.0128628			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046780	gold, Green Published, Green Submitted			2022-12-27	WOS:000355652200086
J	Miralles, A; Hipsley, CA; Erens, J; Gehara, M; Rakotoarison, A; Glaw, F; Muller, J; Vences, M				Miralles, Aurelien; Hipsley, Christy A.; Erens, Jesse; Gehara, Marcelo; Rakotoarison, Andolalao; Glaw, Frank; Mueller, Johannes; Vences, Miguel			Distinct Patterns of Desynchronized Limb Regression in Malagasy Scincine Lizards (Squamata, Scincidae)	PLOS ONE			English	Article							BODY-FORM; MORPHOLOGICAL EVOLUTION; DEVELOPMENTAL BASIS; DIGIT LOSS; LIMBLESSNESS; DNA; REDUCTION; SELECTION; SNAKES; RATES	Scincine lizards in Madagascar form an endemic clade of about 60 species exhibiting a variety of ecomorphological adaptations. Several subclades have adapted to burrowing and convergently regressed their limbs and eyes, resulting in a variety of partial and completely limbless morphologies among extant taxa. However, patterns of limb regression in these taxa have not been studied in detail. Here we fill this gap in knowledge by providing a phylogenetic analysis of DNA sequences of three mitochondrial and four nuclear gene fragments in an extended sampling of Malagasy skinks, and microtomographic analyses of osteology of various burrowing taxa adapted to sand substrate. Based on our data we propose to (i) consider Sirenoscincus Sakata & Hikida, 2003, as junior synonym of Voeltzkowia Boettger, 1893; (ii) resurrect the genus name Grandidierina Mocquard, 1894, for four species previously included in Voeltzkowia; and (iii) consider Androngo Brygoo, 1982, as junior synonym of Pygomeles Grandidier, 1867. By supporting the clade consisting of the limbless Voeltzkowia mira and the forelimb-only taxa V. mobydick and V. yamagishii, our data indicate that full regression of limbs and eyes occurred in parallel twice in the genus Voeltzkowia (as hitherto defined) that we consider as a sand-swimming ecomorph: in the Voeltzkowia clade sensu stricto the regression first affected the hindlimbs and subsequently the forelimbs, whereas the Grandidierina clade first regressed the forelimbs and subsequently the hindlimbs following the pattern prevalent in squamates. Timetree reconstructions for the Malagasy Scincidae contain a substantial amount of uncertainty due to the absence of suitable primary fossil calibrations. However, our preliminary reconstructions suggest rapid limb regression in Malagasy scincids with an estimated maximal duration of 6 MYr for a complete regression in Paracontias, and 4 and 8 MYr respectively for complete regression of forelimbs in Grandidierina and hindlimbs in Voeltzkowia.	[Miralles, Aurelien] CNRS, Ctr Ecol Fonct & Evolut, F-34033 Montpellier, France; [Miralles, Aurelien; Erens, Jesse; Rakotoarison, Andolalao; Vences, Miguel] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Div Evolutionary Biol, Braunschweig, Germany; [Hipsley, Christy A.; Mueller, Johannes] Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Berlin, Germany; [Hipsley, Christy A.] Univ Melbourne, Sch BioSci, Melbourne, Vic, Australia; [Erens, Jesse] Wageningen Univ, Biosystemat Grp, NL-6700 AP Wageningen, Netherlands; [Gehara, Marcelo] Univ Fed Rio Grande do Norte, Ctr Biociencias, BR-59072970 Natal, RN, Brazil; [Rakotoarison, Andolalao] Univ Antananarivo, Dept Anim Biol, Antananarivo, Madagascar; [Glaw, Frank] Zool Staatssammlung Munchen, Munich, Germany	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Braunschweig University of Technology; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Melbourne; Wageningen University & Research; Universidade Federal do Rio Grande do Norte; University Antananarivo	Miralles, A (corresponding author), CNRS, Ctr Ecol Fonct & Evolut, F-34033 Montpellier, France.	miralles.skink@gmail.com	Miralles, Aurélien/AAD-7987-2020; Gehara, Marcelo/J-6533-2014; Müller, Johannes/A-6293-2017	Miralles, Aurélien/0000-0002-2538-7710; Müller, Johannes/0000-0001-5801-856X; Hipsley, Christy/0000-0002-5740-9363; Vences, Miguel/0000-0003-0747-0817; Rakotoarison, Andolalao/0000-0003-2620-440X; , Jesse/0000-0001-8503-4610	Alexander von Humboldt Foundation; SYNTHESYS grant [FR-TAF-842]; Deutsche Forschungsgemeinschaft [MU 1760/7-1]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); SYNTHESYS grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	AM was supported by a postdoctoral Research Fellowship from the Alexander von Humboldt Foundation and by a SYNTHESYS grant (FR-TAF-842). CAH and JM were financially supported by the Deutsche Forschungsgemeinschaft (MU 1760/7-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreone F, 2002, J ZOOL, V258, P139, DOI 10.1017/S0952836902001280; Brandley MC, 2008, EVOLUTION, V62, P2042, DOI 10.1111/j.1558-5646.2008.00430.x; BRYGOO E R, 1984, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V6, P769; BRYGOO E R, 1987, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V9, P255; BRYGOO E R, 1980, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V2, P905; BRYGOO E R, 1981, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V3, P675; Caldwell MW, 2003, CAN J EARTH SCI, V40, P573, DOI 10.1139/E02-081; Carranza S, 2008, MOL PHYLOGENET EVOL, V46, P1071, DOI 10.1016/j.ympev.2007.11.018; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chan-ard Tanya, 2011, Thailand Natural History Museum Journal, V5, P17; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cohn MJ, 1999, NATURE, V399, P474, DOI 10.1038/20944; Crottini A, 2012, P NATL ACAD SCI USA, V109, P5358, DOI 10.1073/pnas.1112487109; Crottini A, 2009, MOL PHYLOGENET EVOL, V53, P345, DOI 10.1016/j.ympev.2009.05.024; de Bakker MAG, 2013, NATURE, V500, P445, DOI 10.1038/nature12336; Domning DP, 2001, NATURE, V413, P625, DOI 10.1038/35098072; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Eo SH, 2010, P ROY SOC B-BIOL SCI, V277, P3587, DOI 10.1098/rspb.2010.0965; Falush D, 2003, GENETICS, V164, P1567; Galis F, 2010, EVOLUTION, V64, P2466, DOI 10.1111/j.1558-5646.2010.01041.x; GANS C, 1975, AM ZOOL, V15, P455; Gans C., 1974, BIOMECHANICS APPROAC, DOI 10.3998/mpub.7275; Glaw F, 2007, FIELD GUIDE AMPHIBIA; Grandidier A., 1869, Revue et Magazin de Zoologie, P337; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hipsley CA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00138; Huynen L, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-75; Jerez A, 2009, ACTA ZOOL-STOCKHOLM, V90, P42, DOI 10.1111/j.1463-6395.2008.00331.x; Kearney M, 2004, P ROY SOC B-BIOL SCI, V271, P1677, DOI 10.1098/rspb.2004.2771; Kohlsdorf T, 2006, EVOLUTION, V60, P1896; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lee MSY, 2013, J BIOGEOGR, V40, P1290, DOI 10.1111/jbi.12094; Lee MSY, 1998, PHILOS T ROY SOC B, V353, P1521, DOI 10.1098/rstb.1998.0308; Li B, 2009, ZOOL SCR, V38, P101, DOI 10.1111/j.1463-6409.2008.00361.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mahler DL, 2013, SCIENCE, V341, P292, DOI 10.1126/science.1232392; Micheletti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047694; Minguillon C, 2005, DEV CELL, V8, P75, DOI 10.1016/j.devcel.2004.11.013; Miralles A, 2011, ZOOTAXA, P47, DOI 10.11646/zootaxa.2918.1.5; Miralles A, 2011, ZOOTAXA, P1; Miralles A, 2012, ZOOSYSTEMA, V34, P701, DOI 10.5252/z2012n4a3; Miralles A, 2011, ORG DIVERS EVOL, V11, P135, DOI 10.1007/s13127-011-0042-6; Moch JG, 2011, J ZOOL, V285, P274, DOI 10.1111/j.1469-7998.2011.00839.x; Muller J, 2011, NATURE, V473, P364, DOI 10.1038/nature09919; Niemann S, 2004, AM J HUM GENET, V74, P558, DOI 10.1086/382196; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Perl RGB, 2014, AMPHIBIA-REPTILIA, V35, P197, DOI 10.1163/15685381-00002942; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Rambaut A, 2009, TRACER V1 5; Rambaut A., 2014, FIGTREE V1 4 3 SOFTW; Retaux S, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-26; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sakata Shuichi, 2003, Current Herpetology, V22, P9; Schmitz A, 2005, MOL PHYLOGENET EVOL, V34, P118, DOI 10.1016/j.ympev.2004.08.016; Shapiro MD, 2002, J MORPHOL, V254, P211, DOI 10.1002/jmor.10027; Siler CD, 2011, MOL PHYLOGENET EVOL, V59, P53, DOI 10.1016/j.ympev.2010.12.019; Sites JW, 2011, ANNU REV ECOL EVOL S, V42, P227, DOI 10.1146/annurev-ecolsys-102710-145051; SKET B, 1994, BIJDR DIERKD, V64, P33, DOI 10.1163/26660644-06401002; Skinner A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-310; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; SWOFFORD DL, PAUP PHYLOGENETIC AN; TEMPLETON AR, 1992, GENETICS, V132, P619; Thewissen JGM, 2006, P NATL ACAD SCI USA, V103, P8414, DOI 10.1073/pnas.0602920103; Uetz P, 2014, REPTILE DATABASE; Underwood G., 1970, P1; Vences M, 2013, ZOOTAXA, V3636, P201, DOI 10.11646/zootaxa.3636.2.1; Wells N, 2003, NATURAL HIST MADAGAS, P16; Whiting Alison S., 2004, African Journal of Herpetology, V53, P135; Whiting AS, 2003, MOL PHYLOGENET EVOL, V29, P582, DOI 10.1016/S1055-7903(03)00142-8; Wiens JJ, 2006, EVOLUTION, V60, P123, DOI 10.1111/j.0014-3820.2006.tb01088.x; Wiens JJ, 2001, EVOLUTION, V55, P2303; Wiens John J., 2009, Journal of Biology (London), V8, P19, DOI 10.1186/jbiol112; Williams EE., 1972, EVOL BIOL, V6, P47, DOI [DOI 10.1007/978-1-4684-9063-3_3, 10. 1007/978-1-4684-9063-3]; Woltering JM, 2009, DEV BIOL, V332, P82, DOI 10.1016/j.ydbio.2009.04.031; Young RL, 2009, EVOL DEV, V11, P647, DOI 10.1111/j.1525-142X.2009.00372.x	76	23	23	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0126074	10.1371/journal.pone.0126074	http://dx.doi.org/10.1371/journal.pone.0126074			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042667	Green Submitted, Green Published, gold			2022-12-27	WOS:000355701600005
J	Yue, CY; Zhang, B; Ying, CM				Yue, Chao-yan; Zhang, Bin; Ying, Chun-mei			Elevated Serum Level of IL-35 Associated with the Maintenance of Maternal-Fetal Immune Tolerance in Normal Pregnancy	PLOS ONE			English	Article							REGULATORY T-CELLS; IMMUNOSUPPRESSIVE CYTOKINE IL-35; SPONTANEOUS-ABORTION; FOXP3 EXPRESSION; TGF-BETA; B-CELLS; INDUCTION; TREG; MICE; AUTOIMMUNE	Objectives IL-35 is a novel inhibitory cytokine. In this study, we investigate the serum levels of inhibitory cytokines IL-35, IL-10 and TGF-beta in both normal pregnancies and non-pregnant females, and whether IL-35 is associated with the pathogenesis of recurrent spontaneous abortion. We also try to elucidate the relationships of IL-35 with estrogen and alpha-fetoprotein (AFP). Methods The levels of IL-35, IL-10, TGF-beta, estradiol (E2), unconjugated estriol (uE3) and AFP were analyzed in 120 normal pregnancies, 40 women suffering recurrent spontaneous abortion, 40 postpartum healthy women and 40 non-pregnant women by enzyme-linked immunosorbent assay (ELISA). The correlations between inhibitory cytokines, estrogen and AFP were assessed with the Spearman rank correlation coefficient. Results Data are expressed as median and percentiles (Q1, Q3). The level of serum IL-35 in normal pregnancies was significantly higher than that in non-pregnant women [333.6 (59.32, 1391) pg/mL vs. 123.9 (8.763, 471.7) pg/mL; P < 0.001]. A significantly higher level of TGF-beta was observed in the first trimester only as compared to non-pregnant women [473.4 (398.0, 580.5) pg/mL vs. 379.7 (311.0, 441.3) pg/mL, P < 0.01]. The difference in serum IL-10 level between pregnant women and non-pregnant women was not significant [8.602 (5.854, 12.89) pg/mL vs. 9.339 (5.691, 12.07) pg/mL; P > 0.05]. The level of serum IL-35 in recurrent spontaneous abortion was significantly lower than that in normal early pregnancy [220.4 (4.951, 702.0) pg/mL vs. 386.5 (64.37, 1355) pg/mL; P < 0.05]. The higher IL-35 level in first trimester pregnant women correlated with E2 (r = 0.3062, P < 0.01) and AFP (r = 0.3179, P < 0.01). Conclusion Serum levels of IL-35 increased in normal pregnancy and decreased in recurrent spontaneous abortion. Increased IL-35 correlated with estrogen and AFP levels in early pregnancy. IL-35 is becoming recognized as an active player in the maintenance of a successful pregnancy, but this is not the case for IL-10 or TGF-beta.	[Yue, Chao-yan; Zhang, Bin; Ying, Chun-mei] Fudan Univ, Obstet & Gynecol Hosp, Dept Lab Med, Shanghai 200433, Peoples R China	Fudan University	Ying, CM (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Dept Lab Med, Shanghai 200433, Peoples R China.	ycmzh2012@163.com						Alisa A, 2008, J IMMUNOL, V180, P5109, DOI 10.4049/jimmunol.180.7.5109; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Arck PC, 2013, NAT MED, V19, P548, DOI 10.1038/nm.3160; Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406; Bao SH, 2011, EUR J OBSTET GYN R B, V155, P94, DOI 10.1016/j.ejogrb.2010.11.007; Chaturvedi V, 2011, J IMMUNOL, V186, P6661, DOI 10.4049/jimmunol.1100315; Chen SJ, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/258391; Choi J, 2015, CLIN REV AL IN PRESS; Clark DA, 2008, AM J REPROD IMMUNOL, V59, P525, DOI 10.1111/j.1600-0897.2008.00582.x; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Dixon KO, 2015, EUR J IMMUN IN PRESS; Enninga EAL, 2014, MAYO CLIN PROC, V89, P520, DOI 10.1016/j.mayocp.2014.01.006; Heikkinen J, 2004, CLIN EXP IMMUNOL, V136, P373, DOI 10.1111/j.1365-2249.2004.02441.x; Jin EH, 2014, ROM J MORPHOL EMBRYO, V55, P1353; Jin LP, 2009, CLIN IMMUNOL, V133, P402, DOI 10.1016/j.clim.2009.08.009; Lee SK, 2011, HUM REPROD, V26, P2964, DOI 10.1093/humrep/der301; Len XG, 2010, CHINESE MED J-PEKING, V123, P2593, DOI 10.3760/cma.j.issn.0366-6999.2010.18.019; Loewendorf AI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096723; Mao GP, 2010, ENDOCRINOLOGY, V151, P5477, DOI 10.1210/en.2010-0426; Mao HT, 2013, HUM IMMUNOL, V74, P872, DOI 10.1016/j.humimm.2013.04.010; Mei SS, 2010, FERTIL STERIL, V94, P2244, DOI 10.1016/j.fertnstert.2009.11.020; Mjosberg J, 2010, BIOL REPROD, V82, P698, DOI 10.1095/biolreprod.109.081208; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; Ozkan ZS, 2014, J MATERN-FETAL NEO M, V27, P1513, DOI 10.3109/14767058.2013.861415; Ozkan ZS, 2014, J MATERN-FETAL NEO M, V22, P1; Polanczyk MJ, 2005, J NEUROIMMUNOL, V170, P85, DOI 10.1016/j.jneuroim.2005.08.023; Prieto GA, 2006, IMMUNOLOGY, V118, P58, DOI 10.1111/j.1365-2567.2006.02339.x; Saito S, 2005, J REPROD IMMUNOL, V65, P111, DOI 10.1016/j.jri.2005.01.004; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Sarandakou A, 2007, CRIT REV CL LAB SCI, V44, P151, DOI 10.1080/10408360601003143; Sasaki Y, 2004, MOL HUM REPROD, V10, P347, DOI 10.1093/molehr/gah044; Schumacher A, 2009, J IMMUNOL, V182, P5488, DOI 10.4049/jimmunol.0803177; Seyer M, 2010, EUR J IMMUNOL, V40, P321, DOI 10.1002/eji.200939527; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Shima T, 2010, J REPROD IMMUNOL, V85, P121, DOI 10.1016/j.jri.2010.02.006; Shirshev S V, 2011, Dokl Biol Sci, V440, P343, DOI 10.1134/S0012496611050024; Somerset DA, 2004, IMMUNOLOGY, V112, P38, DOI 10.1111/j.1365-2567.2004.01869.x; Svensson L, 2001, J REPROD IMMUNOL, V51, P3, DOI 10.1016/S0165-0378(01)00065-1; Tai P, 2008, J CELL PHYSIOL, V214, P456, DOI 10.1002/jcp.21221; Tedder TF, 2014, NAT REV RHEUMATOL, V10, DOI 10.1038/nrrheum.2014.95; Teles A, 2013, AM J REPROD IMMUNOL, V69, P331, DOI 10.1111/aji.12067; Terayama H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096120; Thuere C, 2007, AM J REPROD IMMUNOL, V58, P514, DOI 10.1111/j.1600-0897.2007.00538.x; Tilburgs T, 2006, PLACENTA, V27, pS47, DOI 10.1016/j.placenta.2005.11.008; Valor L, 2011, EUR J CLIN INVEST, V41, P357, DOI 10.1111/j.1365-2362.2010.02414.x; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wang RX, 2014, NAT MED, V20, P633, DOI 10.1038/nm.3554; Workman CJ, 2009, CELL MOL LIFE SCI, V66, P2603, DOI 10.1007/s00018-009-0026-2; Zenclussen AC, 2005, AM J PATHOL, V166, P811, DOI 10.1016/S0002-9440(10)62302-4; Zhao JX, 2007, J REPROD IMMUNOL, V75, P71, DOI 10.1016/j.jri.2007.06.052	52	26	28	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128219	10.1371/journal.pone.0128219	http://dx.doi.org/10.1371/journal.pone.0128219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042836	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600039
J	Cui, XY; Yang, CJ; Wang, J; Liang, BB; Yi, SJ; Li, H; Liu, HB; Li, P; Wu, ZH; Xie, J; Jia, LL; Hao, RZ; Wang, LG; Hua, YJ; Qiu, SF; Song, HB				Cui, Xianyan; Yang, Chaojie; Wang, Jian; Liang, Beibei; Yi, Shengjie; Li, Hao; Liu, Hongbo; Li, Peng; Wu, Zhihao; Xie, Jing; Jia, Leili; Hao, Rongzhang; Wang, Ligui; Hua, Yuejin; Qiu, Shaofu; Song, Hongbin			Antimicrobial Resistance of Shigella flexneri Serotype 1b Isolates in China	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; BETA-LACTAMASES; EPIDEMIOLOGY; STRAINS; SONNEI; BURDEN	Shigella flexneri serotype 1b is among the most prominent serotypes in developing countries, followed by serotype 2a. However, only limited data is available on the global phenotypic and genotypic characteristics of S. flexneri 1b. In the present study, 40 S. flexneri 1b isolates from different regions of China were confirmed by serotyping and biochemical characterization. Antimicrobial susceptibility testing showed that 85% of these isolates were multidrug-resistant strains and antibiotic susceptibility profiles varied between geographical locations. Strains from Yunnan were far more resistant than those from Xinjiang, while only one strain from Shanghai was resistant to ceftazidime and aztreonam. Fifteen cephalosporin resistant isolates were identified in this study. ESBL genes (bla(SHV), bla(TEM), bla(OXA), and bla(CTX-M)) and ampC genes (bla(MOX), bla(FOX), bla(MIR) (ACT-1), bla(DHA), bla(CIT) and bla(ACC)) were subsequently detected among the 15 isolates. The results showed that these strains were positive only for bla(TEM), bla(OXA), bla(CTX-M), intI1, and intI2. Furthermore, pulsed-field gel electrophoresis (PFGE) analysis showed that the 40 isolates formed different profiles, and the PFGE patterns of Xinjiang isolates were distinct from Yunnan and Shanghai isolates by one obvious, large, missing band. In summary, similarities in resistance patterns were observed in strains with the same PFGE pattern. Overall, the results supported the need for more prudent selection and use of antibiotics in China. We suggest that antibiotic susceptibility testing should be performed at the start of an outbreak, and antibiotic use should be restricted to severe Shigella cases, based on resistance pattern variations observed in different regions. The data obtained in the current study might help to develop a strategy for the treatment of infections caused by S. flexneri 1b in China.	[Cui, Xianyan; Hua, Yuejin] Zhejiang Univ, Dept Nucl Agr Sci, Hangzhou 310027, Zhejiang, Peoples R China; [Cui, Xianyan; Yang, Chaojie; Wang, Jian; Liang, Beibei; Yi, Shengjie; Li, Hao; Liu, Hongbo; Li, Peng; Wu, Zhihao; Xie, Jing; Jia, Leili; Hao, Rongzhang; Wang, Ligui; Qiu, Shaofu; Song, Hongbin] Acad Mil Med Sci, Dept Dis Control & Prevent, Beijing, Peoples R China	Zhejiang University; Academy of Military Medical Sciences - China	Hua, YJ (corresponding author), Zhejiang Univ, Dept Nucl Agr Sci, Hangzhou 310027, Zhejiang, Peoples R China.	yjhua@zju.edu.cn; qiushf0613@hotmail.com; hongbinsong@263.net	Qiu, Shaofu/CAJ-0602-2022		National Major Scientific and Technological Special Projects for Infectious Diseases during the Twelfth Five-year Plan Period [2012ZX10004215, 2013ZX10004607]; National Nature Science Foundation of China [81371854, 81373053, 81202252, 31200942]; Beijing Science and Technology Nova program [xx2013061]	National Major Scientific and Technological Special Projects for Infectious Diseases during the Twelfth Five-year Plan Period; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Science and Technology Nova program	This research was supported by the National Major Scientific and Technological Special Projects for Infectious Diseases during the Twelfth Five-year Plan Period (Nos. 2012ZX10004215 and 2013ZX10004607); the National Nature Science Foundation of China (Nos. 81371854, 81373053, 81202252 and 31200942); and the Beijing Science and Technology Nova program (No. xx2013061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2006, J MED MICROBIOL, V55, P1685, DOI 10.1099/jmm.0.46725-0; Ahmed SF, 2006, EPIDEMIOL INFECT, V134, P1237, DOI 10.1017/S095026880600642X; Bhattacharya D, 2011, MICROB DRUG RESIST, V17, P329, DOI 10.1089/mdr.2010.0084; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Galani I, 2010, INT J ANTIMICROB AG, V36, P252, DOI 10.1016/j.ijantimicag.2010.05.004; Gendrel D, 2008, ARCH PEDIATRIE, V15, pS93, DOI 10.1016/S0929-693X(08)74223-4; Ke X, 2011, ARCH MICROBIOL, V193, P767, DOI 10.1007/s00203-011-0744-3; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Matar GM, 2007, ANN TROP MED PARASIT, V101, P511, DOI 10.1179/136485907X193860; Pan JC, 2006, J ANTIMICROB CHEMOTH, V58, P288, DOI 10.1093/jac/dkl228; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Pickering LK., 2004, ANTIMICROBIAL RESIST, P71; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Qiu SF, 2013, EMERG INFECT DIS, V19, P1147, DOI 10.3201/eid1907.111221; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Schaad UB, 2005, INFECT DIS CLIN N AM, V19, P617, DOI 10.1016/j.idc.2005.05.005; Siu LK, 2000, ANTIMICROB AGENTS CH, V44, P2034, DOI 10.1128/AAC.44.8.2034-2038.2000; Sui JL, 2010, DIS SURVEILL, V25, P947, DOI DOI 10.3784/J.ISSN.1003-9961.2010.12.006; Sun QZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070238; Talukder KA, 2001, J CLIN MICROBIOL, V39, P3757, DOI 10.1128/JCM.39.10.3757-3759.2001; Tariq A, 2012, CAN J MICROBIOL, V58, P1047, DOI [10.1139/w2012-085, 10.1139/W2012-085]; von Seidlein L, 2006, PLOS MED, V3, P1556, DOI 10.1371/journal.pmed.0030353; Zhang WL, 2011, J ANTIMICROB CHEMOTH, V66, P2527, DOI 10.1093/jac/dkr341	23	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0129009	10.1371/journal.pone.0129009	http://dx.doi.org/10.1371/journal.pone.0129009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039698	gold, Green Published, Green Submitted			2022-12-27	WOS:000355700700135
J	Grow, A; Van Bavel, J				Grow, Andre; Van Bavel, Jan			Assortative Mating and the Reversal of Gender Inequality in Education in Europe: An Agent-Based Model	PLOS ONE			English	Article							MATE CHOICE; MARRIAGE MARKETS; SEX-DIFFERENCES; WEDDING-RING; 37 CULTURES; PREFERENCES; PATTERNS; HOMOGAMY; DEMOGRAPHY; SELECTION	While men have always received more education than women in the past, this gender imbalance in education has turned around in large parts of the world. In many countries, women now excel men in terms of participation and success in higher education. This implies that, for the first time in history, there are more highly educated women than men reaching the reproductive ages and looking for a partner. We develop an agent-based computational model that explicates the mechanisms that may have linked the reversal of gender inequality in education with observed changes in educational assortative mating. Our model builds on the notion that individuals search for spouses in a marriage market and evaluate potential candidates based on preferences. Based on insights from earlier research, we assume that men and women prefer partners with similar educational attainment and high earnings prospects, that women tend to prefer men who are somewhat older than themselves, and that men prefer women who are in their mid-twenties. We also incorporate the insight that the educational system structures meeting opportunities on the marriage market. We assess the explanatory power of our model with systematic computational experiments, in which we simulate marriage market dynamics in 12 European countries among individuals born between 1921 and 2012. In these experiments, we make use of realistic agent populations in terms of educational attainment and earnings prospects and validate model outcomes with data from the European Social Survey. We demonstrate that the observed changes in educational assortative mating can be explained without any change in male or female preferences. We argue that our model provides a useful computational laboratory to explore and quantify the implications of scenarios for the future.	[Grow, Andre; Van Bavel, Jan] Univ Leuven, Ctr Sociol Res, Leuven, Belgium	KU Leuven	Grow, A (corresponding author), Univ Leuven, Ctr Sociol Res, Leuven, Belgium.	andre.grow@soc.kuleuven.be		Grow, Andre/0000-0003-2470-0071	European Research Council under the European Union's Seventh Framework Programme (FP) / ERC [312290]	European Research Council under the European Union's Seventh Framework Programme (FP) / ERC(European Research Council (ERC))	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement no. 312290 for the GENDERBALL project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, ESS ROUND 5 EUR SOC; [Anonymous], 2012, ESS ROUND 6 EUR SOC; Barakat B, 2010, DEMOGR RES, V22, P383; BIELBY WT, 1986, AM J SOCIOL, V91, P759, DOI 10.1086/228350; Bijak J, 2013, DEMOGR RES, V29, P729, DOI 10.4054/DemRes.2013.29.27; Billari FC, 2003, CONTRIB ECON, P1; Billari FC, 2007, DEMOGR RES, V17, P59, DOI 10.4054/DemRes.2007.17.3; Blossfeld HP, 2009, ANNU REV SOCIOL, V35, P513, DOI 10.1146/annurev-soc-070308-115913; Bozon M., 1989, POPULATION, V44, P91, DOI DOI 10.2307/1533112; Bruze G, 2011, J HUM CAPITAL, V5, P1, DOI 10.1086/660108; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; BUSS DM, 1990, J CROSS CULT PSYCHOL, V21, P5, DOI 10.1177/0022022190211001; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; Buss DM, 2001, J MARRIAGE FAM, V63, P491, DOI 10.1111/j.1741-3737.2001.00491.x; Coleman JamesS., 1961, ADOLESCENT SOC SOCIA; Dagsvik JK, 2001, MATH POPUL STUD, V9, P97, DOI DOI 10.1080/08898480109525498; DIMAGGIO P, 1985, AM J SOCIOL, V90, P1231, DOI 10.1086/228209; Eagly AH, 2009, PERS SOC PSYCHOL B, V35, P403, DOI 10.1177/0146167208329696; England P, 2009, POPUL DEV REV, V35, P797, DOI 10.1111/j.1728-4457.2009.00309.x; Epstein B, 2013, SYNTHESE, V190, P203, DOI 10.1007/s11229-012-0142-7; Epstein J.M., 1996, GROWING ARTIFICIAL S; Esteve A, 2012, POPUL DEV REV, V38, P535, DOI 10.1111/j.1728-4457.2012.00515.x; Flache A., 2009, OXFORD HDB ANAL SOCI, P245; French RM, 2008, ADAPT BEHAV, V16, P71, DOI 10.1177/1059712307087598; Gil-Burmann C, 2002, HUM NATURE-INT BIOS, V13, P493, DOI 10.1007/s12110-002-1005-6; Glick PC, 1950, AM SOCIOL REV, V15, P517, DOI 10.2307/2087311; Hills T, 2008, JASSS-J ARTIF SOC S, V11; Hitsch GJ, 2010, QME-QUANT MARK ECON, V8, P393, DOI 10.1007/s11129-010-9088-6; KALMIJN M, 1994, AM J SOCIOL, V100, P422, DOI 10.1086/230542; Kalmijn M, 1998, ANNU REV SOCIOL, V24, P395, DOI 10.1146/annurev.soc.24.1.395; Kalmijn M, 2001, SOC FORCES, V79, P1289, DOI 10.1353/sof.2001.0044; KENRICK DT, 1992, BEHAV BRAIN SCI, V15, P75, DOI 10.1017/S0140525X00067595; Knittel AK, 2011, ADAPT BEHAV, V19, P425, DOI 10.1177/1059712311422611; Kulu H, 2014, DEMOGRAPHY, V51, P881, DOI 10.1007/s13524-013-0278-1; LICHTER DT, 1990, SOC SCI QUART, V71, P802; LICHTER DT, 1992, AM SOCIOL REV, V57, P781, DOI 10.2307/2096123; LICHTER DT, 1995, J FAM ISSUES, V16, P412, DOI 10.1177/019251395016004001; Lutz W., 2007, VIENNA YB POPULATION, V5, P193, DOI DOI 10.1553/POPULATIONYEARBOOK2007S193; Lutz W, 2008, SCIENCE, V319, P1047, DOI 10.1126/science.1151753; Macy MW, 2002, ANNU REV SOCIOL, V28, P143, DOI 10.1146/annurev.soc.28.110601.141117; MARE RD, 1991, AM SOCIOL REV, V56, P15, DOI 10.2307/2095670; Matthews AP, 2013, THEOR POPUL BIOL, V88, P78, DOI 10.1016/j.tpb.2013.01.006; OPPENHEIMER VK, 1988, AM J SOCIOL, V94, P563, DOI 10.1086/229030; OPPENHEIMER VK, 1994, POPUL DEV REV, V20, P293, DOI 10.2307/2137521; Padavic I, 2002, TEACHING SOCIOLOGY; Pawlowski B, 1999, P ROY SOC B-BIOL SCI, V266, P281, DOI 10.1098/rspb.1999.0634; Schofer E, 2005, AM SOCIOL REV, V70, P898, DOI 10.1177/000312240507000602; Schwartz CR, 2013, ANNU REV SOCIOL, V39, P451, DOI 10.1146/annurev-soc-071312-145544; Schwartz CR, 2005, DEMOGRAPHY, V42, P621, DOI 10.1353/dem.2005.0036; Silverman E, 2013, JASSS-J ARTIF SOC S, V16, DOI 10.18564/jasss.2327; Simao J, 2002, ADAPT BEHAV, V10, P113, DOI 10.1177/1059712302010002003; Simao J, 2003, ARTIF LIFE, V9, P403, DOI 10.1162/106454603322694843; Skopek J, 2011, Z FAMILIENFORSCH, V23, P267; Skopek J, 2011, EUR SOCIOL REV, V27, P180, DOI 10.1093/esr/jcp068; STEVENS G, 1991, SOCIOL FORUM, V6, P715, DOI 10.1007/BF01114409; Thiele JC, 2014, JASSS-J ARTIF SOC S, V17, DOI 10.18564/jasss.2503; Todd PM, 2005, DEMOGRAPHY, V42, P559, DOI 10.1353/dem.2005.0027; Van Bavel J., 2012, VIENNA YB POPULATION, V10, P127, DOI DOI 10.1553/POPULATIONYEARBOOK2012S127; Van Poppel F, 2001, POP STUD-J DEMOG, V55, P1, DOI 10.1080/00324720127681; Wilensky U., 1999, NETLOGO	60	51	51	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127806	10.1371/journal.pone.0127806	http://dx.doi.org/10.1371/journal.pone.0127806			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7ST	26039151	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700076
J	Li, T; Weng, XS; Bian, YY; Zhou, L; Cui, FZ; Qiu, ZY				Li, Tao; Weng, Xisheng; Bian, Yanyan; Zhou, Lei; Cui, Fuzhai; Qiu, Zhiye			Influence of Nano-HA Coated Bone Collagen to Acrylic (Polymethylmethacrylate) Bone Cement on Mechanical Properties and Bioactivity	PLOS ONE			English	Article							CALCIUM-SULFATE HEMIHYDRATE; IN-VITRO; TITANIA PARTICLES; GRAFT-COPOLYMERS; FILLER CONTENT; BETA-TCP; MODULUS; HYDROXYAPATITE; STRENGTH; AUGMENTATION	Objective This research investigated the mechanical properties and bioactivity of polymethylmethacrylate (PMMA) bone cement after addition of the nano-hydroxyapatite(HA) coated bone collagen (mineralized collagen, MC). Materials & Methods The MC in different proportions were added to the PMMA bone cement to detect the compressive strength, compression modulus, coagulation properties and biosafety. The MC-PMMA was embedded into rabbits and co-cultured with MG 63 cells to exam bone tissue compatibility and gene expression of osteogenesis. Results 15.0%(wt) impregnated MC-PMMA significantly lowered compressive modulus while little affected compressive strength and solidification. MC-PMMA bone cement was biologically safe and indicated excellent bone tissue compatibility. The bone-cement interface crosslinking was significantly higher in MC-PMMA than control after 6 months implantation in the femur of rabbits. The genes of osteogenesis exhibited significantly higher expression level in MC-PMMA. Conclusions MC-PMMA presented perfect mechanical properties, good biosafety and excellent biocompatibility with bone tissues, which has profoundly clinical values.	[Li, Tao] Southern Med Univ, Nanfang Hosp, Dept Orthoped Surg, Guangzhou 510515, Guangdong, Peoples R China; [Weng, Xisheng; Bian, Yanyan; Zhou, Lei] Peking Union Med Coll Hosp, Dept Orthoped Surg, Peking Union Med Coll, Beijing 100730, Peoples R China; [Cui, Fuzhai; Qiu, Zhiye] Tsinghua Univ, Dept Mat Sci & Engn, Beijing 100087, Peoples R China	Southern Medical University - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Tsinghua University	Weng, XS (corresponding author), Peking Union Med Coll Hosp, Dept Orthoped Surg, Peking Union Med Coll, Beijing 100730, Peoples R China.	litchn@163.com		Weng, Xisheng/0000-0002-6021-1462				[Anonymous], ASTM C191 A, DOI 10.1520/C0191; [Anonymous], ISO 5833 2002; [Anonymous], ISO 10993 I; ASCENZI A, 1967, ANAT REC, V158, P375, DOI 10.1002/ar.1091580403; ASCENZI A, 1968, ANAT REC, V161, P377, DOI 10.1002/ar.1091610309; Bauer TW, 2002, CLIN ORTHOP RELAT R, P11; Beall DP, 2010, SKELETAL RADIOL, V39, P117, DOI 10.1007/s00256-009-0722-x; Boner V, 2009, J BIOMED MATER RES B, V90B, P842, DOI 10.1002/jbm.b.31353; Brown TE, 2013, ORTHOPEDICS, V36, P380, DOI 10.3928/01477447-20130426-10; Canul-Chuil A, 2003, J BIOMED MATER RES B, V64B, P27, DOI 10.1002/jbm.b.10486; CHARNLEY J, 1970, Journal of Bone and Joint Surgery British Volume, V52, P340; DEB S, 1995, BIOMATERIALS, V16, P1095, DOI 10.1016/0142-9612(95)98906-U; Draenert K, 1981, Hip, P71; Driscoll M, 2011, J BODYW MOV THER, V15, P335, DOI 10.1016/j.jbmt.2010.05.002; Feith R, 1975, Acta Orthop Scand Suppl, V161, P3; Fukuda C, 2010, J BIOMED MATER RES B, V95B, P407, DOI 10.1002/jbm.b.31731; Funk MJ, 1998, BIOMATERIALS, V19, P1561, DOI 10.1016/S0142-9612(97)00116-6; Gomoll AH, 2008, ACTA ORTHOP, V79, P421, DOI 10.1080/17453670710015349; Goodwin CJ, 1997, J BIOMED MATER RES, V34, P47; Goto K, 2006, J BIOMED MATER RES A, V78A, P629, DOI 10.1002/jbm.a.30793; Goto K, 2005, BIOMATERIALS, V26, P6496, DOI 10.1016/j.biomaterials.2005.04.044; Hao W, 2010, INT ORTHOP, V34, P1341, DOI 10.1007/s00264-009-0946-3; Hayashi K, 1989, J Arthroplasty, V4, P257, DOI 10.1016/S0883-5403(89)80022-1; He Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042525; Hedia HS, 2000, BIO-MED MATER ENG, V10, P141; Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus; Islas-Blancas ME, 2001, J BIOMAT SCI-POLYM E, V12, P893, DOI 10.1163/156856201753113088; Jager M, 2003, J BIOMAT SCI-POLYM E, V14, P1283, DOI 10.1163/156856203322553491; Jamsen E, 2014, CLIN ORTHOP RELAT R, V472, P2779, DOI 10.1007/s11999-014-3641-7; Kim SB, 2004, BIOMATERIALS, V25, P5715, DOI 10.1016/j.biomaterials.2004.01.022; Kinzl M, 2012, EUR SPINE J, V21, P920, DOI 10.1007/s00586-011-2119-5; Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9; Kolb JP, 2013, EUR SPINE J, V22, P1650, DOI 10.1007/s00586-013-2809-2; Lam WM, 2011, J BIOMED MATER RES B, V96B, P76, DOI 10.1002/jbm.b.31741; Li JF, 2011, J ORTHOP RES, V29, P1745, DOI 10.1002/jor.21439; Lian Kai, 2013, Biomatter, V3, DOI 10.4161/biom.27250; Liao SS, 2004, TISSUE ENG, V10, P73, DOI 10.1089/107632704322791718; Liao SS, 2003, SPINE, V28, P1954, DOI 10.1097/01.BRS.0000083240.13332.F6; Lin KL, 2013, BIOMATERIALS, V34, P10028, DOI 10.1016/j.biomaterials.2013.09.056; LINDER L, 1983, J BONE JOINT SURG BR, V65, P646, DOI 10.1302/0301-620X.65B5.6643571; LITSKY AS, 1990, J ORTHOPAED RES, V8, P623, DOI 10.1002/jor.1100080420; Liu HY, 2010, TISSUE ENG PT A, V16, P2075, DOI [10.1089/ten.tea.2009.0669, 10.1089/ten.TEA.2009.0669]; Liu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075668; Liu X, 2013, J BIOMATER APPL, V28, P12, DOI 10.1177/0885328211433618; Liu X, 2010, J BIOMED MATER RES B, V94B, P72, DOI 10.1002/jbm.b.31625; LIU YK, 1987, J BIOMED MATER RES, V21, P247, DOI 10.1002/jbm.820210208; Makela KT, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7592; Mattila RH, 2009, ACTA BIOMATER, V5, P1639, DOI 10.1016/j.actbio.2009.01.020; Miller MA, 2014, CLIN ORTHOP RELAT R, V472, P304, DOI 10.1007/s11999-013-3248-4; Minari C, 2000, ARTIF ORGANS, V24, P751, DOI 10.1046/j.1525-1594.2000.06571-3.x; Minari C, 2001, P I MECH ENG H, V215, P251, DOI 10.1243/0954411011533643; Muijs SPJ, 2011, J BONE JOINT SURG BR, V93B, P1149, DOI 10.1302/0301-620X.93B9.26152; Muller SD, 2002, ACTA ORTHOP SCAND, V73, P684, DOI 10.1080/000164702321039688; Nguyen S, 2006, J BIOMED MATER RES B, V77B, P5, DOI 10.1002/jbm.b.30430; Nguyen S, 2004, MACROMOL BIOSCI, V4, P262, DOI 10.1002/mabi.200300088; Parker MJ, 2010, THE COCHRANE DATABAS, DOI [10.1002/14651858.CD001706.pub4, DOI 10.1002/14651858.CD001706]; RHO JY, 1993, J BIOMECH, V26, P111, DOI 10.1016/0021-9290(93)90042-D; Sadoghi P, 2013, J ARTHROPLASTY, V28, P1329, DOI 10.1016/j.arth.2013.01.012; SAITO M, 1994, BIOMATERIALS, V15, P156, DOI 10.1016/0142-9612(94)90266-6; SAVARINO L, 1995, J BIOMED MATER RES, V29, P701, DOI 10.1002/jbm.820290605; Scolaro JA, 2014, J AM ACAD ORTHOP SUR, V22, P90, DOI 10.5435/JAAOS-22-02-90; Shinzato S, 2001, J BIOMED MATER RES, V54, P491, DOI 10.1002/1097-4636(20010315)54:4<491::AID-JBM40>3.3.CO;2-F; Shinzato S, 2001, J BIOMED MATER RES, V56, P452, DOI 10.1002/1097-4636(20010905)56:3<452::AID-JBM1115>3.0.CO;2-1; Stanczyk M, 2004, J BIOMECH, V37, P1803, DOI [10.1016/j.biomech.2004.03.002, 10.1016/j.jbiomech.2004.03.002]; Thormann U, 2013, BIOMATERIALS, V34, P8589, DOI 10.1016/j.biomaterials.2013.07.036; Vazquez B, 2005, BIOMATERIALS, V26, P4309, DOI 10.1016/j.biomaterials.2004.10.042; WILLERT HG, 1972, ARCH ORTHOPAD UNFALL, V72, P33, DOI 10.1007/BF00415858; WILLIAMS JL, 1989, J BIOMECH, V22, P673, DOI 10.1016/0021-9290(89)90017-1; Wolf-Brandstetter C, 2013, J BIOMED MATER RES B, V101B, P599, DOI 10.1002/jbm.b.32862; Wong CT, 2004, J BIOMED MATER RES A, V68A, P513, DOI 10.1002/jbm.a.20089; Zuo DQ, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-156; Zwartele R, 2013, HIP INT, V23, P111, DOI 10.5301/HIP.2013.11049	72	15	15	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0129018	10.1371/journal.pone.0129018	http://dx.doi.org/10.1371/journal.pone.0129018			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039750	Green Submitted, Green Published, gold			2022-12-27	WOS:000355700700136
J	Lopez-Rodriguez, AB; Acaz-Fonseca, E; Viveros, MP; Garcia-Segura, LM				Lopez-Rodriguez, Ana Belen; Acaz-Fonseca, Estefania; Viveros, Maria-Paz; Garcia-Segura, Luis M.			Changes in Cannabinoid Receptors, Aquaporin 4 and Vimentin Expression after Traumatic Brain Injury in Adolescent Male Mice. Association with Edema and Neurological Deficit	PLOS ONE			English	Article							CLOSED-HEAD INJURY; MESSENGER-RNA EXPRESSION; CEREBRAL EDEMA; ENDOCANNABINOID SYSTEM; BARRIER PERMEABILITY; TEMPORAL PROFILE; D-AMPHETAMINE; UP-REGULATION; MURINE MODEL; ASTROCYTES	Traumatic brain injury (TBI) incidence rises during adolescence because during this critical neurodevelopmental period some risky behaviors increase. The purpose of this study was to assess the contribution of cannabinoid receptors (CB1 and CB2), blood brain barrier proteins (AQP4) and astrogliosis markers (vimentin) to neurological deficit and brain edema formation in a TBI weight drop model in adolescent male mice. These molecules were selected since they are known to change shortly after lesion. Here we extended their study in three different timepoints after TBI, including short (24h), early mid-term (72h) and late midterm (two weeks). Our results showed that TBI induced an increase in brain edema up to 72 h after lesion that was directly associated with neurological deficit. Neurological deficit appeared 24 h after TBI and was completely recovered two weeks after trauma. CB1 receptor expression decreased after TBI and was negatively correlated with edema formation and behavioral impairments. CB2 receptor increased after injury and was associated with high neurological deficit whereas no correlation with edema was found. AQP4 increased after TBI and was positively correlated with edema and neurological impairments as occurred with vimentin expression in the same manner. The results suggest that CB1 and CB2 differ in the mechanisms to resolve TBI and also that some of their neuroprotective effects related to the control of reactive astrogliosis may be due to the regulation of AQP4 expression on the end-feet of astrocytes.	[Lopez-Rodriguez, Ana Belen; Acaz-Fonseca, Estefania; Garcia-Segura, Luis M.] Univ Complutense Madrid, Fac Biol, Dept Anim Physiol 2, Madrid, Spain; [Lopez-Rodriguez, Ana Belen; Viveros, Maria-Paz] CSIC, Inst Cajal, E-28002 Madrid, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Lopez-Rodriguez, AB (corresponding author), Univ Complutense Madrid, Fac Biol, Dept Anim Physiol 2, Madrid, Spain.	lranabelen@gmail.com	Lopez-Rodriguez, Ana Belen/H-3631-2017; Garcia-Segura, Luis M/U-3711-2017; Acaz-Fonseca, Estefania/S-5884-2016; Viveros, Maria-Paz/S-6855-2016	Lopez-Rodriguez, Ana Belen/0000-0002-0747-7966; Garcia-Segura, Luis M/0000-0002-2450-2916; Acaz-Fonseca, Estefania/0000-0003-2549-6420; Viveros, Maria-Paz/0000-0002-4119-4636	Ministerio de Economia y Competitividad, Spain [BFU2011-30217-C03-01, BFU2012-38144]; Instituto de Salud Carlos III, Redes tematicas de Investigacion Cooperativa en Salud, Red de Trastornos Adictivos [RD2012/0028/0021]; GRUPO UCM [951579]	Ministerio de Economia y Competitividad, Spain; Instituto de Salud Carlos III, Redes tematicas de Investigacion Cooperativa en Salud, Red de Trastornos Adictivos; GRUPO UCM	Support was provided by the Ministerio de Economia y Competitividad, Spain (BFU2011-30217-C03-01 and BFU2012-38144), Instituto de Salud Carlos III, Redes tematicas de Investigacion Cooperativa en Salud, Red de Trastornos Adictivos (RD2012/0028/0021) and GRUPO UCM (951579). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson PD, 1998, ACT NEUR S, V71, P104; Adriani W, 2004, NEUROPSYCHOPHARMACOL, V29, P869, DOI 10.1038/sj.npp.1300366; Adriani W, 2003, BEHAV NEUROSCI, V117, P695, DOI 10.1037/0735-7044.117.4.695; Adriani W, 1998, BEHAV NEUROSCI, V112, P1152, DOI 10.1037/0735-7044.112.5.1152; Amenta PS, 2012, J NEUROSCI RES, V90, P2293, DOI 10.1002/jnr.23114; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Bardutzky J, 2007, STROKE, V38, P3084, DOI 10.1161/STROKEAHA.107.490193; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Lopez-Rodriguez AB, 2015, PSYCHONEUROENDOCRINO, V56, P1, DOI 10.1016/j.psyneuen.2015.02.018; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen Y, 2000, CIRC RES, V87, P323, DOI 10.1161/01.RES.87.4.323; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Dardiotis E, 2014, J NEUROTRAUM, V31, P1920, DOI 10.1089/neu.2014.3347; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Ekmark-Lewen S, 2010, RESTOR NEUROL NEUROS, V28, P311, DOI 10.3233/RNN-2010-0529; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; FRANKE WW, 1982, DIFFERENTIATION, V23, P43, DOI 10.1111/j.1432-0436.1982.tb01266.x; Fukuda AM, 2013, J CEREBR BLOOD F MET, V33, P1621, DOI 10.1038/jcbfm.2013.118; Garcia-Gutierrez MS, 2013, NEUROPHARMACOLOGY, V73, P388, DOI 10.1016/j.neuropharm.2013.05.034; Hellal F, 2004, NEUROSCI LETT, V357, P21, DOI 10.1016/j.neulet.2003.12.036; Hellal F, 2003, J NEUROTRAUM, V20, P841, DOI 10.1089/089771503322385773; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Iring A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053390; Kapoor S, 2013, J NEUROSCI, V33, P17398, DOI 10.1523/JNEUROSCI.2756-13.2013; KENT S, 1992, TRENDS PHARMACOL SCI, V13, P24, DOI 10.1016/0165-6147(92)90012-U; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; KOLB B, 1986, BRAIN RES, V397, P315, DOI 10.1016/0006-8993(86)90633-5; Kreiter KT, 2002, STROKE, V33, P200, DOI 10.1161/hs0102.101080; Larson SJ, 2001, BRAIN BEHAV IMMUN, V15, P371, DOI 10.1006/brbi.2001.0643; Lin Y, 2012, LAB INVEST, V92, P1623, DOI 10.1038/labinvest.2012.118; Litvin Y, 2013, GENES BRAIN BEHAV, V12, P479, DOI 10.1111/gbb.12045; De Jesus ML, 2010, NEUROCHEM INT, V56, P829, DOI 10.1016/j.neuint.2010.03.007; Rodriguez ABL, 2011, CEREB CORTEX, V21, P2046, DOI 10.1093/cercor/bhq277; Lopez-Rodriguez AB, 2015, CEREB CORTEX, V25, P35, DOI 10.1093/cercor/bht202; Marco EM, 2009, MINI-REV MED CHEM, V9, P1407, DOI 10.2174/138955709789957468; Marmarou A, 2003, ACT NEUR S, V86, P7; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McCarron RM, 2006, J PHYSIOL PHARMACOL, V57, P133; Mechoulam R, 2007, MOL NEUROBIOL, V36, P68, DOI 10.1007/s12035-007-8008-6; O'Connor CA, 2006, ACTA NEUROCHIR SUPPL, V96, P121; Onaivi ES, 2011, CURR NEUROPHARMACOL, V9, P205, DOI 10.2174/157015911795017416; Palazuelos J, 2006, FASEB J, V20, P2405, DOI 10.1096/fj.06-6164fje; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Pekny M, 2007, INT REV NEUROBIOL, V82, P95, DOI 10.1016/S0074-7742(07)82005-8; Potokar M, 2013, GLIA, V61, P917, DOI 10.1002/glia.22485; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Rodriguez JJ, 2001, J NEUROSCI, V21, P823, DOI 10.1523/JNEUROSCI.21-03-00823.2001; ROPPER AH, 1984, ARCH NEUROL-CHICAGO, V41, P26, DOI 10.1001/archneur.1984.04050130032017; Schwarzmaier SM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-32; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Shenaq M, 2012, J NEUROL SCI, V323, P134, DOI 10.1016/j.jns.2012.08.036; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Siopi E, 2012, J NEUROTRAUM, V29, P354, DOI 10.1089/neu.2011.2055; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Straiker A, 2006, AAPS J, V8, pE272; Verkman AS, 2006, BBA-BIOMEMBRANES, V1758, P1085, DOI 10.1016/j.bbamem.2006.02.018; Viveros MP, 2012, J PSYCHOPHARMACOL, V26, P164, DOI 10.1177/0269881111408956; Vizuete ML, 1999, NEUROBIOL DIS, V6, P245, DOI 10.1006/nbdi.1999.0246; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Zhang M, 2008, NEUROSCIENCE, V152, P753, DOI 10.1016/j.neuroscience.2008.01.022	71	43	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128782	10.1371/journal.pone.0128782	http://dx.doi.org/10.1371/journal.pone.0128782			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039099	gold, Green Published, Green Submitted			2022-12-27	WOS:000355700700120
J	Mao, LF; Ning, HS; Wang, JY				Mao, Ling-Feng; Ning, Huan-Sheng; Wang, Jin-Yan			The Current Collapse in AlGaN/GaN High-Electron Mobility Transistors Can Originate from the Energy Relaxation of Channel Electrons?	PLOS ONE			English	Article							TRANSPORT; DEFECT; GAN	Influence of the energy relaxation of the channel electrons on the performance of AlGaN/ GaN high-electron mobility transistors (HEMTs) has been investigated using self-consistent solution to the coupled Schrodinger equation and Poisson equation. The first quantized energy level in the inversion layer rises and the average channel electron density decreases when the channel electric field increases from 20 kV/cm to 120 kV/cm. This research also demonstrates that the energy relaxation of the channel electrons can lead to current collapse and suggests that the energy relaxation should be considered in modeling the performance of AlGaN/GaN HEMTs such as, the gate leakage current, threshold voltage, sourcedrain current, capacitance-voltage curve, etc.	[Mao, Ling-Feng; Ning, Huan-Sheng] Univ Sci & Technol Beijing, Sch Comp & Commun Engn, Beijing 100083, Peoples R China; [Wang, Jin-Yan] Peking Univ, Inst Microelect, Beijing 100871, Peoples R China	University of Science & Technology Beijing; Peking University	Mao, LF (corresponding author), Univ Sci & Technol Beijing, Sch Comp & Commun Engn, 30 Xueyuan Rd, Beijing 100083, Peoples R China.	mail_lingfeng@aliyun.com		Ning, Huansheng/0000-0001-6413-193X; Mao, Ling-Feng/0000-0001-8886-2315	National Natural Science Foundation of China (NSFC) [61076102, 61471035]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China (NSFC) grant Nos. 61076102 and 61471035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alivov YI, 2003, APPL PHYS LETT, V83, P4719, DOI 10.1063/1.1632537; Anand MJ, 2013, PHYS STATUS SOLIDI C, V10, P1421, DOI 10.1002/pssc.201300219; [Anonymous], 1981, PHYS SEMICONDUCTOR D; BARKER AS, 1973, PHYS REV B, V7, P743, DOI 10.1103/PhysRevB.7.743; Hashizume T, 2002, APPL PHYS LETT, V80, P4564, DOI 10.1063/1.1485309; Iqbal M, 2014, CURR APPL PHYS, V14, P1099, DOI 10.1016/j.cap.2014.05.014; Jin D, 2013, IEDM, V2013, P148; Lee C, 2004, ELECTRON LETT, V40, P1147; Lenka TR, 2012, PRAMANA-J PHYS, V79, P151, DOI 10.1007/s12043-012-0290-9; Mao LF, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2789733; Mao LF, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2735929; Martin G, 1996, APPL PHYS LETT, V68, P2541, DOI 10.1063/1.116177; Mittereder JA, 2003, APPL PHYS LETT, V83, P1650, DOI 10.1063/1.1604472; O'Leary SK, 1998, SOLID STATE COMMUN, V105, P621, DOI 10.1016/S0038-1098(97)10207-1; Padmanabhan B, 2012, J COMPUT ELECTRON, V11, P129, DOI 10.1007/s10825-012-0385-z; Rao H, 2013, SOLID STATE ELECTRON, V79, P11, DOI 10.1016/j.sse.2012.06.014; Schoche S, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4833195; TAN IH, 1990, J APPL PHYS, V68, P4071, DOI 10.1063/1.346245; Uren MJ, 2012, IEEE T ELECTRON DEV, V59, P3327, DOI 10.1109/TED.2012.2216535; Wang XD, 2011, OPT QUANT ELECTRON, V42, P755, DOI 10.1007/s11082-011-9473-8; Wu YR, 2008, J ELECTRON MATER, V37, P578, DOI 10.1007/s11664-007-0320-4; Xiao Y -N, 2010, ADV OPTOELECTRON MIC, P1, DOI [10.1109/AOM.2010.5713524, DOI 10.1109/AOM.2010.5713524]; Zanoni E, 1997, IEDM, V1997, P381	23	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128438	10.1371/journal.pone.0128438	http://dx.doi.org/10.1371/journal.pone.0128438			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039589	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700102
J	Nic-Can, GI; Galaz-Avalos, RM; De-la-Pena, C; Alcazar-Magana, A; Wrobel, K; Loyola-Vargas, VM				Nic-Can, Geovanny I.; Galaz-Avalos, Rosa M.; De-la-Pena, Clelia; Alcazar-Magana, Armando; Wrobel, Kazimierz; Loyola-Vargas, Victor M.			Somatic Embryogenesis: Identified Factors that Lead to Embryogenic Repression. A Case of Species of the Same Genus	PLOS ONE			English	Article							VANILLYL BENZYL ETHER; DNA-METHYLATION; COFFEA-ARABICA; CAFFEINE INHIBITION; CHLOROGENIC ACID; CELL-CULTURES; DIFFERENTIATION; CYTOKINESIS; INDUCTION; GROWTH	Somatic embryogenesis is a powerful biotechnological tool for the mass production of economically important cultivars. Due to the cellular totipotency of plants, somatic cells under appropriate conditions are able to develop a complete functional embryo. During the induction of somatic embryogenesis, there are different factors involved in the success or failure of the somatic embryogenesis response. Among these factors, the origin of the explant, the culture medium and the in vitro environmental conditions have been the most studied. However, the secretion of molecules into the media has not been fully addressed. We found that the somatic embryogenesis of Coffea canephora, a highly direct embryogenic species, is disrupted by the metabolites secreted from C. arabica, a poorly direct embryogenic species. These metabolites also affect DNA methylation. Our results show that the abundance of two major phenolic compounds, caffeine and chlorogenic acid, are responsible for inhibiting somatic embryogenesis in C. canephora.	[Nic-Can, Geovanny I.; Galaz-Avalos, Rosa M.; Loyola-Vargas, Victor M.] Ctr Invest Cient Yucatan, Unidad Bioquim & Biol Mol Plantas, Merida 97200, Yucatan, Mexico; [De-la-Pena, Clelia] Ctr Invest Cient Yucatan, Unidad Biotecnol, Merida 97200, Yucatan, Mexico; [Alcazar-Magana, Armando; Wrobel, Kazimierz] Univ Guanajuato, Dept Chem, Guanajuato 36000, Mexico	Centro de Investigacion Cientifica de Yucatan; Centro de Investigacion Cientifica de Yucatan; Universidad de Guanajuato	Loyola-Vargas, VM (corresponding author), Ctr Invest Cient Yucatan, Unidad Bioquim & Biol Mol Plantas, Calle 43 130,Col Chuburna Hidalgo, Merida 97200, Yucatan, Mexico.	vmloyola@cicy.mx	Loyola-Vargas, Victor M/Q-8255-2016; Nic-Can, Geovanny/P-9273-2019; Nic-Can, Geovanny I./C-9300-2016	Nic-Can, Geovanny/0000-0001-8003-7716; Alcazar Magana, Armando/0000-0002-4731-0247; Wrobel, Kazimierz/0000-0003-4357-3178	National Council for Science and Technology [157014, 178149, 213451]	National Council for Science and Technology(Consiliul National al Cercetarii Stiintifice (CNCS))	This work was supported by the National Council for Science and Technology (157014 to V.M.L.V., 178149 to C.D.L.P.). G.I.N.C. was supported by a scholarship (213451) from the National Council for Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS RJ, 1994, J EXP BOT, V45, P497, DOI 10.1093/jxb/45.4.497; Magana AA, 2015, FOOD ANAL METHOD, V8, P864, DOI 10.1007/s12161-014-9967-7; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; Causevic A, 2005, PLANT PHYSIOL BIOCH, V43, P681, DOI 10.1016/j.plaphy.2005.05.011; Chakrabarty D, 2003, PLANT SCI, V165, P61, DOI 10.1016/S0168-9452(03)00127-4; Crescenti A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065744; Cvikrova M, 2003, PLANT PHYSIOL BIOCH, V41, P251, DOI 10.1016/S0981-9428(03)00016-0; De-la-Pena C, 2008, MOL BIOTECHNOL, V39, P215, DOI 10.1007/s12033-008-9037-8; De-la-Pena C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-203; DEJONG AJ, 1992, PLANT CELL, V4, P425, DOI 10.2307/3869444; DEJONG AJ, 1993, PLANT CELL, V5, P615, DOI 10.2307/3869804; DEVRIES SC, 1988, GENE DEV, V2, P462, DOI 10.1101/gad.2.4.462; Echevarria-Machado I, 2005, MOL BIOTECHNOL, V31, P129, DOI 10.1385/MB:31:2:129; El-Bellaj M., 2004, Biotechnology, V3, P155; Feher Attila, 2008, Acta Biologica Szegediensis, V52, P53; Fini L, 2007, J NUTR, V137, P2622, DOI 10.1093/jn/137.12.2622; FRIDBORG G, 1978, PHYSIOL PLANTARUM, V43, P104, DOI 10.1111/j.1399-3054.1978.tb01575.x; FRIEDMAN J, 1983, J CHEM ECOL, V9, P1099, DOI 10.1007/BF00982214; Fu CH, 2012, PLANT CELL REP, V31, P1321, DOI 10.1007/s00299-012-1251-y; Fuentes-Cerda CFJ, 2001, BIOTECHNOL LETT, V23, P1341, DOI 10.1023/A:1010545818671; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; HEPLER PK, 1990, PROTOPLASMA, V157, P182, DOI 10.1007/BF01322651; HERNANDEZ P, 1986, MUTAT RES, V164, P327, DOI 10.1016/0165-1161(86)90003-8; Higashi K, 1998, PLANT CELL REP, V18, P2, DOI 10.1007/s002990050522; Igasaki T, 2003, PLANT CELL PHYSIOL, V44, P1412, DOI 10.1093/pcp/pcg161; Ikeda M, 2006, PLANT BIOTECHNOL, V23, P153, DOI DOI 10.5511/PLANTBIOTECHNOLOGY.23.153; Kobayashi T, 2001, PHYSIOL PLANTARUM, V112, P280, DOI 10.1034/j.1399-3054.2001.1120217.x; Kobayashi T, 2000, PLANT CELL PHYSIOL, V41, P268, DOI 10.1093/pcp/41.3.268; Kobayashi T, 2001, PLANT BIOTECHNOL, V18, P93; Koshiishi C, 2001, FEBS LETT, V499, P50, DOI 10.1016/S0014-5793(01)02512-1; Kouakou TH, 2007, PLANT CELL TISS ORG, V90, P25, DOI 10.1007/s11240-007-9243-2; KREUGER M, 1993, PLANTA, V189, P243, DOI 10.1007/BF00195083; Lee WJ, 2006, CARCINOGENESIS, V27, P269, DOI 10.1093/carcin/bgi206; Leljak-Levanic D, 2004, J PLANT PHYSIOL, V161, P229, DOI 10.1078/0176-1617-01055; Leljak-Levanic D, 2009, PROPAG ORNAM PLANTS, V9, P3; LIU CM, 1993, PLANT CELL, V5, P621, DOI 10.1105/tpc.5.6.621; LOSCHIAVO F, 1989, THEOR APPL GENET, V77, P325, DOI 10.1007/BF00305823; Loyola-Vargas V. M., 2008, PROTEIN CELL BIOMETH, P875, DOI [10.1007/978-1-60327-375-6_50, DOI 10.1007/978-1-60327-375-6_50]; Matthys-Rochon E, 2002, BIOLOGIA, V57, P1; MATTHYSROCHON E, 2005, ACTA BIOL CRACOV BOT, V47, P23; MICHAUXFERRIERE N, 1987, 12 COLL SCI INT CAF, P418; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nic-Can GI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072160; Noceda C, 2009, TREES-STRUCT FUNCT, V23, P1285, DOI 10.1007/s00468-009-0370-8; Papanastasiou I, 2008, PLANT CELL TISS ORG, V92, P215, DOI 10.1007/s11240-007-9326-0; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; Quiroz-Figueroa F, 2001, PLANT CELL REP, V20, P679, DOI 10.1007/s002990100386; Quiroz-Figueroa Francisco, 2006, Methods Mol Biol, V318, P111; Rojas-Herrera R., 2002, Physiology and Molecular Biology of Plants, V8, P171; Santiago R, 2009, EUR J PLANT PATHOL, V124, P439, DOI 10.1007/s10658-009-9431-5; Santos D, 2002, PLANT CELL TISS ORG, V70, P155, DOI 10.1023/A:1016369921067; Schneider-Stock R, 2012, FRONT BIOSCI-LANDMRK, V17, P129, DOI 10.2741/3919; SONDAHL MR, 1977, Z PFLANZENPHYSIOL, V81, P395; Umehara M, 2005, PLANT CELL PHYSIOL, V46, P445, DOI 10.1093/pcp/pci041; Umehara M, 2007, JPN J PLANT SCI, V1, P1; Umehara M, 2004, PLANT BIOTECHNOL-NAR, V21, P87, DOI 10.5511/plantbiotechnology.21.87; Umehara M, 2007, IN VITRO CELL DEV-PL, V43, P203, DOI 10.1007/s11627-006-9016-3; Valster AH, 1997, PROTOPLASMA, V196, P155, DOI 10.1007/BF01279564; Verma DPS, 2001, ANNU REV PLANT PHYS, V52, P751, DOI 10.1146/annurev.arplant.52.1.751; Viejo M, 2010, SEX PLANT REPROD, V23, P315, DOI 10.1007/s00497-010-0145-9; Vogel G, 2005, SCIENCE, V309, P86, DOI 10.1126/science.309.5731.86; Waldhauser SSM, 1996, PHYTOCHEMISTRY, V42, P985, DOI 10.1016/0031-9422(96)00072-6; Xiao WY, 2006, PLANT CELL, V18, P805, DOI 10.1105/tpc.105.038836; Xu ML, 2004, THEOR APPL GENET, V109, P899, DOI 10.1007/s00122-004-1717-6; Yamamoto N, 2005, J PLANT PHYSIOL, V162, P47, DOI 10.1016/j.jplph.2004.05.013; Yang XY, 2010, CRIT REV PLANT SCI, V29, P36, DOI 10.1080/07352680903436291; YASUDA T, 1985, PLANT CELL PHYSIOL, V26, P595, DOI 10.1093/oxfordjournals.pcp.a076946; ZIMMERMAN JL, 1993, PLANT CELL, V5, P1411, DOI 10.1105/tpc.5.10.1411	70	36	41	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126414	10.1371/journal.pone.0126414	http://dx.doi.org/10.1371/journal.pone.0126414			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26038822	Green Submitted, Green Published, gold			2022-12-27	WOS:000355700700028
J	Owili, PO; Hsu, YHE; Chern, JY; Chiu, CHM; Wang, B; Huang, KC; Muga, MA				Owili, Patrick Opiyo; Hsu, Yi-Hsin Elsa; Chern, Jin-Yuan; Chiu, Chiung-Hsuan Megan; Wang, Bill; Huang, Kuo-Cherh; Muga, Miriam Adoyo			Perceptions and Attitudes of Health Professionals in Kenya on National Health Care Resource Allocation Mechanisms: A Structural Equation Modeling	PLOS ONE			English	Article							JOB-SATISFACTION; ORGANIZATIONAL CULTURE; PHYSICIANS ATTITUDES; SYSTEM REFORM; FIT; WORKERS; SUPPORT; NAIROBI; VIEWS	Background Health care resource allocation is key towards attaining equity in the health system. However, health professionals' perceived impact and attitude towards health care resource allocation in Sub-Saharan Africa is unknown; furthermore, they occupy a position which makes them notice the impact of different policies in their health system. This study explored perceptions and attitudes of health professionals in Kenya on health care resource allocation mechanism. Method We conducted a survey of a representative sample of 341 health professionals in Moi Teaching and Referral Hospital from February to April 2012, consisting of over 3000 employees. We assessed health professionals' perceived impact and attitudes on health care resource allocation mechanism in Kenya. We used structural equation modeling and applied a Confirmatory Factor Analysis using Robust Maximum Likelihood estimation procedure to test the hypothesized model. Results We found that the allocation mechanism was negatively associated with their perceived positive impact (-1.04, p < .001), health professionals' satisfaction (-0.24, p < .01), and professionals' attitudes (-1.55, p < .001) while it was positively associated with perceived negative impact (1.14, p < .001). Perceived positive impact of the allocation mechanism was negatively associated with their overall satisfaction (-0.08) and attitude (-0.98) at p < .001, respectively. Furthermore, overall satisfaction was negatively associated with attitude (-1.10, p < .001). On the other hand, perceived negative impact of the allocation was positively associated with overall satisfaction (0.29, p < .001) but was not associated with attitude. Conclusion The result suggests that health care resource allocation mechanism has a negative effect towards perceptions, attitudes and overall satisfaction of health professionals who are at the frontline in health care. These findings can serve as a crucial reference for policymakers as the Kenyan health system move towards devolving the system of governance.	[Owili, Patrick Opiyo; Hsu, Yi-Hsin Elsa; Chiu, Chiung-Hsuan Megan; Huang, Kuo-Cherh] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Owili, Patrick Opiyo] Natl Yang Ming Univ, Inst Publ Hlth, Int Hlth Program, Taipei 112, Taiwan; [Chern, Jin-Yuan] Chang Jung Christian Univ, Dept Hlth Care Adm, Tainan, Taiwan; [Wang, Bill] Asia Univ, Dept Hlth Care Adm, Taichung, Taiwan; [Muga, Miriam Adoyo] Great Lakes Univ Kisumu, Inst Community Hlth & Dev, Kisumu, Kenya	Taipei Medical University; National Yang Ming Chiao Tung University; Chang Jung Christian University; Asia University Taiwan	Hsu, YHE (corresponding author), Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan.	elsahsu@tmu.edu.tw	Owili, Patrick Opiyo/J-8948-2019	Owili, Patrick Opiyo/0000-0002-9417-8947; Chiu, Chiung-hsuan/0000-0002-6030-5960; Muga, Miriam/0000-0002-9180-5394	School of Health Care Administration of Taipei Medical University	School of Health Care Administration of Taipei Medical University	The authors are indebted to School of Health Care Administration of Taipei Medical University for their scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker GM, 2004, COMMUNITY MENT HLT J, V40, P65, DOI 10.1023/B:COMH.0000015218.12111.26; American College of Physicians, 2011, CAN OUR NAT CONS DIS; An JY, 2011, J TRANSCULT NURS, V22, P22, DOI 10.1177/1043659609360849; [Anonymous], 2012, BEGINNERS GUIDE STRU; Bailie R, 1998, FAM PRACT, V15, P58, DOI 10.1093/fampra/15.1.58; Barrett K., 2008, SPSS INTERMEDIATE ST, V3rd ed.; Barrett P, 2007, PERS INDIV DIFFER, V42, P815, DOI 10.1016/j.paid.2006.09.018; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; BLENDON RJ, 1994, JAMA-J AM MED ASSOC, V272, P1546, DOI 10.1001/jama.272.19.1546; Box G. E., 1979, ALL MODELS ARE WRONG; Brazil K, 2010, HEALTH CARE MANAGE R, V35, P365, DOI 10.1097/HMR.0b013e3181edd957; Briscombe B, 2010, IMPROVING RESOURCE A; Brock Dan W, 2003, Cost Eff Resour Alloc, V1, P4, DOI 10.1186/1478-7547-1-4; Byrne B.M., 2013, STRUCTURAL EQUATION, DOI 10.4324/9781410600219; Capacity Kenya, 2010, NAT HUM RES HLTH HRH; Carrin G, 2007, SAMJ S AFR MED J, V97, P130; Central Intelligence Agency, 2011, WORLD FACTB 2011; Chao MC, 2015, ASIA-PAC J PUBLIC HE, V27, pNP1827, DOI 10.1177/1010539513506604; Chien TC, 2008, ASIAN J HLTH INFORM, V3, P69; Cornuz J, 2000, FAM PRACT, V17, P535, DOI 10.1093/fampra/17.6.535; DAHLGREN G, 1991, SCAND J SOC MED, P67; DeFrank R. S., 1998, ACAD MANAGEMENT EXEC, V12, P55, DOI [DOI 10.5465/AME.1998.1109050, 10.2307/4165477]; Demetra, 2011, CALC SAMPL SIZ; Diderichsen F, 2004, RESOURCE ALLOCATION; Division of Health Management Information Systems-Kenya, 2009, ANN HLTH SECT STAT R; El-Ashry M.T., 2009, WATER ARID LANDS W U; Farren C., 1999, STRATEGY LEADERSHIP, V27, P36; George D, 2011, SPSS WINDOWS STEP ST; Goldacre MJ, 1998, J PUBLIC HEALTH MED, V20, P86, DOI 10.1093/oxfordjournals.pubmed.a024725; Gross R, 2007, SOC SCI MED, V64, P1450, DOI 10.1016/j.socscimed.2006.11.012; Guindo Lalla Aida, 2012, Cost Eff Resour Alloc, V10, P9, DOI 10.1186/1478-7547-10-9; Hair J., 2010, MULTIVARIATE DATA AN, V7; Health and Safety Executive, 2014, STRESS REL PSYCH DIS; Hoyle R.H., 1995, STRUCTURAL EQUATION, P158; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hurst SA, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-137; Jackson DL, 2009, PSYCHOL METHODS, V14, P6, DOI 10.1037/a0014694; Joreskog K. G., 1996, PRELIS 2 USERS REFER; Joreskog K.G., 1993, LISREL 8 STRUCTURAL; Khamlub S, 2013, NAGOYA J MED SCI, V75, P233; Kline R.B., 2010, PRINCIPLES PRACTICE; Ko DW, 2002, TOURISM MANAGE, V23, P521, DOI 10.1016/S0261-5177(02)00006-7; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; McIntosh CN, 2007, PERS INDIV DIFFER, V42, P859, DOI 10.1016/j.paid.2006.09.020; Miller DC, 1991, HDB RES DESIGN SOCIA; Ministry of Health-Kenya, 2008, 20080920102011 MTEF; Ministry of State for Planning National Development and Vision 2030, 2008, MED TERM PLAN 2008 2; Ministry of State for Planning National Development and Vision 2030-Kenya, 2007, VIS 2030 BROCH MIN S; Minnis William, 2008, J Hosp Mark Public Relations, V18, P115, DOI 10.1080/15390940802232408; Muga FA, 2008, SOC PSYCH PSYCH EPID, V43, P477, DOI 10.1007/s00127-008-0327-z; Muia E, 1999, CONTRACEPTION, V60, P223, DOI 10.1016/S0010-7824(99)00089-X; Muthen, 2020, MPLUS DISCUSSION LAT; Nation Team, 2011, HOSP CRIPPL DOCT GO; Nyong'o PA, 2010, CITIZENS ENGAGEMENT; Orengo P, 2011, CHAOS PUBLIC HOSP DO; Oyugi LN, 2005, 98 NEPRU; Page J, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-6; PARASURAMAN A, 1988, J RETAILING, V64, P12; PERDUE RR, 1990, ANN TOURISM RES, V17, P586, DOI 10.1016/0160-7383(90)90029-Q; Perneger TV, 2002, MED DECIS MAKING, V22, P65, DOI 10.1177/02729890222062928; Peterson SB, 1994, PUBLIC BUDGETING FIN, V14, P55, DOI [10.1111/540-5850.01012, DOI 10.1111/540-5850.01012]; Phelps CE, 2010, HEALTH ECON; Polit DF, 2007, RES NURS HEALTH, V30, P459, DOI 10.1002/nur.20199; Quaye R K, 1997, J Manag Med, V11, P246, DOI 10.1108/02689239710181139; Raviola G, 2002, CULT MED PSYCHIAT, V26, P55, DOI 10.1023/A:1015289132151; Raykov T., 2006, 1 COURSE STRUCTURAL, V2nd; Regan S, 2010, MED CARE, V48, P547, DOI 10.1097/MLR.0b013e3181d559d0; Rice T, 2006, ELGAR ORIG REF, P261; Schumacker R. E, 2004, BEGINNERS GUIDE STRU, V2nd, DOI DOI 10.4135/9781412973380.N17; Schwartz PA, 2003, CLIN PERINATOL, V30, P167, DOI 10.1016/S0095-5108(02)00092-1; Sealy S, 2010, ESTIMATED GOVT SPEND; See KE, 2009, J PERS SOC PSYCHOL, V96, P104, DOI 10.1037/a0013266; Sharma S, 2005, J BUS RES, V58, P935, DOI 10.1016/j.jbusres.2003.10.007; Stuckler D, 2011, AM J PUBLIC HEALTH, V101, P165, DOI 10.2105/AJPH.2009.184895; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; TEEKENS R, 1972, ECONOMETRICA, V40, P793, DOI 10.2307/1912069; Tomarken AJ, 2005, ANNU REV CLIN PSYCHO, V1, P31, DOI 10.1146/annurev.clinpsy.1.102803.144239; Transparency International-Kenya, 2011, KEN HLTH SECT INT ST, DOI Transparency International-Kenya; United Nations Development and Programme, 2005, HUMAN DEV REPORT 200; United Nations Development Programme, 2011, HUM DEV REP 2011 MAN; Waltz CF., 2010, MEASUREMENT NURSING; Woodward A, 2000, J EPIDEMIOL COMMUN H, V54, P923, DOI 10.1136/jech.54.12.923; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, 2009, WHO COUNTR COOP STRA	86	11	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127160	10.1371/journal.pone.0127160	http://dx.doi.org/10.1371/journal.pone.0127160			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7ST	26039053	Green Submitted, Green Published, gold			2022-12-27	WOS:000355700700051
J	Rojas, M; Golovko, G; Khanipov, K; Albayrak, L; Chumakov, S; Pettitt, BM; Strongin, AY; Fofanov, Y				Rojas, Mark; Golovko, Georgiy; Khanipov, Kamil; Albayrak, Levent; Chumakov, Sergei; Pettitt, B. Montgomery; Strongin, Alex Y.; Fofanov, Yuriy			Secondary Analysis of the NCI-60 Whole Exome Sequencing Data Indicates Significant Presence of Propionibacterium acnes Genomic Material in Leukemia (RPMI-8226) and Central Nervous System (SF-295, SF-539, and SNB-19) Cell Lines	PLOS ONE			English	Article							PANEL	The NCI-60 human tumor cell line panel has been used in a broad range of cancer research over the last two decades. A landmark 2013 whole exome sequencing study of this panel added an exceptional new resource for cancer biologists. The complementary analysis of the sequencing data produced by this study suggests the presence of Propionibacterium acnes genomic sequences in almost half of the datasets, with the highest abundance in the leukemia (RPMI-8226) and central nervous system (SF-295, SF-539, and SNB-19) cell lines. While the origin of these contaminating bacterial sequences remains to be determined, observed results suggest that computational control for the presence of microbial genomic material is a necessary step in the analysis of the high throughput sequencing (HTS) data.	[Rojas, Mark; Golovko, Georgiy; Khanipov, Kamil; Albayrak, Levent; Pettitt, B. Montgomery; Fofanov, Yuriy] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Pettitt, B. Montgomery] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Rojas, Mark; Golovko, Georgiy; Khanipov, Kamil; Albayrak, Levent; Pettitt, B. Montgomery; Fofanov, Yuriy] Univ Texas Med Branch, Sealy Ctr Struct Biol, Galveston, TX 77555 USA; [Chumakov, Sergei] Univ Guadalajara, Dept Phys, Guadalajara 44430, Jalisco, Mexico; [Strongin, Alex Y.] Sanford Burnham Med Res Inst, Inflammatory & Infect Dis Ctr, Canc Res Ctr, La Jolla, CA USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Universidad de Guadalajara; Sanford Burnham Prebys Medical Discovery Institute	Rojas, M (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.	mmrojas@utmb.edu	Khanipov, Kamil/Y-6486-2019; Strongin, Alex/R-6609-2019; Rojas, Mark/U-8689-2019	Khanipov, Kamil/0000-0002-3881-737X; Strongin, Alex/0000-0003-3765-3016; Golovko, George/0000-0003-4609-2767	NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA030199] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Cao SB, 2015, J VIROL, V89, P713, DOI 10.1128/JVI.02570-14; Chen YX, 2013, BIOINFORMATICS, V29, P266, DOI 10.1093/bioinformatics/bts665; Deschavanne PJ, 1999, MOL BIOL EVOL, V16, P1391, DOI 10.1093/oxfordjournals.molbev.a026048; Fofanov Y, 2004, BIOINFORMATICS, V20, P2421, DOI 10.1093/bioinformatics/bth266; KARLIN S, 1994, P NATL ACAD SCI USA, V91, P12832, DOI 10.1073/pnas.91.26.12832; Khoury JD, 2013, J VIROL, V87, P8916, DOI 10.1128/JVI.00340-13; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lorenzi PL, 2009, MOL CANCER THER, V8, P713, DOI 10.1158/1535-7163.MCT-08-0921; Lusk RW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110808; NUSSINOV R, 1984, NUCLEIC ACIDS RES, V12, P1749, DOI 10.1093/nar/12.3.1749; Pevsner J, 2009, BIOINFORMATICS FUNCT; Samuels DC, 2013, TRENDS GENET, V29, P593, DOI 10.1016/j.tig.2013.07.006; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951	15	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127799	10.1371/journal.pone.0127799	http://dx.doi.org/10.1371/journal.pone.0127799			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039084	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700075
J	Sherstyuk, VV; Shevchenko, AI; Zakian, SM				Sherstyuk, Vladimir V.; Shevchenko, Alexander I.; Zakian, Suren M.			Mapping of Replication Origins in the X Inactivation Center of Vole Microtus levis Reveals Extended Replication Initiation Zone	PLOS ONE			English	Article							DIHYDROFOLATE-REDUCTASE ORIGIN; VARIANT HISTONE H3.3; DNA-REPLICATION; GENOME-WIDE; XIST LOCUS; CHROMOSOME; CHROMATIN; SITES; GENE; CELLS	DNA replication initiates at specific positions termed replication origins. Genome-wide studies of human replication origins have shown that origins are organized into replication initiation zones. However, only few replication initiation zones have been described so far. Moreover, few origins were mapped in other mammalian species besides human and mouse. Here we analyzed pattern of short nascent strands in the X inactivation center (XIC) of vole Microtus levis in fibroblasts, trophoblast stem cells, and extraembryonic endoderm stem cells and confirmed origins locations by ChIP approach. We found that replication could be initiated in a significant part of XIC. We also analyzed state of XIC chromatin in these cell types. We compared origin localization in the mouse and vole XIC. Interestingly, origins associated with gene promoters are conserved in these species. The data obtained allow us to suggest that the X inactivation center of M. levis is one extended replication initiation zone.	[Sherstyuk, Vladimir V.; Shevchenko, Alexander I.; Zakian, Suren M.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; [Sherstyuk, Vladimir V.; Shevchenko, Alexander I.; Zakian, Suren M.] State Res Inst Circulat Pathol, Novosibirsk, Russia; [Sherstyuk, Vladimir V.; Shevchenko, Alexander I.; Zakian, Suren M.] Russian Acad Sci, Siberian Branch, Inst Chem Biol & Fundamental Med, Novosibirsk, Russia; [Zakian, Suren M.] Novosibirsk State Univ, Novosibirsk 630090, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Meshalkin National Medical Research Center; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University	Zakian, SM (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia.	zakian@bionet.nsc.ru	Shevchenko, Alexander I./T-3400-2018; Sherstyuk, Vladimir V/B-1939-2018; Zakian, Suren/J-2196-2018	Sherstyuk, Vladimir/0000-0001-8863-6545; Zakian, Suren/0000-0003-2448-6511	Russian Foundation for Basic Research [14-04-00710]; Russian State Project VI [60.1.2]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian State Project VI	This work was supported by the Russian Foundation for Basic Research (grant no. 14-04-00710), and Russian State Project VI. 60.1.2 (http://www.rfbr.ru/rffi/ru/) (https://kias.rfbr.ru/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Aladjem MI, 2002, MOL CELL BIOL, V22, P442, DOI 10.1128/MCB.22.2.442-452.2002; Aladjem MI, 2007, NAT REV GENET, V8, P588, DOI 10.1038/nrg2143; Austin RJ, 1999, GENE DEV, V13, P2639, DOI 10.1101/gad.13.20.2639; Besnard E, 2012, NAT STRUCT MOL BIOL, V19, P837, DOI 10.1038/nsmb.2339; Borowiec JA, 2011, CURR OPIN CELL BIOL, V23, P284, DOI 10.1016/j.ceb.2011.04.004; Cadoret JC, 2008, P NATL ACAD SCI USA, V105, P15837, DOI 10.1073/pnas.0805208105; Cayrou C, 2012, CELL CYCLE, V11, P658, DOI 10.4161/cc.11.4.19097; Cayrou C, 2011, GENOME RES, V21, P1438, DOI 10.1101/gr.121830.111; Chow CM, 2005, EMBO REP, V6, P354, DOI 10.1038/sj.embor.7400366; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; Conroy RS, 2010, EUR BIOPHYS J BIOPHY, V39, P337, DOI 10.1007/s00249-009-0502-5; Dazy S, 2006, EMBO REP, V7, P806, DOI 10.1038/sj.embor.7400736; DIFFLEY JFX, 1994, CURR OPIN CELL BIOL, V6, P368, DOI 10.1016/0955-0674(94)90028-0; DIJKWEL PA, 1995, MOL CELL BIOL, V15, P3023; Dijkwel PA, 2002, MOL CELL BIOL, V22, P3053, DOI 10.1128/MCB.22.9.3053-3065.2002; Eaton ML, 2011, GENOME RES, V21, P164, DOI 10.1101/gr.116038.110; Eddy J, 2009, MOL CARCINOGEN, V48, P319, DOI 10.1002/mc.20496; Elisaphenko EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002521; Gencheva M, 1996, J BIOL CHEM, V271, P2608, DOI 10.1074/jbc.271.5.2608; Gerbi SA, 1997, METHODS, V13, P271, DOI 10.1006/meth.1997.0526; Gerbi Susan A., 2004, V296, P167; GIACCA M, 1994, P NATL ACAD SCI USA, V91, P7119, DOI 10.1073/pnas.91.15.7119; Gilbert DM, 2010, NAT REV GENET, V11, P673, DOI 10.1038/nrg2830; Gomez M, 2004, P NATL ACAD SCI USA, V101, P6923, DOI 10.1073/pnas.0401854101; Gregoire D, 2006, EMBO REP, V7, P812, DOI 10.1038/sj.embor.7400758; Grigor'eva EV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007161; Halder R, 2010, MOL BIOSYST, V6, P2439, DOI 10.1039/c0mb00009d; Hayashi MT, 2011, CHROMOSOMA, V120, P39, DOI 10.1007/s00412-010-0287-4; Hoshina S, 2013, J BIOL CHEM, V288, P30161, DOI 10.1074/jbc.M113.492504; HUBERMAN JA, 1966, P NATL ACAD SCI USA, V55, P599, DOI 10.1073/pnas.55.3.599; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Johnston CM, 2002, GENOMICS, V80, P236, DOI 10.1006/geno.2002.6819; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; Keller C, 2002, J BIOL CHEM, V277, P31430, DOI 10.1074/jbc.M202165200; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Ladenburger EM, 2002, MOL CELL BIOL, V22, P1036, DOI 10.1128/MCB.22.4.1036-1048.2002; Lebofsky R, 2006, MOL BIOL CELL, V17, P5337, DOI 10.1091/mbc.E06-04-0298; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lombrana R, 2013, EMBO J, V32, P2631, DOI 10.1038/emboj.2013.195; Lubelsky Y, 2011, NUCLEIC ACIDS RES, V39, P3141, DOI 10.1093/nar/gkq1276; Luikenhuis S, 2001, MOL CELL BIOL, V21, P8512, DOI 10.1128/MCB.21.24.8512-8520.2001; LYON MF, 1986, NATURE, V320, P313, DOI 10.1038/320313b0; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Mazurok N. A., 2003, Ontogenez, V34, P193; Mesner LD, 2013, GENOME RES, V23, P1774, DOI 10.1101/gr.155218.113; Navarro P, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-8; NESTEROVA TB, 1994, CYTOGENET CELL GENET, V65, P250, DOI 10.1159/000133641; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; Norio P, 2005, MOL CELL, V20, P575, DOI 10.1016/j.molcel.2005.10.029; Ogawa Y, 1999, MOL CELL BIOL, V19, P7228; Ohhata T, 2006, CYTOGENET GENOME RES, V113, P345, DOI 10.1159/000090851; Orishchenko KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033994; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Pera RAR, 2009, DIFFERENTIATION, V78, P18, DOI 10.1016/j.diff.2009.03.004; Perkins TT, 2003, SCIENCE, V301, P1914, DOI 10.1126/science.1088047; Picard F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004282; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; Rowntree RK, 2006, MOL CELL BIOL, V26, P3707, DOI 10.1128/MCB.26.10.3707-3717.2006; Schultz SS, 2010, MOL CELL BIOL, V30, P4521, DOI 10.1128/MCB.00380-10; Sequeira-Mendes J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000446; Sherstyuk VV, 2014, CHROMOSOMA, V123, P183, DOI 10.1007/s00412-013-0448-3; Shevchenko A I, 2008, Genetika, V44, P1477; Shevchenko AI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022771; Shevchenko AI, 2009, MAMM GENOME, V20, P644, DOI 10.1007/s00335-009-9201-x; Stavropoulos N, 2001, P NATL ACAD SCI USA, V98, P10232, DOI 10.1073/pnas.171243598; Stroud H, 2012, P NATL ACAD SCI USA, V109, P5370, DOI 10.1073/pnas.1203145109; Sun S, 2013, CELL, V153, P1537, DOI 10.1016/j.cell.2013.05.028; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Toledo F, 1998, NUCLEIC ACIDS RES, V26, P2313, DOI 10.1093/nar/26.10.2313; Tsai CL, 2008, DEV BIOL, V319, P416, DOI 10.1016/j.ydbio.2008.04.010; Valton AL, 2014, EMBO J, V33, P732, DOI 10.1002/embj.201387506; Vaskova EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088256; Wirbelauer C, 2005, GENE DEV, V19, P1761, DOI 10.1101/gad.347705; Wongtawan T, 2011, J CELL SCI, V124, P1878, DOI 10.1242/jcs.080721; Yen ZC, 2007, GENOMICS, V90, P453, DOI 10.1016/j.ygeno.2007.07.002; Zhou J, 2002, P NATL ACAD SCI USA, V99, P13693, DOI 10.1073/pnas.212392399	79	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128497	10.1371/journal.pone.0128497	http://dx.doi.org/10.1371/journal.pone.0128497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26038842	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700105
J	Vrbsky, J; Tereh, T; Kyrylenko, S; Dvorak, P; Krejci, L				Vrbsky, Jan; Tereh, Tamas; Kyrylenko, Sergiy; Dvorak, Petr; Krejci, Lumir			MEK and TGF-beta Inhibition Promotes Reprogramming without the Use of Transcription Factor	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; HUMAN SOMATIC-CELLS; SMALL-MOLECULE COMPOUNDS; PRIMORDIAL GERM-CELLS; SELF-RENEWAL; NEURONAL DIFFERENTIATION; PROGENITOR CELLS; MOUSE; INDUCTION; NANOG	The possibility of replacing the originally discovered and widely used DNA reprogramming transcription factors is stimulating enormous effort to identify more effective compounds that would not alter the genetic information. Here, we describe the generation of induced pluripotent stem cells (iPSc) from head-derived primary culture of mouse embryonic cells using small chemical inhibitors of the MEK and TGF-beta pathways without delivery of exogenous transcription factors. These iPSc express standard pluripotency markers and retain their potential to differentiate into cells of all germ layers. Our data indicate that head-derived embryonic neural cells might have the reprogramming potential while neither the same primary cells cultivated over five passages in vitro nor a cell population derived from adult brain possesses this capacity. Our results reveal the potential for small molecules to functionally replace routinely used transcription factors and lift the veil on molecular regulation controlling pluripotency. The conditions described here could provide a platform upon which other genome non integrative and safer reprogramming processes could be developed. This work also shows novel potential for developing embryonic neural cells.	[Vrbsky, Jan; Tereh, Tamas; Kyrylenko, Sergiy; Dvorak, Petr; Krejci, Lumir] Masaryk Univ, Fac Med, Dept Biol, Brno 62500, Czech Republic; [Vrbsky, Jan; Dvorak, Petr; Krejci, Lumir] St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno 65691, Czech Republic; [Krejci, Lumir] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Brno 60200, Czech Republic	Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno	Krejci, L (corresponding author), Masaryk Univ, Fac Med, Dept Biol, Kamenice 5, Brno 62500, Czech Republic.	lkrejci@chemi.muni.cz	Dvorak, Petr/N-8936-2016; Krejci, Lumir/B-7842-2009; Kyrylenko, Sergiy/AAH-1090-2019	Dvorak, Petr/0000-0002-3229-140X; Krejci, Lumir/0000-0002-4732-1405; Kyrylenko, Sergiy/0000-0002-4343-0065	Czech Science Foundation [GACR P207/12/2323, 13-26629S]; European Regional Development Fund - Project FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]; European Social Fund; state budget of the Czech Republic [CZ.1.07/2.3.00/20.0011]; European Community within the Seventh Framework Programme (FP) [229603]; South Moravian Region of Czech Republic within the SoMoPro programme;  [IGA MZ NS10231-3/2009]	Czech Science Foundation(Grant Agency of the Czech Republic); European Regional Development Fund - Project FNUSA-ICRC; European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic; European Community within the Seventh Framework Programme (FP); South Moravian Region of Czech Republic within the SoMoPro programme; 	This study was supported by grant IGA MZNS10231-3/2009; Czech Science Foundation (GACR P207/12/2323 and 13-26629S); European Regional Development Fund - Project FNUSA-ICRC (CZ.1.05/1.1.00/02.0123), co-financed from the European Social Fund and the state budget of the Czech Republic (CZ.1.07/2.3.00/20.0011); and European Community within the Seventh Framework Programme (FP/2007-2013) under Grant Agreement No. 229603, co-financed by the South Moravian Region of Czech Republic within the SoMoPro programme (for SK). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A EM, 2007, CURR PROTOC STEM CEL; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Bru T, 2008, EXP CELL RES, V314, P2634, DOI 10.1016/j.yexcr.2008.05.009; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen JK, 2011, CELL RES, V21, P205, DOI 10.1038/cr.2010.172; De-Miguel MP, 2009, INT J DEV BIOL, V53, P1529, DOI 10.1387/ijdb.072413md; Durcova-Hills G, 2004, ISOLATION MAINTENANC, P451; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; Eiselleova L, 2008, INT J DEV BIOL, V52, P353, DOI 10.1387/ijdb.082590le; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Guo J, 2009, BIOCHEM BIOPH RES CO, V390, P1081, DOI 10.1016/j.bbrc.2009.11.017; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hayashi K, 2009, CELL STEM CELL, V4, P493, DOI 10.1016/j.stem.2009.05.007; Hester ME, 2009, PLOS ONE, V4; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Imamura M, 2010, MOL REPROD DEV, V77, P802, DOI 10.1002/mrd.21223; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kaufman MH, 1995, ATLAS MOUSE DEV; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Li M, 2012, AM J STEM CELLS, V1, P75; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; McLaren A, 2005, DIFFERENTIATION, V73, P435, DOI 10.1111/j.1432-0436.2005.00049.x; Minina V I, 2009, Genetika, V45, P239; Nakagomi N, 2009, STEM CELLS, V27, P2185, DOI 10.1002/stem.161; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Raghavan S, 2013, BIOMATERIALS, V34, P6649, DOI 10.1016/j.biomaterials.2013.05.023; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Sun XY, 2010, AGEING RES REV, V9, P475, DOI 10.1016/j.arr.2010.06.002; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Viviani Barbara, 2006, Curr Protoc Cell Biol, VChapter 2, DOI 10.1002/0471143030.cb0207s32; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yakubov E, 2010, BIOCHEM BIOPH RES CO, V394, P189, DOI 10.1016/j.bbrc.2010.02.150; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	52	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127739	10.1371/journal.pone.0127739	http://dx.doi.org/10.1371/journal.pone.0127739			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039048	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700073
J	Wilson, EC; Jin, H; Liu, A; Raymond, HF				Wilson, Erin C.; Jin, Harry; Liu, Albert; Raymond, H. Fisher			Knowledge, Indications and Willingness to Take Pre-Exposure Prophylaxis among Transwomen in San Francisco, 2013	PLOS ONE			English	Article							TO-FEMALE TRANSGENDER; HEALTH-CARE; ANTIRETROVIRAL PROPHYLAXIS; HIV-INFECTION; RISK BEHAVIORS; SEX; MEN; BARRIERS; SAMPLE; FACILITATORS	Safe and effective HIV prevention strategies are needed for transwomen. Transwomen in the US have a 34 times greater odds of being infected with HIV than all adults age 15-49, and in San Francisco, California 42.4% of transwomen are estimated to be infected with HIV. Pre-exposure prophylaxis (PrEP) is the first biomedical intervention with promise for reducing HIV acquisition in transwomen. However, little is known about whether transwomen know about PrEP, are taking PrEP and would be good candidates for PrEP based on their risk profile and behaviors. A population-based dataset was analyzed to determine how many transwomen in San Francisco knew about PrEP by the end of 2013 - more than a year after iPrex results demonstrated efficacy of PrEP in preventing HIV. We found that of 233 transwomen, only 13.7% had heard of PrEP. Transwomen who were living with HIV compared to those who were HIV-negative, and those who recently injected drugs compared to non-injection drug users were more likely to have heard of PrEP. Based on CDC guidelines for PrEP among MSM and IDU, 45 (30.2%) transwomen of the 149 HIV-negative transwomen in the sample were candidates for PrEP. This estimate based on CDC criteria is arguably low. Given that almost half of transwomen in San Francisco are living with HIV, this findings points to a need for further consideration of PrEP criteria that are specific and tailored to the risks for HIV faced by transwomen that are different from MSM and injection drug users. Research to scale up access and test the effectiveness of PrEP for transwomen is also urgently needed.	[Wilson, Erin C.; Jin, Harry; Raymond, H. Fisher] San Francisco Dept Publ Hlth, Ctr Publ Hlth Res, San Francisco, CA 94102 USA; [Liu, Albert] San Francisco Dept Publ Hlth, Bridge HIV, San Francisco, CA USA	San Francisco Department of Public Health; San Francisco Department of Public Health	Wilson, EC (corresponding author), San Francisco Dept Publ Hlth, Ctr Publ Hlth Res, San Francisco, CA 94102 USA.	erin.wilson@sfdph.org		Raymond, Henry/0000-0001-8621-2749				Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Andrasik MP, 2014, PREV SCI, V15, P268, DOI 10.1007/s11121-013-0371-0; [Anonymous], 2012, FDA APPROVES FIRST D; [Anonymous], 2014, J SEX MED; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Bradford J, 2013, AM J PUBLIC HEALTH, V103, P1820, DOI 10.2105/AJPH.2012.300796; Campbell JD, 2013, AM J PREV MED, V44, pS63, DOI 10.1016/j.amepre.2012.09.045; Clements-Nolle K, 2001, AM J PUBLIC HEALTH, V91, P915, DOI 10.2105/AJPH.91.6.915; De Santis JP, 2009, J ASSOC NURSE AIDS C, V20, P362, DOI 10.1016/j.jana.2009.06.005; Edwards JW, 2007, AM J PUBLIC HEALTH, V97, P1030, DOI 10.2105/AJPH.2006.097717; Galea JT, 2011, INT J STD AIDS, V22, P256, DOI 10.1258/ijsa.2009.009255; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grohskopf L, 2011, AM J TRANSPLANT, V11, P2250, DOI 10.1111/j.1600-6143.2011.03793.x; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Holmes D, 2012, LANCET, V380, P325, DOI 10.1016/S0140-6736(12)61235-5; Jones A, 2014, LANCET; Kenagy GP, 2005, HEALTH SOC WORK, V30, P19, DOI 10.1093/hsw/30.1.19; Kosenko K, 2013, MED CARE, V51, P819, DOI 10.1097/MLR.0b013e31829fa90d; Krakower DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033119; Leibowitz AA, 2011, AM J PUBLIC HEALTH, V101, P982, DOI 10.2105/AJPH.2010.300066; Logie CH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001124; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; McKnight C, 2006, J URBAN HEALTH, V83, pI54, DOI 10.1007/s11524-006-9102-1; Mereish EH, 2014, PSYCHOL HEALTH MED, V19, P1, DOI 10.1080/13548506.2013.780129; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; Nemoto T, 2004, AM J PUBLIC HEALTH, V94, P1193, DOI 10.2105/AJPH.94.7.1193; Nemoto T, 2011, AM J PUBLIC HEALTH, V101, P1980, DOI 10.2105/AJPH.2010.197285; Organization WH, 2012, GUIDANCE ON PRE EXPO; Poteat T, 2013, SOC SCI MED, V84, P22, DOI 10.1016/j.socscimed.2013.02.019; Pujazon-Zazik M, 2010, AM J MENS HEALTH, V4, P77, DOI 10.1177/1557988309360819; Rapues J, 2013, AM J PUBLIC HEALTH, V103, P1485, DOI 10.2105/AJPH.2012.301109; Roberts TK, 2014, CLIN BIOCHEM, V47, P983, DOI 10.1016/j.clinbiochem.2014.02.009; Rucinski KB, 2013, AIDS BEHAV, V17, P2180, DOI 10.1007/s10461-013-0443-y; Sevelius J, 2013, 8TH INTERNATIONAL CO; (SFDPH) SFDoPH, 2008, HIV AIDS EPIDEMIOLOG; Smith D. K., 2012, Morbidity and Mortality Weekly Report, V61, P586; Smith DK, 2013, MMWR-MORBID MORTAL W, V62, P463; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; US Public Health Service, 2014, PREEXPOSURE PROPHYLA; Warren MJ, 2013, AM J PREV MED, V44, pS167, DOI 10.1016/j.amepre.2012.10.006; Wejnert C, 2008, SOCIOL METHOD RES, V37, P105, DOI 10.1177/0049124108318333; Wilson E, 2014, J SEX MED, V11, P1717, DOI 10.1111/jsm.12558; Wilson EC, 2013, INT J TRANSGENDERISM, V14, P182, DOI 10.1080/15532739.2014.890090; Wilson EC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-430	47	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128971	10.1371/journal.pone.0128971	http://dx.doi.org/10.1371/journal.pone.0128971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7ST	26039511	Green Submitted, Green Published, gold			2022-12-27	WOS:000355700700133
J	Yan, DP; Lu, YZ; Levy, D				Yan, Danping; Lu, Yongzhong; Levy, David			Parameter Identification of Robot Manipulators: A Heuristic Particle Swarm Search Approach	PLOS ONE			English	Article							INERTIAL PARAMETERS; OPTIMIZATION; PSO; ALGORITHMS	Parameter identification of robot manipulators is an indispensable pivotal process of achieving accurate dynamic robot models. Since these kinetic models are highly nonlinear, it is not easy to tackle the matter of identifying their parameters. To solve the difficulty effectively, we herewith present an intelligent approach, namely, a heuristic particle swarm optimization (PSO) algorithm, which we call the elitist learning strategy (ELS) and proportional integral derivative (PID) controller hybridized PSO approach (ELPIDSO). A specified PID controller is designed to improve particles' local and global positions information together with ELS. Parameter identification of robot manipulators is conducted for performance evaluation of our proposed approach. Experimental results clearly indicate the following findings: Compared with standard PSO (SPSO) algorithm, ELPIDSO has improved a lot. It not only enhances the diversity of the swarm, but also features better search effectiveness and efficiency in solving practical optimization problems. Accordingly, ELPIDSO is superior to least squares (LS) method, genetic algorithm (GA), and SPSO algorithm in estimating the parameters of the kinetic models of robot manipulators.	[Yan, Danping] Huazhong Univ Sci & Technol, Coll Publ Adm, Wuhan 430074, Hubei, Peoples R China; [Yan, Danping] Huazhong Univ Sci & Technol, Nontradit Secur Ctr, Wuhan 430074, Hubei, Peoples R China; [Lu, Yongzhong] Huazhong Univ Sci & Technol, Sch Software Engn, Wuhan 430074, Hubei, Peoples R China; [Levy, David] Univ Sydney, Fac Engn & Informat Technol, Sydney, NSW 2006, Australia	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Sydney	Lu, YZ (corresponding author), Huazhong Univ Sci & Technol, Sch Software Engn, Wuhan 430074, Hubei, Peoples R China.	yongzhonglu@gmail.com	Levy, David/GPS-4945-2022		National 985 Project of Non-traditional Security at Huazhong University of Science and Technology; Fundamental Research Funds for the Central Universities, HUST [2014AA027]	National 985 Project of Non-traditional Security at Huazhong University of Science and Technology; Fundamental Research Funds for the Central Universities, HUST(Fundamental Research Funds for the Central Universities)	The authors declare that this work is supported by National 985 Project of Non-traditional Security at Huazhong University of Science and Technology, and is also funded by the Fundamental Research Funds for the Central Universities, HUST: 2014AA027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghababa MP, 2012, APPL OCEAN RES, V38, P48, DOI 10.1016/j.apor.2012.06.002; Anh Ho Pham Huy, 2009, 2009 IEEE/ASME International Conference on Advanced Intelligent Mechatronics (AIM), P1282, DOI 10.1109/AIM.2009.5229833; ARMSTRONG B, 1989, INT J ROBOT RES, V8, P28, DOI 10.1177/027836498900800603; ATKESON CG, 1986, INT J ROBOT RES, V5, P101, DOI 10.1177/027836498600500306; BILLINGS SA, 1978, P I ELECTR ENG, V125, P691, DOI 10.1049/piee.1978.0161; Bingul Z, 2011, EXPERT SYST APPL, V38, P4136, DOI 10.1016/j.eswa.2010.09.076; Calanca A, 2011, IEEE T CONTR SYST T, V19, P1214, DOI 10.1109/TCST.2010.2077294; Calvini M, 2015, IEEE T IND ELECTRON, V62, P768, DOI 10.1109/TIE.2014.2349478; Diaz-Rodriguez M, 2010, MECH MACH THEORY, V45, P1337, DOI 10.1016/j.mechmachtheory.2010.04.007; Eberhart R., 1995, MHS'95. Proceedings of the Sixth International Symposium on Micro Machine and Human Science (Cat. No.95TH8079), P39, DOI 10.1109/MHS.1995.494215; Gao Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09295; Garcia-Nieto J, 2013, IEEE T EVOLUT COMPUT, V17, P823, DOI 10.1109/TEVC.2013.2260755; GAUTIER M, 1990, IEEE T ROBOTIC AUTOM, V6, P368, DOI 10.1109/70.56655; Gautier M, 2013, IEEE T CONTR SYST T, V21, P428, DOI 10.1109/TCST.2012.2185697; Ghamisi P, 2015, IEEE T GEOSCI REMOTE, V53, P2935, DOI 10.1109/TGRS.2014.2367010; Janot A, 2014, IEEE T CONTR SYST T, V22, P132, DOI 10.1109/TCST.2013.2246163; Jiang B, 2014, SOFT COMPUT, V18, P1079, DOI 10.1007/s00500-013-1128-1; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; KHEMAISSIA S, 1992, IEE CONF PUBL, V360, P299; Koker R, 2013, INFORM SCIENCES, V222, P528, DOI 10.1016/j.ins.2012.07.051; Kusetogullari H, 2015, IEEE J-STSP, V9, DOI 10.1109/JSTSP.2014.2331911; Levine W., 1996, CONTROL HDB; Liang JJ, 2006, IEEE T EVOLUT COMPUT, V10, P281, DOI 10.1109/TEVC.2005.857610; Liang XL, 2015, SOFT COMPUT, V19, P431, DOI 10.1007/s00500-014-1262-4; LIN SK, 1992, J ROBOTIC SYST, V9, P505, DOI 10.1002/rob.4620090405; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097822; Lu Y, 2015, APPL INTELLIGENCE; Lu YZ, 2015, INFORM SCIENCES, V297, P21, DOI 10.1016/j.ins.2014.11.017; Lu YZ, 2011, CONNECT SCI, V23, P45, DOI 10.1080/09540091.2011.573070; Mata V, 2005, ADV ROBOTICS, V19, P101, DOI 10.1163/1568553053020269; Montes de Oca MA, 2009, IEEE T EVOLUT COMPUT, V13, P1120, DOI 10.1109/TEVC.2009.2021465; Olsen MM, 2001, IEEE T ROBOTIC AUTOM, V17, P95, DOI 10.1109/70.917088; Ratnaweera A, 2004, IEEE T EVOLUT COMPUT, V8, P240, DOI [10.1109/TEVC.2004.826071, 10.1109/tevc.2004.826071]; SLOTINE JJE, 1987, INT J ROBOT RES, V6, P49, DOI 10.1177/027836498700600303; Supriyono H, 2012, ENG APPL ARTIF INTEL, V25, P898, DOI 10.1016/j.engappai.2012.03.004; Swevers J, 2007, IEEE CONTR SYST MAG, V27, P58, DOI 10.1109/MCS.2007.904659; Tanweer MR, 2015, INFORM SCIENCES, V294, P182, DOI 10.1016/j.ins.2014.09.053; Thanh TD, 2012, MECH MACH THEORY, V52, P277, DOI 10.1016/j.mechmachtheory.2012.02.002; VANDANJON PO, 1995, IEEE INT CONF ROBOT, P3033, DOI 10.1109/ROBOT.1995.525715; Vuong ND, 2009, ACTA POLYTECH HUNG, V6, P51; Wang WQ, 2015, IEEE GEOSCI REMOTE S, V12, P781, DOI 10.1109/LGRS.2014.2361834; Wang YX, 2010, ACM T AUTON ADAP SYS, V5, DOI 10.1145/1671948.1671949; Wu J, 2010, ROBOT CIM-INT MANUF, V26, P414, DOI 10.1016/j.rcim.2010.03.013; Xian WM, 2014, IEEE T INSTRUM MEAS, V63, P2, DOI 10.1109/TIM.2013.2276473; Yoshida K, 2000, INT J ROBOT RES, V19, P498, DOI 10.1177/02783640022066996; Zhan ZH, 2009, IEEE T SYST MAN CY B, V39, P1362, DOI 10.1109/TSMCB.2009.2015956; Zhang L, 2015, ARCH BIOCHEM BIOPHYS, V573, P69, DOI 10.1016/j.abb.2015.03.015	48	7	7	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0129157	10.1371/journal.pone.0129157	http://dx.doi.org/10.1371/journal.pone.0129157			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039090	gold, Green Published, Green Submitted			2022-12-27	WOS:000355700700141
J	Nasiri, MJ; Dabiri, H; Darban-Sarokhalil, D; Shahraki, AH				Nasiri, Mohammad Javad; Dabiri, Hossein; Darban-Sarokhalil, Davood; Shahraki, Abdolrazagh Hashemi			Prevalence of Non-Tuberculosis Mycobacterial Infections among Tuberculosis Suspects in Iran: Systematic Review and Meta-Analysis	PLOS ONE			English	Article							IDENTIFICATION	Introduction The infections due to Non-Tuberculosis Mycobacteria (NTM) are becoming an important health problem in many countries in the world. Globally, an increase in NTM infections has been reported from many countries around the world. However, limited information is available about the prevalence of NTM infections in Iran. Material and Methods The data of the prevalence of NTM infections were collected from databases such as PubMed, Web of science, Cochrane Library, Embase, Scopus, Iranmedex, and Scientific Information Database. Comprehensive Meta-Analysis (V2.0, Biostat) software was used to analyze the data. Results The meta-analyses showed that the prevalence of NTM infections was 10.2% (95% confidence interval [95% CI] 6.3-15.9) among culture-positive cases of tuberculosis (TB) in Iran. The further stratified analyses indicated that the prevalence of NTM was higher in studies that were done after year 2000. Additionally, M. simiae (43.3% [95% CI 36.8-50.0]), M. intracellucar (27.3% [95% CI 0.7-95.5]) and M. fortuitum (22.7% [95% CI 16.1-30.9]) were the most prevalent NTM species, respectively. Discussion The relatively high prevalence of NTM infections (10.2%) among culture positive cases for TB underlines the need for greater enforcement of infection control strategies. Establishment of appropriate diagnostic criteria and management guidelines for NTM diseases and expanding the number and quality of regional reference laboratories may facilitate more accurate action for prevention and control of NTM infections in Iran.	[Nasiri, Mohammad Javad; Dabiri, Hossein] Shahid Beheshti Univ Med Sci, Sch Med, Dept Microbiol, Tehran, Iran; [Darban-Sarokhalil, Davood] Iran Univ Med Sci, Sch Med, Dept Microbiol, Tehran, Iran; [Shahraki, Abdolrazagh Hashemi] Pasteur Inst Iran, Dept Epidemiol, Tehran, Iran	Shahid Beheshti University Medical Sciences; Iran University of Medical Sciences; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Nasiri, MJ (corresponding author), Shahid Beheshti Univ Med Sci, Sch Med, Dept Microbiol, Tehran, Iran.	mj.nasiri@hotmail.com	Hashemi Shahraki, Abdolrazagh/AAG-2663-2021	Hashemi Shahraki, Abdolrazagh/0000-0003-1852-194X				Bahrmand AR, 1996, SCAND J INFECT DIS, V28, P275, DOI 10.3109/00365549609027172; CARSON LA, 1978, APPL ENVIRON MICROB, V36, P839, DOI 10.1128/AEM.36.6.839-846.1978; Cassidy PM, 2009, CLIN INFECT DIS, V49, pE124, DOI 10.1086/648443; De Groote MA, 2006, CLIN INFECT DIS, V42, P1756, DOI 10.1086/504381; Derakhshani Z, 2014, KURDESTAN MED J, V19, P31; Gopinath K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000615; Hashemi-Shahraki A, 2013, JPN J INFECT DIS, V66, P475, DOI 10.7883/yoken.66.475; Heidarnejad H, 2001, ARC IRAN MED, V4, P1; Henry MT, 2004, EUR RESPIR J, V23, P741, DOI 10.1183/09031936.04.00114004; Heydari F, 2009, ZANJAN MED J, V17, P33; Javid S, 2009, MED LAB J, V3, P7; Khosravi A. D., 2009, Research Journal of Microbiology, V4, P143, DOI 10.3923/jm.2009.143.149; Marras TK, 2007, THORAX, V62, P661, DOI 10.1136/thx.2006.070797; McCallum AD, 2011, J ROY COLL PHYS EDIN, V41, P294, DOI 10.4997/JRCPE.2011.403; Moghtaderi P, 2011, IRANIAN J INFECT DIS, V17, P59; Mohammadi M, 1998, TEB VA TAZKIYEH, V28, P23; Moher D, 2015, CULT MED PSYCHIAT, V4, DOI DOI 10.1023/B:MEDI.0000005484.26741.79; Moniri R, 2001, J SHAHID SADUGHI U M, V9, P67; Naderi M., 2006, Research Journal of Microbiology, V1, P375; Namaei M, 2003, ARDABIL MED J, V2, P8; Nasiri MJ, 2014, AM J INFECT CONTROL, V42, P1212, DOI 10.1016/j.ajic.2014.07.017; Nasiri MJ, 2014, ASIAN PAC J TROP MED, V7, P193, DOI 10.1016/S1995-7645(14)60019-5; Nasrollahi M, 2012, MAZAN MED J, V21, P132; Oliver Antonio, 2001, Clinical Infectious Diseases, V32, P1298, DOI 10.1086/319987; Piersimoni C, 2008, LANCET INFECT DIS, V8, P323, DOI 10.1016/S1473-3099(08)70100-2; Richard J, 1990, AM REV RESPIR DIS, V142, P940; Roayaei M, 1999, AHWAZ MED J, V2, P69; Rohani M., 2009, Tehran University Medical Journal, V67, P173; Shafipour M., 2013, Annals of Biological Research, V4, P133; Taghi-Naserpour Farivar, 2006, Journal of Medical Sciences (Pakistan), V6, P292; Yazdi M. K. S., 2012, African Journal of Biotechnology, V11, P702	31	28	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129073	10.1371/journal.pone.0129073	http://dx.doi.org/10.1371/journal.pone.0129073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052701	Green Submitted, Green Published, gold			2022-12-27	WOS:000355955300082
J	Laass, MW; Rober, N; Range, U; Noss, L; Roggenbuck, D; Conrad, K				Laass, Martin W.; Roeber, Nadja; Range, Ursula; Noss, Lydia; Roggenbuck, Dirk; Conrad, Karsten			Loss and Gain of Tolerance to Pancreatic Glycoprotein 2 in Celiac Disease	PLOS ONE			English	Article							GRANULE MEMBRANE GLYCOPROTEIN; INFLAMMATORY BOWEL DISEASES; GLUTEN-FREE DIET; CROHNS-DISEASE; ANTIBODIES; GP2; AUTOANTIBODIES; PROTEIN; DIAGNOSIS; CLASSIFICATION	Background Autoantibodies against pancreatic secretory-granule membrane glycoprotein 2 (GP2) have been demonstrated in patients with Crohn's disease but recently also with celiac disease (CD). Both entities are characterized by intestinal barrier impairment with increased gut permeability. Pathophysiological hallmark of CD is a permanent loss of tolerance to alimentary gliadin and a transient loss of tolerance to the autoantigen human tissue transglutaminase (tTG). Therefore, we explored the behavior of loss of tolerance to GP2 reported in CD. Methods We assessed prevalences and levels of autoantibodies against GP2, CD-specific antibodies to endomysial antigens and tTG as well as Crohn's disease-specific anti-Saccharomyces cerevisiae antibodies in sera of 174 patients with active CD, 84 patients under glutenfree diet (GFD) and 129 controls. Furthermore, we looked for an association between anti-GP2 antibody positivity and degree of mucosal damage in CD. Results We found significantly elevated anti-GP2 IgA positivity in active CD patients (19.5%) compared to CD patients under GFD (0.0%) and controls (5.4%, p < 0.001, respectively). Anti-GP2 IgA levels correlated significantly with CD-specific antibodies (p < 0.001). Anti-GP2 autoantibody positivity disappeared under GFD similarly to CD-specific autoantibodies against tTG and endomysial antigens. For the first time, IgA antibody levels to GP2 are demonstrated to be associated with degree of villous atrophy according to Marsh classification. Conclusions Anti-GP2 IgA seems to be associated with disease activity in a distinct subgroup of patients with CD. The observed loss of tolerance to GP2 in a subset of patients with CD is transient and disappears under GFD.	[Laass, Martin W.; Noss, Lydia] Tech Univ Dresden, Med Fac Carl Gustav Carus, Childrens Hosp, D-01307 Dresden, Germany; [Roeber, Nadja; Conrad, Karsten] Tech Univ Dresden, Inst Immunol, D-01307 Dresden, Germany; [Range, Ursula] Tech Univ Dresden, Inst Med Informat & Biometry, D-01307 Dresden, Germany; [Roggenbuck, Dirk] GA Gener Assays GmbH, D-15827 Dahlewitz Berlin, Germany; [Roggenbuck, Dirk] Brandenburg Univ Technol Cottbus Senftenberg, Fac Sci, D-01968 Senftenberg, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Technische Universitat Dresden; Brandenburg University of Technology Cottbus	Laass, MW (corresponding author), Tech Univ Dresden, Med Fac Carl Gustav Carus, Childrens Hosp, D-01307 Dresden, Germany.	martin.laass@uniklinikum-dresden.de		Roggenbuck, Dirk/0000-0002-6861-6827; Laass, Martin/0000-0003-3670-3640	GA Generic Assays GmbH	GA Generic Assays GmbH	GA Generic Assays GmbH provided support in the form of salary for author DR but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ashorn S, 2009, J CLIN IMMUNOL, V29, P190, DOI 10.1007/s10875-008-9255-7; Bogdanos DP, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-102; Bogdanos DP, 2011, AUTOIMMUN REV, V11, P143, DOI 10.1016/j.autrev.2011.09.004; Bonaci-Nikolic B, 2012, CLIN CHIM ACTA, V413, P822, DOI 10.1016/j.cca.2012.01.005; Bonneau J, 2015, AUTOIMMUN REV, V14, P231, DOI 10.1016/j.autrev.2014.11.004; Conrad K, 2002, EUR J GASTROEN HEPAT, V14, P129, DOI 10.1097/00042737-200202000-00006; Conrad K, 2014, AUTOIMMUN REV, V13, P463, DOI 10.1016/j.autrev.2014.01.028; Conrad K, 2012, CLIN CHEM LAB MED, V50, P337, DOI [10.1515/CCLM.2011.760, 10.1515/cclm.2011.760]; De Beeck KO, 2012, GUT, V61, P162, DOI 10.1136/gut.2010.233148; Evans KE, 2010, DIGEST DIS SCI, V55, P2999, DOI 10.1007/s10620-010-1261-y; Festen EAM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001283; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gross S, 2014, J GASTROINTEST LIVER, V23, P127; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Holzl MA, 2011, CELL IMMUNOL, V267, P88, DOI 10.1016/j.cellimm.2010.12.001; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Juste C, 2014, GUT, V63, P1566, DOI 10.1136/gutjnl-2012-303786; Komorowski L, 2013, J CROHNS COLITIS, V7, P780, DOI 10.1016/j.crohns.2012.10.011; Laass MW, 2014, AUTOIMMUN REV, V13, P467, DOI 10.1016/j.autrev.2014.01.029; Mallant-Hent RC, 2006, EUR J GASTROEN HEPAT, V18, P75, DOI 10.1097/00042737-200601000-00013; Mitsuyama K, 2014, J GASTROENTEROL, V49, P683, DOI 10.1007/s00535-013-0916-9; Ohno H, 2010, GUT MICROBES, V1, P407, DOI 10.4161/gmic.1.6.14078; Oxford EC, 2013, AM J GASTROENTEROL, V108, P1123, DOI 10.1038/ajg.2013.20; Pavlidis P, 2011, CLIN CHIM ACTA, V412, P1163, DOI 10.1016/j.cca.2011.02.005; Rieder F, 2013, GASTROENTEROLOGY, V144, pS617; Roggenbuck D, 2009, GUT, V58, P1620, DOI 10.1136/gut.2008.162495; Roggenbuck D., 2009, PATHOGENESIS THERAPY, P449; Roggenbuck D, 2015, CLIN CHEM LAB MED, V53, P1349, DOI 10.1515/cclm-2014-0238; Roggenbuck D, 2015, CLIN CHIM ACTA, V442, P82, DOI 10.1016/j.cca.2015.01.018; Roggenbuck D, 2014, CLIN CHEM LAB MED, V52, P483, DOI 10.1515/cclm-2013-0801; Roggenbuck Dirk, 2013, J Crohns Colitis, V7, pe273, DOI 10.1016/j.crohns.2012.12.013; Roggenbuck D, 2013, ADV CLIN CHEM, V60, P187, DOI 10.1016/B978-0-12-407681-5.00006-4; Roggenbuck D, 2013, J PEDIATR GASTR NUTR, V56, pE5, DOI 10.1097/MPG.0b013e318275fa77; Roggenbuck D, 2012, GUT, V61, P164, DOI 10.1136/gut.2010.237214; Roggenbuck D, 2011, CLIN CHIM ACTA, V412, P718, DOI 10.1016/j.cca.2010.12.029; RONZIO RA, 1978, BIOCHIM BIOPHYS ACTA, V508, P65, DOI 10.1016/0005-2736(78)90189-X; Schierack P, 2015, GUT, V64, DOI 10.1136/gutjnl-2014-307854; Somma V, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/683824; Suzuki H, 2008, GASTROENTEROLOGY, V135, P917, DOI 10.1053/j.gastro.2008.05.037; Terahara K, 2008, J IMMUNOL, V180, P7840, DOI 10.4049/jimmunol.180.12.7840; Watanabe C, 2014, J GASTROENTEROL, V49, P825, DOI 10.1007/s00535-013-0838-6; Werner Lael, 2013, J Crohns Colitis, V7, pe604, DOI 10.1016/j.crohns.2013.06.017; Werner Lael, 2013, J Crohns Colitis, V7, pe522, DOI 10.1016/j.crohns.2013.03.009; Werner L, 2012, J IMMUNOL, V189, P2774, DOI 10.4049/jimmunol.1103190; Yu S, 2004, J BIOL CHEM, V279, P50274, DOI 10.1074/jbc.M410599200; Yu S, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-58	46	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128104	10.1371/journal.pone.0128104	http://dx.doi.org/10.1371/journal.pone.0128104			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047356	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200040
J	Obirikorang, C; Osakunor, DNM; Anto, EO; Amponsah, SO; Adarkwa, OK				Obirikorang, Christian; Osakunor, Derick Nii Mensah; Anto, Enoch Odame; Amponsah, Samuel Opoku; Adarkwa, Opei Kwafo			Obesity and Cardio-Metabolic Risk Factors in an Urban and Rural Population in the Ashanti Region-Ghana: A Comparative Cross-Sectional Study	PLOS ONE			English	Article							BODY-MASS INDEX; ABDOMINAL OBESITY; HYPERTENSION; ASSOCIATION; ENVIRONMENT; PREVALENCE; ADIPOSITY; DISEASE	There is a surge in chronic diseases in the developing world, driven by a high prevalence of cardio-metabolic risk factors. This study described differences in prevalence of obesity and cardio-metabolic risk factors between urban and rural settlements in the Ashanti Region of Ghana. This comparative cross-sectional study included 672 participants (median age 50 years), of which 312 were from Kumasi (urban) and 360 from Jachie-Pramso (rural). Demographic, anthropometric and other cardio-metabolic risk factors were gathered and venous blood samples were drawn for biochemical assays. Results suggested significant differences in diastolic blood pressure (80.0 mmHg vs 79.5 mmHg; p = 0.0078), and fasting blood sugar (5.0 mmo/l vs 4.5 mmol/l; p < 0.0001) between the two groups. Further differences in anthropometric measures suggested greater adiposity amongst participants in the urban area. Participants in the urban area were more likely than rural participants, to have high total cholesterol and LDL-c (p < 0.0001 respectively). Risk factors including BMI >= 25 (p < 0.0001), BMI >= 30 (p < 0.0001), high waist circumference (p < 0.0001), high waist-to-height ratio (p < 0.0001) and alcohol consumption (p = 0.0186) were more prevalent amongst participants in the urban area. Markers of adiposity were higher amongst females than males in both areas (p < 0.05). In the urban area, hypertension, diabetes and lifestyle risk factors were more prevalent amongst males than females. Differences in risk factors by urban / rural residence remained significant after adjusting for gender and age. Obesity and cardio-metabolic risk factors are more prevalent amongst urban settlers, highlighting an urgent need to avert the rise of diet and lifestyle-related chronic diseases.	[Obirikorang, Christian; Osakunor, Derick Nii Mensah; Anto, Enoch Odame] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Mol Med, Coll Hlth Sci, Kumasi, Ghana; [Amponsah, Samuel Opoku] Kwame Nkrumah Univ Sci & Technol, Fac Allied Hlth Sci, Coll Hlth Sci, Dept Med Lab Technol, Kumasi, Ghana; [Adarkwa, Opei Kwafo] Komfo Anokye Teaching Hosp, Dept Obstet & Gynaecol, Kumasi, Ghana	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Osakunor, DNM (corresponding author), Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Mol Med, Coll Hlth Sci, Kumasi, Ghana.	osakunor@gmail.com	Obirikorang, Christian/F-5843-2011; Anto, Enoch Odame/AAJ-7426-2020	Obirikorang, Christian/0000-0002-6128-1358; Anto, Enoch Odame/0000-0001-9023-6612; Osakunor, Derick Nii Mensah/0000-0002-4853-5384				Agyemang C, 2009, PUBLIC HEALTH NUTR, V12, P909, DOI 10.1017/S1368980008003510; Allender S, 2010, B WORLD HEALTH ORGAN, V88, P297, DOI 10.2471/BLT.09.065847; Amoah AGB, 2003, PUBLIC HEALTH NUTR, V6, P751, DOI 10.1079/PHN2003506; Amoah Albert G B, 2003, Ethn Dis, V13, pS97; [Anonymous], 2005, PREV CHRON DIS VIT I; Antecol H, 2006, DEMOGRAPHY, V43, P337, DOI 10.1353/dem.2006.0011; BARRETTCONNOR E, 1985, CIRCULATION, V72, P53, DOI 10.1161/01.CIR.72.1.53; BARRETTCONNOR EL, 1985, ANN INTERN MED, V103, P1010, DOI 10.7326/0003-4819-103-6-1010; Campbell T, 2007, J URBAN HEALTH, V84, pI54, DOI 10.1007/s11524-007-9181-7; Chalmers J, 1999, CLIN EXP HYPERTENS, V21, P1009; Dahly DL, 2007, SOC SCI MED, V64, P1407, DOI 10.1016/j.socscimed.2006.11.019; Dake FAA, 2011, PUBLIC HEALTH NUTR, V14, P1285, DOI 10.1017/S1368980010002879; Despres JP, 2001, BMJ-BRIT MED J, V322, P716, DOI 10.1136/bmj.322.7288.716; DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; Doll S, 2002, INT J OBESITY, V26, P48, DOI 10.1038/sj.ijo.0801854; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gregory CO, 2007, J NUTR, V137, P1314, DOI 10.1093/jn/137.5.1314; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HORTOBAGYI T, 1994, EUR J CLIN NUTR, V48, P369; Iloh GUP, 2012, NIGER J CLIN PRACT, V15, P462, DOI 10.4103/1119-3077.104528; Kinra S, 2011, AM J EPIDEMIOL, V174, P154, DOI 10.1093/aje/kwr053; KIRKENDALL WM, 1967, CIRCULATION, V36, P980, DOI 10.1161/01.CIR.36.6.980; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Monda KL, 2007, SOC SCI MED, V64, P858, DOI 10.1016/j.socscimed.2006.10.019; Novak NL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-530; Okosun IS, 2001, J HUM HYPERTENS, V15, P307, DOI 10.1038/sj.jhh.1001179; Okosun IS, 1999, J HUM HYPERTENS, V13, P425, DOI 10.1038/sj.jhh.1000862; Owiredu WKBA, 2008, J MED SCI, V8; Population and Housing Census, 2010, POP HOUS CENS; Riha J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001683; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Siminialayi I M, 2008, Niger J Med, V17, P340; Sobngwi E, 2004, INT J EPIDEMIOL, V33, P769, DOI 10.1093/ije/dyh044; Sodjinou R, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-84; Thomas AG, 2012, HARRISONS PRINCIPLES; Wahrenberg H, 2005, BRIT MED J, V330, P1363, DOI 10.1136/bmj.38429.473310.AE; Walker ARP, 2003, SAMJ S AFR MED J, V93, P598; WHO, 2014, OB OV; World Health Organization, 2008, WAIST CIRCUMFERENCE; World Health Organization, 2006, DEF DIAGN DIAB MELL; World Health Organization (WHO), 2006, OB OV GEN; Ziraba AK, 2009, BMC PUBLIC HEALTH, V9, P465, DOI DOI 10.1186/1471-2458-9-465	43	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129494	10.1371/journal.pone.0129494	http://dx.doi.org/10.1371/journal.pone.0129494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7CR	26046349	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200163
J	Pedersen, L; Wogensen, L; Marcussen, N; Cecchi, CR; Dalsgaard, T; Dagnaes-Hansen, F				Pedersen, Lea; Wogensen, Lise; Marcussen, Niels; Cecchi, Claudia R.; Dalsgaard, Trine; Dagnaes-Hansen, Frederik			Restoration of Haemoglobin Level Using Hydrodynamic Gene Therapy with Erythropoietin Does Not Alleviate the Disease Progression in an Anaemic Mouse Model for TGF beta 1-Induced Chronic Kidney Disease	PLOS ONE			English	Article							LONG-TERM; EXTRACELLULAR-MATRIX; EXPRESSION; NORMALIZATION; PROTECTS; HORMONE; INJURY; DARBEPOETIN; GROWTH; BLOOD	Erythropoietin, Epo, is a 30.4 kDa glycoprotein hormone produced primarily by the fetal liver and the adult kidney. Epo exerts its haematopoietic effects by stimulating the proliferation and differentiation of erythrocytes with subsequent improved tissue oxygenation. Epo receptors are furthermore expressed in non-haematopoietic tissue and today, Epo is recognised as a cytokine with many pleiotropic effects. We hypothesize that hydrodynamic gene therapy with Epo can restore haemoglobin levels in anaemic transgenic mice and that this will attenuate the extracellular matrix accumulation in the kidneys. The experiment is conducted by hydrodynamic gene transfer of a plasmid encoding murine Epo in a transgenic mouse model that overexpresses TGF-beta 1 locally in the kidneys. This model develops anaemia due to chronic kidney disease characterised by thickening of the glomerular basement membrane, deposition of mesangial matrix and mild interstitial fibrosis. A group of age matched wildtype littermates are treated accordingly. After a single hydrodynamic administration of plasmid DNA containing murine EPO gene, sustained high haemoglobin levels are observed in both transgenic and wildtype mice from 7.5 +/- 0.6 mmol/L to 9.4 +/- 1.2 mmol/L and 10.7 +/- 0.3 mmol/L to 15.5 +/- 0.5 mmol/L, respectively. We did not observe any effects in the thickness of glomerular or tubular basement membrane, on the expression of different collagen types in the kidneys or in kidney function after prolonged treatment with Epo. Thus, Epo treatment in this model of chronic kidney disease normalises haemoglobin levels but has no effect on kidney fibrosis or function.	[Pedersen, Lea; Wogensen, Lise] Aarhus Univ Hosp, Inst Clin Med, Res Lab Biochem Pathol, DK-8000 Aarhus, Denmark; [Marcussen, Niels] Odense Univ Hosp, Dept Pathol, DK-5000 Odense, Denmark; [Cecchi, Claudia R.; Dalsgaard, Trine; Dagnaes-Hansen, Frederik] Aarhus Univ, Dept Biomed, Aarhus, Denmark	Aarhus University; University of Southern Denmark; Odense University Hospital; Aarhus University	Pedersen, L (corresponding author), Aarhus Univ Hosp, Inst Clin Med, Res Lab Biochem Pathol, DK-8000 Aarhus, Denmark.	lea.pedersen@ki.au.dk	Cecchi, Claudia R./H-7280-2012	Cecchi, Claudia R./0000-0001-8612-9216; Dagnaes-Hansen, Frederik/0000-0002-6622-0853	Aase og Ejnar Danielsens Fond [10881]; Fonden til Laegevidenskabens Fremme [12091]	Aase og Ejnar Danielsens Fond; Fonden til Laegevidenskabens Fremme	This project is funded by "Aase og Ejnar Danielsens Fond" (URL: http://www.danielsensfond.dk/Fonden_st%C3%B8tter/L%C3%A6gevidenskabelig_forskning.aspx) (Grant nr. 10881) and "Fonden til Laegevidenskabens Fremme" (URL: http://www.apmollerfonde.dk/ansoegning/laegefonden.aspx) (Grant nr. 12091). Both of these funds have financially supported the project and made it possible to purchase material and reagents. The funding is based on a project description composed by the 1st author (LP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellizzi V, 1998, NEPHROL DIAL TRANSPL, V13, P2210, DOI 10.1093/ndt/13.9.2210; Chai Q, 2003, HISTOCHEM CELL BIOL, V119, P267, DOI 10.1007/s00418-003-0513-8; Dagnaes-Hansen F, 2002, J MOL MED-JMM, V80, P665, DOI 10.1007/s00109-002-0371-1; DANIELSEN CC, 1988, J BIOMECH, V21, P207, DOI 10.1016/0021-9290(88)90171-6; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; ESCHBACH JW, 1995, NEPHROL DIAL TRANSPL, V10, P96, DOI 10.1093/ndt/10.supp2.96; Fisher JW, 1996, BRIT J HAEMATOL, V95, P27, DOI 10.1046/j.1365-2141.1996.d01-1864.x; Fliser D, 2007, SEMIN HEMATOL, V44, P212, DOI 10.1053/j.seminhematol.2007.04.008; Frenay ARS, 2012, J RENIN-ANGIO-ALDO S, V13, P232, DOI 10.1177/1470320311432186; FRIED W, 1995, ANNU REV NUTR, V15, P353, DOI 10.1146/annurev.nu.15.070195.002033; Genovese F, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-4; Gong H, 2004, KIDNEY INT, V66, P683, DOI 10.1111/j.1523-1755.2004.00791.x; Gurtler A, 2013, ANAL BIOCHEM, V433, P105, DOI 10.1016/j.ab.2012.10.010; GUNDERSEN HJG, 1978, J MICROSC-OXFORD, V113, P27, DOI 10.1111/j.1365-2818.1978.tb00091.x; Haase VH, 2010, AM J PHYSIOL-RENAL, V299, pF1, DOI 10.1152/ajprenal.00174.2010; Hojman P, 2007, GENE THER, V14, P950, DOI 10.1038/sj.gt.3302951; Imamura R, 2007, TRANSPLANTATION, V83, P1371, DOI 10.1097/01.tp.0000264200.38926.70; JACOBS C, 1995, NEPHROL DIAL TRANSPL, V10, P43, DOI 10.1093/ndt/10.supp2.43; Jakobsen JE, 2011, TRANSGENIC RES, V20, P533, DOI 10.1007/s11248-010-9438-x; Johnson DW, 2006, KIDNEY INT, V69, P1806, DOI 10.1038/sj.ki.5000356; Kameda S, 2003, BIOCHEM BIOPH RES CO, V309, P929, DOI 10.1016/j.bbrc.2003.08.087; Kellenberger T, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.181; Krag S, 2005, KIDNEY INT, V68, P2651, DOI 10.1111/j.1523-1755.2005.00737.x; Krag S, 2000, LAB INVEST, V80, P1855, DOI 10.1038/labinvest.3780196; Krag S, 2007, NEPHROL DIAL TRANSPL, V22, P2485, DOI 10.1093/ndt/gfm229; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Loeffler I, 2013, AM J PHYSIOL-RENAL, V305, pF911, DOI 10.1152/ajprenal.00643.2012; Lombardero M, 2011, PATHOBIOLOGY, V78, P41, DOI 10.1159/000322975; Maruyama H, 2002, HUM GENE THER, V13, P455, DOI 10.1089/10430340252792585; Maruyama H, 2002, J GENE MED, V4, P333, DOI 10.1002/jgm.281; Miao CH, 2001, MOL THER, V3, P947, DOI 10.1006/mthe.2001.0333; Miner JH, 1999, KIDNEY INT, V56, P2016, DOI 10.1046/j.1523-1755.1999.00785.x; Nangaku M, 2013, KIDNEY INT, V84, P427, DOI 10.1038/ki.2013.140; Nemoto T, 2001, KIDNEY INT, V59, P246, DOI 10.1046/j.1523-1755.2001.00485.x; Sharpies EJ, 2006, SEMIN NEPHROL, V26, P325, DOI 10.1016/j.semnephrol.2006.05.010; Solling C, 2011, ACTA ANAESTH SCAND, V55, P185, DOI 10.1111/j.1399-6576.2010.02369.x; Sondergaard M, 2003, AM J PHYSIOL-ENDOC M, V285, pE427, DOI 10.1152/ajpendo.00573.2002; Tanaka T, 2012, EXP CELL RES, V318, P1068, DOI 10.1016/j.yexcr.2012.02.035; Teixeira AM, 2010, RENAL FAILURE, V32, P1073, DOI 10.3109/0886022X.2010.509897; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Westenfelder C, 2002, EXP NEPHROL, V10, P294, DOI 10.1159/000065304; Wogensen L, 1999, DIABETES, V48, P182, DOI 10.2337/diabetes.48.1.182; Zhang G, 2000, GENE THER, V7, P1344, DOI 10.1038/sj.gt.3301229; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734	44	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128367	10.1371/journal.pone.0128367	http://dx.doi.org/10.1371/journal.pone.0128367			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046536	Green Submitted, gold, Green Published			2022-12-27	WOS:000355652200064
J	Ribbons, KA; McElduff, P; Boz, C; Trojano, M; Izquierdo, G; Duquette, P; Girard, M; Grand'Maison, F; Hupperts, R; Grammond, P; Oreja-Guevara, C; Petersen, T; Bergamaschi, R; Giuliani, G; Barnett, M; van Pesch, V; Amato, MP; Iuliano, G; Fiol, M; Slee, M; Verheul, F; Cristiano, E; Fernandez-Bolanos, R; Saladino, ML; Rio, ME; Cabrera-Gomez, J; Butzkueven, H; van Munster, E; Den Braber-Moerland, L; La Spitaleri, D; Lugaresi, A; Shaygannejad, V; Gray, O; Deri, N; Alroughani, R; Lechner-Scott, J				Ribbons, Karen Ann; McElduff, Patrick; Boz, Cavit; Trojano, Maria; Izquierdo, Guillermo; Duquette, Pierre; Girard, Marc; Grand'Maison, Francois; Hupperts, Raymond; Grammond, Pierre; Oreja-Guevara, Celia; Petersen, Thor; Bergamaschi, Roberto; Giuliani, Giorgio; Barnett, Michael; van Pesch, Vincent; Amato, Maria-Pia; Iuliano, Gerardo; Fiol, Marcela; Slee, Mark; Verheul, Freek; Cristiano, Edgardo; Fernandez-Bolanos, Ricardo; Saladino, Maria-Laura; Rio, Maria Edite; Cabrera-Gomez, Jose; Butzkueven, Helmut; van Munster, Erik; Den Braber-Moerland, Leontien; La Spitaleri, Daniele; Lugaresi, Alessandra; Shaygannejad, Vahid; Gray, Orla; Deri, Norma; Alroughani, Raed; Lechner-Scott, Jeannette			Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; NATURAL-HISTORY; BRITISH-COLUMBIA; AGE; DETERMINANT; PHASE	Background Multiple Sclerosis is more common in women than men and females have more relapses than men. In a large international cohort we have evaluated the effect of gender on disability accumulation and disease progression to determine if male MS patients have a worse clinical outcome than females. Methods Using the MSBase Registry, data from 15,826 MS patients from 25 countries was analysed. Changes in the severity of MS (EDSS) were compared between sexes using a repeated measures analysis in generalised linear mixed models. Kaplan-Meier analysis was used to test for sex difference in the time to reach EDSS milestones 3 and 6 and the secondary progressive MS. Results In relapse onset MS patients (n = 14,453), males progressed significantly faster in their EDSS than females (0.133 vs 0.112 per year, P<0.001,). Females had a reduced risk of secondary progressive MS (HR (95% CI) = 0.77 (0.67 to 0.90) P = 0.001). In primary progressive MS (n = 1,373), there was a significant increase in EDSS over time in males and females (P<0.001) but there was no significant sex effect on the annualized rate of EDSS change. Conclusion Among registrants of MSBase, male relapse-onset patients accumulate disability faster than female patients. In contrast, the rate of disability accumulation between male and female patients with primary progressive MS is similar.	[Ribbons, Karen Ann; Lechner-Scott, Jeannette] John Hunter Hosp, Newcastle, NSW, Australia; [McElduff, Patrick] Univ Newcastle, Newcastle, NSW 2300, Australia; [Boz, Cavit] Karadeniz Tech Univ, Trabzon, Turkey; [Trojano, Maria] Univ Bari, Bari, Italy; [Izquierdo, Guillermo] Univ Hosp, Seville, Spain; [Duquette, Pierre; Girard, Marc] Hop Notre Dame De Bon Secours, Montreal, PQ, Canada; [Grand'Maison, Francois] Neuro Rive Sud, Quebec City, PQ, Canada; [Hupperts, Raymond] Maaslandziekenhuis, Sittard, Netherlands; [Grammond, Pierre] Hotel Dieu de Levis, Quebec City, PQ, Canada; [Oreja-Guevara, Celia] Univ Hosp La Paz, IdiPAZ, Madrid, Spain; [Petersen, Thor] Kommunehosp, Aarhus C, Denmark; [Bergamaschi, Roberto] Neurol Inst IRCCS Mondino, Pavia, Italy; [Giuliani, Giorgio] Osped Macerata, Macerata, Italy; [Barnett, Michael] Brain & Mind Res Inst, Sydney, NSW, Australia; [van Pesch, Vincent] Clin Univ St Luc, B-1200 Brussels, Belgium; [Amato, Maria-Pia] Univ Florence, Dept Neurol, Florence, Italy; [Iuliano, Gerardo] Osped Riuniti Salerno, Salerno, Italy; [Fiol, Marcela] FLENI, Buenos Aires, DF, Argentina; [Slee, Mark] Flinders Med Ctr, Adelaide, SA, Australia; [Verheul, Freek] Groen Hart Ziekenhuis, Gouda, Netherlands; [Cristiano, Edgardo] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina; [Fernandez-Bolanos, Ricardo] Hosp Univ Virgen de Valme, Seville, Spain; [Saladino, Maria-Laura] Craigavon Area Hosp, Craigavon, North Ireland; [Rio, Maria Edite] Hosp Sao Joao, Porto, Portugal; [Cabrera-Gomez, Jose] Int Ctr Neurol Restorat, Multiple Sclerosis Clin, Havana, Cuba; [Butzkueven, Helmut] Royal Melbourne Hosp, Melbourne, Vic, Australia; [van Munster, Erik] Jeroen Bosch Ziekenhuis, Den Bosch, Netherlands; [Den Braber-Moerland, Leontien] Francicus Ziekenhuis, Roosendaal, Netherlands; [La Spitaleri, Daniele] AORN San Giuseppe Moscati, Avellino, Italy; [Lugaresi, Alessandra] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Shaygannejad, Vahid] Isfahan Univ Med Sci, Al Zahara Hop, Esfahan, Iran; [Gray, Orla] Craigavon Area Hosp, Armagh, North Ireland; [Deri, Norma] Hosp Fernandez, Buenos Aires, Argentina; [Alroughani, Raed] Amiri Hosp, Qurtoba, Kuwait	John Hunter Hospital; University of Newcastle; Karadeniz Technical University; Universita degli Studi di Bari Aldo Moro; Universite de Montreal; Laval University; Hospital Universitario La Paz; Aarhus University; IRCCS Fondazione Casimiro Mondino; University of Sydney; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University of Florence; Flinders Medical Centre; Hospital Italiano de Buenos Aires; University of Buenos Aires; Hospital Valme; Sao Joao Hospital; Royal Melbourne Hospital; Jeroen Bosch Ziekenhuis; San Giuseppe Moscati Hospital; G d'Annunzio University of Chieti-Pescara; Isfahan University Medical Science; University of Buenos Aires	Ribbons, KA (corresponding author), John Hunter Hosp, Newcastle, NSW, Australia.	Karen.Ribbons@hnehealth.nsw.gov.au	Lugaresi, Alessandra/C-7743-2012; Oreja-Guevara, Celia/N-5151-2019; van Pesch, Vincent/AAK-9506-2020; BOZ, Cavit/V-5127-2017; Shaygannejad, Vahid/N-3495-2018; amato, Maria Pia/AAL-5998-2020; Slee, Mark/J-4731-2015; Amato, Maria Pia/AAC-5940-2022; Boz, Cavit/AAR-2268-2020	Lugaresi, Alessandra/0000-0003-2902-5589; Oreja-Guevara, Celia/0000-0002-9221-5716; Shaygannejad, Vahid/0000-0002-6226-0161; amato, Maria Pia/0000-0003-3325-3760; Slee, Mark/0000-0003-4323-2453; Boz, Cavit/0000-0003-0956-3304; Lechner-Scott, Jeannette/0000-0002-3850-447X; Butzkueven, Helmut/0000-0003-3940-8727; van Pesch, Vincent/0000-0003-2885-9004; Petersen, Thor/0000-0001-5633-2600; Shaygannejad, Vahid/0000-0002-9732-4153; Trojano, Maria/0000-0002-6329-8946	Merck Serono	Merck Serono(Merck & Company)	Merck Serono supports iMED which is the software program used by MSBASE for data acquisition at each collaborating centre and does not impact on the studies derived from data collected by this program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bove R, 2013, CLIN IMMUNOL, V149, P201, DOI 10.1016/j.clim.2013.03.005; Bove R, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-73; Bove RM, 2012, MULT SCLER J, V18, P1472, DOI 10.1177/1352458512438236; Butzkueven H, 2006, MULT SCLER, V12, P769, DOI 10.1177/1352458506070775; Confavreux C, 2006, BRAIN, V129, P595, DOI 10.1093/brain/awh714; Confavreux C, 2000, NEW ENGL J MED, V343, P1430, DOI 10.1056/NEJM200011163432001; Confavreux C, 2003, BRAIN, V126, P770, DOI 10.1093/brain/awg081; Cossburn M, 2012, MULT SCLER J, V18, P45, DOI 10.1177/1352458511417479; Cottrell DA, 1999, BRAIN, V122, P641, DOI 10.1093/brain/122.4.641; Cottrell DA, 1999, BRAIN, V122, P625, DOI 10.1093/brain/122.4.625; Debouverie M, 2008, EUR J NEUROL, V15, P916, DOI 10.1111/j.1468-1331.2008.02241.x; Debouverie M, 2009, J NEUROL SCI, V286, P14, DOI 10.1016/j.jns.2009.07.012; Ebers GC, 2004, MULT SCLER J, V10, pS8, DOI 10.1191/1352458504ms1025oa; Gholipour T, 2011, NEUROLOGY, V76, P1996, DOI 10.1212/WNL.0b013e31821e559d; Harding K, 2014, JOURNAL OF NEUROL NE; Kalincik T, 2013, BRAIN, V136, P3609, DOI 10.1093/brain/awt281; Katz Sand Ilana B, 2013, Continuum (Minneap Minn), V19, P922, DOI 10.1212/01.CON.0000433290.15468.21; Khaleeli Z, 2008, ANN NEUROL, V63, P790, DOI 10.1002/ana.21375; Koch M, 2008, MULT SCLER J, V14, P799, DOI 10.1177/1352458508089361; Koch M, 2007, J NEUROL SCI, V255, P35, DOI 10.1016/j.jns.2007.01.067; Koch M, 2010, J NEUROL NEUROSUR PS, V81, P1039, DOI 10.1136/jnnp.2010.208173; Koch M, 2009, NEUROLOGY, V73, P1996, DOI 10.1212/WNL.0b013e3181c5b47f; Leray E, 2010, BRAIN, V133, P1900, DOI 10.1093/brain/awq076; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Miller DH, 2007, LANCET NEUROL, V6, P903, DOI 10.1016/S1474-4422(07)70243-0; Ramagopalan SV, 2010, EUR J NEUROL, V17, P634, DOI 10.1111/j.1468-1331.2009.02850.x; Rice GPA, 2002, MULT SCLER J, V8, P81, DOI 10.1177/135245850200800116; Scalfari A, 2010, BRAIN, V133, P1914, DOI 10.1093/brain/awq118; Shirani A, 2012, MULT SCLER J, V18, P442, DOI 10.1177/1352458511422097; Spelman T, 2013, MULT SCLER J, V19, P38; Stankoff B, 2007, NEUROLOGY, V68, P779, DOI 10.1212/01.wnl.0000256732.36565.4a; Tremlett H, 2005, NEUROLOGY, V65, P1919, DOI 10.1212/01.wnl.0000188880.17038.1d; Tremlett H, 2006, NEUROLOGY, V66, P172, DOI 10.1212/01.wnl.0000194259.90286.fe; Tremlett H, 2009, NEUROLOGY, V73, P1616, DOI 10.1212/WNL.0b013e3181c1e44f; Tremlett H, 2008, MULT SCLER J, V14, P314, DOI 10.1177/1352458507084264; Tremlett H, 2009, J NEUROL, V256, P374, DOI 10.1007/s00415-009-0039-7; Vukusic S, 2003, J NEUROL SCI, V206, P135, DOI 10.1016/S0022-510X(02)00426-4	37	93	94	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0122686	10.1371/journal.pone.0122686	http://dx.doi.org/10.1371/journal.pone.0122686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046348	gold, Green Published			2022-12-27	WOS:000355652200003
J	Szmolka, A; Wiener, Z; Matulova, ME; Varmuzova, K; Rychlik, I				Szmolka, Ama; Wiener, Zoltan; Matulova, Marta Elsheimer; Varmuzova, Karolina; Rychlik, Ivan			Gene Expression Profiles of Chicken Embryo Fibroblasts in Response to Salmonella Enteritidis Infection	PLOS ONE			English	Article							IMMUNE-RESPONSE; ENTERICA; TYPHIMURIUM; RESISTANT; CELLS	The response of chicken to non-typhoidal Salmonella infection is becoming well characterised but the role of particular cell types in this response is still far from being understood. Therefore, in this study we characterised the response of chicken embryo fibroblasts (CEFs) to infection with two different S. Enteritidis strains by microarray analysis. The expression of chicken genes identified as significantly up-or down-regulated (>= 3-fold) by microarray analysis was verified by real-time PCR followed by functional classification of the genes and prediction of interactions between the proteins using Gene Ontology and STRING Database. Finally the expression of the newly identified genes was tested in HD11 macrophages and in vivo in chickens. Altogether 19 genes were induced in CEFs after S. Enteritidis infection. Twelve of them were also induced in HD11 macrophages and thirteen in the caecum of orally infected chickens. The majority of these genes were assigned different functions in the immune response, however five of them (LOC101750351, K123, BU460569, MOBKL2C and G0S2) have not been associated with the response of chicken to Salmonella infection so far. K123 and G0S2 were the only 'non-immune' genes inducible by S. Enteritidis in fibroblasts, HD11 macrophages and in the caecum after oral infection. The function of K123 is unknown but G0S2 is involved in lipid metabolism and in beta-oxidation of fatty acids in mitochondria.	[Szmolka, Ama] Hungarian Acad Sci, Agr Res Ctr, Vet Med Res Inst, Budapest, Hungary; [Wiener, Zoltan] Semmelweis Univ, Dept Genet Cell & Immunobiol, H-1085 Budapest, Hungary; [Matulova, Marta Elsheimer; Varmuzova, Karolina; Rychlik, Ivan] Vet Res Inst, CS-62132 Brno, Czech Republic	Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute; Semmelweis University; Czech Veterinary Research Institute	Szmolka, A (corresponding author), Hungarian Acad Sci, Agr Res Ctr, Vet Med Res Inst, Budapest, Hungary.	szmolka.annamaria@agrar.mta.hu	, Ivan/GPS-9674-2022; Szmolka, Ama/Z-4598-2019	, Ivan/0000-0001-7995-6483; 	European Network of Excellence MedVetNet (EU) [5061022]; EU [265877]; Czech Ministry of Education [CZ.1.05/2.1.00/01.0006-ED0006/01/01]; Hungarian Academy of Sciences	European Network of Excellence MedVetNet (EU); EU(European Commission); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This study was supported by the European Network of Excellence MedVetNet (EU FP6 NoE Contract no. 5061022) and by the EU FP7 Collaborative Project PROMISE (Grant agreement no. 265877). Czech partners were supported by the AdmireVet project CZ.1.05/2.1.00/01.0006-ED0006/01/01 from the Czech Ministry of Education. A. Szmolka is holder of a Bolyai Janos Stipend from the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt A, 2007, INFECT IMMUN, V75, P5993, DOI 10.1128/IAI.00695-07; Burlak C, 2006, MOL CELL PROTEOMICS, V5, P620, DOI 10.1074/mcp.M500336-MCP200; Cano DA, 2001, INFECT IMMUN, V69, P6463, DOI 10.1128/IAI.69.10.6463-6474.2001; Chausse AM, 2014, VET IMMUNOL IMMUNOP, V159, P16, DOI 10.1016/j.vetimm.2014.03.001; Chow A, 2010, INT J CANCER, V126, P2079, DOI 10.1002/ijc.24878; Correnti C, 2011, STRUCTURE, V19, P1796, DOI 10.1016/j.str.2011.09.019; Coudevylle N, 2011, BIOCHEMISTRY-US, V50, P9192, DOI 10.1021/bi201115q; Crhanova M, 2011, INFECT IMMUN, V79, P2755, DOI 10.1128/IAI.01375-10; EFSA, 2006, EFSA J, V81, P1; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fritsche G, 2003, J IMMUNOL, V171, P1994, DOI 10.4049/jimmunol.171.4.1994; Gewirtz AT, 1999, INFECT IMMUN, V67, P608, DOI 10.1128/IAI.67.2.608-617.1999; Hall CJ, 2013, CELL METAB, V18, P265, DOI 10.1016/j.cmet.2013.06.018; Haunshi S, 2014, POULTRY SCI, V93, P550, DOI 10.3382/ps.2013-03597; Heckmann BL, 2013, BBA-MOL CELL BIOL L, V1831, P276, DOI 10.1016/j.bbalip.2012.09.016; Higgs R, 2006, INFECT IMMUN, V74, P1692, DOI 10.1128/IAI.74.3.1692-1698.2006; Imre A, 2011, FEMS MICROBIOL LETT, V317, P52, DOI 10.1111/j.1574-6968.2011.02210.x; Keates AC, 2001, J BIOL CHEM, V276, P43713, DOI 10.1074/jbc.M107838200; KUNSCH C, 1993, MOL CELL BIOL, V13, P6137, DOI 10.1128/MCB.13.10.6137; Li YK, 2013, J BIOL CHEM, V288, P16225, DOI 10.1074/jbc.M113.454538; Matulova M, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-37; Matulova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048101; METHNER U, 1995, J VET MED B, V42, P459, DOI 10.1111/j.1439-0450.1995.tb00737.x; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Portillo FGD, 2008, CURR OPIN MICROBIOL, V11, P46, DOI 10.1016/j.mib.2008.01.001; Schokker D, 2010, DEV COMP IMMUNOL, V34, P1090, DOI 10.1016/j.dci.2010.05.013; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Swaggerty CL, 2004, IMMUNOLOGY, V113, P139, DOI 10.1111/j.1365-2567.2004.01939.x; Van Immerseel F, 2002, DEV COMP IMMUNOL, V26, P355, DOI 10.1016/S0145-305X(01)00084-2; Withanage GSK, 2004, INFECT IMMUN, V72, P2152, DOI 10.1128/IAI.72.4.2152-2159.2004; Yue Hua, 2010, Virologica Sinica, V25, P425, DOI 10.1007/s12250-010-3114-4	31	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127708	10.1371/journal.pone.0127708	http://dx.doi.org/10.1371/journal.pone.0127708			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046914	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000355652200027
J	Tang, FT; Chan, EQ; Lu, ML; Zhang, XW; Dai, CM; Mei, M; Zhang, SP; Wang, HX; Song, Q				Tang, Futian; Chan, Erqing; Lu, Meili; Zhang, Xiaowen; Dai, Chunmei; Mei, Meng; Zhang, Suping; Wang, Hongxin; Song, Qing			Calpain-1 Mediated Disorder of Pyrophosphate Metabolism Contributes to Vascular Calcification Induced by oxLDL	PLOS ONE			English	Article							ENDOTHELIUM-DEPENDENT RELAXATION; LOW-DENSITY-LIPOPROTEIN; ATP-SYNTHASE; INORGANIC PYROPHOSPHATE; BETA-GLYCEROPHOSPHATE; ALKALINE-PHOSPHATASE; RAT MODEL; VITAMIN-D; IN-VITRO; INHIBITION	We previously reported that oxidized low density lipoprotein (oxLDL) accelerated the calcification in aorta of rats and rat vascular smooth muscle cells (RVSMCs). However, the molecular mechanism underlying the acceleration remains poorly understood. The present study aimed to investigate the role of calpain-1, Ca2+-sensitive intracellular cysteine proteases, in the vascular calcification of rats treated with both high dose of vitamin D-2 and high cholesterol diet. The results showed that calpain activity significantly increased in calcified aortic tissue of rats and RVSMCs treated with oxLDL. Specific calpain inhibitor I (CAI, 0.5mg/kg, intraperitoneal) inhibited the vascular calcification in rats with hypercholesterolemia accompanied by the increase in the level of extracellular inorganic pyrophosphate (PPi), the endogenous inhibitor of vascular calcification. In addition, CAI increased the content of adenosine triphosphate (ATP), decreased the activity, mRNA and protein expression of alkaline phosphatase (ALP) and reduced the production of superoxide anion in calcified aortic tissue. CAI also increased the activity of ATP synthase as well as protein expression of ATP5D, delta subunit of ATP synthase. In the in vitro study, suppression of calpain-1 using siRNA assay inhibited the calcium deposition, increased the levels of PPi and ATP, improved the activity of ATP synthase as well as protein expression of ATP5D in RVSMCs treated with oxLDL. Calpain-1 suppression also decreased the activity, mRNA and protein expression of ALP and reduced the mitochondrial ROS (Mito-ROS) production in RVSMCs. However, mito-TEMPO, the mitochondria-targeted ROS scavenger, reduced the calcium deposition, increased the PPi in culture medium, decreased the activity, mRNA and protein expression of ALP in RVSMCs treated with oxLDL. Taken together, the results suggested that calpain-1 activation plays critical role in vascular calcification caused by oxLDL, which might be mediated by PPi metabolism disorder. The results also implied that Mito-ROS might contribute to the PPi metabolism disorder through regulation of the activity and expression of ALP.	[Tang, Futian; Lu, Meili; Dai, Chunmei; Mei, Meng; Zhang, Suping; Wang, Hongxin] Liaoning Med Univ, Inst Drug Res, Key Lab Cardio & Cerebrovasc Drug Res Liaoning Pr, Jinzhou, Peoples R China; [Chan, Erqing] Gansu Prov Hosp, Cerebrovasc Dis Ctr, Lanzhou, Peoples R China; [Zhang, Xiaowen] Guangzhou Inst Sports Sci, Guangzhou, Guangdong, Peoples R China; [Song, Qing] Guangzhou Vocat & Tech Coll, Guangzhou, Guangdong, Peoples R China	Jinzhou Medical University	Wang, HX (corresponding author), Liaoning Med Univ, Inst Drug Res, Key Lab Cardio & Cerebrovasc Drug Res Liaoning Pr, Jinzhou, Peoples R China.	jyhxwang@163.com; songqing168@hotmail.com			National Natural Science Foundation of China [81374008]; Talent Foundation of Liaoning Medical University of China [2014-18]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Talent Foundation of Liaoning Medical University of China	This work was supported by the National Natural Science Foundation (No. 81374008) of China and the Talent Foundation of Liaoning Medical University (No. 2014-18) of China.	Ali MAM, 2012, BIOCHEM BIOPH RES CO, V423, P1, DOI 10.1016/j.bbrc.2012.05.005; Bear M, 2008, J CELL BIOCHEM, V105, P185, DOI 10.1002/jcb.21812; Chen LS, 2009, BIOCHEM PHARMACOL, V78, P583, DOI 10.1016/j.bcp.2009.05.019; Clinkinbeard T, 2013, BRAIN RES, V1499, P129, DOI 10.1016/j.brainres.2012.12.039; Costello JC, 2011, CONNECT TISSUE RES, V52, P139, DOI 10.3109/03008207.2010.491928; Fish RS, 2013, EUR J CLIN INVEST, V43, P405, DOI 10.1111/eci.12055; He K, 2014, AM J PHYSL HEART CIR; Hua YN, 2015, BBA-MOL BASIS DIS, V1852, P195, DOI 10.1016/j.bbadis.2014.04.032; Jansen RS, 2014, ARTERIOSCL THROM VAS, V34, P1985, DOI 10.1161/ATVBAHA.114.304017; Jiang LQ, 2012, HYPERTENSION, V60, P1192, DOI 10.1161/HYPERTENSIONAHA.112.196840; KITAGAWA S, 1992, JPN J PHARMACOL, V59, P339, DOI 10.1254/jjp.59.339; Lanzer P, 2014, EUR HEART J, V35, P1515, DOI 10.1093/eurheartj/ehu163; Leopold Jane A, 2014, Cells, V3, P963, DOI 10.3390/cells3040963; Liu HY, 2014, MOL CELL BIOCHEM, V391, P85, DOI 10.1007/s11010-014-1990-x; Liu L, 2011, ACTA PHARMACOL SIN, V32, P1491, DOI 10.1038/aps.2011.128; Lohman AW, 2012, CARDIOVASC RES, V95, P269, DOI 10.1093/cvr/cvs187; Lomashvili KA, 2008, KIDNEY INT, V73, P1024, DOI 10.1038/ki.2008.26; Loor G, 2011, BBA-MOL CELL RES, V1813, P1382, DOI 10.1016/j.bbamcr.2010.12.008; Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006; Lu Q, 2014, AM J CHINESE MED, V42, P337, DOI 10.1142/S0192415X14500220; Miyazaki T, 2013, J ATHEROSCLER THROMB, V20, P228, DOI 10.5551/jat.14787; Narisawa S, 2007, J BONE MINER RES, V22, P1700, DOI 10.1359/JBMR.070714; Natera-Naranjo O, 2012, MOL CELL NEUROSCI, V49, P263, DOI 10.1016/j.mcn.2011.12.006; Paloian NJ, 2014, AM J PHYSIOL-RENAL, V307, pF891, DOI 10.1152/ajprenal.00163.2014; Pandurangan Muthuraman, 2014, Pathophysiology, V21, P161, DOI 10.1016/j.pathophys.2014.01.003; PK S, 2014, J CLIN DIAGN RES, V8, DOI [10.7860/JCDR/2014/10150.5285, DOI 10.7860/JCDR/2014/10150.5285]; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; Proudfoot D, 2001, Z Kardiol, V90 Suppl 3, P43; Ramio-Lluch L, 2014, REPROD FERT DEVELOP, V26, P883, DOI 10.1071/RD13145; Ruetten H, 1997, BRIT J PHARMACOL, V121, P695, DOI 10.1038/sj.bjp.0701180; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; Smith MA, 2012, CARDIOVASC RES, V96, P32, DOI 10.1093/cvr/cvs163; Takeshita D, 2013, J PHYSIOL SCI, V63, P113, DOI 10.1007/s12576-012-0243-6; Tang FT, 2006, CALCIFIED TISSUE INT, V79, P326, DOI 10.1007/s00223-006-0004-8; Tang FT, 2006, BIOCHEM PHARMACOL, V72, P558, DOI 10.1016/j.bcp.2006.05.018; Tang FT, 2007, VASC PHARMACOL, V46, P427, DOI 10.1016/j.vph.2007.01.001; Tantisattamo E, 2015, ARTERIOSCL THROM VAS, V35, P237, DOI 10.1161/ATVBAHA.114.304392; Taylor J, 2011, J CELL BIOCHEM, V112, P581, DOI 10.1002/jcb.22948; Tu L, 2013, MICROCIRCULATION, V20, P736, DOI 10.1111/micc.12074; Villa-Bellosta R, 2013, CIRC J, V77, P2145, DOI 10.1253/circj.CJ-13-0016; Villa-Bellosta R, 2013, CIRCULATION, V127, P2442, DOI 10.1161/CIRCULATIONAHA.112.000571; Villa-Bellosta R, 2011, CIRC J, V75, P2705, DOI 10.1253/circj.CJ-11-0477; Villa-Bellosta R, 2011, AM J PHYSIOL-HEART C, V301, pH61, DOI 10.1152/ajpheart.01020.2010; Vindis C, 2005, ARTERIOSCL THROM VAS, V25, P639, DOI 10.1161/01.ATV.0000154359.60886.33; Wallin R, 2001, MED RES REV, V21, P274, DOI 10.1002/med.1010.abs; Zhang P, 2010, BIOCHEMISTRY-US, V49, P5570, DOI 10.1021/bi100656j; Zhu D, 2014, J CELL MOL MED	47	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129128	10.1371/journal.pone.0129128	http://dx.doi.org/10.1371/journal.pone.0129128			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047104	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200129
J	Ramchani-Ben Othman, K; Cercy, C; Amri, M; Doly, M; Ranchon-Cole, I				Ramchani-Ben Othman, Khaoula; Cercy, Christine; Amri, Mohamed; Doly, Michel; Ranchon-Cole, Isabelle			Dietary Supplement Enriched in Antioxidants and Omega-3 Protects from Progressive Light-Induced Retinal Degeneration	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; MACULAR DEGENERATION; ANIMAL-CELLS; DAMAGE; PLASMALOGENS; SUSCEPTIBILITY; RHODOPSIN; LIPIDS; MODEL; DHA	In the present study, we have evaluated one of the dietary supplements enriched with antioxidants and fish oil used in clinical care for patient with age-related macular degeneration. Rats were orally fed by a gastric canula daily with 0.2 ml of water or dietary supplement until they were sacrificed. After one week of treatment, animals were either sacrificed for lipid analysis in plasma and retina, or used for evaluation of rod-response recovery by electroretinography (ERG) followed by their sacrifice to measure rhodopsin content, or used for progressive light-induced retinal degeneration (PLIRD). For PLIRD, animals were transferred to bright cyclic light for one week. Retinal damage was quantified by ERG, histology and detection of apoptotic nuclei. Animals kept in dim-cyclic-light were processed in parallel. PLIRD induced a thinning of the outer nuclear layer and a reduction of the b-wave amplitude of the ERG in the water group. Retinal structure and function were preserved in supplemented animals. Supplement induced a significant increase in omega-3 fatty acids in plasma by 168% for eicosapentaenoic acid (EPA), 142% for docosapentaenoic acid (DPA) and 19% for docosahexaenoic acid (DHA) and a decrease in the omega-6 fatty acids, DPA by 28%. In the retina, supplement induced significant reduction of linolenic acid by 67% and an increase in EPA and DPA by 80% and 72%, respectively, associated with significant decrease in omega-6 DPA by 42%. Supplement did not affect rhodopsin content or rod-response recovery. The present data indicate that supplement rapidly modified the fatty acid content and induced an accumulation of EPA in the retina without affecting rhodopsin content or recovery. In addition, it protected the retina from oxidative stress induced by light. Therefore, this supplement might be beneficial to slow down progression of certain retinal degeneration.	[Ramchani-Ben Othman, Khaoula; Cercy, Christine; Doly, Michel; Ranchon-Cole, Isabelle] Univ Auvergne, UFR Pharm, Inserm UMR 1107, Lab Biophys Neurosensorielle, Clermont Ferrand, France; [Ramchani-Ben Othman, Khaoula; Amri, Mohamed] Tunis El Manar Univ, Dept Biol Sci, Lab Funct Neurophysiol & Pathol, Tunis 1, Tunisia	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Universite de Tunis-El-Manar	Ranchon-Cole, I (corresponding author), Univ Auvergne, UFR Pharm, Inserm UMR 1107, Lab Biophys Neurosensorielle, Clermont Ferrand, France.	isabelle.ranchon-cole@udamail.fr		Amri, Mohamed/0000-0001-5309-7633; Ranchon-Cole, Isabelle/0000-0002-7092-6744				Acar N, 2007, EXP EYE RES, V84, P143, DOI 10.1016/j.exer.2006.09.009; Alex AF, 2013, OPHTHALMOLOGE, V110, P321, DOI 10.1007/s00347-012-2744-3; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Anderson RE, 2002, INVEST OPHTH VIS SCI, V42, P1715; BAZAN NG, 1992, ADV EXP MED BIOL, V318, P295; Bazan NG, 2009, J LIPID RES, V50, pS400, DOI 10.1194/jlr.R800068-JLR200; Bicknell IR, 2002, MOL VIS, V8, P333; Bohm F, 2012, ACTA BIOCHIM POL, V59, P27; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Broniec A, 2011, FREE RADICAL BIO MED, V50, P892, DOI 10.1016/j.freeradbiomed.2011.01.002; Chang CW, 2003, CAN J OPHTHALMOL, V38, P27, DOI 10.1016/S0008-4182(03)80005-4; Charkoudian LD, 2008, OPHTHALMOLOGY, V115, P1032, DOI 10.1016/j.ophtha.2007.08.003; Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Cideciyan AV, 2005, P NATL ACAD SCI USA, V102, P5233, DOI 10.1073/pnas.0408892102; CLELAND LG, 1992, AM J CLIN NUTR, V55, P395, DOI 10.1093/ajcn/55.2.395; CONVERSE CA, 1983, T OPHTHAL SOC UK, V103, P508; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; Farooqui AA, 1995, BRAIN RES REV, V21, P152, DOI 10.1016/0165-0173(95)00008-9; FOLCH J, 1957, J BIOL CHEM, V226, P497; Granit R, 1933, J PHYSIOL-LONDON, V77, P207, DOI 10.1113/jphysiol.1933.sp002964; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; Hoffman DR, 2001, J LIPID RES, V42, P1395; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Hunter JJ, 2012, PROG RETIN EYE RES, V31, P28, DOI 10.1016/j.preteyeres.2011.11.001; Jacobson SG, 2010, NEW ENGL J MED, V363, P1669, DOI 10.1056/NEJMcibr1007685; JUANEDA P, 1985, LIPIDS, V20, P40, DOI 10.1007/BF02534360; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; KATZ ML, 1989, INVEST OPHTH VIS SCI, V30, P37; Koushan K, 2013, NUTRIENTS, V5, P1823, DOI 10.3390/nu5051823; Kubota S, 2010, AM J PATHOL, V177, P1725, DOI 10.2353/ajpath.2010.100098; LAMB TD, 1992, TRENDS NEUROSCI, V15, P291, DOI 10.1016/0166-2236(92)90079-N; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Mandal MNA, 2011, J BIOL CHEM, V286, P32491, DOI 10.1074/jbc.M111.255877; Maude MB, 1998, INVEST OPHTH VIS SCI, V39, P2164; McCarty CA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1455; Mitchell DC, 2012, CHEM PHYS LIPIDS, V165, P393, DOI 10.1016/j.chemphyslip.2012.02.008; Mo MS, 2013, NEUROSCIENCE, V228, P1, DOI 10.1016/j.neuroscience.2012.10.002; MORAND OH, 1988, J BIOL CHEM, V263, P11597; Morandat S, 2003, BBA-BIOMEMBRANES, V1616, P137, DOI 10.1016/j.bbamem.2003.08.001; Organisciak D T, 1989, Prog Clin Biol Res, V314, P493; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; ORGANISCIAK DT, 1985, INVEST OPHTH VIS SCI, V26, P1580; Paskowitz DM, 2006, BRIT J OPHTHALMOL, V90, P1060, DOI 10.1136/bjo.2006.097436; Pemp B, 2010, INVEST OPHTH VIS SCI, V51, P2, DOI 10.1167/iovs.09-3888; Radu RA, 2004, P NATL ACAD SCI USA, V101, P5928, DOI 10.1073/pnas.0308302101; Ranchon I, 1999, INVEST OPHTH VIS SCI, V40, P1191; Ranchon I, 2003, J NEUROSCI, V23, P6050, DOI 10.1523/JNEUROSCI.23-14-06050.2003; Saab S, 2014, BIOCHIMIE, V107, P58, DOI 10.1016/j.biochi.2014.07.023; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; SCHAEFER EJ, 1995, J LIPID RES, V36, P1427; Schnebelen C, 2009, OPHTHALMIC RES, V41, P216, DOI 10.1159/000217726; Schnebelen C, 2009, LIPIDS, V44, P465, DOI 10.1007/s11745-009-3289-3; Stadelmann-Ingrand S, 2004, CHEM PHYS LIPIDS, V131, P93, DOI 10.1016/j.chemphyslip.2004.04.008; Su HM, 1999, PEDIATR RES, V45, P87, DOI 10.1203/00006450-199901000-00015; Sui GY, 2013, BRIT J OPHTHALMOL, V97, P389, DOI 10.1136/bjophthalmol-2012-302281; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Tremblay F, 2013, J NUTR BIOCHEM, V24, P647, DOI 10.1016/j.jnutbio.2012.03.011; Volker D, 2000, J RHEUMATOL, V27, P2343; Wang M, 1997, VISUAL NEUROSCI, V14, P55, DOI 10.1017/S0952523800008750; WINKLER BS, 1972, VISION RES, V12, P1183, DOI 10.1016/0042-6989(72)90106-X; Xie ZG, 2007, CURR EYE RES, V32, P471, DOI 10.1080/02713680701257621; Zhu YA, 2010, INVEST OPHTH VIS SCI, V51, P4821, DOI 10.1167/iovs.09-5050; ZOELLER RA, 1988, J BIOL CHEM, V263, P11590	63	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128395	10.1371/journal.pone.0128395	http://dx.doi.org/10.1371/journal.pone.0128395			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042773	gold, Green Submitted, Green Published			2022-12-27	WOS:000355701600047
J	Souframanien, J; Reddy, KS				Souframanien, J.; Reddy, Kandali Sreenivasulu			De novo Assembly, Characterization of Immature Seed Transcriptome and Development of Genic-SSR Markers in Black Gram [Vigna mungo (L.) Hepper]	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; ANGULARIS WILLD. OHWI; MICROSATELLITE MARKERS; FOXTAIL MILLET; GENOTYPING APPLICATIONS; GENETIC DIVERSITY; LINKAGE MAP; DNA; TRANSFERABILITY; CONSERVATION	Black gram [V. mungo (L.) Hepper] is an important legume crop extensively grown in south and south-east Asia, where it is a major source of dietary protein for its predominantly vegetarian population. However, lack of genomic information and markers has become a limitation for genetic improvement of this crop. Here, we report the transcriptome sequencing of the immature seeds of black gram cv. TU94-2, by Illumina paired end sequencing technology to generate transcriptome sequences for gene discovery and genic-SSR marker development. A total of 17.2 million paired-end reads were generated and 48,291 transcript contigs (TCS) were assembled with an average length of 443 bp. Based on sequence similarity search, 33,766 TCS showed significant similarity to known proteins. Among these, only 29,564 TCS were annotated with gene ontology (GO) functional categories. A total number of 138 unique KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways were identified, of which majority of TCS are grouped into purine metabolism (678) followed by pyrimidine metabolism (263). A total of 48,291 TCS were searched for SSRs and 1,840 SSRs were identified in 1,572 TCS with an average frequency of one SSR per 11.9 kb. The tri-nucleotide repeats were most abundant (35%) followed by di-nucleotide repeats (32%). PCR primer pairs were successfully designed for 933 SSR loci. Sequences analyses indicate that about 64.4% and 35.6% of the SSR motifs were present in the coding sequences (CDS) and untranslated regions (UTRs) respectively. Tri-nucleotide repeats (57.3%) were preferentially present in the CDS. The rate of successful amplification and polymorphism were investigated using selected primers among 18 black gram accessions. Genic-SSR markers developed from the Illumina paired end sequencing of black gram immature seed transcriptome will provide a valuable resource for genetic diversity, evolution, linkage mapping, comparative genomics and marker-assisted selection in black gram.	[Souframanien, J.; Reddy, Kandali Sreenivasulu] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Bombay 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC)	Souframanien, J (corresponding author), Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Bombay 400085, Maharashtra, India.	souf@scientist.com						ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; ASHIHARA H, 1977, Z PFLANZENPHYSIOL, V81, P199, DOI 10.1016/S0044-328X(77)80195-5; Atkins C, 2000, PROKARYOTIC NITROGEN FIXATION, P559; Bainbridge MN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-246; Blair MW, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-50; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BOUTIN SR, 1995, GENOME, V38, P928, DOI 10.1139/g95-122; Cardle L, 2000, GENETICS, V156, P847; Chaitieng B, 2006, THEOR APPL GENET, V113, P1261, DOI 10.1007/s00122-006-0380-5; Choudhary S, 2009, THEOR APPL GENET, V118, P591, DOI 10.1007/s00122-008-0923-z; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; FATOKUN CA, 1993, THEOR APPL GENET, V86, P97, DOI 10.1007/BF00223813; Fu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057686; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Gupta P. K., 2004, Functional & Integrative Genomics, V4, P139, DOI 10.1007/s10142-004-0107-0; Gupta S, 2012, PROJECT COORDINATORS; Gupta SK, 2008, GENOME, V51, P628, DOI 10.1139/G08-050; Gupta SK, 2014, EUPHYTICA, V195, P245, DOI 10.1007/s10681-013-0993-0; Gupta SK, 2010, GENOME, V53, P508, DOI [10.1139/G10-028, 10.1139/g10-028]; Gupta SK, 2009, GENOME, V52, P120, DOI [10.1139/g08-107, 10.1139/G08-107]; Gupta S, 2012, PLANT CELL REP, V31, P323, DOI 10.1007/s00299-011-1168-x; Gupta S, 2009, GENOME, V52, P761, DOI [10.1139/g09-051, 10.1139/G09-051]; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang YJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6443; Kumari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067742; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Liao D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00060; Liu ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083549; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Mantello CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102665; Martins WS, 2009, BIOINFORMATION, V3, P282, DOI 10.6026/97320630003282; Metzgar D, 2000, GENOME RES, V10, P72; Moe KT, 2011, J INTEGR PLANT BIOL, V53, P63, DOI 10.1111/j.1744-7909.2010.01012.x; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Pandey G, 2013, DNA RES, V20, P197, DOI 10.1093/dnares/dst002; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Paul S, 2014, J INTEGR PLANT BIOL, V56, P15, DOI 10.1111/jipb.12115; Rohlf FJ, 1998, NTSYS PC NUMERICAL T; Roy SW, 2007, MOL BIOL EVOL, V24, P1140, DOI 10.1093/molbev/msm045; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Somta P, 2009, CONSERV GENET, V10, P1939, DOI 10.1007/s10592-009-9860-x; Souframanien J, 2004, THEOR APPL GENET, V109, P1687, DOI 10.1007/s00122-004-1797-3; Souframanien J., 2009, Journal of Food Legumes, V22, P11; Tangphatsornruang S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-137; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Tian AG, 2004, THEOR APPL GENET, V108, P903, DOI 10.1007/s00122-003-1499-2; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Wang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062293; Wang ZY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-139; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Yadav CB, 2014, MOL BREEDING, V34, P2219, DOI 10.1007/s11032-014-0137-9	59	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128748	10.1371/journal.pone.0128748	http://dx.doi.org/10.1371/journal.pone.0128748			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042595	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600064
J	Vasan, SK; Rostgaard, K; Ullum, H; Melbye, M; Hjalgrim, H; Edgren, G				Vasan, Senthil K.; Rostgaard, Klaus; Ullum, Henrik; Melbye, Mads; Hjalgrim, Henrik; Edgren, Gustaf			ABO Blood Group and Dementia Risk - A Scandinavian Record-Linkage Study	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; VASCULAR DEMENTIA; COGNITIVE IMPAIRMENT; ALZHEIMER-DISEASE; FACTOR-VIII; METAANALYSIS; POPULATION; PREVALENCE; ACTIVATION; REGISTER	Background Dementia includes a group of neuro-degenerative disorders characterized by varying degrees of cognitive impairment. Recent data indicates that blood group AB is associated with impaired cognition in elderly patients. To date there are no large-scale studies that have examined the relationship between ABO blood group and dementia-related disorders in detail. Methods We used data from the SCANDAT2 database that contains information on over 1.6 million blood donors from 1968 in Sweden and 1981 from Denmark. The database was linked with health outcomes data from nationwide patient and cause of death registers to investigate the relationship between blood groups and risk of different types of dementia. The incident rate ratios were estimated using log-linear Poisson regression models. Results Among 1,598,294 donors followed over 24 million person-years of observation we ascertained 3,615 cases of Alzheimer's disease, 1,842 cases of vascular dementia, and 9,091 cases of unspecified dementia. Overall, our study showed no association between ABO blood group and risk of Alzheimer's disease, vascular dementia or unspecified dementia. This was also true when analyses were restricted to donors aged 70 years or older except for a slight, but significantly decreased risk of all dementia combined in subjects with blood group A (IRR, 0.93; 95% confidence interval [CI], 0.88-0.98), compared to those with blood group O. Conclusions Our results provide no evidence that ABO blood group influences the risk of dementia.	[Vasan, Senthil K.; Edgren, Gustaf] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Rostgaard, Klaus; Melbye, Mads; Hjalgrim, Henrik] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Ullum, Henrik] Univ Copenhagen Hosp, Rigshosp, Blood Bank, Dept Clin Immunol, DK-2100 Copenhagen, Denmark; [Edgren, Gustaf] Karolinska Univ Hosp, Hematol Ctr, Stockholm, Sweden	Karolinska Institutet; Statens Serum Institut; Rigshospitalet; University of Copenhagen; Karolinska Institutet; Karolinska University Hospital	Vasan, SK (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	vasan.kandaswamy@ki.se	Hjalgrim, Henrik/AAG-4973-2021; Edgren, Gustaf/F-4013-2014	Edgren, Gustaf/0000-0002-2198-4745; melbye, mads/0000-0001-8264-6785; Ullum, Henrik/0000-0001-7306-9058; Rostgaard, Klaus/0000-0001-6220-9414; Vasan, Senthil/0000-0002-3630-6568	Strategic research program in epidemiology at Karolinska Institutet; Swedish research council; Swedish Heart-Lung Foundation; Swedish Society for Medical Research	Strategic research program in epidemiology at Karolinska Institutet; Swedish research council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Society for Medical Research	This work was supported by funds from the Strategic research program in epidemiology at Karolinska Institutet, the Swedish research council, the Swedish Heart-Lung Foundation, and the Swedish Society for Medical Research.	Alexander KS, 2014, NEUROLOGY, V83, P1271, DOI 10.1212/WNL.0000000000000844; Carcaillon L, 2009, J THROMB HAEMOST, V7, P1972, DOI 10.1111/j.1538-7836.2009.03603.x; Deramecourt V, 2012, NEUROLOGY, V78, P1043, DOI 10.1212/WNL.0b013e31824e8e7f; Desmond DW, 1999, ALZ DIS ASSOC DIS, V13, pS21, DOI 10.1097/00002093-199912001-00005; Edgren G, 2006, VOX SANG, V91, P316, DOI 10.1111/j.1423-0410.2006.00817.x; Edgren G, 2015, TRANSFUSION; Fakhoury M., 2015, NEURODEGENER DIS; Graham JE, 1997, LANCET, V349, P1793, DOI 10.1016/S0140-6736(97)01007-6; Gustafson DR, 2009, NEUROLOGY, V73, P1559, DOI 10.1212/WNL.0b013e3181c0d4b6; James BD, 2012, JAMA-J AM MED ASSOC, V307, P1798, DOI 10.1001/jama.2012.3556; Jaremo P, 2013, SCAND J CLIN LAB INV, V73, P170, DOI 10.3109/00365513.2013.764572; Jellinger KA, 2005, J NEUROL SCI, V229, P37, DOI 10.1016/j.jns.2004.11.018; Jenkins PV, 2006, TRANSFUSION, V46, P1836, DOI 10.1111/j.1537-2995.2006.00975.x; Jin P, 2004, NEUROLOGY, V63, P739, DOI 10.1212/01.WNL.0000134604.48018.97; Lathe R, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-36; Lu FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004144; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Paglieri C, 2004, CLIN EXP HYPERTENS, V26, P277, DOI 10.1081/CEH-120034134; Peters Ruth, 2008, BMC Geriatr, V8, P36, DOI 10.1186/1471-2318-8-36; RENVOIZE EB, 1985, AGE AGEING, V14, P43, DOI 10.1093/ageing/14.1.43; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Snyder HM, 2015, ALZHEIMERS DEMENT, V11, P710, DOI 10.1016/j.jalz.2014.10.008; Souto JC, 2000, ARTERIOSCL THROM VAS, V20, P2024, DOI 10.1161/01.ATV.20.8.2024; Stellos K, 2010, J CEREBR BLOOD F MET, V30, P1817, DOI 10.1038/jcbfm.2010.140; Stott DJ, 2010, ARTERIOSCL THROM VAS, V30, P605, DOI 10.1161/ATVBAHA.109.199448; van Oijen M, 2005, STROKE, V36, P2637, DOI 10.1161/01.STR.0000189721.31432.26; Wu O, 2008, J THROMB HAEMOST, V6, P62; Zahr NM, 2011, NAT REV NEUROL, V7, P284, DOI 10.1038/nrneurol.2011.42	29	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0129115	10.1371/journal.pone.0129115	http://dx.doi.org/10.1371/journal.pone.0129115			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042891	Green Submitted, Green Published, gold			2022-12-27	WOS:000355701600089
J	Zhang, C; Shi, YR; Liu, XR; Cao, YC; Zhen, D; Jia, ZY; Jiang, JQ; Tian, JH; Gao, JM				Zhang, Chao; Shi, Ya-Ran; Liu, Xiao-Ran; Cao, Yong-Chun; Zhen, Di; Jia, Zi-Ye; Jiang, Jin-Qi; Tian, Jian-Hui; Gao, Jian-Ming			The Anti-Apoptotic Role of Berberine in Preimplantation Embryo In Vitro Development through Regulation of miRNA-21	PLOS ONE			English	Article							MICRORNA-21; EXPRESSION; PROLIFERATION; ACTIVATION; PATHWAY; DICER	Traditional Chinese medicinal herbs containing berberine have been historically used to prevent miscarriage. Here, we investigated whether the anti-apoptotic effects of berberine on pre-implantation embryonic development are regulated by miRNA-21. Mouse pronuclear embryos were cultured in medium with or without berberine, and some were then microinjected with a miRNA-21 inhibitor. The in vitro developmental rates of 2- and 4-cell embryos and blastocysts, blastocyst cell numbers, apoptotic rates, and apoptotic cell numbers were measured in each group. Furthermore, we examined the transcription levels of miRNA-21 and its target genes (caspase-3, PTEN, and Bcl-2) and their translation levels. Comparisons were made with in vivo-developed and untreated embryos. We found that berberine significantly increased the developmental rates and cell numbers of mouse blastocysts and decreased apoptotic cell rates in vitro. Berberine also significantly increased miRNA-21 and Bcl-2 transcription levels and significantly decreased caspase-3 and PTEN transcription levels. In embryos treated with a miRNA-21 inhibitor, the results followed the opposite trend; PTEN and caspase-3 transcription levels increased significantly, while the transcription level of Bcl-2 decreased significantly. Additionally, berberine treatment significantly increased the Bcl-2 protein level and significantly decreased the caspase-3 and PTEN protein levels in blastocysts, but there were no significant differences observed in the levels of these proteins in 2-and 4-cell embryos. This study revealed that miRNA-21 is important for pre-implantation embryonic development, especially blastocyst development in vitro. Berberine elevates miRNA-21 expression, decreases PTEN and caspase-3 levels, increases Bcl-2 levels, and exerts anti-apoptotic and pro-growth effects.	[Zhang, Chao; Shi, Ya-Ran; Liu, Xiao-Ran; Cao, Yong-Chun; Zhen, Di; Jia, Zi-Ye; Jiang, Jin-Qi; Gao, Jian-Ming] Beijing Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Tian, Jian-Hui] China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China	Beijing University of Agriculture; China Agricultural University	Tian, JH (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China.	tianjh@cau.edu.cn; gjmbac@sohu.com			Beijing Natural Science Foundation of China [6112004]; National Key Technology RD Program [2011BAD19B01]; National HighTech RD Program [2011AA100303]; High Quality Paper Support Project of Beijing University of Agriculture, China [GL2012006]	Beijing Natural Science Foundation of China(Beijing Natural Science Foundation); National Key Technology RD Program(National Key Technology R&D Program); National HighTech RD Program(National High Technology Research and Development Program of China); High Quality Paper Support Project of Beijing University of Agriculture, China	This work was supported by grants from the Beijing Natural Science Foundation of China (Nos. 6112004), the National Key Technology R&D Program (Nos. 2011BAD19B01), National HighTech R&D Program (Nos. 2011AA100303) and the High Quality Paper Support Project of Beijing University of Agriculture, China (Nos. GL2012006). The funders (Jian-Ming Gao and Jian-Hui Tian) had a role in study design, data collection and analysis, the decision to publish, and preparation of the manuscript.	Aguado-Fraile E, 2013, NEFROLOGIA, V33, P826, DOI 10.3265/Nefrologia.pre2013.Aug.12198; Audrito V, 2011, CANCER RES, V71, P4473, DOI 10.1158/0008-5472.CAN-10-4452; Barbagallo D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-62; Barber DL, 2012, BLOOD, V119, P648, DOI 10.1182/blood-2011-11-382614; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen Y, 2008, CANCER LETT, V272, P197, DOI 10.1016/j.canlet.2008.06.034; Chen ZW, 2008, CHINA OCCUP MED, V35, P207; Ellis L, 2013, ONCOTARGET, V4, P2225, DOI 10.18632/oncotarget.1314; Gao JM, 2006, CHINESE JOURNAL OF A, V15, P16; Gao JM, 2013, REPRODUCTION IN DOME, V47, P90; Ghorpade DS, 2012, MOL CELL BIOL, V32, P2239, DOI 10.1128/MCB.06597-11; Hu JZ, 2013, J NEUROTRAUM, V30, P1349, DOI 10.1089/neu.2012.2748; Jorgensen HF, 2009, DEVELOPMENT, V136, P715, DOI 10.1242/dev.028548; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Le F, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106070; Lee HW, 2008, J BONE MINER RES, V23, P1227, DOI 10.1359/JBMR.080325; Lee YM, 2012, MOL HUM REPROD, V18, P184, DOI 10.1093/molehr/gar072; Li DD, 2008, P 14 S AN REPR BRANC, P427; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Li T, 2013, WORLD J GASTROENTERO, V19, P5615, DOI 10.3748/wjg.v19.i34.5615; Li Y, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003934; Lin JP, 2007, ANTICANCER RES, V27, P3379; Liu SL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002751; Luo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047914; Lv XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047351; Maccani MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021210; Maegdefessel L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003441; Mahata S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-39; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; Matthew S, 2009, CANCER CELL, V23, P139; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Mouillet JF, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110049; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Park KS, 2012, YONSEI MED J, V53, P346, DOI 10.3349/ymj.2012.53.2.346; Shen XH, 2009, MOL REPROD DEV, V76, P854, DOI 10.1002/mrd.21048; Shi YR, 2013, J INTEGR AGR, V12, P663, DOI 10.1016/S2095-3119(13)60284-1; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Sun YuCheng, 2006, Chinese Journal of Veterinary Science, V26, P570; Tateno H, 2007, BIOL REPROD, V77, P336, DOI 10.1095/biolreprod.106.057778; Vigneault C, 2004, BIOL REPROD, V70, P1701, DOI 10.1095/biolreprod.103.022970; Wang XH, 2012, REPROD BIOMED ONLINE, V25, P415, DOI 10.1016/j.rbmo.2012.06.022; Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117; Xu H, 2011, MODERN PREVENTIVE ME, V38, P2120; XU J, 2009, CHINA ANIMAL HUSBAND, V36, P112; Yang L, 2007, JOURNAL OF CLINICAL, V21, P538; Zeng ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073278; ZHANG RX, 1990, CHINESE MED J-PEKING, V103, P658; Zhao Ju, 2010, Jiepou Xuebao, V41, P623, DOI 10.3969/j.issn.0529-1356.2010.04.028; Zheng GXY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002054; Zhou XQ, 2008, NEUROSCI LETT, V447, P31, DOI 10.1016/j.neulet.2008.09.064	51	22	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0129527	10.1371/journal.pone.0129527	http://dx.doi.org/10.1371/journal.pone.0129527			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042820	Green Submitted, gold, Green Published			2022-12-27	WOS:000355701600098
J	Zheng, J; Ying, ZB; Cai, ZY; Sun, DM; He, ZY; Gao, YL; Zhang, T; Zhu, Y; Chen, Y; Guan, MX				Zheng, Jing; Ying, Zhengbiao; Cai, Zhaoyang; Sun, Dongmei; He, Zheyun; Gao, Yinglong; Zhang, Ting; Zhu, Yi; Chen, Ye; Guan, Min-Xin			GJB2 Mutation Spectrum and Genotype-Phenotype Correlation in 1067 Han Chinese Subjects with Non-Syndromic Hearing Loss	PLOS ONE			English	Article							26 GENE GJB2; CONNEXIN-26 MUTATIONS; MOLECULAR ANALYSIS; IMPAIRMENT; DEAFNESS; PREVALENCE; FREQUENCY; VARIANTS	Mutations in Gap Junction Beta 2 (GJB2) have been reported to be a major cause of non-syndromic hearing loss in many populations worldwide. The spectrums and frequencies of GJB2 variants vary substantially among different ethnic groups, and the genotypes among these populations remain poorly understood. In the present study, we carried out a systematic and extended mutational screening of GJB2 gene in 1067 Han Chinese subjects with non-syndromic hearing loss, and the resultant GJB2 variants were evaluated by phylogenetic, structural and bioinformatic analysis. A total of 25 (23 known and 2 novel) GJB2 variants were identified, including 6 frameshift mutations, 1 nonsense mutation, 16 missense mutations and 2 silent mutations. In this cohort, c.235delC is the most frequently observed pathogenic mutation. The phylogenetic, structural and bioinformatic analysis showed that 2 novel variants c.127G>T (p.V43L), c.293G>C (p.R98P) and 2 known variants c.107T>C (p.L36P) and c.187G>T (p.V63L) are localized at highly conserved amino acids. In addition, these 4 mutations are absent in 203 healthy individuals, therefore, they are probably the most likely candidate pathogenic mutations. In addition, 66 (24 novel and 42 known) genotypes were identified, including 6 homozygotes, 20 compound heterozygotes, 18 single heterozygotes, 21 genotypes harboring only polymorphism(s) and the wild type genotype. Among these, 153 (14.34%) subjects were homozygous for pathogenic mutations, 63 (5.91%) were compound heterozygotes, and 157 (14.71%) carried single heterozygous mutation. Furthermore, 65.28% (141/216) of these cases with two pathogenic mutations exhibited profound hearing loss. These data suggested that mutations in GJB2 gene are responsible for approximately 34.96% of non-syndromic hearing loss in Han Chinese population from Zhejiang Province in eastern China. In addition, our results also strongly supported the idea that other factors such as alterations in regulatory regions, additional genes, and environmental factors may contribute to the clinical manifestation of deafness.	[Zheng, Jing; Chen, Ye; Guan, Min-Xin] Zhejiang Univ, Sch Med, Inst Genet, Hangzhou 310003, Zhejiang, Peoples R China; [Ying, Zhengbiao; Cai, Zhaoyang; Zhang, Ting] Wenzhou Med Univ, Wenling Peoples Hosp, Dept Otolaryngol, Taizhou, Peoples R China; [Sun, Dongmei] Jinhua Municipal Cent Hosp, Dept Lab Med, Jinhua, Peoples R China; [He, Zheyun; Gao, Yinglong] Wenzhou Med Univ, Sch Lab Med & Life Sci, Attardi Inst Mitochondrial Biomed, Wenzhou, Peoples R China; [Zhu, Yi] Wenzhou Med Univ, Affiliated Hosp 1, Dept Otolaryngol, Wenzhou, Peoples R China; [Chen, Ye; Guan, Min-Xin] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Chen, Y (corresponding author), Zhejiang Univ, Sch Med, Inst Genet, Hangzhou 310003, Zhejiang, Peoples R China.	yechency@zju.edu.cn	Chen, Ye/D-1164-2015; he, zhe/GSJ-2307-2022	Chen, Ye/0000-0003-3671-2504; gao, yinglong/0000-0002-9707-8669; Guan, Min-Xin/0000-0001-5067-6736	973 Program from the Ministry of Science and Technology of China (MXG) [2014CB541704]; National Natural Science Foundation of China [81470685, 81330024]; China Postdoctoral Science Foundation [2013M531742]	973 Program from the Ministry of Science and Technology of China (MXG); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the 973 Program (2014CB541704) from the Ministry of Science and Technology of China (MXG), projects (81470685 and 81330024) from National Natural Science Foundation of China (YC and MXG), and China Postdoctoral Science Foundation (2013M531742 to JZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj Y, 2008, CLIN OTOLARYNGOL, V33, P313, DOI 10.1111/j.1749-4486.2008.01754.x; Bason L, 2002, CLIN GENET, V61, P459, DOI 10.1034/j.1399-0004.2002.610611.x; Chan DK, 2014, LARYNGOSCOPE, V124, pE34, DOI 10.1002/lary.24332; Cryns K, 2004, J MED GENET, V41, P147, DOI 10.1136/jmg.2003.013896; Dai P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-26; del Castillo I, 2002, NEW ENGL J MED, V346, P243, DOI 10.1056/NEJMoa012052; Dror AA, 2010, NEURON, V68, P293, DOI 10.1016/j.neuron.2010.10.011; Dzhemileva LU, 2010, J HUM GENET, V55, P749, DOI 10.1038/jhg.2010.101; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Han SH, 2008, J HUM GENET, V53, P1022, DOI 10.1007/s10038-008-0342-7; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Hwa HL, 2003, GENET MED, V5, P161, DOI 10.1097/01.GIM.0000066796.11916.94; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kenneson A, 2002, GENET MED, V4, P258, DOI 10.1097/00125817-200207000-00004; Khandelwal G, 2009, J LARYNGOL OTOL, V123, P273, DOI 10.1017/S0022215108002892; Kim SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061592; Lee KY, 2008, INT J PEDIATR OTORHI, V72, P1301, DOI 10.1016/j.ijporl.2008.05.007; Li R, 2004, J MED GENET, V41, P615, DOI 10.1136/jmg.2004.020230; Liu XZ, 2002, HUM GENET, V111, P394, DOI 10.1007/s00439-002-0811-6; Lucotte G, 2005, GENET TEST, V9, P20, DOI 10.1089/gte.2005.9.20; Mehl AL, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.1.e7; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Mueller RF, 1999, INT J PEDIATR OTORHI, V50, P3, DOI 10.1016/S0165-5876(99)00242-6; Oguchi T, 2005, J HUM GENET, V50, P76, DOI 10.1007/s10038-004-0223-7; Ortolano S, 2008, P NATL ACAD SCI USA, V105, P18776, DOI 10.1073/pnas.0800831105; Palmada M, 2006, NEUROBIOL DIS, V22, P112, DOI 10.1016/j.nbd.2005.10.005; Park HJ, 2000, LARYNGOSCOPE, V110, P1535, DOI 10.1097/00005537-200009000-00023; Propst EJ, 2006, INT J PEDIATR OTORHI, V70, P435, DOI 10.1016/j.ijporl.2005.07.013; RamShankar M, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.5.e68; Santos RLP, 2005, CLIN GENET, V67, P61, DOI 10.1111/j.1399-0004.2005.00379.x; Shen ZS, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-4; Shi GZ, 2004, HEARING RES, V197, P19, DOI 10.1016/j.heares.2004.06.012; Tekin M, 2010, ANN HUM GENET, V74, P155, DOI 10.1111/j.1469-1809.2010.00564.x; Tsukada K, 2010, CLIN GENET, V78, P464, DOI 10.1111/j.1399-0004.2010.01407.x; Usami S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031276; Wang YC, 2002, EUR J HUM GENET, V10, P495, DOI 10.1038/sj.ejhg.5200838; Yan D, 2003, HUM GENET, V114, P44, DOI 10.1007/s00439-003-1018-1; Yao J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-136; Yilmaz A, 2014, CELL BIOCH BIOPHYS; Yuan Y, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-79; Zhao FF, 2011, GENET TEST MOL BIOMA, V15, P619, DOI 10.1089/gtmb.2010.0192	42	29	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128691	10.1371/journal.pone.0128691	http://dx.doi.org/10.1371/journal.pone.0128691			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043044	gold, Green Published, Green Submitted			2022-12-27	WOS:000355701600061
J	Bellmunt, J; Werner, L; Leow, JJ; Mullane, SA; Fay, AP; Riester, M; Van Hummelen, P; Taplin, ME; Choueiri, TK; Van Allen, E; Rosenberg, J				Bellmunt, Joaquim; Werner, Lillian; Leow, Jeffrey J.; Mullane, Stephanie A.; Fay, Andre P.; Riester, Markus; Van Hummelen, Paul; Taplin, Mary-Ellen; Choueiri, Toni K.; Van Allen, Eliezer; Rosenberg, Jonathan			Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial Tumors	PLOS ONE			English	Article							BLADDER-CANCER; PIK3CA MUTATION; FGFR3; CARCINOMA; FREQUENT; TARGETS; AMPLIFICATION; THERAPY; RAS	Background An integrative analysis was conducted to identify genomic alterations at a pathway level that could predict overall survival (OS) in patients with advanced urothelial carcinoma (UC) treated with platinum-based chemotherapy. Patients and Methods DNA and RNA were extracted from 103 formalin-fixed paraffin embedded (FFPE) invasive high-grade UC samples and were screened for mutations, copy number variation (CNV) and gene expression analysis. Clinical data were available from 85 cases. Mutations were analyzed by mass-spectrometry based on genotyping platform (Oncomap 3) and genomic imbalances were detected by comparative genomic hybridization (CGH) analysis. Regions with threshold of log2 ratio >= 0.4, or <= 0.6 were defined as either having copy number gain or loss and significantly recurrent CNV across the set of samples were determined using a GISTIC analysis. Expression analysis on selected relevant UC genes was conducted using Nanostring. To define the co-occurrence pattern of mutations and CNV, we grouped genomic events into 5 core signal transduction pathways: 1) TP53 pathway, 2) RTK/RAS/RAF pathway, 3) PI3K/AKT/mTOR pathway, 4) WNT/CTNNB1, 5) RB1 pathway. Cox regression was used to assess pathways abnormalities with survival outcomes. Results 35 samples (41%) harbored mutations on at least one gene: TP53 (16%), PIK3CA (9%), FGFR3 (2%), HRAS/KRAS (5%), and CTNNB1 (1%). 66% of patients had some sort of CNV. PIK3CA/AKT/mTOR pathway alteration (mutations+CNV) had the greatest impact on OS (p=0.055). At a gene level, overexpression of CTNNB1 (p=0.0008) and PIK3CA (p=0.02) were associated with shorter OS. Mutational status on PIK3CA was not associated with survival. Among other individually found genomic alterations, TP53 mutations (p=0.07), mTOR gain (p=0.07) and PTEN overexpression (p=0.08) have a marginally significant negative impact on OS. Conclusions Our study suggests that targeted therapies focusing on the PIK3CA/AKT/mTOR pathway genomic alterations can generate the greatest impact in the overall patient population of high-grade advanced UC.	[Bellmunt, Joaquim; Leow, Jeffrey J.; Mullane, Stephanie A.; Fay, Andre P.; Taplin, Mary-Ellen; Choueiri, Toni K.; Van Allen, Eliezer] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dana Farber Canc Inst,Lank Ctr Genitourinary Onco, Boston, MA 02115 USA; [Werner, Lillian; Riester, Markus] Harvard Univ, Sch Med, Dana Farber Canc Inst, Biostat & Computat Biol, Boston, MA 02115 USA; [Van Hummelen, Paul] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Rosenberg, Jonathan] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Memorial Sloan Kettering Cancer Center	Bellmunt, J (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dana Farber Canc Inst,Lank Ctr Genitourinary Onco, Boston, MA 02115 USA.	joaquim_bellmunt@dfci.harvard.edu	Bellmunt, Joaquim/B-8151-2019; Choueiri, Toni/K-5238-2019; Leow, Jeffrey/AAL-8931-2020	Bellmunt, Joaquim/0000-0003-2328-3421; Choueiri, Toni/0000-0002-9201-3217; Leow, Jeffrey/0000-0002-6216-1913; van hummelen, paul/0000-0002-4801-8600; Rosenberg, Jonathan/0000-0003-2637-4249	Spanish Health Ministry Grant "Fondo de Investigacion Sanitaria" [PI061513]; RTICC grants [06/0020/19]; Pla Director d'Oncologia de Catalunya (XBTC); Friends of Dana-Farber; Retired Professional Fire Fighters Cancer Fund; Whole Foods Golf Classic; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Spanish Health Ministry Grant "Fondo de Investigacion Sanitaria"; RTICC grants; Pla Director d'Oncologia de Catalunya (XBTC); Friends of Dana-Farber; Retired Professional Fire Fighters Cancer Fund; Whole Foods Golf Classic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported by PI061513 (Spanish Health Ministry Grant "Fondo de Investigacion Sanitaria") and RTICC 06/0020/19 grants. Fundacio Cellex (Barcelona) provided a generous donation to the Group of Molecular Therapeutics and Biomarkers, Hospital del Mar. The Tumor Bank of the Department of Pathology of Hospital del Mar (RD09/0076/0036) and the Xarxa de Bancs de Tumors sponsored by Pla Director d'Oncologia de Catalunya (XBTC) provided tissue samples. This study was also possible thanks to a Grant from Friends of Dana-Farber, the Retired Professional Fire Fighters Cancer Fund, and the generous support of Whole Foods Golf Classic for bladder cancer research in memoriam of Christopher Snell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abol-Enein H, 2005, EUR UROL, V48, P202, DOI 10.1016/j.eururo.2005.04.006; Ahmad I, 2011, DIS MODEL MECH, V4, P548, DOI 10.1242/dmm.006874; Bambury RM, 2013, CURR OPIN UROL, V23, P472, DOI 10.1097/MOU.0b013e328363a3cd; Burger M, 2013, EUR UROL, V63, P36, DOI 10.1016/j.eururo.2012.08.061; CAIRNS P, 1991, ONCOGENE, V6, P2305; Cancer Genome Atlas Research Network, 2014, NATURE; Ching CB, 2010, LAB INVEST, V90, P1406, DOI 10.1038/labinvest.2010.133; Fleischmann A, 2011, EUR UROL, V60, P350, DOI 10.1016/j.eururo.2011.05.035; Galsky MD, 2012, INVEST NEW DRUG, V30, P695, DOI 10.1007/s10637-010-9541-0; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Houede N, 2014, PHARM THERAPEUTICS; Iyer G, 2013, J CLIN ONCOL, V31, P3133, DOI 10.1200/JCO.2012.46.5740; Juanpere N, 2012, HUM PATHOL, V43, P1573, DOI 10.1016/j.humpath.2011.10.026; Kalinsky K, 2009, CLIN CANCER RES, V15, P5049, DOI 10.1158/1078-0432.CCR-09-0632; Kim PH, 2014, EUROPEAN UROLOGY; Kompier LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013821; Korkolopoulou P, 2012, BJU INT, V110, pE1237, DOI 10.1111/j.1464-410X.2012.11569.x; Lae M, 2010, ANN ONCOL, V21, P815, DOI 10.1093/annonc/mdp488; Lamont FR, 2011, BRIT J CANCER, V104, P75, DOI 10.1038/sj.bjc.6606016; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Matulonis UA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024433; Memon AA, 2006, BRIT J CANCER, V94, P1703, DOI 10.1038/sj.bjc.6603154; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Millis SZ, 2014, CLIN GENITOURINARY C; Milowsky MI, 2013, J CLIN ONCOL, V31, DOI 10.1200/jco.2013.31.6_suppl.255; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898; Polivka J, 2014, PHARMACOL THERAPEUT, V142, P164, DOI 10.1016/j.pharmthera.2013.12.004; Rastislav B, 2014, J CLIN ONCOL S, V32, p5s; Ross JS, 2014, MODERN PATHOL, V27, P271, DOI 10.1038/modpathol.2013.135; Sequist LV, 2014, 2014 AACR ANN M APR; Shigaki H, 2013, CLIN CANCER RES, V19, P2451, DOI 10.1158/1078-0432.CCR-12-3559; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; van Rhijn BWG, 2012, J UROLOGY, V187, P310, DOI 10.1016/j.juro.2011.09.008; Williams SV, 2013, HUM MOL GENET, V22, P795, DOI 10.1093/hmg/dds486	35	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0124711	10.1371/journal.pone.0124711	http://dx.doi.org/10.1371/journal.pone.0124711			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039708	gold, Green Published			2022-12-27	WOS:000355700700004
J	Bolnick, DI; Shim, KC; Schmerer, M; Brock, CD				Bolnick, Daniel I.; Shim, Kum Chuan; Schmerer, Matthew; Brock, Chad D.			Population-Specific Covariation between Immune Function and Color of Nesting Male Threespine Stickleback	PLOS ONE			English	Article							SEXUAL SELECTION; MATE CHOICE; GASTEROSTEUS-ACULEATUS; 3-SPINED STICKLEBACKS; SENSORY DRIVE; NUPTIAL COLOR; TRADE-OFFS; FITNESS CONSEQUENCES; RECEIVER BIASES; FLOW-CYTOMETRY	Multiple biological processes can generate sexual selection on male visual signals such as color. For example, females may prefer colorful males because those males are more readily detected (perceptual bias), or because male color conveys information about male quality and associated direct or indirect benefits to females. For example, male threespine stickleback often exhibit red throat coloration, which females prefer both because red is more visible in certain environments, and red color is correlated with male immune function and parasite load. However, not all light environments favor red nuptial coloration: more tanninstained water tends to favor the evolution of a melanic male phenotype. Do such population differences in stickleback male color, driven by divergent light environments, lead to changes in the relationship between color and immunity? Here, we show that, within stickleback populations, multiple components of male color (brightness and hue of four body parts) are correlated with multiple immune variables (ROS production, phagocytosis rates, and lymphocyte: leukocyte ratios). Some of these color-immune associations persist across stickleback populations with very different male color patterns, whereas other color-immune associations are population-specific. Overall, lakes with red males exhibit stronger color-immune covariance while melanic male populations exhibit weak if any color-immune associations. Our finding that color-immunity relationships are labile implies that any evolution of male color traits ( e.g., due to female perceptual bias in a given light environment), can alter the utility of color as an indicator of male quality.	[Bolnick, Daniel I.] Univ Texas Austin, Howard Hughes Med Inst, Austin, TX 78712 USA; [Bolnick, Daniel I.; Shim, Kum Chuan; Schmerer, Matthew; Brock, Chad D.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Bolnick, DI (corresponding author), Univ Texas Austin, Howard Hughes Med Inst, Austin, TX 78712 USA.	danbolnick@austin.utexas.edu			Howard Hughes Medical Institute; David and Lucille Packard Foundation fellowship; NSF [IOS-1145468]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); David and Lucille Packard Foundation fellowship(The David & Lucile Packard Foundation); NSF(National Science Foundation (NSF))	This work received funding from: Howard Hughes Medical Institute (no grant number) Early Career Scientist fellowship to DIB (paid for development of immunological methods and equipment); David and Lucille Packard Foundation fellowship to DIB (paid for field researchers' travel, lodging, reagents, and salary); NSF IOS-1145468 (paid for additional sample acquisition and costs of data analysis).	BAKKER TCM, 1994, BEHAV ECOL, V5, P74, DOI 10.1093/beheco/5.1.74; Barber I, 2000, J FISH BIOL, V57, P777, DOI 10.1111/j.1095-8649.2000.tb00274.x; Barber I, 2003, PARASITOLOGY, V126, P359, DOI 10.1017/S0031182002002925; Barber I, 2010, PARASITOLOGY, V137, P411, DOI 10.1017/S0031182009991466; Barber I, 2001, P ROY SOC B-BIOL SCI, V268, P71, DOI 10.1098/rspb.2000.1331; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Braithwaite VA, 2000, BEHAV ECOL SOCIOBIOL, V47, P413, DOI 10.1007/s002650050684; Candolin U, 1999, ANIM BEHAV, V58, P1261, DOI 10.1006/anbe.1999.1259; Chandler CH, 2013, EVOLUTION, V67, P110, DOI 10.1111/j.1558-5646.2012.01750.x; CHELLAPPA S, 1995, J FISH BIOL, V47, P775, DOI 10.1111/j.1095-8649.1995.tb06002.x; Chew BP, 2004, J NUTR, V134, p257S, DOI 10.1093/jn/134.1.257S; Clarke JM, 2011, BIOL J LINN SOC, V102, P902, DOI 10.1111/j.1095-8312.2011.01623.x; Clotfelter ED, 2007, BEHAV ECOL, V18, P1139, DOI 10.1093/beheco/arm090; Cummings ME, 2007, EVOLUTION, V61, P530, DOI 10.1111/j.1558-5646.2007.00047.x; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Engstrom-Ost J, 2007, BEHAV ECOL, V18, P393, DOI 10.1093/beheco/arl097; Fisher RA, 1915, EUGEN REV, V7, P184; Fitze PS, 2007, AM NAT, V169, pS137, DOI 10.1086/510094; FOLSTAD I, 1994, OIKOS, V69, P511, DOI 10.2307/3545863; Fuller RC, 2005, AM NAT, V166, P437, DOI 10.1086/444443; Graham AL, 2011, FUNCT ECOL, V25, P5, DOI 10.1111/j.1365-2435.2010.01777.x; Grether GF, 1996, EVOLUTION, V50, P1949, DOI 10.1111/j.1558-5646.1996.tb03582.x; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Heins DC, 2003, J PARASITOL, V89, P1, DOI 10.1645/0022-3395(2003)089[0001:ROESIN]2.0.CO;2; Heuschele J, 2009, BEHAV ECOL, V20, P1223, DOI 10.1093/beheco/arp123; Jamieson IG, 1994, ECOSCIENCE, V1, P281, DOI 10.1080/11956860.1994.11682253; Kalbe M, 2006, PARASITOLOGY, V132, P105, DOI 10.1017/S0031182005008681; KIRKPATRICK M, 1982, EVOLUTION, V36, P1, DOI 10.1111/j.1558-5646.1982.tb05003.x; Kirkpatrick M, 1996, EVOLUTION, V50, P2125, DOI [10.2307/2410684, 10.1111/j.1558-5646.1996.tb03603.x]; Kokko H, 2006, ANNU REV ECOL EVOL S, V37, P43, DOI 10.1146/annurev.ecolsys.37.091305.110259; Kraak SBM, 1999, BEHAV ECOL, V10, P696, DOI 10.1093/beheco/10.6.696; Kurtz J, 2007, AM NAT, V170, P509, DOI 10.1086/521316; Lehmann AK, 2000, J IMMUNOL METHODS, V243, P229, DOI 10.1016/S0022-1759(00)00237-4; Lewandowski E, 2008, BIOL J LINN SOC, V94, P663, DOI 10.1111/j.1095-8312.2008.01021.x; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Maan ME, 2004, P ROY SOC B-BIOL SCI, V271, P2445, DOI 10.1098/rspb.2004.2911; Macnab V, 2011, HORM BEHAV, V60, P371, DOI 10.1016/j.yhbeh.2011.07.005; Malek TB, 2012, MOL ECOL, V21, P5265, DOI 10.1111/j.1365-294X.2012.05660.x; McGraw KJ, 2006, ETHOLOGY, V112, P1209, DOI 10.1111/j.1439-0310.2006.01280.x; MILINSKI M, 1990, NATURE, V344, P330, DOI 10.1038/344330a0; Milinski M, 2003, J FISH BIOL, V63, P1, DOI 10.1111/j.1095-8649.2003.00215.x; Milinski M, 2006, ANNU REV ECOL EVOL S, V37, P159, DOI 10.1146/annurev.ecolsys.37.091305.110242; Moller AP, 1999, Q REV BIOL, V74, P3, DOI 10.1086/392949; Pike TW, 2007, P ROY SOC B-BIOL SCI, V274, P1591, DOI 10.1098/rspb.2007.0317; Pomiankowski A, 1998, P NATL ACAD SCI USA, V95, P5106, DOI 10.1073/pnas.95.9.5106; R Development Core Team, 2007, R LANG ENV STAT COMP; REIMCHEN TE, 1989, EVOLUTION, V43, P450, DOI 10.1111/j.1558-5646.1989.tb04239.x; Richardson MP, 1998, J IMMUNOL METHODS, V219, P187, DOI 10.1016/S0022-1759(98)00136-7; Rick IP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025554; ROWLAND WJ, 1995, ANIM BEHAV, V49, P1559, DOI 10.1016/0003-3472(95)90077-2; Ryan MJ, 2013, ANNU REV ECOL EVOL S, V44, P437, DOI 10.1146/annurev-ecolsys-110512-135901; Ryan MJ, 1998, SCIENCE, V281, P1999, DOI 10.1126/science.281.5385.1999; Saino N, 1999, AM NAT, V154, P441, DOI 10.1086/303246; Schade FM, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0164-5; Scharsack JP, 2007, P ROY SOC B-BIOL SCI, V274, P1523, DOI 10.1098/rspb.2007.0210; Scharsack JP, 2007, P ROY SOC B-BIOL SCI, V274, P3151, DOI 10.1098/rspb.2007.1148; Scharsack JP, 2004, DIS AQUAT ORGAN, V59, P141, DOI 10.3354/dao059141; Schulenburg H, 2009, PHILOS T R SOC B, V364, P3, DOI 10.1098/rstb.2008.0249; Scott RJ, 2001, J FISH BIOL, V59, P1520, DOI 10.1111/j.1095-8649.2001.tb00217.x; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Shykoff JA, 1996, NATURWISSENSCHAFTEN, V83, P113, DOI 10.1007/BF01142175; Simons MJP, 2011, BEHAV ECOL, V22, P755, DOI 10.1093/beheco/arr043; Sunyer J. Oriol, 2012, Infectious Disorders - Drug Targets, V12, P200; Thompson CW, 1997, AM NAT, V149, P270, DOI 10.1086/285990; Wong BBM, 2007, AM NAT, V170, P184, DOI 10.1086/519398; Yang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082972	69	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126000	10.1371/journal.pone.0126000	http://dx.doi.org/10.1371/journal.pone.0126000			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039044	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700018
J	Degremont, L; Lamy, JB; Pepin, JF; Travers, MA; Renault, T				Degremont, Lionel; Lamy, Jean-Baptiste; Pepin, Jean-Francois; Travers, Marie-Agnes; Renault, Tristan			New Insight for the Genetic Evaluation of Resistance to Ostreid Herpesvirus Infection, a Worldwide Disease, in Crassostrea gigas	PLOS ONE			English	Article							SACCOSTREA-GLOMERATA GOULD; SPOT SYNDROME VIRUS; PACIFIC OYSTER; SUMMER MORTALITY; RAINBOW-TROUT; OSHV-1; SURVIVAL; SELECTION; GROWTH; DOMESTICATION	The Pacific oyster, Crassostrea gigas, is the most important commercial oyster species cultivated in the world. Meanwhile, the ostreid herpesvirus 1 (OsHV-1) is one of the major pathogens affecting the Pacific oyster, and numerous mortality outbreaks related to this pathogen are now reported worldwide. To assess the genetic basis of resistance to OsHV-1 infection in spat C. gigas and to facilitate breeding programs for such a trait, if any exist, we compared the mortality of half-and full-sib families using three field methods and a controlled challenge by OsHV-1 in the laboratory. In the field, three methods were tested: (A) one family per bag; (B) one family per small soft mesh bag and all families inside one bag; (C) same as the previous methods but the oysters were individually labelled and then mixed. The mean mortality ranged from 80 to 82% and was related to OsHV-1 based on viral DNA detection. The narrow-sense heritability for mortality, and thus OsHV-1 resistance, ranged from 0.49 to 0.60. The high positive genetic correlations across the field methods suggested no genotype by environment interaction. Ideally, selective breeding could use method B, which is less time-and space-consuming. The narrow sense heritability for mortality under OsHV-1 challenge was 0.61, and genetic correlation between the field and the laboratory was ranged from 0.68 to 0.75, suggesting a weak genotype by environment interaction. Thus, most of families showing the highest survival performed well in field and laboratory conditions, and a similar trend was also observed for families with the lowest survival. In conclusion, this is the first study demonstrating a large additive genetic variation for resistance to OsHV-1 infection in C. gigas, regardless of the methods used, which should help in selective breeding to improve resistance to viral infection in C. gigas.	[Degremont, Lionel; Lamy, Jean-Baptiste; Travers, Marie-Agnes; Renault, Tristan] Ifremer, Lab Genet & Pathol Mollusques Marins, F-17390 La Tremblade, France; [Pepin, Jean-Francois] Ifremer, Lab Environm Resources Pertuis Charentais, F-17390 La Tremblade, France	Ifremer; Ifremer	Degremont, L (corresponding author), Ifremer, Lab Genet & Pathol Mollusques Marins, Ave Mus Loup, F-17390 La Tremblade, France.	lionel.degremont@ifremer.fr	PEPIN, jean francois/AAO-3649-2020; degremont, lionel/A-4163-2011	PEPIN, jean francois/0000-0001-8548-8938; degremont, lionel/0000-0001-6759-6791; Travers, Marie-Agnes/0000-0001-5340-7435; Lamy, Jean-Baptiste/0000-0002-6078-0905	Institut Francais de Recherche pour l'Exploitation de la Mer LD, European project Bivalife PF7 [266157 TR LD JFP MAT]	Institut Francais de Recherche pour l'Exploitation de la Mer LD, European project Bivalife PF7	This study was supported by the Institut Francais de Recherche pour l'Exploitation de la Mer LD, European project Bivalife PF7 No., 266157 TR LD JFP MAT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber BJ, 1998, J SHELLFISH RES, V17, P1171; Batista FM, 2015, AQUACULTURE, V435, P43, DOI 10.1016/j.aquaculture.2014.09.016; BEATTIE J H, 1980, Proceedings National Shellfisheries Association, V70, P184; Blanc JM, 2003, J WORLD AQUACULT SOC, V34, P425, DOI 10.1111/j.1749-7345.2003.tb00081.x; Boudry P, 2003, AQUACULT INT, V11, P429, DOI 10.1023/B:AQUI.0000004189.49517.c0; Burge CA, 2006, DIS AQUAT ORGAN, V72, P31, DOI 10.3354/dao072031; Cameron A, 2011, FINAL REPORT OSHV 1, P101; Cuellar-Anjel J, 2012, AQUACULTURE, V368, P36, DOI 10.1016/j.aquaculture.2012.08.048; Culloty SC, 2001, AQUACULTURE, V199, P229, DOI 10.1016/S0044-8486(01)00569-5; Degremont L., 2003, ETUDE BASES GENETIQU, P333; Degremont L, 2014, AQUACULTURE RES; Degremont L, 2007, AQUACULTURE, V262, P41, DOI 10.1016/j.aquaculture.2006.10.025; Degremont L, 2013, AQUACULTURE, V416, P129, DOI 10.1016/j.aquaculture.2013.09.011; Degremont L, 2011, AQUACULTURE, V317, P94, DOI 10.1016/j.aquaculture.2011.04.029; Degremont L, 2010, J SHELLFISH RES, V29, P847, DOI 10.2983/035.029.0419; Degremont L, 2010, AQUACULTURE, V299, P44, DOI 10.1016/j.aquaculture.2009.12.009; Degremont L, 2010, AQUACULTURE, V299, P21, DOI 10.1016/j.aquaculture.2009.11.017; DEMPSTER ER, 1950, GENETICS, V35, P212; Domeneghetti S, 2014, FISH SHELLFISH IMMUN, V41, P37, DOI 10.1016/j.fsi.2014.05.023; Dove MC, 2013, AQUAC RES, V44, P1791, DOI 10.1111/are.12012; Dunham R. A., 2004, AQUACULTURE FISHERIE; Evans S, 2006, AQUACULTURE, V261, P522, DOI 10.1016/j.aquaculture.2006.07.022; Falconer D. S., 1996, INTRO QUANTITATIVE G; FAO, 2014, FISHSTATJ SOFTW FISH; FORD SE, 1987, J PARASITOL, V73, P368, DOI 10.2307/3282092; Frank-Lawale A, 2014, J SHELLFISH RES, V33, P153, DOI 10.2983/035.033.0115; Garcia C, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-73; Gitterle T, 2005, AQUACULTURE, V246, P139, DOI 10.1016/j.aquaculture.2005.02.011; Hayes BJ, 2010, AQUAC RES, V41, pe872, DOI 10.1111/j.1365-2109.2010.02611.x; Henryon M, 2005, AQUACULTURE, V250, P621, DOI 10.1016/j.aquaculture.2004.12.022; Jenkins C, 2013, DIS AQUAT ORGAN, V105, P109, DOI 10.3354/dao02623; Keeling SE, 2014, DIS AQUAT ORGAN, V109, P231, DOI 10.3354/dao02735; Kong N, 2013, AQUACULTURE RES; Lynch SA, 2012, PARASITOLOGY, V139, P1526, DOI 10.1017/S0031182012000881; Martin A-G, 1993, BORD AQ 92 EAS EUR A; Matson S, 2011, DEV EVALUATION APPL, P161; MOAV R, 1974, HEREDITY, V33, P181, DOI 10.1038/hdy.1974.86; Naciri-Graven Y, 1998, J EXP MAR BIOL ECOL, V224, P91, DOI 10.1016/S0022-0981(97)00171-8; NAMBA K, 1995, FISHERIES SCI, V61, P241, DOI 10.2331/fishsci.61.241; Nell JA, 2000, AQUAC RES, V31, P45, DOI 10.1046/j.1365-2109.2000.00387.x; Odegard J, 2007, AQUACULTURE, V271, P173, DOI 10.1016/j.aquaculture.2007.06.006; Oliver JL, 2000, J AQUAT ANIM HEALTH, V12, P136, DOI 10.1577/1548-8667(200006)012&lt;0136:PIAISB&gt;2.0.CO;2; Overturf K, 2010, J FISH DIS, V33, P321, DOI 10.1111/j.1365-2761.2009.01124.x; Paul-Pont I, 2014, AQUACULTURE, V422, P146, DOI 10.1016/j.aquaculture.2013.12.009; Paul-Pont I, 2013, AQUACULTURE, V412, P202, DOI 10.1016/j.aquaculture.2013.07.038; Pepin JF, 2008, J VIROL METHODS, V149, P269, DOI 10.1016/j.jviromet.2008.01.022; Pernet F, 2012, AQUACULT ENV INTERAC, V2, P215, DOI 10.3354/aei00041; Roque A, 2012, AQUACULTURE, V324, P303, DOI 10.1016/j.aquaculture.2011.10.018; Samain J.-F., 2007, SUMMER MORTALITY PAC; SAS, 2014, SAS SOFTW 9 4 SAS HE; Schikorski D, 2011, VIRUS RES, V155, P28, DOI 10.1016/j.virusres.2010.07.031; Schikorski D, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-27; Segarra A, 2010, VIRUS RES, V153, P92, DOI 10.1016/j.virusres.2010.07.011; Shimahara Y, 2012, FISH PATHOL, V47, P129, DOI 10.3147/jsfp.47.129; Trinkler N, 2010, J INVERTEBR PATHOL, V104, P8, DOI 10.1016/j.jip.2009.12.007; Usuki Hironori, 2002, Bulletin of Fisheries Research Agency, V4, P40; Vandeputte M, 2009, AQUACULTURE, V286, P20, DOI 10.1016/j.aquaculture.2008.09.008; Ward RD, 2005, 20002006 FDRC CSIRO, P193; Webb SC, 2007, AQUACULTURE, V272, P126, DOI 10.1016/j.aquaculture.2007.07.224	59	49	49	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127917	10.1371/journal.pone.0127917	http://dx.doi.org/10.1371/journal.pone.0127917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039375	gold, Green Published, Green Submitted			2022-12-27	WOS:000355700700078
J	Johnson, SA; Javurek, AB; Painter, MS; Peritore, MP; Ellersieck, MR; Roberts, RM; Rosenfeld, CS				Johnson, Sarah A.; Javurek, Angela B.; Painter, Michele S.; Peritore, Michael P.; Ellersieck, Mark R.; Roberts, R. Michael; Rosenfeld, Cheryl S.			Disruption of Parenting Behaviors in California Mice, a Monogamous Rodent Species, by Endocrine Disrupting Chemicals	PLOS ONE			English	Article							BISPHENOL-A EXPOSURE; MATERNAL-BEHAVIOR; PEROMYSCUS-CALIFORNICUS; DEVELOPMENTAL EXPOSURE; PATERNAL BEHAVIOR; SEX-RATIO; CARE; MOUSE; EXPRESSION; OXYTOCIN	The nature and extent of care received by an infant can affect social, emotional and cognitive development, features that endure into adulthood. Here we employed the monogamous, California mouse (Peromyscus californicus), a species, like the human, where both parents invest in offspring care, to determine whether early exposure to endocrine disrupting chemicals (EDC: bisphenol A, BPA; ethinyl estradiol, EE) of one or both parents altered their behaviors towards their pups. Females exposed to either compound spent less time nursing, grooming and being associated with their pups than controls, although there was little consequence on their weight gain. Care of pups by males was less affected by exposure to BPA and EE, but control, non-exposed females appeared able to "sense" a male partner previously exposed to either compound and, as a consequence, reduced their own parental investment in offspring from such pairings. The data emphasize the potential vulnerability of pups born to parents that had been exposed during their own early development to EDC, and that effects on the male, although subtle, also have consequences on overall parental care due to lack of full acceptance of the male by the female partner.	[Johnson, Sarah A.; Javurek, Angela B.; Painter, Michele S.; Peritore, Michael P.; Roberts, R. Michael; Rosenfeld, Cheryl S.] Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA; [Johnson, Sarah A.; Javurek, Angela B.; Painter, Michele S.; Peritore, Michael P.; Rosenfeld, Cheryl S.] Univ Missouri, Biomed Sci, Columbia, MO 65211 USA; [Ellersieck, Mark R.] Univ Missouri, Agr Expt Stn Stat, Columbia, MO 65211 USA; [Roberts, R. Michael] Univ Missouri, Anim Sci, Columbia, MO 65211 USA; [Roberts, R. Michael] Univ Missouri, Biochem, Columbia, MO 65211 USA; [Roberts, R. Michael; Rosenfeld, Cheryl S.] Univ Missouri, Genet Area Program, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Rosenfeld, CS (corresponding author), Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA.	rosenfeldc@missouri.edu			National Institutes of Health National Institute of Environmental Health and Sciences [5R21ES023150-02]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES023150] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Environmental Health and Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided by the National Institutes of Health (National Institute of Environmental Health and Sciences (http://www.niehs.nih.gov/) 5R21ES023150-02 to CSR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akther S, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-41; Bagot RC, 2012, P NATL ACAD SCI USA, V109, P17200, DOI 10.1073/pnas.1204599109; Bhandari RK, 2015, GEN COMP ENDOCR, V214, P195, DOI 10.1016/j.ygcen.2014.09.014; Birnie AK, 2013, PSYCHONEUROENDOCRINO, V38, P3003, DOI 10.1016/j.psyneuen.2013.08.011; Blass EM, 1996, REGUL PEPTIDES, V66, P109, DOI 10.1016/0167-0115(96)00045-6; Boudalia S, 2014, NEUROTOXICOL TERATOL, V41, P16, DOI 10.1016/j.ntt.2013.11.002; Bredy TW, 2004, HORM BEHAV, V46, P30, DOI 10.1016/j.yhbeh.2003.09.017; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Cummings JA, 2005, PHYSIOL BEHAV, V85, P83, DOI 10.1016/j.physbeh.2005.04.001; Della Seta D, 2005, BRAIN RES BULL, V65, P255, DOI 10.1016/j.brainresbull.2004.11.017; Dougherty LR, 2013, J ABNORM CHILD PSYCH, V41, P1299, DOI 10.1007/s10802-013-9763-7; DRICKAMER LC, 1973, J MAMMAL, V54, P523, DOI 10.2307/1379147; Dulac C, 2014, SCIENCE, V345, P765, DOI 10.1126/science.1253291; EISENBERG JOHN F., 1962, BEHAVIOUR, V19, P177, DOI 10.1163/156853962X00014; Engell MD, 2006, NEUROTOXICOL TERATOL, V28, P103, DOI 10.1016/j.ntt.2005.10.002; Febo M, 2005, J NEUROSCI, V25, P11637, DOI 10.1523/JNEUROSCI.3604-05.2005; Gray PB, 2013, AM J PHYS ANTHROPOL, V152, P94, DOI 10.1002/ajpa.22394; GUBERNICK DJ, 1995, HORM BEHAV, V29, P59, DOI 10.1006/hbeh.1995.1005; GUBERNICK DJ, 1987, J COMP PSYCHOL, V101, P169, DOI 10.1037/0735-7036.101.2.169; GUBERNICK DJ, 1989, HORM BEHAV, V23, P203, DOI 10.1016/0018-506X(89)90061-5; Gubernick DJ, 2000, P ROY SOC B-BIOL SCI, V267, P147, DOI 10.1098/rspb.2000.0979; Jasarevic E, 2013, HORM BEHAV, V63, P180, DOI 10.1016/j.yhbeh.2012.09.009; Jasarevic E, 2012, ANIM BEHAV, V84, P1141, DOI 10.1016/j.anbehav.2012.08.015; Jasarevic E, 2011, P NATL ACAD SCI USA, V108, P11715, DOI 10.1073/pnas.1107958108; Jia R, 2009, BEHAV PROCESS, V82, P271, DOI 10.1016/j.beproc.2009.07.006; Kundakovic M, 2013, P NATL ACAD SCI USA, V110, P9956, DOI 10.1073/pnas.1214056110; Layne JN, 1968, BIOL PEROMYSCUS RODE; Li YN, 2015, J COMP PHYSIOL A, V201, P285, DOI 10.1007/s00359-015-0979-6; Ligon RA, 2010, ANIM BEHAV, V79, P727, DOI 10.1016/j.anbehav.2009.12.028; Littell RC, 1998, J ANIM SCI, V76, P1216; Lonstein JS, 2005, HORM BEHAV, V47, P241, DOI 10.1016/j.yhbeh.2004.11.001; Mashoodh R, 2012, P NATL ACAD SCI USA, V109, P17232, DOI 10.1073/pnas.1121083109; Palanza P, 2002, ENVIRON HEALTH PERSP, V110, P415, DOI 10.1289/ehp.02110s3415; Parent CI, 2013, DEV PSYCHOBIOL, V55, P745, DOI 10.1002/dev.21070; Perez-Cano FJ, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/537310; Pinkernelle J, 2009, DEV NEUROBIOL, V69, P663, DOI 10.1002/dneu.20726; Rilling JK, 2014, SCIENCE, V345, P771, DOI 10.1126/science.1252723; ROOD JP, 1966, AM MIDL NAT, V76, P496, DOI 10.2307/2423101; Rosenfeld CS, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00057; Rosenfeld CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075725; Rosenfeld CS, 2004, BIOL REPROD, V71, P1063, DOI 10.1095/biolreprod.104.030890; Rosenfeld CS, 2003, P NATL ACAD SCI USA, V100, P4628, DOI 10.1073/pnas.0330808100; Saal FSV, 2005, BIRTH DEFECTS RES A, V73, P140, DOI 10.1002/bdra.20120; Sieli PT, 2011, ENVIRON HEALTH PERSP, V119, P1260, DOI 10.1289/ehp.1003385; Sieli PT, 2011, ENV HLTH PERSPECT; Szyf M, 2005, FRONT NEUROENDOCRIN, V26, P139, DOI 10.1016/j.yfrne.2005.10.002; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Williams SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055698; WOODROFFE R, 1994, TRENDS ECOL EVOL, V9, P294, DOI 10.1016/0169-5347(94)90033-7	52	34	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126284	10.1371/journal.pone.0126284	http://dx.doi.org/10.1371/journal.pone.0126284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039462	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700024
J	Pizza, F; Jaussent, I; Lopez, R; Pesenti, C; Plazzi, G; Drouot, X; Leu-Semenescu, S; Beziat, S; Arnulf, I; Dauvilliers, Y				Pizza, Fabio; Jaussent, Isabelle; Lopez, Regis; Pesenti, Carole; Plazzi, Giuseppe; Drouot, Xavier; Leu-Semenescu, Smaranda; Beziat, Severine; Arnulf, Isabelle; Dauvilliers, Yves			Car Crashes and Central Disorders of Hypersomnolence: A French Study	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; SIMULATED DRIVING PERFORMANCE; MOTOR-VEHICLE CRASHES; DAYTIME SLEEPINESS; WAKEFULNESS TEST; GENERAL-POPULATION; THORACIC SOCIETY; NARCOLEPSY; RISK; ACCIDENTS	Background Drowsiness compromises driving ability by reducing alertness and attentiveness, and delayed reaction times. Sleep-related car crashes account for a considerable proportion of accident at the wheel. Narcolepsy type 1 (NT1), narcolepsy type 2 (NT2) and idiopathic hypersomnia (IH) are rare central disorders of hypersomnolence, the most severe causes of sleepiness thus being potential dangerous conditions for both personal and public safety with increasing scientific, social, and political attention. Our main objective was to assess the frequency of recent car crashes in a large cohort of patients affected with well-defined central disorders of hypersomnolence versus subjects from the general population. Methods We performed a cross-sectional study in French reference centres for rare hypersomnia diseases and included 527 patients and 781 healthy subjects. All participants included needed to have a driving license, information available on potential accident events during the last 5 years, and on potential confounders; thus analyses were performed on 282 cases (71 IH, 82 NT2, 129 NT1) and 470 healthy subjects. Results Patients reported more frequently than healthy subjects the occurrence of recent car crashes (in the previous five years), a risk that was confirmed in both treated and untreated subjects at study inclusion (Untreated, OR = 2.21 95%CI = [1.30-3.76], Treated OR = 2.04 95%CI = [1.26-3.30]), as well as in all disease categories, and was modulated by subjective sleepiness level (Epworth scale and naps). Conversely, the risk of car accidents of patients treated for at least 5 years was not different to healthy subjects (OR = 1.23 95%CI = [0.56-2.69]). Main risk factors were analogous in patients and healthy subjects. Conclusion Patients affected with central disorders of hypersomnolence had increased risk of recent car crashes compared to subjects from the general population, a finding potentially reversed by long-term treatment.	[Pizza, Fabio; Lopez, Regis; Pesenti, Carole; Dauvilliers, Yves] CHU Montpellier, Gui de Chauliac Hosp, Sleep Disorders Ctr, Dept Neurol, Montpellier, France; [Pizza, Fabio; Plazzi, Giuseppe] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Bologna, Italy; [Pizza, Fabio; Plazzi, Giuseppe] ASL Bologna, IRCCS Ist Sci Neurol, Bologna, Italy; [Jaussent, Isabelle; Lopez, Regis; Pesenti, Carole; Beziat, Severine; Dauvilliers, Yves] Inserm U1061, Montpellier, France; [Jaussent, Isabelle; Lopez, Regis; Pesenti, Carole; Beziat, Severine; Dauvilliers, Yves] Univ Montpellier I, Montpellier, France; [Lopez, Regis; Pesenti, Carole; Leu-Semenescu, Smaranda; Arnulf, Isabelle; Dauvilliers, Yves] Narcolepsy Idiopath Hypersomnia & Kleine Levin Sy, Natl Reference Ctr Orphan Dis, Paris, France; [Drouot, Xavier] CHU Poitiers, Dept Clin Neurophysiol, F-8600 Poitiers, France; [Leu-Semenescu, Smaranda; Arnulf, Isabelle] Univ Paris 06, Sorbonne Univ, Pitie Salpetriere Univ Hosp,CNRS UMR 7225, AP HP,Sleep Disorders Unit,Brain Res Inst,CRICM,I, F-75005 Paris, France	Universite de Montpellier; CHU de Montpellier; University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU Poitiers; Universite de Poitiers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Dauvilliers, Y (corresponding author), CHU Montpellier, Gui de Chauliac Hosp, Sleep Disorders Ctr, Dept Neurol, Montpellier, France.	ydauvilliers@yahoo.fr	Plazzi, Giuseppe/AAB-9627-2020; Pizza, Fabio/AAC-1794-2020; Lopez, Regis/X-4694-2019	Drouot, Xavier/0000-0002-3940-4825; Arnulf, Isabelle/0000-0002-2240-2516; Jaussent, Isabelle/0000-0002-8205-7590; Plazzi, Giuseppe/0000-0002-1051-0472; Dauvilliers, yves/0000-0003-0683-6506; PIZZA, FABIO/0000-0003-2294-9551; Lopez, Regis/0000-0001-8591-0553	French Health Ministry (promotor: Assistance Publique Hopitaux de Paris, IA) [PHRC AOM07-138]; European narcolepsy Network (EU-NN) Senior Investigator Grant	French Health Ministry (promotor: Assistance Publique Hopitaux de Paris, IA); European narcolepsy Network (EU-NN) Senior Investigator Grant	The study was financed and supported by the PHRC AOM07-138 from the French Health Ministry (promotor: Assistance Publique Hopitaux de Paris, IA), and a European narcolepsy Network (EU-NN) Senior Investigator Grant 2014 to FP.	ALDRICH MS, 1989, SLEEP, V12, P487, DOI 10.1093/sleep/12.6.487; American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS, V3rd; Ayas N, 2014, CAN RESPIR J, V21, P114, DOI 10.1155/2014/357327; Bayon V, 2009, SLEEP MED REV, V13, P421, DOI 10.1016/j.smrv.2009.02.001; BROUGHTON RJ, 1984, EPILEPSIA, V25, P423, DOI 10.1111/j.1528-1157.1984.tb03438.x; Dauvilliers Y, 2009, J NEUROL NEUROSUR PS, V80, P636, DOI 10.1136/jnnp.2008.161588; Dauvilliers Y, 2006, CURR NEUROL NEUROSCI, V6, P156, DOI 10.1007/s11910-996-0039-2; Dauvilliers Y, 2007, LANCET, V369, P499, DOI 10.1016/S0140-6736(07)60237-2; Drake C, 2010, SLEEP, V33, P745, DOI 10.1093/sleep/33.6.745; Ellen RLB, 2006, J CLIN SLEEP MED, V2, P193; Findley LJ, 1999, SLEEP, V22, P804, DOI 10.1093/sleep/22.6.804; Garbarino S, 2011, G Ital Med Lav Ergon, V33, P199; Garbarino S, 2001, SLEEP, V24, P203; George CFP, 1996, SLEEP, V19, P711, DOI 10.1093/sleep/19.9.711; Goncalves M, 2015, J SLEEP RES, V24, P242, DOI 10.1111/jsr.12267; HORNE JA, 1995, BRIT MED J, V310, P565, DOI 10.1136/bmj.310.6979.565; Ingravallo F, 2012, SLEEP MED, V13, P1293, DOI 10.1016/j.sleep.2012.08.002; Jennum P, 2013, SLEEP, V36, P835, DOI 10.5665/sleep.2706; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Karimi M, 2014, SLEEP; Kim H, 2005, SLEEP, V28, P625, DOI 10.1093/sleep/28.5.625; Kotterba S, 2004, CLIN NEUROL NEUROSUR, V106, P275, DOI 10.1016/j.clineuro.2003.12.003; Kotterba S, 2002, SOMNOLOGIE, V6, P39; Littner MR, 2005, SLEEP, V28, P113, DOI 10.1093/sleep/28.1.113; Lyznicki JM, 1998, JAMA-J AM MED ASSOC, V279, P1908, DOI 10.1001/jama.279.23.1908; Ohayon MM, 2014, SLEEP, V37, P439, DOI 10.5665/sleep.3470; Ohayon MM, 2012, ARCH GEN PSYCHIAT, V69, P71, DOI 10.1001/archgenpsychiatry.2011.1240; Ozaki A, 2008, J CLIN SLEEP MED, V4, P572; Philip P, 2005, SLEEP, V28, P1511, DOI 10.1093/sleep/28.12.1511; Philip P, 2008, ANN NEUROL, V64, P410, DOI 10.1002/ana.21448; Philip P, 2014, SLEEP, V37, P483, DOI 10.5665/sleep.3480; Philip P, 2013, INT J PSYCHOPHYSIOL, V89, P195, DOI 10.1016/j.ijpsycho.2013.05.013; Philip P, 2010, SLEEP MED, V11, P973, DOI 10.1016/j.sleep.2010.07.010; Pizza F, 2011, THORAX, V66, P725, DOI 10.1136/thx.2010.140988; Pizza F, 2009, SLEEP, V32, P382, DOI 10.1093/sleep/32.3.382; Powell NB, 2007, SLEEP, V30, P331, DOI 10.1093/sleep/30.3.331; Rodenstein D, 2008, J SLEEP RES, V17, P281, DOI 10.1111/j.1365-2869.2008.00669.x; Strohl KP, 2013, AM J RESP CRIT CARE, V187, P1259, DOI 10.1164/rccm.201304-0726ST; Thorpy MJ, 2015, SLEEP MED, V16, P9, DOI 10.1016/j.sleep.2014.10.002; Thorpy MJ, 2014, SLEEP MED, V15, P502, DOI 10.1016/j.sleep.2014.01.015; Tran Jason, 2014, J Public Health Epidemiol, V8, P202; Tregear S, 2009, J CLIN SLEEP MED, V5, P573	42	43	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129386	10.1371/journal.pone.0129386	http://dx.doi.org/10.1371/journal.pone.0129386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052938	gold, Green Published, Green Submitted			2022-12-27	WOS:000355955300122
J	Arora, A; Shafiq, N; Jain, S; Khuller, GK; Sharma, S; Malhotra, S				Arora, Anjuman; Shafiq, Nusrat; Jain, Sanjay; Khuller, G. K.; Sharma, Sadhana; Malhotra, Samir			Development of Sustained Release "NanoFDC (Fixed Dose Combination)" for Hypertension - An Experimental Study	PLOS ONE			English	Article							DRUG-DELIVERY; ARTERIAL-HYPERTENSION; MANAGEMENT; NANOPARTICLES; OPTIMIZATION; THERAPY	Objectives The present study was planned to formulate, characterize and evaluate the pharmacokinetics of a novel "NanoFDC" comprising three commonly prescribed anti-hypertensive drugs, hydrochlorothiazide (a diuretic), candesartan (ARB) and amlodipine (a calcium channel blocker). Basic Methods The candidate drugs were loaded in Poly (DL-lactide-co-gycolide) (PLGA) by emulsion-diffusion-evaporation method. The formulations were evaluated for their size, morphology, drug loading and in vitro release individually. Single dose pharmacokinetic profiles of the nanoformulations alone and in combination, as a NanoFDC, were evaluated in Wistar rats. Results The candidate drugs encapsulated inside PLGA showed entrapment efficiencies ranging from 30%, 33.5% and 32% for hydrochlorothiazide, candesartan and amlodipine respectively. The nanoparticles ranged in size from 110 to 180 nm. In vitro release profile of the nanoformulation showed 100% release by day 6 in the physiological pH 7.4 set up with PBS (phosphate buffer saline) and by day 4-5 in the intestinal pH 1.2 and 8.0 set up SGF (simulated gastric fluid) and SIF (simulated intestinal fluid) respectively. In pharmacokinetic analysis a sustained-release for 6 days and significant increase in the mean residence time (MRT), as compared to the respective free drugs was noted [MRT of amlodipine, hydrochlorothiazide and candesartan changed from 8.9 to 80.59 hours, 11 to 69.20 hours and 9 to 101.49 hours respectively]. Conclusion We have shown for the first time that encapsulating amlodipine, hydrochlorothiazide and candesartan into a single nanoformulation, to get the "NanoFDC (Fixed Dose Combination)" is a feasible strategy which aims to decrease pill burden.	[Arora, Anjuman; Shafiq, Nusrat; Malhotra, Samir] Postgrad Inst Med Educ & Res, Dept Pharmacol, Chandigarh 160012, India; [Jain, Sanjay] Postgrad Inst Med Educ & Res, Dept Internal Med, Chandigarh 160012, India; [Khuller, G. K.; Sharma, Sadhana] Postgrad Inst Med Educ & Res, Dept Biochem, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Malhotra, S (corresponding author), Postgrad Inst Med Educ & Res, Dept Pharmacol, Chandigarh 160012, India.	Samirmalhotra345@yahoo.com		Jain, Sanjay K/0000-0002-9241-3114	Department of Science and Technology, new Delhi [SR/FT/LS-047/2008]	Department of Science and Technology, new Delhi(Department of Science & Technology (India))	Funding provided by Department of Science and Technology, new Delhi: SR/FT/LS-047/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, PHARM TOXICOLOGY JUL; Arora A, 2014, CURR NANOSCI, V10, P816, DOI 10.2174/1573413710666140512221814; Baggarly SA, 2014, RES SOC ADMIN PHARM, P1, DOI [10.1016/j.sapharm.2014.04.002, DOI 10.1016/J.SAPHARM.2014.04.002]; Barrios V, 2010, EXPERT REV CARDIOVAS, V8, P1609, DOI [10.1586/erc.10.115, 10.1586/ERC.10.115]; Cao Y, 2011, FUTURE ONCOL, V7, P1347, DOI [10.2217/FON.11.109, 10.2217/fon.11.109]; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dickson M, 2008, AM J CARDIOVASC DRUG, V8, P45, DOI 10.2165/00129784-200808010-00006; Hackam DG, 2010, CAN J CARDIOL, V26, P249, DOI 10.1016/S0828-282X(10)70379-2; He WL, 2007, INT J PHARMACEUT, V334, P173, DOI 10.1016/j.ijpharm.2006.10.025; Heng D, 2008, PHARM RES-DORDR, V25, P1696, DOI 10.1007/s11095-008-9560-0; Italia JL, 2007, J CONTROL RELEASE, V119, P197, DOI 10.1016/j.jconrel.2007.02.004; Jain R, 1998, DRUG DEV IND PHARM, V24, P703, DOI 10.3109/03639049809082719; Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0; JAMES PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI DOI 10.1001/JAMA.2013.284427; Khan MU, 2014, J PHARM BIOALLIED SC, V6, P104, DOI 10.4103/0975-7406.129175; Kumar G, 2012, J PHARM SCI-US, V101, P2165, DOI 10.1002/jps.23087; Kumar G, 2011, DRUG DELIV, V18, P65, DOI 10.3109/10717544.2010.509367; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Martin J., 2008, JLGH, V3, P91; Okuda T., 2012, J BIOMATER NANOBIOTE, V3, P50; Pandey Rajesh, 2006, Indian Journal of Experimental Biology, V44, P459; Rojas J, 1999, INT J PHARM, V183, P67, DOI 10.1016/S0378-5173(99)00046-0; Sanz G, 2009, NAT CLIN PRACT CARD, V6, P101, DOI 10.1038/ncpcardio1419; Stevanovic M, 2009, CURR NANOSCI, V5, P1, DOI 10.2174/157341309787314566; Thrall G, 2004, J HUM HYPERTENS, V18, P595, DOI 10.1038/sj.jhh.1001722; Tocci G, 2011, HIGH BLOOD PRESS CAR, V18, P3, DOI 10.2165/1159615-s0-000000000-00000; Ullavapally KR, 2011, J PHARM RES, V4, P894; van Galen KA, 2014, AIDS RES TREAT, V2014, DOI 10.1155/2014/967073; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Wald NJ, 2004, UK patent GB, Patent No. 2361186; Xinhuan W, 2014, ASIAN J PHARM SCI, V9, P1, DOI 10.1016/j.ajps.2013.12.005	31	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128208	10.1371/journal.pone.0128208	http://dx.doi.org/10.1371/journal.pone.0128208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047011	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200048
J	Berding, G; Wilke, F; Rode, T; Haense, C; Joseph, G; Meyer, GJ; Mamach, M; Lenarz, M; Geworski, L; Bengel, FM; Lenarz, T; Lim, HH				Berding, Georg; Wilke, Florian; Rode, Thilo; Haense, Cathleen; Joseph, Gert; Meyer, Geerd J.; Mamach, Martin; Lenarz, Minoo; Geworski, Lilli; Bengel, Frank M.; Lenarz, Thomas; Lim, Hubert H.			Positron Emission Tomography Imaging Reveals Auditory and Frontal Cortical Regions Involved with Speech Perception and Loudness Adaptation	PLOS ONE			English	Article							COCHLEAR IMPLANT; SINGLE-SUBJECT; DEAFNESS REHABILITATION; MIDBRAIN IMPLANT; BRAIN; TINNITUS; PET; STIMULATION; ACTIVATION; PLASTICITY	Considerable progress has been made in the treatment of hearing loss with auditory implants. However, there are still many implanted patients that experience hearing deficiencies, such as limited speech understanding or vanishing perception with continuous stimulation (i.e., abnormal loudness adaptation). The present study aims to identify specific patterns of cerebral cortex activity involved with such deficiencies. We performed O-15-water positron emission tomography (PET) in patients implanted with electrodes within the cochlea, brainstem, or midbrain to investigate the pattern of cortical activation in response to speech or continuous multi-tone stimuli directly inputted into the implant processor that then delivered electrical patterns through those electrodes. Statistical parametric mapping was performed on a single subject basis. Better speech understanding was correlated with a larger extent of bilateral auditory cortex activation. In contrast to speech, the continuous multi-tone stimulus elicited mainly unilateral auditory cortical activity in which greater loudness adaptation corresponded to weaker activation and even deactivation. Interestingly, greater loudness adaptation was correlated with stronger activity within the ventral prefrontal cortex, which could be up-regulated to suppress the irrelevant or aberrant signals into the auditory cortex. The ability to detect these specific cortical patterns and differences across patients and stimuli demonstrates the potential for using PET to diagnose auditory function or dysfunction in implant patients, which in turn could guide the development of appropriate stimulation strategies for improving hearing rehabilitation. Beyond hearing restoration, our study also reveals a potential role of the frontal cortex in suppressing irrelevant or aberrant activity within the auditory cortex, and thus may be relevant for understanding and treating tinnitus.	[Berding, Georg; Haense, Cathleen; Meyer, Geerd J.; Mamach, Martin; Bengel, Frank M.] Hannover Med Sch, Dept Nucl Med, Hannover, Germany; [Berding, Georg; Rode, Thilo; Mamach, Martin; Lenarz, Thomas] Hannover Med Sch, Cluster Excellence Hearing4all, Hannover, Germany; [Wilke, Florian; Geworski, Lilli] Hannover Med Sch, Dept Med Phys & Radiat Protect, Hannover, Germany; [Rode, Thilo; Joseph, Gert; Lenarz, Thomas] Hannover Med Sch, Dept Otorhinolaryngol, Hannover, Germany; [Lenarz, Minoo] Charite, Dept Otolaryngol, D-13353 Berlin, Germany; [Lim, Hubert H.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN USA; [Lim, Hubert H.] Univ Minnesota, Dept Otolaryngol Head & Neck Surg, Minneapolis, MN USA	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Berding, G (corresponding author), Hannover Med Sch, Dept Nucl Med, Hannover, Germany.	berding.georg@mh-hannover.de	Bengel, Frank/AAR-7353-2020	Mamach, Martin/0000-0002-3461-2668; Bengel, Frank/0000-0003-4529-7963; Lim, Hubert/0000-0001-5653-9679	German Ministry of Research and Education [01GQ0816]; University of Minnesota (Institute for Translational Neuroscience); University of Minnesota (College of Science and Engineering)	German Ministry of Research and Education(Federal Ministry of Education & Research (BMBF)); University of Minnesota (Institute for Translational Neuroscience); University of Minnesota (College of Science and Engineering)	This work was funded by the German Ministry of Research and Education (Grant No. 01GQ0816). Start-up funds were received from the University of Minnesota (Institute for Translational Neuroscience and the College of Science and Engineering).	ALHO K, 1994, ELECTROEN CLIN NEURO, V91, P353, DOI 10.1016/0013-4694(94)00173-1; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Chmielowska J, 1999, J CEREBR BLOOD F MET, V19, P570, DOI 10.1097/00004647-199905000-00011; Chmielowska J, 1998, J CEREBR BLOOD F MET, V18, P433, DOI 10.1097/00004647-199804000-00012; Coez A, 2008, J NUCL MED, V49, P60, DOI 10.2967/jnumed.107.044545; Coez Arnaud, 2011, Cochlear Implants Int, V12 Suppl 1, pS124, DOI 10.1179/146701011X13001036693539; Coez A, 2009, NEUROIMAGE, V47, P1792, DOI 10.1016/j.neuroimage.2009.05.053; De Ridder D, 2013, BRAIN STIMUL, V6, P355, DOI 10.1016/j.brs.2012.07.002; De Ridder D, 2012, WORLD NEUROSURG, V77, P778, DOI 10.1016/j.wneu.2011.09.009; Di Nardo W, 2004, Acta Otorhinolaryngol Ital, V24, P321; Di Nardo W, 2001, EUR ARCH OTO-RHINO-L, V258, P496, DOI 10.1007/s004050100379; FRACKOWIAK RSJ, 1994, J ANAT, V184, P211; Fujiki N, 2000, ANN OTO RHINOL LARYN, V109, P12, DOI 10.1177/0003489400109S1204; Fujiki Nobuya, 1999, Auris Nasus Larynx, V26, P229, DOI 10.1016/S0385-8146(99)00009-7; Giraud AL, 2001, AUDIOL NEURO-OTOL, V6, P381, DOI 10.1159/000046847; Giraud AL, 2001, BRAIN, V124, P1307, DOI 10.1093/brain/124.7.1307; Gu JW, 2010, J NEUROPHYSIOL, V104, P3361, DOI 10.1152/jn.00226.2010; Henry JA, 2014, J AM ACAD AUDIOL, V25, P5, DOI 10.3766/jaaa.25.1.2; Hirano S, 2000, Auris Nasus Larynx, V27, P303, DOI 10.1016/S0385-8146(00)00072-9; Johnson MD, 2013, IEEE T BIO-MED ENG, V60, P610, DOI 10.1109/TBME.2013.2244890; Johnsrude IS, 2002, AUDIOL NEURO-OTOL, V7, P251, DOI 10.1159/000064446; Kaltenbach JA, 2011, HEARING RES, V276, P52, DOI 10.1016/j.heares.2010.12.003; Kinahan PE, 1999, NEUROIMAGE, V9, P430, DOI 10.1006/nimg.1998.0420; KNIGHT RT, 1989, BRAIN RES, V504, P338, DOI 10.1016/0006-8993(89)91381-4; Lanting CP, 2009, HEARING RES, V255, P1, DOI 10.1016/j.heares.2009.06.009; Lenarz T, 2006, OTOL NEUROTOL, V27, P838, DOI 10.1097/01.mao.0000232010.01116.e9; Lim HH, 2008, NEUROSCIENCE, V154, P370, DOI 10.1016/j.neuroscience.2008.02.041; Lim HH, 2015, BRAIN STIMUL, V8, P439, DOI 10.1016/j.brs.2014.10.016; Lim HH, 2015, HEARING RES, V322, P212, DOI 10.1016/j.heares.2015.01.006; Lim Hubert H, 2009, Trends Amplif, V13, P149, DOI 10.1177/1084713809348372; Matzke K.-H., 1993, Journal of Labelled Compounds and Radiopharmaceuticals, V32, P459; Miyamoto RT, 2001, J COMMUN DISORD, V34, P473, DOI 10.1016/S0021-9924(01)00062-4; Miyamoto RT, 1999, AM J OTOL, V20, P596; Moller AR, 2011, TEXTBOOK OF TINNITUS, P1; Morris JS, 1998, P ROY SOC B-BIOL SCI, V265, P649, DOI 10.1098/rspb.1998.0343; NAITO Y, 1995, COGNITIVE BRAIN RES, V2, P207, DOI 10.1016/0926-6410(95)90009-8; Nishimura H, 2000, NEUROREPORT, V11, P811, DOI 10.1097/00001756-200003200-00031; Okazawa H, 1996, BRAIN, V119, P1297, DOI 10.1093/brain/119.4.1297; Rauschecker JP, 2011, AUDITORY CORTEX, P99, DOI 10.1007/978-1-4419-0074-6_4; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Warburton E, 1999, J NEUROL NEUROSUR PS, V66, P155, DOI 10.1136/jnnp.66.2.155; Zatorre RJ, 2012, SPRINGER HANDB AUDIT, V43, P261, DOI 10.1007/978-1-4614-2314-0_10	42	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128743	10.1371/journal.pone.0128743	http://dx.doi.org/10.1371/journal.pone.0128743			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046763	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200096
J	Fu, XL; Wang, JL; Di, YB; Wang, HM				Fu, Xiaoli; Wang, Jianlei; Di, Yuebao; Wang, Huimin			Differences in Fine-Root Biomass of Trees and Understory Vegetation among Stand Types in Subtropical Forests	PLOS ONE			English	Article							BELOW-GROUND CARBON; NORWAY SPRUCE; SPECIES-DIVERSITY; INTERSPECIFIC COMPETITION; EUROPEAN BEECH; PINE; PRODUCTIVITY; PLANTATIONS; CHINA; AGE	Variation of total fine-root biomass among types of tree stands has previously been attributed to the characteristics of the stand layers. The effects of the understory vegetation on total fine-root biomass are less well studied. We examined the variation of total fine-root biomass in subtropical tree stands at two sites of Datian and Huitong in China. The two sites have similar humid monsoon climate but different soil organic carbon. One examination compared two categories of basal areas (high vs. low basal area) in stands of single species. A second examination compared single-species and mixed stands with comparable basal areas. Low basal area did not correlate with low total fine-root biomass in the single-species stands. The increase in seedling density but decrease in stem density for the low basal area stands at Datian and the quite similar stand structures for the basal-area contrast at Huitong helped in the lack of association between basal area and total fine-root biomass at the two sites, respectively. The mixed stands also did not yield higher total fine-root biomasses. In addition to the lack of niche complementarity between tree species, the differences in stem and seedling densities and the belowground competition between the tree and non-tree species also contributed to the similarity of the total fine-root biomasses in the mixed and single-species stands. Across stand types, the more fertile site Datian yielded higher tree, non-tree and total fine-root biomasses than Huitong. However, the contribution of non-tree fine-root biomass to the total fine-root biomass was higher at Huitong (29.4%) than that at Datian (16.7%). This study suggests that the variation of total fine-root biomass across stand types not only was associated with the characteristics of trees, but also may be highly dependent on the understory layer.	[Fu, Xiaoli; Wang, Jianlei; Di, Yuebao; Wang, Huimin] Chinese Acad Sci, Qianyanzhou Ecol Stn, Key Lab Ecosystem Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Wang, HM (corresponding author), Chinese Acad Sci, Qianyanzhou Ecol Stn, Key Lab Ecosystem Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China.	wanghm@igsnrr.ac.cn	wang, huimin/HDM-8421-2022		National Key Basic Research Special Foundation Project [2012CB416903]; NSFC Projects of International Cooperation and Exchanges [31210103920]; National Natural Science Foundations of China [41101203]; National Key Technology Support Program [2012BAC11B05]	National Key Basic Research Special Foundation Project(National Basic Research Program of China); NSFC Projects of International Cooperation and Exchanges; National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); National Key Technology Support Program(National Key Technology R&D Program)	This work was funded by the National Key Basic Research Special Foundation Project (2012CB416903), the NSFC Projects of International Cooperation and Exchanges (31210103920), the National Natural Science Foundations of China (41101203), and the National Key Technology Support Program (2012BAC11B05).	Bakker MR, 2006, PLANT SOIL, V286, P37, DOI 10.1007/s11104-006-9024-4; Barnes PW, 1999, J VEG SCI, V10, P525, DOI 10.2307/3237187; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bolte A, 2006, EUR J FOREST RES, V125, P15, DOI 10.1007/s10342-005-0075-5; Brassard BW, 2013, J ECOL, V101, P210, DOI 10.1111/1365-2745.12023; Brassard BW, 2011, FUNCT ECOL, V25, P238, DOI 10.1111/j.1365-2435.2010.01769.x; Chen Guang-Shui, 2008, Zhiwu Shengtai Xuebao, V32, P1285, DOI 10.3773/j.issn.1005-264x.2008.06.009; Chen J, 2014, FOREST RES, V27, P99, DOI [10.1021/tx400350b, DOI 10.1021/TX400350B]; Claus A, 2005, CAN J FOREST RES, V35, P1617, DOI 10.1139/x05-079; Duan WJ, 2010, RESTOR ECOL, V18, P206, DOI 10.1111/j.1526-100X.2008.00444.x; [樊后保 FAN Houbao], 2011, [生态学报, Acta Ecologica Sinica], V31, P3277; Finer L, 2011, FOREST ECOL MANAG, V261, P265, DOI 10.1016/j.foreco.2010.10.016; Helmisaari HS, 2007, TREE PHYSIOL, V27, P1493, DOI 10.1093/treephys/27.10.1493; Hwang J, 2007, J PLANT NUTR, V30, P1821, DOI 10.1080/01904160701628940; Jacob A, 2013, OIKOS, V122, P463, DOI 10.1111/j.1600-0706.2012.20476.x; Kucbel S, 2011, PLANT ROOT, V5, P46, DOI 10.3117/plantroot.5.46; Laclau JP, 2013, OECOLOGIA, V172, P903, DOI 10.1007/s00442-012-2526-2; Lang'at JKS, 2013, OECOLOGIA, V172, P271, DOI 10.1007/s00442-012-2490-x; Lei PF, 2012, OECOLOGIA, V169, P1105, DOI 10.1007/s00442-012-2259-2; Leuschner C, 2004, PLANT SOIL, V258, P43, DOI 10.1023/B:PLSO.0000016508.20173.80; Lopez BC, 2003, TREE PHYSIOL, V23, P1217, DOI 10.1093/treephys/23.17.1217; Lu L, 2012, J SUBTROPICAL RESOUR, V7, P70; Margalef R., 1957, GEN SYST, V3, P36, DOI DOI 10.12691/AJSS-2-5-1; Maron JL, 2011, ECOL LETT, V14, P36, DOI 10.1111/j.1461-0248.2010.01547.x; McHugh TA, 2006, NEW PHYTOL, V171, P171, DOI 10.1111/j.1469-8137.2006.01735.x; Meinen C, 2009, TREES-STRUCT FUNCT, V23, P941, DOI 10.1007/s00468-009-0336-x; Rewald B, 2009, EUR J FOREST RES, V128, P387, DOI 10.1007/s10342-009-0276-4; Rolo V, 2012, TREES-STRUCT FUNCT, V26, P977; Schmid I, 2002, FOREST ECOL MANAG, V159, P37, DOI 10.1016/S0378-1127(01)00708-3; Schmid I, 2002, BASIC APPL ECOL, V3, P339, DOI 10.1078/1439-1791-00116; Tian DL, 2010, PEDOSPHERE, V20, P486, DOI 10.1016/S1002-0160(10)60038-0; Tong S, 1989, FOR SCI TECHNOL, V8, P9; Vargas R, 2009, BIOTROPICA, V41, P302, DOI 10.1111/j.1744-7429.2009.00494.x; Vogt KA, 1996, PLANT SOIL, V187, P159, DOI 10.1007/BF00017088; VOGT KA, 1987, J ECOL, V75, P857, DOI 10.2307/2260210; Wang QK, 2008, FOREST ECOL MANAG, V255, P1210, DOI 10.1016/j.foreco.2007.10.026; Yanai RD, 2006, CAN J FOREST RES, V36, P450, DOI 10.1139/X05-254; Yang Y.S., 2001, SCI SILVAE SINICAE, V37, P35; Zhang WJ, 2011, BIOGEOSCIENCES, V8, P1667, DOI 10.5194/bg-8-1667-2011; Zhao J, 2012, SOIL BIOL BIOCHEM, V49, P78, DOI 10.1016/j.soilbio.2012.02.020	40	15	20	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128894	10.1371/journal.pone.0128894	http://dx.doi.org/10.1371/journal.pone.0128894			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047358	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200110
J	Sobral, TA; Gomes, MAF; Machado, NR; Brito, VP				Sobral, Thiago A.; Gomes, Marcelo A. F.; Machado, Nubia R.; Brito, Valdemiro P.			Unpacking of a Crumpled Wire from Two-Dimensional Cavities	PLOS ONE			English	Article							DRUG-DELIVERY; PARTICLES; PACKING	The physics of tightly packed structures of a wire and other threadlike materials confined in cavities has been explored in recent years in connection with crumpled systems and a number of topics ranging from applications to DNA packing in viral capsids and surgical interventions with catheter to analogies with the electron gas at finite temperature and with theories of two-dimensional quantum gravity. When a long piece of wire is injected into two-dimensional cavities, it bends and originates in the jammed limit a series of closed structures that we call loops. In this work we study the extraction of a crumpled tightly packed wire from a circular cavity aiming to remove loops individually. The size of each removed loop, the maximum value of the force needed to unpack each loop, and the total length of the extracted wire were measured and related to an exponential growth and a mean field model consistent with the literature of crumpled wires. Scaling laws for this process are reported and the relationship between the processes of packing and unpacking of wire is commented upon.	[Sobral, Thiago A.; Gomes, Marcelo A. F.] Univ Fed Pernambuco, Dept Fis, BR-50670901 Recife, PE, Brazil; [Machado, Nubia R.; Brito, Valdemiro P.] Univ Fed Piaui, Dept Fis, Teresina, PI, Brazil	Universidade Federal de Pernambuco; Universidade Federal do Piaui	Gomes, MAF (corresponding author), Univ Fed Pernambuco, Dept Fis, BR-50670901 Recife, PE, Brazil.	mafg@ufpe.br		Sobral, Thiago/0000-0003-1723-2812	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Programa Nacional de Cooperacao Academica (PROCAD); Programa de Nucleos de Excelencia (PRONEX)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa Nacional de Cooperacao Academica (PROCAD); Programa de Nucleos de Excelencia (PRONEX)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We would like to acknowledge the anonymous reviewers whose questions and notes helped us to clarify critical arguments in several parts of this manuscript. We acknowledge Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Programa Nacional de Cooperacao Academica (PROCAD), and Programa de Nucleos de Excelencia (PRONEX), all Brazilian Government Agencies, for financial support.	Agrawal, 2012, J CRANIO MAX DIS, V1, P12, DOI [10.4103/2278-9588.102468, DOI 10.4103/2278-9588.102468]; AGUIAR JA, 1991, J PHYS A-MATH GEN, V24, pL109, DOI 10.1088/0305-4470/24/3/002; Artin M., 1988, SPHERE PACKINGS LATT; Bayart E, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012407; Boue L, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.166104; Boue L, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/54002; Chan HK, 2003, ADV DRUG DELIVER REV, V55, P793, DOI 10.1016/S0169-409X(03)00078-4; Couldwell WT, 1996, J NEUROSURG, V85, P425, DOI 10.3171/jns.1996.85.3.0425; da Cunha BC, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/31001; Deboeuf S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.104301; Donato CC, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.066113; Donato CC, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026110; Donato CC, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.015102; Frenot A, 2003, CURR OPIN COLLOID IN, V8, P64, DOI 10.1016/S1359-0294(03)00004-9; Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70; Gomes MAF, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.052103; Gomes MAF, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/25/255401; Gomes MAF, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031127; GOMES MAF, 1987, AM J PHYS, V55, P649, DOI 10.1119/1.15094; Gomes MAF, 2008, J BRAZIL CHEM SOC, V19, P293, DOI 10.1590/S0103-50532008000200014; KANTOR Y, 1986, PHYS REV LETT, V57, P791, DOI 10.1103/PhysRevLett.57.791; Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1; Katzav E, 2006, P NATL ACAD SCI USA, V103, P18900, DOI 10.1073/pnas.0609079103; Martin CR, 2003, NAT REV DRUG DISCOV, V2, P29, DOI 10.1038/nrd988; Needham D, 2001, ADV DRUG DELIVER REV, V53, P285, DOI 10.1016/S0169-409X(01)00233-2; Purohit PK, 2005, BIOPHYS J, V88, P851, DOI 10.1529/biophysj.104.047134; Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020; Solovev AA, 2012, ACS NANO, V6, P1751, DOI 10.1021/nn204762w; Stoop N, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.094101; Tsapis N, 2002, P NATL ACAD SCI USA, V99, P12001, DOI 10.1073/pnas.182233999; Vetter R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5437	31	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128568	10.1371/journal.pone.0128568	http://dx.doi.org/10.1371/journal.pone.0128568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047315	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200080
J	Su, M; Alonso, S; Jones, JW; Yu, JS; Kane, MA; Jones, RJ; Ghiaur, G				Su, Meng; Alonso, Salvador; Jones, Jace W.; Yu, Jianshi; Kane, Maureen A.; Jones, Richard J.; Ghiaur, Gabriel			All-Trans Retinoic Acid Activity in Acute Myeloid Leukemia: Role of Cytochrome P450 Enzyme Expression by the Microenvironment	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; DIFFERENTIATION THERAPY; SELF-RENEWAL; BLAST CELLS; IN-VIVO; ATRA; AML; CHEMOTHERAPY; TRANSCRIPTION; METABOLISM	Differentiation therapy with all-trans retinoic acid (atRA) has markedly improved outcome in acute promyelocytic leukemia (APL) but has had little clinical impact in other AML subtypes. Cell intrinsic mechanisms of resistance have been previously reported, yet the majority of AML blasts are sensitive to atRA in vitro. Even in APL, single agent atRA induces remission without cure. The microenvironment expression of cytochrome P450 (CYP) 26, a retinoid-metabolizing enzyme was shown to determine normal hematopoietic stem cell fate. Accordingly, we hypothesized that the bone marrow (BM) microenvironment is responsible for difference between in vitro sensitivity and in vivo resistance of AML to atRA-induced differentiation. We observed that the pro-differentiation effects of atRA on APL and non-APL AML cells as well as on leukemia stem cells from clinical specimens were blocked by BM stroma. In addition, BM stroma produced a precipitous drop in atRA levels. Inhibition of CYP26 rescued atRA levels and AML cell sensitivity in the presence of stroma. Our data suggest that stromal CYP26 activity creates retinoid low sanctuaries in the BM that protect AML cells from systemic atRA therapy. Inhibition of CYP26 provides new opportunities to expand the clinical activity of atRA in both APL and non-APL AML.	[Su, Meng; Alonso, Salvador; Jones, Richard J.; Ghiaur, Gabriel] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA; [Jones, Jace W.; Yu, Jianshi; Kane, Maureen A.] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore	Ghiaur, G (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.	gghiaur1@jhmi.edu		Ghiaur, Gabriel/0000-0002-3955-7944; Jones, Jace/0000-0003-0460-0380; Alonso Martinez, Salvador/0000-0003-4604-7691	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases [HHSN272202000046C]; University of Maryland School of Pharmacy Mass Spectrometry Center [SOP1841-IQB2014]; NIH [P01 CA15396, CA70790]; American Society of Hematology Research Fellow Award; Maryland Stem Cell Research Award; Passano Clinician Scientist Award; NATIONAL CANCER INSTITUTE [R21CA070790, P01CA015396] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL127269] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Maryland School of Pharmacy Mass Spectrometry Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology Research Fellow Award; Maryland Stem Cell Research Award; Passano Clinician Scientist Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by: National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases #HHSN272202000046C and the University of Maryland School of Pharmacy Mass Spectrometry Center #SOP1841-IQB2014 (MAK); NIH Grants P01 CA15396 and CA70790 (RJJ) and American Society of Hematology Research Fellow Award, Maryland Stem Cell Research Award and Passano Clinician Scientist Award (GG).	Adamson PC, 1997, J CLIN ONCOL, V15, P3330, DOI 10.1200/JCO.1997.15.11.3330; Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; ASOU H, 1991, BLOOD, V77, P2031; Balusu R, 2011, BLOOD, V118, P3096, DOI 10.1182/blood-2010-09-309674; BEDI A, 1995, BLOOD, V86, P1148, DOI 10.1182/blood.V86.3.1148.bloodjournal8631148; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; BREEMS DA, 1994, LEUKEMIA, V8, P1095; Bullinger L, 2013, CLIN CANCER RES, V19, P2562, DOI 10.1158/1078-0432.CCR-11-2524; Burnett AK, 2007, CANCER, V109, P1114, DOI 10.1002/cncr.22496; Burnett AK, 2010, BLOOD, V115, P948, DOI 10.1182/blood-2009-08-236588; dos Santos GA, 2013, J EXP MED, V210, P2793, DOI 10.1084/jem.20131121; ECKHOFF C, 1991, J NUTR, V121, P1016, DOI 10.1093/jn/121.7.1016; Estey EH, 1999, BLOOD, V93, P2478, DOI 10.1182/blood.V93.8.2478.408k04_2478_2484; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Gerber JM, 2012, BLOOD, V119, P3571, DOI 10.1182/blood-2011-06-364182; Geria AN, 2008, CURR OPIN INVEST DR, V9, P1228; Ghiaur G, 2013, P NATL ACAD SCI USA, V110, P16121, DOI 10.1073/pnas.1305937110; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kane MA, 2010, METHODS MOL BIOL, V652, P1, DOI 10.1007/978-1-60327-325-1_1; LANOTTE M, 1991, BLOOD, V77, P1080; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lehmann S, 2002, LEUKEMIA LYMPHOMA, V43, P851, DOI 10.1080/10428190290016999; Lehmann S, 2000, LEUKEMIA RES, V24, P19, DOI 10.1016/S0145-2126(99)00153-8; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Manfredini R, 1999, CANCER RES, V59, P3803; Matsui WH, 2002, CELL GROWTH DIFFER, V13, P275; Milligan DW, 2006, BLOOD, V107, P4614, DOI 10.1182/blood-2005-10-4202; Nazha A, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00218; Osanai M, 2005, MOL PHARMACOL, V67, P1808, DOI 10.1124/mol.104.005769; Ozpolat B, 2005, LEUKEMIA LYMPHOMA, V46, P1497, DOI 10.1080/10428190500174737; Petrie K, 2009, CURR OPIN HEMATOL, V16, P84, DOI 10.1097/MOH.0b013e3283257aee; Ray WJ, 1997, J BIOL CHEM, V272, P18702, DOI 10.1074/jbc.272.30.18702; Rice AM, 2004, LEUKEMIA RES, V28, P1227, DOI 10.1016/j.leukres.2004.03.017; Ryningen A, 2008, EXPERT OPIN INV DRUG, V17, P1623, DOI [10.1517/13543784.17.11.1623, 10.1517/13543784.17.11.1623 ]; Sakamoto K, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.25; SAKASHITA A, 1993, BLOOD, V81, P1009; Schlenk RF, 2004, LEUKEMIA, V18, P1798, DOI 10.1038/sj.leu.2403528; Schlenk RF, 2009, HAEMATOL-HEMATOL J, V94, P54, DOI 10.3324/haematol.13378; Seiter K, 2000, BRIT J HAEMATOL, V108, P40, DOI 10.1046/j.1365-2141.2000.01804.x; Theodosiou M, 2010, CELL MOL LIFE SCI, V67, P1423, DOI 10.1007/s00018-010-0268-z; Tobita T, 1997, BLOOD, V90, P967, DOI 10.1182/blood.V90.3.967.967_967_973; TURHAN AG, 1995, BLOOD, V85, P2154, DOI 10.1182/blood.V85.8.2154.bloodjournal8582154; VENDITTI A, 1995, LEUKEMIA, V9, P1121; Wang YP, 2002, ARCH BIOCHEM BIOPHYS, V401, P235, DOI 10.1016/S0003-9861(02)00043-7; WANG Z Y, 1990, Nouvelle Revue Francaise d'Hematologie, V32, P34; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; WARRELL RP, 1991, NEW ENGL J MED, V324, P1385, DOI 10.1056/NEJM199105163242002; WILLIAMS JB, 1985, P NATL ACAD SCI USA, V82, P4658, DOI 10.1073/pnas.82.14.4658	48	42	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127790	10.1371/journal.pone.0127790	http://dx.doi.org/10.1371/journal.pone.0127790			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047326	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200030
J	Yang, Q; Fang, LF; Fu, Y; Du, XX; Shen, YQ; Yu, YS				Yang, Qing; Fang, Lanfang; Fu, Ying; Du, Xiaoxing; Shen, Yuqin; Yu, Yunsong			Dissemination of NDM-1-Producing Enterobacteriaceae Mediated by the IncX3-Type Plasmid	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; NDM-1; IDENTIFICATION; EMERGENCE; WORLDWIDE; ISOLATE; SPREAD; HEALTH	The emergence and spread of NDM-1-producing Enterobacteriaceae have resulted in a worldwide public health risk that has affected some provinces of China. China is an exceptionally large country, and there is a crucial need to investigate the epidemic of blaNDM-1positive Enterobacteriaceae in our province. A total of 186 carbapenem-resistant Enterobacteriaceae isolates (CRE) were collected in a grade-3 hospital in Zhejiang province. Carbapenem-resistant genes, including bla(KPC), bla(IMP), bla(VIM), bla(OXA-48) and bla(NDM-1) were screened and sequenced. Ninety isolates were identified as harboring the bla(KPC-2) genes, and five bla(NDM-1)-positive isolates were uncovered. XbaI-PFGE revealed that three bla(NDM-1)- positive K. pneumoniae isolates belonged to two different clones. S1-PFGE and southern blot suggested that the bla(NDM-1) genes were located on IncX3-type plasmids with two different sizes ranging from 33.3 to 54.7 kb (n=4) and 104.5 to 138.9 kb (n=1), respectively, all of which could easily transfer to Escherichia coli by conjugation and electrotransformation. The high-throughput sequencing of two plasmids was performed leading to the identification of a smaller 54-kb plasmid, which had high sequence similarity with a previously reported pCFNDM-CN, and a larger plasmid in which only a 7.8-kb sequence of a common gene environment around bla(NDM-1) (bla(NDM-1)-trpF-dsbC-cutA1-groEL-Delta InsE,) was detected. PCR mapping and sequencing demonstrated that four smaller bla(NDM-1) plasmids contained a common gene environment around blaNDM-1 (IS5-bla(NDM-1)-trpF-dsbC-cutA1-groEL). We monitored the CRE epidemic in our hospital and determined that KPC-2 carbapenemase was a major risk to patient health and the IncX3-type plasmid played a vital role in the spread of the bla(NDM-1) gene among the CRE.	[Yang, Qing; Shen, Yuqin; Yu, Yunsong] Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Collaborat Innovat Ctr Diag & Treatment Infect Di, Coll Med,Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Fang, Lanfang] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Fu, Ying; Du, Xiaoxing; Yu, Yunsong] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang University; Zhejiang University	Yu, YS (corresponding author), Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	yvys119@163.com			National Natural Science Foundation of China [NSFC31170130, NSFC81471986]; National High-Technology Research and Development Program ("863" Program) of China [2013AA020203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Technology Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China (no. NSFC31170130 and no. NSFC81471986) and National High-Technology Research and Development Program ("863" Program) of China (no. 2013AA020203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Chen Y, 2011, J ANTIMICROB CHEMOTH, V66, P1255, DOI 10.1093/jac/dkr082; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Dolejska M, 2013, J ANTIMICROB CHEMOTH, V68, P34, DOI 10.1093/jac/dks357; Doyle D, 2012, J CLIN MICROBIOL, V50, P3877, DOI 10.1128/JCM.02117-12; Du XX, 2013, J MED MICROBIOL, V62, P1332, DOI 10.1099/jmm.0.057091-0; Ho PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017989; Ho PL, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.37; Ho PL, 2012, J ANTIMICROB CHEMOTH, V67, P1553, DOI 10.1093/jac/dks095; Johnson TJ, 2012, PLASMID, V68, P43, DOI 10.1016/j.plasmid.2012.03.001; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; Mulvey MR, 2011, EMERG INFECT DIS, V17, P103, DOI 10.3201/eid1701.101358; Nordmann P, 2014, MED MALADIES INFECT, V44, P51, DOI 10.1016/j.medmal.2013.11.007; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Pharmaceuticals, W TYPACIL PRODUCT IN; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P4224, DOI 10.1128/AAC.00165-11; Qin SS, 2014, ANTIMICROB AGENTS CH, V58, P4275, DOI 10.1128/AAC.02813-13; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Schwaber MJ, 2008, JAMA-J AM MED ASSOC, V300, P2911, DOI 10.1001/jama.2008.896; Shen P, 2009, ANTIMICROB AGENTS CH, V53, P4333, DOI 10.1128/AAC.00260-09; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Wei ZQ, 2007, ANTIMICROB AGENTS CH, V51, P763, DOI 10.1128/AAC.01053-06; Witonski D, 2006, J CLIN MICROBIOL, V44, P3849, DOI 10.1128/JCM.00469-06; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09	25	12	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129454	10.1371/journal.pone.0129454	http://dx.doi.org/10.1371/journal.pone.0129454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047502	gold, Green Published, Green Submitted			2022-12-27	WOS:000355652200162
J	Zhou, S; Zu, Y; Sun, ZL; Zhuang, FY; Yang, C				Zhou, Shuai; Zu, Yan; Sun, Zhenglong; Zhuang, Fengyuan; Yang, Chun			Effects of Hypergravity on Osteopontin Expression in Osteoblasts	PLOS ONE			English	Article							PERIODONTAL-LIGAMENT FIBROBLASTS; THYROID-CANCER CELLS; EXTRACELLULAR-MATRIX; MECHANICAL-STRESS; GENE-EXPRESSION; MC3T3-E1 OSTEOBLASTS; BONE-RESORPTION; MESSENGER-RNA; FLUID-FLOW; MECHANOTRANSDUCTION	Mechanical stimuli play crucial roles in bone remodeling and resorption. Osteopontin (OPN), a marker for osteoblasts, is important in cell communication and matrix mineralization, and is known to function during mechanotransduction. Hypergravity is a convenient approach to forge mechanical stimuli on cells. It has positive effects on certain markers of osteoblast maturation, making it a possible strategy for bone tissue engineering. We investigated the effects of hypergravity on OPN expression and cell signaling in osteoblasts. Hypergravity treatment at 20 g for 24 hours upregulated OPN expression in MC3T3-E1 cells at the protein as well as mRNA level. Hypergravity promoted OPN expression by facilitating focal adhesion assembly, strengthening actin bundles, and increasing Runx2 expression. In the hypergravity-triggered OPN expression pathway, focal adhesion assembly-associated FAK phosphorylation was upstream of actin bundle assembly.	[Zhou, Shuai; Zhuang, Fengyuan] Beihang Univ, Sch Biol Sci & Med Engn, Beijing 100191, Peoples R China; [Zu, Yan; Sun, Zhenglong; Yang, Chun] Tsinghua Univ, Sch Aerosp Engn, Inst Biomechan & Med Engn, Beijing 100084, Peoples R China	Beihang University; Tsinghua University	Yang, C (corresponding author), Tsinghua Univ, Sch Aerosp Engn, Inst Biomechan & Med Engn, Beijing 100084, Peoples R China.	yangchun@mail.tsinghua.edu.cn	Yang, Chun/A-7467-2008	Yang, Chun/0000-0003-1191-7642	National Natural Science Foundation of China [31170885, 31370939]; Tsinghua University [2011Z02175]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University	This work was financially supported by the National Natural Science Foundation of China (Nos. 31170885 and 31370939), and Tsinghua University (2011Z02175). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batra NN, 2005, J BIOMECH, V38, P1909, DOI 10.1016/j.jbiomech.2004.08.009; Ciofani G, 2012, J BIOSCI BIOENG, V113, P258, DOI 10.1016/j.jbiosc.2011.09.025; Denhardt DT, 1998, J CELL BIOCHEM, P92, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; Denhardt DT, 2001, BIOCHEM BIOPH RES CO, V288, P448, DOI 10.1006/bbrc.2001.5780; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Fitzgerald J, 1996, EXP CELL RES, V228, P168, DOI 10.1006/excr.1996.0313; Fitzgerald J, 1999, FASEB J, V13, P553, DOI 10.1096/fasebj.13.3.553; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Giachelli CM, 2000, MATRIX BIOL, V19, P615, DOI 10.1016/S0945-053X(00)00108-6; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Hong SY, 2010, MOL CELL BIOCHEM, V335, P263, DOI 10.1007/s11010-009-0276-1; Ishijima M, 2002, J BONE MINER RES, V17, P661, DOI 10.1359/jbmr.2002.17.4.661; Ishijima M, 2001, J EXP MED, V193, P399, DOI 10.1084/jem.193.3.399; Ishijima M, 2006, EXP CELL RES, V312, P3075, DOI 10.1016/j.yexcr.2006.06.003; Jackson RA, 2006, J CELL PHYSIOL, V209, P894, DOI 10.1002/jcp.20779; Jeon YM, 2009, MOL CELL BIOCHEM, V320, P45, DOI 10.1007/s11010-008-9897-z; Kacena MA, 2004, MICROGRAVITY SCI TEC, V15, P28, DOI 10.1007/BF02870949; Kim CH, 2003, J BONE MINER RES, V18, P2116, DOI 10.1359/jbmr.2003.18.12.2116; Komori T, 2002, J CELL BIOCHEM, V87, P1, DOI 10.1002/jcb.10276; Kreke MR, 2005, BONE, V36, P1047, DOI 10.1016/j.bone.2005.03.008; Li J, 2008, MOL CELL BIOCHEM, V309, P41, DOI 10.1007/s11010-007-9641-0; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Ma X, 2014, FASEB J, V28, P813, DOI 10.1096/fj.13-243287; Mishra S, 2012, INTEGR BIOL-UK, V4, P1498, DOI 10.1039/c2ib20200j; Mori N, 2007, MATRIX BIOL, V26, P42, DOI 10.1016/j.matbio.2006.09.002; Morita S, 2004, ANN NY ACAD SCI, V1030, P158, DOI 10.1196/annals.1329.020; Nabavi N, 2011, BONE, V49, P965, DOI 10.1016/j.bone.2011.07.036; Nishimori S, 2001, J BIOL CHEM, V276, P10700, DOI 10.1074/jbc.M007499200; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; Prodanov L, 2013, TISSUE ENG PT A, V19, P114, DOI [10.1089/ten.TEA.2012.0267, 10.1089/ten.tea.2012.0267]; Qin YX, 2003, J BIOMECH, V36, P1427, DOI 10.1016/S0021-9290(03)00127-1; Rath B, 2008, J BIOMECH, V41, P1095, DOI 10.1016/j.jbiomech.2007.11.024; REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Saito M, 2003, J BONE MINER RES, V18, P1695, DOI 10.1359/jbmr.2003.18.9.1695; Searby ND, 2005, AM J PHYSIOL-CELL PH, V289, pC148, DOI 10.1152/ajpcell.00524.2003; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Standal T, 2004, EXP ONCOL, V26, P179; Terai K, 1999, J BONE MINER RES, V14, P839, DOI 10.1359/jbmr.1999.14.6.839; Thompson WR, 2012, GENE, V503, P179, DOI 10.1016/j.gene.2012.04.076; Tomakidi P, 2014, CELL TISSUE RES, V357, P515, DOI 10.1007/s00441-014-1945-2; Ulbrich C, 2011, CELL PHYSIOL BIOCHEM, V28, P185, DOI 10.1159/000331730; Vorselen D, 2014, FASEB J, V28, P536, DOI 10.1096/fj.13-236356; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Wei FL, 2008, ARCH ORAL BIOL, V53, P35, DOI 10.1016/j.archoralbio.2007.07.008; Zhang ZL, 2012, BIOTECHNOL LETT, V34, P197, DOI 10.1007/s10529-011-0756-8; Ziros PG, 2002, J BIOL CHEM, V277, P23934, DOI 10.1074/jbc.M109881200	49	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128846	10.1371/journal.pone.0128846	http://dx.doi.org/10.1371/journal.pone.0128846			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046934	gold, Green Submitted, Green Published			2022-12-27	WOS:000355652200107
J	Buchner, H; Rehfuess, EA				Buchner, Hannes; Rehfuess, Eva A.			Cooking and Season as Risk Factors for Acute Lower Respiratory Infections in African Children: A Cross-Sectional Multi-Country Analysis	PLOS ONE			English	Article							INDOOR AIR-POLLUTION; SOLID-FUEL USE; DEVELOPING-COUNTRIES; PNEUMONIA; DISEASE; STOVES; IMPROVEMENT; XUANWEI; BURDEN	Background Acute lower respiratory infections (ALRI) are a leading cause of death among African children under five. A significant proportion of these are attributable to household air pollution from solid fuel use. Methods We assessed the relationship between cooking practices and ALRI in pooled datasets of Demographic and Health Surveys conducted between 2000 and 2011 in countries of sub-Saharan Africa. The impacts of main cooking fuel, cooking location and stove ventilation were examined in 18 (n = 56,437), 9 (n = 23,139) and 6 countries (n = 14,561) respectively. We used a causal diagram and multivariable logistic mixed models to assess the influence of covariates at individual, regional and national levels. Results Main cooking fuel had a statistically significant impact on ALRI risk (p<0.0001), with season acting as an effect modifier (p = 0.034). During the rainy season, relative to clean fuels, the odds of suffering from ALRI were raised for kerosene (OR 1.64; CI: 0.99, 2.71), coal and charcoal (OR 1.54; CI: 1.21, 1.97), wood (OR 1.20; CI: 0.95, 1.51) and lower-grade biomass fuels (OR 1.49; CI: 0.93, 2.35). In contrast, during the dry season the corresponding odds were reduced for kerosene (OR 1.23; CI: 0.77, 1.95), coal and charcoal (OR 1.35; CI: 1.06, 1.72) and lower-grade biomass fuels (OR 1.07; CI: 0.69, 1.66) but increased for wood (OR 1.32; CI: 1.04, 1.66). Cooking location also emerged as a season-dependent statistically significant (p = 0.0070) determinant of ALRI, in particular cooking indoors without a separate kitchen during the rainy season (OR 1.80; CI: 1.30, 2.50). Due to infrequent use in Africa we could, however, not demonstrate an effect of stove ventilation. Conclusions We found differential and season-dependent risks for different types of solid fuels and kerosene as well as cooking location on child ALRI. Future household air pollution studies should consider potential effect modification of cooking fuel by season.	[Buchner, Hannes; Rehfuess, Eva A.] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany	University of Munich	Buchner, H (corresponding author), Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany.	buchner@staburo.de	Rehfuess, Eva Annette/ABD-8167-2021		Munich Center of Health Sciences	Munich Center of Health Sciences	This work was supported by the Munich Center of Health Sciences (http://www.en.mc-health.uni-muenchen.de/profil/index.html).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Balding DJ, 2004, APPL LONGITUDINAL AN; Boerma JT, 1996, B WORLD HEALTH ORGAN, V74, P209; Bonjour S, 2013, ENVIRON HEALTH PERSP, V121, P784, DOI 10.1289/ehp.1205987; Bruce N, 2000, B WORLD HEALTH ORGAN, V78, P1078; Chapman RS, 2005, BMJ-BRIT MED J, V331, P1050, DOI 10.1136/bmj.38628.676088.55; Chengappa C., 2007, ENERGY SUSTAIN DEV, V11, P33, DOI [10.1016/S0973-0826(08)60398-1, DOI 10.1016/S0973-0826(08)60398-1, 10.1016/S0973-0826(08)60398-1.]; CIA, 2012, WORLD FACTBOOK; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; Fenske N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078692; Haspil-Corgan TA, 2004, ANN EMERG MED, V44, pS37, DOI 10.1016/j.annemergmed.2004.07.121; Institute for Health Metrics and Evaluation, 2013, GBD HEAT MAP; Joffe M, 2012, EMERG THEMES EPIDEMI, V9, DOI 10.1186/1742-7622-9-1; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lan Q, 2002, J NATL CANCER I, V94, P826, DOI 10.1093/jnci/94.11.826; LANATA CF, 1994, INT J EPIDEMIOL, V23, P827, DOI 10.1093/ije/23.4.827; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Markovitz AR, 2012, INT J EPIDEMIOL, V41, P504, DOI 10.1093/ije/dyr194; Masera OR, 2000, WORLD DEV, V28, P2083, DOI 10.1016/S0305-750X(00)00076-0; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Mishra V, 2005, POPUL ENVIRON, V26, P375, DOI 10.1007/s1111-005-0005-y; Mishra V, 2003, INT J EPIDEMIOL, V32, P847, DOI 10.1093/ije/dyg240; Mueller V, 2011, INT J EPIDEMIOL, V40, P1643, DOI 10.1093/ije/dyr150; *ORCMACRO INT INC, 2008, DEM HLTH SURV; Paynter S, 2013, EPIDEMIOL INFECT, V141, P1328, DOI 10.1017/S0950268812001379; Rehfuess E, 2006, ENVIRON HEALTH PERSP, V114, P373, DOI 10.1289/ehp.8603; Rehfuess EA, 2009, J EPIDEMIOL COMMUN H, V63, P887, DOI 10.1136/jech.2008.082685; Rehfuess EA, IMPACTS INT IN PRESS; Rehfuess EA, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-13; Rehfuess EA, 2014, ENVIRON HEALTH PERSP, V122, P120, DOI 10.1289/ehp.1306639; Rehfuess EA, 2010, ENVIRON RES, V110, P725, DOI 10.1016/j.envres.2010.07.006; Rutstein S. O., 2004, DHS COMP REPORTS; Sinton JE, 2004, ENERGY SUSTAIN DEV, V8, P33, DOI [10.1016/S0973-0826(08)60465-2, DOI 10.1016/S0973-0826(08)60465-2]; Smith KR, 2014, ANNU REV PUBL HEALTH, V35, P185, DOI 10.1146/annurev-publhealth-032013-182356; Smith KR, 2011, LANCET, V378, P1717, DOI 10.1016/S0140-6736(11)60921-5; UN Habitat (United Nations Human Settlements Programme), 2004, URB IND GUID MON HAB; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA, V138; Wichmann J., 2006, Southern African Journal of Epidemiology & Infection, V21, P48	39	25	25	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128933	10.1371/journal.pone.0128933	http://dx.doi.org/10.1371/journal.pone.0128933			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042802	Green Published, gold, Green Submitted			2022-12-27	WOS:000355701600078
J	Cao, JL; Yuan, P; Abuduwufuer, A; Lv, W; Yang, YH; Hu, J				Cao, Jin-Lin; Yuan, Ping; Abuduwufuer, Abudumailamu; Lv, Wang; Yang, Yun-Hai; Hu, Jian			Association between the TERT Genetic Polymorphism rs2853676 and Cancer Risk: Meta-Analysis of 76 108 Cases and 134 215 Controls	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN TELOMERASE; SUSCEPTIBILITY LOCI; IDENTIFIES VARIANTS; TERT-CLPTM1L LOCUS; SEQUENCE VARIANTS; BREAST-CANCER; LENGTH; 5P15.33	Background Several recent studies have identified that the TERT genetic polymorphism rs2853676 is associated with cancer risk, but presented inconsistent results. We investigated these inconclusive results by performing a meta-analysis to systematically evaluate the association. Methods We conducted a search in PubMed, Google Scholar and ISI Web of Science to select studies on the association between TERT rs2853676 and cancer risk. We conducted a stratified analysis using cancer type, ethnicity and source of controls. We calculated the odds ratios (OR) and 95% confidence intervals (CI). Article quality, heterogeneity, sensitivity, publication bias and statistical power were also assessed. Results 26 articles covering 76 108 cases and 134 215 controls met our inclusion criteria. A significant association between TERT rs2853676 allele A and cancer susceptibility was demonstrated under a per-allele risk analysis (OR = 1.08, 95% CI = 1.04-1.13). Stratification analysis revealed an increased cancer risk in subgroups of glioma, lung cancer and ovarian cancer. No significant increase was found in melanoma, breast cancer, pancreatic cancer and colorectal cancer. In a subgroup analysis of lung cancer, a statistically significant increase was only observed in adenocarcinoma. Moreover, a stratified analysis performed for ethnic groups revealed that the significant increase was only observed in Caucasians, whereas a non-significant increase was found in Asians. Conclusions This meta-analysis suggests that the TERT genetic polymorphism rs2853676 is associated with increased risk of glioma, lung adenocarcinoma and ovarian cancer among Caucasians. Further functional studies are warranted to validate this association and investigate further.	[Cao, Jin-Lin; Yuan, Ping; Abuduwufuer, Abudumailamu; Lv, Wang; Yang, Yun-Hai; Hu, Jian] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Thorac Surg, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Hu, J (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Thorac Surg, Hangzhou 310003, Zhejiang, Peoples R China.	hujian_med@163.com			National Natural Science Foundation of China [NSFC 31170720]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC 31170720). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Beesley J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024987; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Bender E, 2014, NATURE, V509, pS64, DOI 10.1038/509S64a; Bodelon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052466; Campa D, 2015, INT J CANCER, V136, pE351, DOI 10.1002/ijc.29101; Chen HY, 2011, AM J EPIDEMIOL, V173, P915, DOI 10.1093/aje/kwq457; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egan KM, 2011, J NEURO-ONCOL, V104, P535, DOI 10.1007/s11060-010-0506-0; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Freier K, 2007, J ORAL PATHOL MED, V36, P267, DOI 10.1111/j.1600-0714.2007.00531.x; Gillis AJ, 2008, NATURE, V455, P633, DOI 10.1038/nature07283; He J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06159; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hofer P, 2012, MOL CARCINOGEN, V51, pE176, DOI 10.1002/mc.21911; Hsiung CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001051; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jin TB, 2013, TUMOR BIOL, V34, P3659, DOI 10.1007/s13277-013-0947-0; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kote-Jarai Z, 2013, HUM MOL GENET, V22, P2520, DOI 10.1093/hmg/ddt086; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Liu HB, 2012, ASIAN PAC J CANCER P, V13, P4905, DOI 10.7314/APJCP.2012.13.10.4905; MANTEL N, 1959, J NATL CANCER I, V22, P719; Melin BS, 2012, GENET EPIDEMIOL, V36, P368, DOI 10.1002/gepi.21630; Mocellin S, 2012, JNCI-J NATL CANCER I, V104, P840, DOI 10.1093/jnci/djs222; Muncer S, 2002, J ADV NURS, V38, P274, DOI 10.1046/j.1365-2648.2002.02177.x; Nan HM, 2011, HUM GENET, V129, P247, DOI 10.1007/s00439-010-0921-5; Park SL, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju061; Pellatt AJ, 2013, MOL CARCINOGEN, V52, P507, DOI 10.1002/mc.21885; Pellatt AJ, 2013, GENE CHROMOSOME CANC, V52, P595, DOI 10.1002/gcc.22056; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Pooley KA, 2010, CANCER RES, V70, P3170, DOI 10.1158/0008-5472.CAN-09-4595; Prescott J, 2010, CANCER-AM CANCER SOC, V116, P4275, DOI 10.1002/cncr.25328; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Sheng XJ, 2013, CARCINOGENESIS, V34, P228, DOI 10.1093/carcin/bgs325; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Shiraishi K, 2012, NAT GENET, V44, P900, DOI 10.1038/ng.2353; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Terry KL, 2012, CANCER EPIDEM BIOMAR, V21, P504, DOI 10.1158/1055-9965.EPI-11-0867; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Voils CI, 2011, J EVAL CLIN PRACT, V17, P429, DOI 10.1111/j.1365-2753.2010.01444.x; Wang K, 2011, NATURE, V469, P216, DOI 10.1038/nature09609; Wick M, 1999, GENE, V232, P97, DOI 10.1016/S0378-1119(99)00108-0; Wu HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076372; Wyatt HDM, 2010, NUCLEIC ACIDS RES, V38, P5609, DOI 10.1093/nar/gkq370; Yin JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050650; Young NS, 2010, HEMATOL-AM SOC HEMAT, P30, DOI 10.1182/asheducation-2010.1.30; Zachos I, 2009, J CANCER RES CLIN, V135, P1169, DOI 10.1007/s00432-009-0557-9; Zhang AJ, 2000, CANCER RES, V60, P6230; Zhao ZH, 2013, EXP LUNG RES, V39, P91, DOI 10.3109/01902148.2012.762436; Zheng YL, 2012, BREAST CANCER RES TR, V132, P341, DOI 10.1007/s10549-011-1890-7; Zou P, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-7	55	11	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128829	10.1371/journal.pone.0128829	http://dx.doi.org/10.1371/journal.pone.0128829			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042809	Green Submitted, gold, Green Published			2022-12-27	WOS:000355701600068
J	Dorshorst, B; Henegar, C; Liao, XP; Almen, MS; Rubin, CJ; Ito, S; Wakamatsu, K; Stothard, P; Van Doormaal, B; Plastow, G; Barsh, GS; Andersson, L				Dorshorst, Ben; Henegar, Corneliu; Liao, Xiaoping; Almen, Markus Sallman; Rubin, Carl-Johan; Ito, Shosuke; Wakamatsu, Kazumasa; Stothard, Paul; Van Doormaal, Brian; Plastow, Graham; Barsh, Gregory S.; Andersson, Leif			Dominant Red Coat Color in Holstein Cattle Is Associated with a Missense Mutation in the Coatomer Protein Complex, Subunit Alpha (COPA) Gene	PLOS ONE			English	Article							TOOL; PHEOMELANIN; EUMELANIN; TRANSPORT; ALIGNMENT; RECEPTOR	Coat color in Holstein dairy cattle is primarily controlled by the melanocortin 1 receptor (MC1R) gene, a central determinant of black (eumelanin) vs. red/brown pheomelanin synthesis across animal species. The major MC1R alleles in Holsteins are Dominant Black (MC1R(D)) and Recessive Red (MC1R(e)). A novel form of dominant red coat color was first observed in an animal born in 1980. The mutation underlying this phenotype was named Dominant Red and is epistatic to the constitutively activated MC1R(D). Here we show that a missense mutation in the coatomer protein complex, subunit alpha (COPA), a gene with previously no known role in pigmentation synthesis, is completely associated with Dominant Red in Holstein dairy cattle. The mutation results in an arginine to cysteine substitution at an amino acid residue completely conserved across eukaryotes. Despite this high level of conservation we show that both heterozygotes and homozygotes are healthy and viable. Analysis of hair pigment composition shows that the Dominant Red phenotype is similar to the MC1R Recessive Red phenotype, although less effective at reducing eumelanin synthesis. RNA-seq data similarly show that Dominant Red animals achieve predominantly pheomelanin synthesis by down regulating genes normally required for eumelanin synthesis. COPA is a component of the coat protein I seven subunit complex that is involved with retrograde and cis-Golgi intracellular coated vesicle transport of both protein and RNA cargo. This suggests that Dominant Red may be caused by aberrant MC1R protein or mRNA trafficking within the highly compartmentalized melanocyte, mimicking the effect of the Recessive Red loss of function MC1R allele.	[Dorshorst, Ben; Almen, Markus Sallman; Rubin, Carl-Johan; Andersson, Leif] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Dorshorst, Ben] Virginia Tech, Dept Anim & Poultry Sci, Blacksburg, VA USA; [Henegar, Corneliu; Barsh, Gregory S.] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Liao, Xiaoping; Stothard, Paul; Plastow, Graham] Univ Alberta, Dept Agr Food & Nutr Sci, Livestock Gentec, Edmonton, AB, Canada; [Ito, Shosuke; Wakamatsu, Kazumasa] Fujita Hlth Univ, Sch Hlth Sci, Dept Chem, Toyoake, Aichi, Japan; [Van Doormaal, Brian] Canadian Dairy Network, Guelph, ON, Canada; [Barsh, Gregory S.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Sci Life Lab, Uppsala, Sweden	Uppsala University; Virginia Polytechnic Institute & State University; HudsonAlpha Institute for Biotechnology; University of Alberta; Fujita Health University; Stanford University; Swedish University of Agricultural Sciences	Dorshorst, B (corresponding author), Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Uppsala, Sweden.	ben.dorshorst@vt.edu	Wakamatsu, Kazumasa/AAZ-5877-2020; Henegar, Corneliu R/K-9166-2013	Wakamatsu, Kazumasa/0000-0003-1748-9001; Henegar, Corneliu R/0000-0002-8486-5591; Ito, Shosuke/0000-0001-9182-5144; Sallman Almen, Markus/0000-0001-9591-9228; Rubin, Carl-Johan/0000-0001-8238-5052; Plastow, Graham/0000-0002-3774-3110	Dairy Cattle Genetics Research and Development (DairyGen) Council of Canadian Dairy Network; Japan Society for the Promotion of Science (JSPC) [23591659, 26461705]; Genome Canada; Alberta Livestock and Meat Agency; Alberta Innovates Bio Solutions	Dairy Cattle Genetics Research and Development (DairyGen) Council of Canadian Dairy Network; Japan Society for the Promotion of Science (JSPC)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Genome Canada(Genome Canada); Alberta Livestock and Meat Agency; Alberta Innovates Bio Solutions	This project was financially supported by a grant from the Dairy Cattle Genetics Research and Development (DairyGen) Council of Canadian Dairy Network. SI and KW were supported, in part, by a Japan Society for the Promotion of Science (JSPC) grant (No. 23591659 and 26461705). Additional funding was provided by Genome Canada and the Alberta Livestock and Meat Agency. PS and GP thank Alberta Innovates Bio Solutions for support.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; Bi J, 2007, P NATL ACAD SCI USA, V104, P13810, DOI 10.1073/pnas.0703805104; Boichard D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034130; Bruford Elspeth A., 2010, Human Genomics, V4, P213; Cosson P, 1997, CURR OPIN CELL BIOL, V9, P484, DOI 10.1016/S0955-0674(97)80023-3; d'Ischia M, 2013, PIGM CELL MELANOMA R, V26, P616, DOI 10.1111/pcmr.12121; Daetwyler HD, 2014, NAT GENET, V46, P858, DOI 10.1038/ng.3034; Dorhorst B., 2014, P 10 WORLD C GEN APP; Dreger DL, 2010, ANIM GENET, V41, P109, DOI 10.1111/j.1365-2052.2009.01969.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Garcia-Borron JC, 2014, PIGM CELL MELANOMA R, V27, P699, DOI 10.1111/pcmr.12257; Grant JR, 2011, BIOINFORMATICS, V27, P2300, DOI 10.1093/bioinformatics/btr372; Green P., 1990, DOCUMENTATION CRIMAP; Ito S, 2011, PIGM CELL MELANOMA R, V24, P605, DOI 10.1111/j.1755-148X.2011.00864.x; Joerg H, 1996, MAMM GENOME, V7, P317, DOI 10.1007/s003359900090; KLUNGLAND H, 1995, MAMM GENOME, V6, P636, DOI 10.1007/BF00352371; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Leduc M., 2006, HOLSTEIN J, P45; Lee WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090581; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lowe M, 1998, BBA-MOL CELL RES, V1404, P53, DOI 10.1016/S0167-4889(98)00046-9; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Ozeki H, 1996, PIGM CELL RES, V9, P265, DOI 10.1111/j.1600-0749.1996.tb00116.x; Peter CJ, 2011, HUM MOL GENET, V20, P1701, DOI 10.1093/hmg/ddr046; Prifti E, 2008, BIOINFORMATICS, V24, P2636, DOI 10.1093/bioinformatics/btn492; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Stothard P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-559; Wakamatsu K, 2002, PIGM CELL RES, V15, P225, DOI 10.1034/j.1600-0749.2002.02009.x; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Zeitouni B, 2010, BIOINFORMATICS, V26, P1895, DOI 10.1093/bioinformatics/btq293; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	34	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128969	10.1371/journal.pone.0128969	http://dx.doi.org/10.1371/journal.pone.0128969			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042826	Green Submitted, gold, Green Published			2022-12-27	WOS:000355701600079
J	Liu, YW; Wang, HJ; Weng, SF; Su, WJ; Wang, X; Guo, YF; Yu, D; Du, LL; Zhou, T; Chen, WH; Shi, TM				Liu, Yuewei; Wang, Haijiao; Weng, Shaofan; Su, Wenjin; Wang, Xin; Guo, Yanfei; Yu, Dan; Du, Lili; Zhou, Ting; Chen, Weihong; Shi, Tingming			Occupational Hearing Loss among Chinese Municipal Solid Waste Landfill Workers: A Cross-Sectional Study	PLOS ONE			English	Article							ORGANIC-SOLVENTS; NOISE; PREVALENCE; THRESHOLDS; INDUSTRY; PLANT	Background Occupational hearing loss is an increasingly prevalent occupational condition worldwide, and has been reported to occur in a wide range of workplaces; however, its prevalence among workers from municipal solid waste landfills (MSWLs) remains less clear. This study aimed to investigate the occupational hearing loss among Chinese MSWL workers. Methods A cross-sectional study of 247 workers from 4 Chinese MSWLs was conducted. Noise and total volatile organic compounds (TVOCs) levels at worksites were determined. We conducted hearing examinations to determine hearing thresholds. A worker was identified as having hearing loss if the mean threshold at 2000, 3000 and 4000 Hz in either ear was equal to or greater than 25 dB. Prevalence of occupational hearing loss was then evaluated. Using unconditional Logistic regression models, we estimated the odds ratios (ORs) of MSWL work associated with hearing loss. Results According to the job title for each worker, the study subjects were divided into 3 groups, including group 1 of 63 workers without MSWL occupational hazards exposure (control group), group 2 of 84 workers with a few or short-period MSWL occupational hazards exposure, and group 3 of 100 workers with continuous MSWL occupational hazards exposure. Both noise and TVOCs levels were significantly higher at worksites for group 3. Significantly poorer hearing thresholds at frequencies of 2000, 3000 and 4000 Hz were found in group 3, compared with that in group 1 and group 2. The overall prevalence rate of hearing loss was 23.5%, with the highest in group 3 (36.0%). The OR of MSWL work associated with hearing loss was 3.39 (95% confidence interval [CI]: 1.28-8.96). Conclusion The results of this study suggest significantly higher prevalence of hearing loss among MSWL workers. Further studies are needed to explore possible exposure-response relationship between MSWL occupational hazards exposure and hearing loss.	[Liu, Yuewei; Shi, Tingming] Hubei Ctr Dis Control & Prevent, Inst Hlth Surveillance Anal & Protect, Wuhan 430079, Hubei, Peoples R China; [Liu, Yuewei; Wang, Haijiao; Weng, Shaofan; Su, Wenjin; Wang, Xin; Guo, Yanfei; Yu, Dan; Du, Lili; Zhou, Ting; Chen, Weihong] Minist Educ, Key Lab Environm & Hlth, Wuhan 430030, Hubei, Peoples R China; [Liu, Yuewei; Wang, Haijiao; Weng, Shaofan; Su, Wenjin; Wang, Xin; Guo, Yanfei; Yu, Dan; Du, Lili; Zhou, Ting; Chen, Weihong] Minist Environm Protect, Wuhan 430030, Hubei, Peoples R China; [Liu, Yuewei; Wang, Haijiao; Weng, Shaofan; Su, Wenjin; Wang, Xin; Guo, Yanfei; Yu, Dan; Du, Lili; Zhou, Ting; Chen, Weihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Occupat & Environm Hlth,State Key Lab Enviro, Wuhan 430030, Hubei, Peoples R China	Huazhong University of Science & Technology	Chen, WH (corresponding author), Minist Educ, Key Lab Environm & Hlth, Wuhan 430030, Hubei, Peoples R China.	wchen@mails.tjmu.edu.cn; tmingshi@163.com	Liu, Yuewei/J-5147-2019; Chen, Weihong/D-2177-2011	Liu, Yuewei/0000-0001-5970-4262; Chen, Weihong/0000-0001-8689-7311	Ministry of Housing and Urban-Rural Development of the People's Republic of China [06K417]	Ministry of Housing and Urban-Rural Development of the People's Republic of China	This study was funded by the Ministry of Housing and Urban-Rural Development of the People's Republic of China (grant number: 06K417; http://www.mohurd.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHATTACHARYA SK, 1990, IND HEALTH, V28, P203, DOI 10.2486/indhealth.28.203; Campo Pierre, 2007, International Journal of Occupational Medicine and Environmental Health, V20, P265, DOI 10.2478/v10001-007-0031-3; Chiriac R, 2007, J HAZARD MATER, V149, P249, DOI 10.1016/j.jhazmat.2007.07.094; Fuente A, 2006, INT J AUDIOL, V45, P367, DOI 10.1080/14992020600753205; Gopal KV, 2008, NOISE HEALTH, V10, P74, DOI 10.4103/1463-1741.44345; HESSEL PA, 1987, S AFR MED J, V71, P364; Kim J, 2005, IND HEALTH, V43, P567, DOI 10.2486/indhealth.43.567; Kirchner DB, 2012, J OCCUP ENVIRON MED, V54, P106, DOI 10.1097/JOM.0b013e318242677d; Lin FR, 2011, ARCH INTERN MED, V171, P1851, DOI 10.1001/archinternmed.2011.506; Liu YW, 2012, J HUAZHONG U SCI-MED, V32, P130, DOI 10.1007/s11596-012-0023-9; McCullagh MC, 2011, NOISE HEALTH, V13, P340, DOI 10.4103/1463-1741.85504; Metwally FM, 2012, TOXICOL IND HEALTH, V28, P901, DOI 10.1177/0748233711427051; Mohammadi S, 2010, ARH HIG RADA TOKSIKO, V61, P267, DOI 10.2478/10004-1254-61-2010-2013; Morata TC, 1997, SCAND J WORK ENV HEA, V23, P289, DOI 10.5271/sjweh.222; Nelson DI, 2005, AM J IND MED, V48, P446, DOI 10.1002/ajim.20223; OLERU UG, 1990, INT ARCH OCC ENV HEA, V62, P199, DOI 10.1007/BF00379432; Schaper M, 2008, INT J OCCUP MED ENV, V21, P191, DOI 10.2478/v10001-008-0030-z; Shi Ting-Ming, 2011, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V29, P514; Stanbury M, 2008, J OCCUP ENVIRON MED, V50, P72, DOI 10.1097/JOM.0b013e31815b568c; Stucken EZ, 2014, CURR OPIN OTOLARYNGO, V22, P388, DOI 10.1097/MOO.0000000000000079; Zhang DQ, 2010, J ENVIRON MANAGE, V91, P1623, DOI 10.1016/j.jenvman.2010.03.012	21	8	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128719	10.1371/journal.pone.0128719	http://dx.doi.org/10.1371/journal.pone.0128719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042421	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000355701600063
J	Rogers, E; Myatt, M; Woodhead, S; Guerrero, S; Alvarez, JL				Rogers, Eleanor; Myatt, Mark; Woodhead, Sophie; Guerrero, Saul; Alvarez, Jose Luis			Coverage of Community-Based Management of Severe Acute Malnutrition Programmes in Twenty-One Countries, 2012-2013	PLOS ONE			English	Article							INTERVENTIONS	Objective This paper reviews coverage data from programmes treating severe acute malnutrition (SAM) collected between July 2012 and June 2013. Design This is a descriptive study of coverage levels and barriers to coverage collected by coverage assessments of community-based SAM treatment programmes in 21 countries that were supported by the Coverage Monitoring Network. Data from 44 coverage assessments are reviewed. Setting These assessments analyse malnourished populations from 6 to 59 months old to understand the accessibility and coverage of services for treatment of acute malnutrition. The majority of assessments are from sub-Saharan Africa. Results Most of the programmes (33 of 44) failed to meet context-specific internationally agreed minimum standards for coverage. The mean level of estimated coverage achieved by the programmes in this analysis was 38.3%. The most frequently reported barriers to access were lack of awareness of malnutrition, lack of awareness of the programme, high opportunity costs, inter-programme interface problems, and previous rejection. Conclusions This study shows that coverage of CMAM is lower than previous analyses of early CTC programmes; therefore reducing programme impact. Barriers to access need to be addressed in order to start improving coverage by paying greater attention to certain activities such as community sensitisation. As barriers are interconnected focusing on specific activities, such as decentralising services to satellite sites, is likely to increase significantly utilisation of nutrition services. Programmes need to ensure that barriers are continuously monitored to ensure timely removal and increased coverage.	[Rogers, Eleanor; Woodhead, Sophie; Guerrero, Saul; Alvarez, Jose Luis] Act Hunger UK, Coverage Monitoring Network, London, England; [Myatt, Mark] Brixton Hlth, Llawr Y Glyn, Powys, England		Alvarez, JL (corresponding author), Act Hunger UK, Coverage Monitoring Network, First Floor, London, England.	j.alvarez@actionagainsthunger.org.uk			United States Agency for International Development's (USAID) Office of Foreign Disaster Assistance (OFDA); European Commission Humanitarian Office (ECHO)	United States Agency for International Development's (USAID) Office of Foreign Disaster Assistance (OFDA)(United States Agency for International Development (USAID)); European Commission Humanitarian Office (ECHO)	The CMN consortium is funded by the United States Agency for International Development's (USAID) Office of Foreign Disaster Assistance (OFDA) and the European Commission Humanitarian Office (ECHO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, SPHERE HDB HUMANITAR, DOI [10.1111/j.0361-3666.2004.00245.x, DOI 10.1111/J.0361-3666.2004.00245.X]; [Anonymous], 2013, COV MON NETW PROF FI, p[46, 43]; COLLINS S, 2004, 48 HUM PRACT NETW; Collins S, 2005, KEY ISSUES SUCCESS C; Collins S, 2006, LANCET, V368, P1992, DOI 10.1016/S0140-6736(06)69443-9; Guerrero S, 2013, IS COMM BAS TREATM S; Guerrero S, 2013, QUANTITY QUALITY SCA; Guerrero S, 2010, DISASTERS, V34, P571, DOI 10.1111/j.1467-7717.2009.01144.x; Guevarra E., 2012, Field Exchange - Emergency Nutrition Network ENN, P39; International Food Policy Research Institute, 2014, GLOB NUTR REP 2014 A; Myatt M, 2013, FIELD EXCHANGE, V45, P39; Myatt M., 2012, SEMI QUANTITATIVE EV; Perez Bernabe B, 2013, SEMI QUANTITATIVE EV; Puett C., 2013, ACCESS ALL; Sadler K., 2011, COMMUNITY CASE MANAG; Sadler K, 2008, THESIS U COLL LONDON; Sadler K, 2007, PUBLIC HEALTH NUTR, V10, P907, DOI 10.1017/S1368980007711035; Schofield L, 2010, FIELD EXCHANGE EMERG, V38, P35; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; Tekeste Asayehegn, 2012, Cost Eff Resour Alloc, V10, P4, DOI 10.1186/1478-7547-10-4; UNICEF, 2013, GLOB SAM MAN UPD SUM; Van Damme W, 2002, LANCET, V359, P260, DOI 10.1016/S0140-6736(02)07422-6; Victora CG, 2004, LANCET, V364, P1541, DOI 10.1016/S0140-6736(04)17279-6	23	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128666	10.1371/journal.pone.0128666	http://dx.doi.org/10.1371/journal.pone.0128666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042827	Green Published, Green Submitted, gold			2022-12-27	WOS:000355701600059
J	Barron, E; Lara, J; White, M; Mathers, JC				Barron, Evelyn; Lara, Jose; White, Martin; Mathers, John C.			Blood-Borne Biomarkers of Mortality Risk: Systematic Review of Cohort Studies	PLOS ONE			English	Review							C-REACTIVE PROTEIN; ALL-CAUSE MORTALITY; LIPOPROTEIN CHOLESTEROL LEVEL; BRAIN NATRIURETIC PEPTIDE; CARDIOVASCULAR-DISEASE; FOLLOW-UP; LIFE-STYLE; URIC-ACID; MEN; EVENTS	Background Lifespan and the proportion of older people in the population are increasing, with far reaching consequences for the social, political and economic landscape. Unless accompanied by an increase in health span, increases in age-related diseases will increase the burden on health care resources. Intervention studies to enhance healthy ageing need appropriate outcome measures, such as blood-borne biomarkers, which are easily obtainable, cost-effective, and widely accepted. To date there have been no systematic reviews of blood-borne biomarkers of mortality. Aim To conduct a systematic review to identify available blood-borne biomarkers of mortality that can be used to predict healthy ageing post-retirement. Methods Four databases (Medline, Embase, Scopus, Web of Science) were searched. We included prospective cohort studies with a minimum of two years follow up and data available for participants with a mean age of 50 to 75 years at baseline. Results From a total of 11,555 studies identified in initial searches, 23 fulfilled the inclusion criteria. Fifty-one blood borne biomarkers potentially predictive of mortality risk were identified. In total, 20 biomarkers were associated with mortality risk. Meta-analyses of mortality risk showed significant associations with C-reactive protein (Hazard ratios for all-cause mortality 1.42, p<0.001; Cancer-mortality 1.62, p<0.009; CVD-mortality 1.31, p = 0.033), N Terminal-pro brain natriuretic peptide (Hazard ratios for all-cause mortality 1.43, p<0.001; CHD-mortality 1.58, p<0.001; CVD-mortality 1.67, p<0.001) and white blood cell count (Hazard ratios for all-cause mortality 1.36, p = 0.001). There was also evidence that brain natriuretic peptide, cholesterol fractions, erythrocyte sedimentation rate, fibrinogen, granulocytes, homocysteine, intercellular adhesion molecule-1, neutrophils, osteoprotegerin, procollagen type III aminoterminal peptide, serum uric acid, soluble urokinase plasminogen activator receptor, tissue inhibitor of metalloproteinases 1 and tumour necrosis factor receptor II may predict mortality risk. There was equivocal evidence for the utility of 14 biomarkers and no association with mortality risk for CD40 ligand, cortisol, dehydroepiandrosterone, ferritin, haemoglobin, interleukin-12, monocyte chemoattractant protein 1, matrix metalloproteinase 9, myelopereoxidase, P-selectin, receptor activator of nuclear factor KappaB ligand, sex hormone binding globulin, testosterone, transferrin, and thyroid stimulating hormone and thyroxine. Conclusions Twenty biomarkers should be prioritised as potential predictors of mortality in future studies. More studies using standardised protocols and reporting methods, and which focus on mortality rather than risk of disease or health status as an outcome, are needed.	[Barron, Evelyn; Lara, Jose; White, Martin; Mathers, John C.] Newcastle Univ, Inst Cellular Med, Human Nutr Res Ctr, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England; [White, Martin] Newcastle Univ, Fac Med Sci, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [White, Martin] Fac Med Sci, Inst Hlth & Soc, UKCRC Ctr Translat Res Publ Hlth, Fuse, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Barron, E (corresponding author), Newcastle Univ, Inst Cellular Med, Human Nutr Res Ctr, Biomed Res Bldg,Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.	evelyn.barron@newcastle.ac.uk	Baron, Evelyn/R-1113-2016	Baron, Evelyn/0000-0002-8992-3332; Mathers, John/0000-0003-3406-3002; White, Martin/0000-0002-1861-6757; Lara, Jose/0000-0002-4449-9304	Lifelong Health and Wellbeing (LLHW) Cross-Council Programme initiative in partnership with the UK Health Departments.; Economic and Social Research Council [ES/G007470/1] Funding Source: researchfish; Medical Research Council [G0900686, G0700718, MR/K006312/1, MR/L016354/1, G0700718B] Funding Source: researchfish; ESRC [ES/G007470/1] Funding Source: UKRI; MRC [MR/L016354/1, G0900686, G0700718, MR/K006312/1] Funding Source: UKRI	Lifelong Health and Wellbeing (LLHW) Cross-Council Programme initiative in partnership with the UK Health Departments.; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research for this manuscript was funded by the Lifelong Health and Wellbeing (LLHW) Cross-Council Programme initiative in partnership with the UK Health Departments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker GT, 1988, EXPT GERONTOLOGY, V23, P233; Baune BT, 2011, AGE, V33, P209, DOI 10.1007/s11357-010-9165-5; Baylis D, 2013, AGE, V35, P963, DOI 10.1007/s11357-012-9396-8; Berger U, 2005, AGEING SOC, V25, P181, DOI 10.1017/S0144686X04002739; BMJ Clinical Evidence, 2011, BMJ; Buckley BM, 2001, EUR HEART J SUPPL, V3, pN6, DOI 10.1016/S1520-765X(01)90131-2; Carriere I, 2008, J AM GERIATR SOC, V56, P840, DOI 10.1111/j.1532-5415.2008.01677.x; Cui YD, 2001, ARCH INTERN MED, V161, P1413, DOI 10.1001/archinte.161.11.1413; Eugen-Olsen J, 2010, J INTERN MED, V268, P296, DOI 10.1111/j.1365-2796.2010.02252.x; Franco OH, 2009, MATURITAS, V63, P13, DOI 10.1016/j.maturitas.2009.02.006; Glatt SJ, 2007, BIOL PSYCHIAT, V62, P282, DOI 10.1016/j.biopsych.2006.09.015; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Ingram DK, 2001, EXP GERONTOL, V36, P1025, DOI 10.1016/S0531-5565(01)00110-3; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Johnson TE, 2006, EXP GERONTOL, V41, P1243, DOI 10.1016/j.exger.2006.09.006; Kabagambe EK, 2011, AM J EPIDEMIOL, V174, P284, DOI 10.1093/aje/kwr085; Kaplan MS, 2008, J GERONTOL A-BIOL, V63, P1097, DOI 10.1093/gerona/63.10.1097; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kim KI, 2013, EXP GERONTOL, V48, P103, DOI 10.1016/j.exger.2012.11.016; Kistorp C, 2005, JAMA-J AM MED ASSOC, V293, P1609, DOI 10.1001/jama.293.13.1609; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Koenig W, 2008, CLIN CHEM, V54, P335, DOI 10.1373/clinchem.2007.100271; Krintus M, 2014, CRIT REV CL LAB SCI, V51, P263, DOI 10.3109/10408363.2014.913549; Kuper H, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4265; Lara J, 2013, MATURITAS, V76, P189, DOI 10.1016/j.maturitas.2013.07.007; Lee DC, 2010, J PSYCHOPHARMACOL, V24, P27, DOI 10.1177/1359786810382057; Lieb W, 2010, ARTERIOSCL THROM VAS, V30, P1849, DOI 10.1161/ATVBAHA.109.199661; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Makita S, 2009, ATHEROSCLEROSIS, V204, P234, DOI 10.1016/j.atherosclerosis.2008.07.040; Margolis KL, 2005, ARCH INTERN MED, V165, P500, DOI 10.1001/archinte.165.5.500; Martin-Ruiz C, 2011, MECH AGEING DEV, V132, P496, DOI 10.1016/j.mad.2011.08.001; McClearn GE, 1997, EXP GERONTOL, V32, P87, DOI 10.1016/S0531-5565(96)00067-8; McKie PM, 2006, HYPERTENSION, V47, P874, DOI 10.1161/01.HYP.0000216794.24161.8c; Menke A, 2012, NUTR METAB CARDIOVAS, V22, P734, DOI 10.1016/j.numecd.2010.11.011; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mueller C, 2008, SWISS MED WKLY, V138, P225, DOI 2008/15/smw-12180; NHS Centre for Reviews & Dissemination, 2009, SYST REV CRDS GUID U, DOI [10.1007/s00120-009-2058-5, DOI 10.1007/S00120-009-2058-5]; Niskanen LK, 2004, ARCH INTERN MED, V164, P1546, DOI 10.1001/archinte.164.14.1546; Nooyens ACJ, 2005, PUBLIC HEALTH NUTR, V8, P1266, DOI 10.1079/PHN2005756; Office for National Statistics, 2011, NAT POP PROJ UK2009; Okamura T, 2006, ATHEROSCLEROSIS, V184, P143, DOI 10.1016/j.atherosclerosis.2005.03.042; Penninx BWJH, 2001, ARCH INTERN MED, V161, P2309, DOI 10.1001/archinte.161.19.2309; Ptolemy AS, 2010, SCAND J CLIN LAB INV, V70, P6, DOI 10.3109/00365513.2010.493354; RESTREPO HE, 1994, SOC SCI MED, V39, P1323, DOI 10.1016/0277-9536(94)90364-6; Ridker PM, 2014, CIRC RES, V114, P594, DOI 10.1161/CIRCRESAHA.114.303215; Schnabel RB, 2013, ARTERIOSCL THROM VAS, V33, P1728, DOI 10.1161/ATVBAHA.112.301174; Strasak AM, 2008, INT J CARDIOL, V125, P232, DOI 10.1016/j.ijcard.2007.11.094; van Dam RM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1440; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; Velagaleti RS, 2010, ARTERIOSCL THROM VAS, V30, P2283, DOI 10.1161/ATVBAHA.110.208462; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wannamethee SG, 2011, J AM COLL CARDIOL, V58, P56, DOI 10.1016/j.jacc.2011.02.041; Well GA, 2011, NEWCASTLE OTTAWA SCA; Welsh P, 2013, EUR HEART J, V34, P443, DOI 10.1093/eurheartj/ehs239; Wu CK, 2011, ATHEROSCLEROSIS, V216, P226, DOI 10.1016/j.atherosclerosis.2011.01.046; Yousuf O, 2013, J AM COLL CARDIOL, V62, P397, DOI 10.1016/j.jacc.2013.05.016	57	58	58	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127550	10.1371/journal.pone.0127550	http://dx.doi.org/10.1371/journal.pone.0127550			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039142	gold, Green Published, Green Submitted			2022-12-27	WOS:000355700700065
J	Dworzak, J; Renvoise, B; Habchi, J; Yates, EV; Combadiere, C; Knowles, TP; Dobson, CM; Blackstone, C; Paulsen, O; Murphy, PM				Dworzak, Jenny; Renvoise, Benoit; Habchi, Johnny; Yates, Emma V.; Combadiere, Christophe; Knowles, Tuomas P.; Dobson, Christopher M.; Blackstone, Craig; Paulsen, Ole; Murphy, Philip M.			Neuronal Cx3cr1 Deficiency Protects against Amyloid beta-Induced Neurotoxicity	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RAT HIPPOCAMPAL-NEURONS; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; A-BETA; GLUTAMATERGIC SYNAPSES; MICROGLIAL ACTIVATION; FRACTALKINE RECEPTOR; SYNAPTIC PLASTICITY; CHEMOKINE RECEPTORS	Cx3cr1, the receptor for the chemokine Cx3cl1 (fractalkine), has been implicated in the progression and severity of Alzheimer's disease-like pathology in mice, but the underlying mechanisms remain unclear. A complicating factor is that Cx3cr1 has been demonstrated in both neurons and microglia. Here, we have dissected the differences between neuronal and microglial Cx3cr1, specifically by comparing direct amyloid-beta-induced toxicity in cultured, mature, microglia-depleted hippocampal neurons from wild-type and Cx3cr1(-/-) mice. Wild-type neurons expressed both Cx3cl1 and Cx3cr1 and released Cx3cl1 in response to amyloid-beta. Knockout of neuronal Cx3cr1 abated amyloid-beta-induced lactate dehydrogenase release. Furthermore, amyloid-beta differentially induced depression of pre- and postsynaptic components of miniature excitatory postsynaptic currents, in a peptide conformation-dependent manner. Knockout of neuronal Cx3cr1 abated effects of both amyloid-beta conformational states, which were differentiable by aggregation kinetics and peptide morphology. We obtained similar results after both acute and chronic treatment of cultured neurons with the Cx3cr1 antagonist F1. Thus, neuronal Cx3cr1 may impact Alzheimer's disease-like pathology by modulating conformational state-dependent amyloid-beta-induced synaptotoxicity.	[Dworzak, Jenny; Murphy, Philip M.] NIAID, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Dworzak, Jenny; Paulsen, Ole] Univ Cambridge, Dept Physiol Dev & Neurosci, Neuronal Oscillat Grp, Cambridge, England; [Dworzak, Jenny; Renvoise, Benoit; Blackstone, Craig] NINDS, Cell Biol Sect, Neurogenet Branch, NIH, Bethesda, MD 20892 USA; [Habchi, Johnny; Yates, Emma V.; Knowles, Tuomas P.; Dobson, Christopher M.; Murphy, Philip M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Combadiere, Christophe] INSERM, Ctr Immunol & Malad Infect Paris, Paris, France	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm)	Paulsen, O (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Neuronal Oscillat Grp, Cambridge, England.	op210@cam.ac.uk; pmm@nih.gov	Paulsen, Ole/ABB-4843-2020; Knowles, Tuomas/C-6663-2009; Combadiere, Christophe/I-5639-2013	Paulsen, Ole/0000-0002-2258-5455; Knowles, Tuomas/0000-0002-7879-0140; Combadiere, Christophe/0000-0002-1755-4531	Division of Intramural Research, NIAID; NINDS, NIH; Alzheimer's Research UK [ARUK-PPG2012B-12]; NIH-Oxford-Cambridge Biomedical Scholars fellowship; Medical Scientist Training Program of Icahn School of Medicine at Mount Sinai; Alzheimers Research UK [ARUK-PPG2012B-12] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003025] Funding Source: NIH RePORTER	Division of Intramural Research, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); NIH-Oxford-Cambridge Biomedical Scholars fellowship; Medical Scientist Training Program of Icahn School of Medicine at Mount Sinai; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Division of Intramural Research, NIAID and NINDS, NIH and Alzheimer's Research UK (ARUK-PPG2012B-12). JD is a MD/PhD biomedical scholar supported by the NIH-Oxford-Cambridge Biomedical Scholars fellowship and Medical Scientist Training Program of Icahn School of Medicine at Mount Sinai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Capone R, 2009, NEUROTOX RES, V16, P1, DOI 10.1007/s12640-009-9033-1; Chang EH, 2006, P NATL ACAD SCI USA, V103, P3410, DOI 10.1073/pnas.0507313103; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Cho SH, 2011, J BIOL CHEM, V286, P32713, DOI 10.1074/jbc.M111.254268; Cizas P, 2010, ARCH BIOCHEM BIOPHYS, V496, P84, DOI 10.1016/j.abb.2010.02.001; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608916; Deiva K, 2004, EUR J NEUROSCI, V20, P3222, DOI 10.1111/j.1460-9568.2004.03800.x; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Dorgham K, 2009, J LEUKOCYTE BIOL, V86, P903, DOI 10.1189/jlb.0308158; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Gillard SE, 2002, J NEUROIMMUNOL, V124, P16, DOI 10.1016/S0165-5728(02)00005-X; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Hatori K, 2002, J NEUROSCI RES, V69, P418, DOI 10.1002/jnr.10304; Hebron ML, 2014, EXP NEUROL, V251, P127, DOI 10.1016/j.expneurol.2013.01.009; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hughes PM, 2002, GLIA, V37, P314, DOI 10.1002/glia.10037; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Liang JH, 2009, NEUROCHEM INT, V55, P741, DOI 10.1016/j.neuint.2009.07.004; Limatola C, 2005, J NEUROIMMUNOL, V166, P19, DOI 10.1016/j.jneuroim.2005.03.023; Liu ZQ, 2010, J NEUROSCI, V30, P17091, DOI 10.1523/JNEUROSCI.4403-10.2010; Lynch G, 2002, NAT NEUROSCI, V5, P1035, DOI 10.1038/nn935; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Miyata S, 2007, BRAIN RES, V1150, P200, DOI 10.1016/j.brainres.2007.02.066; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Parameshwaran K, 2008, EXP NEUROL, V210, P7, DOI 10.1016/j.expneurol.2007.10.008; Parameshwaran K, 2007, SYNAPSE, V61, P367, DOI 10.1002/syn.20386; Parodi J, 2010, J BIOL CHEM, V285, P2506, DOI 10.1074/jbc.M109.030023; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Piccinin S, 2010, J NEUROIMMUNOL, V224, P85, DOI 10.1016/j.jneuroim.2010.05.012; Ragozzino D, 2006, J NEUROSCI, V26, P10488, DOI 10.1523/JNEUROSCI.3192-06.2006; Ransohoff RM, 2007, INT REV NEUROBIOL, V82, P187, DOI 10.1016/S0074-7742(07)82010-1; Raymond CR, 2003, BRAIN RES, V968, P263, DOI 10.1016/S0006-8993(03)02269-8; Rogers JT, 2011, J NEUROSCI, V31, P16241, DOI 10.1523/JNEUROSCI.3667-11.2011; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Saeed F., 2010, JoVE J. Vis. Exp.; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shan S, 2011, NEUROBIOL AGING, V32, P443, DOI 10.1016/j.neurobiolaging.2009.03.004; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Shipton OA, 2011, J NEUROSCI, V31, P1688, DOI 10.1523/JNEUROSCI.2610-10.2011; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Tong N, 2000, J IMMUNOL, V164, P1333, DOI 10.4049/jimmunol.164.3.1333; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Walsh DM, 2009, FEBS J, V276, P1266, DOI 10.1111/j.1742-4658.2008.06862.x; Wang JY, 2011, ARTERIOSCL THROM VAS, V31, pE11, DOI 10.1161/ATVBAHA.110.215517; Wu J, 2013, NEUROBIOL AGING, V34, P2843, DOI 10.1016/j.neurobiolaging.2013.06.003; Zagorski MG, 1999, METHOD ENZYMOL, V309, P189; Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182	56	19	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127730	10.1371/journal.pone.0127730	http://dx.doi.org/10.1371/journal.pone.0127730			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26038823	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700072
J	George, NI; Bowyer, JF; Crabtree, NM; Chang, CW				George, Nysia I.; Bowyer, John F.; Crabtree, Nathaniel M.; Chang, Ching-Wei			An Iterative Leave-One-Out Approach to Outlier Detection in RNA-Seq Data	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; DISPERSION	The discrete data structure and large sequencing depth of RNA sequencing (RNA-seq) experiments can often generate outlier read counts in one or more RNA samples within a homogeneous group. Thus, how to identify and manage outlier observations in RNA-seq data is an emerging topic of interest. One of the main objectives in these research efforts is to develop statistical methodology that effectively balances the impact of outlier observations and achieves maximal power for statistical testing. To reach that goal, strengthening the accuracy of outlier detection is an important precursor. Current outlier detection algorithms for RNA-seq data are executed within a testing framework and may be sensitive to sparse data and heavy-tailed distributions. Therefore, we propose a univariate algorithm that utilizes a probabilistic approach to measure the deviation between an observation and the distribution generating the remaining data and implement it within in an iterative leave-one-out design strategy. Analyses of real and simulated RNA-seq data show that the proposed methodology has higher outlier detection rates for both non-normalized and normalized negative binomial distributed data.	[George, Nysia I.; Chang, Ching-Wei] US FDA, Div Bioinformat & Biostat, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Bowyer, John F.] US FDA, Div Neurotoxicol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Crabtree, Nathaniel M.] Univ Arkansas, Joint Bioinformat Grad Program, Little Rock, AR 72204 USA; [Crabtree, Nathaniel M.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; University of Arkansas System; University of Arkansas Medical Sciences	Chang, CW (corresponding author), US FDA, Div Bioinformat & Biostat, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	Ching-Wei.Chang@fda.hhs.gov						Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Frazee AC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-449; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Huber P. J., 2011, ROBUST STAT; Landau WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081415; Li J, 2013, STAT METHODS MED RES, V22, P519, DOI 10.1177/0962280211428386; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; PIETERS EP, 1977, BIOMETRICS, V33, P718, DOI 10.2307/2529470; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wu H, 2013, BIOSTATISTICS, V14, P232, DOI 10.1093/biostatistics/kxs033; Zhou X, 2014, NUCLEIC	17	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0125224	10.1371/journal.pone.0125224	http://dx.doi.org/10.1371/journal.pone.0125224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039068	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700008
J	Karamchandani, RR; Vahidy, F; Bajgur, S; Vu, KYT; Choi, HA; Hamilton, RK; Rahbar, MH; Savitz, SI				Karamchandani, Rahul R.; Vahidy, Farhaan; Bajgur, Suhas; Vu, Kim Yen Thi; Choi, H. Alex; Hamilton, Robert Kirk; Rahbar, Mohammad H.; Savitz, Sean I.			Early Depression Screening Is Feasible in Hospitalized Stroke Patients	PLOS ONE			English	Article							POSTSTROKE DEPRESSION; COGNITIVE IMPAIRMENT; SYMPTOMS; VALIDITY; APHASIA; PHQ-9	Background and Purpose Post-stroke depression (PSD) is common but is not routinely assessed for in hospitalized patients. As a Comprehensive Stroke Center, we screen all stroke inpatients for depression, though the feasibility of early screening has not been established. We assessed the hypothesis that early depression screening in stroke patients is feasible. We also explored patient level factors associated with being screened for PSD and the presence of early PSD. Methods The medical records of all patients admitted with ischemic stroke (IS) or intracerebral hemorrhage (ICH) between 01/02/13 and 15/04/13 were reviewed. A depression screen, modified from the Patient Health Questionnaire-9, was administered (maximum score 27, higher scores indicating worse depression). Patients were eligible if they did not have a medical condition precluding screening. Feasibility was defined as screening 75% of all eligible patients. Results Of 303 IS and ICH inpatients, 70% (211) were eligible for screening, and 75% (158) of all eligible patients were screened. More than one-third of all patients screened positive for depression (score >4). Women (OR 2.06, 95% CI 1.06-4.01) and younger patients (OR 0.97, 95% CI 0.96-0.99) were more likely to screen positive. Screening positive was not associated with poor discharge/day 7 outcome (mRS > 3; OR 1.45, 95% CI 0.74-2.83). Conclusions Screening stroke inpatients for depression is feasible and early depression after stroke is common. Women and younger patients are more likely to experience early PSD. Our results provide preliminary evidence supporting continued screening for depression in hospitalized stroke patients.	[Karamchandani, Rahul R.; Vahidy, Farhaan; Bajgur, Suhas; Hamilton, Robert Kirk; Savitz, Sean I.] Univ Texas Houston, Sch Med, Dept Neurol, Stroke Program, Houston, TX 77054 USA; [Vu, Kim Yen Thi] Texas Med Ctr, Mem Hermann Hosp, Houston, TX USA; [Choi, H. Alex] Univ Texas Houston, Sch Med, Dept Neurol, Houston, TX USA; [Choi, H. Alex] Univ Texas Houston, Sch Med, Dept Neurosurg, Houston, TX USA; [Rahbar, Mohammad H.] Univ Texas Houston, Sch Med, Dept Internal Med, Div Clin & Translat Sci, Houston, TX USA; [Rahbar, Mohammad H.] Univ Texas Sch Publ Hlth Houston, Div Epidemiol Human Genet & Environm Sci, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Karamchandani, RR (corresponding author), Univ Texas Houston, Sch Med, Dept Neurol, Stroke Program, Houston, TX 77054 USA.	rahul.karamchandani@gmail.com	Vahidy, Farhaan S./I-6050-2019; Vahidy, Farhaan/AAC-1049-2019	Vahidy, Farhaan S./0000-0002-3464-2111; Vahidy, Farhaan/0000-0002-3464-2111	National Institutes of Health (U.S.) training grant [5 T32 NS 7412-15]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007412] Funding Source: NIH RePORTER	National Institutes of Health (U.S.) training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (U.S.) training grant to RRK, 5 T32 NS 7412-15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MAJ DEPR DIS AD; Bartoli F, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/862978; Cobley CS, 2012, CLIN REHABIL, V26, P372, DOI 10.1177/0269215511422388; Silva CEDE, 2013, CEREBROVASC DIS, V35, P385, DOI 10.1159/000348852; de Man-van Ginkel JM, 2012, STROKE, V43, P854, DOI 10.1161/STROKEAHA.111.640276; Gillen R, 2001, ARCH PHYS MED REHAB, V82, P1645, DOI 10.1053/apmr.2001.26249; Hackett ML, 2005, STROKE, V36, P2296, DOI 10.1161/01.STR.0000183622.75135.a4; Joint Commission, 2013, ADV DIS SPEC CAR CER; Kauhanen ML, 1999, STROKE, V30, P1875, DOI 10.1161/01.STR.30.9.1875; Kauhanen ML, 2000, CEREBROVASC DIS, V10, P455, DOI 10.1159/000016107; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Laska AC, 2007, CEREBROVASC DIS, V24, P74, DOI 10.1159/000103119; MORRIS PLP, 1993, AUST NZ J PSYCHIAT, V27, P443, DOI 10.3109/00048679309075801; Pohjasvaara T, 2001, EUR J NEUROL, V8, P315, DOI 10.1046/j.1468-1331.2001.00182.x; Rahbar MH, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-61; Sibolt G, 2013, CEREBROVASC DIS, V36, P336, DOI 10.1159/000355145; Sibon I, 2012, CEREBROVASC DIS, V33, P280, DOI 10.1159/000334663; SINYOR D, 1986, STROKE, V17, P1102, DOI 10.1161/01.STR.17.6.1102; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; Sutcliffe LM, 1998, CLIN REHABIL, V12, P506, DOI 10.1191/026921598672167702; van de Weg FB, 1999, CLIN REHABIL, V13, P268, DOI 10.1191/026921599672495022; Williams LS, 2005, STROKE, V36, P635, DOI 10.1161/01.STR.0000155688.18207.33	22	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128246	10.1371/journal.pone.0128246	http://dx.doi.org/10.1371/journal.pone.0128246			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039704	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700092
J	Leslie, LS; Wrobel, TP; Mayerich, D; Bindra, S; Emmadi, R; Bhargava, R				Leslie, L. Suzanne; Wrobel, Tomasz P.; Mayerich, David; Bindra, Snehal; Emmadi, Rajyasree; Bhargava, Rohit			High Definition Infrared Spectroscopic Imaging for Lymph Node Histopathology	PLOS ONE			English	Article							SPECTRAL DETECTION; MICRO-METASTASES; CELLS; RESOLUTION; MICROSPECTROSCOPY; IDENTIFICATION; LYMPHOCYTES; GRADE	Chemical imaging is a rapidly emerging field in which molecular information within samples can be used to predict biological function and recognize disease without the use of stains or manual identification. In Fourier transform infrared (FT-IR) spectroscopic imaging, molecular absorption contrast provides a large signal relative to noise. Due to the long mid-IR wavelengths and sub-optimal instrument design, however, pixel sizes have historically been much larger than cells. This limits both the accuracy of the technique in identifying small regions, as well as the ability to visualize single cells. Here we obtain data with micron-sized sampling using a tabletop FT-IR instrument, and demonstrate that the high-definition (HD) data lead to accurate identification of multiple cells in lymph nodes that was not previously possible. Highly accurate recognition of eight distinct classes - naive and memory B cells, T cells, erythrocytes, connective tissue, fibrovascular network, smooth muscle, and light and dark zone activated B cells was achieved in healthy, reactive, and malignant lymph node biopsies using a random forest classifier. The results demonstrate that cells currently identifiable only through immunohistochemical stains and cumbersome manual recognition of optical microscopy images can now be distinguished to a similar level through a single IR spectroscopic image from a lymph node biopsy.	[Leslie, L. Suzanne; Wrobel, Tomasz P.; Bhargava, Rohit] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Leslie, L. Suzanne; Bindra, Snehal; Bhargava, Rohit] Univ Illinois, Dept Bioengn, Urbana, IL USA; [Mayerich, David] Univ Houston, Dept Elect & Comp Engn, Houston, TX USA; [Emmadi, Rajyasree] Univ Illinois, Dept Pathol, Chicago, IL USA; [Bhargava, Rohit] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Bhargava, Rohit] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA; [Bhargava, Rohit] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA; [Bhargava, Rohit] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Houston System; University of Houston; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Bhargava, R (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.	rxb@illinois.edu	Wrobel, Tomasz/AAE-3620-2019; Mayerich, David/J-9882-2019	Wrobel, Tomasz/0000-0003-2053-0570; Mayerich, David/0000-0002-3949-6133; Bhargava, Rohit/0000-0001-7360-994X	National Institutes of Health [2R01EB009745]; Beckman Postdoctoral Fellows Program; Foundation for Polish Science through the START program; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009745] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R00LM011390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Postdoctoral Fellows Program; Foundation for Polish Science through the START program; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The work reported in this manuscript was funded in part by the National Institutes of Health via grant number 2R01EB009745 to RB (http://www.nih.gov/). Partial funding was also received through the Beckman Postdoctoral Fellows Program to TPW (http://beckman.illinois.edu/research/fellows-and-awards/postdoctoral). TPW acknowledges support from the Foundation for Polish Science through the START program (http://www.fnp.org.pl/en/oferta/start3/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrus PGL, 1998, BIOSPECTROSCOPY, V4, P37, DOI 10.1002/(SICI)1520-6343(1998)4:1<37::AID-BSPY4>3.0.CO;2-P; Babrah J, 2009, ANALYST, V134, P763, DOI 10.1039/b807967f; Bhargava R, 2000, APPL SPECTROSC, V54, P486, DOI 10.1366/0003702001949898; Bhargava R, 2006, BBA-BIOMEMBRANES, V1758, P830, DOI 10.1016/j.bbamem.2006.05.007; Bhargava R, 2012, APPL SPECTROSC, V66, P1091, DOI 10.1366/12-06801; Bird B, 2011, TECHNOL CANCER RES T, V10, P135, DOI 10.7785/tcrt.2012.500188; Bird B, 2010, J BIOPHOTONICS, V3, P597, DOI 10.1002/jbio.201000024; Bird B, 2009, ANALYST, V134, P1067, DOI 10.1039/b821166c; Bird B, 2008, BMC CLIN PATHOL, V8, DOI 10.1186/1472-6890-8-8; Bird B, 2009, J BIOPHOTONICS, V2, P37, DOI 10.1002/jbio.200810066; Borovecki A, 2008, CROAT MED J, V49, P625, DOI 10.3325/cmj.2008.5.625; Bruni P, 2004, FARADAY DISCUSS, V126, P19, DOI 10.1039/b306787b; Burattini E, 2007, J MOL STRUCT, V834, P170, DOI 10.1016/j.molstruc.2006.11.068; Davis BJ, 2010, HOMOGENEOUS SAMPLES, V82, P3474, DOI [10.1021/ac902068e, DOI 10.1021/AC902068E]; Davis BJ, 2010, ANAL CHEM, V82, P3487, DOI 10.1021/ac902068e; Diem M, 2004, ANALYST, V129, P880, DOI 10.1039/b408952a; Fernandez DC, 2005, NAT BIOTECHNOL, V23, P469, DOI 10.1038/nbt1080; Findlay CR, 2015, ANALYST, V140, P2493, DOI 10.1039/c4an01982b; Gazi E, 2006, EUR UROL, V50, P750, DOI 10.1016/j.eururo.2006.03.031; GREEN AA, 1988, IEEE T GEOSCI REMOTE, V26, P65, DOI 10.1109/36.3001; GroBerueschkamp F, 2015, MARKER FREE AUTOMATE, DOI [10.1039/C4AN01978D, DOI 10.1039/C4AN01978D]; Gu-Trantien C, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26066; Hahn H, 2010, CURR MED CHEM, V17, P2956, DOI 10.2174/092986710792065063; Hirschmugl CJ, 2012, APPL SPECTROSC, V66, P475, DOI 10.1366/12-06629; Ioachim HL., 2009, IOACHIMS LYMPH NODE; Isabelle M, 2008, SPECTROSC-INT J, V22, P97, DOI 10.1155/2008/871940; Isabelle M, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3386061; Kazarian SG, 2013, ANALYST, V138, P1940, DOI 10.1039/c3an36865c; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Kole MR, 2012, ANAL CHEM, V84, P10366, DOI 10.1021/ac302513f; Krafft C, 2005, CYTOM PART A, V64A, P53, DOI 10.1002/cyto.a.20117; Kwak JT, 2015, SCI REP-UK, V5, DOI 10.1038/srep08758; Kwak JT, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-62; LEE JB, 1990, IEEE T GEOSCI REMOTE, V28, P295, DOI 10.1109/36.54356; Leong AS-Y., 2011, PATTERN APPROACH LYM; Mayerich D, TECHNOLOGY IN PRESS; Mayerich D, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-156; Mazur AI, 2013, J BIOPHOTONICS, V6, P101, DOI 10.1002/jbio.201200136; Nasse MJ, 2011, NAT METHODS, V8, P413, DOI [10.1038/NMETH.1585, 10.1038/nmeth.1585]; Reddy RK, 2013, APPL SPECTROSC, V67, P93, DOI 10.1366/11-06568; Reddy RK, 2010, ANALYST, V135, P2818, DOI 10.1039/c0an00350f; Romeo M.J., 2008, VIB SPECTROSC, P1, DOI DOI 10.1002/0470027320.S8923; Romeo MJ, 2005, VIB SPECTROSC, V38, P115, DOI 10.1016/j.vibspec.2005.03.009; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Verdonck M, 2015, ANALYST, V140, P2247, DOI 10.1039/c4an01855a; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Walsh MJ, 2012, HIGH RESOLUTION MID, V8219, DOI [10.1117/12.909339, DOI 10.1117/12.909339]; Wang XY, 2007, APPL INTELL, V27, P237, DOI 10.1007/s10489-007-0065-z; Willard-Mack CL, 2006, TOXICOL PATHOL, V34, P409, DOI 10.1080/01926230600867727; Yeh K, 2015, ANAL CHEM, V87, P485, DOI 10.1021/ac5027513	50	42	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127238	10.1371/journal.pone.0127238	http://dx.doi.org/10.1371/journal.pone.0127238			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039216	gold, Green Submitted, Green Published			2022-12-27	WOS:000355700700055
J	Tsai, MH; Liou, HH; Leu, JG; Yen, MF; Chen, HH				Tsai, Ming-Hsien; Liou, Hung-Hsiang; Leu, Jyh-Gang; Yen, Ming-Fang; Chen, Hsiu-Hsi			Sites of Peripheral Artery Occlusive Disease as a Predictor for All-Cause and Cardiovascular Mortality in Chronic Hemodialysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; BLOOD-PRESSURE INDEX; ANKLE BRACHIAL INDEX; DIALYSIS; ASSOCIATION; PREVALENCE; RISK; CALCIFICATION; DIFFERENCE	Background The ankle-brachial blood pressure (BP) index (ABI) not only indicates the presence of peripheral artery occlusive disease (PAOD) but predicts mortality in patients undergoing hemodialysis (HD). However, whether the site of PAOD can provide additional contribution to predicting mortality have not been investigated yet. Our primary objective was to determine the associations between the site of PAOD and all-cause and cardiovascular mortality in chronic HD (CHD) patients. Methods A retrospective cohort study was conducted to evaluate 444 Taiwanese CHD patients between December 2006 and June 2013. The site of PAOD together with other explanatory variables such as demographic data, body mass index, a history of cardiovascular diseases, HD vintage, biochemical data, and cardiothoracic ratio (CTR) were assessed by the Cox proportional hazards regression model. Results The frequency of PAOD was 14.6% in both legs, 4.9% in the right side only, and 5.1% in the left side only. During the study period, 127 all-cause and 93 cardiovascular deaths occurred. PAOD site was found to have significant predictive power for all-cause mortality with the order of 3.04 (95% CI: 1.56-5.90) hazard ratio on the right side, 2.48 (95% CI: 1.27-4.82) on the left side, and 4.11 (95% CI: 2.76-6.13) on both sides. The corresponding figures for cardiovascular mortality were 3.81 (95% CI: 1.87-7.76) on the right side, 2.76 (95% CI: 1.30-5.82) on the left side, and 3.95 (95% CI: 2.45-6.36) on both sides. After adjustment for other explanatory variables, only right-sided PAOD still remained to have significant predictive power for all-cause and cardiovascular mortality and bilateral PAOD kept the significant association with all-cause mortality. Conclusions The site of PAOD revealed various predictive powers for all-cause and cardiovascular mortality in CHD patients and only right-sided PAOD remained an independent predictor for both types of mortality making allowance for relevant confounding factors.	[Tsai, Ming-Hsien; Leu, Jyh-Gang] Shin Kong Wu Ho Su Mem Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan; [Liou, Hung-Hsiang] Hsin Jen Hosp, Dept Med, Div Nephrol, New Taipei City, Taiwan; [Yen, Ming-Fang] Taipei Med Univ, Coll Oral Med, Sch Oral Hyg, Taipei, Taiwan; [Tsai, Ming-Hsien; Chen, Hsiu-Hsi] Natl Taiwan Univ, Inst Epidemiol, Coll Publ Hlth, Div Biostat, Taipei 10764, Taiwan; [Tsai, Ming-Hsien; Chen, Hsiu-Hsi] Natl Taiwan Univ, Inst Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan	Shin Kong Wu Ho Su Memorial Hospital; Taipei Medical University; National Taiwan University; National Taiwan University	Chen, HH (corresponding author), Natl Taiwan Univ, Inst Epidemiol, Coll Publ Hlth, Div Biostat, Taipei 10764, Taiwan.	Chenlin@ntu.edu.tw		Tsai, Ming Hsien/0000-0003-3561-4689; Chen, Hsiu-Hsi/0000-0002-5799-6705	Shin Kong Wu Ho-Su Memorial Hospital [SKH-8302-104-DR-08]	Shin Kong Wu Ho-Su Memorial Hospital	This study was sponsored by the Shin Kong Wu Ho-Su Memorial Hospital (SKH-8302-104-DR-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohn E, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-263; Jimenez ZNC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042290; Chen KH, 2011, THER APHER DIAL, V15, P81, DOI 10.1111/j.1744-9987.2010.00860.x; Chen SC, 2012, CLIN J AM SOC NEPHRO, V7, P1646, DOI 10.2215/CJN.04570512; Chen SC, 2010, NEPHROLOGY, V15, P294, DOI 10.1111/j.1440-1797.2010.01187.x; Cheung AK, 2000, KIDNEY INT, V58, P353, DOI 10.1046/j.1523-1755.2000.00173.x; Clark CE, 2002, FAM PRACT, V19, P439, DOI 10.1093/fampra/19.5.439; de Vinuesa SG, 2005, KIDNEY INT, V67, pS44, DOI 10.1111/j.1523-1755.2005.09310.x; Disthabanchong Sinee, 2012, World J Nephrol, V1, P43, DOI 10.5527/wjn.v1.i2.43; FISHBANE S, 1995, AM J KIDNEY DIS, V25, P34, DOI 10.1016/0272-6386(95)90622-3; Guerrero A, 2006, NEPHROL DIAL TRANSPL, V21, P3525, DOI 10.1093/ndt/gfl470; Kitahara T, 2005, AM J KIDNEY DIS, V46, P688, DOI 10.1053/j.ajkd.2005.06.016; LAING S, 1983, BRIT J SURG, V70, P628, DOI 10.1002/bjs.1800701017; Leng GC, 1996, INT J EPIDEMIOL, V25, P1172, DOI 10.1093/ije/25.6.1172; Leskinen Y, 2002, AM J KIDNEY DIS, V40, P472, DOI 10.1053/ajkd.2002.34885; Lin CY, 2015, RENAL FAILURE, V37, P88, DOI 10.3109/0886022X.2014.976104; MALLICK NP, 1995, AM J KIDNEY DIS, V25, P176, DOI 10.1016/0272-6386(95)90642-8; Mehrotra R, 2006, KIDNEY INT, V69, P195, DOI 10.1038/sj.ki.5000039; Merkus MP, 2000, AM J KIDNEY DIS, V35, P69, DOI 10.1016/S0272-6386(00)70304-0; Newman AB, 1997, J AM GERIATR SOC, V45, P1472, DOI 10.1111/j.1532-5415.1997.tb03198.x; NEWMAN AB, 1993, JAMA-J AM MED ASSOC, V270, P487, DOI 10.1001/jama.270.4.487; Newman AB, 1999, ARTERIOSCL THROM VAS, V19, P538, DOI 10.1161/01.ATV.19.3.538; O'Hare AM, 2002, J AM SOC NEPHROL, V13, P497, DOI 10.1681/ASN.V132497; Ono K, 2003, J AM SOC NEPHROL, V14, P1591, DOI 10.1097/01.ASN.0000065547.98258.3D; Ortiz A, 2014, LANCET, V383, P1831, DOI 10.1016/S0140-6736(14)60384-6; Shinzato T, 1999, KIDNEY INT, V55, P700, DOI 10.1046/j.1523-1755.1999.00297.x; SHINZATO T, 1994, NEPHRON, V67, P280, DOI 10.1159/000187980; Yen TH, 2009, AM J MED SCI, V337, P421, DOI 10.1097/MAJ.0b013e31819bbec1; Zhang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070777	29	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128968	10.1371/journal.pone.0128968	http://dx.doi.org/10.1371/journal.pone.0128968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035831	Green Submitted, Green Published, gold			2022-12-27	WOS:000355699100058
J	Karki, TB; Sah, SK; Thapa, RB; McDonald, AJ; Davis, AS				Karki, Tika B.; Sah, Shrawan K.; Thapa, Resam B.; McDonald, Andrew J.; Davis, Adam S.			Identifying Pathways for Improving Household Food Self-Sufficiency Outcomes in the Hills of Nepal	PLOS ONE			English	Article							SECURITY; MANAGEMENT; MIDHILLS; MAIZE; YIELD	Maintaining and improving household food self-sufficiency (FSS) in mountain regions is an ongoing challenge. There are many facets to the issue, including comparatively high levels of land fragmentation, challenging terrain and transportation bottlenecks, declining labor availability due to out-migration, and low technical knowledge, among others. Using a nonparametric multivariate approach, we quantified primary associations underlying current levels of FSS in the mid-hills of Nepal. A needs assessment survey was administered to 77 households in Lungaun (Baglung District), Pang (Parbat District), and Pathlekhet (Myagdi District), with a total of 80 variables covering five performance areas; resulting data were analyzed using Classification and Regression Trees. The most parsimonious statistical model for household FSS highlighted associations with agronomic management, including yields of maize and fingermillet within a relay cropping system and adoption of improved crop cultivars. Secondary analyses of the variables retained in the first model again focused primarily on crop and livestock management. It thus appears that continued emphasis on technical agricultural improvements is warranted, independent of factors such as land holding size that, in any case, are very difficult to change through development interventions. Initiatives to increase household FSS in the mid-hills of Nepal will benefit from placing a primary focus on methods of agricultural intensification to improve crop yields and effective technology transfer to increase adoption of these methods.	[Karki, Tika B.; Sah, Shrawan K.; Thapa, Resam B.] Tribhuvan Univ, Inst Agr & Anim Sci, Rampur, Nepal; [McDonald, Andrew J.] CIMMYT, South Asia Reg Off, Kathmandu, Nepal; [Davis, Adam S.] USDA ARS, Urbana, IL 61801 USA	Tribhuvan University; Institute of Agriculture & Animal Science (IAAS) - Nepal; United States Department of Agriculture (USDA)	Davis, AS (corresponding author), USDA ARS, Urbana, IL 61801 USA.	adam.davis@ars.usda.gov	Karki, Tika/HHS-5568-2022	Davis, Adam/0000-0002-7196-1197	Bill and Melinda Gates Foundation; US Agency for International Development through the International Maize and Wheat Improvement Center (CIMMYT), Mexico	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); US Agency for International Development through the International Maize and Wheat Improvement Center (CIMMYT), Mexico(United States Agency for International Development (USAID))	T. B. Karki received fellowship support of his doctoral research from the Bill and Melinda Gates Foundation and US Agency for International Development through the International Maize and Wheat Improvement Center (CIMMYT), Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breiman L., 1984, CLASSIFICATION REGRE; Dahal BM, 2009, INT J AGR SUSTAIN, V7, P249, DOI 10.3763/ijas.2009.0436; Dame J, 2011, FOOD SECUR, V3, P179, DOI 10.1007/s12571-011-0127-2; Dawadi D. R., 2012, Tropical Agricultural Research, V23, P218; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Gartaula H, 2012, FOOD SECUR, V4, P181, DOI 10.1007/s12571-012-0190-3; Gurung B, 2002, MT RES DEV, V22, P240, DOI 10.1659/0276-4741(2002)022[0240:AFSIMM]2.0.CO;2; Joshi KD, 2012, FIELD CROP RES, V131, P40, DOI 10.1016/j.fcr.2012.03.001; Karki T. B., 2014, INT J APPL SCI BIOTE, V2, P275; Karki TB, 2014, J AGR ALLIED SCI, V3, P24; Maharjan KL, 2011, J MT SCI-ENGL, V8, P403, DOI 10.1007/s11629-011-2001-2; Marquis G, 2012, MT RES DEV, V32, P226, DOI 10.1659/MRD-JOURNAL-D-12-00034.1; Olmstead J., 2011, FEEDING WORLD 12 YEA; Pilbeam CJ, 2005, AGR HUM VALUES, V22, P243, DOI 10.1007/s10460-004-8284-y; R Core Team, 2020, R LANG ENV STAT COMP; Raut N, 2011, INT J AGR SUSTAIN, V9, P537, DOI 10.1080/14735903.2011.609648; Rea L.M., 1997, DESIGNING CONDUCTING, V2nd ed.; Subedi KD, 1996, EXP AGR, V32, P57, DOI 10.1017/S0014479700025850; Subedi KD, 2001, P SUST MAIZ PROD SYS; Tiwari TP, 2009, FIELD CROP RES, V111, P137, DOI 10.1016/j.fcr.2008.11.008; Tiwari TP, 2004, EXP AGR, V40, P397, DOI 10.1017/S001447970400208X; van Ittersum MK, 2013, FIELD CROP RES, V143, P4, DOI 10.1016/j.fcr.2012.09.009; Venables WN., 2002, MODERN APPL STAT S 4; World Food Programme, 2010, WFP FOOD SEC ATL NEP	25	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127513	10.1371/journal.pone.0127513	http://dx.doi.org/10.1371/journal.pone.0127513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047508	gold, Green Submitted, Green Published			2022-12-27	WOS:000355652200022
J	Mekov, E; Slavova, Y; Tsakova, A; Genova, M; Kostadinov, D; Minchev, D; Marinova, D; Tafradjiiska, M				Mekov, Evgeni; Slavova, Yanina; Tsakova, Adelina; Genova, Marianka; Kostadinov, Dimitar; Minchev, Delcho; Marinova, Dora; Tafradjiiska, Maya			Vitamin D Deficiency and Insufficiency in Hospitalized COPD Patients	PLOS ONE			English	Article							BONE-MINERAL DENSITY; 3RD NATIONAL-HEALTH; 25-HYDROXYVITAMIN D; PULMONARY-FUNCTION; LUNG-FUNCTION; RISK; EXACERBATIONS; ASSOCIATION; DISEASE	Introduction 31-77% of patients with COPD have vitamin D deficiency and insufficiency, with results being highly variable between studies. Vitamin D may also correlate with disease characteristics. Aim To find out the prevalence of vitamin D deficiency and insufficiency in patients with COPD admitted for exacerbation and a risk factors for lower vitamin D levels among comorbidities and COPD characteristics. Methods 152 patients were studied for vitamin D serum levels (25(OH) D). All of them were also assessed for diabetes mellitus (DM) and metabolic syndrome (MS). Data were gathered also for smoking status and exacerbations in last year. All patients completed CAT and mMRC questionnaires and underwent spirometry. Results A total of 83,6% of patients have reduced levels of vitamin D. 42,8% (65/152) have vitamin D insufficiency (defined as 25-50 nmol/L) and 40,8% (62/152) have vitamin D deficiency (<25 nmol/L). The mean level of 25(OH) D for all patients is 31,97 nmol/L (95% CI 29,12-34,68). Vitamin D deficiency and insufficiency are more prevalent in females vs. males (97,7 vs 77,8%; p = 0.003). The prevalence and severity of vitamin D deficiency and insufficiency in this study is significantly higher when compared to an unselected Bulgarian population (prevalence 75,8%; mean level 38,75 nmol/L). Vitamin D levels correlate with quality of life (measured by the mMRC scale) and lung function (FVC, FEV1, FEV6, FEF2575, FEV3, but not with FEV1/FVC ratio and PEF), it does not correlate with the presence of arterial hypertension, DM, MS and number of moderate, severe and total exacerbations. Vitamin D deficiency is a risk factor for longer hospital stay. Conclusions The patients with COPD admitted for exacerbation are a risk group for vitamin D deficiency and insufficiency, which is associated with worse disease characteristics.	[Mekov, Evgeni; Slavova, Yanina; Kostadinov, Dimitar; Minchev, Delcho; Marinova, Dora; Tafradjiiska, Maya] SHATPD Sveta Sofia, Clin Ctr Pulm Dis, Sofia, Bulgaria; [Tsakova, Adelina; Genova, Marianka] UMHAT Alexandrovska, Cent Clin Lab, Sofia, Bulgaria	Medical University Sofia; Medical University Sofia	Mekov, E (corresponding author), SHATPD Sveta Sofia, Clin Ctr Pulm Dis, Sofia, Bulgaria.	dr_mekov@abv.bg	Tsakova, Adelina/AAD-2412-2022	Marinova, Dora/0000-0001-7633-6342; Tsakova, Adelina/0000-0002-8611-3908	Medical University-Sofia, Sofia, Bulgaria [15-D/2014, 22-D/2014]	Medical University-Sofia, Sofia, Bulgaria	This work was supported by Medical University-Sofia, Sofia, Bulgaria (grant number 15-D/2014, project number 22-D/2014) (http://mu-sofia.bg/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Ampikaipakan SN, 2011, THORAX, V66, P541, DOI 10.1136/thx.2009.134338; Bahar-Shany K, 2010, J CELL PHYSIOL, V222, P729, DOI 10.1002/jcp.22004; Black PN, 2005, CHEST, V128, P3792, DOI 10.1378/chest.128.6.3792; Borissova A-M, 2012, ENDOCRINOLOGIA, V17, P135; Borissova A-M, 2012, ENDOCRINOLOGIA, V3, P122; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Forli L, 2004, J INTERN MED, V256, P56, DOI 10.1111/j.1365-2796.2004.01337.x; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; Franco CB, 2009, OSTEOPOROSIS INT, V20, P1881, DOI 10.1007/s00198-009-0890-5; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; GOLD, 2011, GLOB STRAT DIAGN MAN; Graat-Verboom L, 2008, EUR RESPIR J, pP3374; Heulens N, 2013, AM J RESP CRIT CARE, V187, P214, DOI 10.1164/ajrccm.187.2.214a; Hewison M, 2011, NAT REV ENDOCRINOL, V7, P336, DOI 10.1038/nrendo.2010.226; Holmgaard DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053670; Institute of Medicine, 2011, DIETARY REFERENCE IN; Janssens W, 2010, THORAX, V65, P215, DOI 10.1136/thx.2009.120659; Kunisaki KM, 2011, EUR RESPIR J, V37, P238, DOI 10.1183/09031936.00146509; Kunisaki KM, 2012, AM J RESP CRIT CARE, V185, P286, DOI 10.1164/rccm.201109-1644OC; Lange NE, 2012, AM J RESP CRIT CARE, V186, P616, DOI 10.1164/rccm.201110-1868OC; Mahlin C, 2014, CLIN RESPIR J, V8, P24, DOI 10.1111/crj.12030; Mekov E, 2014, THORACIC MED, V6, P18; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Persson LJP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038934; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Puhan MA, 2014, CHEST, V145, P37, DOI 10.1378/chest.13-1296; Quint JK, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-28; Razzaque MS, 2006, FASEB J, V20, P720, DOI 10.1096/fj.05-5432fje; Romme EAPM, 2013, ANN MED, V45, P91, DOI 10.3109/07853890.2012.671536; Schlaich C, 1998, OSTEOPOROSIS INT, V8, P261, DOI 10.1007/s001980050063; Shaheen SO, 2011, THORAX, V66, P692, DOI 10.1136/thx.2010.155234; Sin DD, 2003, AM J MED, V114, P10, DOI 10.1016/S0002-9343(02)01297-4; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; US Centers for Disease Control and Prevention, 2010, VITAL HLTH STAT SERI, V10, P80; Vestbo J, 2014, CLIN CHEST MED, V35, P1, DOI 10.1016/j.ccm.2013.10.010; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; World Health Organization, 2008, WHO STEPWISE APPR SU; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Wright RJ, 2005, CHEST, V128, P3781, DOI 10.1378/chest.128.6.3781; Zasloff M, 2006, NAT MED, V12, P388, DOI 10.1038/nm0406-388; Zittermann A, 2006, PROG BIOPHYS MOL BIO, V92, P39, DOI 10.1016/j.pbiomolbio.2006.02.001	43	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129080	10.1371/journal.pone.0129080	http://dx.doi.org/10.1371/journal.pone.0129080			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047485	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200121
J	Navarro-Lopez, J; Fargallo, JA				Navarro-Lopez, Juan; Antonio Fargallo, Juan			Trophic Niche in a Raptor Species: The Relationship between Diet Diversity, Habitat Diversity and Territory Quality	PLOS ONE			English	Article							BREEDING PERFORMANCE; EURASIAN KESTRELS; HETEROGENEITY; POPULATION; PATTERNS; GENERALISTS; PREFERENCES; PREDATION; SELECTION; BIRDS	Recent research reports that many populations of species showing a wide trophic niche (generalists) are made up of both generalist individuals and individuals with a narrow trophic niche (specialists), suggesting trophic specializations at an individual level. If true, foraging strategies should be associated with individual quality and fitness. Optimal foraging theory predicts that individuals will select the most favourable habitats for feeding. In addition, the "landscape heterogeneity hypothesis" predicts a higher number of species in more diverse landscapes. Thus, it can be predicted that individuals with a wider realized trophic niche should have foraging territories with greater habitat diversity, suggesting that foraging strategies, territory quality and habitat diversity are inter-correlated. This was tested for a population of common kestrels Falco tinnunculus. Diet diversity, territory occupancy (as a measure of territory quality) and habitat diversity of territories were measured over an 8-year period. Our results show that: 1) territory quality was quadratically correlated with habitat diversity, with the best territories being the least and most diverse; 2) diet diversity was not correlated with territory quality; and 3) diet diversity was negatively correlated with landscape heterogeneity. Our study suggests that niche generalist foraging strategies are based on an active search for different prey species within or between habitats rather than on the selection of territories with high habitat diversity.	[Navarro-Lopez, Juan; Antonio Fargallo, Juan] CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, Madrid 28006, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Navarro-Lopez, J (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, Jose Gutierrez Abascal 2, Madrid 28006, Spain.	navarro-lopez.juan@mncn.csic.es	Fargallo, Juan A/I-5585-2015	Fargallo, Juan A/0000-0003-4090-9000	Project of Ministerio de economia y competitividad (MIMECO) [CGL2007-61395, CGL2010-15726]; Ministerio de economia y competitividad (MIMECO) [BES-2011-043956]	Project of Ministerio de economia y competitividad (MIMECO); Ministerio de economia y competitividad (MIMECO)	This work was supported by Project of Ministerio de economia y competitividad (MIMECO) CGL2007-61395 and Project of Ministerio de economia y competitividad (MIMECO) CGL2010-15726 (http://www.mineco.gob.es/). JNL was supported by a fellowship of Ministerio de economia y competitividad (MIMECO) BES-2011-043956 (http://www.mineco.gob.es/).	Allouche O, 2012, P NATL ACAD SCI USA, V109, P17495, DOI 10.1073/pnas.1208652109; Aparicio JM, 1998, J AVIAN BIOL, V29, P121, DOI 10.2307/3677189; Aparicio JM, 2000, ORNIS FENNICA, V77, P169; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Barrientos R, 2014, BIRD CONSERV INT, V24, P138, DOI 10.1017/S0959270913000270; Barton K., MUMIN MULTIMODEL INF; Begon M., 2009, ECOLOGY INDIVIDUALS; Bernays EA, 1999, P ROY SOC B-BIOL SCI, V266, P151, DOI 10.1098/rspb.1999.0615; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.1890/0012-9658(2002)083[2936:MILRS]2.0.CO;2; Byholm P, 2007, J ANIM ECOL, V76, P392, DOI 10.1111/j.1365-2656.2007.01211.x; Cucherousset J, 2011, OECOLOGIA, V167, P75, DOI 10.1007/s00442-011-1974-4; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; Dennis RLH, 2011, BIOL J LINN SOC, V104, P725, DOI 10.1111/j.1095-8312.2011.01789.x; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Fargallo JA, 2001, BIRD STUDY, V48, P236, DOI 10.1080/00063650109461223; Fargallo JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004311; Germain RR, 2014, ECOLOGY, V95, P436, DOI 10.1890/13-0467.1; Kadmon R, 2007, AM NAT, V170, P443, DOI 10.1086/519853; KORPIMAKI E, 1991, ECOLOGY, V72, P814, DOI 10.2307/1940584; KORPIMAKI E, 1986, Ornis Fennica, V63, P84; Kuznetsova A., 2013, CHRISTENSEN RHB LMER; LACK D, 1969, BIRD STUDY, V16, P193, DOI 10.1080/00063656909476244; Loxdale HD, 2011, BIOL J LINN SOC, V103, P1, DOI 10.1111/j.1095-8312.2011.01627.x; MAC ARTHUR ROBERT H., 1967; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Margalida A, 2007, J ORNITHOL, V148, P309, DOI 10.1007/s10336-007-0133-5; Margalida A, 2012, IBIS, V154, P184, DOI 10.1111/j.1474-919X.2011.01189.x; Margalida A, 2009, IBIS, V151, P235; Martin T.E., 1992, Current Ornithology, V9, P163; Martinez-Padilla J, 2008, NATURWISSENSCHAFTEN, V95, P391, DOI 10.1007/s00114-007-0337-9; Mayntz D, 2001, OECOLOGIA, V127, P207, DOI 10.1007/s004420000591; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Navarro-Lopez J, 2014, OECOLOGIA, V174, P1215, DOI 10.1007/s00442-013-2855-9; Newton I., 1998, POPULATION LIMITATIO; Newton I., 1979, POPULATION ECOLOGY R; Oksanen J., 2013, PACKAGE VEGAN, DOI 10.1109/MSPEC.2006.1611759; Penteriani V, 2002, J ZOOL, V257, P365, DOI 10.1017/S0952836902000961; Ponce C, 2014, ECOL EVOL, V4, P2834, DOI 10.1002/ece3.1125; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; Quevedo M, 2009, ECOLOGY, V90, P2263, DOI 10.1890/07-1580.1; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Sergio F, 2003, J ANIM ECOL, V72, P857, DOI 10.1046/j.1365-2656.2003.00758.x; SHRUBB M, 1993, BIRD STUDY, V40, P63, DOI 10.1080/00063659309477130; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Stephens D.W., 1986, pi; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; Tanferna A, 2013, BIOL CONSERV, V160, P1, DOI 10.1016/j.biocon.2012.12.031; Tapia L, 2008, VIE MILIEU, V58, P257; Telleria JL, 2008, ECOGRAPHY, V31, P381, DOI 10.1111/j.0906-7590.2008.05283.x; Terraube J, 2011, BIODIVERS CONSERV, V20, P2111, DOI 10.1007/s10531-011-0077-1; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Torre I, 2007, BASIC APPL ECOL, V8, P565, DOI 10.1016/j.baae.2006.09.016; VILLAGE A, 1982, BIRD STUDY, V29, P129, DOI 10.1080/00063658209476747; Village A., 1990, THE KESTREL; Zabala J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090254	57	18	19	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128855	10.1371/journal.pone.0128855	http://dx.doi.org/10.1371/journal.pone.0128855			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047025	gold, Green Submitted, Green Published			2022-12-27	WOS:000355652200108
J	Zhu, LL; Yuan, L; Wang, H; Ye, L; Yao, GY; Liu, C; Sun, NN; Li, XJ; Zhai, SC; Niu, LJ; Zhang, JB; Ji, HL; Li, XM				Zhu, Li-Li; Yuan, Ling; Wang, Hui; Ye, Lin; Yao, Gui-Ying; Liu, Cui; Sun, Niu-Niu; Li, Xiao-Jing; Zhai, Shi-Cong; Niu, Ling-Juan; Zhang, Jun-Bo; Ji, Hong-Long; Li, Xiu-Min			A Meta-Analysis of Concurrent Chemoradiotherapy for Advanced Esophageal Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HIGH-DOSE RADIATION; PHASE-II; NEOADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIAL; CONFORMAL RADIOTHERAPY; CISPLATIN; 5-FLUOROURACIL; THERAPY; CONCOMITANT	Background Concurrent chemoradiotherapy is a standard treatment for local advanced esophageal cancer, but the outcomes are controversial. Our goals were to compare the therapeutic effects of concurrent chemoradiotherapy and radiotherapy alone in local advanced esophageal cancer using meta-analysis. Methods MEDLINE, EMBASE and the Cochrane library were searched for studies comparing chemoradiotherapy with radiotherapy alone for advanced esophageal cancer. Only randomized controlled trials were included, and extracted data were analyzed with Review Manager Version 5.2. The pooled relative risks (RR) and their 95% confidence intervals (CI) were calculated for statistical analysis. Results Nine studies were included. Of 1,135 cases, 612 received concurrent chemoradiotherapy and 523 were treated with radiotherapy alone. The overall response rate (complete remission and partial remission) was 93.4% for concurrent chemoradiotherapy and 83.7% for radiotherapy alone (P = 0.05). The RR values of 1-year, 3-year, and 5-year survival rates were 1.14 (95% CI: 1.04 - 1.24, P = 0.006), 1.66 (95% CI: 1.34 - 2.06, P < 0.001), and 2.43 (95% CI: 1.63 - 3.63, P < 0.001), respectively. The RR value of the merged occurrence rate of acute toxic effects was 2.34 (95% CI: 1.90 - 2.90, P < 0.001). There was no difference in the incidence of late toxic effects, which had an RR value of 1.21 (95% CI: 0.96 - 1.54, P = 0.11). The RR level of persistence and recurrence was 0.71 (95% CI: 0.62 - 0.81, P < 0.001), and for the distant metastasis rate, the RR value was 0.79 ( 95% CI: 0.61 - 1.02, P = 0.07). Conclusions Concurrent chemoradiotherapy significantly improved overall survival rate, reduced the risk of persistence and recurrence, but had little effect on the primary tumor response, and increased the occurrence of acute toxic effects.	[Zhu, Li-Li; Ye, Lin; Yao, Gui-Ying; Liu, Cui; Sun, Niu-Niu; Li, Xiao-Jing; Niu, Ling-Juan; Zhang, Jun-Bo] Xinxiang Med Univ, Sch Nursing, Xinxiang, Henan, Peoples R China; [Yuan, Ling] Henan Canc Hosp, Radiat Dept, Zhengzhou, Henan, Peoples R China; [Yuan, Ling] Zhengzhou Univ, Canc Hosp, Zhengzhou, Henan, Peoples R China; [Wang, Hui] Univ Toronto, Ontario Canc Inst, Toronto, ON M5S 1A1, Canada; [Zhai, Shi-Cong] Xinxiang Med Univ, Affiliated Hosp 3, Dept Oncol, Xinxiang, Henan, Peoples R China; [Ji, Hong-Long] Univ Texas Tyler, Sci Ctr Tyler, Dept Mol & Cellular Biol, Tyler, TX 75799 USA; [Li, Xiu-Min] Xinxiang Med Univ, Ctr Canc Res, Xinxiang, Henan, Peoples R China	Xinxiang Medical University; Zhengzhou University; Zhengzhou University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Xinxiang Medical University; University of Texas System; University of Texas at Tyler; Xinxiang Medical University	Ji, HL (corresponding author), Univ Texas Tyler, Sci Ctr Tyler, Dept Mol & Cellular Biol, Tyler, TX 75799 USA.	honglong.ji@uthct.edu; lxm3029981@126.com	li, xiu/GXV-1745-2022		American Heart Association [14GRNT20130034]; National High Technology Research and Development Program of China [2012AA02A201-1]; Science and Technology Development Plan [112102310283, 122102310198]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087017] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Science and Technology Development Plan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the American Heart Association (14GRNT20130034 to HLJ), National High Technology Research and Development Program of China (2012AA02A201-1, http://program.most.gov.cn/) to LXM, who conceived and designed the experiments for this manuscript. The study was also supported by the Science and Technology Development Plan (112102310283; 122102310198, http://www.hnkjt.gov.cn/).	Abitbol AA, 1997, CANCER-AM CANCER SOC, V80, P266, DOI 10.1002/(SICI)1097-0142(19970715)80:2<266::AID-CNCR15>3.0.CO;2-S; ARAUJO CMM, 1991, CANCER, V67, P2258, DOI 10.1002/1097-0142(19910501)67:9<2258::AID-CNCR2820670908>3.0.CO;2-G; Bedford JL, 2000, RADIOTHER ONCOL, V57, P183, DOI 10.1016/S0167-8140(00)00258-9; Button MR, 2009, INT J RADIAT ONCOL, V73, P818, DOI 10.1016/j.ijrobp.2008.04.062; Cho SH, 2008, DIS ESOPHAGUS, V21, P697, DOI 10.1111/j.1442-2050.2008.00837.x; Constantinou M, 2003, CANCER INVEST, V21, P887, DOI 10.1081/CNV-120025092; Cooper JS, 1999, JAMA-J AM MED ASSOC, V281, P1623, DOI 10.1001/jama.281.17.1623; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Fan YJ, 2008, WORLD J SURG, V32, P1980, DOI 10.1007/s00268-008-9674-x; Fenkell L, 2008, RADIOTHER ONCOL, V89, P287, DOI 10.1016/j.radonc.2008.08.008; Gao XS, 2002, ONCOL REP, V9, P767; Greer SE, 2005, SURGERY, V137, P172, DOI 10.1016/j.surg.2004.06.033; Han JH, 2012, TUMORI J, V98, P60, DOI 10.1700/1053.11501; Han QX SX, 1994, MODERN ONCOLOGY; HERSKOVIC A, 1988, INT J RADIAT ONCOL, V15, P655, DOI 10.1016/0360-3016(88)90308-2; HERSKOVIC A, 1992, NEW ENGL J MED, V326, P1593, DOI 10.1056/NEJM199206113262403; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ishida K, 2004, JPN J CLIN ONCOL, V34, P615, DOI 10.1093/jjco/hyh107; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin HL, 2009, WORLD J GASTROENTERO, V15, P5983, DOI 10.3748/wjg.15.5983; Kumar S, 2007, RADIOTHER ONCOL, V83, P139, DOI 10.1016/j.radonc.2007.03.013; Lin JY, 2012, ASIAN PAC J CANCER P, V13, P5415, DOI 10.7314/APJCP.2012.13.11.5415; Liu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097225; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Minsky BD, 1996, J CLIN ONCOL, V14, P149, DOI 10.1200/JCO.1996.14.1.149; Minsky BD, 1999, INT J RADIAT ONCOL, V43, P517, DOI 10.1016/S0360-3016(98)00463-5; Mirinezhad SK, 2013, ASIAN PAC J CANCER P, V14, P1677, DOI 10.7314/APJCP.2013.14.3.1677; Poltinnikov IM, 2005, INT J RADIAT ONCOL, V62, P652, DOI 10.1016/j.ijrobp.2004.10.030; Seung SK, 2004, SEMIN ONCOL, V31, P13, DOI 10.1053/j.seminoncol.2004.12.006; Sharma D, 1997, AM J CLIN ONCOL-CANC, V20, P151, DOI 10.1097/00000421-199704000-00009; Sheng W FX, 2011, CHINESE J ONCOL, P9; Shim HJ, 2012, CANCER CHEMOTH PHARM, V70, P683, DOI 10.1007/s00280-012-1962-3; Sjoquist KM, 2011, LANCET ONCOL, V12, P681, DOI 10.1016/S1470-2045(11)70142-5; Slabber CF, 1998, AM J CLIN ONCOL-CANC, V21, P462, DOI 10.1097/00000421-199810000-00008; Suntharalingam M, 2003, INT J RADIAT ONCOL, V56, P981, DOI 10.1016/S0360-3016(03)00256-6; TF CJSJP, 1995, INT J RADIALONCOL BI, V31, P6; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Vosmik M, 2010, WORLD J GASTROENTERO, V16, P5555, DOI 10.3748/wjg.v16.i44.5555; Welsh J, 2011, CURR ONCOL REP, V13, P157, DOI 10.1007/s11912-011-0158-z; Wong RKS, 2003, INT J RADIAT ONCOL, V55, P930, DOI 10.1016/S0360-3016(02)04278-5; Yin YB YZ, 2008, RADIOTION ONCOLOGY; Zhao KL, 2005, INT J RADIAT ONCOL, V62, P1014, DOI 10.1016/j.ijrobp.2004.12.022; Zheng B, 2013, CHINESE MED J-PEKING, V126, P1178, DOI 10.3760/cma.j.issn.0366-6999.20121798	45	25	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128616	10.1371/journal.pone.0128616	http://dx.doi.org/10.1371/journal.pone.0128616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046353	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200083
J	Sletten, TL; Segal, AY; Flynn-Evans, EE; Lockley, SW; Rajaratnam, SMW				Sletten, Tracey L.; Segal, Ahuva Y.; Flynn-Evans, Erin E.; Lockley, Steven W.; Rajaratnam, Shantha M. W.			Inter-Individual Differences in Neurobehavioural Impairment following Sleep Restriction Are Associated with Circadian Rhythm Phase	PLOS ONE			English	Article							PSYCHOMOTOR VIGILANCE PERFORMANCE; EVENING-TYPE INDIVIDUALS; MORNINGNESS-EVENINGNESS; SUBSEQUENT RECOVERY; BIOLOGICAL NIGHT; SEX-DIFFERENCES; DOSE-RESPONSE; YOUNG-ADULTS; DEPRIVATION; MELATONIN	Although sleep restriction is associated with decrements in daytime alertness and neurobehavioural performance, there are considerable inter-individual differences in the degree of impairment. This study examined the effects of short-term sleep restriction on neurobehavioural performance and sleepiness, and the associations between individual differences in impairments and circadian rhythm phase. Healthy adults (n = 43; 22 M) aged 22.5 +/- 3.1 (mean +/- SD) years maintained a regular 8: 16 h sleep: wake routine for at least three weeks prior to laboratory admission. Sleep opportunity was restricted to 5 hours time-in-bed at home the night before admission and 3 hours time-in-bed in the laboratory, aligned by wake time. Hourly saliva samples were collected from 5.5 h before until 5 h after the pre-laboratory scheduled bedtime to assess dim light melatonin onset (DLMO) as a marker of circadian phase. Participants completed a 10-min auditory Psychomotor Vigilance Task (PVT), the Karolinska Sleepiness Scale (KSS) and had slow eye movements (SEM) measured by electrooculography two hours after waking. We observed substantial inter-individual variability in neurobehavioural performance, particularly in the number of PVT lapses. Increased PVT lapses (r = -0.468, p < 0.01), greater sleepiness (r = 0.510, p < 0.0001), and more slow eye movements (r = 0.375, p = 0.022) were significantly associated with later DLMO, consistent with participants waking at an earlier circadian phase. When the difference between DLMO and sleep onset was less than 2 hours, individuals were significantly more likely to have at least three attentional lapses the following morning. This study demonstrates that the phase of an individual's circadian system is an important variable in predicting the degree of neurobehavioural performance impairment in the hours after waking following sleep restriction, and confirms that other factors influencing performance decrements require further investigation.	[Sletten, Tracey L.; Segal, Ahuva Y.; Lockley, Steven W.; Rajaratnam, Shantha M. W.] Monash Univ, Sch Psychol Sci, Sleep & Circadian Med Lab, Melbourne, Vic 3004, Australia; [Flynn-Evans, Erin E.; Lockley, Steven W.; Rajaratnam, Shantha M. W.] Brigham & Womens Hosp, Dept Med, Div Sleep & Circadian Disorders, Boston, MA 02115 USA; [Flynn-Evans, Erin E.; Lockley, Steven W.; Rajaratnam, Shantha M. W.] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Flynn-Evans, Erin E.; Lockley, Steven W.; Rajaratnam, Shantha M. W.] Harvard Univ, Sch Med, Div Sleep Med, Boston, MA USA	Monash University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sletten, TL (corresponding author), Monash Univ, Sch Psychol Sci, Sleep & Circadian Med Lab, Melbourne, Vic 3004, Australia.	tracey.sletten@monash.edu		Lockley, Steven/0000-0001-5209-2881; Rajaratnam, Shantha/0000-0001-7527-8558; Sletten, Tracey/0000-0002-0005-7838	National Health and Medical Research Council [436758]; US Air Force Office of Scientific Research STTR Phase I grant [83337]; Apollo Health Inc.; National Center for Research Resources [M01-RR02635]; Harvard Medical School Division of Sleep Medicine [T32-HL-07901]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002635] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007901] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); US Air Force Office of Scientific Research STTR Phase I grant; Apollo Health Inc.; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Harvard Medical School Division of Sleep Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by a National Health and Medical Research Council project grant (#436758; PI: Rajaratnam) (https://www.nhmrc.gov.au/), a US Air Force Office of Scientific Research STTR Phase I grant (#83337, PI: Adams, Site PI: Lockley) (http://www.wpafb.af.mil/library/factsheets/factsheet.asp?id=9330), and an investigator-initiated research grant from Apollo Health Inc. (PI: Lockley). The work conducted at Brigham and Women's Hospital was supported by a General Clinical Research Center grant from the National Center for Research Resources (M01-RR02635). Dr Flynn-Evans was supported in-part by a fellowship from the Harvard Medical School Division of Sleep Medicine T32 Training Program in Sleep, Circadian and Respiratory Neurobiology (T32-HL-07901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschbach D, 2003, J CLIN ENDOCR METAB, V88, P26, DOI 10.1210/jc.2002-020827; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Aoki H, 2001, CHRONOBIOL INT, V18, P263, DOI 10.1081/CBI-100103190; Archer SN, 2003, SLEEP, V26, P413, DOI 10.1093/sleep/26.4.413; Axelsson J, 2008, CHRONOBIOL INT, V25, P297, DOI 10.1080/07420520802107031; Baehr EK, 2000, J SLEEP RES, V9, P117, DOI 10.1046/j.1365-2869.2000.00196.x; Bailey SL, 2001, CHRONOBIOL INT, V18, P249, DOI 10.1081/CBI-100103189; Barger LK, 2009, CURR NEUROL NEUROSCI, V9, P155, DOI 10.1007/s11910-009-0024-7; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; Binks PG, 1999, SLEEP, V22, P328, DOI 10.1093/sleep/22.3.328; Blatter K, 2006, BEHAV BRAIN RES, V168, P312, DOI 10.1016/j.bbr.2005.11.018; Broman JE, 1996, NEUROPHYSIOL CLIN, V26, P30, DOI 10.1016/0987-7053(96)81532-2; Burgess Helen J, 2003, Behav Sleep Med, V1, P102, DOI 10.1207/S15402010BSM0102_3; Cain SW, 2010, J BIOL RHYTHM, V25, P288, DOI 10.1177/0748730410374943; Carskadon MA, 2004, ANN NY ACAD SCI, V1021, P276, DOI 10.1196/annals.1308.032; Corsi-Cabrera M, 2003, INT J PSYCHOPHYSIOL, V50, P213, DOI 10.1016/S0167-8760(03)00168-5; Danner F, 2008, J CLIN SLEEP MED, V4, P533; DIJK DJ, 1994, NEUROSCI LETT, V166, P63, DOI 10.1016/0304-3940(94)90841-9; Dijk DJ, 2002, J APPL PHYSIOL, V92, P852, DOI 10.1152/japplphysiol.00924.2001; Dinges DF, 1997, SLEEP, V20, P267; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Dinges DF., 1991, SLEEP SLEEPINESS PER, P97; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Drake CL, 2001, PSYCHOPHYSIOLOGY, V38, P979, DOI 10.1111/1469-8986.3860979; Duffy JF, 2009, J AM GERIATR SOC, V57, P1245, DOI 10.1111/j.1532-5415.2009.02303.x; Duffy JF, 2002, AM J PHYSIOL-ENDOC M, V282, pE297, DOI 10.1152/ajpendo.00268.2001; Duffy JF, 1999, J INVEST MED, V47, P141; Duffy JF, 2001, BEHAV NEUROSCI, V115, P895, DOI 10.1037//0735-7044.115.4.895; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Ferrara M, 2001, SLEEP MED REV, V5, P155, DOI 10.1053/smrv.2000.0138; Frey DJ, 2004, J SLEEP RES, V13, P305, DOI 10.1111/j.1365-2869.2004.00429.x; Goel N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005874; Gooley JJ, 2011, J CLIN ENDOCR METAB, V96, pE463, DOI 10.1210/jc.2010-2098; Groeger JA, 2008, SLEEP, V31, P1159; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Kerkhof GA, 1998, PERCEPT MOTOR SKILL, V86, P264, DOI 10.2466/pms.1998.86.1.264; Kerkhof GA, 1996, NEUROSCI LETT, V218, P153, DOI 10.1016/S0304-3940(96)13140-2; KERKHOF GA, 1985, BIOL PSYCHOL, V20, P83, DOI 10.1016/0301-0511(85)90019-5; Klerman EB, 2002, J BIOL RHYTHM, V17, P181, DOI 10.1177/074873002129002474; LAVIE P, 1986, ELECTROEN CLIN NEURO, V63, P414, DOI 10.1016/0013-4694(86)90123-9; Leproult R, 2003, AM J PHYSIOL-REG I, V284, pR280, DOI 10.1152/ajpregu.00197.2002; Lewy AJ, 1996, BEHAV BRAIN RES, V73, P131; Lewy AJ, 2001, NEUROSCI LETT, V313, P158, DOI 10.1016/S0304-3940(01)02261-3; Lewy AJ, 2006, P NATL ACAD SCI USA, V103, P7414, DOI 10.1073/pnas.0602425103; Lindberg E, 1997, SLEEP, V20, P381, DOI 10.1093/sleep/20.6.381; Lockley SW, 2008, J SLEEP RES, V17, P207, DOI 10.1111/j.1365-2869.2008.00656.x; Martin SK, 2002, CHRONOBIOL INT, V19, P695, DOI 10.1081/CBI-120006080; McNair D., 1971, MANUAL PROFILE MOOD; Mongrain V, 2006, J SLEEP RES, V15, P162, DOI 10.1111/j.1365-2869.2006.00532.x; National Sleep Foundation, 2012, 2012 SLEEP AM POLL; Okawa M, 2007, SLEEP MED REV, V11, P485, DOI 10.1016/j.smrv.2007.08.001; Philip P, 2004, J SLEEP RES, V13, P105, DOI 10.1111/j.1365-2869.2004.00399.x; REYNER A, 1995, SLEEP, V18, P127; Rupp TL, 2013, J SLEEP RES, V22, P160, DOI 10.1111/j.1365-2869.2012.01062.x; SACK RL, 1992, SLEEP, V15, P434, DOI 10.1093/sleep/15.5.434; Scheer FAJL, 2008, J BIOL RHYTHM, V23, P353, DOI 10.1177/0748730408318081; Schmidt C, 2007, COGN NEUROPSYCHOL, V24, P755, DOI 10.1080/02643290701754158; Shekleton JA, 2013, J CLIN SLEEP MED, V9, P353, DOI 10.5664/jcsm.2588; Sletten Tracey L, 2010, Front Neurol, V1, P137, DOI 10.3389/fneur.2010.00137; STROGATZ SH, 1987, AM J PHYSIOL, V253, pR172, DOI 10.1152/ajpregu.1987.253.1.R172; Van Dongen H.P., 2003, SLEEP BIOL RHYTHM, V1, P5, DOI [10.1046/j.1446-9235.2003.00006.x, DOI 10.1046/J.1446-9235.2003.00006.X]; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Van Dongen HPA, 2005, CLIN SPORT MED, V24, P237, DOI 10.1016/j.csm.2004.12.007; Van Dongen HPA, 2004, AVIAT SPACE ENVIR MD, V75, pA147; Van Dongen HPA, 2004, SLEEP, V27, P423; Viola AU, 2007, CURR BIOL, V17, P613, DOI 10.1016/j.cub.2007.01.073; Voultsios A, 1997, J BIOL RHYTHM, V12, P457, DOI 10.1177/074873049701200507; WEBB WB, 1984, ERGONOMICS, V27, P45, DOI 10.1080/00140138408963462; WILKINSON R, 1961, J EXP PSYCHOL, V62, P263, DOI 10.1037/h0048787; Wright KP, 2005, J BIOL RHYTHM, V20, P168, DOI 10.1177/0748730404274265; Wright KP, 2001, P NATL ACAD SCI USA, V98, P14027, DOI 10.1073/pnas.201530198	71	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128273	10.1371/journal.pone.0128273	http://dx.doi.org/10.1371/journal.pone.0128273			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043207	Green Submitted, Green Published, gold			2022-12-27	WOS:000355701600042
J	Amoaku, WM; Gale, RP; Lotery, AJ; Menon, G; Sivaprasad, S; Petrillo, J; Quinn, J				Amoaku, Winfried M.; Gale, Richard P.; Lotery, Andrew J.; Menon, Geeta; Sivaprasad, Sobha; Petrillo, Jennifer; Quinn, Jennifer			Treatment Satisfaction and Well-Being in Patients with Myopic Choroidal Neovascularization Treated with Ranibizumab in the REPAIR Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; UTILITY VALUES; INDIVIDUALIZED MEASURE; MACULAR DEGENERATION; PATHOLOGICAL MYOPIA; QUESTIONNAIRE; SECONDARY; PEOPLE; IMPACT	The Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen (REPAIR) trial was a prospective study exploring the efficacy and safety of intravitreal ranibizumab 0.5 mg using an individualized treatment regimen over 12 months. The current study investigated the impact of treatment with ranibizumab as needed (pro re nata [PRN]) on individuals with myopic choroidal neovascularization (mCNV) in the REPAIR study, using patient-reported outcome measures (PROMs) for treatment satisfaction and well-being. This study included 65 adults with mCNV and a best-corrected visual acuity (BCVA) letter score of 24-78 in the study eye. Patients completed the Macular Disease Treatment Satisfaction Questionnaire (MacTSQ) at months 1, 6 and 12, and the 12-item Well-Being Questionnaire (W-BQ12) at baseline and months 1, 6 and 12. Subgroup analyses investigated the relationship between PROM scores and treatment in the better-or worse-seeing eye (BSE/WSE), number of injections received, baseline BCVA, BCVA improvement and age. Pearson correlations between change in BCVA, MacTSQ scores and W-BQ12 scores were calculated. The main outcome measures were treatment satisfaction measured with the MacTSQ (score 0-72) and wellbeing measured with the W-BQ12 (score 0-36). Treatment satisfaction significantly increased over the study period (p = 0.0001). Mean MacTSQ scores increased by 9.7 and 10.0 in patients treated in their WSE and BSE, respectively. Treatment satisfaction was highest in individuals receiving only one injection at month 1; however, by month 12, scores were similar across injection subgroups. Patients aged 68 years or older had the highest MacTSQ scores. Well-being scores also significantly increased over the study period (p = 0.03). Mean W-BQ12 scores increased by 1.7 in patients treated in their WSE and by 2.1 in patients treated in their BSE. Individuals aged 40 years or younger had the greatest increases in general well- being. Patients who experienced stable or improved BCVA at month 12 had greater increases in W-BQ12 scores than those who experienced a decrease. Correlations between BCVA, MacTSQ scores and W-BQ12 scores were largely non-significant. In conclusion, treatment satisfaction and well-being increased during treatment with ranibizumab PRN. Although directly comparable data are limited for the MacTSQ and W-BQ12 in mCNV, these results complement PROM outcomes reported in related studies.	[Amoaku, Winfried M.] Univ Nottingham, Acad Ophthalmol, Div Clin Neurosci, Nottingham NG7 2RD, England; [Amoaku, Winfried M.] Nottingham Univ Hosp NHS Trust, Nottingham, England; [Gale, Richard P.] York Teaching Hosp NHS Fdn Trust, York, N Yorkshire, England; [Lotery, Andrew J.] Univ Southampton, Fac Med, Clin & Expt Sci, Southampton SO9 5NH, Hants, England; [Menon, Geeta] Frimley Pk Hosp NHS Fdn Trust, Frimley, Surrey, England; [Sivaprasad, Sobha] Kings Coll Hosp NHS Fdn Trust, NIHR Moorfields Biomed Res Ctr, London, England; [Petrillo, Jennifer] Novartis Pharma AG, Basel, Switzerland; [Quinn, Jennifer] Novartis Pharmaceut UK Ltd, Frimley, Surrey, England	University of Nottingham; Nottingham University Hospital NHS Trust; University of Southampton; King's College Hospital NHS Foundation Trust; Novartis; Novartis	Amoaku, WM (corresponding author), Univ Nottingham, Acad Ophthalmol, Div Clin Neurosci, Nottingham NG7 2RD, England.	Winfried.Amoaku@nottingham.ac.uk	Sivaprasad, S./D-6876-2015	Sivaprasad, S./0000-0001-8952-0659; Amoaku, Winfried/0000-0001-5028-7984; Lotery, Andrew/0000-0001-5541-4305	Novartis Pharmaceuticals UK	Novartis Pharmaceuticals UK	The work was sponsored by Novartis Pharmaceuticals UK. The sponsor participated in the design of the study, data analysis and review of the manuscript. The funders had complete control over study design, data collection and analysis, decision to publish, and preparation of the manuscript.	BRADLEY C, 1990, DIABETIC MED, V7, P445, DOI 10.1111/j.1464-5491.1990.tb01421.x; Bradley C., 1994, HDB PSYCHOL DIABETES, VFirst; Bradley G, 2000, DIABETES CARE, V23, P875; Bressler NM, 2010, OPHTHALMOLOGY, V117, P747, DOI 10.1016/j.ophtha.2009.09.002; Brown GC, 2000, ARCH OPHTHALMOL-CHIC, V118, P47; Brown Melissa M., 2001, International Ophthalmology, V24, P123, DOI 10.1023/A:1021171000838; Brown MM, 1999, AM J OPHTHALMOL, V128, P324, DOI 10.1016/S0002-9394(99)00146-4; Brown MM, 2003, OPHTHALMOLOGY, V110, P1076, DOI 10.1016/S0161-6420(03)00254-9; Brown MM, 2001, BRIT J OPHTHALMOL, V85, P327, DOI 10.1136/bjo.85.3.327; Chakravarthy U, 2013, LANCET, V382, P1258, DOI 10.1016/S0140-6736(13)61501-9; Chan WM, 2005, BRIT J OPHTHALMOL, V89, P1522, DOI 10.1136/bjo.2005.074716; Cohen SY, 1996, OPHTHALMOLOGY, V103, P1241, DOI 10.1016/S0161-6420(96)30515-0; Denniston AK, 2014, EYE, V28, P637, DOI 10.1038/eye.2014.41; Frick KD, 2012, INVEST OPHTH VIS SCI, V53, P1169, DOI 10.1167/iovs.11-8259; GROSSNIKLAUS HE, 1992, RETINA-J RET VIT DIS, V12, P127, DOI 10.1097/00006982-199212020-00009; Hayashi K, 2010, OPHTHALMOLOGY, V117, P1595, DOI 10.1016/j.ophtha.2009.11.003; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Mitchell J, 2001, QUAL LIFE RES, V10, P465, DOI 10.1023/A:1012540100613; Mitchell J, 2007, QUAL LIFE RES, V120, P2; Mitchell J, 2008, AM J OPHTHALMOL, V146, P447, DOI 10.1016/j.ajo.2008.04.031; Mitchell J, 2004, QUAL LIFE RES, V13, P1548, DOI 10.1023/B:QURE.0000031348.51292.4a; Neelam K, 2012, PROG RETIN EYE RES, V31, P495, DOI 10.1016/j.preteyeres.2012.04.001; Poku E, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-74; Riazi A, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-40; Takashima T, 2001, JPN J OPHTHALMOL, V45, P84, DOI 10.1016/S0021-5155(00)00305-1; Tufail A, 2013, EYE, V27, P709, DOI 10.1038/eye.2013.8; Tufail A, 2013, OPHTHALMOLOGY, V120, P1944, DOI 10.1016/j.ophtha.2013.06.010; Wolf S, 2014, OPHTHALMOLOGY, V121, P682, DOI 10.1016/j.ophtha.2013.10.023; Woodcock A., 2006, P VIS 2005 INT C SER, V1282, P342; Yoshida T, 2003, OPHTHALMOLOGY, V110, P1297, DOI 10.1016/S0161-6420(03)00461-5	30	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128403	10.1371/journal.pone.0128403	http://dx.doi.org/10.1371/journal.pone.0128403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7ST	26039355	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700100
J	Camilleri, GM; Mejean, C; Bellisle, F; Hercberg, S; Peneau, S				Camilleri, Geraldine M.; Mejean, Caroline; Bellisle, France; Hercberg, Serge; Peneau, Sandrine			Association between Mindfulness and Weight Status in a General Population from the NutriNet-Sante Study	PLOS ONE			English	Article							RELATIVE BODY-WEIGHT; PHYSICAL-ACTIVITY; THOUGHT SUPPRESSION; EATING INTERVENTION; SELF-REPORT; MASS INDEX; QUESTIONNAIRE; METAANALYSIS; VALIDATION; VALIDITY	Background Mindfulness is defined as non-judgmental awareness of the present moment. There is some evidence of the efficacy of mindfulness-based interventions in weight loss. However, this psychological concept has only been rarely explored in observational studies, and no study to date has examined the association between dispositional mindfulness and weight status in a large population-based sample. Objective We aimed to examine the relationship between mindfulness scores and weight status in a large sample of the adult general population in France. Design and Methods A total of 14,400 men and 49,228 women aged >= 18 y participating in the NutriNet-Sante study were included in this cross-sectional analysis. We collected mindfulness data using the Five Facet Mindfulness Questionnaire as well as self-reported weight and height. The association between weight status and dispositional mindfulness, as well as its subscales (observing, describing, acting with awareness, non-judging and non-reactivity), was assessed using multinomial logistic regression models adjusted for socio-demographic and lifestyle factors. Results Women with higher dispositional mindfulness scores were less likely to be overweight (excluding obesity) (OR quartile 4 vs. 1 = 0.84, 95% CI: 0.79-0.90) and obese (OR quartile 4 vs. 1 = 0.71, 95% CI: 0.65-0.78). In addition, overall, in this group, all subscales were inversely associated with weight status, with the strongest association found for the "observing" subscale. In men, higher mindfulness was associated only with lower odds of obesity (OR quartile 4 vs. 1 = 0.81 (0.69, 0.96)), and only the "observing" and "non-reactivity" subscales were significantly inversely associated with weight status. Conclusion Results support the interest of a shift in perspective that takes into account positive psychological and cognitive factors such as dispositional mindfulness in the investigation of obesity and its associated factors.	[Camilleri, Geraldine M.; Mejean, Caroline; Bellisle, France; Hercberg, Serge; Peneau, Sandrine] Univ Paris 13, Equipe Rech Epidemiol Nutr, Ctr Rech Epidemiol & Stat, Inserm U1153,Inra U1125,Cnam,COMUE Sorbonne Paris, Bobigny, France; [Hercberg, Serge] Univ Paris 13, Sorbonne Paris Cite, Inst Veille Sanit, Unite Surveillance & Epidemiol Nutr, Bobigny, France; [Hercberg, Serge] Hop Avicenne, Dept Sante Publ, F-93009 Bobigny, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Institute of Public Health Surveillance; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13	Camilleri, GM (corresponding author), Univ Paris 13, Equipe Rech Epidemiol Nutr, Ctr Rech Epidemiol & Stat, Inserm U1153,Inra U1125,Cnam,COMUE Sorbonne Paris, Bobigny, France.	g.camilleri@eren.smbh.univ-paris13.fr	Serge, Hercberg/F-3038-2017; HERCBERG, Serge/B-4429-2008; Mejean, Caroline/F-2792-2017; Peneau, Sandrine/F-2701-2017	Serge, Hercberg/0000-0002-3168-1350; HERCBERG, Serge/0000-0002-3168-1350; Mejean, Caroline/0000-0001-6467-5056; Peneau, Sandrine/0000-0002-3463-0989; Bellisle, France/0000-0002-6952-6890	French Ministry of Health; Institut de Veille Sanitaire; Institut National de la Prevention et de l'Education pour la Sante; Fondation pour la Recherche Medicale; Institut National de la Sante et de la Recherche Medicale; Institut National de la Recherche Agronomique; Conservatoire National des Arts et Metiers; Paris 13 University	French Ministry of Health; Institut de Veille Sanitaire; Institut National de la Prevention et de l'Education pour la Sante; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National de la Recherche Agronomique; Conservatoire National des Arts et Metiers; Paris 13 University	The Nutrinet-Sante study is supported by the following institutions: The French Ministry of Health, the Institut de Veille Sanitaire (http://www.invs.sante.fr/en), the Institut National de la Prevention et de l'Education pour la Sante (http://www.inpes.sante.fr), the Fondation pour la Recherche Medicale (http://www.frm.org/), the Institut National de la Sante et de la Recherche Medicale (http://english.inserm.fr/), the Institut National de la Recherche Agronomique (http://www.inra.fr/en/), the Conservatoire National des Arts et Metiers (http://the.cnam.eu/), and Paris 13 University (http://www.univ-paris13.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz JS, 2001, CLIN PSYCHOL REV, V21, P683, DOI 10.1016/S0272-7358(00)00057-X; Alberts HJEM, 2012, APPETITE, V58, P847, DOI 10.1016/j.appet.2012.01.009; Alberts HJEM, 2010, APPETITE, V55, P160, DOI 10.1016/j.appet.2010.05.044; Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; Baer RA, 2004, ASSESSMENT, V11, P191, DOI 10.1177/1073191104268029; Baer RA, 2008, ASSESSMENT, V15, P329, DOI 10.1177/1073191107313003; Barnes RD, 2010, EAT WEIGHT DISORD-ST, V15, pE265, DOI 10.1007/BF03325308; Bergomi C, 2013, MINDFULNESS, V4, P18, DOI 10.1007/s12671-012-0102-9; Beshara M, 2013, APPETITE, V67, P25, DOI 10.1016/j.appet.2013.03.012; Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077; Carr D, 2012, ECON HUM BIOL, V10, P419, DOI 10.1016/j.ehb.2012.04.007; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Daubenmier J, 2011, J OBES, V2011, DOI 10.1155/2011/651936; Dundas I, 2013, SCAND J PSYCHOL, V54, P250, DOI 10.1111/sjop.12044; Faith MS, 2001, OBES RES, V9, P647, DOI 10.1038/oby.2001.86; Feldman G, 2007, J PSYCHOPATHOL BEHAV, V29, P177, DOI 10.1007/s10862-006-9035-8; Fiorletta P, 2010, KINESITHER REV, V103, P24; Framson C, 2009, J AM DIET ASSOC, V109, P1439, DOI 10.1016/j.jada.2009.05.006; Gardener EKT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073475; Gilbert DD, 2010, MINDFULNESS, V1, P227, DOI DOI 10.1007/S12671-010-0032-3; Godsey J, 2013, COMPLEMENT THER MED, V21, P430, DOI 10.1016/j.ctim.2013.06.003; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Grinnell S, 2011, J AM COLL HEALTH, V59, P539, DOI 10.1080/07448481.2011.555932; Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7; Heeren A, 2011, EUR REV APPL PSYCHOL, V61, P147, DOI 10.1016/j.erap.2011.02.001; Hercberg S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-242; Jeffery RW, 2000, HEALTH PSYCHOL, V19, P5, DOI 10.1037/0278-6133.19.Suppl1.5; Johnston L, 1999, INT J EAT DISORDER, V26, P21, DOI 10.1002/(SICI)1098-108X(199907)26:1<21::AID-EAT3>3.0.CO;2-7; Kabat-Zinn J, 2003, CLIN PSYCHOL-SCI PR, V10, P144, DOI 10.1093/clipsy/bpg016; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Kristeller J, 2013, MINDFULNESS, V3, P1; Kristeller Jean L, 2011, Eat Disord, V19, P49, DOI 10.1080/10640266.2011.533605; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Lassale C, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2575; Lattimore P, 2011, APPETITE, V56, P241, DOI 10.1016/j.appet.2010.12.007; Liebman M, 2003, INT J OBESITY, V27, P684, DOI 10.1038/sj.ijo.0802277; Lilja Josefine L., 2011, Cognitive Behaviour Therapy, V40, P291, DOI 10.1080/16506073.2011.580367; Mann T, 2007, AM PSYCHOL, V62, P220, DOI 10.1037/0003-066X.62.3.220; Mantzios M, 2015, MINDFULNESS, V6, P545, DOI 10.1007/s12671-014-0286-2; Mantzios M, 2014, PSYCHOL HEALTH, V29, P422, DOI 10.1080/08870446.2013.863883; Miller CK, 2012, J ACAD NUTR DIET, V112, P1835, DOI 10.1016/j.jand.2012.07.036; Molarius A, 2000, AM J PUBLIC HEALTH, V90, P1260, DOI 10.2105/AJPH.90.8.1260; Moor KR, 2013, MINDFULNESS, V4, P269, DOI 10.1007/s12671-012-0124-3; O'Reilly GA, 2014, OBES REV, V15, P453, DOI 10.1111/obr.12156; Papies EK, 2015, J PERS SOC PSYCHOL, V108, P148, DOI 10.1037/a0038032; Peneau S, 2013, AM J CLIN NUTR, V97, P1307, DOI 10.3945/ajcn.112.054916; Roberts KC, 2011, J AM COLL HEALTH, V59, P165, DOI 10.1080/07448481.2010.484452; Robinson E, 2013, AM J CLIN NUTR, V97, P728, DOI 10.3945/ajcn.112.045245; Shapiro SL, 2006, J CLIN PSYCHOL, V62, P373, DOI 10.1002/jclp.20237; Tapper K, 2009, APPETITE, V52, P396, DOI 10.1016/j.appet.2008.11.012; THAYER RE, 1994, J PERS SOC PSYCHOL, V67, P910, DOI 10.1037/0022-3514.67.5.910; Timmerman GM, 2012, J NUTR EDUC BEHAV, V44, P22, DOI 10.1016/j.jneb.2011.03.143; Touvier M, 2010, EUR J EPIDEMIOL, V25, P287, DOI 10.1007/s10654-010-9433-9; Trousselard M, 2010, BIOPSYCHOSOC MED, V4, DOI 10.1186/1751-0759-4-8; Verplanken B, 2007, J PERS SOC PSYCHOL, V92, P526, DOI 10.1037/0022-3514.92.3.526; WHO, 2003, DIET NUTR PREVENTION, V916; World Health Organization, 2000, WHO TECHN REP SER, V894	57	23	23	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127447	10.1371/journal.pone.0127447	http://dx.doi.org/10.1371/journal.pone.0127447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7ST	26038824	Green Submitted, Green Published, gold			2022-12-27	WOS:000355700700061
J	Deng, SM; Zhang, W; Zhang, B; Chen, YY; Li, JH; Wu, YW				Deng, Sheng-ming; Zhang, Wei; Zhang, Bin; Chen, Yin-yin; Li, Ji-hui; Wu, Yi-wei			Correlation between the Uptake of F-18-Fluorodeoxyglucose (F-18-FDG) and the Expression of Proliferation-Associated Antigen Ki-67 in Cancer Patients: A Meta-Analysis	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CELL LUNG-CANCER; GASTROINTESTINAL STROMAL TUMORS; STANDARDIZED UPTAKE VALUE; GLUCOSE METABOLIC-RATE; SOFT-TISSUE SARCOMAS; NON-HODGKIN-LYMPHOMA; BREAST-CANCER; FDG UPTAKE; PROGNOSTIC-FACTORS	Objective To study the correlation between F-18-FDG uptake and cell proliferation in cancer patients by meta-analysis of published articles. Methods We searched PubMed (MEDLINE included), EMBASE, and Cochrane Database of Systematic Review, and selected research articles on the relationship between F-18-FDG uptake and Ki-67 expression (published between August 1, 1994-August 1, 2014), according to the literature inclusion and exclusion criteria. The publishing language was limited to English. The quality of included articles was evaluated according to the Quality Assessment of Diagnosis Accuracy Studies-2 (QUADAS-2). The correlation coefficient (r) was extracted from the included articles and processed by Fisher's r-to-z transformation. The combined correlation coefficient (r) and the 95% confidence interval (CI) were calculated with STATA 11.0 software under a random-effects model. Begg's test was used to analyze the existence of publication bias and draw funnel plot, and the sources of heterogeneity were explored by sensitivity and subgroup analyses. Results According to the inclusion and exclusion criteria, 79 articles were finally included, including 81 studies involving a total of 3242 patients. All the studies had a combined r of 0.44 (95% CI, 0.41-0.46), but with a significant heterogeneity (I-2 = 80.9%, P<0.01). Subgroup analysis for different tumor types indicated that most subgroups showed a reduced heterogeneity. Malignant melanoma (n = 1) had the minimum correlation coefficient (-0.22) between F-18-FDG uptake and Ki-67 expression, while the thymic epithelial tumors (TETs; n = 2) showed the maximum correlation coefficient of 0.81. The analytical results confirmed that correlation between F-18-FDG uptake and Ki-67 expression was extremely significant in TETs, significant in gastrointestinal stromal tumors (GISTs), moderate in patients with lung, breast, bone and soft tissue, pancreatic, oral, thoracic, and uterine and ovarian cancers, average in brain, esophageal and colorectal cancers, and poor in head and neck, thyroid, gastric and malignant melanoma tumors. Subgroup analysis indicated that positron emission tomography (PET) or PET/CT imaging technology or Ki-67 and standardized uptake value (SUV) measurement technology did not significantly affect the results of r values, and Begg's test showed no significant publication bias. Conclusion In cancer patients, F-18-FDG uptake showed a moderate positive correlation with tumor cell proliferation. Different tumor types exhibited varied degree of correlation, and the correlation was significant in TETs and GSTs. However, our results need further validation by clinical trials with a large sample of different tumor types.	[Deng, Sheng-ming; Zhang, Wei; Zhang, Bin; Li, Ji-hui; Wu, Yi-wei] Soochow Univ, Dept Nucl Med, Affiliated Hosp 1, Suzhou, Peoples R China; [Deng, Sheng-ming] Soochow Univ, Coll Med, Sch Radiat Med & Protect, Suzhou, Peoples R China; [Zhang, Bin] Jiangsu Inst Nucl Med, Jiangsu Key Lab Mol Nucl Med, Minist Hlth, Key Lab Nucl Med, Wuxi, Peoples R China; [Chen, Yin-yin] Soochow Univ, Dept Radiol, Affiliated Hosp 1, Suzhou, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Zhang, B (corresponding author), Soochow Univ, Dept Nucl Med, Affiliated Hosp 1, Suzhou, Peoples R China.	zbnuclmd@126.com		Deng, Shengming/0000-0002-1450-7721	Open Program of Key Laboratory of Nuclear Medicine, Ministry of Health and Jiangsu Key Laboratory of Molecular Nuclear Medicine [KF201305, KF201306]; Science and Technology Development Program of Suzhou [SYSD2013076]; Application Foundation Research Program of Suzhou [SYS201224]	Open Program of Key Laboratory of Nuclear Medicine, Ministry of Health and Jiangsu Key Laboratory of Molecular Nuclear Medicine; Science and Technology Development Program of Suzhou; Application Foundation Research Program of Suzhou	This study was supported by the Open Program of Key Laboratory of Nuclear Medicine, Ministry of Health and Jiangsu Key Laboratory of Molecular Nuclear Medicine (KF201305 and KF201306), Science and Technology Development Program of Suzhou (SYSD2013076), Application Foundation Research Program of Suzhou (SYS201224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avril N, 2001, J NUCL MED, V42, P9; Bai B, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0339-0; Barthel H, 2005, EUR J NUCL MED MOL I, V32, P257, DOI 10.1007/s00259-004-1611-0; Buchmann I, 2003, CANCER BIOTHER RADIO, V18, P327, DOI 10.1089/108497803322285080; Buchmann I, 2008, CANCER BIOTHER RADIO, V23, P172, DOI 10.1089/cbr.2007.349; Buck A, 2002, EUR J NUCL MED MOL I, V29, P1317, DOI 10.1007/s00259-002-0880-8; Buck AC, 2001, J NUCL MED, V42, P721; Buck AK, 2003, J NUCL MED, V44, P1426; Buck AK, 2006, CANCER RES, V66, P11055, DOI 10.1158/0008-5472.CAN-06-1955; Chalkidou A, 2012, EUR J CANCER, V48, P3499, DOI 10.1016/j.ejca.2012.05.001; Chang CC, 2012, CLIN NUCL MED, V37, pE189, DOI 10.1097/RLU.0b013e318251e16e; Chen LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079008; Chen W, 2005, J NUCL MED, V46, P945; Cheng JY, 2013, J NUCL MED, V54, P333, DOI 10.2967/jnumed.112.111963; Cher LM, 2006, J NUCL MED, V47, P410; Cherk MH, 2006, J NUCL MED, V47, P1921; Chihara D, 2011, INT J HEMATOL, V93, P502, DOI 10.1007/s12185-011-0822-y; Cochet A, 2012, J NUCL MED, V53, P512, DOI 10.2967/jnumed.111.096834; Deron P, 2011, NUKLEARMED-NUCL MED, V50, P15, DOI 10.3413/nukmed-0324-10-06; Folpe AL, 2000, CLIN CANCER RES, V6, P1279; Francis DL, 2003, GUT, V52, P1602, DOI 10.1136/gut.52.11.1602; Garcia-Esquinas MG, 2014, Q J NUCL MED MOL IM, V58, P66; Vicente AMG, 2012, CLIN NUCL MED, V37, P460, DOI 10.1097/RLU.0b013e31823926c9; Han B, 2009, NUCL MED COMMUN, V30, P831, DOI 10.1097/MNM.0b013e32832dcfc4; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirose Y, 2014, LEUKEMIA LYMPHOMA, V55, P520, DOI 10.3109/10428194.2013.807509; Hoshikawa H, 2011, MOL IMAGING BIOL, V13, P172, DOI 10.1007/s11307-010-0331-z; Hu SL, 2013, NUCL MED COMMUN, V34, P533, DOI 10.1097/MNM.0b013e328360668a; Humbert O, 2014, EUR J NUCL MED MOL I, V41, P416, DOI 10.1007/s00259-013-2616-3; Ikenaga N, 2007, AM SURGEON, V73, P1151; Ishii Y, 2012, ACTA HAEMATOL-BASEL, V128, P110, DOI 10.1159/000338263; Jacob R, 2001, ORL J OTO-RHINO-LARY, V63, P307, DOI 10.1159/000055764; Kaida H, 2014, NUCL MED COMMUN, V35, P36, DOI 10.1097/MNM.0000000000000019; Kaira K, 2012, EUR J CANCER, V48, P1244, DOI 10.1016/j.ejca.2012.01.016; Kaira K, 2009, CANCER SCI, V100, P753, DOI 10.1111/j.1349-7006.2008.01077.x; Kameyama R, 2009, EUR J NUCL MED MOL I, V36, P382, DOI 10.1007/s00259-008-0970-3; Kamiyama Y, 2005, WORLD J SURG, V29, P1429, DOI 10.1007/s00268-005-0045-6; Kato T, 2008, AM J NEURORADIOL, V29, P1176, DOI 10.3174/ajnr.A1008; Kazama T, 2005, RADIOGRAPHICS, V25, P191, DOI 10.1148/rg.251045045; Kim IJ, 2010, CANCER BIOTHER RADIO, V25, P309, DOI 10.1089/cbr.2009.0636; Kim S, 2005, EUR J NUCL MED MOL I, V32, P52, DOI 10.1007/s00259-004-1598-6; Kitagawa Y, 2003, EUR J NUCL MED MOL I, V30, P63, DOI 10.1007/s00259-002-0978-z; Kitamura K, 2011, J HEPATOL, V55, P846, DOI 10.1016/j.jhep.2011.01.038; Koolen BB, 2012, EUR J NUCL MED MOL I, V39, P1830, DOI 10.1007/s00259-012-2211-z; Kurland BF, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-34; Kurokawa T, 2004, INT J CANCER, V109, P926, DOI 10.1002/ijc.20057; Kuyumcu S, 2012, ANN NUCL MED, V26, P689, DOI 10.1007/s12149-012-0628-x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee JW, 2009, EUR J NUCL MED MOL I, V36, P1574, DOI 10.1007/s00259-009-1133-x; Leonard JP, 2012, BLOOD, V119, P4597, DOI 10.1182/blood-2011-10-388298; Matsumoto I, 2013, ANN THORAC SURG, V95, P305, DOI 10.1016/j.athoracsur.2012.09.052; Minamimoto R, 2012, J NUCL MED, V53, P199, DOI 10.2967/jnumed.111.095539; Miyake K, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/205818; Miyashita G, 2010, ANN NUCL MED, V24, P579, DOI 10.1007/s12149-010-0398-2; Murakami S, 2010, EUR J RADIOL, V75, pE62, DOI 10.1016/j.ejrad.2009.11.020; Nakamura H, 2009, ANN THORAC CARDIOVAS, V15, P304; Nguyen XC, 2007, EUR J RADIOL, V62, P214, DOI 10.1016/j.ejrad.2006.12.008; Nishiyama Y, 2012, JPN J CLIN ONCOL, V42, P912, DOI 10.1093/jjco/hys116; Papajik T, 2011, EUR J HAEMATOL, V86, P32, DOI 10.1111/j.1600-0609.2010.01532.x; Park JW, 2011, J GASTRIC CANCER, V11, P173, DOI 10.5230/jgc.2011.11.3.173; Park SG, 2012, NUCL MED BIOL, V39, P1167, DOI 10.1016/j.nucmedbio.2012.07.003; Riedl CC, 2007, J NUCL MED, V48, P771, DOI 10.2967/jnumed.106.037291; Rupinski MT, 1996, EDUC PSYCHOL MEAS, V56, P419, DOI 10.1177/0013164496056003004; Sauter AW, 2012, J NUCL MED, V53, P521, DOI 10.2967/jnumed.111.097865; Shibata H, 2009, ANN NUCL MED, V23, P609, DOI 10.1007/s12149-009-0278-9; Shimoda Wataru, 2007, Breast Cancer, V14, P260, DOI 10.2325/jbcs.14.260; Shimomura H, 2015, INT J CLIN ONCOL, V20, P308, DOI 10.1007/s10147-014-0711-5; Shou Y, 2012, J CANCER RES THER, V8, P96, DOI 10.4103/0973-1482.95182; Suzuki S, 2014, BRIT J CANCER, V110, P1985, DOI 10.1038/bjc.2014.142; Takenaka T, 2009, J SURG ONCOL, V100, P688, DOI 10.1002/jso.21386; Tanaka R, 2013, CLIN IMAG, V37, P876, DOI 10.1016/j.clinimag.2013.06.001; Tang BF, 2009, MOL IMAGING BIOL, V11, P296, DOI 10.1007/s11307-009-0226-z; Tateishi U, 2006, EUR J NUCL MED MOL I, V33, P683, DOI 10.1007/s00259-005-0044-8; Tchou J, 2010, MOL IMAGING BIOL, V12, P657, DOI 10.1007/s11307-009-0294-0; Tsujikawa T, 2011, EUR J NUCL MED MOL I, V38, P37, DOI 10.1007/s00259-010-1589-8; Ueda S, 2011, BREAST CANCER-TOKYO, V18, P299, DOI 10.1007/s12282-010-0212-y; van Westreenen HL, 2005, J NUCL MED, V46, P400; Vesselle H, 2008, J THORAC ONCOL, V3, P971, DOI 10.1097/JTO.0b013e31818307a7; Viti A, 2014, EUR J CARDIO-THORAC, V46, P369, DOI 10.1093/ejcts/ezu030; Walter F, 2011, PEDIATR HEMAT ONCOL, V28, P579, DOI 10.3109/08880018.2011.602180; Watanabe K, 2006, JPN J CLIN ONCOL, V36, P403, DOI 10.1093/jjco/hyl043; Watanabe R, 2010, LEUKEMIA LYMPHOMA, V51, P279, DOI 10.3109/10428190903440953; Westerterp M, 2008, J CANCER RES CLIN, V134, P227, DOI 10.1007/s00432-007-0275-0; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wu XC, 2012, LEUKEMIA LYMPHOMA, V53, P400, DOI 10.3109/10428194.2011.622420; Yamada M, 2007, SCAND J GASTROENTERO, V42, P633, DOI 10.1080/00365520601040450; Yamamoto Y, 2007, EUR J NUCL MED MOL I, V34, P1610, DOI 10.1007/s00259-007-0449-7; Yamamoto Y, 2009, NUCL MED COMMUN, V30, P841, DOI 10.1097/MNM.0b013e328330294d; Yang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078192; Yap CS, 2006, CHEST, V129, P393, DOI 10.1378/chest.129.2.393; Yoshikawa K, 2013, SURG TODAY, V43, P1162, DOI 10.1007/s00595-012-0411-6; Zhang J, 2014, INT J CANCER, V134, P606, DOI 10.1002/ijc.28394; Zhao ZH, 2013, J NUCL MED, V54, P499, DOI 10.2967/jnumed.112.113472	94	53	54	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0129028	10.1371/journal.pone.0129028	http://dx.doi.org/10.1371/journal.pone.0129028			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26038827	Green Submitted, Green Published, gold			2022-12-27	WOS:000355700700138
J	Bianchi, JI; Stockert, JC; Buzz, LI; Blazquez-Castro, A; Simonetta, SH				Ignacio Bianchi, Javier; Carlos Stockert, Juan; Ines Buzz, Lucila; Blazquez-Castro, Alfonso; Hernan Simonetta, Sergio			Reliable Screening of Dye Phototoxicity by Using a Caenorhabditis elegans Fast Bioassay	PLOS ONE			English	Article							PHOTODYNAMIC TOXICITY; PHOTOCHEMISTRY; PHOTOSENSITIZERS; MECHANISMS; SYSTEM; DAMAGE	Phototoxicity consists in the capability of certain innocuous molecules to become toxic when subjected to suitable illumination. In order to discover new photoactive drugs or characterize phototoxic pollutants, it would be advantageous to use simple biological tests of phototoxicy. In this work, we present a pilot screening of 37 dyes to test for phototoxic effects in the roundworm Caenorhabditis elegans. Populations of this nematode were treated with different dyes, and subsequently exposed to 30 min of white light. Behavioral outcomes were quantified by recording the global motility using an infrared tracking device (WMicrotracker). Of the tested compounds, 17 dyes were classified as photoactive, being phloxine B, primuline, eosin Y, acridine orange and rose Bengal the most phototoxic. To assess photoactivity after uptake, compounds were retested after washing them out of the medium before light irradiation. Dye uptake into the worms was also analyzed by staining or fluorescence. All the positive drugs were incorporated by animals and produced phototoxic effects after washing. We also tested the stress response being triggered by the treatments through reporter strains. Endoplasmic reticulum stress response (hsp-4::GFP strain) was activated by 22% of phototoxic dyes, and mitochondrial stress response (hsp-6::GFP strain) was induced by 16% of phototoxic dyes. These results point to a phototoxic perturbation of the protein functionality and an oxidative stress similar to that reported in cell cultures. Our work shows for the first time the feasibility of C. elegans for running phototoxic screenings and underscores its application on photoactive drugs and environmental pollutants assessment.	[Ignacio Bianchi, Javier; Ines Buzz, Lucila; Hernan Simonetta, Sergio] Fdn Inst Leloir, CONICET, Buenos Aires, DF, Argentina; [Carlos Stockert, Juan] Univ Autonoma Madrid, Fac Ciencias, Dept Biol, E-28049 Madrid, Spain; [Blazquez-Castro, Alfonso] Aarhus Univ, Aarhus Inst Adv Studies, Aarhus, Denmark	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; Autonomous University of Madrid; Aarhus University	Simonetta, SH (corresponding author), Fdn Inst Leloir, CONICET, Patricias Argentinas 435, Buenos Aires, DF, Argentina.	ssimonetta@leloir.org.ar	Blázquez-Castro, Alfonso/A-9716-2017	Blázquez-Castro, Alfonso/0000-0002-3270-7065	PICTStartup; Ministry of Science and Technology Argentina [PAEBT2009-19]; Ministerio de Economia y Competitividad, Spain [CTQ2013-48767-C3-3R]; NIH; C. elegans knockout consortium	PICTStartup; Ministry of Science and Technology Argentina; Ministerio de Economia y Competitividad, Spain; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); C. elegans knockout consortium	This work was supported by grants PICTStartup and PAEBT2009-19 from Ministry of Science and Technology Argentina, and CTQ2013-48767-C3-3R from the Ministerio de Economia y Competitividad, Spain. The strains used in this work were provided by the CGC Center, which is supported by the NIH, and the C. elegans knockout consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anliker Q.R., 1986, TOXIC HAZARD ASSESSM, P166; Artal-Sanz Marto, 2006, Biotechnology Journal, V1, P1405, DOI 10.1002/biot.200600176; BRENNER S, 1974, GENETICS, V77, P71; Buzzi LI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027025; Canete M, 2009, J PORPHYR PHTHALOCYA, V13, P544, DOI 10.1142/S1088424609000516; Gocke E, 2001, J Environ Pathol Toxicol Oncol, V20, P285; Gupta I, 2000, INDIAN J BIOCHEM BIO, V37, P498; Herkovits J, 2007, RES J CHEM ENVIRON, V11, P86; Hetherington A M, 1984, Photodermatol, V1, P255; Horobin RW, 2002, CONNS BIOL STRAINS H; Huang Z, 2005, TECHNOL CANCER RES T, V4, P283, DOI 10.1177/153303460500400308; Inbaraj JJ, 2001, CHEM RES TOXICOL, V14, P1529, DOI 10.1021/tx0155247; JOSE JG, 1979, P NATL ACAD SCI USA, V76, P469, DOI 10.1073/pnas.76.1.469; JOSHI PC, 1986, BIOCHEM BIOPH RES CO, V139, P79, DOI 10.1016/S0006-291X(86)80082-1; Kandela IK, 2002, PHOTOCH PHOTOBIO SCI, V1, P309, DOI 10.1039/b110572h; KNUDSEN EA, 1985, PHOTODERMATOLOGY, V2, P80; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Kussovski VK, 2001, MICROBIOS, V105, P119; LEWIS DFV, 1990, TOXICOLOGY, V65, P33, DOI 10.1016/0300-483X(90)90077-T; MARTHY HJ, 1990, J PHOTOCH PHOTOBIO B, V7, P303, DOI 10.1016/1011-1344(90)85164-R; Mellish KJ, 2002, PHOTOCHEM PHOTOBIOL, V75, P392, DOI 10.1562/0031-8655(2002)075<0392:IVPAOA>2.0.CO;2; MERLIN JL, 1992, EUR J CANCER, V28A, P1452, DOI 10.1016/0959-8049(92)90542-A; MOLERO ML, 1985, J PLANT PHYSIOL, V120, P91, DOI 10.1016/S0176-1617(85)80126-7; Riddle D, 1997, C ELEGANS; Robertson CA, 2009, J PHOTOCH PHOTOBIO B, V96, P1, DOI 10.1016/j.jphotobiol.2009.04.001; Robertson PKJ, 2009, J PHOTOCH PHOTOBIO B, V95, P58, DOI 10.1016/j.jphotobiol.2008.12.009; Robinson T, 2001, BIORESOURCE TECHNOL, V77, P247, DOI 10.1016/S0960-8524(00)00080-8; Scrano L, 2002, J ENVIRON QUAL, V31, P268, DOI 10.2134/jeq2002.0268; Seliger HH, 1965, LIGHT PHYSICAL BIOLO, P324; Simonetta SH, 2007, J NEUROSCI METH, V161, P273, DOI 10.1016/j.jneumeth.2006.11.015; Singer H, 2002, ENVIRON SCI TECHNOL, V36, P4998, DOI 10.1021/es025750i; Smijs TGM, 2004, PHOTOCHEM PHOTOBIOL, V79, P332, DOI 10.1562/2003-12-03-RA.1; Song SJ, 2007, ANAL BIOANAL CHEM, V387, P2917, DOI 10.1007/s00216-007-1130-5; Stockert JC, 2003, TOXICOLOGY, V192, P211, DOI 10.1016/S0300-483X(03)00334-2; Stockert JC, 1996, CANCER CHEMOTH PHARM, V39, P167, DOI 10.1007/s002800050554; Stockert JC, 2004, CURR TOP PHARM, V8, P185, DOI DOI 10.1111/PHP.12602; Sugden JK, 2004, BIOTECH HISTOCHEM, V79, P71, DOI 10.1080/10520290412331292400; VAIDYA AA, 1982, COLOURAGE, V29, P3; Villanueva A., 2002, HDB PHOTOCHEMISTRY P, V4, P79; WAGAI N, 1991, TOXICOL LETT, V58, P215; Wagner SJ, 2003, BIOTECH HISTOCHEM, V78, P171, DOI 10.1080/1052029032000140894; Wainwright M, 2003, BIOTECH HISTOCHEM, V78, P147, DOI 10.1080/10520290310001602404; WILLIAMS PL, 1990, ENVIRON TOXICOL CHEM, V9, P1285, DOI [10.1897/1552-8618(1990)9[1285:ATTUTN]2.0.CO;2, 10.1002/etc.5620091007]; ZDOLSEK JM, 1990, PHOTOCHEM PHOTOBIOL, V51, P67, DOI 10.1111/j.1751-1097.1990.tb01685.x	44	11	11	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128898	10.1371/journal.pone.0128898	http://dx.doi.org/10.1371/journal.pone.0128898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039060	Green Published, gold			2022-12-27	WOS:000355700700128
J	Yin, L; Chen, KN; Guo, L; Cheng, LJ; Wang, FY; Yang, L				Yin, Li; Chen, Kaining; Guo, Lin; Cheng, Liangjun; Wang, Fuyou; Yang, Liu			Identifying the Functional Flexion-extension Axis of the Knee: An In-Vivo Kinematics Study	PLOS ONE			English	Article							IMAGE-MATCHING TECHNIQUE; EPICONDYLAR AXIS; WEIGHT-BEARING; TRANSEPICONDYLAR AXIS; CYLINDRICAL AXIS; DISTAL FEMUR; JOINT; MOTION; AXES; ROTATION	CK Purpose This study aimed to calculate the flexion-extension axis (FEA) of the knee through in-vivo knee kinematics data, and then compare it with two major anatomical axes of the femoral condyles: the transepicondylar axis (TEA) defined by connecting the medial sulcus and lateral prominence, and the cylinder axis (CA) defined by connecting the centers of posterior condyles. Methods The knee kinematics data of 20 healthy subjects were acquired under weight-bearing condition using bi-planar x-ray imaging and 3D-2D registration techniques. By tracking the vertical coordinate change of all points on the surface of femur during knee flexion, the FEA was determined as the line connecting the points with the least vertical shift in the medial and lateral condyles respectively. Angular deviation and distance among the TEA, CA and FEA were measured. Results The TEA-FEA angular deviation was significantly larger than that of the CA-FEA in 3D and transverse plane (3.45 degrees; vs. 1.98 degrees;, p < 0.001; 2.72 degrees; vs. 1.19 degrees;, p = 0.002), but not in the coronal plane (1.61 degrees; vs. 0.83 degrees;, p = 0.076). The TEA-FEA distance was significantly greater than that of the CA-FEA in the medial side (6.7 mm vs. 1.9 mm, p < 0.001), but not in the lateral side (3.2 mm vs. 2.0 mm, p = 0.16). Conclusion The CA is closer to the FEA compared with the TEA; it can better serve as an anatomical surrogate for the functional knee axis.	[Yin, Li; Chen, Kaining; Guo, Lin; Wang, Fuyou; Yang, Liu] Third Mil Med Univ, Southwest Hosp, Ctr Joint Surg, Chongqing, Peoples R China; [Cheng, Liangjun] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Yang, L (corresponding author), Third Mil Med Univ, Southwest Hosp, Ctr Joint Surg, Chongqing, Peoples R China.	jointsurgery@163.com	yang, liu/GVU-8760-2022; liu, yang/HHY-8583-2022	Yin, Li/0000-0002-4566-8616				Asano T, 2005, J ARTHROPLASTY, V20, P1060, DOI 10.1016/j.arth.2004.08.005; Asano T, 2001, CLIN ORTHOP RELAT R, P157, DOI 10.1097/00003086-200107000-00023; BLANKEVOORT L, 1990, J BIOMECH, V23, P1219, DOI 10.1016/0021-9290(90)90379-H; Chen KN, 2013, J SPORT SCI MED, V12, P579; Cobb JP, 2008, J BONE JOINT SURG BR, V90B, P1032, DOI 10.1302/0301-620X.90B8.19905; Doro Lisa Case, 2008, Open Biomed Eng J, V2, P52, DOI 10.2174/1874120700802010052; Eckhoff DG, 2005, J BONE JOINT SURG AM, V87A, P71, DOI 10.2106/JBJS.E.00440; Eckhoff D, 2007, CLIN ORTHOP RELAT R, P238, DOI 10.1097/BLO.0b013e318112416b; ELIAS SG, 1990, CLIN ORTHOP RELAT R, P98, DOI 10.1097/00003086-199011000-00018; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; Hancock CW, 2013, CLIN ORTHOP RELAT R, V471, P2278, DOI 10.1007/s11999-013-2864-3; HOLLISTER AM, 1993, CLIN ORTHOP RELAT R, P259; Insall JN, 2012, INSALL SCOTT SURG KN; Johal P, 2005, J BIOMECH, V38, P269, DOI 10.1016/j.jbiomech.2004.02.008; Kinzel V, 2005, KNEE, V12, P293, DOI 10.1016/j.knee.2004.09.003; Li GA, 2008, J BIOMECH, V41, P1616, DOI 10.1016/j.jbiomech.2008.01.034; Mochizuki T, 2014, J ORTHOP SCI, V19, P451, DOI 10.1007/s00776-014-0536-0; Most E, 2004, J BIOMECH, V37, P1743, DOI 10.1016/j.jbiomech.2004.01.025; Pinskerova V, 2000, ORTHOPADE, V29, pS3, DOI 10.1007/PL00003679; Qi W, 2013, J BIOMECH, V46, P1576, DOI 10.1016/j.jbiomech.2013.03.014; Roland M, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000163; Sheehan FT, 2007, J BIOMECH, V40, P1038, DOI 10.1016/j.jbiomech.2006.04.006; Smith PN, 2003, ARCH PHYS MED REHAB, V84, P1895, DOI 10.1016/S0003-9993(03)00281-8; Tanifuji O, 2013, KNEE SURG SPORT TR A, V21, P2301, DOI 10.1007/s00167-012-2010-x; Tanifuji O, 2013, CLIN ORTHOP RELAT R, V471, P1014, DOI 10.1007/s11999-012-2741-5; Victor J, 2009, ORTHOP TRAUMATOL-SUR, V95, P365, DOI 10.1016/j.otsr.2009.04.011; Victor J, 2009, J BONE JOINT SURG BR, V91B, P683, DOI 10.1302/0301-620X.91B5.21827; Victor J, 2010, J ORTHOP RES, V28, P419, DOI 10.1002/jor.21019; Williams A, 2004, KNEE, V11, P81, DOI 10.1016/j.knee.2003.12.004	30	19	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128877	10.1371/journal.pone.0128877	http://dx.doi.org/10.1371/journal.pone.0128877			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039711	Green Published, Green Submitted, gold			2022-12-27	WOS:000355700700126
J	Shi, H; Yang, SW; Liu, Y; Huang, P; Lin, N; Sun, XR; Yu, RB; Zhang, YY; Qin, YM; Wang, LJ				Shi, Hui; Yang, Shiwei; Liu, Yan; Huang, Peng; Lin, Ning; Sun, Xiaoru; Yu, Rongbin; Zhang, Yuanyuan; Qin, Yuming; Wang, Lijuan			Study on Environmental Causes and SNPs of MTHFR, MS and CBS Genes Related to Congenital Heart Disease	PLOS ONE			English	Article							CYSTATHIONINE BETA-SYNTHASE; PATENT DUCTUS-ARTERIOSUS; REDUCTASE GENE; C677T POLYMORPHISM; DEFECTS; ASSOCIATION; RISK; HOMOCYSTEINE; MULTIVITAMIN; METAANALYSIS	Purpose Congenital heart diseases (CHD) are among the most common birth defects in China. Environmental causes and folate metabolism changes may alter susceptibility to CHD. The aim of this study is to evaluate the relevant risk-factors of children with CHD and their mothers. Methods 138 children with CHD and 207 normal children for controls were recruited. Their mothers were also enlisted in this study and interviewed following a questionnaire about their pregnant history and early pregnancy situation. Five single nucleotide polymorphisms (SNPs) in methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MS) and cystathionine beta-synthase (CBS) of mothers and children were genotyped. Results There were significant differences in the gender of children, occupation of mothers, family history with CHD, history of abortion, history of adverse pregnancy, early pregnancy health, fetus during pregnancy, pesticide exposure and drug exposure in CHD group and control group (P < 0.05). Logistic regression analyses showed that after adjustment for above factors, MTHFR rs1801131 were significantly associated with their offspring CHD risk in mothers. Compared with the mothers whose MTHFR were rs1801131 AA and AC genotypes, the mothers who got a mutation of MTHFR rs1801131 CC genotypes had a 267% increase in risk of given birth of a CHD children (OR=3.67, 95%CI=1.12-12.05). Meanwhile, MTHFR rs1801131 were significantly associated with CHD susceptibility in children (OR = 1.42, 95% CI = 1.00-2.44 in additive model). Conclusions Besides mothers' social and fertility characteristics, our results suggested that the genetic variants in folate metabolism pathway might be one of the most related risk-factors of CHD. MTHFR rs1801131 were identified as loci in Chinese population that were involved in CHD.	[Shi, Hui; Liu, Yan; Lin, Ning; Sun, Xiaoru; Wang, Lijuan] Jiangsu Inst Planned Parenthood Res, Nanjing 210036, Jiangsu, Peoples R China; [Yang, Shiwei; Qin, Yuming] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Cardiol, Nanjing 210008, Jiangsu, Peoples R China; [Huang, Peng; Yu, Rongbin; Zhang, Yuanyuan] Nanjing Med Univ, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Sun, XR (corresponding author), Jiangsu Inst Planned Parenthood Res, Nanjing 210036, Jiangsu, Peoples R China.	sunxr@nju.edu.cn	sun, xiaoru/GZL-0771-2022		Natural Science Foundation of Science and Technology Department of Jiangsu Province [BK2011862]; National Natural Science Foundation [NSFC81000076]	Natural Science Foundation of Science and Technology Department of Jiangsu Province; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The Natural Science Foundation of Science and Technology Department of Jiangsu Province (BK2011862) had a role in study design, data analysis, decision to publish and preparation of the manuscript. SY, who received funding from the National Natural Science Foundation (NSFC81000076), had a role in materials collection and quality control.	[Anonymous], 2014, MCHSCN ANN REP NAT M; Barbosa PR, 2008, EUR J CLIN NUTR, V62, P1010, DOI 10.1038/sj.ejcn.1602810; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Botto LD, 2000, AM J EPIDEMIOL, V151, P878, DOI 10.1093/oxfordjournals.aje.a010291; Botto LD, 2003, AM J MED GENET A, V121A, P95, DOI 10.1002/ajmg.a.20132; Chao CS, 2014, HEART LUNG CIRC, V23, P655, DOI 10.1016/j.hlc.2014.01.010; Chen L, 2012, DNA CELL BIOL, V31, P238, DOI 10.1089/dna.2011.1281; Harvey MS, 2001, METABOLIC MOL BASES, P2007; Hobbs CA, 2006, J MED GENET, V43, P162, DOI 10.1136/jmg.2005.032656; Lee CN, 2005, ACTA OBSTET GYN SCAN, V84, P1134, DOI 10.1111/j.0001-6349.2005.00611.x; Locke AE, 2010, GENET EPIDEMIOL, V34, P613, DOI 10.1002/gepi.20518; Ma DH, 2014, ACTA U MED NANJING, V34, P1273; Pereira AC, 2005, INT J CARDIOL, V105, P15, DOI 10.1016/j.ijcard.2004.10.049; Quere I, 1999, BIOCHEM BIOPH RES CO, V254, P127, DOI 10.1006/bbrc.1998.9079; Robert K, 2003, J HISTOCHEM CYTOCHEM, V51, P363, DOI 10.1177/002215540305100311; Song XM, 2006, BIOMED ENVIRON SCI, V19, P452; Storti S, 2003, CLIN CHEM LAB MED, V41, P276, DOI 10.1515/CCLM.2003.043; Tsai MY, 2000, ATHEROSCLEROSIS, V149, P131, DOI 10.1016/S0021-9150(99)00297-X; van Beynum IM, 2007, QJM-INT J MED, V100, P743, DOI 10.1093/qjmed/hcm094; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058041; Zhao JY, 2012, CELL RES; Zhu WL, 2006, MOL HUM REPROD, V12, P51, DOI 10.1093/molehr/gah252; Zidan HE, 2013, GENE, V529, P119, DOI 10.1016/j.gene.2013.07.053	24	24	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128646	10.1371/journal.pone.0128646	http://dx.doi.org/10.1371/journal.pone.0128646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035828	Green Published, gold, Green Submitted			2022-12-27	WOS:000355699100041
J	Ovalle-Bracho, C; Franco-Munoz, C; Londono-Barbosa, D; Restrepo-Montoya, D; Clavijo-Ramirez, C				Ovalle-Bracho, Clemencia; Franco-Munoz, Carlos; Londono-Barbosa, Diana; Restrepo-Montoya, Daniel; Clavijo-Ramirez, Carlos			Changes in Macrophage Gene Expression Associated with Leishmania (Viannia) braziliensis Infection	PLOS ONE			English	Article							CERAMIDE GENERATION; DONOVANI INFECTION; SURVIVAL; CHOLESTEROL; ACTIVATION; PATHWAYS	Different Leishmania species cause distinct clinical manifestations of the infectious disease leishmaniasis. It is fundamentally important to understand the mechanisms governing the interaction between Leishmania and its host cell. Little is known about this interaction between Leishmania (Viannia) braziliensis and human macrophages. In this study, we aimed to identify differential gene expression between non-infected and L. (V) braziliensis-infected U937-derived macrophages. We deployed a whole human transcriptome microarray analysis using 72 hours post-infection samples and compared those samples with their noninfected counterparts. We found that 218 genes were differentially expressed between infected and non-infected macrophages. A total of 71.6% of these genes were down-regulated in the infected macrophages. Functional enrichment analyses identified the steroid and sterol/cholesterol biosynthetic processes between regulatory networks down-regulated in infected macrophages. RT-qPCR further confirmed this down-regulation in genes belonging to these pathways. These findings contrast with those from studies involving other Leishmania species at earlier infection stages, where gene up-regulation for this metabolic pathway has been reported. Sterol biosynthesis could be an important biological process associated with the expression profile of macrophages infected by L. (V.) braziliensis. Differential transcriptional results suggest a negative regulation of the genetic regulatory network involved in cholesterol biosynthesis.	[Ovalle-Bracho, Clemencia; Franco-Munoz, Carlos; Londono-Barbosa, Diana; Restrepo-Montoya, Daniel] Ctr Dermatol Federico Lleras Acosta, Bogota, Colombia; [Ovalle-Bracho, Clemencia] Univ Nacl Colombia, Fac Med, Bogota, Colombia; [Clavijo-Ramirez, Carlos] Univ Nacl Colombia, Dept Biol, Bogota, Colombia	Universidad Nacional de Colombia; Universidad Nacional de Colombia	Ovalle-Bracho, C (corresponding author), Ctr Dermatol Federico Lleras Acosta, Bogota, Colombia.	clemovalle@gmail.com	Ovalle-bracho, Clemencia/O-4004-2018	Londono Barbosa, Diana Alexandra/0000-0002-0158-5157; Restrepo-Montoya, Daniel/0000-0003-4910-7880; Clavijo-Ramirez, Carlos Arturo/0000-0001-8546-1831	Centro Dermatologico Federico Lleras Acosta; Departamento Administrativo de Ciencia y Tecnologia - COLCIENCIAS [212051928534, RC 314-2010];  [4000.16.1N]	Centro Dermatologico Federico Lleras Acosta; Departamento Administrativo de Ciencia y Tecnologia - COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); 	Funding provided by Centro Dermatologico Federico Lleras Acosta (www.dermatologia.gov.co); project was approved in scientific committee 10 - 2010 with project code 4000.16.1N, COB; Departamento Administrativo de Ciencia y Tecnologia - COLCIENCIAS (www.colciencias.gov.co) with project code 212051928534 and contract number RC 314-2010, COB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barr SD, 2003, J BIOL CHEM, V278, P10816, DOI 10.1074/jbc.M212990200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buates S, 2001, J IMMUNOL, V166, P3416, DOI 10.4049/jimmunol.166.5.3416; Chaussabel D, 2003, BLOOD, V102, P672, DOI 10.1182/blood-2002-10-3232; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Dogra N, 2007, INFECT IMMUN, V75, P3506, DOI 10.1128/IAI.00277-07; Edgar R, 2006, NAT BIOTECHNOL, V24, P1471, DOI 10.1038/nbt1206-1471; Ettinger NA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000252; Forget G, 2005, EUR J IMMUNOL, V35, P1906, DOI 10.1002/eji.200526037; Ghosh S, 2003, BIOCHEM J, V369, P447, DOI 10.1042/BJ20021684; Ghosh S, 2002, INFECT IMMUN, V70, P6828, DOI 10.1128/IAI.70.12.6828-6838.2002; Giudice A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-75; Goldston AM, 2012, TRENDS PARASITOL, V28, P417, DOI 10.1016/j.pt.2012.07.002; Goluszko P, 2005, INFECT IMMUN, V73, P7791, DOI 10.1128/IAI.73.12.7791-7796.2005; Gregory DJ, 2008, INFECT IMMUN, V76, P1186, DOI 10.1128/IAI.01320-07; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jaramillo M, 2011, CELL HOST MICROBE, V9, P331, DOI 10.1016/j.chom.2011.03.008; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; KAYE PM, 1994, EUR J IMMUNOL, V24, P2850, DOI 10.1002/eji.1830241140; Lemaire J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002478; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majumder S, 2012, J INFECT DIS, V205, P1607, DOI 10.1093/infdis/jis229; McConville MJ, 2011, ANNU REV MICROBIOL, V65, P543, DOI 10.1146/annurev-micro-090110-102913; MINTA JO, 1985, AM J PATHOL, V119, P111; Misra S, 2005, J BIOL CHEM, V280, P29364, DOI 10.1074/jbc.M504162200; Moreira D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004684; Mougneau E, 2011, IMMUNOL REV, V240, P286, DOI 10.1111/j.1600-065X.2010.00983.x; Novais FO, 2015, J INVEST DERMATOL, V135, P94, DOI 10.1038/jid.2014.305; Osorio y Fortea Jose, 2009, BMC Genomics, V10, P119, DOI 10.1186/1471-2164-10-119; PAHO, 2013, LEISHMANIASES EPIDEM; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Pucadyil TJ, 2004, MOL BIOCHEM PARASIT, V133, P145, DOI 10.1016/j.molbiopara.2003.10.002; Rabhi I, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-723; Rabhi I, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001763; Ramirez C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001866; REINER NE, 1987, J IMMUNOL, V138, P1926; Rodriguez NE, 2004, INFECT IMMUN, V72, P2111, DOI 10.1128/IAI.72.4.2111-2122.2004; Rodriguez NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019000; Rub A, 2009, NAT IMMUNOL, V10, P273, DOI 10.1038/ni.1705; Zhang SY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000648	42	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128934	10.1371/journal.pone.0128934	http://dx.doi.org/10.1371/journal.pone.0128934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052705	Green Published, Green Submitted, gold			2022-12-27	WOS:000355955300069
J	Barnett, J; Dastjerdi, A; Davison, N; Deaville, R; Everest, D; Peake, J; Finnegan, C; Jepson, P; Steinbach, F				Barnett, James; Dastjerdi, Akbar; Davison, Nick; Deaville, Rob; Everest, David; Peake, Julie; Finnegan, Christopher; Jepson, Paul; Steinbach, Falko			Identification of Novel Cetacean Poxviruses in Cetaceans Stranded in South West England	PLOS ONE			English	Article							SEALS HALICHOERUS-GRYPUS; POX-LIKE LESIONS; INCIDENTAL LESIONS; BRITISH WATERS; PARAPOXVIRUS; INFECTION; MORTALITY; PARASITES; DOLPHINS; PHOCOENA	Poxvirus infections in marine mammals have been mainly reported through their clinical lesions and electron microscopy (EM). Poxvirus particles in association with such lesions have been demonstrated by EM and were previously classified as two new viruses, cetacean poxvirus 1 (CePV-1) and cetacean poxvirus 2 (CePV-2). In this study, epidermal pox lesions in cetaceans stranded in South West England (Cornwall) between 2008 and 2012 were investigated by electron microscopy and molecular analysis. PCR and sequencing of a highly conserved region within the viral DNA polymerase gene ruled out both parapox- and orthopoxviruses. Moreover, phylogenetic analysis of the PCR product clustered the sequences with those previously described as cetacean poxviruses. However, taking the close genetic distance of this gene fragment across the family of poxviridae into account, it is reasonable to postulate further, novel cetacean poxvirus species. The nucleotide similarity within each cluster (tentative species) detected ranged from 98.6% to 100%, whilst the similarity between the clusters was no more than 95%. The detection of several species of poxvirus in different cetacean species confirms the likelihood of a heterogeneous cetacean poxvirus genus, comparable to the heterogeneity observed in other poxvirus genera.	[Barnett, James; Davison, Nick] Anim & Plant Hlth Agcy, Truro, England; [Dastjerdi, Akbar; Peake, Julie; Finnegan, Christopher; Steinbach, Falko] APHA, Div Sci, Dept Virol, Addlestone, Surrey, England; [Deaville, Rob; Jepson, Paul] Zool Soc London, Inst Zool, UK Cetacean Strandings Invest Programme, London NW1 4RY, England; [Everest, David] APHA, Div Sci, Dept Pathol, Addlestone, Surrey, England; [Barnett, James] Univ Exeter Cornwall Campus, Environm & Sustainabil Inst, Penryn, England; [Davison, Nick] Scottish Marine Anim Stranding Scheme, SRUC Vet Serv, Inverness, Scotland; [Steinbach, Falko] Univ Surrey, Fac Hlth & Med Sci, Sch Vet Med, Guildford GU2 5XH, Surrey, England	Animal & Plant Health Agency UK; Zoological Society of London; University of Exeter; University of Surrey	Barnett, J (corresponding author), Anim & Plant Hlth Agcy, Truro, England.	jamesbarnettvet@gmail.com	Steinbach, Falko/V-1682-2019; Dastjerdi, Akbar/E-1803-2011	Steinbach, Falko/0000-0003-1236-2837; Davison, Nicholas/0000-0001-7286-1836	Defra, UK; Devolved Administrations in Scotland and Wales; Defra [SE0537]	Defra, UK(Department for Environment, Food & Rural Affairs (DEFRA)); Devolved Administrations in Scotland and Wales; Defra(Department for Environment, Food & Rural Affairs (DEFRA))	Post-mortem investigations were carried out under the UK Cetacean Strandings Investigation Programme, which is funded by Defra, UK and the Devolved Administrations in Scotland and Wales. The molecular analysis was supported by Defra grant SE0537. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER JR, 1992, VET REC, V130, P569, DOI 10.1136/vr.130.26.569; BAKER JR, 1992, VET REC, V130, P554, DOI 10.1136/vr.130.25.554; Barnett J, 2013, MARINE MAMMAL MEDIC; Blacklaws BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071734; Bracht AJ, 2006, ARCH VIROL, V151, P423, DOI 10.1007/s00705-005-0679-6; Burek KA, 2005, J WILDLIFE DIS, V41, P745, DOI 10.7589/0090-3558-41.4.745; Davison NJ, 2011, VET REC, V169, DOI 10.1136/vr.d2714; Deaville R, UK CETACEAN STRANDIN; FLOM JO, 1979, J WILDLIFE DIS, V15, P593, DOI 10.7589/0090-3558-15.4.593; GERACI JR, 1979, CAN J COMP MED, V43, P399; Geraci JR., 2005, MARINE MAMMALS ASHOR, V2; HICKS BD, 1987, J WILDLIFE DIS, V23, P1, DOI 10.7589/0090-3558-23.1.1; Inoshima Y, 2000, J VIROL METHODS, V84, P201, DOI 10.1016/S0166-0934(99)00144-5; Muller G, 2003, VET PATHOL, V40, P445, DOI 10.1354/vp.40-4-445; OKADA K, 1984, JPN J VET SCI, V46, P401; OSTERHAUS ADME, 1994, VET REC, V135, P601; OSTERHAUS ADME, 1990, VET REC, V127, P91; SIMPSON VR, 1994, VET REC, V134, P292, DOI 10.1136/vr.134.12.292; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; SWEENEY JC, 1975, J AM VET MED ASSOC, V167, P533; Van Bressem MF, 2009, DIS AQUAT ORGAN, V86, P143, DOI 10.3354/dao02101; van Elk N, 2000, IAAAM 31 ANN C P NEW; VanBressem MF, 1996, MAR MAMMAL SCI, V12, P371; VANBRESSEM MF, 1993, J WILDLIFE DIS, V29, P109, DOI 10.7589/0090-3558-29.1.109; Yang W-C, 2007, IAAAM 38 ANN C P ORL	26	16	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0124315	10.1371/journal.pone.0124315	http://dx.doi.org/10.1371/journal.pone.0124315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046847	Green Submitted, Green Published, gold			2022-12-27	WOS:000355652200007
J	Pellegrina, DVD; Severino, P; Barbeiro, HV; Andreghetto, FM; Velasco, IT; de Souza, HP; Machado, MCC; Reis, EM; da Silva, FP				da Silva Pellegrina, Diogo Vieira; Severino, Patricia; Barbeiro, Hermes Vieira; Andreghetto, Flavia Maziero; Velasco, Irineu Tadeu; de Souza, Heraldo Possolo; Cesar Machado, Marcel Cerqueira; Reis, Eduardo Moraes; da Silva, Fabiano Pinheiro			Septic Shock in Advanced Age: Transcriptome Analysis Reveals Altered Molecular Signatures in Neutrophil Granulocytes	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; HEMATOPOIETIC STEM-CELLS; CYTOKINE PRODUCTION; OXIDATIVE STRESS; EXPRESSION PROFILES; MITOCHONDRIAL-DNA; MONONUCLEAR-CELLS; INNATE IMMUNITY; OLDER PATIENTS; HUMAN SEPSIS	Sepsis is one of the highest causes of mortality in hospitalized people and a common complication in both surgical and clinical patients admitted to hospital for non-infectious reasons. Sepsis is especially common in older people and its incidence is likely to increase substantially as a population ages. Despite its increased prevalence and mortality in older people, immune responses in the elderly during septic shock appear similar to that in younger patients. The purpose of this study was to conduct a genome-wide gene expression analysis of circulating neutrophils from old and young septic patients to better understand how aged individuals respond to severe infectious insult. We detected several genes whose expression could be used to differentiate immune responses of the elderly from those of young people, including genes related to oxidative phosphorylation, mitochondrial dysfunction and TGF-a signaling, among others. Our results identify major molecular pathways that are particularly affected in the elderly during sepsis, which might have a pivotal role in worsening clinical outcomes compared with young people with sepsis.	[da Silva Pellegrina, Diogo Vieira] Univ Sao Paulo, Programa Interunidades Posgrad Bioinformat, Sao Paulo, Brazil; [Severino, Patricia; Andreghetto, Flavia Maziero] Hosp Israelita Albert Einstein, Inst Israelita Ensino & Pesquisa, Sao Paulo, Brazil; [Barbeiro, Hermes Vieira; Velasco, Irineu Tadeu; de Souza, Heraldo Possolo; Cesar Machado, Marcel Cerqueira; da Silva, Fabiano Pinheiro] Univ Sao Paulo, Fac Med, Dept Emergencias Clin, Sao Paulo, Brazil; [Reis, Eduardo Moraes] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil	Universidade de Sao Paulo; Hospital Israelita Albert Einstein; Universidade de Sao Paulo; Universidade de Sao Paulo	da Silva, FP (corresponding author), Univ Sao Paulo, Fac Med, Dept Emergencias Clin, Sao Paulo, Brazil.	pinheirofabiano@hotmail.com	Souza, Heraldo P/C-2498-2012; Severino, Patricia/H-2013-2012; Barbeiro, Hermes V/E-2814-2010; Reis, Eduardo M/H-2008-2011; Reis, Eduardo Moraes Rego/AAF-3553-2020; Barbeiro, Hermes V/S-5926-2016; da Silva, Fabiano Pinheiro/F-3464-2011; Souza, Heraldo Possolo/AAX-7878-2021	Severino, Patricia/0000-0002-6682-9343; Barbeiro, Hermes V/0000-0002-8209-4463; Reis, Eduardo M/0000-0002-9556-3070; Barbeiro, Hermes V/0000-0002-8209-4463; da Silva, Fabiano Pinheiro/0000-0003-2673-2202; Souza, Heraldo Possolo/0000-0003-2499-5674; Pellegrina, Diogo/0000-0001-6423-5093	Sao Paulo Research Foundation [2012/03677-9]; CNPq; National Council for Scientific and Technological Development [470539/2013-15]; FAPESP [2014/03150-6]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	MCCM is supported by FAPESP, the Sao Paulo Research Foundation (grant # 2012/03677-9). FPS is supported by CNPq, the National Council for Scientific and Technological Development (grant # 470539/2013-15). DVSP receives a M.Sc. fellowship from FAPESP (2014/03150-6) and EMR received an established investigator fellowship from CNPq.	Aloe L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-239; Boehmer ED, 2004, J LEUKOCYTE BIOL, V75, P342, DOI 10.1189/jlb.0803389; Bone RC, 1997, CHEST, V112, P235, DOI 10.1378/chest.112.1.235; Bone RC, 1996, JAMA-J AM MED ASSOC, V276, P565, DOI 10.1001/jama.276.7.565; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bone RC, 1996, CRIT CARE MED, V24, P1125, DOI 10.1097/00003246-199607000-00010; Bosmann M, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-4; Cannizzo ES, 2011, J PROTEOMICS, V74, P2313, DOI 10.1016/j.jprot.2011.06.005; Cevenini E, 2013, CURR OPIN CLIN NUTR, V16, P14, DOI 10.1097/MCO.0b013e32835ada13; Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84; Christie JD, 2005, CRIT CARE MED, V33, pS449, DOI 10.1097/01.CCM.0000186078.26361.96; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cordero D, 2014, CURRENT PHARM BIOTEC; Cvijanovich N, 2008, PHYSIOL GENOMICS, V34, P127, DOI 10.1152/physiolgenomics.00025.2008; da Silva FP, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-21; da Silva FP, 2013, PEPTIDES, V44, P135, DOI 10.1016/j.peptides.2013.03.029; De Gaudio AR, 2009, CURR DRUG TARGETS, V10, P60, DOI 10.2174/138945009787122879; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Deutschman CS, 2013, CRIT CARE, V17, DOI 10.1186/cc12723; FAGIOLO U, 1993, EUR J IMMUNOL, V23, P2375, DOI 10.1002/eji.1830230950; Florian MC, 2013, NATURE, V503, P392, DOI 10.1038/nature12631; Floyd RA, 2011, FREE RADICAL BIO MED, V51, P931, DOI 10.1016/j.freeradbiomed.2011.04.014; Franceschi C, 2000, VACCINE, V18, P1717, DOI 10.1016/S0264-410X(99)00513-7; Galley HF, 2011, BRIT J ANAESTH, V107, P57, DOI 10.1093/bja/aer093; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Geiger H, 2002, NAT IMMUNOL, V3, P329, DOI 10.1038/ni0402-329; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Girard TD, 2005, CLIN INFECT DIS, V40, P719, DOI 10.1086/427876; Grubeck-Loebenstein B, 2002, ADV IMMUNOL, V80, P243, DOI 10.1016/S0065-2776(02)80017-7; Harries LW, 2014, GENES-BASEL, V5, P656, DOI 10.3390/genes5030656; Heppner HJ, 2013, CRIT CARE CLIN, V29, P757, DOI 10.1016/j.ccc.2013.03.016; Hiraki S, 2012, SURGERY, V151, P313, DOI 10.1016/j.surg.2011.07.019; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Howcroft TK, 2013, AGING-US, V5, P84, DOI 10.18632/aging.100531; Iskander KN, 2013, PHYSIOL REV, V93, P1247, DOI 10.1152/physrev.00037.2012; Kale S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013852; Kale SS, 2011, AGING DIS, V2, P501; Kelly E, 2009, RESPIROLOGY, V14, P210, DOI 10.1111/j.1440-1843.2008.01423.x; Khoo MLM, 2014, AGING CELL, V13, P744, DOI 10.1111/acel.12229; Kim SD, 2012, J IMMUNOL, V189, P2000, DOI 10.4049/jimmunol.1200635; Kritas SK, 2014, INT J IMMUNOPATH PH, V27, P15, DOI 10.1177/039463201402700103; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manni L, 2013, GROWTH FACTORS, V31, P115, DOI 10.3109/08977194.2013.804073; MARI D, 1995, BLOOD, V85, P3144, DOI 10.1182/blood.V85.11.3144.bloodjournal85113144; Mascarucci P, 2001, AGING-CLIN EXP RES, V13, P85, DOI 10.1007/BF03351530; Maslove DM, 2014, TRENDS MOL MED, V20, P204, DOI 10.1016/j.molmed.2014.01.006; Maslove DM, 2012, CRIT CARE, V16, DOI 10.1186/cc11667; Muller L, 2014, BRAIN BEHAV IMMUN, V39, P8, DOI 10.1016/j.bbi.2013.11.015; Nakaya HI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r43; Nasa Prashant, 2012, World J Crit Care Med, V1, P23, DOI 10.5492/wjccm.v1.i1.23; Oh SA, 2013, J IMMUNOL, V191, P3973, DOI 10.4049/jimmunol.1301843; Opal SM, 2005, CLIN INFECT DIS, V41, pS504, DOI 10.1086/432007; Plackett TP, 2003, FASEB J, V17, P688, DOI 10.1096/fj.02-0452fje; Plackett TP, 2004, J LEUKOCYTE BIOL, V76, P291, DOI 10.1189/jlb.1103592; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Renshaw M, 2002, J IMMUNOL, V169, P4697, DOI 10.4049/jimmunol.169.9.4697; Risco A, 2012, P NATL ACAD SCI USA, V109, P11200, DOI 10.1073/pnas.1207290109; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Severino P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091886; Shanley TP, 2007, MOL MED, V13, P495, DOI 10.2119/2007-00065.Shanley; Sharma L, 2014, METHODS MOL BIOL, V1172, P137, DOI 10.1007/978-1-4939-0928-5_12; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Shi Y, 2012, INFLAMM RES, V61, P1369, DOI 10.1007/s00011-012-0538-3; Shinkai S, 1998, CAN J PHYSIOL PHARM, V76, P562, DOI 10.1139/cjpp-76-5-562; Silva-Garcia O, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/310183; Starr ME, 2014, AGING DIS, V5, P126, DOI 10.14336/AD.2014.0500126; Su DM, 2013, CURR OPIN IMMUNOL, V25, P498, DOI 10.1016/j.coi.2013.05.018; Suliman HB, 2003, AM J RESP CRIT CARE, V167, P570, DOI 10.1164/rccm.200206-518OC; Tang BM, 2010, CRIT CARE, V14, DOI 10.1186/cc9392; Tang BMP, 2007, AM J RESP CRIT CARE, V176, P676, DOI 10.1164/rccm.200612-1819OC; Tang BMP, 2009, CRIT CARE MED, V37, P882, DOI 10.1097/CCM.0b013e31819b52fd; Tateda K, 1996, INFECT IMMUN, V64, P769, DOI 10.1128/IAI.64.3.769-774.1996; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tseng CW, 2014, CURR OPIN IMMUNOL, V29, P43, DOI 10.1016/j.coi.2014.03.009; Tu E, 2014, CYTOKINE GROWTH F R, V25, P423, DOI 10.1016/j.cytogfr.2014.07.014; Turnbull IR, 2003, SHOCK, V19, P310, DOI 10.1097/00024382-200304000-00003; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valencia J, 2011, J IMMUNOL, V187, P4129, DOI 10.4049/jimmunol.1101243; Van Camp J, 2014, STEM CELL REV REP, V10, P207, DOI 10.1007/s12015-013-9486-8; Weidner CI, 2014, BIOL CHEM, V395, P1307, DOI 10.1515/hsz-2014-0180; Weksler ME, 2002, SPRINGER SEMIN IMMUN, V24, P35, DOI 10.1007/s00281-001-0094-3; Wendel M, 2010, WIEN MED WOCHENSCHR, V160, P118, DOI 10.1007/s10354-010-0766-5; Wong HR, 2010, PEDIATR CRIT CARE ME, V11, P349, DOI 10.1097/PCC.0b013e3181c519b4; Wong HR, 2009, CRIT CARE MED, V37, P1558, DOI 10.1097/CCM.0b013e31819fcc08; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Zhang DY, 2013, MOL CELL BIOCHEM, V374, P13, DOI 10.1007/s11010-012-1498-1; Zhong B, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003708	89	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128341	10.1371/journal.pone.0128341	http://dx.doi.org/10.1371/journal.pone.0128341			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047321	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200060
J	Dietrich, SJ; Fass, MI; Jacobo, PV; Sobarzo, CMA; Lustig, L; Theas, MS				Jarazo Dietrich, Sabrina; Irina Fass, Monica; Veronica Jacobo, Patricia; Alejandro Sobarzo, Cristian Marcelo; Lustig, Livia; Susana Theas, Maria			Inhibition of NOS-NO System Prevents Autoimmune Orchitis Development in Rats: Relevance of NO Released by Testicular Macrophages in Germ Cell Apoptosis and Testosterone Secretion	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; LEYDIG-CELL; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; EXPRESSION; STEROIDOGENESIS; TESTES; ACETYLCYSTEINE; ANTIOXIDANT	Background Although the testis is considered an immunoprivileged organ it can orchestrate immune responses against pathological insults such as infection and trauma. Experimental autoimmune orchitis (EAO) is a model of chronic inflammation whose main histopathological features it shares with human orchitis. In EAO an increased number of macrophages infiltrate the interstitium concomitantly with progressive germ cell degeneration and impaired steroidogenesis. Up-regulation of nitric oxide (NO)-NO synthase (NOS) system occurs, macrophages being the main producers of NO. Objective The aim of our study was to evaluate the role of NO-NOS system in orchitis development and determine the involvement of NO released by testicular macrophages on germ cell apoptosis and testosterone secretion. Method and Results EAO was induced in rats by immunization with testicular homogenate and adjuvants (E group) and a group of untreated normal rats (N) was also studied. Blockage of NOS by i.p. injection of E rats with a competitive inhibitor of NOS, L-NAME (8mg/kg), significantly reduced the incidence and severity of orchitis and lowered testicular nitrite content. L-NAME reduced germ cell apoptosis and restored intratesticular testosterone levels, without variations in serum LH. Co-culture of N testicular fragments with testicular macrophages obtained from EAO rats significantly increased germ cell apoptosis and testosterone secretion, whereas addition of L-NAME lowered both effects and reduced nitrite content. Incubation of testicular fragments from N rats with a NO donor DETA-NOnoate (DETA-NO) induced germ cell apoptosis through external and internal apoptotic pathways, an effect prevented by N-acetyl-L-cysteine (NAC). DETA-NO inhibited testosterone released from Leydig cells, whereas NAC (from 2.5 to 15 mM) did not prevent this effect. Conclusions We demonstrated that NO-NOS system is involved in the impairment of testicular function in orchitis. NO secreted mainly by testicular macrophages could promote oxidative stress inducing ST damage and interfering in Leydig cell function.	[Jarazo Dietrich, Sabrina; Irina Fass, Monica; Veronica Jacobo, Patricia; Alejandro Sobarzo, Cristian Marcelo; Lustig, Livia; Susana Theas, Maria] Univ Buenos Aires, Fac Med, Inst Invest Biomed UBA CONICET, Buenos Aires, DF, Argentina	University of Buenos Aires	Theas, MS (corresponding author), Univ Buenos Aires, Fac Med, Inst Invest Biomed UBA CONICET, Buenos Aires, DF, Argentina.	msusanatheas@yahoo.com.ar	THEAS, MARIA SUSANA/AAU-3250-2020; Lustig, Livia/ABI-4914-2020	THEAS, MARIA SUSANA/0000-0002-8971-9833; 	Universidad Nacional de Buenos Aires (UBA) [UBA M 0194]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 01481]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT) [PICT 00993]	Universidad Nacional de Buenos Aires (UBA)(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT)(ANPCyT)	This work was supported by Universidad Nacional de Buenos Aires (UBA) UBA M 0194, www.uba.ar, MST; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) PIP 01481, www.conicet.gov.ar, LL MST; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT) PICT 00993, www.agencia.mincyt.gob.ar, LL MST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidi P, 2008, J ENDOCRINOL, V198, P193, DOI 10.1677/JOE-07-0570; Afane M, 1998, ANDROLOGIA, V30, P71; Chae IH, 2004, CLIN CHIM ACTA, V341, P83, DOI 10.1016/j.cccn.2003.11.009; Costur P, 2012, ANDROLOGIA, V44, P654, DOI 10.1111/j.1439-0272.2011.01245.x; DelPunta K, 1996, ENDOCRINOLOGY, V137, P5337, DOI 10.1210/en.137.12.5337; DONCEL GF, 1989, AM J REPROD IMMUNOL, V20, P44, DOI 10.1111/j.1600-0897.1989.tb00638.x; Doronzo G, 2011, ATHEROSCLEROSIS, V216, P44, DOI 10.1016/j.atherosclerosis.2011.01.019; Ducsay CA, 2011, J ENDOCRINOL, V210, P259, DOI 10.1530/JOE-11-0034; Fijak M, 2015, AM J REPROD IMMUNOL, V74, P12, DOI 10.1111/aji.12363; Frungieri MB, 2002, FERTIL STERIL, V78, P298, DOI 10.1016/S0015-0282(02)03206-5; Fujisawa M, 2001, BJU INT, V87, P85, DOI 10.1046/j.1464-410x.2001.00986.x; Gharagozloo P, 2011, HUM REPROD, V26, P1628, DOI 10.1093/humrep/der132; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hogg N, 1999, BBA-BIOENERGETICS, V1411, P378, DOI 10.1016/S0005-2728(99)00027-4; Jacobo P, 2011, AUTOIMMUN REV, V10, P201, DOI 10.1016/j.autrev.2010.09.026; Jarazo-Dietrich S, 2012, IMMUNOBIOLOGY, V217, P778, DOI 10.1016/j.imbio.2012.04.007; Lasram MM, 2014, LIFE SCI, V107, P50, DOI 10.1016/j.lfs.2014.04.033; Le Bras M, 2005, HISTOL HISTOPATHOL, V20, P205, DOI 10.14670/HH-20.205; Lee YW, 2000, FEBS LETT, V485, P122, DOI 10.1016/S0014-5793(00)02208-0; LOMBARDVIGNON N, 1992, INT J ANDROL, V15, P144, DOI 10.1111/j.1365-2605.1992.tb01123.x; Lustig L, 2006, AUTOIMMUNE DISEASES, 4TH EDITION, P841, DOI 10.1016/B978-012595961-2/50063-9; Maheshwari A, 2011, MOL REPROD DEV, V78, P69, DOI 10.1002/mrd.21268; Vigueras-Villasenor RM, 2011, INT J EXP PATHOL, V92, P131, DOI 10.1111/j.1365-2613.2010.00757.x; Mauduit C, 1998, ENDOCRINOLOGY, V139, P2863, DOI 10.1210/en.139.6.2863; MCCARTNEYFRANCIS N, 1993, J EXP MED, V178, P749, DOI 10.1084/jem.178.2.749; Nishimura Y, 2008, HYPERTENS RES, V31, P535, DOI 10.1291/hypres.31.535; NOUROOZZADEH J, 1994, ANAL BIOCHEM, V220, P403, DOI 10.1006/abio.1994.1357; Park SY, 2004, EUR J BIOCHEM, V271, P4222, DOI 10.1111/j.1432-1033.2004.04362.x; Payabvash S, 2007, UROL INT, V79, P248, DOI 10.1159/000107958; Pomerantz DK, 1998, ENDOCRINOLOGY, V139, P922, DOI 10.1210/en.139.3.922; Qi FH, 2012, FOOD CHEM TOXICOL, V50, P295, DOI 10.1016/j.fct.2011.10.040; Ranade AV, 2011, SINGAP MED J, V52, P742; Rival C, 2008, J PATHOL, V215, P108, DOI 10.1002/path.2328; Rival C, 2006, J REPROD IMMUNOL, V70, P43, DOI 10.1016/j.jri.2005.10.006; Roulet V, 2006, HUM REPROD, V21, P1564, DOI 10.1093/humrep/del018; Schuppe HC, 2008, ANDROLOGIA, V40, P84, DOI 10.1111/j.1439-0272.2008.00837.x; SUESCUN MO, 1994, J ANDROL, V15, P442; Suescun MO, 2000, AM J REPROD IMMUNOL, V43, P116, DOI 10.1111/j.8755-8920.2000.430208.x; SUN XR, 1993, ENDOCRINOLOGY, V132, P186, DOI 10.1210/en.132.1.186; Theas MS, 2008, HUM REPROD, V23, P1865, DOI 10.1093/humrep/den240; Theas MS, 2006, HUM REPROD, V21, P1734, DOI 10.1093/humrep/del066; Theas M. S., 2013, SPERMATOGENESIS, V3; Theas S, 2003, AM J REPROD IMMUNOL, V50, P166, DOI 10.1034/j.1600-0897.2003.00074.x; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Turner TT, 2008, J ANDROL, V29, P488, DOI 10.2164/jandrol.108.005132; Valenti S, 1999, INT J ANDROL, V22, P336, DOI 10.1046/j.1365-2605.1999.00189.x; Perez CV, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101709; Wang XJ, 2005, ACTA PHARMACOL SIN, V26, P934, DOI 10.1111/j.1745-7254.2005.00152.x; Wang YQ, 2010, PROTEIN CELL, V1, P133, DOI 10.1007/s13238-010-0018-x; WARREN DW, 1990, J ANDROL, V11, P353; WEINBERG JB, 1994, J EXP MED, V179, P651, DOI 10.1084/jem.179.2.651; Wurstle ML, 2012, EXP CELL RES, V318, P1213, DOI 10.1016/j.yexcr.2012.02.013; YEE JB, 1985, ENDOCRINOLOGY, V116, P2682, DOI 10.1210/endo-116-6-2682	53	22	24	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128709	10.1371/journal.pone.0128709	http://dx.doi.org/10.1371/journal.pone.0128709			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046347	gold, Green Published, Green Submitted			2022-12-27	WOS:000355652200093
J	Massari, F; Bria, E; Ciccarese, C; Munari, E; Modena, A; Zambonin, V; Sperduti, I; Artibani, W; Cheng, L; Martignoni, G; Tortora, G; Brunelli, M				Massari, Francesco; Bria, Emilio; Ciccarese, Chiara; Munari, Enrico; Modena, Alessandra; Zambonin, Valentina; Sperduti, Isabella; Artibani, Walter; Cheng, Liang; Martignoni, Guido; Tortora, Giampaolo; Brunelli, Matteo			Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder	PLOS ONE			English	Article							III BETA-TUBULIN; LUNG-CANCER; EXPRESSION; INHIBITION	Background To date, putative prognostic biomarkers have shown limited utility from the clinical perspective for bladder urothelial carcinoma. Herein, the expression of beta-tubulin-3 and c-Myc was evaluated to determine their prognostic potential. Methods In formalin fixed-paraffin embedded blocks, immunohistochemical expression of c-Myc and beta-tubulin-3 was evaluated. H score ranging from 0 to 300 was obtained by multiplying the percentage of positive cells by intensity (0-3); c-Myc and beta-tubulin-3 expression was defined: 0: negative, 1: weakly positive, 2: strongly positive. Results beta-tubulin-3 and c-Myc immunoexpression was available for 46 cases. At the univariate analysis, node-involvement, beta-tubulin-3 and c-Myc overexpression discriminate shorter DFS (HR 2.19, p = 0.043; HR 3.10, p = 0.24 and HR 3.05, p = 0.011, respectively); 2-yrs DFS log-rank analysis according to low versus high level of immunoexpression were statistically significant; beta-tubulin-3, 53% low vs 12.7% high (p = value 0.02) and c-Myc 28 low vs 8 high (p-value 0.007). Patients displaying negative beta-tubulin-3/c-Myc had statistically significant better 2-yrs DFS than those with mixed expression or double positivity (54.5% versus 18.7% versus 0%, log-rank p = 0.006). Conclusions c-Myc and beta-tubulin-3 show improvement for prognostic risk stratification in patients with muscle invasive bladder urothelial carcinoma. These molecular pathways may also be candidate to improve predictiveness to targeted therapies.	[Massari, Francesco; Bria, Emilio; Ciccarese, Chiara; Modena, Alessandra; Zambonin, Valentina; Tortora, Giampaolo] AOUI, Med Oncol dU, Verona, Italy; [Massari, Francesco; Bria, Emilio; Ciccarese, Chiara; Munari, Enrico; Modena, Alessandra; Zambonin, Valentina; Artibani, Walter; Martignoni, Guido; Tortora, Giampaolo; Brunelli, Matteo] Univ Verona, I-37100 Verona, Italy; [Munari, Enrico; Martignoni, Guido; Brunelli, Matteo] AOUI, Dept Pathol & Diagnost, Verona, Italy; [Sperduti, Isabella] Regina Elena Inst Canc Res, Biostat, Rome, Italy; [Artibani, Walter] AOUI, Dept Oncol & Surg Sci, Urol Clin, Verona, Italy; [Cheng, Liang] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Indiana University System; Indiana University Bloomington	Tortora, G (corresponding author), AOUI, Med Oncol dU, Verona, Italy.	giampaolo.tortora@univr.it	Sperduti, Isabella/K-8902-2016; Bria, Emilio/A-8574-2019; Brunelli, Matteo/AAA-7679-2019; Tortora, Giampaolo/AAA-1252-2019; Massari, Francesco/K-7239-2016; Ciccarese, Chiara/AAB-7602-2019; Tortora, Giampaolo/HGB-6261-2022; Munari, Enrico/J-7516-2016	Sperduti, Isabella/0000-0001-5115-3099; Bria, Emilio/0000-0002-2333-704X; Massari, Francesco/0000-0001-6476-6871; Ciccarese, Chiara/0000-0002-3283-4339; Munari, Enrico/0000-0002-3867-6685; BRUNELLI, Matteo/0000-0002-3832-2676; Tortora, Giampaolo/0000-0002-1378-4962	Italian Association for Cancer Research [AIRC-MFAG 14282, IG 11930]; MIUR-PRIN [2009X23L78_005]	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); MIUR-PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This research was supported by a grant of the Italian Association for Cancer Research (AIRC-MFAG 14282 and IG 11930) and from MIUR-PRIN (2009X23L78_ 005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buti S, 2015, FUTURE ONCOL, V11, P107, DOI 10.2217/fon.14.172; Cheng L, 2014, CRIT REV ONCOL HEMAT, V89, P73, DOI 10.1016/j.critrevonc.2013.08.008; Cheng LA, 2011, HUM PATHOL, V42, P455, DOI 10.1016/j.humpath.2010.07.007; Choi JW, 2014, WORLD J UROL, V32, P347, DOI 10.1007/s00345-012-0993-z; COX DR, 1972, J R STAT SOC B, V34, P187; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Edelman MJ, 2013, J CLIN ONCOL, V31, P1990, DOI 10.1200/JCO.2012.45.3282; HESS KR, 1995, STAT MED, V14, P1707, DOI 10.1002/sim.4780141510; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Larsson LG, 2010, EXP CELL RES, V316, P1429, DOI 10.1016/j.yexcr.2010.03.025; Lindeman NI, 2013, J MOL DIAGN, V15, P415, DOI 10.1016/j.jmoldx.2013.03.001; Mahdy E, 2001, ANTICANCER RES, V21, P3167; Ploussard G, 2010, CANCER RES, V70, P9253, DOI 10.1158/0008-5472.CAN-10-1447; Senetta R, 2013, J NEUROPATH EXP NEUR, V72, P432, DOI 10.1097/NEN.0b013e3182901f41; Seruga B, 2011, NAT REV CLIN ONCOL, V8, P12, DOI 10.1038/nrclinonc.2010.136; Seve P, 2005, MOL CANCER THER, V4, P2001, DOI 10.1158/1535-7163.MCT-05-0244; Seve P, 2005, CLIN CANCER RES, V11, P5481, DOI 10.1158/1078-0432.CCR-05-0285; SHUSTER JJ, 1991, J CLIN ONCOL, V9, P191, DOI 10.1200/JCO.1991.9.1.191; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Soucek L, 2013, GENE DEV, V27, P504, DOI 10.1101/gad.205542.112; Watters AD, 2002, BRIT J CANCER, V87, P654, DOI 10.1038/sj.bjc.6600531; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA; Zaharieva B, 2005, INT J CANCER, V117, P952, DOI 10.1002/ijc.21253	24	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127908	10.1371/journal.pone.0127908	http://dx.doi.org/10.1371/journal.pone.0127908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046361	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200033
J	Sunde, M; Simonsen, GS; Slettemeas, JS; Bockerman, I; Norstrom, M				Sunde, Marianne; Simonsen, Gunnar Skov; Slettemeas, Jannice Schau; Bockerman, Inger; Norstrom, Madelaine			Integron, Plasmid and Host Strain Characteristics of Escherichia coli from Humans and Food Included in the Norwegian Antimicrobial Resistance Monitoring Programs	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; GENE CASSETTES; MOLECULAR ANALYSIS; CLASS-1 INTEGRONS; MEAT-PRODUCTS; RETAIL MEATS; ENTEROBACTERIACEAE; PREVALENCE; VIRULENCE; SWINE	Antimicrobial resistant Escherichia coli (n=331) isolates from humans with bloodstream infections were investigated for the presence of class 1 and class 2 integrons. The integron cassettes arrays were characterized and the findings were compared with data from similar investigations on resistant Escherichia coli from meat and meat products (n=241) produced during the same time period. All isolates were obtained from the Norwegian monitoring programs for antimicrobial resistance in human pathogens and in the veterinary sector. Methods used included PCR, sequencing, conjugation experiments, plasmid replicon typing and subtyping, pulsed-field-gel-electrophoresis and serotyping. Integrons of class 1 and 2 occurred significantly more frequently among human isolates; 45.4% (95% CI: 39.9-50.9) than among isolates from meat; 18% (95% CI: 13.2 -23.3), (p<0.01, Chi-square test). Identical cassette arrays including dfrA1-aadA1, aadA1, dfrA12-orfF-aadA2, oxa-30-aadA1 (class 1 integrons) and dfrA1-sat1-aadA1(class 2 integrons) were detected from both humans and meat. However, the most prevalent cassette array in human isolates, dfrA17-aadA5, did not occur in isolates from meat, suggesting a possible linkage between this class 1 integron and a subpopulation of Escherichia coli adapted to a human host. The drfA1-aadA1and aadA1class 1 integrons were found frequently in both human and meat isolates. These isolates were subjected to further studies to investigate similarities with regard to transferability, plasmid and host strain characteristics. We detected incF plasmids with pMLST profile F24:A-:B1 carrying drfA1-aadA1integrons in isolates from pork and in a more distantly related Escherichia coli strain from a human with septicaemia. Furthermore, we showed that most of the class 1 integrons with aadA1 were located on incF plasmids with pMLST profile F51:A-:B10 in human isolates. The plasmid was present in unrelated as well as closely related host strains, demonstrating that dissemination of this integron also could be attributed to clonal spread. In conclusion, among the systematically collected isolates from two different sources, some significant differences concerning integron prevalence and integron variants were observed. However, closely related plasmids as vehicles for specific class 1 integrons in isolates from meat and from a human with bloodstream infection were found. The occurrence of similar multi-resistance plasmids in bacteria from a food source and from a human clinical sample highlights the possible role of meat as a source of resistance elements for pathogenic bacteria.	[Sunde, Marianne; Slettemeas, Jannice Schau; Bockerman, Inger] Norwegian Vet Inst, Dept Lab Serv, Oslo, Norway; [Simonsen, Gunnar Skov] Univ Hosp North Norway, Dept Microbiol & Infect Control, Tromso, Norway; [Simonsen, Gunnar Skov] Norwegian Arctic Univ, Univ Tromso, Res Grp Host Microbe Interact, Inst Med Biol,Fac Hlth Sci, Tromso, Norway; [Norstrom, Madelaine] Norwegian Vet Inst, Dept Hlth Surveillance, Oslo, Norway	Norwegian Veterinary Institute; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; Norwegian Veterinary Institute	Norstrom, M (corresponding author), Norwegian Vet Inst, Dept Hlth Surveillance, Oslo, Norway.	madelaine.norstrom@vetinst.no		Slettemeas, Jannice Schau/0000-0003-2542-6991; Sunde, Marianne/0000-0002-2326-4338	Norwegian Research Council [167822/I10]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by a grant from the Norwegian Research Council; www.forskningsraadet.no - grant no 167822/I10. The following authors received the funding: MS, IB, JSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Sapper S, 2013, ANTIMICROB AGENTS CH, V57, P490, DOI 10.1128/AAC.01025-12; [Anonymous], 2001, NORM NORM VET 2001 C; [Anonymous], 2002, NORM NORM VET 2002 C; [Anonymous], 2003, NORM NORM VET 2003 U; [Anonymous], 2000, NORM NORM VET 2000 C; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2001, VET RES, V32, P243, DOI 10.1051/vetres:2001122; de Been M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004776; Deng YT, 2011, ANTIMICROB AGENTS CH, V55, P4926, DOI 10.1128/AAC.00133-11; Doumith M, 2012, J CLIN MICROBIOL, V50, P3108, DOI 10.1128/JCM.01468-12; Fluit AC, 2004, CLIN MICROBIOL INFEC, V10, P272, DOI 10.1111/j.1198-743X.2004.00858.x; Hannah EL, 2009, FOODBORNE PATHOG DIS, V6, P285, DOI 10.1089/fpd.2008.0176; Johnson JR, 2008, J CLIN MICROBIOL, V46, P417, DOI 10.1128/JCM.00674-07; Johnson JR, 2009, CLIN INFECT DIS, V49, P195, DOI 10.1086/599830; Kadlec K, 2008, J ANTIMICROB CHEMOTH, V62, P469, DOI 10.1093/jac/dkn233; Kang HY, 2005, J ANTIMICROB CHEMOTH, V55, P639, DOI 10.1093/jac/dki076; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Lapierre L, 2008, MICROB DRUG RESIST, V14, P265, DOI 10.1089/mdr.2008.0810; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; Li D, 2010, J MICROBIOL METH, V82, P71, DOI 10.1016/j.mimet.2010.04.008; Machado E, 2008, J ANTIMICROB CHEMOTH, V62, P296, DOI 10.1093/jac/dkn179; Machado E, 2007, ANTIMICROB AGENTS CH, V51, P2201, DOI 10.1128/AAC.01389-06; Machado E, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00080; Marchant M, 2013, VET MICROBIOL, V163, P124, DOI 10.1016/j.vetmic.2012.12.011; Naseer U, 2011, MICROB DRUG RESIST, V17, P83, DOI 10.1089/mdr.2010.0132; Peigne C, 2009, INFECT IMMUN, V77, P2272, DOI 10.1128/IAI.01333-08; Recchia GD, 1995, MICROBIOL-UK, V141, P3015, DOI 10.1099/13500872-141-12-3015; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; del Castillo BR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-84; STOKES HW, 1989, MOL MICROBIOL, V3, P1669, DOI 10.1111/j.1365-2958.1989.tb00153.x; Sunde M, 2005, J ANTIMICROB CHEMOTH, V56, P1019, DOI 10.1093/jac/dki377; Sunde M, 2008, VET MICROBIOL, V130, P422, DOI 10.1016/j.vetmic.2008.02.001; Sunde M, 2006, J ANTIMICROB CHEMOTH, V58, P741, DOI 10.1093/jac/dkl294; Team RC, 2012, R LANG ENV STAT COMP; van Essen-Zandbergen A, 2007, J ANTIMICROB CHEMOTH, V59, P746, DOI 10.1093/jac/dkl549; Vasilakopoulou A, 2009, FOODBORNE PATHOG DIS, V6, P1211, DOI 10.1089/fpd.2009.0281; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Vinue L, 2008, J ANTIMICROB CHEMOTH, V62, P934, DOI 10.1093/jac/dkn331; White PA, 2001, ANTIMICROB AGENTS CH, V45, P2658, DOI 10.1128/AAC.45.9.2658-2661.2001; Zhao WH, 2009, J MED MICROBIOL, V58, P1080, DOI 10.1099/jmm.0.010017-0	42	33	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128797	10.1371/journal.pone.0128797	http://dx.doi.org/10.1371/journal.pone.0128797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047499	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200102
J	Thekkiniath, J; Zabet-Moghaddam, M; Kottapalli, KR; Pasham, MR; Francisco, SS; Francisco, MS				Thekkiniath, Jose; Zabet-Moghaddam, Masoud; Kottapalli, Kameswara Rao; Pasham, Mithun R.; Francisco, Susan San; Francisco, Michael San			Quantitative Proteomics of an Amphibian Pathogen, Batrachochytrium dendrobatidis, following Exposure to Thyroid Hormone	PLOS ONE			English	Article							FUNGUS BLASTOCLADIELLA-EMERSONII; EMERGING INFECTIOUS-DISEASE; HEAT-SHOCK-PROTEIN; CHYTRID FUNGUS; SACCHAROMYCES-CEREVISIAE; POPULATION DECLINES; CYTOSOLIC CALCIUM; L-6 MYOBLASTS; PLANT-CELLS; EXPRESSION	Batrachochytrium dendrobatidis(Bd), a chytrid fungus, has increasingly been implicated as a major factor in the worldwide decline of amphibian populations. The fungus causes chytridiomycosis in susceptible species leading to massive die-offs of adult amphibians. Although Bd infects the keratinized mouthparts of tadpoles and negatively affects foraging behavior, these infections are non-lethal. An important morphogen controlling amphibian metamorphosis is thyroid hormone (T-3). Tadpoles may be infected with Bd and the fungus may be exposed to T-3 during metamorphosis. We hypothesize that exposure of Bd to T-3 may induce the expression of factors associated with host colonization and pathogenicity. We utilized a proteomics approach to better understand the dynamics of the Bd-T-3 interaction. Using liquid chromatography-mass spectrometry (LC-MS), we generated a data set of a large number of cytoplasmic and membrane proteins following exposure of Bd to T-3. From these data, we identified a total of 263 proteins whose expression was significantly changed following T-3 exposure. We provide evidence for expression of an array of proteins that may play key roles in both genomic and non-genomic actions of T-3 in Bd. Additionally, our proteomics study shows an increase in several proteins including proteases and a class of uncommon crinkler and crinkler-like effector proteins suggesting their importance in Bd pathogenicity as well as those involved in metabolism and energy transfer, protein fate, transport and stress responses. This approach provides insights into the mechanistic basis of the Bd-amphibian interaction following T-3 exposure.	[Thekkiniath, Jose] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Zabet-Moghaddam, Masoud; Kottapalli, Kameswara Rao; Francisco, Susan San] Texas Tech Univ, Ctr Biotechnol & Genom, Lubbock, TX 79402 USA; [Pasham, Mithun R.] Harvard Univ, Sch Med, Dept Cell Biol & Pediat, Boston, MA 02115 USA; [Pasham, Mithun R.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Francisco, Susan San; Francisco, Michael San] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	Yale University; Texas Tech University System; Texas Tech University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Texas Tech University System; Texas Tech University	Francisco, MS (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	Michael.sanfrancisco@ttu.edu			Department of Biological Sciences	Department of Biological Sciences	We thank the Department of Biological Sciences for support during this work.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BANUETT F, 1994, GENE DEV, V8, P1367, DOI 10.1101/gad.8.12.1367; BARDWELL L, 1994, DEV BIOL, V166, P363, DOI 10.1006/dbio.1994.1323; Berger L, 2005, DIS AQUAT ORGAN, V68, P65, DOI 10.3354/dao068065; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bleackley R C, 1995, Curr Top Microbiol Immunol, V198, P145; Blumwald E, 2000, BBA-BIOMEMBRANES, V1465, P140, DOI 10.1016/S0005-2736(00)00135-8; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandhorst TT, 2004, J IMMUNOL, V173, P7444, DOI 10.4049/jimmunol.173.12.7444; Brutyn M, 2012, FUNGAL GENET BIOL, V49, P830, DOI 10.1016/j.fgb.2012.07.002; BUSH DS, 1993, PLANT PHYSIOL, V103, P7, DOI 10.1104/pp.103.1.7; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Coppolino MG, 1999, BIOCHEM J, V340, P41, DOI 10.1042/0264-6021:3400041; Corrao S, 2010, LIFE SCI, V86, P145, DOI 10.1016/j.lfs.2009.11.004; D'Arezzo S, 2004, ENDOCRINOLOGY, V145, P5694, DOI 10.1210/en.2004-0890; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; DAVIS FB, 1983, J CLIN INVEST, V71, P579, DOI 10.1172/JCI110803; Ebanks RO, 2006, PROTEOMICS, V6, P2147, DOI 10.1002/pmic.200500100; Ellison AR, 2014, G3-GENES GENOM GENET, V4, P1275, DOI 10.1534/g3.114.010744; Fernandez-Arenas E, 2007, MOL CELL PROTEOMICS, V6, P460, DOI 10.1074/mcp.M600210-MCP200; Fisher MC, 2009, MOL ECOL, V18, P415, DOI 10.1111/j.1365-294X.2008.04041.x; Fites JS, 2013, SCIENCE, V342, P366, DOI 10.1126/science.1243316; Friesema ECH, 2005, VITAM HORM, V70, P137, DOI 10.1016/S0083-6729(05)70005-4; GALO MG, 1981, J BIOL CHEM, V256, P7113; GEHRING CA, 1990, P NATL ACAD SCI USA, V87, P9645, DOI 10.1073/pnas.87.24.9645; Genevieve S, 2000, J TOXICOL ENV HEAL B, V3, P109; GOMES SL, 1979, FEBS LETT, V99, P39, DOI 10.1016/0014-5793(79)80243-4; Gonzalez-Fernandez R, 2012, J PROTEOME RES, V11, P3, DOI 10.1021/pr200873p; Hepler PK, 2005, PLANT CELL, V17, P2142, DOI 10.1105/tpc.105.032508; Hoffmann B, 2000, MOL GEN GENET, V262, P1001, DOI 10.1007/PL00008643; Hong SW, 2001, PLANT J, V27, P25, DOI 10.1046/j.1365-313x.2001.01066.x; Incerpi S, 1999, ENDOCRINOLOGY, V140, P683, DOI 10.1210/en.140.2.683; INGBAR SH, 1975, ANNU REV MED, V26, P443, DOI 10.1146/annurev.me.26.020175.002303; Fernandez-Acero FJ, 2007, ARCH MICROBIOL, V187, P207, DOI 10.1007/s00203-006-0188-3; Jia Haibo, 2011, Int J Biochem Mol Biol, V2, P47; Johnson BJ, 2005, J BIOL CHEM, V280, P4037, DOI 10.1074/jbc.M411569200; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Keeler SJ, 2000, PLANT PHYSIOL, V123, P1121, DOI 10.1104/pp.123.3.1121; Krain LP, 2004, J ENDOCRINOL, V181, P91, DOI 10.1677/joe.0.1810091; Krauke Y., 2008, BMC MICROBIOL, V8, P1, DOI DOI 10.1186/1471-2180-8-1; Kraus PR, 2003, BIOCHEM BIOPH RES CO, V311, P1151, DOI 10.1016/S0006-291X(03)01528-6; Krause KH, 1997, CELL, V88, P439, DOI 10.1016/S0092-8674(00)81884-X; LAKSHMANAN M, 1990, ENDOCRINOLOGY, V126, P3245, DOI 10.1210/endo-126-6-3245; Lee SC, 1998, MOL CELLS, V8, P698; LEONHARDT SA, 1993, MOL CELL BIOL, V13, P6304, DOI 10.1128/MCB.13.10.6304; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; MACHLIS L, 1957, J BACTERIOL, V73, P627, DOI 10.1128/JB.73.5.627-631.1957; May P, 2008, GENETICS, V179, P157, DOI 10.1534/genetics.108.088336; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; McMahon TA, 2013, P NATL ACAD SCI USA, V110, P210, DOI 10.1073/pnas.1200592110; MICHALAK M, 1992, BIOCHEM J, V285, P681, DOI 10.1042/bj2850681; Montero-Barrientos M, 2007, CURR GENET, V52, P45, DOI 10.1007/s00294-007-0140-3; Moss AS, 2010, DIS AQUAT ORGAN, V92, P149, DOI 10.3354/dao02223; Nanney LB, 2008, AM J PATHOL, V173, P610, DOI 10.2353/ajpath.2008.071027; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pugliese L, 2008, GENE, V411, P59, DOI 10.1016/j.gene.2008.01.005; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; Rosenblum EB, 2008, P NATL ACAD SCI USA, V105, P17034, DOI 10.1073/pnas.0804173105; Rosenblum EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049924; Rosenblum EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006494; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Shapiro RS, 2009, CURR BIOL, V19, P621, DOI 10.1016/j.cub.2009.03.017; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; Sun GL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-195; Sung DY, 2003, TRENDS PLANT SCI, V8, P179, DOI 10.1016/S1360-1385(03)00047-5; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tata JR, 1996, DEV GROWTH DIFFER, V38, P223; Thekkiniath JC, 2013, FUNGAL BIOL-UK, V117, P451, DOI 10.1016/j.funbio.2013.05.002; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Venesky MD, 2010, J PARASITOL, V96, P552, DOI 10.1645/GE-2353.1; Vieira ALG, 2010, EUKARYOT CELL, V9, P415, DOI 10.1128/EC.00312-09; VINCENZI FF, 1980, FED PROC, V39, P2427; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Walker SF, 2010, ECOL LETT, V13, P372, DOI 10.1111/j.1461-0248.2009.01434.x; Warwar V, 1996, APPL ENVIRON MICROB, V62, P74, DOI 10.1128/AEM.62.1.74-79.1996; White B.A., 1981, P363; WILLIAMS RJP, 1992, CELL CALCIUM, V13, P355, DOI 10.1016/0143-4160(92)90049-X; Yajima W, 2006, PROTEOMICS, V6, P5995, DOI 10.1002/pmic.200600424; Yang JK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002179; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	89	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0123637	10.1371/journal.pone.0123637	http://dx.doi.org/10.1371/journal.pone.0123637			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046527	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200004
J	Wang, JP; Chiu, CC; Yang, TH; Liu, TH; Wu, CY; Chou, P				Wang, Jen-Pang; Chiu, Chih-Chiang; Yang, Tsu-Hui; Liu, Tzong-Hsien; Wu, Chia-Yi; Chou, Pesus			The Low Proportion and Associated Factors of Involuntary Admission in the Psychiatric Emergency Service in Taiwan	PLOS ONE			English	Article							INFLUENCING COMPULSORY ADMISSION; HEALTH ACT 1983; MENTALLY-ILL; CHANGING PATTERNS; BIPOLAR DISORDER; ACUTE MANIA; AMSTERDAM; RISK; ETHNICITY; CARE	Background The involuntary admission regulated under the Mental Health Act has become an increasingly important issue in the developed countries in recent years. Most studies about the distribution and associated factors of involuntary admission were carried out in the western countries; however, the results may vary in different areas with different legal and sociocultural backgrounds. Aims The aim of this study was to investigate the proportion and associated factors of involuntary admission in a psychiatric emergency service in Taiwan. Methods The study cohort included patients admitted from a psychiatric emergency service over a two-year period. Demographic, psychiatric emergency service utilization, and clinical variables were compared between those who were voluntarily and involuntarily admitted to explore the associated factors of involuntary admission. Results Among 2,777 admitted patients, 110 (4.0%) were involuntarily admitted. Police referrals and presenting problems as violence assessed by psychiatric nurses were found to be associated with involuntary admission. These patients were more likely to be involuntarily admitted during the night shift and stayed longer in the psychiatric emergency service. Conclusions The proportion of involuntary admissions in Taiwan was in the lower range when compared to Western countries. Dangerous conditions evaluated by the psychiatric nurses and police rather than diagnosis made by the psychiatrists were related factors of involuntary admission. As it spent more time to admit involuntary patients, it was suggested that multidisciplinary professionals should be included in and educated for during the process of involuntary admission.	[Wang, Jen-Pang; Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Wang, Jen-Pang; Chou, Pesus] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Wang, Jen-Pang; Chiu, Chih-Chiang; Yang, Tsu-Hui; Liu, Tzong-Hsien] Taipei City Hosp, Taipei City Psychiat Ctr, Dept Psychiat, Taipei, Taiwan; [Wang, Jen-Pang] Natl Taipei Univ Nursing & Hlth Sci, Dept Healthcare Management, Taipei, Taiwan; [Chiu, Chih-Chiang] Taipei Med Univ, Sch Med, Dept Psychiat, Taipei, Taiwan; [Yang, Tsu-Hui] Taipei City Govt, Dept Hlth, Med Affairs Div, Taipei, Taiwan; [Wu, Chia-Yi] Natl Taiwan Univ, Coll Med, Dept Nursing, Taipei 10764, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital; National Taipei University of Nursing & Health Science (NTUNHS); Taipei Medical University; National Taiwan University	Chou, P (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan.	pschou@ym.edu.tw	WU, CHIA-YI/E-4992-2010	WU, CHIA-YI/0000-0003-1756-557X	Taipei City Hospital, Taiwan [10201-62-051]	Taipei City Hospital, Taiwan	This study was funded by Taipei City Hospital, Taiwan in 2013 (grant number: 10201-62-051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEBBINGTON PE, 1994, BRIT J PSYCHIAT, V165, P743, DOI 10.1192/bjp.165.6.743; Beveridge R., 1999, CAN J EMERG MED, V1, pS1; Bola JR, 2011, COMMUNITY MENT HLT J, V47, P603, DOI 10.1007/s10597-011-9396-7; Chen YY, 2008, LANCET, V372, P1629, DOI 10.1016/S0140-6736(08)61679-7; Chen YY, 2012, EPIDEMIOL REV, V34, P129, DOI 10.1093/epirev/mxr025; Cougnard A, 2004, SOC PSYCH PSYCH EPID, V39, P804, DOI 10.1007/s00127-004-0826-5; Davies S, 1996, BRIT MED J, V312, P533, DOI 10.1136/bmj.312.7030.533; Douzenis A, 2012, INT J SOC PSYCHIATR, V58, P172, DOI 10.1177/0020764010387477; Dressing H, 2004, SOC PSYCH PSYCH EPID, V39, P797, DOI 10.1007/s00127-004-0814-9; Fennig S, 1999, PSYCHIAT SERV, V50, P1049, DOI 10.1176/ps.50.8.1049; Hansson L, 1999, SOC PSYCH PSYCH EPID, V34, P99, DOI 10.1007/s001270050118; Hotopf M, 2000, BRIT J PSYCHIAT, V176, P479, DOI 10.1192/bjp.176.5.479; Keown P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3736; Keown P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1837; Kessell ER, 2006, PSYCHIAT SERV, V57, P1435, DOI 10.1176/appi.ps.57.10.1435; Lelliott P, 2003, BRIT J PSYCHIAT, V182, P68, DOI 10.1192/bjp.182.1.68; Lindsey MA, 2010, GEN HOSP PSYCHIAT, V32, P300, DOI 10.1016/j.genhosppsych.2010.01.007; Morgan C, 2005, BRIT J PSYCHIAT, V186, P281, DOI 10.1192/bjp.186.4.281; Mulder CL, 2008, INT J LAW PSYCHIAT, V31, P331, DOI 10.1016/j.ijlp.2008.06.007; Mulder CL, 2006, BRIT J PSYCHIAT, V188, P386, DOI 10.1192/bjp.188.4.386; Myklebust LH, 2012, NORD J PSYCHIAT, V66, P178, DOI 10.3109/08039488.2011.611252; Oluwatayo O, 2004, SOC PSYCH PSYCH EPID, V39, P739, DOI 10.1007/s00127-004-0794-9; RIECHER A, 1991, PSYCHOL MED, V21, P197, DOI 10.1017/S0033291700014781; RIECHERROSSLER A, 1993, ACTA PSYCHIAT SCAND, V87, P231, DOI 10.1111/j.1600-0447.1993.tb03363.x; Salize HJ, 2004, BRIT J PSYCHIAT, V184, P163, DOI 10.1192/bjp.184.2.163; Schuepbach D, 2008, PHARMACOPSYCHIATRY, V41, P29, DOI 10.1055/s-2007-993213; Schuepbach D, 2006, J AFFECT DISORDERS, V90, P57, DOI 10.1016/j.jad.2005.09.012; Singh SP, 1998, SOC PSYCH PSYCH EPID, V33, P39; THOMAS CS, 1993, BRIT J PSYCHIAT, V163, P91, DOI 10.1192/bjp.163.1.91; van der Post L, 2012, INT J SOC PSYCHIATR, V58, P374, DOI 10.1177/0020764011399970; van der Post L, 2009, PSYCHIAT SERV, V60, P1543, DOI 10.1176/appi.ps.60.11.1543; van der Post LFM, 2014, INT J SOC PSYCHIATR, V60, P125, DOI 10.1177/0020764012470234; van der Post LFM, 2014, SOC PSYCH PSYCH EPID, V49, P283, DOI 10.1007/s00127-013-0742-7; van der Post LFM, 2012, PSYCHIAT SERV, V63, P577, DOI 10.1176/appi.ps.201100080; Wierdsma AI, 2007, J EPIDEMIOL COMMUN H, V61, P613, DOI 10.1136/jech.2005.044974; Wierdsma Andre I, 2009, Int J Integr Care, V9, pe90; Zinkler M, 2002, ACTA PSYCHIAT SCAND, V106, P3, DOI 10.1034/j.1600-0447.2002.02268.x	37	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129204	10.1371/journal.pone.0129204	http://dx.doi.org/10.1371/journal.pone.0129204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7CR	26046529	gold, Green Published			2022-12-27	WOS:000355652200134
J	Witwicka, H; Hwang, SY; Reyes-Gutierrez, P; Jia, H; Odgren, PE; Donahue, LR; Birnbaum, MJ; Odgren, PR				Witwicka, Hanna; Hwang, Sung-Yong; Reyes-Gutierrez, Pablo; Jia, Hong; Odgren, Paul E.; Donahue, Leah Rae; Birnbaum, Mark J.; Odgren, Paul R.			Studies of OC-STAMP in Osteoclast Fusion: A New Knockout Mouse Model, Rescue of Cell Fusion, and Transmembrane Topology	PLOS ONE			English	Article							BODY GIANT-CELLS; DC-STAMP; RESORBING OSTEOCLASTS; TARTRATE-RESISTANT; ACID-PHOSPHATASE; IN-VITRO; BONE; PROTEIN; RANKL; GENE	The fusion of monocyte/macrophage lineage cells into fully active, multinucleated, bone resorbing osteoclasts is a complex cell biological phenomenon that utilizes specialized proteins. OC-STAMP, a multi-pass transmembrane protein, has been shown to be required for pre-osteoclast fusion and for optimal bone resorption activity. A previously reported knockout mouse model had only mononuclear osteoclasts with markedly reduced resorption activity in vitro, but with paradoxically normal skeletal micro-CT parameters. To further explore this and related questions, we used mouse ES cells carrying a gene trap allele to generate a second OC-STAMP null mouse strain. Bone histology showed overall normal bone form with large numbers of TRAP-positive, mononuclear osteoclasts. Micro-CT parameters were not significantly different between knockout and wild type mice at 2 or 6 weeks old. At 6 weeks, metaphyseal TRAP-positive areas were lower and mean size of the areas were smaller in knockout femora, but bone turnover markers in serum were normal. Bone marrow mononuclear cells became TRAP-positive when cultured with CSF-1 and RANKL, but they did not fuse. Expression levels of other osteoclast markers, such as cathepsin K, carbonic anhydrase II, and NFATc1, were not significantly different compared to wild type. Actin rings were present, but small, and pit assays showed a 3.5-fold decrease in area resorbed. Restoring OC-STAMP in knockout cells by lentiviral transduction rescued fusion and resorption. N- and C-termini of OC-STAMP were intracellular, and a predicted glycosylation site was shown to be utilized and to lie on an extracellular loop. The site is conserved in all terrestrial vertebrates and appears to be required for protein stability, but not for fusion. Based on this and other results, we present a topological model of OC-STAMP as a 6-transmembrane domain protein. We also contrast the osteoclast-specific roles of OC-and DC-STAMP with more generalized cell fusion mechanisms.	[Witwicka, Hanna; Hwang, Sung-Yong; Reyes-Gutierrez, Pablo; Jia, Hong; Odgren, Paul R.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01655 USA; [Odgren, Paul E.] Parallax Pictures, Princeton, MA USA; [Donahue, Leah Rae] Jackson Lab, Bar Harbor, ME 04609 USA; [Birnbaum, Mark J.] Merrimack Coll, Dept Biol, N Andover, MA 01845 USA	University of Massachusetts System; University of Massachusetts Worcester; Jackson Laboratory; Merrimack College	Odgren, PR (corresponding author), Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01655 USA.	paul.odgren@umassmed.edu			National Institute of Dental and Craniofacial Research, USA [RO1 DE 007444]; National Institute of Musculoskeletal and Skin Diseases, USA [RO1 AR061504]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE007444] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Musculoskeletal and Skin Diseases, USA; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by RO1 DE 007444 to PRO, National Institute of Dental and Craniofacial Research, USA (www.nidcr.nih.gov/), and RO1 AR061504 to PRO, National Institute of Musculoskeletal and Skin Diseases, USA (http://www.niams.nih.gov/).	Bangs PL, 1996, J CELL BIOCHEM, V61, P48, DOI 10.1002/(SICI)1097-4644(19960401)61:1<48::AID-JCB7>3.0.CO;2-2; Beamer WG, 2007, J BONE MINER RES, V22, P1187, DOI 10.1359/JBMR.070419; EKRYLANDER B, 1991, J BIOL CHEM, V266, P24684; FISHMAN GI, 1991, GENOMICS, V10, P250, DOI 10.1016/0888-7543(91)90507-B; Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200; Hartgers FC, 2001, IMMUNOGENETICS, V53, P145, DOI 10.1007/s002510100302; Hartgers FC, 2000, EUR J IMMUNOL, V30, P3585, DOI 10.1002/1521-4141(200012)30:12<3585::AID-IMMU3585>3.3.CO;2-P; Hobolt-Pedersen AS, 2014, CALCIFIED TISSUE INT, V95, P73, DOI 10.1007/s00223-014-9864-5; Hwang SY, 2012, FASEB J, V26, P1484, DOI 10.1096/fj.11-194399; Khan UA, 2013, J CELL BIOCHEM, V114, P1772, DOI 10.1002/jcb.24518; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; LINDUNGER A, 1990, BONE MINER, V10, P109, DOI 10.1016/0169-6009(90)90086-U; Lundberg P, 2007, BIOCHEM BIOPH RES CO, V352, P444, DOI 10.1016/j.bbrc.2006.11.057; Maile LA, 2011, J BONE MINER RES, V26, P2068, DOI 10.1002/jbmr.441; Mensah KA, 2010, J CELL PHYSIOL, V223, P76, DOI 10.1002/jcp.22012; Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575; Nesbitt SA, 1997, SCIENCE, V276, P266, DOI 10.1126/science.276.5310.266; Odgren PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009959; Odgren PR, 2003, CONNECT TISSUE RES, V44, P264, DOI 10.1080/03008200390181753; Oikawa T, 2012, J CELL BIOL, V197, P553, DOI 10.1083/jcb.201111116; Salo J, 1997, SCIENCE, V276, P270, DOI 10.1126/science.276.5310.270; Shin NY, 2014, J CELL BIOL, V207, P73, DOI 10.1083/jcb.201401137; Sobacchi C, 2013, NAT REV ENDOCRINOL, V9, P522, DOI 10.1038/nrendo.2013.137; Soe K, 2015, BONE, V73, P181, DOI 10.1016/j.bone.2014.12.010; Soe K, 2011, BONE, V48, P837, DOI 10.1016/j.bone.2010.11.011; Stenbeck G, 2004, J CELL SCI, V117, P827, DOI 10.1242/jcs.00935; Stenbeck G, 2014, CURR OPIN PHARMACOL, V16, P7, DOI 10.1016/j.coph.2014.01.003; Wang J, 2009, J LIPID RES, V50, P1653, DOI 10.1194/jlr.M800669-JLR200; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yang M, 2008, J CELL PHYSIOL, V215, P497, DOI 10.1002/jcp.21331; Yang MH, 2006, BLOOD, V107, P2262, DOI 10.1182/blood-2005-08-3365	31	43	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128275	10.1371/journal.pone.0128275	http://dx.doi.org/10.1371/journal.pone.0128275			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042409	Green Published, gold, Green Submitted			2022-12-27	WOS:000355701600043
J	Bar-Zeev, N; Mtunthama, N; Gordon, SB; Mwafulirwa, G; French, N				Bar-Zeev, Naor; Mtunthama, Neema; Gordon, Stephen B.; Mwafulirwa, Gershom; French, Neil			Minimum Incidence of Adult Invasive Pneumococcal Disease in Blantyre, Malawi an Urban African Setting: A Hospital Based Prospective Cohort Study	PLOS ONE			English	Article							CONJUGATE VACCINE; EPIDEMIOLOGY; CHILDREN; BACTEREMIA; REGION; ERA	Invasive pneumococcal disease causes substantial morbidity and mortality in Africa. Evaluating population level indirect impact on adult disease of pneumococcal conjugate vaccine (PCV) programmes in infants requires baseline population incidence rates but these are often lacking in areas with limited disease surveillance. We used hospital based blood culture and cerebrospinal fluid surveillance to calculate minimal incidence of invasive pneumococcal disease in the adult (>= 15 years old) population of Blantyre, a rapidly growing urban centre in southern Malawi, in the period preceding vaccine introduction. Invasive pneumococcal disease incidence in Blantyre district was high, mean 58.1 (95% confidence interval (CI): 53.7, 62.7) per 100,000 person years and peaking among 35 to 40 year olds at 108.8 (95% CI: 89.0, 131.7) mirroring the population age prevalence of HIV infection. For pneumococcal bacteraemia in urban Blantyre, mean incidence was 60.6 (95% CI: 55.2, 66.5) per 100,000 person years, peaking among 35 to 40 year olds at 114.8 (95% CI: 90.3, 143.9). We suspected that our surveillance may under-ascertain the true burden of disease, so we used location data from bacteraemic subjects and projected population estimates to calculate local sub-district incidence, then examined the impact of community level socio-demographic covariates as possible predictors of local sub-district incidence of pneumococcal and non-pneumococcal pathogenic bacteraemia. Geographic heterogeneity in incidence was marked with localised hotspots but ward level covariates apart from prison were not associated with pneumococcal bacteraemia incidence. Modelling suggests that the current sentinel surveillance system under-ascertains the true burden of disease. We outline a number of challenges to surveillance for pneumococcal disease in our low-resource setting. Subsequent surveillance in the vaccine era will have to account for geographic heterogeneity when evaluating population level indirect impact of PCV13 introduction to the childhood immunisation program.	[Bar-Zeev, Naor; Mtunthama, Neema; Mwafulirwa, Gershom; French, Neil] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Bar-Zeev, Naor; French, Neil] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Gordon, Stephen B.] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England	University of Malawi; University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool	Bar-Zeev, N (corresponding author), Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.	Naor.Bar-Zeev@liverpool.ac.uk	Bar-Zeev, Naor/ABF-8648-2021	Bar-Zeev, Naor/0000-0003-0570-4624; Mtunthama Toto, Neema/0000-0002-9047-217X; Gordon, Stephen/0000-0001-6576-1116; French, Neil/0000-0003-4814-8293	Wellcome Trust through Malawi-Liverpool-Wellcome Trust; Wellcome Trust programme grant award [WT091909/Z/10/Z]	Wellcome Trust through Malawi-Liverpool-Wellcome Trust(Wellcome Trust); Wellcome Trust programme grant award(Wellcome Trust)	This work was supported by the Wellcome Trust through its Malawi-Liverpool-Wellcome Trust core grant and through awards to NF, SBG and NM. NBZ is supported by a Wellcome Trust programme grant awarded to NF [WT091909/Z/10/Z].	Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P893; Desmond NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068163; Feikin DR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-186; Foster D, 2008, J MED MICROBIOL, V57, P480, DOI 10.1099/jmm.0.47690-0; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; Garcia LS, 2010, CLIN MICROBIOLOGY PR; Gilks CF, 1996, LANCET, V347, P718, DOI 10.1016/S0140-6736(96)90076-8; Gordon SB, 2002, AIDS, V16, P1409, DOI 10.1097/00002030-200207050-00013; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Janoff EN, 1997, MICROB DRUG RESIST, V3, P215, DOI 10.1089/mdr.1997.3.215; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Mackenzie GA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001161; MacPherson P, 2013, THESIS U LIVERPOOL; McBean AM, 2005, VACCINE, V23, P5641, DOI 10.1016/j.vaccine.2005.05.043; Mosha Fausta, 2011, Pan Afr Med J, V10 Supp 1, P14; Mtunthama N, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-137; National Statistical Office, 2011, MAL DEM HLTH SURV 20; National Statistics Office, 2009, MAL CENS POP HOUS 20; Nunes MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027929; Rudnick W, 2013, VACCINE, V31, P5863, DOI 10.1016/j.vaccine.2013.09.049; Usen S, 1998, PEDIATR INFECT DIS J, V17, P23, DOI 10.1097/00006454-199801000-00006; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914; von Gottberg A, 2013, VACCINE, V31, P4200, DOI 10.1016/j.vaccine.2013.04.077; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; World Health Organization, 2014, INT MAN AD AD ILLN I; Yin Z, 2012, AIDS, V26, P87, DOI 10.1097/QAD.0b013e32834dcf27	28	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128738	10.1371/journal.pone.0128738	http://dx.doi.org/10.1371/journal.pone.0128738			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039077	Green Accepted, Green Published, gold			2022-12-27	WOS:000355700700119
J	Hsueh, YH; Ke, WJ; Hsieh, CT; Lin, KS; Tzou, DY; Chiang, CL				Hsueh, Yi-Huang; Ke, Wan-Ju; Hsieh, Chien-Te; Lin, Kuen-Song; Tzou, Dong-Ying; Chiang, Chao-Lung			ZnO Nanoparticles Affect Bacillus subtilis Cell Growth and Biofilm Formation	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; ESCHERICHIA-COLI; OXIDE NANOPARTICLES; MASTER REGULATOR; THIN-FILMS; BACTERIAL; BIOCONTROL; EXPRESSION; TOXICITY; STRAINS	Zinc oxide nanoparticles (ZnO NPs) are an important antimicrobial additive in many industrial applications. However, mass-produced ZnO NPs are ultimately disposed of in the environment, which can threaten soil-dwelling microorganisms that play important roles in biodegradation, nutrient recycling, plant protection, and ecological balance. This study sought to understand how ZnO NPs affect Bacillus subtilis, a plant-beneficial bacterium ubiquitously found in soil. The impact of ZnO NPs on B. subtilis growth, FtsZ ring formation, cytosolic protein activity, and biofilm formation were assessed, and our results show that B. subtilis growth is inhibited by high concentrations of ZnO NPs (>= 50 ppm), with cells exhibiting a prolonged lag phase and delayed medial FtsZ ring formation. RedoxSensor and P-hag-GFP fluorescence data further show that at ZnO-NP concentrations above 50 ppm, B. subtilis reductase activity, membrane stability, and protein expression all decrease. SDSPAGE Stains-All staining results and FT-IR data further demonstrate that ZnO NPs negatively affect exopolysaccharide production. Moreover, it was found that B. subtilis biofilm surface structures became smooth under ZnO-NP concentrations of only 5-10 ppm, with concentrations <= 25 ppm significantly reducing biofilm formation activity. XANES and EXAFS spectra analysis further confirmed the presence of ZnO in co-cultured B. subtilis cells, which suggests penetration of cell membranes by either ZnO NPs or toxic Zn+ ions from ionized ZnO NPs, the latter of which may be deionized to ZnO within bacterial cells. Together, these results demonstrate that ZnO NPs can affect B. subtilis viability through the inhibition of cell growth, cytosolic protein expression, and biofilm formation, and suggest that future ZnO-NP waste management strategies would do well to mitigate the potential environmental impact engendered by the disposal of these nanoparticles.	[Hsueh, Yi-Huang] Yuan Ze Univ, Grad Sch Biotechnol & Bioengn, Taoyuan, Taiwan; [Ke, Wan-Ju] Chang Gung Univ, Grad Inst Biomed Sci, Taoyuan, Taiwan; [Ke, Wan-Ju] Chang Gung Univ, Res Ctr Bacterial Pathogenesis, Taoyuan, Taiwan; [Hsieh, Chien-Te; Lin, Kuen-Song; Tzou, Dong-Ying; Chiang, Chao-Lung] Yuan Ze Univ, Dept Chem Engn & Mat Sci, Taoyuan, Taiwan	Yuan Ze University; Chang Gung University; Chang Gung University; Yuan Ze University	Hsueh, YH (corresponding author), Yuan Ze Univ, Grad Sch Biotechnol & Bioengn, Taoyuan, Taiwan.	yihhsueh@saturn.yzu.edu.tw	Chiang, Chao-Lung/AAF-1568-2019	Chiang, Chao-Lung/0000-0002-6251-9276	Yuan Ze University, Taiwan [3070111]	Yuan Ze University, Taiwan	This work was supported by Grant 307011-1 from Yuan Ze University, Taiwan, to Yi-Huang Hsueh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajilogba CF, 2013, BIOCONTROL SCI, V18, P117, DOI 10.4265/bio.18.117; Applerot G, 2009, ADV FUNCT MATER, V19, P842, DOI 10.1002/adfm.200801081; Azam A, 2014, INT J NANOMED, V9, P2109, DOI 10.2147/IJN.S60839; Baek YW, 2011, SCI TOTAL ENVIRON, V409, P1603, DOI 10.1016/j.scitotenv.2011.01.014; Bais HP, 2004, PLANT PHYSIOL, V134, P307, DOI 10.1104/pp.103.028712; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Cawoy H, 2014, MOL PLANT MICROBE IN, V27, P87, DOI 10.1094/MPMI-09-13-0262-R; Chu F, 2006, MOL MICROBIOL, V59, P1216, DOI 10.1111/j.1365-2958.2005.05019.x; Chu SY, 2000, CERAM INT, V26, P733, DOI 10.1016/S0272-8842(00)00012-2; Dastjerdi R, 2010, COLLOID SURFACE B, V79, P5, DOI 10.1016/j.colsurfb.2010.03.029; Dutta RK, 2012, COLLOID SURFACE B, V94, P143, DOI 10.1016/j.colsurfb.2012.01.046; Feris K, 2010, LANGMUIR, V26, P4429, DOI 10.1021/la903491z; Ferreira AS, 2010, APPL ENVIRON MICROB, V76, P441, DOI 10.1128/AEM.01828-09; Foldes T, 2000, J APPL MICROBIOL, V89, P840, DOI 10.1046/j.1365-2672.2000.01184.x; Guttenplan SB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001243; He LL, 2011, MICROBIOL RES, V166, P207, DOI 10.1016/j.micres.2010.03.003; Hsueh YH, 2007, APPL ENVIRON MICROB, V73, P7225, DOI 10.1128/AEM.00690-07; Huang ZB, 2008, LANGMUIR, V24, P4140, DOI 10.1021/la7035949; Jiang W, 2009, ENVIRON POLLUT, V157, P1619, DOI 10.1016/j.envpol.2008.12.025; Jin T, 2009, J FOOD SCI, V74, pM46, DOI 10.1111/j.1750-3841.2008.01013.x; Jones N, 2008, FEMS MICROBIOL LETT, V279, P71, DOI 10.1111/j.1574-6968.2007.01012.x; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Kim SW, 2012, APPL MICROBIOL BIOT, V95, P243, DOI 10.1007/s00253-012-4153-6; Kim YS, 2005, THIN SOLID FILMS, V491, P153, DOI 10.1016/j.tsf.2005.06.013; Kobayashi K, 2007, MOL MICROBIOL, V66, P395, DOI 10.1111/j.1365-2958.2007.05923.x; Kobayashi K, 2007, J BACTERIOL, V189, P4920, DOI 10.1128/JB.00157-07; Lahlali R, 2013, PHYTOPATHOLOGY, V103, P245, DOI 10.1094/PHYTO-06-12-0123-R; Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028; Li LH, 2010, CHEM ENG J, V160, P378, DOI 10.1016/j.cej.2010.03.051; Lipovsky A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/10/105101; Lipovsky A, 2009, J PHYS CHEM C, V113, P15997, DOI 10.1021/jp904864g; Liu S, 2014, RSC ADV, V4, P4363, DOI 10.1039/c3ra46177g; Liu Y, 2009, J APPL MICROBIOL, V107, P1193, DOI 10.1111/j.1365-2672.2009.04303.x; Lynch AS, 2008, ANNU REV MED, V59, P415, DOI 10.1146/annurev.med.59.110106.132000; Ma H, 2011, ENVIRON POLLUT, V159, P1473, DOI 10.1016/j.envpol.2011.03.013; Ma HB, 2013, ENVIRON POLLUT, V172, P76, DOI 10.1016/j.envpol.2012.08.011; Manna AC, 2012, NANOANTIMICROBIALS, P151, DOI [DOI 10.1007/978-3-642-24428-5_5, 10.1007/978- 3-642-24428-5_5]; Meulenkamp EA, 1998, J PHYS CHEM B, V102, P5566, DOI 10.1021/jp980730h; Nair S, 2009, J MATER SCI-MATER M, V20, P235, DOI 10.1007/s10856-008-3548-5; Ngugi HK, 2005, BIOL CONTROL, V33, P32, DOI 10.1016/j.biocontrol.2005.01.002; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Padmavathy N, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/3/035004; Piccinno F, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1109-9; Raghupathi KR, 2011, LANGMUIR, V27, P4020, DOI 10.1021/la104825u; Reddy KM, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2742324; Salunkhe VP, 2013, J AGR FOOD CHEM, V61, P7195, DOI 10.1021/jf400528d; Santimano MC, 2013, ENVIRON MONIT ASSESS, V185, P7205, DOI 10.1007/s10661-013-3094-6; Sathiyanarayanan G, 2013, COLLOID SURFACE B, V102, P13, DOI 10.1016/j.colsurfb.2012.07.032; Wu QL, 2013, CHEMOSPHERE, V90, P1123, DOI 10.1016/j.chemosphere.2012.09.019; Xie YP, 2011, APPL ENVIRON MICROB, V77, P2325, DOI 10.1128/AEM.02149-10; YASBIN RE, 1974, J VIROL, V14, P1343, DOI 10.1128/JVI.14.6.1343-1348.1974; Zeriouh H, 2014, ENVIRON MICROBIOL, V16, P2196, DOI 10.1111/1462-2920.12271	52	56	56	4	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128457	10.1371/journal.pone.0128457	http://dx.doi.org/10.1371/journal.pone.0128457			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039692	gold, Green Published, Green Submitted			2022-12-27	WOS:000355700700103
J	Kotoula, V; Lyberopoulou, A; Papadopoulou, K; Charalambous, E; Alexopoulou, Z; Gakou, C; Lakis, S; Tsolaki, E; Lilakos, K; Fountzilas, G				Kotoula, Vassiliki; Lyberopoulou, Aggeliki; Papadopoulou, Kyriaki; Charalambous, Elpida; Alexopoulou, Zoi; Gakou, Chryssa; Lakis, Sotiris; Tsolaki, Eleftheria; Lilakos, Konstantinos; Fountzilas, George			Evaluation of Two Highly-Multiplexed Custom Panels for Massively Parallel Semiconductor Sequencing on Paraffin DNA	PLOS ONE			English	Article							DENSE SEQUENTIAL CHEMOTHERAPY; RANDOMIZED PHASE-III; BREAST-CANCER; MOLECULAR DIAGNOSIS; READ ALIGNMENT; GENERATION; MUTATIONS; EPIRUBICIN; PACLITAXEL; GENES	Background-Aim Massively parallel sequencing (MPS) holds promise for expanding cancer translational research and diagnostics. As yet, it has been applied on paraffin DNA (FFPE) with commercially available highly multiplexed gene panels (100s of DNA targets), while custom panels of low multiplexing are used for re-sequencing. Here, we evaluated the performance of two highly multiplexed custom panels on FFPE DNA. Methods Two custom multiplex amplification panels (B, 373 amplicons; T, 286 amplicons) were coupled with semiconductor sequencing on DNA samples from FFPE breast tumors and matched peripheral blood samples (n samples: 316; n libraries: 332). The two panels shared 37% DNA targets (common or shifted amplicons). Panel performance was evaluated in paired sample groups and quartets of libraries, where possible. Results Amplicon read ratios yielded similar patterns per gene with the same panel in FFPE and blood samples; however, performance of common amplicons differed between panels (p<0.001). FFPE genotypes were compared for 1267 coding and non-coding variant replicates, 999 out of which (78.8%) were concordant in different paired sample combinations. Variant frequency was highly reproducible (Spearman's rho 0.959). Repeatedly discordant variants were of high coverage /low frequency (p<0.001). Genotype concordance was (a) high, for intra-run duplicates with the same panel (mean +/- SD: 97.2 +/- 4.7, 95% CI: 94.8-99.7, p<0.001); (b) modest, when the same DNA was analyzed with different panels (mean +/- SD: 81.1 +/- 20.3, 95% CI: 66.1-95.1, p = 0.004); and (c) low, when different DNA samples from the same tumor were compared with the same panel (mean +/- SD: 59.9 +/- 24.0; 95% CI: 43.3-76.5; p = 0.282). Low coverage / low frequency variants were validated with Sanger sequencing even in samples with unfavourable DNA quality. Conclusions Custom MPS may yield novel information on genomic alterations, provided that data evaluation is adjusted to tumor tissue FFPE DNA. To this scope, eligibility of all amplicons along with variant coverage and frequency need to be assessed.	[Kotoula, Vassiliki; Lyberopoulou, Aggeliki; Papadopoulou, Kyriaki; Charalambous, Elpida; Gakou, Chryssa; Lakis, Sotiris; Tsolaki, Eleftheria; Fountzilas, George] Aristotle Univ Thessaloniki, Sch Med, Hellen Fdn Canc Res, Mol Oncol Lab, GR-54006 Thessaloniki, Greece; [Kotoula, Vassiliki] Aristotle Univ Thessaloniki, Sch Med, Dept Pathol, GR-54006 Thessaloniki, Greece; [Alexopoulou, Zoi] Hlth Data Specialists Ltd, Athens, Greece; [Lilakos, Konstantinos] Univ Athens, Sch Med, Dept Haematol, Laikon Gen Hosp, GR-11527 Athens, Greece	Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens	Kotoula, V (corresponding author), Aristotle Univ Thessaloniki, Sch Med, Hellen Fdn Canc Res, Mol Oncol Lab, GR-54006 Thessaloniki, Greece.	vkotoula@auth.gr	Fountzilas, George/ABF-2139-2020	Papadopoulou, Kyriaki/0000-0003-0389-4209; Fountzilas, George/0000-0001-8045-2186	internal Hellenic Cooperative Oncology Group (HeCOG) translational research grant (HE TRANS_BR); Greek General Secretary for Research and Technology (GSRT) Program, Research in Excellence II - European Union; Operational Program "Education & Lifelong Learning" ESPA-THALIS of the Ministry of Education, Lifelong Learning & Religious Affairs [266]	internal Hellenic Cooperative Oncology Group (HeCOG) translational research grant (HE TRANS_BR); Greek General Secretary for Research and Technology (GSRT) Program, Research in Excellence II - European Union; Operational Program "Education & Lifelong Learning" ESPA-THALIS of the Ministry of Education, Lifelong Learning & Religious Affairs	This study was supported by an internal Hellenic Cooperative Oncology Group (HeCOG) translational research grant (HE TRANS_BR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also partly supported by the Greek General Secretary for Research and Technology (GSRT) Program, Research in Excellence II, funded by 75% from the European Union and the Operational Program "Education & Lifelong Learning" ESPA-THALIS#266 of the Ministry of Education, Lifelong Learning & Religious Affairs. Health Data Specialists Ltd provided support in the form of salaries for author Z.A., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. Health Data Specialists Ltd did not provide financial support in any other form.	Beadling C, 2013, J MOL DIAGN, V15, P171, DOI 10.1016/j.jmoldx.2012.09.003; Chen GL, 2014, MOL DIAGN THER, V18, P587, DOI 10.1007/s40291-014-0115-2; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Do HD, 2013, CLIN CHEM, V59, P1376, DOI 10.1373/clinchem.2012.202390; Fang WJ, 2014, ONCOL LETT, V7, P1761, DOI 10.3892/ol.2014.2047; Fountzilas G, 2008, ANN ONCOL, V19, P853, DOI [10.1093/annonc/mdm539, 10.1093/annonc/mdm464]; Fountzilas G, 2005, ANN ONCOL, V16, P1762, DOI 10.1093/annonc/mdi366; Fountzilas G, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-515; Fu Q, 2013, INVEST OPHTH VIS SCI, V54, P4158, DOI 10.1167/iovs.13-11672; Gogas H, 2012, BREAST CANCER RES TR, V132, P609, DOI 10.1007/s10549-011-1913-4; Hadd AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/j.jmoldx.2012.11.006; Hagemann IS, 2015, CANCER-AM CANCER SOC, V121, P631, DOI 10.1002/cncr.29089; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kol N, 2013, METHODS MOL BIOL, V1038, P81, DOI 10.1007/978-1-62703-514-9_5; Kothari N, 2014, J CLIN PATHOL, V67, P764, DOI 10.1136/jclinpath-2014-202405; Kotoula V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007746; Kraus C, 2015, INT J CANCER, V136, pE559, DOI 10.1002/ijc.29149; Li H, 2012, BIOINFORMATICS, V28, P1838, DOI 10.1093/bioinformatics/bts280; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li XM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064577, 10.1371/journal.pone.0067744]; Mafficini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104979; McCall CM, 2014, J MOL DIAGN, V16, P541, DOI 10.1016/j.jmoldx.2014.06.001; Millat G, 2014, MOL DIAGN THER, V18, P533, DOI 10.1007/s40291-014-0099-y; Nikiforova MN, 2013, J CLIN ENDOCR METAB, V98, pE1852, DOI 10.1210/jc.2013-2292; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Raphael BJ, 2014, GENOME MED, V6, DOI 10.1186/gm524; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Salto-Tellez M, 2014, J PATHOL, V234, P5, DOI 10.1002/path.4365; Schaefer E, 2014, EUR J MED GENET, V57, P129, DOI 10.1016/j.ejmg.2014.02.015; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Simen BB, 2015, ARCH PATHOL LAB MED, V139, P508, DOI 10.5858/arpa.2013-0710-OA; Singh RR, 2014, BRIT J CANCER, V111, P2014, DOI 10.1038/bjc.2014.518; Singh RR, 2013, J MOL DIAGN, V15, P607, DOI 10.1016/j.jmoldx.2013.05.003; Song S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045835; Spencer DH, 2013, J MOL DIAGN, V15, P623, DOI 10.1016/j.jmoldx.2013.05.004; Stavropoulou AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058182; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Tung N, 2015, CANCER-AM CANCER SOC, V121, P25, DOI 10.1002/cncr.29010; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Wall JD, 2014, GENOME RES, V24, P1734, DOI 10.1101/gr.168393.113; Wang YL, 2014, J HUM GENET, V59, P393, DOI 10.1038/jhg.2014.40; Wong SQ, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-23; Yan B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106575; Zhang LX, 2014, ONCOLOGIST, V19, P336, DOI 10.1634/theoncologist.2013-0180	47	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128818	10.1371/journal.pone.0128818	http://dx.doi.org/10.1371/journal.pone.0128818			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039550	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700124
J	Lindenmayer, DB; Wood, J; MacGregor, C; Buckley, YM; Dexter, N; Fortescue, M; Hobbs, RJ; Catford, JA				Lindenmayer, David B.; Wood, Jeff; MacGregor, Christopher; Buckley, Yvonne M.; Dexter, Nicholas; Fortescue, Martin; Hobbs, Richard J.; Catford, Jane A.			A Long-Term Experimental Case Study of the Ecological Effectiveness and Cost Effectiveness of Invasive Plant Management in Achieving Conservation Goals: Bitou Bush Control in Booderee National Park in Eastern Australia	PLOS ONE			English	Article							MONILIFERA SSP ROTUNDATA; NEW-SOUTH-WALES; IMPACTS; WEEDS; BIODIVERSITY; COMMUNITIES; DISTURBANCE; SHRUB	Invasive plant management is often justified in terms of conservation goals, yet progress is rarely assessed against these broader goals, instead focussing on short-term reductions of the invader as a measure of success. Key questions commonly remain unanswered including whether invader removal reverses invader impacts and whether management itself has negative ecosystem impacts. We addressed these knowledge gaps using a seven year experimental investigation of Bitou Bush, Chrysanthemoides monilifera subsp. rotundata. Our case study took advantage of the realities of applied management interventions for Bitou Bush to assess whether it is a driver or passenger of environmental change, and quantified conservation benefits relative to management costs of different treatment regimes. Among treatments examined, spraying with herbicide followed by burning and subsequent respraying (spray-fire-spray) proved the most effective for reducing the number of individuals and cover of Bitou Bush. Other treatment regimes (e.g. fire followed by spraying, or two fires in succession) were less effective or even exacerbated Bitou Bush invasion. The spray-fire-spray regime did not increase susceptibility of treated areas to re-invasion by Bitou Bush or other exotic species. This regime significantly reduced plant species richness and cover, but these effects were short-lived. The spray-fire-spray regime was the most cost-effective approach to controlling a highly invasive species and facilitating restoration of native plant species richness to levels characteristic of uninvaded sites. We provide a decision tree to guide management, where recommended actions depend on the outcome of post-treatment monitoring and performance against objectives. Critical to success is avoiding partial treatments and treatment sequences that may exacerbate invasive species impacts. We also show the value of taking advantage of unplanned events, such as wildfires, to achieve management objectives at reduced cost.	[Lindenmayer, David B.; Wood, Jeff; MacGregor, Christopher; Catford, Jane A.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Lindenmayer, David B.; Wood, Jeff; MacGregor, Christopher; Catford, Jane A.] Australian Natl Univ, ARC Ctr Excellence Environm Decis, Canberra, ACT, Australia; [Lindenmayer, David B.; Wood, Jeff; MacGregor, Christopher] Australian Natl Univ, Natl Environm Res Program, Canberra, ACT, Australia; [Lindenmayer, David B.; MacGregor, Christopher] Australian Natl Univ, Terr Ecosyst Res Network, Long Term Ecol Res Network, Canberra, ACT, Australia; [Buckley, Yvonne M.] Univ Queensland, ARC Ctr Excellence Environm Decis, Brisbane, Qld, Australia; [Buckley, Yvonne M.] Univ Dublin, Sch Nat Sci, Dublin, Ireland; [Buckley, Yvonne M.] Univ Dublin, Trin Ctr Biodivers Res, Trinity Coll, Zool, Dublin, Ireland; [Dexter, Nicholas; Fortescue, Martin] Parks Australia, Dept Environm, Jervis Bay Village, Jervis Bay Terr, Australia; [Hobbs, Richard J.] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Hobbs, Richard J.] Univ Western Australia, ARC Ctr Excellence Environm Decis, Crawley, WA, Australia; [Catford, Jane A.] Univ Melbourne, Sch BioSci, Melbourne, Vic, Australia; [Catford, Jane A.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	Australian National University; Australian National University; Australian National University; Australian National University; University of Queensland; Trinity College Dublin; University of Western Australia; University of Western Australia; University of Melbourne; University of Minnesota System; University of Minnesota Twin Cities	Lindenmayer, DB (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia.	david.lindenmayer@anu.edu.au	Catford, Jane/B-9578-2012; MacGregor, Christopher/AFQ-6785-2022; Lindenmayer, David B/P-7183-2017; Buckley, Yvonne/B-1281-2008; Catford, Jane/N-1253-2019; Hobbs, Richard J/F-5883-2010	Catford, Jane/0000-0003-0582-5960; MacGregor, Christopher/0000-0002-7908-204X; Lindenmayer, David B/0000-0002-4766-4088; Buckley, Yvonne/0000-0001-7599-3201; Catford, Jane/0000-0003-0582-5960; Hobbs, Richard J/0000-0003-4047-3147	Australian Research Council [LP0989292]	Australian Research Council(Australian Research Council)	Funding for this work was provided to DBL from Australian Research Council Linkage Grant LP0989292. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair RJ, 2012, BIOLOGICAL CONTROL OF WEEDS IN AUSTRALIA, P170; Australian Government, 2011, BOOD NAT PARK DRAFT, DOI [10.1186/1475-2875-12-59, DOI 10.1186/1475-2875-12-59]; Australian Weeds Committee, 2012, BIT BUSH CHRYS MON S; Buckley YM, 2007, ECOL LETT, V10, P809, DOI 10.1111/j.1461-0248.2007.01067.x; Buckley YM, 2014, SCIENCE, V344, P975, DOI 10.1126/science.1254662; Catford JA, 2012, PERSPECT PLANT ECOL, V14, P231, DOI 10.1016/j.ppees.2011.12.002; Dexter N, 2012, ECOSYSTEMS, V15, P1363, DOI 10.1007/s10021-012-9590-7; Downey Paul O., 2009, Ecological Management & Restoration, V10, pS53, DOI 10.1111/j.1442-8903.2009.00451.x; Ens EJ, 2009, PLANT SOIL, V316, P125, DOI 10.1007/s11104-008-9765-3; Ens EJ, 2008, BIOL CONSERV, V141, P590, DOI 10.1016/j.biocon.2007.12.012; Firn J, 2010, J APPL ECOL, V47, P96, DOI 10.1111/j.1365-2664.2009.01741.x; French K, 1997, WILDLIFE RES, V24, P727, DOI 10.1071/WR96011; French Kris, 2008, Plant Protection Quarterly, V23, P24; Hamilton MA, 2010, 17 AUSTR WEEDS C CHR, P166; Lamb D, 2011, WORLD FORESTS, V8, P1, DOI 10.1007/978-90-481-9870-2; Lampert A, 2014, SCIENCE, V344, P1028, DOI 10.1126/science.1250763; Lee Y., 2006, GEN LINEAR MODELS RA; Lindenmayer D. B., 2014, BOODEREE NATL PARK J; Lindsay EA, 2005, J APPL ECOL, V42, P556, DOI 10.1111/j.1365-2664.2005.01036.x; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; Mason TJ, 2007, BIOL CONSERV, V136, P246, DOI 10.1016/j.biocon.2006.11.023; Matarczyk JA, 2002, BIOL CONSERV, V108, P133, DOI 10.1016/S0006-3207(02)00062-9; McNeely J. A., 2003, Conservation Biology in Practice, V4, P30; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Richardson D M, 2013, NOVEL ECOSYSTEMS INT, P102, DOI DOI 10.1002/9781118354186.CH11; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Roe J.J., 2013, INCREASING SOCIAL IN; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schoeman J, 2010, WEED RES, V50, P67, DOI 10.1111/j.1365-3180.2009.00753.x; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shackelford N, 2013, BIOL CONSERV, V158, P55, DOI 10.1016/j.biocon.2012.08.020; Sinden Jack, 2008, Plant Protection Quarterly, V23, P34; Sinden J, 2013, J ENVIRON MANAGE, V128, P1071, DOI 10.1016/j.jenvman.2013.06.018; Thomas Jeff, 2006, Ecological Management & Restoration, V7, P79, DOI 10.1111/j.1442-8903.2006.00262.x; Toth J., 1993, Proceedings II of the 10th Australian Weeds Conference and 14th Asian Pacific Weed Science Society Conference, Brisbane, Australia, 6-10 September, 1993, P67; Vranjic JA, 2012, AUSTRAL ECOL, V37, P78, DOI 10.1111/j.1442-9993.2011.02242.x; WEISS PW, 1984, AUST J ECOL, V9, P99, DOI 10.1111/j.1442-9993.1984.tb01348.x; Winkler M. A., 2008, BITOU BUSH MANAGEMEN; Yeates A., 2013, THESIS U QUEENSLAND	39	21	21	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128482	10.1371/journal.pone.0128482	http://dx.doi.org/10.1371/journal.pone.0128482			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039730	Green Published, gold, Green Accepted			2022-12-27	WOS:000355700700104
J	Qin, YL; Banerjee, S; Agrawal, A; Shi, HL; Banasik, M; Lin, F; Rohl, K; LaBranche, C; Montefiori, DC; Cho, MW				Qin, Yali; Banerjee, Saikat; Agrawal, Aditi; Shi, Heliang; Banasik, Marisa; Lin, Feng; Rohl, Kari; LaBranche, Celia; Montefiori, David C.; Cho, Michael W.			Characterization of a Large Panel of Rabbit Monoclonal Antibodies against HIV-1 gp120 and Isolation of Novel Neutralizing Antibodies against the V3 Loop	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VACCINE EFFICACY; STANDARDIZED ASSESSMENTS; DEPENDENT EPITOPE; IMMUNOGEN DESIGN; BROAD; DIVERSITY; IDENTIFICATION; CONFORMATION; IMMUNIZATION	We recently reported the induction of potent, cross-clade neutralizing antibodies (nAbs) against Human Immunodeficiency Virus type-1 (HIV-1) in rabbits using gp120 based on an M-group consensus sequence. To better characterize these antibodies, 93 hybridomas were generated, which represent the largest panel of monoclonal antibodies (mAbs) ever generated from a vaccinated rabbit. The single most frequently recognized epitope of the isolated mAbs was at the very C-terminal end of the protein (APTKAKRRVVEREKR), followed by the V3 loop. A total of seven anti-V3 loop mAbs were isolated, two of which (10A3 and 10A37) exhibited neutralizing activity. In contrast to 10A3 and most other anti-V3 loop nAbs, 10A37 was atypical with its epitope positioned more towards the C-terminal half of the loop. To our knowledge, 10A37 is the most potent and broadly neutralizing anti-V3 loop mAb induced by vaccination. Interestingly, all seven anti-V3 loop mAbs competed with PGT121, suggesting a possibility that early induction of potent anti-V3 loop antibodies could prevent induction of more broadly neutralizing PGT121-like antibodies that target the conserved base of the V3 loop stem.	[Qin, Yali; Banerjee, Saikat; Agrawal, Aditi; Shi, Heliang; Banasik, Marisa; Lin, Feng; Rohl, Kari; Cho, Michael W.] Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA; [Qin, Yali; Banerjee, Saikat; Agrawal, Aditi; Shi, Heliang; Banasik, Marisa; Lin, Feng; Rohl, Kari; Cho, Michael W.] Iowa State Univ, Ctr Adv Host Defenses Immunobiot & Translat Compa, Ames, IA 50011 USA; [LaBranche, Celia; Montefiori, David C.] Duke Univ, Dept Surg, Durham, NC 27710 USA	Iowa State University; Iowa State University; Duke University	Cho, MW (corresponding author), Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA.	mcho@iastate.edu	Agrawal, Aditi/GZG-6827-2022	Agrawal, Aditi/0000-0001-8731-9003; Cho, Michael/0000-0003-0522-345X	NIH [P01AI074286]; Iowa State University; NIAID-NIH [HHSN27201100016C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI074286] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Iowa State University; NIAID-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIH grant P01AI074286 and Iowa State University, and NIAID-NIH Contract # HHSN27201100016C (DCM).	Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Chen YX, 2013, J VIROL, V87, P10232, DOI 10.1128/JVI.00837-13; CONLEY AJ, 1994, J VIROL, V68, P6994, DOI 10.1128/JVI.68.11.6994-7000.1994; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; deCamp A, 2014, J VIROL, V88, P2489, DOI 10.1128/JVI.02853-13; Derby NR, 2007, VIROLOGY, V366, P433, DOI 10.1016/j.virol.2007.05.020; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; EARL PL, 1994, J VIROL, V68, P3015, DOI 10.1128/JVI.68.5.3015-3026.1994; Earl PL, 1997, J VIROL, V71, P2674, DOI 10.1128/JVI.71.4.2674-2684.1997; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Gao F, 2005, J VIROL, V79, P1154, DOI 10.1128/JVI.79.2.1154-1163.2005; Gao F, 2009, VIROLOGY, V394, P91, DOI 10.1016/j.virol.2009.07.041; Graur D, 1996, NATURE, V379, P333, DOI 10.1038/379333a0; Haynes BF, 2006, EXPERT REV VACCINES, V5, P578; Haynes BF, 2014, J ALLERGY CLIN IMMUN, V134, P3, DOI 10.1016/j.jaci.2014.04.025; Haynes BF, 2014, SCIENCE, V344, P588, DOI 10.1126/science.1254990; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; JAVAHERIAN K, 1990, SCIENCE, V250, P1590, DOI 10.1126/science.1703322; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; KNIGHT KL, 1992, ANNU REV IMMUNOL, V10, P593, DOI 10.1146/annurev.iy.10.040192.003113; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; LI WH, 1990, P NATL ACAD SCI USA, V87, P6703, DOI 10.1073/pnas.87.17.6703; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; MCKEATING JA, 1993, J VIROL, V67, P4932, DOI 10.1128/JVI.67.8.4932-4944.1993; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; MOORE JP, 1994, J VIROL, V68, P469, DOI 10.1128/JVI.68.1.469-484.1994; Novacek MJ, 1996, NATURE, V379, P299, DOI 10.1038/379299a0; Pan RM, 2013, J VIROL, V87, P10221, DOI 10.1128/JVI.00843-13; Pinheiro A, 2011, IMMUNOGENETICS, V63, P397, DOI 10.1007/s00251-011-0533-9; Popkov M, 2003, J MOL BIOL, V325, P325, DOI 10.1016/S0022-2836(02)01232-9; Qin YL, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0125-5; Qin YL, 2014, VIROLOGY, V462, P363, DOI 10.1016/j.virol.2014.06.006; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; Sehgal D, 1999, IMMUNOGENETICS, V50, P31, DOI 10.1007/s002510050683; SHOTTON C, 1995, J VIROL, V69, P222, DOI 10.1128/JVI.69.1.222-230.1995; SPIEKERPOLET H, 1995, P NATL ACAD SCI USA, V92, P9348, DOI 10.1073/pnas.92.20.9348; Sundling C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003752; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang LW, 2010, BIOCHEMISTRY-US, V49, P9032, DOI 10.1021/bi1011332; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Winstead CR, 1999, J IMMUNOL, V162, P6602; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307	60	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0128823	10.1371/journal.pone.0128823	http://dx.doi.org/10.1371/journal.pone.0128823			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039641	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700125
J	Semlali, A; Al Amri, A; Azzi, A; Al Shahrani, O; Arafah, M; Kohailan, M; Aljebreen, AM; Alharbi, O; Almadi, MA; Azzam, NA; Parine, NR; Rouabhia, M; Alanazi, MS				Semlali, Abdelhabib; Al Amri, Abdullah; Azzi, Arezki; Al Shahrani, Omair; Arafah, Maha; Kohailan, Muhammad; Aljebreen, Abdulrahman M.; Alharbi, Othman; Almadi, Majid A.; Azzam, Nahla Ali; Parine, Narasimha Reddy; Rouabhia, Mahmoud; Alanazi, Mohammad S.			Expression and New Exon Mutations of the Human Beta Defensins and Their Association on Colon Cancer Development	PLOS ONE			English	Article							DNA METHYLATION; ANTIMICROBIAL PEPTIDES; HUMAN BETA-DEFENSIN-1; MOLECULAR-ORIGINS; PROTEIN STABILITY; FAMILY; HYPERMETHYLATION; EPIGENETICS; STATISTICS; MYD88	The development of cancer involves genetic predisposition and a variety of environmental exposures. Genome-wide linkage analyses provide evidence for the significant linkage of many diseases to susceptibility loci on chromosome 8p23, the location of the human defensin gene cluster. Human beta-defensins (hBDs) are important molecules of innate immunity. This study was designed to analyze the expression and genetic variations in hBDs (hBD-1, hBD-2, hBD-3 and hBD-4) and their putative association with colon cancer. hBD gene expression and relative protein expression were evaluated by Real-Time polymerase chain reaction (qPCR) and immunohistochemistry, respectively, from 40 normal patients and 40 age-matched patients with colon cancer in Saudi Arabia. In addition, hBD polymorphisms were genotyped by exon sequencing and by promoter methylation. hBD-1, hBD-2, hBD-3 and hBD-4 basal messenger RNA expression was significantly lower in tumor tissues compared with normal tissues. Several insertion mutations were detected in different exons of the analyzed hBDs. However, no methylation in any hBDs promoters was detected because of the limited number of CpG islands in these regions. We demonstrated for the first time a link between hBD expression and colon cancer. This suggests that there is a significant link between innate immunity deregulation through disruption of cationic peptides (hBDs) and the potential development of colon cancer.	[Semlali, Abdelhabib; Al Amri, Abdullah; Al Shahrani, Omair; Kohailan, Muhammad; Parine, Narasimha Reddy; Alanazi, Mohammad S.] King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh 11451, Saudi Arabia; [Arafah, Maha; Aljebreen, Abdulrahman M.; Alharbi, Othman; Azzam, Nahla Ali] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia; [Aljebreen, Abdulrahman M.; Alharbi, Othman; Almadi, Majid A.; Azzam, Nahla Ali] King Saud Univ, King Khalid Univ Hosp, Div Gastroenterol, Riyadh, Saudi Arabia; [Almadi, Majid A.] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Div Gastroenterol, Montreal, PQ H3G 1A4, Canada; [Rouabhia, Mahmoud] Univ Laval, Fac Med, Grp Rech Ecol Buccale, Dept Stomatol, Quebec City, PQ G1K 7P4, Canada; [Azzi, Arezki] Al Imam Muhammad Ibn Saud Islamic Univ IMSIU, Coll Med, Riyadh, Saudi Arabia	King Saud University; King Saud University; King Saud University; King Khalid University Hospital; McGill University; Laval University; Imam Mohammad Ibn Saud Islamic University (IMSIU)	Semlali, A (corresponding author), King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh 11451, Saudi Arabia.	asemlali@ksu.edu.sa	Almadi, Majid A/K-7819-2017; Semlali, Abdelhabib/AAP-7043-2020; Arafah, Maha/GZM-4328-2022; Alamri, Abdullah M/C-3108-2012; Parine, Narasimha Reddy/B-7975-2011	Almadi, Majid A/0000-0001-9917-2758; Semlali, Abdelhabib/0000-0002-1643-0377; Arafah, Maha/0000-0003-4966-2358; Alamri, Abdullah M/0000-0002-3045-1350; Parine, Narasimha Reddy/0000-0002-0765-9022; Rouabhia, Mahmoud/0000-0003-2205-8281	Deanship of Scientific Research at King Saud University [RGP-VPP-260]; Fonds Emile-Beaulieu (Laval University Foundation)	Deanship of Scientific Research at King Saud University(King Saud University); Fonds Emile-Beaulieu (Laval University Foundation)	The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding the work through the research group project No: RGP-VPP-260 and by a grant from the Fonds Emile-Beaulieu (Laval University Foundation).	Al-Ahwal MS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-73; BIRKELAND SA, 1995, INT J CANCER, V60, P183, DOI 10.1002/ijc.2910600209; Brandwein-Gensler A, 2005, AM J SURG PATHOL, V29, P167; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Burstein HJ, 2008, NEW ENGL J MED, V358, P527, DOI 10.1056/NEJMe0800065; Chen XJ, 2007, EUR J IMMUNOL, V37, P434, DOI 10.1002/eji.200636379; Crovella S, 2005, CURR PROTEIN PEPT SC, V6, P7, DOI 10.2174/1389203053027593; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; Donald CD, 2003, LAB INVEST, V83, P501, DOI 10.1097/01.LAB.0000063929.61760.F6; Esteller M, 2001, CANCER RES, V61, P4689; Esteller M, 2005, ANNU REV PHARMACOL, V45, P629, DOI 10.1146/annurev.pharmtox.45.120403.095832; Esteller M, 2001, CANCER RES, V61, P3225; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Gambichler T, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-163; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gonzalgo ML, 1998, CANCER RES, V58, P1245; GREGER V, 1989, HUM GENET, V83, P155, DOI 10.1007/BF00286709; Han Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091867; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023; Harder Juergen, 2005, V86, P22, DOI 10.1159/000086650; Hoover DM, 2001, J BIOL CHEM, V276, P39021, DOI 10.1074/jbc.M103830200; Ibrahim Ezzeldin M, 2008, Saudi J Gastroenterol, V14, P178, DOI 10.4103/1319-3767.43275; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Lao VV, 2011, NAT REV GASTRO HEPAT, V8, P686, DOI 10.1038/nrgastro.2011.173; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Meng Yu-Sheng, 2013, Hua Xi Kou Qiang Yi Xue Za Zhi, V31, P514; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parsons BL, 2009, BIOMARK MED, V3, P757, DOI 10.2217/BMM.09.95; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Polyak K, 2002, CURR OPIN ONCOL, V14, P92, DOI 10.1097/00001622-200201000-00016; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Rouabhia M, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/398207; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; Scott RB, 2002, BRAIN, V125, P562, DOI 10.1093/brain/awf046; Semiali A, 2008, AM J RESP CELL MOL, V38, P202, DOI 10.1165/rcmb.2007-0031OC; Semlali A, 2011, PEPTIDES, V32, P859, DOI 10.1016/j.peptides.2011.01.020; Semlali A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052614; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Sun CQ, 2006, CANCER RES, V66, P8542, DOI 10.1158/0008-5472.CAN-06-0294; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Wang K, 2012, HEAD NECK ONCOL, V4, DOI 10.1186/1758-3284-4-41; Winter J, 2011, CANCER INVEST, V29, P196, DOI 10.3109/07357907.2010.543210; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268; Zhuravel E., 2011, Experimental Oncology, V33, P114	51	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126868	10.1371/journal.pone.0126868	http://dx.doi.org/10.1371/journal.pone.0126868			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26038828	Green Published, gold, Green Submitted			2022-12-27	WOS:000355700700039
J	Pires, R; Carvalho, T; Spurling, G; Goldenstein, S; Wainer, J; Luckie, A; Jelinek, HF; Rocha, A				Pires, Ramon; Carvalho, Tiago; Spurling, Geoffrey; Goldenstein, Siome; Wainer, Jacques; Luckie, Alan; Jelinek, Herbert F.; Rocha, Anderson			Automated Multi-Lesion Detection for Referable Diabetic Retinopathy in Indigenous Health Care	PLOS ONE			English	Article							COLOR FUNDUS PHOTOGRAPHS; IDENTIFICATION	Diabetic Retinopathy (DR) is a complication of diabetes mellitus that affects more than one-quarter of the population with diabetes, and can lead to blindness if not discovered in time. An automated screening enables the identification of patients who need further medical attention. This study aimed to classify retinal images of Aboriginal and Torres Strait Islander peoples utilizing an automated computer-based multi-lesion eye screening program for diabetic retinopathy. The multi-lesion classifier was trained on 1,014 images from the Sao Paulo Eye Hospital and tested on retinal images containing no DR-related lesion, single lesions, or multiple types of lesions from the Inala Aboriginal and Torres Strait Islander health care centre. The automated multi-lesion classifier has the potential to enhance the efficiency of clinical practice delivering diabetic retinopathy screening. Our program does not necessitate image samples for training from any specific ethnic group or population being assessed and is independent of image pre- or post-processing to identify retinal lesions. In this Aboriginal and Torres Strait Islander population, the program achieved 100% sensitivity and 88.9% specificity in identifying bright lesions, while detection of red lesions achieved a sensitivity of 67% and specificity of 95%. When both bright and red lesions were present, 100% sensitivity with 88.9% specificity was obtained. All results obtained with this automated screening program meet WHO standards for diabetic retinopathy screening.	[Pires, Ramon; Carvalho, Tiago; Goldenstein, Siome; Wainer, Jacques; Rocha, Anderson] Univ Estadual Campinas, Inst Comp, Campinas, SP, Brazil; [Spurling, Geoffrey] Queensland Hlth, Southern Queensland Ctr Excellence Aboriginal & T, Brisbane, Qld, Australia; [Spurling, Geoffrey] Sch Med, Discipline Gen Practice, Brisbane, Qld, Australia; [Luckie, Alan] Albury Eye Clin, Retinal Div, Albury, NSW, Australia; [Jelinek, Herbert F.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [Jelinek, Herbert F.] Charles Sturt Univ, Ctr Res Complex Syst, Albury, NSW, Australia; [Jelinek, Herbert F.] Charles Sturt Univ, Sch Community Hlth, Albury, NSW, Australia	Universidade Estadual de Campinas; Queensland Health; Macquarie University; Charles Sturt University; Charles Sturt University	Pires, R (corresponding author), Univ Estadual Campinas, Inst Comp, Campinas, SP, Brazil.	pires.ramon@ic.unicamp.br	Carvalho, Tiago J/F-8589-2015; Spurling, Geoffrey K/F-1783-2010; Wainer, Jacques/B-4241-2012; Jelinek, Herbert/AAQ-6825-2020; Jelinek, Herbert F/S-6779-2019; Wainer, Jacques/AAQ-6029-2021	Spurling, Geoffrey K/0000-0002-3525-4663; Wainer, Jacques/0000-0001-5201-1244; Jelinek, Herbert F/0000-0001-5457-6193; Wainer, Jacques/0000-0001-5201-1244; Pires, Ramon/0000-0002-0023-1971; Carvalho, Tiago/0000-0002-7779-1950	Microsoft Research; Sao Paulo Research Foundation FAPESP under the grant MSR-Fapesp [2008/54443-2]; Sao Paulo Research Foundation FAPESP under the grant Fapesp [2010/05647-4]; Sao Paulo Research Foundation FAPESP under the grant Samsung	Microsoft Research(Microsoft); Sao Paulo Research Foundation FAPESP under the grant MSR-Fapesp; Sao Paulo Research Foundation FAPESP under the grant Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Sao Paulo Research Foundation FAPESP under the grant Samsung(Samsung)	This work was supported in part by Microsoft Research (http://www.microsoft.com), Sao Paulo Research Foundation FAPESP (http://www.fapesp.br) under the grants MSR-Fapesp 2008/54443-2 and Fapesp 2010/05647-4, and Samsung (http://www.samsung.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2013, JAMA OPHTHALMOL, V131, P351, DOI 10.1001/jamaophthalmol.2013.1743; Abramoff MD, 2008, DIABETES CARE, V31, P193, DOI 10.2337/dc07-1312; AIHW, 2011, EYE HLTH AB TORR STR; British Diabetic Association, 1967, EPH546 BRIT DIAB ASS; Fleming AD, 2010, BRIT J OPHTHALMOL, V94, P706, DOI 10.1136/bjo.2008.149807; Giancardo L, 2011, IEEE ENG MED BIO, P5939, DOI 10.1109/IEMBS.2011.6091562; Jelinek HF, 2009, IFMBE PROC, V25, P127, DOI 10.1007/978-3-642-03891-4_34; Jelinek H. F., 2013, IEEE ENG MED BIOL SO, P5857; Jelinek HF, 2007, J OPT SOC AM A, V24, P1448, DOI 10.1364/JOSAA.24.001448; Jelinek HF, 2011, INT C IEEE ENG MED B, P127; Li YQ, 2011, TELEMED E-HEALTH, V17, P627, DOI 10.1089/tmj.2011.0004; Mitchell P., 2008, GUIDELINES MANAGEMEN; Niemeijer M, 2007, INVEST OPHTH VIS SCI, V48, P2260, DOI 10.1167/iovs.06-0996; Olson J, 2006, ROLE AUTOMATED GRADI; Osareh A, 2003, BRIT J OPHTHALMOL, V87, P1220, DOI 10.1136/bjo.87.10.1220; Patton N, 2006, PROG RETIN EYE RES, V25, P99, DOI 10.1016/j.preteyeres.2005.07.001; Pires R., 2012, 2012 XXV SIBGRAPI - Conference on Graphics, Patterns and Images (SIBGRAPI 2012), P229, DOI 10.1109/SIBGRAPI.2012.39; Pires R, 2014, IEEE ENG MED BIO, P146, DOI 10.1109/EMBC.2014.6943550; Pires R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096814; Pires R, 2013, IEEE T BIO-MED ENG, V60, P3391, DOI 10.1109/TBME.2013.2278845; Rocha A, 2012, IEEE T BIO-MED ENG, V59, P2244, DOI 10.1109/TBME.2012.2201717; Ruggeri A, 2011, IEEE ENG MED BIO, P3379, DOI 10.1109/IEMBS.2011.6090915; Scanlon PH, 2003, BRIT J OPHTHALMOL, V87, P1258, DOI 10.1136/bjo.87.10.1258; Spurling GKP, 2010, AUST NZ J PUBL HEAL, V34, pS30, DOI 10.1111/j.1753-6405.2010.00549.x; Strong K, 1998, 1 AUSTR I HLTH WELF; Taylor HR, 2001, BRIT J OPHTHALMOL, V85, P261, DOI 10.1136/bjo.85.3.261; WHO, 1989, DIAB CAR RES EUR STV	27	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0127664	10.1371/journal.pone.0127664	http://dx.doi.org/10.1371/journal.pone.0127664			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035836	Green Published, gold, Green Submitted			2022-12-27	WOS:000355699100018
J	Yan, M; Wen, J; Liang, M; Lu, YF; Kamata, M; Chen, ISY				Yan, Ming; Wen, Jing; Liang, Min; Lu, Yunfeng; Kamata, Masakazu; Chen, Irvin S. Y.			Modulation of Gene Expression by Polymer Nanocapsule Delivery of DNA Cassettes Encoding Small RNAs	PLOS ONE			English	Article							VECTORS; SYSTEM; CCR5; CURE	Small RNAs, including siRNAs, gRNAs and miRNAs, modulate gene expression and serve as potential therapies for human diseases. Delivery to target cells remains the fundamental limitation for use of these RNAs in humans. To address this challenge, we have developed a nanocapsule delivery technology that encapsulates small DNA molecules encoding RNAs into a small (30nm) polymer nanocapsule. For proof of concept, we transduced DNA expression cassettes for three small RNAs. In one application, the DNA cassette encodes an shRNA transcriptional unit that downregulates CCR5 and protects from HIV-1 infection. The DNA cassette nanocapsules were further engineered for timed release of the DNA cargo for prolonged knockdown of CCR5. Secondly, the nanocapsules provide an efficient means for delivery of gRNAs in the CRISPR/Cas9 system to mutate integrated HIV-1. Finally, delivery of microRNA-125b to mobilized human CD34+ cells enhances survival and expansion of the CD34+ cells in culture.	[Yan, Ming; Wen, Jing; Liang, Min; Chen, Irvin S. Y.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Lu, Yunfeng] Univ Calif Los Angeles, Dept Biomol & Chem Engn, Los Angeles, CA 90095 USA; [Yan, Ming; Lu, Yunfeng] Univ Calif Los Angeles, Calif NanoSyst Inst CNSI, Los Angeles, CA 90095 USA; [Kamata, Masakazu] Univ Calif Los Angeles, David Geffen Sch Med, Dept Hematol Oncol, Los Angeles, CA 90095 USA; [Yan, Ming; Wen, Jing; Kamata, Masakazu; Chen, Irvin S. Y.] Univ Calif Los Angeles, AIDS Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Chen, ISY (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	syuchen@mednet.ucla.edu	KAMATA, MASAKAZU/E-7550-2017; Wen, Jing/F-1949-2019	Wen, Jing/0000-0002-6127-6276; Kamata, Masakazu/0000-0003-0323-3742	UCLA AIDS Institute; UCLA Center for AIDS Research [AI28697]; UCLA California NanoSystems Institute; NIH [R21 AI114433]; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI114433] Funding Source: NIH RePORTER	UCLA AIDS Institute; UCLA Center for AIDS Research; UCLA California NanoSystems Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the UCLA AIDS Institute, the UCLA Center for AIDS Research (AI28697), the UCLA California NanoSystems Institute, and NIH R21 AI114433. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dosari MS, 2009, AAPS J, V11, P671, DOI 10.1208/s12248-009-9143-y; An DS, 2007, P NATL ACAD SCI USA, V104, P13110, DOI 10.1073/pnas.0705474104; Bousquet M, 2010, P NATL ACAD SCI USA, V107, P21558, DOI 10.1073/pnas.1016611107; Castanotto D, 2002, RNA, V8, P1454, DOI 10.1017/S1355838202021362; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davidson BL, 2011, NAT REV GENET, V12, P329, DOI 10.1038/nrg2968; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Holkers M, 2014, NAT METHODS, V11, P1051, DOI [10.1038/NMETH.3075, 10.1038/nmeth.3075]; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Johnston SH, 2009, J VIROL, V83, P11016, DOI 10.1128/JVI.01242-09; Jones CH, 2013, MOL PHARMACEUT, V10, P4082, DOI 10.1021/mp400467x; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Klinman DM, 1997, J IMMUNOL, V158, P3635; Li MJ, 2003, MOL THER, V8, P196, DOI 10.1016/S1525-0016(03)00165-5; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; Pang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096445; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rao DD, 2009, ADV DRUG DELIVER REV, V61, P746, DOI 10.1016/j.addr.2009.04.004; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schiffer JT, 2012, J VIROL, V86, P8920, DOI 10.1128/JVI.00052-12; Shimizu S, 2010, BLOOD, V115, P1534, DOI 10.1182/blood-2009-04-215855; Shimizu Saki, 2009, Genet Vaccines Ther, V7, P8, DOI 10.1186/1479-0556-7-8; So AYL, 2014, BLOOD, V124, P1502, DOI 10.1182/blood-2014-02-553842; Wang JB, 2014, P NATL ACAD SCI USA, V111, P13157, DOI 10.1073/pnas.1410785111; Wang WW, 2013, CURR PHARM BIOTECHNO, V14, P46; Yan M, 2012, J AM CHEM SOC, V134, P13542, DOI 10.1021/ja304649a; Yan M, 2010, NAT NANOTECHNOL, V5, P48, DOI [10.1038/NNANO.2009.341, 10.1038/nnano.2009.341]; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763	34	19	22	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0127986	10.1371/journal.pone.0127986	http://dx.doi.org/10.1371/journal.pone.0127986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035832	Green Published, gold			2022-12-27	WOS:000355699100026
J	Chen, Y; Yan, H; Song, ZQ; Chen, FR; Wang, H; Niu, J; Shi, XW; Zhang, DM; Zhang, N; Zhai, ZF; Zhong, BY; Cheng, LJ; Qian, T; Hao, F				Chen, Yan; Yan, Heng; Song, Zhiqiang; Chen, Fangru; Wang, Huan; Niu, Jun; Shi, Xiaowei; Zhang, Dongmei; Zhang, Na; Zhai, Zhifang; Zhong, Baiyu; Cheng, Liangjin; Qian, Tian; Hao, Fei			Downregulation of TNIP1 Expression Leads to Increased Proliferation of Human Keratinocytes and Severer Psoriasis-Like Conditions in an Imiquimod-Induced Mouse Model of Dermatitis	PLOS ONE			English	Article							NF-KAPPA-B; SUSCEPTIBILITY LOCI; A20-BINDING INHIBITOR; PLAQUE-FORMATION; GENE-EXPRESSION; SKIN; PROTEIN; ASSOCIATION; BINDING; CELLS	Psoriasis is a chronic, inflammatory skin disease involving both environmental and genetic factors. According to genome-wide association studies (GWAS), the TNIP1 gene, which encodes the TNF-alpha-induced protein 3-interacting protein 1 (TNIP1), is strongly linked to the susceptibility of psoriasis. TNIP1 is a widely expressed ubiquitin sensor that binds to the ubiquitin-editing protein A20 and restricts TNF- and TLR-induced signals. In our study, TNIP1 expression decreased in specimens of epidermis affected by psoriasis. Based on previous studies suggesting a role for TNIP1 in modulating cancer cell growth, we investigated its role in keratinocyte proliferation, which is clearly abnormal in psoriasis. To mimic the downregulation or upregulation of TNIP1 in HaCaT cells and primary human keratinocytes (PHKs), we used a TNIP1 specific small interfering hairpin RNA (TNIP1 shRNA) lentiviral vector or a recombinant TNIP1 (rTNIP1) lentiviral vector, respectively. Blocking TNIP1 expression increased keratinocyte proliferation, while overexpression of TNIP1 decreased keratinocyte proliferation. Furthermore, we showed that TNIP1 signaling might involve extracellular signal-regulated kinase1/2 (Erk1/2) and CCAAT/enhancer-binding protein beta (C/EBP beta) activity. Intradermal injection of TNIP1 shRNA in BALB/c mice led to exaggerated psoriatic conditions in imiquimod (IMQ)-induced psoriasis-like dermatitis. These findings indicate that TNIP1 has a protective role in psoriasis and therefore could be a promising therapeutic target.	[Chen, Yan; Yan, Heng; Song, Zhiqiang; Chen, Fangru; Wang, Huan; Niu, Jun; Shi, Xiaowei; Zhang, Dongmei; Zhang, Na; Zhai, Zhifang; Zhong, Baiyu; Cheng, Liangjin; Qian, Tian; Hao, Fei] Third Mil Med Univ, Southwest Hosp, Dept Dermatol, Chongqing, Peoples R China	Army Medical University	Hao, F (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Dermatol, Chongqing, Peoples R China.	haofei62@medmail.com.cn	zhai, zhifang/AAK-8284-2020	zhai, zhifang/0000-0003-2565-0272	National Science Foundation of China [NO 81101200]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Science Foundation of China (NO 81101200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2010, NAT PROTOC, V5, P371, DOI 10.1038/nprot.2009.241; Abbas-Terki T, 2002, HUM GENE THER, V13, P2197, DOI 10.1089/104303402320987888; Albanesi C, 2007, CLIN DERMATOL, V25, P581, DOI 10.1016/j.clindermatol.2007.08.013; Allen M, 2003, AM J HUM GENET, V73, P430; Baek SC, 2001, HUM GENE THER, V12, P1551, DOI 10.1089/10430340152480276; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Callahan JA, 2013, J IMMUNOL, V191, P535, DOI 10.4049/jimmunol.1203335; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; El Bakkouri K, 2005, J BIOL CHEM, V280, P17938, DOI 10.1074/jbc.M413588200; Flores AM, 2011, ARCH BIOCHEM BIOPHYS, V516, P58, DOI 10.1016/j.abb.2011.08.014; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Gurevich I, 2011, J HISTOCHEM CYTOCHEM, V59, P1101, DOI 10.1369/0022155411427728; Gurevich I, 2009, BIOCHEM BIOPH RES CO, V389, P409, DOI 10.1016/j.bbrc.2009.08.159; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Heyninck K, 2003, FEBS LETT, V536, P135, DOI 10.1016/S0014-5793(03)00041-3; HSU W, 1994, MOL CELL BIOL, V14, P268, DOI 10.1128/MCB.14.1.268; Huang L, 2008, ONCOGENE, V27, P6131, DOI 10.1038/onc.2008.208; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jakobsen M, 2009, MOL THER, V17, P1743, DOI 10.1038/mt.2009.141; Johansen C, 2005, BRIT J DERMATOL, V152, P37, DOI 10.1111/J.1365-2133.2004.06304.X; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Joyce CE, 2011, HUM MOL GENET, V20, P4025, DOI 10.1093/hmg/ddr331; Komine M, 2001, J INVEST DERMATOL, V116, P330, DOI 10.1046/j.1523-1747.2001.01249.x; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li CC, 2006, BIOCHEM BIOPH RES CO, V342, P300, DOI 10.1016/j.bbrc.2006.01.114; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; MCKAY IA, 1995, CLIN DERMATOL, V13, P105, DOI 10.1016/0738-081X(95)93817-8; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nanda SK, 2011, J EXP MED, V208, P1215, DOI 10.1084/jem.20102177; Olarerin-George AO, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-19; Oshima S, 2009, NATURE, V457, P906, DOI 10.1038/nature07575; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Raoul C, 2005, NAT MED, V11, P423, DOI 10.1038/nm1207; Schon MP, 2007, BRIT J DERMATOL, V157, P8, DOI 10.1111/j.1365-2133.2007.08265.x; Semizarov D, 2003, P NATL ACAD SCI USA, V100, P6347, DOI 10.1073/pnas.1131959100; Shen F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000066; Song LB, 2013, CELL RES, V23, P274, DOI 10.1038/cr.2012.174; Sun LD, 2010, NAT GENET, V42, P1005, DOI 10.1038/ng.690; Sun W, 2010, ANNU REV BIOMED ENG, P121; Tejasvi T, 2012, J INVEST DERMATOL, V132, P593, DOI 10.1038/jid.2011.376; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Verstrepen L, 2009, BIOCHEM PHARMACOL, V78, P105, DOI 10.1016/j.bcp.2009.02.009; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wohn C, 2013, P NATL ACAD SCI USA, V110, P10723, DOI 10.1073/pnas.1307569110; Woodley DT, 2004, MOL THER, V10, P318, DOI 10.1016/j.ymthe.2004.05.016; WroneSmith T, 1996, J CLIN INVEST, V98, P1878, DOI 10.1172/JCI118989; Yoshiki R, 2014, J INVEST DERMATOL, V134, P1912, DOI 10.1038/jid.2014.98; Zellmer S, 2001, HISTOCHEM CELL BIOL, V115, P41, DOI 10.1007/s004180000225; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438; Zhang DM, 2013, J RHEUMATOL, V40, P1535, DOI 10.3899/jrheum.121391; Zhang SL, 2002, BIOCHEM BIOPH RES CO, V297, P17, DOI 10.1016/S0006-291X(02)02086-7; Zhou JR, 2011, P NATL ACAD SCI USA, V108, pE998, DOI 10.1073/pnas.1106232108	57	27	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127957	10.1371/journal.pone.0127957	http://dx.doi.org/10.1371/journal.pone.0127957			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046540	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200034
J	Kirkpatrick, BW; Morris, CA				Kirkpatrick, Brian W.; Morris, Chris A.			A Major Gene for Bovine Ovulation Rate	PLOS ONE			English	Article							PREMATURE OVARIAN FAILURE; GROWTH-DIFFERENTIATION FACTOR-9; BONE MORPHOGENETIC PROTEIN-15; GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCI; SHEEP OVIS-ARIES; BMP15 GENE; CANDIDATE GENES; BOOROOLA SHEEP; LACAUNE SHEEP	Half-sib daughters sired by a bull believed to be a carrier of a major gene for high ovulation rate were evaluated for ovulation rate and genotyped in an effort to both test the hypothesis of segregation of a major gene and to map the gene's location. A total of 131 daughters were produced over four consecutive years at a University of Wisconsin-Madison research farm. All were evaluated for ovulation rate over an average of four estrous cycles using transrectal ultrasonography. The sire and all daughters were genotyped using a 3K SNP chip and the genotype and phenotype data were used in a linkage analysis. Subsequently, daughters recombinant within the QTL region and the sire were genotyped successively with 50K and 777K SNP chips to refine the location of the causative polymorphism. Positional candidate genes within the fine-mapped region were examined for polymorphism by Sanger sequencing of PCR amplicons encompassing coding and 5' and 3' flanking regions of the genes. Sire DNA was used as template in the PCR reactions. Strong evidence of a major gene for ovulation rate was observed (p<1x10(-28)) with the gene localized to bovine chromosome 10. Fine-mapping subsequently reduced the location to a 1.2 Mb region between 13.6 and 14.8 Mb on chromosome 10. The location identified does not correspond to that for any previously identified major gene for ovulation rate. This region contains three candidate genes, SMAD3, SMAD6 and IQCH. While candidate gene screening failed to identify the causative polymorphism, three polymorphisms were identified that can be used as a haplotype to track inheritance of the high ovulation rate allele in descendants of the carrier sire.	[Kirkpatrick, Brian W.] Univ Wisconsin, Dept Anim Sci, Madison, WI 53706 USA; [Morris, Chris A.] AgResearch, Ruakura Res Ctr, Hamilton, New Zealand	University of Wisconsin System; University of Wisconsin Madison; AgResearch - New Zealand	Kirkpatrick, BW (corresponding author), Univ Wisconsin, Dept Anim Sci, Madison, WI 53706 USA.	bwkirkpa@wisc.edu			Agricultural Experiment Station at the University of Wisconsin-Madison [WIS01648]	Agricultural Experiment Station at the University of Wisconsin-Madison	This work was supported by a Hatch grant (WIS01648) from the Agricultural Experiment Station at the University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barzegari A, 2010, REPROD DOMEST ANIM, V45, P666, DOI 10.1111/j.1439-0531.2008.01327.x; Bindon B M, 1986, Basic Life Sci, V37, P67; Bodin L, 2002, GENET SEL EVOL, V34, P447, DOI [10.1186/1297-9686-34-4-447, 10.1051/gse:2002017]; Bodin L, 2007, ENDOCRINOLOGY, V148, P393, DOI 10.1210/en.2006-0764; Chand AL, 2006, FERTIL STERIL, V86, P1009, DOI 10.1016/j.fertnstert.2006.02.107; Chu MX, 2007, ANIM BIOTECHNOL, V18, P263, DOI 10.1080/10495390701331114; Chu MX, 2007, J ANIM SCI, V85, P598, DOI 10.2527/jas.2006-324; Chu MX, 2004, ANIM BIOTECHNOL, V15, P111, DOI [10.1081/ABIO-200032582, 10.1081/labt-200032582]; Cobanoglu O, 2005, ANIM GENET, V36, P303, DOI 10.1111/j.1365-2052.2005.01299.x; Davis GH, 2002, BIOL REPROD, V66, P1869, DOI 10.1095/biolreprod66.6.1869; DAVIS GH, 1982, NEW ZEAL J AGR RES, V25, P525, DOI 10.1080/00288233.1982.10425216; Davis GH, 2001, BIOL REPROD, V64, P216, DOI 10.1095/biolreprod64.1.216; DAVIS GH, 1991, BIOL REPROD, V44, P620, DOI 10.1095/biolreprod44.4.620; Di Pasquale E, 2006, J CLIN ENDOCR METAB, V91, P1976, DOI 10.1210/jc.2005-2650; Di Pasquale E, 2004, AM J HUM GENET, V75, P106, DOI 10.1086/422103; Dixit H, 2006, HUM GENET, V119, P408, DOI 10.1007/s00439-006-0150-0; Dixit H, 2005, MENOPAUSE, V12, P749, DOI 10.1097/01.gme.0000184424.96437.7a; Drouilhet L, 2009, ANIM GENET, V40, P804, DOI 10.1111/j.1365-2052.2009.01919.x; Drouilhet L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003809; Echternkamp SE, 2007, J ANIM SCI, V85, P3228, DOI 10.2527/jas.2007-0209; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Ewens KG, 2010, J CLIN ENDOCR METAB, V95, P2306, DOI 10.1210/jc.2009-2703; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; Gonzalez A, 2008, FERTIL STERIL, V90, P447, DOI 10.1016/j.fertnstert.2007.06.083; Goodarzi MO, 2008, HUM REPROD, V23, P2842, DOI 10.1093/humrep/den324; Gregory KE, 1997, J ANIM SCI, V75, P1213; Hanrahan JP, 2004, BIOL REPROD, V70, P900, DOI 10.1095/biolreprod.103.023093; Inagaki K, 2010, MOL CELL ENDOCRINOL, V328, P1, DOI 10.1016/j.mce.2010.05.017; Juengel JL, 2011, BIOL REPROD, V85, P113, DOI 10.1095/biolreprod.110.090514; Khatib H, 2004, PLANT AN GEN 12 C SA, P290; Kirkpatrick BW, 1998, MAMM GENOME, V9, P97, DOI 10.1007/s003359900696; Kovanci E, 2007, FERTIL STERIL, V87, P143, DOI 10.1016/j.fertnstert.2006.05.079; Laissue P, 2006, EUR J ENDOCRINOL, V154, P739, DOI 10.1530/eje.1.02135; Monteagudo LV, 2009, ANIM REPROD SCI, V110, P139, DOI 10.1016/j.anireprosci.2008.01.005; Montgomery GW, 2004, TWIN RES, V7, P548, DOI 10.1375/1369052042663823; Morris CA, 2010, LIVEST SCI, V128, P193, DOI 10.1016/j.livsci.2009.11.009; Mulsant P, 2001, P NATL ACAD SCI USA, V98, P5104, DOI 10.1073/pnas.091577598; Nicol L, 2009, REPRODUCTION, V138, P921, DOI 10.1530/REP-09-0193; O'Shea T, 1996, P AUST SOC ANIM PROD, V21, P200; Palmer JS, 2006, J CLIN ENDOCR METAB, V91, P4713, DOI 10.1210/jc.2006-0970; Polley S, 2010, TROP ANIM HEALTH PRO, V42, P985, DOI 10.1007/s11250-009-9518-1; Scaramuzzi RJ, 2006, REPROD NUTR DEV, V46, P339, DOI 10.1051/rnd:2006016; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schneider JF, 2014, J ANIM SCI, V92, P3792, DOI 10.2527/jas.2014-7788; Schneider JF, 2012, J ANIM SCI, V90, P3360, DOI 10.2527/jas.2011-4759; Silva BDM, 2011, ANIM GENET, V42, P89, DOI 10.1111/j.1365-2052.2010.02078.x; Souza CJH, 2001, J ENDOCRINOL, V169, pR1, DOI 10.1677/joe.0.169R001; Spelman RJ, 1996, GENETICS, V144, P1799; Sproul K, 2010, BJOG-INT J OBSTET GY, V117, P756, DOI 10.1111/j.1471-0528.2010.02527.x; Teixeira FL, 2002, J CLIN ENDOCR METAB, V87, P1337, DOI 10.1210/jc.87.3.1337; Tiotiu D, 2010, HUM REPROD, V25, P1581, DOI 10.1093/humrep/deq073; Vinet AT JL, 2010, 9 MAP WORLD C GEN AP; Wang BB, 2010, REPROD BIOMED ONLINE, V21, P344, DOI 10.1016/j.rbmo.2010.04.013; Wilson T, 2001, BIOL REPROD, V64, P1225, DOI 10.1095/biolreprod64.4.1225; Ye X, 2006, POULTRY SCI, V85, P1165, DOI 10.1093/ps/85.7.1165; Zhao ZZ, 2008, HUM REPROD, V23, P2372, DOI 10.1093/humrep/den268	57	20	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129025	10.1371/journal.pone.0129025	http://dx.doi.org/10.1371/journal.pone.0129025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046917	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200117
J	Li, B; Li, W; Ahmad, H; Zhang, LL; Wang, C; Wang, T				Li, Bo; Li, Wei; Ahmad, Hussain; Zhang, Lili; Wang, Chao; Wang, Tian			Effects of Choline on Meat Quality and Intramuscular Fat in Intrauterine Growth Retardation Pigs	PLOS ONE			English	Article							IMPAIRED OXIDATIVE-PHOSPHORYLATION; DIETARY CHOLINE; SKELETAL-MUSCLE; PROGRAMMED OBESITY; FETAL; STRESS; LIVER; RESTRICTION; MODEL; GENE	The aim of this study was to investigate the effects of choline supplementation on intramuscular fat (IMF) and lipid oxidation in IUGR pigs. Twelve normal body weight (NBW) and twelve intrauterine growth retardation (IUGR) newborn piglets were collected and distributed into 4 treatments (Normal: N, Normal+Choline: N+C, IUGR: I, and IUGR+Choline: I+C) with 6 piglets in each treatment. At 23 d of age, NBW and IUGR pigs were fed basal or choline supplemented diets. The results showed that the IUGR pigs had significantly lower (P<0.05) BW as compared with the NBW pigs at 23 d, 73 d, and 120 d of age, however, there was a slight decreased (P>0.05) in BW of IUGR pigs than the NBW pigs at 200 d. Compared with the NBW pigs, pH of meat longissimus dorsi muscle was significantly lower (P<0.05), and the meat color was improved in IUGR pigs. The malondialdehyde (MDA) levels were significantly decreased (P<0.05), while triglyceride (TG) and IMF contents were significantly higher (P<0.05) in the IUGR pigs than the NBW pigs. IUGR up-regulated the mRNA gene expression of fatty acid synthetase (FAS) and acetyl-CoA carboxylase (ACC). Dietary choline significantly increased (P<0.05) the BW at 120d of age, however, significantly decreased (P<0.05) the TG and IMF contents in both IUGR and NBW pigs. FAS and sterol regulatory element-binding proteins 1 (SREBP1) mRNA gene expressions were increased (P<0.05) while the muscle-carnitine palmityl transferase (M-CPT) and peroxisome proliferators-activated receptor. (PPAR.) mRNA (P<0.05) gene expressions were decreased in the muscles of the IUGR pigs by choline supplementation. Furthermore, choline supplementation significantly increased (P<0.05) the MDA content as well as the O2 center dot scavenging activity in meat of IUGR pigs. The results suggested that IUGR pigs showed a permanent stunting effect on the growth performance, increased fat deposition and oxidative stress in muscles. However, dietary supplementation of choline improved the fat deposition via enhancing the lipogenesis and reducing the lipolysis.	[Li, Bo; Li, Wei; Ahmad, Hussain; Zhang, Lili; Wang, Chao; Wang, Tian] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Wang, T (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	tianwangnjau@163.com	Ahmad, hussain/AAP-9386-2020	Wang, Tian/0000-0002-9038-5009	National Natural Science Foundation of China [31272454]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This experiment was supported by the National Natural Science Foundation of China (Grant No. 31272454).	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Beijing animal husbandry and veterinary institute Chinese academy of agricultural sciences, DAT CHIN FEED; Best CH, 1935, J PHYSIOL-LONDON, V83, P255, DOI 10.1113/jphysiol.1935.sp003227; Cheng ZH, 2006, J AGR FOOD CHEM, V54, P7429, DOI 10.1021/jf0611668; DARRAGH AJ, 1995, J PEDIATR GASTR NUTR, V21, P387, DOI 10.1097/00005176-199511000-00004; Desai M, 2005, AM J PHYSIOL-REG I, V288, pR91, DOI 10.1152/ajpregu.00340.2004; Desai M, 2011, SEMIN REPROD MED, V29, P237, DOI 10.1055/s-0031-1275517; Dudonne S, 2009, J AGR FOOD CHEM, V57, P1768, DOI 10.1021/jf803011r; Fernandez-Figares I, 2012, ANIMAL, V6, P1058, DOI 10.1017/S1751731111002308; Fujita K, 2006, CIRC J, V70, P1437, DOI 10.1253/circj.70.1437; Fukami T, 2012, REPROD SCI, V19, P423, DOI 10.1177/1933719111424448; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Germani D, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-14; Hensley K, 2000, CARCINOGENESIS, V21, P983, DOI 10.1093/carcin/21.5.983; Hongu N, 2000, J NUTR, V130, P152, DOI 10.1093/jn/130.2.152; Jangjoo A, 2010, INDIAN J SURG, V72, P236, DOI 10.1007/s12262-010-0059-7; Karunaratne JF, 2005, J ANAT, V207, P763, DOI 10.1111/j.1469-7580.2005.00494.x; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; KENNEY JL, 1995, INT J SPORTS MED, V16, P114, DOI 10.1055/s-2007-972975; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Mehta AK, 2010, IMMUNOBIOLOGY, V215, P527, DOI 10.1016/j.imbio.2009.09.004; MERLETBENICHOU C, 1994, PEDIATR NEPHROL, V8, P175, DOI 10.1007/BF00865473; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Michel CL, 2012, J EXP ZOOL PART A, V317A, P24, DOI 10.1002/jez.714; Michel V, 2011, FOOD FUNCT, V2, P53, DOI 10.1039/c0fo00069h; MILLER ER, 1987, ANNU REV NUTR, V7, P361, DOI 10.1146/annurev.nu.07.070187.002045; Neitzke U, 2011, MICROCIRCULATION, V18, P304, DOI 10.1111/j.1549-8719.2011.00089.x; Niculescu MD, 2006, FASEB J, V20, P43, DOI 10.1096/fj.05-4707com; Niculescu MD, 2002, J NUTR, V132, p2333S, DOI 10.1093/jn/132.8.2333S; Ossani GP, 2013, FOOD FUNCT, V4, P448, DOI 10.1039/c2fo30229b; Pacelli C, 2010, J NUTR, V140, P1072, DOI 10.3945/jn.109.116673; PESTI GM, 1980, POULTRY SCI, V59, P1073, DOI 10.3382/ps.0591073; Peterside IE, 2003, AM J PHYSIOL-ENDOC M, V285, pE1258, DOI 10.1152/ajpendo.00437.2002; Puglianiello A, 2007, PEDIATR RES, V61, P433, DOI 10.1203/pdr.0b013e3180332d4e; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Redmer DA, 2004, DOMEST ANIM ENDOCRIN, V27, P199, DOI 10.1016/j.domaniend.2004.06.006; Rosenberg A, 2008, SEMIN PERINATOL, V32, P219, DOI 10.1053/j.semperi.2007.11.003; Sachan DS, 2005, J AM COLL NUTR, V24, P172, DOI 10.1080/07315724.2005.10719462; SAUNDERSON CL, 1990, BRIT J NUTR, V63, P339, DOI 10.1079/BJN19900120; Schugar RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074806; Selak MA, 2003, AM J PHYSIOL-ENDOC M, V285, pE130, DOI 10.1152/ajpendo.00322.2002; Symonds ME, 2013, ANN NUTR METAB, V62, P137, DOI 10.1159/000345598; Tryndyak V, 2012, FASEB J, V26, P4592, DOI 10.1096/fj.12-209569; Wang JJ, 2008, J NUTR, V138, P60, DOI 10.1093/jn/138.1.60; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Wu GS, 2013, J BIOL CHEM, V288, P837, DOI 10.1074/jbc.M112.415117; Wu G, 2010, ASIAN POLIT ECON SEC, P27; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Wu P, 2013, FISH SHELLFISH IMMUN, V35, P697, DOI 10.1016/j.fsi.2013.05.030; XU RJ, 1994, J PEDIATR GASTR NUTR, V18, P231, DOI 10.1097/00005176-199402000-00018; ZEISEL SH, 1981, ANNU REV NUTR, V1, P95, DOI 10.1146/annurev.nu.01.070181.000523	51	17	18	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129109	10.1371/journal.pone.0129109	http://dx.doi.org/10.1371/journal.pone.0129109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046629	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200125
J	Pester, B; Ligges, C; Leistritz, L; Witte, H; Schiecke, K				Pester, Britta; Ligges, Carolin; Leistritz, Lutz; Witte, Herbert; Schiecke, Karin			Advanced Insights into Functional Brain Connectivity by Combining Tensor Decomposition and Partial Directed Coherence	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; EVENT-RELATED-POTENTIALS; EEG DATA; MEMORY; EFFICIENT; NUMBER; FORM	Quantification of functional connectivity in physiological networks is frequently performed by means of time-variant partial directed coherence (tvPDC), based on time-variant multi-variate autoregressive models. The principle advantage of tvPDC lies in the combination of directionality, time variance and frequency selectivity simultaneously, offering a more differentiated view into complex brain networks. Yet the advantages specific to tvPDC also cause a large number of results, leading to serious problems in interpretability. To counter this issue, we propose the decomposition of multi-dimensional tvPDC results into a sum of rank-1 outer products. This leads to a data condensation which enables an advanced interpretation of results. Furthermore it is thereby possible to uncover inherent interaction patterns of induced neuronal subsystems by limiting the decomposition to several relevant channels, while retaining the global influence determined by the preceding multivariate AR estimation and tvPDC calculation of the entire scalp. Finally a comparison between several subjects is considerably easier, as individual tvPDC results are summarized within a comprehensive model equipped with subject-specific loading coefficients. A proof-of-principle of the approach is provided by means of simulated data; EEG data of an experiment concerning visual evoked potentials are used to demonstrate the applicability to real data.	[Pester, Britta; Leistritz, Lutz; Witte, Herbert; Schiecke, Karin] Univ Jena, Jena Univ Hosp, Inst Med Stat Comp Sci & Documentat, Bernstein Grp Computat Neurosci Jena, Jena, Germany; [Ligges, Carolin] Univ Jena, Jena Univ Hosp, Dept Child & Adolescent Psychiat Psychosomat Med, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Pester, B (corresponding author), Univ Jena, Jena Univ Hosp, Inst Med Stat Comp Sci & Documentat, Bernstein Grp Computat Neurosci Jena, Bachstr 18, Jena, Germany.	Britta.Pester@med.uni-jena.de	Ligges, Carolin/ABA-7581-2021	Ligges, Carolin/0000-0002-3973-0532	German Research Foundation [Wi 1166/16-1, Le 2025/6-1]; Federal Ministry of Education and Research (Germany) [01GQ1202]; Interdisciplinary Center for Clinical Research Jena [T.P. 1.2/B 307-04004]; Innovationsfonds fur Zwecke der Gleichstellung Friedrich Schiller University Jena; habilitation grant from the Hochschul- und Wissenschaftsprogramm/Thuringia	German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research (Germany)(Federal Ministry of Education & Research (BMBF)); Interdisciplinary Center for Clinical Research Jena; Innovationsfonds fur Zwecke der Gleichstellung Friedrich Schiller University Jena; habilitation grant from the Hochschul- und Wissenschaftsprogramm/Thuringia	This work was supported by the German Research Foundation under Wi 1166/16-1 and Le 2025/6-1 (www.dfg.de; HW LL), by the grant 01GQ1202 of the Federal Ministry of Education and Research (Germany, www.bmbf.de; LL), by the Interdisciplinary Center for Clinical Research Jena under T.P. 1.2/B 307-04004 (www.izkf.uniklinikumjena.de; CL), Innovationsfonds fur Zwecke der Gleichstellung Friedrich Schiller University Jena (www.uni-jena.de; CL), and by a habilitation grant from the Hochschul- und Wissenschaftsprogramm/Thuringia (personal grant for Carolin Ligges). All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson CA, 2000, CHEMOMETR INTELL LAB, V52, P1, DOI 10.1016/S0169-7439(00)00071-X; [Anonymous], 1994, J Clin Neurophysiol, V11, P111; Astolfi L, 2007, HUM BRAIN MAPP, V28, P143, DOI 10.1002/hbm.20263; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Baccala LA, 2007, DIG SIGN PROC 2007 1; Bressler SL, 2008, J NEUROSCI, V28, P10056, DOI 10.1523/JNEUROSCI.1776-08.2008; Bro R, 2003, J CHEMOMETR, V17, P274, DOI 10.1002/cem.801; Bro R, 1997, CHEMOMETR INTELL LAB, V38, P149, DOI 10.1016/S0169-7439(97)00032-4; Bro R., 1998, MULTIWAY ANAL FOOD I; Bugli C, 2007, BIOMETRICAL J, V49, P312, DOI 10.1002/bimj.200510285; BURDICK DS, 1995, CHEMOMETR INTELL LAB, V28, P229, DOI 10.1016/0169-7439(95)98599-2; CARROLL JD, 1970, PSYCHOMETRIKA, V35, P283, DOI 10.1007/BF02310791; Chen ZP, 2001, ANAL CHIM ACTA, V444, P295, DOI 10.1016/S0003-2670(01)01179-5; Cichocki A, 2009, NONNEGATIVE MATRIX A; DURELL SR, 1990, ARCH BIOCHEM BIOPHYS, V278, P148, DOI 10.1016/0003-9861(90)90243-R; Estienne F, 2001, CHEMOMETR INTELL LAB, V58, P59, DOI 10.1016/S0169-7439(01)00140-X; Faes L, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/140513; FIELD A S, 1991, Brain Topography, V3, P407, DOI 10.1007/BF01129000; Godsil C.D., 2001, ALGEBRAIC GRAPH THEO; Gomez-Herrero G, 2008, NEUROIMAGE, V43, P497, DOI 10.1016/j.neuroimage.2008.07.032; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Harshman Richard A., 1970, FDN PARAFAC PROCEDUR; Haufe S, 2013, NEUROIMAGE, V64, P120, DOI 10.1016/j.neuroimage.2012.09.036; Hitchcock FL, 1927, EXPRESSION TENSOR PO; Katzner S, 2013, CURR OPIN NEUROBIOL, V23, P202, DOI 10.1016/j.conb.2013.01.019; Kayser J, 2003, COGNITIVE BRAIN RES, V16, P11, DOI 10.1016/S0926-6410(02)00205-7; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Krijnen WP, 2008, PSYCHOMETRIKA, V73, P431, DOI 10.1007/s11336-008-9056-1; Leistritz L, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0616; Liitkepohl H, 2007, NEW INTRO MULTIPLE T; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Mecklinger A, 1996, J COGNITIVE NEUROSCI, V8, P453, DOI 10.1162/jocn.1996.8.5.453; Milde T, 2010, NEUROIMAGE, V50, P960, DOI 10.1016/j.neuroimage.2009.12.110; Miwakeichi F, 2004, NEUROIMAGE, V22, P1035, DOI 10.1016/j.neuroimage.2004.03.039; MOCKS J, 1988, BIOL PSYCHOL, V26, P199, DOI 10.1016/0301-0511(88)90020-8; Morup M, 2006, NEUROIMAGE, V29, P938, DOI 10.1016/j.neuroimage.2005.08.005; Onton J, 2006, NEUROSCI BIOBEHAV R, V30, P808, DOI 10.1016/j.neubiorev.2006.06.007; PAATERO P, 1994, ENVIRONMETRICS, V5, P111, DOI 10.1002/env.3170050203; Plomp G, 2014, NEUROIMAGE, V97, P206, DOI 10.1016/j.neuroimage.2014.04.016; Richards JE, 2004, INT J PSYCHOPHYSIOL, V54, P201, DOI 10.1016/j.ijpsycho.2004.03.009; Sakkalis V, 2011, COMPUT BIOL MED, V41, P1110, DOI 10.1016/j.compbiomed.2011.06.020; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Schulte-Korne G, 2004, NEUROREPORT, V15, P1075, DOI 10.1097/01.wnr.000012338787650.e2; Sidiropoulos ND, 2000, J CHEMOMETR, V14, P229, DOI 10.1002/1099-128X(200005/06)14:3<229::AID-CEM587>3.0.CO;2-N; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Wacker M, 2011, IEEE T BIO-MED ENG, V58, P3069, DOI 10.1109/TBME.2011.2160640; Wang KM, 2000, BRAIN TOPOGR, V12, P263, DOI 10.1023/A:1023455404934; Weis M, 2009, INT CONF ACOUST SPEE, P349, DOI 10.1109/ICASSP.2009.4959592	49	12	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129293	10.1371/journal.pone.0129293	http://dx.doi.org/10.1371/journal.pone.0129293			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7CR	26046537	Green Published, gold, Green Submitted			2022-12-27	WOS:000355652200144
J	Platel, M; Goldar, A; Wiggins, JM; Barbosa, P; Libeau, P; Priam, P; Narassimprakash, H; Grodzenski, X; Marheineke, K				Platel, Marie; Goldar, Arach; Wiggins, Jennifer M.; Barbosa, Pedro; Libeau, Pierre; Priam, Pierre; Narassimprakash, Hemalatha; Grodzenski, Xenia; Marheineke, Kathrin			Tight Chk1 Levels Control Replication Cluster Activation in Xenopus	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; S-PHASE CHECKPOINT; REPLICON CLUSTERS; FORK PROGRESSION; PROTEIN-KINASE; FIRING TIME; ATR; ORIGINS; INITIATION; TARGETS	DNA replication in higher eukaryotes initiates at thousands of origins according to a spatio-temporal program. The ATR/Chk1 dependent replication checkpoint inhibits the activation of later firing origins. In the Xenopus in vitro system initiations are not sequence dependent and 2-5 origins are grouped in clusters that fire at different times despite a very short S phase. We have shown that the temporal program is stochastic at the level of single origins and replication clusters. It is unclear how the replication checkpoint inhibits late origins but permits origin activation in early clusters. Here, we analyze the role of Chk1 in the replication program in sperm nuclei replicating in Xenopus egg extracts by a combination of experimental and modelling approaches. After Chk1 inhibition or immunodepletion, we observed an increase of the replication extent and fork density in the presence or absence of external stress. However, overexpression of Chk1 in the absence of external replication stress inhibited DNA replication by decreasing fork densities due to lower Cdk2 kinase activity. Thus, Chk1 levels need to be tightly controlled in order to properly regulate the replication program even during normal S phase. DNA combing experiments showed that Chk1 inhibits origins outside, but not inside, already active clusters. Numerical simulations of initiation frequencies in the absence and presence of Chk1 activity are consistent with a global inhibition of origins by Chk1 at the level of clusters but need to be combined with a local repression of Chk1 action close to activated origins to fit our data.	[Platel, Marie; Goldar, Arach; Wiggins, Jennifer M.; Barbosa, Pedro; Libeau, Pierre; Priam, Pierre; Narassimprakash, Hemalatha; Grodzenski, Xenia; Marheineke, Kathrin] Paris South Univ, CEA, CNRS, Dept Genome Biol,Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Marheineke, K (corresponding author), Paris South Univ, CEA, CNRS, Dept Genome Biol,Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France.	kathrin.marheineke@cgm.cnrs-gif.fr		WIGGINS, JENNIFER/0000-0002-5196-2299; Marheineke, Kathrin/0000-0002-1514-0167	"Fondation pour la recherche contre le Cancer" [SFI20111203831]; LIGUE contre le cancer [5FI10137LJMK]; Paris-South University; Ministery for Education, Research and Technology	"Fondation pour la recherche contre le Cancer"; LIGUE contre le cancer(Ligue nationale contre le cancer); Paris-South University; Ministery for Education, Research and Technology	This work was supported by the "Fondation pour la recherche contre le Cancer, SFI20111203831, (http://www.fondation-arc.org/)" and "LIGUE contre le cancer," 5FI10137LJMK, (http://www.ligue-cancer.net/) for KM lab. M.P. has a PhD-fellowship of the Paris-South University and the Ministery for Education, Research and Technology (http://www.enseignementsup-recherche.gouv.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezney R, 2000, CHROMOSOMA, V108, P471, DOI 10.1007/s004120050399; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; BLOW JJ, 1988, NATURE, V332, P546, DOI 10.1038/332546a0; Blow JJ, 2001, J CELL BIOL, V152, P15, DOI 10.1083/jcb.152.1.15; Busby EC, 2000, CANCER RES, V60, P2108; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Conn CW, 2004, DEV CELL, V7, P275, DOI 10.1016/j.devcel.2004.07.003; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; Gaggioli V, 2013, NUCLEIC ACIDS RES, V41, P7313, DOI 10.1093/nar/gkt494; Ge XQ, 2010, J CELL BIOL, V191, P1285, DOI 10.1083/jcb.201007074; Goldar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005899; Goldar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002919; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Guo C, 2015, MOL CELL, V57, P492, DOI 10.1016/j.molcel.2014.12.003; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Han XZ, 2014, J BIOL CHEM, V289, P24716, DOI 10.1074/jbc.M114.575035; Herrick J, 2002, J MOL BIOL, V320, P741, DOI 10.1016/S0022-2836(02)00522-3; Hoglund A, 2011, CLIN CANCER RES, V17, P7067, DOI 10.1158/1078-0432.CCR-11-1198; Hyrien O, 2003, BIOESSAYS, V25, P116, DOI 10.1002/bies.10208; HYRIEN O, 1993, EMBO J, V12, P4511, DOI 10.1002/j.1460-2075.1993.tb06140.x; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Katsuno Y, 2009, P NATL ACAD SCI USA, V106, P3184, DOI 10.1073/pnas.0809350106; Knott SRV, 2012, CELL, V148, P99, DOI 10.1016/j.cell.2011.12.012; Krasinska L, 2008, EMBO J, V27, P758, DOI 10.1038/emboj.2008.16; Kumagai A, 1998, J CELL BIOL, V142, P1559, DOI 10.1083/jcb.142.6.1559; Labit H, 2008, NUCLEIC ACIDS RES, V36, P5623, DOI 10.1093/nar/gkn533; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Lemaitre JM, 2005, CELL, V123, P787, DOI 10.1016/j.cell.2005.08.045; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lopez-Contreras AJ, 2012, J EXP MED, V209, P455, DOI 10.1084/jem.20112147; Luciani MG, 2004, J CELL SCI, V117, P6019, DOI 10.1242/jcs.01400; MacDougall CA, 2007, GENE DEV, V21, P898, DOI 10.1101/gad.1522607; Marheineke K, 2004, J BIOL CHEM, V279, P28071, DOI 10.1074/jbc.M401574200; Marheineke K, 2001, J BIOL CHEM, V276, P17092, DOI 10.1074/jbc.M100271200; Marheineke Kathrin, 2009, V521, P575, DOI [10.1007/978-1-60327-817-5_33, 10.1007/978-1-60327-815-7_33]; Marsolier MC, 2000, GENETICS, V154, P1523; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Maya-Mendoza A, 2007, EMBO J, V26, P2719, DOI 10.1038/sj.emboj.7601714; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; Murphy CM, 2013, J BIOL CHEM, V288, P29382, DOI 10.1074/jbc.M113.499012; NEWPORT J, 1989, J CELL SCI, P149; Oza V, 2012, J MED CHEM, V55, P5130, DOI 10.1021/jm300025r; Peng A, 2007, MOL CELL BIOL, V27, P6852, DOI 10.1128/MCB.00195-07; Petermann E, 2006, MOL CELL BIOL, V26, P3319, DOI 10.1128/MCB.26.8.3319-3326.2006; Rhind N, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010132; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Shimada K, 2002, GENE DEV, V16, P3236, DOI 10.1101/gad.239802; Shimuta K, 2002, EMBO J, V21, P3694, DOI 10.1093/emboj/cdf357; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Sive Hazel L, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4737; Smits VAJ, 2006, CURR BIOL, V16, P150, DOI 10.1016/j.cub.2005.11.066; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Taricani L, 2009, CELL CYCLE, V8, P482, DOI 10.4161/cc.8.3.7661; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Trenz K, 2008, EMBO J, V27, P876, DOI 10.1038/emboj.2008.29; Verlinden L, 2007, CANCER RES, V67, P6574, DOI 10.1158/0008-5472.CAN-06-3545; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Yekezare M, 2013, J CELL SCI, V126, P1297, DOI 10.1242/jcs.096701; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	63	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129090	10.1371/journal.pone.0129090	http://dx.doi.org/10.1371/journal.pone.0129090			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046346	gold, Green Published, Green Submitted			2022-12-27	WOS:000355652200123
J	Zhbanov, A; Yang, S				Zhbanov, Alexander; Yang, Sung			Effects of Aggregation on Blood Sedimentation and Conductivity	PLOS ONE			English	Article							ERYTHROCYTE SEDIMENTATION; HEMATOCRIT; FLOW; TEMPERATURE; RESISTIVITY; SUSPENSIONS; MECHANISM; VISCOSITY; IMPEDANCE; BEDS	The erythrocyte sedimentation rate (ESR) test has been used for over a century. The Westergren method is routinely used in a variety of clinics. However, the mechanism of erythrocyte sedimentation remains unclear, and the 60 min required for the test seems excessive. We investigated the effects of cell aggregation during blood sedimentation and electrical conductivity at different hematocrits. A sample of blood was drop cast into a small chamber with two planar electrodes placed on the bottom. The measured blood conductivity increased slightly during the first minute and decreased thereafter. We explored various methods of enhancing or retarding the erythrocyte aggregation. Using experimental measurements and theoretical calculations, we show that the initial increase in blood conductivity was indeed caused by aggregation, while the subsequent decrease in conductivity resulted from the deposition of erythrocytes. We present a method for calculating blood conductivity based on effective medium theory. Erythrocytes are modeled as conducting spheroids surrounded by a thin insulating membrane. A digital camera was used to investigate the erythrocyte sedimentation behavior and the distribution of the cell volume fraction in a capillary tube. Experimental observations and theoretical estimations of the settling velocity are provided. We experimentally demonstrate that the disaggregated cells settle much slower than the aggregated cells. We show that our method of measuring the electrical conductivity credibly reflected the ESR. The method was very sensitive to the initial stage of aggregation and sedimentation, while the sedimentation curve for the Westergren ESR test has a very mild slope in the initial time. We tested our method for rapid estimation of the Westergren ESR. We show a correlation between our method of measuring changes in blood conductivity and standard Westergren ESR method. In the future, our method could be examined as a potential means of accelerating ESR tests in clinical practice.	[Zhbanov, Alexander; Yang, Sung] Gwangju Inst Sci & Technol, Dept Med Syst Engn, Gwangju, South Korea; [Yang, Sung] Gwangju Inst Sci & Technol, Sch Mechatron, Gwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Yang, S (corresponding author), Gwangju Inst Sci & Technol, Dept Med Syst Engn, Gwangju, South Korea.	syang@gist.ac.kr	Zhbanov, Alexander/AAC-7537-2022	Zhbanov, Alexander/0000-0003-2336-5494	Ministry of Education, Science and Technology (MEST) [KRF-20110028861]; institute of Medical System Engineering (iMSE) at the Gwangju Institute of Science and Technology (GIST), Republic of Korea	Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); institute of Medical System Engineering (iMSE) at the Gwangju Institute of Science and Technology (GIST), Republic of Korea	This work was funded by grants from the Ministry of Education, Science and Technology (MEST, KRF-20110028861) and the institute of Medical System Engineering (iMSE) at the Gwangju Institute of Science and Technology (GIST), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexy T, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3212564; An R, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4867557; Antonova N, 2010, CLIN HEMORHEOL MICRO, V45, P253, DOI 10.3233/CH-2010-1310; Antonova N, 2010, IFMBE P SERIES, V29, P647; Asami K, 2002, PROG POLYM SCI, V27, P1617, DOI 10.1016/S0079-6700(02)00015-1; Asami K, 2007, J PHYS D APPL PHYS, V40, P2197, DOI 10.1088/0022-3727/40/7/051; Bruggeman DAG, 1935, ANN PHYS-BERLIN, V24, P636, DOI 10.1002/andp.19354160705; CHA K, 1994, PHYSIOL MEAS, V15, P499, DOI 10.1088/0967-3334/15/4/011; DIFELICE R, 1995, CHEM ENG SCI, V50, P1213, DOI 10.1016/0009-2509(95)98838-6; Elad D, 2003, STANDARD HDB BIOMEDI; Elsner R, 2004, MAR MAMMAL SCI, V20, P339, DOI 10.1111/j.1748-7692.2004.tb01163.x; FABRY TL, 1987, BLOOD, V70, P1572; Fahraeus R, 1918, BIOCHEM Z, V89, P355; GEDDES LA, 1976, MED BIOL ENG, V14, P180, DOI 10.1007/BF02478745; Giordano S, 2003, J ELECTROSTAT, V58, P59, DOI 10.1016/S0304-3886(02)00199-7; Giordano S, 2008, EUR PHYS J B, V66, P29, DOI 10.1140/epjb/e2008-00382-7; Grzybowski A, 2011, J RHEUMATOL, V38, P1521, DOI 10.3899/jrheum.101312; Hawkins BG, 2011, ANAL CHEM, V83, P3507, DOI 10.1021/ac2002017; HILL DW, 1975, MED BIOL ENG, V13, P182, DOI 10.1007/BF02477725; HIRSCH FG, 1950, BLOOD, V5, P1017, DOI 10.1182/blood.V5.11.1017.1017; IDONUMA A, 1994, JPN J APPL PHYS 1, V33, P2128, DOI 10.1143/JJAP.33.2128; Jou JM, 2011, INT J LAB HEMATOL, V33, P125, DOI 10.1111/j.1751-553X.2011.01302.x; Kaliviotis E, 2010, CLIN HEMORHEOL MICRO, V44, P43, DOI 10.3233/CH-2009-1251; KENNER T, 1989, BASIC RES CARDIOL, V84, P111, DOI 10.1007/BF01907921; KERNICK D, 1974, CAN J PHYSIOL PHARM, V52, P1167, DOI 10.1139/y74-152; Kesmarky G, 2008, CLIN HEMORHEOL MICRO, V39, P243, DOI 10.3233/CH-2008-1088; Kim M, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4871706; Kim M, 2012, BIOSENS BIOELECTRON, V35, P416, DOI 10.1016/j.bios.2012.02.010; Leonard KM, 2011, ELECTROPHORESIS, V32, P2512, DOI 10.1002/elps.201100077; Loth E, 2008, POWDER TECHNOL, V182, P342, DOI 10.1016/j.powtec.2007.06.001; MOHAPATRA SN, 1975, EUR J INTEN CARE MED, V1, P153, DOI 10.1007/BF00624433; Neu B, 2008, BIOPHYS J, V95, P3059, DOI 10.1529/biophysj.108.130328; Nguyen NQ, 2005, J FLUID MECH, V525, P73, DOI 10.1017/S0022112004002563; OKA S, 1985, BIORHEOLOGY, V22, P315; Pribush A, 2011, INT J LAB HEMATOL, V33, P251, DOI 10.1111/j.1751-553X.2010.01277.x; Pribush A, 2010, COLLOID SURFACE B, V75, P224, DOI 10.1016/j.colsurfb.2009.08.037; Pribush A, 2010, COLLOID SURFACE B, V75, P214, DOI 10.1016/j.colsurfb.2009.08.036; Pribush A, 2011, COLLOID SURFACE B, V82, P518, DOI 10.1016/j.colsurfb.2010.10.010; PUCCINI C, 1977, BIORHEOLOGY, V14, P43; Richardson J.F., 1954, T I CHEM ENG-LOND, V32, P35, DOI DOI 10.1016/S0263-8762(97)80006-8; SANDBERG K, 1981, PEDIATR RES, V15, P964, DOI 10.1203/00006450-198106000-00017; SCHMIDSCHONBEIN H, 1973, RES EXP MED, V161, P58, DOI 10.1007/BF01851023; Schwan H., 1948, COLLOID POLYM SCI, V111, P53; Sethu P, 2006, LAB CHIP, V6, P83, DOI 10.1039/b512049g; Shteinshnaider M, 2010, EUR J INTERN MED, V21, P226, DOI 10.1016/j.ejim.2010.02.002; Thelen TV, 1997, CHEM ENG SCI, V52, P3333, DOI 10.1016/S0009-2509(97)00149-8; VISSER KR, 1992, MED BIOL ENG COMPUT, V30, P636, DOI 10.1007/BF02446796; Vykoukal DM, 2009, INTEGR BIOL-UK, V1, P477, DOI 10.1039/b906137a; Westergren A., 1921, ACTA MED SCAND, V54, P247, DOI DOI 10.1111/J.0954-6820.1921.TB15179.X; YAGUPSKY P, 1987, PEDIATR INFECT DIS J, V6, P494; Yang JZ, 2003, CHEM ENG J, V92, P7, DOI 10.1016/S1385-8947(02)00084-0; ZHAO TX, 1993, BIOCHIM BIOPHYS ACTA, V1153, P243, DOI 10.1016/0005-2736(93)90411-R; Zhbanov A, 2012, 6 INT C QUANT NAN MI, P18	54	48	50	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129337	10.1371/journal.pone.0129337	http://dx.doi.org/10.1371/journal.pone.0129337			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047511	Green Published, Green Submitted, gold			2022-12-27	WOS:000355652200152
J	Ariza, X; Sola, E; Elia, C; Barreto, R; Moreira, R; Morales-Ruiz, M; Graupera, I; Rodriguez, E; Huelin, P; Sole, C; Fernandez, J; Jimenez, W; Arroyo, V; Ginses, P				Ariza, Xavier; Sola, Elsa; Elia, Chiara; Barreto, Rogelio; Moreira, Rebeca; Morales-Ruiz, Manuel; Graupera, Isabel; Rodriguez, Ezequiel; Huelin, Patricia; Sole, Cristina; Fernandez, Javier; Jimenez, Wladimiro; Arroyo, Vicente; Ginses, Pere			Analysis of a Urinary Biomarker Panel for Clinical Outcomes Assessment in Cirrhosis	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; ACUTE KIDNEY INJURY; CHRONIC LIVER-FAILURE; DIFFERENTIAL-DIAGNOSIS; ACUTE DECOMPENSATION; CARDIAC-SURGERY; EXPRESSION; OSTEOPONTIN; IMPAIRMENT; MANAGEMENT	Background Biomarkers are potentially useful in assessment of outcomes in patients with cirrhosis, but information is very limited. Given the large number of biomarkers, adequate choice of which biomarker(s) to investigate first is important. Aim Analysis of potential usefulness of a panel of urinary biomarkers in outcome assessment in cirrhosis. Patients and Methods Fifty-five patients with acute decompensation of cirrhosis were studied: 39 had Acute Kidney Injury (AKI) (Prerenal 12, type-1 HRS (hepatorenal syndrome) 15 and Acute Tubular Necrosis (ATN) 12) and 16 acute decompensation without AKI. Thirty-four patients had Acute-on-chronic liver failure (ACLF). A panel of 12 urinary biomarkers was assessed, using a multiplex assay, for their relationship with ATN, ACLF and mortality. Results Biomarker with best accuracy for ATN diagnosis was NGAL (neutrophil-gelatinase associated lipocalin): 36 [26-125], 104 [58-208] and 1807 [494-3,716] mu g/g creatinine in Prerenal-AKI, type-1 HRS and ATN, respectively; p<0.0001 (AUROC 0.957). Other attractive biomarkers for ATN diagnosis were IL-18, albumin, trefoil-factor-3 (TFF-3) and glutathione-S-transferase-p (GST-p) Biomarkers with less accuracy for ATN AUCROC<0.8 were beta 2-microglobulin, calbindin, cystatin-C, clusterin and KIM-1 (kidney injury molecule-1). For ACLF, the biomarker with the best accuracy was NGAL (ACLF vs. No-ACLF: 165 [67-676] and 32 [19-40] mu g/g creatinine; respectively; p<0.0001; AUROC 0.878). Interestingly, other biomarkers with high accuracy for ACLF were osteopontin, albumin, and TFF-3. Biomarkers with best accuracy for prognosis were those associated with ACLF. Conclusions A number of biomarkers appear promising for differential diagnosis between ATN and other types of AKI. The most interesting biomarkers for ACLF and prognosis are NGAL, osteopontin, albumin, and TFF-3. These results support the role of major inflammatory reaction in the pathogenesis of ACLF.	[Ariza, Xavier; Sola, Elsa; Elia, Chiara; Barreto, Rogelio; Moreira, Rebeca; Graupera, Isabel; Rodriguez, Ezequiel; Huelin, Patricia; Sole, Cristina; Fernandez, Javier; Arroyo, Vicente; Ginses, Pere] Univ Barcelona, Hosp Clin, Liver Unit, Barcelona, Catalunya, Spain; [Ariza, Xavier; Sola, Elsa; Elia, Chiara; Barreto, Rogelio; Moreira, Rebeca; Morales-Ruiz, Manuel; Graupera, Isabel; Rodriguez, Ezequiel; Huelin, Patricia; Sole, Cristina; Fernandez, Javier; Jimenez, Wladimiro; Arroyo, Vicente; Ginses, Pere] Inst Invest Biomed August Pi Sunyer IDIBAPS, Barcelona, Spain; [Ariza, Xavier; Sola, Elsa; Elia, Chiara; Barreto, Rogelio; Moreira, Rebeca; Morales-Ruiz, Manuel; Graupera, Isabel; Rodriguez, Ezequiel; Huelin, Patricia; Sole, Cristina; Fernandez, Javier; Jimenez, Wladimiro; Arroyo, Vicente; Ginses, Pere] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Ariza, Xavier; Sola, Elsa; Elia, Chiara; Barreto, Rogelio; Moreira, Rebeca; Graupera, Isabel; Rodriguez, Ezequiel; Huelin, Patricia; Sole, Cristina; Fernandez, Javier; Arroyo, Vicente; Ginses, Pere] IRSIN, Barcelona, Spain; [Morales-Ruiz, Manuel; Jimenez, Wladimiro] Univ Barcelona, Hosp Clin, Dept Biochem & Mol Genet, Barcelona, Catalunya, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona	Ginses, P (corresponding author), Univ Barcelona, Hosp Clin, Liver Unit, Barcelona, Catalunya, Spain.	pgines@clinic.ub.es	Morales-Ruiz, Manuel/L-1031-2014; Gines, Pere/B-6646-2009; Morales-Ruiz, Manuel/AAM-1487-2020; Ginès, Pere/C-7730-2014; Morales-Ruiz, Manuel/Z-2332-2019; Arroyo, Vicente/F-9189-2015	Morales-Ruiz, Manuel/0000-0002-9074-2272; Gines, Pere/0000-0003-4657-4504; Ginès, Pere/0000-0003-4657-4504; Morales-Ruiz, Manuel/0000-0002-9074-2272; SOLA, ELSA/0000-0001-6897-2760; Sole, Cristina/0000-0002-6104-8345; huelin alvarez, patricia/0000-0003-2340-4772; Rodriguez, Ezequiel/0000-0001-8578-0699; Jimenez, Wladimiro/0000-0002-9376-0214; Graupera, Isabel/0000-0001-9170-9784; Arroyo, Vicente/0000-0002-2728-1848	ISCIII-Subdireccion General de Evaluacion and European Regional Development Fund (ERDF); CIBEReHD; Fondo de Investigacion Sanitaria Carlos III;  [PI08/0126];  [PI12/00330]	ISCIII-Subdireccion General de Evaluacion and European Regional Development Fund (ERDF); CIBEReHD; Fondo de Investigacion Sanitaria Carlos III; ; 	Part of the work reported in this study has been funded by the project PI08/0126 and also PI12/00330, integrated in the Plan Nacional I+D+I and cofunded by ISCIII-Subdireccion General de Evaluacion and European Regional Development Fund (ERDF) with both grants awarded to Pere Gines. Additional funding was provided by CIBEReHD and Fondo de Investigacion Sanitaria Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamann L, 2014, WORLD J GASTROENTERO, V20, P3223, DOI 10.3748/wjg.v20.i12.3223; Ariza X, 2014, J HEPATOL, V60, pS30, DOI 10.1016/S0168-8278(14)60076-3; Bai Jane P F, 2011, AAPS J, V13, P274, DOI 10.1208/s12248-011-9265-x; Barreto R, 2014, J HEPATOL, V61, P35, DOI 10.1016/j.jhep.2014.02.023; Belcher JM, 2014, CLIN J AM SOC NEPHRO, V9, P1857, DOI 10.2215/CJN.09430913; Belcher JM, 2014, HEPATOLOGY, V60, P622, DOI 10.1002/hep.26980; Borkham-Kamphorst E, 2013, BBA-MOL BASIS DIS, V1832, P660, DOI 10.1016/j.bbadis.2013.01.014; Borkham-Kamphorst E, 2011, LIVER INT, V31, P656, DOI 10.1111/j.1478-3231.2011.02495.x; Cardenas A, 2013, ACP MEDICINE; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Fagundes C, 2013, J HEPATOL, V59, P474, DOI 10.1016/j.jhep.2013.04.036; Fagundes C, 2012, J HEPATOL, V57, P267, DOI 10.1016/j.jhep.2012.03.015; Gines P, 2012, J HEPATOL, V56, pS13, DOI 10.1016/S0168-8278(12)60003-8; Gines P, 2010, J HEPATOL, V53, P397, DOI 10.1016/j.jhep.2010.05.004; Gines P, 2009, NEW ENGL J MED, V361, P1279, DOI 10.1056/NEJMra0809139; Hoffmann W, 2005, CELL MOL LIFE SCI, V62, P2932, DOI 10.1007/s00018-005-5481-9; Jalan R, 2014, GASTROENTEROLOGY, V147, P4, DOI 10.1053/j.gastro.2014.05.005; Jalan R, 2014, J HEPATOL, V60, P1310, DOI 10.1016/j.jhep.2014.01.024; Jalan R, 2012, J HEPATOL, V57, P1336, DOI 10.1016/j.jhep.2012.06.026; Kahles F, 2014, MOL METAB, V3, P384, DOI 10.1016/j.molmet.2014.03.004; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Koyner JL, 2013, CLIN J AM SOC NEPHRO, V8, P1034, DOI 10.2215/CJN.05150512; Koyner JL, 2010, CLIN J AM SOC NEPHRO, V5, P2154, DOI 10.2215/CJN.00740110; Levitsky J, 2014, HEPATOLOGY, V60, P2017, DOI 10.1002/hep.27346; McMahon BA, 2010, CURR OPIN CRIT CARE, V16, P550, DOI 10.1097/MCC.0b013e32833fdd9a; Morales-Ibanez O, 2013, HEPATOLOGY, V58, P1742, DOI 10.1002/hep.26521; Moreau R, 2014, CLIN GASTROENTEROL H; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Munshi R, 2011, J AM SOC NEPHROL, V22, P165, DOI 10.1681/ASN.2010060641; Murray PT, 2014, KIDNEY INT, V85, P513, DOI 10.1038/ki.2013.374; O'Seaghdha CM, 2013, J AM SOC NEPHROL, V24, P1880, DOI 10.1681/ASN.2013010019; Papper S., 1983, THE KIDNEY IN LIVER, P87; Piano S, 2013, J HEPATOL, V59, P482, DOI 10.1016/j.jhep.2013.03.039; Sasaki M, 2004, LIVER INT, V24, P29, DOI 10.1111/j.1478-3231.2004.00883.x; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Srivatsa G, 2002, HISTOPATHOLOGY, V40, P261, DOI 10.1046/j.1365-2559.2002.01347.x; Syn WK, 2012, GUT, V61, P1323, DOI 10.1136/gutjnl-2011-301857; Verna EC, 2012, DIGEST DIS SCI, V57, P2362, DOI 10.1007/s10620-012-2180-x; Xu MJ, 2015, HEPATOLOGY, V61, P692, DOI 10.1002/hep.27447	39	67	70	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128145	10.1371/journal.pone.0128145	http://dx.doi.org/10.1371/journal.pone.0128145			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042740	gold, Green Submitted, Green Published			2022-12-27	WOS:000355701600036
J	Brutemark, A; Vandelannoote, A; Engstrom-Ost, J; Suikkanen, S				Brutemark, Andreas; Vandelannoote, Angelique; Engstrom-Ost, Jonna; Suikkanen, Sanna			A Less Saline Baltic Sea Promotes Cyanobacterial Growth, Hampers Intracellular Microcystin Production, and Leads to Strain-Specific Differences in Allelopathy	PLOS ONE			English	Article							NITROGEN-FIXING CYANOBACTERIA; LONG-TERM CHANGES; NODULARIA-SPUMIGENA; TOXIN PRODUCTION; PHYTOPLANKTON COMMUNITIES; BIOLOGICAL ROLE; ANABAENA; GULF; AERUGINOSA; PLANKTON	Salinity is one of the main factors that explain the distribution of species in the Baltic Sea. Increased precipitation and consequent increase in freshwater inflow is predicted to decrease salinity in some areas of the Baltic Sea. Clearly such changes may have profound effects on the organisms living there. Here we investigate the response of the commonly occurring cyanobacterium Dolichospermum spp. to three salinities, 0, 3 and 6. For the three strains tested we recorded growth, intracellular toxicity (microcystin) and allelopathic properties. We show that Dolichospermum can grow in all the three salinities tested with highest growth rates in the lowest salinity. All strains showed allelopathic potential and it differed significantly between strains and salinities, but was highest in the intermediate salinity and lowest in freshwater. Intracellular toxin concentration was highest in salinity 6. In addition, based on monitoring data from the northern Baltic Proper and the Gulf of Finland, we show that salinity has decreased, while Dolichospermum spp. biomass has increased between 1979 and 2013. Thus, based on our experimental findings it is evident that salinity plays a large role in Dolichospermum growth, allelopathic properties and toxicity. In combination with our long-term data analyses, we conclude that decreasing salinity is likely to result in a more favourable environment for Dolichospermum spp. in some areas of the Baltic Sea.	[Brutemark, Andreas; Engstrom-Ost, Jonna] Novia Univ Appl Sci, ARONIA Coastal Zone Res Team, Ekenas, Finland; [Brutemark, Andreas; Engstrom-Ost, Jonna] Abo Akad Univ, Ekenas, Finland; [Brutemark, Andreas; Engstrom-Ost, Jonna] Univ Helsinki, Tvarminne Zool Stn, Hango, Finland; [Vandelannoote, Angelique; Suikkanen, Sanna] Finnish Environm Inst SYKE, Ctr Marine Res, Helsinki, Finland	Novia University of Applied Sciences; Abo Akademi University; University of Helsinki; Finnish Environment Institute	Brutemark, A (corresponding author), Calluna AB, Stockholm, Sweden.	andreas.brutemark@calluna.se	Engström-Öst, Jonna/C-7373-2008	Engström-Öst, Jonna/0000-0003-1792-7702; Suikkanen, Sanna/0000-0002-0768-8149	Walter and Andree de Nottbeck Foundation; Norden Havgruppe; Academy of Finland [259357]; EU	Walter and Andree de Nottbeck Foundation; Norden Havgruppe; Academy of Finland(Academy of Finland); EU(European Commission)	This work was supported by Walter and Andree de Nottbeck Foundation (AB) (http://www.nottbeck.org/), Norden Havgruppe (JEO) (http://www.norden.org/en), Academy of Finland (grant 259357) (SS) (http://www.aka.fi/en-GB/A/) and EU Erasmus student exchange programme (AV) (http://www.esn.org/content/erasmus-programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackburn SI, 1996, PHYCOLOGIA, V35, P511, DOI 10.2216/i0031-8884-35-6-511.1; Brutemark A, 2013, INT REV HYDROBIOL, V98, P225, DOI 10.1002/iroh.201301633; De Nobel WT, 1998, NEW PHYTOL, V138, P579, DOI 10.1046/j.1469-8137.1998.00155.x; Dippner JW, 2012, J MARINE SYST, V105, P115, DOI 10.1016/j.jmarsys.2012.07.001; Dziallas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025569; Engstrom-Ost J, 2011, HARMFUL ALGAE, V10, P530, DOI 10.1016/j.hal.2011.04.002; FERNANDES TA, 1993, APPL ENVIRON MICROB, V59, P899, DOI 10.1128/AEM.59.3.899-904.1993; Fewer DP, 2009, ENVIRON MICROBIOL, V11, P855, DOI 10.1111/j.1462-2920.2008.01806.x; Graham LP, 2004, AMBIO, V33, P235, DOI 10.1639/0044-7447(2004)033[0235:CCEORF]2.0.CO;2; Graneli E, 2008, HARMFUL ALGAE, V8, P94, DOI 10.1016/j.hal.2008.08.011; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Halinen K, 2007, APPL ENVIRON MICROB, V73, P6543, DOI 10.1128/AEM.01377-07; Kaplan A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00138; Kearns KD, 2000, ENVIRON MICROBIOL, V2, P291, DOI 10.1046/j.1462-2920.2000.00104.x; Kjellstrom E, 2007, CLIMATIC CHANGE, V81, P281, DOI 10.1007/s10584-006-9219-y; KOCH AL, 1984, J BACTERIOL, V159, P919, DOI 10.1128/JB.159.3.919-924.1984; Kotai J, 1972, NORWEGIAN I WATER B; Leao PN, 2009, CRIT REV MICROBIOL, V35, P271, DOI 10.3109/10408410902823705; Legrand C, 2003, PHYCOLOGIA, V42, P406, DOI 10.2216/i0031-8884-42-4-406.1; Lehtimaki J, 1997, APPL ENVIRON MICROB, V63, P1647, DOI 10.1128/AEM.63.5.1647-1656.1997; Lenth R. V., 2013, ISMEANS LEAST SQUARE; Long BM, 2001, APPL ENVIRON MICROB, V67, P278, DOI 10.1128/AEM.67.1.278-283.2001; Makower AK, 2015, APPL ENVIRON MICROB, V81, P544, DOI 10.1128/AEM.02601-14; Mazur-Marzec H, 2005, J APPL PHYCOL, V17, P171, DOI 10.1007/s10811-005-5767-1; Mazur-Marzec H, 2009, OCEANOLOGIA, V51, P293, DOI 10.5697/oc.51-3.293; McKnight DM, 2000, J PHYCOL, V36, P852, DOI 10.1046/j.1529-8817.2000.00031.x; Metcalf JS, 2003, CHEM RES TOXICOL, V16, P103, DOI 10.1021/tx0200562; Mogelhoj MK, 2006, AQUAT MICROB ECOL, V43, P43, DOI 10.3354/ame043043; Moisander PH, 2002, MICROB ECOL, V43, P432, DOI 10.1007/s00248-001-1044-2; Myrberg K., 2006, YLIOPISTOPAINO, DOI [10.31885/2018.00022, DOI 10.31885/2018.00022]; Olenina I., 2006, BALT SEA ENV P, V106; Orr PT, 1998, LIMNOL OCEANOGR, V43, P1604, DOI 10.4319/lo.1998.43.7.1604; R Core Team, 2012, R LANG ENV STAT COMP; Raudsepp U, 2001, NORD HYDROL, V32, P135; Ray S, 2001, NEW PHYTOL, V149, P455, DOI 10.1046/j.1469-8137.2001.00061.x; Ritz C., 2013, R PACKAGE DRC ANAL D; Ronkkonen S, 2004, CAN J FISH AQUAT SCI, V61, P219, DOI 10.1139/F03-167; Salt LA, 2013, J GEOPHYS RES-BIOGEO, V118, P1584, DOI 10.1002/2013JG002306; Samuelsson M, 1996, CONT SHELF RES, V16, P1463, DOI 10.1016/0278-4343(95)00082-8; Sarkar D., 2019, NLME LINEAR NONLINEA; Schatz D, 2007, ENVIRON MICROBIOL, V9, P965, DOI 10.1111/j.1462-2920.2006.01218.x; Sellner KG, 1997, LIMNOL OCEANOGR, V42, P1089, DOI 10.4319/lo.1997.42.5_part_2.1089; Shapiguzov A, 2005, MICROBIOL-SGM, V151, P447, DOI 10.1099/mic.0.27530-0; Simis SGH, 2012, PHOTOSYNTH RES, V112, P13, DOI 10.1007/s11120-012-9729-6; Singh SP, 2013, BIOCHEM BIOPH RES CO, V433, P84, DOI 10.1016/j.bbrc.2013.02.060; Sivonen K, 1999, TOXIC CYANOBACTERIA, P41, DOI DOI 10.4324/9780203478073; Srivastava AK, 2008, ENVIRON EXP BOT, V64, P49, DOI 10.1016/j.envexpbot.2007.12.012; Srivastava AK, 2011, MICROBIOL-SGM, V157, P911, DOI 10.1099/mic.0.045682-0; Srivastava AK, 2010, J MICROBIOL BIOTECHN, V20, P1506, DOI 10.4014/jmb.1005.05037; Suikkanen S, 2005, MAR ECOL PROG SER, V287, P1, DOI 10.3354/meps287001; Suikkanen S, 2004, J EXP MAR BIOL ECOL, V308, P85, DOI 10.1016/j.jembe.2004.02.012; Suikkanen S, 2007, ESTUAR COAST SHELF S, V71, P580, DOI 10.1016/j.ecss.2006.09.004; Suikkanen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066475; Tillmann U, 2008, HARMFUL ALGAE, V7, P52, DOI 10.1016/j.hal.2007.05.009; Tonk L, 2007, AQUAT MICROB ECOL, V46, P117, DOI 10.3354/ame046117; Wacklin P, 2009, FOTTEA, V9, P59, DOI 10.5507/fot.2009.005; Wasmund N, 2011, J MARINE SYST, V87, P145, DOI 10.1016/j.jmarsys.2011.03.010; Wood AM., 2005, ALGAL CULTURING TECH, P269, DOI DOI 10.1016/B978-012088426-1/50019-6; Zak A, 2012, ESTUAR COAST SHELF S, V112, P4, DOI 10.1016/j.ecss.2011.10.007; Zilliges Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017615	60	22	22	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128904	10.1371/journal.pone.0128904	http://dx.doi.org/10.1371/journal.pone.0128904			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042598	Green Published, gold, Green Submitted			2022-12-27	WOS:000355701600074
J	Goncalves, EM; Ribeiro, RR; de Carvalho, WRG; de Moraes, AM; Roman, EP; Santos, KD; Medaets, PAR; Veiga, NN; Coelho, ACLD; Krahenbuhl, T; Sewaybricker, LE; Barros, AD; Morcillo, AM; Guerra, G				Goncalves, Ezequiel Moreira; Ribeiro, Roberto Regis; Gomes de Carvalho, Wellington Roberto; de Moraes, Anderson Marques; Roman, Everton Paulo; Santos, Keila Donassolo; Rodrigues Medaets, Pedro Augusto; Veiga-Junior, Nelio Neves; Lace de Moraes Coelho, Adrielle Caroline; Krahenbuehl, Tathyane; Sewaybricker, Leticia Esposito; Barros-Filho, Antonio de Azevedo; Morcillo, Andre Moreno; Guerra-Junior, Gil			Brazilian Pediatric Reference Data for Quantitative Ultrasound of Phalanges According to Gender, Age, Height and Weight	PLOS ONE			English	Article							BONE MASS ACCUMULATION; PROXIMAL PHALANGES; HEALTHY-CHILDREN; SKELETAL STATUS; FRACTURE RISK; LMS METHOD; ADOLESCENTS; HAND; QUALITY; GROWTH	Aims To establish normative data for phalangeal quantitative ultrasound (QUS) measures in Brazilian students. Methods The sample was composed of 6870 students (3688 females and 3182 males), aged 6 to 17 years. The bone status parameter, Amplitude Dependent Speed of Sound (AD-SoS) was assessed by QUS of the phalanges using DBM Sonic BP (IGEA, Carpi, Italy) equipment. Skin color was obtained by self-evaluation. The LMS method was used to derive smoothed percentiles reference charts for AD-SoS according to sex, age, height and weight and to generate the L, M, and S parameters. Results Girls showed higher AD-SoS values than boys in the age groups 7-16 (p<0.001). There were no differences on AD-SoS Z-scores according to skin color. In both sexes, the obese group showed lower values of AD-SoS Z-scores compared with subjects classified as thin or normal weight. Age (r(2) = 0.48) and height (r(2) = 0.35) were independent predictors of AD-SoS in females and males, respectively. Conclusion AD-SoS values in Brazilian children and adolescents were influenced by sex, age and weight status, but not by skin color. Our normative data could be used for monitoring AD-SoS in children or adolescents aged 6-17 years.	[Goncalves, Ezequiel Moreira; Ribeiro, Roberto Regis; Gomes de Carvalho, Wellington Roberto; de Moraes, Anderson Marques; Roman, Everton Paulo; Santos, Keila Donassolo; Rodrigues Medaets, Pedro Augusto; Veiga-Junior, Nelio Neves; Lace de Moraes Coelho, Adrielle Caroline; Krahenbuehl, Tathyane; Sewaybricker, Leticia Esposito; Barros-Filho, Antonio de Azevedo; Morcillo, Andre Moreno; Guerra-Junior, Gil] Univ Estadual Campinas, UNICAMP, Sch Med Sci FCM, Ctr Invest Pediat CIPED,Growth & Dev Lab, Campinas, SP, Brazil; [Ribeiro, Roberto Regis; Roman, Everton Paulo] Assis Gurgacz Fac, Dept Phys Educ, Cascavel, PR, Brazil; [Gomes de Carvalho, Wellington Roberto] Fed Univ Maranhao UFMA, Ctr Biol Sci & Hlth, Dept Phys Educ, Sao Luis, MA, Brazil; [Sewaybricker, Leticia Esposito; Barros-Filho, Antonio de Azevedo; Morcillo, Andre Moreno; Guerra-Junior, Gil] Univ Estadual Campinas, FCM, Dept Pediat, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Federal do Maranhao; Universidade Estadual de Campinas; Universidade Federal de Sao Paulo (UNIFESP)	Goncalves, EM (corresponding author), Univ Estadual Campinas, UNICAMP, Sch Med Sci FCM, Ctr Invest Pediat CIPED,Growth & Dev Lab, Campinas, SP, Brazil.	emaildozeique@gmail.com	Sewaybricker, Leticia Esposito/C-5033-2019; Junior, Nelio Veiga/AAD-5735-2019; de Moraes, Anderson Marques/B-8466-2015; Guerra-Junior, Gil/C-1609-2012; Morcillo, André Moreno/ABH-8814-2020; DE MORAES, ANDERSON/GNP-2325-2022; Morcillo, André M/J-8728-2012; Sewaybricker, Leticia Esposito/AAY-4097-2020; Goncalves, Ezequiel/C-4313-2012	Sewaybricker, Leticia Esposito/0000-0003-1904-9499; de Moraes, Anderson Marques/0000-0001-8647-1230; Guerra-Junior, Gil/0000-0002-2991-7678; Morcillo, André Moreno/0000-0002-2088-972X; Morcillo, André M/0000-0002-2088-972X; Sewaybricker, Leticia Esposito/0000-0003-1904-9499; Goncalves, Ezequiel/0000-0001-8470-9479; Carvalho, Wellington Roberto Gomes de/0000-0003-4185-526X	Sao Paulo Research Foundation (FAPESP) [2006/01978-0, 2011/23460-1, 2002/13021-1, 2012/16778-8]; Coordination for the Improvement of Higher Education Personnel (CAPES); National Council for Scientific and Technological Development (CNPq)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Sao Paulo Research Foundation (E.M.G and G.G-J.) (FAPESP: Process n<SUP>o</SUP> 2006/01978-0 and 2011/23460-1 (E.M.G); 2002/13021-1 and 2012/16778-8 (G.G-J)), (R.R.R. and W.R.G.C.) by the Coordination for the Improvement of Higher Education Personnel (CAPES) and (P.A.R.M., N.N.V-J and A.C.L.M.C.) by National Council for Scientific and Technological Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese CV, 2009, ULTRASOUND MED BIOL, V35, P537, DOI 10.1016/j.ultrasmedbio.2008.09.027; Bajaj M, 2010, PEDIATR RES, V68, P81, DOI 10.1203/00006450-201011001-00155; Barkmann R, 2002, OSTEOPOROSIS INT, V13, P55, DOI 10.1007/s198-002-8338-8; Barkmann R, 2000, OSTEOPOROSIS INT, V11, P745, DOI 10.1007/s001980070053; Baroncelli GI, 2006, BONE, V39, P159, DOI 10.1016/j.bone.2005.12.010; Baroncelli GI, 2003, PEDIATR RES, V54, P125, DOI 10.1203/01.PDR.0000069845.27657.EB; Baroncelli GI, 2001, PEDIATR RES, V49, P713, DOI 10.1203/00006450-200105000-00017; Baroncelli GI, 2008, PEDIATR RES, V63, P220, DOI 10.1203/PDR.0b013e318163a286; Baroncelli GI, 2010, BONE, V46, P182, DOI 10.1016/j.bone.2009.09.010; BONJOUR JP, 1991, J CLIN ENDOCR METAB, V73, P555, DOI 10.1210/jcem-73-3-555; Bonnick SL, 2001, J CLIN DENSITOM, V4, P105, DOI 10.1385/JCD:4:2:105; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; de Moraes AM, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-117; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dib L, 2005, BONE, V36, P736, DOI 10.1016/j.bone.2005.01.009; Drozdzowska B, 2003, OSTEOPOROSIS INT, V14, P295, DOI 10.1007/s00198-002-1355-2; Fielding KT, 2003, J CLIN DENSITOM, V6, P7, DOI 10.1385/JCD:6:1:7; FUERST T, 1995, EUR J RADIOL, V20, P188, DOI 10.1016/0720-048X(95)00650-F; Gimeno Ballester J, 2001, An Esp Pediatr, V54, P540; de Carvalho WRG, 2011, REV ASSOC MED BRAS, V57, P662; Guglielmi G, 2013, J CLIN DENSITOM, V16, P341, DOI 10.1016/j.jocd.2012.07.006; Guglielmi G, 2010, J CLIN DENSITOM, V13, P219, DOI 10.1016/j.jocd.2010.01.002; Halaba Z, 1997, ULTRASOUND MED BIOL, V23, P1331, DOI 10.1016/S0301-5629(97)00144-0; Halaba ZP, 2008, ULTRASOUND MED BIOL, V34, P1547, DOI 10.1016/j.ultrasmedbio.2008.03.007; Halaba ZP, 2004, ULTRASOUND MED BIOL, V30, P239, DOI 10.1016/j.ultrasmedbio.2003.10.023; INEP-Instituto Nacional de Estudos e Pesquisas Educacionais Anisio Teixeira, MOSTR SUA RAC DECL S; Janicka A, 2007, J CLIN ENDOCR METAB, V92, P143, DOI 10.1210/jc.2006-0794; KAUFMAN JJ, 1993, J BONE MINER RES, V8, P517; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Longhi S, 2013, CLIN ENDOCRINOL, V78, P79, DOI 10.1111/j.1365-2265.2012.04476.x; Loomba-Albrecht LA, 2009, CURR OPIN ENDOCRINOL, V16, P10, DOI 10.1097/MED.0b013e328320d54c; Moayyeri A, 2012, OSTEOPOROSIS INT, V23, P143, DOI 10.1007/s00198-011-1817-5; Mosca LN, 2014, NUTRITION, V30, P847, DOI 10.1016/j.nut.2013.12.003; Mussa A, 2012, OSTEOPOROSIS INT, V23, P1987, DOI 10.1007/s00198-011-1794-8; Mussa A, 2007, AM J KIDNEY DIS, V50, P441, DOI 10.1053/j.ajkd.2007.06.002; Mussa A, 2010, BONE, V46, P1016, DOI 10.1016/j.bone.2009.12.019; Njeh CF, 1997, OSTEOPOROSIS INT, V7, P7, DOI 10.1007/BF01623454; Pan H, 2000, LMSCHARTMAKER PROGRA; Porta F, 2008, ULTRASOUND MED BIOL, V34, P1049, DOI 10.1016/j.ultrasmedbio.2007.12.013; Ribeiro RR, 2010, BRAZ J MED BIOL RES, V43, P976, DOI 10.1590/S0100-879X2010001000009; Ribeiro RR, 2009, J BONE MINER METAB, V27, P494, DOI 10.1007/s00774-009-0062-x; Santos KD, 2009, J BONE MINER METAB, V27, P507, DOI 10.1007/s00774-009-0067-5; THEINTZ G, 1992, J CLIN ENDOCR METAB, V75, P1060, DOI 10.1210/jc.75.4.1060; Vignolo M, 2003, CALCIFIED TISSUE INT, V72, P681, DOI 10.1007/s00223-002-2028-z; Wuster C, 2000, J BONE MINER RES, V15, P1603, DOI 10.1359/jbmr.2000.15.8.1603	47	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0127294	10.1371/journal.pone.0127294	http://dx.doi.org/10.1371/journal.pone.0127294			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26043082	Green Submitted, Green Published, gold			2022-12-27	WOS:000355701600010
J	McDonald, SA; Dahlui, M; Mohamed, R; Naning, H; Shabaruddin, FH; Kamarulzaman, A				McDonald, Scott A.; Dahlui, Maznah; Mohamed, Rosmawati; Naning, Herlianna; Shabaruddin, Fatiha Hana; Kamarulzaman, Adeeba			Projections of the Current and Future Disease Burden of Hepatitis C Virus Infection in Malaysia	PLOS ONE			English	Article							COST-EFFECTIVENESS; HIV COINFECTION; HEALTH BURDEN; DRUG-USERS; CIRRHOSIS; MORTALITY; RIBAVIRIN; EPIDEMIC; REGIMENS; BENEFITS	Background The prevalence of hepatitis C virus (HCV) infection in Malaysia has been estimated at 2.5% of the adult population. Our objective, satisfying one of the directives of the WHO Framework for Global Action on Viral Hepatitis, was to forecast the HCV disease burden in Malaysia using modelling methods. Methods An age-structured multi-state Markov model was developed to simulate the natural history of HCV infection. We tested three historical incidence scenarios that would give rise to the estimated prevalence in 2009, and calculated the incidence of cirrhosis, end-stage liver disease, and death, and disability-adjusted life-years (DALYs) under each scenario, to the year 2039. In the baseline scenario, current antiviral treatment levels were extended from 2014 to the end of the simulation period. To estimate the disease burden averted under current sustained virological response rates and treatment levels, the baseline scenario was compared to a counterfactual scenario in which no past or future treatment is assumed. Results In the baseline scenario, the projected disease burden for the year 2039 is 94,900 DALYs/year (95% credible interval (CrI): 77,100 to 124,500), with 2,002 (95% CrI: 1340 to 3040) and 540 (95% CrI: 251 to 1,030) individuals predicted to develop decompensated cirrhosis and hepatocellular carcinoma, respectively, in that year. Although current treatment practice is estimated to avert a cumulative total of 2,200 deaths from DC or HCC, a cumulative total of 63,900 HCV-related deaths is projected by 2039. Conclusions The HCV-related disease burden is already high and is forecast to rise steeply over the coming decades under current levels of antiviral treatment. Increased governmental resources to improve HCV screening and treatment rates and to reduce transmission are essential to address the high projected HCV disease burden in Malaysia.	[McDonald, Scott A.; Naning, Herlianna; Kamarulzaman, Adeeba] Univ Malaya, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia; [McDonald, Scott A.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [McDonald, Scott A.] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow G4 0BA, Lanark, Scotland; [Dahlui, Maznah; Shabaruddin, Fatiha Hana; Kamarulzaman, Adeeba] Univ Malaya, Fac Med, Julius Ctr, Kuala Lumpur, Malaysia; [Mohamed, Rosmawati] Univ Malaya, Fac Med, Kuala Lumpur, Malaysia	Universiti Malaya; Netherlands National Institute for Public Health & the Environment; Glasgow Caledonian University; Universiti Malaya; Universiti Malaya	McDonald, SA (corresponding author), Univ Malaya, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia.	scott.mcdonald@rivm.nl	KAMARULZAMAN, ADEEBA/B-5216-2010; Dahlui, Maznah/F-9665-2010; DAHLUI, MAZNAH/B-8976-2010; Shabaruddin, Fatiha/I-5327-2015	DAHLUI, MAZNAH/0000-0003-4923-9410; 	University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research grant [E000010-20001]	University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research grant	This study is supported by the University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research grant (E000010-20001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, LANCET, V385, P1045, DOI 10.1016/S0140-6736(15)60584-0; Armstrong GL, 2003, INT J EPIDEMIOL, V32, P725, DOI 10.1093/ije/dyg266; Brady B, 2007, TECHNOLOGY OVERVIEW; Davis GL, 2003, LIVER TRANSPLANT, V9, P331, DOI 10.1053/jlts.2003.50073; De Angelis D, 2009, STAT METHODS MED RES, V18, P361, DOI 10.1177/0962280208094691; Department of Statistics Malaysia, 2012, STATISTICS YEARBOOK; Department of Statistics Malaysia, POPULATION STATISTIC; Department of Statistics Malaysia, 2009, YEARBOOK OF STATISTI; Department of Statistics Malaysia, 2007, YEARBOOK OF STATISTI; Deuffic-Burban S, 2007, J VIRAL HEPATITIS, V14, P107, DOI 10.1111/j.1365-2893.2006.00785.x; Deuffic-Burban S, 2004, J HEPATOL, V40, P319, DOI 10.1016/j.jhep.2003.10.018; Devleesschauwer B, 2014, INT J PUBLIC HEALTH, V59, P565, DOI 10.1007/s00038-014-0552-z; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Grebely J, 2013, CLIN INFECT DIS, V57, P1014, DOI 10.1093/cid/cit377; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hartwell D, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15170; Hutchinson Sharon J, 2006, Expert Rev Pharmacoecon Outcomes Res, V6, P627, DOI 10.1586/14737167.6.6.627; Hutchinson SJ, 2005, HEPATOLOGY, V42, P711, DOI 10.1002/hep.20836; Innes H, 2014, J HEPATOL, V60, P1118, DOI 10.1016/j.jhep.2014.01.020; Kirby Institute, 2011, AUSTRALIAN NSP SURVE; Kretzschmar M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001205; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Linas BP, 2015, ANN INTERN MED, V162, P619, DOI 10.7326/M14-1313; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Martin NK, 2012, HEPATOLOGY, V55, P49, DOI 10.1002/hep.24656; Matser A, 2012, ADDICTION, V107, P614, DOI 10.1111/j.1360-0443.2011.03654.x; McDonald SA, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0564-6; McDonald SA, 2009, STAT METHODS MED RES, V18, P271, DOI 10.1177/0962280208094690; Ministry of Health Malaysia, 2012, MALAYSIA 2012 UNGASS; Ministry of Health Malaysia, 2014, MALAYSIA 2014 COUNTR; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Murray CJL, 1996, THE GLOBAL BURDEN OF; Najafzadeh M, 2015, ANN INTERN MED, V162, P407, DOI 10.7326/M14-1152; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; R Core Team, 2014, R A LANGUAGE AND ENV; Razali K, 2007, DRUG ALCOHOL DEPEN, V91, P228, DOI 10.1016/j.drugalcdep.2007.05.026; Razavi H, 2014, J VIRAL HEPATITIS, V21, P34, DOI 10.1111/jvh.12248; Reau NS, 2014, HEPATOLOGY, V59, P1246, DOI 10.1002/hep.27039; Shepherd J, 2007, HEALTH TECHNOL ASSES, V11, P1; Stouthard ME, 1997, DISABILITY WEIGHTS F; Sweeting MJ, 2007, J VIRAL HEPATITIS, V14, P570, DOI 10.1111/j.1365-2893.2007.00851.x; Sweeting MJ, 2006, J CLIN EPIDEMIOL, V59, P144, DOI 10.1016/j.jclinepi.2005.06.008; Sypsa V, 2004, J VIRAL HEPATITIS, V11, P366, DOI 10.1111/j.1365-2893.2004.00517.x; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; Vicknasingam B, 2009, AIDS CARE, V21, P984, DOI 10.1080/09540120802657530; Wedemeyer H, 2014, J VIRAL HEPATITIS, V21, P18, DOI 10.1111/jvh.12332_20; World Health Organisation, 2012, PREVENTION AND CONTR; World Health Organisation, 2014, GLOBAL HEALTH OBSERV; Wright M, 2006, HEALTH TECHNOL ASSES, V10, P1	51	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2015	10	6							e0128091	10.1371/journal.pone.0128091	http://dx.doi.org/10.1371/journal.pone.0128091			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7TC	26042425	gold, Green Submitted, Green Published			2022-12-27	WOS:000355701600033
J	Calcaterra, V; Veggiotti, P; Palestrini, C; De Giorgis, V; Raschetti, R; Tumminelli, M; Mencherini, S; Papotti, F; Klersy, C; Albertini, R; Ostuni, S; Pelizzo, G				Calcaterra, Valeria; Veggiotti, Pierangelo; Palestrini, Clara; De Giorgis, Valentina; Raschetti, Roberto; Tumminelli, Massimiliano; Mencherini, Simonetta; Papotti, Francesca; Klersy, Catherine; Albertini, Riccardo; Ostuni, Selene; Pelizzo, Gloria			Post-Operative Benefits of Animal-Assisted Therapy in Pediatric Surgery: A Randomised Study	PLOS ONE			English	Article							CHILDREN; LONELINESS; ANXIETY; STRESS; THETA; DOGS	Background Interest in animal-assisted therapy has been fuelled by studies supporting the many health benefits. The purpose of this study was to better understand the impact of an animal-assisted therapy program on children response to stress and pain in the immediate postsurgical period. Patients and Methods Forty children (3-17 years) were enrolled in the randomised open-label, controlled, pilot study. Patients were randomly assigned to the animal-assisted therapy-group (n = 20, who underwent a 20 min session with an animal-assisted therapy dog, after surgery) or the standard- group (n = 20, standard postoperative care). The study variables were determined in each patient, independently of the assigned group, by a researcher unblinded to the patient's group. The outcomes of the study were to define the neurological, cardiovascular and endocrinological impact of animal-assisted therapy in response to stress and pain. Electroencephalogram activity, heart rate, blood pressure, oxygen saturation, cerebral prefrontal oxygenation, salivary cortisol levels and the faces pain scale were considered as outcome measures. Results After entrance of the dog faster electroencephalogram diffuse beta-activity (> 14 Hz) was reported in all children of the animal-assisted therapy group; in the standard-group no beta-activity was recorded (100% vs 0%, p<0.001). During observation, some differences in the time profile between groups were observed for heart rate (test for interaction p = 0.018), oxygen saturation (test for interaction p = 0.06) and cerebral oxygenation (test for interaction p = 0.09). Systolic and diastolic blood pressure were influenced by animal-assisted therapy, though a higher variability in diastolic pressure was observed. Salivary cortisol levels did not show different behaviours over time between groups (p=0.70). Lower pain perception was noted in the animal-assisted group in comparison with the standard-group (p = 0.01). Conclusion Animal-assisted therapy facilitated rapid recovery in vigilance and activity after anaesthesia, modified pain perception and induced emotional prefrontal responses. An adaptative cardiovascular response was also present.	[Calcaterra, Valeria; Raschetti, Roberto] Fdn IRCCS Policlin San Matteo, Dept Mother & Child Hlth, Pediat Unit, Pavia, Italy; [Calcaterra, Valeria] Univ Pavia, Dept Internal Med, I-27100 Pavia, Italy; [Veggiotti, Pierangelo; Tumminelli, Massimiliano] C Mondino Natl Neurol Inst, Dept Child Neurol & Psychiat, Pavia, Italy; [Veggiotti, Pierangelo; De Giorgis, Valentina] Univ Pavia, Brain & Behav Dept, I-27100 Pavia, Italy; [Palestrini, Clara; Papotti, Francesca] Univ Milan, Dipartimento Sci Vet & Sanita Pubbl, Milan, Italy; [Mencherini, Simonetta] Fdn IRCCS Policlin San Matteo, Dept Anaesthesiol & Intens Care, Pavia, Italy; [Klersy, Catherine] Fdn IRCCS Policlin San Matteo, Biometry & Clin Epidemiol, Sci Direct, Pavia, Italy; [Albertini, Riccardo] Fdn IRCCS Policlin San Matteo, Clin Chem Lab, Pavia, Italy; [Ostuni, Selene; Pelizzo, Gloria] Fdn IRCCS Policlin San Matteo, Dept Mother & Child Hlth, Pediat Surg Unit, Pavia, Italy; [Pelizzo, Gloria] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, I-27100 Pavia, Italy	IRCCS Fondazione San Matteo; University of Pavia; IRCCS Fondazione Casimiro Mondino; University of Pavia; University of Milan; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; University of Pavia	Pelizzo, G (corresponding author), Fdn IRCCS Policlin San Matteo, Dept Mother & Child Hlth, Pediat Surg Unit, Pavia, Italy.	g.pelizzo@smatteo.pv.it	De Giorgis, Valentina/AAB-7643-2019; palestrini, clara/K-6721-2017; De Giorgis, Valentina/K-4730-2018; Raschetti, Roberto/AAH-5397-2019; albertini, riccardo/AAB-7779-2019; klersy, catherine/AAA-3003-2019; Calcaterra, Valeria/AAB-7563-2022	De Giorgis, Valentina/0000-0002-5828-7070; palestrini, clara/0000-0002-5178-906X; De Giorgis, Valentina/0000-0002-5828-7070; klersy, catherine/0000-0003-0314-8548; Calcaterra, Valeria/0000-0002-2137-5974; Calcaterra, Valeria/0000-0003-3862-7872; ALBERTINI, REGIANE/0000-0002-4143-0387; Pelizzo, Gloria/0000-0002-5253-8828				[Anonymous], 2012, FRONT PSYCHOL, DOI DOI 10.3389/FPSYG.2012.00234; Banks MR, 2008, J AM MED DIR ASSOC, V9, P173, DOI 10.1016/j.jamda.2007.11.007; Banks MR, 2002, J GERONTOL A-BIOL, V57, pM428, DOI 10.1093/gerona/57.7.M428; Barba B E, 1995, Clin Nurse Spec, V9, P199, DOI 10.1097/00002800-199507000-00005; Bardill N, 1997, J Child Adolesc Psychiatr Nurs, V10, P17, DOI 10.1111/j.1744-6171.1997.tb00208.x; Barker SB, 2008, J VET MED EDUC, V35, P487, DOI 10.3138/jvme.35.4.487; Barker SB, 2005, PSYCHOL REP, V96, P713; Barker SB, 2003, J ECT, V19, P38, DOI 10.1097/00124509-200303000-00008; Barker SB, 1998, PSYCHIATR SERV, V49, P797, DOI 10.1176/ps.49.6.797; Beetz A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00352; Bekkedal MYV, 2011, NEUROSCI BIOBEHAV R, V35, P1959, DOI 10.1016/j.neubiorev.2011.05.001; Berry A, 2013, J ALTERN COMPLEM MED, V19, P73, DOI 10.1089/acm.2011.0835; Braun Carie, 2009, Complement Ther Clin Pract, V15, P105, DOI 10.1016/j.ctcp.2009.02.008; Cole K M, 2000, AACN Clin Issues, V11, P139, DOI 10.1097/00044067-200002000-00015; Corazza I, 2014, COMPUT METH PROG BIO, V117, P267, DOI 10.1016/j.cmpb.2014.08.002; Ernst Lorraine S, 2013, Nurs Manage, V44, P16, DOI 10.1097/01.NUMA.0000427181.19436.19; Ernst Lorraine S, 2012, Nursing, V42, P54; Fisher A, 2014, LAB ANIMAL, V43, P122, DOI 10.1038/laban.499; Harmon-Jones E., 2007, SOCIAL NEUROSCIENCE, P137; Herrmann MJ, 2003, BIOL PSYCHOL, V64, P255, DOI 10.1016/S0301-0511(03)00095-4; Hooker Shirley D, 2002, Holist Nurs Pract, V16, P17; Jausovec N, 2001, NEUROSCI LETT, V311, P93, DOI 10.1016/S0304-3940(01)02141-3; Kaldy Joanne, 2013, Consult Pharm, V28, P84, DOI 10.4140/TCP.n.2013.84; Kamioka H, 2014, COMPLEMENT THER MED, V22, P371, DOI 10.1016/j.ctim.2013.12.016; Kim MK, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/573734; Kinner VL, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00397; Makovac E, 2015, NEUROPSYCHOPHARMACOL, V40, P1649, DOI 10.1038/npp.2015.10; Marcus DA, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0322-2; Martin F, 2002, WESTERN J NURS RES, V24, P657, DOI 10.1177/019394502320555403; Mhuircheartaigh RN, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006007; Miller J, 2003, NURSING, V30, P65; Moghimi S, 2012, NEUROSCI LETT, V525, P7, DOI 10.1016/j.neulet.2012.07.009; Murphy M, 2011, SLEEP, V34, P283, DOI 10.1093/sleep/34.3.283; O'Haire ME, 2013, J AUTISM DEV DISORD, V43, P1606, DOI 10.1007/s10803-012-1707-5; Richeson Nancy E, 2003, Am J Alzheimers Dis Other Demen, V18, P353, DOI 10.1177/153331750301800610; Spiga F, 2014, COMPR PHYSIOL, V4, P1273, DOI 10.1002/cphy.c140003; Viau R, 2010, PSYCHONEUROENDOCRINO, V35, P1187, DOI 10.1016/j.psyneuen.2010.02.004; Wohlfarth R, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00796; WOODSIDE DB, 1991, CAN J PSYCHIAT, V36, P746, DOI 10.1177/070674379103601011	39	55	56	3	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0125813	10.1371/journal.pone.0125813	http://dx.doi.org/10.1371/journal.pone.0125813			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7ST	26039494	Green Submitted, gold, Green Published			2022-12-27	WOS:000355700700013
J	Jiang, XL; Nevins, JR; Shats, I; Chi, JT				Jiang, Xiaolei; Nevins, Joseph Roy; Shats, Igor; Chi, Jen-Tsan			E2F1-Mediated Induction of NFYB Attenuates Apoptosis via Joint Regulation of a Pro-Survival Transcriptional Program	PLOS ONE			English	Article							NUCLEAR-FACTOR-Y; CELL-CYCLE REGULATION; DNA-DAMAGE; E2F1-INDUCED APOPTOSIS; TUMOR-SUPPRESSOR; FAMILY-MEMBERS; UP-REGULATION; E2F1; PROMOTER; P53	The E2F1 transcription factor regulates cell proliferation and apoptosis through the control of a considerable variety of target genes. Previous work has detailed the role of other transcription factors in mediating the specificity of E2F function. Here we identify the NF-YB transcription factor as a novel direct E2F1 target. Genome-wide expression analysis of the effects of NFYB knockdown on E2F1-mediated transcription identified a large group of genes that are co-regulated by E2F1 and NFYB. We also provide evidence that knockdown of NFYB enhances E2F1-induced apoptosis, suggesting a pro-survival function of the NFYB/E2F1 joint transcriptional program. Bioinformatic analysis suggests that deregulation of these NFY-dependent E2F1 target genes might play a role in sarcomagenesis as well as drug resistance.	[Jiang, Xiaolei; Shats, Igor; Chi, Jen-Tsan] Duke Univ, Duke Ctr Genom & Computat Biol, Durham, NC 27708 USA; [Jiang, Xiaolei; Nevins, Joseph Roy; Chi, Jen-Tsan] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA; [Shats, Igor] Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC USA	Duke University; Duke University; Duke University	Shats, I (corresponding author), Duke Univ, Duke Ctr Genom & Computat Biol, Durham, NC 27708 USA.	gori73@gmail.com; jentsan.chi@duke.edu	Shats, Igor/AAD-8775-2019; Chi, Jen-Tsan/AAI-4125-2020	Shats, Igor/0000-0001-6449-5979; Chi, Jen-Tsan/0000-0003-3433-903X	National Institutes of Health [CA125618, CA106520]; NATIONAL CANCER INSTITUTE [R01CA125618, R01CA106520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (www.nih.gov) grants CA125618 and CA106520 awarded to JRN and JTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benatti P, 2008, NUCLEIC ACIDS RES, V36, P1415, DOI 10.1093/nar/gkm1046; Bolognese F, 1999, ONCOGENE, V18, P1845, DOI 10.1038/sj.onc.1202494; Bosco EE, 2007, CELL CYCLE, V6, P667, DOI 10.4161/cc.6.6.3988; Cassimere EK, 2009, CELL DEATH DIFFER, V16, P1641, DOI 10.1038/cdd.2009.98; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Croxton R, 2002, ONCOGENE, V21, P1359, DOI 10.1038/sj.onc.1205157; DeGregori J, 2006, CURR MOL MED, V6, P739; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Farina A, 1999, ONCOGENE, V18, P2818, DOI 10.1038/sj.onc.1202472; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Fortin A, 2004, J BIOL CHEM, V279, P28706, DOI 10.1074/jbc.M400376200; Gatta R, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.45; Giangrande PH, 2003, MOL CELL BIOL, V23, P3707, DOI 10.1128/MCB.23.11.3707-3720.2003; Ginsberg D, 2002, FEBS LETT, V529, P122, DOI 10.1016/S0014-5793(02)03270-2; Gurtner A, 2010, CANCER RES, V70, P9711, DOI 10.1158/0008-5472.CAN-10-0721; Hallstrom TC, 2006, GENE DEV, V20, P613, DOI 10.1101/gad.1345006; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Johnson DG, 2006, CURR MOL MED, V6, P731; Knudsen ES, 2006, EXP BIOL MED, V231, P1271; Korner K, 2001, J BIOL CHEM, V276, P9662, DOI 10.1074/jbc.M008696200; KOWALIK TF, 1995, J VIROL, V69, P2491, DOI 10.1128/JVI.69.4.2491-2500.1995; Lin WC, 2001, GENE DEV, V15, P1833; Liu K, 2004, GENE DEV, V18, P673, DOI 10.1101/gad.1180204; Lu HR, 2013, J BIOL CHEM, V288, P23833, DOI 10.1074/jbc.M112.447276; Morris EJ, 2006, PLOS GENET, V2, P1834, DOI 10.1371/journal.pgen.0020196; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nicolas M, 2003, BIOCHEM J, V371, P265, DOI 10.1042/BJ20021166; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Prasad KVS, 1997, P NATL ACAD SCI USA, V94, P6346, DOI 10.1073/pnas.94.12.6346; Qiao Q, 2013, MOL CELL, V51, P766, DOI 10.1016/j.molcel.2013.08.032; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Shats I, 2013, CANCER RES, V73, P6056, DOI 10.1158/0008-5472.CAN-13-0453; Tabach Y, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100030; Zhou DJ, 2005, GENE, V361, P89, DOI 10.1016/j.gene.2005.07.012; ZWICKER J, 1995, EMBO J, V14, P4514, DOI 10.1002/j.1460-2075.1995.tb00130.x	44	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127951	10.1371/journal.pone.0127951	http://dx.doi.org/10.1371/journal.pone.0127951			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039627	Green Published, gold			2022-12-27	WOS:000355700700080
J	Kiran, KC; Rothenberg, ME; Sherrill, JD				Kiran, K. C.; Rothenberg, Marc E.; Sherrill, Joseph D.			In Vitro Model for Studying Esophageal Epithelial Differentiation and Allergic Inflammatory Responses Identifies Keratin Involvement in Eosinophilic Esophagitis	PLOS ONE			English	Article							EPIDERMAL DIFFERENTIATION; INTERMEDIATE-FILAMENTS; GENE-EXPRESSION; RNA-SEQ; IL-13; DESMOSOMES; INTEGRITY; CULTURE; MOUSE; CELLS	Epithelial differentiation is an essential physiological process that imparts mechanical strength and barrier function to squamous epithelia. Perturbation of this process can give rise to numerous human diseases, such as atopic dermatitis, in which antigenic stimuli can penetrate the weakened epithelial barrier to initiate the allergic inflammatory cascade. We recently described a simplified air-liquid interface (ALI) culture system that facilitates the study of differentiated squamous epithelia in vitro. Herein, we use RNA sequencing to define the genome-wide transcriptional changes that occur within the ALI system during epithelial differentiation and in response to allergic inflammation. We identified 2,191 and 781 genes that were significantly altered upon epithelial differentiation or dysregulated in the presence of interleukin 13 (IL-13), respectively. Notably, 286 genes that were modified by IL-13 in the ALI system overlapped with the gene signature present within the inflamed esophageal tissue from patients with eosinophilic esophagitis (EoE), an allergic inflammatory disorder of the esophagus that is characterized by elevated IL-13 levels, altered epithelial differentiation, and pro-inflammatory gene expression. Pathway analysis of these overlapping genes indicated enrichment in keratin genes; for example, the gene encoding keratin 78, an uncharacterized type II keratin, was upregulated during epithelial differentiation (45-fold) yet downregulated in response to IL-13 and in inflamed esophageal tissue from patients. Thus, our findings delineate an in vitro experimental system that models epithelial differentiation that is dynamically regulated by IL-13. Using this system and analyses of patient tissues, we identify an altered expression profile of novel keratin differentiation markers in response to IL-13 and disease activity, substantiating the potential of this combined approach to identify relevant molecular processes that contribute to human allergic inflammatory disease.	[Kiran, K. C.; Rothenberg, Marc E.; Sherrill, Joseph D.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati Childrens Med Ctr,Div Allergy & Immuno, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Sherrill, JD (corresponding author), Procter & Gamble Co, Mason Business Ctr, Mason, OH 45040 USA.	sherrill.jd@pg.com			Thrasher Research Fund Early Career Award [NR-0171]; NIH [P30 DK078392]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	Thrasher Research Fund Early Career Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by the Thrasher Research Fund Early Career Award (NR-0171) (JDS - PI) (https://www.thrasherresearch.org/SitePages/early-career-award.aspx); and the NIH P30 DK078392 Bench to Bedside Research in Pediatric Digestive Disease Pilot and Feasibility Grant (JDS PI) (http://www.cincinnatichildrens.org/research/divisions/d/dhc/default/?utm_source=Digestive% 2BHealth%2BCenter&utm_medium = shortcut&utm_campaign=dhc).	Andl CD, 2003, J BIOL CHEM, V278, P1824, DOI 10.1074/jbc.M209148200; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Blanchard C, 2007, J ALLERGY CLIN IMMUN, V120, P1292, DOI 10.1016/j.jaci.2007.10.024; Blanchard C, 2010, J IMMUNOL, V184, P4033, DOI 10.4049/jimmunol.0903069; Coulombe PA, 2012, J INVEST DERMATOL, V132, P763, DOI 10.1038/jid.2011.450; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gericke J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062643; Gschwandtner M, 2013, ALLERGY, V68, P37, DOI 10.1111/all.12051; Hartman KG, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt366; Hatakeyama S, 2004, J ORAL PATHOL MED, V33, P622, DOI 10.1111/j.1600-0714.2004.00245.x; Jensen JM, 2004, J INVEST DERMATOL, V122, P1423, DOI 10.1111/j.0022-202X.2004.22621.x; Kagalwalla AF, 2012, J ALLERGY CLIN IMMUN, V129, P1387, DOI 10.1016/j.jaci.2012.03.005; Kalabis J, 2012, NAT PROTOC, V7, P235, DOI 10.1038/nprot.2011.437; Kottyan LC, 2014, NAT GENET, V46, P895, DOI 10.1038/ng.3033; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee WH, 2005, J INVEST DERMATOL, V125, P995, DOI 10.1111/j.0022-202X.2005.23887.x; Luo AP, 2004, ONCOGENE, V23, P1291, DOI 10.1038/sj.onc.1207218; Macara IG, 2014, CURR BIOL, V24, pR815, DOI 10.1016/j.cub.2014.06.068; Marenholz I, 1996, GENOMICS, V37, P295, DOI 10.1006/geno.1996.0563; Muir AB, 2013, EXP CELL RES, V319, P850, DOI 10.1016/j.yexcr.2012.12.002; Ness SL, 1998, J BIOL CHEM, V273, P23904, DOI 10.1074/jbc.273.37.23904; Oh JW, 2013, J INVEST DERMATOL, V133, pE14, DOI 10.1038/jid.2013.387; Ohashi S, 2010, GASTROENTEROLOGY, V139, P2113, DOI 10.1053/j.gastro.2010.08.040; Omori-Miyake M, 2014, J INVEST DERMATOL, V134, P1342, DOI 10.1038/jid.2013.503; Ramms L, 2013, P NATL ACAD SCI USA, V110, P18513, DOI 10.1073/pnas.1313491110; Ridge KM, 2005, J BIOL CHEM, V280, P30400, DOI 10.1074/jbc.M504239200; Rochman M, 2015, MUCOSAL IMMUNOL, V8, P785, DOI 10.1038/mi.2014.109; Rogers MA, 2005, J INVEST DERMATOL, V124, P536, DOI 10.1111/j.0022-202X.2004.23530.x; Rothenberg ME, 2015, J ALLERGY CLIN IMMUN, V135, P500, DOI 10.1016/j.jaci.2014.07.049; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Sherrill JD, 2014, GENES IMMUN, V15, P361, DOI 10.1038/gene.2014.27; Sherrill JD, 2014, MUCOSAL IMMUNOL, V7, P718, DOI 10.1038/mi.2013.90; Sherrill JD, 2010, J ALLERGY CLIN IMMUN, V126, P160, DOI 10.1016/j.jaci.2010.04.037; Smith EA, 1998, J CELL BIOL, V141, P1229, DOI 10.1083/jcb.141.5.1229; Stairs DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003534; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Zuo L, 2010, J IMMUNOL, V185, P660, DOI 10.4049/jimmunol.1000471	38	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0127755	10.1371/journal.pone.0127755	http://dx.doi.org/10.1371/journal.pone.0127755			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039063	Green Submitted, Green Published, gold			2022-12-27	WOS:000355700700074
J	Maugg, D; Rothenaigner, I; Schorpp, K; Potukuchi, HK; Korsching, E; Baumhoer, D; Hadian, K; Smida, J; Nathrath, M				Maugg, Doris; Rothenaigner, Ina; Schorpp, Kenji; Potukuchi, Harish Kumar; Korsching, Eberhard; Baumhoer, Daniel; Hadian, Kamyar; Smida, Jan; Nathrath, Michaela			New Small Molecules Targeting Apoptosis and Cell Viability in Osteosarcoma	PLOS ONE			English	Article							BONE-MARROW; LINES; P53; CYTOTOXICITY; CHEMOTHERAPY; DISCOVERY; MEDICINES; NECROSIS; SURVIVAL; SARCOMAS	Despite the option of multimodal therapy in the treatment strategies of osteosarcoma (OS), the most common primary malignant bone tumor, the standard therapy has not changed over the last decades and still involves multidrug chemotherapy and radical surgery. Although successfully applied in many patients a large number of patients eventually develop recurrent or metastatic disease in which current therapeutic regimens often lack efficacy. Thus, new therapeutic strategies are urgently needed. In this study, we performed a phenotypic high-throughput screening campaign using a 25,000 small-molecule diversity library to identify new small molecules selectively targeting osteosarcoma cells. We could identify two new small molecules that specifically reduced cell viability in OS cell lines U2OS and HOS, but affected neither hepatocellular carcinoma cell line (HepG2) nor primary human osteoblasts (hOB). In addition, the two compounds induced caspase 3 and 7 activity in the U2OS cell line. Compared to conventional drugs generally used in OS treatment such as doxorubicin, we indeed observed a greater sensitivity of OS cell viability to the newly identified compounds compared to doxorubicin and staurosporine. The p53-negative OS cell line Saos-2 almost completely lacked sensitivity to compound treatment that could indicate a role of p53 in the drug response. Taken together, our data show potential implications for designing more efficient therapies in OS.	[Maugg, Doris; Baumhoer, Daniel; Smida, Jan; Nathrath, Michaela] Helmholtz Zentrum Munchen, Natl Res Ctr Environm Hlth, Inst Radiat Biol, Clin Cooperat Grp Osteosarcoma, Neuherberg, Germany; [Maugg, Doris; Smida, Jan; Nathrath, Michaela] Tech Univ Munich, Dept Pediat, D-80290 Munich, Germany; [Maugg, Doris; Smida, Jan; Nathrath, Michaela] Tech Univ Munich, Childrens Canc Res Ctr, D-80290 Munich, Germany; [Nathrath, Michaela] Klinikum Kassel, Dept Pediat Oncol, Kassel, Germany; [Rothenaigner, Ina; Schorpp, Kenji; Hadian, Kamyar] Helmholtz Zentrum Munchen, Natl Res Ctr Environm Hlth, Assay Dev & Screening Platform, Inst Mol Toxicol & Pharmacol, Neuherberg, Germany; [Potukuchi, Harish Kumar] Tech Univ Munich, Lehrstuhl Organ Chem 1, Garching, Germany; [Potukuchi, Harish Kumar] Tech Univ Munich, Catalysis Res Ctr, Garching, Germany; [Potukuchi, Harish Kumar] Helmholtz Zentrum Munchen, Natl Res Ctr Environm Hlth, Inst Biol Struct, Neuherberg, Germany; [Korsching, Eberhard] Univ Munster, Inst Bioinformat, D-48149 Munster, Germany; [Baumhoer, Daniel] Univ Basel Hosp, Inst Pathol, Bone Tumor Reference Ctr, CH-4031 Basel, Switzerland	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Klinikum Kassel; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munster; University of Basel	Maugg, D (corresponding author), Helmholtz Zentrum Munchen, Natl Res Ctr Environm Hlth, Inst Radiat Biol, Clin Cooperat Grp Osteosarcoma, Neuherberg, Germany.	doris.maugg@gmx.net	Hadian, Kamyar/B-6314-2013; Smida, Jan/P-2486-2014	Hadian, Kamyar/0000-0001-8727-2575; Smida, Jan/0000-0001-6055-8207	Translational Sarcoma Research Network (TranSarNet) [FKZ 01GM0870, FKZ 01GM0869]; European TRANSCAN I consortium-PROspective VAlidation of Biomarkers in Ewing Sarcoma for personalized translational medicine [FZK 01KT1310]; Bundesministerium fur Bildung und Forschung; Helmholtz Zentrum Munchen	Translational Sarcoma Research Network (TranSarNet); European TRANSCAN I consortium-PROspective VAlidation of Biomarkers in Ewing Sarcoma for personalized translational medicine; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Helmholtz Zentrum Munchen(Helmholtz Association)	This work was funded by the Translational Sarcoma Research Network (TranSarNet) FKZ 01GM0870 to JS, MN, DM, and FKZ 01GM0869 to EK, and by the European TRANSCAN I consortium-PROspective VAlidation of Biomarkers in Ewing Sarcoma for personalized translational medicine FZK 01KT1310 to EK. All authors were supported by the Bundesministerium fur Bildung und Forschung. Financial support to HKP from Helmholtz Zentrum Munchen is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham VC, 2008, J BIOMOL SCREEN, V13, P527, DOI 10.1177/1087057108318428; Baumhoer D, 2012, CANCER GENET-NY, V205, P212, DOI 10.1016/j.cancergen.2012.03.001; Bayani J, 2003, GENE CHROMOSOME CANC, V36, P7, DOI 10.1002/gcc.10132; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bielack SS, 2009, J CLIN ONCOL, V27, P557, DOI 10.1200/JCO.2008.16.2305; Botter SM, 2014, CURR OPIN PHARMACOL, V16, P15, DOI 10.1016/j.coph.2014.02.002; Calvert RJ, 2013, IN VITRO CELL DEV-AN, V49, P95, DOI 10.1007/s11626-012-9573-1; Cao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106249; Carmody LC, 2012, J BIOMOL SCREEN, V17, P1204, DOI 10.1177/1087057112458317; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Chipoy C, 2007, ONCOGENE, V26, P6653, DOI 10.1038/sj.onc.1210492; Conrad C, 2008, STEM CELLS DEV, V17, P23, DOI 10.1089/scd.2007.0159; De Boer JP, 2012, ONCOTARGET, V3, P1169; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Ferrari S, 2007, CURR OPIN ONCOL, V19, P341, DOI 10.1097/CCO.0b013e328122d73f; Fleuren EDG, 2014, BBA-REV CANCER, V1845, P266, DOI 10.1016/j.bbcan.2014.02.005; FLORENES VA, 1994, J NATL CANCER I, V86, P1297, DOI 10.1093/jnci/86.17.1297; Fulda S, 2013, CANCER LETT, V332, P369, DOI 10.1016/j.canlet.2010.10.003; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Guerzoni C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-137; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; Khanna C, 2014, CLIN CANCER RES, V20, P4200, DOI 10.1158/1078-0432.CCR-13-2574; Koul D, 2012, CLIN CANCER RES, V18, P184, DOI 10.1158/1078-0432.CCR-11-1558; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Ma D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028780; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; Manara MC, 2010, CLIN CANCER RES, V16, P530, DOI 10.1158/1078-0432.CCR-09-0816; Meyers PA, 2008, J CLIN ONCOL, V26, P633, DOI 10.1200/JCO.2008.14.0095; Mohseny AB, 2009, J PATHOL, V219, P294, DOI 10.1002/path.2603; Niles AL, 2015, METHODS MOL BIOL, V1219, P21, DOI 10.1007/978-1-4939-1661-0_3; Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Ottaviano L, 2010, GENE CHROMOSOME CANC, V49, P40, DOI 10.1002/gcc.20717; Overholtzer M, 2003, P NATL ACAD SCI USA, V100, P11547, DOI 10.1073/pnas.1934852100; Perry JA, 2014, P NATL ACAD SCI US; Poos K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003210; Ribi S, 2015, ONCOTARGET; Sampson VB, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00132; Schorpp K, 2014, J BIOMOL SCREEN, V19, P715, DOI 10.1177/1087057113516861; Sebaugh JL, 2011, PHARM STAT, V10, P128, DOI 10.1002/pst.426; Shimizu T, 2014, CANCER RES, V74, P6531, DOI 10.1158/0008-5472.CAN-14-0914; Silva MT, 2010, FEBS LETT, V584, P4491, DOI 10.1016/j.febslet.2010.10.046; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Subramaniam M, 2002, J CELL BIOCHEM, V87, P9, DOI 10.1002/jcb.10259; Swinney DC, 2013, J BIOMOL SCREEN, V18, P1186, DOI 10.1177/1087057113501199; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Tacar O, 2014, J PHARM PHARM; THALMEIER K, 1994, BLOOD, V83, P1799; Van Maerken T, 2014, CANCER LETT, V344, P157, DOI 10.1016/j.canlet.2013.11.002; van Maldegem AM, 2012, CLIN SARCOMA RES, V2, DOI 10.1186/2045-3329-2-5; Wan XL, 2005, CANCER RES, V65, P2406, DOI 10.1158/0008-5472.CAN-04-3135; Wawer MJ, 2014, P NATL ACAD SCI USA, V111, P10911, DOI 10.1073/pnas.1410933111; Yen ML, 2007, STEM CELLS, V25, P125, DOI 10.1634/stemcells.2006-0295; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	54	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0129058	10.1371/journal.pone.0129058	http://dx.doi.org/10.1371/journal.pone.0129058			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039064	gold, Green Submitted, Green Published			2022-12-27	WOS:000355700700140
J	Pendrak, ML; Roberts, DD				Pendrak, Michael L.; Roberts, David D.			Hbr1 Activates and Represses Hyphal Growth in Candida albicans and Regulates Fungal Morphogenesis under Embedded Conditions	PLOS ONE			English	Article							INVASIVE FILAMENTOUS GROWTH; TRANSCRIPTION FACTOR; GENE DISRUPTION; PESCADILLO HOMOLOG; ADENYLYL-CYCLASE; IN-VIVO; YEAST; VIRULENCE; PROTEINS; METABOLISM	Transitions between yeast and hyphae are essential for Candida albicans pathogenesis. The genetic programs that regulate its hyphal development can be distinguished by embedded versus aerobic surface agar invasion. Hbr1, a regulator of white-opaque switching, is also a positive and negative regulator of hyphal invasion. During embedded growth at 24 degrees C, an HBR1/hbr1 strain formed constitutively filamentous colonies throughout the matrix, resembling EFG1 null colonies, and a subset of long unbranched hyphal aggregates enclosed in a spindle-shaped capsule. Inhibition of adenylate cyclase with farnesol perturbed the filamentation of HBR1/hbr1 cells producing cytokinesis-defective hyphae whereas farnesol treated EFG1 null cells produced abundant opaque-like cells. Point mutations in the Hbr1 ATP-binding domain caused distinct filamentation phenotypes including uniform radial hyphae, hyphal sprouts, and massive yeast cell production. Conversely, aerobic surface colonies of the HBR1 heterozygote on Spider and GlcNAc media lacked filamentation that could be rescued by growth under low (5%) O-2. Consistent with these morphogenesis defects, the HBR1 heterozygote exhibited attenuated virulence in a mouse candidemia model. These data define Hbr1 as an ATP-dependent positive and negative regulator of hyphal development that is sensitive to hypoxia.	[Pendrak, Michael L.; Roberts, David D.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pendrak, ML (corresponding author), NCI, Pathol Lab, Ctr Canc Res, NIH, 10 Ctr Dr,Bldg 10,Room 2A33, Bethesda, MD 20892 USA.	pendrakm@mail.nih.gov; droberts@helix.nih.gov	Roberts, David D./A-9699-2008	Roberts, David D./0000-0002-2481-2981	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIASC009173] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research.	Bennett RJ, 2005, ANNU REV MICROBIOL, V59, P233, DOI 10.1146/annurev.micro.59.030804.121310; Blankenship JR, 2006, CURR OPIN MICROBIOL, V9, P588, DOI 10.1016/j.mib.2006.10.003; Brand Alexandra, 2012, Int J Microbiol, V2012, P517529, DOI 10.1155/2012/517529; Brown DH, 1999, MOL MICROBIOL, V34, P651, DOI 10.1046/j.1365-2958.1999.01619.x; Cao F, 2006, MOL BIOL CELL, V17, P295, DOI 10.1091/mbc.E05-06-0502; Csank C, 1997, MOL BIOL CELL, V8, P2539, DOI 10.1091/mbc.8.12.2539; Csank C, 1998, INFECT IMMUN, V66, P2713, DOI 10.1128/IAI.66.6.2713-2721.1998; Davis D, 2000, INFECT IMMUN, V68, P5953, DOI 10.1128/IAI.68.10.5953-5959.2000; Davis-Hanna A, 2008, MOL MICROBIOL, V67, P47, DOI 10.1111/j.1365-2958.2007.06013.x; Dennison PMJ, 2005, FUNGAL GENET BIOL, V42, P737, DOI 10.1016/j.fgb.2005.05.006; Doedt T, 2004, MOL BIOL CELL, V15, P3167, DOI 10.1091/mbc.E03-11-0782; Douglas LM, 2013, MBIO, V4, DOI 10.1128/mBio.00723-13; Drakou CE, 2012, PROTEINS, V80, P206, DOI 10.1002/prot.23186; Dumitru R, 2007, EUKARYOT CELL, V6, P465, DOI 10.1128/EC.00316-06; Elson SL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000664; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Giusani AD, 2002, GENETICS, V160, P1749; Granneman S, 2005, MOL CELL BIOL, V25, P10352, DOI 10.1128/MCB.25.23.10352-10364.2005; Guthrie C, 1991, METHODS ENZYMOLOGY, V194; Hall RA, 2011, EUKARYOT CELL, V10, P1034, DOI 10.1128/EC.05060-11; Hall RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001193; Hogan DA, 2011, CURR OPIN MICROBIOL, V14, P682, DOI 10.1016/j.mib.2011.09.014; Hope H, 2008, MOL BIOL CELL, V19, P3638, DOI 10.1091/mbc.E07-12-1272; Hornby JM, 2001, APPL ENVIRON MICROB, V67, P2982, DOI 10.1128/AEM.67.7.2982-2992.2001; Klengel T, 2005, CURR BIOL, V15, P2021, DOI 10.1016/j.cub.2005.10.040; Lindsay AK, 2012, EUKARYOT CELL, V11, P1219, DOI 10.1128/EC.00144-12; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lu Y, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001105; MacCallum DM, 2005, MYCOSES, V48, P151, DOI 10.1111/j.1439-0507.2005.01121.x; Mao XM, 2008, FEMS MICROBIOL LETT, V285, P233, DOI 10.1111/j.1574-6968.2008.01236.x; Mao XM, 2006, FEBS LETT, V580, P2615, DOI 10.1016/j.febslet.2006.04.009; Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913; Miwa T, 2004, EUKARYOT CELL, V3, P919, DOI 10.1128/EC.3.4.919-931.2004; Moore D., 1995, GROWING FUNGUS, P423; Mulhern SM, 2006, EUKARYOT CELL, V5, P2001, DOI 10.1128/EC.00155-06; Pendrak ML, 2007, MED MYCOL, V45, P157, DOI 10.1080/13693780601164314; Pendrak ML, 2004, EUKARYOT CELL, V3, P764, DOI 10.1128/EC.3.3.764-775.2004; Peterson AW, 2011, J BIOL CHEM, V286, P13914, DOI 10.1074/jbc.M110.180190; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P732; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Santama N, 2005, J BIOL CHEM, V280, P36429, DOI 10.1074/jbc.M501982200; Saputo S, 2014, EUKARYOT CELL, V7, P00148; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Shen JQ, 2008, P NATL ACAD SCI USA, V105, P20918, DOI 10.1073/pnas.0809147105; SIMONETTI N, 1974, NATURE, V250, P344, DOI 10.1038/250344a0; Sonneborn A, 1999, INFECT IMMUN, V67, P4655, DOI 10.1128/IAI.67.9.4655-4660.1999; Srikantha T, 2000, J BACTERIOL, V182, P1580, DOI 10.1128/JB.182.6.1580-1591.2000; Staniszewska M, 2013, BRAZ J MICROBIOL, V44, P813, DOI 10.1590/S1517-83822013005000056; Stichternoth C, 2009, APPL ENVIRON MICROB, V75, P3663, DOI 10.1128/AEM.00098-09; Strunk BS, 2012, CELL, V150, P111, DOI 10.1016/j.cell.2012.04.044; Su C, 2009, EUKARYOT CELL, V8, P1780, DOI 10.1128/EC.00190-09; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Uppuluri P, 2012, EUKARYOT CELL, V11, P1552, DOI 10.1128/EC.00171-12; Uppuluri P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000828; Uversky VN, 2013, BIOPOLYMERS, V99, P870, DOI 10.1002/bip.22298; Uversky Vladimir N, 2013, F1000 Biol Rep, V5, P1, DOI 10.3410/B5-1; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Wang A, 2009, MOL CELL BIOL, V29, P4406, DOI 10.1128/MCB.01502-08; Wightman R, 2004, J CELL BIOL, V164, P581, DOI 10.1083/jcb.200307176; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999	65	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0126919	10.1371/journal.pone.0126919	http://dx.doi.org/10.1371/journal.pone.0126919			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039220	gold, Green Submitted, Green Published			2022-12-27	WOS:000355700700043
J	Shah, P; Baylis, K				Shah, Payal; Baylis, Kathy			Evaluating Heterogeneous Conservation Effects of Forest Protection in Indonesia	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; COSTA-RICA; DEFORESTATION; AREAS; POVERTY; KALIMANTAN; EMISSIONS; PAYMENTS; SUMATRA; IMPACT	Establishing legal protection for forest areas is the most common policy used to limit forest loss. This article evaluates the effectiveness of seven Indonesian forest protected areas introduced between 1999 and 2012. Specifically, we explore how the effectiveness of these parks varies over space. Protected areas have mixed success in preserving forest, and it is important for conservationists to understand where they work and where they do not. Observed differences in the estimated treatment effect of protection may be driven by several factors. Indonesia is particularly diverse, with the landscape, forest and forest threats varying greatly from region to region, and this diversity may drive differences in the effectiveness of protected areas in conserving forest. However, the observed variation may also be spurious and arise from differing degrees of bias in the estimated treatment effect over space. In this paper, we use a difference-in-differences approach comparing treated observations and matched controls to estimate the effect of each protected area. We then distinguish the true variation in protected area effectiveness from spurious variation driven by several sources of estimation bias. Based on our most flexible method that allows the data generating process to vary across space, we find that the national average effect of protection preserves an additional 1.1% of forest cover; however the effect of individual parks range from a decrease of 3.4% to an increase of 5.3% and the effect of most parks differ from the national average. Potential biases may affect estimates in two parks, but results consistently show Sebangau National Park is more effective while two parks are substantially less able to protect forest cover than the national average.	[Shah, Payal] Grad Univ, Okinawa Inst Sci & Technol, Onna Son, Okinawa, Japan; [Baylis, Kathy] Univ Illinois, Dept Agr & Consumer Econ, Champaign, IL USA	Okinawa Institute of Science & Technology Graduate University; University of Illinois System; University of Illinois Urbana-Champaign	Shah, P (corresponding author), Grad Univ, Okinawa Inst Sci & Technol, Onna Son, Okinawa, Japan.	paya.shah@oist.jp	Shah, Payal/G-2933-2015	Shah, Payal/0000-0002-9349-4614				Alix-Garcia J, 2007, J ENVIRON ECON MANAG, V53, P141, DOI 10.1016/j.jeem.2006.09.004; Alix-Garcia JM, 2012, LAND ECON, V88, P613, DOI 10.3368/le.88.4.613; Alix-Garcia JM, 2010, WORKING PAPER; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Andam KS, 2010, P NATL ACAD SCI USA, V107, P9996, DOI 10.1073/pnas.0914177107; Angelsen A, 1999, WORLD BANK RES OBSER, V14, P73, DOI 10.1093/wbro/14.1.73; Anselin L, 2002, AGR ECON-BLACKWELL, V27, P247, DOI 10.1111/j.1574-0862.2002.tb00120.x; Atmadja S, 2010, REDD FOREST GOVERNAN, P73; Baylis K, 2015, ALL SOC SCI ANN M JA; Burgess R, 2011, W17417 NAT BUR EC RE; Busch J, 2010, OPEN SOURCE IMPACTS; Busch J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034028; Busch J, 2012, P NATL ACAD SCI USA, V109, P1062, DOI 10.1073/pnas.1109034109; Cannon CH, 2007, BIOTROPICA, V39, P747, DOI 10.1111/j.1744-7429.2007.00323.x; Carlson KM, 2012, P NATL ACAD SCI USA, V109, P7559, DOI 10.1073/pnas.1200452109; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Ferraro P., 2009, ENV PROGRAM POLICY E, P75, DOI [10.1002/ev.297, DOI 10.1002/EV.297]; Ferraro PJ, 2011, P NATL ACAD SCI USA, V108, P13913, DOI 10.1073/pnas.1011529108; Ferraro PJ, 2011, ENVIRON RESOUR ECON, V48, P269, DOI 10.1007/s10640-010-9408-z; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Fuller DO, 2004, CONSERV BIOL, V18, P249, DOI 10.1111/j.1523-1739.2004.00018.x; Fuller DO, 2011, ENVIRON MANAGE, V48, P436, DOI 10.1007/s00267-011-9643-2; Gaveau D, 2012, ARD LEARNING EXCHANG; Gaveau DLA, 2012, CONSERV LETT, V5, P142, DOI 10.1111/j.1755-263X.2011.00220.x; Gaveau DLA, 2007, BIOL CONSERV, V134, P495, DOI 10.1016/j.biocon.2006.08.035; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Haruna A, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/035007; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Ho DE, 2009, J STAT SOFTW, V42, P1; Honey-Roses J, 2011, CONSERV BIOL, V25, P1032, DOI 10.1111/j.1523-1739.2011.01729.x; Imbens G, 2009, LECT NOTES; Irawan DE, 2006, P IAEG C; Ishii A, 2007, THESIS DUKE U; IUCN and UNEP-WCMC, 2011, WORLD DAT PROT AR WD; Jacoby WG, 2000, ELECT STUD, V19, P577, DOI 10.1016/S0261-3794(99)00028-1; Jepson P, 2001, SCIENCE, V292, P859, DOI 10.1126/science.1061727; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P1633, DOI 10.1098/rspb.2010.1713; Kinnaird MF, 2003, CONSERV BIOL, V17, P245, DOI 10.1046/j.1523-1739.2003.02040.x; Levang P, 2012, CONSERV SOC, V10, P243, DOI 10.4103/0972-4923.101838; Linkie M, 2008, CONSERV BIOL, V22, P683, DOI 10.1111/j.1523-1739.2008.00906.x; Linkie M, 2007, BIOL CONSERV, V137, P20, DOI 10.1016/j.biocon.2007.01.016; Lorena RB, 2009, APPL GEOGR, V29, P171, DOI 10.1016/j.apgeog.2008.09.003; Margono B. A., 2014, NATURE CLIMATE CHANG; McMillen D, 2015, J REGIONAL SCI, V55, P391, DOI 10.1111/jors.12174; Mertens B, 2000, ANN ASSOC AM GEOGR, V90, P467, DOI 10.1111/0004-5608.00205; Nelson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022722; Olsen N, 2008, FINANCIAL COSTS REDD; Page SE., 2007, PEATLANDS INT, V2, P26; Pagiola S., 2000, LAND USE CHANGE INDO; Pfaff A, 2014, AGR APPL EC ASS ANN; Pfaff A, 2014, WORLD DEV, V55, P7, DOI 10.1016/j.worlddev.2013.01.011; Pfaff A, 2013, REV ENV ECON POLICY, V7, P114, DOI 10.1093/reep/res023; Pfaff A, 2012, OXFORD REV ECON POL, V28, P164, DOI 10.1093/oxrep/grs012; Pfaff A, 2009, BE J ECON ANAL POLI, V9, DOI 10.2202/1935-1682.1990; Rhee S, 2004, REPORT BIODIVERSITY; Riswan SW, 2011, ORANGUTAN EC SUSTAIN; Rosenbaum P.R., 2002, SENSITIVITY HIDDEN B; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sanchez-Azofeifa GA, 2007, CONSERV BIOL, V21, P1165, DOI 10.1111/j.1523-1739.2007.00751.x; Schwarze S., 2009, STORMA DISCUSSION PA; Sekhon JS, 2007, J STAT SOFTWARE, V42; Sims KRE, 2010, J ENVIRON ECON MANAG, V60, P94, DOI 10.1016/j.jeem.2010.05.003; Sunderlin WD, 1996, 9E CIFOR, DOI 10.17528/cifor/000056; Vetter J., 2009, THESIS DUKE U; WARDOJO W., 2002, POLICY TREND REPORT, P77; Wheeler D, 2012, CENTER FOR GLOBAL DE, V294; WWF-Indonesia Palming off a national park, 2013, TRACK ILL OIL PALM F	69	21	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0124872	10.1371/journal.pone.0124872	http://dx.doi.org/10.1371/journal.pone.0124872			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	26039754	Green Published, gold			2022-12-27	WOS:000355700700005
